id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
8070016|NCT04646109|19897182|P2|NOT COMPLETED|Overall Study||6
8070017|NCT04646109|19897183|P1|NOT COMPLETED|Overall Study||0
8070018|NCT04646109|19897182|P2|COMPLETED|Overall Study||30
8070019|NCT04646109|19897183|P1|COMPLETED|Overall Study||30
8070020|NCT04646109|19897182|P2|STARTED|Overall Study||36
8070021|NCT04646109|19897183|P1|STARTED|Overall Study||30
8070022|NCT04608500|19897244|P2|NOT COMPLETED|Overall Study||18
8070023|NCT04608500|19897245|P1|NOT COMPLETED|Overall Study||35
8070024|NCT04608500|19897244|P2|COMPLETED|Overall Study||239
8070025|NCT04608500|19897245|P1|COMPLETED|Overall Study||479
8070026|NCT04608500|19897244|P2|STARTED|Overall Study||257
8070027|NCT04608500|19897245|P1|STARTED|Overall Study||514
8070028|NCT04578496|19897263|P1|NOT COMPLETED|Overall Study||4
8070029|NCT04578496|19897263|P1|COMPLETED|Overall Study||12
8070030|NCT04578496|19897263|P1|STARTED|Overall Study||16
8070031|NCT04574999|19897270|P2|NOT COMPLETED|Overall Study||5
8070032|NCT04574999|19897271|P1|NOT COMPLETED|Overall Study||9
8070033|NCT04574999|19897270|P2|COMPLETED|Overall Study||48
8070034|NCT04574999|19897271|P1|COMPLETED|Overall Study||105
8070035|NCT04574999|19897270|P2|STARTED|Overall Study||53
8070036|NCT04574999|19897271|P1|STARTED|Overall Study||114
8070037|NCT04555525|19897289|P2|NOT COMPLETED|Overall Study||0
8070038|NCT04555525|19897290|P1|NOT COMPLETED|Overall Study||3
8070039|NCT04555525|19897289|P2|COMPLETED|Overall Study||25
8070040|NCT04555525|19897290|P1|COMPLETED|Overall Study||72
8070041|NCT04555525|19897289|P2|STARTED|Overall Study||25
8070042|NCT04555525|19897290|P1|STARTED|Overall Study||75
8070043|NCT04553497|19897308|P2|NOT COMPLETED|Overall Study||1
8070044|NCT04553497|19897309|P1|NOT COMPLETED|Overall Study||2
8070045|NCT04553497|19897308|P2|COMPLETED|Overall Study||17
8070046|NCT04553497|19897309|P1|COMPLETED|Overall Study||15
8070047|NCT04553497|19897308|P2|STARTED|Overall Study||18
8070048|NCT04553497|19897309|P1|STARTED|Overall Study||17
8070049|NCT04548622|19897319|P1|NOT COMPLETED|Overall Study||0
8070050|NCT04548622|19897319|P1|COMPLETED|Overall Study||15
8070051|NCT04548622|19897319|P1|STARTED|Overall Study||15
8070052|NCT04542694|19897327|P2|NOT COMPLETED|Overall Study||0
8070053|NCT04542694|19897328|P1|NOT COMPLETED|Overall Study||4
8070054|NCT04542694|19897327|P2|COMPLETED|Overall Study||100
8070055|NCT04542694|19897328|P1|COMPLETED|Overall Study||96
8070056|NCT04542694|19897327|P2|STARTED|Overall Study||100
8070057|NCT04542694|19897328|P1|STARTED|Overall Study||100
8070058|NCT04542226|19897356|P1|NOT COMPLETED|Overall Study||0
8070059|NCT04542226|19897356|P1|COMPLETED|Overall Study||81
8070060|NCT04542226|19897356|P1|STARTED|Overall Study||81
8070061|NCT04534491|19897368|P1|NOT COMPLETED|Overall Study||152
8070062|NCT04534491|19897368|P1|COMPLETED|Overall Study||703
8070063|NCT04534491|19897368|P1|Treated|Overall Study||727
8070064|NCT04534491|19897368|P1|STARTED|Overall Study||855
8070065|NCT04534465|19897377|P5|NOT COMPLETED|Overall Study||0
8070066|NCT04534465|19897378|P4|NOT COMPLETED|Overall Study||0
8070067|NCT04534465|19897379|P3|NOT COMPLETED|Overall Study||0
8070068|NCT04534465|19897380|P2|NOT COMPLETED|Overall Study||0
8070069|NCT04534465|19897381|P1|NOT COMPLETED|Overall Study||0
8070070|NCT04534465|19897377|P5|COMPLETED|Overall Study||10
8070071|NCT04534465|19897378|P4|COMPLETED|Overall Study||10
8070072|NCT04534465|19897379|P3|COMPLETED|Overall Study||10
8070073|NCT04534465|19897380|P2|COMPLETED|Overall Study||10
8070074|NCT04534465|19897381|P1|COMPLETED|Overall Study||10
8070075|NCT04534465|19897377|P5|STARTED|Overall Study||10
8070076|NCT04534465|19897378|P4|STARTED|Overall Study||10
8070077|NCT04534465|19897379|P3|STARTED|Overall Study||10
8070078|NCT04534465|19897380|P2|STARTED|Overall Study||10
8070079|NCT04534465|19897381|P1|STARTED|Overall Study||10
8070080|NCT04532164|19897463|P1|NOT COMPLETED|Overall Study||24
8070081|NCT04532164|19897463|P1|COMPLETED|Overall Study||113
8070082|NCT04532164|19897463|P1|Treated|Overall Study||132
8070083|NCT04532164|19897463|P1|STARTED|Overall Study||137
8070084|NCT04531813|19897474|P1|NOT COMPLETED|Overall Study||2
8070085|NCT04531813|19897474|P1|COMPLETED|Overall Study||30
8070086|NCT04531813|19897474|P1|Treated|Overall Study||31
8070087|NCT04531813|19897474|P1|STARTED|Overall Study||32
8070088|NCT04531540|19897478|P1|NOT COMPLETED|Overall Study||9
8070089|NCT04531540|19897478|P1|COMPLETED|Overall Study||216
8070090|NCT04531540|19897478|P1|Treated|Overall Study||222
8070091|NCT04531540|19897478|P1|STARTED|Overall Study||225
8070092|NCT04531527|19897485|P1|NOT COMPLETED|Overall Study||3
8070093|NCT04531527|19897485|P1|COMPLETED|Overall Study||29
8070094|NCT04531527|19897485|P1|Treated|Overall Study||29
8070095|NCT04531527|19897485|P1|STARTED|Overall Study||32
8070096|NCT04523831|19897492|P2|NOT COMPLETED|Overall Study||20
8070097|NCT04523831|19897493|P1|NOT COMPLETED|Overall Study||17
8070098|NCT04523831|19897492|P2|COMPLETED|Overall Study||180
8070099|NCT04523831|19897493|P1|COMPLETED|Overall Study||183
8070100|NCT04523831|19897492|P2|STARTED|Overall Study||200
8070101|NCT04523831|19897493|P1|STARTED|Overall Study||200
8070105|NCT04512482|19897516|P2|NOT COMPLETED|Second Intervention (1 Day)||1
8070106|NCT04512482|19897517|P1|NOT COMPLETED|Second Intervention (1 Day)||2
8070107|NCT04512482|19897516|P2|COMPLETED|Second Intervention (1 Day)||20
8070108|NCT04512482|19897517|P1|COMPLETED|Second Intervention (1 Day)||22
8070109|NCT04512482|19897516|P2|Post-Waterpik Photographs|Second Intervention (1 Day)||20
8070110|NCT04512482|19897517|P1|Post-Waterpik Photographs|Second Intervention (1 Day)||22
8070111|NCT04512482|19897516|P2|Waterpik Utilization|Second Intervention (1 Day)||20
8070112|NCT04512482|19897517|P1|Waterpik Utilization|Second Intervention (1 Day)||22
8070113|NCT04512482|19897516|P2|Post-toothbrush Photographs|Second Intervention (1 Day)||20
8070114|NCT04512482|19897517|P1|Post-toothbrush Photographs|Second Intervention (1 Day)||22
8070115|NCT04512482|19897516|P2|Toothbrush Utilization|Second Intervention (1 Day)||20
8070116|NCT04512482|19897517|P1|Toothbrush Utilization|Second Intervention (1 Day)||22
8070117|NCT04512482|19897516|P2|Post-rinse Photographs|Second Intervention (1 Day)||20
8070118|NCT04512482|19897517|P1|Post-rinse Photographs|Second Intervention (1 Day)||22
8070119|NCT04512482|19897516|P2|Received Intervention|Second Intervention (1 Day)||20
8070120|NCT04512482|19897517|P1|Received Intervention|Second Intervention (1 Day)||22
8070121|NCT04512482|19897516|P2|Baseline Photographs|Second Intervention (1 Day)||20
8070122|NCT04512482|19897517|P1|Baseline Photographs|Second Intervention (1 Day)||22
8070123|NCT04512482|19897516|P2|Baseline Plaque Assessment|Second Intervention (1 Day)||20
8070124|NCT04512482|19897517|P1|Baseline Plaque Assessment|Second Intervention (1 Day)||22
8070125|NCT04512482|19897516|P2|STARTED|Second Intervention (1 Day)||21
8070126|NCT04512482|19897517|P1|STARTED|Second Intervention (1 Day)||24
8070127|NCT04512482|19897516|P2|NOT COMPLETED|Washout (1 Week)||0
8070128|NCT04512482|19897517|P1|NOT COMPLETED|Washout (1 Week)||0
8070129|NCT04512482|19897516|P2|COMPLETED|Washout (1 Week)||21
8070130|NCT04512482|19897517|P1|COMPLETED|Washout (1 Week)||24
8070131|NCT04512482|19897516|P2|STARTED|Washout (1 Week)||21
8070132|NCT04512482|19897517|P1|STARTED|Washout (1 Week)||24
8070133|NCT04512482|19897516|P2|NOT COMPLETED|First Intervention (1 Day)||0
8070134|NCT04512482|19897517|P1|NOT COMPLETED|First Intervention (1 Day)||0
8070135|NCT04512482|19897516|P2|COMPLETED|First Intervention (1 Day)||21
8070136|NCT04512482|19897517|P1|COMPLETED|First Intervention (1 Day)||24
8070137|NCT04512482|19897516|P2|Post-Waterpik Photographs|First Intervention (1 Day)||21
8070138|NCT04512482|19897517|P1|Post-Waterpik Photographs|First Intervention (1 Day)||24
8070139|NCT04512482|19897516|P2|Waterpik Utilization|First Intervention (1 Day)||21
8070140|NCT04512482|19897517|P1|Waterpik Utilization|First Intervention (1 Day)||24
8070141|NCT04512482|19897516|P2|Post-toothbrush Photographs|First Intervention (1 Day)||21
8070142|NCT04512482|19897517|P1|Post-toothbrush Photographs|First Intervention (1 Day)||24
8070143|NCT04512482|19897516|P2|Toothbrush Utilization|First Intervention (1 Day)||21
8070144|NCT04512482|19897517|P1|Toothbrush Utilization|First Intervention (1 Day)||24
8070145|NCT04512482|19897516|P2|Post-rinse Photographs|First Intervention (1 Day)||21
8070146|NCT04512482|19897517|P1|Post-rinse Photographs|First Intervention (1 Day)||24
8070147|NCT04512482|19897516|P2|Received Rinse Intervention|First Intervention (1 Day)||21
8070148|NCT04512482|19897517|P1|Received Rinse Intervention|First Intervention (1 Day)||24
8070149|NCT04512482|19897516|P2|Baseline Photographs|First Intervention (1 Day)||21
8070150|NCT04512482|19897517|P1|Baseline Photographs|First Intervention (1 Day)||24
8070151|NCT04512482|19897516|P2|Baseline Plaque Assessment|First Intervention (1 Day)||21
8070152|NCT04512482|19897517|P1|Baseline Plaque Assessment|First Intervention (1 Day)||24
8070153|NCT04512482|19897516|P2|STARTED|First Intervention (1 Day)||21
8070154|NCT04512482|19897517|P1|STARTED|First Intervention (1 Day)||24
8070155|NCT04502979|19897525|P2|NOT COMPLETED|Overall Study||4
8070156|NCT04502979|19897526|P1|NOT COMPLETED|Overall Study||3
8070157|NCT04502979|19897525|P2|COMPLETED|Overall Study||30
8070158|NCT04502979|19897526|P1|COMPLETED|Overall Study||34
8070159|NCT04502979|19897525|P2|STARTED|Overall Study||34
8070160|NCT04502979|19897526|P1|STARTED|Overall Study||37
8070161|NCT04495712|19897536|P2|NOT COMPLETED|Overall Study||0
8070162|NCT04495712|19897537|P1|NOT COMPLETED|Overall Study||0
8070163|NCT04495712|19897536|P2|COMPLETED|Overall Study||46
8070164|NCT04495712|19897537|P1|COMPLETED|Overall Study||44
8070165|NCT04495712|19897536|P2|STARTED|Overall Study||46
8070166|NCT04495712|19897537|P1|STARTED|Overall Study||44
8070167|NCT04491994|19897555|P2|NOT COMPLETED|Overall Study||11
8070168|NCT04491994|19897556|P1|NOT COMPLETED|Overall Study||29
8070169|NCT04491994|19897555|P2|COMPLETED|Overall Study||349
8070170|NCT04491994|19897556|P1|COMPLETED|Overall Study||151
8070171|NCT04491994|19897555|P2|STARTED|Overall Study||360
8070172|NCT04491994|19897556|P1|STARTED|Overall Study||180
8070173|NCT04491240|19897565|P3|NOT COMPLETED|Overall Study||0
8070174|NCT04491240|19897566|P2|NOT COMPLETED|Overall Study||0
8070175|NCT04491240|19897567|P1|NOT COMPLETED|Overall Study||0
8070176|NCT04491240|19897565|P3|COMPLETED|Overall Study||10
8070177|NCT04491240|19897566|P2|COMPLETED|Overall Study||10
8070178|NCT04491240|19897567|P1|COMPLETED|Overall Study||10
8070179|NCT04491240|19897565|P3|STARTED|Overall Study||10
8070180|NCT04491240|19897566|P2|STARTED|Overall Study||10
8070181|NCT04491240|19897567|P1|STARTED|Overall Study||10
8070182|NCT04483011|19897592|P2|NOT COMPLETED|Intervention Period 2 (8 Days)||0
8070183|NCT04483011|19897593|P1|NOT COMPLETED|Intervention Period 2 (8 Days)||0
8070184|NCT04483011|19897592|P2|COMPLETED|Intervention Period 2 (8 Days)||8
8070185|NCT04483011|19897593|P1|COMPLETED|Intervention Period 2 (8 Days)||9
8070186|NCT04483011|19897592|P2|STARTED|Intervention Period 2 (8 Days)||8
8070187|NCT04483011|19897593|P1|STARTED|Intervention Period 2 (8 Days)||9
8070188|NCT04483011|19897592|P2|NOT COMPLETED|Washout (7 Days)||1
8070189|NCT04483011|19897593|P1|NOT COMPLETED|Washout (7 Days)||0
8070190|NCT04483011|19897592|P2|COMPLETED|Washout (7 Days)||8
8070191|NCT04483011|19897593|P1|COMPLETED|Washout (7 Days)||9
8070192|NCT04483011|19897592|P2|STARTED|Washout (7 Days)||9
8070193|NCT04483011|19897593|P1|STARTED|Washout (7 Days)||9
8070194|NCT04483011|19897592|P2|NOT COMPLETED|Intervention Period 1 (8 Days)||0
8070195|NCT04483011|19897593|P1|NOT COMPLETED|Intervention Period 1 (8 Days)||0
8070196|NCT04483011|19897592|P2|COMPLETED|Intervention Period 1 (8 Days)||9
8070197|NCT04483011|19897593|P1|COMPLETED|Intervention Period 1 (8 Days)||9
8070198|NCT04483011|19897592|P2|STARTED|Intervention Period 1 (8 Days)||9
8070199|NCT04483011|19897593|P1|STARTED|Intervention Period 1 (8 Days)||9
8070200|NCT04474405|19897627|P6|NOT COMPLETED|Overall Study||0
8070201|NCT04474405|19897628|P5|NOT COMPLETED|Overall Study||4
8070202|NCT04474405|19897629|P4|NOT COMPLETED|Overall Study||0
8070203|NCT04474405|19897630|P3|NOT COMPLETED|Overall Study||1
8070204|NCT04474405|19897631|P2|NOT COMPLETED|Overall Study||0
8070205|NCT04474405|19897632|P1|NOT COMPLETED|Overall Study||0
8070206|NCT04474405|19897627|P6|COMPLETED|Overall Study||7
8070207|NCT04474405|19897628|P5|COMPLETED|Overall Study||9
8070208|NCT04474405|19897629|P4|COMPLETED|Overall Study||4
8070209|NCT04474405|19897630|P3|COMPLETED|Overall Study||4
8070210|NCT04474405|19897631|P2|COMPLETED|Overall Study||3
8070211|NCT04474405|19897632|P1|COMPLETED|Overall Study||4
8070212|NCT04474405|19897627|P6|Florbetapir PET Scan|Overall Study||4
8070213|NCT04474405|19897628|P5|Florbetapir PET Scan|Overall Study||0
8070214|NCT04474405|19897629|P4|Florbetapir PET Scan|Overall Study||4
8070215|NCT04474405|19897630|P3|Florbetapir PET Scan|Overall Study||0
8070216|NCT04474405|19897631|P2|Florbetapir PET Scan|Overall Study||3
8070217|NCT04474405|19897632|P1|Florbetapir PET Scan|Overall Study||4
8070218|NCT04474405|19897627|P6|Flortaucipir PET Scan|Overall Study||0
8070219|NCT04474405|19897628|P5|Flortaucipir PET Scan|Overall Study||9
8070220|NCT04474405|19897629|P4|Flortaucipir PET Scan|Overall Study||4
8070221|NCT04474405|19897630|P3|Flortaucipir PET Scan|Overall Study||4
8070222|NCT04474405|19897631|P2|Flortaucipir PET Scan|Overall Study||3
8070223|NCT04474405|19897632|P1|Flortaucipir PET Scan|Overall Study||4
8070224|NCT04474405|19897627|P6|STARTED|Overall Study||7
8070225|NCT04474405|19897628|P5|STARTED|Overall Study||13
8070226|NCT04474405|19897629|P4|STARTED|Overall Study||4
8070227|NCT04474405|19897630|P3|STARTED|Overall Study||5
8070228|NCT04474405|19897631|P2|STARTED|Overall Study||3
8070229|NCT04474405|19897632|P1|STARTED|Overall Study||4
8070233|NCT04468347|19897659|P4|NOT COMPLETED|Overall Study||4
8070234|NCT04468347|19897660|P3|NOT COMPLETED|Overall Study||6
8070235|NCT04468347|19897661|P2|NOT COMPLETED|Overall Study||1
8070236|NCT04468347|19897662|P1|NOT COMPLETED|Overall Study||2
8070237|NCT04468347|19897659|P4|COMPLETED|Overall Study||21
8070238|NCT04468347|19897660|P3|COMPLETED|Overall Study||41
8070239|NCT04468347|19897661|P2|COMPLETED|Overall Study||10
8070240|NCT04468347|19897662|P1|COMPLETED|Overall Study||4
8070241|NCT04468347|19897659|P4|Baseline Flortacuipir PET Scan|Overall Study||25
8070242|NCT04468347|19897660|P3|Baseline Flortacuipir PET Scan|Overall Study||45
8070243|NCT04468347|19897661|P2|Baseline Flortacuipir PET Scan|Overall Study||11
8070244|NCT04468347|19897662|P1|Baseline Flortacuipir PET Scan|Overall Study||5
8070245|NCT04468347|19897659|P4|STARTED|Overall Study||25
8070246|NCT04468347|19897660|P3|STARTED|Overall Study||47
8070247|NCT04468347|19897661|P2|STARTED|Overall Study||11
8070248|NCT04468347|19897662|P1|STARTED|Overall Study||6
8070249|NCT04462731|19897684|P2|NOT COMPLETED|Overall Study||46
8070250|NCT04462731|19897685|P1|NOT COMPLETED|Overall Study||56
8070251|NCT04462731|19897684|P2|COMPLETED|Overall Study||51
8070252|NCT04462731|19897685|P1|COMPLETED|Overall Study||41
8070253|NCT04462731|19897684|P2|STARTED|Overall Study||97
8070254|NCT04462731|19897685|P1|STARTED|Overall Study||97
8070255|NCT04454138|19897693|P2|NOT COMPLETED|Overall Study||0
8070256|NCT04454138|19897694|P1|NOT COMPLETED|Overall Study||0
8070257|NCT04454138|19897693|P2|COMPLETED|Overall Study||77
8070258|NCT04454138|19897694|P1|COMPLETED|Overall Study||65
8070259|NCT04454138|19897693|P2|STARTED|Overall Study||77
8070260|NCT04454138|19897694|P1|STARTED|Overall Study||65
8070261|NCT04450823|19897714|P1|NOT COMPLETED|Overall Study||3
8070262|NCT04450823|19897714|P1|COMPLETED|Overall Study||58
8070263|NCT04450823|19897714|P1|STARTED|Overall Study||61
8070264|NCT04448210|19897733|P2|NOT COMPLETED|Overall Study||0
8070265|NCT04448210|19897734|P1|NOT COMPLETED|Overall Study||0
8070266|NCT04448210|19897733|P2|COMPLETED|Overall Study||20
8070267|NCT04448210|19897734|P1|COMPLETED|Overall Study||22
8070268|NCT04448210|19897733|P2|STARTED|Overall Study||20
8070269|NCT04448210|19897734|P1|STARTED|Overall Study||22
8070270|NCT04446247|19897756|P1|NOT COMPLETED|Overall Study||0
8070271|NCT04446247|19897756|P1|COMPLETED|Overall Study||14
8070272|NCT04446247|19897756|P1|STARTED|Overall Study||14
8070279|NCT04435808|19897789|P2|NOT COMPLETED|Overall Study||1
8070280|NCT04435808|19897790|P1|NOT COMPLETED|Overall Study||0
8070281|NCT04435808|19897789|P2|COMPLETED|Overall Study|Study stopped prior to any data collection for this lone participant|0
8070282|NCT04435808|19897790|P1|COMPLETED|Overall Study||0
8070283|NCT04435808|19897789|P2|STARTED|Overall Study||1
8070284|NCT04435808|19897790|P1|STARTED|Overall Study||0
8070285|NCT04425863|19897799|P3|NOT COMPLETED|Overall Study||1
8070286|NCT04425863|19897800|P2|NOT COMPLETED|Overall Study||0
8070287|NCT04425863|19897801|P1|NOT COMPLETED|Overall Study||0
8070288|NCT04425863|19897799|P3|COMPLETED|Overall Study||19
8070289|NCT04425863|19897800|P2|COMPLETED|Overall Study||12
8070290|NCT04425863|19897801|P1|COMPLETED|Overall Study||135
8070291|NCT04425863|19897799|P3|STARTED|Overall Study||20
8070292|NCT04425863|19897800|P2|STARTED|Overall Study||12
8070293|NCT04425863|19897801|P1|STARTED|Overall Study||135
8070294|NCT04425850|19897823|P2|NOT COMPLETED|Overall Study||0
8070295|NCT04425850|19897824|P1|NOT COMPLETED|Overall Study||0
8070296|NCT04425850|19897823|P2|COMPLETED|Overall Study||98
8070297|NCT04425850|19897824|P1|COMPLETED|Overall Study||131
8070298|NCT04425850|19897823|P2|STARTED|Overall Study|Standard prophylactic measures and PPE only|98
8070299|NCT04425850|19897824|P1|STARTED|Overall Study|Standard prophylactic measures and PPE + iota carrageenan (nasal and buccal) and ivermectin (buccal)|131
8070300|NCT04422561|19897834|P2|NOT COMPLETED|Overall Study||11
8070301|NCT04422561|19897835|P1|NOT COMPLETED|Overall Study||25
8070302|NCT04422561|19897834|P2|COMPLETED|Overall Study||101
8070303|NCT04422561|19897835|P1|COMPLETED|Overall Study||203
8070304|NCT04422561|19897834|P2|STARTED|Overall Study||112
8070305|NCT04422561|19897835|P1|STARTED|Overall Study||228
8070306|NCT04410159|19897845|P4|NOT COMPLETED|Overall Study||0
8070307|NCT04410159|19897846|P3|NOT COMPLETED|Overall Study||0
8070308|NCT04410159|19897847|P2|NOT COMPLETED|Overall Study||0
8070309|NCT04410159|19897848|P1|NOT COMPLETED|Overall Study||0
8070310|NCT04410159|19897845|P4|COMPLETED|Overall Study||5
8070311|NCT04410159|19897846|P3|COMPLETED|Overall Study||5
8070312|NCT04410159|19897847|P2|COMPLETED|Overall Study||5
8070313|NCT04410159|19897848|P1|COMPLETED|Overall Study||5
8070314|NCT04410159|19897845|P4|STARTED|Overall Study||5
8070315|NCT04410159|19897846|P3|STARTED|Overall Study||5
8070316|NCT04410159|19897847|P2|STARTED|Overall Study||5
8070317|NCT04410159|19897848|P1|STARTED|Overall Study||5
8070318|NCT04406194|19897876|P2|NOT COMPLETED|Period 2||0
8070319|NCT04406194|19897877|P1|NOT COMPLETED|Period 2||0
8070320|NCT04406194|19897876|P2|COMPLETED|Period 2||14
8070321|NCT04406194|19897877|P1|COMPLETED|Period 2||15
8070322|NCT04406194|19897876|P2|STARTED|Period 2||14
8070323|NCT04406194|19897877|P1|STARTED|Period 2||15
8070324|NCT04406194|19897876|P2|NOT COMPLETED|Period 1||1
8070325|NCT04406194|19897877|P1|NOT COMPLETED|Period 1||0
8070326|NCT04406194|19897876|P2|COMPLETED|Period 1||14
8070327|NCT04406194|19897877|P1|COMPLETED|Period 1||15
8070328|NCT04406194|19897876|P2|STARTED|Period 1||15
8070329|NCT04406194|19897877|P1|STARTED|Period 1||15
8070330|NCT04404907|19897891|P2|NOT COMPLETED|Overall Study||0
8070331|NCT04404907|19897892|P1|NOT COMPLETED|Overall Study||0
8070332|NCT04404907|19897891|P2|COMPLETED|Overall Study||95
8070333|NCT04404907|19897892|P1|COMPLETED|Overall Study||442
8070334|NCT04404907|19897891|P2|Frequent Tan|Overall Study||7
8070335|NCT04404907|19897892|P1|Frequent Tan|Overall Study||0
8070336|NCT04404907|19897891|P2|Occasional Tan|Overall Study||88
8070337|NCT04404907|19897892|P1|Occasional Tan|Overall Study||0
8070338|NCT04404907|19897891|P2|STARTED|Overall Study||95
8070339|NCT04404907|19897892|P1|STARTED|Overall Study||442
8070340|NCT04403399|19897900|P2|NOT COMPLETED|Period 2||1
8070341|NCT04403399|19897901|P1|NOT COMPLETED|Period 2||0
8070342|NCT04403399|19897900|P2|COMPLETED|Period 2||15
8070343|NCT04403399|19897901|P1|COMPLETED|Period 2||18
8070344|NCT04403399|19897900|P2|STARTED|Period 2||16
8070345|NCT04403399|19897901|P1|STARTED|Period 2||18
8070346|NCT04403399|19897900|P2|NOT COMPLETED|Period 1||0
8070347|NCT04403399|19897901|P1|NOT COMPLETED|Period 1||0
8070348|NCT04403399|19897900|P2|COMPLETED|Period 1||16
8070349|NCT04403399|19897901|P1|COMPLETED|Period 1||18
8070350|NCT04403399|19897900|P2|STARTED|Period 1||16
8070351|NCT04403399|19897901|P1|STARTED|Period 1||18
8070352|NCT04403113|19897913|P2|NOT COMPLETED|Overall Study||0
8070353|NCT04403113|19897914|P1|NOT COMPLETED|Overall Study||0
8070354|NCT04403113|19897913|P2|COMPLETED|Overall Study||20
8070355|NCT04403113|19897914|P1|COMPLETED|Overall Study||20
8070356|NCT04403113|19897913|P2|STARTED|Overall Study||20
8070357|NCT04403113|19897914|P1|STARTED|Overall Study||20
8070358|NCT04400682|19897934|P2|NOT COMPLETED|Period 2||0
8070359|NCT04400682|19897935|P1|NOT COMPLETED|Period 2||0
8070360|NCT04400682|19897934|P2|COMPLETED|Period 2||11
8070361|NCT04400682|19897935|P1|COMPLETED|Period 2||14
8070362|NCT04400682|19897934|P2|STARTED|Period 2||11
8070363|NCT04400682|19897935|P1|STARTED|Period 2||14
8070364|NCT04400682|19897934|P2|NOT COMPLETED|Period 1||4
8070365|NCT04400682|19897935|P1|NOT COMPLETED|Period 1||1
8070366|NCT04400682|19897934|P2|COMPLETED|Period 1||11
8070367|NCT04400682|19897935|P1|COMPLETED|Period 1||14
8070368|NCT04400682|19897934|P2|STARTED|Period 1||15
8070369|NCT04400682|19897935|P1|STARTED|Period 1||15
8070370|NCT04399161|19897950|P3|NOT COMPLETED|Overall Study||2
8070371|NCT04399161|19897951|P2|NOT COMPLETED|Overall Study||2
8070372|NCT04399161|19897952|P1|NOT COMPLETED|Overall Study||2
8070373|NCT04399161|19897950|P3|COMPLETED|Overall Study||18
8070374|NCT04399161|19897951|P2|COMPLETED|Overall Study||18
8070375|NCT04399161|19897952|P1|COMPLETED|Overall Study||18
8070376|NCT04399161|19897950|P3|STARTED|Overall Study||20
8070377|NCT04399161|19897951|P2|STARTED|Overall Study||20
8070378|NCT04399161|19897952|P1|STARTED|Overall Study||20
8070379|NCT04397094|19897962|P2|NOT COMPLETED|Overall Study||0
8070380|NCT04397094|19897963|P1|NOT COMPLETED|Overall Study||0
8070381|NCT04397094|19897962|P2|COMPLETED|Overall Study||30
8070382|NCT04397094|19897963|P1|COMPLETED|Overall Study||30
8070383|NCT04397094|19897962|P2|STARTED|Overall Study||30
8070384|NCT04397094|19897963|P1|STARTED|Overall Study||30
8070385|NCT04393493|19897973|P2|NOT COMPLETED|First 4 Days of Intervention||7
8070386|NCT04393493|19897974|P1|NOT COMPLETED|First 4 Days of Intervention||5
8070387|NCT04393493|19897973|P2|COMPLETED|First 4 Days of Intervention||33
8070388|NCT04393493|19897974|P1|COMPLETED|First 4 Days of Intervention||35
8070389|NCT04393493|19897973|P2|STARTED|First 4 Days of Intervention||40
8070390|NCT04393493|19897974|P1|STARTED|First 4 Days of Intervention||40
8070391|NCT04393493|19897973|P2|NOT COMPLETED|Follow up||0
8070392|NCT04393493|19897974|P1|NOT COMPLETED|Follow up||0
8070393|NCT04393493|19897973|P2|COMPLETED|Follow up||40
8070394|NCT04393493|19897974|P1|COMPLETED|Follow up||40
8070395|NCT04393493|19897973|P2|STARTED|Follow up||40
8070396|NCT04393493|19897974|P1|STARTED|Follow up||40
8070397|NCT04390022|19898028|P2|NOT COMPLETED|Overall Study||0
8070398|NCT04390022|19898029|P1|NOT COMPLETED|Overall Study||0
8070399|NCT04390022|19898028|P2|COMPLETED|Overall Study||12
8070400|NCT04390022|19898029|P1|COMPLETED|Overall Study||12
8070401|NCT04390022|19898028|P2|STARTED|Overall Study||12
8070402|NCT04390022|19898029|P1|STARTED|Overall Study||12
8070403|NCT04385238|19898045|P2|NOT COMPLETED|Overall Study||0
8070404|NCT04385238|19898046|P1|NOT COMPLETED|Overall Study||0
8070405|NCT04385238|19898045|P2|COMPLETED|Overall Study||1182
8070406|NCT04385238|19898046|P1|COMPLETED|Overall Study||5712
8070407|NCT04385238|19898045|P2|STARTED|Overall Study||1182
8070408|NCT04385238|19898046|P1|STARTED|Overall Study||5712
8070409|NCT04383132|19898056|P2|NOT COMPLETED|Overall Study||0
8070410|NCT04383132|19898057|P1|NOT COMPLETED|Overall Study||0
8070411|NCT04383132|19898056|P2|COMPLETED|Overall Study||173
8070412|NCT04383132|19898057|P1|COMPLETED|Overall Study||173
8070413|NCT04383132|19898056|P2|STARTED|Overall Study||173
8070414|NCT04383132|19898057|P1|STARTED|Overall Study||173
8070415|NCT04376060|19898075|P1|NOT COMPLETED|Overall Study||1
8070416|NCT04376060|19898075|P1|COMPLETED|Overall Study||14
8070417|NCT04376060|19898075|P1|STARTED|Overall Study||15
8070418|NCT04374500|19898089|P3|NOT COMPLETED|Overall Study||0
8070419|NCT04374500|19898090|P2|NOT COMPLETED|Overall Study||0
8070420|NCT04374500|19898091|P1|NOT COMPLETED|Overall Study||0
8070421|NCT04374500|19898089|P3|COMPLETED|Overall Study||83
8070422|NCT04374500|19898090|P2|COMPLETED|Overall Study||10
8070423|NCT04374500|19898091|P1|COMPLETED|Overall Study||10
8070424|NCT04374500|19898089|P3|STARTED|Overall Study||83
8070425|NCT04374500|19898090|P2|STARTED|Overall Study||10
8070426|NCT04374500|19898091|P1|STARTED|Overall Study||10
8070427|NCT04366583|19898110|P2|NOT COMPLETED|Overall Study||0
8070428|NCT04366583|19898111|P1|NOT COMPLETED|Overall Study||0
8070429|NCT04366583|19898110|P2|COMPLETED|Overall Study||84
8070430|NCT04366583|19898111|P1|COMPLETED|Overall Study||82
8070431|NCT04366583|19898110|P2|STARTED|Overall Study||84
8070432|NCT04366583|19898111|P1|STARTED|Overall Study||82
8070436|NCT04363879|19898128|P2|NOT COMPLETED|Overall Study||0
8070437|NCT04363879|19898129|P1|NOT COMPLETED|Overall Study||0
8070438|NCT04363879|19898128|P2|COMPLETED|Overall Study||92
8070439|NCT04363879|19898129|P1|COMPLETED|Overall Study||78
8070440|NCT04363879|19898128|P2|STARTED|Overall Study||92
8070441|NCT04363879|19898129|P1|STARTED|Overall Study||78
8070442|NCT04359771|19898143|P2|NOT COMPLETED|Overall Study||2
8070443|NCT04359771|19898144|P1|NOT COMPLETED|Overall Study||2
8070444|NCT04359771|19898143|P2|COMPLETED|Overall Study|The left eye of every participant was assigned to the diode MPL group|13
8070445|NCT04359771|19898144|P1|COMPLETED|Overall Study|The right eye of each participant was assigned to the diode MPL group|13
8070446|NCT04359771|19898143|P2|STARTED|Overall Study|Left eye of every participant was assigned to the diode MPL group|15
8070447|NCT04359771|19898144|P1|STARTED|Overall Study|Right eye of every participant was assigned to the diode MPL group|15
8070448|NCT04358991|19898152|P1|NOT COMPLETED|Overall Study||0
8070449|NCT04358991|19898152|P1|COMPLETED|Overall Study||20
8070450|NCT04358991|19898152|P1|STARTED|Overall Study||20
8070451|NCT04355663|19898159|P3|NOT COMPLETED|Overall Study||4
8070452|NCT04355663|19898160|P2|NOT COMPLETED|Overall Study||15
8070453|NCT04355663|19898161|P1|NOT COMPLETED|Overall Study||2
8070454|NCT04355663|19898159|P3|COMPLETED|Overall Study||17
8070455|NCT04355663|19898160|P2|COMPLETED|Overall Study||14
8070456|NCT04355663|19898161|P1|COMPLETED|Overall Study||40
8070457|NCT04355663|19898159|P3|STARTED|Overall Study||21
8070458|NCT04355663|19898160|P2|STARTED|Overall Study||29
8070459|NCT04355663|19898161|P1|STARTED|Overall Study||42
8070460|NCT04352660|19898183|P2|NOT COMPLETED|Overall Study||10
8070461|NCT04352660|19898184|P1|NOT COMPLETED|Overall Study||14
8070462|NCT04352660|19898183|P2|COMPLETED|Overall Study||40
8070463|NCT04352660|19898184|P1|COMPLETED|Overall Study||36
8070464|NCT04352660|19898183|P2|STARTED|Overall Study||50
8070465|NCT04352660|19898184|P1|STARTED|Overall Study||50
8070466|NCT04350788|19898204|P2|NOT COMPLETED|Overall Study||6
8070467|NCT04350788|19898205|P1|NOT COMPLETED|Overall Study||12
8070468|NCT04350788|19898204|P2|COMPLETED|Overall Study||56
8070469|NCT04350788|19898205|P1|COMPLETED|Overall Study||50
8070470|NCT04350788|19898204|P2|STARTED|Overall Study||62
8070471|NCT04350788|19898205|P1|STARTED|Overall Study||62
8070472|NCT04350307|19898248|P2|NOT COMPLETED|Overall Study||0
8070473|NCT04350307|19898249|P1|NOT COMPLETED|Overall Study||0
8070474|NCT04350307|19898248|P2|COMPLETED|Overall Study||78
8070475|NCT04350307|19898249|P1|COMPLETED|Overall Study||84
8070476|NCT04350307|19898248|P2|STARTED|Overall Study||78
8070477|NCT04350307|19898249|P1|STARTED|Overall Study||84
8070478|NCT04349917|19898259|P2|NOT COMPLETED|Second Intervention (2-4 Hours)||0
8070479|NCT04349917|19898260|P1|NOT COMPLETED|Second Intervention (2-4 Hours)||0
8070480|NCT04349917|19898259|P2|COMPLETED|Second Intervention (2-4 Hours)||16
8070481|NCT04349917|19898260|P1|COMPLETED|Second Intervention (2-4 Hours)||19
8070482|NCT04349917|19898259|P2|Received Intervention|Second Intervention (2-4 Hours)||16
8070483|NCT04349917|19898260|P1|Received Intervention|Second Intervention (2-4 Hours)||19
8070484|NCT04349917|19898259|P2|STARTED|Second Intervention (2-4 Hours)||16
8070485|NCT04349917|19898260|P1|STARTED|Second Intervention (2-4 Hours)||19
8070486|NCT04349917|19898259|P2|NOT COMPLETED|Washout Period (4-20 Days)||0
8070487|NCT04349917|19898260|P1|NOT COMPLETED|Washout Period (4-20 Days)||0
8070488|NCT04349917|19898259|P2|COMPLETED|Washout Period (4-20 Days)||16
8070489|NCT04349917|19898260|P1|COMPLETED|Washout Period (4-20 Days)||19
8070490|NCT04349917|19898259|P2|STARTED|Washout Period (4-20 Days)||16
8070491|NCT04349917|19898260|P1|STARTED|Washout Period (4-20 Days)||19
8070492|NCT04349917|19898259|P2|NOT COMPLETED|First Intervention (2-4 Hours)||2
8070493|NCT04349917|19898260|P1|NOT COMPLETED|First Intervention (2-4 Hours)||0
8070494|NCT04349917|19898259|P2|COMPLETED|First Intervention (2-4 Hours)||16
8070495|NCT04349917|19898260|P1|COMPLETED|First Intervention (2-4 Hours)||19
8070496|NCT04349917|19898259|P2|Received Intervention|First Intervention (2-4 Hours)||17
8070497|NCT04349917|19898260|P1|Received Intervention|First Intervention (2-4 Hours)||19
8070498|NCT04349917|19898259|P2|STARTED|First Intervention (2-4 Hours)||18
8070499|NCT04349917|19898260|P1|STARTED|First Intervention (2-4 Hours)||19
8070500|NCT04348851|19898281|P4|NOT COMPLETED|Post-Test 2||1
8070501|NCT04348851|19898282|P3|NOT COMPLETED|Post-Test 2||0
8070502|NCT04348851|19898283|P2|NOT COMPLETED|Post-Test 2||1
8070503|NCT04348851|19898284|P1|NOT COMPLETED|Post-Test 2||0
8070504|NCT04348851|19898281|P4|COMPLETED|Post-Test 2||13
8070505|NCT04348851|19898282|P3|COMPLETED|Post-Test 2||13
8070506|NCT04348851|19898283|P2|COMPLETED|Post-Test 2||10
8070507|NCT04348851|19898284|P1|COMPLETED|Post-Test 2||13
8070508|NCT04348851|19898281|P4|STARTED|Post-Test 2||14
8070509|NCT04348851|19898282|P3|STARTED|Post-Test 2||13
8070510|NCT04348851|19898283|P2|STARTED|Post-Test 2||11
8070511|NCT04348851|19898284|P1|STARTED|Post-Test 2||13
8070512|NCT04348851|19898281|P4|NOT COMPLETED|Post-Test 1||0
8070513|NCT04348851|19898282|P3|NOT COMPLETED|Post-Test 1||0
8070514|NCT04348851|19898283|P2|NOT COMPLETED|Post-Test 1||2
8070515|NCT04348851|19898284|P1|NOT COMPLETED|Post-Test 1||0
8070516|NCT04348851|19898281|P4|COMPLETED|Post-Test 1||14
8070517|NCT04348851|19898282|P3|COMPLETED|Post-Test 1||13
8070518|NCT04348851|19898283|P2|COMPLETED|Post-Test 1||11
8070519|NCT04348851|19898284|P1|COMPLETED|Post-Test 1||13
8070520|NCT04348851|19898281|P4|STARTED|Post-Test 1||14
8070521|NCT04348851|19898282|P3|STARTED|Post-Test 1||13
8070522|NCT04348851|19898283|P2|STARTED|Post-Test 1||13
8070523|NCT04348851|19898284|P1|STARTED|Post-Test 1||13
8070524|NCT04348357|19898364|P2|NOT COMPLETED|Overall Study||12
8070525|NCT04348357|19898365|P1|NOT COMPLETED|Overall Study||0
8070526|NCT04348357|19898364|P2|COMPLETED|Overall Study||16
8070527|NCT04348357|19898365|P1|COMPLETED|Overall Study||25
8070528|NCT04348357|19898364|P2|STARTED|Overall Study||28
8070529|NCT04348357|19898365|P1|STARTED|Overall Study||25
8070530|NCT04343261|19898391|P1|NOT COMPLETED|Overall Study||8
8070531|NCT04343261|19898391|P1|COMPLETED|Overall Study||40
8070532|NCT04343261|19898391|P1|STARTED|Overall Study||48
8070533|NCT04343222|19898400|P3|NOT COMPLETED|Overall Study||0
8070534|NCT04343222|19898401|P2|NOT COMPLETED|Overall Study||0
8070535|NCT04343222|19898402|P1|NOT COMPLETED|Overall Study||0
8070536|NCT04343222|19898400|P3|COMPLETED|Overall Study||15
8070537|NCT04343222|19898401|P2|COMPLETED|Overall Study||15
8070538|NCT04343222|19898402|P1|COMPLETED|Overall Study||16
8070539|NCT04343222|19898400|P3|STARTED|Overall Study||15
8070540|NCT04343222|19898401|P2|STARTED|Overall Study||15
8070541|NCT04343222|19898402|P1|STARTED|Overall Study||16
8070542|NCT04343092|19898425|P1|NOT COMPLETED|Overall Study||0
8070543|NCT04343092|19898425|P1|COMPLETED|Overall Study||16
8070544|NCT04343092|19898425|P1|STARTED|Overall Study||16
8070545|NCT04339296|19898432|P2|NOT COMPLETED|Overall Study||9
8070546|NCT04339296|19898433|P1|NOT COMPLETED|Overall Study||8
8070547|NCT04339296|19898432|P2|COMPLETED|Overall Study||17
8070548|NCT04339296|19898433|P1|COMPLETED|Overall Study||16
8070549|NCT04339296|19898432|P2|Received Allocated Intervention|Overall Study||24
8070550|NCT04339296|19898433|P1|Received Allocated Intervention|Overall Study||21
8070551|NCT04339296|19898432|P2|Completed Baseline|Overall Study||25
8070552|NCT04339296|19898433|P1|Completed Baseline|Overall Study||23
8070553|NCT04339296|19898432|P2|STARTED|Overall Study||26
8070554|NCT04339296|19898433|P1|STARTED|Overall Study||24
8070555|NCT04336475|19898443|P2|NOT COMPLETED|Overall Study||2
8070556|NCT04336475|19898444|P1|NOT COMPLETED|Overall Study||2
8070557|NCT04336475|19898443|P2|COMPLETED|Overall Study||28
8070558|NCT04336475|19898444|P1|COMPLETED|Overall Study||28
8070559|NCT04336475|19898443|P2|STARTED|Overall Study||30
8070560|NCT04336475|19898444|P1|STARTED|Overall Study||30
8070569|NCT04329923|19898465|P6|NOT COMPLETED|Overall Study||5
8070644|NCT04032613|19898607|P2|NOT COMPLETED|Overall Study||2
8070645|NCT04032613|19898608|P1|NOT COMPLETED|Overall Study||5
8070646|NCT04032613|19898607|P2|COMPLETED|Overall Study||23
8070647|NCT04032613|19898608|P1|COMPLETED|Overall Study||16
8070648|NCT04032613|19898607|P2|STARTED|Overall Study||25
8070649|NCT04032613|19898608|P1|STARTED|Overall Study||21
8070650|NCT04025684|19898620|P4|NOT COMPLETED|Overall Study||1
8070651|NCT04025684|19898621|P3|NOT COMPLETED|Overall Study||0
8070652|NCT04025684|19898622|P2|NOT COMPLETED|Overall Study||4
8070653|NCT04025684|19898623|P1|NOT COMPLETED|Overall Study||2
8070654|NCT04025684|19898620|P4|COMPLETED|Overall Study||20
8070655|NCT04025684|19898621|P3|COMPLETED|Overall Study||20
8070656|NCT04025684|19898622|P2|COMPLETED|Overall Study||15
8070657|NCT04025684|19898623|P1|COMPLETED|Overall Study||18
8070658|NCT04025684|19898620|P4|STARTED|Overall Study||21
8070659|NCT04025684|19898621|P3|STARTED|Overall Study||20
8070660|NCT04025684|19898622|P2|STARTED|Overall Study||19
8070661|NCT04025684|19898623|P1|STARTED|Overall Study||20
8070570|NCT04329923|19898466|P5|NOT COMPLETED|Overall Study||2
8070571|NCT04329923|19898467|P4|NOT COMPLETED|Overall Study||1
8070572|NCT04329923|19898468|P3|NOT COMPLETED|Overall Study||1
8070573|NCT04329923|19898469|P2|NOT COMPLETED|Overall Study||4
8070574|NCT04329923|19898470|P1|NOT COMPLETED|Overall Study||1
8070575|NCT04329923|19898465|P6|COMPLETED|Overall Study||61
8070576|NCT04329923|19898466|P5|COMPLETED|Overall Study||64
8070577|NCT04329923|19898467|P4|COMPLETED|Overall Study||2
8070578|NCT04329923|19898468|P3|COMPLETED|Overall Study||3
8070579|NCT04329923|19898469|P2|COMPLETED|Overall Study||13
8070580|NCT04329923|19898470|P1|COMPLETED|Overall Study||16
8070581|NCT04329923|19898465|P6|STARTED|Overall Study||66
8070582|NCT04329923|19898466|P5|STARTED|Overall Study||66
8070583|NCT04329923|19898467|P4|STARTED|Overall Study||3
8070584|NCT04329923|19898468|P3|STARTED|Overall Study||4
8070585|NCT04329923|19898469|P2|STARTED|Overall Study||17
8070586|NCT04329923|19898470|P1|STARTED|Overall Study||17
8070593|NCT04326842|19898510|P2|NOT COMPLETED|Overall Study||58
8070594|NCT04326842|19898511|P1|NOT COMPLETED|Overall Study||9
8070595|NCT04326842|19898510|P2|COMPLETED|Overall Study||31
8070596|NCT04326842|19898511|P1|COMPLETED|Overall Study||31
8070597|NCT04326842|19898510|P2|STARTED|Overall Study||89
8070598|NCT04326842|19898511|P1|STARTED|Overall Study||40
8070599|NCT04325542|19898529|P1|NOT COMPLETED|Overall Study||1
8070600|NCT04325542|19898529|P1|COMPLETED|Overall Study||742
8070601|NCT04325542|19898529|P1|STARTED|Overall Study|one participant withdraw consent during the study|743
8070602|NCT04323592|19898535|P2|NOT COMPLETED|Overall Study||0
8070603|NCT04323592|19898536|P1|NOT COMPLETED|Overall Study||0
8070604|NCT04323592|19898535|P2|COMPLETED|Overall Study||90
8070605|NCT04323592|19898536|P1|COMPLETED|Overall Study||83
8070606|NCT04323592|19898535|P2|STARTED|Overall Study||90
8070607|NCT04323592|19898536|P1|STARTED|Overall Study||83
8070608|NCT04322968|19898556|P4|NOT COMPLETED|Overall Study||0
8070609|NCT04322968|19898557|P3|NOT COMPLETED|Overall Study||0
8070610|NCT04322968|19898558|P2|NOT COMPLETED|Overall Study||1
8070611|NCT04322968|19898559|P1|NOT COMPLETED|Overall Study||1
8070612|NCT04322968|19898556|P4|COMPLETED|Overall Study||10
8070613|NCT04322968|19898557|P3|COMPLETED|Overall Study||10
8070614|NCT04322968|19898558|P2|COMPLETED|Overall Study||9
8070615|NCT04322968|19898559|P1|COMPLETED|Overall Study||10
8070616|NCT04322968|19898556|P4|STARTED|Overall Study||10
8070617|NCT04322968|19898557|P3|STARTED|Overall Study||10
8070618|NCT04322968|19898558|P2|STARTED|Overall Study||10
8070619|NCT04322968|19898559|P1|STARTED|Overall Study||11
8070620|NCT04322526|19898587|P2|NOT COMPLETED|Second Intervention (1day)||0
8070621|NCT04322526|19898588|P1|NOT COMPLETED|Second Intervention (1day)||0
8070622|NCT04322526|19898587|P2|COMPLETED|Second Intervention (1day)||9
8070623|NCT04322526|19898588|P1|COMPLETED|Second Intervention (1day)||11
8070624|NCT04322526|19898587|P2|STARTED|Second Intervention (1day)||9
8070625|NCT04322526|19898588|P1|STARTED|Second Intervention (1day)||11
8070626|NCT04322526|19898587|P2|NOT COMPLETED|Washout (1 Week)||2
8070627|NCT04322526|19898588|P1|NOT COMPLETED|Washout (1 Week)||1
8070628|NCT04322526|19898587|P2|COMPLETED|Washout (1 Week)||9
8070629|NCT04322526|19898588|P1|COMPLETED|Washout (1 Week)||11
8070630|NCT04322526|19898587|P2|STARTED|Washout (1 Week)||11
8070631|NCT04322526|19898588|P1|STARTED|Washout (1 Week)||12
8070632|NCT04322526|19898587|P2|NOT COMPLETED|First Intervention (1 Day)||1
8070633|NCT04322526|19898588|P1|NOT COMPLETED|First Intervention (1 Day)||1
8070634|NCT04322526|19898587|P2|COMPLETED|First Intervention (1 Day)||11
8070635|NCT04322526|19898588|P1|COMPLETED|First Intervention (1 Day)||12
8070636|NCT04322526|19898587|P2|STARTED|First Intervention (1 Day)||12
8070637|NCT04322526|19898588|P1|STARTED|First Intervention (1 Day)||13
8070638|NCT04322500|19898596|P2|NOT COMPLETED|Overall Study||0
8070639|NCT04322500|19898597|P1|NOT COMPLETED|Overall Study||0
8070640|NCT04322500|19898596|P2|COMPLETED|Overall Study||13
8070641|NCT04322500|19898597|P1|COMPLETED|Overall Study||13
8070642|NCT04322500|19898596|P2|STARTED|Overall Study||13
8070643|NCT04322500|19898597|P1|STARTED|Overall Study||13
8070662|NCT04318535|19898697|P3|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
8070663|NCT04318535|19898698|P2|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
8070664|NCT04318535|19898699|P1|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
8070665|NCT04318535|19898697|P3|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
8070666|NCT04318535|19898698|P2|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||11
8070667|NCT04318535|19898699|P1|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
8070668|NCT04318535|19898697|P3|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
8070669|NCT04318535|19898698|P2|STARTED|Treatment Period 3 (Day 17 to Day 22)||11
8070670|NCT04318535|19898699|P1|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
8070671|NCT04318535|19898697|P3|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
8070672|NCT04318535|19898698|P2|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||1
8070673|NCT04318535|19898699|P1|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
8070674|NCT04318535|19898697|P3|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
8070675|NCT04318535|19898698|P2|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||11
8070676|NCT04318535|19898699|P1|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
8070677|NCT04318535|19898697|P3|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
8070678|NCT04318535|19898698|P2|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
8070679|NCT04318535|19898699|P1|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
8070680|NCT04318535|19898697|P3|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
8070681|NCT04318535|19898698|P2|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
8070682|NCT04318535|19898699|P1|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
8070683|NCT04318535|19898697|P3|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
8070684|NCT04318535|19898698|P2|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
8070685|NCT04318535|19898699|P1|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
8070686|NCT04318535|19898697|P3|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
8070687|NCT04318535|19898698|P2|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
8070688|NCT04318535|19898699|P1|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
8070689|NCT04318535|19898697|P3|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
8070690|NCT04318535|19898698|P2|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
8070691|NCT04318535|19898699|P1|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
8070692|NCT04318535|19898697|P3|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
8070693|NCT04318535|19898698|P2|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
8070694|NCT04318535|19898699|P1|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
8070695|NCT04318535|19898697|P3|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
8070696|NCT04318535|19898698|P2|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
8070697|NCT04318535|19898699|P1|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
8070698|NCT04318535|19898697|P3|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
8070699|NCT04318535|19898698|P2|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
8070700|NCT04318535|19898699|P1|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
8070701|NCT04318535|19898697|P3|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
8070702|NCT04318535|19898698|P2|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
8070703|NCT04318535|19898699|P1|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
8070704|NCT04318535|19898697|P3|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
8070705|NCT04318535|19898698|P2|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
8070706|NCT04318535|19898699|P1|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
8070707|NCT04316260|19898738|P2|NOT COMPLETED|Overall Study||0
8070708|NCT04316260|19898739|P1|NOT COMPLETED|Overall Study||0
8070709|NCT04316260|19898738|P2|COMPLETED|Overall Study||17
8070710|NCT04316260|19898739|P1|COMPLETED|Overall Study||34
8070711|NCT04316260|19898738|P2|STARTED|Overall Study||17
8070712|NCT04316260|19898739|P1|STARTED|Overall Study||34
8070776|NCT04308239|19898883|P2|NOT COMPLETED|Post-intervention Evaluation (1 Week)||4
8070777|NCT04308239|19898884|P1|NOT COMPLETED|Post-intervention Evaluation (1 Week)||1
8070778|NCT04308239|19898883|P2|COMPLETED|Post-intervention Evaluation (1 Week)||10
8070779|NCT04308239|19898884|P1|COMPLETED|Post-intervention Evaluation (1 Week)||19
8070780|NCT04308239|19898883|P2|STARTED|Post-intervention Evaluation (1 Week)||14
8070781|NCT04308239|19898884|P1|STARTED|Post-intervention Evaluation (1 Week)||20
8070782|NCT04308239|19898883|P2|NOT COMPLETED|Intervention (2 Weeks)||0
8070783|NCT04308239|19898884|P1|NOT COMPLETED|Intervention (2 Weeks)||0
8070784|NCT04308239|19898883|P2|COMPLETED|Intervention (2 Weeks)||14
8070785|NCT04308239|19898884|P1|COMPLETED|Intervention (2 Weeks)||20
8070786|NCT04308239|19898883|P2|STARTED|Intervention (2 Weeks)||14
8070787|NCT04308239|19898884|P1|STARTED|Intervention (2 Weeks)||20
8070788|NCT04308239|19898883|P2|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
8070789|NCT04308239|19898884|P1|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
8070790|NCT04308239|19898883|P2|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|11
8070791|NCT04308239|19898884|P1|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|17
8070792|NCT04308239|19898883|P2|STARTED|Pre-intervention Evaluation (1 Week)||14
8070793|NCT04308239|19898884|P1|STARTED|Pre-intervention Evaluation (1 Week)||20
8070809|NCT03719612|19898919|P1|NOT COMPLETED|Overall Study||12
8070810|NCT03719612|19898919|P1|COMPLETED|Overall Study||148
8070811|NCT03719612|19898919|P1|STARTED|Overall Study||160
8070815|NCT03641716|19898947|P1|NOT COMPLETED|Overall Study||5
8070816|NCT03641716|19898947|P1|COMPLETED|Overall Study||15
8070817|NCT03641716|19898947|P1|STARTED|Overall Study||20
8070818|NCT03637842|19898955|P2|NOT COMPLETED|Overall Study||0
8070819|NCT03637842|19898956|P1|NOT COMPLETED|Overall Study||0
8070820|NCT03637842|19898955|P2|COMPLETED|Overall Study||2
8070821|NCT03637842|19898956|P1|COMPLETED|Overall Study||2
8070822|NCT03637842|19898955|P2|STARTED|Overall Study||2
8070823|NCT03637842|19898956|P1|STARTED|Overall Study||2
8070824|NCT03615404|19898962|P1|NOT COMPLETED|Overall Study||2
8070825|NCT03615404|19898962|P1|COMPLETED|Overall Study||9
8070826|NCT03615404|19898962|P1|STARTED|Overall Study||11
8070827|NCT03577171|19898969|P2|NOT COMPLETED|Overall Study||0
8070828|NCT03577171|19898970|P1|NOT COMPLETED|Overall Study||0
8070829|NCT03577171|19898969|P2|COMPLETED|Overall Study||12
8070830|NCT03577171|19898970|P1|COMPLETED|Overall Study||13
8070831|NCT03577171|19898969|P2|STARTED|Overall Study||12
8070832|NCT03577171|19898970|P1|STARTED|Overall Study||13
8070845|NCT04296227|19899050|P1|NOT COMPLETED|Overall Study||0
8070846|NCT04296227|19899050|P1|COMPLETED|Overall Study||85
8070847|NCT04296227|19899050|P1|STARTED|Overall Study||85
8070851|NCT04295356|19899068|P2|NOT COMPLETED|Overall Study||4
8070852|NCT04295356|19899069|P1|NOT COMPLETED|Overall Study||1
8070853|NCT04295356|19899068|P2|COMPLETED|Overall Study||83
8070854|NCT04295356|19899069|P1|COMPLETED|Overall Study||92
8070855|NCT04295356|19899068|P2|STARTED|Overall Study||87
8070856|NCT04295356|19899069|P1|STARTED|Overall Study||93
8070890|NCT03466099|19899159|P3|NOT COMPLETED|Overall Study||17
8070891|NCT03466099|19899160|P2|NOT COMPLETED|Overall Study||14
8070892|NCT03466099|19899161|P1|NOT COMPLETED|Overall Study||17
8070893|NCT03466099|19899159|P3|COMPLETED|Overall Study||28
8070894|NCT03466099|19899160|P2|COMPLETED|Overall Study||30
8070895|NCT03466099|19899161|P1|COMPLETED|Overall Study||24
8070896|NCT03466099|19899159|P3|Treated|Overall Study||44
8070897|NCT03466099|19899160|P2|Treated|Overall Study||44
8070898|NCT03466099|19899161|P1|Treated|Overall Study||41
8070899|NCT03466099|19899159|P3|STARTED|Overall Study|One study subject consented and was randomized, but withdrew prior to receiving any study treatments|45
8070900|NCT03466099|19899160|P2|STARTED|Overall Study||44
8070901|NCT03466099|19899161|P1|STARTED|Overall Study||41
8070926|NCT03435614|19899208|P2|NOT COMPLETED|Overall Study||0
8070927|NCT03435614|19899209|P1|NOT COMPLETED|Overall Study||0
8070928|NCT03435614|19899208|P2|COMPLETED|Overall Study||23
8070929|NCT03435614|19899209|P1|COMPLETED|Overall Study||6
8070930|NCT03435614|19899208|P2|STARTED|Overall Study||23
8070931|NCT03435614|19899209|P1|STARTED|Overall Study||6
8070941|NCT03417141|19899235|P1|NOT COMPLETED|Overall Study||4
8070942|NCT03417141|19899235|P1|COMPLETED|Overall Study||8
8070943|NCT03417141|19899235|P1|STARTED|Overall Study||12
8070968|NCT03357952|19899311|P2|NOT COMPLETED|Overall Study||1
8070969|NCT03357952|19899312|P1|NOT COMPLETED|Overall Study||9
8070970|NCT03357952|19899311|P2|COMPLETED|Overall Study||0
8070971|NCT03357952|19899312|P1|COMPLETED|Overall Study||0
8070972|NCT03357952|19899311|P2|STARTED|Overall Study||1
8070973|NCT03357952|19899312|P1|STARTED|Overall Study||9
8070983|NCT03346070|19899343|P5|NOT COMPLETED|Overall Study||5
8070984|NCT03346070|19899344|P4|NOT COMPLETED|Overall Study||6
8070985|NCT03346070|19899345|P3|NOT COMPLETED|Overall Study||4
8070986|NCT03346070|19899346|P2|NOT COMPLETED|Overall Study||4
8070987|NCT03346070|19899347|P1|NOT COMPLETED|Overall Study||3
8070988|NCT03346070|19899343|P5|COMPLETED|Overall Study||37
8070989|NCT03346070|19899344|P4|COMPLETED|Overall Study||36
8070990|NCT03346070|19899345|P3|COMPLETED|Overall Study||37
8070991|NCT03346070|19899346|P2|COMPLETED|Overall Study||37
8070992|NCT03346070|19899347|P1|COMPLETED|Overall Study||38
8070993|NCT03346070|19899343|P5|Treated|Overall Study||38
8070994|NCT03346070|19899344|P4|Treated|Overall Study||36
8070995|NCT03346070|19899345|P3|Treated|Overall Study||38
8070996|NCT03346070|19899346|P2|Treated|Overall Study||38
8070997|NCT03346070|19899347|P1|Treated|Overall Study||38
8070998|NCT03346070|19899343|P5|STARTED|Overall Study||42
8070999|NCT03346070|19899344|P4|STARTED|Overall Study||42
8071000|NCT03346070|19899345|P3|STARTED|Overall Study||41
8071001|NCT03346070|19899346|P2|STARTED|Overall Study||41
8071002|NCT03346070|19899347|P1|STARTED|Overall Study||41
8070902|NCT04292899|19899174|P4|NOT COMPLETED|Overall Study||645
8070903|NCT04292899|19899175|P3|NOT COMPLETED|Overall Study||223
8070904|NCT04292899|19899176|P2|NOT COMPLETED|Overall Study||33
8070905|NCT04292899|19899177|P1|NOT COMPLETED|Overall Study||32
8070906|NCT04292899|19899174|P4|COMPLETED|Overall Study||2952
8070907|NCT04292899|19899175|P3|COMPLETED|Overall Study||621
8070908|NCT04292899|19899176|P2|COMPLETED|Overall Study||164
8070909|NCT04292899|19899177|P1|COMPLETED|Overall Study||168
8070910|NCT04292899|19899174|P4|STARTED|Overall Study||3597
8070911|NCT04292899|19899175|P3|STARTED|Overall Study||844
8070912|NCT04292899|19899176|P2|STARTED|Overall Study||197
8070913|NCT04292899|19899177|P1|STARTED|Overall Study||200
8070914|NCT04292730|19899191|P4|NOT COMPLETED|Overall Study||80
8070915|NCT04292730|19899192|P3|NOT COMPLETED|Overall Study||22
8070916|NCT04292730|19899193|P2|NOT COMPLETED|Overall Study||21
8070917|NCT04292730|19899194|P1|NOT COMPLETED|Overall Study||20
8070918|NCT04292730|19899191|P4|COMPLETED|Overall Study||437
8070919|NCT04292730|19899192|P3|COMPLETED|Overall Study||178
8070920|NCT04292730|19899193|P2|COMPLETED|Overall Study||176
8070921|NCT04292730|19899194|P1|COMPLETED|Overall Study||179
8070922|NCT04292730|19899191|P4|STARTED|Overall Study||517
8070923|NCT04292730|19899192|P3|STARTED|Overall Study||200
8070924|NCT04292730|19899193|P2|STARTED|Overall Study||197
8070925|NCT04292730|19899194|P1|STARTED|Overall Study||199
8070932|NCT04292639|19899214|P1|NOT COMPLETED|Overall Study||0
8070933|NCT04292639|19899214|P1|COMPLETED|Overall Study||20
8070934|NCT04292639|19899214|P1|STARTED|Overall Study||20
8070935|NCT04292171|19899220|P2|NOT COMPLETED|Overall Study||1
8070936|NCT04292171|19899221|P1|NOT COMPLETED|Overall Study||2
8070937|NCT04292171|19899220|P2|COMPLETED|Overall Study||109
8070938|NCT04292171|19899221|P1|COMPLETED|Overall Study||107
8070939|NCT04292171|19899220|P2|STARTED|Overall Study||110
8070940|NCT04292171|19899221|P1|STARTED|Overall Study||109
8070974|NCT04289714|19899322|P3|NOT COMPLETED|Overall Study||6
8070975|NCT04289714|19899323|P2|NOT COMPLETED|Overall Study||5
8070976|NCT04289714|19899324|P1|NOT COMPLETED|Overall Study||6
8070977|NCT04289714|19899322|P3|COMPLETED|Overall Study||4
8070978|NCT04289714|19899323|P2|COMPLETED|Overall Study||6
8070979|NCT04289714|19899324|P1|COMPLETED|Overall Study||8
8070980|NCT04289714|19899322|P3|STARTED|Overall Study||10
8070981|NCT04289714|19899323|P2|STARTED|Overall Study||11
8070982|NCT04289714|19899324|P1|STARTED|Overall Study||14
8071017|NCT03287635|19899456|P1|NOT COMPLETED|Overall Study||7
8071018|NCT03287635|19899456|P1|COMPLETED|Overall Study||12
8071019|NCT03287635|19899456|P1|STARTED|Overall Study||19
8071020|NCT03287219|19899464|P2|NOT COMPLETED|Overall Study||2
8071021|NCT03287219|19899465|P1|NOT COMPLETED|Overall Study||0
8071022|NCT03287219|19899464|P2|COMPLETED|Overall Study||88
8071023|NCT03287219|19899465|P1|COMPLETED|Overall Study||24
8071024|NCT03287219|19899464|P2|STARTED|Overall Study||90
8071025|NCT03287219|19899465|P1|STARTED|Overall Study||24
8071032|NCT04287517|19899539|P2|NOT COMPLETED|Overall Study||1
8071033|NCT04287517|19899540|P1|NOT COMPLETED|Overall Study||1
8071034|NCT04287517|19899539|P2|COMPLETED|Overall Study||18
8071035|NCT04287517|19899540|P1|COMPLETED|Overall Study||18
8071036|NCT04287517|19899539|P2|STARTED|Overall Study||19
8071037|NCT04287517|19899540|P1|STARTED|Overall Study||19
8071041|NCT04285411|19899578|P1|NOT COMPLETED|Overall Study||0
8071042|NCT04285411|19899578|P1|COMPLETED|Overall Study||10
8071043|NCT04285411|19899578|P1|STARTED|Overall Study||10
8071044|NCT04284930|19899586|P3|NOT COMPLETED|Overall Study||0
8071045|NCT04284930|19899587|P2|NOT COMPLETED|Overall Study||0
8071046|NCT04284930|19899588|P1|NOT COMPLETED|Overall Study||0
8071047|NCT04284930|19899586|P3|COMPLETED|Overall Study||8
8071048|NCT04284930|19899587|P2|COMPLETED|Overall Study||5
8071049|NCT04284930|19899588|P1|COMPLETED|Overall Study||8
8071050|NCT04284930|19899586|P3|STARTED|Overall Study||8
8071051|NCT04284930|19899587|P2|STARTED|Overall Study||5
8071052|NCT04284930|19899588|P1|STARTED|Overall Study||8
8071053|NCT03198871|19899598|P2|NOT COMPLETED|Overall Study||12
8071054|NCT03198871|19899599|P1|NOT COMPLETED|Overall Study||14
8071055|NCT03198871|19899598|P2|COMPLETED|Overall Study||78
8071056|NCT03198871|19899599|P1|COMPLETED|Overall Study||76
8071057|NCT03198871|19899598|P2|STARTED|Overall Study||90
8071058|NCT03198871|19899599|P1|STARTED|Overall Study||90
8071059|NCT03198715|19899634|P5|NOT COMPLETED|Overall Study||2
8071060|NCT03198715|19899635|P4|NOT COMPLETED|Overall Study||0
8071061|NCT03198715|19899636|P3|NOT COMPLETED|Overall Study||2
8071062|NCT03198715|19899637|P2|NOT COMPLETED|Overall Study||1
8071063|NCT03198715|19899638|P1|NOT COMPLETED|Overall Study||0
8071064|NCT03198715|19899634|P5|COMPLETED|Overall Study||7
8071065|NCT03198715|19899635|P4|COMPLETED|Overall Study||3
8071066|NCT03198715|19899636|P3|COMPLETED|Overall Study||10
8071067|NCT03198715|19899637|P2|COMPLETED|Overall Study||11
8071068|NCT03198715|19899638|P1|COMPLETED|Overall Study||6
8071069|NCT03198715|19899634|P5|STARTED|Overall Study||9
8071070|NCT03198715|19899635|P4|STARTED|Overall Study||3
8071071|NCT03198715|19899636|P3|STARTED|Overall Study||12
8071072|NCT03198715|19899637|P2|STARTED|Overall Study||12
8071073|NCT03198715|19899638|P1|STARTED|Overall Study||6
8071165|NCT02975297|19899979|P2|NOT COMPLETED|Overall Study||6
8071166|NCT02975297|19899980|P1|NOT COMPLETED|Overall Study||7
8071148|NCT04280705|19899871|P2|NOT COMPLETED|Overall Study||24
8071149|NCT04280705|19899872|P1|NOT COMPLETED|Overall Study||13
8071150|NCT04280705|19899871|P2|COMPLETED|Overall Study||517
8071151|NCT04280705|19899872|P1|COMPLETED|Overall Study||508
8071152|NCT04280705|19899871|P2|Received Treatment|Overall Study||531
8071153|NCT04280705|19899872|P1|Received Treatment|Overall Study||517
8071154|NCT04280705|19899871|P2|STARTED|Overall Study||541
8071155|NCT04280705|19899872|P1|STARTED|Overall Study||521
8071156|NCT04280653|19899956|P1|NOT COMPLETED|Overall Study||0
8071157|NCT04280653|19899956|P1|COMPLETED|Overall Study||15
8071158|NCT04280653|19899956|P1|STARTED|Overall Study||15
8071167|NCT02975297|19899979|P2|COMPLETED|Overall Study||35
8071168|NCT02975297|19899980|P1|COMPLETED|Overall Study||34
8071169|NCT02975297|19899979|P2|STARTED|Overall Study||41
8071170|NCT02975297|19899980|P1|STARTED|Overall Study||41
8071171|NCT02951195|19900010|P8|NOT COMPLETED|Overall Study||0
8071172|NCT02951195|19900011|P7|NOT COMPLETED|Overall Study||0
8071173|NCT02951195|19900012|P6|NOT COMPLETED|Overall Study||0
8071174|NCT02951195|19900013|P5|NOT COMPLETED|Overall Study||0
8071175|NCT02951195|19900014|P4|NOT COMPLETED|Overall Study||0
8071176|NCT02951195|19900015|P3|NOT COMPLETED|Overall Study||0
8071177|NCT02951195|19900016|P2|NOT COMPLETED|Overall Study||0
8071178|NCT02951195|19900017|P1|NOT COMPLETED|Overall Study||0
8071179|NCT02951195|19900010|P8|COMPLETED|Overall Study||21
8071180|NCT02951195|19900011|P7|COMPLETED|Overall Study||7
8071181|NCT02951195|19900012|P6|COMPLETED|Overall Study||10
8071182|NCT02951195|19900013|P5|COMPLETED|Overall Study||4
8071183|NCT02951195|19900014|P4|COMPLETED|Overall Study||10
8071184|NCT02951195|19900015|P3|COMPLETED|Overall Study||10
8071185|NCT02951195|19900016|P2|COMPLETED|Overall Study||6
8071186|NCT02951195|19900017|P1|COMPLETED|Overall Study||8
8071187|NCT02951195|19900010|P8|STARTED|Overall Study||21
8071188|NCT02951195|19900011|P7|STARTED|Overall Study||7
8071189|NCT02951195|19900012|P6|STARTED|Overall Study||10
8071190|NCT02951195|19900013|P5|STARTED|Overall Study||4
8071191|NCT02951195|19900014|P4|STARTED|Overall Study||10
8071192|NCT02951195|19900015|P3|STARTED|Overall Study||10
8071193|NCT02951195|19900016|P2|STARTED|Overall Study||6
8071194|NCT02951195|19900017|P1|STARTED|Overall Study||8
8071229|NCT02798211|19900142|P6|NOT COMPLETED|Period 2||6
8071230|NCT02798211|19900143|P5|NOT COMPLETED|Period 2||8
8071231|NCT02798211|19900144|P4|NOT COMPLETED|Period 2||7
8071232|NCT02798211|19900145|P3|NOT COMPLETED|Period 2||0
8071233|NCT02798211|19900146|P2|NOT COMPLETED|Period 2||0
8071234|NCT02798211|19900147|P1|NOT COMPLETED|Period 2||14
8071235|NCT02798211|19900142|P6|COMPLETED|Period 2||40
8071236|NCT02798211|19900143|P5|COMPLETED|Period 2||34
8071237|NCT02798211|19900144|P4|COMPLETED|Period 2||43
8071238|NCT02798211|19900145|P3|COMPLETED|Period 2||0
8071239|NCT02798211|19900146|P2|COMPLETED|Period 2||0
8071240|NCT02798211|19900147|P1|COMPLETED|Period 2||83
8071241|NCT02798211|19900142|P6|STARTED|Period 2||46
8071242|NCT02798211|19900143|P5|STARTED|Period 2||42
8071243|NCT02798211|19900144|P4|STARTED|Period 2||50
8071244|NCT02798211|19900145|P3|STARTED|Period 2||0
8071245|NCT02798211|19900146|P2|STARTED|Period 2||0
8071246|NCT02798211|19900147|P1|STARTED|Period 2||97
8071247|NCT02798211|19900142|P6|NOT COMPLETED|Period 1||0
8071248|NCT02798211|19900143|P5|NOT COMPLETED|Period 1||0
8071249|NCT02798211|19900144|P4|NOT COMPLETED|Period 1||0
8071250|NCT02798211|19900145|P3|NOT COMPLETED|Period 1||6
8071251|NCT02798211|19900146|P2|NOT COMPLETED|Period 1||10
8071252|NCT02798211|19900147|P1|NOT COMPLETED|Period 1||6
8071253|NCT02798211|19900142|P6|COMPLETED|Period 1||0
8071254|NCT02798211|19900143|P5|COMPLETED|Period 1||0
8071255|NCT02798211|19900144|P4|COMPLETED|Period 1||0
8071256|NCT02798211|19900145|P3|COMPLETED|Period 1||46
8071257|NCT02798211|19900146|P2|COMPLETED|Period 1||93
8071258|NCT02798211|19900147|P1|COMPLETED|Period 1||97
8071259|NCT02798211|19900142|P6|STARTED|Period 1||0
8071260|NCT02798211|19900143|P5|STARTED|Period 1||0
8071261|NCT02798211|19900144|P4|STARTED|Period 1||0
8071262|NCT02798211|19900145|P3|STARTED|Period 1||52
8071263|NCT02798211|19900146|P2|STARTED|Period 1||103
8071264|NCT02798211|19900147|P1|STARTED|Period 1||103
8071271|NCT02730793|19900264|P2|NOT COMPLETED|Overall Study||2
8071272|NCT02730793|19900265|P1|NOT COMPLETED|Overall Study||0
8071273|NCT02730793|19900264|P2|COMPLETED|Overall Study||1
8071274|NCT02730793|19900265|P1|COMPLETED|Overall Study||2
8071275|NCT02730793|19900264|P2|STARTED|Overall Study||3
8071276|NCT02730793|19900265|P1|STARTED|Overall Study||2
8071283|NCT02721355|19900316|P2|NOT COMPLETED|Overall Study||1
8071284|NCT02721355|19900317|P1|NOT COMPLETED|Overall Study||6
8071285|NCT02721355|19900316|P2|COMPLETED|Overall Study||41
8071286|NCT02721355|19900317|P1|COMPLETED|Overall Study||36
8071287|NCT02721355|19900316|P2|STARTED|Overall Study||42
8071288|NCT02721355|19900317|P1|STARTED|Overall Study||42
8071295|NCT04272775|19900341|P2|NOT COMPLETED|Overall Study||7
8071296|NCT04272775|19900342|P1|NOT COMPLETED|Overall Study||7
8071297|NCT04272775|19900341|P2|COMPLETED|Overall Study||0
8071298|NCT04272775|19900342|P1|COMPLETED|Overall Study||0
8071299|NCT04272775|19900341|P2|STARTED|Overall Study||7
8071300|NCT04272775|19900342|P1|STARTED|Overall Study||7
8071328|NCT02617628|19900531|P2|NOT COMPLETED|Overall Study||61
8071329|NCT02617628|19900532|P1|NOT COMPLETED|Overall Study||62
8071330|NCT02617628|19900531|P2|COMPLETED|Overall Study||11
8071331|NCT02617628|19900532|P1|COMPLETED|Overall Study||12
8071332|NCT02617628|19900531|P2|STARTED|Overall Study||72
8071333|NCT02617628|19900532|P1|STARTED|Overall Study||74
8071334|NCT04271020|19900540|P1|NOT COMPLETED|Overall Study||0
8071335|NCT04271020|19900540|P1|COMPLETED|Overall Study||12
8071336|NCT04271020|19900540|P1|STARTED|Overall Study||12
8071337|NCT02526277|19900550|P4|NOT COMPLETED|Overall Study||0
8071338|NCT02526277|19900551|P3|NOT COMPLETED|Overall Study||0
8071339|NCT02526277|19900552|P2|NOT COMPLETED|Overall Study||0
8071340|NCT02526277|19900553|P1|NOT COMPLETED|Overall Study||0
8071341|NCT02526277|19900550|P4|COMPLETED|Overall Study||7
8071342|NCT02526277|19900551|P3|COMPLETED|Overall Study||7
8071343|NCT02526277|19900552|P2|COMPLETED|Overall Study||6
8071344|NCT02526277|19900553|P1|COMPLETED|Overall Study||8
8071345|NCT02526277|19900550|P4|STARTED|Overall Study||7
8071346|NCT02526277|19900551|P3|STARTED|Overall Study||7
8071347|NCT02526277|19900552|P2|STARTED|Overall Study||6
8071348|NCT02526277|19900553|P1|STARTED|Overall Study||8
8071349|NCT04270292|19900571|P1|NOT COMPLETED|Overall Study||0
8071350|NCT04270292|19900571|P1|COMPLETED|Overall Study||164
8071351|NCT04270292|19900571|P1|STARTED|Overall Study||164
8071389|NCT02357979|19900711|P2|NOT COMPLETED|Overall Study||5
8071390|NCT02357979|19900712|P1|NOT COMPLETED|Overall Study||5
8071391|NCT02357979|19900711|P2|COMPLETED|Overall Study||55
8071392|NCT02357979|19900712|P1|COMPLETED|Overall Study||55
8071393|NCT02357979|19900711|P2|STARTED|Overall Study||60
8071394|NCT02357979|19900712|P1|STARTED|Overall Study||60
8071401|NCT02340676|19900769|P1|NOT COMPLETED|Overall Study||0
8071402|NCT02340676|19900769|P1|COMPLETED|Overall Study||25
8071403|NCT02340676|19900769|P1|STARTED|Overall Study||25
8071404|NCT02338960|19900782|P2|NOT COMPLETED|Open Label Extension||79
8071405|NCT02338960|19900783|P1|NOT COMPLETED|Open Label Extension||114
8071406|NCT02338960|19900782|P2|COMPLETED|Open Label Extension||51
8071407|NCT02338960|19900783|P1|COMPLETED|Open Label Extension||77
8071408|NCT02338960|19900782|P2|STARTED|Open Label Extension||130
8071409|NCT02338960|19900783|P1|STARTED|Open Label Extension||191
8071410|NCT02338960|19900782|P2|NOT COMPLETED|Core Study||135
8071411|NCT02338960|19900783|P1|NOT COMPLETED|Core Study||87
8071412|NCT02338960|19900782|P2|COMPLETED|Core Study||173
8071413|NCT02338960|19900783|P1|COMPLETED|Core Study||219
8071414|NCT02338960|19900782|P2|Received Intervention|Core Study||301
8071415|NCT02338960|19900783|P1|Received Intervention|Core Study||303
8071416|NCT02338960|19900782|P2|STARTED|Core Study||308
8071417|NCT02338960|19900783|P1|STARTED|Core Study||306
8071444|NCT02245815|19900917|P2|NOT COMPLETED|Overall Study||0
8071445|NCT02245815|19900918|P1|NOT COMPLETED|Overall Study||0
8071446|NCT02245815|19900917|P2|COMPLETED|Overall Study||45
8071447|NCT02245815|19900918|P1|COMPLETED|Overall Study||45
8071448|NCT02245815|19900917|P2|STARTED|Overall Study||45
8071449|NCT02245815|19900918|P1|STARTED|Overall Study||45
8071450|NCT02213380|19900928|P2|NOT COMPLETED|Per-protocol Analysis||36
8071451|NCT02213380|19900929|P1|NOT COMPLETED|Per-protocol Analysis||32
8071452|NCT02213380|19900928|P2|COMPLETED|Per-protocol Analysis||435
8071453|NCT02213380|19900929|P1|COMPLETED|Per-protocol Analysis||439
8071454|NCT02213380|19900928|P2|STARTED|Per-protocol Analysis||471
8071455|NCT02213380|19900929|P1|STARTED|Per-protocol Analysis||471
8071456|NCT02213380|19900928|P2|NOT COMPLETED|Underwent Randomization||3
8071457|NCT02213380|19900929|P1|NOT COMPLETED|Underwent Randomization||5
8071458|NCT02213380|19900928|P2|COMPLETED|Underwent Randomization||471
8071459|NCT02213380|19900929|P1|COMPLETED|Underwent Randomization||471
8071460|NCT02213380|19900928|P2|STARTED|Underwent Randomization||474
8071461|NCT02213380|19900929|P1|STARTED|Underwent Randomization||476
8071364|NCT04269629|19900623|P1|NOT COMPLETED|Overall Study||239
8071365|NCT04269629|19900623|P1|COMPLETED|Overall Study|Visit 3 was performed with 1186 patients|1186
8071366|NCT04269629|19900623|P1|Number of Patients Who Performed VIT|Overall Study|Visit 2 was performed with 1342 patients|1342
8071367|NCT04269629|19900623|P1|STARTED|Overall Study|1425 patients were included in the study (=Visit 1)|1425
8071383|NCT04267770|19900679|P2|NOT COMPLETED|Overall Study||0
8071384|NCT04267770|19900680|P1|NOT COMPLETED|Overall Study||0
8071385|NCT04267770|19900679|P2|COMPLETED|Overall Study||8
8071386|NCT04267770|19900680|P1|COMPLETED|Overall Study||9
8071387|NCT04267770|19900679|P2|STARTED|Overall Study||8
8071388|NCT04267770|19900680|P1|STARTED|Overall Study||9
8071395|NCT04267380|19900724|P2|NOT COMPLETED|Overall Study||0
8071396|NCT04267380|19900725|P1|NOT COMPLETED|Overall Study||0
8071397|NCT04267380|19900724|P2|COMPLETED|Overall Study||149
8071398|NCT04267380|19900725|P1|COMPLETED|Overall Study||149
8071399|NCT04267380|19900724|P2|STARTED|Overall Study||149
8071400|NCT04267380|19900725|P1|STARTED|Overall Study||149
8071418|NCT04266925|19900821|P2|NOT COMPLETED|3 Referee Game (~1 Hour)||0
8071419|NCT04266925|19900822|P1|NOT COMPLETED|3 Referee Game (~1 Hour)||0
8071420|NCT04266925|19900821|P2|COMPLETED|3 Referee Game (~1 Hour)||26
8071421|NCT04266925|19900822|P1|COMPLETED|3 Referee Game (~1 Hour)||23
8071422|NCT04266925|19900821|P2|STARTED|3 Referee Game (~1 Hour)||26
8071423|NCT04266925|19900822|P1|STARTED|3 Referee Game (~1 Hour)||23
8071424|NCT04266925|19900821|P2|NOT COMPLETED|1 Referee Game (~1 Hour)||0
8071425|NCT04266925|19900822|P1|NOT COMPLETED|1 Referee Game (~1 Hour)||0
8071426|NCT04266925|19900821|P2|COMPLETED|1 Referee Game (~1 Hour)||26
8071427|NCT04266925|19900822|P1|COMPLETED|1 Referee Game (~1 Hour)||23
8071428|NCT04266925|19900821|P2|STARTED|1 Referee Game (~1 Hour)||26
8071429|NCT04266925|19900822|P1|STARTED|1 Referee Game (~1 Hour)||23
8071497|NCT02180165|19900997|P4|NOT COMPLETED|Overall Study||6
8071498|NCT02180165|19900998|P3|NOT COMPLETED|Overall Study||29
8071499|NCT02180165|19900999|P2|NOT COMPLETED|Overall Study||1
8071500|NCT02180165|19901000|P1|NOT COMPLETED|Overall Study||11
8071501|NCT02180165|19900997|P4|COMPLETED|Overall Study||25
8071502|NCT02180165|19900998|P3|COMPLETED|Overall Study||34
8071503|NCT02180165|19900999|P2|COMPLETED|Overall Study||6
8071504|NCT02180165|19901000|P1|COMPLETED|Overall Study||4
8071505|NCT02180165|19900997|P4|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27
8071506|NCT02180165|19900998|P3|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57
8071507|NCT02180165|19900999|P2|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7
8071508|NCT02180165|19901000|P1|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15
8071509|NCT02180165|19900997|P4|Treated Participants|Overall Study||31
8071510|NCT02180165|19900998|P3|Treated Participants|Overall Study||62
8071511|NCT02180165|19900999|P2|Treated Participants|Overall Study||7
8071512|NCT02180165|19901000|P1|Treated Participants|Overall Study||15
8071513|NCT02180165|19900997|P4|STARTED|Overall Study||31
8071514|NCT02180165|19900998|P3|STARTED|Overall Study||63
8071515|NCT02180165|19900999|P2|STARTED|Overall Study||7
8071516|NCT02180165|19901000|P1|STARTED|Overall Study||15
8071538|NCT02137837|19901147|P3|NOT COMPLETED|Overall Study||12
8071539|NCT02137837|19901148|P2|NOT COMPLETED|Overall Study||12
8071540|NCT02137837|19901149|P1|NOT COMPLETED|Overall Study||13
8071541|NCT02137837|19901147|P3|COMPLETED|Overall Study||0
8071542|NCT02137837|19901148|P2|COMPLETED|Overall Study||0
8071543|NCT02137837|19901149|P1|COMPLETED|Overall Study||0
8071544|NCT02137837|19901147|P3|Received Protocol Therapy|Overall Study||12
8071545|NCT02137837|19901148|P2|Received Protocol Therapy|Overall Study||11
8071546|NCT02137837|19901149|P1|Received Protocol Therapy|Overall Study||13
8071547|NCT02137837|19901147|P3|STARTED|Overall Study||12
8071548|NCT02137837|19901148|P2|STARTED|Overall Study||12
8071549|NCT02137837|19901149|P1|STARTED|Overall Study||13
8071550|NCT02132754|19901209|P34|NOT COMPLETED|Overall Study||23
8071551|NCT02132754|19901210|P33|NOT COMPLETED|Overall Study||4
8071552|NCT02132754|19901211|P32|NOT COMPLETED|Overall Study||3
8071553|NCT02132754|19901212|P31|NOT COMPLETED|Overall Study||3
8071554|NCT02132754|19901213|P30|NOT COMPLETED|Overall Study||3
8071555|NCT02132754|19901214|P29|NOT COMPLETED|Overall Study||3
8071556|NCT02132754|19901215|P28|NOT COMPLETED|Overall Study||3
8071557|NCT02132754|19901216|P27|NOT COMPLETED|Overall Study||4
8071558|NCT02132754|19901217|P26|NOT COMPLETED|Overall Study||3
8071559|NCT02132754|19901218|P25|NOT COMPLETED|Overall Study||3
8071560|NCT02132754|19901219|P24|NOT COMPLETED|Overall Study||3
8071561|NCT02132754|19901220|P23|NOT COMPLETED|Overall Study||3
8071562|NCT02132754|19901221|P22|NOT COMPLETED|Overall Study||5
8071563|NCT02132754|19901222|P21|NOT COMPLETED|Overall Study||3
8071564|NCT02132754|19901223|P20|NOT COMPLETED|Overall Study||4
8071565|NCT02132754|19901224|P19|NOT COMPLETED|Overall Study||3
8071566|NCT02132754|19901225|P18|NOT COMPLETED|Overall Study||3
8071567|NCT02132754|19901226|P17|NOT COMPLETED|Overall Study||4
8071568|NCT02132754|19901227|P16|NOT COMPLETED|Overall Study||5
8071569|NCT02132754|19901228|P15|NOT COMPLETED|Overall Study||3
8071570|NCT02132754|19901229|P14|NOT COMPLETED|Overall Study||3
8071571|NCT02132754|19901230|P13|NOT COMPLETED|Overall Study||4
8071572|NCT02132754|19901231|P12|NOT COMPLETED|Overall Study||3
8071573|NCT02132754|19901232|P11|NOT COMPLETED|Overall Study||3
8071574|NCT02132754|19901233|P10|NOT COMPLETED|Overall Study||6
8071575|NCT02132754|19901234|P9|NOT COMPLETED|Overall Study||1
8071576|NCT02132754|19901235|P8|NOT COMPLETED|Overall Study||1
8071577|NCT02132754|19901236|P7|NOT COMPLETED|Overall Study||1
8071578|NCT02132754|19901237|P6|NOT COMPLETED|Overall Study||1
8071579|NCT02132754|19901238|P5|NOT COMPLETED|Overall Study||1
8071580|NCT02132754|19901239|P4|NOT COMPLETED|Overall Study||1
8071581|NCT02132754|19901240|P3|NOT COMPLETED|Overall Study||1
8071582|NCT02132754|19901241|P2|NOT COMPLETED|Overall Study||1
8071583|NCT02132754|19901242|P1|NOT COMPLETED|Overall Study||1
8071584|NCT02132754|19901209|P34|COMPLETED|Overall Study||0
8071585|NCT02132754|19901210|P33|COMPLETED|Overall Study||0
8071586|NCT02132754|19901211|P32|COMPLETED|Overall Study||0
8071587|NCT02132754|19901212|P31|COMPLETED|Overall Study||0
8071588|NCT02132754|19901213|P30|COMPLETED|Overall Study||0
8071589|NCT02132754|19901214|P29|COMPLETED|Overall Study||0
8071590|NCT02132754|19901215|P28|COMPLETED|Overall Study||0
8071591|NCT02132754|19901216|P27|COMPLETED|Overall Study||0
8071592|NCT02132754|19901217|P26|COMPLETED|Overall Study||0
8071593|NCT02132754|19901218|P25|COMPLETED|Overall Study||0
8071594|NCT02132754|19901219|P24|COMPLETED|Overall Study||0
8071595|NCT02132754|19901220|P23|COMPLETED|Overall Study||0
8071596|NCT02132754|19901221|P22|COMPLETED|Overall Study||0
8071597|NCT02132754|19901222|P21|COMPLETED|Overall Study||0
8071598|NCT02132754|19901223|P20|COMPLETED|Overall Study||0
8071599|NCT02132754|19901224|P19|COMPLETED|Overall Study||0
8071600|NCT02132754|19901225|P18|COMPLETED|Overall Study||0
8071601|NCT02132754|19901226|P17|COMPLETED|Overall Study||0
8071602|NCT02132754|19901227|P16|COMPLETED|Overall Study||0
8071603|NCT02132754|19901228|P15|COMPLETED|Overall Study||0
8071604|NCT02132754|19901229|P14|COMPLETED|Overall Study||0
8071605|NCT02132754|19901230|P13|COMPLETED|Overall Study||0
8071606|NCT02132754|19901231|P12|COMPLETED|Overall Study||0
8071607|NCT02132754|19901232|P11|COMPLETED|Overall Study||0
8071608|NCT02132754|19901233|P10|COMPLETED|Overall Study||0
8071609|NCT02132754|19901234|P9|COMPLETED|Overall Study||0
8071610|NCT02132754|19901235|P8|COMPLETED|Overall Study||0
8071611|NCT02132754|19901236|P7|COMPLETED|Overall Study||0
8071612|NCT02132754|19901237|P6|COMPLETED|Overall Study||0
8071613|NCT02132754|19901238|P5|COMPLETED|Overall Study||0
8071614|NCT02132754|19901239|P4|COMPLETED|Overall Study||0
8071615|NCT02132754|19901240|P3|COMPLETED|Overall Study||0
8071616|NCT02132754|19901241|P2|COMPLETED|Overall Study||0
8071617|NCT02132754|19901242|P1|COMPLETED|Overall Study||0
8071618|NCT02132754|19901209|P34|Treated|Overall Study||23
8071619|NCT02132754|19901210|P33|Treated|Overall Study||4
8071620|NCT02132754|19901211|P32|Treated|Overall Study||3
8071621|NCT02132754|19901212|P31|Treated|Overall Study||3
8071622|NCT02132754|19901213|P30|Treated|Overall Study||3
8071623|NCT02132754|19901214|P29|Treated|Overall Study||3
8071624|NCT02132754|19901215|P28|Treated|Overall Study||3
8071625|NCT02132754|19901216|P27|Treated|Overall Study||4
8071626|NCT02132754|19901217|P26|Treated|Overall Study||3
8071627|NCT02132754|19901218|P25|Treated|Overall Study||3
8071628|NCT02132754|19901219|P24|Treated|Overall Study||3
8071629|NCT02132754|19901220|P23|Treated|Overall Study||3
8071630|NCT02132754|19901221|P22|Treated|Overall Study||4
8071631|NCT02132754|19901222|P21|Treated|Overall Study||3
8071632|NCT02132754|19901223|P20|Treated|Overall Study||3
8071633|NCT02132754|19901224|P19|Treated|Overall Study||3
8071634|NCT02132754|19901225|P18|Treated|Overall Study||3
8071635|NCT02132754|19901226|P17|Treated|Overall Study||4
8071636|NCT02132754|19901227|P16|Treated|Overall Study||5
8071637|NCT02132754|19901228|P15|Treated|Overall Study||3
8071638|NCT02132754|19901229|P14|Treated|Overall Study||3
8071639|NCT02132754|19901230|P13|Treated|Overall Study||3
8071640|NCT02132754|19901231|P12|Treated|Overall Study||3
8071641|NCT02132754|19901232|P11|Treated|Overall Study||3
8071642|NCT02132754|19901233|P10|Treated|Overall Study||6
8071643|NCT02132754|19901234|P9|Treated|Overall Study||1
8071644|NCT02132754|19901235|P8|Treated|Overall Study||1
8071645|NCT02132754|19901236|P7|Treated|Overall Study||1
8071646|NCT02132754|19901237|P6|Treated|Overall Study||1
8071647|NCT02132754|19901238|P5|Treated|Overall Study||1
8071648|NCT02132754|19901239|P4|Treated|Overall Study||1
8071649|NCT02132754|19901240|P3|Treated|Overall Study||1
8071650|NCT02132754|19901241|P2|Treated|Overall Study||1
8071651|NCT02132754|19901242|P1|Treated|Overall Study||1
8071652|NCT02132754|19901209|P34|STARTED|Overall Study||23
8071653|NCT02132754|19901210|P33|STARTED|Overall Study||4
8071654|NCT02132754|19901211|P32|STARTED|Overall Study||3
8071655|NCT02132754|19901212|P31|STARTED|Overall Study||3
8071656|NCT02132754|19901213|P30|STARTED|Overall Study||3
8071657|NCT02132754|19901214|P29|STARTED|Overall Study||3
8071658|NCT02132754|19901215|P28|STARTED|Overall Study||3
8071659|NCT02132754|19901216|P27|STARTED|Overall Study||4
8071660|NCT02132754|19901217|P26|STARTED|Overall Study||3
8071661|NCT02132754|19901218|P25|STARTED|Overall Study||3
8071662|NCT02132754|19901219|P24|STARTED|Overall Study||3
8071663|NCT02132754|19901220|P23|STARTED|Overall Study||3
8071664|NCT02132754|19901221|P22|STARTED|Overall Study||5
8071665|NCT02132754|19901222|P21|STARTED|Overall Study||3
8071666|NCT02132754|19901223|P20|STARTED|Overall Study||4
8071667|NCT02132754|19901224|P19|STARTED|Overall Study||3
8071668|NCT02132754|19901225|P18|STARTED|Overall Study||3
8071669|NCT02132754|19901226|P17|STARTED|Overall Study||4
8071670|NCT02132754|19901227|P16|STARTED|Overall Study||5
8071671|NCT02132754|19901228|P15|STARTED|Overall Study||3
8071672|NCT02132754|19901229|P14|STARTED|Overall Study||3
8071673|NCT02132754|19901230|P13|STARTED|Overall Study||4
8071674|NCT02132754|19901231|P12|STARTED|Overall Study||3
8071675|NCT02132754|19901232|P11|STARTED|Overall Study||3
8071676|NCT02132754|19901233|P10|STARTED|Overall Study||6
8071677|NCT02132754|19901234|P9|STARTED|Overall Study||1
8071678|NCT02132754|19901235|P8|STARTED|Overall Study||1
8071679|NCT02132754|19901236|P7|STARTED|Overall Study||1
8071680|NCT02132754|19901237|P6|STARTED|Overall Study||1
8071681|NCT02132754|19901238|P5|STARTED|Overall Study||1
8071682|NCT02132754|19901239|P4|STARTED|Overall Study||1
8071683|NCT02132754|19901240|P3|STARTED|Overall Study||1
8071684|NCT02132754|19901241|P2|STARTED|Overall Study||1
8071685|NCT02132754|19901242|P1|STARTED|Overall Study||1
8071686|NCT02036853|19901966|P2|NOT COMPLETED|Overall Study||6
8071687|NCT02036853|19901967|P1|NOT COMPLETED|Overall Study||0
8071688|NCT02036853|19901966|P2|COMPLETED|Overall Study||8
8071689|NCT02036853|19901967|P1|COMPLETED|Overall Study||6
8071690|NCT02036853|19901966|P2|STARTED|Overall Study||14
8071691|NCT02036853|19901967|P1|STARTED|Overall Study||6
8071725|NCT01838044|19902071|P2|NOT COMPLETED|Overall Study||16
8071726|NCT01838044|19902072|P1|NOT COMPLETED|Overall Study||8
8071727|NCT01838044|19902071|P2|COMPLETED|Overall Study||75
8071728|NCT01838044|19902072|P1|COMPLETED|Overall Study||81
8071729|NCT01838044|19902071|P2|STARTED|Overall Study||91
8071730|NCT01838044|19902072|P1|STARTED|Overall Study||89
8071751|NCT01727791|19902146|P1|NOT COMPLETED|Overall Study||0
8071752|NCT01727791|19902146|P1|COMPLETED|Overall Study||10
8071753|NCT01727791|19902146|P1|STARTED|Overall Study||10
8071754|NCT01701362|19902178|P2|NOT COMPLETED|Overall Study||56
8071755|NCT01701362|19902179|P1|NOT COMPLETED|Overall Study||42
8071756|NCT01701362|19902178|P2|COMPLETED|Overall Study||211
8071757|NCT01701362|19902179|P1|COMPLETED|Overall Study||233
8071758|NCT01701362|19902178|P2|TREATED|Overall Study||265
8071759|NCT01701362|19902179|P1|TREATED|Overall Study||274
8071760|NCT01701362|19902178|P2|STARTED|Overall Study||267
8071761|NCT01701362|19902179|P1|STARTED|Overall Study||275
8071816|NCT01645306|19902302|P3|NOT COMPLETED|Overall Study||5
8071817|NCT01645306|19902303|P2|NOT COMPLETED|Overall Study||4
8071818|NCT01645306|19902304|P1|NOT COMPLETED|Overall Study||2
8071819|NCT01645306|19902302|P3|COMPLETED|Overall Study||48
8071820|NCT01645306|19902303|P2|COMPLETED|Overall Study||50
8071821|NCT01645306|19902304|P1|COMPLETED|Overall Study||49
8071822|NCT01645306|19902302|P3|STARTED|Overall Study||53
8071823|NCT01645306|19902303|P2|STARTED|Overall Study||54
8071824|NCT01645306|19902304|P1|STARTED|Overall Study||51
8071831|NCT01524796|19902344|P1|NOT COMPLETED|Overall Study||28
8071832|NCT01524796|19902344|P1|COMPLETED|Overall Study||100
8071833|NCT01524796|19902344|P1|STARTED|Overall Study||128
8071834|NCT01488578|19902357|P1|NOT COMPLETED|Overall Study||1836
8071835|NCT01488578|19902357|P1|COMPLETED|Overall Study||9321
8071836|NCT01488578|19902357|P1|STARTED|Overall Study||11157
8071837|NCT01485887|19902391|P1|NOT COMPLETED|Overall Study||12
8071838|NCT01485887|19902391|P1|COMPLETED|Overall Study||38
8071839|NCT01485887|19902391|P1|STARTED|Overall Study||50
8071840|NCT01474772|19902405|P2|NOT COMPLETED|Follow-up||1
8071841|NCT01474772|19902406|P1|NOT COMPLETED|Follow-up||0
8071842|NCT01474772|19902405|P2|COMPLETED|Follow-up||86
8071843|NCT01474772|19902406|P1|COMPLETED|Follow-up||77
8071844|NCT01474772|19902405|P2|STARTED|Follow-up||87
8071845|NCT01474772|19902406|P1|STARTED|Follow-up||77
8071846|NCT01474772|19902405|P2|NOT COMPLETED|Period 2||10
8071847|NCT01474772|19902406|P1|NOT COMPLETED|Period 2||9
8071848|NCT01474772|19902405|P2|COMPLETED|Period 2||87
8071849|NCT01474772|19902406|P1|COMPLETED|Period 2||77
8071850|NCT01474772|19902405|P2|STARTED|Period 2||97
8071851|NCT01474772|19902406|P1|STARTED|Period 2||86
8071852|NCT01474772|19902405|P2|NOT COMPLETED|Washout||2
8071853|NCT01474772|19902406|P1|NOT COMPLETED|Washout||3
8071854|NCT01474772|19902405|P2|COMPLETED|Washout||97
8071855|NCT01474772|19902406|P1|COMPLETED|Washout||86
8071856|NCT01474772|19902405|P2|STARTED|Washout||99
8071857|NCT01474772|19902406|P1|STARTED|Washout||89
8071858|NCT01474772|19902405|P2|NOT COMPLETED|Period 1||3
8071859|NCT01474772|19902406|P1|NOT COMPLETED|Period 1||12
8071860|NCT01474772|19902405|P2|COMPLETED|Period 1||99
8071861|NCT01474772|19902406|P1|COMPLETED|Period 1||89
8071862|NCT01474772|19902405|P2|STARTED|Period 1|STARTED=treated|102
8071863|NCT01474772|19902406|P1|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
8071870|NCT01455428|19902465|P2|NOT COMPLETED|Overall Study||18
8071871|NCT01455428|19902466|P1|NOT COMPLETED|Overall Study||14
8071872|NCT01455428|19902465|P2|COMPLETED|Overall Study||92
8071873|NCT01455428|19902466|P1|COMPLETED|Overall Study||98
8071874|NCT01455428|19902465|P2|Treated|Overall Study||109
8071875|NCT01455428|19902466|P1|Treated|Overall Study||111
8071876|NCT01455428|19902465|P2|STARTED|Overall Study||110
8071877|NCT01455428|19902466|P1|STARTED|Overall Study||112
8071878|NCT01455415|19902522|P2|NOT COMPLETED|Follow-up||2
8071879|NCT01455415|19902523|P1|NOT COMPLETED|Follow-up||3
8071880|NCT01455415|19902522|P2|COMPLETED|Follow-up||104
8071881|NCT01455415|19902523|P1|COMPLETED|Follow-up||111
8071882|NCT01455415|19902522|P2|STARTED|Follow-up||106
8071883|NCT01455415|19902523|P1|STARTED|Follow-up||114
8071884|NCT01455415|19902522|P2|NOT COMPLETED|Period 2||10
8071885|NCT01455415|19902523|P1|NOT COMPLETED|Period 2||13
8071886|NCT01455415|19902522|P2|COMPLETED|Period 2||106
8071887|NCT01455415|19902523|P1|COMPLETED|Period 2||114
8071888|NCT01455415|19902522|P2|STARTED|Period 2||116
8071889|NCT01455415|19902523|P1|STARTED|Period 2||127
8071890|NCT01455415|19902522|P2|NOT COMPLETED|Washout||7
8071891|NCT01455415|19902523|P1|NOT COMPLETED|Washout||8
8071892|NCT01455415|19902522|P2|COMPLETED|Washout||116
8071893|NCT01455415|19902523|P1|COMPLETED|Washout||127
8071894|NCT01455415|19902522|P2|STARTED|Washout||123
8071895|NCT01455415|19902523|P1|STARTED|Washout||135
8071896|NCT01455415|19902522|P2|NOT COMPLETED|Period 1||24
8071897|NCT01455415|19902523|P1|NOT COMPLETED|Period 1||19
8071898|NCT01455415|19902522|P2|COMPLETED|Period 1||123
8071899|NCT01455415|19902523|P1|COMPLETED|Period 1||135
8071900|NCT01455415|19902522|P2|STARTED|Period 1|Started=Treated|147
8071901|NCT01455415|19902523|P1|STARTED|Period 1|Started=Treated|154
8071902|NCT01441440|19902576|P3|NOT COMPLETED|Overall Study||22
8071903|NCT01441440|19902577|P2|NOT COMPLETED|Overall Study||23
8071904|NCT01441440|19902578|P1|NOT COMPLETED|Overall Study||17
8071905|NCT01441440|19902576|P3|COMPLETED|Overall Study||158
8071906|NCT01441440|19902577|P2|COMPLETED|Overall Study||151
8071907|NCT01441440|19902578|P1|COMPLETED|Overall Study||166
8071908|NCT01441440|19902576|P3|STARTED|Overall Study|Safety analysis set|180
8071909|NCT01441440|19902577|P2|STARTED|Overall Study|Safety analysis set|174
8071910|NCT01441440|19902578|P1|STARTED|Overall Study|Safety analysis set|183
8071911|NCT01424722|19902601|P1|NOT COMPLETED|Overall Study||2258
8071912|NCT01424722|19902601|P1|COMPLETED|Overall Study||0
8071913|NCT01424722|19902601|P1|STARTED|Overall Study||2258
8071914|NCT01387607|19902607|P2|NOT COMPLETED|Overall Study||45
8071915|NCT01387607|19902608|P1|NOT COMPLETED|Overall Study||51
8071916|NCT01387607|19902607|P2|COMPLETED|Overall Study||125
8071917|NCT01387607|19902608|P1|COMPLETED|Overall Study||122
8071918|NCT01387607|19902607|P2|Received Treatment|Overall Study||164
8071919|NCT01387607|19902608|P1|Received Treatment|Overall Study||170
8071920|NCT01387607|19902607|P2|STARTED|Overall Study||170
8071921|NCT01387607|19902608|P1|STARTED|Overall Study||173
8071928|NCT01366092|19902699|P1|NOT COMPLETED|Overall Study||4
8071929|NCT01366092|19902699|P1|COMPLETED|Overall Study||31
8071930|NCT01366092|19902699|P1|STARTED|Overall Study||35
8071931|NCT01355068|19902708|P2|NOT COMPLETED|Second Intervention Period||0
8071932|NCT01355068|19902709|P1|NOT COMPLETED|Second Intervention Period||0
8071933|NCT01355068|19902708|P2|COMPLETED|Second Intervention Period||11
8071934|NCT01355068|19902709|P1|COMPLETED|Second Intervention Period||13
8071935|NCT01355068|19902708|P2|STARTED|Second Intervention Period||11
8071936|NCT01355068|19902709|P1|STARTED|Second Intervention Period||13
8071937|NCT01355068|19902708|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8071938|NCT01355068|19902709|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8071939|NCT01355068|19902708|P2|COMPLETED|Washout Period (at Least 7 Days)||11
8071940|NCT01355068|19902709|P1|COMPLETED|Washout Period (at Least 7 Days)||13
8071941|NCT01355068|19902708|P2|STARTED|Washout Period (at Least 7 Days)||11
8071942|NCT01355068|19902709|P1|STARTED|Washout Period (at Least 7 Days)||13
8071943|NCT01355068|19902708|P2|NOT COMPLETED|First Intervention Period||2
8071944|NCT01355068|19902709|P1|NOT COMPLETED|First Intervention Period||0
8071945|NCT01355068|19902708|P2|COMPLETED|First Intervention Period||11
8071946|NCT01355068|19902709|P1|COMPLETED|First Intervention Period||13
8071947|NCT01355068|19902708|P2|STARTED|First Intervention Period||13
8071948|NCT01355068|19902709|P1|STARTED|First Intervention Period||13
8071949|NCT01336634|19902728|P3|NOT COMPLETED|Overall Study||36
8071950|NCT01336634|19902729|P2|NOT COMPLETED|Overall Study||57
8071951|NCT01336634|19902730|P1|NOT COMPLETED|Overall Study||84
8071952|NCT01336634|19902728|P3|COMPLETED|Overall Study||0
8071953|NCT01336634|19902729|P2|COMPLETED|Overall Study||0
8071954|NCT01336634|19902730|P1|COMPLETED|Overall Study||0
8071955|NCT01336634|19902728|P3|STARTED|Overall Study||36
8071956|NCT01336634|19902729|P2|STARTED|Overall Study||57
8071957|NCT01336634|19902730|P1|STARTED|Overall Study||84
8071958|NCT01332149|19902773|P2|NOT COMPLETED|Overall Study||38
8071959|NCT01332149|19902774|P1|NOT COMPLETED|Overall Study||30
8071960|NCT01332149|19902773|P2|COMPLETED|Overall Study||271
8071961|NCT01332149|19902774|P1|COMPLETED|Overall Study||284
8071962|NCT01332149|19902773|P2|Treated|Overall Study||307
8071963|NCT01332149|19902774|P1|Treated|Overall Study||313
8071964|NCT01332149|19902773|P2|STARTED|Overall Study|Assigned to study treatment.|309
8071965|NCT01332149|19902774|P1|STARTED|Overall Study|Assigned to study treatment.|314
8071966|NCT01302938|19902830|P2|NOT COMPLETED|Overall Study||0
8071967|NCT01302938|19902831|P1|NOT COMPLETED|Overall Study||2
8071968|NCT01302938|19902830|P2|COMPLETED|Overall Study||6
8071969|NCT01302938|19902831|P1|COMPLETED|Overall Study||10
8071970|NCT01302938|19902830|P2|STARTED|Overall Study||6
8071971|NCT01302938|19902831|P1|STARTED|Overall Study||12
8071998|NCT01270828|19902900|P3|NOT COMPLETED|Double Blind Phase||0
8071999|NCT01270828|19902901|P2|NOT COMPLETED|Double Blind Phase||45
8072000|NCT01270828|19902902|P1|NOT COMPLETED|Double Blind Phase||26
8072001|NCT01270828|19902900|P3|COMPLETED|Double Blind Phase||0
8072002|NCT01270828|19902901|P2|COMPLETED|Double Blind Phase||160
8072003|NCT01270828|19902902|P1|COMPLETED|Double Blind Phase||182
8072004|NCT01270828|19902900|P3|STARTED|Double Blind Phase||0
8072005|NCT01270828|19902901|P2|STARTED|Double Blind Phase||205
8072006|NCT01270828|19902902|P1|STARTED|Double Blind Phase||208
8072007|NCT01270828|19902900|P3|NOT COMPLETED|Pregabalin CR SB||146
8072008|NCT01270828|19902901|P2|NOT COMPLETED|Pregabalin CR SB||0
8072009|NCT01270828|19902902|P1|NOT COMPLETED|Pregabalin CR SB||0
8072010|NCT01270828|19902900|P3|COMPLETED|Pregabalin CR SB||660
8072011|NCT01270828|19902901|P2|COMPLETED|Pregabalin CR SB||0
8072012|NCT01270828|19902902|P1|COMPLETED|Pregabalin CR SB||0
8072013|NCT01270828|19902900|P3|STARTED|Pregabalin CR SB||806
8072014|NCT01270828|19902901|P2|STARTED|Pregabalin CR SB||0
8072015|NCT01270828|19902902|P1|STARTED|Pregabalin CR SB||0
8072016|NCT01252563|19902942|P1|NOT COMPLETED|Overall Study||432
8072017|NCT01252563|19902942|P1|COMPLETED|Overall Study||13343
8072018|NCT01252563|19902942|P1|STARTED|Overall Study||13775
8072019|NCT01202227|19902979|P1|NOT COMPLETED|Overall Study||19
8072020|NCT01202227|19902979|P1|COMPLETED|Overall Study||84
8072021|NCT01202227|19902979|P1|STARTED|Overall Study|Treated|103
8072022|NCT01190007|19902998|P1|NOT COMPLETED|Overall Study||14
8072023|NCT01190007|19902998|P1|COMPLETED|Overall Study||145
8072024|NCT01190007|19902998|P1|STARTED|Overall Study|Treated|159
8072025|NCT01177293|19903013|P2|NOT COMPLETED|Second Intervention Period||0
8072026|NCT01177293|19903014|P1|NOT COMPLETED|Second Intervention Period||0
8072027|NCT01177293|19903013|P2|COMPLETED|Second Intervention Period||6
8072028|NCT01177293|19903014|P1|COMPLETED|Second Intervention Period||7
8072029|NCT01177293|19903013|P2|STARTED|Second Intervention Period||6
8072030|NCT01177293|19903014|P1|STARTED|Second Intervention Period||7
8072031|NCT01177293|19903013|P2|NOT COMPLETED|Washout Period (of 14 Days)||1
8072032|NCT01177293|19903014|P1|NOT COMPLETED|Washout Period (of 14 Days)||0
8072033|NCT01177293|19903013|P2|COMPLETED|Washout Period (of 14 Days)||6
8072034|NCT01177293|19903014|P1|COMPLETED|Washout Period (of 14 Days)||7
8072035|NCT01177293|19903013|P2|STARTED|Washout Period (of 14 Days)||7
8072036|NCT01177293|19903014|P1|STARTED|Washout Period (of 14 Days)||7
8072037|NCT01177293|19903013|P2|NOT COMPLETED|First Intervention Period||0
8072038|NCT01177293|19903014|P1|NOT COMPLETED|First Intervention Period||0
8072039|NCT01177293|19903013|P2|COMPLETED|First Intervention Period||7
8072040|NCT01177293|19903014|P1|COMPLETED|First Intervention Period||7
8072041|NCT01177293|19903013|P2|STARTED|First Intervention Period||7
8072042|NCT01177293|19903014|P1|STARTED|First Intervention Period||7
8072043|NCT01145417|19903030|P2|NOT COMPLETED|Overall Study||47
8072044|NCT01145417|19903031|P1|NOT COMPLETED|Overall Study||41
8072045|NCT01145417|19903030|P2|COMPLETED|Overall Study||62
8072046|NCT01145417|19903031|P1|COMPLETED|Overall Study||67
8072047|NCT01145417|19903030|P2|STARTED|Overall Study||109
8072048|NCT01145417|19903031|P1|STARTED|Overall Study||108
8072049|NCT01139515|19903053|P4|NOT COMPLETED|Fourth Intervention Period||0
8072050|NCT01139515|19903054|P3|NOT COMPLETED|Fourth Intervention Period||0
8072051|NCT01139515|19903055|P2|NOT COMPLETED|Fourth Intervention Period||0
8072052|NCT01139515|19903056|P1|NOT COMPLETED|Fourth Intervention Period||0
8072053|NCT01139515|19903053|P4|COMPLETED|Fourth Intervention Period||4
8072054|NCT01139515|19903054|P3|COMPLETED|Fourth Intervention Period||4
8072055|NCT01139515|19903055|P2|COMPLETED|Fourth Intervention Period||4
8072056|NCT01139515|19903056|P1|COMPLETED|Fourth Intervention Period||4
8072057|NCT01139515|19903053|P4|STARTED|Fourth Intervention Period||4
8072058|NCT01139515|19903054|P3|STARTED|Fourth Intervention Period||4
8072059|NCT01139515|19903055|P2|STARTED|Fourth Intervention Period||4
8072060|NCT01139515|19903056|P1|STARTED|Fourth Intervention Period||4
8072061|NCT01139515|19903053|P4|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
8072062|NCT01139515|19903054|P3|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
8072063|NCT01139515|19903055|P2|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
8072064|NCT01139515|19903056|P1|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
8072065|NCT01139515|19903053|P4|COMPLETED|Washout Period 3 (46 Hrs)||4
8072066|NCT01139515|19903054|P3|COMPLETED|Washout Period 3 (46 Hrs)||4
8072067|NCT01139515|19903055|P2|COMPLETED|Washout Period 3 (46 Hrs)||4
8072068|NCT01139515|19903056|P1|COMPLETED|Washout Period 3 (46 Hrs)||4
8072069|NCT01139515|19903053|P4|STARTED|Washout Period 3 (46 Hrs)||4
8072070|NCT01139515|19903054|P3|STARTED|Washout Period 3 (46 Hrs)||4
8072071|NCT01139515|19903055|P2|STARTED|Washout Period 3 (46 Hrs)||4
8072072|NCT01139515|19903056|P1|STARTED|Washout Period 3 (46 Hrs)||4
8072073|NCT01139515|19903053|P4|NOT COMPLETED|Third Intervention Period||0
8072074|NCT01139515|19903054|P3|NOT COMPLETED|Third Intervention Period||0
8072075|NCT01139515|19903055|P2|NOT COMPLETED|Third Intervention Period||0
8072076|NCT01139515|19903056|P1|NOT COMPLETED|Third Intervention Period||0
8072077|NCT01139515|19903053|P4|COMPLETED|Third Intervention Period||4
8072078|NCT01139515|19903054|P3|COMPLETED|Third Intervention Period||4
8072079|NCT01139515|19903055|P2|COMPLETED|Third Intervention Period||4
8072080|NCT01139515|19903056|P1|COMPLETED|Third Intervention Period||4
8072081|NCT01139515|19903053|P4|STARTED|Third Intervention Period||4
8072082|NCT01139515|19903054|P3|STARTED|Third Intervention Period||4
8072083|NCT01139515|19903055|P2|STARTED|Third Intervention Period||4
8072084|NCT01139515|19903056|P1|STARTED|Third Intervention Period||4
8072085|NCT01139515|19903053|P4|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
8072086|NCT01139515|19903054|P3|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
8072087|NCT01139515|19903055|P2|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
8072088|NCT01139515|19903056|P1|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
8072089|NCT01139515|19903053|P4|COMPLETED|Washout Period 2 (46 Hrs)||4
8072090|NCT01139515|19903054|P3|COMPLETED|Washout Period 2 (46 Hrs)||4
8072091|NCT01139515|19903055|P2|COMPLETED|Washout Period 2 (46 Hrs)||4
8072092|NCT01139515|19903056|P1|COMPLETED|Washout Period 2 (46 Hrs)||4
8072093|NCT01139515|19903053|P4|STARTED|Washout Period 2 (46 Hrs)||4
8072094|NCT01139515|19903054|P3|STARTED|Washout Period 2 (46 Hrs)||4
8072095|NCT01139515|19903055|P2|STARTED|Washout Period 2 (46 Hrs)||4
8072096|NCT01139515|19903056|P1|STARTED|Washout Period 2 (46 Hrs)||4
8072097|NCT01139515|19903053|P4|NOT COMPLETED|Second Intervention Period||0
8072098|NCT01139515|19903054|P3|NOT COMPLETED|Second Intervention Period||0
8072099|NCT01139515|19903055|P2|NOT COMPLETED|Second Intervention Period||0
8072100|NCT01139515|19903056|P1|NOT COMPLETED|Second Intervention Period||0
8072101|NCT01139515|19903053|P4|COMPLETED|Second Intervention Period||4
8072102|NCT01139515|19903054|P3|COMPLETED|Second Intervention Period||4
8072103|NCT01139515|19903055|P2|COMPLETED|Second Intervention Period||4
8072104|NCT01139515|19903056|P1|COMPLETED|Second Intervention Period||4
8072105|NCT01139515|19903053|P4|STARTED|Second Intervention Period||4
8072106|NCT01139515|19903054|P3|STARTED|Second Intervention Period||4
8072107|NCT01139515|19903055|P2|STARTED|Second Intervention Period||4
8072108|NCT01139515|19903056|P1|STARTED|Second Intervention Period||4
8072109|NCT01139515|19903053|P4|NOT COMPLETED|Washout Period I (46hrs)||0
8072110|NCT01139515|19903054|P3|NOT COMPLETED|Washout Period I (46hrs)||0
8072111|NCT01139515|19903055|P2|NOT COMPLETED|Washout Period I (46hrs)||0
8072112|NCT01139515|19903056|P1|NOT COMPLETED|Washout Period I (46hrs)||0
8072113|NCT01139515|19903053|P4|COMPLETED|Washout Period I (46hrs)||4
8072114|NCT01139515|19903054|P3|COMPLETED|Washout Period I (46hrs)||4
8072115|NCT01139515|19903055|P2|COMPLETED|Washout Period I (46hrs)||4
8072116|NCT01139515|19903056|P1|COMPLETED|Washout Period I (46hrs)||4
8072117|NCT01139515|19903053|P4|STARTED|Washout Period I (46hrs)||4
8072118|NCT01139515|19903054|P3|STARTED|Washout Period I (46hrs)||4
8072119|NCT01139515|19903055|P2|STARTED|Washout Period I (46hrs)||4
8072120|NCT01139515|19903056|P1|STARTED|Washout Period I (46hrs)||4
8072121|NCT01139515|19903053|P4|NOT COMPLETED|First Intervention Period||0
8072122|NCT01139515|19903054|P3|NOT COMPLETED|First Intervention Period||0
8072123|NCT01139515|19903055|P2|NOT COMPLETED|First Intervention Period||0
8072124|NCT01139515|19903056|P1|NOT COMPLETED|First Intervention Period||0
8072125|NCT01139515|19903053|P4|COMPLETED|First Intervention Period||4
8072126|NCT01139515|19903054|P3|COMPLETED|First Intervention Period||4
8072127|NCT01139515|19903055|P2|COMPLETED|First Intervention Period||4
8072128|NCT01139515|19903056|P1|COMPLETED|First Intervention Period||4
8072129|NCT01139515|19903053|P4|STARTED|First Intervention Period||4
8072130|NCT01139515|19903054|P3|STARTED|First Intervention Period||4
8072131|NCT01139515|19903055|P2|STARTED|First Intervention Period||4
8072132|NCT01139515|19903056|P1|STARTED|First Intervention Period||4
8072133|NCT01138826|19903082|P6|NOT COMPLETED|Third Intervention Period||0
8072134|NCT01138826|19903083|P5|NOT COMPLETED|Third Intervention Period||0
8072135|NCT01138826|19903084|P4|NOT COMPLETED|Third Intervention Period||0
8072136|NCT01138826|19903085|P3|NOT COMPLETED|Third Intervention Period||0
8072137|NCT01138826|19903086|P2|NOT COMPLETED|Third Intervention Period||0
8072138|NCT01138826|19903087|P1|NOT COMPLETED|Third Intervention Period||0
8072139|NCT01138826|19903082|P6|COMPLETED|Third Intervention Period||3
8072140|NCT01138826|19903083|P5|COMPLETED|Third Intervention Period||2
8072141|NCT01138826|19903084|P4|COMPLETED|Third Intervention Period||3
8072142|NCT01138826|19903085|P3|COMPLETED|Third Intervention Period||3
8072143|NCT01138826|19903086|P2|COMPLETED|Third Intervention Period||2
8072144|NCT01138826|19903087|P1|COMPLETED|Third Intervention Period||2
8072145|NCT01138826|19903082|P6|STARTED|Third Intervention Period||3
8072146|NCT01138826|19903083|P5|STARTED|Third Intervention Period||2
8072147|NCT01138826|19903084|P4|STARTED|Third Intervention Period||3
8072148|NCT01138826|19903085|P3|STARTED|Third Intervention Period||3
8072149|NCT01138826|19903086|P2|STARTED|Third Intervention Period||2
8072150|NCT01138826|19903087|P1|STARTED|Third Intervention Period||2
8072151|NCT01138826|19903082|P6|NOT COMPLETED|Washout Period II (of 16 Days)||0
8072152|NCT01138826|19903083|P5|NOT COMPLETED|Washout Period II (of 16 Days)||0
8072153|NCT01138826|19903084|P4|NOT COMPLETED|Washout Period II (of 16 Days)||0
8072154|NCT01138826|19903085|P3|NOT COMPLETED|Washout Period II (of 16 Days)||0
8072155|NCT01138826|19903086|P2|NOT COMPLETED|Washout Period II (of 16 Days)||0
8072156|NCT01138826|19903087|P1|NOT COMPLETED|Washout Period II (of 16 Days)||0
8072157|NCT01138826|19903082|P6|COMPLETED|Washout Period II (of 16 Days)||3
8072158|NCT01138826|19903083|P5|COMPLETED|Washout Period II (of 16 Days)||2
8072159|NCT01138826|19903084|P4|COMPLETED|Washout Period II (of 16 Days)||3
8072160|NCT01138826|19903085|P3|COMPLETED|Washout Period II (of 16 Days)||3
8072161|NCT01138826|19903086|P2|COMPLETED|Washout Period II (of 16 Days)||2
8072162|NCT01138826|19903087|P1|COMPLETED|Washout Period II (of 16 Days)||2
8072163|NCT01138826|19903082|P6|STARTED|Washout Period II (of 16 Days)||3
8072164|NCT01138826|19903083|P5|STARTED|Washout Period II (of 16 Days)||2
8072165|NCT01138826|19903084|P4|STARTED|Washout Period II (of 16 Days)||3
8072166|NCT01138826|19903085|P3|STARTED|Washout Period II (of 16 Days)||3
8072167|NCT01138826|19903086|P2|STARTED|Washout Period II (of 16 Days)||2
8072168|NCT01138826|19903087|P1|STARTED|Washout Period II (of 16 Days)||2
8072169|NCT01138826|19903082|P6|NOT COMPLETED|Second Intervention Period||0
8072170|NCT01138826|19903083|P5|NOT COMPLETED|Second Intervention Period||0
8072171|NCT01138826|19903084|P4|NOT COMPLETED|Second Intervention Period||0
8072172|NCT01138826|19903085|P3|NOT COMPLETED|Second Intervention Period||0
8072173|NCT01138826|19903086|P2|NOT COMPLETED|Second Intervention Period||0
8072174|NCT01138826|19903087|P1|NOT COMPLETED|Second Intervention Period||0
8072175|NCT01138826|19903082|P6|COMPLETED|Second Intervention Period||3
8072176|NCT01138826|19903083|P5|COMPLETED|Second Intervention Period||2
8072177|NCT01138826|19903084|P4|COMPLETED|Second Intervention Period||3
8072178|NCT01138826|19903085|P3|COMPLETED|Second Intervention Period||3
8072179|NCT01138826|19903086|P2|COMPLETED|Second Intervention Period||2
8072180|NCT01138826|19903087|P1|COMPLETED|Second Intervention Period||2
8072181|NCT01138826|19903082|P6|STARTED|Second Intervention Period||3
8072182|NCT01138826|19903083|P5|STARTED|Second Intervention Period||2
8072183|NCT01138826|19903084|P4|STARTED|Second Intervention Period||3
8072184|NCT01138826|19903085|P3|STARTED|Second Intervention Period||3
8072185|NCT01138826|19903086|P2|STARTED|Second Intervention Period||2
8072186|NCT01138826|19903087|P1|STARTED|Second Intervention Period||2
8072187|NCT01138826|19903082|P6|NOT COMPLETED|Washout Period I (of 16 Days)||0
8072188|NCT01138826|19903083|P5|NOT COMPLETED|Washout Period I (of 16 Days)||1
8072189|NCT01138826|19903084|P4|NOT COMPLETED|Washout Period I (of 16 Days)||0
8072190|NCT01138826|19903085|P3|NOT COMPLETED|Washout Period I (of 16 Days)||0
8072191|NCT01138826|19903086|P2|NOT COMPLETED|Washout Period I (of 16 Days)||1
8072192|NCT01138826|19903087|P1|NOT COMPLETED|Washout Period I (of 16 Days)||1
8072193|NCT01138826|19903082|P6|COMPLETED|Washout Period I (of 16 Days)||3
8072194|NCT01138826|19903083|P5|COMPLETED|Washout Period I (of 16 Days)||2
8072195|NCT01138826|19903084|P4|COMPLETED|Washout Period I (of 16 Days)||3
8072196|NCT01138826|19903085|P3|COMPLETED|Washout Period I (of 16 Days)||3
8072197|NCT01138826|19903086|P2|COMPLETED|Washout Period I (of 16 Days)||2
8072198|NCT01138826|19903087|P1|COMPLETED|Washout Period I (of 16 Days)||2
8072199|NCT01138826|19903082|P6|STARTED|Washout Period I (of 16 Days)||3
8072200|NCT01138826|19903083|P5|STARTED|Washout Period I (of 16 Days)||3
8072201|NCT01138826|19903084|P4|STARTED|Washout Period I (of 16 Days)||3
8072202|NCT01138826|19903085|P3|STARTED|Washout Period I (of 16 Days)||3
8072203|NCT01138826|19903086|P2|STARTED|Washout Period I (of 16 Days)||3
8072204|NCT01138826|19903087|P1|STARTED|Washout Period I (of 16 Days)||3
8072205|NCT01138826|19903082|P6|NOT COMPLETED|First Intervention Period||0
8072206|NCT01138826|19903083|P5|NOT COMPLETED|First Intervention Period||0
8072207|NCT01138826|19903084|P4|NOT COMPLETED|First Intervention Period||0
8072208|NCT01138826|19903085|P3|NOT COMPLETED|First Intervention Period||0
8072209|NCT01138826|19903086|P2|NOT COMPLETED|First Intervention Period||0
8072210|NCT01138826|19903087|P1|NOT COMPLETED|First Intervention Period||0
8072211|NCT01138826|19903082|P6|COMPLETED|First Intervention Period||3
8072212|NCT01138826|19903083|P5|COMPLETED|First Intervention Period||3
8072213|NCT01138826|19903084|P4|COMPLETED|First Intervention Period||3
8072214|NCT01138826|19903085|P3|COMPLETED|First Intervention Period||3
8072215|NCT01138826|19903086|P2|COMPLETED|First Intervention Period||3
8072216|NCT01138826|19903087|P1|COMPLETED|First Intervention Period||3
8072217|NCT01138826|19903082|P6|STARTED|First Intervention Period||3
8072218|NCT01138826|19903083|P5|STARTED|First Intervention Period||3
8072219|NCT01138826|19903084|P4|STARTED|First Intervention Period||3
8072220|NCT01138826|19903085|P3|STARTED|First Intervention Period||3
8072221|NCT01138826|19903086|P2|STARTED|First Intervention Period||3
8072222|NCT01138826|19903087|P1|STARTED|First Intervention Period||3
8072223|NCT01107743|19903107|P1|NOT COMPLETED|Overall Study||46
8072224|NCT01107743|19903107|P1|COMPLETED|Overall Study||1245
8072225|NCT01107743|19903107|P1|STARTED|Overall Study||1291
8072226|NCT01049217|19903195|P2|NOT COMPLETED|Overall Study||63
8072227|NCT01049217|19903196|P1|NOT COMPLETED|Overall Study||56
8072228|NCT01049217|19903195|P2|COMPLETED|Overall Study||131
8072229|NCT01049217|19903196|P1|COMPLETED|Overall Study||127
8072230|NCT01049217|19903195|P2|Treated|Overall Study||192
8072231|NCT01049217|19903196|P1|Treated|Overall Study||183
8072232|NCT01049217|19903195|P2|STARTED|Overall Study||194
8072233|NCT01049217|19903196|P1|STARTED|Overall Study||183
8072234|NCT01020526|19903266|P1|NOT COMPLETED|Overall Study||14
8072235|NCT01020526|19903266|P1|COMPLETED|Overall Study||49
8072236|NCT01020526|19903266|P1|STARTED|Overall Study||63
8072237|NCT01020474|19903272|P2|NOT COMPLETED|Overall Study||17
8072238|NCT01020474|19903273|P1|NOT COMPLETED|Overall Study||10
8072239|NCT01020474|19903272|P2|COMPLETED|Overall Study||36
8072240|NCT01020474|19903273|P1|COMPLETED|Overall Study||44
8072241|NCT01020474|19903272|P2|STARTED|Overall Study||53
8072242|NCT01020474|19903273|P1|STARTED|Overall Study||54
8072243|NCT01004614|19903297|P4|NOT COMPLETED|Second Intervention||0
8072244|NCT01004614|19903298|P3|NOT COMPLETED|Second Intervention||0
8072245|NCT01004614|19903299|P2|NOT COMPLETED|Second Intervention||0
8072246|NCT01004614|19903300|P1|NOT COMPLETED|Second Intervention||0
8072247|NCT01004614|19903297|P4|COMPLETED|Second Intervention||12
8072248|NCT01004614|19903298|P3|COMPLETED|Second Intervention||12
8072249|NCT01004614|19903299|P2|COMPLETED|Second Intervention||11
8072250|NCT01004614|19903300|P1|COMPLETED|Second Intervention||12
8072251|NCT01004614|19903297|P4|STARTED|Second Intervention||12
8072252|NCT01004614|19903298|P3|STARTED|Second Intervention||12
8072253|NCT01004614|19903299|P2|STARTED|Second Intervention||11
8072254|NCT01004614|19903300|P1|STARTED|Second Intervention||12
8072255|NCT01004614|19903297|P4|NOT COMPLETED|Washout||0
8072256|NCT01004614|19903298|P3|NOT COMPLETED|Washout||0
8072257|NCT01004614|19903299|P2|NOT COMPLETED|Washout||1
8072258|NCT01004614|19903300|P1|NOT COMPLETED|Washout||0
8072259|NCT01004614|19903297|P4|COMPLETED|Washout||12
8072260|NCT01004614|19903298|P3|COMPLETED|Washout||12
8072261|NCT01004614|19903299|P2|COMPLETED|Washout||11
8072262|NCT01004614|19903300|P1|COMPLETED|Washout||12
8072263|NCT01004614|19903297|P4|STARTED|Washout||12
8072264|NCT01004614|19903298|P3|STARTED|Washout||12
8072265|NCT01004614|19903299|P2|STARTED|Washout||12
8072266|NCT01004614|19903300|P1|STARTED|Washout||12
8072267|NCT01004614|19903297|P4|NOT COMPLETED|First Intervention||0
8072268|NCT01004614|19903298|P3|NOT COMPLETED|First Intervention||0
8072269|NCT01004614|19903299|P2|NOT COMPLETED|First Intervention||0
8072270|NCT01004614|19903300|P1|NOT COMPLETED|First Intervention||0
8072271|NCT01004614|19903297|P4|COMPLETED|First Intervention||12
8072272|NCT01004614|19903298|P3|COMPLETED|First Intervention||12
8072273|NCT01004614|19903299|P2|COMPLETED|First Intervention||12
8072274|NCT01004614|19903300|P1|COMPLETED|First Intervention||12
8072275|NCT01004614|19903297|P4|STARTED|First Intervention||12
8072276|NCT01004614|19903298|P3|STARTED|First Intervention||12
8072277|NCT01004614|19903299|P2|STARTED|First Intervention||12
8072278|NCT01004614|19903300|P1|STARTED|First Intervention||12
8072279|NCT01004029|19903336|P2|NOT COMPLETED|Overall Study||73
8072280|NCT01004029|19903337|P1|NOT COMPLETED|Overall Study||48
8072281|NCT01004029|19903336|P2|COMPLETED|Overall Study||1057
8072282|NCT01004029|19903337|P1|COMPLETED|Overall Study||530
8072283|NCT01004029|19903336|P2|Safety Population|Overall Study||1128
8072284|NCT01004029|19903337|P1|Safety Population|Overall Study||578
8072285|NCT01004029|19903336|P2|STARTED|Overall Study||1130
8072286|NCT01004029|19903337|P1|STARTED|Overall Study||578
8072287|NCT01003886|19903355|P1|NOT COMPLETED|Overall Study||230
8072288|NCT01003886|19903355|P1|COMPLETED|Overall Study||759
8072289|NCT01003886|19903355|P1|STARTED|Overall Study||989
8072290|NCT00936611|19903364|P1|NOT COMPLETED|Overall Study||39
8072291|NCT00936611|19903364|P1|COMPLETED|Overall Study||0
8072292|NCT00936611|19903364|P1|Starting Dose Reduction: 30 mg to 25 mg|Overall Study||12
8072293|NCT00936611|19903364|P1|Treated|Overall Study||36
8072294|NCT00936611|19903364|P1|STARTED|Overall Study||39
8072295|NCT04252092|19903375|P2|NOT COMPLETED|Overall Study||0
8072296|NCT04252092|19903376|P1|NOT COMPLETED|Overall Study||0
8072297|NCT04252092|19903375|P2|COMPLETED|Overall Study||15
8072298|NCT04252092|19903376|P1|COMPLETED|Overall Study||15
8072299|NCT04252092|19903375|P2|STARTED|Overall Study||15
8072300|NCT04252092|19903376|P1|STARTED|Overall Study||15
8072307|NCT04251884|19903419|P2|NOT COMPLETED|Overall Study||0
8072308|NCT04251884|19903420|P1|NOT COMPLETED|Overall Study||0
8072309|NCT04251884|19903419|P2|COMPLETED|Overall Study||26
8072310|NCT04251884|19903420|P1|COMPLETED|Overall Study||23
8072311|NCT04251884|19903419|P2|STARTED|Overall Study||26
8072312|NCT04251884|19903420|P1|STARTED|Overall Study||23
8072331|NCT04250987|19903492|P1|NOT COMPLETED|Overall Study||0
8072332|NCT04250987|19903492|P1|COMPLETED|Overall Study||12
8072333|NCT04250987|19903492|P1|STARTED|Overall Study||12
8072313|NCT00920621|19903438|P4|NOT COMPLETED|Overall Study||35
8072314|NCT00920621|19903439|P3|NOT COMPLETED|Overall Study||35
8072315|NCT00920621|19903440|P2|NOT COMPLETED|Overall Study||45
8072316|NCT00920621|19903441|P1|NOT COMPLETED|Overall Study||54
8072317|NCT00920621|19903438|P4|COMPLETED|Overall Study||401
8072318|NCT00920621|19903439|P3|COMPLETED|Overall Study||405
8072319|NCT00920621|19903440|P2|COMPLETED|Overall Study||391
8072320|NCT00920621|19903441|P1|COMPLETED|Overall Study||386
8072321|NCT00920621|19903438|P4|STARTED|Overall Study||436
8072322|NCT00920621|19903439|P3|STARTED|Overall Study||440
8072323|NCT00920621|19903440|P2|STARTED|Overall Study||436
8072324|NCT00920621|19903441|P1|STARTED|Overall Study||440
8072325|NCT00905437|19903473|P2|NOT COMPLETED|Overall Study||10
8072326|NCT00905437|19903474|P1|NOT COMPLETED|Overall Study||8
8072327|NCT00905437|19903473|P2|COMPLETED|Overall Study||27
8072328|NCT00905437|19903474|P1|COMPLETED|Overall Study||27
8072329|NCT00905437|19903473|P2|STARTED|Overall Study||37
8072330|NCT00905437|19903474|P1|STARTED|Overall Study||35
8072339|NCT00698828|19903551|P3|NOT COMPLETED|Overall Study||11
8072340|NCT00698828|19903552|P2|NOT COMPLETED|Overall Study||15
8072341|NCT00698828|19903553|P1|NOT COMPLETED|Overall Study||9
8072342|NCT00698828|19903551|P3|COMPLETED|Overall Study||65
8072343|NCT00698828|19903552|P2|COMPLETED|Overall Study||60
8072344|NCT00698828|19903553|P1|COMPLETED|Overall Study||67
8072345|NCT00698828|19903551|P3|STARTED|Overall Study||76
8072346|NCT00698828|19903552|P2|STARTED|Overall Study||75
8072347|NCT00698828|19903553|P1|STARTED|Overall Study||76
8072351|NCT00624780|19903610|P6|NOT COMPLETED|Follow-up (Week 26)||0
8072352|NCT00624780|19903611|P5|NOT COMPLETED|Follow-up (Week 26)||2
8072353|NCT00624780|19903612|P4|NOT COMPLETED|Follow-up (Week 26)||0
8072354|NCT00624780|19903613|P3|NOT COMPLETED|Follow-up (Week 26)||2
8072355|NCT00624780|19903614|P2|NOT COMPLETED|Follow-up (Week 26)||1
8072356|NCT00624780|19903615|P1|NOT COMPLETED|Follow-up (Week 26)||2
8072357|NCT00624780|19903610|P6|COMPLETED|Follow-up (Week 26)||29
8072358|NCT00624780|19903611|P5|COMPLETED|Follow-up (Week 26)||93
8072359|NCT00624780|19903612|P4|COMPLETED|Follow-up (Week 26)||26
8072360|NCT00624780|19903613|P3|COMPLETED|Follow-up (Week 26)||89
8072361|NCT00624780|19903614|P2|COMPLETED|Follow-up (Week 26)||27
8072362|NCT00624780|19903615|P1|COMPLETED|Follow-up (Week 26)||102
8072363|NCT00624780|19903610|P6|STARTED|Follow-up (Week 26)||29
8072364|NCT00624780|19903611|P5|STARTED|Follow-up (Week 26)||95
8072365|NCT00624780|19903612|P4|STARTED|Follow-up (Week 26)||26
8072366|NCT00624780|19903613|P3|STARTED|Follow-up (Week 26)||91
8072367|NCT00624780|19903614|P2|STARTED|Follow-up (Week 26)||28
8072368|NCT00624780|19903615|P1|STARTED|Follow-up (Week 26)||104
8072369|NCT00624780|19903610|P6|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
8072370|NCT00624780|19903611|P5|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
8072371|NCT00624780|19903612|P4|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
8072372|NCT00624780|19903613|P3|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
8072373|NCT00624780|19903614|P2|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
8072374|NCT00624780|19903615|P1|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
8072375|NCT00624780|19903610|P6|COMPLETED|Treatment Discontinuation (Week 25)||29
8072376|NCT00624780|19903611|P5|COMPLETED|Treatment Discontinuation (Week 25)||95
8072377|NCT00624780|19903612|P4|COMPLETED|Treatment Discontinuation (Week 25)||26
8072378|NCT00624780|19903613|P3|COMPLETED|Treatment Discontinuation (Week 25)||91
8072379|NCT00624780|19903614|P2|COMPLETED|Treatment Discontinuation (Week 25)||28
8072380|NCT00624780|19903615|P1|COMPLETED|Treatment Discontinuation (Week 25)||104
8072381|NCT00624780|19903610|P6|STARTED|Treatment Discontinuation (Week 25)||30
8072382|NCT00624780|19903611|P5|STARTED|Treatment Discontinuation (Week 25)||95
8072383|NCT00624780|19903612|P4|STARTED|Treatment Discontinuation (Week 25)||27
8072384|NCT00624780|19903613|P3|STARTED|Treatment Discontinuation (Week 25)||94
8072385|NCT00624780|19903614|P2|STARTED|Treatment Discontinuation (Week 25)||28
8072386|NCT00624780|19903615|P1|STARTED|Treatment Discontinuation (Week 25)||106
8072387|NCT00624780|19903610|P6|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
8072388|NCT00624780|19903611|P5|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
8072389|NCT00624780|19903612|P4|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
8072390|NCT00624780|19903613|P3|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
8072391|NCT00624780|19903614|P2|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
8072392|NCT00624780|19903615|P1|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
8072393|NCT00624780|19903610|P6|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
8072394|NCT00624780|19903611|P5|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
8072395|NCT00624780|19903612|P4|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
8072396|NCT00624780|19903613|P3|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
8072397|NCT00624780|19903614|P2|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
8072398|NCT00624780|19903615|P1|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
8072399|NCT00624780|19903610|P6|STARTED|Fixed Dosing (Week 13 to Week 24)||39
8072400|NCT00624780|19903611|P5|STARTED|Fixed Dosing (Week 13 to Week 24)||114
8072401|NCT00624780|19903612|P4|STARTED|Fixed Dosing (Week 13 to Week 24)||38
8072402|NCT00624780|19903613|P3|STARTED|Fixed Dosing (Week 13 to Week 24)||112
8072403|NCT00624780|19903614|P2|STARTED|Fixed Dosing (Week 13 to Week 24)||39
8072404|NCT00624780|19903615|P1|STARTED|Fixed Dosing (Week 13 to Week 24)||121
8072405|NCT00624780|19903610|P6|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
8072406|NCT00624780|19903611|P5|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
8072407|NCT00624780|19903612|P4|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
8072408|NCT00624780|19903613|P3|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
8072409|NCT00624780|19903614|P2|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
8072410|NCT00624780|19903615|P1|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
8072411|NCT00624780|19903610|P6|COMPLETED|Treatment Optimization (Up to Week 12)||39
8072412|NCT00624780|19903611|P5|COMPLETED|Treatment Optimization (Up to Week 12)||114
8072413|NCT00624780|19903612|P4|COMPLETED|Treatment Optimization (Up to Week 12)||38
8072414|NCT00624780|19903613|P3|COMPLETED|Treatment Optimization (Up to Week 12)||112
8072415|NCT00624780|19903614|P2|COMPLETED|Treatment Optimization (Up to Week 12)||39
8072416|NCT00624780|19903615|P1|COMPLETED|Treatment Optimization (Up to Week 12)||121
8072417|NCT00624780|19903610|P6|STARTED|Treatment Optimization (Up to Week 12)||50
8072418|NCT00624780|19903611|P5|STARTED|Treatment Optimization (Up to Week 12)||153
8072419|NCT00624780|19903612|P4|STARTED|Treatment Optimization (Up to Week 12)||52
8072420|NCT00624780|19903613|P3|STARTED|Treatment Optimization (Up to Week 12)||154
8072421|NCT00624780|19903614|P2|STARTED|Treatment Optimization (Up to Week 12)||52
8072422|NCT00624780|19903615|P1|STARTED|Treatment Optimization (Up to Week 12)||154
8072441|NCT00605917|19903822|P1|NOT COMPLETED|Overall Study||79
8072442|NCT00605917|19903822|P1|COMPLETED|Overall Study||908
8072443|NCT00605917|19903822|P1|STARTED|Overall Study||987
8072444|NCT00605865|19903861|P1|NOT COMPLETED|Overall Study||115
8072445|NCT00605865|19903861|P1|COMPLETED|Overall Study||2157
8072446|NCT00605865|19903861|P1|STARTED|Overall Study||2272
8072447|NCT00605813|19903900|P1|NOT COMPLETED|Overall Study||25
8072448|NCT00605813|19903900|P1|COMPLETED|Overall Study||517
8072449|NCT00605813|19903900|P1|STARTED|Overall Study||542
8072450|NCT00579254|19903913|P1|NOT COMPLETED|Overall Study||112
8072451|NCT00579254|19903913|P1|COMPLETED|Overall Study||0
8072452|NCT00579254|19903913|P1|STARTED|Overall Study||112
8072541|NCT00537238|19903968|P2|NOT COMPLETED|Overall Study||173
8072542|NCT00537238|19903969|P1|NOT COMPLETED|Overall Study||174
8072543|NCT00537238|19903968|P2|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
8072544|NCT00537238|19903969|P1|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
8072545|NCT00537238|19903968|P2|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
8072546|NCT00537238|19903969|P1|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
8072547|NCT00537238|19903968|P2|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
8072548|NCT00537238|19903969|P1|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
8072549|NCT00537238|19903968|P2|Completed Titration Phase|Overall Study||236
8072550|NCT00537238|19903969|P1|Completed Titration Phase|Overall Study||226
8072551|NCT00537238|19903968|P2|STARTED|Overall Study||255
8072552|NCT00537238|19903969|P1|STARTED|Overall Study||254
8072553|NCT00530946|19903993|P4|NOT COMPLETED|Overall Study||2
8072554|NCT00530946|19903994|P3|NOT COMPLETED|Overall Study||1
8072555|NCT00530946|19903995|P2|NOT COMPLETED|Overall Study||2
8072556|NCT00530946|19903996|P1|NOT COMPLETED|Overall Study||2
8072557|NCT00530946|19903993|P4|COMPLETED|Overall Study||38
8072558|NCT00530946|19903994|P3|COMPLETED|Overall Study||40
8072559|NCT00530946|19903995|P2|COMPLETED|Overall Study||39
8072560|NCT00530946|19903996|P1|COMPLETED|Overall Study||41
8072561|NCT00530946|19903993|P4|STARTED|Overall Study||40
8072562|NCT00530946|19903994|P3|STARTED|Overall Study||41
8072563|NCT00530946|19903995|P2|STARTED|Overall Study||41
8072564|NCT00530946|19903996|P1|STARTED|Overall Study||43
8072577|NCT00407537|19904062|P2|NOT COMPLETED|Overall Study||44
8072578|NCT00407537|19904063|P1|NOT COMPLETED|Overall Study||93
8072579|NCT00407537|19904062|P2|COMPLETED|Overall Study||638
8072580|NCT00407537|19904063|P1|COMPLETED|Overall Study||686
8072581|NCT00407537|19904062|P2|Eligible for Efficacy Analysis|Overall Study||657
8072582|NCT00407537|19904063|P1|Eligible for Efficacy Analysis|Overall Study||760
8072583|NCT00407537|19904062|P2|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
8072584|NCT00407537|19904063|P1|STARTED|Overall Study||779
8072588|NCT00280059|19904122|P2|NOT COMPLETED|Extension Phase||38
8072589|NCT00280059|19904123|P1|NOT COMPLETED|Extension Phase||49
8072590|NCT00280059|19904122|P2|COMPLETED|Extension Phase||177
8072591|NCT00280059|19904123|P1|COMPLETED|Extension Phase||145
8072592|NCT00280059|19904122|P2|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
8072593|NCT00280059|19904123|P1|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
8072594|NCT00280059|19904122|P2|NOT COMPLETED|Efficacy Assessment Phase||80
8072595|NCT00280059|19904123|P1|NOT COMPLETED|Efficacy Assessment Phase||94
8072596|NCT00280059|19904122|P2|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
8072597|NCT00280059|19904123|P1|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
8072598|NCT00280059|19904122|P2|STARTED|Efficacy Assessment Phase||330
8072599|NCT00280059|19904123|P1|STARTED|Efficacy Assessment Phase||330
8072606|NCT00090844|19904224|P2|NOT COMPLETED|Overall Study||1
8072607|NCT00090844|19904225|P1|NOT COMPLETED|Overall Study||1
8072608|NCT00090844|19904224|P2|COMPLETED|Overall Study||21
8072609|NCT00090844|19904225|P1|COMPLETED|Overall Study||26
8072610|NCT00090844|19904224|P2|STARTED|Overall Study||22
8072611|NCT00090844|19904225|P1|STARTED|Overall Study||27
8072615|NCT04243421|19904237|P1|NOT COMPLETED|Overall Study||0
8072616|NCT04243421|19904237|P1|COMPLETED|Overall Study||30
8072617|NCT04243421|19904237|P1|STARTED|Overall Study||30
8072618|NCT04243369|19904242|P1|NOT COMPLETED|Overall Study||0
8072619|NCT04243369|19904242|P1|COMPLETED|Overall Study||30
8072620|NCT04243369|19904242|P1|STARTED|Overall Study||30
8072621|NCT04241146|19904255|P2|NOT COMPLETED|Overall Study||0
8072622|NCT04241146|19904256|P1|NOT COMPLETED|Overall Study||0
8072623|NCT04241146|19904255|P2|COMPLETED|Overall Study||28
8072624|NCT04241146|19904256|P1|COMPLETED|Overall Study||24
8072625|NCT04241146|19904255|P2|STARTED|Overall Study||28
8072626|NCT04241146|19904256|P1|STARTED|Overall Study||24
8072627|NCT04238429|19904266|P2|NOT COMPLETED|Overall Study||2
8072628|NCT04238429|19904267|P1|NOT COMPLETED|Overall Study||3
8072629|NCT04238429|19904266|P2|COMPLETED|Overall Study||41
8072630|NCT04238429|19904267|P1|COMPLETED|Overall Study||40
8072631|NCT04238429|19904266|P2|STARTED|Overall Study||43
8072632|NCT04238429|19904267|P1|STARTED|Overall Study||43
8072633|NCT04234425|19904283|P1|NOT COMPLETED|Overall Study||0
8072634|NCT04234425|19904283|P1|COMPLETED|Overall Study||18
8072635|NCT04234425|19904283|P1|Midpoint-Week 4|Overall Study||18
8072636|NCT04234425|19904283|P1|STARTED|Overall Study||18
8072637|NCT04232137|19904293|P2|NOT COMPLETED|Overall Study||0
8072638|NCT04232137|19904294|P1|NOT COMPLETED|Overall Study||0
8072639|NCT04232137|19904293|P2|COMPLETED|Overall Study||185
8072640|NCT04232137|19904294|P1|COMPLETED|Overall Study||254
8072641|NCT04232137|19904293|P2|STARTED|Overall Study||185
8072642|NCT04232137|19904294|P1|STARTED|Overall Study||254
8072643|NCT04224753|19904300|P1|NOT COMPLETED|Overall Study||0
8072644|NCT04224753|19904300|P1|COMPLETED|Overall Study||51
8072645|NCT04224753|19904300|P1|STARTED|Overall Study||51
8072646|NCT04223232|19904304|P1|NOT COMPLETED|Overall Study||1
8072647|NCT04223232|19904304|P1|COMPLETED|Overall Study||5
8072648|NCT04223232|19904304|P1|STARTED|Overall Study||6
8072649|NCT04222699|19904333|P1|NOT COMPLETED|Overall Study||2
8072650|NCT04222699|19904333|P1|COMPLETED|Overall Study||26
8072651|NCT04222699|19904333|P1|STARTED|Overall Study||28
8072652|NCT04218799|19904340|P1|NOT COMPLETED|Overall Study||0
8072653|NCT04218799|19904340|P1|COMPLETED|Overall Study||7
8072654|NCT04218799|19904340|P1|STARTED|Overall Study||7
8072655|NCT04214951|19904349|P2|NOT COMPLETED|Overall Study||40
8072656|NCT04214951|19904350|P1|NOT COMPLETED|Overall Study||40
8072657|NCT04214951|19904349|P2|COMPLETED|Overall Study||10
8072658|NCT04214951|19904350|P1|COMPLETED|Overall Study||10
8072659|NCT04214951|19904349|P2|STARTED|Overall Study||50
8072660|NCT04214951|19904350|P1|STARTED|Overall Study||50
8072661|NCT04214600|19904368|P2|NOT COMPLETED|Overall Study||14
8072662|NCT04214600|19904369|P1|NOT COMPLETED|Overall Study||9
8072663|NCT04214600|19904368|P2|COMPLETED|Overall Study||36
8072664|NCT04214600|19904369|P1|COMPLETED|Overall Study||41
8072665|NCT04214600|19904368|P2|STARTED|Overall Study||50
8072666|NCT04214600|19904369|P1|STARTED|Overall Study||50
8072667|NCT04214080|19904379|P2|NOT COMPLETED|Overall Study||0
8072668|NCT04214080|19904380|P1|NOT COMPLETED|Overall Study||0
8072669|NCT04214080|19904379|P2|COMPLETED|Overall Study||20
8072670|NCT04214080|19904380|P1|COMPLETED|Overall Study||20
8072671|NCT04214080|19904379|P2|STARTED|Overall Study||20
8072672|NCT04214080|19904380|P1|STARTED|Overall Study||20
8072673|NCT04209335|19904398|P1|NOT COMPLETED|Overall Study||0
8072674|NCT04209335|19904398|P1|COMPLETED|Overall Study||48
8072675|NCT04209335|19904398|P1|STARTED|Overall Study||48
8072676|NCT04206800|19904407|P2|NOT COMPLETED|Overall Study||0
8072677|NCT04206800|19904408|P1|NOT COMPLETED|Overall Study||0
8072678|NCT04206800|19904407|P2|COMPLETED|Overall Study||1
8072679|NCT04206800|19904408|P1|COMPLETED|Overall Study||4
8072680|NCT04206800|19904407|P2|STARTED|Overall Study||1
8072681|NCT04206800|19904408|P1|STARTED|Overall Study||4
8072682|NCT04205669|19904416|P2|NOT COMPLETED|Overall Study||12
8072683|NCT04205669|19904417|P1|NOT COMPLETED|Overall Study||13
8072684|NCT04205669|19904416|P2|COMPLETED|Overall Study||45
8072685|NCT04205669|19904417|P1|COMPLETED|Overall Study||34
8072686|NCT04205669|19904416|P2|STARTED|Overall Study||57
8072687|NCT04205669|19904417|P1|STARTED|Overall Study||47
8072688|NCT04204200|19904426|P3|NOT COMPLETED|Overall Study||0
8072689|NCT04204200|19904427|P2|NOT COMPLETED|Overall Study||0
8072690|NCT04204200|19904428|P1|NOT COMPLETED|Overall Study||0
8072691|NCT04204200|19904426|P3|COMPLETED|Overall Study||22
8072692|NCT04204200|19904427|P2|COMPLETED|Overall Study||22
8072693|NCT04204200|19904428|P1|COMPLETED|Overall Study||22
8072694|NCT04204200|19904426|P3|STARTED|Overall Study||22
8072695|NCT04204200|19904427|P2|STARTED|Overall Study||22
8072696|NCT04204200|19904428|P1|STARTED|Overall Study||22
8072697|NCT04195893|19904445|P2|NOT COMPLETED|Second Intervention||0
8072698|NCT04195893|19904446|P1|NOT COMPLETED|Second Intervention||1
8072699|NCT04195893|19904445|P2|COMPLETED|Second Intervention||29
8072700|NCT04195893|19904446|P1|COMPLETED|Second Intervention||26
8072701|NCT04195893|19904445|P2|STARTED|Second Intervention||29
8072702|NCT04195893|19904446|P1|STARTED|Second Intervention||27
8072703|NCT04195893|19904445|P2|NOT COMPLETED|First Intervention||0
8072704|NCT04195893|19904446|P1|NOT COMPLETED|First Intervention||0
8072705|NCT04195893|19904445|P2|COMPLETED|First Intervention||29
8072706|NCT04195893|19904446|P1|COMPLETED|First Intervention||27
8072707|NCT04195893|19904445|P2|STARTED|First Intervention||29
8072708|NCT04195893|19904446|P1|STARTED|First Intervention||27
8072709|NCT04195880|19904490|P2|NOT COMPLETED|Overall Study||0
8072710|NCT04195880|19904491|P1|NOT COMPLETED|Overall Study||0
8072711|NCT04195880|19904490|P2|COMPLETED|Overall Study||3338
8072712|NCT04195880|19904491|P1|COMPLETED|Overall Study||3205
8072713|NCT04195880|19904490|P2|STARTED|Overall Study||3338
8072714|NCT04195880|19904491|P1|STARTED|Overall Study||3205
8072715|NCT04194151|19904505|P6|NOT COMPLETED|Overall Study||1
8072716|NCT04194151|19904506|P5|NOT COMPLETED|Overall Study||0
8072717|NCT04194151|19904507|P4|NOT COMPLETED|Overall Study||1
8072718|NCT04194151|19904508|P3|NOT COMPLETED|Overall Study||1
8072719|NCT04194151|19904509|P2|NOT COMPLETED|Overall Study||2
8072720|NCT04194151|19904510|P1|NOT COMPLETED|Overall Study||1
8072721|NCT04194151|19904505|P6|COMPLETED|Overall Study||31
8072722|NCT04194151|19904506|P5|COMPLETED|Overall Study||32
8072723|NCT04194151|19904507|P4|COMPLETED|Overall Study||31
8072724|NCT04194151|19904508|P3|COMPLETED|Overall Study||31
8072725|NCT04194151|19904509|P2|COMPLETED|Overall Study||30
8072726|NCT04194151|19904510|P1|COMPLETED|Overall Study||31
8072727|NCT04194151|19904505|P6|STARTED|Overall Study||32
8072728|NCT04194151|19904506|P5|STARTED|Overall Study||32
8072729|NCT04194151|19904507|P4|STARTED|Overall Study||32
8072730|NCT04194151|19904508|P3|STARTED|Overall Study||32
8072731|NCT04194151|19904509|P2|STARTED|Overall Study||32
8072732|NCT04194151|19904510|P1|STARTED|Overall Study||32
8072733|NCT04186806|19904550|P2|NOT COMPLETED|Period 2: 7 Days||0
8072734|NCT04186806|19904551|P1|NOT COMPLETED|Period 2: 7 Days||0
8072735|NCT04186806|19904550|P2|COMPLETED|Period 2: 7 Days||20
8072736|NCT04186806|19904551|P1|COMPLETED|Period 2: 7 Days||19
8072737|NCT04186806|19904550|P2|STARTED|Period 2: 7 Days||20
8072738|NCT04186806|19904551|P1|STARTED|Period 2: 7 Days||19
8072739|NCT04186806|19904550|P2|NOT COMPLETED|Washout Period: at Least 2 Days||0
8072740|NCT04186806|19904551|P1|NOT COMPLETED|Washout Period: at Least 2 Days||0
8072741|NCT04186806|19904550|P2|COMPLETED|Washout Period: at Least 2 Days||20
8072742|NCT04186806|19904551|P1|COMPLETED|Washout Period: at Least 2 Days||19
8072743|NCT04186806|19904550|P2|STARTED|Washout Period: at Least 2 Days||20
8072744|NCT04186806|19904551|P1|STARTED|Washout Period: at Least 2 Days||19
8072745|NCT04186806|19904550|P2|NOT COMPLETED|Period 1: 7 Days||0
8072746|NCT04186806|19904551|P1|NOT COMPLETED|Period 1: 7 Days||1
8072747|NCT04186806|19904550|P2|COMPLETED|Period 1: 7 Days||20
8072748|NCT04186806|19904551|P1|COMPLETED|Period 1: 7 Days||19
8072749|NCT04186806|19904550|P2|STARTED|Period 1: 7 Days||20
8072750|NCT04186806|19904551|P1|STARTED|Period 1: 7 Days||20
8072751|NCT04186780|19904641|P2|NOT COMPLETED|Overall Study||7
8072752|NCT04186780|19904642|P1|NOT COMPLETED|Overall Study||14
8072753|NCT04186780|19904641|P2|COMPLETED|Overall Study||25
8072754|NCT04186780|19904642|P1|COMPLETED|Overall Study||22
8072755|NCT04186780|19904641|P2|STARTED|Overall Study||32
8072756|NCT04186780|19904642|P1|STARTED|Overall Study||36
8072757|NCT04184297|19904658|P2|NOT COMPLETED|Overall Study||0
8072758|NCT04184297|19904659|P1|NOT COMPLETED|Overall Study||0
8072759|NCT04184297|19904658|P2|COMPLETED|Overall Study||24326
8072760|NCT04184297|19904659|P1|COMPLETED|Overall Study||2864
8072761|NCT04184297|19904658|P2|STARTED|Overall Study||24326
8072762|NCT04184297|19904659|P1|STARTED|Overall Study||2864
8072763|NCT04184271|19904669|P1|NOT COMPLETED|Overall Study||0
8072764|NCT04184271|19904669|P1|COMPLETED|Overall Study||16
8072765|NCT04184271|19904669|P1|STARTED|Overall Study||16
8072766|NCT04183231|19904678|P1|NOT COMPLETED|Overall Study||0
8072767|NCT04183231|19904678|P1|COMPLETED|Overall Study||16
8072768|NCT04183231|19904678|P1|STARTED|Overall Study||16
8072769|NCT04182217|19904694|P1|NOT COMPLETED|Overall Study||0
8072770|NCT04182217|19904694|P1|COMPLETED|Overall Study||91
8072771|NCT04182217|19904694|P1|STARTED|Overall Study||91
8072772|NCT04179838|19904707|P2|NOT COMPLETED|Second Intervention (1 Day)||1
8072773|NCT04179838|19904708|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8072774|NCT04179838|19904707|P2|COMPLETED|Second Intervention (1 Day)||12
8072775|NCT04179838|19904708|P1|COMPLETED|Second Intervention (1 Day)||13
8072776|NCT04179838|19904707|P2|STARTED|Second Intervention (1 Day)||13
8072777|NCT04179838|19904708|P1|STARTED|Second Intervention (1 Day)||13
8072778|NCT04179838|19904707|P2|NOT COMPLETED|Washout (4 Weeks)||0
8072779|NCT04179838|19904708|P1|NOT COMPLETED|Washout (4 Weeks)||0
8072780|NCT04179838|19904707|P2|COMPLETED|Washout (4 Weeks)||13
8072781|NCT04179838|19904708|P1|COMPLETED|Washout (4 Weeks)||13
8072782|NCT04179838|19904707|P2|STARTED|Washout (4 Weeks)||13
8072783|NCT04179838|19904708|P1|STARTED|Washout (4 Weeks)||13
8072784|NCT04179838|19904707|P2|NOT COMPLETED|First Intervention (1 Day)||3
8072785|NCT04179838|19904708|P1|NOT COMPLETED|First Intervention (1 Day)||0
8072786|NCT04179838|19904707|P2|COMPLETED|First Intervention (1 Day)||13
8072787|NCT04179838|19904708|P1|COMPLETED|First Intervention (1 Day)||13
8072788|NCT04179838|19904707|P2|STARTED|First Intervention (1 Day)||16
8072789|NCT04179838|19904708|P1|STARTED|First Intervention (1 Day)||13
8072790|NCT04178590|19904726|P1|NOT COMPLETED|Overall Study||2
8072791|NCT04178590|19904726|P1|COMPLETED|Overall Study||30
8072792|NCT04178590|19904726|P1|STARTED|Overall Study||32
8072793|NCT04176406|19904834|P4|NOT COMPLETED|Overall Study||0
8072794|NCT04176406|19904835|P3|NOT COMPLETED|Overall Study||0
8072795|NCT04176406|19904836|P2|NOT COMPLETED|Overall Study||0
8072796|NCT04176406|19904837|P1|NOT COMPLETED|Overall Study||0
8072797|NCT04176406|19904834|P4|COMPLETED|Overall Study||0
8072798|NCT04176406|19904835|P3|COMPLETED|Overall Study||0
8072799|NCT04176406|19904836|P2|COMPLETED|Overall Study||0
8072800|NCT04176406|19904837|P1|COMPLETED|Overall Study||0
8072801|NCT04176406|19904834|P4|STARTED|Overall Study||0
8072802|NCT04176406|19904835|P3|STARTED|Overall Study||0
8072803|NCT04176406|19904836|P2|STARTED|Overall Study||0
8072804|NCT04176406|19904837|P1|STARTED|Overall Study||0
8072805|NCT04173741|19904850|P2|NOT COMPLETED|Overall Study||1
8072806|NCT04173741|19904851|P1|NOT COMPLETED|Overall Study||1
8072807|NCT04173741|19904850|P2|COMPLETED|Overall Study||22
8072808|NCT04173741|19904851|P1|COMPLETED|Overall Study||22
8072809|NCT04173741|19904850|P2|STARTED|Overall Study||23
8072810|NCT04173741|19904851|P1|STARTED|Overall Study||23
8072811|NCT04171102|19904860|P3|NOT COMPLETED|Overall Study||0
8072812|NCT04171102|19904861|P2|NOT COMPLETED|Overall Study||0
8072813|NCT04171102|19904862|P1|NOT COMPLETED|Overall Study||0
8072814|NCT04171102|19904860|P3|COMPLETED|Overall Study||6
8072815|NCT04171102|19904861|P2|COMPLETED|Overall Study||5
8072816|NCT04171102|19904862|P1|COMPLETED|Overall Study||4
8072817|NCT04171102|19904860|P3|STARTED|Overall Study||6
8072818|NCT04171102|19904861|P2|STARTED|Overall Study||5
8072819|NCT04171102|19904862|P1|STARTED|Overall Study||4
8072832|NCT04169113|19904897|P2|NOT COMPLETED|Overall Study||6
8072833|NCT04169113|19904898|P1|NOT COMPLETED|Overall Study||5
8072834|NCT04169113|19904897|P2|COMPLETED|Overall Study||53
8072835|NCT04169113|19904898|P1|COMPLETED|Overall Study||47
8072836|NCT04169113|19904897|P2|STARTED|Overall Study||59
8072837|NCT04169113|19904898|P1|STARTED|Overall Study||52
8072838|NCT04161079|19904940|P1|NOT COMPLETED|2010-040FU5 >5 Years Follow-up||0
8072925|NCT04143945|19905207|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8072839|NCT04161079|19904940|P1|COMPLETED|2010-040FU5 >5 Years Follow-up|Timepoint distribution for individual patients ranged approximately 6-8 yrs after MAR implantation.|7
8072840|NCT04161079|19904940|P1|STARTED|2010-040FU5 >5 Years Follow-up|Of 11 subjects 3 refused to participate and 1 died.|7
8072841|NCT04161079|19904940|P1|NOT COMPLETED|Clinical Investigation 2010-040||1
8072842|NCT04161079|19904940|P1|COMPLETED|Clinical Investigation 2010-040||11
8072843|NCT04161079|19904940|P1|STARTED|Clinical Investigation 2010-040||12
8072844|NCT04158466|19904962|P2|NOT COMPLETED|Overall Study||1
8072845|NCT04158466|19904963|P1|NOT COMPLETED|Overall Study||3
8072846|NCT04158466|19904962|P2|COMPLETED|Overall Study||126
8072847|NCT04158466|19904963|P1|COMPLETED|Overall Study||121
8072848|NCT04158466|19904962|P2|STARTED|Overall Study||127
8072849|NCT04158466|19904963|P1|STARTED|Overall Study||124
8072850|NCT04150861|19904974|P3|NOT COMPLETED|Overall Study||0
8072851|NCT04150861|19904975|P2|NOT COMPLETED|Overall Study||0
8072852|NCT04150861|19904976|P1|NOT COMPLETED|Overall Study||0
8072853|NCT04150861|19904974|P3|COMPLETED|Overall Study||8
8072854|NCT04150861|19904975|P2|COMPLETED|Overall Study||8
8072855|NCT04150861|19904976|P1|COMPLETED|Overall Study||8
8072856|NCT04150861|19904974|P3|STARTED|Overall Study||8
8072857|NCT04150861|19904975|P2|STARTED|Overall Study||8
8072858|NCT04150861|19904976|P1|STARTED|Overall Study||8
8072859|NCT04150224|19905026|P6|NOT COMPLETED|Overall Study||0
8072860|NCT04150224|19905027|P5|NOT COMPLETED|Overall Study||0
8072861|NCT04150224|19905028|P4|NOT COMPLETED|Overall Study||0
8072862|NCT04150224|19905029|P3|NOT COMPLETED|Overall Study||0
8072863|NCT04150224|19905030|P2|NOT COMPLETED|Overall Study||0
8072864|NCT04150224|19905031|P1|NOT COMPLETED|Overall Study||0
8072865|NCT04150224|19905026|P6|COMPLETED|Overall Study|Period 2: Multple Dosing|10
8072866|NCT04150224|19905027|P5|COMPLETED|Overall Study||10
8072867|NCT04150224|19905028|P4|COMPLETED|Overall Study||10
8072868|NCT04150224|19905029|P3|COMPLETED|Overall Study||10
8072869|NCT04150224|19905030|P2|COMPLETED|Overall Study||10
8072870|NCT04150224|19905031|P1|COMPLETED|Overall Study||10
8072871|NCT04150224|19905026|P6|STARTED|Overall Study|Period 2: Multple Dosing|10
8072872|NCT04150224|19905027|P5|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
8072873|NCT04150224|19905028|P4|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
8072874|NCT04150224|19905029|P3|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
8072875|NCT04150224|19905030|P2|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
8072876|NCT04150224|19905031|P1|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
8072895|NCT04149353|19905178|P1|NOT COMPLETED|Overall Study||1
8072896|NCT04149353|19905178|P1|COMPLETED|Overall Study||0
8072897|NCT04149353|19905178|P1|STARTED|Overall Study|The study was terminated for low recruitment before this subject's second imaging scan was due.|1
8072898|NCT04148651|19905183|P1|NOT COMPLETED|Overall Study||2
8072899|NCT04148651|19905183|P1|COMPLETED|Overall Study|2 subjects didn't complete final follow-up due to COVID-19 pandemic|10
8072900|NCT04148651|19905183|P1|STARTED|Overall Study||12
8072901|NCT04144088|19905194|P3|NOT COMPLETED|Overall Study||7
8072902|NCT04144088|19905195|P2|NOT COMPLETED|Overall Study||5
8072903|NCT04144088|19905196|P1|NOT COMPLETED|Overall Study||6
8072904|NCT04144088|19905194|P3|COMPLETED|Overall Study||13
8072905|NCT04144088|19905195|P2|COMPLETED|Overall Study||15
8072906|NCT04144088|19905196|P1|COMPLETED|Overall Study||14
8072907|NCT04144088|19905194|P3|STARTED|Overall Study||20
8072908|NCT04144088|19905195|P2|STARTED|Overall Study||20
8072909|NCT04144088|19905196|P1|STARTED|Overall Study||20
8072910|NCT04143945|19905204|P4|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8072911|NCT04143945|19905205|P3|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8072912|NCT04143945|19905206|P2|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8072913|NCT04143945|19905207|P1|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8072914|NCT04143945|19905204|P4|COMPLETED|Treatment Period 2 (Day 1)||26
8072915|NCT04143945|19905205|P3|COMPLETED|Treatment Period 2 (Day 1)||26
8072916|NCT04143945|19905206|P2|COMPLETED|Treatment Period 2 (Day 1)||26
8072917|NCT04143945|19905207|P1|COMPLETED|Treatment Period 2 (Day 1)||26
8072918|NCT04143945|19905204|P4|STARTED|Treatment Period 2 (Day 1)||26
8072919|NCT04143945|19905205|P3|STARTED|Treatment Period 2 (Day 1)||26
8072920|NCT04143945|19905206|P2|STARTED|Treatment Period 2 (Day 1)||26
8072921|NCT04143945|19905207|P1|STARTED|Treatment Period 2 (Day 1)||26
8072922|NCT04143945|19905204|P4|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8072923|NCT04143945|19905205|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8072924|NCT04143945|19905206|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8072926|NCT04143945|19905204|P4|COMPLETED|Treatment Period 1 (Day 1)||26
8072927|NCT04143945|19905205|P3|COMPLETED|Treatment Period 1 (Day 1)||26
8072928|NCT04143945|19905206|P2|COMPLETED|Treatment Period 1 (Day 1)||26
8072929|NCT04143945|19905207|P1|COMPLETED|Treatment Period 1 (Day 1)||26
8072930|NCT04143945|19905204|P4|Per Protocol Set|Treatment Period 1 (Day 1)||26
8072931|NCT04143945|19905205|P3|Per Protocol Set|Treatment Period 1 (Day 1)||26
8072932|NCT04143945|19905206|P2|Per Protocol Set|Treatment Period 1 (Day 1)||26
8072933|NCT04143945|19905207|P1|Per Protocol Set|Treatment Period 1 (Day 1)||26
8072934|NCT04143945|19905204|P4|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
8072935|NCT04143945|19905205|P3|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
8072936|NCT04143945|19905206|P2|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
8072937|NCT04143945|19905207|P1|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
8072938|NCT04143945|19905204|P4|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
8072939|NCT04143945|19905205|P3|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
8072940|NCT04143945|19905206|P2|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
8072941|NCT04143945|19905207|P1|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
8072942|NCT04143945|19905204|P4|STARTED|Treatment Period 1 (Day 1)||26
8072943|NCT04143945|19905205|P3|STARTED|Treatment Period 1 (Day 1)||26
8072944|NCT04143945|19905206|P2|STARTED|Treatment Period 1 (Day 1)||26
8072945|NCT04143945|19905207|P1|STARTED|Treatment Period 1 (Day 1)||26
8072946|NCT04143373|19905212|P2|NOT COMPLETED|Overall Study||0
8072947|NCT04143373|19905213|P1|NOT COMPLETED|Overall Study||0
8072948|NCT04143373|19905212|P2|COMPLETED|Overall Study||20
8072949|NCT04143373|19905213|P1|COMPLETED|Overall Study||20
8072950|NCT04143373|19905212|P2|STARTED|Overall Study||20
8072951|NCT04143373|19905213|P1|STARTED|Overall Study||20
8072952|NCT04142216|19905222|P2|NOT COMPLETED|Overall Study||6
8072953|NCT04142216|19905223|P1|NOT COMPLETED|Overall Study||6
8072954|NCT04142216|19905222|P2|COMPLETED|Overall Study||22
8072955|NCT04142216|19905223|P1|COMPLETED|Overall Study||22
8072956|NCT04142216|19905222|P2|STARTED|Overall Study||28
8072957|NCT04142216|19905223|P1|STARTED|Overall Study||28
8072958|NCT04140890|19905245|P2|NOT COMPLETED|Overall Study||1
8072959|NCT04140890|19905246|P1|NOT COMPLETED|Overall Study||0
8072960|NCT04140890|19905245|P2|COMPLETED|Overall Study||11
8072961|NCT04140890|19905246|P1|COMPLETED|Overall Study||9
8072962|NCT04140890|19905245|P2|STARTED|Overall Study||12
8072963|NCT04140890|19905246|P1|STARTED|Overall Study||9
8072964|NCT04138810|19905274|P2|NOT COMPLETED|Overall Study||1
8072965|NCT04138810|19905275|P1|NOT COMPLETED|Overall Study||1
8072966|NCT04138810|19905274|P2|COMPLETED|Overall Study||26
8072967|NCT04138810|19905275|P1|COMPLETED|Overall Study||26
8072968|NCT04138810|19905274|P2|STARTED|Overall Study||27
8072969|NCT04138810|19905275|P1|STARTED|Overall Study||27
8072970|NCT04138758|19905283|P2|NOT COMPLETED|Overall Study||0
8072971|NCT04138758|19905284|P1|NOT COMPLETED|Overall Study||0
8072972|NCT04138758|19905283|P2|COMPLETED|Overall Study||40353
8072973|NCT04138758|19905284|P1|COMPLETED|Overall Study||2600
8072974|NCT04138758|19905283|P2|STARTED|Overall Study||40353
8072975|NCT04138758|19905284|P1|STARTED|Overall Study||2600
8072976|NCT04137627|19905302|P2|NOT COMPLETED|Overall Study||13
8072977|NCT04137627|19905303|P1|NOT COMPLETED|Overall Study||12
8072978|NCT04137627|19905302|P2|COMPLETED|Overall Study||12
8072979|NCT04137627|19905303|P1|COMPLETED|Overall Study||13
8072980|NCT04137627|19905302|P2|STARTED|Overall Study||25
8072981|NCT04137627|19905303|P1|STARTED|Overall Study||25
8072982|NCT04136145|19905319|P2|NOT COMPLETED|Overall Study||0
8072983|NCT04136145|19905320|P1|NOT COMPLETED|Overall Study||0
8072984|NCT04136145|19905319|P2|COMPLETED|Overall Study||24
8072985|NCT04136145|19905320|P1|COMPLETED|Overall Study||12
8072986|NCT04136145|19905319|P2|STARTED|Overall Study||24
8072987|NCT04136145|19905320|P1|STARTED|Overall Study||12
8072988|NCT04131556|19905340|P1|NOT COMPLETED|Overall Study||2
8072989|NCT04131556|19905340|P1|COMPLETED|Overall Study||18
8072990|NCT04131556|19905340|P1|STARTED|Overall Study||20
8072991|NCT04130425|19905371|P1|NOT COMPLETED|Overall Study||0
8072992|NCT04130425|19905371|P1|COMPLETED|Overall Study||30
8072993|NCT04130425|19905371|P1|STARTED|Overall Study||30
8072994|NCT04128293|19905386|P4|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8072995|NCT04128293|19905387|P3|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8072996|NCT04128293|19905388|P2|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8072997|NCT04128293|19905389|P1|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8072998|NCT04128293|19905386|P4|COMPLETED|Treatment Period 4 (1 Day)||0
8072999|NCT04128293|19905387|P3|COMPLETED|Treatment Period 4 (1 Day)||0
8073000|NCT04128293|19905388|P2|COMPLETED|Treatment Period 4 (1 Day)||0
8073001|NCT04128293|19905389|P1|COMPLETED|Treatment Period 4 (1 Day)||0
8073002|NCT04128293|19905386|P4|STARTED|Treatment Period 4 (1 Day)||0
8073003|NCT04128293|19905387|P3|STARTED|Treatment Period 4 (1 Day)||0
8073004|NCT04128293|19905388|P2|STARTED|Treatment Period 4 (1 Day)||0
8073005|NCT04128293|19905389|P1|STARTED|Treatment Period 4 (1 Day)||0
8073006|NCT04128293|19905386|P4|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073007|NCT04128293|19905387|P3|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073008|NCT04128293|19905388|P2|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073009|NCT04128293|19905389|P1|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073010|NCT04128293|19905386|P4|COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073011|NCT04128293|19905387|P3|COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073012|NCT04128293|19905388|P2|COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073013|NCT04128293|19905389|P1|COMPLETED|Washout Period 3 (Up to 7 Days)||0
8073014|NCT04128293|19905386|P4|STARTED|Washout Period 3 (Up to 7 Days)||0
8073015|NCT04128293|19905387|P3|STARTED|Washout Period 3 (Up to 7 Days)||0
8073016|NCT04128293|19905388|P2|STARTED|Washout Period 3 (Up to 7 Days)||0
8073017|NCT04128293|19905389|P1|STARTED|Washout Period 3 (Up to 7 Days)||0
8073018|NCT04128293|19905386|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8073019|NCT04128293|19905387|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8073020|NCT04128293|19905388|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8073021|NCT04128293|19905389|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8073022|NCT04128293|19905386|P4|COMPLETED|Treatment Period 3 (1 Day)||0
8073023|NCT04128293|19905387|P3|COMPLETED|Treatment Period 3 (1 Day)||0
8073024|NCT04128293|19905388|P2|COMPLETED|Treatment Period 3 (1 Day)||0
8073025|NCT04128293|19905389|P1|COMPLETED|Treatment Period 3 (1 Day)||0
8073026|NCT04128293|19905386|P4|STARTED|Treatment Period 3 (1 Day)||0
8073027|NCT04128293|19905387|P3|STARTED|Treatment Period 3 (1 Day)||0
8073028|NCT04128293|19905388|P2|STARTED|Treatment Period 3 (1 Day)||0
8073029|NCT04128293|19905389|P1|STARTED|Treatment Period 3 (1 Day)||0
8073030|NCT04128293|19905386|P4|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
8073031|NCT04128293|19905387|P3|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
8073032|NCT04128293|19905388|P2|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
8073033|NCT04128293|19905389|P1|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
8073034|NCT04128293|19905386|P4|COMPLETED|Washout Period 2 (Up to 7 Days)||0
8073035|NCT04128293|19905387|P3|COMPLETED|Washout Period 2 (Up to 7 Days)||0
8073036|NCT04128293|19905388|P2|COMPLETED|Washout Period 2 (Up to 7 Days)||0
8073037|NCT04128293|19905389|P1|COMPLETED|Washout Period 2 (Up to 7 Days)||0
8073038|NCT04128293|19905386|P4|STARTED|Washout Period 2 (Up to 7 Days)||4
8073039|NCT04128293|19905387|P3|STARTED|Washout Period 2 (Up to 7 Days)||4
8073040|NCT04128293|19905388|P2|STARTED|Washout Period 2 (Up to 7 Days)||4
8073041|NCT04128293|19905389|P1|STARTED|Washout Period 2 (Up to 7 Days)||4
8073042|NCT04128293|19905386|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8073043|NCT04128293|19905387|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8073044|NCT04128293|19905388|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8073045|NCT04128293|19905389|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8073046|NCT04128293|19905386|P4|COMPLETED|Treatment Period 2 (1 Day)||4
8073047|NCT04128293|19905387|P3|COMPLETED|Treatment Period 2 (1 Day)||4
8073048|NCT04128293|19905388|P2|COMPLETED|Treatment Period 2 (1 Day)||4
8073049|NCT04128293|19905389|P1|COMPLETED|Treatment Period 2 (1 Day)||4
8073050|NCT04128293|19905386|P4|STARTED|Treatment Period 2 (1 Day)||4
8073051|NCT04128293|19905387|P3|STARTED|Treatment Period 2 (1 Day)||4
8073052|NCT04128293|19905388|P2|STARTED|Treatment Period 2 (1 Day)||4
8073053|NCT04128293|19905389|P1|STARTED|Treatment Period 2 (1 Day)||4
8073054|NCT04128293|19905386|P4|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
8073055|NCT04128293|19905387|P3|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
8073056|NCT04128293|19905388|P2|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
8073057|NCT04128293|19905389|P1|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
8073058|NCT04128293|19905386|P4|COMPLETED|Washout Period 1 (Up to 7 Days)||4
8073059|NCT04128293|19905387|P3|COMPLETED|Washout Period 1 (Up to 7 Days)||4
8073060|NCT04128293|19905388|P2|COMPLETED|Washout Period 1 (Up to 7 Days)||4
8073061|NCT04128293|19905389|P1|COMPLETED|Washout Period 1 (Up to 7 Days)||4
8073062|NCT04128293|19905386|P4|STARTED|Washout Period 1 (Up to 7 Days)||4
8073063|NCT04128293|19905387|P3|STARTED|Washout Period 1 (Up to 7 Days)||4
8073064|NCT04128293|19905388|P2|STARTED|Washout Period 1 (Up to 7 Days)||4
8073065|NCT04128293|19905389|P1|STARTED|Washout Period 1 (Up to 7 Days)||4
8073066|NCT04128293|19905386|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8073067|NCT04128293|19905387|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8073068|NCT04128293|19905388|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8073069|NCT04128293|19905389|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8073070|NCT04128293|19905386|P4|COMPLETED|Treatment Period 1 (1 Day)||4
8073071|NCT04128293|19905387|P3|COMPLETED|Treatment Period 1 (1 Day)||4
8073072|NCT04128293|19905388|P2|COMPLETED|Treatment Period 1 (1 Day)||4
8073073|NCT04128293|19905389|P1|COMPLETED|Treatment Period 1 (1 Day)||4
8073074|NCT04128293|19905386|P4|STARTED|Treatment Period 1 (1 Day)||4
8073075|NCT04128293|19905387|P3|STARTED|Treatment Period 1 (1 Day)||4
8073076|NCT04128293|19905388|P2|STARTED|Treatment Period 1 (1 Day)||4
8073077|NCT04128293|19905389|P1|STARTED|Treatment Period 1 (1 Day)||4
8073078|NCT04123665|19905589|P2|NOT COMPLETED|Overall Study||0
8073079|NCT04123665|19905590|P1|NOT COMPLETED|Overall Study||8
8073080|NCT04123665|19905589|P2|COMPLETED|Overall Study||48
8073081|NCT04123665|19905590|P1|COMPLETED|Overall Study||42
8073082|NCT04123665|19905589|P2|STARTED|Overall Study||48
8073083|NCT04123665|19905590|P1|STARTED|Overall Study||50
8073084|NCT04122534|19905612|P1|NOT COMPLETED|Overall Study||4
8073085|NCT04122534|19905612|P1|COMPLETED|Overall Study||44
8073086|NCT04122534|19905612|P1|STARTED|Overall Study||48
8073087|NCT04121078|19905619|P2|NOT COMPLETED|Study Period 2 (1 Day)||0
8073088|NCT04121078|19905620|P1|NOT COMPLETED|Study Period 2 (1 Day)||0
8073089|NCT04121078|19905619|P2|COMPLETED|Study Period 2 (1 Day)||6
8073090|NCT04121078|19905620|P1|COMPLETED|Study Period 2 (1 Day)||6
8073091|NCT04121078|19905619|P2|STARTED|Study Period 2 (1 Day)||6
8073092|NCT04121078|19905620|P1|STARTED|Study Period 2 (1 Day)||6
8073093|NCT04121078|19905619|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8073094|NCT04121078|19905620|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8073095|NCT04121078|19905619|P2|COMPLETED|Washout Period (at Least 7 Days)||6
8073096|NCT04121078|19905620|P1|COMPLETED|Washout Period (at Least 7 Days)||6
8073097|NCT04121078|19905619|P2|STARTED|Washout Period (at Least 7 Days)||6
8073098|NCT04121078|19905620|P1|STARTED|Washout Period (at Least 7 Days)||6
8073099|NCT04121078|19905619|P2|NOT COMPLETED|Study Period 1 (1 Day)||0
8073100|NCT04121078|19905620|P1|NOT COMPLETED|Study Period 1 (1 Day)||0
8073101|NCT04121078|19905619|P2|COMPLETED|Study Period 1 (1 Day)||6
8073102|NCT04121078|19905620|P1|COMPLETED|Study Period 1 (1 Day)||6
8073103|NCT04121078|19905619|P2|STARTED|Study Period 1 (1 Day)||6
8073104|NCT04121078|19905620|P1|STARTED|Study Period 1 (1 Day)||6
8073105|NCT04113785|19905638|P1|NOT COMPLETED|Overall Study||0
8073106|NCT04113785|19905638|P1|COMPLETED|Overall Study||21
8073107|NCT04113785|19905638|P1|STARTED|Overall Study||21
8073108|NCT04112160|19905647|P2|NOT COMPLETED|Overall Study||0
8073109|NCT04112160|19905648|P1|NOT COMPLETED|Overall Study||1
8073110|NCT04112160|19905647|P2|COMPLETED|Overall Study||62
8073111|NCT04112160|19905648|P1|COMPLETED|Overall Study||62
8073112|NCT04112160|19905647|P2|STARTED|Overall Study||62
8073113|NCT04112160|19905648|P1|STARTED|Overall Study||63
8073114|NCT04112069|19905664|P2|NOT COMPLETED|Overall Study||0
8073115|NCT04112069|19905665|P1|NOT COMPLETED|Overall Study||0
8073116|NCT04112069|19905664|P2|COMPLETED|Overall Study||10
8073117|NCT04112069|19905665|P1|COMPLETED|Overall Study||10
8073118|NCT04112069|19905664|P2|STARTED|Overall Study||10
8073119|NCT04112069|19905665|P1|STARTED|Overall Study||10
8073120|NCT04109703|19905687|P2|NOT COMPLETED|Overall Study||0
8073121|NCT04109703|19905688|P1|NOT COMPLETED|Overall Study||0
8073122|NCT04109703|19905687|P2|COMPLETED|Overall Study||51
8073123|NCT04109703|19905688|P1|COMPLETED|Overall Study||49
8073124|NCT04109703|19905687|P2|STARTED|Overall Study||51
8073125|NCT04109703|19905688|P1|STARTED|Overall Study||49
8073126|NCT04109222|19905699|P3|NOT COMPLETED|Overall Study||0
8073127|NCT04109222|19905700|P2|NOT COMPLETED|Overall Study||0
8073128|NCT04109222|19905701|P1|NOT COMPLETED|Overall Study||1
8073129|NCT04109222|19905699|P3|COMPLETED|Overall Study||30
8073130|NCT04109222|19905700|P2|COMPLETED|Overall Study||30
8073131|NCT04109222|19905701|P1|COMPLETED|Overall Study||29
8073132|NCT04109222|19905699|P3|STARTED|Overall Study||30
8073133|NCT04109222|19905700|P2|STARTED|Overall Study||30
8073134|NCT04109222|19905701|P1|STARTED|Overall Study||30
8073135|NCT04106817|19905712|P3|NOT COMPLETED|Overall Study||0
8073136|NCT04106817|19905713|P2|NOT COMPLETED|Overall Study||0
8073137|NCT04106817|19905714|P1|NOT COMPLETED|Overall Study||1
8073138|NCT04106817|19905712|P3|COMPLETED|Overall Study||12
8073139|NCT04106817|19905713|P2|COMPLETED|Overall Study||11
8073140|NCT04106817|19905714|P1|COMPLETED|Overall Study||11
8073141|NCT04106817|19905712|P3|STARTED|Overall Study||12
8073142|NCT04106817|19905713|P2|STARTED|Overall Study||11
8073143|NCT04106817|19905714|P1|STARTED|Overall Study||12
8073144|NCT04098809|19905730|P2|NOT COMPLETED|Overall Study||4
8073145|NCT04098809|19905731|P1|NOT COMPLETED|Overall Study||3
8073146|NCT04098809|19905730|P2|COMPLETED|Overall Study||21
8073147|NCT04098809|19905731|P1|COMPLETED|Overall Study||24
8073148|NCT04098809|19905730|P2|STARTED|Overall Study||25
8073149|NCT04098809|19905731|P1|STARTED|Overall Study||27
8073150|NCT04095286|19905757|P6|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
8073151|NCT04095286|19905758|P5|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
8073152|NCT04095286|19905759|P4|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
8073153|NCT04095286|19905760|P3|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
8073154|NCT04095286|19905761|P2|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
8073155|NCT04095286|19905762|P1|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
8073156|NCT04095286|19905757|P6|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
8073157|NCT04095286|19905758|P5|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
8073158|NCT04095286|19905759|P4|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
8073159|NCT04095286|19905760|P3|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||2
8073160|NCT04095286|19905761|P2|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
8073161|NCT04095286|19905762|P1|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||3
8073162|NCT04095286|19905757|P6|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
8073163|NCT04095286|19905758|P5|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
8073164|NCT04095286|19905759|P4|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
8073165|NCT04095286|19905760|P3|STARTED|Period 3 (4 Days) + Follow up (14 Days)||2
8073166|NCT04095286|19905761|P2|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
8073167|NCT04095286|19905762|P1|STARTED|Period 3 (4 Days) + Follow up (14 Days)||3
8073168|NCT04095286|19905757|P6|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
8073169|NCT04095286|19905758|P5|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||1
8073170|NCT04095286|19905759|P4|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
8073171|NCT04095286|19905760|P3|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||2
8073172|NCT04095286|19905761|P2|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
8073173|NCT04095286|19905762|P1|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
8073174|NCT04095286|19905757|P6|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
8073175|NCT04095286|19905758|P5|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
8073176|NCT04095286|19905759|P4|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
8073177|NCT04095286|19905760|P3|COMPLETED|Period 2 (4 Days) + Washout (7days)||2
8073178|NCT04095286|19905761|P2|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
8073179|NCT04095286|19905762|P1|COMPLETED|Period 2 (4 Days) + Washout (7days)||3
8073180|NCT04095286|19905757|P6|STARTED|Period 2 (4 Days) + Washout (7days)||5
8073181|NCT04095286|19905758|P5|STARTED|Period 2 (4 Days) + Washout (7days)||5
8073182|NCT04095286|19905759|P4|STARTED|Period 2 (4 Days) + Washout (7days)||5
8073183|NCT04095286|19905760|P3|STARTED|Period 2 (4 Days) + Washout (7days)||4
8073184|NCT04095286|19905761|P2|STARTED|Period 2 (4 Days) + Washout (7days)||4
8073185|NCT04095286|19905762|P1|STARTED|Period 2 (4 Days) + Washout (7days)||3
8073186|NCT04095286|19905757|P6|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
8073187|NCT04095286|19905758|P5|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
8073188|NCT04095286|19905759|P4|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
8073189|NCT04095286|19905760|P3|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
8073190|NCT04095286|19905761|P2|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
8073191|NCT04095286|19905762|P1|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
8073192|NCT04095286|19905757|P6|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
8073193|NCT04095286|19905758|P5|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
8073194|NCT04095286|19905759|P4|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
8073195|NCT04095286|19905760|P3|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
8073196|NCT04095286|19905761|P2|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
8073197|NCT04095286|19905762|P1|COMPLETED|Period 1 (4 Days) + Washout (7days)||3
8073198|NCT04095286|19905757|P6|STARTED|Period 1 (4 Days) + Washout (7days)||5
8073199|NCT04095286|19905758|P5|STARTED|Period 1 (4 Days) + Washout (7days)||5
8073200|NCT04095286|19905759|P4|STARTED|Period 1 (4 Days) + Washout (7days)||5
8073201|NCT04095286|19905760|P3|STARTED|Period 1 (4 Days) + Washout (7days)||5
8073202|NCT04095286|19905761|P2|STARTED|Period 1 (4 Days) + Washout (7days)||5
8073203|NCT04095286|19905762|P1|STARTED|Period 1 (4 Days) + Washout (7days)||4
8073204|NCT04091659|19905805|P2|NOT COMPLETED|Overall Study||1
8073205|NCT04091659|19905806|P1|NOT COMPLETED|Overall Study||3
8073206|NCT04091659|19905805|P2|COMPLETED|Overall Study||57
8073207|NCT04091659|19905806|P1|COMPLETED|Overall Study||37
8073208|NCT04091659|19905805|P2|STARTED|Overall Study||58
8073209|NCT04091659|19905806|P1|STARTED|Overall Study||40
8073210|NCT04090164|19905816|P2|NOT COMPLETED|Overall Study||0
8073211|NCT04090164|19905817|P1|NOT COMPLETED|Overall Study||245
8073212|NCT04090164|19905816|P2|COMPLETED|Overall Study||145
8073213|NCT04090164|19905817|P1|COMPLETED|Overall Study|Number of patients analyzed.|405
8073214|NCT04090164|19905816|P2|STARTED|Overall Study||145
8073215|NCT04090164|19905817|P1|STARTED|Overall Study|Number of patients retrivied from the hospital files.|650
8073216|NCT04086641|19905826|P2|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
8073217|NCT04086641|19905827|P1|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
8073218|NCT04086641|19905826|P2|COMPLETED|Foot 2 (Two Week Utilization)||1
8073219|NCT04086641|19905827|P1|COMPLETED|Foot 2 (Two Week Utilization)||1
8073220|NCT04086641|19905826|P2|STARTED|Foot 2 (Two Week Utilization)||1
8073221|NCT04086641|19905827|P1|STARTED|Foot 2 (Two Week Utilization)||1
8073222|NCT04086641|19905826|P2|NOT COMPLETED|Foot 1 (Two Week Utilization)||2
8073223|NCT04086641|19905827|P1|NOT COMPLETED|Foot 1 (Two Week Utilization)||1
8073224|NCT04086641|19905826|P2|COMPLETED|Foot 1 (Two Week Utilization)||1
8073225|NCT04086641|19905827|P1|COMPLETED|Foot 1 (Two Week Utilization)||1
8073226|NCT04086641|19905826|P2|STARTED|Foot 1 (Two Week Utilization)||3
8073227|NCT04086641|19905827|P1|STARTED|Foot 1 (Two Week Utilization)||2
8073228|NCT04086576|19905849|P2|NOT COMPLETED|Overall Study||0
8073229|NCT04086576|19905850|P1|NOT COMPLETED|Overall Study||0
8073230|NCT04086576|19905849|P2|COMPLETED|Overall Study||10
8073231|NCT04086576|19905850|P1|COMPLETED|Overall Study||10
8073232|NCT04086576|19905849|P2|STARTED|Overall Study||10
8073233|NCT04086576|19905850|P1|STARTED|Overall Study||10
8073234|NCT04086433|19905871|P2|NOT COMPLETED|Overall Study||0
8073235|NCT04086433|19905872|P1|NOT COMPLETED|Overall Study||0
8073236|NCT04086433|19905871|P2|COMPLETED|Overall Study||18
8073237|NCT04086433|19905872|P1|COMPLETED|Overall Study||17
8073238|NCT04086433|19905871|P2|STARTED|Overall Study||18
8073239|NCT04086433|19905872|P1|STARTED|Overall Study||17
8073240|NCT04086407|19905878|P1|NOT COMPLETED|Overall Study||0
8073241|NCT04086407|19905878|P1|COMPLETED|Overall Study||8
8073242|NCT04086407|19905878|P1|STARTED|Overall Study||8
8073243|NCT04083404|19905885|P1|NOT COMPLETED|Overall Study||0
8073244|NCT04083404|19905885|P1|COMPLETED|Overall Study||202
8073245|NCT04083404|19905885|P1|STARTED|Overall Study||202
8073246|NCT04082819|19905893|P3|NOT COMPLETED|Overall Study||0
8073247|NCT04082819|19905894|P2|NOT COMPLETED|Overall Study||0
8073248|NCT04082819|19905895|P1|NOT COMPLETED|Overall Study||0
8073249|NCT04082819|19905893|P3|COMPLETED|Overall Study||3
8073250|NCT04082819|19905894|P2|COMPLETED|Overall Study||54
8073251|NCT04082819|19905895|P1|COMPLETED|Overall Study||37
8073252|NCT04082819|19905893|P3|STARTED|Overall Study||3
8073253|NCT04082819|19905894|P2|STARTED|Overall Study||54
8073254|NCT04082819|19905895|P1|STARTED|Overall Study||37
8073255|NCT04081961|19905909|P3|NOT COMPLETED|Overall Study||0
8073256|NCT04081961|19905910|P2|NOT COMPLETED|Overall Study||0
8073257|NCT04081961|19905911|P1|NOT COMPLETED|Overall Study||0
8073258|NCT04081961|19905909|P3|COMPLETED|Overall Study||9
8073259|NCT04081961|19905910|P2|COMPLETED|Overall Study||9
8073260|NCT04081961|19905911|P1|COMPLETED|Overall Study||9
8073261|NCT04081961|19905909|P3|STARTED|Overall Study||9
8073262|NCT04081961|19905910|P2|STARTED|Overall Study||9
8073263|NCT04081961|19905911|P1|STARTED|Overall Study||9
8073264|NCT04080882|19905927|P2|NOT COMPLETED|Overall Study||2
8073265|NCT04080882|19905928|P1|NOT COMPLETED|Overall Study||2
8073266|NCT04080882|19905927|P2|COMPLETED|Overall Study||58
8073267|NCT04080882|19905928|P1|COMPLETED|Overall Study||18
8073268|NCT04080882|19905927|P2|STARTED|Overall Study||60
8073269|NCT04080882|19905928|P1|STARTED|Overall Study||20
8073270|NCT04080297|19905936|P2|NOT COMPLETED|Overall Study||3
8073271|NCT04080297|19905937|P1|NOT COMPLETED|Overall Study||2
8073272|NCT04080297|19905936|P2|COMPLETED|Overall Study||8
8073273|NCT04080297|19905937|P1|COMPLETED|Overall Study||8
8073274|NCT04080297|19905936|P2|STARTED|Overall Study||11
8073275|NCT04080297|19905937|P1|STARTED|Overall Study||10
8073276|NCT04079790|19905959|P4|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
8073277|NCT04079790|19905960|P3|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
8073278|NCT04079790|19905961|P2|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
8073279|NCT04079790|19905962|P1|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
8073280|NCT04079790|19905959|P4|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||3
8073281|NCT04079790|19905960|P3|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||12
8073282|NCT04079790|19905961|P2|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
8073283|NCT04079790|19905962|P1|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
8073284|NCT04079790|19905959|P4|STARTED|Part 2, Period 2 (Day 1 to Day 3)||3
8073285|NCT04079790|19905960|P3|STARTED|Part 2, Period 2 (Day 1 to Day 3)||12
8073286|NCT04079790|19905961|P2|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
8073287|NCT04079790|19905962|P1|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
8073288|NCT04079790|19905959|P4|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
8073289|NCT04079790|19905960|P3|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
8073290|NCT04079790|19905961|P2|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
8073291|NCT04079790|19905962|P1|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
8073292|NCT04079790|19905959|P4|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
8073293|NCT04079790|19905960|P3|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||12
8073294|NCT04079790|19905961|P2|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
8073295|NCT04079790|19905962|P1|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
8073296|NCT04079790|19905959|P4|STARTED|Part 2, Period 1 (Day 1 to Day 3)||3
8073297|NCT04079790|19905960|P3|STARTED|Part 2, Period 1 (Day 1 to Day 3)||15
8073298|NCT04079790|19905961|P2|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
8073299|NCT04079790|19905962|P1|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
8073300|NCT04079790|19905959|P4|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
8073301|NCT04079790|19905960|P3|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
8073302|NCT04079790|19905961|P2|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
8073303|NCT04079790|19905962|P1|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
8073304|NCT04079790|19905959|P4|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
8073305|NCT04079790|19905960|P3|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
8073306|NCT04079790|19905961|P2|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||2
8073307|NCT04079790|19905962|P1|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||13
8073308|NCT04079790|19905959|P4|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
8073309|NCT04079790|19905960|P3|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
8073310|NCT04079790|19905961|P2|STARTED|Part 1, Period 3 (Day 9 to Day 11)||2
8073311|NCT04079790|19905962|P1|STARTED|Part 1, Period 3 (Day 9 to Day 11)||13
8073312|NCT04079790|19905959|P4|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
8073313|NCT04079790|19905960|P3|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
8073314|NCT04079790|19905961|P2|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
8073315|NCT04079790|19905962|P1|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
8073316|NCT04079790|19905959|P4|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
8073317|NCT04079790|19905960|P3|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
8073318|NCT04079790|19905961|P2|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||2
8073319|NCT04079790|19905962|P1|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||13
8073320|NCT04079790|19905959|P4|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
8073321|NCT04079790|19905960|P3|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
8073322|NCT04079790|19905961|P2|STARTED|Part 1, Period 2 (Day 5 to Day 8)||2
8073323|NCT04079790|19905962|P1|STARTED|Part 1, Period 2 (Day 5 to Day 8)||13
8073324|NCT04079790|19905959|P4|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
8073325|NCT04079790|19905960|P3|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
8073326|NCT04079790|19905961|P2|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
8073327|NCT04079790|19905962|P1|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||1
8073328|NCT04079790|19905959|P4|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
8073329|NCT04079790|19905960|P3|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
8073330|NCT04079790|19905961|P2|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||2
8073331|NCT04079790|19905962|P1|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||13
8073332|NCT04079790|19905959|P4|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
8073333|NCT04079790|19905960|P3|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
8073334|NCT04079790|19905961|P2|STARTED|Part 1, Period 1(Day 1 to Day 4)||2
8073335|NCT04079790|19905962|P1|STARTED|Part 1, Period 1(Day 1 to Day 4)||14
8073339|NCT04079114|19906106|P1|NOT COMPLETED|Overall Study||166
8073340|NCT04079114|19906106|P1|COMPLETED|Overall Study|Study prematurely terminated.|0
8073341|NCT04079114|19906106|P1|STARTED|Overall Study||166
8073351|NCT04072432|19906144|P3|NOT COMPLETED|Overall Study||0
8073352|NCT04072432|19906145|P2|NOT COMPLETED|Overall Study||0
8073353|NCT04072432|19906146|P1|NOT COMPLETED|Overall Study||0
8073354|NCT04072432|19906144|P3|COMPLETED|Overall Study||6
8073355|NCT04072432|19906145|P2|COMPLETED|Overall Study||6
8073356|NCT04072432|19906146|P1|COMPLETED|Overall Study||6
8073357|NCT04072432|19906144|P3|STARTED|Overall Study||6
8073358|NCT04072432|19906145|P2|STARTED|Overall Study||6
8073359|NCT04072432|19906146|P1|STARTED|Overall Study||6
8073360|NCT04071392|19906156|P2|NOT COMPLETED|Overall Study||2
8073361|NCT04071392|19906157|P1|NOT COMPLETED|Overall Study||2
8073362|NCT04071392|19906156|P2|COMPLETED|Overall Study||10
8073363|NCT04071392|19906157|P1|COMPLETED|Overall Study||10
8073364|NCT04071392|19906156|P2|STARTED|Overall Study||12
8073365|NCT04071392|19906157|P1|STARTED|Overall Study||12
8073372|NCT04069221|19906198|P4|NOT COMPLETED|Overall Study||0
8073373|NCT04069221|19906199|P3|NOT COMPLETED|Overall Study||0
8073374|NCT04069221|19906200|P2|NOT COMPLETED|Overall Study||0
8073375|NCT04069221|19906201|P1|NOT COMPLETED|Overall Study||0
8073376|NCT04069221|19906198|P4|COMPLETED|Overall Study||6
8073377|NCT04069221|19906199|P3|COMPLETED|Overall Study||6
8073378|NCT04069221|19906200|P2|COMPLETED|Overall Study||6
8073379|NCT04069221|19906201|P1|COMPLETED|Overall Study||8
8073380|NCT04069221|19906198|P4|STARTED|Overall Study||6
8073381|NCT04069221|19906199|P3|STARTED|Overall Study||6
8073382|NCT04069221|19906200|P2|STARTED|Overall Study||6
8073383|NCT04069221|19906201|P1|STARTED|Overall Study||8
8073384|NCT04067401|19906222|P2|NOT COMPLETED|Overall Study||0
8073385|NCT04067401|19906223|P1|NOT COMPLETED|Overall Study||8
8073386|NCT04067401|19906222|P2|COMPLETED|Overall Study||737
8073387|NCT04067401|19906223|P1|COMPLETED|Overall Study||740
8073388|NCT04067401|19906222|P2|6 Month Survey Completion|Overall Study||618
8073389|NCT04067401|19906223|P1|6 Month Survey Completion|Overall Study||629
8073390|NCT04067401|19906222|P2|1 Month Survey Completion|Overall Study||694
8073391|NCT04067401|19906223|P1|1 Month Survey Completion|Overall Study||697
8073392|NCT04067401|19906222|P2|Baseline Survey Completion|Overall Study||735
8073393|NCT04067401|19906223|P1|Baseline Survey Completion|Overall Study||746
8073394|NCT04067401|19906222|P2|STARTED|Overall Study||737
8073395|NCT04067401|19906223|P1|STARTED|Overall Study||748
8073396|NCT04067141|19906243|P2|NOT COMPLETED|Second Intervention||2
8073397|NCT04067141|19906244|P1|NOT COMPLETED|Second Intervention||0
8073398|NCT04067141|19906243|P2|COMPLETED|Second Intervention||31
8073399|NCT04067141|19906244|P1|COMPLETED|Second Intervention||34
8073400|NCT04067141|19906243|P2|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject|33
8073401|NCT04067141|19906244|P1|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject.|34
8073402|NCT04067141|19906243|P2|NOT COMPLETED|First Intervention||1
8073403|NCT04067141|19906244|P1|NOT COMPLETED|First Intervention||0
8073404|NCT04067141|19906243|P2|COMPLETED|First Intervention||34
8073405|NCT04067141|19906244|P1|COMPLETED|First Intervention||35
8073406|NCT04067141|19906243|P2|STARTED|First Intervention||35
8073407|NCT04067141|19906244|P1|STARTED|First Intervention||35
8073408|NCT04066647|19906290|P1|NOT COMPLETED|Overall Study||0
8073409|NCT04066647|19906290|P1|COMPLETED|Overall Study||7
8073410|NCT04066647|19906290|P1|STARTED|Overall Study||7
8073411|NCT04065074|19906294|P1|NOT COMPLETED|Overall Study||2
8073412|NCT04065074|19906294|P1|COMPLETED|Overall Study||14
8073413|NCT04065074|19906294|P1|STARTED|Overall Study||16
8073414|NCT04061694|19906300|P2|NOT COMPLETED|Overall Study||0
8073415|NCT04061694|19906301|P1|NOT COMPLETED|Overall Study||2
8073416|NCT04061694|19906300|P2|COMPLETED|Overall Study||25
8073417|NCT04061694|19906301|P1|COMPLETED|Overall Study||19
8073418|NCT04061694|19906300|P2|STARTED|Overall Study||25
8073419|NCT04061694|19906301|P1|STARTED|Overall Study||21
8073423|NCT04057235|19906319|P1|NOT COMPLETED|Overall Study||0
8073424|NCT04057235|19906319|P1|COMPLETED|Overall Study|All 129 participants had data for at least one of the primary/secondary outcomes or adverse events|129
8073425|NCT04057235|19906319|P1|Had VAS Leg Data|Overall Study||45
8073426|NCT04057235|19906319|P1|Had VAS Back Data|Overall Study||45
8073427|NCT04057235|19906319|P1|Had ODI Data|Overall Study||43
8073428|NCT04057235|19906319|P1|Had Radiographic Data|Overall Study||58
8073429|NCT04057235|19906319|P1|STARTED|Overall Study||129
8073430|NCT04055675|19906328|P2|NOT COMPLETED|Overall Study||0
8073431|NCT04055675|19906329|P1|NOT COMPLETED|Overall Study||0
8073432|NCT04055675|19906328|P2|COMPLETED|Overall Study||104
8073433|NCT04055675|19906329|P1|COMPLETED|Overall Study||96
8073434|NCT04055675|19906328|P2|STARTED|Overall Study||104
8073435|NCT04055675|19906329|P1|STARTED|Overall Study||96
8073436|NCT04054011|19906335|P1|NOT COMPLETED|Overall Study||3
8073437|NCT04054011|19906335|P1|COMPLETED|Overall Study||12
8073438|NCT04054011|19906335|P1|STARTED|Overall Study||15
8073439|NCT04053465|19906345|P2|NOT COMPLETED|Overall Study||4
8073440|NCT04053465|19906346|P1|NOT COMPLETED|Overall Study||4
8073441|NCT04053465|19906345|P2|COMPLETED|Overall Study||8
8073442|NCT04053465|19906346|P1|COMPLETED|Overall Study||18
8073443|NCT04053465|19906345|P2|STARTED|Overall Study||12
8073444|NCT04053465|19906346|P1|STARTED|Overall Study||22
8073445|NCT04053270|19906356|P2|NOT COMPLETED|Overall Study||5
8073446|NCT04053270|19906357|P1|NOT COMPLETED|Overall Study||2
8073447|NCT04053270|19906356|P2|COMPLETED|Overall Study||46
8073448|NCT04053270|19906357|P1|COMPLETED|Overall Study||47
8073449|NCT04053270|19906356|P2|STARTED|Overall Study||51
8073450|NCT04053270|19906357|P1|STARTED|Overall Study||49
8073451|NCT04053023|19906375|P2|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
8073452|NCT04053023|19906376|P1|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
8073453|NCT04053023|19906375|P2|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
8073454|NCT04053023|19906376|P1|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
8073455|NCT04053023|19906375|P2|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
8073456|NCT04053023|19906376|P1|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
8073457|NCT04053023|19906375|P2|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
8073458|NCT04053023|19906376|P1|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
8073459|NCT04053023|19906375|P2|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
8073460|NCT04053023|19906376|P1|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
8073461|NCT04053023|19906375|P2|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
8073462|NCT04053023|19906376|P1|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
8073463|NCT04053023|19906375|P2|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
8073464|NCT04053023|19906376|P1|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||1
8073465|NCT04053023|19906375|P2|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
8073466|NCT04053023|19906376|P1|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||18
8073467|NCT04053023|19906375|P2|STARTED|Part A: Period 2 (Day 20 to Day 38)||0
8073468|NCT04053023|19906376|P1|STARTED|Part A: Period 2 (Day 20 to Day 38)||19
8073469|NCT04053023|19906375|P2|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
8073470|NCT04053023|19906376|P1|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
8073471|NCT04053023|19906375|P2|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
8073472|NCT04053023|19906376|P1|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||19
8073473|NCT04053023|19906375|P2|STARTED|Part A: Period 1 (Day 1 to Day 19)||0
8073474|NCT04053023|19906376|P1|STARTED|Part A: Period 1 (Day 1 to Day 19)||19
8073475|NCT04051710|19906541|P3|NOT COMPLETED|Overall Study||4
8073476|NCT04051710|19906542|P2|NOT COMPLETED|Overall Study||8
8073477|NCT04051710|19906543|P1|NOT COMPLETED|Overall Study||4
8073478|NCT04051710|19906541|P3|COMPLETED|Overall Study||306
8073479|NCT04051710|19906542|P2|COMPLETED|Overall Study||612
8073480|NCT04051710|19906543|P1|COMPLETED|Overall Study||616
8073481|NCT04051710|19906541|P3|STARTED|Overall Study||310
8073482|NCT04051710|19906542|P2|STARTED|Overall Study||620
8073483|NCT04051710|19906543|P1|STARTED|Overall Study||620
8073484|NCT04051684|19906553|P2|NOT COMPLETED|Overall Study||0
8073485|NCT04051684|19906554|P1|NOT COMPLETED|Overall Study||0
8073486|NCT04051684|19906553|P2|COMPLETED|Overall Study||11
8073487|NCT04051684|19906554|P1|COMPLETED|Overall Study||12
8073488|NCT04051684|19906553|P2|STARTED|Overall Study||11
8073489|NCT04051684|19906554|P1|STARTED|Overall Study||12
8073490|NCT04050722|19906568|P2|NOT COMPLETED|Overall Study||0
8073491|NCT04050722|19906569|P1|NOT COMPLETED|Overall Study||1
8073492|NCT04050722|19906568|P2|COMPLETED|Overall Study||65
8073493|NCT04050722|19906569|P1|COMPLETED|Overall Study||64
8073494|NCT04050722|19906568|P2|STARTED|Overall Study||65
8073495|NCT04050722|19906569|P1|STARTED|Overall Study||65
8073496|NCT04050618|19906587|P2|NOT COMPLETED|Second Intervention||0
8073497|NCT04050618|19906588|P1|NOT COMPLETED|Second Intervention||1
8073498|NCT04050618|19906587|P2|COMPLETED|Second Intervention||56
8073499|NCT04050618|19906588|P1|COMPLETED|Second Intervention||55
8073500|NCT04050618|19906587|P2|STARTED|Second Intervention||56
8073501|NCT04050618|19906588|P1|STARTED|Second Intervention||56
8073502|NCT04050618|19906587|P2|NOT COMPLETED|First Intervention||0
8073503|NCT04050618|19906588|P1|NOT COMPLETED|First Intervention||2
8073504|NCT04050618|19906587|P2|COMPLETED|First Intervention||56
8073505|NCT04050618|19906588|P1|COMPLETED|First Intervention||56
8073506|NCT04050618|19906587|P2|STARTED|First Intervention||56
8073507|NCT04050618|19906588|P1|STARTED|First Intervention||58
8073508|NCT04050605|19906726|P1|NOT COMPLETED|Overall Study||0
8073509|NCT04050605|19906726|P1|COMPLETED|Overall Study||40
8073510|NCT04050605|19906726|P1|STARTED|Overall Study||40
8073511|NCT04049578|19906756|P1|NOT COMPLETED|Overall Study||1
8073512|NCT04049578|19906756|P1|COMPLETED|Overall Study||1
8073513|NCT04049578|19906756|P1|STARTED|Overall Study||2
8073514|NCT04049552|19906766|P1|NOT COMPLETED|Overall Study||1
8073515|NCT04049552|19906766|P1|COMPLETED|Overall Study||3
8073516|NCT04049552|19906766|P1|STARTED|Overall Study||4
8073517|NCT04048681|19906774|P5|NOT COMPLETED|Overall Study||0
8073518|NCT04048681|19906775|P4|NOT COMPLETED|Overall Study||1
8073519|NCT04048681|19906776|P3|NOT COMPLETED|Overall Study||0
8073520|NCT04048681|19906777|P2|NOT COMPLETED|Overall Study||0
8073521|NCT04048681|19906778|P1|NOT COMPLETED|Overall Study||0
8073522|NCT04048681|19906774|P5|COMPLETED|Overall Study||1
8073523|NCT04048681|19906775|P4|COMPLETED|Overall Study||0
8073524|NCT04048681|19906776|P3|COMPLETED|Overall Study||1
8073525|NCT04048681|19906777|P2|COMPLETED|Overall Study||1
8073526|NCT04048681|19906778|P1|COMPLETED|Overall Study||1
8073527|NCT04048681|19906774|P5|STARTED|Overall Study||1
8073528|NCT04048681|19906775|P4|STARTED|Overall Study||1
8073529|NCT04048681|19906776|P3|STARTED|Overall Study||1
8073530|NCT04048681|19906777|P2|STARTED|Overall Study||1
8073531|NCT04048681|19906778|P1|STARTED|Overall Study||1
8073532|NCT04047342|19906791|P2|NOT COMPLETED|Overall Study||0
8073533|NCT04047342|19906792|P1|NOT COMPLETED|Overall Study||0
8073534|NCT04047342|19906791|P2|COMPLETED|Overall Study||415
8073535|NCT04047342|19906792|P1|COMPLETED|Overall Study||409
8073536|NCT04047342|19906791|P2|STARTED|Overall Study||415
8073537|NCT04047342|19906792|P1|STARTED|Overall Study||409
8073538|NCT04047121|19906806|P6|NOT COMPLETED|Overall Study||0
8073539|NCT04047121|19906807|P5|NOT COMPLETED|Overall Study||0
8073540|NCT04047121|19906808|P4|NOT COMPLETED|Overall Study||0
8073541|NCT04047121|19906809|P3|NOT COMPLETED|Overall Study||0
8073542|NCT04047121|19906810|P2|NOT COMPLETED|Overall Study||0
8073543|NCT04047121|19906811|P1|NOT COMPLETED|Overall Study||0
8073544|NCT04047121|19906806|P6|COMPLETED|Overall Study||262
8073545|NCT04047121|19906807|P5|COMPLETED|Overall Study||112
8073546|NCT04047121|19906808|P4|COMPLETED|Overall Study||287
8073547|NCT04047121|19906809|P3|COMPLETED|Overall Study||79
8073548|NCT04047121|19906810|P2|COMPLETED|Overall Study||299
8073549|NCT04047121|19906811|P1|COMPLETED|Overall Study||310
8073550|NCT04047121|19906806|P6|STARTED|Overall Study||262
8073551|NCT04047121|19906807|P5|STARTED|Overall Study||112
8073552|NCT04047121|19906808|P4|STARTED|Overall Study||287
8073553|NCT04047121|19906809|P3|STARTED|Overall Study||79
8073554|NCT04047121|19906810|P2|STARTED|Overall Study||299
8073555|NCT04047121|19906811|P1|STARTED|Overall Study||310
8073556|NCT04045964|19907073|P2|NOT COMPLETED|Overall Study||1
8073557|NCT04045964|19907074|P1|NOT COMPLETED|Overall Study||1
8073558|NCT04045964|19907073|P2|COMPLETED|Overall Study||15
8073559|NCT04045964|19907074|P1|COMPLETED|Overall Study||15
8073560|NCT04045964|19907073|P2|Follow up Visit 2|Overall Study||15
8073561|NCT04045964|19907074|P1|Follow up Visit 2|Overall Study||15
8073562|NCT04045964|19907073|P2|Follow up Visit 1|Overall Study||15
8073563|NCT04045964|19907074|P1|Follow up Visit 1|Overall Study||15
8073564|NCT04045964|19907073|P2|Intervention Visit(s)|Overall Study||16
8073565|NCT04045964|19907074|P1|Intervention Visit(s)|Overall Study||15
8073566|NCT04045964|19907073|P2|STARTED|Overall Study||16
8073567|NCT04045964|19907074|P1|STARTED|Overall Study||16
8073568|NCT04043416|19907105|P2|NOT COMPLETED|Campaign 2||0
8073569|NCT04043416|19907106|P1|NOT COMPLETED|Campaign 2||0
8073570|NCT04043416|19907105|P2|COMPLETED|Campaign 2||13
8073571|NCT04043416|19907106|P1|COMPLETED|Campaign 2||14
8073572|NCT04043416|19907105|P2|STARTED|Campaign 2||13
8073573|NCT04043416|19907106|P1|STARTED|Campaign 2||14
8073574|NCT04043416|19907105|P2|NOT COMPLETED|Washout||1
8073575|NCT04043416|19907106|P1|NOT COMPLETED|Washout||0
8073576|NCT04043416|19907105|P2|COMPLETED|Washout||13
8073577|NCT04043416|19907106|P1|COMPLETED|Washout||14
8073578|NCT04043416|19907105|P2|STARTED|Washout||14
8073579|NCT04043416|19907106|P1|STARTED|Washout||14
8073580|NCT04043416|19907105|P2|NOT COMPLETED|Campaign 1||0
8073581|NCT04043416|19907106|P1|NOT COMPLETED|Campaign 1||0
8073582|NCT04043416|19907105|P2|COMPLETED|Campaign 1||14
8073583|NCT04043416|19907106|P1|COMPLETED|Campaign 1||14
8073584|NCT04043416|19907105|P2|STARTED|Campaign 1||14
8073585|NCT04043416|19907106|P1|STARTED|Campaign 1||14
8073586|NCT04042324|19907140|P3|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
8073587|NCT04042324|19907141|P2|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
8073588|NCT04042324|19907142|P1|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
8073589|NCT04042324|19907140|P3|COMPLETED|Triferic Pre-dialyzer (Day 5)||12
8073590|NCT04042324|19907141|P2|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
8073591|NCT04042324|19907142|P1|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
8073592|NCT04042324|19907140|P3|STARTED|Triferic Pre-dialyzer (Day 5)||12
8073593|NCT04042324|19907141|P2|STARTED|Triferic Pre-dialyzer (Day 5)||0
8073594|NCT04042324|19907142|P1|STARTED|Triferic Pre-dialyzer (Day 5)||0
8073595|NCT04042324|19907140|P3|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
8073596|NCT04042324|19907141|P2|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
8073597|NCT04042324|19907142|P1|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
8073598|NCT04042324|19907140|P3|COMPLETED|Triferic Post-dialyzer (Day 3)||0
8073599|NCT04042324|19907141|P2|COMPLETED|Triferic Post-dialyzer (Day 3)||12
8073600|NCT04042324|19907142|P1|COMPLETED|Triferic Post-dialyzer (Day 3)||0
8073601|NCT04042324|19907140|P3|STARTED|Triferic Post-dialyzer (Day 3)||0
8073602|NCT04042324|19907141|P2|STARTED|Triferic Post-dialyzer (Day 3)||12
8073603|NCT04042324|19907142|P1|STARTED|Triferic Post-dialyzer (Day 3)||0
8073604|NCT04042324|19907140|P3|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
8073605|NCT04042324|19907141|P2|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
8073606|NCT04042324|19907142|P1|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
8073607|NCT04042324|19907140|P3|COMPLETED|UFH and Triferic Admixture (Day 1)||0
8073608|NCT04042324|19907141|P2|COMPLETED|UFH and Triferic Admixture (Day 1)||0
8073609|NCT04042324|19907142|P1|COMPLETED|UFH and Triferic Admixture (Day 1)||12
8073610|NCT04042324|19907140|P3|STARTED|UFH and Triferic Admixture (Day 1)||0
8073611|NCT04042324|19907141|P2|STARTED|UFH and Triferic Admixture (Day 1)||0
8073612|NCT04042324|19907142|P1|STARTED|UFH and Triferic Admixture (Day 1)||12
8073613|NCT04041453|19907166|P4|NOT COMPLETED|Overall Study||18
8073614|NCT04041453|19907167|P3|NOT COMPLETED|Overall Study||5
8073615|NCT04041453|19907168|P2|NOT COMPLETED|Overall Study||22
8073616|NCT04041453|19907169|P1|NOT COMPLETED|Overall Study||14
8073617|NCT04041453|19907166|P4|COMPLETED|Overall Study||40
8073618|NCT04041453|19907167|P3|COMPLETED|Overall Study||18
8073619|NCT04041453|19907168|P2|COMPLETED|Overall Study||35
8073620|NCT04041453|19907169|P1|COMPLETED|Overall Study||24
8073621|NCT04041453|19907166|P4|Safety Population|Overall Study||58
8073622|NCT04041453|19907167|P3|Safety Population|Overall Study||23
8073623|NCT04041453|19907168|P2|Safety Population|Overall Study||56
8073624|NCT04041453|19907169|P1|Safety Population|Overall Study||38
8073625|NCT04041453|19907166|P4|STARTED|Overall Study||58
8073626|NCT04041453|19907167|P3|STARTED|Overall Study||23
8073627|NCT04041453|19907168|P2|STARTED|Overall Study||57
8073628|NCT04041453|19907169|P1|STARTED|Overall Study||38
8073629|NCT04041219|19907183|P1|NOT COMPLETED|Overall Study||0
8073630|NCT04041219|19907183|P1|COMPLETED|Overall Study||10
8073631|NCT04041219|19907183|P1|STARTED|Overall Study||10
8073638|NCT04039412|19907204|P3|NOT COMPLETED|Overall Study||2
8073639|NCT04039412|19907205|P2|NOT COMPLETED|Overall Study||3
8073640|NCT04039412|19907206|P1|NOT COMPLETED|Overall Study||1
8073641|NCT04039412|19907204|P3|COMPLETED|Overall Study||108
8073642|NCT04039412|19907205|P2|COMPLETED|Overall Study||107
8073643|NCT04039412|19907206|P1|COMPLETED|Overall Study||109
8073644|NCT04039412|19907204|P3|STARTED|Overall Study||110
8073645|NCT04039412|19907205|P2|STARTED|Overall Study||110
8073646|NCT04039412|19907206|P1|STARTED|Overall Study||110
8073647|NCT04037748|19907222|P2|NOT COMPLETED|Treatment Period 2||1
8073648|NCT04037748|19907223|P1|NOT COMPLETED|Treatment Period 2||2
8073649|NCT04037748|19907222|P2|COMPLETED|Treatment Period 2||29
8073650|NCT04037748|19907223|P1|COMPLETED|Treatment Period 2||26
8073651|NCT04037748|19907222|P2|STARTED|Treatment Period 2||30
8073652|NCT04037748|19907223|P1|STARTED|Treatment Period 2||28
8073653|NCT04037748|19907222|P2|NOT COMPLETED|Treatment Period 1||6
8073654|NCT04037748|19907223|P1|NOT COMPLETED|Treatment Period 1||8
8073655|NCT04037748|19907222|P2|COMPLETED|Treatment Period 1||30
8073656|NCT04037748|19907223|P1|COMPLETED|Treatment Period 1||28
8073657|NCT04037748|19907222|P2|STARTED|Treatment Period 1||36
8073658|NCT04037748|19907223|P1|STARTED|Treatment Period 1||36
8073659|NCT04036838|19907237|P1|NOT COMPLETED|Overall Study||91
8073660|NCT04036838|19907237|P1|COMPLETED|Overall Study||324
8073661|NCT04036838|19907237|P1|STARTED|Overall Study||415
8073671|NCT04035577|19907269|P1|NOT COMPLETED|Overall Study||2
8073672|NCT04035577|19907269|P1|COMPLETED|Overall Study||19
8073673|NCT04035577|19907269|P1|STARTED|Overall Study|One participant withdrew after signing the consent but before initiating any study activities.|21
8073674|NCT04035564|19907289|P2|NOT COMPLETED|Overall Study||6
8073675|NCT04035564|19907290|P1|NOT COMPLETED|Overall Study||4
8073676|NCT04035564|19907289|P2|COMPLETED|Overall Study||19
8073677|NCT04035564|19907290|P1|COMPLETED|Overall Study||23
8073678|NCT04035564|19907289|P2|STARTED|Overall Study||25
8073679|NCT04035564|19907290|P1|STARTED|Overall Study||27
8073680|NCT04034043|19907312|P1|NOT COMPLETED|Overall Study||0
8073681|NCT04034043|19907312|P1|COMPLETED|Overall Study||68
8073682|NCT04034043|19907312|P1|STARTED|Overall Study||68
8073683|NCT04032652|19907321|P2|NOT COMPLETED|Overall Study||1
8073684|NCT04032652|19907322|P1|NOT COMPLETED|Overall Study||1
8073685|NCT04032652|19907321|P2|COMPLETED|Overall Study||0
8073686|NCT04032652|19907322|P1|COMPLETED|Overall Study||0
8073687|NCT04032652|19907321|P2|STARTED|Overall Study||1
8073688|NCT04032652|19907322|P1|STARTED|Overall Study||1
8073689|NCT04027803|19907332|P2|NOT COMPLETED|Overall Study||0
8073690|NCT04027803|19907333|P1|NOT COMPLETED|Overall Study||0
8073691|NCT04027803|19907332|P2|COMPLETED|Overall Study||39
8073692|NCT04027803|19907333|P1|COMPLETED|Overall Study||39
8073693|NCT04027803|19907332|P2|STARTED|Overall Study||39
8073694|NCT04027803|19907333|P1|STARTED|Overall Study||39
8073695|NCT04027218|19907371|P6|NOT COMPLETED|Overall Study||0
8073696|NCT04027218|19907372|P5|NOT COMPLETED|Overall Study||0
8073697|NCT04027218|19907373|P4|NOT COMPLETED|Overall Study||0
8073698|NCT04027218|19907374|P3|NOT COMPLETED|Overall Study||0
8073699|NCT04027218|19907375|P2|NOT COMPLETED|Overall Study||3
8073700|NCT04027218|19907376|P1|NOT COMPLETED|Overall Study||0
8073701|NCT04027218|19907371|P6|COMPLETED|Overall Study||11
8073702|NCT04027218|19907372|P5|COMPLETED|Overall Study||10
8073703|NCT04027218|19907373|P4|COMPLETED|Overall Study||11
8073704|NCT04027218|19907374|P3|COMPLETED|Overall Study||9
8073705|NCT04027218|19907375|P2|COMPLETED|Overall Study||8
8073706|NCT04027218|19907376|P1|COMPLETED|Overall Study||10
8073707|NCT04027218|19907371|P6|STARTED|Overall Study||11
8073708|NCT04027218|19907372|P5|STARTED|Overall Study||10
8073709|NCT04027218|19907373|P4|STARTED|Overall Study||11
8073710|NCT04027218|19907374|P3|STARTED|Overall Study||9
8073711|NCT04027218|19907375|P2|STARTED|Overall Study||11
8073712|NCT04027218|19907376|P1|STARTED|Overall Study||10
8073716|NCT04024228|19907475|P2|NOT COMPLETED|Overall Study||6
8073717|NCT04024228|19907476|P1|NOT COMPLETED|Overall Study||4
8073718|NCT04024228|19907475|P2|COMPLETED|Overall Study||759
8073719|NCT04024228|19907476|P1|COMPLETED|Overall Study||770
8073810|NCT04016259|19907692|P2|NOT COMPLETED|Overall Study||0
8073720|NCT04024228|19907475|P2|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 381 participants (>=65 years).|758
8073721|NCT04024228|19907476|P1|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 392 participants (>=65 years).|769
8073722|NCT04024228|19907475|P2|Vaccinated|Overall Study||761
8073723|NCT04024228|19907476|P1|Vaccinated|Overall Study||772
8073724|NCT04024228|19907475|P2|STARTED|Overall Study||765
8073725|NCT04024228|19907476|P1|STARTED|Overall Study||774
8073726|NCT04023695|19907510|P2|NOT COMPLETED|Overall Study||0
8073727|NCT04023695|19907511|P1|NOT COMPLETED|Overall Study||0
8073728|NCT04023695|19907510|P2|COMPLETED|Overall Study||53
8073729|NCT04023695|19907511|P1|COMPLETED|Overall Study||57
8073730|NCT04023695|19907510|P2|STARTED|Overall Study||53
8073731|NCT04023695|19907511|P1|STARTED|Overall Study||57
8073732|NCT04023578|19907519|P1|NOT COMPLETED|Overall Study||2
8073733|NCT04023578|19907519|P1|COMPLETED|Overall Study||13
8073734|NCT04023578|19907519|P1|STARTED|Overall Study||15
8073735|NCT04022668|19907527|P3|NOT COMPLETED|Overall Study||0
8073736|NCT04022668|19907528|P2|NOT COMPLETED|Overall Study||27
8073737|NCT04022668|19907529|P1|NOT COMPLETED|Overall Study||14
8073738|NCT04022668|19907527|P3|COMPLETED|Overall Study||1000
8073739|NCT04022668|19907528|P2|COMPLETED|Overall Study||973
8073740|NCT04022668|19907529|P1|COMPLETED|Overall Study||986
8073741|NCT04022668|19907527|P3|STARTED|Overall Study||1000
8073742|NCT04022668|19907528|P2|STARTED|Overall Study||1000
8073743|NCT04022668|19907529|P1|STARTED|Overall Study||1000
8073744|NCT04020822|19907552|P1|NOT COMPLETED|Overall Study||0
8073745|NCT04020822|19907552|P1|COMPLETED|Overall Study||19
8073746|NCT04020822|19907552|P1|STARTED|Overall Study||19
8073747|NCT04019990|19907556|P2|NOT COMPLETED|Overall Study||3
8073748|NCT04019990|19907557|P1|NOT COMPLETED|Overall Study||1
8073749|NCT04019990|19907556|P2|COMPLETED|Overall Study||12
8073750|NCT04019990|19907557|P1|COMPLETED|Overall Study||12
8073751|NCT04019990|19907556|P2|STARTED|Overall Study||15
8073752|NCT04019990|19907557|P1|STARTED|Overall Study||13
8073753|NCT04018664|19907572|P8|NOT COMPLETED|Overall Study||0
8073754|NCT04018664|19907573|P7|NOT COMPLETED|Overall Study||0
8073755|NCT04018664|19907574|P6|NOT COMPLETED|Overall Study||0
8073756|NCT04018664|19907575|P5|NOT COMPLETED|Overall Study||0
8073757|NCT04018664|19907576|P4|NOT COMPLETED|Overall Study||0
8073758|NCT04018664|19907577|P3|NOT COMPLETED|Overall Study||0
8073759|NCT04018664|19907578|P2|NOT COMPLETED|Overall Study||0
8073760|NCT04018664|19907579|P1|NOT COMPLETED|Overall Study||0
8073761|NCT04018664|19907572|P8|COMPLETED|Overall Study||6
8073762|NCT04018664|19907573|P7|COMPLETED|Overall Study||6
8073763|NCT04018664|19907574|P6|COMPLETED|Overall Study||6
8073764|NCT04018664|19907575|P5|COMPLETED|Overall Study||6
8073765|NCT04018664|19907576|P4|COMPLETED|Overall Study||6
8073766|NCT04018664|19907577|P3|COMPLETED|Overall Study||6
8073767|NCT04018664|19907578|P2|COMPLETED|Overall Study||6
8073768|NCT04018664|19907579|P1|COMPLETED|Overall Study||14
8073769|NCT04018664|19907572|P8|STARTED|Overall Study||6
8073770|NCT04018664|19907573|P7|STARTED|Overall Study||6
8073771|NCT04018664|19907574|P6|STARTED|Overall Study||6
8073772|NCT04018664|19907575|P5|STARTED|Overall Study||6
8073773|NCT04018664|19907576|P4|STARTED|Overall Study||6
8073774|NCT04018664|19907577|P3|STARTED|Overall Study||6
8073775|NCT04018664|19907578|P2|STARTED|Overall Study||6
8073776|NCT04018664|19907579|P1|STARTED|Overall Study||14
8073777|NCT04018001|19907599|P2|NOT COMPLETED|Overall Study||0
8073778|NCT04018001|19907600|P1|NOT COMPLETED|Overall Study||0
8073779|NCT04018001|19907599|P2|COMPLETED|Overall Study||379
8073780|NCT04018001|19907600|P1|COMPLETED|Overall Study||678
8073781|NCT04018001|19907599|P2|STARTED|Overall Study||379
8073782|NCT04018001|19907600|P1|STARTED|Overall Study||678
8073783|NCT04017611|19907630|P1|NOT COMPLETED|Overall Study||1
8073784|NCT04017611|19907630|P1|COMPLETED|Overall Study||12
8073785|NCT04017611|19907630|P1|STARTED|Overall Study||13
8073786|NCT04016623|19907634|P1|NOT COMPLETED|Pair 4 Test /Control Follow up||0
8073787|NCT04016623|19907634|P1|COMPLETED|Pair 4 Test /Control Follow up||10
8073788|NCT04016623|19907634|P1|STARTED|Pair 4 Test /Control Follow up||10
8073789|NCT04016623|19907634|P1|NOT COMPLETED|Pair 4 Test / Control Dispense||0
8073790|NCT04016623|19907634|P1|COMPLETED|Pair 4 Test / Control Dispense||10
8073791|NCT04016623|19907634|P1|STARTED|Pair 4 Test / Control Dispense||10
8073792|NCT04016623|19907634|P1|NOT COMPLETED|Pair 3 Test /Control Follow up||0
8073793|NCT04016623|19907634|P1|COMPLETED|Pair 3 Test /Control Follow up||10
8073794|NCT04016623|19907634|P1|STARTED|Pair 3 Test /Control Follow up||10
8073795|NCT04016623|19907634|P1|NOT COMPLETED|Pair 3 Test / Control Dispense||0
8073796|NCT04016623|19907634|P1|COMPLETED|Pair 3 Test / Control Dispense||10
8073797|NCT04016623|19907634|P1|STARTED|Pair 3 Test / Control Dispense||10
8073798|NCT04016623|19907634|P1|NOT COMPLETED|Pair 2 Test /Control Follow up||0
8073799|NCT04016623|19907634|P1|COMPLETED|Pair 2 Test /Control Follow up||10
8073800|NCT04016623|19907634|P1|STARTED|Pair 2 Test /Control Follow up||10
8073801|NCT04016623|19907634|P1|NOT COMPLETED|Pair 2 Test / Control Dispense||0
8073802|NCT04016623|19907634|P1|COMPLETED|Pair 2 Test / Control Dispense||10
8073803|NCT04016623|19907634|P1|STARTED|Pair 2 Test / Control Dispense||10
8073804|NCT04016623|19907634|P1|NOT COMPLETED|Pair 1 Test /Control Follow up||0
8073805|NCT04016623|19907634|P1|COMPLETED|Pair 1 Test /Control Follow up||10
8073806|NCT04016623|19907634|P1|STARTED|Pair 1 Test /Control Follow up||10
8073807|NCT04016623|19907634|P1|NOT COMPLETED|Pair 1 Test / Control Dispense||0
8073808|NCT04016623|19907634|P1|COMPLETED|Pair 1 Test / Control Dispense||10
8073809|NCT04016623|19907634|P1|STARTED|Pair 1 Test / Control Dispense||10
8073811|NCT04016259|19907693|P1|NOT COMPLETED|Overall Study||0
8073812|NCT04016259|19907692|P2|COMPLETED|Overall Study||15
8073813|NCT04016259|19907693|P1|COMPLETED|Overall Study||15
8073814|NCT04016259|19907692|P2|STARTED|Overall Study||15
8073815|NCT04016259|19907693|P1|STARTED|Overall Study||15
8073816|NCT04015232|19907729|P2|NOT COMPLETED|Overall Study||7
8073817|NCT04015232|19907730|P1|NOT COMPLETED|Overall Study||11
8073818|NCT04015232|19907729|P2|COMPLETED|Overall Study||93
8073819|NCT04015232|19907730|P1|COMPLETED|Overall Study||89
8073820|NCT04015232|19907729|P2|STARTED|Overall Study||100
8073821|NCT04015232|19907730|P1|STARTED|Overall Study||100
8073822|NCT04014062|19907802|P2|NOT COMPLETED|Period II: Crossover Dosing||0
8073823|NCT04014062|19907803|P1|NOT COMPLETED|Period II: Crossover Dosing||0
8073824|NCT04014062|19907802|P2|COMPLETED|Period II: Crossover Dosing||65
8073825|NCT04014062|19907803|P1|COMPLETED|Period II: Crossover Dosing||64
8073826|NCT04014062|19907802|P2|STARTED|Period II: Crossover Dosing||65
8073827|NCT04014062|19907803|P1|STARTED|Period II: Crossover Dosing||64
8073828|NCT04014062|19907802|P2|NOT COMPLETED|Period I: Dosing||6
8073829|NCT04014062|19907803|P1|NOT COMPLETED|Period I: Dosing||7
8073830|NCT04014062|19907802|P2|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65
8073831|NCT04014062|19907803|P1|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64
8073832|NCT04014062|19907802|P2|STARTED|Period I: Dosing||71
8073833|NCT04014062|19907803|P1|STARTED|Period I: Dosing||71
8073834|NCT04013789|19907841|P2|NOT COMPLETED|Second Wear Period (1 Week)||0
8073835|NCT04013789|19907842|P1|NOT COMPLETED|Second Wear Period (1 Week)||0
8073836|NCT04013789|19907841|P2|COMPLETED|Second Wear Period (1 Week)||34
8073837|NCT04013789|19907842|P1|COMPLETED|Second Wear Period (1 Week)||32
8073838|NCT04013789|19907841|P2|STARTED|Second Wear Period (1 Week)||34
8073839|NCT04013789|19907842|P1|STARTED|Second Wear Period (1 Week)|One subject withdrew from the study between the first wear period and the second wear period.|32
8073840|NCT04013789|19907841|P2|NOT COMPLETED|First Wear Period (1 Week)||0
8073841|NCT04013789|19907842|P1|NOT COMPLETED|First Wear Period (1 Week)||0
8073842|NCT04013789|19907841|P2|COMPLETED|First Wear Period (1 Week)||34
8073843|NCT04013789|19907842|P1|COMPLETED|First Wear Period (1 Week)||33
8073844|NCT04013789|19907841|P2|STARTED|First Wear Period (1 Week)||34
8073845|NCT04013789|19907842|P1|STARTED|First Wear Period (1 Week)||33
8073846|NCT04012970|19907852|P2|NOT COMPLETED|Control Session, 30 Minutes||0
8073847|NCT04012970|19907853|P1|NOT COMPLETED|Control Session, 30 Minutes||0
8073848|NCT04012970|19907852|P2|COMPLETED|Control Session, 30 Minutes||14
8073849|NCT04012970|19907853|P1|COMPLETED|Control Session, 30 Minutes||26
8073850|NCT04012970|19907852|P2|STARTED|Control Session, 30 Minutes||14
8073851|NCT04012970|19907853|P1|STARTED|Control Session, 30 Minutes||26
8073852|NCT04012970|19907852|P2|NOT COMPLETED|Intervention Session, 30 Minutes||0
8073853|NCT04012970|19907853|P1|NOT COMPLETED|Intervention Session, 30 Minutes||0
8073854|NCT04012970|19907852|P2|COMPLETED|Intervention Session, 30 Minutes||14
8073855|NCT04012970|19907853|P1|COMPLETED|Intervention Session, 30 Minutes||26
8073856|NCT04012970|19907852|P2|STARTED|Intervention Session, 30 Minutes||14
8073857|NCT04012970|19907853|P1|STARTED|Intervention Session, 30 Minutes||26
8073858|NCT04011592|19907867|P2|NOT COMPLETED|Overall Study||0
8073859|NCT04011592|19907868|P1|NOT COMPLETED|Overall Study||0
8073860|NCT04011592|19907867|P2|COMPLETED|Overall Study||0
8073861|NCT04011592|19907868|P1|COMPLETED|Overall Study||1
8073862|NCT04011592|19907867|P2|STARTED|Overall Study||0
8073863|NCT04011592|19907868|P1|STARTED|Overall Study||1
8073864|NCT04010370|19907886|P1|NOT COMPLETED|Overall Study||0
8073865|NCT04010370|19907886|P1|COMPLETED|Overall Study||25
8073866|NCT04010370|19907886|P1|STARTED|Overall Study||25
8073867|NCT04007159|19907904|P1|NOT COMPLETED|Challenge Phase||3
8073868|NCT04007159|19907904|P1|COMPLETED|Challenge Phase||255
8073869|NCT04007159|19907904|P1|STARTED|Challenge Phase||258
8073870|NCT04007159|19907904|P1|NOT COMPLETED|Rest Phase||0
8073871|NCT04007159|19907904|P1|COMPLETED|Rest Phase||258
8073872|NCT04007159|19907904|P1|STARTED|Rest Phase||258
8073873|NCT04007159|19907904|P1|NOT COMPLETED|Induction Phase||22
8073874|NCT04007159|19907904|P1|COMPLETED|Induction Phase||258
8073875|NCT04007159|19907904|P1|STARTED|Induction Phase||280
8073876|NCT04007107|19907919|P4|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8073877|NCT04007107|19907920|P3|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8073878|NCT04007107|19907921|P2|NOT COMPLETED|Treatment Period 2 (Day 1)||1
8073879|NCT04007107|19907922|P1|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8073880|NCT04007107|19907919|P4|COMPLETED|Treatment Period 2 (Day 1)||26
8073881|NCT04007107|19907920|P3|COMPLETED|Treatment Period 2 (Day 1)||25
8073882|NCT04007107|19907921|P2|COMPLETED|Treatment Period 2 (Day 1)||25
8073883|NCT04007107|19907922|P1|COMPLETED|Treatment Period 2 (Day 1)||26
8073884|NCT04007107|19907919|P4|STARTED|Treatment Period 2 (Day 1)||26
8073885|NCT04007107|19907920|P3|STARTED|Treatment Period 2 (Day 1)||25
8073886|NCT04007107|19907921|P2|STARTED|Treatment Period 2 (Day 1)||26
8073887|NCT04007107|19907922|P1|STARTED|Treatment Period 2 (Day 1)||26
8073888|NCT04007107|19907919|P4|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8073889|NCT04007107|19907920|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8073890|NCT04007107|19907921|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8073891|NCT04007107|19907922|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8073892|NCT04007107|19907919|P4|COMPLETED|Treatment Period 1 (Day 1)||26
8073893|NCT04007107|19907920|P3|COMPLETED|Treatment Period 1 (Day 1)||25
8073894|NCT04007107|19907921|P2|COMPLETED|Treatment Period 1 (Day 1)||26
8073895|NCT04007107|19907922|P1|COMPLETED|Treatment Period 1 (Day 1)||26
8073896|NCT04007107|19907919|P4|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
8073897|NCT04007107|19907920|P3|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
8073898|NCT04007107|19907921|P2|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
8073899|NCT04007107|19907922|P1|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
8073900|NCT04007107|19907919|P4|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
8073901|NCT04007107|19907920|P3|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||25
8073902|NCT04007107|19907921|P2|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
8073903|NCT04007107|19907922|P1|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
8073904|NCT04007107|19907919|P4|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
8073905|NCT04007107|19907920|P3|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||25
8073906|NCT04007107|19907921|P2|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
8073907|NCT04007107|19907922|P1|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
8073908|NCT04007107|19907919|P4|STARTED|Treatment Period 1 (Day 1)||26
8073909|NCT04007107|19907920|P3|STARTED|Treatment Period 1 (Day 1)||25
8073910|NCT04007107|19907921|P2|STARTED|Treatment Period 1 (Day 1)||26
8073911|NCT04007107|19907922|P1|STARTED|Treatment Period 1 (Day 1)||26
8073921|NCT04006366|19907950|P1|NOT COMPLETED|Overall Study||1
8073922|NCT04006366|19907950|P1|COMPLETED|Overall Study||5
8073923|NCT04006366|19907950|P1|STARTED|Overall Study||6
8073924|NCT04005885|19907956|P2|NOT COMPLETED|Third Intervention||0
8073925|NCT04005885|19907957|P1|NOT COMPLETED|Third Intervention||0
8073926|NCT04005885|19907956|P2|COMPLETED|Third Intervention||26
8073927|NCT04005885|19907957|P1|COMPLETED|Third Intervention||25
8073928|NCT04005885|19907956|P2|STARTED|Third Intervention||26
8073929|NCT04005885|19907957|P1|STARTED|Third Intervention||25
8073930|NCT04005885|19907956|P2|NOT COMPLETED|Second Intervention||2
8073931|NCT04005885|19907957|P1|NOT COMPLETED|Second Intervention||0
8073932|NCT04005885|19907956|P2|COMPLETED|Second Intervention||26
8073933|NCT04005885|19907957|P1|COMPLETED|Second Intervention||25
8073934|NCT04005885|19907956|P2|STARTED|Second Intervention||28
8073935|NCT04005885|19907957|P1|STARTED|Second Intervention||25
8073936|NCT04005885|19907956|P2|NOT COMPLETED|First Intervention||1
8073937|NCT04005885|19907957|P1|NOT COMPLETED|First Intervention||1
8073938|NCT04005885|19907956|P2|COMPLETED|First Intervention||28
8073939|NCT04005885|19907957|P1|COMPLETED|First Intervention||25
8073940|NCT04005885|19907956|P2|STARTED|First Intervention||29
8073941|NCT04005885|19907957|P1|STARTED|First Intervention||26
8073948|NCT04002973|19908012|P1|NOT COMPLETED|Overall Study||0
8073949|NCT04002973|19908012|P1|COMPLETED|Overall Study||11
8073950|NCT04002973|19908012|P1|STARTED|Overall Study||11
8073951|NCT04002960|19908016|P1|NOT COMPLETED|Overall Study||2
8073952|NCT04002960|19908016|P1|COMPLETED|Overall Study||21
8073953|NCT04002960|19908016|P1|STARTED|Overall Study||23
8073954|NCT04002791|19908022|P2|NOT COMPLETED|Overall Study||0
8073955|NCT04002791|19908023|P1|NOT COMPLETED|Overall Study||0
8073956|NCT04002791|19908022|P2|COMPLETED|Overall Study||126
8073957|NCT04002791|19908023|P1|COMPLETED|Overall Study||127
8073958|NCT04002791|19908022|P2|STARTED|Overall Study||126
8073959|NCT04002791|19908023|P1|STARTED|Overall Study||127
8073960|NCT04002648|19908033|P2|NOT COMPLETED|Overall Study||0
8073961|NCT04002648|19908034|P1|NOT COMPLETED|Overall Study||2
8073962|NCT04002648|19908033|P2|COMPLETED|Overall Study||104
8073963|NCT04002648|19908034|P1|COMPLETED|Overall Study||102
8073964|NCT04002648|19908033|P2|STARTED|Overall Study||104
8073965|NCT04002648|19908034|P1|STARTED|Overall Study||104
8073966|NCT04000815|19908045|P3|NOT COMPLETED|Overall Study||7
8073967|NCT04000815|19908046|P2|NOT COMPLETED|Overall Study||5
8073968|NCT04000815|19908047|P1|NOT COMPLETED|Overall Study||14
8073969|NCT04000815|19908045|P3|COMPLETED|Overall Study||15
8073970|NCT04000815|19908046|P2|COMPLETED|Overall Study||15
8073971|NCT04000815|19908047|P1|COMPLETED|Overall Study||15
8073972|NCT04000815|19908045|P3|STARTED|Overall Study||22
8073973|NCT04000815|19908046|P2|STARTED|Overall Study||20
8073974|NCT04000815|19908047|P1|STARTED|Overall Study||29
8073975|NCT04000373|19908061|P1|NOT COMPLETED|Overall Study||0
8073976|NCT04000373|19908061|P1|COMPLETED|Overall Study||5
8073977|NCT04000373|19908061|P1|STARTED|Overall Study||5
8073978|NCT03997825|19908067|P1|NOT COMPLETED|Overall Study||17
8073979|NCT03997825|19908067|P1|COMPLETED|Overall Study||100
8073980|NCT03997825|19908067|P1|STARTED|Overall Study||117
8073981|NCT03995680|19908078|P2|NOT COMPLETED|Overall Study||2
8073982|NCT03995680|19908079|P1|NOT COMPLETED|Overall Study||2
8073983|NCT03995680|19908078|P2|COMPLETED|Overall Study||196
8073984|NCT03995680|19908079|P1|COMPLETED|Overall Study||197
8073985|NCT03995680|19908078|P2|STARTED|Overall Study||198
8073986|NCT03995680|19908079|P1|STARTED|Overall Study||199
8073991|NCT03993210|19908114|P2|NOT COMPLETED|Overall Study||0
8073992|NCT03993210|19908115|P1|NOT COMPLETED|Overall Study||0
8073993|NCT03993210|19908114|P2|COMPLETED|Overall Study||0
8073994|NCT03993210|19908115|P1|COMPLETED|Overall Study||1
8073995|NCT03993210|19908114|P2|STARTED|Overall Study||0
8073996|NCT03993210|19908115|P1|STARTED|Overall Study||1
8073997|NCT03992482|19908139|P2|NOT COMPLETED|Overall Study||0
8073998|NCT03992482|19908140|P1|NOT COMPLETED|Overall Study||0
8073999|NCT03992482|19908139|P2|COMPLETED|Overall Study||14
8074000|NCT03992482|19908140|P1|COMPLETED|Overall Study||13
8074001|NCT03992482|19908139|P2|STARTED|Overall Study||14
8074002|NCT03992482|19908140|P1|STARTED|Overall Study||13
8074003|NCT03992014|19908150|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8074004|NCT03992014|19908150|P1|COMPLETED|Treatment Period 2 (8 Days)||6
8074005|NCT03992014|19908150|P1|STARTED|Treatment Period 2 (8 Days)||6
8074006|NCT03992014|19908150|P1|NOT COMPLETED|Washout Period (7 Days)||0
8074007|NCT03992014|19908150|P1|COMPLETED|Washout Period (7 Days)||6
8074008|NCT03992014|19908150|P1|STARTED|Washout Period (7 Days)||6
8074009|NCT03992014|19908150|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8074010|NCT03992014|19908150|P1|COMPLETED|Treatment Period 1 (8 Days)||6
8074011|NCT03992014|19908150|P1|STARTED|Treatment Period 1 (8 Days)||6
8074012|NCT03991715|19908209|P1|NOT COMPLETED|Overall Study||0
8074013|NCT03991715|19908209|P1|COMPLETED|Overall Study||5
8074014|NCT03991715|19908209|P1|STARTED|Overall Study||5
8074015|NCT03989570|19908221|P3|NOT COMPLETED|Overall Study||0
8074016|NCT03989570|19908222|P2|NOT COMPLETED|Overall Study||0
8074017|NCT03989570|19908223|P1|NOT COMPLETED|Overall Study||0
8074018|NCT03989570|19908221|P3|COMPLETED|Overall Study||31
8074019|NCT03989570|19908222|P2|COMPLETED|Overall Study||31
8074020|NCT03989570|19908223|P1|COMPLETED|Overall Study||31
8074021|NCT03989570|19908221|P3|STARTED|Overall Study||31
8074022|NCT03989570|19908222|P2|STARTED|Overall Study||31
8074023|NCT03989570|19908223|P1|STARTED|Overall Study||31
8074024|NCT03989427|19908239|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8074025|NCT03989427|19908240|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8074026|NCT03989427|19908239|P2|COMPLETED|Second Intervention (2 Weeks)||15
8074027|NCT03989427|19908240|P1|COMPLETED|Second Intervention (2 Weeks)||15
8074028|NCT03989427|19908239|P2|STARTED|Second Intervention (2 Weeks)||15
8074029|NCT03989427|19908240|P1|STARTED|Second Intervention (2 Weeks)||15
8074030|NCT03989427|19908239|P2|NOT COMPLETED|Washout (1 Week)||0
8074031|NCT03989427|19908240|P1|NOT COMPLETED|Washout (1 Week)||0
8074032|NCT03989427|19908239|P2|COMPLETED|Washout (1 Week)||15
8074033|NCT03989427|19908240|P1|COMPLETED|Washout (1 Week)||15
8074034|NCT03989427|19908239|P2|STARTED|Washout (1 Week)||15
8074035|NCT03989427|19908240|P1|STARTED|Washout (1 Week)||15
8074036|NCT03989427|19908239|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
8074037|NCT03989427|19908240|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8074038|NCT03989427|19908239|P2|COMPLETED|First Intervention (2 Weeks)||15
8074039|NCT03989427|19908240|P1|COMPLETED|First Intervention (2 Weeks)||15
8074040|NCT03989427|19908239|P2|STARTED|First Intervention (2 Weeks)||15
8074041|NCT03989427|19908240|P1|STARTED|First Intervention (2 Weeks)||15
8074042|NCT03988907|19908249|P2|NOT COMPLETED|Overall Study||1
8074043|NCT03988907|19908250|P1|NOT COMPLETED|Overall Study||0
8074044|NCT03988907|19908249|P2|COMPLETED|Overall Study||26
8074045|NCT03988907|19908250|P1|COMPLETED|Overall Study||8
8074046|NCT03988907|19908249|P2|STARTED|Overall Study||27
8074047|NCT03988907|19908250|P1|STARTED|Overall Study||8
8074048|NCT03988426|19908282|P1|NOT COMPLETED|Overall Study||1
8074049|NCT03988426|19908282|P1|COMPLETED|Overall Study||24
8074050|NCT03988426|19908282|P1|STARTED|Overall Study||25
8074051|NCT03988088|19908306|P4|NOT COMPLETED|Open-Label Addendum||0
8074052|NCT03988088|19908307|P3|NOT COMPLETED|Open-Label Addendum||1
8074053|NCT03988088|19908308|P2|NOT COMPLETED|Open-Label Addendum||0
8074054|NCT03988088|19908309|P1|NOT COMPLETED|Open-Label Addendum||0
8074055|NCT03988088|19908306|P4|COMPLETED|Open-Label Addendum||2
8074056|NCT03988088|19908307|P3|COMPLETED|Open-Label Addendum||1
8074057|NCT03988088|19908308|P2|COMPLETED|Open-Label Addendum||0
8074058|NCT03988088|19908309|P1|COMPLETED|Open-Label Addendum||0
8074059|NCT03988088|19908306|P4|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
8074060|NCT03988088|19908307|P3|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
8074061|NCT03988088|19908308|P2|STARTED|Open-Label Addendum||0
8074062|NCT03988088|19908309|P1|STARTED|Open-Label Addendum||0
8074063|NCT03988088|19908306|P4|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
8074064|NCT03988088|19908307|P3|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
8074065|NCT03988088|19908308|P2|NOT COMPLETED|Single-Dose Pharmacokinetic Study||1
8074066|NCT03988088|19908309|P1|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
8074067|NCT03988088|19908306|P4|COMPLETED|Single-Dose Pharmacokinetic Study||0
8074068|NCT03988088|19908307|P3|COMPLETED|Single-Dose Pharmacokinetic Study||0
8074069|NCT03988088|19908308|P2|COMPLETED|Single-Dose Pharmacokinetic Study||6
8074070|NCT03988088|19908309|P1|COMPLETED|Single-Dose Pharmacokinetic Study||11
8074071|NCT03988088|19908306|P4|STARTED|Single-Dose Pharmacokinetic Study||0
8074072|NCT03988088|19908307|P3|STARTED|Single-Dose Pharmacokinetic Study||0
8074073|NCT03988088|19908308|P2|STARTED|Single-Dose Pharmacokinetic Study||7
8074074|NCT03988088|19908309|P1|STARTED|Single-Dose Pharmacokinetic Study||11
8074075|NCT03985657|19908319|P2|NOT COMPLETED|Intervention 2 (One Night)||0
8074076|NCT03985657|19908320|P1|NOT COMPLETED|Intervention 2 (One Night)||0
8074077|NCT03985657|19908319|P2|COMPLETED|Intervention 2 (One Night)||10
8074078|NCT03985657|19908320|P1|COMPLETED|Intervention 2 (One Night)||20
8074079|NCT03985657|19908319|P2|STARTED|Intervention 2 (One Night)||10
8074080|NCT03985657|19908320|P1|STARTED|Intervention 2 (One Night)||20
8074081|NCT03985657|19908319|P2|NOT COMPLETED|Washout (Up to 1 Week)||0
8074082|NCT03985657|19908320|P1|NOT COMPLETED|Washout (Up to 1 Week)||0
8074083|NCT03985657|19908319|P2|COMPLETED|Washout (Up to 1 Week)||10
8074084|NCT03985657|19908320|P1|COMPLETED|Washout (Up to 1 Week)||20
8074085|NCT03985657|19908319|P2|STARTED|Washout (Up to 1 Week)||10
8074086|NCT03985657|19908320|P1|STARTED|Washout (Up to 1 Week)||20
8074087|NCT03985657|19908319|P2|NOT COMPLETED|Intervention 1 (One Night)||1
8074088|NCT03985657|19908320|P1|NOT COMPLETED|Intervention 1 (One Night)||0
8074089|NCT03985657|19908319|P2|COMPLETED|Intervention 1 (One Night)||10
8074090|NCT03985657|19908320|P1|COMPLETED|Intervention 1 (One Night)||20
8074091|NCT03985657|19908319|P2|STARTED|Intervention 1 (One Night)||11
8074092|NCT03985657|19908320|P1|STARTED|Intervention 1 (One Night)||20
8074093|NCT03984838|19908332|P1|NOT COMPLETED|Overall Study||0
8074094|NCT03984838|19908332|P1|COMPLETED|Overall Study||16
8074095|NCT03984838|19908332|P1|STARTED|Overall Study||16
8074096|NCT03984825|19908392|P1|NOT COMPLETED|Treatment Period 2 (Day 11 to 21)||4
8074097|NCT03984825|19908392|P1|COMPLETED|Treatment Period 2 (Day 11 to 21)||17
8074098|NCT03984825|19908392|P1|STARTED|Treatment Period 2 (Day 11 to 21)||21
8074099|NCT03984825|19908392|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 10)||2
8074100|NCT03984825|19908392|P1|COMPLETED|Treatment Period 1 (Day 1 to 10)||21
8074101|NCT03984825|19908392|P1|STARTED|Treatment Period 1 (Day 1 to 10)||23
8074102|NCT03984825|19908392|P1|NOT COMPLETED|Run-in Period (Day -3 to -1)||0
8074103|NCT03984825|19908392|P1|COMPLETED|Run-in Period (Day -3 to -1)||23
8074104|NCT03984825|19908392|P1|STARTED|Run-in Period (Day -3 to -1)||23
8074105|NCT03983317|19908506|P1|NOT COMPLETED|Overall Study||5
8074106|NCT03983317|19908506|P1|COMPLETED|Overall Study||20
8074107|NCT03983317|19908506|P1|STARTED|Overall Study||25
8074108|NCT03982433|19908513|P1|NOT COMPLETED|Overall Study||1
8074109|NCT03982433|19908513|P1|COMPLETED|Overall Study||7
8074110|NCT03982433|19908513|P1|STARTED|Overall Study||8
8074111|NCT03979807|19908526|P2|NOT COMPLETED|Overall Study||0
8074112|NCT03979807|19908527|P1|NOT COMPLETED|Overall Study||0
8074113|NCT03979807|19908526|P2|COMPLETED|Overall Study||7420
8074114|NCT03979807|19908527|P1|COMPLETED|Overall Study||3876
8074115|NCT03979807|19908526|P2|STARTED|Overall Study||7420
8074116|NCT03979807|19908527|P1|STARTED|Overall Study||3876
8074117|NCT03979079|19908533|P1|NOT COMPLETED|Overall Study||0
8074118|NCT03979079|19908533|P1|COMPLETED|Overall Study||2384
8074119|NCT03979079|19908533|P1|STARTED|Overall Study||2384
8074120|NCT03979066|19908541|P2|NOT COMPLETED|Overall Study||0
8074121|NCT03979066|19908542|P1|NOT COMPLETED|Overall Study||0
8074122|NCT03979066|19908541|P2|COMPLETED|Overall Study||0
8074123|NCT03979066|19908542|P1|COMPLETED|Overall Study||0
8074124|NCT03979066|19908541|P2|STARTED|Overall Study||0
8074125|NCT03979066|19908542|P1|STARTED|Overall Study||0
8074126|NCT03977935|19908558|P2|NOT COMPLETED|Overall Study||0
8074127|NCT03977935|19908559|P1|NOT COMPLETED|Overall Study||0
8074128|NCT03977935|19908558|P2|COMPLETED|Overall Study||40
8074129|NCT03977935|19908559|P1|COMPLETED|Overall Study||40
8074130|NCT03977935|19908558|P2|STARTED|Overall Study||40
8074131|NCT03977935|19908559|P1|STARTED|Overall Study||40
8074132|NCT03977818|19908585|P1|NOT COMPLETED|Overall Study||0
8074133|NCT03977818|19908585|P1|COMPLETED|Overall Study||2165
8074134|NCT03977818|19908585|P1|STARTED|Overall Study||2165
8074135|NCT03977727|19908591|P2|NOT COMPLETED|Second Treatment||3
8074136|NCT03977727|19908592|P1|NOT COMPLETED|Second Treatment||0
8074137|NCT03977727|19908591|P2|COMPLETED|Second Treatment||17
8074138|NCT03977727|19908592|P1|COMPLETED|Second Treatment||20
8074139|NCT03977727|19908591|P2|STARTED|Second Treatment||20
8074140|NCT03977727|19908592|P1|STARTED|Second Treatment||20
8074141|NCT03977727|19908591|P2|NOT COMPLETED|First Treatment||0
8074142|NCT03977727|19908592|P1|NOT COMPLETED|First Treatment||0
8074143|NCT03977727|19908591|P2|COMPLETED|First Treatment||20
8074144|NCT03977727|19908592|P1|COMPLETED|First Treatment||20
8074145|NCT03977727|19908591|P2|Received Treatment|First Treatment||20
8074146|NCT03977727|19908592|P1|Received Treatment|First Treatment||20
8074147|NCT03977727|19908591|P2|STARTED|First Treatment||20
8074148|NCT03977727|19908592|P1|STARTED|First Treatment||20
8074149|NCT03976531|19908636|P1|NOT COMPLETED|Overall Study||0
8074150|NCT03976531|19908636|P1|COMPLETED|Overall Study||42
8074151|NCT03976531|19908636|P1|STARTED|Overall Study||42
8074152|NCT03976466|19908649|P2|NOT COMPLETED|Overall Study||3
8074153|NCT03976466|19908650|P1|NOT COMPLETED|Overall Study||1
8074154|NCT03976466|19908649|P2|COMPLETED|Overall Study||40
8074155|NCT03976466|19908650|P1|COMPLETED|Overall Study||43
8074156|NCT03976466|19908649|P2|STARTED|Overall Study||43
8074157|NCT03976466|19908650|P1|STARTED|Overall Study||44
8074158|NCT03975790|19908661|P3|NOT COMPLETED|Overall Study||0
8074159|NCT03975790|19908662|P2|NOT COMPLETED|Overall Study||0
8074160|NCT03975790|19908663|P1|NOT COMPLETED|Overall Study||0
8074161|NCT03975790|19908661|P3|COMPLETED|Overall Study||48
8074162|NCT03975790|19908662|P2|COMPLETED|Overall Study||94
8074163|NCT03975790|19908663|P1|COMPLETED|Overall Study||337
8074164|NCT03975790|19908661|P3|STARTED|Overall Study||48
8074165|NCT03975790|19908662|P2|STARTED|Overall Study||94
8074166|NCT03975790|19908663|P1|STARTED|Overall Study||337
8074167|NCT03974802|19908876|P1|NOT COMPLETED|Overall Study||0
8074168|NCT03974802|19908876|P1|COMPLETED|Overall Study||41
8074169|NCT03974802|19908876|P1|STARTED|Overall Study||41
8074170|NCT03973905|19908913|P2|NOT COMPLETED|Overall Study||0
8074171|NCT03973905|19908914|P1|NOT COMPLETED|Overall Study||0
8074172|NCT03973905|19908913|P2|COMPLETED|Overall Study||183
8074173|NCT03973905|19908914|P1|COMPLETED|Overall Study||107
8074174|NCT03973905|19908913|P2|STARTED|Overall Study||183
8074175|NCT03973905|19908914|P1|STARTED|Overall Study||107
8074176|NCT03972137|19908926|P1|NOT COMPLETED|Overall Study||6
8074177|NCT03972137|19908926|P1|COMPLETED|Overall Study||4
8074178|NCT03972137|19908926|P1|Follow-up Completed|Overall Study||4
8074179|NCT03972137|19908926|P1|Treatment Completed|Overall Study||6
8074180|NCT03972137|19908926|P1|Enrolled|Overall Study||10
8074181|NCT03972137|19908926|P1|STARTED|Overall Study||10
8074182|NCT03970824|19908951|P3|NOT COMPLETED|Overall Study||4
8074183|NCT03970824|19908952|P2|NOT COMPLETED|Overall Study||3
8074184|NCT03970824|19908953|P1|NOT COMPLETED|Overall Study||2
8074185|NCT03970824|19908951|P3|COMPLETED|Overall Study||102
8074186|NCT03970824|19908952|P2|COMPLETED|Overall Study||100
8074187|NCT03970824|19908953|P1|COMPLETED|Overall Study||101
8074188|NCT03970824|19908951|P3|STARTED|Overall Study||106
8074189|NCT03970824|19908952|P2|STARTED|Overall Study||103
8074190|NCT03970824|19908953|P1|STARTED|Overall Study||103
8074197|NCT03966365|19908994|P2|NOT COMPLETED|Overall Study||0
8074198|NCT03966365|19908995|P1|NOT COMPLETED|Overall Study||1
8074199|NCT03966365|19908994|P2|COMPLETED|Overall Study||12
8074200|NCT03966365|19908995|P1|COMPLETED|Overall Study||11
8074201|NCT03966365|19908994|P2|STARTED|Overall Study||12
8074202|NCT03966365|19908995|P1|STARTED|Overall Study||12
8074215|NCT03965533|19909041|P7|NOT COMPLETED|Part B (112 Days)||0
8074216|NCT03965533|19909042|P6|NOT COMPLETED|Part B (112 Days)||0
8074217|NCT03965533|19909043|P5|NOT COMPLETED|Part B (112 Days)||0
8074218|NCT03965533|19909044|P4|NOT COMPLETED|Part B (112 Days)||0
8074219|NCT03965533|19909045|P3|NOT COMPLETED|Part B (112 Days)||0
8074220|NCT03965533|19909046|P2|NOT COMPLETED|Part B (112 Days)||0
8074221|NCT03965533|19909047|P1|NOT COMPLETED|Part B (112 Days)||0
8074222|NCT03965533|19909041|P7|COMPLETED|Part B (112 Days)||8
8074223|NCT03965533|19909042|P6|COMPLETED|Part B (112 Days)||8
8074224|NCT03965533|19909043|P5|COMPLETED|Part B (112 Days)||4
8074225|NCT03965533|19909044|P4|COMPLETED|Part B (112 Days)||0
8074226|NCT03965533|19909045|P3|COMPLETED|Part B (112 Days)||0
8074227|NCT03965533|19909046|P2|COMPLETED|Part B (112 Days)||0
8074228|NCT03965533|19909047|P1|COMPLETED|Part B (112 Days)||0
8074229|NCT03965533|19909041|P7|STARTED|Part B (112 Days)||8
8074230|NCT03965533|19909042|P6|STARTED|Part B (112 Days)||8
8074231|NCT03965533|19909043|P5|STARTED|Part B (112 Days)||4
8074232|NCT03965533|19909044|P4|STARTED|Part B (112 Days)||0
8074233|NCT03965533|19909045|P3|STARTED|Part B (112 Days)||0
8074234|NCT03965533|19909046|P2|STARTED|Part B (112 Days)||0
8074235|NCT03965533|19909047|P1|STARTED|Part B (112 Days)||0
8074236|NCT03965533|19909041|P7|NOT COMPLETED|Part A (112 Days)||0
8074237|NCT03965533|19909042|P6|NOT COMPLETED|Part A (112 Days)||0
8074238|NCT03965533|19909043|P5|NOT COMPLETED|Part A (112 Days)||0
8074239|NCT03965533|19909044|P4|NOT COMPLETED|Part A (112 Days)||0
8074240|NCT03965533|19909045|P3|NOT COMPLETED|Part A (112 Days)||0
8074241|NCT03965533|19909046|P2|NOT COMPLETED|Part A (112 Days)||0
8074242|NCT03965533|19909047|P1|NOT COMPLETED|Part A (112 Days)||0
8074243|NCT03965533|19909041|P7|COMPLETED|Part A (112 Days)||0
8074244|NCT03965533|19909042|P6|COMPLETED|Part A (112 Days)||0
8074245|NCT03965533|19909043|P5|COMPLETED|Part A (112 Days)||0
8074246|NCT03965533|19909044|P4|COMPLETED|Part A (112 Days)||6
8074247|NCT03965533|19909045|P3|COMPLETED|Part A (112 Days)||2
8074248|NCT03965533|19909046|P2|COMPLETED|Part A (112 Days)||6
8074249|NCT03965533|19909047|P1|COMPLETED|Part A (112 Days)||2
8074250|NCT03965533|19909041|P7|STARTED|Part A (112 Days)||0
8074251|NCT03965533|19909042|P6|STARTED|Part A (112 Days)||0
8074252|NCT03965533|19909043|P5|STARTED|Part A (112 Days)||0
8074253|NCT03965533|19909044|P4|STARTED|Part A (112 Days)||6
8074254|NCT03965533|19909045|P3|STARTED|Part A (112 Days)||2
8074255|NCT03965533|19909046|P2|STARTED|Part A (112 Days)||6
8074256|NCT03965533|19909047|P1|STARTED|Part A (112 Days)||2
8074257|NCT03965403|19909130|P1|NOT COMPLETED|Overall Study||1
8074258|NCT03965403|19909130|P1|COMPLETED|Overall Study||6
8074259|NCT03965403|19909130|P1|STARTED|Overall Study||7
8074260|NCT03965052|19909143|P2|NOT COMPLETED|Overall Study||0
8074261|NCT03965052|19909144|P1|NOT COMPLETED|Overall Study||1
8074262|NCT03965052|19909143|P2|COMPLETED|Overall Study||12
8074263|NCT03965052|19909144|P1|COMPLETED|Overall Study||11
8074264|NCT03965052|19909143|P2|STARTED|Overall Study||12
8074265|NCT03965052|19909144|P1|STARTED|Overall Study||12
8074266|NCT03965039|19909166|P4|NOT COMPLETED|Overall Study||1
8074267|NCT03965039|19909167|P3|NOT COMPLETED|Overall Study||0
8074268|NCT03965039|19909168|P2|NOT COMPLETED|Overall Study||1
8074269|NCT03965039|19909169|P1|NOT COMPLETED|Overall Study||0
8074270|NCT03965039|19909166|P4|COMPLETED|Overall Study||29
8074271|NCT03965039|19909167|P3|COMPLETED|Overall Study||30
8074272|NCT03965039|19909168|P2|COMPLETED|Overall Study||29
8074273|NCT03965039|19909169|P1|COMPLETED|Overall Study||30
8074274|NCT03965039|19909166|P4|STARTED|Overall Study||30
8074275|NCT03965039|19909167|P3|STARTED|Overall Study||30
8074276|NCT03965039|19909168|P2|STARTED|Overall Study||30
8074277|NCT03965039|19909169|P1|STARTED|Overall Study||30
8074278|NCT03964220|19909225|P2|NOT COMPLETED|Overall Study||0
8074279|NCT03964220|19909226|P1|NOT COMPLETED|Overall Study||0
8074280|NCT03964220|19909225|P2|COMPLETED|Overall Study||5238
8074281|NCT03964220|19909226|P1|COMPLETED|Overall Study||2619
8074282|NCT03964220|19909225|P2|STARTED|Overall Study||5238
8074283|NCT03964220|19909226|P1|STARTED|Overall Study||2619
8074284|NCT03962790|19909240|P2|NOT COMPLETED|Period 2||0
8074285|NCT03962790|19909241|P1|NOT COMPLETED|Period 2||0
8074286|NCT03962790|19909240|P2|COMPLETED|Period 2||44
8074287|NCT03962790|19909241|P1|COMPLETED|Period 2||45
8074288|NCT03962790|19909240|P2|STARTED|Period 2||44
8074289|NCT03962790|19909241|P1|STARTED|Period 2||45
8074290|NCT03962790|19909240|P2|NOT COMPLETED|Period 1||2
8074291|NCT03962790|19909241|P1|NOT COMPLETED|Period 1||3
8074292|NCT03962790|19909240|P2|COMPLETED|Period 1||44
8074293|NCT03962790|19909241|P1|COMPLETED|Period 1||45
8074294|NCT03962790|19909240|P2|STARTED|Period 1||46
8074295|NCT03962790|19909241|P1|STARTED|Period 1||48
8074296|NCT03962634|19909255|P2|NOT COMPLETED|Overall Study||0
8074297|NCT03962634|19909256|P1|NOT COMPLETED|Overall Study||0
8074298|NCT03962634|19909255|P2|COMPLETED|Overall Study||2
8074299|NCT03962634|19909256|P1|COMPLETED|Overall Study||1
8074300|NCT03962634|19909255|P2|STARTED|Overall Study||2
8074301|NCT03962634|19909256|P1|STARTED|Overall Study||1
8074302|NCT03961308|19909276|P2|NOT COMPLETED|Overall Study||2
8074303|NCT03961308|19909277|P1|NOT COMPLETED|Overall Study||2
8074304|NCT03961308|19909276|P2|COMPLETED|Overall Study||100
8074305|NCT03961308|19909277|P1|COMPLETED|Overall Study||100
8074306|NCT03961308|19909276|P2|STARTED|Overall Study||102
8074307|NCT03961308|19909277|P1|STARTED|Overall Study||102
8074308|NCT03961295|19909289|P2|NOT COMPLETED|Overall Study||0
8074309|NCT03961295|19909290|P1|NOT COMPLETED|Overall Study||0
8074310|NCT03961295|19909289|P2|COMPLETED|Overall Study||12
8074311|NCT03961295|19909290|P1|COMPLETED|Overall Study||12
8074312|NCT03961295|19909289|P2|STARTED|Overall Study||12
8074313|NCT03961295|19909290|P1|STARTED|Overall Study||12
8074314|NCT03961100|19909305|P5|NOT COMPLETED|Part 2||0
8074315|NCT03961100|19909306|P4|NOT COMPLETED|Part 2||0
8074316|NCT03961100|19909307|P3|NOT COMPLETED|Part 2||0
8074317|NCT03961100|19909308|P2|NOT COMPLETED|Part 2||0
8074318|NCT03961100|19909309|P1|NOT COMPLETED|Part 2||0
8074319|NCT03961100|19909305|P5|COMPLETED|Part 2||8
8074320|NCT03961100|19909306|P4|COMPLETED|Part 2||8
8074321|NCT03961100|19909307|P3|COMPLETED|Part 2||0
8074322|NCT03961100|19909308|P2|COMPLETED|Part 2||0
8074323|NCT03961100|19909309|P1|COMPLETED|Part 2||0
8074324|NCT03961100|19909305|P5|STARTED|Part 2||8
8074325|NCT03961100|19909306|P4|STARTED|Part 2||8
8074326|NCT03961100|19909307|P3|STARTED|Part 2||0
8074327|NCT03961100|19909308|P2|STARTED|Part 2||0
8074328|NCT03961100|19909309|P1|STARTED|Part 2||0
8074329|NCT03961100|19909305|P5|NOT COMPLETED|Part 1||0
8074330|NCT03961100|19909306|P4|NOT COMPLETED|Part 1||0
8074331|NCT03961100|19909307|P3|NOT COMPLETED|Part 1||0
8074332|NCT03961100|19909308|P2|NOT COMPLETED|Part 1||0
8074333|NCT03961100|19909309|P1|NOT COMPLETED|Part 1||0
8074334|NCT03961100|19909305|P5|COMPLETED|Part 1||0
8074335|NCT03961100|19909306|P4|COMPLETED|Part 1||0
8074336|NCT03961100|19909307|P3|COMPLETED|Part 1||5
8074337|NCT03961100|19909308|P2|COMPLETED|Part 1||5
8074338|NCT03961100|19909309|P1|COMPLETED|Part 1||5
8074339|NCT03961100|19909305|P5|STARTED|Part 1||0
8074340|NCT03961100|19909306|P4|STARTED|Part 1||0
8074341|NCT03961100|19909307|P3|STARTED|Part 1||5
8074342|NCT03961100|19909308|P2|STARTED|Part 1||5
8074343|NCT03961100|19909309|P1|STARTED|Part 1||5
8074344|NCT03959332|19909343|P2|NOT COMPLETED|Overall Study||0
8074345|NCT03959332|19909344|P1|NOT COMPLETED|Overall Study||0
8074346|NCT03959332|19909343|P2|COMPLETED|Overall Study||16
8074347|NCT03959332|19909344|P1|COMPLETED|Overall Study||16
8074348|NCT03959332|19909343|P2|STARTED|Overall Study||16
8074349|NCT03959332|19909344|P1|STARTED|Overall Study||16
8074359|NCT03954626|19909397|P1|NOT COMPLETED|Overall Study||0
8074360|NCT03954626|19909397|P1|COMPLETED|Overall Study||14
8074361|NCT03954626|19909397|P1|STARTED|Overall Study||14
8074362|NCT03954158|19909405|P4|NOT COMPLETED|Overall Study||0
8074363|NCT03954158|19909406|P3|NOT COMPLETED|Overall Study||0
8074364|NCT03954158|19909407|P2|NOT COMPLETED|Overall Study||0
8074365|NCT03954158|19909408|P1|NOT COMPLETED|Overall Study||0
8074366|NCT03954158|19909405|P4|COMPLETED|Overall Study||20
8074367|NCT03954158|19909406|P3|COMPLETED|Overall Study||20
8074368|NCT03954158|19909407|P2|COMPLETED|Overall Study||21
8074369|NCT03954158|19909408|P1|COMPLETED|Overall Study||20
8074370|NCT03954158|19909405|P4|STARTED|Overall Study||20
8074371|NCT03954158|19909406|P3|STARTED|Overall Study||20
8074372|NCT03954158|19909407|P2|STARTED|Overall Study||21
8074373|NCT03954158|19909408|P1|STARTED|Overall Study||20
8074374|NCT03953820|19909470|P3|NOT COMPLETED|DBF Following High-Fat Meal||0
8074375|NCT03953820|19909471|P2|NOT COMPLETED|DBF Following High-Fat Meal||0
8074376|NCT03953820|19909472|P1|NOT COMPLETED|DBF Following High-Fat Meal||0
8074377|NCT03953820|19909470|P3|COMPLETED|DBF Following High-Fat Meal||10
8074378|NCT03953820|19909471|P2|COMPLETED|DBF Following High-Fat Meal||0
8074379|NCT03953820|19909472|P1|COMPLETED|DBF Following High-Fat Meal||0
8074380|NCT03953820|19909470|P3|STARTED|DBF Following High-Fat Meal|Participants in Period 2 completed 1 of the 2 arms in Period 1 and volunteered to continue.|10
8074381|NCT03953820|19909471|P2|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
8074382|NCT03953820|19909472|P1|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
8074383|NCT03953820|19909470|P3|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
8074384|NCT03953820|19909471|P2|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
8074385|NCT03953820|19909472|P1|NOT COMPLETED|Two-Sequence, Two-Way Crossover||2
8074386|NCT03953820|19909470|P3|COMPLETED|Two-Sequence, Two-Way Crossover||0
8074387|NCT03953820|19909471|P2|COMPLETED|Two-Sequence, Two-Way Crossover||16
8074388|NCT03953820|19909472|P1|COMPLETED|Two-Sequence, Two-Way Crossover||13
8074389|NCT03953820|19909470|P3|STARTED|Two-Sequence, Two-Way Crossover||0
8074390|NCT03953820|19909471|P2|STARTED|Two-Sequence, Two-Way Crossover||16
8074391|NCT03953820|19909472|P1|STARTED|Two-Sequence, Two-Way Crossover||15
8074392|NCT03953183|19909488|P2|NOT COMPLETED|Overall Study||2
8074393|NCT03953183|19909489|P1|NOT COMPLETED|Overall Study||0
8074394|NCT03953183|19909488|P2|COMPLETED|Overall Study||28
8074395|NCT03953183|19909489|P1|COMPLETED|Overall Study||30
8074396|NCT03953183|19909488|P2|STARTED|Overall Study||30
8074397|NCT03953183|19909489|P1|STARTED|Overall Study||30
8074418|NCT03951610|19909574|P2|NOT COMPLETED|Second Intervention||0
8074419|NCT03951610|19909575|P1|NOT COMPLETED|Second Intervention||0
8074420|NCT03951610|19909574|P2|COMPLETED|Second Intervention||25
8074421|NCT03951610|19909575|P1|COMPLETED|Second Intervention||27
8074422|NCT03951610|19909574|P2|STARTED|Second Intervention||25
8074423|NCT03951610|19909575|P1|STARTED|Second Intervention||27
8074424|NCT03951610|19909574|P2|NOT COMPLETED|First Intervention||0
8074425|NCT03951610|19909575|P1|NOT COMPLETED|First Intervention||0
8074426|NCT03951610|19909574|P2|COMPLETED|First Intervention||25
8074427|NCT03951610|19909575|P1|COMPLETED|First Intervention||27
8074428|NCT03951610|19909574|P2|STARTED|First Intervention||25
8074429|NCT03951610|19909575|P1|STARTED|First Intervention||27
8074430|NCT03950674|19909613|P2|NOT COMPLETED|Overall Study||15
8074431|NCT03950674|19909614|P1|NOT COMPLETED|Overall Study||25
8074432|NCT03950674|19909613|P2|COMPLETED|Overall Study||0
8074433|NCT03950674|19909614|P1|COMPLETED|Overall Study||0
8074434|NCT03950674|19909613|P2|Switched to Pembrolizumab|Overall Study||4
8074435|NCT03950674|19909614|P1|Switched to Pembrolizumab|Overall Study||0
8074436|NCT03950674|19909613|P2|Treated|Overall Study||15
8074437|NCT03950674|19909614|P1|Treated|Overall Study||25
8074438|NCT03950674|19909613|P2|STARTED|Overall Study||15
8074439|NCT03950674|19909614|P1|STARTED|Overall Study||25
8074440|NCT03949621|19909635|P2|NOT COMPLETED|Overall Study||0
8074441|NCT03949621|19909636|P1|NOT COMPLETED|Overall Study||0
8074442|NCT03949621|19909635|P2|COMPLETED|Overall Study||12
8074443|NCT03949621|19909636|P1|COMPLETED|Overall Study||12
8074444|NCT03949621|19909635|P2|STARTED|Overall Study||12
8074445|NCT03949621|19909636|P1|STARTED|Overall Study||12
8074446|NCT03948581|19909648|P2|NOT COMPLETED|Overall Study||1
8074447|NCT03948581|19909649|P1|NOT COMPLETED|Overall Study||0
8074448|NCT03948581|19909648|P2|COMPLETED|Overall Study||50
8074449|NCT03948581|19909649|P1|COMPLETED|Overall Study||51
8074450|NCT03948581|19909648|P2|STARTED|Overall Study||51
8074451|NCT03948581|19909649|P1|STARTED|Overall Study||51
8074452|NCT03946124|19909659|P1|NOT COMPLETED|Overall Study||19
8074453|NCT03946124|19909659|P1|COMPLETED|Overall Study||55
8074454|NCT03946124|19909659|P1|STARTED|Overall Study||74
8074455|NCT03943095|19909665|P2|NOT COMPLETED|Overall Study||1
8074456|NCT03943095|19909666|P1|NOT COMPLETED|Overall Study||1
8074457|NCT03943095|19909665|P2|COMPLETED|Overall Study||51
8074458|NCT03943095|19909666|P1|COMPLETED|Overall Study||51
8074459|NCT03943095|19909665|P2|STARTED|Overall Study||52
8074460|NCT03943095|19909666|P1|STARTED|Overall Study||52
8074461|NCT03937479|19909715|P5|NOT COMPLETED|Overall Study||5
8074462|NCT03937479|19909716|P4|NOT COMPLETED|Overall Study||6
8074463|NCT03937479|19909717|P3|NOT COMPLETED|Overall Study||7
8074464|NCT03937479|19909718|P2|NOT COMPLETED|Overall Study||15
8074465|NCT03937479|19909719|P1|NOT COMPLETED|Overall Study||10
8074466|NCT03937479|19909715|P5|COMPLETED|Overall Study||79
8074467|NCT03937479|19909716|P4|COMPLETED|Overall Study||76
8074468|NCT03937479|19909717|P3|COMPLETED|Overall Study||75
8074469|NCT03937479|19909718|P2|COMPLETED|Overall Study||70
8074470|NCT03937479|19909719|P1|COMPLETED|Overall Study||73
8074471|NCT03937479|19909715|P5|Received Treatment|Overall Study||84
8074472|NCT03937479|19909716|P4|Received Treatment|Overall Study||82
8074473|NCT03937479|19909717|P3|Received Treatment|Overall Study||81
8074474|NCT03937479|19909718|P2|Received Treatment|Overall Study||83
8074475|NCT03937479|19909719|P1|Received Treatment|Overall Study||83
8074476|NCT03937479|19909715|P5|STARTED|Overall Study||84
8074477|NCT03937479|19909716|P4|STARTED|Overall Study||82
8074478|NCT03937479|19909717|P3|STARTED|Overall Study||82
8074479|NCT03937479|19909718|P2|STARTED|Overall Study||85
8074480|NCT03937479|19909719|P1|STARTED|Overall Study||83
8074481|NCT03936608|19909813|P2|NOT COMPLETED|Overall Study||2
8074482|NCT03936608|19909814|P1|NOT COMPLETED|Overall Study||2
8074483|NCT03936608|19909813|P2|COMPLETED|Overall Study||0
8074484|NCT03936608|19909814|P1|COMPLETED|Overall Study||0
8074485|NCT03936608|19909813|P2|STARTED|Overall Study||2
8074486|NCT03936608|19909814|P1|STARTED|Overall Study||2
8074487|NCT03936244|19909822|P2|NOT COMPLETED|Overall Study||4
8074488|NCT03936244|19909823|P1|NOT COMPLETED|Overall Study||12
8074489|NCT03936244|19909822|P2|COMPLETED|Overall Study||39
8074490|NCT03936244|19909823|P1|COMPLETED|Overall Study||45
8074491|NCT03936244|19909822|P2|STARTED|Overall Study||43
8074492|NCT03936244|19909823|P1|STARTED|Overall Study||57
8074493|NCT03933774|19909891|P2|NOT COMPLETED|Overall Study||2
8074494|NCT03933774|19909892|P1|NOT COMPLETED|Overall Study||2
8074495|NCT03933774|19909891|P2|COMPLETED|Overall Study||11
8074496|NCT03933774|19909892|P1|COMPLETED|Overall Study||10
8074497|NCT03933774|19909891|P2|STARTED|Overall Study||13
8074498|NCT03933774|19909892|P1|STARTED|Overall Study||12
8074499|NCT03933618|19909906|P6|NOT COMPLETED|Week 16 to Week 24||0
8074500|NCT03933618|19909907|P5|NOT COMPLETED|Week 16 to Week 24||0
8074501|NCT03933618|19909908|P4|NOT COMPLETED|Week 16 to Week 24||0
8074502|NCT03933618|19909909|P3|NOT COMPLETED|Week 16 to Week 24||0
8074503|NCT03933618|19909910|P2|NOT COMPLETED|Week 16 to Week 24||0
8074504|NCT03933618|19909911|P1|NOT COMPLETED|Week 16 to Week 24||0
8074505|NCT03933618|19909906|P6|COMPLETED|Week 16 to Week 24||4
8074506|NCT03933618|19909907|P5|COMPLETED|Week 16 to Week 24||4
8074507|NCT03933618|19909908|P4|COMPLETED|Week 16 to Week 24||4
8074508|NCT03933618|19909909|P3|COMPLETED|Week 16 to Week 24||4
8074509|NCT03933618|19909910|P2|COMPLETED|Week 16 to Week 24||4
8074510|NCT03933618|19909911|P1|COMPLETED|Week 16 to Week 24||4
8074511|NCT03933618|19909906|P6|STARTED|Week 16 to Week 24||4
8074512|NCT03933618|19909907|P5|STARTED|Week 16 to Week 24||4
8074513|NCT03933618|19909908|P4|STARTED|Week 16 to Week 24||4
8074514|NCT03933618|19909909|P3|STARTED|Week 16 to Week 24||4
8074515|NCT03933618|19909910|P2|STARTED|Week 16 to Week 24||4
8074516|NCT03933618|19909911|P1|STARTED|Week 16 to Week 24||4
8074517|NCT03933618|19909906|P6|NOT COMPLETED|Week 8 to Week 16||0
8074518|NCT03933618|19909907|P5|NOT COMPLETED|Week 8 to Week 16||0
8074519|NCT03933618|19909908|P4|NOT COMPLETED|Week 8 to Week 16||0
8074520|NCT03933618|19909909|P3|NOT COMPLETED|Week 8 to Week 16||0
8074521|NCT03933618|19909910|P2|NOT COMPLETED|Week 8 to Week 16||0
8074522|NCT03933618|19909911|P1|NOT COMPLETED|Week 8 to Week 16||0
8074523|NCT03933618|19909906|P6|COMPLETED|Week 8 to Week 16||4
8074524|NCT03933618|19909907|P5|COMPLETED|Week 8 to Week 16||4
8074525|NCT03933618|19909908|P4|COMPLETED|Week 8 to Week 16||4
8074526|NCT03933618|19909909|P3|COMPLETED|Week 8 to Week 16||4
8074527|NCT03933618|19909910|P2|COMPLETED|Week 8 to Week 16||4
8074528|NCT03933618|19909911|P1|COMPLETED|Week 8 to Week 16||4
8074529|NCT03933618|19909906|P6|STARTED|Week 8 to Week 16||4
8074530|NCT03933618|19909907|P5|STARTED|Week 8 to Week 16||4
8074531|NCT03933618|19909908|P4|STARTED|Week 8 to Week 16||4
8074532|NCT03933618|19909909|P3|STARTED|Week 8 to Week 16||4
8074533|NCT03933618|19909910|P2|STARTED|Week 8 to Week 16||4
8074534|NCT03933618|19909911|P1|STARTED|Week 8 to Week 16||4
8074535|NCT03933618|19909906|P6|NOT COMPLETED|Baseline to Week 8||0
8074536|NCT03933618|19909907|P5|NOT COMPLETED|Baseline to Week 8||0
8074537|NCT03933618|19909908|P4|NOT COMPLETED|Baseline to Week 8||0
8074538|NCT03933618|19909909|P3|NOT COMPLETED|Baseline to Week 8||0
8074539|NCT03933618|19909910|P2|NOT COMPLETED|Baseline to Week 8||0
8074540|NCT03933618|19909911|P1|NOT COMPLETED|Baseline to Week 8||0
8074541|NCT03933618|19909906|P6|COMPLETED|Baseline to Week 8||4
8074542|NCT03933618|19909907|P5|COMPLETED|Baseline to Week 8||4
8074543|NCT03933618|19909908|P4|COMPLETED|Baseline to Week 8||4
8074544|NCT03933618|19909909|P3|COMPLETED|Baseline to Week 8||4
8074545|NCT03933618|19909910|P2|COMPLETED|Baseline to Week 8||4
8074546|NCT03933618|19909911|P1|COMPLETED|Baseline to Week 8||4
8074547|NCT03933618|19909906|P6|STARTED|Baseline to Week 8||4
8074548|NCT03933618|19909907|P5|STARTED|Baseline to Week 8||4
8074549|NCT03933618|19909908|P4|STARTED|Baseline to Week 8||4
8074550|NCT03933618|19909909|P3|STARTED|Baseline to Week 8||4
8074551|NCT03933618|19909910|P2|STARTED|Baseline to Week 8||4
8074552|NCT03933618|19909911|P1|STARTED|Baseline to Week 8||4
8074553|NCT03933618|19909906|P6|NOT COMPLETED|Baseline||0
8074554|NCT03933618|19909907|P5|NOT COMPLETED|Baseline||0
8074555|NCT03933618|19909908|P4|NOT COMPLETED|Baseline||0
8074556|NCT03933618|19909909|P3|NOT COMPLETED|Baseline||0
8074557|NCT03933618|19909910|P2|NOT COMPLETED|Baseline||0
8074558|NCT03933618|19909911|P1|NOT COMPLETED|Baseline||0
8074559|NCT03933618|19909906|P6|COMPLETED|Baseline||4
8074560|NCT03933618|19909907|P5|COMPLETED|Baseline||4
8074561|NCT03933618|19909908|P4|COMPLETED|Baseline||4
8074562|NCT03933618|19909909|P3|COMPLETED|Baseline||4
8074563|NCT03933618|19909910|P2|COMPLETED|Baseline||4
8074564|NCT03933618|19909911|P1|COMPLETED|Baseline||4
8074565|NCT03933618|19909906|P6|STARTED|Baseline||4
8074566|NCT03933618|19909907|P5|STARTED|Baseline||4
8074567|NCT03933618|19909908|P4|STARTED|Baseline||4
8074568|NCT03933618|19909909|P3|STARTED|Baseline||4
8074569|NCT03933618|19909910|P2|STARTED|Baseline||4
8074570|NCT03933618|19909911|P1|STARTED|Baseline||4
8074571|NCT03933462|19910159|P2|NOT COMPLETED|Overall Study||0
8074572|NCT03933462|19910160|P1|NOT COMPLETED|Overall Study||2
8074573|NCT03933462|19910159|P2|COMPLETED|Overall Study||10
8074574|NCT03933462|19910160|P1|COMPLETED|Overall Study||8
8074575|NCT03933462|19910159|P2|Crossover|Overall Study||10
8074576|NCT03933462|19910160|P1|Crossover|Overall Study||8
8074577|NCT03933462|19910159|P2|STARTED|Overall Study||10
8074578|NCT03933462|19910160|P1|STARTED|Overall Study||10
8074579|NCT03933449|19910184|P2|NOT COMPLETED|Overall Study||61
8074580|NCT03933449|19910185|P1|NOT COMPLETED|Overall Study||62
8074581|NCT03933449|19910184|P2|COMPLETED|Overall Study||0
8074582|NCT03933449|19910185|P1|COMPLETED|Overall Study||0
8074583|NCT03933449|19910184|P2|Treated|Overall Study||59
8074584|NCT03933449|19910185|P1|Treated|Overall Study||62
8074585|NCT03933449|19910184|P2|STARTED|Overall Study||61
8074586|NCT03933449|19910185|P1|STARTED|Overall Study||62
8074587|NCT03930641|19910207|P1|NOT COMPLETED|Overall Study||0
8074588|NCT03930641|19910207|P1|COMPLETED|Overall Study||34
8074589|NCT03930641|19910207|P1|STARTED|Overall Study||34
8074590|NCT03928522|19910216|P5|NOT COMPLETED|Overall Study||0
8074591|NCT03928522|19910217|P4|NOT COMPLETED|Overall Study||0
8074592|NCT03928522|19910218|P3|NOT COMPLETED|Overall Study||0
8074593|NCT03928522|19910219|P2|NOT COMPLETED|Overall Study||0
8074594|NCT03928522|19910220|P1|NOT COMPLETED|Overall Study||0
8074595|NCT03928522|19910216|P5|COMPLETED|Overall Study||12
8074596|NCT03928522|19910217|P4|COMPLETED|Overall Study||12
8074597|NCT03928522|19910218|P3|COMPLETED|Overall Study||12
8074598|NCT03928522|19910219|P2|COMPLETED|Overall Study||12
8074599|NCT03928522|19910220|P1|COMPLETED|Overall Study||12
8074600|NCT03928522|19910216|P5|STARTED|Overall Study||12
8074601|NCT03928522|19910217|P4|STARTED|Overall Study||12
8074602|NCT03928522|19910218|P3|STARTED|Overall Study||12
8074603|NCT03928522|19910219|P2|STARTED|Overall Study||12
8074604|NCT03928522|19910220|P1|STARTED|Overall Study||12
8074605|NCT03928327|19910234|P2|NOT COMPLETED|Period 2||0
8074606|NCT03928327|19910235|P1|NOT COMPLETED|Period 2||0
8074607|NCT03928327|19910234|P2|COMPLETED|Period 2||12
8074608|NCT03928327|19910235|P1|COMPLETED|Period 2||12
8074609|NCT03928327|19910234|P2|STARTED|Period 2||12
8074610|NCT03928327|19910235|P1|STARTED|Period 2||12
8074611|NCT03928327|19910234|P2|NOT COMPLETED|Washout Period||0
8074612|NCT03928327|19910235|P1|NOT COMPLETED|Washout Period||0
8074613|NCT03928327|19910234|P2|COMPLETED|Washout Period||12
8074614|NCT03928327|19910235|P1|COMPLETED|Washout Period||12
8074615|NCT03928327|19910234|P2|STARTED|Washout Period||12
8074616|NCT03928327|19910235|P1|STARTED|Washout Period||12
8074617|NCT03928327|19910234|P2|NOT COMPLETED|Period 1||0
8074618|NCT03928327|19910235|P1|NOT COMPLETED|Period 1||0
8074619|NCT03928327|19910234|P2|COMPLETED|Period 1||12
8074620|NCT03928327|19910235|P1|COMPLETED|Period 1||12
8074621|NCT03928327|19910234|P2|STARTED|Period 1||12
8074622|NCT03928327|19910235|P1|STARTED|Period 1||12
8074623|NCT03927950|19910261|P1|NOT COMPLETED|Overall Study||9
8074624|NCT03927950|19910261|P1|COMPLETED|Overall Study||126
8074625|NCT03927950|19910261|P1|STARTED|Overall Study||135
8074626|NCT03926065|19910266|P5|NOT COMPLETED|Study Week 4||0
8074627|NCT03926065|19910267|P4|NOT COMPLETED|Study Week 4||0
8074628|NCT03926065|19910268|P3|NOT COMPLETED|Study Week 4||0
8074629|NCT03926065|19910269|P2|NOT COMPLETED|Study Week 4||0
8074630|NCT03926065|19910270|P1|NOT COMPLETED|Study Week 4||0
8074631|NCT03926065|19910266|P5|COMPLETED|Study Week 4||15
8074632|NCT03926065|19910267|P4|COMPLETED|Study Week 4||18
8074633|NCT03926065|19910268|P3|COMPLETED|Study Week 4||14
8074634|NCT03926065|19910269|P2|COMPLETED|Study Week 4||9
8074635|NCT03926065|19910270|P1|COMPLETED|Study Week 4||11
8074636|NCT03926065|19910266|P5|STARTED|Study Week 4||15
8074637|NCT03926065|19910267|P4|STARTED|Study Week 4||18
8074638|NCT03926065|19910268|P3|STARTED|Study Week 4||14
8074639|NCT03926065|19910269|P2|STARTED|Study Week 4||9
8074640|NCT03926065|19910270|P1|STARTED|Study Week 4||11
8074641|NCT03926065|19910266|P5|NOT COMPLETED|Study Week 3||0
8074642|NCT03926065|19910267|P4|NOT COMPLETED|Study Week 3||0
8074643|NCT03926065|19910268|P3|NOT COMPLETED|Study Week 3||0
8074644|NCT03926065|19910269|P2|NOT COMPLETED|Study Week 3||0
8074645|NCT03926065|19910270|P1|NOT COMPLETED|Study Week 3||0
8074646|NCT03926065|19910266|P5|COMPLETED|Study Week 3||15
8074647|NCT03926065|19910267|P4|COMPLETED|Study Week 3||18
8074648|NCT03926065|19910268|P3|COMPLETED|Study Week 3||14
8074649|NCT03926065|19910269|P2|COMPLETED|Study Week 3||9
8074650|NCT03926065|19910270|P1|COMPLETED|Study Week 3||11
8074651|NCT03926065|19910266|P5|STARTED|Study Week 3||15
8074652|NCT03926065|19910267|P4|STARTED|Study Week 3||18
8074653|NCT03926065|19910268|P3|STARTED|Study Week 3||14
8074654|NCT03926065|19910269|P2|STARTED|Study Week 3||9
8074655|NCT03926065|19910270|P1|STARTED|Study Week 3||11
8074656|NCT03926065|19910266|P5|NOT COMPLETED|Study Week 2||0
8074657|NCT03926065|19910267|P4|NOT COMPLETED|Study Week 2||0
8074658|NCT03926065|19910268|P3|NOT COMPLETED|Study Week 2||0
8074659|NCT03926065|19910269|P2|NOT COMPLETED|Study Week 2||0
8074660|NCT03926065|19910270|P1|NOT COMPLETED|Study Week 2||0
8074661|NCT03926065|19910266|P5|COMPLETED|Study Week 2||15
8074662|NCT03926065|19910267|P4|COMPLETED|Study Week 2||18
8074663|NCT03926065|19910268|P3|COMPLETED|Study Week 2||14
8074664|NCT03926065|19910269|P2|COMPLETED|Study Week 2||9
8074665|NCT03926065|19910270|P1|COMPLETED|Study Week 2||11
8074666|NCT03926065|19910266|P5|STARTED|Study Week 2||15
8074667|NCT03926065|19910267|P4|STARTED|Study Week 2||18
8074668|NCT03926065|19910268|P3|STARTED|Study Week 2||14
8074669|NCT03926065|19910269|P2|STARTED|Study Week 2||9
8074670|NCT03926065|19910270|P1|STARTED|Study Week 2||11
8074671|NCT03926065|19910266|P5|NOT COMPLETED|Study Week 1||0
8074672|NCT03926065|19910267|P4|NOT COMPLETED|Study Week 1||0
8074673|NCT03926065|19910268|P3|NOT COMPLETED|Study Week 1||0
8074674|NCT03926065|19910269|P2|NOT COMPLETED|Study Week 1||0
8074675|NCT03926065|19910270|P1|NOT COMPLETED|Study Week 1||0
8074676|NCT03926065|19910266|P5|COMPLETED|Study Week 1||15
8074677|NCT03926065|19910267|P4|COMPLETED|Study Week 1||18
8074678|NCT03926065|19910268|P3|COMPLETED|Study Week 1||14
8074679|NCT03926065|19910269|P2|COMPLETED|Study Week 1||9
8074680|NCT03926065|19910270|P1|COMPLETED|Study Week 1||11
8074681|NCT03926065|19910266|P5|STARTED|Study Week 1||15
8074682|NCT03926065|19910267|P4|STARTED|Study Week 1||18
8074683|NCT03926065|19910268|P3|STARTED|Study Week 1||14
8074684|NCT03926065|19910269|P2|STARTED|Study Week 1||9
8074685|NCT03926065|19910270|P1|STARTED|Study Week 1||11
8074686|NCT03923933|19910294|P2|NOT COMPLETED|Overall Study||1
8074687|NCT03923933|19910295|P1|NOT COMPLETED|Overall Study||1
8074688|NCT03923933|19910294|P2|COMPLETED|Overall Study||16
8074689|NCT03923933|19910295|P1|COMPLETED|Overall Study||16
8074690|NCT03923933|19910294|P2|STARTED|Overall Study||17
8074691|NCT03923933|19910295|P1|STARTED|Overall Study||17
8074692|NCT03923530|19910313|P1|NOT COMPLETED|Overall Study||4
8074693|NCT03923530|19910313|P1|COMPLETED|Overall Study||8
8074694|NCT03923530|19910313|P1|STARTED|Overall Study||12
8074710|NCT03921723|19910360|P1|NOT COMPLETED|Period 3 (4 Days)||1
8074711|NCT03921723|19910360|P1|COMPLETED|Period 3 (4 Days)||18
8074712|NCT03921723|19910360|P1|STARTED|Period 3 (4 Days)||19
8074713|NCT03921723|19910360|P1|NOT COMPLETED|Period 2 (4 Days)||3
8074714|NCT03921723|19910360|P1|COMPLETED|Period 2 (4 Days)||19
8074715|NCT03921723|19910360|P1|STARTED|Period 2 (4 Days)||22
8074716|NCT03921723|19910360|P1|NOT COMPLETED|Period 1 (4 Days)||0
8074717|NCT03921723|19910360|P1|COMPLETED|Period 1 (4 Days)||22
8074718|NCT03921723|19910360|P1|STARTED|Period 1 (4 Days)||22
8074719|NCT03921190|19910430|P2|NOT COMPLETED|Overall Study||0
8074720|NCT03921190|19910431|P1|NOT COMPLETED|Overall Study||0
8074721|NCT03921190|19910430|P2|COMPLETED|Overall Study||64
8074722|NCT03921190|19910431|P1|COMPLETED|Overall Study||56
8074723|NCT03921190|19910430|P2|STARTED|Overall Study||64
8074724|NCT03921190|19910431|P1|STARTED|Overall Study||56
8074725|NCT03919422|19910443|P2|NOT COMPLETED|Overall Study||0
8074726|NCT03919422|19910444|P1|NOT COMPLETED|Overall Study||0
8074727|NCT03919422|19910443|P2|COMPLETED|Overall Study||40
8074728|NCT03919422|19910444|P1|COMPLETED|Overall Study||40
8074729|NCT03919422|19910443|P2|STARTED|Overall Study||40
8074730|NCT03919422|19910444|P1|STARTED|Overall Study||40
8074731|NCT03918239|19910466|P2|NOT COMPLETED|Overall Study||7
8074732|NCT03918239|19910467|P1|NOT COMPLETED|Overall Study||10
8074733|NCT03918239|19910466|P2|COMPLETED|Overall Study||89
8074734|NCT03918239|19910467|P1|COMPLETED|Overall Study||84
8074735|NCT03918239|19910466|P2|STARTED|Overall Study||96
8074736|NCT03918239|19910467|P1|STARTED|Overall Study||94
8074737|NCT03914950|19910491|P1|NOT COMPLETED|Overall Study||54
8074738|NCT03914950|19910491|P1|COMPLETED|Overall Study||120
8074739|NCT03914950|19910491|P1|STARTED|Overall Study||174
8074740|NCT03914417|19910501|P1|NOT COMPLETED|Overall Study||2
8074741|NCT03914417|19910501|P1|COMPLETED|Overall Study||19
8074742|NCT03914417|19910501|P1|STARTED|Overall Study||21
8074761|NCT03911960|19910527|P2|NOT COMPLETED|Overall Study||3
8074762|NCT03911960|19910528|P1|NOT COMPLETED|Overall Study||5
8074763|NCT03911960|19910527|P2|COMPLETED|Overall Study||2
8074764|NCT03911960|19910528|P1|COMPLETED|Overall Study||4
8074765|NCT03911960|19910527|P2|STARTED|Overall Study||5
8074766|NCT03911960|19910528|P1|STARTED|Overall Study||9
8074767|NCT03911752|19910550|P3|NOT COMPLETED|Overall Study||0
8074768|NCT03911752|19910551|P2|NOT COMPLETED|Overall Study||0
8074769|NCT03911752|19910552|P1|NOT COMPLETED|Overall Study||0
8074770|NCT03911752|19910550|P3|COMPLETED|Overall Study||2
8074771|NCT03911752|19910551|P2|COMPLETED|Overall Study||2
8074772|NCT03911752|19910552|P1|COMPLETED|Overall Study||8
8074773|NCT03911752|19910550|P3|STARTED|Overall Study||2
8074774|NCT03911752|19910551|P2|STARTED|Overall Study||2
8074775|NCT03911752|19910552|P1|STARTED|Overall Study||8
8074776|NCT03911401|19910572|P3|NOT COMPLETED|Overall Study||25
8074777|NCT03911401|19910573|P2|NOT COMPLETED|Overall Study||9
8074778|NCT03911401|19910574|P1|NOT COMPLETED|Overall Study||7
8074779|NCT03911401|19910572|P3|COMPLETED|Overall Study||58
8074780|NCT03911401|19910573|P2|COMPLETED|Overall Study||76
8074781|NCT03911401|19910574|P1|COMPLETED|Overall Study||76
8074782|NCT03911401|19910572|P3|STARTED|Overall Study||83
8074783|NCT03911401|19910573|P2|STARTED|Overall Study||85
8074784|NCT03911401|19910574|P1|STARTED|Overall Study||83
8074785|NCT03909763|19910588|P1|NOT COMPLETED|Overall Study||10
8074786|NCT03909763|19910588|P1|COMPLETED|Overall Study||45
8074787|NCT03909763|19910588|P1|STARTED|Overall Study||55
8074788|NCT03909295|19910595|P1|NOT COMPLETED|Overall Study||52
8074789|NCT03909295|19910595|P1|COMPLETED|Overall Study||0
8074790|NCT03909295|19910595|P1|Safety Set (SAF)|Overall Study||52
8074791|NCT03909295|19910595|P1|STARTED|Overall Study||52
8074792|NCT03909009|19910601|P2|NOT COMPLETED|Overall Study||0
8074793|NCT03909009|19910602|P1|NOT COMPLETED|Overall Study||0
8074794|NCT03909009|19910601|P2|COMPLETED|Overall Study||10
8074795|NCT03909009|19910602|P1|COMPLETED|Overall Study||10
8074796|NCT03909009|19910601|P2|STARTED|Overall Study||10
8074797|NCT03909009|19910602|P1|STARTED|Overall Study||10
8074798|NCT03908970|19910624|P2|NOT COMPLETED|Overall Study||47
8074799|NCT03908970|19910625|P1|NOT COMPLETED|Overall Study||17
8074800|NCT03908970|19910624|P2|COMPLETED|Overall Study||135
8074801|NCT03908970|19910625|P1|COMPLETED|Overall Study||165
8074802|NCT03908970|19910624|P2|STARTED|Overall Study||182
8074803|NCT03908970|19910625|P1|STARTED|Overall Study||182
8074804|NCT03907579|19910635|P1|NOT COMPLETED|Overall Study||0
8074805|NCT03907579|19910635|P1|COMPLETED|Overall Study||100
8074806|NCT03907579|19910635|P1|STARTED|Overall Study||100
8074807|NCT03907241|19910644|P1|NOT COMPLETED|Overall Study||4
8074808|NCT03907241|19910644|P1|COMPLETED|Overall Study||23
8074809|NCT03907241|19910644|P1|STARTED|Overall Study||27
8074810|NCT03905642|19910763|P1|NOT COMPLETED|Overall Study||8
8074811|NCT03905642|19910763|P1|COMPLETED|Overall Study||41
8074812|NCT03905642|19910763|P1|STARTED|Overall Study||49
8074813|NCT03904420|19910774|P2|NOT COMPLETED|Overall Study||2
8074814|NCT03904420|19910775|P1|NOT COMPLETED|Overall Study||2
8074815|NCT03904420|19910774|P2|COMPLETED|Overall Study||0
8074816|NCT03904420|19910775|P1|COMPLETED|Overall Study||0
8074817|NCT03904420|19910774|P2|STARTED|Overall Study||2
8074818|NCT03904420|19910775|P1|STARTED|Overall Study||2
8074819|NCT03902613|19910781|P1|NOT COMPLETED|Overall Study||1
8074820|NCT03902613|19910781|P1|COMPLETED|Overall Study||0
8074821|NCT03902613|19910781|P1|STARTED|Overall Study||1
8074822|NCT03902392|19910787|P2|NOT COMPLETED|Overall Study||7
8074823|NCT03902392|19910788|P1|NOT COMPLETED|Overall Study||7
8074824|NCT03902392|19910787|P2|COMPLETED|Overall Study||18
8074825|NCT03902392|19910788|P1|COMPLETED|Overall Study||18
8074826|NCT03902392|19910787|P2|STARTED|Overall Study||25
8074827|NCT03902392|19910788|P1|STARTED|Overall Study||25
8074828|NCT03901313|19910796|P6|NOT COMPLETED|Overall Study||0
8074829|NCT03901313|19910797|P5|NOT COMPLETED|Overall Study||0
8074830|NCT03901313|19910798|P4|NOT COMPLETED|Overall Study||0
8074831|NCT03901313|19910799|P3|NOT COMPLETED|Overall Study||0
8074832|NCT03901313|19910800|P2|NOT COMPLETED|Overall Study||0
8074833|NCT03901313|19910801|P1|NOT COMPLETED|Overall Study||0
8074834|NCT03901313|19910796|P6|COMPLETED|Overall Study||4
8074835|NCT03901313|19910797|P5|COMPLETED|Overall Study||4
8074836|NCT03901313|19910798|P4|COMPLETED|Overall Study||4
8074837|NCT03901313|19910799|P3|COMPLETED|Overall Study||4
8074838|NCT03901313|19910800|P2|COMPLETED|Overall Study||4
8074839|NCT03901313|19910801|P1|COMPLETED|Overall Study||4
8074840|NCT03901313|19910796|P6|STARTED|Overall Study||4
8074841|NCT03901313|19910797|P5|STARTED|Overall Study||4
8074842|NCT03901313|19910798|P4|STARTED|Overall Study||4
8074843|NCT03901313|19910799|P3|STARTED|Overall Study||4
8074844|NCT03901313|19910800|P2|STARTED|Overall Study||4
8074845|NCT03901313|19910801|P1|STARTED|Overall Study||4
8074846|NCT03901105|19910818|P1|NOT COMPLETED|Overall Study||0
8074847|NCT03901105|19910818|P1|COMPLETED|Overall Study||205
8074848|NCT03901105|19910818|P1|STARTED|Overall Study||205
8074849|NCT03901092|19910828|P2|NOT COMPLETED|Overall Study||0
8074850|NCT03901092|19910829|P1|NOT COMPLETED|Overall Study||0
8074851|NCT03901092|19910828|P2|COMPLETED|Overall Study||159
8074852|NCT03901092|19910829|P1|COMPLETED|Overall Study||83
8074853|NCT03901092|19910828|P2|STARTED|Overall Study||159
8074854|NCT03901092|19910829|P1|STARTED|Overall Study||83
8074855|NCT03900299|19910846|P2|NOT COMPLETED|Overall Study||0
8074856|NCT03900299|19910847|P1|NOT COMPLETED|Overall Study||0
8074857|NCT03900299|19910846|P2|COMPLETED|Overall Study||58
8074858|NCT03900299|19910847|P1|COMPLETED|Overall Study||56
8074859|NCT03900299|19910846|P2|STARTED|Overall Study||58
8074860|NCT03900299|19910847|P1|STARTED|Overall Study||56
8074861|NCT03899064|19910854|P1|NOT COMPLETED|Overall Study||7
8074862|NCT03899064|19910854|P1|COMPLETED|Overall Study||51
8074863|NCT03899064|19910854|P1|Control, Irradiation|Overall Study||58
8074864|NCT03899064|19910854|P1|MC2-01 Vehicle, no Irradiation|Overall Study||58
8074865|NCT03899064|19910854|P1|MC2-01 Vehicle, Irradiation|Overall Study||58
8074866|NCT03899064|19910854|P1|MC2-01 Cream, No Irradiation|Overall Study||58
8074867|NCT03899064|19910854|P1|MC2-01 Cream, Irradiation|Overall Study||58
8074868|NCT03899064|19910854|P1|STARTED|Overall Study||58
8074869|NCT03898349|19910862|P2|NOT COMPLETED|Overall Study||610
8074870|NCT03898349|19910863|P1|NOT COMPLETED|Overall Study||110
8074871|NCT03898349|19910862|P2|COMPLETED|Overall Study||15
8074872|NCT03898349|19910863|P1|COMPLETED|Overall Study||15
8074873|NCT03898349|19910862|P2|STARTED|Overall Study||625
8074874|NCT03898349|19910863|P1|STARTED|Overall Study||125
8074875|NCT03897179|19910869|P1|NOT COMPLETED|Overall Study||1
8074876|NCT03897179|19910869|P1|COMPLETED|Overall Study||26
8074877|NCT03897179|19910869|P1|STARTED|Overall Study||27
8074887|NCT03895632|19910890|P1|NOT COMPLETED|Overall Study||0
8074888|NCT03895632|19910890|P1|COMPLETED|Overall Study||25
8074889|NCT03895632|19910890|P1|STARTED|Overall Study||25
8074902|NCT03894449|19910996|P5|NOT COMPLETED|Overall Study||0
8074903|NCT03894449|19910997|P4|NOT COMPLETED|Overall Study||0
8074904|NCT03894449|19910998|P3|NOT COMPLETED|Overall Study||0
8074905|NCT03894449|19910999|P2|NOT COMPLETED|Overall Study||0
8074906|NCT03894449|19911000|P1|NOT COMPLETED|Overall Study||0
8074907|NCT03894449|19910996|P5|COMPLETED|Overall Study||15
8074908|NCT03894449|19910997|P4|COMPLETED|Overall Study||15
8074909|NCT03894449|19910998|P3|COMPLETED|Overall Study||15
8074910|NCT03894449|19910999|P2|COMPLETED|Overall Study||15
8074911|NCT03894449|19911000|P1|COMPLETED|Overall Study||15
8074912|NCT03894449|19910996|P5|STARTED|Overall Study||15
8074913|NCT03894449|19910997|P4|STARTED|Overall Study||15
8074914|NCT03894449|19910998|P3|STARTED|Overall Study||15
8074915|NCT03894449|19910999|P2|STARTED|Overall Study||15
8074916|NCT03894449|19911000|P1|STARTED|Overall Study||15
8074917|NCT03892564|19911112|P1|NOT COMPLETED|Overall Study||2
8074918|NCT03892564|19911112|P1|COMPLETED|Overall Study||33
8074919|NCT03892564|19911112|P1|Control Site|Overall Study||35
8074920|NCT03892564|19911112|P1|MC2-01 Vehicle + Non-irridiation|Overall Study||35
8074921|NCT03892564|19911112|P1|MC2-01 Vehicle + Irridiation|Overall Study||35
8074922|NCT03892564|19911112|P1|MC2-01 Cream + Non-irridiation|Overall Study||35
8074923|NCT03892564|19911112|P1|MC2-01 Cream + Irridiation|Overall Study||35
8074924|NCT03892564|19911112|P1|STARTED|Overall Study||35
8074925|NCT03891641|19911120|P2|NOT COMPLETED|Overall Study||2
8074926|NCT03891641|19911121|P1|NOT COMPLETED|Overall Study||2
8074927|NCT03891641|19911120|P2|COMPLETED|Overall Study||5
8074928|NCT03891641|19911121|P1|COMPLETED|Overall Study||8
8074929|NCT03891641|19911120|P2|STARTED|Overall Study||7
8074930|NCT03891641|19911121|P1|STARTED|Overall Study||10
8074931|NCT03889444|19911133|P1|NOT COMPLETED|Overall Study||0
8074932|NCT03889444|19911133|P1|COMPLETED|Overall Study||141
8074933|NCT03889444|19911133|P1|STARTED|Overall Study||141
8074934|NCT03889028|19911146|P3|NOT COMPLETED|Overall Study||0
8074935|NCT03889028|19911147|P2|NOT COMPLETED|Overall Study||0
8074936|NCT03889028|19911148|P1|NOT COMPLETED|Overall Study||0
8074937|NCT03889028|19911146|P3|COMPLETED|Overall Study||312
8074938|NCT03889028|19911147|P2|COMPLETED|Overall Study||422
8074939|NCT03889028|19911148|P1|COMPLETED|Overall Study||144
8074940|NCT03889028|19911146|P3|STARTED|Overall Study||312
8074941|NCT03889028|19911147|P2|STARTED|Overall Study||422
8074942|NCT03889028|19911148|P1|STARTED|Overall Study||144
8074946|NCT03888482|19911182|P2|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
8074947|NCT03888482|19911183|P1|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
8074948|NCT03888482|19911182|P2|COMPLETED|Second Wear (8 -1/+2 Days)||74
8074949|NCT03888482|19911183|P1|COMPLETED|Second Wear (8 -1/+2 Days)||73
8074950|NCT03888482|19911182|P2|STARTED|Second Wear (8 -1/+2 Days)||75
8074951|NCT03888482|19911183|P1|STARTED|Second Wear (8 -1/+2 Days)|2 subjects were discontinued between Treatment 1 and Treatment 2.|74
8074952|NCT03888482|19911182|P2|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
8074953|NCT03888482|19911183|P1|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
8074954|NCT03888482|19911182|P2|COMPLETED|First Wear Period (8 -1/+2 Days)||75
8074955|NCT03888482|19911183|P1|COMPLETED|First Wear Period (8 -1/+2 Days)||76
8074956|NCT03888482|19911182|P2|STARTED|First Wear Period (8 -1/+2 Days)||75
8074957|NCT03888482|19911183|P1|STARTED|First Wear Period (8 -1/+2 Days)||76
8074958|NCT03888469|19911193|P2|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
8074959|NCT03888469|19911194|P1|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
8074960|NCT03888469|19911193|P2|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
8074961|NCT03888469|19911194|P1|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
8074962|NCT03888469|19911193|P2|STARTED|Second Wear Period (8 -1/+2 Days)||46
8074963|NCT03888469|19911194|P1|STARTED|Second Wear Period (8 -1/+2 Days)||46
8074964|NCT03888469|19911193|P2|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
8074965|NCT03888469|19911194|P1|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
8074966|NCT03888469|19911193|P2|COMPLETED|First Wear Period (8 -1/+2 Days)||46
8074967|NCT03888469|19911194|P1|COMPLETED|First Wear Period (8 -1/+2 Days)||46
8074968|NCT03888469|19911193|P2|STARTED|First Wear Period (8 -1/+2 Days)||46
8074969|NCT03888469|19911194|P1|STARTED|First Wear Period (8 -1/+2 Days)||46
8074970|NCT03888391|19911202|P1|NOT COMPLETED|Overall Study||15
8074971|NCT03888391|19911202|P1|COMPLETED|Overall Study||3
8074972|NCT03888391|19911202|P1|STARTED|Overall Study||18
8074973|NCT03888274|19911212|P1|NOT COMPLETED|Overall Study||0
8074974|NCT03888274|19911212|P1|COMPLETED|Overall Study||30
8074975|NCT03888274|19911212|P1|STARTED|Overall Study||30
8074976|NCT03887442|19911220|P2|NOT COMPLETED|Overall Study||0
8074977|NCT03887442|19911221|P1|NOT COMPLETED|Overall Study||1
8074978|NCT03887442|19911220|P2|COMPLETED|Overall Study||8
8074979|NCT03887442|19911221|P1|COMPLETED|Overall Study||8
8074980|NCT03887442|19911220|P2|STARTED|Overall Study||8
8074981|NCT03887442|19911221|P1|STARTED|Overall Study||9
8074982|NCT03887429|19911239|P4|NOT COMPLETED|Overall Study||1
8074983|NCT03887429|19911240|P3|NOT COMPLETED|Overall Study||2
8074984|NCT03887429|19911241|P2|NOT COMPLETED|Overall Study||1
8074985|NCT03887429|19911242|P1|NOT COMPLETED|Overall Study||1
8074986|NCT03887429|19911239|P4|COMPLETED|Overall Study||7
8074987|NCT03887429|19911240|P3|COMPLETED|Overall Study||7
8074988|NCT03887429|19911241|P2|COMPLETED|Overall Study||8
8074989|NCT03887429|19911242|P1|COMPLETED|Overall Study||7
8074990|NCT03887429|19911239|P4|Completed Second Intervention (5 Days)|Overall Study||7
8074991|NCT03887429|19911240|P3|Completed Second Intervention (5 Days)|Overall Study||7
8074992|NCT03887429|19911241|P2|Completed Second Intervention (5 Days)|Overall Study||8
8074993|NCT03887429|19911242|P1|Completed Second Intervention (5 Days)|Overall Study||7
8074994|NCT03887429|19911239|P4|Completed Washout (9 Days)|Overall Study||7
8074995|NCT03887429|19911240|P3|Completed Washout (9 Days)|Overall Study||7
8074996|NCT03887429|19911241|P2|Completed Washout (9 Days)|Overall Study||8
8074997|NCT03887429|19911242|P1|Completed Washout (9 Days)|Overall Study||7
8074998|NCT03887429|19911239|P4|Completed First Intervention (5 Days)|Overall Study||7
8074999|NCT03887429|19911240|P3|Completed First Intervention (5 Days)|Overall Study||7
8075000|NCT03887429|19911241|P2|Completed First Intervention (5 Days)|Overall Study||8
8075001|NCT03887429|19911242|P1|Completed First Intervention (5 Days)|Overall Study||7
8075002|NCT03887429|19911239|P4|STARTED|Overall Study||8
8075003|NCT03887429|19911240|P3|STARTED|Overall Study||9
8075004|NCT03887429|19911241|P2|STARTED|Overall Study||9
8075005|NCT03887429|19911242|P1|STARTED|Overall Study||8
8075006|NCT03887286|19911266|P1|NOT COMPLETED|Overall Study||0
8075007|NCT03887286|19911266|P1|COMPLETED|Overall Study||47
8075008|NCT03887286|19911266|P1|STARTED|Overall Study||47
8075009|NCT03886701|19911271|P1|NOT COMPLETED|Period 2: Study Days 7-21||0
8075010|NCT03886701|19911271|P1|COMPLETED|Period 2: Study Days 7-21||11
8075011|NCT03886701|19911271|P1|STARTED|Period 2: Study Days 7-21||11
8075012|NCT03886701|19911271|P1|NOT COMPLETED|Period 1: Study Days 1-4||0
8075013|NCT03886701|19911271|P1|COMPLETED|Period 1: Study Days 1-4||11
8075014|NCT03886701|19911271|P1|STARTED|Period 1: Study Days 1-4||11
8075015|NCT03885726|19911283|P1|NOT COMPLETED|Overall Study||4
8075016|NCT03885726|19911283|P1|COMPLETED|Overall Study||28
8075017|NCT03885726|19911283|P1|STARTED|Overall Study||32
8075018|NCT03883386|19911349|P2|NOT COMPLETED|Washout and Second Assignment||0
8075019|NCT03883386|19911350|P1|NOT COMPLETED|Washout and Second Assignment||0
8075020|NCT03883386|19911349|P2|COMPLETED|Washout and Second Assignment||0
8075021|NCT03883386|19911350|P1|COMPLETED|Washout and Second Assignment||0
8075022|NCT03883386|19911349|P2|STARTED|Washout and Second Assignment||0
8075023|NCT03883386|19911350|P1|STARTED|Washout and Second Assignment||0
8075024|NCT03883386|19911349|P2|NOT COMPLETED|First Assignment||1
8075025|NCT03883386|19911350|P1|NOT COMPLETED|First Assignment||2
8075026|NCT03883386|19911349|P2|COMPLETED|First Assignment||0
8075027|NCT03883386|19911350|P1|COMPLETED|First Assignment||0
8075028|NCT03883386|19911349|P2|Surveys Begun|First Assignment||1
8075029|NCT03883386|19911350|P1|Surveys Begun|First Assignment||1
8075030|NCT03883386|19911349|P2|STARTED|First Assignment||1
8075031|NCT03883386|19911350|P1|STARTED|First Assignment||2
8075032|NCT03882801|19911360|P2|NOT COMPLETED|Period 2||1
8075033|NCT03882801|19911361|P1|NOT COMPLETED|Period 2||0
8075034|NCT03882801|19911360|P2|COMPLETED|Period 2||8
8075035|NCT03882801|19911361|P1|COMPLETED|Period 2||10
8075036|NCT03882801|19911360|P2|STARTED|Period 2||9
8075037|NCT03882801|19911361|P1|STARTED|Period 2||10
8075038|NCT03882801|19911360|P2|NOT COMPLETED|Washout Period||1
8075039|NCT03882801|19911361|P1|NOT COMPLETED|Washout Period||0
8075040|NCT03882801|19911360|P2|COMPLETED|Washout Period||9
8075041|NCT03882801|19911361|P1|COMPLETED|Washout Period||10
8075042|NCT03882801|19911360|P2|STARTED|Washout Period||10
8075043|NCT03882801|19911361|P1|STARTED|Washout Period||10
8075044|NCT03882801|19911360|P2|NOT COMPLETED|Period 1||2
8075045|NCT03882801|19911361|P1|NOT COMPLETED|Period 1||2
8075046|NCT03882801|19911360|P2|COMPLETED|Period 1||10
8075047|NCT03882801|19911361|P1|COMPLETED|Period 1||10
8075048|NCT03882801|19911360|P2|Treated|Period 1||12
8075049|NCT03882801|19911361|P1|Treated|Period 1|1 participant did not receive any dose of study drug|11
8075050|NCT03882801|19911360|P2|STARTED|Period 1||12
8075051|NCT03882801|19911361|P1|STARTED|Period 1||12
8075052|NCT03882424|19911376|P3|NOT COMPLETED|Overall Study||0
8075053|NCT03882424|19911377|P2|NOT COMPLETED|Overall Study||0
8075054|NCT03882424|19911378|P1|NOT COMPLETED|Overall Study||4
8075055|NCT03882424|19911376|P3|COMPLETED|Overall Study||38
8075056|NCT03882424|19911377|P2|COMPLETED|Overall Study||38
8075057|NCT03882424|19911378|P1|COMPLETED|Overall Study||34
8075058|NCT03882424|19911376|P3|STARTED|Overall Study||38
8075059|NCT03882424|19911377|P2|STARTED|Overall Study||38
8075060|NCT03882424|19911378|P1|STARTED|Overall Study||38
8075061|NCT03882047|19911401|P3|NOT COMPLETED|Overall Study||16
8075062|NCT03882047|19911402|P2|NOT COMPLETED|Overall Study||10
8075063|NCT03882047|19911403|P1|NOT COMPLETED|Overall Study||6
8075064|NCT03882047|19911401|P3|COMPLETED|Overall Study||88
8075065|NCT03882047|19911402|P2|COMPLETED|Overall Study||95
8075066|NCT03882047|19911403|P1|COMPLETED|Overall Study||98
8075067|NCT03882047|19911401|P3|Treated|Overall Study||103
8075068|NCT03882047|19911402|P2|Treated|Overall Study||104
8075069|NCT03882047|19911403|P1|Treated|Overall Study||104
8075070|NCT03882047|19911401|P3|STARTED|Overall Study||104
8075071|NCT03882047|19911402|P2|STARTED|Overall Study||105
8075072|NCT03882047|19911403|P1|STARTED|Overall Study||104
8075073|NCT03881670|19911443|P2|NOT COMPLETED|Overall Study||0
8075074|NCT03881670|19911444|P1|NOT COMPLETED|Overall Study||0
8075075|NCT03881670|19911443|P2|COMPLETED|Overall Study||12
8075076|NCT03881670|19911444|P1|COMPLETED|Overall Study||12
8075077|NCT03881670|19911443|P2|Completed Second Intervetion|Overall Study||12
8075078|NCT03881670|19911444|P1|Completed Second Intervetion|Overall Study||12
8075079|NCT03881670|19911443|P2|Completed First Intervention|Overall Study||12
8075080|NCT03881670|19911444|P1|Completed First Intervention|Overall Study||12
8075081|NCT03881670|19911443|P2|STARTED|Overall Study||12
8075082|NCT03881670|19911444|P1|STARTED|Overall Study||12
8075086|NCT03879772|19911480|P5|NOT COMPLETED|Overall Study||8
8075087|NCT03879772|19911481|P4|NOT COMPLETED|Overall Study||8
8075088|NCT03879772|19911482|P3|NOT COMPLETED|Overall Study||10
8075089|NCT03879772|19911483|P2|NOT COMPLETED|Overall Study||3
8075090|NCT03879772|19911484|P1|NOT COMPLETED|Overall Study||4
8075091|NCT03879772|19911480|P5|COMPLETED|Overall Study||128
8075092|NCT03879772|19911481|P4|COMPLETED|Overall Study||130
8075093|NCT03879772|19911482|P3|COMPLETED|Overall Study||123
8075094|NCT03879772|19911483|P2|COMPLETED|Overall Study||132
8075095|NCT03879772|19911484|P1|COMPLETED|Overall Study||133
8075096|NCT03879772|19911480|P5|STARTED|Overall Study||136
8075097|NCT03879772|19911481|P4|STARTED|Overall Study||138
8075098|NCT03879772|19911482|P3|STARTED|Overall Study||133
8075099|NCT03879772|19911483|P2|STARTED|Overall Study||135
8075100|NCT03879772|19911484|P1|STARTED|Overall Study||137
8075101|NCT03878758|19911521|P1|NOT COMPLETED|Overall Study||4
8075102|NCT03878758|19911521|P1|COMPLETED|Overall Study||154
8075103|NCT03878758|19911521|P1|STARTED|Overall Study||158
8075104|NCT03878745|19911544|P1|NOT COMPLETED|Overall Study||0
8075105|NCT03878745|19911544|P1|COMPLETED|Overall Study||55
8075106|NCT03878745|19911544|P1|STARTED|Overall Study||55
8075107|NCT03877432|19911558|P1|NOT COMPLETED|Overall Study||0
8075108|NCT03877432|19911558|P1|COMPLETED|Overall Study||10
8075109|NCT03877432|19911558|P1|STARTED|Overall Study||10
8075110|NCT03876743|19911570|P4|NOT COMPLETED|Overall Study||7
8075111|NCT03876743|19911571|P3|NOT COMPLETED|Overall Study||4
8075112|NCT03876743|19911572|P2|NOT COMPLETED|Overall Study||4
8075113|NCT03876743|19911573|P1|NOT COMPLETED|Overall Study||6
8075114|NCT03876743|19911570|P4|COMPLETED|Overall Study||43
8075115|NCT03876743|19911571|P3|COMPLETED|Overall Study||42
8075116|NCT03876743|19911572|P2|COMPLETED|Overall Study||47
8075117|NCT03876743|19911573|P1|COMPLETED|Overall Study||48
8075118|NCT03876743|19911570|P4|STARTED|Overall Study||50
8075119|NCT03876743|19911571|P3|STARTED|Overall Study||46
8075120|NCT03876743|19911572|P2|STARTED|Overall Study||51
8075121|NCT03876743|19911573|P1|STARTED|Overall Study||54
8075122|NCT03875664|19911637|P2|NOT COMPLETED|Overall Study||0
8075123|NCT03875664|19911638|P1|NOT COMPLETED|Overall Study||0
8075124|NCT03875664|19911637|P2|COMPLETED|Overall Study|Vaginal surgery n=18; vaginal + abdominal surgery n=17|35
8075125|NCT03875664|19911638|P1|COMPLETED|Overall Study|vaginal surgery n=18; vaginal + abdominal surgery n=19|37
8075126|NCT03875664|19911637|P2|STARTED|Overall Study||35
8075127|NCT03875664|19911638|P1|STARTED|Overall Study||37
8075128|NCT03870997|19911668|P6|NOT COMPLETED|Overall Study||10531
8075129|NCT03870997|19911669|P5|NOT COMPLETED|Overall Study||10588
8075130|NCT03870997|19911670|P4|NOT COMPLETED|Overall Study||10947
8075131|NCT03870997|19911671|P3|NOT COMPLETED|Overall Study||10978
8075132|NCT03870997|19911672|P2|NOT COMPLETED|Overall Study||10431
8075133|NCT03870997|19911673|P1|NOT COMPLETED|Overall Study||10544
8075134|NCT03870997|19911668|P6|COMPLETED|Overall Study||5171
8075135|NCT03870997|19911669|P5|COMPLETED|Overall Study||5114
8075136|NCT03870997|19911670|P4|COMPLETED|Overall Study||4810
8075137|NCT03870997|19911671|P3|COMPLETED|Overall Study||4778
8075138|NCT03870997|19911672|P2|COMPLETED|Overall Study||5271
8075139|NCT03870997|19911673|P1|COMPLETED|Overall Study||5158
8075140|NCT03870997|19911668|P6|STARTED|Overall Study||15702
8075141|NCT03870997|19911669|P5|STARTED|Overall Study||15702
8075142|NCT03870997|19911670|P4|STARTED|Overall Study||15757
8075143|NCT03870997|19911671|P3|STARTED|Overall Study||15756
8075144|NCT03870997|19911672|P2|STARTED|Overall Study||15702
8075145|NCT03870997|19911673|P1|STARTED|Overall Study||15702
8075146|NCT03870893|19911684|P2|NOT COMPLETED|Overall Study||1
8075147|NCT03870893|19911685|P1|NOT COMPLETED|Overall Study||0
8075148|NCT03870893|19911684|P2|COMPLETED|Overall Study||23
8075149|NCT03870893|19911685|P1|COMPLETED|Overall Study||23
8075150|NCT03870893|19911684|P2|STARTED|Overall Study||24
8075151|NCT03870893|19911685|P1|STARTED|Overall Study||23
8075152|NCT03870737|19911727|P1|NOT COMPLETED|Overall Study||2
8075153|NCT03870737|19911727|P1|COMPLETED|Overall Study||20
8075154|NCT03870737|19911727|P1|STARTED|Overall Study||22
8075155|NCT03870555|19911740|P3|NOT COMPLETED|Period 3 (2 Days)||0
8075156|NCT03870555|19911741|P2|NOT COMPLETED|Period 3 (2 Days)||0
8075157|NCT03870555|19911742|P1|NOT COMPLETED|Period 3 (2 Days)||1
8075158|NCT03870555|19911740|P3|COMPLETED|Period 3 (2 Days)||2
8075159|NCT03870555|19911741|P2|COMPLETED|Period 3 (2 Days)||2
8075160|NCT03870555|19911742|P1|COMPLETED|Period 3 (2 Days)||1
8075161|NCT03870555|19911740|P3|STARTED|Period 3 (2 Days)||2
8075162|NCT03870555|19911741|P2|STARTED|Period 3 (2 Days)||2
8075163|NCT03870555|19911742|P1|STARTED|Period 3 (2 Days)||2
8075164|NCT03870555|19911740|P3|NOT COMPLETED|Washout Period (at Least 16 Days)||0
8075165|NCT03870555|19911741|P2|NOT COMPLETED|Washout Period (at Least 16 Days)||0
8075166|NCT03870555|19911742|P1|NOT COMPLETED|Washout Period (at Least 16 Days)||0
8075167|NCT03870555|19911740|P3|COMPLETED|Washout Period (at Least 16 Days)||2
8075168|NCT03870555|19911741|P2|COMPLETED|Washout Period (at Least 16 Days)||2
8075169|NCT03870555|19911742|P1|COMPLETED|Washout Period (at Least 16 Days)||2
8075170|NCT03870555|19911740|P3|STARTED|Washout Period (at Least 16 Days)||2
8075171|NCT03870555|19911741|P2|STARTED|Washout Period (at Least 16 Days)||2
8075172|NCT03870555|19911742|P1|STARTED|Washout Period (at Least 16 Days)||2
8075173|NCT03870555|19911740|P3|NOT COMPLETED|Period 2 (2 Days)||0
8075174|NCT03870555|19911741|P2|NOT COMPLETED|Period 2 (2 Days)||0
8075175|NCT03870555|19911742|P1|NOT COMPLETED|Period 2 (2 Days)||0
8075176|NCT03870555|19911740|P3|COMPLETED|Period 2 (2 Days)||2
8075177|NCT03870555|19911741|P2|COMPLETED|Period 2 (2 Days)||2
8075178|NCT03870555|19911742|P1|COMPLETED|Period 2 (2 Days)||2
8075179|NCT03870555|19911740|P3|STARTED|Period 2 (2 Days)||2
8075180|NCT03870555|19911741|P2|STARTED|Period 2 (2 Days)||2
8075181|NCT03870555|19911742|P1|STARTED|Period 2 (2 Days)||2
8075182|NCT03870555|19911740|P3|NOT COMPLETED|Washout Period (at Least 16 Days)||0
8075183|NCT03870555|19911741|P2|NOT COMPLETED|Washout Period (at Least 16 Days)||0
8075184|NCT03870555|19911742|P1|NOT COMPLETED|Washout Period (at Least 16 Days)||0
8075185|NCT03870555|19911740|P3|COMPLETED|Washout Period (at Least 16 Days)||2
8075186|NCT03870555|19911741|P2|COMPLETED|Washout Period (at Least 16 Days)||2
8075187|NCT03870555|19911742|P1|COMPLETED|Washout Period (at Least 16 Days)||2
8075188|NCT03870555|19911740|P3|STARTED|Washout Period (at Least 16 Days)||2
8075189|NCT03870555|19911741|P2|STARTED|Washout Period (at Least 16 Days)||2
8075190|NCT03870555|19911742|P1|STARTED|Washout Period (at Least 16 Days)||2
8075191|NCT03870555|19911740|P3|NOT COMPLETED|Period 1 (2 Days)||0
8075192|NCT03870555|19911741|P2|NOT COMPLETED|Period 1 (2 Days)||0
8075193|NCT03870555|19911742|P1|NOT COMPLETED|Period 1 (2 Days)||0
8075194|NCT03870555|19911740|P3|COMPLETED|Period 1 (2 Days)||2
8075195|NCT03870555|19911741|P2|COMPLETED|Period 1 (2 Days)||2
8075196|NCT03870555|19911742|P1|COMPLETED|Period 1 (2 Days)||2
8075197|NCT03870555|19911740|P3|STARTED|Period 1 (2 Days)||2
8075198|NCT03870555|19911741|P2|STARTED|Period 1 (2 Days)||2
8075199|NCT03870555|19911742|P1|STARTED|Period 1 (2 Days)||2
8075200|NCT03869450|19911810|P3|NOT COMPLETED|Overall Study||0
8075201|NCT03869450|19911811|P2|NOT COMPLETED|Overall Study||2
8075202|NCT03869450|19911812|P1|NOT COMPLETED|Overall Study||1
8075203|NCT03869450|19911810|P3|COMPLETED|Overall Study||34
8075204|NCT03869450|19911811|P2|COMPLETED|Overall Study||23
8075205|NCT03869450|19911812|P1|COMPLETED|Overall Study||30
8075206|NCT03869450|19911810|P3|STARTED|Overall Study||34
8075207|NCT03869450|19911811|P2|STARTED|Overall Study||25
8075208|NCT03869450|19911812|P1|STARTED|Overall Study||31
8075209|NCT03868631|19911828|P2|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1
8075210|NCT03868631|19911829|P1|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4
8075211|NCT03868631|19911828|P2|COMPLETED|Week 6 to Week 12 (Study Completion)||26
8075212|NCT03868631|19911829|P1|COMPLETED|Week 6 to Week 12 (Study Completion)||22
8075213|NCT03868631|19911828|P2|STARTED|Week 6 to Week 12 (Study Completion)||27
8075214|NCT03868631|19911829|P1|STARTED|Week 6 to Week 12 (Study Completion)||26
8075215|NCT03868631|19911828|P2|NOT COMPLETED|Baseline to Week 6||4
8075216|NCT03868631|19911829|P1|NOT COMPLETED|Baseline to Week 6||4
8075217|NCT03868631|19911828|P2|COMPLETED|Baseline to Week 6||27
8075218|NCT03868631|19911829|P1|COMPLETED|Baseline to Week 6||26
8075219|NCT03868631|19911828|P2|STARTED|Baseline to Week 6||31
8075220|NCT03868631|19911829|P1|STARTED|Baseline to Week 6||30
8075221|NCT03868254|19911843|P2|NOT COMPLETED|Overall Study||0
8075222|NCT03868254|19911844|P1|NOT COMPLETED|Overall Study||0
8075223|NCT03868254|19911843|P2|COMPLETED|Overall Study||76
8075224|NCT03868254|19911844|P1|COMPLETED|Overall Study||98
8075225|NCT03868254|19911843|P2|STARTED|Overall Study||76
8075226|NCT03868254|19911844|P1|STARTED|Overall Study||98
8075230|NCT03865446|19911884|P2|NOT COMPLETED|Overall Study||0
8075231|NCT03865446|19911885|P1|NOT COMPLETED|Overall Study||0
8075232|NCT03865446|19911884|P2|COMPLETED|Overall Study||8
8075233|NCT03865446|19911885|P1|COMPLETED|Overall Study||8
8075234|NCT03865446|19911884|P2|STARTED|Overall Study||8
8075235|NCT03865446|19911885|P1|STARTED|Overall Study||8
8075236|NCT03865329|19911905|P1|NOT COMPLETED|Overall Study||0
8075237|NCT03865329|19911905|P1|COMPLETED|Overall Study||9
8075238|NCT03865329|19911905|P1|STARTED|Overall Study||9
8075239|NCT03864653|19911917|P1|NOT COMPLETED|Overall Study||1
8075240|NCT03864653|19911917|P1|COMPLETED|Overall Study||38
8075241|NCT03864653|19911917|P1|STARTED|Overall Study||39
8075242|NCT03864627|19911924|P2|NOT COMPLETED|Overall Study||12
8075243|NCT03864627|19911925|P1|NOT COMPLETED|Overall Study||4
8075244|NCT03864627|19911924|P2|COMPLETED|Overall Study||10
8075245|NCT03864627|19911925|P1|COMPLETED|Overall Study||7
8075246|NCT03864627|19911924|P2|STARTED|Overall Study||22
8075247|NCT03864627|19911925|P1|STARTED|Overall Study||11
8075248|NCT03863210|19911934|P1|NOT COMPLETED|Overall Study||2
8075249|NCT03863210|19911934|P1|COMPLETED|Overall Study|September 1st, 2014.|102
8075250|NCT03863210|19911934|P1|STARTED|Overall Study|March 1st, 2014.|104
8075251|NCT03862040|19911943|P1|NOT COMPLETED|Overall Study||0
8075252|NCT03862040|19911943|P1|COMPLETED|Overall Study||7
8075253|NCT03862040|19911943|P1|STARTED|Overall Study||7
8075254|NCT03861845|19911951|P3|NOT COMPLETED|Overall Study||0
8075255|NCT03861845|19911952|P2|NOT COMPLETED|Overall Study||0
8075256|NCT03861845|19911953|P1|NOT COMPLETED|Overall Study||0
8075257|NCT03861845|19911951|P3|COMPLETED|Overall Study||4
8075258|NCT03861845|19911952|P2|COMPLETED|Overall Study||5
8075259|NCT03861845|19911953|P1|COMPLETED|Overall Study||6
8075260|NCT03861845|19911951|P3|STARTED|Overall Study||4
8075261|NCT03861845|19911952|P2|STARTED|Overall Study||5
8075262|NCT03861845|19911953|P1|STARTED|Overall Study||6
8075263|NCT03861559|19911969|P2|NOT COMPLETED|Overall Study||5
8075264|NCT03861559|19911970|P1|NOT COMPLETED|Overall Study||2
8075265|NCT03861559|19911969|P2|COMPLETED|Overall Study||95
8075266|NCT03861559|19911970|P1|COMPLETED|Overall Study||99
8075267|NCT03861559|19911969|P2|STARTED|Overall Study||100
8075268|NCT03861559|19911970|P1|STARTED|Overall Study||101
8075269|NCT03860753|19912018|P2|NOT COMPLETED|Overall Study||0
8075270|NCT03860753|19912019|P1|NOT COMPLETED|Overall Study||0
8075271|NCT03860753|19912018|P2|COMPLETED|Overall Study||0
8075272|NCT03860753|19912019|P1|COMPLETED|Overall Study||4
8075273|NCT03860753|19912018|P2|STARTED|Overall Study||0
8075274|NCT03860753|19912019|P1|STARTED|Overall Study||4
8075275|NCT03859960|19912039|P2|NOT COMPLETED|Overall Study||0
8075276|NCT03859960|19912040|P1|NOT COMPLETED|Overall Study||0
8075277|NCT03859960|19912039|P2|COMPLETED|Overall Study||19
8075278|NCT03859960|19912040|P1|COMPLETED|Overall Study||14
8075279|NCT03859960|19912039|P2|STARTED|Overall Study||19
8075280|NCT03859960|19912040|P1|STARTED|Overall Study||14
8075281|NCT03859622|19912056|P1|NOT COMPLETED|Overall Study||0
8075282|NCT03859622|19912056|P1|COMPLETED|Overall Study||289
8075283|NCT03859622|19912056|P1|STARTED|Overall Study||289
8075284|NCT03858894|19912066|P2|NOT COMPLETED|Overall Study||0
8075285|NCT03858894|19912067|P1|NOT COMPLETED|Overall Study||4
8075286|NCT03858894|19912066|P2|COMPLETED|Overall Study||50
8075287|NCT03858894|19912067|P1|COMPLETED|Overall Study||44
8075288|NCT03858894|19912066|P2|STARTED|Overall Study||50
8075289|NCT03858894|19912067|P1|STARTED|Overall Study||48
8075290|NCT03858335|19912087|P2|NOT COMPLETED|Overall Study||4
8075291|NCT03858335|19912088|P1|NOT COMPLETED|Overall Study||4
8075292|NCT03858335|19912087|P2|COMPLETED|Overall Study||12
8075293|NCT03858335|19912088|P1|COMPLETED|Overall Study||12
8075294|NCT03858335|19912087|P2|STARTED|Overall Study||16
8075295|NCT03858335|19912088|P1|STARTED|Overall Study||16
8075296|NCT03857750|19912108|P2|NOT COMPLETED|Overall Study||0
8075297|NCT03857750|19912109|P1|NOT COMPLETED|Overall Study||0
8075298|NCT03857750|19912108|P2|COMPLETED|Overall Study||16
8075299|NCT03857750|19912109|P1|COMPLETED|Overall Study||16
8075300|NCT03857750|19912108|P2|STARTED|Overall Study||16
8075301|NCT03857750|19912109|P1|STARTED|Overall Study||16
8075302|NCT03857243|19912121|P2|NOT COMPLETED|Overall Study||0
8075303|NCT03857243|19912122|P1|NOT COMPLETED|Overall Study||0
8075304|NCT03857243|19912121|P2|COMPLETED|Overall Study||1
8075305|NCT03857243|19912122|P1|COMPLETED|Overall Study||1
8075306|NCT03857243|19912121|P2|STARTED|Overall Study||1
8075307|NCT03857243|19912122|P1|STARTED|Overall Study||1
8075308|NCT03857230|19912134|P2|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
8075309|NCT03857230|19912135|P1|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
8075310|NCT03857230|19912134|P2|COMPLETED|Period 2 (Gonal-F-Primapur)||12
8075311|NCT03857230|19912135|P1|COMPLETED|Period 2 (Gonal-F-Primapur)||12
8075312|NCT03857230|19912134|P2|STARTED|Period 2 (Gonal-F-Primapur)||12
8075313|NCT03857230|19912135|P1|STARTED|Period 2 (Gonal-F-Primapur)||12
8075314|NCT03857230|19912134|P2|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
8075315|NCT03857230|19912135|P1|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
8075316|NCT03857230|19912134|P2|COMPLETED|Period 1 (Primapur-Gonal-F)||12
8075317|NCT03857230|19912135|P1|COMPLETED|Period 1 (Primapur-Gonal-F)||12
8075318|NCT03857230|19912134|P2|STARTED|Period 1 (Primapur-Gonal-F)||12
8075319|NCT03857230|19912135|P1|STARTED|Period 1 (Primapur-Gonal-F)||12
8075320|NCT03856164|19912151|P2|NOT COMPLETED|Overall Study||0
8075321|NCT03856164|19912152|P1|NOT COMPLETED|Overall Study||0
8075322|NCT03856164|19912151|P2|COMPLETED|Overall Study||55
8075323|NCT03856164|19912152|P1|COMPLETED|Overall Study||55
8075324|NCT03856164|19912151|P2|STARTED|Overall Study||55
8075325|NCT03856164|19912152|P1|STARTED|Overall Study||55
8075326|NCT03855228|19912174|P4|NOT COMPLETED|Overall Study||19
8075327|NCT03855228|19912175|P3|NOT COMPLETED|Overall Study||8
8075328|NCT03855228|19912176|P2|NOT COMPLETED|Overall Study||9
8075329|NCT03855228|19912177|P1|NOT COMPLETED|Overall Study||3
8075330|NCT03855228|19912174|P4|COMPLETED|Overall Study||158
8075331|NCT03855228|19912175|P3|COMPLETED|Overall Study||174
8075332|NCT03855228|19912176|P2|COMPLETED|Overall Study||167
8075333|NCT03855228|19912177|P1|COMPLETED|Overall Study||166
8075334|NCT03855228|19912174|P4|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176
8075335|NCT03855228|19912175|P3|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181
8075336|NCT03855228|19912176|P2|Treated|Overall Study||176
8075337|NCT03855228|19912177|P1|Treated|Overall Study||169
8075338|NCT03855228|19912174|P4|STARTED|Overall Study||177
8075339|NCT03855228|19912175|P3|STARTED|Overall Study||182
8075340|NCT03855228|19912176|P2|STARTED|Overall Study||176
8075341|NCT03855228|19912177|P1|STARTED|Overall Study||169
8075342|NCT03855189|19912226|P3|NOT COMPLETED|Overall Study||6
8075343|NCT03855189|19912227|P2|NOT COMPLETED|Overall Study||7
8075344|NCT03855189|19912228|P1|NOT COMPLETED|Overall Study||10
8075345|NCT03855189|19912226|P3|COMPLETED|Overall Study||110
8075346|NCT03855189|19912227|P2|COMPLETED|Overall Study||109
8075347|NCT03855189|19912228|P1|COMPLETED|Overall Study||103
8075348|NCT03855189|19912226|P3|Treated|Overall Study||116
8075349|NCT03855189|19912227|P2|Treated|Overall Study||116
8075350|NCT03855189|19912228|P1|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112
8075351|NCT03855189|19912226|P3|STARTED|Overall Study||116
8075352|NCT03855189|19912227|P2|STARTED|Overall Study||116
8075353|NCT03855189|19912228|P1|STARTED|Overall Study||113
8075354|NCT03854253|19912319|P2|NOT COMPLETED|Overall Study||0
8075355|NCT03854253|19912320|P1|NOT COMPLETED|Overall Study||1
8075356|NCT03854253|19912319|P2|COMPLETED|Overall Study||50
8075357|NCT03854253|19912320|P1|COMPLETED|Overall Study||49
8075358|NCT03854253|19912319|P2|STARTED|Overall Study||50
8075359|NCT03854253|19912320|P1|STARTED|Overall Study||50
8075360|NCT03851016|19912346|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8075361|NCT03851016|19912347|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8075362|NCT03851016|19912346|P2|COMPLETED|Second Intervention (3 Weeks)||10
8075363|NCT03851016|19912347|P1|COMPLETED|Second Intervention (3 Weeks)||11
8075364|NCT03851016|19912346|P2|STARTED|Second Intervention (3 Weeks)||10
8075365|NCT03851016|19912347|P1|STARTED|Second Intervention (3 Weeks)||11
8075366|NCT03851016|19912346|P2|NOT COMPLETED|Washout (1 Week)||0
8075367|NCT03851016|19912347|P1|NOT COMPLETED|Washout (1 Week)||0
8075368|NCT03851016|19912346|P2|COMPLETED|Washout (1 Week)||10
8075369|NCT03851016|19912347|P1|COMPLETED|Washout (1 Week)||11
8075370|NCT03851016|19912346|P2|STARTED|Washout (1 Week)||10
8075371|NCT03851016|19912347|P1|STARTED|Washout (1 Week)||11
8075372|NCT03851016|19912346|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
8075373|NCT03851016|19912347|P1|NOT COMPLETED|First Intervention (3 Weeks)||1
8075374|NCT03851016|19912346|P2|COMPLETED|First Intervention (3 Weeks)||10
8075375|NCT03851016|19912347|P1|COMPLETED|First Intervention (3 Weeks)||11
8075376|NCT03851016|19912346|P2|STARTED|First Intervention (3 Weeks)||12
8075377|NCT03851016|19912347|P1|STARTED|First Intervention (3 Weeks)||12
8075378|NCT03850496|19912360|P3|NOT COMPLETED|Overall Study||4
8075379|NCT03850496|19912361|P2|NOT COMPLETED|Overall Study||1
8075380|NCT03850496|19912362|P1|NOT COMPLETED|Overall Study||1
8075381|NCT03850496|19912360|P3|COMPLETED|Overall Study||21
8075382|NCT03850496|19912361|P2|COMPLETED|Overall Study||24
8075383|NCT03850496|19912362|P1|COMPLETED|Overall Study||25
8075384|NCT03850496|19912360|P3|STARTED|Overall Study||25
8075385|NCT03850496|19912361|P2|STARTED|Overall Study||25
8075386|NCT03850496|19912362|P1|STARTED|Overall Study||26
8075387|NCT03850444|19912384|P2|NOT COMPLETED|Overall Study||134
8075388|NCT03850444|19912385|P1|NOT COMPLETED|Overall Study||128
8075389|NCT03850444|19912384|P2|COMPLETED|Overall Study||0
8075390|NCT03850444|19912385|P1|COMPLETED|Overall Study||0
8075391|NCT03850444|19912384|P2|STARTED|Overall Study||134
8075392|NCT03850444|19912385|P1|STARTED|Overall Study||128
8075393|NCT03850093|19912414|P3|NOT COMPLETED|Overall Study||2
8075394|NCT03850093|19912415|P2|NOT COMPLETED|Overall Study||0
8075395|NCT03850093|19912416|P1|NOT COMPLETED|Overall Study||1
8075396|NCT03850093|19912414|P3|COMPLETED|Overall Study||17
8075397|NCT03850093|19912415|P2|COMPLETED|Overall Study||22
8075398|NCT03850093|19912416|P1|COMPLETED|Overall Study||21
8075399|NCT03850093|19912414|P3|STARTED|Overall Study||19
8075400|NCT03850093|19912415|P2|STARTED|Overall Study||22
8075401|NCT03850093|19912416|P1|STARTED|Overall Study||22
8075411|NCT03849300|19912478|P4|NOT COMPLETED|Overall Study||6
8075412|NCT03849300|19912479|P3|NOT COMPLETED|Overall Study||4
8075413|NCT03849300|19912480|P2|NOT COMPLETED|Overall Study||7
8075414|NCT03849300|19912481|P1|NOT COMPLETED|Overall Study||5
8075415|NCT03849300|19912478|P4|COMPLETED|Overall Study||25
8075416|NCT03849300|19912479|P3|COMPLETED|Overall Study||28
8075417|NCT03849300|19912480|P2|COMPLETED|Overall Study||35
8075418|NCT03849300|19912481|P1|COMPLETED|Overall Study||37
8075419|NCT03849300|19912478|P4|STARTED|Overall Study||31
8075420|NCT03849300|19912479|P3|STARTED|Overall Study||32
8075421|NCT03849300|19912480|P2|STARTED|Overall Study||42
8075422|NCT03849300|19912481|P1|STARTED|Overall Study||42
8075423|NCT03848910|19912535|P1|NOT COMPLETED|Overall Study||0
8075424|NCT03848910|19912535|P1|COMPLETED|Overall Study||11
8075425|NCT03848910|19912535|P1|STARTED|Overall Study||11
8075426|NCT03848871|19912552|P1|NOT COMPLETED|Overall Study||0
8075427|NCT03848871|19912552|P1|COMPLETED|Overall Study||20
8075428|NCT03848871|19912552|P1|STARTED|Overall Study||20
8075429|NCT03848455|19912564|P3|NOT COMPLETED|Overall Study||0
8075430|NCT03848455|19912565|P2|NOT COMPLETED|Overall Study||0
8075431|NCT03848455|19912566|P1|NOT COMPLETED|Overall Study||0
8075432|NCT03848455|19912564|P3|COMPLETED|Overall Study||23
8075433|NCT03848455|19912565|P2|COMPLETED|Overall Study||125
8075434|NCT03848455|19912566|P1|COMPLETED|Overall Study||90
8075435|NCT03848455|19912564|P3|STARTED|Overall Study||23
8075436|NCT03848455|19912565|P2|STARTED|Overall Study||125
8075437|NCT03848455|19912566|P1|STARTED|Overall Study||90
8075438|NCT03848416|19912583|P3|NOT COMPLETED|Overall Study||1
8075439|NCT03848416|19912584|P2|NOT COMPLETED|Overall Study||0
8075440|NCT03848416|19912585|P1|NOT COMPLETED|Overall Study||1
8075441|NCT03848416|19912583|P3|COMPLETED|Overall Study||32
8075442|NCT03848416|19912584|P2|COMPLETED|Overall Study||33
8075443|NCT03848416|19912585|P1|COMPLETED|Overall Study||32
8075444|NCT03848416|19912583|P3|Received at Least One Dose of Study Drug|Overall Study||33
8075445|NCT03848416|19912584|P2|Received at Least One Dose of Study Drug|Overall Study||33
8075446|NCT03848416|19912585|P1|Received at Least One Dose of Study Drug|Overall Study||33
8075447|NCT03848416|19912583|P3|STARTED|Overall Study||33
8075448|NCT03848416|19912584|P2|STARTED|Overall Study||33
8075449|NCT03848416|19912585|P1|STARTED|Overall Study||33
8075450|NCT03848403|19912599|P3|NOT COMPLETED|Period 3 (Day 15)||0
8075451|NCT03848403|19912600|P2|NOT COMPLETED|Period 3 (Day 15)||0
8075452|NCT03848403|19912601|P1|NOT COMPLETED|Period 3 (Day 15)||0
8075453|NCT03848403|19912599|P3|COMPLETED|Period 3 (Day 15)||15
8075454|NCT03848403|19912600|P2|COMPLETED|Period 3 (Day 15)||15
8075455|NCT03848403|19912601|P1|COMPLETED|Period 3 (Day 15)||15
8075456|NCT03848403|19912599|P3|STARTED|Period 3 (Day 15)||15
8075457|NCT03848403|19912600|P2|STARTED|Period 3 (Day 15)||15
8075458|NCT03848403|19912601|P1|STARTED|Period 3 (Day 15)||15
8075459|NCT03848403|19912599|P3|NOT COMPLETED|Period 2 (Day 8)||7
8075460|NCT03848403|19912600|P2|NOT COMPLETED|Period 2 (Day 8)||9
8075461|NCT03848403|19912601|P1|NOT COMPLETED|Period 2 (Day 8)||9
8075462|NCT03848403|19912599|P3|COMPLETED|Period 2 (Day 8)||15
8075463|NCT03848403|19912600|P2|COMPLETED|Period 2 (Day 8)||15
8075464|NCT03848403|19912601|P1|COMPLETED|Period 2 (Day 8)||15
8075465|NCT03848403|19912599|P3|Received at Least One Dose of Study Drug|Period 2 (Day 8)||22
8075466|NCT03848403|19912600|P2|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
8075467|NCT03848403|19912601|P1|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
8075468|NCT03848403|19912599|P3|STARTED|Period 2 (Day 8)||22
8075469|NCT03848403|19912600|P2|STARTED|Period 2 (Day 8)||24
8075470|NCT03848403|19912601|P1|STARTED|Period 2 (Day 8)||24
8075471|NCT03848403|19912599|P3|NOT COMPLETED|Period 1 (Day 1)||0
8075472|NCT03848403|19912600|P2|NOT COMPLETED|Period 1 (Day 1)||0
8075473|NCT03848403|19912601|P1|NOT COMPLETED|Period 1 (Day 1)||0
8075474|NCT03848403|19912599|P3|COMPLETED|Period 1 (Day 1)||22
8075475|NCT03848403|19912600|P2|COMPLETED|Period 1 (Day 1)||24
8075476|NCT03848403|19912601|P1|COMPLETED|Period 1 (Day 1)||24
8075477|NCT03848403|19912599|P3|Received Intervention|Period 1 (Day 1)||22
8075478|NCT03848403|19912600|P2|Received Intervention|Period 1 (Day 1)||24
8075479|NCT03848403|19912601|P1|Received Intervention|Period 1 (Day 1)||24
8075480|NCT03848403|19912599|P3|STARTED|Period 1 (Day 1)||22
8075481|NCT03848403|19912600|P2|STARTED|Period 1 (Day 1)||24
8075482|NCT03848403|19912601|P1|STARTED|Period 1 (Day 1)||24
8075483|NCT03848221|19912612|P3|NOT COMPLETED|Overall Study||0
8075484|NCT03848221|19912613|P2|NOT COMPLETED|Overall Study||0
8075485|NCT03848221|19912614|P1|NOT COMPLETED|Overall Study||0
8075486|NCT03848221|19912612|P3|COMPLETED|Overall Study||24
8075487|NCT03848221|19912613|P2|COMPLETED|Overall Study||24
8075488|NCT03848221|19912614|P1|COMPLETED|Overall Study||25
8075489|NCT03848221|19912612|P3|STARTED|Overall Study||24
8075490|NCT03848221|19912613|P2|STARTED|Overall Study||24
8075491|NCT03848221|19912614|P1|STARTED|Overall Study||25
8075492|NCT03848208|19912635|P10|NOT COMPLETED|Overall Study||0
8075493|NCT03848208|19912636|P9|NOT COMPLETED|Overall Study||0
8075494|NCT03848208|19912637|P8|NOT COMPLETED|Overall Study||0
8075495|NCT03848208|19912638|P7|NOT COMPLETED|Overall Study||0
8075496|NCT03848208|19912639|P6|NOT COMPLETED|Overall Study||0
8075497|NCT03848208|19912640|P5|NOT COMPLETED|Overall Study||0
8075498|NCT03848208|19912641|P4|NOT COMPLETED|Overall Study||0
8075499|NCT03848208|19912642|P3|NOT COMPLETED|Overall Study||0
8075500|NCT03848208|19912643|P2|NOT COMPLETED|Overall Study||0
8075501|NCT03848208|19912644|P1|NOT COMPLETED|Overall Study||0
8075502|NCT03848208|19912635|P10|COMPLETED|Overall Study||6
8075503|NCT03848208|19912636|P9|COMPLETED|Overall Study||6
8075504|NCT03848208|19912637|P8|COMPLETED|Overall Study||6
8075505|NCT03848208|19912638|P7|COMPLETED|Overall Study||6
8075506|NCT03848208|19912639|P6|COMPLETED|Overall Study||6
8075507|NCT03848208|19912640|P5|COMPLETED|Overall Study||6
8075508|NCT03848208|19912641|P4|COMPLETED|Overall Study||6
8075509|NCT03848208|19912642|P3|COMPLETED|Overall Study||6
8075510|NCT03848208|19912643|P2|COMPLETED|Overall Study||6
8075511|NCT03848208|19912644|P1|COMPLETED|Overall Study||18
8075512|NCT03848208|19912635|P10|STARTED|Overall Study||6
8075513|NCT03848208|19912636|P9|STARTED|Overall Study||6
8075514|NCT03848208|19912637|P8|STARTED|Overall Study||6
8075515|NCT03848208|19912638|P7|STARTED|Overall Study||6
8075516|NCT03848208|19912639|P6|STARTED|Overall Study||6
8075517|NCT03848208|19912640|P5|STARTED|Overall Study||6
8075518|NCT03848208|19912641|P4|STARTED|Overall Study||6
8075519|NCT03848208|19912642|P3|STARTED|Overall Study||6
8075520|NCT03848208|19912643|P2|STARTED|Overall Study||6
8075521|NCT03848208|19912644|P1|STARTED|Overall Study||18
8075522|NCT03847987|19912686|P2|NOT COMPLETED|Overall Study||0
8075523|NCT03847987|19912687|P1|NOT COMPLETED|Overall Study||3
8075524|NCT03847987|19912686|P2|COMPLETED|Overall Study||8
8075525|NCT03847987|19912687|P1|COMPLETED|Overall Study||13
8075526|NCT03847987|19912686|P2|STARTED|Overall Study||8
8075527|NCT03847987|19912687|P1|STARTED|Overall Study||16
8075528|NCT03847610|19912710|P1|NOT COMPLETED|Overall Study||1
8075529|NCT03847610|19912710|P1|COMPLETED|Overall Study||10
8075530|NCT03847610|19912710|P1|STARTED|Overall Study||11
8075534|NCT03845933|19912723|P2|NOT COMPLETED|Overall Study||0
8075535|NCT03845933|19912724|P1|NOT COMPLETED|Overall Study||0
8075536|NCT03845933|19912723|P2|COMPLETED|Overall Study||131
8075537|NCT03845933|19912724|P1|COMPLETED|Overall Study||131
8075538|NCT03845933|19912723|P2|STARTED|Overall Study||131
8075539|NCT03845933|19912724|P1|STARTED|Overall Study||131
8075540|NCT03844945|19912734|P4|NOT COMPLETED|Overall Study||1
8075541|NCT03844945|19912735|P3|NOT COMPLETED|Overall Study||5
8075542|NCT03844945|19912736|P2|NOT COMPLETED|Overall Study||1
8075543|NCT03844945|19912737|P1|NOT COMPLETED|Overall Study||1
8075544|NCT03844945|19912734|P4|COMPLETED|Overall Study||54
8075545|NCT03844945|19912735|P3|COMPLETED|Overall Study||46
8075546|NCT03844945|19912736|P2|COMPLETED|Overall Study||53
8075547|NCT03844945|19912737|P1|COMPLETED|Overall Study||54
8075548|NCT03844945|19912734|P4|STARTED|Overall Study||55
8075549|NCT03844945|19912735|P3|STARTED|Overall Study||51
8075550|NCT03844945|19912736|P2|STARTED|Overall Study||54
8075551|NCT03844945|19912737|P1|STARTED|Overall Study||55
8075552|NCT03843372|19912749|P2|NOT COMPLETED|Overall Study||2
8075553|NCT03843372|19912750|P1|NOT COMPLETED|Overall Study||2
8075554|NCT03843372|19912749|P2|COMPLETED|Overall Study||16
8075555|NCT03843372|19912750|P1|COMPLETED|Overall Study||12
8075556|NCT03843372|19912749|P2|STARTED|Overall Study||18
8075557|NCT03843372|19912750|P1|STARTED|Overall Study||14
8075558|NCT03842683|19912762|P1|NOT COMPLETED|Overall Study||0
8075559|NCT03842683|19912762|P1|COMPLETED|Overall Study||472
8075560|NCT03842683|19912762|P1|STARTED|Overall Study||472
8075567|NCT03840278|19912790|P2|NOT COMPLETED|Overall Study||0
8075568|NCT03840278|19912791|P1|NOT COMPLETED|Overall Study||0
8075569|NCT03840278|19912790|P2|COMPLETED|Overall Study||5
8075570|NCT03840278|19912791|P1|COMPLETED|Overall Study||5
8075571|NCT03840278|19912790|P2|STARTED|Overall Study||5
8075572|NCT03840278|19912791|P1|STARTED|Overall Study||5
8075573|NCT03840135|19912811|P2|NOT COMPLETED|Overall Study||1
8075574|NCT03840135|19912812|P1|NOT COMPLETED|Overall Study||7
8075575|NCT03840135|19912811|P2|COMPLETED|Overall Study||85
8075576|NCT03840135|19912812|P1|COMPLETED|Overall Study||79
8075577|NCT03840135|19912811|P2|STARTED|Overall Study||86
8075578|NCT03840135|19912812|P1|STARTED|Overall Study||86
8075579|NCT03837028|19912842|P4|NOT COMPLETED|Overall Study||7
8075580|NCT03837028|19912843|P3|NOT COMPLETED|Overall Study||13
8075581|NCT03837028|19912844|P2|NOT COMPLETED|Overall Study||11
8075582|NCT03837028|19912845|P1|NOT COMPLETED|Overall Study||16
8075583|NCT03837028|19912842|P4|COMPLETED|Overall Study||18
8075584|NCT03837028|19912843|P3|COMPLETED|Overall Study||20
8075585|NCT03837028|19912844|P2|COMPLETED|Overall Study||23
8075586|NCT03837028|19912845|P1|COMPLETED|Overall Study||19
8075587|NCT03837028|19912842|P4|STARTED|Overall Study||25
8075588|NCT03837028|19912843|P3|STARTED|Overall Study||33
8075589|NCT03837028|19912844|P2|STARTED|Overall Study||34
8075590|NCT03837028|19912845|P1|STARTED|Overall Study||35
8075591|NCT03836859|19912861|P2|NOT COMPLETED|Overall Study||0
8075592|NCT03836859|19912862|P1|NOT COMPLETED|Overall Study||0
8075593|NCT03836859|19912861|P2|COMPLETED|Overall Study||10
8075594|NCT03836859|19912862|P1|COMPLETED|Overall Study||20
8075595|NCT03836859|19912861|P2|STARTED|Overall Study||10
8075596|NCT03836859|19912862|P1|STARTED|Overall Study||20
8075597|NCT03836729|19912898|P1|NOT COMPLETED|Treatment Period 2 (Up to Day 7)||1
8075598|NCT03836729|19912898|P1|COMPLETED|Treatment Period 2 (Up to Day 7)||15
8075599|NCT03836729|19912898|P1|STARTED|Treatment Period 2 (Up to Day 7)||16
8075600|NCT03836729|19912898|P1|NOT COMPLETED|Treatment Period 1 (Up to Day 14)||0
8075601|NCT03836729|19912898|P1|COMPLETED|Treatment Period 1 (Up to Day 14)||16
8075602|NCT03836729|19912898|P1|STARTED|Treatment Period 1 (Up to Day 14)||16
8075603|NCT03836664|19913012|P2|NOT COMPLETED|Overall Study||3
8075604|NCT03836664|19913013|P1|NOT COMPLETED|Overall Study||3
8075605|NCT03836664|19913012|P2|COMPLETED|Overall Study||8
8075606|NCT03836664|19913013|P1|COMPLETED|Overall Study||11
8075607|NCT03836664|19913012|P2|STARTED|Overall Study||11
8075608|NCT03836664|19913013|P1|STARTED|Overall Study||14
8075609|NCT03835546|19913026|P3|NOT COMPLETED|Overall Study||0
8075610|NCT03835546|19913027|P2|NOT COMPLETED|Overall Study||0
8075611|NCT03835546|19913028|P1|NOT COMPLETED|Overall Study||3
8075612|NCT03835546|19913026|P3|COMPLETED|Overall Study||15
8075613|NCT03835546|19913027|P2|COMPLETED|Overall Study||15
8075614|NCT03835546|19913028|P1|COMPLETED|Overall Study||12
8075615|NCT03835546|19913026|P3|STARTED|Overall Study||15
8075616|NCT03835546|19913027|P2|STARTED|Overall Study||15
8075617|NCT03835546|19913028|P1|STARTED|Overall Study||15
8075618|NCT03835221|19913054|P1|NOT COMPLETED|Fanfilcon A||0
8075619|NCT03835221|19913054|P1|COMPLETED|Fanfilcon A||42
8075620|NCT03835221|19913054|P1|STARTED|Fanfilcon A||42
8075621|NCT03835221|19913054|P1|NOT COMPLETED|Methafilcon A||1
8075622|NCT03835221|19913054|P1|COMPLETED|Methafilcon A||42
8075623|NCT03835221|19913054|P1|STARTED|Methafilcon A||43
8075624|NCT03835078|19913099|P1|NOT COMPLETED|Overall Study||0
8075625|NCT03835078|19913099|P1|COMPLETED|Overall Study||39
8075626|NCT03835078|19913099|P1|STARTED|Overall Study||39
8075627|NCT03832387|19913136|P2|NOT COMPLETED|Overall Study||7
8075628|NCT03832387|19913137|P1|NOT COMPLETED|Overall Study||5
8075629|NCT03832387|19913136|P2|COMPLETED|Overall Study||32
8075630|NCT03832387|19913137|P1|COMPLETED|Overall Study||33
8075631|NCT03832387|19913136|P2|STARTED|Overall Study||39
8075632|NCT03832387|19913137|P1|STARTED|Overall Study||38
8075633|NCT03832322|19913167|P2|NOT COMPLETED|Overall Study||1
8075634|NCT03832322|19913168|P1|NOT COMPLETED|Overall Study||3
8075635|NCT03832322|19913167|P2|COMPLETED|Overall Study||86
8075636|NCT03832322|19913168|P1|COMPLETED|Overall Study||86
8075637|NCT03832322|19913167|P2|STARTED|Overall Study||87
8075638|NCT03832322|19913168|P1|STARTED|Overall Study||89
8075639|NCT03831971|19913176|P1|NOT COMPLETED|Overall Study||0
8075640|NCT03831971|19913176|P1|COMPLETED|Overall Study||12
8075641|NCT03831971|19913176|P1|STARTED|Overall Study||12
8075642|NCT03831451|19913197|P2|NOT COMPLETED|Overall Study||0
8075643|NCT03831451|19913198|P1|NOT COMPLETED|Overall Study||0
8075644|NCT03831451|19913197|P2|COMPLETED|Overall Study||55
8075645|NCT03831451|19913198|P1|COMPLETED|Overall Study||74
8075646|NCT03831451|19913197|P2|STARTED|Overall Study||55
8075647|NCT03831451|19913198|P1|STARTED|Overall Study||74
8075648|NCT03831282|19913204|P1|NOT COMPLETED|Overall Study||1
8075649|NCT03831282|19913204|P1|COMPLETED|Overall Study||11
8075650|NCT03831282|19913204|P1|STARTED|Overall Study||12
8075651|NCT03830307|19913208|P1|NOT COMPLETED|Overall Study||0
8075652|NCT03830307|19913208|P1|COMPLETED|Overall Study||5
8075653|NCT03830307|19913208|P1|STARTED|Overall Study||5
8075654|NCT03830281|19913231|P2|NOT COMPLETED|Treatment Period (16 Weeks)||17
8075655|NCT03830281|19913232|P1|NOT COMPLETED|Treatment Period (16 Weeks)||12
8075656|NCT03830281|19913231|P2|COMPLETED|Treatment Period (16 Weeks)||198
8075657|NCT03830281|19913232|P1|COMPLETED|Treatment Period (16 Weeks)||205
8075658|NCT03830281|19913231|P2|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|215
8075659|NCT03830281|19913232|P1|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|217
8075660|NCT03830281|19913231|P2|NOT COMPLETED|Lead-in Period (2 Weeks)||0
8075661|NCT03830281|19913232|P1|NOT COMPLETED|Lead-in Period (2 Weeks)||39
8075662|NCT03830281|19913231|P2|COMPLETED|Lead-in Period (2 Weeks)||0
8075663|NCT03830281|19913232|P1|COMPLETED|Lead-in Period (2 Weeks)||432
8075664|NCT03830281|19913231|P2|STARTED|Lead-in Period (2 Weeks)||0
8075665|NCT03830281|19913232|P1|STARTED|Lead-in Period (2 Weeks)||471
8075666|NCT03828734|19913263|P2|NOT COMPLETED|Second Intervention||0
8075667|NCT03828734|19913264|P1|NOT COMPLETED|Second Intervention||0
8075668|NCT03828734|19913263|P2|COMPLETED|Second Intervention||24
8075669|NCT03828734|19913264|P1|COMPLETED|Second Intervention||25
8075670|NCT03828734|19913263|P2|STARTED|Second Intervention||24
8075671|NCT03828734|19913264|P1|STARTED|Second Intervention||25
8075672|NCT03828734|19913263|P2|NOT COMPLETED|First Washout (1 Week)||1
8075673|NCT03828734|19913264|P1|NOT COMPLETED|First Washout (1 Week)||0
8075674|NCT03828734|19913263|P2|COMPLETED|First Washout (1 Week)||24
8075675|NCT03828734|19913264|P1|COMPLETED|First Washout (1 Week)||25
8075676|NCT03828734|19913263|P2|STARTED|First Washout (1 Week)||25
8075677|NCT03828734|19913264|P1|STARTED|First Washout (1 Week)||25
8075678|NCT03828734|19913263|P2|NOT COMPLETED|First Intervention||0
8075679|NCT03828734|19913264|P1|NOT COMPLETED|First Intervention||4
8075680|NCT03828734|19913263|P2|COMPLETED|First Intervention||25
8075681|NCT03828734|19913264|P1|COMPLETED|First Intervention||25
8075682|NCT03828734|19913263|P2|STARTED|First Intervention||25
8075683|NCT03828734|19913264|P1|STARTED|First Intervention||29
8075684|NCT03828734|19913263|P2|NOT COMPLETED|Pre-Randomization (1 Week)||1
8075685|NCT03828734|19913264|P1|NOT COMPLETED|Pre-Randomization (1 Week)||3
8075686|NCT03828734|19913263|P2|COMPLETED|Pre-Randomization (1 Week)||25
8075687|NCT03828734|19913264|P1|COMPLETED|Pre-Randomization (1 Week)||29
8075688|NCT03828734|19913263|P2|STARTED|Pre-Randomization (1 Week)||26
8075689|NCT03828734|19913264|P1|STARTED|Pre-Randomization (1 Week)||32
8075690|NCT03828734|19913263|P2|NOT COMPLETED|Baseline||0
8075691|NCT03828734|19913264|P1|NOT COMPLETED|Baseline||0
8075692|NCT03828734|19913263|P2|COMPLETED|Baseline||26
8075693|NCT03828734|19913264|P1|COMPLETED|Baseline||32
8075694|NCT03828734|19913263|P2|STARTED|Baseline||26
8075695|NCT03828734|19913264|P1|STARTED|Baseline||32
8075696|NCT03828617|19913278|P4|NOT COMPLETED|Overall Study||10
8075697|NCT03828617|19913279|P3|NOT COMPLETED|Overall Study||26
8075698|NCT03828617|19913280|P2|NOT COMPLETED|Overall Study||15
8075699|NCT03828617|19913281|P1|NOT COMPLETED|Overall Study||24
8075700|NCT03828617|19913278|P4|COMPLETED|Overall Study||235
8075701|NCT03828617|19913279|P3|COMPLETED|Overall Study||460
8075702|NCT03828617|19913280|P2|COMPLETED|Overall Study||475
8075703|NCT03828617|19913281|P1|COMPLETED|Overall Study||465
8075704|NCT03828617|19913278|P4|Evaluable Immunogenicity Population(EIP)|Overall Study||232
8075705|NCT03828617|19913279|P3|Evaluable Immunogenicity Population(EIP)|Overall Study||456
8075706|NCT03828617|19913280|P2|Evaluable Immunogenicity Population(EIP)|Overall Study||473
8075707|NCT03828617|19913281|P1|Evaluable Immunogenicity Population(EIP)|Overall Study||463
8075708|NCT03828617|19913278|P4|Safety Population|Overall Study||245
8075709|NCT03828617|19913279|P3|Safety Population|Overall Study||486
8075710|NCT03828617|19913280|P2|Safety Population|Overall Study||489
8075711|NCT03828617|19913281|P1|Safety Population|Overall Study||488
8075712|NCT03828617|19913278|P4|Vaccinated|Overall Study||245
8075713|NCT03828617|19913279|P3|Vaccinated|Overall Study||486
8075714|NCT03828617|19913280|P2|Vaccinated|Overall Study||489
8075715|NCT03828617|19913281|P1|Vaccinated|Overall Study||488
8075716|NCT03828617|19913278|P4|STARTED|Overall Study||245
8075717|NCT03828617|19913279|P3|STARTED|Overall Study||486
8075718|NCT03828617|19913280|P2|STARTED|Overall Study||490
8075719|NCT03828617|19913281|P1|STARTED|Overall Study||489
8075720|NCT03828149|19913309|P2|NOT COMPLETED|Second Intervention (Single Dose)||0
8075721|NCT03828149|19913310|P1|NOT COMPLETED|Second Intervention (Single Dose)||0
8075722|NCT03828149|19913309|P2|COMPLETED|Second Intervention (Single Dose)||8
8075723|NCT03828149|19913310|P1|COMPLETED|Second Intervention (Single Dose)||9
8075724|NCT03828149|19913309|P2|STARTED|Second Intervention (Single Dose)||8
8075725|NCT03828149|19913310|P1|STARTED|Second Intervention (Single Dose)||9
8075726|NCT03828149|19913309|P2|NOT COMPLETED|Washout (6 Days)||0
8075727|NCT03828149|19913310|P1|NOT COMPLETED|Washout (6 Days)||0
8075728|NCT03828149|19913309|P2|COMPLETED|Washout (6 Days)||8
8075729|NCT03828149|19913310|P1|COMPLETED|Washout (6 Days)||9
8075730|NCT03828149|19913309|P2|STARTED|Washout (6 Days)||8
8075731|NCT03828149|19913310|P1|STARTED|Washout (6 Days)||9
8075732|NCT03828149|19913309|P2|NOT COMPLETED|First Intervention (Single Dose)||0
8075733|NCT03828149|19913310|P1|NOT COMPLETED|First Intervention (Single Dose)||0
8075734|NCT03828149|19913309|P2|COMPLETED|First Intervention (Single Dose)||8
8075735|NCT03828149|19913310|P1|COMPLETED|First Intervention (Single Dose)||9
8075736|NCT03828149|19913309|P2|STARTED|First Intervention (Single Dose)||8
8075737|NCT03828149|19913310|P1|STARTED|First Intervention (Single Dose)||9
8075738|NCT03827473|19913318|P2|NOT COMPLETED|Overall Study||0
8075739|NCT03827473|19913319|P1|NOT COMPLETED|Overall Study||1
8075740|NCT03827473|19913318|P2|COMPLETED|Overall Study||0
8075741|NCT03827473|19913319|P1|COMPLETED|Overall Study||0
8075742|NCT03827473|19913318|P2|STARTED|Overall Study||0
8075743|NCT03827473|19913319|P1|STARTED|Overall Study||1
8075744|NCT03826914|19913335|P2|NOT COMPLETED|Overall Study||1
8075745|NCT03826914|19913336|P1|NOT COMPLETED|Overall Study||1
8075746|NCT03826914|19913335|P2|COMPLETED|Overall Study||33
8075747|NCT03826914|19913336|P1|COMPLETED|Overall Study||34
8075748|NCT03826914|19913335|P2|STARTED|Overall Study||34
8075749|NCT03826914|19913336|P1|STARTED|Overall Study||35
8075750|NCT03825393|19913346|P2|NOT COMPLETED|Overall Study||0
8075751|NCT03825393|19913347|P1|NOT COMPLETED|Overall Study||0
8075752|NCT03825393|19913346|P2|COMPLETED|Overall Study||100
8075753|NCT03825393|19913347|P1|COMPLETED|Overall Study||100
8075754|NCT03825393|19913346|P2|STARTED|Overall Study||100
8075755|NCT03825393|19913347|P1|STARTED|Overall Study||100
8075756|NCT03825042|19913359|P2|NOT COMPLETED|Overall Study||0
8075757|NCT03825042|19913360|P1|NOT COMPLETED|Overall Study||2
8075758|NCT03825042|19913359|P2|COMPLETED|Overall Study||40
8075759|NCT03825042|19913360|P1|COMPLETED|Overall Study||38
8075760|NCT03825042|19913359|P2|STARTED|Overall Study||40
8075761|NCT03825042|19913360|P1|STARTED|Overall Study||40
8075762|NCT03824912|19913373|P3|NOT COMPLETED|Overall Study||68
8075763|NCT03824912|19913374|P2|NOT COMPLETED|Overall Study||134
8075764|NCT03824912|19913375|P1|NOT COMPLETED|Overall Study||140
8075765|NCT03824912|19913373|P3|COMPLETED|Overall Study||96
8075766|NCT03824912|19913374|P2|COMPLETED|Overall Study||201
8075767|NCT03824912|19913375|P1|COMPLETED|Overall Study||192
8075768|NCT03824912|19913373|P3|STARTED|Overall Study||164
8075769|NCT03824912|19913374|P2|STARTED|Overall Study||335
8075770|NCT03824912|19913375|P1|STARTED|Overall Study||332
8075771|NCT03824236|19913398|P3|NOT COMPLETED|Overall Study||1
8075772|NCT03824236|19913399|P2|NOT COMPLETED|Overall Study||0
8075773|NCT03824236|19913400|P1|NOT COMPLETED|Overall Study||0
8075774|NCT03824236|19913398|P3|COMPLETED|Overall Study||11
8075775|NCT03824236|19913399|P2|COMPLETED|Overall Study||24
8075776|NCT03824236|19913400|P1|COMPLETED|Overall Study||25
8075777|NCT03824236|19913398|P3|STARTED|Overall Study||12
8075778|NCT03824236|19913399|P2|STARTED|Overall Study||24
8075779|NCT03824236|19913400|P1|STARTED|Overall Study||25
8075780|NCT03823937|19913435|P2|NOT COMPLETED|Overall Study||0
8075781|NCT03823937|19913436|P1|NOT COMPLETED|Overall Study||0
8075782|NCT03823937|19913435|P2|COMPLETED|Overall Study||20
8075783|NCT03823937|19913436|P1|COMPLETED|Overall Study||30
8075784|NCT03823937|19913435|P2|STARTED|Overall Study||20
8075785|NCT03823937|19913436|P1|STARTED|Overall Study||30
8075786|NCT03822884|19913458|P6|NOT COMPLETED|Overall Study||0
8075787|NCT03822884|19913459|P5|NOT COMPLETED|Overall Study||1
8075788|NCT03822884|19913460|P4|NOT COMPLETED|Overall Study||0
8075789|NCT03822884|19913461|P3|NOT COMPLETED|Overall Study||0
8075790|NCT03822884|19913462|P2|NOT COMPLETED|Overall Study||0
8075791|NCT03822884|19913463|P1|NOT COMPLETED|Overall Study||0
8075792|NCT03822884|19913458|P6|COMPLETED|Overall Study||4
8075793|NCT03822884|19913459|P5|COMPLETED|Overall Study||3
8075794|NCT03822884|19913460|P4|COMPLETED|Overall Study||4
8075795|NCT03822884|19913461|P3|COMPLETED|Overall Study||4
8075796|NCT03822884|19913462|P2|COMPLETED|Overall Study||4
8075797|NCT03822884|19913463|P1|COMPLETED|Overall Study||4
8075798|NCT03822884|19913458|P6|STARTED|Overall Study||4
8075799|NCT03822884|19913459|P5|STARTED|Overall Study||4
8075800|NCT03822884|19913460|P4|STARTED|Overall Study||4
8075801|NCT03822884|19913461|P3|STARTED|Overall Study||4
8075802|NCT03822884|19913462|P2|STARTED|Overall Study||4
8075803|NCT03822884|19913463|P1|STARTED|Overall Study||4
8075804|NCT03822182|19913495|P3|NOT COMPLETED|Overall Study||1
8075805|NCT03822182|19913496|P2|NOT COMPLETED|Overall Study||1
8075806|NCT03822182|19913497|P1|NOT COMPLETED|Overall Study||0
8075807|NCT03822182|19913495|P3|COMPLETED|Overall Study||26
8075808|NCT03822182|19913496|P2|COMPLETED|Overall Study||24
8075809|NCT03822182|19913497|P1|COMPLETED|Overall Study||26
8075810|NCT03822182|19913495|P3|STARTED|Overall Study||27
8075811|NCT03822182|19913496|P2|STARTED|Overall Study||25
8075812|NCT03822182|19913497|P1|STARTED|Overall Study||26
8075813|NCT03822078|19913514|P6|NOT COMPLETED|Overall Study||0
8075814|NCT03822078|19913515|P5|NOT COMPLETED|Overall Study||1
8075815|NCT03822078|19913516|P4|NOT COMPLETED|Overall Study||2
8075816|NCT03822078|19913517|P3|NOT COMPLETED|Overall Study||0
8075817|NCT03822078|19913518|P2|NOT COMPLETED|Overall Study||0
8075818|NCT03822078|19913519|P1|NOT COMPLETED|Overall Study||2
8075819|NCT03822078|19913514|P6|COMPLETED|Overall Study||6
8075820|NCT03822078|19913515|P5|COMPLETED|Overall Study||6
8075821|NCT03822078|19913516|P4|COMPLETED|Overall Study||6
8075822|NCT03822078|19913517|P3|COMPLETED|Overall Study||6
8075823|NCT03822078|19913518|P2|COMPLETED|Overall Study||6
8075824|NCT03822078|19913519|P1|COMPLETED|Overall Study||10
8075825|NCT03822078|19913514|P6|Received Study Drug|Overall Study||6
8075826|NCT03822078|19913515|P5|Received Study Drug|Overall Study||6
8075827|NCT03822078|19913516|P4|Received Study Drug|Overall Study||6
8075828|NCT03822078|19913517|P3|Received Study Drug|Overall Study||6
8075829|NCT03822078|19913518|P2|Received Study Drug|Overall Study||6
8075830|NCT03822078|19913519|P1|Received Study Drug|Overall Study||10
8075831|NCT03822078|19913514|P6|STARTED|Overall Study||6
8075832|NCT03822078|19913515|P5|STARTED|Overall Study||7
8075833|NCT03822078|19913516|P4|STARTED|Overall Study||8
8075834|NCT03822078|19913517|P3|STARTED|Overall Study||6
8075835|NCT03822078|19913518|P2|STARTED|Overall Study||6
8075836|NCT03822078|19913519|P1|STARTED|Overall Study||12
8075837|NCT03821259|19913577|P1|NOT COMPLETED|Overall Study||0
8075838|NCT03821259|19913577|P1|COMPLETED|Overall Study||88
8075839|NCT03821259|19913577|P1|STARTED|Overall Study||88
8075840|NCT03820544|19913587|P2|NOT COMPLETED|Overall Study||0
8075841|NCT03820544|19913588|P1|NOT COMPLETED|Overall Study||0
8075842|NCT03820544|19913587|P2|COMPLETED|Overall Study||2
8075843|NCT03820544|19913588|P1|COMPLETED|Overall Study||2
8075844|NCT03820544|19913587|P2|STARTED|Overall Study||2
8075845|NCT03820544|19913588|P1|STARTED|Overall Study||2
8075846|NCT03820258|19913596|P1|NOT COMPLETED|Overall Study||0
8075847|NCT03820258|19913596|P1|COMPLETED|Overall Study||21
8075848|NCT03820258|19913596|P1|STARTED|Overall Study||21
8075849|NCT03819491|19913625|P2|NOT COMPLETED|After Randomization||0
8075850|NCT03819491|19913626|P1|NOT COMPLETED|After Randomization||0
8075851|NCT03819491|19913625|P2|COMPLETED|After Randomization||12
8075852|NCT03819491|19913626|P1|COMPLETED|After Randomization||12
8075853|NCT03819491|19913625|P2|STARTED|After Randomization||12
8075854|NCT03819491|19913626|P1|STARTED|After Randomization||12
8075855|NCT03819491|19913625|P2|NOT COMPLETED|Before Randomization||0
8075856|NCT03819491|19913626|P1|NOT COMPLETED|Before Randomization||0
8075857|NCT03819491|19913625|P2|COMPLETED|Before Randomization||0
8075858|NCT03819491|19913626|P1|COMPLETED|Before Randomization||24
8075859|NCT03819491|19913625|P2|STARTED|Before Randomization||0
8075860|NCT03819491|19913626|P1|STARTED|Before Randomization||24
8075861|NCT03818815|19913639|P2|NOT COMPLETED|Overall Study||5
8075862|NCT03818815|19913640|P1|NOT COMPLETED|Overall Study||8
8075863|NCT03818815|19913639|P2|COMPLETED|Overall Study||42
8075864|NCT03818815|19913640|P1|COMPLETED|Overall Study||48
8075865|NCT03818815|19913639|P2|STARTED|Overall Study||47
8075866|NCT03818815|19913640|P1|STARTED|Overall Study||56
8075867|NCT03817879|19913652|P2|NOT COMPLETED|Overall Study||13
8075868|NCT03817879|19913653|P1|NOT COMPLETED|Overall Study||5
8075869|NCT03817879|19913652|P2|COMPLETED|Overall Study||22
8075870|NCT03817879|19913653|P1|COMPLETED|Overall Study||30
8075871|NCT03817879|19913652|P2|STARTED|Overall Study||35
8075872|NCT03817879|19913653|P1|STARTED|Overall Study||35
8075873|NCT03817775|19913661|P2|NOT COMPLETED|Overall Study||0
8075874|NCT03817775|19913662|P1|NOT COMPLETED|Overall Study||0
8075875|NCT03817775|19913661|P2|COMPLETED|Overall Study||54
8075876|NCT03817775|19913662|P1|COMPLETED|Overall Study||22
8075877|NCT03817775|19913661|P2|STARTED|Overall Study||54
8075878|NCT03817775|19913662|P1|STARTED|Overall Study||22
8075879|NCT03816761|19913689|P6|NOT COMPLETED|Second Treatment Period (7 Days)||0
8075880|NCT03816761|19913690|P5|NOT COMPLETED|Second Treatment Period (7 Days)||0
8075881|NCT03816761|19913691|P4|NOT COMPLETED|Second Treatment Period (7 Days)||1
8075882|NCT03816761|19913692|P3|NOT COMPLETED|Second Treatment Period (7 Days)||0
8075883|NCT03816761|19913693|P2|NOT COMPLETED|Second Treatment Period (7 Days)||0
8075884|NCT03816761|19913694|P1|NOT COMPLETED|Second Treatment Period (7 Days)||0
8075885|NCT03816761|19913689|P6|COMPLETED|Second Treatment Period (7 Days)||3
8075886|NCT03816761|19913690|P5|COMPLETED|Second Treatment Period (7 Days)||4
8075887|NCT03816761|19913691|P4|COMPLETED|Second Treatment Period (7 Days)||3
8075888|NCT03816761|19913692|P3|COMPLETED|Second Treatment Period (7 Days)||4
8075889|NCT03816761|19913693|P2|COMPLETED|Second Treatment Period (7 Days)||4
8075890|NCT03816761|19913694|P1|COMPLETED|Second Treatment Period (7 Days)||4
8075891|NCT03816761|19913689|P6|STARTED|Second Treatment Period (7 Days)||3
8075892|NCT03816761|19913690|P5|STARTED|Second Treatment Period (7 Days)||4
8075893|NCT03816761|19913691|P4|STARTED|Second Treatment Period (7 Days)||4
8075894|NCT03816761|19913692|P3|STARTED|Second Treatment Period (7 Days)||4
8075895|NCT03816761|19913693|P2|STARTED|Second Treatment Period (7 Days)||4
8075896|NCT03816761|19913694|P1|STARTED|Second Treatment Period (7 Days)||4
8075897|NCT03816761|19913689|P6|NOT COMPLETED|First Treatment Period (7 Days)||1
8075898|NCT03816761|19913690|P5|NOT COMPLETED|First Treatment Period (7 Days)||0
8075899|NCT03816761|19913691|P4|NOT COMPLETED|First Treatment Period (7 Days)||0
8075900|NCT03816761|19913692|P3|NOT COMPLETED|First Treatment Period (7 Days)||0
8075901|NCT03816761|19913693|P2|NOT COMPLETED|First Treatment Period (7 Days)||0
8075902|NCT03816761|19913694|P1|NOT COMPLETED|First Treatment Period (7 Days)||0
8075903|NCT03816761|19913689|P6|COMPLETED|First Treatment Period (7 Days)||3
8075904|NCT03816761|19913690|P5|COMPLETED|First Treatment Period (7 Days)||4
8075905|NCT03816761|19913691|P4|COMPLETED|First Treatment Period (7 Days)||4
8075906|NCT03816761|19913692|P3|COMPLETED|First Treatment Period (7 Days)||4
8075907|NCT03816761|19913693|P2|COMPLETED|First Treatment Period (7 Days)||4
8075908|NCT03816761|19913694|P1|COMPLETED|First Treatment Period (7 Days)||4
8075909|NCT03816761|19913689|P6|STARTED|First Treatment Period (7 Days)||4
8075910|NCT03816761|19913690|P5|STARTED|First Treatment Period (7 Days)||4
8075911|NCT03816761|19913691|P4|STARTED|First Treatment Period (7 Days)||4
8075912|NCT03816761|19913692|P3|STARTED|First Treatment Period (7 Days)||4
8075913|NCT03816761|19913693|P2|STARTED|First Treatment Period (7 Days)||4
8075914|NCT03816761|19913694|P1|STARTED|First Treatment Period (7 Days)||4
8075915|NCT03816696|19913792|P1|NOT COMPLETED|Period 3 (Up to Day 11)||0
8075916|NCT03816696|19913792|P1|COMPLETED|Period 3 (Up to Day 11)||16
8075917|NCT03816696|19913792|P1|STARTED|Period 3 (Up to Day 11)||16
8075918|NCT03816696|19913792|P1|NOT COMPLETED|Period 2 (Up to Day 7)||0
8075919|NCT03816696|19913792|P1|COMPLETED|Period 2 (Up to Day 7)||16
8075920|NCT03816696|19913792|P1|STARTED|Period 2 (Up to Day 7)||16
8075921|NCT03816696|19913792|P1|NOT COMPLETED|Wash Out Period (Days 6 to 9)||0
8075922|NCT03816696|19913792|P1|COMPLETED|Wash Out Period (Days 6 to 9)||16
8075923|NCT03816696|19913792|P1|STARTED|Wash Out Period (Days 6 to 9)||16
8075924|NCT03816696|19913792|P1|NOT COMPLETED|Period 1 (Up to Day 5)||0
8075925|NCT03816696|19913792|P1|COMPLETED|Period 1 (Up to Day 5)||16
8075926|NCT03816696|19913792|P1|STARTED|Period 1 (Up to Day 5)||16
8075927|NCT03815240|19913937|P9|NOT COMPLETED|Intervention Optifoam Dressing||0
8075928|NCT03815240|19913938|P8|NOT COMPLETED|Intervention Optifoam Dressing||0
8075929|NCT03815240|19913939|P7|NOT COMPLETED|Intervention Optifoam Dressing||0
8075930|NCT03815240|19913940|P6|NOT COMPLETED|Intervention Optifoam Dressing||0
8075931|NCT03815240|19913941|P5|NOT COMPLETED|Intervention Optifoam Dressing||0
8075932|NCT03815240|19913942|P4|NOT COMPLETED|Intervention Optifoam Dressing||0
8075933|NCT03815240|19913943|P3|NOT COMPLETED|Intervention Optifoam Dressing||0
8075934|NCT03815240|19913944|P2|NOT COMPLETED|Intervention Optifoam Dressing||0
8075935|NCT03815240|19913945|P1|NOT COMPLETED|Intervention Optifoam Dressing||0
8075936|NCT03815240|19913937|P9|COMPLETED|Intervention Optifoam Dressing||1
8075937|NCT03815240|19913938|P8|COMPLETED|Intervention Optifoam Dressing||1
8075938|NCT03815240|19913939|P7|COMPLETED|Intervention Optifoam Dressing||1
8075939|NCT03815240|19913940|P6|COMPLETED|Intervention Optifoam Dressing||2
8075940|NCT03815240|19913941|P5|COMPLETED|Intervention Optifoam Dressing||1
8075941|NCT03815240|19913942|P4|COMPLETED|Intervention Optifoam Dressing||2
8075942|NCT03815240|19913943|P3|COMPLETED|Intervention Optifoam Dressing||1
8075943|NCT03815240|19913944|P2|COMPLETED|Intervention Optifoam Dressing||1
8075944|NCT03815240|19913945|P1|COMPLETED|Intervention Optifoam Dressing||2
8075945|NCT03815240|19913937|P9|STARTED|Intervention Optifoam Dressing||1
8075946|NCT03815240|19913938|P8|STARTED|Intervention Optifoam Dressing||1
8075947|NCT03815240|19913939|P7|STARTED|Intervention Optifoam Dressing||1
8075948|NCT03815240|19913940|P6|STARTED|Intervention Optifoam Dressing||2
8075949|NCT03815240|19913941|P5|STARTED|Intervention Optifoam Dressing||1
8075950|NCT03815240|19913942|P4|STARTED|Intervention Optifoam Dressing||2
8075951|NCT03815240|19913943|P3|STARTED|Intervention Optifoam Dressing||1
8075952|NCT03815240|19913944|P2|STARTED|Intervention Optifoam Dressing||1
8075953|NCT03815240|19913945|P1|STARTED|Intervention Optifoam Dressing||2
8075954|NCT03815240|19913937|P9|NOT COMPLETED|Intervention Allevyn Dressing||0
8075955|NCT03815240|19913938|P8|NOT COMPLETED|Intervention Allevyn Dressing||0
8075956|NCT03815240|19913939|P7|NOT COMPLETED|Intervention Allevyn Dressing||0
8075957|NCT03815240|19913940|P6|NOT COMPLETED|Intervention Allevyn Dressing||0
8075958|NCT03815240|19913941|P5|NOT COMPLETED|Intervention Allevyn Dressing||0
8075959|NCT03815240|19913942|P4|NOT COMPLETED|Intervention Allevyn Dressing||0
8075960|NCT03815240|19913943|P3|NOT COMPLETED|Intervention Allevyn Dressing||0
8075961|NCT03815240|19913944|P2|NOT COMPLETED|Intervention Allevyn Dressing||0
8075962|NCT03815240|19913945|P1|NOT COMPLETED|Intervention Allevyn Dressing||0
8075963|NCT03815240|19913937|P9|COMPLETED|Intervention Allevyn Dressing||1
8075964|NCT03815240|19913938|P8|COMPLETED|Intervention Allevyn Dressing||1
8075965|NCT03815240|19913939|P7|COMPLETED|Intervention Allevyn Dressing||1
8075966|NCT03815240|19913940|P6|COMPLETED|Intervention Allevyn Dressing||2
8075967|NCT03815240|19913941|P5|COMPLETED|Intervention Allevyn Dressing||1
8075968|NCT03815240|19913942|P4|COMPLETED|Intervention Allevyn Dressing||2
8075969|NCT03815240|19913943|P3|COMPLETED|Intervention Allevyn Dressing||1
8075970|NCT03815240|19913944|P2|COMPLETED|Intervention Allevyn Dressing||1
8075971|NCT03815240|19913945|P1|COMPLETED|Intervention Allevyn Dressing||2
8075972|NCT03815240|19913937|P9|STARTED|Intervention Allevyn Dressing||1
8075973|NCT03815240|19913938|P8|STARTED|Intervention Allevyn Dressing||1
8075974|NCT03815240|19913939|P7|STARTED|Intervention Allevyn Dressing||1
8075975|NCT03815240|19913940|P6|STARTED|Intervention Allevyn Dressing||2
8075976|NCT03815240|19913941|P5|STARTED|Intervention Allevyn Dressing||1
8075977|NCT03815240|19913942|P4|STARTED|Intervention Allevyn Dressing||2
8075978|NCT03815240|19913943|P3|STARTED|Intervention Allevyn Dressing||1
8075979|NCT03815240|19913944|P2|STARTED|Intervention Allevyn Dressing||1
8075980|NCT03815240|19913945|P1|STARTED|Intervention Allevyn Dressing||2
8075981|NCT03815240|19913937|P9|NOT COMPLETED|Intervention Mepilex Dressing||0
8075982|NCT03815240|19913938|P8|NOT COMPLETED|Intervention Mepilex Dressing||0
8075983|NCT03815240|19913939|P7|NOT COMPLETED|Intervention Mepilex Dressing||0
8075984|NCT03815240|19913940|P6|NOT COMPLETED|Intervention Mepilex Dressing||0
8075985|NCT03815240|19913941|P5|NOT COMPLETED|Intervention Mepilex Dressing||0
8075986|NCT03815240|19913942|P4|NOT COMPLETED|Intervention Mepilex Dressing||0
8075987|NCT03815240|19913943|P3|NOT COMPLETED|Intervention Mepilex Dressing||0
8075988|NCT03815240|19913944|P2|NOT COMPLETED|Intervention Mepilex Dressing||0
8075989|NCT03815240|19913945|P1|NOT COMPLETED|Intervention Mepilex Dressing||0
8075990|NCT03815240|19913937|P9|COMPLETED|Intervention Mepilex Dressing||1
8075991|NCT03815240|19913938|P8|COMPLETED|Intervention Mepilex Dressing||1
8075992|NCT03815240|19913939|P7|COMPLETED|Intervention Mepilex Dressing||1
8075993|NCT03815240|19913940|P6|COMPLETED|Intervention Mepilex Dressing||2
8075994|NCT03815240|19913941|P5|COMPLETED|Intervention Mepilex Dressing||1
8075995|NCT03815240|19913942|P4|COMPLETED|Intervention Mepilex Dressing||2
8075996|NCT03815240|19913943|P3|COMPLETED|Intervention Mepilex Dressing||1
8075997|NCT03815240|19913944|P2|COMPLETED|Intervention Mepilex Dressing||1
8075998|NCT03815240|19913945|P1|COMPLETED|Intervention Mepilex Dressing||2
8075999|NCT03815240|19913937|P9|STARTED|Intervention Mepilex Dressing||1
8076000|NCT03815240|19913938|P8|STARTED|Intervention Mepilex Dressing||1
8076001|NCT03815240|19913939|P7|STARTED|Intervention Mepilex Dressing||1
8076002|NCT03815240|19913940|P6|STARTED|Intervention Mepilex Dressing||2
8076003|NCT03815240|19913941|P5|STARTED|Intervention Mepilex Dressing||1
8076004|NCT03815240|19913942|P4|STARTED|Intervention Mepilex Dressing||2
8076005|NCT03815240|19913943|P3|STARTED|Intervention Mepilex Dressing||1
8076006|NCT03815240|19913944|P2|STARTED|Intervention Mepilex Dressing||1
8076007|NCT03815240|19913945|P1|STARTED|Intervention Mepilex Dressing||2
8076008|NCT03815240|19913937|P9|NOT COMPLETED|Intervention no Dressing||0
8076009|NCT03815240|19913938|P8|NOT COMPLETED|Intervention no Dressing||0
8076010|NCT03815240|19913939|P7|NOT COMPLETED|Intervention no Dressing||0
8076011|NCT03815240|19913940|P6|NOT COMPLETED|Intervention no Dressing||0
8076012|NCT03815240|19913941|P5|NOT COMPLETED|Intervention no Dressing||0
8076013|NCT03815240|19913942|P4|NOT COMPLETED|Intervention no Dressing||0
8076014|NCT03815240|19913943|P3|NOT COMPLETED|Intervention no Dressing||0
8076015|NCT03815240|19913944|P2|NOT COMPLETED|Intervention no Dressing||0
8076016|NCT03815240|19913945|P1|NOT COMPLETED|Intervention no Dressing||0
8076017|NCT03815240|19913937|P9|COMPLETED|Intervention no Dressing||1
8076018|NCT03815240|19913938|P8|COMPLETED|Intervention no Dressing||1
8076019|NCT03815240|19913939|P7|COMPLETED|Intervention no Dressing||1
8076020|NCT03815240|19913940|P6|COMPLETED|Intervention no Dressing||2
8076021|NCT03815240|19913941|P5|COMPLETED|Intervention no Dressing||1
8076022|NCT03815240|19913942|P4|COMPLETED|Intervention no Dressing||2
8076023|NCT03815240|19913943|P3|COMPLETED|Intervention no Dressing||1
8076024|NCT03815240|19913944|P2|COMPLETED|Intervention no Dressing||1
8076025|NCT03815240|19913945|P1|COMPLETED|Intervention no Dressing||2
8076026|NCT03815240|19913937|P9|STARTED|Intervention no Dressing||1
8076027|NCT03815240|19913938|P8|STARTED|Intervention no Dressing||1
8076028|NCT03815240|19913939|P7|STARTED|Intervention no Dressing||1
8076029|NCT03815240|19913940|P6|STARTED|Intervention no Dressing||2
8076030|NCT03815240|19913941|P5|STARTED|Intervention no Dressing||1
8076031|NCT03815240|19913942|P4|STARTED|Intervention no Dressing||2
8076032|NCT03815240|19913943|P3|STARTED|Intervention no Dressing||1
8076033|NCT03815240|19913944|P2|STARTED|Intervention no Dressing||1
8076034|NCT03815240|19913945|P1|STARTED|Intervention no Dressing||2
8076035|NCT03813719|19913991|P1|NOT COMPLETED|Overall Study||0
8076036|NCT03813719|19913991|P1|COMPLETED|Overall Study||250
8076037|NCT03813719|19913991|P1|STARTED|Overall Study||250
8076038|NCT03812510|19913997|P1|NOT COMPLETED|Overall Study||152
8076039|NCT03812510|19913997|P1|COMPLETED|Overall Study||274
8076040|NCT03812510|19913997|P1|STARTED|Overall Study||426
8076041|NCT03812328|19914029|P3|NOT COMPLETED|Overall Study||1
8076042|NCT03812328|19914030|P2|NOT COMPLETED|Overall Study||3
8076043|NCT03812328|19914031|P1|NOT COMPLETED|Overall Study||0
8076044|NCT03812328|19914029|P3|COMPLETED|Overall Study||88
8076045|NCT03812328|19914030|P2|COMPLETED|Overall Study||60
8076046|NCT03812328|19914031|P1|COMPLETED|Overall Study||55
8076047|NCT03812328|19914029|P3|Safety Population|Overall Study||88
8076048|NCT03812328|19914030|P2|Safety Population|Overall Study||63
8076049|NCT03812328|19914031|P1|Safety Population|Overall Study||55
8076050|NCT03812328|19914029|P3|Modified Intent-to-Treat (mITT) Population|Overall Study||84
8076051|NCT03812328|19914030|P2|Modified Intent-to-Treat (mITT) Population|Overall Study||61
8076052|NCT03812328|19914031|P1|Modified Intent-to-Treat (mITT) Population|Overall Study||48
8076053|NCT03812328|19914029|P3|STARTED|Overall Study||89
8076054|NCT03812328|19914030|P2|STARTED|Overall Study||63
8076055|NCT03812328|19914031|P1|STARTED|Overall Study||55
8076056|NCT03811093|19914044|P2|NOT COMPLETED|Overall Study||4
8076057|NCT03811093|19914045|P1|NOT COMPLETED|Overall Study||2
8076058|NCT03811093|19914044|P2|COMPLETED|Overall Study||15
8076059|NCT03811093|19914045|P1|COMPLETED|Overall Study||18
8076060|NCT03811093|19914044|P2|STARTED|Overall Study||19
8076061|NCT03811093|19914045|P1|STARTED|Overall Study||20
8076062|NCT03810235|19914057|P2|NOT COMPLETED|Overall Study||0
8076063|NCT03810235|19914058|P1|NOT COMPLETED|Overall Study||2
8076064|NCT03810235|19914057|P2|COMPLETED|Overall Study||31
8076065|NCT03810235|19914058|P1|COMPLETED|Overall Study||30
8076066|NCT03810235|19914057|P2|Participant Data Analyzed|Overall Study||31
8076067|NCT03810235|19914058|P1|Participant Data Analyzed|Overall Study||30
8076068|NCT03810235|19914057|P2|STARTED|Overall Study||31
8076069|NCT03810235|19914058|P1|STARTED|Overall Study||32
8076070|NCT03810183|19914088|P2|NOT COMPLETED|Overall Study||1
8076071|NCT03810183|19914089|P1|NOT COMPLETED|Overall Study||2
8076072|NCT03810183|19914088|P2|COMPLETED|Overall Study||2
8076073|NCT03810183|19914089|P1|COMPLETED|Overall Study||4
8076074|NCT03810183|19914088|P2|STARTED|Overall Study||3
8076075|NCT03810183|19914089|P1|STARTED|Overall Study||6
8076076|NCT03810014|19914100|P4|NOT COMPLETED|Overall Study||2
8076077|NCT03810014|19914101|P3|NOT COMPLETED|Overall Study||0
8076078|NCT03810014|19914102|P2|NOT COMPLETED|Overall Study||2
8076079|NCT03810014|19914103|P1|NOT COMPLETED|Overall Study||2
8076080|NCT03810014|19914100|P4|COMPLETED|Overall Study||211
8076081|NCT03810014|19914101|P3|COMPLETED|Overall Study||210
8076082|NCT03810014|19914102|P2|COMPLETED|Overall Study||202
8076083|NCT03810014|19914103|P1|COMPLETED|Overall Study||213
8076084|NCT03810014|19914100|P4|STARTED|Overall Study||213
8076085|NCT03810014|19914101|P3|STARTED|Overall Study||210
8076086|NCT03810014|19914102|P2|STARTED|Overall Study||204
8076087|NCT03810014|19914103|P1|STARTED|Overall Study||215
8076088|NCT03809910|19914125|P2|NOT COMPLETED|Period 3 (Visit 4)||0
8076089|NCT03809910|19914126|P1|NOT COMPLETED|Period 3 (Visit 4)||0
8076090|NCT03809910|19914125|P2|COMPLETED|Period 3 (Visit 4)||19
8076091|NCT03809910|19914126|P1|COMPLETED|Period 3 (Visit 4)||20
8076092|NCT03809910|19914125|P2|STARTED|Period 3 (Visit 4)||19
8076093|NCT03809910|19914126|P1|STARTED|Period 3 (Visit 4)||20
8076094|NCT03809910|19914125|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
8076095|NCT03809910|19914126|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
8076096|NCT03809910|19914125|P2|COMPLETED|Washout Period 2 (3 Days)||19
8076097|NCT03809910|19914126|P1|COMPLETED|Washout Period 2 (3 Days)||20
8076098|NCT03809910|19914125|P2|STARTED|Washout Period 2 (3 Days)||19
8076099|NCT03809910|19914126|P1|STARTED|Washout Period 2 (3 Days)||20
8076100|NCT03809910|19914125|P2|NOT COMPLETED|Period 2 (Visit 3)||0
8076101|NCT03809910|19914126|P1|NOT COMPLETED|Period 2 (Visit 3)||0
8076102|NCT03809910|19914125|P2|COMPLETED|Period 2 (Visit 3)||19
8076103|NCT03809910|19914126|P1|COMPLETED|Period 2 (Visit 3)||20
8076104|NCT03809910|19914125|P2|STARTED|Period 2 (Visit 3)||19
8076105|NCT03809910|19914126|P1|STARTED|Period 2 (Visit 3)||20
8076106|NCT03809910|19914125|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
8076107|NCT03809910|19914126|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
8076108|NCT03809910|19914125|P2|COMPLETED|Washout Period 1 (3 Days)||19
8076109|NCT03809910|19914126|P1|COMPLETED|Washout Period 1 (3 Days)||20
8076110|NCT03809910|19914125|P2|STARTED|Washout Period 1 (3 Days)||19
8076111|NCT03809910|19914126|P1|STARTED|Washout Period 1 (3 Days)||20
8076112|NCT03809910|19914125|P2|NOT COMPLETED|Period 1 (Visit 2)||0
8076113|NCT03809910|19914126|P1|NOT COMPLETED|Period 1 (Visit 2)||0
8076114|NCT03809910|19914125|P2|COMPLETED|Period 1 (Visit 2)||19
8076115|NCT03809910|19914126|P1|COMPLETED|Period 1 (Visit 2)||20
8076116|NCT03809910|19914125|P2|STARTED|Period 1 (Visit 2)||19
8076117|NCT03809910|19914126|P1|STARTED|Period 1 (Visit 2)||20
8076118|NCT03809611|19914160|P2|NOT COMPLETED|Overall Study||1
8076119|NCT03809611|19914161|P1|NOT COMPLETED|Overall Study||1
8076120|NCT03809611|19914160|P2|COMPLETED|Overall Study||61
8076121|NCT03809611|19914161|P1|COMPLETED|Overall Study||61
8076122|NCT03809611|19914160|P2|STARTED|Overall Study||62
8076123|NCT03809611|19914161|P1|STARTED|Overall Study||62
8076124|NCT03809182|19914174|P2|NOT COMPLETED|Overall Study||0
8076125|NCT03809182|19914175|P1|NOT COMPLETED|Overall Study||0
8076126|NCT03809182|19914174|P2|COMPLETED|Overall Study||20
8076127|NCT03809182|19914175|P1|COMPLETED|Overall Study||20
8076128|NCT03809182|19914174|P2|STARTED|Overall Study||20
8076129|NCT03809182|19914175|P1|STARTED|Overall Study||20
8076130|NCT03809104|19914193|P1|NOT COMPLETED|Overall Study||3
8076131|NCT03809104|19914193|P1|COMPLETED|Overall Study||40
8076132|NCT03809104|19914193|P1|STARTED|Overall Study||43
8076133|NCT03808688|19914204|P2|NOT COMPLETED|Overall Study||23
8076134|NCT03808688|19914205|P1|NOT COMPLETED|Overall Study||18
8076135|NCT03808688|19914204|P2|COMPLETED|Overall Study||138
8076136|NCT03808688|19914205|P1|COMPLETED|Overall Study||81
8076137|NCT03808688|19914204|P2|STARTED|Overall Study||161
8076138|NCT03808688|19914205|P1|STARTED|Overall Study||99
8076139|NCT03808493|19914217|P4|NOT COMPLETED|Overall Study||0
8076140|NCT03808493|19914218|P3|NOT COMPLETED|Overall Study||0
8076141|NCT03808493|19914219|P2|NOT COMPLETED|Overall Study||0
8076142|NCT03808493|19914220|P1|NOT COMPLETED|Overall Study||0
8076143|NCT03808493|19914217|P4|COMPLETED|Overall Study||12
8076144|NCT03808493|19914218|P3|COMPLETED|Overall Study||12
8076145|NCT03808493|19914219|P2|COMPLETED|Overall Study||12
8076146|NCT03808493|19914220|P1|COMPLETED|Overall Study||12
8076147|NCT03808493|19914217|P4|STARTED|Overall Study||12
8076148|NCT03808493|19914218|P3|STARTED|Overall Study||12
8076149|NCT03808493|19914219|P2|STARTED|Overall Study||12
8076150|NCT03808493|19914220|P1|STARTED|Overall Study||12
8076151|NCT03808298|19914250|P1|NOT COMPLETED|Overall Study||8
8076152|NCT03808298|19914250|P1|COMPLETED|Overall Study||49
8076153|NCT03808298|19914250|P1|STARTED|Overall Study||57
8076154|NCT03807739|19914327|P4|NOT COMPLETED|Overall Study||0
8076155|NCT03807739|19914328|P3|NOT COMPLETED|Overall Study||0
8076156|NCT03807739|19914329|P2|NOT COMPLETED|Overall Study||0
8076157|NCT03807739|19914330|P1|NOT COMPLETED|Overall Study||2
8076158|NCT03807739|19914327|P4|COMPLETED|Overall Study||10
8076159|NCT03807739|19914328|P3|COMPLETED|Overall Study||9
8076160|NCT03807739|19914329|P2|COMPLETED|Overall Study||10
8076161|NCT03807739|19914330|P1|COMPLETED|Overall Study||7
8076162|NCT03807739|19914327|P4|STARTED|Overall Study||10
8076163|NCT03807739|19914328|P3|STARTED|Overall Study||9
8076164|NCT03807739|19914329|P2|STARTED|Overall Study||10
8076165|NCT03807739|19914330|P1|STARTED|Overall Study||9
8076166|NCT03807700|19914346|P2|NOT COMPLETED|Overall Study||1
8076167|NCT03807700|19914347|P1|NOT COMPLETED|Overall Study||2
8076168|NCT03807700|19914346|P2|COMPLETED|Overall Study||58
8076169|NCT03807700|19914347|P1|COMPLETED|Overall Study||58
8076170|NCT03807700|19914346|P2|STARTED|Overall Study||59
8076171|NCT03807700|19914347|P1|STARTED|Overall Study||60
8076172|NCT03807544|19914370|P1|NOT COMPLETED|Overall Study||0
8076173|NCT03807544|19914370|P1|COMPLETED|Overall Study||17
8076174|NCT03807544|19914370|P1|STARTED|Overall Study||17
8076184|NCT03807089|19914402|P2|NOT COMPLETED|Overall Study||0
8076185|NCT03807089|19914403|P1|NOT COMPLETED|Overall Study||0
8076186|NCT03807089|19914402|P2|COMPLETED|Overall Study||93
8076187|NCT03807089|19914403|P1|COMPLETED|Overall Study||101
8076188|NCT03807089|19914402|P2|STARTED|Overall Study||93
8076189|NCT03807089|19914403|P1|STARTED|Overall Study||101
8076190|NCT03806790|19914419|P2|NOT COMPLETED|Overall Study||0
8076191|NCT03806790|19914420|P1|NOT COMPLETED|Overall Study||0
8076192|NCT03806790|19914419|P2|COMPLETED|Overall Study||95
8076193|NCT03806790|19914420|P1|COMPLETED|Overall Study||87
8076194|NCT03806790|19914419|P2|STARTED|Overall Study||95
8076195|NCT03806790|19914420|P1|STARTED|Overall Study||87
8076196|NCT03806270|19914435|P3|NOT COMPLETED|Overall Study||0
8076197|NCT03806270|19914436|P2|NOT COMPLETED|Overall Study||0
8076198|NCT03806270|19914437|P1|NOT COMPLETED|Overall Study||0
8076199|NCT03806270|19914435|P3|COMPLETED|Overall Study||15
8076200|NCT03806270|19914436|P2|COMPLETED|Overall Study||15
8076201|NCT03806270|19914437|P1|COMPLETED|Overall Study||15
8076202|NCT03806270|19914435|P3|STARTED|Overall Study||15
8076203|NCT03806270|19914436|P2|STARTED|Overall Study||15
8076204|NCT03806270|19914437|P1|STARTED|Overall Study||15
8076205|NCT03805971|19914463|P1|NOT COMPLETED|Overall Study||3
8076206|NCT03805971|19914463|P1|COMPLETED|Overall Study||62
8076207|NCT03805971|19914463|P1|STARTED|Overall Study||65
8076208|NCT03805672|19914478|P2|NOT COMPLETED|Overall Study||0
8076209|NCT03805672|19914479|P1|NOT COMPLETED|Overall Study||0
8076210|NCT03805672|19914478|P2|COMPLETED|Overall Study||2
8076211|NCT03805672|19914479|P1|COMPLETED|Overall Study||2
8076212|NCT03805672|19914478|P2|STARTED|Overall Study||2
8076213|NCT03805672|19914479|P1|STARTED|Overall Study||2
8076214|NCT03804918|19914485|P1|NOT COMPLETED|Overall Study||1
8076215|NCT03804918|19914485|P1|COMPLETED|Overall Study||16
8076216|NCT03804918|19914485|P1|STARTED|Overall Study||17
8076217|NCT03804710|19914492|P2|NOT COMPLETED|Overall Study||5
8076218|NCT03804710|19914493|P1|NOT COMPLETED|Overall Study||2
8076219|NCT03804710|19914492|P2|COMPLETED|Overall Study||69
8076220|NCT03804710|19914493|P1|COMPLETED|Overall Study||73
8076221|NCT03804710|19914492|P2|STARTED|Overall Study||74
8076222|NCT03804710|19914493|P1|STARTED|Overall Study||75
8076223|NCT03803085|19914550|P2|NOT COMPLETED|Overall Study||2
8076224|NCT03803085|19914551|P1|NOT COMPLETED|Overall Study||2
8076225|NCT03803085|19914550|P2|COMPLETED|Overall Study||28
8076226|NCT03803085|19914551|P1|COMPLETED|Overall Study||28
8076227|NCT03803085|19914550|P2|STARTED|Overall Study||30
8076228|NCT03803085|19914551|P1|STARTED|Overall Study||30
8076229|NCT03802864|19914563|P2|NOT COMPLETED|Overall Study||0
8076230|NCT03802864|19914564|P1|NOT COMPLETED|Overall Study||0
8076231|NCT03802864|19914563|P2|COMPLETED|Overall Study||25
8076232|NCT03802864|19914564|P1|COMPLETED|Overall Study||25
8076233|NCT03802864|19914563|P2|STARTED|Overall Study||25
8076234|NCT03802864|19914564|P1|STARTED|Overall Study||25
8076250|NCT03802344|19914606|P3|NOT COMPLETED|Overall Study||13
8076251|NCT03802344|19914607|P2|NOT COMPLETED|Overall Study||6
8076252|NCT03802344|19914608|P1|NOT COMPLETED|Overall Study||8
8076253|NCT03802344|19914606|P3|COMPLETED|Overall Study||55
8076254|NCT03802344|19914607|P2|COMPLETED|Overall Study||203
8076255|NCT03802344|19914608|P1|COMPLETED|Overall Study||205
8076256|NCT03802344|19914606|P3|STARTED|Overall Study||68
8076257|NCT03802344|19914607|P2|STARTED|Overall Study||209
8076258|NCT03802344|19914608|P1|STARTED|Overall Study||213
8076259|NCT03801148|19914623|P4|NOT COMPLETED|Follow-Up (12 Days)||0
8076260|NCT03801148|19914624|P3|NOT COMPLETED|Follow-Up (12 Days)||1
8076261|NCT03801148|19914625|P2|NOT COMPLETED|Follow-Up (12 Days)||1
8076262|NCT03801148|19914626|P1|NOT COMPLETED|Follow-Up (12 Days)||0
8076263|NCT03801148|19914623|P4|COMPLETED|Follow-Up (12 Days)||29
8076264|NCT03801148|19914624|P3|COMPLETED|Follow-Up (12 Days)||28
8076265|NCT03801148|19914625|P2|COMPLETED|Follow-Up (12 Days)||29
8076266|NCT03801148|19914626|P1|COMPLETED|Follow-Up (12 Days)||30
8076267|NCT03801148|19914623|P4|STARTED|Follow-Up (12 Days)||29
8076268|NCT03801148|19914624|P3|STARTED|Follow-Up (12 Days)||29
8076269|NCT03801148|19914625|P2|STARTED|Follow-Up (12 Days)||30
8076270|NCT03801148|19914626|P1|STARTED|Follow-Up (12 Days)||30
8076271|NCT03801148|19914623|P4|NOT COMPLETED|Period 2 (2 Days)||0
8076272|NCT03801148|19914624|P3|NOT COMPLETED|Period 2 (2 Days)||0
8076273|NCT03801148|19914625|P2|NOT COMPLETED|Period 2 (2 Days)||0
8076274|NCT03801148|19914626|P1|NOT COMPLETED|Period 2 (2 Days)||0
8076275|NCT03801148|19914623|P4|COMPLETED|Period 2 (2 Days)||29
8076276|NCT03801148|19914624|P3|COMPLETED|Period 2 (2 Days)||29
8076277|NCT03801148|19914625|P2|COMPLETED|Period 2 (2 Days)||30
8076278|NCT03801148|19914626|P1|COMPLETED|Period 2 (2 Days)||30
8076279|NCT03801148|19914623|P4|STARTED|Period 2 (2 Days)||29
8076280|NCT03801148|19914624|P3|STARTED|Period 2 (2 Days)||29
8076281|NCT03801148|19914625|P2|STARTED|Period 2 (2 Days)||30
8076282|NCT03801148|19914626|P1|STARTED|Period 2 (2 Days)||30
8076283|NCT03801148|19914623|P4|NOT COMPLETED|Washout Period (at Least 5 Days)||1
8076284|NCT03801148|19914624|P3|NOT COMPLETED|Washout Period (at Least 5 Days)||1
8076285|NCT03801148|19914625|P2|NOT COMPLETED|Washout Period (at Least 5 Days)||0
8076286|NCT03801148|19914626|P1|NOT COMPLETED|Washout Period (at Least 5 Days)||0
8076287|NCT03801148|19914623|P4|COMPLETED|Washout Period (at Least 5 Days)||29
8076288|NCT03801148|19914624|P3|COMPLETED|Washout Period (at Least 5 Days)||29
8076289|NCT03801148|19914625|P2|COMPLETED|Washout Period (at Least 5 Days)||30
8076290|NCT03801148|19914626|P1|COMPLETED|Washout Period (at Least 5 Days)||30
8076291|NCT03801148|19914623|P4|STARTED|Washout Period (at Least 5 Days)||30
8076292|NCT03801148|19914624|P3|STARTED|Washout Period (at Least 5 Days)||30
8076293|NCT03801148|19914625|P2|STARTED|Washout Period (at Least 5 Days)||30
8076294|NCT03801148|19914626|P1|STARTED|Washout Period (at Least 5 Days)||30
8076295|NCT03801148|19914623|P4|NOT COMPLETED|Period 1 (2 Days)||0
8076296|NCT03801148|19914624|P3|NOT COMPLETED|Period 1 (2 Days)||0
8076297|NCT03801148|19914625|P2|NOT COMPLETED|Period 1 (2 Days)||1
8076298|NCT03801148|19914626|P1|NOT COMPLETED|Period 1 (2 Days)||1
8076299|NCT03801148|19914623|P4|COMPLETED|Period 1 (2 Days)||30
8076300|NCT03801148|19914624|P3|COMPLETED|Period 1 (2 Days)||30
8076301|NCT03801148|19914625|P2|COMPLETED|Period 1 (2 Days)||30
8076302|NCT03801148|19914626|P1|COMPLETED|Period 1 (2 Days)||30
8076303|NCT03801148|19914623|P4|STARTED|Period 1 (2 Days)||30
8076304|NCT03801148|19914624|P3|STARTED|Period 1 (2 Days)||30
8076305|NCT03801148|19914625|P2|STARTED|Period 1 (2 Days)||31
8076306|NCT03801148|19914626|P1|STARTED|Period 1 (2 Days)||31
8076307|NCT03801044|19914648|P1|NOT COMPLETED|Overall Study||0
8076308|NCT03801044|19914648|P1|COMPLETED|Overall Study||21
8076309|NCT03801044|19914648|P1|STARTED|Overall Study||21
8076310|NCT03800030|19914667|P6|NOT COMPLETED|Third Intervention||0
8076311|NCT03800030|19914668|P5|NOT COMPLETED|Third Intervention||0
8076312|NCT03800030|19914669|P4|NOT COMPLETED|Third Intervention||0
8076313|NCT03800030|19914670|P3|NOT COMPLETED|Third Intervention||0
8076314|NCT03800030|19914671|P2|NOT COMPLETED|Third Intervention||0
8076315|NCT03800030|19914672|P1|NOT COMPLETED|Third Intervention||0
8076316|NCT03800030|19914667|P6|COMPLETED|Third Intervention||4
8076317|NCT03800030|19914668|P5|COMPLETED|Third Intervention||4
8076318|NCT03800030|19914669|P4|COMPLETED|Third Intervention||4
8076319|NCT03800030|19914670|P3|COMPLETED|Third Intervention||4
8076320|NCT03800030|19914671|P2|COMPLETED|Third Intervention||4
8076321|NCT03800030|19914672|P1|COMPLETED|Third Intervention||4
8076322|NCT03800030|19914667|P6|STARTED|Third Intervention||4
8076323|NCT03800030|19914668|P5|STARTED|Third Intervention||4
8076324|NCT03800030|19914669|P4|STARTED|Third Intervention||4
8076325|NCT03800030|19914670|P3|STARTED|Third Intervention||4
8076326|NCT03800030|19914671|P2|STARTED|Third Intervention||4
8076327|NCT03800030|19914672|P1|STARTED|Third Intervention||4
8076328|NCT03800030|19914667|P6|NOT COMPLETED|Second Washout (1 Week)||0
8076329|NCT03800030|19914668|P5|NOT COMPLETED|Second Washout (1 Week)||0
8076330|NCT03800030|19914669|P4|NOT COMPLETED|Second Washout (1 Week)||1
8076331|NCT03800030|19914670|P3|NOT COMPLETED|Second Washout (1 Week)||0
8076332|NCT03800030|19914671|P2|NOT COMPLETED|Second Washout (1 Week)||0
8076333|NCT03800030|19914672|P1|NOT COMPLETED|Second Washout (1 Week)||0
8076334|NCT03800030|19914667|P6|COMPLETED|Second Washout (1 Week)||4
8076335|NCT03800030|19914668|P5|COMPLETED|Second Washout (1 Week)||4
8076336|NCT03800030|19914669|P4|COMPLETED|Second Washout (1 Week)||4
8076337|NCT03800030|19914670|P3|COMPLETED|Second Washout (1 Week)||4
8076338|NCT03800030|19914671|P2|COMPLETED|Second Washout (1 Week)||4
8076339|NCT03800030|19914672|P1|COMPLETED|Second Washout (1 Week)||4
8076340|NCT03800030|19914667|P6|STARTED|Second Washout (1 Week)||4
8076341|NCT03800030|19914668|P5|STARTED|Second Washout (1 Week)||4
8076342|NCT03800030|19914669|P4|STARTED|Second Washout (1 Week)||5
8076343|NCT03800030|19914670|P3|STARTED|Second Washout (1 Week)||4
8076344|NCT03800030|19914671|P2|STARTED|Second Washout (1 Week)||4
8076345|NCT03800030|19914672|P1|STARTED|Second Washout (1 Week)||4
8076346|NCT03800030|19914667|P6|NOT COMPLETED|Second Intervention||0
8076347|NCT03800030|19914668|P5|NOT COMPLETED|Second Intervention||0
8076348|NCT03800030|19914669|P4|NOT COMPLETED|Second Intervention||1
8076349|NCT03800030|19914670|P3|NOT COMPLETED|Second Intervention||0
8076350|NCT03800030|19914671|P2|NOT COMPLETED|Second Intervention||0
8076351|NCT03800030|19914672|P1|NOT COMPLETED|Second Intervention||0
8076352|NCT03800030|19914667|P6|COMPLETED|Second Intervention||4
8076353|NCT03800030|19914668|P5|COMPLETED|Second Intervention||4
8076354|NCT03800030|19914669|P4|COMPLETED|Second Intervention||5
8076355|NCT03800030|19914670|P3|COMPLETED|Second Intervention||4
8076356|NCT03800030|19914671|P2|COMPLETED|Second Intervention||4
8076357|NCT03800030|19914672|P1|COMPLETED|Second Intervention||4
8076358|NCT03800030|19914667|P6|STARTED|Second Intervention||4
8076359|NCT03800030|19914668|P5|STARTED|Second Intervention||4
8076360|NCT03800030|19914669|P4|STARTED|Second Intervention||6
8076361|NCT03800030|19914670|P3|STARTED|Second Intervention||4
8076362|NCT03800030|19914671|P2|STARTED|Second Intervention||4
8076363|NCT03800030|19914672|P1|STARTED|Second Intervention||4
8076364|NCT03800030|19914667|P6|NOT COMPLETED|First Washout (1 Week)||0
8076365|NCT03800030|19914668|P5|NOT COMPLETED|First Washout (1 Week)||0
8076366|NCT03800030|19914669|P4|NOT COMPLETED|First Washout (1 Week)||0
8076367|NCT03800030|19914670|P3|NOT COMPLETED|First Washout (1 Week)||0
8076368|NCT03800030|19914671|P2|NOT COMPLETED|First Washout (1 Week)||0
8076369|NCT03800030|19914672|P1|NOT COMPLETED|First Washout (1 Week)||0
8076370|NCT03800030|19914667|P6|COMPLETED|First Washout (1 Week)||4
8076371|NCT03800030|19914668|P5|COMPLETED|First Washout (1 Week)||4
8076372|NCT03800030|19914669|P4|COMPLETED|First Washout (1 Week)||6
8076373|NCT03800030|19914670|P3|COMPLETED|First Washout (1 Week)||4
8076374|NCT03800030|19914671|P2|COMPLETED|First Washout (1 Week)||4
8076375|NCT03800030|19914672|P1|COMPLETED|First Washout (1 Week)||4
8076376|NCT03800030|19914667|P6|STARTED|First Washout (1 Week)||4
8076377|NCT03800030|19914668|P5|STARTED|First Washout (1 Week)||4
8076378|NCT03800030|19914669|P4|STARTED|First Washout (1 Week)||6
8076379|NCT03800030|19914670|P3|STARTED|First Washout (1 Week)||4
8076380|NCT03800030|19914671|P2|STARTED|First Washout (1 Week)||4
8076381|NCT03800030|19914672|P1|STARTED|First Washout (1 Week)||4
8076382|NCT03800030|19914667|P6|NOT COMPLETED|First Intervention||0
8076383|NCT03800030|19914668|P5|NOT COMPLETED|First Intervention||0
8076384|NCT03800030|19914669|P4|NOT COMPLETED|First Intervention||0
8076385|NCT03800030|19914670|P3|NOT COMPLETED|First Intervention||0
8076386|NCT03800030|19914671|P2|NOT COMPLETED|First Intervention||0
8076387|NCT03800030|19914672|P1|NOT COMPLETED|First Intervention||0
8076388|NCT03800030|19914667|P6|COMPLETED|First Intervention||4
8076389|NCT03800030|19914668|P5|COMPLETED|First Intervention||4
8076390|NCT03800030|19914669|P4|COMPLETED|First Intervention||6
8076391|NCT03800030|19914670|P3|COMPLETED|First Intervention||4
8076392|NCT03800030|19914671|P2|COMPLETED|First Intervention||4
8076393|NCT03800030|19914672|P1|COMPLETED|First Intervention||4
8076394|NCT03800030|19914667|P6|STARTED|First Intervention||4
8076395|NCT03800030|19914668|P5|STARTED|First Intervention||4
8076396|NCT03800030|19914669|P4|STARTED|First Intervention||6
8076397|NCT03800030|19914670|P3|STARTED|First Intervention||4
8076398|NCT03800030|19914671|P2|STARTED|First Intervention||4
8076399|NCT03800030|19914672|P1|STARTED|First Intervention||4
8076400|NCT03800030|19914667|P6|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
8076401|NCT03800030|19914668|P5|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
8076402|NCT03800030|19914669|P4|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
8076403|NCT03800030|19914670|P3|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
8076404|NCT03800030|19914671|P2|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
8076405|NCT03800030|19914672|P1|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
8076406|NCT03800030|19914667|P6|COMPLETED|Pre-Randomization Period (1 Week)||4
8076407|NCT03800030|19914668|P5|COMPLETED|Pre-Randomization Period (1 Week)||4
8076408|NCT03800030|19914669|P4|COMPLETED|Pre-Randomization Period (1 Week)||6
8076409|NCT03800030|19914670|P3|COMPLETED|Pre-Randomization Period (1 Week)||4
8076410|NCT03800030|19914671|P2|COMPLETED|Pre-Randomization Period (1 Week)||4
8076411|NCT03800030|19914672|P1|COMPLETED|Pre-Randomization Period (1 Week)||4
8076412|NCT03800030|19914667|P6|STARTED|Pre-Randomization Period (1 Week)||4
8076413|NCT03800030|19914668|P5|STARTED|Pre-Randomization Period (1 Week)||4
8076414|NCT03800030|19914669|P4|STARTED|Pre-Randomization Period (1 Week)||6
8076415|NCT03800030|19914670|P3|STARTED|Pre-Randomization Period (1 Week)||4
8076416|NCT03800030|19914671|P2|STARTED|Pre-Randomization Period (1 Week)||4
8076417|NCT03800030|19914672|P1|STARTED|Pre-Randomization Period (1 Week)||4
8076418|NCT03800030|19914667|P6|NOT COMPLETED|Baseline||0
8076419|NCT03800030|19914668|P5|NOT COMPLETED|Baseline||0
8076420|NCT03800030|19914669|P4|NOT COMPLETED|Baseline||0
8076421|NCT03800030|19914670|P3|NOT COMPLETED|Baseline||0
8076422|NCT03800030|19914671|P2|NOT COMPLETED|Baseline||0
8076423|NCT03800030|19914672|P1|NOT COMPLETED|Baseline||0
8076424|NCT03800030|19914667|P6|COMPLETED|Baseline||4
8076425|NCT03800030|19914668|P5|COMPLETED|Baseline||4
8076426|NCT03800030|19914669|P4|COMPLETED|Baseline||6
8076427|NCT03800030|19914670|P3|COMPLETED|Baseline||4
8076428|NCT03800030|19914671|P2|COMPLETED|Baseline||4
8076429|NCT03800030|19914672|P1|COMPLETED|Baseline||4
8076430|NCT03800030|19914667|P6|STARTED|Baseline||4
8076431|NCT03800030|19914668|P5|STARTED|Baseline||4
8076432|NCT03800030|19914669|P4|STARTED|Baseline||6
8076433|NCT03800030|19914670|P3|STARTED|Baseline||4
8076434|NCT03800030|19914671|P2|STARTED|Baseline||4
8076435|NCT03800030|19914672|P1|STARTED|Baseline||4
8076439|NCT03799614|19914702|P2|NOT COMPLETED|Overall Study||0
8076440|NCT03799614|19914703|P1|NOT COMPLETED|Overall Study||0
8076441|NCT03799614|19914702|P2|COMPLETED|Overall Study||15
8076442|NCT03799614|19914703|P1|COMPLETED|Overall Study||15
8076443|NCT03799614|19914702|P2|STARTED|Overall Study||15
8076444|NCT03799614|19914703|P1|STARTED|Overall Study||15
8076445|NCT03799484|19914715|P1|NOT COMPLETED|Overall Study||0
8076446|NCT03799484|19914715|P1|COMPLETED|Overall Study||14
8076447|NCT03799484|19914715|P1|STARTED|Overall Study||14
8076448|NCT03799211|19914745|P2|NOT COMPLETED|Overall Study||13
8076449|NCT03799211|19914746|P1|NOT COMPLETED|Overall Study||4
8076450|NCT03799211|19914745|P2|COMPLETED|Overall Study||27
8076451|NCT03799211|19914746|P1|COMPLETED|Overall Study||32
8076452|NCT03799211|19914745|P2|STARTED|Overall Study||40
8076453|NCT03799211|19914746|P1|STARTED|Overall Study||36
8076454|NCT03796260|19914764|P2|NOT COMPLETED|Period 2||0
8076455|NCT03796260|19914765|P1|NOT COMPLETED|Period 2||0
8076456|NCT03796260|19914764|P2|COMPLETED|Period 2||7
8076457|NCT03796260|19914765|P1|COMPLETED|Period 2||7
8076458|NCT03796260|19914764|P2|STARTED|Period 2||7
8076459|NCT03796260|19914765|P1|STARTED|Period 2||7
8076460|NCT03796260|19914764|P2|NOT COMPLETED|Period 1||0
8076461|NCT03796260|19914765|P1|NOT COMPLETED|Period 1||0
8076462|NCT03796260|19914764|P2|COMPLETED|Period 1||7
8076463|NCT03796260|19914765|P1|COMPLETED|Period 1||7
8076464|NCT03796260|19914764|P2|STARTED|Period 1||7
8076465|NCT03796260|19914765|P1|STARTED|Period 1||7
8076466|NCT03796182|19914777|P2|NOT COMPLETED|Period 2||0
8076467|NCT03796182|19914778|P1|NOT COMPLETED|Period 2||0
8076468|NCT03796182|19914777|P2|COMPLETED|Period 2||6
8076469|NCT03796182|19914778|P1|COMPLETED|Period 2||6
8076470|NCT03796182|19914777|P2|STARTED|Period 2||6
8076471|NCT03796182|19914778|P1|STARTED|Period 2||6
8076472|NCT03796182|19914777|P2|NOT COMPLETED|Washout Period||0
8076473|NCT03796182|19914778|P1|NOT COMPLETED|Washout Period||0
8076474|NCT03796182|19914777|P2|COMPLETED|Washout Period||6
8076475|NCT03796182|19914778|P1|COMPLETED|Washout Period||6
8076476|NCT03796182|19914777|P2|STARTED|Washout Period||6
8076477|NCT03796182|19914778|P1|STARTED|Washout Period||6
8076478|NCT03796182|19914777|P2|NOT COMPLETED|Period 1||0
8076479|NCT03796182|19914778|P1|NOT COMPLETED|Period 1||0
8076480|NCT03796182|19914777|P2|COMPLETED|Period 1||6
8076481|NCT03796182|19914778|P1|COMPLETED|Period 1||6
8076482|NCT03796182|19914777|P2|STARTED|Period 1||6
8076483|NCT03796182|19914778|P1|STARTED|Period 1||6
8076484|NCT03796013|19914812|P2|NOT COMPLETED|Period 2||0
8076485|NCT03796013|19914813|P1|NOT COMPLETED|Period 2||0
8076486|NCT03796013|19914812|P2|COMPLETED|Period 2||14
8076487|NCT03796013|19914813|P1|COMPLETED|Period 2||14
8076488|NCT03796013|19914812|P2|STARTED|Period 2||14
8076489|NCT03796013|19914813|P1|STARTED|Period 2||14
8076490|NCT03796013|19914812|P2|NOT COMPLETED|Period 1||0
8076491|NCT03796013|19914813|P1|NOT COMPLETED|Period 1||0
8076492|NCT03796013|19914812|P2|COMPLETED|Period 1||14
8076493|NCT03796013|19914813|P1|COMPLETED|Period 1||14
8076494|NCT03796013|19914812|P2|STARTED|Period 1||14
8076495|NCT03796013|19914813|P1|STARTED|Period 1||14
8076496|NCT03795753|19914825|P2|NOT COMPLETED|Overall Study||0
8076497|NCT03795753|19914826|P1|NOT COMPLETED|Overall Study||0
8076498|NCT03795753|19914825|P2|COMPLETED|Overall Study||13
8076499|NCT03795753|19914826|P1|COMPLETED|Overall Study||23
8076500|NCT03795753|19914825|P2|STARTED|Overall Study||13
8076501|NCT03795753|19914826|P1|STARTED|Overall Study||23
8076502|NCT03794752|19914838|P1|NOT COMPLETED|Overall Study||0
8076503|NCT03794752|19914838|P1|COMPLETED|Overall Study||8
8076504|NCT03794752|19914838|P1|STARTED|Overall Study||8
8076505|NCT03794024|19914848|P2|NOT COMPLETED|Overall Study||0
8076506|NCT03794024|19914849|P1|NOT COMPLETED|Overall Study||1
8076507|NCT03794024|19914848|P2|COMPLETED|Overall Study||0
8076508|NCT03794024|19914849|P1|COMPLETED|Overall Study||0
8076509|NCT03794024|19914848|P2|STARTED|Overall Study||0
8076510|NCT03794024|19914849|P1|STARTED|Overall Study||1
8076511|NCT03793751|19914871|P2|NOT COMPLETED|Overall Study||0
8076512|NCT03793751|19914872|P1|NOT COMPLETED|Overall Study||0
8076513|NCT03793751|19914871|P2|COMPLETED|Overall Study||60
8076514|NCT03793751|19914872|P1|COMPLETED|Overall Study||60
8076515|NCT03793751|19914871|P2|STARTED|Overall Study||60
8076516|NCT03793751|19914872|P1|STARTED|Overall Study||60
8076517|NCT03793556|19914888|P2|NOT COMPLETED|Overall Study||2
8076518|NCT03793556|19914889|P1|NOT COMPLETED|Overall Study||13
8076519|NCT03793556|19914888|P2|COMPLETED|Overall Study||34
8076520|NCT03793556|19914889|P1|COMPLETED|Overall Study||22
8076521|NCT03793556|19914888|P2|STARTED|Overall Study||36
8076522|NCT03793556|19914889|P1|STARTED|Overall Study||35
8076523|NCT03793010|19914933|P2|NOT COMPLETED|Overall Study||27
8076524|NCT03793010|19914934|P1|NOT COMPLETED|Overall Study||28
8076525|NCT03793010|19914933|P2|COMPLETED|Overall Study||8
8076526|NCT03793010|19914934|P1|COMPLETED|Overall Study||7
8076527|NCT03793010|19914933|P2|Randomized But Not Dosed|Overall Study||0
8076528|NCT03793010|19914934|P1|Randomized But Not Dosed|Overall Study||2
8076529|NCT03793010|19914933|P2|STARTED|Overall Study||35
8076530|NCT03793010|19914934|P1|STARTED|Overall Study||35
8076657|NCT03791489|19914969|P1|NOT COMPLETED|90 Days (Primary Endpoint)||0
8076658|NCT03791489|19914969|P1|COMPLETED|90 Days (Primary Endpoint)||30
8076659|NCT03791489|19914969|P1|STARTED|90 Days (Primary Endpoint)||30
8076660|NCT03791489|19914969|P1|NOT COMPLETED|30 Days||0
8076661|NCT03791489|19914969|P1|COMPLETED|30 Days||30
8076662|NCT03791489|19914969|P1|STARTED|30 Days||30
8076663|NCT03790917|19914976|P1|NOT COMPLETED|Overall Study||1
8076664|NCT03790917|19914976|P1|COMPLETED|Overall Study||200
8076665|NCT03790917|19914976|P1|STARTED|Overall Study||201
8076666|NCT03790306|19914986|P1|NOT COMPLETED|Overall Study||0
8076667|NCT03790306|19914986|P1|COMPLETED|Overall Study||207
8076668|NCT03790306|19914986|P1|STARTED|Overall Study||207
8076669|NCT03789474|19915000|P2|NOT COMPLETED|Overall Study||0
8076670|NCT03789474|19915001|P1|NOT COMPLETED|Overall Study||0
8076671|NCT03789474|19915000|P2|COMPLETED|Overall Study||30
8076672|NCT03789474|19915001|P1|COMPLETED|Overall Study||30
8076673|NCT03789474|19915000|P2|STARTED|Overall Study||30
8076674|NCT03789474|19915001|P1|STARTED|Overall Study||30
8076675|NCT03789175|19915097|P1|NOT COMPLETED|Week 12 to Week 24 of NR||0
8076676|NCT03789175|19915097|P1|COMPLETED|Week 12 to Week 24 of NR|Participant did not meet primary endpoint and completed study at week 24|1
8076677|NCT03789175|19915097|P1|STARTED|Week 12 to Week 24 of NR||1
8076678|NCT03789175|19915097|P1|NOT COMPLETED|Week 0 to Week 12 of NR||0
8076679|NCT03789175|19915097|P1|COMPLETED|Week 0 to Week 12 of NR||1
8076680|NCT03789175|19915097|P1|STARTED|Week 0 to Week 12 of NR||1
8076681|NCT03787472|19915104|P2|NOT COMPLETED|Period 2||0
8076682|NCT03787472|19915105|P1|NOT COMPLETED|Period 2||0
8076683|NCT03787472|19915104|P2|COMPLETED|Period 2||22
8076684|NCT03787472|19915105|P1|COMPLETED|Period 2||23
8076685|NCT03787472|19915104|P2|STARTED|Period 2||22
8076686|NCT03787472|19915105|P1|STARTED|Period 2||23
8076687|NCT03787472|19915104|P2|NOT COMPLETED|Period 1||0
8076688|NCT03787472|19915105|P1|NOT COMPLETED|Period 1||0
8076689|NCT03787472|19915104|P2|COMPLETED|Period 1||22
8076690|NCT03787472|19915105|P1|COMPLETED|Period 1||23
8076691|NCT03787472|19915104|P2|STARTED|Period 1||22
8076692|NCT03787472|19915105|P1|STARTED|Period 1||23
8076693|NCT03787212|19915113|P2|NOT COMPLETED|Period 1||2
8076694|NCT03787212|19915114|P1|NOT COMPLETED|Period 1||2
8076695|NCT03787212|19915113|P2|COMPLETED|Period 1||0
8076696|NCT03787212|19915114|P1|COMPLETED|Period 1||0
8076697|NCT03787212|19915113|P2|STARTED|Period 1||2
8076698|NCT03787212|19915114|P1|STARTED|Period 1||2
8076699|NCT03787212|19915113|P2|NOT COMPLETED|Period 1||0
8076700|NCT03787212|19915114|P1|NOT COMPLETED|Period 1||0
8076701|NCT03787212|19915113|P2|COMPLETED|Period 1||2
8076702|NCT03787212|19915114|P1|COMPLETED|Period 1||2
8076703|NCT03787212|19915113|P2|STARTED|Period 1||2
8076704|NCT03787212|19915114|P1|STARTED|Period 1||2
8076705|NCT03786744|19915122|P2|NOT COMPLETED|Overall Study||0
8076706|NCT03786744|19915123|P1|NOT COMPLETED|Overall Study||0
8076707|NCT03786744|19915122|P2|COMPLETED|Overall Study||10
8076708|NCT03786744|19915123|P1|COMPLETED|Overall Study||10
8076709|NCT03786744|19915122|P2|STARTED|Overall Study||10
8076710|NCT03786744|19915123|P1|STARTED|Overall Study||10
8076714|NCT03785548|19915151|P2|NOT COMPLETED|Overall Study||0
8076715|NCT03785548|19915152|P1|NOT COMPLETED|Overall Study||2
8076716|NCT03785548|19915151|P2|COMPLETED|Overall Study||74
8076717|NCT03785548|19915152|P1|COMPLETED|Overall Study||71
8076718|NCT03785548|19915151|P2|STARTED|Overall Study||74
8076719|NCT03785548|19915152|P1|STARTED|Overall Study||73
8076720|NCT03784898|19915160|P1|NOT COMPLETED|Overall Study||0
8076721|NCT03784898|19915160|P1|COMPLETED|Overall Study||13
8076722|NCT03784898|19915160|P1|STARTED|Overall Study||13
8076723|NCT03784001|19915167|P3|NOT COMPLETED|Overall Study||1
8076724|NCT03784001|19915168|P2|NOT COMPLETED|Overall Study||0
8076725|NCT03784001|19915169|P1|NOT COMPLETED|Overall Study||2
8076726|NCT03784001|19915167|P3|COMPLETED|Overall Study||40
8076727|NCT03784001|19915168|P2|COMPLETED|Overall Study||38
8076728|NCT03784001|19915169|P1|COMPLETED|Overall Study||44
8076729|NCT03784001|19915167|P3|STARTED|Overall Study||41
8076730|NCT03784001|19915168|P2|STARTED|Overall Study||38
8076731|NCT03784001|19915169|P1|STARTED|Overall Study||46
8076732|NCT03783780|19915201|P1|NOT COMPLETED|Overall Study||1
8076733|NCT03783780|19915201|P1|COMPLETED|Overall Study||20
8076734|NCT03783780|19915201|P1|STARTED|Overall Study||21
8076741|NCT03782571|19915215|P4|NOT COMPLETED|Period 4||0
8076742|NCT03782571|19915216|P3|NOT COMPLETED|Period 4||0
8076743|NCT03782571|19915217|P2|NOT COMPLETED|Period 4||0
8076744|NCT03782571|19915218|P1|NOT COMPLETED|Period 4||0
8076745|NCT03782571|19915215|P4|COMPLETED|Period 4||7
8076746|NCT03782571|19915216|P3|COMPLETED|Period 4||6
8076747|NCT03782571|19915217|P2|COMPLETED|Period 4||6
8076748|NCT03782571|19915218|P1|COMPLETED|Period 4||3
8076749|NCT03782571|19915215|P4|STARTED|Period 4||7
8076750|NCT03782571|19915216|P3|STARTED|Period 4||6
8076751|NCT03782571|19915217|P2|STARTED|Period 4||6
8076752|NCT03782571|19915218|P1|STARTED|Period 4||3
8076753|NCT03782571|19915215|P4|NOT COMPLETED|Period 3||0
8076754|NCT03782571|19915216|P3|NOT COMPLETED|Period 3||0
8076755|NCT03782571|19915217|P2|NOT COMPLETED|Period 3||0
8076756|NCT03782571|19915218|P1|NOT COMPLETED|Period 3||2
8076757|NCT03782571|19915215|P4|COMPLETED|Period 3||7
8076758|NCT03782571|19915216|P3|COMPLETED|Period 3||6
8076759|NCT03782571|19915217|P2|COMPLETED|Period 3||6
8076760|NCT03782571|19915218|P1|COMPLETED|Period 3||3
8076761|NCT03782571|19915215|P4|STARTED|Period 3||7
8076762|NCT03782571|19915216|P3|STARTED|Period 3||6
8076763|NCT03782571|19915217|P2|STARTED|Period 3||6
8076764|NCT03782571|19915218|P1|STARTED|Period 3||5
8076765|NCT03782571|19915215|P4|NOT COMPLETED|Period 2||0
8076766|NCT03782571|19915216|P3|NOT COMPLETED|Period 2||0
8076767|NCT03782571|19915217|P2|NOT COMPLETED|Period 2||0
8076768|NCT03782571|19915218|P1|NOT COMPLETED|Period 2||0
8076769|NCT03782571|19915215|P4|COMPLETED|Period 2||7
8076770|NCT03782571|19915216|P3|COMPLETED|Period 2||6
8076771|NCT03782571|19915217|P2|COMPLETED|Period 2||6
8076772|NCT03782571|19915218|P1|COMPLETED|Period 2||5
8076773|NCT03782571|19915215|P4|STARTED|Period 2||7
8076774|NCT03782571|19915216|P3|STARTED|Period 2||6
8076775|NCT03782571|19915217|P2|STARTED|Period 2||6
8076776|NCT03782571|19915218|P1|STARTED|Period 2||5
8076777|NCT03782571|19915215|P4|NOT COMPLETED|Period 1||0
8076778|NCT03782571|19915216|P3|NOT COMPLETED|Period 1||0
8076779|NCT03782571|19915217|P2|NOT COMPLETED|Period 1||0
8076780|NCT03782571|19915218|P1|NOT COMPLETED|Period 1||1
8076781|NCT03782571|19915215|P4|COMPLETED|Period 1||7
8076782|NCT03782571|19915216|P3|COMPLETED|Period 1||6
8076783|NCT03782571|19915217|P2|COMPLETED|Period 1||6
8076784|NCT03782571|19915218|P1|COMPLETED|Period 1||5
8076785|NCT03782571|19915215|P4|STARTED|Period 1||7
8076786|NCT03782571|19915216|P3|STARTED|Period 1||6
8076787|NCT03782571|19915217|P2|STARTED|Period 1||6
8076788|NCT03782571|19915218|P1|STARTED|Period 1||6
8076789|NCT03782233|19915244|P2|NOT COMPLETED|Overall Study||2
8076790|NCT03782233|19915245|P1|NOT COMPLETED|Overall Study||4
8076791|NCT03782233|19915244|P2|COMPLETED|Overall Study||31
8076792|NCT03782233|19915245|P1|COMPLETED|Overall Study||46
8076793|NCT03782233|19915244|P2|STARTED|Overall Study||33
8076794|NCT03782233|19915245|P1|STARTED|Overall Study||50
8076795|NCT03782181|19915289|P2|NOT COMPLETED|Overall Study||0
8076796|NCT03782181|19915290|P1|NOT COMPLETED|Overall Study||0
8076797|NCT03782181|19915289|P2|COMPLETED|Overall Study||20
8076798|NCT03782181|19915290|P1|COMPLETED|Overall Study||20
8076799|NCT03782181|19915289|P2|STARTED|Overall Study||20
8076800|NCT03782181|19915290|P1|STARTED|Overall Study||20
8076801|NCT03781375|19915316|P2|NOT COMPLETED|Open-label Phase||3
8076802|NCT03781375|19915317|P1|NOT COMPLETED|Open-label Phase||3
8076803|NCT03781375|19915316|P2|COMPLETED|Open-label Phase||6
8076804|NCT03781375|19915317|P1|COMPLETED|Open-label Phase||8
8076805|NCT03781375|19915316|P2|Received Study Drug|Open-label Phase||9
8076806|NCT03781375|19915317|P1|Received Study Drug|Open-label Phase||10
8076807|NCT03781375|19915316|P2|STARTED|Open-label Phase||9
8076808|NCT03781375|19915317|P1|STARTED|Open-label Phase||11
8076809|NCT03781375|19915316|P2|NOT COMPLETED|Double-blind Phase||6
8076810|NCT03781375|19915317|P1|NOT COMPLETED|Double-blind Phase||7
8076811|NCT03781375|19915316|P2|COMPLETED|Double-blind Phase||7
8076812|NCT03781375|19915317|P1|COMPLETED|Double-blind Phase||5
8076813|NCT03781375|19915316|P2|Received Study Drug|Double-blind Phase||13
8076814|NCT03781375|19915317|P1|Received Study Drug|Double-blind Phase||12
8076815|NCT03781375|19915316|P2|STARTED|Double-blind Phase||13
8076816|NCT03781375|19915317|P1|STARTED|Double-blind Phase||12
8076817|NCT03780959|19915331|P3|NOT COMPLETED|Part 2||6
8076818|NCT03780959|19915332|P2|NOT COMPLETED|Part 2||19
8076819|NCT03780959|19915333|P1|NOT COMPLETED|Part 2||0
8076820|NCT03780959|19915331|P3|COMPLETED|Part 2||19
8076821|NCT03780959|19915332|P2|COMPLETED|Part 2||7
8076822|NCT03780959|19915333|P1|COMPLETED|Part 2||0
8076823|NCT03780959|19915331|P3|STARTED|Part 2||25
8076824|NCT03780959|19915332|P2|STARTED|Part 2||26
8076825|NCT03780959|19915333|P1|STARTED|Part 2||0
8076826|NCT03780959|19915331|P3|NOT COMPLETED|Part 1||0
8076827|NCT03780959|19915332|P2|NOT COMPLETED|Part 1||0
8076828|NCT03780959|19915333|P1|NOT COMPLETED|Part 1||5
8076829|NCT03780959|19915331|P3|COMPLETED|Part 1||0
8076830|NCT03780959|19915332|P2|COMPLETED|Part 1||0
8076831|NCT03780959|19915333|P1|COMPLETED|Part 1||64
8076832|NCT03780959|19915331|P3|STARTED|Part 1||0
8076833|NCT03780959|19915332|P2|STARTED|Part 1||0
8076834|NCT03780959|19915333|P1|STARTED|Part 1||69
8076835|NCT03780400|19915345|P1|NOT COMPLETED|Overall Study||7
8076836|NCT03780400|19915345|P1|COMPLETED|Overall Study||53
8076837|NCT03780400|19915345|P1|STARTED|Overall Study||60
8076838|NCT03780010|19915355|P2|NOT COMPLETED|Overall Study||0
8076839|NCT03780010|19915356|P1|NOT COMPLETED|Overall Study||0
8076840|NCT03780010|19915355|P2|COMPLETED|Overall Study||12
8076841|NCT03780010|19915356|P1|COMPLETED|Overall Study||3
8076842|NCT03780010|19915355|P2|STARTED|Overall Study||12
8076843|NCT03780010|19915356|P1|STARTED|Overall Study||3
8076844|NCT03779724|19915383|P2|NOT COMPLETED|Overall Study||4
8076845|NCT03779724|19915384|P1|NOT COMPLETED|Overall Study||6
8076846|NCT03779724|19915383|P2|COMPLETED|Overall Study||21
8076847|NCT03779724|19915384|P1|COMPLETED|Overall Study||19
8076848|NCT03779724|19915383|P2|STARTED|Overall Study||25
8076849|NCT03779724|19915384|P1|STARTED|Overall Study||25
8076850|NCT03779503|19915408|P2|NOT COMPLETED|Second Intervention||0
8076851|NCT03779503|19915409|P1|NOT COMPLETED|Second Intervention||0
8076852|NCT03779503|19915408|P2|COMPLETED|Second Intervention||26
8076853|NCT03779503|19915409|P1|COMPLETED|Second Intervention||27
8076854|NCT03779503|19915408|P2|STARTED|Second Intervention||26
8076855|NCT03779503|19915409|P1|STARTED|Second Intervention||27
8076856|NCT03779503|19915408|P2|NOT COMPLETED|First Intervention||1
8076857|NCT03779503|19915409|P1|NOT COMPLETED|First Intervention||1
8076858|NCT03779503|19915408|P2|COMPLETED|First Intervention||26
8076859|NCT03779503|19915409|P1|COMPLETED|First Intervention||27
8076860|NCT03779503|19915408|P2|STARTED|First Intervention||27
8076861|NCT03779503|19915409|P1|STARTED|First Intervention||28
8076862|NCT03778190|19915433|P1|NOT COMPLETED|Overall Study||0
8076863|NCT03778190|19915433|P1|COMPLETED|Overall Study||10
8076864|NCT03778190|19915433|P1|STARTED|Overall Study||10
8076865|NCT03777865|19915438|P1|NOT COMPLETED|Overall Study||0
8076866|NCT03777865|19915438|P1|COMPLETED|Overall Study||100
8076867|NCT03777865|19915438|P1|STARTED|Overall Study||100
8076868|NCT03776175|19915448|P4|NOT COMPLETED|Follow-Up Period (35 Days)||2
8076869|NCT03776175|19915449|P3|NOT COMPLETED|Follow-Up Period (35 Days)||0
8076870|NCT03776175|19915450|P2|NOT COMPLETED|Follow-Up Period (35 Days)||0
8076871|NCT03776175|19915451|P1|NOT COMPLETED|Follow-Up Period (35 Days)||0
8076872|NCT03776175|19915448|P4|COMPLETED|Follow-Up Period (35 Days)||24
8076873|NCT03776175|19915449|P3|COMPLETED|Follow-Up Period (35 Days)||24
8076874|NCT03776175|19915450|P2|COMPLETED|Follow-Up Period (35 Days)||22
8076875|NCT03776175|19915451|P1|COMPLETED|Follow-Up Period (35 Days)||13
8076876|NCT03776175|19915448|P4|STARTED|Follow-Up Period (35 Days)||26
8076877|NCT03776175|19915449|P3|STARTED|Follow-Up Period (35 Days)||24
8076878|NCT03776175|19915450|P2|STARTED|Follow-Up Period (35 Days)||22
8076879|NCT03776175|19915451|P1|STARTED|Follow-Up Period (35 Days)||13
8076880|NCT03776175|19915448|P4|NOT COMPLETED|Treatment Period (42 Days)||2
8076881|NCT03776175|19915449|P3|NOT COMPLETED|Treatment Period (42 Days)||4
8076882|NCT03776175|19915450|P2|NOT COMPLETED|Treatment Period (42 Days)||7
8076883|NCT03776175|19915451|P1|NOT COMPLETED|Treatment Period (42 Days)||1
8076884|NCT03776175|19915448|P4|COMPLETED|Treatment Period (42 Days)||26
8076885|NCT03776175|19915449|P3|COMPLETED|Treatment Period (42 Days)||24
8076886|NCT03776175|19915450|P2|COMPLETED|Treatment Period (42 Days)||22
8076887|NCT03776175|19915451|P1|COMPLETED|Treatment Period (42 Days)||13
8076888|NCT03776175|19915448|P4|Treated|Treatment Period (42 Days)||28
8076889|NCT03776175|19915449|P3|Treated|Treatment Period (42 Days)||28
8076890|NCT03776175|19915450|P2|Treated|Treatment Period (42 Days)||29
8076891|NCT03776175|19915451|P1|Treated|Treatment Period (42 Days)||14
8076892|NCT03776175|19915448|P4|STARTED|Treatment Period (42 Days)||28
8076893|NCT03776175|19915449|P3|STARTED|Treatment Period (42 Days)||28
8076894|NCT03776175|19915450|P2|STARTED|Treatment Period (42 Days)||29
8076895|NCT03776175|19915451|P1|STARTED|Treatment Period (42 Days)||14
8076896|NCT03774823|19915483|P2|NOT COMPLETED|Overall Study||1
8076897|NCT03774823|19915484|P1|NOT COMPLETED|Overall Study||1
8076898|NCT03774823|19915483|P2|COMPLETED|Overall Study||4
8076899|NCT03774823|19915484|P1|COMPLETED|Overall Study||4
8076900|NCT03774823|19915483|P2|STARTED|Overall Study||5
8076901|NCT03774823|19915484|P1|STARTED|Overall Study||5
8076902|NCT03774745|19915512|P2|NOT COMPLETED|Overall Study||4
8076903|NCT03774745|19915513|P1|NOT COMPLETED|Overall Study||2
8076904|NCT03774745|19915512|P2|COMPLETED|Overall Study||2
8076905|NCT03774745|19915513|P1|COMPLETED|Overall Study||4
8076906|NCT03774745|19915512|P2|Follow-up 2|Overall Study||2
8076907|NCT03774745|19915513|P1|Follow-up 2|Overall Study||4
8076908|NCT03774745|19915512|P2|Follow-Up 1|Overall Study||6
8076909|NCT03774745|19915513|P1|Follow-Up 1|Overall Study||5
8076910|NCT03774745|19915512|P2|STARTED|Overall Study||6
8076911|NCT03774745|19915513|P1|STARTED|Overall Study||6
8076912|NCT03774576|19915527|P1|NOT COMPLETED|Period 2||1
8076913|NCT03774576|19915527|P1|COMPLETED|Period 2||13
8076914|NCT03774576|19915527|P1|STARTED|Period 2||14
8076915|NCT03774576|19915527|P1|NOT COMPLETED|Period 1||0
8076916|NCT03774576|19915527|P1|COMPLETED|Period 1||14
8076917|NCT03774576|19915527|P1|STARTED|Period 1||14
8076918|NCT03773133|19915540|P1|NOT COMPLETED|Overall Study||8
8076919|NCT03773133|19915540|P1|COMPLETED|Overall Study||0
8076920|NCT03773133|19915540|P1|Received the Therapeutic IRPP|Overall Study||0
8076921|NCT03773133|19915540|P1|Received the Screening IIP|Overall Study||8
8076922|NCT03773133|19915540|P1|STARTED|Overall Study||8
8076923|NCT03772522|19915547|P2|NOT COMPLETED|Post-intervention Follow-up||0
8076924|NCT03772522|19915548|P1|NOT COMPLETED|Post-intervention Follow-up||1
8076925|NCT03772522|19915547|P2|COMPLETED|Post-intervention Follow-up||11
8076926|NCT03772522|19915548|P1|COMPLETED|Post-intervention Follow-up||7
8076927|NCT03772522|19915547|P2|STARTED|Post-intervention Follow-up||11
8076928|NCT03772522|19915548|P1|STARTED|Post-intervention Follow-up||8
8076929|NCT03772522|19915547|P2|NOT COMPLETED|Intervention||0
8076930|NCT03772522|19915548|P1|NOT COMPLETED|Intervention||1
8076931|NCT03772522|19915547|P2|COMPLETED|Intervention||11
8076932|NCT03772522|19915548|P1|COMPLETED|Intervention||8
8076933|NCT03772522|19915547|P2|STARTED|Intervention||11
8076934|NCT03772522|19915548|P1|STARTED|Intervention||9
8076935|NCT03772522|19915547|P2|NOT COMPLETED|Pre-intervention||4
8076936|NCT03772522|19915548|P1|NOT COMPLETED|Pre-intervention||3
8076937|NCT03772522|19915547|P2|COMPLETED|Pre-intervention||11
8076938|NCT03772522|19915548|P1|COMPLETED|Pre-intervention||9
8076939|NCT03772522|19915547|P2|STARTED|Pre-intervention||15
8076940|NCT03772522|19915548|P1|STARTED|Pre-intervention||12
8076941|NCT03772327|19915571|P2|NOT COMPLETED|Overall Study||7
8076942|NCT03772327|19915572|P1|NOT COMPLETED|Overall Study||5
8076943|NCT03772327|19915571|P2|COMPLETED|Overall Study||26
8076944|NCT03772327|19915572|P1|COMPLETED|Overall Study||25
8076945|NCT03772327|19915571|P2|Week 0 Visit|Overall Study||33
8076946|NCT03772327|19915572|P1|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28
8076947|NCT03772327|19915571|P2|STARTED|Overall Study||33
8076948|NCT03772327|19915572|P1|STARTED|Overall Study||30
8076949|NCT03771560|19915588|P1|NOT COMPLETED|Overall Study||6
8076950|NCT03771560|19915588|P1|COMPLETED|Overall Study||12
8076951|NCT03771560|19915588|P1|STARTED|Overall Study||18
8076952|NCT03771274|19915596|P1|NOT COMPLETED|Overall Study||0
8076953|NCT03771274|19915596|P1|COMPLETED|Overall Study||39
8076954|NCT03771274|19915596|P1|STARTED|Overall Study||39
8076955|NCT03769207|19915603|P1|NOT COMPLETED|Overall Study||11
8076956|NCT03769207|19915603|P1|COMPLETED|Overall Study||6
8076957|NCT03769207|19915603|P1|Attended Second Study Visit|Overall Study||6
8076958|NCT03769207|19915603|P1|ECG Patch Returned and Readable|Overall Study||9
8076959|NCT03769207|19915603|P1|ECG Patch Shipped|Overall Study||11
8076960|NCT03769207|19915603|P1|Attended First Study Visit|Overall Study||11
8076961|NCT03769207|19915603|P1|STARTED|Overall Study||17
8076962|NCT03768856|19915609|P1|NOT COMPLETED|Overall Study||0
8076963|NCT03768856|19915609|P1|COMPLETED|Overall Study||5
8076964|NCT03768856|19915609|P1|STARTED|Overall Study||5
8076965|NCT03767894|19915618|P1|NOT COMPLETED|Overall Study||1
8076966|NCT03767894|19915618|P1|COMPLETED|Overall Study||11
8076967|NCT03767894|19915618|P1|STARTED|Overall Study||12
8076968|NCT03767062|19915629|P2|NOT COMPLETED|Overall Study||4
8076969|NCT03767062|19915630|P1|NOT COMPLETED|Overall Study||8
8076970|NCT03767062|19915629|P2|COMPLETED|Overall Study||41
8076971|NCT03767062|19915630|P1|COMPLETED|Overall Study||37
8076972|NCT03767062|19915629|P2|STARTED|Overall Study||45
8076973|NCT03767062|19915630|P1|STARTED|Overall Study||45
8076974|NCT03766646|19915640|P2|NOT COMPLETED|Overall Study||3
8076975|NCT03766646|19915641|P1|NOT COMPLETED|Overall Study||1
8076976|NCT03766646|19915640|P2|COMPLETED|Overall Study||12
8076977|NCT03766646|19915641|P1|COMPLETED|Overall Study||18
8076978|NCT03766646|19915640|P2|STARTED|Overall Study||15
8076979|NCT03766646|19915641|P1|STARTED|Overall Study||19
8076980|NCT03766373|19915649|P2|NOT COMPLETED|Overall Study||0
8076981|NCT03766373|19915650|P1|NOT COMPLETED|Overall Study||0
8076982|NCT03766373|19915649|P2|COMPLETED|Overall Study||12
8076983|NCT03766373|19915650|P1|COMPLETED|Overall Study||12
8076984|NCT03766373|19915649|P2|STARTED|Overall Study||12
8076985|NCT03766373|19915650|P1|STARTED|Overall Study||12
8076986|NCT03766165|19915658|P2|NOT COMPLETED|Overall Study||0
8076987|NCT03766165|19915659|P1|NOT COMPLETED|Overall Study||0
8076988|NCT03766165|19915658|P2|COMPLETED|Overall Study||19
8076989|NCT03766165|19915659|P1|COMPLETED|Overall Study||19
8076990|NCT03766165|19915658|P2|STARTED|Overall Study||19
8076991|NCT03766165|19915659|P1|STARTED|Overall Study||19
8076992|NCT03765996|19915685|P2|NOT COMPLETED|Overall Study||0
8076993|NCT03765996|19915686|P1|NOT COMPLETED|Overall Study||4
8076994|NCT03765996|19915685|P2|COMPLETED|Overall Study||18
8076995|NCT03765996|19915686|P1|COMPLETED|Overall Study||14
8076996|NCT03765996|19915685|P2|STARTED|Overall Study||18
8076997|NCT03765996|19915686|P1|STARTED|Overall Study||18
8076998|NCT03765762|19915694|P2|NOT COMPLETED|Overall Study||0
8076999|NCT03765762|19915695|P1|NOT COMPLETED|Overall Study||0
8077000|NCT03765762|19915694|P2|COMPLETED|Overall Study||8
8077001|NCT03765762|19915695|P1|COMPLETED|Overall Study||18
8077002|NCT03765762|19915694|P2|STARTED|Overall Study||8
8077003|NCT03765762|19915695|P1|STARTED|Overall Study||18
8077004|NCT03765502|19915718|P5|NOT COMPLETED|Simulation 2||0
8077005|NCT03765502|19915719|P4|NOT COMPLETED|Simulation 2||0
8077006|NCT03765502|19915720|P3|NOT COMPLETED|Simulation 2||0
8077007|NCT03765502|19915721|P2|NOT COMPLETED|Simulation 2||0
8077008|NCT03765502|19915722|P1|NOT COMPLETED|Simulation 2||0
8077009|NCT03765502|19915718|P5|COMPLETED|Simulation 2||17
8077010|NCT03765502|19915719|P4|COMPLETED|Simulation 2||16
8077011|NCT03765502|19915720|P3|COMPLETED|Simulation 2||32
8077012|NCT03765502|19915721|P2|COMPLETED|Simulation 2||12
8077013|NCT03765502|19915722|P1|COMPLETED|Simulation 2||20
8077014|NCT03765502|19915718|P5|STARTED|Simulation 2||17
8077015|NCT03765502|19915719|P4|STARTED|Simulation 2||16
8077016|NCT03765502|19915720|P3|STARTED|Simulation 2|PWD completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|32
8077017|NCT03765502|19915721|P2|STARTED|Simulation 2|Participant completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|12
8077018|NCT03765502|19915722|P1|STARTED|Simulation 2||20
8077019|NCT03765502|19915718|P5|NOT COMPLETED|Simulation 1||0
8077020|NCT03765502|19915719|P4|NOT COMPLETED|Simulation 1||0
8077021|NCT03765502|19915720|P3|NOT COMPLETED|Simulation 1||0
8077022|NCT03765502|19915721|P2|NOT COMPLETED|Simulation 1||0
8077023|NCT03765502|19915722|P1|NOT COMPLETED|Simulation 1||0
8077024|NCT03765502|19915718|P5|COMPLETED|Simulation 1||17
8077025|NCT03765502|19915719|P4|COMPLETED|Simulation 1||16
8077026|NCT03765502|19915720|P3|COMPLETED|Simulation 1||33
8077027|NCT03765502|19915721|P2|COMPLETED|Simulation 1||13
8077028|NCT03765502|19915722|P1|COMPLETED|Simulation 1||20
8077029|NCT03765502|19915718|P5|STARTED|Simulation 1||17
8077030|NCT03765502|19915719|P4|STARTED|Simulation 1||16
8077031|NCT03765502|19915720|P3|STARTED|Simulation 1||33
8077032|NCT03765502|19915721|P2|STARTED|Simulation 1||13
8077033|NCT03765502|19915722|P1|STARTED|Simulation 1||20
8077034|NCT03765164|19915744|P2|NOT COMPLETED|Post-intervention||72
8077035|NCT03765164|19915745|P1|NOT COMPLETED|Post-intervention||73
8077036|NCT03765164|19915744|P2|COMPLETED|Post-intervention||0
8077037|NCT03765164|19915745|P1|COMPLETED|Post-intervention||0
8077038|NCT03765164|19915744|P2|STARTED|Post-intervention||72
8077039|NCT03765164|19915745|P1|STARTED|Post-intervention||73
8077040|NCT03765164|19915744|P2|NOT COMPLETED|Pre-intervention||6
8077041|NCT03765164|19915745|P1|NOT COMPLETED|Pre-intervention||5
8077042|NCT03765164|19915744|P2|COMPLETED|Pre-intervention||72
8077043|NCT03765164|19915745|P1|COMPLETED|Pre-intervention||73
8077044|NCT03765164|19915744|P2|STARTED|Pre-intervention||78
8077045|NCT03765164|19915745|P1|STARTED|Pre-intervention||78
8077046|NCT03765138|19915755|P1|NOT COMPLETED|Overall Study||1
8077047|NCT03765138|19915755|P1|COMPLETED|Overall Study||0
8077048|NCT03765138|19915755|P1|STARTED|Overall Study||1
8077073|NCT03764449|19915788|P2|NOT COMPLETED|Overall Study||0
8077074|NCT03764449|19915789|P1|NOT COMPLETED|Overall Study||0
8077075|NCT03764449|19915788|P2|COMPLETED|Overall Study||8
8077076|NCT03764449|19915789|P1|COMPLETED|Overall Study||8
8077077|NCT03764449|19915788|P2|STARTED|Overall Study||8
8077078|NCT03764449|19915789|P1|STARTED|Overall Study||8
8077079|NCT03763058|19915879|P1|NOT COMPLETED|Overall Study||2
8077080|NCT03763058|19915879|P1|COMPLETED|Overall Study||18
8077081|NCT03763058|19915879|P1|STARTED|Overall Study||20
8077082|NCT03762668|19915889|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
8077083|NCT03762668|19915890|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
8077084|NCT03762668|19915889|P2|COMPLETED|Period 2, Second Week of Wear||29
8077085|NCT03762668|19915890|P1|COMPLETED|Period 2, Second Week of Wear||30
8077086|NCT03762668|19915889|P2|STARTED|Period 2, Second Week of Wear||29
8077087|NCT03762668|19915890|P1|STARTED|Period 2, Second Week of Wear||30
8077088|NCT03762668|19915889|P2|NOT COMPLETED|Period 1, First Week of Wear||1
8077089|NCT03762668|19915890|P1|NOT COMPLETED|Period 1, First Week of Wear||0
8077090|NCT03762668|19915889|P2|COMPLETED|Period 1, First Week of Wear||29
8077091|NCT03762668|19915890|P1|COMPLETED|Period 1, First Week of Wear||30
8077092|NCT03762668|19915889|P2|STARTED|Period 1, First Week of Wear||30
8077093|NCT03762668|19915890|P1|STARTED|Period 1, First Week of Wear||30
8077094|NCT03762213|19915898|P2|NOT COMPLETED|Overall Study||0
8077095|NCT03762213|19915899|P1|NOT COMPLETED|Overall Study||0
8077096|NCT03762213|19915898|P2|COMPLETED|Overall Study||14
8077097|NCT03762213|19915899|P1|COMPLETED|Overall Study||16
8077098|NCT03762213|19915898|P2|STARTED|Overall Study||14
8077099|NCT03762213|19915899|P1|STARTED|Overall Study||16
8077103|NCT03761368|19915915|P2|NOT COMPLETED|Overall Study||0
8077104|NCT03761368|19915916|P1|NOT COMPLETED|Overall Study||0
8077105|NCT03761368|19915915|P2|COMPLETED|Overall Study||51
8077106|NCT03761368|19915916|P1|COMPLETED|Overall Study||50
8077107|NCT03761368|19915915|P2|STARTED|Overall Study||51
8077108|NCT03761368|19915916|P1|STARTED|Overall Study||50
8077109|NCT03760640|19915930|P2|NOT COMPLETED|Period 2||0
8077110|NCT03760640|19915931|P1|NOT COMPLETED|Period 2||0
8077111|NCT03760640|19915930|P2|COMPLETED|Period 2||22
8077112|NCT03760640|19915931|P1|COMPLETED|Period 2||20
8077113|NCT03760640|19915930|P2|STARTED|Period 2||22
8077114|NCT03760640|19915931|P1|STARTED|Period 2||20
8077115|NCT03760640|19915930|P2|NOT COMPLETED|Period 1||0
8077116|NCT03760640|19915931|P1|NOT COMPLETED|Period 1||0
8077117|NCT03760640|19915930|P2|COMPLETED|Period 1||22
8077118|NCT03760640|19915931|P1|COMPLETED|Period 1||20
8077119|NCT03760640|19915930|P2|Received at Least 1 Dose of Study Drug|Period 1||22
8077120|NCT03760640|19915931|P1|Received at Least 1 Dose of Study Drug|Period 1||20
8077121|NCT03760640|19915930|P2|STARTED|Period 1||22
8077122|NCT03760640|19915931|P1|STARTED|Period 1||20
8077123|NCT03760510|19915949|P2|NOT COMPLETED|Overall Study||97
8077124|NCT03760510|19915950|P1|NOT COMPLETED|Overall Study||105
8077125|NCT03760510|19915949|P2|COMPLETED|Overall Study||153
8077126|NCT03760510|19915950|P1|COMPLETED|Overall Study||145
8077127|NCT03760510|19915949|P2|STARTED|Overall Study||250
8077128|NCT03760510|19915950|P1|STARTED|Overall Study||250
8077129|NCT03760250|19915962|P1|NOT COMPLETED|Overall Study||2
8077130|NCT03760250|19915962|P1|COMPLETED|Overall Study||4
8077131|NCT03760250|19915962|P1|STARTED|Overall Study||6
8077132|NCT03760146|19915973|P6|NOT COMPLETED|Overall Study||8
8077133|NCT03760146|19915974|P5|NOT COMPLETED|Overall Study||17
8077134|NCT03760146|19915975|P4|NOT COMPLETED|Overall Study||2
8077135|NCT03760146|19915976|P3|NOT COMPLETED|Overall Study||11
8077136|NCT03760146|19915977|P2|NOT COMPLETED|Overall Study||78
8077137|NCT03760146|19915978|P1|NOT COMPLETED|Overall Study||96
8077138|NCT03760146|19915973|P6|COMPLETED|Overall Study||104
8077139|NCT03760146|19915974|P5|COMPLETED|Overall Study||319
8077140|NCT03760146|19915975|P4|COMPLETED|Overall Study||109
8077141|NCT03760146|19915976|P3|COMPLETED|Overall Study||323
8077142|NCT03760146|19915977|P2|COMPLETED|Overall Study||1417
8077143|NCT03760146|19915978|P1|COMPLETED|Overall Study||1418
8077144|NCT03760146|19915973|P6|Evaluable-20 Immunogenicity Population|Overall Study||0
8077145|NCT03760146|19915974|P5|Evaluable-20 Immunogenicity Population|Overall Study||317
8077146|NCT03760146|19915975|P4|Evaluable-20 Immunogenicity Population|Overall Study||0
8077147|NCT03760146|19915976|P3|Evaluable-20 Immunogenicity Population|Overall Study||321
8077148|NCT03760146|19915977|P2|Evaluable-20 Immunogenicity Population|Overall Study||0
8077149|NCT03760146|19915978|P1|Evaluable-20 Immunogenicity Population|Overall Study|Only for 60-64 years of age.|946
8077150|NCT03760146|19915973|P6|Safety Population|Overall Study||112
8077151|NCT03760146|19915974|P5|Safety Population|Overall Study||335
8077152|NCT03760146|19915975|P4|Safety Population|Overall Study||111
8077153|NCT03760146|19915976|P3|Safety Population|Overall Study||334
8077154|NCT03760146|19915977|P2|Safety Population|Overall Study||1490
8077155|NCT03760146|19915978|P1|Safety Population|Overall Study||1507
8077156|NCT03760146|19915973|P6|Vaccination 2|Overall Study||0
8077157|NCT03760146|19915974|P5|Vaccination 2|Overall Study||0
8077158|NCT03760146|19915975|P4|Vaccination 2|Overall Study||0
8077159|NCT03760146|19915976|P3|Vaccination 2|Overall Study||0
8077160|NCT03760146|19915977|P2|Vaccination 2|Overall Study||1446
8077161|NCT03760146|19915978|P1|Vaccination 2|Overall Study||1461
8077162|NCT03760146|19915973|P6|Vaccination 1|Overall Study||112
8077163|NCT03760146|19915974|P5|Vaccination 1|Overall Study||335
8077164|NCT03760146|19915975|P4|Vaccination 1|Overall Study||111
8077165|NCT03760146|19915976|P3|Vaccination 1|Overall Study||334
8077166|NCT03760146|19915977|P2|Vaccination 1|Overall Study||1490
8077167|NCT03760146|19915978|P1|Vaccination 1|Overall Study||1507
8077168|NCT03760146|19915973|P6|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
8077169|NCT03760146|19915974|P5|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
8077170|NCT03760146|19915975|P4|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
8077171|NCT03760146|19915976|P3|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
8077172|NCT03760146|19915977|P2|Evaluable 7-Additional Immunogenicity Population|Overall Study||1383
8077173|NCT03760146|19915978|P1|Evaluable 7-Additional Immunogenicity Population|Overall Study||1433
8077174|NCT03760146|19915973|P6|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
8077175|NCT03760146|19915974|P5|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
8077176|NCT03760146|19915975|P4|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
8077177|NCT03760146|19915976|P3|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
8077178|NCT03760146|19915977|P2|Evaluable 13-Matched Immunogenicity Population|Overall Study||1420
8077179|NCT03760146|19915978|P1|Evaluable 13-Matched Immunogenicity Population|Overall Study||1435
8077180|NCT03760146|19915973|P6|STARTED|Overall Study||112
8077181|NCT03760146|19915974|P5|STARTED|Overall Study||336
8077182|NCT03760146|19915975|P4|STARTED|Overall Study||111
8077183|NCT03760146|19915976|P3|STARTED|Overall Study||334
8077184|NCT03760146|19915977|P2|STARTED|Overall Study||1495
8077185|NCT03760146|19915978|P1|STARTED|Overall Study||1514
8077192|NCT03759600|19916063|P1|NOT COMPLETED|Overall Study||20
8077193|NCT03759600|19916063|P1|COMPLETED|Overall Study||0
8077194|NCT03759600|19916063|P1|STARTED|Overall Study||20
8077195|NCT03759587|19916077|P1|NOT COMPLETED|Overall Study||19
8077196|NCT03759587|19916077|P1|COMPLETED|Overall Study||0
8077197|NCT03759587|19916077|P1|STARTED|Overall Study||19
8077198|NCT03759340|19916090|P1|NOT COMPLETED|Overall Study||56
8077199|NCT03759340|19916090|P1|COMPLETED|Overall Study||0
8077200|NCT03759340|19916090|P1|STARTED|Overall Study||56
8077201|NCT03758365|19916099|P1|NOT COMPLETED|Overall Study||0
8077202|NCT03758365|19916099|P1|COMPLETED|Overall Study||36
8077203|NCT03758365|19916099|P1|Vehicle Cream|Overall Study||36
8077204|NCT03758365|19916099|P1|Desonide 0.05% Cream|Overall Study||36
8077205|NCT03758365|19916099|P1|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36
8077206|NCT03758365|19916099|P1|Triamcinolone Acetonide 0,1% Cream|Overall Study||36
8077207|NCT03758365|19916099|P1|Betamethasone Dipropionate 0.05% Cream|Overall Study||36
8077208|NCT03758365|19916099|P1|Clobetasol Propionate 0.05% Lotion|Overall Study||36
8077209|NCT03758365|19916099|P1|MC2-01 Cream|Overall Study||36
8077210|NCT03758365|19916099|P1|STARTED|Overall Study||36
8077211|NCT03757988|19916110|P1|NOT COMPLETED|Overall Study||1
8077212|NCT03757988|19916110|P1|COMPLETED|Overall Study||16
8077213|NCT03757988|19916110|P1|STARTED|Overall Study||17
8077214|NCT03757234|19916133|P5|NOT COMPLETED|Overall Study||4
8077215|NCT03757234|19916134|P4|NOT COMPLETED|Overall Study||1
8077216|NCT03757234|19916135|P3|NOT COMPLETED|Overall Study||0
8077217|NCT03757234|19916136|P2|NOT COMPLETED|Overall Study||2
8077218|NCT03757234|19916137|P1|NOT COMPLETED|Overall Study||3
8077219|NCT03757234|19916133|P5|COMPLETED|Overall Study||70
8077220|NCT03757234|19916134|P4|COMPLETED|Overall Study||16
8077221|NCT03757234|19916135|P3|COMPLETED|Overall Study||17
8077222|NCT03757234|19916136|P2|COMPLETED|Overall Study||16
8077223|NCT03757234|19916137|P1|COMPLETED|Overall Study||72
8077224|NCT03757234|19916133|P5|Completed PTE Visit|Overall Study||71
8077225|NCT03757234|19916134|P4|Completed PTE Visit|Overall Study||16
8077226|NCT03757234|19916135|P3|Completed PTE Visit|Overall Study||17
8077227|NCT03757234|19916136|P2|Completed PTE Visit|Overall Study||16
8077228|NCT03757234|19916137|P1|Completed PTE Visit|Overall Study||72
8077229|NCT03757234|19916133|P5|STARTED|Overall Study||74
8077230|NCT03757234|19916134|P4|STARTED|Overall Study||17
8077231|NCT03757234|19916135|P3|STARTED|Overall Study||17
8077232|NCT03757234|19916136|P2|STARTED|Overall Study||18
8077233|NCT03757234|19916137|P1|STARTED|Overall Study||75
8077234|NCT03757039|19916173|P2|NOT COMPLETED|Overall Study||0
8077235|NCT03757039|19916174|P1|NOT COMPLETED|Overall Study||0
8077236|NCT03757039|19916173|P2|COMPLETED|Overall Study||9
8077237|NCT03757039|19916174|P1|COMPLETED|Overall Study||32
8077238|NCT03757039|19916173|P2|DACP MF|Overall Study||0
8077239|NCT03757039|19916174|P1|DACP MF|Overall Study||10
8077240|NCT03757039|19916173|P2|DT1 MF|Overall Study||0
8077241|NCT03757039|19916174|P1|DT1 MF|Overall Study||11
8077242|NCT03757039|19916173|P2|AOHG MF|Overall Study||0
8077243|NCT03757039|19916174|P1|AOHG MF|Overall Study||11
8077244|NCT03757039|19916173|P2|STARTED|Overall Study||9
8077245|NCT03757039|19916174|P1|STARTED|Overall Study||32
8077252|NCT03756038|19916195|P2|NOT COMPLETED|Overall Study||0
8077253|NCT03756038|19916196|P1|NOT COMPLETED|Overall Study||0
8077254|NCT03756038|19916195|P2|COMPLETED|Overall Study||0
8077255|NCT03756038|19916196|P1|COMPLETED|Overall Study||1
8077256|NCT03756038|19916195|P2|STARTED|Overall Study||0
8077257|NCT03756038|19916196|P1|STARTED|Overall Study||1
8077258|NCT03755882|19916204|P2|NOT COMPLETED|Period 2||0
8077259|NCT03755882|19916205|P1|NOT COMPLETED|Period 2||0
8077260|NCT03755882|19916204|P2|COMPLETED|Period 2||22
8077261|NCT03755882|19916205|P1|COMPLETED|Period 2||19
8077262|NCT03755882|19916204|P2|STARTED|Period 2||22
8077263|NCT03755882|19916205|P1|STARTED|Period 2||19
8077264|NCT03755882|19916204|P2|NOT COMPLETED|Period 1||0
8077265|NCT03755882|19916205|P1|NOT COMPLETED|Period 1||4
8077266|NCT03755882|19916204|P2|COMPLETED|Period 1||22
8077267|NCT03755882|19916205|P1|COMPLETED|Period 1||19
8077268|NCT03755882|19916204|P2|STARTED|Period 1||22
8077269|NCT03755882|19916205|P1|STARTED|Period 1||23
8077270|NCT03754582|19916211|P3|NOT COMPLETED|Follow-up Phase||1
8077271|NCT03754582|19916212|P2|NOT COMPLETED|Follow-up Phase||0
8077272|NCT03754582|19916213|P1|NOT COMPLETED|Follow-up Phase||0
8077273|NCT03754582|19916211|P3|COMPLETED|Follow-up Phase||20
8077274|NCT03754582|19916212|P2|COMPLETED|Follow-up Phase||0
8077275|NCT03754582|19916213|P1|COMPLETED|Follow-up Phase||0
8077276|NCT03754582|19916211|P3|STARTED|Follow-up Phase|1 participant who discontinued in Treatment Phase was assessed at Follow-up Visit.|21
8077277|NCT03754582|19916212|P2|STARTED|Follow-up Phase||0
8077278|NCT03754582|19916213|P1|STARTED|Follow-up Phase||0
8077279|NCT03754582|19916211|P3|NOT COMPLETED|Treatment Phase||0
8077280|NCT03754582|19916212|P2|NOT COMPLETED|Treatment Phase||1
8077281|NCT03754582|19916213|P1|NOT COMPLETED|Treatment Phase||0
8077282|NCT03754582|19916211|P3|COMPLETED|Treatment Phase||0
8077283|NCT03754582|19916212|P2|COMPLETED|Treatment Phase||20
8077284|NCT03754582|19916213|P1|COMPLETED|Treatment Phase||0
8077285|NCT03754582|19916211|P3|STARTED|Treatment Phase||0
8077286|NCT03754582|19916212|P2|STARTED|Treatment Phase||21
8077287|NCT03754582|19916213|P1|STARTED|Treatment Phase||0
8077288|NCT03754582|19916211|P3|NOT COMPLETED|Pretreatment Phase||0
8077289|NCT03754582|19916212|P2|NOT COMPLETED|Pretreatment Phase||0
8077290|NCT03754582|19916213|P1|NOT COMPLETED|Pretreatment Phase||0
8077291|NCT03754582|19916211|P3|COMPLETED|Pretreatment Phase||0
8077292|NCT03754582|19916212|P2|COMPLETED|Pretreatment Phase||0
8077293|NCT03754582|19916213|P1|COMPLETED|Pretreatment Phase||21
8077294|NCT03754582|19916211|P3|STARTED|Pretreatment Phase||0
8077295|NCT03754582|19916212|P2|STARTED|Pretreatment Phase||0
8077296|NCT03754582|19916213|P1|STARTED|Pretreatment Phase||21
8077297|NCT03754556|19916241|P1|NOT COMPLETED|Overall Study||0
8077298|NCT03754556|19916241|P1|COMPLETED|Overall Study||326658
8077299|NCT03754556|19916241|P1|STARTED|Overall Study||326658
8077300|NCT03753113|19916285|P2|NOT COMPLETED|Overall Study||0
8077301|NCT03753113|19916286|P1|NOT COMPLETED|Overall Study||0
8077302|NCT03753113|19916285|P2|COMPLETED|Overall Study||12
8077303|NCT03753113|19916286|P1|COMPLETED|Overall Study||12
8077304|NCT03753113|19916285|P2|STARTED|Overall Study||12
8077305|NCT03753113|19916286|P1|STARTED|Overall Study||12
8077306|NCT03752567|19916296|P1|NOT COMPLETED|Overall Study||0
8077307|NCT03752567|19916296|P1|COMPLETED|Overall Study||40
8077308|NCT03752567|19916296|P1|STARTED|Overall Study||40
8077309|NCT03752528|19916305|P1|NOT COMPLETED|Part B||4
8077310|NCT03752528|19916305|P1|COMPLETED|Part B||20
8077311|NCT03752528|19916305|P1|STARTED|Part B||24
8077312|NCT03752528|19916305|P1|NOT COMPLETED|Part A||2
8077313|NCT03752528|19916305|P1|COMPLETED|Part A||51
8077314|NCT03752528|19916305|P1|STARTED|Part A||53
8077315|NCT03752151|19916324|P1|NOT COMPLETED|Overall Study||2
8077316|NCT03752151|19916324|P1|COMPLETED|Overall Study||75
8077317|NCT03752151|19916324|P1|STARTED|Overall Study||77
8077318|NCT03751280|19916332|P2|NOT COMPLETED|Overall Study||12
8077319|NCT03751280|19916333|P1|NOT COMPLETED|Overall Study||8
8077320|NCT03751280|19916332|P2|COMPLETED|Overall Study||44
8077321|NCT03751280|19916333|P1|COMPLETED|Overall Study||48
8077322|NCT03751280|19916332|P2|Safety Set (SAF)|Overall Study||55
8077323|NCT03751280|19916333|P1|Safety Set (SAF)|Overall Study||55
8077324|NCT03751280|19916332|P2|Full Analysis Set (FAS)|Overall Study||55
8077325|NCT03751280|19916333|P1|Full Analysis Set (FAS)|Overall Study||54
8077326|NCT03751280|19916332|P2|STARTED|Overall Study||56
8077327|NCT03751280|19916333|P1|STARTED|Overall Study||56
8077328|NCT03751020|19916369|P3|NOT COMPLETED|Overall Study||10
8077329|NCT03751020|19916370|P2|NOT COMPLETED|Overall Study||4
8077330|NCT03751020|19916371|P1|NOT COMPLETED|Overall Study||9
8077331|NCT03751020|19916369|P3|COMPLETED|Overall Study||26
8077332|NCT03751020|19916370|P2|COMPLETED|Overall Study||32
8077333|NCT03751020|19916371|P1|COMPLETED|Overall Study||27
8077334|NCT03751020|19916369|P3|3 Month Follow Up|Overall Study||26
8077335|NCT03751020|19916370|P2|3 Month Follow Up|Overall Study||32
8077336|NCT03751020|19916371|P1|3 Month Follow Up|Overall Study||27
8077337|NCT03751020|19916369|P3|Post Intervention|Overall Study||30
8077338|NCT03751020|19916370|P2|Post Intervention|Overall Study||33
8077339|NCT03751020|19916371|P1|Post Intervention|Overall Study||33
8077340|NCT03751020|19916369|P3|STARTED|Overall Study||36
8077341|NCT03751020|19916370|P2|STARTED|Overall Study||36
8077342|NCT03751020|19916371|P1|STARTED|Overall Study||36
8077343|NCT03748979|19916477|P11|NOT COMPLETED|Overall Study||0
8077344|NCT03748979|19916478|P10|NOT COMPLETED|Overall Study||0
8077345|NCT03748979|19916479|P9|NOT COMPLETED|Overall Study||0
8077346|NCT03748979|19916480|P8|NOT COMPLETED|Overall Study||0
8077347|NCT03748979|19916481|P7|NOT COMPLETED|Overall Study||0
8077348|NCT03748979|19916482|P6|NOT COMPLETED|Overall Study||0
8077349|NCT03748979|19916483|P5|NOT COMPLETED|Overall Study||0
8077350|NCT03748979|19916484|P4|NOT COMPLETED|Overall Study||0
8077351|NCT03748979|19916485|P3|NOT COMPLETED|Overall Study||0
8077352|NCT03748979|19916486|P2|NOT COMPLETED|Overall Study||0
8077353|NCT03748979|19916487|P1|NOT COMPLETED|Overall Study||0
8077354|NCT03748979|19916477|P11|COMPLETED|Overall Study||6
8077355|NCT03748979|19916478|P10|COMPLETED|Overall Study||5
8077356|NCT03748979|19916479|P9|COMPLETED|Overall Study||4
8077357|NCT03748979|19916480|P8|COMPLETED|Overall Study||5
8077358|NCT03748979|19916481|P7|COMPLETED|Overall Study||5
8077359|NCT03748979|19916482|P6|COMPLETED|Overall Study||4
8077360|NCT03748979|19916483|P5|COMPLETED|Overall Study||4
8077361|NCT03748979|19916484|P4|COMPLETED|Overall Study||6
8077362|NCT03748979|19916485|P3|COMPLETED|Overall Study||6
8077363|NCT03748979|19916486|P2|COMPLETED|Overall Study||6
8077364|NCT03748979|19916487|P1|COMPLETED|Overall Study||6
8077365|NCT03748979|19916477|P11|STARTED|Overall Study||6
8077366|NCT03748979|19916478|P10|STARTED|Overall Study||5
8077367|NCT03748979|19916479|P9|STARTED|Overall Study||4
8077368|NCT03748979|19916480|P8|STARTED|Overall Study||5
8077369|NCT03748979|19916481|P7|STARTED|Overall Study||5
8077370|NCT03748979|19916482|P6|STARTED|Overall Study||4
8077371|NCT03748979|19916483|P5|STARTED|Overall Study||4
8077372|NCT03748979|19916484|P4|STARTED|Overall Study||6
8077373|NCT03748979|19916485|P3|STARTED|Overall Study||6
8077374|NCT03748979|19916486|P2|STARTED|Overall Study||6
8077375|NCT03748979|19916487|P1|STARTED|Overall Study||6
8077376|NCT03748758|19916541|P3|NOT COMPLETED|Overall Study||1
8077377|NCT03748758|19916542|P2|NOT COMPLETED|Overall Study||0
8077378|NCT03748758|19916543|P1|NOT COMPLETED|Overall Study||0
8077379|NCT03748758|19916541|P3|COMPLETED|Overall Study||5
8077380|NCT03748758|19916542|P2|COMPLETED|Overall Study||12
8077381|NCT03748758|19916543|P1|COMPLETED|Overall Study||12
8077382|NCT03748758|19916541|P3|STARTED|Overall Study||6
8077383|NCT03748758|19916542|P2|STARTED|Overall Study||12
8077384|NCT03748758|19916543|P1|STARTED|Overall Study||12
8077385|NCT03746405|19916597|P2|NOT COMPLETED|Overall Study||2
8077386|NCT03746405|19916598|P1|NOT COMPLETED|Overall Study||3
8077387|NCT03746405|19916597|P2|COMPLETED|Overall Study||6
8077388|NCT03746405|19916598|P1|COMPLETED|Overall Study||7
8077389|NCT03746405|19916597|P2|STARTED|Overall Study||8
8077390|NCT03746405|19916598|P1|STARTED|Overall Study||10
8077391|NCT03745937|19916608|P4|NOT COMPLETED|Overall Study||2
8077392|NCT03745937|19916609|P3|NOT COMPLETED|Overall Study||0
8077393|NCT03745937|19916610|P2|NOT COMPLETED|Overall Study||1
8077394|NCT03745937|19916611|P1|NOT COMPLETED|Overall Study||0
8077395|NCT03745937|19916608|P4|COMPLETED|Overall Study||7
8077396|NCT03745937|19916609|P3|COMPLETED|Overall Study||3
8077397|NCT03745937|19916610|P2|COMPLETED|Overall Study||5
8077398|NCT03745937|19916611|P1|COMPLETED|Overall Study||2
8077399|NCT03745937|19916608|P4|STARTED|Overall Study||9
8077400|NCT03745937|19916609|P3|STARTED|Overall Study||3
8077401|NCT03745937|19916610|P2|STARTED|Overall Study||6
8077402|NCT03745937|19916611|P1|STARTED|Overall Study||2
8077403|NCT03745222|19916725|P3|NOT COMPLETED|Overall Study||0
8077404|NCT03745222|19916726|P2|NOT COMPLETED|Overall Study||1
8077405|NCT03745222|19916727|P1|NOT COMPLETED|Overall Study||0
8077406|NCT03745222|19916725|P3|COMPLETED|Overall Study||0
8077407|NCT03745222|19916726|P2|COMPLETED|Overall Study||0
8077408|NCT03745222|19916727|P1|COMPLETED|Overall Study||0
8077409|NCT03745222|19916725|P3|STARTED|Overall Study||0
8077410|NCT03745222|19916726|P2|STARTED|Overall Study||1
8077411|NCT03745222|19916727|P1|STARTED|Overall Study||0
8077412|NCT03745092|19916767|P2|NOT COMPLETED|Overall Study||0
8077413|NCT03745092|19916768|P1|NOT COMPLETED|Overall Study||0
8077414|NCT03745092|19916767|P2|COMPLETED|Overall Study||23
8077415|NCT03745092|19916768|P1|COMPLETED|Overall Study||26
8077416|NCT03745092|19916767|P2|STARTED|Overall Study||23
8077417|NCT03745092|19916768|P1|STARTED|Overall Study||26
8077418|NCT03744780|19916784|P1|NOT COMPLETED|Overall Study||0
8077419|NCT03744780|19916784|P1|COMPLETED|Overall Study||32
8077420|NCT03744780|19916784|P1|STARTED|Overall Study||32
8077421|NCT03742973|19916804|P2|NOT COMPLETED|Overall Study||0
8077422|NCT03742973|19916805|P1|NOT COMPLETED|Overall Study||0
8077423|NCT03742973|19916804|P2|COMPLETED|Overall Study||0
8077424|NCT03742973|19916805|P1|COMPLETED|Overall Study||0
8077425|NCT03742973|19916804|P2|STARTED|Overall Study||0
8077426|NCT03742973|19916805|P1|STARTED|Overall Study||0
8077427|NCT03742440|19916816|P1|NOT COMPLETED|Overall Study||0
8077428|NCT03742440|19916816|P1|COMPLETED|Overall Study||40
8077429|NCT03742440|19916816|P1|STARTED|Overall Study||40
8077430|NCT03742271|19916822|P1|NOT COMPLETED|Overall Study||12
8077431|NCT03742271|19916822|P1|COMPLETED|Overall Study||115
8077432|NCT03742271|19916822|P1|STARTED|Overall Study||127
8077433|NCT03742154|19916828|P2|NOT COMPLETED|Overall Study||0
8077434|NCT03742154|19916829|P1|NOT COMPLETED|Overall Study||0
8077435|NCT03742154|19916828|P2|COMPLETED|Overall Study||49
8077436|NCT03742154|19916829|P1|COMPLETED|Overall Study||50
8077437|NCT03742154|19916828|P2|STARTED|Overall Study||49
8077438|NCT03742154|19916829|P1|STARTED|Overall Study||50
8077439|NCT03741725|19916839|P3|NOT COMPLETED|Overall Study||0
8077440|NCT03741725|19916840|P2|NOT COMPLETED|Overall Study||0
8077441|NCT03741725|19916841|P1|NOT COMPLETED|Overall Study||0
8077442|NCT03741725|19916839|P3|COMPLETED|Overall Study||100
8077443|NCT03741725|19916840|P2|COMPLETED|Overall Study||100
8077444|NCT03741725|19916841|P1|COMPLETED|Overall Study||101
8077445|NCT03741725|19916839|P3|STARTED|Overall Study||100
8077446|NCT03741725|19916840|P2|STARTED|Overall Study||100
8077447|NCT03741725|19916841|P1|STARTED|Overall Study||101
8077448|NCT03741062|19916872|P2|NOT COMPLETED|Overall Study||0
8077449|NCT03741062|19916873|P1|NOT COMPLETED|Overall Study||1
8077450|NCT03741062|19916872|P2|COMPLETED|Overall Study||6
8077451|NCT03741062|19916873|P1|COMPLETED|Overall Study||4
8077452|NCT03741062|19916872|P2|STARTED|Overall Study||6
8077453|NCT03741062|19916873|P1|STARTED|Overall Study||5
8077454|NCT03740659|19916886|P3|NOT COMPLETED|Overall Study||0
8077455|NCT03740659|19916887|P2|NOT COMPLETED|Overall Study||0
8077456|NCT03740659|19916888|P1|NOT COMPLETED|Overall Study||0
8077457|NCT03740659|19916886|P3|COMPLETED|Overall Study||41
8077458|NCT03740659|19916887|P2|COMPLETED|Overall Study||42
8077459|NCT03740659|19916888|P1|COMPLETED|Overall Study||42
8077460|NCT03740659|19916886|P3|STARTED|Overall Study||41
8077461|NCT03740659|19916887|P2|STARTED|Overall Study||42
8077462|NCT03740659|19916888|P1|STARTED|Overall Study||42
8077463|NCT03740152|19916902|P1|NOT COMPLETED|Overall Study||0
8077464|NCT03740152|19916902|P1|COMPLETED|Overall Study||10
8077465|NCT03740152|19916902|P1|STARTED|Overall Study||10
8077490|NCT03739528|19916992|P2|NOT COMPLETED|Overall Study||17
8077491|NCT03739528|19916993|P1|NOT COMPLETED|Overall Study||15
8077492|NCT03739528|19916992|P2|COMPLETED|Overall Study||388
8077493|NCT03739528|19916993|P1|COMPLETED|Overall Study||388
8077494|NCT03739528|19916992|P2|Received at Least One Treatment|Overall Study||393
8077495|NCT03739528|19916993|P1|Received at Least One Treatment|Overall Study||395
8077496|NCT03739528|19916992|P2|STARTED|Overall Study||405
8077497|NCT03739528|19916993|P1|STARTED|Overall Study||403
8077498|NCT03739242|19917025|P2|NOT COMPLETED|Overall Study||2
8077499|NCT03739242|19917026|P1|NOT COMPLETED|Overall Study||1
8077500|NCT03739242|19917025|P2|COMPLETED|Overall Study||42
8077501|NCT03739242|19917026|P1|COMPLETED|Overall Study||43
8077502|NCT03739242|19917025|P2|STARTED|Overall Study||44
8077503|NCT03739242|19917026|P1|STARTED|Overall Study||44
8077504|NCT03738865|19917064|P2|NOT COMPLETED|Overall Study||4
8077505|NCT03738865|19917065|P1|NOT COMPLETED|Overall Study||5
8077506|NCT03738865|19917064|P2|COMPLETED|Overall Study||62
8077507|NCT03738865|19917065|P1|COMPLETED|Overall Study||61
8077508|NCT03738865|19917064|P2|STARTED|Overall Study||66
8077509|NCT03738865|19917065|P1|STARTED|Overall Study||66
8077510|NCT03738475|19917081|P2|NOT COMPLETED|Overall Study||0
8077511|NCT03738475|19917082|P1|NOT COMPLETED|Overall Study||1
8077512|NCT03738475|19917081|P2|COMPLETED|Overall Study||18
8077513|NCT03738475|19917082|P1|COMPLETED|Overall Study||15
8077514|NCT03738475|19917081|P2|STARTED|Overall Study||18
8077515|NCT03738475|19917082|P1|STARTED|Overall Study||16
8077516|NCT03738020|19917119|P1|NOT COMPLETED|Overall Study||1
8077517|NCT03738020|19917119|P1|COMPLETED|Overall Study||57
8077518|NCT03738020|19917119|P1|STARTED|Overall Study||58
8077519|NCT03736031|19917128|P2|NOT COMPLETED|Overall Study||6
8077520|NCT03736031|19917129|P1|NOT COMPLETED|Overall Study||32
8077521|NCT03736031|19917128|P2|COMPLETED|Overall Study||40
8077522|NCT03736031|19917129|P1|COMPLETED|Overall Study||24
8077523|NCT03736031|19917128|P2|STARTED|Overall Study||46
8077524|NCT03736031|19917129|P1|STARTED|Overall Study||56
8077525|NCT03735862|19917141|P1|NOT COMPLETED|Overall Study||0
8077526|NCT03735862|19917141|P1|COMPLETED|Overall Study||73
8077527|NCT03735862|19917141|P1|STARTED|Overall Study||73
8077528|NCT03734822|19917149|P1|NOT COMPLETED|Overall Study||0
8077529|NCT03734822|19917149|P1|COMPLETED|Overall Study||47
8077530|NCT03734822|19917149|P1|STARTED|Overall Study||47
8077531|NCT03733899|19917153|P6|NOT COMPLETED|Period 3||0
8077532|NCT03733899|19917154|P5|NOT COMPLETED|Period 3||0
8077533|NCT03733899|19917155|P4|NOT COMPLETED|Period 3||0
8077534|NCT03733899|19917156|P3|NOT COMPLETED|Period 3||0
8077535|NCT03733899|19917157|P2|NOT COMPLETED|Period 3||0
8077536|NCT03733899|19917158|P1|NOT COMPLETED|Period 3||1
8077537|NCT03733899|19917153|P6|COMPLETED|Period 3||2
8077538|NCT03733899|19917154|P5|COMPLETED|Period 3||4
8077539|NCT03733899|19917155|P4|COMPLETED|Period 3||4
8077540|NCT03733899|19917156|P3|COMPLETED|Period 3||3
8077541|NCT03733899|19917157|P2|COMPLETED|Period 3||2
8077542|NCT03733899|19917158|P1|COMPLETED|Period 3||2
8077543|NCT03733899|19917153|P6|STARTED|Period 3||2
8077544|NCT03733899|19917154|P5|STARTED|Period 3||4
8077545|NCT03733899|19917155|P4|STARTED|Period 3||4
8077546|NCT03733899|19917156|P3|STARTED|Period 3||3
8077547|NCT03733899|19917157|P2|STARTED|Period 3||2
8077548|NCT03733899|19917158|P1|STARTED|Period 3||3
8077549|NCT03733899|19917153|P6|NOT COMPLETED|Period 2||0
8077550|NCT03733899|19917154|P5|NOT COMPLETED|Period 2||0
8077551|NCT03733899|19917155|P4|NOT COMPLETED|Period 2||0
8077552|NCT03733899|19917156|P3|NOT COMPLETED|Period 2||0
8077553|NCT03733899|19917157|P2|NOT COMPLETED|Period 2||1
8077554|NCT03733899|19917158|P1|NOT COMPLETED|Period 2||0
8077555|NCT03733899|19917153|P6|COMPLETED|Period 2||2
8077556|NCT03733899|19917154|P5|COMPLETED|Period 2||4
8077557|NCT03733899|19917155|P4|COMPLETED|Period 2||4
8077558|NCT03733899|19917156|P3|COMPLETED|Period 2||3
8077559|NCT03733899|19917157|P2|COMPLETED|Period 2||2
8077560|NCT03733899|19917158|P1|COMPLETED|Period 2||3
8077561|NCT03733899|19917153|P6|STARTED|Period 2||2
8077562|NCT03733899|19917154|P5|STARTED|Period 2||4
8077563|NCT03733899|19917155|P4|STARTED|Period 2||4
8077564|NCT03733899|19917156|P3|STARTED|Period 2||3
8077565|NCT03733899|19917157|P2|STARTED|Period 2||3
8077566|NCT03733899|19917158|P1|STARTED|Period 2||3
8077567|NCT03733899|19917153|P6|NOT COMPLETED|Period 1||1
8077568|NCT03733899|19917154|P5|NOT COMPLETED|Period 1||0
8077569|NCT03733899|19917155|P4|NOT COMPLETED|Period 1||0
8077570|NCT03733899|19917156|P3|NOT COMPLETED|Period 1||0
8077571|NCT03733899|19917157|P2|NOT COMPLETED|Period 1||0
8077572|NCT03733899|19917158|P1|NOT COMPLETED|Period 1||0
8077573|NCT03733899|19917153|P6|COMPLETED|Period 1||2
8077574|NCT03733899|19917154|P5|COMPLETED|Period 1||4
8077575|NCT03733899|19917155|P4|COMPLETED|Period 1||4
8077576|NCT03733899|19917156|P3|COMPLETED|Period 1||3
8077577|NCT03733899|19917157|P2|COMPLETED|Period 1||3
8077578|NCT03733899|19917158|P1|COMPLETED|Period 1||3
8077579|NCT03733899|19917153|P6|STARTED|Period 1||3
8077580|NCT03733899|19917154|P5|STARTED|Period 1||4
8077581|NCT03733899|19917155|P4|STARTED|Period 1||4
8077582|NCT03733899|19917156|P3|STARTED|Period 1||3
8077583|NCT03733899|19917157|P2|STARTED|Period 1||3
8077584|NCT03733899|19917158|P1|STARTED|Period 1||3
8077585|NCT03733470|19917186|P2|NOT COMPLETED|Overall Study||1
8077586|NCT03733470|19917187|P1|NOT COMPLETED|Overall Study||1
8077587|NCT03733470|19917186|P2|COMPLETED|Overall Study||10
8077588|NCT03733470|19917187|P1|COMPLETED|Overall Study||7
8077589|NCT03733470|19917186|P2|STARTED|Overall Study||11
8077590|NCT03733470|19917187|P1|STARTED|Overall Study||8
8077591|NCT03733301|19917196|P3|NOT COMPLETED|Overall Study||4
8077592|NCT03733301|19917197|P2|NOT COMPLETED|Overall Study||9
8077593|NCT03733301|19917198|P1|NOT COMPLETED|Overall Study||7
8077594|NCT03733301|19917196|P3|COMPLETED|Overall Study||107
8077595|NCT03733301|19917197|P2|COMPLETED|Overall Study||100
8077596|NCT03733301|19917198|P1|COMPLETED|Overall Study||102
8077597|NCT03733301|19917196|P3|Received One Dose of Study Drug|Overall Study||111
8077598|NCT03733301|19917197|P2|Received One Dose of Study Drug|Overall Study||109
8077599|NCT03733301|19917198|P1|Received One Dose of Study Drug|Overall Study||108
8077600|NCT03733301|19917196|P3|STARTED|Overall Study||111
8077601|NCT03733301|19917197|P2|STARTED|Overall Study||109
8077602|NCT03733301|19917198|P1|STARTED|Overall Study||109
8077603|NCT03732248|19917280|P2|NOT COMPLETED|Overall Study||0
8077604|NCT03732248|19917281|P1|NOT COMPLETED|Overall Study||1
8077605|NCT03732248|19917280|P2|COMPLETED|Overall Study||10
8077606|NCT03732248|19917281|P1|COMPLETED|Overall Study||10
8077607|NCT03732248|19917280|P2|STARTED|Overall Study||10
8077608|NCT03732248|19917281|P1|STARTED|Overall Study||11
8077619|NCT03730116|19917336|P1|NOT COMPLETED|3 Month After Inclusion||17
8077620|NCT03730116|19917336|P1|COMPLETED|3 Month After Inclusion||1892
8077621|NCT03730116|19917336|P1|3 Month After Inclusion|3 Month After Inclusion||1909
8077622|NCT03730116|19917336|P1|STARTED|3 Month After Inclusion||1909
8077623|NCT03730116|19917336|P1|NOT COMPLETED|1 Month After Inclusion||0
8077624|NCT03730116|19917336|P1|COMPLETED|1 Month After Inclusion||1909
8077625|NCT03730116|19917336|P1|1 Month After Inclusion|1 Month After Inclusion||1909
8077626|NCT03730116|19917336|P1|STARTED|1 Month After Inclusion||1909
8077627|NCT03730116|19917336|P1|NOT COMPLETED|Inclusion||0
8077628|NCT03730116|19917336|P1|COMPLETED|Inclusion||1909
8077629|NCT03730116|19917336|P1|FVFP|Inclusion||1909
8077630|NCT03730116|19917336|P1|STARTED|Inclusion|Planned to include 1920 pts, included 1909|1909
8077631|NCT03730103|19917347|P2|NOT COMPLETED|Overall Study||5
8077632|NCT03730103|19917348|P1|NOT COMPLETED|Overall Study||0
8077633|NCT03730103|19917347|P2|COMPLETED|Overall Study||47
8077634|NCT03730103|19917348|P1|COMPLETED|Overall Study||61
8077635|NCT03730103|19917347|P2|STARTED|Overall Study||52
8077636|NCT03730103|19917348|P1|STARTED|Overall Study||61
8077637|NCT03729960|19917360|P1|NOT COMPLETED|Overall Study||0
8077638|NCT03729960|19917360|P1|COMPLETED|Overall Study||20
8077639|NCT03729960|19917360|P1|STARTED|Overall Study||20
8077640|NCT03728790|19917371|P2|NOT COMPLETED|Overall Study||0
8077641|NCT03728790|19917372|P1|NOT COMPLETED|Overall Study||0
8077642|NCT03728790|19917371|P2|COMPLETED|Overall Study||101
8077643|NCT03728790|19917372|P1|COMPLETED|Overall Study||112
8077644|NCT03728790|19917371|P2|STARTED|Overall Study||101
8077645|NCT03728790|19917372|P1|STARTED|Overall Study||112
8077646|NCT03728140|19917396|P2|NOT COMPLETED|Overall Study||7
8077647|NCT03728140|19917397|P1|NOT COMPLETED|Overall Study||10
8077648|NCT03728140|19917396|P2|COMPLETED|Overall Study||168
8077649|NCT03728140|19917397|P1|COMPLETED|Overall Study||150
8077650|NCT03728140|19917396|P2|STARTED|Overall Study|embryo transfer with new culture medium|175
8077651|NCT03728140|19917397|P1|STARTED|Overall Study|embryo transfer with self-spent culture medium|160
8077652|NCT03727854|19917407|P2|NOT COMPLETED|Overall Study||0
8077653|NCT03727854|19917408|P1|NOT COMPLETED|Overall Study||0
8077654|NCT03727854|19917407|P2|COMPLETED|Overall Study||20
8077655|NCT03727854|19917408|P1|COMPLETED|Overall Study||20
8077656|NCT03727854|19917407|P2|STARTED|Overall Study||20
8077657|NCT03727854|19917408|P1|STARTED|Overall Study||20
8077658|NCT03727425|19917430|P1|NOT COMPLETED|Overall Study||0
8077659|NCT03727425|19917430|P1|COMPLETED|Overall Study||55
8077660|NCT03727425|19917430|P1|STARTED|Overall Study||55
8077661|NCT03727373|19917439|P1|NOT COMPLETED|Overall Study||0
8077662|NCT03727373|19917439|P1|COMPLETED|Overall Study||8
8077663|NCT03727373|19917439|P1|STARTED|Overall Study||8
8077664|NCT03726996|19917450|P1|NOT COMPLETED|Overall Study||4
8077665|NCT03726996|19917450|P1|COMPLETED|Overall Study||0
8077666|NCT03726996|19917450|P1|STARTED|Overall Study||4
8077667|NCT03726164|19917460|P2|NOT COMPLETED|Overall Study||197
8077668|NCT03726164|19917461|P1|NOT COMPLETED|Overall Study||211
8077669|NCT03726164|19917460|P2|COMPLETED|Overall Study||119
8077670|NCT03726164|19917461|P1|COMPLETED|Overall Study||99
8077671|NCT03726164|19917460|P2|STARTED|Overall Study||316
8077672|NCT03726164|19917461|P1|STARTED|Overall Study||310
8077673|NCT03725982|19917469|P2|NOT COMPLETED|Second Intervention||0
8077674|NCT03725982|19917470|P1|NOT COMPLETED|Second Intervention||0
8077675|NCT03725982|19917469|P2|COMPLETED|Second Intervention||17
8077676|NCT03725982|19917470|P1|COMPLETED|Second Intervention||19
8077677|NCT03725982|19917469|P2|STARTED|Second Intervention||17
8077678|NCT03725982|19917470|P1|STARTED|Second Intervention||19
8077679|NCT03725982|19917469|P2|NOT COMPLETED|First Intervention||2
8077680|NCT03725982|19917470|P1|NOT COMPLETED|First Intervention||1
8077681|NCT03725982|19917469|P2|COMPLETED|First Intervention||17
8077682|NCT03725982|19917470|P1|COMPLETED|First Intervention||19
8077683|NCT03725982|19917469|P2|STARTED|First Intervention||19
8077684|NCT03725982|19917470|P1|STARTED|First Intervention||20
8077685|NCT03725098|19917494|P2|NOT COMPLETED|Overall Study||0
8077686|NCT03725098|19917495|P1|NOT COMPLETED|Overall Study||0
8077687|NCT03725098|19917494|P2|COMPLETED|Overall Study||52
8077688|NCT03725098|19917495|P1|COMPLETED|Overall Study||53
8077689|NCT03725098|19917494|P2|STARTED|Overall Study||52
8077690|NCT03725098|19917495|P1|STARTED|Overall Study||53
8077691|NCT03725085|19917503|P1|NOT COMPLETED|Overall Study||2
8077692|NCT03725085|19917503|P1|COMPLETED|Overall Study||550
8077693|NCT03725085|19917503|P1|STARTED|Overall Study||552
8077700|NCT03724981|19917526|P2|NOT COMPLETED|Second Device||0
8077701|NCT03724981|19917527|P1|NOT COMPLETED|Second Device||0
8077702|NCT03724981|19917526|P2|COMPLETED|Second Device||155
8077703|NCT03724981|19917527|P1|COMPLETED|Second Device||155
8077704|NCT03724981|19917526|P2|STARTED|Second Device||155
8077705|NCT03724981|19917527|P1|STARTED|Second Device||155
8077706|NCT03724981|19917526|P2|NOT COMPLETED|First Device||1
8077707|NCT03724981|19917527|P1|NOT COMPLETED|First Device||1
8077708|NCT03724981|19917526|P2|COMPLETED|First Device||155
8077709|NCT03724981|19917527|P1|COMPLETED|First Device||155
8077710|NCT03724981|19917526|P2|STARTED|First Device||156
8077711|NCT03724981|19917527|P1|STARTED|First Device||156
8077712|NCT03724877|19917537|P2|NOT COMPLETED|Overall Study||0
8077713|NCT03724877|19917538|P1|NOT COMPLETED|Overall Study||0
8077714|NCT03724877|19917537|P2|COMPLETED|Overall Study||1932
8077715|NCT03724877|19917538|P1|COMPLETED|Overall Study||6921
8077716|NCT03724877|19917537|P2|STARTED|Overall Study||1932
8077717|NCT03724877|19917538|P1|STARTED|Overall Study||6921
8077718|NCT03724253|19917555|P5|NOT COMPLETED|Overall Study||0
8077719|NCT03724253|19917556|P4|NOT COMPLETED|Overall Study||0
8077720|NCT03724253|19917557|P3|NOT COMPLETED|Overall Study||0
8077721|NCT03724253|19917558|P2|NOT COMPLETED|Overall Study||0
8077722|NCT03724253|19917559|P1|NOT COMPLETED|Overall Study||0
8077723|NCT03724253|19917555|P5|COMPLETED|Overall Study||1
8077724|NCT03724253|19917556|P4|COMPLETED|Overall Study||3
8077725|NCT03724253|19917557|P3|COMPLETED|Overall Study||5
8077726|NCT03724253|19917558|P2|COMPLETED|Overall Study||5
8077727|NCT03724253|19917559|P1|COMPLETED|Overall Study||5
8077728|NCT03724253|19917555|P5|STARTED|Overall Study||1
8077729|NCT03724253|19917556|P4|STARTED|Overall Study||3
8077730|NCT03724253|19917557|P3|STARTED|Overall Study||5
8077731|NCT03724253|19917558|P2|STARTED|Overall Study||5
8077732|NCT03724253|19917559|P1|STARTED|Overall Study||5
8077733|NCT03723980|19917632|P2|NOT COMPLETED|Overall Study||5
8077734|NCT03723980|19917633|P1|NOT COMPLETED|Overall Study||7
8077735|NCT03723980|19917632|P2|COMPLETED|Overall Study||35
8077736|NCT03723980|19917633|P1|COMPLETED|Overall Study||33
8077737|NCT03723980|19917632|P2|STARTED|Overall Study||40
8077738|NCT03723980|19917633|P1|STARTED|Overall Study||40
8077739|NCT03723915|19917649|P1|NOT COMPLETED|Survival Follow-up||2
8077740|NCT03723915|19917649|P1|COMPLETED|Survival Follow-up||11
8077741|NCT03723915|19917649|P1|STARTED|Survival Follow-up||13
8077742|NCT03723915|19917649|P1|NOT COMPLETED|On Treatment||2
8077743|NCT03723915|19917649|P1|COMPLETED|On Treatment||13
8077744|NCT03723915|19917649|P1|Received First Dose of Study Drugs|On Treatment||13
8077745|NCT03723915|19917649|P1|Registered on Study|On Treatment||15
8077746|NCT03723915|19917649|P1|STARTED|On Treatment||15
8077747|NCT03723915|19917649|P1|NOT COMPLETED|Screening||2
8077748|NCT03723915|19917649|P1|COMPLETED|Screening||15
8077749|NCT03723915|19917649|P1|STARTED|Screening||17
8077750|NCT03723603|19917653|P1|NOT COMPLETED|Overall Study||3
8077751|NCT03723603|19917653|P1|COMPLETED|Overall Study||5
8077752|NCT03723603|19917653|P1|STARTED|Overall Study||8
8077753|NCT03722810|19917661|P2|NOT COMPLETED|Overall Study||4
8077754|NCT03722810|19917662|P1|NOT COMPLETED|Overall Study||7
8077755|NCT03722810|19917661|P2|COMPLETED|Overall Study||156
8077756|NCT03722810|19917662|P1|COMPLETED|Overall Study||150
8077757|NCT03722810|19917661|P2|STARTED|Overall Study||160
8077758|NCT03722810|19917662|P1|STARTED|Overall Study||157
8077759|NCT03722784|19917677|P2|NOT COMPLETED|Overall Study||2
8077760|NCT03722784|19917678|P1|NOT COMPLETED|Overall Study||2
8077761|NCT03722784|19917677|P2|COMPLETED|Overall Study||28
8077762|NCT03722784|19917678|P1|COMPLETED|Overall Study||56
8077763|NCT03722784|19917677|P2|STARTED|Overall Study||30
8077764|NCT03722784|19917678|P1|STARTED|Overall Study||58
8077765|NCT03722446|19917722|P2|NOT COMPLETED|Overall Study||2
8077766|NCT03722446|19917723|P1|NOT COMPLETED|Overall Study||15
8077767|NCT03722446|19917722|P2|COMPLETED|Overall Study||120
8077768|NCT03722446|19917723|P1|COMPLETED|Overall Study||120
8077769|NCT03722446|19917722|P2|STARTED|Overall Study||122
8077770|NCT03722446|19917723|P1|STARTED|Overall Study||135
8077771|NCT03722264|19917739|P1|NOT COMPLETED|Overall Study||3
8077772|NCT03722264|19917739|P1|COMPLETED|Overall Study||9
8077773|NCT03722264|19917739|P1|STARTED|Overall Study||12
8077780|NCT03721549|19917766|P2|NOT COMPLETED|Overall Study||0
8077781|NCT03721549|19917767|P1|NOT COMPLETED|Overall Study||1
8077782|NCT03721549|19917766|P2|COMPLETED|Overall Study||8
8077783|NCT03721549|19917767|P1|COMPLETED|Overall Study||7
8077784|NCT03721549|19917766|P2|STARTED|Overall Study||8
8077785|NCT03721549|19917767|P1|STARTED|Overall Study||8
8077786|NCT03720938|19917777|P2|NOT COMPLETED|Overall Study||623
8077787|NCT03720938|19917778|P1|NOT COMPLETED|Overall Study||189
8077788|NCT03720938|19917777|P2|COMPLETED|Overall Study||53
8077789|NCT03720938|19917778|P1|COMPLETED|Overall Study||53
8077790|NCT03720938|19917777|P2|STARTED|Overall Study||676
8077791|NCT03720938|19917778|P1|STARTED|Overall Study||242
8077792|NCT03720847|19917822|P2|NOT COMPLETED|Condition 2||0
8077793|NCT03720847|19917823|P1|NOT COMPLETED|Condition 2||0
8077794|NCT03720847|19917822|P2|COMPLETED|Condition 2||13
8077795|NCT03720847|19917823|P1|COMPLETED|Condition 2||14
8077796|NCT03720847|19917822|P2|STARTED|Condition 2||13
8077797|NCT03720847|19917823|P1|STARTED|Condition 2||14
8077798|NCT03720847|19917822|P2|NOT COMPLETED|Washout||2
8077799|NCT03720847|19917823|P1|NOT COMPLETED|Washout||1
8077800|NCT03720847|19917822|P2|COMPLETED|Washout||13
8077801|NCT03720847|19917823|P1|COMPLETED|Washout||14
8077802|NCT03720847|19917822|P2|STARTED|Washout||15
8077803|NCT03720847|19917823|P1|STARTED|Washout||15
8077804|NCT03720847|19917822|P2|NOT COMPLETED|Condition 1||0
8077805|NCT03720847|19917823|P1|NOT COMPLETED|Condition 1||0
8077806|NCT03720847|19917822|P2|COMPLETED|Condition 1||15
8077807|NCT03720847|19917823|P1|COMPLETED|Condition 1||15
8077808|NCT03720847|19917822|P2|STARTED|Condition 1||15
8077809|NCT03720847|19917823|P1|STARTED|Condition 1||15
8077810|NCT03720470|19917845|P6|NOT COMPLETED|Treatment Period: Final 4 Weeks||5
8077811|NCT03720470|19917846|P5|NOT COMPLETED|Treatment Period: Final 4 Weeks||4
8077812|NCT03720470|19917847|P4|NOT COMPLETED|Treatment Period: Final 4 Weeks||7
8077813|NCT03720470|19917848|P3|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
8077814|NCT03720470|19917849|P2|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
8077815|NCT03720470|19917850|P1|NOT COMPLETED|Treatment Period: Final 4 Weeks||0
8077816|NCT03720470|19917845|P6|COMPLETED|Treatment Period: Final 4 Weeks||218
8077817|NCT03720470|19917846|P5|COMPLETED|Treatment Period: Final 4 Weeks||204
8077818|NCT03720470|19917847|P4|COMPLETED|Treatment Period: Final 4 Weeks||210
8077819|NCT03720470|19917848|P3|COMPLETED|Treatment Period: Final 4 Weeks||55
8077820|NCT03720470|19917849|P2|COMPLETED|Treatment Period: Final 4 Weeks||58
8077821|NCT03720470|19917850|P1|COMPLETED|Treatment Period: Final 4 Weeks||0
8077822|NCT03720470|19917845|P6|Full Analysis Set|Treatment Period: Final 4 Weeks||223
8077823|NCT03720470|19917846|P5|Full Analysis Set|Treatment Period: Final 4 Weeks||208
8077824|NCT03720470|19917847|P4|Full Analysis Set|Treatment Period: Final 4 Weeks||217
8077825|NCT03720470|19917848|P3|Full Analysis Set|Treatment Period: Final 4 Weeks||57
8077826|NCT03720470|19917849|P2|Full Analysis Set|Treatment Period: Final 4 Weeks||60
8077827|NCT03720470|19917850|P1|Full Analysis Set|Treatment Period: Final 4 Weeks||0
8077828|NCT03720470|19917845|P6|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||223
8077829|NCT03720470|19917846|P5|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||208
8077830|NCT03720470|19917847|P4|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||217
8077831|NCT03720470|19917848|P3|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||57
8077832|NCT03720470|19917849|P2|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||60
8077833|NCT03720470|19917850|P1|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||0
8077834|NCT03720470|19917845|P6|STARTED|Treatment Period: Final 4 Weeks||223
8077835|NCT03720470|19917846|P5|STARTED|Treatment Period: Final 4 Weeks||208
8077836|NCT03720470|19917847|P4|STARTED|Treatment Period: Final 4 Weeks||217
8077837|NCT03720470|19917848|P3|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|57
8077838|NCT03720470|19917849|P2|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|60
8077839|NCT03720470|19917850|P1|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|0
8077840|NCT03720470|19917845|P6|NOT COMPLETED|Treatment Period: First Part 16 Weeks||20
8077841|NCT03720470|19917846|P5|NOT COMPLETED|Treatment Period: First Part 16 Weeks||18
8077842|NCT03720470|19917847|P4|NOT COMPLETED|Treatment Period: First Part 16 Weeks||21
8077843|NCT03720470|19917848|P3|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
8077844|NCT03720470|19917849|P2|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
8077845|NCT03720470|19917850|P1|NOT COMPLETED|Treatment Period: First Part 16 Weeks||14
8077846|NCT03720470|19917845|P6|COMPLETED|Treatment Period: First Part 16 Weeks||223
8077847|NCT03720470|19917846|P5|COMPLETED|Treatment Period: First Part 16 Weeks||208
8077848|NCT03720470|19917847|P4|COMPLETED|Treatment Period: First Part 16 Weeks||217
8077849|NCT03720470|19917848|P3|COMPLETED|Treatment Period: First Part 16 Weeks||0
8077850|NCT03720470|19917849|P2|COMPLETED|Treatment Period: First Part 16 Weeks||0
8077851|NCT03720470|19917850|P1|COMPLETED|Treatment Period: First Part 16 Weeks||117
8077852|NCT03720470|19917845|P6|Full Analysis Set|Treatment Period: First Part 16 Weeks||242
8077853|NCT03720470|19917846|P5|Full Analysis Set|Treatment Period: First Part 16 Weeks||226
8077854|NCT03720470|19917847|P4|Full Analysis Set|Treatment Period: First Part 16 Weeks||238
8077855|NCT03720470|19917848|P3|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
8077856|NCT03720470|19917849|P2|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
8077857|NCT03720470|19917850|P1|Full Analysis Set|Treatment Period: First Part 16 Weeks||131
8077858|NCT03720470|19917845|P6|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||242
8077859|NCT03720470|19917846|P5|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||226
8077860|NCT03720470|19917847|P4|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||238
8077861|NCT03720470|19917848|P3|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
8077862|NCT03720470|19917849|P2|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
8077863|NCT03720470|19917850|P1|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||131
8077864|NCT03720470|19917845|P6|STARTED|Treatment Period: First Part 16 Weeks||243
8077865|NCT03720470|19917846|P5|STARTED|Treatment Period: First Part 16 Weeks||226
8077866|NCT03720470|19917847|P4|STARTED|Treatment Period: First Part 16 Weeks||238
8077867|NCT03720470|19917848|P3|STARTED|Treatment Period: First Part 16 Weeks||0
8077868|NCT03720470|19917849|P2|STARTED|Treatment Period: First Part 16 Weeks||0
8077869|NCT03720470|19917850|P1|STARTED|Treatment Period: First Part 16 Weeks||131
8077870|NCT03720119|19917994|P1|NOT COMPLETED|Overall Study||9
8077871|NCT03720119|19917994|P1|COMPLETED|Overall Study||69
8077872|NCT03720119|19917994|P1|STARTED|Overall Study||78
8077873|NCT03719885|19918000|P1|NOT COMPLETED|Overall Study||20
8077874|NCT03719885|19918000|P1|COMPLETED|Overall Study||35
8077875|NCT03719885|19918000|P1|STARTED|Overall Study||55
8077876|NCT03719677|19918007|P1|NOT COMPLETED|Overall Study||0
8077877|NCT03719677|19918007|P1|COMPLETED|Overall Study||7
8077878|NCT03719677|19918007|P1|STARTED|Overall Study||7
8077879|NCT03719300|19918011|P1|NOT COMPLETED|Overall Study||0
8077880|NCT03719300|19918011|P1|COMPLETED|Overall Study||32
8077881|NCT03719300|19918011|P1|STARTED|Overall Study||32
8077882|NCT03718455|19918022|P1|NOT COMPLETED|Overall Study||0
8077883|NCT03718455|19918022|P1|COMPLETED|Overall Study||1
8077884|NCT03718455|19918022|P1|STARTED|Overall Study||1
8077885|NCT03718143|19918028|P3|NOT COMPLETED|Overall Study||1
8077886|NCT03718143|19918029|P2|NOT COMPLETED|Overall Study||2
8077887|NCT03718143|19918030|P1|NOT COMPLETED|Overall Study||3
8077888|NCT03718143|19918028|P3|COMPLETED|Overall Study||0
8077889|NCT03718143|19918029|P2|COMPLETED|Overall Study||0
8077890|NCT03718143|19918030|P1|COMPLETED|Overall Study||0
8077891|NCT03718143|19918028|P3|STARTED|Overall Study||1
8077892|NCT03718143|19918029|P2|STARTED|Overall Study||2
8077893|NCT03718143|19918030|P1|STARTED|Overall Study||3
8077894|NCT03718000|19918046|P2|NOT COMPLETED|Overall Study||5
8077895|NCT03718000|19918047|P1|NOT COMPLETED|Overall Study||2
8077896|NCT03718000|19918046|P2|COMPLETED|Overall Study||51
8077897|NCT03718000|19918047|P1|COMPLETED|Overall Study||53
8077898|NCT03718000|19918046|P2|STARTED|Overall Study||56
8077899|NCT03718000|19918047|P1|STARTED|Overall Study||55
8077900|NCT03717064|19918069|P1|NOT COMPLETED|Period 2||1
8077901|NCT03717064|19918069|P1|COMPLETED|Period 2||17
8077902|NCT03717064|19918069|P1|STARTED|Period 2||18
8077903|NCT03717064|19918069|P1|NOT COMPLETED|Period 1||0
8077904|NCT03717064|19918069|P1|COMPLETED|Period 1||18
8077905|NCT03717064|19918069|P1|STARTED|Period 1||18
8077906|NCT03716050|19918101|P8|NOT COMPLETED|Overall Study||2
8077907|NCT03716050|19918102|P7|NOT COMPLETED|Overall Study||0
8077908|NCT03716050|19918103|P6|NOT COMPLETED|Overall Study||0
8077909|NCT03716050|19918104|P5|NOT COMPLETED|Overall Study||0
8077910|NCT03716050|19918105|P4|NOT COMPLETED|Overall Study||2
8077911|NCT03716050|19918106|P3|NOT COMPLETED|Overall Study||1
8077912|NCT03716050|19918107|P2|NOT COMPLETED|Overall Study||0
8077913|NCT03716050|19918108|P1|NOT COMPLETED|Overall Study||0
8077914|NCT03716050|19918101|P8|COMPLETED|Overall Study||0
8077915|NCT03716050|19918102|P7|COMPLETED|Overall Study||4
8077916|NCT03716050|19918103|P6|COMPLETED|Overall Study||0
8077917|NCT03716050|19918104|P5|COMPLETED|Overall Study||1
8077918|NCT03716050|19918105|P4|COMPLETED|Overall Study||1
8077919|NCT03716050|19918106|P3|COMPLETED|Overall Study||0
8077920|NCT03716050|19918107|P2|COMPLETED|Overall Study||4
8077921|NCT03716050|19918108|P1|COMPLETED|Overall Study||2
8077922|NCT03716050|19918101|P8|STARTED|Overall Study||2
8077923|NCT03716050|19918102|P7|STARTED|Overall Study||4
8077924|NCT03716050|19918103|P6|STARTED|Overall Study||0
8077925|NCT03716050|19918104|P5|STARTED|Overall Study||1
8077926|NCT03716050|19918105|P4|STARTED|Overall Study||3
8077927|NCT03716050|19918106|P3|STARTED|Overall Study||1
8077928|NCT03716050|19918107|P2|STARTED|Overall Study||4
8077929|NCT03716050|19918108|P1|STARTED|Overall Study||2
8077930|NCT03716024|19918162|P2|NOT COMPLETED|Overall Study||18
8077931|NCT03716024|19918163|P1|NOT COMPLETED|Overall Study||11
8077932|NCT03716024|19918162|P2|COMPLETED|Overall Study||98
8077933|NCT03716024|19918163|P1|COMPLETED|Overall Study||107
8077934|NCT03716024|19918162|P2|STARTED|Overall Study||116
8077935|NCT03716024|19918163|P1|STARTED|Overall Study||118
8077936|NCT03715803|19918177|P2|NOT COMPLETED|Overall Study||0
8077937|NCT03715803|19918178|P1|NOT COMPLETED|Overall Study||0
8077938|NCT03715803|19918177|P2|COMPLETED|Overall Study||126
8077939|NCT03715803|19918178|P1|COMPLETED|Overall Study||91
8077940|NCT03715803|19918177|P2|STARTED|Overall Study||126
8077941|NCT03715803|19918178|P1|STARTED|Overall Study||91
8077942|NCT03715530|19918197|P3|NOT COMPLETED|Overall Study||2
8077943|NCT03715530|19918198|P2|NOT COMPLETED|Overall Study||1
8077944|NCT03715530|19918199|P1|NOT COMPLETED|Overall Study||3
8077945|NCT03715530|19918197|P3|COMPLETED|Overall Study||85
8077946|NCT03715530|19918198|P2|COMPLETED|Overall Study||41
8077947|NCT03715530|19918199|P1|COMPLETED|Overall Study||30
8077948|NCT03715530|19918197|P3|STARTED|Overall Study||87
8077949|NCT03715530|19918198|P2|STARTED|Overall Study||42
8077950|NCT03715530|19918199|P1|STARTED|Overall Study||33
8077951|NCT03715452|19918207|P1|NOT COMPLETED|Overall Study||0
8077952|NCT03715452|19918207|P1|COMPLETED|Overall Study||114
8077953|NCT03715452|19918207|P1|STARTED|Overall Study||114
8077954|NCT03715426|19918214|P2|NOT COMPLETED|Overall Study||25
8077955|NCT03715426|19918215|P1|NOT COMPLETED|Overall Study||21
8077956|NCT03715426|19918214|P2|COMPLETED|Overall Study||92
8077957|NCT03715426|19918215|P1|COMPLETED|Overall Study||112
8077958|NCT03715426|19918214|P2|4-Month Follow-Up Survey|Overall Study||92
8077959|NCT03715426|19918215|P1|4-Month Follow-Up Survey|Overall Study||112
8077960|NCT03715426|19918214|P2|1-Month Follow-Up Survey|Overall Study||97
8077961|NCT03715426|19918215|P1|1-Month Follow-Up Survey|Overall Study||113
8077962|NCT03715426|19918214|P2|STARTED|Overall Study||117
8077963|NCT03715426|19918215|P1|STARTED|Overall Study||133
8077964|NCT03714672|19918259|P4|NOT COMPLETED|Overall Study||1
8077965|NCT03714672|19918260|P3|NOT COMPLETED|Overall Study||4
8077966|NCT03714672|19918261|P2|NOT COMPLETED|Overall Study||4
8077967|NCT03714672|19918262|P1|NOT COMPLETED|Overall Study||2
8077968|NCT03714672|19918259|P4|COMPLETED|Overall Study||207
8077969|NCT03714672|19918260|P3|COMPLETED|Overall Study||202
8077970|NCT03714672|19918261|P2|COMPLETED|Overall Study||202
8077971|NCT03714672|19918262|P1|COMPLETED|Overall Study||207
8077972|NCT03714672|19918259|P4|Safety Set|Overall Study||207
8077973|NCT03714672|19918260|P3|Safety Set|Overall Study||206
8077974|NCT03714672|19918261|P2|Safety Set|Overall Study||205
8077975|NCT03714672|19918262|P1|Safety Set|Overall Study||208
8077976|NCT03714672|19918259|P4|STARTED|Overall Study||208
8077977|NCT03714672|19918260|P3|STARTED|Overall Study||206
8077978|NCT03714672|19918261|P2|STARTED|Overall Study||206
8077979|NCT03714672|19918262|P1|STARTED|Overall Study||209
8077980|NCT03714659|19918308|P1|NOT COMPLETED|Overall Study||1
8077981|NCT03714659|19918308|P1|COMPLETED|Overall Study||19
8077982|NCT03714659|19918308|P1|STARTED|Overall Study||20
8077983|NCT03714256|19918315|P2|NOT COMPLETED|Overall Study||0
8077984|NCT03714256|19918316|P1|NOT COMPLETED|Overall Study||0
8077985|NCT03714256|19918315|P2|COMPLETED|Overall Study||19
8077986|NCT03714256|19918316|P1|COMPLETED|Overall Study||14
8077987|NCT03714256|19918315|P2|STARTED|Overall Study||19
8077988|NCT03714256|19918316|P1|STARTED|Overall Study||14
8077989|NCT03714022|19918324|P2|NOT COMPLETED|Overall Study||3
8077990|NCT03714022|19918325|P1|NOT COMPLETED|Overall Study||4
8077991|NCT03714022|19918324|P2|COMPLETED|Overall Study||67
8077992|NCT03714022|19918325|P1|COMPLETED|Overall Study||66
8077993|NCT03714022|19918324|P2|STARTED|Overall Study||70
8077994|NCT03714022|19918325|P1|STARTED|Overall Study||70
8077995|NCT03712917|19918378|P3|NOT COMPLETED|Overall Study||9
8077996|NCT03712917|19918379|P2|NOT COMPLETED|Overall Study||8
8077997|NCT03712917|19918380|P1|NOT COMPLETED|Overall Study||9
8077998|NCT03712917|19918378|P3|COMPLETED|Overall Study||31
8077999|NCT03712917|19918379|P2|COMPLETED|Overall Study||32
8078000|NCT03712917|19918380|P1|COMPLETED|Overall Study||31
8078001|NCT03712917|19918378|P3|STARTED|Overall Study||40
8078002|NCT03712917|19918379|P2|STARTED|Overall Study||40
8078003|NCT03712917|19918380|P1|STARTED|Overall Study||40
8078004|NCT03710577|19918393|P2|NOT COMPLETED|Second Intervention||0
8078005|NCT03710577|19918394|P1|NOT COMPLETED|Second Intervention||0
8078006|NCT03710577|19918393|P2|COMPLETED|Second Intervention||4
8078007|NCT03710577|19918394|P1|COMPLETED|Second Intervention||8
8078008|NCT03710577|19918393|P2|STARTED|Second Intervention||4
8078009|NCT03710577|19918394|P1|STARTED|Second Intervention||8
8078010|NCT03710577|19918393|P2|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
8078011|NCT03710577|19918394|P1|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
8078012|NCT03710577|19918393|P2|COMPLETED|Time Between Sessions (2-5 Days)||4
8078013|NCT03710577|19918394|P1|COMPLETED|Time Between Sessions (2-5 Days)||8
8078014|NCT03710577|19918393|P2|STARTED|Time Between Sessions (2-5 Days)||4
8078015|NCT03710577|19918394|P1|STARTED|Time Between Sessions (2-5 Days)||8
8078016|NCT03710577|19918393|P2|NOT COMPLETED|First Intervention||0
8078017|NCT03710577|19918394|P1|NOT COMPLETED|First Intervention||0
8078018|NCT03710577|19918393|P2|COMPLETED|First Intervention||4
8078019|NCT03710577|19918394|P1|COMPLETED|First Intervention||8
8078020|NCT03710577|19918393|P2|STARTED|First Intervention||4
8078021|NCT03710577|19918394|P1|STARTED|First Intervention||8
8078022|NCT03710083|19918408|P1|NOT COMPLETED|Overall Study||3
8078023|NCT03710083|19918408|P1|COMPLETED|Overall Study||63
8078024|NCT03710083|19918408|P1|STARTED|Overall Study||66
8078025|NCT03709823|19918421|P6|NOT COMPLETED|Overall Study||0
8078026|NCT03709823|19918422|P5|NOT COMPLETED|Overall Study||1
8078027|NCT03709823|19918423|P4|NOT COMPLETED|Overall Study||2
8078028|NCT03709823|19918424|P3|NOT COMPLETED|Overall Study||3
8078029|NCT03709823|19918425|P2|NOT COMPLETED|Overall Study||5
8078030|NCT03709823|19918426|P1|NOT COMPLETED|Overall Study||3
8078031|NCT03709823|19918421|P6|COMPLETED|Overall Study||26
8078032|NCT03709823|19918422|P5|COMPLETED|Overall Study||49
8078033|NCT03709823|19918423|P4|COMPLETED|Overall Study||50
8078034|NCT03709823|19918424|P3|COMPLETED|Overall Study||22
8078035|NCT03709823|19918425|P2|COMPLETED|Overall Study||45
8078036|NCT03709823|19918426|P1|COMPLETED|Overall Study||48
8078037|NCT03709823|19918421|P6|STARTED|Overall Study||26
8078038|NCT03709823|19918422|P5|STARTED|Overall Study||50
8078039|NCT03709823|19918423|P4|STARTED|Overall Study||52
8078040|NCT03709823|19918424|P3|STARTED|Overall Study||25
8078041|NCT03709823|19918425|P2|STARTED|Overall Study||50
8078042|NCT03709823|19918426|P1|STARTED|Overall Study||51
8078043|NCT03709810|19918446|P2|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
8078044|NCT03709810|19918447|P1|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
8078045|NCT03709810|19918446|P2|COMPLETED|Treatment Period 2 (Visit 3)||24
8078046|NCT03709810|19918447|P1|COMPLETED|Treatment Period 2 (Visit 3)||24
8078047|NCT03709810|19918446|P2|STARTED|Treatment Period 2 (Visit 3)||24
8078048|NCT03709810|19918447|P1|STARTED|Treatment Period 2 (Visit 3)||24
8078049|NCT03709810|19918446|P2|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
8078050|NCT03709810|19918447|P1|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
8078051|NCT03709810|19918446|P2|COMPLETED|Treatment Period 1 (Visit 2)||24
8078052|NCT03709810|19918447|P1|COMPLETED|Treatment Period 1 (Visit 2)||24
8078053|NCT03709810|19918446|P2|STARTED|Treatment Period 1 (Visit 2)||24
8078054|NCT03709810|19918447|P1|STARTED|Treatment Period 1 (Visit 2)||24
8078055|NCT03709654|19918463|P2|NOT COMPLETED|Overall Study||2
8078056|NCT03709654|19918464|P1|NOT COMPLETED|Overall Study||3
8078057|NCT03709654|19918463|P2|COMPLETED|Overall Study||11
8078058|NCT03709654|19918464|P1|COMPLETED|Overall Study||20
8078059|NCT03709654|19918463|P2|STARTED|Overall Study||13
8078060|NCT03709654|19918464|P1|STARTED|Overall Study||23
8078061|NCT03709602|19918493|P3|NOT COMPLETED|Overall Study||0
8078062|NCT03709602|19918494|P2|NOT COMPLETED|Overall Study||0
8078063|NCT03709602|19918495|P1|NOT COMPLETED|Overall Study||0
8078064|NCT03709602|19918493|P3|COMPLETED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
8078065|NCT03709602|19918494|P2|COMPLETED|Overall Study|Parents recruited for qualitative interviews.|16
8078066|NCT03709602|19918495|P1|COMPLETED|Overall Study|Adolescents recruited for qualitative interviews.|16
8078067|NCT03709602|19918493|P3|STARTED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
8078068|NCT03709602|19918494|P2|STARTED|Overall Study|Parents recruited for qualitative interviews.|16
8078069|NCT03709602|19918495|P1|STARTED|Overall Study|Adolescents recruited for qualitative interviews.|16
8078070|NCT03709576|19918501|P1|NOT COMPLETED|Overall Study||1
8078071|NCT03709576|19918501|P1|COMPLETED|Overall Study||2
8078072|NCT03709576|19918501|P1|STARTED|Overall Study||3
8078073|NCT03708770|19918513|P1|NOT COMPLETED|Overall Study||10
8078074|NCT03708770|19918513|P1|COMPLETED|Overall Study||22
8078075|NCT03708770|19918513|P1|STARTED|Overall Study||32
8078076|NCT03708744|19918524|P4|NOT COMPLETED|Overall Study||0
8078077|NCT03708744|19918525|P3|NOT COMPLETED|Overall Study||1
8078078|NCT03708744|19918526|P2|NOT COMPLETED|Overall Study||0
8078079|NCT03708744|19918527|P1|NOT COMPLETED|Overall Study||0
8078080|NCT03708744|19918524|P4|COMPLETED|Overall Study||6
8078081|NCT03708744|19918525|P3|COMPLETED|Overall Study||4
8078082|NCT03708744|19918526|P2|COMPLETED|Overall Study||6
8078083|NCT03708744|19918527|P1|COMPLETED|Overall Study||7
8078084|NCT03708744|19918524|P4|STARTED|Overall Study||6
8078085|NCT03708744|19918525|P3|STARTED|Overall Study||5
8078086|NCT03708744|19918526|P2|STARTED|Overall Study||6
8078087|NCT03708744|19918527|P1|STARTED|Overall Study||7
8078088|NCT03708562|19918545|P1|NOT COMPLETED|Overall Study||12
8078089|NCT03708562|19918545|P1|COMPLETED|Overall Study||12
8078090|NCT03708562|19918545|P1|STARTED|Overall Study||24
8078091|NCT03708211|19918561|P2|NOT COMPLETED|Overall Study||8
8078092|NCT03708211|19918562|P1|NOT COMPLETED|Overall Study||12
8078093|NCT03708211|19918561|P2|COMPLETED|Overall Study||0
8078094|NCT03708211|19918562|P1|COMPLETED|Overall Study||0
8078095|NCT03708211|19918561|P2|STARTED|Overall Study||8
8078096|NCT03708211|19918562|P1|STARTED|Overall Study||12
8078097|NCT03707912|19918594|P2|NOT COMPLETED|Overall Study||0
8078098|NCT03707912|19918595|P1|NOT COMPLETED|Overall Study||1
8078099|NCT03707912|19918594|P2|COMPLETED|Overall Study||100
8078100|NCT03707912|19918595|P1|COMPLETED|Overall Study||103
8078101|NCT03707912|19918594|P2|STARTED|Overall Study||100
8078102|NCT03707912|19918595|P1|STARTED|Overall Study||104
8078103|NCT03707821|19918615|P2|NOT COMPLETED|Overall Study||1
8078104|NCT03707821|19918616|P1|NOT COMPLETED|Overall Study||2
8078105|NCT03707821|19918615|P2|COMPLETED|Overall Study||125
8078106|NCT03707821|19918616|P1|COMPLETED|Overall Study||123
8078107|NCT03707821|19918615|P2|STARTED|Overall Study||126
8078108|NCT03707821|19918616|P1|STARTED|Overall Study||125
8078109|NCT03707587|19918636|P2|NOT COMPLETED|Overall Study||1
8078110|NCT03707587|19918637|P1|NOT COMPLETED|Overall Study||0
8078111|NCT03707587|19918636|P2|COMPLETED|Overall Study||1
8078112|NCT03707587|19918637|P1|COMPLETED|Overall Study||7
8078113|NCT03707587|19918636|P2|STARTED|Overall Study||2
8078114|NCT03707587|19918637|P1|STARTED|Overall Study||7
8078115|NCT03707522|19918653|P4|NOT COMPLETED|Overall Study||36
8078116|NCT03707522|19918654|P3|NOT COMPLETED|Overall Study||41
8078117|NCT03707522|19918655|P2|NOT COMPLETED|Overall Study||27
8078118|NCT03707522|19918656|P1|NOT COMPLETED|Overall Study||24
8078119|NCT03707522|19918653|P4|COMPLETED|Overall Study||7
8078120|NCT03707522|19918654|P3|COMPLETED|Overall Study||11
8078121|NCT03707522|19918655|P2|COMPLETED|Overall Study||9
8078122|NCT03707522|19918656|P1|COMPLETED|Overall Study||7
8078123|NCT03707522|19918653|P4|STARTED|Overall Study||43
8078124|NCT03707522|19918654|P3|STARTED|Overall Study||52
8078125|NCT03707522|19918655|P2|STARTED|Overall Study||36
8078126|NCT03707522|19918656|P1|STARTED|Overall Study||31
8078145|NCT03705793|19918745|P2|NOT COMPLETED|Overall Study||5
8078146|NCT03705793|19918746|P1|NOT COMPLETED|Overall Study||5
8078147|NCT03705793|19918745|P2|COMPLETED|Overall Study||21
8078148|NCT03705793|19918746|P1|COMPLETED|Overall Study||22
8078149|NCT03705793|19918745|P2|STARTED|Overall Study||26
8078150|NCT03705793|19918746|P1|STARTED|Overall Study||27
8078151|NCT03705494|19918758|P2|NOT COMPLETED|Overall Study||3
8078152|NCT03705494|19918759|P1|NOT COMPLETED|Overall Study||7
8078153|NCT03705494|19918758|P2|COMPLETED|Overall Study||7
8078154|NCT03705494|19918759|P1|COMPLETED|Overall Study||3
8078155|NCT03705494|19918758|P2|STARTED|Overall Study||10
8078156|NCT03705494|19918759|P1|STARTED|Overall Study||10
8078157|NCT03705481|19918773|P1|NOT COMPLETED|Overall Study||0
8078158|NCT03705481|19918773|P1|COMPLETED|Overall Study||5
8078159|NCT03705481|19918773|P1|STARTED|Overall Study||5
8078160|NCT03704467|19918780|P1|NOT COMPLETED|Overall Study||0
8078161|NCT03704467|19918780|P1|COMPLETED|Overall Study||3
8078162|NCT03704467|19918780|P1|STARTED|Overall Study||3
8078163|NCT03704376|19918800|P2|NOT COMPLETED|Overall Study||4
8078164|NCT03704376|19918801|P1|NOT COMPLETED|Overall Study||4
8078165|NCT03704376|19918800|P2|COMPLETED|Overall Study||40
8078166|NCT03704376|19918801|P1|COMPLETED|Overall Study||38
8078167|NCT03704376|19918800|P2|STARTED|Overall Study||44
8078168|NCT03704376|19918801|P1|STARTED|Overall Study||42
8078169|NCT03704194|19918845|P2|NOT COMPLETED|Overall Study||1
8078170|NCT03704194|19918846|P1|NOT COMPLETED|Overall Study||0
8078171|NCT03704194|19918845|P2|COMPLETED|Overall Study||8
8078172|NCT03704194|19918846|P1|COMPLETED|Overall Study||8
8078173|NCT03704194|19918845|P2|STARTED|Overall Study||9
8078174|NCT03704194|19918846|P1|STARTED|Overall Study||8
8078187|NCT03703336|19918910|P2|NOT COMPLETED|Overall Study||14
8078188|NCT03703336|19918911|P1|NOT COMPLETED|Overall Study||38
8078189|NCT03703336|19918910|P2|COMPLETED|Overall Study||259
8078190|NCT03703336|19918911|P1|COMPLETED|Overall Study||514
8078191|NCT03703336|19918910|P2|Safety Population|Overall Study||274
8078192|NCT03703336|19918911|P1|Safety Population|Overall Study||551
8078193|NCT03703336|19918910|P2|Received Dose 2|Overall Study||263
8078194|NCT03703336|19918911|P1|Received Dose 2|Overall Study||518
8078195|NCT03703336|19918910|P2|Received Dose 1|Overall Study||273
8078196|NCT03703336|19918911|P1|Received Dose 1|Overall Study||552
8078197|NCT03703336|19918910|P2|STARTED|Overall Study||273
8078198|NCT03703336|19918911|P1|STARTED|Overall Study||552
8078199|NCT03702608|19918929|P1|NOT COMPLETED|Overall Study||0
8078200|NCT03702608|19918929|P1|COMPLETED|Overall Study||50
8078201|NCT03702608|19918929|P1|STARTED|Overall Study||50
8078205|NCT03701061|19918945|P2|NOT COMPLETED|Overall Study||0
8078206|NCT03701061|19918946|P1|NOT COMPLETED|Overall Study||0
8078207|NCT03701061|19918945|P2|COMPLETED|Overall Study||3
8078208|NCT03701061|19918946|P1|COMPLETED|Overall Study||9
8078209|NCT03701061|19918945|P2|STARTED|Overall Study||3
8078210|NCT03701061|19918946|P1|STARTED|Overall Study||9
8078211|NCT03700671|19918960|P2|NOT COMPLETED|Overall Study||2
8078212|NCT03700671|19918961|P1|NOT COMPLETED|Overall Study||1
8078213|NCT03700671|19918960|P2|COMPLETED|Overall Study||19
8078214|NCT03700671|19918961|P1|COMPLETED|Overall Study||20
8078215|NCT03700671|19918960|P2|STARTED|Overall Study||21
8078216|NCT03700671|19918961|P1|STARTED|Overall Study||21
8078217|NCT03700385|19918973|P1|NOT COMPLETED|Overall Study||1
8078218|NCT03700385|19918973|P1|COMPLETED|Overall Study||39
8078219|NCT03700385|19918973|P1|STARTED|Overall Study||40
8078220|NCT03698591|19918980|P2|NOT COMPLETED|Overall Study||5
8078221|NCT03698591|19918981|P1|NOT COMPLETED|Overall Study||5
8078222|NCT03698591|19918980|P2|COMPLETED|Overall Study||15
8078223|NCT03698591|19918981|P1|COMPLETED|Overall Study||15
8078224|NCT03698591|19918980|P2|STARTED|Overall Study||20
8078225|NCT03698591|19918981|P1|STARTED|Overall Study||20
8078226|NCT03698331|19918995|P2|NOT COMPLETED|Overall Study||6
8078227|NCT03698331|19918996|P1|NOT COMPLETED|Overall Study||4
8078228|NCT03698331|19918995|P2|COMPLETED|Overall Study||39
8078229|NCT03698331|19918996|P1|COMPLETED|Overall Study||40
8078230|NCT03698331|19918995|P2|Entered Withdrawal Period|Overall Study||39
8078231|NCT03698331|19918996|P1|Entered Withdrawal Period|Overall Study||42
8078232|NCT03698331|19918995|P2|STARTED|Overall Study||45
8078233|NCT03698331|19918996|P1|STARTED|Overall Study||44
8078258|NCT03697993|19919119|P2|NOT COMPLETED|Overall Study||5
8078259|NCT03697993|19919120|P1|NOT COMPLETED|Overall Study||10
8078260|NCT03697993|19919119|P2|COMPLETED|Overall Study||25
8078261|NCT03697993|19919120|P1|COMPLETED|Overall Study||22
8078262|NCT03697993|19919119|P2|Treated With at Least Two Dose of Fosfomycin|Overall Study||4
8078263|NCT03697993|19919120|P1|Treated With at Least Two Dose of Fosfomycin|Overall Study||27
8078264|NCT03697993|19919119|P2|Switched Treatment|Overall Study|Five (5) participants switched to Fosfomycin; 1 participant switched to Cefixime.|6
8078265|NCT03697993|19919120|P1|Switched Treatment|Overall Study||0
8078266|NCT03697993|19919119|P2|Initiated Treatment|Overall Study||28
8078267|NCT03697993|19919120|P1|Initiated Treatment|Overall Study||30
8078268|NCT03697993|19919119|P2|STARTED|Overall Study||30
8078269|NCT03697993|19919120|P1|STARTED|Overall Study||32
8078270|NCT03697551|19919139|P1|NOT COMPLETED|Overall Study||0
8078271|NCT03697551|19919139|P1|COMPLETED|Overall Study||4
8078272|NCT03697551|19919139|P1|STARTED|Overall Study||4
8078273|NCT03697252|19919146|P2|NOT COMPLETED|Overall Study||19
8078274|NCT03697252|19919147|P1|NOT COMPLETED|Overall Study||18
8078275|NCT03697252|19919146|P2|COMPLETED|Overall Study||73
8078276|NCT03697252|19919147|P1|COMPLETED|Overall Study||72
8078277|NCT03697252|19919146|P2|STARTED|Overall Study||92
8078278|NCT03697252|19919147|P1|STARTED|Overall Study||90
8078279|NCT03697122|19919163|P1|NOT COMPLETED|Overall Study||0
8078280|NCT03697122|19919163|P1|COMPLETED|Overall Study||14
8078281|NCT03697122|19919163|P1|STARTED|Overall Study||14
8078282|NCT03697083|19919178|P3|NOT COMPLETED|Overall Study||0
8078283|NCT03697083|19919179|P2|NOT COMPLETED|Overall Study||10
8078284|NCT03697083|19919180|P1|NOT COMPLETED|Overall Study||0
8078285|NCT03697083|19919178|P3|COMPLETED|Overall Study||255
8078286|NCT03697083|19919179|P2|COMPLETED|Overall Study||250
8078287|NCT03697083|19919180|P1|COMPLETED|Overall Study||262
8078288|NCT03697083|19919178|P3|STARTED|Overall Study||255
8078289|NCT03697083|19919179|P2|STARTED|Overall Study||260
8078290|NCT03697083|19919180|P1|STARTED|Overall Study||262
8078291|NCT03696589|19919188|P1|NOT COMPLETED|Overall Study||1
8078292|NCT03696589|19919188|P1|COMPLETED|Overall Study||12
8078293|NCT03696589|19919188|P1|STARTED|Overall Study||13
8078294|NCT03695913|19919211|P1|NOT COMPLETED|Overall Study||0
8078295|NCT03695913|19919211|P1|COMPLETED|Overall Study||15
8078296|NCT03695913|19919211|P1|STARTED|Overall Study||15
8078297|NCT03695094|19919228|P2|NOT COMPLETED|Overall Study||1
8078298|NCT03695094|19919229|P1|NOT COMPLETED|Overall Study||2
8078299|NCT03695094|19919228|P2|COMPLETED|Overall Study||14
8078300|NCT03695094|19919229|P1|COMPLETED|Overall Study||14
8078301|NCT03695094|19919228|P2|STARTED|Overall Study||15
8078302|NCT03695094|19919229|P1|STARTED|Overall Study||16
8078303|NCT03694925|19919265|P3|NOT COMPLETED|Overall Study||0
8078304|NCT03694925|19919266|P2|NOT COMPLETED|Overall Study||3
8078305|NCT03694925|19919267|P1|NOT COMPLETED|Overall Study||0
8078306|NCT03694925|19919265|P3|COMPLETED|Overall Study||53
8078307|NCT03694925|19919266|P2|COMPLETED|Overall Study||70
8078308|NCT03694925|19919267|P1|COMPLETED|Overall Study||30
8078309|NCT03694925|19919265|P3|STARTED|Overall Study||53
8078310|NCT03694925|19919266|P2|STARTED|Overall Study||73
8078311|NCT03694925|19919267|P1|STARTED|Overall Study||30
8078312|NCT03694821|19919283|P3|NOT COMPLETED|Overall Study||4
8078313|NCT03694821|19919284|P2|NOT COMPLETED|Overall Study||8
8078314|NCT03694821|19919285|P1|NOT COMPLETED|Overall Study||4
8078315|NCT03694821|19919283|P3|COMPLETED|Overall Study||2
8078316|NCT03694821|19919284|P2|COMPLETED|Overall Study||0
8078317|NCT03694821|19919285|P1|COMPLETED|Overall Study||0
8078318|NCT03694821|19919283|P3|STARTED|Overall Study||6
8078319|NCT03694821|19919284|P2|STARTED|Overall Study||8
8078320|NCT03694821|19919285|P1|STARTED|Overall Study||4
8078321|NCT03693989|19919316|P2|NOT COMPLETED|Overall Study||4
8078322|NCT03693989|19919317|P1|NOT COMPLETED|Overall Study||3
8078323|NCT03693989|19919316|P2|COMPLETED|Overall Study||86
8078324|NCT03693989|19919317|P1|COMPLETED|Overall Study||85
8078325|NCT03693989|19919316|P2|STARTED|Overall Study||90
8078326|NCT03693989|19919317|P1|STARTED|Overall Study||88
8078327|NCT03693950|19919341|P2|NOT COMPLETED|Overall Study||0
8078328|NCT03693950|19919342|P1|NOT COMPLETED|Overall Study||1
8078329|NCT03693950|19919341|P2|COMPLETED|Overall Study||28
8078330|NCT03693950|19919342|P1|COMPLETED|Overall Study||28
8078331|NCT03693950|19919341|P2|STARTED|Overall Study||28
8078332|NCT03693950|19919342|P1|STARTED|Overall Study||29
8078333|NCT03693937|19919360|P1|NOT COMPLETED|Overall Study||0
8078334|NCT03693937|19919360|P1|COMPLETED|Overall Study||776
8078335|NCT03693937|19919360|P1|STARTED|Overall Study||776
8078336|NCT03693625|19919366|P2|NOT COMPLETED|Overall Study||8
8078337|NCT03693625|19919367|P1|NOT COMPLETED|Overall Study||23
8078338|NCT03693625|19919366|P2|COMPLETED|Overall Study||0
8078339|NCT03693625|19919367|P1|COMPLETED|Overall Study||0
8078340|NCT03693625|19919366|P2|STARTED|Overall Study||8
8078341|NCT03693625|19919367|P1|STARTED|Overall Study||23
8078354|NCT03691948|19919398|P2|NOT COMPLETED|Overall Study||3
8078355|NCT03691948|19919399|P1|NOT COMPLETED|Overall Study||1
8078356|NCT03691948|19919398|P2|COMPLETED|Overall Study||30
8078357|NCT03691948|19919399|P1|COMPLETED|Overall Study||26
8078358|NCT03691948|19919398|P2|STARTED|Overall Study||33
8078359|NCT03691948|19919399|P1|STARTED|Overall Study||27
8078360|NCT03691844|19919418|P4|NOT COMPLETED|Overall Study||11
8078361|NCT03691844|19919419|P3|NOT COMPLETED|Overall Study||13
8078362|NCT03691844|19919420|P2|NOT COMPLETED|Overall Study||12
8078363|NCT03691844|19919421|P1|NOT COMPLETED|Overall Study||7
8078364|NCT03691844|19919418|P4|COMPLETED|Overall Study||70
8078365|NCT03691844|19919419|P3|COMPLETED|Overall Study||108
8078366|NCT03691844|19919420|P2|COMPLETED|Overall Study||109
8078367|NCT03691844|19919421|P1|COMPLETED|Overall Study||114
8078368|NCT03691844|19919418|P4|STARTED|Overall Study||81
8078369|NCT03691844|19919419|P3|STARTED|Overall Study||121
8078370|NCT03691844|19919420|P2|STARTED|Overall Study||121
8078371|NCT03691844|19919421|P1|STARTED|Overall Study||121
8078372|NCT03691831|19919486|P2|NOT COMPLETED|Overall Study||31
8078373|NCT03691831|19919487|P1|NOT COMPLETED|Overall Study||27
8078374|NCT03691831|19919486|P2|COMPLETED|Overall Study||220
8078375|NCT03691831|19919487|P1|COMPLETED|Overall Study||224
8078376|NCT03691831|19919486|P2|STARTED|Overall Study||251
8078377|NCT03691831|19919487|P1|STARTED|Overall Study||251
8078384|NCT03689452|19919512|P2|NOT COMPLETED|Overall Study||1
8078385|NCT03689452|19919513|P1|NOT COMPLETED|Overall Study||1
8078386|NCT03689452|19919512|P2|COMPLETED|Overall Study||14
8078387|NCT03689452|19919513|P1|COMPLETED|Overall Study||14
8078388|NCT03689452|19919512|P2|STARTED|Overall Study||15
8078389|NCT03689452|19919513|P1|STARTED|Overall Study||15
8078390|NCT03688880|19919531|P2|NOT COMPLETED|Overall Study||31
8078391|NCT03688880|19919532|P1|NOT COMPLETED|Overall Study||14
8078392|NCT03688880|19919531|P2|COMPLETED|Overall Study||29
8078393|NCT03688880|19919532|P1|COMPLETED|Overall Study||15
8078394|NCT03688880|19919531|P2|STARTED|Overall Study||60
8078395|NCT03688880|19919532|P1|STARTED|Overall Study||29
8078396|NCT03688620|19919559|P3|NOT COMPLETED|Overall Study||8
8078397|NCT03688620|19919560|P2|NOT COMPLETED|Overall Study||1
8078398|NCT03688620|19919561|P1|NOT COMPLETED|Overall Study||16
8078399|NCT03688620|19919559|P3|COMPLETED|Overall Study||445
8078400|NCT03688620|19919560|P2|COMPLETED|Overall Study||277
8078401|NCT03688620|19919561|P1|COMPLETED|Overall Study||313
8078402|NCT03688620|19919559|P3|STARTED|Overall Study||453
8078403|NCT03688620|19919560|P2|STARTED|Overall Study||278
8078404|NCT03688620|19919561|P1|STARTED|Overall Study||329
8078411|NCT03687827|19920055|P2|NOT COMPLETED|Treatment Period 2||3
8078412|NCT03687827|19920056|P1|NOT COMPLETED|Treatment Period 2||5
8078413|NCT03687827|19920055|P2|COMPLETED|Treatment Period 2||238
8078414|NCT03687827|19920056|P1|COMPLETED|Treatment Period 2||230
8078415|NCT03687827|19920055|P2|STARTED|Treatment Period 2||241
8078416|NCT03687827|19920056|P1|STARTED|Treatment Period 2||235
8078417|NCT03687827|19920055|P2|NOT COMPLETED|Treatment Period 1||8
8078418|NCT03687827|19920056|P1|NOT COMPLETED|Treatment Period 1||14
8078419|NCT03687827|19920055|P2|COMPLETED|Treatment Period 1||241
8078420|NCT03687827|19920056|P1|COMPLETED|Treatment Period 1||235
8078421|NCT03687827|19920055|P2|Per Protocol Set|Treatment Period 1||229
8078422|NCT03687827|19920056|P1|Per Protocol Set|Treatment Period 1||219
8078423|NCT03687827|19920055|P2|Safety Analysis Set (SAS)|Treatment Period 1||249
8078424|NCT03687827|19920056|P1|Safety Analysis Set (SAS)|Treatment Period 1||249
8078425|NCT03687827|19920055|P2|Full Analysis Set (FAS)|Treatment Period 1||249
8078426|NCT03687827|19920056|P1|Full Analysis Set (FAS)|Treatment Period 1||249
8078427|NCT03687827|19920055|P2|STARTED|Treatment Period 1||249
8078428|NCT03687827|19920056|P1|STARTED|Treatment Period 1||249
8078429|NCT03687736|19920072|P1|NOT COMPLETED|Overall Study||10
8078430|NCT03687736|19920072|P1|COMPLETED|Overall Study||110
8078431|NCT03687736|19920072|P1|STARTED|Overall Study||120
8078459|NCT03687450|19920189|P2|NOT COMPLETED|Overall Study||2
8078460|NCT03687450|19920190|P1|NOT COMPLETED|Overall Study||12
8078461|NCT03687450|19920189|P2|COMPLETED|Overall Study||16
8078462|NCT03687450|19920190|P1|COMPLETED|Overall Study||26
8078463|NCT03687450|19920189|P2|Two-month Follow-up|Overall Study|2 lost to follow-up (N.B. 1 participant completed 2-month follow-up but not post-program follow-up)|16
8078464|NCT03687450|19920190|P1|Two-month Follow-up|Overall Study|2 lost to follow-up|26
8078465|NCT03687450|19920189|P2|Post-Program Follow-Up|Overall Study|3 lost to follow-up|15
8078466|NCT03687450|19920190|P1|Post-Program Follow-Up|Overall Study|1 withdrew, 9 lost to follow-up|28
8078467|NCT03687450|19920189|P2|STARTED|Overall Study||18
8078468|NCT03687450|19920190|P1|STARTED|Overall Study||38
8078469|NCT03687372|19920218|P2|NOT COMPLETED|Overall Study||39
8078470|NCT03687372|19920219|P1|NOT COMPLETED|Overall Study||17
8078471|NCT03687372|19920218|P2|COMPLETED|Overall Study||210
8078472|NCT03687372|19920219|P1|COMPLETED|Overall Study||237
8078473|NCT03687372|19920218|P2|STARTED|Overall Study||249
8078474|NCT03687372|19920219|P1|STARTED|Overall Study||254
8078475|NCT03686176|19920236|P3|NOT COMPLETED|Overall Study||0
8078476|NCT03686176|19920237|P2|NOT COMPLETED|Overall Study||0
8078477|NCT03686176|19920238|P1|NOT COMPLETED|Overall Study||2
8078478|NCT03686176|19920236|P3|COMPLETED|Overall Study||20
8078479|NCT03686176|19920237|P2|COMPLETED|Overall Study||25
8078480|NCT03686176|19920238|P1|COMPLETED|Overall Study||17
8078481|NCT03686176|19920236|P3|STARTED|Overall Study||20
8078482|NCT03686176|19920237|P2|STARTED|Overall Study||25
8078483|NCT03686176|19920238|P1|STARTED|Overall Study||19
8078484|NCT03686033|19920277|P6|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8078485|NCT03686033|19920278|P5|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8078486|NCT03686033|19920279|P4|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8078487|NCT03686033|19920280|P3|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8078488|NCT03686033|19920281|P2|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8078489|NCT03686033|19920282|P1|NOT COMPLETED|Treatment Period 4 (1 Day)||0
8078490|NCT03686033|19920277|P6|COMPLETED|Treatment Period 4 (1 Day)||0
8078491|NCT03686033|19920278|P5|COMPLETED|Treatment Period 4 (1 Day)||0
8078492|NCT03686033|19920279|P4|COMPLETED|Treatment Period 4 (1 Day)||1
8078493|NCT03686033|19920280|P3|COMPLETED|Treatment Period 4 (1 Day)||1
8078494|NCT03686033|19920281|P2|COMPLETED|Treatment Period 4 (1 Day)||1
8078495|NCT03686033|19920282|P1|COMPLETED|Treatment Period 4 (1 Day)||1
8078496|NCT03686033|19920277|P6|STARTED|Treatment Period 4 (1 Day)||0
8078497|NCT03686033|19920278|P5|STARTED|Treatment Period 4 (1 Day)||0
8078498|NCT03686033|19920279|P4|STARTED|Treatment Period 4 (1 Day)||1
8078499|NCT03686033|19920280|P3|STARTED|Treatment Period 4 (1 Day)||1
8078500|NCT03686033|19920281|P2|STARTED|Treatment Period 4 (1 Day)||1
8078501|NCT03686033|19920282|P1|STARTED|Treatment Period 4 (1 Day)||1
8078502|NCT03686033|19920277|P6|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078503|NCT03686033|19920278|P5|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078504|NCT03686033|19920279|P4|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078505|NCT03686033|19920280|P3|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078506|NCT03686033|19920281|P2|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078507|NCT03686033|19920282|P1|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078508|NCT03686033|19920277|P6|COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078509|NCT03686033|19920278|P5|COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078510|NCT03686033|19920279|P4|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078511|NCT03686033|19920280|P3|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078512|NCT03686033|19920281|P2|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078513|NCT03686033|19920282|P1|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078514|NCT03686033|19920277|P6|STARTED|Washout Phase (at Least 2 Weeks)||0
8078515|NCT03686033|19920278|P5|STARTED|Washout Phase (at Least 2 Weeks)||0
8078516|NCT03686033|19920279|P4|STARTED|Washout Phase (at Least 2 Weeks)||1
8078517|NCT03686033|19920280|P3|STARTED|Washout Phase (at Least 2 Weeks)||1
8078518|NCT03686033|19920281|P2|STARTED|Washout Phase (at Least 2 Weeks)||1
8078519|NCT03686033|19920282|P1|STARTED|Washout Phase (at Least 2 Weeks)||1
8078520|NCT03686033|19920277|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8078521|NCT03686033|19920278|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8078522|NCT03686033|19920279|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8078523|NCT03686033|19920280|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8078524|NCT03686033|19920281|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8078525|NCT03686033|19920282|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8078526|NCT03686033|19920277|P6|COMPLETED|Treatment Period 3 (1 Day)||0
8078527|NCT03686033|19920278|P5|COMPLETED|Treatment Period 3 (1 Day)||0
8078528|NCT03686033|19920279|P4|COMPLETED|Treatment Period 3 (1 Day)||1
8078529|NCT03686033|19920280|P3|COMPLETED|Treatment Period 3 (1 Day)||1
8078530|NCT03686033|19920281|P2|COMPLETED|Treatment Period 3 (1 Day)||1
8078531|NCT03686033|19920282|P1|COMPLETED|Treatment Period 3 (1 Day)||1
8078532|NCT03686033|19920277|P6|STARTED|Treatment Period 3 (1 Day)||0
8078533|NCT03686033|19920278|P5|STARTED|Treatment Period 3 (1 Day)||0
8078534|NCT03686033|19920279|P4|STARTED|Treatment Period 3 (1 Day)||1
8078535|NCT03686033|19920280|P3|STARTED|Treatment Period 3 (1 Day)||1
8078536|NCT03686033|19920281|P2|STARTED|Treatment Period 3 (1 Day)||1
8078537|NCT03686033|19920282|P1|STARTED|Treatment Period 3 (1 Day)||1
8078538|NCT03686033|19920277|P6|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078539|NCT03686033|19920278|P5|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078540|NCT03686033|19920279|P4|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078541|NCT03686033|19920280|P3|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078542|NCT03686033|19920281|P2|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078543|NCT03686033|19920282|P1|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078544|NCT03686033|19920277|P6|COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078545|NCT03686033|19920278|P5|COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078546|NCT03686033|19920279|P4|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078547|NCT03686033|19920280|P3|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078548|NCT03686033|19920281|P2|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078549|NCT03686033|19920282|P1|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078550|NCT03686033|19920277|P6|STARTED|Washout Phase (at Least 2 Weeks)||0
8078551|NCT03686033|19920278|P5|STARTED|Washout Phase (at Least 2 Weeks)||0
8078552|NCT03686033|19920279|P4|STARTED|Washout Phase (at Least 2 Weeks)||1
8078553|NCT03686033|19920280|P3|STARTED|Washout Phase (at Least 2 Weeks)||1
8078554|NCT03686033|19920281|P2|STARTED|Washout Phase (at Least 2 Weeks)||1
8078555|NCT03686033|19920282|P1|STARTED|Washout Phase (at Least 2 Weeks)||1
8078556|NCT03686033|19920277|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8078557|NCT03686033|19920278|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||1
8078558|NCT03686033|19920279|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8078559|NCT03686033|19920280|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8078560|NCT03686033|19920281|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8078561|NCT03686033|19920282|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8078562|NCT03686033|19920277|P6|COMPLETED|Treatment Period 2 (1 Day)||0
8078563|NCT03686033|19920278|P5|COMPLETED|Treatment Period 2 (1 Day)||0
8078564|NCT03686033|19920279|P4|COMPLETED|Treatment Period 2 (1 Day)||1
8078565|NCT03686033|19920280|P3|COMPLETED|Treatment Period 2 (1 Day)||1
8078566|NCT03686033|19920281|P2|COMPLETED|Treatment Period 2 (1 Day)||1
8078567|NCT03686033|19920282|P1|COMPLETED|Treatment Period 2 (1 Day)||1
8078568|NCT03686033|19920277|P6|STARTED|Treatment Period 2 (1 Day)||0
8078569|NCT03686033|19920278|P5|STARTED|Treatment Period 2 (1 Day)||1
8078570|NCT03686033|19920279|P4|STARTED|Treatment Period 2 (1 Day)||1
8078571|NCT03686033|19920280|P3|STARTED|Treatment Period 2 (1 Day)||1
8078572|NCT03686033|19920281|P2|STARTED|Treatment Period 2 (1 Day)||1
8078573|NCT03686033|19920282|P1|STARTED|Treatment Period 2 (1 Day)||1
8078574|NCT03686033|19920277|P6|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078575|NCT03686033|19920278|P5|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078576|NCT03686033|19920279|P4|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078577|NCT03686033|19920280|P3|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078578|NCT03686033|19920281|P2|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078579|NCT03686033|19920282|P1|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078580|NCT03686033|19920277|P6|COMPLETED|Washout Phase (at Least 2 Weeks)||0
8078581|NCT03686033|19920278|P5|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078582|NCT03686033|19920279|P4|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078583|NCT03686033|19920280|P3|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078584|NCT03686033|19920281|P2|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078585|NCT03686033|19920282|P1|COMPLETED|Washout Phase (at Least 2 Weeks)||1
8078586|NCT03686033|19920277|P6|STARTED|Washout Phase (at Least 2 Weeks)||0
8078587|NCT03686033|19920278|P5|STARTED|Washout Phase (at Least 2 Weeks)||1
8078588|NCT03686033|19920279|P4|STARTED|Washout Phase (at Least 2 Weeks)||1
8078589|NCT03686033|19920280|P3|STARTED|Washout Phase (at Least 2 Weeks)||1
8078590|NCT03686033|19920281|P2|STARTED|Washout Phase (at Least 2 Weeks)||1
8078591|NCT03686033|19920282|P1|STARTED|Washout Phase (at Least 2 Weeks)||1
8078592|NCT03686033|19920277|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8078593|NCT03686033|19920278|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8078594|NCT03686033|19920279|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8078595|NCT03686033|19920280|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8078596|NCT03686033|19920281|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8078597|NCT03686033|19920282|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8078598|NCT03686033|19920277|P6|COMPLETED|Treatment Period 1 (1 Day)||0
8078599|NCT03686033|19920278|P5|COMPLETED|Treatment Period 1 (1 Day)||1
8078600|NCT03686033|19920279|P4|COMPLETED|Treatment Period 1 (1 Day)||1
8078601|NCT03686033|19920280|P3|COMPLETED|Treatment Period 1 (1 Day)||1
8078602|NCT03686033|19920281|P2|COMPLETED|Treatment Period 1 (1 Day)||1
8078603|NCT03686033|19920282|P1|COMPLETED|Treatment Period 1 (1 Day)||1
8078604|NCT03686033|19920277|P6|STARTED|Treatment Period 1 (1 Day)||0
8078605|NCT03686033|19920278|P5|STARTED|Treatment Period 1 (1 Day)||1
8078606|NCT03686033|19920279|P4|STARTED|Treatment Period 1 (1 Day)||1
8078607|NCT03686033|19920280|P3|STARTED|Treatment Period 1 (1 Day)||1
8078608|NCT03686033|19920281|P2|STARTED|Treatment Period 1 (1 Day)||1
8078609|NCT03686033|19920282|P1|STARTED|Treatment Period 1 (1 Day)||1
8078610|NCT03685968|19920340|P3|NOT COMPLETED|Overall Study||0
8078611|NCT03685968|19920341|P2|NOT COMPLETED|Overall Study||0
8078612|NCT03685968|19920342|P1|NOT COMPLETED|Overall Study||0
8078613|NCT03685968|19920340|P3|COMPLETED|Overall Study||75
8078614|NCT03685968|19920341|P2|COMPLETED|Overall Study||75
8078615|NCT03685968|19920342|P1|COMPLETED|Overall Study||75
8078616|NCT03685968|19920340|P3|STARTED|Overall Study||75
8078617|NCT03685968|19920341|P2|STARTED|Overall Study||75
8078618|NCT03685968|19920342|P1|STARTED|Overall Study||75
8078619|NCT03685643|19920358|P2|NOT COMPLETED|Overall Study||22
8078620|NCT03685643|19920359|P1|NOT COMPLETED|Overall Study||14
8078621|NCT03685643|19920358|P2|COMPLETED|Overall Study||266
8078622|NCT03685643|19920359|P1|COMPLETED|Overall Study||276
8078623|NCT03685643|19920358|P2|STARTED|Overall Study||288
8078624|NCT03685643|19920359|P1|STARTED|Overall Study||290
8078625|NCT03685396|19920371|P2|NOT COMPLETED|Overall Study||0
8078626|NCT03685396|19920372|P1|NOT COMPLETED|Overall Study||0
8078627|NCT03685396|19920371|P2|COMPLETED|Overall Study||21
8078628|NCT03685396|19920372|P1|COMPLETED|Overall Study||21
8078629|NCT03685396|19920371|P2|STARTED|Overall Study||21
8078630|NCT03685396|19920372|P1|STARTED|Overall Study||21
8078631|NCT03684928|19920384|P2|NOT COMPLETED|Second Intervention||0
8078632|NCT03684928|19920385|P1|NOT COMPLETED|Second Intervention||1
8078633|NCT03684928|19920384|P2|COMPLETED|Second Intervention||19
8078634|NCT03684928|19920385|P1|COMPLETED|Second Intervention||20
8078635|NCT03684928|19920384|P2|STARTED|Second Intervention||19
8078636|NCT03684928|19920385|P1|STARTED|Second Intervention|Two participants discontinued between the first intervention and second intervention.|21
8078637|NCT03684928|19920384|P2|NOT COMPLETED|First Intervention||3
8078638|NCT03684928|19920385|P1|NOT COMPLETED|First Intervention||0
8078639|NCT03684928|19920384|P2|COMPLETED|First Intervention||19
8078640|NCT03684928|19920385|P1|COMPLETED|First Intervention||23
8078641|NCT03684928|19920384|P2|STARTED|First Intervention||22
8078642|NCT03684928|19920385|P1|STARTED|First Intervention||23
8078643|NCT03684265|19920401|P2|NOT COMPLETED|Treatment Period 2||0
8078644|NCT03684265|19920402|P1|NOT COMPLETED|Treatment Period 2||0
8078645|NCT03684265|19920401|P2|COMPLETED|Treatment Period 2||13
8078646|NCT03684265|19920402|P1|COMPLETED|Treatment Period 2||13
8078647|NCT03684265|19920401|P2|STARTED|Treatment Period 2||13
8078648|NCT03684265|19920402|P1|STARTED|Treatment Period 2||13
8078649|NCT03684265|19920401|P2|NOT COMPLETED|Washout Period of 1 Week||0
8078650|NCT03684265|19920402|P1|NOT COMPLETED|Washout Period of 1 Week||0
8078651|NCT03684265|19920401|P2|COMPLETED|Washout Period of 1 Week||13
8078652|NCT03684265|19920402|P1|COMPLETED|Washout Period of 1 Week||13
8078653|NCT03684265|19920401|P2|STARTED|Washout Period of 1 Week||13
8078654|NCT03684265|19920402|P1|STARTED|Washout Period of 1 Week||13
8078655|NCT03684265|19920401|P2|NOT COMPLETED|Treatment Period 1||0
8078656|NCT03684265|19920402|P1|NOT COMPLETED|Treatment Period 1||0
8078657|NCT03684265|19920401|P2|COMPLETED|Treatment Period 1||13
8078658|NCT03684265|19920402|P1|COMPLETED|Treatment Period 1||13
8078659|NCT03684265|19920401|P2|STARTED|Treatment Period 1||13
8078660|NCT03684265|19920402|P1|STARTED|Treatment Period 1||13
8078661|NCT03684044|19920414|P2|NOT COMPLETED|Overall Study||20
8078662|NCT03684044|19920415|P1|NOT COMPLETED|Overall Study||22
8078663|NCT03684044|19920414|P2|COMPLETED|Overall Study||104
8078664|NCT03684044|19920415|P1|COMPLETED|Overall Study||217
8078665|NCT03684044|19920414|P2|STARTED|Overall Study||124
8078666|NCT03684044|19920415|P1|STARTED|Overall Study||239
8078667|NCT03683901|19920472|P1|NOT COMPLETED|Overall Study||0
8078668|NCT03683901|19920472|P1|COMPLETED|Overall Study||10
8078669|NCT03683901|19920472|P1|STARTED|Overall Study||10
8078670|NCT03683758|19920483|P2|NOT COMPLETED|Overall Study||3
8078671|NCT03683758|19920484|P1|NOT COMPLETED|Overall Study||3
8078672|NCT03683758|19920483|P2|COMPLETED|Overall Study||7
8078673|NCT03683758|19920484|P1|COMPLETED|Overall Study||8
8078674|NCT03683758|19920483|P2|STARTED|Overall Study||10
8078675|NCT03683758|19920484|P1|STARTED|Overall Study||11
8078676|NCT03682809|19920498|P2|NOT COMPLETED|Overall Study||0
8078677|NCT03682809|19920499|P1|NOT COMPLETED|Overall Study||0
8078678|NCT03682809|19920498|P2|COMPLETED|Overall Study||24
8078679|NCT03682809|19920499|P1|COMPLETED|Overall Study||22
8078680|NCT03682809|19920498|P2|STARTED|Overall Study||24
8078681|NCT03682809|19920499|P1|STARTED|Overall Study||22
8078682|NCT03682302|19920517|P4|NOT COMPLETED|Overall Study||2
8078683|NCT03682302|19920518|P3|NOT COMPLETED|Overall Study||1
8078684|NCT03682302|19920519|P2|NOT COMPLETED|Overall Study||2
8078685|NCT03682302|19920520|P1|NOT COMPLETED|Overall Study||1
8078686|NCT03682302|19920517|P4|COMPLETED|Overall Study||28
8078687|NCT03682302|19920518|P3|COMPLETED|Overall Study||5
8078688|NCT03682302|19920519|P2|COMPLETED|Overall Study||28
8078689|NCT03682302|19920520|P1|COMPLETED|Overall Study||30
8078690|NCT03682302|19920517|P4|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|30
8078691|NCT03682302|19920518|P3|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|6
8078692|NCT03682302|19920519|P2|STARTED|Overall Study||30
8078693|NCT03682302|19920520|P1|STARTED|Overall Study||31
8078694|NCT03681951|19920558|P8|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078695|NCT03681951|19920559|P7|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078696|NCT03681951|19920560|P6|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078697|NCT03681951|19920561|P5|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078698|NCT03681951|19920562|P4|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078699|NCT03681951|19920563|P3|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078700|NCT03681951|19920564|P2|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078701|NCT03681951|19920565|P1|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078702|NCT03681951|19920558|P8|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078703|NCT03681951|19920559|P7|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078704|NCT03681951|19920560|P6|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078705|NCT03681951|19920561|P5|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078706|NCT03681951|19920562|P4|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078707|NCT03681951|19920563|P3|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078708|NCT03681951|19920564|P2|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078709|NCT03681951|19920565|P1|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078710|NCT03681951|19920558|P8|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078711|NCT03681951|19920559|P7|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078712|NCT03681951|19920560|P6|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078713|NCT03681951|19920561|P5|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078714|NCT03681951|19920562|P4|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078715|NCT03681951|19920563|P3|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078716|NCT03681951|19920564|P2|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078717|NCT03681951|19920565|P1|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
8078718|NCT03681951|19920558|P8|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078719|NCT03681951|19920559|P7|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078720|NCT03681951|19920560|P6|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078721|NCT03681951|19920561|P5|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078722|NCT03681951|19920562|P4|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078723|NCT03681951|19920563|P3|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078724|NCT03681951|19920564|P2|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078725|NCT03681951|19920565|P1|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078726|NCT03681951|19920558|P8|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078727|NCT03681951|19920559|P7|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078728|NCT03681951|19920560|P6|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078729|NCT03681951|19920561|P5|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078730|NCT03681951|19920562|P4|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078731|NCT03681951|19920563|P3|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078732|NCT03681951|19920564|P2|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078733|NCT03681951|19920565|P1|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078734|NCT03681951|19920558|P8|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078735|NCT03681951|19920559|P7|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078736|NCT03681951|19920560|P6|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078737|NCT03681951|19920561|P5|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078738|NCT03681951|19920562|P4|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078739|NCT03681951|19920563|P3|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078740|NCT03681951|19920564|P2|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078741|NCT03681951|19920565|P1|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
8078742|NCT03681951|19920558|P8|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078743|NCT03681951|19920559|P7|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078744|NCT03681951|19920560|P6|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078745|NCT03681951|19920561|P5|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078746|NCT03681951|19920562|P4|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078747|NCT03681951|19920563|P3|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078748|NCT03681951|19920564|P2|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078749|NCT03681951|19920565|P1|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078750|NCT03681951|19920558|P8|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078751|NCT03681951|19920559|P7|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078752|NCT03681951|19920560|P6|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078753|NCT03681951|19920561|P5|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078754|NCT03681951|19920562|P4|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078755|NCT03681951|19920563|P3|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078756|NCT03681951|19920564|P2|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078757|NCT03681951|19920565|P1|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
8078758|NCT03681951|19920558|P8|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078759|NCT03681951|19920559|P7|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078760|NCT03681951|19920560|P6|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078761|NCT03681951|19920561|P5|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078762|NCT03681951|19920562|P4|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078763|NCT03681951|19920563|P3|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078764|NCT03681951|19920564|P2|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078765|NCT03681951|19920565|P1|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
8078766|NCT03681951|19920558|P8|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078767|NCT03681951|19920559|P7|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078768|NCT03681951|19920560|P6|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078769|NCT03681951|19920561|P5|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078770|NCT03681951|19920562|P4|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078771|NCT03681951|19920563|P3|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078772|NCT03681951|19920564|P2|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078773|NCT03681951|19920565|P1|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||8
8078774|NCT03681951|19920558|P8|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078775|NCT03681951|19920559|P7|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078776|NCT03681951|19920560|P6|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078777|NCT03681951|19920561|P5|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078778|NCT03681951|19920562|P4|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078779|NCT03681951|19920563|P3|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078780|NCT03681951|19920564|P2|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078781|NCT03681951|19920565|P1|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
8078782|NCT03681951|19920558|P8|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 4 was not initiated as this study was terminated during Part 1|0
8078783|NCT03681951|19920559|P7|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 3 was not initiated as this study was terminated during Part 1|0
8078784|NCT03681951|19920560|P6|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 2 was not initiated as this study was terminated during Part 1|0
8078785|NCT03681951|19920561|P5|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
8078786|NCT03681951|19920562|P4|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
8078787|NCT03681951|19920563|P3|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID."|0
8078788|NCT03681951|19920564|P2|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
8078789|NCT03681951|19920565|P1|STARTED|Part1: Monotherapy DE (Up to Day 95)||8
8078790|NCT03681886|19920756|P1|NOT COMPLETED|Overall Study||2
8078791|NCT03681886|19920756|P1|COMPLETED|Overall Study||76
8078792|NCT03681886|19920756|P1|Underwent Optic Exchange|Overall Study||4
8078793|NCT03681886|19920756|P1|Failed Implantation|Overall Study||2
8078794|NCT03681886|19920756|P1|Successful Implantation|Overall Study||76
8078795|NCT03681886|19920756|P1|STARTED|Overall Study||78
8078796|NCT03681808|19920797|P2|NOT COMPLETED|Overall Study||17
8078797|NCT03681808|19920798|P1|NOT COMPLETED|Overall Study||14
8078798|NCT03681808|19920797|P2|COMPLETED|Overall Study||102
8078799|NCT03681808|19920798|P1|COMPLETED|Overall Study||109
8078800|NCT03681808|19920797|P2|STARTED|Overall Study||119
8078801|NCT03681808|19920798|P1|STARTED|Overall Study||123
8078820|NCT03681119|19920833|P2|NOT COMPLETED|Overall Study||0
8078821|NCT03681119|19920834|P1|NOT COMPLETED|Overall Study||6
8078822|NCT03681119|19920833|P2|COMPLETED|Overall Study||11
8078823|NCT03681119|19920834|P1|COMPLETED|Overall Study||66
8078824|NCT03681119|19920833|P2|STARTED|Overall Study||11
8078825|NCT03681119|19920834|P1|STARTED|Overall Study||72
8078826|NCT03681093|19920841|P3|NOT COMPLETED|Overall Study||1
8078827|NCT03681093|19920842|P2|NOT COMPLETED|Overall Study||2
8078828|NCT03681093|19920843|P1|NOT COMPLETED|Overall Study||0
8078829|NCT03681093|19920841|P3|COMPLETED|Overall Study||31
8078830|NCT03681093|19920842|P2|COMPLETED|Overall Study||32
8078831|NCT03681093|19920843|P1|COMPLETED|Overall Study||32
8078832|NCT03681093|19920841|P3|Safety Analysis Set (SAF)|Overall Study||32
8078833|NCT03681093|19920842|P2|Safety Analysis Set (SAF)|Overall Study||34
8078834|NCT03681093|19920843|P1|Safety Analysis Set (SAF)|Overall Study||32
8078835|NCT03681093|19920841|P3|Full Analysis Set (FAS)|Overall Study||28
8078836|NCT03681093|19920842|P2|Full Analysis Set (FAS)|Overall Study||32
8078837|NCT03681093|19920843|P1|Full Analysis Set (FAS)|Overall Study||31
8078838|NCT03681093|19920841|P3|STARTED|Overall Study||32
8078839|NCT03681093|19920842|P2|STARTED|Overall Study||34
8078840|NCT03681093|19920843|P1|STARTED|Overall Study||32
8078841|NCT03680105|19920869|P9|NOT COMPLETED|Overall Study||0
8078842|NCT03680105|19920870|P8|NOT COMPLETED|Overall Study||0
8078843|NCT03680105|19920871|P7|NOT COMPLETED|Overall Study||0
8078844|NCT03680105|19920872|P6|NOT COMPLETED|Overall Study||0
8078845|NCT03680105|19920873|P5|NOT COMPLETED|Overall Study||0
8078846|NCT03680105|19920874|P4|NOT COMPLETED|Overall Study||0
8078847|NCT03680105|19920875|P3|NOT COMPLETED|Overall Study||0
8078848|NCT03680105|19920876|P2|NOT COMPLETED|Overall Study||0
8078849|NCT03680105|19920877|P1|NOT COMPLETED|Overall Study||0
8078850|NCT03680105|19920869|P9|COMPLETED|Overall Study||8
8078851|NCT03680105|19920870|P8|COMPLETED|Overall Study||8
8078852|NCT03680105|19920871|P7|COMPLETED|Overall Study||8
8078853|NCT03680105|19920872|P6|COMPLETED|Overall Study||12
8078854|NCT03680105|19920873|P5|COMPLETED|Overall Study||8
8078855|NCT03680105|19920874|P4|COMPLETED|Overall Study||8
8078856|NCT03680105|19920875|P3|COMPLETED|Overall Study||8
8078857|NCT03680105|19920876|P2|COMPLETED|Overall Study||8
8078858|NCT03680105|19920877|P1|COMPLETED|Overall Study||8
8078859|NCT03680105|19920869|P9|STARTED|Overall Study||8
8078860|NCT03680105|19920870|P8|STARTED|Overall Study||8
8078861|NCT03680105|19920871|P7|STARTED|Overall Study||8
8078862|NCT03680105|19920872|P6|STARTED|Overall Study||12
8078863|NCT03680105|19920873|P5|STARTED|Overall Study||8
8078864|NCT03680105|19920874|P4|STARTED|Overall Study||8
8078865|NCT03680105|19920875|P3|STARTED|Overall Study||8
8078866|NCT03680105|19920876|P2|STARTED|Overall Study||8
8078867|NCT03680105|19920877|P1|STARTED|Overall Study||8
8078868|NCT03679975|19920923|P1|NOT COMPLETED|Overall Study||0
8078869|NCT03679975|19920923|P1|COMPLETED|Overall Study||9
8078870|NCT03679975|19920923|P1|STARTED|Overall Study||9
8078871|NCT03679741|19920927|P2|NOT COMPLETED|Period 3||0
8078872|NCT03679741|19920928|P1|NOT COMPLETED|Period 3||0
8078873|NCT03679741|19920927|P2|COMPLETED|Period 3||56
8078874|NCT03679741|19920928|P1|COMPLETED|Period 3||54
8078875|NCT03679741|19920927|P2|STARTED|Period 3||56
8078876|NCT03679741|19920928|P1|STARTED|Period 3||54
8078877|NCT03679741|19920927|P2|NOT COMPLETED|Period 2||2
8078878|NCT03679741|19920928|P1|NOT COMPLETED|Period 2||3
8078879|NCT03679741|19920927|P2|COMPLETED|Period 2||56
8078880|NCT03679741|19920928|P1|COMPLETED|Period 2||54
8078881|NCT03679741|19920927|P2|STARTED|Period 2||58
8078882|NCT03679741|19920928|P1|STARTED|Period 2||57
8078883|NCT03679741|19920927|P2|NOT COMPLETED|Period 1||3
8078884|NCT03679741|19920928|P1|NOT COMPLETED|Period 1||2
8078885|NCT03679741|19920927|P2|COMPLETED|Period 1||58
8078886|NCT03679741|19920928|P1|COMPLETED|Period 1||57
8078887|NCT03679741|19920927|P2|STARTED|Period 1||61
8078888|NCT03679741|19920928|P1|STARTED|Period 1||59
8078889|NCT03679494|19920950|P2|NOT COMPLETED|Overall Study||0
8078890|NCT03679494|19920951|P1|NOT COMPLETED|Overall Study||0
8078891|NCT03679494|19920950|P2|COMPLETED|Overall Study||63
8078892|NCT03679494|19920951|P1|COMPLETED|Overall Study||67
8078893|NCT03679494|19920950|P2|STARTED|Overall Study||63
8078894|NCT03679494|19920951|P1|STARTED|Overall Study||67
8078895|NCT03678870|19920971|P2|NOT COMPLETED|Overall Study||8
8078896|NCT03678870|19920972|P1|NOT COMPLETED|Overall Study||13
8078897|NCT03678870|19920971|P2|COMPLETED|Overall Study||91
8078898|NCT03678870|19920972|P1|COMPLETED|Overall Study||84
8078899|NCT03678870|19920971|P2|STARTED|Overall Study||99
8078900|NCT03678870|19920972|P1|STARTED|Overall Study||97
8078901|NCT03678311|19920984|P1|NOT COMPLETED|Overall Study||0
8078902|NCT03678311|19920984|P1|COMPLETED|Overall Study||9
8078903|NCT03678311|19920984|P1|STARTED|Overall Study||9
8078910|NCT03677375|19921017|P1|NOT COMPLETED|Overall Study||12
8078911|NCT03677375|19921017|P1|COMPLETED|Overall Study||81
8078912|NCT03677375|19921017|P1|STARTED|Overall Study||93
8078913|NCT03677245|19921021|P1|NOT COMPLETED|Overall Study||0
8078914|NCT03677245|19921021|P1|COMPLETED|Overall Study||8
8078915|NCT03677245|19921021|P1|STARTED|Overall Study||8
8078916|NCT03677089|19921028|P1|NOT COMPLETED|Overall Study||34
8078917|NCT03677089|19921028|P1|COMPLETED|Overall Study||114
8078918|NCT03677089|19921028|P1|Follow-Up|Overall Study||114
8078919|NCT03677089|19921028|P1|Post-Intervention|Overall Study||117
8078920|NCT03677089|19921028|P1|Mid-Intervention|Overall Study||120
8078921|NCT03677089|19921028|P1|Baseline/Pre-Intervention|Overall Study||137
8078922|NCT03677089|19921028|P1|STARTED|Overall Study||148
8078923|NCT03676803|19921059|P2|NOT COMPLETED|Overall Study||0
8078924|NCT03676803|19921060|P1|NOT COMPLETED|Overall Study||0
8078925|NCT03676803|19921059|P2|COMPLETED|Overall Study||16
8078926|NCT03676803|19921060|P1|COMPLETED|Overall Study||15
8078927|NCT03676803|19921059|P2|STARTED|Overall Study||16
8078928|NCT03676803|19921060|P1|STARTED|Overall Study||15
8078929|NCT03676270|19921068|P1|NOT COMPLETED|Overall Study||0
8078930|NCT03676270|19921068|P1|COMPLETED|Overall Study||6915
8078931|NCT03676270|19921068|P1|STARTED|Overall Study||6915
8078932|NCT03675776|19921075|P3|NOT COMPLETED|Safety Follow-up Period||0
8078933|NCT03675776|19921076|P2|NOT COMPLETED|Safety Follow-up Period||0
8078934|NCT03675776|19921077|P1|NOT COMPLETED|Safety Follow-up Period||0
8078935|NCT03675776|19921075|P3|COMPLETED|Safety Follow-up Period||7
8078936|NCT03675776|19921076|P2|COMPLETED|Safety Follow-up Period||8
8078937|NCT03675776|19921077|P1|COMPLETED|Safety Follow-up Period||6
8078938|NCT03675776|19921075|P3|STARTED|Safety Follow-up Period||7
8078939|NCT03675776|19921076|P2|STARTED|Safety Follow-up Period||8
8078940|NCT03675776|19921077|P1|STARTED|Safety Follow-up Period||6
8078941|NCT03675776|19921075|P3|NOT COMPLETED|Double Blind Treatment Period||8
8078942|NCT03675776|19921076|P2|NOT COMPLETED|Double Blind Treatment Period||6
8078943|NCT03675776|19921077|P1|NOT COMPLETED|Double Blind Treatment Period||6
8078944|NCT03675776|19921075|P3|COMPLETED|Double Blind Treatment Period||10
8078945|NCT03675776|19921076|P2|COMPLETED|Double Blind Treatment Period||11
8078946|NCT03675776|19921077|P1|COMPLETED|Double Blind Treatment Period||9
8078947|NCT03675776|19921075|P3|STARTED|Double Blind Treatment Period||18
8078948|NCT03675776|19921076|P2|STARTED|Double Blind Treatment Period||17
8078949|NCT03675776|19921077|P1|STARTED|Double Blind Treatment Period||15
8078950|NCT03675685|19921088|P1|NOT COMPLETED|Overall Study||0
8078951|NCT03675685|19921088|P1|COMPLETED|Overall Study||12
8078952|NCT03675685|19921088|P1|STARTED|Overall Study||12
8078953|NCT03675581|19921104|P1|NOT COMPLETED|Period 2: Microgynon + Nintedanib||0
8078954|NCT03675581|19921104|P1|COMPLETED|Period 2: Microgynon + Nintedanib||17
8078955|NCT03675581|19921104|P1|STARTED|Period 2: Microgynon + Nintedanib||17
8078956|NCT03675581|19921104|P1|NOT COMPLETED|Period 1: Microgynon Alone||0
8078957|NCT03675581|19921104|P1|COMPLETED|Period 1: Microgynon Alone||17
8078958|NCT03675581|19921104|P1|STARTED|Period 1: Microgynon Alone||17
8078959|NCT03675451|19921122|P1|NOT COMPLETED|Overall Study||0
8078960|NCT03675451|19921122|P1|COMPLETED|Overall Study||20
8078961|NCT03675451|19921122|P1|STARTED|Overall Study||20
8078962|NCT03674970|19921142|P3|NOT COMPLETED|Overall Study||3
8078963|NCT03674970|19921143|P2|NOT COMPLETED|Overall Study||7
8078964|NCT03674970|19921144|P1|NOT COMPLETED|Overall Study||3
8078965|NCT03674970|19921142|P3|COMPLETED|Overall Study||12
8078966|NCT03674970|19921143|P2|COMPLETED|Overall Study||8
8078967|NCT03674970|19921144|P1|COMPLETED|Overall Study||12
8078968|NCT03674970|19921142|P3|STARTED|Overall Study||15
8078969|NCT03674970|19921143|P2|STARTED|Overall Study||15
8078970|NCT03674970|19921144|P1|STARTED|Overall Study||15
8078971|NCT03674281|19921170|P3|NOT COMPLETED|Overall Study||3
8078972|NCT03674281|19921171|P2|NOT COMPLETED|Overall Study||3
8078973|NCT03674281|19921172|P1|NOT COMPLETED|Overall Study||3
8078974|NCT03674281|19921170|P3|COMPLETED|Overall Study||13
8078975|NCT03674281|19921171|P2|COMPLETED|Overall Study||13
8078976|NCT03674281|19921172|P1|COMPLETED|Overall Study||15
8078977|NCT03674281|19921170|P3|STARTED|Overall Study||16
8078978|NCT03674281|19921171|P2|STARTED|Overall Study||16
8078979|NCT03674281|19921172|P1|STARTED|Overall Study||18
8078992|NCT03673670|19921271|P6|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8078993|NCT03673670|19921272|P5|NOT COMPLETED|Treatment Period 3 (3 Days)||1
8078994|NCT03673670|19921273|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8078995|NCT03673670|19921274|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8078996|NCT03673670|19921275|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8078997|NCT03673670|19921276|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8078998|NCT03673670|19921271|P6|COMPLETED|Treatment Period 3 (3 Days)||11
8078999|NCT03673670|19921272|P5|COMPLETED|Treatment Period 3 (3 Days)||10
8079000|NCT03673670|19921273|P4|COMPLETED|Treatment Period 3 (3 Days)||12
8079001|NCT03673670|19921274|P3|COMPLETED|Treatment Period 3 (3 Days)||11
8079002|NCT03673670|19921275|P2|COMPLETED|Treatment Period 3 (3 Days)||14
8079003|NCT03673670|19921276|P1|COMPLETED|Treatment Period 3 (3 Days)||13
8079004|NCT03673670|19921271|P6|STARTED|Treatment Period 3 (3 Days)||11
8079005|NCT03673670|19921272|P5|STARTED|Treatment Period 3 (3 Days)||11
8079006|NCT03673670|19921273|P4|STARTED|Treatment Period 3 (3 Days)||12
8079007|NCT03673670|19921274|P3|STARTED|Treatment Period 3 (3 Days)||11
8079008|NCT03673670|19921275|P2|STARTED|Treatment Period 3 (3 Days)||14
8079009|NCT03673670|19921276|P1|STARTED|Treatment Period 3 (3 Days)||13
8079010|NCT03673670|19921271|P6|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
8079011|NCT03673670|19921272|P5|NOT COMPLETED|Washout Period 2 (7-14 Days)||1
8079012|NCT03673670|19921273|P4|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
8079013|NCT03673670|19921274|P3|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
8079014|NCT03673670|19921275|P2|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
8079015|NCT03673670|19921276|P1|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
8079016|NCT03673670|19921271|P6|COMPLETED|Washout Period 2 (7-14 Days)||11
8079017|NCT03673670|19921272|P5|COMPLETED|Washout Period 2 (7-14 Days)||11
8079018|NCT03673670|19921273|P4|COMPLETED|Washout Period 2 (7-14 Days)||12
8079019|NCT03673670|19921274|P3|COMPLETED|Washout Period 2 (7-14 Days)||11
8079020|NCT03673670|19921275|P2|COMPLETED|Washout Period 2 (7-14 Days)||14
8079021|NCT03673670|19921276|P1|COMPLETED|Washout Period 2 (7-14 Days)||13
8079022|NCT03673670|19921271|P6|STARTED|Washout Period 2 (7-14 Days)||11
8079023|NCT03673670|19921272|P5|STARTED|Washout Period 2 (7-14 Days)||12
8079024|NCT03673670|19921273|P4|STARTED|Washout Period 2 (7-14 Days)||12
8079025|NCT03673670|19921274|P3|STARTED|Washout Period 2 (7-14 Days)||11
8079026|NCT03673670|19921275|P2|STARTED|Washout Period 2 (7-14 Days)||14
8079027|NCT03673670|19921276|P1|STARTED|Washout Period 2 (7-14 Days)||13
8079028|NCT03673670|19921271|P6|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8079029|NCT03673670|19921272|P5|NOT COMPLETED|Treatment Period 2 (3 Days)||1
8079030|NCT03673670|19921273|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8079031|NCT03673670|19921274|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||1
8079032|NCT03673670|19921275|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8079033|NCT03673670|19921276|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8079034|NCT03673670|19921271|P6|COMPLETED|Treatment Period 2 (3 Days)||11
8079035|NCT03673670|19921272|P5|COMPLETED|Treatment Period 2 (3 Days)||12
8079036|NCT03673670|19921273|P4|COMPLETED|Treatment Period 2 (3 Days)||12
8079037|NCT03673670|19921274|P3|COMPLETED|Treatment Period 2 (3 Days)||11
8079038|NCT03673670|19921275|P2|COMPLETED|Treatment Period 2 (3 Days)||14
8079039|NCT03673670|19921276|P1|COMPLETED|Treatment Period 2 (3 Days)||13
8079040|NCT03673670|19921271|P6|STARTED|Treatment Period 2 (3 Days)||11
8079041|NCT03673670|19921272|P5|STARTED|Treatment Period 2 (3 Days)||13
8079042|NCT03673670|19921273|P4|STARTED|Treatment Period 2 (3 Days)||12
8079043|NCT03673670|19921274|P3|STARTED|Treatment Period 2 (3 Days)||12
8079044|NCT03673670|19921275|P2|STARTED|Treatment Period 2 (3 Days)||14
8079045|NCT03673670|19921276|P1|STARTED|Treatment Period 2 (3 Days)||13
8079046|NCT03673670|19921271|P6|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
8079047|NCT03673670|19921272|P5|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
8079048|NCT03673670|19921273|P4|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
8079049|NCT03673670|19921274|P3|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
8079050|NCT03673670|19921275|P2|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
8079051|NCT03673670|19921276|P1|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
8079052|NCT03673670|19921271|P6|COMPLETED|Washout Period 1 (7-14 Days)||11
8079053|NCT03673670|19921272|P5|COMPLETED|Washout Period 1 (7-14 Days)||13
8079054|NCT03673670|19921273|P4|COMPLETED|Washout Period 1 (7-14 Days)||12
8079055|NCT03673670|19921274|P3|COMPLETED|Washout Period 1 (7-14 Days)||12
8079056|NCT03673670|19921275|P2|COMPLETED|Washout Period 1 (7-14 Days)||14
8079057|NCT03673670|19921276|P1|COMPLETED|Washout Period 1 (7-14 Days)||13
8079058|NCT03673670|19921271|P6|STARTED|Washout Period 1 (7-14 Days)||11
8079059|NCT03673670|19921272|P5|STARTED|Washout Period 1 (7-14 Days)||13
8079060|NCT03673670|19921273|P4|STARTED|Washout Period 1 (7-14 Days)||12
8079061|NCT03673670|19921274|P3|STARTED|Washout Period 1 (7-14 Days)||12
8079062|NCT03673670|19921275|P2|STARTED|Washout Period 1 (7-14 Days)||14
8079063|NCT03673670|19921276|P1|STARTED|Washout Period 1 (7-14 Days)||13
8079064|NCT03673670|19921271|P6|NOT COMPLETED|Treatment Period 1 (3 Days)||2
8079065|NCT03673670|19921272|P5|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8079066|NCT03673670|19921273|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8079067|NCT03673670|19921274|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||1
8079068|NCT03673670|19921275|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8079069|NCT03673670|19921276|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||1
8079070|NCT03673670|19921271|P6|COMPLETED|Treatment Period 1 (3 Days)||11
8079071|NCT03673670|19921272|P5|COMPLETED|Treatment Period 1 (3 Days)||13
8079072|NCT03673670|19921273|P4|COMPLETED|Treatment Period 1 (3 Days)||12
8079073|NCT03673670|19921274|P3|COMPLETED|Treatment Period 1 (3 Days)||12
8079074|NCT03673670|19921275|P2|COMPLETED|Treatment Period 1 (3 Days)||14
8079075|NCT03673670|19921276|P1|COMPLETED|Treatment Period 1 (3 Days)||13
8079076|NCT03673670|19921271|P6|STARTED|Treatment Period 1 (3 Days)||13
8079077|NCT03673670|19921272|P5|STARTED|Treatment Period 1 (3 Days)||13
8079078|NCT03673670|19921273|P4|STARTED|Treatment Period 1 (3 Days)||12
8079079|NCT03673670|19921274|P3|STARTED|Treatment Period 1 (3 Days)||13
8079080|NCT03673670|19921275|P2|STARTED|Treatment Period 1 (3 Days)||14
8079081|NCT03673670|19921276|P1|STARTED|Treatment Period 1 (3 Days)||14
8079085|NCT03672370|19921346|P1|NOT COMPLETED|Overall Study||47
8079086|NCT03672370|19921346|P1|COMPLETED|Overall Study||42
8079087|NCT03672370|19921346|P1|STARTED|Overall Study|11 hips did not receive the study devices acc. to the protocol and therefore had to be excluded.|89
8079088|NCT03670537|19921353|P1|NOT COMPLETED|Overall Study||1
8079089|NCT03670537|19921353|P1|COMPLETED|Overall Study||101
8079090|NCT03670537|19921353|P1|STARTED|Overall Study||102
8079091|NCT03669081|19921359|P2|NOT COMPLETED|Overall Study||1
8079092|NCT03669081|19921360|P1|NOT COMPLETED|Overall Study||1
8079093|NCT03669081|19921359|P2|COMPLETED|Overall Study||29
8079094|NCT03669081|19921360|P1|COMPLETED|Overall Study||33
8079095|NCT03669081|19921359|P2|STARTED|Overall Study||30
8079096|NCT03669081|19921360|P1|STARTED|Overall Study||34
8079097|NCT03668600|19921376|P1|NOT COMPLETED|Overall Study||230
8079098|NCT03668600|19921376|P1|COMPLETED|Overall Study||0
8079099|NCT03668600|19921376|P1|STARTED|Overall Study||230
8079100|NCT03667547|19921380|P1|NOT COMPLETED|Overall Study||0
8079101|NCT03667547|19921380|P1|COMPLETED|Overall Study||12
8079102|NCT03667547|19921380|P1|STARTED|Overall Study||12
8079103|NCT03664544|19921396|P2|NOT COMPLETED|Overall Study||0
8079104|NCT03664544|19921397|P1|NOT COMPLETED|Overall Study||0
8079105|NCT03664544|19921396|P2|COMPLETED|Overall Study||6
8079106|NCT03664544|19921397|P1|COMPLETED|Overall Study||6
8079107|NCT03664544|19921396|P2|STARTED|Overall Study||6
8079108|NCT03664544|19921397|P1|STARTED|Overall Study||6
8079109|NCT03664193|19921427|P1|NOT COMPLETED|Overall Study||0
8079110|NCT03664193|19921427|P1|COMPLETED|Overall Study||30
8079111|NCT03664193|19921427|P1|STARTED|Overall Study||30
8079112|NCT03663582|19921434|P1|NOT COMPLETED|Overall Study||1
8079113|NCT03663582|19921434|P1|COMPLETED|Overall Study||6
8079114|NCT03663582|19921434|P1|STARTED|Overall Study||7
8079115|NCT03663569|19921466|P1|NOT COMPLETED|Overall Study||63
8079116|NCT03663569|19921466|P1|COMPLETED|Overall Study||4756
8079117|NCT03663569|19921466|P1|STARTED|Overall Study||4819
8079118|NCT03663231|19921479|P2|NOT COMPLETED|Second Intervention||0
8079119|NCT03663231|19921480|P1|NOT COMPLETED|Second Intervention||0
8079120|NCT03663231|19921479|P2|COMPLETED|Second Intervention||12
8079121|NCT03663231|19921480|P1|COMPLETED|Second Intervention||14
8079122|NCT03663231|19921479|P2|STARTED|Second Intervention||12
8079123|NCT03663231|19921480|P1|STARTED|Second Intervention||14
8079124|NCT03663231|19921479|P2|NOT COMPLETED|Washout||0
8079125|NCT03663231|19921480|P1|NOT COMPLETED|Washout||0
8079126|NCT03663231|19921479|P2|COMPLETED|Washout||12
8079127|NCT03663231|19921480|P1|COMPLETED|Washout||14
8079128|NCT03663231|19921479|P2|STARTED|Washout||12
8079129|NCT03663231|19921480|P1|STARTED|Washout||14
8079130|NCT03663231|19921479|P2|NOT COMPLETED|First Intervention||1
8079131|NCT03663231|19921480|P1|NOT COMPLETED|First Intervention||2
8079132|NCT03663231|19921479|P2|COMPLETED|First Intervention||12
8079133|NCT03663231|19921480|P1|COMPLETED|First Intervention||14
8079134|NCT03663231|19921479|P2|STARTED|First Intervention||13
8079135|NCT03663231|19921480|P1|STARTED|First Intervention||16
8079136|NCT03663179|19921500|P2|NOT COMPLETED|Overall Study||1
8079137|NCT03663179|19921501|P1|NOT COMPLETED|Overall Study||4
8079138|NCT03663179|19921500|P2|COMPLETED|Overall Study||13
8079139|NCT03663179|19921501|P1|COMPLETED|Overall Study||14
8079140|NCT03663179|19921500|P2|STARTED|Overall Study||14
8079141|NCT03663179|19921501|P1|STARTED|Overall Study||18
8079142|NCT03663101|19921513|P4|NOT COMPLETED|Overall Study||0
8079143|NCT03663101|19921514|P3|NOT COMPLETED|Overall Study||0
8079144|NCT03663101|19921515|P2|NOT COMPLETED|Overall Study||0
8079145|NCT03663101|19921516|P1|NOT COMPLETED|Overall Study||0
8079146|NCT03663101|19921513|P4|COMPLETED|Overall Study||4
8079147|NCT03663101|19921514|P3|COMPLETED|Overall Study||5
8079148|NCT03663101|19921515|P2|COMPLETED|Overall Study||3
8079149|NCT03663101|19921516|P1|COMPLETED|Overall Study||4
8079150|NCT03663101|19921513|P4|STARTED|Overall Study||4
8079151|NCT03663101|19921514|P3|STARTED|Overall Study||5
8079152|NCT03663101|19921515|P2|STARTED|Overall Study||3
8079153|NCT03663101|19921516|P1|STARTED|Overall Study||4
8079154|NCT03662334|19921548|P2|NOT COMPLETED|Part 3: Treatment Period 2||0
8079155|NCT03662334|19921549|P1|NOT COMPLETED|Part 3: Treatment Period 2||0
8079156|NCT03662334|19921548|P2|COMPLETED|Part 3: Treatment Period 2||0
8079157|NCT03662334|19921549|P1|COMPLETED|Part 3: Treatment Period 2||0
8079158|NCT03662334|19921548|P2|STARTED|Part 3: Treatment Period 2||0
8079159|NCT03662334|19921549|P1|STARTED|Part 3: Treatment Period 2||0
8079160|NCT03662334|19921548|P2|NOT COMPLETED|Part 3: Treatment Period 1||0
8079161|NCT03662334|19921549|P1|NOT COMPLETED|Part 3: Treatment Period 1||0
8079162|NCT03662334|19921548|P2|COMPLETED|Part 3: Treatment Period 1||0
8079163|NCT03662334|19921549|P1|COMPLETED|Part 3: Treatment Period 1||0
8079164|NCT03662334|19921548|P2|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
8079165|NCT03662334|19921549|P1|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
8079166|NCT03662334|19921548|P2|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0
8079167|NCT03662334|19921549|P1|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1
8079168|NCT03662334|19921548|P2|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7
8079169|NCT03662334|19921549|P1|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6
8079170|NCT03662334|19921548|P2|STARTED|Part 2: Treatment Period 2 (2 Days)||7
8079171|NCT03662334|19921549|P1|STARTED|Part 2: Treatment Period 2 (2 Days)||7
8079172|NCT03662334|19921548|P2|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
8079173|NCT03662334|19921549|P1|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
8079174|NCT03662334|19921548|P2|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
8079175|NCT03662334|19921549|P1|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
8079176|NCT03662334|19921548|P2|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
8079177|NCT03662334|19921549|P1|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
8079178|NCT03662334|19921548|P2|NOT COMPLETED|Part 1: Treatment Period 2||0
8079179|NCT03662334|19921549|P1|NOT COMPLETED|Part 1: Treatment Period 2||0
8079180|NCT03662334|19921548|P2|COMPLETED|Part 1: Treatment Period 2||0
8079181|NCT03662334|19921549|P1|COMPLETED|Part 1: Treatment Period 2||0
8079182|NCT03662334|19921548|P2|STARTED|Part 1: Treatment Period 2||0
8079183|NCT03662334|19921549|P1|STARTED|Part 1: Treatment Period 2||0
8079184|NCT03662334|19921548|P2|NOT COMPLETED|Part 1: Treatment Period 1||0
8079185|NCT03662334|19921549|P1|NOT COMPLETED|Part 1: Treatment Period 1||0
8079186|NCT03662334|19921548|P2|COMPLETED|Part 1: Treatment Period 1||0
8079187|NCT03662334|19921549|P1|COMPLETED|Part 1: Treatment Period 1||0
8079188|NCT03662334|19921548|P2|STARTED|Part 1: Treatment Period 1||0
8079189|NCT03662334|19921549|P1|STARTED|Part 1: Treatment Period 1||0
8079190|NCT03662282|19921585|P1|NOT COMPLETED|Overall Study||0
8079191|NCT03662282|19921585|P1|COMPLETED|Overall Study||2
8079192|NCT03662282|19921585|P1|STARTED|Overall Study||2
8079193|NCT03662139|19921595|P2|NOT COMPLETED|Overall Study||0
8079194|NCT03662139|19921596|P1|NOT COMPLETED|Overall Study||0
8079195|NCT03662139|19921595|P2|COMPLETED|Overall Study||16
8079196|NCT03662139|19921596|P1|COMPLETED|Overall Study||16
8079197|NCT03662139|19921595|P2|STARTED|Overall Study||16
8079198|NCT03662139|19921596|P1|STARTED|Overall Study||16
8079223|NCT03661814|19921622|P2|NOT COMPLETED|Overall Study||0
8079224|NCT03661814|19921623|P1|NOT COMPLETED|Overall Study||0
8079225|NCT03661814|19921622|P2|COMPLETED|Overall Study||5
8079226|NCT03661814|19921623|P1|COMPLETED|Overall Study||2
8079227|NCT03661814|19921622|P2|STARTED|Overall Study||5
8079228|NCT03661814|19921623|P1|STARTED|Overall Study||2
8079229|NCT03661762|19921633|P1|NOT COMPLETED|Overall Study||8
8079230|NCT03661762|19921633|P1|COMPLETED|Overall Study||10
8079231|NCT03661762|19921633|P1|STARTED|Overall Study||18
8079232|NCT03661697|19921647|P2|NOT COMPLETED|Overall Study||0
8079233|NCT03661697|19921648|P1|NOT COMPLETED|Overall Study||0
8079234|NCT03661697|19921647|P2|COMPLETED|Overall Study||7
8079235|NCT03661697|19921648|P1|COMPLETED|Overall Study||7
8079236|NCT03661697|19921647|P2|STARTED|Overall Study||7
8079237|NCT03661697|19921648|P1|STARTED|Overall Study||7
8079238|NCT03660839|19921660|P4|NOT COMPLETED|Overall Study||0
8079239|NCT03660839|19921661|P3|NOT COMPLETED|Overall Study||0
8079240|NCT03660839|19921662|P2|NOT COMPLETED|Overall Study||0
8079241|NCT03660839|19921663|P1|NOT COMPLETED|Overall Study||0
8079242|NCT03660839|19921660|P4|COMPLETED|Overall Study||33
8079243|NCT03660839|19921661|P3|COMPLETED|Overall Study||36
8079244|NCT03660839|19921662|P2|COMPLETED|Overall Study||36
8079245|NCT03660839|19921663|P1|COMPLETED|Overall Study||35
8079246|NCT03660839|19921660|P4|STARTED|Overall Study||33
8079247|NCT03660839|19921661|P3|STARTED|Overall Study||36
8079248|NCT03660839|19921662|P2|STARTED|Overall Study||36
8079249|NCT03660839|19921663|P1|STARTED|Overall Study||35
8079250|NCT03660787|19921767|P4|NOT COMPLETED|Overall Study||0
8079251|NCT03660787|19921768|P3|NOT COMPLETED|Overall Study||1
8079252|NCT03660787|19921769|P2|NOT COMPLETED|Overall Study||1
8079253|NCT03660787|19921770|P1|NOT COMPLETED|Overall Study||1
8079254|NCT03660787|19921767|P4|COMPLETED|Overall Study||26
8079255|NCT03660787|19921768|P3|COMPLETED|Overall Study||25
8079256|NCT03660787|19921769|P2|COMPLETED|Overall Study||25
8079257|NCT03660787|19921770|P1|COMPLETED|Overall Study||25
8079258|NCT03660787|19921767|P4|STARTED|Overall Study||26
8079259|NCT03660787|19921768|P3|STARTED|Overall Study||26
8079260|NCT03660787|19921769|P2|STARTED|Overall Study||26
8079261|NCT03660787|19921770|P1|STARTED|Overall Study||26
8079262|NCT03660241|19921807|P3|NOT COMPLETED|Overall Study||0
8079263|NCT03660241|19921808|P2|NOT COMPLETED|Overall Study||0
8079264|NCT03660241|19921809|P1|NOT COMPLETED|Overall Study||0
8079265|NCT03660241|19921807|P3|COMPLETED|Overall Study||8
8079266|NCT03660241|19921808|P2|COMPLETED|Overall Study||7
8079267|NCT03660241|19921809|P1|COMPLETED|Overall Study||8
8079268|NCT03660241|19921807|P3|STARTED|Overall Study||8
8079269|NCT03660241|19921808|P2|STARTED|Overall Study||7
8079270|NCT03660241|19921809|P1|STARTED|Overall Study||8
8079271|NCT03658889|19921852|P2|NOT COMPLETED|Overall Study||0
8079272|NCT03658889|19921853|P1|NOT COMPLETED|Overall Study||2
8079273|NCT03658889|19921852|P2|COMPLETED|Overall Study||69
8079274|NCT03658889|19921853|P1|COMPLETED|Overall Study|Analysis population|306
8079275|NCT03658889|19921852|P2|STARTED|Overall Study||69
8079276|NCT03658889|19921853|P1|STARTED|Overall Study|Enrolled population|308
8079277|NCT03658876|19921884|P2|NOT COMPLETED|Overall Study||12
8079278|NCT03658876|19921885|P1|NOT COMPLETED|Overall Study||12
8079279|NCT03658876|19921884|P2|COMPLETED|Overall Study||84
8079280|NCT03658876|19921885|P1|COMPLETED|Overall Study||76
8079281|NCT03658876|19921884|P2|STARTED|Overall Study||96
8079282|NCT03658876|19921885|P1|STARTED|Overall Study||88
8079283|NCT03658811|19921891|P1|NOT COMPLETED|Overall Study||3
8079284|NCT03658811|19921891|P1|COMPLETED|Overall Study||16
8079285|NCT03658811|19921891|P1|STARTED|Overall Study||19
8079286|NCT03657407|19921900|P2|NOT COMPLETED|Overall Study||0
8079287|NCT03657407|19921901|P1|NOT COMPLETED|Overall Study||0
8079288|NCT03657407|19921900|P2|COMPLETED|Overall Study||27
8079289|NCT03657407|19921901|P1|COMPLETED|Overall Study||29
8079290|NCT03657407|19921900|P2|STARTED|Overall Study||27
8079291|NCT03657407|19921901|P1|STARTED|Overall Study||29
8079304|NCT03657095|19921935|P2|NOT COMPLETED|Overall Study||53
8079305|NCT03657095|19921936|P1|NOT COMPLETED|Overall Study||59
8079306|NCT03657095|19921935|P2|COMPLETED|Overall Study||0
8079307|NCT03657095|19921936|P1|COMPLETED|Overall Study||0
8079308|NCT03657095|19921935|P2|Received at Least 1 Dose of Study Drug|Overall Study||53
8079309|NCT03657095|19921936|P1|Received at Least 1 Dose of Study Drug|Overall Study||59
8079310|NCT03657095|19921935|P2|STARTED|Overall Study||53
8079311|NCT03657095|19921936|P1|STARTED|Overall Study||59
8079312|NCT03655951|19921952|P2|NOT COMPLETED|Overall Study||21
8079313|NCT03655951|19921953|P1|NOT COMPLETED|Overall Study||39
8079314|NCT03655951|19921952|P2|COMPLETED|Overall Study||351
8079315|NCT03655951|19921953|P1|COMPLETED|Overall Study||319
8079316|NCT03655951|19921952|P2|Completed Pretest|Overall Study||366
8079317|NCT03655951|19921953|P1|Completed Pretest|Overall Study||344
8079318|NCT03655951|19921952|P2|STARTED|Overall Study||372
8079319|NCT03655951|19921953|P1|STARTED|Overall Study||358
8079320|NCT03655444|19922115|P2|NOT COMPLETED|Overall Study||0
8079321|NCT03655444|19922116|P1|NOT COMPLETED|Overall Study||0
8079322|NCT03655444|19922115|P2|COMPLETED|Overall Study||3
8079323|NCT03655444|19922116|P1|COMPLETED|Overall Study||3
8079324|NCT03655444|19922115|P2|STARTED|Overall Study||3
8079325|NCT03655444|19922116|P1|STARTED|Overall Study||3
8079326|NCT03655301|19922130|P1|NOT COMPLETED|Overall Study||0
8079327|NCT03655301|19922130|P1|COMPLETED|Overall Study||13
8079328|NCT03655301|19922130|P1|STARTED|Overall Study||13
8079329|NCT03655106|19922142|P2|NOT COMPLETED|Overall Study||4
8079330|NCT03655106|19922143|P1|NOT COMPLETED|Overall Study||9
8079331|NCT03655106|19922142|P2|COMPLETED|Overall Study||131
8079332|NCT03655106|19922143|P1|COMPLETED|Overall Study||126
8079333|NCT03655106|19922142|P2|STARTED|Overall Study||135
8079334|NCT03655106|19922143|P1|STARTED|Overall Study||135
8079335|NCT03654560|19922155|P2|NOT COMPLETED|Overall Study||1
8079336|NCT03654560|19922156|P1|NOT COMPLETED|Overall Study||4
8079337|NCT03654560|19922155|P2|COMPLETED|Overall Study||117
8079338|NCT03654560|19922156|P1|COMPLETED|Overall Study||114
8079339|NCT03654560|19922155|P2|STARTED|Overall Study||118
8079340|NCT03654560|19922156|P1|STARTED|Overall Study||118
8079341|NCT03654417|19922172|P2|NOT COMPLETED|Overall Study||0
8079342|NCT03654417|19922173|P1|NOT COMPLETED|Overall Study||0
8079343|NCT03654417|19922172|P2|COMPLETED|Overall Study||18
8079344|NCT03654417|19922173|P1|COMPLETED|Overall Study||19
8079345|NCT03654417|19922172|P2|STARTED|Overall Study||18
8079346|NCT03654417|19922173|P1|STARTED|Overall Study||19
8079347|NCT03653429|19922197|P2|NOT COMPLETED|Overall Study||10
8079348|NCT03653429|19922198|P1|NOT COMPLETED|Overall Study||4
8079349|NCT03653429|19922197|P2|COMPLETED|Overall Study||41
8079350|NCT03653429|19922198|P1|COMPLETED|Overall Study||45
8079351|NCT03653429|19922197|P2|STARTED|Overall Study||51
8079352|NCT03653429|19922198|P1|STARTED|Overall Study||49
8079353|NCT03653416|19922212|P2|NOT COMPLETED|Overall Study||1
8079354|NCT03653416|19922213|P1|NOT COMPLETED|Overall Study||6
8079355|NCT03653416|19922212|P2|COMPLETED|Overall Study||46
8079356|NCT03653416|19922213|P1|COMPLETED|Overall Study||46
8079357|NCT03653416|19922212|P2|STARTED|Overall Study||47
8079358|NCT03653416|19922213|P1|STARTED|Overall Study||52
8079359|NCT03651856|19922231|P1|NOT COMPLETED|Overall Study||0
8079360|NCT03651856|19922231|P1|COMPLETED|Overall Study||10
8079361|NCT03651856|19922231|P1|STARTED|Overall Study||10
8079362|NCT03651479|19922237|P2|NOT COMPLETED|Overall Study||0
8079363|NCT03651479|19922238|P1|NOT COMPLETED|Overall Study||0
8079364|NCT03651479|19922237|P2|COMPLETED|Overall Study||20
8079365|NCT03651479|19922238|P1|COMPLETED|Overall Study||20
8079366|NCT03651479|19922237|P2|STARTED|Overall Study||20
8079367|NCT03651479|19922238|P1|STARTED|Overall Study||20
8079368|NCT03650842|19922254|P1|NOT COMPLETED|Overall Study||0
8079369|NCT03650842|19922254|P1|COMPLETED|Overall Study||25
8079370|NCT03650842|19922254|P1|STARTED|Overall Study||25
8079371|NCT03650400|19922263|P2|NOT COMPLETED|Overall Study||5
8079372|NCT03650400|19922264|P1|NOT COMPLETED|Overall Study||0
8079373|NCT03650400|19922263|P2|COMPLETED|Overall Study||0
8079374|NCT03650400|19922264|P1|COMPLETED|Overall Study||6
8079375|NCT03650400|19922263|P2|STARTED|Overall Study||5
8079376|NCT03650400|19922264|P1|STARTED|Overall Study||6
8079377|NCT03649867|19922292|P1|NOT COMPLETED|Overall Study||0
8079378|NCT03649867|19922292|P1|COMPLETED|Overall Study||13
8079379|NCT03649867|19922292|P1|STARTED|Overall Study||13
8079380|NCT03649815|19922296|P1|NOT COMPLETED|Overall Study||0
8079381|NCT03649815|19922296|P1|COMPLETED|Overall Study||38
8079382|NCT03649815|19922296|P1|STARTED|Overall Study||38
8079383|NCT03649750|19922302|P2|NOT COMPLETED|Period 2||0
8079384|NCT03649750|19922303|P1|NOT COMPLETED|Period 2||0
8079385|NCT03649750|19922302|P2|COMPLETED|Period 2||24
8079386|NCT03649750|19922303|P1|COMPLETED|Period 2||12
8079387|NCT03649750|19922302|P2|STARTED|Period 2||24
8079388|NCT03649750|19922303|P1|STARTED|Period 2||12
8079389|NCT03649750|19922302|P2|NOT COMPLETED|Washout: 7 Days||0
8079390|NCT03649750|19922303|P1|NOT COMPLETED|Washout: 7 Days||0
8079391|NCT03649750|19922302|P2|COMPLETED|Washout: 7 Days||24
8079392|NCT03649750|19922303|P1|COMPLETED|Washout: 7 Days||12
8079393|NCT03649750|19922302|P2|STARTED|Washout: 7 Days||24
8079394|NCT03649750|19922303|P1|STARTED|Washout: 7 Days||12
8079395|NCT03649750|19922302|P2|NOT COMPLETED|Period 1||0
8079396|NCT03649750|19922303|P1|NOT COMPLETED|Period 1||0
8079397|NCT03649750|19922302|P2|COMPLETED|Period 1||24
8079398|NCT03649750|19922303|P1|COMPLETED|Period 1||12
8079399|NCT03649750|19922302|P2|STARTED|Period 1||24
8079400|NCT03649750|19922303|P1|STARTED|Period 1||12
8079401|NCT03649646|19922322|P1|NOT COMPLETED|Overall Study||467
8079402|NCT03649646|19922322|P1|COMPLETED|Overall Study||4075
8079403|NCT03649646|19922322|P1|STARTED|Overall Study||4542
8079404|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Period 6 (4days)||0
8079405|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Period 6 (4days)||0
8079406|NCT03649412|19922331|P2|COMPLETED|Part B, Period 6 (4days)||14
8079407|NCT03649412|19922332|P1|COMPLETED|Part B, Period 6 (4days)||0
8079408|NCT03649412|19922331|P2|STARTED|Part B, Period 6 (4days)|Participant who did not start Period 5 directly joined into Period 6|14
8079409|NCT03649412|19922332|P1|STARTED|Part B, Period 6 (4days)||0
8079410|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||1
8079411|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||0
8079412|NCT03649412|19922331|P2|COMPLETED|Part B, Washout Period 5 (7 Days)||13
8079413|NCT03649412|19922332|P1|COMPLETED|Part B, Washout Period 5 (7 Days)||0
8079414|NCT03649412|19922331|P2|STARTED|Part B, Washout Period 5 (7 Days)||14
8079415|NCT03649412|19922332|P1|STARTED|Part B, Washout Period 5 (7 Days)||0
8079416|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Period 5 (4 Days)||0
8079417|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Period 5 (4 Days)||0
8079418|NCT03649412|19922331|P2|COMPLETED|Part B, Period 5 (4 Days)||14
8079419|NCT03649412|19922332|P1|COMPLETED|Part B, Period 5 (4 Days)||0
8079420|NCT03649412|19922331|P2|STARTED|Part B, Period 5 (4 Days)|One participant did not start in Period 5|14
8079421|NCT03649412|19922332|P1|STARTED|Part B, Period 5 (4 Days)||0
8079422|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
8079423|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
8079424|NCT03649412|19922331|P2|COMPLETED|Part B, Washout Period 4 (7 Days)||15
8079425|NCT03649412|19922332|P1|COMPLETED|Part B, Washout Period 4 (7 Days)||0
8079426|NCT03649412|19922331|P2|STARTED|Part B, Washout Period 4 (7 Days)||15
8079427|NCT03649412|19922332|P1|STARTED|Part B, Washout Period 4 (7 Days)||0
8079428|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Period 4 (4 Days)||0
8079429|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Period 4 (4 Days)||0
8079430|NCT03649412|19922331|P2|COMPLETED|Part B, Period 4 (4 Days)||15
8079431|NCT03649412|19922332|P1|COMPLETED|Part B, Period 4 (4 Days)||0
8079432|NCT03649412|19922331|P2|STARTED|Part B, Period 4 (4 Days)||15
8079433|NCT03649412|19922332|P1|STARTED|Part B, Period 4 (4 Days)||0
8079434|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
8079435|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
8079436|NCT03649412|19922331|P2|COMPLETED|Part B, Washout Period 3 (7 Days)||15
8079437|NCT03649412|19922332|P1|COMPLETED|Part B, Washout Period 3 (7 Days)||0
8079438|NCT03649412|19922331|P2|STARTED|Part B, Washout Period 3 (7 Days)||15
8079439|NCT03649412|19922332|P1|STARTED|Part B, Washout Period 3 (7 Days)||0
8079440|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Period 3 (4 Days)||0
8079441|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Period 3 (4 Days)||0
8079442|NCT03649412|19922331|P2|COMPLETED|Part B, Period 3 (4 Days)||15
8079443|NCT03649412|19922332|P1|COMPLETED|Part B, Period 3 (4 Days)||0
8079444|NCT03649412|19922331|P2|STARTED|Part B, Period 3 (4 Days)||15
8079445|NCT03649412|19922332|P1|STARTED|Part B, Period 3 (4 Days)||0
8079446|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
8079447|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
8079448|NCT03649412|19922331|P2|COMPLETED|Part B, Washout Period 2 (7 Days)||15
8079449|NCT03649412|19922332|P1|COMPLETED|Part B, Washout Period 2 (7 Days)||0
8079450|NCT03649412|19922331|P2|STARTED|Part B, Washout Period 2 (7 Days)||15
8079451|NCT03649412|19922332|P1|STARTED|Part B, Washout Period 2 (7 Days)||0
8079452|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Period 2 (4 Days)||0
8079453|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Period 2 (4 Days)||0
8079454|NCT03649412|19922331|P2|COMPLETED|Part B, Period 2 (4 Days)||15
8079455|NCT03649412|19922332|P1|COMPLETED|Part B, Period 2 (4 Days)||0
8079456|NCT03649412|19922331|P2|STARTED|Part B, Period 2 (4 Days)||15
8079457|NCT03649412|19922332|P1|STARTED|Part B, Period 2 (4 Days)||0
8079458|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||1
8079459|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||0
8079460|NCT03649412|19922331|P2|COMPLETED|Part B, Washout Period 1 (7 Days)||15
8079461|NCT03649412|19922332|P1|COMPLETED|Part B, Washout Period 1 (7 Days)||0
8079462|NCT03649412|19922331|P2|STARTED|Part B, Washout Period 1 (7 Days)||16
8079463|NCT03649412|19922332|P1|STARTED|Part B, Washout Period 1 (7 Days)||0
8079464|NCT03649412|19922331|P2|NOT COMPLETED|Part B, Period 1 (4 Days)||0
8079465|NCT03649412|19922332|P1|NOT COMPLETED|Part B, Period 1 (4 Days)||0
8079466|NCT03649412|19922331|P2|COMPLETED|Part B, Period 1 (4 Days)||16
8079467|NCT03649412|19922332|P1|COMPLETED|Part B, Period 1 (4 Days)||0
8079468|NCT03649412|19922331|P2|STARTED|Part B, Period 1 (4 Days)|16 new participants enrolled in Part B|16
8079469|NCT03649412|19922332|P1|STARTED|Part B, Period 1 (4 Days)|Participants in Part A did not enter Part B|0
8079470|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Period 6 (4 Days)||0
8079471|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Period 6 (4 Days)||0
8079472|NCT03649412|19922331|P2|COMPLETED|Part A, Period 6 (4 Days)||0
8079473|NCT03649412|19922332|P1|COMPLETED|Part A, Period 6 (4 Days)||12
8079474|NCT03649412|19922331|P2|STARTED|Part A, Period 6 (4 Days)||0
8079475|NCT03649412|19922332|P1|STARTED|Part A, Period 6 (4 Days)|1 of the participant who did not start Period 5 directly joined into Period 6|12
8079476|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||0
8079477|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||1
8079478|NCT03649412|19922331|P2|COMPLETED|Part A, Washout Period 5 (7 Days)||0
8079479|NCT03649412|19922332|P1|COMPLETED|Part A, Washout Period 5 (7 Days)||11
8079480|NCT03649412|19922331|P2|STARTED|Part A, Washout Period 5 (7 Days)||0
8079481|NCT03649412|19922332|P1|STARTED|Part A, Washout Period 5 (7 Days)||12
8079482|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Period 5 (4 Days)||0
8079483|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Period 5 (4 Days)||0
8079484|NCT03649412|19922331|P2|COMPLETED|Part A, Period 5 (4 Days)||0
8079485|NCT03649412|19922332|P1|COMPLETED|Part A, Period 5 (4 Days)||12
8079486|NCT03649412|19922331|P2|STARTED|Part A, Period 5 (4 Days)||0
8079487|NCT03649412|19922332|P1|STARTED|Part A, Period 5 (4 Days)|Two participant did not start in Period 5|12
8079488|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||0
8079489|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||2
8079490|NCT03649412|19922331|P2|COMPLETED|Part A, Washout Period 4 (7 Days)||0
8079491|NCT03649412|19922332|P1|COMPLETED|Part A, Washout Period 4 (7 Days)||14
8079492|NCT03649412|19922331|P2|STARTED|Part A, Washout Period 4 (7 Days)||0
8079493|NCT03649412|19922332|P1|STARTED|Part A, Washout Period 4 (7 Days)||16
8079494|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Period 4 (4 Days)||0
8079495|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Period 4 (4 Days)||0
8079496|NCT03649412|19922331|P2|COMPLETED|Part A, Period 4 (4 Days)||0
8079497|NCT03649412|19922332|P1|COMPLETED|Part A, Period 4 (4 Days)||16
8079498|NCT03649412|19922331|P2|STARTED|Part A, Period 4 (4 Days)||0
8079499|NCT03649412|19922332|P1|STARTED|Part A, Period 4 (4 Days)||16
8079500|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
8079501|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
8079502|NCT03649412|19922331|P2|COMPLETED|Part A, Washout Period 3 (7 Days)||0
8079503|NCT03649412|19922332|P1|COMPLETED|Part A, Washout Period 3 (7 Days)||16
8079504|NCT03649412|19922331|P2|STARTED|Part A, Washout Period 3 (7 Days)||0
8079505|NCT03649412|19922332|P1|STARTED|Part A, Washout Period 3 (7 Days)||16
8079506|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Period 3 (4 Days)||0
8079507|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Period 3 (4 Days)||0
8079508|NCT03649412|19922331|P2|COMPLETED|Part A, Period 3 (4 Days)||0
8079509|NCT03649412|19922332|P1|COMPLETED|Part A, Period 3 (4 Days)||16
8079510|NCT03649412|19922331|P2|STARTED|Part A, Period 3 (4 Days)||0
8079511|NCT03649412|19922332|P1|STARTED|Part A, Period 3 (4 Days)||16
8079512|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
8079513|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
8079514|NCT03649412|19922331|P2|COMPLETED|Part A, Washout Period 2 (7 Days)||0
8079515|NCT03649412|19922332|P1|COMPLETED|Part A, Washout Period 2 (7 Days)||16
8079516|NCT03649412|19922331|P2|STARTED|Part A, Washout Period 2 (7 Days)||0
8079517|NCT03649412|19922332|P1|STARTED|Part A, Washout Period 2 (7 Days)||16
8079518|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Period 2 (3 Days)||0
8079519|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Period 2 (3 Days)||0
8079520|NCT03649412|19922331|P2|COMPLETED|Part A, Period 2 (3 Days)||0
8079521|NCT03649412|19922332|P1|COMPLETED|Part A, Period 2 (3 Days)||16
8079522|NCT03649412|19922331|P2|STARTED|Part A, Period 2 (3 Days)||0
8079523|NCT03649412|19922332|P1|STARTED|Part A, Period 2 (3 Days)|1 Replacement par. was enrolled & dosed|16
8079524|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||0
8079525|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||1
8079526|NCT03649412|19922331|P2|COMPLETED|Part A, Washout Period 1 (7 Days)||0
8079527|NCT03649412|19922332|P1|COMPLETED|Part A, Washout Period 1 (7 Days)||15
8079528|NCT03649412|19922331|P2|STARTED|Part A, Washout Period 1 (7 Days)||0
8079529|NCT03649412|19922332|P1|STARTED|Part A, Washout Period 1 (7 Days)||16
8079530|NCT03649412|19922331|P2|NOT COMPLETED|Part A, Period 1 (4 Days)||0
8079531|NCT03649412|19922332|P1|NOT COMPLETED|Part A, Period 1 (4 Days)||0
8079532|NCT03649412|19922331|P2|COMPLETED|Part A, Period 1 (4 Days)||0
8079533|NCT03649412|19922332|P1|COMPLETED|Part A, Period 1 (4 Days)||16
8079534|NCT03649412|19922331|P2|STARTED|Part A, Period 1 (4 Days)||0
8079535|NCT03649412|19922332|P1|STARTED|Part A, Period 1 (4 Days)||16
8079536|NCT03648983|19922490|P1|NOT COMPLETED|Overall Study||95
8079537|NCT03648983|19922490|P1|COMPLETED|Overall Study||0
8079538|NCT03648983|19922490|P1|STARTED|Overall Study||95
8079539|NCT03648853|19922496|P1|NOT COMPLETED|Overall Study||0
8079540|NCT03648853|19922496|P1|COMPLETED|Overall Study||12
8079541|NCT03648853|19922496|P1|STARTED|Overall Study||12
8079542|NCT03647709|19922500|P1|NOT COMPLETED|Overall Study||14
8079543|NCT03647709|19922500|P1|COMPLETED|Overall Study||386
8079544|NCT03647709|19922500|P1|STARTED|Overall Study||400
8079545|NCT03647046|19922516|P1|NOT COMPLETED|Overall Study||4
8079546|NCT03647046|19922516|P1|COMPLETED|Overall Study||8
8079547|NCT03647046|19922516|P1|STARTED|Overall Study||12
8079548|NCT03647033|19922522|P2|NOT COMPLETED|Overall Study||0
8079549|NCT03647033|19922523|P1|NOT COMPLETED|Overall Study||0
8079550|NCT03647033|19922522|P2|COMPLETED|Overall Study||16
8079551|NCT03647033|19922523|P1|COMPLETED|Overall Study||16
8079552|NCT03647033|19922522|P2|STARTED|Overall Study||16
8079553|NCT03647033|19922523|P1|STARTED|Overall Study||16
8079554|NCT03646656|19922533|P2|NOT COMPLETED|Overall Study||0
8079555|NCT03646656|19922534|P1|NOT COMPLETED|Overall Study||3
8079556|NCT03646656|19922533|P2|COMPLETED|Overall Study||3
8079557|NCT03646656|19922534|P1|COMPLETED|Overall Study||9
8079558|NCT03646656|19922533|P2|Attended 1st Group Session|Overall Study||3
8079559|NCT03646656|19922534|P1|Attended 1st Group Session|Overall Study||10
8079560|NCT03646656|19922533|P2|STARTED|Overall Study||3
8079561|NCT03646656|19922534|P1|STARTED|Overall Study||12
8079568|NCT03645811|19922573|P3|NOT COMPLETED|Overall Study||2
8079569|NCT03645811|19922574|P2|NOT COMPLETED|Overall Study||2
8079570|NCT03645811|19922575|P1|NOT COMPLETED|Overall Study||2
8079571|NCT03645811|19922573|P3|COMPLETED|Overall Study||30
8079572|NCT03645811|19922574|P2|COMPLETED|Overall Study||30
8079573|NCT03645811|19922575|P1|COMPLETED|Overall Study||30
8079574|NCT03645811|19922573|P3|STARTED|Overall Study||32
8079575|NCT03645811|19922574|P2|STARTED|Overall Study||32
8079576|NCT03645811|19922575|P1|STARTED|Overall Study||32
8079577|NCT03645434|19922583|P6|NOT COMPLETED|Period 3||0
8079578|NCT03645434|19922584|P5|NOT COMPLETED|Period 3||0
8079579|NCT03645434|19922585|P4|NOT COMPLETED|Period 3||0
8079580|NCT03645434|19922586|P3|NOT COMPLETED|Period 3||0
8079581|NCT03645434|19922587|P2|NOT COMPLETED|Period 3||0
8079582|NCT03645434|19922588|P1|NOT COMPLETED|Period 3||0
8079583|NCT03645434|19922583|P6|COMPLETED|Period 3||11
8079584|NCT03645434|19922584|P5|COMPLETED|Period 3||11
8079585|NCT03645434|19922585|P4|COMPLETED|Period 3||10
8079586|NCT03645434|19922586|P3|COMPLETED|Period 3||11
8079587|NCT03645434|19922587|P2|COMPLETED|Period 3||13
8079588|NCT03645434|19922588|P1|COMPLETED|Period 3||10
8079589|NCT03645434|19922583|P6|STARTED|Period 3||11
8079590|NCT03645434|19922584|P5|STARTED|Period 3||11
8079591|NCT03645434|19922585|P4|STARTED|Period 3||10
8079592|NCT03645434|19922586|P3|STARTED|Period 3|2 subjects discontinued as they did not meet FEV1 stability criteria or pfts variability criteria.|11
8079593|NCT03645434|19922587|P2|STARTED|Period 3||13
8079594|NCT03645434|19922588|P1|STARTED|Period 3||10
8079595|NCT03645434|19922583|P6|NOT COMPLETED|Period 2||0
8079596|NCT03645434|19922584|P5|NOT COMPLETED|Period 2||0
8079597|NCT03645434|19922585|P4|NOT COMPLETED|Period 2||0
8079598|NCT03645434|19922586|P3|NOT COMPLETED|Period 2||0
8079599|NCT03645434|19922587|P2|NOT COMPLETED|Period 2||0
8079600|NCT03645434|19922588|P1|NOT COMPLETED|Period 2||0
8079601|NCT03645434|19922583|P6|COMPLETED|Period 2||11
8079602|NCT03645434|19922584|P5|COMPLETED|Period 2||11
8079603|NCT03645434|19922585|P4|COMPLETED|Period 2||10
8079604|NCT03645434|19922586|P3|COMPLETED|Period 2||13
8079605|NCT03645434|19922587|P2|COMPLETED|Period 2||13
8079606|NCT03645434|19922588|P1|COMPLETED|Period 2||10
8079607|NCT03645434|19922583|P6|STARTED|Period 2|1 subject completed Period 1 but not allowed to enter Period 2 due to physician decision.|11
8079608|NCT03645434|19922584|P5|STARTED|Period 2||11
8079609|NCT03645434|19922585|P4|STARTED|Period 2||10
8079610|NCT03645434|19922586|P3|STARTED|Period 2||13
8079611|NCT03645434|19922587|P2|STARTED|Period 2||13
8079612|NCT03645434|19922588|P1|STARTED|Period 2|2 subject discontinued as they did not meet stability or FEV1 variability.|10
8079613|NCT03645434|19922583|P6|NOT COMPLETED|Period 1||0
8079614|NCT03645434|19922584|P5|NOT COMPLETED|Period 1||1
8079615|NCT03645434|19922585|P4|NOT COMPLETED|Period 1||1
8079616|NCT03645434|19922586|P3|NOT COMPLETED|Period 1||0
8079617|NCT03645434|19922587|P2|NOT COMPLETED|Period 1||0
8079618|NCT03645434|19922588|P1|NOT COMPLETED|Period 1||0
8079619|NCT03645434|19922583|P6|COMPLETED|Period 1||12
8079620|NCT03645434|19922584|P5|COMPLETED|Period 1||11
8079621|NCT03645434|19922585|P4|COMPLETED|Period 1||10
8079622|NCT03645434|19922586|P3|COMPLETED|Period 1||13
8079623|NCT03645434|19922587|P2|COMPLETED|Period 1||13
8079624|NCT03645434|19922588|P1|COMPLETED|Period 1||12
8079625|NCT03645434|19922583|P6|STARTED|Period 1||12
8079626|NCT03645434|19922584|P5|STARTED|Period 1||12
8079627|NCT03645434|19922585|P4|STARTED|Period 1||11
8079628|NCT03645434|19922586|P3|STARTED|Period 1||13
8079629|NCT03645434|19922587|P2|STARTED|Period 1||13
8079630|NCT03645434|19922588|P1|STARTED|Period 1||12
8079631|NCT03645421|19922639|P4|NOT COMPLETED|Overall Study||4
8079632|NCT03645421|19922640|P3|NOT COMPLETED|Overall Study||5
8079633|NCT03645421|19922641|P2|NOT COMPLETED|Overall Study||0
8079634|NCT03645421|19922642|P1|NOT COMPLETED|Overall Study||0
8079635|NCT03645421|19922639|P4|COMPLETED|Overall Study||11
8079636|NCT03645421|19922640|P3|COMPLETED|Overall Study||10
8079637|NCT03645421|19922641|P2|COMPLETED|Overall Study||15
8079638|NCT03645421|19922642|P1|COMPLETED|Overall Study||16
8079639|NCT03645421|19922639|P4|Received Investigational Product (IP)|Overall Study||15
8079640|NCT03645421|19922640|P3|Received Investigational Product (IP)|Overall Study||15
8079641|NCT03645421|19922641|P2|Received Investigational Product (IP)|Overall Study||15
8079642|NCT03645421|19922642|P1|Received Investigational Product (IP)|Overall Study||16
8079643|NCT03645421|19922639|P4|STARTED|Overall Study||15
8079644|NCT03645421|19922640|P3|STARTED|Overall Study||15
8079645|NCT03645421|19922641|P2|STARTED|Overall Study||15
8079646|NCT03645421|19922642|P1|STARTED|Overall Study||16
8079647|NCT03644212|19922708|P2|NOT COMPLETED|Overall Study||0
8079648|NCT03644212|19922709|P1|NOT COMPLETED|Overall Study||0
8079649|NCT03644212|19922708|P2|COMPLETED|Overall Study||16
8079650|NCT03644212|19922709|P1|COMPLETED|Overall Study||63
8079651|NCT03644212|19922708|P2|STARTED|Overall Study||16
8079652|NCT03644212|19922709|P1|STARTED|Overall Study||63
8079653|NCT03644108|19922715|P1|NOT COMPLETED|Overall Study||0
8079654|NCT03644108|19922715|P1|COMPLETED|Overall Study||30
8079655|NCT03644108|19922715|P1|STARTED|Overall Study||30
8079656|NCT03644095|19922726|P2|NOT COMPLETED|Period 2||0
8079657|NCT03644095|19922727|P1|NOT COMPLETED|Period 2||0
8079658|NCT03644095|19922726|P2|COMPLETED|Period 2||15
8079659|NCT03644095|19922727|P1|COMPLETED|Period 2||15
8079660|NCT03644095|19922726|P2|STARTED|Period 2||15
8079661|NCT03644095|19922727|P1|STARTED|Period 2||15
8079662|NCT03644095|19922726|P2|NOT COMPLETED|Washout (7 Days)||0
8079663|NCT03644095|19922727|P1|NOT COMPLETED|Washout (7 Days)||0
8079664|NCT03644095|19922726|P2|COMPLETED|Washout (7 Days)||15
8079665|NCT03644095|19922727|P1|COMPLETED|Washout (7 Days)||15
8079666|NCT03644095|19922726|P2|STARTED|Washout (7 Days)||15
8079667|NCT03644095|19922727|P1|STARTED|Washout (7 Days)||15
8079668|NCT03644095|19922726|P2|NOT COMPLETED|Period 1||0
8079669|NCT03644095|19922727|P1|NOT COMPLETED|Period 1||0
8079670|NCT03644095|19922726|P2|COMPLETED|Period 1||15
8079671|NCT03644095|19922727|P1|COMPLETED|Period 1||15
8079672|NCT03644095|19922726|P2|STARTED|Period 1||15
8079673|NCT03644095|19922727|P1|STARTED|Period 1||15
8079674|NCT03643692|19922747|P1|NOT COMPLETED|Overall Study||0
8079675|NCT03643692|19922747|P1|COMPLETED|Overall Study||12
8079676|NCT03643692|19922747|P1|STARTED|Overall Study||12
8079677|NCT03643575|19922751|P6|NOT COMPLETED|Period 3||0
8079678|NCT03643575|19922752|P5|NOT COMPLETED|Period 3||0
8079679|NCT03643575|19922753|P4|NOT COMPLETED|Period 3||0
8079680|NCT03643575|19922754|P3|NOT COMPLETED|Period 3||0
8079681|NCT03643575|19922755|P2|NOT COMPLETED|Period 3||0
8079682|NCT03643575|19922756|P1|NOT COMPLETED|Period 3||0
8079683|NCT03643575|19922751|P6|COMPLETED|Period 3||5
8079684|NCT03643575|19922752|P5|COMPLETED|Period 3||5
8079685|NCT03643575|19922753|P4|COMPLETED|Period 3||4
8079686|NCT03643575|19922754|P3|COMPLETED|Period 3||5
8079687|NCT03643575|19922755|P2|COMPLETED|Period 3||4
8079688|NCT03643575|19922756|P1|COMPLETED|Period 3||4
8079689|NCT03643575|19922751|P6|STARTED|Period 3||5
8079690|NCT03643575|19922752|P5|STARTED|Period 3||5
8079691|NCT03643575|19922753|P4|STARTED|Period 3||4
8079692|NCT03643575|19922754|P3|STARTED|Period 3||5
8079693|NCT03643575|19922755|P2|STARTED|Period 3||4
8079694|NCT03643575|19922756|P1|STARTED|Period 3||4
8079695|NCT03643575|19922751|P6|NOT COMPLETED|Washout: 7 Days||0
8079696|NCT03643575|19922752|P5|NOT COMPLETED|Washout: 7 Days||0
8079697|NCT03643575|19922753|P4|NOT COMPLETED|Washout: 7 Days||0
8079698|NCT03643575|19922754|P3|NOT COMPLETED|Washout: 7 Days||0
8079699|NCT03643575|19922755|P2|NOT COMPLETED|Washout: 7 Days||1
8079700|NCT03643575|19922756|P1|NOT COMPLETED|Washout: 7 Days||0
8079701|NCT03643575|19922751|P6|COMPLETED|Washout: 7 Days||5
8079702|NCT03643575|19922752|P5|COMPLETED|Washout: 7 Days||5
8079703|NCT03643575|19922753|P4|COMPLETED|Washout: 7 Days||4
8079704|NCT03643575|19922754|P3|COMPLETED|Washout: 7 Days||5
8079705|NCT03643575|19922755|P2|COMPLETED|Washout: 7 Days||4
8079706|NCT03643575|19922756|P1|COMPLETED|Washout: 7 Days||4
8079707|NCT03643575|19922751|P6|STARTED|Washout: 7 Days||5
8079708|NCT03643575|19922752|P5|STARTED|Washout: 7 Days||5
8079709|NCT03643575|19922753|P4|STARTED|Washout: 7 Days||4
8079710|NCT03643575|19922754|P3|STARTED|Washout: 7 Days||5
8079711|NCT03643575|19922755|P2|STARTED|Washout: 7 Days||5
8079712|NCT03643575|19922756|P1|STARTED|Washout: 7 Days||4
8079713|NCT03643575|19922751|P6|NOT COMPLETED|Period 2||0
8079714|NCT03643575|19922752|P5|NOT COMPLETED|Period 2||0
8079715|NCT03643575|19922753|P4|NOT COMPLETED|Period 2||0
8079716|NCT03643575|19922754|P3|NOT COMPLETED|Period 2||0
8079717|NCT03643575|19922755|P2|NOT COMPLETED|Period 2||0
8079718|NCT03643575|19922756|P1|NOT COMPLETED|Period 2||0
8079719|NCT03643575|19922751|P6|COMPLETED|Period 2||5
8079720|NCT03643575|19922752|P5|COMPLETED|Period 2||5
8079721|NCT03643575|19922753|P4|COMPLETED|Period 2||4
8079722|NCT03643575|19922754|P3|COMPLETED|Period 2||5
8079723|NCT03643575|19922755|P2|COMPLETED|Period 2||5
8079724|NCT03643575|19922756|P1|COMPLETED|Period 2||4
8079725|NCT03643575|19922751|P6|STARTED|Period 2||5
8079726|NCT03643575|19922752|P5|STARTED|Period 2||5
8079727|NCT03643575|19922753|P4|STARTED|Period 2||4
8079728|NCT03643575|19922754|P3|STARTED|Period 2||5
8079729|NCT03643575|19922755|P2|STARTED|Period 2||5
8079730|NCT03643575|19922756|P1|STARTED|Period 2||4
8079731|NCT03643575|19922751|P6|NOT COMPLETED|Washout: 7 Days||0
8079732|NCT03643575|19922752|P5|NOT COMPLETED|Washout: 7 Days||0
8079733|NCT03643575|19922753|P4|NOT COMPLETED|Washout: 7 Days||1
8079734|NCT03643575|19922754|P3|NOT COMPLETED|Washout: 7 Days||0
8079735|NCT03643575|19922755|P2|NOT COMPLETED|Washout: 7 Days||0
8079736|NCT03643575|19922756|P1|NOT COMPLETED|Washout: 7 Days||1
8079737|NCT03643575|19922751|P6|COMPLETED|Washout: 7 Days||5
8079738|NCT03643575|19922752|P5|COMPLETED|Washout: 7 Days||5
8079739|NCT03643575|19922753|P4|COMPLETED|Washout: 7 Days||4
8079740|NCT03643575|19922754|P3|COMPLETED|Washout: 7 Days||5
8079741|NCT03643575|19922755|P2|COMPLETED|Washout: 7 Days||5
8079742|NCT03643575|19922756|P1|COMPLETED|Washout: 7 Days||4
8079743|NCT03643575|19922751|P6|STARTED|Washout: 7 Days||5
8079744|NCT03643575|19922752|P5|STARTED|Washout: 7 Days||5
8079745|NCT03643575|19922753|P4|STARTED|Washout: 7 Days||5
8079746|NCT03643575|19922754|P3|STARTED|Washout: 7 Days||5
8079747|NCT03643575|19922755|P2|STARTED|Washout: 7 Days||5
8079748|NCT03643575|19922756|P1|STARTED|Washout: 7 Days||5
8079749|NCT03643575|19922751|P6|NOT COMPLETED|Period 1||0
8079750|NCT03643575|19922752|P5|NOT COMPLETED|Period 1||0
8079751|NCT03643575|19922753|P4|NOT COMPLETED|Period 1||0
8079752|NCT03643575|19922754|P3|NOT COMPLETED|Period 1||0
8079753|NCT03643575|19922755|P2|NOT COMPLETED|Period 1||0
8079754|NCT03643575|19922756|P1|NOT COMPLETED|Period 1||0
8079755|NCT03643575|19922751|P6|COMPLETED|Period 1||5
8079756|NCT03643575|19922752|P5|COMPLETED|Period 1||5
8079757|NCT03643575|19922753|P4|COMPLETED|Period 1||5
8079758|NCT03643575|19922754|P3|COMPLETED|Period 1||5
8079759|NCT03643575|19922755|P2|COMPLETED|Period 1||5
8079760|NCT03643575|19922756|P1|COMPLETED|Period 1||5
8079761|NCT03643575|19922751|P6|STARTED|Period 1||5
8079762|NCT03643575|19922752|P5|STARTED|Period 1||5
8079763|NCT03643575|19922753|P4|STARTED|Period 1||5
8079764|NCT03643575|19922754|P3|STARTED|Period 1||5
8079765|NCT03643575|19922755|P2|STARTED|Period 1||5
8079766|NCT03643575|19922756|P1|STARTED|Period 1||5
8079767|NCT03643432|19922814|P2|NOT COMPLETED|Overall Study||0
8079768|NCT03643432|19922815|P1|NOT COMPLETED|Overall Study||1
8079769|NCT03643432|19922814|P2|COMPLETED|Overall Study||21
8079770|NCT03643432|19922815|P1|COMPLETED|Overall Study||26
8079771|NCT03643432|19922814|P2|STARTED|Overall Study||21
8079772|NCT03643432|19922815|P1|STARTED|Overall Study||27
8079773|NCT03643159|19922839|P1|NOT COMPLETED|Overall Study||2
8079774|NCT03643159|19922839|P1|COMPLETED|Overall Study||0
8079775|NCT03643159|19922839|P1|Received At Least 1 Dose Of Study Drug|Overall Study||2
8079776|NCT03643159|19922839|P1|STARTED|Overall Study||2
8079777|NCT03642873|19922846|P6|NOT COMPLETED|Third Intervention (1 Day)||0
8079778|NCT03642873|19922847|P5|NOT COMPLETED|Third Intervention (1 Day)||1
8079779|NCT03642873|19922848|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8079780|NCT03642873|19922849|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8079781|NCT03642873|19922850|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8079782|NCT03642873|19922851|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8079783|NCT03642873|19922846|P6|COMPLETED|Third Intervention (1 Day)||4
8079784|NCT03642873|19922847|P5|COMPLETED|Third Intervention (1 Day)||3
8079785|NCT03642873|19922848|P4|COMPLETED|Third Intervention (1 Day)||4
8079786|NCT03642873|19922849|P3|COMPLETED|Third Intervention (1 Day)||4
8079787|NCT03642873|19922850|P2|COMPLETED|Third Intervention (1 Day)||4
8079788|NCT03642873|19922851|P1|COMPLETED|Third Intervention (1 Day)||4
8079789|NCT03642873|19922846|P6|STARTED|Third Intervention (1 Day)||4
8079790|NCT03642873|19922847|P5|STARTED|Third Intervention (1 Day)||4
8079791|NCT03642873|19922848|P4|STARTED|Third Intervention (1 Day)||4
8079792|NCT03642873|19922849|P3|STARTED|Third Intervention (1 Day)||4
8079793|NCT03642873|19922850|P2|STARTED|Third Intervention (1 Day)||4
8079794|NCT03642873|19922851|P1|STARTED|Third Intervention (1 Day)||4
8079795|NCT03642873|19922846|P6|NOT COMPLETED|Washout (7 Days)||0
8079796|NCT03642873|19922847|P5|NOT COMPLETED|Washout (7 Days)||0
8079797|NCT03642873|19922848|P4|NOT COMPLETED|Washout (7 Days)||0
8079798|NCT03642873|19922849|P3|NOT COMPLETED|Washout (7 Days)||0
8079799|NCT03642873|19922850|P2|NOT COMPLETED|Washout (7 Days)||0
8079800|NCT03642873|19922851|P1|NOT COMPLETED|Washout (7 Days)||0
8079801|NCT03642873|19922846|P6|COMPLETED|Washout (7 Days)||4
8079802|NCT03642873|19922847|P5|COMPLETED|Washout (7 Days)||4
8079803|NCT03642873|19922848|P4|COMPLETED|Washout (7 Days)||4
8079804|NCT03642873|19922849|P3|COMPLETED|Washout (7 Days)||4
8079805|NCT03642873|19922850|P2|COMPLETED|Washout (7 Days)||4
8079806|NCT03642873|19922851|P1|COMPLETED|Washout (7 Days)||4
8079807|NCT03642873|19922846|P6|STARTED|Washout (7 Days)||4
8079808|NCT03642873|19922847|P5|STARTED|Washout (7 Days)||4
8079809|NCT03642873|19922848|P4|STARTED|Washout (7 Days)||4
8079810|NCT03642873|19922849|P3|STARTED|Washout (7 Days)||4
8079811|NCT03642873|19922850|P2|STARTED|Washout (7 Days)||4
8079812|NCT03642873|19922851|P1|STARTED|Washout (7 Days)||4
8079813|NCT03642873|19922846|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8079814|NCT03642873|19922847|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8079815|NCT03642873|19922848|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8079816|NCT03642873|19922849|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8079817|NCT03642873|19922850|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8079818|NCT03642873|19922851|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8079819|NCT03642873|19922846|P6|COMPLETED|Second Intervention (1 Day)||4
8079820|NCT03642873|19922847|P5|COMPLETED|Second Intervention (1 Day)||4
8079821|NCT03642873|19922848|P4|COMPLETED|Second Intervention (1 Day)||4
8079822|NCT03642873|19922849|P3|COMPLETED|Second Intervention (1 Day)||4
8079823|NCT03642873|19922850|P2|COMPLETED|Second Intervention (1 Day)||4
8079824|NCT03642873|19922851|P1|COMPLETED|Second Intervention (1 Day)||4
8079825|NCT03642873|19922846|P6|STARTED|Second Intervention (1 Day)||4
8079826|NCT03642873|19922847|P5|STARTED|Second Intervention (1 Day)||4
8079827|NCT03642873|19922848|P4|STARTED|Second Intervention (1 Day)||4
8079828|NCT03642873|19922849|P3|STARTED|Second Intervention (1 Day)||4
8079829|NCT03642873|19922850|P2|STARTED|Second Intervention (1 Day)||4
8079830|NCT03642873|19922851|P1|STARTED|Second Intervention (1 Day)||4
8079831|NCT03642873|19922846|P6|NOT COMPLETED|Washout (7 Days)||0
8079832|NCT03642873|19922847|P5|NOT COMPLETED|Washout (7 Days)||0
8079833|NCT03642873|19922848|P4|NOT COMPLETED|Washout (7 Days)||0
8079834|NCT03642873|19922849|P3|NOT COMPLETED|Washout (7 Days)||0
8079835|NCT03642873|19922850|P2|NOT COMPLETED|Washout (7 Days)||0
8079836|NCT03642873|19922851|P1|NOT COMPLETED|Washout (7 Days)||0
8079837|NCT03642873|19922846|P6|COMPLETED|Washout (7 Days)||4
8079838|NCT03642873|19922847|P5|COMPLETED|Washout (7 Days)||4
8079839|NCT03642873|19922848|P4|COMPLETED|Washout (7 Days)||4
8079840|NCT03642873|19922849|P3|COMPLETED|Washout (7 Days)||4
8079841|NCT03642873|19922850|P2|COMPLETED|Washout (7 Days)||4
8079842|NCT03642873|19922851|P1|COMPLETED|Washout (7 Days)||4
8079843|NCT03642873|19922846|P6|STARTED|Washout (7 Days)||4
8079844|NCT03642873|19922847|P5|STARTED|Washout (7 Days)||4
8079845|NCT03642873|19922848|P4|STARTED|Washout (7 Days)||4
8079846|NCT03642873|19922849|P3|STARTED|Washout (7 Days)||4
8079847|NCT03642873|19922850|P2|STARTED|Washout (7 Days)||4
8079848|NCT03642873|19922851|P1|STARTED|Washout (7 Days)||4
8079849|NCT03642873|19922846|P6|NOT COMPLETED|First Intervention (1 Day)||0
8079850|NCT03642873|19922847|P5|NOT COMPLETED|First Intervention (1 Day)||0
8079851|NCT03642873|19922848|P4|NOT COMPLETED|First Intervention (1 Day)||0
8079852|NCT03642873|19922849|P3|NOT COMPLETED|First Intervention (1 Day)||0
8079853|NCT03642873|19922850|P2|NOT COMPLETED|First Intervention (1 Day)||0
8079854|NCT03642873|19922851|P1|NOT COMPLETED|First Intervention (1 Day)||0
8079855|NCT03642873|19922846|P6|COMPLETED|First Intervention (1 Day)||4
8079856|NCT03642873|19922847|P5|COMPLETED|First Intervention (1 Day)||4
8079857|NCT03642873|19922848|P4|COMPLETED|First Intervention (1 Day)||4
8079858|NCT03642873|19922849|P3|COMPLETED|First Intervention (1 Day)||4
8079859|NCT03642873|19922850|P2|COMPLETED|First Intervention (1 Day)||4
8079860|NCT03642873|19922851|P1|COMPLETED|First Intervention (1 Day)||4
8079861|NCT03642873|19922846|P6|STARTED|First Intervention (1 Day)||4
8079862|NCT03642873|19922847|P5|STARTED|First Intervention (1 Day)||4
8079863|NCT03642873|19922848|P4|STARTED|First Intervention (1 Day)||4
8079864|NCT03642873|19922849|P3|STARTED|First Intervention (1 Day)||4
8079865|NCT03642873|19922850|P2|STARTED|First Intervention (1 Day)||4
8079866|NCT03642873|19922851|P1|STARTED|First Intervention (1 Day)||4
8079867|NCT03642457|19922885|P2|NOT COMPLETED|Overall Study||0
8079868|NCT03642457|19922886|P1|NOT COMPLETED|Overall Study||0
8079869|NCT03642457|19922885|P2|COMPLETED|Overall Study||30
8079870|NCT03642457|19922886|P1|COMPLETED|Overall Study||35
8079871|NCT03642457|19922885|P2|STARTED|Overall Study||30
8079872|NCT03642457|19922886|P1|STARTED|Overall Study||35
8079873|NCT03642262|19922902|P2|NOT COMPLETED|Period 2||0
8079874|NCT03642262|19922903|P1|NOT COMPLETED|Period 2||0
8079875|NCT03642262|19922902|P2|COMPLETED|Period 2||16
8079876|NCT03642262|19922903|P1|COMPLETED|Period 2||11
8079877|NCT03642262|19922902|P2|STARTED|Period 2||16
8079878|NCT03642262|19922903|P1|STARTED|Period 2||11
8079879|NCT03642262|19922902|P2|NOT COMPLETED|Washout: 7 Days||0
8079880|NCT03642262|19922903|P1|NOT COMPLETED|Washout: 7 Days||0
8079881|NCT03642262|19922902|P2|COMPLETED|Washout: 7 Days||16
8079882|NCT03642262|19922903|P1|COMPLETED|Washout: 7 Days||11
8079883|NCT03642262|19922902|P2|STARTED|Washout: 7 Days||16
8079884|NCT03642262|19922903|P1|STARTED|Washout: 7 Days||11
8079885|NCT03642262|19922902|P2|NOT COMPLETED|Period 1||2
8079886|NCT03642262|19922903|P1|NOT COMPLETED|Period 1||1
8079887|NCT03642262|19922902|P2|COMPLETED|Period 1||16
8079888|NCT03642262|19922903|P1|COMPLETED|Period 1||11
8079889|NCT03642262|19922902|P2|STARTED|Period 1||18
8079890|NCT03642262|19922903|P1|STARTED|Period 1||12
8079891|NCT03641508|19922924|P2|NOT COMPLETED|Follow-up/Second Injection||0
8079892|NCT03641508|19922925|P1|NOT COMPLETED|Follow-up/Second Injection||0
8079893|NCT03641508|19922924|P2|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
8079894|NCT03641508|19922925|P1|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2
8079895|NCT03641508|19922924|P2|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
8079896|NCT03641508|19922925|P1|STARTED|Follow-up/Second Injection||2
8079897|NCT03641508|19922924|P2|NOT COMPLETED|First Injection||0
8079898|NCT03641508|19922925|P1|NOT COMPLETED|First Injection||2
8079899|NCT03641508|19922924|P2|COMPLETED|First Injection||32
8079900|NCT03641508|19922925|P1|COMPLETED|First Injection||35
8079901|NCT03641508|19922924|P2|STARTED|First Injection||32
8079902|NCT03641508|19922925|P1|STARTED|First Injection||37
8079903|NCT03640832|19922937|P2|NOT COMPLETED|Overall Study||0
8079904|NCT03640832|19922938|P1|NOT COMPLETED|Overall Study||0
8079905|NCT03640832|19922937|P2|COMPLETED|Overall Study||46
8079906|NCT03640832|19922938|P1|COMPLETED|Overall Study||44
8079907|NCT03640832|19922937|P2|STARTED|Overall Study||46
8079908|NCT03640832|19922938|P1|STARTED|Overall Study||44
8079909|NCT03640559|19922952|P2|NOT COMPLETED|Overall Study||1
8079910|NCT03640559|19922953|P1|NOT COMPLETED|Overall Study||2
8079911|NCT03640559|19922952|P2|COMPLETED|Overall Study||24
8079912|NCT03640559|19922953|P1|COMPLETED|Overall Study||23
8079913|NCT03640559|19922952|P2|STARTED|Overall Study||25
8079914|NCT03640559|19922953|P1|STARTED|Overall Study||25
8079915|NCT03640507|19922962|P3|NOT COMPLETED|Overall Study||1
8079916|NCT03640507|19922963|P2|NOT COMPLETED|Overall Study||0
8079917|NCT03640507|19922964|P1|NOT COMPLETED|Overall Study||0
8079918|NCT03640507|19922962|P3|COMPLETED|Overall Study||10
8079919|NCT03640507|19922963|P2|COMPLETED|Overall Study||9
8079920|NCT03640507|19922964|P1|COMPLETED|Overall Study||10
8079921|NCT03640507|19922962|P3|STARTED|Overall Study||11
8079922|NCT03640507|19922963|P2|STARTED|Overall Study||9
8079923|NCT03640507|19922964|P1|STARTED|Overall Study||10
8079924|NCT03640052|19922984|P5|NOT COMPLETED|Overall Study||0
8079925|NCT03640052|19922985|P4|NOT COMPLETED|Overall Study||0
8079926|NCT03640052|19922986|P3|NOT COMPLETED|Overall Study||0
8079927|NCT03640052|19922987|P2|NOT COMPLETED|Overall Study||1
8079928|NCT03640052|19922988|P1|NOT COMPLETED|Overall Study||0
8079929|NCT03640052|19922984|P5|COMPLETED|Overall Study||1
8079930|NCT03640052|19922985|P4|COMPLETED|Overall Study||1
8079931|NCT03640052|19922986|P3|COMPLETED|Overall Study||1
8079932|NCT03640052|19922987|P2|COMPLETED|Overall Study|the patient performed 4 out of 5 nights|0
8079933|NCT03640052|19922988|P1|COMPLETED|Overall Study||2
8079934|NCT03640052|19922984|P5|STARTED|Overall Study||1
8079935|NCT03640052|19922985|P4|STARTED|Overall Study||1
8079936|NCT03640052|19922986|P3|STARTED|Overall Study||1
8079937|NCT03640052|19922987|P2|STARTED|Overall Study||1
8079938|NCT03640052|19922988|P1|STARTED|Overall Study||2
8079939|NCT03639675|19923005|P1|NOT COMPLETED|Overall Study||1
8079940|NCT03639675|19923005|P1|COMPLETED|Overall Study||15
8079941|NCT03639675|19923005|P1|Received Treatment|Overall Study||16
8079942|NCT03639675|19923005|P1|STARTED|Overall Study||16
8079949|NCT03638908|19923095|P1|NOT COMPLETED|Overall Study||1
8079950|NCT03638908|19923095|P1|COMPLETED|Overall Study||7
8079951|NCT03638908|19923095|P1|STARTED|Overall Study||8
8079952|NCT03638635|19923112|P2|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22
8079953|NCT03638635|19923113|P1|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39
8079954|NCT03638635|19923112|P2|COMPLETED|Follow-Up (30 Days After Discharge)||0
8079955|NCT03638635|19923113|P1|COMPLETED|Follow-Up (30 Days After Discharge)||0
8079956|NCT03638635|19923112|P2|STARTED|Follow-Up (30 Days After Discharge)||22
8079957|NCT03638635|19923113|P1|STARTED|Follow-Up (30 Days After Discharge)||39
8079958|NCT03638635|19923112|P2|NOT COMPLETED|Initial Hospitalization||2
8079959|NCT03638635|19923113|P1|NOT COMPLETED|Initial Hospitalization||0
8079960|NCT03638635|19923112|P2|COMPLETED|Initial Hospitalization||22
8079961|NCT03638635|19923113|P1|COMPLETED|Initial Hospitalization||39
8079962|NCT03638635|19923112|P2|STARTED|Initial Hospitalization||24
8079963|NCT03638635|19923113|P1|STARTED|Initial Hospitalization||39
8079964|NCT03638323|19923143|P1|NOT COMPLETED|Overall Study||1
8079965|NCT03638323|19923143|P1|COMPLETED|Overall Study||37
8079966|NCT03638323|19923143|P1|STARTED|Overall Study||38
8079967|NCT03637517|19923167|P3|NOT COMPLETED|Overall Study||0
8079968|NCT03637517|19923168|P2|NOT COMPLETED|Overall Study||0
8079969|NCT03637517|19923169|P1|NOT COMPLETED|Overall Study||0
8079970|NCT03637517|19923167|P3|COMPLETED|Overall Study||14
8079971|NCT03637517|19923168|P2|COMPLETED|Overall Study||14
8079972|NCT03637517|19923169|P1|COMPLETED|Overall Study||14
8079973|NCT03637517|19923167|P3|STARTED|Overall Study||14
8079974|NCT03637517|19923168|P2|STARTED|Overall Study||14
8079975|NCT03637517|19923169|P1|STARTED|Overall Study||14
8079976|NCT03637348|19923195|P1|NOT COMPLETED|Overall Study||0
8079977|NCT03637348|19923195|P1|COMPLETED|Overall Study||45
8079978|NCT03637348|19923195|P1|STARTED|Overall Study||45
8079979|NCT03636893|19923202|P2|NOT COMPLETED|Overall Study||10
8079980|NCT03636893|19923203|P1|NOT COMPLETED|Overall Study||9
8079981|NCT03636893|19923202|P2|COMPLETED|Overall Study||24
8079982|NCT03636893|19923203|P1|COMPLETED|Overall Study||31
8079983|NCT03636893|19923202|P2|STARTED|Overall Study||34
8079984|NCT03636893|19923203|P1|STARTED|Overall Study||40
8079985|NCT03636386|19923211|P2|NOT COMPLETED|Overall Study||0
8079986|NCT03636386|19923212|P1|NOT COMPLETED|Overall Study||0
8079987|NCT03636386|19923211|P2|COMPLETED|Overall Study||24
8079988|NCT03636386|19923212|P1|COMPLETED|Overall Study||24
8079989|NCT03636386|19923211|P2|STARTED|Overall Study||24
8079990|NCT03636386|19923212|P1|STARTED|Overall Study||24
8080003|NCT03634579|19923252|P1|NOT COMPLETED|Overall Study||9
8080004|NCT03634579|19923252|P1|COMPLETED|Overall Study||0
8080005|NCT03634579|19923252|P1|STARTED|Overall Study||9
8080006|NCT03634306|19923263|P3|NOT COMPLETED|Overall Study||0
8080007|NCT03634306|19923264|P2|NOT COMPLETED|Overall Study||0
8080008|NCT03634306|19923265|P1|NOT COMPLETED|Overall Study||0
8080009|NCT03634306|19923263|P3|COMPLETED|Overall Study||5
8080010|NCT03634306|19923264|P2|COMPLETED|Overall Study||15
8080011|NCT03634306|19923265|P1|COMPLETED|Overall Study||15
8080012|NCT03634306|19923263|P3|STARTED|Overall Study||5
8080013|NCT03634306|19923264|P2|STARTED|Overall Study||15
8080014|NCT03634306|19923265|P1|STARTED|Overall Study||15
8080015|NCT03634085|19923350|P2|NOT COMPLETED|Overall Study||2
8080016|NCT03634085|19923351|P1|NOT COMPLETED|Overall Study||1
8080017|NCT03634085|19923350|P2|COMPLETED|Overall Study|"1 subject dropped out due to personal emergency
~1 subject dropped out due to personal circumstances"|6
8080018|NCT03634085|19923351|P1|COMPLETED|Overall Study|1 subject dropped out due to car accident|7
8080019|NCT03634085|19923350|P2|Period 4|Overall Study|this period is not applicable for Cohort B|0
8080020|NCT03634085|19923351|P1|Period 4|Overall Study|8 subjects started BDM2 - 3100 mg and 7 subjects completed BDM2 - 3100 mg (drop out; 1 active)|8
8080021|NCT03634085|19923350|P2|Period 3|Overall Study|8 subjects started and 6 subjects completed BDM2 - 900 mg fed (dropout; 1 active 1 placebo)|8
8080022|NCT03634085|19923351|P1|Period 3|Overall Study|8 subjects started BDM2 - 1800 mg and 7 subjects completed BDM2 - 1800 mg (drop out; 1 active)|8
8080023|NCT03634085|19923350|P2|Period 2|Overall Study|8 subjects started BDM2 - 900 mg fasted and 8 subjects completed BDM2 - 900 mg fasted|8
8080024|NCT03634085|19923351|P1|Period 2|Overall Study|8 subjects started BDM2 - 450 mg and 7 subjects completed BDM2 - 450 mg (drop out; 1 active)|8
8080025|NCT03634085|19923350|P2|Period 1|Overall Study|8 subjects started BDM2 - 150mg and 8 subjects completed BDM2 - 150 mg including matching placebo|8
8080026|NCT03634085|19923351|P1|Period 1|Overall Study|8 subjects started BDM2-50 mg and 8 subjects completed BDM2-50 mg including matching placebo.|8
8080027|NCT03634085|19923350|P2|STARTED|Overall Study||8
8080028|NCT03634085|19923351|P1|STARTED|Overall Study||8
8080029|NCT03633825|19923366|P2|NOT COMPLETED|Analysis||0
8080030|NCT03633825|19923367|P1|NOT COMPLETED|Analysis||0
8080031|NCT03633825|19923366|P2|COMPLETED|Analysis||325
8080032|NCT03633825|19923367|P1|COMPLETED|Analysis||327
8080033|NCT03633825|19923366|P2|STARTED|Analysis||325
8080034|NCT03633825|19923367|P1|STARTED|Analysis||327
8080035|NCT03633825|19923366|P2|NOT COMPLETED|Follow up||450
8080036|NCT03633825|19923367|P1|NOT COMPLETED|Follow up||478
8080037|NCT03633825|19923366|P2|COMPLETED|Follow up||325
8080038|NCT03633825|19923367|P1|COMPLETED|Follow up||327
8080039|NCT03633825|19923366|P2|STARTED|Follow up||775
8080040|NCT03633825|19923367|P1|STARTED|Follow up||805
8080041|NCT03633825|19923366|P2|NOT COMPLETED|Allocation||0
8080042|NCT03633825|19923367|P1|NOT COMPLETED|Allocation||0
8080043|NCT03633825|19923366|P2|COMPLETED|Allocation||775
8080044|NCT03633825|19923367|P1|COMPLETED|Allocation||805
8080045|NCT03633825|19923366|P2|STARTED|Allocation||775
8080046|NCT03633825|19923367|P1|STARTED|Allocation||805
8080047|NCT03633825|19923366|P2|NOT COMPLETED|Enrollment||18837
8080048|NCT03633825|19923367|P1|NOT COMPLETED|Enrollment||19033
8080049|NCT03633825|19923366|P2|COMPLETED|Enrollment||775
8080050|NCT03633825|19923367|P1|COMPLETED|Enrollment||805
8080051|NCT03633825|19923366|P2|STARTED|Enrollment||19612
8080052|NCT03633825|19923367|P1|STARTED|Enrollment||19838
8080053|NCT03633526|19923375|P1|NOT COMPLETED|Overall Study||0
8080054|NCT03633526|19923375|P1|COMPLETED|Overall Study||16
8080055|NCT03633526|19923375|P1|STARTED|Overall Study||16
8080056|NCT03633487|19923385|P1|NOT COMPLETED|Overall Study||0
8080057|NCT03633487|19923385|P1|COMPLETED|Overall Study||24
8080058|NCT03633487|19923385|P1|STARTED|Overall Study||24
8080059|NCT03633448|19923399|P2|NOT COMPLETED|Period 2 (1 Day)||0
8080060|NCT03633448|19923400|P1|NOT COMPLETED|Period 2 (1 Day)||0
8080061|NCT03633448|19923399|P2|COMPLETED|Period 2 (1 Day)||12
8080062|NCT03633448|19923400|P1|COMPLETED|Period 2 (1 Day)||12
8080063|NCT03633448|19923399|P2|STARTED|Period 2 (1 Day)||12
8080064|NCT03633448|19923400|P1|STARTED|Period 2 (1 Day)||12
8080065|NCT03633448|19923399|P2|NOT COMPLETED|Washout (7 Days)||0
8080066|NCT03633448|19923400|P1|NOT COMPLETED|Washout (7 Days)||0
8080067|NCT03633448|19923399|P2|COMPLETED|Washout (7 Days)||12
8080068|NCT03633448|19923400|P1|COMPLETED|Washout (7 Days)||12
8080069|NCT03633448|19923399|P2|STARTED|Washout (7 Days)||12
8080070|NCT03633448|19923400|P1|STARTED|Washout (7 Days)||12
8080071|NCT03633448|19923399|P2|NOT COMPLETED|Period 1 (1 Day)||0
8080072|NCT03633448|19923400|P1|NOT COMPLETED|Period 1 (1 Day)||0
8080073|NCT03633448|19923399|P2|COMPLETED|Period 1 (1 Day)||12
8080074|NCT03633448|19923400|P1|COMPLETED|Period 1 (1 Day)||12
8080075|NCT03633448|19923399|P2|STARTED|Period 1 (1 Day)||12
8080076|NCT03633448|19923400|P1|STARTED|Period 1 (1 Day)||12
8080077|NCT03633344|19923440|P2|NOT COMPLETED|Overall Study||0
8080078|NCT03633344|19923441|P1|NOT COMPLETED|Overall Study||0
8080079|NCT03633344|19923440|P2|COMPLETED|Overall Study||24
8080080|NCT03633344|19923441|P1|COMPLETED|Overall Study||120
8080081|NCT03633344|19923440|P2|STARTED|Overall Study||24
8080082|NCT03633344|19923441|P1|STARTED|Overall Study||120
8080083|NCT03633084|19923456|P3|NOT COMPLETED|Overall Study||0
8080084|NCT03633084|19923457|P2|NOT COMPLETED|Overall Study||0
8080085|NCT03633084|19923458|P1|NOT COMPLETED|Overall Study||0
8080086|NCT03633084|19923456|P3|COMPLETED|Overall Study||3
8080087|NCT03633084|19923457|P2|COMPLETED|Overall Study||3
8080088|NCT03633084|19923458|P1|COMPLETED|Overall Study||3
8080089|NCT03633084|19923456|P3|STARTED|Overall Study||3
8080090|NCT03633084|19923457|P2|STARTED|Overall Study||3
8080091|NCT03633084|19923458|P1|STARTED|Overall Study||3
8080092|NCT03632109|19923472|P1|NOT COMPLETED|Overall Study||0
8080093|NCT03632109|19923472|P1|COMPLETED|Overall Study||13
8080094|NCT03632109|19923472|P1|STARTED|Overall Study||13
8080095|NCT03632083|19923480|P8|NOT COMPLETED|Second Intervention||2
8080096|NCT03632083|19923481|P7|NOT COMPLETED|Second Intervention||0
8080097|NCT03632083|19923482|P6|NOT COMPLETED|Second Intervention||0
8080098|NCT03632083|19923483|P5|NOT COMPLETED|Second Intervention||0
8080099|NCT03632083|19923484|P4|NOT COMPLETED|Second Intervention||0
8080100|NCT03632083|19923485|P3|NOT COMPLETED|Second Intervention||0
8080101|NCT03632083|19923486|P2|NOT COMPLETED|Second Intervention||0
8080102|NCT03632083|19923487|P1|NOT COMPLETED|Second Intervention||0
8080103|NCT03632083|19923480|P8|COMPLETED|Second Intervention||5
8080104|NCT03632083|19923481|P7|COMPLETED|Second Intervention||7
8080105|NCT03632083|19923482|P6|COMPLETED|Second Intervention||9
8080106|NCT03632083|19923483|P5|COMPLETED|Second Intervention||9
8080107|NCT03632083|19923484|P4|COMPLETED|Second Intervention||7
8080108|NCT03632083|19923485|P3|COMPLETED|Second Intervention||7
8080109|NCT03632083|19923486|P2|COMPLETED|Second Intervention||5
8080110|NCT03632083|19923487|P1|COMPLETED|Second Intervention||5
8080111|NCT03632083|19923480|P8|STARTED|Second Intervention||7
8080112|NCT03632083|19923481|P7|STARTED|Second Intervention||7
8080113|NCT03632083|19923482|P6|STARTED|Second Intervention||9
8080114|NCT03632083|19923483|P5|STARTED|Second Intervention||9
8080115|NCT03632083|19923484|P4|STARTED|Second Intervention||7
8080116|NCT03632083|19923485|P3|STARTED|Second Intervention||7
8080117|NCT03632083|19923486|P2|STARTED|Second Intervention||5
8080118|NCT03632083|19923487|P1|STARTED|Second Intervention||5
8080119|NCT03632083|19923480|P8|NOT COMPLETED|First Intervention||0
8080120|NCT03632083|19923481|P7|NOT COMPLETED|First Intervention||0
8080121|NCT03632083|19923482|P6|NOT COMPLETED|First Intervention||0
8080122|NCT03632083|19923483|P5|NOT COMPLETED|First Intervention||0
8080123|NCT03632083|19923484|P4|NOT COMPLETED|First Intervention||0
8080124|NCT03632083|19923485|P3|NOT COMPLETED|First Intervention||0
8080125|NCT03632083|19923486|P2|NOT COMPLETED|First Intervention||0
8080126|NCT03632083|19923487|P1|NOT COMPLETED|First Intervention||0
8080127|NCT03632083|19923480|P8|COMPLETED|First Intervention||7
8080128|NCT03632083|19923481|P7|COMPLETED|First Intervention||7
8080129|NCT03632083|19923482|P6|COMPLETED|First Intervention||9
8080130|NCT03632083|19923483|P5|COMPLETED|First Intervention||9
8080131|NCT03632083|19923484|P4|COMPLETED|First Intervention||7
8080132|NCT03632083|19923485|P3|COMPLETED|First Intervention||7
8080133|NCT03632083|19923486|P2|COMPLETED|First Intervention||5
8080134|NCT03632083|19923487|P1|COMPLETED|First Intervention||5
8080135|NCT03632083|19923480|P8|STARTED|First Intervention||7
8080136|NCT03632083|19923481|P7|STARTED|First Intervention||7
8080137|NCT03632083|19923482|P6|STARTED|First Intervention||9
8080138|NCT03632083|19923483|P5|STARTED|First Intervention||9
8080139|NCT03632083|19923484|P4|STARTED|First Intervention||7
8080140|NCT03632083|19923485|P3|STARTED|First Intervention||7
8080141|NCT03632083|19923486|P2|STARTED|First Intervention||5
8080142|NCT03632083|19923487|P1|STARTED|First Intervention||5
8080143|NCT03631732|19923571|P2|NOT COMPLETED|Overall Study||153
8080144|NCT03631732|19923572|P1|NOT COMPLETED|Overall Study||300
8080145|NCT03631732|19923571|P2|COMPLETED|Overall Study||12
8080146|NCT03631732|19923572|P1|COMPLETED|Overall Study||31
8080147|NCT03631732|19923571|P2|STARTED|Overall Study||165
8080148|NCT03631732|19923572|P1|STARTED|Overall Study||331
8080149|NCT03630679|19923596|P2|NOT COMPLETED|Overall Study||12
8080150|NCT03630679|19923597|P1|NOT COMPLETED|Overall Study||7
8080151|NCT03630679|19923596|P2|COMPLETED|Overall Study||13
8080152|NCT03630679|19923597|P1|COMPLETED|Overall Study||13
8080153|NCT03630679|19923596|P2|STARTED|Overall Study||25
8080154|NCT03630679|19923597|P1|STARTED|Overall Study||20
8080155|NCT03630185|19923613|P2|NOT COMPLETED|Overall Study||4
8080156|NCT03630185|19923614|P1|NOT COMPLETED|Overall Study||4
8080157|NCT03630185|19923613|P2|COMPLETED|Overall Study||0
8080158|NCT03630185|19923614|P1|COMPLETED|Overall Study||0
8080159|NCT03630185|19923613|P2|6 Month Follow up|Overall Study||0
8080160|NCT03630185|19923614|P1|6 Month Follow up|Overall Study||0
8080161|NCT03630185|19923613|P2|90 Day Follow up|Overall Study||1
8080162|NCT03630185|19923614|P1|90 Day Follow up|Overall Study||0
8080163|NCT03630185|19923613|P2|30 Day Follow up|Overall Study||1
8080164|NCT03630185|19923614|P1|30 Day Follow up|Overall Study||1
8080165|NCT03630185|19923613|P2|STARTED|Overall Study||4
8080166|NCT03630185|19923614|P1|STARTED|Overall Study||4
8080179|NCT03630016|19923695|P1|NOT COMPLETED|Overall Study||1
8080180|NCT03630016|19923695|P1|COMPLETED|Overall Study||10
8080181|NCT03630016|19923695|P1|STARTED|Overall Study||11
8080182|NCT03629886|19923701|P2|NOT COMPLETED|Overall Study||180
8080183|NCT03629886|19923702|P1|NOT COMPLETED|Overall Study||0
8080184|NCT03629886|19923701|P2|COMPLETED|Overall Study||1686
8080185|NCT03629886|19923702|P1|COMPLETED|Overall Study||1671
8080186|NCT03629886|19923701|P2|STARTED|Overall Study||1866
8080187|NCT03629886|19923702|P1|STARTED|Overall Study||1671
8080188|NCT03629184|19923721|P2|NOT COMPLETED|Overall Study||1
8080189|NCT03629184|19923722|P1|NOT COMPLETED|Overall Study||3
8080190|NCT03629184|19923721|P2|COMPLETED|Overall Study||57
8080191|NCT03629184|19923722|P1|COMPLETED|Overall Study||112
8080192|NCT03629184|19923721|P2|STARTED|Overall Study||58
8080193|NCT03629184|19923722|P1|STARTED|Overall Study||115
8080194|NCT03629054|19923772|P2|NOT COMPLETED|Period 2 (4 Days)||1
8080195|NCT03629054|19923773|P1|NOT COMPLETED|Period 2 (4 Days)||0
8080196|NCT03629054|19923772|P2|COMPLETED|Period 2 (4 Days)||14
8080197|NCT03629054|19923773|P1|COMPLETED|Period 2 (4 Days)||15
8080198|NCT03629054|19923772|P2|Treated|Period 2 (4 Days)||14
8080199|NCT03629054|19923773|P1|Treated|Period 2 (4 Days)||15
8080200|NCT03629054|19923772|P2|STARTED|Period 2 (4 Days)|Started this period|15
8080201|NCT03629054|19923773|P1|STARTED|Period 2 (4 Days)|Started this period|15
8080202|NCT03629054|19923772|P2|NOT COMPLETED|Wasout Period (35 Days)||0
8080203|NCT03629054|19923773|P1|NOT COMPLETED|Wasout Period (35 Days)||0
8080204|NCT03629054|19923772|P2|COMPLETED|Wasout Period (35 Days)||15
8080205|NCT03629054|19923773|P1|COMPLETED|Wasout Period (35 Days)||15
8080206|NCT03629054|19923772|P2|STARTED|Wasout Period (35 Days)|Started this period|15
8080207|NCT03629054|19923773|P1|STARTED|Wasout Period (35 Days)|Started this period|15
8080208|NCT03629054|19923772|P2|NOT COMPLETED|Period 1 (4 Days)||0
8080209|NCT03629054|19923773|P1|NOT COMPLETED|Period 1 (4 Days)||0
8080210|NCT03629054|19923772|P2|COMPLETED|Period 1 (4 Days)||15
8080211|NCT03629054|19923773|P1|COMPLETED|Period 1 (4 Days)||15
8080212|NCT03629054|19923772|P2|STARTED|Period 1 (4 Days)|Started this period|15
8080213|NCT03629054|19923773|P1|STARTED|Period 1 (4 Days)|Started this period|15
8080214|NCT03629041|19923797|P4|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
8080215|NCT03629041|19923798|P3|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
8080216|NCT03629041|19923799|P2|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1
8080217|NCT03629041|19923800|P1|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
8080218|NCT03629041|19923797|P4|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
8080219|NCT03629041|19923798|P3|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
8080220|NCT03629041|19923799|P2|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3
8080221|NCT03629041|19923800|P1|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
8080222|NCT03629041|19923797|P4|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
8080223|NCT03629041|19923798|P3|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
8080224|NCT03629041|19923799|P2|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
8080225|NCT03629041|19923800|P1|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
8080226|NCT03629041|19923797|P4|NOT COMPLETED|Visit 1||0
8080227|NCT03629041|19923798|P3|NOT COMPLETED|Visit 1||0
8080228|NCT03629041|19923799|P2|NOT COMPLETED|Visit 1||0
8080229|NCT03629041|19923800|P1|NOT COMPLETED|Visit 1||0
8080230|NCT03629041|19923797|P4|COMPLETED|Visit 1||4
8080231|NCT03629041|19923798|P3|COMPLETED|Visit 1||4
8080232|NCT03629041|19923799|P2|COMPLETED|Visit 1||4
8080233|NCT03629041|19923800|P1|COMPLETED|Visit 1||4
8080234|NCT03629041|19923797|P4|STARTED|Visit 1||4
8080235|NCT03629041|19923798|P3|STARTED|Visit 1||4
8080236|NCT03629041|19923799|P2|STARTED|Visit 1||4
8080237|NCT03629041|19923800|P1|STARTED|Visit 1||4
8080238|NCT03629028|19923828|P2|NOT COMPLETED|Overall Study||25
8080239|NCT03629028|19923829|P1|NOT COMPLETED|Overall Study||32
8080240|NCT03629028|19923828|P2|COMPLETED|Overall Study||116
8080241|NCT03629028|19923829|P1|COMPLETED|Overall Study||109
8080242|NCT03629028|19923828|P2|STARTED|Overall Study||141
8080243|NCT03629028|19923829|P1|STARTED|Overall Study||141
8080244|NCT03628885|19923848|P3|NOT COMPLETED|Overall Study||60
8080245|NCT03628885|19923849|P2|NOT COMPLETED|Overall Study||47
8080246|NCT03628885|19923850|P1|NOT COMPLETED|Overall Study||39
8080247|NCT03628885|19923848|P3|COMPLETED|Overall Study||243
8080248|NCT03628885|19923849|P2|COMPLETED|Overall Study||252
8080249|NCT03628885|19923850|P1|COMPLETED|Overall Study||267
8080250|NCT03628885|19923848|P3|STARTED|Overall Study||303
8080251|NCT03628885|19923849|P2|STARTED|Overall Study||299
8080252|NCT03628885|19923850|P1|STARTED|Overall Study||306
8080253|NCT03628599|19923860|P2|NOT COMPLETED|Overall Study||1
8080254|NCT03628599|19923861|P1|NOT COMPLETED|Overall Study||0
8080255|NCT03628599|19923860|P2|COMPLETED|Overall Study||18
8080256|NCT03628599|19923861|P1|COMPLETED|Overall Study||18
8080257|NCT03628599|19923860|P2|STARTED|Overall Study||19
8080258|NCT03628599|19923861|P1|STARTED|Overall Study||18
8080259|NCT03628456|19923871|P1|NOT COMPLETED|Overall Study||0
8080260|NCT03628456|19923871|P1|COMPLETED|Overall Study||10
8080261|NCT03628456|19923871|P1|STARTED|Overall Study||10
8080262|NCT03628417|19923891|P2|NOT COMPLETED|Overall Study||1
8080263|NCT03628417|19923892|P1|NOT COMPLETED|Overall Study||1
8080264|NCT03628417|19923891|P2|COMPLETED|Overall Study|One patient died before the one-year closing visit,this is why decreased the number of metastases|6
8080265|NCT03628417|19923892|P1|COMPLETED|Overall Study|One patient died and 3 more Ca electroporated lesions were removed before the one-year closing visit|6
8080266|NCT03628417|19923891|P2|Day 180|Overall Study||7
8080267|NCT03628417|19923892|P1|Day 180|Overall Study||7
8080268|NCT03628417|19923891|P2|Day 90|Overall Study||7
8080269|NCT03628417|19923892|P1|Day 90|Overall Study||7
8080270|NCT03628417|19923891|P2|Day 60|Overall Study||7
8080271|NCT03628417|19923892|P1|Day 60|Overall Study||7
8080272|NCT03628417|19923891|P2|Day 30|Overall Study||7
8080273|NCT03628417|19923892|P1|Day 30|Overall Study||7
8080274|NCT03628417|19923891|P2|Day 15|Overall Study||7
8080275|NCT03628417|19923892|P1|Day 15|Overall Study||7
8080276|NCT03628417|19923891|P2|Day 7|Overall Study||7
8080277|NCT03628417|19923892|P1|Day 7|Overall Study||7
8080278|NCT03628417|19923891|P2|Day 0|Overall Study||7
8080279|NCT03628417|19923892|P1|Day 0|Overall Study||7
8080280|NCT03628417|19923891|P2|STARTED|Overall Study||7
8080281|NCT03628417|19923892|P1|STARTED|Overall Study||7
8080282|NCT03627832|19923904|P2|NOT COMPLETED|Overall Study||1
8080283|NCT03627832|19923905|P1|NOT COMPLETED|Overall Study||10
8080284|NCT03627832|19923904|P2|COMPLETED|Overall Study||27
8080285|NCT03627832|19923905|P1|COMPLETED|Overall Study||18
8080286|NCT03627832|19923904|P2|STARTED|Overall Study||28
8080287|NCT03627832|19923905|P1|STARTED|Overall Study||28
8080288|NCT03627494|19923939|P12|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080289|NCT03627494|19923940|P11|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080290|NCT03627494|19923941|P10|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080291|NCT03627494|19923942|P9|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080292|NCT03627494|19923943|P8|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080293|NCT03627494|19923944|P7|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080294|NCT03627494|19923945|P6|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080295|NCT03627494|19923946|P5|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080296|NCT03627494|19923947|P4|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080297|NCT03627494|19923948|P3|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080298|NCT03627494|19923949|P2|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080299|NCT03627494|19923950|P1|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080300|NCT03627494|19923939|P12|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
8080301|NCT03627494|19923940|P11|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
8080302|NCT03627494|19923941|P10|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080303|NCT03627494|19923942|P9|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080304|NCT03627494|19923943|P8|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080305|NCT03627494|19923944|P7|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080306|NCT03627494|19923945|P6|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080307|NCT03627494|19923946|P5|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080308|NCT03627494|19923947|P4|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080309|NCT03627494|19923948|P3|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080310|NCT03627494|19923949|P2|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080311|NCT03627494|19923950|P1|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
8080312|NCT03627494|19923939|P12|STARTED|Part C Period2(4days)+Follow-up(14days)||5
8080313|NCT03627494|19923940|P11|STARTED|Part C Period2(4days)+Follow-up(14days)||5
8080314|NCT03627494|19923941|P10|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080315|NCT03627494|19923942|P9|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080316|NCT03627494|19923943|P8|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080317|NCT03627494|19923944|P7|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080318|NCT03627494|19923945|P6|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080319|NCT03627494|19923946|P5|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080320|NCT03627494|19923947|P4|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080321|NCT03627494|19923948|P3|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080322|NCT03627494|19923949|P2|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080323|NCT03627494|19923950|P1|STARTED|Part C Period2(4days)+Follow-up(14days)||0
8080324|NCT03627494|19923939|P12|NOT COMPLETED|Part C Washout 1 (7 Days)||1
8080325|NCT03627494|19923940|P11|NOT COMPLETED|Part C Washout 1 (7 Days)||1
8080326|NCT03627494|19923941|P10|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080327|NCT03627494|19923942|P9|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080328|NCT03627494|19923943|P8|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080329|NCT03627494|19923944|P7|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080330|NCT03627494|19923945|P6|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080331|NCT03627494|19923946|P5|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080332|NCT03627494|19923947|P4|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080333|NCT03627494|19923948|P3|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080334|NCT03627494|19923949|P2|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080335|NCT03627494|19923950|P1|NOT COMPLETED|Part C Washout 1 (7 Days)||0
8080336|NCT03627494|19923939|P12|COMPLETED|Part C Washout 1 (7 Days)||5
8080337|NCT03627494|19923940|P11|COMPLETED|Part C Washout 1 (7 Days)||5
8080338|NCT03627494|19923941|P10|COMPLETED|Part C Washout 1 (7 Days)||0
8080339|NCT03627494|19923942|P9|COMPLETED|Part C Washout 1 (7 Days)||0
8080340|NCT03627494|19923943|P8|COMPLETED|Part C Washout 1 (7 Days)||0
8080341|NCT03627494|19923944|P7|COMPLETED|Part C Washout 1 (7 Days)||0
8080342|NCT03627494|19923945|P6|COMPLETED|Part C Washout 1 (7 Days)||0
8080343|NCT03627494|19923946|P5|COMPLETED|Part C Washout 1 (7 Days)||0
8080344|NCT03627494|19923947|P4|COMPLETED|Part C Washout 1 (7 Days)||0
8080345|NCT03627494|19923948|P3|COMPLETED|Part C Washout 1 (7 Days)||0
8080346|NCT03627494|19923949|P2|COMPLETED|Part C Washout 1 (7 Days)||0
8080347|NCT03627494|19923950|P1|COMPLETED|Part C Washout 1 (7 Days)||0
8080348|NCT03627494|19923939|P12|STARTED|Part C Washout 1 (7 Days)||6
8080349|NCT03627494|19923940|P11|STARTED|Part C Washout 1 (7 Days)||6
8080350|NCT03627494|19923941|P10|STARTED|Part C Washout 1 (7 Days)||0
8080351|NCT03627494|19923942|P9|STARTED|Part C Washout 1 (7 Days)||0
8080352|NCT03627494|19923943|P8|STARTED|Part C Washout 1 (7 Days)||0
8080353|NCT03627494|19923944|P7|STARTED|Part C Washout 1 (7 Days)||0
8080354|NCT03627494|19923945|P6|STARTED|Part C Washout 1 (7 Days)||0
8080355|NCT03627494|19923946|P5|STARTED|Part C Washout 1 (7 Days)||0
8080356|NCT03627494|19923947|P4|STARTED|Part C Washout 1 (7 Days)||0
8080357|NCT03627494|19923948|P3|STARTED|Part C Washout 1 (7 Days)||0
8080358|NCT03627494|19923949|P2|STARTED|Part C Washout 1 (7 Days)||0
8080359|NCT03627494|19923950|P1|STARTED|Part C Washout 1 (7 Days)||0
8080360|NCT03627494|19923939|P12|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080361|NCT03627494|19923940|P11|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080362|NCT03627494|19923941|P10|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080363|NCT03627494|19923942|P9|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080364|NCT03627494|19923943|P8|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080365|NCT03627494|19923944|P7|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080366|NCT03627494|19923945|P6|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080367|NCT03627494|19923946|P5|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080368|NCT03627494|19923947|P4|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080369|NCT03627494|19923948|P3|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080370|NCT03627494|19923949|P2|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080371|NCT03627494|19923950|P1|NOT COMPLETED|Part C Period 1 (4 Days)||0
8080372|NCT03627494|19923939|P12|COMPLETED|Part C Period 1 (4 Days)||6
8080373|NCT03627494|19923940|P11|COMPLETED|Part C Period 1 (4 Days)||6
8080374|NCT03627494|19923941|P10|COMPLETED|Part C Period 1 (4 Days)||0
8080375|NCT03627494|19923942|P9|COMPLETED|Part C Period 1 (4 Days)||0
8080376|NCT03627494|19923943|P8|COMPLETED|Part C Period 1 (4 Days)||0
8080377|NCT03627494|19923944|P7|COMPLETED|Part C Period 1 (4 Days)||0
8080378|NCT03627494|19923945|P6|COMPLETED|Part C Period 1 (4 Days)||0
8080379|NCT03627494|19923946|P5|COMPLETED|Part C Period 1 (4 Days)||0
8080380|NCT03627494|19923947|P4|COMPLETED|Part C Period 1 (4 Days)||0
8080381|NCT03627494|19923948|P3|COMPLETED|Part C Period 1 (4 Days)||0
8080382|NCT03627494|19923949|P2|COMPLETED|Part C Period 1 (4 Days)||0
8080383|NCT03627494|19923950|P1|COMPLETED|Part C Period 1 (4 Days)||0
8080384|NCT03627494|19923939|P12|STARTED|Part C Period 1 (4 Days)||6
8080385|NCT03627494|19923940|P11|STARTED|Part C Period 1 (4 Days)||6
8080386|NCT03627494|19923941|P10|STARTED|Part C Period 1 (4 Days)||0
8080387|NCT03627494|19923942|P9|STARTED|Part C Period 1 (4 Days)||0
8080388|NCT03627494|19923943|P8|STARTED|Part C Period 1 (4 Days)||0
8080389|NCT03627494|19923944|P7|STARTED|Part C Period 1 (4 Days)||0
8080390|NCT03627494|19923945|P6|STARTED|Part C Period 1 (4 Days)||0
8080391|NCT03627494|19923946|P5|STARTED|Part C Period 1 (4 Days)||0
8080392|NCT03627494|19923947|P4|STARTED|Part C Period 1 (4 Days)||0
8080393|NCT03627494|19923948|P3|STARTED|Part C Period 1 (4 Days)||0
8080394|NCT03627494|19923949|P2|STARTED|Part C Period 1 (4 Days)||0
8080395|NCT03627494|19923950|P1|STARTED|Part C Period 1 (4 Days)||0
8080396|NCT03627494|19923939|P12|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080397|NCT03627494|19923940|P11|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080398|NCT03627494|19923941|P10|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080399|NCT03627494|19923942|P9|NOT COMPLETED|Part B (Maximum of 34 Days)||2
8080400|NCT03627494|19923943|P8|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080401|NCT03627494|19923944|P7|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080402|NCT03627494|19923945|P6|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080403|NCT03627494|19923946|P5|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080404|NCT03627494|19923947|P4|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080405|NCT03627494|19923948|P3|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080406|NCT03627494|19923949|P2|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080407|NCT03627494|19923950|P1|NOT COMPLETED|Part B (Maximum of 34 Days)||0
8080408|NCT03627494|19923939|P12|COMPLETED|Part B (Maximum of 34 Days)||0
8080409|NCT03627494|19923940|P11|COMPLETED|Part B (Maximum of 34 Days)||0
8080410|NCT03627494|19923941|P10|COMPLETED|Part B (Maximum of 34 Days)||9
8080411|NCT03627494|19923942|P9|COMPLETED|Part B (Maximum of 34 Days)||7
8080412|NCT03627494|19923943|P8|COMPLETED|Part B (Maximum of 34 Days)||9
8080413|NCT03627494|19923944|P7|COMPLETED|Part B (Maximum of 34 Days)||9
8080414|NCT03627494|19923945|P6|COMPLETED|Part B (Maximum of 34 Days)||0
8080415|NCT03627494|19923946|P5|COMPLETED|Part B (Maximum of 34 Days)||0
8080416|NCT03627494|19923947|P4|COMPLETED|Part B (Maximum of 34 Days)||0
8080417|NCT03627494|19923948|P3|COMPLETED|Part B (Maximum of 34 Days)||0
8080418|NCT03627494|19923949|P2|COMPLETED|Part B (Maximum of 34 Days)||0
8080419|NCT03627494|19923950|P1|COMPLETED|Part B (Maximum of 34 Days)||0
8080420|NCT03627494|19923939|P12|STARTED|Part B (Maximum of 34 Days)||0
8080421|NCT03627494|19923940|P11|STARTED|Part B (Maximum of 34 Days)||0
8080422|NCT03627494|19923941|P10|STARTED|Part B (Maximum of 34 Days)||9
8080423|NCT03627494|19923942|P9|STARTED|Part B (Maximum of 34 Days)||9
8080424|NCT03627494|19923943|P8|STARTED|Part B (Maximum of 34 Days)||9
8080425|NCT03627494|19923944|P7|STARTED|Part B (Maximum of 34 Days)||9
8080426|NCT03627494|19923945|P6|STARTED|Part B (Maximum of 34 Days)||0
8080427|NCT03627494|19923946|P5|STARTED|Part B (Maximum of 34 Days)||0
8080428|NCT03627494|19923947|P4|STARTED|Part B (Maximum of 34 Days)||0
8080429|NCT03627494|19923948|P3|STARTED|Part B (Maximum of 34 Days)||0
8080430|NCT03627494|19923949|P2|STARTED|Part B (Maximum of 34 Days)||0
8080431|NCT03627494|19923950|P1|STARTED|Part B (Maximum of 34 Days)||0
8080432|NCT03627494|19923939|P12|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080433|NCT03627494|19923940|P11|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080434|NCT03627494|19923941|P10|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080435|NCT03627494|19923942|P9|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080436|NCT03627494|19923943|P8|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080437|NCT03627494|19923944|P7|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080438|NCT03627494|19923945|P6|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080439|NCT03627494|19923946|P5|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080440|NCT03627494|19923947|P4|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080441|NCT03627494|19923948|P3|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080442|NCT03627494|19923949|P2|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080443|NCT03627494|19923950|P1|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080444|NCT03627494|19923939|P12|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080445|NCT03627494|19923940|P11|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080446|NCT03627494|19923941|P10|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080447|NCT03627494|19923942|P9|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080448|NCT03627494|19923943|P8|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080449|NCT03627494|19923944|P7|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
8080450|NCT03627494|19923945|P6|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
8080451|NCT03627494|19923946|P5|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
8080452|NCT03627494|19923947|P4|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
8080453|NCT03627494|19923948|P3|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
8080454|NCT03627494|19923949|P2|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
8080455|NCT03627494|19923950|P1|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
8080456|NCT03627494|19923939|P12|STARTED|Part A Period3(4days)+Follow-up(14days)||0
8080457|NCT03627494|19923940|P11|STARTED|Part A Period3(4days)+Follow-up(14days)||0
8080458|NCT03627494|19923941|P10|STARTED|Part A Period3(4days)+Follow-up(14days)||0
8080459|NCT03627494|19923942|P9|STARTED|Part A Period3(4days)+Follow-up(14days)||0
8080460|NCT03627494|19923943|P8|STARTED|Part A Period3(4days)+Follow-up(14days)||0
8080461|NCT03627494|19923944|P7|STARTED|Part A Period3(4days)+Follow-up(14days)||0
8080462|NCT03627494|19923945|P6|STARTED|Part A Period3(4days)+Follow-up(14days)||3
8080463|NCT03627494|19923946|P5|STARTED|Part A Period3(4days)+Follow-up(14days)||3
8080464|NCT03627494|19923947|P4|STARTED|Part A Period3(4days)+Follow-up(14days)||3
8080465|NCT03627494|19923948|P3|STARTED|Part A Period3(4days)+Follow-up(14days)||2
8080466|NCT03627494|19923949|P2|STARTED|Part A Period3(4days)+Follow-up(14days)||3
8080467|NCT03627494|19923950|P1|STARTED|Part A Period3(4days)+Follow-up(14days)||2
8080468|NCT03627494|19923939|P12|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080469|NCT03627494|19923940|P11|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080470|NCT03627494|19923941|P10|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080471|NCT03627494|19923942|P9|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080472|NCT03627494|19923943|P8|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080473|NCT03627494|19923944|P7|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080474|NCT03627494|19923945|P6|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080475|NCT03627494|19923946|P5|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080476|NCT03627494|19923947|P4|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080477|NCT03627494|19923948|P3|NOT COMPLETED|Part A Washout 2 (7 Days)||1
8080478|NCT03627494|19923949|P2|NOT COMPLETED|Part A Washout 2 (7 Days)||0
8080479|NCT03627494|19923950|P1|NOT COMPLETED|Part A Washout 2 (7 Days)||1
8080480|NCT03627494|19923939|P12|COMPLETED|Part A Washout 2 (7 Days)||0
8080481|NCT03627494|19923940|P11|COMPLETED|Part A Washout 2 (7 Days)||0
8080482|NCT03627494|19923941|P10|COMPLETED|Part A Washout 2 (7 Days)||0
8080483|NCT03627494|19923942|P9|COMPLETED|Part A Washout 2 (7 Days)||0
8080484|NCT03627494|19923943|P8|COMPLETED|Part A Washout 2 (7 Days)||0
8080485|NCT03627494|19923944|P7|COMPLETED|Part A Washout 2 (7 Days)||0
8080486|NCT03627494|19923945|P6|COMPLETED|Part A Washout 2 (7 Days)||3
8080487|NCT03627494|19923946|P5|COMPLETED|Part A Washout 2 (7 Days)||3
8080488|NCT03627494|19923947|P4|COMPLETED|Part A Washout 2 (7 Days)||3
8080489|NCT03627494|19923948|P3|COMPLETED|Part A Washout 2 (7 Days)||2
8080490|NCT03627494|19923949|P2|COMPLETED|Part A Washout 2 (7 Days)||3
8080491|NCT03627494|19923950|P1|COMPLETED|Part A Washout 2 (7 Days)||2
8080492|NCT03627494|19923939|P12|STARTED|Part A Washout 2 (7 Days)||0
8080493|NCT03627494|19923940|P11|STARTED|Part A Washout 2 (7 Days)||0
8080494|NCT03627494|19923941|P10|STARTED|Part A Washout 2 (7 Days)||0
8080495|NCT03627494|19923942|P9|STARTED|Part A Washout 2 (7 Days)||0
8080496|NCT03627494|19923943|P8|STARTED|Part A Washout 2 (7 Days)||0
8080497|NCT03627494|19923944|P7|STARTED|Part A Washout 2 (7 Days)||0
8080498|NCT03627494|19923945|P6|STARTED|Part A Washout 2 (7 Days)||3
8080499|NCT03627494|19923946|P5|STARTED|Part A Washout 2 (7 Days)||3
8080500|NCT03627494|19923947|P4|STARTED|Part A Washout 2 (7 Days)||3
8080501|NCT03627494|19923948|P3|STARTED|Part A Washout 2 (7 Days)||3
8080502|NCT03627494|19923949|P2|STARTED|Part A Washout 2 (7 Days)||3
8080503|NCT03627494|19923950|P1|STARTED|Part A Washout 2 (7 Days)||3
8080504|NCT03627494|19923939|P12|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080505|NCT03627494|19923940|P11|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080506|NCT03627494|19923941|P10|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080507|NCT03627494|19923942|P9|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080508|NCT03627494|19923943|P8|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080509|NCT03627494|19923944|P7|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080510|NCT03627494|19923945|P6|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080511|NCT03627494|19923946|P5|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080512|NCT03627494|19923947|P4|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080513|NCT03627494|19923948|P3|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080514|NCT03627494|19923949|P2|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080515|NCT03627494|19923950|P1|NOT COMPLETED|Part A Period 2 (4 Days)||0
8080516|NCT03627494|19923939|P12|COMPLETED|Part A Period 2 (4 Days)||0
8080517|NCT03627494|19923940|P11|COMPLETED|Part A Period 2 (4 Days)||0
8080518|NCT03627494|19923941|P10|COMPLETED|Part A Period 2 (4 Days)||0
8080519|NCT03627494|19923942|P9|COMPLETED|Part A Period 2 (4 Days)||0
8080520|NCT03627494|19923943|P8|COMPLETED|Part A Period 2 (4 Days)||0
8080521|NCT03627494|19923944|P7|COMPLETED|Part A Period 2 (4 Days)||0
8080522|NCT03627494|19923945|P6|COMPLETED|Part A Period 2 (4 Days)||3
8080523|NCT03627494|19923946|P5|COMPLETED|Part A Period 2 (4 Days)||3
8080524|NCT03627494|19923947|P4|COMPLETED|Part A Period 2 (4 Days)||3
8080525|NCT03627494|19923948|P3|COMPLETED|Part A Period 2 (4 Days)||3
8080526|NCT03627494|19923949|P2|COMPLETED|Part A Period 2 (4 Days)||3
8080527|NCT03627494|19923950|P1|COMPLETED|Part A Period 2 (4 Days)||3
8080528|NCT03627494|19923939|P12|STARTED|Part A Period 2 (4 Days)||0
8080529|NCT03627494|19923940|P11|STARTED|Part A Period 2 (4 Days)||0
8080530|NCT03627494|19923941|P10|STARTED|Part A Period 2 (4 Days)||0
8080531|NCT03627494|19923942|P9|STARTED|Part A Period 2 (4 Days)||0
8080532|NCT03627494|19923943|P8|STARTED|Part A Period 2 (4 Days)||0
8080533|NCT03627494|19923944|P7|STARTED|Part A Period 2 (4 Days)||0
8080534|NCT03627494|19923945|P6|STARTED|Part A Period 2 (4 Days)||3
8080535|NCT03627494|19923946|P5|STARTED|Part A Period 2 (4 Days)||3
8080536|NCT03627494|19923947|P4|STARTED|Part A Period 2 (4 Days)||3
8080537|NCT03627494|19923948|P3|STARTED|Part A Period 2 (4 Days)||3
8080538|NCT03627494|19923949|P2|STARTED|Part A Period 2 (4 Days)||3
8080539|NCT03627494|19923950|P1|STARTED|Part A Period 2 (4 Days)||3
8080540|NCT03627494|19923939|P12|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080541|NCT03627494|19923940|P11|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080542|NCT03627494|19923941|P10|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080543|NCT03627494|19923942|P9|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080544|NCT03627494|19923943|P8|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080545|NCT03627494|19923944|P7|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080546|NCT03627494|19923945|P6|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080547|NCT03627494|19923946|P5|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080548|NCT03627494|19923947|P4|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080549|NCT03627494|19923948|P3|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080550|NCT03627494|19923949|P2|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080551|NCT03627494|19923950|P1|NOT COMPLETED|Part A Washout 1 (7 Days)||0
8080552|NCT03627494|19923939|P12|COMPLETED|Part A Washout 1 (7 Days)||0
8080553|NCT03627494|19923940|P11|COMPLETED|Part A Washout 1 (7 Days)||0
8080554|NCT03627494|19923941|P10|COMPLETED|Part A Washout 1 (7 Days)||0
8080555|NCT03627494|19923942|P9|COMPLETED|Part A Washout 1 (7 Days)||0
8080556|NCT03627494|19923943|P8|COMPLETED|Part A Washout 1 (7 Days)||0
8080557|NCT03627494|19923944|P7|COMPLETED|Part A Washout 1 (7 Days)||0
8080558|NCT03627494|19923945|P6|COMPLETED|Part A Washout 1 (7 Days)||3
8080559|NCT03627494|19923946|P5|COMPLETED|Part A Washout 1 (7 Days)||3
8080560|NCT03627494|19923947|P4|COMPLETED|Part A Washout 1 (7 Days)||3
8080561|NCT03627494|19923948|P3|COMPLETED|Part A Washout 1 (7 Days)||3
8080562|NCT03627494|19923949|P2|COMPLETED|Part A Washout 1 (7 Days)||3
8080563|NCT03627494|19923950|P1|COMPLETED|Part A Washout 1 (7 Days)||3
8080564|NCT03627494|19923939|P12|STARTED|Part A Washout 1 (7 Days)||0
8080565|NCT03627494|19923940|P11|STARTED|Part A Washout 1 (7 Days)||0
8080566|NCT03627494|19923941|P10|STARTED|Part A Washout 1 (7 Days)||0
8080567|NCT03627494|19923942|P9|STARTED|Part A Washout 1 (7 Days)||0
8080568|NCT03627494|19923943|P8|STARTED|Part A Washout 1 (7 Days)||0
8080569|NCT03627494|19923944|P7|STARTED|Part A Washout 1 (7 Days)||0
8080570|NCT03627494|19923945|P6|STARTED|Part A Washout 1 (7 Days)||3
8080571|NCT03627494|19923946|P5|STARTED|Part A Washout 1 (7 Days)||3
8080572|NCT03627494|19923947|P4|STARTED|Part A Washout 1 (7 Days)||3
8080573|NCT03627494|19923948|P3|STARTED|Part A Washout 1 (7 Days)||3
8080574|NCT03627494|19923949|P2|STARTED|Part A Washout 1 (7 Days)||3
8080575|NCT03627494|19923950|P1|STARTED|Part A Washout 1 (7 Days)||3
8080576|NCT03627494|19923939|P12|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080577|NCT03627494|19923940|P11|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080578|NCT03627494|19923941|P10|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080579|NCT03627494|19923942|P9|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080580|NCT03627494|19923943|P8|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080581|NCT03627494|19923944|P7|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080582|NCT03627494|19923945|P6|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080583|NCT03627494|19923946|P5|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080584|NCT03627494|19923947|P4|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080585|NCT03627494|19923948|P3|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080586|NCT03627494|19923949|P2|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080587|NCT03627494|19923950|P1|NOT COMPLETED|Part A Period 1 (4 Days)||0
8080588|NCT03627494|19923939|P12|COMPLETED|Part A Period 1 (4 Days)||0
8080589|NCT03627494|19923940|P11|COMPLETED|Part A Period 1 (4 Days)||0
8080590|NCT03627494|19923941|P10|COMPLETED|Part A Period 1 (4 Days)||0
8080591|NCT03627494|19923942|P9|COMPLETED|Part A Period 1 (4 Days)||0
8080592|NCT03627494|19923943|P8|COMPLETED|Part A Period 1 (4 Days)||0
8080593|NCT03627494|19923944|P7|COMPLETED|Part A Period 1 (4 Days)||0
8080594|NCT03627494|19923945|P6|COMPLETED|Part A Period 1 (4 Days)||3
8080595|NCT03627494|19923946|P5|COMPLETED|Part A Period 1 (4 Days)||3
8080596|NCT03627494|19923947|P4|COMPLETED|Part A Period 1 (4 Days)||3
8080597|NCT03627494|19923948|P3|COMPLETED|Part A Period 1 (4 Days)||3
8080598|NCT03627494|19923949|P2|COMPLETED|Part A Period 1 (4 Days)||3
8080599|NCT03627494|19923950|P1|COMPLETED|Part A Period 1 (4 Days)||3
8080600|NCT03627494|19923939|P12|STARTED|Part A Period 1 (4 Days)||0
8080601|NCT03627494|19923940|P11|STARTED|Part A Period 1 (4 Days)||0
8080602|NCT03627494|19923941|P10|STARTED|Part A Period 1 (4 Days)||0
8080603|NCT03627494|19923942|P9|STARTED|Part A Period 1 (4 Days)||0
8080604|NCT03627494|19923943|P8|STARTED|Part A Period 1 (4 Days)||0
8080605|NCT03627494|19923944|P7|STARTED|Part A Period 1 (4 Days)||0
8080606|NCT03627494|19923945|P6|STARTED|Part A Period 1 (4 Days)||3
8080607|NCT03627494|19923946|P5|STARTED|Part A Period 1 (4 Days)||3
8080608|NCT03627494|19923947|P4|STARTED|Part A Period 1 (4 Days)||3
8080609|NCT03627494|19923948|P3|STARTED|Part A Period 1 (4 Days)||3
8080610|NCT03627494|19923949|P2|STARTED|Part A Period 1 (4 Days)||3
8080611|NCT03627494|19923950|P1|STARTED|Part A Period 1 (4 Days)||3
8080612|NCT03627299|19924146|P1|NOT COMPLETED|Overall Study||0
8080613|NCT03627299|19924146|P1|COMPLETED|Overall Study||10
8080614|NCT03627299|19924146|P1|STARTED|Overall Study||10
8080615|NCT03627195|19924164|P6|NOT COMPLETED|Overall Study||0
8080616|NCT03627195|19924165|P5|NOT COMPLETED|Overall Study||0
8080617|NCT03627195|19924166|P4|NOT COMPLETED|Overall Study||0
8080618|NCT03627195|19924167|P3|NOT COMPLETED|Overall Study||0
8080619|NCT03627195|19924168|P2|NOT COMPLETED|Overall Study||0
8080620|NCT03627195|19924169|P1|NOT COMPLETED|Overall Study||1
8080621|NCT03627195|19924164|P6|COMPLETED|Overall Study||10
8080622|NCT03627195|19924165|P5|COMPLETED|Overall Study||6
8080623|NCT03627195|19924166|P4|COMPLETED|Overall Study||6
8080624|NCT03627195|19924167|P3|COMPLETED|Overall Study||6
8080625|NCT03627195|19924168|P2|COMPLETED|Overall Study||6
8080626|NCT03627195|19924169|P1|COMPLETED|Overall Study||5
8080627|NCT03627195|19924164|P6|STARTED|Overall Study||10
8080628|NCT03627195|19924165|P5|STARTED|Overall Study||6
8080629|NCT03627195|19924166|P4|STARTED|Overall Study||6
8080630|NCT03627195|19924167|P3|STARTED|Overall Study||6
8080631|NCT03627195|19924168|P2|STARTED|Overall Study||6
8080632|NCT03627195|19924169|P1|STARTED|Overall Study||6
8080633|NCT03626714|19924195|P1|NOT COMPLETED|Overall Study||0
8080634|NCT03626714|19924195|P1|COMPLETED|Overall Study||8
8080635|NCT03626714|19924195|P1|STARTED|Overall Study||8
8080636|NCT03626415|19924207|P3|NOT COMPLETED|Overall Study||0
8080637|NCT03626415|19924208|P2|NOT COMPLETED|Overall Study||0
8080638|NCT03626415|19924209|P1|NOT COMPLETED|Overall Study||0
8080639|NCT03626415|19924207|P3|COMPLETED|Overall Study||8
8080640|NCT03626415|19924208|P2|COMPLETED|Overall Study||8
8080641|NCT03626415|19924209|P1|COMPLETED|Overall Study||8
8080642|NCT03626415|19924207|P3|STARTED|Overall Study||8
8080643|NCT03626415|19924208|P2|STARTED|Overall Study||8
8080644|NCT03626415|19924209|P1|STARTED|Overall Study||8
8080645|NCT03624946|19924240|P2|NOT COMPLETED|Overall Study||1
8080646|NCT03624946|19924241|P1|NOT COMPLETED|Overall Study||0
8080647|NCT03624946|19924240|P2|COMPLETED|Overall Study||10
8080648|NCT03624946|19924241|P1|COMPLETED|Overall Study||19
8080649|NCT03624946|19924240|P2|STARTED|Overall Study||11
8080650|NCT03624946|19924241|P1|STARTED|Overall Study||19
8080651|NCT03624920|19924267|P6|NOT COMPLETED|Overall Study||1
8080652|NCT03624920|19924268|P5|NOT COMPLETED|Overall Study||4
8080653|NCT03624920|19924269|P4|NOT COMPLETED|Overall Study||1
8080654|NCT03624920|19924270|P3|NOT COMPLETED|Overall Study||1
8080655|NCT03624920|19924271|P2|NOT COMPLETED|Overall Study||2
8080656|NCT03624920|19924272|P1|NOT COMPLETED|Overall Study||1
8080657|NCT03624920|19924267|P6|COMPLETED|Overall Study||11
8080658|NCT03624920|19924268|P5|COMPLETED|Overall Study||7
8080659|NCT03624920|19924269|P4|COMPLETED|Overall Study||12
8080660|NCT03624920|19924270|P3|COMPLETED|Overall Study||12
8080661|NCT03624920|19924271|P2|COMPLETED|Overall Study||12
8080662|NCT03624920|19924272|P1|COMPLETED|Overall Study||13
8080663|NCT03624920|19924267|P6|STARTED|Overall Study||12
8080664|NCT03624920|19924268|P5|STARTED|Overall Study||11
8080665|NCT03624920|19924269|P4|STARTED|Overall Study||13
8080666|NCT03624920|19924270|P3|STARTED|Overall Study||13
8080667|NCT03624920|19924271|P2|STARTED|Overall Study||14
8080668|NCT03624920|19924272|P1|STARTED|Overall Study||14
8080669|NCT03624504|19924295|P1|NOT COMPLETED|Overall Study||1
8080670|NCT03624504|19924295|P1|COMPLETED|Overall Study||81
8080671|NCT03624504|19924295|P1|STARTED|Overall Study||82
8080672|NCT03623698|19924303|P1|NOT COMPLETED|Overall Study||0
8080673|NCT03623698|19924303|P1|COMPLETED|Overall Study||24
8080674|NCT03623698|19924303|P1|STARTED|Overall Study||24
8080675|NCT03623035|19924334|P1|NOT COMPLETED|Overall Study||0
8080676|NCT03623035|19924334|P1|COMPLETED|Overall Study||10
8080677|NCT03623035|19924334|P1|STARTED|Overall Study||10
8080684|NCT03622112|19924362|P7|NOT COMPLETED|Overall Study||9
8080685|NCT03622112|19924363|P6|NOT COMPLETED|Overall Study||42
8080686|NCT03622112|19924364|P5|NOT COMPLETED|Overall Study||10
8080687|NCT03622112|19924365|P4|NOT COMPLETED|Overall Study||22
8080688|NCT03622112|19924366|P3|NOT COMPLETED|Overall Study||16
8080689|NCT03622112|19924367|P2|NOT COMPLETED|Overall Study||20
8080690|NCT03622112|19924368|P1|NOT COMPLETED|Overall Study||25
8080691|NCT03622112|19924362|P7|COMPLETED|Overall Study||103
8080692|NCT03622112|19924363|P6|COMPLETED|Overall Study||71
8080693|NCT03622112|19924364|P5|COMPLETED|Overall Study||124
8080694|NCT03622112|19924365|P4|COMPLETED|Overall Study||91
8080695|NCT03622112|19924366|P3|COMPLETED|Overall Study||95
8080696|NCT03622112|19924367|P2|COMPLETED|Overall Study||92
8080697|NCT03622112|19924368|P1|COMPLETED|Overall Study||85
8080698|NCT03622112|19924362|P7|STARTED|Overall Study||112
8080699|NCT03622112|19924363|P6|STARTED|Overall Study||113
8080700|NCT03622112|19924364|P5|STARTED|Overall Study||134
8080701|NCT03622112|19924365|P4|STARTED|Overall Study||113
8080702|NCT03622112|19924366|P3|STARTED|Overall Study||111
8080703|NCT03622112|19924367|P2|STARTED|Overall Study||112
8080704|NCT03622112|19924368|P1|STARTED|Overall Study||110
8080705|NCT03621878|19924555|P3|NOT COMPLETED|Overall Study||0
8080706|NCT03621878|19924556|P2|NOT COMPLETED|Overall Study||0
8080707|NCT03621878|19924557|P1|NOT COMPLETED|Overall Study||0
8080708|NCT03621878|19924555|P3|COMPLETED|Overall Study||17
8080709|NCT03621878|19924556|P2|COMPLETED|Overall Study||17
8080710|NCT03621878|19924557|P1|COMPLETED|Overall Study||17
8080711|NCT03621878|19924555|P3|STARTED|Overall Study||17
8080712|NCT03621878|19924556|P2|STARTED|Overall Study||17
8080713|NCT03621878|19924557|P1|STARTED|Overall Study||17
8080714|NCT03621787|19924577|P1|NOT COMPLETED|Overall Study||0
8080715|NCT03621787|19924577|P1|COMPLETED|Overall Study||9
8080716|NCT03621787|19924577|P1|STARTED|Overall Study||9
8080717|NCT03621202|19924588|P1|NOT COMPLETED|Overall Study||6
8080718|NCT03621202|19924588|P1|COMPLETED|Overall Study||60
8080719|NCT03621202|19924588|P1|STARTED|Overall Study||66
8080720|NCT03620708|19924597|P3|NOT COMPLETED|Overall Study||3
8080721|NCT03620708|19924598|P2|NOT COMPLETED|Overall Study||1
8080722|NCT03620708|19924599|P1|NOT COMPLETED|Overall Study||1
8080723|NCT03620708|19924597|P3|COMPLETED|Overall Study||17
8080724|NCT03620708|19924598|P2|COMPLETED|Overall Study||18
8080725|NCT03620708|19924599|P1|COMPLETED|Overall Study||18
8080726|NCT03620708|19924597|P3|STARTED|Overall Study||20
8080727|NCT03620708|19924598|P2|STARTED|Overall Study||19
8080728|NCT03620708|19924599|P1|STARTED|Overall Study||19
8080729|NCT03620383|19924621|P2|NOT COMPLETED|Overall Study||0
8080730|NCT03620383|19924622|P1|NOT COMPLETED|Overall Study||0
8080731|NCT03620383|19924621|P2|COMPLETED|Overall Study||15
8080732|NCT03620383|19924622|P1|COMPLETED|Overall Study||30
8080733|NCT03620383|19924621|P2|STARTED|Overall Study||15
8080734|NCT03620383|19924622|P1|STARTED|Overall Study||30
8080735|NCT03619889|19924630|P2|NOT COMPLETED|Overall Study||0
8080736|NCT03619889|19924631|P1|NOT COMPLETED|Overall Study||2
8080737|NCT03619889|19924630|P2|COMPLETED|Overall Study||37
8080738|NCT03619889|19924631|P1|COMPLETED|Overall Study||35
8080739|NCT03619889|19924630|P2|STARTED|Overall Study||37
8080740|NCT03619889|19924631|P1|STARTED|Overall Study||37
8080741|NCT03619590|19924661|P1|NOT COMPLETED|Overall Study||0
8080742|NCT03619590|19924661|P1|COMPLETED|Overall Study||103
8080743|NCT03619590|19924661|P1|STARTED|Overall Study||103
8080744|NCT03619135|19924671|P2|NOT COMPLETED|Overall Study||0
8080745|NCT03619135|19924672|P1|NOT COMPLETED|Overall Study||0
8080746|NCT03619135|19924671|P2|COMPLETED|Overall Study||50
8080747|NCT03619135|19924672|P1|COMPLETED|Overall Study||50
8080748|NCT03619135|19924671|P2|STARTED|Overall Study||50
8080749|NCT03619135|19924672|P1|STARTED|Overall Study||50
8080750|NCT03618628|19924680|P1|NOT COMPLETED|Overall Study||2
8080751|NCT03618628|19924680|P1|COMPLETED|Overall Study||1
8080752|NCT03618628|19924680|P1|STARTED|Overall Study||3
8080753|NCT03618147|19924684|P1|NOT COMPLETED|Overall Study||0
8080754|NCT03618147|19924684|P1|COMPLETED|Overall Study||314
8080755|NCT03618147|19924684|P1|STARTED|Overall Study||314
8080756|NCT03618017|19924691|P2|NOT COMPLETED|Overall Study||5
8080757|NCT03618017|19924692|P1|NOT COMPLETED|Overall Study||7
8080758|NCT03618017|19924691|P2|COMPLETED|Overall Study||28
8080759|NCT03618017|19924692|P1|COMPLETED|Overall Study||26
8080760|NCT03618017|19924691|P2|STARTED|Overall Study||33
8080761|NCT03618017|19924692|P1|STARTED|Overall Study||33
8080762|NCT03617861|19924710|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8080763|NCT03617861|19924711|P3|NOT COMPLETED|Second Intervention (1 Day)||1
8080764|NCT03617861|19924712|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8080765|NCT03617861|19924713|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8080766|NCT03617861|19924710|P4|COMPLETED|Second Intervention (1 Day)||5
8080767|NCT03617861|19924711|P3|COMPLETED|Second Intervention (1 Day)||4
8080768|NCT03617861|19924712|P2|COMPLETED|Second Intervention (1 Day)||5
8080769|NCT03617861|19924713|P1|COMPLETED|Second Intervention (1 Day)||5
8080770|NCT03617861|19924710|P4|STARTED|Second Intervention (1 Day)||5
8080771|NCT03617861|19924711|P3|STARTED|Second Intervention (1 Day)||5
8080772|NCT03617861|19924712|P2|STARTED|Second Intervention (1 Day)||5
8080773|NCT03617861|19924713|P1|STARTED|Second Intervention (1 Day)||5
8080774|NCT03617861|19924710|P4|NOT COMPLETED|Washout (1 to 4 Weeks)||0
8080775|NCT03617861|19924711|P3|NOT COMPLETED|Washout (1 to 4 Weeks)||0
8080776|NCT03617861|19924712|P2|NOT COMPLETED|Washout (1 to 4 Weeks)||0
8080777|NCT03617861|19924713|P1|NOT COMPLETED|Washout (1 to 4 Weeks)||0
8080778|NCT03617861|19924710|P4|COMPLETED|Washout (1 to 4 Weeks)||5
8080779|NCT03617861|19924711|P3|COMPLETED|Washout (1 to 4 Weeks)||5
8080780|NCT03617861|19924712|P2|COMPLETED|Washout (1 to 4 Weeks)||5
8080781|NCT03617861|19924713|P1|COMPLETED|Washout (1 to 4 Weeks)||5
8080782|NCT03617861|19924710|P4|STARTED|Washout (1 to 4 Weeks)||5
8080783|NCT03617861|19924711|P3|STARTED|Washout (1 to 4 Weeks)||5
8080784|NCT03617861|19924712|P2|STARTED|Washout (1 to 4 Weeks)||5
8080785|NCT03617861|19924713|P1|STARTED|Washout (1 to 4 Weeks)||5
8080786|NCT03617861|19924710|P4|NOT COMPLETED|First Intervention (1 Day)||0
8080787|NCT03617861|19924711|P3|NOT COMPLETED|First Intervention (1 Day)||0
8080788|NCT03617861|19924712|P2|NOT COMPLETED|First Intervention (1 Day)||0
8080789|NCT03617861|19924713|P1|NOT COMPLETED|First Intervention (1 Day)||0
8080790|NCT03617861|19924710|P4|COMPLETED|First Intervention (1 Day)||5
8080791|NCT03617861|19924711|P3|COMPLETED|First Intervention (1 Day)||5
8080792|NCT03617861|19924712|P2|COMPLETED|First Intervention (1 Day)||5
8080793|NCT03617861|19924713|P1|COMPLETED|First Intervention (1 Day)||5
8080794|NCT03617861|19924710|P4|STARTED|First Intervention (1 Day)||5
8080795|NCT03617861|19924711|P3|STARTED|First Intervention (1 Day)||5
8080796|NCT03617861|19924712|P2|STARTED|First Intervention (1 Day)||5
8080797|NCT03617861|19924713|P1|STARTED|First Intervention (1 Day)||5
8080798|NCT03617588|19924745|P2|NOT COMPLETED|Overall Study||0
8080799|NCT03617588|19924746|P1|NOT COMPLETED|Overall Study||1
8080800|NCT03617588|19924745|P2|COMPLETED|Overall Study||29
8080801|NCT03617588|19924746|P1|COMPLETED|Overall Study||19
8080802|NCT03617588|19924745|P2|STARTED|Overall Study||29
8080803|NCT03617588|19924746|P1|STARTED|Overall Study||20
8080804|NCT03617523|19924763|P5|NOT COMPLETED|Overall Study||0
8080805|NCT03617523|19924764|P4|NOT COMPLETED|Overall Study||0
8080806|NCT03617523|19924765|P3|NOT COMPLETED|Overall Study||0
8080807|NCT03617523|19924766|P2|NOT COMPLETED|Overall Study||0
8080808|NCT03617523|19924767|P1|NOT COMPLETED|Overall Study||0
8080809|NCT03617523|19924763|P5|COMPLETED|Overall Study||60
8080810|NCT03617523|19924764|P4|COMPLETED|Overall Study||59
8080811|NCT03617523|19924765|P3|COMPLETED|Overall Study||61
8080812|NCT03617523|19924766|P2|COMPLETED|Overall Study||30
8080813|NCT03617523|19924767|P1|COMPLETED|Overall Study||30
8080814|NCT03617523|19924763|P5|STARTED|Overall Study||60
8080815|NCT03617523|19924764|P4|STARTED|Overall Study||59
8080816|NCT03617523|19924765|P3|STARTED|Overall Study||61
8080817|NCT03617523|19924766|P2|STARTED|Overall Study||30
8080818|NCT03617523|19924767|P1|STARTED|Overall Study||30
8080819|NCT03617419|19924799|P1|NOT COMPLETED|Part 2||0
8080820|NCT03617419|19924799|P1|COMPLETED|Part 2||14
8080821|NCT03617419|19924799|P1|STARTED|Part 2||14
8080822|NCT03617419|19924799|P1|NOT COMPLETED|Part 1||0
8080823|NCT03617419|19924799|P1|COMPLETED|Part 1||2
8080824|NCT03617419|19924799|P1|STARTED|Part 1||2
8080825|NCT03616977|19924807|P2|NOT COMPLETED|Period 4||0
8080826|NCT03616977|19924808|P1|NOT COMPLETED|Period 4||0
8080827|NCT03616977|19924807|P2|COMPLETED|Period 4||32
8080828|NCT03616977|19924808|P1|COMPLETED|Period 4||33
8080829|NCT03616977|19924807|P2|STARTED|Period 4||32
8080830|NCT03616977|19924808|P1|STARTED|Period 4||33
8080831|NCT03616977|19924807|P2|NOT COMPLETED|Period 3||1
8080832|NCT03616977|19924808|P1|NOT COMPLETED|Period 3||1
8080833|NCT03616977|19924807|P2|COMPLETED|Period 3||32
8080834|NCT03616977|19924808|P1|COMPLETED|Period 3||33
8080835|NCT03616977|19924807|P2|Received Study Drug|Period 3|Participant not dosed due to adverse event.|32
8080836|NCT03616977|19924808|P1|Received Study Drug|Period 3|Participant not dosed due to adverse event.|33
8080837|NCT03616977|19924807|P2|STARTED|Period 3|Participant completed Period 2 and withdrew from the study.|33
8080838|NCT03616977|19924808|P1|STARTED|Period 3||34
8080839|NCT03616977|19924807|P2|NOT COMPLETED|Period 2||0
8080840|NCT03616977|19924808|P1|NOT COMPLETED|Period 2||0
8080841|NCT03616977|19924807|P2|COMPLETED|Period 2||34
8080842|NCT03616977|19924808|P1|COMPLETED|Period 2||34
8080843|NCT03616977|19924807|P2|STARTED|Period 2||34
8080844|NCT03616977|19924808|P1|STARTED|Period 2||34
8080845|NCT03616977|19924807|P2|NOT COMPLETED|Period 1||1
8080846|NCT03616977|19924808|P1|NOT COMPLETED|Period 1||0
8080847|NCT03616977|19924807|P2|COMPLETED|Period 1||34
8080848|NCT03616977|19924808|P1|COMPLETED|Period 1||34
8080849|NCT03616977|19924807|P2|Received at Least One Dose of Study Drug|Period 1||34
8080850|NCT03616977|19924808|P1|Received at Least One Dose of Study Drug|Period 1||34
8080851|NCT03616977|19924807|P2|STARTED|Period 1||35
8080852|NCT03616977|19924808|P1|STARTED|Period 1||34
8080859|NCT03616171|19924837|P2|NOT COMPLETED|Overall Study||0
8080860|NCT03616171|19924838|P1|NOT COMPLETED|Overall Study||0
8080861|NCT03616171|19924837|P2|COMPLETED|Overall Study||2
8080862|NCT03616171|19924838|P1|COMPLETED|Overall Study||4
8080863|NCT03616171|19924837|P2|STARTED|Overall Study||2
8080864|NCT03616171|19924838|P1|STARTED|Overall Study||4
8080865|NCT03616106|19924853|P2|NOT COMPLETED|Overall Study||1
8080866|NCT03616106|19924854|P1|NOT COMPLETED|Overall Study||14
8080867|NCT03616106|19924853|P2|COMPLETED|Overall Study||2
8080868|NCT03616106|19924854|P1|COMPLETED|Overall Study||42
8080869|NCT03616106|19924853|P2|STARTED|Overall Study||3
8080870|NCT03616106|19924854|P1|STARTED|Overall Study||56
8080871|NCT03615911|19924891|P2|NOT COMPLETED|Overall Study||1
8080872|NCT03615911|19924892|P1|NOT COMPLETED|Overall Study||2
8080873|NCT03615911|19924891|P2|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|11
8080874|NCT03615911|19924892|P1|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|12
8080875|NCT03615911|19924891|P2|Received Late Booster Immunization|Overall Study||7
8080876|NCT03615911|19924892|P1|Received Late Booster Immunization|Overall Study||3
8080877|NCT03615911|19924891|P2|STARTED|Overall Study||12
8080878|NCT03615911|19924892|P1|STARTED|Overall Study||14
8080879|NCT03615807|19924910|P2|NOT COMPLETED|Overall Study||11
8080880|NCT03615807|19924911|P1|NOT COMPLETED|Overall Study||12
8080881|NCT03615807|19924910|P2|COMPLETED|Overall Study||80
8080882|NCT03615807|19924911|P1|COMPLETED|Overall Study||79
8080883|NCT03615807|19924910|P2|STARTED|Overall Study||91
8080884|NCT03615807|19924911|P1|STARTED|Overall Study||91
8080885|NCT03615534|19924923|P4|NOT COMPLETED|Overall Study||1
8080886|NCT03615534|19924924|P3|NOT COMPLETED|Overall Study||0
8080887|NCT03615534|19924925|P2|NOT COMPLETED|Overall Study||0
8080888|NCT03615534|19924926|P1|NOT COMPLETED|Overall Study||2
8080889|NCT03615534|19924923|P4|COMPLETED|Overall Study||13
8080890|NCT03615534|19924924|P3|COMPLETED|Overall Study||14
8080891|NCT03615534|19924925|P2|COMPLETED|Overall Study||15
8080892|NCT03615534|19924926|P1|COMPLETED|Overall Study||12
8080893|NCT03615534|19924923|P4|STARTED|Overall Study||14
8080894|NCT03615534|19924924|P3|STARTED|Overall Study||14
8080895|NCT03615534|19924925|P2|STARTED|Overall Study||15
8080896|NCT03615534|19924926|P1|STARTED|Overall Study||14
8080897|NCT03615508|19924968|P1|NOT COMPLETED|Overall Study||0
8080898|NCT03615508|19924968|P1|COMPLETED|Overall Study||1
8080899|NCT03615508|19924968|P1|STARTED|Overall Study||1
8080900|NCT03615482|19924974|P2|NOT COMPLETED|Overall Study||17
8080901|NCT03615482|19924975|P1|NOT COMPLETED|Overall Study||17
8080902|NCT03615482|19924974|P2|COMPLETED|Overall Study||583
8080903|NCT03615482|19924975|P1|COMPLETED|Overall Study||583
8080904|NCT03615482|19924974|P2|Vaccinated|Overall Study||598
8080905|NCT03615482|19924975|P1|Vaccinated|Overall Study||599
8080906|NCT03615482|19924974|P2|STARTED|Overall Study||600
8080907|NCT03615482|19924975|P1|STARTED|Overall Study||600
8080908|NCT03615183|19925010|P5|NOT COMPLETED|Overall Study||0
8080909|NCT03615183|19925011|P4|NOT COMPLETED|Overall Study||0
8080910|NCT03615183|19925012|P3|NOT COMPLETED|Overall Study||0
8080911|NCT03615183|19925013|P2|NOT COMPLETED|Overall Study||0
8080912|NCT03615183|19925014|P1|NOT COMPLETED|Overall Study||0
8080913|NCT03615183|19925010|P5|COMPLETED|Overall Study||0
8080914|NCT03615183|19925011|P4|COMPLETED|Overall Study||0
8080915|NCT03615183|19925012|P3|COMPLETED|Overall Study||5
8080916|NCT03615183|19925013|P2|COMPLETED|Overall Study||6
8080917|NCT03615183|19925014|P1|COMPLETED|Overall Study||6
8080918|NCT03615183|19925010|P5|STARTED|Overall Study|Panel E was not conducted as the scientific study objectives were met in the conducted panels.|0
8080919|NCT03615183|19925011|P4|STARTED|Overall Study|Panel D was not conducted as the scientific study objectives were met in the conducted panels.|0
8080920|NCT03615183|19925012|P3|STARTED|Overall Study||5
8080921|NCT03615183|19925013|P2|STARTED|Overall Study||6
8080922|NCT03615183|19925014|P1|STARTED|Overall Study||6
8080932|NCT03615001|19925125|P1|NOT COMPLETED|Overall Study||0
8080933|NCT03615001|19925125|P1|COMPLETED|Overall Study||20
8080934|NCT03615001|19925125|P1|STARTED|Overall Study||20
8080935|NCT03614975|19925132|P2|NOT COMPLETED|Overall Study||8
8080936|NCT03614975|19925133|P1|NOT COMPLETED|Overall Study||10
8080937|NCT03614975|19925132|P2|COMPLETED|Overall Study||73
8080938|NCT03614975|19925133|P1|COMPLETED|Overall Study||75
8080939|NCT03614975|19925132|P2|STARTED|Overall Study||81
8080940|NCT03614975|19925133|P1|STARTED|Overall Study||85
8080941|NCT03614416|19925143|P1|NOT COMPLETED|Overall Study||0
8080942|NCT03614416|19925143|P1|COMPLETED|Overall Study||13
8080943|NCT03614416|19925143|P1|STARTED|Overall Study||13
8080944|NCT03614156|19925155|P4|NOT COMPLETED|Safety Follow-Up Period||1
8080945|NCT03614156|19925156|P3|NOT COMPLETED|Safety Follow-Up Period||1
8080946|NCT03614156|19925157|P2|NOT COMPLETED|Safety Follow-Up Period||0
8080947|NCT03614156|19925158|P1|NOT COMPLETED|Safety Follow-Up Period||3
8080948|NCT03614156|19925155|P4|COMPLETED|Safety Follow-Up Period||34
8080949|NCT03614156|19925156|P3|COMPLETED|Safety Follow-Up Period||29
8080950|NCT03614156|19925157|P2|COMPLETED|Safety Follow-Up Period||26
8080951|NCT03614156|19925158|P1|COMPLETED|Safety Follow-Up Period||162
8080952|NCT03614156|19925155|P4|STARTED|Safety Follow-Up Period||35
8080953|NCT03614156|19925156|P3|STARTED|Safety Follow-Up Period||30
8080954|NCT03614156|19925157|P2|STARTED|Safety Follow-Up Period||26
8080955|NCT03614156|19925158|P1|STARTED|Safety Follow-Up Period||165
8080956|NCT03614156|19925155|P4|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||45
8080957|NCT03614156|19925156|P3|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||31
8080958|NCT03614156|19925157|P2|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||30
8080959|NCT03614156|19925158|P1|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
8080960|NCT03614156|19925155|P4|COMPLETED|Double-Blind Treatment Period (DBTP)||10
8080961|NCT03614156|19925156|P3|COMPLETED|Double-Blind Treatment Period (DBTP)||11
8080962|NCT03614156|19925157|P2|COMPLETED|Double-Blind Treatment Period (DBTP)||10
8080963|NCT03614156|19925158|P1|COMPLETED|Double-Blind Treatment Period (DBTP)||0
8080964|NCT03614156|19925155|P4|STARTED|Double-Blind Treatment Period (DBTP)||55
8080965|NCT03614156|19925156|P3|STARTED|Double-Blind Treatment Period (DBTP)||42
8080966|NCT03614156|19925157|P2|STARTED|Double-Blind Treatment Period (DBTP)||40
8080967|NCT03614156|19925158|P1|STARTED|Double-Blind Treatment Period (DBTP)||0
8080968|NCT03614156|19925155|P4|NOT COMPLETED|Open-Label Treatment Period||0
8080969|NCT03614156|19925156|P3|NOT COMPLETED|Open-Label Treatment Period||0
8080970|NCT03614156|19925157|P2|NOT COMPLETED|Open-Label Treatment Period||0
8080971|NCT03614156|19925158|P1|NOT COMPLETED|Open-Label Treatment Period||154
8080972|NCT03614156|19925155|P4|COMPLETED|Open-Label Treatment Period||0
8080973|NCT03614156|19925156|P3|COMPLETED|Open-Label Treatment Period||0
8080974|NCT03614156|19925157|P2|COMPLETED|Open-Label Treatment Period||0
8080975|NCT03614156|19925158|P1|COMPLETED|Open-Label Treatment Period||209
8080976|NCT03614156|19925155|P4|STARTED|Open-Label Treatment Period||0
8080977|NCT03614156|19925156|P3|STARTED|Open-Label Treatment Period||0
8080978|NCT03614156|19925157|P2|STARTED|Open-Label Treatment Period||0
8080979|NCT03614156|19925158|P1|STARTED|Open-Label Treatment Period||363
8080980|NCT03614078|19925170|P3|NOT COMPLETED|Overall Study||5
8080981|NCT03614078|19925171|P2|NOT COMPLETED|Overall Study||7
8080982|NCT03614078|19925172|P1|NOT COMPLETED|Overall Study||3
8080983|NCT03614078|19925170|P3|COMPLETED|Overall Study||26
8080984|NCT03614078|19925171|P2|COMPLETED|Overall Study||23
8080985|NCT03614078|19925172|P1|COMPLETED|Overall Study||28
8080986|NCT03614078|19925170|P3|STARTED|Overall Study||31
8080987|NCT03614078|19925171|P2|STARTED|Overall Study||30
8080988|NCT03614078|19925172|P1|STARTED|Overall Study||31
8080989|NCT03613649|19925201|P12|NOT COMPLETED|Fourth Treatment||0
8080990|NCT03613649|19925202|P11|NOT COMPLETED|Fourth Treatment||0
8080991|NCT03613649|19925203|P10|NOT COMPLETED|Fourth Treatment||0
8080992|NCT03613649|19925204|P9|NOT COMPLETED|Fourth Treatment||0
8080993|NCT03613649|19925205|P8|NOT COMPLETED|Fourth Treatment||0
8080994|NCT03613649|19925206|P7|NOT COMPLETED|Fourth Treatment||1
8080995|NCT03613649|19925207|P6|NOT COMPLETED|Fourth Treatment||0
8080996|NCT03613649|19925208|P5|NOT COMPLETED|Fourth Treatment||1
8080997|NCT03613649|19925209|P4|NOT COMPLETED|Fourth Treatment||0
8080998|NCT03613649|19925210|P3|NOT COMPLETED|Fourth Treatment||0
8080999|NCT03613649|19925211|P2|NOT COMPLETED|Fourth Treatment||0
8081000|NCT03613649|19925212|P1|NOT COMPLETED|Fourth Treatment||1
8081001|NCT03613649|19925201|P12|COMPLETED|Fourth Treatment||4
8081002|NCT03613649|19925202|P11|COMPLETED|Fourth Treatment||6
8081003|NCT03613649|19925203|P10|COMPLETED|Fourth Treatment||6
8081004|NCT03613649|19925204|P9|COMPLETED|Fourth Treatment||6
8081005|NCT03613649|19925205|P8|COMPLETED|Fourth Treatment||6
8081006|NCT03613649|19925206|P7|COMPLETED|Fourth Treatment||4
8081007|NCT03613649|19925207|P6|COMPLETED|Fourth Treatment||6
8081008|NCT03613649|19925208|P5|COMPLETED|Fourth Treatment||3
8081009|NCT03613649|19925209|P4|COMPLETED|Fourth Treatment||6
8081010|NCT03613649|19925210|P3|COMPLETED|Fourth Treatment||5
8081011|NCT03613649|19925211|P2|COMPLETED|Fourth Treatment||6
8081012|NCT03613649|19925212|P1|COMPLETED|Fourth Treatment||5
8081013|NCT03613649|19925201|P12|Received Treatment|Fourth Treatment||4
8081014|NCT03613649|19925202|P11|Received Treatment|Fourth Treatment||6
8081015|NCT03613649|19925203|P10|Received Treatment|Fourth Treatment||6
8081016|NCT03613649|19925204|P9|Received Treatment|Fourth Treatment||6
8081017|NCT03613649|19925205|P8|Received Treatment|Fourth Treatment||6
8081018|NCT03613649|19925206|P7|Received Treatment|Fourth Treatment||4
8081019|NCT03613649|19925207|P6|Received Treatment|Fourth Treatment||6
8081020|NCT03613649|19925208|P5|Received Treatment|Fourth Treatment||4
8081021|NCT03613649|19925209|P4|Received Treatment|Fourth Treatment||6
8081022|NCT03613649|19925210|P3|Received Treatment|Fourth Treatment||5
8081023|NCT03613649|19925211|P2|Received Treatment|Fourth Treatment||6
8081024|NCT03613649|19925212|P1|Received Treatment|Fourth Treatment||5
8081025|NCT03613649|19925201|P12|STARTED|Fourth Treatment||4
8081026|NCT03613649|19925202|P11|STARTED|Fourth Treatment||6
8081027|NCT03613649|19925203|P10|STARTED|Fourth Treatment||6
8081028|NCT03613649|19925204|P9|STARTED|Fourth Treatment||6
8081029|NCT03613649|19925205|P8|STARTED|Fourth Treatment||6
8081030|NCT03613649|19925206|P7|STARTED|Fourth Treatment||5
8081031|NCT03613649|19925207|P6|STARTED|Fourth Treatment||6
8081032|NCT03613649|19925208|P5|STARTED|Fourth Treatment||4
8081033|NCT03613649|19925209|P4|STARTED|Fourth Treatment||6
8081034|NCT03613649|19925210|P3|STARTED|Fourth Treatment||5
8081035|NCT03613649|19925211|P2|STARTED|Fourth Treatment||6
8081036|NCT03613649|19925212|P1|STARTED|Fourth Treatment||6
8081037|NCT03613649|19925201|P12|NOT COMPLETED|Third Treatment||2
8081038|NCT03613649|19925202|P11|NOT COMPLETED|Third Treatment||0
8081039|NCT03613649|19925203|P10|NOT COMPLETED|Third Treatment||0
8081040|NCT03613649|19925204|P9|NOT COMPLETED|Third Treatment||0
8081041|NCT03613649|19925205|P8|NOT COMPLETED|Third Treatment||0
8081042|NCT03613649|19925206|P7|NOT COMPLETED|Third Treatment||1
8081043|NCT03613649|19925207|P6|NOT COMPLETED|Third Treatment||0
8081044|NCT03613649|19925208|P5|NOT COMPLETED|Third Treatment||1
8081045|NCT03613649|19925209|P4|NOT COMPLETED|Third Treatment||0
8081046|NCT03613649|19925210|P3|NOT COMPLETED|Third Treatment||0
8081047|NCT03613649|19925211|P2|NOT COMPLETED|Third Treatment||0
8081048|NCT03613649|19925212|P1|NOT COMPLETED|Third Treatment||0
8081049|NCT03613649|19925201|P12|COMPLETED|Third Treatment||4
8081050|NCT03613649|19925202|P11|COMPLETED|Third Treatment||6
8081051|NCT03613649|19925203|P10|COMPLETED|Third Treatment||6
8081052|NCT03613649|19925204|P9|COMPLETED|Third Treatment||6
8081053|NCT03613649|19925205|P8|COMPLETED|Third Treatment||6
8081054|NCT03613649|19925206|P7|COMPLETED|Third Treatment||5
8081055|NCT03613649|19925207|P6|COMPLETED|Third Treatment||6
8081056|NCT03613649|19925208|P5|COMPLETED|Third Treatment||4
8081057|NCT03613649|19925209|P4|COMPLETED|Third Treatment||6
8081058|NCT03613649|19925210|P3|COMPLETED|Third Treatment||5
8081059|NCT03613649|19925211|P2|COMPLETED|Third Treatment||6
8081060|NCT03613649|19925212|P1|COMPLETED|Third Treatment||6
8081061|NCT03613649|19925201|P12|Received Treatment|Third Treatment||6
8081062|NCT03613649|19925202|P11|Received Treatment|Third Treatment||6
8081063|NCT03613649|19925203|P10|Received Treatment|Third Treatment||6
8081064|NCT03613649|19925204|P9|Received Treatment|Third Treatment||6
8081065|NCT03613649|19925205|P8|Received Treatment|Third Treatment||6
8081066|NCT03613649|19925206|P7|Received Treatment|Third Treatment||5
8081067|NCT03613649|19925207|P6|Received Treatment|Third Treatment||6
8081068|NCT03613649|19925208|P5|Received Treatment|Third Treatment||5
8081069|NCT03613649|19925209|P4|Received Treatment|Third Treatment||6
8081070|NCT03613649|19925210|P3|Received Treatment|Third Treatment||5
8081071|NCT03613649|19925211|P2|Received Treatment|Third Treatment||6
8081072|NCT03613649|19925212|P1|Received Treatment|Third Treatment||6
8081073|NCT03613649|19925201|P12|STARTED|Third Treatment||6
8081074|NCT03613649|19925202|P11|STARTED|Third Treatment||6
8081075|NCT03613649|19925203|P10|STARTED|Third Treatment||6
8081076|NCT03613649|19925204|P9|STARTED|Third Treatment||6
8081077|NCT03613649|19925205|P8|STARTED|Third Treatment||6
8081078|NCT03613649|19925206|P7|STARTED|Third Treatment||6
8081079|NCT03613649|19925207|P6|STARTED|Third Treatment||6
8081080|NCT03613649|19925208|P5|STARTED|Third Treatment||5
8081081|NCT03613649|19925209|P4|STARTED|Third Treatment||6
8081082|NCT03613649|19925210|P3|STARTED|Third Treatment||5
8081083|NCT03613649|19925211|P2|STARTED|Third Treatment||6
8081084|NCT03613649|19925212|P1|STARTED|Third Treatment||6
8081085|NCT03613649|19925201|P12|NOT COMPLETED|Second Treatment||0
8081086|NCT03613649|19925202|P11|NOT COMPLETED|Second Treatment||0
8081087|NCT03613649|19925203|P10|NOT COMPLETED|Second Treatment||0
8081088|NCT03613649|19925204|P9|NOT COMPLETED|Second Treatment||0
8081089|NCT03613649|19925205|P8|NOT COMPLETED|Second Treatment||0
8081090|NCT03613649|19925206|P7|NOT COMPLETED|Second Treatment||0
8081091|NCT03613649|19925207|P6|NOT COMPLETED|Second Treatment||0
8081092|NCT03613649|19925208|P5|NOT COMPLETED|Second Treatment||1
8081093|NCT03613649|19925209|P4|NOT COMPLETED|Second Treatment||0
8081094|NCT03613649|19925210|P3|NOT COMPLETED|Second Treatment||1
8081095|NCT03613649|19925211|P2|NOT COMPLETED|Second Treatment||0
8081096|NCT03613649|19925212|P1|NOT COMPLETED|Second Treatment||0
8081097|NCT03613649|19925201|P12|COMPLETED|Second Treatment||6
8081098|NCT03613649|19925202|P11|COMPLETED|Second Treatment||6
8081099|NCT03613649|19925203|P10|COMPLETED|Second Treatment||6
8081100|NCT03613649|19925204|P9|COMPLETED|Second Treatment||6
8081101|NCT03613649|19925205|P8|COMPLETED|Second Treatment||6
8081102|NCT03613649|19925206|P7|COMPLETED|Second Treatment||6
8081103|NCT03613649|19925207|P6|COMPLETED|Second Treatment||6
8081104|NCT03613649|19925208|P5|COMPLETED|Second Treatment||5
8081105|NCT03613649|19925209|P4|COMPLETED|Second Treatment||6
8081106|NCT03613649|19925210|P3|COMPLETED|Second Treatment||5
8081107|NCT03613649|19925211|P2|COMPLETED|Second Treatment||6
8081108|NCT03613649|19925212|P1|COMPLETED|Second Treatment||6
8081109|NCT03613649|19925201|P12|Received Treatment|Second Treatment||6
8081110|NCT03613649|19925202|P11|Received Treatment|Second Treatment||6
8081111|NCT03613649|19925203|P10|Received Treatment|Second Treatment||6
8081112|NCT03613649|19925204|P9|Received Treatment|Second Treatment||6
8081113|NCT03613649|19925205|P8|Received Treatment|Second Treatment||6
8081114|NCT03613649|19925206|P7|Received Treatment|Second Treatment||6
8081115|NCT03613649|19925207|P6|Received Treatment|Second Treatment||6
8081116|NCT03613649|19925208|P5|Received Treatment|Second Treatment||6
8081117|NCT03613649|19925209|P4|Received Treatment|Second Treatment||6
8081118|NCT03613649|19925210|P3|Received Treatment|Second Treatment||6
8081119|NCT03613649|19925211|P2|Received Treatment|Second Treatment||6
8081120|NCT03613649|19925212|P1|Received Treatment|Second Treatment||6
8081121|NCT03613649|19925201|P12|STARTED|Second Treatment||6
8081122|NCT03613649|19925202|P11|STARTED|Second Treatment||6
8081123|NCT03613649|19925203|P10|STARTED|Second Treatment||6
8081124|NCT03613649|19925204|P9|STARTED|Second Treatment||6
8081125|NCT03613649|19925205|P8|STARTED|Second Treatment||6
8081126|NCT03613649|19925206|P7|STARTED|Second Treatment||6
8081127|NCT03613649|19925207|P6|STARTED|Second Treatment||6
8081128|NCT03613649|19925208|P5|STARTED|Second Treatment||6
8081129|NCT03613649|19925209|P4|STARTED|Second Treatment||6
8081130|NCT03613649|19925210|P3|STARTED|Second Treatment||6
8081131|NCT03613649|19925211|P2|STARTED|Second Treatment||6
8081132|NCT03613649|19925212|P1|STARTED|Second Treatment||6
8081133|NCT03613649|19925201|P12|NOT COMPLETED|First Treatment||0
8081134|NCT03613649|19925202|P11|NOT COMPLETED|First Treatment||0
8081135|NCT03613649|19925203|P10|NOT COMPLETED|First Treatment||0
8081136|NCT03613649|19925204|P9|NOT COMPLETED|First Treatment||0
8081137|NCT03613649|19925205|P8|NOT COMPLETED|First Treatment||0
8081138|NCT03613649|19925206|P7|NOT COMPLETED|First Treatment||0
8081139|NCT03613649|19925207|P6|NOT COMPLETED|First Treatment||0
8081140|NCT03613649|19925208|P5|NOT COMPLETED|First Treatment||0
8081141|NCT03613649|19925209|P4|NOT COMPLETED|First Treatment||0
8081142|NCT03613649|19925210|P3|NOT COMPLETED|First Treatment||0
8081143|NCT03613649|19925211|P2|NOT COMPLETED|First Treatment||0
8081144|NCT03613649|19925212|P1|NOT COMPLETED|First Treatment||0
8081145|NCT03613649|19925201|P12|COMPLETED|First Treatment||6
8081146|NCT03613649|19925202|P11|COMPLETED|First Treatment||6
8081147|NCT03613649|19925203|P10|COMPLETED|First Treatment||6
8081148|NCT03613649|19925204|P9|COMPLETED|First Treatment||6
8081149|NCT03613649|19925205|P8|COMPLETED|First Treatment||6
8081150|NCT03613649|19925206|P7|COMPLETED|First Treatment||6
8081151|NCT03613649|19925207|P6|COMPLETED|First Treatment||6
8081152|NCT03613649|19925208|P5|COMPLETED|First Treatment||6
8081153|NCT03613649|19925209|P4|COMPLETED|First Treatment||6
8081154|NCT03613649|19925210|P3|COMPLETED|First Treatment||6
8081155|NCT03613649|19925211|P2|COMPLETED|First Treatment||6
8081156|NCT03613649|19925212|P1|COMPLETED|First Treatment||6
8081157|NCT03613649|19925201|P12|Received Treatment|First Treatment||6
8081158|NCT03613649|19925202|P11|Received Treatment|First Treatment||6
8081159|NCT03613649|19925203|P10|Received Treatment|First Treatment||6
8081160|NCT03613649|19925204|P9|Received Treatment|First Treatment||6
8081161|NCT03613649|19925205|P8|Received Treatment|First Treatment||6
8081162|NCT03613649|19925206|P7|Received Treatment|First Treatment||6
8081163|NCT03613649|19925207|P6|Received Treatment|First Treatment||6
8081164|NCT03613649|19925208|P5|Received Treatment|First Treatment||6
8081165|NCT03613649|19925209|P4|Received Treatment|First Treatment||6
8081166|NCT03613649|19925210|P3|Received Treatment|First Treatment||6
8081167|NCT03613649|19925211|P2|Received Treatment|First Treatment||6
8081168|NCT03613649|19925212|P1|Received Treatment|First Treatment||6
8081169|NCT03613649|19925201|P12|STARTED|First Treatment||6
8081170|NCT03613649|19925202|P11|STARTED|First Treatment||6
8081171|NCT03613649|19925203|P10|STARTED|First Treatment||6
8081172|NCT03613649|19925204|P9|STARTED|First Treatment||6
8081173|NCT03613649|19925205|P8|STARTED|First Treatment||6
8081174|NCT03613649|19925206|P7|STARTED|First Treatment||6
8081175|NCT03613649|19925207|P6|STARTED|First Treatment||6
8081176|NCT03613649|19925208|P5|STARTED|First Treatment||6
8081177|NCT03613649|19925209|P4|STARTED|First Treatment||6
8081178|NCT03613649|19925210|P3|STARTED|First Treatment||6
8081179|NCT03613649|19925211|P2|STARTED|First Treatment||6
8081180|NCT03613649|19925212|P1|STARTED|First Treatment||6
8081181|NCT03613493|19925341|P4|NOT COMPLETED|Overall Study||7
8081182|NCT03613493|19925342|P3|NOT COMPLETED|Overall Study||0
8081183|NCT03613493|19925343|P2|NOT COMPLETED|Overall Study||2
8081184|NCT03613493|19925344|P1|NOT COMPLETED|Overall Study||0
8081185|NCT03613493|19925341|P4|COMPLETED|Overall Study||83
8081186|NCT03613493|19925342|P3|COMPLETED|Overall Study||0
8081187|NCT03613493|19925343|P2|COMPLETED|Overall Study||73
8081188|NCT03613493|19925344|P1|COMPLETED|Overall Study||10
8081189|NCT03613493|19925341|P4|Enrollment Criteria Met|Overall Study||89
8081190|NCT03613493|19925342|P3|Enrollment Criteria Met|Overall Study||0
8081191|NCT03613493|19925343|P2|Enrollment Criteria Met|Overall Study||74
8081192|NCT03613493|19925344|P1|Enrollment Criteria Met|Overall Study||10
8081193|NCT03613493|19925341|P4|STARTED|Overall Study||90
8081194|NCT03613493|19925342|P3|STARTED|Overall Study||0
8081195|NCT03613493|19925343|P2|STARTED|Overall Study||75
8081196|NCT03613493|19925344|P1|STARTED|Overall Study||10
8081197|NCT03613129|19925357|P5|NOT COMPLETED|Post-treatment Assessment||0
8081198|NCT03613129|19925358|P4|NOT COMPLETED|Post-treatment Assessment||0
8081199|NCT03613129|19925359|P3|NOT COMPLETED|Post-treatment Assessment||0
8081200|NCT03613129|19925360|P2|NOT COMPLETED|Post-treatment Assessment||0
8081201|NCT03613129|19925361|P1|NOT COMPLETED|Post-treatment Assessment||0
8081202|NCT03613129|19925357|P5|COMPLETED|Post-treatment Assessment||2
8081203|NCT03613129|19925358|P4|COMPLETED|Post-treatment Assessment||2
8081204|NCT03613129|19925359|P3|COMPLETED|Post-treatment Assessment||7
8081205|NCT03613129|19925360|P2|COMPLETED|Post-treatment Assessment||3
8081206|NCT03613129|19925361|P1|COMPLETED|Post-treatment Assessment||0
8081207|NCT03613129|19925357|P5|STARTED|Post-treatment Assessment||2
8081208|NCT03613129|19925358|P4|STARTED|Post-treatment Assessment||2
8081209|NCT03613129|19925359|P3|STARTED|Post-treatment Assessment||7
8081210|NCT03613129|19925360|P2|STARTED|Post-treatment Assessment||3
8081211|NCT03613129|19925361|P1|STARTED|Post-treatment Assessment||0
8081212|NCT03613129|19925357|P5|NOT COMPLETED|Treatment||0
8081213|NCT03613129|19925358|P4|NOT COMPLETED|Treatment||0
8081214|NCT03613129|19925359|P3|NOT COMPLETED|Treatment||0
8081215|NCT03613129|19925360|P2|NOT COMPLETED|Treatment||0
8081216|NCT03613129|19925361|P1|NOT COMPLETED|Treatment||0
8081217|NCT03613129|19925357|P5|COMPLETED|Treatment||2
8081218|NCT03613129|19925358|P4|COMPLETED|Treatment|ID34 did not receive 3rd infusion (for lack of venous access)|2
8081219|NCT03613129|19925359|P3|COMPLETED|Treatment||7
8081220|NCT03613129|19925360|P2|COMPLETED|Treatment|ID35 received only 1 infusion (due to symptom worsening)|3
8081221|NCT03613129|19925361|P1|COMPLETED|Treatment||0
8081222|NCT03613129|19925357|P5|STARTED|Treatment||2
8081223|NCT03613129|19925358|P4|STARTED|Treatment||2
8081224|NCT03613129|19925359|P3|STARTED|Treatment||7
8081225|NCT03613129|19925360|P2|STARTED|Treatment||3
8081226|NCT03613129|19925361|P1|STARTED|Treatment||0
8081227|NCT03613129|19925357|P5|NOT COMPLETED|Pre-treatment Assessment||0
8081228|NCT03613129|19925358|P4|NOT COMPLETED|Pre-treatment Assessment||0
8081229|NCT03613129|19925359|P3|NOT COMPLETED|Pre-treatment Assessment||0
8081230|NCT03613129|19925360|P2|NOT COMPLETED|Pre-treatment Assessment||0
8081231|NCT03613129|19925361|P1|NOT COMPLETED|Pre-treatment Assessment||3
8081232|NCT03613129|19925357|P5|COMPLETED|Pre-treatment Assessment||2
8081233|NCT03613129|19925358|P4|COMPLETED|Pre-treatment Assessment||2
8081234|NCT03613129|19925359|P3|COMPLETED|Pre-treatment Assessment||7
8081235|NCT03613129|19925360|P2|COMPLETED|Pre-treatment Assessment||3
8081236|NCT03613129|19925361|P1|COMPLETED|Pre-treatment Assessment||0
8081237|NCT03613129|19925357|P5|STARTED|Pre-treatment Assessment||2
8081238|NCT03613129|19925358|P4|STARTED|Pre-treatment Assessment||2
8081239|NCT03613129|19925359|P3|STARTED|Pre-treatment Assessment||7
8081240|NCT03613129|19925360|P2|STARTED|Pre-treatment Assessment||3
8081241|NCT03613129|19925361|P1|STARTED|Pre-treatment Assessment||3
8081242|NCT03612856|19925386|P3|NOT COMPLETED|Post-dose Period||0
8081243|NCT03612856|19925387|P2|NOT COMPLETED|Post-dose Period||0
8081244|NCT03612856|19925388|P1|NOT COMPLETED|Post-dose Period||0
8081245|NCT03612856|19925386|P3|COMPLETED|Post-dose Period||8
8081246|NCT03612856|19925387|P2|COMPLETED|Post-dose Period||8
8081247|NCT03612856|19925388|P1|COMPLETED|Post-dose Period||8
8081248|NCT03612856|19925386|P3|STARTED|Post-dose Period||8
8081249|NCT03612856|19925387|P2|STARTED|Post-dose Period||8
8081250|NCT03612856|19925388|P1|STARTED|Post-dose Period||8
8081251|NCT03612856|19925386|P3|NOT COMPLETED|Pre-dose Period||1
8081252|NCT03612856|19925387|P2|NOT COMPLETED|Pre-dose Period||2
8081253|NCT03612856|19925388|P1|NOT COMPLETED|Pre-dose Period||0
8081254|NCT03612856|19925386|P3|COMPLETED|Pre-dose Period||8
8081255|NCT03612856|19925387|P2|COMPLETED|Pre-dose Period||8
8081256|NCT03612856|19925388|P1|COMPLETED|Pre-dose Period||8
8081257|NCT03612856|19925386|P3|STARTED|Pre-dose Period||9
8081258|NCT03612856|19925387|P2|STARTED|Pre-dose Period||10
8081259|NCT03612856|19925388|P1|STARTED|Pre-dose Period||8
8081260|NCT03611829|19925542|P2|NOT COMPLETED|Overall Study||25
8081261|NCT03611829|19925543|P1|NOT COMPLETED|Overall Study||22
8081262|NCT03611829|19925542|P2|COMPLETED|Overall Study||19
8081263|NCT03611829|19925543|P1|COMPLETED|Overall Study||21
8081264|NCT03611829|19925542|P2|STARTED|Overall Study||44
8081265|NCT03611829|19925543|P1|STARTED|Overall Study||43
8081266|NCT03610633|19925576|P2|NOT COMPLETED|Overall Study||1
8081267|NCT03610633|19925577|P1|NOT COMPLETED|Overall Study||0
8081268|NCT03610633|19925576|P2|COMPLETED|Overall Study||5
8081269|NCT03610633|19925577|P1|COMPLETED|Overall Study||5
8081270|NCT03610633|19925576|P2|STARTED|Overall Study||6
8081271|NCT03610633|19925577|P1|STARTED|Overall Study||5
8081272|NCT03610464|19925583|P1|NOT COMPLETED|Overall Study||0
8081273|NCT03610464|19925583|P1|COMPLETED|Overall Study||5
8081274|NCT03610464|19925583|P1|STARTED|Overall Study||5
8081275|NCT03610269|19925588|P1|NOT COMPLETED|Overall Study||16
8081276|NCT03610269|19925588|P1|COMPLETED|Overall Study||127
8081277|NCT03610269|19925588|P1|STARTED|Overall Study||143
8081284|NCT03608839|19925606|P3|NOT COMPLETED|Overall Study||0
8081285|NCT03608839|19925607|P2|NOT COMPLETED|Overall Study||0
8081286|NCT03608839|19925608|P1|NOT COMPLETED|Overall Study||0
8081287|NCT03608839|19925606|P3|COMPLETED|Overall Study||9
8081288|NCT03608839|19925607|P2|COMPLETED|Overall Study||9
8081289|NCT03608839|19925608|P1|COMPLETED|Overall Study||9
8081290|NCT03608839|19925606|P3|STARTED|Overall Study||9
8081291|NCT03608839|19925607|P2|STARTED|Overall Study||9
8081292|NCT03608839|19925608|P1|STARTED|Overall Study||9
8081293|NCT03608774|19925633|P2|NOT COMPLETED|Overall Study||7
8081294|NCT03608774|19925634|P1|NOT COMPLETED|Overall Study||7
8081295|NCT03608774|19925633|P2|COMPLETED|Overall Study||81
8081296|NCT03608774|19925634|P1|COMPLETED|Overall Study||82
8081297|NCT03608774|19925633|P2|STARTED|Overall Study||88
8081298|NCT03608774|19925634|P1|STARTED|Overall Study||89
8081299|NCT03608488|19925654|P4|NOT COMPLETED|Overall Study||5
8081300|NCT03608488|19925655|P3|NOT COMPLETED|Overall Study||2
8081301|NCT03608488|19925656|P2|NOT COMPLETED|Overall Study||3
8081302|NCT03608488|19925657|P1|NOT COMPLETED|Overall Study||1
8081303|NCT03608488|19925654|P4|COMPLETED|Overall Study||40
8081304|NCT03608488|19925655|P3|COMPLETED|Overall Study||20
8081305|NCT03608488|19925656|P2|COMPLETED|Overall Study||18
8081306|NCT03608488|19925657|P1|COMPLETED|Overall Study||21
8081307|NCT03608488|19925654|P4|STARTED|Overall Study||45
8081308|NCT03608488|19925655|P3|STARTED|Overall Study||22
8081309|NCT03608488|19925656|P2|STARTED|Overall Study||21
8081310|NCT03608488|19925657|P1|STARTED|Overall Study||22
8081311|NCT03607682|19925695|P1|NOT COMPLETED|Overall Study||2
8081312|NCT03607682|19925695|P1|COMPLETED|Overall Study||0
8081313|NCT03607682|19925695|P1|STARTED|Overall Study||2
8081314|NCT03607487|19925711|P4|NOT COMPLETED|Overall Study||1
8081315|NCT03607487|19925712|P3|NOT COMPLETED|Overall Study||0
8081316|NCT03607487|19925713|P2|NOT COMPLETED|Overall Study||0
8081317|NCT03607487|19925714|P1|NOT COMPLETED|Overall Study||2
8081318|NCT03607487|19925711|P4|COMPLETED|Overall Study||7
8081319|NCT03607487|19925712|P3|COMPLETED|Overall Study||9
8081320|NCT03607487|19925713|P2|COMPLETED|Overall Study||9
8081321|NCT03607487|19925714|P1|COMPLETED|Overall Study||7
8081322|NCT03607487|19925711|P4|STARTED|Overall Study||8
8081323|NCT03607487|19925712|P3|STARTED|Overall Study||9
8081324|NCT03607487|19925713|P2|STARTED|Overall Study||9
8081325|NCT03607487|19925714|P1|STARTED|Overall Study||9
8081326|NCT03606460|19925765|P2|NOT COMPLETED|Overall Study||8
8081327|NCT03606460|19925766|P1|NOT COMPLETED|Overall Study||1
8081328|NCT03606460|19925765|P2|COMPLETED|Overall Study||38
8081329|NCT03606460|19925766|P1|COMPLETED|Overall Study||94
8081330|NCT03606460|19925765|P2|STARTED|Overall Study||46
8081331|NCT03606460|19925766|P1|STARTED|Overall Study||95
8081332|NCT03606343|19925774|P1|NOT COMPLETED|Overall Study||0
8081333|NCT03606343|19925774|P1|COMPLETED|Overall Study||21
8081334|NCT03606343|19925774|P1|STARTED|Overall Study||21
8081335|NCT03605693|19925786|P2|NOT COMPLETED|Overall Study||0
8081336|NCT03605693|19925787|P1|NOT COMPLETED|Overall Study||5
8081337|NCT03605693|19925786|P2|COMPLETED|Overall Study||5
8081338|NCT03605693|19925787|P1|COMPLETED|Overall Study||0
8081339|NCT03605693|19925786|P2|STARTED|Overall Study||5
8081340|NCT03605693|19925787|P1|STARTED|Overall Study||5
8081341|NCT03605303|19925801|P2|NOT COMPLETED|Period 2||0
8081342|NCT03605303|19925802|P1|NOT COMPLETED|Period 2||0
8081343|NCT03605303|19925801|P2|COMPLETED|Period 2||0
8081344|NCT03605303|19925802|P1|COMPLETED|Period 2||0
8081345|NCT03605303|19925801|P2|STARTED|Period 2||0
8081346|NCT03605303|19925802|P1|STARTED|Period 2||0
8081347|NCT03605303|19925801|P2|NOT COMPLETED|Period 1||1
8081348|NCT03605303|19925802|P1|NOT COMPLETED|Period 1||2
8081349|NCT03605303|19925801|P2|COMPLETED|Period 1||0
8081350|NCT03605303|19925802|P1|COMPLETED|Period 1||0
8081351|NCT03605303|19925801|P2|STARTED|Period 1||1
8081352|NCT03605303|19925802|P1|STARTED|Period 1||2
8081353|NCT03604497|19925810|P1|NOT COMPLETED|Overall Study||52
8081354|NCT03604497|19925810|P1|COMPLETED|Overall Study||385
8081355|NCT03604497|19925810|P1|STARTED|Overall Study||437
8081356|NCT03604341|19925820|P2|NOT COMPLETED|Overall Study||2
8081357|NCT03604341|19925821|P1|NOT COMPLETED|Overall Study||2
8081358|NCT03604341|19925820|P2|COMPLETED|Overall Study||33
8081359|NCT03604341|19925821|P1|COMPLETED|Overall Study||33
8081360|NCT03604341|19925820|P2|STARTED|Overall Study||35
8081361|NCT03604341|19925821|P1|STARTED|Overall Study||35
8081362|NCT03604263|19925827|P1|NOT COMPLETED|Overall Study||2
8081363|NCT03604263|19925827|P1|COMPLETED|Overall Study||15
8081364|NCT03604263|19925827|P1|STARTED|Overall Study||17
8081365|NCT03603652|19925831|P1|NOT COMPLETED|Overall Study||2
8081366|NCT03603652|19925831|P1|COMPLETED|Overall Study||8
8081367|NCT03603652|19925831|P1|STARTED|Overall Study||10
8081401|NCT03603028|19925917|P1|NOT COMPLETED|Overall Study||1
8081402|NCT03603028|19925917|P1|COMPLETED|Overall Study||12
8081403|NCT03603028|19925917|P1|STARTED|Overall Study||13
8081404|NCT03602053|19925925|P3|NOT COMPLETED|Overall Study||11
8081405|NCT03602053|19925926|P2|NOT COMPLETED|Overall Study||18
8081406|NCT03602053|19925927|P1|NOT COMPLETED|Overall Study||19
8081407|NCT03602053|19925925|P3|COMPLETED|Overall Study||139
8081408|NCT03602053|19925926|P2|COMPLETED|Overall Study||132
8081409|NCT03602053|19925927|P1|COMPLETED|Overall Study||131
8081410|NCT03602053|19925925|P3|STARTED|Overall Study||150
8081411|NCT03602053|19925926|P2|STARTED|Overall Study||150
8081412|NCT03602053|19925927|P1|STARTED|Overall Study||150
8081413|NCT03601715|19925973|P3|NOT COMPLETED|Third Intervention||0
8081414|NCT03601715|19925974|P2|NOT COMPLETED|Third Intervention||0
8081415|NCT03601715|19925975|P1|NOT COMPLETED|Third Intervention||0
8081416|NCT03601715|19925973|P3|COMPLETED|Third Intervention||6
8081417|NCT03601715|19925974|P2|COMPLETED|Third Intervention||6
8081418|NCT03601715|19925975|P1|COMPLETED|Third Intervention||6
8081419|NCT03601715|19925973|P3|STARTED|Third Intervention||6
8081420|NCT03601715|19925974|P2|STARTED|Third Intervention||6
8081421|NCT03601715|19925975|P1|STARTED|Third Intervention||6
8081422|NCT03601715|19925973|P3|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
8081423|NCT03601715|19925974|P2|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
8081424|NCT03601715|19925975|P1|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
8081425|NCT03601715|19925973|P3|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
8081426|NCT03601715|19925974|P2|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
8081427|NCT03601715|19925975|P1|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
8081428|NCT03601715|19925973|P3|STARTED|Wash Out 2 (at Least 24 Hours)||6
8081429|NCT03601715|19925974|P2|STARTED|Wash Out 2 (at Least 24 Hours)||6
8081430|NCT03601715|19925975|P1|STARTED|Wash Out 2 (at Least 24 Hours)||6
8081431|NCT03601715|19925973|P3|NOT COMPLETED|Second Intervention||0
8081432|NCT03601715|19925974|P2|NOT COMPLETED|Second Intervention||1
8081433|NCT03601715|19925975|P1|NOT COMPLETED|Second Intervention||1
8081434|NCT03601715|19925973|P3|COMPLETED|Second Intervention||6
8081435|NCT03601715|19925974|P2|COMPLETED|Second Intervention||6
8081436|NCT03601715|19925975|P1|COMPLETED|Second Intervention||6
8081437|NCT03601715|19925973|P3|STARTED|Second Intervention||6
8081438|NCT03601715|19925974|P2|STARTED|Second Intervention||7
8081439|NCT03601715|19925975|P1|STARTED|Second Intervention||7
8081440|NCT03601715|19925973|P3|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
8081441|NCT03601715|19925974|P2|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
8081442|NCT03601715|19925975|P1|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
8081443|NCT03601715|19925973|P3|COMPLETED|Washout 1 (at Least 24 Hours)||6
8081444|NCT03601715|19925974|P2|COMPLETED|Washout 1 (at Least 24 Hours)||7
8081445|NCT03601715|19925975|P1|COMPLETED|Washout 1 (at Least 24 Hours)||7
8081446|NCT03601715|19925973|P3|STARTED|Washout 1 (at Least 24 Hours)||6
8081447|NCT03601715|19925974|P2|STARTED|Washout 1 (at Least 24 Hours)||7
8081448|NCT03601715|19925975|P1|STARTED|Washout 1 (at Least 24 Hours)||7
8081449|NCT03601715|19925973|P3|NOT COMPLETED|First Intervention||0
8081450|NCT03601715|19925974|P2|NOT COMPLETED|First Intervention||0
8081451|NCT03601715|19925975|P1|NOT COMPLETED|First Intervention||0
8081452|NCT03601715|19925973|P3|COMPLETED|First Intervention||6
8081453|NCT03601715|19925974|P2|COMPLETED|First Intervention||7
8081454|NCT03601715|19925975|P1|COMPLETED|First Intervention||7
8081455|NCT03601715|19925973|P3|STARTED|First Intervention||6
8081456|NCT03601715|19925974|P2|STARTED|First Intervention||7
8081457|NCT03601715|19925975|P1|STARTED|First Intervention||7
8081458|NCT03599986|19925989|P1|NOT COMPLETED|Overall Study||32
8081459|NCT03599986|19925989|P1|COMPLETED|Overall Study||366
8081460|NCT03599986|19925989|P1|STARTED|Overall Study||398
8081461|NCT03599687|19925997|P2|NOT COMPLETED|Overall Study||0
8081462|NCT03599687|19925998|P1|NOT COMPLETED|Overall Study||0
8081463|NCT03599687|19925997|P2|COMPLETED|Overall Study||82
8081464|NCT03599687|19925998|P1|COMPLETED|Overall Study||82
8081465|NCT03599687|19925997|P2|STARTED|Overall Study||82
8081466|NCT03599687|19925998|P1|STARTED|Overall Study||82
8081467|NCT03599349|19926008|P1|NOT COMPLETED|Overall Study||1
8081468|NCT03599349|19926008|P1|COMPLETED|Overall Study||19
8081469|NCT03599349|19926008|P1|Treated|Overall Study||20
8081470|NCT03599349|19926008|P1|STARTED|Overall Study||20
8081477|NCT03598140|19926037|P2|NOT COMPLETED|Overall Study||0
8081478|NCT03598140|19926038|P1|NOT COMPLETED|Overall Study||1
8081479|NCT03598140|19926037|P2|COMPLETED|Overall Study||11
8081480|NCT03598140|19926038|P1|COMPLETED|Overall Study||9
8081481|NCT03598140|19926037|P2|STARTED|Overall Study||11
8081482|NCT03598140|19926038|P1|STARTED|Overall Study||10
8081483|NCT03597178|19926050|P1|NOT COMPLETED|Overall Study||0
8081484|NCT03597178|19926050|P1|COMPLETED|Overall Study||14
8081485|NCT03597178|19926050|P1|STARTED|Overall Study||14
8081486|NCT03597022|19926057|P3|NOT COMPLETED|Overall Study||8
8081487|NCT03597022|19926058|P2|NOT COMPLETED|Overall Study||8
8081488|NCT03597022|19926059|P1|NOT COMPLETED|Overall Study||8
8081489|NCT03597022|19926057|P3|COMPLETED|Overall Study||0
8081490|NCT03597022|19926058|P2|COMPLETED|Overall Study||0
8081491|NCT03597022|19926059|P1|COMPLETED|Overall Study||0
8081492|NCT03597022|19926057|P3|STARTED|Overall Study||8
8081493|NCT03597022|19926058|P2|STARTED|Overall Study||8
8081494|NCT03597022|19926059|P1|STARTED|Overall Study||8
8081495|NCT03596723|19926078|P2|NOT COMPLETED|Overall Study||0
8081496|NCT03596723|19926079|P1|NOT COMPLETED|Overall Study||0
8081497|NCT03596723|19926078|P2|COMPLETED|Overall Study||1
8081498|NCT03596723|19926079|P1|COMPLETED|Overall Study||1
8081499|NCT03596723|19926078|P2|STARTED|Overall Study||1
8081500|NCT03596723|19926079|P1|STARTED|Overall Study||1
8081516|NCT03594227|19926148|P4|NOT COMPLETED|Overall Study||5
8081517|NCT03594227|19926149|P3|NOT COMPLETED|Overall Study||3
8081518|NCT03594227|19926150|P2|NOT COMPLETED|Overall Study||4
8081519|NCT03594227|19926151|P1|NOT COMPLETED|Overall Study||5
8081520|NCT03594227|19926148|P4|COMPLETED|Overall Study||14
8081521|NCT03594227|19926149|P3|COMPLETED|Overall Study||19
8081522|NCT03594227|19926150|P2|COMPLETED|Overall Study||19
8081523|NCT03594227|19926151|P1|COMPLETED|Overall Study||18
8081524|NCT03594227|19926148|P4|STARTED|Overall Study||19
8081525|NCT03594227|19926149|P3|STARTED|Overall Study||22
8081526|NCT03594227|19926150|P2|STARTED|Overall Study||23
8081527|NCT03594227|19926151|P1|STARTED|Overall Study||23
8081528|NCT03594045|19926287|P2|NOT COMPLETED|Overall Study||0
8081529|NCT03594045|19926288|P1|NOT COMPLETED|Overall Study||0
8081530|NCT03594045|19926287|P2|COMPLETED|Overall Study||5
8081531|NCT03594045|19926288|P1|COMPLETED|Overall Study||0
8081532|NCT03594045|19926287|P2|STARTED|Overall Study||5
8081533|NCT03594045|19926288|P1|STARTED|Overall Study||0
8081534|NCT03593902|19926308|P1|NOT COMPLETED|Overall Study||0
8081535|NCT03593902|19926308|P1|COMPLETED|Overall Study||9
8081536|NCT03593902|19926308|P1|STARTED|Overall Study||9
8081537|NCT03593681|19926313|P1|NOT COMPLETED|Overall Study||35
8081538|NCT03593681|19926313|P1|COMPLETED|Overall Study||115
8081539|NCT03593681|19926313|P1|STARTED|Overall Study||150
8081540|NCT03593200|19926336|P1|NOT COMPLETED|Overall Study||0
8081541|NCT03593200|19926336|P1|COMPLETED|Overall Study||4
8081542|NCT03593200|19926336|P1|STARTED|Overall Study||4
8081543|NCT03592186|19926353|P2|NOT COMPLETED|Overall Study||11
8081544|NCT03592186|19926354|P1|NOT COMPLETED|Overall Study||17
8081545|NCT03592186|19926353|P2|COMPLETED|Overall Study||51
8081546|NCT03592186|19926354|P1|COMPLETED|Overall Study||43
8081547|NCT03592186|19926353|P2|12-week Follow-up|Overall Study||51
8081548|NCT03592186|19926354|P1|12-week Follow-up|Overall Study||47
8081549|NCT03592186|19926353|P2|6-week Follow-up|Overall Study||56
8081550|NCT03592186|19926354|P1|6-week Follow-up|Overall Study||49
8081551|NCT03592186|19926353|P2|STARTED|Overall Study||62
8081552|NCT03592186|19926354|P1|STARTED|Overall Study||60
8081553|NCT03592121|19926362|P2|NOT COMPLETED|Overall Study||0
8081554|NCT03592121|19926363|P1|NOT COMPLETED|Overall Study||0
8081555|NCT03592121|19926362|P2|COMPLETED|Overall Study||0
8081556|NCT03592121|19926363|P1|COMPLETED|Overall Study||3
8081557|NCT03592121|19926362|P2|STARTED|Overall Study||0
8081558|NCT03592121|19926363|P1|STARTED|Overall Study||3
8081559|NCT03591458|19926371|P2|NOT COMPLETED|Overall Study||0
8081560|NCT03591458|19926372|P1|NOT COMPLETED|Overall Study||0
8081561|NCT03591458|19926371|P2|COMPLETED|Overall Study||1
8081562|NCT03591458|19926372|P1|COMPLETED|Overall Study||1
8081563|NCT03591458|19926371|P2|STARTED|Overall Study||1
8081564|NCT03591458|19926372|P1|STARTED|Overall Study||1
8081571|NCT03591068|19926431|P1|NOT COMPLETED|Overall Study||2
8081572|NCT03591068|19926431|P1|COMPLETED|Overall Study||9
8081573|NCT03591068|19926431|P1|STARTED|Overall Study||11
8081574|NCT03590743|19926449|P2|NOT COMPLETED|Overall Study||1
8081575|NCT03590743|19926450|P1|NOT COMPLETED|Overall Study||0
8081576|NCT03590743|19926449|P2|COMPLETED|Overall Study||2
8081577|NCT03590743|19926450|P1|COMPLETED|Overall Study||2
8081578|NCT03590743|19926449|P2|STARTED|Overall Study||3
8081579|NCT03590743|19926450|P1|STARTED|Overall Study||2
8081580|NCT03590613|19926462|P4|NOT COMPLETED|Period 4, 4 Days||0
8081581|NCT03590613|19926463|P3|NOT COMPLETED|Period 4, 4 Days||0
8081582|NCT03590613|19926464|P2|NOT COMPLETED|Period 4, 4 Days||0
8081583|NCT03590613|19926465|P1|NOT COMPLETED|Period 4, 4 Days||0
8081584|NCT03590613|19926462|P4|COMPLETED|Period 4, 4 Days||3
8081585|NCT03590613|19926463|P3|COMPLETED|Period 4, 4 Days||3
8081586|NCT03590613|19926464|P2|COMPLETED|Period 4, 4 Days||3
8081587|NCT03590613|19926465|P1|COMPLETED|Period 4, 4 Days||3
8081588|NCT03590613|19926462|P4|STARTED|Period 4, 4 Days||3
8081589|NCT03590613|19926463|P3|STARTED|Period 4, 4 Days||3
8081590|NCT03590613|19926464|P2|STARTED|Period 4, 4 Days||3
8081591|NCT03590613|19926465|P1|STARTED|Period 4, 4 Days||3
8081592|NCT03590613|19926462|P4|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
8081593|NCT03590613|19926463|P3|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
8081594|NCT03590613|19926464|P2|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
8081595|NCT03590613|19926465|P1|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
8081596|NCT03590613|19926462|P4|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
8081597|NCT03590613|19926463|P3|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
8081598|NCT03590613|19926464|P2|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
8081599|NCT03590613|19926465|P1|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
8081600|NCT03590613|19926462|P4|STARTED|Period 3,Wash-out, at Least 3 Days||3
8081601|NCT03590613|19926463|P3|STARTED|Period 3,Wash-out, at Least 3 Days||3
8081602|NCT03590613|19926464|P2|STARTED|Period 3,Wash-out, at Least 3 Days||3
8081603|NCT03590613|19926465|P1|STARTED|Period 3,Wash-out, at Least 3 Days||3
8081604|NCT03590613|19926462|P4|NOT COMPLETED|Period 3, 4 Days||0
8081605|NCT03590613|19926463|P3|NOT COMPLETED|Period 3, 4 Days||0
8081606|NCT03590613|19926464|P2|NOT COMPLETED|Period 3, 4 Days||0
8081607|NCT03590613|19926465|P1|NOT COMPLETED|Period 3, 4 Days||0
8081608|NCT03590613|19926462|P4|COMPLETED|Period 3, 4 Days||3
8081609|NCT03590613|19926463|P3|COMPLETED|Period 3, 4 Days||3
8081610|NCT03590613|19926464|P2|COMPLETED|Period 3, 4 Days||3
8081611|NCT03590613|19926465|P1|COMPLETED|Period 3, 4 Days||3
8081612|NCT03590613|19926462|P4|STARTED|Period 3, 4 Days||3
8081613|NCT03590613|19926463|P3|STARTED|Period 3, 4 Days||3
8081614|NCT03590613|19926464|P2|STARTED|Period 3, 4 Days||3
8081615|NCT03590613|19926465|P1|STARTED|Period 3, 4 Days||3
8081616|NCT03590613|19926462|P4|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
8081617|NCT03590613|19926463|P3|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
8081618|NCT03590613|19926464|P2|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
8081619|NCT03590613|19926465|P1|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
8081620|NCT03590613|19926462|P4|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
8081621|NCT03590613|19926463|P3|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
8081622|NCT03590613|19926464|P2|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
8081623|NCT03590613|19926465|P1|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
8081624|NCT03590613|19926462|P4|STARTED|Period 2, Wash-out, at Least 3 Days||3
8081625|NCT03590613|19926463|P3|STARTED|Period 2, Wash-out, at Least 3 Days||3
8081626|NCT03590613|19926464|P2|STARTED|Period 2, Wash-out, at Least 3 Days||3
8081627|NCT03590613|19926465|P1|STARTED|Period 2, Wash-out, at Least 3 Days||3
8081628|NCT03590613|19926462|P4|NOT COMPLETED|Period 2, 4 Days||1
8081629|NCT03590613|19926463|P3|NOT COMPLETED|Period 2, 4 Days||0
8081630|NCT03590613|19926464|P2|NOT COMPLETED|Period 2, 4 Days||0
8081631|NCT03590613|19926465|P1|NOT COMPLETED|Period 2, 4 Days||0
8081632|NCT03590613|19926462|P4|COMPLETED|Period 2, 4 Days||3
8081633|NCT03590613|19926463|P3|COMPLETED|Period 2, 4 Days||3
8081634|NCT03590613|19926464|P2|COMPLETED|Period 2, 4 Days||3
8081635|NCT03590613|19926465|P1|COMPLETED|Period 2, 4 Days||3
8081636|NCT03590613|19926462|P4|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4
8081637|NCT03590613|19926463|P3|STARTED|Period 2, 4 Days||3
8081638|NCT03590613|19926464|P2|STARTED|Period 2, 4 Days||3
8081639|NCT03590613|19926465|P1|STARTED|Period 2, 4 Days||3
8081640|NCT03590613|19926462|P4|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
8081641|NCT03590613|19926463|P3|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
8081642|NCT03590613|19926464|P2|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
8081643|NCT03590613|19926465|P1|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
8081644|NCT03590613|19926462|P4|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
8081645|NCT03590613|19926463|P3|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
8081646|NCT03590613|19926464|P2|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
8081647|NCT03590613|19926465|P1|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
8081648|NCT03590613|19926462|P4|STARTED|Period 1, Wash-out, at Least 3 Days||3
8081649|NCT03590613|19926463|P3|STARTED|Period 1, Wash-out, at Least 3 Days||3
8081650|NCT03590613|19926464|P2|STARTED|Period 1, Wash-out, at Least 3 Days||3
8081651|NCT03590613|19926465|P1|STARTED|Period 1, Wash-out, at Least 3 Days||3
8081652|NCT03590613|19926462|P4|NOT COMPLETED|Period 1, 4 Days||0
8081653|NCT03590613|19926463|P3|NOT COMPLETED|Period 1, 4 Days||0
8081654|NCT03590613|19926464|P2|NOT COMPLETED|Period 1, 4 Days||0
8081655|NCT03590613|19926465|P1|NOT COMPLETED|Period 1, 4 Days||0
8081656|NCT03590613|19926462|P4|COMPLETED|Period 1, 4 Days||3
8081657|NCT03590613|19926463|P3|COMPLETED|Period 1, 4 Days||3
8081658|NCT03590613|19926464|P2|COMPLETED|Period 1, 4 Days||3
8081659|NCT03590613|19926465|P1|COMPLETED|Period 1, 4 Days||3
8081660|NCT03590613|19926462|P4|STARTED|Period 1, 4 Days||3
8081661|NCT03590613|19926463|P3|STARTED|Period 1, 4 Days||3
8081662|NCT03590613|19926464|P2|STARTED|Period 1, 4 Days||3
8081663|NCT03590613|19926465|P1|STARTED|Period 1, 4 Days||3
8081664|NCT03588806|19926583|P1|NOT COMPLETED|Overall Study||0
8081665|NCT03588806|19926583|P1|COMPLETED|Overall Study||11
8081666|NCT03588806|19926583|P1|STARTED|Overall Study||11
8081667|NCT03588741|19926594|P1|NOT COMPLETED|Overall Study||1
8081668|NCT03588741|19926594|P1|COMPLETED|Overall Study||0
8081669|NCT03588741|19926594|P1|STARTED|Overall Study||1
8081670|NCT03588572|19926601|P2|NOT COMPLETED|Visitation 3||2
8081671|NCT03588572|19926602|P1|NOT COMPLETED|Visitation 3||3
8081672|NCT03588572|19926601|P2|COMPLETED|Visitation 3||16
8081673|NCT03588572|19926602|P1|COMPLETED|Visitation 3||16
8081674|NCT03588572|19926601|P2|STARTED|Visitation 3||18
8081675|NCT03588572|19926602|P1|STARTED|Visitation 3||19
8081676|NCT03588572|19926601|P2|NOT COMPLETED|Visitation 2||2
8081677|NCT03588572|19926602|P1|NOT COMPLETED|Visitation 2||2
8081678|NCT03588572|19926601|P2|COMPLETED|Visitation 2||18
8081679|NCT03588572|19926602|P1|COMPLETED|Visitation 2||19
8081680|NCT03588572|19926601|P2|STARTED|Visitation 2||20
8081681|NCT03588572|19926602|P1|STARTED|Visitation 2||21
8081682|NCT03588572|19926601|P2|NOT COMPLETED|Visitation 1||1
8081683|NCT03588572|19926602|P1|NOT COMPLETED|Visitation 1||1
8081684|NCT03588572|19926601|P2|COMPLETED|Visitation 1||20
8081685|NCT03588572|19926602|P1|COMPLETED|Visitation 1||21
8081686|NCT03588572|19926601|P2|STARTED|Visitation 1||21
8081687|NCT03588572|19926602|P1|STARTED|Visitation 1||22
8081688|NCT03587974|19926620|P2|NOT COMPLETED|Overall Study||4
8081689|NCT03587974|19926621|P1|NOT COMPLETED|Overall Study||5
8081690|NCT03587974|19926620|P2|COMPLETED|Overall Study||26
8081691|NCT03587974|19926621|P1|COMPLETED|Overall Study||25
8081692|NCT03587974|19926620|P2|STARTED|Overall Study||30
8081693|NCT03587974|19926621|P1|STARTED|Overall Study||30
8081694|NCT03587428|19926631|P6|NOT COMPLETED|Period 3||0
8081695|NCT03587428|19926632|P5|NOT COMPLETED|Period 3||0
8081696|NCT03587428|19926633|P4|NOT COMPLETED|Period 3||0
8081697|NCT03587428|19926634|P3|NOT COMPLETED|Period 3||0
8081698|NCT03587428|19926635|P2|NOT COMPLETED|Period 3||0
8081699|NCT03587428|19926636|P1|NOT COMPLETED|Period 3||0
8081700|NCT03587428|19926631|P6|COMPLETED|Period 3||2
8081701|NCT03587428|19926632|P5|COMPLETED|Period 3||2
8081702|NCT03587428|19926633|P4|COMPLETED|Period 3||3
8081703|NCT03587428|19926634|P3|COMPLETED|Period 3||3
8081704|NCT03587428|19926635|P2|COMPLETED|Period 3||2
8081705|NCT03587428|19926636|P1|COMPLETED|Period 3||3
8081706|NCT03587428|19926631|P6|STARTED|Period 3||2
8081707|NCT03587428|19926632|P5|STARTED|Period 3||2
8081708|NCT03587428|19926633|P4|STARTED|Period 3||3
8081709|NCT03587428|19926634|P3|STARTED|Period 3||3
8081710|NCT03587428|19926635|P2|STARTED|Period 3||2
8081711|NCT03587428|19926636|P1|STARTED|Period 3||3
8081712|NCT03587428|19926631|P6|NOT COMPLETED|Period 2||0
8081713|NCT03587428|19926632|P5|NOT COMPLETED|Period 2||0
8081714|NCT03587428|19926633|P4|NOT COMPLETED|Period 2||0
8081715|NCT03587428|19926634|P3|NOT COMPLETED|Period 2||0
8081716|NCT03587428|19926635|P2|NOT COMPLETED|Period 2||0
8081717|NCT03587428|19926636|P1|NOT COMPLETED|Period 2||0
8081718|NCT03587428|19926631|P6|COMPLETED|Period 2||2
8081719|NCT03587428|19926632|P5|COMPLETED|Period 2||2
8081720|NCT03587428|19926633|P4|COMPLETED|Period 2||3
8081721|NCT03587428|19926634|P3|COMPLETED|Period 2||3
8081722|NCT03587428|19926635|P2|COMPLETED|Period 2||2
8081723|NCT03587428|19926636|P1|COMPLETED|Period 2||3
8081724|NCT03587428|19926631|P6|STARTED|Period 2||2
8081725|NCT03587428|19926632|P5|STARTED|Period 2||2
8081726|NCT03587428|19926633|P4|STARTED|Period 2||3
8081727|NCT03587428|19926634|P3|STARTED|Period 2||3
8081728|NCT03587428|19926635|P2|STARTED|Period 2||2
8081729|NCT03587428|19926636|P1|STARTED|Period 2||3
8081730|NCT03587428|19926631|P6|NOT COMPLETED|Period 1||0
8081731|NCT03587428|19926632|P5|NOT COMPLETED|Period 1||0
8081732|NCT03587428|19926633|P4|NOT COMPLETED|Period 1||0
8081733|NCT03587428|19926634|P3|NOT COMPLETED|Period 1||0
8081734|NCT03587428|19926635|P2|NOT COMPLETED|Period 1||0
8081735|NCT03587428|19926636|P1|NOT COMPLETED|Period 1||0
8081736|NCT03587428|19926631|P6|COMPLETED|Period 1||2
8081737|NCT03587428|19926632|P5|COMPLETED|Period 1||2
8081738|NCT03587428|19926633|P4|COMPLETED|Period 1||3
8081739|NCT03587428|19926634|P3|COMPLETED|Period 1||3
8081740|NCT03587428|19926635|P2|COMPLETED|Period 1||2
8081741|NCT03587428|19926636|P1|COMPLETED|Period 1||3
8081742|NCT03587428|19926631|P6|STARTED|Period 1||2
8081743|NCT03587428|19926632|P5|STARTED|Period 1||2
8081744|NCT03587428|19926633|P4|STARTED|Period 1||3
8081745|NCT03587428|19926634|P3|STARTED|Period 1||3
8081746|NCT03587428|19926635|P2|STARTED|Period 1||2
8081747|NCT03587428|19926636|P1|STARTED|Period 1||3
8081748|NCT03587207|19926658|P5|NOT COMPLETED|Overall Study||0
8081749|NCT03587207|19926659|P4|NOT COMPLETED|Overall Study||0
8081750|NCT03587207|19926660|P3|NOT COMPLETED|Overall Study||0
8081751|NCT03587207|19926661|P2|NOT COMPLETED|Overall Study||0
8081752|NCT03587207|19926662|P1|NOT COMPLETED|Overall Study||0
8081753|NCT03587207|19926658|P5|COMPLETED|Overall Study||102
8081754|NCT03587207|19926659|P4|COMPLETED|Overall Study||94
8081755|NCT03587207|19926660|P3|COMPLETED|Overall Study||100
8081756|NCT03587207|19926661|P2|COMPLETED|Overall Study||104
8081757|NCT03587207|19926662|P1|COMPLETED|Overall Study||100
8081758|NCT03587207|19926658|P5|STARTED|Overall Study||102
8081759|NCT03587207|19926659|P4|STARTED|Overall Study||94
8081760|NCT03587207|19926660|P3|STARTED|Overall Study||100
8081761|NCT03587207|19926661|P2|STARTED|Overall Study||104
8081762|NCT03587207|19926662|P1|STARTED|Overall Study||100
8081763|NCT03586830|19926737|P4|NOT COMPLETED|Overall Study||5
8081764|NCT03586830|19926738|P3|NOT COMPLETED|Overall Study||8
8081765|NCT03586830|19926739|P2|NOT COMPLETED|Overall Study||6
8081766|NCT03586830|19926740|P1|NOT COMPLETED|Overall Study||2
8081767|NCT03586830|19926737|P4|COMPLETED|Overall Study||44
8081768|NCT03586830|19926738|P3|COMPLETED|Overall Study||41
8081769|NCT03586830|19926739|P2|COMPLETED|Overall Study||42
8081770|NCT03586830|19926740|P1|COMPLETED|Overall Study||48
8081771|NCT03586830|19926737|P4|Treated|Overall Study||49
8081772|NCT03586830|19926738|P3|Treated|Overall Study||49
8081773|NCT03586830|19926739|P2|Treated|Overall Study||48
8081774|NCT03586830|19926740|P1|Treated|Overall Study||49
8081775|NCT03586830|19926737|P4|STARTED|Overall Study||49
8081776|NCT03586830|19926738|P3|STARTED|Overall Study||49
8081777|NCT03586830|19926739|P2|STARTED|Overall Study||48
8081778|NCT03586830|19926740|P1|STARTED|Overall Study||50
8081779|NCT03586726|19926762|P1|NOT COMPLETED|Overall Study||1
8081780|NCT03586726|19926762|P1|COMPLETED|Overall Study||15
8081781|NCT03586726|19926762|P1|STARTED|Overall Study||16
8081782|NCT03586648|19926779|P2|NOT COMPLETED|Period 2||0
8081783|NCT03586648|19926780|P1|NOT COMPLETED|Period 2||1
8081784|NCT03586648|19926779|P2|COMPLETED|Period 2||30
8081785|NCT03586648|19926780|P1|COMPLETED|Period 2||31
8081786|NCT03586648|19926779|P2|STARTED|Period 2||30
8081787|NCT03586648|19926780|P1|STARTED|Period 2||32
8081788|NCT03586648|19926779|P2|NOT COMPLETED|Period 1||4
8081789|NCT03586648|19926780|P1|NOT COMPLETED|Period 1||4
8081790|NCT03586648|19926779|P2|COMPLETED|Period 1||30
8081791|NCT03586648|19926780|P1|COMPLETED|Period 1||32
8081792|NCT03586648|19926779|P2|STARTED|Period 1||34
8081793|NCT03586648|19926780|P1|STARTED|Period 1||36
8081794|NCT03586583|19926788|P1|NOT COMPLETED|Overall Study||0
8081795|NCT03586583|19926788|P1|COMPLETED|Overall Study||600
8081796|NCT03586583|19926788|P1|STARTED|Overall Study||600
8081797|NCT03585959|19926793|P1|NOT COMPLETED|Overall Study||3
8081798|NCT03585959|19926793|P1|COMPLETED|Overall Study||47
8081799|NCT03585959|19926793|P1|STARTED|Overall Study||50
8081800|NCT03585790|19926815|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8081801|NCT03585790|19926816|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8081802|NCT03585790|19926815|P2|COMPLETED|Second Intervention (1 Week)||22
8081803|NCT03585790|19926816|P1|COMPLETED|Second Intervention (1 Week)||23
8081804|NCT03585790|19926815|P2|STARTED|Second Intervention (1 Week)||22
8081805|NCT03585790|19926816|P1|STARTED|Second Intervention (1 Week)||23
8081806|NCT03585790|19926815|P2|NOT COMPLETED|First Intervention (1 Week)||0
8081807|NCT03585790|19926816|P1|NOT COMPLETED|First Intervention (1 Week)||0
8081808|NCT03585790|19926815|P2|COMPLETED|First Intervention (1 Week)||22
8081809|NCT03585790|19926816|P1|COMPLETED|First Intervention (1 Week)||23
8081810|NCT03585790|19926815|P2|STARTED|First Intervention (1 Week)||22
8081811|NCT03585790|19926816|P1|STARTED|First Intervention (1 Week)||23
8081812|NCT03585543|19926823|P1|NOT COMPLETED|Overall Study||15
8081813|NCT03585543|19926823|P1|COMPLETED|Overall Study||15
8081814|NCT03585543|19926823|P1|3-month Post-intervention Follow-up (6 m|Overall Study||15
8081815|NCT03585543|19926823|P1|End-of-intervention Assessment (12 Weeks|Overall Study||22
8081816|NCT03585543|19926823|P1|Mid-intervention Assessment (6-weeks)|Overall Study||25
8081817|NCT03585543|19926823|P1|STARTED|Overall Study||30
8081818|NCT03585504|19926844|P2|NOT COMPLETED|Overall Study||29
8081819|NCT03585504|19926845|P1|NOT COMPLETED|Overall Study||26
8081820|NCT03585504|19926844|P2|COMPLETED|Overall Study||11
8081821|NCT03585504|19926845|P1|COMPLETED|Overall Study||15
8081822|NCT03585504|19926844|P2|STARTED|Overall Study||40
8081823|NCT03585504|19926845|P1|STARTED|Overall Study||41
8081824|NCT03585296|19926855|P1|NOT COMPLETED|Overall Study||5
8081825|NCT03585296|19926855|P1|COMPLETED|Overall Study||17
8081826|NCT03585296|19926855|P1|STARTED|Overall Study||22
8081827|NCT03585244|19926859|P1|NOT COMPLETED|Overall Study||15
8081828|NCT03585244|19926859|P1|COMPLETED|Overall Study||165
8081829|NCT03585244|19926859|P1|STARTED|Overall Study||180
8081830|NCT03583450|19926866|P2|NOT COMPLETED|Overall Study||0
8081831|NCT03583450|19926867|P1|NOT COMPLETED|Overall Study||1
8081832|NCT03583450|19926866|P2|COMPLETED|Overall Study||37
8081833|NCT03583450|19926867|P1|COMPLETED|Overall Study||33
8081834|NCT03583450|19926866|P2|STARTED|Overall Study||37
8081835|NCT03583450|19926867|P1|STARTED|Overall Study||34
8081836|NCT03583385|19926889|P2|NOT COMPLETED|Treatment Period 2||0
8081837|NCT03583385|19926890|P1|NOT COMPLETED|Treatment Period 2||1
8081838|NCT03583385|19926889|P2|COMPLETED|Treatment Period 2||23
8081839|NCT03583385|19926890|P1|COMPLETED|Treatment Period 2||21
8081840|NCT03583385|19926889|P2|STARTED|Treatment Period 2||23
8081841|NCT03583385|19926890|P1|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn't attend period2.|22
8081842|NCT03583385|19926889|P2|NOT COMPLETED|Treatment Period 1||1
8081843|NCT03583385|19926890|P1|NOT COMPLETED|Treatment Period 1||1
8081844|NCT03583385|19926889|P2|COMPLETED|Treatment Period 1||23
8081845|NCT03583385|19926890|P1|COMPLETED|Treatment Period 1||23
8081846|NCT03583385|19926889|P2|STARTED|Treatment Period 1||24
8081847|NCT03583385|19926890|P1|STARTED|Treatment Period 1||24
8081848|NCT03582943|19926908|P2|NOT COMPLETED|Analyzed||1
8081849|NCT03582943|19926909|P1|NOT COMPLETED|Analyzed||4
8081850|NCT03582943|19926908|P2|COMPLETED|Analyzed||36
8081851|NCT03582943|19926909|P1|COMPLETED|Analyzed||33
8081852|NCT03582943|19926908|P2|STARTED|Analyzed||37
8081853|NCT03582943|19926909|P1|STARTED|Analyzed||37
8081854|NCT03582943|19926908|P2|NOT COMPLETED|Intervention and Follow up||2
8081855|NCT03582943|19926909|P1|NOT COMPLETED|Intervention and Follow up||4
8081856|NCT03582943|19926908|P2|COMPLETED|Intervention and Follow up||37
8081857|NCT03582943|19926909|P1|COMPLETED|Intervention and Follow up||37
8081858|NCT03582943|19926908|P2|STARTED|Intervention and Follow up||39
8081859|NCT03582943|19926909|P1|STARTED|Intervention and Follow up||41
8081860|NCT03582943|19926908|P2|NOT COMPLETED|Allocated to Groups||1
8081861|NCT03582943|19926909|P1|NOT COMPLETED|Allocated to Groups||1
8081862|NCT03582943|19926908|P2|COMPLETED|Allocated to Groups||39
8081863|NCT03582943|19926909|P1|COMPLETED|Allocated to Groups||41
8081864|NCT03582943|19926908|P2|STARTED|Allocated to Groups||40
8081865|NCT03582943|19926909|P1|STARTED|Allocated to Groups||42
8081866|NCT03582826|19926917|P2|NOT COMPLETED|Overall Study||0
8081867|NCT03582826|19926918|P1|NOT COMPLETED|Overall Study||41
8081868|NCT03582826|19926917|P2|COMPLETED|Overall Study||6
8081869|NCT03582826|19926918|P1|COMPLETED|Overall Study||78
8081870|NCT03582826|19926917|P2|STARTED|Overall Study||6
8081871|NCT03582826|19926918|P1|STARTED|Overall Study||119
8081872|NCT03582813|19926935|P2|NOT COMPLETED|Overall Study||21
8081873|NCT03582813|19926936|P1|NOT COMPLETED|Overall Study||19
8081874|NCT03582813|19926935|P2|COMPLETED|Overall Study||81
8081875|NCT03582813|19926936|P1|COMPLETED|Overall Study||95
8081876|NCT03582813|19926935|P2|STARTED|Overall Study||102
8081877|NCT03582813|19926936|P1|STARTED|Overall Study||114
8081878|NCT03582553|19926960|P6|NOT COMPLETED|Intervention 3/Visit 3||0
8081879|NCT03582553|19926961|P5|NOT COMPLETED|Intervention 3/Visit 3||0
8081880|NCT03582553|19926962|P4|NOT COMPLETED|Intervention 3/Visit 3||0
8081881|NCT03582553|19926963|P3|NOT COMPLETED|Intervention 3/Visit 3||0
8081882|NCT03582553|19926964|P2|NOT COMPLETED|Intervention 3/Visit 3||0
8081883|NCT03582553|19926965|P1|NOT COMPLETED|Intervention 3/Visit 3||0
8081884|NCT03582553|19926960|P6|COMPLETED|Intervention 3/Visit 3||3
8081885|NCT03582553|19926961|P5|COMPLETED|Intervention 3/Visit 3||3
8081886|NCT03582553|19926962|P4|COMPLETED|Intervention 3/Visit 3||3
8081887|NCT03582553|19926963|P3|COMPLETED|Intervention 3/Visit 3||3
8081888|NCT03582553|19926964|P2|COMPLETED|Intervention 3/Visit 3||3
8081889|NCT03582553|19926965|P1|COMPLETED|Intervention 3/Visit 3||3
8081890|NCT03582553|19926960|P6|STARTED|Intervention 3/Visit 3||3
8081891|NCT03582553|19926961|P5|STARTED|Intervention 3/Visit 3||3
8081892|NCT03582553|19926962|P4|STARTED|Intervention 3/Visit 3||3
8081893|NCT03582553|19926963|P3|STARTED|Intervention 3/Visit 3||3
8081894|NCT03582553|19926964|P2|STARTED|Intervention 3/Visit 3||3
8081895|NCT03582553|19926965|P1|STARTED|Intervention 3/Visit 3||3
8081896|NCT03582553|19926960|P6|NOT COMPLETED|Washout Period (At Least 1 Week)||0
8081897|NCT03582553|19926961|P5|NOT COMPLETED|Washout Period (At Least 1 Week)||0
8081898|NCT03582553|19926962|P4|NOT COMPLETED|Washout Period (At Least 1 Week)||0
8081899|NCT03582553|19926963|P3|NOT COMPLETED|Washout Period (At Least 1 Week)||0
8081900|NCT03582553|19926964|P2|NOT COMPLETED|Washout Period (At Least 1 Week)||0
8081901|NCT03582553|19926965|P1|NOT COMPLETED|Washout Period (At Least 1 Week)||0
8081902|NCT03582553|19926960|P6|COMPLETED|Washout Period (At Least 1 Week)||3
8081903|NCT03582553|19926961|P5|COMPLETED|Washout Period (At Least 1 Week)||3
8081904|NCT03582553|19926962|P4|COMPLETED|Washout Period (At Least 1 Week)||3
8081905|NCT03582553|19926963|P3|COMPLETED|Washout Period (At Least 1 Week)||3
8081906|NCT03582553|19926964|P2|COMPLETED|Washout Period (At Least 1 Week)||3
8081907|NCT03582553|19926965|P1|COMPLETED|Washout Period (At Least 1 Week)||3
8081908|NCT03582553|19926960|P6|STARTED|Washout Period (At Least 1 Week)||3
8081909|NCT03582553|19926961|P5|STARTED|Washout Period (At Least 1 Week)||3
8081910|NCT03582553|19926962|P4|STARTED|Washout Period (At Least 1 Week)||3
8081911|NCT03582553|19926963|P3|STARTED|Washout Period (At Least 1 Week)||3
8081912|NCT03582553|19926964|P2|STARTED|Washout Period (At Least 1 Week)||3
8081913|NCT03582553|19926965|P1|STARTED|Washout Period (At Least 1 Week)||3
8081914|NCT03582553|19926960|P6|NOT COMPLETED|Intervention 2/Visit 2||0
8081915|NCT03582553|19926961|P5|NOT COMPLETED|Intervention 2/Visit 2||0
8081916|NCT03582553|19926962|P4|NOT COMPLETED|Intervention 2/Visit 2||0
8081917|NCT03582553|19926963|P3|NOT COMPLETED|Intervention 2/Visit 2||0
8081918|NCT03582553|19926964|P2|NOT COMPLETED|Intervention 2/Visit 2||0
8081919|NCT03582553|19926965|P1|NOT COMPLETED|Intervention 2/Visit 2||0
8081920|NCT03582553|19926960|P6|COMPLETED|Intervention 2/Visit 2||3
8081921|NCT03582553|19926961|P5|COMPLETED|Intervention 2/Visit 2||3
8081922|NCT03582553|19926962|P4|COMPLETED|Intervention 2/Visit 2||3
8081923|NCT03582553|19926963|P3|COMPLETED|Intervention 2/Visit 2||3
8081924|NCT03582553|19926964|P2|COMPLETED|Intervention 2/Visit 2||3
8081925|NCT03582553|19926965|P1|COMPLETED|Intervention 2/Visit 2||3
8081926|NCT03582553|19926960|P6|STARTED|Intervention 2/Visit 2||3
8081927|NCT03582553|19926961|P5|STARTED|Intervention 2/Visit 2||3
8081928|NCT03582553|19926962|P4|STARTED|Intervention 2/Visit 2||3
8081929|NCT03582553|19926963|P3|STARTED|Intervention 2/Visit 2||3
8081930|NCT03582553|19926964|P2|STARTED|Intervention 2/Visit 2||3
8081931|NCT03582553|19926965|P1|STARTED|Intervention 2/Visit 2||3
8081932|NCT03582553|19926960|P6|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
8081933|NCT03582553|19926961|P5|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
8081934|NCT03582553|19926962|P4|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
8081935|NCT03582553|19926963|P3|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
8081936|NCT03582553|19926964|P2|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
8081937|NCT03582553|19926965|P1|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
8081938|NCT03582553|19926960|P6|COMPLETED|Washout Period ( At Least 1 Week)||3
8081939|NCT03582553|19926961|P5|COMPLETED|Washout Period ( At Least 1 Week)||3
8081940|NCT03582553|19926962|P4|COMPLETED|Washout Period ( At Least 1 Week)||3
8081941|NCT03582553|19926963|P3|COMPLETED|Washout Period ( At Least 1 Week)||3
8081942|NCT03582553|19926964|P2|COMPLETED|Washout Period ( At Least 1 Week)||3
8081943|NCT03582553|19926965|P1|COMPLETED|Washout Period ( At Least 1 Week)||3
8081944|NCT03582553|19926960|P6|STARTED|Washout Period ( At Least 1 Week)||3
8081945|NCT03582553|19926961|P5|STARTED|Washout Period ( At Least 1 Week)||3
8081946|NCT03582553|19926962|P4|STARTED|Washout Period ( At Least 1 Week)||3
8081947|NCT03582553|19926963|P3|STARTED|Washout Period ( At Least 1 Week)||3
8081948|NCT03582553|19926964|P2|STARTED|Washout Period ( At Least 1 Week)||3
8081949|NCT03582553|19926965|P1|STARTED|Washout Period ( At Least 1 Week)||3
8081950|NCT03582553|19926960|P6|NOT COMPLETED|Intervention 1/Visit 1||0
8081951|NCT03582553|19926961|P5|NOT COMPLETED|Intervention 1/Visit 1||0
8081952|NCT03582553|19926962|P4|NOT COMPLETED|Intervention 1/Visit 1||0
8081953|NCT03582553|19926963|P3|NOT COMPLETED|Intervention 1/Visit 1||0
8081954|NCT03582553|19926964|P2|NOT COMPLETED|Intervention 1/Visit 1||0
8081955|NCT03582553|19926965|P1|NOT COMPLETED|Intervention 1/Visit 1||0
8081956|NCT03582553|19926960|P6|COMPLETED|Intervention 1/Visit 1||3
8081957|NCT03582553|19926961|P5|COMPLETED|Intervention 1/Visit 1||3
8081958|NCT03582553|19926962|P4|COMPLETED|Intervention 1/Visit 1||3
8081959|NCT03582553|19926963|P3|COMPLETED|Intervention 1/Visit 1||3
8081960|NCT03582553|19926964|P2|COMPLETED|Intervention 1/Visit 1||3
8081961|NCT03582553|19926965|P1|COMPLETED|Intervention 1/Visit 1||3
8081962|NCT03582553|19926960|P6|STARTED|Intervention 1/Visit 1||3
8081963|NCT03582553|19926961|P5|STARTED|Intervention 1/Visit 1||3
8081964|NCT03582553|19926962|P4|STARTED|Intervention 1/Visit 1||3
8081965|NCT03582553|19926963|P3|STARTED|Intervention 1/Visit 1||3
8081966|NCT03582553|19926964|P2|STARTED|Intervention 1/Visit 1||3
8081967|NCT03582553|19926965|P1|STARTED|Intervention 1/Visit 1||3
8081968|NCT03582215|19927003|P8|NOT COMPLETED|Overall Study||2
8081969|NCT03582215|19927004|P7|NOT COMPLETED|Overall Study||2
8081970|NCT03582215|19927005|P6|NOT COMPLETED|Overall Study||0
8081971|NCT03582215|19927006|P5|NOT COMPLETED|Overall Study||0
8081972|NCT03582215|19927007|P4|NOT COMPLETED|Overall Study||0
8081973|NCT03582215|19927008|P3|NOT COMPLETED|Overall Study||0
8081974|NCT03582215|19927009|P2|NOT COMPLETED|Overall Study||0
8081975|NCT03582215|19927010|P1|NOT COMPLETED|Overall Study||1
8081976|NCT03582215|19927003|P8|COMPLETED|Overall Study||10
8081977|NCT03582215|19927004|P7|COMPLETED|Overall Study||10
8081978|NCT03582215|19927005|P6|COMPLETED|Overall Study||12
8081979|NCT03582215|19927006|P5|COMPLETED|Overall Study||12
8081980|NCT03582215|19927007|P4|COMPLETED|Overall Study||6
8081981|NCT03582215|19927008|P3|COMPLETED|Overall Study||6
8081982|NCT03582215|19927009|P2|COMPLETED|Overall Study||6
8081983|NCT03582215|19927010|P1|COMPLETED|Overall Study||5
8081984|NCT03582215|19927003|P8|STARTED|Overall Study||12
8081985|NCT03582215|19927004|P7|STARTED|Overall Study||12
8081986|NCT03582215|19927005|P6|STARTED|Overall Study||12
8081987|NCT03582215|19927006|P5|STARTED|Overall Study||12
8081988|NCT03582215|19927007|P4|STARTED|Overall Study||6
8081989|NCT03582215|19927008|P3|STARTED|Overall Study||6
8081990|NCT03582215|19927009|P2|STARTED|Overall Study||6
8081991|NCT03582215|19927010|P1|STARTED|Overall Study||6
8081992|NCT03581825|19927051|P2|NOT COMPLETED|Period 2||1
8081993|NCT03581825|19927052|P1|NOT COMPLETED|Period 2||0
8081994|NCT03581825|19927051|P2|COMPLETED|Period 2||30
8081995|NCT03581825|19927052|P1|COMPLETED|Period 2||30
8081996|NCT03581825|19927051|P2|STARTED|Period 2||31
8081997|NCT03581825|19927052|P1|STARTED|Period 2||30
8081998|NCT03581825|19927051|P2|NOT COMPLETED|Period 1||0
8081999|NCT03581825|19927052|P1|NOT COMPLETED|Period 1||1
8082000|NCT03581825|19927051|P2|COMPLETED|Period 1||31
8082001|NCT03581825|19927052|P1|COMPLETED|Period 1||30
8082002|NCT03581825|19927051|P2|STARTED|Period 1||31
8082003|NCT03581825|19927052|P1|STARTED|Period 1||31
8082004|NCT03581474|19927059|P1|NOT COMPLETED|Overall Study||0
8082005|NCT03581474|19927059|P1|COMPLETED|Overall Study||12
8082006|NCT03581474|19927059|P1|STARTED|Overall Study||12
8082007|NCT03581097|19927065|P2|NOT COMPLETED|Overall Study||0
8082008|NCT03581097|19927066|P1|NOT COMPLETED|Overall Study||0
8082009|NCT03581097|19927065|P2|COMPLETED|Overall Study||47
8082010|NCT03581097|19927066|P1|COMPLETED|Overall Study||46
8082011|NCT03581097|19927065|P2|STARTED|Overall Study||47
8082012|NCT03581097|19927066|P1|STARTED|Overall Study||46
8082013|NCT03580382|19927088|P2|NOT COMPLETED|Overall Study||3
8082014|NCT03580382|19927089|P1|NOT COMPLETED|Overall Study||0
8082015|NCT03580382|19927088|P2|COMPLETED|Overall Study||0
8082016|NCT03580382|19927089|P1|COMPLETED|Overall Study||0
8082017|NCT03580382|19927088|P2|STARTED|Overall Study||3
8082018|NCT03580382|19927089|P1|STARTED|Overall Study||0
8082019|NCT03579940|19927107|P11|NOT COMPLETED|Period 3||0
8082020|NCT03579940|19927108|P10|NOT COMPLETED|Period 3||0
8082021|NCT03579940|19927109|P9|NOT COMPLETED|Period 3||0
8082022|NCT03579940|19927110|P8|NOT COMPLETED|Period 3||0
8082023|NCT03579940|19927111|P7|NOT COMPLETED|Period 3||0
8082024|NCT03579940|19927112|P6|NOT COMPLETED|Period 3||0
8082025|NCT03579940|19927113|P5|NOT COMPLETED|Period 3||0
8082026|NCT03579940|19927114|P4|NOT COMPLETED|Period 3||0
8082027|NCT03579940|19927115|P3|NOT COMPLETED|Period 3||0
8082028|NCT03579940|19927116|P2|NOT COMPLETED|Period 3||0
8082029|NCT03579940|19927117|P1|NOT COMPLETED|Period 3||0
8082030|NCT03579940|19927107|P11|COMPLETED|Period 3||3
8082031|NCT03579940|19927108|P10|COMPLETED|Period 3||2
8082032|NCT03579940|19927109|P9|COMPLETED|Period 3||3
8082033|NCT03579940|19927110|P8|COMPLETED|Period 3||3
8082034|NCT03579940|19927111|P7|COMPLETED|Period 3||3
8082035|NCT03579940|19927112|P6|COMPLETED|Period 3||2
8082036|NCT03579940|19927113|P5|COMPLETED|Period 3||2
8082037|NCT03579940|19927114|P4|COMPLETED|Period 3||2
8082038|NCT03579940|19927115|P3|COMPLETED|Period 3||1
8082039|NCT03579940|19927116|P2|COMPLETED|Period 3||2
8082040|NCT03579940|19927117|P1|COMPLETED|Period 3||3
8082041|NCT03579940|19927107|P11|STARTED|Period 3||3
8082042|NCT03579940|19927108|P10|STARTED|Period 3||2
8082043|NCT03579940|19927109|P9|STARTED|Period 3||3
8082044|NCT03579940|19927110|P8|STARTED|Period 3||3
8082045|NCT03579940|19927111|P7|STARTED|Period 3||3
8082046|NCT03579940|19927112|P6|STARTED|Period 3||2
8082047|NCT03579940|19927113|P5|STARTED|Period 3||2
8082048|NCT03579940|19927114|P4|STARTED|Period 3||2
8082049|NCT03579940|19927115|P3|STARTED|Period 3||1
8082050|NCT03579940|19927116|P2|STARTED|Period 3||2
8082051|NCT03579940|19927117|P1|STARTED|Period 3||3
8082052|NCT03579940|19927107|P11|NOT COMPLETED|Period 2||0
8082053|NCT03579940|19927108|P10|NOT COMPLETED|Period 2||0
8082054|NCT03579940|19927109|P9|NOT COMPLETED|Period 2||0
8082055|NCT03579940|19927110|P8|NOT COMPLETED|Period 2||0
8082056|NCT03579940|19927111|P7|NOT COMPLETED|Period 2||0
8082057|NCT03579940|19927112|P6|NOT COMPLETED|Period 2||0
8082058|NCT03579940|19927113|P5|NOT COMPLETED|Period 2||0
8082059|NCT03579940|19927114|P4|NOT COMPLETED|Period 2||0
8082060|NCT03579940|19927115|P3|NOT COMPLETED|Period 2||1
8082061|NCT03579940|19927116|P2|NOT COMPLETED|Period 2||0
8082062|NCT03579940|19927117|P1|NOT COMPLETED|Period 2||0
8082063|NCT03579940|19927107|P11|COMPLETED|Period 2||3
8082064|NCT03579940|19927108|P10|COMPLETED|Period 2||2
8082065|NCT03579940|19927109|P9|COMPLETED|Period 2||3
8082066|NCT03579940|19927110|P8|COMPLETED|Period 2||3
8082067|NCT03579940|19927111|P7|COMPLETED|Period 2||3
8082068|NCT03579940|19927112|P6|COMPLETED|Period 2||2
8082069|NCT03579940|19927113|P5|COMPLETED|Period 2||2
8082070|NCT03579940|19927114|P4|COMPLETED|Period 2||2
8082071|NCT03579940|19927115|P3|COMPLETED|Period 2||1
8082072|NCT03579940|19927116|P2|COMPLETED|Period 2||2
8082073|NCT03579940|19927117|P1|COMPLETED|Period 2||3
8082074|NCT03579940|19927107|P11|STARTED|Period 2||3
8082075|NCT03579940|19927108|P10|STARTED|Period 2||2
8082076|NCT03579940|19927109|P9|STARTED|Period 2||3
8082077|NCT03579940|19927110|P8|STARTED|Period 2||3
8082078|NCT03579940|19927111|P7|STARTED|Period 2||3
8082079|NCT03579940|19927112|P6|STARTED|Period 2||2
8082080|NCT03579940|19927113|P5|STARTED|Period 2||2
8082081|NCT03579940|19927114|P4|STARTED|Period 2||2
8082082|NCT03579940|19927115|P3|STARTED|Period 2||2
8082083|NCT03579940|19927116|P2|STARTED|Period 2||2
8082084|NCT03579940|19927117|P1|STARTED|Period 2||3
8082085|NCT03579940|19927107|P11|NOT COMPLETED|Period 1||0
8082086|NCT03579940|19927108|P10|NOT COMPLETED|Period 1||0
8082087|NCT03579940|19927109|P9|NOT COMPLETED|Period 1||0
8082088|NCT03579940|19927110|P8|NOT COMPLETED|Period 1||0
8082089|NCT03579940|19927111|P7|NOT COMPLETED|Period 1||0
8082090|NCT03579940|19927112|P6|NOT COMPLETED|Period 1||0
8082091|NCT03579940|19927113|P5|NOT COMPLETED|Period 1||0
8082092|NCT03579940|19927114|P4|NOT COMPLETED|Period 1||0
8082093|NCT03579940|19927115|P3|NOT COMPLETED|Period 1||0
8082094|NCT03579940|19927116|P2|NOT COMPLETED|Period 1||0
8082095|NCT03579940|19927117|P1|NOT COMPLETED|Period 1||0
8082096|NCT03579940|19927107|P11|COMPLETED|Period 1||3
8082097|NCT03579940|19927108|P10|COMPLETED|Period 1||2
8082098|NCT03579940|19927109|P9|COMPLETED|Period 1||3
8082099|NCT03579940|19927110|P8|COMPLETED|Period 1||3
8082100|NCT03579940|19927111|P7|COMPLETED|Period 1||3
8082101|NCT03579940|19927112|P6|COMPLETED|Period 1||2
8082102|NCT03579940|19927113|P5|COMPLETED|Period 1||2
8082103|NCT03579940|19927114|P4|COMPLETED|Period 1||2
8082104|NCT03579940|19927115|P3|COMPLETED|Period 1||2
8082105|NCT03579940|19927116|P2|COMPLETED|Period 1||2
8082106|NCT03579940|19927117|P1|COMPLETED|Period 1||3
8082107|NCT03579940|19927107|P11|Received at Least 1 Dose of Study Drug|Period 1||3
8082108|NCT03579940|19927108|P10|Received at Least 1 Dose of Study Drug|Period 1||2
8082109|NCT03579940|19927109|P9|Received at Least 1 Dose of Study Drug|Period 1||3
8082110|NCT03579940|19927110|P8|Received at Least 1 Dose of Study Drug|Period 1||3
8082111|NCT03579940|19927111|P7|Received at Least 1 Dose of Study Drug|Period 1||3
8082112|NCT03579940|19927112|P6|Received at Least 1 Dose of Study Drug|Period 1||2
8082113|NCT03579940|19927113|P5|Received at Least 1 Dose of Study Drug|Period 1||2
8082114|NCT03579940|19927114|P4|Received at Least 1 Dose of Study Drug|Period 1||2
8082115|NCT03579940|19927115|P3|Received at Least 1 Dose of Study Drug|Period 1||2
8082116|NCT03579940|19927116|P2|Received at Least 1 Dose of Study Drug|Period 1||2
8082117|NCT03579940|19927117|P1|Received at Least 1 Dose of Study Drug|Period 1||3
8082118|NCT03579940|19927107|P11|STARTED|Period 1||3
8082119|NCT03579940|19927108|P10|STARTED|Period 1||2
8082120|NCT03579940|19927109|P9|STARTED|Period 1||3
8082121|NCT03579940|19927110|P8|STARTED|Period 1||3
8082122|NCT03579940|19927111|P7|STARTED|Period 1||3
8082123|NCT03579940|19927112|P6|STARTED|Period 1||2
8082124|NCT03579940|19927113|P5|STARTED|Period 1||2
8082125|NCT03579940|19927114|P4|STARTED|Period 1||2
8082126|NCT03579940|19927115|P3|STARTED|Period 1||2
8082127|NCT03579940|19927116|P2|STARTED|Period 1||2
8082128|NCT03579940|19927117|P1|STARTED|Period 1||3
8082129|NCT03579719|19927157|P1|NOT COMPLETED|Overall Study||1
8082130|NCT03579719|19927157|P1|COMPLETED|Overall Study||14
8082131|NCT03579719|19927157|P1|STARTED|Overall Study||15
8082132|NCT03579433|19927174|P1|NOT COMPLETED|Overall Study||6
8082133|NCT03579433|19927174|P1|COMPLETED|Overall Study||98
8082134|NCT03579433|19927174|P1|Barrett Calculator|Overall Study||102
8082135|NCT03579433|19927174|P1|ORA With VerifEye+|Overall Study||96
8082136|NCT03579433|19927174|P1|STARTED|Overall Study||104
8082137|NCT03578926|19927182|P2|NOT COMPLETED|Second Intervention||0
8082138|NCT03578926|19927183|P1|NOT COMPLETED|Second Intervention||0
8082139|NCT03578926|19927182|P2|COMPLETED|Second Intervention||21
8082140|NCT03578926|19927183|P1|COMPLETED|Second Intervention||23
8082141|NCT03578926|19927182|P2|STARTED|Second Intervention||21
8082142|NCT03578926|19927183|P1|STARTED|Second Intervention||23
8082143|NCT03578926|19927182|P2|NOT COMPLETED|First Intervention||0
8082144|NCT03578926|19927183|P1|NOT COMPLETED|First Intervention||0
8082145|NCT03578926|19927182|P2|COMPLETED|First Intervention||23
8082146|NCT03578926|19927183|P1|COMPLETED|First Intervention||21
8082147|NCT03578926|19927182|P2|STARTED|First Intervention||23
8082148|NCT03578926|19927183|P1|STARTED|First Intervention||21
8082149|NCT03578549|19927203|P1|NOT COMPLETED|Overall Study||1
8082150|NCT03578549|19927203|P1|COMPLETED|Overall Study||29
8082151|NCT03578549|19927203|P1|STARTED|Overall Study||30
8082152|NCT03578146|19927214|P6|NOT COMPLETED|Overall Study||3
8082153|NCT03578146|19927215|P5|NOT COMPLETED|Overall Study||0
8082154|NCT03578146|19927216|P4|NOT COMPLETED|Overall Study||0
8082155|NCT03578146|19927217|P3|NOT COMPLETED|Overall Study||1
8082156|NCT03578146|19927218|P2|NOT COMPLETED|Overall Study||1
8082157|NCT03578146|19927219|P1|NOT COMPLETED|Overall Study||1
8082158|NCT03578146|19927214|P6|COMPLETED|Overall Study||5
8082159|NCT03578146|19927215|P5|COMPLETED|Overall Study||6
8082160|NCT03578146|19927216|P4|COMPLETED|Overall Study||6
8082161|NCT03578146|19927217|P3|COMPLETED|Overall Study||5
8082162|NCT03578146|19927218|P2|COMPLETED|Overall Study||5
8082163|NCT03578146|19927219|P1|COMPLETED|Overall Study||15
8082164|NCT03578146|19927214|P6|STARTED|Overall Study||8
8082165|NCT03578146|19927215|P5|STARTED|Overall Study||6
8082166|NCT03578146|19927216|P4|STARTED|Overall Study||6
8082167|NCT03578146|19927217|P3|STARTED|Overall Study||6
8082168|NCT03578146|19927218|P2|STARTED|Overall Study||6
8082169|NCT03578146|19927219|P1|STARTED|Overall Study||16
8082170|NCT03577275|19927281|P1|NOT COMPLETED|Overall Study||0
8082171|NCT03577275|19927281|P1|COMPLETED|Overall Study||32
8082172|NCT03577275|19927281|P1|NST-4016 2000mg|Overall Study||32
8082173|NCT03577275|19927281|P1|NST-4016 600mg|Overall Study||32
8082174|NCT03577275|19927281|P1|Moxifloxacin 400mg|Overall Study||32
8082175|NCT03577275|19927281|P1|Placebo|Overall Study||32
8082176|NCT03577275|19927281|P1|STARTED|Overall Study|All participants received all of the 4 interventions|32
8082177|NCT03576118|19927309|P2|NOT COMPLETED|Overall Study||4
8082178|NCT03576118|19927310|P1|NOT COMPLETED|Overall Study||3
8082179|NCT03576118|19927309|P2|COMPLETED|Overall Study||33
8082180|NCT03576118|19927310|P1|COMPLETED|Overall Study||34
8082181|NCT03576118|19927309|P2|STARTED|Overall Study||37
8082182|NCT03576118|19927310|P1|STARTED|Overall Study||37
8082183|NCT03575962|19927316|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8082184|NCT03575962|19927317|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8082185|NCT03575962|19927316|P2|COMPLETED|Treatment Period 2 (4 Days)||7
8082186|NCT03575962|19927317|P1|COMPLETED|Treatment Period 2 (4 Days)||7
8082187|NCT03575962|19927316|P2|STARTED|Treatment Period 2 (4 Days)||7
8082188|NCT03575962|19927317|P1|STARTED|Treatment Period 2 (4 Days)||7
8082189|NCT03575962|19927316|P2|NOT COMPLETED|Washout Period (7 Days)||0
8082190|NCT03575962|19927317|P1|NOT COMPLETED|Washout Period (7 Days)||0
8082191|NCT03575962|19927316|P2|COMPLETED|Washout Period (7 Days)||7
8082192|NCT03575962|19927317|P1|COMPLETED|Washout Period (7 Days)||7
8082193|NCT03575962|19927316|P2|STARTED|Washout Period (7 Days)||7
8082194|NCT03575962|19927317|P1|STARTED|Washout Period (7 Days)||7
8082195|NCT03575962|19927316|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8082196|NCT03575962|19927317|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8082197|NCT03575962|19927316|P2|COMPLETED|Treatment Period 1 (4 Days)||7
8082198|NCT03575962|19927317|P1|COMPLETED|Treatment Period 1 (4 Days)||7
8082199|NCT03575962|19927316|P2|STARTED|Treatment Period 1 (4 Days)||7
8082200|NCT03575962|19927317|P1|STARTED|Treatment Period 1 (4 Days)||7
8082201|NCT03575871|19927360|P3|NOT COMPLETED|Overall Study||26
8082202|NCT03575871|19927361|P2|NOT COMPLETED|Overall Study||14
8082203|NCT03575871|19927362|P1|NOT COMPLETED|Overall Study||21
8082204|NCT03575871|19927360|P3|COMPLETED|Overall Study||52
8082205|NCT03575871|19927361|P2|COMPLETED|Overall Study||141
8082206|NCT03575871|19927362|P1|COMPLETED|Overall Study||137
8082207|NCT03575871|19927360|P3|STARTED|Overall Study||78
8082208|NCT03575871|19927361|P2|STARTED|Overall Study||155
8082209|NCT03575871|19927362|P1|STARTED|Overall Study||158
8082210|NCT03575806|19927426|P2|NOT COMPLETED|Overall Study||4
8082211|NCT03575806|19927427|P1|NOT COMPLETED|Overall Study||0
8082212|NCT03575806|19927426|P2|COMPLETED|Overall Study||23
8082213|NCT03575806|19927427|P1|COMPLETED|Overall Study||25
8082214|NCT03575806|19927426|P2|STARTED|Overall Study||27
8082215|NCT03575806|19927427|P1|STARTED|Overall Study||25
8082222|NCT03575702|19927452|P2|NOT COMPLETED|Overall Study||4
8082223|NCT03575702|19927453|P1|NOT COMPLETED|Overall Study||6
8082224|NCT03575702|19927452|P2|COMPLETED|Overall Study||146
8082225|NCT03575702|19927453|P1|COMPLETED|Overall Study||143
8082226|NCT03575702|19927452|P2|STARTED|Overall Study||150
8082227|NCT03575702|19927453|P1|STARTED|Overall Study||149
8082228|NCT03574818|19927487|P1|NOT COMPLETED|Overall Study||0
8082229|NCT03574818|19927487|P1|COMPLETED|Overall Study||1
8082230|NCT03574818|19927487|P1|STARTED|Overall Study||1
8082231|NCT03574441|19927494|P3|NOT COMPLETED|Overall Study||0
8082232|NCT03574441|19927495|P2|NOT COMPLETED|Overall Study||0
8082233|NCT03574441|19927496|P1|NOT COMPLETED|Overall Study||0
8082234|NCT03574441|19927494|P3|COMPLETED|Overall Study||30
8082235|NCT03574441|19927495|P2|COMPLETED|Overall Study||30
8082236|NCT03574441|19927496|P1|COMPLETED|Overall Study||31
8082237|NCT03574441|19927494|P3|STARTED|Overall Study||30
8082238|NCT03574441|19927495|P2|STARTED|Overall Study||30
8082239|NCT03574441|19927496|P1|STARTED|Overall Study||31
8082240|NCT03573908|19927509|P5|NOT COMPLETED|Randomized Withdrawal Period||2
8082241|NCT03573908|19927510|P4|NOT COMPLETED|Randomized Withdrawal Period||2
8082242|NCT03573908|19927511|P3|NOT COMPLETED|Randomized Withdrawal Period||8
8082243|NCT03573908|19927512|P2|NOT COMPLETED|Randomized Withdrawal Period||0
8082244|NCT03573908|19927513|P1|NOT COMPLETED|Randomized Withdrawal Period||0
8082245|NCT03573908|19927509|P5|COMPLETED|Randomized Withdrawal Period||137
8082246|NCT03573908|19927510|P4|COMPLETED|Randomized Withdrawal Period||136
8082247|NCT03573908|19927511|P3|COMPLETED|Randomized Withdrawal Period||272
8082248|NCT03573908|19927512|P2|COMPLETED|Randomized Withdrawal Period||0
8082249|NCT03573908|19927513|P1|COMPLETED|Randomized Withdrawal Period||0
8082250|NCT03573908|19927509|P5|STARTED|Randomized Withdrawal Period||139
8082251|NCT03573908|19927510|P4|STARTED|Randomized Withdrawal Period||138
8082252|NCT03573908|19927511|P3|STARTED|Randomized Withdrawal Period||280
8082253|NCT03573908|19927512|P2|STARTED|Randomized Withdrawal Period||0
8082254|NCT03573908|19927513|P1|STARTED|Randomized Withdrawal Period||0
8082255|NCT03573908|19927509|P5|NOT COMPLETED|Treatment Period||0
8082256|NCT03573908|19927510|P4|NOT COMPLETED|Treatment Period||0
8082257|NCT03573908|19927511|P3|NOT COMPLETED|Treatment Period||0
8082258|NCT03573908|19927512|P2|NOT COMPLETED|Treatment Period||26
8082259|NCT03573908|19927513|P1|NOT COMPLETED|Treatment Period||24
8082260|NCT03573908|19927509|P5|COMPLETED|Treatment Period||0
8082261|NCT03573908|19927510|P4|COMPLETED|Treatment Period||0
8082262|NCT03573908|19927511|P3|COMPLETED|Treatment Period||0
8082263|NCT03573908|19927512|P2|COMPLETED|Treatment Period||280
8082264|NCT03573908|19927513|P1|COMPLETED|Treatment Period||284
8082265|NCT03573908|19927509|P5|STARTED|Treatment Period||0
8082266|NCT03573908|19927510|P4|STARTED|Treatment Period||0
8082267|NCT03573908|19927511|P3|STARTED|Treatment Period||0
8082268|NCT03573908|19927512|P2|STARTED|Treatment Period||306
8082269|NCT03573908|19927513|P1|STARTED|Treatment Period||308
8082270|NCT03573830|19927530|P2|NOT COMPLETED|Overall Study||7
8082271|NCT03573830|19927531|P1|NOT COMPLETED|Overall Study||4
8082272|NCT03573830|19927530|P2|COMPLETED|Overall Study||360
8082273|NCT03573830|19927531|P1|COMPLETED|Overall Study||360
8082274|NCT03573830|19927530|P2|Reviewed Assigned Material|Overall Study|360 reviewed their assigned material:Transport Canada information plus the enhanced material.|360
8082275|NCT03573830|19927531|P1|Reviewed Assigned Material|Overall Study|All participants assigned to this arm reviewed their assigned material.|364
8082276|NCT03573830|19927530|P2|STARTED|Overall Study||367
8082277|NCT03573830|19927531|P1|STARTED|Overall Study||364
8082286|NCT03573505|19927583|P2|NOT COMPLETED|Overall Study||54
8082287|NCT03573505|19927584|P1|NOT COMPLETED|Overall Study||52
8082288|NCT03573505|19927583|P2|COMPLETED|Overall Study||0
8082289|NCT03573505|19927584|P1|COMPLETED|Overall Study||0
8082290|NCT03573505|19927583|P2|STARTED|Overall Study||54
8082291|NCT03573505|19927584|P1|STARTED|Overall Study||52
8082292|NCT03573336|19927630|P3|NOT COMPLETED|Overall Study||2
8082293|NCT03573336|19927631|P2|NOT COMPLETED|Overall Study||4
8082294|NCT03573336|19927632|P1|NOT COMPLETED|Overall Study||2
8082295|NCT03573336|19927630|P3|COMPLETED|Overall Study||0
8082296|NCT03573336|19927631|P2|COMPLETED|Overall Study||0
8082297|NCT03573336|19927632|P1|COMPLETED|Overall Study||0
8082298|NCT03573336|19927630|P3|Treated|Overall Study||2
8082299|NCT03573336|19927631|P2|Treated|Overall Study||4
8082300|NCT03573336|19927632|P1|Treated|Overall Study||2
8082301|NCT03573336|19927630|P3|STARTED|Overall Study||2
8082302|NCT03573336|19927631|P2|STARTED|Overall Study||4
8082303|NCT03573336|19927632|P1|STARTED|Overall Study||2
8082304|NCT03573323|19927651|P2|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||57
8082305|NCT03573323|19927652|P1|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||59
8082306|NCT03573323|19927651|P2|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||399
8082307|NCT03573323|19927652|P1|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||406
8082308|NCT03573323|19927651|P2|STARTED|Post-Treatment Follow Up (Weeks 25-36)|Excludes participants who completed treatment and did not enter the PTFU.|456
8082309|NCT03573323|19927652|P1|STARTED|Post-Treatment Follow Up (Weeks 25-36)||465
8082310|NCT03573323|19927651|P2|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||48
8082311|NCT03573323|19927652|P1|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||55
8082312|NCT03573323|19927651|P2|COMPLETED|Blinded Treatment Period (Weeks 0-24)||459
8082313|NCT03573323|19927652|P1|COMPLETED|Blinded Treatment Period (Weeks 0-24)||465
8082314|NCT03573323|19927651|P2|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||506
8082315|NCT03573323|19927652|P1|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||519
8082316|NCT03573323|19927651|P2|STARTED|Blinded Treatment Period (Weeks 0-24)||507
8082317|NCT03573323|19927652|P1|STARTED|Blinded Treatment Period (Weeks 0-24)||520
8082318|NCT03573206|19927676|P1|NOT COMPLETED|Overall Study||0
8082319|NCT03573206|19927676|P1|COMPLETED|Overall Study||168
8082320|NCT03573206|19927676|P1|STARTED|Overall Study||168
8082321|NCT03572972|19927691|P5|NOT COMPLETED|Overall Study||0
8082322|NCT03572972|19927692|P4|NOT COMPLETED|Overall Study||0
8082323|NCT03572972|19927693|P3|NOT COMPLETED|Overall Study||0
8082324|NCT03572972|19927694|P2|NOT COMPLETED|Overall Study||0
8082325|NCT03572972|19927695|P1|NOT COMPLETED|Overall Study||0
8082326|NCT03572972|19927691|P5|COMPLETED|Overall Study||16295
8082327|NCT03572972|19927692|P4|COMPLETED|Overall Study||8648
8082328|NCT03572972|19927693|P3|COMPLETED|Overall Study||17779
8082329|NCT03572972|19927694|P2|COMPLETED|Overall Study||11414
8082330|NCT03572972|19927695|P1|COMPLETED|Overall Study||10548
8082331|NCT03572972|19927691|P5|STARTED|Overall Study||16295
8082332|NCT03572972|19927692|P4|STARTED|Overall Study||8648
8082333|NCT03572972|19927693|P3|STARTED|Overall Study||17779
8082334|NCT03572972|19927694|P2|STARTED|Overall Study||11414
8082335|NCT03572972|19927695|P1|STARTED|Overall Study||10548
8082336|NCT03572218|19927800|P2|NOT COMPLETED|Overall Study||5
8082337|NCT03572218|19927801|P1|NOT COMPLETED|Overall Study||6
8082338|NCT03572218|19927800|P2|COMPLETED|Overall Study||31
8082339|NCT03572218|19927801|P1|COMPLETED|Overall Study||30
8082340|NCT03572218|19927800|P2|Week 26|Overall Study||31
8082341|NCT03572218|19927801|P1|Week 26|Overall Study||30
8082342|NCT03572218|19927800|P2|Week 12|Overall Study||31
8082343|NCT03572218|19927801|P1|Week 12|Overall Study||30
8082344|NCT03572218|19927800|P2|STARTED|Overall Study||36
8082345|NCT03572218|19927801|P1|STARTED|Overall Study||36
8082346|NCT03571724|19927919|P4|NOT COMPLETED|Week 1-6||0
8082347|NCT03571724|19927920|P3|NOT COMPLETED|Week 1-6||3
8082348|NCT03571724|19927921|P2|NOT COMPLETED|Week 1-6||8
8082349|NCT03571724|19927922|P1|NOT COMPLETED|Week 1-6||7
8082350|NCT03571724|19927919|P4|COMPLETED|Week 1-6||20
8082351|NCT03571724|19927920|P3|COMPLETED|Week 1-6||19
8082352|NCT03571724|19927921|P2|COMPLETED|Week 1-6||42
8082353|NCT03571724|19927922|P1|COMPLETED|Week 1-6||43
8082354|NCT03571724|19927919|P4|STARTED|Week 1-6||20
8082355|NCT03571724|19927920|P3|STARTED|Week 1-6||22
8082356|NCT03571724|19927921|P2|STARTED|Week 1-6|Menthol VLN subjects were assigned to this arm after randomization at week 1|50
8082357|NCT03571724|19927922|P1|STARTED|Week 1-6|Non-menthol VLN subjects were assigned to this arm after randomization at week 1|50
8082358|NCT03571724|19927919|P4|NOT COMPLETED|Week -1 (Prior to Switching)||0
8082359|NCT03571724|19927920|P3|NOT COMPLETED|Week -1 (Prior to Switching)||0
8082360|NCT03571724|19927921|P2|NOT COMPLETED|Week -1 (Prior to Switching)||0
8082361|NCT03571724|19927922|P1|NOT COMPLETED|Week -1 (Prior to Switching)||0
8082362|NCT03571724|19927919|P4|COMPLETED|Week -1 (Prior to Switching)||70
8082363|NCT03571724|19927920|P3|COMPLETED|Week -1 (Prior to Switching)||72
8082364|NCT03571724|19927921|P2|COMPLETED|Week -1 (Prior to Switching)||0
8082365|NCT03571724|19927922|P1|COMPLETED|Week -1 (Prior to Switching)||0
8082366|NCT03571724|19927919|P4|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
8082367|NCT03571724|19927920|P3|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
8082368|NCT03571724|19927921|P2|PK Nicotine|Week -1 (Prior to Switching)||0
8082369|NCT03571724|19927922|P1|PK Nicotine|Week -1 (Prior to Switching)||0
8082370|NCT03571724|19927919|P4|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
8082371|NCT03571724|19927920|P3|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
8082372|NCT03571724|19927921|P2|Topography|Week -1 (Prior to Switching)||0
8082373|NCT03571724|19927922|P1|Topography|Week -1 (Prior to Switching)||0
8082374|NCT03571724|19927919|P4|STARTED|Week -1 (Prior to Switching)||70
8082375|NCT03571724|19927920|P3|STARTED|Week -1 (Prior to Switching)||72
8082376|NCT03571724|19927921|P2|STARTED|Week -1 (Prior to Switching)||0
8082377|NCT03571724|19927922|P1|STARTED|Week -1 (Prior to Switching)||0
8082378|NCT03571672|19928031|P1|NOT COMPLETED|Overall Study||5
8082379|NCT03571672|19928031|P1|COMPLETED|Overall Study||148
8082380|NCT03571672|19928031|P1|STARTED|Overall Study||153
8082381|NCT03571607|19928054|P2|NOT COMPLETED|Overall Study||0
8082382|NCT03571607|19928055|P1|NOT COMPLETED|Overall Study||0
8082383|NCT03571607|19928054|P2|COMPLETED|Overall Study||153
8082384|NCT03571607|19928055|P1|COMPLETED|Overall Study||53
8082385|NCT03571607|19928054|P2|Vaccinated|Overall Study||153
8082386|NCT03571607|19928055|P1|Vaccinated|Overall Study||53
8082387|NCT03571607|19928054|P2|STARTED|Overall Study||153
8082388|NCT03571607|19928055|P1|STARTED|Overall Study||53
8082404|NCT03570658|19928105|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8082405|NCT03570658|19928106|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8082406|NCT03570658|19928107|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8082407|NCT03570658|19928108|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8082408|NCT03570658|19928105|P4|COMPLETED|Multiple Ascending Dose (MAD)||10
8082409|NCT03570658|19928106|P3|COMPLETED|Multiple Ascending Dose (MAD)||10
8082410|NCT03570658|19928107|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
8082411|NCT03570658|19928108|P1|COMPLETED|Multiple Ascending Dose (MAD)||4
8082412|NCT03570658|19928105|P4|STARTED|Multiple Ascending Dose (MAD)||10
8082413|NCT03570658|19928106|P3|STARTED|Multiple Ascending Dose (MAD)||10
8082414|NCT03570658|19928107|P2|STARTED|Multiple Ascending Dose (MAD)||0
8082415|NCT03570658|19928108|P1|STARTED|Multiple Ascending Dose (MAD)||4
8082416|NCT03570658|19928105|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
8082417|NCT03570658|19928106|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
8082418|NCT03570658|19928107|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
8082419|NCT03570658|19928108|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
8082420|NCT03570658|19928105|P4|COMPLETED|Single Ascending Dose (SAD)||10
8082421|NCT03570658|19928106|P3|COMPLETED|Single Ascending Dose (SAD)||10
8082422|NCT03570658|19928107|P2|COMPLETED|Single Ascending Dose (SAD)||2
8082423|NCT03570658|19928108|P1|COMPLETED|Single Ascending Dose (SAD)||6
8082424|NCT03570658|19928105|P4|STARTED|Single Ascending Dose (SAD)||10
8082425|NCT03570658|19928106|P3|STARTED|Single Ascending Dose (SAD)||10
8082426|NCT03570658|19928107|P2|STARTED|Single Ascending Dose (SAD)||2
8082427|NCT03570658|19928108|P1|STARTED|Single Ascending Dose (SAD)||6
8082428|NCT03570554|19928162|P4|NOT COMPLETED|Overall Study||1
8082429|NCT03570554|19928163|P3|NOT COMPLETED|Overall Study||1
8082430|NCT03570554|19928164|P2|NOT COMPLETED|Overall Study||0
8082431|NCT03570554|19928165|P1|NOT COMPLETED|Overall Study||0
8082432|NCT03570554|19928162|P4|COMPLETED|Overall Study||9
8082433|NCT03570554|19928163|P3|COMPLETED|Overall Study||10
8082434|NCT03570554|19928164|P2|COMPLETED|Overall Study||10
8082435|NCT03570554|19928165|P1|COMPLETED|Overall Study||10
8082436|NCT03570554|19928162|P4|STARTED|Overall Study||10
8082437|NCT03570554|19928163|P3|STARTED|Overall Study||11
8082438|NCT03570554|19928164|P2|STARTED|Overall Study||10
8082439|NCT03570554|19928165|P1|STARTED|Overall Study||10
8082440|NCT03570476|19928183|P1|NOT COMPLETED|Overall Study||0
8082441|NCT03570476|19928183|P1|COMPLETED|Overall Study||2
8082442|NCT03570476|19928183|P1|STARTED|Overall Study||2
8082443|NCT03570255|19928190|P1|NOT COMPLETED|Overall Study||0
8082444|NCT03570255|19928190|P1|COMPLETED|Overall Study||28
8082445|NCT03570255|19928190|P1|STARTED|Overall Study||28
8082446|NCT03570047|19928199|P5|NOT COMPLETED|Overall Study||0
8082447|NCT03570047|19928200|P4|NOT COMPLETED|Overall Study||0
8082448|NCT03570047|19928201|P3|NOT COMPLETED|Overall Study||0
8082449|NCT03570047|19928202|P2|NOT COMPLETED|Overall Study||0
8082450|NCT03570047|19928203|P1|NOT COMPLETED|Overall Study||0
8082451|NCT03570047|19928199|P5|COMPLETED|Overall Study||12262
8082452|NCT03570047|19928200|P4|COMPLETED|Overall Study||16564
8082453|NCT03570047|19928201|P3|COMPLETED|Overall Study||6925
8082454|NCT03570047|19928202|P2|COMPLETED|Overall Study||22336
8082455|NCT03570047|19928203|P1|COMPLETED|Overall Study||15902
8082456|NCT03570047|19928199|P5|STARTED|Overall Study||12262
8082457|NCT03570047|19928200|P4|STARTED|Overall Study||16564
8082458|NCT03570047|19928201|P3|STARTED|Overall Study||6925
8082459|NCT03570047|19928202|P2|STARTED|Overall Study||22336
8082460|NCT03570047|19928203|P1|STARTED|Overall Study||15902
8082461|NCT03569618|19928262|P2|NOT COMPLETED|Overall Study||1
8082462|NCT03569618|19928263|P1|NOT COMPLETED|Overall Study||3
8082463|NCT03569618|19928262|P2|COMPLETED|Overall Study||20
8082464|NCT03569618|19928263|P1|COMPLETED|Overall Study||20
8082465|NCT03569618|19928262|P2|STARTED|Overall Study||21
8082466|NCT03569618|19928263|P1|STARTED|Overall Study||23
8082467|NCT03569371|19928279|P1|NOT COMPLETED|Overall Study||3
8082468|NCT03569371|19928279|P1|COMPLETED|Overall Study||7
8082469|NCT03569371|19928279|P1|STARTED|Overall Study||10
8082470|NCT03569202|19928300|P2|NOT COMPLETED|Part 3||1
8082471|NCT03569202|19928301|P1|NOT COMPLETED|Part 3||2
8082472|NCT03569202|19928300|P2|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|25
8082473|NCT03569202|19928301|P1|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|24
8082474|NCT03569202|19928300|P2|STARTED|Part 3|Control Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
8082475|NCT03569202|19928301|P1|STARTED|Part 3|Emulsion Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
8082476|NCT03569202|19928300|P2|NOT COMPLETED|Part 2||0
8082477|NCT03569202|19928301|P1|NOT COMPLETED|Part 2||0
8082478|NCT03569202|19928300|P2|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
8082479|NCT03569202|19928301|P1|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
8082480|NCT03569202|19928300|P2|STARTED|Part 2|Control Eye Drops were used on contralateral eye. Participants were different from Part 1.|9
8082481|NCT03569202|19928301|P1|STARTED|Part 2|Emulsion Eye Drops were used on one randomized eye. Participants were different from Part 1.|9
8082482|NCT03569202|19928300|P2|NOT COMPLETED|Part 1||0
8082483|NCT03569202|19928301|P1|NOT COMPLETED|Part 1||0
8082484|NCT03569202|19928300|P2|COMPLETED|Part 1||0
8082485|NCT03569202|19928301|P1|COMPLETED|Part 1|No participant completing Part 1 was allowed to continue to Parts 2 or 3.|3
8082486|NCT03569202|19928300|P2|STARTED|Part 1|Control Eye Drops were not used for Part 1.|0
8082487|NCT03569202|19928301|P1|STARTED|Part 1|Emulsion Eye Drops were used on one eye only.|3
8082488|NCT03569033|19928333|P2|NOT COMPLETED|Overall Study||0
8082489|NCT03569033|19928334|P1|NOT COMPLETED|Overall Study||0
8082490|NCT03569033|19928333|P2|COMPLETED|Overall Study||23
8082491|NCT03569033|19928334|P1|COMPLETED|Overall Study||23
8082492|NCT03569033|19928333|P2|STARTED|Overall Study||23
8082493|NCT03569033|19928334|P1|STARTED|Overall Study||23
8082494|NCT03568942|19928350|P1|NOT COMPLETED|Overall Study||2
8082495|NCT03568942|19928350|P1|COMPLETED|Overall Study||20
8082496|NCT03568942|19928350|P1|STARTED|Overall Study||22
8082497|NCT03568500|19928388|P3|NOT COMPLETED|Overall Study||4
8082498|NCT03568500|19928389|P2|NOT COMPLETED|Overall Study||6
8082499|NCT03568500|19928390|P1|NOT COMPLETED|Overall Study||10
8082500|NCT03568500|19928388|P3|COMPLETED|Overall Study||2
8082501|NCT03568500|19928389|P2|COMPLETED|Overall Study||14
8082502|NCT03568500|19928390|P1|COMPLETED|Overall Study||8
8082503|NCT03568500|19928388|P3|Received At Least 1 Dose of Study Drug|Overall Study||6
8082504|NCT03568500|19928389|P2|Received At Least 1 Dose of Study Drug|Overall Study||19
8082505|NCT03568500|19928390|P1|Received At Least 1 Dose of Study Drug|Overall Study||18
8082506|NCT03568500|19928388|P3|STARTED|Overall Study||6
8082507|NCT03568500|19928389|P2|STARTED|Overall Study||20
8082508|NCT03568500|19928390|P1|STARTED|Overall Study||18
8082509|NCT03567005|19928404|P2|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
8082510|NCT03567005|19928405|P1|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
8082511|NCT03567005|19928404|P2|COMPLETED|Period 2, Second 7 Days of Wear||31
8082512|NCT03567005|19928405|P1|COMPLETED|Period 2, Second 7 Days of Wear||29
8082513|NCT03567005|19928404|P2|STARTED|Period 2, Second 7 Days of Wear||31
8082514|NCT03567005|19928405|P1|STARTED|Period 2, Second 7 Days of Wear||29
8082515|NCT03567005|19928404|P2|NOT COMPLETED|Period 1, First 7 Days of Wear||0
8082516|NCT03567005|19928405|P1|NOT COMPLETED|Period 1, First 7 Days of Wear||0
8082517|NCT03567005|19928404|P2|COMPLETED|Period 1, First 7 Days of Wear||31
8082518|NCT03567005|19928405|P1|COMPLETED|Period 1, First 7 Days of Wear||29
8082519|NCT03567005|19928404|P2|STARTED|Period 1, First 7 Days of Wear||31
8082520|NCT03567005|19928405|P1|STARTED|Period 1, First 7 Days of Wear||29
8082521|NCT03566979|19928417|P4|NOT COMPLETED|Overall Study||6
8082522|NCT03566979|19928418|P3|NOT COMPLETED|Overall Study||10
8082523|NCT03566979|19928419|P2|NOT COMPLETED|Overall Study||7
8082524|NCT03566979|19928420|P1|NOT COMPLETED|Overall Study||5
8082525|NCT03566979|19928417|P4|COMPLETED|Overall Study||143
8082526|NCT03566979|19928418|P3|COMPLETED|Overall Study||132
8082527|NCT03566979|19928419|P2|COMPLETED|Overall Study||145
8082528|NCT03566979|19928420|P1|COMPLETED|Overall Study||53
8082529|NCT03566979|19928417|P4|STARTED|Overall Study||149
8082530|NCT03566979|19928418|P3|STARTED|Overall Study||142
8082531|NCT03566979|19928419|P2|STARTED|Overall Study||152
8082532|NCT03566979|19928420|P1|STARTED|Overall Study||58
8082533|NCT03566810|19928436|P4|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8082534|NCT03566810|19928437|P3|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8082535|NCT03566810|19928438|P2|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8082536|NCT03566810|19928439|P1|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8082537|NCT03566810|19928436|P4|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
8082538|NCT03566810|19928437|P3|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
8082539|NCT03566810|19928438|P2|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18
8082540|NCT03566810|19928439|P1|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19
8082541|NCT03566810|19928436|P4|STARTED|Treatment Period 2 (Day 8- Day 10)||8
8082542|NCT03566810|19928437|P3|STARTED|Treatment Period 2 (Day 8- Day 10)||8
8082543|NCT03566810|19928438|P2|STARTED|Treatment Period 2 (Day 8- Day 10)||18
8082544|NCT03566810|19928439|P1|STARTED|Treatment Period 2 (Day 8- Day 10)||19
8082545|NCT03566810|19928436|P4|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
8082546|NCT03566810|19928437|P3|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
8082547|NCT03566810|19928438|P2|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1
8082548|NCT03566810|19928439|P1|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
8082549|NCT03566810|19928436|P4|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
8082550|NCT03566810|19928437|P3|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
8082551|NCT03566810|19928438|P2|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18
8082552|NCT03566810|19928439|P1|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19
8082553|NCT03566810|19928436|P4|Treated|Treatment Period 1 (Day 1-Day 3)||8
8082554|NCT03566810|19928437|P3|Treated|Treatment Period 1 (Day 1-Day 3)||8
8082555|NCT03566810|19928438|P2|Treated|Treatment Period 1 (Day 1-Day 3)||18
8082556|NCT03566810|19928439|P1|Treated|Treatment Period 1 (Day 1-Day 3)||19
8082557|NCT03566810|19928436|P4|STARTED|Treatment Period 1 (Day 1-Day 3)||8
8082558|NCT03566810|19928437|P3|STARTED|Treatment Period 1 (Day 1-Day 3)||8
8082559|NCT03566810|19928438|P2|STARTED|Treatment Period 1 (Day 1-Day 3)||19
8082560|NCT03566810|19928439|P1|STARTED|Treatment Period 1 (Day 1-Day 3)||19
8082561|NCT03566680|19928501|P1|NOT COMPLETED|Overall Study||17
8082562|NCT03566680|19928501|P1|COMPLETED|Overall Study||29
8082563|NCT03566680|19928501|P1|STARTED|Overall Study||46
8082564|NCT03565887|19928512|P2|NOT COMPLETED|Overall Study||2
8082565|NCT03565887|19928513|P1|NOT COMPLETED|Overall Study||1
8082566|NCT03565887|19928512|P2|COMPLETED|Overall Study||53
8082567|NCT03565887|19928513|P1|COMPLETED|Overall Study||108
8082568|NCT03565887|19928512|P2|STARTED|Overall Study||55
8082569|NCT03565887|19928513|P1|STARTED|Overall Study||109
8082570|NCT03565874|19928521|P1|NOT COMPLETED|Overall Study||2
8082571|NCT03565874|19928521|P1|COMPLETED|Overall Study||4
8082572|NCT03565874|19928521|P1|STARTED|Overall Study||6
8082573|NCT03565679|19928534|P1|NOT COMPLETED|Overall Study||0
8082574|NCT03565679|19928534|P1|COMPLETED|Overall Study||10
8082575|NCT03565679|19928534|P1|STARTED|Overall Study||10
8082576|NCT03565666|19928541|P3|NOT COMPLETED|Overall Study||1
8082577|NCT03565666|19928542|P2|NOT COMPLETED|Overall Study||0
8082578|NCT03565666|19928543|P1|NOT COMPLETED|Overall Study||0
8082579|NCT03565666|19928541|P3|COMPLETED|Overall Study||11
8082580|NCT03565666|19928542|P2|COMPLETED|Overall Study||12
8082581|NCT03565666|19928543|P1|COMPLETED|Overall Study||12
8082582|NCT03565666|19928541|P3|STARTED|Overall Study||12
8082583|NCT03565666|19928542|P2|STARTED|Overall Study||12
8082584|NCT03565666|19928543|P1|STARTED|Overall Study||12
8082585|NCT03565328|19928580|P1|NOT COMPLETED|Overall Study||0
8082586|NCT03565328|19928580|P1|COMPLETED|Overall Study||1
8082587|NCT03565328|19928580|P1|STARTED|Overall Study||1
8082588|NCT03565315|19928592|P4|NOT COMPLETED|Overall Study||1
8082589|NCT03565315|19928593|P3|NOT COMPLETED|Overall Study||0
8082590|NCT03565315|19928594|P2|NOT COMPLETED|Overall Study||0
8082591|NCT03565315|19928595|P1|NOT COMPLETED|Overall Study||0
8082592|NCT03565315|19928592|P4|COMPLETED|Overall Study||1
8082593|NCT03565315|19928593|P3|COMPLETED|Overall Study||1
8082594|NCT03565315|19928594|P2|COMPLETED|Overall Study||3
8082595|NCT03565315|19928595|P1|COMPLETED|Overall Study||3
8082596|NCT03565315|19928592|P4|Discontinued Product Administrations|Overall Study|One Group 4 participant enrolled but did not receive product due to IND/PI voluntary study pause.|2
8082597|NCT03565315|19928593|P3|Discontinued Product Administrations|Overall Study||0
8082598|NCT03565315|19928594|P2|Discontinued Product Administrations|Overall Study||3
8082599|NCT03565315|19928595|P1|Discontinued Product Administrations|Overall Study||0
8082600|NCT03565315|19928592|P4|Product Administration Completed|Overall Study||0
8082601|NCT03565315|19928593|P3|Product Administration Completed|Overall Study||1
8082602|NCT03565315|19928594|P2|Product Administration Completed|Overall Study||0
8082603|NCT03565315|19928595|P1|Product Administration Completed|Overall Study||3
8082604|NCT03565315|19928592|P4|STARTED|Overall Study||2
8082605|NCT03565315|19928593|P3|STARTED|Overall Study||1
8082606|NCT03565315|19928594|P2|STARTED|Overall Study||3
8082607|NCT03565315|19928595|P1|STARTED|Overall Study||3
8082608|NCT03565211|19928632|P1|NOT COMPLETED|Overall Study||48
8082609|NCT03565211|19928632|P1|COMPLETED|Overall Study||206
8082610|NCT03565211|19928632|P1|Modified Intention-to-treat (mITT)|Overall Study|Had successful oocyte retrieval, received >=1 dose of IMP, and completed fresh embryo transfer|243
8082611|NCT03565211|19928632|P1|STARTED|Overall Study||254
8082612|NCT03564886|19928657|P2|NOT COMPLETED|Overall Study||1
8082613|NCT03564886|19928658|P1|NOT COMPLETED|Overall Study||1
8082614|NCT03564886|19928657|P2|COMPLETED|Overall Study||23
8082615|NCT03564886|19928658|P1|COMPLETED|Overall Study||23
8082616|NCT03564886|19928657|P2|STARTED|Overall Study||24
8082617|NCT03564886|19928658|P1|STARTED|Overall Study||24
8082618|NCT03564444|19928670|P2|NOT COMPLETED|Overall Study||0
8082619|NCT03564444|19928671|P1|NOT COMPLETED|Overall Study||0
8082620|NCT03564444|19928670|P2|COMPLETED|Overall Study||240
8082621|NCT03564444|19928671|P1|COMPLETED|Overall Study||60
8082622|NCT03564444|19928670|P2|STARTED|Overall Study||240
8082623|NCT03564444|19928671|P1|STARTED|Overall Study||60
8082624|NCT03564353|19928691|P4|NOT COMPLETED|Overall Study||0
8082625|NCT03564353|19928692|P3|NOT COMPLETED|Overall Study||0
8082626|NCT03564353|19928693|P2|NOT COMPLETED|Overall Study||0
8082627|NCT03564353|19928694|P1|NOT COMPLETED|Overall Study||0
8082628|NCT03564353|19928691|P4|COMPLETED|Overall Study||10
8082629|NCT03564353|19928692|P3|COMPLETED|Overall Study||10
8082630|NCT03564353|19928693|P2|COMPLETED|Overall Study||10
8082631|NCT03564353|19928694|P1|COMPLETED|Overall Study||10
8082632|NCT03564353|19928691|P4|STARTED|Overall Study||10
8082633|NCT03564353|19928692|P3|STARTED|Overall Study||10
8082634|NCT03564353|19928693|P2|STARTED|Overall Study||10
8082635|NCT03564353|19928694|P1|STARTED|Overall Study||10
8082642|NCT03563313|19928717|P2|NOT COMPLETED|Overall Study||0
8082643|NCT03563313|19928718|P1|NOT COMPLETED|Overall Study||0
8082644|NCT03563313|19928717|P2|COMPLETED|Overall Study||56
8082645|NCT03563313|19928718|P1|COMPLETED|Overall Study||112
8082646|NCT03563313|19928717|P2|STARTED|Overall Study||56
8082647|NCT03563313|19928718|P1|STARTED|Overall Study||112
8082648|NCT03563209|19928826|P1|NOT COMPLETED|Overall Study||0
8082649|NCT03563209|19928826|P1|COMPLETED|Overall Study||60
8082650|NCT03563209|19928826|P1|STARTED|Overall Study||60
8082651|NCT03563183|19928832|P1|NOT COMPLETED|Overall Study||0
8082652|NCT03563183|19928832|P1|COMPLETED|Overall Study||26976
8082653|NCT03563183|19928832|P1|STARTED|Overall Study||26976
8082654|NCT03562663|19928935|P2|NOT COMPLETED|Overall Study||6
8082655|NCT03562663|19928936|P1|NOT COMPLETED|Overall Study||7
8082656|NCT03562663|19928935|P2|COMPLETED|Overall Study||35
8082657|NCT03562663|19928936|P1|COMPLETED|Overall Study||34
8082658|NCT03562663|19928935|P2|STARTED|Overall Study||41
8082659|NCT03562663|19928936|P1|STARTED|Overall Study||41
8082660|NCT03562559|19928942|P1|NOT COMPLETED|Overall Study||0
8082661|NCT03562559|19928942|P1|COMPLETED|Overall Study||40
8082662|NCT03562559|19928942|P1|STARTED|Overall Study||40
8082663|NCT03562481|19928948|P2|NOT COMPLETED|Second Intervention||0
8082664|NCT03562481|19928949|P1|NOT COMPLETED|Second Intervention||0
8082665|NCT03562481|19928948|P2|COMPLETED|Second Intervention||14
8082666|NCT03562481|19928949|P1|COMPLETED|Second Intervention||11
8082667|NCT03562481|19928948|P2|STARTED|Second Intervention||14
8082668|NCT03562481|19928949|P1|STARTED|Second Intervention||11
8082669|NCT03562481|19928948|P2|NOT COMPLETED|Washout||0
8082670|NCT03562481|19928949|P1|NOT COMPLETED|Washout||0
8082671|NCT03562481|19928948|P2|COMPLETED|Washout||14
8082672|NCT03562481|19928949|P1|COMPLETED|Washout||11
8082673|NCT03562481|19928948|P2|STARTED|Washout||14
8082674|NCT03562481|19928949|P1|STARTED|Washout||11
8082675|NCT03562481|19928948|P2|NOT COMPLETED|First Intervention||0
8082676|NCT03562481|19928949|P1|NOT COMPLETED|First Intervention||1
8082677|NCT03562481|19928948|P2|COMPLETED|First Intervention||14
8082678|NCT03562481|19928949|P1|COMPLETED|First Intervention||11
8082679|NCT03562481|19928948|P2|STARTED|First Intervention||14
8082680|NCT03562481|19928949|P1|STARTED|First Intervention||12
8082699|NCT03560986|19929064|P2|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
8082700|NCT03560986|19929065|P1|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
8082701|NCT03560986|19929064|P2|COMPLETED|Treatment Period B/Follow-up Period 2||0
8082702|NCT03560986|19929065|P1|COMPLETED|Treatment Period B/Follow-up Period 2||1
8082703|NCT03560986|19929064|P2|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
8082704|NCT03560986|19929065|P1|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
8082705|NCT03560986|19929064|P2|STARTED|Treatment Period B/Follow-up Period 2|5 Part. completed Placebo Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|8
8082706|NCT03560986|19929065|P1|STARTED|Treatment Period B/Follow-up Period 2|3 Participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|9
8082707|NCT03560986|19929064|P2|NOT COMPLETED|Treatment Period A/Follow-up Period 1||38
8082708|NCT03560986|19929065|P1|NOT COMPLETED|Treatment Period A/Follow-up Period 1||36
8082709|NCT03560986|19929064|P2|COMPLETED|Treatment Period A/Follow-up Period 1||13
8082710|NCT03560986|19929065|P1|COMPLETED|Treatment Period A/Follow-up Period 1||12
8082711|NCT03560986|19929064|P2|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
8082712|NCT03560986|19929065|P1|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
8082713|NCT03560986|19929064|P2|STARTED|Treatment Period A/Follow-up Period 1|One additional participant was allocated to placebo but not treated.|51
8082714|NCT03560986|19929065|P1|STARTED|Treatment Period A/Follow-up Period 1||48
8082715|NCT03560869|19929087|P2|NOT COMPLETED|Overall Study||9
8082716|NCT03560869|19929088|P1|NOT COMPLETED|Overall Study||7
8082717|NCT03560869|19929087|P2|COMPLETED|Overall Study||12
8082718|NCT03560869|19929088|P1|COMPLETED|Overall Study||7
8082719|NCT03560869|19929087|P2|STARTED|Overall Study||21
8082720|NCT03560869|19929088|P1|STARTED|Overall Study||14
8082721|NCT03560739|19929100|P4|NOT COMPLETED|Overall Study||0
8082722|NCT03560739|19929101|P3|NOT COMPLETED|Overall Study||0
8082723|NCT03560739|19929102|P2|NOT COMPLETED|Overall Study||1
8082724|NCT03560739|19929103|P1|NOT COMPLETED|Overall Study||0
8082725|NCT03560739|19929100|P4|COMPLETED|Overall Study||13
8082726|NCT03560739|19929101|P3|COMPLETED|Overall Study||13
8082727|NCT03560739|19929102|P2|COMPLETED|Overall Study||129
8082728|NCT03560739|19929103|P1|COMPLETED|Overall Study||128
8082729|NCT03560739|19929100|P4|STARTED|Overall Study||13
8082730|NCT03560739|19929101|P3|STARTED|Overall Study||13
8082731|NCT03560739|19929102|P2|STARTED|Overall Study||130
8082732|NCT03560739|19929103|P1|STARTED|Overall Study||128
8082733|NCT03560518|19929132|P3|NOT COMPLETED|Safety Follow-Up Period||0
8082734|NCT03560518|19929133|P2|NOT COMPLETED|Safety Follow-Up Period||0
8082735|NCT03560518|19929134|P1|NOT COMPLETED|Safety Follow-Up Period||0
8082736|NCT03560518|19929132|P3|COMPLETED|Safety Follow-Up Period||22
8082737|NCT03560518|19929133|P2|COMPLETED|Safety Follow-Up Period||17
8082738|NCT03560518|19929134|P1|COMPLETED|Safety Follow-Up Period||10
8082739|NCT03560518|19929132|P3|STARTED|Safety Follow-Up Period||22
8082740|NCT03560518|19929133|P2|STARTED|Safety Follow-Up Period||17
8082741|NCT03560518|19929134|P1|STARTED|Safety Follow-Up Period||10
8082742|NCT03560518|19929132|P3|NOT COMPLETED|Double Blind Treatment Period||23
8082743|NCT03560518|19929133|P2|NOT COMPLETED|Double Blind Treatment Period||29
8082744|NCT03560518|19929134|P1|NOT COMPLETED|Double Blind Treatment Period||25
8082745|NCT03560518|19929132|P3|COMPLETED|Double Blind Treatment Period||124
8082746|NCT03560518|19929133|P2|COMPLETED|Double Blind Treatment Period||116
8082747|NCT03560518|19929134|P1|COMPLETED|Double Blind Treatment Period||122
8082748|NCT03560518|19929132|P3|STARTED|Double Blind Treatment Period||147
8082749|NCT03560518|19929133|P2|STARTED|Double Blind Treatment Period||145
8082750|NCT03560518|19929134|P1|STARTED|Double Blind Treatment Period||147
8082751|NCT03560245|19929147|P2|NOT COMPLETED|Overall Study||7
8082752|NCT03560245|19929148|P1|NOT COMPLETED|Overall Study||5
8082753|NCT03560245|19929147|P2|COMPLETED|Overall Study||48
8082754|NCT03560245|19929148|P1|COMPLETED|Overall Study||48
8082755|NCT03560245|19929147|P2|STARTED|Overall Study||55
8082756|NCT03560245|19929148|P1|STARTED|Overall Study||53
8082757|NCT03560128|19929166|P2|NOT COMPLETED|Overall Study||8
8082758|NCT03560128|19929167|P1|NOT COMPLETED|Overall Study||12
8082759|NCT03560128|19929166|P2|COMPLETED|Overall Study||298
8082760|NCT03560128|19929167|P1|COMPLETED|Overall Study||294
8082761|NCT03560128|19929166|P2|STARTED|Overall Study||306
8082762|NCT03560128|19929167|P1|STARTED|Overall Study||306
8082763|NCT03559829|19929187|P1|NOT COMPLETED|Overall Study||0
8082764|NCT03559829|19929187|P1|COMPLETED|Overall Study||20
8082765|NCT03559829|19929187|P1|STARTED|Overall Study||20
8082766|NCT03559257|19929202|P2|NOT COMPLETED|Open-label Treatment Period||7
8082767|NCT03559257|19929203|P1|NOT COMPLETED|Open-label Treatment Period||10
8082768|NCT03559257|19929202|P2|COMPLETED|Open-label Treatment Period||217
8082769|NCT03559257|19929203|P1|COMPLETED|Open-label Treatment Period||215
8082770|NCT03559257|19929202|P2|STARTED|Open-label Treatment Period|One participant who completed double blind period had discontinued due to adverse event.|224
8082771|NCT03559257|19929203|P1|STARTED|Open-label Treatment Period|One participant who completed double blind period has withdrawn from the study.|225
8082772|NCT03559257|19929202|P2|NOT COMPLETED|Double Blind Treatment Period||8
8082773|NCT03559257|19929203|P1|NOT COMPLETED|Double Blind Treatment Period||4
8082774|NCT03559257|19929202|P2|COMPLETED|Double Blind Treatment Period||225
8082775|NCT03559257|19929203|P1|COMPLETED|Double Blind Treatment Period||226
8082776|NCT03559257|19929202|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Period||232
8082777|NCT03559257|19929203|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Period||230
8082778|NCT03559257|19929202|P2|STARTED|Double Blind Treatment Period||233
8082779|NCT03559257|19929203|P1|STARTED|Double Blind Treatment Period||230
8082780|NCT03559179|19929250|P3|NOT COMPLETED|Overall Study||0
8082781|NCT03559179|19929251|P2|NOT COMPLETED|Overall Study||1
8082782|NCT03559179|19929252|P1|NOT COMPLETED|Overall Study||0
8082783|NCT03559179|19929250|P3|COMPLETED|Overall Study||23
8082784|NCT03559179|19929251|P2|COMPLETED|Overall Study||23
8082785|NCT03559179|19929252|P1|COMPLETED|Overall Study||8
8082786|NCT03559179|19929250|P3|STARTED|Overall Study||23
8082787|NCT03559179|19929251|P2|STARTED|Overall Study||24
8082788|NCT03559179|19929252|P1|STARTED|Overall Study||8
8082789|NCT03559062|19929273|P3|NOT COMPLETED|Overall Study||0
8082790|NCT03559062|19929274|P2|NOT COMPLETED|Overall Study||1
8082791|NCT03559062|19929275|P1|NOT COMPLETED|Overall Study||0
8082792|NCT03559062|19929273|P3|COMPLETED|Overall Study||3
8082793|NCT03559062|19929274|P2|COMPLETED|Overall Study||53
8082794|NCT03559062|19929275|P1|COMPLETED|Overall Study||10
8082795|NCT03559062|19929273|P3|STARTED|Overall Study||3
8082796|NCT03559062|19929274|P2|STARTED|Overall Study||54
8082797|NCT03559062|19929275|P1|STARTED|Overall Study||10
8082798|NCT03558997|19929290|P4|NOT COMPLETED|Overall Study||2
8082799|NCT03558997|19929291|P3|NOT COMPLETED|Overall Study||8
8082800|NCT03558997|19929292|P2|NOT COMPLETED|Overall Study||2
8082801|NCT03558997|19929293|P1|NOT COMPLETED|Overall Study||1
8082802|NCT03558997|19929290|P4|COMPLETED|Overall Study||24
8082803|NCT03558997|19929291|P3|COMPLETED|Overall Study||18
8082804|NCT03558997|19929292|P2|COMPLETED|Overall Study||24
8082805|NCT03558997|19929293|P1|COMPLETED|Overall Study||24
8082806|NCT03558997|19929290|P4|STARTED|Overall Study||26
8082807|NCT03558997|19929291|P3|STARTED|Overall Study||26
8082808|NCT03558997|19929292|P2|STARTED|Overall Study||26
8082809|NCT03558997|19929293|P1|STARTED|Overall Study||25
8082810|NCT03558672|19929325|P1|NOT COMPLETED|Overall Study||10
8082811|NCT03558672|19929325|P1|COMPLETED|Overall Study||8
8082812|NCT03558672|19929325|P1|STARTED|Overall Study||18
8082813|NCT03558555|19929337|P2|NOT COMPLETED|Overall Study||1
8082814|NCT03558555|19929338|P1|NOT COMPLETED|Overall Study||2
8082815|NCT03558555|19929337|P2|COMPLETED|Overall Study||44
8082816|NCT03558555|19929338|P1|COMPLETED|Overall Study||56
8082817|NCT03558555|19929337|P2|STARTED|Overall Study||45
8082818|NCT03558555|19929338|P1|STARTED|Overall Study||58
8082819|NCT03558516|19929356|P2|NOT COMPLETED|Overall Study||2
8082820|NCT03558516|19929357|P1|NOT COMPLETED|Overall Study||2
8082821|NCT03558516|19929356|P2|COMPLETED|Overall Study||38
8082822|NCT03558516|19929357|P1|COMPLETED|Overall Study||38
8082823|NCT03558516|19929356|P2|STARTED|Overall Study||40
8082824|NCT03558516|19929357|P1|STARTED|Overall Study||40
8082825|NCT03558230|19929377|P2|NOT COMPLETED|Overall Study||0
8082826|NCT03558230|19929378|P1|NOT COMPLETED|Overall Study||0
8082827|NCT03558230|19929377|P2|COMPLETED|Overall Study||6
8082828|NCT03558230|19929378|P1|COMPLETED|Overall Study||7
8082829|NCT03558230|19929377|P2|STARTED|Overall Study||6
8082830|NCT03558230|19929378|P1|STARTED|Overall Study||7
8082831|NCT03558074|19929384|P1|NOT COMPLETED|Overall Study||2
8082832|NCT03558074|19929384|P1|COMPLETED|Overall Study||24
8082833|NCT03558074|19929384|P1|STARTED|Overall Study||26
8082834|NCT03558061|19929389|P1|NOT COMPLETED|Overall Study||1
8082835|NCT03558061|19929389|P1|COMPLETED|Overall Study||29
8082836|NCT03558061|19929389|P1|STARTED|Overall Study||30
8082846|NCT03557801|19929430|P3|NOT COMPLETED|Overall Study||3
8082847|NCT03557801|19929431|P2|NOT COMPLETED|Overall Study||1
8082848|NCT03557801|19929432|P1|NOT COMPLETED|Overall Study||2
8082849|NCT03557801|19929430|P3|COMPLETED|Overall Study||30
8082850|NCT03557801|19929431|P2|COMPLETED|Overall Study||32
8082851|NCT03557801|19929432|P1|COMPLETED|Overall Study||32
8082852|NCT03557801|19929430|P3|STARTED|Overall Study||33
8082853|NCT03557801|19929431|P2|STARTED|Overall Study||33
8082854|NCT03557801|19929432|P1|STARTED|Overall Study||34
8082855|NCT03557775|19929449|P3|NOT COMPLETED|Overall Study||4
8082856|NCT03557775|19929450|P2|NOT COMPLETED|Overall Study||3
8082857|NCT03557775|19929451|P1|NOT COMPLETED|Overall Study||1
8082858|NCT03557775|19929449|P3|COMPLETED|Overall Study||4
8082859|NCT03557775|19929450|P2|COMPLETED|Overall Study||4
8082860|NCT03557775|19929451|P1|COMPLETED|Overall Study||4
8082861|NCT03557775|19929449|P3|STARTED|Overall Study||8
8082862|NCT03557775|19929450|P2|STARTED|Overall Study||7
8082863|NCT03557775|19929451|P1|STARTED|Overall Study||5
8082864|NCT03557476|19929509|P2|NOT COMPLETED|Overall Study||0
8082865|NCT03557476|19929510|P1|NOT COMPLETED|Overall Study||0
8082866|NCT03557476|19929509|P2|COMPLETED|Overall Study||13
8082867|NCT03557476|19929510|P1|COMPLETED|Overall Study||13
8082868|NCT03557476|19929509|P2|STARTED|Overall Study||13
8082869|NCT03557476|19929510|P1|STARTED|Overall Study||13
8082870|NCT03556761|19929530|P2|NOT COMPLETED|Overall Study||29
8082871|NCT03556761|19929531|P1|NOT COMPLETED|Overall Study||24
8082872|NCT03556761|19929530|P2|COMPLETED|Overall Study||163
8082873|NCT03556761|19929531|P1|COMPLETED|Overall Study||168
8082874|NCT03556761|19929530|P2|STARTED|Overall Study||192
8082875|NCT03556761|19929531|P1|STARTED|Overall Study||192
8082876|NCT03556579|19929551|P4|NOT COMPLETED|Visit 2||0
8082877|NCT03556579|19929552|P3|NOT COMPLETED|Visit 2||0
8082878|NCT03556579|19929553|P2|NOT COMPLETED|Visit 2||0
8082879|NCT03556579|19929554|P1|NOT COMPLETED|Visit 2||0
8082880|NCT03556579|19929551|P4|COMPLETED|Visit 2||16
8082881|NCT03556579|19929552|P3|COMPLETED|Visit 2||14
8082882|NCT03556579|19929553|P2|COMPLETED|Visit 2||14
8082883|NCT03556579|19929554|P1|COMPLETED|Visit 2||16
8082884|NCT03556579|19929551|P4|STARTED|Visit 2||16
8082885|NCT03556579|19929552|P3|STARTED|Visit 2||14
8082886|NCT03556579|19929553|P2|STARTED|Visit 2||14
8082887|NCT03556579|19929554|P1|STARTED|Visit 2||16
8082888|NCT03556579|19929551|P4|NOT COMPLETED|Visit 1||0
8082889|NCT03556579|19929552|P3|NOT COMPLETED|Visit 1||0
8082890|NCT03556579|19929553|P2|NOT COMPLETED|Visit 1||0
8082891|NCT03556579|19929554|P1|NOT COMPLETED|Visit 1||0
8082892|NCT03556579|19929551|P4|COMPLETED|Visit 1||16
8082893|NCT03556579|19929552|P3|COMPLETED|Visit 1||14
8082894|NCT03556579|19929553|P2|COMPLETED|Visit 1||14
8082895|NCT03556579|19929554|P1|COMPLETED|Visit 1||16
8082896|NCT03556579|19929551|P4|STARTED|Visit 1||16
8082897|NCT03556579|19929552|P3|STARTED|Visit 1||14
8082898|NCT03556579|19929553|P2|STARTED|Visit 1||14
8082899|NCT03556579|19929554|P1|STARTED|Visit 1||16
8082900|NCT03555890|19929582|P4|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
8082901|NCT03555890|19929583|P3|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
8082902|NCT03555890|19929584|P2|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
8082903|NCT03555890|19929585|P1|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
8082904|NCT03555890|19929582|P4|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23
8082905|NCT03555890|19929583|P3|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24
8082906|NCT03555890|19929584|P2|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
8082907|NCT03555890|19929585|P1|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
8082908|NCT03555890|19929582|P4|STARTED|Part 2:Treatment Period 2 (10 Days)||23
8082909|NCT03555890|19929583|P3|STARTED|Part 2:Treatment Period 2 (10 Days)||24
8082910|NCT03555890|19929584|P2|STARTED|Part 2:Treatment Period 2 (10 Days)||0
8082911|NCT03555890|19929585|P1|STARTED|Part 2:Treatment Period 2 (10 Days)||0
8082912|NCT03555890|19929582|P4|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1
8082913|NCT03555890|19929583|P3|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
8082914|NCT03555890|19929584|P2|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
8082915|NCT03555890|19929585|P1|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
8082916|NCT03555890|19929582|P4|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23
8082917|NCT03555890|19929583|P3|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24
8082918|NCT03555890|19929584|P2|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
8082919|NCT03555890|19929585|P1|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
8082920|NCT03555890|19929582|P4|STARTED|Part 2:Washout Period (at Least 5 Days)||24
8082921|NCT03555890|19929583|P3|STARTED|Part 2:Washout Period (at Least 5 Days)||24
8082922|NCT03555890|19929584|P2|STARTED|Part 2:Washout Period (at Least 5 Days)||0
8082923|NCT03555890|19929585|P1|STARTED|Part 2:Washout Period (at Least 5 Days)||0
8082924|NCT03555890|19929582|P4|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
8082925|NCT03555890|19929583|P3|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
8082926|NCT03555890|19929584|P2|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
8082927|NCT03555890|19929585|P1|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
8082928|NCT03555890|19929582|P4|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
8082929|NCT03555890|19929583|P3|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
8082930|NCT03555890|19929584|P2|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
8082931|NCT03555890|19929585|P1|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
8082932|NCT03555890|19929582|P4|STARTED|Part 2:Treatment Period 1 (3 Days)||24
8082933|NCT03555890|19929583|P3|STARTED|Part 2:Treatment Period 1 (3 Days)||24
8082934|NCT03555890|19929584|P2|STARTED|Part 2:Treatment Period 1 (3 Days)||0
8082935|NCT03555890|19929585|P1|STARTED|Part 2:Treatment Period 1 (3 Days)||0
8082936|NCT03555890|19929582|P4|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
8082937|NCT03555890|19929583|P3|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
8082938|NCT03555890|19929584|P2|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
8082939|NCT03555890|19929585|P1|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
8082940|NCT03555890|19929582|P4|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
8082941|NCT03555890|19929583|P3|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
8082942|NCT03555890|19929584|P2|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
8082943|NCT03555890|19929585|P1|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
8082944|NCT03555890|19929582|P4|STARTED|Part 1:Treatment Period 2 (10 Days)||0
8082945|NCT03555890|19929583|P3|STARTED|Part 1:Treatment Period 2 (10 Days)||0
8082946|NCT03555890|19929584|P2|STARTED|Part 1:Treatment Period 2 (10 Days)||12
8082947|NCT03555890|19929585|P1|STARTED|Part 1:Treatment Period 2 (10 Days)||12
8082948|NCT03555890|19929582|P4|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
8082949|NCT03555890|19929583|P3|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
8082950|NCT03555890|19929584|P2|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
8082951|NCT03555890|19929585|P1|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
8082952|NCT03555890|19929582|P4|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
8082953|NCT03555890|19929583|P3|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
8082954|NCT03555890|19929584|P2|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
8082955|NCT03555890|19929585|P1|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
8082956|NCT03555890|19929582|P4|STARTED|Part 1:Washout Period (at Least 5 Days)||0
8082957|NCT03555890|19929583|P3|STARTED|Part 1:Washout Period (at Least 5 Days)||0
8082958|NCT03555890|19929584|P2|STARTED|Part 1:Washout Period (at Least 5 Days)||12
8082959|NCT03555890|19929585|P1|STARTED|Part 1:Washout Period (at Least 5 Days)||12
8082960|NCT03555890|19929582|P4|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
8082961|NCT03555890|19929583|P3|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
8082962|NCT03555890|19929584|P2|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
8082963|NCT03555890|19929585|P1|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
8082964|NCT03555890|19929582|P4|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
8082965|NCT03555890|19929583|P3|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
8082966|NCT03555890|19929584|P2|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
8082967|NCT03555890|19929585|P1|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
8082968|NCT03555890|19929582|P4|STARTED|Part 1:Treatment Period 1 (3 Days)||0
8082969|NCT03555890|19929583|P3|STARTED|Part 1:Treatment Period 1 (3 Days)||0
8082970|NCT03555890|19929584|P2|STARTED|Part 1:Treatment Period 1 (3 Days)||12
8082971|NCT03555890|19929585|P1|STARTED|Part 1:Treatment Period 1 (3 Days)||12
8082972|NCT03555565|19929719|P1|NOT COMPLETED|Overall Study||15
8082973|NCT03555565|19929719|P1|COMPLETED|Overall Study||1011
8082974|NCT03555565|19929719|P1|STARTED|Overall Study||1026
8082984|NCT03555305|19929742|P2|NOT COMPLETED|Period 2||0
8082985|NCT03555305|19929743|P1|NOT COMPLETED|Period 2||0
8082986|NCT03555305|19929742|P2|COMPLETED|Period 2||27
8082987|NCT03555305|19929743|P1|COMPLETED|Period 2||29
8082988|NCT03555305|19929742|P2|STARTED|Period 2||27
8082989|NCT03555305|19929743|P1|STARTED|Period 2||29
8082990|NCT03555305|19929742|P2|NOT COMPLETED|Period 1||2
8082991|NCT03555305|19929743|P1|NOT COMPLETED|Period 1||0
8082992|NCT03555305|19929742|P2|COMPLETED|Period 1||27
8082993|NCT03555305|19929743|P1|COMPLETED|Period 1||29
8082994|NCT03555305|19929742|P2|Received at Least 1 Dose of Study Drug|Period 1||29
8082995|NCT03555305|19929743|P1|Received at Least 1 Dose of Study Drug|Period 1||29
8082996|NCT03555305|19929742|P2|STARTED|Period 1||29
8082997|NCT03555305|19929743|P1|STARTED|Period 1||29
8082998|NCT03554954|19929755|P1|NOT COMPLETED|Overall Study||0
8082999|NCT03554954|19929755|P1|COMPLETED|Overall Study||108
8083000|NCT03554954|19929755|P1|STARTED|Overall Study||108
8083001|NCT03554772|19929810|P4|NOT COMPLETED|Overall Study||2
8083002|NCT03554772|19929811|P3|NOT COMPLETED|Overall Study||0
8083003|NCT03554772|19929812|P2|NOT COMPLETED|Overall Study||0
8083004|NCT03554772|19929813|P1|NOT COMPLETED|Overall Study||0
8083005|NCT03554772|19929810|P4|COMPLETED|Overall Study||29
8083006|NCT03554772|19929811|P3|COMPLETED|Overall Study||29
8083007|NCT03554772|19929812|P2|COMPLETED|Overall Study||30
8083008|NCT03554772|19929813|P1|COMPLETED|Overall Study||30
8083009|NCT03554772|19929810|P4|Completed Treatment Period (8 Hours Post Dose)|Overall Study||31
8083010|NCT03554772|19929811|P3|Completed Treatment Period (8 Hours Post Dose)|Overall Study||29
8083011|NCT03554772|19929812|P2|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
8083012|NCT03554772|19929813|P1|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
8083013|NCT03554772|19929810|P4|STARTED|Overall Study||31
8083014|NCT03554772|19929811|P3|STARTED|Overall Study||29
8083015|NCT03554772|19929812|P2|STARTED|Overall Study||30
8083016|NCT03554772|19929813|P1|STARTED|Overall Study||30
8083017|NCT03554746|19929825|P2|NOT COMPLETED|Overall Study||0
8083018|NCT03554746|19929826|P1|NOT COMPLETED|Overall Study||0
8083019|NCT03554746|19929825|P2|COMPLETED|Overall Study||24
8083020|NCT03554746|19929826|P1|COMPLETED|Overall Study||24
8083021|NCT03554746|19929825|P2|STARTED|Overall Study||24
8083022|NCT03554746|19929826|P1|STARTED|Overall Study||24
8083023|NCT03554629|19929842|P1|NOT COMPLETED|Overall Study||6
8083024|NCT03554629|19929842|P1|COMPLETED|Overall Study|8 filterlines (CCSF) per participate for four scripted activities with supplemental oxygen.|23
8083025|NCT03554629|19929842|P1|STARTED|Overall Study|8 filterlines per participant for four scripted activities with supplemental oxygen|29
8083026|NCT03554005|19929876|P6|NOT COMPLETED|Overall Study||11
8083027|NCT03554005|19929877|P5|NOT COMPLETED|Overall Study||6
8083028|NCT03554005|19929878|P4|NOT COMPLETED|Overall Study||1
8083029|NCT03554005|19929879|P3|NOT COMPLETED|Overall Study||1
8083030|NCT03554005|19929880|P2|NOT COMPLETED|Overall Study||1
8083031|NCT03554005|19929881|P1|NOT COMPLETED|Overall Study||1
8083032|NCT03554005|19929876|P6|COMPLETED|Overall Study||0
8083033|NCT03554005|19929877|P5|COMPLETED|Overall Study||5
8083034|NCT03554005|19929878|P4|COMPLETED|Overall Study||1
8083035|NCT03554005|19929879|P3|COMPLETED|Overall Study||1
8083036|NCT03554005|19929880|P2|COMPLETED|Overall Study||1
8083037|NCT03554005|19929881|P1|COMPLETED|Overall Study||0
8083038|NCT03554005|19929876|P6|STARTED|Overall Study||11
8083039|NCT03554005|19929877|P5|STARTED|Overall Study||11
8083040|NCT03554005|19929878|P4|STARTED|Overall Study||2
8083041|NCT03554005|19929879|P3|STARTED|Overall Study||2
8083042|NCT03554005|19929880|P2|STARTED|Overall Study||2
8083043|NCT03554005|19929881|P1|STARTED|Overall Study||1
8083044|NCT03553758|19929907|P1|NOT COMPLETED|Overall Study||1
8083045|NCT03553758|19929907|P1|COMPLETED|Overall Study||15
8083046|NCT03553758|19929907|P1|Completed Screening Visit|Overall Study||16
8083047|NCT03553758|19929907|P1|STARTED|Overall Study||16
8083048|NCT03552549|19929915|P2|NOT COMPLETED|Overall Study||52
8083049|NCT03552549|19929916|P1|NOT COMPLETED|Overall Study||53
8083050|NCT03552549|19929915|P2|COMPLETED|Overall Study||11
8083051|NCT03552549|19929916|P1|COMPLETED|Overall Study||10
8083052|NCT03552549|19929915|P2|Treated|Overall Study||62
8083053|NCT03552549|19929916|P1|Treated|Overall Study||62
8083054|NCT03552549|19929915|P2|STARTED|Overall Study||63
8083055|NCT03552549|19929916|P1|STARTED|Overall Study||63
8083056|NCT03552536|19929927|P3|NOT COMPLETED|Overall Study||0
8083057|NCT03552536|19929928|P2|NOT COMPLETED|Overall Study||0
8083058|NCT03552536|19929929|P1|NOT COMPLETED|Overall Study||0
8083059|NCT03552536|19929927|P3|COMPLETED|Overall Study||0
8083060|NCT03552536|19929928|P2|COMPLETED|Overall Study||0
8083061|NCT03552536|19929929|P1|COMPLETED|Overall Study||5
8083062|NCT03552536|19929927|P3|STARTED|Overall Study||0
8083063|NCT03552536|19929928|P2|STARTED|Overall Study||0
8083064|NCT03552536|19929929|P1|STARTED|Overall Study||5
8083065|NCT03552523|19929954|P2|NOT COMPLETED|Overall Study||1
8083066|NCT03552523|19929955|P1|NOT COMPLETED|Overall Study||1
8083067|NCT03552523|19929954|P2|COMPLETED|Overall Study||1
8083068|NCT03552523|19929955|P1|COMPLETED|Overall Study||4
8083069|NCT03552523|19929954|P2|STARTED|Overall Study||2
8083070|NCT03552523|19929955|P1|STARTED|Overall Study||5
8083071|NCT03552289|19929965|P2|NOT COMPLETED|Overall Study||3
8083072|NCT03552289|19929966|P1|NOT COMPLETED|Overall Study||1
8083073|NCT03552289|19929965|P2|COMPLETED|Overall Study||106
8083074|NCT03552289|19929966|P1|COMPLETED|Overall Study||101
8083075|NCT03552289|19929965|P2|STARTED|Overall Study||109
8083076|NCT03552289|19929966|P1|STARTED|Overall Study||102
8083077|NCT03551821|19929972|P1|NOT COMPLETED|Overall Study||0
8083078|NCT03551821|19929972|P1|COMPLETED|Overall Study||1
8083079|NCT03551821|19929972|P1|STARTED|Overall Study||1
8083080|NCT03551743|19929981|P4|NOT COMPLETED|Overall Study||0
8083081|NCT03551743|19929982|P3|NOT COMPLETED|Overall Study||0
8083082|NCT03551743|19929983|P2|NOT COMPLETED|Overall Study||0
8083083|NCT03551743|19929984|P1|NOT COMPLETED|Overall Study||2
8083084|NCT03551743|19929981|P4|COMPLETED|Overall Study||6
8083085|NCT03551743|19929982|P3|COMPLETED|Overall Study||6
8083086|NCT03551743|19929983|P2|COMPLETED|Overall Study||6
8083087|NCT03551743|19929984|P1|COMPLETED|Overall Study||8
8083088|NCT03551743|19929981|P4|STARTED|Overall Study||6
8083089|NCT03551743|19929982|P3|STARTED|Overall Study||6
8083090|NCT03551743|19929983|P2|STARTED|Overall Study||6
8083091|NCT03551743|19929984|P1|STARTED|Overall Study||10
8083092|NCT03551730|19930030|P4|NOT COMPLETED|Overall Study||0
8083093|NCT03551730|19930031|P3|NOT COMPLETED|Overall Study||0
8083094|NCT03551730|19930032|P2|NOT COMPLETED|Overall Study||0
8083095|NCT03551730|19930033|P1|NOT COMPLETED|Overall Study||1
8083096|NCT03551730|19930030|P4|COMPLETED|Overall Study||6
8083097|NCT03551730|19930031|P3|COMPLETED|Overall Study||6
8083098|NCT03551730|19930032|P2|COMPLETED|Overall Study||6
8083099|NCT03551730|19930033|P1|COMPLETED|Overall Study||8
8083100|NCT03551730|19930030|P4|STARTED|Overall Study||6
8083101|NCT03551730|19930031|P3|STARTED|Overall Study||6
8083102|NCT03551730|19930032|P2|STARTED|Overall Study||6
8083103|NCT03551730|19930033|P1|STARTED|Overall Study||9
8083104|NCT03550989|19930075|P4|NOT COMPLETED|Overall Study||0
8083105|NCT03550989|19930076|P3|NOT COMPLETED|Overall Study||1
8083106|NCT03550989|19930077|P2|NOT COMPLETED|Overall Study||1
8083107|NCT03550989|19930078|P1|NOT COMPLETED|Overall Study||2
8083108|NCT03550989|19930075|P4|COMPLETED|Overall Study||60
8083109|NCT03550989|19930076|P3|COMPLETED|Overall Study||76
8083110|NCT03550989|19930077|P2|COMPLETED|Overall Study||73
8083111|NCT03550989|19930078|P1|COMPLETED|Overall Study||188
8083112|NCT03550989|19930075|P4|STARTED|Overall Study||60
8083113|NCT03550989|19930076|P3|STARTED|Overall Study||77
8083114|NCT03550989|19930077|P2|STARTED|Overall Study||74
8083115|NCT03550989|19930078|P1|STARTED|Overall Study||190
8083116|NCT03550378|19930155|P2|NOT COMPLETED|Overall Study||1
8083117|NCT03550378|19930156|P1|NOT COMPLETED|Overall Study||0
8083118|NCT03550378|19930155|P2|COMPLETED|Overall Study||20
8083119|NCT03550378|19930156|P1|COMPLETED|Overall Study||20
8083120|NCT03550378|19930155|P2|STARTED|Overall Study||21
8083121|NCT03550378|19930156|P1|STARTED|Overall Study||20
8083122|NCT03550066|19930196|P2|NOT COMPLETED|Overall Study||0
8083123|NCT03550066|19930197|P1|NOT COMPLETED|Overall Study||0
8083124|NCT03550066|19930196|P2|COMPLETED|Overall Study||41
8083125|NCT03550066|19930197|P1|COMPLETED|Overall Study||49
8083126|NCT03550066|19930196|P2|STARTED|Overall Study||41
8083127|NCT03550066|19930197|P1|STARTED|Overall Study||49
8083128|NCT03549598|19930207|P1|NOT COMPLETED|Overall Study||0
8083129|NCT03549598|19930207|P1|COMPLETED|Overall Study||15
8083130|NCT03549598|19930207|P1|STARTED|Overall Study||15
8083131|NCT03549429|19930219|P2|NOT COMPLETED|Overall Study||3
8083132|NCT03549429|19930220|P1|NOT COMPLETED|Overall Study||5
8083133|NCT03549429|19930219|P2|COMPLETED|Overall Study||75
8083134|NCT03549429|19930220|P1|COMPLETED|Overall Study||76
8083135|NCT03549429|19930219|P2|STARTED|Overall Study||78
8083136|NCT03549429|19930220|P1|STARTED|Overall Study||81
8083137|NCT03549338|19930233|P3|NOT COMPLETED|Overall Study||0
8083138|NCT03549338|19930234|P2|NOT COMPLETED|Overall Study||1
8083139|NCT03549338|19930235|P1|NOT COMPLETED|Overall Study||1
8083140|NCT03549338|19930233|P3|COMPLETED|Overall Study||0
8083141|NCT03549338|19930234|P2|COMPLETED|Overall Study|Patient crossed-over to Sym004 at the EOC1 per Sponsor decision following trial termination.|0
8083142|NCT03549338|19930235|P1|COMPLETED|Overall Study||0
8083143|NCT03549338|19930233|P3|STARTED|Overall Study||0
8083144|NCT03549338|19930234|P2|STARTED|Overall Study||1
8083145|NCT03549338|19930235|P1|STARTED|Overall Study||1
8083146|NCT03549234|19930243|P2|NOT COMPLETED|Overall Study||0
8083147|NCT03549234|19930244|P1|NOT COMPLETED|Overall Study||0
8083148|NCT03549234|19930243|P2|COMPLETED|Overall Study||50
8083149|NCT03549234|19930244|P1|COMPLETED|Overall Study||50
8083150|NCT03549234|19930243|P2|STARTED|Overall Study||50
8083151|NCT03549234|19930244|P1|STARTED|Overall Study||50
8083152|NCT03549130|19930262|P2|NOT COMPLETED|Overall Study||2
8083153|NCT03549130|19930263|P1|NOT COMPLETED|Overall Study||0
8083154|NCT03549130|19930262|P2|COMPLETED|Overall Study||64
8083155|NCT03549130|19930263|P1|COMPLETED|Overall Study||64
8083156|NCT03549130|19930262|P2|STARTED|Overall Study||66
8083157|NCT03549130|19930263|P1|STARTED|Overall Study||64
8083158|NCT03549117|19930281|P2|NOT COMPLETED|Overall Study||0
8083159|NCT03549117|19930282|P1|NOT COMPLETED|Overall Study||1
8083160|NCT03549117|19930281|P2|COMPLETED|Overall Study||70
8083161|NCT03549117|19930282|P1|COMPLETED|Overall Study||69
8083162|NCT03549117|19930281|P2|STARTED|Overall Study||70
8083163|NCT03549117|19930282|P1|STARTED|Overall Study||70
8083164|NCT03548337|19930310|P2|NOT COMPLETED|Toddler Dose||1
8083165|NCT03548337|19930311|P1|NOT COMPLETED|Toddler Dose||1
8083166|NCT03548337|19930310|P2|COMPLETED|Toddler Dose||138
8083167|NCT03548337|19930311|P1|COMPLETED|Toddler Dose||138
8083168|NCT03548337|19930310|P2|Vaccination 4|Toddler Dose||139
8083169|NCT03548337|19930311|P1|Vaccination 4|Toddler Dose||139
8083170|NCT03548337|19930310|P2|STARTED|Toddler Dose||139
8083171|NCT03548337|19930311|P1|STARTED|Toddler Dose||139
8083172|NCT03548337|19930310|P2|NOT COMPLETED|Infant Series||11
8083173|NCT03548337|19930311|P1|NOT COMPLETED|Infant Series||12
8083174|NCT03548337|19930310|P2|COMPLETED|Infant Series||139
8083175|NCT03548337|19930311|P1|COMPLETED|Infant Series||139
8083176|NCT03548337|19930310|P2|Vaccination 3|Infant Series||141
8083177|NCT03548337|19930311|P1|Vaccination 3|Infant Series||144
8083178|NCT03548337|19930310|P2|Vaccination 2|Infant Series||144
8083179|NCT03548337|19930311|P1|Vaccination 2|Infant Series||144
8083180|NCT03548337|19930310|P2|Vaccination 1|Infant Series||150
8083181|NCT03548337|19930311|P1|Vaccination 1|Infant Series||150
8083182|NCT03548337|19930310|P2|STARTED|Infant Series||150
8083183|NCT03548337|19930311|P1|STARTED|Infant Series||151
8083184|NCT03547635|19930362|P3|NOT COMPLETED|Overall Study||8
8083185|NCT03547635|19930363|P2|NOT COMPLETED|Overall Study||7
8083186|NCT03547635|19930364|P1|NOT COMPLETED|Overall Study||8
8083187|NCT03547635|19930362|P3|COMPLETED|Overall Study||29
8083188|NCT03547635|19930363|P2|COMPLETED|Overall Study||31
8083189|NCT03547635|19930364|P1|COMPLETED|Overall Study||33
8083190|NCT03547635|19930362|P3|STARTED|Overall Study||37
8083191|NCT03547635|19930363|P2|STARTED|Overall Study||38
8083192|NCT03547635|19930364|P1|STARTED|Overall Study||41
8083193|NCT03547583|19930375|P3|NOT COMPLETED|Overall Study||32
8083194|NCT03547583|19930376|P2|NOT COMPLETED|Overall Study||40
8083195|NCT03547583|19930377|P1|NOT COMPLETED|Overall Study||45
8083196|NCT03547583|19930375|P3|COMPLETED|Overall Study||230
8083197|NCT03547583|19930376|P2|COMPLETED|Overall Study||224
8083198|NCT03547583|19930377|P1|COMPLETED|Overall Study||218
8083199|NCT03547583|19930375|P3|Treated|Overall Study||262
8083200|NCT03547583|19930376|P2|Treated|Overall Study||264
8083201|NCT03547583|19930377|P1|Treated|Overall Study||262
8083202|NCT03547583|19930375|P3|STARTED|Overall Study||262
8083203|NCT03547583|19930376|P2|STARTED|Overall Study||264
8083204|NCT03547583|19930377|P1|STARTED|Overall Study||263
8083205|NCT03547531|19930393|P2|NOT COMPLETED|Overall Study||4
8083206|NCT03547531|19930394|P1|NOT COMPLETED|Overall Study||2
8083207|NCT03547531|19930393|P2|COMPLETED|Overall Study||58
8083208|NCT03547531|19930394|P1|COMPLETED|Overall Study||60
8083209|NCT03547531|19930393|P2|STARTED|Overall Study||62
8083210|NCT03547531|19930394|P1|STARTED|Overall Study||62
8083211|NCT03547167|19930408|P2|NOT COMPLETED|Overall Study||30
8083212|NCT03547167|19930409|P1|NOT COMPLETED|Overall Study||97
8083213|NCT03547167|19930408|P2|COMPLETED|Overall Study||350
8083214|NCT03547167|19930409|P1|COMPLETED|Overall Study||1038
8083215|NCT03547167|19930408|P2|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||346
8083216|NCT03547167|19930409|P1|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||1035
8083217|NCT03547167|19930408|P2|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||379
8083218|NCT03547167|19930409|P1|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||1133
8083219|NCT03547167|19930408|P2|STARTED|Overall Study||380
8083220|NCT03547167|19930409|P1|STARTED|Overall Study||1135
8083221|NCT03547154|19930461|P2|NOT COMPLETED|Overall Study||116
8083222|NCT03547154|19930462|P1|NOT COMPLETED|Overall Study||123
8083223|NCT03547154|19930461|P2|COMPLETED|Overall Study||55
8083224|NCT03547154|19930462|P1|COMPLETED|Overall Study||50
8083225|NCT03547154|19930461|P2|STARTED|Overall Study||171
8083226|NCT03547154|19930462|P1|STARTED|Overall Study||173
8083227|NCT03546842|19930474|P1|NOT COMPLETED|Overall Study||3
8083228|NCT03546842|19930474|P1|COMPLETED|Overall Study||198
8083229|NCT03546842|19930474|P1|Vaccination 3|Overall Study||198
8083230|NCT03546842|19930474|P1|Vaccination 2|Overall Study||200
8083231|NCT03546842|19930474|P1|Vaccination 1|Overall Study||200
8083232|NCT03546842|19930474|P1|STARTED|Overall Study||201
8083251|NCT03546491|19930555|P1|NOT COMPLETED|Overall Study||2
8083252|NCT03546491|19930555|P1|COMPLETED|Overall Study||30
8083253|NCT03546491|19930555|P1|Received Test Product 2|Overall Study||32
8083254|NCT03546491|19930555|P1|Recieved Test Product 1|Overall Study||32
8083255|NCT03546491|19930555|P1|STARTED|Overall Study||32
8083256|NCT03546270|19930569|P2|NOT COMPLETED|Overall Study||0
8083257|NCT03546270|19930570|P1|NOT COMPLETED|Overall Study||0
8083258|NCT03546270|19930569|P2|COMPLETED|Overall Study||48
8083259|NCT03546270|19930570|P1|COMPLETED|Overall Study||52
8083260|NCT03546270|19930569|P2|STARTED|Overall Study||48
8083261|NCT03546270|19930570|P1|STARTED|Overall Study||52
8083262|NCT03546192|19930588|P2|NOT COMPLETED|Overall Study||0
8083263|NCT03546192|19930589|P1|NOT COMPLETED|Overall Study||0
8083264|NCT03546192|19930588|P2|COMPLETED|Overall Study||60
8083265|NCT03546192|19930589|P1|COMPLETED|Overall Study||60
8083266|NCT03546192|19930588|P2|STARTED|Overall Study||60
8083267|NCT03546192|19930589|P1|STARTED|Overall Study||60
8083268|NCT03545984|19930607|P2|NOT COMPLETED|Overall Study||9
8083269|NCT03545984|19930608|P1|NOT COMPLETED|Overall Study||11
8083270|NCT03545984|19930607|P2|COMPLETED|Overall Study||15
8083271|NCT03545984|19930608|P1|COMPLETED|Overall Study||13
8083272|NCT03545984|19930607|P2|STARTED|Overall Study||24
8083273|NCT03545984|19930608|P1|STARTED|Overall Study||24
8083274|NCT03545893|19930616|P2|NOT COMPLETED|Overall Study||0
8083275|NCT03545893|19930617|P1|NOT COMPLETED|Overall Study||0
8083276|NCT03545893|19930616|P2|COMPLETED|Overall Study||35
8083277|NCT03545893|19930617|P1|COMPLETED|Overall Study||35
8083278|NCT03545893|19930616|P2|STARTED|Overall Study||35
8083279|NCT03545893|19930617|P1|STARTED|Overall Study||35
8083280|NCT03545412|19930623|P1|NOT COMPLETED|Overall Study||0
8083281|NCT03545412|19930623|P1|COMPLETED|Overall Study||25
8083282|NCT03545412|19930623|P1|STARTED|Overall Study||25
8083283|NCT03544879|19930635|P2|NOT COMPLETED|Overall Study||1
8083284|NCT03544879|19930636|P1|NOT COMPLETED|Overall Study||0
8083285|NCT03544879|19930635|P2|COMPLETED|Overall Study||23
8083286|NCT03544879|19930636|P1|COMPLETED|Overall Study||22
8083287|NCT03544879|19930635|P2|Completed Follow-up Physical Assessment|Overall Study||21
8083288|NCT03544879|19930636|P1|Completed Follow-up Physical Assessment|Overall Study||20
8083289|NCT03544879|19930635|P2|STARTED|Overall Study||24
8083290|NCT03544879|19930636|P1|STARTED|Overall Study||22
8083291|NCT03544307|19930664|P2|NOT COMPLETED|Overall Study||0
8083292|NCT03544307|19930665|P1|NOT COMPLETED|Overall Study||0
8083293|NCT03544307|19930664|P2|COMPLETED|Overall Study||10
8083294|NCT03544307|19930665|P1|COMPLETED|Overall Study||10
8083295|NCT03544307|19930664|P2|STARTED|Overall Study||10
8083296|NCT03544307|19930665|P1|STARTED|Overall Study||10
8083297|NCT03544242|19930686|P3|NOT COMPLETED|Overall Study||0
8083298|NCT03544242|19930687|P2|NOT COMPLETED|Overall Study||0
8083299|NCT03544242|19930688|P1|NOT COMPLETED|Overall Study||0
8083300|NCT03544242|19930686|P3|COMPLETED|Overall Study||2
8083301|NCT03544242|19930687|P2|COMPLETED|Overall Study||1
8083302|NCT03544242|19930688|P1|COMPLETED|Overall Study||1
8083303|NCT03544242|19930686|P3|STARTED|Overall Study||2
8083304|NCT03544242|19930687|P2|STARTED|Overall Study||1
8083305|NCT03544242|19930688|P1|STARTED|Overall Study||1
8083306|NCT03544216|19930719|P2|NOT COMPLETED|Overall Study||0
8083307|NCT03544216|19930720|P1|NOT COMPLETED|Overall Study||0
8083308|NCT03544216|19930719|P2|COMPLETED|Overall Study||42
8083309|NCT03544216|19930720|P1|COMPLETED|Overall Study||42
8083310|NCT03544216|19930719|P2|STARTED|Overall Study||42
8083311|NCT03544216|19930720|P1|STARTED|Overall Study||42
8083312|NCT03543358|19930727|P2|NOT COMPLETED|Overall Study||0
8083313|NCT03543358|19930728|P1|NOT COMPLETED|Overall Study||3
8083314|NCT03543358|19930727|P2|COMPLETED|Overall Study||0
8083315|NCT03543358|19930728|P1|COMPLETED|Overall Study||0
8083316|NCT03543358|19930727|P2|Received Treatment or Retreatment|Overall Study||0
8083317|NCT03543358|19930728|P1|Received Treatment or Retreatment|Overall Study||0
8083318|NCT03543358|19930727|P2|STARTED|Overall Study||0
8083319|NCT03543358|19930728|P1|STARTED|Overall Study||3
8083320|NCT03543176|19930734|P2|NOT COMPLETED|Overall Study||0
8083321|NCT03543176|19930735|P1|NOT COMPLETED|Overall Study||0
8083322|NCT03543176|19930734|P2|COMPLETED|Overall Study||397
8083323|NCT03543176|19930735|P1|COMPLETED|Overall Study||392
8083324|NCT03543176|19930734|P2|STARTED|Overall Study||397
8083325|NCT03543176|19930735|P1|STARTED|Overall Study||392
8083326|NCT03543137|19930777|P2|NOT COMPLETED|Study Period 2: Up to Day 8||1
8083327|NCT03543137|19930778|P1|NOT COMPLETED|Study Period 2: Up to Day 8||2
8083328|NCT03543137|19930777|P2|COMPLETED|Study Period 2: Up to Day 8||18
8083329|NCT03543137|19930778|P1|COMPLETED|Study Period 2: Up to Day 8||16
8083330|NCT03543137|19930777|P2|Treated|Study Period 2: Up to Day 8||18
8083331|NCT03543137|19930778|P1|Treated|Study Period 2: Up to Day 8||16
8083332|NCT03543137|19930777|P2|STARTED|Study Period 2: Up to Day 8||19
8083333|NCT03543137|19930778|P1|STARTED|Study Period 2: Up to Day 8||18
8083334|NCT03543137|19930777|P2|NOT COMPLETED|Washout Period: 5 to 7 Days||0
8083335|NCT03543137|19930778|P1|NOT COMPLETED|Washout Period: 5 to 7 Days||0
8083336|NCT03543137|19930777|P2|COMPLETED|Washout Period: 5 to 7 Days||19
8083337|NCT03543137|19930778|P1|COMPLETED|Washout Period: 5 to 7 Days||18
8083338|NCT03543137|19930777|P2|STARTED|Washout Period: 5 to 7 Days||19
8083339|NCT03543137|19930778|P1|STARTED|Washout Period: 5 to 7 Days||18
8083340|NCT03543137|19930777|P2|NOT COMPLETED|Study Period 1: Up to Day 1||0
8083341|NCT03543137|19930778|P1|NOT COMPLETED|Study Period 1: Up to Day 1||0
8083342|NCT03543137|19930777|P2|COMPLETED|Study Period 1: Up to Day 1||19
8083343|NCT03543137|19930778|P1|COMPLETED|Study Period 1: Up to Day 1||18
8083344|NCT03543137|19930777|P2|STARTED|Study Period 1: Up to Day 1||19
8083345|NCT03543137|19930778|P1|STARTED|Study Period 1: Up to Day 1||18
8083346|NCT03542474|19930798|P1|NOT COMPLETED|Overall Study||0
8083347|NCT03542474|19930798|P1|COMPLETED|Overall Study||8
8083348|NCT03542474|19930798|P1|STARTED|Overall Study||8
8083349|NCT03541356|19930808|P5|NOT COMPLETED|Overall Study||0
8083350|NCT03541356|19930809|P4|NOT COMPLETED|Overall Study||0
8083351|NCT03541356|19930810|P3|NOT COMPLETED|Overall Study||0
8083352|NCT03541356|19930811|P2|NOT COMPLETED|Overall Study||0
8083353|NCT03541356|19930812|P1|NOT COMPLETED|Overall Study||0
8083354|NCT03541356|19930808|P5|COMPLETED|Overall Study||6
8083355|NCT03541356|19930809|P4|COMPLETED|Overall Study||6
8083356|NCT03541356|19930810|P3|COMPLETED|Overall Study||6
8083357|NCT03541356|19930811|P2|COMPLETED|Overall Study||6
8083358|NCT03541356|19930812|P1|COMPLETED|Overall Study||8
8083359|NCT03541356|19930808|P5|STARTED|Overall Study||6
8083360|NCT03541356|19930809|P4|STARTED|Overall Study||6
8083361|NCT03541356|19930810|P3|STARTED|Overall Study||6
8083362|NCT03541356|19930811|P2|STARTED|Overall Study||6
8083363|NCT03541356|19930812|P1|STARTED|Overall Study||8
8083364|NCT03541044|19930879|P2|NOT COMPLETED|Study Period 2: Up to Day 8||0
8083365|NCT03541044|19930880|P1|NOT COMPLETED|Study Period 2: Up to Day 8||2
8083366|NCT03541044|19930879|P2|COMPLETED|Study Period 2: Up to Day 8||23
8083367|NCT03541044|19930880|P1|COMPLETED|Study Period 2: Up to Day 8||21
8083368|NCT03541044|19930879|P2|STARTED|Study Period 2: Up to Day 8||23
8083369|NCT03541044|19930880|P1|STARTED|Study Period 2: Up to Day 8||23
8083370|NCT03541044|19930879|P2|NOT COMPLETED|Washout Period: 5 to 7 Days||0
8083371|NCT03541044|19930880|P1|NOT COMPLETED|Washout Period: 5 to 7 Days||0
8083372|NCT03541044|19930879|P2|COMPLETED|Washout Period: 5 to 7 Days||23
8083373|NCT03541044|19930880|P1|COMPLETED|Washout Period: 5 to 7 Days||23
8083374|NCT03541044|19930879|P2|STARTED|Washout Period: 5 to 7 Days||23
8083375|NCT03541044|19930880|P1|STARTED|Washout Period: 5 to 7 Days||23
8083376|NCT03541044|19930879|P2|NOT COMPLETED|Study Period 1: Up to Day 1||0
8083377|NCT03541044|19930880|P1|NOT COMPLETED|Study Period 1: Up to Day 1||0
8083378|NCT03541044|19930879|P2|COMPLETED|Study Period 1: Up to Day 1||23
8083379|NCT03541044|19930880|P1|COMPLETED|Study Period 1: Up to Day 1||23
8083380|NCT03541044|19930879|P2|STARTED|Study Period 1: Up to Day 1||23
8083381|NCT03541044|19930880|P1|STARTED|Study Period 1: Up to Day 1||23
8083385|NCT03540030|19930906|P2|NOT COMPLETED|Overall Study||3
8083386|NCT03540030|19930907|P1|NOT COMPLETED|Overall Study||18
8083387|NCT03540030|19930906|P2|COMPLETED|Overall Study||35
8083388|NCT03540030|19930907|P1|COMPLETED|Overall Study||30
8083389|NCT03540030|19930906|P2|STARTED|Overall Study||38
8083390|NCT03540030|19930907|P1|STARTED|Overall Study||48
8083391|NCT03539549|19930943|P1|NOT COMPLETED|Overall Study||17
8083392|NCT03539549|19930943|P1|COMPLETED|Overall Study||106
8083393|NCT03539549|19930943|P1|STARTED|Overall Study||123
8083394|NCT03539484|19930958|P7|NOT COMPLETED|Overall Study||2
8083395|NCT03539484|19930959|P6|NOT COMPLETED|Overall Study||5
8083396|NCT03539484|19930960|P5|NOT COMPLETED|Overall Study||13
8083397|NCT03539484|19930961|P4|NOT COMPLETED|Overall Study||3
8083398|NCT03539484|19930962|P3|NOT COMPLETED|Overall Study||1
8083399|NCT03539484|19930963|P2|NOT COMPLETED|Overall Study||1
8083400|NCT03539484|19930964|P1|NOT COMPLETED|Overall Study||1
8083401|NCT03539484|19930958|P7|COMPLETED|Overall Study||0
8083402|NCT03539484|19930959|P6|COMPLETED|Overall Study||0
8083403|NCT03539484|19930960|P5|COMPLETED|Overall Study||0
8083404|NCT03539484|19930961|P4|COMPLETED|Overall Study||0
8083405|NCT03539484|19930962|P3|COMPLETED|Overall Study||0
8083406|NCT03539484|19930963|P2|COMPLETED|Overall Study||0
8083407|NCT03539484|19930964|P1|COMPLETED|Overall Study||0
8083408|NCT03539484|19930958|P7|STARTED|Overall Study||2
8083409|NCT03539484|19930959|P6|STARTED|Overall Study||5
8083410|NCT03539484|19930960|P5|STARTED|Overall Study||13
8083411|NCT03539484|19930961|P4|STARTED|Overall Study||3
8083412|NCT03539484|19930962|P3|STARTED|Overall Study||1
8083413|NCT03539484|19930963|P2|STARTED|Overall Study||1
8083414|NCT03539484|19930964|P1|STARTED|Overall Study||1
8083415|NCT03539458|19931098|P1|NOT COMPLETED|Overall Study||1
8083416|NCT03539458|19931098|P1|COMPLETED|Overall Study||10
8083417|NCT03539458|19931098|P1|STARTED|Overall Study||11
8083418|NCT03539211|19931104|P2|NOT COMPLETED|Overall Study||0
8083419|NCT03539211|19931105|P1|NOT COMPLETED|Overall Study||0
8083420|NCT03539211|19931104|P2|COMPLETED|Overall Study||15
8083421|NCT03539211|19931105|P1|COMPLETED|Overall Study||16
8083422|NCT03539211|19931104|P2|STARTED|Overall Study||15
8083423|NCT03539211|19931105|P1|STARTED|Overall Study||16
8083424|NCT03538808|19931117|P4|NOT COMPLETED|Overall Study||2
8083425|NCT03538808|19931118|P3|NOT COMPLETED|Overall Study||4
8083426|NCT03538808|19931119|P2|NOT COMPLETED|Overall Study||0
8083427|NCT03538808|19931120|P1|NOT COMPLETED|Overall Study||2
8083428|NCT03538808|19931117|P4|COMPLETED|Overall Study||18
8083429|NCT03538808|19931118|P3|COMPLETED|Overall Study||16
8083430|NCT03538808|19931119|P2|COMPLETED|Overall Study||20
8083431|NCT03538808|19931120|P1|COMPLETED|Overall Study||18
8083432|NCT03538808|19931117|P4|STARTED|Overall Study||20
8083433|NCT03538808|19931118|P3|STARTED|Overall Study||20
8083434|NCT03538808|19931119|P2|STARTED|Overall Study||20
8083435|NCT03538808|19931120|P1|STARTED|Overall Study||20
8083436|NCT03538795|19931138|P1|NOT COMPLETED|Overall Study||0
8083437|NCT03538795|19931138|P1|COMPLETED|Overall Study||3
8083438|NCT03538795|19931138|P1|STARTED|Overall Study||3
8083439|NCT03538743|19931153|P9|NOT COMPLETED|Overall Study||3
8083440|NCT03538743|19931154|P8|NOT COMPLETED|Overall Study||0
8083441|NCT03538743|19931155|P7|NOT COMPLETED|Overall Study||0
8083442|NCT03538743|19931156|P6|NOT COMPLETED|Overall Study||0
8083443|NCT03538743|19931157|P5|NOT COMPLETED|Overall Study||0
8083444|NCT03538743|19931158|P4|NOT COMPLETED|Overall Study||2
8083445|NCT03538743|19931159|P3|NOT COMPLETED|Overall Study||1
8083446|NCT03538743|19931160|P2|NOT COMPLETED|Overall Study||0
8083447|NCT03538743|19931161|P1|NOT COMPLETED|Overall Study||0
8083448|NCT03538743|19931153|P9|COMPLETED|Overall Study||7
8083449|NCT03538743|19931154|P8|COMPLETED|Overall Study||8
8083450|NCT03538743|19931155|P7|COMPLETED|Overall Study||9
8083451|NCT03538743|19931156|P6|COMPLETED|Overall Study||9
8083452|NCT03538743|19931157|P5|COMPLETED|Overall Study||9
8083453|NCT03538743|19931158|P4|COMPLETED|Overall Study||8
8083454|NCT03538743|19931159|P3|COMPLETED|Overall Study||8
8083455|NCT03538743|19931160|P2|COMPLETED|Overall Study||9
8083456|NCT03538743|19931161|P1|COMPLETED|Overall Study||25
8083457|NCT03538743|19931153|P9|Received Treatment|Overall Study||10
8083458|NCT03538743|19931154|P8|Received Treatment|Overall Study||8
8083459|NCT03538743|19931155|P7|Received Treatment|Overall Study||9
8083460|NCT03538743|19931156|P6|Received Treatment|Overall Study||9
8083461|NCT03538743|19931157|P5|Received Treatment|Overall Study||9
8083462|NCT03538743|19931158|P4|Received Treatment|Overall Study||10
8083463|NCT03538743|19931159|P3|Received Treatment|Overall Study||9
8083464|NCT03538743|19931160|P2|Received Treatment|Overall Study||9
8083465|NCT03538743|19931161|P1|Received Treatment|Overall Study||25
8083466|NCT03538743|19931153|P9|STARTED|Overall Study||10
8083467|NCT03538743|19931154|P8|STARTED|Overall Study||8
8083468|NCT03538743|19931155|P7|STARTED|Overall Study||9
8083469|NCT03538743|19931156|P6|STARTED|Overall Study||9
8083470|NCT03538743|19931157|P5|STARTED|Overall Study||9
8083471|NCT03538743|19931158|P4|STARTED|Overall Study||10
8083472|NCT03538743|19931159|P3|STARTED|Overall Study||9
8083473|NCT03538743|19931160|P2|STARTED|Overall Study||9
8083474|NCT03538743|19931161|P1|STARTED|Overall Study||25
8083478|NCT03538015|19931325|P3|NOT COMPLETED|Overall Study||1
8083479|NCT03538015|19931326|P2|NOT COMPLETED|Overall Study||0
8083480|NCT03538015|19931327|P1|NOT COMPLETED|Overall Study||0
8083481|NCT03538015|19931325|P3|COMPLETED|Overall Study||0
8083482|NCT03538015|19931326|P2|COMPLETED|Overall Study||0
8083483|NCT03538015|19931327|P1|COMPLETED|Overall Study||0
8083484|NCT03538015|19931325|P3|STARTED|Overall Study||1
8083485|NCT03538015|19931326|P2|STARTED|Overall Study||0
8083486|NCT03538015|19931327|P1|STARTED|Overall Study||0
8083487|NCT03537664|19931353|P2|NOT COMPLETED|Overall Study||0
8083488|NCT03537664|19931354|P1|NOT COMPLETED|Overall Study||0
8083489|NCT03537664|19931353|P2|COMPLETED|Overall Study||25
8083490|NCT03537664|19931354|P1|COMPLETED|Overall Study||20
8083491|NCT03537664|19931353|P2|Endodontic Success|Overall Study||10
8083492|NCT03537664|19931354|P1|Endodontic Success|Overall Study||20
8083493|NCT03537664|19931353|P2|Bacterial Community Diversity|Overall Study||0
8083494|NCT03537664|19931354|P1|Bacterial Community Diversity|Overall Study||10
8083495|NCT03537664|19931353|P2|Bacterial Levels|Overall Study||25
8083496|NCT03537664|19931354|P1|Bacterial Levels|Overall Study||20
8083497|NCT03537664|19931353|P2|Metabolic Activity of Bacteria|Overall Study||25
8083498|NCT03537664|19931354|P1|Metabolic Activity of Bacteria|Overall Study|5 patients were excluded from metabolic activity analysis (lost of RNA)|15
8083499|NCT03537664|19931353|P2|STARTED|Overall Study||25
8083500|NCT03537664|19931354|P1|STARTED|Overall Study||20
8083501|NCT03537404|19931368|P2|NOT COMPLETED|Third Intervention (A or B or C)||0
8083502|NCT03537404|19931369|P1|NOT COMPLETED|Third Intervention (A or B or C)||0
8083503|NCT03537404|19931368|P2|COMPLETED|Third Intervention (A or B or C)||18
8083504|NCT03537404|19931369|P1|COMPLETED|Third Intervention (A or B or C)||18
8083505|NCT03537404|19931368|P2|STARTED|Third Intervention (A or B or C)||18
8083506|NCT03537404|19931369|P1|STARTED|Third Intervention (A or B or C)||18
8083507|NCT03537404|19931368|P2|NOT COMPLETED|Second Washout Period (8 Days)||0
8083508|NCT03537404|19931369|P1|NOT COMPLETED|Second Washout Period (8 Days)||0
8083509|NCT03537404|19931368|P2|COMPLETED|Second Washout Period (8 Days)||18
8083510|NCT03537404|19931369|P1|COMPLETED|Second Washout Period (8 Days)||18
8083511|NCT03537404|19931368|P2|STARTED|Second Washout Period (8 Days)||18
8083512|NCT03537404|19931369|P1|STARTED|Second Washout Period (8 Days)||18
8083513|NCT03537404|19931368|P2|NOT COMPLETED|Second Intervention (A or B or C)||0
8083514|NCT03537404|19931369|P1|NOT COMPLETED|Second Intervention (A or B or C)||0
8083515|NCT03537404|19931368|P2|COMPLETED|Second Intervention (A or B or C)||18
8083516|NCT03537404|19931369|P1|COMPLETED|Second Intervention (A or B or C)||18
8083517|NCT03537404|19931368|P2|STARTED|Second Intervention (A or B or C)||18
8083518|NCT03537404|19931369|P1|STARTED|Second Intervention (A or B or C)||18
8083519|NCT03537404|19931368|P2|NOT COMPLETED|First Washout Period (8 Days)||0
8083520|NCT03537404|19931369|P1|NOT COMPLETED|First Washout Period (8 Days)||0
8083521|NCT03537404|19931368|P2|COMPLETED|First Washout Period (8 Days)||18
8083522|NCT03537404|19931369|P1|COMPLETED|First Washout Period (8 Days)||18
8083523|NCT03537404|19931368|P2|STARTED|First Washout Period (8 Days)||18
8083524|NCT03537404|19931369|P1|STARTED|First Washout Period (8 Days)||18
8083525|NCT03537404|19931368|P2|NOT COMPLETED|First Intervention (A or B or C)||0
8083526|NCT03537404|19931369|P1|NOT COMPLETED|First Intervention (A or B or C)||0
8083527|NCT03537404|19931368|P2|COMPLETED|First Intervention (A or B or C)||18
8083528|NCT03537404|19931369|P1|COMPLETED|First Intervention (A or B or C)||18
8083529|NCT03537404|19931368|P2|STARTED|First Intervention (A or B or C)||18
8083530|NCT03537404|19931369|P1|STARTED|First Intervention (A or B or C)||18
8083531|NCT03537274|19931415|P4|NOT COMPLETED|Overall Study||76
8083532|NCT03537274|19931416|P3|NOT COMPLETED|Overall Study||76
8083533|NCT03537274|19931417|P2|NOT COMPLETED|Overall Study||69
8083534|NCT03537274|19931418|P1|NOT COMPLETED|Overall Study||60
8083535|NCT03537274|19931415|P4|COMPLETED|Overall Study||231
8083536|NCT03537274|19931416|P3|COMPLETED|Overall Study||228
8083537|NCT03537274|19931417|P2|COMPLETED|Overall Study||229
8083538|NCT03537274|19931418|P1|COMPLETED|Overall Study||255
8083539|NCT03537274|19931415|P4|Treated|Overall Study||303
8083540|NCT03537274|19931416|P3|Treated|Overall Study||304
8083541|NCT03537274|19931417|P2|Treated|Overall Study||297
8083542|NCT03537274|19931418|P1|Treated|Overall Study||315
8083543|NCT03537274|19931415|P4|STARTED|Overall Study||307
8083544|NCT03537274|19931416|P3|STARTED|Overall Study||304
8083545|NCT03537274|19931417|P2|STARTED|Overall Study||298
8083546|NCT03537274|19931418|P1|STARTED|Overall Study||315
8083547|NCT03537092|19931432|P1|NOT COMPLETED|Overall Study||0
8083548|NCT03537092|19931432|P1|COMPLETED|Overall Study||64
8083549|NCT03537092|19931432|P1|STARTED|Overall Study||64
8083550|NCT03536949|19931441|P2|NOT COMPLETED|Overall Study||2
8083551|NCT03536949|19931442|P1|NOT COMPLETED|Overall Study||14
8083552|NCT03536949|19931441|P2|COMPLETED|Overall Study||75
8083553|NCT03536949|19931442|P1|COMPLETED|Overall Study||143
8083554|NCT03536949|19931441|P2|STARTED|Overall Study||77
8083555|NCT03536949|19931442|P1|STARTED|Overall Study||157
8083556|NCT03536923|19931450|P1|NOT COMPLETED|Overall Study||0
8083557|NCT03536923|19931450|P1|COMPLETED|Overall Study||23
8083558|NCT03536923|19931450|P1|STARTED|Overall Study||23
8083559|NCT03536819|19931457|P1|NOT COMPLETED|Overall Study||5
8083560|NCT03536819|19931457|P1|COMPLETED|Overall Study||15
8083561|NCT03536819|19931457|P1|STARTED|Overall Study||20
8083562|NCT03536702|19931470|P2|NOT COMPLETED|Overall Study||12
8083563|NCT03536702|19931471|P1|NOT COMPLETED|Overall Study||14
8083564|NCT03536702|19931470|P2|COMPLETED|Overall Study||8
8083565|NCT03536702|19931471|P1|COMPLETED|Overall Study||26
8083566|NCT03536702|19931470|P2|STARTED|Overall Study||20
8083567|NCT03536702|19931471|P1|STARTED|Overall Study||40
8083568|NCT03536663|19931505|P1|NOT COMPLETED|Endexo||1
8083569|NCT03536663|19931505|P1|COMPLETED|Endexo||17
8083570|NCT03536663|19931505|P1|STARTED|Endexo|One subject completed the Optiflux period but missed Visit 13 and was withdrawn per protocol.|18
8083571|NCT03536663|19931505|P1|NOT COMPLETED|Optiflux||4
8083572|NCT03536663|19931505|P1|COMPLETED|Optiflux||19
8083573|NCT03536663|19931505|P1|STARTED|Optiflux||23
8083574|NCT03535974|19931523|P3|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
8083575|NCT03535974|19931524|P2|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
8083576|NCT03535974|19931525|P1|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
8083577|NCT03535974|19931523|P3|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||5
8083578|NCT03535974|19931524|P2|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||17
8083579|NCT03535974|19931525|P1|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||12
8083580|NCT03535974|19931523|P3|STARTED|Second Intervention Weeks 6-12 (V2-V3)||5
8083581|NCT03535974|19931524|P2|STARTED|Second Intervention Weeks 6-12 (V2-V3)||17
8083582|NCT03535974|19931525|P1|STARTED|Second Intervention Weeks 6-12 (V2-V3)||12
8083583|NCT03535974|19931523|P3|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||0
8083584|NCT03535974|19931524|P2|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
8083585|NCT03535974|19931525|P1|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
8083586|NCT03535974|19931523|P3|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||5
8083587|NCT03535974|19931524|P2|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||17
8083588|NCT03535974|19931525|P1|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||12
8083589|NCT03535974|19931523|P3|STARTED|First Intervention Weeks 0-6 (V1-V2)||5
8083590|NCT03535974|19931524|P2|STARTED|First Intervention Weeks 0-6 (V1-V2)||19
8083591|NCT03535974|19931525|P1|STARTED|First Intervention Weeks 0-6 (V1-V2)||14
8083592|NCT03535844|19931535|P2|NOT COMPLETED|Overall Study||1
8083593|NCT03535844|19931536|P1|NOT COMPLETED|Overall Study||0
8083594|NCT03535844|19931535|P2|COMPLETED|Overall Study||18
8083595|NCT03535844|19931536|P1|COMPLETED|Overall Study||22
8083596|NCT03535844|19931535|P2|STARTED|Overall Study||19
8083597|NCT03535844|19931536|P1|STARTED|Overall Study||22
8083598|NCT03535649|19931572|P1|NOT COMPLETED|Overall Study||0
8083599|NCT03535649|19931572|P1|COMPLETED|Overall Study||105
8083600|NCT03535649|19931572|P1|STARTED|Overall Study||105
8083601|NCT03535571|19931581|P1|NOT COMPLETED|Overall Study||1
8083602|NCT03535571|19931581|P1|COMPLETED|Overall Study||19
8083603|NCT03535571|19931581|P1|STARTED|Overall Study||20
8083604|NCT03534986|19931613|P3|NOT COMPLETED|Overall Study||2
8083605|NCT03534986|19931614|P2|NOT COMPLETED|Overall Study||0
8083606|NCT03534986|19931615|P1|NOT COMPLETED|Overall Study||0
8083607|NCT03534986|19931613|P3|COMPLETED|Overall Study||10
8083608|NCT03534986|19931614|P2|COMPLETED|Overall Study||10
8083609|NCT03534986|19931615|P1|COMPLETED|Overall Study||10
8083610|NCT03534986|19931613|P3|STARTED|Overall Study||12
8083611|NCT03534986|19931614|P2|STARTED|Overall Study||10
8083612|NCT03534986|19931615|P1|STARTED|Overall Study||10
8083613|NCT03534427|19931637|P2|NOT COMPLETED|Overall Study||0
8083614|NCT03534427|19931638|P1|NOT COMPLETED|Overall Study||0
8083615|NCT03534427|19931637|P2|COMPLETED|Overall Study||20
8083616|NCT03534427|19931638|P1|COMPLETED|Overall Study||20
8083617|NCT03534427|19931637|P2|STARTED|Overall Study||20
8083618|NCT03534427|19931638|P1|STARTED|Overall Study||20
8083619|NCT03534362|19931666|P2|NOT COMPLETED|Overall Study||0
8083620|NCT03534362|19931667|P1|NOT COMPLETED|Overall Study||0
8083621|NCT03534362|19931666|P2|COMPLETED|Overall Study||1
8083622|NCT03534362|19931667|P1|COMPLETED|Overall Study||0
8083623|NCT03534362|19931666|P2|STARTED|Overall Study||1
8083624|NCT03534362|19931667|P1|STARTED|Overall Study||0
8083625|NCT03533829|19931680|P3|NOT COMPLETED|Overall Study||0
8083626|NCT03533829|19931681|P2|NOT COMPLETED|Overall Study||0
8083627|NCT03533829|19931682|P1|NOT COMPLETED|Overall Study||0
8083628|NCT03533829|19931680|P3|COMPLETED|Overall Study||10
8083629|NCT03533829|19931681|P2|COMPLETED|Overall Study||10
8083630|NCT03533829|19931682|P1|COMPLETED|Overall Study||10
8083631|NCT03533829|19931680|P3|STARTED|Overall Study||10
8083632|NCT03533829|19931681|P2|STARTED|Overall Study||10
8083633|NCT03533829|19931682|P1|STARTED|Overall Study||10
8083634|NCT03533374|19931782|P2|NOT COMPLETED|Overall Study||0
8083635|NCT03533374|19931783|P1|NOT COMPLETED|Overall Study||0
8083636|NCT03533374|19931782|P2|COMPLETED|Overall Study||46
8083637|NCT03533374|19931783|P1|COMPLETED|Overall Study||54
8083638|NCT03533374|19931782|P2|STARTED|Overall Study||46
8083639|NCT03533374|19931783|P1|STARTED|Overall Study||54
8083640|NCT03533244|19931796|P3|NOT COMPLETED|Overall Study||0
8083641|NCT03533244|19931797|P2|NOT COMPLETED|Overall Study||1
8083642|NCT03533244|19931798|P1|NOT COMPLETED|Overall Study||2
8083643|NCT03533244|19931796|P3|COMPLETED|Overall Study||22
8083644|NCT03533244|19931797|P2|COMPLETED|Overall Study||21
8083645|NCT03533244|19931798|P1|COMPLETED|Overall Study||18
8083646|NCT03533244|19931796|P3|STARTED|Overall Study||22
8083647|NCT03533244|19931797|P2|STARTED|Overall Study||22
8083648|NCT03533244|19931798|P1|STARTED|Overall Study||20
8083649|NCT03533036|19931814|P2|NOT COMPLETED|Overall Study||0
8083650|NCT03533036|19931815|P1|NOT COMPLETED|Overall Study||0
8083651|NCT03533036|19931814|P2|COMPLETED|Overall Study||15
8083652|NCT03533036|19931815|P1|COMPLETED|Overall Study||15
8083653|NCT03533036|19931814|P2|STARTED|Overall Study||15
8083654|NCT03533036|19931815|P1|STARTED|Overall Study||15
8083661|NCT03531905|19931842|P3|NOT COMPLETED|Overall Study||3
8083662|NCT03531905|19931843|P2|NOT COMPLETED|Overall Study||5
8083663|NCT03531905|19931844|P1|NOT COMPLETED|Overall Study||7
8083664|NCT03531905|19931842|P3|COMPLETED|Overall Study||77
8083665|NCT03531905|19931843|P2|COMPLETED|Overall Study||76
8083666|NCT03531905|19931844|P1|COMPLETED|Overall Study||74
8083667|NCT03531905|19931842|P3|STARTED|Overall Study||80
8083668|NCT03531905|19931843|P2|STARTED|Overall Study||81
8083669|NCT03531905|19931844|P1|STARTED|Overall Study||81
8083670|NCT03531710|19931902|P6|NOT COMPLETED|Overall Study||0
8083671|NCT03531710|19931903|P5|NOT COMPLETED|Overall Study||0
8083672|NCT03531710|19931904|P4|NOT COMPLETED|Overall Study||0
8083673|NCT03531710|19931905|P3|NOT COMPLETED|Overall Study||0
8083674|NCT03531710|19931906|P2|NOT COMPLETED|Overall Study||0
8083675|NCT03531710|19931907|P1|NOT COMPLETED|Overall Study||2
8083676|NCT03531710|19931902|P6|COMPLETED|Overall Study||2
8083677|NCT03531710|19931903|P5|COMPLETED|Overall Study||8
8083678|NCT03531710|19931904|P4|COMPLETED|Overall Study||5
8083679|NCT03531710|19931905|P3|COMPLETED|Overall Study||7
8083680|NCT03531710|19931906|P2|COMPLETED|Overall Study||2
8083681|NCT03531710|19931907|P1|COMPLETED|Overall Study||8
8083682|NCT03531710|19931902|P6|STARTED|Overall Study||2
8083683|NCT03531710|19931903|P5|STARTED|Overall Study||8
8083684|NCT03531710|19931904|P4|STARTED|Overall Study||5
8083685|NCT03531710|19931905|P3|STARTED|Overall Study||7
8083686|NCT03531710|19931906|P2|STARTED|Overall Study||2
8083687|NCT03531710|19931907|P1|STARTED|Overall Study||10
8083688|NCT03530917|19931953|P8|NOT COMPLETED|Overall Study||0
8083689|NCT03530917|19931954|P7|NOT COMPLETED|Overall Study||0
8083690|NCT03530917|19931955|P6|NOT COMPLETED|Overall Study||0
8083691|NCT03530917|19931956|P5|NOT COMPLETED|Overall Study||0
8083692|NCT03530917|19931957|P4|NOT COMPLETED|Overall Study||0
8083693|NCT03530917|19931958|P3|NOT COMPLETED|Overall Study||0
8083694|NCT03530917|19931959|P2|NOT COMPLETED|Overall Study||0
8083695|NCT03530917|19931960|P1|NOT COMPLETED|Overall Study||0
8083696|NCT03530917|19931953|P8|COMPLETED|Overall Study||16
8083697|NCT03530917|19931954|P7|COMPLETED|Overall Study||8
8083698|NCT03530917|19931955|P6|COMPLETED|Overall Study||6
8083699|NCT03530917|19931956|P5|COMPLETED|Overall Study||8
8083700|NCT03530917|19931957|P4|COMPLETED|Overall Study||8
8083701|NCT03530917|19931958|P3|COMPLETED|Overall Study||8
8083702|NCT03530917|19931959|P2|COMPLETED|Overall Study||8
8083703|NCT03530917|19931960|P1|COMPLETED|Overall Study||8
8083704|NCT03530917|19931953|P8|STARTED|Overall Study||16
8083705|NCT03530917|19931954|P7|STARTED|Overall Study||8
8083706|NCT03530917|19931955|P6|STARTED|Overall Study||6
8083707|NCT03530917|19931956|P5|STARTED|Overall Study||8
8083708|NCT03530917|19931957|P4|STARTED|Overall Study||8
8083709|NCT03530917|19931958|P3|STARTED|Overall Study||8
8083710|NCT03530917|19931959|P2|STARTED|Overall Study||8
8083711|NCT03530917|19931960|P1|STARTED|Overall Study||8
8083712|NCT03530631|19932044|P1|NOT COMPLETED|Placebo/Deception||0
8083713|NCT03530631|19932044|P1|COMPLETED|Placebo/Deception||4
8083714|NCT03530631|19932044|P1|STARTED|Placebo/Deception||4
8083715|NCT03530631|19932044|P1|NOT COMPLETED|Adderall/Deception||0
8083716|NCT03530631|19932044|P1|COMPLETED|Adderall/Deception||4
8083717|NCT03530631|19932044|P1|STARTED|Adderall/Deception||4
8083718|NCT03530631|19932044|P1|NOT COMPLETED|Placebo/Truth||0
8083719|NCT03530631|19932044|P1|COMPLETED|Placebo/Truth||4
8083720|NCT03530631|19932044|P1|STARTED|Placebo/Truth||4
8083721|NCT03530631|19932044|P1|NOT COMPLETED|Adderall/Truth||0
8083722|NCT03530631|19932044|P1|COMPLETED|Adderall/Truth||4
8083723|NCT03530631|19932044|P1|STARTED|Adderall/Truth||4
8083724|NCT03530345|19932056|P2|NOT COMPLETED|Treatment Period B/Follow-up Period 2||7
8083725|NCT03530345|19932057|P1|NOT COMPLETED|Treatment Period B/Follow-up Period 2||5
8083726|NCT03530345|19932056|P2|COMPLETED|Treatment Period B/Follow-up Period 2||0
8083727|NCT03530345|19932057|P1|COMPLETED|Treatment Period B/Follow-up Period 2||0
8083728|NCT03530345|19932056|P2|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||6
8083729|NCT03530345|19932057|P1|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||4
8083730|NCT03530345|19932056|P2|STARTED|Treatment Period B/Follow-up Period 2||7
8083731|NCT03530345|19932057|P1|STARTED|Treatment Period B/Follow-up Period 2|2 participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|5
8083732|NCT03530345|19932056|P2|NOT COMPLETED|Treatment Period A/Follow-up Period 1||22
8083733|NCT03530345|19932057|P1|NOT COMPLETED|Treatment Period A/Follow-up Period 1||21
8083734|NCT03530345|19932056|P2|COMPLETED|Treatment Period A/Follow-up Period 1||7
8083735|NCT03530345|19932057|P1|COMPLETED|Treatment Period A/Follow-up Period 1||7
8083736|NCT03530345|19932056|P2|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||27
8083737|NCT03530345|19932057|P1|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||26
8083738|NCT03530345|19932056|P2|STARTED|Treatment Period A/Follow-up Period 1||29
8083739|NCT03530345|19932057|P1|STARTED|Treatment Period A/Follow-up Period 1||28
8083750|NCT03529942|19932090|P1|NOT COMPLETED|Overall Study||23
8083751|NCT03529942|19932090|P1|COMPLETED|Overall Study||106
8083752|NCT03529942|19932090|P1|Reached Week 6 With Paired MRI|Overall Study||108
8083753|NCT03529942|19932090|P1|STARTED|Overall Study||129
8083754|NCT03529461|19932104|P2|NOT COMPLETED|Overall Study||0
8083755|NCT03529461|19932105|P1|NOT COMPLETED|Overall Study||0
8083756|NCT03529461|19932104|P2|COMPLETED|Overall Study||28
8083757|NCT03529461|19932105|P1|COMPLETED|Overall Study||28
8083758|NCT03529461|19932104|P2|STARTED|Overall Study||28
8083759|NCT03529461|19932105|P1|STARTED|Overall Study||28
8083760|NCT03528577|19932114|P1|NOT COMPLETED|Sequence 4||3
8083761|NCT03528577|19932114|P1|COMPLETED|Sequence 4||125
8083762|NCT03528577|19932114|P1|STARTED|Sequence 4||128
8083763|NCT03528577|19932114|P1|NOT COMPLETED|Sequence 3||1
8083764|NCT03528577|19932114|P1|COMPLETED|Sequence 3||127
8083765|NCT03528577|19932114|P1|STARTED|Sequence 3||128
8083766|NCT03528577|19932114|P1|NOT COMPLETED|Sequence 2||3
8083767|NCT03528577|19932114|P1|COMPLETED|Sequence 2||125
8083768|NCT03528577|19932114|P1|STARTED|Sequence 2||128
8083769|NCT03528577|19932114|P1|NOT COMPLETED|Sequence 1||2
8083770|NCT03528577|19932114|P1|COMPLETED|Sequence 1|Per report, 119 completed the trial, and all 119 received Treatment A, B, C and D.|126
8083771|NCT03528577|19932114|P1|STARTED|Sequence 1||128
8083772|NCT03528369|19932124|P3|NOT COMPLETED|Overall Study||0
8083773|NCT03528369|19932125|P2|NOT COMPLETED|Overall Study||1
8083774|NCT03528369|19932126|P1|NOT COMPLETED|Overall Study||3
8083775|NCT03528369|19932124|P3|COMPLETED|Overall Study||40
8083776|NCT03528369|19932125|P2|COMPLETED|Overall Study||41
8083777|NCT03528369|19932126|P1|COMPLETED|Overall Study||37
8083778|NCT03528369|19932124|P3|STARTED|Overall Study||40
8083779|NCT03528369|19932125|P2|STARTED|Overall Study||42
8083780|NCT03528369|19932126|P1|STARTED|Overall Study||40
8083781|NCT03528174|19932155|P1|NOT COMPLETED|Overall Study||2
8083782|NCT03528174|19932155|P1|COMPLETED|Overall Study||8
8083783|NCT03528174|19932155|P1|STARTED|Overall Study||10
8083784|NCT03527966|19932175|P2|NOT COMPLETED|Overall Study||0
8083785|NCT03527966|19932176|P1|NOT COMPLETED|Overall Study||3
8083786|NCT03527966|19932175|P2|COMPLETED|Overall Study||0
8083787|NCT03527966|19932176|P1|COMPLETED|Overall Study||0
8083788|NCT03527966|19932175|P2|STARTED|Overall Study||0
8083789|NCT03527966|19932176|P1|STARTED|Overall Study||3
8083790|NCT03527745|19932214|P26|NOT COMPLETED|Overall Study||3
8083791|NCT03527745|19932215|P25|NOT COMPLETED|Overall Study||1
8083792|NCT03527745|19932216|P24|NOT COMPLETED|Overall Study||8
8083793|NCT03527745|19932217|P23|NOT COMPLETED|Overall Study||6
8083794|NCT03527745|19932218|P22|NOT COMPLETED|Overall Study||5
8083795|NCT03527745|19932219|P21|NOT COMPLETED|Overall Study||1
8083796|NCT03527745|19932220|P20|NOT COMPLETED|Overall Study||1
8083797|NCT03527745|19932221|P19|NOT COMPLETED|Overall Study||0
8083798|NCT03527745|19932222|P18|NOT COMPLETED|Overall Study||0
8083799|NCT03527745|19932223|P17|NOT COMPLETED|Overall Study||1
8083800|NCT03527745|19932224|P16|NOT COMPLETED|Overall Study||0
8083801|NCT03527745|19932225|P15|NOT COMPLETED|Overall Study||0
8083802|NCT03527745|19932226|P14|NOT COMPLETED|Overall Study||0
8083803|NCT03527745|19932227|P13|NOT COMPLETED|Overall Study||0
8083804|NCT03527745|19932228|P12|NOT COMPLETED|Overall Study||1
8083805|NCT03527745|19932229|P11|NOT COMPLETED|Overall Study||1
8083806|NCT03527745|19932230|P10|NOT COMPLETED|Overall Study||2
8083807|NCT03527745|19932231|P9|NOT COMPLETED|Overall Study||3
8083808|NCT03527745|19932232|P8|NOT COMPLETED|Overall Study||2
8083809|NCT03527745|19932233|P7|NOT COMPLETED|Overall Study||3
8083810|NCT03527745|19932234|P6|NOT COMPLETED|Overall Study||2
8083811|NCT03527745|19932235|P5|NOT COMPLETED|Overall Study||0
8083812|NCT03527745|19932236|P4|NOT COMPLETED|Overall Study||9
8083813|NCT03527745|19932237|P3|NOT COMPLETED|Overall Study||7
8083814|NCT03527745|19932238|P2|NOT COMPLETED|Overall Study||6
8083815|NCT03527745|19932239|P1|NOT COMPLETED|Overall Study||3
8083816|NCT03527745|19932214|P26|COMPLETED|Overall Study||34
8083817|NCT03527745|19932215|P25|COMPLETED|Overall Study||39
8083818|NCT03527745|19932216|P24|COMPLETED|Overall Study||30
8083819|NCT03527745|19932217|P23|COMPLETED|Overall Study||35
8083820|NCT03527745|19932218|P22|COMPLETED|Overall Study||35
8083821|NCT03527745|19932219|P21|COMPLETED|Overall Study||25
8083822|NCT03527745|19932220|P20|COMPLETED|Overall Study||28
8083823|NCT03527745|19932221|P19|COMPLETED|Overall Study||27
8083824|NCT03527745|19932222|P18|COMPLETED|Overall Study||27
8083825|NCT03527745|19932223|P17|COMPLETED|Overall Study||23
8083826|NCT03527745|19932224|P16|COMPLETED|Overall Study||12
8083827|NCT03527745|19932225|P15|COMPLETED|Overall Study||13
8083828|NCT03527745|19932226|P14|COMPLETED|Overall Study||13
8083829|NCT03527745|19932227|P13|COMPLETED|Overall Study||0
8083830|NCT03527745|19932228|P12|COMPLETED|Overall Study||11
8083831|NCT03527745|19932229|P11|COMPLETED|Overall Study||8
8083832|NCT03527745|19932230|P10|COMPLETED|Overall Study||9
8083833|NCT03527745|19932231|P9|COMPLETED|Overall Study||7
8083834|NCT03527745|19932232|P8|COMPLETED|Overall Study||41
8083835|NCT03527745|19932233|P7|COMPLETED|Overall Study||43
8083836|NCT03527745|19932234|P6|COMPLETED|Overall Study||43
8083837|NCT03527745|19932235|P5|COMPLETED|Overall Study||46
8083838|NCT03527745|19932236|P4|COMPLETED|Overall Study||18
8083839|NCT03527745|19932237|P3|COMPLETED|Overall Study||23
8083840|NCT03527745|19932238|P2|COMPLETED|Overall Study||21
8083841|NCT03527745|19932239|P1|COMPLETED|Overall Study||24
8083842|NCT03527745|19932214|P26|STARTED|Overall Study||37
8083843|NCT03527745|19932215|P25|STARTED|Overall Study||40
8083844|NCT03527745|19932216|P24|STARTED|Overall Study||38
8083845|NCT03527745|19932217|P23|STARTED|Overall Study||41
8083846|NCT03527745|19932218|P22|STARTED|Overall Study||40
8083847|NCT03527745|19932219|P21|STARTED|Overall Study||26
8083848|NCT03527745|19932220|P20|STARTED|Overall Study||29
8083849|NCT03527745|19932221|P19|STARTED|Overall Study||27
8083850|NCT03527745|19932222|P18|STARTED|Overall Study||27
8083851|NCT03527745|19932223|P17|STARTED|Overall Study||24
8083852|NCT03527745|19932224|P16|STARTED|Overall Study||12
8083853|NCT03527745|19932225|P15|STARTED|Overall Study||13
8083854|NCT03527745|19932226|P14|STARTED|Overall Study||13
8083855|NCT03527745|19932227|P13|STARTED|Overall Study|During screening, the principal investigator decided to remove the this arm due to recruitment.|0
8083856|NCT03527745|19932228|P12|STARTED|Overall Study||12
8083857|NCT03527745|19932229|P11|STARTED|Overall Study||9
8083858|NCT03527745|19932230|P10|STARTED|Overall Study||11
8083859|NCT03527745|19932231|P9|STARTED|Overall Study||10
8083860|NCT03527745|19932232|P8|STARTED|Overall Study||43
8083861|NCT03527745|19932233|P7|STARTED|Overall Study||46
8083862|NCT03527745|19932234|P6|STARTED|Overall Study||45
8083863|NCT03527745|19932235|P5|STARTED|Overall Study||46
8083864|NCT03527745|19932236|P4|STARTED|Overall Study||27
8083865|NCT03527745|19932237|P3|STARTED|Overall Study||30
8083866|NCT03527745|19932238|P2|STARTED|Overall Study||27
8083867|NCT03527745|19932239|P1|STARTED|Overall Study||27
8083868|NCT03527173|19932321|P2|NOT COMPLETED|Overall Study||7
8083869|NCT03527173|19932322|P1|NOT COMPLETED|Overall Study||7
8083870|NCT03527173|19932321|P2|COMPLETED|Overall Study||28
8083871|NCT03527173|19932322|P1|COMPLETED|Overall Study||29
8083872|NCT03527173|19932321|P2|STARTED|Overall Study||35
8083873|NCT03527173|19932322|P1|STARTED|Overall Study||36
8083874|NCT03526055|19932364|P2|NOT COMPLETED|Second Program||0
8083875|NCT03526055|19932365|P1|NOT COMPLETED|Second Program||0
8083876|NCT03526055|19932364|P2|COMPLETED|Second Program||5
8083877|NCT03526055|19932365|P1|COMPLETED|Second Program||5
8083878|NCT03526055|19932364|P2|STARTED|Second Program||5
8083879|NCT03526055|19932365|P1|STARTED|Second Program||5
8083880|NCT03526055|19932364|P2|NOT COMPLETED|Initial Program||0
8083881|NCT03526055|19932365|P1|NOT COMPLETED|Initial Program||0
8083882|NCT03526055|19932364|P2|COMPLETED|Initial Program||5
8083883|NCT03526055|19932365|P1|COMPLETED|Initial Program||5
8083884|NCT03526055|19932364|P2|STARTED|Initial Program||5
8083885|NCT03526055|19932365|P1|STARTED|Initial Program||5
8083886|NCT03525678|19932382|P3|NOT COMPLETED|Overall Study||25
8083887|NCT03525678|19932383|P2|NOT COMPLETED|Overall Study||99
8083888|NCT03525678|19932384|P1|NOT COMPLETED|Overall Study||97
8083889|NCT03525678|19932382|P3|COMPLETED|Overall Study||0
8083890|NCT03525678|19932383|P2|COMPLETED|Overall Study||0
8083891|NCT03525678|19932384|P1|COMPLETED|Overall Study||0
8083892|NCT03525678|19932382|P3|Received Study Treatment|Overall Study||24
8083893|NCT03525678|19932383|P2|Received Study Treatment|Overall Study||99
8083894|NCT03525678|19932384|P1|Received Study Treatment|Overall Study||95
8083895|NCT03525678|19932382|P3|STARTED|Overall Study||25
8083896|NCT03525678|19932383|P2|STARTED|Overall Study||99
8083897|NCT03525678|19932384|P1|STARTED|Overall Study||97
8083898|NCT03525548|19932569|P2|NOT COMPLETED|Overall Study||0
8083899|NCT03525548|19932570|P1|NOT COMPLETED|Overall Study||0
8083900|NCT03525548|19932569|P2|COMPLETED|Overall Study||55
8083901|NCT03525548|19932570|P1|COMPLETED|Overall Study||52
8083902|NCT03525548|19932569|P2|STARTED|Overall Study||55
8083903|NCT03525548|19932570|P1|STARTED|Overall Study||52
8083904|NCT03525444|19932586|P2|NOT COMPLETED|Overall Study||3
8083905|NCT03525444|19932587|P1|NOT COMPLETED|Overall Study||0
8083906|NCT03525444|19932586|P2|COMPLETED|Overall Study||197
8083907|NCT03525444|19932587|P1|COMPLETED|Overall Study||203
8083908|NCT03525444|19932586|P2|Safety Set|Overall Study||202
8083909|NCT03525444|19932587|P1|Safety Set|Overall Study||201
8083910|NCT03525444|19932586|P2|STARTED|Overall Study||200
8083911|NCT03525444|19932587|P1|STARTED|Overall Study||203
8083912|NCT03525210|19932618|P2|NOT COMPLETED|Overall Study||2
8083913|NCT03525210|19932619|P1|NOT COMPLETED|Overall Study||4
8083914|NCT03525210|19932618|P2|COMPLETED|Overall Study||169
8083915|NCT03525210|19932619|P1|COMPLETED|Overall Study||96
8083916|NCT03525210|19932618|P2|STARTED|Overall Study||171
8083917|NCT03525210|19932619|P1|STARTED|Overall Study||100
8083918|NCT03525119|19932630|P3|NOT COMPLETED|Overall Study||43
8083919|NCT03525119|19932631|P2|NOT COMPLETED|Overall Study||39
8083920|NCT03525119|19932632|P1|NOT COMPLETED|Overall Study||40
8083921|NCT03525119|19932630|P3|COMPLETED|Overall Study||257
8083922|NCT03525119|19932631|P2|COMPLETED|Overall Study||261
8083923|NCT03525119|19932632|P1|COMPLETED|Overall Study||260
8083924|NCT03525119|19932630|P3|Safety Population|Overall Study||298
8083925|NCT03525119|19932631|P2|Safety Population|Overall Study||300
8083926|NCT03525119|19932632|P1|Safety Population|Overall Study||299
8083927|NCT03525119|19932630|P3|STARTED|Overall Study||300
8083928|NCT03525119|19932631|P2|STARTED|Overall Study||300
8083929|NCT03525119|19932632|P1|STARTED|Overall Study||300
8083930|NCT03524157|19932667|P3|NOT COMPLETED|Overall Study||1
8083931|NCT03524157|19932668|P2|NOT COMPLETED|Overall Study||0
8083932|NCT03524157|19932669|P1|NOT COMPLETED|Overall Study||0
8083933|NCT03524157|19932667|P3|COMPLETED|Overall Study||9
8083934|NCT03524157|19932668|P2|COMPLETED|Overall Study||10
8083935|NCT03524157|19932669|P1|COMPLETED|Overall Study||10
8083936|NCT03524157|19932667|P3|STARTED|Overall Study||10
8083937|NCT03524157|19932668|P2|STARTED|Overall Study||10
8083938|NCT03524157|19932669|P1|STARTED|Overall Study||10
8083939|NCT03523988|19932707|P3|NOT COMPLETED|Overall Study||18
8083940|NCT03523988|19932708|P2|NOT COMPLETED|Overall Study||16
8083941|NCT03523988|19932709|P1|NOT COMPLETED|Overall Study||17
8083942|NCT03523988|19932707|P3|COMPLETED|Overall Study||7
8083943|NCT03523988|19932708|P2|COMPLETED|Overall Study||8
8083944|NCT03523988|19932709|P1|COMPLETED|Overall Study||7
8083945|NCT03523988|19932707|P3|STARTED|Overall Study||25
8083946|NCT03523988|19932708|P2|STARTED|Overall Study||24
8083947|NCT03523988|19932709|P1|STARTED|Overall Study||24
8083948|NCT03522675|19932723|P1|NOT COMPLETED|Overall Study||2
8083949|NCT03522675|19932723|P1|COMPLETED|Overall Study||20
8083950|NCT03522675|19932723|P1|STARTED|Overall Study||22
8084035|NCT03522441|19932795|P3|NOT COMPLETED|Overall Study||11
8084036|NCT03522441|19932796|P2|NOT COMPLETED|Overall Study||19
8084037|NCT03522441|19932797|P1|NOT COMPLETED|Overall Study||26
8084038|NCT03522441|19932795|P3|COMPLETED|Overall Study||214
8084039|NCT03522441|19932796|P2|COMPLETED|Overall Study||431
8084040|NCT03522441|19932797|P1|COMPLETED|Overall Study||424
8084041|NCT03522441|19932795|P3|STARTED|Overall Study||225
8084042|NCT03522441|19932796|P2|STARTED|Overall Study||450
8084043|NCT03522441|19932797|P1|STARTED|Overall Study||450
8084044|NCT03522350|19932808|P2|NOT COMPLETED|Overall Study||0
8084045|NCT03522350|19932809|P1|NOT COMPLETED|Overall Study||0
8084046|NCT03522350|19932808|P2|COMPLETED|Overall Study||18
8084047|NCT03522350|19932809|P1|COMPLETED|Overall Study||18
8084048|NCT03522350|19932808|P2|STARTED|Overall Study||18
8084049|NCT03522350|19932809|P1|STARTED|Overall Study||18
8084050|NCT03521817|19932822|P2|NOT COMPLETED|Overall Study||1
8084051|NCT03521817|19932823|P1|NOT COMPLETED|Overall Study||0
8084052|NCT03521817|19932822|P2|COMPLETED|Overall Study|1 completer was non adherent based on weekly intervention body weight|4
8084053|NCT03521817|19932823|P1|COMPLETED|Overall Study||7
8084054|NCT03521817|19932822|P2|STARTED|Overall Study||5
8084055|NCT03521817|19932823|P1|STARTED|Overall Study||7
8084056|NCT03521791|19932831|P2|NOT COMPLETED|Overall Study||17
8084057|NCT03521791|19932832|P1|NOT COMPLETED|Overall Study||7
8084058|NCT03521791|19932831|P2|COMPLETED|Overall Study||73
8084059|NCT03521791|19932832|P1|COMPLETED|Overall Study||69
8084060|NCT03521791|19932831|P2|STARTED|Overall Study||90
8084061|NCT03521791|19932832|P1|STARTED|Overall Study||76
8084062|NCT03521141|19932859|P3|NOT COMPLETED|Overall Study||1
8084063|NCT03521141|19932860|P2|NOT COMPLETED|Overall Study||0
8084064|NCT03521141|19932861|P1|NOT COMPLETED|Overall Study||1
8084065|NCT03521141|19932859|P3|COMPLETED|Overall Study||19
8084066|NCT03521141|19932860|P2|COMPLETED|Overall Study||19
8084067|NCT03521141|19932861|P1|COMPLETED|Overall Study||18
8084068|NCT03521141|19932859|P3|STARTED|Overall Study||20
8084069|NCT03521141|19932860|P2|STARTED|Overall Study||19
8084070|NCT03521141|19932861|P1|STARTED|Overall Study||19
8084071|NCT03521089|19932886|P2|NOT COMPLETED|Overall Study||0
8084072|NCT03521089|19932887|P1|NOT COMPLETED|Overall Study||0
8084073|NCT03521089|19932886|P2|COMPLETED|Overall Study||8
8084074|NCT03521089|19932887|P1|COMPLETED|Overall Study||8
8084075|NCT03521089|19932886|P2|STARTED|Overall Study||8
8084076|NCT03521089|19932887|P1|STARTED|Overall Study||8
8084077|NCT03520959|19932907|P2|NOT COMPLETED|Overall Study||1
8084078|NCT03520959|19932908|P1|NOT COMPLETED|Overall Study||0
8084079|NCT03520959|19932907|P2|COMPLETED|Overall Study||0
8084080|NCT03520959|19932908|P1|COMPLETED|Overall Study||0
8084081|NCT03520959|19932907|P2|STARTED|Overall Study||1
8084082|NCT03520959|19932908|P1|STARTED|Overall Study||0
8084083|NCT03520348|19932930|P2|NOT COMPLETED|Overall Study||0
8084084|NCT03520348|19932931|P1|NOT COMPLETED|Overall Study||0
8084085|NCT03520348|19932930|P2|COMPLETED|Overall Study||12
8084086|NCT03520348|19932931|P1|COMPLETED|Overall Study||12
8084087|NCT03520348|19932930|P2|STARTED|Overall Study||12
8084088|NCT03520348|19932931|P1|STARTED|Overall Study||12
8084089|NCT03519932|19932955|P2|NOT COMPLETED|Second Intervention||0
8084090|NCT03519932|19932956|P1|NOT COMPLETED|Second Intervention||0
8084091|NCT03519932|19932955|P2|COMPLETED|Second Intervention||23
8084092|NCT03519932|19932956|P1|COMPLETED|Second Intervention||22
8084093|NCT03519932|19932955|P2|STARTED|Second Intervention|Subjects who wore comfilcon A toric at 1st intervention wear Samfilcon A toric at 2nd intervention|23
8084094|NCT03519932|19932956|P1|STARTED|Second Intervention|Subjects who wore samfilcon A toric at 1st intervention wear comfilcon A toric at 2nd intervention|22
8084095|NCT03519932|19932955|P2|NOT COMPLETED|First Intervention||3
8084096|NCT03519932|19932956|P1|NOT COMPLETED|First Intervention||1
8084097|NCT03519932|19932955|P2|COMPLETED|First Intervention|3 subjects had non-significant adverse events and data not included in analysis.|22
8084098|NCT03519932|19932956|P1|COMPLETED|First Intervention|One subject had non-significant adverse event and data not included in the analysis|23
8084099|NCT03519932|19932955|P2|STARTED|First Intervention||25
8084100|NCT03519932|19932956|P1|STARTED|First Intervention||24
8084101|NCT03519919|19932982|P1|NOT COMPLETED|Overall Study||3
8084102|NCT03519919|19932982|P1|COMPLETED|Overall Study||48
8084103|NCT03519919|19932982|P1|STARTED|Overall Study||51
8084104|NCT03519867|19933034|P10|NOT COMPLETED|Overall Study||0
8084105|NCT03519867|19933035|P9|NOT COMPLETED|Overall Study||1
8084106|NCT03519867|19933036|P8|NOT COMPLETED|Overall Study||1
8084107|NCT03519867|19933037|P7|NOT COMPLETED|Overall Study||1
8084108|NCT03519867|19933038|P6|NOT COMPLETED|Overall Study||3
8084109|NCT03519867|19933039|P5|NOT COMPLETED|Overall Study||0
8084110|NCT03519867|19933040|P4|NOT COMPLETED|Overall Study||1
8084111|NCT03519867|19933041|P3|NOT COMPLETED|Overall Study||1
8084112|NCT03519867|19933042|P2|NOT COMPLETED|Overall Study||3
8084113|NCT03519867|19933043|P1|NOT COMPLETED|Overall Study||3
8084114|NCT03519867|19933034|P10|COMPLETED|Overall Study||4
8084115|NCT03519867|19933035|P9|COMPLETED|Overall Study||3
8084116|NCT03519867|19933036|P8|COMPLETED|Overall Study||4
8084117|NCT03519867|19933037|P7|COMPLETED|Overall Study||3
8084118|NCT03519867|19933038|P6|COMPLETED|Overall Study||2
8084119|NCT03519867|19933039|P5|COMPLETED|Overall Study||5
8084120|NCT03519867|19933040|P4|COMPLETED|Overall Study||3
8084121|NCT03519867|19933041|P3|COMPLETED|Overall Study||5
8084122|NCT03519867|19933042|P2|COMPLETED|Overall Study||4
8084123|NCT03519867|19933043|P1|COMPLETED|Overall Study||3
8084124|NCT03519867|19933034|P10|Treated|Overall Study||4
8084125|NCT03519867|19933035|P9|Treated|Overall Study||3
8084126|NCT03519867|19933036|P8|Treated|Overall Study||4
8084127|NCT03519867|19933037|P7|Treated|Overall Study||4
8084128|NCT03519867|19933038|P6|Treated|Overall Study||4
8084129|NCT03519867|19933039|P5|Treated|Overall Study||5
8084130|NCT03519867|19933040|P4|Treated|Overall Study||3
8084131|NCT03519867|19933041|P3|Treated|Overall Study||5
8084132|NCT03519867|19933042|P2|Treated|Overall Study||6
8084133|NCT03519867|19933043|P1|Treated|Overall Study||5
8084134|NCT03519867|19933034|P10|STARTED|Overall Study||4
8084135|NCT03519867|19933035|P9|STARTED|Overall Study||4
8084136|NCT03519867|19933036|P8|STARTED|Overall Study||5
8084137|NCT03519867|19933037|P7|STARTED|Overall Study||4
8084138|NCT03519867|19933038|P6|STARTED|Overall Study||5
8084139|NCT03519867|19933039|P5|STARTED|Overall Study||5
8084140|NCT03519867|19933040|P4|STARTED|Overall Study||4
8084141|NCT03519867|19933041|P3|STARTED|Overall Study||6
8084142|NCT03519867|19933042|P2|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7
8084143|NCT03519867|19933043|P1|STARTED|Overall Study||6
8084144|NCT03519854|19933093|P18|NOT COMPLETED|Overall Study||0
8084145|NCT03519854|19933094|P17|NOT COMPLETED|Overall Study||0
8084146|NCT03519854|19933095|P16|NOT COMPLETED|Overall Study||0
8084147|NCT03519854|19933096|P15|NOT COMPLETED|Overall Study||0
8084148|NCT03519854|19933097|P14|NOT COMPLETED|Overall Study||0
8084149|NCT03519854|19933098|P13|NOT COMPLETED|Overall Study||0
8084150|NCT03519854|19933099|P12|NOT COMPLETED|Overall Study||0
8084151|NCT03519854|19933100|P11|NOT COMPLETED|Overall Study||0
8084152|NCT03519854|19933101|P10|NOT COMPLETED|Overall Study||0
8084153|NCT03519854|19933102|P9|NOT COMPLETED|Overall Study||0
8084154|NCT03519854|19933103|P8|NOT COMPLETED|Overall Study||0
8084155|NCT03519854|19933104|P7|NOT COMPLETED|Overall Study||0
8084156|NCT03519854|19933105|P6|NOT COMPLETED|Overall Study||0
8084157|NCT03519854|19933106|P5|NOT COMPLETED|Overall Study||0
8084158|NCT03519854|19933107|P4|NOT COMPLETED|Overall Study||0
8084159|NCT03519854|19933108|P3|NOT COMPLETED|Overall Study||1
8084160|NCT03519854|19933109|P2|NOT COMPLETED|Overall Study||0
8084161|NCT03519854|19933110|P1|NOT COMPLETED|Overall Study||0
8084162|NCT03519854|19933093|P18|COMPLETED|Overall Study||6
8084163|NCT03519854|19933094|P17|COMPLETED|Overall Study||6
8084164|NCT03519854|19933095|P16|COMPLETED|Overall Study||6
8084165|NCT03519854|19933096|P15|COMPLETED|Overall Study||6
8084166|NCT03519854|19933097|P14|COMPLETED|Overall Study||6
8084167|NCT03519854|19933098|P13|COMPLETED|Overall Study||3
8084168|NCT03519854|19933099|P12|COMPLETED|Overall Study||6
8084169|NCT03519854|19933100|P11|COMPLETED|Overall Study||6
8084170|NCT03519854|19933101|P10|COMPLETED|Overall Study||6
8084171|NCT03519854|19933102|P9|COMPLETED|Overall Study||6
8084172|NCT03519854|19933103|P8|COMPLETED|Overall Study||6
8084173|NCT03519854|19933104|P7|COMPLETED|Overall Study||3
8084174|NCT03519854|19933105|P6|COMPLETED|Overall Study||6
8084175|NCT03519854|19933106|P5|COMPLETED|Overall Study||6
8084176|NCT03519854|19933107|P4|COMPLETED|Overall Study||6
8084177|NCT03519854|19933108|P3|COMPLETED|Overall Study||4
8084178|NCT03519854|19933109|P2|COMPLETED|Overall Study||6
8084179|NCT03519854|19933110|P1|COMPLETED|Overall Study||4
8084180|NCT03519854|19933093|P18|Treated|Overall Study||6
8084181|NCT03519854|19933094|P17|Treated|Overall Study||6
8084182|NCT03519854|19933095|P16|Treated|Overall Study||6
8084183|NCT03519854|19933096|P15|Treated|Overall Study||6
8084184|NCT03519854|19933097|P14|Treated|Overall Study||6
8084185|NCT03519854|19933098|P13|Treated|Overall Study||3
8084186|NCT03519854|19933099|P12|Treated|Overall Study||6
8084187|NCT03519854|19933100|P11|Treated|Overall Study||6
8084188|NCT03519854|19933101|P10|Treated|Overall Study||6
8084189|NCT03519854|19933102|P9|Treated|Overall Study||6
8084190|NCT03519854|19933103|P8|Treated|Overall Study||6
8084191|NCT03519854|19933104|P7|Treated|Overall Study||3
8084192|NCT03519854|19933105|P6|Treated|Overall Study||6
8084193|NCT03519854|19933106|P5|Treated|Overall Study||6
8084194|NCT03519854|19933107|P4|Treated|Overall Study||6
8084195|NCT03519854|19933108|P3|Treated|Overall Study||4
8084196|NCT03519854|19933109|P2|Treated|Overall Study||6
8084197|NCT03519854|19933110|P1|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4
8084198|NCT03519854|19933093|P18|STARTED|Overall Study||6
8084199|NCT03519854|19933094|P17|STARTED|Overall Study||6
8084200|NCT03519854|19933095|P16|STARTED|Overall Study||6
8084201|NCT03519854|19933096|P15|STARTED|Overall Study||6
8084202|NCT03519854|19933097|P14|STARTED|Overall Study||6
8084203|NCT03519854|19933098|P13|STARTED|Overall Study||3
8084204|NCT03519854|19933099|P12|STARTED|Overall Study||6
8084205|NCT03519854|19933100|P11|STARTED|Overall Study||6
8084206|NCT03519854|19933101|P10|STARTED|Overall Study||6
8084207|NCT03519854|19933102|P9|STARTED|Overall Study||6
8084208|NCT03519854|19933103|P8|STARTED|Overall Study||6
8084209|NCT03519854|19933104|P7|STARTED|Overall Study||3
8084210|NCT03519854|19933105|P6|STARTED|Overall Study||6
8084211|NCT03519854|19933106|P5|STARTED|Overall Study||6
8084212|NCT03519854|19933107|P4|STARTED|Overall Study||6
8084213|NCT03519854|19933108|P3|STARTED|Overall Study||5
8084214|NCT03519854|19933109|P2|STARTED|Overall Study||6
8084215|NCT03519854|19933110|P1|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4
8084216|NCT03519516|19933276|P2|NOT COMPLETED|Overall Study||1
8084217|NCT03519516|19933277|P1|NOT COMPLETED|Overall Study||0
8084218|NCT03519516|19933276|P2|COMPLETED|Overall Study||14
8084219|NCT03519516|19933277|P1|COMPLETED|Overall Study||15
8084220|NCT03519516|19933276|P2|STARTED|Overall Study||15
8084221|NCT03519516|19933277|P1|STARTED|Overall Study||15
8084222|NCT03519282|19933301|P2|NOT COMPLETED|Second Intervention||0
8084223|NCT03519282|19933302|P1|NOT COMPLETED|Second Intervention||0
8084224|NCT03519282|19933301|P2|COMPLETED|Second Intervention||5
8084225|NCT03519282|19933302|P1|COMPLETED|Second Intervention||5
8084226|NCT03519282|19933301|P2|STARTED|Second Intervention||5
8084227|NCT03519282|19933302|P1|STARTED|Second Intervention||5
8084228|NCT03519282|19933301|P2|NOT COMPLETED|First Intervention||0
8084229|NCT03519282|19933302|P1|NOT COMPLETED|First Intervention||0
8084230|NCT03519282|19933301|P2|COMPLETED|First Intervention||5
8084231|NCT03519282|19933302|P1|COMPLETED|First Intervention||5
8084232|NCT03519282|19933301|P2|STARTED|First Intervention||5
8084233|NCT03519282|19933302|P1|STARTED|First Intervention||5
8084246|NCT03519204|19933351|P2|NOT COMPLETED|Overall Study||15
8084247|NCT03519204|19933352|P1|NOT COMPLETED|Overall Study||13
8084248|NCT03519204|19933351|P2|COMPLETED|Overall Study||118
8084249|NCT03519204|19933352|P1|COMPLETED|Overall Study||30
8084250|NCT03519204|19933351|P2|Safety Population|Overall Study||136
8084251|NCT03519204|19933352|P1|Safety Population|Overall Study||40
8084252|NCT03519204|19933351|P2|mITT Population|Overall Study||130
8084253|NCT03519204|19933352|P1|mITT Population|Overall Study||33
8084254|NCT03519204|19933351|P2|STARTED|Overall Study||133
8084255|NCT03519204|19933352|P1|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43
8084256|NCT03519087|19933371|P5|NOT COMPLETED|Laboratory Testing||6
8084257|NCT03519087|19933372|P4|NOT COMPLETED|Laboratory Testing||4
8084258|NCT03519087|19933373|P3|NOT COMPLETED|Laboratory Testing||2
8084259|NCT03519087|19933374|P2|NOT COMPLETED|Laboratory Testing||0
8084260|NCT03519087|19933375|P1|NOT COMPLETED|Laboratory Testing||0
8084261|NCT03519087|19933371|P5|COMPLETED|Laboratory Testing||1
8084262|NCT03519087|19933372|P4|COMPLETED|Laboratory Testing||2
8084263|NCT03519087|19933373|P3|COMPLETED|Laboratory Testing||4
8084264|NCT03519087|19933374|P2|COMPLETED|Laboratory Testing||0
8084265|NCT03519087|19933375|P1|COMPLETED|Laboratory Testing||0
8084266|NCT03519087|19933371|P5|Baseline Lab Testing|Laboratory Testing||3
8084267|NCT03519087|19933372|P4|Baseline Lab Testing|Laboratory Testing||4
8084268|NCT03519087|19933373|P3|Baseline Lab Testing|Laboratory Testing||5
8084269|NCT03519087|19933374|P2|Baseline Lab Testing|Laboratory Testing||0
8084270|NCT03519087|19933375|P1|Baseline Lab Testing|Laboratory Testing||0
8084271|NCT03519087|19933371|P5|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (3) evaluation from Period 1|7
8084272|NCT03519087|19933372|P4|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
8084273|NCT03519087|19933373|P3|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
8084274|NCT03519087|19933374|P2|STARTED|Laboratory Testing||0
8084275|NCT03519087|19933375|P1|STARTED|Laboratory Testing||0
8084276|NCT03519087|19933371|P5|NOT COMPLETED|Re-randomization for Treatment||0
8084277|NCT03519087|19933372|P4|NOT COMPLETED|Re-randomization for Treatment||0
8084278|NCT03519087|19933373|P3|NOT COMPLETED|Re-randomization for Treatment||0
8084279|NCT03519087|19933374|P2|NOT COMPLETED|Re-randomization for Treatment||32
8084280|NCT03519087|19933375|P1|NOT COMPLETED|Re-randomization for Treatment||27
8084281|NCT03519087|19933371|P5|COMPLETED|Re-randomization for Treatment||0
8084282|NCT03519087|19933372|P4|COMPLETED|Re-randomization for Treatment||0
8084283|NCT03519087|19933373|P3|COMPLETED|Re-randomization for Treatment||0
8084284|NCT03519087|19933374|P2|COMPLETED|Re-randomization for Treatment||7
8084285|NCT03519087|19933375|P1|COMPLETED|Re-randomization for Treatment||12
8084286|NCT03519087|19933371|P5|STARTED|Re-randomization for Treatment||0
8084287|NCT03519087|19933372|P4|STARTED|Re-randomization for Treatment||0
8084288|NCT03519087|19933373|P3|STARTED|Re-randomization for Treatment||0
8084289|NCT03519087|19933374|P2|STARTED|Re-randomization for Treatment||39
8084290|NCT03519087|19933375|P1|STARTED|Re-randomization for Treatment||39
8084291|NCT03519087|19933371|P5|NOT COMPLETED|Clinic Evaluation||0
8084292|NCT03519087|19933372|P4|NOT COMPLETED|Clinic Evaluation||0
8084293|NCT03519087|19933373|P3|NOT COMPLETED|Clinic Evaluation||0
8084294|NCT03519087|19933374|P2|NOT COMPLETED|Clinic Evaluation||18
8084295|NCT03519087|19933375|P1|NOT COMPLETED|Clinic Evaluation||16
8084296|NCT03519087|19933371|P5|COMPLETED|Clinic Evaluation||0
8084297|NCT03519087|19933372|P4|COMPLETED|Clinic Evaluation||0
8084298|NCT03519087|19933373|P3|COMPLETED|Clinic Evaluation||0
8084299|NCT03519087|19933374|P2|COMPLETED|Clinic Evaluation||39
8084300|NCT03519087|19933375|P1|COMPLETED|Clinic Evaluation||39
8084301|NCT03519087|19933371|P5|Confirmed Diagnosis by Physician|Clinic Evaluation||0
8084302|NCT03519087|19933372|P4|Confirmed Diagnosis by Physician|Clinic Evaluation||0
8084303|NCT03519087|19933373|P3|Confirmed Diagnosis by Physician|Clinic Evaluation||0
8084304|NCT03519087|19933374|P2|Confirmed Diagnosis by Physician|Clinic Evaluation||39
8084305|NCT03519087|19933375|P1|Confirmed Diagnosis by Physician|Clinic Evaluation||39
8084306|NCT03519087|19933371|P5|Received Assigned Intervention|Clinic Evaluation||0
8084307|NCT03519087|19933372|P4|Received Assigned Intervention|Clinic Evaluation||0
8084308|NCT03519087|19933373|P3|Received Assigned Intervention|Clinic Evaluation||0
8084309|NCT03519087|19933374|P2|Received Assigned Intervention|Clinic Evaluation||57
8084310|NCT03519087|19933375|P1|Received Assigned Intervention|Clinic Evaluation||54
8084311|NCT03519087|19933371|P5|STARTED|Clinic Evaluation||0
8084312|NCT03519087|19933372|P4|STARTED|Clinic Evaluation||0
8084313|NCT03519087|19933373|P3|STARTED|Clinic Evaluation||0
8084314|NCT03519087|19933374|P2|STARTED|Clinic Evaluation||57
8084315|NCT03519087|19933375|P1|STARTED|Clinic Evaluation||55
8084316|NCT03518840|19933411|P1|NOT COMPLETED|Overall Study||6
8084317|NCT03518840|19933411|P1|COMPLETED|Overall Study||57
8084318|NCT03518840|19933411|P1|STARTED|Overall Study||63
8084319|NCT03518125|19933424|P6|NOT COMPLETED|Overall Study||8
8084320|NCT03518125|19933425|P5|NOT COMPLETED|Overall Study||4
8084321|NCT03518125|19933426|P4|NOT COMPLETED|Overall Study||1
8084322|NCT03518125|19933427|P3|NOT COMPLETED|Overall Study||0
8084323|NCT03518125|19933428|P2|NOT COMPLETED|Overall Study||4
8084324|NCT03518125|19933429|P1|NOT COMPLETED|Overall Study||2
8084325|NCT03518125|19933424|P6|COMPLETED|Overall Study||44
8084326|NCT03518125|19933425|P5|COMPLETED|Overall Study||48
8084327|NCT03518125|19933426|P4|COMPLETED|Overall Study||51
8084328|NCT03518125|19933427|P3|COMPLETED|Overall Study||49
8084329|NCT03518125|19933428|P2|COMPLETED|Overall Study||46
8084330|NCT03518125|19933429|P1|COMPLETED|Overall Study||48
8084331|NCT03518125|19933424|P6|STARTED|Overall Study||52
8084332|NCT03518125|19933425|P5|STARTED|Overall Study||52
8084333|NCT03518125|19933426|P4|STARTED|Overall Study||52
8084334|NCT03518125|19933427|P3|STARTED|Overall Study||49
8084335|NCT03518125|19933428|P2|STARTED|Overall Study||50
8084336|NCT03518125|19933429|P1|STARTED|Overall Study||50
8084337|NCT03518008|19933527|P2|NOT COMPLETED|Period 2, Second Week of Wear||1
8084338|NCT03518008|19933528|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
8084339|NCT03518008|19933527|P2|COMPLETED|Period 2, Second Week of Wear||10
8084340|NCT03518008|19933528|P1|COMPLETED|Period 2, Second Week of Wear||11
8084341|NCT03518008|19933527|P2|STARTED|Period 2, Second Week of Wear||11
8084342|NCT03518008|19933528|P1|STARTED|Period 2, Second Week of Wear||11
8084343|NCT03518008|19933527|P2|NOT COMPLETED|Period 1, First Week of Wear||0
8084344|NCT03518008|19933528|P1|NOT COMPLETED|Period 1, First Week of Wear||0
8084345|NCT03518008|19933527|P2|COMPLETED|Period 1, First Week of Wear||11
8084346|NCT03518008|19933528|P1|COMPLETED|Period 1, First Week of Wear||11
8084347|NCT03518008|19933527|P2|STARTED|Period 1, First Week of Wear||11
8084348|NCT03518008|19933528|P1|STARTED|Period 1, First Week of Wear||11
8084349|NCT03516227|19933536|P2|NOT COMPLETED|Overall Study||4
8084350|NCT03516227|19933537|P1|NOT COMPLETED|Overall Study||1
8084351|NCT03516227|19933536|P2|COMPLETED|Overall Study||16
8084352|NCT03516227|19933537|P1|COMPLETED|Overall Study||19
8084353|NCT03516227|19933536|P2|STARTED|Overall Study||20
8084354|NCT03516227|19933537|P1|STARTED|Overall Study||20
8084355|NCT03515941|19933553|P2|NOT COMPLETED|Overall Study||0
8084356|NCT03515941|19933554|P1|NOT COMPLETED|Overall Study||1
8084357|NCT03515941|19933553|P2|COMPLETED|Overall Study||2
8084358|NCT03515941|19933554|P1|COMPLETED|Overall Study||3
8084359|NCT03515941|19933553|P2|STARTED|Overall Study||2
8084360|NCT03515941|19933554|P1|STARTED|Overall Study||4
8084371|NCT03514966|19933585|P2|NOT COMPLETED|Overall Study||0
8084372|NCT03514966|19933586|P1|NOT COMPLETED|Overall Study||0
8084373|NCT03514966|19933585|P2|COMPLETED|Overall Study||43
8084374|NCT03514966|19933586|P1|COMPLETED|Overall Study||40
8084375|NCT03514966|19933585|P2|STARTED|Overall Study||43
8084376|NCT03514966|19933586|P1|STARTED|Overall Study||40
8084377|NCT03514277|19933599|P3|NOT COMPLETED|Overall Study||0
8084378|NCT03514277|19933600|P2|NOT COMPLETED|Overall Study||0
8084379|NCT03514277|19933601|P1|NOT COMPLETED|Overall Study||0
8084380|NCT03514277|19933599|P3|COMPLETED|Overall Study||4
8084381|NCT03514277|19933600|P2|COMPLETED|Overall Study||4
8084382|NCT03514277|19933601|P1|COMPLETED|Overall Study||11
8084383|NCT03514277|19933599|P3|STARTED|Overall Study||4
8084384|NCT03514277|19933600|P2|STARTED|Overall Study||4
8084385|NCT03514277|19933601|P1|STARTED|Overall Study||11
8084386|NCT03513848|19933620|P2|NOT COMPLETED|Overall Study||0
8084387|NCT03513848|19933621|P1|NOT COMPLETED|Overall Study||0
8084388|NCT03513848|19933620|P2|COMPLETED|Overall Study||6
8084389|NCT03513848|19933621|P1|COMPLETED|Overall Study||9
8084390|NCT03513848|19933620|P2|STARTED|Overall Study||6
8084391|NCT03513848|19933621|P1|STARTED|Overall Study||9
8084392|NCT03513757|19933631|P2|NOT COMPLETED|Overall Study||0
8084393|NCT03513757|19933632|P1|NOT COMPLETED|Overall Study||0
8084394|NCT03513757|19933631|P2|COMPLETED|Overall Study||18
8084395|NCT03513757|19933632|P1|COMPLETED|Overall Study||22
8084396|NCT03513757|19933631|P2|STARTED|Overall Study||18
8084397|NCT03513757|19933632|P1|STARTED|Overall Study||22
8084398|NCT03513588|19933665|P3|NOT COMPLETED|Overall Study||2
8084399|NCT03513588|19933666|P2|NOT COMPLETED|Overall Study||2
8084400|NCT03513588|19933667|P1|NOT COMPLETED|Overall Study||1
8084401|NCT03513588|19933665|P3|COMPLETED|Overall Study||13
8084402|NCT03513588|19933666|P2|COMPLETED|Overall Study||15
8084403|NCT03513588|19933667|P1|COMPLETED|Overall Study||15
8084404|NCT03513588|19933665|P3|STARTED|Overall Study||15
8084405|NCT03513588|19933666|P2|STARTED|Overall Study||17
8084406|NCT03513588|19933667|P1|STARTED|Overall Study||16
8084413|NCT03512353|19933710|P1|NOT COMPLETED|Overall Study||4
8084414|NCT03512353|19933710|P1|COMPLETED|Overall Study||3
8084415|NCT03512353|19933710|P1|Received Treatment|Overall Study||6
8084416|NCT03512353|19933710|P1|STARTED|Overall Study||7
8084417|NCT03512067|19933736|P1|NOT COMPLETED|Overall Study||0
8084418|NCT03512067|19933736|P1|COMPLETED|Overall Study||1
8084419|NCT03512067|19933736|P1|STARTED|Overall Study||1
8084420|NCT03512041|19933745|P4|NOT COMPLETED|Overall Study||0
8084421|NCT03512041|19933746|P3|NOT COMPLETED|Overall Study||0
8084422|NCT03512041|19933747|P2|NOT COMPLETED|Overall Study||0
8084423|NCT03512041|19933748|P1|NOT COMPLETED|Overall Study||0
8084424|NCT03512041|19933745|P4|COMPLETED|Overall Study||9
8084425|NCT03512041|19933746|P3|COMPLETED|Overall Study||11
8084426|NCT03512041|19933747|P2|COMPLETED|Overall Study||10
8084427|NCT03512041|19933748|P1|COMPLETED|Overall Study||10
8084428|NCT03512041|19933745|P4|STARTED|Overall Study||9
8084429|NCT03512041|19933746|P3|STARTED|Overall Study||11
8084430|NCT03512041|19933747|P2|STARTED|Overall Study||10
8084431|NCT03512041|19933748|P1|STARTED|Overall Study||10
8084432|NCT03512028|19933768|P2|NOT COMPLETED|Overall Study||0
8084433|NCT03512028|19933769|P1|NOT COMPLETED|Overall Study||4
8084434|NCT03512028|19933768|P2|COMPLETED|Overall Study||15
8084435|NCT03512028|19933769|P1|COMPLETED|Overall Study||15
8084436|NCT03512028|19933768|P2|STARTED|Overall Study||15
8084437|NCT03512028|19933769|P1|STARTED|Overall Study||19
8084438|NCT03511521|19933777|P2|NOT COMPLETED|Overall Study||0
8084439|NCT03511521|19933778|P1|NOT COMPLETED|Overall Study||0
8084440|NCT03511521|19933777|P2|COMPLETED|Overall Study||1
8084441|NCT03511521|19933778|P1|COMPLETED|Overall Study||2
8084442|NCT03511521|19933777|P2|STARTED|Overall Study||1
8084443|NCT03511521|19933778|P1|STARTED|Overall Study||2
8084453|NCT03510910|19933852|P2|NOT COMPLETED|Overall Study||3
8084454|NCT03510910|19933853|P1|NOT COMPLETED|Overall Study||2
8084455|NCT03510910|19933852|P2|COMPLETED|Overall Study||40
8084456|NCT03510910|19933853|P1|COMPLETED|Overall Study||40
8084457|NCT03510910|19933852|P2|STARTED|Overall Study||43
8084458|NCT03510910|19933853|P1|STARTED|Overall Study||42
8084459|NCT03510715|19933869|P2|NOT COMPLETED|Overall Study||0
8084460|NCT03510715|19933870|P1|NOT COMPLETED|Overall Study||1
8084461|NCT03510715|19933869|P2|COMPLETED|Overall Study||9
8084462|NCT03510715|19933870|P1|COMPLETED|Overall Study||8
8084463|NCT03510715|19933869|P2|STARTED|Overall Study||9
8084464|NCT03510715|19933870|P1|STARTED|Overall Study||9
8084465|NCT03510273|19933888|P1|NOT COMPLETED|Overall Study||9
8084466|NCT03510273|19933888|P1|COMPLETED|Overall Study||310
8084467|NCT03510273|19933888|P1|Completed All One-year Follow up Visits|Overall Study||118
8084468|NCT03510273|19933888|P1|Completed 1-mth Follow-up Visit & Cont'd|Overall Study||126
8084469|NCT03510273|19933888|P1|Completed 1-mth Follow-up Visit & Exited|Overall Study||192
8084470|NCT03510273|19933888|P1|Treated With Thermal Coagulation|Overall Study||319
8084471|NCT03510273|19933888|P1|STARTED|Overall Study||319
8084472|NCT03510195|19933897|P1|NOT COMPLETED|Overall Study||166
8084473|NCT03510195|19933897|P1|COMPLETED|Overall Study||101
8084474|NCT03510195|19933897|P1|STARTED|Overall Study||267
8084475|NCT03509948|19933911|P2|NOT COMPLETED|Overall Study||1
8084476|NCT03509948|19933912|P1|NOT COMPLETED|Overall Study||0
8084477|NCT03509948|19933911|P2|COMPLETED|Overall Study||6
8084478|NCT03509948|19933912|P1|COMPLETED|Overall Study||6
8084479|NCT03509948|19933911|P2|STARTED|Overall Study||7
8084480|NCT03509948|19933912|P1|STARTED|Overall Study||6
8084481|NCT03509883|19933936|P2|NOT COMPLETED|Cross-over and Treatment||0
8084482|NCT03509883|19933937|P1|NOT COMPLETED|Cross-over and Treatment||0
8084483|NCT03509883|19933936|P2|COMPLETED|Cross-over and Treatment||15
8084484|NCT03509883|19933937|P1|COMPLETED|Cross-over and Treatment||15
8084485|NCT03509883|19933936|P2|STARTED|Cross-over and Treatment||15
8084486|NCT03509883|19933937|P1|STARTED|Cross-over and Treatment||15
8084487|NCT03509883|19933936|P2|NOT COMPLETED|Initial Treatment Washout||0
8084488|NCT03509883|19933937|P1|NOT COMPLETED|Initial Treatment Washout||0
8084489|NCT03509883|19933936|P2|COMPLETED|Initial Treatment Washout||15
8084490|NCT03509883|19933937|P1|COMPLETED|Initial Treatment Washout||15
8084491|NCT03509883|19933936|P2|STARTED|Initial Treatment Washout||15
8084492|NCT03509883|19933937|P1|STARTED|Initial Treatment Washout||15
8084493|NCT03509883|19933936|P2|NOT COMPLETED|Initial Treatment||0
8084494|NCT03509883|19933937|P1|NOT COMPLETED|Initial Treatment||0
8084495|NCT03509883|19933936|P2|COMPLETED|Initial Treatment||15
8084496|NCT03509883|19933937|P1|COMPLETED|Initial Treatment||15
8084497|NCT03509883|19933936|P2|STARTED|Initial Treatment||15
8084498|NCT03509883|19933937|P1|STARTED|Initial Treatment||15
8084499|NCT03509766|19933972|P1|NOT COMPLETED|Overall Study||0
8084500|NCT03509766|19933972|P1|COMPLETED|Overall Study||24
8084501|NCT03509766|19933972|P1|STARTED|Overall Study||24
8084502|NCT03509675|19933980|P2|NOT COMPLETED|Second Intervention )7 Days)||0
8084503|NCT03509675|19933981|P1|NOT COMPLETED|Second Intervention )7 Days)||2
8084504|NCT03509675|19933980|P2|COMPLETED|Second Intervention )7 Days)||8
8084505|NCT03509675|19933981|P1|COMPLETED|Second Intervention )7 Days)||4
8084506|NCT03509675|19933980|P2|STARTED|Second Intervention )7 Days)||8
8084507|NCT03509675|19933981|P1|STARTED|Second Intervention )7 Days)||6
8084508|NCT03509675|19933980|P2|NOT COMPLETED|Washout Period (7 Days)||0
8084509|NCT03509675|19933981|P1|NOT COMPLETED|Washout Period (7 Days)||0
8084510|NCT03509675|19933980|P2|COMPLETED|Washout Period (7 Days)||8
8084511|NCT03509675|19933981|P1|COMPLETED|Washout Period (7 Days)||6
8084512|NCT03509675|19933980|P2|STARTED|Washout Period (7 Days)||8
8084513|NCT03509675|19933981|P1|STARTED|Washout Period (7 Days)||6
8084514|NCT03509675|19933980|P2|NOT COMPLETED|First Intervention (7 Days)||4
8084515|NCT03509675|19933981|P1|NOT COMPLETED|First Intervention (7 Days)||5
8084516|NCT03509675|19933980|P2|COMPLETED|First Intervention (7 Days)||8
8084517|NCT03509675|19933981|P1|COMPLETED|First Intervention (7 Days)||6
8084518|NCT03509675|19933980|P2|STARTED|First Intervention (7 Days)||12
8084519|NCT03509675|19933981|P1|STARTED|First Intervention (7 Days)||11
8084526|NCT03509207|19933996|P1|NOT COMPLETED|Overall Study||2
8084527|NCT03509207|19933996|P1|COMPLETED|Overall Study||1
8084528|NCT03509207|19933996|P1|STARTED|Overall Study||3
8084529|NCT03508843|19934001|P1|NOT COMPLETED|Overall Study||3
8084530|NCT03508843|19934001|P1|COMPLETED|Overall Study||147
8084531|NCT03508843|19934001|P1|STARTED|Overall Study||150
8084532|NCT03508687|19934009|P2|NOT COMPLETED|Overall Study||0
8084533|NCT03508687|19934010|P1|NOT COMPLETED|Overall Study||0
8084534|NCT03508687|19934009|P2|COMPLETED|Overall Study||3
8084535|NCT03508687|19934010|P1|COMPLETED|Overall Study||2
8084536|NCT03508687|19934009|P2|STARTED|Overall Study||3
8084537|NCT03508687|19934010|P1|STARTED|Overall Study||2
8084538|NCT03508661|19934052|P1|NOT COMPLETED|Overall Study||0
8084539|NCT03508661|19934052|P1|COMPLETED|Overall Study||10
8084540|NCT03508661|19934052|P1|STARTED|Overall Study||10
8084541|NCT03508609|19934066|P1|NOT COMPLETED|Overall Study||1
8084542|NCT03508609|19934066|P1|COMPLETED|Overall Study||19
8084543|NCT03508609|19934066|P1|STARTED|Overall Study||20
8084544|NCT03508050|19934078|P2|NOT COMPLETED|Overall Study||2
8084545|NCT03508050|19934079|P1|NOT COMPLETED|Overall Study||5
8084546|NCT03508050|19934078|P2|COMPLETED|Overall Study||15
8084547|NCT03508050|19934079|P1|COMPLETED|Overall Study||15
8084548|NCT03508050|19934078|P2|STARTED|Overall Study||17
8084549|NCT03508050|19934079|P1|STARTED|Overall Study||20
8084550|NCT03507569|19934113|P4|NOT COMPLETED|Overall Study||0
8084551|NCT03507569|19934114|P3|NOT COMPLETED|Overall Study||0
8084552|NCT03507569|19934115|P2|NOT COMPLETED|Overall Study||0
8084553|NCT03507569|19934116|P1|NOT COMPLETED|Overall Study||0
8084554|NCT03507569|19934113|P4|COMPLETED|Overall Study||1
8084555|NCT03507569|19934114|P3|COMPLETED|Overall Study||2
8084556|NCT03507569|19934115|P2|COMPLETED|Overall Study||1
8084557|NCT03507569|19934116|P1|COMPLETED|Overall Study||2
8084558|NCT03507569|19934113|P4|STARTED|Overall Study||1
8084559|NCT03507569|19934114|P3|STARTED|Overall Study||2
8084560|NCT03507569|19934115|P2|STARTED|Overall Study||1
8084561|NCT03507569|19934116|P1|STARTED|Overall Study||2
8084562|NCT03507036|19934134|P1|NOT COMPLETED|Overall Study||5
8084563|NCT03507036|19934134|P1|COMPLETED|Overall Study||15
8084564|NCT03507036|19934134|P1|STARTED|Overall Study||20
8084565|NCT03506477|19934154|P2|NOT COMPLETED|Overall Study||0
8084566|NCT03506477|19934155|P1|NOT COMPLETED|Overall Study||1
8084567|NCT03506477|19934154|P2|COMPLETED|Overall Study||5
8084568|NCT03506477|19934155|P1|COMPLETED|Overall Study||19
8084569|NCT03506477|19934154|P2|STARTED|Overall Study||5
8084570|NCT03506477|19934155|P1|STARTED|Overall Study||20
8084571|NCT03506425|19934184|P3|NOT COMPLETED|Overall Study||1
8084572|NCT03506425|19934185|P2|NOT COMPLETED|Overall Study||3
8084573|NCT03506425|19934186|P1|NOT COMPLETED|Overall Study||2
8084574|NCT03506425|19934184|P3|COMPLETED|Overall Study||4
8084575|NCT03506425|19934185|P2|COMPLETED|Overall Study||2
8084576|NCT03506425|19934186|P1|COMPLETED|Overall Study||3
8084577|NCT03506425|19934184|P3|STARTED|Overall Study||5
8084578|NCT03506425|19934185|P2|STARTED|Overall Study||5
8084579|NCT03506425|19934186|P1|STARTED|Overall Study||5
8084580|NCT03506347|19934199|P2|NOT COMPLETED|Overall Study||0
8084581|NCT03506347|19934200|P1|NOT COMPLETED|Overall Study||0
8084582|NCT03506347|19934199|P2|COMPLETED|Overall Study||12
8084583|NCT03506347|19934200|P1|COMPLETED|Overall Study||12
8084584|NCT03506347|19934199|P2|STARTED|Overall Study||12
8084585|NCT03506347|19934200|P1|STARTED|Overall Study||12
8084586|NCT03506295|19934208|P1|NOT COMPLETED|Overall Study||0
8084587|NCT03506295|19934208|P1|COMPLETED|Overall Study||10
8084588|NCT03506295|19934208|P1|STARTED|Overall Study||10
8084589|NCT03505593|19934221|P1|NOT COMPLETED|Overall Study||5
8084590|NCT03505593|19934221|P1|COMPLETED|Overall Study||43
8084591|NCT03505593|19934221|P1|STARTED|Overall Study||48
8084592|NCT03505372|19934227|P1|NOT COMPLETED|Overall Study||0
8084593|NCT03505372|19934227|P1|COMPLETED|Overall Study||5
8084594|NCT03505372|19934227|P1|STARTED|Overall Study||5
8084595|NCT03505190|19934237|P5|NOT COMPLETED|Overall Study||0
8084596|NCT03505190|19934238|P4|NOT COMPLETED|Overall Study||0
8084597|NCT03505190|19934239|P3|NOT COMPLETED|Overall Study||0
8084598|NCT03505190|19934240|P2|NOT COMPLETED|Overall Study||0
8084599|NCT03505190|19934241|P1|NOT COMPLETED|Overall Study||0
8084600|NCT03505190|19934237|P5|COMPLETED|Overall Study||8
8084601|NCT03505190|19934238|P4|COMPLETED|Overall Study||8
8084602|NCT03505190|19934239|P3|COMPLETED|Overall Study||8
8084603|NCT03505190|19934240|P2|COMPLETED|Overall Study||8
8084604|NCT03505190|19934241|P1|COMPLETED|Overall Study||9
8084605|NCT03505190|19934237|P5|STARTED|Overall Study||8
8084606|NCT03505190|19934238|P4|STARTED|Overall Study||8
8084607|NCT03505190|19934239|P3|STARTED|Overall Study||8
8084608|NCT03505190|19934240|P2|STARTED|Overall Study||8
8084609|NCT03505190|19934241|P1|STARTED|Overall Study||9
8084610|NCT03504189|19934318|P1|NOT COMPLETED|Overall Study||4
8084611|NCT03504189|19934318|P1|COMPLETED|Overall Study||147
8084612|NCT03504189|19934318|P1|STARTED|Overall Study||151
8084613|NCT03503578|19934327|P1|NOT COMPLETED|Overall Study||0
8084614|NCT03503578|19934327|P1|COMPLETED|Overall Study||12
8084615|NCT03503578|19934327|P1|STARTED|Overall Study||12
8084616|NCT03503292|19934333|P2|NOT COMPLETED|Overall Study||0
8084617|NCT03503292|19934334|P1|NOT COMPLETED|Overall Study||0
8084618|NCT03503292|19934333|P2|COMPLETED|Overall Study||90
8084619|NCT03503292|19934334|P1|COMPLETED|Overall Study||2
8084620|NCT03503292|19934333|P2|STARTED|Overall Study||90
8084621|NCT03503292|19934334|P1|STARTED|Overall Study||2
8084622|NCT03503188|19934344|P2|NOT COMPLETED|Overall Study||1
8084623|NCT03503188|19934345|P1|NOT COMPLETED|Overall Study||0
8084624|NCT03503188|19934344|P2|COMPLETED|Overall Study||145
8084625|NCT03503188|19934345|P1|COMPLETED|Overall Study||128
8084626|NCT03503188|19934344|P2|Sub-study|Overall Study||44
8084627|NCT03503188|19934345|P1|Sub-study|Overall Study||29
8084628|NCT03503188|19934344|P2|Main Study|Overall Study||101
8084629|NCT03503188|19934345|P1|Main Study|Overall Study||99
8084630|NCT03503188|19934344|P2|Entered in the Entire Study|Overall Study||145
8084631|NCT03503188|19934345|P1|Entered in the Entire Study|Overall Study||128
8084632|NCT03503188|19934344|P2|STARTED|Overall Study||146
8084633|NCT03503188|19934345|P1|STARTED|Overall Study||128
8084634|NCT03502915|19934363|P2|NOT COMPLETED|Overall Study||0
8084635|NCT03502915|19934364|P1|NOT COMPLETED|Overall Study||0
8084636|NCT03502915|19934363|P2|COMPLETED|Overall Study||24
8084637|NCT03502915|19934364|P1|COMPLETED|Overall Study||24
8084638|NCT03502915|19934363|P2|STARTED|Overall Study||24
8084639|NCT03502915|19934364|P1|STARTED|Overall Study||24
8084640|NCT03502681|19934380|P2|NOT COMPLETED|Overall Study||2
8084641|NCT03502681|19934381|P1|NOT COMPLETED|Overall Study||3
8084642|NCT03502681|19934380|P2|COMPLETED|Overall Study||1
8084643|NCT03502681|19934381|P1|COMPLETED|Overall Study||0
8084644|NCT03502681|19934380|P2|STARTED|Overall Study||3
8084645|NCT03502681|19934381|P1|STARTED|Overall Study||3
8084646|NCT03502616|19934402|P2|NOT COMPLETED|Week 16 to Week 48||3
8084647|NCT03502616|19934403|P1|NOT COMPLETED|Week 16 to Week 48||6
8084648|NCT03502616|19934402|P2|COMPLETED|Week 16 to Week 48||130
8084649|NCT03502616|19934403|P1|COMPLETED|Week 16 to Week 48||126
8084650|NCT03502616|19934402|P2|Treated|Week 16 to Week 48||133
8084651|NCT03502616|19934403|P1|Treated|Week 16 to Week 48||132
8084652|NCT03502616|19934402|P2|STARTED|Week 16 to Week 48||133
8084653|NCT03502616|19934403|P1|STARTED|Week 16 to Week 48||132
8084654|NCT03502616|19934402|P2|NOT COMPLETED|Up to Week 16||3
8084655|NCT03502616|19934403|P1|NOT COMPLETED|Up to Week 16||2
8084656|NCT03502616|19934402|P2|COMPLETED|Up to Week 16||133
8084657|NCT03502616|19934403|P1|COMPLETED|Up to Week 16||132
8084658|NCT03502616|19934402|P2|Treated|Up to Week 16||136
8084659|NCT03502616|19934403|P1|Treated|Up to Week 16||133
8084660|NCT03502616|19934402|P2|STARTED|Up to Week 16||136
8084661|NCT03502616|19934403|P1|STARTED|Up to Week 16||134
8084662|NCT03502070|19934497|P1|NOT COMPLETED|Overall Study||2
8084663|NCT03502070|19934497|P1|COMPLETED|Overall Study||45
8084664|NCT03502070|19934497|P1|STARTED|Overall Study||47
8084665|NCT03501693|19934501|P2|NOT COMPLETED|Second Reading Session||0
8084666|NCT03501693|19934502|P1|NOT COMPLETED|Second Reading Session||0
8084667|NCT03501693|19934501|P2|COMPLETED|Second Reading Session||75
8084668|NCT03501693|19934502|P1|COMPLETED|Second Reading Session||75
8084669|NCT03501693|19934501|P2|STARTED|Second Reading Session||75
8084670|NCT03501693|19934502|P1|STARTED|Second Reading Session||75
8084671|NCT03501693|19934501|P2|NOT COMPLETED|4 Week Memory Washout Period||0
8084672|NCT03501693|19934502|P1|NOT COMPLETED|4 Week Memory Washout Period||0
8084673|NCT03501693|19934501|P2|COMPLETED|4 Week Memory Washout Period||75
8084674|NCT03501693|19934502|P1|COMPLETED|4 Week Memory Washout Period||75
8084675|NCT03501693|19934501|P2|STARTED|4 Week Memory Washout Period||75
8084676|NCT03501693|19934502|P1|STARTED|4 Week Memory Washout Period||75
8084677|NCT03501693|19934501|P2|NOT COMPLETED|First Reading Session||0
8084678|NCT03501693|19934502|P1|NOT COMPLETED|First Reading Session||0
8084679|NCT03501693|19934501|P2|COMPLETED|First Reading Session||75
8084680|NCT03501693|19934502|P1|COMPLETED|First Reading Session||75
8084681|NCT03501693|19934501|P2|STARTED|First Reading Session||75
8084682|NCT03501693|19934502|P1|STARTED|First Reading Session||75
8084683|NCT03501277|19934518|P4|NOT COMPLETED|Intervention Period 4 (4 Days)||0
8084684|NCT03501277|19934519|P3|NOT COMPLETED|Intervention Period 4 (4 Days)||0
8084685|NCT03501277|19934520|P2|NOT COMPLETED|Intervention Period 4 (4 Days)||0
8084686|NCT03501277|19934521|P1|NOT COMPLETED|Intervention Period 4 (4 Days)||0
8084687|NCT03501277|19934518|P4|COMPLETED|Intervention Period 4 (4 Days)||15
8084688|NCT03501277|19934519|P3|COMPLETED|Intervention Period 4 (4 Days)||17
8084689|NCT03501277|19934520|P2|COMPLETED|Intervention Period 4 (4 Days)||18
8084690|NCT03501277|19934521|P1|COMPLETED|Intervention Period 4 (4 Days)||18
8084691|NCT03501277|19934518|P4|STARTED|Intervention Period 4 (4 Days)||15
8084692|NCT03501277|19934519|P3|STARTED|Intervention Period 4 (4 Days)||17
8084693|NCT03501277|19934520|P2|STARTED|Intervention Period 4 (4 Days)||18
8084694|NCT03501277|19934521|P1|STARTED|Intervention Period 4 (4 Days)||18
8084695|NCT03501277|19934518|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8084696|NCT03501277|19934519|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8084697|NCT03501277|19934520|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8084698|NCT03501277|19934521|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8084699|NCT03501277|19934518|P4|COMPLETED|Washout Period 3 (7 Days)||15
8084700|NCT03501277|19934519|P3|COMPLETED|Washout Period 3 (7 Days)||17
8084701|NCT03501277|19934520|P2|COMPLETED|Washout Period 3 (7 Days)||18
8084702|NCT03501277|19934521|P1|COMPLETED|Washout Period 3 (7 Days)||18
8084703|NCT03501277|19934518|P4|STARTED|Washout Period 3 (7 Days)||15
8084704|NCT03501277|19934519|P3|STARTED|Washout Period 3 (7 Days)||17
8084705|NCT03501277|19934520|P2|STARTED|Washout Period 3 (7 Days)||18
8084706|NCT03501277|19934521|P1|STARTED|Washout Period 3 (7 Days)||18
8084707|NCT03501277|19934518|P4|NOT COMPLETED|Intervention Period 3 (4 Days)||1
8084708|NCT03501277|19934519|P3|NOT COMPLETED|Intervention Period 3 (4 Days)||0
8084709|NCT03501277|19934520|P2|NOT COMPLETED|Intervention Period 3 (4 Days)||0
8084710|NCT03501277|19934521|P1|NOT COMPLETED|Intervention Period 3 (4 Days)||0
8084711|NCT03501277|19934518|P4|COMPLETED|Intervention Period 3 (4 Days)||15
8084712|NCT03501277|19934519|P3|COMPLETED|Intervention Period 3 (4 Days)||17
8084713|NCT03501277|19934520|P2|COMPLETED|Intervention Period 3 (4 Days)||18
8084714|NCT03501277|19934521|P1|COMPLETED|Intervention Period 3 (4 Days)||18
8084715|NCT03501277|19934518|P4|STARTED|Intervention Period 3 (4 Days)||16
8084716|NCT03501277|19934519|P3|STARTED|Intervention Period 3 (4 Days)||17
8084717|NCT03501277|19934520|P2|STARTED|Intervention Period 3 (4 Days)||18
8084718|NCT03501277|19934521|P1|STARTED|Intervention Period 3 (4 Days)||18
8084719|NCT03501277|19934518|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8084720|NCT03501277|19934519|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8084721|NCT03501277|19934520|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8084722|NCT03501277|19934521|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8084723|NCT03501277|19934518|P4|COMPLETED|Washout Period 2 (7 Days)||16
8084724|NCT03501277|19934519|P3|COMPLETED|Washout Period 2 (7 Days)||17
8084725|NCT03501277|19934520|P2|COMPLETED|Washout Period 2 (7 Days)||18
8084726|NCT03501277|19934521|P1|COMPLETED|Washout Period 2 (7 Days)||18
8084727|NCT03501277|19934518|P4|STARTED|Washout Period 2 (7 Days)||16
8084728|NCT03501277|19934519|P3|STARTED|Washout Period 2 (7 Days)||17
8084729|NCT03501277|19934520|P2|STARTED|Washout Period 2 (7 Days)||18
8084730|NCT03501277|19934521|P1|STARTED|Washout Period 2 (7 Days)||18
8084731|NCT03501277|19934518|P4|NOT COMPLETED|Intervention Period 2 (4 Days)||1
8084732|NCT03501277|19934519|P3|NOT COMPLETED|Intervention Period 2 (4 Days)||0
8084733|NCT03501277|19934520|P2|NOT COMPLETED|Intervention Period 2 (4 Days)||0
8084734|NCT03501277|19934521|P1|NOT COMPLETED|Intervention Period 2 (4 Days)||0
8084735|NCT03501277|19934518|P4|COMPLETED|Intervention Period 2 (4 Days)||16
8084736|NCT03501277|19934519|P3|COMPLETED|Intervention Period 2 (4 Days)||17
8084737|NCT03501277|19934520|P2|COMPLETED|Intervention Period 2 (4 Days)||18
8084738|NCT03501277|19934521|P1|COMPLETED|Intervention Period 2 (4 Days)||18
8084739|NCT03501277|19934518|P4|STARTED|Intervention Period 2 (4 Days)||17
8084740|NCT03501277|19934519|P3|STARTED|Intervention Period 2 (4 Days)||17
8084741|NCT03501277|19934520|P2|STARTED|Intervention Period 2 (4 Days)||18
8084742|NCT03501277|19934521|P1|STARTED|Intervention Period 2 (4 Days)||18
8084743|NCT03501277|19934518|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8084744|NCT03501277|19934519|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8084745|NCT03501277|19934520|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8084746|NCT03501277|19934521|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8084747|NCT03501277|19934518|P4|COMPLETED|Washout Period 1 (7 Days)||17
8084748|NCT03501277|19934519|P3|COMPLETED|Washout Period 1 (7 Days)||17
8084749|NCT03501277|19934520|P2|COMPLETED|Washout Period 1 (7 Days)||18
8084750|NCT03501277|19934521|P1|COMPLETED|Washout Period 1 (7 Days)||18
8084751|NCT03501277|19934518|P4|STARTED|Washout Period 1 (7 Days)||17
8084752|NCT03501277|19934519|P3|STARTED|Washout Period 1 (7 Days)||17
8084753|NCT03501277|19934520|P2|STARTED|Washout Period 1 (7 Days)||18
8084754|NCT03501277|19934521|P1|STARTED|Washout Period 1 (7 Days)||18
8084755|NCT03501277|19934518|P4|NOT COMPLETED|Intervention Period 1 (4 Days)||1
8084756|NCT03501277|19934519|P3|NOT COMPLETED|Intervention Period 1 (4 Days)||1
8084757|NCT03501277|19934520|P2|NOT COMPLETED|Intervention Period 1 (4 Days)||0
8084758|NCT03501277|19934521|P1|NOT COMPLETED|Intervention Period 1 (4 Days)||0
8084759|NCT03501277|19934518|P4|COMPLETED|Intervention Period 1 (4 Days)||17
8084760|NCT03501277|19934519|P3|COMPLETED|Intervention Period 1 (4 Days)||17
8084761|NCT03501277|19934520|P2|COMPLETED|Intervention Period 1 (4 Days)||18
8084762|NCT03501277|19934521|P1|COMPLETED|Intervention Period 1 (4 Days)||18
8084763|NCT03501277|19934518|P4|Safety Analysis Set|Intervention Period 1 (4 Days)||17
8084764|NCT03501277|19934519|P3|Safety Analysis Set|Intervention Period 1 (4 Days)||17
8084765|NCT03501277|19934520|P2|Safety Analysis Set|Intervention Period 1 (4 Days)||18
8084766|NCT03501277|19934521|P1|Safety Analysis Set|Intervention Period 1 (4 Days)||18
8084767|NCT03501277|19934518|P4|STARTED|Intervention Period 1 (4 Days)||18
8084768|NCT03501277|19934519|P3|STARTED|Intervention Period 1 (4 Days)||18
8084769|NCT03501277|19934520|P2|STARTED|Intervention Period 1 (4 Days)||18
8084770|NCT03501277|19934521|P1|STARTED|Intervention Period 1 (4 Days)||18
8084771|NCT03501264|19934537|P2|NOT COMPLETED|Overall Study||0
8084772|NCT03501264|19934538|P1|NOT COMPLETED|Overall Study||0
8084773|NCT03501264|19934537|P2|COMPLETED|Overall Study||120
8084774|NCT03501264|19934538|P1|COMPLETED|Overall Study||120
8084775|NCT03501264|19934537|P2|STARTED|Overall Study||120
8084776|NCT03501264|19934538|P1|STARTED|Overall Study||120
8084777|NCT03501069|19934553|P9|NOT COMPLETED|Period B||0
8084778|NCT03501069|19934554|P8|NOT COMPLETED|Period B||0
8084779|NCT03501069|19934555|P7|NOT COMPLETED|Period B||0
8084780|NCT03501069|19934556|P6|NOT COMPLETED|Period B||0
8084781|NCT03501069|19934557|P5|NOT COMPLETED|Period B||0
8084782|NCT03501069|19934558|P4|NOT COMPLETED|Period B||0
8084783|NCT03501069|19934559|P3|NOT COMPLETED|Period B||0
8084784|NCT03501069|19934560|P2|NOT COMPLETED|Period B||0
8084785|NCT03501069|19934561|P1|NOT COMPLETED|Period B||0
8084786|NCT03501069|19934553|P9|COMPLETED|Period B||0
8084787|NCT03501069|19934554|P8|COMPLETED|Period B||0
8084788|NCT03501069|19934555|P7|COMPLETED|Period B||0
8084789|NCT03501069|19934556|P6|COMPLETED|Period B||0
8084790|NCT03501069|19934557|P5|COMPLETED|Period B||0
8084791|NCT03501069|19934558|P4|COMPLETED|Period B||0
8084792|NCT03501069|19934559|P3|COMPLETED|Period B||2
8084793|NCT03501069|19934560|P2|COMPLETED|Period B||4
8084794|NCT03501069|19934561|P1|COMPLETED|Period B||2
8084795|NCT03501069|19934553|P9|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084796|NCT03501069|19934554|P8|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084797|NCT03501069|19934555|P7|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084798|NCT03501069|19934556|P6|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084799|NCT03501069|19934557|P5|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084800|NCT03501069|19934558|P4|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084801|NCT03501069|19934559|P3|STARTED|Period B||2
8084802|NCT03501069|19934560|P2|STARTED|Period B||4
8084803|NCT03501069|19934561|P1|STARTED|Period B||2
8084804|NCT03501069|19934553|P9|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084805|NCT03501069|19934554|P8|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084806|NCT03501069|19934555|P7|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084807|NCT03501069|19934556|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084808|NCT03501069|19934557|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084809|NCT03501069|19934558|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084810|NCT03501069|19934559|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084811|NCT03501069|19934560|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084812|NCT03501069|19934561|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8084813|NCT03501069|19934553|P9|COMPLETED|Washout Period (at Least 14 Days)||0
8084814|NCT03501069|19934554|P8|COMPLETED|Washout Period (at Least 14 Days)||0
8084815|NCT03501069|19934555|P7|COMPLETED|Washout Period (at Least 14 Days)||0
8084816|NCT03501069|19934556|P6|COMPLETED|Washout Period (at Least 14 Days)||0
8084817|NCT03501069|19934557|P5|COMPLETED|Washout Period (at Least 14 Days)||0
8084818|NCT03501069|19934558|P4|COMPLETED|Washout Period (at Least 14 Days)||0
8084819|NCT03501069|19934559|P3|COMPLETED|Washout Period (at Least 14 Days)||2
8084820|NCT03501069|19934560|P2|COMPLETED|Washout Period (at Least 14 Days)||4
8084821|NCT03501069|19934561|P1|COMPLETED|Washout Period (at Least 14 Days)||2
8084822|NCT03501069|19934553|P9|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084823|NCT03501069|19934554|P8|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084824|NCT03501069|19934555|P7|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084825|NCT03501069|19934556|P6|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084826|NCT03501069|19934557|P5|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084827|NCT03501069|19934558|P4|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
8084828|NCT03501069|19934559|P3|STARTED|Washout Period (at Least 14 Days)||2
8084829|NCT03501069|19934560|P2|STARTED|Washout Period (at Least 14 Days)||4
8084830|NCT03501069|19934561|P1|STARTED|Washout Period (at Least 14 Days)||2
8084831|NCT03501069|19934553|P9|NOT COMPLETED|Period A||0
8084832|NCT03501069|19934554|P8|NOT COMPLETED|Period A||0
8084833|NCT03501069|19934555|P7|NOT COMPLETED|Period A||0
8084834|NCT03501069|19934556|P6|NOT COMPLETED|Period A||0
8084835|NCT03501069|19934557|P5|NOT COMPLETED|Period A||0
8084836|NCT03501069|19934558|P4|NOT COMPLETED|Period A||0
8084837|NCT03501069|19934559|P3|NOT COMPLETED|Period A||0
8084838|NCT03501069|19934560|P2|NOT COMPLETED|Period A||0
8084839|NCT03501069|19934561|P1|NOT COMPLETED|Period A||0
8084840|NCT03501069|19934553|P9|COMPLETED|Period A||3
8084841|NCT03501069|19934554|P8|COMPLETED|Period A||3
8084842|NCT03501069|19934555|P7|COMPLETED|Period A||6
8084843|NCT03501069|19934556|P6|COMPLETED|Period A||6
8084844|NCT03501069|19934557|P5|COMPLETED|Period A||1
8084845|NCT03501069|19934558|P4|COMPLETED|Period A||5
8084846|NCT03501069|19934559|P3|COMPLETED|Period A||2
8084847|NCT03501069|19934560|P2|COMPLETED|Period A||4
8084848|NCT03501069|19934561|P1|COMPLETED|Period A||2
8084849|NCT03501069|19934553|P9|STARTED|Period A||3
8084850|NCT03501069|19934554|P8|STARTED|Period A||3
8084851|NCT03501069|19934555|P7|STARTED|Period A||6
8084852|NCT03501069|19934556|P6|STARTED|Period A||6
8084853|NCT03501069|19934557|P5|STARTED|Period A||1
8084854|NCT03501069|19934558|P4|STARTED|Period A||5
8084855|NCT03501069|19934559|P3|STARTED|Period A||2
8084856|NCT03501069|19934560|P2|STARTED|Period A||4
8084857|NCT03501069|19934561|P1|STARTED|Period A||2
8084858|NCT03501043|19934631|P1|NOT COMPLETED|Overall Study||1
8084859|NCT03501043|19934631|P1|COMPLETED|Overall Study||10
8084860|NCT03501043|19934631|P1|STARTED|Overall Study||11
8084861|NCT03500679|19934648|P2|NOT COMPLETED|Overall Study||3
8084862|NCT03500679|19934649|P1|NOT COMPLETED|Overall Study||9
8084863|NCT03500679|19934648|P2|COMPLETED|Overall Study||22
8084864|NCT03500679|19934649|P1|COMPLETED|Overall Study||66
8084865|NCT03500679|19934648|P2|STARTED|Overall Study||25
8084866|NCT03500679|19934649|P1|STARTED|Overall Study||75
8084867|NCT03500406|19934697|P2|NOT COMPLETED|Overall Study||0
8084868|NCT03500406|19934698|P1|NOT COMPLETED|Overall Study||0
8084869|NCT03500406|19934697|P2|COMPLETED|Overall Study||20
8084870|NCT03500406|19934698|P1|COMPLETED|Overall Study||4
8084871|NCT03500406|19934697|P2|STARTED|Overall Study||20
8084872|NCT03500406|19934698|P1|STARTED|Overall Study||4
8084873|NCT03500302|19934716|P1|NOT COMPLETED|Overall Study||0
8084874|NCT03500302|19934716|P1|COMPLETED|Overall Study||19
8084875|NCT03500302|19934716|P1|STARTED|Overall Study||19
8084876|NCT03500289|19934723|P2|NOT COMPLETED|Overall Study||0
8084877|NCT03500289|19934724|P1|NOT COMPLETED|Overall Study||0
8084878|NCT03500289|19934723|P2|COMPLETED|Overall Study||6
8084879|NCT03500289|19934724|P1|COMPLETED|Overall Study||12
8084880|NCT03500289|19934723|P2|STARTED|Overall Study||6
8084881|NCT03500289|19934724|P1|STARTED|Overall Study||12
8084882|NCT03500224|19934740|P1|NOT COMPLETED|Overall Study||2
8084883|NCT03500224|19934740|P1|COMPLETED|Overall Study||4
8084884|NCT03500224|19934740|P1|STARTED|Overall Study||6
8084885|NCT03500211|19934779|P2|NOT COMPLETED|Overall Study||1
8084886|NCT03500211|19934780|P1|NOT COMPLETED|Overall Study||1
8084887|NCT03500211|19934779|P2|COMPLETED|Overall Study||24
8084888|NCT03500211|19934780|P1|COMPLETED|Overall Study||24
8084889|NCT03500211|19934779|P2|STARTED|Overall Study||25
8084890|NCT03500211|19934780|P1|STARTED|Overall Study||25
8084891|NCT03500198|19934796|P2|NOT COMPLETED|Overall Study||1
8084892|NCT03500198|19934797|P1|NOT COMPLETED|Overall Study||0
8084893|NCT03500198|19934796|P2|COMPLETED|Overall Study||107
8084894|NCT03500198|19934797|P1|COMPLETED|Overall Study||110
8084895|NCT03500198|19934796|P2|Second Eye|Overall Study||108
8084896|NCT03500198|19934797|P1|Second Eye|Overall Study||109
8084897|NCT03500198|19934796|P2|First Eye|Overall Study||108
8084898|NCT03500198|19934797|P1|First Eye|Overall Study||110
8084899|NCT03500198|19934796|P2|STARTED|Overall Study||108
8084900|NCT03500198|19934797|P1|STARTED|Overall Study||110
8084901|NCT03500159|19934813|P2|NOT COMPLETED|Overall Study||1
8084902|NCT03500159|19934814|P1|NOT COMPLETED|Overall Study||2
8084903|NCT03500159|19934813|P2|COMPLETED|Overall Study||0
8084904|NCT03500159|19934814|P1|COMPLETED|Overall Study||0
8084905|NCT03500159|19934813|P2|STARTED|Overall Study||1
8084906|NCT03500159|19934814|P1|STARTED|Overall Study||2
8084907|NCT03499067|19934820|P2|NOT COMPLETED|Second Intervention||0
8084908|NCT03499067|19934821|P1|NOT COMPLETED|Second Intervention||0
8084909|NCT03499067|19934820|P2|COMPLETED|Second Intervention||24
8084910|NCT03499067|19934821|P1|COMPLETED|Second Intervention||22
8084911|NCT03499067|19934820|P2|STARTED|Second Intervention||24
8084912|NCT03499067|19934821|P1|STARTED|Second Intervention||22
8084913|NCT03499067|19934820|P2|NOT COMPLETED|First Intervention||7
8084914|NCT03499067|19934821|P1|NOT COMPLETED|First Intervention||5
8084915|NCT03499067|19934820|P2|COMPLETED|First Intervention||24
8084916|NCT03499067|19934821|P1|COMPLETED|First Intervention||22
8084917|NCT03499067|19934820|P2|STARTED|First Intervention||31
8084918|NCT03499067|19934821|P1|STARTED|First Intervention||27
8084919|NCT03498560|19934861|P1|NOT COMPLETED|Overall Study||21
8084920|NCT03498560|19934861|P1|COMPLETED|Overall Study||17
8084921|NCT03498560|19934861|P1|Completed PSG|Overall Study||25
8084922|NCT03498560|19934861|P1|Completed Baseline Assessment|Overall Study||32
8084923|NCT03498560|19934861|P1|STARTED|Overall Study||38
8084924|NCT03498300|19934868|P2|NOT COMPLETED|Overall Study||8
8084925|NCT03498300|19934869|P1|NOT COMPLETED|Overall Study||3
8084926|NCT03498300|19934868|P2|COMPLETED|Overall Study||13
8084927|NCT03498300|19934869|P1|COMPLETED|Overall Study||18
8084928|NCT03498300|19934868|P2|STARTED|Overall Study||21
8084929|NCT03498300|19934869|P1|STARTED|Overall Study||21
8084930|NCT03498287|19934878|P2|NOT COMPLETED|Overall Study||5
8084931|NCT03498287|19934879|P1|NOT COMPLETED|Overall Study||3
8084932|NCT03498287|19934878|P2|COMPLETED|Overall Study||38
8084933|NCT03498287|19934879|P1|COMPLETED|Overall Study||42
8084934|NCT03498287|19934878|P2|STARTED|Overall Study||43
8084935|NCT03498287|19934879|P1|STARTED|Overall Study||45
8084936|NCT03498196|19934887|P1|NOT COMPLETED|Overall Study||0
8084937|NCT03498196|19934887|P1|COMPLETED|Overall Study||1
8084938|NCT03498196|19934887|P1|STARTED|Overall Study||1
8084939|NCT03497845|19934906|P12|NOT COMPLETED|Overall Study||22
8084940|NCT03497845|19934907|P11|NOT COMPLETED|Overall Study||15
8084941|NCT03497845|19934908|P10|NOT COMPLETED|Overall Study||6
8084942|NCT03497845|19934909|P9|NOT COMPLETED|Overall Study||14
8084943|NCT03497845|19934910|P8|NOT COMPLETED|Overall Study||10
8084944|NCT03497845|19934911|P7|NOT COMPLETED|Overall Study||8
8084945|NCT03497845|19934912|P6|NOT COMPLETED|Overall Study||18
8084946|NCT03497845|19934913|P5|NOT COMPLETED|Overall Study||21
8084947|NCT03497845|19934914|P4|NOT COMPLETED|Overall Study||10
8084948|NCT03497845|19934915|P3|NOT COMPLETED|Overall Study||11
8084949|NCT03497845|19934916|P2|NOT COMPLETED|Overall Study||13
8084950|NCT03497845|19934917|P1|NOT COMPLETED|Overall Study||5
8084951|NCT03497845|19934906|P12|COMPLETED|Overall Study|Day 262|38
8084952|NCT03497845|19934907|P11|COMPLETED|Overall Study|Day 262|46
8084953|NCT03497845|19934908|P10|COMPLETED|Overall Study|Day 142|53
8084954|NCT03497845|19934909|P9|COMPLETED|Overall Study|Day 142|47
8084955|NCT03497845|19934910|P8|COMPLETED|Overall Study|Day 142|50
8084956|NCT03497845|19934911|P7|COMPLETED|Overall Study|Day 142|51
8084957|NCT03497845|19934912|P6|COMPLETED|Overall Study|Day 262|44
8084958|NCT03497845|19934913|P5|COMPLETED|Overall Study|Day 262|38
8084959|NCT03497845|19934914|P4|COMPLETED|Overall Study|Day 142|50
8084960|NCT03497845|19934915|P3|COMPLETED|Overall Study|Day 142|50
8084961|NCT03497845|19934916|P2|COMPLETED|Overall Study|Day 142|45
8084962|NCT03497845|19934917|P1|COMPLETED|Overall Study|Day 142|55
8084963|NCT03497845|19934906|P12|STARTED|Overall Study||60
8084964|NCT03497845|19934907|P11|STARTED|Overall Study||61
8084965|NCT03497845|19934908|P10|STARTED|Overall Study||59
8084966|NCT03497845|19934909|P9|STARTED|Overall Study||61
8084967|NCT03497845|19934910|P8|STARTED|Overall Study||60
8084968|NCT03497845|19934911|P7|STARTED|Overall Study||59
8084969|NCT03497845|19934912|P6|STARTED|Overall Study||62
8084970|NCT03497845|19934913|P5|STARTED|Overall Study||59
8084971|NCT03497845|19934914|P4|STARTED|Overall Study||60
8084972|NCT03497845|19934915|P3|STARTED|Overall Study||61
8084973|NCT03497845|19934916|P2|STARTED|Overall Study||58
8084974|NCT03497845|19934917|P1|STARTED|Overall Study||60
8084975|NCT03497585|19934971|P1|NOT COMPLETED|Overall Study||55
8084976|NCT03497585|19934971|P1|COMPLETED|Overall Study||57
8084977|NCT03497585|19934971|P1|STARTED|Overall Study|112 participants were recruited: 107 patients, plus 5 HCPs for the acceptability interviews.|112
8084978|NCT03497130|19935004|P2|NOT COMPLETED|Overall Study||1
8084979|NCT03497130|19935005|P1|NOT COMPLETED|Overall Study||1
8084980|NCT03497130|19935004|P2|COMPLETED|Overall Study||13
8084981|NCT03497130|19935005|P1|COMPLETED|Overall Study||39
8084982|NCT03497130|19935004|P2|STARTED|Overall Study||14
8084983|NCT03497130|19935005|P1|STARTED|Overall Study||40
8084984|NCT03497039|19935017|P2|NOT COMPLETED|Overall Study||1
8084985|NCT03497039|19935018|P1|NOT COMPLETED|Overall Study||1
8084986|NCT03497039|19935017|P2|COMPLETED|Overall Study||16
8084987|NCT03497039|19935018|P1|COMPLETED|Overall Study||29
8084988|NCT03497039|19935017|P2|Treated|Overall Study||17
8084989|NCT03497039|19935018|P1|Treated|Overall Study||29
8084990|NCT03497039|19935017|P2|STARTED|Overall Study||17
8084991|NCT03497039|19935018|P1|STARTED|Overall Study||30
8084992|NCT03496987|19935032|P2|NOT COMPLETED|Overall Study||0
8084993|NCT03496987|19935033|P1|NOT COMPLETED|Overall Study||0
8084994|NCT03496987|19935032|P2|COMPLETED|Overall Study||51
8084995|NCT03496987|19935033|P1|COMPLETED|Overall Study||49
8084996|NCT03496987|19935032|P2|STARTED|Overall Study||51
8084997|NCT03496987|19935033|P1|STARTED|Overall Study||49
8085004|NCT03496428|19935088|P1|NOT COMPLETED|Overall Study||0
8085005|NCT03496428|19935088|P1|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
8085006|NCT03496428|19935088|P1|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
8085007|NCT03496324|19935093|P4|NOT COMPLETED|Period 7: Period 4||0
8085008|NCT03496324|19935094|P3|NOT COMPLETED|Period 7: Period 4||0
8085009|NCT03496324|19935095|P2|NOT COMPLETED|Period 7: Period 4||0
8085010|NCT03496324|19935096|P1|NOT COMPLETED|Period 7: Period 4||0
8085011|NCT03496324|19935093|P4|COMPLETED|Period 7: Period 4||6
8085012|NCT03496324|19935094|P3|COMPLETED|Period 7: Period 4||6
8085013|NCT03496324|19935095|P2|COMPLETED|Period 7: Period 4||6
8085014|NCT03496324|19935096|P1|COMPLETED|Period 7: Period 4||6
8085015|NCT03496324|19935093|P4|STARTED|Period 7: Period 4||6
8085016|NCT03496324|19935094|P3|STARTED|Period 7: Period 4||6
8085017|NCT03496324|19935095|P2|STARTED|Period 7: Period 4||6
8085018|NCT03496324|19935096|P1|STARTED|Period 7: Period 4||6
8085019|NCT03496324|19935093|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8085020|NCT03496324|19935094|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8085021|NCT03496324|19935095|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8085022|NCT03496324|19935096|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8085023|NCT03496324|19935093|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||6
8085024|NCT03496324|19935094|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
8085025|NCT03496324|19935095|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||6
8085026|NCT03496324|19935096|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
8085027|NCT03496324|19935093|P4|STARTED|Period 3: Washout (3 to 7 Days)||6
8085028|NCT03496324|19935094|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
8085029|NCT03496324|19935095|P2|STARTED|Period 3: Washout (3 to 7 Days)||6
8085030|NCT03496324|19935096|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
8085031|NCT03496324|19935093|P4|NOT COMPLETED|Period 3||0
8085032|NCT03496324|19935094|P3|NOT COMPLETED|Period 3||0
8085033|NCT03496324|19935095|P2|NOT COMPLETED|Period 3||0
8085034|NCT03496324|19935096|P1|NOT COMPLETED|Period 3||0
8085035|NCT03496324|19935093|P4|COMPLETED|Period 3||6
8085036|NCT03496324|19935094|P3|COMPLETED|Period 3||6
8085037|NCT03496324|19935095|P2|COMPLETED|Period 3||6
8085038|NCT03496324|19935096|P1|COMPLETED|Period 3||6
8085039|NCT03496324|19935093|P4|STARTED|Period 3||6
8085040|NCT03496324|19935094|P3|STARTED|Period 3||6
8085041|NCT03496324|19935095|P2|STARTED|Period 3||6
8085042|NCT03496324|19935096|P1|STARTED|Period 3||6
8085043|NCT03496324|19935093|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
8085044|NCT03496324|19935094|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
8085045|NCT03496324|19935095|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
8085046|NCT03496324|19935096|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
8085047|NCT03496324|19935093|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||6
8085048|NCT03496324|19935094|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
8085049|NCT03496324|19935095|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||6
8085050|NCT03496324|19935096|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
8085051|NCT03496324|19935093|P4|STARTED|Period 2: Washout (3 to 7 Days)||6
8085052|NCT03496324|19935094|P3|STARTED|Period 2: Washout (3 to 7 Days)||6
8085053|NCT03496324|19935095|P2|STARTED|Period 2: Washout (3 to 7 Days)||6
8085054|NCT03496324|19935096|P1|STARTED|Period 2: Washout (3 to 7 Days)||6
8085055|NCT03496324|19935093|P4|NOT COMPLETED|Period 2||0
8085056|NCT03496324|19935094|P3|NOT COMPLETED|Period 2||0
8085057|NCT03496324|19935095|P2|NOT COMPLETED|Period 2||0
8085058|NCT03496324|19935096|P1|NOT COMPLETED|Period 2||0
8085059|NCT03496324|19935093|P4|COMPLETED|Period 2||6
8085060|NCT03496324|19935094|P3|COMPLETED|Period 2||6
8085061|NCT03496324|19935095|P2|COMPLETED|Period 2||6
8085062|NCT03496324|19935096|P1|COMPLETED|Period 2||6
8085063|NCT03496324|19935093|P4|STARTED|Period 2||6
8085064|NCT03496324|19935094|P3|STARTED|Period 2||6
8085065|NCT03496324|19935095|P2|STARTED|Period 2||6
8085066|NCT03496324|19935096|P1|STARTED|Period 2||6
8085067|NCT03496324|19935093|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8085068|NCT03496324|19935094|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8085069|NCT03496324|19935095|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8085070|NCT03496324|19935096|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8085071|NCT03496324|19935093|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||6
8085072|NCT03496324|19935094|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||6
8085073|NCT03496324|19935095|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||6
8085074|NCT03496324|19935096|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||6
8085075|NCT03496324|19935093|P4|STARTED|Period 1: Washout (3 to 7 Days)||6
8085076|NCT03496324|19935094|P3|STARTED|Period 1: Washout (3 to 7 Days)||6
8085077|NCT03496324|19935095|P2|STARTED|Period 1: Washout (3 to 7 Days)||6
8085078|NCT03496324|19935096|P1|STARTED|Period 1: Washout (3 to 7 Days)||6
8085079|NCT03496324|19935093|P4|NOT COMPLETED|Period 1||0
8085080|NCT03496324|19935094|P3|NOT COMPLETED|Period 1||0
8085081|NCT03496324|19935095|P2|NOT COMPLETED|Period 1||0
8085082|NCT03496324|19935096|P1|NOT COMPLETED|Period 1||0
8085083|NCT03496324|19935093|P4|COMPLETED|Period 1||6
8085084|NCT03496324|19935094|P3|COMPLETED|Period 1||6
8085085|NCT03496324|19935095|P2|COMPLETED|Period 1||6
8085086|NCT03496324|19935096|P1|COMPLETED|Period 1||6
8085087|NCT03496324|19935093|P4|STARTED|Period 1||6
8085088|NCT03496324|19935094|P3|STARTED|Period 1||6
8085089|NCT03496324|19935095|P2|STARTED|Period 1||6
8085090|NCT03496324|19935096|P1|STARTED|Period 1||6
8085091|NCT03496220|19935136|P3|NOT COMPLETED|Third Intervention||0
8085092|NCT03496220|19935137|P2|NOT COMPLETED|Third Intervention||0
8085093|NCT03496220|19935138|P1|NOT COMPLETED|Third Intervention||0
8085094|NCT03496220|19935136|P3|COMPLETED|Third Intervention||5
8085095|NCT03496220|19935137|P2|COMPLETED|Third Intervention||8
8085096|NCT03496220|19935138|P1|COMPLETED|Third Intervention||11
8085097|NCT03496220|19935136|P3|STARTED|Third Intervention||5
8085098|NCT03496220|19935137|P2|STARTED|Third Intervention||8
8085099|NCT03496220|19935138|P1|STARTED|Third Intervention||11
8085100|NCT03496220|19935136|P3|NOT COMPLETED|Second Intervention||0
8085101|NCT03496220|19935137|P2|NOT COMPLETED|Second Intervention||0
8085102|NCT03496220|19935138|P1|NOT COMPLETED|Second Intervention||0
8085103|NCT03496220|19935136|P3|COMPLETED|Second Intervention||11
8085104|NCT03496220|19935137|P2|COMPLETED|Second Intervention||9
8085105|NCT03496220|19935138|P1|COMPLETED|Second Intervention||17
8085106|NCT03496220|19935136|P3|STARTED|Second Intervention||11
8085107|NCT03496220|19935137|P2|STARTED|Second Intervention||9
8085108|NCT03496220|19935138|P1|STARTED|Second Intervention||17
8085109|NCT03496220|19935136|P3|NOT COMPLETED|First Intervention||0
8085110|NCT03496220|19935137|P2|NOT COMPLETED|First Intervention||0
8085111|NCT03496220|19935138|P1|NOT COMPLETED|First Intervention||0
8085112|NCT03496220|19935136|P3|COMPLETED|First Intervention||10
8085113|NCT03496220|19935137|P2|COMPLETED|First Intervention||4
8085114|NCT03496220|19935138|P1|COMPLETED|First Intervention||15
8085115|NCT03496220|19935136|P3|STARTED|First Intervention||10
8085116|NCT03496220|19935137|P2|STARTED|First Intervention||4
8085117|NCT03496220|19935138|P1|STARTED|First Intervention||15
8085124|NCT03495856|19935165|P1|NOT COMPLETED|Overall Study||1
8085125|NCT03495856|19935165|P1|COMPLETED|Overall Study||22
8085126|NCT03495856|19935165|P1|STARTED|Overall Study||23
8085127|NCT03495817|19935183|P1|NOT COMPLETED|26 Week Extension||2
8085128|NCT03495817|19935183|P1|COMPLETED|26 Week Extension||17
8085129|NCT03495817|19935183|P1|STARTED|26 Week Extension||19
8085130|NCT03495817|19935183|P1|NOT COMPLETED|26 Week Open Label||8
8085131|NCT03495817|19935183|P1|COMPLETED|26 Week Open Label||23
8085132|NCT03495817|19935183|P1|STARTED|26 Week Open Label||31
8085133|NCT03495102|19935201|P3|NOT COMPLETED|Overall Study||54
8085134|NCT03495102|19935202|P2|NOT COMPLETED|Overall Study||67
8085135|NCT03495102|19935203|P1|NOT COMPLETED|Overall Study||56
8085136|NCT03495102|19935201|P3|COMPLETED|Overall Study||560
8085137|NCT03495102|19935202|P2|COMPLETED|Overall Study||549
8085138|NCT03495102|19935203|P1|COMPLETED|Overall Study||556
8085139|NCT03495102|19935201|P3|Received at Least One Dose of Study Drug|Overall Study||614
8085140|NCT03495102|19935202|P2|Received at Least One Dose of Study Drug|Overall Study||616
8085141|NCT03495102|19935203|P1|Received at Least One Dose of Study Drug|Overall Study||612
8085142|NCT03495102|19935201|P3|STARTED|Overall Study||614
8085143|NCT03495102|19935202|P2|STARTED|Overall Study||616
8085144|NCT03495102|19935203|P1|STARTED|Overall Study||612
8085145|NCT03494985|19935233|P4|NOT COMPLETED|Overall Study||5
8085146|NCT03494985|19935234|P3|NOT COMPLETED|Overall Study||6
8085147|NCT03494985|19935235|P2|NOT COMPLETED|Overall Study||6
8085148|NCT03494985|19935236|P1|NOT COMPLETED|Overall Study||5
8085149|NCT03494985|19935233|P4|COMPLETED|Overall Study||94
8085150|NCT03494985|19935234|P3|COMPLETED|Overall Study||92
8085151|NCT03494985|19935235|P2|COMPLETED|Overall Study||92
8085152|NCT03494985|19935236|P1|COMPLETED|Overall Study||96
8085153|NCT03494985|19935233|P4|STARTED|Overall Study||99
8085154|NCT03494985|19935234|P3|STARTED|Overall Study||98
8085155|NCT03494985|19935235|P2|STARTED|Overall Study||98
8085156|NCT03494985|19935236|P1|STARTED|Overall Study||101
8085179|NCT03493828|19935294|P3|NOT COMPLETED|Overall Study||0
8085180|NCT03493828|19935295|P2|NOT COMPLETED|Overall Study||0
8085181|NCT03493828|19935296|P1|NOT COMPLETED|Overall Study||0
8085182|NCT03493828|19935294|P3|COMPLETED|Overall Study||20
8085183|NCT03493828|19935295|P2|COMPLETED|Overall Study||20
8085184|NCT03493828|19935296|P1|COMPLETED|Overall Study||20
8085185|NCT03493828|19935294|P3|STARTED|Overall Study||20
8085186|NCT03493828|19935295|P2|STARTED|Overall Study||20
8085187|NCT03493828|19935296|P1|STARTED|Overall Study||20
8085188|NCT03493815|19935306|P2|NOT COMPLETED|Overall Study||11
8085189|NCT03493815|19935307|P1|NOT COMPLETED|Overall Study||9
8085190|NCT03493815|19935306|P2|COMPLETED|Overall Study||32
8085191|NCT03493815|19935307|P1|COMPLETED|Overall Study||33
8085192|NCT03493815|19935306|P2|STARTED|Overall Study||43
8085193|NCT03493815|19935307|P1|STARTED|Overall Study||42
8085194|NCT03493698|19935319|P1|NOT COMPLETED|Treatment Period D||0
8085195|NCT03493698|19935319|P1|COMPLETED|Treatment Period D||15
8085196|NCT03493698|19935319|P1|STARTED|Treatment Period D||15
8085197|NCT03493698|19935319|P1|NOT COMPLETED|Treatment Period C||2
8085198|NCT03493698|19935319|P1|COMPLETED|Treatment Period C||15
8085199|NCT03493698|19935319|P1|STARTED|Treatment Period C||17
8085200|NCT03493698|19935319|P1|NOT COMPLETED|Treatment Period B||0
8085201|NCT03493698|19935319|P1|COMPLETED|Treatment Period B||17
8085202|NCT03493698|19935319|P1|STARTED|Treatment Period B||17
8085203|NCT03493698|19935319|P1|NOT COMPLETED|Treatment Period A||0
8085204|NCT03493698|19935319|P1|COMPLETED|Treatment Period A||17
8085205|NCT03493698|19935319|P1|STARTED|Treatment Period A||17
8085206|NCT03493542|19935344|P2|NOT COMPLETED|Overall Study||9
8085207|NCT03493542|19935345|P1|NOT COMPLETED|Overall Study||7
8085208|NCT03493542|19935344|P2|COMPLETED|Overall Study||374
8085209|NCT03493542|19935345|P1|COMPLETED|Overall Study||376
8085210|NCT03493542|19935344|P2|Vaccination 3|Overall Study||374
8085211|NCT03493542|19935345|P1|Vaccination 3|Overall Study||376
8085212|NCT03493542|19935344|P2|Vaccination 2|Overall Study||378
8085213|NCT03493542|19935345|P1|Vaccination 2|Overall Study||379
8085214|NCT03493542|19935344|P2|Vaccination 1|Overall Study||383
8085215|NCT03493542|19935345|P1|Vaccination 1|Overall Study||383
8085216|NCT03493542|19935344|P2|STARTED|Overall Study||383
8085217|NCT03493542|19935345|P1|STARTED|Overall Study||383
8085218|NCT03493386|19935369|P4|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
8085219|NCT03493386|19935370|P3|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
8085220|NCT03493386|19935371|P2|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
8085221|NCT03493386|19935372|P1|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
8085222|NCT03493386|19935369|P4|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
8085223|NCT03493386|19935370|P3|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
8085224|NCT03493386|19935371|P2|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
8085225|NCT03493386|19935372|P1|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
8085226|NCT03493386|19935369|P4|STARTED|Part 2, Intervention Period 2 (2 Days)||6
8085227|NCT03493386|19935370|P3|STARTED|Part 2, Intervention Period 2 (2 Days)||6
8085228|NCT03493386|19935371|P2|STARTED|Part 2, Intervention Period 2 (2 Days)||0
8085229|NCT03493386|19935372|P1|STARTED|Part 2, Intervention Period 2 (2 Days)||0
8085230|NCT03493386|19935369|P4|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
8085231|NCT03493386|19935370|P3|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
8085232|NCT03493386|19935371|P2|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
8085233|NCT03493386|19935372|P1|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
8085234|NCT03493386|19935369|P4|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
8085235|NCT03493386|19935370|P3|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
8085236|NCT03493386|19935371|P2|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
8085237|NCT03493386|19935372|P1|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
8085238|NCT03493386|19935369|P4|STARTED|Part 2, Washout Period (at Least 5 Days)||6
8085239|NCT03493386|19935370|P3|STARTED|Part 2, Washout Period (at Least 5 Days)||6
8085240|NCT03493386|19935371|P2|STARTED|Part 2, Washout Period (at Least 5 Days)||0
8085241|NCT03493386|19935372|P1|STARTED|Part 2, Washout Period (at Least 5 Days)||0
8085242|NCT03493386|19935369|P4|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
8085243|NCT03493386|19935370|P3|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
8085244|NCT03493386|19935371|P2|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
8085245|NCT03493386|19935372|P1|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
8085246|NCT03493386|19935369|P4|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
8085247|NCT03493386|19935370|P3|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
8085248|NCT03493386|19935371|P2|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
8085249|NCT03493386|19935372|P1|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
8085250|NCT03493386|19935369|P4|STARTED|Part 2, Intervention Period 1 (2 Days)||6
8085251|NCT03493386|19935370|P3|STARTED|Part 2, Intervention Period 1 (2 Days)||6
8085252|NCT03493386|19935371|P2|STARTED|Part 2, Intervention Period 1 (2 Days)||0
8085253|NCT03493386|19935372|P1|STARTED|Part 2, Intervention Period 1 (2 Days)||0
8085254|NCT03493386|19935369|P4|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
8085255|NCT03493386|19935370|P3|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
8085256|NCT03493386|19935371|P2|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
8085257|NCT03493386|19935372|P1|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
8085258|NCT03493386|19935369|P4|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
8085259|NCT03493386|19935370|P3|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
8085260|NCT03493386|19935371|P2|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25
8085261|NCT03493386|19935372|P1|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26
8085262|NCT03493386|19935369|P4|STARTED|Part 1, Intervention Period 2 (2 Days)||0
8085263|NCT03493386|19935370|P3|STARTED|Part 1, Intervention Period 2 (2 Days)||0
8085264|NCT03493386|19935371|P2|STARTED|Part 1, Intervention Period 2 (2 Days)||25
8085265|NCT03493386|19935372|P1|STARTED|Part 1, Intervention Period 2 (2 Days)||26
8085266|NCT03493386|19935369|P4|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
8085267|NCT03493386|19935370|P3|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
8085268|NCT03493386|19935371|P2|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1
8085269|NCT03493386|19935372|P1|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
8085270|NCT03493386|19935369|P4|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
8085271|NCT03493386|19935370|P3|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
8085272|NCT03493386|19935371|P2|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25
8085273|NCT03493386|19935372|P1|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26
8085274|NCT03493386|19935369|P4|STARTED|Part 1, Washout Period (at Least 5 Days)||0
8085275|NCT03493386|19935370|P3|STARTED|Part 1, Washout Period (at Least 5 Days)||0
8085276|NCT03493386|19935371|P2|STARTED|Part 1, Washout Period (at Least 5 Days)||26
8085277|NCT03493386|19935372|P1|STARTED|Part 1, Washout Period (at Least 5 Days)||26
8085278|NCT03493386|19935369|P4|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
8085279|NCT03493386|19935370|P3|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
8085280|NCT03493386|19935371|P2|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
8085281|NCT03493386|19935372|P1|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
8085282|NCT03493386|19935369|P4|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
8085283|NCT03493386|19935370|P3|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
8085284|NCT03493386|19935371|P2|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
8085285|NCT03493386|19935372|P1|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
8085286|NCT03493386|19935369|P4|STARTED|Part 1, Intervention Period 1 (2 Days)||0
8085287|NCT03493386|19935370|P3|STARTED|Part 1, Intervention Period 1 (2 Days)||0
8085288|NCT03493386|19935371|P2|STARTED|Part 1, Intervention Period 1 (2 Days)||26
8085289|NCT03493386|19935372|P1|STARTED|Part 1, Intervention Period 1 (2 Days)||26
8085290|NCT03492554|19935492|P2|NOT COMPLETED|Overall Study||14
8085291|NCT03492554|19935493|P1|NOT COMPLETED|Overall Study||0
8085292|NCT03492554|19935492|P2|COMPLETED|Overall Study||287
8085293|NCT03492554|19935493|P1|COMPLETED|Overall Study||301
8085294|NCT03492554|19935492|P2|STARTED|Overall Study||301
8085295|NCT03492554|19935493|P1|STARTED|Overall Study||301
8085299|NCT03491917|19935509|P2|NOT COMPLETED|Second Reading Session||0
8085300|NCT03491917|19935510|P1|NOT COMPLETED|Second Reading Session||0
8085301|NCT03491917|19935509|P2|COMPLETED|Second Reading Session||50
8085302|NCT03491917|19935510|P1|COMPLETED|Second Reading Session||50
8085303|NCT03491917|19935509|P2|STARTED|Second Reading Session||50
8085304|NCT03491917|19935510|P1|STARTED|Second Reading Session||50
8085305|NCT03491917|19935509|P2|NOT COMPLETED|4 Week Memory Washout Period||0
8085306|NCT03491917|19935510|P1|NOT COMPLETED|4 Week Memory Washout Period||0
8085307|NCT03491917|19935509|P2|COMPLETED|4 Week Memory Washout Period||50
8085308|NCT03491917|19935510|P1|COMPLETED|4 Week Memory Washout Period||50
8085309|NCT03491917|19935509|P2|STARTED|4 Week Memory Washout Period||50
8085310|NCT03491917|19935510|P1|STARTED|4 Week Memory Washout Period||50
8085311|NCT03491917|19935509|P2|NOT COMPLETED|First Reading Session||0
8085312|NCT03491917|19935510|P1|NOT COMPLETED|First Reading Session||0
8085313|NCT03491917|19935509|P2|COMPLETED|First Reading Session||50
8085314|NCT03491917|19935510|P1|COMPLETED|First Reading Session||50
8085315|NCT03491917|19935509|P2|STARTED|First Reading Session||50
8085316|NCT03491917|19935510|P1|STARTED|First Reading Session||50
8085317|NCT03491891|19935518|P2|NOT COMPLETED|Overall Study||380
8085318|NCT03491891|19935519|P1|NOT COMPLETED|Overall Study||853
8085319|NCT03491891|19935518|P2|COMPLETED|Overall Study||2058
8085320|NCT03491891|19935519|P1|COMPLETED|Overall Study||5185
8085321|NCT03491891|19935518|P2|STARTED|Overall Study||2438
8085322|NCT03491891|19935519|P1|STARTED|Overall Study||6038
8085323|NCT03491800|19935528|P3|NOT COMPLETED|Overall Study||0
8085324|NCT03491800|19935529|P2|NOT COMPLETED|Overall Study||0
8085325|NCT03491800|19935530|P1|NOT COMPLETED|Overall Study||0
8085326|NCT03491800|19935528|P3|COMPLETED|Overall Study||7
8085327|NCT03491800|19935529|P2|COMPLETED|Overall Study||23
8085328|NCT03491800|19935530|P1|COMPLETED|Overall Study||23
8085329|NCT03491800|19935528|P3|STARTED|Overall Study||7
8085330|NCT03491800|19935529|P2|STARTED|Overall Study||23
8085331|NCT03491800|19935530|P1|STARTED|Overall Study||23
8085350|NCT03491228|19935681|P1|NOT COMPLETED|Overall Study||0
8085351|NCT03491228|19935681|P1|COMPLETED|Overall Study||107
8085352|NCT03491228|19935681|P1|STARTED|Overall Study||107
8085353|NCT03491150|19935689|P2|NOT COMPLETED|Overall Study||73
8085354|NCT03491150|19935690|P1|NOT COMPLETED|Overall Study||76
8085355|NCT03491150|19935689|P2|COMPLETED|Overall Study||0
8085356|NCT03491150|19935690|P1|COMPLETED|Overall Study||0
8085357|NCT03491150|19935689|P2|STARTED|Overall Study||73
8085358|NCT03491150|19935690|P1|STARTED|Overall Study||76
8085359|NCT03490916|19935700|P2|NOT COMPLETED|Overall Study||0
8085360|NCT03490916|19935701|P1|NOT COMPLETED|Overall Study||0
8085361|NCT03490916|19935700|P2|COMPLETED|Overall Study||0
8085362|NCT03490916|19935701|P1|COMPLETED|Overall Study||0
8085363|NCT03490916|19935700|P2|STARTED|Overall Study||0
8085364|NCT03490916|19935701|P1|STARTED|Overall Study||0
8085365|NCT03490110|19935711|P2|NOT COMPLETED|Overall Study||3
8085366|NCT03490110|19935712|P1|NOT COMPLETED|Overall Study||3
8085367|NCT03490110|19935711|P2|COMPLETED|Overall Study||6
8085368|NCT03490110|19935712|P1|COMPLETED|Overall Study||6
8085369|NCT03490110|19935711|P2|STARTED|Overall Study||9
8085370|NCT03490110|19935712|P1|STARTED|Overall Study||9
8085371|NCT03490032|19935729|P3|NOT COMPLETED|Overall Study||0
8085372|NCT03490032|19935730|P2|NOT COMPLETED|Overall Study||0
8085373|NCT03490032|19935731|P1|NOT COMPLETED|Overall Study||1
8085374|NCT03490032|19935729|P3|COMPLETED|Overall Study||12
8085375|NCT03490032|19935730|P2|COMPLETED|Overall Study||12
8085376|NCT03490032|19935731|P1|COMPLETED|Overall Study||5
8085377|NCT03490032|19935729|P3|STARTED|Overall Study||12
8085378|NCT03490032|19935730|P2|STARTED|Overall Study||12
8085379|NCT03490032|19935731|P1|STARTED|Overall Study||6
8085380|NCT03489863|19935771|P2|NOT COMPLETED|Overall Study||1
8085381|NCT03489863|19935772|P1|NOT COMPLETED|Overall Study||0
8085382|NCT03489863|19935771|P2|COMPLETED|Overall Study||6
8085383|NCT03489863|19935772|P1|COMPLETED|Overall Study||7
8085384|NCT03489863|19935771|P2|STARTED|Overall Study||7
8085385|NCT03489863|19935772|P1|STARTED|Overall Study||7
8085386|NCT03489720|19935780|P2|NOT COMPLETED|Overall Study||0
8085387|NCT03489720|19935781|P1|NOT COMPLETED|Overall Study||2
8085388|NCT03489720|19935780|P2|COMPLETED|Overall Study||22
8085389|NCT03489720|19935781|P1|COMPLETED|Overall Study||22
8085390|NCT03489720|19935780|P2|STARTED|Overall Study||22
8085391|NCT03489720|19935781|P1|STARTED|Overall Study||24
8085392|NCT03489551|19935806|P1|NOT COMPLETED|Overall Study||2
8085393|NCT03489551|19935806|P1|COMPLETED|Overall Study||15
8085394|NCT03489551|19935806|P1|STARTED|Overall Study||17
8085395|NCT03489304|19935810|P1|NOT COMPLETED|Overall Study||4
8085396|NCT03489304|19935810|P1|COMPLETED|Overall Study||16
8085397|NCT03489304|19935810|P1|STARTED|Overall Study||20
8085398|NCT03488927|19935819|P3|NOT COMPLETED|Overall Study||217
8085399|NCT03488927|19935820|P2|NOT COMPLETED|Overall Study||118
8085400|NCT03488927|19935821|P1|NOT COMPLETED|Overall Study||44
8085401|NCT03488927|19935819|P3|COMPLETED|Overall Study||314
8085402|NCT03488927|19935820|P2|COMPLETED|Overall Study||314
8085403|NCT03488927|19935821|P1|COMPLETED|Overall Study||261
8085404|NCT03488927|19935819|P3|STARTED|Overall Study||531
8085405|NCT03488927|19935820|P2|STARTED|Overall Study||432
8085406|NCT03488927|19935821|P1|STARTED|Overall Study||305
8085407|NCT03488108|19935834|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
8085408|NCT03488108|19935835|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
8085409|NCT03488108|19935834|P2|COMPLETED|Second Intervention (12 Weeks)||9
8085410|NCT03488108|19935835|P1|COMPLETED|Second Intervention (12 Weeks)||9
8085411|NCT03488108|19935834|P2|STARTED|Second Intervention (12 Weeks)||9
8085412|NCT03488108|19935835|P1|STARTED|Second Intervention (12 Weeks)||10
8085413|NCT03488108|19935834|P2|NOT COMPLETED|Washout (2 Months)||0
8085414|NCT03488108|19935835|P1|NOT COMPLETED|Washout (2 Months)||0
8085415|NCT03488108|19935834|P2|COMPLETED|Washout (2 Months)||9
8085416|NCT03488108|19935835|P1|COMPLETED|Washout (2 Months)||10
8085417|NCT03488108|19935834|P2|STARTED|Washout (2 Months)||9
8085418|NCT03488108|19935835|P1|STARTED|Washout (2 Months)||10
8085419|NCT03488108|19935834|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
8085420|NCT03488108|19935835|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
8085421|NCT03488108|19935834|P2|COMPLETED|First Intervention (12 Weeks)||9
8085422|NCT03488108|19935835|P1|COMPLETED|First Intervention (12 Weeks)||10
8085423|NCT03488108|19935834|P2|STARTED|First Intervention (12 Weeks)||10
8085424|NCT03488108|19935835|P1|STARTED|First Intervention (12 Weeks)||10
8085425|NCT03488030|19935853|P2|NOT COMPLETED|Overall Study||0
8085426|NCT03488030|19935854|P1|NOT COMPLETED|Overall Study||0
8085427|NCT03488030|19935853|P2|COMPLETED|Overall Study||145
8085428|NCT03488030|19935854|P1|COMPLETED|Overall Study||101
8085429|NCT03488030|19935853|P2|STARTED|Overall Study||145
8085430|NCT03488030|19935854|P1|STARTED|Overall Study||101
8085431|NCT03487588|19935902|P1|NOT COMPLETED|Overall Study||0
8085432|NCT03487588|19935902|P1|COMPLETED|Overall Study||41
8085433|NCT03487588|19935902|P1|STARTED|Overall Study||41
8085434|NCT03486990|19935917|P9|NOT COMPLETED|Overall Study||0
8085435|NCT03486990|19935918|P8|NOT COMPLETED|Overall Study||0
8085436|NCT03486990|19935919|P7|NOT COMPLETED|Overall Study||0
8085437|NCT03486990|19935920|P6|NOT COMPLETED|Overall Study||0
8085438|NCT03486990|19935921|P5|NOT COMPLETED|Overall Study||0
8085439|NCT03486990|19935922|P4|NOT COMPLETED|Overall Study||0
8085440|NCT03486990|19935923|P3|NOT COMPLETED|Overall Study||0
8085441|NCT03486990|19935924|P2|NOT COMPLETED|Overall Study||0
8085442|NCT03486990|19935925|P1|NOT COMPLETED|Overall Study||0
8085443|NCT03486990|19935917|P9|COMPLETED|Overall Study||2
8085444|NCT03486990|19935918|P8|COMPLETED|Overall Study||2
8085445|NCT03486990|19935919|P7|COMPLETED|Overall Study||2
8085446|NCT03486990|19935920|P6|COMPLETED|Overall Study||4
8085447|NCT03486990|19935921|P5|COMPLETED|Overall Study||3
8085448|NCT03486990|19935922|P4|COMPLETED|Overall Study||3
8085449|NCT03486990|19935923|P3|COMPLETED|Overall Study||3
8085450|NCT03486990|19935924|P2|COMPLETED|Overall Study||2
8085451|NCT03486990|19935925|P1|COMPLETED|Overall Study||2
8085452|NCT03486990|19935917|P9|STARTED|Overall Study||2
8085453|NCT03486990|19935918|P8|STARTED|Overall Study||2
8085454|NCT03486990|19935919|P7|STARTED|Overall Study||2
8085455|NCT03486990|19935920|P6|STARTED|Overall Study||4
8085456|NCT03486990|19935921|P5|STARTED|Overall Study||3
8085457|NCT03486990|19935922|P4|STARTED|Overall Study||3
8085458|NCT03486990|19935923|P3|STARTED|Overall Study||3
8085459|NCT03486990|19935924|P2|STARTED|Overall Study||2
8085460|NCT03486990|19935925|P1|STARTED|Overall Study||2
8085461|NCT03486392|19936104|P5|NOT COMPLETED|Overall Study||4
8085462|NCT03486392|19936105|P4|NOT COMPLETED|Overall Study||9
8085463|NCT03486392|19936106|P3|NOT COMPLETED|Overall Study||14
8085464|NCT03486392|19936107|P2|NOT COMPLETED|Overall Study||0
8085465|NCT03486392|19936108|P1|NOT COMPLETED|Overall Study||3
8085466|NCT03486392|19936104|P5|COMPLETED|Overall Study||115
8085467|NCT03486392|19936105|P4|COMPLETED|Overall Study||109
8085468|NCT03486392|19936106|P3|COMPLETED|Overall Study||104
8085469|NCT03486392|19936107|P2|COMPLETED|Overall Study||59
8085470|NCT03486392|19936108|P1|COMPLETED|Overall Study||57
8085471|NCT03486392|19936104|P5|STARTED|Overall Study||119
8085472|NCT03486392|19936105|P4|STARTED|Overall Study||118
8085473|NCT03486392|19936106|P3|STARTED|Overall Study||118
8085474|NCT03486392|19936107|P2|STARTED|Overall Study||59
8085475|NCT03486392|19936108|P1|STARTED|Overall Study||60
8085476|NCT03485976|19936140|P1|NOT COMPLETED|Overall Study||1
8085477|NCT03485976|19936140|P1|COMPLETED|Overall Study||11
8085478|NCT03485976|19936140|P1|STARTED|Overall Study||12
8085479|NCT03483896|19936148|P2|NOT COMPLETED|Overall Study||4
8085480|NCT03483896|19936149|P1|NOT COMPLETED|Overall Study||2
8085481|NCT03483896|19936148|P2|COMPLETED|Overall Study||46
8085482|NCT03483896|19936149|P1|COMPLETED|Overall Study||31
8085483|NCT03483896|19936148|P2|STARTED|Overall Study||50
8085484|NCT03483896|19936149|P1|STARTED|Overall Study||33
8085485|NCT03483623|19936157|P1|NOT COMPLETED|Overall Study||1
8085486|NCT03483623|19936157|P1|COMPLETED|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
8085487|NCT03483623|19936157|P1|Completed RAVEN FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
8085488|NCT03483623|19936157|P1|Started RAVEN FIS|Overall Study||44
8085489|NCT03483623|19936157|P1|Completed RAVEN WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
8085490|NCT03483623|19936157|P1|Started RAVEN WELP|Overall Study||44
8085491|NCT03483623|19936157|P1|Completed NATO FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
8085492|NCT03483623|19936157|P1|Started NATO FIS|Overall Study||44
8085493|NCT03483623|19936157|P1|Completeded NATO WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
8085494|NCT03483623|19936157|P1|Started NATO WELP|Overall Study||44
8085495|NCT03483623|19936157|P1|STARTED|Overall Study||44
8085496|NCT03483051|19936170|P2|NOT COMPLETED|Second Treatment, After Crossover||0
8085497|NCT03483051|19936171|P1|NOT COMPLETED|Second Treatment, After Crossover||0
8085498|NCT03483051|19936170|P2|COMPLETED|Second Treatment, After Crossover||1
8085499|NCT03483051|19936171|P1|COMPLETED|Second Treatment, After Crossover||2
8085500|NCT03483051|19936170|P2|STARTED|Second Treatment, After Crossover||1
8085501|NCT03483051|19936171|P1|STARTED|Second Treatment, After Crossover||2
8085502|NCT03483051|19936170|P2|NOT COMPLETED|First Treatment, Pre Crossover||0
8085503|NCT03483051|19936171|P1|NOT COMPLETED|First Treatment, Pre Crossover||0
8085504|NCT03483051|19936170|P2|COMPLETED|First Treatment, Pre Crossover||1
8085505|NCT03483051|19936171|P1|COMPLETED|First Treatment, Pre Crossover||2
8085506|NCT03483051|19936170|P2|STARTED|First Treatment, Pre Crossover||1
8085507|NCT03483051|19936171|P1|STARTED|First Treatment, Pre Crossover||2
8085508|NCT03482973|19936191|P2|NOT COMPLETED|Overall Study||0
8085509|NCT03482973|19936192|P1|NOT COMPLETED|Overall Study||0
8085510|NCT03482973|19936191|P2|COMPLETED|Overall Study||40
8085511|NCT03482973|19936192|P1|COMPLETED|Overall Study||40
8085512|NCT03482973|19936191|P2|STARTED|Overall Study||40
8085513|NCT03482973|19936192|P1|STARTED|Overall Study||40
8085514|NCT03482882|19936206|P1|NOT COMPLETED|Overall Study||7
8085515|NCT03482882|19936206|P1|COMPLETED|Overall Study||40
8085516|NCT03482882|19936206|P1|STARTED|Overall Study||47
8085517|NCT03482713|19936219|P2|NOT COMPLETED|Overall Study||0
8085518|NCT03482713|19936220|P1|NOT COMPLETED|Overall Study||0
8085519|NCT03482713|19936219|P2|COMPLETED|Overall Study||12
8085520|NCT03482713|19936220|P1|COMPLETED|Overall Study||11
8085521|NCT03482713|19936219|P2|STARTED|Overall Study||12
8085522|NCT03482713|19936220|P1|STARTED|Overall Study||11
8085523|NCT03482583|19936235|P3|NOT COMPLETED|Overall Study||21
8085524|NCT03482583|19936236|P2|NOT COMPLETED|Overall Study||9
8085525|NCT03482583|19936237|P1|NOT COMPLETED|Overall Study||25
8085526|NCT03482583|19936235|P3|COMPLETED|Overall Study||18
8085527|NCT03482583|19936236|P2|COMPLETED|Overall Study||5
8085528|NCT03482583|19936237|P1|COMPLETED|Overall Study||12
8085529|NCT03482583|19936235|P3|STARTED|Overall Study||39
8085530|NCT03482583|19936236|P2|STARTED|Overall Study||14
8085531|NCT03482583|19936237|P1|STARTED|Overall Study||37
8085532|NCT03482453|19936267|P12|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085533|NCT03482453|19936268|P11|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085534|NCT03482453|19936269|P10|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085535|NCT03482453|19936270|P9|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085536|NCT03482453|19936271|P8|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085537|NCT03482453|19936272|P7|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085538|NCT03482453|19936273|P6|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085539|NCT03482453|19936274|P5|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085540|NCT03482453|19936275|P4|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085541|NCT03482453|19936276|P3|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085542|NCT03482453|19936277|P2|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085543|NCT03482453|19936278|P1|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085544|NCT03482453|19936267|P12|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
8085545|NCT03482453|19936268|P11|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
8085546|NCT03482453|19936269|P10|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
8085547|NCT03482453|19936270|P9|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
8085548|NCT03482453|19936271|P8|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
8085549|NCT03482453|19936272|P7|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
8085550|NCT03482453|19936273|P6|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085551|NCT03482453|19936274|P5|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085552|NCT03482453|19936275|P4|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085553|NCT03482453|19936276|P3|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085554|NCT03482453|19936277|P2|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085555|NCT03482453|19936278|P1|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085556|NCT03482453|19936267|P12|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
8085557|NCT03482453|19936268|P11|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
8085558|NCT03482453|19936269|P10|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
8085559|NCT03482453|19936270|P9|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
8085560|NCT03482453|19936271|P8|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
8085561|NCT03482453|19936272|P7|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
8085562|NCT03482453|19936273|P6|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085563|NCT03482453|19936274|P5|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085564|NCT03482453|19936275|P4|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085565|NCT03482453|19936276|P3|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085566|NCT03482453|19936277|P2|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085567|NCT03482453|19936278|P1|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
8085568|NCT03482453|19936267|P12|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085569|NCT03482453|19936268|P11|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085570|NCT03482453|19936269|P10|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085571|NCT03482453|19936270|P9|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085572|NCT03482453|19936271|P8|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085573|NCT03482453|19936272|P7|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085574|NCT03482453|19936273|P6|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085575|NCT03482453|19936274|P5|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085576|NCT03482453|19936275|P4|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085577|NCT03482453|19936276|P3|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085578|NCT03482453|19936277|P2|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085579|NCT03482453|19936278|P1|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085580|NCT03482453|19936267|P12|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
8085581|NCT03482453|19936268|P11|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
8085582|NCT03482453|19936269|P10|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
8085583|NCT03482453|19936270|P9|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
8085584|NCT03482453|19936271|P8|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
8085585|NCT03482453|19936272|P7|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
8085586|NCT03482453|19936273|P6|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085587|NCT03482453|19936274|P5|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085588|NCT03482453|19936275|P4|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085589|NCT03482453|19936276|P3|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085590|NCT03482453|19936277|P2|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085591|NCT03482453|19936278|P1|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
8085592|NCT03482453|19936267|P12|STARTED|Parts 2, 3 Washout Period (7 Days)||6
8085593|NCT03482453|19936268|P11|STARTED|Parts 2, 3 Washout Period (7 Days)||6
8085594|NCT03482453|19936269|P10|STARTED|Parts 2, 3 Washout Period (7 Days)||5
8085595|NCT03482453|19936270|P9|STARTED|Parts 2, 3 Washout Period (7 Days)||5
8085596|NCT03482453|19936271|P8|STARTED|Parts 2, 3 Washout Period (7 Days)||3
8085597|NCT03482453|19936272|P7|STARTED|Parts 2, 3 Washout Period (7 Days)||3
8085598|NCT03482453|19936273|P6|STARTED|Parts 2, 3 Washout Period (7 Days)||0
8085599|NCT03482453|19936274|P5|STARTED|Parts 2, 3 Washout Period (7 Days)||0
8085600|NCT03482453|19936275|P4|STARTED|Parts 2, 3 Washout Period (7 Days)||0
8085601|NCT03482453|19936276|P3|STARTED|Parts 2, 3 Washout Period (7 Days)||0
8085602|NCT03482453|19936277|P2|STARTED|Parts 2, 3 Washout Period (7 Days)||0
8085603|NCT03482453|19936278|P1|STARTED|Parts 2, 3 Washout Period (7 Days)||0
8085604|NCT03482453|19936267|P12|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085605|NCT03482453|19936268|P11|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1
8085606|NCT03482453|19936269|P10|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085607|NCT03482453|19936270|P9|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085608|NCT03482453|19936271|P8|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085609|NCT03482453|19936272|P7|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085610|NCT03482453|19936273|P6|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085611|NCT03482453|19936274|P5|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085612|NCT03482453|19936275|P4|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085613|NCT03482453|19936276|P3|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085614|NCT03482453|19936277|P2|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085615|NCT03482453|19936278|P1|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085616|NCT03482453|19936267|P12|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
8085617|NCT03482453|19936268|P11|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
8085618|NCT03482453|19936269|P10|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
8085619|NCT03482453|19936270|P9|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
8085620|NCT03482453|19936271|P8|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
8085621|NCT03482453|19936272|P7|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
8085622|NCT03482453|19936273|P6|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085623|NCT03482453|19936274|P5|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085624|NCT03482453|19936275|P4|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085625|NCT03482453|19936276|P3|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085626|NCT03482453|19936277|P2|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085627|NCT03482453|19936278|P1|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085628|NCT03482453|19936267|P12|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6
8085629|NCT03482453|19936268|P11|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7
8085630|NCT03482453|19936269|P10|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
8085631|NCT03482453|19936270|P9|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
8085632|NCT03482453|19936271|P8|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
8085633|NCT03482453|19936272|P7|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
8085634|NCT03482453|19936273|P6|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085635|NCT03482453|19936274|P5|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085636|NCT03482453|19936275|P4|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085637|NCT03482453|19936276|P3|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085638|NCT03482453|19936277|P2|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085639|NCT03482453|19936278|P1|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
8085640|NCT03482453|19936267|P12|NOT COMPLETED|Part 1 (1 Day)||0
8085641|NCT03482453|19936268|P11|NOT COMPLETED|Part 1 (1 Day)||0
8085642|NCT03482453|19936269|P10|NOT COMPLETED|Part 1 (1 Day)||0
8085643|NCT03482453|19936270|P9|NOT COMPLETED|Part 1 (1 Day)||0
8085644|NCT03482453|19936271|P8|NOT COMPLETED|Part 1 (1 Day)||0
8085645|NCT03482453|19936272|P7|NOT COMPLETED|Part 1 (1 Day)||0
8085646|NCT03482453|19936273|P6|NOT COMPLETED|Part 1 (1 Day)||0
8085647|NCT03482453|19936274|P5|NOT COMPLETED|Part 1 (1 Day)||0
8085648|NCT03482453|19936275|P4|NOT COMPLETED|Part 1 (1 Day)||0
8085649|NCT03482453|19936276|P3|NOT COMPLETED|Part 1 (1 Day)||0
8085650|NCT03482453|19936277|P2|NOT COMPLETED|Part 1 (1 Day)||0
8085651|NCT03482453|19936278|P1|NOT COMPLETED|Part 1 (1 Day)||0
8085652|NCT03482453|19936267|P12|COMPLETED|Part 1 (1 Day)||0
8085653|NCT03482453|19936268|P11|COMPLETED|Part 1 (1 Day)||0
8085654|NCT03482453|19936269|P10|COMPLETED|Part 1 (1 Day)||0
8085655|NCT03482453|19936270|P9|COMPLETED|Part 1 (1 Day)||0
8085656|NCT03482453|19936271|P8|COMPLETED|Part 1 (1 Day)||0
8085657|NCT03482453|19936272|P7|COMPLETED|Part 1 (1 Day)||0
8085658|NCT03482453|19936273|P6|COMPLETED|Part 1 (1 Day)||6
8085659|NCT03482453|19936274|P5|COMPLETED|Part 1 (1 Day)||6
8085660|NCT03482453|19936275|P4|COMPLETED|Part 1 (1 Day)||6
8085661|NCT03482453|19936276|P3|COMPLETED|Part 1 (1 Day)||6
8085662|NCT03482453|19936277|P2|COMPLETED|Part 1 (1 Day)||6
8085663|NCT03482453|19936278|P1|COMPLETED|Part 1 (1 Day)||10
8085664|NCT03482453|19936267|P12|STARTED|Part 1 (1 Day)||0
8085665|NCT03482453|19936268|P11|STARTED|Part 1 (1 Day)||0
8085666|NCT03482453|19936269|P10|STARTED|Part 1 (1 Day)||0
8085667|NCT03482453|19936270|P9|STARTED|Part 1 (1 Day)||0
8085668|NCT03482453|19936271|P8|STARTED|Part 1 (1 Day)||0
8085669|NCT03482453|19936272|P7|STARTED|Part 1 (1 Day)||0
8085670|NCT03482453|19936273|P6|STARTED|Part 1 (1 Day)||6
8085671|NCT03482453|19936274|P5|STARTED|Part 1 (1 Day)||6
8085672|NCT03482453|19936275|P4|STARTED|Part 1 (1 Day)||6
8085673|NCT03482453|19936276|P3|STARTED|Part 1 (1 Day)||6
8085674|NCT03482453|19936277|P2|STARTED|Part 1 (1 Day)||6
8085675|NCT03482453|19936278|P1|STARTED|Part 1 (1 Day)||10
8085676|NCT03482011|19936397|P8|NOT COMPLETED|Follow-up Period (12 Weeks)||17
8085677|NCT03482011|19936398|P7|NOT COMPLETED|Follow-up Period (12 Weeks)||2
8085678|NCT03482011|19936399|P6|NOT COMPLETED|Follow-up Period (12 Weeks)||1
8085679|NCT03482011|19936400|P5|NOT COMPLETED|Follow-up Period (12 Weeks)||0
8085680|NCT03482011|19936401|P4|NOT COMPLETED|Follow-up Period (12 Weeks)||5
8085681|NCT03482011|19936402|P3|NOT COMPLETED|Follow-up Period (12 Weeks)||1
8085682|NCT03482011|19936403|P2|NOT COMPLETED|Follow-up Period (12 Weeks)||0
8085683|NCT03482011|19936404|P1|NOT COMPLETED|Follow-up Period (12 Weeks)||0
8085684|NCT03482011|19936397|P8|COMPLETED|Follow-up Period (12 Weeks)||4
8085685|NCT03482011|19936398|P7|COMPLETED|Follow-up Period (12 Weeks)||2
8085686|NCT03482011|19936399|P6|COMPLETED|Follow-up Period (12 Weeks)||3
8085687|NCT03482011|19936400|P5|COMPLETED|Follow-up Period (12 Weeks)||2
8085688|NCT03482011|19936401|P4|COMPLETED|Follow-up Period (12 Weeks)||5
8085689|NCT03482011|19936402|P3|COMPLETED|Follow-up Period (12 Weeks)||0
8085690|NCT03482011|19936403|P2|COMPLETED|Follow-up Period (12 Weeks)||0
8085691|NCT03482011|19936404|P1|COMPLETED|Follow-up Period (12 Weeks)||0
8085692|NCT03482011|19936397|P8|STARTED|Follow-up Period (12 Weeks)||21
8085693|NCT03482011|19936398|P7|STARTED|Follow-up Period (12 Weeks)||4
8085694|NCT03482011|19936399|P6|STARTED|Follow-up Period (12 Weeks)||4
8085695|NCT03482011|19936400|P5|STARTED|Follow-up Period (12 Weeks)||2
8085696|NCT03482011|19936401|P4|STARTED|Follow-up Period (12 Weeks)||10
8085697|NCT03482011|19936402|P3|STARTED|Follow-up Period (12 Weeks)||1
8085698|NCT03482011|19936403|P2|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
8085699|NCT03482011|19936404|P1|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
8085700|NCT03482011|19936397|P8|NOT COMPLETED|Maintenance Period (36 Weeks)||17
8085701|NCT03482011|19936398|P7|NOT COMPLETED|Maintenance Period (36 Weeks)||4
8085702|NCT03482011|19936399|P6|NOT COMPLETED|Maintenance Period (36 Weeks)||4
8085703|NCT03482011|19936400|P5|NOT COMPLETED|Maintenance Period (36 Weeks)||5
8085704|NCT03482011|19936401|P4|NOT COMPLETED|Maintenance Period (36 Weeks)||4
8085705|NCT03482011|19936402|P3|NOT COMPLETED|Maintenance Period (36 Weeks)||1
8085706|NCT03482011|19936403|P2|NOT COMPLETED|Maintenance Period (36 Weeks)||0
8085707|NCT03482011|19936404|P1|NOT COMPLETED|Maintenance Period (36 Weeks)||0
8085708|NCT03482011|19936397|P8|COMPLETED|Maintenance Period (36 Weeks)||123
8085709|NCT03482011|19936398|P7|COMPLETED|Maintenance Period (36 Weeks)||87
8085710|NCT03482011|19936399|P6|COMPLETED|Maintenance Period (36 Weeks)||86
8085711|NCT03482011|19936400|P5|COMPLETED|Maintenance Period (36 Weeks)||86
8085712|NCT03482011|19936401|P4|COMPLETED|Maintenance Period (36 Weeks)||90
8085713|NCT03482011|19936402|P3|COMPLETED|Maintenance Period (36 Weeks)||6
8085714|NCT03482011|19936403|P2|COMPLETED|Maintenance Period (36 Weeks)||0
8085715|NCT03482011|19936404|P1|COMPLETED|Maintenance Period (36 Weeks)||0
8085716|NCT03482011|19936397|P8|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||121
8085717|NCT03482011|19936398|P7|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||87
8085718|NCT03482011|19936399|P6|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||85
8085719|NCT03482011|19936400|P5|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||86
8085720|NCT03482011|19936401|P4|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||88
8085721|NCT03482011|19936402|P3|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||6
8085722|NCT03482011|19936403|P2|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
8085723|NCT03482011|19936404|P1|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
8085724|NCT03482011|19936397|P8|Relapse|Maintenance Period (36 Weeks)||0
8085725|NCT03482011|19936398|P7|Relapse|Maintenance Period (36 Weeks)||2
8085726|NCT03482011|19936399|P6|Relapse|Maintenance Period (36 Weeks)||3
8085727|NCT03482011|19936400|P5|Relapse|Maintenance Period (36 Weeks)||41
8085728|NCT03482011|19936401|P4|Relapse|Maintenance Period (36 Weeks)||0
8085729|NCT03482011|19936402|P3|Relapse|Maintenance Period (36 Weeks)||1
8085730|NCT03482011|19936403|P2|Relapse|Maintenance Period (36 Weeks)||0
8085731|NCT03482011|19936404|P1|Relapse|Maintenance Period (36 Weeks)||0
8085732|NCT03482011|19936397|P8|STARTED|Maintenance Period (36 Weeks)||140
8085733|NCT03482011|19936398|P7|STARTED|Maintenance Period (36 Weeks)||91
8085734|NCT03482011|19936399|P6|STARTED|Maintenance Period (36 Weeks)||90
8085735|NCT03482011|19936400|P5|STARTED|Maintenance Period (36 Weeks)||91
8085736|NCT03482011|19936401|P4|STARTED|Maintenance Period (36 Weeks)||94
8085737|NCT03482011|19936402|P3|STARTED|Maintenance Period (36 Weeks)||7
8085738|NCT03482011|19936403|P2|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
8085739|NCT03482011|19936404|P1|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
8085740|NCT03482011|19936397|P8|NOT COMPLETED|Induction Period (16 Weeks)||0
8085741|NCT03482011|19936398|P7|NOT COMPLETED|Induction Period (16 Weeks)||0
8085742|NCT03482011|19936399|P6|NOT COMPLETED|Induction Period (16 Weeks)||0
8085743|NCT03482011|19936400|P5|NOT COMPLETED|Induction Period (16 Weeks)||0
8085744|NCT03482011|19936401|P4|NOT COMPLETED|Induction Period (16 Weeks)||0
8085745|NCT03482011|19936402|P3|NOT COMPLETED|Induction Period (16 Weeks)||0
8085746|NCT03482011|19936403|P2|NOT COMPLETED|Induction Period (16 Weeks)||11
8085747|NCT03482011|19936404|P1|NOT COMPLETED|Induction Period (16 Weeks)||6
8085748|NCT03482011|19936397|P8|COMPLETED|Induction Period (16 Weeks)||0
8085749|NCT03482011|19936398|P7|COMPLETED|Induction Period (16 Weeks)||0
8085750|NCT03482011|19936399|P6|COMPLETED|Induction Period (16 Weeks)||0
8085751|NCT03482011|19936400|P5|COMPLETED|Induction Period (16 Weeks)||0
8085752|NCT03482011|19936401|P4|COMPLETED|Induction Period (16 Weeks)||0
8085753|NCT03482011|19936402|P3|COMPLETED|Induction Period (16 Weeks)||0
8085754|NCT03482011|19936403|P2|COMPLETED|Induction Period (16 Weeks)||412
8085755|NCT03482011|19936404|P1|COMPLETED|Induction Period (16 Weeks)||101
8085756|NCT03482011|19936397|P8|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8085757|NCT03482011|19936398|P7|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8085758|NCT03482011|19936399|P6|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8085759|NCT03482011|19936400|P5|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8085760|NCT03482011|19936401|P4|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8085761|NCT03482011|19936402|P3|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8085762|NCT03482011|19936403|P2|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||422
8085763|NCT03482011|19936404|P1|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||107
8085764|NCT03482011|19936397|P8|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
8085765|NCT03482011|19936398|P7|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
8085766|NCT03482011|19936399|P6|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
8085767|NCT03482011|19936400|P5|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
8085768|NCT03482011|19936401|P4|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
8085769|NCT03482011|19936402|P3|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
8085770|NCT03482011|19936403|P2|STARTED|Induction Period (16 Weeks)||423
8085771|NCT03482011|19936404|P1|STARTED|Induction Period (16 Weeks)||107
8085874|NCT03481270|19936512|P2|NOT COMPLETED|Overall Study||0
8085875|NCT03481270|19936513|P1|NOT COMPLETED|Overall Study||0
8085876|NCT03481270|19936512|P2|COMPLETED|Overall Study||313
8085877|NCT03481270|19936513|P1|COMPLETED|Overall Study||324
8085878|NCT03481270|19936512|P2|STARTED|Overall Study||313
8085879|NCT03481270|19936513|P1|STARTED|Overall Study||324
8085880|NCT03480919|19936522|P3|NOT COMPLETED|Overall Study||0
8085881|NCT03480919|19936523|P2|NOT COMPLETED|Overall Study||0
8085882|NCT03480919|19936524|P1|NOT COMPLETED|Overall Study||0
8085883|NCT03480919|19936522|P3|COMPLETED|Overall Study||1
8085884|NCT03480919|19936523|P2|COMPLETED|Overall Study||2
8085885|NCT03480919|19936524|P1|COMPLETED|Overall Study||1
8085886|NCT03480919|19936522|P3|STARTED|Overall Study||1
8085887|NCT03480919|19936523|P2|STARTED|Overall Study||2
8085888|NCT03480919|19936524|P1|STARTED|Overall Study||1
8085889|NCT03480841|19936538|P1|NOT COMPLETED|Overall Study||2
8085890|NCT03480841|19936538|P1|COMPLETED|Overall Study||8
8085891|NCT03480841|19936538|P1|Time 2 Data Collection (T2)|Overall Study||8
8085892|NCT03480841|19936538|P1|LENA Time 5|Overall Study||8
8085893|NCT03480841|19936538|P1|LENA Time 4|Overall Study||9
8085894|NCT03480841|19936538|P1|LENA Time 3|Overall Study||10
8085895|NCT03480841|19936538|P1|LENA Time 2|Overall Study||10
8085896|NCT03480841|19936538|P1|LENA Time 1|Overall Study||10
8085897|NCT03480841|19936538|P1|LENA Baseline|Overall Study||10
8085898|NCT03480841|19936538|P1|Time 1 Data Collection (T1)|Overall Study||10
8085899|NCT03480841|19936538|P1|STARTED|Overall Study||10
8085900|NCT03480802|19936549|P2|NOT COMPLETED|Overall Study||3
8085901|NCT03480802|19936550|P1|NOT COMPLETED|Overall Study||7
8085902|NCT03480802|19936549|P2|COMPLETED|Overall Study||147
8085903|NCT03480802|19936550|P1|COMPLETED|Overall Study||145
8085904|NCT03480802|19936549|P2|Week 8|Overall Study||148
8085905|NCT03480802|19936550|P1|Week 8|Overall Study||150
8085906|NCT03480802|19936549|P2|STARTED|Overall Study||150
8085907|NCT03480802|19936550|P1|STARTED|Overall Study||152
8085908|NCT03480763|19936578|P2|NOT COMPLETED|Overall Study||19
8085909|NCT03480763|19936579|P1|NOT COMPLETED|Overall Study||24
8085910|NCT03480763|19936578|P2|COMPLETED|Overall Study||306
8085911|NCT03480763|19936579|P1|COMPLETED|Overall Study||303
8085912|NCT03480763|19936578|P2|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||302
8085913|NCT03480763|19936579|P1|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||298
8085914|NCT03480763|19936578|P2|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||325
8085915|NCT03480763|19936579|P1|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||326
8085916|NCT03480763|19936578|P2|STARTED|Overall Study||325
8085917|NCT03480763|19936579|P1|STARTED|Overall Study||327
8085918|NCT03480750|19936647|P6|NOT COMPLETED|Overall Study||1
8085919|NCT03480750|19936648|P5|NOT COMPLETED|Overall Study||0
8085920|NCT03480750|19936649|P4|NOT COMPLETED|Overall Study||0
8085921|NCT03480750|19936650|P3|NOT COMPLETED|Overall Study||0
8085922|NCT03480750|19936651|P2|NOT COMPLETED|Overall Study||1
8085923|NCT03480750|19936652|P1|NOT COMPLETED|Overall Study||0
8085924|NCT03480750|19936647|P6|COMPLETED|Overall Study||1
8085925|NCT03480750|19936648|P5|COMPLETED|Overall Study||3
8085926|NCT03480750|19936649|P4|COMPLETED|Overall Study||3
8085927|NCT03480750|19936650|P3|COMPLETED|Overall Study||3
8085928|NCT03480750|19936651|P2|COMPLETED|Overall Study||3
8085929|NCT03480750|19936652|P1|COMPLETED|Overall Study||3
8085930|NCT03480750|19936647|P6|STARTED|Overall Study||2
8085931|NCT03480750|19936648|P5|STARTED|Overall Study||3
8085932|NCT03480750|19936649|P4|STARTED|Overall Study||3
8085933|NCT03480750|19936650|P3|STARTED|Overall Study||3
8085934|NCT03480750|19936651|P2|STARTED|Overall Study||4
8085935|NCT03480750|19936652|P1|STARTED|Overall Study||3
8085936|NCT03480425|19936676|P1|NOT COMPLETED|Overall Study||1
8085937|NCT03480425|19936676|P1|COMPLETED|Overall Study||10
8085938|NCT03480425|19936676|P1|STARTED|Overall Study||11
8085939|NCT03480152|19936682|P3|NOT COMPLETED|Phase II||0
8085940|NCT03480152|19936683|P2|NOT COMPLETED|Phase II||0
8085941|NCT03480152|19936684|P1|NOT COMPLETED|Phase II||0
8085942|NCT03480152|19936682|P3|COMPLETED|Phase II||0
8085943|NCT03480152|19936683|P2|COMPLETED|Phase II||0
8085944|NCT03480152|19936684|P1|COMPLETED|Phase II||0
8085945|NCT03480152|19936682|P3|STARTED|Phase II||0
8085946|NCT03480152|19936683|P2|STARTED|Phase II||0
8085947|NCT03480152|19936684|P1|STARTED|Phase II||0
8085948|NCT03480152|19936682|P3|NOT COMPLETED|Phase I||0
8085949|NCT03480152|19936683|P2|NOT COMPLETED|Phase I||0
8085950|NCT03480152|19936684|P1|NOT COMPLETED|Phase I||1
8085951|NCT03480152|19936682|P3|COMPLETED|Phase I||0
8085952|NCT03480152|19936683|P2|COMPLETED|Phase I||2
8085953|NCT03480152|19936684|P1|COMPLETED|Phase I||2
8085954|NCT03480152|19936682|P3|Received Intervention|Phase I||0
8085955|NCT03480152|19936683|P2|Received Intervention|Phase I||2
8085956|NCT03480152|19936684|P1|Received Intervention|Phase I||2
8085957|NCT03480152|19936682|P3|STARTED|Phase I||0
8085958|NCT03480152|19936683|P2|STARTED|Phase I||2
8085959|NCT03480152|19936684|P1|STARTED|Phase I||3
8085960|NCT03480048|19936701|P2|NOT COMPLETED|Overall Study||8
8085961|NCT03480048|19936702|P1|NOT COMPLETED|Overall Study||10
8085962|NCT03480048|19936701|P2|COMPLETED|Overall Study||17
8085963|NCT03480048|19936702|P1|COMPLETED|Overall Study||18
8085964|NCT03480048|19936701|P2|STARTED|Overall Study||25
8085965|NCT03480048|19936702|P1|STARTED|Overall Study||28
8085966|NCT03480009|19936714|P4|NOT COMPLETED|Overall Study||0
8085967|NCT03480009|19936715|P3|NOT COMPLETED|Overall Study||4
8085968|NCT03480009|19936716|P2|NOT COMPLETED|Overall Study||5
8085969|NCT03480009|19936717|P1|NOT COMPLETED|Overall Study||4
8085970|NCT03480009|19936714|P4|COMPLETED|Overall Study||16
8085971|NCT03480009|19936715|P3|COMPLETED|Overall Study||12
8085972|NCT03480009|19936716|P2|COMPLETED|Overall Study||57
8085973|NCT03480009|19936717|P1|COMPLETED|Overall Study||58
8085974|NCT03480009|19936714|P4|STARTED|Overall Study||16
8085975|NCT03480009|19936715|P3|STARTED|Overall Study||16
8085976|NCT03480009|19936716|P2|STARTED|Overall Study||62
8085977|NCT03480009|19936717|P1|STARTED|Overall Study||62
8085978|NCT03479944|19936739|P1|NOT COMPLETED|Overall Study||0
8085979|NCT03479944|19936739|P1|COMPLETED|Overall Study||55
8085980|NCT03479944|19936739|P1|Full Analysis Set|Overall Study||53
8085981|NCT03479944|19936739|P1|Conventional|Overall Study||55
8085982|NCT03479944|19936739|P1|FLACS|Overall Study||55
8085983|NCT03479944|19936739|P1|STARTED|Overall Study||55
8085984|NCT03479216|19936752|P2|NOT COMPLETED|Overall Study||5
8085985|NCT03479216|19936753|P1|NOT COMPLETED|Overall Study||5
8085986|NCT03479216|19936752|P2|COMPLETED|Overall Study||26
8085987|NCT03479216|19936753|P1|COMPLETED|Overall Study||26
8085988|NCT03479216|19936752|P2|STARTED|Overall Study||31
8085989|NCT03479216|19936753|P1|STARTED|Overall Study||31
8086006|NCT03478891|19936803|P3|NOT COMPLETED|Overall Study||3
8086007|NCT03478891|19936804|P2|NOT COMPLETED|Overall Study||0
8086008|NCT03478891|19936805|P1|NOT COMPLETED|Overall Study||1
8086009|NCT03478891|19936803|P3|COMPLETED|Overall Study||8
8086010|NCT03478891|19936804|P2|COMPLETED|Overall Study||5
8086011|NCT03478891|19936805|P1|COMPLETED|Overall Study||2
8086012|NCT03478891|19936803|P3|Received MAb114|Overall Study|One Group 3 subject discontinued prior to MAb114 infusion due to inadequate venous access|10
8086013|NCT03478891|19936804|P2|Received MAb114|Overall Study||5
8086014|NCT03478891|19936805|P1|Received MAb114|Overall Study||3
8086015|NCT03478891|19936803|P3|STARTED|Overall Study||11
8086016|NCT03478891|19936804|P2|STARTED|Overall Study||5
8086017|NCT03478891|19936805|P1|STARTED|Overall Study||3
8086018|NCT03478696|19936856|P2|NOT COMPLETED|Overall Study||12
8086019|NCT03478696|19936857|P1|NOT COMPLETED|Overall Study||17
8086020|NCT03478696|19936856|P2|COMPLETED|Overall Study||354
8086021|NCT03478696|19936857|P1|COMPLETED|Overall Study||349
8086022|NCT03478696|19936856|P2|STARTED|Overall Study||366
8086023|NCT03478696|19936857|P1|STARTED|Overall Study||366
8086024|NCT03478683|19936871|P2|NOT COMPLETED|Overall Study||18
8086025|NCT03478683|19936872|P1|NOT COMPLETED|Overall Study||13
8086026|NCT03478683|19936871|P2|COMPLETED|Overall Study||347
8086027|NCT03478683|19936872|P1|COMPLETED|Overall Study||350
8086028|NCT03478683|19936871|P2|STARTED|Overall Study||365
8086029|NCT03478683|19936872|P1|STARTED|Overall Study||363
8086036|NCT03478644|19936902|P2|NOT COMPLETED|Phase 2||1
8086037|NCT03478644|19936903|P1|NOT COMPLETED|Phase 2||3
8086038|NCT03478644|19936902|P2|COMPLETED|Phase 2||75
8086039|NCT03478644|19936903|P1|COMPLETED|Phase 2||73
8086040|NCT03478644|19936902|P2|STARTED|Phase 2||76
8086041|NCT03478644|19936903|P1|STARTED|Phase 2||76
8086042|NCT03478644|19936902|P2|NOT COMPLETED|Phase 1||0
8086043|NCT03478644|19936903|P1|NOT COMPLETED|Phase 1||0
8086044|NCT03478644|19936902|P2|COMPLETED|Phase 1||0
8086045|NCT03478644|19936903|P1|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
8086046|NCT03478644|19936902|P2|STARTED|Phase 1||0
8086047|NCT03478644|19936903|P1|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
8086048|NCT03478371|19936915|P1|NOT COMPLETED|Overall Study||5
8086049|NCT03478371|19936915|P1|COMPLETED|Overall Study||89
8086050|NCT03478371|19936915|P1|Received Tampon V|Overall Study||91
8086051|NCT03478371|19936915|P1|Recived Tampon T|Overall Study||90
8086052|NCT03478371|19936915|P1|Received Tampon M|Overall Study||92
8086053|NCT03478371|19936915|P1|Received Tampon D|Overall Study||91
8086054|NCT03478371|19936915|P1|STARTED|Overall Study||94
8086055|NCT03478254|19936937|P1|NOT COMPLETED|Overall Study||0
8086056|NCT03478254|19936937|P1|COMPLETED|Overall Study||300
8086057|NCT03478254|19936937|P1|STARTED|Overall Study||300
8086058|NCT03477903|19936943|P1|NOT COMPLETED|Overall Study||1
8086059|NCT03477903|19936943|P1|COMPLETED|Overall Study||0
8086060|NCT03477903|19936943|P1|STARTED|Overall Study||1
8086061|NCT03476850|19936956|P2|NOT COMPLETED|Overall Study||0
8086062|NCT03476850|19936957|P1|NOT COMPLETED|Overall Study||0
8086063|NCT03476850|19936956|P2|COMPLETED|Overall Study||24
8086064|NCT03476850|19936957|P1|COMPLETED|Overall Study||24
8086065|NCT03476850|19936956|P2|STARTED|Overall Study||24
8086066|NCT03476850|19936957|P1|STARTED|Overall Study||24
8086067|NCT03476278|19936973|P1|NOT COMPLETED|Overall Study||0
8086068|NCT03476278|19936973|P1|COMPLETED|Overall Study||300
8086069|NCT03476278|19936973|P1|STARTED|Overall Study||300
8086075|NCT03476135|19937040|P2|NOT COMPLETED|Overall Study||0
8086076|NCT03476135|19937041|P1|NOT COMPLETED|Overall Study||0
8086077|NCT03476135|19937040|P2|COMPLETED|Overall Study||49
8086078|NCT03476135|19937041|P1|COMPLETED|Overall Study||42
8086079|NCT03476135|19937040|P2|STARTED|Overall Study||49
8086080|NCT03476135|19937041|P1|STARTED|Overall Study||42
8086081|NCT03475875|19937069|P2|NOT COMPLETED|Period 3||0
8086082|NCT03475875|19937070|P1|NOT COMPLETED|Period 3||0
8086083|NCT03475875|19937069|P2|COMPLETED|Period 3||43
8086084|NCT03475875|19937070|P1|COMPLETED|Period 3||40
8086085|NCT03475875|19937069|P2|STARTED|Period 3||43
8086086|NCT03475875|19937070|P1|STARTED|Period 3||40
8086087|NCT03475875|19937069|P2|NOT COMPLETED|Period 2||1
8086088|NCT03475875|19937070|P1|NOT COMPLETED|Period 2||3
8086089|NCT03475875|19937069|P2|COMPLETED|Period 2||43
8086090|NCT03475875|19937070|P1|COMPLETED|Period 2||40
8086091|NCT03475875|19937069|P2|STARTED|Period 2||44
8086092|NCT03475875|19937070|P1|STARTED|Period 2||43
8086093|NCT03475875|19937069|P2|NOT COMPLETED|Period 1||1
8086094|NCT03475875|19937070|P1|NOT COMPLETED|Period 1||3
8086095|NCT03475875|19937069|P2|COMPLETED|Period 1||44
8086096|NCT03475875|19937070|P1|COMPLETED|Period 1||43
8086097|NCT03475875|19937069|P2|STARTED|Period 1||45
8086098|NCT03475875|19937070|P1|STARTED|Period 1||46
8086107|NCT03474874|19937115|P1|NOT COMPLETED|Overall Study||14
8086108|NCT03474874|19937115|P1|COMPLETED|Overall Study||54
8086109|NCT03474874|19937115|P1|STARTED|Overall Study||68
8086110|NCT03474172|19937126|P2|NOT COMPLETED|Overall Study||0
8086111|NCT03474172|19937127|P1|NOT COMPLETED|Overall Study||0
8086112|NCT03474172|19937126|P2|COMPLETED|Overall Study||30
8086113|NCT03474172|19937127|P1|COMPLETED|Overall Study||30
8086114|NCT03474172|19937126|P2|STARTED|Overall Study||30
8086115|NCT03474172|19937127|P1|STARTED|Overall Study||30
8086124|NCT03473886|19937162|P1|NOT COMPLETED|Overall Study||1
8086125|NCT03473886|19937162|P1|COMPLETED|Overall Study||7
8086126|NCT03473886|19937162|P1|STARTED|Overall Study||8
8086127|NCT03473808|19937187|P1|NOT COMPLETED|Overall Study||1
8086128|NCT03473808|19937187|P1|COMPLETED|Overall Study||4
8086129|NCT03473808|19937187|P1|STARTED|Overall Study||5
8086130|NCT03473665|19937194|P1|NOT COMPLETED|Overall Study||0
8086131|NCT03473665|19937194|P1|COMPLETED|Overall Study||9
8086132|NCT03473665|19937194|P1|STARTED|Overall Study||9
8086133|NCT03473236|19937219|P10|NOT COMPLETED|Overall Study||0
8086134|NCT03473236|19937220|P9|NOT COMPLETED|Overall Study||1
8086135|NCT03473236|19937221|P8|NOT COMPLETED|Overall Study||0
8086136|NCT03473236|19937222|P7|NOT COMPLETED|Overall Study||0
8086137|NCT03473236|19937223|P6|NOT COMPLETED|Overall Study||1
8086138|NCT03473236|19937224|P5|NOT COMPLETED|Overall Study||0
8086139|NCT03473236|19937225|P4|NOT COMPLETED|Overall Study||0
8086140|NCT03473236|19937226|P3|NOT COMPLETED|Overall Study||0
8086141|NCT03473236|19937227|P2|NOT COMPLETED|Overall Study||0
8086142|NCT03473236|19937228|P1|NOT COMPLETED|Overall Study||0
8086143|NCT03473236|19937219|P10|COMPLETED|Overall Study||6
8086144|NCT03473236|19937220|P9|COMPLETED|Overall Study||6
8086145|NCT03473236|19937221|P8|COMPLETED|Overall Study||6
8086146|NCT03473236|19937222|P7|COMPLETED|Overall Study||6
8086147|NCT03473236|19937223|P6|COMPLETED|Overall Study||6
8086148|NCT03473236|19937224|P5|COMPLETED|Overall Study||6
8086149|NCT03473236|19937225|P4|COMPLETED|Overall Study||6
8086150|NCT03473236|19937226|P3|COMPLETED|Overall Study||6
8086151|NCT03473236|19937227|P2|COMPLETED|Overall Study||6
8086152|NCT03473236|19937228|P1|COMPLETED|Overall Study||10
8086153|NCT03473236|19937219|P10|STARTED|Overall Study||6
8086154|NCT03473236|19937220|P9|STARTED|Overall Study||7
8086155|NCT03473236|19937221|P8|STARTED|Overall Study||6
8086156|NCT03473236|19937222|P7|STARTED|Overall Study||6
8086157|NCT03473236|19937223|P6|STARTED|Overall Study||7
8086158|NCT03473236|19937224|P5|STARTED|Overall Study||6
8086159|NCT03473236|19937225|P4|STARTED|Overall Study||6
8086160|NCT03473236|19937226|P3|STARTED|Overall Study||6
8086161|NCT03473236|19937227|P2|STARTED|Overall Study||6
8086162|NCT03473236|19937228|P1|STARTED|Overall Study||10
8086163|NCT03473197|19937395|P1|NOT COMPLETED|Overall Study||10
8086164|NCT03473197|19937395|P1|COMPLETED|Overall Study||51
8086165|NCT03473197|19937395|P1|Untreated Irradiated|Overall Study||51
8086166|NCT03473197|19937395|P1|Vehicle Ointment Non-irradiated|Overall Study||51
8086167|NCT03473197|19937395|P1|Diacerein 1% Ointment Non-irradiated|Overall Study||51
8086168|NCT03473197|19937395|P1|Vehicle Ointment Irradiated|Overall Study||51
8086169|NCT03473197|19937395|P1|Diacerein 1% Ointment Irradiated|Overall Study||51
8086170|NCT03473197|19937395|P1|STARTED|Overall Study||61
8086171|NCT03473184|19937399|P1|NOT COMPLETED|Overall Study||0
8086172|NCT03473184|19937399|P1|COMPLETED|Overall Study||34
8086173|NCT03473184|19937399|P1|Untreated Irradiated|Overall Study||34
8086174|NCT03473184|19937399|P1|Vehicle Ointment Non-irradiated|Overall Study||34
8086175|NCT03473184|19937399|P1|Diacerein 1% Ointment Non-irradiated|Overall Study||34
8086176|NCT03473184|19937399|P1|Vehicle Ointment Irradiated|Overall Study||34
8086177|NCT03473184|19937399|P1|Diacerein 1% Ointment Irradiated|Overall Study||34
8086178|NCT03473184|19937399|P1|STARTED|Overall Study||34
8086179|NCT03473171|19937403|P1|NOT COMPLETED|Overall Study||0
8086180|NCT03473171|19937403|P1|COMPLETED|Overall Study||5
8086181|NCT03473171|19937403|P1|STARTED|Overall Study||5
8086182|NCT03472547|19937407|P1|NOT COMPLETED|Overall Study||30
8086183|NCT03472547|19937407|P1|COMPLETED|Overall Study||204
8086184|NCT03472547|19937407|P1|STARTED|Overall Study||234
8086185|NCT03472534|19937411|P1|NOT COMPLETED|Overall Study||11
8086186|NCT03472534|19937411|P1|COMPLETED|Overall Study||35
8086187|NCT03472534|19937411|P1|0.9% Saline|Overall Study||46
8086188|NCT03472534|19937411|P1|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46
8086189|NCT03472534|19937411|P1|Vehicle Ointment|Overall Study||46
8086190|NCT03472534|19937411|P1|Diacerein 1% Ointment|Overall Study||46
8086191|NCT03472534|19937411|P1|STARTED|Overall Study|Each participant receives all 4 unit interventions.|46
8086192|NCT03472326|19937417|P4|NOT COMPLETED|Part 2: Combination Therapy||3
8086193|NCT03472326|19937418|P3|NOT COMPLETED|Part 2: Combination Therapy||1
8086194|NCT03472326|19937419|P2|NOT COMPLETED|Part 2: Combination Therapy||0
8086195|NCT03472326|19937420|P1|NOT COMPLETED|Part 2: Combination Therapy||0
8086196|NCT03472326|19937417|P4|COMPLETED|Part 2: Combination Therapy||0
8086197|NCT03472326|19937418|P3|COMPLETED|Part 2: Combination Therapy||0
8086198|NCT03472326|19937419|P2|COMPLETED|Part 2: Combination Therapy||0
8086199|NCT03472326|19937420|P1|COMPLETED|Part 2: Combination Therapy||0
8086200|NCT03472326|19937417|P4|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 3 participants entered in Part 2.|3
8086201|NCT03472326|19937418|P3|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 1 participant entered in Part 2.|1
8086202|NCT03472326|19937419|P2|STARTED|Part 2: Combination Therapy||0
8086203|NCT03472326|19937420|P1|STARTED|Part 2: Combination Therapy||0
8086204|NCT03472326|19937417|P4|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
8086205|NCT03472326|19937418|P3|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
8086206|NCT03472326|19937419|P2|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
8086207|NCT03472326|19937420|P1|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
8086208|NCT03472326|19937417|P4|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
8086209|NCT03472326|19937418|P3|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
8086210|NCT03472326|19937419|P2|COMPLETED|Part 1: GS-9131 Functional Monotherapy||10
8086211|NCT03472326|19937420|P1|COMPLETED|Part 1: GS-9131 Functional Monotherapy||11
8086212|NCT03472326|19937417|P4|STARTED|Part 1: GS-9131 Functional Monotherapy||0
8086213|NCT03472326|19937418|P3|STARTED|Part 1: GS-9131 Functional Monotherapy||0
8086214|NCT03472326|19937419|P2|STARTED|Part 1: GS-9131 Functional Monotherapy||10
8086215|NCT03472326|19937420|P1|STARTED|Part 1: GS-9131 Functional Monotherapy||11
8086216|NCT03472287|19937442|P2|NOT COMPLETED|Overall Study||0
8086217|NCT03472287|19937443|P1|NOT COMPLETED|Overall Study||0
8086218|NCT03472287|19937442|P2|COMPLETED|Overall Study||3
8086219|NCT03472287|19937443|P1|COMPLETED|Overall Study||8
8086220|NCT03472287|19937442|P2|STARTED|Overall Study||3
8086221|NCT03472287|19937443|P1|STARTED|Overall Study||8
8086222|NCT03472014|19937449|P1|NOT COMPLETED|Overall Study||4
8086223|NCT03472014|19937449|P1|COMPLETED|Overall Study||18
8086224|NCT03472014|19937449|P1|STARTED|Overall Study||22
8086225|NCT03471975|19937460|P2|NOT COMPLETED|Overall Study||0
8086226|NCT03471975|19937461|P1|NOT COMPLETED|Overall Study||0
8086227|NCT03471975|19937460|P2|COMPLETED|Overall Study||20
8086228|NCT03471975|19937461|P1|COMPLETED|Overall Study||17
8086229|NCT03471975|19937460|P2|STARTED|Overall Study||20
8086230|NCT03471975|19937461|P1|STARTED|Overall Study||17
8086231|NCT03471871|19937471|P5|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
8086232|NCT03471871|19937472|P4|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
8086233|NCT03471871|19937473|P3|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
8086234|NCT03471871|19937474|P2|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
8086235|NCT03471871|19937475|P1|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
8086236|NCT03471871|19937471|P5|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
8086237|NCT03471871|19937472|P4|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
8086238|NCT03471871|19937473|P3|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
8086239|NCT03471871|19937474|P2|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
8086240|NCT03471871|19937475|P1|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6
8086241|NCT03471871|19937471|P5|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
8086242|NCT03471871|19937472|P4|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
8086243|NCT03471871|19937473|P3|STARTED|Follow Up (14 Days for Both HV and OSA)||5
8086244|NCT03471871|19937474|P2|STARTED|Follow Up (14 Days for Both HV and OSA)||5
8086245|NCT03471871|19937475|P1|STARTED|Follow Up (14 Days for Both HV and OSA)||6
8086246|NCT03471871|19937471|P5|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
8086247|NCT03471871|19937472|P4|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
8086248|NCT03471871|19937473|P3|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
8086249|NCT03471871|19937474|P2|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
8086250|NCT03471871|19937475|P1|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
8086251|NCT03471871|19937471|P5|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
8086252|NCT03471871|19937472|P4|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
8086253|NCT03471871|19937473|P3|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
8086254|NCT03471871|19937474|P2|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
8086255|NCT03471871|19937475|P1|COMPLETED|Treatment Period 3: ( HV:1 Day)||6
8086256|NCT03471871|19937471|P5|STARTED|Treatment Period 3: ( HV:1 Day)||0
8086257|NCT03471871|19937472|P4|STARTED|Treatment Period 3: ( HV:1 Day)||0
8086258|NCT03471871|19937473|P3|STARTED|Treatment Period 3: ( HV:1 Day)||5
8086259|NCT03471871|19937474|P2|STARTED|Treatment Period 3: ( HV:1 Day)||5
8086260|NCT03471871|19937475|P1|STARTED|Treatment Period 3: ( HV:1 Day)||6
8086261|NCT03471871|19937471|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
8086262|NCT03471871|19937472|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
8086263|NCT03471871|19937473|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
8086264|NCT03471871|19937474|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
8086265|NCT03471871|19937475|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
8086266|NCT03471871|19937471|P5|COMPLETED|Washout Period 2 (14 Days)||0
8086267|NCT03471871|19937472|P4|COMPLETED|Washout Period 2 (14 Days)||0
8086268|NCT03471871|19937473|P3|COMPLETED|Washout Period 2 (14 Days)||5
8086269|NCT03471871|19937474|P2|COMPLETED|Washout Period 2 (14 Days)||5
8086270|NCT03471871|19937475|P1|COMPLETED|Washout Period 2 (14 Days)||6
8086271|NCT03471871|19937471|P5|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
8086272|NCT03471871|19937472|P4|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
8086273|NCT03471871|19937473|P3|STARTED|Washout Period 2 (14 Days)||5
8086274|NCT03471871|19937474|P2|STARTED|Washout Period 2 (14 Days)||5
8086275|NCT03471871|19937475|P1|STARTED|Washout Period 2 (14 Days)||6
8086276|NCT03471871|19937471|P5|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1
8086277|NCT03471871|19937472|P4|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
8086278|NCT03471871|19937473|P3|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
8086279|NCT03471871|19937474|P2|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
8086280|NCT03471871|19937475|P1|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
8086281|NCT03471871|19937471|P5|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
8086282|NCT03471871|19937472|P4|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
8086283|NCT03471871|19937473|P3|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
8086284|NCT03471871|19937474|P2|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
8086285|NCT03471871|19937475|P1|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
8086286|NCT03471871|19937471|P5|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19
8086287|NCT03471871|19937472|P4|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
8086288|NCT03471871|19937473|P3|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
8086289|NCT03471871|19937474|P2|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
8086290|NCT03471871|19937475|P1|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
8086291|NCT03471871|19937471|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
8086292|NCT03471871|19937472|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
8086293|NCT03471871|19937473|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
8086294|NCT03471871|19937474|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
8086295|NCT03471871|19937475|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
8086296|NCT03471871|19937471|P5|COMPLETED|Washout Period 1 (14 Days)||19
8086297|NCT03471871|19937472|P4|COMPLETED|Washout Period 1 (14 Days)||18
8086298|NCT03471871|19937473|P3|COMPLETED|Washout Period 1 (14 Days)||5
8086299|NCT03471871|19937474|P2|COMPLETED|Washout Period 1 (14 Days)||5
8086300|NCT03471871|19937475|P1|COMPLETED|Washout Period 1 (14 Days)||6
8086301|NCT03471871|19937471|P5|STARTED|Washout Period 1 (14 Days)||19
8086302|NCT03471871|19937472|P4|STARTED|Washout Period 1 (14 Days)||18
8086303|NCT03471871|19937473|P3|STARTED|Washout Period 1 (14 Days)||5
8086304|NCT03471871|19937474|P2|STARTED|Washout Period 1 (14 Days)||5
8086305|NCT03471871|19937475|P1|STARTED|Washout Period 1 (14 Days)||6
8086306|NCT03471871|19937471|P5|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
8086307|NCT03471871|19937472|P4|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
8086308|NCT03471871|19937473|P3|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
8086309|NCT03471871|19937474|P2|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
8086310|NCT03471871|19937475|P1|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
8086311|NCT03471871|19937471|P5|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
8086312|NCT03471871|19937472|P4|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
8086313|NCT03471871|19937473|P3|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
8086314|NCT03471871|19937474|P2|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
8086315|NCT03471871|19937475|P1|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
8086316|NCT03471871|19937471|P5|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
8086317|NCT03471871|19937472|P4|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
8086318|NCT03471871|19937473|P3|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
8086319|NCT03471871|19937474|P2|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
8086320|NCT03471871|19937475|P1|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
8086321|NCT03471871|19937471|P5|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
8086322|NCT03471871|19937472|P4|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
8086323|NCT03471871|19937473|P3|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
8086324|NCT03471871|19937474|P2|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
8086325|NCT03471871|19937475|P1|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
8086326|NCT03471832|19937504|P2|NOT COMPLETED|Overall Study||0
8086327|NCT03471832|19937505|P1|NOT COMPLETED|Overall Study||0
8086328|NCT03471832|19937504|P2|COMPLETED|Overall Study||40
8086329|NCT03471832|19937505|P1|COMPLETED|Overall Study||40
8086330|NCT03471832|19937504|P2|STARTED|Overall Study||40
8086331|NCT03471832|19937505|P1|STARTED|Overall Study||40
8086332|NCT03471065|19937562|P1|NOT COMPLETED|Overall Study||0
8086333|NCT03471065|19937562|P1|COMPLETED|Overall Study||100
8086334|NCT03471065|19937562|P1|STARTED|Overall Study||100
8086335|NCT03470740|19937570|P2|NOT COMPLETED|Overall Study||6
8086336|NCT03470740|19937571|P1|NOT COMPLETED|Overall Study||4
8086337|NCT03470740|19937570|P2|COMPLETED|Overall Study||106
8086338|NCT03470740|19937571|P1|COMPLETED|Overall Study||108
8086339|NCT03470740|19937570|P2|STARTED|Overall Study||112
8086340|NCT03470740|19937571|P1|STARTED|Overall Study||112
8086341|NCT03470012|19937589|P1|NOT COMPLETED|Overall Study||0
8086342|NCT03470012|19937589|P1|COMPLETED|Overall Study||24
8086343|NCT03470012|19937589|P1|STARTED|Overall Study||24
8086344|NCT03469349|19937595|P2|NOT COMPLETED|Overall Study||10
8086345|NCT03469349|19937596|P1|NOT COMPLETED|Overall Study||5
8086346|NCT03469349|19937595|P2|COMPLETED|Overall Study||174
8086347|NCT03469349|19937596|P1|COMPLETED|Overall Study||177
8086348|NCT03469349|19937595|P2|STARTED|Overall Study||184
8086349|NCT03469349|19937596|P1|STARTED|Overall Study||182
8086350|NCT03469336|19937612|P1|NOT COMPLETED|Overall Study||1
8086351|NCT03469336|19937612|P1|COMPLETED|Overall Study||17
8086352|NCT03469336|19937612|P1|STARTED|Overall Study||18
8086353|NCT03469258|19937635|P1|NOT COMPLETED|Overall Study||4
8086354|NCT03469258|19937635|P1|COMPLETED|Overall Study||0
8086355|NCT03469258|19937635|P1|STARTED|Overall Study||4
8086356|NCT03468920|19937649|P2|NOT COMPLETED|Overall Study||0
8086357|NCT03468920|19937650|P1|NOT COMPLETED|Overall Study||0
8086358|NCT03468920|19937649|P2|COMPLETED|Overall Study||60
8086359|NCT03468920|19937650|P1|COMPLETED|Overall Study||60
8086360|NCT03468920|19937649|P2|STARTED|Overall Study||60
8086361|NCT03468920|19937650|P1|STARTED|Overall Study||60
8086362|NCT03468855|19937664|P1|NOT COMPLETED|Overall Study||11
8086363|NCT03468855|19937664|P1|COMPLETED|Overall Study||23
8086364|NCT03468855|19937664|P1|STARTED|Overall Study||34
8086365|NCT03468816|19937700|P2|NOT COMPLETED|Overall Study||0
8086366|NCT03468816|19937701|P1|NOT COMPLETED|Overall Study||0
8086367|NCT03468816|19937700|P2|COMPLETED|Overall Study||3
8086368|NCT03468816|19937701|P1|COMPLETED|Overall Study||2
8086369|NCT03468816|19937700|P2|STARTED|Overall Study||3
8086370|NCT03468816|19937701|P1|STARTED|Overall Study||2
8086371|NCT03468543|19937718|P1|NOT COMPLETED|Overall Study||3
8086372|NCT03468543|19937718|P1|COMPLETED|Overall Study||0
8086373|NCT03468543|19937718|P1|STARTED|Overall Study||3
8086374|NCT03468179|19937722|P1|NOT COMPLETED|Overall Study||0
8086375|NCT03468179|19937722|P1|COMPLETED|Overall Study||10
8086376|NCT03468179|19937722|P1|STARTED|Overall Study||10
8086377|NCT03468075|19937728|P1|NOT COMPLETED|Overall Study||0
8086378|NCT03468075|19937728|P1|COMPLETED|Overall Study||10
8086379|NCT03468075|19937728|P1|STARTED|Overall Study||10
8086380|NCT03467971|19937737|P2|NOT COMPLETED|Treatment Period 2||1
8086381|NCT03467971|19937738|P1|NOT COMPLETED|Treatment Period 2||0
8086382|NCT03467971|19937737|P2|COMPLETED|Treatment Period 2||10
8086383|NCT03467971|19937738|P1|COMPLETED|Treatment Period 2||10
8086384|NCT03467971|19937737|P2|STARTED|Treatment Period 2||11
8086385|NCT03467971|19937738|P1|STARTED|Treatment Period 2||10
8086386|NCT03467971|19937737|P2|NOT COMPLETED|Treatment Period 1||0
8086387|NCT03467971|19937738|P1|NOT COMPLETED|Treatment Period 1||0
8086388|NCT03467971|19937737|P2|COMPLETED|Treatment Period 1||11
8086389|NCT03467971|19937738|P1|COMPLETED|Treatment Period 1||10
8086390|NCT03467971|19937737|P2|STARTED|Treatment Period 1||11
8086391|NCT03467971|19937738|P1|STARTED|Treatment Period 1||10
8086392|NCT03467945|19937762|P4|NOT COMPLETED|Treatment Period 4||0
8086393|NCT03467945|19937763|P3|NOT COMPLETED|Treatment Period 4||0
8086394|NCT03467945|19937764|P2|NOT COMPLETED|Treatment Period 4||0
8086395|NCT03467945|19937765|P1|NOT COMPLETED|Treatment Period 4||0
8086396|NCT03467945|19937762|P4|COMPLETED|Treatment Period 4||9
8086397|NCT03467945|19937763|P3|COMPLETED|Treatment Period 4||8
8086398|NCT03467945|19937764|P2|COMPLETED|Treatment Period 4||9
8086399|NCT03467945|19937765|P1|COMPLETED|Treatment Period 4||9
8086400|NCT03467945|19937762|P4|STARTED|Treatment Period 4||9
8086401|NCT03467945|19937763|P3|STARTED|Treatment Period 4||8
8086402|NCT03467945|19937764|P2|STARTED|Treatment Period 4||9
8086403|NCT03467945|19937765|P1|STARTED|Treatment Period 4||9
8086404|NCT03467945|19937762|P4|NOT COMPLETED|Treatment Period 3||1
8086405|NCT03467945|19937763|P3|NOT COMPLETED|Treatment Period 3||2
8086406|NCT03467945|19937764|P2|NOT COMPLETED|Treatment Period 3||0
8086407|NCT03467945|19937765|P1|NOT COMPLETED|Treatment Period 3||1
8086408|NCT03467945|19937762|P4|COMPLETED|Treatment Period 3||9
8086409|NCT03467945|19937763|P3|COMPLETED|Treatment Period 3||8
8086410|NCT03467945|19937764|P2|COMPLETED|Treatment Period 3||9
8086411|NCT03467945|19937765|P1|COMPLETED|Treatment Period 3||9
8086412|NCT03467945|19937762|P4|STARTED|Treatment Period 3||10
8086413|NCT03467945|19937763|P3|STARTED|Treatment Period 3||10
8086414|NCT03467945|19937764|P2|STARTED|Treatment Period 3||9
8086415|NCT03467945|19937765|P1|STARTED|Treatment Period 3||10
8086416|NCT03467945|19937762|P4|NOT COMPLETED|Treatment Period 2||0
8086417|NCT03467945|19937763|P3|NOT COMPLETED|Treatment Period 2||0
8086418|NCT03467945|19937764|P2|NOT COMPLETED|Treatment Period 2||1
8086419|NCT03467945|19937765|P1|NOT COMPLETED|Treatment Period 2||0
8086420|NCT03467945|19937762|P4|COMPLETED|Treatment Period 2||10
8086421|NCT03467945|19937763|P3|COMPLETED|Treatment Period 2||10
8086422|NCT03467945|19937764|P2|COMPLETED|Treatment Period 2||9
8086423|NCT03467945|19937765|P1|COMPLETED|Treatment Period 2||10
8086424|NCT03467945|19937762|P4|STARTED|Treatment Period 2||10
8086425|NCT03467945|19937763|P3|STARTED|Treatment Period 2||10
8086426|NCT03467945|19937764|P2|STARTED|Treatment Period 2||10
8086427|NCT03467945|19937765|P1|STARTED|Treatment Period 2||10
8086428|NCT03467945|19937762|P4|NOT COMPLETED|Treatment Period 1||0
8086429|NCT03467945|19937763|P3|NOT COMPLETED|Treatment Period 1||0
8086430|NCT03467945|19937764|P2|NOT COMPLETED|Treatment Period 1||0
8086431|NCT03467945|19937765|P1|NOT COMPLETED|Treatment Period 1||0
8086432|NCT03467945|19937762|P4|COMPLETED|Treatment Period 1||10
8086433|NCT03467945|19937763|P3|COMPLETED|Treatment Period 1||10
8086434|NCT03467945|19937764|P2|COMPLETED|Treatment Period 1||10
8086435|NCT03467945|19937765|P1|COMPLETED|Treatment Period 1||10
8086436|NCT03467945|19937762|P4|STARTED|Treatment Period 1||10
8086437|NCT03467945|19937763|P3|STARTED|Treatment Period 1||10
8086438|NCT03467945|19937764|P2|STARTED|Treatment Period 1||10
8086439|NCT03467945|19937765|P1|STARTED|Treatment Period 1||10
8086440|NCT03467763|19937817|P1|NOT COMPLETED|Overall Study||3
8086441|NCT03467763|19937817|P1|COMPLETED|Overall Study||10
8086442|NCT03467763|19937817|P1|Weeks 15-16|Overall Study||2
8086443|NCT03467763|19937817|P1|Weeks 13-14|Overall Study||2
8086444|NCT03467763|19937817|P1|Week 11-12|Overall Study||6
8086445|NCT03467763|19937817|P1|Weeks 9 - 10|Overall Study||6
8086446|NCT03467763|19937817|P1|Weeks 7-8|Overall Study||7
8086447|NCT03467763|19937817|P1|Weeks 5-6|Overall Study||8
8086448|NCT03467763|19937817|P1|Weeks 3-4|Overall Study||10
8086449|NCT03467763|19937817|P1|Weeks 1-2|Overall Study||13
8086450|NCT03467763|19937817|P1|STARTED|Overall Study||13
8086451|NCT03467685|19937827|P2|NOT COMPLETED|Overall Study||0
8086452|NCT03467685|19937828|P1|NOT COMPLETED|Overall Study||0
8086453|NCT03467685|19937827|P2|COMPLETED|Overall Study||49
8086454|NCT03467685|19937828|P1|COMPLETED|Overall Study||52
8086455|NCT03467685|19937827|P2|STARTED|Overall Study||49
8086456|NCT03467685|19937828|P1|STARTED|Overall Study||52
8086457|NCT03467477|19937834|P1|NOT COMPLETED|Overall Study||0
8086458|NCT03467477|19937834|P1|COMPLETED|Overall Study||161
8086459|NCT03467477|19937834|P1|STARTED|Overall Study||161
8086460|NCT03467425|19937847|P2|NOT COMPLETED|Overall Study||54
8086461|NCT03467425|19937848|P1|NOT COMPLETED|Overall Study||47
8086462|NCT03467425|19937847|P2|COMPLETED|Overall Study||1493
8086463|NCT03467425|19937848|P1|COMPLETED|Overall Study||1498
8086464|NCT03467425|19937847|P2|WIP: Withdrawal by Participant|Overall Study||78
8086465|NCT03467425|19937848|P1|WIP: Withdrawal by Participant|Overall Study||91
8086466|NCT03467425|19937847|P2|WIP: Physician Decision|Overall Study||27
8086467|NCT03467425|19937848|P1|WIP: Physician Decision|Overall Study||14
8086468|NCT03467425|19937847|P2|WIP: Lack of Efficacy|Overall Study||28
8086469|NCT03467425|19937848|P1|WIP: Lack of Efficacy|Overall Study||56
8086470|NCT03467425|19937847|P2|WIP: Adverse Event|Overall Study||29
8086471|NCT03467425|19937848|P1|WIP: Adverse Event|Overall Study||112
8086472|NCT03467425|19937847|P2|WIP: Protocol Deviation|Overall Study||2
8086473|NCT03467425|19937848|P1|WIP: Protocol Deviation|Overall Study||0
8086474|NCT03467425|19937847|P2|Withdrew IP (WIP): Lost to Follow-up|Overall Study||24
8086475|NCT03467425|19937848|P1|Withdrew IP (WIP): Lost to Follow-up|Overall Study||15
8086476|NCT03467425|19937847|P2|Not Completed IP|Overall Study||188
8086477|NCT03467425|19937848|P1|Not Completed IP|Overall Study||288
8086478|NCT03467425|19937847|P2|Completed IP|Overall Study||1359
8086479|NCT03467425|19937848|P1|Completed IP|Overall Study||1256
8086480|NCT03467425|19937847|P2|Randomized But Did Not Start IP|Overall Study||0
8086481|NCT03467425|19937848|P1|Randomized But Did Not Start IP|Overall Study||1
8086482|NCT03467425|19937847|P2|STARTED|Overall Study||1547
8086483|NCT03467425|19937848|P1|STARTED|Overall Study||1545
8086484|NCT03467412|19937858|P5|NOT COMPLETED|Overall Study||3
8086485|NCT03467412|19937859|P4|NOT COMPLETED|Overall Study||2
8086486|NCT03467412|19937860|P3|NOT COMPLETED|Overall Study||5
8086487|NCT03467412|19937861|P2|NOT COMPLETED|Overall Study||1
8086488|NCT03467412|19937862|P1|NOT COMPLETED|Overall Study||3
8086489|NCT03467412|19937858|P5|COMPLETED|Overall Study||17
8086490|NCT03467412|19937859|P4|COMPLETED|Overall Study||23
8086491|NCT03467412|19937860|P3|COMPLETED|Overall Study||20
8086492|NCT03467412|19937861|P2|COMPLETED|Overall Study||24
8086493|NCT03467412|19937862|P1|COMPLETED|Overall Study||22
8086494|NCT03467412|19937858|P5|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|20
8086495|NCT03467412|19937859|P4|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
8086496|NCT03467412|19937860|P3|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
8086497|NCT03467412|19937861|P2|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
8086498|NCT03467412|19937862|P1|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
8086499|NCT03467048|19937897|P2|NOT COMPLETED|Overall Study||1
8086500|NCT03467048|19937898|P1|NOT COMPLETED|Overall Study||0
8086501|NCT03467048|19937897|P2|COMPLETED|Overall Study||63
8086502|NCT03467048|19937898|P1|COMPLETED|Overall Study||66
8086503|NCT03467048|19937897|P2|STARTED|Overall Study||64
8086504|NCT03467048|19937898|P1|STARTED|Overall Study||66
8086505|NCT03466918|19937908|P1|NOT COMPLETED|Overall Study||0
8086601|NCT03465904|19938022|P1|STARTED|Overall Study||298
8086506|NCT03466918|19937908|P1|COMPLETED|Overall Study|All 58 patients completed the 30-day primary endpoint.|58
8086507|NCT03466918|19937908|P1|Analysis Population|Overall Study||50
8086508|NCT03466918|19937908|P1|STARTED|Overall Study||58
8086509|NCT03466658|19937915|P1|NOT COMPLETED|Overall Study||3
8086510|NCT03466658|19937915|P1|COMPLETED|Overall Study||14
8086511|NCT03466658|19937915|P1|STARTED|Overall Study||17
8086512|NCT03466086|19937921|P2|NOT COMPLETED|Period 2||0
8086513|NCT03466086|19937922|P1|NOT COMPLETED|Period 2||0
8086514|NCT03466086|19937921|P2|COMPLETED|Period 2||27
8086515|NCT03466086|19937922|P1|COMPLETED|Period 2||26
8086516|NCT03466086|19937921|P2|STARTED|Period 2||27
8086517|NCT03466086|19937922|P1|STARTED|Period 2||26
8086518|NCT03466086|19937921|P2|NOT COMPLETED|Period 1||0
8086519|NCT03466086|19937922|P1|NOT COMPLETED|Period 1||2
8086520|NCT03466086|19937921|P2|COMPLETED|Period 1||27
8086521|NCT03466086|19937922|P1|COMPLETED|Period 1||26
8086522|NCT03466086|19937921|P2|STARTED|Period 1||27
8086523|NCT03466086|19937922|P1|STARTED|Period 1||28
8086524|NCT03466073|19937936|P6|NOT COMPLETED|Overall Study||1
8086525|NCT03466073|19937937|P5|NOT COMPLETED|Overall Study||0
8086526|NCT03466073|19937938|P4|NOT COMPLETED|Overall Study||0
8086527|NCT03466073|19937939|P3|NOT COMPLETED|Overall Study||0
8086528|NCT03466073|19937940|P2|NOT COMPLETED|Overall Study||0
8086529|NCT03466073|19937941|P1|NOT COMPLETED|Overall Study||1
8086530|NCT03466073|19937936|P6|COMPLETED|Overall Study||6
8086531|NCT03466073|19937937|P5|COMPLETED|Overall Study||6
8086532|NCT03466073|19937938|P4|COMPLETED|Overall Study||6
8086533|NCT03466073|19937939|P3|COMPLETED|Overall Study||6
8086534|NCT03466073|19937940|P2|COMPLETED|Overall Study||2
8086535|NCT03466073|19937941|P1|COMPLETED|Overall Study||5
8086536|NCT03466073|19937936|P6|STARTED|Overall Study||7
8086537|NCT03466073|19937937|P5|STARTED|Overall Study||6
8086538|NCT03466073|19937938|P4|STARTED|Overall Study||6
8086539|NCT03466073|19937939|P3|STARTED|Overall Study||6
8086540|NCT03466073|19937940|P2|STARTED|Overall Study||2
8086541|NCT03466073|19937941|P1|STARTED|Overall Study||6
8086542|NCT03466060|19937974|P6|NOT COMPLETED|Period 2||0
8086543|NCT03466060|19937975|P5|NOT COMPLETED|Period 2||0
8086544|NCT03466060|19937976|P4|NOT COMPLETED|Period 2||0
8086545|NCT03466060|19937977|P3|NOT COMPLETED|Period 2||1
8086546|NCT03466060|19937978|P2|NOT COMPLETED|Period 2||0
8086547|NCT03466060|19937979|P1|NOT COMPLETED|Period 2||0
8086548|NCT03466060|19937974|P6|COMPLETED|Period 2||18
8086549|NCT03466060|19937975|P5|COMPLETED|Period 2||20
8086550|NCT03466060|19937976|P4|COMPLETED|Period 2||17
8086551|NCT03466060|19937977|P3|COMPLETED|Period 2||16
8086552|NCT03466060|19937978|P2|COMPLETED|Period 2||16
8086553|NCT03466060|19937979|P1|COMPLETED|Period 2||19
8086554|NCT03466060|19937974|P6|STARTED|Period 2||18
8086555|NCT03466060|19937975|P5|STARTED|Period 2||20
8086556|NCT03466060|19937976|P4|STARTED|Period 2||17
8086557|NCT03466060|19937977|P3|STARTED|Period 2||17
8086558|NCT03466060|19937978|P2|STARTED|Period 2||16
8086559|NCT03466060|19937979|P1|STARTED|Period 2||19
8086560|NCT03466060|19937974|P6|NOT COMPLETED|Period 1||0
8086561|NCT03466060|19937975|P5|NOT COMPLETED|Period 1||0
8086562|NCT03466060|19937976|P4|NOT COMPLETED|Period 1||1
8086563|NCT03466060|19937977|P3|NOT COMPLETED|Period 1||3
8086564|NCT03466060|19937978|P2|NOT COMPLETED|Period 1||2
8086565|NCT03466060|19937979|P1|NOT COMPLETED|Period 1||0
8086566|NCT03466060|19937974|P6|COMPLETED|Period 1||18
8086567|NCT03466060|19937975|P5|COMPLETED|Period 1||20
8086568|NCT03466060|19937976|P4|COMPLETED|Period 1||17
8086569|NCT03466060|19937977|P3|COMPLETED|Period 1||17
8086570|NCT03466060|19937978|P2|COMPLETED|Period 1||16
8086571|NCT03466060|19937979|P1|COMPLETED|Period 1||19
8086572|NCT03466060|19937974|P6|STARTED|Period 1||18
8086573|NCT03466060|19937975|P5|STARTED|Period 1||20
8086574|NCT03466060|19937976|P4|STARTED|Period 1||18
8086575|NCT03466060|19937977|P3|STARTED|Period 1||20
8086576|NCT03466060|19937978|P2|STARTED|Period 1||18
8086577|NCT03466060|19937979|P1|STARTED|Period 1||19
8086578|NCT03466047|19937993|P1|NOT COMPLETED|Fat Small Intestine (1 Day)||0
8086579|NCT03466047|19937993|P1|COMPLETED|Fat Small Intestine (1 Day)||8
8086580|NCT03466047|19937993|P1|STARTED|Fat Small Intestine (1 Day)||8
8086581|NCT03466047|19937993|P1|NOT COMPLETED|Fat Stomach (1 Day)||0
8086582|NCT03466047|19937993|P1|COMPLETED|Fat Stomach (1 Day)||8
8086583|NCT03466047|19937993|P1|STARTED|Fat Stomach (1 Day)||8
8086584|NCT03466047|19937993|P1|NOT COMPLETED|CHO Small Intestine (1 Day)||0
8086585|NCT03466047|19937993|P1|COMPLETED|CHO Small Intestine (1 Day)||8
8086586|NCT03466047|19937993|P1|STARTED|CHO Small Intestine (1 Day)||8
8086587|NCT03466047|19937993|P1|NOT COMPLETED|CHO Stomach (1 Day)||0
8086588|NCT03466047|19937993|P1|COMPLETED|CHO Stomach (1 Day)||8
8086589|NCT03466047|19937993|P1|STARTED|CHO Stomach (1 Day)||8
8086590|NCT03466047|19937993|P1|NOT COMPLETED|Protein Small Intestine (1 Day)||0
8086591|NCT03466047|19937993|P1|COMPLETED|Protein Small Intestine (1 Day)||8
8086592|NCT03466047|19937993|P1|STARTED|Protein Small Intestine (1 Day)||8
8086593|NCT03466047|19937993|P1|NOT COMPLETED|Protein Stomach (1day)||0
8086594|NCT03466047|19937993|P1|COMPLETED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
8086595|NCT03466047|19937993|P1|STARTED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
8086596|NCT03465904|19938021|P2|NOT COMPLETED|Overall Study||66
8086597|NCT03465904|19938022|P1|NOT COMPLETED|Overall Study||89
8086598|NCT03465904|19938021|P2|COMPLETED|Overall Study||237
8086599|NCT03465904|19938022|P1|COMPLETED|Overall Study||209
8086600|NCT03465904|19938021|P2|STARTED|Overall Study||303
8086602|NCT03465891|19938042|P2|NOT COMPLETED|Overall Study||1
8086603|NCT03465891|19938043|P1|NOT COMPLETED|Overall Study||1
8086604|NCT03465891|19938042|P2|COMPLETED|Overall Study||0
8086605|NCT03465891|19938043|P1|COMPLETED|Overall Study||0
8086606|NCT03465891|19938042|P2|STARTED|Overall Study||1
8086607|NCT03465891|19938043|P1|STARTED|Overall Study||1
8086608|NCT03465878|19938051|P4|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
8086609|NCT03465878|19938052|P3|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
8086610|NCT03465878|19938053|P2|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
8086611|NCT03465878|19938054|P1|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
8086612|NCT03465878|19938051|P4|COMPLETED|Period2-Part B Second Intervention Day 1||17
8086613|NCT03465878|19938052|P3|COMPLETED|Period2-Part B Second Intervention Day 1||20
8086614|NCT03465878|19938053|P2|COMPLETED|Period2-Part B Second Intervention Day 1||0
8086615|NCT03465878|19938054|P1|COMPLETED|Period2-Part B Second Intervention Day 1||0
8086616|NCT03465878|19938051|P4|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||5
8086617|NCT03465878|19938052|P3|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||7
8086618|NCT03465878|19938053|P2|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
8086619|NCT03465878|19938054|P1|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
8086620|NCT03465878|19938051|P4|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||6
8086621|NCT03465878|19938052|P3|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||7
8086622|NCT03465878|19938053|P2|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
8086623|NCT03465878|19938054|P1|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
8086624|NCT03465878|19938051|P4|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
8086625|NCT03465878|19938052|P3|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
8086626|NCT03465878|19938053|P2|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
8086627|NCT03465878|19938054|P1|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
8086628|NCT03465878|19938051|P4|STARTED|Period2-Part B Second Intervention Day 1||17
8086629|NCT03465878|19938052|P3|STARTED|Period2-Part B Second Intervention Day 1||20
8086630|NCT03465878|19938053|P2|STARTED|Period2-Part B Second Intervention Day 1||0
8086631|NCT03465878|19938054|P1|STARTED|Period2-Part B Second Intervention Day 1||0
8086632|NCT03465878|19938051|P4|NOT COMPLETED|Period 1-Part B First Intervention Day 1||2
8086633|NCT03465878|19938052|P3|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
8086634|NCT03465878|19938053|P2|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
8086635|NCT03465878|19938054|P1|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
8086636|NCT03465878|19938051|P4|COMPLETED|Period 1-Part B First Intervention Day 1||17
8086637|NCT03465878|19938052|P3|COMPLETED|Period 1-Part B First Intervention Day 1||20
8086638|NCT03465878|19938053|P2|COMPLETED|Period 1-Part B First Intervention Day 1||0
8086639|NCT03465878|19938054|P1|COMPLETED|Period 1-Part B First Intervention Day 1||0
8086640|NCT03465878|19938051|P4|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||5
8086641|NCT03465878|19938052|P3|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||7
8086642|NCT03465878|19938053|P2|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
8086643|NCT03465878|19938054|P1|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
8086644|NCT03465878|19938051|P4|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||6
8086645|NCT03465878|19938052|P3|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||7
8086646|NCT03465878|19938053|P2|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
8086647|NCT03465878|19938054|P1|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
8086648|NCT03465878|19938051|P4|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
8086649|NCT03465878|19938052|P3|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
8086650|NCT03465878|19938053|P2|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
8086651|NCT03465878|19938054|P1|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
8086652|NCT03465878|19938051|P4|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||17
8086653|NCT03465878|19938052|P3|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||20
8086654|NCT03465878|19938053|P2|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
8086655|NCT03465878|19938054|P1|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
8086656|NCT03465878|19938051|P4|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|19
8086657|NCT03465878|19938052|P3|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|20
8086658|NCT03465878|19938053|P2|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
8086659|NCT03465878|19938054|P1|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
8086660|NCT03465878|19938051|P4|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
8086661|NCT03465878|19938052|P3|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
8086662|NCT03465878|19938053|P2|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
8086663|NCT03465878|19938054|P1|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
8086664|NCT03465878|19938051|P4|COMPLETED|Period2-Part A Second Intervention Day 1||0
8086665|NCT03465878|19938052|P3|COMPLETED|Period2-Part A Second Intervention Day 1||0
8086666|NCT03465878|19938053|P2|COMPLETED|Period2-Part A Second Intervention Day 1||20
8086667|NCT03465878|19938054|P1|COMPLETED|Period2-Part A Second Intervention Day 1||21
8086668|NCT03465878|19938051|P4|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
8086669|NCT03465878|19938052|P3|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
8086670|NCT03465878|19938053|P2|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
8086671|NCT03465878|19938054|P1|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
8086672|NCT03465878|19938051|P4|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
8086673|NCT03465878|19938052|P3|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
8086674|NCT03465878|19938053|P2|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
8086675|NCT03465878|19938054|P1|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
8086676|NCT03465878|19938051|P4|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
8086677|NCT03465878|19938052|P3|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
8086678|NCT03465878|19938053|P2|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||6
8086679|NCT03465878|19938054|P1|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||7
8086680|NCT03465878|19938051|P4|STARTED|Period2-Part A Second Intervention Day 1||0
8086681|NCT03465878|19938052|P3|STARTED|Period2-Part A Second Intervention Day 1||0
8086682|NCT03465878|19938053|P2|STARTED|Period2-Part A Second Intervention Day 1||20
8086683|NCT03465878|19938054|P1|STARTED|Period2-Part A Second Intervention Day 1||21
8086684|NCT03465878|19938051|P4|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
8086685|NCT03465878|19938052|P3|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
8086686|NCT03465878|19938053|P2|NOT COMPLETED|Period 1-Part A First Intervention Day 1||1
8086687|NCT03465878|19938054|P1|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
8086688|NCT03465878|19938051|P4|COMPLETED|Period 1-Part A First Intervention Day 1||0
8086689|NCT03465878|19938052|P3|COMPLETED|Period 1-Part A First Intervention Day 1||0
8086690|NCT03465878|19938053|P2|COMPLETED|Period 1-Part A First Intervention Day 1||20
8086691|NCT03465878|19938054|P1|COMPLETED|Period 1-Part A First Intervention Day 1||21
8086692|NCT03465878|19938051|P4|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
8086693|NCT03465878|19938052|P3|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
8086694|NCT03465878|19938053|P2|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||8
8086695|NCT03465878|19938054|P1|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||7
8086696|NCT03465878|19938051|P4|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
8086697|NCT03465878|19938052|P3|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
8086698|NCT03465878|19938053|P2|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
8086699|NCT03465878|19938054|P1|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
8086700|NCT03465878|19938051|P4|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
8086701|NCT03465878|19938052|P3|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
8086702|NCT03465878|19938053|P2|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||6
8086703|NCT03465878|19938054|P1|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||7
8086704|NCT03465878|19938051|P4|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
8086705|NCT03465878|19938052|P3|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
8086706|NCT03465878|19938053|P2|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
8086707|NCT03465878|19938054|P1|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
8086708|NCT03465878|19938051|P4|STARTED|Period 1-Part A First Intervention Day 1||0
8086709|NCT03465878|19938052|P3|STARTED|Period 1-Part A First Intervention Day 1||0
8086710|NCT03465878|19938053|P2|STARTED|Period 1-Part A First Intervention Day 1||21
8086711|NCT03465878|19938054|P1|STARTED|Period 1-Part A First Intervention Day 1||21
8086712|NCT03465735|19938094|P2|NOT COMPLETED|Overall Study||2
8086713|NCT03465735|19938095|P1|NOT COMPLETED|Overall Study||1
8086714|NCT03465735|19938094|P2|COMPLETED|Overall Study||5
8086715|NCT03465735|19938095|P1|COMPLETED|Overall Study||7
8086716|NCT03465735|19938094|P2|STARTED|Overall Study||7
8086717|NCT03465735|19938095|P1|STARTED|Overall Study||8
8086718|NCT03465709|19938101|P1|NOT COMPLETED|Overall Study||17
8086719|NCT03465709|19938101|P1|COMPLETED|Overall Study||0
8086720|NCT03465709|19938101|P1|STARTED|Overall Study||17
8086721|NCT03465436|19938113|P4|NOT COMPLETED|Period 4||0
8086722|NCT03465436|19938114|P3|NOT COMPLETED|Period 4||1
8086723|NCT03465436|19938115|P2|NOT COMPLETED|Period 4||0
8086724|NCT03465436|19938116|P1|NOT COMPLETED|Period 4||0
8086725|NCT03465436|19938113|P4|COMPLETED|Period 4||14
8086726|NCT03465436|19938114|P3|COMPLETED|Period 4||12
8086727|NCT03465436|19938115|P2|COMPLETED|Period 4||12
8086728|NCT03465436|19938116|P1|COMPLETED|Period 4||13
8086729|NCT03465436|19938113|P4|Received at Least 1 Dose of Study Drug|Period 4||14
8086730|NCT03465436|19938114|P3|Received at Least 1 Dose of Study Drug|Period 4||13
8086731|NCT03465436|19938115|P2|Received at Least 1 Dose of Study Drug|Period 4||12
8086732|NCT03465436|19938116|P1|Received at Least 1 Dose of Study Drug|Period 4||13
8086733|NCT03465436|19938113|P4|STARTED|Period 4||14
8086734|NCT03465436|19938114|P3|STARTED|Period 4||13
8086735|NCT03465436|19938115|P2|STARTED|Period 4||12
8086736|NCT03465436|19938116|P1|STARTED|Period 4||13
8086737|NCT03465436|19938113|P4|NOT COMPLETED|Period 3||0
8086738|NCT03465436|19938114|P3|NOT COMPLETED|Period 3||0
8086739|NCT03465436|19938115|P2|NOT COMPLETED|Period 3||1
8086740|NCT03465436|19938116|P1|NOT COMPLETED|Period 3||1
8086741|NCT03465436|19938113|P4|COMPLETED|Period 3||14
8086742|NCT03465436|19938114|P3|COMPLETED|Period 3||13
8086743|NCT03465436|19938115|P2|COMPLETED|Period 3||12
8086744|NCT03465436|19938116|P1|COMPLETED|Period 3||13
8086745|NCT03465436|19938113|P4|Received at Least One Dose of Study Drug|Period 3||14
8086746|NCT03465436|19938114|P3|Received at Least One Dose of Study Drug|Period 3||13
8086747|NCT03465436|19938115|P2|Received at Least One Dose of Study Drug|Period 3||12
8086748|NCT03465436|19938116|P1|Received at Least One Dose of Study Drug|Period 3||13
8086749|NCT03465436|19938113|P4|STARTED|Period 3||14
8086750|NCT03465436|19938114|P3|STARTED|Period 3||13
8086751|NCT03465436|19938115|P2|STARTED|Period 3||13
8086752|NCT03465436|19938116|P1|STARTED|Period 3||14
8086753|NCT03465436|19938113|P4|NOT COMPLETED|Period 2||0
8086754|NCT03465436|19938114|P3|NOT COMPLETED|Period 2||0
8086755|NCT03465436|19938115|P2|NOT COMPLETED|Period 2||1
8086756|NCT03465436|19938116|P1|NOT COMPLETED|Period 2||0
8086757|NCT03465436|19938113|P4|COMPLETED|Period 2||14
8086758|NCT03465436|19938114|P3|COMPLETED|Period 2||13
8086759|NCT03465436|19938115|P2|COMPLETED|Period 2||13
8086760|NCT03465436|19938116|P1|COMPLETED|Period 2||14
8086761|NCT03465436|19938113|P4|Received at Least 1 Dose of Study Drug|Period 2||14
8086762|NCT03465436|19938114|P3|Received at Least 1 Dose of Study Drug|Period 2||13
8086763|NCT03465436|19938115|P2|Received at Least 1 Dose of Study Drug|Period 2||13
8086764|NCT03465436|19938116|P1|Received at Least 1 Dose of Study Drug|Period 2||14
8086765|NCT03465436|19938113|P4|STARTED|Period 2||14
8086766|NCT03465436|19938114|P3|STARTED|Period 2||13
8086767|NCT03465436|19938115|P2|STARTED|Period 2||14
8086768|NCT03465436|19938116|P1|STARTED|Period 2||14
8086769|NCT03465436|19938113|P4|NOT COMPLETED|Period 1||0
8086770|NCT03465436|19938114|P3|NOT COMPLETED|Period 1||1
8086771|NCT03465436|19938115|P2|NOT COMPLETED|Period 1||0
8086772|NCT03465436|19938116|P1|NOT COMPLETED|Period 1||0
8086773|NCT03465436|19938113|P4|COMPLETED|Period 1||14
8086774|NCT03465436|19938114|P3|COMPLETED|Period 1||13
8086775|NCT03465436|19938115|P2|COMPLETED|Period 1||14
8086776|NCT03465436|19938116|P1|COMPLETED|Period 1||14
8086777|NCT03465436|19938113|P4|Received at Least 1 Dose of Study Drug|Period 1||14
8086778|NCT03465436|19938114|P3|Received at Least 1 Dose of Study Drug|Period 1||14
8086779|NCT03465436|19938115|P2|Received at Least 1 Dose of Study Drug|Period 1||14
8086780|NCT03465436|19938116|P1|Received at Least 1 Dose of Study Drug|Period 1||14
8086781|NCT03465436|19938113|P4|STARTED|Period 1||14
8086782|NCT03465436|19938114|P3|STARTED|Period 1||14
8086783|NCT03465436|19938115|P2|STARTED|Period 1||14
8086784|NCT03465436|19938116|P1|STARTED|Period 1||14
8086785|NCT03464383|19938153|P3|NOT COMPLETED|Overall Study||0
8086786|NCT03464383|19938154|P2|NOT COMPLETED|Overall Study||1
8086787|NCT03464383|19938155|P1|NOT COMPLETED|Overall Study||1
8086788|NCT03464383|19938153|P3|COMPLETED|Overall Study||63
8086789|NCT03464383|19938154|P2|COMPLETED|Overall Study||2
8086790|NCT03464383|19938155|P1|COMPLETED|Overall Study||2
8086791|NCT03464383|19938153|P3|STARTED|Overall Study||63
8086792|NCT03464383|19938154|P2|STARTED|Overall Study||3
8086793|NCT03464383|19938155|P1|STARTED|Overall Study||3
8086794|NCT03463941|19938180|P1|NOT COMPLETED|Overall Study||18
8086795|NCT03463941|19938180|P1|COMPLETED|Overall Study||62
8086796|NCT03463941|19938180|P1|STARTED|Overall Study||80
8086797|NCT03463512|19938192|P2|NOT COMPLETED|Overall Study||0
8086798|NCT03463512|19938193|P1|NOT COMPLETED|Overall Study||0
8086799|NCT03463512|19938192|P2|COMPLETED|Overall Study||62
8086800|NCT03463512|19938193|P1|COMPLETED|Overall Study||62
8086801|NCT03463512|19938192|P2|STARTED|Overall Study||62
8086802|NCT03463512|19938193|P1|STARTED|Overall Study||62
8086803|NCT03463161|19938203|P1|NOT COMPLETED|Overall Study||0
8086804|NCT03463161|19938203|P1|COMPLETED|Overall Study||2
8086805|NCT03463161|19938203|P1|STARTED|Overall Study||2
8086806|NCT03463031|19938212|P2|NOT COMPLETED|Overall Study||5
8086807|NCT03463031|19938213|P1|NOT COMPLETED|Overall Study||10
8086808|NCT03463031|19938212|P2|COMPLETED|Overall Study||216
8086809|NCT03463031|19938213|P1|COMPLETED|Overall Study||215
8086810|NCT03463031|19938212|P2|STARTED|Overall Study||221
8086811|NCT03463031|19938213|P1|STARTED|Overall Study||225
8086812|NCT03462927|19938227|P2|NOT COMPLETED|Overall Study||2
8086813|NCT03462927|19938228|P1|NOT COMPLETED|Overall Study||6
8086814|NCT03462927|19938227|P2|COMPLETED|Overall Study||29
8086815|NCT03462927|19938228|P1|COMPLETED|Overall Study||26
8086816|NCT03462927|19938227|P2|STARTED|Overall Study||31
8086817|NCT03462927|19938228|P1|STARTED|Overall Study||32
8086818|NCT03462745|19938254|P2|NOT COMPLETED|Overall Study||0
8086819|NCT03462745|19938255|P1|NOT COMPLETED|Overall Study||0
8086820|NCT03462745|19938254|P2|COMPLETED|Overall Study||92
8086821|NCT03462745|19938255|P1|COMPLETED|Overall Study||92
8086822|NCT03462745|19938254|P2|STARTED|Overall Study||92
8086823|NCT03462745|19938255|P1|STARTED|Overall Study||92
8086824|NCT03462082|19938261|P8|NOT COMPLETED|Open Label Phase||2
8086825|NCT03462082|19938262|P7|NOT COMPLETED|Open Label Phase||1
8086826|NCT03462082|19938263|P6|NOT COMPLETED|Open Label Phase||0
8086827|NCT03462082|19938264|P5|NOT COMPLETED|Open Label Phase||0
8086828|NCT03462082|19938265|P4|NOT COMPLETED|Open Label Phase||0
8086829|NCT03462082|19938266|P3|NOT COMPLETED|Open Label Phase||0
8086830|NCT03462082|19938267|P2|NOT COMPLETED|Open Label Phase||0
8086831|NCT03462082|19938268|P1|NOT COMPLETED|Open Label Phase||0
8086832|NCT03462082|19938261|P8|COMPLETED|Open Label Phase||8
8086833|NCT03462082|19938262|P7|COMPLETED|Open Label Phase||6
8086834|NCT03462082|19938263|P6|COMPLETED|Open Label Phase||0
8086835|NCT03462082|19938264|P5|COMPLETED|Open Label Phase||0
8086836|NCT03462082|19938265|P4|COMPLETED|Open Label Phase||0
8086837|NCT03462082|19938266|P3|COMPLETED|Open Label Phase||0
8086838|NCT03462082|19938267|P2|COMPLETED|Open Label Phase||0
8086839|NCT03462082|19938268|P1|COMPLETED|Open Label Phase||0
8086840|NCT03462082|19938261|P8|STARTED|Open Label Phase||10
8086841|NCT03462082|19938262|P7|STARTED|Open Label Phase||7
8086842|NCT03462082|19938263|P6|STARTED|Open Label Phase||0
8086843|NCT03462082|19938264|P5|STARTED|Open Label Phase||0
8086844|NCT03462082|19938265|P4|STARTED|Open Label Phase||0
8086845|NCT03462082|19938266|P3|STARTED|Open Label Phase||0
8086846|NCT03462082|19938267|P2|STARTED|Open Label Phase||0
8086847|NCT03462082|19938268|P1|STARTED|Open Label Phase||0
8086848|NCT03462082|19938261|P8|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086849|NCT03462082|19938262|P7|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086850|NCT03462082|19938263|P6|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086851|NCT03462082|19938264|P5|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086852|NCT03462082|19938265|P4|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086853|NCT03462082|19938266|P3|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086854|NCT03462082|19938267|P2|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086855|NCT03462082|19938268|P1|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086856|NCT03462082|19938261|P8|COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086857|NCT03462082|19938262|P7|COMPLETED|Study Phase (Randomized, Blinded Period)||0
8086858|NCT03462082|19938263|P6|COMPLETED|Study Phase (Randomized, Blinded Period)||5
8086859|NCT03462082|19938264|P5|COMPLETED|Study Phase (Randomized, Blinded Period)||3
8086860|NCT03462082|19938265|P4|COMPLETED|Study Phase (Randomized, Blinded Period)||3
8086861|NCT03462082|19938266|P3|COMPLETED|Study Phase (Randomized, Blinded Period)||4
8086862|NCT03462082|19938267|P2|COMPLETED|Study Phase (Randomized, Blinded Period)||4
8086863|NCT03462082|19938268|P1|COMPLETED|Study Phase (Randomized, Blinded Period)||3
8086864|NCT03462082|19938261|P8|STARTED|Study Phase (Randomized, Blinded Period)||0
8086865|NCT03462082|19938262|P7|STARTED|Study Phase (Randomized, Blinded Period)||0
8086866|NCT03462082|19938263|P6|STARTED|Study Phase (Randomized, Blinded Period)||5
8086867|NCT03462082|19938264|P5|STARTED|Study Phase (Randomized, Blinded Period)||3
8086868|NCT03462082|19938265|P4|STARTED|Study Phase (Randomized, Blinded Period)||3
8086869|NCT03462082|19938266|P3|STARTED|Study Phase (Randomized, Blinded Period)||4
8086870|NCT03462082|19938267|P2|STARTED|Study Phase (Randomized, Blinded Period)||4
8086871|NCT03462082|19938268|P1|STARTED|Study Phase (Randomized, Blinded Period)||3
8086872|NCT03461757|19938319|P2|NOT COMPLETED|Overall Study||45
8086873|NCT03461757|19938320|P1|NOT COMPLETED|Overall Study||53
8086874|NCT03461757|19938319|P2|COMPLETED|Overall Study||689
8086875|NCT03461757|19938320|P1|COMPLETED|Overall Study||679
8086876|NCT03461757|19938319|P2|Treated|Overall Study||693
8086877|NCT03461757|19938320|P1|Treated|Overall Study||682
8086878|NCT03461757|19938319|P2|STARTED|Overall Study||734
8086879|NCT03461757|19938320|P1|STARTED|Overall Study||732
8086880|NCT03461705|19938370|P1|NOT COMPLETED|Overall Study||0
8086881|NCT03461705|19938370|P1|COMPLETED|Overall Study||5
8086882|NCT03461705|19938370|P1|STARTED|Overall Study||5
8086883|NCT03460990|19938383|P2|NOT COMPLETED|Overall Study||0
8086884|NCT03460990|19938384|P1|NOT COMPLETED|Overall Study||0
8086885|NCT03460990|19938383|P2|COMPLETED|Overall Study||54
8086886|NCT03460990|19938384|P1|COMPLETED|Overall Study||57
8086887|NCT03460990|19938383|P2|STARTED|Overall Study||54
8086888|NCT03460990|19938384|P1|STARTED|Overall Study||57
8086889|NCT03460899|19938398|P1|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0
8086890|NCT03460899|19938398|P1|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14
8086891|NCT03460899|19938398|P1|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14
8086892|NCT03460899|19938398|P1|NOT COMPLETED|Euglycaemic Clamp||0
8086893|NCT03460899|19938398|P1|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14
8086894|NCT03460899|19938398|P1|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14
8086895|NCT03460587|19938405|P1|NOT COMPLETED|Overall Study||0
8086896|NCT03460587|19938405|P1|COMPLETED|Overall Study||13
8086897|NCT03460587|19938405|P1|STARTED|Overall Study||13
8086898|NCT03459794|19938412|P2|NOT COMPLETED|Overall Study||0
8086899|NCT03459794|19938413|P1|NOT COMPLETED|Overall Study||0
8086900|NCT03459794|19938412|P2|COMPLETED|Overall Study||4
8086901|NCT03459794|19938413|P1|COMPLETED|Overall Study||8
8086902|NCT03459794|19938412|P2|STARTED|Overall Study||4
8086903|NCT03459794|19938413|P1|STARTED|Overall Study||8
8086904|NCT03459612|19938433|P4|NOT COMPLETED|Period 4||0
8086905|NCT03459612|19938434|P3|NOT COMPLETED|Period 4||0
8086906|NCT03459612|19938435|P2|NOT COMPLETED|Period 4||0
8086907|NCT03459612|19938436|P1|NOT COMPLETED|Period 4||0
8086908|NCT03459612|19938433|P4|COMPLETED|Period 4||17
8086909|NCT03459612|19938434|P3|COMPLETED|Period 4||16
8086910|NCT03459612|19938435|P2|COMPLETED|Period 4||17
8086911|NCT03459612|19938436|P1|COMPLETED|Period 4||17
8086912|NCT03459612|19938433|P4|Received at Least 1 Dose of Study Drug|Period 4||17
8086913|NCT03459612|19938434|P3|Received at Least 1 Dose of Study Drug|Period 4||16
8086914|NCT03459612|19938435|P2|Received at Least 1 Dose of Study Drug|Period 4||17
8086915|NCT03459612|19938436|P1|Received at Least 1 Dose of Study Drug|Period 4||17
8086916|NCT03459612|19938433|P4|STARTED|Period 4||17
8086917|NCT03459612|19938434|P3|STARTED|Period 4|One participant completed period 3 and withdrew for personal reasons prior to Period 4.|16
8086918|NCT03459612|19938435|P2|STARTED|Period 4||17
8086919|NCT03459612|19938436|P1|STARTED|Period 4||17
8086920|NCT03459612|19938433|P4|NOT COMPLETED|Period 3||0
8086921|NCT03459612|19938434|P3|NOT COMPLETED|Period 3||0
8086922|NCT03459612|19938435|P2|NOT COMPLETED|Period 3||0
8086923|NCT03459612|19938436|P1|NOT COMPLETED|Period 3||0
8086924|NCT03459612|19938433|P4|COMPLETED|Period 3||17
8086925|NCT03459612|19938434|P3|COMPLETED|Period 3||17
8086926|NCT03459612|19938435|P2|COMPLETED|Period 3||17
8086927|NCT03459612|19938436|P1|COMPLETED|Period 3||17
8086928|NCT03459612|19938433|P4|Received at Least 1 Dose of Study Drug|Period 3||17
8086929|NCT03459612|19938434|P3|Received at Least 1 Dose of Study Drug|Period 3||17
8086930|NCT03459612|19938435|P2|Received at Least 1 Dose of Study Drug|Period 3||17
8086931|NCT03459612|19938436|P1|Received at Least 1 Dose of Study Drug|Period 3||17
8086932|NCT03459612|19938433|P4|STARTED|Period 3||17
8086933|NCT03459612|19938434|P3|STARTED|Period 3||17
8086934|NCT03459612|19938435|P2|STARTED|Period 3||17
8086935|NCT03459612|19938436|P1|STARTED|Period 3||17
8086936|NCT03459612|19938433|P4|NOT COMPLETED|Period 2||0
8086937|NCT03459612|19938434|P3|NOT COMPLETED|Period 2||0
8086938|NCT03459612|19938435|P2|NOT COMPLETED|Period 2||0
8086939|NCT03459612|19938436|P1|NOT COMPLETED|Period 2||0
8086940|NCT03459612|19938433|P4|COMPLETED|Period 2||17
8086941|NCT03459612|19938434|P3|COMPLETED|Period 2||17
8086942|NCT03459612|19938435|P2|COMPLETED|Period 2||17
8086943|NCT03459612|19938436|P1|COMPLETED|Period 2||17
8086944|NCT03459612|19938433|P4|Received at Least 1 Dose of Study Drug|Period 2||17
8086945|NCT03459612|19938434|P3|Received at Least 1 Dose of Study Drug|Period 2||17
8086946|NCT03459612|19938435|P2|Received at Least 1 Dose of Study Drug|Period 2||17
8086947|NCT03459612|19938436|P1|Received at Least 1 Dose of Study Drug|Period 2||17
8086948|NCT03459612|19938433|P4|STARTED|Period 2||17
8086949|NCT03459612|19938434|P3|STARTED|Period 2||17
8086950|NCT03459612|19938435|P2|STARTED|Period 2||17
8086951|NCT03459612|19938436|P1|STARTED|Period 2||17
8086952|NCT03459612|19938433|P4|NOT COMPLETED|Period 1||0
8086953|NCT03459612|19938434|P3|NOT COMPLETED|Period 1||0
8086954|NCT03459612|19938435|P2|NOT COMPLETED|Period 1||0
8086955|NCT03459612|19938436|P1|NOT COMPLETED|Period 1||0
8086956|NCT03459612|19938433|P4|COMPLETED|Period 1||17
8086957|NCT03459612|19938434|P3|COMPLETED|Period 1||17
8086958|NCT03459612|19938435|P2|COMPLETED|Period 1||17
8086959|NCT03459612|19938436|P1|COMPLETED|Period 1||17
8086960|NCT03459612|19938433|P4|Received at Least 1 Dose of Study Drug|Period 1||17
8086961|NCT03459612|19938434|P3|Received at Least 1 Dose of Study Drug|Period 1||17
8086962|NCT03459612|19938435|P2|Received at Least 1 Dose of Study Drug|Period 1||17
8086963|NCT03459612|19938436|P1|Received at Least 1 Dose of Study Drug|Period 1||17
8086964|NCT03459612|19938433|P4|STARTED|Period 1||17
8086965|NCT03459612|19938434|P3|STARTED|Period 1||17
8086966|NCT03459612|19938435|P2|STARTED|Period 1||17
8086967|NCT03459612|19938436|P1|STARTED|Period 1||17
8086968|NCT03459196|19938494|P1|NOT COMPLETED|Overall Study||2
8086969|NCT03459196|19938494|P1|COMPLETED|Overall Study||52
8086970|NCT03459196|19938494|P1|STARTED|Overall Study||54
8086971|NCT03459131|19938499|P2|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
8086972|NCT03459131|19938500|P1|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
8086973|NCT03459131|19938499|P2|COMPLETED|Period 2, Second 7 Days of Wear||8
8086974|NCT03459131|19938500|P1|COMPLETED|Period 2, Second 7 Days of Wear||7
8086975|NCT03459131|19938499|P2|STARTED|Period 2, Second 7 Days of Wear||8
8086976|NCT03459131|19938500|P1|STARTED|Period 2, Second 7 Days of Wear||7
8086977|NCT03459131|19938499|P2|NOT COMPLETED|Period 1, First 7 Days of Wear||0
8086978|NCT03459131|19938500|P1|NOT COMPLETED|Period 1, First 7 Days of Wear||0
8086979|NCT03459131|19938499|P2|COMPLETED|Period 1, First 7 Days of Wear||8
8086980|NCT03459131|19938500|P1|COMPLETED|Period 1, First 7 Days of Wear||7
8086981|NCT03459131|19938499|P2|STARTED|Period 1, First 7 Days of Wear||8
8086982|NCT03459131|19938500|P1|STARTED|Period 1, First 7 Days of Wear||7
8086983|NCT03458871|19938508|P1|NOT COMPLETED|Overall Study||0
8086984|NCT03458871|19938508|P1|COMPLETED|Overall Study||16
8086985|NCT03458871|19938508|P1|STARTED|Overall Study||16
8086986|NCT03458702|19938538|P2|NOT COMPLETED|Picture Rating/Body Composition||0
8086987|NCT03458702|19938539|P1|NOT COMPLETED|Picture Rating/Body Composition||0
8086988|NCT03458702|19938538|P2|COMPLETED|Picture Rating/Body Composition||20
8086989|NCT03458702|19938539|P1|COMPLETED|Picture Rating/Body Composition||20
8086990|NCT03458702|19938538|P2|STARTED|Picture Rating/Body Composition||20
8086991|NCT03458702|19938539|P1|STARTED|Picture Rating/Body Composition||20
8086992|NCT03458702|19938538|P2|NOT COMPLETED|Study Condition B (Yoga or Rest)||2
8086993|NCT03458702|19938539|P1|NOT COMPLETED|Study Condition B (Yoga or Rest)||4
8086994|NCT03458702|19938538|P2|COMPLETED|Study Condition B (Yoga or Rest)||20
8086995|NCT03458702|19938539|P1|COMPLETED|Study Condition B (Yoga or Rest)||20
8086996|NCT03458702|19938538|P2|STARTED|Study Condition B (Yoga or Rest)||22
8086997|NCT03458702|19938539|P1|STARTED|Study Condition B (Yoga or Rest)||24
8086998|NCT03458702|19938538|P2|NOT COMPLETED|Study Condition A (Yoga or Rest)||6
8086999|NCT03458702|19938539|P1|NOT COMPLETED|Study Condition A (Yoga or Rest)||4
8087000|NCT03458702|19938538|P2|COMPLETED|Study Condition A (Yoga or Rest)||22
8087001|NCT03458702|19938539|P1|COMPLETED|Study Condition A (Yoga or Rest)||24
8087002|NCT03458702|19938538|P2|STARTED|Study Condition A (Yoga or Rest)||28
8087003|NCT03458702|19938539|P1|STARTED|Study Condition A (Yoga or Rest)||28
8087004|NCT03457909|19938555|P1|NOT COMPLETED|Overall Study||0
8087005|NCT03457909|19938555|P1|COMPLETED|Overall Study||25
8087006|NCT03457909|19938555|P1|STARTED|Overall Study||25
8087175|NCT03457636|19938768|P1|NOT COMPLETED|Overall Study||2
8087176|NCT03457636|19938768|P1|COMPLETED|Overall Study||20
8087177|NCT03457636|19938768|P1|STARTED|Overall Study||22
8087178|NCT03456960|19938781|P6|NOT COMPLETED|Period 2 (1 Day)||0
8087179|NCT03456960|19938782|P5|NOT COMPLETED|Period 2 (1 Day)||0
8087180|NCT03456960|19938783|P4|NOT COMPLETED|Period 2 (1 Day)||1
8087181|NCT03456960|19938784|P3|NOT COMPLETED|Period 2 (1 Day)||0
8087182|NCT03456960|19938785|P2|NOT COMPLETED|Period 2 (1 Day)||0
8087183|NCT03456960|19938786|P1|NOT COMPLETED|Period 2 (1 Day)||1
8087184|NCT03456960|19938781|P6|COMPLETED|Period 2 (1 Day)||6
8087185|NCT03456960|19938782|P5|COMPLETED|Period 2 (1 Day)||6
8087186|NCT03456960|19938783|P4|COMPLETED|Period 2 (1 Day)||117
8087187|NCT03456960|19938784|P3|COMPLETED|Period 2 (1 Day)||119
8087188|NCT03456960|19938785|P2|COMPLETED|Period 2 (1 Day)||12
8087189|NCT03456960|19938786|P1|COMPLETED|Period 2 (1 Day)||11
8087190|NCT03456960|19938781|P6|STARTED|Period 2 (1 Day)||6
8087191|NCT03456960|19938782|P5|STARTED|Period 2 (1 Day)||6
8087192|NCT03456960|19938783|P4|STARTED|Period 2 (1 Day)||118
8087193|NCT03456960|19938784|P3|STARTED|Period 2 (1 Day)||119
8087194|NCT03456960|19938785|P2|STARTED|Period 2 (1 Day)||12
8087195|NCT03456960|19938786|P1|STARTED|Period 2 (1 Day)||12
8087196|NCT03456960|19938781|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8087197|NCT03456960|19938782|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8087198|NCT03456960|19938783|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||2
8087199|NCT03456960|19938784|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||1
8087200|NCT03456960|19938785|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8087201|NCT03456960|19938786|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8087202|NCT03456960|19938781|P6|COMPLETED|Washout Period (at Least 14 Days)||6
8087203|NCT03456960|19938782|P5|COMPLETED|Washout Period (at Least 14 Days)||6
8087204|NCT03456960|19938783|P4|COMPLETED|Washout Period (at Least 14 Days)||118
8087205|NCT03456960|19938784|P3|COMPLETED|Washout Period (at Least 14 Days)||119
8087206|NCT03456960|19938785|P2|COMPLETED|Washout Period (at Least 14 Days)||12
8087207|NCT03456960|19938786|P1|COMPLETED|Washout Period (at Least 14 Days)||12
8087208|NCT03456960|19938781|P6|STARTED|Washout Period (at Least 14 Days)||6
8087209|NCT03456960|19938782|P5|STARTED|Washout Period (at Least 14 Days)||6
8087210|NCT03456960|19938783|P4|STARTED|Washout Period (at Least 14 Days)||120
8087211|NCT03456960|19938784|P3|STARTED|Washout Period (at Least 14 Days)||120
8087212|NCT03456960|19938785|P2|STARTED|Washout Period (at Least 14 Days)||12
8087213|NCT03456960|19938786|P1|STARTED|Washout Period (at Least 14 Days)||12
8087214|NCT03456960|19938781|P6|NOT COMPLETED|Period 1 (1 Day)||0
8087215|NCT03456960|19938782|P5|NOT COMPLETED|Period 1 (1 Day)||0
8087216|NCT03456960|19938783|P4|NOT COMPLETED|Period 1 (1 Day)||0
8087217|NCT03456960|19938784|P3|NOT COMPLETED|Period 1 (1 Day)||0
8087218|NCT03456960|19938785|P2|NOT COMPLETED|Period 1 (1 Day)||0
8087219|NCT03456960|19938786|P1|NOT COMPLETED|Period 1 (1 Day)||0
8087220|NCT03456960|19938781|P6|COMPLETED|Period 1 (1 Day)||6
8087221|NCT03456960|19938782|P5|COMPLETED|Period 1 (1 Day)||6
8087222|NCT03456960|19938783|P4|COMPLETED|Period 1 (1 Day)||120
8087223|NCT03456960|19938784|P3|COMPLETED|Period 1 (1 Day)||120
8087224|NCT03456960|19938785|P2|COMPLETED|Period 1 (1 Day)||12
8087225|NCT03456960|19938786|P1|COMPLETED|Period 1 (1 Day)||12
8087226|NCT03456960|19938781|P6|STARTED|Period 1 (1 Day)||6
8087227|NCT03456960|19938782|P5|STARTED|Period 1 (1 Day)||6
8087228|NCT03456960|19938783|P4|STARTED|Period 1 (1 Day)||120
8087229|NCT03456960|19938784|P3|STARTED|Period 1 (1 Day)||120
8087230|NCT03456960|19938785|P2|STARTED|Period 1 (1 Day)||12
8087231|NCT03456960|19938786|P1|STARTED|Period 1 (1 Day)||12
8087232|NCT03456856|19938878|P1|NOT COMPLETED|Overall Study||3
8087233|NCT03456856|19938878|P1|COMPLETED|Overall Study||27
8087234|NCT03456856|19938878|P1|STARTED|Overall Study||30
8087238|NCT03456427|19938890|P1|NOT COMPLETED|Overall Study||3
8087239|NCT03456427|19938890|P1|COMPLETED|Overall Study||33
8087240|NCT03456427|19938890|P1|STARTED|Overall Study||36
8087241|NCT03456245|19938899|P1|NOT COMPLETED|Overall Study||15
8087242|NCT03456245|19938899|P1|COMPLETED|Overall Study||190
8087243|NCT03456245|19938899|P1|STARTED|Overall Study||205
8087244|NCT03455556|19938903|P1|NOT COMPLETED|Overall Study||0
8087245|NCT03455556|19938903|P1|COMPLETED|Overall Study||1
8087246|NCT03455556|19938903|P1|STARTED|Overall Study||1
8087247|NCT03455543|19938914|P3|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||37
8087248|NCT03455543|19938915|P2|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
8087249|NCT03455543|19938916|P1|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
8087250|NCT03455543|19938914|P3|COMPLETED|Part B: Open-label Extension (24 Weeks)||115
8087251|NCT03455543|19938915|P2|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
8087252|NCT03455543|19938916|P1|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
8087253|NCT03455543|19938914|P3|STARTED|Part B: Open-label Extension (24 Weeks)||152
8087254|NCT03455543|19938915|P2|STARTED|Part B: Open-label Extension (24 Weeks)||0
8087255|NCT03455543|19938916|P1|STARTED|Part B: Open-label Extension (24 Weeks)||0
8087256|NCT03455543|19938914|P3|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
8087257|NCT03455543|19938915|P2|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||7
8087258|NCT03455543|19938916|P1|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||11
8087259|NCT03455543|19938914|P3|COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
8087260|NCT03455543|19938915|P2|COMPLETED|Part A: Randomized Treatment (17 Weeks)||83
8087261|NCT03455543|19938916|P1|COMPLETED|Part A: Randomized Treatment (17 Weeks)||81
8087262|NCT03455543|19938914|P3|STARTED|Part A: Randomized Treatment (17 Weeks)||0
8087263|NCT03455543|19938915|P2|STARTED|Part A: Randomized Treatment (17 Weeks)||90
8087264|NCT03455543|19938916|P1|STARTED|Part A: Randomized Treatment (17 Weeks)||92
8087265|NCT03455491|19938957|P3|NOT COMPLETED|Overall Study||0
8087266|NCT03455491|19938958|P2|NOT COMPLETED|Overall Study||0
8087267|NCT03455491|19938959|P1|NOT COMPLETED|Overall Study||0
8087268|NCT03455491|19938957|P3|COMPLETED|Overall Study||40
8087269|NCT03455491|19938958|P2|COMPLETED|Overall Study||40
8087270|NCT03455491|19938959|P1|COMPLETED|Overall Study||40
8087271|NCT03455491|19938957|P3|STARTED|Overall Study||40
8087272|NCT03455491|19938958|P2|STARTED|Overall Study||40
8087273|NCT03455491|19938959|P1|STARTED|Overall Study||40
8087274|NCT03455218|19938978|P2|NOT COMPLETED|Overall Study||0
8087275|NCT03455218|19938979|P1|NOT COMPLETED|Overall Study||0
8087276|NCT03455218|19938978|P2|COMPLETED|Overall Study||22
8087277|NCT03455218|19938979|P1|COMPLETED|Overall Study||18
8087278|NCT03455218|19938978|P2|STARTED|Overall Study||22
8087279|NCT03455218|19938979|P1|STARTED|Overall Study||18
8087280|NCT03454581|19939018|P3|NOT COMPLETED|Overall Study||3
8087281|NCT03454581|19939019|P2|NOT COMPLETED|Overall Study||3
8087282|NCT03454581|19939020|P1|NOT COMPLETED|Overall Study||4
8087283|NCT03454581|19939018|P3|COMPLETED|Overall Study||14
8087284|NCT03454581|19939019|P2|COMPLETED|Overall Study||13
8087285|NCT03454581|19939020|P1|COMPLETED|Overall Study||14
8087286|NCT03454581|19939018|P3|STARTED|Overall Study||17
8087287|NCT03454581|19939019|P2|STARTED|Overall Study||16
8087288|NCT03454581|19939020|P1|STARTED|Overall Study||18
8087289|NCT03454048|19939053|P4|NOT COMPLETED|Overall Study||0
8087290|NCT03454048|19939054|P3|NOT COMPLETED|Overall Study||0
8087291|NCT03454048|19939055|P2|NOT COMPLETED|Overall Study||0
8087292|NCT03454048|19939056|P1|NOT COMPLETED|Overall Study||0
8087293|NCT03454048|19939053|P4|COMPLETED|Overall Study||6
8087294|NCT03454048|19939054|P3|COMPLETED|Overall Study||6
8087295|NCT03454048|19939055|P2|COMPLETED|Overall Study||6
8087296|NCT03454048|19939056|P1|COMPLETED|Overall Study||6
8087297|NCT03454048|19939053|P4|STARTED|Overall Study||6
8087298|NCT03454048|19939054|P3|STARTED|Overall Study||6
8087299|NCT03454048|19939055|P2|STARTED|Overall Study||6
8087300|NCT03454048|19939056|P1|STARTED|Overall Study||6
8087301|NCT03453515|19939088|P2|NOT COMPLETED|Overall Study||13
8087302|NCT03453515|19939089|P1|NOT COMPLETED|Overall Study||6
8087303|NCT03453515|19939088|P2|COMPLETED|Overall Study||100
8087304|NCT03453515|19939089|P1|COMPLETED|Overall Study||107
8087305|NCT03453515|19939088|P2|STARTED|Overall Study||113
8087306|NCT03453515|19939089|P1|STARTED|Overall Study||113
8087307|NCT03453151|19939105|P1|NOT COMPLETED|Overall Study||4
8087308|NCT03453151|19939105|P1|COMPLETED|Overall Study||15
8087309|NCT03453151|19939105|P1|STARTED|Overall Study||19
8087310|NCT03453060|19939119|P5|NOT COMPLETED|Overall Study||0
8087311|NCT03453060|19939120|P4|NOT COMPLETED|Overall Study||0
8087312|NCT03453060|19939121|P3|NOT COMPLETED|Overall Study||0
8087313|NCT03453060|19939122|P2|NOT COMPLETED|Overall Study||0
8087314|NCT03453060|19939123|P1|NOT COMPLETED|Overall Study||0
8087315|NCT03453060|19939119|P5|COMPLETED|Overall Study||5
8087316|NCT03453060|19939120|P4|COMPLETED|Overall Study||4
8087317|NCT03453060|19939121|P3|COMPLETED|Overall Study||4
8087318|NCT03453060|19939122|P2|COMPLETED|Overall Study||4
8087319|NCT03453060|19939123|P1|COMPLETED|Overall Study||4
8087320|NCT03453060|19939119|P5|STARTED|Overall Study||5
8087321|NCT03453060|19939120|P4|STARTED|Overall Study||4
8087322|NCT03453060|19939121|P3|STARTED|Overall Study||4
8087323|NCT03453060|19939122|P2|STARTED|Overall Study||4
8087324|NCT03453060|19939123|P1|STARTED|Overall Study||4
8087341|NCT03452371|19939359|P2|NOT COMPLETED|Overall Study||0
8087342|NCT03452371|19939360|P1|NOT COMPLETED|Overall Study||0
8087343|NCT03452371|19939359|P2|COMPLETED|Overall Study||23
8087344|NCT03452371|19939360|P1|COMPLETED|Overall Study||21
8087345|NCT03452371|19939359|P2|STARTED|Overall Study||23
8087346|NCT03452371|19939360|P1|STARTED|Overall Study||21
8087347|NCT03452176|19939378|P2|NOT COMPLETED|Overall Study||0
8087348|NCT03452176|19939379|P1|NOT COMPLETED|Overall Study||0
8087349|NCT03452176|19939378|P2|COMPLETED|Overall Study||11
8087350|NCT03452176|19939379|P1|COMPLETED|Overall Study||11
8087351|NCT03452176|19939378|P2|STARTED|Overall Study||11
8087352|NCT03452176|19939379|P1|STARTED|Overall Study||11
8087353|NCT03451721|19939395|P1|NOT COMPLETED|Overall Study||1
8087354|NCT03451721|19939395|P1|COMPLETED|Overall Study||19
8087355|NCT03451721|19939395|P1|STARTED|Overall Study||20
8087356|NCT03450369|19939406|P2|NOT COMPLETED|Overall Study||0
8087357|NCT03450369|19939407|P1|NOT COMPLETED|Overall Study||0
8087358|NCT03450369|19939406|P2|COMPLETED|Overall Study||5
8087359|NCT03450369|19939407|P1|COMPLETED|Overall Study||5
8087360|NCT03450369|19939406|P2|STARTED|Overall Study||5
8087361|NCT03450369|19939407|P1|STARTED|Overall Study||5
8087368|NCT03450070|19939458|P1|NOT COMPLETED|Overall Study||8
8087369|NCT03450070|19939458|P1|COMPLETED|Overall Study||110
8087370|NCT03450070|19939458|P1|STARTED|Overall Study||118
8087371|NCT03449979|19939466|P4|NOT COMPLETED|Overall Study||1
8087372|NCT03449979|19939467|P3|NOT COMPLETED|Overall Study||0
8087373|NCT03449979|19939468|P2|NOT COMPLETED|Overall Study||0
8087374|NCT03449979|19939469|P1|NOT COMPLETED|Overall Study||0
8087375|NCT03449979|19939466|P4|COMPLETED|Overall Study||21
8087376|NCT03449979|19939467|P3|COMPLETED|Overall Study||21
8087377|NCT03449979|19939468|P2|COMPLETED|Overall Study||20
8087378|NCT03449979|19939469|P1|COMPLETED|Overall Study||21
8087379|NCT03449979|19939466|P4|STARTED|Overall Study||22
8087380|NCT03449979|19939467|P3|STARTED|Overall Study||21
8087381|NCT03449979|19939468|P2|STARTED|Overall Study||20
8087382|NCT03449979|19939469|P1|STARTED|Overall Study||21
8087383|NCT03449758|19939479|P1|NOT COMPLETED|Overall Study||19
8087384|NCT03449758|19939479|P1|COMPLETED|Overall Study||65
8087385|NCT03449758|19939479|P1|STARTED|Overall Study||84
8087386|NCT03449446|19939519|P7|NOT COMPLETED|Overall Study||1
8087387|NCT03449446|19939520|P6|NOT COMPLETED|Overall Study||9
8087388|NCT03449446|19939521|P5|NOT COMPLETED|Overall Study||12
8087389|NCT03449446|19939522|P4|NOT COMPLETED|Overall Study||9
8087390|NCT03449446|19939523|P3|NOT COMPLETED|Overall Study||7
8087391|NCT03449446|19939524|P2|NOT COMPLETED|Overall Study||7
8087392|NCT03449446|19939525|P1|NOT COMPLETED|Overall Study||36
8087393|NCT03449446|19939519|P7|COMPLETED|Overall Study||38
8087394|NCT03449446|19939520|P6|COMPLETED|Overall Study||69
8087395|NCT03449446|19939521|P5|COMPLETED|Overall Study||66
8087396|NCT03449446|19939522|P4|COMPLETED|Overall Study||71
8087397|NCT03449446|19939523|P3|COMPLETED|Overall Study||34
8087398|NCT03449446|19939524|P2|COMPLETED|Overall Study||33
8087399|NCT03449446|19939525|P1|COMPLETED|Overall Study||3
8087400|NCT03449446|19939519|P7|STARTED|Overall Study||39
8087401|NCT03449446|19939520|P6|STARTED|Overall Study||78
8087402|NCT03449446|19939521|P5|STARTED|Overall Study||78
8087403|NCT03449446|19939522|P4|STARTED|Overall Study||80
8087404|NCT03449446|19939523|P3|STARTED|Overall Study||41
8087405|NCT03449446|19939524|P2|STARTED|Overall Study||40
8087406|NCT03449446|19939525|P1|STARTED|Overall Study||39
8087407|NCT03449433|19939557|P5|NOT COMPLETED|Period 4||0
8087408|NCT03449433|19939558|P4|NOT COMPLETED|Period 4||0
8087409|NCT03449433|19939559|P3|NOT COMPLETED|Period 4||0
8087410|NCT03449433|19939560|P2|NOT COMPLETED|Period 4||0
8087411|NCT03449433|19939561|P1|NOT COMPLETED|Period 4||0
8087412|NCT03449433|19939557|P5|COMPLETED|Period 4||12
8087413|NCT03449433|19939558|P4|COMPLETED|Period 4||17
8087414|NCT03449433|19939559|P3|COMPLETED|Period 4||18
8087415|NCT03449433|19939560|P2|COMPLETED|Period 4||15
8087416|NCT03449433|19939561|P1|COMPLETED|Period 4||17
8087417|NCT03449433|19939557|P5|Received at Least 1 Dose of Study Drug|Period 4||0
8087418|NCT03449433|19939558|P4|Received at Least 1 Dose of Study Drug|Period 4||17
8087419|NCT03449433|19939559|P3|Received at Least 1 Dose of Study Drug|Period 4||18
8087420|NCT03449433|19939560|P2|Received at Least 1 Dose of Study Drug|Period 4||15
8087421|NCT03449433|19939561|P1|Received at Least 1 Dose of Study Drug|Period 4||17
8087422|NCT03449433|19939557|P5|STARTED|Period 4||12
8087423|NCT03449433|19939558|P4|STARTED|Period 4||17
8087424|NCT03449433|19939559|P3|STARTED|Period 4||18
8087425|NCT03449433|19939560|P2|STARTED|Period 4||15
8087426|NCT03449433|19939561|P1|STARTED|Period 4||17
8087427|NCT03449433|19939557|P5|NOT COMPLETED|Period 3||0
8087428|NCT03449433|19939558|P4|NOT COMPLETED|Period 3||0
8087429|NCT03449433|19939559|P3|NOT COMPLETED|Period 3||0
8087430|NCT03449433|19939560|P2|NOT COMPLETED|Period 3||1
8087431|NCT03449433|19939561|P1|NOT COMPLETED|Period 3||0
8087432|NCT03449433|19939557|P5|COMPLETED|Period 3||12
8087433|NCT03449433|19939558|P4|COMPLETED|Period 3||17
8087434|NCT03449433|19939559|P3|COMPLETED|Period 3||18
8087435|NCT03449433|19939560|P2|COMPLETED|Period 3||15
8087436|NCT03449433|19939561|P1|COMPLETED|Period 3||17
8087437|NCT03449433|19939557|P5|Received at Least 1 Dose of Study Drug|Period 3||0
8087438|NCT03449433|19939558|P4|Received at Least 1 Dose of Study Drug|Period 3||17
8087439|NCT03449433|19939559|P3|Received at Least 1 Dose of Study Drug|Period 3||18
8087440|NCT03449433|19939560|P2|Received at Least 1 Dose of Study Drug|Period 3||15
8087441|NCT03449433|19939561|P1|Received at Least 1 Dose of Study Drug|Period 3||17
8087442|NCT03449433|19939557|P5|STARTED|Period 3||12
8087443|NCT03449433|19939558|P4|STARTED|Period 3||17
8087444|NCT03449433|19939559|P3|STARTED|Period 3||18
8087445|NCT03449433|19939560|P2|STARTED|Period 3||16
8087446|NCT03449433|19939561|P1|STARTED|Period 3||17
8087447|NCT03449433|19939557|P5|NOT COMPLETED|Period 2||0
8087448|NCT03449433|19939558|P4|NOT COMPLETED|Period 2||0
8087449|NCT03449433|19939559|P3|NOT COMPLETED|Period 2||0
8087450|NCT03449433|19939560|P2|NOT COMPLETED|Period 2||0
8087451|NCT03449433|19939561|P1|NOT COMPLETED|Period 2||0
8087452|NCT03449433|19939557|P5|COMPLETED|Period 2||12
8087453|NCT03449433|19939558|P4|COMPLETED|Period 2||17
8087454|NCT03449433|19939559|P3|COMPLETED|Period 2||18
8087455|NCT03449433|19939560|P2|COMPLETED|Period 2||16
8087456|NCT03449433|19939561|P1|COMPLETED|Period 2||17
8087457|NCT03449433|19939557|P5|Received at Least 1 Dose of Study Drug|Period 2||0
8087458|NCT03449433|19939558|P4|Received at Least 1 Dose of Study Drug|Period 2||17
8087459|NCT03449433|19939559|P3|Received at Least 1 Dose of Study Drug|Period 2||18
8087460|NCT03449433|19939560|P2|Received at Least 1 Dose of Study Drug|Period 2||16
8087461|NCT03449433|19939561|P1|Received at Least 1 Dose of Study Drug|Period 2||17
8087462|NCT03449433|19939557|P5|STARTED|Period 2||12
8087463|NCT03449433|19939558|P4|STARTED|Period 2||17
8087464|NCT03449433|19939559|P3|STARTED|Period 2||18
8087465|NCT03449433|19939560|P2|STARTED|Period 2||16
8087466|NCT03449433|19939561|P1|STARTED|Period 2||17
8087467|NCT03449433|19939557|P5|NOT COMPLETED|Period 1||0
8087468|NCT03449433|19939558|P4|NOT COMPLETED|Period 1||0
8087469|NCT03449433|19939559|P3|NOT COMPLETED|Period 1||0
8087470|NCT03449433|19939560|P2|NOT COMPLETED|Period 1||0
8087471|NCT03449433|19939561|P1|NOT COMPLETED|Period 1||0
8087472|NCT03449433|19939557|P5|COMPLETED|Period 1||12
8087473|NCT03449433|19939558|P4|COMPLETED|Period 1||17
8087474|NCT03449433|19939559|P3|COMPLETED|Period 1||18
8087475|NCT03449433|19939560|P2|COMPLETED|Period 1||16
8087476|NCT03449433|19939561|P1|COMPLETED|Period 1||17
8087477|NCT03449433|19939557|P5|Received at Least 1 Dose of Study Drug|Period 1||0
8087478|NCT03449433|19939558|P4|Received at Least 1 Dose of Study Drug|Period 1||17
8087479|NCT03449433|19939559|P3|Received at Least 1 Dose of Study Drug|Period 1||18
8087480|NCT03449433|19939560|P2|Received at Least 1 Dose of Study Drug|Period 1||16
8087481|NCT03449433|19939561|P1|Received at Least 1 Dose of Study Drug|Period 1||17
8087482|NCT03449433|19939557|P5|STARTED|Period 1||12
8087483|NCT03449433|19939558|P4|STARTED|Period 1||17
8087484|NCT03449433|19939559|P3|STARTED|Period 1||18
8087485|NCT03449433|19939560|P2|STARTED|Period 1||16
8087486|NCT03449433|19939561|P1|STARTED|Period 1||17
8087487|NCT03449342|19939579|P2|NOT COMPLETED|Overall Study||0
8087488|NCT03449342|19939580|P1|NOT COMPLETED|Overall Study||0
8087489|NCT03449342|19939579|P2|COMPLETED|Overall Study||50
8087490|NCT03449342|19939580|P1|COMPLETED|Overall Study||10
8087491|NCT03449342|19939579|P2|STARTED|Overall Study||50
8087492|NCT03449342|19939580|P1|STARTED|Overall Study||10
8087493|NCT03448536|19939596|P2|NOT COMPLETED|Overall Study||4
8087494|NCT03448536|19939597|P1|NOT COMPLETED|Overall Study||12
8087495|NCT03448536|19939596|P2|COMPLETED|Overall Study||97
8087496|NCT03448536|19939597|P1|COMPLETED|Overall Study||88
8087497|NCT03448536|19939596|P2|Completed Second Intervention|Overall Study||87
8087498|NCT03448536|19939597|P1|Completed Second Intervention|Overall Study||82
8087499|NCT03448536|19939596|P2|Completed First Intervention|Overall Study||97
8087500|NCT03448536|19939597|P1|Completed First Intervention|Overall Study||95
8087501|NCT03448536|19939596|P2|Completed First Intervention|Overall Study||78
8087502|NCT03448536|19939597|P1|Completed First Intervention|Overall Study||83
8087503|NCT03448536|19939596|P2|STARTED|Overall Study||101
8087504|NCT03448536|19939597|P1|STARTED|Overall Study||100
8087505|NCT03448419|19939623|P2|NOT COMPLETED|Overall Study||16
8087506|NCT03448419|19939624|P1|NOT COMPLETED|Overall Study||13
8087507|NCT03448419|19939623|P2|COMPLETED|Overall Study||140
8087508|NCT03448419|19939624|P1|COMPLETED|Overall Study||143
8087509|NCT03448419|19939623|P2|Treated|Overall Study||155
8087510|NCT03448419|19939624|P1|Treated|Overall Study||156
8087511|NCT03448419|19939623|P2|STARTED|Overall Study||156
8087512|NCT03448419|19939624|P1|STARTED|Overall Study||156
8087513|NCT03448406|19939650|P2|NOT COMPLETED|Overall Study||13
8087514|NCT03448406|19939651|P1|NOT COMPLETED|Overall Study||11
8087515|NCT03448406|19939650|P2|COMPLETED|Overall Study||144
8087516|NCT03448406|19939651|P1|COMPLETED|Overall Study||147
8087517|NCT03448406|19939650|P2|STARTED|Overall Study||157
8087518|NCT03448406|19939651|P1|STARTED|Overall Study||158
8087519|NCT03448224|19939677|P2|NOT COMPLETED|Overall Study||0
8087520|NCT03448224|19939678|P1|NOT COMPLETED|Overall Study||1
8087521|NCT03448224|19939677|P2|COMPLETED|Overall Study||26
8087522|NCT03448224|19939678|P1|COMPLETED|Overall Study||27
8087523|NCT03448224|19939677|P2|STARTED|Overall Study||26
8087524|NCT03448224|19939678|P1|STARTED|Overall Study||28
8087525|NCT03447821|19939695|P3|NOT COMPLETED|Overall Study||1
8087526|NCT03447821|19939696|P2|NOT COMPLETED|Overall Study||1
8087527|NCT03447821|19939697|P1|NOT COMPLETED|Overall Study||1
8087528|NCT03447821|19939695|P3|COMPLETED|Overall Study||12
8087529|NCT03447821|19939696|P2|COMPLETED|Overall Study||12
8087530|NCT03447821|19939697|P1|COMPLETED|Overall Study||13
8087531|NCT03447821|19939695|P3|STARTED|Overall Study||13
8087532|NCT03447821|19939696|P2|STARTED|Overall Study||13
8087533|NCT03447821|19939697|P1|STARTED|Overall Study||14
8087543|NCT03447639|19939741|P2|NOT COMPLETED|Overall Study||2
8087544|NCT03447639|19939742|P1|NOT COMPLETED|Overall Study||0
8087545|NCT03447639|19939741|P2|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1
8087546|NCT03447639|19939742|P1|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
8087547|NCT03447639|19939741|P2|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3
8087548|NCT03447639|19939742|P1|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
8087549|NCT03447353|19939752|P1|NOT COMPLETED|Overall Study||10
8087550|NCT03447353|19939752|P1|COMPLETED|Overall Study||8
8087551|NCT03447353|19939752|P1|STARTED|Overall Study||18
8087552|NCT03447249|19939768|P2|NOT COMPLETED|Overall Study||0
8087553|NCT03447249|19939769|P1|NOT COMPLETED|Overall Study||5
8087554|NCT03447249|19939768|P2|COMPLETED|Overall Study||192
8087555|NCT03447249|19939769|P1|COMPLETED|Overall Study||185
8087556|NCT03447249|19939768|P2|Safety Set|Overall Study||193
8087557|NCT03447249|19939769|P1|Safety Set|Overall Study||189
8087558|NCT03447249|19939768|P2|STARTED|Overall Study||192
8087559|NCT03447249|19939769|P1|STARTED|Overall Study||190
8087560|NCT03447015|19939800|P2|NOT COMPLETED|Overall Study||44
8087561|NCT03447015|19939801|P1|NOT COMPLETED|Overall Study||45
8087562|NCT03447015|19939800|P2|COMPLETED|Overall Study||106
8087563|NCT03447015|19939801|P1|COMPLETED|Overall Study||95
8087564|NCT03447015|19939800|P2|STARTED|Overall Study||150
8087565|NCT03447015|19939801|P1|STARTED|Overall Study||140
8087566|NCT03446846|19939820|P3|NOT COMPLETED|Overall Study||16
8087567|NCT03446846|19939821|P2|NOT COMPLETED|Overall Study||5
8087568|NCT03446846|19939822|P1|NOT COMPLETED|Overall Study||7
8087569|NCT03446846|19939820|P3|COMPLETED|Overall Study||162
8087570|NCT03446846|19939821|P2|COMPLETED|Overall Study||87
8087571|NCT03446846|19939822|P1|COMPLETED|Overall Study||83
8087572|NCT03446846|19939820|P3|STARTED|Overall Study||178
8087573|NCT03446846|19939821|P2|STARTED|Overall Study||92
8087574|NCT03446846|19939822|P1|STARTED|Overall Study||90
8087575|NCT03446781|19939841|P2|NOT COMPLETED|Overall Study||17
8087576|NCT03446781|19939842|P1|NOT COMPLETED|Overall Study||28
8087577|NCT03446781|19939841|P2|COMPLETED|Overall Study||191
8087578|NCT03446781|19939842|P1|COMPLETED|Overall Study||186
8087579|NCT03446781|19939841|P2|STARTED|Overall Study||208
8087580|NCT03446781|19939842|P1|STARTED|Overall Study||214
8087581|NCT03446690|19939891|P2|NOT COMPLETED|Overall Study||0
8087582|NCT03446690|19939892|P1|NOT COMPLETED|Overall Study||7
8087583|NCT03446690|19939891|P2|COMPLETED|Overall Study||29
8087584|NCT03446690|19939892|P1|COMPLETED|Overall Study||26
8087585|NCT03446690|19939891|P2|STARTED|Overall Study||29
8087586|NCT03446690|19939892|P1|STARTED|Overall Study||33
8087593|NCT03445390|19939973|P2|NOT COMPLETED|Second Intervention||1
8087594|NCT03445390|19939974|P1|NOT COMPLETED|Second Intervention||2
8087595|NCT03445390|19939973|P2|COMPLETED|Second Intervention||10
8087596|NCT03445390|19939974|P1|COMPLETED|Second Intervention||10
8087597|NCT03445390|19939973|P2|STARTED|Second Intervention||11
8087598|NCT03445390|19939974|P1|STARTED|Second Intervention||12
8087599|NCT03445390|19939973|P2|NOT COMPLETED|First Intervention||2
8087600|NCT03445390|19939974|P1|NOT COMPLETED|First Intervention||2
8087601|NCT03445390|19939973|P2|COMPLETED|First Intervention||11
8087602|NCT03445390|19939974|P1|COMPLETED|First Intervention||12
8087603|NCT03445390|19939973|P2|STARTED|First Intervention||13
8087604|NCT03445390|19939974|P1|STARTED|First Intervention||14
8087605|NCT03445195|19939986|P2|NOT COMPLETED|Overall Study||0
8087606|NCT03445195|19939987|P1|NOT COMPLETED|Overall Study||2
8087607|NCT03445195|19939986|P2|COMPLETED|Overall Study||27
8087608|NCT03445195|19939987|P1|COMPLETED|Overall Study||51
8087609|NCT03445195|19939986|P2|STARTED|Overall Study||27
8087610|NCT03445195|19939987|P1|STARTED|Overall Study||53
8087611|NCT03445156|19940002|P3|NOT COMPLETED|Experiment Proper||0
8087612|NCT03445156|19940003|P2|NOT COMPLETED|Experiment Proper||0
8087613|NCT03445156|19940004|P1|NOT COMPLETED|Experiment Proper||0
8087614|NCT03445156|19940002|P3|COMPLETED|Experiment Proper||59
8087615|NCT03445156|19940003|P2|COMPLETED|Experiment Proper||115
8087616|NCT03445156|19940004|P1|COMPLETED|Experiment Proper||113
8087617|NCT03445156|19940002|P3|STARTED|Experiment Proper||59
8087618|NCT03445156|19940003|P2|STARTED|Experiment Proper||115
8087619|NCT03445156|19940004|P1|STARTED|Experiment Proper||113
8087620|NCT03445156|19940002|P3|NOT COMPLETED|Pilot Study||0
8087621|NCT03445156|19940003|P2|NOT COMPLETED|Pilot Study||0
8087622|NCT03445156|19940004|P1|NOT COMPLETED|Pilot Study||0
8087623|NCT03445156|19940002|P3|COMPLETED|Pilot Study||0
8087624|NCT03445156|19940003|P2|COMPLETED|Pilot Study||20
8087625|NCT03445156|19940004|P1|COMPLETED|Pilot Study||20
8087626|NCT03445156|19940002|P3|STARTED|Pilot Study||0
8087627|NCT03445156|19940003|P2|STARTED|Pilot Study||20
8087628|NCT03445156|19940004|P1|STARTED|Pilot Study||20
8087629|NCT03444766|19940021|P1|NOT COMPLETED|Overall Study||66
8087630|NCT03444766|19940021|P1|COMPLETED|Overall Study||34
8087631|NCT03444766|19940021|P1|STARTED|Overall Study||100
8087632|NCT03444584|19940030|P2|NOT COMPLETED|Overall Study||2
8087633|NCT03444584|19940031|P1|NOT COMPLETED|Overall Study||0
8087634|NCT03444584|19940030|P2|COMPLETED|Overall Study||23
8087635|NCT03444584|19940031|P1|COMPLETED|Overall Study||24
8087636|NCT03444584|19940030|P2|STARTED|Overall Study||25
8087637|NCT03444584|19940031|P1|STARTED|Overall Study||24
8087638|NCT03444090|19940089|P2|NOT COMPLETED|Overall Study||4
8087639|NCT03444090|19940090|P1|NOT COMPLETED|Overall Study||3
8087640|NCT03444090|19940089|P2|COMPLETED|Overall Study||210
8087641|NCT03444090|19940090|P1|COMPLETED|Overall Study||211
8087642|NCT03444090|19940089|P2|STARTED|Overall Study||214
8087643|NCT03444090|19940090|P1|STARTED|Overall Study||214
8087644|NCT03443713|19940101|P3|NOT COMPLETED|Close-out Visit (30 Minutes)||0
8087645|NCT03443713|19940102|P2|NOT COMPLETED|Close-out Visit (30 Minutes)||0
8087646|NCT03443713|19940103|P1|NOT COMPLETED|Close-out Visit (30 Minutes)||0
8087647|NCT03443713|19940101|P3|COMPLETED|Close-out Visit (30 Minutes)||8
8087648|NCT03443713|19940102|P2|COMPLETED|Close-out Visit (30 Minutes)||8
8087649|NCT03443713|19940103|P1|COMPLETED|Close-out Visit (30 Minutes)||8
8087650|NCT03443713|19940101|P3|STARTED|Close-out Visit (30 Minutes)||8
8087651|NCT03443713|19940102|P2|STARTED|Close-out Visit (30 Minutes)||8
8087652|NCT03443713|19940103|P1|STARTED|Close-out Visit (30 Minutes)||8
8087653|NCT03443713|19940101|P3|NOT COMPLETED|Third at Home Period (8-12 Days)||0
8087654|NCT03443713|19940102|P2|NOT COMPLETED|Third at Home Period (8-12 Days)||0
8087655|NCT03443713|19940103|P1|NOT COMPLETED|Third at Home Period (8-12 Days)||0
8087656|NCT03443713|19940101|P3|COMPLETED|Third at Home Period (8-12 Days)||8
8087657|NCT03443713|19940102|P2|COMPLETED|Third at Home Period (8-12 Days)||8
8087658|NCT03443713|19940103|P1|COMPLETED|Third at Home Period (8-12 Days)||8
8087659|NCT03443713|19940101|P3|STARTED|Third at Home Period (8-12 Days)||8
8087660|NCT03443713|19940102|P2|STARTED|Third at Home Period (8-12 Days)||8
8087661|NCT03443713|19940103|P1|STARTED|Third at Home Period (8-12 Days)||8
8087662|NCT03443713|19940101|P3|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
8087663|NCT03443713|19940102|P2|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
8087664|NCT03443713|19940103|P1|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
8087665|NCT03443713|19940101|P3|COMPLETED|Second Exercise Visit (1 Hour)||8
8087666|NCT03443713|19940102|P2|COMPLETED|Second Exercise Visit (1 Hour)||8
8087667|NCT03443713|19940103|P1|COMPLETED|Second Exercise Visit (1 Hour)||8
8087668|NCT03443713|19940101|P3|STARTED|Second Exercise Visit (1 Hour)||8
8087669|NCT03443713|19940102|P2|STARTED|Second Exercise Visit (1 Hour)||8
8087670|NCT03443713|19940103|P1|STARTED|Second Exercise Visit (1 Hour)||8
8087671|NCT03443713|19940101|P3|NOT COMPLETED|Second at Home Period (2-11 Days)||0
8087672|NCT03443713|19940102|P2|NOT COMPLETED|Second at Home Period (2-11 Days)||0
8087673|NCT03443713|19940103|P1|NOT COMPLETED|Second at Home Period (2-11 Days)||0
8087674|NCT03443713|19940101|P3|COMPLETED|Second at Home Period (2-11 Days)||8
8087675|NCT03443713|19940102|P2|COMPLETED|Second at Home Period (2-11 Days)||8
8087676|NCT03443713|19940103|P1|COMPLETED|Second at Home Period (2-11 Days)||8
8087677|NCT03443713|19940101|P3|STARTED|Second at Home Period (2-11 Days)||8
8087678|NCT03443713|19940102|P2|STARTED|Second at Home Period (2-11 Days)||8
8087679|NCT03443713|19940103|P1|STARTED|Second at Home Period (2-11 Days)||8
8087680|NCT03443713|19940101|P3|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
8087681|NCT03443713|19940102|P2|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
8087682|NCT03443713|19940103|P1|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
8087683|NCT03443713|19940101|P3|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
8087684|NCT03443713|19940102|P2|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
8087685|NCT03443713|19940103|P1|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
8087686|NCT03443713|19940101|P3|STARTED|Dexcom Insertion Visit (30 Minutes)||8
8087687|NCT03443713|19940102|P2|STARTED|Dexcom Insertion Visit (30 Minutes)||8
8087688|NCT03443713|19940103|P1|STARTED|Dexcom Insertion Visit (30 Minutes)||8
8087689|NCT03443713|19940101|P3|NOT COMPLETED|First Exercise Visit (1 Hour)||0
8087690|NCT03443713|19940102|P2|NOT COMPLETED|First Exercise Visit (1 Hour)||0
8087691|NCT03443713|19940103|P1|NOT COMPLETED|First Exercise Visit (1 Hour)||0
8087692|NCT03443713|19940101|P3|COMPLETED|First Exercise Visit (1 Hour)||8
8087693|NCT03443713|19940102|P2|COMPLETED|First Exercise Visit (1 Hour)||8
8087694|NCT03443713|19940103|P1|COMPLETED|First Exercise Visit (1 Hour)||8
8087695|NCT03443713|19940101|P3|STARTED|First Exercise Visit (1 Hour)||8
8087696|NCT03443713|19940102|P2|STARTED|First Exercise Visit (1 Hour)||8
8087697|NCT03443713|19940103|P1|STARTED|First Exercise Visit (1 Hour)||8
8087698|NCT03443713|19940101|P3|NOT COMPLETED|First at Home Period (9-14 Days)||1
8087699|NCT03443713|19940102|P2|NOT COMPLETED|First at Home Period (9-14 Days)||0
8087700|NCT03443713|19940103|P1|NOT COMPLETED|First at Home Period (9-14 Days)||0
8087701|NCT03443713|19940101|P3|COMPLETED|First at Home Period (9-14 Days)||8
8087702|NCT03443713|19940102|P2|COMPLETED|First at Home Period (9-14 Days)||8
8087703|NCT03443713|19940103|P1|COMPLETED|First at Home Period (9-14 Days)||8
8087704|NCT03443713|19940101|P3|STARTED|First at Home Period (9-14 Days)||9
8087705|NCT03443713|19940102|P2|STARTED|First at Home Period (9-14 Days)||8
8087706|NCT03443713|19940103|P1|STARTED|First at Home Period (9-14 Days)||8
8087707|NCT03443713|19940101|P3|NOT COMPLETED|Start up Visit (2 Hours)||0
8087708|NCT03443713|19940102|P2|NOT COMPLETED|Start up Visit (2 Hours)||0
8087709|NCT03443713|19940103|P1|NOT COMPLETED|Start up Visit (2 Hours)||0
8087710|NCT03443713|19940101|P3|COMPLETED|Start up Visit (2 Hours)||9
8087711|NCT03443713|19940102|P2|COMPLETED|Start up Visit (2 Hours)||8
8087712|NCT03443713|19940103|P1|COMPLETED|Start up Visit (2 Hours)||8
8087713|NCT03443713|19940101|P3|STARTED|Start up Visit (2 Hours)||9
8087714|NCT03443713|19940102|P2|STARTED|Start up Visit (2 Hours)||8
8087715|NCT03443713|19940103|P1|STARTED|Start up Visit (2 Hours)||8
8087722|NCT03443414|19940172|P5|NOT COMPLETED|Overall Study||5
8087723|NCT03443414|19940173|P4|NOT COMPLETED|Overall Study||5
8087724|NCT03443414|19940174|P3|NOT COMPLETED|Overall Study||6
8087725|NCT03443414|19940175|P2|NOT COMPLETED|Overall Study||3
8087726|NCT03443414|19940176|P1|NOT COMPLETED|Overall Study||11
8087727|NCT03443414|19940172|P5|COMPLETED|Overall Study||75
8087728|NCT03443414|19940173|P4|COMPLETED|Overall Study||75
8087729|NCT03443414|19940174|P3|COMPLETED|Overall Study||76
8087730|NCT03443414|19940175|P2|COMPLETED|Overall Study||78
8087731|NCT03443414|19940176|P1|COMPLETED|Overall Study||71
8087732|NCT03443414|19940172|P5|Received Treatment|Overall Study||79
8087733|NCT03443414|19940173|P4|Received Treatment|Overall Study||80
8087734|NCT03443414|19940174|P3|Received Treatment|Overall Study||82
8087735|NCT03443414|19940175|P2|Received Treatment|Overall Study||81
8087736|NCT03443414|19940176|P1|Received Treatment|Overall Study||81
8087737|NCT03443414|19940172|P5|STARTED|Overall Study||80
8087738|NCT03443414|19940173|P4|STARTED|Overall Study||80
8087739|NCT03443414|19940174|P3|STARTED|Overall Study||82
8087740|NCT03443414|19940175|P2|STARTED|Overall Study||81
8087741|NCT03443414|19940176|P1|STARTED|Overall Study||82
8087742|NCT03443063|19940215|P2|NOT COMPLETED|Overall Study||0
8087743|NCT03443063|19940216|P1|NOT COMPLETED|Overall Study||0
8087744|NCT03443063|19940215|P2|COMPLETED|Overall Study||8
8087745|NCT03443063|19940216|P1|COMPLETED|Overall Study||8
8087746|NCT03443063|19940215|P2|STARTED|Overall Study||8
8087747|NCT03443063|19940216|P1|STARTED|Overall Study||8
8087748|NCT03442933|19940266|P2|NOT COMPLETED|Overall Study||0
8087749|NCT03442933|19940267|P1|NOT COMPLETED|Overall Study||0
8087750|NCT03442933|19940266|P2|COMPLETED|Overall Study||20
8087751|NCT03442933|19940267|P1|COMPLETED|Overall Study||20
8087752|NCT03442933|19940266|P2|STARTED|Overall Study||20
8087753|NCT03442933|19940267|P1|STARTED|Overall Study||20
8087754|NCT03442868|19940278|P1|NOT COMPLETED|Overall Study||0
8087755|NCT03442868|19940278|P1|COMPLETED|Overall Study||15
8087756|NCT03442868|19940278|P1|STARTED|Overall Study||15
8087757|NCT03442829|19940287|P2|NOT COMPLETED|Overall Study||2
8087758|NCT03442829|19940288|P1|NOT COMPLETED|Overall Study||4
8087759|NCT03442829|19940287|P2|COMPLETED|Overall Study||25
8087760|NCT03442829|19940288|P1|COMPLETED|Overall Study||23
8087761|NCT03442829|19940287|P2|STARTED|Overall Study||27
8087762|NCT03442829|19940288|P1|STARTED|Overall Study||27
8087763|NCT03442725|19940304|P2|NOT COMPLETED|Overall Study||0
8087764|NCT03442725|19940305|P1|NOT COMPLETED|Overall Study||0
8087765|NCT03442725|19940304|P2|COMPLETED|Overall Study||8
8087766|NCT03442725|19940305|P1|COMPLETED|Overall Study||8
8087767|NCT03442725|19940304|P2|STARTED|Overall Study||8
8087768|NCT03442725|19940305|P1|STARTED|Overall Study||8
8087769|NCT03442699|19940337|P1|NOT COMPLETED|Overall Study||0
8087770|NCT03442699|19940337|P1|COMPLETED|Overall Study||6
8087771|NCT03442699|19940337|P1|STARTED|Overall Study||6
8087772|NCT03442595|19940347|P2|NOT COMPLETED|Overall Study||0
8087773|NCT03442595|19940348|P1|NOT COMPLETED|Overall Study||94
8087774|NCT03442595|19940347|P2|COMPLETED|Overall Study||366
8087775|NCT03442595|19940348|P1|COMPLETED|Overall Study||366
8087776|NCT03442595|19940347|P2|STARTED|Overall Study||366
8087777|NCT03442595|19940348|P1|STARTED|Overall Study||460
8087784|NCT03441984|19940380|P12|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087785|NCT03441984|19940381|P11|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087786|NCT03441984|19940382|P10|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087787|NCT03441984|19940383|P9|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087788|NCT03441984|19940384|P8|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087789|NCT03441984|19940385|P7|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087790|NCT03441984|19940386|P6|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087791|NCT03441984|19940387|P5|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087792|NCT03441984|19940388|P4|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087793|NCT03441984|19940389|P3|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087794|NCT03441984|19940390|P2|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087795|NCT03441984|19940391|P1|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087796|NCT03441984|19940380|P12|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
8087797|NCT03441984|19940381|P11|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
8087798|NCT03441984|19940382|P10|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
8087799|NCT03441984|19940383|P9|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
8087800|NCT03441984|19940384|P8|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
8087801|NCT03441984|19940385|P7|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
8087802|NCT03441984|19940386|P6|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087803|NCT03441984|19940387|P5|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087804|NCT03441984|19940388|P4|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087805|NCT03441984|19940389|P3|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087806|NCT03441984|19940390|P2|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087807|NCT03441984|19940391|P1|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
8087808|NCT03441984|19940380|P12|STARTED|Part 2: Period 3 (Up to Day 4)||3
8087809|NCT03441984|19940381|P11|STARTED|Part 2: Period 3 (Up to Day 4)||3
8087810|NCT03441984|19940382|P10|STARTED|Part 2: Period 3 (Up to Day 4)||3
8087811|NCT03441984|19940383|P9|STARTED|Part 2: Period 3 (Up to Day 4)||3
8087812|NCT03441984|19940384|P8|STARTED|Part 2: Period 3 (Up to Day 4)||3
8087813|NCT03441984|19940385|P7|STARTED|Part 2: Period 3 (Up to Day 4)||3
8087814|NCT03441984|19940386|P6|STARTED|Part 2: Period 3 (Up to Day 4)||0
8087815|NCT03441984|19940387|P5|STARTED|Part 2: Period 3 (Up to Day 4)||0
8087816|NCT03441984|19940388|P4|STARTED|Part 2: Period 3 (Up to Day 4)||0
8087817|NCT03441984|19940389|P3|STARTED|Part 2: Period 3 (Up to Day 4)||0
8087818|NCT03441984|19940390|P2|STARTED|Part 2: Period 3 (Up to Day 4)||0
8087819|NCT03441984|19940391|P1|STARTED|Part 2: Period 3 (Up to Day 4)||0
8087820|NCT03441984|19940380|P12|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087821|NCT03441984|19940381|P11|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087822|NCT03441984|19940382|P10|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087823|NCT03441984|19940383|P9|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087824|NCT03441984|19940384|P8|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087825|NCT03441984|19940385|P7|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087826|NCT03441984|19940386|P6|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087827|NCT03441984|19940387|P5|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087828|NCT03441984|19940388|P4|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087829|NCT03441984|19940389|P3|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087830|NCT03441984|19940390|P2|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087831|NCT03441984|19940391|P1|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087832|NCT03441984|19940380|P12|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087833|NCT03441984|19940381|P11|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087834|NCT03441984|19940382|P10|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087835|NCT03441984|19940383|P9|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087836|NCT03441984|19940384|P8|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087837|NCT03441984|19940385|P7|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087838|NCT03441984|19940386|P6|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087839|NCT03441984|19940387|P5|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087840|NCT03441984|19940388|P4|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087841|NCT03441984|19940389|P3|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087842|NCT03441984|19940390|P2|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087843|NCT03441984|19940391|P1|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087844|NCT03441984|19940380|P12|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087845|NCT03441984|19940381|P11|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087846|NCT03441984|19940382|P10|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087847|NCT03441984|19940383|P9|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087848|NCT03441984|19940384|P8|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087849|NCT03441984|19940385|P7|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
8087850|NCT03441984|19940386|P6|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087851|NCT03441984|19940387|P5|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087852|NCT03441984|19940388|P4|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087853|NCT03441984|19940389|P3|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087854|NCT03441984|19940390|P2|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087855|NCT03441984|19940391|P1|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
8087856|NCT03441984|19940380|P12|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087857|NCT03441984|19940381|P11|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087858|NCT03441984|19940382|P10|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087859|NCT03441984|19940383|P9|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087860|NCT03441984|19940384|P8|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087861|NCT03441984|19940385|P7|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087862|NCT03441984|19940386|P6|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087863|NCT03441984|19940387|P5|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087864|NCT03441984|19940388|P4|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087865|NCT03441984|19940389|P3|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087866|NCT03441984|19940390|P2|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087867|NCT03441984|19940391|P1|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087868|NCT03441984|19940380|P12|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
8087869|NCT03441984|19940381|P11|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
8087870|NCT03441984|19940382|P10|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
8087871|NCT03441984|19940383|P9|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
8087872|NCT03441984|19940384|P8|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
8087873|NCT03441984|19940385|P7|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
8087874|NCT03441984|19940386|P6|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087875|NCT03441984|19940387|P5|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087876|NCT03441984|19940388|P4|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087877|NCT03441984|19940389|P3|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087878|NCT03441984|19940390|P2|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087879|NCT03441984|19940391|P1|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
8087880|NCT03441984|19940380|P12|STARTED|Part 2: Period 2 (Up to Day 4)||3
8087881|NCT03441984|19940381|P11|STARTED|Part 2: Period 2 (Up to Day 4)||3
8087882|NCT03441984|19940382|P10|STARTED|Part 2: Period 2 (Up to Day 4)||3
8087883|NCT03441984|19940383|P9|STARTED|Part 2: Period 2 (Up to Day 4)||3
8087884|NCT03441984|19940384|P8|STARTED|Part 2: Period 2 (Up to Day 4)||3
8087885|NCT03441984|19940385|P7|STARTED|Part 2: Period 2 (Up to Day 4)||3
8087886|NCT03441984|19940386|P6|STARTED|Part 2: Period 2 (Up to Day 4)||0
8087887|NCT03441984|19940387|P5|STARTED|Part 2: Period 2 (Up to Day 4)||0
8087888|NCT03441984|19940388|P4|STARTED|Part 2: Period 2 (Up to Day 4)||0
8087889|NCT03441984|19940389|P3|STARTED|Part 2: Period 2 (Up to Day 4)||0
8087890|NCT03441984|19940390|P2|STARTED|Part 2: Period 2 (Up to Day 4)||0
8087891|NCT03441984|19940391|P1|STARTED|Part 2: Period 2 (Up to Day 4)||0
8087892|NCT03441984|19940380|P12|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087893|NCT03441984|19940381|P11|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087894|NCT03441984|19940382|P10|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087895|NCT03441984|19940383|P9|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087896|NCT03441984|19940384|P8|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087897|NCT03441984|19940385|P7|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087898|NCT03441984|19940386|P6|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087899|NCT03441984|19940387|P5|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087900|NCT03441984|19940388|P4|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087901|NCT03441984|19940389|P3|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087902|NCT03441984|19940390|P2|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087903|NCT03441984|19940391|P1|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087904|NCT03441984|19940380|P12|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087905|NCT03441984|19940381|P11|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087906|NCT03441984|19940382|P10|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087907|NCT03441984|19940383|P9|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087908|NCT03441984|19940384|P8|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087909|NCT03441984|19940385|P7|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087910|NCT03441984|19940386|P6|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087911|NCT03441984|19940387|P5|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087912|NCT03441984|19940388|P4|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087913|NCT03441984|19940389|P3|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087914|NCT03441984|19940390|P2|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087915|NCT03441984|19940391|P1|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087916|NCT03441984|19940380|P12|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087917|NCT03441984|19940381|P11|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087918|NCT03441984|19940382|P10|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087919|NCT03441984|19940383|P9|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087920|NCT03441984|19940384|P8|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087921|NCT03441984|19940385|P7|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
8087922|NCT03441984|19940386|P6|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087923|NCT03441984|19940387|P5|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087924|NCT03441984|19940388|P4|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087925|NCT03441984|19940389|P3|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087926|NCT03441984|19940390|P2|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087927|NCT03441984|19940391|P1|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
8087928|NCT03441984|19940380|P12|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087929|NCT03441984|19940381|P11|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087930|NCT03441984|19940382|P10|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087931|NCT03441984|19940383|P9|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087932|NCT03441984|19940384|P8|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087933|NCT03441984|19940385|P7|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087934|NCT03441984|19940386|P6|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087935|NCT03441984|19940387|P5|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087936|NCT03441984|19940388|P4|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087937|NCT03441984|19940389|P3|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087938|NCT03441984|19940390|P2|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087939|NCT03441984|19940391|P1|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087940|NCT03441984|19940380|P12|COMPLETED|Part 2: Period 1(Up to Day 4)||3
8087941|NCT03441984|19940381|P11|COMPLETED|Part 2: Period 1(Up to Day 4)||3
8087942|NCT03441984|19940382|P10|COMPLETED|Part 2: Period 1(Up to Day 4)||3
8087943|NCT03441984|19940383|P9|COMPLETED|Part 2: Period 1(Up to Day 4)||3
8087944|NCT03441984|19940384|P8|COMPLETED|Part 2: Period 1(Up to Day 4)||3
8087945|NCT03441984|19940385|P7|COMPLETED|Part 2: Period 1(Up to Day 4)||3
8087946|NCT03441984|19940386|P6|COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087947|NCT03441984|19940387|P5|COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087948|NCT03441984|19940388|P4|COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087949|NCT03441984|19940389|P3|COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087950|NCT03441984|19940390|P2|COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087951|NCT03441984|19940391|P1|COMPLETED|Part 2: Period 1(Up to Day 4)||0
8087952|NCT03441984|19940380|P12|STARTED|Part 2: Period 1(Up to Day 4)||3
8087953|NCT03441984|19940381|P11|STARTED|Part 2: Period 1(Up to Day 4)||3
8087954|NCT03441984|19940382|P10|STARTED|Part 2: Period 1(Up to Day 4)||3
8087955|NCT03441984|19940383|P9|STARTED|Part 2: Period 1(Up to Day 4)||3
8087956|NCT03441984|19940384|P8|STARTED|Part 2: Period 1(Up to Day 4)||3
8087957|NCT03441984|19940385|P7|STARTED|Part 2: Period 1(Up to Day 4)||3
8087958|NCT03441984|19940386|P6|STARTED|Part 2: Period 1(Up to Day 4)||0
8087959|NCT03441984|19940387|P5|STARTED|Part 2: Period 1(Up to Day 4)||0
8087960|NCT03441984|19940388|P4|STARTED|Part 2: Period 1(Up to Day 4)||0
8087961|NCT03441984|19940389|P3|STARTED|Part 2: Period 1(Up to Day 4)||0
8087962|NCT03441984|19940390|P2|STARTED|Part 2: Period 1(Up to Day 4)||0
8087963|NCT03441984|19940391|P1|STARTED|Part 2: Period 1(Up to Day 4)||0
8087964|NCT03441984|19940380|P12|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087965|NCT03441984|19940381|P11|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087966|NCT03441984|19940382|P10|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087967|NCT03441984|19940383|P9|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087968|NCT03441984|19940384|P8|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087969|NCT03441984|19940385|P7|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087970|NCT03441984|19940386|P6|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087971|NCT03441984|19940387|P5|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087972|NCT03441984|19940388|P4|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087973|NCT03441984|19940389|P3|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087974|NCT03441984|19940390|P2|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087975|NCT03441984|19940391|P1|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087976|NCT03441984|19940380|P12|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087977|NCT03441984|19940381|P11|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087978|NCT03441984|19940382|P10|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087979|NCT03441984|19940383|P9|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087980|NCT03441984|19940384|P8|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087981|NCT03441984|19940385|P7|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
8087982|NCT03441984|19940386|P6|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
8087983|NCT03441984|19940387|P5|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
8087984|NCT03441984|19940388|P4|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
8087985|NCT03441984|19940389|P3|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2
8087986|NCT03441984|19940390|P2|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
8087987|NCT03441984|19940391|P1|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
8087988|NCT03441984|19940380|P12|STARTED|Part 1: Period 3 (Up to Day 4 )||0
8087989|NCT03441984|19940381|P11|STARTED|Part 1: Period 3 (Up to Day 4 )||0
8087990|NCT03441984|19940382|P10|STARTED|Part 1: Period 3 (Up to Day 4 )||0
8087991|NCT03441984|19940383|P9|STARTED|Part 1: Period 3 (Up to Day 4 )||0
8087992|NCT03441984|19940384|P8|STARTED|Part 1: Period 3 (Up to Day 4 )||0
8087993|NCT03441984|19940385|P7|STARTED|Part 1: Period 3 (Up to Day 4 )||0
8087994|NCT03441984|19940386|P6|STARTED|Part 1: Period 3 (Up to Day 4 )||3
8087995|NCT03441984|19940387|P5|STARTED|Part 1: Period 3 (Up to Day 4 )||3
8087996|NCT03441984|19940388|P4|STARTED|Part 1: Period 3 (Up to Day 4 )||3
8087997|NCT03441984|19940389|P3|STARTED|Part 1: Period 3 (Up to Day 4 )||2
8087998|NCT03441984|19940390|P2|STARTED|Part 1: Period 3 (Up to Day 4 )||3
8087999|NCT03441984|19940391|P1|STARTED|Part 1: Period 3 (Up to Day 4 )||3
8088000|NCT03441984|19940380|P12|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088001|NCT03441984|19940381|P11|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088002|NCT03441984|19940382|P10|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088003|NCT03441984|19940383|P9|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088004|NCT03441984|19940384|P8|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088005|NCT03441984|19940385|P7|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088006|NCT03441984|19940386|P6|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088007|NCT03441984|19940387|P5|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088008|NCT03441984|19940388|P4|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088009|NCT03441984|19940389|P3|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088010|NCT03441984|19940390|P2|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088011|NCT03441984|19940391|P1|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088012|NCT03441984|19940380|P12|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088013|NCT03441984|19940381|P11|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088014|NCT03441984|19940382|P10|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088015|NCT03441984|19940383|P9|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088016|NCT03441984|19940384|P8|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088017|NCT03441984|19940385|P7|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088018|NCT03441984|19940386|P6|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088019|NCT03441984|19940387|P5|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088020|NCT03441984|19940388|P4|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088021|NCT03441984|19940389|P3|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2
8088022|NCT03441984|19940390|P2|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088023|NCT03441984|19940391|P1|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088024|NCT03441984|19940380|P12|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088025|NCT03441984|19940381|P11|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088026|NCT03441984|19940382|P10|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088027|NCT03441984|19940383|P9|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088028|NCT03441984|19940384|P8|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088029|NCT03441984|19940385|P7|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
8088030|NCT03441984|19940386|P6|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088031|NCT03441984|19940387|P5|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088032|NCT03441984|19940388|P4|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088033|NCT03441984|19940389|P3|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2
8088034|NCT03441984|19940390|P2|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088035|NCT03441984|19940391|P1|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
8088036|NCT03441984|19940380|P12|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088037|NCT03441984|19940381|P11|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088038|NCT03441984|19940382|P10|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088039|NCT03441984|19940383|P9|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088040|NCT03441984|19940384|P8|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088041|NCT03441984|19940385|P7|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088042|NCT03441984|19940386|P6|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088043|NCT03441984|19940387|P5|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088044|NCT03441984|19940388|P4|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088045|NCT03441984|19940389|P3|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1
8088046|NCT03441984|19940390|P2|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088047|NCT03441984|19940391|P1|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088048|NCT03441984|19940380|P12|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088049|NCT03441984|19940381|P11|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088050|NCT03441984|19940382|P10|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088051|NCT03441984|19940383|P9|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088052|NCT03441984|19940384|P8|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088053|NCT03441984|19940385|P7|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
8088054|NCT03441984|19940386|P6|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
8088055|NCT03441984|19940387|P5|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
8088056|NCT03441984|19940388|P4|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
8088057|NCT03441984|19940389|P3|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2
8088058|NCT03441984|19940390|P2|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
8088059|NCT03441984|19940391|P1|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
8088060|NCT03441984|19940380|P12|STARTED|Part 1: Period 2 (Up to Day 4 )||0
8088061|NCT03441984|19940381|P11|STARTED|Part 1: Period 2 (Up to Day 4 )||0
8088062|NCT03441984|19940382|P10|STARTED|Part 1: Period 2 (Up to Day 4 )||0
8088063|NCT03441984|19940383|P9|STARTED|Part 1: Period 2 (Up to Day 4 )||0
8088064|NCT03441984|19940384|P8|STARTED|Part 1: Period 2 (Up to Day 4 )||0
8088065|NCT03441984|19940385|P7|STARTED|Part 1: Period 2 (Up to Day 4 )||0
8088066|NCT03441984|19940386|P6|STARTED|Part 1: Period 2 (Up to Day 4 )||3
8088067|NCT03441984|19940387|P5|STARTED|Part 1: Period 2 (Up to Day 4 )||3
8088068|NCT03441984|19940388|P4|STARTED|Part 1: Period 2 (Up to Day 4 )||3
8088069|NCT03441984|19940389|P3|STARTED|Part 1: Period 2 (Up to Day 4 )||3
8088070|NCT03441984|19940390|P2|STARTED|Part 1: Period 2 (Up to Day 4 )||3
8088071|NCT03441984|19940391|P1|STARTED|Part 1: Period 2 (Up to Day 4 )||3
8088072|NCT03441984|19940380|P12|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088073|NCT03441984|19940381|P11|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088074|NCT03441984|19940382|P10|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088075|NCT03441984|19940383|P9|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088076|NCT03441984|19940384|P8|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088077|NCT03441984|19940385|P7|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088078|NCT03441984|19940386|P6|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088079|NCT03441984|19940387|P5|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088080|NCT03441984|19940388|P4|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088081|NCT03441984|19940389|P3|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088082|NCT03441984|19940390|P2|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088083|NCT03441984|19940391|P1|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088084|NCT03441984|19940380|P12|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088085|NCT03441984|19940381|P11|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088086|NCT03441984|19940382|P10|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088087|NCT03441984|19940383|P9|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088088|NCT03441984|19940384|P8|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088089|NCT03441984|19940385|P7|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088090|NCT03441984|19940386|P6|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088091|NCT03441984|19940387|P5|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088092|NCT03441984|19940388|P4|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088093|NCT03441984|19940389|P3|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088094|NCT03441984|19940390|P2|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088095|NCT03441984|19940391|P1|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088096|NCT03441984|19940380|P12|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088097|NCT03441984|19940381|P11|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088098|NCT03441984|19940382|P10|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088099|NCT03441984|19940383|P9|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088100|NCT03441984|19940384|P8|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088101|NCT03441984|19940385|P7|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
8088102|NCT03441984|19940386|P6|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088103|NCT03441984|19940387|P5|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088104|NCT03441984|19940388|P4|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088105|NCT03441984|19940389|P3|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088106|NCT03441984|19940390|P2|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088107|NCT03441984|19940391|P1|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
8088108|NCT03441984|19940380|P12|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088109|NCT03441984|19940381|P11|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088110|NCT03441984|19940382|P10|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088111|NCT03441984|19940383|P9|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088112|NCT03441984|19940384|P8|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088113|NCT03441984|19940385|P7|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088114|NCT03441984|19940386|P6|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088115|NCT03441984|19940387|P5|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088116|NCT03441984|19940388|P4|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088117|NCT03441984|19940389|P3|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088118|NCT03441984|19940390|P2|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088119|NCT03441984|19940391|P1|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088120|NCT03441984|19940380|P12|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088121|NCT03441984|19940381|P11|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088122|NCT03441984|19940382|P10|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088123|NCT03441984|19940383|P9|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088124|NCT03441984|19940384|P8|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088125|NCT03441984|19940385|P7|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
8088126|NCT03441984|19940386|P6|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
8088127|NCT03441984|19940387|P5|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
8088128|NCT03441984|19940388|P4|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
8088129|NCT03441984|19940389|P3|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
8088130|NCT03441984|19940390|P2|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
8088131|NCT03441984|19940391|P1|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
8088132|NCT03441984|19940380|P12|STARTED|Part 1: Period 1 (Up to Day 4)||0
8088133|NCT03441984|19940381|P11|STARTED|Part 1: Period 1 (Up to Day 4)||0
8088134|NCT03441984|19940382|P10|STARTED|Part 1: Period 1 (Up to Day 4)||0
8088135|NCT03441984|19940383|P9|STARTED|Part 1: Period 1 (Up to Day 4)||0
8088136|NCT03441984|19940384|P8|STARTED|Part 1: Period 1 (Up to Day 4)||0
8088137|NCT03441984|19940385|P7|STARTED|Part 1: Period 1 (Up to Day 4)||0
8088138|NCT03441984|19940386|P6|STARTED|Part 1: Period 1 (Up to Day 4)||3
8088139|NCT03441984|19940387|P5|STARTED|Part 1: Period 1 (Up to Day 4)||3
8088140|NCT03441984|19940388|P4|STARTED|Part 1: Period 1 (Up to Day 4)||3
8088141|NCT03441984|19940389|P3|STARTED|Part 1: Period 1 (Up to Day 4)||3
8088142|NCT03441984|19940390|P2|STARTED|Part 1: Period 1 (Up to Day 4)||3
8088143|NCT03441984|19940391|P1|STARTED|Part 1: Period 1 (Up to Day 4)||3
8088144|NCT03441789|19940752|P2|NOT COMPLETED|Overall Study||4
8088145|NCT03441789|19940753|P1|NOT COMPLETED|Overall Study||1
8088146|NCT03441789|19940752|P2|COMPLETED|Overall Study||10
8088147|NCT03441789|19940753|P1|COMPLETED|Overall Study||13
8088148|NCT03441789|19940752|P2|STARTED|Overall Study||14
8088149|NCT03441789|19940753|P1|STARTED|Overall Study||14
8088150|NCT03441633|19940779|P10|NOT COMPLETED|Overall Study||0
8088151|NCT03441633|19940780|P9|NOT COMPLETED|Overall Study||0
8088152|NCT03441633|19940781|P8|NOT COMPLETED|Overall Study||0
8088153|NCT03441633|19940782|P7|NOT COMPLETED|Overall Study||0
8088154|NCT03441633|19940783|P6|NOT COMPLETED|Overall Study||0
8088155|NCT03441633|19940784|P5|NOT COMPLETED|Overall Study||0
8088156|NCT03441633|19940785|P4|NOT COMPLETED|Overall Study||0
8088157|NCT03441633|19940786|P3|NOT COMPLETED|Overall Study||0
8088158|NCT03441633|19940787|P2|NOT COMPLETED|Overall Study||0
8088159|NCT03441633|19940788|P1|NOT COMPLETED|Overall Study||0
8088160|NCT03441633|19940779|P10|COMPLETED|Overall Study||1562
8088161|NCT03441633|19940780|P9|COMPLETED|Overall Study||5132
8088162|NCT03441633|19940781|P8|COMPLETED|Overall Study||953
8088163|NCT03441633|19940782|P7|COMPLETED|Overall Study||2855
8088164|NCT03441633|19940783|P6|COMPLETED|Overall Study||363
8088165|NCT03441633|19940784|P5|COMPLETED|Overall Study||2286
8088166|NCT03441633|19940785|P4|COMPLETED|Overall Study||192
8088167|NCT03441633|19940786|P3|COMPLETED|Overall Study||32212
8088168|NCT03441633|19940787|P2|COMPLETED|Overall Study||1423
8088169|NCT03441633|19940788|P1|COMPLETED|Overall Study||4712
8088170|NCT03441633|19940779|P10|STARTED|Overall Study||1562
8088171|NCT03441633|19940780|P9|STARTED|Overall Study||5132
8088172|NCT03441633|19940781|P8|STARTED|Overall Study||953
8088173|NCT03441633|19940782|P7|STARTED|Overall Study||2855
8088174|NCT03441633|19940783|P6|STARTED|Overall Study||363
8088175|NCT03441633|19940784|P5|STARTED|Overall Study||2286
8088176|NCT03441633|19940785|P4|STARTED|Overall Study||192
8088177|NCT03441633|19940786|P3|STARTED|Overall Study||32212
8088178|NCT03441633|19940787|P2|STARTED|Overall Study||1423
8088179|NCT03441633|19940788|P1|STARTED|Overall Study||4712
8088180|NCT03441594|19940928|P1|NOT COMPLETED|Overall Study||0
8088181|NCT03441594|19940928|P1|COMPLETED|Overall Study||56
8088182|NCT03441594|19940928|P1|STARTED|Overall Study||56
8088183|NCT03441269|19940936|P3|NOT COMPLETED|Overall Study||1
8088184|NCT03441269|19940937|P2|NOT COMPLETED|Overall Study||1
8088185|NCT03441269|19940938|P1|NOT COMPLETED|Overall Study||0
8088186|NCT03441269|19940936|P3|COMPLETED|Overall Study||74
8088187|NCT03441269|19940937|P2|COMPLETED|Overall Study||74
8088188|NCT03441269|19940938|P1|COMPLETED|Overall Study||75
8088189|NCT03441269|19940936|P3|STARTED|Overall Study||75
8088190|NCT03441269|19940937|P2|STARTED|Overall Study||75
8088191|NCT03441269|19940938|P1|STARTED|Overall Study||75
8088192|NCT03441178|19940952|P3|NOT COMPLETED|Overall Study||1
8088193|NCT03441178|19940953|P2|NOT COMPLETED|Overall Study||1
8088194|NCT03441178|19940954|P1|NOT COMPLETED|Overall Study||0
8088195|NCT03441178|19940952|P3|COMPLETED|Overall Study||20
8088196|NCT03441178|19940953|P2|COMPLETED|Overall Study||43
8088197|NCT03441178|19940954|P1|COMPLETED|Overall Study||36
8088198|NCT03441178|19940952|P3|STARTED|Overall Study||21
8088199|NCT03441178|19940953|P2|STARTED|Overall Study||44
8088200|NCT03441178|19940954|P1|STARTED|Overall Study||36
8088201|NCT03440918|19940974|P2|NOT COMPLETED|Overall Study||16
8088202|NCT03440918|19940975|P1|NOT COMPLETED|Overall Study||0
8088203|NCT03440918|19940974|P2|COMPLETED|Overall Study||122
8088204|NCT03440918|19940975|P1|COMPLETED|Overall Study||133
8088205|NCT03440918|19940974|P2|STARTED|Overall Study||138
8088206|NCT03440918|19940975|P1|STARTED|Overall Study||133
8088207|NCT03440619|19941003|P1|NOT COMPLETED|Overall Study||0
8088208|NCT03440619|19941003|P1|COMPLETED|Overall Study||28
8088209|NCT03440619|19941003|P1|STARTED|Overall Study||28
8088210|NCT03440424|19941010|P3|NOT COMPLETED|Overall Study||0
8088211|NCT03440424|19941011|P2|NOT COMPLETED|Overall Study||0
8088212|NCT03440424|19941012|P1|NOT COMPLETED|Overall Study||0
8088213|NCT03440424|19941010|P3|COMPLETED|Overall Study||8
8088214|NCT03440424|19941011|P2|COMPLETED|Overall Study||8
8088215|NCT03440424|19941012|P1|COMPLETED|Overall Study||8
8088216|NCT03440424|19941010|P3|STARTED|Overall Study||8
8088217|NCT03440424|19941011|P2|STARTED|Overall Study||8
8088218|NCT03440424|19941012|P1|STARTED|Overall Study||8
8088219|NCT03439124|19941073|P2|NOT COMPLETED|Overall Study||0
8088220|NCT03439124|19941074|P1|NOT COMPLETED|Overall Study||4
8088221|NCT03439124|19941073|P2|COMPLETED|Overall Study||44
8088222|NCT03439124|19941074|P1|COMPLETED|Overall Study||90
8088223|NCT03439124|19941073|P2|STARTED|Overall Study||44
8088224|NCT03439124|19941074|P1|STARTED|Overall Study||94
8088225|NCT03439072|19941088|P2|NOT COMPLETED|Overall Study||4
8088226|NCT03439072|19941089|P1|NOT COMPLETED|Overall Study||2
8088227|NCT03439072|19941088|P2|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36
8088228|NCT03439072|19941089|P1|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39
8088229|NCT03439072|19941088|P2|STARTED|Overall Study||40
8088230|NCT03439072|19941089|P1|STARTED|Overall Study||41
8088231|NCT03438578|19941123|P2|NOT COMPLETED|Overall Study||4
8088232|NCT03438578|19941124|P1|NOT COMPLETED|Overall Study||1
8088233|NCT03438578|19941123|P2|COMPLETED|Overall Study||96
8088234|NCT03438578|19941124|P1|COMPLETED|Overall Study||99
8088235|NCT03438578|19941123|P2|STARTED|Overall Study||100
8088236|NCT03438578|19941124|P1|STARTED|Overall Study||100
8088237|NCT03438539|19941140|P6|NOT COMPLETED|Overall Study||8
8088238|NCT03438539|19941141|P5|NOT COMPLETED|Overall Study||3
8088239|NCT03438539|19941142|P4|NOT COMPLETED|Overall Study||9
8088240|NCT03438539|19941143|P3|NOT COMPLETED|Overall Study||10
8088241|NCT03438539|19941144|P2|NOT COMPLETED|Overall Study||4
8088242|NCT03438539|19941145|P1|NOT COMPLETED|Overall Study||8
8088243|NCT03438539|19941140|P6|COMPLETED|Overall Study||66
8088244|NCT03438539|19941141|P5|COMPLETED|Overall Study||70
8088245|NCT03438539|19941142|P4|COMPLETED|Overall Study||64
8088246|NCT03438539|19941143|P3|COMPLETED|Overall Study||66
8088247|NCT03438539|19941144|P2|COMPLETED|Overall Study||68
8088248|NCT03438539|19941145|P1|COMPLETED|Overall Study||68
8088249|NCT03438539|19941140|P6|STARTED|Overall Study||74
8088250|NCT03438539|19941141|P5|STARTED|Overall Study||73
8088251|NCT03438539|19941142|P4|STARTED|Overall Study||73
8088252|NCT03438539|19941143|P3|STARTED|Overall Study||76
8088253|NCT03438539|19941144|P2|STARTED|Overall Study||72
8088254|NCT03438539|19941145|P1|STARTED|Overall Study||76
8088255|NCT03438383|19941173|P2|NOT COMPLETED|Overall Study||3
8088256|NCT03438383|19941174|P1|NOT COMPLETED|Overall Study||9
8088257|NCT03438383|19941173|P2|COMPLETED|Overall Study||21
8088258|NCT03438383|19941174|P1|COMPLETED|Overall Study||14
8088259|NCT03438383|19941173|P2|STARTED|Overall Study||24
8088260|NCT03438383|19941174|P1|STARTED|Overall Study||23
8088261|NCT03438266|19941194|P1|NOT COMPLETED|Overall Study||0
8088262|NCT03438266|19941194|P1|COMPLETED|Overall Study||60
8088263|NCT03438266|19941194|P1|STARTED|Overall Study||60
8088264|NCT03437733|19941205|P2|NOT COMPLETED|Overall Study||3
8088265|NCT03437733|19941206|P1|NOT COMPLETED|Overall Study||0
8088266|NCT03437733|19941205|P2|COMPLETED|Overall Study||87
8088267|NCT03437733|19941206|P1|COMPLETED|Overall Study||8
8088268|NCT03437733|19941205|P2|Safety|Overall Study||87
8088269|NCT03437733|19941206|P1|Safety|Overall Study||8
8088270|NCT03437733|19941205|P2|STARTED|Overall Study||90
8088271|NCT03437733|19941206|P1|STARTED|Overall Study||8
8088272|NCT03437564|19941229|P2|NOT COMPLETED|Overall Study||0
8088273|NCT03437564|19941230|P1|NOT COMPLETED|Overall Study||0
8088274|NCT03437564|19941229|P2|COMPLETED|Overall Study||14
8088275|NCT03437564|19941230|P1|COMPLETED|Overall Study||14
8088276|NCT03437564|19941229|P2|STARTED|Overall Study||14
8088277|NCT03437564|19941230|P1|STARTED|Overall Study||14
8088278|NCT03437447|19941261|P3|NOT COMPLETED|Treatment Period 3||0
8088279|NCT03437447|19941262|P2|NOT COMPLETED|Treatment Period 3||0
8088280|NCT03437447|19941263|P1|NOT COMPLETED|Treatment Period 3||0
8088281|NCT03437447|19941261|P3|COMPLETED|Treatment Period 3||19
8088282|NCT03437447|19941262|P2|COMPLETED|Treatment Period 3||20
8088283|NCT03437447|19941263|P1|COMPLETED|Treatment Period 3||20
8088284|NCT03437447|19941261|P3|STARTED|Treatment Period 3||19
8088285|NCT03437447|19941262|P2|STARTED|Treatment Period 3||20
8088286|NCT03437447|19941263|P1|STARTED|Treatment Period 3||20
8088287|NCT03437447|19941261|P3|NOT COMPLETED|Treatment Period 2||0
8088288|NCT03437447|19941262|P2|NOT COMPLETED|Treatment Period 2||0
8088289|NCT03437447|19941263|P1|NOT COMPLETED|Treatment Period 2||0
8088290|NCT03437447|19941261|P3|COMPLETED|Treatment Period 2||19
8088291|NCT03437447|19941262|P2|COMPLETED|Treatment Period 2||20
8088292|NCT03437447|19941263|P1|COMPLETED|Treatment Period 2||20
8088293|NCT03437447|19941261|P3|STARTED|Treatment Period 2||19
8088294|NCT03437447|19941262|P2|STARTED|Treatment Period 2||20
8088295|NCT03437447|19941263|P1|STARTED|Treatment Period 2||20
8088296|NCT03437447|19941261|P3|NOT COMPLETED|Treatment Period 1||1
8088297|NCT03437447|19941262|P2|NOT COMPLETED|Treatment Period 1||0
8088298|NCT03437447|19941263|P1|NOT COMPLETED|Treatment Period 1||0
8088299|NCT03437447|19941261|P3|COMPLETED|Treatment Period 1||19
8088300|NCT03437447|19941262|P2|COMPLETED|Treatment Period 1||20
8088301|NCT03437447|19941263|P1|COMPLETED|Treatment Period 1||20
8088302|NCT03437447|19941261|P3|STARTED|Treatment Period 1||20
8088303|NCT03437447|19941262|P2|STARTED|Treatment Period 1||20
8088304|NCT03437447|19941263|P1|STARTED|Treatment Period 1||20
8088305|NCT03436732|19941318|P2|NOT COMPLETED|Overall Study||1
8088306|NCT03436732|19941319|P1|NOT COMPLETED|Overall Study||4
8088307|NCT03436732|19941318|P2|COMPLETED|Overall Study||0
8088308|NCT03436732|19941319|P1|COMPLETED|Overall Study||0
8088309|NCT03436732|19941318|P2|STARTED|Overall Study||1
8088310|NCT03436732|19941319|P1|STARTED|Overall Study||4
8088311|NCT03436420|19941332|P1|NOT COMPLETED|Overall Study||3
8088312|NCT03436420|19941332|P1|COMPLETED|Overall Study||3
8088313|NCT03436420|19941332|P1|STARTED|Overall Study||6
8088314|NCT03436147|19941375|P2|NOT COMPLETED|Overall Study||11
8088315|NCT03436147|19941376|P1|NOT COMPLETED|Overall Study||4
8088316|NCT03436147|19941375|P2|COMPLETED|Overall Study||19
8088317|NCT03436147|19941376|P1|COMPLETED|Overall Study||15
8088318|NCT03436147|19941375|P2|STARTED|Overall Study||30
8088319|NCT03436147|19941376|P1|STARTED|Overall Study||19
8088320|NCT03435783|19941388|P2|NOT COMPLETED|Overall Study||1
8088321|NCT03435783|19941389|P1|NOT COMPLETED|Overall Study||0
8088322|NCT03435783|19941388|P2|COMPLETED|Overall Study||19
8088323|NCT03435783|19941389|P1|COMPLETED|Overall Study||20
8088324|NCT03435783|19941388|P2|STARTED|Overall Study||20
8088325|NCT03435783|19941389|P1|STARTED|Overall Study||20
8088326|NCT03435562|19941403|P1|NOT COMPLETED|Overall Study||4
8088327|NCT03435562|19941403|P1|COMPLETED|Overall Study||18
8088328|NCT03435562|19941403|P1|STARTED|Overall Study||22
8088329|NCT03435497|19941485|P2|NOT COMPLETED|Overall Study||6
8088330|NCT03435497|19941486|P1|NOT COMPLETED|Overall Study||2
8088331|NCT03435497|19941485|P2|COMPLETED|Overall Study||41
8088332|NCT03435497|19941486|P1|COMPLETED|Overall Study||49
8088333|NCT03435497|19941485|P2|STARTED|Overall Study||47
8088334|NCT03435497|19941486|P1|STARTED|Overall Study||51
8088335|NCT03435185|19941502|P2|NOT COMPLETED|Overall Study||15
8088336|NCT03435185|19941503|P1|NOT COMPLETED|Overall Study||1
8088337|NCT03435185|19941502|P2|COMPLETED|Overall Study||28
8088338|NCT03435185|19941503|P1|COMPLETED|Overall Study||43
8088339|NCT03435185|19941502|P2|STARTED|Overall Study||43
8088340|NCT03435185|19941503|P1|STARTED|Overall Study||44
8088353|NCT03434977|19941593|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8088354|NCT03434977|19941594|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8088355|NCT03434977|19941593|P2|COMPLETED|Intervention Period 2 (6 Days)||5
8088356|NCT03434977|19941594|P1|COMPLETED|Intervention Period 2 (6 Days)||6
8088357|NCT03434977|19941593|P2|STARTED|Intervention Period 2 (6 Days)||5
8088358|NCT03434977|19941594|P1|STARTED|Intervention Period 2 (6 Days)||6
8088359|NCT03434977|19941593|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||1
8088360|NCT03434977|19941594|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
8088361|NCT03434977|19941593|P2|COMPLETED|Washout Period (at Least 6 Days)||5
8088362|NCT03434977|19941594|P1|COMPLETED|Washout Period (at Least 6 Days)||6
8088363|NCT03434977|19941593|P2|STARTED|Washout Period (at Least 6 Days)||6
8088364|NCT03434977|19941594|P1|STARTED|Washout Period (at Least 6 Days)||6
8088365|NCT03434977|19941593|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8088366|NCT03434977|19941594|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8088367|NCT03434977|19941593|P2|COMPLETED|Intervention Period 1 (6 Days)||6
8088368|NCT03434977|19941594|P1|COMPLETED|Intervention Period 1 (6 Days)||6
8088369|NCT03434977|19941593|P2|STARTED|Intervention Period 1 (6 Days)||6
8088370|NCT03434977|19941594|P1|STARTED|Intervention Period 1 (6 Days)||6
8088371|NCT03434457|19941628|P1|NOT COMPLETED|Overall Study||0
8088372|NCT03434457|19941628|P1|COMPLETED|Overall Study||630
8088373|NCT03434457|19941628|P1|STARTED|Overall Study||630
8088374|NCT03434249|19941661|P2|NOT COMPLETED|Overall Study||3
8088375|NCT03434249|19941662|P1|NOT COMPLETED|Overall Study||5
8088376|NCT03434249|19941661|P2|COMPLETED|Overall Study||37
8088377|NCT03434249|19941662|P1|COMPLETED|Overall Study||35
8088378|NCT03434249|19941661|P2|STARTED|Overall Study||40
8088379|NCT03434249|19941662|P1|STARTED|Overall Study||40
8088380|NCT03434119|19941696|P2|NOT COMPLETED|Overall Study||113
8088381|NCT03434119|19941697|P1|NOT COMPLETED|Overall Study||107
8088382|NCT03434119|19941696|P2|COMPLETED|Overall Study||12
8088383|NCT03434119|19941697|P1|COMPLETED|Overall Study||9
8088384|NCT03434119|19941696|P2|Treated|Overall Study||125
8088385|NCT03434119|19941697|P1|Treated|Overall Study||115
8088386|NCT03434119|19941696|P2|STARTED|Overall Study||125
8088387|NCT03434119|19941697|P1|STARTED|Overall Study||116
8088388|NCT03433794|19941718|P3|NOT COMPLETED|9-Month Assessment||142
8088389|NCT03433794|19941719|P2|NOT COMPLETED|9-Month Assessment||121
8088390|NCT03433794|19941720|P1|NOT COMPLETED|9-Month Assessment||134
8088391|NCT03433794|19941718|P3|COMPLETED|9-Month Assessment||39
8088392|NCT03433794|19941719|P2|COMPLETED|9-Month Assessment||52
8088393|NCT03433794|19941720|P1|COMPLETED|9-Month Assessment||49
8088394|NCT03433794|19941718|P3|STARTED|9-Month Assessment||181
8088395|NCT03433794|19941719|P2|STARTED|9-Month Assessment||173
8088396|NCT03433794|19941720|P1|STARTED|9-Month Assessment||183
8088397|NCT03433794|19941718|P3|NOT COMPLETED|6-Month Assessment||131
8088398|NCT03433794|19941719|P2|NOT COMPLETED|6-Month Assessment||115
8088399|NCT03433794|19941720|P1|NOT COMPLETED|6-Month Assessment||118
8088400|NCT03433794|19941718|P3|COMPLETED|6-Month Assessment||50
8088401|NCT03433794|19941719|P2|COMPLETED|6-Month Assessment||58
8088402|NCT03433794|19941720|P1|COMPLETED|6-Month Assessment||65
8088403|NCT03433794|19941718|P3|STARTED|6-Month Assessment||181
8088404|NCT03433794|19941719|P2|STARTED|6-Month Assessment||173
8088405|NCT03433794|19941720|P1|STARTED|6-Month Assessment||183
8088406|NCT03433794|19941718|P3|NOT COMPLETED|3-Month Assessment||110
8088407|NCT03433794|19941719|P2|NOT COMPLETED|3-Month Assessment||100
8088408|NCT03433794|19941720|P1|NOT COMPLETED|3-Month Assessment||114
8088409|NCT03433794|19941718|P3|COMPLETED|3-Month Assessment||71
8088410|NCT03433794|19941719|P2|COMPLETED|3-Month Assessment||73
8088411|NCT03433794|19941720|P1|COMPLETED|3-Month Assessment||69
8088412|NCT03433794|19941718|P3|STARTED|3-Month Assessment||181
8088413|NCT03433794|19941719|P2|STARTED|3-Month Assessment||173
8088414|NCT03433794|19941720|P1|STARTED|3-Month Assessment||183
8088415|NCT03433794|19941718|P3|NOT COMPLETED|6-Week Assessment||101
8088416|NCT03433794|19941719|P2|NOT COMPLETED|6-Week Assessment||88
8088417|NCT03433794|19941720|P1|NOT COMPLETED|6-Week Assessment||89
8088418|NCT03433794|19941718|P3|COMPLETED|6-Week Assessment||80
8088419|NCT03433794|19941719|P2|COMPLETED|6-Week Assessment||85
8088420|NCT03433794|19941720|P1|COMPLETED|6-Week Assessment||94
8088421|NCT03433794|19941718|P3|STARTED|6-Week Assessment||181
8088422|NCT03433794|19941719|P2|STARTED|6-Week Assessment||173
8088423|NCT03433794|19941720|P1|STARTED|6-Week Assessment||183
8088424|NCT03433794|19941718|P3|NOT COMPLETED|4-Week Assessment||90
8088425|NCT03433794|19941719|P2|NOT COMPLETED|4-Week Assessment||78
8088426|NCT03433794|19941720|P1|NOT COMPLETED|4-Week Assessment||85
8088427|NCT03433794|19941718|P3|COMPLETED|4-Week Assessment||91
8088428|NCT03433794|19941719|P2|COMPLETED|4-Week Assessment||95
8088429|NCT03433794|19941720|P1|COMPLETED|4-Week Assessment||98
8088430|NCT03433794|19941718|P3|STARTED|4-Week Assessment||181
8088431|NCT03433794|19941719|P2|STARTED|4-Week Assessment||173
8088432|NCT03433794|19941720|P1|STARTED|4-Week Assessment||183
8088433|NCT03433794|19941718|P3|NOT COMPLETED|2-Week Assessment||72
8088434|NCT03433794|19941719|P2|NOT COMPLETED|2-Week Assessment||61
8088435|NCT03433794|19941720|P1|NOT COMPLETED|2-Week Assessment||66
8088436|NCT03433794|19941718|P3|COMPLETED|2-Week Assessment||109
8088437|NCT03433794|19941719|P2|COMPLETED|2-Week Assessment||112
8088438|NCT03433794|19941720|P1|COMPLETED|2-Week Assessment||117
8088439|NCT03433794|19941718|P3|STARTED|2-Week Assessment||181
8088440|NCT03433794|19941719|P2|STARTED|2-Week Assessment||173
8088441|NCT03433794|19941720|P1|STARTED|2-Week Assessment||183
8088442|NCT03433794|19941718|P3|NOT COMPLETED|Baseline||0
8088443|NCT03433794|19941719|P2|NOT COMPLETED|Baseline||0
8088444|NCT03433794|19941720|P1|NOT COMPLETED|Baseline||0
8088445|NCT03433794|19941718|P3|COMPLETED|Baseline||181
8088446|NCT03433794|19941719|P2|COMPLETED|Baseline||173
8088447|NCT03433794|19941720|P1|COMPLETED|Baseline||183
8088448|NCT03433794|19941718|P3|STARTED|Baseline||181
8088449|NCT03433794|19941719|P2|STARTED|Baseline||173
8088450|NCT03433794|19941720|P1|STARTED|Baseline||183
8088451|NCT03433703|19941731|P1|NOT COMPLETED|Overall Study||2
8088452|NCT03433703|19941731|P1|COMPLETED|Overall Study||0
8088453|NCT03433703|19941731|P1|STARTED|Overall Study||2
8088454|NCT03433677|19941740|P2|NOT COMPLETED|Period 2||1
8088455|NCT03433677|19941741|P1|NOT COMPLETED|Period 2||1
8088456|NCT03433677|19941740|P2|COMPLETED|Period 2||24
8088457|NCT03433677|19941741|P1|COMPLETED|Period 2||22
8088458|NCT03433677|19941740|P2|Received at Least 1 Dose of Study Drug|Period 2||25
8088459|NCT03433677|19941741|P1|Received at Least 1 Dose of Study Drug|Period 2||23
8088460|NCT03433677|19941740|P2|STARTED|Period 2||25
8088461|NCT03433677|19941741|P1|STARTED|Period 2||23
8088462|NCT03433677|19941740|P2|NOT COMPLETED|Period 1||0
8088463|NCT03433677|19941741|P1|NOT COMPLETED|Period 1||1
8088464|NCT03433677|19941740|P2|COMPLETED|Period 1||25
8088465|NCT03433677|19941741|P1|COMPLETED|Period 1||23
8088466|NCT03433677|19941740|P2|Received at Least 1 Dose of Study Drug|Period 1||25
8088467|NCT03433677|19941741|P1|Received at Least 1 Dose of Study Drug|Period 1||24
8088468|NCT03433677|19941740|P2|STARTED|Period 1||25
8088469|NCT03433677|19941741|P1|STARTED|Period 1||24
8088470|NCT03432533|19941761|P2|NOT COMPLETED|Overall Study||11
8088471|NCT03432533|19941762|P1|NOT COMPLETED|Overall Study||15
8088472|NCT03432533|19941761|P2|COMPLETED|Overall Study||131
8088473|NCT03432533|19941762|P1|COMPLETED|Overall Study||126
8088474|NCT03432533|19941761|P2|Completed 6-Month Treatment Period|Overall Study||137
8088475|NCT03432533|19941762|P1|Completed 6-Month Treatment Period|Overall Study||136
8088476|NCT03432533|19941761|P2|STARTED|Overall Study||142
8088477|NCT03432533|19941762|P1|STARTED|Overall Study||141
8088478|NCT03432390|19941778|P2|NOT COMPLETED|Recovery Period||0
8088479|NCT03432390|19941779|P1|NOT COMPLETED|Recovery Period||0
8088480|NCT03432390|19941778|P2|COMPLETED|Recovery Period||34
8088481|NCT03432390|19941779|P1|COMPLETED|Recovery Period||34
8088482|NCT03432390|19941778|P2|STARTED|Recovery Period||34
8088483|NCT03432390|19941779|P1|STARTED|Recovery Period||34
8088484|NCT03432390|19941778|P2|NOT COMPLETED|Apnea Period||2
8088485|NCT03432390|19941779|P1|NOT COMPLETED|Apnea Period||2
8088486|NCT03432390|19941778|P2|COMPLETED|Apnea Period||34
8088487|NCT03432390|19941779|P1|COMPLETED|Apnea Period||34
8088488|NCT03432390|19941778|P2|STARTED|Apnea Period||36
8088489|NCT03432390|19941779|P1|STARTED|Apnea Period||36
8088490|NCT03431441|19941789|P1|NOT COMPLETED|Overall Study||5
8088491|NCT03431441|19941789|P1|COMPLETED|Overall Study||19
8088492|NCT03431441|19941789|P1|STARTED|Overall Study||24
8088493|NCT03431012|19941797|P4|NOT COMPLETED|Overall Study||0
8088494|NCT03431012|19941798|P3|NOT COMPLETED|Overall Study||0
8088495|NCT03431012|19941799|P2|NOT COMPLETED|Overall Study||0
8088496|NCT03431012|19941800|P1|NOT COMPLETED|Overall Study||0
8088497|NCT03431012|19941797|P4|COMPLETED|Overall Study||53
8088498|NCT03431012|19941798|P3|COMPLETED|Overall Study||56
8088499|NCT03431012|19941799|P2|COMPLETED|Overall Study||60
8088500|NCT03431012|19941800|P1|COMPLETED|Overall Study||47
8088501|NCT03431012|19941797|P4|STARTED|Overall Study||53
8088502|NCT03431012|19941798|P3|STARTED|Overall Study||56
8088503|NCT03431012|19941799|P2|STARTED|Overall Study||60
8088504|NCT03431012|19941800|P1|STARTED|Overall Study||47
8088505|NCT03430986|19941824|P2|NOT COMPLETED|24-week Post-Control Period||2
8088506|NCT03430986|19941825|P1|NOT COMPLETED|24-week Post-Control Period||1
8088507|NCT03430986|19941824|P2|COMPLETED|24-week Post-Control Period||116
8088508|NCT03430986|19941825|P1|COMPLETED|24-week Post-Control Period||30
8088509|NCT03430986|19941824|P2|STARTED|24-week Post-Control Period||118
8088510|NCT03430986|19941825|P1|STARTED|24-week Post-Control Period|Not all participants received the Optional Treatment.|31
8088511|NCT03430986|19941824|P2|NOT COMPLETED|24-week Control Period||4
8088512|NCT03430986|19941825|P1|NOT COMPLETED|24-week Control Period||8
8088513|NCT03430986|19941824|P2|COMPLETED|24-week Control Period||118
8088514|NCT03430986|19941825|P1|COMPLETED|24-week Control Period||34
8088515|NCT03430986|19941824|P2|Treated as Randomized|24-week Control Period||120
8088516|NCT03430986|19941825|P1|Treated as Randomized|24-week Control Period||42
8088517|NCT03430986|19941824|P2|STARTED|24-week Control Period||122
8088518|NCT03430986|19941825|P1|STARTED|24-week Control Period||42
8088519|NCT03430856|19941842|P3|NOT COMPLETED|Overall Study||1
8088520|NCT03430856|19941843|P2|NOT COMPLETED|Overall Study||3
8088521|NCT03430856|19941844|P1|NOT COMPLETED|Overall Study||2
8088522|NCT03430856|19941842|P3|COMPLETED|Overall Study||29
8088523|NCT03430856|19941843|P2|COMPLETED|Overall Study||27
8088524|NCT03430856|19941844|P1|COMPLETED|Overall Study||29
8088525|NCT03430856|19941842|P3|Exposed|Overall Study||30
8088526|NCT03430856|19941843|P2|Exposed|Overall Study||30
8088527|NCT03430856|19941844|P1|Exposed|Overall Study||31
8088528|NCT03430856|19941842|P3|STARTED|Overall Study||30
8088529|NCT03430856|19941843|P2|STARTED|Overall Study||30
8088530|NCT03430856|19941844|P1|STARTED|Overall Study||31
8088531|NCT03430245|19941882|P1|NOT COMPLETED|Overall Study||7
8088532|NCT03430245|19941882|P1|COMPLETED|Overall Study|6 subjects withdrew from study due to lengthy treatment. Treatment protocol amended.|9
8088533|NCT03430245|19941882|P1|STARTED|Overall Study||16
8088534|NCT03430206|19941891|P2|NOT COMPLETED|Overall Study||17
8088535|NCT03430206|19941892|P1|NOT COMPLETED|Overall Study||22
8088536|NCT03430206|19941891|P2|COMPLETED|Overall Study||21
8088537|NCT03430206|19941892|P1|COMPLETED|Overall Study||18
8088538|NCT03430206|19941891|P2|STARTED|Overall Study||38
8088539|NCT03430206|19941892|P1|STARTED|Overall Study||40
8088540|NCT03430050|19941912|P2|NOT COMPLETED|Overall Study||0
8088541|NCT03430050|19941913|P1|NOT COMPLETED|Overall Study||0
8088542|NCT03430050|19941912|P2|COMPLETED|Overall Study||5
8088543|NCT03430050|19941913|P1|COMPLETED|Overall Study||3
8088544|NCT03430050|19941912|P2|STARTED|Overall Study||5
8088545|NCT03430050|19941913|P1|STARTED|Overall Study||3
8088546|NCT03429712|19941921|P1|NOT COMPLETED|Overall Study||9
8088547|NCT03429712|19941921|P1|COMPLETED|Overall Study||10
8088548|NCT03429712|19941921|P1|STARTED|Overall Study||19
8088549|NCT03429556|19941929|P4|NOT COMPLETED|Overall Study||0
8088550|NCT03429556|19941930|P3|NOT COMPLETED|Overall Study||0
8088551|NCT03429556|19941931|P2|NOT COMPLETED|Overall Study||1
8088552|NCT03429556|19941932|P1|NOT COMPLETED|Overall Study||0
8088553|NCT03429556|19941929|P4|COMPLETED|Overall Study||3
8088554|NCT03429556|19941930|P3|COMPLETED|Overall Study||4
8088555|NCT03429556|19941931|P2|COMPLETED|Overall Study||3
8088556|NCT03429556|19941932|P1|COMPLETED|Overall Study||12
8088557|NCT03429556|19941929|P4|STARTED|Overall Study||3
8088558|NCT03429556|19941930|P3|STARTED|Overall Study||4
8088559|NCT03429556|19941931|P2|STARTED|Overall Study||4
8088560|NCT03429556|19941932|P1|STARTED|Overall Study||12
8088561|NCT03429270|19941978|P1|NOT COMPLETED|Overall Study||0
8088562|NCT03429270|19941978|P1|COMPLETED|Overall Study||28
8088563|NCT03429270|19941978|P1|STARTED|Overall Study||28
8088564|NCT03428997|19941983|P1|NOT COMPLETED|Overall Study||8
8088565|NCT03428997|19941983|P1|COMPLETED|Overall Study||16
8088566|NCT03428997|19941983|P1|STARTED|Overall Study||24
8088567|NCT03428750|19941991|P2|NOT COMPLETED|Overall Study||21
8088568|NCT03428750|19941992|P1|NOT COMPLETED|Overall Study||24
8088569|NCT03428750|19941991|P2|COMPLETED|Overall Study||192
8088570|NCT03428750|19941992|P1|COMPLETED|Overall Study||186
8088571|NCT03428750|19941991|P2|STARTED|Overall Study||213
8088572|NCT03428750|19941992|P1|STARTED|Overall Study||210
8088573|NCT03428152|19942041|P2|NOT COMPLETED|Overall Study||11
8088574|NCT03428152|19942042|P1|NOT COMPLETED|Overall Study||7
8088575|NCT03428152|19942041|P2|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30
8088576|NCT03428152|19942042|P1|COMPLETED|Overall Study||30
8088577|NCT03428152|19942041|P2|STARTED|Overall Study||41
8088578|NCT03428152|19942042|P1|STARTED|Overall Study||37
8088595|NCT03427931|19942180|P1|NOT COMPLETED|Overall Study||2
8088596|NCT03427931|19942180|P1|COMPLETED|Overall Study||5
8088597|NCT03427931|19942180|P1|STARTED|Overall Study||7
8088598|NCT03427892|19942185|P1|NOT COMPLETED|Overall Study||2
8088599|NCT03427892|19942185|P1|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19
8088600|NCT03427892|19942185|P1|STARTED|Overall Study||21
8088601|NCT03427177|19942203|P2|NOT COMPLETED|Overall Study||27
8088602|NCT03427177|19942204|P1|NOT COMPLETED|Overall Study||33
8088603|NCT03427177|19942203|P2|COMPLETED|Overall Study||105
8088604|NCT03427177|19942204|P1|COMPLETED|Overall Study||92
8088605|NCT03427177|19942203|P2|STARTED|Overall Study||132
8088606|NCT03427177|19942204|P1|STARTED|Overall Study||125
8088607|NCT03427073|19942226|P8|NOT COMPLETED|Overall Study||4
8088608|NCT03427073|19942227|P7|NOT COMPLETED|Overall Study||3
8088609|NCT03427073|19942228|P6|NOT COMPLETED|Overall Study||4
8088610|NCT03427073|19942229|P5|NOT COMPLETED|Overall Study||3
8088611|NCT03427073|19942230|P4|NOT COMPLETED|Overall Study||3
8088612|NCT03427073|19942231|P3|NOT COMPLETED|Overall Study||1
8088613|NCT03427073|19942232|P2|NOT COMPLETED|Overall Study||1
8088614|NCT03427073|19942233|P1|NOT COMPLETED|Overall Study||1
8088615|NCT03427073|19942226|P8|COMPLETED|Overall Study||0
8088616|NCT03427073|19942227|P7|COMPLETED|Overall Study||0
8088617|NCT03427073|19942228|P6|COMPLETED|Overall Study||0
8088618|NCT03427073|19942229|P5|COMPLETED|Overall Study||0
8088619|NCT03427073|19942230|P4|COMPLETED|Overall Study||0
8088620|NCT03427073|19942231|P3|COMPLETED|Overall Study||0
8088621|NCT03427073|19942232|P2|COMPLETED|Overall Study||0
8088622|NCT03427073|19942233|P1|COMPLETED|Overall Study||0
8088623|NCT03427073|19942226|P8|STARTED|Overall Study||4
8088624|NCT03427073|19942227|P7|STARTED|Overall Study||3
8088625|NCT03427073|19942228|P6|STARTED|Overall Study||4
8088626|NCT03427073|19942229|P5|STARTED|Overall Study||3
8088627|NCT03427073|19942230|P4|STARTED|Overall Study||3
8088628|NCT03427073|19942231|P3|STARTED|Overall Study||1
8088629|NCT03427073|19942232|P2|STARTED|Overall Study||1
8088630|NCT03427073|19942233|P1|STARTED|Overall Study||1
8088631|NCT03426995|19942302|P19|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088632|NCT03426995|19942303|P18|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088633|NCT03426995|19942304|P17|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088634|NCT03426995|19942305|P16|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||12
8088635|NCT03426995|19942306|P15|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||9
8088636|NCT03426995|19942307|P14|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088637|NCT03426995|19942308|P13|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088638|NCT03426995|19942309|P12|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088639|NCT03426995|19942310|P11|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088640|NCT03426995|19942311|P10|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088641|NCT03426995|19942312|P9|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088642|NCT03426995|19942313|P8|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088643|NCT03426995|19942314|P7|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088644|NCT03426995|19942315|P6|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088645|NCT03426995|19942316|P5|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088646|NCT03426995|19942317|P4|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088647|NCT03426995|19942318|P3|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088648|NCT03426995|19942319|P2|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088649|NCT03426995|19942320|P1|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088650|NCT03426995|19942302|P19|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088651|NCT03426995|19942303|P18|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088652|NCT03426995|19942304|P17|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088653|NCT03426995|19942305|P16|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
8088654|NCT03426995|19942306|P15|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
8088655|NCT03426995|19942307|P14|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088656|NCT03426995|19942308|P13|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088657|NCT03426995|19942309|P12|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088658|NCT03426995|19942310|P11|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088659|NCT03426995|19942311|P10|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088660|NCT03426995|19942312|P9|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088661|NCT03426995|19942313|P8|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088662|NCT03426995|19942314|P7|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088663|NCT03426995|19942315|P6|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088740|NCT03426995|19942316|P5|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088664|NCT03426995|19942316|P5|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088665|NCT03426995|19942317|P4|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088666|NCT03426995|19942318|P3|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088667|NCT03426995|19942319|P2|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088668|NCT03426995|19942320|P1|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088669|NCT03426995|19942302|P19|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088670|NCT03426995|19942303|P18|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088671|NCT03426995|19942304|P17|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088672|NCT03426995|19942305|P16|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||14
8088673|NCT03426995|19942306|P15|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||11
8088674|NCT03426995|19942307|P14|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088675|NCT03426995|19942308|P13|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088676|NCT03426995|19942309|P12|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088677|NCT03426995|19942310|P11|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088678|NCT03426995|19942311|P10|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088679|NCT03426995|19942312|P9|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088680|NCT03426995|19942313|P8|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088681|NCT03426995|19942314|P7|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088682|NCT03426995|19942315|P6|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088683|NCT03426995|19942316|P5|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088684|NCT03426995|19942317|P4|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088685|NCT03426995|19942318|P3|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088686|NCT03426995|19942319|P2|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088687|NCT03426995|19942320|P1|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
8088688|NCT03426995|19942302|P19|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088689|NCT03426995|19942303|P18|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088690|NCT03426995|19942304|P17|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088691|NCT03426995|19942305|P16|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088692|NCT03426995|19942306|P15|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088693|NCT03426995|19942307|P14|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088694|NCT03426995|19942308|P13|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088695|NCT03426995|19942309|P12|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088696|NCT03426995|19942310|P11|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088697|NCT03426995|19942311|P10|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088698|NCT03426995|19942312|P9|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088699|NCT03426995|19942313|P8|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088700|NCT03426995|19942314|P7|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088701|NCT03426995|19942315|P6|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088702|NCT03426995|19942316|P5|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088703|NCT03426995|19942317|P4|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088704|NCT03426995|19942318|P3|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088705|NCT03426995|19942319|P2|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088706|NCT03426995|19942320|P1|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088707|NCT03426995|19942302|P19|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088708|NCT03426995|19942303|P18|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088709|NCT03426995|19942304|P17|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088710|NCT03426995|19942305|P16|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088711|NCT03426995|19942306|P15|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088712|NCT03426995|19942307|P14|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088713|NCT03426995|19942308|P13|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088714|NCT03426995|19942309|P12|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088715|NCT03426995|19942310|P11|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088716|NCT03426995|19942311|P10|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088717|NCT03426995|19942312|P9|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088718|NCT03426995|19942313|P8|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088719|NCT03426995|19942314|P7|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088720|NCT03426995|19942315|P6|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088721|NCT03426995|19942316|P5|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088722|NCT03426995|19942317|P4|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088723|NCT03426995|19942318|P3|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088724|NCT03426995|19942319|P2|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088725|NCT03426995|19942320|P1|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
8088726|NCT03426995|19942302|P19|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088727|NCT03426995|19942303|P18|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088728|NCT03426995|19942304|P17|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088729|NCT03426995|19942305|P16|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088730|NCT03426995|19942306|P15|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088731|NCT03426995|19942307|P14|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088732|NCT03426995|19942308|P13|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088733|NCT03426995|19942309|P12|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088734|NCT03426995|19942310|P11|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088735|NCT03426995|19942311|P10|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088736|NCT03426995|19942312|P9|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088737|NCT03426995|19942313|P8|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088738|NCT03426995|19942314|P7|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088739|NCT03426995|19942315|P6|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088741|NCT03426995|19942317|P4|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088742|NCT03426995|19942318|P3|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088743|NCT03426995|19942319|P2|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088744|NCT03426995|19942320|P1|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
8088745|NCT03426995|19942302|P19|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088746|NCT03426995|19942303|P18|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088747|NCT03426995|19942304|P17|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088748|NCT03426995|19942305|P16|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088749|NCT03426995|19942306|P15|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088750|NCT03426995|19942307|P14|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088751|NCT03426995|19942308|P13|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088752|NCT03426995|19942309|P12|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088753|NCT03426995|19942310|P11|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088754|NCT03426995|19942311|P10|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088755|NCT03426995|19942312|P9|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088756|NCT03426995|19942313|P8|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088757|NCT03426995|19942314|P7|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088758|NCT03426995|19942315|P6|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088759|NCT03426995|19942316|P5|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088760|NCT03426995|19942317|P4|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088761|NCT03426995|19942318|P3|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088762|NCT03426995|19942319|P2|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088763|NCT03426995|19942320|P1|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088764|NCT03426995|19942302|P19|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088765|NCT03426995|19942303|P18|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088766|NCT03426995|19942304|P17|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088767|NCT03426995|19942305|P16|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088768|NCT03426995|19942306|P15|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088769|NCT03426995|19942307|P14|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088770|NCT03426995|19942308|P13|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088771|NCT03426995|19942309|P12|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088772|NCT03426995|19942310|P11|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088773|NCT03426995|19942311|P10|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088774|NCT03426995|19942312|P9|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088775|NCT03426995|19942313|P8|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088776|NCT03426995|19942314|P7|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088777|NCT03426995|19942315|P6|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088778|NCT03426995|19942316|P5|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088779|NCT03426995|19942317|P4|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088780|NCT03426995|19942318|P3|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088781|NCT03426995|19942319|P2|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088782|NCT03426995|19942320|P1|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088783|NCT03426995|19942302|P19|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088784|NCT03426995|19942303|P18|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088785|NCT03426995|19942304|P17|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088786|NCT03426995|19942305|P16|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088787|NCT03426995|19942306|P15|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088788|NCT03426995|19942307|P14|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088789|NCT03426995|19942308|P13|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088790|NCT03426995|19942309|P12|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088791|NCT03426995|19942310|P11|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088792|NCT03426995|19942311|P10|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088793|NCT03426995|19942312|P9|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088794|NCT03426995|19942313|P8|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088795|NCT03426995|19942314|P7|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088796|NCT03426995|19942315|P6|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088797|NCT03426995|19942316|P5|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088798|NCT03426995|19942317|P4|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088799|NCT03426995|19942318|P3|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088800|NCT03426995|19942319|P2|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088801|NCT03426995|19942320|P1|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
8088802|NCT03426995|19942302|P19|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088803|NCT03426995|19942303|P18|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088804|NCT03426995|19942304|P17|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088805|NCT03426995|19942305|P16|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088806|NCT03426995|19942306|P15|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088807|NCT03426995|19942307|P14|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088808|NCT03426995|19942308|P13|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088809|NCT03426995|19942309|P12|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088810|NCT03426995|19942310|P11|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088811|NCT03426995|19942311|P10|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088812|NCT03426995|19942312|P9|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088813|NCT03426995|19942313|P8|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088814|NCT03426995|19942314|P7|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088815|NCT03426995|19942315|P6|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088816|NCT03426995|19942316|P5|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088817|NCT03426995|19942317|P4|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088818|NCT03426995|19942318|P3|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088819|NCT03426995|19942319|P2|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088820|NCT03426995|19942320|P1|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088821|NCT03426995|19942302|P19|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088822|NCT03426995|19942303|P18|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088823|NCT03426995|19942304|P17|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088824|NCT03426995|19942305|P16|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088825|NCT03426995|19942306|P15|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088826|NCT03426995|19942307|P14|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088827|NCT03426995|19942308|P13|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088828|NCT03426995|19942309|P12|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088829|NCT03426995|19942310|P11|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088830|NCT03426995|19942311|P10|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088831|NCT03426995|19942312|P9|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088832|NCT03426995|19942313|P8|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088833|NCT03426995|19942314|P7|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088834|NCT03426995|19942315|P6|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088835|NCT03426995|19942316|P5|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088836|NCT03426995|19942317|P4|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088837|NCT03426995|19942318|P3|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088838|NCT03426995|19942319|P2|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088839|NCT03426995|19942320|P1|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
8088840|NCT03426995|19942302|P19|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088841|NCT03426995|19942303|P18|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088842|NCT03426995|19942304|P17|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088843|NCT03426995|19942305|P16|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088844|NCT03426995|19942306|P15|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088845|NCT03426995|19942307|P14|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088846|NCT03426995|19942308|P13|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088847|NCT03426995|19942309|P12|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088848|NCT03426995|19942310|P11|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088849|NCT03426995|19942311|P10|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088850|NCT03426995|19942312|P9|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088851|NCT03426995|19942313|P8|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088852|NCT03426995|19942314|P7|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088853|NCT03426995|19942315|P6|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088854|NCT03426995|19942316|P5|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088855|NCT03426995|19942317|P4|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088856|NCT03426995|19942318|P3|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088857|NCT03426995|19942319|P2|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088858|NCT03426995|19942320|P1|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
8088859|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088860|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088861|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088862|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088863|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088864|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088865|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088866|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088867|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
8088868|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088869|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088870|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
8088871|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088872|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088873|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088874|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088875|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088876|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088877|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088878|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088879|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088880|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088881|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088882|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088883|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088884|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088885|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
8088886|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088887|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
8088888|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
8088889|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
8088890|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
8088891|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088892|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088893|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088894|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088895|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088896|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
8088897|NCT03426995|19942302|P19|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088898|NCT03426995|19942303|P18|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088899|NCT03426995|19942304|P17|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088900|NCT03426995|19942305|P16|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088901|NCT03426995|19942306|P15|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088902|NCT03426995|19942307|P14|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088903|NCT03426995|19942308|P13|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088904|NCT03426995|19942309|P12|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
8088905|NCT03426995|19942310|P11|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
8088906|NCT03426995|19942311|P10|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
8088907|NCT03426995|19942312|P9|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
8088908|NCT03426995|19942313|P8|STARTED|Part A: Cohort 2-Period 4 (Day1)|New participant enrolled and dosed.|3
8088909|NCT03426995|19942314|P7|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
8088910|NCT03426995|19942315|P6|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088911|NCT03426995|19942316|P5|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088912|NCT03426995|19942317|P4|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088913|NCT03426995|19942318|P3|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088914|NCT03426995|19942319|P2|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088915|NCT03426995|19942320|P1|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
8088916|NCT03426995|19942302|P19|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088917|NCT03426995|19942303|P18|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088918|NCT03426995|19942304|P17|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088919|NCT03426995|19942305|P16|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088920|NCT03426995|19942306|P15|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088921|NCT03426995|19942307|P14|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088922|NCT03426995|19942308|P13|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088923|NCT03426995|19942309|P12|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088924|NCT03426995|19942310|P11|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088925|NCT03426995|19942311|P10|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088926|NCT03426995|19942312|P9|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088927|NCT03426995|19942313|P8|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088928|NCT03426995|19942314|P7|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088929|NCT03426995|19942315|P6|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088930|NCT03426995|19942316|P5|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088931|NCT03426995|19942317|P4|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088932|NCT03426995|19942318|P3|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088933|NCT03426995|19942319|P2|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088934|NCT03426995|19942320|P1|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088935|NCT03426995|19942302|P19|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088936|NCT03426995|19942303|P18|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088937|NCT03426995|19942304|P17|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088938|NCT03426995|19942305|P16|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088939|NCT03426995|19942306|P15|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088940|NCT03426995|19942307|P14|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088941|NCT03426995|19942308|P13|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088942|NCT03426995|19942309|P12|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
8088943|NCT03426995|19942310|P11|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
8088944|NCT03426995|19942311|P10|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
8088945|NCT03426995|19942312|P9|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
8088946|NCT03426995|19942313|P8|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
8088947|NCT03426995|19942314|P7|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
8088948|NCT03426995|19942315|P6|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088949|NCT03426995|19942316|P5|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088950|NCT03426995|19942317|P4|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088951|NCT03426995|19942318|P3|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088952|NCT03426995|19942319|P2|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088953|NCT03426995|19942320|P1|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088954|NCT03426995|19942302|P19|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088955|NCT03426995|19942303|P18|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088956|NCT03426995|19942304|P17|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088957|NCT03426995|19942305|P16|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088958|NCT03426995|19942306|P15|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088959|NCT03426995|19942307|P14|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088960|NCT03426995|19942308|P13|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088961|NCT03426995|19942309|P12|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
8088962|NCT03426995|19942310|P11|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
8088963|NCT03426995|19942311|P10|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
8088964|NCT03426995|19942312|P9|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
8088965|NCT03426995|19942313|P8|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
8088966|NCT03426995|19942314|P7|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
8088967|NCT03426995|19942315|P6|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088968|NCT03426995|19942316|P5|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088969|NCT03426995|19942317|P4|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088970|NCT03426995|19942318|P3|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088971|NCT03426995|19942319|P2|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088972|NCT03426995|19942320|P1|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
8088973|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088974|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088975|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088976|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088977|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088978|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088979|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088980|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088981|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088982|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088983|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088984|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088985|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088986|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088987|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088988|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088989|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088990|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088991|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088992|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088993|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088994|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088995|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088996|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088997|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088998|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8088999|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
8089000|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
8089001|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
8089002|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
8089003|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
8089004|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
8089005|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8089006|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8089007|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8089008|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8089009|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8089010|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
8089011|NCT03426995|19942302|P19|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089012|NCT03426995|19942303|P18|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089013|NCT03426995|19942304|P17|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089014|NCT03426995|19942305|P16|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089015|NCT03426995|19942306|P15|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089016|NCT03426995|19942307|P14|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089017|NCT03426995|19942308|P13|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089018|NCT03426995|19942309|P12|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
8089019|NCT03426995|19942310|P11|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
8089020|NCT03426995|19942311|P10|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
8089021|NCT03426995|19942312|P9|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
8089022|NCT03426995|19942313|P8|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
8089023|NCT03426995|19942314|P7|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
8089024|NCT03426995|19942315|P6|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089025|NCT03426995|19942316|P5|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089026|NCT03426995|19942317|P4|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089027|NCT03426995|19942318|P3|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089028|NCT03426995|19942319|P2|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089029|NCT03426995|19942320|P1|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
8089030|NCT03426995|19942302|P19|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089031|NCT03426995|19942303|P18|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089032|NCT03426995|19942304|P17|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089033|NCT03426995|19942305|P16|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089034|NCT03426995|19942306|P15|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089035|NCT03426995|19942307|P14|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089036|NCT03426995|19942308|P13|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089037|NCT03426995|19942309|P12|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089038|NCT03426995|19942310|P11|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089039|NCT03426995|19942311|P10|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089040|NCT03426995|19942312|P9|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089041|NCT03426995|19942313|P8|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089042|NCT03426995|19942314|P7|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089043|NCT03426995|19942315|P6|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089044|NCT03426995|19942316|P5|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089045|NCT03426995|19942317|P4|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089046|NCT03426995|19942318|P3|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089047|NCT03426995|19942319|P2|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089048|NCT03426995|19942320|P1|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089049|NCT03426995|19942302|P19|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089050|NCT03426995|19942303|P18|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089051|NCT03426995|19942304|P17|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089052|NCT03426995|19942305|P16|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089053|NCT03426995|19942306|P15|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089054|NCT03426995|19942307|P14|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089055|NCT03426995|19942308|P13|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089056|NCT03426995|19942309|P12|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
8089057|NCT03426995|19942310|P11|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
8089058|NCT03426995|19942311|P10|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
8089059|NCT03426995|19942312|P9|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
8089060|NCT03426995|19942313|P8|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
8089061|NCT03426995|19942314|P7|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
8089062|NCT03426995|19942315|P6|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089063|NCT03426995|19942316|P5|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089064|NCT03426995|19942317|P4|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089065|NCT03426995|19942318|P3|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089066|NCT03426995|19942319|P2|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089067|NCT03426995|19942320|P1|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089068|NCT03426995|19942302|P19|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089069|NCT03426995|19942303|P18|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089070|NCT03426995|19942304|P17|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089071|NCT03426995|19942305|P16|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089072|NCT03426995|19942306|P15|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089073|NCT03426995|19942307|P14|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089074|NCT03426995|19942308|P13|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089075|NCT03426995|19942309|P12|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
8089076|NCT03426995|19942310|P11|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
8089077|NCT03426995|19942311|P10|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
8089078|NCT03426995|19942312|P9|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
8089079|NCT03426995|19942313|P8|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
8089080|NCT03426995|19942314|P7|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
8089081|NCT03426995|19942315|P6|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089082|NCT03426995|19942316|P5|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089083|NCT03426995|19942317|P4|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089084|NCT03426995|19942318|P3|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089085|NCT03426995|19942319|P2|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089086|NCT03426995|19942320|P1|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
8089087|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089088|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089089|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089090|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089091|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089092|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089093|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089094|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089095|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089096|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089097|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089098|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089099|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089100|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089101|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089102|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089103|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089104|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089105|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089106|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089107|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089108|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089109|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089110|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089111|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089112|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089113|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
8089114|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
8089115|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
8089116|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
8089117|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
8089118|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
8089119|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089120|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089121|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089122|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089123|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089124|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
8089125|NCT03426995|19942302|P19|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089126|NCT03426995|19942303|P18|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089127|NCT03426995|19942304|P17|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089128|NCT03426995|19942305|P16|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089129|NCT03426995|19942306|P15|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089130|NCT03426995|19942307|P14|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089131|NCT03426995|19942308|P13|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089132|NCT03426995|19942309|P12|STARTED|Part A: Cohort 2-Period 2 (Day1)|New participant enrolled and dosed.|2
8089133|NCT03426995|19942310|P11|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
8089134|NCT03426995|19942311|P10|STARTED|Part A: Cohort 2-Period 2 (Day1)|Two additional participants were enrolled and dosed.|2
8089135|NCT03426995|19942312|P9|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
8089136|NCT03426995|19942313|P8|STARTED|Part A: Cohort 2-Period 2 (Day1)||2
8089137|NCT03426995|19942314|P7|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
8089138|NCT03426995|19942315|P6|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089139|NCT03426995|19942316|P5|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089140|NCT03426995|19942317|P4|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089141|NCT03426995|19942318|P3|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089142|NCT03426995|19942319|P2|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089143|NCT03426995|19942320|P1|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
8089144|NCT03426995|19942302|P19|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089145|NCT03426995|19942303|P18|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089146|NCT03426995|19942304|P17|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089147|NCT03426995|19942305|P16|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089148|NCT03426995|19942306|P15|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089149|NCT03426995|19942307|P14|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089150|NCT03426995|19942308|P13|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089151|NCT03426995|19942309|P12|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089152|NCT03426995|19942310|P11|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089153|NCT03426995|19942311|P10|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089154|NCT03426995|19942312|P9|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089155|NCT03426995|19942313|P8|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089156|NCT03426995|19942314|P7|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089157|NCT03426995|19942315|P6|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089158|NCT03426995|19942316|P5|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089159|NCT03426995|19942317|P4|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089160|NCT03426995|19942318|P3|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089161|NCT03426995|19942319|P2|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089162|NCT03426995|19942320|P1|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089163|NCT03426995|19942302|P19|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089164|NCT03426995|19942303|P18|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089165|NCT03426995|19942304|P17|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089166|NCT03426995|19942305|P16|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089167|NCT03426995|19942306|P15|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089168|NCT03426995|19942307|P14|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089169|NCT03426995|19942308|P13|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089170|NCT03426995|19942309|P12|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089171|NCT03426995|19942310|P11|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089172|NCT03426995|19942311|P10|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089173|NCT03426995|19942312|P9|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089174|NCT03426995|19942313|P8|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
8089175|NCT03426995|19942314|P7|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089176|NCT03426995|19942315|P6|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089177|NCT03426995|19942316|P5|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089178|NCT03426995|19942317|P4|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089179|NCT03426995|19942318|P3|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089180|NCT03426995|19942319|P2|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089181|NCT03426995|19942320|P1|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089182|NCT03426995|19942302|P19|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089183|NCT03426995|19942303|P18|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089184|NCT03426995|19942304|P17|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089185|NCT03426995|19942305|P16|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089186|NCT03426995|19942306|P15|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089187|NCT03426995|19942307|P14|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089188|NCT03426995|19942308|P13|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089189|NCT03426995|19942309|P12|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089190|NCT03426995|19942310|P11|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089191|NCT03426995|19942311|P10|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089192|NCT03426995|19942312|P9|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089193|NCT03426995|19942313|P8|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
8089194|NCT03426995|19942314|P7|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
8089195|NCT03426995|19942315|P6|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089196|NCT03426995|19942316|P5|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089197|NCT03426995|19942317|P4|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089198|NCT03426995|19942318|P3|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089199|NCT03426995|19942319|P2|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089200|NCT03426995|19942320|P1|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
8089201|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089202|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089203|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089204|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089205|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089206|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089207|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089208|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089209|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089210|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089211|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089212|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089213|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089214|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089215|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089216|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089217|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089218|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089219|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089220|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089221|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089222|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089223|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089224|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089225|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089226|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089227|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
8089228|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
8089229|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089230|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
8089231|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2
8089232|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
8089233|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089234|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089235|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089236|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089237|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089238|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
8089239|NCT03426995|19942302|P19|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089240|NCT03426995|19942303|P18|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089241|NCT03426995|19942304|P17|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089242|NCT03426995|19942305|P16|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089243|NCT03426995|19942306|P15|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089244|NCT03426995|19942307|P14|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089245|NCT03426995|19942308|P13|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089246|NCT03426995|19942309|P12|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
8089247|NCT03426995|19942310|P11|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
8089248|NCT03426995|19942311|P10|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089249|NCT03426995|19942312|P9|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
8089250|NCT03426995|19942313|P8|STARTED|Part A: Cohort 2-Period 1 (Day1)||2
8089251|NCT03426995|19942314|P7|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
8089252|NCT03426995|19942315|P6|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089253|NCT03426995|19942316|P5|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089254|NCT03426995|19942317|P4|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089255|NCT03426995|19942318|P3|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089256|NCT03426995|19942319|P2|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089257|NCT03426995|19942320|P1|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
8089258|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089259|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089260|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089261|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089262|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089263|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089264|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089265|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089266|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089267|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089268|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089269|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089270|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089271|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089272|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089273|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089274|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089275|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089276|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089277|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089278|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089279|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089280|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089281|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089282|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089283|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089284|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089285|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089286|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089287|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089288|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089289|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
8089290|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
8089291|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
8089292|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
8089293|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
8089294|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
8089295|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
8089296|NCT03426995|19942302|P19|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089297|NCT03426995|19942303|P18|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089298|NCT03426995|19942304|P17|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089299|NCT03426995|19942305|P16|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089300|NCT03426995|19942306|P15|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089301|NCT03426995|19942307|P14|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089302|NCT03426995|19942308|P13|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089303|NCT03426995|19942309|P12|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089304|NCT03426995|19942310|P11|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089305|NCT03426995|19942311|P10|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089306|NCT03426995|19942312|P9|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089307|NCT03426995|19942313|P8|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089308|NCT03426995|19942314|P7|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
8089309|NCT03426995|19942315|P6|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
8089310|NCT03426995|19942316|P5|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
8089311|NCT03426995|19942317|P4|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
8089312|NCT03426995|19942318|P3|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
8089313|NCT03426995|19942319|P2|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
8089314|NCT03426995|19942320|P1|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
8089315|NCT03426995|19942302|P19|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089316|NCT03426995|19942303|P18|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089317|NCT03426995|19942304|P17|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089318|NCT03426995|19942305|P16|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089319|NCT03426995|19942306|P15|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089320|NCT03426995|19942307|P14|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089321|NCT03426995|19942308|P13|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089322|NCT03426995|19942309|P12|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089323|NCT03426995|19942310|P11|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089324|NCT03426995|19942311|P10|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089325|NCT03426995|19942312|P9|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089326|NCT03426995|19942313|P8|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089327|NCT03426995|19942314|P7|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089328|NCT03426995|19942315|P6|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089329|NCT03426995|19942316|P5|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089330|NCT03426995|19942317|P4|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089331|NCT03426995|19942318|P3|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089332|NCT03426995|19942319|P2|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089333|NCT03426995|19942320|P1|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089334|NCT03426995|19942302|P19|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089335|NCT03426995|19942303|P18|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089336|NCT03426995|19942304|P17|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089337|NCT03426995|19942305|P16|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089338|NCT03426995|19942306|P15|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089339|NCT03426995|19942307|P14|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089340|NCT03426995|19942308|P13|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089341|NCT03426995|19942309|P12|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089342|NCT03426995|19942310|P11|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089343|NCT03426995|19942311|P10|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089344|NCT03426995|19942312|P9|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089345|NCT03426995|19942313|P8|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089346|NCT03426995|19942314|P7|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089347|NCT03426995|19942315|P6|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
8089348|NCT03426995|19942316|P5|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
8089349|NCT03426995|19942317|P4|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
8089350|NCT03426995|19942318|P3|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
8089351|NCT03426995|19942319|P2|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
8089352|NCT03426995|19942320|P1|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
8089353|NCT03426995|19942302|P19|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089354|NCT03426995|19942303|P18|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089355|NCT03426995|19942304|P17|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089356|NCT03426995|19942305|P16|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089357|NCT03426995|19942306|P15|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089358|NCT03426995|19942307|P14|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089359|NCT03426995|19942308|P13|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089360|NCT03426995|19942309|P12|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089361|NCT03426995|19942310|P11|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089362|NCT03426995|19942311|P10|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089363|NCT03426995|19942312|P9|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089364|NCT03426995|19942313|P8|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089365|NCT03426995|19942314|P7|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
8089366|NCT03426995|19942315|P6|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
8089367|NCT03426995|19942316|P5|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
8089368|NCT03426995|19942317|P4|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
8089369|NCT03426995|19942318|P3|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
8089370|NCT03426995|19942319|P2|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
8089371|NCT03426995|19942320|P1|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
8089372|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089373|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089374|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089375|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089376|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089377|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089378|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089379|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089380|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089381|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089382|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089383|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089384|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089385|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089386|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089387|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089388|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089389|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089390|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089391|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089392|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089393|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089394|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089395|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089396|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089397|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089398|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089399|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089400|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089401|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089402|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089403|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
8089404|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
8089405|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
8089406|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
8089407|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
8089408|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
8089409|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
8089410|NCT03426995|19942302|P19|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089411|NCT03426995|19942303|P18|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089412|NCT03426995|19942304|P17|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089413|NCT03426995|19942305|P16|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089414|NCT03426995|19942306|P15|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089415|NCT03426995|19942307|P14|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089416|NCT03426995|19942308|P13|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089417|NCT03426995|19942309|P12|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089418|NCT03426995|19942310|P11|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089419|NCT03426995|19942311|P10|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089420|NCT03426995|19942312|P9|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089421|NCT03426995|19942313|P8|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089422|NCT03426995|19942314|P7|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
8089423|NCT03426995|19942315|P6|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|2
8089424|NCT03426995|19942316|P5|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|1
8089425|NCT03426995|19942317|P4|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
8089426|NCT03426995|19942318|P3|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
8089427|NCT03426995|19942319|P2|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
8089428|NCT03426995|19942320|P1|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
8089429|NCT03426995|19942302|P19|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089430|NCT03426995|19942303|P18|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089431|NCT03426995|19942304|P17|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089432|NCT03426995|19942305|P16|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089433|NCT03426995|19942306|P15|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089434|NCT03426995|19942307|P14|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089435|NCT03426995|19942308|P13|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089436|NCT03426995|19942309|P12|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089437|NCT03426995|19942310|P11|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089438|NCT03426995|19942311|P10|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089439|NCT03426995|19942312|P9|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089440|NCT03426995|19942313|P8|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089441|NCT03426995|19942314|P7|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089442|NCT03426995|19942315|P6|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089443|NCT03426995|19942316|P5|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089444|NCT03426995|19942317|P4|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089445|NCT03426995|19942318|P3|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089446|NCT03426995|19942319|P2|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089447|NCT03426995|19942320|P1|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089448|NCT03426995|19942302|P19|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089449|NCT03426995|19942303|P18|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089450|NCT03426995|19942304|P17|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089451|NCT03426995|19942305|P16|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089452|NCT03426995|19942306|P15|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089453|NCT03426995|19942307|P14|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089454|NCT03426995|19942308|P13|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089455|NCT03426995|19942309|P12|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089456|NCT03426995|19942310|P11|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089457|NCT03426995|19942311|P10|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089458|NCT03426995|19942312|P9|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089459|NCT03426995|19942313|P8|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089460|NCT03426995|19942314|P7|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089461|NCT03426995|19942315|P6|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
8089462|NCT03426995|19942316|P5|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089463|NCT03426995|19942317|P4|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
8089464|NCT03426995|19942318|P3|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
8089465|NCT03426995|19942319|P2|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
8089466|NCT03426995|19942320|P1|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
8089467|NCT03426995|19942302|P19|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089468|NCT03426995|19942303|P18|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089469|NCT03426995|19942304|P17|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089470|NCT03426995|19942305|P16|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089471|NCT03426995|19942306|P15|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089472|NCT03426995|19942307|P14|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089473|NCT03426995|19942308|P13|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089474|NCT03426995|19942309|P12|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089475|NCT03426995|19942310|P11|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089476|NCT03426995|19942311|P10|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089477|NCT03426995|19942312|P9|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089478|NCT03426995|19942313|P8|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089479|NCT03426995|19942314|P7|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089480|NCT03426995|19942315|P6|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
8089481|NCT03426995|19942316|P5|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
8089482|NCT03426995|19942317|P4|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
8089483|NCT03426995|19942318|P3|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
8089484|NCT03426995|19942319|P2|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
8089485|NCT03426995|19942320|P1|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
8089486|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089487|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089488|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089489|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089490|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089491|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089492|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089493|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089494|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089495|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089496|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089497|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089498|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089499|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
8089500|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
8089501|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089502|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089503|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089504|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089505|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089506|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089507|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089508|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089509|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089510|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089511|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089512|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089513|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089514|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089515|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089516|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089517|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089518|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
8089519|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
8089520|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
8089521|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
8089522|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
8089523|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
8089524|NCT03426995|19942302|P19|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089525|NCT03426995|19942303|P18|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089526|NCT03426995|19942304|P17|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089527|NCT03426995|19942305|P16|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089528|NCT03426995|19942306|P15|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089529|NCT03426995|19942307|P14|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089530|NCT03426995|19942308|P13|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089531|NCT03426995|19942309|P12|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089532|NCT03426995|19942310|P11|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089533|NCT03426995|19942311|P10|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089534|NCT03426995|19942312|P9|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089535|NCT03426995|19942313|P8|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089536|NCT03426995|19942314|P7|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
8089537|NCT03426995|19942315|P6|STARTED|Part A: Cohort 1-Period 2 (Day1)|Two additional participants were enrolled and dosed.|3
8089538|NCT03426995|19942316|P5|STARTED|Part A: Cohort 1-Period 2 (Day1)||1
8089539|NCT03426995|19942317|P4|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
8089540|NCT03426995|19942318|P3|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
8089541|NCT03426995|19942319|P2|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
8089542|NCT03426995|19942320|P1|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
8089543|NCT03426995|19942302|P19|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089544|NCT03426995|19942303|P18|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089545|NCT03426995|19942304|P17|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089546|NCT03426995|19942305|P16|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089547|NCT03426995|19942306|P15|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089548|NCT03426995|19942307|P14|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089549|NCT03426995|19942308|P13|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089550|NCT03426995|19942309|P12|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089551|NCT03426995|19942310|P11|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089552|NCT03426995|19942311|P10|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089553|NCT03426995|19942312|P9|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089554|NCT03426995|19942313|P8|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089555|NCT03426995|19942314|P7|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089556|NCT03426995|19942315|P6|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089557|NCT03426995|19942316|P5|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089558|NCT03426995|19942317|P4|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089559|NCT03426995|19942318|P3|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089560|NCT03426995|19942319|P2|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089561|NCT03426995|19942320|P1|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089562|NCT03426995|19942302|P19|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089563|NCT03426995|19942303|P18|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089564|NCT03426995|19942304|P17|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089565|NCT03426995|19942305|P16|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089566|NCT03426995|19942306|P15|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089567|NCT03426995|19942307|P14|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089568|NCT03426995|19942308|P13|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089569|NCT03426995|19942309|P12|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089570|NCT03426995|19942310|P11|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089571|NCT03426995|19942311|P10|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089572|NCT03426995|19942312|P9|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089573|NCT03426995|19942313|P8|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089574|NCT03426995|19942314|P7|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089575|NCT03426995|19942315|P6|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
8089576|NCT03426995|19942316|P5|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
8089655|NCT03426995|19942319|P2|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
8089577|NCT03426995|19942317|P4|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
8089578|NCT03426995|19942318|P3|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089579|NCT03426995|19942319|P2|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
8089580|NCT03426995|19942320|P1|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089581|NCT03426995|19942302|P19|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089582|NCT03426995|19942303|P18|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089583|NCT03426995|19942304|P17|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089584|NCT03426995|19942305|P16|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089585|NCT03426995|19942306|P15|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089586|NCT03426995|19942307|P14|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089587|NCT03426995|19942308|P13|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089588|NCT03426995|19942309|P12|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089589|NCT03426995|19942310|P11|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089590|NCT03426995|19942311|P10|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089591|NCT03426995|19942312|P9|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089592|NCT03426995|19942313|P8|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089593|NCT03426995|19942314|P7|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089594|NCT03426995|19942315|P6|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
8089595|NCT03426995|19942316|P5|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
8089596|NCT03426995|19942317|P4|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
8089597|NCT03426995|19942318|P3|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089598|NCT03426995|19942319|P2|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
8089599|NCT03426995|19942320|P1|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
8089600|NCT03426995|19942302|P19|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089601|NCT03426995|19942303|P18|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089602|NCT03426995|19942304|P17|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089603|NCT03426995|19942305|P16|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089604|NCT03426995|19942306|P15|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089605|NCT03426995|19942307|P14|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089606|NCT03426995|19942308|P13|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089607|NCT03426995|19942309|P12|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089608|NCT03426995|19942310|P11|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089609|NCT03426995|19942311|P10|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089610|NCT03426995|19942312|P9|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089611|NCT03426995|19942313|P8|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089612|NCT03426995|19942314|P7|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089613|NCT03426995|19942315|P6|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089614|NCT03426995|19942316|P5|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089615|NCT03426995|19942317|P4|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089616|NCT03426995|19942318|P3|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
8089617|NCT03426995|19942319|P2|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089618|NCT03426995|19942320|P1|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089619|NCT03426995|19942302|P19|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089620|NCT03426995|19942303|P18|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089621|NCT03426995|19942304|P17|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089622|NCT03426995|19942305|P16|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089623|NCT03426995|19942306|P15|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089624|NCT03426995|19942307|P14|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089625|NCT03426995|19942308|P13|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089626|NCT03426995|19942309|P12|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089627|NCT03426995|19942310|P11|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089628|NCT03426995|19942311|P10|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089629|NCT03426995|19942312|P9|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089630|NCT03426995|19942313|P8|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089631|NCT03426995|19942314|P7|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089632|NCT03426995|19942315|P6|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
8089633|NCT03426995|19942316|P5|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
8089634|NCT03426995|19942317|P4|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
8089635|NCT03426995|19942318|P3|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089636|NCT03426995|19942319|P2|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
8089637|NCT03426995|19942320|P1|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
8089638|NCT03426995|19942302|P19|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089639|NCT03426995|19942303|P18|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089640|NCT03426995|19942304|P17|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089641|NCT03426995|19942305|P16|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089642|NCT03426995|19942306|P15|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089643|NCT03426995|19942307|P14|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089644|NCT03426995|19942308|P13|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089645|NCT03426995|19942309|P12|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089646|NCT03426995|19942310|P11|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089647|NCT03426995|19942311|P10|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089648|NCT03426995|19942312|P9|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089649|NCT03426995|19942313|P8|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089650|NCT03426995|19942314|P7|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089651|NCT03426995|19942315|P6|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
8089652|NCT03426995|19942316|P5|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
8089653|NCT03426995|19942317|P4|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
8089654|NCT03426995|19942318|P3|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
8089656|NCT03426995|19942320|P1|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
8089657|NCT03426787|19942667|P1|NOT COMPLETED|Overall Study||14
8089658|NCT03426787|19942667|P1|COMPLETED|Overall Study||56
8089659|NCT03426787|19942667|P1|STARTED|Overall Study||70
8089660|NCT03426631|19942677|P2|NOT COMPLETED|Overall Study||1
8089661|NCT03426631|19942678|P1|NOT COMPLETED|Overall Study||0
8089662|NCT03426631|19942677|P2|COMPLETED|Overall Study||5
8089663|NCT03426631|19942678|P1|COMPLETED|Overall Study||7
8089664|NCT03426631|19942677|P2|STARTED|Overall Study||6
8089665|NCT03426631|19942678|P1|STARTED|Overall Study||7
8089666|NCT03426566|19942684|P1|NOT COMPLETED|Overall Study||0
8089667|NCT03426566|19942684|P1|COMPLETED|Overall Study||974
8089668|NCT03426566|19942684|P1|STARTED|Overall Study||974
8089669|NCT03426436|19942690|P1|NOT COMPLETED|Overall Study||19
8089670|NCT03426436|19942690|P1|COMPLETED|Overall Study||295
8089671|NCT03426436|19942690|P1|STARTED|Overall Study||314
8089681|NCT03425396|19942713|P5|NOT COMPLETED|Overall Study||1
8089682|NCT03425396|19942714|P4|NOT COMPLETED|Overall Study||1
8089683|NCT03425396|19942715|P3|NOT COMPLETED|Overall Study||3
8089684|NCT03425396|19942716|P2|NOT COMPLETED|Overall Study||7
8089685|NCT03425396|19942717|P1|NOT COMPLETED|Overall Study||2
8089686|NCT03425396|19942713|P5|COMPLETED|Overall Study||53
8089687|NCT03425396|19942714|P4|COMPLETED|Overall Study||7
8089688|NCT03425396|19942715|P3|COMPLETED|Overall Study||51
8089689|NCT03425396|19942716|P2|COMPLETED|Overall Study||47
8089690|NCT03425396|19942717|P1|COMPLETED|Overall Study||53
8089691|NCT03425396|19942713|P5|Completed Final Follow-up Visit|Overall Study||53
8089692|NCT03425396|19942714|P4|Completed Final Follow-up Visit|Overall Study||7
8089693|NCT03425396|19942715|P3|Completed Final Follow-up Visit|Overall Study||51
8089694|NCT03425396|19942716|P2|Completed Final Follow-up Visit|Overall Study||47
8089695|NCT03425396|19942717|P1|Completed Final Follow-up Visit|Overall Study||53
8089696|NCT03425396|19942713|P5|Completed Post-therapy Evaluation Visit|Overall Study||54
8089697|NCT03425396|19942714|P4|Completed Post-therapy Evaluation Visit|Overall Study||7
8089698|NCT03425396|19942715|P3|Completed Post-therapy Evaluation Visit|Overall Study||51
8089699|NCT03425396|19942716|P2|Completed Post-therapy Evaluation Visit|Overall Study||49
8089700|NCT03425396|19942717|P1|Completed Post-therapy Evaluation Visit|Overall Study||53
8089701|NCT03425396|19942713|P5|Completed End of Treatment Visit|Overall Study||53
8089702|NCT03425396|19942714|P4|Completed End of Treatment Visit|Overall Study||7
8089703|NCT03425396|19942715|P3|Completed End of Treatment Visit|Overall Study||51
8089704|NCT03425396|19942716|P2|Completed End of Treatment Visit|Overall Study||52
8089705|NCT03425396|19942717|P1|Completed End of Treatment Visit|Overall Study||53
8089706|NCT03425396|19942713|P5|STARTED|Overall Study||54
8089707|NCT03425396|19942714|P4|STARTED|Overall Study||8
8089708|NCT03425396|19942715|P3|STARTED|Overall Study||54
8089709|NCT03425396|19942716|P2|STARTED|Overall Study||54
8089710|NCT03425396|19942717|P1|STARTED|Overall Study||55
8089711|NCT03425253|19942799|P1|NOT COMPLETED|Overall Study||16
8089712|NCT03425253|19942799|P1|COMPLETED|Overall Study||42
8089713|NCT03425253|19942799|P1|Evaluable Set (ES)|Overall Study||42
8089714|NCT03425253|19942799|P1|FAS|Overall Study||53
8089715|NCT03425253|19942799|P1|Safety Analysis Set|Overall Study||53
8089716|NCT03425253|19942799|P1|STARTED|Overall Study||58
8089717|NCT03424681|19942813|P2|NOT COMPLETED|Overall Study||1
8089718|NCT03424681|19942814|P1|NOT COMPLETED|Overall Study||0
8089719|NCT03424681|19942813|P2|COMPLETED|Overall Study||5
8089720|NCT03424681|19942814|P1|COMPLETED|Overall Study||6
8089721|NCT03424681|19942813|P2|STARTED|Overall Study||6
8089722|NCT03424681|19942814|P1|STARTED|Overall Study||6
8089729|NCT03424044|19942835|P9|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089730|NCT03424044|19942836|P8|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089731|NCT03424044|19942837|P7|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089732|NCT03424044|19942838|P6|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089733|NCT03424044|19942839|P5|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089734|NCT03424044|19942840|P4|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089735|NCT03424044|19942841|P3|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089736|NCT03424044|19942842|P2|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089737|NCT03424044|19942843|P1|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089738|NCT03424044|19942835|P9|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
8089739|NCT03424044|19942836|P8|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
8089740|NCT03424044|19942837|P7|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089741|NCT03424044|19942838|P6|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089742|NCT03424044|19942839|P5|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089743|NCT03424044|19942840|P4|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089744|NCT03424044|19942841|P3|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089745|NCT03424044|19942842|P2|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089746|NCT03424044|19942843|P1|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
8089747|NCT03424044|19942835|P9|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
8089748|NCT03424044|19942836|P8|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
8089749|NCT03424044|19942837|P7|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8089750|NCT03424044|19942838|P6|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8089751|NCT03424044|19942839|P5|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8089752|NCT03424044|19942840|P4|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8089753|NCT03424044|19942841|P3|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8089754|NCT03424044|19942842|P2|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8089755|NCT03424044|19942843|P1|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
8089756|NCT03424044|19942835|P9|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089757|NCT03424044|19942836|P8|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089758|NCT03424044|19942837|P7|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089759|NCT03424044|19942838|P6|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089760|NCT03424044|19942839|P5|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089761|NCT03424044|19942840|P4|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089762|NCT03424044|19942841|P3|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089763|NCT03424044|19942842|P2|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089764|NCT03424044|19942843|P1|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089765|NCT03424044|19942835|P9|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
8089766|NCT03424044|19942836|P8|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
8089767|NCT03424044|19942837|P7|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089768|NCT03424044|19942838|P6|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089769|NCT03424044|19942839|P5|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089770|NCT03424044|19942840|P4|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089771|NCT03424044|19942841|P3|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089772|NCT03424044|19942842|P2|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089773|NCT03424044|19942843|P1|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
8089774|NCT03424044|19942835|P9|STARTED|Optional Fourth Rest Period (7-45 Days)||1
8089775|NCT03424044|19942836|P8|STARTED|Optional Fourth Rest Period (7-45 Days)||1
8089776|NCT03424044|19942837|P7|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8089777|NCT03424044|19942838|P6|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8089778|NCT03424044|19942839|P5|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8089779|NCT03424044|19942840|P4|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8089780|NCT03424044|19942841|P3|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8089781|NCT03424044|19942842|P2|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8089782|NCT03424044|19942843|P1|STARTED|Optional Fourth Rest Period (7-45 Days)||0
8089783|NCT03424044|19942835|P9|NOT COMPLETED|Third Intervention (76 Hours)||0
8089784|NCT03424044|19942836|P8|NOT COMPLETED|Third Intervention (76 Hours)||0
8089785|NCT03424044|19942837|P7|NOT COMPLETED|Third Intervention (76 Hours)||1
8089786|NCT03424044|19942838|P6|NOT COMPLETED|Third Intervention (76 Hours)||0
8089787|NCT03424044|19942839|P5|NOT COMPLETED|Third Intervention (76 Hours)||0
8089788|NCT03424044|19942840|P4|NOT COMPLETED|Third Intervention (76 Hours)||1
8089789|NCT03424044|19942841|P3|NOT COMPLETED|Third Intervention (76 Hours)||0
8089790|NCT03424044|19942842|P2|NOT COMPLETED|Third Intervention (76 Hours)||0
8089791|NCT03424044|19942843|P1|NOT COMPLETED|Third Intervention (76 Hours)||1
8089792|NCT03424044|19942835|P9|COMPLETED|Third Intervention (76 Hours)||1
8089793|NCT03424044|19942836|P8|COMPLETED|Third Intervention (76 Hours)||1
8089794|NCT03424044|19942837|P7|COMPLETED|Third Intervention (76 Hours)||0
8089795|NCT03424044|19942838|P6|COMPLETED|Third Intervention (76 Hours)||4
8089796|NCT03424044|19942839|P5|COMPLETED|Third Intervention (76 Hours)||2
8089797|NCT03424044|19942840|P4|COMPLETED|Third Intervention (76 Hours)||2
8089798|NCT03424044|19942841|P3|COMPLETED|Third Intervention (76 Hours)||2
8089799|NCT03424044|19942842|P2|COMPLETED|Third Intervention (76 Hours)||3
8089800|NCT03424044|19942843|P1|COMPLETED|Third Intervention (76 Hours)||3
8089801|NCT03424044|19942835|P9|STARTED|Third Intervention (76 Hours)||1
8089802|NCT03424044|19942836|P8|STARTED|Third Intervention (76 Hours)||1
8089803|NCT03424044|19942837|P7|STARTED|Third Intervention (76 Hours)||1
8089804|NCT03424044|19942838|P6|STARTED|Third Intervention (76 Hours)||4
8089805|NCT03424044|19942839|P5|STARTED|Third Intervention (76 Hours)||2
8089806|NCT03424044|19942840|P4|STARTED|Third Intervention (76 Hours)||3
8089807|NCT03424044|19942841|P3|STARTED|Third Intervention (76 Hours)||2
8089808|NCT03424044|19942842|P2|STARTED|Third Intervention (76 Hours)||3
8089809|NCT03424044|19942843|P1|STARTED|Third Intervention (76 Hours)||4
8089810|NCT03424044|19942835|P9|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089811|NCT03424044|19942836|P8|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089812|NCT03424044|19942837|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089813|NCT03424044|19942838|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089814|NCT03424044|19942839|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089815|NCT03424044|19942840|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089816|NCT03424044|19942841|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089817|NCT03424044|19942842|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089818|NCT03424044|19942843|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8089819|NCT03424044|19942835|P9|COMPLETED|Third Rest Period (7-45 Days)||1
8089820|NCT03424044|19942836|P8|COMPLETED|Third Rest Period (7-45 Days)||1
8089821|NCT03424044|19942837|P7|COMPLETED|Third Rest Period (7-45 Days)||1
8089822|NCT03424044|19942838|P6|COMPLETED|Third Rest Period (7-45 Days)||4
8089823|NCT03424044|19942839|P5|COMPLETED|Third Rest Period (7-45 Days)||2
8089824|NCT03424044|19942840|P4|COMPLETED|Third Rest Period (7-45 Days)||3
8089825|NCT03424044|19942841|P3|COMPLETED|Third Rest Period (7-45 Days)||2
8089826|NCT03424044|19942842|P2|COMPLETED|Third Rest Period (7-45 Days)||3
8089827|NCT03424044|19942843|P1|COMPLETED|Third Rest Period (7-45 Days)||4
8089828|NCT03424044|19942835|P9|STARTED|Third Rest Period (7-45 Days)||1
8089829|NCT03424044|19942836|P8|STARTED|Third Rest Period (7-45 Days)||1
8089830|NCT03424044|19942837|P7|STARTED|Third Rest Period (7-45 Days)||1
8089831|NCT03424044|19942838|P6|STARTED|Third Rest Period (7-45 Days)||4
8089832|NCT03424044|19942839|P5|STARTED|Third Rest Period (7-45 Days)||2
8089833|NCT03424044|19942840|P4|STARTED|Third Rest Period (7-45 Days)||3
8089834|NCT03424044|19942841|P3|STARTED|Third Rest Period (7-45 Days)||2
8089835|NCT03424044|19942842|P2|STARTED|Third Rest Period (7-45 Days)||3
8089836|NCT03424044|19942843|P1|STARTED|Third Rest Period (7-45 Days)||4
8089837|NCT03424044|19942835|P9|NOT COMPLETED|Second Intervention (76 Hours)||0
8089838|NCT03424044|19942836|P8|NOT COMPLETED|Second Intervention (76 Hours)||0
8089839|NCT03424044|19942837|P7|NOT COMPLETED|Second Intervention (76 Hours)||0
8089840|NCT03424044|19942838|P6|NOT COMPLETED|Second Intervention (76 Hours)||0
8089841|NCT03424044|19942839|P5|NOT COMPLETED|Second Intervention (76 Hours)||0
8089842|NCT03424044|19942840|P4|NOT COMPLETED|Second Intervention (76 Hours)||0
8089843|NCT03424044|19942841|P3|NOT COMPLETED|Second Intervention (76 Hours)||0
8089844|NCT03424044|19942842|P2|NOT COMPLETED|Second Intervention (76 Hours)||0
8089845|NCT03424044|19942843|P1|NOT COMPLETED|Second Intervention (76 Hours)||0
8089846|NCT03424044|19942835|P9|COMPLETED|Second Intervention (76 Hours)||1
8089847|NCT03424044|19942836|P8|COMPLETED|Second Intervention (76 Hours)||1
8089848|NCT03424044|19942837|P7|COMPLETED|Second Intervention (76 Hours)||1
8089849|NCT03424044|19942838|P6|COMPLETED|Second Intervention (76 Hours)||4
8089850|NCT03424044|19942839|P5|COMPLETED|Second Intervention (76 Hours)||2
8089851|NCT03424044|19942840|P4|COMPLETED|Second Intervention (76 Hours)||3
8089852|NCT03424044|19942841|P3|COMPLETED|Second Intervention (76 Hours)||2
8089853|NCT03424044|19942842|P2|COMPLETED|Second Intervention (76 Hours)||3
8089854|NCT03424044|19942843|P1|COMPLETED|Second Intervention (76 Hours)||4
8089855|NCT03424044|19942835|P9|STARTED|Second Intervention (76 Hours)||1
8089856|NCT03424044|19942836|P8|STARTED|Second Intervention (76 Hours)||1
8089857|NCT03424044|19942837|P7|STARTED|Second Intervention (76 Hours)||1
8089858|NCT03424044|19942838|P6|STARTED|Second Intervention (76 Hours)||4
8089859|NCT03424044|19942839|P5|STARTED|Second Intervention (76 Hours)||2
8089860|NCT03424044|19942840|P4|STARTED|Second Intervention (76 Hours)||3
8089861|NCT03424044|19942841|P3|STARTED|Second Intervention (76 Hours)||2
8089862|NCT03424044|19942842|P2|STARTED|Second Intervention (76 Hours)||3
8089863|NCT03424044|19942843|P1|STARTED|Second Intervention (76 Hours)||4
8089864|NCT03424044|19942835|P9|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089865|NCT03424044|19942836|P8|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089866|NCT03424044|19942837|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089867|NCT03424044|19942838|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089868|NCT03424044|19942839|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089869|NCT03424044|19942840|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089870|NCT03424044|19942841|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089871|NCT03424044|19942842|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089872|NCT03424044|19942843|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8089873|NCT03424044|19942835|P9|COMPLETED|Second Rest Period (7-45 Days)||1
8089874|NCT03424044|19942836|P8|COMPLETED|Second Rest Period (7-45 Days)||1
8089875|NCT03424044|19942837|P7|COMPLETED|Second Rest Period (7-45 Days)||1
8089876|NCT03424044|19942838|P6|COMPLETED|Second Rest Period (7-45 Days)||4
8089877|NCT03424044|19942839|P5|COMPLETED|Second Rest Period (7-45 Days)||2
8089878|NCT03424044|19942840|P4|COMPLETED|Second Rest Period (7-45 Days)||3
8089879|NCT03424044|19942841|P3|COMPLETED|Second Rest Period (7-45 Days)||2
8089880|NCT03424044|19942842|P2|COMPLETED|Second Rest Period (7-45 Days)||3
8089881|NCT03424044|19942843|P1|COMPLETED|Second Rest Period (7-45 Days)||4
8089882|NCT03424044|19942835|P9|STARTED|Second Rest Period (7-45 Days)||1
8089883|NCT03424044|19942836|P8|STARTED|Second Rest Period (7-45 Days)||1
8089884|NCT03424044|19942837|P7|STARTED|Second Rest Period (7-45 Days)||1
8089885|NCT03424044|19942838|P6|STARTED|Second Rest Period (7-45 Days)||4
8089886|NCT03424044|19942839|P5|STARTED|Second Rest Period (7-45 Days)||2
8089887|NCT03424044|19942840|P4|STARTED|Second Rest Period (7-45 Days)||3
8089888|NCT03424044|19942841|P3|STARTED|Second Rest Period (7-45 Days)||2
8089889|NCT03424044|19942842|P2|STARTED|Second Rest Period (7-45 Days)||3
8089890|NCT03424044|19942843|P1|STARTED|Second Rest Period (7-45 Days)||4
8089891|NCT03424044|19942835|P9|NOT COMPLETED|First Intervention (76 Hours)||1
8089892|NCT03424044|19942836|P8|NOT COMPLETED|First Intervention (76 Hours)||1
8089893|NCT03424044|19942837|P7|NOT COMPLETED|First Intervention (76 Hours)||1
8089894|NCT03424044|19942838|P6|NOT COMPLETED|First Intervention (76 Hours)||0
8089895|NCT03424044|19942839|P5|NOT COMPLETED|First Intervention (76 Hours)||1
8089896|NCT03424044|19942840|P4|NOT COMPLETED|First Intervention (76 Hours)||0
8089897|NCT03424044|19942841|P3|NOT COMPLETED|First Intervention (76 Hours)||0
8089898|NCT03424044|19942842|P2|NOT COMPLETED|First Intervention (76 Hours)||0
8089899|NCT03424044|19942843|P1|NOT COMPLETED|First Intervention (76 Hours)||0
8089900|NCT03424044|19942835|P9|COMPLETED|First Intervention (76 Hours)||0
8089901|NCT03424044|19942836|P8|COMPLETED|First Intervention (76 Hours)||0
8089902|NCT03424044|19942837|P7|COMPLETED|First Intervention (76 Hours)||0
8089903|NCT03424044|19942838|P6|COMPLETED|First Intervention (76 Hours)||4
8089904|NCT03424044|19942839|P5|COMPLETED|First Intervention (76 Hours)||2
8089905|NCT03424044|19942840|P4|COMPLETED|First Intervention (76 Hours)||3
8089906|NCT03424044|19942841|P3|COMPLETED|First Intervention (76 Hours)||2
8089907|NCT03424044|19942842|P2|COMPLETED|First Intervention (76 Hours)||3
8089908|NCT03424044|19942843|P1|COMPLETED|First Intervention (76 Hours)||4
8089909|NCT03424044|19942835|P9|STARTED|First Intervention (76 Hours)||1
8089910|NCT03424044|19942836|P8|STARTED|First Intervention (76 Hours)||1
8089911|NCT03424044|19942837|P7|STARTED|First Intervention (76 Hours)||1
8089912|NCT03424044|19942838|P6|STARTED|First Intervention (76 Hours)||4
8089913|NCT03424044|19942839|P5|STARTED|First Intervention (76 Hours)||3
8089914|NCT03424044|19942840|P4|STARTED|First Intervention (76 Hours)||3
8089915|NCT03424044|19942841|P3|STARTED|First Intervention (76 Hours)||2
8089916|NCT03424044|19942842|P2|STARTED|First Intervention (76 Hours)||3
8089917|NCT03424044|19942843|P1|STARTED|First Intervention (76 Hours)||4
8089918|NCT03424044|19942835|P9|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089919|NCT03424044|19942836|P8|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089920|NCT03424044|19942837|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089921|NCT03424044|19942838|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089922|NCT03424044|19942839|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089923|NCT03424044|19942840|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089924|NCT03424044|19942841|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||1
8089925|NCT03424044|19942842|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089926|NCT03424044|19942843|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8089927|NCT03424044|19942835|P9|COMPLETED|First Rest Period (1-12 Weeks)||1
8089928|NCT03424044|19942836|P8|COMPLETED|First Rest Period (1-12 Weeks)||1
8089929|NCT03424044|19942837|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
8089930|NCT03424044|19942838|P6|COMPLETED|First Rest Period (1-12 Weeks)||4
8089931|NCT03424044|19942839|P5|COMPLETED|First Rest Period (1-12 Weeks)||3
8089932|NCT03424044|19942840|P4|COMPLETED|First Rest Period (1-12 Weeks)||3
8089933|NCT03424044|19942841|P3|COMPLETED|First Rest Period (1-12 Weeks)||2
8089934|NCT03424044|19942842|P2|COMPLETED|First Rest Period (1-12 Weeks)||3
8089935|NCT03424044|19942843|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
8089936|NCT03424044|19942835|P9|STARTED|First Rest Period (1-12 Weeks)||1
8089937|NCT03424044|19942836|P8|STARTED|First Rest Period (1-12 Weeks)||1
8089938|NCT03424044|19942837|P7|STARTED|First Rest Period (1-12 Weeks)||1
8089939|NCT03424044|19942838|P6|STARTED|First Rest Period (1-12 Weeks)||4
8089940|NCT03424044|19942839|P5|STARTED|First Rest Period (1-12 Weeks)||3
8089941|NCT03424044|19942840|P4|STARTED|First Rest Period (1-12 Weeks)||3
8089942|NCT03424044|19942841|P3|STARTED|First Rest Period (1-12 Weeks)||3
8089943|NCT03424044|19942842|P2|STARTED|First Rest Period (1-12 Weeks)||3
8089944|NCT03424044|19942843|P1|STARTED|First Rest Period (1-12 Weeks)||4
8089945|NCT03424044|19942835|P9|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089946|NCT03424044|19942836|P8|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089947|NCT03424044|19942837|P7|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089948|NCT03424044|19942838|P6|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089949|NCT03424044|19942839|P5|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089950|NCT03424044|19942840|P4|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089951|NCT03424044|19942841|P3|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089952|NCT03424044|19942842|P2|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089953|NCT03424044|19942843|P1|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
8089954|NCT03424044|19942835|P9|COMPLETED|Dexcom Training Visit (1 Week)||1
8089955|NCT03424044|19942836|P8|COMPLETED|Dexcom Training Visit (1 Week)||1
8089956|NCT03424044|19942837|P7|COMPLETED|Dexcom Training Visit (1 Week)||1
8089957|NCT03424044|19942838|P6|COMPLETED|Dexcom Training Visit (1 Week)||4
8089958|NCT03424044|19942839|P5|COMPLETED|Dexcom Training Visit (1 Week)||3
8089959|NCT03424044|19942840|P4|COMPLETED|Dexcom Training Visit (1 Week)||3
8089960|NCT03424044|19942841|P3|COMPLETED|Dexcom Training Visit (1 Week)||3
8089961|NCT03424044|19942842|P2|COMPLETED|Dexcom Training Visit (1 Week)||3
8089962|NCT03424044|19942843|P1|COMPLETED|Dexcom Training Visit (1 Week)||4
8089963|NCT03424044|19942835|P9|STARTED|Dexcom Training Visit (1 Week)||1
8089964|NCT03424044|19942836|P8|STARTED|Dexcom Training Visit (1 Week)||1
8089965|NCT03424044|19942837|P7|STARTED|Dexcom Training Visit (1 Week)||1
8089966|NCT03424044|19942838|P6|STARTED|Dexcom Training Visit (1 Week)||4
8089967|NCT03424044|19942839|P5|STARTED|Dexcom Training Visit (1 Week)||3
8089968|NCT03424044|19942840|P4|STARTED|Dexcom Training Visit (1 Week)||3
8089969|NCT03424044|19942841|P3|STARTED|Dexcom Training Visit (1 Week)||3
8089970|NCT03424044|19942842|P2|STARTED|Dexcom Training Visit (1 Week)||3
8089971|NCT03424044|19942843|P1|STARTED|Dexcom Training Visit (1 Week)||4
8089972|NCT03423654|19942870|P2|NOT COMPLETED|Overall Study||0
8089973|NCT03423654|19942871|P1|NOT COMPLETED|Overall Study||0
8089974|NCT03423654|19942870|P2|COMPLETED|Overall Study||3
8089975|NCT03423654|19942871|P1|COMPLETED|Overall Study||3
8089976|NCT03423654|19942870|P2|STARTED|Overall Study||3
8089977|NCT03423654|19942871|P1|STARTED|Overall Study||3
8089978|NCT03423641|19942879|P2|NOT COMPLETED|Overall Study||8074
8089979|NCT03423641|19942880|P1|NOT COMPLETED|Overall Study||331
8089980|NCT03423641|19942879|P2|COMPLETED|Overall Study||10210
8089981|NCT03423641|19942880|P1|COMPLETED|Overall Study||15193
8089982|NCT03423641|19942879|P2|STARTED|Overall Study||18284
8089983|NCT03423641|19942880|P1|STARTED|Overall Study||15524
8089984|NCT03423173|19942915|P4|NOT COMPLETED|Overall Study||30
8089985|NCT03423173|19942916|P3|NOT COMPLETED|Overall Study||27
8089986|NCT03423173|19942917|P2|NOT COMPLETED|Overall Study||35
8089987|NCT03423173|19942918|P1|NOT COMPLETED|Overall Study||19
8089988|NCT03423173|19942915|P4|COMPLETED|Overall Study||234
8089989|NCT03423173|19942916|P3|COMPLETED|Overall Study||237
8089990|NCT03423173|19942917|P2|COMPLETED|Overall Study||228
8089991|NCT03423173|19942918|P1|COMPLETED|Overall Study||113
8089992|NCT03423173|19942915|P4|Received at Least 1 Dose of the IP|Overall Study||263
8089993|NCT03423173|19942916|P3|Received at Least 1 Dose of the IP|Overall Study|1 participant of TDV Lot 2 received vaccine of Lot 1 and was included in TDV Lot 1 in Safety Set.|262
8089994|NCT03423173|19942917|P2|Received at Least 1 Dose of the IP|Overall Study||263
8089995|NCT03423173|19942918|P1|Received at Least 1 Dose of the IP|Overall Study||131
8089996|NCT03423173|19942915|P4|STARTED|Overall Study||264
8089997|NCT03423173|19942916|P3|STARTED|Overall Study||264
8089998|NCT03423173|19942917|P2|STARTED|Overall Study||263
8089999|NCT03423173|19942918|P1|STARTED|Overall Study||132
8090000|NCT03423082|19942956|P1|NOT COMPLETED|Overall Study||0
8090001|NCT03423082|19942956|P1|COMPLETED|Overall Study||1
8090002|NCT03423082|19942956|P1|STARTED|Overall Study||1
8090003|NCT03421886|19942965|P2|NOT COMPLETED|Overall Study||2
8090004|NCT03421886|19942966|P1|NOT COMPLETED|Overall Study||7
8090005|NCT03421886|19942965|P2|COMPLETED|Overall Study||13
8090006|NCT03421886|19942966|P1|COMPLETED|Overall Study||23
8090007|NCT03421886|19942965|P2|STARTED|Overall Study||15
8090008|NCT03421886|19942966|P1|STARTED|Overall Study||30
8090009|NCT03421730|19942972|P12|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090010|NCT03421730|19942973|P11|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090011|NCT03421730|19942974|P10|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090012|NCT03421730|19942975|P9|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090013|NCT03421730|19942976|P8|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090014|NCT03421730|19942977|P7|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090015|NCT03421730|19942978|P6|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090016|NCT03421730|19942979|P5|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090017|NCT03421730|19942980|P4|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090018|NCT03421730|19942981|P3|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090019|NCT03421730|19942982|P2|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090020|NCT03421730|19942983|P1|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
8090021|NCT03421730|19942972|P12|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090022|NCT03421730|19942973|P11|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090023|NCT03421730|19942974|P10|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2
8090024|NCT03421730|19942975|P9|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090025|NCT03421730|19942976|P8|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090026|NCT03421730|19942977|P7|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090027|NCT03421730|19942978|P6|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090028|NCT03421730|19942979|P5|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090029|NCT03421730|19942980|P4|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090030|NCT03421730|19942981|P3|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090031|NCT03421730|19942982|P2|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090032|NCT03421730|19942983|P1|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
8090033|NCT03421730|19942972|P12|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090034|NCT03421730|19942973|P11|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090035|NCT03421730|19942974|P10|STARTED|Second Intervention (Day 8±3, Visit 3)||2
8090036|NCT03421730|19942975|P9|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090037|NCT03421730|19942976|P8|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090038|NCT03421730|19942977|P7|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090039|NCT03421730|19942978|P6|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090040|NCT03421730|19942979|P5|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090041|NCT03421730|19942980|P4|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090042|NCT03421730|19942981|P3|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090043|NCT03421730|19942982|P2|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090044|NCT03421730|19942983|P1|STARTED|Second Intervention (Day 8±3, Visit 3)||1
8090045|NCT03421730|19942972|P12|NOT COMPLETED|Washout (Days 4 to 10)||0
8090046|NCT03421730|19942973|P11|NOT COMPLETED|Washout (Days 4 to 10)||0
8090047|NCT03421730|19942974|P10|NOT COMPLETED|Washout (Days 4 to 10)||0
8090048|NCT03421730|19942975|P9|NOT COMPLETED|Washout (Days 4 to 10)||0
8090049|NCT03421730|19942976|P8|NOT COMPLETED|Washout (Days 4 to 10)||0
8090050|NCT03421730|19942977|P7|NOT COMPLETED|Washout (Days 4 to 10)||0
8090051|NCT03421730|19942978|P6|NOT COMPLETED|Washout (Days 4 to 10)||0
8090052|NCT03421730|19942979|P5|NOT COMPLETED|Washout (Days 4 to 10)||2
8090053|NCT03421730|19942980|P4|NOT COMPLETED|Washout (Days 4 to 10)||0
8090054|NCT03421730|19942981|P3|NOT COMPLETED|Washout (Days 4 to 10)||0
8090055|NCT03421730|19942982|P2|NOT COMPLETED|Washout (Days 4 to 10)||0
8090056|NCT03421730|19942983|P1|NOT COMPLETED|Washout (Days 4 to 10)||0
8090057|NCT03421730|19942972|P12|COMPLETED|Washout (Days 4 to 10)||1
8090058|NCT03421730|19942973|P11|COMPLETED|Washout (Days 4 to 10)||1
8090059|NCT03421730|19942974|P10|COMPLETED|Washout (Days 4 to 10)||2
8090060|NCT03421730|19942975|P9|COMPLETED|Washout (Days 4 to 10)||1
8090061|NCT03421730|19942976|P8|COMPLETED|Washout (Days 4 to 10)||1
8090062|NCT03421730|19942977|P7|COMPLETED|Washout (Days 4 to 10)||1
8090063|NCT03421730|19942978|P6|COMPLETED|Washout (Days 4 to 10)||1
8090064|NCT03421730|19942979|P5|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1
8090065|NCT03421730|19942980|P4|COMPLETED|Washout (Days 4 to 10)||1
8090066|NCT03421730|19942981|P3|COMPLETED|Washout (Days 4 to 10)||1
8090067|NCT03421730|19942982|P2|COMPLETED|Washout (Days 4 to 10)||1
8090068|NCT03421730|19942983|P1|COMPLETED|Washout (Days 4 to 10)||1
8090069|NCT03421730|19942972|P12|STARTED|Washout (Days 4 to 10)||1
8090070|NCT03421730|19942973|P11|STARTED|Washout (Days 4 to 10)||1
8090071|NCT03421730|19942974|P10|STARTED|Washout (Days 4 to 10)||2
8090072|NCT03421730|19942975|P9|STARTED|Washout (Days 4 to 10)||1
8090073|NCT03421730|19942976|P8|STARTED|Washout (Days 4 to 10)||1
8090074|NCT03421730|19942977|P7|STARTED|Washout (Days 4 to 10)||1
8090075|NCT03421730|19942978|P6|STARTED|Washout (Days 4 to 10)||1
8090076|NCT03421730|19942979|P5|STARTED|Washout (Days 4 to 10)||3
8090077|NCT03421730|19942980|P4|STARTED|Washout (Days 4 to 10)||1
8090078|NCT03421730|19942981|P3|STARTED|Washout (Days 4 to 10)||1
8090079|NCT03421730|19942982|P2|STARTED|Washout (Days 4 to 10)||1
8090080|NCT03421730|19942983|P1|STARTED|Washout (Days 4 to 10)||1
8090081|NCT03421730|19942972|P12|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090082|NCT03421730|19942973|P11|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090083|NCT03421730|19942974|P10|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090084|NCT03421730|19942975|P9|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090085|NCT03421730|19942976|P8|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090086|NCT03421730|19942977|P7|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090087|NCT03421730|19942978|P6|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090088|NCT03421730|19942979|P5|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090089|NCT03421730|19942980|P4|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090090|NCT03421730|19942981|P3|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090091|NCT03421730|19942982|P2|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2
8090092|NCT03421730|19942983|P1|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
8090093|NCT03421730|19942972|P12|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090094|NCT03421730|19942973|P11|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090095|NCT03421730|19942974|P10|COMPLETED|First Intervention (Day 1, Visit 2)||2
8090096|NCT03421730|19942975|P9|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090097|NCT03421730|19942976|P8|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090098|NCT03421730|19942977|P7|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090099|NCT03421730|19942978|P6|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090100|NCT03421730|19942979|P5|COMPLETED|First Intervention (Day 1, Visit 2)||3
8090101|NCT03421730|19942980|P4|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090102|NCT03421730|19942981|P3|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090103|NCT03421730|19942982|P2|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1
8090104|NCT03421730|19942983|P1|COMPLETED|First Intervention (Day 1, Visit 2)||1
8090105|NCT03421730|19942972|P12|STARTED|First Intervention (Day 1, Visit 2)||1
8090106|NCT03421730|19942973|P11|STARTED|First Intervention (Day 1, Visit 2)||1
8090107|NCT03421730|19942974|P10|STARTED|First Intervention (Day 1, Visit 2)||2
8090108|NCT03421730|19942975|P9|STARTED|First Intervention (Day 1, Visit 2)||1
8090109|NCT03421730|19942976|P8|STARTED|First Intervention (Day 1, Visit 2)||1
8090110|NCT03421730|19942977|P7|STARTED|First Intervention (Day 1, Visit 2)||1
8090111|NCT03421730|19942978|P6|STARTED|First Intervention (Day 1, Visit 2)||1
8090112|NCT03421730|19942979|P5|STARTED|First Intervention (Day 1, Visit 2)||3
8090113|NCT03421730|19942980|P4|STARTED|First Intervention (Day 1, Visit 2)||1
8090114|NCT03421730|19942981|P3|STARTED|First Intervention (Day 1, Visit 2)||1
8090115|NCT03421730|19942982|P2|STARTED|First Intervention (Day 1, Visit 2)||3
8090116|NCT03421730|19942983|P1|STARTED|First Intervention (Day 1, Visit 2)||1
8090117|NCT03421379|19943056|P2|NOT COMPLETED|Period 2||0
8090118|NCT03421379|19943057|P1|NOT COMPLETED|Period 2||0
8090119|NCT03421379|19943056|P2|COMPLETED|Period 2||37
8090120|NCT03421379|19943057|P1|COMPLETED|Period 2||32
8090121|NCT03421379|19943056|P2|STARTED|Period 2||37
8090122|NCT03421379|19943057|P1|STARTED|Period 2||32
8090123|NCT03421379|19943056|P2|NOT COMPLETED|Washout Period (3 to 14 Days)||0
8090124|NCT03421379|19943057|P1|NOT COMPLETED|Washout Period (3 to 14 Days)||0
8090125|NCT03421379|19943056|P2|COMPLETED|Washout Period (3 to 14 Days)||37
8090126|NCT03421379|19943057|P1|COMPLETED|Washout Period (3 to 14 Days)||32
8090127|NCT03421379|19943056|P2|STARTED|Washout Period (3 to 14 Days)||37
8090128|NCT03421379|19943057|P1|STARTED|Washout Period (3 to 14 Days)||32
8090129|NCT03421379|19943056|P2|NOT COMPLETED|Period 1||4
8090130|NCT03421379|19943057|P1|NOT COMPLETED|Period 1||2
8090131|NCT03421379|19943056|P2|COMPLETED|Period 1||37
8090132|NCT03421379|19943057|P1|COMPLETED|Period 1||32
8090133|NCT03421379|19943056|P2|Received at Least One Dose of Study Drug|Period 1||39
8090134|NCT03421379|19943057|P1|Received at Least One Dose of Study Drug|Period 1||33
8090135|NCT03421379|19943056|P2|STARTED|Period 1||41
8090136|NCT03421379|19943057|P1|STARTED|Period 1||34
8090137|NCT03421210|19943073|P1|NOT COMPLETED|Overall Study||53
8090138|NCT03421210|19943073|P1|COMPLETED|Overall Study||35
8090139|NCT03421210|19943073|P1|Received Functional Magnetic Resonance Imaging (fMRI)|Overall Study||42
8090140|NCT03421210|19943073|P1|STARTED|Overall Study||88
8090141|NCT03420625|19943079|P1|NOT COMPLETED|Overall Study||0
8090142|NCT03420625|19943079|P1|COMPLETED|Overall Study||10
8090143|NCT03420625|19943079|P1|Calf NMES|Overall Study||10
8090144|NCT03420625|19943079|P1|Slow Calf IPC|Overall Study||10
8090145|NCT03420625|19943079|P1|Rapid Calf IPC|Overall Study||10
8090146|NCT03420625|19943079|P1|Foot IPC|Overall Study||10
8090147|NCT03420625|19943079|P1|Baseline|Overall Study||10
8090148|NCT03420625|19943079|P1|STARTED|Overall Study||10
8090149|NCT03420300|19943109|P1|NOT COMPLETED|Overall Study||2
8090150|NCT03420300|19943109|P1|COMPLETED|Overall Study||38
8090151|NCT03420300|19943109|P1|STARTED|Overall Study||40
8090152|NCT03419962|19943118|P1|NOT COMPLETED|Overall Study||37
8090153|NCT03419962|19943118|P1|COMPLETED|Overall Study||1322
8090154|NCT03419962|19943118|P1|STARTED|Overall Study||1359
8090155|NCT03419780|19943130|P2|NOT COMPLETED|Overall Study||0
8090156|NCT03419780|19943131|P1|NOT COMPLETED|Overall Study||0
8090157|NCT03419780|19943130|P2|COMPLETED|Overall Study||33
8090158|NCT03419780|19943131|P1|COMPLETED|Overall Study||33
8090159|NCT03419780|19943130|P2|STARTED|Overall Study||33
8090160|NCT03419780|19943131|P1|STARTED|Overall Study||33
8090161|NCT03419598|19943149|P1|NOT COMPLETED|Overall Study||2
8090162|NCT03419598|19943149|P1|COMPLETED|Overall Study||28
8090163|NCT03419598|19943149|P1|FE Models Solved for Generic HTO Plate Stabilised Cohort Copy|Overall Study||28
8090164|NCT03419598|19943149|P1|FE Models Solved for Personalised HTO Plate Stabilised Cohort Copy|Overall Study||28
8090165|NCT03419598|19943149|P1|FE Models Created for Cohort Copy Stabilised by Generic HTO Plate|Overall Study||28
8090166|NCT03419598|19943149|P1|Finite Element (FE) Model Created for Cohort Copy Stabilised by Personalised HTO Plate|Overall Study||28
8090167|NCT03419598|19943149|P1|Virtual Cohort Duplicated Into A. Personalised and B. Generic Copies|Overall Study||28
8090168|NCT03419598|19943149|P1|Subject Specific Tibia Models Created and Virtual Osteotomy Performed|Overall Study||28
8090169|NCT03419598|19943149|P1|STARTED|Overall Study||30
8090170|NCT03419078|19943159|P3|NOT COMPLETED|Overall Study||0
8090171|NCT03419078|19943160|P2|NOT COMPLETED|Overall Study||0
8090172|NCT03419078|19943161|P1|NOT COMPLETED|Overall Study||0
8090173|NCT03419078|19943159|P3|COMPLETED|Overall Study||91
8090174|NCT03419078|19943160|P2|COMPLETED|Overall Study||148
8090175|NCT03419078|19943161|P1|COMPLETED|Overall Study||245
8090176|NCT03419078|19943159|P3|STARTED|Overall Study||91
8090177|NCT03419078|19943160|P2|STARTED|Overall Study||148
8090178|NCT03419078|19943161|P1|STARTED|Overall Study||245
8090179|NCT03418662|19943180|P2|NOT COMPLETED|Overall Study||4
8090180|NCT03418662|19943181|P1|NOT COMPLETED|Overall Study||3
8090181|NCT03418662|19943180|P2|COMPLETED|Overall Study||278
8090182|NCT03418662|19943181|P1|COMPLETED|Overall Study||284
8090183|NCT03418662|19943180|P2|STARTED|Overall Study||282
8090184|NCT03418662|19943181|P1|STARTED|Overall Study||287
8090185|NCT03418571|19943205|P2|NOT COMPLETED|Overall Study||0
8090186|NCT03418571|19943206|P1|NOT COMPLETED|Overall Study||1
8090187|NCT03418571|19943205|P2|COMPLETED|Overall Study||3
8090188|NCT03418571|19943206|P1|COMPLETED|Overall Study||11
8090189|NCT03418571|19943205|P2|STARTED|Overall Study||3
8090190|NCT03418571|19943206|P1|STARTED|Overall Study||12
8090191|NCT03418376|19943218|P4|NOT COMPLETED|Overall Study||1
8090192|NCT03418376|19943219|P3|NOT COMPLETED|Overall Study||3
8090193|NCT03418376|19943220|P2|NOT COMPLETED|Overall Study||5
8090194|NCT03418376|19943221|P1|NOT COMPLETED|Overall Study||1
8090195|NCT03418376|19943218|P4|COMPLETED|Overall Study||10
8090196|NCT03418376|19943219|P3|COMPLETED|Overall Study||8
8090197|NCT03418376|19943220|P2|COMPLETED|Overall Study||6
8090198|NCT03418376|19943221|P1|COMPLETED|Overall Study||11
8090199|NCT03418376|19943218|P4|STARTED|Overall Study||11
8090200|NCT03418376|19943219|P3|STARTED|Overall Study||11
8090201|NCT03418376|19943220|P2|STARTED|Overall Study||11
8090202|NCT03418376|19943221|P1|STARTED|Overall Study||12
8090203|NCT03418324|19943249|P2|NOT COMPLETED|Overall Study||2
8090204|NCT03418324|19943250|P1|NOT COMPLETED|Overall Study||1
8090205|NCT03418324|19943249|P2|COMPLETED|Overall Study||6
8090206|NCT03418324|19943250|P1|COMPLETED|Overall Study||2
8090207|NCT03418324|19943249|P2|STARTED|Overall Study||8
8090208|NCT03418324|19943250|P1|STARTED|Overall Study||3
8090209|NCT03418064|19943268|P2|NOT COMPLETED|Second Intervention (1 Month)||0
8090210|NCT03418064|19943269|P1|NOT COMPLETED|Second Intervention (1 Month)||0
8090211|NCT03418064|19943268|P2|COMPLETED|Second Intervention (1 Month)||21
8090212|NCT03418064|19943269|P1|COMPLETED|Second Intervention (1 Month)||21
8090213|NCT03418064|19943268|P2|STARTED|Second Intervention (1 Month)||21
8090214|NCT03418064|19943269|P1|STARTED|Second Intervention (1 Month)||21
8090215|NCT03418064|19943268|P2|NOT COMPLETED|First Intervention (1 Month)||0
8090216|NCT03418064|19943269|P1|NOT COMPLETED|First Intervention (1 Month)||0
8090217|NCT03418064|19943268|P2|COMPLETED|First Intervention (1 Month)||21
8090218|NCT03418064|19943269|P1|COMPLETED|First Intervention (1 Month)||21
8090219|NCT03418064|19943268|P2|STARTED|First Intervention (1 Month)||21
8090220|NCT03418064|19943269|P1|STARTED|First Intervention (1 Month)||21
8090221|NCT03417830|19943300|P2|NOT COMPLETED|Part B (up to 26 Days)||0
8090222|NCT03417830|19943301|P1|NOT COMPLETED|Part B (up to 26 Days)||0
8090223|NCT03417830|19943300|P2|COMPLETED|Part B (up to 26 Days)||0
8090224|NCT03417830|19943301|P1|COMPLETED|Part B (up to 26 Days)||0
8090225|NCT03417830|19943300|P2|STARTED|Part B (up to 26 Days)||0
8090226|NCT03417830|19943301|P1|STARTED|Part B (up to 26 Days)||0
8090227|NCT03417830|19943300|P2|NOT COMPLETED|Part A (up to 26 Days)||0
8090228|NCT03417830|19943301|P1|NOT COMPLETED|Part A (up to 26 Days)||1
8090229|NCT03417830|19943300|P2|COMPLETED|Part A (up to 26 Days)||0
8090230|NCT03417830|19943301|P1|COMPLETED|Part A (up to 26 Days)||1
8090231|NCT03417830|19943300|P2|STARTED|Part A (up to 26 Days)||0
8090232|NCT03417830|19943301|P1|STARTED|Part A (up to 26 Days)||2
8090233|NCT03417778|19943397|P2|NOT COMPLETED|Overall Study||0
8090234|NCT03417778|19943398|P1|NOT COMPLETED|Overall Study||0
8090235|NCT03417778|19943397|P2|COMPLETED|Overall Study||10
8090236|NCT03417778|19943398|P1|COMPLETED|Overall Study||10
8090237|NCT03417778|19943397|P2|STARTED|Overall Study||10
8090238|NCT03417778|19943398|P1|STARTED|Overall Study||10
8090239|NCT03417752|19943421|P3|NOT COMPLETED|Overall Study||40
8090240|NCT03417752|19943422|P2|NOT COMPLETED|Overall Study||42
8090241|NCT03417752|19943423|P1|NOT COMPLETED|Overall Study||34
8090242|NCT03417752|19943421|P3|COMPLETED|Overall Study||110
8090243|NCT03417752|19943422|P2|COMPLETED|Overall Study||133
8090244|NCT03417752|19943423|P1|COMPLETED|Overall Study||115
8090245|NCT03417752|19943421|P3|STARTED|Overall Study||150
8090246|NCT03417752|19943422|P2|STARTED|Overall Study||175
8090247|NCT03417752|19943423|P1|STARTED|Overall Study||149
8090248|NCT03417713|19943440|P1|NOT COMPLETED|Overall Study||3
8090249|NCT03417713|19943440|P1|COMPLETED|Overall Study||30
8090250|NCT03417713|19943440|P1|STARTED|Overall Study||33
8090251|NCT03417557|19943445|P2|NOT COMPLETED|2nd Intervention (3 Hours)||0
8090252|NCT03417557|19943446|P1|NOT COMPLETED|2nd Intervention (3 Hours)||0
8090253|NCT03417557|19943445|P2|COMPLETED|2nd Intervention (3 Hours)||8
8090254|NCT03417557|19943446|P1|COMPLETED|2nd Intervention (3 Hours)||9
8090255|NCT03417557|19943445|P2|STARTED|2nd Intervention (3 Hours)||8
8090256|NCT03417557|19943446|P1|STARTED|2nd Intervention (3 Hours)||9
8090257|NCT03417557|19943445|P2|NOT COMPLETED|1st Intervention (3 Hours)||0
8090258|NCT03417557|19943446|P1|NOT COMPLETED|1st Intervention (3 Hours)||0
8090259|NCT03417557|19943445|P2|COMPLETED|1st Intervention (3 Hours)||9
8090260|NCT03417557|19943446|P1|COMPLETED|1st Intervention (3 Hours)||8
8090261|NCT03417557|19943445|P2|STARTED|1st Intervention (3 Hours)||9
8090262|NCT03417557|19943446|P1|STARTED|1st Intervention (3 Hours)||8
8090263|NCT03417505|19943458|P2|NOT COMPLETED|Second Lens Type (30 Days)||0
8090264|NCT03417505|19943459|P1|NOT COMPLETED|Second Lens Type (30 Days)||0
8090265|NCT03417505|19943458|P2|COMPLETED|Second Lens Type (30 Days)||11
8090266|NCT03417505|19943459|P1|COMPLETED|Second Lens Type (30 Days)||8
8090267|NCT03417505|19943458|P2|STARTED|Second Lens Type (30 Days)||11
8090268|NCT03417505|19943459|P1|STARTED|Second Lens Type (30 Days)||8
8090269|NCT03417505|19943458|P2|NOT COMPLETED|Washout Period (7 Days)||0
8090270|NCT03417505|19943459|P1|NOT COMPLETED|Washout Period (7 Days)||0
8090271|NCT03417505|19943458|P2|COMPLETED|Washout Period (7 Days)||11
8090272|NCT03417505|19943459|P1|COMPLETED|Washout Period (7 Days)||8
8090273|NCT03417505|19943458|P2|STARTED|Washout Period (7 Days)||11
8090274|NCT03417505|19943459|P1|STARTED|Washout Period (7 Days)||8
8090275|NCT03417505|19943458|P2|NOT COMPLETED|First Lens Type (30 Days)||1
8090276|NCT03417505|19943459|P1|NOT COMPLETED|First Lens Type (30 Days)||1
8090277|NCT03417505|19943458|P2|COMPLETED|First Lens Type (30 Days)||11
8090278|NCT03417505|19943459|P1|COMPLETED|First Lens Type (30 Days)||8
8090279|NCT03417505|19943458|P2|STARTED|First Lens Type (30 Days)||12
8090280|NCT03417505|19943459|P1|STARTED|First Lens Type (30 Days)||9
8090281|NCT03417466|19943481|P1|NOT COMPLETED|Overall Study||0
8090282|NCT03417466|19943481|P1|COMPLETED|Overall Study||66
8090283|NCT03417466|19943481|P1|STARTED|Overall Study||66
8090284|NCT03417219|19943490|P2|NOT COMPLETED|Overall Study||3
8090285|NCT03417219|19943491|P1|NOT COMPLETED|Overall Study||0
8090286|NCT03417219|19943490|P2|COMPLETED|Overall Study||5
8090287|NCT03417219|19943491|P1|COMPLETED|Overall Study||8
8090288|NCT03417219|19943490|P2|STARTED|Overall Study||8
8090289|NCT03417219|19943491|P1|STARTED|Overall Study||8
8090290|NCT03417024|19943501|P1|NOT COMPLETED|Overall Study||13
8090291|NCT03417024|19943501|P1|COMPLETED|Overall Study||0
8090292|NCT03417024|19943501|P1|STARTED|Overall Study||13
8090293|NCT03416985|19943510|P3|NOT COMPLETED|Overall Study||6
8090294|NCT03416985|19943511|P2|NOT COMPLETED|Overall Study||0
8090295|NCT03416985|19943512|P1|NOT COMPLETED|Overall Study||2
8090296|NCT03416985|19943510|P3|COMPLETED|Overall Study||24
8090297|NCT03416985|19943511|P2|COMPLETED|Overall Study||30
8090298|NCT03416985|19943512|P1|COMPLETED|Overall Study||28
8090299|NCT03416985|19943510|P3|STARTED|Overall Study||30
8090300|NCT03416985|19943511|P2|STARTED|Overall Study||30
8090301|NCT03416985|19943512|P1|STARTED|Overall Study||30
8090302|NCT03416127|19943526|P3|NOT COMPLETED|Overall Study||1
8090303|NCT03416127|19943527|P2|NOT COMPLETED|Overall Study||1
8090304|NCT03416127|19943528|P1|NOT COMPLETED|Overall Study||0
8090305|NCT03416127|19943526|P3|COMPLETED|Overall Study||11
8090306|NCT03416127|19943527|P2|COMPLETED|Overall Study||11
8090307|NCT03416127|19943528|P1|COMPLETED|Overall Study||12
8090308|NCT03416127|19943526|P3|STARTED|Overall Study||12
8090309|NCT03416127|19943527|P2|STARTED|Overall Study||12
8090310|NCT03416127|19943528|P1|STARTED|Overall Study||12
8090311|NCT03415243|19943607|P2|NOT COMPLETED|Overall Study||0
8090312|NCT03415243|19943608|P1|NOT COMPLETED|Overall Study||0
8090313|NCT03415243|19943607|P2|COMPLETED|Overall Study||14
8090314|NCT03415243|19943608|P1|COMPLETED|Overall Study||14
8090315|NCT03415243|19943607|P2|STARTED|Overall Study||14
8090316|NCT03415243|19943608|P1|STARTED|Overall Study||14
8090317|NCT03415178|19943672|P2|NOT COMPLETED|Single Arm Period (up to Week 16)||1
8090318|NCT03415178|19943673|P1|NOT COMPLETED|Single Arm Period (up to Week 16)||0
8090319|NCT03415178|19943672|P2|COMPLETED|Single Arm Period (up to Week 16)||65
8090320|NCT03415178|19943673|P1|COMPLETED|Single Arm Period (up to Week 16)||0
8090321|NCT03415178|19943672|P2|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66
8090322|NCT03415178|19943673|P1|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0
8090323|NCT03415178|19943672|P2|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2
8090324|NCT03415178|19943673|P1|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0
8090325|NCT03415178|19943672|P2|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33
8090326|NCT03415178|19943673|P1|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34
8090327|NCT03415178|19943672|P2|Treated|Parallel-Arm Period (up to Week 4)||33
8090328|NCT03415178|19943673|P1|Treated|Parallel-Arm Period (up to Week 4)||34
8090329|NCT03415178|19943672|P2|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35
8090330|NCT03415178|19943673|P1|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34
8090331|NCT03415152|19943708|P1|NOT COMPLETED|Overall Study||1025
8090332|NCT03415152|19943708|P1|COMPLETED|Overall Study||1975
8090333|NCT03415152|19943708|P1|STARTED|Overall Study||3000
8090340|NCT03414359|19943738|P2|NOT COMPLETED|Overall Study||2
8090341|NCT03414359|19943739|P1|NOT COMPLETED|Overall Study||1
8090342|NCT03414359|19943738|P2|COMPLETED|Overall Study||33
8090343|NCT03414359|19943739|P1|COMPLETED|Overall Study||34
8090344|NCT03414359|19943738|P2|STARTED|Overall Study||35
8090345|NCT03414359|19943739|P1|STARTED|Overall Study||35
8090364|NCT03412929|19943814|P1|NOT COMPLETED|Overall Study||3
8090365|NCT03412929|19943814|P1|COMPLETED|Overall Study||5
8090366|NCT03412929|19943814|P1|STARTED|Overall Study||8
8090367|NCT03412734|19943825|P2|NOT COMPLETED|Overall Study||0
8090368|NCT03412734|19943826|P1|NOT COMPLETED|Overall Study||3
8090369|NCT03412734|19943825|P2|COMPLETED|Overall Study||41
8090370|NCT03412734|19943826|P1|COMPLETED|Overall Study||44
8090371|NCT03412734|19943825|P2|STARTED|Overall Study||41
8090372|NCT03412734|19943826|P1|STARTED|Overall Study||47
8090373|NCT03412084|19943834|P2|NOT COMPLETED|Overall Study||1
8090374|NCT03412084|19943835|P1|NOT COMPLETED|Overall Study||4
8090375|NCT03412084|19943834|P2|COMPLETED|Overall Study||35
8090376|NCT03412084|19943835|P1|COMPLETED|Overall Study||44
8090377|NCT03412084|19943834|P2|STARTED|Overall Study||36
8090378|NCT03412084|19943835|P1|STARTED|Overall Study||48
8090379|NCT03412019|19943845|P2|NOT COMPLETED|Overall Study||1
8090380|NCT03412019|19943846|P1|NOT COMPLETED|Overall Study||1
8090381|NCT03412019|19943845|P2|COMPLETED|Overall Study||10
8090382|NCT03412019|19943846|P1|COMPLETED|Overall Study||10
8090383|NCT03412019|19943845|P2|STARTED|Overall Study||11
8090384|NCT03412019|19943846|P1|STARTED|Overall Study||11
8090391|NCT03410862|19943879|P2|NOT COMPLETED|Overall Study||2
8090392|NCT03410862|19943880|P1|NOT COMPLETED|Overall Study||2
8090393|NCT03410862|19943879|P2|COMPLETED|Overall Study||42
8090394|NCT03410862|19943880|P1|COMPLETED|Overall Study||41
8090395|NCT03410862|19943879|P2|STARTED|Overall Study||44
8090396|NCT03410862|19943880|P1|STARTED|Overall Study||43
8090397|NCT03410797|19943888|P1|NOT COMPLETED|Overall Study||0
8090398|NCT03410797|19943888|P1|COMPLETED|Overall Study||11
8090399|NCT03410797|19943888|P1|STARTED|Overall Study||11
8090400|NCT03410628|19943897|P1|NOT COMPLETED|Overall Study||6
8090401|NCT03410628|19943897|P1|COMPLETED|Overall Study||15
8090402|NCT03410628|19943897|P1|STARTED|Overall Study||21
8090403|NCT03409796|19943904|P2|NOT COMPLETED|Overall Study||1
8090404|NCT03409796|19943905|P1|NOT COMPLETED|Overall Study||2
8090405|NCT03409796|19943904|P2|COMPLETED|Overall Study||6
8090406|NCT03409796|19943905|P1|COMPLETED|Overall Study||7
8090407|NCT03409796|19943904|P2|STARTED|Overall Study||7
8090408|NCT03409796|19943905|P1|STARTED|Overall Study||9
8090424|NCT03408639|19944011|P2|NOT COMPLETED|Overall Study||22
8090425|NCT03408639|19944012|P1|NOT COMPLETED|Overall Study||11
8090426|NCT03408639|19944011|P2|COMPLETED|Overall Study||56
8090427|NCT03408639|19944012|P1|COMPLETED|Overall Study||67
8090428|NCT03408639|19944011|P2|STARTED|Overall Study||78
8090429|NCT03408639|19944012|P1|STARTED|Overall Study||78
8090436|NCT03408392|19944069|P2|NOT COMPLETED|Treatment Period 2 (16 Days)||0
8090437|NCT03408392|19944070|P1|NOT COMPLETED|Treatment Period 2 (16 Days)||0
8090438|NCT03408392|19944069|P2|COMPLETED|Treatment Period 2 (16 Days)||14
8090439|NCT03408392|19944070|P1|COMPLETED|Treatment Period 2 (16 Days)||14
8090440|NCT03408392|19944069|P2|STARTED|Treatment Period 2 (16 Days)||14
8090441|NCT03408392|19944070|P1|STARTED|Treatment Period 2 (16 Days)||14
8090442|NCT03408392|19944069|P2|NOT COMPLETED|Wash-out Period (14 Days)||0
8090443|NCT03408392|19944070|P1|NOT COMPLETED|Wash-out Period (14 Days)||0
8090444|NCT03408392|19944069|P2|COMPLETED|Wash-out Period (14 Days)||14
8090445|NCT03408392|19944070|P1|COMPLETED|Wash-out Period (14 Days)||14
8090446|NCT03408392|19944069|P2|STARTED|Wash-out Period (14 Days)||14
8090447|NCT03408392|19944070|P1|STARTED|Wash-out Period (14 Days)||14
8090448|NCT03408392|19944069|P2|NOT COMPLETED|Treatment Period 1 (16 Days)||0
8090449|NCT03408392|19944070|P1|NOT COMPLETED|Treatment Period 1 (16 Days)||0
8090450|NCT03408392|19944069|P2|COMPLETED|Treatment Period 1 (16 Days)||14
8090451|NCT03408392|19944070|P1|COMPLETED|Treatment Period 1 (16 Days)||14
8090452|NCT03408392|19944069|P2|STARTED|Treatment Period 1 (16 Days)||14
8090453|NCT03408392|19944070|P1|STARTED|Treatment Period 1 (16 Days)||14
8090454|NCT03408171|19944124|P2|NOT COMPLETED|Overall Study||0
8090455|NCT03408171|19944125|P1|NOT COMPLETED|Overall Study||0
8090456|NCT03408171|19944124|P2|COMPLETED|Overall Study||20
8090457|NCT03408171|19944125|P1|COMPLETED|Overall Study||20
8090458|NCT03408171|19944124|P2|STARTED|Overall Study||20
8090459|NCT03408171|19944125|P1|STARTED|Overall Study||20
8090460|NCT03407625|19944153|P2|NOT COMPLETED|Overall Study||0
8090461|NCT03407625|19944154|P1|NOT COMPLETED|Overall Study||0
8090462|NCT03407625|19944153|P2|COMPLETED|Overall Study||1110
8090463|NCT03407625|19944154|P1|COMPLETED|Overall Study||1117
8090464|NCT03407625|19944153|P2|STARTED|Overall Study||1110
8090465|NCT03407625|19944154|P1|STARTED|Overall Study||1117
8090466|NCT03407612|19944208|P2|NOT COMPLETED|Overall Study||0
8090467|NCT03407612|19944209|P1|NOT COMPLETED|Overall Study||0
8090468|NCT03407612|19944208|P2|COMPLETED|Overall Study||23
8090469|NCT03407612|19944209|P1|COMPLETED|Overall Study||19
8090470|NCT03407612|19944208|P2|STARTED|Overall Study||23
8090471|NCT03407612|19944209|P1|STARTED|Overall Study||19
8090472|NCT03407482|19944219|P1|NOT COMPLETED|Overall Study||131
8090473|NCT03407482|19944219|P1|COMPLETED|Overall Study||29
8090474|NCT03407482|19944219|P1|STARTED|Overall Study||160
8090475|NCT03407430|19944230|P2|NOT COMPLETED|Second Intervention||0
8090476|NCT03407430|19944231|P1|NOT COMPLETED|Second Intervention||0
8090477|NCT03407430|19944230|P2|COMPLETED|Second Intervention||3
8090478|NCT03407430|19944231|P1|COMPLETED|Second Intervention||4
8090479|NCT03407430|19944230|P2|STARTED|Second Intervention||3
8090480|NCT03407430|19944231|P1|STARTED|Second Intervention||4
8090481|NCT03407430|19944230|P2|NOT COMPLETED|Washout||0
8090482|NCT03407430|19944231|P1|NOT COMPLETED|Washout||1
8090483|NCT03407430|19944230|P2|COMPLETED|Washout||3
8090484|NCT03407430|19944231|P1|COMPLETED|Washout||4
8090485|NCT03407430|19944230|P2|STARTED|Washout||3
8090486|NCT03407430|19944231|P1|STARTED|Washout||5
8090487|NCT03407430|19944230|P2|NOT COMPLETED|First Intervention||0
8090488|NCT03407430|19944231|P1|NOT COMPLETED|First Intervention||0
8090489|NCT03407430|19944230|P2|COMPLETED|First Intervention||3
8090490|NCT03407430|19944231|P1|COMPLETED|First Intervention||5
8090491|NCT03407430|19944230|P2|STARTED|First Intervention||3
8090492|NCT03407430|19944231|P1|STARTED|First Intervention||5
8090493|NCT03407170|19944263|P1|NOT COMPLETED|Overall Study||1
8090494|NCT03407170|19944263|P1|COMPLETED|Overall Study||0
8090495|NCT03407170|19944263|P1|STARTED|Overall Study||1
8090496|NCT03407118|19944276|P2|NOT COMPLETED|Period 2||0
8090497|NCT03407118|19944277|P1|NOT COMPLETED|Period 2||1
8090498|NCT03407118|19944276|P2|COMPLETED|Period 2||17
8090499|NCT03407118|19944277|P1|COMPLETED|Period 2||13
8090500|NCT03407118|19944276|P2|Received at Least 1 Dose of Study Drug|Period 2||17
8090501|NCT03407118|19944277|P1|Received at Least 1 Dose of Study Drug|Period 2||13
8090502|NCT03407118|19944276|P2|STARTED|Period 2||17
8090503|NCT03407118|19944277|P1|STARTED|Period 2||14
8090504|NCT03407118|19944276|P2|NOT COMPLETED|Period 1||0
8090505|NCT03407118|19944277|P1|NOT COMPLETED|Period 1||0
8090506|NCT03407118|19944276|P2|COMPLETED|Period 1||17
8090507|NCT03407118|19944277|P1|COMPLETED|Period 1||14
8090508|NCT03407118|19944276|P2|Received at Least 1 Dose of Study Drug|Period 1||17
8090509|NCT03407118|19944277|P1|Received at Least 1 Dose of Study Drug|Period 1||14
8090510|NCT03407118|19944276|P2|STARTED|Period 1||17
8090511|NCT03407118|19944277|P1|STARTED|Period 1||14
8090512|NCT03406325|19944293|P8|NOT COMPLETED|Overall Study||0
8090513|NCT03406325|19944294|P7|NOT COMPLETED|Overall Study||0
8090514|NCT03406325|19944295|P6|NOT COMPLETED|Overall Study||0
8090515|NCT03406325|19944296|P5|NOT COMPLETED|Overall Study||0
8090516|NCT03406325|19944297|P4|NOT COMPLETED|Overall Study||0
8090517|NCT03406325|19944298|P3|NOT COMPLETED|Overall Study||0
8090518|NCT03406325|19944299|P2|NOT COMPLETED|Overall Study||0
8090519|NCT03406325|19944300|P1|NOT COMPLETED|Overall Study||0
8090520|NCT03406325|19944293|P8|COMPLETED|Overall Study||1
8090521|NCT03406325|19944294|P7|COMPLETED|Overall Study||1
8090522|NCT03406325|19944295|P6|COMPLETED|Overall Study||1
8090523|NCT03406325|19944296|P5|COMPLETED|Overall Study||1
8090524|NCT03406325|19944297|P4|COMPLETED|Overall Study||1
8090525|NCT03406325|19944298|P3|COMPLETED|Overall Study||1
8090526|NCT03406325|19944299|P2|COMPLETED|Overall Study||1
8090527|NCT03406325|19944300|P1|COMPLETED|Overall Study||12
8090528|NCT03406325|19944293|P8|STARTED|Overall Study||1
8090529|NCT03406325|19944294|P7|STARTED|Overall Study||1
8090530|NCT03406325|19944295|P6|STARTED|Overall Study||1
8090531|NCT03406325|19944296|P5|STARTED|Overall Study||1
8090532|NCT03406325|19944297|P4|STARTED|Overall Study||1
8090533|NCT03406325|19944298|P3|STARTED|Overall Study||1
8090534|NCT03406325|19944299|P2|STARTED|Overall Study||1
8090535|NCT03406325|19944300|P1|STARTED|Overall Study||12
8090536|NCT03406260|19944354|P6|NOT COMPLETED|Period 3||0
8090537|NCT03406260|19944355|P5|NOT COMPLETED|Period 3||0
8090538|NCT03406260|19944356|P4|NOT COMPLETED|Period 3||0
8090539|NCT03406260|19944357|P3|NOT COMPLETED|Period 3||0
8090540|NCT03406260|19944358|P2|NOT COMPLETED|Period 3||0
8090541|NCT03406260|19944359|P1|NOT COMPLETED|Period 3||0
8090542|NCT03406260|19944354|P6|COMPLETED|Period 3||6
8090543|NCT03406260|19944355|P5|COMPLETED|Period 3||5
8090544|NCT03406260|19944356|P4|COMPLETED|Period 3||6
8090545|NCT03406260|19944357|P3|COMPLETED|Period 3||6
8090546|NCT03406260|19944358|P2|COMPLETED|Period 3||6
8090547|NCT03406260|19944359|P1|COMPLETED|Period 3||6
8090548|NCT03406260|19944354|P6|STARTED|Period 3||6
8090549|NCT03406260|19944355|P5|STARTED|Period 3||5
8090550|NCT03406260|19944356|P4|STARTED|Period 3||6
8090551|NCT03406260|19944357|P3|STARTED|Period 3||6
8090552|NCT03406260|19944358|P2|STARTED|Period 3||6
8090553|NCT03406260|19944359|P1|STARTED|Period 3||6
8090554|NCT03406260|19944354|P6|NOT COMPLETED|Period 2||0
8090555|NCT03406260|19944355|P5|NOT COMPLETED|Period 2||0
8090556|NCT03406260|19944356|P4|NOT COMPLETED|Period 2||0
8090557|NCT03406260|19944357|P3|NOT COMPLETED|Period 2||0
8090558|NCT03406260|19944358|P2|NOT COMPLETED|Period 2||0
8090559|NCT03406260|19944359|P1|NOT COMPLETED|Period 2||0
8090560|NCT03406260|19944354|P6|COMPLETED|Period 2||6
8090561|NCT03406260|19944355|P5|COMPLETED|Period 2||5
8090562|NCT03406260|19944356|P4|COMPLETED|Period 2||6
8090563|NCT03406260|19944357|P3|COMPLETED|Period 2||6
8090564|NCT03406260|19944358|P2|COMPLETED|Period 2||6
8090565|NCT03406260|19944359|P1|COMPLETED|Period 2||6
8090566|NCT03406260|19944354|P6|STARTED|Period 2||6
8090567|NCT03406260|19944355|P5|STARTED|Period 2||5
8090568|NCT03406260|19944356|P4|STARTED|Period 2||6
8090569|NCT03406260|19944357|P3|STARTED|Period 2||6
8090570|NCT03406260|19944358|P2|STARTED|Period 2||6
8090571|NCT03406260|19944359|P1|STARTED|Period 2||6
8090572|NCT03406260|19944354|P6|NOT COMPLETED|Period 1||0
8090573|NCT03406260|19944355|P5|NOT COMPLETED|Period 1||1
8090574|NCT03406260|19944356|P4|NOT COMPLETED|Period 1||0
8090575|NCT03406260|19944357|P3|NOT COMPLETED|Period 1||0
8090576|NCT03406260|19944358|P2|NOT COMPLETED|Period 1||0
8090577|NCT03406260|19944359|P1|NOT COMPLETED|Period 1||0
8090578|NCT03406260|19944354|P6|COMPLETED|Period 1||6
8090579|NCT03406260|19944355|P5|COMPLETED|Period 1||5
8090580|NCT03406260|19944356|P4|COMPLETED|Period 1||6
8090581|NCT03406260|19944357|P3|COMPLETED|Period 1||6
8090582|NCT03406260|19944358|P2|COMPLETED|Period 1||6
8090583|NCT03406260|19944359|P1|COMPLETED|Period 1||6
8090584|NCT03406260|19944354|P6|Received at Least 1 Dose of Study Drug|Period 1||6
8090585|NCT03406260|19944355|P5|Received at Least 1 Dose of Study Drug|Period 1||6
8090586|NCT03406260|19944356|P4|Received at Least 1 Dose of Study Drug|Period 1||6
8090587|NCT03406260|19944357|P3|Received at Least 1 Dose of Study Drug|Period 1||6
8090588|NCT03406260|19944358|P2|Received at Least 1 Dose of Study Drug|Period 1||6
8090589|NCT03406260|19944359|P1|Received at Least 1 Dose of Study Drug|Period 1||6
8090590|NCT03406260|19944354|P6|STARTED|Period 1||6
8090591|NCT03406260|19944355|P5|STARTED|Period 1||6
8090592|NCT03406260|19944356|P4|STARTED|Period 1||6
8090593|NCT03406260|19944357|P3|STARTED|Period 1||6
8090594|NCT03406260|19944358|P2|STARTED|Period 1||6
8090595|NCT03406260|19944359|P1|STARTED|Period 1||6
8090596|NCT03405935|19944371|P1|NOT COMPLETED|Overall Study||8
8090597|NCT03405935|19944371|P1|COMPLETED|Overall Study||78
8090598|NCT03405935|19944371|P1|STARTED|Overall Study||86
8090599|NCT03405818|19944398|P1|NOT COMPLETED|Overall Study||8
8090600|NCT03405818|19944398|P1|COMPLETED|Overall Study||47
8090601|NCT03405818|19944398|P1|STARTED|Overall Study||55
8090602|NCT03405259|19944441|P2|NOT COMPLETED|Overall Study||0
8090603|NCT03405259|19944442|P1|NOT COMPLETED|Overall Study||0
8090604|NCT03405259|19944441|P2|COMPLETED|Overall Study||11
8090605|NCT03405259|19944442|P1|COMPLETED|Overall Study||11
8090606|NCT03405259|19944441|P2|STARTED|Overall Study||11
8090607|NCT03405259|19944442|P1|STARTED|Overall Study||11
8090608|NCT03404843|19944452|P2|NOT COMPLETED|Overall Study||1
8090609|NCT03404843|19944453|P1|NOT COMPLETED|Overall Study||4
8090610|NCT03404843|19944452|P2|COMPLETED|Overall Study||13
8090611|NCT03404843|19944453|P1|COMPLETED|Overall Study||13
8090612|NCT03404843|19944452|P2|STARTED|Overall Study||14
8090613|NCT03404843|19944453|P1|STARTED|Overall Study||17
8090614|NCT03404674|19944485|P6|NOT COMPLETED|Overall Study||1
8090615|NCT03404674|19944486|P5|NOT COMPLETED|Overall Study||0
8090616|NCT03404674|19944487|P4|NOT COMPLETED|Overall Study||1
8090617|NCT03404674|19944488|P3|NOT COMPLETED|Overall Study||2
8090618|NCT03404674|19944489|P2|NOT COMPLETED|Overall Study||1
8090619|NCT03404674|19944490|P1|NOT COMPLETED|Overall Study||0
8090620|NCT03404674|19944485|P6|COMPLETED|Overall Study||9
8090621|NCT03404674|19944486|P5|COMPLETED|Overall Study||10
8090622|NCT03404674|19944487|P4|COMPLETED|Overall Study||9
8090623|NCT03404674|19944488|P3|COMPLETED|Overall Study||8
8090624|NCT03404674|19944489|P2|COMPLETED|Overall Study||4
8090625|NCT03404674|19944490|P1|COMPLETED|Overall Study||5
8090626|NCT03404674|19944485|P6|Received Dose 3|Overall Study||9
8090627|NCT03404674|19944486|P5|Received Dose 3|Overall Study||10
8090628|NCT03404674|19944487|P4|Received Dose 3|Overall Study||9
8090629|NCT03404674|19944488|P3|Received Dose 3|Overall Study||9
8090630|NCT03404674|19944489|P2|Received Dose 3|Overall Study||4
8090631|NCT03404674|19944490|P1|Received Dose 3|Overall Study||5
8090632|NCT03404674|19944485|P6|Received Dose 2|Overall Study||10
8090633|NCT03404674|19944486|P5|Received Dose 2|Overall Study||10
8090634|NCT03404674|19944487|P4|Received Dose 2|Overall Study||9
8090635|NCT03404674|19944488|P3|Received Dose 2|Overall Study||10
8090636|NCT03404674|19944489|P2|Received Dose 2|Overall Study||4
8090637|NCT03404674|19944490|P1|Received Dose 2|Overall Study||5
8090638|NCT03404674|19944485|P6|STARTED|Overall Study||10
8090639|NCT03404674|19944486|P5|STARTED|Overall Study||10
8090640|NCT03404674|19944487|P4|STARTED|Overall Study||10
8090641|NCT03404674|19944488|P3|STARTED|Overall Study||10
8090642|NCT03404674|19944489|P2|STARTED|Overall Study||5
8090643|NCT03404674|19944490|P1|STARTED|Overall Study||5
8090644|NCT03404206|19944585|P3|NOT COMPLETED|Overall Study||0
8090645|NCT03404206|19944586|P2|NOT COMPLETED|Overall Study||2
8090646|NCT03404206|19944587|P1|NOT COMPLETED|Overall Study||4
8090647|NCT03404206|19944585|P3|COMPLETED|Overall Study||55
8090648|NCT03404206|19944586|P2|COMPLETED|Overall Study||164
8090649|NCT03404206|19944587|P1|COMPLETED|Overall Study||162
8090650|NCT03404206|19944585|P3|STARTED|Overall Study||55
8090651|NCT03404206|19944586|P2|STARTED|Overall Study||166
8090652|NCT03404206|19944587|P1|STARTED|Overall Study||166
8090653|NCT03404167|19944601|P1|NOT COMPLETED|Overall Study||0
8090654|NCT03404167|19944601|P1|COMPLETED|Overall Study||8
8090655|NCT03404167|19944601|P1|STARTED|Overall Study||8
8090656|NCT03403712|19944638|P2|NOT COMPLETED|Overall Study||100
8090657|NCT03403712|19944639|P1|NOT COMPLETED|Overall Study||105
8090658|NCT03403712|19944638|P2|COMPLETED|Overall Study||102
8090659|NCT03403712|19944639|P1|COMPLETED|Overall Study||95
8090660|NCT03403712|19944638|P2|STARTED|Overall Study||202
8090661|NCT03403712|19944639|P1|STARTED|Overall Study||200
8090662|NCT03403517|19944661|P2|NOT COMPLETED|Overall Study||0
8090663|NCT03403517|19944662|P1|NOT COMPLETED|Overall Study||0
8090664|NCT03403517|19944661|P2|COMPLETED|Overall Study||86
8090665|NCT03403517|19944662|P1|COMPLETED|Overall Study||88
8090666|NCT03403517|19944661|P2|STARTED|Overall Study||86
8090667|NCT03403517|19944662|P1|STARTED|Overall Study||88
8090668|NCT03403504|19944678|P2|NOT COMPLETED|Period 2||0
8090669|NCT03403504|19944679|P1|NOT COMPLETED|Period 2||0
8090670|NCT03403504|19944678|P2|COMPLETED|Period 2||11
8090671|NCT03403504|19944679|P1|COMPLETED|Period 2||12
8090672|NCT03403504|19944678|P2|STARTED|Period 2||11
8090673|NCT03403504|19944679|P1|STARTED|Period 2||12
8090674|NCT03403504|19944678|P2|NOT COMPLETED|Period 1||1
8090675|NCT03403504|19944679|P1|NOT COMPLETED|Period 1||0
8090676|NCT03403504|19944678|P2|COMPLETED|Period 1||11
8090677|NCT03403504|19944679|P1|COMPLETED|Period 1||12
8090678|NCT03403504|19944678|P2|STARTED|Period 1||12
8090679|NCT03403504|19944679|P1|STARTED|Period 1||12
8090680|NCT03403491|19944699|P2|NOT COMPLETED|Overall Study||5
8090681|NCT03403491|19944700|P1|NOT COMPLETED|Overall Study||3
8090682|NCT03403491|19944699|P2|COMPLETED|Overall Study||18
8090683|NCT03403491|19944700|P1|COMPLETED|Overall Study||17
8090684|NCT03403491|19944699|P2|STARTED|Overall Study||23
8090685|NCT03403491|19944700|P1|STARTED|Overall Study||20
8090686|NCT03403426|19944732|P1|NOT COMPLETED|Overall Study||3
8090687|NCT03403426|19944732|P1|COMPLETED|Overall Study||82
8090688|NCT03403426|19944732|P1|STARTED|Overall Study||85
8090689|NCT03403413|19944745|P1|NOT COMPLETED|Overall Study||2
8090690|NCT03403413|19944745|P1|COMPLETED|Overall Study||3
8090691|NCT03403413|19944745|P1|STARTED|Overall Study||5
8090692|NCT03403400|19944763|P3|NOT COMPLETED|Overall Study||2
8090693|NCT03403400|19944764|P2|NOT COMPLETED|Overall Study||0
8090694|NCT03403400|19944765|P1|NOT COMPLETED|Overall Study||2
8090695|NCT03403400|19944763|P3|COMPLETED|Overall Study||4
8090696|NCT03403400|19944764|P2|COMPLETED|Overall Study||6
8090697|NCT03403400|19944765|P1|COMPLETED|Overall Study||3
8090698|NCT03403400|19944763|P3|STARTED|Overall Study||6
8090699|NCT03403400|19944764|P2|STARTED|Overall Study||6
8090700|NCT03403400|19944765|P1|STARTED|Overall Study||5
8090701|NCT03403374|19944797|P1|NOT COMPLETED|Overall Study||1
8090702|NCT03403374|19944797|P1|COMPLETED|Overall Study||29
8090703|NCT03403374|19944797|P1|STARTED|Overall Study||30
8090707|NCT03402932|19944814|P4|NOT COMPLETED|Overall Study||0
8090708|NCT03402932|19944815|P3|NOT COMPLETED|Overall Study||0
8090709|NCT03402932|19944816|P2|NOT COMPLETED|Overall Study||0
8090710|NCT03402932|19944817|P1|NOT COMPLETED|Overall Study||0
8090711|NCT03402932|19944814|P4|COMPLETED|Overall Study||8
8090712|NCT03402932|19944815|P3|COMPLETED|Overall Study||8
8090713|NCT03402932|19944816|P2|COMPLETED|Overall Study||8
8090714|NCT03402932|19944817|P1|COMPLETED|Overall Study||13
8090715|NCT03402932|19944814|P4|STARTED|Overall Study||8
8090716|NCT03402932|19944815|P3|STARTED|Overall Study||8
8090717|NCT03402932|19944816|P2|STARTED|Overall Study||8
8090718|NCT03402932|19944817|P1|STARTED|Overall Study||13
8090719|NCT03402893|19944831|P1|NOT COMPLETED|Overall Study||1
8090720|NCT03402893|19944831|P1|COMPLETED|Overall Study||20
8090721|NCT03402893|19944831|P1|STARTED|Overall Study||21
8090722|NCT03402750|19944842|P2|NOT COMPLETED|Overall Study||1
8090723|NCT03402750|19944843|P1|NOT COMPLETED|Overall Study||2
8090724|NCT03402750|19944842|P2|COMPLETED|Overall Study||19
8090725|NCT03402750|19944843|P1|COMPLETED|Overall Study||18
8090726|NCT03402750|19944842|P2|STARTED|Overall Study||20
8090727|NCT03402750|19944843|P1|STARTED|Overall Study||20
8090728|NCT03402555|19944857|P1|NOT COMPLETED|Overall Study||5
8090729|NCT03402555|19944857|P1|COMPLETED|Overall Study||91
8090730|NCT03402555|19944857|P1|STARTED|Overall Study||96
8090737|NCT03401450|19944908|P2|NOT COMPLETED|Overall Study||13
8090738|NCT03401450|19944909|P1|NOT COMPLETED|Overall Study||12
8090739|NCT03401450|19944908|P2|COMPLETED|Overall Study||23
8090740|NCT03401450|19944909|P1|COMPLETED|Overall Study||21
8090741|NCT03401450|19944908|P2|STARTED|Overall Study||36
8090742|NCT03401450|19944909|P1|STARTED|Overall Study||33
8090743|NCT03400800|19944921|P2|NOT COMPLETED|Overall Study||37
8090744|NCT03400800|19944922|P1|NOT COMPLETED|Overall Study||38
8090745|NCT03400800|19944921|P2|COMPLETED|Overall Study||770
8090746|NCT03400800|19944922|P1|COMPLETED|Overall Study||772
8090747|NCT03400800|19944921|P2|STARTED|Overall Study||807
8090748|NCT03400800|19944922|P1|STARTED|Overall Study||810
8090757|NCT03400579|19944951|P1|NOT COMPLETED|Overall Study||0
8090758|NCT03400579|19944951|P1|COMPLETED|Overall Study||10
8090759|NCT03400579|19944951|P1|STARTED|Overall Study||10
8090760|NCT03400475|19944963|P2|NOT COMPLETED|Overall Study||0
8090761|NCT03400475|19944964|P1|NOT COMPLETED|Overall Study||0
8090762|NCT03400475|19944963|P2|COMPLETED|Overall Study||22
8090763|NCT03400475|19944964|P1|COMPLETED|Overall Study||24
8090764|NCT03400475|19944963|P2|STARTED|Overall Study||22
8090765|NCT03400475|19944964|P1|STARTED|Overall Study||24
8090766|NCT03400449|19945006|P2|NOT COMPLETED|Overall Study||0
8090767|NCT03400449|19945007|P1|NOT COMPLETED|Overall Study||1
8090768|NCT03400449|19945006|P2|COMPLETED|Overall Study||119
8090769|NCT03400449|19945007|P1|COMPLETED|Overall Study||120
8090770|NCT03400449|19945006|P2|STARTED|Overall Study||119
8090771|NCT03400449|19945007|P1|STARTED|Overall Study||121
8090784|NCT03399370|19945054|P2|NOT COMPLETED|Overall Study||86
8090785|NCT03399370|19945055|P1|NOT COMPLETED|Overall Study||60
8090786|NCT03399370|19945054|P2|COMPLETED|Overall Study||694
8090787|NCT03399370|19945055|P1|COMPLETED|Overall Study||721
8090788|NCT03399370|19945054|P2|STARTED|Overall Study||780
8090789|NCT03399370|19945055|P1|STARTED|Overall Study||781
8090790|NCT03398928|19945077|P2|NOT COMPLETED|Overall Study||0
8090791|NCT03398928|19945078|P1|NOT COMPLETED|Overall Study||0
8090792|NCT03398928|19945077|P2|COMPLETED|Overall Study||31
8090793|NCT03398928|19945078|P1|COMPLETED|Overall Study||50
8090794|NCT03398928|19945077|P2|STARTED|Overall Study||31
8090795|NCT03398928|19945078|P1|STARTED|Overall Study||50
8090796|NCT03398798|19945106|P4|NOT COMPLETED|Overall Study||0
8090797|NCT03398798|19945107|P3|NOT COMPLETED|Overall Study||0
8090798|NCT03398798|19945108|P2|NOT COMPLETED|Overall Study||0
8090799|NCT03398798|19945109|P1|NOT COMPLETED|Overall Study||0
8090800|NCT03398798|19945106|P4|COMPLETED|Overall Study||9
8090801|NCT03398798|19945107|P3|COMPLETED|Overall Study||9
8090802|NCT03398798|19945108|P2|COMPLETED|Overall Study||9
8090803|NCT03398798|19945109|P1|COMPLETED|Overall Study||9
8090804|NCT03398798|19945106|P4|STARTED|Overall Study||9
8090805|NCT03398798|19945107|P3|STARTED|Overall Study||9
8090806|NCT03398798|19945108|P2|STARTED|Overall Study||9
8090807|NCT03398798|19945109|P1|STARTED|Overall Study||9
8090808|NCT03398421|19945143|P2|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
8090809|NCT03398421|19945144|P1|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
8090810|NCT03398421|19945143|P2|COMPLETED|Treatment Period 2 (Up to 11 Days)||20
8090811|NCT03398421|19945144|P1|COMPLETED|Treatment Period 2 (Up to 11 Days)||0
8090812|NCT03398421|19945143|P2|STARTED|Treatment Period 2 (Up to 11 Days)||20
8090813|NCT03398421|19945144|P1|STARTED|Treatment Period 2 (Up to 11 Days)||0
8090814|NCT03398421|19945143|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
8090815|NCT03398421|19945144|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
8090816|NCT03398421|19945143|P2|COMPLETED|Washout Period (Up to 14 Days)||0
8090817|NCT03398421|19945144|P1|COMPLETED|Washout Period (Up to 14 Days)||20
8090818|NCT03398421|19945143|P2|STARTED|Washout Period (Up to 14 Days)||0
8090819|NCT03398421|19945144|P1|STARTED|Washout Period (Up to 14 Days)||20
8090820|NCT03398421|19945143|P2|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
8090821|NCT03398421|19945144|P1|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
8090822|NCT03398421|19945143|P2|COMPLETED|Treatment Period 1 (Up to 6 Days)||0
8090823|NCT03398421|19945144|P1|COMPLETED|Treatment Period 1 (Up to 6 Days)||20
8090824|NCT03398421|19945143|P2|STARTED|Treatment Period 1 (Up to 6 Days)||0
8090825|NCT03398421|19945144|P1|STARTED|Treatment Period 1 (Up to 6 Days)||20
8090826|NCT03398356|19945208|P3|NOT COMPLETED|After 15 Weeks of Treatment||0
8090827|NCT03398356|19945209|P2|NOT COMPLETED|After 15 Weeks of Treatment||0
8090828|NCT03398356|19945210|P1|NOT COMPLETED|After 15 Weeks of Treatment||0
8090829|NCT03398356|19945208|P3|COMPLETED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8090830|NCT03398356|19945209|P2|COMPLETED|After 15 Weeks of Treatment||11
8090831|NCT03398356|19945210|P1|COMPLETED|After 15 Weeks of Treatment||14
8090832|NCT03398356|19945208|P3|STARTED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8090833|NCT03398356|19945209|P2|STARTED|After 15 Weeks of Treatment||11
8090834|NCT03398356|19945210|P1|STARTED|After 15 Weeks of Treatment||14
8090835|NCT03398356|19945208|P3|NOT COMPLETED|After 12 Weeks of Treatment||0
8090836|NCT03398356|19945209|P2|NOT COMPLETED|After 12 Weeks of Treatment||0
8090837|NCT03398356|19945210|P1|NOT COMPLETED|After 12 Weeks of Treatment||0
8090838|NCT03398356|19945208|P3|COMPLETED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8090839|NCT03398356|19945209|P2|COMPLETED|After 12 Weeks of Treatment||11
8090840|NCT03398356|19945210|P1|COMPLETED|After 12 Weeks of Treatment||14
8090841|NCT03398356|19945208|P3|STARTED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8090842|NCT03398356|19945209|P2|STARTED|After 12 Weeks of Treatment||11
8090843|NCT03398356|19945210|P1|STARTED|After 12 Weeks of Treatment||14
8090844|NCT03398356|19945208|P3|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
8090845|NCT03398356|19945209|P2|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
8090846|NCT03398356|19945210|P1|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
8090847|NCT03398356|19945208|P3|COMPLETED|Post 6 Week Period Initial Evaluation||0
8090848|NCT03398356|19945209|P2|COMPLETED|Post 6 Week Period Initial Evaluation||11
8090849|NCT03398356|19945210|P1|COMPLETED|Post 6 Week Period Initial Evaluation||14
8090850|NCT03398356|19945208|P3|STARTED|Post 6 Week Period Initial Evaluation||0
8090851|NCT03398356|19945209|P2|STARTED|Post 6 Week Period Initial Evaluation||11
8090852|NCT03398356|19945210|P1|STARTED|Post 6 Week Period Initial Evaluation|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|14
8090853|NCT03398356|19945208|P3|NOT COMPLETED|After 6 Weeks of Treatment||0
8090854|NCT03398356|19945209|P2|NOT COMPLETED|After 6 Weeks of Treatment||2
8090855|NCT03398356|19945210|P1|NOT COMPLETED|After 6 Weeks of Treatment||0
8090856|NCT03398356|19945208|P3|COMPLETED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8090857|NCT03398356|19945209|P2|COMPLETED|After 6 Weeks of Treatment||11
8090858|NCT03398356|19945210|P1|COMPLETED|After 6 Weeks of Treatment||12
8090859|NCT03398356|19945208|P3|STARTED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
8090860|NCT03398356|19945209|P2|STARTED|After 6 Weeks of Treatment||13
8090861|NCT03398356|19945210|P1|STARTED|After 6 Weeks of Treatment||12
8090862|NCT03398356|19945208|P3|NOT COMPLETED|Before Treatment||11
8090863|NCT03398356|19945209|P2|NOT COMPLETED|Before Treatment||8
8090864|NCT03398356|19945210|P1|NOT COMPLETED|Before Treatment||3
8090865|NCT03398356|19945208|P3|COMPLETED|Before Treatment|only baseline parameters were taken, this group did not participate in the further part of the study|0
8090866|NCT03398356|19945209|P2|COMPLETED|Before Treatment||13
8090867|NCT03398356|19945210|P1|COMPLETED|Before Treatment||12
8090868|NCT03398356|19945208|P3|STARTED|Before Treatment||11
8090869|NCT03398356|19945209|P2|STARTED|Before Treatment||21
8090870|NCT03398356|19945210|P1|STARTED|Before Treatment||15
8090871|NCT03398330|19945235|P2|NOT COMPLETED|Period 2||0
8090872|NCT03398330|19945236|P1|NOT COMPLETED|Period 2||1
8090873|NCT03398330|19945235|P2|COMPLETED|Period 2||17
8090874|NCT03398330|19945236|P1|COMPLETED|Period 2||19
8090875|NCT03398330|19945235|P2|STARTED|Period 2||17
8090876|NCT03398330|19945236|P1|STARTED|Period 2||20
8090877|NCT03398330|19945235|P2|NOT COMPLETED|Period 1||4
8090878|NCT03398330|19945236|P1|NOT COMPLETED|Period 1||1
8090879|NCT03398330|19945235|P2|COMPLETED|Period 1||17
8090880|NCT03398330|19945236|P1|COMPLETED|Period 1||20
8090881|NCT03398330|19945235|P2|STARTED|Period 1||21
8090882|NCT03398330|19945236|P1|STARTED|Period 1||21
8090883|NCT03398278|19945258|P2|NOT COMPLETED|Period 2||2
8090884|NCT03398278|19945259|P1|NOT COMPLETED|Period 2||2
8090885|NCT03398278|19945258|P2|COMPLETED|Period 2||17
8090886|NCT03398278|19945259|P1|COMPLETED|Period 2||16
8090887|NCT03398278|19945258|P2|STARTED|Period 2||19
8090888|NCT03398278|19945259|P1|STARTED|Period 2||18
8090889|NCT03398278|19945258|P2|NOT COMPLETED|Period 1||0
8090890|NCT03398278|19945259|P1|NOT COMPLETED|Period 1||1
8090891|NCT03398278|19945258|P2|COMPLETED|Period 1||19
8090892|NCT03398278|19945259|P1|COMPLETED|Period 1||18
8090893|NCT03398278|19945258|P2|STARTED|Period 1||19
8090894|NCT03398278|19945259|P1|STARTED|Period 1||19
8090895|NCT03398213|19945282|P3|NOT COMPLETED|Overall Study||0
8090896|NCT03398213|19945283|P2|NOT COMPLETED|Overall Study||0
8090897|NCT03398213|19945284|P1|NOT COMPLETED|Overall Study||0
8090898|NCT03398213|19945282|P3|COMPLETED|Overall Study||22
8090899|NCT03398213|19945283|P2|COMPLETED|Overall Study||24
8090900|NCT03398213|19945284|P1|COMPLETED|Overall Study||26
8090901|NCT03398213|19945282|P3|STARTED|Overall Study||22
8090902|NCT03398213|19945283|P2|STARTED|Overall Study||24
8090903|NCT03398213|19945284|P1|STARTED|Overall Study||26
8090904|NCT03397771|19945315|P2|NOT COMPLETED|Overall Study||7
8090905|NCT03397771|19945316|P1|NOT COMPLETED|Overall Study||8
8090906|NCT03397771|19945315|P2|COMPLETED|Overall Study||22
8090907|NCT03397771|19945316|P1|COMPLETED|Overall Study||45
8090908|NCT03397771|19945315|P2|STARTED|Overall Study||29
8090909|NCT03397771|19945316|P1|STARTED|Overall Study||53
8090910|NCT03397394|19945327|P3|NOT COMPLETED|Overall Study||0
8090911|NCT03397394|19945328|P2|NOT COMPLETED|Overall Study||0
8090912|NCT03397394|19945329|P1|NOT COMPLETED|Overall Study||0
8090913|NCT03397394|19945327|P3|COMPLETED|Overall Study||20
8090914|NCT03397394|19945328|P2|COMPLETED|Overall Study||30
8090915|NCT03397394|19945329|P1|COMPLETED|Overall Study||47
8090916|NCT03397394|19945327|P3|STARTED|Overall Study||20
8090917|NCT03397394|19945328|P2|STARTED|Overall Study||30
8090918|NCT03397394|19945329|P1|STARTED|Overall Study||47
8090919|NCT03397121|19945353|P2|NOT COMPLETED|Overall Study||9
8090920|NCT03397121|19945354|P1|NOT COMPLETED|Overall Study||7
8090921|NCT03397121|19945353|P2|COMPLETED|Overall Study||231
8090922|NCT03397121|19945354|P1|COMPLETED|Overall Study||235
8090923|NCT03397121|19945353|P2|STARTED|Overall Study||240
8090924|NCT03397121|19945354|P1|STARTED|Overall Study||242
8090925|NCT03396913|19945376|P2|NOT COMPLETED|Overall Study||6
8090926|NCT03396913|19945377|P1|NOT COMPLETED|Overall Study||0
8090927|NCT03396913|19945376|P2|COMPLETED|Overall Study||39
8090928|NCT03396913|19945377|P1|COMPLETED|Overall Study||43
8090929|NCT03396913|19945376|P2|STARTED|Overall Study||45
8090930|NCT03396913|19945377|P1|STARTED|Overall Study||43
8090931|NCT03396835|19945387|P1|NOT COMPLETED|Overall Study||2
8090932|NCT03396835|19945387|P1|COMPLETED|Overall Study||14
8090933|NCT03396835|19945387|P1|STARTED|Overall Study||16
8090940|NCT03395990|19945402|P2|NOT COMPLETED|Overall Study||0
8090941|NCT03395990|19945403|P1|NOT COMPLETED|Overall Study||0
8090942|NCT03395990|19945402|P2|COMPLETED|Overall Study||8
8090943|NCT03395990|19945403|P1|COMPLETED|Overall Study||8
8090944|NCT03395990|19945402|P2|STARTED|Overall Study||8
8090945|NCT03395990|19945403|P1|STARTED|Overall Study||8
8090946|NCT03395886|19945411|P2|NOT COMPLETED|Overall Study||38
8090947|NCT03395886|19945412|P1|NOT COMPLETED|Overall Study||52
8090948|NCT03395886|19945411|P2|COMPLETED|Overall Study||0
8090949|NCT03395886|19945412|P1|COMPLETED|Overall Study||0
8090950|NCT03395886|19945411|P2|STARTED|Overall Study||38
8090951|NCT03395886|19945412|P1|STARTED|Overall Study||52
8090952|NCT03394508|19945422|P2|NOT COMPLETED|Overall Study||3
8090953|NCT03394508|19945423|P1|NOT COMPLETED|Overall Study||1
8090954|NCT03394508|19945422|P2|COMPLETED|Overall Study||14
8090955|NCT03394508|19945423|P1|COMPLETED|Overall Study||12
8090956|NCT03394508|19945422|P2|STARTED|Overall Study||17
8090957|NCT03394508|19945423|P1|STARTED|Overall Study||13
8090958|NCT03394391|19945449|P2|NOT COMPLETED|Overall Study||2
8090959|NCT03394391|19945450|P1|NOT COMPLETED|Overall Study||1
8090960|NCT03394391|19945449|P2|COMPLETED|Overall Study||104
8090961|NCT03394391|19945450|P1|COMPLETED|Overall Study||105
8090962|NCT03394391|19945449|P2|STARTED|Overall Study||106
8090963|NCT03394391|19945450|P1|STARTED|Overall Study||106
8090964|NCT03393806|19945468|P2|NOT COMPLETED|Overall Study||0
8090965|NCT03393806|19945469|P1|NOT COMPLETED|Overall Study||1
8090966|NCT03393806|19945468|P2|COMPLETED|Overall Study||8
8090967|NCT03393806|19945469|P1|COMPLETED|Overall Study||8
8090968|NCT03393806|19945468|P2|STARTED|Overall Study||8
8090969|NCT03393806|19945469|P1|STARTED|Overall Study||9
8090970|NCT03393754|19945514|P2|NOT COMPLETED|Overall Study||38
8090971|NCT03393754|19945515|P1|NOT COMPLETED|Overall Study||26
8090972|NCT03393754|19945514|P2|COMPLETED|Overall Study||758
8090973|NCT03393754|19945515|P1|COMPLETED|Overall Study||785
8090974|NCT03393754|19945514|P2|STARTED|Overall Study||796
8090975|NCT03393754|19945515|P1|STARTED|Overall Study||811
8090985|NCT03393208|19945545|P4|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8090986|NCT03393208|19945546|P3|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8090987|NCT03393208|19945547|P2|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8090988|NCT03393208|19945548|P1|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
8090989|NCT03393208|19945545|P4|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
8090990|NCT03393208|19945546|P3|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
8090991|NCT03393208|19945547|P2|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
8090992|NCT03393208|19945548|P1|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
8090993|NCT03393208|19945545|P4|STARTED|Treatment Period 2 (Day 8- Day 10)||9
8090994|NCT03393208|19945546|P3|STARTED|Treatment Period 2 (Day 8- Day 10)||9
8090995|NCT03393208|19945547|P2|STARTED|Treatment Period 2 (Day 8- Day 10)||13
8090996|NCT03393208|19945548|P1|STARTED|Treatment Period 2 (Day 8- Day 10)||13
8090997|NCT03393208|19945545|P4|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
8090998|NCT03393208|19945546|P3|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
8090999|NCT03393208|19945547|P2|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
8091000|NCT03393208|19945548|P1|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
8091001|NCT03393208|19945545|P4|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
8091002|NCT03393208|19945546|P3|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
8091003|NCT03393208|19945547|P2|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
8091004|NCT03393208|19945548|P1|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
8091005|NCT03393208|19945545|P4|STARTED|Treatment Period 1 (Day 1-Day 3)||9
8091006|NCT03393208|19945546|P3|STARTED|Treatment Period 1 (Day 1-Day 3)||9
8091007|NCT03393208|19945547|P2|STARTED|Treatment Period 1 (Day 1-Day 3)||13
8091008|NCT03393208|19945548|P1|STARTED|Treatment Period 1 (Day 1-Day 3)||13
8091009|NCT03392532|19945602|P2|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
8091010|NCT03392532|19945603|P1|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
8091011|NCT03392532|19945602|P2|COMPLETED|Period 2, Second 30 Minutes of Wear||18
8091012|NCT03392532|19945603|P1|COMPLETED|Period 2, Second 30 Minutes of Wear||18
8091013|NCT03392532|19945602|P2|STARTED|Period 2, Second 30 Minutes of Wear||18
8091014|NCT03392532|19945603|P1|STARTED|Period 2, Second 30 Minutes of Wear||18
8091015|NCT03392532|19945602|P2|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
8091016|NCT03392532|19945603|P1|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
8091017|NCT03392532|19945602|P2|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
8091018|NCT03392532|19945603|P1|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
8091019|NCT03392532|19945602|P2|STARTED|Period 1, FIrst 30 Minutes of Wear||18
8091020|NCT03392532|19945603|P1|STARTED|Period 1, FIrst 30 Minutes of Wear||18
8091021|NCT03392194|19945611|P2|NOT COMPLETED|Overall Study||2
8091022|NCT03392194|19945612|P1|NOT COMPLETED|Overall Study||2
8091023|NCT03392194|19945611|P2|COMPLETED|Overall Study||15
8091024|NCT03392194|19945612|P1|COMPLETED|Overall Study||14
8091025|NCT03392194|19945611|P2|STARTED|Overall Study||17
8091026|NCT03392194|19945612|P1|STARTED|Overall Study||16
8091027|NCT03391986|19945621|P3|NOT COMPLETED|Overall Study||0
8091028|NCT03391986|19945622|P2|NOT COMPLETED|Overall Study||0
8091029|NCT03391986|19945623|P1|NOT COMPLETED|Overall Study||0
8091030|NCT03391986|19945621|P3|COMPLETED|Overall Study||50
8091031|NCT03391986|19945622|P2|COMPLETED|Overall Study||50
8091032|NCT03391986|19945623|P1|COMPLETED|Overall Study||53
8091033|NCT03391986|19945621|P3|STARTED|Overall Study||50
8091034|NCT03391986|19945622|P2|STARTED|Overall Study||50
8091035|NCT03391986|19945623|P1|STARTED|Overall Study||53
8091048|NCT03390257|19945660|P1|NOT COMPLETED|Overall Study||0
8091049|NCT03390257|19945660|P1|COMPLETED|Overall Study||14
8091050|NCT03390257|19945660|P1|STARTED|Overall Study||14
8091051|NCT03390166|19945668|P2|NOT COMPLETED|Overall Study||10
8091052|NCT03390166|19945669|P1|NOT COMPLETED|Overall Study||12
8091053|NCT03390166|19945668|P2|COMPLETED|Overall Study||305
8091054|NCT03390166|19945669|P1|COMPLETED|Overall Study||618
8091055|NCT03390166|19945668|P2|STARTED|Overall Study||315
8091056|NCT03390166|19945669|P1|STARTED|Overall Study||630
8091057|NCT03389854|19945685|P4|NOT COMPLETED|Overall Study||8
8091058|NCT03389854|19945686|P3|NOT COMPLETED|Overall Study||5
8091059|NCT03389854|19945687|P2|NOT COMPLETED|Overall Study||6
8091060|NCT03389854|19945688|P1|NOT COMPLETED|Overall Study||1
8091061|NCT03389854|19945685|P4|COMPLETED|Overall Study||19
8091062|NCT03389854|19945686|P3|COMPLETED|Overall Study||23
8091063|NCT03389854|19945687|P2|COMPLETED|Overall Study||21
8091064|NCT03389854|19945688|P1|COMPLETED|Overall Study||27
8091065|NCT03389854|19945685|P4|STARTED|Overall Study||27
8091066|NCT03389854|19945686|P3|STARTED|Overall Study||28
8091067|NCT03389854|19945687|P2|STARTED|Overall Study||27
8091068|NCT03389854|19945688|P1|STARTED|Overall Study||28
8091069|NCT03389308|19945723|P1|NOT COMPLETED|Overall Study||12
8091070|NCT03389308|19945723|P1|COMPLETED|Overall Study||39
8091071|NCT03389308|19945723|P1|STARTED|Overall Study||51
8091072|NCT03388645|19945729|P2|NOT COMPLETED|High Dose RSV A2||1
8091073|NCT03388645|19945730|P1|NOT COMPLETED|High Dose RSV A2||0
8091074|NCT03388645|19945729|P2|COMPLETED|High Dose RSV A2||7
8091075|NCT03388645|19945730|P1|COMPLETED|High Dose RSV A2||0
8091076|NCT03388645|19945729|P2|STARTED|High Dose RSV A2||8
8091077|NCT03388645|19945730|P1|STARTED|High Dose RSV A2||0
8091078|NCT03388645|19945729|P2|NOT COMPLETED|Low Dose RSV A2||0
8091079|NCT03388645|19945730|P1|NOT COMPLETED|Low Dose RSV A2||0
8091080|NCT03388645|19945729|P2|COMPLETED|Low Dose RSV A2||0
8091081|NCT03388645|19945730|P1|COMPLETED|Low Dose RSV A2||4
8091082|NCT03388645|19945729|P2|STARTED|Low Dose RSV A2||0
8091083|NCT03388645|19945730|P1|STARTED|Low Dose RSV A2||4
8091084|NCT03387683|19945748|P2|NOT COMPLETED|Overall Study||0
8091085|NCT03387683|19945749|P1|NOT COMPLETED|Overall Study||2
8091086|NCT03387683|19945748|P2|COMPLETED|Overall Study||26
8091087|NCT03387683|19945749|P1|COMPLETED|Overall Study||25
8091088|NCT03387683|19945748|P2|STARTED|Overall Study||26
8091089|NCT03387683|19945749|P1|STARTED|Overall Study||27
8091090|NCT03387462|19945757|P1|NOT COMPLETED|Overall Study||1
8091091|NCT03387462|19945757|P1|COMPLETED|Overall Study||19
8091092|NCT03387462|19945757|P1|8 Weeks|Overall Study||19
8091093|NCT03387462|19945757|P1|4 Weeks|Overall Study||20
8091094|NCT03387462|19945757|P1|STARTED|Overall Study||20
8091095|NCT03387319|19945766|P2|NOT COMPLETED|Overall Study||0
8091096|NCT03387319|19945767|P1|NOT COMPLETED|Overall Study||0
8091097|NCT03387319|19945766|P2|COMPLETED|Overall Study||25
8091098|NCT03387319|19945767|P1|COMPLETED|Overall Study||25
8091099|NCT03387319|19945766|P2|STARTED|Overall Study||25
8091100|NCT03387319|19945767|P1|STARTED|Overall Study||25
8091101|NCT03387059|19945787|P2|NOT COMPLETED|Overall Study||4
8091102|NCT03387059|19945788|P1|NOT COMPLETED|Overall Study||5
8091103|NCT03387059|19945787|P2|COMPLETED|Overall Study||0
8091104|NCT03387059|19945788|P1|COMPLETED|Overall Study||0
8091105|NCT03387059|19945787|P2|STARTED|Overall Study||4
8091106|NCT03387059|19945788|P1|STARTED|Overall Study||5
8091107|NCT03387046|19945802|P2|NOT COMPLETED|Overall Study||1
8091108|NCT03387046|19945803|P1|NOT COMPLETED|Overall Study||1
8091109|NCT03387046|19945802|P2|COMPLETED|Overall Study||1
8091110|NCT03387046|19945803|P1|COMPLETED|Overall Study||4
8091111|NCT03387046|19945802|P2|STARTED|Overall Study||2
8091112|NCT03387046|19945803|P1|STARTED|Overall Study||5
8091113|NCT03386994|19945830|P1|NOT COMPLETED|Overall Study||38
8091114|NCT03386994|19945830|P1|COMPLETED|Overall Study||166
8091115|NCT03386994|19945830|P1|STARTED|Overall Study||204
8091116|NCT03386474|19945890|P2|NOT COMPLETED|Overall Study||1
8091117|NCT03386474|19945891|P1|NOT COMPLETED|Overall Study||1
8091118|NCT03386474|19945890|P2|COMPLETED|Overall Study||42
8091119|NCT03386474|19945891|P1|COMPLETED|Overall Study||106
8091120|NCT03386474|19945890|P2|STARTED|Overall Study||43
8091121|NCT03386474|19945891|P1|STARTED|Overall Study||107
8091122|NCT03386448|19945913|P2|NOT COMPLETED|Overall Study||2
8091123|NCT03386448|19945914|P1|NOT COMPLETED|Overall Study||0
8091124|NCT03386448|19945913|P2|COMPLETED|Overall Study||6
8091125|NCT03386448|19945914|P1|COMPLETED|Overall Study||6
8091126|NCT03386448|19945913|P2|STARTED|Overall Study||8
8091127|NCT03386448|19945914|P1|STARTED|Overall Study||6
8091128|NCT03386435|19945922|P2|NOT COMPLETED|Overall Study||7
8091129|NCT03386435|19945923|P1|NOT COMPLETED|Overall Study||5
8091130|NCT03386435|19945922|P2|COMPLETED|Overall Study||73
8091131|NCT03386435|19945923|P1|COMPLETED|Overall Study||75
8091132|NCT03386435|19945922|P2|STARTED|Overall Study||80
8091133|NCT03386435|19945923|P1|STARTED|Overall Study||80
8091134|NCT03386032|19945938|P3|NOT COMPLETED|Overall Study||0
8091135|NCT03386032|19945939|P2|NOT COMPLETED|Overall Study||7
8091136|NCT03386032|19945940|P1|NOT COMPLETED|Overall Study||18
8091137|NCT03386032|19945938|P3|COMPLETED|Overall Study||11
8091138|NCT03386032|19945939|P2|COMPLETED|Overall Study||11
8091139|NCT03386032|19945940|P1|COMPLETED|Overall Study||18
8091140|NCT03386032|19945938|P3|STARTED|Overall Study||11
8091141|NCT03386032|19945939|P2|STARTED|Overall Study||18
8091142|NCT03386032|19945940|P1|STARTED|Overall Study||36
8091143|NCT03384953|19945953|P2|NOT COMPLETED|Overall Study||8
8091144|NCT03384953|19945954|P1|NOT COMPLETED|Overall Study||40
8091145|NCT03384953|19945953|P2|COMPLETED|Overall Study||4
8091146|NCT03384953|19945954|P1|COMPLETED|Overall Study||51
8091147|NCT03384953|19945953|P2|Completed Treatment|Overall Study||6
8091148|NCT03384953|19945954|P1|Completed Treatment|Overall Study||68
8091149|NCT03384953|19945953|P2|STARTED|Overall Study||12
8091150|NCT03384953|19945954|P1|STARTED|Overall Study||91
8091151|NCT03384329|19945962|P2|NOT COMPLETED|Overall Study||0
8091152|NCT03384329|19945963|P1|NOT COMPLETED|Overall Study||0
8091153|NCT03384329|19945962|P2|COMPLETED|Overall Study||11
8091154|NCT03384329|19945963|P1|COMPLETED|Overall Study||11
8091155|NCT03384329|19945962|P2|STARTED|Overall Study||11
8091156|NCT03384329|19945963|P1|STARTED|Overall Study||11
8091157|NCT03384316|19945975|P2|NOT COMPLETED|Overall Study||1
8091158|NCT03384316|19945976|P1|NOT COMPLETED|Overall Study||0
8091159|NCT03384316|19945975|P2|COMPLETED|Overall Study||4
8091160|NCT03384316|19945976|P1|COMPLETED|Overall Study||6
8091161|NCT03384316|19945975|P2|STARTED|Overall Study||5
8091162|NCT03384316|19945976|P1|STARTED|Overall Study||6
8091163|NCT03384173|19946001|P1|NOT COMPLETED|Overall Study||0
8091164|NCT03384173|19946001|P1|COMPLETED|Overall Study||35
8091165|NCT03384173|19946001|P1|STARTED|Overall Study||35
8091166|NCT03383887|19946015|P2|NOT COMPLETED|Overall Study||1
8091167|NCT03383887|19946016|P1|NOT COMPLETED|Overall Study||0
8091168|NCT03383887|19946015|P2|COMPLETED|Overall Study||5
8091169|NCT03383887|19946016|P1|COMPLETED|Overall Study||5
8091170|NCT03383887|19946015|P2|STARTED|Overall Study||6
8091171|NCT03383887|19946016|P1|STARTED|Overall Study||5
8091172|NCT03383783|19946024|P1|NOT COMPLETED|Overall Study||2
8091173|NCT03383783|19946024|P1|COMPLETED|Overall Study||25
8091174|NCT03383783|19946024|P1|STARTED|Overall Study||27
8091175|NCT03383757|19946088|P1|NOT COMPLETED|Overall Study||39
8091176|NCT03383757|19946088|P1|COMPLETED|Overall Study||78
8091177|NCT03383757|19946088|P1|TruSignal Sensitive Sensor Data Pairs|Overall Study||51
8091178|NCT03383757|19946088|P1|TruSignal AllFit Sensor Data Pairs|Overall Study||52
8091179|NCT03383757|19946088|P1|TruSignal Sensitive Sensor Subjects|Overall Study||59
8091180|NCT03383757|19946088|P1|TruSignal AllFit Sensor Subjects|Overall Study||56
8091181|NCT03383757|19946088|P1|STARTED|Overall Study||117
8091185|NCT03383614|19946108|P4|NOT COMPLETED|Overall Study||0
8091186|NCT03383614|19946109|P3|NOT COMPLETED|Overall Study||0
8091187|NCT03383614|19946110|P2|NOT COMPLETED|Overall Study||1
8091188|NCT03383614|19946111|P1|NOT COMPLETED|Overall Study||0
8091189|NCT03383614|19946108|P4|COMPLETED|Overall Study||6
8091190|NCT03383614|19946109|P3|COMPLETED|Overall Study||6
8091191|NCT03383614|19946110|P2|COMPLETED|Overall Study||5
8091192|NCT03383614|19946111|P1|COMPLETED|Overall Study||6
8091193|NCT03383614|19946108|P4|STARTED|Overall Study||6
8091194|NCT03383614|19946109|P3|STARTED|Overall Study||6
8091195|NCT03383614|19946110|P2|STARTED|Overall Study||6
8091196|NCT03383614|19946111|P1|STARTED|Overall Study||6
8091197|NCT03383588|19946278|P3|NOT COMPLETED|Overall Study||0
8091198|NCT03383588|19946279|P2|NOT COMPLETED|Overall Study||0
8091199|NCT03383588|19946280|P1|NOT COMPLETED|Overall Study||0
8091200|NCT03383588|19946278|P3|COMPLETED|Overall Study||9
8091201|NCT03383588|19946279|P2|COMPLETED|Overall Study||9
8091202|NCT03383588|19946280|P1|COMPLETED|Overall Study||8
8091203|NCT03383588|19946278|P3|STARTED|Overall Study||9
8091204|NCT03383588|19946279|P2|STARTED|Overall Study||9
8091205|NCT03383588|19946280|P1|STARTED|Overall Study||8
8091206|NCT03383523|19946295|P7|NOT COMPLETED|Overall Study||0
8091207|NCT03383523|19946296|P6|NOT COMPLETED|Overall Study||0
8091208|NCT03383523|19946297|P5|NOT COMPLETED|Overall Study||0
8091209|NCT03383523|19946298|P4|NOT COMPLETED|Overall Study||0
8091210|NCT03383523|19946299|P3|NOT COMPLETED|Overall Study||1
8091211|NCT03383523|19946300|P2|NOT COMPLETED|Overall Study||0
8091212|NCT03383523|19946301|P1|NOT COMPLETED|Overall Study||1
8091213|NCT03383523|19946295|P7|COMPLETED|Overall Study||10
8091214|NCT03383523|19946296|P6|COMPLETED|Overall Study||12
8091215|NCT03383523|19946297|P5|COMPLETED|Overall Study||11
8091216|NCT03383523|19946298|P4|COMPLETED|Overall Study||12
8091217|NCT03383523|19946299|P3|COMPLETED|Overall Study||9
8091218|NCT03383523|19946300|P2|COMPLETED|Overall Study||11
8091219|NCT03383523|19946301|P1|COMPLETED|Overall Study||10
8091220|NCT03383523|19946295|P7|STARTED|Overall Study||10
8091221|NCT03383523|19946296|P6|STARTED|Overall Study||12
8091222|NCT03383523|19946297|P5|STARTED|Overall Study||11
8091223|NCT03383523|19946298|P4|STARTED|Overall Study||12
8091224|NCT03383523|19946299|P3|STARTED|Overall Study||10
8091225|NCT03383523|19946300|P2|STARTED|Overall Study||11
8091226|NCT03383523|19946301|P1|STARTED|Overall Study||11
8091227|NCT03383198|19946368|P2|NOT COMPLETED|Overall Study||0
8091228|NCT03383198|19946369|P1|NOT COMPLETED|Overall Study||0
8091229|NCT03383198|19946368|P2|COMPLETED|Overall Study||1
8091230|NCT03383198|19946369|P1|COMPLETED|Overall Study||4
8091231|NCT03383198|19946368|P2|STARTED|Overall Study||1
8091232|NCT03383198|19946369|P1|STARTED|Overall Study||4
8091233|NCT03382912|19946379|P2|NOT COMPLETED|Overall Study||12
8091234|NCT03382912|19946380|P1|NOT COMPLETED|Overall Study||6
8091235|NCT03382912|19946379|P2|COMPLETED|Overall Study||13
8091236|NCT03382912|19946380|P1|COMPLETED|Overall Study||21
8091237|NCT03382912|19946379|P2|Received at Least 1 Dose of Study Drug|Overall Study||24
8091238|NCT03382912|19946380|P1|Received at Least 1 Dose of Study Drug|Overall Study||27
8091239|NCT03382912|19946379|P2|STARTED|Overall Study||25
8091240|NCT03382912|19946380|P1|STARTED|Overall Study||27
8091241|NCT03382899|19946396|P2|NOT COMPLETED|Overall Study||35
8091242|NCT03382899|19946397|P1|NOT COMPLETED|Overall Study||31
8091243|NCT03382899|19946396|P2|COMPLETED|Overall Study||15
8091244|NCT03382899|19946397|P1|COMPLETED|Overall Study||20
8091245|NCT03382899|19946396|P2|Received at Least 1 Dose of Study Drug|Overall Study||48
8091246|NCT03382899|19946397|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
8091247|NCT03382899|19946396|P2|STARTED|Overall Study||50
8091248|NCT03382899|19946397|P1|STARTED|Overall Study||51
8091255|NCT03382665|19946426|P1|NOT COMPLETED|Overall Study||45
8091256|NCT03382665|19946426|P1|COMPLETED|Overall Study||25
8091257|NCT03382665|19946426|P1|5 Year Follow up|Overall Study||25
8091258|NCT03382665|19946426|P1|Actual Enrollment|Overall Study||59
8091259|NCT03382665|19946426|P1|STARTED|Overall Study||70
8091260|NCT03382262|19946438|P4|NOT COMPLETED|Overall Study||1
8091261|NCT03382262|19946439|P3|NOT COMPLETED|Overall Study||1
8091262|NCT03382262|19946440|P2|NOT COMPLETED|Overall Study||0
8091263|NCT03382262|19946441|P1|NOT COMPLETED|Overall Study||0
8091264|NCT03382262|19946438|P4|COMPLETED|Overall Study||14
8091265|NCT03382262|19946439|P3|COMPLETED|Overall Study||14
8091266|NCT03382262|19946440|P2|COMPLETED|Overall Study||13
8091267|NCT03382262|19946441|P1|COMPLETED|Overall Study||12
8091268|NCT03382262|19946438|P4|STARTED|Overall Study||15
8091269|NCT03382262|19946439|P3|STARTED|Overall Study||15
8091270|NCT03382262|19946440|P2|STARTED|Overall Study||13
8091271|NCT03382262|19946441|P1|STARTED|Overall Study||12
8091275|NCT03381742|19946464|P4|NOT COMPLETED|Overall Study||0
8091276|NCT03381742|19946465|P3|NOT COMPLETED|Overall Study||0
8091277|NCT03381742|19946466|P2|NOT COMPLETED|Overall Study||0
8091278|NCT03381742|19946467|P1|NOT COMPLETED|Overall Study||0
8091279|NCT03381742|19946464|P4|COMPLETED|Overall Study||506
8091280|NCT03381742|19946465|P3|COMPLETED|Overall Study||1511
8091281|NCT03381742|19946466|P2|COMPLETED|Overall Study||501
8091282|NCT03381742|19946467|P1|COMPLETED|Overall Study||525
8091283|NCT03381742|19946464|P4|STARTED|Overall Study||506
8091284|NCT03381742|19946465|P3|STARTED|Overall Study||1511
8091285|NCT03381742|19946466|P2|STARTED|Overall Study||501
8091286|NCT03381742|19946467|P1|STARTED|Overall Study||525
8091287|NCT03381248|19946499|P2|NOT COMPLETED|Overall Study||6
8091288|NCT03381248|19946500|P1|NOT COMPLETED|Overall Study||13
8091289|NCT03381248|19946499|P2|COMPLETED|Overall Study||82
8091290|NCT03381248|19946500|P1|COMPLETED|Overall Study||76
8091291|NCT03381248|19946499|P2|STARTED|Overall Study||88
8091292|NCT03381248|19946500|P1|STARTED|Overall Study||89
8091293|NCT03380845|19946514|P1|NOT COMPLETED|Overall Study||0
8091294|NCT03380845|19946514|P1|COMPLETED|Overall Study||4
8091295|NCT03380845|19946514|P1|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4
8091296|NCT03380780|19946524|P1|NOT COMPLETED|Overall Study||0
8091297|NCT03380780|19946524|P1|COMPLETED|Overall Study||16
8091298|NCT03380780|19946524|P1|STARTED|Overall Study||16
8091299|NCT03380572|19946593|P2|NOT COMPLETED|Overall Study||0
8091300|NCT03380572|19946594|P1|NOT COMPLETED|Overall Study||0
8091301|NCT03380572|19946593|P2|COMPLETED|Overall Study||20
8091302|NCT03380572|19946594|P1|COMPLETED|Overall Study||20
8091303|NCT03380572|19946593|P2|STARTED|Overall Study||20
8091304|NCT03380572|19946594|P1|STARTED|Overall Study||20
8091320|NCT03380390|19946664|P1|NOT COMPLETED|Overall Study||3
8091321|NCT03380390|19946664|P1|COMPLETED|Overall Study||43
8091322|NCT03380390|19946664|P1|STARTED|Overall Study||46
8091323|NCT03379753|19946672|P2|NOT COMPLETED|Overall Study||25
8091324|NCT03379753|19946673|P1|NOT COMPLETED|Overall Study||15
8091325|NCT03379753|19946672|P2|COMPLETED|Overall Study||46
8091326|NCT03379753|19946673|P1|COMPLETED|Overall Study||46
8091327|NCT03379753|19946672|P2|STARTED|Overall Study||71
8091328|NCT03379753|19946673|P1|STARTED|Overall Study||61
8091329|NCT03379740|19946681|P2|NOT COMPLETED|Overall Study||0
8091330|NCT03379740|19946682|P1|NOT COMPLETED|Overall Study||0
8091331|NCT03379740|19946681|P2|COMPLETED|Overall Study||7
8091332|NCT03379740|19946682|P1|COMPLETED|Overall Study||8
8091333|NCT03379740|19946681|P2|STARTED|Overall Study||7
8091334|NCT03379740|19946682|P1|STARTED|Overall Study||8
8091350|NCT03379376|19946822|P1|NOT COMPLETED|Overall Study||5
8091351|NCT03379376|19946822|P1|COMPLETED|Overall Study||5
8091352|NCT03379376|19946822|P1|STARTED|Overall Study||10
8091353|NCT03379233|19946832|P2|NOT COMPLETED|Overall Study||6
8091354|NCT03379233|19946833|P1|NOT COMPLETED|Overall Study||1
8091355|NCT03379233|19946832|P2|COMPLETED|Overall Study||0
8091356|NCT03379233|19946833|P1|COMPLETED|Overall Study||0
8091357|NCT03379233|19946832|P2|STARTED|Overall Study||6
8091358|NCT03379233|19946833|P1|STARTED|Overall Study||1
8091359|NCT03378973|19946847|P2|NOT COMPLETED|Overall Study||0
8091360|NCT03378973|19946848|P1|NOT COMPLETED|Overall Study||0
8091361|NCT03378973|19946847|P2|COMPLETED|Overall Study||3
8091362|NCT03378973|19946848|P1|COMPLETED|Overall Study||4
8091363|NCT03378973|19946847|P2|STARTED|Overall Study||3
8091364|NCT03378973|19946848|P1|STARTED|Overall Study||4
8091365|NCT03378076|19946856|P2|NOT COMPLETED|Overall Study||0
8091366|NCT03378076|19946857|P1|NOT COMPLETED|Overall Study||0
8091367|NCT03378076|19946856|P2|COMPLETED|Overall Study||12
8091368|NCT03378076|19946857|P1|COMPLETED|Overall Study||12
8091369|NCT03378076|19946856|P2|STARTED|Overall Study||12
8091370|NCT03378076|19946857|P1|STARTED|Overall Study||12
8091371|NCT03377634|19946867|P2|NOT COMPLETED|Study Period||0
8091372|NCT03377634|19946868|P1|NOT COMPLETED|Study Period||2
8091373|NCT03377634|19946867|P2|COMPLETED|Study Period||13
8091374|NCT03377634|19946868|P1|COMPLETED|Study Period||13
8091375|NCT03377634|19946867|P2|STARTED|Study Period||13
8091376|NCT03377634|19946868|P1|STARTED|Study Period||15
8091377|NCT03377634|19946867|P2|NOT COMPLETED|Intervention Usability Testing Period||0
8091378|NCT03377634|19946868|P1|NOT COMPLETED|Intervention Usability Testing Period||0
8091379|NCT03377634|19946867|P2|COMPLETED|Intervention Usability Testing Period||0
8091380|NCT03377634|19946868|P1|COMPLETED|Intervention Usability Testing Period||5
8091381|NCT03377634|19946867|P2|STARTED|Intervention Usability Testing Period||0
8091382|NCT03377634|19946868|P1|STARTED|Intervention Usability Testing Period||5
8091383|NCT03376516|19946890|P1|NOT COMPLETED|Overall Study||2
8091384|NCT03376516|19946890|P1|COMPLETED|Overall Study||9
8091385|NCT03376516|19946890|P1|SURG Population|Overall Study||2
8091386|NCT03376516|19946890|P1|PP Population|Overall Study||9
8091387|NCT03376516|19946890|P1|PK Population|Overall Study||10
8091388|NCT03376516|19946890|P1|FAS Population|Overall Study||10
8091389|NCT03376516|19946890|P1|SAF Population|Overall Study||10
8091390|NCT03376516|19946890|P1|Received Treatment|Overall Study||10
8091391|NCT03376516|19946890|P1|STARTED|Overall Study||11
8091392|NCT03376295|19946922|P2|NOT COMPLETED|Overall Study||0
8091393|NCT03376295|19946923|P1|NOT COMPLETED|Overall Study||0
8091394|NCT03376295|19946922|P2|COMPLETED|Overall Study||1977
8091395|NCT03376295|19946923|P1|COMPLETED|Overall Study||1977
8091396|NCT03376295|19946922|P2|STARTED|Overall Study||1977
8091397|NCT03376295|19946923|P1|STARTED|Overall Study||1977
8091398|NCT03376256|19946935|P2|NOT COMPLETED|Overall Study||0
8091399|NCT03376256|19946936|P1|NOT COMPLETED|Overall Study||0
8091400|NCT03376256|19946935|P2|COMPLETED|Overall Study||0
8091401|NCT03376256|19946936|P1|COMPLETED|Overall Study||2
8091402|NCT03376256|19946935|P2|STARTED|Overall Study||0
8091403|NCT03376256|19946936|P1|STARTED|Overall Study||2
8091410|NCT03375294|19946965|P1|NOT COMPLETED|Overall Study||0
8091411|NCT03375294|19946965|P1|COMPLETED|Overall Study||3
8091412|NCT03375294|19946965|P1|STARTED|Overall Study||3
8091413|NCT03374995|19946971|P2|NOT COMPLETED|Overall Study||1
8091414|NCT03374995|19946972|P1|NOT COMPLETED|Overall Study||0
8091415|NCT03374995|19946971|P2|COMPLETED|Overall Study||11
8091416|NCT03374995|19946972|P1|COMPLETED|Overall Study||13
8091417|NCT03374995|19946971|P2|STARTED|Overall Study||12
8091418|NCT03374995|19946972|P1|STARTED|Overall Study||13
8091419|NCT03374488|19946986|P2|NOT COMPLETED|Overall Study||37
8091420|NCT03374488|19946987|P1|NOT COMPLETED|Overall Study||41
8091421|NCT03374488|19946986|P2|COMPLETED|Overall Study||5
8091422|NCT03374488|19946987|P1|COMPLETED|Overall Study||1
8091423|NCT03374488|19946986|P2|All Participants as Treated (APaT)|Overall Study||41
8091424|NCT03374488|19946987|P1|All Participants as Treated (APaT)|Overall Study||42
8091425|NCT03374488|19946986|P2|Intention-to-Treat (ITT)|Overall Study||42
8091426|NCT03374488|19946987|P1|Intention-to-Treat (ITT)|Overall Study||42
8091427|NCT03374488|19946986|P2|STARTED|Overall Study||42
8091428|NCT03374488|19946987|P1|STARTED|Overall Study||42
8091429|NCT03374189|19946999|P2|NOT COMPLETED|Overall Study||0
8091430|NCT03374189|19947000|P1|NOT COMPLETED|Overall Study||1
8091431|NCT03374189|19946999|P2|COMPLETED|Overall Study||39
8091432|NCT03374189|19947000|P1|COMPLETED|Overall Study||39
8091433|NCT03374189|19946999|P2|STARTED|Overall Study||39
8091434|NCT03374189|19947000|P1|STARTED|Overall Study||40
8091435|NCT03374176|19947020|P2|NOT COMPLETED|Overall Study||0
8091436|NCT03374176|19947021|P1|NOT COMPLETED|Overall Study||0
8091437|NCT03374176|19947020|P2|COMPLETED|Overall Study||21
8091438|NCT03374176|19947021|P1|COMPLETED|Overall Study||21
8091439|NCT03374176|19947020|P2|STARTED|Overall Study||21
8091440|NCT03374176|19947021|P1|STARTED|Overall Study||21
8091441|NCT03373890|19947035|P2|NOT COMPLETED|Overall Study||0
8091442|NCT03373890|19947036|P1|NOT COMPLETED|Overall Study||0
8091443|NCT03373890|19947035|P2|COMPLETED|Overall Study||6
8091444|NCT03373890|19947036|P1|COMPLETED|Overall Study||6
8091445|NCT03373890|19947035|P2|STARTED|Overall Study||6
8091446|NCT03373890|19947036|P1|STARTED|Overall Study||6
8091447|NCT03373591|19947059|P3|NOT COMPLETED|Overall Study||0
8091448|NCT03373591|19947060|P2|NOT COMPLETED|Overall Study||0
8091449|NCT03373591|19947061|P1|NOT COMPLETED|Overall Study||0
8091450|NCT03373591|19947059|P3|COMPLETED|Overall Study||73
8091451|NCT03373591|19947060|P2|COMPLETED|Overall Study||71
8091452|NCT03373591|19947061|P1|COMPLETED|Overall Study||75
8091453|NCT03373591|19947059|P3|STARTED|Overall Study||73
8091454|NCT03373591|19947060|P2|STARTED|Overall Study||71
8091455|NCT03373591|19947061|P1|STARTED|Overall Study||75
8091456|NCT03373240|19947092|P2|NOT COMPLETED|Overall Study||4
8091457|NCT03373240|19947093|P1|NOT COMPLETED|Overall Study||11
8091458|NCT03373240|19947092|P2|COMPLETED|Overall Study|This is the 1-month post follow-up|20
8091459|NCT03373240|19947093|P1|COMPLETED|Overall Study|This is the 1-month post follow-up|11
8091460|NCT03373240|19947092|P2|4-week Post Treatment|Overall Study||23
8091461|NCT03373240|19947093|P1|4-week Post Treatment|Overall Study||14
8091462|NCT03373240|19947092|P2|STARTED|Overall Study||24
8091463|NCT03373240|19947093|P1|STARTED|Overall Study||22
8091464|NCT03373162|19947117|P1|NOT COMPLETED|Overall Study||0
8091465|NCT03373162|19947117|P1|COMPLETED|Overall Study||10
8091466|NCT03373162|19947117|P1|STARTED|Overall Study||10
8091467|NCT03373006|19947123|P1|NOT COMPLETED|Overall Study||0
8091468|NCT03373006|19947123|P1|COMPLETED|Overall Study||20
8091469|NCT03373006|19947123|P1|STARTED|Overall Study||20
8091470|NCT03372928|19947127|P2|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
8091471|NCT03372928|19947128|P1|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
8091472|NCT03372928|19947127|P2|COMPLETED|Second Intervention (5 d Energy Deficit)||9
8091473|NCT03372928|19947128|P1|COMPLETED|Second Intervention (5 d Energy Deficit)||10
8091474|NCT03372928|19947127|P2|STARTED|Second Intervention (5 d Energy Deficit)||9
8091475|NCT03372928|19947128|P1|STARTED|Second Intervention (5 d Energy Deficit)||10
8091476|NCT03372928|19947127|P2|NOT COMPLETED|Washout (14 d)||1
8091477|NCT03372928|19947128|P1|NOT COMPLETED|Washout (14 d)||0
8091478|NCT03372928|19947127|P2|COMPLETED|Washout (14 d)||9
8091479|NCT03372928|19947128|P1|COMPLETED|Washout (14 d)||10
8091480|NCT03372928|19947127|P2|STARTED|Washout (14 d)||10
8091481|NCT03372928|19947128|P1|STARTED|Washout (14 d)||10
8091482|NCT03372928|19947127|P2|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
8091483|NCT03372928|19947128|P1|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
8091484|NCT03372928|19947127|P2|COMPLETED|First Intervention (5 d Energy Deficit)||10
8091485|NCT03372928|19947128|P1|COMPLETED|First Intervention (5 d Energy Deficit)||10
8091486|NCT03372928|19947127|P2|STARTED|First Intervention (5 d Energy Deficit)||10
8091487|NCT03372928|19947128|P1|STARTED|First Intervention (5 d Energy Deficit)||10
8091488|NCT03372603|19947140|P2|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0
8091489|NCT03372603|19947141|P1|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1
8091490|NCT03372603|19947140|P2|COMPLETED|Treatment Period 2 (Up to 7 Days)||8
8091491|NCT03372603|19947141|P1|COMPLETED|Treatment Period 2 (Up to 7 Days)||7
8091492|NCT03372603|19947140|P2|STARTED|Treatment Period 2 (Up to 7 Days)||8
8091493|NCT03372603|19947141|P1|STARTED|Treatment Period 2 (Up to 7 Days)||8
8091494|NCT03372603|19947140|P2|NOT COMPLETED|Wash-out Period (14-21 Days)||0
8091495|NCT03372603|19947141|P1|NOT COMPLETED|Wash-out Period (14-21 Days)||1
8091496|NCT03372603|19947140|P2|COMPLETED|Wash-out Period (14-21 Days)||8
8091497|NCT03372603|19947141|P1|COMPLETED|Wash-out Period (14-21 Days)||8
8091498|NCT03372603|19947140|P2|STARTED|Wash-out Period (14-21 Days)||8
8091499|NCT03372603|19947141|P1|STARTED|Wash-out Period (14-21 Days)||9
8091500|NCT03372603|19947140|P2|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
8091501|NCT03372603|19947141|P1|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
8091502|NCT03372603|19947140|P2|COMPLETED|Treatment Period 1 (Up to 7 Days)||8
8091503|NCT03372603|19947141|P1|COMPLETED|Treatment Period 1 (Up to 7 Days)||9
8091504|NCT03372603|19947140|P2|STARTED|Treatment Period 1 (Up to 7 Days)||8
8091505|NCT03372603|19947141|P1|STARTED|Treatment Period 1 (Up to 7 Days)||9
8091506|NCT03372551|19947183|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8091507|NCT03372551|19947184|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8091508|NCT03372551|19947183|P2|COMPLETED|Second Intervention (1 Week)||16
8091509|NCT03372551|19947184|P1|COMPLETED|Second Intervention (1 Week)||16
8091510|NCT03372551|19947183|P2|STARTED|Second Intervention (1 Week)||16
8091511|NCT03372551|19947184|P1|STARTED|Second Intervention (1 Week)||16
8091512|NCT03372551|19947183|P2|NOT COMPLETED|First Intervention (1 Week)||0
8091513|NCT03372551|19947184|P1|NOT COMPLETED|First Intervention (1 Week)||1
8091514|NCT03372551|19947183|P2|COMPLETED|First Intervention (1 Week)||16
8091515|NCT03372551|19947184|P1|COMPLETED|First Intervention (1 Week)||16
8091516|NCT03372551|19947183|P2|STARTED|First Intervention (1 Week)||16
8091517|NCT03372551|19947184|P1|STARTED|First Intervention (1 Week)||17
8091518|NCT03372382|19947203|P2|NOT COMPLETED|Overall Study||4
8091519|NCT03372382|19947204|P1|NOT COMPLETED|Overall Study||9
8091520|NCT03372382|19947203|P2|COMPLETED|Overall Study||81
8091521|NCT03372382|19947204|P1|COMPLETED|Overall Study||76
8091522|NCT03372382|19947203|P2|STARTED|Overall Study||85
8091523|NCT03372382|19947204|P1|STARTED|Overall Study||85
8091524|NCT03372369|19947214|P2|NOT COMPLETED|Intervention and Follow-Up Period||3
8091525|NCT03372369|19947215|P1|NOT COMPLETED|Intervention and Follow-Up Period||3
8091526|NCT03372369|19947214|P2|COMPLETED|Intervention and Follow-Up Period||470
8091527|NCT03372369|19947215|P1|COMPLETED|Intervention and Follow-Up Period||466
8091528|NCT03372369|19947214|P2|STARTED|Intervention and Follow-Up Period||473
8091529|NCT03372369|19947215|P1|STARTED|Intervention and Follow-Up Period||469
8091530|NCT03372369|19947214|P2|NOT COMPLETED|Qualification Period||22
8091531|NCT03372369|19947215|P1|NOT COMPLETED|Qualification Period||26
8091532|NCT03372369|19947214|P2|COMPLETED|Qualification Period||473
8091533|NCT03372369|19947215|P1|COMPLETED|Qualification Period||469
8091534|NCT03372369|19947214|P2|STARTED|Qualification Period||495
8091535|NCT03372369|19947215|P1|STARTED|Qualification Period||495
8091536|NCT03372083|19947227|P1|NOT COMPLETED|Overall Study||5
8091537|NCT03372083|19947227|P1|COMPLETED|Overall Study||39
8091538|NCT03372083|19947227|P1|STARTED|Overall Study||44
8091539|NCT03371459|19947259|P2|NOT COMPLETED|Period 2||0
8091540|NCT03371459|19947260|P1|NOT COMPLETED|Period 2||0
8091541|NCT03371459|19947259|P2|COMPLETED|Period 2||22
8091542|NCT03371459|19947260|P1|COMPLETED|Period 2||23
8091543|NCT03371459|19947259|P2|STARTED|Period 2||22
8091544|NCT03371459|19947260|P1|STARTED|Period 2||23
8091545|NCT03371459|19947259|P2|NOT COMPLETED|Washout||1
8091546|NCT03371459|19947260|P1|NOT COMPLETED|Washout||0
8091547|NCT03371459|19947259|P2|COMPLETED|Washout||22
8091548|NCT03371459|19947260|P1|COMPLETED|Washout||23
8091549|NCT03371459|19947259|P2|STARTED|Washout||23
8091550|NCT03371459|19947260|P1|STARTED|Washout||23
8091551|NCT03371459|19947259|P2|NOT COMPLETED|Period 1||0
8091552|NCT03371459|19947260|P1|NOT COMPLETED|Period 1||0
8091553|NCT03371459|19947259|P2|COMPLETED|Period 1||23
8091554|NCT03371459|19947260|P1|COMPLETED|Period 1||23
8091555|NCT03371459|19947259|P2|STARTED|Period 1||23
8091556|NCT03371459|19947260|P1|STARTED|Period 1||23
8091557|NCT03371381|19947268|P1|NOT COMPLETED|Overall Study||12
8091558|NCT03371381|19947268|P1|COMPLETED|Overall Study||0
8091559|NCT03371381|19947268|P1|STARTED|Overall Study||12
8091560|NCT03370770|19947280|P1|NOT COMPLETED|Overall Study||106
8091561|NCT03370770|19947280|P1|COMPLETED|Overall Study||98
8091562|NCT03370770|19947280|P1|STARTED|Overall Study||204
8091563|NCT03370536|19947285|P1|NOT COMPLETED|Overall Study||1
8091564|NCT03370536|19947285|P1|COMPLETED|Overall Study||0
8091565|NCT03370536|19947285|P1|STARTED|Overall Study||1
8091566|NCT03370419|19947294|P1|NOT COMPLETED|Overall Study||16
8091567|NCT03370419|19947294|P1|COMPLETED|Overall Study||24
8091568|NCT03370419|19947294|P1|STARTED|Overall Study||40
8091605|NCT03370289|19947406|P1|NOT COMPLETED|Overall Study||5
8091606|NCT03370289|19947406|P1|COMPLETED|Overall Study||50
8091607|NCT03370289|19947406|P1|STARTED|Overall Study||55
8091608|NCT03370042|19947425|P2|NOT COMPLETED|Overall Study||0
8091609|NCT03370042|19947426|P1|NOT COMPLETED|Overall Study||0
8091610|NCT03370042|19947425|P2|COMPLETED|Overall Study||10
8091611|NCT03370042|19947426|P1|COMPLETED|Overall Study||10
8091612|NCT03370042|19947425|P2|STARTED|Overall Study||10
8091613|NCT03370042|19947426|P1|STARTED|Overall Study||10
8091614|NCT03369951|19947440|P1|NOT COMPLETED|Overall Study||6
8091615|NCT03369951|19947440|P1|COMPLETED|Overall Study||52
8091616|NCT03369951|19947440|P1|Received Study Drug|Overall Study||57
8091617|NCT03369951|19947440|P1|STARTED|Overall Study||58
8091618|NCT03369756|19947465|P1|NOT COMPLETED|Overall Study||7
8091619|NCT03369756|19947465|P1|COMPLETED|Overall Study|36 completed 4 weeks of treatment; 40 were considered statistical completers|36
8091620|NCT03369756|19947465|P1|STARTED|Overall Study||43
8091621|NCT03369704|19947475|P2|NOT COMPLETED|Follow-up Epoch||0
8091622|NCT03369704|19947476|P1|NOT COMPLETED|Follow-up Epoch||1
8091623|NCT03369704|19947475|P2|COMPLETED|Follow-up Epoch||174
8091624|NCT03369704|19947476|P1|COMPLETED|Follow-up Epoch||160
8091625|NCT03369704|19947475|P2|STARTED|Follow-up Epoch||174
8091626|NCT03369704|19947476|P1|STARTED|Follow-up Epoch||161
8091627|NCT03369704|19947475|P2|NOT COMPLETED|Treatment Epoch||3
8091628|NCT03369704|19947476|P1|NOT COMPLETED|Treatment Epoch||4
8091629|NCT03369704|19947475|P2|COMPLETED|Treatment Epoch||172
8091630|NCT03369704|19947476|P1|COMPLETED|Treatment Epoch||158
8091631|NCT03369704|19947475|P2|STARTED|Treatment Epoch||175
8091632|NCT03369704|19947476|P1|STARTED|Treatment Epoch||162
8091633|NCT03369418|19947511|P2|NOT COMPLETED|Overall Study||3
8091634|NCT03369418|19947512|P1|NOT COMPLETED|Overall Study||3
8091635|NCT03369418|19947511|P2|COMPLETED|Overall Study||11
8091636|NCT03369418|19947512|P1|COMPLETED|Overall Study||13
8091637|NCT03369418|19947511|P2|STARTED|Overall Study||14
8091638|NCT03369418|19947512|P1|STARTED|Overall Study||16
8091639|NCT03369340|19947520|P6|NOT COMPLETED|Day 4||0
8091640|NCT03369340|19947521|P5|NOT COMPLETED|Day 4||0
8091641|NCT03369340|19947522|P4|NOT COMPLETED|Day 4||0
8091642|NCT03369340|19947523|P3|NOT COMPLETED|Day 4||0
8091643|NCT03369340|19947524|P2|NOT COMPLETED|Day 4||0
8091644|NCT03369340|19947525|P1|NOT COMPLETED|Day 4||0
8091645|NCT03369340|19947520|P6|COMPLETED|Day 4||3
8091646|NCT03369340|19947521|P5|COMPLETED|Day 4||3
8091647|NCT03369340|19947522|P4|COMPLETED|Day 4||3
8091648|NCT03369340|19947523|P3|COMPLETED|Day 4||3
8091649|NCT03369340|19947524|P2|COMPLETED|Day 4||3
8091650|NCT03369340|19947525|P1|COMPLETED|Day 4||3
8091651|NCT03369340|19947520|P6|STARTED|Day 4||3
8091652|NCT03369340|19947521|P5|STARTED|Day 4||3
8091653|NCT03369340|19947522|P4|STARTED|Day 4||3
8091654|NCT03369340|19947523|P3|STARTED|Day 4||3
8091655|NCT03369340|19947524|P2|STARTED|Day 4||3
8091656|NCT03369340|19947525|P1|STARTED|Day 4||3
8091657|NCT03369340|19947520|P6|NOT COMPLETED|Day 3||0
8091658|NCT03369340|19947521|P5|NOT COMPLETED|Day 3||0
8091659|NCT03369340|19947522|P4|NOT COMPLETED|Day 3||0
8091660|NCT03369340|19947523|P3|NOT COMPLETED|Day 3||0
8091661|NCT03369340|19947524|P2|NOT COMPLETED|Day 3||0
8091662|NCT03369340|19947525|P1|NOT COMPLETED|Day 3||0
8091663|NCT03369340|19947520|P6|COMPLETED|Day 3||3
8091664|NCT03369340|19947521|P5|COMPLETED|Day 3||3
8091665|NCT03369340|19947522|P4|COMPLETED|Day 3||3
8091666|NCT03369340|19947523|P3|COMPLETED|Day 3||3
8091667|NCT03369340|19947524|P2|COMPLETED|Day 3||3
8091668|NCT03369340|19947525|P1|COMPLETED|Day 3||3
8091669|NCT03369340|19947520|P6|STARTED|Day 3||3
8091670|NCT03369340|19947521|P5|STARTED|Day 3||3
8091671|NCT03369340|19947522|P4|STARTED|Day 3||3
8091672|NCT03369340|19947523|P3|STARTED|Day 3||3
8091673|NCT03369340|19947524|P2|STARTED|Day 3||3
8091674|NCT03369340|19947525|P1|STARTED|Day 3||3
8091675|NCT03369340|19947520|P6|NOT COMPLETED|Day 2||0
8091676|NCT03369340|19947521|P5|NOT COMPLETED|Day 2||0
8091677|NCT03369340|19947522|P4|NOT COMPLETED|Day 2||0
8091678|NCT03369340|19947523|P3|NOT COMPLETED|Day 2||0
8091679|NCT03369340|19947524|P2|NOT COMPLETED|Day 2||0
8091680|NCT03369340|19947525|P1|NOT COMPLETED|Day 2||0
8091681|NCT03369340|19947520|P6|COMPLETED|Day 2||3
8091682|NCT03369340|19947521|P5|COMPLETED|Day 2||3
8091683|NCT03369340|19947522|P4|COMPLETED|Day 2||3
8091684|NCT03369340|19947523|P3|COMPLETED|Day 2||3
8091685|NCT03369340|19947524|P2|COMPLETED|Day 2||3
8091686|NCT03369340|19947525|P1|COMPLETED|Day 2||3
8091687|NCT03369340|19947520|P6|STARTED|Day 2||3
8091688|NCT03369340|19947521|P5|STARTED|Day 2||3
8091689|NCT03369340|19947522|P4|STARTED|Day 2||3
8091690|NCT03369340|19947523|P3|STARTED|Day 2||3
8091691|NCT03369340|19947524|P2|STARTED|Day 2||3
8091692|NCT03369340|19947525|P1|STARTED|Day 2||3
8091693|NCT03369197|19947605|P2|NOT COMPLETED|Overall Study||0
8091694|NCT03369197|19947606|P1|NOT COMPLETED|Overall Study||0
8091695|NCT03369197|19947605|P2|COMPLETED|Overall Study||57
8091696|NCT03369197|19947606|P1|COMPLETED|Overall Study||53
8091697|NCT03369197|19947605|P2|STARTED|Overall Study||57
8091698|NCT03369197|19947606|P1|STARTED|Overall Study||53
8091699|NCT03369158|19947626|P2|NOT COMPLETED|Overall Study||0
8091700|NCT03369158|19947627|P1|NOT COMPLETED|Overall Study||0
8091701|NCT03369158|19947626|P2|COMPLETED|Overall Study||15
8091702|NCT03369158|19947627|P1|COMPLETED|Overall Study||14
8091703|NCT03369158|19947626|P2|STARTED|Overall Study||15
8091704|NCT03369158|19947627|P1|STARTED|Overall Study||14
8091705|NCT03368937|19947639|P1|NOT COMPLETED|Overall Study||0
8091706|NCT03368937|19947639|P1|COMPLETED|Overall Study||5
8091707|NCT03368937|19947639|P1|STARTED|Overall Study||5
8091708|NCT03368898|19947646|P3|NOT COMPLETED|Overall Study||0
8091709|NCT03368898|19947647|P2|NOT COMPLETED|Overall Study||0
8091710|NCT03368898|19947648|P1|NOT COMPLETED|Overall Study||0
8091711|NCT03368898|19947646|P3|COMPLETED|Overall Study||34
8091712|NCT03368898|19947647|P2|COMPLETED|Overall Study||33
8091713|NCT03368898|19947648|P1|COMPLETED|Overall Study||37
8091714|NCT03368898|19947646|P3|STARTED|Overall Study||34
8091715|NCT03368898|19947647|P2|STARTED|Overall Study||33
8091716|NCT03368898|19947648|P1|STARTED|Overall Study||37
8091717|NCT03368807|19947668|P1|NOT COMPLETED|Period 2 (Unblinded CGM)||0
8091718|NCT03368807|19947668|P1|COMPLETED|Period 2 (Unblinded CGM)||73
8091719|NCT03368807|19947668|P1|STARTED|Period 2 (Unblinded CGM)||73
8091720|NCT03368807|19947668|P1|NOT COMPLETED|Period 1 (Blinded CGM)||6
8091721|NCT03368807|19947668|P1|COMPLETED|Period 1 (Blinded CGM)||73
8091722|NCT03368807|19947668|P1|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78
8091723|NCT03368807|19947668|P1|STARTED|Period 1 (Blinded CGM)||79
8091724|NCT03368235|19947684|P2|NOT COMPLETED|Overall Study||0
8091725|NCT03368235|19947685|P1|NOT COMPLETED|Overall Study||0
8091726|NCT03368235|19947684|P2|COMPLETED|Overall Study||10
8091727|NCT03368235|19947685|P1|COMPLETED|Overall Study||11
8091728|NCT03368235|19947684|P2|STARTED|Overall Study||10
8091729|NCT03368235|19947685|P1|STARTED|Overall Study||11
8091730|NCT03368170|19947718|P2|NOT COMPLETED|Overall Study||1
8091731|NCT03368170|19947719|P1|NOT COMPLETED|Overall Study||2
8091732|NCT03368170|19947718|P2|COMPLETED|Overall Study||35
8091733|NCT03368170|19947719|P1|COMPLETED|Overall Study||37
8091734|NCT03368170|19947718|P2|STARTED|Overall Study||36
8091735|NCT03368170|19947719|P1|STARTED|Overall Study||39
8091736|NCT03368053|19947731|P1|NOT COMPLETED|Overall Study||0
8091737|NCT03368053|19947731|P1|COMPLETED|Overall Study||36
8091738|NCT03368053|19947731|P1|STARTED|Overall Study||36
8091739|NCT03366207|19947746|P1|NOT COMPLETED|Overall Study||8
8091740|NCT03366207|19947746|P1|COMPLETED|Overall Study||242
8091741|NCT03366207|19947746|P1|STARTED|Overall Study||250
8091742|NCT03365934|19947751|P1|NOT COMPLETED|Overall Study||2
8091743|NCT03365934|19947751|P1|COMPLETED|Overall Study||33
8091744|NCT03365934|19947751|P1|STARTED|Overall Study||35
8091745|NCT03365778|19948027|P3|NOT COMPLETED|Overall Study||0
8091746|NCT03365778|19948028|P2|NOT COMPLETED|Overall Study||0
8091747|NCT03365778|19948029|P1|NOT COMPLETED|Overall Study||0
8091748|NCT03365778|19948027|P3|COMPLETED|Overall Study||53
8091749|NCT03365778|19948028|P2|COMPLETED|Overall Study||17
8091750|NCT03365778|19948029|P1|COMPLETED|Overall Study||16
8091751|NCT03365778|19948027|P3|STARTED|Overall Study||53
8091752|NCT03365778|19948028|P2|STARTED|Overall Study||17
8091753|NCT03365778|19948029|P1|STARTED|Overall Study||16
8091754|NCT03365011|19948041|P2|NOT COMPLETED|Overall Study||2
8091755|NCT03365011|19948042|P1|NOT COMPLETED|Overall Study||1
8091756|NCT03365011|19948041|P2|COMPLETED|Overall Study||18
8091757|NCT03365011|19948042|P1|COMPLETED|Overall Study||19
8091758|NCT03365011|19948041|P2|STARTED|Overall Study||20
8091759|NCT03365011|19948042|P1|STARTED|Overall Study||20
8091760|NCT03364608|19948052|P1|NOT COMPLETED|Overall Study||8
8091761|NCT03364608|19948052|P1|COMPLETED|Overall Study||78
8091762|NCT03364608|19948052|P1|Proventil 180 µg|Overall Study||79
8091763|NCT03364608|19948052|P1|Proventil 90 µg|Overall Study||82
8091764|NCT03364608|19948052|P1|AS MDI 180 µg|Overall Study||81
8091765|NCT03364608|19948052|P1|AS MDI 90 µg|Overall Study||81
8091766|NCT03364608|19948052|P1|Placebo MDI|Overall Study||82
8091767|NCT03364608|19948052|P1|STARTED|Overall Study||86
8091768|NCT03364335|19948079|P5|NOT COMPLETED|Overall Study||11
8091769|NCT03364335|19948080|P4|NOT COMPLETED|Overall Study||13
8091770|NCT03364335|19948081|P3|NOT COMPLETED|Overall Study||11
8091771|NCT03364335|19948082|P2|NOT COMPLETED|Overall Study||11
8091772|NCT03364335|19948083|P1|NOT COMPLETED|Overall Study||10
8091773|NCT03364335|19948079|P5|COMPLETED|Overall Study||41
8091774|NCT03364335|19948080|P4|COMPLETED|Overall Study||37
8091775|NCT03364335|19948081|P3|COMPLETED|Overall Study||42
8091776|NCT03364335|19948082|P2|COMPLETED|Overall Study||40
8091777|NCT03364335|19948083|P1|COMPLETED|Overall Study||42
8091778|NCT03364335|19948079|P5|STARTED|Overall Study||52
8091779|NCT03364335|19948080|P4|STARTED|Overall Study||50
8091780|NCT03364335|19948081|P3|STARTED|Overall Study||53
8091781|NCT03364335|19948082|P2|STARTED|Overall Study||51
8091782|NCT03364335|19948083|P1|STARTED|Overall Study||52
8091783|NCT03364192|19948155|P1|NOT COMPLETED|Overall Study||16
8091784|NCT03364192|19948155|P1|COMPLETED|Overall Study||12
8091785|NCT03364192|19948155|P1|STARTED|Overall Study||28
8091786|NCT03364023|19948162|P1|NOT COMPLETED|Overall Study||17
8091787|NCT03364023|19948162|P1|COMPLETED|Overall Study||166
8091788|NCT03364023|19948162|P1|STARTED|Overall Study||183
8091789|NCT03363906|19948169|P2|NOT COMPLETED|Period 2 (Test or Reference)||1
8091790|NCT03363906|19948170|P1|NOT COMPLETED|Period 2 (Test or Reference)||4
8091791|NCT03363906|19948169|P2|COMPLETED|Period 2 (Test or Reference)||9
8091792|NCT03363906|19948170|P1|COMPLETED|Period 2 (Test or Reference)||10
8091793|NCT03363906|19948169|P2|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9
8091794|NCT03363906|19948170|P1|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12
8091795|NCT03363906|19948169|P2|STARTED|Period 2 (Test or Reference)||10
8091796|NCT03363906|19948170|P1|STARTED|Period 2 (Test or Reference)||14
8091797|NCT03363906|19948169|P2|NOT COMPLETED|Period 1 (Reference or Test)||2
8091798|NCT03363906|19948170|P1|NOT COMPLETED|Period 1 (Reference or Test)||1
8091799|NCT03363906|19948169|P2|COMPLETED|Period 1 (Reference or Test)||10
8091800|NCT03363906|19948170|P1|COMPLETED|Period 1 (Reference or Test)||14
8091801|NCT03363906|19948169|P2|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11
8091802|NCT03363906|19948170|P1|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15
8091803|NCT03363906|19948169|P2|STARTED|Period 1 (Reference or Test)||12
8091804|NCT03363906|19948170|P1|STARTED|Period 1 (Reference or Test)||15
8091877|NCT03363776|19948243|P3|NOT COMPLETED|Overall Study||2
8091878|NCT03363776|19948244|P2|NOT COMPLETED|Overall Study||3
8091879|NCT03363776|19948245|P1|NOT COMPLETED|Overall Study||3
8091880|NCT03363776|19948243|P3|COMPLETED|Overall Study||1
8091881|NCT03363776|19948244|P2|COMPLETED|Overall Study||0
8091882|NCT03363776|19948245|P1|COMPLETED|Overall Study||1
8091883|NCT03363776|19948243|P3|STARTED|Overall Study||3
8091884|NCT03363776|19948244|P2|STARTED|Overall Study||3
8091885|NCT03363776|19948245|P1|STARTED|Overall Study||4
8091886|NCT03363633|19948337|P1|NOT COMPLETED|Overall Study||12
8091887|NCT03363633|19948337|P1|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
8091888|NCT03363633|19948337|P1|STARTED|Overall Study||12
8091889|NCT03362944|19948345|P2|NOT COMPLETED|Second Intervention||0
8091890|NCT03362944|19948346|P1|NOT COMPLETED|Second Intervention||0
8091891|NCT03362944|19948345|P2|COMPLETED|Second Intervention||8
8091892|NCT03362944|19948346|P1|COMPLETED|Second Intervention||8
8091893|NCT03362944|19948345|P2|STARTED|Second Intervention||8
8091894|NCT03362944|19948346|P1|STARTED|Second Intervention||8
8091895|NCT03362944|19948345|P2|NOT COMPLETED|Single Week Washout Period||0
8091896|NCT03362944|19948346|P1|NOT COMPLETED|Single Week Washout Period||0
8091897|NCT03362944|19948345|P2|COMPLETED|Single Week Washout Period||8
8091898|NCT03362944|19948346|P1|COMPLETED|Single Week Washout Period||8
8091899|NCT03362944|19948345|P2|STARTED|Single Week Washout Period||8
8091900|NCT03362944|19948346|P1|STARTED|Single Week Washout Period||8
8091901|NCT03362944|19948345|P2|NOT COMPLETED|First Intervention||0
8091902|NCT03362944|19948346|P1|NOT COMPLETED|First Intervention||0
8091903|NCT03362944|19948345|P2|COMPLETED|First Intervention||8
8091904|NCT03362944|19948346|P1|COMPLETED|First Intervention||8
8091905|NCT03362944|19948345|P2|STARTED|First Intervention||8
8091906|NCT03362944|19948346|P1|STARTED|First Intervention||8
8091907|NCT03362879|19948362|P1|NOT COMPLETED|Overall Study||0
8091908|NCT03362879|19948362|P1|COMPLETED|Overall Study||409
8091909|NCT03362879|19948362|P1|STARTED|Overall Study||409
8091910|NCT03361917|19948380|P2|NOT COMPLETED|Overall Study||0
8091911|NCT03361917|19948381|P1|NOT COMPLETED|Overall Study||0
8091912|NCT03361917|19948380|P2|COMPLETED|Overall Study||101
8091913|NCT03361917|19948381|P1|COMPLETED|Overall Study||99
8091914|NCT03361917|19948380|P2|STARTED|Overall Study||101
8091915|NCT03361917|19948381|P1|STARTED|Overall Study||99
8091916|NCT03361865|19948399|P2|NOT COMPLETED|Overall Study||49
8091917|NCT03361865|19948400|P1|NOT COMPLETED|Overall Study||43
8091918|NCT03361865|19948399|P2|COMPLETED|Overall Study||0
8091919|NCT03361865|19948400|P1|COMPLETED|Overall Study||1
8091920|NCT03361865|19948399|P2|All Participants as Treated (APaT)|Overall Study||49
8091921|NCT03361865|19948400|P1|All Participants as Treated (APaT)|Overall Study||43
8091922|NCT03361865|19948399|P2|Intention-to-Treat (ITT)|Overall Study||49
8091923|NCT03361865|19948400|P1|Intention-to-Treat (ITT)|Overall Study||44
8091924|NCT03361865|19948399|P2|STARTED|Overall Study||49
8091925|NCT03361865|19948400|P1|STARTED|Overall Study||44
8091926|NCT03361605|19948410|P1|NOT COMPLETED|Overall Study||3
8091927|NCT03361605|19948410|P1|COMPLETED|Overall Study||26
8091928|NCT03361605|19948410|P1|STARTED|Overall Study||29
8091929|NCT03361228|19948417|P2|NOT COMPLETED|Overall Study||1
8091930|NCT03361228|19948418|P1|NOT COMPLETED|Overall Study||4
8091931|NCT03361228|19948417|P2|COMPLETED|Overall Study||0
8091932|NCT03361228|19948418|P1|COMPLETED|Overall Study||0
8091933|NCT03361228|19948417|P2|STARTED|Overall Study||1
8091934|NCT03361228|19948418|P1|STARTED|Overall Study||4
8091935|NCT03361176|19948440|P2|NOT COMPLETED|Overall Study||5
8091936|NCT03361176|19948441|P1|NOT COMPLETED|Overall Study||1
8091937|NCT03361176|19948440|P2|COMPLETED|Overall Study||15
8091938|NCT03361176|19948441|P1|COMPLETED|Overall Study||9
8091939|NCT03361176|19948440|P2|STARTED|Overall Study||20
8091940|NCT03361176|19948441|P1|STARTED|Overall Study||10
8091941|NCT03360903|19948453|P2|NOT COMPLETED|Second Intervention||0
8091942|NCT03360903|19948454|P1|NOT COMPLETED|Second Intervention||0
8091943|NCT03360903|19948453|P2|COMPLETED|Second Intervention||4
8091944|NCT03360903|19948454|P1|COMPLETED|Second Intervention||4
8091945|NCT03360903|19948453|P2|STARTED|Second Intervention||4
8091946|NCT03360903|19948454|P1|STARTED|Second Intervention||4
8091947|NCT03360903|19948453|P2|NOT COMPLETED|Washout (2 Weeks)||0
8091948|NCT03360903|19948454|P1|NOT COMPLETED|Washout (2 Weeks)||0
8091949|NCT03360903|19948453|P2|COMPLETED|Washout (2 Weeks)||4
8091950|NCT03360903|19948454|P1|COMPLETED|Washout (2 Weeks)||4
8091951|NCT03360903|19948453|P2|STARTED|Washout (2 Weeks)||4
8091952|NCT03360903|19948454|P1|STARTED|Washout (2 Weeks)||4
8091953|NCT03360903|19948453|P2|NOT COMPLETED|First Intervention||0
8091954|NCT03360903|19948454|P1|NOT COMPLETED|First Intervention||0
8091955|NCT03360903|19948453|P2|COMPLETED|First Intervention||4
8091956|NCT03360903|19948454|P1|COMPLETED|First Intervention||4
8091957|NCT03360903|19948453|P2|STARTED|First Intervention||4
8091958|NCT03360903|19948454|P1|STARTED|First Intervention||4
8091959|NCT03360747|19948472|P1|NOT COMPLETED|Overall Study||1
8091960|NCT03360747|19948472|P1|COMPLETED|Overall Study||2
8091961|NCT03360747|19948472|P1|STARTED|Overall Study||3
8091962|NCT03360344|19948488|P3|NOT COMPLETED|Overall Study||1
8091963|NCT03360344|19948489|P2|NOT COMPLETED|Overall Study||1
8091964|NCT03360344|19948490|P1|NOT COMPLETED|Overall Study||0
8091965|NCT03360344|19948488|P3|COMPLETED|Overall Study||12
8091966|NCT03360344|19948489|P2|COMPLETED|Overall Study||15
8091967|NCT03360344|19948490|P1|COMPLETED|Overall Study||15
8091968|NCT03360344|19948488|P3|STARTED|Overall Study||13
8091969|NCT03360344|19948489|P2|STARTED|Overall Study||16
8091970|NCT03360344|19948490|P1|STARTED|Overall Study||15
8091971|NCT03360110|19948510|P2|NOT COMPLETED|Second Intervention||0
8091972|NCT03360110|19948511|P1|NOT COMPLETED|Second Intervention||0
8091973|NCT03360110|19948510|P2|COMPLETED|Second Intervention||26
8091974|NCT03360110|19948511|P1|COMPLETED|Second Intervention||27
8091975|NCT03360110|19948510|P2|STARTED|Second Intervention||26
8091976|NCT03360110|19948511|P1|STARTED|Second Intervention||27
8091977|NCT03360110|19948510|P2|NOT COMPLETED|First Intervention||0
8091978|NCT03360110|19948511|P1|NOT COMPLETED|First Intervention||0
8091979|NCT03360110|19948510|P2|COMPLETED|First Intervention||26
8091980|NCT03360110|19948511|P1|COMPLETED|First Intervention||27
8091981|NCT03360110|19948510|P2|STARTED|First Intervention||26
8091982|NCT03360110|19948511|P1|STARTED|First Intervention||27
8091983|NCT03360071|19948553|P2|NOT COMPLETED|Overall Study||0
8091984|NCT03360071|19948554|P1|NOT COMPLETED|Overall Study||1
8091985|NCT03360071|19948553|P2|COMPLETED|Overall Study||14
8091986|NCT03360071|19948554|P1|COMPLETED|Overall Study||16
8091987|NCT03360071|19948553|P2|STARTED|Overall Study||14
8091988|NCT03360071|19948554|P1|STARTED|Overall Study||17
8092001|NCT03359629|19948641|P2|NOT COMPLETED|Overall Study||0
8092002|NCT03359629|19948642|P1|NOT COMPLETED|Overall Study||0
8092003|NCT03359629|19948641|P2|COMPLETED|Overall Study||10
8092004|NCT03359629|19948642|P1|COMPLETED|Overall Study||200
8092005|NCT03359629|19948641|P2|STARTED|Overall Study||10
8092006|NCT03359629|19948642|P1|STARTED|Overall Study||200
8092007|NCT03359473|19948652|P4|NOT COMPLETED|Overall Study||5
8092008|NCT03359473|19948653|P3|NOT COMPLETED|Overall Study||6
8092009|NCT03359473|19948654|P2|NOT COMPLETED|Overall Study||6
8092010|NCT03359473|19948655|P1|NOT COMPLETED|Overall Study||2
8092011|NCT03359473|19948652|P4|COMPLETED|Overall Study||20
8092012|NCT03359473|19948653|P3|COMPLETED|Overall Study||18
8092013|NCT03359473|19948654|P2|COMPLETED|Overall Study||18
8092014|NCT03359473|19948655|P1|COMPLETED|Overall Study||21
8092015|NCT03359473|19948652|P4|STARTED|Overall Study||25
8092016|NCT03359473|19948653|P3|STARTED|Overall Study||24
8092017|NCT03359473|19948654|P2|STARTED|Overall Study||24
8092018|NCT03359473|19948655|P1|STARTED|Overall Study||23
8092019|NCT03358576|19948867|P2|NOT COMPLETED|Overall Study||25
8092020|NCT03358576|19948868|P1|NOT COMPLETED|Overall Study||26
8092021|NCT03358576|19948867|P2|COMPLETED|Overall Study||311
8092022|NCT03358576|19948868|P1|COMPLETED|Overall Study||312
8092023|NCT03358576|19948867|P2|STARTED|Overall Study||336
8092024|NCT03358576|19948868|P1|STARTED|Overall Study||338
8092040|NCT03358407|19948905|P10|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092041|NCT03358407|19948906|P9|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092042|NCT03358407|19948907|P8|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092043|NCT03358407|19948908|P7|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092044|NCT03358407|19948909|P6|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092045|NCT03358407|19948910|P5|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092046|NCT03358407|19948911|P4|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092047|NCT03358407|19948912|P3|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092048|NCT03358407|19948913|P2|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092049|NCT03358407|19948914|P1|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
8092050|NCT03358407|19948905|P10|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092051|NCT03358407|19948906|P9|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092052|NCT03358407|19948907|P8|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092053|NCT03358407|19948908|P7|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092054|NCT03358407|19948909|P6|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092055|NCT03358407|19948910|P5|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092056|NCT03358407|19948911|P4|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092057|NCT03358407|19948912|P3|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092058|NCT03358407|19948913|P2|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092059|NCT03358407|19948914|P1|COMPLETED|Part B: Overall Period (11 Weeks)||0
8092060|NCT03358407|19948905|P10|STARTED|Part B: Overall Period (11 Weeks)||0
8092061|NCT03358407|19948906|P9|STARTED|Part B: Overall Period (11 Weeks)||0
8092062|NCT03358407|19948907|P8|STARTED|Part B: Overall Period (11 Weeks)||0
8092063|NCT03358407|19948908|P7|STARTED|Part B: Overall Period (11 Weeks)||0
8092064|NCT03358407|19948909|P6|STARTED|Part B: Overall Period (11 Weeks)||0
8092065|NCT03358407|19948910|P5|STARTED|Part B: Overall Period (11 Weeks)||0
8092066|NCT03358407|19948911|P4|STARTED|Part B: Overall Period (11 Weeks)||0
8092067|NCT03358407|19948912|P3|STARTED|Part B: Overall Period (11 Weeks)||0
8092068|NCT03358407|19948913|P2|STARTED|Part B: Overall Period (11 Weeks)||0
8092069|NCT03358407|19948914|P1|STARTED|Part B: Overall Period (11 Weeks)||0
8092070|NCT03358407|19948905|P10|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092071|NCT03358407|19948906|P9|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092072|NCT03358407|19948907|P8|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||6
8092073|NCT03358407|19948908|P7|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
8092074|NCT03358407|19948909|P6|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
8092075|NCT03358407|19948910|P5|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092076|NCT03358407|19948911|P4|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092077|NCT03358407|19948912|P3|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092078|NCT03358407|19948913|P2|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092079|NCT03358407|19948914|P1|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092080|NCT03358407|19948905|P10|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092081|NCT03358407|19948906|P9|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092082|NCT03358407|19948907|P8|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092083|NCT03358407|19948908|P7|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092084|NCT03358407|19948909|P6|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092085|NCT03358407|19948910|P5|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092086|NCT03358407|19948911|P4|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092087|NCT03358407|19948912|P3|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092088|NCT03358407|19948913|P2|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092089|NCT03358407|19948914|P1|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092090|NCT03358407|19948905|P10|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092091|NCT03358407|19948906|P9|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092092|NCT03358407|19948907|P8|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: GSK 200mg/GSK 400mg arm|6
8092093|NCT03358407|19948908|P7|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|1 participant was added to Part A-Cohort 2: GSK 200mg/ Placebo arm|3
8092094|NCT03358407|19948909|P6|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: Placebo/GSK 400mg arm|3
8092095|NCT03358407|19948910|P5|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092096|NCT03358407|19948911|P4|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092097|NCT03358407|19948912|P3|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092098|NCT03358407|19948913|P2|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092099|NCT03358407|19948914|P1|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
8092100|NCT03358407|19948905|P10|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092101|NCT03358407|19948906|P9|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092102|NCT03358407|19948907|P8|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
8092103|NCT03358407|19948908|P7|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||1
8092104|NCT03358407|19948909|P6|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
8092105|NCT03358407|19948910|P5|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092106|NCT03358407|19948911|P4|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092107|NCT03358407|19948912|P3|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092108|NCT03358407|19948913|P2|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092109|NCT03358407|19948914|P1|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092110|NCT03358407|19948905|P10|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092111|NCT03358407|19948906|P9|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092112|NCT03358407|19948907|P8|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
8092113|NCT03358407|19948908|P7|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||2
8092114|NCT03358407|19948909|P6|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092115|NCT03358407|19948910|P5|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092116|NCT03358407|19948911|P4|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092117|NCT03358407|19948912|P3|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092118|NCT03358407|19948913|P2|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092119|NCT03358407|19948914|P1|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092120|NCT03358407|19948905|P10|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092121|NCT03358407|19948906|P9|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092122|NCT03358407|19948907|P8|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||6
8092123|NCT03358407|19948908|P7|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
8092124|NCT03358407|19948909|P6|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
8092125|NCT03358407|19948910|P5|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092126|NCT03358407|19948911|P4|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092127|NCT03358407|19948912|P3|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092128|NCT03358407|19948913|P2|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092129|NCT03358407|19948914|P1|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
8092130|NCT03358407|19948905|P10|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092131|NCT03358407|19948906|P9|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092132|NCT03358407|19948907|P8|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092133|NCT03358407|19948908|P7|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092134|NCT03358407|19948909|P6|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092135|NCT03358407|19948910|P5|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092136|NCT03358407|19948911|P4|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092137|NCT03358407|19948912|P3|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092138|NCT03358407|19948913|P2|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092139|NCT03358407|19948914|P1|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092140|NCT03358407|19948905|P10|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092141|NCT03358407|19948906|P9|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092142|NCT03358407|19948907|P8|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092143|NCT03358407|19948908|P7|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092144|NCT03358407|19948909|P6|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092145|NCT03358407|19948910|P5|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092146|NCT03358407|19948911|P4|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092147|NCT03358407|19948912|P3|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092148|NCT03358407|19948913|P2|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092149|NCT03358407|19948914|P1|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092150|NCT03358407|19948905|P10|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092151|NCT03358407|19948906|P9|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092152|NCT03358407|19948907|P8|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092153|NCT03358407|19948908|P7|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092154|NCT03358407|19948909|P6|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
8092155|NCT03358407|19948910|P5|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/GSK 10mg/GSK 30mg/Placebo arm|2
8092156|NCT03358407|19948911|P4|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092157|NCT03358407|19948912|P3|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092158|NCT03358407|19948913|P2|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092159|NCT03358407|19948914|P1|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
8092160|NCT03358407|19948905|P10|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092161|NCT03358407|19948906|P9|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092162|NCT03358407|19948907|P8|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092163|NCT03358407|19948908|P7|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092164|NCT03358407|19948909|P6|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092165|NCT03358407|19948910|P5|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
8092166|NCT03358407|19948911|P4|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092167|NCT03358407|19948912|P3|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092168|NCT03358407|19948913|P2|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092169|NCT03358407|19948914|P1|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092170|NCT03358407|19948905|P10|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092171|NCT03358407|19948906|P9|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092172|NCT03358407|19948907|P8|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092173|NCT03358407|19948908|P7|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092174|NCT03358407|19948909|P6|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092175|NCT03358407|19948910|P5|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
8092176|NCT03358407|19948911|P4|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092177|NCT03358407|19948912|P3|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092178|NCT03358407|19948913|P2|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092179|NCT03358407|19948914|P1|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092180|NCT03358407|19948905|P10|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092181|NCT03358407|19948906|P9|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092182|NCT03358407|19948907|P8|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092183|NCT03358407|19948908|P7|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092184|NCT03358407|19948909|P6|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
8092185|NCT03358407|19948910|P5|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092186|NCT03358407|19948911|P4|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092187|NCT03358407|19948912|P3|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092188|NCT03358407|19948913|P2|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092189|NCT03358407|19948914|P1|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
8092190|NCT03358407|19948905|P10|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092191|NCT03358407|19948906|P9|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092192|NCT03358407|19948907|P8|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092193|NCT03358407|19948908|P7|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092194|NCT03358407|19948909|P6|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092195|NCT03358407|19948910|P5|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092196|NCT03358407|19948911|P4|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092197|NCT03358407|19948912|P3|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092198|NCT03358407|19948913|P2|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092199|NCT03358407|19948914|P1|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092200|NCT03358407|19948905|P10|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092201|NCT03358407|19948906|P9|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092202|NCT03358407|19948907|P8|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092203|NCT03358407|19948908|P7|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092204|NCT03358407|19948909|P6|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092205|NCT03358407|19948910|P5|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092206|NCT03358407|19948911|P4|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092207|NCT03358407|19948912|P3|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092208|NCT03358407|19948913|P2|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092209|NCT03358407|19948914|P1|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092210|NCT03358407|19948905|P10|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092211|NCT03358407|19948906|P9|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092212|NCT03358407|19948907|P8|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092213|NCT03358407|19948908|P7|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092214|NCT03358407|19948909|P6|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
8092215|NCT03358407|19948910|P5|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092216|NCT03358407|19948911|P4|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092217|NCT03358407|19948912|P3|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/Placebo/GSK 30mg/GSK 100mg arm|2
8092218|NCT03358407|19948913|P2|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092219|NCT03358407|19948914|P1|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
8092220|NCT03358407|19948905|P10|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092221|NCT03358407|19948906|P9|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092222|NCT03358407|19948907|P8|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092223|NCT03358407|19948908|P7|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092224|NCT03358407|19948909|P6|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092225|NCT03358407|19948910|P5|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092226|NCT03358407|19948911|P4|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092227|NCT03358407|19948912|P3|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
8092228|NCT03358407|19948913|P2|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092229|NCT03358407|19948914|P1|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092230|NCT03358407|19948905|P10|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092231|NCT03358407|19948906|P9|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092232|NCT03358407|19948907|P8|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092233|NCT03358407|19948908|P7|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092234|NCT03358407|19948909|P6|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092235|NCT03358407|19948910|P5|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092236|NCT03358407|19948911|P4|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092237|NCT03358407|19948912|P3|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
8092238|NCT03358407|19948913|P2|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092239|NCT03358407|19948914|P1|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092240|NCT03358407|19948905|P10|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092241|NCT03358407|19948906|P9|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092242|NCT03358407|19948907|P8|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092243|NCT03358407|19948908|P7|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092244|NCT03358407|19948909|P6|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
8092245|NCT03358407|19948910|P5|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092246|NCT03358407|19948911|P4|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092247|NCT03358407|19948912|P3|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092248|NCT03358407|19948913|P2|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092249|NCT03358407|19948914|P1|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
8092250|NCT03358407|19948905|P10|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092251|NCT03358407|19948906|P9|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092252|NCT03358407|19948907|P8|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092253|NCT03358407|19948908|P7|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092254|NCT03358407|19948909|P6|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092255|NCT03358407|19948910|P5|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092256|NCT03358407|19948911|P4|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092257|NCT03358407|19948912|P3|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092258|NCT03358407|19948913|P2|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092259|NCT03358407|19948914|P1|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092260|NCT03358407|19948905|P10|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092261|NCT03358407|19948906|P9|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092262|NCT03358407|19948907|P8|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092263|NCT03358407|19948908|P7|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092264|NCT03358407|19948909|P6|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092265|NCT03358407|19948910|P5|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092266|NCT03358407|19948911|P4|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092267|NCT03358407|19948912|P3|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092268|NCT03358407|19948913|P2|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092269|NCT03358407|19948914|P1|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092270|NCT03358407|19948905|P10|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092271|NCT03358407|19948906|P9|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092272|NCT03358407|19948907|P8|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092273|NCT03358407|19948908|P7|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092274|NCT03358407|19948909|P6|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
8092275|NCT03358407|19948910|P5|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092276|NCT03358407|19948911|P4|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092277|NCT03358407|19948912|P3|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092278|NCT03358407|19948913|P2|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092279|NCT03358407|19948914|P1|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
8092280|NCT03358355|19949176|P1|NOT COMPLETED|Overall Study||0
8092281|NCT03358355|19949176|P1|COMPLETED|Overall Study||9
8092282|NCT03358355|19949176|P1|STARTED|Overall Study||9
8092283|NCT03358329|19949191|P1|NOT COMPLETED|Overall Study||4
8092284|NCT03358329|19949191|P1|COMPLETED|Overall Study||46
8092285|NCT03358329|19949191|P1|STARTED|Overall Study||50
8092286|NCT03358251|19949197|P1|NOT COMPLETED|Overall Study||0
8092287|NCT03358251|19949197|P1|COMPLETED|Overall Study||34
8092288|NCT03358251|19949197|P1|STARTED|Overall Study||34
8092289|NCT03358238|19949222|P2|NOT COMPLETED|Overall Study||1
8092290|NCT03358238|19949223|P1|NOT COMPLETED|Overall Study||0
8092291|NCT03358238|19949222|P2|COMPLETED|Overall Study||24
8092292|NCT03358238|19949223|P1|COMPLETED|Overall Study||23
8092293|NCT03358238|19949222|P2|STARTED|Overall Study||25
8092294|NCT03358238|19949223|P1|STARTED|Overall Study||23
8092295|NCT03358147|19949243|P5|NOT COMPLETED|Overall Study||14
8092296|NCT03358147|19949244|P4|NOT COMPLETED|Overall Study||36
8092297|NCT03358147|19949245|P3|NOT COMPLETED|Overall Study||34
8092298|NCT03358147|19949246|P2|NOT COMPLETED|Overall Study||39
8092299|NCT03358147|19949247|P1|NOT COMPLETED|Overall Study||34
8092300|NCT03358147|19949243|P5|COMPLETED|Overall Study||105
8092301|NCT03358147|19949244|P4|COMPLETED|Overall Study||201
8092302|NCT03358147|19949245|P3|COMPLETED|Overall Study||206
8092303|NCT03358147|19949246|P2|COMPLETED|Overall Study||201
8092304|NCT03358147|19949247|P1|COMPLETED|Overall Study||201
8092305|NCT03358147|19949243|P5|STARTED|Overall Study||119
8092306|NCT03358147|19949244|P4|STARTED|Overall Study||237
8092307|NCT03358147|19949245|P3|STARTED|Overall Study||240
8092308|NCT03358147|19949246|P2|STARTED|Overall Study||240
8092309|NCT03358147|19949247|P1|STARTED|Overall Study||235
8092310|NCT03357731|19949284|P6|NOT COMPLETED|Overall Study||1
8092311|NCT03357731|19949285|P5|NOT COMPLETED|Overall Study||1
8092312|NCT03357731|19949286|P4|NOT COMPLETED|Overall Study||3
8092313|NCT03357731|19949287|P3|NOT COMPLETED|Overall Study||1
8092314|NCT03357731|19949288|P2|NOT COMPLETED|Overall Study||0
8092315|NCT03357731|19949289|P1|NOT COMPLETED|Overall Study||0
8092316|NCT03357731|19949284|P6|COMPLETED|Overall Study||7
8092317|NCT03357731|19949285|P5|COMPLETED|Overall Study||7
8092318|NCT03357731|19949286|P4|COMPLETED|Overall Study||4
8092319|NCT03357731|19949287|P3|COMPLETED|Overall Study|1 discontinuation due to hypotension|6
8092320|NCT03357731|19949288|P2|COMPLETED|Overall Study||7
8092321|NCT03357731|19949289|P1|COMPLETED|Overall Study||8
8092322|NCT03357731|19949284|P6|Completed Period 2 (P2)|Overall Study|1 discontinued P2 due to an Adverse Event (AE)|7
8092323|NCT03357731|19949285|P5|Completed Period 2 (P2)|Overall Study|1 only completed P1, did not continue to P2/P3 (withdrew consent due to personal reasons)|7
8092324|NCT03357731|19949286|P4|Completed Period 2 (P2)|Overall Study|"1 completed P1, did not proceed to P2/P3 (lost to follow-up);
~1 discontinued P2 due to hypotension"|4
8092325|NCT03357731|19949287|P3|Completed Period 2 (P2)|Overall Study||7
8092326|NCT03357731|19949288|P2|Completed Period 2 (P2)|Overall Study||7
8092327|NCT03357731|19949289|P1|Completed Period 2 (P2)|Overall Study||8
8092328|NCT03357731|19949284|P6|Completed Period 1 (P1)|Overall Study||8
8092329|NCT03357731|19949285|P5|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to hypotension but resumed P2/P3|7
8092330|NCT03357731|19949286|P4|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to acute bradycardia and hypotension|6
8092331|NCT03357731|19949287|P3|Completed Period 1 (P1)|Overall Study||7
8092332|NCT03357731|19949288|P2|Completed Period 1 (P1)|Overall Study||7
8092333|NCT03357731|19949289|P1|Completed Period 1 (P1)|Overall Study|1 withdrew post-P1 completion/prior to P2 therapy due to acute cholecystitis, but returned for P2/P3|8
8092334|NCT03357731|19949284|P6|STARTED|Overall Study||8
8092335|NCT03357731|19949285|P5|STARTED|Overall Study||8
8092336|NCT03357731|19949286|P4|STARTED|Overall Study||7
8092337|NCT03357731|19949287|P3|STARTED|Overall Study||7
8092338|NCT03357731|19949288|P2|STARTED|Overall Study||7
8092339|NCT03357731|19949289|P1|STARTED|Overall Study||8
8092340|NCT03357614|19949317|P2|NOT COMPLETED|Overall Study||28
8092341|NCT03357614|19949318|P1|NOT COMPLETED|Overall Study||25
8092342|NCT03357614|19949317|P2|COMPLETED|Overall Study||670
8092343|NCT03357614|19949318|P1|COMPLETED|Overall Study||672
8092344|NCT03357614|19949317|P2|STARTED|Overall Study||698
8092345|NCT03357614|19949318|P1|STARTED|Overall Study||697
8092346|NCT03357471|19949328|P2|NOT COMPLETED|Overall Study||0
8092347|NCT03357471|19949329|P1|NOT COMPLETED|Overall Study||2
8092348|NCT03357471|19949328|P2|COMPLETED|Overall Study||32
8092349|NCT03357471|19949329|P1|COMPLETED|Overall Study||33
8092350|NCT03357471|19949328|P2|STARTED|Overall Study||32
8092351|NCT03357471|19949329|P1|STARTED|Overall Study||35
8092352|NCT03357393|19949356|P3|NOT COMPLETED|Overall Study||0
8092353|NCT03357393|19949357|P2|NOT COMPLETED|Overall Study||0
8092354|NCT03357393|19949358|P1|NOT COMPLETED|Overall Study||0
8092355|NCT03357393|19949356|P3|COMPLETED|Overall Study||50
8092356|NCT03357393|19949357|P2|COMPLETED|Overall Study||50
8092357|NCT03357393|19949358|P1|COMPLETED|Overall Study||50
8092358|NCT03357393|19949356|P3|STARTED|Overall Study||50
8092359|NCT03357393|19949357|P2|STARTED|Overall Study||50
8092360|NCT03357393|19949358|P1|STARTED|Overall Study||50
8092361|NCT03357341|19949386|P2|NOT COMPLETED|Overall Study||12
8092362|NCT03357341|19949387|P1|NOT COMPLETED|Overall Study||7
8092363|NCT03357341|19949386|P2|COMPLETED|Overall Study||86
8092364|NCT03357341|19949387|P1|COMPLETED|Overall Study||89
8092365|NCT03357341|19949386|P2|STARTED|Overall Study||98
8092366|NCT03357341|19949387|P1|STARTED|Overall Study||96
8092367|NCT03356977|19949427|P1|NOT COMPLETED|Overall Study||5
8092368|NCT03356977|19949427|P1|COMPLETED|Overall Study||132
8092369|NCT03356977|19949427|P1|STARTED|Overall Study||137
8092370|NCT03355820|19949439|P1|NOT COMPLETED|Overall Study||0
8092371|NCT03355820|19949439|P1|COMPLETED|Overall Study||227
8092372|NCT03355820|19949439|P1|STARTED|Overall Study||227
8092373|NCT03354754|19949452|P2|NOT COMPLETED|Overall Study||0
8092374|NCT03354754|19949453|P1|NOT COMPLETED|Overall Study||0
8092375|NCT03354754|19949452|P2|COMPLETED|Overall Study||1
8092376|NCT03354754|19949453|P1|COMPLETED|Overall Study||2
8092377|NCT03354754|19949452|P2|STARTED|Overall Study||1
8092378|NCT03354754|19949453|P1|STARTED|Overall Study||2
8092379|NCT03354663|19949475|P1|NOT COMPLETED|Completed 30-day Visit||2
8092380|NCT03354663|19949475|P1|COMPLETED|Completed 30-day Visit||149
8092381|NCT03354663|19949475|P1|STARTED|Completed 30-day Visit||151
8092382|NCT03354663|19949475|P1|NOT COMPLETED|Enrollment to Catheter Insertion||5
8092383|NCT03354663|19949475|P1|COMPLETED|Enrollment to Catheter Insertion||151
8092384|NCT03354663|19949475|P1|STARTED|Enrollment to Catheter Insertion||156
8092385|NCT03354637|19949502|P3|NOT COMPLETED|Open Label Extension||28
8092386|NCT03354637|19949503|P2|NOT COMPLETED|Open Label Extension||0
8092387|NCT03354637|19949504|P1|NOT COMPLETED|Open Label Extension||0
8092388|NCT03354637|19949502|P3|COMPLETED|Open Label Extension||33
8092389|NCT03354637|19949503|P2|COMPLETED|Open Label Extension||0
8092390|NCT03354637|19949504|P1|COMPLETED|Open Label Extension||0
8092391|NCT03354637|19949502|P3|STARTED|Open Label Extension||61
8092392|NCT03354637|19949503|P2|STARTED|Open Label Extension||0
8092393|NCT03354637|19949504|P1|STARTED|Open Label Extension||0
8092394|NCT03354637|19949502|P3|NOT COMPLETED|Double-blind Period||7
8092395|NCT03354637|19949503|P2|NOT COMPLETED|Double-blind Period||13
8092396|NCT03354637|19949504|P1|NOT COMPLETED|Double-blind Period||17
8092397|NCT03354637|19949502|P3|COMPLETED|Double-blind Period||35
8092398|NCT03354637|19949503|P2|COMPLETED|Double-blind Period||31
8092399|NCT03354637|19949504|P1|COMPLETED|Double-blind Period||26
8092400|NCT03354637|19949502|P3|STARTED|Double-blind Period||42
8092401|NCT03354637|19949503|P2|STARTED|Double-blind Period||44
8092402|NCT03354637|19949504|P1|STARTED|Double-blind Period||43
8092403|NCT03354598|19949563|P2|NOT COMPLETED|Overall Study||75
8092404|NCT03354598|19949564|P1|NOT COMPLETED|Overall Study||80
8092405|NCT03354598|19949563|P2|COMPLETED|Overall Study||761
8092406|NCT03354598|19949564|P1|COMPLETED|Overall Study||755
8092407|NCT03354598|19949563|P2|Safety Participants|Overall Study||827
8092408|NCT03354598|19949564|P1|Safety Participants|Overall Study||833
8092409|NCT03354598|19949563|P2|Intent to Treat (ITT) Participants|Overall Study||803
8092410|NCT03354598|19949564|P1|Intent to Treat (ITT) Participants|Overall Study||787
8092411|NCT03354598|19949563|P2|Modified Intent to Treat (MITT) Participants|Overall Study||794
8092412|NCT03354598|19949564|P1|Modified Intent to Treat (MITT) Participants|Overall Study||785
8092413|NCT03354598|19949563|P2|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||554
8092414|NCT03354598|19949564|P1|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||517
8092415|NCT03354598|19949563|P2|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||415
8092416|NCT03354598|19949564|P1|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||370
8092417|NCT03354598|19949563|P2|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||139
8092418|NCT03354598|19949564|P1|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||147
8092419|NCT03354598|19949563|P2|STARTED|Overall Study||836
8092420|NCT03354598|19949564|P1|STARTED|Overall Study||835
8092421|NCT03354429|19949578|P2|NOT COMPLETED|Overall Study||7
8092422|NCT03354429|19949579|P1|NOT COMPLETED|Overall Study||9
8092423|NCT03354429|19949578|P2|COMPLETED|Overall Study||5486
8092424|NCT03354429|19949579|P1|COMPLETED|Overall Study||5514
8092425|NCT03354429|19949578|P2|STARTED|Overall Study||5493
8092426|NCT03354429|19949579|P1|STARTED|Overall Study||5523
8092427|NCT03354325|19949599|P2|NOT COMPLETED|Overall Study||15
8092428|NCT03354325|19949600|P1|NOT COMPLETED|Overall Study||20
8092429|NCT03354325|19949599|P2|COMPLETED|Overall Study||138
8092430|NCT03354325|19949600|P1|COMPLETED|Overall Study||131
8092431|NCT03354325|19949599|P2|STARTED|Overall Study||153
8092432|NCT03354325|19949600|P1|STARTED|Overall Study||151
8092433|NCT03353922|19949630|P6|NOT COMPLETED|Overall Study||0
8092434|NCT03353922|19949631|P5|NOT COMPLETED|Overall Study||0
8092435|NCT03353922|19949632|P4|NOT COMPLETED|Overall Study||1
8092436|NCT03353922|19949633|P3|NOT COMPLETED|Overall Study||1
8092437|NCT03353922|19949634|P2|NOT COMPLETED|Overall Study||1
8092438|NCT03353922|19949635|P1|NOT COMPLETED|Overall Study||1
8092439|NCT03353922|19949630|P6|COMPLETED|Overall Study||6
8092440|NCT03353922|19949631|P5|COMPLETED|Overall Study||5
8092441|NCT03353922|19949632|P4|COMPLETED|Overall Study||5
8092442|NCT03353922|19949633|P3|COMPLETED|Overall Study||5
8092443|NCT03353922|19949634|P2|COMPLETED|Overall Study||5
8092444|NCT03353922|19949635|P1|COMPLETED|Overall Study||5
8092445|NCT03353922|19949630|P6|STARTED|Overall Study||6
8092446|NCT03353922|19949631|P5|STARTED|Overall Study||5
8092447|NCT03353922|19949632|P4|STARTED|Overall Study||6
8092448|NCT03353922|19949633|P3|STARTED|Overall Study||6
8092449|NCT03353922|19949634|P2|STARTED|Overall Study||6
8092450|NCT03353922|19949635|P1|STARTED|Overall Study||6
8092451|NCT03353246|19949652|P1|NOT COMPLETED|Overall Study||0
8092452|NCT03353246|19949652|P1|COMPLETED|Overall Study||500
8092453|NCT03353246|19949652|P1|STARTED|Overall Study||500
8092454|NCT03352882|19949669|P1|NOT COMPLETED|Overall Study||0
8092455|NCT03352882|19949669|P1|COMPLETED|Overall Study||1
8092456|NCT03352882|19949669|P1|STARTED|Overall Study||1
8092457|NCT03352713|19949677|P1|NOT COMPLETED|Overall Study||26
8092458|NCT03352713|19949677|P1|COMPLETED|Overall Study|Participants who completed at least 1 EMA for inclusion in data analysis|159
8092459|NCT03352713|19949677|P1|STARTED|Overall Study||185
8092460|NCT03352609|19949685|P2|NOT COMPLETED|Overall Study||0
8092461|NCT03352609|19949686|P1|NOT COMPLETED|Overall Study||0
8092462|NCT03352609|19949685|P2|COMPLETED|Overall Study||3
8092463|NCT03352609|19949686|P1|COMPLETED|Overall Study||2
8092464|NCT03352609|19949685|P2|STARTED|Overall Study||3
8092465|NCT03352609|19949686|P1|STARTED|Overall Study||2
8092466|NCT03352453|19949698|P2|NOT COMPLETED|Overall Study||32
8092467|NCT03352453|19949699|P1|NOT COMPLETED|Overall Study||22
8092468|NCT03352453|19949698|P2|COMPLETED|Overall Study||40
8092469|NCT03352453|19949699|P1|COMPLETED|Overall Study||44
8092470|NCT03352453|19949698|P2|STARTED|Overall Study||72
8092471|NCT03352453|19949699|P1|STARTED|Overall Study||66
8092472|NCT03352323|19949711|P1|NOT COMPLETED|Overall Study||1
8092473|NCT03352323|19949711|P1|COMPLETED|Overall Study||49
8092474|NCT03352323|19949711|P1|STARTED|Overall Study||50
8092475|NCT03351933|19949715|P1|NOT COMPLETED|Overall Study||2
8092476|NCT03351933|19949715|P1|COMPLETED|Overall Study||26
8092477|NCT03351933|19949715|P1|STARTED|Overall Study||28
8092478|NCT03351738|19949725|P6|NOT COMPLETED|Overall Study||0
8092479|NCT03351738|19949726|P5|NOT COMPLETED|Overall Study||0
8092480|NCT03351738|19949727|P4|NOT COMPLETED|Overall Study||1
8092481|NCT03351738|19949728|P3|NOT COMPLETED|Overall Study||0
8092482|NCT03351738|19949729|P2|NOT COMPLETED|Overall Study||1
8092483|NCT03351738|19949730|P1|NOT COMPLETED|Overall Study||0
8092484|NCT03351738|19949725|P6|COMPLETED|Overall Study||22
8092485|NCT03351738|19949726|P5|COMPLETED|Overall Study||21
8092486|NCT03351738|19949727|P4|COMPLETED|Overall Study||21
8092487|NCT03351738|19949728|P3|COMPLETED|Overall Study||24
8092488|NCT03351738|19949729|P2|COMPLETED|Overall Study||19
8092489|NCT03351738|19949730|P1|COMPLETED|Overall Study||23
8092490|NCT03351738|19949725|P6|STARTED|Overall Study||22
8092491|NCT03351738|19949726|P5|STARTED|Overall Study||21
8092492|NCT03351738|19949727|P4|STARTED|Overall Study||22
8092493|NCT03351738|19949728|P3|STARTED|Overall Study||24
8092494|NCT03351738|19949729|P2|STARTED|Overall Study||20
8092495|NCT03351738|19949730|P1|STARTED|Overall Study||23
8092496|NCT03351699|19949806|P5|NOT COMPLETED|Overall Study||0
8092497|NCT03351699|19949807|P4|NOT COMPLETED|Overall Study||0
8092498|NCT03351699|19949808|P3|NOT COMPLETED|Overall Study||0
8092499|NCT03351699|19949809|P2|NOT COMPLETED|Overall Study||0
8092500|NCT03351699|19949810|P1|NOT COMPLETED|Overall Study||0
8092501|NCT03351699|19949806|P5|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
8092502|NCT03351699|19949807|P4|COMPLETED|Overall Study||6
8092503|NCT03351699|19949808|P3|COMPLETED|Overall Study||6
8092504|NCT03351699|19949809|P2|COMPLETED|Overall Study||6
8092505|NCT03351699|19949810|P1|COMPLETED|Overall Study||6
8092506|NCT03351699|19949806|P5|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
8092507|NCT03351699|19949807|P4|STARTED|Overall Study||6
8092508|NCT03351699|19949808|P3|STARTED|Overall Study||6
8092509|NCT03351699|19949809|P2|STARTED|Overall Study||6
8092510|NCT03351699|19949810|P1|STARTED|Overall Study||6
8092511|NCT03351335|19949882|P3|NOT COMPLETED|Overall Study||4
8092512|NCT03351335|19949883|P2|NOT COMPLETED|Overall Study||0
8092513|NCT03351335|19949884|P1|NOT COMPLETED|Overall Study||0
8092514|NCT03351335|19949882|P3|COMPLETED|Overall Study||16
8092515|NCT03351335|19949883|P2|COMPLETED|Overall Study||19
8092516|NCT03351335|19949884|P1|COMPLETED|Overall Study||21
8092517|NCT03351335|19949882|P3|STARTED|Overall Study||20
8092518|NCT03351335|19949883|P2|STARTED|Overall Study||19
8092519|NCT03351335|19949884|P1|STARTED|Overall Study||21
8092520|NCT03351231|19949904|P1|NOT COMPLETED|Safety Follow-Up Period||3
8092521|NCT03351231|19949904|P1|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0
8092522|NCT03351231|19949904|P1|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3
8092523|NCT03351231|19949904|P1|NOT COMPLETED|Combination Therapy Period||5
8092524|NCT03351231|19949904|P1|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0
8092525|NCT03351231|19949904|P1|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5
8092526|NCT03351101|19949928|P2|NOT COMPLETED|Overall Study||3
8092527|NCT03351101|19949929|P1|NOT COMPLETED|Overall Study||1
8092528|NCT03351101|19949928|P2|COMPLETED|Overall Study||129
8092529|NCT03351101|19949929|P1|COMPLETED|Overall Study||135
8092530|NCT03351101|19949928|P2|STARTED|Overall Study||132
8092531|NCT03351101|19949929|P1|STARTED|Overall Study||136
8092532|NCT03350984|19949939|P2|NOT COMPLETED|Overall Study||8
8092533|NCT03350984|19949940|P1|NOT COMPLETED|Overall Study||8
8092534|NCT03350984|19949939|P2|COMPLETED|Overall Study||28
8092535|NCT03350984|19949940|P1|COMPLETED|Overall Study||31
8092536|NCT03350984|19949939|P2|STARTED|Overall Study||36
8092537|NCT03350984|19949940|P1|STARTED|Overall Study||39
8092538|NCT03350919|19949952|P2|NOT COMPLETED|Overall Study||0
8092539|NCT03350919|19949953|P1|NOT COMPLETED|Overall Study||2
8092540|NCT03350919|19949952|P2|COMPLETED|Overall Study||23
8092541|NCT03350919|19949953|P1|COMPLETED|Overall Study||23
8092542|NCT03350919|19949952|P2|STARTED|Overall Study||23
8092543|NCT03350919|19949953|P1|STARTED|Overall Study||25
8092544|NCT03350724|19949963|P2|NOT COMPLETED|Overall Study||0
8092545|NCT03350724|19949964|P1|NOT COMPLETED|Overall Study||0
8092546|NCT03350724|19949963|P2|COMPLETED|Overall Study||17
8092547|NCT03350724|19949964|P1|COMPLETED|Overall Study||17
8092548|NCT03350724|19949963|P2|STARTED|Overall Study||17
8092549|NCT03350724|19949964|P1|STARTED|Overall Study||17
8092553|NCT03350256|19950022|P1|NOT COMPLETED|Overall Study||36
8092554|NCT03350256|19950022|P1|COMPLETED|Overall Study||24
8092555|NCT03350256|19950022|P1|6 Month Follow up|Overall Study||24
8092556|NCT03350256|19950022|P1|3 Month Follow up|Overall Study||27
8092557|NCT03350256|19950022|P1|1 Month Follow up|Overall Study||30
8092558|NCT03350256|19950022|P1|Permanent Implant|Overall Study|subjects that underwent permanent SCS implant|35
8092559|NCT03350256|19950022|P1|Spinal Cord Stimulation Trial|Overall Study|Subject that underwent SCS trial|50
8092560|NCT03350256|19950022|P1|STARTED|Overall Study||60
8092561|NCT03350217|19950044|P2|NOT COMPLETED|Overall Study||0
8092562|NCT03350217|19950045|P1|NOT COMPLETED|Overall Study||2
8092563|NCT03350217|19950044|P2|COMPLETED|Overall Study||81
8092564|NCT03350217|19950045|P1|COMPLETED|Overall Study||77
8092565|NCT03350217|19950044|P2|STARTED|Overall Study||81
8092566|NCT03350217|19950045|P1|STARTED|Overall Study||79
8092567|NCT03349632|19950075|P6|NOT COMPLETED|Period 2, Second Week of Wear||0
8092568|NCT03349632|19950076|P5|NOT COMPLETED|Period 2, Second Week of Wear||0
8092569|NCT03349632|19950077|P4|NOT COMPLETED|Period 2, Second Week of Wear||0
8092570|NCT03349632|19950078|P3|NOT COMPLETED|Period 2, Second Week of Wear||0
8092571|NCT03349632|19950079|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
8092572|NCT03349632|19950080|P1|NOT COMPLETED|Period 2, Second Week of Wear||0
8092573|NCT03349632|19950075|P6|COMPLETED|Period 2, Second Week of Wear||11
8092574|NCT03349632|19950076|P5|COMPLETED|Period 2, Second Week of Wear||11
8092575|NCT03349632|19950077|P4|COMPLETED|Period 2, Second Week of Wear||11
8092576|NCT03349632|19950078|P3|COMPLETED|Period 2, Second Week of Wear||11
8092577|NCT03349632|19950079|P2|COMPLETED|Period 2, Second Week of Wear||11
8092578|NCT03349632|19950080|P1|COMPLETED|Period 2, Second Week of Wear||11
8092579|NCT03349632|19950075|P6|STARTED|Period 2, Second Week of Wear||11
8092580|NCT03349632|19950076|P5|STARTED|Period 2, Second Week of Wear||11
8092581|NCT03349632|19950077|P4|STARTED|Period 2, Second Week of Wear||11
8092582|NCT03349632|19950078|P3|STARTED|Period 2, Second Week of Wear||11
8092583|NCT03349632|19950079|P2|STARTED|Period 2, Second Week of Wear||11
8092584|NCT03349632|19950080|P1|STARTED|Period 2, Second Week of Wear||11
8092585|NCT03349632|19950075|P6|NOT COMPLETED|Period 1, First Week of Wear||0
8092586|NCT03349632|19950076|P5|NOT COMPLETED|Period 1, First Week of Wear||0
8092587|NCT03349632|19950077|P4|NOT COMPLETED|Period 1, First Week of Wear||0
8092588|NCT03349632|19950078|P3|NOT COMPLETED|Period 1, First Week of Wear||0
8092589|NCT03349632|19950079|P2|NOT COMPLETED|Period 1, First Week of Wear||0
8092590|NCT03349632|19950080|P1|NOT COMPLETED|Period 1, First Week of Wear||0
8092591|NCT03349632|19950075|P6|COMPLETED|Period 1, First Week of Wear||11
8092592|NCT03349632|19950076|P5|COMPLETED|Period 1, First Week of Wear||11
8092593|NCT03349632|19950077|P4|COMPLETED|Period 1, First Week of Wear||11
8092594|NCT03349632|19950078|P3|COMPLETED|Period 1, First Week of Wear||11
8092595|NCT03349632|19950079|P2|COMPLETED|Period 1, First Week of Wear||11
8092596|NCT03349632|19950080|P1|COMPLETED|Period 1, First Week of Wear||11
8092597|NCT03349632|19950075|P6|STARTED|Period 1, First Week of Wear||11
8092598|NCT03349632|19950076|P5|STARTED|Period 1, First Week of Wear||11
8092599|NCT03349632|19950077|P4|STARTED|Period 1, First Week of Wear||11
8092600|NCT03349632|19950078|P3|STARTED|Period 1, First Week of Wear||11
8092601|NCT03349632|19950079|P2|STARTED|Period 1, First Week of Wear||11
8092602|NCT03349632|19950080|P1|STARTED|Period 1, First Week of Wear||11
8092603|NCT03349515|19950096|P2|NOT COMPLETED|Overall Study||1
8092604|NCT03349515|19950097|P1|NOT COMPLETED|Overall Study||5
8092605|NCT03349515|19950096|P2|COMPLETED|Overall Study||50
8092606|NCT03349515|19950097|P1|COMPLETED|Overall Study||50
8092607|NCT03349515|19950096|P2|STARTED|Overall Study||51
8092608|NCT03349515|19950097|P1|STARTED|Overall Study||55
8092609|NCT03349437|19950103|P3|NOT COMPLETED|Intervention||0
8092610|NCT03349437|19950104|P2|NOT COMPLETED|Intervention||0
8092611|NCT03349437|19950105|P1|NOT COMPLETED|Intervention||0
8092612|NCT03349437|19950103|P3|COMPLETED|Intervention||10
8092613|NCT03349437|19950104|P2|COMPLETED|Intervention||10
8092614|NCT03349437|19950105|P1|COMPLETED|Intervention||0
8092615|NCT03349437|19950103|P3|STARTED|Intervention||10
8092616|NCT03349437|19950104|P2|STARTED|Intervention||10
8092617|NCT03349437|19950105|P1|STARTED|Intervention||0
8092618|NCT03349437|19950103|P3|NOT COMPLETED|Screening||0
8092619|NCT03349437|19950104|P2|NOT COMPLETED|Screening||0
8092620|NCT03349437|19950105|P1|NOT COMPLETED|Screening||5
8092621|NCT03349437|19950103|P3|COMPLETED|Screening||0
8092622|NCT03349437|19950104|P2|COMPLETED|Screening||0
8092623|NCT03349437|19950105|P1|COMPLETED|Screening||20
8092624|NCT03349437|19950103|P3|STARTED|Screening||0
8092625|NCT03349437|19950104|P2|STARTED|Screening||0
8092626|NCT03349437|19950105|P1|STARTED|Screening||25
8092627|NCT03349333|19950112|P1|NOT COMPLETED|Overall Study||71
8092628|NCT03349333|19950112|P1|COMPLETED|Overall Study||0
8092629|NCT03349333|19950112|P1|STARTED|Overall Study||71
8092630|NCT03349099|19950135|P2|NOT COMPLETED|Overall Study||4
8092631|NCT03349099|19950136|P1|NOT COMPLETED|Overall Study||4
8092632|NCT03349099|19950135|P2|COMPLETED|Overall Study||43
8092633|NCT03349099|19950136|P1|COMPLETED|Overall Study||44
8092634|NCT03349099|19950135|P2|STARTED|Overall Study||47
8092635|NCT03349099|19950136|P1|STARTED|Overall Study||48
8092636|NCT03349060|19950149|P3|NOT COMPLETED|Overall Study||16
8092637|NCT03349060|19950150|P2|NOT COMPLETED|Overall Study||17
8092638|NCT03349060|19950151|P1|NOT COMPLETED|Overall Study||21
8092639|NCT03349060|19950149|P3|COMPLETED|Overall Study||61
8092640|NCT03349060|19950150|P2|COMPLETED|Overall Study||137
8092641|NCT03349060|19950151|P1|COMPLETED|Overall Study||135
8092642|NCT03349060|19950149|P3|STARTED|Overall Study||77
8092643|NCT03349060|19950150|P2|STARTED|Overall Study||154
8092644|NCT03349060|19950151|P1|STARTED|Overall Study||156
8092645|NCT03349034|19950292|P2|NOT COMPLETED|Overall Study||2
8092646|NCT03349034|19950293|P1|NOT COMPLETED|Overall Study||4
8092647|NCT03349034|19950292|P2|COMPLETED|Overall Study||10
8092648|NCT03349034|19950293|P1|COMPLETED|Overall Study||8
8092649|NCT03349034|19950292|P2|STARTED|Overall Study||12
8092650|NCT03349034|19950293|P1|STARTED|Overall Study||12
8092651|NCT03348904|19950314|P3|NOT COMPLETED|Overall Study||0
8092652|NCT03348904|19950315|P2|NOT COMPLETED|Overall Study||1
8092653|NCT03348904|19950316|P1|NOT COMPLETED|Overall Study||0
8092654|NCT03348904|19950314|P3|COMPLETED|Overall Study||0
8092655|NCT03348904|19950315|P2|COMPLETED|Overall Study||1
8092656|NCT03348904|19950316|P1|COMPLETED|Overall Study||0
8092657|NCT03348904|19950314|P3|STARTED|Overall Study||0
8092658|NCT03348904|19950315|P2|STARTED|Overall Study||2
8092659|NCT03348904|19950316|P1|STARTED|Overall Study||0
8092660|NCT03348683|19950335|P2|NOT COMPLETED|Overall Study||0
8092661|NCT03348683|19950336|P1|NOT COMPLETED|Overall Study||0
8092662|NCT03348683|19950335|P2|COMPLETED|Overall Study||119
8092663|NCT03348683|19950336|P1|COMPLETED|Overall Study||121
8092664|NCT03348683|19950335|P2|STARTED|Overall Study||119
8092665|NCT03348683|19950336|P1|STARTED|Overall Study||121
8092666|NCT03346902|19950360|P2|NOT COMPLETED|Overall Study||0
8092667|NCT03346902|19950361|P1|NOT COMPLETED|Overall Study||0
8092668|NCT03346902|19950360|P2|COMPLETED|Overall Study||8
8092669|NCT03346902|19950361|P1|COMPLETED|Overall Study||4
8092670|NCT03346902|19950360|P2|STARTED|Overall Study||8
8092671|NCT03346902|19950361|P1|STARTED|Overall Study||4
8092672|NCT03346850|19950369|P2|NOT COMPLETED|Overall Study||3
8092673|NCT03346850|19950370|P1|NOT COMPLETED|Overall Study||2
8092674|NCT03346850|19950369|P2|COMPLETED|Overall Study||17
8092675|NCT03346850|19950370|P1|COMPLETED|Overall Study||18
8092676|NCT03346850|19950369|P2|STARTED|Overall Study||20
8092677|NCT03346850|19950370|P1|STARTED|Overall Study||20
8092678|NCT03346759|19950392|P2|NOT COMPLETED|Third Menstrual Cycle||0
8092679|NCT03346759|19950393|P1|NOT COMPLETED|Third Menstrual Cycle||0
8092680|NCT03346759|19950392|P2|COMPLETED|Third Menstrual Cycle||10
8092681|NCT03346759|19950393|P1|COMPLETED|Third Menstrual Cycle||11
8092682|NCT03346759|19950392|P2|STARTED|Third Menstrual Cycle||10
8092683|NCT03346759|19950393|P1|STARTED|Third Menstrual Cycle||11
8092684|NCT03346759|19950392|P2|NOT COMPLETED|Second Menstrual Cycle||0
8092685|NCT03346759|19950393|P1|NOT COMPLETED|Second Menstrual Cycle||1
8092686|NCT03346759|19950392|P2|COMPLETED|Second Menstrual Cycle||10
8092687|NCT03346759|19950393|P1|COMPLETED|Second Menstrual Cycle||11
8092688|NCT03346759|19950392|P2|STARTED|Second Menstrual Cycle||10
8092689|NCT03346759|19950393|P1|STARTED|Second Menstrual Cycle||12
8092690|NCT03346759|19950392|P2|NOT COMPLETED|First Menstrual Cycle||0
8092691|NCT03346759|19950393|P1|NOT COMPLETED|First Menstrual Cycle||1
8092692|NCT03346759|19950392|P2|COMPLETED|First Menstrual Cycle||10
8092693|NCT03346759|19950393|P1|COMPLETED|First Menstrual Cycle||12
8092694|NCT03346759|19950392|P2|STARTED|First Menstrual Cycle||10
8092695|NCT03346759|19950393|P1|STARTED|First Menstrual Cycle||13
8092696|NCT03346759|19950392|P2|NOT COMPLETED|Enrollment to Baseline Data Collected||3
8092697|NCT03346759|19950393|P1|NOT COMPLETED|Enrollment to Baseline Data Collected||2
8092698|NCT03346759|19950392|P2|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
8092699|NCT03346759|19950393|P1|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
8092700|NCT03346759|19950392|P2|STARTED|Enrollment to Baseline Data Collected||13
8092701|NCT03346759|19950393|P1|STARTED|Enrollment to Baseline Data Collected||15
8092702|NCT03346161|19950404|P2|NOT COMPLETED|Overall Study||0
8092703|NCT03346161|19950405|P1|NOT COMPLETED|Overall Study||0
8092704|NCT03346161|19950404|P2|COMPLETED|Overall Study||60
8092705|NCT03346161|19950405|P1|COMPLETED|Overall Study||60
8092706|NCT03346161|19950404|P2|STARTED|Overall Study||60
8092707|NCT03346161|19950405|P1|STARTED|Overall Study||60
8092708|NCT03346057|19950437|P4|NOT COMPLETED|Overall Study||2
8092709|NCT03346057|19950438|P3|NOT COMPLETED|Overall Study||1
8092710|NCT03346057|19950439|P2|NOT COMPLETED|Overall Study||8
8092711|NCT03346057|19950440|P1|NOT COMPLETED|Overall Study||7
8092712|NCT03346057|19950437|P4|COMPLETED|Overall Study||51
8092713|NCT03346057|19950438|P3|COMPLETED|Overall Study||67
8092714|NCT03346057|19950439|P2|COMPLETED|Overall Study||104
8092715|NCT03346057|19950440|P1|COMPLETED|Overall Study||104
8092716|NCT03346057|19950437|P4|Treated|Overall Study||51
8092717|NCT03346057|19950438|P3|Treated|Overall Study||68
8092718|NCT03346057|19950439|P2|Treated|Overall Study||107
8092719|NCT03346057|19950440|P1|Treated|Overall Study||105
8092720|NCT03346057|19950437|P4|STARTED|Overall Study||53
8092721|NCT03346057|19950438|P3|STARTED|Overall Study||68
8092722|NCT03346057|19950439|P2|STARTED|Overall Study||112
8092723|NCT03346057|19950440|P1|STARTED|Overall Study||111
8092724|NCT03345979|19950472|P2|NOT COMPLETED|Overall Study||58
8092725|NCT03345979|19950473|P1|NOT COMPLETED|Overall Study||43
8092726|NCT03345979|19950472|P2|COMPLETED|Overall Study||43
8092727|NCT03345979|19950473|P1|COMPLETED|Overall Study||56
8092728|NCT03345979|19950472|P2|STARTED|Overall Study||101
8092729|NCT03345979|19950473|P1|STARTED|Overall Study||99
8092730|NCT03345914|19950494|P3|NOT COMPLETED|Overall Study||122
8092731|NCT03345914|19950495|P2|NOT COMPLETED|Overall Study||122
8092732|NCT03345914|19950496|P1|NOT COMPLETED|Overall Study||123
8092733|NCT03345914|19950494|P3|COMPLETED|Overall Study||0
8092734|NCT03345914|19950495|P2|COMPLETED|Overall Study||0
8092735|NCT03345914|19950496|P1|COMPLETED|Overall Study||0
8092736|NCT03345914|19950494|P3|Completed Week 28 End of Study|Overall Study||0
8092737|NCT03345914|19950495|P2|Completed Week 28 End of Study|Overall Study||0
8092738|NCT03345914|19950496|P1|Completed Week 28 End of Study|Overall Study||0
8092739|NCT03345914|19950494|P3|Completed Week 16 Study Treatment|Overall Study||119
8092740|NCT03345914|19950495|P2|Completed Week 16 Study Treatment|Overall Study||118
8092741|NCT03345914|19950496|P1|Completed Week 16 Study Treatment|Overall Study||114
8092742|NCT03345914|19950494|P3|STARTED|Overall Study||122
8092743|NCT03345914|19950495|P2|STARTED|Overall Study||122
8092744|NCT03345914|19950496|P1|STARTED|Overall Study||123
8092745|NCT03345901|19950567|P1|NOT COMPLETED|Overall Study||18
8092746|NCT03345901|19950567|P1|COMPLETED|Overall Study||0
8092747|NCT03345901|19950567|P1|STARTED|Overall Study||18
8092748|NCT03345472|19950572|P1|NOT COMPLETED|3 Months to 12 Months||8
8092749|NCT03345472|19950572|P1|COMPLETED|3 Months to 12 Months||91
8092750|NCT03345472|19950572|P1|STARTED|3 Months to 12 Months||99
8092751|NCT03345472|19950572|P1|NOT COMPLETED|Implant to 3 Months||4
8092752|NCT03345472|19950572|P1|COMPLETED|Implant to 3 Months||99
8092753|NCT03345472|19950572|P1|STARTED|Implant to 3 Months||103
8092775|NCT03345108|19950777|P6|NOT COMPLETED|Period-3||0
8092776|NCT03345108|19950778|P5|NOT COMPLETED|Period-3||0
8092777|NCT03345108|19950779|P4|NOT COMPLETED|Period-3||0
8092778|NCT03345108|19950780|P3|NOT COMPLETED|Period-3||0
8092779|NCT03345108|19950781|P2|NOT COMPLETED|Period-3||0
8092780|NCT03345108|19950782|P1|NOT COMPLETED|Period-3||0
8092781|NCT03345108|19950777|P6|COMPLETED|Period-3||8
8092782|NCT03345108|19950778|P5|COMPLETED|Period-3||8
8092783|NCT03345108|19950779|P4|COMPLETED|Period-3||8
8092784|NCT03345108|19950780|P3|COMPLETED|Period-3||8
8092785|NCT03345108|19950781|P2|COMPLETED|Period-3||8
8092786|NCT03345108|19950782|P1|COMPLETED|Period-3||7
8092787|NCT03345108|19950777|P6|STARTED|Period-3||8
8092788|NCT03345108|19950778|P5|STARTED|Period-3||8
8092789|NCT03345108|19950779|P4|STARTED|Period-3||8
8092790|NCT03345108|19950780|P3|STARTED|Period-3||8
8092791|NCT03345108|19950781|P2|STARTED|Period-3||8
8092792|NCT03345108|19950782|P1|STARTED|Period-3||7
8092793|NCT03345108|19950777|P6|NOT COMPLETED|Period-2||0
8092794|NCT03345108|19950778|P5|NOT COMPLETED|Period-2||0
8092795|NCT03345108|19950779|P4|NOT COMPLETED|Period-2||0
8092796|NCT03345108|19950780|P3|NOT COMPLETED|Period-2||0
8092797|NCT03345108|19950781|P2|NOT COMPLETED|Period-2||0
8092798|NCT03345108|19950782|P1|NOT COMPLETED|Period-2||0
8092799|NCT03345108|19950777|P6|COMPLETED|Period-2||8
8092800|NCT03345108|19950778|P5|COMPLETED|Period-2||8
8092801|NCT03345108|19950779|P4|COMPLETED|Period-2||8
8092802|NCT03345108|19950780|P3|COMPLETED|Period-2||8
8092803|NCT03345108|19950781|P2|COMPLETED|Period-2||8
8092804|NCT03345108|19950782|P1|COMPLETED|Period-2||8
8092805|NCT03345108|19950777|P6|STARTED|Period-2||8
8092806|NCT03345108|19950778|P5|STARTED|Period-2||8
8092807|NCT03345108|19950779|P4|STARTED|Period-2||8
8092808|NCT03345108|19950780|P3|STARTED|Period-2||8
8092809|NCT03345108|19950781|P2|STARTED|Period-2||8
8092810|NCT03345108|19950782|P1|STARTED|Period-2||8
8092811|NCT03345108|19950777|P6|NOT COMPLETED|Period-1||0
8092812|NCT03345108|19950778|P5|NOT COMPLETED|Period-1||0
8092813|NCT03345108|19950779|P4|NOT COMPLETED|Period-1||0
8092814|NCT03345108|19950780|P3|NOT COMPLETED|Period-1||0
8092815|NCT03345108|19950781|P2|NOT COMPLETED|Period-1||0
8092816|NCT03345108|19950782|P1|NOT COMPLETED|Period-1||0
8092817|NCT03345108|19950777|P6|COMPLETED|Period-1||8
8092818|NCT03345108|19950778|P5|COMPLETED|Period-1||8
8092819|NCT03345108|19950779|P4|COMPLETED|Period-1||8
8092820|NCT03345108|19950780|P3|COMPLETED|Period-1||8
8092821|NCT03345108|19950781|P2|COMPLETED|Period-1||8
8092822|NCT03345108|19950782|P1|COMPLETED|Period-1||8
8092823|NCT03345108|19950777|P6|STARTED|Period-1||8
8092824|NCT03345108|19950778|P5|STARTED|Period-1||8
8092825|NCT03345108|19950779|P4|STARTED|Period-1||8
8092826|NCT03345108|19950780|P3|STARTED|Period-1||8
8092827|NCT03345108|19950781|P2|STARTED|Period-1||8
8092828|NCT03345108|19950782|P1|STARTED|Period-1||8
8092829|NCT03344861|19950790|P1|NOT COMPLETED|Overall Study||0
8092830|NCT03344861|19950790|P1|COMPLETED|Overall Study||10
8092831|NCT03344861|19950790|P1|STARTED|Overall Study||10
8092832|NCT03344640|19950821|P2|NOT COMPLETED|Follow-up Epoch||2
8092833|NCT03344640|19950822|P1|NOT COMPLETED|Follow-up Epoch||0
8092834|NCT03344640|19950821|P2|COMPLETED|Follow-up Epoch||42
8092835|NCT03344640|19950822|P1|COMPLETED|Follow-up Epoch||46
8092836|NCT03344640|19950821|P2|STARTED|Follow-up Epoch||44
8092837|NCT03344640|19950822|P1|STARTED|Follow-up Epoch||46
8092838|NCT03344640|19950821|P2|NOT COMPLETED|Overall Study||3
8092839|NCT03344640|19950822|P1|NOT COMPLETED|Overall Study||3
8092840|NCT03344640|19950821|P2|COMPLETED|Overall Study||44
8092841|NCT03344640|19950822|P1|COMPLETED|Overall Study||46
8092842|NCT03344640|19950821|P2|STARTED|Overall Study||47
8092843|NCT03344640|19950822|P1|STARTED|Overall Study||49
8092844|NCT03344562|19950851|P2|NOT COMPLETED|Overall Study||0
8092845|NCT03344562|19950852|P1|NOT COMPLETED|Overall Study||2
8092846|NCT03344562|19950851|P2|COMPLETED|Overall Study||9
8092847|NCT03344562|19950852|P1|COMPLETED|Overall Study||8
8092848|NCT03344562|19950851|P2|STARTED|Overall Study||9
8092849|NCT03344562|19950852|P1|STARTED|Overall Study||10
8092850|NCT03344510|19950862|P2|NOT COMPLETED|Second Injection (5 Minutes)||0
8092851|NCT03344510|19950863|P1|NOT COMPLETED|Second Injection (5 Minutes)||0
8092852|NCT03344510|19950862|P2|COMPLETED|Second Injection (5 Minutes)||26
8092853|NCT03344510|19950863|P1|COMPLETED|Second Injection (5 Minutes)||21
8092854|NCT03344510|19950862|P2|Received Injection|Second Injection (5 Minutes)||26
8092855|NCT03344510|19950863|P1|Received Injection|Second Injection (5 Minutes)||21
8092856|NCT03344510|19950862|P2|STARTED|Second Injection (5 Minutes)||26
8092857|NCT03344510|19950863|P1|STARTED|Second Injection (5 Minutes)||21
8092858|NCT03344510|19950862|P2|NOT COMPLETED|Wash Out (10 Minutes||0
8092859|NCT03344510|19950863|P1|NOT COMPLETED|Wash Out (10 Minutes||0
8092860|NCT03344510|19950862|P2|COMPLETED|Wash Out (10 Minutes||26
8092861|NCT03344510|19950863|P1|COMPLETED|Wash Out (10 Minutes||21
8092862|NCT03344510|19950862|P2|STARTED|Wash Out (10 Minutes||26
8092863|NCT03344510|19950863|P1|STARTED|Wash Out (10 Minutes||21
8092864|NCT03344510|19950862|P2|NOT COMPLETED|First Injection (5 Minutes)||0
8092865|NCT03344510|19950863|P1|NOT COMPLETED|First Injection (5 Minutes)||0
8092866|NCT03344510|19950862|P2|COMPLETED|First Injection (5 Minutes)||26
8092867|NCT03344510|19950863|P1|COMPLETED|First Injection (5 Minutes)||21
8092868|NCT03344510|19950862|P2|Received Injection|First Injection (5 Minutes)||26
8092869|NCT03344510|19950863|P1|Received Injection|First Injection (5 Minutes)||21
8092870|NCT03344510|19950862|P2|STARTED|First Injection (5 Minutes)||26
8092871|NCT03344510|19950863|P1|STARTED|First Injection (5 Minutes)||21
8092872|NCT03344172|19950872|P2|NOT COMPLETED|Overall Study||0
8092873|NCT03344172|19950873|P1|NOT COMPLETED|Overall Study||1
8092874|NCT03344172|19950872|P2|COMPLETED|Overall Study||16
8092875|NCT03344172|19950873|P1|COMPLETED|Overall Study||15
8092876|NCT03344172|19950872|P2|STARTED|Overall Study||16
8092877|NCT03344172|19950873|P1|STARTED|Overall Study||16
8092884|NCT03343080|19950906|P2|NOT COMPLETED|Overall Study||0
8092885|NCT03343080|19950907|P1|NOT COMPLETED|Overall Study||0
8092886|NCT03343080|19950906|P2|COMPLETED|Overall Study||18
8092887|NCT03343080|19950907|P1|COMPLETED|Overall Study||14
8092888|NCT03343080|19950906|P2|STARTED|Overall Study||18
8092889|NCT03343080|19950907|P1|STARTED|Overall Study||14
8092890|NCT03343067|19950920|P3|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1
8092891|NCT03343067|19950921|P2|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3
8092892|NCT03343067|19950922|P1|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0
8092893|NCT03343067|19950920|P3|COMPLETED|Double Blind Period: Month 3 to Month 6||0
8092894|NCT03343067|19950921|P2|COMPLETED|Double Blind Period: Month 3 to Month 6||0
8092895|NCT03343067|19950922|P1|COMPLETED|Double Blind Period: Month 3 to Month 6||0
8092896|NCT03343067|19950920|P3|STARTED|Double Blind Period: Month 3 to Month 6||1
8092897|NCT03343067|19950921|P2|STARTED|Double Blind Period: Month 3 to Month 6||3
8092898|NCT03343067|19950922|P1|STARTED|Double Blind Period: Month 3 to Month 6||0
8092899|NCT03343067|19950920|P3|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
8092900|NCT03343067|19950921|P2|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
8092901|NCT03343067|19950922|P1|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7
8092902|NCT03343067|19950920|P3|COMPLETED|Open Label Period: Day 1 to Month 3||1
8092903|NCT03343067|19950921|P2|COMPLETED|Open Label Period: Day 1 to Month 3||3
8092904|NCT03343067|19950922|P1|COMPLETED|Open Label Period: Day 1 to Month 3||0
8092905|NCT03343067|19950920|P3|STARTED|Open Label Period: Day 1 to Month 3||1
8092906|NCT03343067|19950921|P2|STARTED|Open Label Period: Day 1 to Month 3||3
8092907|NCT03343067|19950922|P1|STARTED|Open Label Period: Day 1 to Month 3||7
8092908|NCT03342898|19951050|P3|NOT COMPLETED|Overall Study||54
8092909|NCT03342898|19951051|P2|NOT COMPLETED|Overall Study||53
8092910|NCT03342898|19951052|P1|NOT COMPLETED|Overall Study||54
8092911|NCT03342898|19951050|P3|COMPLETED|Overall Study||246
8092912|NCT03342898|19951051|P2|COMPLETED|Overall Study||247
8092913|NCT03342898|19951052|P1|COMPLETED|Overall Study||246
8092914|NCT03342898|19951050|P3|STARTED|Overall Study||300
8092915|NCT03342898|19951051|P2|STARTED|Overall Study||300
8092916|NCT03342898|19951052|P1|STARTED|Overall Study||300
8092917|NCT03342638|19951095|P2|NOT COMPLETED|Overall Study||1
8092918|NCT03342638|19951096|P1|NOT COMPLETED|Overall Study||1
8092919|NCT03342638|19951095|P2|COMPLETED|Overall Study||31
8092920|NCT03342638|19951096|P1|COMPLETED|Overall Study||33
8092921|NCT03342638|19951095|P2|STARTED|Overall Study||32
8092922|NCT03342638|19951096|P1|STARTED|Overall Study||34
8092923|NCT03342560|19951102|P1|NOT COMPLETED|Overall Study||2
8092924|NCT03342560|19951102|P1|COMPLETED|Overall Study||28
8092925|NCT03342560|19951102|P1|STARTED|Overall Study||30
8092926|NCT03342469|19951112|P4|NOT COMPLETED|Overall Study||0
8092927|NCT03342469|19951113|P3|NOT COMPLETED|Overall Study||0
8092928|NCT03342469|19951114|P2|NOT COMPLETED|Overall Study||1
8092929|NCT03342469|19951115|P1|NOT COMPLETED|Overall Study||0
8092930|NCT03342469|19951112|P4|COMPLETED|Overall Study||8
8092931|NCT03342469|19951113|P3|COMPLETED|Overall Study||3
8092932|NCT03342469|19951114|P2|COMPLETED|Overall Study||8
8092933|NCT03342469|19951115|P1|COMPLETED|Overall Study||9
8092934|NCT03342469|19951112|P4|STARTED|Overall Study||8
8092935|NCT03342469|19951113|P3|STARTED|Overall Study||3
8092936|NCT03342469|19951114|P2|STARTED|Overall Study||9
8092937|NCT03342469|19951115|P1|STARTED|Overall Study||9
8092938|NCT03342157|19951133|P2|NOT COMPLETED|Overall Study||0
8092939|NCT03342157|19951134|P1|NOT COMPLETED|Overall Study||0
8092940|NCT03342157|19951133|P2|COMPLETED|Overall Study||1
8092941|NCT03342157|19951134|P1|COMPLETED|Overall Study||1
8092942|NCT03342157|19951133|P2|STARTED|Overall Study||1
8092943|NCT03342157|19951134|P1|STARTED|Overall Study||1
8092944|NCT03342053|19951146|P2|NOT COMPLETED|Overall Study||1
8092945|NCT03342053|19951147|P1|NOT COMPLETED|Overall Study||2
8092946|NCT03342053|19951146|P2|COMPLETED|Overall Study||22
8092947|NCT03342053|19951147|P1|COMPLETED|Overall Study||21
8092948|NCT03342053|19951146|P2|STARTED|Overall Study||23
8092949|NCT03342053|19951147|P1|STARTED|Overall Study||23
8092950|NCT03341923|19951165|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||1
8092951|NCT03341923|19951166|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
8092952|NCT03341923|19951165|P2|COMPLETED|Period 2, Second 14 Days of Wear||65
8092953|NCT03341923|19951166|P1|COMPLETED|Period 2, Second 14 Days of Wear||67
8092954|NCT03341923|19951165|P2|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66
8092955|NCT03341923|19951166|P1|STARTED|Period 2, Second 14 Days of Wear||67
8092956|NCT03341923|19951165|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||0
8092957|NCT03341923|19951166|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
8092958|NCT03341923|19951165|P2|COMPLETED|Period 1, First 14 Days of Wear||67
8092959|NCT03341923|19951166|P1|COMPLETED|Period 1, First 14 Days of Wear||67
8092960|NCT03341923|19951165|P2|STARTED|Period 1, First 14 Days of Wear||67
8092961|NCT03341923|19951166|P1|STARTED|Period 1, First 14 Days of Wear||67
8092962|NCT03341910|19951178|P4|NOT COMPLETED|Overall Study||0
8092963|NCT03341910|19951179|P3|NOT COMPLETED|Overall Study||0
8092964|NCT03341910|19951180|P2|NOT COMPLETED|Overall Study||0
8092965|NCT03341910|19951181|P1|NOT COMPLETED|Overall Study||0
8092966|NCT03341910|19951178|P4|COMPLETED|Overall Study||26
8092967|NCT03341910|19951179|P3|COMPLETED|Overall Study||26
8092968|NCT03341910|19951180|P2|COMPLETED|Overall Study||49
8092969|NCT03341910|19951181|P1|COMPLETED|Overall Study||54
8092970|NCT03341910|19951178|P4|STARTED|Overall Study||26
8092971|NCT03341910|19951179|P3|STARTED|Overall Study||26
8092972|NCT03341910|19951180|P2|STARTED|Overall Study||49
8092973|NCT03341910|19951181|P1|STARTED|Overall Study||54
8092974|NCT03341728|19951191|P2|NOT COMPLETED|Session 2||0
8092975|NCT03341728|19951192|P1|NOT COMPLETED|Session 2||0
8092976|NCT03341728|19951191|P2|COMPLETED|Session 2||7
8092977|NCT03341728|19951192|P1|COMPLETED|Session 2||7
8092978|NCT03341728|19951191|P2|STARTED|Session 2||7
8092979|NCT03341728|19951192|P1|STARTED|Session 2||7
8092980|NCT03341728|19951191|P2|NOT COMPLETED|Washout (1 Week)||0
8092981|NCT03341728|19951192|P1|NOT COMPLETED|Washout (1 Week)||0
8092982|NCT03341728|19951191|P2|COMPLETED|Washout (1 Week)||7
8092983|NCT03341728|19951192|P1|COMPLETED|Washout (1 Week)||7
8092984|NCT03341728|19951191|P2|STARTED|Washout (1 Week)||7
8092985|NCT03341728|19951192|P1|STARTED|Washout (1 Week)||7
8092986|NCT03341728|19951191|P2|NOT COMPLETED|Session 1||0
8092987|NCT03341728|19951192|P1|NOT COMPLETED|Session 1||0
8092988|NCT03341728|19951191|P2|COMPLETED|Session 1||7
8092989|NCT03341728|19951192|P1|COMPLETED|Session 1||7
8092990|NCT03341728|19951191|P2|STARTED|Session 1||7
8092991|NCT03341728|19951192|P1|STARTED|Session 1||7
8092992|NCT03341637|19951210|P2|NOT COMPLETED|Overall Study||4
8092993|NCT03341637|19951211|P1|NOT COMPLETED|Overall Study||5
8092994|NCT03341637|19951210|P2|COMPLETED|Overall Study||296
8092995|NCT03341637|19951211|P1|COMPLETED|Overall Study||95
8092996|NCT03341637|19951210|P2|STARTED|Overall Study||300
8092997|NCT03341637|19951211|P1|STARTED|Overall Study||100
8092998|NCT03341546|19951233|P1|NOT COMPLETED|Overall Study||0
8092999|NCT03341546|19951233|P1|COMPLETED|Overall Study||20
8093000|NCT03341546|19951233|P1|STARTED|Overall Study||20
8093001|NCT03341533|19951239|P2|NOT COMPLETED|Overall Study||2
8093002|NCT03341533|19951240|P1|NOT COMPLETED|Overall Study||3
8093003|NCT03341533|19951239|P2|COMPLETED|Overall Study||68
8093004|NCT03341533|19951240|P1|COMPLETED|Overall Study||69
8093005|NCT03341533|19951239|P2|STARTED|Overall Study||70
8093006|NCT03341533|19951240|P1|STARTED|Overall Study||72
8093007|NCT03341312|19951252|P4|NOT COMPLETED|Period 4||0
8093008|NCT03341312|19951253|P3|NOT COMPLETED|Period 4||0
8093009|NCT03341312|19951254|P2|NOT COMPLETED|Period 4||0
8093010|NCT03341312|19951255|P1|NOT COMPLETED|Period 4||0
8093011|NCT03341312|19951252|P4|COMPLETED|Period 4||8
8093012|NCT03341312|19951253|P3|COMPLETED|Period 4||9
8093013|NCT03341312|19951254|P2|COMPLETED|Period 4||9
8093014|NCT03341312|19951255|P1|COMPLETED|Period 4||9
8093015|NCT03341312|19951252|P4|STARTED|Period 4||8
8093016|NCT03341312|19951253|P3|STARTED|Period 4||9
8093017|NCT03341312|19951254|P2|STARTED|Period 4||9
8093018|NCT03341312|19951255|P1|STARTED|Period 4||9
8093019|NCT03341312|19951252|P4|NOT COMPLETED|Period 3||0
8093020|NCT03341312|19951253|P3|NOT COMPLETED|Period 3||0
8093021|NCT03341312|19951254|P2|NOT COMPLETED|Period 3||0
8093022|NCT03341312|19951255|P1|NOT COMPLETED|Period 3||0
8093023|NCT03341312|19951252|P4|COMPLETED|Period 3||8
8093024|NCT03341312|19951253|P3|COMPLETED|Period 3||9
8093025|NCT03341312|19951254|P2|COMPLETED|Period 3||9
8093026|NCT03341312|19951255|P1|COMPLETED|Period 3||9
8093027|NCT03341312|19951252|P4|STARTED|Period 3||8
8093028|NCT03341312|19951253|P3|STARTED|Period 3||9
8093029|NCT03341312|19951254|P2|STARTED|Period 3||9
8093030|NCT03341312|19951255|P1|STARTED|Period 3||9
8093031|NCT03341312|19951252|P4|NOT COMPLETED|Period 2||0
8093032|NCT03341312|19951253|P3|NOT COMPLETED|Period 2||0
8093033|NCT03341312|19951254|P2|NOT COMPLETED|Period 2||0
8093034|NCT03341312|19951255|P1|NOT COMPLETED|Period 2||0
8093035|NCT03341312|19951252|P4|COMPLETED|Period 2||8
8093036|NCT03341312|19951253|P3|COMPLETED|Period 2||9
8093037|NCT03341312|19951254|P2|COMPLETED|Period 2||9
8093038|NCT03341312|19951255|P1|COMPLETED|Period 2||9
8093039|NCT03341312|19951252|P4|STARTED|Period 2||8
8093040|NCT03341312|19951253|P3|STARTED|Period 2||9
8093041|NCT03341312|19951254|P2|STARTED|Period 2||9
8093042|NCT03341312|19951255|P1|STARTED|Period 2||9
8093043|NCT03341312|19951252|P4|NOT COMPLETED|Period 1||0
8093044|NCT03341312|19951253|P3|NOT COMPLETED|Period 1||0
8093045|NCT03341312|19951254|P2|NOT COMPLETED|Period 1||1
8093046|NCT03341312|19951255|P1|NOT COMPLETED|Period 1||0
8093047|NCT03341312|19951252|P4|COMPLETED|Period 1||8
8093048|NCT03341312|19951253|P3|COMPLETED|Period 1||9
8093049|NCT03341312|19951254|P2|COMPLETED|Period 1||9
8093050|NCT03341312|19951255|P1|COMPLETED|Period 1||9
8093051|NCT03341312|19951252|P4|Received at Least One Dose of Study Drug|Period 1||8
8093052|NCT03341312|19951253|P3|Received at Least One Dose of Study Drug|Period 1||9
8093053|NCT03341312|19951254|P2|Received at Least One Dose of Study Drug|Period 1||10
8093054|NCT03341312|19951255|P1|Received at Least One Dose of Study Drug|Period 1||9
8093055|NCT03341312|19951252|P4|STARTED|Period 1||8
8093056|NCT03341312|19951253|P3|STARTED|Period 1||9
8093057|NCT03341312|19951254|P2|STARTED|Period 1||10
8093058|NCT03341312|19951255|P1|STARTED|Period 1||9
8093059|NCT03341299|19951267|P4|NOT COMPLETED|Period 4||0
8093060|NCT03341299|19951268|P3|NOT COMPLETED|Period 4||0
8093061|NCT03341299|19951269|P2|NOT COMPLETED|Period 4||0
8093062|NCT03341299|19951270|P1|NOT COMPLETED|Period 4||0
8093063|NCT03341299|19951267|P4|COMPLETED|Period 4||9
8093064|NCT03341299|19951268|P3|COMPLETED|Period 4||8
8093065|NCT03341299|19951269|P2|COMPLETED|Period 4||9
8093066|NCT03341299|19951270|P1|COMPLETED|Period 4||9
8093067|NCT03341299|19951267|P4|STARTED|Period 4||9
8093068|NCT03341299|19951268|P3|STARTED|Period 4||8
8093069|NCT03341299|19951269|P2|STARTED|Period 4||9
8093070|NCT03341299|19951270|P1|STARTED|Period 4||9
8093071|NCT03341299|19951267|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093072|NCT03341299|19951268|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093073|NCT03341299|19951269|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093074|NCT03341299|19951270|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093075|NCT03341299|19951267|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093076|NCT03341299|19951268|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
8093077|NCT03341299|19951269|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093078|NCT03341299|19951270|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093079|NCT03341299|19951267|P4|STARTED|Washout (A Minimum of 21 Hours)||9
8093080|NCT03341299|19951268|P3|STARTED|Washout (A Minimum of 21 Hours)||8
8093081|NCT03341299|19951269|P2|STARTED|Washout (A Minimum of 21 Hours)||9
8093082|NCT03341299|19951270|P1|STARTED|Washout (A Minimum of 21 Hours)||9
8093083|NCT03341299|19951267|P4|NOT COMPLETED|Period 3||0
8093084|NCT03341299|19951268|P3|NOT COMPLETED|Period 3||0
8093085|NCT03341299|19951269|P2|NOT COMPLETED|Period 3||0
8093086|NCT03341299|19951270|P1|NOT COMPLETED|Period 3||0
8093087|NCT03341299|19951267|P4|COMPLETED|Period 3||9
8093088|NCT03341299|19951268|P3|COMPLETED|Period 3||8
8093089|NCT03341299|19951269|P2|COMPLETED|Period 3||9
8093090|NCT03341299|19951270|P1|COMPLETED|Period 3||9
8093091|NCT03341299|19951267|P4|STARTED|Period 3||9
8093092|NCT03341299|19951268|P3|STARTED|Period 3||8
8093093|NCT03341299|19951269|P2|STARTED|Period 3||9
8093094|NCT03341299|19951270|P1|STARTED|Period 3||9
8093095|NCT03341299|19951267|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093096|NCT03341299|19951268|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093097|NCT03341299|19951269|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093098|NCT03341299|19951270|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093099|NCT03341299|19951267|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093100|NCT03341299|19951268|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
8093101|NCT03341299|19951269|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093102|NCT03341299|19951270|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093103|NCT03341299|19951267|P4|STARTED|Washout (A Minimum of 21 Hours)||9
8093104|NCT03341299|19951268|P3|STARTED|Washout (A Minimum of 21 Hours)||8
8093105|NCT03341299|19951269|P2|STARTED|Washout (A Minimum of 21 Hours)||9
8093106|NCT03341299|19951270|P1|STARTED|Washout (A Minimum of 21 Hours)||9
8093107|NCT03341299|19951267|P4|NOT COMPLETED|Period 2||0
8093108|NCT03341299|19951268|P3|NOT COMPLETED|Period 2||0
8093109|NCT03341299|19951269|P2|NOT COMPLETED|Period 2||0
8093110|NCT03341299|19951270|P1|NOT COMPLETED|Period 2||0
8093111|NCT03341299|19951267|P4|COMPLETED|Period 2||9
8093112|NCT03341299|19951268|P3|COMPLETED|Period 2||8
8093113|NCT03341299|19951269|P2|COMPLETED|Period 2||9
8093114|NCT03341299|19951270|P1|COMPLETED|Period 2||9
8093115|NCT03341299|19951267|P4|STARTED|Period 2||9
8093116|NCT03341299|19951268|P3|STARTED|Period 2||8
8093117|NCT03341299|19951269|P2|STARTED|Period 2||9
8093118|NCT03341299|19951270|P1|STARTED|Period 2||9
8093119|NCT03341299|19951267|P4|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093120|NCT03341299|19951268|P3|NOT COMPLETED|Washout (A Minimum of 21 Hours)||1
8093121|NCT03341299|19951269|P2|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093122|NCT03341299|19951270|P1|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
8093123|NCT03341299|19951267|P4|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093124|NCT03341299|19951268|P3|COMPLETED|Washout (A Minimum of 21 Hours)||8
8093125|NCT03341299|19951269|P2|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093126|NCT03341299|19951270|P1|COMPLETED|Washout (A Minimum of 21 Hours)||9
8093127|NCT03341299|19951267|P4|STARTED|Washout (A Minimum of 21 Hours)||9
8093128|NCT03341299|19951268|P3|STARTED|Washout (A Minimum of 21 Hours)||9
8093129|NCT03341299|19951269|P2|STARTED|Washout (A Minimum of 21 Hours)||9
8093130|NCT03341299|19951270|P1|STARTED|Washout (A Minimum of 21 Hours)||9
8093131|NCT03341299|19951267|P4|NOT COMPLETED|Period 1||0
8093132|NCT03341299|19951268|P3|NOT COMPLETED|Period 1||0
8093133|NCT03341299|19951269|P2|NOT COMPLETED|Period 1||0
8093134|NCT03341299|19951270|P1|NOT COMPLETED|Period 1||0
8093135|NCT03341299|19951267|P4|COMPLETED|Period 1||9
8093136|NCT03341299|19951268|P3|COMPLETED|Period 1||9
8093137|NCT03341299|19951269|P2|COMPLETED|Period 1||9
8093138|NCT03341299|19951270|P1|COMPLETED|Period 1||9
8093139|NCT03341299|19951267|P4|STARTED|Period 1||9
8093140|NCT03341299|19951268|P3|STARTED|Period 1||9
8093141|NCT03341299|19951269|P2|STARTED|Period 1||9
8093142|NCT03341299|19951270|P1|STARTED|Period 1||9
8093173|NCT03340805|19951370|P2|NOT COMPLETED|Overall Study||0
8093174|NCT03340805|19951371|P1|NOT COMPLETED|Overall Study||0
8093175|NCT03340805|19951370|P2|COMPLETED|Overall Study||26
8093176|NCT03340805|19951371|P1|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24
8093177|NCT03340805|19951370|P2|STARTED|Overall Study||26
8093178|NCT03340805|19951371|P1|STARTED|Overall Study||24
8093179|NCT03340610|19951391|P1|NOT COMPLETED|Overall Study||3
8093180|NCT03340610|19951391|P1|COMPLETED|Overall Study||27
8093181|NCT03340610|19951391|P1|STARTED|Overall Study||30
8093182|NCT03340350|19951395|P1|NOT COMPLETED|Overall Study||6
8093183|NCT03340350|19951395|P1|COMPLETED|Overall Study||4
8093184|NCT03340350|19951395|P1|STARTED|Overall Study||10
8093185|NCT03339726|19951410|P3|NOT COMPLETED|Overall Study||0
8093186|NCT03339726|19951411|P2|NOT COMPLETED|Overall Study||1
8093187|NCT03339726|19951412|P1|NOT COMPLETED|Overall Study||1
8093188|NCT03339726|19951410|P3|COMPLETED|Overall Study||63
8093189|NCT03339726|19951411|P2|COMPLETED|Overall Study||65
8093190|NCT03339726|19951412|P1|COMPLETED|Overall Study||63
8093191|NCT03339726|19951410|P3|STARTED|Overall Study||63
8093192|NCT03339726|19951411|P2|STARTED|Overall Study||66
8093193|NCT03339726|19951412|P1|STARTED|Overall Study||64
8093194|NCT03339583|19951470|P2|NOT COMPLETED|Follow-up (14 Days)||3
8093195|NCT03339583|19951471|P1|NOT COMPLETED|Follow-up (14 Days)||6
8093196|NCT03339583|19951470|P2|COMPLETED|Follow-up (14 Days)||18
8093197|NCT03339583|19951471|P1|COMPLETED|Follow-up (14 Days)||12
8093198|NCT03339583|19951470|P2|STARTED|Follow-up (14 Days)||21
8093199|NCT03339583|19951471|P1|STARTED|Follow-up (14 Days)||18
8093200|NCT03339583|19951470|P2|NOT COMPLETED|Second Intervention (14 Days)||2
8093201|NCT03339583|19951471|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8093202|NCT03339583|19951470|P2|COMPLETED|Second Intervention (14 Days)||21
8093203|NCT03339583|19951471|P1|COMPLETED|Second Intervention (14 Days)||18
8093204|NCT03339583|19951470|P2|STARTED|Second Intervention (14 Days)||23
8093205|NCT03339583|19951471|P1|STARTED|Second Intervention (14 Days)||18
8093206|NCT03339583|19951470|P2|NOT COMPLETED|Washout (14 Days)||0
8093207|NCT03339583|19951471|P1|NOT COMPLETED|Washout (14 Days)||0
8093208|NCT03339583|19951470|P2|COMPLETED|Washout (14 Days)||23
8093209|NCT03339583|19951471|P1|COMPLETED|Washout (14 Days)||18
8093210|NCT03339583|19951470|P2|STARTED|Washout (14 Days)||23
8093211|NCT03339583|19951471|P1|STARTED|Washout (14 Days)||18
8093212|NCT03339583|19951470|P2|NOT COMPLETED|First Intervention (14 Days)||0
8093213|NCT03339583|19951471|P1|NOT COMPLETED|First Intervention (14 Days)||1
8093214|NCT03339583|19951470|P2|COMPLETED|First Intervention (14 Days)||23
8093215|NCT03339583|19951471|P1|COMPLETED|First Intervention (14 Days)||18
8093216|NCT03339583|19951470|P2|STARTED|First Intervention (14 Days)||23
8093217|NCT03339583|19951471|P1|STARTED|First Intervention (14 Days)||19
8093218|NCT03339453|19951509|P2|NOT COMPLETED|Second Visit for Alternate Glucagon||0
8093219|NCT03339453|19951510|P1|NOT COMPLETED|Second Visit for Alternate Glucagon||0
8093220|NCT03339453|19951509|P2|COMPLETED|Second Visit for Alternate Glucagon||34
8093221|NCT03339453|19951510|P1|COMPLETED|Second Visit for Alternate Glucagon||35
8093222|NCT03339453|19951509|P2|STARTED|Second Visit for Alternate Glucagon||34
8093223|NCT03339453|19951510|P1|STARTED|Second Visit for Alternate Glucagon||35
8093224|NCT03339453|19951509|P2|NOT COMPLETED|First Visit of Glucagon Treatment||1
8093225|NCT03339453|19951510|P1|NOT COMPLETED|First Visit of Glucagon Treatment||0
8093226|NCT03339453|19951509|P2|COMPLETED|First Visit of Glucagon Treatment||34
8093227|NCT03339453|19951510|P1|COMPLETED|First Visit of Glucagon Treatment||35
8093228|NCT03339453|19951509|P2|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
8093229|NCT03339453|19951510|P1|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
8093230|NCT03339453|19951509|P2|STARTED|First Visit of Glucagon Treatment||35
8093231|NCT03339453|19951510|P1|STARTED|First Visit of Glucagon Treatment||35
8093232|NCT03339401|19951528|P2|NOT COMPLETED|Overall Study||4
8093233|NCT03339401|19951529|P1|NOT COMPLETED|Overall Study||9
8093234|NCT03339401|19951528|P2|COMPLETED|Overall Study||5
8093235|NCT03339401|19951529|P1|COMPLETED|Overall Study||11
8093236|NCT03339401|19951528|P2|STARTED|Overall Study||9
8093237|NCT03339401|19951529|P1|STARTED|Overall Study||20
8093238|NCT03339206|19951538|P3|NOT COMPLETED|Overall Study||0
8093239|NCT03339206|19951539|P2|NOT COMPLETED|Overall Study||0
8093240|NCT03339206|19951540|P1|NOT COMPLETED|Overall Study||0
8093241|NCT03339206|19951538|P3|COMPLETED|Overall Study||264
8093242|NCT03339206|19951539|P2|COMPLETED|Overall Study||263
8093243|NCT03339206|19951540|P1|COMPLETED|Overall Study||262
8093244|NCT03339206|19951538|P3|STARTED|Overall Study||264
8093245|NCT03339206|19951539|P2|STARTED|Overall Study||263
8093246|NCT03339206|19951540|P1|STARTED|Overall Study||262
8093247|NCT03338855|19951583|P2|NOT COMPLETED|Overall Study||0
8093248|NCT03338855|19951584|P1|NOT COMPLETED|Overall Study||1
8093249|NCT03338855|19951583|P2|COMPLETED|Overall Study||14
8093250|NCT03338855|19951584|P1|COMPLETED|Overall Study||11
8093251|NCT03338855|19951583|P2|Received Treatment in Period 2|Overall Study||14
8093252|NCT03338855|19951584|P1|Received Treatment in Period 2|Overall Study||11
8093253|NCT03338855|19951583|P2|Received Treatment in Period 1|Overall Study||14
8093254|NCT03338855|19951584|P1|Received Treatment in Period 1|Overall Study||12
8093255|NCT03338855|19951583|P2|STARTED|Overall Study||14
8093256|NCT03338855|19951584|P1|STARTED|Overall Study||12
8093269|NCT03338803|19951635|P1|NOT COMPLETED|Overall Study||0
8093270|NCT03338803|19951635|P1|COMPLETED|Overall Study||11001
8093271|NCT03338803|19951635|P1|STARTED|Overall Study||11001
8093272|NCT03338673|19951644|P2|NOT COMPLETED|Overall Study||1
8093273|NCT03338673|19951645|P1|NOT COMPLETED|Overall Study||1
8093274|NCT03338673|19951644|P2|COMPLETED|Overall Study||5
8093275|NCT03338673|19951645|P1|COMPLETED|Overall Study||5
8093276|NCT03338673|19951644|P2|STARTED|Overall Study||6
8093277|NCT03338673|19951645|P1|STARTED|Overall Study||6
8093278|NCT03338556|19951657|P4|NOT COMPLETED|Overall Study||2
8093279|NCT03338556|19951658|P3|NOT COMPLETED|Overall Study||2
8093280|NCT03338556|19951659|P2|NOT COMPLETED|Overall Study||4
8093281|NCT03338556|19951660|P1|NOT COMPLETED|Overall Study||2
8093282|NCT03338556|19951657|P4|COMPLETED|Overall Study||24
8093283|NCT03338556|19951658|P3|COMPLETED|Overall Study||22
8093284|NCT03338556|19951659|P2|COMPLETED|Overall Study||23
8093285|NCT03338556|19951660|P1|COMPLETED|Overall Study||23
8093286|NCT03338556|19951657|P4|STARTED|Overall Study||26
8093287|NCT03338556|19951658|P3|STARTED|Overall Study||24
8093288|NCT03338556|19951659|P2|STARTED|Overall Study||27
8093289|NCT03338556|19951660|P1|STARTED|Overall Study||25
8093296|NCT03338036|19951691|P4|NOT COMPLETED|Overall Study||0
8093297|NCT03338036|19951692|P3|NOT COMPLETED|Overall Study||3
8093298|NCT03338036|19951693|P2|NOT COMPLETED|Overall Study||4
8093299|NCT03338036|19951694|P1|NOT COMPLETED|Overall Study||0
8093300|NCT03338036|19951691|P4|COMPLETED|Overall Study||8
8093301|NCT03338036|19951692|P3|COMPLETED|Overall Study||9
8093302|NCT03338036|19951693|P2|COMPLETED|Overall Study||7
8093303|NCT03338036|19951694|P1|COMPLETED|Overall Study||0
8093304|NCT03338036|19951691|P4|STARTED|Overall Study||8
8093305|NCT03338036|19951692|P3|STARTED|Overall Study||12
8093306|NCT03338036|19951693|P2|STARTED|Overall Study||11
8093307|NCT03338036|19951694|P1|STARTED|Overall Study||0
8093308|NCT03337490|19951717|P3|NOT COMPLETED|Overall Study||35
8093309|NCT03337490|19951718|P2|NOT COMPLETED|Overall Study||14
8093310|NCT03337490|19951719|P1|NOT COMPLETED|Overall Study||11
8093311|NCT03337490|19951717|P3|COMPLETED|Overall Study||7
8093312|NCT03337490|19951718|P2|COMPLETED|Overall Study||112
8093313|NCT03337490|19951719|P1|COMPLETED|Overall Study||117
8093314|NCT03337490|19951717|P3|STARTED|Overall Study||42
8093315|NCT03337490|19951718|P2|STARTED|Overall Study||126
8093316|NCT03337490|19951719|P1|STARTED|Overall Study||128
8093317|NCT03337477|19951732|P2|NOT COMPLETED|Overall Study||13
8093318|NCT03337477|19951733|P1|NOT COMPLETED|Overall Study||11
8093319|NCT03337477|19951732|P2|COMPLETED|Overall Study||24
8093320|NCT03337477|19951733|P1|COMPLETED|Overall Study||22
8093321|NCT03337477|19951732|P2|STARTED|Overall Study||37
8093322|NCT03337477|19951733|P1|STARTED|Overall Study||33
8093323|NCT03337308|19951757|P4|NOT COMPLETED|Overall Study||2
8093324|NCT03337308|19951758|P3|NOT COMPLETED|Overall Study||5
8093325|NCT03337308|19951759|P2|NOT COMPLETED|Overall Study||7
8093326|NCT03337308|19951760|P1|NOT COMPLETED|Overall Study||5
8093327|NCT03337308|19951757|P4|COMPLETED|Overall Study||53
8093328|NCT03337308|19951758|P3|COMPLETED|Overall Study||104
8093329|NCT03337308|19951759|P2|COMPLETED|Overall Study||103
8093330|NCT03337308|19951760|P1|COMPLETED|Overall Study||103
8093331|NCT03337308|19951757|P4|STARTED|Overall Study||55
8093332|NCT03337308|19951758|P3|STARTED|Overall Study||109
8093333|NCT03337308|19951759|P2|STARTED|Overall Study||110
8093334|NCT03337308|19951760|P1|STARTED|Overall Study||108
8093335|NCT03337139|19951796|P2|NOT COMPLETED|Phase II||3
8093336|NCT03337139|19951797|P1|NOT COMPLETED|Phase II||5
8093337|NCT03337139|19951796|P2|COMPLETED|Phase II||36
8093338|NCT03337139|19951797|P1|COMPLETED|Phase II||33
8093339|NCT03337139|19951796|P2|26 Week Assessment|Phase II||37
8093340|NCT03337139|19951797|P1|26 Week Assessment|Phase II||34
8093341|NCT03337139|19951796|P2|STARTED|Phase II||39
8093342|NCT03337139|19951797|P1|STARTED|Phase II||38
8093343|NCT03337139|19951796|P2|NOT COMPLETED|Phase I||0
8093344|NCT03337139|19951797|P1|NOT COMPLETED|Phase I||10
8093345|NCT03337139|19951796|P2|COMPLETED|Phase I||0
8093346|NCT03337139|19951797|P1|COMPLETED|Phase I||77
8093347|NCT03337139|19951796|P2|STARTED|Phase I|There were not two conditions in Phase I: all participants received standard group LM treatment.|0
8093348|NCT03337139|19951797|P1|STARTED|Phase I||87
8093349|NCT03336853|19951817|P2|NOT COMPLETED|Overall Study||0
8093350|NCT03336853|19951818|P1|NOT COMPLETED|Overall Study||0
8093351|NCT03336853|19951817|P2|COMPLETED|Overall Study||30
8093352|NCT03336853|19951818|P1|COMPLETED|Overall Study||30
8093353|NCT03336853|19951817|P2|STARTED|Overall Study||30
8093354|NCT03336853|19951818|P1|STARTED|Overall Study||30
8093355|NCT03336645|19951824|P1|NOT COMPLETED|Overall Study||0
8093356|NCT03336645|19951824|P1|COMPLETED|Overall Study||25
8093357|NCT03336645|19951824|P1|STARTED|Overall Study||25
8093358|NCT03336502|19951848|P2|NOT COMPLETED|Overall Study||9
8093359|NCT03336502|19951849|P1|NOT COMPLETED|Overall Study||4
8093360|NCT03336502|19951848|P2|COMPLETED|Overall Study||31
8093361|NCT03336502|19951849|P1|COMPLETED|Overall Study||26
8093362|NCT03336502|19951848|P2|STARTED|Overall Study||40
8093363|NCT03336502|19951849|P1|STARTED|Overall Study||30
8093364|NCT03335800|19951876|P1|NOT COMPLETED|Overall Study||419531
8093365|NCT03335800|19951876|P1|COMPLETED|Overall Study||396
8093366|NCT03335800|19951876|P1|Attended Second Study Visit|Overall Study||396
8093367|NCT03335800|19951876|P1|ECG Patch Returned for Analysis|Overall Study||450
8093368|NCT03335800|19951876|P1|ECG Patch Shipped|Overall Study||658
8093369|NCT03335800|19951876|P1|Attended First Study Visit|Overall Study||945
8093370|NCT03335800|19951876|P1|Received Irregular Pulse Notification|Overall Study||2161
8093371|NCT03335800|19951876|P1|STARTED|Overall Study||419927
8093372|NCT03335761|19951886|P3|NOT COMPLETED|Overall Study||2
8093373|NCT03335761|19951887|P2|NOT COMPLETED|Overall Study||1
8093374|NCT03335761|19951888|P1|NOT COMPLETED|Overall Study||2
8093375|NCT03335761|19951886|P3|COMPLETED|Overall Study||13
8093376|NCT03335761|19951887|P2|COMPLETED|Overall Study||13
8093377|NCT03335761|19951888|P1|COMPLETED|Overall Study||17
8093378|NCT03335761|19951886|P3|Implanted With a Neurostimulator Device|Overall Study||14
8093379|NCT03335761|19951887|P2|Implanted With a Neurostimulator Device|Overall Study||14
8093380|NCT03335761|19951888|P1|Implanted With a Neurostimulator Device|Overall Study||18
8093381|NCT03335761|19951886|P3|STARTED|Overall Study||15
8093382|NCT03335761|19951887|P2|STARTED|Overall Study||14
8093383|NCT03335761|19951888|P1|STARTED|Overall Study||19
8093384|NCT03335566|19951901|P2|NOT COMPLETED|Overall Study||3
8093385|NCT03335566|19951902|P1|NOT COMPLETED|Overall Study||4
8093386|NCT03335566|19951901|P2|COMPLETED|Overall Study||203
8093387|NCT03335566|19951902|P1|COMPLETED|Overall Study||214
8093388|NCT03335566|19951901|P2|STARTED|Overall Study||206
8093389|NCT03335566|19951902|P1|STARTED|Overall Study||218
8093390|NCT03335254|19951934|P20|NOT COMPLETED|Period 3, Day 26-30||0
8093391|NCT03335254|19951935|P19|NOT COMPLETED|Period 3, Day 26-30||0
8093392|NCT03335254|19951936|P18|NOT COMPLETED|Period 3, Day 26-30||0
8093393|NCT03335254|19951937|P17|NOT COMPLETED|Period 3, Day 26-30||0
8093394|NCT03335254|19951938|P16|NOT COMPLETED|Period 3, Day 26-30||0
8093395|NCT03335254|19951939|P15|NOT COMPLETED|Period 3, Day 26-30||0
8093396|NCT03335254|19951940|P14|NOT COMPLETED|Period 3, Day 26-30||0
8093397|NCT03335254|19951941|P13|NOT COMPLETED|Period 3, Day 26-30||0
8093398|NCT03335254|19951942|P12|NOT COMPLETED|Period 3, Day 26-30||0
8093399|NCT03335254|19951943|P11|NOT COMPLETED|Period 3, Day 26-30||0
8093400|NCT03335254|19951944|P10|NOT COMPLETED|Period 3, Day 26-30||0
8093401|NCT03335254|19951945|P9|NOT COMPLETED|Period 3, Day 26-30||0
8093402|NCT03335254|19951946|P8|NOT COMPLETED|Period 3, Day 26-30||0
8093403|NCT03335254|19951947|P7|NOT COMPLETED|Period 3, Day 26-30||0
8093404|NCT03335254|19951948|P6|NOT COMPLETED|Period 3, Day 26-30||0
8093405|NCT03335254|19951949|P5|NOT COMPLETED|Period 3, Day 26-30||0
8093406|NCT03335254|19951950|P4|NOT COMPLETED|Period 3, Day 26-30||0
8093407|NCT03335254|19951951|P3|NOT COMPLETED|Period 3, Day 26-30||0
8093408|NCT03335254|19951952|P2|NOT COMPLETED|Period 3, Day 26-30||0
8093409|NCT03335254|19951953|P1|NOT COMPLETED|Period 3, Day 26-30||0
8093410|NCT03335254|19951934|P20|COMPLETED|Period 3, Day 26-30||0
8093411|NCT03335254|19951935|P19|COMPLETED|Period 3, Day 26-30||0
8093412|NCT03335254|19951936|P18|COMPLETED|Period 3, Day 26-30||0
8093413|NCT03335254|19951937|P17|COMPLETED|Period 3, Day 26-30||0
8093414|NCT03335254|19951938|P16|COMPLETED|Period 3, Day 26-30||0
8093415|NCT03335254|19951939|P15|COMPLETED|Period 3, Day 26-30||0
8093416|NCT03335254|19951940|P14|COMPLETED|Period 3, Day 26-30||0
8093417|NCT03335254|19951941|P13|COMPLETED|Period 3, Day 26-30||0
8093418|NCT03335254|19951942|P12|COMPLETED|Period 3, Day 26-30||0
8093419|NCT03335254|19951943|P11|COMPLETED|Period 3, Day 26-30||0
8093420|NCT03335254|19951944|P10|COMPLETED|Period 3, Day 26-30||0
8093421|NCT03335254|19951945|P9|COMPLETED|Period 3, Day 26-30||0
8093422|NCT03335254|19951946|P8|COMPLETED|Period 3, Day 26-30||0
8093423|NCT03335254|19951947|P7|COMPLETED|Period 3, Day 26-30||0
8093424|NCT03335254|19951948|P6|COMPLETED|Period 3, Day 26-30||0
8093425|NCT03335254|19951949|P5|COMPLETED|Period 3, Day 26-30||0
8093426|NCT03335254|19951950|P4|COMPLETED|Period 3, Day 26-30||0
8093427|NCT03335254|19951951|P3|COMPLETED|Period 3, Day 26-30||0
8093428|NCT03335254|19951952|P2|COMPLETED|Period 3, Day 26-30||0
8093429|NCT03335254|19951953|P1|COMPLETED|Period 3, Day 26-30||9
8093430|NCT03335254|19951934|P20|STARTED|Period 3, Day 26-30||0
8093431|NCT03335254|19951935|P19|STARTED|Period 3, Day 26-30||0
8093432|NCT03335254|19951936|P18|STARTED|Period 3, Day 26-30||0
8093433|NCT03335254|19951937|P17|STARTED|Period 3, Day 26-30||0
8093434|NCT03335254|19951938|P16|STARTED|Period 3, Day 26-30||0
8093435|NCT03335254|19951939|P15|STARTED|Period 3, Day 26-30||0
8093436|NCT03335254|19951940|P14|STARTED|Period 3, Day 26-30||0
8093437|NCT03335254|19951941|P13|STARTED|Period 3, Day 26-30||0
8093438|NCT03335254|19951942|P12|STARTED|Period 3, Day 26-30||0
8093439|NCT03335254|19951943|P11|STARTED|Period 3, Day 26-30||0
8093440|NCT03335254|19951944|P10|STARTED|Period 3, Day 26-30||0
8093441|NCT03335254|19951945|P9|STARTED|Period 3, Day 26-30||0
8093442|NCT03335254|19951946|P8|STARTED|Period 3, Day 26-30||0
8093443|NCT03335254|19951947|P7|STARTED|Period 3, Day 26-30||0
8093444|NCT03335254|19951948|P6|STARTED|Period 3, Day 26-30||0
8093445|NCT03335254|19951949|P5|STARTED|Period 3, Day 26-30||0
8093446|NCT03335254|19951950|P4|STARTED|Period 3, Day 26-30||0
8093447|NCT03335254|19951951|P3|STARTED|Period 3, Day 26-30||0
8093448|NCT03335254|19951952|P2|STARTED|Period 3, Day 26-30||0
8093449|NCT03335254|19951953|P1|STARTED|Period 3, Day 26-30||9
8093450|NCT03335254|19951934|P20|NOT COMPLETED|Period 3, Day 16-25||0
8093451|NCT03335254|19951935|P19|NOT COMPLETED|Period 3, Day 16-25||0
8093452|NCT03335254|19951936|P18|NOT COMPLETED|Period 3, Day 16-25||0
8093453|NCT03335254|19951937|P17|NOT COMPLETED|Period 3, Day 16-25||0
8093454|NCT03335254|19951938|P16|NOT COMPLETED|Period 3, Day 16-25||0
8093455|NCT03335254|19951939|P15|NOT COMPLETED|Period 3, Day 16-25||0
8093456|NCT03335254|19951940|P14|NOT COMPLETED|Period 3, Day 16-25||0
8093457|NCT03335254|19951941|P13|NOT COMPLETED|Period 3, Day 16-25||0
8093458|NCT03335254|19951942|P12|NOT COMPLETED|Period 3, Day 16-25||0
8093459|NCT03335254|19951943|P11|NOT COMPLETED|Period 3, Day 16-25||0
8093460|NCT03335254|19951944|P10|NOT COMPLETED|Period 3, Day 16-25||0
8093461|NCT03335254|19951945|P9|NOT COMPLETED|Period 3, Day 16-25||0
8093462|NCT03335254|19951946|P8|NOT COMPLETED|Period 3, Day 16-25||0
8093463|NCT03335254|19951947|P7|NOT COMPLETED|Period 3, Day 16-25||0
8093464|NCT03335254|19951948|P6|NOT COMPLETED|Period 3, Day 16-25||0
8093465|NCT03335254|19951949|P5|NOT COMPLETED|Period 3, Day 16-25||0
8093466|NCT03335254|19951950|P4|NOT COMPLETED|Period 3, Day 16-25||0
8093467|NCT03335254|19951951|P3|NOT COMPLETED|Period 3, Day 16-25||0
8093468|NCT03335254|19951952|P2|NOT COMPLETED|Period 3, Day 16-25||0
8093469|NCT03335254|19951953|P1|NOT COMPLETED|Period 3, Day 16-25||0
8093470|NCT03335254|19951934|P20|COMPLETED|Period 3, Day 16-25||0
8093471|NCT03335254|19951935|P19|COMPLETED|Period 3, Day 16-25||0
8093472|NCT03335254|19951936|P18|COMPLETED|Period 3, Day 16-25||0
8093473|NCT03335254|19951937|P17|COMPLETED|Period 3, Day 16-25||0
8093474|NCT03335254|19951938|P16|COMPLETED|Period 3, Day 16-25||0
8093475|NCT03335254|19951939|P15|COMPLETED|Period 3, Day 16-25||0
8093476|NCT03335254|19951940|P14|COMPLETED|Period 3, Day 16-25||0
8093477|NCT03335254|19951941|P13|COMPLETED|Period 3, Day 16-25||0
8093478|NCT03335254|19951942|P12|COMPLETED|Period 3, Day 16-25||0
8093479|NCT03335254|19951943|P11|COMPLETED|Period 3, Day 16-25||0
8093480|NCT03335254|19951944|P10|COMPLETED|Period 3, Day 16-25||0
8093481|NCT03335254|19951945|P9|COMPLETED|Period 3, Day 16-25||0
8093482|NCT03335254|19951946|P8|COMPLETED|Period 3, Day 16-25||0
8093483|NCT03335254|19951947|P7|COMPLETED|Period 3, Day 16-25||0
8093484|NCT03335254|19951948|P6|COMPLETED|Period 3, Day 16-25||0
8093485|NCT03335254|19951949|P5|COMPLETED|Period 3, Day 16-25||0
8093486|NCT03335254|19951950|P4|COMPLETED|Period 3, Day 16-25||0
8093487|NCT03335254|19951951|P3|COMPLETED|Period 3, Day 16-25||0
8093488|NCT03335254|19951952|P2|COMPLETED|Period 3, Day 16-25||0
8093489|NCT03335254|19951953|P1|COMPLETED|Period 3, Day 16-25||9
8093490|NCT03335254|19951934|P20|STARTED|Period 3, Day 16-25||0
8093491|NCT03335254|19951935|P19|STARTED|Period 3, Day 16-25||0
8093492|NCT03335254|19951936|P18|STARTED|Period 3, Day 16-25||0
8093493|NCT03335254|19951937|P17|STARTED|Period 3, Day 16-25||0
8093494|NCT03335254|19951938|P16|STARTED|Period 3, Day 16-25||0
8093495|NCT03335254|19951939|P15|STARTED|Period 3, Day 16-25||0
8093496|NCT03335254|19951940|P14|STARTED|Period 3, Day 16-25||0
8093497|NCT03335254|19951941|P13|STARTED|Period 3, Day 16-25||0
8093498|NCT03335254|19951942|P12|STARTED|Period 3, Day 16-25||0
8093499|NCT03335254|19951943|P11|STARTED|Period 3, Day 16-25||0
8093500|NCT03335254|19951944|P10|STARTED|Period 3, Day 16-25||0
8093501|NCT03335254|19951945|P9|STARTED|Period 3, Day 16-25||0
8093502|NCT03335254|19951946|P8|STARTED|Period 3, Day 16-25||0
8093503|NCT03335254|19951947|P7|STARTED|Period 3, Day 16-25||0
8093504|NCT03335254|19951948|P6|STARTED|Period 3, Day 16-25||0
8093505|NCT03335254|19951949|P5|STARTED|Period 3, Day 16-25||0
8093506|NCT03335254|19951950|P4|STARTED|Period 3, Day 16-25||0
8093507|NCT03335254|19951951|P3|STARTED|Period 3, Day 16-25||0
8093508|NCT03335254|19951952|P2|STARTED|Period 3, Day 16-25||0
8093509|NCT03335254|19951953|P1|STARTED|Period 3, Day 16-25||9
8093510|NCT03335254|19951934|P20|NOT COMPLETED|Period 2, Day 1-15||0
8093511|NCT03335254|19951935|P19|NOT COMPLETED|Period 2, Day 1-15||0
8093512|NCT03335254|19951936|P18|NOT COMPLETED|Period 2, Day 1-15||0
8093513|NCT03335254|19951937|P17|NOT COMPLETED|Period 2, Day 1-15||0
8093514|NCT03335254|19951938|P16|NOT COMPLETED|Period 2, Day 1-15||0
8093515|NCT03335254|19951939|P15|NOT COMPLETED|Period 2, Day 1-15||0
8093516|NCT03335254|19951940|P14|NOT COMPLETED|Period 2, Day 1-15||0
8093517|NCT03335254|19951941|P13|NOT COMPLETED|Period 2, Day 1-15||0
8093518|NCT03335254|19951942|P12|NOT COMPLETED|Period 2, Day 1-15||0
8093519|NCT03335254|19951943|P11|NOT COMPLETED|Period 2, Day 1-15||0
8093520|NCT03335254|19951944|P10|NOT COMPLETED|Period 2, Day 1-15||0
8093521|NCT03335254|19951945|P9|NOT COMPLETED|Period 2, Day 1-15||0
8093522|NCT03335254|19951946|P8|NOT COMPLETED|Period 2, Day 1-15||0
8093523|NCT03335254|19951947|P7|NOT COMPLETED|Period 2, Day 1-15||0
8093524|NCT03335254|19951948|P6|NOT COMPLETED|Period 2, Day 1-15||0
8093525|NCT03335254|19951949|P5|NOT COMPLETED|Period 2, Day 1-15||0
8093526|NCT03335254|19951950|P4|NOT COMPLETED|Period 2, Day 1-15||0
8093527|NCT03335254|19951951|P3|NOT COMPLETED|Period 2, Day 1-15||0
8093528|NCT03335254|19951952|P2|NOT COMPLETED|Period 2, Day 1-15||0
8093529|NCT03335254|19951953|P1|NOT COMPLETED|Period 2, Day 1-15||0
8093530|NCT03335254|19951934|P20|COMPLETED|Period 2, Day 1-15||0
8093531|NCT03335254|19951935|P19|COMPLETED|Period 2, Day 1-15||0
8093532|NCT03335254|19951936|P18|COMPLETED|Period 2, Day 1-15||0
8093533|NCT03335254|19951937|P17|COMPLETED|Period 2, Day 1-15||0
8093534|NCT03335254|19951938|P16|COMPLETED|Period 2, Day 1-15||0
8093535|NCT03335254|19951939|P15|COMPLETED|Period 2, Day 1-15||0
8093536|NCT03335254|19951940|P14|COMPLETED|Period 2, Day 1-15||0
8093537|NCT03335254|19951941|P13|COMPLETED|Period 2, Day 1-15||0
8093538|NCT03335254|19951942|P12|COMPLETED|Period 2, Day 1-15||0
8093539|NCT03335254|19951943|P11|COMPLETED|Period 2, Day 1-15||0
8093540|NCT03335254|19951944|P10|COMPLETED|Period 2, Day 1-15||0
8093541|NCT03335254|19951945|P9|COMPLETED|Period 2, Day 1-15||0
8093542|NCT03335254|19951946|P8|COMPLETED|Period 2, Day 1-15||0
8093543|NCT03335254|19951947|P7|COMPLETED|Period 2, Day 1-15||0
8093544|NCT03335254|19951948|P6|COMPLETED|Period 2, Day 1-15||0
8093545|NCT03335254|19951949|P5|COMPLETED|Period 2, Day 1-15||0
8093546|NCT03335254|19951950|P4|COMPLETED|Period 2, Day 1-15||0
8093547|NCT03335254|19951951|P3|COMPLETED|Period 2, Day 1-15||0
8093548|NCT03335254|19951952|P2|COMPLETED|Period 2, Day 1-15||0
8093549|NCT03335254|19951953|P1|COMPLETED|Period 2, Day 1-15||9
8093550|NCT03335254|19951934|P20|STARTED|Period 2, Day 1-15||0
8093551|NCT03335254|19951935|P19|STARTED|Period 2, Day 1-15||0
8093552|NCT03335254|19951936|P18|STARTED|Period 2, Day 1-15||0
8093553|NCT03335254|19951937|P17|STARTED|Period 2, Day 1-15||0
8093554|NCT03335254|19951938|P16|STARTED|Period 2, Day 1-15||0
8093555|NCT03335254|19951939|P15|STARTED|Period 2, Day 1-15||0
8093556|NCT03335254|19951940|P14|STARTED|Period 2, Day 1-15||0
8093557|NCT03335254|19951941|P13|STARTED|Period 2, Day 1-15||0
8093558|NCT03335254|19951942|P12|STARTED|Period 2, Day 1-15||0
8093559|NCT03335254|19951943|P11|STARTED|Period 2, Day 1-15||0
8093560|NCT03335254|19951944|P10|STARTED|Period 2, Day 1-15||0
8093561|NCT03335254|19951945|P9|STARTED|Period 2, Day 1-15||0
8093562|NCT03335254|19951946|P8|STARTED|Period 2, Day 1-15||0
8093563|NCT03335254|19951947|P7|STARTED|Period 2, Day 1-15||0
8093564|NCT03335254|19951948|P6|STARTED|Period 2, Day 1-15||0
8093565|NCT03335254|19951949|P5|STARTED|Period 2, Day 1-15||0
8093566|NCT03335254|19951950|P4|STARTED|Period 2, Day 1-15||0
8093567|NCT03335254|19951951|P3|STARTED|Period 2, Day 1-15||0
8093568|NCT03335254|19951952|P2|STARTED|Period 2, Day 1-15||0
8093569|NCT03335254|19951953|P1|STARTED|Period 2, Day 1-15||9
8093570|NCT03335254|19951934|P20|NOT COMPLETED|Period 1||0
8093571|NCT03335254|19951935|P19|NOT COMPLETED|Period 1||0
8093572|NCT03335254|19951936|P18|NOT COMPLETED|Period 1||0
8093573|NCT03335254|19951937|P17|NOT COMPLETED|Period 1||0
8093574|NCT03335254|19951938|P16|NOT COMPLETED|Period 1||0
8093575|NCT03335254|19951939|P15|NOT COMPLETED|Period 1||0
8093576|NCT03335254|19951940|P14|NOT COMPLETED|Period 1||0
8093577|NCT03335254|19951941|P13|NOT COMPLETED|Period 1||0
8093578|NCT03335254|19951942|P12|NOT COMPLETED|Period 1||0
8093579|NCT03335254|19951943|P11|NOT COMPLETED|Period 1||0
8093580|NCT03335254|19951944|P10|NOT COMPLETED|Period 1||0
8093581|NCT03335254|19951945|P9|NOT COMPLETED|Period 1||0
8093582|NCT03335254|19951946|P8|NOT COMPLETED|Period 1||0
8093583|NCT03335254|19951947|P7|NOT COMPLETED|Period 1||0
8093584|NCT03335254|19951948|P6|NOT COMPLETED|Period 1||0
8093585|NCT03335254|19951949|P5|NOT COMPLETED|Period 1||0
8093586|NCT03335254|19951950|P4|NOT COMPLETED|Period 1||0
8093587|NCT03335254|19951951|P3|NOT COMPLETED|Period 1||0
8093588|NCT03335254|19951952|P2|NOT COMPLETED|Period 1||0
8093589|NCT03335254|19951953|P1|NOT COMPLETED|Period 1||0
8093590|NCT03335254|19951934|P20|COMPLETED|Period 1||0
8093591|NCT03335254|19951935|P19|COMPLETED|Period 1||0
8093592|NCT03335254|19951936|P18|COMPLETED|Period 1||0
8093593|NCT03335254|19951937|P17|COMPLETED|Period 1||0
8093594|NCT03335254|19951938|P16|COMPLETED|Period 1||0
8093595|NCT03335254|19951939|P15|COMPLETED|Period 1||0
8093596|NCT03335254|19951940|P14|COMPLETED|Period 1||0
8093597|NCT03335254|19951941|P13|COMPLETED|Period 1||0
8093598|NCT03335254|19951942|P12|COMPLETED|Period 1||0
8093599|NCT03335254|19951943|P11|COMPLETED|Period 1||0
8093600|NCT03335254|19951944|P10|COMPLETED|Period 1||0
8093601|NCT03335254|19951945|P9|COMPLETED|Period 1||0
8093602|NCT03335254|19951946|P8|COMPLETED|Period 1||0
8093603|NCT03335254|19951947|P7|COMPLETED|Period 1||0
8093604|NCT03335254|19951948|P6|COMPLETED|Period 1||0
8093605|NCT03335254|19951949|P5|COMPLETED|Period 1||0
8093606|NCT03335254|19951950|P4|COMPLETED|Period 1||0
8093607|NCT03335254|19951951|P3|COMPLETED|Period 1||0
8093608|NCT03335254|19951952|P2|COMPLETED|Period 1||0
8093609|NCT03335254|19951953|P1|COMPLETED|Period 1||9
8093610|NCT03335254|19951934|P20|STARTED|Period 1||0
8093611|NCT03335254|19951935|P19|STARTED|Period 1||0
8093612|NCT03335254|19951936|P18|STARTED|Period 1||0
8093613|NCT03335254|19951937|P17|STARTED|Period 1||0
8093614|NCT03335254|19951938|P16|STARTED|Period 1||0
8093615|NCT03335254|19951939|P15|STARTED|Period 1||0
8093616|NCT03335254|19951940|P14|STARTED|Period 1||0
8093617|NCT03335254|19951941|P13|STARTED|Period 1||0
8093618|NCT03335254|19951942|P12|STARTED|Period 1||0
8093619|NCT03335254|19951943|P11|STARTED|Period 1||0
8093620|NCT03335254|19951944|P10|STARTED|Period 1||0
8093621|NCT03335254|19951945|P9|STARTED|Period 1||0
8093622|NCT03335254|19951946|P8|STARTED|Period 1||0
8093623|NCT03335254|19951947|P7|STARTED|Period 1||0
8093624|NCT03335254|19951948|P6|STARTED|Period 1||0
8093625|NCT03335254|19951949|P5|STARTED|Period 1||0
8093626|NCT03335254|19951950|P4|STARTED|Period 1||0
8093627|NCT03335254|19951951|P3|STARTED|Period 1||0
8093628|NCT03335254|19951952|P2|STARTED|Period 1||0
8093629|NCT03335254|19951953|P1|STARTED|Period 1||9
8093630|NCT03334825|19951984|P2|NOT COMPLETED|Overall Study||4
8093631|NCT03334825|19951985|P1|NOT COMPLETED|Overall Study||7
8093632|NCT03334825|19951984|P2|COMPLETED|Overall Study||113
8093633|NCT03334825|19951985|P1|COMPLETED|Overall Study||112
8093634|NCT03334825|19951984|P2|STARTED|Overall Study||117
8093635|NCT03334825|19951985|P1|STARTED|Overall Study||119
8093636|NCT03334812|19951997|P4|NOT COMPLETED|Overall Study||0
8093637|NCT03334812|19951998|P3|NOT COMPLETED|Overall Study||0
8093638|NCT03334812|19951999|P2|NOT COMPLETED|Overall Study||0
8093639|NCT03334812|19952000|P1|NOT COMPLETED|Overall Study||0
8093640|NCT03334812|19951997|P4|COMPLETED|Overall Study||0
8093641|NCT03334812|19951998|P3|COMPLETED|Overall Study||0
8093642|NCT03334812|19951999|P2|COMPLETED|Overall Study||5
8093643|NCT03334812|19952000|P1|COMPLETED|Overall Study||9
8093644|NCT03334812|19951997|P4|STARTED|Overall Study||0
8093645|NCT03334812|19951998|P3|STARTED|Overall Study||0
8093646|NCT03334812|19951999|P2|STARTED|Overall Study||5
8093647|NCT03334812|19952000|P1|STARTED|Overall Study||9
8093648|NCT03334747|19952031|P9|NOT COMPLETED|Follow-Up Phase||1
8093649|NCT03334747|19952032|P8|NOT COMPLETED|Follow-Up Phase||0
8093650|NCT03334747|19952033|P7|NOT COMPLETED|Follow-Up Phase||1
8093651|NCT03334747|19952034|P6|NOT COMPLETED|Follow-Up Phase||0
8093652|NCT03334747|19952035|P5|NOT COMPLETED|Follow-Up Phase||0
8093653|NCT03334747|19952036|P4|NOT COMPLETED|Follow-Up Phase||0
8093654|NCT03334747|19952037|P3|NOT COMPLETED|Follow-Up Phase||0
8093655|NCT03334747|19952038|P2|NOT COMPLETED|Follow-Up Phase||0
8093656|NCT03334747|19952039|P1|NOT COMPLETED|Follow-Up Phase||0
8093657|NCT03334747|19952031|P9|COMPLETED|Follow-Up Phase||50
8093658|NCT03334747|19952032|P8|COMPLETED|Follow-Up Phase||22
8093659|NCT03334747|19952033|P7|COMPLETED|Follow-Up Phase||20
8093660|NCT03334747|19952034|P6|COMPLETED|Follow-Up Phase||19
8093661|NCT03334747|19952035|P5|COMPLETED|Follow-Up Phase||21
8093662|NCT03334747|19952036|P4|COMPLETED|Follow-Up Phase||20
8093663|NCT03334747|19952037|P3|COMPLETED|Follow-Up Phase||12
8093664|NCT03334747|19952038|P2|COMPLETED|Follow-Up Phase||10
8093665|NCT03334747|19952039|P1|COMPLETED|Follow-Up Phase||9
8093666|NCT03334747|19952031|P9|STARTED|Follow-Up Phase||51
8093667|NCT03334747|19952032|P8|STARTED|Follow-Up Phase||22
8093668|NCT03334747|19952033|P7|STARTED|Follow-Up Phase||21
8093669|NCT03334747|19952034|P6|STARTED|Follow-Up Phase||19
8093670|NCT03334747|19952035|P5|STARTED|Follow-Up Phase||21
8093671|NCT03334747|19952036|P4|STARTED|Follow-Up Phase||20
8093672|NCT03334747|19952037|P3|STARTED|Follow-Up Phase||12
8093673|NCT03334747|19952038|P2|STARTED|Follow-Up Phase||10
8093674|NCT03334747|19952039|P1|STARTED|Follow-Up Phase||9
8093675|NCT03334747|19952031|P9|NOT COMPLETED|Treatment Phase||0
8093676|NCT03334747|19952032|P8|NOT COMPLETED|Treatment Phase||0
8093677|NCT03334747|19952033|P7|NOT COMPLETED|Treatment Phase||0
8093678|NCT03334747|19952034|P6|NOT COMPLETED|Treatment Phase||1
8093679|NCT03334747|19952035|P5|NOT COMPLETED|Treatment Phase||1
8093680|NCT03334747|19952036|P4|NOT COMPLETED|Treatment Phase||0
8093681|NCT03334747|19952037|P3|NOT COMPLETED|Treatment Phase||0
8093682|NCT03334747|19952038|P2|NOT COMPLETED|Treatment Phase||0
8093683|NCT03334747|19952039|P1|NOT COMPLETED|Treatment Phase||1
8093684|NCT03334747|19952031|P9|COMPLETED|Treatment Phase||51
8093685|NCT03334747|19952032|P8|COMPLETED|Treatment Phase||22
8093686|NCT03334747|19952033|P7|COMPLETED|Treatment Phase||21
8093687|NCT03334747|19952034|P6|COMPLETED|Treatment Phase||19
8093688|NCT03334747|19952035|P5|COMPLETED|Treatment Phase||21
8093689|NCT03334747|19952036|P4|COMPLETED|Treatment Phase||20
8093690|NCT03334747|19952037|P3|COMPLETED|Treatment Phase||12
8093691|NCT03334747|19952038|P2|COMPLETED|Treatment Phase||10
8093692|NCT03334747|19952039|P1|COMPLETED|Treatment Phase||9
8093693|NCT03334747|19952031|P9|STARTED|Treatment Phase||51
8093694|NCT03334747|19952032|P8|STARTED|Treatment Phase||22
8093695|NCT03334747|19952033|P7|STARTED|Treatment Phase||21
8093696|NCT03334747|19952034|P6|STARTED|Treatment Phase||20
8093697|NCT03334747|19952035|P5|STARTED|Treatment Phase||22
8093698|NCT03334747|19952036|P4|STARTED|Treatment Phase||20
8093699|NCT03334747|19952037|P3|STARTED|Treatment Phase||12
8093700|NCT03334747|19952038|P2|STARTED|Treatment Phase||10
8093701|NCT03334747|19952039|P1|STARTED|Treatment Phase||10
8093702|NCT03334734|19952131|P4|NOT COMPLETED|Overall Study||0
8093703|NCT03334734|19952132|P3|NOT COMPLETED|Overall Study||2
8093704|NCT03334734|19952133|P2|NOT COMPLETED|Overall Study||0
8093705|NCT03334734|19952134|P1|NOT COMPLETED|Overall Study||0
8093706|NCT03334734|19952131|P4|COMPLETED|Overall Study||1
8093707|NCT03334734|19952132|P3|COMPLETED|Overall Study||5
8093708|NCT03334734|19952133|P2|COMPLETED|Overall Study||4
8093709|NCT03334734|19952134|P1|COMPLETED|Overall Study||4
8093710|NCT03334734|19952131|P4|STARTED|Overall Study||1
8093711|NCT03334734|19952132|P3|STARTED|Overall Study||7
8093712|NCT03334734|19952133|P2|STARTED|Overall Study||4
8093713|NCT03334734|19952134|P1|STARTED|Overall Study||4
8093714|NCT03334721|19952229|P2|NOT COMPLETED|Overall Study||0
8093715|NCT03334721|19952230|P1|NOT COMPLETED|Overall Study||2
8093716|NCT03334721|19952229|P2|COMPLETED|Overall Study||11
8093717|NCT03334721|19952230|P1|COMPLETED|Overall Study||10
8093718|NCT03334721|19952229|P2|STARTED|Overall Study||11
8093719|NCT03334721|19952230|P1|STARTED|Overall Study||12
8093726|NCT03334448|19952281|P4|NOT COMPLETED|Period 4||0
8093727|NCT03334448|19952282|P3|NOT COMPLETED|Period 4||0
8093728|NCT03334448|19952283|P2|NOT COMPLETED|Period 4||0
8093729|NCT03334448|19952284|P1|NOT COMPLETED|Period 4||0
8093730|NCT03334448|19952281|P4|COMPLETED|Period 4||11
8093731|NCT03334448|19952282|P3|COMPLETED|Period 4||13
8093732|NCT03334448|19952283|P2|COMPLETED|Period 4||11
8093733|NCT03334448|19952284|P1|COMPLETED|Period 4||12
8093734|NCT03334448|19952281|P4|Received at Least 1 Dose of Study Drug|Period 4||11
8093735|NCT03334448|19952282|P3|Received at Least 1 Dose of Study Drug|Period 4||13
8093736|NCT03334448|19952283|P2|Received at Least 1 Dose of Study Drug|Period 4||11
8093737|NCT03334448|19952284|P1|Received at Least 1 Dose of Study Drug|Period 4||12
8093738|NCT03334448|19952281|P4|STARTED|Period 4||11
8093739|NCT03334448|19952282|P3|STARTED|Period 4||13
8093740|NCT03334448|19952283|P2|STARTED|Period 4||11
8093741|NCT03334448|19952284|P1|STARTED|Period 4||12
8093742|NCT03334448|19952281|P4|NOT COMPLETED|Washout||1
8093743|NCT03334448|19952282|P3|NOT COMPLETED|Washout||0
8093744|NCT03334448|19952283|P2|NOT COMPLETED|Washout||0
8093745|NCT03334448|19952284|P1|NOT COMPLETED|Washout||0
8093746|NCT03334448|19952281|P4|COMPLETED|Washout||11
8093747|NCT03334448|19952282|P3|COMPLETED|Washout||13
8093748|NCT03334448|19952283|P2|COMPLETED|Washout||11
8093749|NCT03334448|19952284|P1|COMPLETED|Washout||12
8093750|NCT03334448|19952281|P4|STARTED|Washout||12
8093751|NCT03334448|19952282|P3|STARTED|Washout||13
8093752|NCT03334448|19952283|P2|STARTED|Washout||11
8093753|NCT03334448|19952284|P1|STARTED|Washout||12
8093754|NCT03334448|19952281|P4|NOT COMPLETED|Period 3||0
8093755|NCT03334448|19952282|P3|NOT COMPLETED|Period 3||0
8093756|NCT03334448|19952283|P2|NOT COMPLETED|Period 3||0
8093757|NCT03334448|19952284|P1|NOT COMPLETED|Period 3||0
8093758|NCT03334448|19952281|P4|COMPLETED|Period 3||12
8093759|NCT03334448|19952282|P3|COMPLETED|Period 3||13
8093760|NCT03334448|19952283|P2|COMPLETED|Period 3||11
8093761|NCT03334448|19952284|P1|COMPLETED|Period 3||12
8093762|NCT03334448|19952281|P4|Received at Least 1 Dose of Study Drug|Period 3||12
8093763|NCT03334448|19952282|P3|Received at Least 1 Dose of Study Drug|Period 3||13
8093764|NCT03334448|19952283|P2|Received at Least 1 Dose of Study Drug|Period 3||11
8093765|NCT03334448|19952284|P1|Received at Least 1 Dose of Study Drug|Period 3||12
8093766|NCT03334448|19952281|P4|STARTED|Period 3||12
8093767|NCT03334448|19952282|P3|STARTED|Period 3||13
8093768|NCT03334448|19952283|P2|STARTED|Period 3||11
8093769|NCT03334448|19952284|P1|STARTED|Period 3||12
8093770|NCT03334448|19952281|P4|NOT COMPLETED|Washout||0
8093771|NCT03334448|19952282|P3|NOT COMPLETED|Washout||0
8093772|NCT03334448|19952283|P2|NOT COMPLETED|Washout||1
8093773|NCT03334448|19952284|P1|NOT COMPLETED|Washout||0
8093774|NCT03334448|19952281|P4|COMPLETED|Washout||12
8093775|NCT03334448|19952282|P3|COMPLETED|Washout||13
8093776|NCT03334448|19952283|P2|COMPLETED|Washout||11
8093777|NCT03334448|19952284|P1|COMPLETED|Washout||12
8093778|NCT03334448|19952281|P4|STARTED|Washout||12
8093779|NCT03334448|19952282|P3|STARTED|Washout||13
8093780|NCT03334448|19952283|P2|STARTED|Washout||12
8093781|NCT03334448|19952284|P1|STARTED|Washout||12
8093782|NCT03334448|19952281|P4|NOT COMPLETED|Period 2||0
8093783|NCT03334448|19952282|P3|NOT COMPLETED|Period 2||0
8093784|NCT03334448|19952283|P2|NOT COMPLETED|Period 2||0
8093785|NCT03334448|19952284|P1|NOT COMPLETED|Period 2||0
8093786|NCT03334448|19952281|P4|COMPLETED|Period 2||12
8093787|NCT03334448|19952282|P3|COMPLETED|Period 2||13
8093788|NCT03334448|19952283|P2|COMPLETED|Period 2||12
8093789|NCT03334448|19952284|P1|COMPLETED|Period 2||12
8093790|NCT03334448|19952281|P4|Received at Least 1 Dose of Study Drug|Period 2||12
8093791|NCT03334448|19952282|P3|Received at Least 1 Dose of Study Drug|Period 2||13
8093792|NCT03334448|19952283|P2|Received at Least 1 Dose of Study Drug|Period 2||12
8093793|NCT03334448|19952284|P1|Received at Least 1 Dose of Study Drug|Period 2||12
8093794|NCT03334448|19952281|P4|STARTED|Period 2||12
8093795|NCT03334448|19952282|P3|STARTED|Period 2||13
8093796|NCT03334448|19952283|P2|STARTED|Period 2||12
8093797|NCT03334448|19952284|P1|STARTED|Period 2||12
8093798|NCT03334448|19952281|P4|NOT COMPLETED|Washout||0
8093799|NCT03334448|19952282|P3|NOT COMPLETED|Washout||0
8093800|NCT03334448|19952283|P2|NOT COMPLETED|Washout||0
8093801|NCT03334448|19952284|P1|NOT COMPLETED|Washout||0
8093802|NCT03334448|19952281|P4|COMPLETED|Washout||12
8093803|NCT03334448|19952282|P3|COMPLETED|Washout||13
8093804|NCT03334448|19952283|P2|COMPLETED|Washout||12
8093805|NCT03334448|19952284|P1|COMPLETED|Washout||12
8093806|NCT03334448|19952281|P4|STARTED|Washout||12
8093807|NCT03334448|19952282|P3|STARTED|Washout||13
8093808|NCT03334448|19952283|P2|STARTED|Washout||12
8093809|NCT03334448|19952284|P1|STARTED|Washout||12
8093810|NCT03334448|19952281|P4|NOT COMPLETED|Period 1||0
8093811|NCT03334448|19952282|P3|NOT COMPLETED|Period 1||0
8093812|NCT03334448|19952283|P2|NOT COMPLETED|Period 1||0
8093813|NCT03334448|19952284|P1|NOT COMPLETED|Period 1||0
8093814|NCT03334448|19952281|P4|COMPLETED|Period 1||12
8093815|NCT03334448|19952282|P3|COMPLETED|Period 1||13
8093816|NCT03334448|19952283|P2|COMPLETED|Period 1||12
8093817|NCT03334448|19952284|P1|COMPLETED|Period 1||12
8093818|NCT03334448|19952281|P4|Received at Least 1 Dose of Study Drug|Period 1||12
8093819|NCT03334448|19952282|P3|Received at Least 1 Dose of Study Drug|Period 1||13
8093820|NCT03334448|19952283|P2|Received at Least 1 Dose of Study Drug|Period 1||12
8093821|NCT03334448|19952284|P1|Received at Least 1 Dose of Study Drug|Period 1||12
8093822|NCT03334448|19952281|P4|STARTED|Period 1||12
8093823|NCT03334448|19952282|P3|STARTED|Period 1||13
8093824|NCT03334448|19952283|P2|STARTED|Period 1||12
8093825|NCT03334448|19952284|P1|STARTED|Period 1||12
8093826|NCT03334422|19952296|P4|NOT COMPLETED|Overall Study||6
8093827|NCT03334422|19952297|P3|NOT COMPLETED|Overall Study||10
8093828|NCT03334422|19952298|P2|NOT COMPLETED|Overall Study||10
8093829|NCT03334422|19952299|P1|NOT COMPLETED|Overall Study||19
8093830|NCT03334422|19952296|P4|COMPLETED|Overall Study||117
8093831|NCT03334422|19952297|P3|COMPLETED|Overall Study||113
8093832|NCT03334422|19952298|P2|COMPLETED|Overall Study||115
8093833|NCT03334422|19952299|P1|COMPLETED|Overall Study||225
8093834|NCT03334422|19952296|P4|Received at Least One Dose of Study Drug|Overall Study||123
8093835|NCT03334422|19952297|P3|Received at Least One Dose of Study Drug|Overall Study||123
8093836|NCT03334422|19952298|P2|Received at Least One Dose of Study Drug|Overall Study||124
8093837|NCT03334422|19952299|P1|Received at Least One Dose of Study Drug|Overall Study||244
8093838|NCT03334422|19952296|P4|STARTED|Overall Study||123
8093839|NCT03334422|19952297|P3|STARTED|Overall Study||123
8093840|NCT03334422|19952298|P2|STARTED|Overall Study||125
8093841|NCT03334422|19952299|P1|STARTED|Overall Study||244
8093842|NCT03334396|19952406|P8|NOT COMPLETED|Overall Study||1
8093843|NCT03334396|19952407|P7|NOT COMPLETED|Overall Study||3
8093844|NCT03334396|19952408|P6|NOT COMPLETED|Overall Study||1
8093845|NCT03334396|19952409|P5|NOT COMPLETED|Overall Study||3
8093846|NCT03334396|19952410|P4|NOT COMPLETED|Overall Study||5
8093847|NCT03334396|19952411|P3|NOT COMPLETED|Overall Study||10
8093848|NCT03334396|19952412|P2|NOT COMPLETED|Overall Study||11
8093849|NCT03334396|19952413|P1|NOT COMPLETED|Overall Study||23
8093850|NCT03334396|19952406|P8|COMPLETED|Overall Study||7
8093851|NCT03334396|19952407|P7|COMPLETED|Overall Study||5
8093852|NCT03334396|19952408|P6|COMPLETED|Overall Study||4
8093853|NCT03334396|19952409|P5|COMPLETED|Overall Study||12
8093854|NCT03334396|19952410|P4|COMPLETED|Overall Study||120
8093855|NCT03334396|19952411|P3|COMPLETED|Overall Study||113
8093856|NCT03334396|19952412|P2|COMPLETED|Overall Study||116
8093857|NCT03334396|19952413|P1|COMPLETED|Overall Study||226
8093858|NCT03334396|19952406|P8|Received at Least One Dose of Study Drug|Overall Study||8
8093859|NCT03334396|19952407|P7|Received at Least One Dose of Study Drug|Overall Study||8
8093860|NCT03334396|19952408|P6|Received at Least One Dose of Study Drug|Overall Study||5
8093861|NCT03334396|19952409|P5|Received at Least One Dose of Study Drug|Overall Study||15
8093862|NCT03334396|19952410|P4|Received at Least One Dose of Study Drug|Overall Study||125
8093863|NCT03334396|19952411|P3|Received at Least One Dose of Study Drug|Overall Study||123
8093864|NCT03334396|19952412|P2|Received at Least One Dose of Study Drug|Overall Study||127
8093865|NCT03334396|19952413|P1|Received at Least One Dose of Study Drug|Overall Study||249
8093866|NCT03334396|19952406|P8|STARTED|Overall Study||8
8093867|NCT03334396|19952407|P7|STARTED|Overall Study||8
8093868|NCT03334396|19952408|P6|STARTED|Overall Study||5
8093869|NCT03334396|19952409|P5|STARTED|Overall Study||15
8093870|NCT03334396|19952410|P4|STARTED|Overall Study||125
8093871|NCT03334396|19952411|P3|STARTED|Overall Study||123
8093872|NCT03334396|19952412|P2|STARTED|Overall Study||127
8093873|NCT03334396|19952413|P1|STARTED|Overall Study||249
8093874|NCT03334214|19952518|P2|NOT COMPLETED|Overall Study||2
8093875|NCT03334214|19952519|P1|NOT COMPLETED|Overall Study||1
8093876|NCT03334214|19952518|P2|COMPLETED|Overall Study||27
8093877|NCT03334214|19952519|P1|COMPLETED|Overall Study||14
8093878|NCT03334214|19952518|P2|STARTED|Overall Study||29
8093879|NCT03334214|19952519|P1|STARTED|Overall Study||15
8093880|NCT03334175|19952545|P2|NOT COMPLETED|Overall Study||1
8093881|NCT03334175|19952546|P1|NOT COMPLETED|Overall Study||0
8093882|NCT03334175|19952545|P2|COMPLETED|Overall Study||9
8093883|NCT03334175|19952546|P1|COMPLETED|Overall Study||8
8093884|NCT03334175|19952545|P2|STARTED|Overall Study||10
8093885|NCT03334175|19952546|P1|STARTED|Overall Study||8
8093886|NCT03333876|19952568|P1|NOT COMPLETED|Positional Therapy||0
8093887|NCT03333876|19952568|P1|COMPLETED|Positional Therapy||54
8093888|NCT03333876|19952568|P1|STARTED|Positional Therapy||54
8093889|NCT03333876|19952568|P1|NOT COMPLETED|Mandibular Advancement||4
8093890|NCT03333876|19952568|P1|COMPLETED|Mandibular Advancement||50
8093891|NCT03333876|19952568|P1|STARTED|Mandibular Advancement||54
8093892|NCT03333876|19952568|P1|NOT COMPLETED|Nasal Dilator||6
8093893|NCT03333876|19952568|P1|COMPLETED|Nasal Dilator||48
8093894|NCT03333876|19952568|P1|STARTED|Nasal Dilator||54
8093895|NCT03333876|19952568|P1|NOT COMPLETED|Screening Period||4
8093896|NCT03333876|19952568|P1|COMPLETED|Screening Period||54
8093897|NCT03333876|19952568|P1|STARTED|Screening Period||58
8093898|NCT03333746|19952589|P1|NOT COMPLETED|Overall Study||1
8093899|NCT03333746|19952589|P1|COMPLETED|Overall Study||0
8093900|NCT03333746|19952589|P1|STARTED|Overall Study||1
8093901|NCT03333577|19952600|P1|NOT COMPLETED|Overall Study||7
8093902|NCT03333577|19952600|P1|COMPLETED|Overall Study||25
8093903|NCT03333577|19952600|P1|STARTED|Overall Study||32
8093904|NCT03333317|19952608|P3|NOT COMPLETED|Overall Study||0
8093905|NCT03333317|19952609|P2|NOT COMPLETED|Overall Study||0
8093906|NCT03333317|19952610|P1|NOT COMPLETED|Overall Study||0
8093907|NCT03333317|19952608|P3|COMPLETED|Overall Study||3
8093908|NCT03333317|19952609|P2|COMPLETED|Overall Study||1
8093909|NCT03333317|19952610|P1|COMPLETED|Overall Study||3
8093910|NCT03333317|19952608|P3|STARTED|Overall Study||3
8093911|NCT03333317|19952609|P2|STARTED|Overall Study||1
8093912|NCT03333317|19952610|P1|STARTED|Overall Study||3
8093913|NCT03332979|19952728|P1|NOT COMPLETED|Overall Study||0
8093914|NCT03332979|19952728|P1|COMPLETED|Overall Study||150
8093915|NCT03332979|19952728|P1|STARTED|Overall Study||150
8094105|NCT03332160|19953048|P2|NOT COMPLETED|Overall Study||5
8094106|NCT03332160|19953049|P1|NOT COMPLETED|Overall Study||1
8094107|NCT03332160|19953048|P2|COMPLETED|Overall Study||19
8094108|NCT03332160|19953049|P1|COMPLETED|Overall Study||24
8094109|NCT03332160|19953048|P2|STARTED|Overall Study||24
8094110|NCT03332160|19953049|P1|STARTED|Overall Study||25
8094111|NCT03331965|19953081|P2|NOT COMPLETED|Overall Study||4
8094112|NCT03331965|19953082|P1|NOT COMPLETED|Overall Study||10
8094113|NCT03331965|19953081|P2|COMPLETED|Overall Study||51
8094114|NCT03331965|19953082|P1|COMPLETED|Overall Study||45
8094115|NCT03331965|19953081|P2|STARTED|Overall Study||55
8094116|NCT03331965|19953082|P1|STARTED|Overall Study||55
8094117|NCT03331835|19953098|P2|NOT COMPLETED|Overall Study||47
8094118|NCT03331835|19953099|P1|NOT COMPLETED|Overall Study||14
8094119|NCT03331835|19953098|P2|COMPLETED|Overall Study||58
8094120|NCT03331835|19953099|P1|COMPLETED|Overall Study||91
8094121|NCT03331835|19953098|P2|STARTED|Overall Study||105
8094122|NCT03331835|19953099|P1|STARTED|Overall Study||105
8094123|NCT03331315|19953133|P2|NOT COMPLETED|Overall Study||14
8094124|NCT03331315|19953134|P1|NOT COMPLETED|Overall Study||18
8094125|NCT03331315|19953133|P2|COMPLETED|Overall Study||68
8094126|NCT03331315|19953134|P1|COMPLETED|Overall Study||70
8094127|NCT03331315|19953133|P2|STARTED|Overall Study||82
8094128|NCT03331315|19953134|P1|STARTED|Overall Study||88
8094129|NCT03331185|19953156|P2|NOT COMPLETED|Overall Study||0
8094130|NCT03331185|19953157|P1|NOT COMPLETED|Overall Study||0
8094131|NCT03331185|19953156|P2|COMPLETED|Overall Study||12
8094132|NCT03331185|19953157|P1|COMPLETED|Overall Study||14
8094133|NCT03331185|19953156|P2|STARTED|Overall Study||12
8094134|NCT03331185|19953157|P1|STARTED|Overall Study||14
8094135|NCT03331042|19953171|P4|NOT COMPLETED|Overall Study||1
8094136|NCT03331042|19953172|P3|NOT COMPLETED|Overall Study||1
8094137|NCT03331042|19953173|P2|NOT COMPLETED|Overall Study||0
8094138|NCT03331042|19953174|P1|NOT COMPLETED|Overall Study||1
8094139|NCT03331042|19953171|P4|COMPLETED|Overall Study||20
8094140|NCT03331042|19953172|P3|COMPLETED|Overall Study||20
8094141|NCT03331042|19953173|P2|COMPLETED|Overall Study||21
8094142|NCT03331042|19953174|P1|COMPLETED|Overall Study||21
8094143|NCT03331042|19953171|P4|STARTED|Overall Study||21
8094144|NCT03331042|19953172|P3|STARTED|Overall Study||21
8094145|NCT03331042|19953173|P2|STARTED|Overall Study||21
8094146|NCT03331042|19953174|P1|STARTED|Overall Study||22
8094147|NCT03330834|19953220|P1|NOT COMPLETED|Overall Study||0
8094148|NCT03330834|19953220|P1|COMPLETED|Overall Study||1
8094149|NCT03330834|19953220|P1|STARTED|Overall Study||1
8094150|NCT03330457|19953230|P4|NOT COMPLETED|Overall Study||0
8094151|NCT03330457|19953231|P3|NOT COMPLETED|Overall Study||0
8094152|NCT03330457|19953232|P2|NOT COMPLETED|Overall Study||0
8094153|NCT03330457|19953233|P1|NOT COMPLETED|Overall Study||0
8094154|NCT03330457|19953230|P4|COMPLETED|Overall Study||3
8094155|NCT03330457|19953231|P3|COMPLETED|Overall Study||6
8094156|NCT03330457|19953232|P2|COMPLETED|Overall Study||3
8094157|NCT03330457|19953233|P1|COMPLETED|Overall Study||6
8094158|NCT03330457|19953230|P4|STARTED|Overall Study||3
8094159|NCT03330457|19953231|P3|STARTED|Overall Study||6
8094160|NCT03330457|19953232|P2|STARTED|Overall Study||3
8094161|NCT03330457|19953233|P1|STARTED|Overall Study||6
8094162|NCT03330275|19953247|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094163|NCT03330275|19953248|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094164|NCT03330275|19953249|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094165|NCT03330275|19953250|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094166|NCT03330275|19953251|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094167|NCT03330275|19953252|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094168|NCT03330275|19953253|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094169|NCT03330275|19953254|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094170|NCT03330275|19953255|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094171|NCT03330275|19953256|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094172|NCT03330275|19953247|P10|COMPLETED|Visits 2, 3 and 4 - Period 3||4
8094173|NCT03330275|19953248|P9|COMPLETED|Visits 2, 3 and 4 - Period 3||4
8094174|NCT03330275|19953249|P8|COMPLETED|Visits 2, 3 and 4 - Period 3||4
8094175|NCT03330275|19953250|P7|COMPLETED|Visits 2, 3 and 4 - Period 3||4
8094176|NCT03330275|19953251|P6|COMPLETED|Visits 2, 3 and 4 - Period 3||4
8094177|NCT03330275|19953252|P5|COMPLETED|Visits 2, 3 and 4 - Period 3||4
8094178|NCT03330275|19953253|P4|COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094179|NCT03330275|19953254|P3|COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094180|NCT03330275|19953255|P2|COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094181|NCT03330275|19953256|P1|COMPLETED|Visits 2, 3 and 4 - Period 3||0
8094182|NCT03330275|19953247|P10|STARTED|Visits 2, 3 and 4 - Period 3||4
8094183|NCT03330275|19953248|P9|STARTED|Visits 2, 3 and 4 - Period 3||4
8094184|NCT03330275|19953249|P8|STARTED|Visits 2, 3 and 4 - Period 3||4
8094185|NCT03330275|19953250|P7|STARTED|Visits 2, 3 and 4 - Period 3||4
8094186|NCT03330275|19953251|P6|STARTED|Visits 2, 3 and 4 - Period 3||4
8094187|NCT03330275|19953252|P5|STARTED|Visits 2, 3 and 4 - Period 3||4
8094188|NCT03330275|19953253|P4|STARTED|Visits 2, 3 and 4 - Period 3||0
8094189|NCT03330275|19953254|P3|STARTED|Visits 2, 3 and 4 - Period 3||0
8094190|NCT03330275|19953255|P2|STARTED|Visits 2, 3 and 4 - Period 3||0
8094191|NCT03330275|19953256|P1|STARTED|Visits 2, 3 and 4 - Period 3||0
8094192|NCT03330275|19953247|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094193|NCT03330275|19953248|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094194|NCT03330275|19953249|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094195|NCT03330275|19953250|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094196|NCT03330275|19953251|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094197|NCT03330275|19953252|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094198|NCT03330275|19953253|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094199|NCT03330275|19953254|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094200|NCT03330275|19953255|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094201|NCT03330275|19953256|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094202|NCT03330275|19953247|P10|COMPLETED|Visits 2, 3 and 4 - Period 2||4
8094203|NCT03330275|19953248|P9|COMPLETED|Visits 2, 3 and 4 - Period 2||4
8094204|NCT03330275|19953249|P8|COMPLETED|Visits 2, 3 and 4 - Period 2||4
8094205|NCT03330275|19953250|P7|COMPLETED|Visits 2, 3 and 4 - Period 2||4
8094206|NCT03330275|19953251|P6|COMPLETED|Visits 2, 3 and 4 - Period 2||4
8094207|NCT03330275|19953252|P5|COMPLETED|Visits 2, 3 and 4 - Period 2||4
8094208|NCT03330275|19953253|P4|COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094209|NCT03330275|19953254|P3|COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094210|NCT03330275|19953255|P2|COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094211|NCT03330275|19953256|P1|COMPLETED|Visits 2, 3 and 4 - Period 2||0
8094212|NCT03330275|19953247|P10|STARTED|Visits 2, 3 and 4 - Period 2||4
8094213|NCT03330275|19953248|P9|STARTED|Visits 2, 3 and 4 - Period 2||4
8094214|NCT03330275|19953249|P8|STARTED|Visits 2, 3 and 4 - Period 2||4
8094215|NCT03330275|19953250|P7|STARTED|Visits 2, 3 and 4 - Period 2||4
8094216|NCT03330275|19953251|P6|STARTED|Visits 2, 3 and 4 - Period 2||4
8094217|NCT03330275|19953252|P5|STARTED|Visits 2, 3 and 4 - Period 2||4
8094218|NCT03330275|19953253|P4|STARTED|Visits 2, 3 and 4 - Period 2||0
8094219|NCT03330275|19953254|P3|STARTED|Visits 2, 3 and 4 - Period 2||0
8094220|NCT03330275|19953255|P2|STARTED|Visits 2, 3 and 4 - Period 2||0
8094221|NCT03330275|19953256|P1|STARTED|Visits 2, 3 and 4 - Period 2||0
8094222|NCT03330275|19953247|P10|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094223|NCT03330275|19953248|P9|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094224|NCT03330275|19953249|P8|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094225|NCT03330275|19953250|P7|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094226|NCT03330275|19953251|P6|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094227|NCT03330275|19953252|P5|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094228|NCT03330275|19953253|P4|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094229|NCT03330275|19953254|P3|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094230|NCT03330275|19953255|P2|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094231|NCT03330275|19953256|P1|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094232|NCT03330275|19953247|P10|COMPLETED|Visits 2, 3 and 4 - Period 1||4
8094233|NCT03330275|19953248|P9|COMPLETED|Visits 2, 3 and 4 - Period 1||4
8094234|NCT03330275|19953249|P8|COMPLETED|Visits 2, 3 and 4 - Period 1||4
8094235|NCT03330275|19953250|P7|COMPLETED|Visits 2, 3 and 4 - Period 1||4
8094236|NCT03330275|19953251|P6|COMPLETED|Visits 2, 3 and 4 - Period 1||4
8094237|NCT03330275|19953252|P5|COMPLETED|Visits 2, 3 and 4 - Period 1||4
8094238|NCT03330275|19953253|P4|COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094239|NCT03330275|19953254|P3|COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094240|NCT03330275|19953255|P2|COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094241|NCT03330275|19953256|P1|COMPLETED|Visits 2, 3 and 4 - Period 1||0
8094242|NCT03330275|19953247|P10|STARTED|Visits 2, 3 and 4 - Period 1||4
8094243|NCT03330275|19953248|P9|STARTED|Visits 2, 3 and 4 - Period 1||4
8094244|NCT03330275|19953249|P8|STARTED|Visits 2, 3 and 4 - Period 1||4
8094245|NCT03330275|19953250|P7|STARTED|Visits 2, 3 and 4 - Period 1||4
8094246|NCT03330275|19953251|P6|STARTED|Visits 2, 3 and 4 - Period 1||4
8094247|NCT03330275|19953252|P5|STARTED|Visits 2, 3 and 4 - Period 1||4
8094248|NCT03330275|19953253|P4|STARTED|Visits 2, 3 and 4 - Period 1||0
8094249|NCT03330275|19953254|P3|STARTED|Visits 2, 3 and 4 - Period 1||0
8094250|NCT03330275|19953255|P2|STARTED|Visits 2, 3 and 4 - Period 1||0
8094251|NCT03330275|19953256|P1|STARTED|Visits 2, 3 and 4 - Period 1||0
8094252|NCT03330275|19953247|P10|NOT COMPLETED|Visit 1 - Period 2||0
8094253|NCT03330275|19953248|P9|NOT COMPLETED|Visit 1 - Period 2||0
8094254|NCT03330275|19953249|P8|NOT COMPLETED|Visit 1 - Period 2||0
8094255|NCT03330275|19953250|P7|NOT COMPLETED|Visit 1 - Period 2||0
8094256|NCT03330275|19953251|P6|NOT COMPLETED|Visit 1 - Period 2||0
8094257|NCT03330275|19953252|P5|NOT COMPLETED|Visit 1 - Period 2||0
8094258|NCT03330275|19953253|P4|NOT COMPLETED|Visit 1 - Period 2||0
8094259|NCT03330275|19953254|P3|NOT COMPLETED|Visit 1 - Period 2||0
8094260|NCT03330275|19953255|P2|NOT COMPLETED|Visit 1 - Period 2||0
8094261|NCT03330275|19953256|P1|NOT COMPLETED|Visit 1 - Period 2||0
8094262|NCT03330275|19953247|P10|COMPLETED|Visit 1 - Period 2||0
8094263|NCT03330275|19953248|P9|COMPLETED|Visit 1 - Period 2||0
8094264|NCT03330275|19953249|P8|COMPLETED|Visit 1 - Period 2||0
8094265|NCT03330275|19953250|P7|COMPLETED|Visit 1 - Period 2||0
8094266|NCT03330275|19953251|P6|COMPLETED|Visit 1 - Period 2||0
8094267|NCT03330275|19953252|P5|COMPLETED|Visit 1 - Period 2||0
8094268|NCT03330275|19953253|P4|COMPLETED|Visit 1 - Period 2||6
8094269|NCT03330275|19953254|P3|COMPLETED|Visit 1 - Period 2||6
8094270|NCT03330275|19953255|P2|COMPLETED|Visit 1 - Period 2||6
8094271|NCT03330275|19953256|P1|COMPLETED|Visit 1 - Period 2||6
8094272|NCT03330275|19953247|P10|STARTED|Visit 1 - Period 2||0
8094273|NCT03330275|19953248|P9|STARTED|Visit 1 - Period 2||0
8094274|NCT03330275|19953249|P8|STARTED|Visit 1 - Period 2||0
8094275|NCT03330275|19953250|P7|STARTED|Visit 1 - Period 2||0
8094276|NCT03330275|19953251|P6|STARTED|Visit 1 - Period 2||0
8094277|NCT03330275|19953252|P5|STARTED|Visit 1 - Period 2||0
8094278|NCT03330275|19953253|P4|STARTED|Visit 1 - Period 2||6
8094279|NCT03330275|19953254|P3|STARTED|Visit 1 - Period 2||6
8094280|NCT03330275|19953255|P2|STARTED|Visit 1 - Period 2||6
8094281|NCT03330275|19953256|P1|STARTED|Visit 1 - Period 2||6
8094282|NCT03330275|19953247|P10|NOT COMPLETED|Visit 1 - Period 1||0
8094283|NCT03330275|19953248|P9|NOT COMPLETED|Visit 1 - Period 1||0
8094284|NCT03330275|19953249|P8|NOT COMPLETED|Visit 1 - Period 1||0
8094285|NCT03330275|19953250|P7|NOT COMPLETED|Visit 1 - Period 1||0
8094286|NCT03330275|19953251|P6|NOT COMPLETED|Visit 1 - Period 1||0
8094287|NCT03330275|19953252|P5|NOT COMPLETED|Visit 1 - Period 1||0
8094288|NCT03330275|19953253|P4|NOT COMPLETED|Visit 1 - Period 1||0
8094289|NCT03330275|19953254|P3|NOT COMPLETED|Visit 1 - Period 1||0
8094290|NCT03330275|19953255|P2|NOT COMPLETED|Visit 1 - Period 1||0
8094291|NCT03330275|19953256|P1|NOT COMPLETED|Visit 1 - Period 1||0
8094292|NCT03330275|19953247|P10|COMPLETED|Visit 1 - Period 1||0
8094293|NCT03330275|19953248|P9|COMPLETED|Visit 1 - Period 1||0
8094294|NCT03330275|19953249|P8|COMPLETED|Visit 1 - Period 1||0
8094295|NCT03330275|19953250|P7|COMPLETED|Visit 1 - Period 1||0
8094296|NCT03330275|19953251|P6|COMPLETED|Visit 1 - Period 1||0
8094297|NCT03330275|19953252|P5|COMPLETED|Visit 1 - Period 1||0
8094298|NCT03330275|19953253|P4|COMPLETED|Visit 1 - Period 1||6
8094299|NCT03330275|19953254|P3|COMPLETED|Visit 1 - Period 1||6
8094300|NCT03330275|19953255|P2|COMPLETED|Visit 1 - Period 1||6
8094301|NCT03330275|19953256|P1|COMPLETED|Visit 1 - Period 1||6
8094302|NCT03330275|19953247|P10|STARTED|Visit 1 - Period 1||0
8094303|NCT03330275|19953248|P9|STARTED|Visit 1 - Period 1||0
8094304|NCT03330275|19953249|P8|STARTED|Visit 1 - Period 1||0
8094305|NCT03330275|19953250|P7|STARTED|Visit 1 - Period 1||0
8094306|NCT03330275|19953251|P6|STARTED|Visit 1 - Period 1||0
8094307|NCT03330275|19953252|P5|STARTED|Visit 1 - Period 1||0
8094308|NCT03330275|19953253|P4|STARTED|Visit 1 - Period 1||6
8094309|NCT03330275|19953254|P3|STARTED|Visit 1 - Period 1||6
8094310|NCT03330275|19953255|P2|STARTED|Visit 1 - Period 1||6
8094311|NCT03330275|19953256|P1|STARTED|Visit 1 - Period 1||6
8094312|NCT03330236|19953284|P2|NOT COMPLETED|Overall Study||84
8094313|NCT03330236|19953285|P1|NOT COMPLETED|Overall Study||100
8094314|NCT03330236|19953284|P2|COMPLETED|Overall Study||697
8094315|NCT03330236|19953285|P1|COMPLETED|Overall Study||679
8094316|NCT03330236|19953284|P2|Modified ITT|Overall Study||774
8094317|NCT03330236|19953285|P1|Modified ITT|Overall Study||773
8094318|NCT03330236|19953284|P2|Received Surgery|Overall Study||781
8094319|NCT03330236|19953285|P1|Received Surgery|Overall Study||779
8094320|NCT03330236|19953284|P2|STARTED|Overall Study||781
8094321|NCT03330236|19953285|P1|STARTED|Overall Study||779
8094325|NCT03329989|19953319|P1|NOT COMPLETED|Overall Study||23
8094326|NCT03329989|19953319|P1|COMPLETED|Overall Study||135
8094327|NCT03329989|19953319|P1|STARTED|Overall Study||158
8094328|NCT03329937|19953331|P1|NOT COMPLETED|Overall Study||0
8094329|NCT03329937|19953331|P1|COMPLETED|Overall Study||21
8094330|NCT03329937|19953331|P1|STARTED|Overall Study||21
8094331|NCT03329885|19953346|P9|NOT COMPLETED|Overall Study||0
8094332|NCT03329885|19953347|P8|NOT COMPLETED|Overall Study||1
8094333|NCT03329885|19953348|P7|NOT COMPLETED|Overall Study||1
8094334|NCT03329885|19953349|P6|NOT COMPLETED|Overall Study||0
8094335|NCT03329885|19953350|P5|NOT COMPLETED|Overall Study||0
8094336|NCT03329885|19953351|P4|NOT COMPLETED|Overall Study||0
8094337|NCT03329885|19953352|P3|NOT COMPLETED|Overall Study||0
8094338|NCT03329885|19953353|P2|NOT COMPLETED|Overall Study||0
8094339|NCT03329885|19953354|P1|NOT COMPLETED|Overall Study||0
8094340|NCT03329885|19953346|P9|COMPLETED|Overall Study||0
8094341|NCT03329885|19953347|P8|COMPLETED|Overall Study||0
8094342|NCT03329885|19953348|P7|COMPLETED|Overall Study||0
8094343|NCT03329885|19953349|P6|COMPLETED|Overall Study||3
8094344|NCT03329885|19953350|P5|COMPLETED|Overall Study||6
8094345|NCT03329885|19953351|P4|COMPLETED|Overall Study||6
8094346|NCT03329885|19953352|P3|COMPLETED|Overall Study||6
8094347|NCT03329885|19953353|P2|COMPLETED|Overall Study||6
8094348|NCT03329885|19953354|P1|COMPLETED|Overall Study||9
8094349|NCT03329885|19953346|P9|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0
8094350|NCT03329885|19953347|P8|STARTED|Overall Study||1
8094351|NCT03329885|19953348|P7|STARTED|Overall Study||1
8094352|NCT03329885|19953349|P6|STARTED|Overall Study||3
8094353|NCT03329885|19953350|P5|STARTED|Overall Study||6
8094354|NCT03329885|19953351|P4|STARTED|Overall Study||6
8094355|NCT03329885|19953352|P3|STARTED|Overall Study||6
8094356|NCT03329885|19953353|P2|STARTED|Overall Study||6
8094357|NCT03329885|19953354|P1|STARTED|Overall Study||9
8094378|NCT03329573|19953609|P4|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
8094379|NCT03329573|19953610|P3|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
8094380|NCT03329573|19953611|P2|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
8094381|NCT03329573|19953612|P1|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
8094382|NCT03329573|19953609|P4|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
8094383|NCT03329573|19953610|P3|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
8094384|NCT03329573|19953611|P2|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20
8094385|NCT03329573|19953612|P1|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21
8094386|NCT03329573|19953609|P4|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
8094387|NCT03329573|19953610|P3|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
8094388|NCT03329573|19953611|P2|STARTED|Treatment Period 2 (Day 12 to Day 26)||21
8094389|NCT03329573|19953612|P1|STARTED|Treatment Period 2 (Day 12 to Day 26)||22
8094390|NCT03329573|19953609|P4|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
8094391|NCT03329573|19953610|P3|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
8094392|NCT03329573|19953611|P2|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
8094393|NCT03329573|19953612|P1|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
8094394|NCT03329573|19953609|P4|COMPLETED|Washout Period (Day 6 to Day 11)||19
8094395|NCT03329573|19953610|P3|COMPLETED|Washout Period (Day 6 to Day 11)||19
8094396|NCT03329573|19953611|P2|COMPLETED|Washout Period (Day 6 to Day 11)||21
8094397|NCT03329573|19953612|P1|COMPLETED|Washout Period (Day 6 to Day 11)||22
8094398|NCT03329573|19953609|P4|STARTED|Washout Period (Day 6 to Day 11)||19
8094399|NCT03329573|19953610|P3|STARTED|Washout Period (Day 6 to Day 11)||19
8094400|NCT03329573|19953611|P2|STARTED|Washout Period (Day 6 to Day 11)||21
8094401|NCT03329573|19953612|P1|STARTED|Washout Period (Day 6 to Day 11)||22
8094402|NCT03329573|19953609|P4|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
8094403|NCT03329573|19953610|P3|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
8094404|NCT03329573|19953611|P2|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3
8094405|NCT03329573|19953612|P1|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1
8094406|NCT03329573|19953609|P4|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
8094407|NCT03329573|19953610|P3|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
8094408|NCT03329573|19953611|P2|COMPLETED|Treatment Period 1 (Up to 5 Days)||21
8094409|NCT03329573|19953612|P1|COMPLETED|Treatment Period 1 (Up to 5 Days)||22
8094410|NCT03329573|19953609|P4|STARTED|Treatment Period 1 (Up to 5 Days)||19
8094411|NCT03329573|19953610|P3|STARTED|Treatment Period 1 (Up to 5 Days)||19
8094412|NCT03329573|19953611|P2|STARTED|Treatment Period 1 (Up to 5 Days)||24
8094413|NCT03329573|19953612|P1|STARTED|Treatment Period 1 (Up to 5 Days)||23
8094414|NCT03329209|19953678|P1|NOT COMPLETED|Overall Study||0
8094415|NCT03329209|19953678|P1|COMPLETED|Overall Study||16
8094416|NCT03329209|19953678|P1|STARTED|Overall Study||16
8094417|NCT03328949|19953686|P1|NOT COMPLETED|Overall Study||0
8094418|NCT03328949|19953686|P1|COMPLETED|Overall Study||120
8094419|NCT03328949|19953686|P1|STARTED|Overall Study||120
8094420|NCT03328897|19953696|P3|NOT COMPLETED|Follow-up Epoch||2
8094421|NCT03328897|19953697|P2|NOT COMPLETED|Follow-up Epoch||3
8094422|NCT03328897|19953698|P1|NOT COMPLETED|Follow-up Epoch||8
8094423|NCT03328897|19953696|P3|COMPLETED|Follow-up Epoch||79
8094424|NCT03328897|19953697|P2|COMPLETED|Follow-up Epoch||160
8094425|NCT03328897|19953698|P1|COMPLETED|Follow-up Epoch||153
8094426|NCT03328897|19953696|P3|STARTED|Follow-up Epoch||81
8094427|NCT03328897|19953697|P2|STARTED|Follow-up Epoch||163
8094428|NCT03328897|19953698|P1|STARTED|Follow-up Epoch||161
8094429|NCT03328897|19953696|P3|NOT COMPLETED|Randomized-treatment Epoch||2
8094430|NCT03328897|19953697|P2|NOT COMPLETED|Randomized-treatment Epoch||5
8094431|NCT03328897|19953698|P1|NOT COMPLETED|Randomized-treatment Epoch||16
8094432|NCT03328897|19953696|P3|COMPLETED|Randomized-treatment Epoch||81
8094433|NCT03328897|19953697|P2|COMPLETED|Randomized-treatment Epoch||162
8094434|NCT03328897|19953698|P1|COMPLETED|Randomized-treatment Epoch||152
8094435|NCT03328897|19953696|P3|Full Analysis Set (FAS)|Randomized-treatment Epoch||83
8094436|NCT03328897|19953697|P2|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
8094437|NCT03328897|19953698|P1|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
8094438|NCT03328897|19953696|P3|STARTED|Randomized-treatment Epoch||83
8094439|NCT03328897|19953697|P2|STARTED|Randomized-treatment Epoch||167
8094440|NCT03328897|19953698|P1|STARTED|Randomized-treatment Epoch||168
8094441|NCT03328624|19953727|P1|NOT COMPLETED|Overall Study||0
8094442|NCT03328624|19953727|P1|COMPLETED|Overall Study||36
8094443|NCT03328624|19953727|P1|STARTED|Overall Study||36
8094444|NCT03328208|19953733|P2|NOT COMPLETED|Overall Study||0
8094445|NCT03328208|19953734|P1|NOT COMPLETED|Overall Study||0
8094446|NCT03328208|19953733|P2|COMPLETED|Overall Study||35
8094447|NCT03328208|19953734|P1|COMPLETED|Overall Study||37
8094448|NCT03328208|19953733|P2|STARTED|Overall Study||35
8094449|NCT03328208|19953734|P1|STARTED|Overall Study||37
8094450|NCT03328182|19953760|P1|NOT COMPLETED|Overall Study||4
8094451|NCT03328182|19953760|P1|COMPLETED|Overall Study||30
8094452|NCT03328182|19953760|P1|STARTED|Overall Study||34
8094458|NCT03327051|19953800|P2|NOT COMPLETED|Overall Study||5
8094459|NCT03327051|19953801|P1|NOT COMPLETED|Overall Study||5
8094460|NCT03327051|19953800|P2|COMPLETED|Overall Study||15
8094461|NCT03327051|19953801|P1|COMPLETED|Overall Study||14
8094462|NCT03327051|19953800|P2|Attended Visit 2 (Week 0)|Overall Study||15
8094463|NCT03327051|19953801|P1|Attended Visit 2 (Week 0)|Overall Study||15
8094464|NCT03327051|19953800|P2|Received Treatment|Overall Study||16
8094465|NCT03327051|19953801|P1|Received Treatment|Overall Study||16
8094466|NCT03327051|19953800|P2|STARTED|Overall Study||20
8094467|NCT03327051|19953801|P1|STARTED|Overall Study||19
8094468|NCT03326999|19953815|P2|NOT COMPLETED|Overall Study||0
8094469|NCT03326999|19953816|P1|NOT COMPLETED|Overall Study||0
8094470|NCT03326999|19953815|P2|COMPLETED|Overall Study||30
8094471|NCT03326999|19953816|P1|COMPLETED|Overall Study||30
8094472|NCT03326999|19953815|P2|STARTED|Overall Study||30
8094473|NCT03326999|19953816|P1|STARTED|Overall Study||30
8094474|NCT03326986|19953835|P3|NOT COMPLETED|Overall Study||0
8094475|NCT03326986|19953836|P2|NOT COMPLETED|Overall Study||0
8094476|NCT03326986|19953837|P1|NOT COMPLETED|Overall Study||0
8094477|NCT03326986|19953835|P3|COMPLETED|Overall Study||8
8094478|NCT03326986|19953836|P2|COMPLETED|Overall Study||8
8094479|NCT03326986|19953837|P1|COMPLETED|Overall Study||8
8094480|NCT03326986|19953835|P3|STARTED|Overall Study||8
8094481|NCT03326986|19953836|P2|STARTED|Overall Study||8
8094482|NCT03326986|19953837|P1|STARTED|Overall Study||8
8094483|NCT03326895|19954077|P1|NOT COMPLETED|Overall Study||0
8094484|NCT03326895|19954077|P1|COMPLETED|Overall Study||168
8094485|NCT03326895|19954077|P1|STARTED|Overall Study||168
8094486|NCT03326869|19954084|P2|NOT COMPLETED|Overall Study||1
8094487|NCT03326869|19954085|P1|NOT COMPLETED|Overall Study||1
8094488|NCT03326869|19954084|P2|COMPLETED|Overall Study||0
8094489|NCT03326869|19954085|P1|COMPLETED|Overall Study||0
8094490|NCT03326869|19954084|P2|STARTED|Overall Study||1
8094491|NCT03326869|19954085|P1|STARTED|Overall Study||1
8094492|NCT03326843|19954093|P1|NOT COMPLETED|Overall Study||0
8094493|NCT03326843|19954093|P1|COMPLETED|Overall Study||4
8094494|NCT03326843|19954093|P1|STARTED|Overall Study||4
8094495|NCT03326518|19954101|P3|NOT COMPLETED|Overall Study||1
8094496|NCT03326518|19954102|P2|NOT COMPLETED|Overall Study||0
8094497|NCT03326518|19954103|P1|NOT COMPLETED|Overall Study||3
8094498|NCT03326518|19954101|P3|COMPLETED|Overall Study||13
8094499|NCT03326518|19954102|P2|COMPLETED|Overall Study||12
8094500|NCT03326518|19954103|P1|COMPLETED|Overall Study||16
8094501|NCT03326518|19954101|P3|STARTED|Overall Study||14
8094502|NCT03326518|19954102|P2|STARTED|Overall Study||12
8094503|NCT03326518|19954103|P1|STARTED|Overall Study||19
8094504|NCT03326323|19954138|P1|NOT COMPLETED|Overall Study||3
8094505|NCT03326323|19954138|P1|COMPLETED|Overall Study||40
8094506|NCT03326323|19954138|P1|STARTED|Overall Study||43
8094521|NCT03325673|19954243|P2|NOT COMPLETED|Overall Study||0
8094522|NCT03325673|19954244|P1|NOT COMPLETED|Overall Study||4
8094523|NCT03325673|19954243|P2|COMPLETED|Overall Study||42
8094524|NCT03325673|19954244|P1|COMPLETED|Overall Study||38
8094525|NCT03325673|19954243|P2|STARTED|Overall Study||42
8094526|NCT03325673|19954244|P1|STARTED|Overall Study||42
8094527|NCT03325114|19954256|P1|NOT COMPLETED|Overall Study||1
8094528|NCT03325114|19954256|P1|COMPLETED|Overall Study||0
8094529|NCT03325114|19954256|P1|STARTED|Overall Study||1
8094530|NCT03324607|19954263|P1|NOT COMPLETED|Overall Study||0
8094531|NCT03324607|19954263|P1|COMPLETED|Overall Study||20
8094532|NCT03324607|19954263|P1|STARTED|Overall Study||20
8094533|NCT03324451|19954280|P2|NOT COMPLETED|Overall Study||13
8094534|NCT03324451|19954281|P1|NOT COMPLETED|Overall Study||32
8094535|NCT03324451|19954280|P2|COMPLETED|Overall Study||41
8094536|NCT03324451|19954281|P1|COMPLETED|Overall Study||65
8094537|NCT03324451|19954280|P2|STARTED|Overall Study||54
8094538|NCT03324451|19954281|P1|STARTED|Overall Study||97
8094551|NCT03323723|19954311|P1|NOT COMPLETED|Treatment Phase||9
8094552|NCT03323723|19954311|P1|COMPLETED|Treatment Phase||51
8094553|NCT03323723|19954311|P1|STARTED|Treatment Phase||60
8094554|NCT03323723|19954311|P1|NOT COMPLETED|Baseline Phase||4
8094555|NCT03323723|19954311|P1|COMPLETED|Baseline Phase||60
8094556|NCT03323723|19954311|P1|STARTED|Baseline Phase||64
8094557|NCT03323723|19954311|P1|NOT COMPLETED|Screening||9
8094558|NCT03323723|19954311|P1|COMPLETED|Screening||64
8094559|NCT03323723|19954311|P1|STARTED|Screening||73
8094560|NCT03323307|19954318|P1|NOT COMPLETED|Overall Study||0
8094561|NCT03323307|19954318|P1|COMPLETED|Overall Study||70
8094562|NCT03323307|19954318|P1|STARTED|Overall Study||70
8094563|NCT03323164|19954327|P2|NOT COMPLETED|Overall Study||2
8094564|NCT03323164|19954328|P1|NOT COMPLETED|Overall Study||2
8094565|NCT03323164|19954327|P2|COMPLETED|Overall Study||15
8094566|NCT03323164|19954328|P1|COMPLETED|Overall Study||16
8094567|NCT03323164|19954327|P2|STARTED|Overall Study||17
8094568|NCT03323164|19954328|P1|STARTED|Overall Study||18
8094569|NCT03323086|19954354|P2|NOT COMPLETED|Overall Study||2
8094570|NCT03323086|19954355|P1|NOT COMPLETED|Overall Study||3
8094571|NCT03323086|19954354|P2|COMPLETED|Overall Study||20
8094572|NCT03323086|19954355|P1|COMPLETED|Overall Study||23
8094573|NCT03323086|19954354|P2|STARTED|Overall Study||22
8094574|NCT03323086|19954355|P1|STARTED|Overall Study||26
8094575|NCT03322930|19954373|P2|NOT COMPLETED|Overall Study||0
8094576|NCT03322930|19954374|P1|NOT COMPLETED|Overall Study||0
8094577|NCT03322930|19954373|P2|COMPLETED|Overall Study||20
8094578|NCT03322930|19954374|P1|COMPLETED|Overall Study||20
8094579|NCT03322930|19954373|P2|STARTED|Overall Study|recruitment of 20 patients with macular degeneration|20
8094580|NCT03322930|19954374|P1|STARTED|Overall Study|recruitment of 20 patients with retinitis pigmentosa|20
8094581|NCT03322566|19954383|P3|NOT COMPLETED|Overall Study||55
8094582|NCT03322566|19954384|P2|NOT COMPLETED|Overall Study||87
8094583|NCT03322566|19954385|P1|NOT COMPLETED|Overall Study||91
8094584|NCT03322566|19954383|P3|COMPLETED|Overall Study||0
8094585|NCT03322566|19954384|P2|COMPLETED|Overall Study||0
8094586|NCT03322566|19954385|P1|COMPLETED|Overall Study||0
8094587|NCT03322566|19954383|P3|STARTED|Overall Study||55
8094588|NCT03322566|19954384|P2|STARTED|Overall Study||87
8094589|NCT03322566|19954385|P1|STARTED|Overall Study||91
8094590|NCT03322540|19954404|P2|NOT COMPLETED|Overall Study||77
8094591|NCT03322540|19954405|P1|NOT COMPLETED|Overall Study||77
8094592|NCT03322540|19954404|P2|COMPLETED|Overall Study||0
8094593|NCT03322540|19954405|P1|COMPLETED|Overall Study||0
8094594|NCT03322540|19954404|P2|STARTED|Overall Study||77
8094595|NCT03322540|19954405|P1|STARTED|Overall Study||77
8094596|NCT03322514|19954413|P2|NOT COMPLETED|Overall Study||1
8094597|NCT03322514|19954414|P1|NOT COMPLETED|Overall Study||1
8094598|NCT03322514|19954413|P2|COMPLETED|Overall Study||5
8094599|NCT03322514|19954414|P1|COMPLETED|Overall Study||5
8094600|NCT03322514|19954413|P2|STARTED|Overall Study||6
8094601|NCT03322514|19954414|P1|STARTED|Overall Study||6
8094602|NCT03322462|19954424|P1|NOT COMPLETED|Overall Study||3
8094603|NCT03322462|19954424|P1|COMPLETED|Overall Study||152
8094604|NCT03322462|19954424|P1|Flortaucipir PET Scan|Overall Study||155
8094605|NCT03322462|19954424|P1|STARTED|Overall Study||155
8094606|NCT03322423|19954433|P2|NOT COMPLETED|Period 2||2
8094607|NCT03322423|19954434|P1|NOT COMPLETED|Period 2||1
8094608|NCT03322423|19954433|P2|COMPLETED|Period 2||36
8094609|NCT03322423|19954434|P1|COMPLETED|Period 2||35
8094610|NCT03322423|19954433|P2|STARTED|Period 2||38
8094611|NCT03322423|19954434|P1|STARTED|Period 2||36
8094612|NCT03322423|19954433|P2|NOT COMPLETED|Period 1||2
8094613|NCT03322423|19954434|P1|NOT COMPLETED|Period 1||2
8094614|NCT03322423|19954433|P2|COMPLETED|Period 1||38
8094615|NCT03322423|19954434|P1|COMPLETED|Period 1||36
8094616|NCT03322423|19954433|P2|STARTED|Period 1||40
8094617|NCT03322423|19954434|P1|STARTED|Period 1||38
8094618|NCT03322293|19954447|P3|NOT COMPLETED|Overall Study||1
8094619|NCT03322293|19954448|P2|NOT COMPLETED|Overall Study||0
8094620|NCT03322293|19954449|P1|NOT COMPLETED|Overall Study||0
8094621|NCT03322293|19954447|P3|COMPLETED|Overall Study||7
8094622|NCT03322293|19954448|P2|COMPLETED|Overall Study||8
8094623|NCT03322293|19954449|P1|COMPLETED|Overall Study||8
8094624|NCT03322293|19954447|P3|STARTED|Overall Study||8
8094625|NCT03322293|19954448|P2|STARTED|Overall Study||8
8094626|NCT03322293|19954449|P1|STARTED|Overall Study||8
8094627|NCT03321721|19954472|P3|NOT COMPLETED|Overall Study||11
8094628|NCT03321721|19954473|P2|NOT COMPLETED|Overall Study||8
8094629|NCT03321721|19954474|P1|NOT COMPLETED|Overall Study||4
8094630|NCT03321721|19954472|P3|COMPLETED|Overall Study||1
8094631|NCT03321721|19954473|P2|COMPLETED|Overall Study||2
8094632|NCT03321721|19954474|P1|COMPLETED|Overall Study||0
8094633|NCT03321721|19954472|P3|STARTED|Overall Study||12
8094634|NCT03321721|19954473|P2|STARTED|Overall Study||10
8094635|NCT03321721|19954474|P1|STARTED|Overall Study||4
8094636|NCT03321396|19954491|P1|NOT COMPLETED|Overall Study||1
8094637|NCT03321396|19954491|P1|COMPLETED|Overall Study||12
8094638|NCT03321396|19954491|P1|STARTED|Overall Study||13
8094639|NCT03321253|19954497|P1|NOT COMPLETED|Overall Study||0
8094640|NCT03321253|19954497|P1|COMPLETED|Overall Study||38
8094641|NCT03321253|19954497|P1|STARTED|Overall Study||38
8094642|NCT03321097|19954507|P2|NOT COMPLETED|Overall Study||0
8094643|NCT03321097|19954508|P1|NOT COMPLETED|Overall Study||0
8094644|NCT03321097|19954507|P2|COMPLETED|Overall Study||18
8094645|NCT03321097|19954508|P1|COMPLETED|Overall Study||18
8094646|NCT03321097|19954507|P2|STARTED|Overall Study||18
8094647|NCT03321097|19954508|P1|STARTED|Overall Study||18
8094648|NCT03320941|19954529|P5|NOT COMPLETED|Overall Study||0
8094649|NCT03320941|19954530|P4|NOT COMPLETED|Overall Study||1
8094650|NCT03320941|19954531|P3|NOT COMPLETED|Overall Study||0
8094651|NCT03320941|19954532|P2|NOT COMPLETED|Overall Study||0
8094652|NCT03320941|19954533|P1|NOT COMPLETED|Overall Study||0
8094653|NCT03320941|19954529|P5|COMPLETED|Overall Study||29
8094654|NCT03320941|19954530|P4|COMPLETED|Overall Study||30
8094655|NCT03320941|19954531|P3|COMPLETED|Overall Study||28
8094656|NCT03320941|19954532|P2|COMPLETED|Overall Study||19
8094657|NCT03320941|19954533|P1|COMPLETED|Overall Study||19
8094658|NCT03320941|19954529|P5|STARTED|Overall Study||29
8094659|NCT03320941|19954530|P4|STARTED|Overall Study||31
8094660|NCT03320941|19954531|P3|STARTED|Overall Study||28
8094661|NCT03320941|19954532|P2|STARTED|Overall Study||19
8094662|NCT03320941|19954533|P1|STARTED|Overall Study||19
8094663|NCT03320824|19954636|P2|NOT COMPLETED|Overall Study||4
8094664|NCT03320824|19954637|P1|NOT COMPLETED|Overall Study||18
8094665|NCT03320824|19954636|P2|COMPLETED|Overall Study||85
8094666|NCT03320824|19954637|P1|COMPLETED|Overall Study||166
8094667|NCT03320824|19954636|P2|STARTED|Overall Study||89
8094668|NCT03320824|19954637|P1|STARTED|Overall Study||184
8094669|NCT03320564|19954653|P1|NOT COMPLETED|Overall Study||1
8094670|NCT03320564|19954653|P1|COMPLETED|Overall Study||1
8094671|NCT03320564|19954653|P1|STARTED|Overall Study||2
8094672|NCT03320369|19954657|P1|NOT COMPLETED|Overall Study||3
8094673|NCT03320369|19954657|P1|COMPLETED|Overall Study||15
8094674|NCT03320369|19954657|P1|STARTED|Overall Study||18
8094675|NCT03320096|19954666|P1|NOT COMPLETED|Overall Study||0
8094676|NCT03320096|19954666|P1|COMPLETED|Overall Study||20
8094677|NCT03320096|19954666|P1|STARTED|Overall Study||20
8094678|NCT03319810|19954673|P1|NOT COMPLETED|Overall Study||0
8094679|NCT03319810|19954673|P1|COMPLETED|Overall Study||5
8094680|NCT03319810|19954673|P1|STARTED|Overall Study||5
8094681|NCT03319719|19954678|P1|NOT COMPLETED|Overall Study||1
8094682|NCT03319719|19954678|P1|COMPLETED|Overall Study||51
8094683|NCT03319719|19954678|P1|STARTED|Overall Study||52
8094684|NCT03319407|19954692|P1|NOT COMPLETED|Overall Study||21
8094685|NCT03319407|19954692|P1|COMPLETED|Overall Study||0
8094686|NCT03319407|19954692|P1|STARTED|Overall Study||21
8094687|NCT03319277|19954698|P2|NOT COMPLETED|Overall Study||0
8094688|NCT03319277|19954699|P1|NOT COMPLETED|Overall Study||0
8094689|NCT03319277|19954698|P2|COMPLETED|Overall Study||59
8094690|NCT03319277|19954699|P1|COMPLETED|Overall Study||59
8094691|NCT03319277|19954698|P2|STARTED|Overall Study||59
8094692|NCT03319277|19954699|P1|STARTED|Overall Study||59
8094693|NCT03319212|19954711|P2|NOT COMPLETED|Overall Study||5
8094694|NCT03319212|19954712|P1|NOT COMPLETED|Overall Study||3
8094695|NCT03319212|19954711|P2|COMPLETED|Overall Study||47
8094696|NCT03319212|19954712|P1|COMPLETED|Overall Study||26
8094697|NCT03319212|19954711|P2|STARTED|Overall Study||52
8094698|NCT03319212|19954712|P1|STARTED|Overall Study||29
8094699|NCT03319173|19954739|P2|NOT COMPLETED|Overall Study||0
8094700|NCT03319173|19954740|P1|NOT COMPLETED|Overall Study||0
8094701|NCT03319173|19954739|P2|COMPLETED|Overall Study||50
8094702|NCT03319173|19954740|P1|COMPLETED|Overall Study||48
8094703|NCT03319173|19954739|P2|STARTED|Overall Study||50
8094704|NCT03319173|19954740|P1|STARTED|Overall Study||48
8094705|NCT03319134|19954779|P3|NOT COMPLETED|Overall Study||0
8094706|NCT03319134|19954780|P2|NOT COMPLETED|Overall Study||0
8094707|NCT03319134|19954781|P1|NOT COMPLETED|Overall Study||0
8094708|NCT03319134|19954779|P3|COMPLETED|Overall Study||15
8094709|NCT03319134|19954780|P2|COMPLETED|Overall Study||15
8094710|NCT03319134|19954781|P1|COMPLETED|Overall Study||15
8094711|NCT03319134|19954779|P3|STARTED|Overall Study||15
8094712|NCT03319134|19954780|P2|STARTED|Overall Study||15
8094713|NCT03319134|19954781|P1|STARTED|Overall Study||15
8094729|NCT03318809|19954846|P2|NOT COMPLETED|Overall Study||0
8094730|NCT03318809|19954847|P1|NOT COMPLETED|Overall Study||0
8094731|NCT03318809|19954846|P2|COMPLETED|Overall Study||6
8094732|NCT03318809|19954847|P1|COMPLETED|Overall Study||6
8094733|NCT03318809|19954846|P2|STARTED|Overall Study||6
8094734|NCT03318809|19954847|P1|STARTED|Overall Study||6
8094735|NCT03318783|19954865|P2|NOT COMPLETED|Overall Study||2
8094736|NCT03318783|19954866|P1|NOT COMPLETED|Overall Study||0
8094737|NCT03318783|19954865|P2|COMPLETED|Overall Study||8
8094738|NCT03318783|19954866|P1|COMPLETED|Overall Study||10
8094739|NCT03318783|19954865|P2|STARTED|Overall Study||10
8094740|NCT03318783|19954866|P1|STARTED|Overall Study||10
8094741|NCT03318341|19954892|P2|NOT COMPLETED|Month 2||0
8094742|NCT03318341|19954893|P1|NOT COMPLETED|Month 2||0
8094743|NCT03318341|19954892|P2|COMPLETED|Month 2||12
8094744|NCT03318341|19954893|P1|COMPLETED|Month 2||13
8094745|NCT03318341|19954892|P2|STARTED|Month 2||12
8094746|NCT03318341|19954893|P1|STARTED|Month 2||13
8094747|NCT03318341|19954892|P2|NOT COMPLETED|Month 1||1
8094748|NCT03318341|19954893|P1|NOT COMPLETED|Month 1||0
8094749|NCT03318341|19954892|P2|COMPLETED|Month 1||12
8094750|NCT03318341|19954893|P1|COMPLETED|Month 1||13
8094751|NCT03318341|19954892|P2|STARTED|Month 1||13
8094752|NCT03318341|19954893|P1|STARTED|Month 1||13
8094753|NCT03318315|19954906|P3|NOT COMPLETED|Overall Study||4
8094754|NCT03318315|19954907|P2|NOT COMPLETED|Overall Study||3
8094755|NCT03318315|19954908|P1|NOT COMPLETED|Overall Study||4
8094756|NCT03318315|19954906|P3|COMPLETED|Overall Study||30
8094757|NCT03318315|19954907|P2|COMPLETED|Overall Study||50
8094758|NCT03318315|19954908|P1|COMPLETED|Overall Study||58
8094759|NCT03318315|19954906|P3|Received Third Vaccination|Overall Study||0
8094760|NCT03318315|19954907|P2|Received Third Vaccination|Overall Study||46
8094761|NCT03318315|19954908|P1|Received Third Vaccination|Overall Study||0
8094762|NCT03318315|19954906|P3|Received Second Vaccination|Overall Study||0
8094763|NCT03318315|19954907|P2|Received Second Vaccination|Overall Study||48
8094764|NCT03318315|19954908|P1|Received Second Vaccination|Overall Study||59
8094765|NCT03318315|19954906|P3|Received First Vaccination|Overall Study||34
8094766|NCT03318315|19954907|P2|Received First Vaccination|Overall Study||53
8094767|NCT03318315|19954908|P1|Received First Vaccination|Overall Study||62
8094768|NCT03318315|19954906|P3|STARTED|Overall Study||34
8094769|NCT03318315|19954907|P2|STARTED|Overall Study||53
8094770|NCT03318315|19954908|P1|STARTED|Overall Study||62
8094771|NCT03317431|19954999|P1|NOT COMPLETED|Overall Study||0
8094772|NCT03317431|19954999|P1|COMPLETED|Overall Study||46
8094773|NCT03317431|19954999|P1|STARTED|Overall Study||46
8094774|NCT03316976|19955009|P2|NOT COMPLETED|Overall Study||0
8094775|NCT03316976|19955010|P1|NOT COMPLETED|Overall Study||0
8094776|NCT03316976|19955009|P2|COMPLETED|Overall Study||20
8094777|NCT03316976|19955010|P1|COMPLETED|Overall Study||20
8094778|NCT03316976|19955009|P2|STARTED|Overall Study||20
8094779|NCT03316976|19955010|P1|STARTED|Overall Study||20
8094780|NCT03316911|19955022|P2|NOT COMPLETED|Overall Study||29
8094781|NCT03316911|19955023|P1|NOT COMPLETED|Overall Study||33
8094782|NCT03316911|19955022|P2|COMPLETED|Overall Study||110
8094783|NCT03316911|19955023|P1|COMPLETED|Overall Study||89
8094784|NCT03316911|19955022|P2|5-Month Follow-up Survey|Overall Study||110
8094785|NCT03316911|19955023|P1|5-Month Follow-up Survey|Overall Study||89
8094786|NCT03316911|19955022|P2|3-Month Follow-up Survey|Overall Study||112
8094787|NCT03316911|19955023|P1|3-Month Follow-up Survey|Overall Study||93
8094788|NCT03316911|19955022|P2|STARTED|Overall Study|3 did not complete baseline survey|139
8094789|NCT03316911|19955023|P1|STARTED|Overall Study|2 did not complete baseline survey|122
8094790|NCT03316807|19955057|P2|NOT COMPLETED|Overall Study||26
8094791|NCT03316807|19955058|P1|NOT COMPLETED|Overall Study||31
8094792|NCT03316807|19955057|P2|COMPLETED|Overall Study||65
8094793|NCT03316807|19955058|P1|COMPLETED|Overall Study||60
8094794|NCT03316807|19955057|P2|STARTED|Overall Study||91
8094795|NCT03316807|19955058|P1|STARTED|Overall Study||91
8094796|NCT03316378|19955090|P2|NOT COMPLETED|Overall Study||0
8094797|NCT03316378|19955091|P1|NOT COMPLETED|Overall Study||0
8094798|NCT03316378|19955090|P2|COMPLETED|Overall Study||23
8094799|NCT03316378|19955091|P1|COMPLETED|Overall Study||23
8094800|NCT03316378|19955090|P2|STARTED|Overall Study||23
8094801|NCT03316378|19955091|P1|STARTED|Overall Study||23
8094802|NCT03316131|19955101|P2|NOT COMPLETED|Treatment Period 2||0
8094803|NCT03316131|19955102|P1|NOT COMPLETED|Treatment Period 2||1
8094804|NCT03316131|19955101|P2|COMPLETED|Treatment Period 2||18
8094805|NCT03316131|19955102|P1|COMPLETED|Treatment Period 2||17
8094806|NCT03316131|19955101|P2|STARTED|Treatment Period 2||18
8094807|NCT03316131|19955102|P1|STARTED|Treatment Period 2||18
8094808|NCT03316131|19955101|P2|NOT COMPLETED|Treatment Period 1||0
8094809|NCT03316131|19955102|P1|NOT COMPLETED|Treatment Period 1||0
8094810|NCT03316131|19955101|P2|COMPLETED|Treatment Period 1||18
8094811|NCT03316131|19955102|P1|COMPLETED|Treatment Period 1||18
8094812|NCT03316131|19955101|P2|STARTED|Treatment Period 1||18
8094813|NCT03316131|19955102|P1|STARTED|Treatment Period 1||18
8094814|NCT03316105|19955122|P2|NOT COMPLETED|Overall Study||0
8094815|NCT03316105|19955123|P1|NOT COMPLETED|Overall Study||0
8094816|NCT03316105|19955122|P2|COMPLETED|Overall Study||7
8094817|NCT03316105|19955123|P1|COMPLETED|Overall Study||9
8094818|NCT03316105|19955122|P2|STARTED|Overall Study||7
8094819|NCT03316105|19955123|P1|STARTED|Overall Study||9
8094820|NCT03315949|19955131|P2|NOT COMPLETED|Overall Study||10
8094821|NCT03315949|19955132|P1|NOT COMPLETED|Overall Study||5
8094822|NCT03315949|19955131|P2|COMPLETED|Overall Study||166
8094823|NCT03315949|19955132|P1|COMPLETED|Overall Study||171
8094824|NCT03315949|19955131|P2|STARTED|Overall Study||176
8094825|NCT03315949|19955132|P1|STARTED|Overall Study||176
8094826|NCT03315793|19955140|P2|NOT COMPLETED|Overall Study||3
8094827|NCT03315793|19955141|P1|NOT COMPLETED|Overall Study||5
8094828|NCT03315793|19955140|P2|COMPLETED|Overall Study||71
8094829|NCT03315793|19955141|P1|COMPLETED|Overall Study||70
8094830|NCT03315793|19955140|P2|Received at Least 1 Dose of Study Drug|Overall Study||74
8094831|NCT03315793|19955141|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
8094832|NCT03315793|19955140|P2|STARTED|Overall Study||74
8094833|NCT03315793|19955141|P1|STARTED|Overall Study||75
8094834|NCT03315780|19955155|P2|NOT COMPLETED|Period 2||0
8094835|NCT03315780|19955156|P1|NOT COMPLETED|Period 2||0
8094836|NCT03315780|19955155|P2|COMPLETED|Period 2||6
8094837|NCT03315780|19955156|P1|COMPLETED|Period 2||6
8094838|NCT03315780|19955155|P2|STARTED|Period 2||6
8094839|NCT03315780|19955156|P1|STARTED|Period 2||6
8094840|NCT03315780|19955155|P2|NOT COMPLETED|Period 1||0
8094841|NCT03315780|19955156|P1|NOT COMPLETED|Period 1||0
8094842|NCT03315780|19955155|P2|COMPLETED|Period 1||6
8094843|NCT03315780|19955156|P1|COMPLETED|Period 1||6
8094844|NCT03315780|19955155|P2|Received One Dose of Study Drug|Period 1||6
8094845|NCT03315780|19955156|P1|Received One Dose of Study Drug|Period 1||6
8094846|NCT03315780|19955155|P2|STARTED|Period 1||6
8094847|NCT03315780|19955156|P1|STARTED|Period 1||6
8094848|NCT03315702|19955176|P1|NOT COMPLETED|Overall Study||0
8094849|NCT03315702|19955176|P1|COMPLETED|Overall Study||52
8094850|NCT03315702|19955176|P1|STARTED|Overall Study||52
8094851|NCT03315689|19955185|P2|NOT COMPLETED|Open Label Extension = 52 Weeks||3
8094852|NCT03315689|19955186|P1|NOT COMPLETED|Open Label Extension = 52 Weeks||0
8094853|NCT03315689|19955185|P2|COMPLETED|Open Label Extension = 52 Weeks||7
8094854|NCT03315689|19955186|P1|COMPLETED|Open Label Extension = 52 Weeks||0
8094855|NCT03315689|19955185|P2|STARTED|Open Label Extension = 52 Weeks||10
8094856|NCT03315689|19955186|P1|STARTED|Open Label Extension = 52 Weeks||0
8094857|NCT03315689|19955185|P2|NOT COMPLETED|Double-blind Period = 28 Days||0
8094858|NCT03315689|19955186|P1|NOT COMPLETED|Double-blind Period = 28 Days||1
8094859|NCT03315689|19955185|P2|COMPLETED|Double-blind Period = 28 Days||7
8094860|NCT03315689|19955186|P1|COMPLETED|Double-blind Period = 28 Days||3
8094861|NCT03315689|19955185|P2|STARTED|Double-blind Period = 28 Days||7
8094862|NCT03315689|19955186|P1|STARTED|Double-blind Period = 28 Days||4
8094863|NCT03315572|19955216|P2|NOT COMPLETED|Overall Study||0
8094864|NCT03315572|19955217|P1|NOT COMPLETED|Overall Study||0
8094865|NCT03315572|19955216|P2|COMPLETED|Overall Study||14
8094866|NCT03315572|19955217|P1|COMPLETED|Overall Study||14
8094867|NCT03315572|19955216|P2|STARTED|Overall Study||14
8094868|NCT03315572|19955217|P1|STARTED|Overall Study||14
8094869|NCT03315559|19955240|P1|NOT COMPLETED|Treatment Period 2 (15 Days)||0
8094870|NCT03315559|19955240|P1|COMPLETED|Treatment Period 2 (15 Days)||6
8094871|NCT03315559|19955240|P1|STARTED|Treatment Period 2 (15 Days)||6
8094872|NCT03315559|19955240|P1|NOT COMPLETED|Washout Period (14 Days)||0
8094873|NCT03315559|19955240|P1|COMPLETED|Washout Period (14 Days)||6
8094874|NCT03315559|19955240|P1|STARTED|Washout Period (14 Days)||6
8094875|NCT03315559|19955240|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8094876|NCT03315559|19955240|P1|COMPLETED|Treatment Period 1 (8 Days)||6
8094877|NCT03315559|19955240|P1|STARTED|Treatment Period 1 (8 Days)||6
8094878|NCT03315286|19955280|P2|NOT COMPLETED|Overall Study||4
8094879|NCT03315286|19955281|P1|NOT COMPLETED|Overall Study||1
8094880|NCT03315286|19955280|P2|COMPLETED|Overall Study||43
8094881|NCT03315286|19955281|P1|COMPLETED|Overall Study||49
8094882|NCT03315286|19955280|P2|STARTED|Overall Study||47
8094883|NCT03315286|19955281|P1|STARTED|Overall Study||50
8094884|NCT03315104|19955300|P3|NOT COMPLETED|Overall Study||5
8094885|NCT03315104|19955301|P2|NOT COMPLETED|Overall Study||4
8094886|NCT03315104|19955302|P1|NOT COMPLETED|Overall Study||3
8094887|NCT03315104|19955300|P3|COMPLETED|Overall Study||19
8094888|NCT03315104|19955301|P2|COMPLETED|Overall Study||16
8094889|NCT03315104|19955302|P1|COMPLETED|Overall Study||18
8094890|NCT03315104|19955300|P3|Dosed (Safety Population)|Overall Study||22
8094891|NCT03315104|19955301|P2|Dosed (Safety Population)|Overall Study||19
8094892|NCT03315104|19955302|P1|Dosed (Safety Population)|Overall Study||19
8094893|NCT03315104|19955300|P3|STARTED|Overall Study||24
8094894|NCT03315104|19955301|P2|STARTED|Overall Study||20
8094895|NCT03315104|19955302|P1|STARTED|Overall Study||21
8094896|NCT03314857|19955322|P1|NOT COMPLETED|Overall Study||5
8094897|NCT03314857|19955322|P1|COMPLETED|Overall Study|62/67 patients completed the 30-day primary endpoint visit.|62
8094898|NCT03314857|19955322|P1|Analysis Population|Overall Study||61
8094899|NCT03314857|19955322|P1|STARTED|Overall Study||67
8094900|NCT03314753|19955330|P2|NOT COMPLETED|Overall Study||0
8094901|NCT03314753|19955331|P1|NOT COMPLETED|Overall Study||0
8094902|NCT03314753|19955330|P2|COMPLETED|Overall Study||36
8094903|NCT03314753|19955331|P1|COMPLETED|Overall Study||53
8094904|NCT03314753|19955330|P2|STARTED|Overall Study||36
8094905|NCT03314753|19955331|P1|STARTED|Overall Study||53
8094906|NCT03314662|19955356|P3|NOT COMPLETED|Overall Study||5
8094907|NCT03314662|19955357|P2|NOT COMPLETED|Overall Study||5
8094908|NCT03314662|19955358|P1|NOT COMPLETED|Overall Study||8
8094909|NCT03314662|19955356|P3|COMPLETED|Overall Study||439
8094910|NCT03314662|19955357|P2|COMPLETED|Overall Study||440
8094911|NCT03314662|19955358|P1|COMPLETED|Overall Study||881
8094912|NCT03314662|19955356|P3|Treated|Overall Study||444
8094913|NCT03314662|19955357|P2|Treated|Overall Study||444
8094914|NCT03314662|19955358|P1|Treated|Overall Study||888
8094915|NCT03314662|19955356|P3|STARTED|Overall Study||444
8094916|NCT03314662|19955357|P2|STARTED|Overall Study||445
8094917|NCT03314662|19955358|P1|STARTED|Overall Study||889
8094918|NCT03314519|19955403|P2|NOT COMPLETED|Overall Study||2
8094919|NCT03314519|19955404|P1|NOT COMPLETED|Overall Study||3
8094920|NCT03314519|19955403|P2|COMPLETED|Overall Study||98
8094921|NCT03314519|19955404|P1|COMPLETED|Overall Study||97
8094922|NCT03314519|19955403|P2|STARTED|Overall Study||100
8094923|NCT03314519|19955404|P1|STARTED|Overall Study||100
8094924|NCT03314233|19955414|P1|NOT COMPLETED|Overall Study||1
8094925|NCT03314233|19955414|P1|COMPLETED|Overall Study|20 mothers who had provided informed consent met eligibility criteria at time of delivery.|20
8094926|NCT03314233|19955414|P1|STARTED|Overall Study|21 mothers provided informed consent for participation in the trial.|21
8094927|NCT03313310|19955427|P2|NOT COMPLETED|Phase 3||1
8094928|NCT03313310|19955428|P1|NOT COMPLETED|Phase 3||0
8094929|NCT03313310|19955427|P2|COMPLETED|Phase 3||40
8094930|NCT03313310|19955428|P1|COMPLETED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
8094931|NCT03313310|19955427|P2|STARTED|Phase 3||41
8094932|NCT03313310|19955428|P1|STARTED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
8094933|NCT03313310|19955427|P2|NOT COMPLETED|Phase 2||0
8094934|NCT03313310|19955428|P1|NOT COMPLETED|Phase 2||4
8094935|NCT03313310|19955427|P2|COMPLETED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
8094936|NCT03313310|19955428|P1|COMPLETED|Phase 2||47
8094937|NCT03313310|19955427|P2|STARTED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
8094938|NCT03313310|19955428|P1|STARTED|Phase 2||51
8094939|NCT03313050|19955470|P4|NOT COMPLETED|Stage 2: 12 Months||20
8094940|NCT03313050|19955471|P3|NOT COMPLETED|Stage 2: 12 Months||11
8094941|NCT03313050|19955472|P2|NOT COMPLETED|Stage 2: 12 Months||0
8094942|NCT03313050|19955473|P1|NOT COMPLETED|Stage 2: 12 Months||0
8094943|NCT03313050|19955470|P4|COMPLETED|Stage 2: 12 Months||204
8094944|NCT03313050|19955471|P3|COMPLETED|Stage 2: 12 Months||210
8094945|NCT03313050|19955472|P2|COMPLETED|Stage 2: 12 Months||0
8094946|NCT03313050|19955473|P1|COMPLETED|Stage 2: 12 Months||0
8094947|NCT03313050|19955470|P4|Vaccinated|Stage 2: 12 Months||223
8094948|NCT03313050|19955471|P3|Vaccinated|Stage 2: 12 Months||221
8094949|NCT03313050|19955472|P2|Vaccinated|Stage 2: 12 Months||0
8094950|NCT03313050|19955473|P1|Vaccinated|Stage 2: 12 Months||0
8094951|NCT03313050|19955470|P4|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|224
8094952|NCT03313050|19955471|P3|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|221
8094953|NCT03313050|19955472|P2|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
8094954|NCT03313050|19955473|P1|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
8094955|NCT03313050|19955470|P4|NOT COMPLETED|Stage 1: 6 Months||0
8094956|NCT03313050|19955471|P3|NOT COMPLETED|Stage 1: 6 Months||0
8094957|NCT03313050|19955472|P2|NOT COMPLETED|Stage 1: 6 Months||0
8094958|NCT03313050|19955473|P1|NOT COMPLETED|Stage 1: 6 Months||0
8094959|NCT03313050|19955470|P4|COMPLETED|Stage 1: 6 Months||0
8094960|NCT03313050|19955471|P3|COMPLETED|Stage 1: 6 Months||0
8094961|NCT03313050|19955472|P2|COMPLETED|Stage 1: 6 Months||32
8094962|NCT03313050|19955473|P1|COMPLETED|Stage 1: 6 Months||34
8094963|NCT03313050|19955470|P4|Vaccinated|Stage 1: 6 Months||0
8094964|NCT03313050|19955471|P3|Vaccinated|Stage 1: 6 Months||0
8094965|NCT03313050|19955472|P2|Vaccinated|Stage 1: 6 Months||32
8094966|NCT03313050|19955473|P1|Vaccinated|Stage 1: 6 Months||34
8094967|NCT03313050|19955470|P4|STARTED|Stage 1: 6 Months||0
8094968|NCT03313050|19955471|P3|STARTED|Stage 1: 6 Months||0
8094969|NCT03313050|19955472|P2|STARTED|Stage 1: 6 Months||32
8094970|NCT03313050|19955473|P1|STARTED|Stage 1: 6 Months||34
8094971|NCT03313037|19955513|P2|NOT COMPLETED|Overall Study||20
8094972|NCT03313037|19955514|P1|NOT COMPLETED|Overall Study||20
8094973|NCT03313037|19955513|P2|COMPLETED|Overall Study||202
8094974|NCT03313037|19955514|P1|COMPLETED|Overall Study||202
8094975|NCT03313037|19955513|P2|Evaluable Immunogenicity Population(EIP)|Overall Study||208
8094976|NCT03313037|19955514|P1|Evaluable Immunogenicity Population(EIP)|Overall Study||210
8094977|NCT03313037|19955513|P2|Safety Population|Overall Study||222
8094978|NCT03313037|19955514|P1|Safety Population|Overall Study||221
8094979|NCT03313037|19955513|P2|STARTED|Overall Study||222
8094980|NCT03313037|19955514|P1|STARTED|Overall Study||222
8094981|NCT03312933|19955536|P1|NOT COMPLETED|Overall Study||54
8094982|NCT03312933|19955536|P1|COMPLETED|Overall Study||46
8094983|NCT03312933|19955536|P1|STARTED|Overall Study||100
8094984|NCT03312543|19955542|P2|NOT COMPLETED|Regression (Week 12 to Week 24)||2
8094985|NCT03312543|19955543|P1|NOT COMPLETED|Regression (Week 12 to Week 24)||1
8094986|NCT03312543|19955542|P2|COMPLETED|Regression (Week 12 to Week 24)||52
8094987|NCT03312543|19955543|P1|COMPLETED|Regression (Week 12 to Week 24)||55
8094988|NCT03312543|19955542|P2|STARTED|Regression (Week 12 to Week 24)||54
8094989|NCT03312543|19955543|P1|STARTED|Regression (Week 12 to Week 24)||56
8094990|NCT03312543|19955542|P2|NOT COMPLETED|Treatment (Baseline to Week 12)||5
8094991|NCT03312543|19955543|P1|NOT COMPLETED|Treatment (Baseline to Week 12)||4
8094992|NCT03312543|19955542|P2|COMPLETED|Treatment (Baseline to Week 12)||54
8094993|NCT03312543|19955543|P1|COMPLETED|Treatment (Baseline to Week 12)||56
8094994|NCT03312543|19955542|P2|STARTED|Treatment (Baseline to Week 12)||59
8094995|NCT03312543|19955543|P1|STARTED|Treatment (Baseline to Week 12)||60
8094996|NCT03312543|19955542|P2|NOT COMPLETED|Before Treatment (Screening to Baseline)||4
8094997|NCT03312543|19955543|P1|NOT COMPLETED|Before Treatment (Screening to Baseline)||1
8094998|NCT03312543|19955542|P2|COMPLETED|Before Treatment (Screening to Baseline)||59
8094999|NCT03312543|19955543|P1|COMPLETED|Before Treatment (Screening to Baseline)||60
8095000|NCT03312543|19955542|P2|STARTED|Before Treatment (Screening to Baseline)||63
8095001|NCT03312543|19955543|P1|STARTED|Before Treatment (Screening to Baseline)||61
8095002|NCT03312517|19955617|P6|NOT COMPLETED|Overall Study||0
8095003|NCT03312517|19955618|P5|NOT COMPLETED|Overall Study||0
8095004|NCT03312517|19955619|P4|NOT COMPLETED|Overall Study||0
8095005|NCT03312517|19955620|P3|NOT COMPLETED|Overall Study||0
8095006|NCT03312517|19955621|P2|NOT COMPLETED|Overall Study||0
8095007|NCT03312517|19955622|P1|NOT COMPLETED|Overall Study||0
8095008|NCT03312517|19955617|P6|COMPLETED|Overall Study||2
8095009|NCT03312517|19955618|P5|COMPLETED|Overall Study||2
8095010|NCT03312517|19955619|P4|COMPLETED|Overall Study||2
8095011|NCT03312517|19955620|P3|COMPLETED|Overall Study||2
8095012|NCT03312517|19955621|P2|COMPLETED|Overall Study||2
8095013|NCT03312517|19955622|P1|COMPLETED|Overall Study||2
8095014|NCT03312517|19955617|P6|STARTED|Overall Study||2
8095015|NCT03312517|19955618|P5|STARTED|Overall Study||2
8095016|NCT03312517|19955619|P4|STARTED|Overall Study||2
8095017|NCT03312517|19955620|P3|STARTED|Overall Study||2
8095018|NCT03312517|19955621|P2|STARTED|Overall Study||2
8095019|NCT03312517|19955622|P1|STARTED|Overall Study||2
8095020|NCT03312348|19955630|P1|NOT COMPLETED|Overall Study||0
8095021|NCT03312348|19955630|P1|COMPLETED|Overall Study||30
8095022|NCT03312348|19955630|P1|STARTED|Overall Study||30
8095023|NCT03312231|19955639|P5|NOT COMPLETED|Overall Study||1
8095024|NCT03312231|19955640|P4|NOT COMPLETED|Overall Study||3
8095025|NCT03312231|19955641|P3|NOT COMPLETED|Overall Study||4
8095026|NCT03312231|19955642|P2|NOT COMPLETED|Overall Study||11
8095027|NCT03312231|19955643|P1|NOT COMPLETED|Overall Study||3
8095028|NCT03312231|19955639|P5|COMPLETED|Overall Study||89
8095029|NCT03312231|19955640|P4|COMPLETED|Overall Study||86
8095030|NCT03312231|19955641|P3|COMPLETED|Overall Study||177
8095031|NCT03312231|19955642|P2|COMPLETED|Overall Study||165
8095032|NCT03312231|19955643|P1|COMPLETED|Overall Study||181
8095033|NCT03312231|19955639|P5|STARTED|Overall Study||90
8095034|NCT03312231|19955640|P4|STARTED|Overall Study||89
8095035|NCT03312231|19955641|P3|STARTED|Overall Study||181
8095036|NCT03312231|19955642|P2|STARTED|Overall Study||176
8095037|NCT03312231|19955643|P1|STARTED|Overall Study||184
8095038|NCT03312114|19955845|P1|NOT COMPLETED|Overall Study||5
8095039|NCT03312114|19955845|P1|COMPLETED|Overall Study||0
8095040|NCT03312114|19955845|P1|STARTED|Overall Study||5
8095041|NCT03311841|19955855|P5|NOT COMPLETED|Period 2||0
8095042|NCT03311841|19955856|P4|NOT COMPLETED|Period 2||0
8095043|NCT03311841|19955857|P3|NOT COMPLETED|Period 2||0
8095044|NCT03311841|19955858|P2|NOT COMPLETED|Period 2||0
8095045|NCT03311841|19955859|P1|NOT COMPLETED|Period 2||0
8095046|NCT03311841|19955855|P5|COMPLETED|Period 2||6
8095047|NCT03311841|19955856|P4|COMPLETED|Period 2||6
8095048|NCT03311841|19955857|P3|COMPLETED|Period 2||6
8095049|NCT03311841|19955858|P2|COMPLETED|Period 2||6
8095050|NCT03311841|19955859|P1|COMPLETED|Period 2||6
8095051|NCT03311841|19955855|P5|STARTED|Period 2||6
8095052|NCT03311841|19955856|P4|STARTED|Period 2||6
8095053|NCT03311841|19955857|P3|STARTED|Period 2||6
8095054|NCT03311841|19955858|P2|STARTED|Period 2||6
8095055|NCT03311841|19955859|P1|STARTED|Period 2||6
8095056|NCT03311841|19955855|P5|NOT COMPLETED|14-day Wash-out||0
8095057|NCT03311841|19955856|P4|NOT COMPLETED|14-day Wash-out||1
8095058|NCT03311841|19955857|P3|NOT COMPLETED|14-day Wash-out||0
8095059|NCT03311841|19955858|P2|NOT COMPLETED|14-day Wash-out||1
8095060|NCT03311841|19955859|P1|NOT COMPLETED|14-day Wash-out||0
8095061|NCT03311841|19955855|P5|COMPLETED|14-day Wash-out||6
8095062|NCT03311841|19955856|P4|COMPLETED|14-day Wash-out||6
8095063|NCT03311841|19955857|P3|COMPLETED|14-day Wash-out||6
8095064|NCT03311841|19955858|P2|COMPLETED|14-day Wash-out||6
8095065|NCT03311841|19955859|P1|COMPLETED|14-day Wash-out||6
8095066|NCT03311841|19955855|P5|STARTED|14-day Wash-out||6
8095067|NCT03311841|19955856|P4|STARTED|14-day Wash-out||7
8095068|NCT03311841|19955857|P3|STARTED|14-day Wash-out||6
8095069|NCT03311841|19955858|P2|STARTED|14-day Wash-out||7
8095070|NCT03311841|19955859|P1|STARTED|14-day Wash-out||6
8095071|NCT03311841|19955855|P5|NOT COMPLETED|Period 1||0
8095072|NCT03311841|19955856|P4|NOT COMPLETED|Period 1||0
8095073|NCT03311841|19955857|P3|NOT COMPLETED|Period 1||0
8095074|NCT03311841|19955858|P2|NOT COMPLETED|Period 1||0
8095075|NCT03311841|19955859|P1|NOT COMPLETED|Period 1||0
8095076|NCT03311841|19955855|P5|COMPLETED|Period 1||6
8095077|NCT03311841|19955856|P4|COMPLETED|Period 1||7
8095078|NCT03311841|19955857|P3|COMPLETED|Period 1||6
8095079|NCT03311841|19955858|P2|COMPLETED|Period 1||7
8095080|NCT03311841|19955859|P1|COMPLETED|Period 1||6
8095081|NCT03311841|19955855|P5|STARTED|Period 1||6
8095082|NCT03311841|19955856|P4|STARTED|Period 1||7
8095083|NCT03311841|19955857|P3|STARTED|Period 1||6
8095084|NCT03311841|19955858|P2|STARTED|Period 1||7
8095085|NCT03311841|19955859|P1|STARTED|Period 1||6
8095086|NCT03311659|19955960|P1|NOT COMPLETED|Overall Study||1
8095087|NCT03311659|19955960|P1|COMPLETED|Overall Study||446
8095088|NCT03311659|19955960|P1|STARTED|Overall Study||447
8095089|NCT03311646|19955975|P1|NOT COMPLETED|Overall Study||15
8095090|NCT03311646|19955975|P1|COMPLETED|Overall Study|Completed VLNC Condition|16
8095091|NCT03311646|19955975|P1|STARTED|Overall Study|Number who were eligible and consented.|31
8095092|NCT03311373|19955982|P1|NOT COMPLETED|Overall Study||9
8095093|NCT03311373|19955982|P1|COMPLETED|Overall Study||47
8095094|NCT03311373|19955982|P1|STARTED|Overall Study||56
8095095|NCT03311230|19956040|P4|NOT COMPLETED|Overall Study||7
8095096|NCT03311230|19956041|P3|NOT COMPLETED|Overall Study||2
8095097|NCT03311230|19956042|P2|NOT COMPLETED|Overall Study||5
8095098|NCT03311230|19956043|P1|NOT COMPLETED|Overall Study||1
8095099|NCT03311230|19956040|P4|COMPLETED|Overall Study||143
8095100|NCT03311230|19956041|P3|COMPLETED|Overall Study||148
8095101|NCT03311230|19956042|P2|COMPLETED|Overall Study||146
8095102|NCT03311230|19956043|P1|COMPLETED|Overall Study||150
8095103|NCT03311230|19956040|P4|STARTED|Overall Study||150
8095104|NCT03311230|19956041|P3|STARTED|Overall Study||150
8095105|NCT03311230|19956042|P2|STARTED|Overall Study||151
8095106|NCT03311230|19956043|P1|STARTED|Overall Study||151
8095107|NCT03310775|19956067|P2|NOT COMPLETED|Overall Study||4
8095108|NCT03310775|19956068|P1|NOT COMPLETED|Overall Study||2
8095109|NCT03310775|19956067|P2|COMPLETED|Overall Study||14
8095110|NCT03310775|19956068|P1|COMPLETED|Overall Study||17
8095111|NCT03310775|19956067|P2|STARTED|Overall Study||18
8095112|NCT03310775|19956068|P1|STARTED|Overall Study||19
8095113|NCT03310723|19956086|P2|NOT COMPLETED|Overall Study||3
8095114|NCT03310723|19956087|P1|NOT COMPLETED|Overall Study||0
8095115|NCT03310723|19956086|P2|COMPLETED|Overall Study||17
8095116|NCT03310723|19956087|P1|COMPLETED|Overall Study||20
8095117|NCT03310723|19956086|P2|STARTED|Overall Study||20
8095118|NCT03310723|19956087|P1|STARTED|Overall Study||20
8095119|NCT03310580|19956098|P3|NOT COMPLETED|Overall Study||0
8095120|NCT03310580|19956099|P2|NOT COMPLETED|Overall Study||1
8095121|NCT03310580|19956100|P1|NOT COMPLETED|Overall Study||0
8095122|NCT03310580|19956098|P3|COMPLETED|Overall Study||12
8095123|NCT03310580|19956099|P2|COMPLETED|Overall Study||14
8095124|NCT03310580|19956100|P1|COMPLETED|Overall Study||15
8095125|NCT03310580|19956098|P3|STARTED|Overall Study||12
8095126|NCT03310580|19956099|P2|STARTED|Overall Study||15
8095127|NCT03310580|19956100|P1|STARTED|Overall Study||15
8095128|NCT03310450|19956114|P3|NOT COMPLETED|Overall Study||0
8095129|NCT03310450|19956115|P2|NOT COMPLETED|Overall Study||4
8095130|NCT03310450|19956116|P1|NOT COMPLETED|Overall Study||2
8095131|NCT03310450|19956114|P3|COMPLETED|Overall Study||28
8095132|NCT03310450|19956115|P2|COMPLETED|Overall Study||30
8095133|NCT03310450|19956116|P1|COMPLETED|Overall Study||30
8095134|NCT03310450|19956114|P3|STARTED|Overall Study||28
8095135|NCT03310450|19956115|P2|STARTED|Overall Study||34
8095136|NCT03310450|19956116|P1|STARTED|Overall Study||32
8095137|NCT03310411|19956133|P4|NOT COMPLETED|Period Title: Period 4||0
8095138|NCT03310411|19956134|P3|NOT COMPLETED|Period Title: Period 4||0
8095139|NCT03310411|19956135|P2|NOT COMPLETED|Period Title: Period 4||0
8095140|NCT03310411|19956136|P1|NOT COMPLETED|Period Title: Period 4||0
8095141|NCT03310411|19956133|P4|COMPLETED|Period Title: Period 4||9
8095142|NCT03310411|19956134|P3|COMPLETED|Period Title: Period 4||10
8095143|NCT03310411|19956135|P2|COMPLETED|Period Title: Period 4||10
8095144|NCT03310411|19956136|P1|COMPLETED|Period Title: Period 4||10
8095145|NCT03310411|19956133|P4|STARTED|Period Title: Period 4||9
8095146|NCT03310411|19956134|P3|STARTED|Period Title: Period 4||10
8095147|NCT03310411|19956135|P2|STARTED|Period Title: Period 4||10
8095148|NCT03310411|19956136|P1|STARTED|Period Title: Period 4||10
8095149|NCT03310411|19956133|P4|NOT COMPLETED|Period 3||0
8095150|NCT03310411|19956134|P3|NOT COMPLETED|Period 3||0
8095151|NCT03310411|19956135|P2|NOT COMPLETED|Period 3||0
8095152|NCT03310411|19956136|P1|NOT COMPLETED|Period 3||0
8095153|NCT03310411|19956133|P4|COMPLETED|Period 3||9
8095154|NCT03310411|19956134|P3|COMPLETED|Period 3||10
8095155|NCT03310411|19956135|P2|COMPLETED|Period 3||10
8095156|NCT03310411|19956136|P1|COMPLETED|Period 3||10
8095157|NCT03310411|19956133|P4|STARTED|Period 3||9
8095158|NCT03310411|19956134|P3|STARTED|Period 3||10
8095159|NCT03310411|19956135|P2|STARTED|Period 3||10
8095160|NCT03310411|19956136|P1|STARTED|Period 3||10
8095161|NCT03310411|19956133|P4|NOT COMPLETED|Period 2||0
8095162|NCT03310411|19956134|P3|NOT COMPLETED|Period 2||0
8095163|NCT03310411|19956135|P2|NOT COMPLETED|Period 2||0
8095164|NCT03310411|19956136|P1|NOT COMPLETED|Period 2||0
8095165|NCT03310411|19956133|P4|COMPLETED|Period 2||9
8095166|NCT03310411|19956134|P3|COMPLETED|Period 2||10
8095167|NCT03310411|19956135|P2|COMPLETED|Period 2||10
8095168|NCT03310411|19956136|P1|COMPLETED|Period 2||10
8095169|NCT03310411|19956133|P4|STARTED|Period 2||9
8095170|NCT03310411|19956134|P3|STARTED|Period 2||10
8095171|NCT03310411|19956135|P2|STARTED|Period 2||10
8095172|NCT03310411|19956136|P1|STARTED|Period 2||10
8095173|NCT03310411|19956133|P4|NOT COMPLETED|Period 1||1
8095174|NCT03310411|19956134|P3|NOT COMPLETED|Period 1||0
8095175|NCT03310411|19956135|P2|NOT COMPLETED|Period 1||0
8095176|NCT03310411|19956136|P1|NOT COMPLETED|Period 1||0
8095177|NCT03310411|19956133|P4|COMPLETED|Period 1||9
8095178|NCT03310411|19956134|P3|COMPLETED|Period 1||10
8095179|NCT03310411|19956135|P2|COMPLETED|Period 1||10
8095180|NCT03310411|19956136|P1|COMPLETED|Period 1||10
8095181|NCT03310411|19956133|P4|Received at Least 1 Dose of Study Drug|Period 1||10
8095182|NCT03310411|19956134|P3|Received at Least 1 Dose of Study Drug|Period 1||10
8095183|NCT03310411|19956135|P2|Received at Least 1 Dose of Study Drug|Period 1||10
8095184|NCT03310411|19956136|P1|Received at Least 1 Dose of Study Drug|Period 1||10
8095185|NCT03310411|19956133|P4|STARTED|Period 1||10
8095186|NCT03310411|19956134|P3|STARTED|Period 1||10
8095187|NCT03310411|19956135|P2|STARTED|Period 1||10
8095188|NCT03310411|19956136|P1|STARTED|Period 1||10
8095189|NCT03310268|19956157|P3|NOT COMPLETED|Overall Study||0
8095190|NCT03310268|19956158|P2|NOT COMPLETED|Overall Study||5
8095191|NCT03310268|19956159|P1|NOT COMPLETED|Overall Study||1
8095192|NCT03310268|19956157|P3|COMPLETED|Overall Study||61
8095193|NCT03310268|19956158|P2|COMPLETED|Overall Study||57
8095194|NCT03310268|19956159|P1|COMPLETED|Overall Study||61
8095195|NCT03310268|19956157|P3|STARTED|Overall Study||61
8095196|NCT03310268|19956158|P2|STARTED|Overall Study||62
8095197|NCT03310268|19956159|P1|STARTED|Overall Study||62
8095198|NCT03310021|19956190|P20|NOT COMPLETED|Overall Study||0
8095199|NCT03310021|19956191|P19|NOT COMPLETED|Overall Study||0
8095200|NCT03310021|19956192|P18|NOT COMPLETED|Overall Study||0
8095201|NCT03310021|19956193|P17|NOT COMPLETED|Overall Study||0
8095202|NCT03310021|19956194|P16|NOT COMPLETED|Overall Study||0
8095203|NCT03310021|19956195|P15|NOT COMPLETED|Overall Study||0
8095204|NCT03310021|19956196|P14|NOT COMPLETED|Overall Study||0
8095205|NCT03310021|19956197|P13|NOT COMPLETED|Overall Study||0
8095206|NCT03310021|19956198|P12|NOT COMPLETED|Overall Study||0
8095207|NCT03310021|19956199|P11|NOT COMPLETED|Overall Study||1
8095208|NCT03310021|19956200|P10|NOT COMPLETED|Overall Study||0
8095209|NCT03310021|19956201|P9|NOT COMPLETED|Overall Study||0
8095210|NCT03310021|19956202|P8|NOT COMPLETED|Overall Study||0
8095211|NCT03310021|19956203|P7|NOT COMPLETED|Overall Study||1
8095212|NCT03310021|19956204|P6|NOT COMPLETED|Overall Study||0
8095213|NCT03310021|19956205|P5|NOT COMPLETED|Overall Study||0
8095214|NCT03310021|19956206|P4|NOT COMPLETED|Overall Study||0
8095215|NCT03310021|19956207|P3|NOT COMPLETED|Overall Study||0
8095216|NCT03310021|19956208|P2|NOT COMPLETED|Overall Study||0
8095217|NCT03310021|19956209|P1|NOT COMPLETED|Overall Study||0
8095218|NCT03310021|19956190|P20|COMPLETED|Overall Study||3
8095219|NCT03310021|19956191|P19|COMPLETED|Overall Study||8
8095220|NCT03310021|19956192|P18|COMPLETED|Overall Study||5
8095221|NCT03310021|19956193|P17|COMPLETED|Overall Study||10
8095222|NCT03310021|19956194|P16|COMPLETED|Overall Study||3
8095223|NCT03310021|19956195|P15|COMPLETED|Overall Study||6
8095224|NCT03310021|19956196|P14|COMPLETED|Overall Study||4
8095225|NCT03310021|19956197|P13|COMPLETED|Overall Study||8
8095226|NCT03310021|19956198|P12|COMPLETED|Overall Study||3
8095227|NCT03310021|19956199|P11|COMPLETED|Overall Study||5
8095228|NCT03310021|19956200|P10|COMPLETED|Overall Study||3
8095229|NCT03310021|19956201|P9|COMPLETED|Overall Study||6
8095230|NCT03310021|19956202|P8|COMPLETED|Overall Study||4
8095231|NCT03310021|19956203|P7|COMPLETED|Overall Study||7
8095232|NCT03310021|19956204|P6|COMPLETED|Overall Study||4
8095233|NCT03310021|19956205|P5|COMPLETED|Overall Study||8
8095234|NCT03310021|19956206|P4|COMPLETED|Overall Study||3
8095235|NCT03310021|19956207|P3|COMPLETED|Overall Study||6
8095236|NCT03310021|19956208|P2|COMPLETED|Overall Study||3
8095237|NCT03310021|19956209|P1|COMPLETED|Overall Study||6
8095238|NCT03310021|19956190|P20|STARTED|Overall Study||3
8095239|NCT03310021|19956191|P19|STARTED|Overall Study||8
8095240|NCT03310021|19956192|P18|STARTED|Overall Study||5
8095241|NCT03310021|19956193|P17|STARTED|Overall Study||10
8095242|NCT03310021|19956194|P16|STARTED|Overall Study||3
8095243|NCT03310021|19956195|P15|STARTED|Overall Study||6
8095244|NCT03310021|19956196|P14|STARTED|Overall Study||4
8095245|NCT03310021|19956197|P13|STARTED|Overall Study||8
8095246|NCT03310021|19956198|P12|STARTED|Overall Study||3
8095247|NCT03310021|19956199|P11|STARTED|Overall Study||6
8095248|NCT03310021|19956200|P10|STARTED|Overall Study||3
8095249|NCT03310021|19956201|P9|STARTED|Overall Study||6
8095250|NCT03310021|19956202|P8|STARTED|Overall Study||4
8095251|NCT03310021|19956203|P7|STARTED|Overall Study||8
8095252|NCT03310021|19956204|P6|STARTED|Overall Study||4
8095253|NCT03310021|19956205|P5|STARTED|Overall Study||8
8095254|NCT03310021|19956206|P4|STARTED|Overall Study||3
8095255|NCT03310021|19956207|P3|STARTED|Overall Study||6
8095256|NCT03310021|19956208|P2|STARTED|Overall Study||3
8095257|NCT03310021|19956209|P1|STARTED|Overall Study||6
8095258|NCT03309943|19956353|P2|NOT COMPLETED|Overall Study||2
8095259|NCT03309943|19956354|P1|NOT COMPLETED|Overall Study||0
8095260|NCT03309943|19956353|P2|COMPLETED|Overall Study||20
8095261|NCT03309943|19956354|P1|COMPLETED|Overall Study||22
8095262|NCT03309943|19956353|P2|STARTED|Overall Study||22
8095263|NCT03309943|19956354|P1|STARTED|Overall Study||22
8095264|NCT03309787|19956383|P3|NOT COMPLETED|Overall Study||2
8095265|NCT03309787|19956384|P2|NOT COMPLETED|Overall Study||6
8095266|NCT03309787|19956385|P1|NOT COMPLETED|Overall Study||2
8095267|NCT03309787|19956383|P3|COMPLETED|Overall Study||7
8095268|NCT03309787|19956384|P2|COMPLETED|Overall Study||14
8095269|NCT03309787|19956385|P1|COMPLETED|Overall Study||6
8095270|NCT03309787|19956383|P3|STARTED|Overall Study||9
8095271|NCT03309787|19956384|P2|STARTED|Overall Study||20
8095272|NCT03309787|19956385|P1|STARTED|Overall Study||8
8095273|NCT03309696|19956417|P4|NOT COMPLETED|Overall Study||0
8095274|NCT03309696|19956418|P3|NOT COMPLETED|Overall Study||0
8095275|NCT03309696|19956419|P2|NOT COMPLETED|Overall Study||5
8095276|NCT03309696|19956420|P1|NOT COMPLETED|Overall Study||0
8095277|NCT03309696|19956417|P4|COMPLETED|Overall Study||0
8095278|NCT03309696|19956418|P3|COMPLETED|Overall Study||0
8095279|NCT03309696|19956419|P2|COMPLETED|Overall Study||0
8095280|NCT03309696|19956420|P1|COMPLETED|Overall Study||5
8095281|NCT03309696|19956417|P4|STARTED|Overall Study||0
8095282|NCT03309696|19956418|P3|STARTED|Overall Study||0
8095283|NCT03309696|19956419|P2|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
8095284|NCT03309696|19956420|P1|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
8095285|NCT03309657|19956428|P1|NOT COMPLETED|Overall Study||0
8095286|NCT03309657|19956428|P1|COMPLETED|Overall Study||10
8095287|NCT03309657|19956428|P1|STARTED|Overall Study||10
8095288|NCT03309202|19956439|P4|NOT COMPLETED|Overall Study||0
8095289|NCT03309202|19956440|P3|NOT COMPLETED|Overall Study||0
8095290|NCT03309202|19956441|P2|NOT COMPLETED|Overall Study||0
8095291|NCT03309202|19956442|P1|NOT COMPLETED|Overall Study||1
8095292|NCT03309202|19956439|P4|COMPLETED|Overall Study||6
8095293|NCT03309202|19956440|P3|COMPLETED|Overall Study||6
8095294|NCT03309202|19956441|P2|COMPLETED|Overall Study||6
8095295|NCT03309202|19956442|P1|COMPLETED|Overall Study||5
8095296|NCT03309202|19956439|P4|STARTED|Overall Study||6
8095297|NCT03309202|19956440|P3|STARTED|Overall Study||6
8095298|NCT03309202|19956441|P2|STARTED|Overall Study||6
8095299|NCT03309202|19956442|P1|STARTED|Overall Study||6
8095300|NCT03309072|19956526|P2|NOT COMPLETED|Overall Study||0
8095301|NCT03309072|19956527|P1|NOT COMPLETED|Overall Study||0
8095302|NCT03309072|19956526|P2|COMPLETED|Overall Study||15
8095303|NCT03309072|19956527|P1|COMPLETED|Overall Study||15
8095304|NCT03309072|19956526|P2|STARTED|Overall Study||15
8095305|NCT03309072|19956527|P1|STARTED|Overall Study||15
8095306|NCT03308968|19956536|P3|NOT COMPLETED|Open-Label Period (12 Weeks)||12
8095307|NCT03308968|19956537|P2|NOT COMPLETED|Open-Label Period (12 Weeks)||12
8095308|NCT03308968|19956538|P1|NOT COMPLETED|Open-Label Period (12 Weeks)||11
8095309|NCT03308968|19956536|P3|COMPLETED|Open-Label Period (12 Weeks)||260
8095310|NCT03308968|19956537|P2|COMPLETED|Open-Label Period (12 Weeks)||259
8095311|NCT03308968|19956538|P1|COMPLETED|Open-Label Period (12 Weeks)||253
8095312|NCT03308968|19956536|P3|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272
8095313|NCT03308968|19956537|P2|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271
8095314|NCT03308968|19956538|P1|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263
8095315|NCT03308968|19956536|P3|STARTED|Open-Label Period (12 Weeks)||272
8095316|NCT03308968|19956537|P2|STARTED|Open-Label Period (12 Weeks)||271
8095317|NCT03308968|19956538|P1|STARTED|Open-Label Period (12 Weeks)||264
8095318|NCT03308968|19956536|P3|NOT COMPLETED|Double-Blind Period (12 Weeks)||11
8095319|NCT03308968|19956537|P2|NOT COMPLETED|Double-Blind Period (12 Weeks)||5
8095320|NCT03308968|19956538|P1|NOT COMPLETED|Double-Blind Period (12 Weeks)||15
8095321|NCT03308968|19956536|P3|COMPLETED|Double-Blind Period (12 Weeks)||272
8095322|NCT03308968|19956537|P2|COMPLETED|Double-Blind Period (12 Weeks)||271
8095323|NCT03308968|19956538|P1|COMPLETED|Double-Blind Period (12 Weeks)||264
8095324|NCT03308968|19956536|P3|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283
8095325|NCT03308968|19956537|P2|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276
8095326|NCT03308968|19956538|P1|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278
8095327|NCT03308968|19956536|P3|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285
8095328|NCT03308968|19956537|P2|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276
8095329|NCT03308968|19956538|P1|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277
8095330|NCT03308968|19956536|P3|STARTED|Double-Blind Period (12 Weeks)||283
8095331|NCT03308968|19956537|P2|STARTED|Double-Blind Period (12 Weeks)||276
8095332|NCT03308968|19956538|P1|STARTED|Double-Blind Period (12 Weeks)||279
8095333|NCT03308825|19956616|P4|NOT COMPLETED|Overall Study||0
8095334|NCT03308825|19956617|P3|NOT COMPLETED|Overall Study||1
8095335|NCT03308825|19956618|P2|NOT COMPLETED|Overall Study||4
8095336|NCT03308825|19956619|P1|NOT COMPLETED|Overall Study||2
8095337|NCT03308825|19956616|P4|COMPLETED|Overall Study||60
8095338|NCT03308825|19956617|P3|COMPLETED|Overall Study||59
8095339|NCT03308825|19956618|P2|COMPLETED|Overall Study||57
8095340|NCT03308825|19956619|P1|COMPLETED|Overall Study||57
8095341|NCT03308825|19956616|P4|STARTED|Overall Study||60
8095342|NCT03308825|19956617|P3|STARTED|Overall Study||60
8095343|NCT03308825|19956618|P2|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
8095344|NCT03308825|19956619|P1|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
8095345|NCT03308799|19956648|P3|NOT COMPLETED|Overall Study||21
8095346|NCT03308799|19956649|P2|NOT COMPLETED|Overall Study||28
8095347|NCT03308799|19956650|P1|NOT COMPLETED|Overall Study||22
8095348|NCT03308799|19956648|P3|COMPLETED|Overall Study||94
8095349|NCT03308799|19956649|P2|COMPLETED|Overall Study||309
8095350|NCT03308799|19956650|P1|COMPLETED|Overall Study||320
8095351|NCT03308799|19956648|P3|STARTED|Overall Study||115
8095352|NCT03308799|19956649|P2|STARTED|Overall Study||337
8095353|NCT03308799|19956650|P1|STARTED|Overall Study||342
8095354|NCT03308669|19956666|P2|NOT COMPLETED|Overall Study||0
8095355|NCT03308669|19956667|P1|NOT COMPLETED|Overall Study||0
8095356|NCT03308669|19956666|P2|COMPLETED|Overall Study||20
8095357|NCT03308669|19956667|P1|COMPLETED|Overall Study||10
8095358|NCT03308669|19956666|P2|Received at Least One Dose of Study Drug|Overall Study||20
8095359|NCT03308669|19956667|P1|Received at Least One Dose of Study Drug|Overall Study||10
8095360|NCT03308669|19956666|P2|STARTED|Overall Study||20
8095361|NCT03308669|19956667|P1|STARTED|Overall Study||10
8095362|NCT03308058|19956689|P2|NOT COMPLETED|Overall Study||0
8095363|NCT03308058|19956690|P1|NOT COMPLETED|Overall Study||0
8095364|NCT03308058|19956689|P2|COMPLETED|Overall Study||23
8095365|NCT03308058|19956690|P1|COMPLETED|Overall Study||23
8095366|NCT03308058|19956689|P2|STARTED|Overall Study||23
8095367|NCT03308058|19956690|P1|STARTED|Overall Study||23
8095368|NCT03307252|19956707|P11|NOT COMPLETED|Part 3, Period 4||0
8095369|NCT03307252|19956708|P10|NOT COMPLETED|Part 3, Period 4||0
8095370|NCT03307252|19956709|P9|NOT COMPLETED|Part 3, Period 4||0
8095371|NCT03307252|19956710|P8|NOT COMPLETED|Part 3, Period 4||0
8095372|NCT03307252|19956711|P7|NOT COMPLETED|Part 3, Period 4||0
8095373|NCT03307252|19956712|P6|NOT COMPLETED|Part 3, Period 4||0
8095374|NCT03307252|19956713|P5|NOT COMPLETED|Part 3, Period 4||0
8095375|NCT03307252|19956714|P4|NOT COMPLETED|Part 3, Period 4||0
8095376|NCT03307252|19956715|P3|NOT COMPLETED|Part 3, Period 4||0
8095377|NCT03307252|19956716|P2|NOT COMPLETED|Part 3, Period 4||0
8095378|NCT03307252|19956717|P1|NOT COMPLETED|Part 3, Period 4||0
8095379|NCT03307252|19956707|P11|COMPLETED|Part 3, Period 4||3
8095380|NCT03307252|19956708|P10|COMPLETED|Part 3, Period 4||4
8095381|NCT03307252|19956709|P9|COMPLETED|Part 3, Period 4||4
8095382|NCT03307252|19956710|P8|COMPLETED|Part 3, Period 4||4
8095383|NCT03307252|19956711|P7|COMPLETED|Part 3, Period 4||0
8095384|NCT03307252|19956712|P6|COMPLETED|Part 3, Period 4||0
8095385|NCT03307252|19956713|P5|COMPLETED|Part 3, Period 4||0
8095386|NCT03307252|19956714|P4|COMPLETED|Part 3, Period 4||0
8095387|NCT03307252|19956715|P3|COMPLETED|Part 3, Period 4||0
8095388|NCT03307252|19956716|P2|COMPLETED|Part 3, Period 4||0
8095389|NCT03307252|19956717|P1|COMPLETED|Part 3, Period 4||0
8095390|NCT03307252|19956707|P11|STARTED|Part 3, Period 4||3
8095391|NCT03307252|19956708|P10|STARTED|Part 3, Period 4||4
8095392|NCT03307252|19956709|P9|STARTED|Part 3, Period 4||4
8095393|NCT03307252|19956710|P8|STARTED|Part 3, Period 4||4
8095394|NCT03307252|19956711|P7|STARTED|Part 3, Period 4||0
8095395|NCT03307252|19956712|P6|STARTED|Part 3, Period 4||0
8095396|NCT03307252|19956713|P5|STARTED|Part 3, Period 4||0
8095397|NCT03307252|19956714|P4|STARTED|Part 3, Period 4||0
8095398|NCT03307252|19956715|P3|STARTED|Part 3, Period 4||0
8095399|NCT03307252|19956716|P2|STARTED|Part 3, Period 4||0
8095400|NCT03307252|19956717|P1|STARTED|Part 3, Period 4||0
8095401|NCT03307252|19956707|P11|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1
8095402|NCT03307252|19956708|P10|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095403|NCT03307252|19956709|P9|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095404|NCT03307252|19956710|P8|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095405|NCT03307252|19956711|P7|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095406|NCT03307252|19956712|P6|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095407|NCT03307252|19956713|P5|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095408|NCT03307252|19956714|P4|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095409|NCT03307252|19956715|P3|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095410|NCT03307252|19956716|P2|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095411|NCT03307252|19956717|P1|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095412|NCT03307252|19956707|P11|COMPLETED|Part 3, Washout Period 3 (7 Days)||3
8095413|NCT03307252|19956708|P10|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
8095414|NCT03307252|19956709|P9|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
8095415|NCT03307252|19956710|P8|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
8095416|NCT03307252|19956711|P7|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095417|NCT03307252|19956712|P6|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095418|NCT03307252|19956713|P5|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095419|NCT03307252|19956714|P4|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095420|NCT03307252|19956715|P3|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095421|NCT03307252|19956716|P2|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095422|NCT03307252|19956717|P1|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
8095423|NCT03307252|19956707|P11|STARTED|Part 3, Washout Period 3 (7 Days)||4
8095424|NCT03307252|19956708|P10|STARTED|Part 3, Washout Period 3 (7 Days)||4
8095425|NCT03307252|19956709|P9|STARTED|Part 3, Washout Period 3 (7 Days)||4
8095426|NCT03307252|19956710|P8|STARTED|Part 3, Washout Period 3 (7 Days)||4
8095427|NCT03307252|19956711|P7|STARTED|Part 3, Washout Period 3 (7 Days)||0
8095428|NCT03307252|19956712|P6|STARTED|Part 3, Washout Period 3 (7 Days)||0
8095429|NCT03307252|19956713|P5|STARTED|Part 3, Washout Period 3 (7 Days)||0
8095430|NCT03307252|19956714|P4|STARTED|Part 3, Washout Period 3 (7 Days)||0
8095431|NCT03307252|19956715|P3|STARTED|Part 3, Washout Period 3 (7 Days)||0
8095432|NCT03307252|19956716|P2|STARTED|Part 3, Washout Period 3 (7 Days)||0
8095433|NCT03307252|19956717|P1|STARTED|Part 3, Washout Period 3 (7 Days)||0
8095434|NCT03307252|19956707|P11|NOT COMPLETED|Part 3, Period 3||0
8095435|NCT03307252|19956708|P10|NOT COMPLETED|Part 3, Period 3||0
8095436|NCT03307252|19956709|P9|NOT COMPLETED|Part 3, Period 3||0
8095437|NCT03307252|19956710|P8|NOT COMPLETED|Part 3, Period 3||0
8095438|NCT03307252|19956711|P7|NOT COMPLETED|Part 3, Period 3||0
8095439|NCT03307252|19956712|P6|NOT COMPLETED|Part 3, Period 3||0
8095440|NCT03307252|19956713|P5|NOT COMPLETED|Part 3, Period 3||0
8095441|NCT03307252|19956714|P4|NOT COMPLETED|Part 3, Period 3||0
8095442|NCT03307252|19956715|P3|NOT COMPLETED|Part 3, Period 3||0
8095443|NCT03307252|19956716|P2|NOT COMPLETED|Part 3, Period 3||0
8095444|NCT03307252|19956717|P1|NOT COMPLETED|Part 3, Period 3||0
8095445|NCT03307252|19956707|P11|COMPLETED|Part 3, Period 3||4
8095446|NCT03307252|19956708|P10|COMPLETED|Part 3, Period 3||4
8095447|NCT03307252|19956709|P9|COMPLETED|Part 3, Period 3||4
8095448|NCT03307252|19956710|P8|COMPLETED|Part 3, Period 3||4
8095449|NCT03307252|19956711|P7|COMPLETED|Part 3, Period 3||0
8095450|NCT03307252|19956712|P6|COMPLETED|Part 3, Period 3||0
8095451|NCT03307252|19956713|P5|COMPLETED|Part 3, Period 3||0
8095452|NCT03307252|19956714|P4|COMPLETED|Part 3, Period 3||0
8095453|NCT03307252|19956715|P3|COMPLETED|Part 3, Period 3||0
8095454|NCT03307252|19956716|P2|COMPLETED|Part 3, Period 3||0
8095455|NCT03307252|19956717|P1|COMPLETED|Part 3, Period 3||0
8095456|NCT03307252|19956707|P11|STARTED|Part 3, Period 3||4
8095457|NCT03307252|19956708|P10|STARTED|Part 3, Period 3||4
8095458|NCT03307252|19956709|P9|STARTED|Part 3, Period 3||4
8095459|NCT03307252|19956710|P8|STARTED|Part 3, Period 3||4
8095460|NCT03307252|19956711|P7|STARTED|Part 3, Period 3||0
8095461|NCT03307252|19956712|P6|STARTED|Part 3, Period 3||0
8095462|NCT03307252|19956713|P5|STARTED|Part 3, Period 3||0
8095463|NCT03307252|19956714|P4|STARTED|Part 3, Period 3||0
8095464|NCT03307252|19956715|P3|STARTED|Part 3, Period 3||0
8095465|NCT03307252|19956716|P2|STARTED|Part 3, Period 3||0
8095466|NCT03307252|19956717|P1|STARTED|Part 3, Period 3||0
8095467|NCT03307252|19956707|P11|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095468|NCT03307252|19956708|P10|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095469|NCT03307252|19956709|P9|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095470|NCT03307252|19956710|P8|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095471|NCT03307252|19956711|P7|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095472|NCT03307252|19956712|P6|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095473|NCT03307252|19956713|P5|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095474|NCT03307252|19956714|P4|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095475|NCT03307252|19956715|P3|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095476|NCT03307252|19956716|P2|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095477|NCT03307252|19956717|P1|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095478|NCT03307252|19956707|P11|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
8095479|NCT03307252|19956708|P10|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
8095480|NCT03307252|19956709|P9|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
8095481|NCT03307252|19956710|P8|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
8095482|NCT03307252|19956711|P7|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095483|NCT03307252|19956712|P6|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095484|NCT03307252|19956713|P5|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095485|NCT03307252|19956714|P4|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095486|NCT03307252|19956715|P3|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095487|NCT03307252|19956716|P2|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095488|NCT03307252|19956717|P1|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
8095489|NCT03307252|19956707|P11|STARTED|Part 3, Washout Period 2 (7 Days)||4
8095490|NCT03307252|19956708|P10|STARTED|Part 3, Washout Period 2 (7 Days)||4
8095491|NCT03307252|19956709|P9|STARTED|Part 3, Washout Period 2 (7 Days)||4
8095492|NCT03307252|19956710|P8|STARTED|Part 3, Washout Period 2 (7 Days)||4
8095493|NCT03307252|19956711|P7|STARTED|Part 3, Washout Period 2 (7 Days)||0
8095494|NCT03307252|19956712|P6|STARTED|Part 3, Washout Period 2 (7 Days)||0
8095495|NCT03307252|19956713|P5|STARTED|Part 3, Washout Period 2 (7 Days)||0
8095496|NCT03307252|19956714|P4|STARTED|Part 3, Washout Period 2 (7 Days)||0
8095497|NCT03307252|19956715|P3|STARTED|Part 3, Washout Period 2 (7 Days)||0
8095498|NCT03307252|19956716|P2|STARTED|Part 3, Washout Period 2 (7 Days)||0
8095499|NCT03307252|19956717|P1|STARTED|Part 3, Washout Period 2 (7 Days)||0
8095500|NCT03307252|19956707|P11|NOT COMPLETED|Part 3, Period 2||0
8095501|NCT03307252|19956708|P10|NOT COMPLETED|Part 3, Period 2||0
8095502|NCT03307252|19956709|P9|NOT COMPLETED|Part 3, Period 2||0
8095503|NCT03307252|19956710|P8|NOT COMPLETED|Part 3, Period 2||0
8095504|NCT03307252|19956711|P7|NOT COMPLETED|Part 3, Period 2||0
8095505|NCT03307252|19956712|P6|NOT COMPLETED|Part 3, Period 2||0
8095506|NCT03307252|19956713|P5|NOT COMPLETED|Part 3, Period 2||0
8095507|NCT03307252|19956714|P4|NOT COMPLETED|Part 3, Period 2||0
8095508|NCT03307252|19956715|P3|NOT COMPLETED|Part 3, Period 2||0
8095509|NCT03307252|19956716|P2|NOT COMPLETED|Part 3, Period 2||0
8095510|NCT03307252|19956717|P1|NOT COMPLETED|Part 3, Period 2||0
8095511|NCT03307252|19956707|P11|COMPLETED|Part 3, Period 2||4
8095512|NCT03307252|19956708|P10|COMPLETED|Part 3, Period 2||4
8095513|NCT03307252|19956709|P9|COMPLETED|Part 3, Period 2||4
8095514|NCT03307252|19956710|P8|COMPLETED|Part 3, Period 2||4
8095515|NCT03307252|19956711|P7|COMPLETED|Part 3, Period 2||0
8095516|NCT03307252|19956712|P6|COMPLETED|Part 3, Period 2||0
8095517|NCT03307252|19956713|P5|COMPLETED|Part 3, Period 2||0
8095518|NCT03307252|19956714|P4|COMPLETED|Part 3, Period 2||0
8095519|NCT03307252|19956715|P3|COMPLETED|Part 3, Period 2||0
8095520|NCT03307252|19956716|P2|COMPLETED|Part 3, Period 2||0
8095521|NCT03307252|19956717|P1|COMPLETED|Part 3, Period 2||0
8095522|NCT03307252|19956707|P11|STARTED|Part 3, Period 2||4
8095523|NCT03307252|19956708|P10|STARTED|Part 3, Period 2||4
8095524|NCT03307252|19956709|P9|STARTED|Part 3, Period 2||4
8095525|NCT03307252|19956710|P8|STARTED|Part 3, Period 2||4
8095526|NCT03307252|19956711|P7|STARTED|Part 3, Period 2||0
8095527|NCT03307252|19956712|P6|STARTED|Part 3, Period 2||0
8095528|NCT03307252|19956713|P5|STARTED|Part 3, Period 2||0
8095529|NCT03307252|19956714|P4|STARTED|Part 3, Period 2||0
8095530|NCT03307252|19956715|P3|STARTED|Part 3, Period 2||0
8095531|NCT03307252|19956716|P2|STARTED|Part 3, Period 2||0
8095532|NCT03307252|19956717|P1|STARTED|Part 3, Period 2||0
8095533|NCT03307252|19956707|P11|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095534|NCT03307252|19956708|P10|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095535|NCT03307252|19956709|P9|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095536|NCT03307252|19956710|P8|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095537|NCT03307252|19956711|P7|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095538|NCT03307252|19956712|P6|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095539|NCT03307252|19956713|P5|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095540|NCT03307252|19956714|P4|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095541|NCT03307252|19956715|P3|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095542|NCT03307252|19956716|P2|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095543|NCT03307252|19956717|P1|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095544|NCT03307252|19956707|P11|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
8095545|NCT03307252|19956708|P10|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
8095546|NCT03307252|19956709|P9|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
8095547|NCT03307252|19956710|P8|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
8095548|NCT03307252|19956711|P7|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095549|NCT03307252|19956712|P6|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095550|NCT03307252|19956713|P5|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095551|NCT03307252|19956714|P4|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095552|NCT03307252|19956715|P3|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095553|NCT03307252|19956716|P2|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095554|NCT03307252|19956717|P1|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
8095555|NCT03307252|19956707|P11|STARTED|Part 3, Washout Period 1 (7 Days)||4
8095556|NCT03307252|19956708|P10|STARTED|Part 3, Washout Period 1 (7 Days)||4
8095557|NCT03307252|19956709|P9|STARTED|Part 3, Washout Period 1 (7 Days)||4
8095558|NCT03307252|19956710|P8|STARTED|Part 3, Washout Period 1 (7 Days)||4
8095559|NCT03307252|19956711|P7|STARTED|Part 3, Washout Period 1 (7 Days)||0
8095560|NCT03307252|19956712|P6|STARTED|Part 3, Washout Period 1 (7 Days)||0
8095561|NCT03307252|19956713|P5|STARTED|Part 3, Washout Period 1 (7 Days)||0
8095562|NCT03307252|19956714|P4|STARTED|Part 3, Washout Period 1 (7 Days)||0
8095563|NCT03307252|19956715|P3|STARTED|Part 3, Washout Period 1 (7 Days)||0
8095564|NCT03307252|19956716|P2|STARTED|Part 3, Washout Period 1 (7 Days)||0
8095565|NCT03307252|19956717|P1|STARTED|Part 3, Washout Period 1 (7 Days)||0
8095566|NCT03307252|19956707|P11|NOT COMPLETED|Part 3, Period 1||0
8095567|NCT03307252|19956708|P10|NOT COMPLETED|Part 3, Period 1||0
8095568|NCT03307252|19956709|P9|NOT COMPLETED|Part 3, Period 1||0
8095569|NCT03307252|19956710|P8|NOT COMPLETED|Part 3, Period 1||0
8095570|NCT03307252|19956711|P7|NOT COMPLETED|Part 3, Period 1||0
8095571|NCT03307252|19956712|P6|NOT COMPLETED|Part 3, Period 1||0
8095572|NCT03307252|19956713|P5|NOT COMPLETED|Part 3, Period 1||0
8095573|NCT03307252|19956714|P4|NOT COMPLETED|Part 3, Period 1||0
8095574|NCT03307252|19956715|P3|NOT COMPLETED|Part 3, Period 1||0
8095575|NCT03307252|19956716|P2|NOT COMPLETED|Part 3, Period 1||0
8095576|NCT03307252|19956717|P1|NOT COMPLETED|Part 3, Period 1||0
8095577|NCT03307252|19956707|P11|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
8095578|NCT03307252|19956708|P10|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
8095579|NCT03307252|19956709|P9|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
8095580|NCT03307252|19956710|P8|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
8095581|NCT03307252|19956711|P7|COMPLETED|Part 3, Period 1||0
8095582|NCT03307252|19956712|P6|COMPLETED|Part 3, Period 1||0
8095583|NCT03307252|19956713|P5|COMPLETED|Part 3, Period 1||0
8095584|NCT03307252|19956714|P4|COMPLETED|Part 3, Period 1||0
8095585|NCT03307252|19956715|P3|COMPLETED|Part 3, Period 1||0
8095586|NCT03307252|19956716|P2|COMPLETED|Part 3, Period 1||0
8095587|NCT03307252|19956717|P1|COMPLETED|Part 3, Period 1||0
8095588|NCT03307252|19956707|P11|STARTED|Part 3, Period 1||4
8095589|NCT03307252|19956708|P10|STARTED|Part 3, Period 1||4
8095590|NCT03307252|19956709|P9|STARTED|Part 3, Period 1||4
8095591|NCT03307252|19956710|P8|STARTED|Part 3, Period 1||4
8095592|NCT03307252|19956711|P7|STARTED|Part 3, Period 1||0
8095593|NCT03307252|19956712|P6|STARTED|Part 3, Period 1||0
8095594|NCT03307252|19956713|P5|STARTED|Part 3, Period 1||0
8095595|NCT03307252|19956714|P4|STARTED|Part 3, Period 1||0
8095596|NCT03307252|19956715|P3|STARTED|Part 3, Period 1||0
8095597|NCT03307252|19956716|P2|STARTED|Part 3, Period 1||0
8095598|NCT03307252|19956717|P1|STARTED|Part 3, Period 1||0
8095599|NCT03307252|19956707|P11|NOT COMPLETED|Part 2, Period 4||0
8095600|NCT03307252|19956708|P10|NOT COMPLETED|Part 2, Period 4||0
8095601|NCT03307252|19956709|P9|NOT COMPLETED|Part 2, Period 4||0
8095602|NCT03307252|19956710|P8|NOT COMPLETED|Part 2, Period 4||0
8095603|NCT03307252|19956711|P7|NOT COMPLETED|Part 2, Period 4||1
8095604|NCT03307252|19956712|P6|NOT COMPLETED|Part 2, Period 4||0
8095605|NCT03307252|19956713|P5|NOT COMPLETED|Part 2, Period 4||0
8095606|NCT03307252|19956714|P4|NOT COMPLETED|Part 2, Period 4||0
8095607|NCT03307252|19956715|P3|NOT COMPLETED|Part 2, Period 4||0
8095608|NCT03307252|19956716|P2|NOT COMPLETED|Part 2, Period 4||0
8095609|NCT03307252|19956717|P1|NOT COMPLETED|Part 2, Period 4||0
8095610|NCT03307252|19956707|P11|COMPLETED|Part 2, Period 4||0
8095611|NCT03307252|19956708|P10|COMPLETED|Part 2, Period 4||0
8095612|NCT03307252|19956709|P9|COMPLETED|Part 2, Period 4||0
8095613|NCT03307252|19956710|P8|COMPLETED|Part 2, Period 4||0
8095614|NCT03307252|19956711|P7|COMPLETED|Part 2, Period 4||4
8095615|NCT03307252|19956712|P6|COMPLETED|Part 2, Period 4||3
8095616|NCT03307252|19956713|P5|COMPLETED|Part 2, Period 4||3
8095617|NCT03307252|19956714|P4|COMPLETED|Part 2, Period 4||4
8095618|NCT03307252|19956715|P3|COMPLETED|Part 2, Period 4||0
8095619|NCT03307252|19956716|P2|COMPLETED|Part 2, Period 4||0
8095620|NCT03307252|19956717|P1|COMPLETED|Part 2, Period 4||0
8095621|NCT03307252|19956707|P11|STARTED|Part 2, Period 4||0
8095622|NCT03307252|19956708|P10|STARTED|Part 2, Period 4||0
8095623|NCT03307252|19956709|P9|STARTED|Part 2, Period 4||0
8095624|NCT03307252|19956710|P8|STARTED|Part 2, Period 4||0
8095625|NCT03307252|19956711|P7|STARTED|Part 2, Period 4||5
8095626|NCT03307252|19956712|P6|STARTED|Part 2, Period 4||3
8095627|NCT03307252|19956713|P5|STARTED|Part 2, Period 4||3
8095628|NCT03307252|19956714|P4|STARTED|Part 2, Period 4||4
8095629|NCT03307252|19956715|P3|STARTED|Part 2, Period 4||0
8095630|NCT03307252|19956716|P2|STARTED|Part 2, Period 4||0
8095631|NCT03307252|19956717|P1|STARTED|Part 2, Period 4||0
8095632|NCT03307252|19956707|P11|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095633|NCT03307252|19956708|P10|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095634|NCT03307252|19956709|P9|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095635|NCT03307252|19956710|P8|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095636|NCT03307252|19956711|P7|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1
8095637|NCT03307252|19956712|P6|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095638|NCT03307252|19956713|P5|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095639|NCT03307252|19956714|P4|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095640|NCT03307252|19956715|P3|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095641|NCT03307252|19956716|P2|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095642|NCT03307252|19956717|P1|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095643|NCT03307252|19956707|P11|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095644|NCT03307252|19956708|P10|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095645|NCT03307252|19956709|P9|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095646|NCT03307252|19956710|P8|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095647|NCT03307252|19956711|P7|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
8095648|NCT03307252|19956712|P6|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
8095649|NCT03307252|19956713|P5|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
8095650|NCT03307252|19956714|P4|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
8095651|NCT03307252|19956715|P3|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095652|NCT03307252|19956716|P2|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095653|NCT03307252|19956717|P1|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
8095654|NCT03307252|19956707|P11|STARTED|Part 2, Washout Period 3 (7 Days)||0
8095655|NCT03307252|19956708|P10|STARTED|Part 2, Washout Period 3 (7 Days)||0
8095656|NCT03307252|19956709|P9|STARTED|Part 2, Washout Period 3 (7 Days)||0
8095657|NCT03307252|19956710|P8|STARTED|Part 2, Washout Period 3 (7 Days)||0
8095658|NCT03307252|19956711|P7|STARTED|Part 2, Washout Period 3 (7 Days)||5
8095659|NCT03307252|19956712|P6|STARTED|Part 2, Washout Period 3 (7 Days)||3
8095660|NCT03307252|19956713|P5|STARTED|Part 2, Washout Period 3 (7 Days)||3
8095661|NCT03307252|19956714|P4|STARTED|Part 2, Washout Period 3 (7 Days)||4
8095662|NCT03307252|19956715|P3|STARTED|Part 2, Washout Period 3 (7 Days)||0
8095663|NCT03307252|19956716|P2|STARTED|Part 2, Washout Period 3 (7 Days)||0
8095664|NCT03307252|19956717|P1|STARTED|Part 2, Washout Period 3 (7 Days)||0
8095665|NCT03307252|19956707|P11|NOT COMPLETED|Part 2, Period 3||0
8095666|NCT03307252|19956708|P10|NOT COMPLETED|Part 2, Period 3||0
8095667|NCT03307252|19956709|P9|NOT COMPLETED|Part 2, Period 3||0
8095668|NCT03307252|19956710|P8|NOT COMPLETED|Part 2, Period 3||0
8095669|NCT03307252|19956711|P7|NOT COMPLETED|Part 2, Period 3||0
8095670|NCT03307252|19956712|P6|NOT COMPLETED|Part 2, Period 3||0
8095671|NCT03307252|19956713|P5|NOT COMPLETED|Part 2, Period 3||1
8095672|NCT03307252|19956714|P4|NOT COMPLETED|Part 2, Period 3||0
8095673|NCT03307252|19956715|P3|NOT COMPLETED|Part 2, Period 3||0
8095674|NCT03307252|19956716|P2|NOT COMPLETED|Part 2, Period 3||0
8095675|NCT03307252|19956717|P1|NOT COMPLETED|Part 2, Period 3||0
8095676|NCT03307252|19956707|P11|COMPLETED|Part 2, Period 3||0
8095677|NCT03307252|19956708|P10|COMPLETED|Part 2, Period 3||0
8095678|NCT03307252|19956709|P9|COMPLETED|Part 2, Period 3||0
8095679|NCT03307252|19956710|P8|COMPLETED|Part 2, Period 3||0
8095680|NCT03307252|19956711|P7|COMPLETED|Part 2, Period 3||5
8095681|NCT03307252|19956712|P6|COMPLETED|Part 2, Period 3||3
8095682|NCT03307252|19956713|P5|COMPLETED|Part 2, Period 3||3
8095683|NCT03307252|19956714|P4|COMPLETED|Part 2, Period 3||4
8095684|NCT03307252|19956715|P3|COMPLETED|Part 2, Period 3||0
8095685|NCT03307252|19956716|P2|COMPLETED|Part 2, Period 3||0
8095686|NCT03307252|19956717|P1|COMPLETED|Part 2, Period 3||0
8095687|NCT03307252|19956707|P11|STARTED|Part 2, Period 3||0
8095688|NCT03307252|19956708|P10|STARTED|Part 2, Period 3||0
8095689|NCT03307252|19956709|P9|STARTED|Part 2, Period 3||0
8095690|NCT03307252|19956710|P8|STARTED|Part 2, Period 3||0
8095691|NCT03307252|19956711|P7|STARTED|Part 2, Period 3||5
8095692|NCT03307252|19956712|P6|STARTED|Part 2, Period 3||3
8095693|NCT03307252|19956713|P5|STARTED|Part 2, Period 3||4
8095694|NCT03307252|19956714|P4|STARTED|Part 2, Period 3||4
8095695|NCT03307252|19956715|P3|STARTED|Part 2, Period 3||0
8095696|NCT03307252|19956716|P2|STARTED|Part 2, Period 3||0
8095697|NCT03307252|19956717|P1|STARTED|Part 2, Period 3||0
8095698|NCT03307252|19956707|P11|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095699|NCT03307252|19956708|P10|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095700|NCT03307252|19956709|P9|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095701|NCT03307252|19956710|P8|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095702|NCT03307252|19956711|P7|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095703|NCT03307252|19956712|P6|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095704|NCT03307252|19956713|P5|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095705|NCT03307252|19956714|P4|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095706|NCT03307252|19956715|P3|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095707|NCT03307252|19956716|P2|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095708|NCT03307252|19956717|P1|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095709|NCT03307252|19956707|P11|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095710|NCT03307252|19956708|P10|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095711|NCT03307252|19956709|P9|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095712|NCT03307252|19956710|P8|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095713|NCT03307252|19956711|P7|COMPLETED|Part 2, Washout Period 2 (7 Days)||5
8095714|NCT03307252|19956712|P6|COMPLETED|Part 2, Washout Period 2 (7 Days)||3
8095715|NCT03307252|19956713|P5|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
8095716|NCT03307252|19956714|P4|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
8095717|NCT03307252|19956715|P3|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095718|NCT03307252|19956716|P2|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095719|NCT03307252|19956717|P1|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
8095720|NCT03307252|19956707|P11|STARTED|Part 2, Washout Period 2 (7 Days)||0
8095721|NCT03307252|19956708|P10|STARTED|Part 2, Washout Period 2 (7 Days)||0
8095722|NCT03307252|19956709|P9|STARTED|Part 2, Washout Period 2 (7 Days)||0
8095723|NCT03307252|19956710|P8|STARTED|Part 2, Washout Period 2 (7 Days)||0
8095724|NCT03307252|19956711|P7|STARTED|Part 2, Washout Period 2 (7 Days)||5
8095725|NCT03307252|19956712|P6|STARTED|Part 2, Washout Period 2 (7 Days)||3
8095726|NCT03307252|19956713|P5|STARTED|Part 2, Washout Period 2 (7 Days)||4
8095727|NCT03307252|19956714|P4|STARTED|Part 2, Washout Period 2 (7 Days)||4
8095728|NCT03307252|19956715|P3|STARTED|Part 2, Washout Period 2 (7 Days)||0
8095729|NCT03307252|19956716|P2|STARTED|Part 2, Washout Period 2 (7 Days)||0
8095730|NCT03307252|19956717|P1|STARTED|Part 2, Washout Period 2 (7 Days)||0
8095731|NCT03307252|19956707|P11|NOT COMPLETED|Part 2, Period 2||0
8095732|NCT03307252|19956708|P10|NOT COMPLETED|Part 2, Period 2||0
8095733|NCT03307252|19956709|P9|NOT COMPLETED|Part 2, Period 2||0
8095734|NCT03307252|19956710|P8|NOT COMPLETED|Part 2, Period 2||0
8095735|NCT03307252|19956711|P7|NOT COMPLETED|Part 2, Period 2||0
8095736|NCT03307252|19956712|P6|NOT COMPLETED|Part 2, Period 2||0
8095737|NCT03307252|19956713|P5|NOT COMPLETED|Part 2, Period 2||0
8095738|NCT03307252|19956714|P4|NOT COMPLETED|Part 2, Period 2||0
8095739|NCT03307252|19956715|P3|NOT COMPLETED|Part 2, Period 2||0
8095740|NCT03307252|19956716|P2|NOT COMPLETED|Part 2, Period 2||0
8095741|NCT03307252|19956717|P1|NOT COMPLETED|Part 2, Period 2||0
8095742|NCT03307252|19956707|P11|COMPLETED|Part 2, Period 2||0
8095743|NCT03307252|19956708|P10|COMPLETED|Part 2, Period 2||0
8095744|NCT03307252|19956709|P9|COMPLETED|Part 2, Period 2||0
8095745|NCT03307252|19956710|P8|COMPLETED|Part 2, Period 2||0
8095746|NCT03307252|19956711|P7|COMPLETED|Part 2, Period 2||5
8095747|NCT03307252|19956712|P6|COMPLETED|Part 2, Period 2||3
8095748|NCT03307252|19956713|P5|COMPLETED|Part 2, Period 2||4
8095749|NCT03307252|19956714|P4|COMPLETED|Part 2, Period 2||4
8095750|NCT03307252|19956715|P3|COMPLETED|Part 2, Period 2||0
8095751|NCT03307252|19956716|P2|COMPLETED|Part 2, Period 2||0
8095752|NCT03307252|19956717|P1|COMPLETED|Part 2, Period 2||0
8095753|NCT03307252|19956707|P11|STARTED|Part 2, Period 2||0
8095754|NCT03307252|19956708|P10|STARTED|Part 2, Period 2||0
8095755|NCT03307252|19956709|P9|STARTED|Part 2, Period 2||0
8095756|NCT03307252|19956710|P8|STARTED|Part 2, Period 2||0
8095757|NCT03307252|19956711|P7|STARTED|Part 2, Period 2||5
8095758|NCT03307252|19956712|P6|STARTED|Part 2, Period 2||3
8095759|NCT03307252|19956713|P5|STARTED|Part 2, Period 2||4
8095760|NCT03307252|19956714|P4|STARTED|Part 2, Period 2||4
8095761|NCT03307252|19956715|P3|STARTED|Part 2, Period 2||0
8095762|NCT03307252|19956716|P2|STARTED|Part 2, Period 2||0
8095763|NCT03307252|19956717|P1|STARTED|Part 2, Period 2||0
8095764|NCT03307252|19956707|P11|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095765|NCT03307252|19956708|P10|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095766|NCT03307252|19956709|P9|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095767|NCT03307252|19956710|P8|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095768|NCT03307252|19956711|P7|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095769|NCT03307252|19956712|P6|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095770|NCT03307252|19956713|P5|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095771|NCT03307252|19956714|P4|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095772|NCT03307252|19956715|P3|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095773|NCT03307252|19956716|P2|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095774|NCT03307252|19956717|P1|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095775|NCT03307252|19956707|P11|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095776|NCT03307252|19956708|P10|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095777|NCT03307252|19956709|P9|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095778|NCT03307252|19956710|P8|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095779|NCT03307252|19956711|P7|COMPLETED|Part 2, Washout Period 1 (7 Days)||5
8095780|NCT03307252|19956712|P6|COMPLETED|Part 2, Washout Period 1 (7 Days)||3
8095781|NCT03307252|19956713|P5|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
8095782|NCT03307252|19956714|P4|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
8095783|NCT03307252|19956715|P3|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095784|NCT03307252|19956716|P2|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095785|NCT03307252|19956717|P1|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8095786|NCT03307252|19956707|P11|STARTED|Part 2, Washout Period 1 (7 Days)||0
8095787|NCT03307252|19956708|P10|STARTED|Part 2, Washout Period 1 (7 Days)||0
8095788|NCT03307252|19956709|P9|STARTED|Part 2, Washout Period 1 (7 Days)||0
8095789|NCT03307252|19956710|P8|STARTED|Part 2, Washout Period 1 (7 Days)||0
8095790|NCT03307252|19956711|P7|STARTED|Part 2, Washout Period 1 (7 Days)||5
8095791|NCT03307252|19956712|P6|STARTED|Part 2, Washout Period 1 (7 Days)||3
8095792|NCT03307252|19956713|P5|STARTED|Part 2, Washout Period 1 (7 Days)||4
8095793|NCT03307252|19956714|P4|STARTED|Part 2, Washout Period 1 (7 Days)||4
8095794|NCT03307252|19956715|P3|STARTED|Part 2, Washout Period 1 (7 Days)||0
8095795|NCT03307252|19956716|P2|STARTED|Part 2, Washout Period 1 (7 Days)||0
8095796|NCT03307252|19956717|P1|STARTED|Part 2, Washout Period 1 (7 Days)||0
8095797|NCT03307252|19956707|P11|NOT COMPLETED|Part 2, Period 1||0
8095798|NCT03307252|19956708|P10|NOT COMPLETED|Part 2, Period 1||0
8095799|NCT03307252|19956709|P9|NOT COMPLETED|Part 2, Period 1||0
8095800|NCT03307252|19956710|P8|NOT COMPLETED|Part 2, Period 1||0
8095801|NCT03307252|19956711|P7|NOT COMPLETED|Part 2, Period 1||0
8095802|NCT03307252|19956712|P6|NOT COMPLETED|Part 2, Period 1||1
8095803|NCT03307252|19956713|P5|NOT COMPLETED|Part 2, Period 1||0
8095804|NCT03307252|19956714|P4|NOT COMPLETED|Part 2, Period 1||0
8095805|NCT03307252|19956715|P3|NOT COMPLETED|Part 2, Period 1||0
8095806|NCT03307252|19956716|P2|NOT COMPLETED|Part 2, Period 1||0
8095807|NCT03307252|19956717|P1|NOT COMPLETED|Part 2, Period 1||0
8095808|NCT03307252|19956707|P11|COMPLETED|Part 2, Period 1||0
8095809|NCT03307252|19956708|P10|COMPLETED|Part 2, Period 1||0
8095810|NCT03307252|19956709|P9|COMPLETED|Part 2, Period 1||0
8095811|NCT03307252|19956710|P8|COMPLETED|Part 2, Period 1||0
8095812|NCT03307252|19956711|P7|COMPLETED|Part 2, Period 1||5
8095813|NCT03307252|19956712|P6|COMPLETED|Part 2, Period 1||3
8095814|NCT03307252|19956713|P5|COMPLETED|Part 2, Period 1||4
8095815|NCT03307252|19956714|P4|COMPLETED|Part 2, Period 1||4
8095816|NCT03307252|19956715|P3|COMPLETED|Part 2, Period 1||0
8095817|NCT03307252|19956716|P2|COMPLETED|Part 2, Period 1||0
8095818|NCT03307252|19956717|P1|COMPLETED|Part 2, Period 1||0
8095819|NCT03307252|19956707|P11|STARTED|Part 2, Period 1||0
8095820|NCT03307252|19956708|P10|STARTED|Part 2, Period 1||0
8095821|NCT03307252|19956709|P9|STARTED|Part 2, Period 1||0
8095822|NCT03307252|19956710|P8|STARTED|Part 2, Period 1||0
8095823|NCT03307252|19956711|P7|STARTED|Part 2, Period 1|Participants randomized in Part 2|5
8095824|NCT03307252|19956712|P6|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
8095825|NCT03307252|19956713|P5|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
8095826|NCT03307252|19956714|P4|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
8095827|NCT03307252|19956715|P3|STARTED|Part 2, Period 1||0
8095828|NCT03307252|19956716|P2|STARTED|Part 2, Period 1||0
8095829|NCT03307252|19956717|P1|STARTED|Part 2, Period 1||0
8095830|NCT03307252|19956707|P11|NOT COMPLETED|Part 1, Period 3||0
8095831|NCT03307252|19956708|P10|NOT COMPLETED|Part 1, Period 3||0
8095832|NCT03307252|19956709|P9|NOT COMPLETED|Part 1, Period 3||0
8095833|NCT03307252|19956710|P8|NOT COMPLETED|Part 1, Period 3||0
8095834|NCT03307252|19956711|P7|NOT COMPLETED|Part 1, Period 3||0
8095835|NCT03307252|19956712|P6|NOT COMPLETED|Part 1, Period 3||0
8095836|NCT03307252|19956713|P5|NOT COMPLETED|Part 1, Period 3||0
8095837|NCT03307252|19956714|P4|NOT COMPLETED|Part 1, Period 3||0
8095838|NCT03307252|19956715|P3|NOT COMPLETED|Part 1, Period 3||0
8095839|NCT03307252|19956716|P2|NOT COMPLETED|Part 1, Period 3||0
8095840|NCT03307252|19956717|P1|NOT COMPLETED|Part 1, Period 3||0
8095841|NCT03307252|19956707|P11|COMPLETED|Part 1, Period 3||0
8095842|NCT03307252|19956708|P10|COMPLETED|Part 1, Period 3||0
8095843|NCT03307252|19956709|P9|COMPLETED|Part 1, Period 3||0
8095844|NCT03307252|19956710|P8|COMPLETED|Part 1, Period 3||0
8095845|NCT03307252|19956711|P7|COMPLETED|Part 1, Period 3||0
8095846|NCT03307252|19956712|P6|COMPLETED|Part 1, Period 3||0
8095847|NCT03307252|19956713|P5|COMPLETED|Part 1, Period 3||0
8095848|NCT03307252|19956714|P4|COMPLETED|Part 1, Period 3||0
8095849|NCT03307252|19956715|P3|COMPLETED|Part 1, Period 3||4
8095850|NCT03307252|19956716|P2|COMPLETED|Part 1, Period 3||4
8095851|NCT03307252|19956717|P1|COMPLETED|Part 1, Period 3||4
8095852|NCT03307252|19956707|P11|STARTED|Part 1, Period 3||0
8095853|NCT03307252|19956708|P10|STARTED|Part 1, Period 3||0
8095854|NCT03307252|19956709|P9|STARTED|Part 1, Period 3||0
8095855|NCT03307252|19956710|P8|STARTED|Part 1, Period 3||0
8095856|NCT03307252|19956711|P7|STARTED|Part 1, Period 3||0
8095857|NCT03307252|19956712|P6|STARTED|Part 1, Period 3||0
8095858|NCT03307252|19956713|P5|STARTED|Part 1, Period 3||0
8095859|NCT03307252|19956714|P4|STARTED|Part 1, Period 3||0
8095860|NCT03307252|19956715|P3|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
8095861|NCT03307252|19956716|P2|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
8095862|NCT03307252|19956717|P1|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
8095863|NCT03307252|19956707|P11|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095864|NCT03307252|19956708|P10|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095865|NCT03307252|19956709|P9|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095866|NCT03307252|19956710|P8|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095867|NCT03307252|19956711|P7|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095868|NCT03307252|19956712|P6|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095869|NCT03307252|19956713|P5|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095870|NCT03307252|19956714|P4|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095871|NCT03307252|19956715|P3|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095872|NCT03307252|19956716|P2|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095873|NCT03307252|19956717|P1|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095874|NCT03307252|19956707|P11|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095875|NCT03307252|19956708|P10|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095876|NCT03307252|19956709|P9|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095877|NCT03307252|19956710|P8|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095878|NCT03307252|19956711|P7|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095879|NCT03307252|19956712|P6|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095880|NCT03307252|19956713|P5|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095881|NCT03307252|19956714|P4|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
8095882|NCT03307252|19956715|P3|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
8095883|NCT03307252|19956716|P2|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
8095884|NCT03307252|19956717|P1|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
8095885|NCT03307252|19956707|P11|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095886|NCT03307252|19956708|P10|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095887|NCT03307252|19956709|P9|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095888|NCT03307252|19956710|P8|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095889|NCT03307252|19956711|P7|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095890|NCT03307252|19956712|P6|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095891|NCT03307252|19956713|P5|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095892|NCT03307252|19956714|P4|STARTED|Part 1, Washout Period 2 (13 Days)||0
8095893|NCT03307252|19956715|P3|STARTED|Part 1, Washout Period 2 (13 Days)||4
8095894|NCT03307252|19956716|P2|STARTED|Part 1, Washout Period 2 (13 Days)||4
8095895|NCT03307252|19956717|P1|STARTED|Part 1, Washout Period 2 (13 Days)||4
8095896|NCT03307252|19956707|P11|NOT COMPLETED|Part 1, Period 2||0
8095897|NCT03307252|19956708|P10|NOT COMPLETED|Part 1, Period 2||0
8095898|NCT03307252|19956709|P9|NOT COMPLETED|Part 1, Period 2||0
8095899|NCT03307252|19956710|P8|NOT COMPLETED|Part 1, Period 2||0
8095900|NCT03307252|19956711|P7|NOT COMPLETED|Part 1, Period 2||0
8095901|NCT03307252|19956712|P6|NOT COMPLETED|Part 1, Period 2||0
8095902|NCT03307252|19956713|P5|NOT COMPLETED|Part 1, Period 2||0
8095903|NCT03307252|19956714|P4|NOT COMPLETED|Part 1, Period 2||0
8095904|NCT03307252|19956715|P3|NOT COMPLETED|Part 1, Period 2||0
8095905|NCT03307252|19956716|P2|NOT COMPLETED|Part 1, Period 2||0
8095906|NCT03307252|19956717|P1|NOT COMPLETED|Part 1, Period 2||0
8095907|NCT03307252|19956707|P11|COMPLETED|Part 1, Period 2||0
8095908|NCT03307252|19956708|P10|COMPLETED|Part 1, Period 2||0
8095909|NCT03307252|19956709|P9|COMPLETED|Part 1, Period 2||0
8095910|NCT03307252|19956710|P8|COMPLETED|Part 1, Period 2||0
8095911|NCT03307252|19956711|P7|COMPLETED|Part 1, Period 2||0
8095912|NCT03307252|19956712|P6|COMPLETED|Part 1, Period 2||0
8095913|NCT03307252|19956713|P5|COMPLETED|Part 1, Period 2||0
8095914|NCT03307252|19956714|P4|COMPLETED|Part 1, Period 2||0
8095915|NCT03307252|19956715|P3|COMPLETED|Part 1, Period 2||4
8095916|NCT03307252|19956716|P2|COMPLETED|Part 1, Period 2||4
8095917|NCT03307252|19956717|P1|COMPLETED|Part 1, Period 2||4
8095918|NCT03307252|19956707|P11|STARTED|Part 1, Period 2||0
8095919|NCT03307252|19956708|P10|STARTED|Part 1, Period 2||0
8095920|NCT03307252|19956709|P9|STARTED|Part 1, Period 2||0
8095921|NCT03307252|19956710|P8|STARTED|Part 1, Period 2||0
8095922|NCT03307252|19956711|P7|STARTED|Part 1, Period 2||0
8095923|NCT03307252|19956712|P6|STARTED|Part 1, Period 2||0
8095924|NCT03307252|19956713|P5|STARTED|Part 1, Period 2||0
8095925|NCT03307252|19956714|P4|STARTED|Part 1, Period 2||0
8095926|NCT03307252|19956715|P3|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
8095927|NCT03307252|19956716|P2|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
8095928|NCT03307252|19956717|P1|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
8095929|NCT03307252|19956707|P11|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095930|NCT03307252|19956708|P10|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095931|NCT03307252|19956709|P9|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095932|NCT03307252|19956710|P8|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095933|NCT03307252|19956711|P7|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095934|NCT03307252|19956712|P6|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095935|NCT03307252|19956713|P5|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095936|NCT03307252|19956714|P4|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095937|NCT03307252|19956715|P3|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095938|NCT03307252|19956716|P2|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095939|NCT03307252|19956717|P1|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095940|NCT03307252|19956707|P11|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095941|NCT03307252|19956708|P10|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095942|NCT03307252|19956709|P9|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095943|NCT03307252|19956710|P8|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095944|NCT03307252|19956711|P7|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095945|NCT03307252|19956712|P6|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095946|NCT03307252|19956713|P5|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095947|NCT03307252|19956714|P4|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
8095948|NCT03307252|19956715|P3|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
8095949|NCT03307252|19956716|P2|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
8095950|NCT03307252|19956717|P1|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
8095951|NCT03307252|19956707|P11|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095952|NCT03307252|19956708|P10|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095953|NCT03307252|19956709|P9|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095954|NCT03307252|19956710|P8|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095955|NCT03307252|19956711|P7|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095956|NCT03307252|19956712|P6|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095957|NCT03307252|19956713|P5|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095958|NCT03307252|19956714|P4|STARTED|Part 1, Washout Period 1 (13 Days)||0
8095959|NCT03307252|19956715|P3|STARTED|Part 1, Washout Period 1 (13 Days)||4
8095960|NCT03307252|19956716|P2|STARTED|Part 1, Washout Period 1 (13 Days)||4
8095961|NCT03307252|19956717|P1|STARTED|Part 1, Washout Period 1 (13 Days)||4
8095962|NCT03307252|19956707|P11|NOT COMPLETED|Part 1, Period 1||0
8095963|NCT03307252|19956708|P10|NOT COMPLETED|Part 1, Period 1||0
8095964|NCT03307252|19956709|P9|NOT COMPLETED|Part 1, Period 1||0
8095965|NCT03307252|19956710|P8|NOT COMPLETED|Part 1, Period 1||0
8095966|NCT03307252|19956711|P7|NOT COMPLETED|Part 1, Period 1||0
8095967|NCT03307252|19956712|P6|NOT COMPLETED|Part 1, Period 1||0
8095968|NCT03307252|19956713|P5|NOT COMPLETED|Part 1, Period 1||0
8095969|NCT03307252|19956714|P4|NOT COMPLETED|Part 1, Period 1||0
8095970|NCT03307252|19956715|P3|NOT COMPLETED|Part 1, Period 1||0
8095971|NCT03307252|19956716|P2|NOT COMPLETED|Part 1, Period 1||0
8095972|NCT03307252|19956717|P1|NOT COMPLETED|Part 1, Period 1||0
8095973|NCT03307252|19956707|P11|COMPLETED|Part 1, Period 1||0
8095974|NCT03307252|19956708|P10|COMPLETED|Part 1, Period 1||0
8095975|NCT03307252|19956709|P9|COMPLETED|Part 1, Period 1||0
8095976|NCT03307252|19956710|P8|COMPLETED|Part 1, Period 1||0
8095977|NCT03307252|19956711|P7|COMPLETED|Part 1, Period 1||0
8095978|NCT03307252|19956712|P6|COMPLETED|Part 1, Period 1||0
8095979|NCT03307252|19956713|P5|COMPLETED|Part 1, Period 1||0
8095980|NCT03307252|19956714|P4|COMPLETED|Part 1, Period 1||0
8095981|NCT03307252|19956715|P3|COMPLETED|Part 1, Period 1||4
8095982|NCT03307252|19956716|P2|COMPLETED|Part 1, Period 1||4
8095983|NCT03307252|19956717|P1|COMPLETED|Part 1, Period 1||4
8095984|NCT03307252|19956707|P11|STARTED|Part 1, Period 1||0
8095985|NCT03307252|19956708|P10|STARTED|Part 1, Period 1||0
8095986|NCT03307252|19956709|P9|STARTED|Part 1, Period 1||0
8095987|NCT03307252|19956710|P8|STARTED|Part 1, Period 1||0
8095988|NCT03307252|19956711|P7|STARTED|Part 1, Period 1||0
8095989|NCT03307252|19956712|P6|STARTED|Part 1, Period 1||0
8095990|NCT03307252|19956713|P5|STARTED|Part 1, Period 1||0
8095991|NCT03307252|19956714|P4|STARTED|Part 1, Period 1||0
8095992|NCT03307252|19956715|P3|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
8095993|NCT03307252|19956716|P2|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
8095994|NCT03307252|19956717|P1|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
8095995|NCT03307174|19956754|P2|NOT COMPLETED|Overall Study||7
8095996|NCT03307174|19956755|P1|NOT COMPLETED|Overall Study||14
8095997|NCT03307174|19956754|P2|COMPLETED|Overall Study||53
8095998|NCT03307174|19956755|P1|COMPLETED|Overall Study||46
8095999|NCT03307174|19956754|P2|STARTED|Overall Study||60
8096000|NCT03307174|19956755|P1|STARTED|Overall Study||60
8096001|NCT03307005|19956775|P2|NOT COMPLETED|Overall Study||0
8096002|NCT03307005|19956776|P1|NOT COMPLETED|Overall Study||0
8096003|NCT03307005|19956775|P2|COMPLETED|Overall Study||2
8096004|NCT03307005|19956776|P1|COMPLETED|Overall Study||3
8096005|NCT03307005|19956775|P2|STARTED|Overall Study||2
8096006|NCT03307005|19956776|P1|STARTED|Overall Study||3
8096007|NCT03306641|19956794|P2|NOT COMPLETED|Second Intervention||0
8096008|NCT03306641|19956795|P1|NOT COMPLETED|Second Intervention||0
8096009|NCT03306641|19956794|P2|COMPLETED|Second Intervention||22
8096010|NCT03306641|19956795|P1|COMPLETED|Second Intervention||23
8096011|NCT03306641|19956794|P2|STARTED|Second Intervention||22
8096012|NCT03306641|19956795|P1|STARTED|Second Intervention||23
8096013|NCT03306641|19956794|P2|NOT COMPLETED|First Intervention||0
8096014|NCT03306641|19956795|P1|NOT COMPLETED|First Intervention||0
8096015|NCT03306641|19956794|P2|COMPLETED|First Intervention||22
8096016|NCT03306641|19956795|P1|COMPLETED|First Intervention||23
8096017|NCT03306641|19956794|P2|STARTED|First Intervention||22
8096018|NCT03306641|19956795|P1|STARTED|First Intervention||23
8096019|NCT03306589|19956809|P6|NOT COMPLETED|Part 2 (69 Days)||0
8096020|NCT03306589|19956810|P5|NOT COMPLETED|Part 2 (69 Days)||0
8096021|NCT03306589|19956811|P4|NOT COMPLETED|Part 2 (69 Days)||0
8096022|NCT03306589|19956812|P3|NOT COMPLETED|Part 2 (69 Days)||0
8096023|NCT03306589|19956813|P2|NOT COMPLETED|Part 2 (69 Days)||0
8096024|NCT03306589|19956814|P1|NOT COMPLETED|Part 2 (69 Days)||0
8096025|NCT03306589|19956809|P6|COMPLETED|Part 2 (69 Days)||0
8096026|NCT03306589|19956810|P5|COMPLETED|Part 2 (69 Days)||0
8096027|NCT03306589|19956811|P4|COMPLETED|Part 2 (69 Days)||0
8096028|NCT03306589|19956812|P3|COMPLETED|Part 2 (69 Days)||0
8096029|NCT03306589|19956813|P2|COMPLETED|Part 2 (69 Days)||0
8096030|NCT03306589|19956814|P1|COMPLETED|Part 2 (69 Days)||0
8096031|NCT03306589|19956809|P6|STARTED|Part 2 (69 Days)||0
8096032|NCT03306589|19956810|P5|STARTED|Part 2 (69 Days)||0
8096033|NCT03306589|19956811|P4|STARTED|Part 2 (69 Days)||0
8096034|NCT03306589|19956812|P3|STARTED|Part 2 (69 Days)||0
8096035|NCT03306589|19956813|P2|STARTED|Part 2 (69 Days)||0
8096036|NCT03306589|19956814|P1|STARTED|Part 2 (69 Days)||0
8096037|NCT03306589|19956809|P6|NOT COMPLETED|Part 1 (69 Days)||0
8096038|NCT03306589|19956810|P5|NOT COMPLETED|Part 1 (69 Days)||0
8096039|NCT03306589|19956811|P4|NOT COMPLETED|Part 1 (69 Days)||0
8096040|NCT03306589|19956812|P3|NOT COMPLETED|Part 1 (69 Days)||0
8096041|NCT03306589|19956813|P2|NOT COMPLETED|Part 1 (69 Days)||0
8096042|NCT03306589|19956814|P1|NOT COMPLETED|Part 1 (69 Days)||0
8096043|NCT03306589|19956809|P6|COMPLETED|Part 1 (69 Days)||0
8096044|NCT03306589|19956810|P5|COMPLETED|Part 1 (69 Days)||0
8096045|NCT03306589|19956811|P4|COMPLETED|Part 1 (69 Days)||4
8096046|NCT03306589|19956812|P3|COMPLETED|Part 1 (69 Days)||2
8096047|NCT03306589|19956813|P2|COMPLETED|Part 1 (69 Days)||4
8096048|NCT03306589|19956814|P1|COMPLETED|Part 1 (69 Days)||2
8096049|NCT03306589|19956809|P6|STARTED|Part 1 (69 Days)||0
8096050|NCT03306589|19956810|P5|STARTED|Part 1 (69 Days)||0
8096051|NCT03306589|19956811|P4|STARTED|Part 1 (69 Days)||4
8096052|NCT03306589|19956812|P3|STARTED|Part 1 (69 Days)||2
8096053|NCT03306589|19956813|P2|STARTED|Part 1 (69 Days)||4
8096054|NCT03306589|19956814|P1|STARTED|Part 1 (69 Days)||2
8096055|NCT03306420|19956920|P5|NOT COMPLETED|Overall Study||0
8096056|NCT03306420|19956921|P4|NOT COMPLETED|Overall Study||0
8096057|NCT03306420|19956922|P3|NOT COMPLETED|Overall Study||0
8096058|NCT03306420|19956923|P2|NOT COMPLETED|Overall Study||0
8096059|NCT03306420|19956924|P1|NOT COMPLETED|Overall Study||0
8096060|NCT03306420|19956920|P5|COMPLETED|Overall Study||3
8096061|NCT03306420|19956921|P4|COMPLETED|Overall Study||3
8096062|NCT03306420|19956922|P3|COMPLETED|Overall Study||3
8096063|NCT03306420|19956923|P2|COMPLETED|Overall Study||3
8096064|NCT03306420|19956924|P1|COMPLETED|Overall Study||3
8096065|NCT03306420|19956920|P5|STARTED|Overall Study||3
8096066|NCT03306420|19956921|P4|STARTED|Overall Study||3
8096067|NCT03306420|19956922|P3|STARTED|Overall Study||3
8096068|NCT03306420|19956923|P2|STARTED|Overall Study||3
8096069|NCT03306420|19956924|P1|STARTED|Overall Study||3
8096073|NCT03306199|19957043|P1|NOT COMPLETED|Overall Study||15
8096074|NCT03306199|19957043|P1|COMPLETED|Overall Study||67
8096075|NCT03306199|19957043|P1|STARTED|Overall Study||82
8096076|NCT03306043|19957047|P1|NOT COMPLETED|Overall Study||4
8096077|NCT03306043|19957047|P1|COMPLETED|Overall Study||98
8096078|NCT03306043|19957047|P1|STARTED|Overall Study||102
8096079|NCT03305887|19957055|P2|NOT COMPLETED|Overall Study||10
8096080|NCT03305887|19957056|P1|NOT COMPLETED|Overall Study||11
8096081|NCT03305887|19957055|P2|COMPLETED|Overall Study||83
8096082|NCT03305887|19957056|P1|COMPLETED|Overall Study||80
8096083|NCT03305887|19957055|P2|STARTED|Overall Study||93
8096084|NCT03305887|19957056|P1|STARTED|Overall Study||91
8096085|NCT03305822|19957062|P2|NOT COMPLETED|Period 2||0
8096086|NCT03305822|19957063|P1|NOT COMPLETED|Period 2||0
8096087|NCT03305822|19957062|P2|COMPLETED|Period 2||18
8096088|NCT03305822|19957063|P1|COMPLETED|Period 2||20
8096089|NCT03305822|19957062|P2|Received at Least 1 Dose of Study Drug|Period 2||18
8096090|NCT03305822|19957063|P1|Received at Least 1 Dose of Study Drug|Period 2||20
8096091|NCT03305822|19957062|P2|STARTED|Period 2||18
8096092|NCT03305822|19957063|P1|STARTED|Period 2||20
8096093|NCT03305822|19957062|P2|NOT COMPLETED|Washout||0
8096094|NCT03305822|19957063|P1|NOT COMPLETED|Washout||0
8096095|NCT03305822|19957062|P2|COMPLETED|Washout||18
8096096|NCT03305822|19957063|P1|COMPLETED|Washout||20
8096097|NCT03305822|19957062|P2|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|18
8096098|NCT03305822|19957063|P1|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|20
8096099|NCT03305822|19957062|P2|NOT COMPLETED|Period 1||0
8096100|NCT03305822|19957063|P1|NOT COMPLETED|Period 1||0
8096101|NCT03305822|19957062|P2|COMPLETED|Period 1||18
8096102|NCT03305822|19957063|P1|COMPLETED|Period 1||20
8096103|NCT03305822|19957062|P2|Received at Least 1 Dose of Study Drug|Period 1||18
8096104|NCT03305822|19957063|P1|Received at Least 1 Dose of Study Drug|Period 1||20
8096105|NCT03305822|19957062|P2|STARTED|Period 1||18
8096106|NCT03305822|19957063|P1|STARTED|Period 1||20
8096107|NCT03305770|19957073|P2|NOT COMPLETED|Overall Study||1
8096108|NCT03305770|19957074|P1|NOT COMPLETED|Overall Study||1
8096109|NCT03305770|19957073|P2|COMPLETED|Overall Study||36
8096110|NCT03305770|19957074|P1|COMPLETED|Overall Study||69
8096111|NCT03305770|19957073|P2|Completed Analysis Set|Overall Study||36
8096112|NCT03305770|19957074|P1|Completed Analysis Set|Overall Study||69
8096113|NCT03305770|19957073|P2|Enrolled Dispensed Analysis Set|Overall Study||36
8096114|NCT03305770|19957074|P1|Enrolled Dispensed Analysis Set|Overall Study||70
8096115|NCT03305770|19957073|P2|STARTED|Overall Study||37
8096116|NCT03305770|19957074|P1|STARTED|Overall Study||70
8096117|NCT03305731|19957082|P1|NOT COMPLETED|Overall Study||1
8096118|NCT03305731|19957082|P1|COMPLETED|Overall Study||20
8096119|NCT03305731|19957082|P1|Week 11|Overall Study||20
8096120|NCT03305731|19957082|P1|Week 6|Overall Study||20
8096121|NCT03305731|19957082|P1|STARTED|Overall Study||21
8096122|NCT03305575|19957093|P2|NOT COMPLETED|Overall Study||0
8096123|NCT03305575|19957094|P1|NOT COMPLETED|Overall Study||1
8096124|NCT03305575|19957093|P2|COMPLETED|Overall Study||5
8096125|NCT03305575|19957094|P1|COMPLETED|Overall Study||4
8096126|NCT03305575|19957093|P2|STARTED|Overall Study||5
8096127|NCT03305575|19957094|P1|STARTED|Overall Study||5
8096128|NCT03305419|19957114|P8|NOT COMPLETED|Part B (14 Days)||0
8096129|NCT03305419|19957115|P7|NOT COMPLETED|Part B (14 Days)||5
8096130|NCT03305419|19957116|P6|NOT COMPLETED|Part B (14 Days)||10
8096131|NCT03305419|19957117|P5|NOT COMPLETED|Part B (14 Days)||3
8096132|NCT03305419|19957118|P4|NOT COMPLETED|Part B (14 Days)||0
8096133|NCT03305419|19957119|P3|NOT COMPLETED|Part B (14 Days)||0
8096134|NCT03305419|19957120|P2|NOT COMPLETED|Part B (14 Days)||0
8096135|NCT03305419|19957121|P1|NOT COMPLETED|Part B (14 Days)||0
8096136|NCT03305419|19957114|P8|COMPLETED|Part B (14 Days)||0
8096137|NCT03305419|19957115|P7|COMPLETED|Part B (14 Days)||8
8096138|NCT03305419|19957116|P6|COMPLETED|Part B (14 Days)||10
8096139|NCT03305419|19957117|P5|COMPLETED|Part B (14 Days)||11
8096140|NCT03305419|19957118|P4|COMPLETED|Part B (14 Days)||0
8096141|NCT03305419|19957119|P3|COMPLETED|Part B (14 Days)||0
8096142|NCT03305419|19957120|P2|COMPLETED|Part B (14 Days)||0
8096143|NCT03305419|19957121|P1|COMPLETED|Part B (14 Days)||0
8096144|NCT03305419|19957114|P8|STARTED|Part B (14 Days)||0
8096145|NCT03305419|19957115|P7|STARTED|Part B (14 Days)||13
8096146|NCT03305419|19957116|P6|STARTED|Part B (14 Days)||20
8096147|NCT03305419|19957117|P5|STARTED|Part B (14 Days)||14
8096148|NCT03305419|19957118|P4|STARTED|Part B (14 Days)||0
8096149|NCT03305419|19957119|P3|STARTED|Part B (14 Days)||0
8096150|NCT03305419|19957120|P2|STARTED|Part B (14 Days)||0
8096151|NCT03305419|19957121|P1|STARTED|Part B (14 Days)||0
8096152|NCT03305419|19957114|P8|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096153|NCT03305419|19957115|P7|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096154|NCT03305419|19957116|P6|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096155|NCT03305419|19957117|P5|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096156|NCT03305419|19957118|P4|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096157|NCT03305419|19957119|P3|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096158|NCT03305419|19957120|P2|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096159|NCT03305419|19957121|P1|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096160|NCT03305419|19957114|P8|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096161|NCT03305419|19957115|P7|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096162|NCT03305419|19957116|P6|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096163|NCT03305419|19957117|P5|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
8096164|NCT03305419|19957118|P4|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
8096165|NCT03305419|19957119|P3|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
8096166|NCT03305419|19957120|P2|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
8096167|NCT03305419|19957121|P1|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
8096168|NCT03305419|19957114|P8|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
8096169|NCT03305419|19957115|P7|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
8096170|NCT03305419|19957116|P6|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
8096171|NCT03305419|19957117|P5|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
8096172|NCT03305419|19957118|P4|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
8096173|NCT03305419|19957119|P3|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
8096174|NCT03305419|19957120|P2|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
8096175|NCT03305419|19957121|P1|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3
8096176|NCT03305419|19957114|P8|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096177|NCT03305419|19957115|P7|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096178|NCT03305419|19957116|P6|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096179|NCT03305419|19957117|P5|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096180|NCT03305419|19957118|P4|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096181|NCT03305419|19957119|P3|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096182|NCT03305419|19957120|P2|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096183|NCT03305419|19957121|P1|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2
8096184|NCT03305419|19957114|P8|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096185|NCT03305419|19957115|P7|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096186|NCT03305419|19957116|P6|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096187|NCT03305419|19957117|P5|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
8096188|NCT03305419|19957118|P4|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
8096189|NCT03305419|19957119|P3|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
8096190|NCT03305419|19957120|P2|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
8096191|NCT03305419|19957121|P1|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1
8096192|NCT03305419|19957114|P8|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
8096193|NCT03305419|19957115|P7|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
8096194|NCT03305419|19957116|P6|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
8096195|NCT03305419|19957117|P5|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
8096196|NCT03305419|19957118|P4|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
8096197|NCT03305419|19957119|P3|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
8096198|NCT03305419|19957120|P2|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3
8096199|NCT03305419|19957121|P1|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
8096200|NCT03305419|19957114|P8|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096201|NCT03305419|19957115|P7|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096202|NCT03305419|19957116|P6|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096203|NCT03305419|19957117|P5|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096204|NCT03305419|19957118|P4|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096205|NCT03305419|19957119|P3|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096206|NCT03305419|19957120|P2|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1
8096207|NCT03305419|19957121|P1|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096208|NCT03305419|19957114|P8|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096209|NCT03305419|19957115|P7|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096210|NCT03305419|19957116|P6|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096211|NCT03305419|19957117|P5|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
8096212|NCT03305419|19957118|P4|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
8096213|NCT03305419|19957119|P3|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
8096214|NCT03305419|19957120|P2|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2
8096215|NCT03305419|19957121|P1|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
8096216|NCT03305419|19957114|P8|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
8096217|NCT03305419|19957115|P7|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
8096218|NCT03305419|19957116|P6|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
8096219|NCT03305419|19957117|P5|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
8096220|NCT03305419|19957118|P4|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
8096221|NCT03305419|19957119|P3|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
8096222|NCT03305419|19957120|P2|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
8096223|NCT03305419|19957121|P1|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
8096224|NCT03305159|19957253|P2|NOT COMPLETED|Overall Study||8
8096225|NCT03305159|19957254|P1|NOT COMPLETED|Overall Study||3
8096226|NCT03305159|19957253|P2|COMPLETED|Overall Study||60
8096227|NCT03305159|19957254|P1|COMPLETED|Overall Study||63
8096228|NCT03305159|19957253|P2|STARTED|Overall Study||68
8096229|NCT03305159|19957254|P1|STARTED|Overall Study||66
8096230|NCT03305081|19957262|P2|NOT COMPLETED|Overall Study||15
8096231|NCT03305081|19957263|P1|NOT COMPLETED|Overall Study||10
8096232|NCT03305081|19957262|P2|COMPLETED|Overall Study||5
8096233|NCT03305081|19957263|P1|COMPLETED|Overall Study||15
8096234|NCT03305081|19957262|P2|STARTED|Overall Study||20
8096235|NCT03305081|19957263|P1|STARTED|Overall Study||25
8096236|NCT03305055|19957273|P2|NOT COMPLETED|Overall Study||2
8096237|NCT03305055|19957274|P1|NOT COMPLETED|Overall Study||1
8096238|NCT03305055|19957273|P2|COMPLETED|Overall Study||0
8096239|NCT03305055|19957274|P1|COMPLETED|Overall Study||1
8096240|NCT03305055|19957273|P2|STARTED|Overall Study||2
8096241|NCT03305055|19957274|P1|STARTED|Overall Study||2
8096242|NCT03304873|19957292|P2|NOT COMPLETED|Overall Study||8
8096243|NCT03304873|19957293|P1|NOT COMPLETED|Overall Study||1
8096244|NCT03304873|19957292|P2|COMPLETED|Overall Study||16
8096245|NCT03304873|19957293|P1|COMPLETED|Overall Study||22
8096246|NCT03304873|19957292|P2|STARTED|Overall Study||24
8096247|NCT03304873|19957293|P1|STARTED|Overall Study||23
8096248|NCT03304119|19957303|P2|NOT COMPLETED|Overall Study||0
8096249|NCT03304119|19957304|P1|NOT COMPLETED|Overall Study||0
8096250|NCT03304119|19957303|P2|COMPLETED|Overall Study||55
8096251|NCT03304119|19957304|P1|COMPLETED|Overall Study||37
8096252|NCT03304119|19957303|P2|STARTED|Overall Study||55
8096253|NCT03304119|19957304|P1|STARTED|Overall Study||37
8096254|NCT03304106|19957316|P2|NOT COMPLETED|Overall Study||2
8096255|NCT03304106|19957317|P1|NOT COMPLETED|Overall Study||13
8096256|NCT03304106|19957316|P2|COMPLETED|Overall Study||56
8096257|NCT03304106|19957317|P1|COMPLETED|Overall Study||31
8096258|NCT03304106|19957316|P2|STARTED|Overall Study||58
8096259|NCT03304106|19957317|P1|STARTED|Overall Study||44
8096263|NCT03303911|19957329|P2|NOT COMPLETED|Overall Study||0
8096264|NCT03303911|19957330|P1|NOT COMPLETED|Overall Study||0
8096265|NCT03303911|19957329|P2|COMPLETED|Overall Study||13
8096266|NCT03303911|19957330|P1|COMPLETED|Overall Study||13
8096267|NCT03303911|19957329|P2|STARTED|Overall Study||13
8096268|NCT03303911|19957330|P1|STARTED|Overall Study||13
8096269|NCT03303794|19957386|P2|NOT COMPLETED|Overall Study||0
8096270|NCT03303794|19957387|P1|NOT COMPLETED|Overall Study||0
8096271|NCT03303794|19957386|P2|COMPLETED|Overall Study||12
8096272|NCT03303794|19957387|P1|COMPLETED|Overall Study||13
8096273|NCT03303794|19957386|P2|STARTED|Overall Study||12
8096274|NCT03303794|19957387|P1|STARTED|Overall Study||13
8096275|NCT03303521|19957399|P2|NOT COMPLETED|Overall Study||3
8096276|NCT03303521|19957400|P1|NOT COMPLETED|Overall Study||5
8096277|NCT03303521|19957399|P2|COMPLETED|Overall Study||96
8096278|NCT03303521|19957400|P1|COMPLETED|Overall Study||92
8096279|NCT03303521|19957399|P2|STARTED|Overall Study||99
8096280|NCT03303521|19957400|P1|STARTED|Overall Study||97
8096281|NCT03303417|19957410|P2|NOT COMPLETED|Overall Study||1
8096282|NCT03303417|19957411|P1|NOT COMPLETED|Overall Study||1
8096283|NCT03303417|19957410|P2|COMPLETED|Overall Study||7
8096284|NCT03303417|19957411|P1|COMPLETED|Overall Study||7
8096285|NCT03303417|19957410|P2|STARTED|Overall Study||8
8096286|NCT03303417|19957411|P1|STARTED|Overall Study||8
8096287|NCT03303404|19957425|P1|NOT COMPLETED|Overall Study||0
8096288|NCT03303404|19957425|P1|COMPLETED|Overall Study||22
8096289|NCT03303404|19957425|P1|STARTED|Overall Study||22
8096290|NCT03303196|19957429|P2|NOT COMPLETED|Overall Study||0
8096291|NCT03303196|19957430|P1|NOT COMPLETED|Overall Study||0
8096292|NCT03303196|19957429|P2|COMPLETED|Overall Study||5
8096293|NCT03303196|19957430|P1|COMPLETED|Overall Study||5
8096294|NCT03303196|19957429|P2|Washout|Overall Study||5
8096295|NCT03303196|19957430|P1|Washout|Overall Study||5
8096296|NCT03303196|19957429|P2|STARTED|Overall Study|Individuals who were assigned to SC admission then BHBP admission.|5
8096297|NCT03303196|19957430|P1|STARTED|Overall Study|Individuals who were assigned to BHBP admission then SC admission.|5
8096298|NCT03303144|19957435|P3|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||1
8096299|NCT03303144|19957436|P2|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
8096300|NCT03303144|19957437|P1|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
8096301|NCT03303144|19957435|P3|COMPLETED|Triferic Via IV Infusion (Day 10)||25
8096302|NCT03303144|19957436|P2|COMPLETED|Triferic Via IV Infusion (Day 10)||0
8096303|NCT03303144|19957437|P1|COMPLETED|Triferic Via IV Infusion (Day 10)||0
8096304|NCT03303144|19957435|P3|STARTED|Triferic Via IV Infusion (Day 10)||26
8096305|NCT03303144|19957436|P2|STARTED|Triferic Via IV Infusion (Day 10)||0
8096306|NCT03303144|19957437|P1|STARTED|Triferic Via IV Infusion (Day 10)||0
8096307|NCT03303144|19957435|P3|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
8096308|NCT03303144|19957436|P2|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||1
8096309|NCT03303144|19957437|P1|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
8096310|NCT03303144|19957435|P3|COMPLETED|Triferic Via IV Infusion (Day 8)||0
8096311|NCT03303144|19957436|P2|COMPLETED|Triferic Via IV Infusion (Day 8)||25
8096312|NCT03303144|19957437|P1|COMPLETED|Triferic Via IV Infusion (Day 8)||0
8096313|NCT03303144|19957435|P3|STARTED|Triferic Via IV Infusion (Day 8)||0
8096314|NCT03303144|19957436|P2|STARTED|Triferic Via IV Infusion (Day 8)||26
8096315|NCT03303144|19957437|P1|STARTED|Triferic Via IV Infusion (Day 8)||0
8096316|NCT03303144|19957435|P3|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
8096317|NCT03303144|19957436|P2|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
8096318|NCT03303144|19957437|P1|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
8096319|NCT03303144|19957435|P3|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
8096320|NCT03303144|19957436|P2|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
8096321|NCT03303144|19957437|P1|COMPLETED|Triferic Via Hemodialysate (Day 3)||26
8096322|NCT03303144|19957435|P3|STARTED|Triferic Via Hemodialysate (Day 3)||0
8096323|NCT03303144|19957436|P2|STARTED|Triferic Via Hemodialysate (Day 3)||0
8096324|NCT03303144|19957437|P1|STARTED|Triferic Via Hemodialysate (Day 3)||26
8096325|NCT03302975|19957452|P1|NOT COMPLETED|Overall Study||4
8096326|NCT03302975|19957452|P1|COMPLETED|Overall Study||12
8096327|NCT03302975|19957452|P1|STARTED|Overall Study||16
8096328|NCT03302936|19957460|P2|NOT COMPLETED|Overall Study||4
8096329|NCT03302936|19957461|P1|NOT COMPLETED|Overall Study||3
8096330|NCT03302936|19957460|P2|COMPLETED|Overall Study||45
8096331|NCT03302936|19957461|P1|COMPLETED|Overall Study||46
8096332|NCT03302936|19957460|P2|STARTED|Overall Study||49
8096333|NCT03302936|19957461|P1|STARTED|Overall Study||49
8096334|NCT03302793|19957471|P2|NOT COMPLETED|Overall Study||2
8096335|NCT03302793|19957472|P1|NOT COMPLETED|Overall Study||0
8096336|NCT03302793|19957471|P2|COMPLETED|Overall Study||4
8096337|NCT03302793|19957472|P1|COMPLETED|Overall Study||6
8096338|NCT03302793|19957471|P2|STARTED|Overall Study||6
8096339|NCT03302793|19957472|P1|STARTED|Overall Study||6
8096346|NCT03302741|19957493|P2|NOT COMPLETED|Overall Study||1
8096347|NCT03302741|19957494|P1|NOT COMPLETED|Overall Study||1
8096348|NCT03302741|19957493|P2|COMPLETED|Overall Study||8
8096349|NCT03302741|19957494|P1|COMPLETED|Overall Study||7
8096350|NCT03302741|19957493|P2|STARTED|Overall Study||9
8096351|NCT03302741|19957494|P1|STARTED|Overall Study||8
8096352|NCT03302559|19957510|P1|NOT COMPLETED|Overall Study||6
8096353|NCT03302559|19957510|P1|COMPLETED|Overall Study||23
8096354|NCT03302559|19957510|P1|STARTED|Overall Study||29
8096355|NCT03302416|19957524|P1|NOT COMPLETED|Overall Study||0
8096356|NCT03302416|19957524|P1|COMPLETED|Overall Study||19
8096357|NCT03302416|19957524|P1|STARTED|Overall Study||19
8096358|NCT03302247|19957528|P1|NOT COMPLETED|Overall Study||3
8096359|NCT03302247|19957528|P1|COMPLETED|Overall Study||0
8096360|NCT03302247|19957528|P1|STARTED|Overall Study||3
8096361|NCT03301844|19957535|P2|NOT COMPLETED|Overall Study||1
8096362|NCT03301844|19957536|P1|NOT COMPLETED|Overall Study||1
8096363|NCT03301844|19957535|P2|COMPLETED|Overall Study||18
8096364|NCT03301844|19957536|P1|COMPLETED|Overall Study||18
8096365|NCT03301844|19957535|P2|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
8096366|NCT03301844|19957536|P1|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
8096367|NCT03301779|19957550|P2|NOT COMPLETED|Overall Study||7
8096368|NCT03301779|19957551|P1|NOT COMPLETED|Overall Study||8
8096369|NCT03301779|19957550|P2|COMPLETED|Overall Study||45
8096370|NCT03301779|19957551|P1|COMPLETED|Overall Study||40
8096371|NCT03301779|19957550|P2|STARTED|Overall Study||52
8096372|NCT03301779|19957551|P1|STARTED|Overall Study||48
8096373|NCT03301740|19957563|P2|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||0
8096374|NCT03301740|19957564|P1|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||1
8096375|NCT03301740|19957563|P2|COMPLETED|Phase 4 Intervention (3 Weeks)||16
8096376|NCT03301740|19957564|P1|COMPLETED|Phase 4 Intervention (3 Weeks)||16
8096377|NCT03301740|19957563|P2|STARTED|Phase 4 Intervention (3 Weeks)||16
8096378|NCT03301740|19957564|P1|STARTED|Phase 4 Intervention (3 Weeks)||17
8096379|NCT03301740|19957563|P2|NOT COMPLETED|Third Washout (1 Week)||0
8096380|NCT03301740|19957564|P1|NOT COMPLETED|Third Washout (1 Week)||0
8096381|NCT03301740|19957563|P2|COMPLETED|Third Washout (1 Week)||16
8096382|NCT03301740|19957564|P1|COMPLETED|Third Washout (1 Week)||17
8096383|NCT03301740|19957563|P2|STARTED|Third Washout (1 Week)||16
8096384|NCT03301740|19957564|P1|STARTED|Third Washout (1 Week)||17
8096385|NCT03301740|19957563|P2|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
8096386|NCT03301740|19957564|P1|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
8096387|NCT03301740|19957563|P2|COMPLETED|Phase 3 Intervention (3 Weeks)||16
8096388|NCT03301740|19957564|P1|COMPLETED|Phase 3 Intervention (3 Weeks)||17
8096389|NCT03301740|19957563|P2|STARTED|Phase 3 Intervention (3 Weeks)||16
8096390|NCT03301740|19957564|P1|STARTED|Phase 3 Intervention (3 Weeks)||17
8096391|NCT03301740|19957563|P2|NOT COMPLETED|Second Washout (1 Week)||0
8096392|NCT03301740|19957564|P1|NOT COMPLETED|Second Washout (1 Week)||0
8096393|NCT03301740|19957563|P2|COMPLETED|Second Washout (1 Week)||16
8096394|NCT03301740|19957564|P1|COMPLETED|Second Washout (1 Week)||17
8096395|NCT03301740|19957563|P2|STARTED|Second Washout (1 Week)||16
8096396|NCT03301740|19957564|P1|STARTED|Second Washout (1 Week)||17
8096397|NCT03301740|19957563|P2|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||0
8096398|NCT03301740|19957564|P1|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||1
8096399|NCT03301740|19957563|P2|COMPLETED|Phase 2 Intervention (3 Weeks)||16
8096400|NCT03301740|19957564|P1|COMPLETED|Phase 2 Intervention (3 Weeks)||17
8096401|NCT03301740|19957563|P2|STARTED|Phase 2 Intervention (3 Weeks)||16
8096402|NCT03301740|19957564|P1|STARTED|Phase 2 Intervention (3 Weeks)||18
8096403|NCT03301740|19957563|P2|NOT COMPLETED|First Washout (1 Week)||0
8096404|NCT03301740|19957564|P1|NOT COMPLETED|First Washout (1 Week)||0
8096405|NCT03301740|19957563|P2|COMPLETED|First Washout (1 Week)||16
8096406|NCT03301740|19957564|P1|COMPLETED|First Washout (1 Week)||18
8096407|NCT03301740|19957563|P2|STARTED|First Washout (1 Week)||16
8096408|NCT03301740|19957564|P1|STARTED|First Washout (1 Week)||18
8096409|NCT03301740|19957563|P2|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
8096410|NCT03301740|19957564|P1|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
8096411|NCT03301740|19957563|P2|COMPLETED|Phase 1 Intervention (3 Weeks)||16
8096412|NCT03301740|19957564|P1|COMPLETED|Phase 1 Intervention (3 Weeks)||18
8096413|NCT03301740|19957563|P2|STARTED|Phase 1 Intervention (3 Weeks)||16
8096414|NCT03301740|19957564|P1|STARTED|Phase 1 Intervention (3 Weeks)||18
8096415|NCT03301714|19957607|P3|NOT COMPLETED|Overall Study||7
8096416|NCT03301714|19957608|P2|NOT COMPLETED|Overall Study||6
8096417|NCT03301714|19957609|P1|NOT COMPLETED|Overall Study||10
8096418|NCT03301714|19957607|P3|COMPLETED|Overall Study||53
8096419|NCT03301714|19957608|P2|COMPLETED|Overall Study||54
8096420|NCT03301714|19957609|P1|COMPLETED|Overall Study||50
8096421|NCT03301714|19957607|P3|STARTED|Overall Study||60
8096422|NCT03301714|19957608|P2|STARTED|Overall Study||60
8096423|NCT03301714|19957609|P1|STARTED|Overall Study||60
8096424|NCT03301649|19957626|P3|NOT COMPLETED|Overall Study||85
8096425|NCT03301649|19957627|P2|NOT COMPLETED|Overall Study||44
8096426|NCT03301649|19957628|P1|NOT COMPLETED|Overall Study||43
8096427|NCT03301649|19957626|P3|COMPLETED|Overall Study||27
8096428|NCT03301649|19957627|P2|COMPLETED|Overall Study||356
8096429|NCT03301649|19957628|P1|COMPLETED|Overall Study||356
8096430|NCT03301649|19957626|P3|Per-protocol (PP) Population|Overall Study||103
8096431|NCT03301649|19957627|P2|Per-protocol (PP) Population|Overall Study||354
8096432|NCT03301649|19957628|P1|Per-protocol (PP) Population|Overall Study||345
8096433|NCT03301649|19957626|P3|Modified Intent-to-treat(mITT)Population|Overall Study||111
8096434|NCT03301649|19957627|P2|Modified Intent-to-treat(mITT)Population|Overall Study||380
8096435|NCT03301649|19957628|P1|Modified Intent-to-treat(mITT)Population|Overall Study||372
8096436|NCT03301649|19957626|P3|Safety Population|Overall Study||112
8096437|NCT03301649|19957627|P2|Safety Population|Overall Study||400
8096438|NCT03301649|19957628|P1|Safety Population|Overall Study||399
8096439|NCT03301649|19957626|P3|STARTED|Overall Study||112
8096440|NCT03301649|19957627|P2|STARTED|Overall Study||400
8096441|NCT03301649|19957628|P1|STARTED|Overall Study||399
8096442|NCT03301298|19957650|P7|NOT COMPLETED|Fed Conditions||0
8096443|NCT03301298|19957651|P6|NOT COMPLETED|Fed Conditions||0
8096444|NCT03301298|19957652|P5|NOT COMPLETED|Fed Conditions||0
8096445|NCT03301298|19957653|P4|NOT COMPLETED|Fed Conditions||0
8096446|NCT03301298|19957654|P3|NOT COMPLETED|Fed Conditions||0
8096447|NCT03301298|19957655|P2|NOT COMPLETED|Fed Conditions||0
8096448|NCT03301298|19957656|P1|NOT COMPLETED|Fed Conditions||0
8096449|NCT03301298|19957650|P7|COMPLETED|Fed Conditions||2
8096450|NCT03301298|19957651|P6|COMPLETED|Fed Conditions||0
8096451|NCT03301298|19957652|P5|COMPLETED|Fed Conditions||5
8096452|NCT03301298|19957653|P4|COMPLETED|Fed Conditions||0
8096453|NCT03301298|19957654|P3|COMPLETED|Fed Conditions||0
8096454|NCT03301298|19957655|P2|COMPLETED|Fed Conditions||0
8096455|NCT03301298|19957656|P1|COMPLETED|Fed Conditions||0
8096456|NCT03301298|19957650|P7|STARTED|Fed Conditions||2
8096457|NCT03301298|19957651|P6|STARTED|Fed Conditions||0
8096458|NCT03301298|19957652|P5|STARTED|Fed Conditions||5
8096459|NCT03301298|19957653|P4|STARTED|Fed Conditions||0
8096460|NCT03301298|19957654|P3|STARTED|Fed Conditions||0
8096461|NCT03301298|19957655|P2|STARTED|Fed Conditions||0
8096462|NCT03301298|19957656|P1|STARTED|Fed Conditions||0
8096463|NCT03301298|19957650|P7|NOT COMPLETED|Unfed Conditions||0
8096464|NCT03301298|19957651|P6|NOT COMPLETED|Unfed Conditions||0
8096465|NCT03301298|19957652|P5|NOT COMPLETED|Unfed Conditions||0
8096466|NCT03301298|19957653|P4|NOT COMPLETED|Unfed Conditions||0
8096467|NCT03301298|19957654|P3|NOT COMPLETED|Unfed Conditions||0
8096468|NCT03301298|19957655|P2|NOT COMPLETED|Unfed Conditions||0
8096469|NCT03301298|19957656|P1|NOT COMPLETED|Unfed Conditions||0
8096470|NCT03301298|19957650|P7|COMPLETED|Unfed Conditions||12
8096471|NCT03301298|19957651|P6|COMPLETED|Unfed Conditions||6
8096472|NCT03301298|19957652|P5|COMPLETED|Unfed Conditions||6
8096473|NCT03301298|19957653|P4|COMPLETED|Unfed Conditions||6
8096474|NCT03301298|19957654|P3|COMPLETED|Unfed Conditions||6
8096475|NCT03301298|19957655|P2|COMPLETED|Unfed Conditions||6
8096476|NCT03301298|19957656|P1|COMPLETED|Unfed Conditions||6
8096477|NCT03301298|19957650|P7|STARTED|Unfed Conditions||12
8096478|NCT03301298|19957651|P6|STARTED|Unfed Conditions||6
8096479|NCT03301298|19957652|P5|STARTED|Unfed Conditions||6
8096480|NCT03301298|19957653|P4|STARTED|Unfed Conditions||6
8096481|NCT03301298|19957654|P3|STARTED|Unfed Conditions||6
8096482|NCT03301298|19957655|P2|STARTED|Unfed Conditions||6
8096483|NCT03301298|19957656|P1|STARTED|Unfed Conditions||6
8096484|NCT03301272|19957694|P2|NOT COMPLETED|Second Intervention (30 Days)||0
8096485|NCT03301272|19957695|P1|NOT COMPLETED|Second Intervention (30 Days)||0
8096486|NCT03301272|19957694|P2|COMPLETED|Second Intervention (30 Days)||9
8096487|NCT03301272|19957695|P1|COMPLETED|Second Intervention (30 Days)||7
8096488|NCT03301272|19957694|P2|STARTED|Second Intervention (30 Days)||9
8096489|NCT03301272|19957695|P1|STARTED|Second Intervention (30 Days)||7
8096490|NCT03301272|19957694|P2|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
8096491|NCT03301272|19957695|P1|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
8096492|NCT03301272|19957694|P2|COMPLETED|Washout (90 Days From 1st Intervention)||9
8096493|NCT03301272|19957695|P1|COMPLETED|Washout (90 Days From 1st Intervention)||7
8096494|NCT03301272|19957694|P2|STARTED|Washout (90 Days From 1st Intervention)||9
8096495|NCT03301272|19957695|P1|STARTED|Washout (90 Days From 1st Intervention)||7
8096496|NCT03301272|19957694|P2|NOT COMPLETED|First Intervention (30 Days)||0
8096497|NCT03301272|19957695|P1|NOT COMPLETED|First Intervention (30 Days)||0
8096498|NCT03301272|19957694|P2|COMPLETED|First Intervention (30 Days)||9
8096499|NCT03301272|19957695|P1|COMPLETED|First Intervention (30 Days)||7
8096500|NCT03301272|19957694|P2|STARTED|First Intervention (30 Days)||9
8096501|NCT03301272|19957695|P1|STARTED|First Intervention (30 Days)||7
8096502|NCT03301155|19957711|P2|NOT COMPLETED|Overall Study||7
8096503|NCT03301155|19957712|P1|NOT COMPLETED|Overall Study||8
8096504|NCT03301155|19957711|P2|COMPLETED|Overall Study||501
8096505|NCT03301155|19957712|P1|COMPLETED|Overall Study||520
8096506|NCT03301155|19957711|P2|STARTED|Overall Study||508
8096507|NCT03301155|19957712|P1|STARTED|Overall Study||528
8096508|NCT03300843|19957726|P1|NOT COMPLETED|Overall Study||0
8096509|NCT03300843|19957726|P1|COMPLETED|Overall Study||1
8096510|NCT03300843|19957726|P1|STARTED|Overall Study||1
8096511|NCT03300674|19957734|P2|NOT COMPLETED|Overall Study||0
8096512|NCT03300674|19957735|P1|NOT COMPLETED|Overall Study||0
8096513|NCT03300674|19957734|P2|COMPLETED|Overall Study||77
8096514|NCT03300674|19957735|P1|COMPLETED|Overall Study||77
8096515|NCT03300674|19957734|P2|STARTED|Overall Study||77
8096516|NCT03300674|19957735|P1|STARTED|Overall Study||77
8096523|NCT03300466|19957760|P2|NOT COMPLETED|Overall Study||0
8096524|NCT03300466|19957761|P1|NOT COMPLETED|Overall Study||1
8096525|NCT03300466|19957760|P2|COMPLETED|Overall Study||10
8096526|NCT03300466|19957761|P1|COMPLETED|Overall Study||9
8096527|NCT03300466|19957760|P2|STARTED|Overall Study||10
8096528|NCT03300466|19957761|P1|STARTED|Overall Study||10
8096529|NCT03300024|19957771|P2|NOT COMPLETED|Overall Study||6
8096530|NCT03300024|19957772|P1|NOT COMPLETED|Overall Study||4
8096531|NCT03300024|19957771|P2|COMPLETED|Overall Study||0
8096532|NCT03300024|19957772|P1|COMPLETED|Overall Study||0
8096533|NCT03300024|19957771|P2|STARTED|Overall Study||6
8096534|NCT03300024|19957772|P1|STARTED|Overall Study||4
8096535|NCT03299686|19957826|P2|NOT COMPLETED|Follow-up Epoch||1
8096536|NCT03299686|19957827|P1|NOT COMPLETED|Follow-up Epoch||0
8096537|NCT03299686|19957826|P2|COMPLETED|Follow-up Epoch||43
8096538|NCT03299686|19957827|P1|COMPLETED|Follow-up Epoch||59
8096539|NCT03299686|19957826|P2|STARTED|Follow-up Epoch||44
8096540|NCT03299686|19957827|P1|STARTED|Follow-up Epoch||59
8096541|NCT03299686|19957826|P2|NOT COMPLETED|Treatment Epoch||4
8096542|NCT03299686|19957827|P1|NOT COMPLETED|Treatment Epoch||11
8096543|NCT03299686|19957826|P2|COMPLETED|Treatment Epoch||44
8096544|NCT03299686|19957827|P1|COMPLETED|Treatment Epoch||59
8096545|NCT03299686|19957826|P2|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||48
8096546|NCT03299686|19957827|P1|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||69
8096547|NCT03299686|19957826|P2|STARTED|Treatment Epoch||48
8096548|NCT03299686|19957827|P1|STARTED|Treatment Epoch||70
8096549|NCT03299101|19957843|P1|NOT COMPLETED|Overall Study||10
8096550|NCT03299101|19957843|P1|COMPLETED|Overall Study||25
8096551|NCT03299101|19957843|P1|STARTED|Overall Study||35
8096564|NCT03298412|19957983|P1|NOT COMPLETED|Treatment Period||0
8096565|NCT03298412|19957983|P1|COMPLETED|Treatment Period||1
8096566|NCT03298412|19957983|P1|STARTED|Treatment Period||1
8096567|NCT03298412|19957983|P1|NOT COMPLETED|Run-in Period||9
8096568|NCT03298412|19957983|P1|COMPLETED|Run-in Period||1
8096569|NCT03298412|19957983|P1|STARTED|Run-in Period||10
8096570|NCT03298113|19957993|P2|NOT COMPLETED|Overall Study||0
8096571|NCT03298113|19957994|P1|NOT COMPLETED|Overall Study||0
8096572|NCT03298113|19957993|P2|COMPLETED|Overall Study||10
8096573|NCT03298113|19957994|P1|COMPLETED|Overall Study||10
8096574|NCT03298113|19957993|P2|IAD 2A|Overall Study||6
8096575|NCT03298113|19957994|P1|IAD 2A|Overall Study||7
8096576|NCT03298113|19957993|P2|IAD 1A|Overall Study||4
8096577|NCT03298113|19957994|P1|IAD 1A|Overall Study||3
8096578|NCT03298113|19957993|P2|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10
8096579|NCT03298113|19957994|P1|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10
8096580|NCT03298048|19958033|P3|NOT COMPLETED|Overall Study||0
8096581|NCT03298048|19958034|P2|NOT COMPLETED|Overall Study||0
8096582|NCT03298048|19958035|P1|NOT COMPLETED|Overall Study||0
8096583|NCT03298048|19958033|P3|COMPLETED|Overall Study||8
8096584|NCT03298048|19958034|P2|COMPLETED|Overall Study||3
8096585|NCT03298048|19958035|P1|COMPLETED|Overall Study||4
8096586|NCT03298048|19958033|P3|STARTED|Overall Study||8
8096587|NCT03298048|19958034|P2|STARTED|Overall Study||3
8096588|NCT03298048|19958035|P1|STARTED|Overall Study||4
8096589|NCT03298035|19958060|P2|NOT COMPLETED|Overall Study||2
8096590|NCT03298035|19958061|P1|NOT COMPLETED|Overall Study||1
8096591|NCT03298035|19958060|P2|COMPLETED|Overall Study||7
8096592|NCT03298035|19958061|P1|COMPLETED|Overall Study||9
8096593|NCT03298035|19958060|P2|Received Intervention|Overall Study||7
8096594|NCT03298035|19958061|P1|Received Intervention|Overall Study||9
8096595|NCT03298035|19958060|P2|STARTED|Overall Study||9
8096596|NCT03298035|19958061|P1|STARTED|Overall Study||10
8096597|NCT03297944|19958083|P1|NOT COMPLETED|Overall Study||0
8096598|NCT03297944|19958083|P1|COMPLETED|Overall Study||15
8096599|NCT03297944|19958083|P1|PLC/ALP|Overall Study||15
8096600|NCT03297944|19958083|P1|PLC/PLC|Overall Study||15
8096601|NCT03297944|19958083|P1|ZOL/PLC|Overall Study||15
8096602|NCT03297944|19958083|P1|0.5ALP/PLC|Overall Study||15
8096603|NCT03297944|19958083|P1|1ALP/PLC|Overall Study||15
8096604|NCT03297944|19958083|P1|2ALP/PLC|Overall Study||15
8096605|NCT03297944|19958083|P1|STARTED|Overall Study||15
8096606|NCT03297294|19958094|P5|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8096607|NCT03297294|19958095|P4|NOT COMPLETED|Treatment Withdrawal Period (TW)||1
8096608|NCT03297294|19958096|P3|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8096609|NCT03297294|19958097|P2|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8096610|NCT03297294|19958098|P1|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8096611|NCT03297294|19958094|P5|COMPLETED|Treatment Withdrawal Period (TW)||27
8096612|NCT03297294|19958095|P4|COMPLETED|Treatment Withdrawal Period (TW)||11
8096613|NCT03297294|19958096|P3|COMPLETED|Treatment Withdrawal Period (TW)||14
8096614|NCT03297294|19958097|P2|COMPLETED|Treatment Withdrawal Period (TW)||0
8096615|NCT03297294|19958098|P1|COMPLETED|Treatment Withdrawal Period (TW)||0
8096616|NCT03297294|19958094|P5|STARTED|Treatment Withdrawal Period (TW)||27
8096617|NCT03297294|19958095|P4|STARTED|Treatment Withdrawal Period (TW)||12
8096618|NCT03297294|19958096|P3|STARTED|Treatment Withdrawal Period (TW)||14
8096619|NCT03297294|19958097|P2|STARTED|Treatment Withdrawal Period (TW)||0
8096620|NCT03297294|19958098|P1|STARTED|Treatment Withdrawal Period (TW)||0
8096621|NCT03297294|19958094|P5|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8096622|NCT03297294|19958095|P4|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8096623|NCT03297294|19958096|P3|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8096624|NCT03297294|19958097|P2|NOT COMPLETED|Double-Blind Treatment Period (DB)||37
8096625|NCT03297294|19958098|P1|NOT COMPLETED|Double-Blind Treatment Period (DB)||38
8096626|NCT03297294|19958094|P5|COMPLETED|Double-Blind Treatment Period (DB)||0
8096627|NCT03297294|19958095|P4|COMPLETED|Double-Blind Treatment Period (DB)||0
8096628|NCT03297294|19958096|P3|COMPLETED|Double-Blind Treatment Period (DB)||0
8096629|NCT03297294|19958097|P2|COMPLETED|Double-Blind Treatment Period (DB)||30
8096630|NCT03297294|19958098|P1|COMPLETED|Double-Blind Treatment Period (DB)||32
8096631|NCT03297294|19958094|P5|STARTED|Double-Blind Treatment Period (DB)||0
8096632|NCT03297294|19958095|P4|STARTED|Double-Blind Treatment Period (DB)||0
8096633|NCT03297294|19958096|P3|STARTED|Double-Blind Treatment Period (DB)||0
8096634|NCT03297294|19958097|P2|STARTED|Double-Blind Treatment Period (DB)||67
8096635|NCT03297294|19958098|P1|STARTED|Double-Blind Treatment Period (DB)||70
8096636|NCT03297112|19958132|P1|NOT COMPLETED|Overall Study||0
8096637|NCT03297112|19958132|P1|COMPLETED|Overall Study||12
8096638|NCT03297112|19958132|P1|STARTED|Overall Study||12
8096639|NCT03297021|19958140|P3|NOT COMPLETED|Overall Study||4
8096640|NCT03297021|19958141|P2|NOT COMPLETED|Overall Study||4
8096641|NCT03297021|19958142|P1|NOT COMPLETED|Overall Study||5
8096642|NCT03297021|19958140|P3|COMPLETED|Overall Study||43
8096643|NCT03297021|19958141|P2|COMPLETED|Overall Study||42
8096644|NCT03297021|19958142|P1|COMPLETED|Overall Study||43
8096645|NCT03297021|19958140|P3|STARTED|Overall Study||47
8096646|NCT03297021|19958141|P2|STARTED|Overall Study||46
8096647|NCT03297021|19958142|P1|STARTED|Overall Study||48
8096648|NCT03296787|19958166|P4|NOT COMPLETED|Overall Study||0
8096649|NCT03296787|19958167|P3|NOT COMPLETED|Overall Study||0
8096650|NCT03296787|19958168|P2|NOT COMPLETED|Overall Study||0
8096651|NCT03296787|19958169|P1|NOT COMPLETED|Overall Study||0
8096652|NCT03296787|19958166|P4|COMPLETED|Overall Study||7
8096653|NCT03296787|19958167|P3|COMPLETED|Overall Study||9
8096654|NCT03296787|19958168|P2|COMPLETED|Overall Study||8
8096655|NCT03296787|19958169|P1|COMPLETED|Overall Study||8
8096656|NCT03296787|19958166|P4|STARTED|Overall Study||7
8096657|NCT03296787|19958167|P3|STARTED|Overall Study||9
8096658|NCT03296787|19958168|P2|STARTED|Overall Study||8
8096659|NCT03296787|19958169|P1|STARTED|Overall Study||8
8096660|NCT03296566|19958206|P2|NOT COMPLETED|Overall Study||49
8096661|NCT03296566|19958207|P1|NOT COMPLETED|Overall Study||19
8096662|NCT03296566|19958206|P2|COMPLETED|Overall Study||103
8096663|NCT03296566|19958207|P1|COMPLETED|Overall Study||126
8096664|NCT03296566|19958206|P2|STARTED|Overall Study||152
8096665|NCT03296566|19958207|P1|STARTED|Overall Study||145
8096666|NCT03296280|19958223|P2|NOT COMPLETED|Overall Study||7
8096667|NCT03296280|19958224|P1|NOT COMPLETED|Overall Study||6
8096668|NCT03296280|19958223|P2|COMPLETED|Overall Study||36
8096669|NCT03296280|19958224|P1|COMPLETED|Overall Study||67
8096670|NCT03296280|19958223|P2|STARTED|Overall Study||43
8096671|NCT03296280|19958224|P1|STARTED|Overall Study||73
8096672|NCT03296072|19958244|P6|NOT COMPLETED|Treament Period 3||0
8096673|NCT03296072|19958245|P5|NOT COMPLETED|Treament Period 3||0
8096674|NCT03296072|19958246|P4|NOT COMPLETED|Treament Period 3||0
8096675|NCT03296072|19958247|P3|NOT COMPLETED|Treament Period 3||0
8096676|NCT03296072|19958248|P2|NOT COMPLETED|Treament Period 3||0
8096677|NCT03296072|19958249|P1|NOT COMPLETED|Treament Period 3||0
8096678|NCT03296072|19958244|P6|COMPLETED|Treament Period 3||11
8096679|NCT03296072|19958245|P5|COMPLETED|Treament Period 3||10
8096680|NCT03296072|19958246|P4|COMPLETED|Treament Period 3||10
8096681|NCT03296072|19958247|P3|COMPLETED|Treament Period 3||10
8096682|NCT03296072|19958248|P2|COMPLETED|Treament Period 3||11
8096683|NCT03296072|19958249|P1|COMPLETED|Treament Period 3||10
8096684|NCT03296072|19958244|P6|STARTED|Treament Period 3||11
8096685|NCT03296072|19958245|P5|STARTED|Treament Period 3||10
8096686|NCT03296072|19958246|P4|STARTED|Treament Period 3||10
8096687|NCT03296072|19958247|P3|STARTED|Treament Period 3||10
8096688|NCT03296072|19958248|P2|STARTED|Treament Period 3||11
8096689|NCT03296072|19958249|P1|STARTED|Treament Period 3||10
8096690|NCT03296072|19958244|P6|NOT COMPLETED|Treament Period 2: Wash Out Period||0
8096691|NCT03296072|19958245|P5|NOT COMPLETED|Treament Period 2: Wash Out Period||0
8096692|NCT03296072|19958246|P4|NOT COMPLETED|Treament Period 2: Wash Out Period||0
8096693|NCT03296072|19958247|P3|NOT COMPLETED|Treament Period 2: Wash Out Period||0
8096694|NCT03296072|19958248|P2|NOT COMPLETED|Treament Period 2: Wash Out Period||0
8096695|NCT03296072|19958249|P1|NOT COMPLETED|Treament Period 2: Wash Out Period||0
8096696|NCT03296072|19958244|P6|COMPLETED|Treament Period 2: Wash Out Period||11
8096697|NCT03296072|19958245|P5|COMPLETED|Treament Period 2: Wash Out Period||10
8096698|NCT03296072|19958246|P4|COMPLETED|Treament Period 2: Wash Out Period||10
8096699|NCT03296072|19958247|P3|COMPLETED|Treament Period 2: Wash Out Period||10
8096700|NCT03296072|19958248|P2|COMPLETED|Treament Period 2: Wash Out Period||11
8096701|NCT03296072|19958249|P1|COMPLETED|Treament Period 2: Wash Out Period||10
8096702|NCT03296072|19958244|P6|STARTED|Treament Period 2: Wash Out Period||11
8096703|NCT03296072|19958245|P5|STARTED|Treament Period 2: Wash Out Period||10
8096704|NCT03296072|19958246|P4|STARTED|Treament Period 2: Wash Out Period||10
8096705|NCT03296072|19958247|P3|STARTED|Treament Period 2: Wash Out Period||10
8096706|NCT03296072|19958248|P2|STARTED|Treament Period 2: Wash Out Period||11
8096707|NCT03296072|19958249|P1|STARTED|Treament Period 2: Wash Out Period||10
8096708|NCT03296072|19958244|P6|NOT COMPLETED|Treament Period 2||0
8096709|NCT03296072|19958245|P5|NOT COMPLETED|Treament Period 2||0
8096710|NCT03296072|19958246|P4|NOT COMPLETED|Treament Period 2||0
8096711|NCT03296072|19958247|P3|NOT COMPLETED|Treament Period 2||0
8096712|NCT03296072|19958248|P2|NOT COMPLETED|Treament Period 2||0
8096713|NCT03296072|19958249|P1|NOT COMPLETED|Treament Period 2||0
8096714|NCT03296072|19958244|P6|COMPLETED|Treament Period 2||11
8096715|NCT03296072|19958245|P5|COMPLETED|Treament Period 2||10
8096716|NCT03296072|19958246|P4|COMPLETED|Treament Period 2||10
8096717|NCT03296072|19958247|P3|COMPLETED|Treament Period 2||10
8096718|NCT03296072|19958248|P2|COMPLETED|Treament Period 2||11
8096719|NCT03296072|19958249|P1|COMPLETED|Treament Period 2||10
8096720|NCT03296072|19958244|P6|STARTED|Treament Period 2||11
8096721|NCT03296072|19958245|P5|STARTED|Treament Period 2||10
8096722|NCT03296072|19958246|P4|STARTED|Treament Period 2||10
8096723|NCT03296072|19958247|P3|STARTED|Treament Period 2||10
8096724|NCT03296072|19958248|P2|STARTED|Treament Period 2||11
8096725|NCT03296072|19958249|P1|STARTED|Treament Period 2||10
8096726|NCT03296072|19958244|P6|NOT COMPLETED|Treament Period 1: Wash Out Period||0
8096727|NCT03296072|19958245|P5|NOT COMPLETED|Treament Period 1: Wash Out Period||0
8096728|NCT03296072|19958246|P4|NOT COMPLETED|Treament Period 1: Wash Out Period||0
8096729|NCT03296072|19958247|P3|NOT COMPLETED|Treament Period 1: Wash Out Period||0
8096730|NCT03296072|19958248|P2|NOT COMPLETED|Treament Period 1: Wash Out Period||0
8096731|NCT03296072|19958249|P1|NOT COMPLETED|Treament Period 1: Wash Out Period||0
8096732|NCT03296072|19958244|P6|COMPLETED|Treament Period 1: Wash Out Period||11
8096733|NCT03296072|19958245|P5|COMPLETED|Treament Period 1: Wash Out Period||10
8096734|NCT03296072|19958246|P4|COMPLETED|Treament Period 1: Wash Out Period||10
8096735|NCT03296072|19958247|P3|COMPLETED|Treament Period 1: Wash Out Period||10
8096736|NCT03296072|19958248|P2|COMPLETED|Treament Period 1: Wash Out Period||11
8096737|NCT03296072|19958249|P1|COMPLETED|Treament Period 1: Wash Out Period||10
8096738|NCT03296072|19958244|P6|STARTED|Treament Period 1: Wash Out Period||11
8096739|NCT03296072|19958245|P5|STARTED|Treament Period 1: Wash Out Period||10
8096740|NCT03296072|19958246|P4|STARTED|Treament Period 1: Wash Out Period||10
8096741|NCT03296072|19958247|P3|STARTED|Treament Period 1: Wash Out Period||10
8096742|NCT03296072|19958248|P2|STARTED|Treament Period 1: Wash Out Period||11
8096743|NCT03296072|19958249|P1|STARTED|Treament Period 1: Wash Out Period||10
8096744|NCT03296072|19958244|P6|NOT COMPLETED|Treatment Period 1||0
8096745|NCT03296072|19958245|P5|NOT COMPLETED|Treatment Period 1||0
8096746|NCT03296072|19958246|P4|NOT COMPLETED|Treatment Period 1||0
8096747|NCT03296072|19958247|P3|NOT COMPLETED|Treatment Period 1||0
8096748|NCT03296072|19958248|P2|NOT COMPLETED|Treatment Period 1||0
8096749|NCT03296072|19958249|P1|NOT COMPLETED|Treatment Period 1||0
8096750|NCT03296072|19958244|P6|COMPLETED|Treatment Period 1||11
8096751|NCT03296072|19958245|P5|COMPLETED|Treatment Period 1||10
8096752|NCT03296072|19958246|P4|COMPLETED|Treatment Period 1||10
8096753|NCT03296072|19958247|P3|COMPLETED|Treatment Period 1||10
8096754|NCT03296072|19958248|P2|COMPLETED|Treatment Period 1||11
8096755|NCT03296072|19958249|P1|COMPLETED|Treatment Period 1||10
8096756|NCT03296072|19958244|P6|STARTED|Treatment Period 1||11
8096757|NCT03296072|19958245|P5|STARTED|Treatment Period 1||10
8096758|NCT03296072|19958246|P4|STARTED|Treatment Period 1||10
8096759|NCT03296072|19958247|P3|STARTED|Treatment Period 1||10
8096760|NCT03296072|19958248|P2|STARTED|Treatment Period 1||11
8096761|NCT03296072|19958249|P1|STARTED|Treatment Period 1||10
8096762|NCT03295630|19958266|P1|NOT COMPLETED|Overall Study||0
8096763|NCT03295630|19958266|P1|COMPLETED|Overall Study||20
8096764|NCT03295630|19958266|P1|STARTED|Overall Study||20
8096765|NCT03295266|19958273|P2|NOT COMPLETED|Overall Study||0
8096766|NCT03295266|19958274|P1|NOT COMPLETED|Overall Study||0
8096767|NCT03295266|19958273|P2|COMPLETED|Overall Study||4
8096768|NCT03295266|19958274|P1|COMPLETED|Overall Study||5
8096769|NCT03295266|19958273|P2|STARTED|Overall Study||4
8096770|NCT03295266|19958274|P1|STARTED|Overall Study||5
8096771|NCT03295201|19958304|P2|NOT COMPLETED|Overall Study||2
8096772|NCT03295201|19958305|P1|NOT COMPLETED|Overall Study||1
8096773|NCT03295201|19958304|P2|COMPLETED|Overall Study||9
8096774|NCT03295201|19958305|P1|COMPLETED|Overall Study||10
8096775|NCT03295201|19958304|P2|STARTED|Overall Study||11
8096776|NCT03295201|19958305|P1|STARTED|Overall Study||11
8096777|NCT03294681|19958357|P1|NOT COMPLETED|Overall Study||1
8096778|NCT03294681|19958357|P1|COMPLETED|Overall Study||152
8096779|NCT03294681|19958357|P1|STARTED|Overall Study||153
8096780|NCT03294629|19958363|P2|NOT COMPLETED|Second Intervention (2 Weeks)||2
8096781|NCT03294629|19958364|P1|NOT COMPLETED|Second Intervention (2 Weeks)||2
8096782|NCT03294629|19958363|P2|COMPLETED|Second Intervention (2 Weeks)||13
8096783|NCT03294629|19958364|P1|COMPLETED|Second Intervention (2 Weeks)||12
8096784|NCT03294629|19958363|P2|STARTED|Second Intervention (2 Weeks)||15
8096785|NCT03294629|19958364|P1|STARTED|Second Intervention (2 Weeks)||14
8096786|NCT03294629|19958363|P2|NOT COMPLETED|First Intervention (2 Weeks)||4
8096787|NCT03294629|19958364|P1|NOT COMPLETED|First Intervention (2 Weeks)||2
8096788|NCT03294629|19958363|P2|COMPLETED|First Intervention (2 Weeks)||15
8096789|NCT03294629|19958364|P1|COMPLETED|First Intervention (2 Weeks)||14
8096790|NCT03294629|19958363|P2|STARTED|First Intervention (2 Weeks)||19
8096791|NCT03294629|19958364|P1|STARTED|First Intervention (2 Weeks)||16
8096792|NCT03294538|19958395|P3|NOT COMPLETED|Overall Study||2
8096793|NCT03294538|19958396|P2|NOT COMPLETED|Overall Study||5
8096794|NCT03294538|19958397|P1|NOT COMPLETED|Overall Study||5
8096795|NCT03294538|19958395|P3|COMPLETED|Overall Study||131
8096796|NCT03294538|19958396|P2|COMPLETED|Overall Study||257
8096797|NCT03294538|19958397|P1|COMPLETED|Overall Study||263
8096798|NCT03294538|19958395|P3|PP Population|Overall Study||126
8096799|NCT03294538|19958396|P2|PP Population|Overall Study||227
8096800|NCT03294538|19958397|P1|PP Population|Overall Study||244
8096801|NCT03294538|19958395|P3|mITT Population|Overall Study||132
8096802|NCT03294538|19958396|P2|mITT Population|Overall Study||262
8096803|NCT03294538|19958397|P1|mITT Population|Overall Study||267
8096804|NCT03294538|19958395|P3|Safety Population|Overall Study||132
8096805|NCT03294538|19958396|P2|Safety Population|Overall Study||262
8096806|NCT03294538|19958397|P1|Safety Population|Overall Study||267
8096807|NCT03294538|19958395|P3|STARTED|Overall Study||133
8096808|NCT03294538|19958396|P2|STARTED|Overall Study||262
8096809|NCT03294538|19958397|P1|STARTED|Overall Study||268
8096823|NCT03293394|19958466|P2|NOT COMPLETED|Follow-up (6 Months)||2
8096824|NCT03293394|19958467|P1|NOT COMPLETED|Follow-up (6 Months)||4
8096825|NCT03293394|19958466|P2|COMPLETED|Follow-up (6 Months)||8
8096826|NCT03293394|19958467|P1|COMPLETED|Follow-up (6 Months)||16
8096827|NCT03293394|19958466|P2|STARTED|Follow-up (6 Months)||10
8096828|NCT03293394|19958467|P1|STARTED|Follow-up (6 Months)||20
8096829|NCT03293394|19958466|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
8096830|NCT03293394|19958467|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8096831|NCT03293394|19958466|P2|COMPLETED|First Intervention (2 Weeks)||10
8096832|NCT03293394|19958467|P1|COMPLETED|First Intervention (2 Weeks)||20
8096833|NCT03293394|19958466|P2|STARTED|First Intervention (2 Weeks)||10
8096834|NCT03293394|19958467|P1|STARTED|First Intervention (2 Weeks)||20
8096835|NCT03293238|19958491|P4|NOT COMPLETED|Overall Study||0
8096836|NCT03293238|19958492|P3|NOT COMPLETED|Overall Study||0
8096837|NCT03293238|19958493|P2|NOT COMPLETED|Overall Study||0
8096838|NCT03293238|19958494|P1|NOT COMPLETED|Overall Study||0
8096839|NCT03293238|19958491|P4|COMPLETED|Overall Study||14
8096840|NCT03293238|19958492|P3|COMPLETED|Overall Study||14
8096841|NCT03293238|19958493|P2|COMPLETED|Overall Study||16
8096842|NCT03293238|19958494|P1|COMPLETED|Overall Study||19
8096843|NCT03293238|19958491|P4|STARTED|Overall Study||14
8096844|NCT03293238|19958492|P3|STARTED|Overall Study||14
8096845|NCT03293238|19958493|P2|STARTED|Overall Study||16
8096846|NCT03293238|19958494|P1|STARTED|Overall Study||19
8096847|NCT03292692|19958514|P2|NOT COMPLETED|Overall Study||38
8096848|NCT03292692|19958515|P1|NOT COMPLETED|Overall Study||38
8096849|NCT03292692|19958514|P2|COMPLETED|Overall Study||260
8096850|NCT03292692|19958515|P1|COMPLETED|Overall Study||264
8096851|NCT03292692|19958514|P2|STARTED|Overall Study||298
8096852|NCT03292692|19958515|P1|STARTED|Overall Study||302
8096859|NCT03292614|19958540|P1|NOT COMPLETED|Overall Study||0
8096860|NCT03292614|19958540|P1|COMPLETED|Overall Study||25
8096861|NCT03292614|19958540|P1|STARTED|Overall Study||25
8096862|NCT03292562|19958546|P2|NOT COMPLETED|Overall Study||1
8096863|NCT03292562|19958547|P1|NOT COMPLETED|Overall Study||6
8096864|NCT03292562|19958546|P2|COMPLETED|Overall Study||30
8096865|NCT03292562|19958547|P1|COMPLETED|Overall Study||29
8096866|NCT03292562|19958546|P2|STARTED|Overall Study||31
8096867|NCT03292562|19958547|P1|STARTED|Overall Study||35
8096876|NCT03292016|19958596|P6|NOT COMPLETED|Third Intervention||0
8096877|NCT03292016|19958597|P5|NOT COMPLETED|Third Intervention||0
8096878|NCT03292016|19958598|P4|NOT COMPLETED|Third Intervention||0
8096879|NCT03292016|19958599|P3|NOT COMPLETED|Third Intervention||0
8096880|NCT03292016|19958600|P2|NOT COMPLETED|Third Intervention||0
8096881|NCT03292016|19958601|P1|NOT COMPLETED|Third Intervention||0
8096882|NCT03292016|19958596|P6|COMPLETED|Third Intervention||2
8096883|NCT03292016|19958597|P5|COMPLETED|Third Intervention||1
8096884|NCT03292016|19958598|P4|COMPLETED|Third Intervention||1
8096885|NCT03292016|19958599|P3|COMPLETED|Third Intervention||2
8096886|NCT03292016|19958600|P2|COMPLETED|Third Intervention||0
8096887|NCT03292016|19958601|P1|COMPLETED|Third Intervention||1
8096888|NCT03292016|19958596|P6|STARTED|Third Intervention||2
8096889|NCT03292016|19958597|P5|STARTED|Third Intervention||1
8096890|NCT03292016|19958598|P4|STARTED|Third Intervention||1
8096891|NCT03292016|19958599|P3|STARTED|Third Intervention||2
8096892|NCT03292016|19958600|P2|STARTED|Third Intervention||0
8096893|NCT03292016|19958601|P1|STARTED|Third Intervention||1
8096894|NCT03292016|19958596|P6|NOT COMPLETED|Second Washout||0
8096895|NCT03292016|19958597|P5|NOT COMPLETED|Second Washout||0
8096896|NCT03292016|19958598|P4|NOT COMPLETED|Second Washout||0
8096897|NCT03292016|19958599|P3|NOT COMPLETED|Second Washout||0
8096898|NCT03292016|19958600|P2|NOT COMPLETED|Second Washout||1
8096899|NCT03292016|19958601|P1|NOT COMPLETED|Second Washout||0
8096900|NCT03292016|19958596|P6|COMPLETED|Second Washout||2
8096901|NCT03292016|19958597|P5|COMPLETED|Second Washout||1
8096902|NCT03292016|19958598|P4|COMPLETED|Second Washout||1
8096903|NCT03292016|19958599|P3|COMPLETED|Second Washout||2
8096904|NCT03292016|19958600|P2|COMPLETED|Second Washout||0
8096905|NCT03292016|19958601|P1|COMPLETED|Second Washout||1
8096906|NCT03292016|19958596|P6|STARTED|Second Washout||2
8096907|NCT03292016|19958597|P5|STARTED|Second Washout||1
8096908|NCT03292016|19958598|P4|STARTED|Second Washout||1
8096909|NCT03292016|19958599|P3|STARTED|Second Washout||2
8096910|NCT03292016|19958600|P2|STARTED|Second Washout||1
8096911|NCT03292016|19958601|P1|STARTED|Second Washout||1
8096912|NCT03292016|19958596|P6|NOT COMPLETED|Second Intervention||0
8096913|NCT03292016|19958597|P5|NOT COMPLETED|Second Intervention||0
8096914|NCT03292016|19958598|P4|NOT COMPLETED|Second Intervention||0
8096915|NCT03292016|19958599|P3|NOT COMPLETED|Second Intervention||0
8096916|NCT03292016|19958600|P2|NOT COMPLETED|Second Intervention||0
8096917|NCT03292016|19958601|P1|NOT COMPLETED|Second Intervention||0
8096918|NCT03292016|19958596|P6|COMPLETED|Second Intervention||2
8096919|NCT03292016|19958597|P5|COMPLETED|Second Intervention||1
8096920|NCT03292016|19958598|P4|COMPLETED|Second Intervention||1
8096921|NCT03292016|19958599|P3|COMPLETED|Second Intervention||2
8096922|NCT03292016|19958600|P2|COMPLETED|Second Intervention||1
8096923|NCT03292016|19958601|P1|COMPLETED|Second Intervention||1
8096924|NCT03292016|19958596|P6|STARTED|Second Intervention||2
8096925|NCT03292016|19958597|P5|STARTED|Second Intervention||1
8096926|NCT03292016|19958598|P4|STARTED|Second Intervention||1
8096927|NCT03292016|19958599|P3|STARTED|Second Intervention||2
8096928|NCT03292016|19958600|P2|STARTED|Second Intervention||1
8096929|NCT03292016|19958601|P1|STARTED|Second Intervention||1
8096930|NCT03292016|19958596|P6|NOT COMPLETED|First Washout||0
8096931|NCT03292016|19958597|P5|NOT COMPLETED|First Washout||0
8096932|NCT03292016|19958598|P4|NOT COMPLETED|First Washout||0
8096933|NCT03292016|19958599|P3|NOT COMPLETED|First Washout||0
8096934|NCT03292016|19958600|P2|NOT COMPLETED|First Washout||0
8096935|NCT03292016|19958601|P1|NOT COMPLETED|First Washout||0
8096936|NCT03292016|19958596|P6|COMPLETED|First Washout||2
8096937|NCT03292016|19958597|P5|COMPLETED|First Washout||1
8096938|NCT03292016|19958598|P4|COMPLETED|First Washout||1
8096939|NCT03292016|19958599|P3|COMPLETED|First Washout||2
8096940|NCT03292016|19958600|P2|COMPLETED|First Washout||1
8096941|NCT03292016|19958601|P1|COMPLETED|First Washout||1
8096942|NCT03292016|19958596|P6|STARTED|First Washout||2
8096943|NCT03292016|19958597|P5|STARTED|First Washout||1
8096944|NCT03292016|19958598|P4|STARTED|First Washout||1
8096945|NCT03292016|19958599|P3|STARTED|First Washout||2
8096946|NCT03292016|19958600|P2|STARTED|First Washout||1
8096947|NCT03292016|19958601|P1|STARTED|First Washout||1
8096948|NCT03292016|19958596|P6|NOT COMPLETED|First Intervention||0
8096949|NCT03292016|19958597|P5|NOT COMPLETED|First Intervention||0
8096950|NCT03292016|19958598|P4|NOT COMPLETED|First Intervention||0
8096951|NCT03292016|19958599|P3|NOT COMPLETED|First Intervention||0
8096952|NCT03292016|19958600|P2|NOT COMPLETED|First Intervention||0
8096953|NCT03292016|19958601|P1|NOT COMPLETED|First Intervention||0
8096954|NCT03292016|19958596|P6|COMPLETED|First Intervention||2
8096955|NCT03292016|19958597|P5|COMPLETED|First Intervention||1
8096956|NCT03292016|19958598|P4|COMPLETED|First Intervention||1
8096957|NCT03292016|19958599|P3|COMPLETED|First Intervention||2
8096958|NCT03292016|19958600|P2|COMPLETED|First Intervention||1
8096959|NCT03292016|19958601|P1|COMPLETED|First Intervention||1
8096960|NCT03292016|19958596|P6|STARTED|First Intervention||2
8096961|NCT03292016|19958597|P5|STARTED|First Intervention||1
8096962|NCT03292016|19958598|P4|STARTED|First Intervention||1
8096963|NCT03292016|19958599|P3|STARTED|First Intervention||2
8096964|NCT03292016|19958600|P2|STARTED|First Intervention||1
8096965|NCT03292016|19958601|P1|STARTED|First Intervention||1
8096966|NCT03291613|19958639|P1|NOT COMPLETED|Overall Study||1
8096967|NCT03291613|19958639|P1|COMPLETED|Overall Study||12
8096968|NCT03291613|19958639|P1|STARTED|Overall Study||13
8096983|NCT03291197|19958686|P1|NOT COMPLETED|Overall Study||0
8096984|NCT03291197|19958686|P1|COMPLETED|Overall Study||5
8096985|NCT03291197|19958686|P1|STARTED|Overall Study||5
8096989|NCT03290378|19958708|P3|NOT COMPLETED|Overall Study||16
8096990|NCT03290378|19958709|P2|NOT COMPLETED|Overall Study||10
8096991|NCT03290378|19958710|P1|NOT COMPLETED|Overall Study||3
8096992|NCT03290378|19958708|P3|COMPLETED|Overall Study||120
8096993|NCT03290378|19958709|P2|COMPLETED|Overall Study||123
8096994|NCT03290378|19958710|P1|COMPLETED|Overall Study||137
8096995|NCT03290378|19958708|P3|STARTED|Overall Study||136
8096996|NCT03290378|19958709|P2|STARTED|Overall Study||133
8096997|NCT03290378|19958710|P1|STARTED|Overall Study||140
8096998|NCT03290300|19958718|P1|NOT COMPLETED|Overall Study||3
8096999|NCT03290300|19958718|P1|COMPLETED|Overall Study||36
8097000|NCT03290300|19958718|P1|STARTED|Overall Study||39
8097013|NCT03289676|19958751|P2|NOT COMPLETED|Overall Study||1
8097014|NCT03289676|19958752|P1|NOT COMPLETED|Overall Study||4
8097015|NCT03289676|19958751|P2|COMPLETED|Overall Study|Received 80% of the allotted intervention|25
8097016|NCT03289676|19958752|P1|COMPLETED|Overall Study||23
8097017|NCT03289676|19958751|P2|STARTED|Overall Study||26
8097018|NCT03289676|19958752|P1|STARTED|Overall Study||27
8097019|NCT03289533|19958762|P1|NOT COMPLETED|Overall Study||22
8097020|NCT03289533|19958762|P1|COMPLETED|Overall Study||0
8097021|NCT03289533|19958762|P1|STARTED|Overall Study||22
8097028|NCT03289234|19958801|P3|NOT COMPLETED|Overall Study||0
8097029|NCT03289234|19958802|P2|NOT COMPLETED|Overall Study||0
8097030|NCT03289234|19958803|P1|NOT COMPLETED|Overall Study||0
8097031|NCT03289234|19958801|P3|COMPLETED|Overall Study||8
8097032|NCT03289234|19958802|P2|COMPLETED|Overall Study||6
8097033|NCT03289234|19958803|P1|COMPLETED|Overall Study||8
8097034|NCT03289234|19958801|P3|STARTED|Overall Study||8
8097035|NCT03289234|19958802|P2|STARTED|Overall Study||6
8097036|NCT03289234|19958803|P1|STARTED|Overall Study||8
8097037|NCT03289208|19958823|P3|NOT COMPLETED|Overall Study||0
8097038|NCT03289208|19958824|P2|NOT COMPLETED|Overall Study||0
8097039|NCT03289208|19958825|P1|NOT COMPLETED|Overall Study||1
8097040|NCT03289208|19958823|P3|COMPLETED|Overall Study||11
8097041|NCT03289208|19958824|P2|COMPLETED|Overall Study||8
8097042|NCT03289208|19958825|P1|COMPLETED|Overall Study||10
8097043|NCT03289208|19958823|P3|STARTED|Overall Study||11
8097044|NCT03289208|19958824|P2|STARTED|Overall Study||8
8097045|NCT03289208|19958825|P1|STARTED|Overall Study||11
8097046|NCT03288987|19958844|P2|NOT COMPLETED|Overall Study||4
8097047|NCT03288987|19958845|P1|NOT COMPLETED|Overall Study||10
8097048|NCT03288987|19958844|P2|COMPLETED|Overall Study|Per protocol population|40
8097049|NCT03288987|19958845|P1|COMPLETED|Overall Study|Per protocol population|72
8097050|NCT03288987|19958844|P2|Patients Receiving Medication|Overall Study||44
8097051|NCT03288987|19958845|P1|Patients Receiving Medication|Overall Study||80
8097052|NCT03288987|19958844|P2|STARTED|Overall Study||44
8097053|NCT03288987|19958845|P1|STARTED|Overall Study||82
8097054|NCT03288779|19958861|P1|NOT COMPLETED|Overall Study||3
8097055|NCT03288779|19958861|P1|COMPLETED|Overall Study||3
8097056|NCT03288779|19958861|P1|STARTED|Overall Study||6
8097057|NCT03287869|19958868|P2|NOT COMPLETED|Overall Study||93
8097058|NCT03287869|19958869|P1|NOT COMPLETED|Overall Study||83
8097059|NCT03287869|19958868|P2|COMPLETED|Overall Study||100
8097060|NCT03287869|19958869|P1|COMPLETED|Overall Study||105
8097061|NCT03287869|19958868|P2|Analyzed For Safety (Safety Sample)|Overall Study||184
8097062|NCT03287869|19958869|P1|Analyzed For Safety (Safety Sample)|Overall Study||184
8097063|NCT03287869|19958868|P2|STARTED|Overall Study||193
8097064|NCT03287869|19958869|P1|STARTED|Overall Study||188
8097075|NCT03287804|19958890|P1|NOT COMPLETED|Overall Study||11
8097076|NCT03287804|19958890|P1|COMPLETED|Overall Study||1
8097077|NCT03287804|19958890|P1|Received Study Treatment|Overall Study||11
8097078|NCT03287804|19958890|P1|Started Pre-conditioning Therapy|Overall Study||11
8097079|NCT03287804|19958890|P1|Leukaperesed|Overall Study||12
8097080|NCT03287804|19958890|P1|STARTED|Overall Study||12
8097081|NCT03287791|19958906|P3|NOT COMPLETED|Overall Study||36
8097082|NCT03287791|19958907|P2|NOT COMPLETED|Overall Study||36
8097083|NCT03287791|19958908|P1|NOT COMPLETED|Overall Study||32
8097084|NCT03287791|19958906|P3|COMPLETED|Overall Study||264
8097085|NCT03287791|19958907|P2|COMPLETED|Overall Study||276
8097086|NCT03287791|19958908|P1|COMPLETED|Overall Study||280
8097087|NCT03287791|19958906|P3|PP Population|Overall Study||245
8097088|NCT03287791|19958907|P2|PP Population|Overall Study||259
8097089|NCT03287791|19958908|P1|PP Population|Overall Study||262
8097090|NCT03287791|19958906|P3|mITT Population|Overall Study||283
8097091|NCT03287791|19958907|P2|mITT Population|Overall Study||291
8097092|NCT03287791|19958908|P1|mITT Population|Overall Study||291
8097093|NCT03287791|19958906|P3|Safety Population|Overall Study||291
8097094|NCT03287791|19958907|P2|Safety Population|Overall Study||297
8097095|NCT03287791|19958908|P1|Safety Population|Overall Study||306
8097096|NCT03287791|19958906|P3|STARTED|Overall Study||300
8097097|NCT03287791|19958907|P2|STARTED|Overall Study||312
8097098|NCT03287791|19958908|P1|STARTED|Overall Study||312
8097099|NCT03287622|19958921|P2|NOT COMPLETED|Overall Study||48
8097100|NCT03287622|19958922|P1|NOT COMPLETED|Overall Study||58
8097101|NCT03287622|19958921|P2|COMPLETED|Overall Study||308
8097102|NCT03287622|19958922|P1|COMPLETED|Overall Study||298
8097103|NCT03287622|19958921|P2|Sub-randomized to Nudge/NoNudge|Overall Study||266
8097104|NCT03287622|19958922|P1|Sub-randomized to Nudge/NoNudge|Overall Study||253
8097105|NCT03287622|19958921|P2|STARTED|Overall Study||356
8097106|NCT03287622|19958922|P1|STARTED|Overall Study||356
8097107|NCT03287089|19958944|P2|NOT COMPLETED|Overall Study||6
8097108|NCT03287089|19958945|P1|NOT COMPLETED|Overall Study||0
8097109|NCT03287089|19958944|P2|COMPLETED|Overall Study||76
8097110|NCT03287089|19958945|P1|COMPLETED|Overall Study||82
8097111|NCT03287089|19958944|P2|STARTED|Overall Study||82
8097112|NCT03287089|19958945|P1|STARTED|Overall Study||82
8097113|NCT03286829|19958959|P4|NOT COMPLETED|Overall Study||0
8097114|NCT03286829|19958960|P3|NOT COMPLETED|Overall Study||0
8097115|NCT03286829|19958961|P2|NOT COMPLETED|Overall Study||0
8097116|NCT03286829|19958962|P1|NOT COMPLETED|Overall Study||0
8097117|NCT03286829|19958959|P4|COMPLETED|Overall Study||15
8097118|NCT03286829|19958960|P3|COMPLETED|Overall Study||15
8097119|NCT03286829|19958961|P2|COMPLETED|Overall Study||15
8097120|NCT03286829|19958962|P1|COMPLETED|Overall Study||15
8097121|NCT03286829|19958959|P4|STARTED|Overall Study||15
8097122|NCT03286829|19958960|P3|STARTED|Overall Study||15
8097123|NCT03286829|19958961|P2|STARTED|Overall Study||15
8097124|NCT03286829|19958962|P1|STARTED|Overall Study||15
8097125|NCT03286751|19958980|P6|NOT COMPLETED|Period 6||0
8097126|NCT03286751|19958981|P5|NOT COMPLETED|Period 6||0
8097127|NCT03286751|19958982|P4|NOT COMPLETED|Period 6||0
8097128|NCT03286751|19958983|P3|NOT COMPLETED|Period 6||0
8097129|NCT03286751|19958984|P2|NOT COMPLETED|Period 6||0
8097130|NCT03286751|19958985|P1|NOT COMPLETED|Period 6||0
8097131|NCT03286751|19958980|P6|COMPLETED|Period 6||7
8097132|NCT03286751|19958981|P5|COMPLETED|Period 6||5
8097133|NCT03286751|19958982|P4|COMPLETED|Period 6||7
8097134|NCT03286751|19958983|P3|COMPLETED|Period 6||7
8097135|NCT03286751|19958984|P2|COMPLETED|Period 6||6
8097136|NCT03286751|19958985|P1|COMPLETED|Period 6||7
8097137|NCT03286751|19958980|P6|STARTED|Period 6||7
8097138|NCT03286751|19958981|P5|STARTED|Period 6||5
8097139|NCT03286751|19958982|P4|STARTED|Period 6||7
8097140|NCT03286751|19958983|P3|STARTED|Period 6||7
8097141|NCT03286751|19958984|P2|STARTED|Period 6||6
8097142|NCT03286751|19958985|P1|STARTED|Period 6||7
8097143|NCT03286751|19958980|P6|NOT COMPLETED|Washout Period 5||0
8097144|NCT03286751|19958981|P5|NOT COMPLETED|Washout Period 5||1
8097145|NCT03286751|19958982|P4|NOT COMPLETED|Washout Period 5||0
8097146|NCT03286751|19958983|P3|NOT COMPLETED|Washout Period 5||0
8097147|NCT03286751|19958984|P2|NOT COMPLETED|Washout Period 5||0
8097148|NCT03286751|19958985|P1|NOT COMPLETED|Washout Period 5||0
8097149|NCT03286751|19958980|P6|COMPLETED|Washout Period 5||7
8097150|NCT03286751|19958981|P5|COMPLETED|Washout Period 5||5
8097151|NCT03286751|19958982|P4|COMPLETED|Washout Period 5||7
8097152|NCT03286751|19958983|P3|COMPLETED|Washout Period 5||7
8097153|NCT03286751|19958984|P2|COMPLETED|Washout Period 5||6
8097154|NCT03286751|19958985|P1|COMPLETED|Washout Period 5||7
8097155|NCT03286751|19958980|P6|STARTED|Washout Period 5||7
8097156|NCT03286751|19958981|P5|STARTED|Washout Period 5||6
8097157|NCT03286751|19958982|P4|STARTED|Washout Period 5||7
8097158|NCT03286751|19958983|P3|STARTED|Washout Period 5||7
8097159|NCT03286751|19958984|P2|STARTED|Washout Period 5||6
8097160|NCT03286751|19958985|P1|STARTED|Washout Period 5||7
8097161|NCT03286751|19958980|P6|NOT COMPLETED|Period 5||0
8097162|NCT03286751|19958981|P5|NOT COMPLETED|Period 5||0
8097163|NCT03286751|19958982|P4|NOT COMPLETED|Period 5||0
8097164|NCT03286751|19958983|P3|NOT COMPLETED|Period 5||0
8097165|NCT03286751|19958984|P2|NOT COMPLETED|Period 5||0
8097166|NCT03286751|19958985|P1|NOT COMPLETED|Period 5||0
8097167|NCT03286751|19958980|P6|COMPLETED|Period 5||7
8097168|NCT03286751|19958981|P5|COMPLETED|Period 5||6
8097169|NCT03286751|19958982|P4|COMPLETED|Period 5||7
8097170|NCT03286751|19958983|P3|COMPLETED|Period 5||7
8097171|NCT03286751|19958984|P2|COMPLETED|Period 5||6
8097172|NCT03286751|19958985|P1|COMPLETED|Period 5||7
8097173|NCT03286751|19958980|P6|STARTED|Period 5||7
8097174|NCT03286751|19958981|P5|STARTED|Period 5||6
8097175|NCT03286751|19958982|P4|STARTED|Period 5||7
8097176|NCT03286751|19958983|P3|STARTED|Period 5||7
8097177|NCT03286751|19958984|P2|STARTED|Period 5||6
8097178|NCT03286751|19958985|P1|STARTED|Period 5||7
8097179|NCT03286751|19958980|P6|NOT COMPLETED|Washout Period 4||0
8097180|NCT03286751|19958981|P5|NOT COMPLETED|Washout Period 4||0
8097181|NCT03286751|19958982|P4|NOT COMPLETED|Washout Period 4||0
8097182|NCT03286751|19958983|P3|NOT COMPLETED|Washout Period 4||0
8097183|NCT03286751|19958984|P2|NOT COMPLETED|Washout Period 4||0
8097184|NCT03286751|19958985|P1|NOT COMPLETED|Washout Period 4||0
8097185|NCT03286751|19958980|P6|COMPLETED|Washout Period 4||7
8097186|NCT03286751|19958981|P5|COMPLETED|Washout Period 4||6
8097187|NCT03286751|19958982|P4|COMPLETED|Washout Period 4||7
8097188|NCT03286751|19958983|P3|COMPLETED|Washout Period 4||7
8097189|NCT03286751|19958984|P2|COMPLETED|Washout Period 4||6
8097190|NCT03286751|19958985|P1|COMPLETED|Washout Period 4||7
8097191|NCT03286751|19958980|P6|STARTED|Washout Period 4||7
8097192|NCT03286751|19958981|P5|STARTED|Washout Period 4||6
8097193|NCT03286751|19958982|P4|STARTED|Washout Period 4||7
8097194|NCT03286751|19958983|P3|STARTED|Washout Period 4||7
8097195|NCT03286751|19958984|P2|STARTED|Washout Period 4||6
8097196|NCT03286751|19958985|P1|STARTED|Washout Period 4||7
8097197|NCT03286751|19958980|P6|NOT COMPLETED|Period 4||0
8097198|NCT03286751|19958981|P5|NOT COMPLETED|Period 4||0
8097199|NCT03286751|19958982|P4|NOT COMPLETED|Period 4||0
8097200|NCT03286751|19958983|P3|NOT COMPLETED|Period 4||0
8097201|NCT03286751|19958984|P2|NOT COMPLETED|Period 4||0
8097202|NCT03286751|19958985|P1|NOT COMPLETED|Period 4||0
8097203|NCT03286751|19958980|P6|COMPLETED|Period 4||7
8097204|NCT03286751|19958981|P5|COMPLETED|Period 4||6
8097205|NCT03286751|19958982|P4|COMPLETED|Period 4||7
8097206|NCT03286751|19958983|P3|COMPLETED|Period 4||7
8097207|NCT03286751|19958984|P2|COMPLETED|Period 4||6
8097208|NCT03286751|19958985|P1|COMPLETED|Period 4||7
8097209|NCT03286751|19958980|P6|STARTED|Period 4||7
8097210|NCT03286751|19958981|P5|STARTED|Period 4||6
8097211|NCT03286751|19958982|P4|STARTED|Period 4||7
8097212|NCT03286751|19958983|P3|STARTED|Period 4||7
8097213|NCT03286751|19958984|P2|STARTED|Period 4||6
8097214|NCT03286751|19958985|P1|STARTED|Period 4||7
8097215|NCT03286751|19958980|P6|NOT COMPLETED|Washout Period 3||0
8097216|NCT03286751|19958981|P5|NOT COMPLETED|Washout Period 3||0
8097217|NCT03286751|19958982|P4|NOT COMPLETED|Washout Period 3||0
8097218|NCT03286751|19958983|P3|NOT COMPLETED|Washout Period 3||0
8097219|NCT03286751|19958984|P2|NOT COMPLETED|Washout Period 3||0
8097220|NCT03286751|19958985|P1|NOT COMPLETED|Washout Period 3||0
8097221|NCT03286751|19958980|P6|COMPLETED|Washout Period 3||7
8097222|NCT03286751|19958981|P5|COMPLETED|Washout Period 3||6
8097223|NCT03286751|19958982|P4|COMPLETED|Washout Period 3||7
8097224|NCT03286751|19958983|P3|COMPLETED|Washout Period 3||7
8097225|NCT03286751|19958984|P2|COMPLETED|Washout Period 3||6
8097226|NCT03286751|19958985|P1|COMPLETED|Washout Period 3||7
8097227|NCT03286751|19958980|P6|STARTED|Washout Period 3||7
8097228|NCT03286751|19958981|P5|STARTED|Washout Period 3||6
8097229|NCT03286751|19958982|P4|STARTED|Washout Period 3||7
8097230|NCT03286751|19958983|P3|STARTED|Washout Period 3||7
8097231|NCT03286751|19958984|P2|STARTED|Washout Period 3||6
8097232|NCT03286751|19958985|P1|STARTED|Washout Period 3||7
8097233|NCT03286751|19958980|P6|NOT COMPLETED|Period 3||0
8097234|NCT03286751|19958981|P5|NOT COMPLETED|Period 3||0
8097235|NCT03286751|19958982|P4|NOT COMPLETED|Period 3||0
8097236|NCT03286751|19958983|P3|NOT COMPLETED|Period 3||0
8097237|NCT03286751|19958984|P2|NOT COMPLETED|Period 3||0
8097238|NCT03286751|19958985|P1|NOT COMPLETED|Period 3||0
8097239|NCT03286751|19958980|P6|COMPLETED|Period 3||7
8097240|NCT03286751|19958981|P5|COMPLETED|Period 3||6
8097241|NCT03286751|19958982|P4|COMPLETED|Period 3||7
8097242|NCT03286751|19958983|P3|COMPLETED|Period 3||7
8097243|NCT03286751|19958984|P2|COMPLETED|Period 3||6
8097244|NCT03286751|19958985|P1|COMPLETED|Period 3||7
8097245|NCT03286751|19958980|P6|STARTED|Period 3||7
8097246|NCT03286751|19958981|P5|STARTED|Period 3||6
8097247|NCT03286751|19958982|P4|STARTED|Period 3||7
8097248|NCT03286751|19958983|P3|STARTED|Period 3||7
8097249|NCT03286751|19958984|P2|STARTED|Period 3||6
8097250|NCT03286751|19958985|P1|STARTED|Period 3||7
8097251|NCT03286751|19958980|P6|NOT COMPLETED|Washout Period 2||0
8097252|NCT03286751|19958981|P5|NOT COMPLETED|Washout Period 2||0
8097253|NCT03286751|19958982|P4|NOT COMPLETED|Washout Period 2||0
8097254|NCT03286751|19958983|P3|NOT COMPLETED|Washout Period 2||0
8097255|NCT03286751|19958984|P2|NOT COMPLETED|Washout Period 2||1
8097256|NCT03286751|19958985|P1|NOT COMPLETED|Washout Period 2||0
8097257|NCT03286751|19958980|P6|COMPLETED|Washout Period 2||7
8097258|NCT03286751|19958981|P5|COMPLETED|Washout Period 2||6
8097259|NCT03286751|19958982|P4|COMPLETED|Washout Period 2||7
8097260|NCT03286751|19958983|P3|COMPLETED|Washout Period 2||7
8097261|NCT03286751|19958984|P2|COMPLETED|Washout Period 2||6
8097262|NCT03286751|19958985|P1|COMPLETED|Washout Period 2||7
8097263|NCT03286751|19958980|P6|STARTED|Washout Period 2||7
8097264|NCT03286751|19958981|P5|STARTED|Washout Period 2||6
8097265|NCT03286751|19958982|P4|STARTED|Washout Period 2||7
8097266|NCT03286751|19958983|P3|STARTED|Washout Period 2||7
8097267|NCT03286751|19958984|P2|STARTED|Washout Period 2||7
8097268|NCT03286751|19958985|P1|STARTED|Washout Period 2||7
8097269|NCT03286751|19958980|P6|NOT COMPLETED|Period 2||0
8097270|NCT03286751|19958981|P5|NOT COMPLETED|Period 2||0
8097271|NCT03286751|19958982|P4|NOT COMPLETED|Period 2||0
8097272|NCT03286751|19958983|P3|NOT COMPLETED|Period 2||0
8097273|NCT03286751|19958984|P2|NOT COMPLETED|Period 2||0
8097274|NCT03286751|19958985|P1|NOT COMPLETED|Period 2||0
8097275|NCT03286751|19958980|P6|COMPLETED|Period 2||7
8097276|NCT03286751|19958981|P5|COMPLETED|Period 2||6
8097277|NCT03286751|19958982|P4|COMPLETED|Period 2||7
8097278|NCT03286751|19958983|P3|COMPLETED|Period 2||7
8097279|NCT03286751|19958984|P2|COMPLETED|Period 2||7
8097280|NCT03286751|19958985|P1|COMPLETED|Period 2||7
8097281|NCT03286751|19958980|P6|STARTED|Period 2||7
8097282|NCT03286751|19958981|P5|STARTED|Period 2||6
8097283|NCT03286751|19958982|P4|STARTED|Period 2||7
8097284|NCT03286751|19958983|P3|STARTED|Period 2||7
8097285|NCT03286751|19958984|P2|STARTED|Period 2||7
8097286|NCT03286751|19958985|P1|STARTED|Period 2||7
8097287|NCT03286751|19958980|P6|NOT COMPLETED|Washout Period 1||0
8097288|NCT03286751|19958981|P5|NOT COMPLETED|Washout Period 1||1
8097289|NCT03286751|19958982|P4|NOT COMPLETED|Washout Period 1||0
8097290|NCT03286751|19958983|P3|NOT COMPLETED|Washout Period 1||0
8097291|NCT03286751|19958984|P2|NOT COMPLETED|Washout Period 1||0
8097292|NCT03286751|19958985|P1|NOT COMPLETED|Washout Period 1||0
8097293|NCT03286751|19958980|P6|COMPLETED|Washout Period 1||7
8097294|NCT03286751|19958981|P5|COMPLETED|Washout Period 1||6
8097295|NCT03286751|19958982|P4|COMPLETED|Washout Period 1||7
8097296|NCT03286751|19958983|P3|COMPLETED|Washout Period 1||7
8097297|NCT03286751|19958984|P2|COMPLETED|Washout Period 1||7
8097298|NCT03286751|19958985|P1|COMPLETED|Washout Period 1||7
8097299|NCT03286751|19958980|P6|STARTED|Washout Period 1||7
8097300|NCT03286751|19958981|P5|STARTED|Washout Period 1||7
8097301|NCT03286751|19958982|P4|STARTED|Washout Period 1||7
8097302|NCT03286751|19958983|P3|STARTED|Washout Period 1||7
8097303|NCT03286751|19958984|P2|STARTED|Washout Period 1||7
8097304|NCT03286751|19958985|P1|STARTED|Washout Period 1||7
8097305|NCT03286751|19958980|P6|NOT COMPLETED|Period 1||0
8097306|NCT03286751|19958981|P5|NOT COMPLETED|Period 1||0
8097307|NCT03286751|19958982|P4|NOT COMPLETED|Period 1||0
8097308|NCT03286751|19958983|P3|NOT COMPLETED|Period 1||0
8097309|NCT03286751|19958984|P2|NOT COMPLETED|Period 1||0
8097310|NCT03286751|19958985|P1|NOT COMPLETED|Period 1||0
8097311|NCT03286751|19958980|P6|COMPLETED|Period 1||7
8097312|NCT03286751|19958981|P5|COMPLETED|Period 1||7
8097313|NCT03286751|19958982|P4|COMPLETED|Period 1||7
8097314|NCT03286751|19958983|P3|COMPLETED|Period 1||7
8097315|NCT03286751|19958984|P2|COMPLETED|Period 1||7
8097316|NCT03286751|19958985|P1|COMPLETED|Period 1||7
8097317|NCT03286751|19958980|P6|Received at Least One Dose of Study Drug|Period 1||7
8097318|NCT03286751|19958981|P5|Received at Least One Dose of Study Drug|Period 1||7
8097319|NCT03286751|19958982|P4|Received at Least One Dose of Study Drug|Period 1||7
8097320|NCT03286751|19958983|P3|Received at Least One Dose of Study Drug|Period 1||7
8097321|NCT03286751|19958984|P2|Received at Least One Dose of Study Drug|Period 1||7
8097322|NCT03286751|19958985|P1|Received at Least One Dose of Study Drug|Period 1||7
8097323|NCT03286751|19958980|P6|STARTED|Period 1||7
8097324|NCT03286751|19958981|P5|STARTED|Period 1||7
8097325|NCT03286751|19958982|P4|STARTED|Period 1||7
8097326|NCT03286751|19958983|P3|STARTED|Period 1||7
8097327|NCT03286751|19958984|P2|STARTED|Period 1||7
8097328|NCT03286751|19958985|P1|STARTED|Period 1||7
8097329|NCT03286400|19959005|P1|NOT COMPLETED|Overall Study||25
8097330|NCT03286400|19959005|P1|COMPLETED|Overall Study||102
8097331|NCT03286400|19959005|P1|STARTED|Overall Study||127
8097332|NCT03286283|19959018|P1|NOT COMPLETED|Overall Study||0
8097333|NCT03286283|19959018|P1|COMPLETED|Overall Study||55
8097334|NCT03286283|19959018|P1|STARTED|Overall Study||55
8097335|NCT03286218|19959034|P12|NOT COMPLETED|Treatment Phase Period 5||0
8097336|NCT03286218|19959035|P11|NOT COMPLETED|Treatment Phase Period 5||0
8097337|NCT03286218|19959036|P10|NOT COMPLETED|Treatment Phase Period 5||0
8097338|NCT03286218|19959037|P9|NOT COMPLETED|Treatment Phase Period 5||0
8097339|NCT03286218|19959038|P8|NOT COMPLETED|Treatment Phase Period 5||0
8097340|NCT03286218|19959039|P7|NOT COMPLETED|Treatment Phase Period 5||0
8097341|NCT03286218|19959040|P6|NOT COMPLETED|Treatment Phase Period 5||0
8097342|NCT03286218|19959041|P5|NOT COMPLETED|Treatment Phase Period 5||0
8097343|NCT03286218|19959042|P4|NOT COMPLETED|Treatment Phase Period 5||0
8097344|NCT03286218|19959043|P3|NOT COMPLETED|Treatment Phase Period 5||0
8097345|NCT03286218|19959044|P2|NOT COMPLETED|Treatment Phase Period 5||0
8097346|NCT03286218|19959045|P1|NOT COMPLETED|Treatment Phase Period 5||0
8097347|NCT03286218|19959034|P12|COMPLETED|Treatment Phase Period 5||4
8097348|NCT03286218|19959035|P11|COMPLETED|Treatment Phase Period 5||5
8097349|NCT03286218|19959036|P10|COMPLETED|Treatment Phase Period 5||6
8097350|NCT03286218|19959037|P9|COMPLETED|Treatment Phase Period 5||6
8097351|NCT03286218|19959038|P8|COMPLETED|Treatment Phase Period 5||6
8097352|NCT03286218|19959039|P7|COMPLETED|Treatment Phase Period 5||6
8097353|NCT03286218|19959040|P6|COMPLETED|Treatment Phase Period 5||5
8097354|NCT03286218|19959041|P5|COMPLETED|Treatment Phase Period 5||5
8097355|NCT03286218|19959042|P4|COMPLETED|Treatment Phase Period 5||5
8097356|NCT03286218|19959043|P3|COMPLETED|Treatment Phase Period 5||5
8097357|NCT03286218|19959044|P2|COMPLETED|Treatment Phase Period 5||0
8097358|NCT03286218|19959045|P1|COMPLETED|Treatment Phase Period 5||0
8097359|NCT03286218|19959034|P12|STARTED|Treatment Phase Period 5||4
8097360|NCT03286218|19959035|P11|STARTED|Treatment Phase Period 5||5
8097361|NCT03286218|19959036|P10|STARTED|Treatment Phase Period 5||6
8097362|NCT03286218|19959037|P9|STARTED|Treatment Phase Period 5||6
8097363|NCT03286218|19959038|P8|STARTED|Treatment Phase Period 5||6
8097364|NCT03286218|19959039|P7|STARTED|Treatment Phase Period 5||6
8097365|NCT03286218|19959040|P6|STARTED|Treatment Phase Period 5||5
8097366|NCT03286218|19959041|P5|STARTED|Treatment Phase Period 5||5
8097367|NCT03286218|19959042|P4|STARTED|Treatment Phase Period 5||5
8097368|NCT03286218|19959043|P3|STARTED|Treatment Phase Period 5||5
8097369|NCT03286218|19959044|P2|STARTED|Treatment Phase Period 5||0
8097370|NCT03286218|19959045|P1|STARTED|Treatment Phase Period 5||0
8097371|NCT03286218|19959034|P12|NOT COMPLETED|Treatment Phase Period 4||1
8097372|NCT03286218|19959035|P11|NOT COMPLETED|Treatment Phase Period 4||0
8097373|NCT03286218|19959036|P10|NOT COMPLETED|Treatment Phase Period 4||0
8097374|NCT03286218|19959037|P9|NOT COMPLETED|Treatment Phase Period 4||0
8097375|NCT03286218|19959038|P8|NOT COMPLETED|Treatment Phase Period 4||0
8097376|NCT03286218|19959039|P7|NOT COMPLETED|Treatment Phase Period 4||0
8097377|NCT03286218|19959040|P6|NOT COMPLETED|Treatment Phase Period 4||0
8097378|NCT03286218|19959041|P5|NOT COMPLETED|Treatment Phase Period 4||0
8097379|NCT03286218|19959042|P4|NOT COMPLETED|Treatment Phase Period 4||0
8097380|NCT03286218|19959043|P3|NOT COMPLETED|Treatment Phase Period 4||0
8097381|NCT03286218|19959044|P2|NOT COMPLETED|Treatment Phase Period 4||0
8097382|NCT03286218|19959045|P1|NOT COMPLETED|Treatment Phase Period 4||0
8097383|NCT03286218|19959034|P12|COMPLETED|Treatment Phase Period 4||4
8097384|NCT03286218|19959035|P11|COMPLETED|Treatment Phase Period 4||5
8097385|NCT03286218|19959036|P10|COMPLETED|Treatment Phase Period 4||6
8097386|NCT03286218|19959037|P9|COMPLETED|Treatment Phase Period 4||6
8097387|NCT03286218|19959038|P8|COMPLETED|Treatment Phase Period 4||6
8097388|NCT03286218|19959039|P7|COMPLETED|Treatment Phase Period 4||6
8097389|NCT03286218|19959040|P6|COMPLETED|Treatment Phase Period 4||5
8097390|NCT03286218|19959041|P5|COMPLETED|Treatment Phase Period 4||5
8097391|NCT03286218|19959042|P4|COMPLETED|Treatment Phase Period 4||5
8097392|NCT03286218|19959043|P3|COMPLETED|Treatment Phase Period 4||5
8097393|NCT03286218|19959044|P2|COMPLETED|Treatment Phase Period 4||0
8097394|NCT03286218|19959045|P1|COMPLETED|Treatment Phase Period 4||0
8097395|NCT03286218|19959034|P12|STARTED|Treatment Phase Period 4||5
8097396|NCT03286218|19959035|P11|STARTED|Treatment Phase Period 4||5
8097397|NCT03286218|19959036|P10|STARTED|Treatment Phase Period 4||6
8097398|NCT03286218|19959037|P9|STARTED|Treatment Phase Period 4||6
8097399|NCT03286218|19959038|P8|STARTED|Treatment Phase Period 4||6
8097400|NCT03286218|19959039|P7|STARTED|Treatment Phase Period 4||6
8097401|NCT03286218|19959040|P6|STARTED|Treatment Phase Period 4||5
8097402|NCT03286218|19959041|P5|STARTED|Treatment Phase Period 4||5
8097403|NCT03286218|19959042|P4|STARTED|Treatment Phase Period 4||5
8097404|NCT03286218|19959043|P3|STARTED|Treatment Phase Period 4||5
8097405|NCT03286218|19959044|P2|STARTED|Treatment Phase Period 4||0
8097406|NCT03286218|19959045|P1|STARTED|Treatment Phase Period 4||0
8097407|NCT03286218|19959034|P12|NOT COMPLETED|Treatment Phase Period 3||0
8097408|NCT03286218|19959035|P11|NOT COMPLETED|Treatment Phase Period 3||0
8097409|NCT03286218|19959036|P10|NOT COMPLETED|Treatment Phase Period 3||0
8097410|NCT03286218|19959037|P9|NOT COMPLETED|Treatment Phase Period 3||0
8097411|NCT03286218|19959038|P8|NOT COMPLETED|Treatment Phase Period 3||0
8097412|NCT03286218|19959039|P7|NOT COMPLETED|Treatment Phase Period 3||0
8097413|NCT03286218|19959040|P6|NOT COMPLETED|Treatment Phase Period 3||0
8097414|NCT03286218|19959041|P5|NOT COMPLETED|Treatment Phase Period 3||0
8097415|NCT03286218|19959042|P4|NOT COMPLETED|Treatment Phase Period 3||0
8097416|NCT03286218|19959043|P3|NOT COMPLETED|Treatment Phase Period 3||0
8097417|NCT03286218|19959044|P2|NOT COMPLETED|Treatment Phase Period 3||0
8097418|NCT03286218|19959045|P1|NOT COMPLETED|Treatment Phase Period 3||0
8097419|NCT03286218|19959034|P12|COMPLETED|Treatment Phase Period 3||5
8097420|NCT03286218|19959035|P11|COMPLETED|Treatment Phase Period 3||5
8097421|NCT03286218|19959036|P10|COMPLETED|Treatment Phase Period 3||6
8097422|NCT03286218|19959037|P9|COMPLETED|Treatment Phase Period 3||6
8097423|NCT03286218|19959038|P8|COMPLETED|Treatment Phase Period 3||6
8097424|NCT03286218|19959039|P7|COMPLETED|Treatment Phase Period 3||6
8097425|NCT03286218|19959040|P6|COMPLETED|Treatment Phase Period 3||5
8097426|NCT03286218|19959041|P5|COMPLETED|Treatment Phase Period 3||5
8097427|NCT03286218|19959042|P4|COMPLETED|Treatment Phase Period 3||5
8097428|NCT03286218|19959043|P3|COMPLETED|Treatment Phase Period 3||5
8097429|NCT03286218|19959044|P2|COMPLETED|Treatment Phase Period 3||0
8097430|NCT03286218|19959045|P1|COMPLETED|Treatment Phase Period 3||0
8097431|NCT03286218|19959034|P12|STARTED|Treatment Phase Period 3||5
8097432|NCT03286218|19959035|P11|STARTED|Treatment Phase Period 3||5
8097433|NCT03286218|19959036|P10|STARTED|Treatment Phase Period 3||6
8097434|NCT03286218|19959037|P9|STARTED|Treatment Phase Period 3||6
8097435|NCT03286218|19959038|P8|STARTED|Treatment Phase Period 3||6
8097436|NCT03286218|19959039|P7|STARTED|Treatment Phase Period 3||6
8097437|NCT03286218|19959040|P6|STARTED|Treatment Phase Period 3||5
8097438|NCT03286218|19959041|P5|STARTED|Treatment Phase Period 3||5
8097439|NCT03286218|19959042|P4|STARTED|Treatment Phase Period 3||5
8097440|NCT03286218|19959043|P3|STARTED|Treatment Phase Period 3||5
8097441|NCT03286218|19959044|P2|STARTED|Treatment Phase Period 3||0
8097442|NCT03286218|19959045|P1|STARTED|Treatment Phase Period 3||0
8097443|NCT03286218|19959034|P12|NOT COMPLETED|Treatment Phase Period 2||0
8097444|NCT03286218|19959035|P11|NOT COMPLETED|Treatment Phase Period 2||0
8097445|NCT03286218|19959036|P10|NOT COMPLETED|Treatment Phase Period 2||0
8097446|NCT03286218|19959037|P9|NOT COMPLETED|Treatment Phase Period 2||0
8097447|NCT03286218|19959038|P8|NOT COMPLETED|Treatment Phase Period 2||0
8097448|NCT03286218|19959039|P7|NOT COMPLETED|Treatment Phase Period 2||0
8097449|NCT03286218|19959040|P6|NOT COMPLETED|Treatment Phase Period 2||0
8097450|NCT03286218|19959041|P5|NOT COMPLETED|Treatment Phase Period 2||0
8097451|NCT03286218|19959042|P4|NOT COMPLETED|Treatment Phase Period 2||0
8097452|NCT03286218|19959043|P3|NOT COMPLETED|Treatment Phase Period 2||0
8097453|NCT03286218|19959044|P2|NOT COMPLETED|Treatment Phase Period 2||0
8097454|NCT03286218|19959045|P1|NOT COMPLETED|Treatment Phase Period 2||0
8097455|NCT03286218|19959034|P12|COMPLETED|Treatment Phase Period 2||5
8097456|NCT03286218|19959035|P11|COMPLETED|Treatment Phase Period 2||5
8097457|NCT03286218|19959036|P10|COMPLETED|Treatment Phase Period 2||6
8097458|NCT03286218|19959037|P9|COMPLETED|Treatment Phase Period 2||6
8097459|NCT03286218|19959038|P8|COMPLETED|Treatment Phase Period 2||6
8097460|NCT03286218|19959039|P7|COMPLETED|Treatment Phase Period 2||6
8097461|NCT03286218|19959040|P6|COMPLETED|Treatment Phase Period 2||5
8097462|NCT03286218|19959041|P5|COMPLETED|Treatment Phase Period 2||5
8097463|NCT03286218|19959042|P4|COMPLETED|Treatment Phase Period 2||5
8097464|NCT03286218|19959043|P3|COMPLETED|Treatment Phase Period 2||5
8097465|NCT03286218|19959044|P2|COMPLETED|Treatment Phase Period 2||0
8097466|NCT03286218|19959045|P1|COMPLETED|Treatment Phase Period 2||0
8097467|NCT03286218|19959034|P12|STARTED|Treatment Phase Period 2||5
8097468|NCT03286218|19959035|P11|STARTED|Treatment Phase Period 2||5
8097469|NCT03286218|19959036|P10|STARTED|Treatment Phase Period 2||6
8097470|NCT03286218|19959037|P9|STARTED|Treatment Phase Period 2||6
8097471|NCT03286218|19959038|P8|STARTED|Treatment Phase Period 2||6
8097472|NCT03286218|19959039|P7|STARTED|Treatment Phase Period 2||6
8097473|NCT03286218|19959040|P6|STARTED|Treatment Phase Period 2||5
8097474|NCT03286218|19959041|P5|STARTED|Treatment Phase Period 2||5
8097475|NCT03286218|19959042|P4|STARTED|Treatment Phase Period 2||5
8097476|NCT03286218|19959043|P3|STARTED|Treatment Phase Period 2||5
8097477|NCT03286218|19959044|P2|STARTED|Treatment Phase Period 2||0
8097478|NCT03286218|19959045|P1|STARTED|Treatment Phase Period 2||0
8097479|NCT03286218|19959034|P12|NOT COMPLETED|Treatment Phase Period 1||1
8097480|NCT03286218|19959035|P11|NOT COMPLETED|Treatment Phase Period 1||0
8097481|NCT03286218|19959036|P10|NOT COMPLETED|Treatment Phase Period 1||0
8097482|NCT03286218|19959037|P9|NOT COMPLETED|Treatment Phase Period 1||0
8097483|NCT03286218|19959038|P8|NOT COMPLETED|Treatment Phase Period 1||0
8097484|NCT03286218|19959039|P7|NOT COMPLETED|Treatment Phase Period 1||0
8097485|NCT03286218|19959040|P6|NOT COMPLETED|Treatment Phase Period 1||1
8097486|NCT03286218|19959041|P5|NOT COMPLETED|Treatment Phase Period 1||0
8097487|NCT03286218|19959042|P4|NOT COMPLETED|Treatment Phase Period 1||1
8097488|NCT03286218|19959043|P3|NOT COMPLETED|Treatment Phase Period 1||1
8097489|NCT03286218|19959044|P2|NOT COMPLETED|Treatment Phase Period 1||0
8097490|NCT03286218|19959045|P1|NOT COMPLETED|Treatment Phase Period 1||0
8097491|NCT03286218|19959034|P12|COMPLETED|Treatment Phase Period 1||5
8097492|NCT03286218|19959035|P11|COMPLETED|Treatment Phase Period 1||5
8097493|NCT03286218|19959036|P10|COMPLETED|Treatment Phase Period 1||6
8097494|NCT03286218|19959037|P9|COMPLETED|Treatment Phase Period 1||6
8097495|NCT03286218|19959038|P8|COMPLETED|Treatment Phase Period 1||6
8097496|NCT03286218|19959039|P7|COMPLETED|Treatment Phase Period 1||6
8097497|NCT03286218|19959040|P6|COMPLETED|Treatment Phase Period 1||5
8097498|NCT03286218|19959041|P5|COMPLETED|Treatment Phase Period 1||5
8097499|NCT03286218|19959042|P4|COMPLETED|Treatment Phase Period 1||5
8097500|NCT03286218|19959043|P3|COMPLETED|Treatment Phase Period 1||5
8097501|NCT03286218|19959044|P2|COMPLETED|Treatment Phase Period 1||0
8097502|NCT03286218|19959045|P1|COMPLETED|Treatment Phase Period 1||0
8097503|NCT03286218|19959034|P12|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097504|NCT03286218|19959035|P11|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
8097505|NCT03286218|19959036|P10|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097506|NCT03286218|19959037|P9|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097507|NCT03286218|19959038|P8|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097508|NCT03286218|19959039|P7|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097509|NCT03286218|19959040|P6|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097510|NCT03286218|19959041|P5|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
8097511|NCT03286218|19959042|P4|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097512|NCT03286218|19959043|P3|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
8097513|NCT03286218|19959044|P2|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
8097514|NCT03286218|19959045|P1|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
8097515|NCT03286218|19959034|P12|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097516|NCT03286218|19959035|P11|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
8097517|NCT03286218|19959036|P10|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097518|NCT03286218|19959037|P9|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097519|NCT03286218|19959038|P8|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097520|NCT03286218|19959039|P7|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097521|NCT03286218|19959040|P6|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097522|NCT03286218|19959041|P5|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
8097523|NCT03286218|19959042|P4|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097524|NCT03286218|19959043|P3|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
8097525|NCT03286218|19959044|P2|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
8097526|NCT03286218|19959045|P1|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
8097527|NCT03286218|19959034|P12|NOT COMPLETED|Qualification Phase Period 2||0
8097528|NCT03286218|19959035|P11|NOT COMPLETED|Qualification Phase Period 2||0
8097529|NCT03286218|19959036|P10|NOT COMPLETED|Qualification Phase Period 2||0
8097530|NCT03286218|19959037|P9|NOT COMPLETED|Qualification Phase Period 2||0
8097531|NCT03286218|19959038|P8|NOT COMPLETED|Qualification Phase Period 2||0
8097532|NCT03286218|19959039|P7|NOT COMPLETED|Qualification Phase Period 2||0
8097533|NCT03286218|19959040|P6|NOT COMPLETED|Qualification Phase Period 2||0
8097534|NCT03286218|19959041|P5|NOT COMPLETED|Qualification Phase Period 2||0
8097535|NCT03286218|19959042|P4|NOT COMPLETED|Qualification Phase Period 2||0
8097536|NCT03286218|19959043|P3|NOT COMPLETED|Qualification Phase Period 2||0
8097537|NCT03286218|19959044|P2|NOT COMPLETED|Qualification Phase Period 2||19
8097538|NCT03286218|19959045|P1|NOT COMPLETED|Qualification Phase Period 2||17
8097539|NCT03286218|19959034|P12|COMPLETED|Qualification Phase Period 2||0
8097540|NCT03286218|19959035|P11|COMPLETED|Qualification Phase Period 2||0
8097541|NCT03286218|19959036|P10|COMPLETED|Qualification Phase Period 2||0
8097542|NCT03286218|19959037|P9|COMPLETED|Qualification Phase Period 2||0
8097543|NCT03286218|19959038|P8|COMPLETED|Qualification Phase Period 2||0
8097544|NCT03286218|19959039|P7|COMPLETED|Qualification Phase Period 2||0
8097545|NCT03286218|19959040|P6|COMPLETED|Qualification Phase Period 2||0
8097546|NCT03286218|19959041|P5|COMPLETED|Qualification Phase Period 2||0
8097547|NCT03286218|19959042|P4|COMPLETED|Qualification Phase Period 2||0
8097548|NCT03286218|19959043|P3|COMPLETED|Qualification Phase Period 2||0
8097549|NCT03286218|19959044|P2|COMPLETED|Qualification Phase Period 2||28
8097550|NCT03286218|19959045|P1|COMPLETED|Qualification Phase Period 2||30
8097551|NCT03286218|19959034|P12|STARTED|Qualification Phase Period 2||0
8097552|NCT03286218|19959035|P11|STARTED|Qualification Phase Period 2||0
8097553|NCT03286218|19959036|P10|STARTED|Qualification Phase Period 2||0
8097554|NCT03286218|19959037|P9|STARTED|Qualification Phase Period 2||0
8097555|NCT03286218|19959038|P8|STARTED|Qualification Phase Period 2||0
8097556|NCT03286218|19959039|P7|STARTED|Qualification Phase Period 2||0
8097557|NCT03286218|19959040|P6|STARTED|Qualification Phase Period 2||0
8097558|NCT03286218|19959041|P5|STARTED|Qualification Phase Period 2||0
8097559|NCT03286218|19959042|P4|STARTED|Qualification Phase Period 2||0
8097560|NCT03286218|19959043|P3|STARTED|Qualification Phase Period 2||0
8097561|NCT03286218|19959044|P2|STARTED|Qualification Phase Period 2||47
8097562|NCT03286218|19959045|P1|STARTED|Qualification Phase Period 2||47
8097563|NCT03286218|19959034|P12|NOT COMPLETED|Qualification Phase Period 1||0
8097564|NCT03286218|19959035|P11|NOT COMPLETED|Qualification Phase Period 1||0
8097565|NCT03286218|19959036|P10|NOT COMPLETED|Qualification Phase Period 1||0
8097566|NCT03286218|19959037|P9|NOT COMPLETED|Qualification Phase Period 1||0
8097567|NCT03286218|19959038|P8|NOT COMPLETED|Qualification Phase Period 1||0
8097568|NCT03286218|19959039|P7|NOT COMPLETED|Qualification Phase Period 1||0
8097569|NCT03286218|19959040|P6|NOT COMPLETED|Qualification Phase Period 1||0
8097570|NCT03286218|19959041|P5|NOT COMPLETED|Qualification Phase Period 1||0
8097571|NCT03286218|19959042|P4|NOT COMPLETED|Qualification Phase Period 1||0
8097572|NCT03286218|19959043|P3|NOT COMPLETED|Qualification Phase Period 1||0
8097573|NCT03286218|19959044|P2|NOT COMPLETED|Qualification Phase Period 1||1
8097574|NCT03286218|19959045|P1|NOT COMPLETED|Qualification Phase Period 1||1
8097575|NCT03286218|19959034|P12|COMPLETED|Qualification Phase Period 1||0
8097576|NCT03286218|19959035|P11|COMPLETED|Qualification Phase Period 1||0
8097577|NCT03286218|19959036|P10|COMPLETED|Qualification Phase Period 1||0
8097578|NCT03286218|19959037|P9|COMPLETED|Qualification Phase Period 1||0
8097579|NCT03286218|19959038|P8|COMPLETED|Qualification Phase Period 1||0
8097580|NCT03286218|19959039|P7|COMPLETED|Qualification Phase Period 1||0
8097581|NCT03286218|19959040|P6|COMPLETED|Qualification Phase Period 1||0
8097582|NCT03286218|19959041|P5|COMPLETED|Qualification Phase Period 1||0
8097583|NCT03286218|19959042|P4|COMPLETED|Qualification Phase Period 1||0
8097584|NCT03286218|19959043|P3|COMPLETED|Qualification Phase Period 1||0
8097585|NCT03286218|19959044|P2|COMPLETED|Qualification Phase Period 1||47
8097586|NCT03286218|19959045|P1|COMPLETED|Qualification Phase Period 1||47
8097587|NCT03286218|19959034|P12|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097588|NCT03286218|19959035|P11|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097589|NCT03286218|19959036|P10|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097590|NCT03286218|19959037|P9|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097591|NCT03286218|19959038|P8|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097592|NCT03286218|19959039|P7|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097593|NCT03286218|19959040|P6|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097594|NCT03286218|19959041|P5|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097595|NCT03286218|19959042|P4|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097596|NCT03286218|19959043|P3|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
8097597|NCT03286218|19959044|P2|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
8097598|NCT03286218|19959045|P1|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
8097599|NCT03286218|19959034|P12|STARTED|Qualification Phase Period 1||0
8097600|NCT03286218|19959035|P11|STARTED|Qualification Phase Period 1||0
8097601|NCT03286218|19959036|P10|STARTED|Qualification Phase Period 1||0
8097602|NCT03286218|19959037|P9|STARTED|Qualification Phase Period 1||0
8097603|NCT03286218|19959038|P8|STARTED|Qualification Phase Period 1||0
8097604|NCT03286218|19959039|P7|STARTED|Qualification Phase Period 1||0
8097605|NCT03286218|19959040|P6|STARTED|Qualification Phase Period 1||0
8097606|NCT03286218|19959041|P5|STARTED|Qualification Phase Period 1||0
8097607|NCT03286218|19959042|P4|STARTED|Qualification Phase Period 1||0
8097608|NCT03286218|19959043|P3|STARTED|Qualification Phase Period 1||0
8097609|NCT03286218|19959044|P2|STARTED|Qualification Phase Period 1||48
8097610|NCT03286218|19959045|P1|STARTED|Qualification Phase Period 1||48
8097611|NCT03285984|19959087|P1|NOT COMPLETED|Overall Study||0
8097612|NCT03285984|19959087|P1|COMPLETED|Overall Study||56
8097613|NCT03285984|19959087|P1|Received Test Product 4|Overall Study||56
8097614|NCT03285984|19959087|P1|Received Test Product 3|Overall Study||56
8097615|NCT03285984|19959087|P1|Received Test Product 2|Overall Study||56
8097616|NCT03285984|19959087|P1|Received Test Product 1|Overall Study||56
8097617|NCT03285984|19959087|P1|STARTED|Overall Study||56
8097618|NCT03285724|19959099|P1|NOT COMPLETED|Overall Study||0
8097619|NCT03285724|19959099|P1|COMPLETED|Overall Study||1
8097620|NCT03285724|19959099|P1|STARTED|Overall Study||1
8097621|NCT03285711|19959108|P4|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
8097622|NCT03285711|19959109|P3|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
8097623|NCT03285711|19959110|P2|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
8097624|NCT03285711|19959111|P1|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
8097625|NCT03285711|19959108|P4|COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
8097626|NCT03285711|19959109|P3|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
8097627|NCT03285711|19959110|P2|COMPLETED|Extended Blinded Phase (Week 32 to 52)||2
8097628|NCT03285711|19959111|P1|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
8097629|NCT03285711|19959108|P4|STARTED|Extended Blinded Phase (Week 32 to 52)||1
8097630|NCT03285711|19959109|P3|STARTED|Extended Blinded Phase (Week 32 to 52)||0
8097631|NCT03285711|19959110|P2|STARTED|Extended Blinded Phase (Week 32 to 52)||3
8097632|NCT03285711|19959111|P1|STARTED|Extended Blinded Phase (Week 32 to 52)||0
8097633|NCT03285711|19959108|P4|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
8097634|NCT03285711|19959109|P3|NOT COMPLETED|Blinded Phase (Week 16 to 32)||1
8097635|NCT03285711|19959110|P2|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
8097636|NCT03285711|19959111|P1|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
8097637|NCT03285711|19959108|P4|COMPLETED|Blinded Phase (Week 16 to 32)||1
8097638|NCT03285711|19959109|P3|COMPLETED|Blinded Phase (Week 16 to 32)||0
8097639|NCT03285711|19959110|P2|COMPLETED|Blinded Phase (Week 16 to 32)||3
8097640|NCT03285711|19959111|P1|COMPLETED|Blinded Phase (Week 16 to 32)||0
8097641|NCT03285711|19959108|P4|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from filgotinib.|1
8097642|NCT03285711|19959109|P3|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from lanraplenib.|1
8097643|NCT03285711|19959110|P2|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to lanraplenib.|3
8097644|NCT03285711|19959111|P1|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to filgotinib.|0
8097645|NCT03285711|19959108|P4|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
8097646|NCT03285711|19959109|P3|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
8097647|NCT03285711|19959110|P2|NOT COMPLETED|Blinded Phase (Up to Week 16)||1
8097648|NCT03285711|19959111|P1|NOT COMPLETED|Blinded Phase (Up to Week 16)||3
8097649|NCT03285711|19959108|P4|COMPLETED|Blinded Phase (Up to Week 16)||0
8097650|NCT03285711|19959109|P3|COMPLETED|Blinded Phase (Up to Week 16)||0
8097651|NCT03285711|19959110|P2|COMPLETED|Blinded Phase (Up to Week 16)||4
8097652|NCT03285711|19959111|P1|COMPLETED|Blinded Phase (Up to Week 16)||1
8097653|NCT03285711|19959108|P4|STARTED|Blinded Phase (Up to Week 16)||0
8097654|NCT03285711|19959109|P3|STARTED|Blinded Phase (Up to Week 16)||0
8097655|NCT03285711|19959110|P2|STARTED|Blinded Phase (Up to Week 16)||5
8097656|NCT03285711|19959111|P1|STARTED|Blinded Phase (Up to Week 16)||4
8097657|NCT03285555|19959133|P2|NOT COMPLETED|Overall Study||0
8097658|NCT03285555|19959134|P1|NOT COMPLETED|Overall Study||0
8097659|NCT03285555|19959133|P2|COMPLETED|Overall Study||30
8097660|NCT03285555|19959134|P1|COMPLETED|Overall Study||30
8097661|NCT03285555|19959133|P2|STARTED|Overall Study||30
8097662|NCT03285555|19959134|P1|STARTED|Overall Study||30
8097669|NCT03285529|19959157|P2|NOT COMPLETED|Overall Study||0
8097670|NCT03285529|19959158|P1|NOT COMPLETED|Overall Study||0
8097671|NCT03285529|19959157|P2|COMPLETED|Overall Study||30
8097672|NCT03285529|19959158|P1|COMPLETED|Overall Study||30
8097673|NCT03285529|19959157|P2|STARTED|Overall Study||30
8097674|NCT03285529|19959158|P1|STARTED|Overall Study||30
8097675|NCT03285373|19959166|P4|NOT COMPLETED|Overall Study||0
8097676|NCT03285373|19959167|P3|NOT COMPLETED|Overall Study||0
8097677|NCT03285373|19959168|P2|NOT COMPLETED|Overall Study||0
8097678|NCT03285373|19959169|P1|NOT COMPLETED|Overall Study||0
8097679|NCT03285373|19959166|P4|COMPLETED|Overall Study||130
8097680|NCT03285373|19959167|P3|COMPLETED|Overall Study||266
8097681|NCT03285373|19959168|P2|COMPLETED|Overall Study||253
8097682|NCT03285373|19959169|P1|COMPLETED|Overall Study||314
8097683|NCT03285373|19959166|P4|STARTED|Overall Study||130
8097684|NCT03285373|19959167|P3|STARTED|Overall Study||266
8097685|NCT03285373|19959168|P2|STARTED|Overall Study||253
8097686|NCT03285373|19959169|P1|STARTED|Overall Study||314
8097687|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s Chagas Follow-Up||0
8097688|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s Chagas Follow-Up||0
8097689|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s Chagas Follow-Up||0
8097690|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s Chagas Follow-Up||0
8097691|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s Chagas Follow-Up||13
8097692|NCT03285295|19959219|P5|COMPLETED|Alinity s Chagas Follow-Up||0
8097693|NCT03285295|19959220|P4|COMPLETED|Alinity s Chagas Follow-Up||0
8097694|NCT03285295|19959221|P3|COMPLETED|Alinity s Chagas Follow-Up||0
8097695|NCT03285295|19959222|P2|COMPLETED|Alinity s Chagas Follow-Up||0
8097696|NCT03285295|19959223|P1|COMPLETED|Alinity s Chagas Follow-Up||1
8097697|NCT03285295|19959219|P5|STARTED|Alinity s Chagas Follow-Up||0
8097698|NCT03285295|19959220|P4|STARTED|Alinity s Chagas Follow-Up||0
8097699|NCT03285295|19959221|P3|STARTED|Alinity s Chagas Follow-Up||0
8097700|NCT03285295|19959222|P2|STARTED|Alinity s Chagas Follow-Up||0
8097701|NCT03285295|19959223|P1|STARTED|Alinity s Chagas Follow-Up||14
8097702|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s Chagas||0
8097703|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s Chagas||0
8097704|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s Chagas||0
8097705|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s Chagas||0
8097706|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s Chagas||219
8097707|NCT03285295|19959219|P5|COMPLETED|Alinity s Chagas||0
8097708|NCT03285295|19959220|P4|COMPLETED|Alinity s Chagas||615
8097709|NCT03285295|19959221|P3|COMPLETED|Alinity s Chagas||0
8097710|NCT03285295|19959222|P2|COMPLETED|Alinity s Chagas||320
8097711|NCT03285295|19959223|P1|COMPLETED|Alinity s Chagas||15804
8097712|NCT03285295|19959219|P5|STARTED|Alinity s Chagas||0
8097713|NCT03285295|19959220|P4|STARTED|Alinity s Chagas||615
8097714|NCT03285295|19959221|P3|STARTED|Alinity s Chagas||0
8097715|NCT03285295|19959222|P2|STARTED|Alinity s Chagas||320
8097716|NCT03285295|19959223|P1|STARTED|Alinity s Chagas||16023
8097717|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097718|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097719|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097720|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097721|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14
8097722|NCT03285295|19959219|P5|COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097723|NCT03285295|19959220|P4|COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097724|NCT03285295|19959221|P3|COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097725|NCT03285295|19959222|P2|COMPLETED|Alinity s Anti-HBc Follow-Up||0
8097726|NCT03285295|19959223|P1|COMPLETED|Alinity s Anti-HBc Follow-Up||2
8097727|NCT03285295|19959219|P5|STARTED|Alinity s Anti-HBc Follow-Up||0
8097728|NCT03285295|19959220|P4|STARTED|Alinity s Anti-HBc Follow-Up||0
8097729|NCT03285295|19959221|P3|STARTED|Alinity s Anti-HBc Follow-Up||0
8097730|NCT03285295|19959222|P2|STARTED|Alinity s Anti-HBc Follow-Up||0
8097731|NCT03285295|19959223|P1|STARTED|Alinity s Anti-HBc Follow-Up||16
8097732|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s Anti-HBc||0
8097733|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s Anti-HBc||0
8097734|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s Anti-HBc||0
8097735|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s Anti-HBc||1
8097736|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s Anti-HBc||91
8097737|NCT03285295|19959219|P5|COMPLETED|Alinity s Anti-HBc||0
8097738|NCT03285295|19959220|P4|COMPLETED|Alinity s Anti-HBc||0
8097739|NCT03285295|19959221|P3|COMPLETED|Alinity s Anti-HBc||403
8097740|NCT03285295|19959222|P2|COMPLETED|Alinity s Anti-HBc||404
8097741|NCT03285295|19959223|P1|COMPLETED|Alinity s Anti-HBc||15877
8097742|NCT03285295|19959219|P5|STARTED|Alinity s Anti-HBc||0
8097743|NCT03285295|19959220|P4|STARTED|Alinity s Anti-HBc||0
8097744|NCT03285295|19959221|P3|STARTED|Alinity s Anti-HBc||403
8097745|NCT03285295|19959222|P2|STARTED|Alinity s Anti-HBc||405
8097746|NCT03285295|19959223|P1|STARTED|Alinity s Anti-HBc||15968
8097747|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097748|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097749|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097750|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097751|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11
8097752|NCT03285295|19959219|P5|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097753|NCT03285295|19959220|P4|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097754|NCT03285295|19959221|P3|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097755|NCT03285295|19959222|P2|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097756|NCT03285295|19959223|P1|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4
8097757|NCT03285295|19959219|P5|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097758|NCT03285295|19959220|P4|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097759|NCT03285295|19959221|P3|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097760|NCT03285295|19959222|P2|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
8097761|NCT03285295|19959223|P1|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15
8097762|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
8097763|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
8097764|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
8097765|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
8097766|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99
8097767|NCT03285295|19959219|P5|COMPLETED|Alinity s HIV Ag/Ab Combo||0
8097768|NCT03285295|19959220|P4|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
8097769|NCT03285295|19959221|P3|COMPLETED|Alinity s HIV Ag/Ab Combo||605
8097770|NCT03285295|19959222|P2|COMPLETED|Alinity s HIV Ag/Ab Combo||1336
8097771|NCT03285295|19959223|P1|COMPLETED|Alinity s HIV Ag/Ab Combo||16996
8097772|NCT03285295|19959219|P5|STARTED|Alinity s HIV Ag/Ab Combo||0
8097773|NCT03285295|19959220|P4|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
8097774|NCT03285295|19959221|P3|STARTED|Alinity s HIV Ag/Ab Combo||605
8097775|NCT03285295|19959222|P2|STARTED|Alinity s HIV Ag/Ab Combo||1336
8097776|NCT03285295|19959223|P1|STARTED|Alinity s HIV Ag/Ab Combo||17095
8097777|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097778|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097779|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097780|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097781|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18
8097782|NCT03285295|19959219|P5|COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097783|NCT03285295|19959220|P4|COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097784|NCT03285295|19959221|P3|COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097785|NCT03285295|19959222|P2|COMPLETED|Alinity s Anti-HCV Follow-Up||0
8097786|NCT03285295|19959223|P1|COMPLETED|Alinity s Anti-HCV Follow-Up||2
8097787|NCT03285295|19959219|P5|STARTED|Alinity s Anti-HCV Follow-Up||0
8097788|NCT03285295|19959220|P4|STARTED|Alinity s Anti-HCV Follow-Up||0
8097789|NCT03285295|19959221|P3|STARTED|Alinity s Anti-HCV Follow-Up||0
8097790|NCT03285295|19959222|P2|STARTED|Alinity s Anti-HCV Follow-Up||0
8097791|NCT03285295|19959223|P1|STARTED|Alinity s Anti-HCV Follow-Up||20
8097792|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s Anti-HCV||0
8097793|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s Anti-HCV||0
8097794|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s Anti-HCV||0
8097795|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s Anti-HCV||0
8097796|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s Anti-HCV||96
8097797|NCT03285295|19959219|P5|COMPLETED|Alinity s Anti-HCV||0
8097798|NCT03285295|19959220|P4|COMPLETED|Alinity s Anti-HCV||0
8097799|NCT03285295|19959221|P3|COMPLETED|Alinity s Anti-HCV||407
8097800|NCT03285295|19959222|P2|COMPLETED|Alinity s Anti-HCV||402
8097801|NCT03285295|19959223|P1|COMPLETED|Alinity s Anti-HCV||16999
8097802|NCT03285295|19959219|P5|STARTED|Alinity s Anti-HCV||0
8097803|NCT03285295|19959220|P4|STARTED|Alinity s Anti-HCV||0
8097804|NCT03285295|19959221|P3|STARTED|Alinity s Anti-HCV||407
8097805|NCT03285295|19959222|P2|STARTED|Alinity s Anti-HCV||402
8097806|NCT03285295|19959223|P1|STARTED|Alinity s Anti-HCV||17095
8097807|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097808|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097809|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097810|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097811|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4
8097812|NCT03285295|19959219|P5|COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097813|NCT03285295|19959220|P4|COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097814|NCT03285295|19959221|P3|COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097815|NCT03285295|19959222|P2|COMPLETED|Alinity s HTLV I/II Follow-Up||0
8097816|NCT03285295|19959223|P1|COMPLETED|Alinity s HTLV I/II Follow-Up||8
8097817|NCT03285295|19959219|P5|STARTED|Alinity s HTLV I/II Follow-Up||0
8097818|NCT03285295|19959220|P4|STARTED|Alinity s HTLV I/II Follow-Up||0
8097819|NCT03285295|19959221|P3|STARTED|Alinity s HTLV I/II Follow-Up||0
8097820|NCT03285295|19959222|P2|STARTED|Alinity s HTLV I/II Follow-Up||0
8097821|NCT03285295|19959223|P1|STARTED|Alinity s HTLV I/II Follow-Up||12
8097822|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s HTLV I/II||0
8097823|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s HTLV I/II||0
8097824|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s HTLV I/II||0
8097825|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s HTLV I/II||0
8097826|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s HTLV I/II||91
8097827|NCT03285295|19959219|P5|COMPLETED|Alinity s HTLV I/II||0
8097828|NCT03285295|19959220|P4|COMPLETED|Alinity s HTLV I/II||509
8097829|NCT03285295|19959221|P3|COMPLETED|Alinity s HTLV I/II||502
8097830|NCT03285295|19959222|P2|COMPLETED|Alinity s HTLV I/II||706
8097831|NCT03285295|19959223|P1|COMPLETED|Alinity s HTLV I/II||15877
8097832|NCT03285295|19959219|P5|STARTED|Alinity s HTLV I/II||0
8097833|NCT03285295|19959220|P4|STARTED|Alinity s HTLV I/II||509
8097834|NCT03285295|19959221|P3|STARTED|Alinity s HTLV I/II||502
8097835|NCT03285295|19959222|P2|STARTED|Alinity s HTLV I/II||706
8097836|NCT03285295|19959223|P1|STARTED|Alinity s HTLV I/II||15968
8097837|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
8097838|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
8097839|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
8097840|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
8097841|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
8097842|NCT03285295|19959219|P5|COMPLETED|Alinity s HBsAg Follow-Up||0
8097843|NCT03285295|19959220|P4|COMPLETED|Alinity s HBsAg Follow-Up||0
8097844|NCT03285295|19959221|P3|COMPLETED|Alinity s HBsAg Follow-Up||0
8097845|NCT03285295|19959222|P2|COMPLETED|Alinity s HBsAg Follow-Up||0
8097846|NCT03285295|19959223|P1|COMPLETED|Alinity s HBsAg Follow-Up||0
8097847|NCT03285295|19959219|P5|STARTED|Alinity s HBsAg Follow-Up||0
8097848|NCT03285295|19959220|P4|STARTED|Alinity s HBsAg Follow-Up||0
8097849|NCT03285295|19959221|P3|STARTED|Alinity s HBsAg Follow-Up||0
8097850|NCT03285295|19959222|P2|STARTED|Alinity s HBsAg Follow-Up||0
8097851|NCT03285295|19959223|P1|STARTED|Alinity s HBsAg Follow-Up||0
8097852|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
8097853|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
8097854|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
8097855|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
8097856|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
8097857|NCT03285295|19959219|P5|COMPLETED|Alinity s HBsAg Confirmatory||0
8097858|NCT03285295|19959220|P4|COMPLETED|Alinity s HBsAg Confirmatory||0
8097859|NCT03285295|19959221|P3|COMPLETED|Alinity s HBsAg Confirmatory||3
8097860|NCT03285295|19959222|P2|COMPLETED|Alinity s HBsAg Confirmatory||432
8097861|NCT03285295|19959223|P1|COMPLETED|Alinity s HBsAg Confirmatory||8
8097862|NCT03285295|19959219|P5|STARTED|Alinity s HBsAg Confirmatory||0
8097863|NCT03285295|19959220|P4|STARTED|Alinity s HBsAg Confirmatory||0
8097864|NCT03285295|19959221|P3|STARTED|Alinity s HBsAg Confirmatory||3
8097865|NCT03285295|19959222|P2|STARTED|Alinity s HBsAg Confirmatory||432
8097866|NCT03285295|19959223|P1|STARTED|Alinity s HBsAg Confirmatory||8
8097867|NCT03285295|19959219|P5|NOT COMPLETED|Alinity s HBsAg||0
8097868|NCT03285295|19959220|P4|NOT COMPLETED|Alinity s HBsAg||0
8097869|NCT03285295|19959221|P3|NOT COMPLETED|Alinity s HBsAg||0
8097870|NCT03285295|19959222|P2|NOT COMPLETED|Alinity s HBsAg||6
8097871|NCT03285295|19959223|P1|NOT COMPLETED|Alinity s HBsAg||102
8097872|NCT03285295|19959219|P5|COMPLETED|Alinity s HBsAg||51
8097873|NCT03285295|19959220|P4|COMPLETED|Alinity s HBsAg||0
8097874|NCT03285295|19959221|P3|COMPLETED|Alinity s HBsAg||403
8097875|NCT03285295|19959222|P2|COMPLETED|Alinity s HBsAg||432
8097876|NCT03285295|19959223|P1|COMPLETED|Alinity s HBsAg||16993
8097877|NCT03285295|19959219|P5|STARTED|Alinity s HBsAg||51
8097878|NCT03285295|19959220|P4|STARTED|Alinity s HBsAg||0
8097879|NCT03285295|19959221|P3|STARTED|Alinity s HBsAg||403
8097880|NCT03285295|19959222|P2|STARTED|Alinity s HBsAg||438
8097881|NCT03285295|19959223|P1|STARTED|Alinity s HBsAg||17095
8097882|NCT03285113|19959252|P1|NOT COMPLETED|Overall Study||2
8097883|NCT03285113|19959252|P1|COMPLETED|Overall Study||8
8097884|NCT03285113|19959252|P1|STARTED|Overall Study||10
8097885|NCT03285061|19959261|P2|NOT COMPLETED|Overall Study||2
8097886|NCT03285061|19959262|P1|NOT COMPLETED|Overall Study||1
8097887|NCT03285061|19959261|P2|COMPLETED|Overall Study||36
8097888|NCT03285061|19959262|P1|COMPLETED|Overall Study||36
8097889|NCT03285061|19959261|P2|STARTED|Overall Study||38
8097890|NCT03285061|19959262|P1|STARTED|Overall Study||37
8097891|NCT03284411|19959268|P1|NOT COMPLETED|Overall Study||0
8097892|NCT03284411|19959268|P1|COMPLETED|Overall Study||30
8097893|NCT03284411|19959268|P1|STARTED|Overall Study||30
8097894|NCT03284229|19959273|P1|NOT COMPLETED|Overall Study||3
8097895|NCT03284229|19959273|P1|COMPLETED|Overall Study||25
8097896|NCT03284229|19959273|P1|STARTED|Overall Study||28
8097906|NCT03283709|19959307|P2|NOT COMPLETED|Overall Study||1
8097907|NCT03283709|19959308|P1|NOT COMPLETED|Overall Study||0
8097908|NCT03283709|19959307|P2|COMPLETED|Overall Study||0
8097909|NCT03283709|19959308|P1|COMPLETED|Overall Study||0
8097910|NCT03283709|19959307|P2|STARTED|Overall Study||1
8097911|NCT03283709|19959308|P1|STARTED|Overall Study||0
8097912|NCT03283696|19959340|P2|NOT COMPLETED|Overall Study||6
8097913|NCT03283696|19959341|P1|NOT COMPLETED|Overall Study||7
8097914|NCT03283696|19959340|P2|COMPLETED|Overall Study||2
8097915|NCT03283696|19959341|P1|COMPLETED|Overall Study||9
8097916|NCT03283696|19959340|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8097917|NCT03283696|19959341|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
8097918|NCT03283696|19959340|P2|STARTED|Overall Study||8
8097919|NCT03283696|19959341|P1|STARTED|Overall Study||16
8097920|NCT03283436|19959369|P2|NOT COMPLETED|Overall Study||0
8097921|NCT03283436|19959370|P1|NOT COMPLETED|Overall Study||6
8097922|NCT03283436|19959369|P2|COMPLETED|Overall Study||50
8097923|NCT03283436|19959370|P1|COMPLETED|Overall Study||44
8097924|NCT03283436|19959369|P2|STARTED|Overall Study||50
8097925|NCT03283436|19959370|P1|STARTED|Overall Study||50
8097926|NCT03283319|19959386|P6|NOT COMPLETED|Overall Study||4
8097927|NCT03283319|19959387|P5|NOT COMPLETED|Overall Study||4
8097928|NCT03283319|19959388|P4|NOT COMPLETED|Overall Study||7
8097929|NCT03283319|19959389|P3|NOT COMPLETED|Overall Study||7
8097930|NCT03283319|19959390|P2|NOT COMPLETED|Overall Study||6
8097931|NCT03283319|19959391|P1|NOT COMPLETED|Overall Study||7
8097932|NCT03283319|19959386|P6|COMPLETED|Overall Study||57
8097933|NCT03283319|19959387|P5|COMPLETED|Overall Study||56
8097934|NCT03283319|19959388|P4|COMPLETED|Overall Study||54
8097935|NCT03283319|19959389|P3|COMPLETED|Overall Study||55
8097936|NCT03283319|19959390|P2|COMPLETED|Overall Study||54
8097937|NCT03283319|19959391|P1|COMPLETED|Overall Study||55
8097938|NCT03283319|19959386|P6|STARTED|Overall Study||61
8097939|NCT03283319|19959387|P5|STARTED|Overall Study||60
8097940|NCT03283319|19959388|P4|STARTED|Overall Study||61
8097941|NCT03283319|19959389|P3|STARTED|Overall Study||62
8097942|NCT03283319|19959390|P2|STARTED|Overall Study||60
8097943|NCT03283319|19959391|P1|STARTED|Overall Study||62
8097944|NCT03283098|19959533|P2|NOT COMPLETED|Overall Study||1
8097945|NCT03283098|19959534|P1|NOT COMPLETED|Overall Study||0
8097946|NCT03283098|19959533|P2|COMPLETED|Overall Study||24
8097947|NCT03283098|19959534|P1|COMPLETED|Overall Study||8
8097948|NCT03283098|19959533|P2|STARTED|Overall Study||25
8097949|NCT03283098|19959534|P1|STARTED|Overall Study||8
8097965|NCT03282240|19959654|P3|NOT COMPLETED|Overall Study||3
8097966|NCT03282240|19959655|P2|NOT COMPLETED|Overall Study||3
8097967|NCT03282240|19959656|P1|NOT COMPLETED|Overall Study||10
8097968|NCT03282240|19959654|P3|COMPLETED|Overall Study||447
8097969|NCT03282240|19959655|P2|COMPLETED|Overall Study||440
8097970|NCT03282240|19959656|P1|COMPLETED|Overall Study||1767
8097971|NCT03282240|19959654|P3|STARTED|Overall Study||450
8097972|NCT03282240|19959655|P2|STARTED|Overall Study||443
8097973|NCT03282240|19959656|P1|STARTED|Overall Study||1777
8097974|NCT03282227|19959708|P1|NOT COMPLETED|Overall Study||215
8097975|NCT03282227|19959708|P1|COMPLETED|Overall Study||127
8097976|NCT03282227|19959708|P1|Completed at Least 6 Months|Overall Study||257
8097977|NCT03282227|19959708|P1|STARTED|Overall Study||342
8097978|NCT03282071|19959720|P2|NOT COMPLETED|Overall Study||9
8097979|NCT03282071|19959721|P1|NOT COMPLETED|Overall Study||10
8097980|NCT03282071|19959720|P2|COMPLETED|Overall Study||60
8097981|NCT03282071|19959721|P1|COMPLETED|Overall Study||65
8097982|NCT03282071|19959720|P2|STARTED|Overall Study||69
8097983|NCT03282071|19959721|P1|STARTED|Overall Study||75
8097984|NCT03281876|19959744|P2|NOT COMPLETED|Overall Study||39
8097985|NCT03281876|19959745|P1|NOT COMPLETED|Overall Study||23
8097986|NCT03281876|19959744|P2|COMPLETED|Overall Study||263
8097987|NCT03281876|19959745|P1|COMPLETED|Overall Study||281
8097988|NCT03281876|19959744|P2|STARTED|Overall Study||302
8097989|NCT03281876|19959745|P1|STARTED|Overall Study||304
8097990|NCT03281668|19959815|P1|NOT COMPLETED|Overall Study||8
8097991|NCT03281668|19959815|P1|COMPLETED|Overall Study||21
8097992|NCT03281668|19959815|P1|STARTED|Overall Study||29
8097993|NCT03281577|19959843|P4|NOT COMPLETED|Overall Study||1
8097994|NCT03281577|19959844|P3|NOT COMPLETED|Overall Study||0
8097995|NCT03281577|19959845|P2|NOT COMPLETED|Overall Study||0
8097996|NCT03281577|19959846|P1|NOT COMPLETED|Overall Study||1
8097997|NCT03281577|19959843|P4|COMPLETED|Overall Study||6
8097998|NCT03281577|19959844|P3|COMPLETED|Overall Study||9
8097999|NCT03281577|19959845|P2|COMPLETED|Overall Study||10
8098000|NCT03281577|19959846|P1|COMPLETED|Overall Study||9
8098001|NCT03281577|19959843|P4|STARTED|Overall Study||7
8098002|NCT03281577|19959844|P3|STARTED|Overall Study||9
8098003|NCT03281577|19959845|P2|STARTED|Overall Study||10
8098004|NCT03281577|19959846|P1|STARTED|Overall Study||10
8098005|NCT03281200|19959877|P1|NOT COMPLETED|Overall Study||0
8098006|NCT03281200|19959877|P1|COMPLETED|Overall Study||172
8098007|NCT03281200|19959877|P1|STARTED|Overall Study||172
8098008|NCT03280615|19959901|P2|NOT COMPLETED|Overall Study||5
8098009|NCT03280615|19959902|P1|NOT COMPLETED|Overall Study||4
8098010|NCT03280615|19959901|P2|COMPLETED|Overall Study||45
8098011|NCT03280615|19959902|P1|COMPLETED|Overall Study||46
8098012|NCT03280615|19959901|P2|STARTED|Overall Study||50
8098013|NCT03280615|19959902|P1|STARTED|Overall Study||50
8098014|NCT03280550|19959914|P2|NOT COMPLETED|Overall Study||3
8098015|NCT03280550|19959915|P1|NOT COMPLETED|Overall Study||2
8098016|NCT03280550|19959914|P2|COMPLETED|Overall Study||69
8098017|NCT03280550|19959915|P1|COMPLETED|Overall Study||64
8098018|NCT03280550|19959914|P2|STARTED|Overall Study||72
8098019|NCT03280550|19959915|P1|STARTED|Overall Study||66
8098020|NCT03280537|19959967|P2|NOT COMPLETED|Overall Study||4
8098021|NCT03280537|19959968|P1|NOT COMPLETED|Overall Study||2
8098022|NCT03280537|19959967|P2|COMPLETED|Overall Study||58
8098023|NCT03280537|19959968|P1|COMPLETED|Overall Study||63
8098024|NCT03280537|19959967|P2|STARTED|Overall Study||62
8098025|NCT03280537|19959968|P1|STARTED|Overall Study||65
8098026|NCT03280381|19960020|P2|NOT COMPLETED|Overall Study||2
8098027|NCT03280381|19960021|P1|NOT COMPLETED|Overall Study||0
8098028|NCT03280381|19960020|P2|COMPLETED|Overall Study||97
8098029|NCT03280381|19960021|P1|COMPLETED|Overall Study||101
8098030|NCT03280381|19960020|P2|STARTED|Overall Study||99
8098031|NCT03280381|19960021|P1|STARTED|Overall Study||101
8098035|NCT03280108|19960037|P2|NOT COMPLETED|Overall Study||0
8098036|NCT03280108|19960038|P1|NOT COMPLETED|Overall Study||2
8098037|NCT03280108|19960037|P2|COMPLETED|Overall Study||114
8098038|NCT03280108|19960038|P1|COMPLETED|Overall Study||127
8098039|NCT03280108|19960037|P2|STARTED|Overall Study||114
8098040|NCT03280108|19960038|P1|STARTED|Overall Study||129
8098041|NCT03279731|19960071|P2|NOT COMPLETED|Overall Study||3
8098042|NCT03279731|19960072|P1|NOT COMPLETED|Overall Study||6
8098043|NCT03279731|19960071|P2|COMPLETED|Overall Study||14
8098044|NCT03279731|19960072|P1|COMPLETED|Overall Study||13
8098045|NCT03279731|19960071|P2|STARTED|Overall Study||17
8098046|NCT03279731|19960072|P1|STARTED|Overall Study||19
8098047|NCT03279458|19960084|P1|NOT COMPLETED|Overall Study||0
8098048|NCT03279458|19960084|P1|COMPLETED|Overall Study||40
8098049|NCT03279458|19960084|P1|STARTED|Overall Study||40
8098050|NCT03279237|19960090|P1|NOT COMPLETED|Overall Study||5
8098051|NCT03279237|19960090|P1|COMPLETED|Overall Study||20
8098052|NCT03279237|19960090|P1|Surgical Resection|Overall Study||20
8098053|NCT03279237|19960090|P1|Chemo-radiation|Overall Study||23
8098054|NCT03279237|19960090|P1|STARTED|Overall Study||25
8098055|NCT03278886|19960099|P2|NOT COMPLETED|Overall Study||1
8098056|NCT03278886|19960100|P1|NOT COMPLETED|Overall Study||0
8098057|NCT03278886|19960099|P2|COMPLETED|Overall Study||2
8098058|NCT03278886|19960100|P1|COMPLETED|Overall Study||8
8098059|NCT03278886|19960099|P2|STARTED|Overall Study||3
8098060|NCT03278886|19960100|P1|STARTED|Overall Study||8
8098061|NCT03278106|19960120|P1|NOT COMPLETED|Overall Study||1
8098062|NCT03278106|19960120|P1|COMPLETED|Overall Study||27
8098063|NCT03278106|19960120|P1|STARTED|Overall Study||28
8098064|NCT03278067|19960131|P3|NOT COMPLETED|Overall Study||0
8098065|NCT03278067|19960132|P2|NOT COMPLETED|Overall Study||0
8098066|NCT03278067|19960133|P1|NOT COMPLETED|Overall Study||0
8098067|NCT03278067|19960131|P3|COMPLETED|Overall Study||4196
8098068|NCT03278067|19960132|P2|COMPLETED|Overall Study||3310
8098069|NCT03278067|19960133|P1|COMPLETED|Overall Study||16433
8098070|NCT03278067|19960131|P3|STARTED|Overall Study||4196
8098071|NCT03278067|19960132|P2|STARTED|Overall Study||3310
8098072|NCT03278067|19960133|P1|STARTED|Overall Study||16433
8098073|NCT03278028|19960536|P2|NOT COMPLETED|Overall Study||2
8098074|NCT03278028|19960537|P1|NOT COMPLETED|Overall Study||4
8098075|NCT03278028|19960536|P2|COMPLETED|Overall Study||76
8098076|NCT03278028|19960537|P1|COMPLETED|Overall Study||77
8098077|NCT03278028|19960536|P2|STARTED|Overall Study||78
8098078|NCT03278028|19960537|P1|STARTED|Overall Study||81
8098079|NCT03277846|19960545|P2|NOT COMPLETED|Overall Study||11
8098080|NCT03277846|19960546|P1|NOT COMPLETED|Overall Study||12
8098081|NCT03277846|19960545|P2|COMPLETED|Overall Study||40
8098082|NCT03277846|19960546|P1|COMPLETED|Overall Study||38
8098083|NCT03277846|19960545|P2|STARTED|Overall Study||51
8098084|NCT03277846|19960546|P1|STARTED|Overall Study||50
8098085|NCT03277378|19960554|P2|NOT COMPLETED|Overall Study||34
8098086|NCT03277378|19960555|P1|NOT COMPLETED|Overall Study||24
8098087|NCT03277378|19960554|P2|COMPLETED|Overall Study||101
8098088|NCT03277378|19960555|P1|COMPLETED|Overall Study||111
8098089|NCT03277378|19960554|P2|Exit Study|Overall Study||8
8098090|NCT03277378|19960555|P1|Exit Study|Overall Study||11
8098091|NCT03277378|19960554|P2|Completed Extended Trial With Tonic Stim|Overall Study||12
8098092|NCT03277378|19960555|P1|Completed Extended Trial With Tonic Stim|Overall Study||8
8098093|NCT03277378|19960554|P2|Not Qualified for Permanent Implant|Overall Study||20
8098094|NCT03277378|19960555|P1|Not Qualified for Permanent Implant|Overall Study||19
8098095|NCT03277378|19960554|P2|Qualified for Permanent Implant|Overall Study||93
8098096|NCT03277378|19960555|P1|Qualified for Permanent Implant|Overall Study||103
8098097|NCT03277378|19960554|P2|Completed Initial Trial|Overall Study||122
8098098|NCT03277378|19960555|P1|Completed Initial Trial|Overall Study||126
8098099|NCT03277378|19960554|P2|Received Lead Implant|Overall Study||123
8098100|NCT03277378|19960555|P1|Received Lead Implant|Overall Study||129
8098101|NCT03277378|19960554|P2|STARTED|Overall Study||135
8098102|NCT03277378|19960555|P1|STARTED|Overall Study||135
8098103|NCT03277274|19960606|P3|NOT COMPLETED|Overall Study||0
8098104|NCT03277274|19960607|P2|NOT COMPLETED|Overall Study||0
8098105|NCT03277274|19960608|P1|NOT COMPLETED|Overall Study||0
8098106|NCT03277274|19960606|P3|COMPLETED|Overall Study||7
8098107|NCT03277274|19960607|P2|COMPLETED|Overall Study||10
8098108|NCT03277274|19960608|P1|COMPLETED|Overall Study||8
8098109|NCT03277274|19960606|P3|STARTED|Overall Study||7
8098110|NCT03277274|19960607|P2|STARTED|Overall Study||10
8098111|NCT03277274|19960608|P1|STARTED|Overall Study||8
8098112|NCT03277183|19960639|P2|NOT COMPLETED|Overall Study||2
8098113|NCT03277183|19960640|P1|NOT COMPLETED|Overall Study||3
8098114|NCT03277183|19960639|P2|COMPLETED|Overall Study||0
8098115|NCT03277183|19960640|P1|COMPLETED|Overall Study||0
8098116|NCT03277183|19960639|P2|STARTED|Overall Study||2
8098117|NCT03277183|19960640|P1|STARTED|Overall Study||3
8098126|NCT03276936|19960687|P2|NOT COMPLETED|Overall Study||38
8098127|NCT03276936|19960688|P1|NOT COMPLETED|Overall Study||56
8098128|NCT03276936|19960687|P2|COMPLETED|Overall Study||134
8098129|NCT03276936|19960688|P1|COMPLETED|Overall Study||276
8098130|NCT03276936|19960687|P2|STARTED|Overall Study||172
8098131|NCT03276936|19960688|P1|STARTED|Overall Study||332
8098132|NCT03276871|19960708|P2|NOT COMPLETED|Overall Study||0
8098133|NCT03276871|19960709|P1|NOT COMPLETED|Overall Study||0
8098134|NCT03276871|19960708|P2|COMPLETED|Overall Study||19
8098135|NCT03276871|19960709|P1|COMPLETED|Overall Study||21
8098136|NCT03276871|19960708|P2|STARTED|Overall Study||19
8098137|NCT03276871|19960709|P1|STARTED|Overall Study||21
8098138|NCT03276494|19960721|P1|NOT COMPLETED|Overall Study||1
8098139|NCT03276494|19960721|P1|COMPLETED|Overall Study||5
8098140|NCT03276494|19960721|P1|STARTED|Overall Study||6
8098141|NCT03276078|19960726|P1|NOT COMPLETED|Overall Study||1
8098142|NCT03276078|19960726|P1|COMPLETED|Overall Study||19
8098143|NCT03276078|19960726|P1|STARTED|Overall Study||20
8098144|NCT03276026|19960755|P2|NOT COMPLETED|Overall Study||0
8098145|NCT03276026|19960756|P1|NOT COMPLETED|Overall Study||1
8098146|NCT03276026|19960755|P2|COMPLETED|Overall Study||33
8098147|NCT03276026|19960756|P1|COMPLETED|Overall Study||34
8098148|NCT03276026|19960755|P2|STARTED|Overall Study||33
8098149|NCT03276026|19960756|P1|STARTED|Overall Study||35
8098150|NCT03275870|19960766|P1|NOT COMPLETED|Overall Study||14
8098151|NCT03275870|19960766|P1|COMPLETED|Overall Study||3
8098152|NCT03275870|19960766|P1|STARTED|Overall Study||17
8098153|NCT03275623|19960773|P2|NOT COMPLETED|Overall Study||2
8098154|NCT03275623|19960774|P1|NOT COMPLETED|Overall Study||5
8098155|NCT03275623|19960773|P2|COMPLETED|Overall Study||28
8098156|NCT03275623|19960774|P1|COMPLETED|Overall Study||25
8098157|NCT03275623|19960773|P2|STARTED|Overall Study||30
8098158|NCT03275623|19960774|P1|STARTED|Overall Study||30
8098159|NCT03274986|19960784|P2|NOT COMPLETED|Overall Study||2
8098160|NCT03274986|19960785|P1|NOT COMPLETED|Overall Study||0
8098161|NCT03274986|19960784|P2|COMPLETED|Overall Study||111
8098162|NCT03274986|19960785|P1|COMPLETED|Overall Study||107
8098163|NCT03274986|19960784|P2|Successful Implantation, as Treated|Overall Study||113
8098164|NCT03274986|19960785|P1|Successful Implantation, as Treated|Overall Study||107
8098165|NCT03274986|19960784|P2|STARTED|Overall Study||113
8098166|NCT03274986|19960785|P1|STARTED|Overall Study||107
8098167|NCT03274856|19960818|P2|NOT COMPLETED|Overall Study||0
8098168|NCT03274856|19960819|P1|NOT COMPLETED|Overall Study||0
8098169|NCT03274856|19960818|P2|COMPLETED|Overall Study||9
8098170|NCT03274856|19960819|P1|COMPLETED|Overall Study||10
8098171|NCT03274856|19960818|P2|STARTED|Overall Study||9
8098172|NCT03274856|19960819|P1|STARTED|Overall Study||10
8098173|NCT03274518|19960835|P2|NOT COMPLETED|Second Intervention||0
8098174|NCT03274518|19960836|P1|NOT COMPLETED|Second Intervention||0
8098175|NCT03274518|19960835|P2|COMPLETED|Second Intervention||8
8098176|NCT03274518|19960836|P1|COMPLETED|Second Intervention||8
8098177|NCT03274518|19960835|P2|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8
8098178|NCT03274518|19960836|P1|STARTED|Second Intervention||8
8098179|NCT03274518|19960835|P2|NOT COMPLETED|Washout Period||0
8098180|NCT03274518|19960836|P1|NOT COMPLETED|Washout Period||0
8098181|NCT03274518|19960835|P2|COMPLETED|Washout Period||8
8098182|NCT03274518|19960836|P1|COMPLETED|Washout Period||8
8098183|NCT03274518|19960835|P2|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8
8098184|NCT03274518|19960836|P1|STARTED|Washout Period||8
8098185|NCT03274518|19960835|P2|NOT COMPLETED|First Intervention||0
8098186|NCT03274518|19960836|P1|NOT COMPLETED|First Intervention||0
8098187|NCT03274518|19960835|P2|COMPLETED|First Intervention||8
8098188|NCT03274518|19960836|P1|COMPLETED|First Intervention||8
8098189|NCT03274518|19960835|P2|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8
8098190|NCT03274518|19960836|P1|STARTED|First Intervention||8
8098191|NCT03274453|19960852|P4|NOT COMPLETED|Overall Study||4
8098192|NCT03274453|19960853|P3|NOT COMPLETED|Overall Study||4
8098193|NCT03274453|19960854|P2|NOT COMPLETED|Overall Study||6
8098194|NCT03274453|19960855|P1|NOT COMPLETED|Overall Study||4
8098195|NCT03274453|19960852|P4|COMPLETED|Overall Study||25
8098196|NCT03274453|19960853|P3|COMPLETED|Overall Study||28
8098197|NCT03274453|19960854|P2|COMPLETED|Overall Study||24
8098198|NCT03274453|19960855|P1|COMPLETED|Overall Study||34
8098199|NCT03274453|19960852|P4|STARTED|Overall Study||29
8098200|NCT03274453|19960853|P3|STARTED|Overall Study||32
8098201|NCT03274453|19960854|P2|STARTED|Overall Study||30
8098202|NCT03274453|19960855|P1|STARTED|Overall Study||38
8098203|NCT03274440|19960865|P6|NOT COMPLETED|Overall Study||0
8098204|NCT03274440|19960866|P5|NOT COMPLETED|Overall Study||0
8098205|NCT03274440|19960867|P4|NOT COMPLETED|Overall Study||1
8098206|NCT03274440|19960868|P3|NOT COMPLETED|Overall Study||0
8098207|NCT03274440|19960869|P2|NOT COMPLETED|Overall Study||0
8098208|NCT03274440|19960870|P1|NOT COMPLETED|Overall Study||1
8098209|NCT03274440|19960865|P6|COMPLETED|Overall Study||3
8098210|NCT03274440|19960866|P5|COMPLETED|Overall Study||1
8098211|NCT03274440|19960867|P4|COMPLETED|Overall Study||0
8098212|NCT03274440|19960868|P3|COMPLETED|Overall Study||4
8098213|NCT03274440|19960869|P2|COMPLETED|Overall Study||2
8098214|NCT03274440|19960870|P1|COMPLETED|Overall Study||2
8098215|NCT03274440|19960865|P6|STARTED|Overall Study||3
8098216|NCT03274440|19960866|P5|STARTED|Overall Study||1
8098217|NCT03274440|19960867|P4|STARTED|Overall Study||1
8098218|NCT03274440|19960868|P3|STARTED|Overall Study||4
8098219|NCT03274440|19960869|P2|STARTED|Overall Study||2
8098220|NCT03274440|19960870|P1|STARTED|Overall Study||3
8098221|NCT03274076|19960883|P4|NOT COMPLETED|24 Weeks Open Label||1
8098222|NCT03274076|19960884|P3|NOT COMPLETED|24 Weeks Open Label||2
8098223|NCT03274076|19960885|P2|NOT COMPLETED|24 Weeks Open Label||0
8098224|NCT03274076|19960886|P1|NOT COMPLETED|24 Weeks Open Label||0
8098225|NCT03274076|19960883|P4|COMPLETED|24 Weeks Open Label||3
8098226|NCT03274076|19960884|P3|COMPLETED|24 Weeks Open Label||8
8098227|NCT03274076|19960885|P2|COMPLETED|24 Weeks Open Label||0
8098228|NCT03274076|19960886|P1|COMPLETED|24 Weeks Open Label||0
8098229|NCT03274076|19960883|P4|STARTED|24 Weeks Open Label||4
8098230|NCT03274076|19960884|P3|STARTED|24 Weeks Open Label||10
8098231|NCT03274076|19960885|P2|STARTED|24 Weeks Open Label||0
8098232|NCT03274076|19960886|P1|STARTED|24 Weeks Open Label||0
8098233|NCT03274076|19960883|P4|NOT COMPLETED|24 Weeks Double Blind||0
8098234|NCT03274076|19960884|P3|NOT COMPLETED|24 Weeks Double Blind||0
8098235|NCT03274076|19960885|P2|NOT COMPLETED|24 Weeks Double Blind||1
8098236|NCT03274076|19960886|P1|NOT COMPLETED|24 Weeks Double Blind||0
8098237|NCT03274076|19960883|P4|COMPLETED|24 Weeks Double Blind||0
8098238|NCT03274076|19960884|P3|COMPLETED|24 Weeks Double Blind||0
8098239|NCT03274076|19960885|P2|COMPLETED|24 Weeks Double Blind||4
8098240|NCT03274076|19960886|P1|COMPLETED|24 Weeks Double Blind||10
8098241|NCT03274076|19960883|P4|STARTED|24 Weeks Double Blind||0
8098242|NCT03274076|19960884|P3|STARTED|24 Weeks Double Blind||0
8098243|NCT03274076|19960885|P2|STARTED|24 Weeks Double Blind||5
8098244|NCT03274076|19960886|P1|STARTED|24 Weeks Double Blind||10
8098245|NCT03273946|19960914|P1|NOT COMPLETED|Overall Study||9
8098246|NCT03273946|19960914|P1|COMPLETED|Overall Study||149
8098247|NCT03273946|19960914|P1|STARTED|Overall Study||158
8098248|NCT03273673|19960922|P2|NOT COMPLETED|Overall Study||0
8098249|NCT03273673|19960923|P1|NOT COMPLETED|Overall Study||4
8098250|NCT03273673|19960922|P2|COMPLETED|Overall Study||22
8098251|NCT03273673|19960923|P1|COMPLETED|Overall Study||14
8098252|NCT03273673|19960922|P2|STARTED|Overall Study||22
8098253|NCT03273673|19960923|P1|STARTED|Overall Study||18
8098254|NCT03273543|19960941|P2|NOT COMPLETED|Overall Study||0
8098255|NCT03273543|19960942|P1|NOT COMPLETED|Overall Study||0
8098256|NCT03273543|19960941|P2|COMPLETED|Overall Study||10
8098257|NCT03273543|19960942|P1|COMPLETED|Overall Study||10
8098258|NCT03273543|19960941|P2|STARTED|Overall Study||10
8098259|NCT03273543|19960942|P1|STARTED|Overall Study||10
8098260|NCT03273426|19960950|P2|NOT COMPLETED|Overall Study||0
8098261|NCT03273426|19960951|P1|NOT COMPLETED|Overall Study||0
8098262|NCT03273426|19960950|P2|COMPLETED|Overall Study||20
8098263|NCT03273426|19960951|P1|COMPLETED|Overall Study||20
8098264|NCT03273426|19960950|P2|STARTED|Overall Study||20
8098265|NCT03273426|19960951|P1|STARTED|Overall Study||20
8098266|NCT03273387|19960962|P2|NOT COMPLETED|Overall Study||3
8098267|NCT03273387|19960963|P1|NOT COMPLETED|Overall Study||3
8098268|NCT03273387|19960962|P2|COMPLETED|Overall Study||10
8098269|NCT03273387|19960963|P1|COMPLETED|Overall Study||10
8098270|NCT03273387|19960962|P2|STARTED|Overall Study||13
8098271|NCT03273387|19960963|P1|STARTED|Overall Study||13
8098272|NCT03273283|19960975|P2|NOT COMPLETED|Overall Study||20
8098273|NCT03273283|19960976|P1|NOT COMPLETED|Overall Study||27
8098274|NCT03273283|19960975|P2|COMPLETED|Overall Study||81
8098275|NCT03273283|19960976|P1|COMPLETED|Overall Study||72
8098276|NCT03273283|19960975|P2|STARTED|Overall Study||101
8098277|NCT03273283|19960976|P1|STARTED|Overall Study||99
8098278|NCT03273166|19960984|P1|NOT COMPLETED|Overall Study||31
8098279|NCT03273166|19960984|P1|COMPLETED|Overall Study||51
8098280|NCT03273166|19960984|P1|STARTED|Overall Study||82
8098287|NCT03272711|19961014|P2|NOT COMPLETED|Overall Study||8
8098288|NCT03272711|19961015|P1|NOT COMPLETED|Overall Study||7
8098289|NCT03272711|19961014|P2|COMPLETED|Overall Study||41
8098290|NCT03272711|19961015|P1|COMPLETED|Overall Study||44
8098291|NCT03272711|19961014|P2|STARTED|Overall Study||49
8098292|NCT03272711|19961015|P1|STARTED|Overall Study||51
8098293|NCT03272139|19961027|P2|NOT COMPLETED|Overall Study||0
8098294|NCT03272139|19961028|P1|NOT COMPLETED|Overall Study||0
8098295|NCT03272139|19961027|P2|COMPLETED|Overall Study||63
8098296|NCT03272139|19961028|P1|COMPLETED|Overall Study||63
8098297|NCT03272139|19961027|P2|STARTED|Overall Study||63
8098298|NCT03272139|19961028|P1|STARTED|Overall Study||63
8098299|NCT03271424|19961041|P3|NOT COMPLETED|April-May 2016||0
8098300|NCT03271424|19961042|P2|NOT COMPLETED|April-May 2016||0
8098301|NCT03271424|19961043|P1|NOT COMPLETED|April-May 2016||0
8098302|NCT03271424|19961041|P3|COMPLETED|April-May 2016||40
8098303|NCT03271424|19961042|P2|COMPLETED|April-May 2016||0
8098304|NCT03271424|19961043|P1|COMPLETED|April-May 2016||0
8098305|NCT03271424|19961041|P3|STARTED|April-May 2016||40
8098306|NCT03271424|19961042|P2|STARTED|April-May 2016||0
8098307|NCT03271424|19961043|P1|STARTED|April-May 2016||0
8098308|NCT03271424|19961041|P3|NOT COMPLETED|December 2015||0
8098309|NCT03271424|19961042|P2|NOT COMPLETED|December 2015||0
8098310|NCT03271424|19961043|P1|NOT COMPLETED|December 2015||0
8098311|NCT03271424|19961041|P3|COMPLETED|December 2015||0
8098312|NCT03271424|19961042|P2|COMPLETED|December 2015||35
8098313|NCT03271424|19961043|P1|COMPLETED|December 2015||0
8098314|NCT03271424|19961041|P3|STARTED|December 2015||0
8098315|NCT03271424|19961042|P2|STARTED|December 2015||35
8098316|NCT03271424|19961043|P1|STARTED|December 2015||0
8098317|NCT03271424|19961041|P3|NOT COMPLETED|November 2015||0
8098318|NCT03271424|19961042|P2|NOT COMPLETED|November 2015||0
8098319|NCT03271424|19961043|P1|NOT COMPLETED|November 2015||0
8098320|NCT03271424|19961041|P3|COMPLETED|November 2015||0
8098321|NCT03271424|19961042|P2|COMPLETED|November 2015||0
8098322|NCT03271424|19961043|P1|COMPLETED|November 2015||20
8098323|NCT03271424|19961041|P3|STARTED|November 2015||0
8098324|NCT03271424|19961042|P2|STARTED|November 2015||0
8098325|NCT03271424|19961043|P1|STARTED|November 2015||20
8098326|NCT03271307|19961058|P5|NOT COMPLETED|Overall Study||91
8098327|NCT03271307|19961059|P4|NOT COMPLETED|Overall Study||28
8098328|NCT03271307|19961060|P3|NOT COMPLETED|Overall Study||0
8098329|NCT03271307|19961061|P2|NOT COMPLETED|Overall Study||0
8098330|NCT03271307|19961062|P1|NOT COMPLETED|Overall Study||0
8098331|NCT03271307|19961058|P5|COMPLETED|Overall Study||258
8098332|NCT03271307|19961059|P4|COMPLETED|Overall Study||107
8098333|NCT03271307|19961060|P3|COMPLETED|Overall Study||2097
8098334|NCT03271307|19961061|P2|COMPLETED|Overall Study||1837
8098335|NCT03271307|19961062|P1|COMPLETED|Overall Study||1951
8098336|NCT03271307|19961058|P5|STARTED|Overall Study||349
8098337|NCT03271307|19961059|P4|STARTED|Overall Study||135
8098338|NCT03271307|19961060|P3|STARTED|Overall Study||2097
8098339|NCT03271307|19961061|P2|STARTED|Overall Study||1837
8098340|NCT03271307|19961062|P1|STARTED|Overall Study||1951
8098341|NCT03271021|19961118|P2|NOT COMPLETED|Overall Study||106
8098342|NCT03271021|19961119|P1|NOT COMPLETED|Overall Study||89
8098343|NCT03271021|19961118|P2|COMPLETED|Overall Study||644
8098344|NCT03271021|19961119|P1|COMPLETED|Overall Study||649
8098345|NCT03271021|19961118|P2|STARTED|Overall Study||750
8098346|NCT03271021|19961119|P1|STARTED|Overall Study||738
8098347|NCT03270657|19961137|P1|NOT COMPLETED|Overall Study||1
8098348|NCT03270657|19961137|P1|COMPLETED|Overall Study||4
8098349|NCT03270657|19961137|P1|STARTED|Overall Study||5
8098350|NCT03270644|19961143|P1|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1
8098351|NCT03270644|19961143|P1|COMPLETED|Day 4 - 10 Propranolol Reference||42
8098352|NCT03270644|19961143|P1|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42
8098353|NCT03270644|19961143|P1|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43
8098354|NCT03270644|19961143|P1|STARTED|Day 4 - 10 Propranolol Reference||43
8098355|NCT03270644|19961143|P1|NOT COMPLETED|Day 1 Lasmiditan Reference||1
8098356|NCT03270644|19961143|P1|COMPLETED|Day 1 Lasmiditan Reference||43
8098357|NCT03270644|19961143|P1|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44
8098358|NCT03270644|19961143|P1|STARTED|Day 1 Lasmiditan Reference||44
8098359|NCT03270436|19961166|P2|NOT COMPLETED|6 Months Post-Intervention||51
8098360|NCT03270436|19961167|P1|NOT COMPLETED|6 Months Post-Intervention||40
8098361|NCT03270436|19961166|P2|COMPLETED|6 Months Post-Intervention||116
8098362|NCT03270436|19961167|P1|COMPLETED|6 Months Post-Intervention||173
8098363|NCT03270436|19961166|P2|STARTED|6 Months Post-Intervention||167
8098364|NCT03270436|19961167|P1|STARTED|6 Months Post-Intervention||213
8098365|NCT03270436|19961166|P2|NOT COMPLETED|Immediate Post-Intervention||56
8098366|NCT03270436|19961167|P1|NOT COMPLETED|Immediate Post-Intervention||41
8098367|NCT03270436|19961166|P2|COMPLETED|Immediate Post-Intervention||111
8098368|NCT03270436|19961167|P1|COMPLETED|Immediate Post-Intervention||172
8098369|NCT03270436|19961166|P2|STARTED|Immediate Post-Intervention||167
8098370|NCT03270436|19961167|P1|STARTED|Immediate Post-Intervention||213
8098371|NCT03270436|19961166|P2|NOT COMPLETED|Baseline||1
8098372|NCT03270436|19961167|P1|NOT COMPLETED|Baseline||1
8098373|NCT03270436|19961166|P2|COMPLETED|Baseline||166
8098374|NCT03270436|19961167|P1|COMPLETED|Baseline||212
8098375|NCT03270436|19961166|P2|STARTED|Baseline||167
8098376|NCT03270436|19961167|P1|STARTED|Baseline||213
8098377|NCT03270085|19961193|P2|NOT COMPLETED|Overall Study||0
8098378|NCT03270085|19961194|P1|NOT COMPLETED|Overall Study||1
8098379|NCT03270085|19961193|P2|COMPLETED|Overall Study||15
8098380|NCT03270085|19961194|P1|COMPLETED|Overall Study||14
8098381|NCT03270085|19961193|P2|STARTED|Overall Study||15
8098382|NCT03270085|19961194|P1|STARTED|Overall Study||15
8098383|NCT03269968|19961206|P2|NOT COMPLETED|Overall Study||0
8098384|NCT03269968|19961207|P1|NOT COMPLETED|Overall Study||0
8098385|NCT03269968|19961206|P2|COMPLETED|Overall Study||0
8098386|NCT03269968|19961207|P1|COMPLETED|Overall Study||0
8098387|NCT03269968|19961206|P2|STARTED|Overall Study||0
8098388|NCT03269968|19961207|P1|STARTED|Overall Study||0
8098389|NCT03269552|19961215|P1|NOT COMPLETED|Overall Study||2
8098390|NCT03269552|19961215|P1|COMPLETED|Overall Study||2
8098391|NCT03269552|19961215|P1|STARTED|Overall Study||4
8098392|NCT03268941|19961226|P7|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098393|NCT03268941|19961227|P6|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098394|NCT03268941|19961228|P5|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098395|NCT03268941|19961229|P4|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098396|NCT03268941|19961230|P3|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098397|NCT03268941|19961231|P2|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098398|NCT03268941|19961232|P1|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098399|NCT03268941|19961226|P7|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098400|NCT03268941|19961227|P6|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6
8098401|NCT03268941|19961228|P5|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098402|NCT03268941|19961229|P4|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098403|NCT03268941|19961230|P3|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098404|NCT03268941|19961231|P2|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098405|NCT03268941|19961232|P1|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
8098406|NCT03268941|19961226|P7|STARTED|Part 2: Period 2: Fasted (Day 25)||0
8098407|NCT03268941|19961227|P6|STARTED|Part 2: Period 2: Fasted (Day 25)||6
8098408|NCT03268941|19961228|P5|STARTED|Part 2: Period 2: Fasted (Day 25)||0
8098409|NCT03268941|19961229|P4|STARTED|Part 2: Period 2: Fasted (Day 25)||0
8098410|NCT03268941|19961230|P3|STARTED|Part 2: Period 2: Fasted (Day 25)||0
8098411|NCT03268941|19961231|P2|STARTED|Part 2: Period 2: Fasted (Day 25)||0
8098412|NCT03268941|19961232|P1|STARTED|Part 2: Period 2: Fasted (Day 25)||0
8098413|NCT03268941|19961226|P7|NOT COMPLETED|Part 2: Days 17 to 25||2
8098414|NCT03268941|19961227|P6|NOT COMPLETED|Part 2: Days 17 to 25||0
8098415|NCT03268941|19961228|P5|NOT COMPLETED|Part 2: Days 17 to 25||0
8098416|NCT03268941|19961229|P4|NOT COMPLETED|Part 2: Days 17 to 25||0
8098417|NCT03268941|19961230|P3|NOT COMPLETED|Part 2: Days 17 to 25||0
8098418|NCT03268941|19961231|P2|NOT COMPLETED|Part 2: Days 17 to 25||0
8098419|NCT03268941|19961232|P1|NOT COMPLETED|Part 2: Days 17 to 25||0
8098420|NCT03268941|19961226|P7|COMPLETED|Part 2: Days 17 to 25||13
8098421|NCT03268941|19961227|P6|COMPLETED|Part 2: Days 17 to 25||0
8098422|NCT03268941|19961228|P5|COMPLETED|Part 2: Days 17 to 25||6
8098423|NCT03268941|19961229|P4|COMPLETED|Part 2: Days 17 to 25||0
8098424|NCT03268941|19961230|P3|COMPLETED|Part 2: Days 17 to 25||0
8098425|NCT03268941|19961231|P2|COMPLETED|Part 2: Days 17 to 25||0
8098426|NCT03268941|19961232|P1|COMPLETED|Part 2: Days 17 to 25||0
8098427|NCT03268941|19961226|P7|Treated|Part 2: Days 17 to 25||13
8098428|NCT03268941|19961227|P6|Treated|Part 2: Days 17 to 25||0
8098429|NCT03268941|19961228|P5|Treated|Part 2: Days 17 to 25||6
8098430|NCT03268941|19961229|P4|Treated|Part 2: Days 17 to 25||0
8098431|NCT03268941|19961230|P3|Treated|Part 2: Days 17 to 25||0
8098432|NCT03268941|19961231|P2|Treated|Part 2: Days 17 to 25||0
8098433|NCT03268941|19961232|P1|Treated|Part 2: Days 17 to 25||0
8098434|NCT03268941|19961226|P7|STARTED|Part 2: Days 17 to 25||15
8098435|NCT03268941|19961227|P6|STARTED|Part 2: Days 17 to 25||0
8098436|NCT03268941|19961228|P5|STARTED|Part 2: Days 17 to 25||6
8098437|NCT03268941|19961229|P4|STARTED|Part 2: Days 17 to 25||0
8098438|NCT03268941|19961230|P3|STARTED|Part 2: Days 17 to 25||0
8098439|NCT03268941|19961231|P2|STARTED|Part 2: Days 17 to 25||0
8098440|NCT03268941|19961232|P1|STARTED|Part 2: Days 17 to 25||0
8098441|NCT03268941|19961226|P7|NOT COMPLETED|Part 1 (Days 1 to 9)||0
8098442|NCT03268941|19961227|P6|NOT COMPLETED|Part 1 (Days 1 to 9)||0
8098443|NCT03268941|19961228|P5|NOT COMPLETED|Part 1 (Days 1 to 9)||0
8098444|NCT03268941|19961229|P4|NOT COMPLETED|Part 1 (Days 1 to 9)||2
8098445|NCT03268941|19961230|P3|NOT COMPLETED|Part 1 (Days 1 to 9)||0
8098446|NCT03268941|19961231|P2|NOT COMPLETED|Part 1 (Days 1 to 9)||0
8098447|NCT03268941|19961232|P1|NOT COMPLETED|Part 1 (Days 1 to 9)||1
8098448|NCT03268941|19961226|P7|COMPLETED|Part 1 (Days 1 to 9)||0
8098449|NCT03268941|19961227|P6|COMPLETED|Part 1 (Days 1 to 9)||0
8098450|NCT03268941|19961228|P5|COMPLETED|Part 1 (Days 1 to 9)||0
8098451|NCT03268941|19961229|P4|COMPLETED|Part 1 (Days 1 to 9)||11
8098452|NCT03268941|19961230|P3|COMPLETED|Part 1 (Days 1 to 9)||12
8098453|NCT03268941|19961231|P2|COMPLETED|Part 1 (Days 1 to 9)||14
8098454|NCT03268941|19961232|P1|COMPLETED|Part 1 (Days 1 to 9)||11
8098455|NCT03268941|19961226|P7|STARTED|Part 1 (Days 1 to 9)||0
8098456|NCT03268941|19961227|P6|STARTED|Part 1 (Days 1 to 9)||0
8098457|NCT03268941|19961228|P5|STARTED|Part 1 (Days 1 to 9)||0
8098458|NCT03268941|19961229|P4|STARTED|Part 1 (Days 1 to 9)||13
8098459|NCT03268941|19961230|P3|STARTED|Part 1 (Days 1 to 9)||12
8098460|NCT03268941|19961231|P2|STARTED|Part 1 (Days 1 to 9)||14
8098461|NCT03268941|19961232|P1|STARTED|Part 1 (Days 1 to 9)||12
8098462|NCT03268746|19961294|P1|NOT COMPLETED|Overall Study||1
8098463|NCT03268746|19961294|P1|COMPLETED|Overall Study||44
8098464|NCT03268746|19961294|P1|STARTED|Overall Study||45
8098465|NCT03268590|19961316|P1|NOT COMPLETED|Overall Study||1
8098466|NCT03268590|19961316|P1|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32
8098467|NCT03268590|19961316|P1|STARTED|Overall Study||33
8098468|NCT03268343|19961323|P2|NOT COMPLETED|Overall Study||0
8098469|NCT03268343|19961324|P1|NOT COMPLETED|Overall Study||0
8098470|NCT03268343|19961323|P2|COMPLETED|Overall Study||12
8098471|NCT03268343|19961324|P1|COMPLETED|Overall Study||12
8098472|NCT03268343|19961323|P2|STARTED|Overall Study||12
8098473|NCT03268343|19961324|P1|STARTED|Overall Study||12
8098474|NCT03268005|19961351|P2|NOT COMPLETED|Overall Study||14
8098475|NCT03268005|19961352|P1|NOT COMPLETED|Overall Study||15
8098476|NCT03268005|19961351|P2|COMPLETED|Overall Study||531
8098477|NCT03268005|19961352|P1|COMPLETED|Overall Study||531
8098478|NCT03268005|19961351|P2|Safety Analysis Set|Overall Study||544
8098479|NCT03268005|19961352|P1|Safety Analysis Set|Overall Study||544
8098480|NCT03268005|19961351|P2|Full Analysis Set|Overall Study||545
8098481|NCT03268005|19961352|P1|Full Analysis Set|Overall Study||546
8098482|NCT03268005|19961351|P2|STARTED|Overall Study||545
8098483|NCT03268005|19961352|P1|STARTED|Overall Study||546
8098484|NCT03267940|19961466|P6|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
8098485|NCT03267940|19961467|P5|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
8098486|NCT03267940|19961468|P4|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22
8098487|NCT03267940|19961469|P3|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21
8098488|NCT03267940|19961470|P2|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
8098489|NCT03267940|19961471|P1|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
8098490|NCT03267940|19961466|P6|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
8098491|NCT03267940|19961467|P5|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1
8098492|NCT03267940|19961468|P4|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
8098493|NCT03267940|19961469|P3|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3
8098494|NCT03267940|19961470|P2|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
8098495|NCT03267940|19961471|P1|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
8098496|NCT03267940|19961466|P6|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10
8098497|NCT03267940|19961467|P5|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11
8098498|NCT03267940|19961468|P4|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22
8098499|NCT03267940|19961469|P3|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24
8098500|NCT03267940|19961470|P2|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
8098501|NCT03267940|19961471|P1|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
8098502|NCT03267940|19961466|P6|STARTED|Expansion (Maximum Exposure: 421 Days)||10
8098503|NCT03267940|19961467|P5|STARTED|Expansion (Maximum Exposure: 421 Days)||11
8098504|NCT03267940|19961468|P4|STARTED|Expansion (Maximum Exposure: 421 Days)||22
8098505|NCT03267940|19961469|P3|STARTED|Expansion (Maximum Exposure: 421 Days)||24
8098506|NCT03267940|19961470|P2|STARTED|Expansion (Maximum Exposure: 421 Days)||0
8098507|NCT03267940|19961471|P1|STARTED|Expansion (Maximum Exposure: 421 Days)||0
8098508|NCT03267940|19961466|P6|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098509|NCT03267940|19961467|P5|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098510|NCT03267940|19961468|P4|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098511|NCT03267940|19961469|P3|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098512|NCT03267940|19961470|P2|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7
8098513|NCT03267940|19961471|P1|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8
8098514|NCT03267940|19961466|P6|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098515|NCT03267940|19961467|P5|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098516|NCT03267940|19961468|P4|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098517|NCT03267940|19961469|P3|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
8098518|NCT03267940|19961470|P2|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2
8098519|NCT03267940|19961471|P1|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1
8098520|NCT03267940|19961466|P6|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
8098521|NCT03267940|19961467|P5|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
8098522|NCT03267940|19961468|P4|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
8098523|NCT03267940|19961469|P3|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
8098524|NCT03267940|19961470|P2|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
8098525|NCT03267940|19961471|P1|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
8098526|NCT03267940|19961466|P6|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
8098527|NCT03267940|19961467|P5|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
8098528|NCT03267940|19961468|P4|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
8098529|NCT03267940|19961469|P3|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
8098530|NCT03267940|19961470|P2|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
8098531|NCT03267940|19961471|P1|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
8098532|NCT03267576|19961573|P2|NOT COMPLETED|Period 2: Day 44 to 71||2
8098533|NCT03267576|19961574|P1|NOT COMPLETED|Period 2: Day 44 to 71||1
8098534|NCT03267576|19961573|P2|COMPLETED|Period 2: Day 44 to 71||30
8098535|NCT03267576|19961574|P1|COMPLETED|Period 2: Day 44 to 71||30
8098536|NCT03267576|19961573|P2|STARTED|Period 2: Day 44 to 71||32
8098537|NCT03267576|19961574|P1|STARTED|Period 2: Day 44 to 71||31
8098538|NCT03267576|19961573|P2|NOT COMPLETED|Washout Period: 16 Days||0
8098539|NCT03267576|19961574|P1|NOT COMPLETED|Washout Period: 16 Days||0
8098540|NCT03267576|19961573|P2|COMPLETED|Washout Period: 16 Days||32
8098541|NCT03267576|19961574|P1|COMPLETED|Washout Period: 16 Days||31
8098542|NCT03267576|19961573|P2|STARTED|Washout Period: 16 Days||32
8098543|NCT03267576|19961574|P1|STARTED|Washout Period: 16 Days||31
8098544|NCT03267576|19961573|P2|NOT COMPLETED|Period 1: Day 0 to 27||0
8098545|NCT03267576|19961574|P1|NOT COMPLETED|Period 1: Day 0 to 27||0
8098546|NCT03267576|19961573|P2|COMPLETED|Period 1: Day 0 to 27||32
8098547|NCT03267576|19961574|P1|COMPLETED|Period 1: Day 0 to 27||31
8098548|NCT03267576|19961573|P2|STARTED|Period 1: Day 0 to 27||32
8098549|NCT03267576|19961574|P1|STARTED|Period 1: Day 0 to 27||31
8098550|NCT03267511|19961612|P4|NOT COMPLETED|Overall Study||1
8098551|NCT03267511|19961613|P3|NOT COMPLETED|Overall Study||0
8098552|NCT03267511|19961614|P2|NOT COMPLETED|Overall Study||0
8098553|NCT03267511|19961615|P1|NOT COMPLETED|Overall Study||0
8098554|NCT03267511|19961612|P4|COMPLETED|Overall Study||30
8098555|NCT03267511|19961613|P3|COMPLETED|Overall Study||30
8098556|NCT03267511|19961614|P2|COMPLETED|Overall Study||31
8098557|NCT03267511|19961615|P1|COMPLETED|Overall Study||31
8098558|NCT03267511|19961612|P4|STARTED|Overall Study||31
8098559|NCT03267511|19961613|P3|STARTED|Overall Study||30
8098560|NCT03267511|19961614|P2|STARTED|Overall Study||31
8098561|NCT03267511|19961615|P1|STARTED|Overall Study||31
8098562|NCT03267264|19961631|P4|NOT COMPLETED|Overall Study||4
8098563|NCT03267264|19961632|P3|NOT COMPLETED|Overall Study||2
8098564|NCT03267264|19961633|P2|NOT COMPLETED|Overall Study||0
8098565|NCT03267264|19961634|P1|NOT COMPLETED|Overall Study||1
8098566|NCT03267264|19961631|P4|COMPLETED|Overall Study||61
8098567|NCT03267264|19961632|P3|COMPLETED|Overall Study||66
8098568|NCT03267264|19961633|P2|COMPLETED|Overall Study||49
8098569|NCT03267264|19961634|P1|COMPLETED|Overall Study||65
8098570|NCT03267264|19961631|P4|Sequence B(Comparator)|Overall Study||32
8098571|NCT03267264|19961632|P3|Sequence B(Comparator)|Overall Study||33
8098572|NCT03267264|19961633|P2|Sequence B(Comparator)|Overall Study||24
8098573|NCT03267264|19961634|P1|Sequence B(Comparator)|Overall Study||32
8098574|NCT03267264|19961631|P4|Sequence A(Nucleus)|Overall Study||33
8098575|NCT03267264|19961632|P3|Sequence A(Nucleus)|Overall Study||33
8098576|NCT03267264|19961633|P2|Sequence A(Nucleus)|Overall Study||25
8098577|NCT03267264|19961634|P1|Sequence A(Nucleus)|Overall Study||34
8098578|NCT03267264|19961631|P4|STARTED|Overall Study||65
8098579|NCT03267264|19961632|P3|STARTED|Overall Study||68
8098580|NCT03267264|19961633|P2|STARTED|Overall Study||49
8098581|NCT03267264|19961634|P1|STARTED|Overall Study||66
8098582|NCT03267212|19961651|P2|NOT COMPLETED|Second Intervention||0
8098583|NCT03267212|19961652|P1|NOT COMPLETED|Second Intervention||0
8098584|NCT03267212|19961651|P2|COMPLETED|Second Intervention||6
8098585|NCT03267212|19961652|P1|COMPLETED|Second Intervention||4
8098586|NCT03267212|19961651|P2|STARTED|Second Intervention||6
8098587|NCT03267212|19961652|P1|STARTED|Second Intervention||4
8098588|NCT03267212|19961651|P2|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||0
8098589|NCT03267212|19961652|P1|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||1
8098590|NCT03267212|19961651|P2|COMPLETED|Washout (Min 2 Days / Max 7 Days)||6
8098591|NCT03267212|19961652|P1|COMPLETED|Washout (Min 2 Days / Max 7 Days)||4
8098592|NCT03267212|19961651|P2|STARTED|Washout (Min 2 Days / Max 7 Days)||6
8098593|NCT03267212|19961652|P1|STARTED|Washout (Min 2 Days / Max 7 Days)||5
8098594|NCT03267212|19961651|P2|NOT COMPLETED|First Intervention||3
8098595|NCT03267212|19961652|P1|NOT COMPLETED|First Intervention||1
8098596|NCT03267212|19961651|P2|COMPLETED|First Intervention||6
8098597|NCT03267212|19961652|P1|COMPLETED|First Intervention||5
8098598|NCT03267212|19961651|P2|Low SCI|First Intervention||4
8098599|NCT03267212|19961652|P1|Low SCI|First Intervention||4
8098600|NCT03267212|19961651|P2|High SCI|First Intervention||5
8098601|NCT03267212|19961652|P1|High SCI|First Intervention||2
8098602|NCT03267212|19961651|P2|STARTED|First Intervention|"First Intervention (1 day), Washout (2 days), and Second Intervention (1 day)"|9
8098603|NCT03267212|19961652|P1|STARTED|First Intervention|Non-invasive ventilation|6
8098604|NCT03266588|19961667|P3|NOT COMPLETED|Long-term Treatment Period||65
8098605|NCT03266588|19961668|P2|NOT COMPLETED|Long-term Treatment Period||240
8098606|NCT03266588|19961669|P1|NOT COMPLETED|Long-term Treatment Period||406
8098607|NCT03266588|19961667|P3|COMPLETED|Long-term Treatment Period||243
8098608|NCT03266588|19961668|P2|COMPLETED|Long-term Treatment Period||271
8098609|NCT03266588|19961669|P1|COMPLETED|Long-term Treatment Period||683
8098610|NCT03266588|19961667|P3|Treated|Long-term Treatment Period||286
8098611|NCT03266588|19961668|P2|Treated|Long-term Treatment Period||481
8098612|NCT03266588|19961669|P1|Treated|Long-term Treatment Period||1033
8098613|NCT03266588|19961667|P3|STARTED|Long-term Treatment Period||308
8098614|NCT03266588|19961668|P2|STARTED|Long-term Treatment Period||511
8098615|NCT03266588|19961669|P1|STARTED|Long-term Treatment Period||1089
8098616|NCT03266588|19961667|P3|NOT COMPLETED|Observational Period||168
8098617|NCT03266588|19961668|P2|NOT COMPLETED|Observational Period||275
8098618|NCT03266588|19961669|P1|NOT COMPLETED|Observational Period||516
8098619|NCT03266588|19961667|P3|COMPLETED|Observational Period||308
8098620|NCT03266588|19961668|P2|COMPLETED|Observational Period||511
8098621|NCT03266588|19961669|P1|COMPLETED|Observational Period||1089
8098622|NCT03266588|19961667|P3|STARTED|Observational Period||476
8098623|NCT03266588|19961668|P2|STARTED|Observational Period||786
8098624|NCT03266588|19961669|P1|STARTED|Observational Period||1605
8098625|NCT03266419|19961688|P2|NOT COMPLETED|Overall Study||0
8098626|NCT03266419|19961689|P1|NOT COMPLETED|Overall Study||0
8098627|NCT03266419|19961688|P2|COMPLETED|Overall Study||49
8098628|NCT03266419|19961689|P1|COMPLETED|Overall Study||51
8098629|NCT03266419|19961688|P2|STARTED|Overall Study||49
8098630|NCT03266419|19961689|P1|STARTED|Overall Study||51
8098838|NCT03266107|19961947|P1|NOT COMPLETED|12-Month Follow-up Visit||1
8098839|NCT03266107|19961947|P1|COMPLETED|12-Month Follow-up Visit||45
8098840|NCT03266107|19961947|P1|STARTED|12-Month Follow-up Visit||46
8098841|NCT03266107|19961947|P1|NOT COMPLETED|3-Month Follow-up Visit||1
8098842|NCT03266107|19961947|P1|COMPLETED|3-Month Follow-up Visit||46
8098843|NCT03266107|19961947|P1|STARTED|3-Month Follow-up Visit||47
8098844|NCT03266107|19961947|P1|NOT COMPLETED|Enrollment to Procedure||3
8098845|NCT03266107|19961947|P1|COMPLETED|Enrollment to Procedure||47
8098846|NCT03266107|19961947|P1|STARTED|Enrollment to Procedure||50
8098847|NCT03266094|19961959|P1|NOT COMPLETED|Overall Study||2
8098848|NCT03266094|19961959|P1|COMPLETED|Overall Study||58
8098849|NCT03266094|19961959|P1|STARTED|Overall Study||60
8098850|NCT03265938|19961977|P1|NOT COMPLETED|Overall Study||8
8098851|NCT03265938|19961977|P1|COMPLETED|Overall Study||92
8098852|NCT03265938|19961977|P1|STARTED|Overall Study||100
8098853|NCT03265600|19961990|P2|NOT COMPLETED|Overall Study||12
8098854|NCT03265600|19961991|P1|NOT COMPLETED|Overall Study||24
8098855|NCT03265600|19961990|P2|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|32
8098856|NCT03265600|19961991|P1|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|68
8098857|NCT03265600|19961990|P2|STARTED|Overall Study||44
8098858|NCT03265600|19961991|P1|STARTED|Overall Study||92
8098871|NCT03264456|19962125|P1|NOT COMPLETED|Overall Study||4
8098872|NCT03264456|19962125|P1|COMPLETED|Overall Study||14
8098873|NCT03264456|19962125|P1|STARTED|Overall Study||18
8098874|NCT03264248|19962132|P1|NOT COMPLETED|Overall Study||0
8098875|NCT03264248|19962132|P1|COMPLETED|Overall Study||9
8098876|NCT03264248|19962132|P1|STARTED|Overall Study||9
8098877|NCT03264157|19962141|P2|NOT COMPLETED|Overall Study||7
8098878|NCT03264157|19962142|P1|NOT COMPLETED|Overall Study||13
8098879|NCT03264157|19962141|P2|COMPLETED|Overall Study||74
8098880|NCT03264157|19962142|P1|COMPLETED|Overall Study||68
8098881|NCT03264157|19962141|P2|STARTED|Overall Study||81
8098882|NCT03264157|19962142|P1|STARTED|Overall Study||81
8098883|NCT03263806|19962160|P2|NOT COMPLETED|Overall Study||7
8098884|NCT03263806|19962161|P1|NOT COMPLETED|Overall Study||6
8098885|NCT03263806|19962160|P2|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
8098886|NCT03263806|19962161|P1|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
8098887|NCT03263806|19962160|P2|STARTED|Overall Study||7
8098888|NCT03263806|19962161|P1|STARTED|Overall Study||6
8098889|NCT03263702|19962175|P2|NOT COMPLETED|Overall Study||4
8098890|NCT03263702|19962176|P1|NOT COMPLETED|Overall Study||3
8098891|NCT03263702|19962175|P2|COMPLETED|Overall Study||22
8098892|NCT03263702|19962176|P1|COMPLETED|Overall Study||35
8098893|NCT03263702|19962175|P2|STARTED|Overall Study||26
8098894|NCT03263702|19962176|P1|STARTED|Overall Study||38
8098895|NCT03262441|19962202|P1|NOT COMPLETED|Overall Study||1
8098896|NCT03262441|19962202|P1|COMPLETED|Overall Study||4
8098897|NCT03262441|19962202|P1|STARTED|Overall Study||5
8098898|NCT03262233|19962214|P4|NOT COMPLETED|Overall Study||29
8098899|NCT03262233|19962215|P3|NOT COMPLETED|Overall Study||25
8098900|NCT03262233|19962216|P2|NOT COMPLETED|Overall Study||21
8098901|NCT03262233|19962217|P1|NOT COMPLETED|Overall Study||18
8098902|NCT03262233|19962214|P4|COMPLETED|Overall Study||32
8098903|NCT03262233|19962215|P3|COMPLETED|Overall Study||34
8098904|NCT03262233|19962216|P2|COMPLETED|Overall Study||32
8098905|NCT03262233|19962217|P1|COMPLETED|Overall Study||35
8098906|NCT03262233|19962214|P4|STARTED|Overall Study||61
8098907|NCT03262233|19962215|P3|STARTED|Overall Study||59
8098908|NCT03262233|19962216|P2|STARTED|Overall Study||53
8098909|NCT03262233|19962217|P1|STARTED|Overall Study||53
8098910|NCT03262038|19962241|P2|NOT COMPLETED|Overall Study||1
8098911|NCT03262038|19962242|P1|NOT COMPLETED|Overall Study||0
8098912|NCT03262038|19962241|P2|COMPLETED|Overall Study||27
8098913|NCT03262038|19962242|P1|COMPLETED|Overall Study||18
8098914|NCT03262038|19962241|P2|STARTED|Overall Study||28
8098915|NCT03262038|19962242|P1|STARTED|Overall Study||18
8098916|NCT03262012|19962258|P4|NOT COMPLETED|Overall Study||15
8098917|NCT03262012|19962259|P3|NOT COMPLETED|Overall Study||14
8098918|NCT03262012|19962260|P2|NOT COMPLETED|Overall Study||36
8098919|NCT03262012|19962261|P1|NOT COMPLETED|Overall Study||27
8098920|NCT03262012|19962258|P4|COMPLETED|Overall Study||54
8098921|NCT03262012|19962259|P3|COMPLETED|Overall Study||56
8098922|NCT03262012|19962260|P2|COMPLETED|Overall Study||102
8098923|NCT03262012|19962261|P1|COMPLETED|Overall Study||112
8098924|NCT03262012|19962258|P4|STARTED|Overall Study||69
8098925|NCT03262012|19962259|P3|STARTED|Overall Study||70
8098926|NCT03262012|19962260|P2|STARTED|Overall Study||138
8098927|NCT03262012|19962261|P1|STARTED|Overall Study||139
8098928|NCT03261999|19962279|P1|NOT COMPLETED|Overall Study||15
8098929|NCT03261999|19962279|P1|COMPLETED|Overall Study||129
8098930|NCT03261999|19962279|P1|PP|Overall Study||132
8098931|NCT03261999|19962279|P1|ITT|Overall Study||144
8098932|NCT03261999|19962279|P1|STARTED|Overall Study||144
8098933|NCT03261531|19962284|P1|NOT COMPLETED|Overall Study||4
8098934|NCT03261531|19962284|P1|COMPLETED|Overall Study||3
8098935|NCT03261531|19962284|P1|STARTED|Overall Study||7
8098936|NCT03261167|19962302|P2|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
8098937|NCT03261167|19962303|P1|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
8098938|NCT03261167|19962302|P2|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40
8098939|NCT03261167|19962303|P1|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43
8098940|NCT03261167|19962302|P2|STARTED|Open-label(Treatment cycle4,Upto Week48)||40
8098941|NCT03261167|19962303|P1|STARTED|Open-label(Treatment cycle4,Upto Week48)||43
8098942|NCT03261167|19962302|P2|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
8098943|NCT03261167|19962303|P1|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
8098944|NCT03261167|19962302|P2|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55
8098945|NCT03261167|19962303|P1|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54
8098946|NCT03261167|19962302|P2|STARTED|Open-label(Treatment cycle3,Upto Week48)||56
8098947|NCT03261167|19962303|P1|STARTED|Open-label(Treatment cycle3,Upto Week48)||55
8098948|NCT03261167|19962302|P2|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0
8098949|NCT03261167|19962303|P1|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2
8098950|NCT03261167|19962302|P2|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57
8098951|NCT03261167|19962303|P1|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58
8098952|NCT03261167|19962302|P2|STARTED|Open-label(Treatment cycle2,Upto Week48)||57
8098953|NCT03261167|19962303|P1|STARTED|Open-label(Treatment cycle2,Upto Week48)||60
8098954|NCT03261167|19962302|P2|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4
8098955|NCT03261167|19962303|P1|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3
8098956|NCT03261167|19962302|P2|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57
8098957|NCT03261167|19962303|P1|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60
8098958|NCT03261167|19962302|P2|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61
8098959|NCT03261167|19962303|P1|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63
8098960|NCT03260894|19962341|P2|NOT COMPLETED|Overall Study||50
8098961|NCT03260894|19962342|P1|NOT COMPLETED|Overall Study||46
8098962|NCT03260894|19962341|P2|COMPLETED|Overall Study||15
8098963|NCT03260894|19962342|P1|COMPLETED|Overall Study||18
8098964|NCT03260894|19962341|P2|All Subjects as Treated (ASaT)|Overall Study||63
8098965|NCT03260894|19962342|P1|All Subjects as Treated (ASaT)|Overall Study||64
8098966|NCT03260894|19962341|P2|Intention-to-Treat (ITT)|Overall Study||65
8098967|NCT03260894|19962342|P1|Intention-to-Treat (ITT)|Overall Study||64
8098968|NCT03260894|19962341|P2|STARTED|Overall Study||65
8098969|NCT03260894|19962342|P1|STARTED|Overall Study||64
8098970|NCT03260868|19962354|P2|NOT COMPLETED|Overall Study||3
8098971|NCT03260868|19962355|P1|NOT COMPLETED|Overall Study||3
8098972|NCT03260868|19962354|P2|COMPLETED|Overall Study||4
8098973|NCT03260868|19962355|P1|COMPLETED|Overall Study||5
8098974|NCT03260868|19962354|P2|Safety Population|Overall Study||6
8098975|NCT03260868|19962355|P1|Safety Population|Overall Study||8
8098976|NCT03260868|19962354|P2|STARTED|Overall Study||7
8098977|NCT03260868|19962355|P1|STARTED|Overall Study||8
8098978|NCT03260699|19962395|P2|NOT COMPLETED|Overall Study||2
8098979|NCT03260699|19962396|P1|NOT COMPLETED|Overall Study||0
8098980|NCT03260699|19962395|P2|COMPLETED|Overall Study||2
8098981|NCT03260699|19962396|P1|COMPLETED|Overall Study||5
8098982|NCT03260699|19962395|P2|STARTED|Overall Study||4
8098983|NCT03260699|19962396|P1|STARTED|Overall Study||5
8098984|NCT03260595|19962425|P3|NOT COMPLETED|Overall Study||0
8098985|NCT03260595|19962426|P2|NOT COMPLETED|Overall Study||0
8098986|NCT03260595|19962427|P1|NOT COMPLETED|Overall Study||0
8098987|NCT03260595|19962425|P3|COMPLETED|Overall Study||2
8098988|NCT03260595|19962426|P2|COMPLETED|Overall Study||10
8098989|NCT03260595|19962427|P1|COMPLETED|Overall Study||20
8098990|NCT03260595|19962425|P3|STARTED|Overall Study||2
8098991|NCT03260595|19962426|P2|STARTED|Overall Study||10
8098992|NCT03260595|19962427|P1|STARTED|Overall Study||20
8098993|NCT03260426|19962451|P2|NOT COMPLETED|Overall Study||0
8098994|NCT03260426|19962452|P1|NOT COMPLETED|Overall Study||0
8098995|NCT03260426|19962451|P2|COMPLETED|Overall Study||50
8098996|NCT03260426|19962452|P1|COMPLETED|Overall Study||50
8098997|NCT03260426|19962451|P2|STARTED|Overall Study||50
8098998|NCT03260426|19962452|P1|STARTED|Overall Study||50
8099019|NCT03259555|19962544|P2|NOT COMPLETED|Overall Study||30
8099020|NCT03259555|19962545|P1|NOT COMPLETED|Overall Study||34
8099021|NCT03259555|19962544|P2|COMPLETED|Overall Study||134
8099022|NCT03259555|19962545|P1|COMPLETED|Overall Study||124
8099023|NCT03259555|19962544|P2|Received At Least 1 Dose of Study Drug|Overall Study||163
8099024|NCT03259555|19962545|P1|Received At Least 1 Dose of Study Drug|Overall Study||158
8099025|NCT03259555|19962544|P2|STARTED|Overall Study||164
8099026|NCT03259555|19962545|P1|STARTED|Overall Study||158
8099027|NCT03259490|19962555|P2|NOT COMPLETED|Period 2||0
8099028|NCT03259490|19962556|P1|NOT COMPLETED|Period 2||1
8099029|NCT03259490|19962555|P2|COMPLETED|Period 2||14
8099030|NCT03259490|19962556|P1|COMPLETED|Period 2||14
8099031|NCT03259490|19962555|P2|STARTED|Period 2||14
8099032|NCT03259490|19962556|P1|STARTED|Period 2||15
8099033|NCT03259490|19962555|P2|NOT COMPLETED|Period 1||1
8099034|NCT03259490|19962556|P1|NOT COMPLETED|Period 1||0
8099035|NCT03259490|19962555|P2|COMPLETED|Period 1||14
8099036|NCT03259490|19962556|P1|COMPLETED|Period 1||15
8099037|NCT03259490|19962555|P2|STARTED|Period 1||15
8099038|NCT03259490|19962556|P1|STARTED|Period 1||15
8099039|NCT03259425|19962578|P1|NOT COMPLETED|Overall Study||1
8099040|NCT03259425|19962578|P1|COMPLETED|Overall Study||6
8099041|NCT03259425|19962578|P1|Surgery|Overall Study||6
8099042|NCT03259425|19962578|P1|STARTED|Overall Study||7
8099043|NCT03259139|19962588|P6|NOT COMPLETED|Overall Study||6
8099044|NCT03259139|19962589|P5|NOT COMPLETED|Overall Study||6
8099045|NCT03259139|19962590|P4|NOT COMPLETED|Overall Study||5
8099046|NCT03259139|19962591|P3|NOT COMPLETED|Overall Study||5
8099047|NCT03259139|19962592|P2|NOT COMPLETED|Overall Study||4
8099048|NCT03259139|19962593|P1|NOT COMPLETED|Overall Study||4
8099049|NCT03259139|19962588|P6|COMPLETED|Overall Study||35
8099050|NCT03259139|19962589|P5|COMPLETED|Overall Study||35
8099051|NCT03259139|19962590|P4|COMPLETED|Overall Study||37
8099052|NCT03259139|19962591|P3|COMPLETED|Overall Study||37
8099053|NCT03259139|19962592|P2|COMPLETED|Overall Study||38
8099054|NCT03259139|19962593|P1|COMPLETED|Overall Study||38
8099055|NCT03259139|19962588|P6|Found Handgun|Overall Study||35
8099056|NCT03259139|19962589|P5|Found Handgun|Overall Study||35
8099057|NCT03259139|19962590|P4|Found Handgun|Overall Study||37
8099058|NCT03259139|19962591|P3|Found Handgun|Overall Study||37
8099059|NCT03259139|19962592|P2|Found Handgun|Overall Study||38
8099060|NCT03259139|19962593|P1|Found Handgun|Overall Study||38
8099061|NCT03259139|19962588|P6|Outlier Elimination|Overall Study||39
8099062|NCT03259139|19962589|P5|Outlier Elimination|Overall Study||39
8099063|NCT03259139|19962590|P4|Outlier Elimination|Overall Study||41
8099064|NCT03259139|19962591|P3|Outlier Elimination|Overall Study||41
8099065|NCT03259139|19962592|P2|Outlier Elimination|Overall Study||41
8099066|NCT03259139|19962593|P1|Outlier Elimination|Overall Study||41
8099067|NCT03259139|19962588|P6|Eligible|Overall Study||41
8099068|NCT03259139|19962589|P5|Eligible|Overall Study||41
8099069|NCT03259139|19962590|P4|Eligible|Overall Study||41
8099070|NCT03259139|19962591|P3|Eligible|Overall Study||41
8099071|NCT03259139|19962592|P2|Eligible|Overall Study||41
8099072|NCT03259139|19962593|P1|Eligible|Overall Study||41
8099073|NCT03259139|19962588|P6|STARTED|Overall Study||41
8099074|NCT03259139|19962589|P5|STARTED|Overall Study||41
8099075|NCT03259139|19962590|P4|STARTED|Overall Study||42
8099076|NCT03259139|19962591|P3|STARTED|Overall Study||42
8099077|NCT03259139|19962592|P2|STARTED|Overall Study||42
8099078|NCT03259139|19962593|P1|STARTED|Overall Study||42
8099079|NCT03259087|19962624|P5|NOT COMPLETED|Period 2 of Part 2||1
8099080|NCT03259087|19962625|P4|NOT COMPLETED|Period 2 of Part 2||0
8099081|NCT03259087|19962626|P3|NOT COMPLETED|Period 2 of Part 2||0
8099082|NCT03259087|19962627|P2|NOT COMPLETED|Period 2 of Part 2||0
8099083|NCT03259087|19962628|P1|NOT COMPLETED|Period 2 of Part 2||0
8099084|NCT03259087|19962624|P5|COMPLETED|Period 2 of Part 2||6
8099085|NCT03259087|19962625|P4|COMPLETED|Period 2 of Part 2||0
8099086|NCT03259087|19962626|P3|COMPLETED|Period 2 of Part 2||0
8099087|NCT03259087|19962627|P2|COMPLETED|Period 2 of Part 2||0
8099088|NCT03259087|19962628|P1|COMPLETED|Period 2 of Part 2||0
8099089|NCT03259087|19962624|P5|STARTED|Period 2 of Part 2||7
8099090|NCT03259087|19962625|P4|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
8099091|NCT03259087|19962626|P3|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
8099092|NCT03259087|19962627|P2|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
8099093|NCT03259087|19962628|P1|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
8099094|NCT03259087|19962624|P5|NOT COMPLETED|Part 1 and Period 1 of Part 2||1
8099095|NCT03259087|19962625|P4|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
8099096|NCT03259087|19962626|P3|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
8099097|NCT03259087|19962627|P2|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
8099098|NCT03259087|19962628|P1|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
8099099|NCT03259087|19962624|P5|COMPLETED|Part 1 and Period 1 of Part 2||7
8099100|NCT03259087|19962625|P4|COMPLETED|Part 1 and Period 1 of Part 2||10
8099101|NCT03259087|19962626|P3|COMPLETED|Part 1 and Period 1 of Part 2||8
8099102|NCT03259087|19962627|P2|COMPLETED|Part 1 and Period 1 of Part 2||8
8099103|NCT03259087|19962628|P1|COMPLETED|Part 1 and Period 1 of Part 2||8
8099104|NCT03259087|19962624|P5|STARTED|Part 1 and Period 1 of Part 2||8
8099105|NCT03259087|19962625|P4|STARTED|Part 1 and Period 1 of Part 2||10
8099106|NCT03259087|19962626|P3|STARTED|Part 1 and Period 1 of Part 2||8
8099107|NCT03259087|19962627|P2|STARTED|Part 1 and Period 1 of Part 2||8
8099108|NCT03259087|19962628|P1|STARTED|Part 1 and Period 1 of Part 2||8
8099109|NCT03258814|19962756|P3|NOT COMPLETED|Overall Study||10
8099110|NCT03258814|19962757|P2|NOT COMPLETED|Overall Study||3
8099111|NCT03258814|19962758|P1|NOT COMPLETED|Overall Study||4
8099112|NCT03258814|19962756|P3|COMPLETED|Overall Study||0
8099113|NCT03258814|19962757|P2|COMPLETED|Overall Study||0
8099114|NCT03258814|19962758|P1|COMPLETED|Overall Study||0
8099115|NCT03258814|19962756|P3|STARTED|Overall Study||10
8099116|NCT03258814|19962757|P2|STARTED|Overall Study||3
8099117|NCT03258814|19962758|P1|STARTED|Overall Study||4
8099118|NCT03258762|19962813|P2|NOT COMPLETED|Overall Study||1
8099119|NCT03258762|19962814|P1|NOT COMPLETED|Overall Study||0
8099120|NCT03258762|19962813|P2|COMPLETED|Overall Study||6
8099121|NCT03258762|19962814|P1|COMPLETED|Overall Study||7
8099122|NCT03258762|19962813|P2|STARTED|Overall Study||7
8099123|NCT03258762|19962814|P1|STARTED|Overall Study||7
8099124|NCT03258710|19962874|P1|NOT COMPLETED|Overall Study||3
8099125|NCT03258710|19962874|P1|COMPLETED|Overall Study||72
8099126|NCT03258710|19962874|P1|STARTED|Overall Study||75
8099127|NCT03258645|19962913|P1|NOT COMPLETED|Overall Study||0
8099128|NCT03258645|19962913|P1|COMPLETED|Overall Study||1489
8099129|NCT03258645|19962913|P1|STARTED|Overall Study||1489
8099130|NCT03257995|19962968|P6|NOT COMPLETED|Overall Study||2
8099131|NCT03257995|19962969|P5|NOT COMPLETED|Overall Study||0
8099132|NCT03257995|19962970|P4|NOT COMPLETED|Overall Study||0
8099133|NCT03257995|19962971|P3|NOT COMPLETED|Overall Study||0
8099134|NCT03257995|19962972|P2|NOT COMPLETED|Overall Study||1
8099135|NCT03257995|19962973|P1|NOT COMPLETED|Overall Study||0
8099136|NCT03257995|19962968|P6|COMPLETED|Overall Study||7
8099137|NCT03257995|19962969|P5|COMPLETED|Overall Study||9
8099138|NCT03257995|19962970|P4|COMPLETED|Overall Study||9
8099139|NCT03257995|19962971|P3|COMPLETED|Overall Study||9
8099140|NCT03257995|19962972|P2|COMPLETED|Overall Study||8
8099141|NCT03257995|19962973|P1|COMPLETED|Overall Study||9
8099142|NCT03257995|19962968|P6|STARTED|Overall Study||9
8099143|NCT03257995|19962969|P5|STARTED|Overall Study||9
8099144|NCT03257995|19962970|P4|STARTED|Overall Study||9
8099145|NCT03257995|19962971|P3|STARTED|Overall Study||9
8099146|NCT03257995|19962972|P2|STARTED|Overall Study||9
8099147|NCT03257995|19962973|P1|STARTED|Overall Study||9
8099148|NCT03257865|19963023|P2|NOT COMPLETED|Overall Study||35
8099149|NCT03257865|19963024|P1|NOT COMPLETED|Overall Study||35
8099150|NCT03257865|19963023|P2|COMPLETED|Overall Study||135
8099151|NCT03257865|19963024|P1|COMPLETED|Overall Study||128
8099152|NCT03257865|19963023|P2|Received at Least 1 Dose of Study Drug|Overall Study||170
8099153|NCT03257865|19963024|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
8099154|NCT03257865|19963023|P2|STARTED|Overall Study||170
8099155|NCT03257865|19963024|P1|STARTED|Overall Study||163
8099156|NCT03257813|19963034|P2|NOT COMPLETED|Overall Study||3
8099157|NCT03257813|19963035|P1|NOT COMPLETED|Overall Study||6
8099158|NCT03257813|19963034|P2|COMPLETED|Overall Study||27
8099159|NCT03257813|19963035|P1|COMPLETED|Overall Study||24
8099160|NCT03257813|19963034|P2|STARTED|Overall Study||30
8099161|NCT03257813|19963035|P1|STARTED|Overall Study||30
8099162|NCT03257657|19963057|P2|NOT COMPLETED|Overall Study||5
8099163|NCT03257657|19963058|P1|NOT COMPLETED|Overall Study||0
8099164|NCT03257657|19963057|P2|COMPLETED|Overall Study||15
8099165|NCT03257657|19963058|P1|COMPLETED|Overall Study||22
8099166|NCT03257657|19963057|P2|STARTED|Overall Study||20
8099167|NCT03257657|19963058|P1|STARTED|Overall Study||22
8099168|NCT03257631|19963089|P4|NOT COMPLETED|Overall Study||10
8099169|NCT03257631|19963090|P3|NOT COMPLETED|Overall Study||23
8099170|NCT03257631|19963091|P2|NOT COMPLETED|Overall Study||9
8099171|NCT03257631|19963092|P1|NOT COMPLETED|Overall Study||11
8099172|NCT03257631|19963089|P4|COMPLETED|Overall Study||0
8099173|NCT03257631|19963090|P3|COMPLETED|Overall Study||0
8099174|NCT03257631|19963091|P2|COMPLETED|Overall Study||0
8099175|NCT03257631|19963092|P1|COMPLETED|Overall Study||0
8099176|NCT03257631|19963089|P4|Received Study Drug|Overall Study||10
8099177|NCT03257631|19963090|P3|Received Study Drug|Overall Study||22
8099178|NCT03257631|19963091|P2|Received Study Drug|Overall Study||9
8099179|NCT03257631|19963092|P1|Received Study Drug|Overall Study||11
8099180|NCT03257631|19963089|P4|STARTED|Overall Study||10
8099181|NCT03257631|19963090|P3|STARTED|Overall Study||23
8099182|NCT03257631|19963091|P2|STARTED|Overall Study||9
8099183|NCT03257631|19963092|P1|STARTED|Overall Study||11
8099184|NCT03257410|19963128|P2|NOT COMPLETED|Overall Study||21
8099185|NCT03257410|19963129|P1|NOT COMPLETED|Overall Study||21
8099186|NCT03257410|19963128|P2|COMPLETED|Overall Study||65
8099187|NCT03257410|19963129|P1|COMPLETED|Overall Study||65
8099188|NCT03257410|19963128|P2|STARTED|Overall Study||86
8099189|NCT03257410|19963129|P1|STARTED|Overall Study||86
8099190|NCT03257371|19963269|P1|NOT COMPLETED|Overall Study||1
8099191|NCT03257371|19963269|P1|COMPLETED|Overall Study||9
8099192|NCT03257371|19963269|P1|STARTED|Overall Study||10
8099193|NCT03257358|19963278|P2|NOT COMPLETED|Overall Study||34
8099194|NCT03257358|19963279|P1|NOT COMPLETED|Overall Study||71
8099195|NCT03257358|19963278|P2|COMPLETED|Overall Study||183
8099196|NCT03257358|19963279|P1|COMPLETED|Overall Study||94
8099197|NCT03257358|19963278|P2|Never Received Treatment|Overall Study||0
8099198|NCT03257358|19963279|P1|Never Received Treatment|Overall Study||2
8099199|NCT03257358|19963278|P2|STARTED|Overall Study||217
8099200|NCT03257358|19963279|P1|STARTED|Overall Study||165
8099201|NCT03257202|19963379|P1|NOT COMPLETED|Overall Study||0
8099202|NCT03257202|19963379|P1|COMPLETED|Overall Study||12
8099203|NCT03257202|19963379|P1|STARTED|Overall Study||12
8099204|NCT03257189|19963389|P1|NOT COMPLETED|Overall Study||0
8099205|NCT03257189|19963389|P1|COMPLETED|Overall Study||30
8099206|NCT03257189|19963389|P1|STARTED|Overall Study||30
8099207|NCT03256968|19963401|P1|NOT COMPLETED|Overall Study||0
8099208|NCT03256968|19963401|P1|COMPLETED|Overall Study||1
8099209|NCT03256968|19963401|P1|STARTED|Overall Study||1
8099210|NCT03256851|19963407|P2|NOT COMPLETED|Overall Study||0
8099211|NCT03256851|19963408|P1|NOT COMPLETED|Overall Study||1
8099212|NCT03256851|19963407|P2|COMPLETED|Overall Study||10
8099213|NCT03256851|19963408|P1|COMPLETED|Overall Study||9
8099214|NCT03256851|19963407|P2|STARTED|Overall Study||10
8099215|NCT03256851|19963408|P1|STARTED|Overall Study||10
8099216|NCT03256799|19963416|P1|NOT COMPLETED|Overall Study||0
8099217|NCT03256799|19963416|P1|COMPLETED|Overall Study||1
8099218|NCT03256799|19963416|P1|STARTED|Overall Study||1
8099219|NCT03256695|19963420|P1|NOT COMPLETED|Overall Study||39
8099220|NCT03256695|19963420|P1|COMPLETED|Overall Study||366
8099221|NCT03256695|19963420|P1|Used ABS eMDPI at Least Once|Overall Study||390
8099222|NCT03256695|19963420|P1|STARTED|Overall Study||405
8099229|NCT03256552|19963481|P1|NOT COMPLETED|Overall Study||5
8099230|NCT03256552|19963481|P1|COMPLETED|Overall Study||61
8099231|NCT03256552|19963481|P1|Placebo MDI|Overall Study||65
8099232|NCT03256552|19963481|P1|GP MDI 7.2 µg|Overall Study||62
8099233|NCT03256552|19963481|P1|GP MDI 14.4 µg|Overall Study||63
8099234|NCT03256552|19963481|P1|GP MDI 28.8 µg|Overall Study||61
8099235|NCT03256552|19963481|P1|STARTED|Overall Study||66
8099236|NCT03256526|19963506|P3|NOT COMPLETED|Overall Study||3
8099237|NCT03256526|19963507|P2|NOT COMPLETED|Overall Study||0
8099238|NCT03256526|19963508|P1|NOT COMPLETED|Overall Study||2
8099239|NCT03256526|19963506|P3|COMPLETED|Overall Study||14
8099240|NCT03256526|19963507|P2|COMPLETED|Overall Study||17
8099241|NCT03256526|19963508|P1|COMPLETED|Overall Study||17
8099242|NCT03256526|19963506|P3|STARTED|Overall Study||17
8099243|NCT03256526|19963507|P2|STARTED|Overall Study||17
8099244|NCT03256526|19963508|P1|STARTED|Overall Study||19
8099245|NCT03256253|19963528|P1|NOT COMPLETED|Overall Study||12
8099246|NCT03256253|19963528|P1|COMPLETED|Overall Study||6
8099247|NCT03256253|19963528|P1|STARTED|Overall Study||18
8099248|NCT03256162|19963534|P2|NOT COMPLETED|Overall Study||4
8099249|NCT03256162|19963535|P1|NOT COMPLETED|Overall Study||5
8099250|NCT03256162|19963534|P2|COMPLETED|Overall Study||8
8099251|NCT03256162|19963535|P1|COMPLETED|Overall Study||8
8099252|NCT03256162|19963534|P2|STARTED|Overall Study||12
8099253|NCT03256162|19963535|P1|STARTED|Overall Study||13
8099254|NCT03256136|19963557|P4|NOT COMPLETED|Overall Study||0
8099255|NCT03256136|19963558|P3|NOT COMPLETED|Overall Study||0
8099256|NCT03256136|19963559|P2|NOT COMPLETED|Overall Study||0
8099257|NCT03256136|19963560|P1|NOT COMPLETED|Overall Study||0
8099258|NCT03256136|19963557|P4|COMPLETED|Overall Study||1
8099259|NCT03256136|19963558|P3|COMPLETED|Overall Study||4
8099260|NCT03256136|19963559|P2|COMPLETED|Overall Study||1
8099261|NCT03256136|19963560|P1|COMPLETED|Overall Study||3
8099262|NCT03256136|19963557|P4|STARTED|Overall Study||1
8099263|NCT03256136|19963558|P3|STARTED|Overall Study||4
8099264|NCT03256136|19963559|P2|STARTED|Overall Study||1
8099265|NCT03256136|19963560|P1|STARTED|Overall Study||3
8099266|NCT03255980|19963590|P4|NOT COMPLETED|Overall Study||12
8099267|NCT03255980|19963591|P3|NOT COMPLETED|Overall Study||6
8099268|NCT03255980|19963592|P2|NOT COMPLETED|Overall Study||8
8099269|NCT03255980|19963593|P1|NOT COMPLETED|Overall Study||3
8099270|NCT03255980|19963590|P4|COMPLETED|Overall Study||8
8099271|NCT03255980|19963591|P3|COMPLETED|Overall Study||14
8099272|NCT03255980|19963592|P2|COMPLETED|Overall Study||12
8099273|NCT03255980|19963593|P1|COMPLETED|Overall Study||17
8099274|NCT03255980|19963590|P4|STARTED|Overall Study||20
8099275|NCT03255980|19963591|P3|STARTED|Overall Study||20
8099276|NCT03255980|19963592|P2|STARTED|Overall Study||20
8099277|NCT03255980|19963593|P1|STARTED|Overall Study||20
8099278|NCT03255902|19963603|P1|NOT COMPLETED|Overall Study||2
8099279|NCT03255902|19963603|P1|COMPLETED|Overall Study||5
8099280|NCT03255902|19963603|P1|STARTED|Overall Study||7
8099281|NCT03255824|19963610|P2|NOT COMPLETED|Overall Study||1
8099282|NCT03255824|19963611|P1|NOT COMPLETED|Overall Study||2
8099283|NCT03255824|19963610|P2|COMPLETED|Overall Study||74
8099284|NCT03255824|19963611|P1|COMPLETED|Overall Study||67
8099285|NCT03255824|19963610|P2|STARTED|Overall Study||75
8099286|NCT03255824|19963611|P1|STARTED|Overall Study||69
8099287|NCT03255733|19963639|P1|NOT COMPLETED|Overall Study||4
8099288|NCT03255733|19963639|P1|COMPLETED|Overall Study||25
8099289|NCT03255733|19963639|P1|STARTED|Overall Study||29
8099290|NCT03255655|19963646|P2|NOT COMPLETED|Overall Study||4
8099291|NCT03255655|19963647|P1|NOT COMPLETED|Overall Study||7
8099292|NCT03255655|19963646|P2|COMPLETED|Overall Study||8
8099293|NCT03255655|19963647|P1|COMPLETED|Overall Study||22
8099294|NCT03255655|19963646|P2|STARTED|Overall Study||12
8099295|NCT03255655|19963647|P1|STARTED|Overall Study||29
8099296|NCT03255382|19963657|P2|NOT COMPLETED|Overall Study||0
8099297|NCT03255382|19963658|P1|NOT COMPLETED|Overall Study||13
8099298|NCT03255382|19963657|P2|COMPLETED|Overall Study||60
8099299|NCT03255382|19963658|P1|COMPLETED|Overall Study||47
8099300|NCT03255382|19963657|P2|STARTED|Overall Study||60
8099301|NCT03255382|19963658|P1|STARTED|Overall Study||60
8099302|NCT03255291|19963832|P6|NOT COMPLETED|Overall Study||10
8099303|NCT03255291|19963833|P5|NOT COMPLETED|Overall Study||7
8099304|NCT03255291|19963834|P4|NOT COMPLETED|Overall Study||6
8099305|NCT03255291|19963835|P3|NOT COMPLETED|Overall Study||6
8099306|NCT03255291|19963836|P2|NOT COMPLETED|Overall Study||12
8099307|NCT03255291|19963837|P1|NOT COMPLETED|Overall Study||13
8099308|NCT03255291|19963832|P6|COMPLETED|Overall Study||85
8099309|NCT03255291|19963833|P5|COMPLETED|Overall Study||88
8099310|NCT03255291|19963834|P4|COMPLETED|Overall Study||84
8099311|NCT03255291|19963835|P3|COMPLETED|Overall Study||85
8099312|NCT03255291|19963836|P2|COMPLETED|Overall Study||78
8099313|NCT03255291|19963837|P1|COMPLETED|Overall Study||80
8099314|NCT03255291|19963832|P6|STARTED|Overall Study||95
8099315|NCT03255291|19963833|P5|STARTED|Overall Study||95
8099316|NCT03255291|19963834|P4|STARTED|Overall Study||90
8099317|NCT03255291|19963835|P3|STARTED|Overall Study||91
8099318|NCT03255291|19963836|P2|STARTED|Overall Study||90
8099319|NCT03255291|19963837|P1|STARTED|Overall Study||93
8099320|NCT03255187|19963870|P2|NOT COMPLETED|Period at Fourth Follow-up||0
8099321|NCT03255187|19963871|P1|NOT COMPLETED|Period at Fourth Follow-up||0
8099322|NCT03255187|19963870|P2|COMPLETED|Period at Fourth Follow-up||31
8099323|NCT03255187|19963871|P1|COMPLETED|Period at Fourth Follow-up||34
8099324|NCT03255187|19963870|P2|STARTED|Period at Fourth Follow-up||31
8099325|NCT03255187|19963871|P1|STARTED|Period at Fourth Follow-up||34
8099326|NCT03255187|19963870|P2|NOT COMPLETED|Period From Third to Fourth Follow-up||0
8099327|NCT03255187|19963871|P1|NOT COMPLETED|Period From Third to Fourth Follow-up||0
8099328|NCT03255187|19963870|P2|COMPLETED|Period From Third to Fourth Follow-up||31
8099329|NCT03255187|19963871|P1|COMPLETED|Period From Third to Fourth Follow-up||34
8099330|NCT03255187|19963870|P2|STARTED|Period From Third to Fourth Follow-up||31
8099331|NCT03255187|19963871|P1|STARTED|Period From Third to Fourth Follow-up||34
8099332|NCT03255187|19963870|P2|NOT COMPLETED|Period From Second to Third Follow-up||0
8099333|NCT03255187|19963871|P1|NOT COMPLETED|Period From Second to Third Follow-up||0
8099334|NCT03255187|19963870|P2|COMPLETED|Period From Second to Third Follow-up||31
8099335|NCT03255187|19963871|P1|COMPLETED|Period From Second to Third Follow-up||34
8099336|NCT03255187|19963870|P2|STARTED|Period From Second to Third Follow-up||31
8099337|NCT03255187|19963871|P1|STARTED|Period From Second to Third Follow-up||34
8099338|NCT03255187|19963870|P2|NOT COMPLETED|Period From First to Second Follow-up||1
8099339|NCT03255187|19963871|P1|NOT COMPLETED|Period From First to Second Follow-up||0
8099340|NCT03255187|19963870|P2|COMPLETED|Period From First to Second Follow-up||31
8099341|NCT03255187|19963871|P1|COMPLETED|Period From First to Second Follow-up||34
8099342|NCT03255187|19963870|P2|STARTED|Period From First to Second Follow-up||32
8099343|NCT03255187|19963871|P1|STARTED|Period From First to Second Follow-up||34
8099344|NCT03255187|19963870|P2|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3
8099345|NCT03255187|19963871|P1|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1
8099346|NCT03255187|19963870|P2|COMPLETED|Periodfrom Enrollment to First Follow-up||32
8099347|NCT03255187|19963871|P1|COMPLETED|Periodfrom Enrollment to First Follow-up||34
8099348|NCT03255187|19963870|P2|STARTED|Periodfrom Enrollment to First Follow-up||35
8099349|NCT03255187|19963871|P1|STARTED|Periodfrom Enrollment to First Follow-up||35
8099350|NCT03254719|19963911|P1|NOT COMPLETED|Overall Study||0
8099351|NCT03254719|19963911|P1|COMPLETED|Overall Study||40
8099352|NCT03254719|19963911|P1|STARTED|Overall Study||40
8099353|NCT03254602|19963930|P1|NOT COMPLETED|Overall Study||4
8099354|NCT03254602|19963930|P1|COMPLETED|Overall Study||29
8099355|NCT03254602|19963930|P1|STARTED|Overall Study||33
8099356|NCT03254459|19963938|P2|NOT COMPLETED|Overall Study||23
8099357|NCT03254459|19963939|P1|NOT COMPLETED|Overall Study||10
8099358|NCT03254459|19963938|P2|COMPLETED|Overall Study||27
8099359|NCT03254459|19963939|P1|COMPLETED|Overall Study||40
8099360|NCT03254459|19963938|P2|STARTED|Overall Study||50
8099361|NCT03254459|19963939|P1|STARTED|Overall Study||50
8099362|NCT03254147|19963957|P1|NOT COMPLETED|Overall Study||0
8099363|NCT03254147|19963957|P1|COMPLETED|Overall Study||53969
8099364|NCT03254147|19963957|P1|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969
8099365|NCT03254134|19963964|P2|NOT COMPLETED|Overall Study||3630
8099366|NCT03254134|19963965|P1|NOT COMPLETED|Overall Study||599
8099367|NCT03254134|19963964|P2|COMPLETED|Overall Study||13115
8099368|NCT03254134|19963965|P1|COMPLETED|Overall Study||5146
8099369|NCT03254134|19963964|P2|STARTED|Overall Study||16745
8099370|NCT03254134|19963965|P1|STARTED|Overall Study||5745
8099371|NCT03252964|19963973|P1|NOT COMPLETED|Overall Study||32
8099372|NCT03252964|19963973|P1|COMPLETED|Overall Study||20
8099373|NCT03252964|19963973|P1|STARTED|Overall Study||52
8099374|NCT03252353|19963989|P2|NOT COMPLETED|Overall Study||0
8099375|NCT03252353|19963990|P1|NOT COMPLETED|Overall Study||0
8099376|NCT03252353|19963989|P2|COMPLETED|Overall Study||28
8099377|NCT03252353|19963990|P1|COMPLETED|Overall Study||28
8099378|NCT03252353|19963989|P2|STARTED|Overall Study||28
8099379|NCT03252353|19963990|P1|STARTED|Overall Study||28
8099380|NCT03252145|19964002|P2|NOT COMPLETED|Overall Study||2
8099381|NCT03252145|19964003|P1|NOT COMPLETED|Overall Study||2
8099382|NCT03252145|19964002|P2|COMPLETED|Overall Study||13
8099383|NCT03252145|19964003|P1|COMPLETED|Overall Study||11
8099384|NCT03252145|19964002|P2|STARTED|Overall Study||15
8099385|NCT03252145|19964003|P1|STARTED|Overall Study||13
8099386|NCT03252015|19964071|P4|NOT COMPLETED|Overall Study||1
8099387|NCT03252015|19964072|P3|NOT COMPLETED|Overall Study||1
8099388|NCT03252015|19964073|P2|NOT COMPLETED|Overall Study||1
8099389|NCT03252015|19964074|P1|NOT COMPLETED|Overall Study||1
8099390|NCT03252015|19964071|P4|COMPLETED|Overall Study||14
8099391|NCT03252015|19964072|P3|COMPLETED|Overall Study||14
8099392|NCT03252015|19964073|P2|COMPLETED|Overall Study||27
8099393|NCT03252015|19964074|P1|COMPLETED|Overall Study||11
8099394|NCT03252015|19964071|P4|Received at Least 1 Dose of Study Drug|Overall Study||15
8099395|NCT03252015|19964072|P3|Received at Least 1 Dose of Study Drug|Overall Study||15
8099396|NCT03252015|19964073|P2|Received at Least 1 Dose of Study Drug|Overall Study||28
8099397|NCT03252015|19964074|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
8099398|NCT03252015|19964071|P4|STARTED|Overall Study||15
8099399|NCT03252015|19964072|P3|STARTED|Overall Study||15
8099400|NCT03252015|19964073|P2|STARTED|Overall Study||28
8099401|NCT03252015|19964074|P1|STARTED|Overall Study||12
8099402|NCT03251963|19964112|P2|NOT COMPLETED|Overall Study||5
8099403|NCT03251963|19964113|P1|NOT COMPLETED|Overall Study||9
8099404|NCT03251963|19964112|P2|COMPLETED|Overall Study||61
8099405|NCT03251963|19964113|P1|COMPLETED|Overall Study||56
8099406|NCT03251963|19964112|P2|STARTED|Overall Study||66
8099407|NCT03251963|19964113|P1|STARTED|Overall Study||65
8099411|NCT03251482|19964132|P5|NOT COMPLETED|Overall Study||0
8099412|NCT03251482|19964133|P4|NOT COMPLETED|Overall Study||0
8099413|NCT03251482|19964134|P3|NOT COMPLETED|Overall Study||0
8099414|NCT03251482|19964135|P2|NOT COMPLETED|Overall Study||1
8099415|NCT03251482|19964136|P1|NOT COMPLETED|Overall Study||0
8099416|NCT03251482|19964132|P5|COMPLETED|Overall Study||63
8099417|NCT03251482|19964133|P4|COMPLETED|Overall Study||122
8099418|NCT03251482|19964134|P3|COMPLETED|Overall Study||43
8099419|NCT03251482|19964135|P2|COMPLETED|Overall Study||40
8099420|NCT03251482|19964136|P1|COMPLETED|Overall Study||39
8099421|NCT03251482|19964132|P5|Treated|Overall Study||63
8099422|NCT03251482|19964133|P4|Treated|Overall Study||122
8099423|NCT03251482|19964134|P3|Treated|Overall Study||42
8099424|NCT03251482|19964135|P2|Treated|Overall Study||40
8099425|NCT03251482|19964136|P1|Treated|Overall Study||38
8099426|NCT03251482|19964132|P5|STARTED|Overall Study||63
8099427|NCT03251482|19964133|P4|STARTED|Overall Study||122
8099428|NCT03251482|19964134|P3|STARTED|Overall Study||43
8099429|NCT03251482|19964135|P2|STARTED|Overall Study||41
8099430|NCT03251482|19964136|P1|STARTED|Overall Study||39
8099431|NCT03251326|19964208|P4|NOT COMPLETED|Overall Study||0
8099432|NCT03251326|19964209|P3|NOT COMPLETED|Overall Study||0
8099433|NCT03251326|19964210|P2|NOT COMPLETED|Overall Study||0
8099434|NCT03251326|19964211|P1|NOT COMPLETED|Overall Study||0
8099435|NCT03251326|19964208|P4|COMPLETED|Overall Study||0
8099436|NCT03251326|19964209|P3|COMPLETED|Overall Study||0
8099437|NCT03251326|19964210|P2|COMPLETED|Overall Study||0
8099438|NCT03251326|19964211|P1|COMPLETED|Overall Study||0
8099439|NCT03251326|19964208|P4|STARTED|Overall Study||0
8099440|NCT03251326|19964209|P3|STARTED|Overall Study||0
8099441|NCT03251326|19964210|P2|STARTED|Overall Study||0
8099442|NCT03251326|19964211|P1|STARTED|Overall Study||0
8099443|NCT03250845|19964221|P1|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0
8099444|NCT03250845|19964221|P1|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30
8099445|NCT03250845|19964221|P1|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30
8099446|NCT03250845|19964221|P1|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0
8099447|NCT03250845|19964221|P1|COMPLETED|Multigam 5% Infusion (Baseline)||30
8099448|NCT03250845|19964221|P1|STARTED|Multigam 5% Infusion (Baseline)||30
8099455|NCT03249935|19964293|P1|NOT COMPLETED|Overall Study||45
8099456|NCT03249935|19964293|P1|COMPLETED|Overall Study||55
8099457|NCT03249935|19964293|P1|STARTED|Overall Study||100
8099458|NCT03249909|19964302|P3|NOT COMPLETED|Overall Study||0
8099459|NCT03249909|19964303|P2|NOT COMPLETED|Overall Study||1
8099460|NCT03249909|19964304|P1|NOT COMPLETED|Overall Study||6
8099461|NCT03249909|19964302|P3|COMPLETED|Overall Study||16
8099462|NCT03249909|19964303|P2|COMPLETED|Overall Study||14
8099463|NCT03249909|19964304|P1|COMPLETED|Overall Study||72
8099464|NCT03249909|19964302|P3|STARTED|Overall Study||16
8099465|NCT03249909|19964303|P2|STARTED|Overall Study||15
8099466|NCT03249909|19964304|P1|STARTED|Overall Study||78
8099467|NCT03249779|19964339|P1|NOT COMPLETED|Overall Study||0
8099468|NCT03249779|19964339|P1|COMPLETED|Overall Study||8
8099469|NCT03249779|19964339|P1|STARTED|Overall Study||8
8099470|NCT03249584|19964344|P1|NOT COMPLETED|Overall Study||98
8099471|NCT03249584|19964344|P1|COMPLETED|Overall Study||2
8099472|NCT03249584|19964344|P1|Month 3 Primary Objective|Overall Study|Included the first 42 Thoracic/Lumbar RF Ablation subjects to complete Month 3|42
8099473|NCT03249584|19964344|P1|Month 3|Overall Study||46
8099474|NCT03249584|19964344|P1|STARTED|Overall Study|87 subjects in the Thoracic/Lumbar and 13 subjects in the Periacetabulum, Iliac Crest, and/or Sacrum|100
8099475|NCT03249454|19964348|P11|NOT COMPLETED|Overall Study||1
8099476|NCT03249454|19964349|P10|NOT COMPLETED|Overall Study||1
8099477|NCT03249454|19964350|P9|NOT COMPLETED|Overall Study||0
8099478|NCT03249454|19964351|P8|NOT COMPLETED|Overall Study||0
8099479|NCT03249454|19964352|P7|NOT COMPLETED|Overall Study||0
8099480|NCT03249454|19964353|P6|NOT COMPLETED|Overall Study||0
8099481|NCT03249454|19964354|P5|NOT COMPLETED|Overall Study||0
8099482|NCT03249454|19964355|P4|NOT COMPLETED|Overall Study||0
8099483|NCT03249454|19964356|P3|NOT COMPLETED|Overall Study||0
8099484|NCT03249454|19964357|P2|NOT COMPLETED|Overall Study||0
8099485|NCT03249454|19964358|P1|NOT COMPLETED|Overall Study||0
8099486|NCT03249454|19964348|P11|COMPLETED|Overall Study||0
8099487|NCT03249454|19964349|P10|COMPLETED|Overall Study||0
8099488|NCT03249454|19964350|P9|COMPLETED|Overall Study||1
8099489|NCT03249454|19964351|P8|COMPLETED|Overall Study||1
8099490|NCT03249454|19964352|P7|COMPLETED|Overall Study||1
8099491|NCT03249454|19964353|P6|COMPLETED|Overall Study||2
8099492|NCT03249454|19964354|P5|COMPLETED|Overall Study||1
8099493|NCT03249454|19964355|P4|COMPLETED|Overall Study||1
8099494|NCT03249454|19964356|P3|COMPLETED|Overall Study||2
8099495|NCT03249454|19964357|P2|COMPLETED|Overall Study||1
8099496|NCT03249454|19964358|P1|COMPLETED|Overall Study||1
8099497|NCT03249454|19964348|P11|Fifth Intervention (1 Day)|Overall Study||0
8099498|NCT03249454|19964349|P10|Fifth Intervention (1 Day)|Overall Study||0
8099499|NCT03249454|19964350|P9|Fifth Intervention (1 Day)|Overall Study||1
8099500|NCT03249454|19964351|P8|Fifth Intervention (1 Day)|Overall Study||1
8099501|NCT03249454|19964352|P7|Fifth Intervention (1 Day)|Overall Study||1
8099502|NCT03249454|19964353|P6|Fifth Intervention (1 Day)|Overall Study||2
8099503|NCT03249454|19964354|P5|Fifth Intervention (1 Day)|Overall Study||1
8099504|NCT03249454|19964355|P4|Fifth Intervention (1 Day)|Overall Study||1
8099505|NCT03249454|19964356|P3|Fifth Intervention (1 Day)|Overall Study||2
8099506|NCT03249454|19964357|P2|Fifth Intervention (1 Day)|Overall Study||1
8099507|NCT03249454|19964358|P1|Fifth Intervention (1 Day)|Overall Study||1
8099508|NCT03249454|19964348|P11|Washout (1 Week)|Overall Study||0
8099509|NCT03249454|19964349|P10|Washout (1 Week)|Overall Study||0
8099510|NCT03249454|19964350|P9|Washout (1 Week)|Overall Study||1
8099511|NCT03249454|19964351|P8|Washout (1 Week)|Overall Study||1
8099512|NCT03249454|19964352|P7|Washout (1 Week)|Overall Study||1
8099513|NCT03249454|19964353|P6|Washout (1 Week)|Overall Study||2
8099514|NCT03249454|19964354|P5|Washout (1 Week)|Overall Study||1
8099515|NCT03249454|19964355|P4|Washout (1 Week)|Overall Study||1
8099516|NCT03249454|19964356|P3|Washout (1 Week)|Overall Study||2
8099517|NCT03249454|19964357|P2|Washout (1 Week)|Overall Study||1
8099518|NCT03249454|19964358|P1|Washout (1 Week)|Overall Study||1
8099519|NCT03249454|19964348|P11|Fourth Intervention (1 Day)|Overall Study||0
8099520|NCT03249454|19964349|P10|Fourth Intervention (1 Day)|Overall Study||0
8099521|NCT03249454|19964350|P9|Fourth Intervention (1 Day)|Overall Study||1
8099522|NCT03249454|19964351|P8|Fourth Intervention (1 Day)|Overall Study||1
8099523|NCT03249454|19964352|P7|Fourth Intervention (1 Day)|Overall Study||1
8099524|NCT03249454|19964353|P6|Fourth Intervention (1 Day)|Overall Study||2
8099525|NCT03249454|19964354|P5|Fourth Intervention (1 Day)|Overall Study||1
8099526|NCT03249454|19964355|P4|Fourth Intervention (1 Day)|Overall Study||1
8099527|NCT03249454|19964356|P3|Fourth Intervention (1 Day)|Overall Study||2
8099528|NCT03249454|19964357|P2|Fourth Intervention (1 Day)|Overall Study||1
8099529|NCT03249454|19964358|P1|Fourth Intervention (1 Day)|Overall Study||1
8099530|NCT03249454|19964348|P11|Washout (1 Week)|Overall Study||0
8099531|NCT03249454|19964349|P10|Washout (1 Week)|Overall Study||0
8099532|NCT03249454|19964350|P9|Washout (1 Week)|Overall Study||1
8099533|NCT03249454|19964351|P8|Washout (1 Week)|Overall Study||1
8099534|NCT03249454|19964352|P7|Washout (1 Week)|Overall Study||1
8099535|NCT03249454|19964353|P6|Washout (1 Week)|Overall Study||2
8099536|NCT03249454|19964354|P5|Washout (1 Week)|Overall Study||1
8099537|NCT03249454|19964355|P4|Washout (1 Week)|Overall Study||1
8099538|NCT03249454|19964356|P3|Washout (1 Week)|Overall Study||2
8099539|NCT03249454|19964357|P2|Washout (1 Week)|Overall Study||1
8099540|NCT03249454|19964358|P1|Washout (1 Week)|Overall Study||1
8099541|NCT03249454|19964348|P11|Third Intervention (1 Day)|Overall Study||0
8099542|NCT03249454|19964349|P10|Third Intervention (1 Day)|Overall Study||0
8099543|NCT03249454|19964350|P9|Third Intervention (1 Day)|Overall Study||1
8099544|NCT03249454|19964351|P8|Third Intervention (1 Day)|Overall Study||1
8099545|NCT03249454|19964352|P7|Third Intervention (1 Day)|Overall Study||1
8099546|NCT03249454|19964353|P6|Third Intervention (1 Day)|Overall Study||2
8099547|NCT03249454|19964354|P5|Third Intervention (1 Day)|Overall Study||1
8099548|NCT03249454|19964355|P4|Third Intervention (1 Day)|Overall Study||1
8099549|NCT03249454|19964356|P3|Third Intervention (1 Day)|Overall Study||2
8099550|NCT03249454|19964357|P2|Third Intervention (1 Day)|Overall Study||1
8099551|NCT03249454|19964358|P1|Third Intervention (1 Day)|Overall Study||1
8099552|NCT03249454|19964348|P11|Washout (1 Week)|Overall Study||0
8099553|NCT03249454|19964349|P10|Washout (1 Week)|Overall Study||0
8099554|NCT03249454|19964350|P9|Washout (1 Week)|Overall Study||1
8099555|NCT03249454|19964351|P8|Washout (1 Week)|Overall Study||1
8099556|NCT03249454|19964352|P7|Washout (1 Week)|Overall Study||1
8099557|NCT03249454|19964353|P6|Washout (1 Week)|Overall Study||2
8099558|NCT03249454|19964354|P5|Washout (1 Week)|Overall Study||1
8099559|NCT03249454|19964355|P4|Washout (1 Week)|Overall Study||1
8099560|NCT03249454|19964356|P3|Washout (1 Week)|Overall Study||2
8099561|NCT03249454|19964357|P2|Washout (1 Week)|Overall Study||1
8099562|NCT03249454|19964358|P1|Washout (1 Week)|Overall Study||1
8099563|NCT03249454|19964348|P11|Second Intervention (1 Day)|Overall Study||0
8099564|NCT03249454|19964349|P10|Second Intervention (1 Day)|Overall Study||0
8099565|NCT03249454|19964350|P9|Second Intervention (1 Day)|Overall Study||1
8099566|NCT03249454|19964351|P8|Second Intervention (1 Day)|Overall Study||1
8099567|NCT03249454|19964352|P7|Second Intervention (1 Day)|Overall Study||1
8099568|NCT03249454|19964353|P6|Second Intervention (1 Day)|Overall Study||2
8099569|NCT03249454|19964354|P5|Second Intervention (1 Day)|Overall Study||1
8099570|NCT03249454|19964355|P4|Second Intervention (1 Day)|Overall Study||1
8099571|NCT03249454|19964356|P3|Second Intervention (1 Day)|Overall Study||2
8099572|NCT03249454|19964357|P2|Second Intervention (1 Day)|Overall Study||1
8099573|NCT03249454|19964358|P1|Second Intervention (1 Day)|Overall Study||1
8099574|NCT03249454|19964348|P11|Washout (1 Week)|Overall Study||0
8099575|NCT03249454|19964349|P10|Washout (1 Week)|Overall Study||0
8099576|NCT03249454|19964350|P9|Washout (1 Week)|Overall Study||1
8099577|NCT03249454|19964351|P8|Washout (1 Week)|Overall Study||1
8099578|NCT03249454|19964352|P7|Washout (1 Week)|Overall Study||1
8099579|NCT03249454|19964353|P6|Washout (1 Week)|Overall Study||2
8099580|NCT03249454|19964354|P5|Washout (1 Week)|Overall Study||1
8099581|NCT03249454|19964355|P4|Washout (1 Week)|Overall Study||1
8099582|NCT03249454|19964356|P3|Washout (1 Week)|Overall Study||2
8099583|NCT03249454|19964357|P2|Washout (1 Week)|Overall Study||1
8099584|NCT03249454|19964358|P1|Washout (1 Week)|Overall Study||1
8099585|NCT03249454|19964348|P11|First Intervention (1 Day)|Overall Study||0
8099586|NCT03249454|19964349|P10|First Intervention (1 Day)|Overall Study||0
8099587|NCT03249454|19964350|P9|First Intervention (1 Day)|Overall Study||1
8099588|NCT03249454|19964351|P8|First Intervention (1 Day)|Overall Study||1
8099589|NCT03249454|19964352|P7|First Intervention (1 Day)|Overall Study||1
8099590|NCT03249454|19964353|P6|First Intervention (1 Day)|Overall Study||2
8099591|NCT03249454|19964354|P5|First Intervention (1 Day)|Overall Study||1
8099592|NCT03249454|19964355|P4|First Intervention (1 Day)|Overall Study||1
8099593|NCT03249454|19964356|P3|First Intervention (1 Day)|Overall Study||2
8099594|NCT03249454|19964357|P2|First Intervention (1 Day)|Overall Study||1
8099595|NCT03249454|19964358|P1|First Intervention (1 Day)|Overall Study||1
8099596|NCT03249454|19964348|P11|STARTED|Overall Study||1
8099597|NCT03249454|19964349|P10|STARTED|Overall Study||1
8099598|NCT03249454|19964350|P9|STARTED|Overall Study||1
8099599|NCT03249454|19964351|P8|STARTED|Overall Study||1
8099600|NCT03249454|19964352|P7|STARTED|Overall Study||1
8099601|NCT03249454|19964353|P6|STARTED|Overall Study||2
8099602|NCT03249454|19964354|P5|STARTED|Overall Study||1
8099603|NCT03249454|19964355|P4|STARTED|Overall Study||1
8099604|NCT03249454|19964356|P3|STARTED|Overall Study||2
8099605|NCT03249454|19964357|P2|STARTED|Overall Study||1
8099606|NCT03249454|19964358|P1|STARTED|Overall Study||1
8099607|NCT03249272|19964381|P3|NOT COMPLETED|Overall Study||0
8099608|NCT03249272|19964382|P2|NOT COMPLETED|Overall Study||0
8099609|NCT03249272|19964383|P1|NOT COMPLETED|Overall Study||0
8099610|NCT03249272|19964381|P3|COMPLETED|Overall Study||6
8099611|NCT03249272|19964382|P2|COMPLETED|Overall Study||6
8099612|NCT03249272|19964383|P1|COMPLETED|Overall Study||19
8099613|NCT03249272|19964381|P3|STARTED|Overall Study||6
8099614|NCT03249272|19964382|P2|STARTED|Overall Study||6
8099615|NCT03249272|19964383|P1|STARTED|Overall Study||19
8099616|NCT03249116|19964406|P3|NOT COMPLETED|Overall Study||0
8099617|NCT03249116|19964407|P2|NOT COMPLETED|Overall Study||0
8099618|NCT03249116|19964408|P1|NOT COMPLETED|Overall Study||0
8099619|NCT03249116|19964406|P3|COMPLETED|Overall Study||25
8099620|NCT03249116|19964407|P2|COMPLETED|Overall Study||25
8099621|NCT03249116|19964408|P1|COMPLETED|Overall Study||25
8099622|NCT03249116|19964406|P3|STARTED|Overall Study||25
8099623|NCT03249116|19964407|P2|STARTED|Overall Study||25
8099624|NCT03249116|19964408|P1|STARTED|Overall Study||25
8099628|NCT03248882|19964446|P5|NOT COMPLETED|Overall Study||13
8099629|NCT03248882|19964447|P4|NOT COMPLETED|Overall Study||10
8099630|NCT03248882|19964448|P3|NOT COMPLETED|Overall Study||7
8099631|NCT03248882|19964449|P2|NOT COMPLETED|Overall Study||5
8099632|NCT03248882|19964450|P1|NOT COMPLETED|Overall Study||7
8099633|NCT03248882|19964446|P5|COMPLETED|Overall Study||48
8099634|NCT03248882|19964447|P4|COMPLETED|Overall Study||48
8099635|NCT03248882|19964448|P3|COMPLETED|Overall Study||55
8099636|NCT03248882|19964449|P2|COMPLETED|Overall Study||58
8099637|NCT03248882|19964450|P1|COMPLETED|Overall Study||54
8099638|NCT03248882|19964446|P5|Received Treatment|Overall Study||61
8099639|NCT03248882|19964447|P4|Received Treatment|Overall Study||58
8099640|NCT03248882|19964448|P3|Received Treatment|Overall Study||62
8099641|NCT03248882|19964449|P2|Received Treatment|Overall Study||63
8099642|NCT03248882|19964450|P1|Received Treatment|Overall Study||61
8099643|NCT03248882|19964446|P5|STARTED|Overall Study||61
8099644|NCT03248882|19964447|P4|STARTED|Overall Study||58
8099645|NCT03248882|19964448|P3|STARTED|Overall Study||62
8099646|NCT03248882|19964449|P2|STARTED|Overall Study||63
8099647|NCT03248882|19964450|P1|STARTED|Overall Study||61
8099663|NCT03248141|19964536|P2|NOT COMPLETED|Overall Study||0
8099664|NCT03248141|19964537|P1|NOT COMPLETED|Overall Study||0
8099665|NCT03248141|19964536|P2|COMPLETED|Overall Study||0
8099666|NCT03248141|19964537|P1|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11
8099667|NCT03248141|19964536|P2|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0
8099668|NCT03248141|19964537|P1|STARTED|Overall Study||11
8099669|NCT03247985|19964547|P2|NOT COMPLETED|Overall Study||0
8099670|NCT03247985|19964548|P1|NOT COMPLETED|Overall Study||0
8099671|NCT03247985|19964547|P2|COMPLETED|Overall Study||19
8099672|NCT03247985|19964548|P1|COMPLETED|Overall Study||19
8099673|NCT03247985|19964547|P2|STARTED|Overall Study||19
8099674|NCT03247985|19964548|P1|STARTED|Overall Study||19
8099675|NCT03247816|19964562|P1|NOT COMPLETED|Overall Study||29
8099676|NCT03247816|19964562|P1|COMPLETED|Overall Study||30
8099677|NCT03247816|19964562|P1|STARTED|Overall Study||59
8099678|NCT03247790|19964592|P1|NOT COMPLETED|Period 2: Inter-ictal Period||0
8099679|NCT03247790|19964592|P1|COMPLETED|Period 2: Inter-ictal Period||16
8099680|NCT03247790|19964592|P1|STARTED|Period 2: Inter-ictal Period||16
8099681|NCT03247790|19964592|P1|NOT COMPLETED|Period 1: Migraine Attack||0
8099682|NCT03247790|19964592|P1|COMPLETED|Period 1: Migraine Attack||16
8099683|NCT03247790|19964592|P1|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16
8099684|NCT03247790|19964592|P1|STARTED|Period 1: Migraine Attack||16
8099685|NCT03247738|19964606|P2|NOT COMPLETED|Overall Study||0
8099686|NCT03247738|19964607|P1|NOT COMPLETED|Overall Study||0
8099687|NCT03247738|19964606|P2|COMPLETED|Overall Study||25
8099688|NCT03247738|19964607|P1|COMPLETED|Overall Study||25
8099689|NCT03247738|19964606|P2|STARTED|Overall Study||25
8099690|NCT03247738|19964607|P1|STARTED|Overall Study||25
8099691|NCT03247673|19964618|P3|NOT COMPLETED|Overall Study||4
8099692|NCT03247673|19964619|P2|NOT COMPLETED|Overall Study||0
8099693|NCT03247673|19964620|P1|NOT COMPLETED|Overall Study||1
8099694|NCT03247673|19964618|P3|COMPLETED|Overall Study||44
8099695|NCT03247673|19964619|P2|COMPLETED|Overall Study||47
8099696|NCT03247673|19964620|P1|COMPLETED|Overall Study||45
8099697|NCT03247673|19964618|P3|STARTED|Overall Study||48
8099698|NCT03247673|19964619|P2|STARTED|Overall Study||47
8099699|NCT03247673|19964620|P1|STARTED|Overall Study||46
8099700|NCT03246724|19964644|P4|NOT COMPLETED|Overall Study||8
8099701|NCT03246724|19964645|P3|NOT COMPLETED|Overall Study||15
8099702|NCT03246724|19964646|P2|NOT COMPLETED|Overall Study||7
8099703|NCT03246724|19964647|P1|NOT COMPLETED|Overall Study||14
8099704|NCT03246724|19964644|P4|COMPLETED|Overall Study||44
8099705|NCT03246724|19964645|P3|COMPLETED|Overall Study||70
8099706|NCT03246724|19964646|P2|COMPLETED|Overall Study||84
8099707|NCT03246724|19964647|P1|COMPLETED|Overall Study||85
8099708|NCT03246724|19964644|P4|STARTED|Overall Study||52
8099709|NCT03246724|19964645|P3|STARTED|Overall Study||85
8099710|NCT03246724|19964646|P2|STARTED|Overall Study||91
8099711|NCT03246724|19964647|P1|STARTED|Overall Study||99
8099712|NCT03246672|19964673|P1|NOT COMPLETED|Overall Study||2
8099713|NCT03246672|19964673|P1|COMPLETED|Overall Study||28
8099714|NCT03246672|19964673|P1|Completed First Phone Call|Overall Study||29
8099715|NCT03246672|19964673|P1|STARTED|Overall Study||30
8099716|NCT03246152|19964679|P1|NOT COMPLETED|Overall Study||3
8099717|NCT03246152|19964679|P1|COMPLETED|Overall Study||28
8099718|NCT03246152|19964679|P1|STARTED|Overall Study||31
8099719|NCT03246061|19964687|P2|NOT COMPLETED|Overall Study||21
8099720|NCT03246061|19964688|P1|NOT COMPLETED|Overall Study||15
8099721|NCT03246061|19964687|P2|COMPLETED|Overall Study||53
8099722|NCT03246061|19964688|P1|COMPLETED|Overall Study||51
8099723|NCT03246061|19964687|P2|Interim Analysis|Overall Study||53
8099724|NCT03246061|19964688|P1|Interim Analysis|Overall Study||51
8099725|NCT03246061|19964687|P2|STARTED|Overall Study||74
8099726|NCT03246061|19964688|P1|STARTED|Overall Study||66
8099727|NCT03245762|19964698|P2|NOT COMPLETED|Overall Study||0
8099728|NCT03245762|19964699|P1|NOT COMPLETED|Overall Study||0
8099729|NCT03245762|19964698|P2|COMPLETED|Overall Study||5
8099730|NCT03245762|19964699|P1|COMPLETED|Overall Study||10
8099731|NCT03245762|19964698|P2|STARTED|Overall Study||5
8099732|NCT03245762|19964699|P1|STARTED|Overall Study||10
8099733|NCT03245619|19964722|P17|NOT COMPLETED|Part C (Up to 34 Days)||0
8099734|NCT03245619|19964723|P16|NOT COMPLETED|Part C (Up to 34 Days)||0
8099735|NCT03245619|19964724|P15|NOT COMPLETED|Part C (Up to 34 Days)||0
8099736|NCT03245619|19964725|P14|NOT COMPLETED|Part C (Up to 34 Days)||0
8099737|NCT03245619|19964726|P13|NOT COMPLETED|Part C (Up to 34 Days)||0
8099738|NCT03245619|19964727|P12|NOT COMPLETED|Part C (Up to 34 Days)||0
8099739|NCT03245619|19964728|P11|NOT COMPLETED|Part C (Up to 34 Days)||0
8099740|NCT03245619|19964729|P10|NOT COMPLETED|Part C (Up to 34 Days)||0
8099741|NCT03245619|19964730|P9|NOT COMPLETED|Part C (Up to 34 Days)||0
8099742|NCT03245619|19964731|P8|NOT COMPLETED|Part C (Up to 34 Days)||0
8099743|NCT03245619|19964732|P7|NOT COMPLETED|Part C (Up to 34 Days)||0
8099744|NCT03245619|19964733|P6|NOT COMPLETED|Part C (Up to 34 Days)||0
8099745|NCT03245619|19964734|P5|NOT COMPLETED|Part C (Up to 34 Days)||0
8099746|NCT03245619|19964735|P4|NOT COMPLETED|Part C (Up to 34 Days)||0
8099747|NCT03245619|19964736|P3|NOT COMPLETED|Part C (Up to 34 Days)||0
8099748|NCT03245619|19964737|P2|NOT COMPLETED|Part C (Up to 34 Days)||0
8099749|NCT03245619|19964738|P1|NOT COMPLETED|Part C (Up to 34 Days)||0
8099750|NCT03245619|19964722|P17|COMPLETED|Part C (Up to 34 Days)||0
8099751|NCT03245619|19964723|P16|COMPLETED|Part C (Up to 34 Days)||0
8099752|NCT03245619|19964724|P15|COMPLETED|Part C (Up to 34 Days)||0
8099753|NCT03245619|19964725|P14|COMPLETED|Part C (Up to 34 Days)||0
8099754|NCT03245619|19964726|P13|COMPLETED|Part C (Up to 34 Days)||0
8099755|NCT03245619|19964727|P12|COMPLETED|Part C (Up to 34 Days)||0
8099756|NCT03245619|19964728|P11|COMPLETED|Part C (Up to 34 Days)||0
8099757|NCT03245619|19964729|P10|COMPLETED|Part C (Up to 34 Days)||0
8099758|NCT03245619|19964730|P9|COMPLETED|Part C (Up to 34 Days)||0
8099759|NCT03245619|19964731|P8|COMPLETED|Part C (Up to 34 Days)||0
8099760|NCT03245619|19964732|P7|COMPLETED|Part C (Up to 34 Days)||0
8099761|NCT03245619|19964733|P6|COMPLETED|Part C (Up to 34 Days)||0
8099762|NCT03245619|19964734|P5|COMPLETED|Part C (Up to 34 Days)||0
8099763|NCT03245619|19964735|P4|COMPLETED|Part C (Up to 34 Days)||0
8099764|NCT03245619|19964736|P3|COMPLETED|Part C (Up to 34 Days)||0
8099765|NCT03245619|19964737|P2|COMPLETED|Part C (Up to 34 Days)||0
8099766|NCT03245619|19964738|P1|COMPLETED|Part C (Up to 34 Days)||0
8099767|NCT03245619|19964722|P17|STARTED|Part C (Up to 34 Days)||0
8099768|NCT03245619|19964723|P16|STARTED|Part C (Up to 34 Days)||0
8099769|NCT03245619|19964724|P15|STARTED|Part C (Up to 34 Days)||0
8099770|NCT03245619|19964725|P14|STARTED|Part C (Up to 34 Days)||0
8099771|NCT03245619|19964726|P13|STARTED|Part C (Up to 34 Days)||0
8099772|NCT03245619|19964727|P12|STARTED|Part C (Up to 34 Days)||0
8099773|NCT03245619|19964728|P11|STARTED|Part C (Up to 34 Days)||0
8099774|NCT03245619|19964729|P10|STARTED|Part C (Up to 34 Days)||0
8099775|NCT03245619|19964730|P9|STARTED|Part C (Up to 34 Days)||0
8099776|NCT03245619|19964731|P8|STARTED|Part C (Up to 34 Days)||0
8099777|NCT03245619|19964732|P7|STARTED|Part C (Up to 34 Days)||0
8099778|NCT03245619|19964733|P6|STARTED|Part C (Up to 34 Days)||0
8099779|NCT03245619|19964734|P5|STARTED|Part C (Up to 34 Days)||0
8099780|NCT03245619|19964735|P4|STARTED|Part C (Up to 34 Days)||0
8099781|NCT03245619|19964736|P3|STARTED|Part C (Up to 34 Days)||0
8099782|NCT03245619|19964737|P2|STARTED|Part C (Up to 34 Days)||0
8099783|NCT03245619|19964738|P1|STARTED|Part C (Up to 34 Days)||0
8099784|NCT03245619|19964722|P17|NOT COMPLETED|Part B (Up to 34 Days)||0
8099785|NCT03245619|19964723|P16|NOT COMPLETED|Part B (Up to 34 Days)||0
8099786|NCT03245619|19964724|P15|NOT COMPLETED|Part B (Up to 34 Days)||0
8099787|NCT03245619|19964725|P14|NOT COMPLETED|Part B (Up to 34 Days)||0
8099788|NCT03245619|19964726|P13|NOT COMPLETED|Part B (Up to 34 Days)||0
8099789|NCT03245619|19964727|P12|NOT COMPLETED|Part B (Up to 34 Days)||0
8099790|NCT03245619|19964728|P11|NOT COMPLETED|Part B (Up to 34 Days)||0
8099791|NCT03245619|19964729|P10|NOT COMPLETED|Part B (Up to 34 Days)||0
8099792|NCT03245619|19964730|P9|NOT COMPLETED|Part B (Up to 34 Days)||0
8099793|NCT03245619|19964731|P8|NOT COMPLETED|Part B (Up to 34 Days)||0
8099794|NCT03245619|19964732|P7|NOT COMPLETED|Part B (Up to 34 Days)||0
8099795|NCT03245619|19964733|P6|NOT COMPLETED|Part B (Up to 34 Days)||0
8099796|NCT03245619|19964734|P5|NOT COMPLETED|Part B (Up to 34 Days)||0
8099797|NCT03245619|19964735|P4|NOT COMPLETED|Part B (Up to 34 Days)||0
8099798|NCT03245619|19964736|P3|NOT COMPLETED|Part B (Up to 34 Days)||0
8099799|NCT03245619|19964737|P2|NOT COMPLETED|Part B (Up to 34 Days)||0
8099800|NCT03245619|19964738|P1|NOT COMPLETED|Part B (Up to 34 Days)||0
8099801|NCT03245619|19964722|P17|COMPLETED|Part B (Up to 34 Days)||0
8099802|NCT03245619|19964723|P16|COMPLETED|Part B (Up to 34 Days)||0
8099803|NCT03245619|19964724|P15|COMPLETED|Part B (Up to 34 Days)||0
8099804|NCT03245619|19964725|P14|COMPLETED|Part B (Up to 34 Days)||0
8099805|NCT03245619|19964726|P13|COMPLETED|Part B (Up to 34 Days)||0
8099806|NCT03245619|19964727|P12|COMPLETED|Part B (Up to 34 Days)||0
8099807|NCT03245619|19964728|P11|COMPLETED|Part B (Up to 34 Days)||0
8099808|NCT03245619|19964729|P10|COMPLETED|Part B (Up to 34 Days)||0
8099809|NCT03245619|19964730|P9|COMPLETED|Part B (Up to 34 Days)||0
8099810|NCT03245619|19964731|P8|COMPLETED|Part B (Up to 34 Days)||0
8099811|NCT03245619|19964732|P7|COMPLETED|Part B (Up to 34 Days)||0
8099812|NCT03245619|19964733|P6|COMPLETED|Part B (Up to 34 Days)||0
8099813|NCT03245619|19964734|P5|COMPLETED|Part B (Up to 34 Days)||0
8099814|NCT03245619|19964735|P4|COMPLETED|Part B (Up to 34 Days)||0
8099815|NCT03245619|19964736|P3|COMPLETED|Part B (Up to 34 Days)||0
8099816|NCT03245619|19964737|P2|COMPLETED|Part B (Up to 34 Days)||0
8099817|NCT03245619|19964738|P1|COMPLETED|Part B (Up to 34 Days)||0
8099818|NCT03245619|19964722|P17|STARTED|Part B (Up to 34 Days)||0
8099819|NCT03245619|19964723|P16|STARTED|Part B (Up to 34 Days)||0
8099820|NCT03245619|19964724|P15|STARTED|Part B (Up to 34 Days)||0
8099821|NCT03245619|19964725|P14|STARTED|Part B (Up to 34 Days)||0
8099822|NCT03245619|19964726|P13|STARTED|Part B (Up to 34 Days)||0
8099823|NCT03245619|19964727|P12|STARTED|Part B (Up to 34 Days)||0
8099824|NCT03245619|19964728|P11|STARTED|Part B (Up to 34 Days)||0
8099825|NCT03245619|19964729|P10|STARTED|Part B (Up to 34 Days)||0
8099826|NCT03245619|19964730|P9|STARTED|Part B (Up to 34 Days)||0
8099827|NCT03245619|19964731|P8|STARTED|Part B (Up to 34 Days)||0
8099828|NCT03245619|19964732|P7|STARTED|Part B (Up to 34 Days)||0
8099829|NCT03245619|19964733|P6|STARTED|Part B (Up to 34 Days)||0
8099830|NCT03245619|19964734|P5|STARTED|Part B (Up to 34 Days)||0
8099831|NCT03245619|19964735|P4|STARTED|Part B (Up to 34 Days)||0
8099832|NCT03245619|19964736|P3|STARTED|Part B (Up to 34 Days)||0
8099833|NCT03245619|19964737|P2|STARTED|Part B (Up to 34 Days)||0
8099834|NCT03245619|19964738|P1|STARTED|Part B (Up to 34 Days)||0
8099835|NCT03245619|19964722|P17|NOT COMPLETED|Part A (Up to Day 22)||0
8099836|NCT03245619|19964723|P16|NOT COMPLETED|Part A (Up to Day 22)||0
8099837|NCT03245619|19964724|P15|NOT COMPLETED|Part A (Up to Day 22)||0
8099838|NCT03245619|19964725|P14|NOT COMPLETED|Part A (Up to Day 22)||0
8099839|NCT03245619|19964726|P13|NOT COMPLETED|Part A (Up to Day 22)||0
8099840|NCT03245619|19964727|P12|NOT COMPLETED|Part A (Up to Day 22)||0
8099841|NCT03245619|19964728|P11|NOT COMPLETED|Part A (Up to Day 22)||0
8099842|NCT03245619|19964729|P10|NOT COMPLETED|Part A (Up to Day 22)||0
8099843|NCT03245619|19964730|P9|NOT COMPLETED|Part A (Up to Day 22)||0
8099844|NCT03245619|19964731|P8|NOT COMPLETED|Part A (Up to Day 22)||0
8099845|NCT03245619|19964732|P7|NOT COMPLETED|Part A (Up to Day 22)||0
8099846|NCT03245619|19964733|P6|NOT COMPLETED|Part A (Up to Day 22)||0
8099847|NCT03245619|19964734|P5|NOT COMPLETED|Part A (Up to Day 22)||0
8099848|NCT03245619|19964735|P4|NOT COMPLETED|Part A (Up to Day 22)||0
8099849|NCT03245619|19964736|P3|NOT COMPLETED|Part A (Up to Day 22)||6
8099850|NCT03245619|19964737|P2|NOT COMPLETED|Part A (Up to Day 22)||6
8099851|NCT03245619|19964738|P1|NOT COMPLETED|Part A (Up to Day 22)||4
8099852|NCT03245619|19964722|P17|COMPLETED|Part A (Up to Day 22)||0
8099853|NCT03245619|19964723|P16|COMPLETED|Part A (Up to Day 22)||0
8099854|NCT03245619|19964724|P15|COMPLETED|Part A (Up to Day 22)||0
8099855|NCT03245619|19964725|P14|COMPLETED|Part A (Up to Day 22)||0
8099856|NCT03245619|19964726|P13|COMPLETED|Part A (Up to Day 22)||0
8099857|NCT03245619|19964727|P12|COMPLETED|Part A (Up to Day 22)||0
8099858|NCT03245619|19964728|P11|COMPLETED|Part A (Up to Day 22)||0
8099859|NCT03245619|19964729|P10|COMPLETED|Part A (Up to Day 22)||0
8099860|NCT03245619|19964730|P9|COMPLETED|Part A (Up to Day 22)||0
8099861|NCT03245619|19964731|P8|COMPLETED|Part A (Up to Day 22)||0
8099862|NCT03245619|19964732|P7|COMPLETED|Part A (Up to Day 22)||0
8099863|NCT03245619|19964733|P6|COMPLETED|Part A (Up to Day 22)||0
8099864|NCT03245619|19964734|P5|COMPLETED|Part A (Up to Day 22)||0
8099865|NCT03245619|19964735|P4|COMPLETED|Part A (Up to Day 22)||1
8099866|NCT03245619|19964736|P3|COMPLETED|Part A (Up to Day 22)||0
8099867|NCT03245619|19964737|P2|COMPLETED|Part A (Up to Day 22)||0
8099868|NCT03245619|19964738|P1|COMPLETED|Part A (Up to Day 22)||1
8099869|NCT03245619|19964722|P17|STARTED|Part A (Up to Day 22)||0
8099870|NCT03245619|19964723|P16|STARTED|Part A (Up to Day 22)||0
8099871|NCT03245619|19964724|P15|STARTED|Part A (Up to Day 22)||0
8099872|NCT03245619|19964725|P14|STARTED|Part A (Up to Day 22)||0
8099873|NCT03245619|19964726|P13|STARTED|Part A (Up to Day 22)||0
8099874|NCT03245619|19964727|P12|STARTED|Part A (Up to Day 22)||0
8099875|NCT03245619|19964728|P11|STARTED|Part A (Up to Day 22)||0
8099876|NCT03245619|19964729|P10|STARTED|Part A (Up to Day 22)||0
8099877|NCT03245619|19964730|P9|STARTED|Part A (Up to Day 22)||0
8099878|NCT03245619|19964731|P8|STARTED|Part A (Up to Day 22)||0
8099879|NCT03245619|19964732|P7|STARTED|Part A (Up to Day 22)||0
8099880|NCT03245619|19964733|P6|STARTED|Part A (Up to Day 22)||0
8099881|NCT03245619|19964734|P5|STARTED|Part A (Up to Day 22)||0
8099882|NCT03245619|19964735|P4|STARTED|Part A (Up to Day 22)||1
8099883|NCT03245619|19964736|P3|STARTED|Part A (Up to Day 22)||6
8099884|NCT03245619|19964737|P2|STARTED|Part A (Up to Day 22)||6
8099885|NCT03245619|19964738|P1|STARTED|Part A (Up to Day 22)||5
8099886|NCT03245463|19964993|P2|NOT COMPLETED|Overall Study||0
8099887|NCT03245463|19964994|P1|NOT COMPLETED|Overall Study||0
8099888|NCT03245463|19964993|P2|COMPLETED|Overall Study||12
8099889|NCT03245463|19964994|P1|COMPLETED|Overall Study||12
8099890|NCT03245463|19964993|P2|STARTED|Overall Study||12
8099891|NCT03245463|19964994|P1|STARTED|Overall Study||12
8099892|NCT03245398|19965012|P2|NOT COMPLETED|Overall Study||0
8099893|NCT03245398|19965013|P1|NOT COMPLETED|Overall Study||1
8099894|NCT03245398|19965012|P2|COMPLETED|Overall Study||93
8099895|NCT03245398|19965013|P1|COMPLETED|Overall Study||92
8099896|NCT03245398|19965012|P2|STARTED|Overall Study||93
8099897|NCT03245398|19965013|P1|STARTED|Overall Study||93
8099898|NCT03244865|19965035|P1|NOT COMPLETED|Overall Study||0
8099899|NCT03244865|19965035|P1|COMPLETED|Overall Study||35
8099900|NCT03244865|19965035|P1|STARTED|Overall Study||35
8099901|NCT03244800|19965043|P4|NOT COMPLETED|Overall Study||2
8099902|NCT03244800|19965044|P3|NOT COMPLETED|Overall Study||0
8099903|NCT03244800|19965045|P2|NOT COMPLETED|Overall Study||1
8099904|NCT03244800|19965046|P1|NOT COMPLETED|Overall Study||0
8099905|NCT03244800|19965043|P4|COMPLETED|Overall Study||18
8099906|NCT03244800|19965044|P3|COMPLETED|Overall Study||6
8099907|NCT03244800|19965045|P2|COMPLETED|Overall Study||25
8099908|NCT03244800|19965046|P1|COMPLETED|Overall Study||13
8099909|NCT03244800|19965043|P4|STARTED|Overall Study||20
8099910|NCT03244800|19965044|P3|STARTED|Overall Study||6
8099911|NCT03244800|19965045|P2|STARTED|Overall Study||26
8099912|NCT03244800|19965046|P1|STARTED|Overall Study||13
8099913|NCT03244618|19965106|P2|NOT COMPLETED|Overall Study||9
8099914|NCT03244618|19965107|P1|NOT COMPLETED|Overall Study||7
8099915|NCT03244618|19965106|P2|COMPLETED|Overall Study||122
8099916|NCT03244618|19965107|P1|COMPLETED|Overall Study||125
8099917|NCT03244618|19965106|P2|Week 2|Overall Study||125
8099918|NCT03244618|19965107|P1|Week 2|Overall Study||128
8099919|NCT03244618|19965106|P2|STARTED|Overall Study||131
8099920|NCT03244618|19965107|P1|STARTED|Overall Study||132
8099921|NCT03243981|19965123|P1|NOT COMPLETED|Overall Study||0
8099922|NCT03243981|19965123|P1|COMPLETED|Overall Study||5
8099923|NCT03243981|19965123|P1|STARTED|Overall Study||5
8099924|NCT03243630|19965142|P1|NOT COMPLETED|Overall Study||2
8099925|NCT03243630|19965142|P1|COMPLETED|Overall Study||22
8099926|NCT03243630|19965142|P1|Green Apple and Menthol E-liquid Lower|Overall Study||21
8099927|NCT03243630|19965142|P1|Green Apple and Menthol E-liquid Higher|Overall Study||21
8099928|NCT03243630|19965142|P1|Green Apple and Menthol E-liquid Saline|Overall Study||21
8099929|NCT03243630|19965142|P1|Green Apple E-liquid Lower|Overall Study||20
8099930|NCT03243630|19965142|P1|Green Apple E-liquid Higher|Overall Study||20
8099931|NCT03243630|19965142|P1|Green Apple E-liquid Saline|Overall Study||20
8099932|NCT03243630|19965142|P1|Menthol E-liquid Lower|Overall Study||22
8099933|NCT03243630|19965142|P1|Menthol E-liquid Higher|Overall Study||22
8099934|NCT03243630|19965142|P1|Menthol E-liquid Saline|Overall Study||22
8099935|NCT03243630|19965142|P1|STARTED|Overall Study||24
8099936|NCT03243305|19965150|P1|NOT COMPLETED|Overall Study||935
8099937|NCT03243305|19965150|P1|COMPLETED|Overall Study||449
8099938|NCT03243305|19965150|P1|STARTED|Overall Study||1384
8099939|NCT03243084|19965157|P2|NOT COMPLETED|Session 2||0
8099940|NCT03243084|19965158|P1|NOT COMPLETED|Session 2||0
8099941|NCT03243084|19965157|P2|COMPLETED|Session 2||10
8099942|NCT03243084|19965158|P1|COMPLETED|Session 2||10
8099943|NCT03243084|19965157|P2|STARTED|Session 2||10
8099944|NCT03243084|19965158|P1|STARTED|Session 2||10
8099945|NCT03243084|19965157|P2|NOT COMPLETED|Washout (1-3 Weeks)||0
8099946|NCT03243084|19965158|P1|NOT COMPLETED|Washout (1-3 Weeks)||1
8099947|NCT03243084|19965157|P2|COMPLETED|Washout (1-3 Weeks)||10
8099948|NCT03243084|19965158|P1|COMPLETED|Washout (1-3 Weeks)||10
8099949|NCT03243084|19965157|P2|STARTED|Washout (1-3 Weeks)||10
8099950|NCT03243084|19965158|P1|STARTED|Washout (1-3 Weeks)||11
8099951|NCT03243084|19965157|P2|NOT COMPLETED|Session 1||0
8099952|NCT03243084|19965158|P1|NOT COMPLETED|Session 1||0
8099953|NCT03243084|19965157|P2|COMPLETED|Session 1||10
8099954|NCT03243084|19965158|P1|COMPLETED|Session 1||11
8099955|NCT03243084|19965157|P2|STARTED|Session 1||10
8099956|NCT03243084|19965158|P1|STARTED|Session 1||11
8099957|NCT03242941|19965168|P1|NOT COMPLETED|Overall Study||2
8099958|NCT03242941|19965168|P1|COMPLETED|Overall Study||14
8099959|NCT03242941|19965168|P1|STARTED|Overall Study||16
8099960|NCT03242863|19965174|P6|NOT COMPLETED|Study Week 3||0
8099961|NCT03242863|19965175|P5|NOT COMPLETED|Study Week 3||0
8099962|NCT03242863|19965176|P4|NOT COMPLETED|Study Week 3||0
8099963|NCT03242863|19965177|P3|NOT COMPLETED|Study Week 3||0
8099964|NCT03242863|19965178|P2|NOT COMPLETED|Study Week 3||0
8099965|NCT03242863|19965179|P1|NOT COMPLETED|Study Week 3||0
8099966|NCT03242863|19965174|P6|COMPLETED|Study Week 3||5
8099967|NCT03242863|19965175|P5|COMPLETED|Study Week 3||12
8099968|NCT03242863|19965176|P4|COMPLETED|Study Week 3||4
8099969|NCT03242863|19965177|P3|COMPLETED|Study Week 3||4
8099970|NCT03242863|19965178|P2|COMPLETED|Study Week 3||15
8099971|NCT03242863|19965179|P1|COMPLETED|Study Week 3||13
8099972|NCT03242863|19965174|P6|STARTED|Study Week 3||5
8099973|NCT03242863|19965175|P5|STARTED|Study Week 3||12
8099974|NCT03242863|19965176|P4|STARTED|Study Week 3||4
8099975|NCT03242863|19965177|P3|STARTED|Study Week 3||4
8099976|NCT03242863|19965178|P2|STARTED|Study Week 3||15
8099977|NCT03242863|19965179|P1|STARTED|Study Week 3||13
8099978|NCT03242863|19965174|P6|NOT COMPLETED|Study Week 2||0
8099979|NCT03242863|19965175|P5|NOT COMPLETED|Study Week 2||0
8099980|NCT03242863|19965176|P4|NOT COMPLETED|Study Week 2||0
8099981|NCT03242863|19965177|P3|NOT COMPLETED|Study Week 2||0
8099982|NCT03242863|19965178|P2|NOT COMPLETED|Study Week 2||0
8099983|NCT03242863|19965179|P1|NOT COMPLETED|Study Week 2||0
8099984|NCT03242863|19965174|P6|COMPLETED|Study Week 2||5
8099985|NCT03242863|19965175|P5|COMPLETED|Study Week 2||12
8099986|NCT03242863|19965176|P4|COMPLETED|Study Week 2||4
8099987|NCT03242863|19965177|P3|COMPLETED|Study Week 2||4
8099988|NCT03242863|19965178|P2|COMPLETED|Study Week 2||15
8099989|NCT03242863|19965179|P1|COMPLETED|Study Week 2||13
8099990|NCT03242863|19965174|P6|STARTED|Study Week 2||5
8099991|NCT03242863|19965175|P5|STARTED|Study Week 2||12
8099992|NCT03242863|19965176|P4|STARTED|Study Week 2||4
8099993|NCT03242863|19965177|P3|STARTED|Study Week 2||4
8099994|NCT03242863|19965178|P2|STARTED|Study Week 2||15
8099995|NCT03242863|19965179|P1|STARTED|Study Week 2||13
8099996|NCT03242863|19965174|P6|NOT COMPLETED|Study Week 1||0
8099997|NCT03242863|19965175|P5|NOT COMPLETED|Study Week 1||3
8099998|NCT03242863|19965176|P4|NOT COMPLETED|Study Week 1||0
8099999|NCT03242863|19965177|P3|NOT COMPLETED|Study Week 1||0
8100000|NCT03242863|19965178|P2|NOT COMPLETED|Study Week 1||1
8100001|NCT03242863|19965179|P1|NOT COMPLETED|Study Week 1||0
8100002|NCT03242863|19965174|P6|COMPLETED|Study Week 1||5
8100003|NCT03242863|19965175|P5|COMPLETED|Study Week 1||12
8100004|NCT03242863|19965176|P4|COMPLETED|Study Week 1||4
8100005|NCT03242863|19965177|P3|COMPLETED|Study Week 1||4
8100006|NCT03242863|19965178|P2|COMPLETED|Study Week 1||15
8100007|NCT03242863|19965179|P1|COMPLETED|Study Week 1||13
8100008|NCT03242863|19965174|P6|STARTED|Study Week 1||5
8100009|NCT03242863|19965175|P5|STARTED|Study Week 1||15
8100010|NCT03242863|19965176|P4|STARTED|Study Week 1||4
8100011|NCT03242863|19965177|P3|STARTED|Study Week 1||4
8100012|NCT03242863|19965178|P2|STARTED|Study Week 1||16
8100013|NCT03242863|19965179|P1|STARTED|Study Week 1||13
8100014|NCT03242590|19965196|P1|NOT COMPLETED|Overall Study||0
8100015|NCT03242590|19965196|P1|COMPLETED|Overall Study||95
8100016|NCT03242590|19965196|P1|STARTED|Overall Study||95
8100017|NCT03242434|19965202|P2|NOT COMPLETED|Overall Study||2
8100018|NCT03242434|19965203|P1|NOT COMPLETED|Overall Study||0
8100019|NCT03242434|19965202|P2|COMPLETED|Overall Study||1
8100020|NCT03242434|19965203|P1|COMPLETED|Overall Study||15
8100021|NCT03242434|19965202|P2|STARTED|Overall Study||3
8100022|NCT03242434|19965203|P1|STARTED|Overall Study||15
8100023|NCT03242408|19965211|P1|NOT COMPLETED|Overall Study||2
8100024|NCT03242408|19965211|P1|COMPLETED|Overall Study||98
8100025|NCT03242408|19965211|P1|STARTED|Overall Study||100
8100026|NCT03241927|19965215|P2|NOT COMPLETED|Overall Study||0
8100027|NCT03241927|19965216|P1|NOT COMPLETED|Overall Study||1
8100028|NCT03241927|19965215|P2|COMPLETED|Overall Study||0
8100029|NCT03241927|19965216|P1|COMPLETED|Overall Study||0
8100030|NCT03241927|19965215|P2|STARTED|Overall Study||0
8100031|NCT03241927|19965216|P1|STARTED|Overall Study||1
8100032|NCT03241862|19965236|P1|NOT COMPLETED|Overall Study||0
8100033|NCT03241862|19965236|P1|COMPLETED|Overall Study||20
8100034|NCT03241862|19965236|P1|STARTED|Overall Study||20
8100035|NCT03241810|19965243|P2|NOT COMPLETED|Overall Study||0
8100036|NCT03241810|19965244|P1|NOT COMPLETED|Overall Study||0
8100037|NCT03241810|19965243|P2|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
8100038|NCT03241810|19965244|P1|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
8100039|NCT03241810|19965243|P2|STARTED|Overall Study||11
8100040|NCT03241810|19965244|P1|STARTED|Overall Study||11
8100041|NCT03241368|19965262|P1|NOT COMPLETED|Overall Study||39
8100042|NCT03241368|19965262|P1|COMPLETED|Overall Study||119
8100043|NCT03241368|19965262|P1|STARTED|Overall Study||158
8100053|NCT03240575|19965286|P4|NOT COMPLETED|Overall Study||2
8100054|NCT03240575|19965287|P3|NOT COMPLETED|Overall Study||0
8100055|NCT03240575|19965288|P2|NOT COMPLETED|Overall Study||14
8100056|NCT03240575|19965289|P1|NOT COMPLETED|Overall Study||2
8100057|NCT03240575|19965286|P4|COMPLETED|Overall Study||3
8100058|NCT03240575|19965287|P3|COMPLETED|Overall Study||6
8100059|NCT03240575|19965288|P2|COMPLETED|Overall Study||131
8100060|NCT03240575|19965289|P1|COMPLETED|Overall Study||144
8100061|NCT03240575|19965286|P4|STARTED|Overall Study||5
8100062|NCT03240575|19965287|P3|STARTED|Overall Study||6
8100063|NCT03240575|19965288|P2|STARTED|Overall Study||145
8100064|NCT03240575|19965289|P1|STARTED|Overall Study||146
8100065|NCT03240081|19965311|P2|NOT COMPLETED|Overall Study||3
8100066|NCT03240081|19965312|P1|NOT COMPLETED|Overall Study||0
8100067|NCT03240081|19965311|P2|COMPLETED|Overall Study||22
8100068|NCT03240081|19965312|P1|COMPLETED|Overall Study||25
8100069|NCT03240081|19965311|P2|STARTED|Overall Study||25
8100070|NCT03240081|19965312|P1|STARTED|Overall Study||25
8100071|NCT03239873|19965322|P2|NOT COMPLETED|Overall Study||27
8100072|NCT03239873|19965323|P1|NOT COMPLETED|Overall Study||32
8100073|NCT03239873|19965322|P2|COMPLETED|Overall Study||273
8100074|NCT03239873|19965323|P1|COMPLETED|Overall Study||268
8100075|NCT03239873|19965322|P2|Vaccination 2|Overall Study||282
8100076|NCT03239873|19965323|P1|Vaccination 2|Overall Study||276
8100077|NCT03239873|19965322|P2|Vaccination 1|Overall Study||300
8100078|NCT03239873|19965323|P1|Vaccination 1|Overall Study||299
8100079|NCT03239873|19965322|P2|STARTED|Overall Study||300
8100080|NCT03239873|19965323|P1|STARTED|Overall Study||300
8100081|NCT03239665|19965369|P2|NOT COMPLETED|Overall Study||20
8100082|NCT03239665|19965370|P1|NOT COMPLETED|Overall Study||28
8100083|NCT03239665|19965369|P2|COMPLETED|Overall Study||140
8100084|NCT03239665|19965370|P1|COMPLETED|Overall Study||147
8100085|NCT03239665|19965369|P2|Submitted Survey Data|Overall Study||140
8100086|NCT03239665|19965370|P1|Submitted Survey Data|Overall Study||147
8100087|NCT03239665|19965369|P2|Met Inclusion Criteria|Overall Study||144
8100088|NCT03239665|19965370|P1|Met Inclusion Criteria|Overall Study||150
8100089|NCT03239665|19965369|P2|STARTED|Overall Study||160
8100090|NCT03239665|19965370|P1|STARTED|Overall Study||175
8100091|NCT03239522|19965390|P1|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0
8100092|NCT03239522|19965390|P1|COMPLETED|Treatment Period 2 (Up to 15 Days)||6
8100093|NCT03239522|19965390|P1|STARTED|Treatment Period 2 (Up to 15 Days)||6
8100094|NCT03239522|19965390|P1|NOT COMPLETED|Washout Period (Up to 7 Days)||0
8100095|NCT03239522|19965390|P1|COMPLETED|Washout Period (Up to 7 Days)||6
8100096|NCT03239522|19965390|P1|STARTED|Washout Period (Up to 7 Days)||6
8100097|NCT03239522|19965390|P1|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
8100098|NCT03239522|19965390|P1|COMPLETED|Treatment Period 1 (Up to 7 Days)||6
8100099|NCT03239522|19965390|P1|STARTED|Treatment Period 1 (Up to 7 Days)||6
8100100|NCT03239496|19965484|P4|NOT COMPLETED|Overall Study||14
8100101|NCT03239496|19965485|P3|NOT COMPLETED|Overall Study||12
8100102|NCT03239496|19965486|P2|NOT COMPLETED|Overall Study||10
8100103|NCT03239496|19965487|P1|NOT COMPLETED|Overall Study||14
8100104|NCT03239496|19965484|P4|COMPLETED|Overall Study||203
8100105|NCT03239496|19965485|P3|COMPLETED|Overall Study||166
8100106|NCT03239496|19965486|P2|COMPLETED|Overall Study||168
8100107|NCT03239496|19965487|P1|COMPLETED|Overall Study||186
8100108|NCT03239496|19965484|P4|STARTED|Overall Study||217
8100109|NCT03239496|19965485|P3|STARTED|Overall Study||178
8100110|NCT03239496|19965486|P2|STARTED|Overall Study||178
8100111|NCT03239496|19965487|P1|STARTED|Overall Study||200
8100112|NCT03239483|19965515|P2|NOT COMPLETED|Overall Study||0
8100113|NCT03239483|19965516|P1|NOT COMPLETED|Overall Study||2
8100114|NCT03239483|19965515|P2|COMPLETED|Overall Study||9
8100115|NCT03239483|19965516|P1|COMPLETED|Overall Study||17
8100116|NCT03239483|19965515|P2|STARTED|Overall Study||9
8100117|NCT03239483|19965516|P1|STARTED|Overall Study||19
8100121|NCT03238924|19965537|P2|NOT COMPLETED|Overall Study||2
8100122|NCT03238924|19965538|P1|NOT COMPLETED|Overall Study||2
8100123|NCT03238924|19965537|P2|COMPLETED|Overall Study||7
8100124|NCT03238924|19965538|P1|COMPLETED|Overall Study||6
8100125|NCT03238924|19965537|P2|STARTED|Overall Study||9
8100126|NCT03238924|19965538|P1|STARTED|Overall Study||8
8100127|NCT03238911|19965550|P2|NOT COMPLETED|Overall Study||3
8100128|NCT03238911|19965551|P1|NOT COMPLETED|Overall Study||3
8100129|NCT03238911|19965550|P2|COMPLETED|Overall Study||58
8100130|NCT03238911|19965551|P1|COMPLETED|Overall Study||59
8100131|NCT03238911|19965550|P2|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|60
8100132|NCT03238911|19965551|P1|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|63
8100133|NCT03238911|19965550|P2|STARTED|Overall Study||61
8100134|NCT03238911|19965551|P1|STARTED|Overall Study||62
8100135|NCT03238781|19965594|P3|NOT COMPLETED|Overall Study||20
8100136|NCT03238781|19965595|P2|NOT COMPLETED|Overall Study||17
8100137|NCT03238781|19965596|P1|NOT COMPLETED|Overall Study||26
8100138|NCT03238781|19965594|P3|COMPLETED|Overall Study||82
8100139|NCT03238781|19965595|P2|COMPLETED|Overall Study||87
8100140|NCT03238781|19965596|P1|COMPLETED|Overall Study||111
8100141|NCT03238781|19965594|P3|STARTED|Overall Study||102
8100142|NCT03238781|19965595|P2|STARTED|Overall Study||104
8100143|NCT03238781|19965596|P1|STARTED|Overall Study||137
8100144|NCT03238352|19965646|P3|NOT COMPLETED|Overall Study||1
8100145|NCT03238352|19965647|P2|NOT COMPLETED|Overall Study||3
8100146|NCT03238352|19965648|P1|NOT COMPLETED|Overall Study||0
8100147|NCT03238352|19965646|P3|COMPLETED|Overall Study||22
8100148|NCT03238352|19965647|P2|COMPLETED|Overall Study||20
8100149|NCT03238352|19965648|P1|COMPLETED|Overall Study||43
8100150|NCT03238352|19965646|P3|STARTED|Overall Study||23
8100151|NCT03238352|19965647|P2|STARTED|Overall Study||23
8100152|NCT03238352|19965648|P1|STARTED|Overall Study||43
8100153|NCT03238001|19965659|P1|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
8100154|NCT03238001|19965659|P1|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
8100155|NCT03238001|19965659|P1|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
8100156|NCT03238001|19965659|P1|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
8100157|NCT03238001|19965659|P1|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
8100158|NCT03238001|19965659|P1|STARTED|Visit 1 (Primary Endpoint Cohort)||436
8100159|NCT03237871|19965682|P1|NOT COMPLETED|Overall Study||6
8100160|NCT03237871|19965682|P1|COMPLETED|Overall Study||11
8100161|NCT03237871|19965682|P1|STARTED|Overall Study||17
8100162|NCT03237845|19965690|P2|NOT COMPLETED|Overall Study||50
8100163|NCT03237845|19965691|P1|NOT COMPLETED|Overall Study||56
8100164|NCT03237845|19965690|P2|COMPLETED|Overall Study||542
8100165|NCT03237845|19965691|P1|COMPLETED|Overall Study||538
8100166|NCT03237845|19965690|P2|Treated|Overall Study||543
8100167|NCT03237845|19965691|P1|Treated|Overall Study||543
8100168|NCT03237845|19965690|P2|STARTED|Overall Study||592
8100169|NCT03237845|19965691|P1|STARTED|Overall Study||594
8100170|NCT03237156|19965725|P4|NOT COMPLETED|Overall Study||0
8100171|NCT03237156|19965726|P3|NOT COMPLETED|Overall Study||0
8100172|NCT03237156|19965727|P2|NOT COMPLETED|Overall Study||0
8100173|NCT03237156|19965728|P1|NOT COMPLETED|Overall Study||0
8100174|NCT03237156|19965725|P4|COMPLETED|Overall Study||6
8100175|NCT03237156|19965726|P3|COMPLETED|Overall Study||6
8100176|NCT03237156|19965727|P2|COMPLETED|Overall Study||6
8100177|NCT03237156|19965728|P1|COMPLETED|Overall Study||6
8100178|NCT03237156|19965725|P4|STARTED|Overall Study||6
8100179|NCT03237156|19965726|P3|STARTED|Overall Study||6
8100180|NCT03237156|19965727|P2|STARTED|Overall Study||6
8100181|NCT03237156|19965728|P1|STARTED|Overall Study||6
8100182|NCT03237065|19965821|P2|NOT COMPLETED|Overall Study||4
8100183|NCT03237065|19965822|P1|NOT COMPLETED|Overall Study||4
8100184|NCT03237065|19965821|P2|COMPLETED|Overall Study||57
8100185|NCT03237065|19965822|P1|COMPLETED|Overall Study||57
8100186|NCT03237065|19965821|P2|Safety Analysis Set|Overall Study||57
8100187|NCT03237065|19965822|P1|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|62
8100188|NCT03237065|19965821|P2|STARTED|Overall Study||61
8100189|NCT03237065|19965822|P1|STARTED|Overall Study||61
8100190|NCT03237013|19965865|P3|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37
8100191|NCT03237013|19965866|P2|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30
8100192|NCT03237013|19965867|P1|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43
8100193|NCT03237013|19965865|P3|COMPLETED|Immediate Post-treatment to 1-mo F/u||36
8100194|NCT03237013|19965866|P2|COMPLETED|Immediate Post-treatment to 1-mo F/u||43
8100195|NCT03237013|19965867|P1|COMPLETED|Immediate Post-treatment to 1-mo F/u||30
8100196|NCT03237013|19965865|P3|STARTED|Immediate Post-treatment to 1-mo F/u||73
8100197|NCT03237013|19965866|P2|STARTED|Immediate Post-treatment to 1-mo F/u||73
8100198|NCT03237013|19965867|P1|STARTED|Immediate Post-treatment to 1-mo F/u||73
8100199|NCT03237013|19965865|P3|NOT COMPLETED|Baseline to Immediate Post-treatment||0
8100200|NCT03237013|19965866|P2|NOT COMPLETED|Baseline to Immediate Post-treatment||0
8100201|NCT03237013|19965867|P1|NOT COMPLETED|Baseline to Immediate Post-treatment||0
8100202|NCT03237013|19965865|P3|COMPLETED|Baseline to Immediate Post-treatment||73
8100203|NCT03237013|19965866|P2|COMPLETED|Baseline to Immediate Post-treatment||73
8100204|NCT03237013|19965867|P1|COMPLETED|Baseline to Immediate Post-treatment||73
8100205|NCT03237013|19965865|P3|STARTED|Baseline to Immediate Post-treatment||73
8100206|NCT03237013|19965866|P2|STARTED|Baseline to Immediate Post-treatment||73
8100207|NCT03237013|19965867|P1|STARTED|Baseline to Immediate Post-treatment||73
8100208|NCT03236779|19965916|P2|NOT COMPLETED|Overall Study||21
8100209|NCT03236779|19965917|P1|NOT COMPLETED|Overall Study||13
8100210|NCT03236779|19965916|P2|COMPLETED|Overall Study||30
8100211|NCT03236779|19965917|P1|COMPLETED|Overall Study||38
8100212|NCT03236779|19965916|P2|STARTED|Overall Study||51
8100213|NCT03236779|19965917|P1|STARTED|Overall Study||51
8100214|NCT03236311|19965931|P2|NOT COMPLETED|Overall Study||3
8100215|NCT03236311|19965932|P1|NOT COMPLETED|Overall Study||0
8100216|NCT03236311|19965931|P2|COMPLETED|Overall Study||2
8100217|NCT03236311|19965932|P1|COMPLETED|Overall Study||5
8100218|NCT03236311|19965931|P2|STARTED|Overall Study||5
8100219|NCT03236311|19965932|P1|STARTED|Overall Study||5
8100220|NCT03236168|19965942|P1|NOT COMPLETED|Overall Study||11
8100221|NCT03236168|19965942|P1|COMPLETED|Overall Study||107
8100222|NCT03236168|19965942|P1|STARTED|Overall Study||118
8100223|NCT03235817|19965949|P3|NOT COMPLETED|Overall Study||2
8100224|NCT03235817|19965950|P2|NOT COMPLETED|Overall Study||1
8100225|NCT03235817|19965951|P1|NOT COMPLETED|Overall Study||3
8100226|NCT03235817|19965949|P3|COMPLETED|Overall Study||11
8100227|NCT03235817|19965950|P2|COMPLETED|Overall Study||12
8100228|NCT03235817|19965951|P1|COMPLETED|Overall Study||10
8100229|NCT03235817|19965949|P3|STARTED|Overall Study||13
8100230|NCT03235817|19965950|P2|STARTED|Overall Study||13
8100231|NCT03235817|19965951|P1|STARTED|Overall Study||13
8100232|NCT03235726|19965976|P10|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100233|NCT03235726|19965977|P9|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100234|NCT03235726|19965978|P8|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100235|NCT03235726|19965979|P7|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100236|NCT03235726|19965980|P6|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100237|NCT03235726|19965981|P5|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100238|NCT03235726|19965982|P4|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100239|NCT03235726|19965983|P3|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100240|NCT03235726|19965984|P2|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100241|NCT03235726|19965985|P1|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100242|NCT03235726|19965976|P10|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8
8100243|NCT03235726|19965977|P9|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100244|NCT03235726|19965978|P8|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100245|NCT03235726|19965979|P7|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100246|NCT03235726|19965980|P6|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100247|NCT03235726|19965981|P5|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100248|NCT03235726|19965982|P4|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100249|NCT03235726|19965983|P3|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100250|NCT03235726|19965984|P2|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100251|NCT03235726|19965985|P1|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
8100252|NCT03235726|19965976|P10|STARTED|Part 2 (Cohort B - Days 1 to 14)||8
8100253|NCT03235726|19965977|P9|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100254|NCT03235726|19965978|P8|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100255|NCT03235726|19965979|P7|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100256|NCT03235726|19965980|P6|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100257|NCT03235726|19965981|P5|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100258|NCT03235726|19965982|P4|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100259|NCT03235726|19965983|P3|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100260|NCT03235726|19965984|P2|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100261|NCT03235726|19965985|P1|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
8100262|NCT03235726|19965976|P10|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100263|NCT03235726|19965977|P9|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100264|NCT03235726|19965978|P8|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100265|NCT03235726|19965979|P7|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100266|NCT03235726|19965980|P6|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100267|NCT03235726|19965981|P5|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100268|NCT03235726|19965982|P4|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100269|NCT03235726|19965983|P3|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100270|NCT03235726|19965984|P2|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100271|NCT03235726|19965985|P1|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
8100272|NCT03235726|19965976|P10|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100273|NCT03235726|19965977|P9|COMPLETED|Part 2 (Cohort A - Day 1)||2
8100274|NCT03235726|19965978|P8|COMPLETED|Part 2 (Cohort A - Day 1)||6
8100275|NCT03235726|19965979|P7|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100276|NCT03235726|19965980|P6|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100277|NCT03235726|19965981|P5|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100278|NCT03235726|19965982|P4|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100279|NCT03235726|19965983|P3|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100280|NCT03235726|19965984|P2|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100281|NCT03235726|19965985|P1|COMPLETED|Part 2 (Cohort A - Day 1)||0
8100282|NCT03235726|19965976|P10|STARTED|Part 2 (Cohort A - Day 1)||0
8100283|NCT03235726|19965977|P9|STARTED|Part 2 (Cohort A - Day 1)||2
8100284|NCT03235726|19965978|P8|STARTED|Part 2 (Cohort A - Day 1)||6
8100285|NCT03235726|19965979|P7|STARTED|Part 2 (Cohort A - Day 1)||0
8100286|NCT03235726|19965980|P6|STARTED|Part 2 (Cohort A - Day 1)||0
8100287|NCT03235726|19965981|P5|STARTED|Part 2 (Cohort A - Day 1)||0
8100288|NCT03235726|19965982|P4|STARTED|Part 2 (Cohort A - Day 1)||0
8100289|NCT03235726|19965983|P3|STARTED|Part 2 (Cohort A - Day 1)||0
8100290|NCT03235726|19965984|P2|STARTED|Part 2 (Cohort A - Day 1)||0
8100291|NCT03235726|19965985|P1|STARTED|Part 2 (Cohort A - Day 1)||0
8100292|NCT03235726|19965976|P10|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100293|NCT03235726|19965977|P9|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100294|NCT03235726|19965978|P8|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100295|NCT03235726|19965979|P7|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100296|NCT03235726|19965980|P6|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100297|NCT03235726|19965981|P5|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
8100298|NCT03235726|19965982|P4|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100299|NCT03235726|19965983|P3|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100300|NCT03235726|19965984|P2|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100301|NCT03235726|19965985|P1|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100302|NCT03235726|19965976|P10|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100303|NCT03235726|19965977|P9|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100304|NCT03235726|19965978|P8|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100305|NCT03235726|19965979|P7|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14
8100306|NCT03235726|19965980|P6|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
8100307|NCT03235726|19965981|P5|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10
8100308|NCT03235726|19965982|P4|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100309|NCT03235726|19965983|P3|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100310|NCT03235726|19965984|P2|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100311|NCT03235726|19965985|P1|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100312|NCT03235726|19965976|P10|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100313|NCT03235726|19965977|P9|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100314|NCT03235726|19965978|P8|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100315|NCT03235726|19965979|P7|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14
8100316|NCT03235726|19965980|P6|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2
8100317|NCT03235726|19965981|P5|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12
8100318|NCT03235726|19965982|P4|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100319|NCT03235726|19965983|P3|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100320|NCT03235726|19965984|P2|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100321|NCT03235726|19965985|P1|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
8100322|NCT03235726|19965976|P10|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100323|NCT03235726|19965977|P9|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100324|NCT03235726|19965978|P8|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100325|NCT03235726|19965979|P7|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100326|NCT03235726|19965980|P6|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100327|NCT03235726|19965981|P5|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100328|NCT03235726|19965982|P4|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100329|NCT03235726|19965983|P3|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100330|NCT03235726|19965984|P2|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100331|NCT03235726|19965985|P1|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100332|NCT03235726|19965976|P10|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100333|NCT03235726|19965977|P9|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100334|NCT03235726|19965978|P8|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100335|NCT03235726|19965979|P7|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100336|NCT03235726|19965980|P6|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100337|NCT03235726|19965981|P5|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100338|NCT03235726|19965982|P4|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
8100339|NCT03235726|19965983|P3|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
8100340|NCT03235726|19965984|P2|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100341|NCT03235726|19965985|P1|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100342|NCT03235726|19965976|P10|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100343|NCT03235726|19965977|P9|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100344|NCT03235726|19965978|P8|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100345|NCT03235726|19965979|P7|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100346|NCT03235726|19965980|P6|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100347|NCT03235726|19965981|P5|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100348|NCT03235726|19965982|P4|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
8100349|NCT03235726|19965983|P3|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
8100350|NCT03235726|19965984|P2|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100351|NCT03235726|19965985|P1|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
8100352|NCT03235726|19965976|P10|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100353|NCT03235726|19965977|P9|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100354|NCT03235726|19965978|P8|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100355|NCT03235726|19965979|P7|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100356|NCT03235726|19965980|P6|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100357|NCT03235726|19965981|P5|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100358|NCT03235726|19965982|P4|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100359|NCT03235726|19965983|P3|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100360|NCT03235726|19965984|P2|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100361|NCT03235726|19965985|P1|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100362|NCT03235726|19965976|P10|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100363|NCT03235726|19965977|P9|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100364|NCT03235726|19965978|P8|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100365|NCT03235726|19965979|P7|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100366|NCT03235726|19965980|P6|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100367|NCT03235726|19965981|P5|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100368|NCT03235726|19965982|P4|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2
8100369|NCT03235726|19965983|P3|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100370|NCT03235726|19965984|P2|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6
8100371|NCT03235726|19965985|P1|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
8100372|NCT03235726|19965976|P10|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100373|NCT03235726|19965977|P9|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100374|NCT03235726|19965978|P8|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100375|NCT03235726|19965979|P7|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100376|NCT03235726|19965980|P6|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100377|NCT03235726|19965981|P5|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100378|NCT03235726|19965982|P4|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2
8100379|NCT03235726|19965983|P3|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100380|NCT03235726|19965984|P2|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6
8100381|NCT03235726|19965985|P1|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
8100382|NCT03235726|19965976|P10|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100383|NCT03235726|19965977|P9|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100384|NCT03235726|19965978|P8|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100385|NCT03235726|19965979|P7|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100386|NCT03235726|19965980|P6|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100387|NCT03235726|19965981|P5|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100388|NCT03235726|19965982|P4|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100389|NCT03235726|19965983|P3|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100390|NCT03235726|19965984|P2|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100391|NCT03235726|19965985|P1|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100392|NCT03235726|19965976|P10|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100393|NCT03235726|19965977|P9|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100394|NCT03235726|19965978|P8|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100395|NCT03235726|19965979|P7|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100396|NCT03235726|19965980|P6|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100397|NCT03235726|19965981|P5|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100398|NCT03235726|19965982|P4|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2
8100399|NCT03235726|19965983|P3|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100400|NCT03235726|19965984|P2|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
8100401|NCT03235726|19965985|P1|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6
8100402|NCT03235726|19965976|P10|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100403|NCT03235726|19965977|P9|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100404|NCT03235726|19965978|P8|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100405|NCT03235726|19965979|P7|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100406|NCT03235726|19965980|P6|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100407|NCT03235726|19965981|P5|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100408|NCT03235726|19965982|P4|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2
8100409|NCT03235726|19965983|P3|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100410|NCT03235726|19965984|P2|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
8100411|NCT03235726|19965985|P1|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6
8100412|NCT03235479|19966139|P2|NOT COMPLETED|Overall Study||40
8100413|NCT03235479|19966140|P1|NOT COMPLETED|Overall Study||41
8100414|NCT03235479|19966139|P2|COMPLETED|Overall Study||540
8100415|NCT03235479|19966140|P1|COMPLETED|Overall Study||541
8100416|NCT03235479|19966139|P2|Treated|Overall Study||549
8100417|NCT03235479|19966140|P1|Treated|Overall Study||546
8100418|NCT03235479|19966139|P2|STARTED|Overall Study||580
8100419|NCT03235479|19966140|P1|STARTED|Overall Study||582
8100420|NCT03235414|19966170|P1|NOT COMPLETED|Overall Study||0
8100421|NCT03235414|19966170|P1|COMPLETED|Overall Study||101
8100422|NCT03235414|19966170|P1|STARTED|Overall Study||101
8100423|NCT03235349|19966177|P1|NOT COMPLETED|Overall Study||2
8100424|NCT03235349|19966177|P1|COMPLETED|Overall Study||158
8100425|NCT03235349|19966177|P1|STARTED|Overall Study||160
8100426|NCT03235284|19966187|P3|NOT COMPLETED|Overall Study||1
8100427|NCT03235284|19966188|P2|NOT COMPLETED|Overall Study||2
8100428|NCT03235284|19966189|P1|NOT COMPLETED|Overall Study||1
8100429|NCT03235284|19966187|P3|COMPLETED|Overall Study||14
8100430|NCT03235284|19966188|P2|COMPLETED|Overall Study||13
8100431|NCT03235284|19966189|P1|COMPLETED|Overall Study||14
8100432|NCT03235284|19966187|P3|STARTED|Overall Study||15
8100433|NCT03235284|19966188|P2|STARTED|Overall Study||15
8100434|NCT03235284|19966189|P1|STARTED|Overall Study||15
8100435|NCT03235115|19966206|P6|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8100436|NCT03235115|19966207|P5|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8100437|NCT03235115|19966208|P4|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8100438|NCT03235115|19966209|P3|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8100439|NCT03235115|19966210|P2|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8100440|NCT03235115|19966211|P1|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
8100441|NCT03235115|19966206|P6|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
8100442|NCT03235115|19966207|P5|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
8100443|NCT03235115|19966208|P4|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
8100444|NCT03235115|19966209|P3|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
8100445|NCT03235115|19966210|P2|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
8100446|NCT03235115|19966211|P1|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
8100447|NCT03235115|19966206|P6|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
8100448|NCT03235115|19966207|P5|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
8100449|NCT03235115|19966208|P4|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
8100450|NCT03235115|19966209|P3|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
8100451|NCT03235115|19966210|P2|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
8100452|NCT03235115|19966211|P1|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
8100453|NCT03235115|19966206|P6|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8100454|NCT03235115|19966207|P5|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8100455|NCT03235115|19966208|P4|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8100456|NCT03235115|19966209|P3|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8100457|NCT03235115|19966210|P2|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8100458|NCT03235115|19966211|P1|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
8100459|NCT03235115|19966206|P6|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
8100460|NCT03235115|19966207|P5|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
8100461|NCT03235115|19966208|P4|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
8100462|NCT03235115|19966209|P3|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
8100463|NCT03235115|19966210|P2|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
8100464|NCT03235115|19966211|P1|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
8100465|NCT03235115|19966206|P6|STARTED|Second Intervention (1 Hour, Visit 4)||5
8100466|NCT03235115|19966207|P5|STARTED|Second Intervention (1 Hour, Visit 4)||6
8100467|NCT03235115|19966208|P4|STARTED|Second Intervention (1 Hour, Visit 4)||6
8100468|NCT03235115|19966209|P3|STARTED|Second Intervention (1 Hour, Visit 4)||7
8100469|NCT03235115|19966210|P2|STARTED|Second Intervention (1 Hour, Visit 4)||6
8100470|NCT03235115|19966211|P1|STARTED|Second Intervention (1 Hour, Visit 4)||9
8100471|NCT03235115|19966206|P6|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
8100472|NCT03235115|19966207|P5|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8100473|NCT03235115|19966208|P4|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8100474|NCT03235115|19966209|P3|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8100475|NCT03235115|19966210|P2|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8100476|NCT03235115|19966211|P1|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
8100477|NCT03235115|19966206|P6|COMPLETED|First Intervention (1 Hour, Visit 2)||5
8100478|NCT03235115|19966207|P5|COMPLETED|First Intervention (1 Hour, Visit 2)||6
8100479|NCT03235115|19966208|P4|COMPLETED|First Intervention (1 Hour, Visit 2)||6
8100480|NCT03235115|19966209|P3|COMPLETED|First Intervention (1 Hour, Visit 2)||7
8100481|NCT03235115|19966210|P2|COMPLETED|First Intervention (1 Hour, Visit 2)||6
8100482|NCT03235115|19966211|P1|COMPLETED|First Intervention (1 Hour, Visit 2)||9
8100483|NCT03235115|19966206|P6|STARTED|First Intervention (1 Hour, Visit 2)||6
8100484|NCT03235115|19966207|P5|STARTED|First Intervention (1 Hour, Visit 2)||6
8100485|NCT03235115|19966208|P4|STARTED|First Intervention (1 Hour, Visit 2)||6
8100486|NCT03235115|19966209|P3|STARTED|First Intervention (1 Hour, Visit 2)||7
8100487|NCT03235115|19966210|P2|STARTED|First Intervention (1 Hour, Visit 2)||6
8100488|NCT03235115|19966211|P1|STARTED|First Intervention (1 Hour, Visit 2)||9
8100489|NCT03235089|19966231|P2|NOT COMPLETED|Overall Study||3
8100490|NCT03235089|19966232|P1|NOT COMPLETED|Overall Study||3
8100491|NCT03235089|19966231|P2|COMPLETED|Overall Study||28
8100492|NCT03235089|19966232|P1|COMPLETED|Overall Study||28
8100493|NCT03235089|19966231|P2|STARTED|Overall Study||31
8100494|NCT03235089|19966232|P1|STARTED|Overall Study||31
8100495|NCT03235050|19966273|P5|NOT COMPLETED|Overall Study||11
8100496|NCT03235050|19966274|P4|NOT COMPLETED|Overall Study||14
8100497|NCT03235050|19966275|P3|NOT COMPLETED|Overall Study||4
8100498|NCT03235050|19966276|P2|NOT COMPLETED|Overall Study||5
8100499|NCT03235050|19966277|P1|NOT COMPLETED|Overall Study||4
8100500|NCT03235050|19966273|P5|COMPLETED|Overall Study||245
8100501|NCT03235050|19966274|P4|COMPLETED|Overall Study||242
8100502|NCT03235050|19966275|P3|COMPLETED|Overall Study||96
8100503|NCT03235050|19966276|P2|COMPLETED|Overall Study||105
8100504|NCT03235050|19966277|P1|COMPLETED|Overall Study||108
8100505|NCT03235050|19966273|P5|STARTED|Overall Study||256
8100506|NCT03235050|19966274|P4|STARTED|Overall Study||256
8100507|NCT03235050|19966275|P3|STARTED|Overall Study||100
8100508|NCT03235050|19966276|P2|STARTED|Overall Study||110
8100509|NCT03235050|19966277|P1|STARTED|Overall Study||112
8100510|NCT03234465|19966338|P2|NOT COMPLETED|Overall Study||40
8100511|NCT03234465|19966339|P1|NOT COMPLETED|Overall Study||33
8100512|NCT03234465|19966338|P2|COMPLETED|Overall Study||60
8100513|NCT03234465|19966339|P1|COMPLETED|Overall Study||67
8100514|NCT03234465|19966338|P2|STARTED|Overall Study||100
8100515|NCT03234465|19966339|P1|STARTED|Overall Study||100
8100522|NCT03234036|19966369|P4|NOT COMPLETED|Part 2 (Up to 25 Days)||0
8100523|NCT03234036|19966370|P3|NOT COMPLETED|Part 2 (Up to 25 Days)||0
8100524|NCT03234036|19966371|P2|NOT COMPLETED|Part 2 (Up to 25 Days)||0
8100525|NCT03234036|19966372|P1|NOT COMPLETED|Part 2 (Up to 25 Days)||0
8100526|NCT03234036|19966369|P4|COMPLETED|Part 2 (Up to 25 Days)||7
8100527|NCT03234036|19966370|P3|COMPLETED|Part 2 (Up to 25 Days)||3
8100528|NCT03234036|19966371|P2|COMPLETED|Part 2 (Up to 25 Days)||0
8100529|NCT03234036|19966372|P1|COMPLETED|Part 2 (Up to 25 Days)||0
8100530|NCT03234036|19966369|P4|STARTED|Part 2 (Up to 25 Days)||7
8100531|NCT03234036|19966370|P3|STARTED|Part 2 (Up to 25 Days)||3
8100532|NCT03234036|19966371|P2|STARTED|Part 2 (Up to 25 Days)||0
8100533|NCT03234036|19966372|P1|STARTED|Part 2 (Up to 25 Days)||0
8100534|NCT03234036|19966369|P4|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100535|NCT03234036|19966370|P3|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100536|NCT03234036|19966371|P2|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100537|NCT03234036|19966372|P1|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100538|NCT03234036|19966369|P4|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100539|NCT03234036|19966370|P3|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100540|NCT03234036|19966371|P2|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
8100541|NCT03234036|19966372|P1|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
8100542|NCT03234036|19966369|P4|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100543|NCT03234036|19966370|P3|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
8100544|NCT03234036|19966371|P2|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
8100545|NCT03234036|19966372|P1|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
8100546|NCT03234036|19966369|P4|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100547|NCT03234036|19966370|P3|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100548|NCT03234036|19966371|P2|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100549|NCT03234036|19966372|P1|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100550|NCT03234036|19966369|P4|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100551|NCT03234036|19966370|P3|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100552|NCT03234036|19966371|P2|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
8100553|NCT03234036|19966372|P1|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
8100554|NCT03234036|19966369|P4|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100555|NCT03234036|19966370|P3|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
8100556|NCT03234036|19966371|P2|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
8100557|NCT03234036|19966372|P1|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
8100558|NCT03234036|19966369|P4|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100559|NCT03234036|19966370|P3|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100560|NCT03234036|19966371|P2|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100561|NCT03234036|19966372|P1|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100562|NCT03234036|19966369|P4|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100563|NCT03234036|19966370|P3|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100564|NCT03234036|19966371|P2|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
8100565|NCT03234036|19966372|P1|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
8100566|NCT03234036|19966369|P4|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100567|NCT03234036|19966370|P3|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
8100568|NCT03234036|19966371|P2|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
8100569|NCT03234036|19966372|P1|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
8100570|NCT03234036|19966369|P4|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
8100571|NCT03234036|19966370|P3|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
8100572|NCT03234036|19966371|P2|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
8100573|NCT03234036|19966372|P1|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
8100574|NCT03234036|19966369|P4|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
8100575|NCT03234036|19966370|P3|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
8100576|NCT03234036|19966371|P2|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
8100577|NCT03234036|19966372|P1|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
8100578|NCT03234036|19966369|P4|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
8100579|NCT03234036|19966370|P3|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
8100580|NCT03234036|19966371|P2|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
8100581|NCT03234036|19966372|P1|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
8100582|NCT03234036|19966369|P4|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100583|NCT03234036|19966370|P3|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100584|NCT03234036|19966371|P2|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100585|NCT03234036|19966372|P1|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100586|NCT03234036|19966369|P4|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100587|NCT03234036|19966370|P3|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100588|NCT03234036|19966371|P2|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
8100589|NCT03234036|19966372|P1|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
8100590|NCT03234036|19966369|P4|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100591|NCT03234036|19966370|P3|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
8100592|NCT03234036|19966371|P2|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
8100593|NCT03234036|19966372|P1|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
8100594|NCT03233737|19966479|P5|NOT COMPLETED|Overall Study||0
8100595|NCT03233737|19966480|P4|NOT COMPLETED|Overall Study||0
8100596|NCT03233737|19966481|P3|NOT COMPLETED|Overall Study||0
8100597|NCT03233737|19966482|P2|NOT COMPLETED|Overall Study||0
8100598|NCT03233737|19966483|P1|NOT COMPLETED|Overall Study||0
8100599|NCT03233737|19966479|P5|COMPLETED|Overall Study||26
8100600|NCT03233737|19966480|P4|COMPLETED|Overall Study||24
8100601|NCT03233737|19966481|P3|COMPLETED|Overall Study||5
8100602|NCT03233737|19966482|P2|COMPLETED|Overall Study||10
8100603|NCT03233737|19966483|P1|COMPLETED|Overall Study||10
8100604|NCT03233737|19966479|P5|STARTED|Overall Study||26
8100605|NCT03233737|19966480|P4|STARTED|Overall Study||24
8100606|NCT03233737|19966481|P3|STARTED|Overall Study||5
8100607|NCT03233737|19966482|P2|STARTED|Overall Study||10
8100608|NCT03233737|19966483|P1|STARTED|Overall Study||10
8100609|NCT03233529|19966543|P1|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1
8100610|NCT03233529|19966543|P1|COMPLETED|Open-Label Period (Day 15 to Day 71)||38
8100611|NCT03233529|19966543|P1|STARTED|Open-Label Period (Day 15 to Day 71)||39
8100612|NCT03233529|19966543|P1|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1
8100613|NCT03233529|19966543|P1|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39
8100614|NCT03233529|19966543|P1|STARTED|Double-Blind Period (Day 1 to Day 15)||40
8100615|NCT03233438|19966587|P2|NOT COMPLETED|Overall Study||11
8100616|NCT03233438|19966588|P1|NOT COMPLETED|Overall Study||6
8100617|NCT03233438|19966587|P2|COMPLETED|Overall Study||32
8100618|NCT03233438|19966588|P1|COMPLETED|Overall Study||42
8100619|NCT03233438|19966587|P2|STARTED|Overall Study||43
8100620|NCT03233438|19966588|P1|STARTED|Overall Study||48
8100621|NCT03233308|19966654|P1|NOT COMPLETED|Overall Study||2
8100622|NCT03233308|19966654|P1|COMPLETED|Overall Study||18
8100623|NCT03233308|19966654|P1|STARTED|Overall Study||20
8100624|NCT03233230|19966670|P4|NOT COMPLETED|Overall Study||8
8100625|NCT03233230|19966671|P3|NOT COMPLETED|Overall Study||12
8100626|NCT03233230|19966672|P2|NOT COMPLETED|Overall Study||15
8100627|NCT03233230|19966673|P1|NOT COMPLETED|Overall Study||15
8100628|NCT03233230|19966670|P4|COMPLETED|Overall Study||91
8100629|NCT03233230|19966671|P3|COMPLETED|Overall Study||84
8100630|NCT03233230|19966672|P2|COMPLETED|Overall Study||83
8100631|NCT03233230|19966673|P1|COMPLETED|Overall Study||82
8100632|NCT03233230|19966670|P4|STARTED|Overall Study||99
8100633|NCT03233230|19966671|P3|STARTED|Overall Study||96
8100634|NCT03233230|19966672|P2|STARTED|Overall Study||98
8100635|NCT03233230|19966673|P1|STARTED|Overall Study||97
8100636|NCT03233217|19966832|P5|NOT COMPLETED|Overall Study||0
8100637|NCT03233217|19966833|P4|NOT COMPLETED|Overall Study||0
8100638|NCT03233217|19966834|P3|NOT COMPLETED|Overall Study||0
8100639|NCT03233217|19966835|P2|NOT COMPLETED|Overall Study||0
8100640|NCT03233217|19966836|P1|NOT COMPLETED|Overall Study||0
8100641|NCT03233217|19966832|P5|COMPLETED|Overall Study||55
8100642|NCT03233217|19966833|P4|COMPLETED|Overall Study||55
8100643|NCT03233217|19966834|P3|COMPLETED|Overall Study||55
8100644|NCT03233217|19966835|P2|COMPLETED|Overall Study||5
8100645|NCT03233217|19966836|P1|COMPLETED|Overall Study||5
8100646|NCT03233217|19966832|P5|Per-protocol Analysis Set (PPAS)|Overall Study||54
8100647|NCT03233217|19966833|P4|Per-protocol Analysis Set (PPAS)|Overall Study||55
8100648|NCT03233217|19966834|P3|Per-protocol Analysis Set (PPAS)|Overall Study||55
8100649|NCT03233217|19966835|P2|Per-protocol Analysis Set (PPAS)|Overall Study||5
8100650|NCT03233217|19966836|P1|Per-protocol Analysis Set (PPAS)|Overall Study||5
8100651|NCT03233217|19966832|P5|Safety Analysis Set (SafAS)|Overall Study||55
8100652|NCT03233217|19966833|P4|Safety Analysis Set (SafAS)|Overall Study||55
8100653|NCT03233217|19966834|P3|Safety Analysis Set (SafAS)|Overall Study||55
8100654|NCT03233217|19966835|P2|Safety Analysis Set (SafAS)|Overall Study||5
8100655|NCT03233217|19966836|P1|Safety Analysis Set (SafAS)|Overall Study||5
8100656|NCT03233217|19966832|P5|STARTED|Overall Study||55
8100657|NCT03233217|19966833|P4|STARTED|Overall Study||55
8100658|NCT03233217|19966834|P3|STARTED|Overall Study||55
8100659|NCT03233217|19966835|P2|STARTED|Overall Study||5
8100660|NCT03233217|19966836|P1|STARTED|Overall Study||5
8100661|NCT03233009|19966865|P1|NOT COMPLETED|Overall Study||1
8100662|NCT03233009|19966865|P1|COMPLETED|Overall Study||39
8100663|NCT03233009|19966865|P1|Reference Product|Overall Study||39
8100664|NCT03233009|19966865|P1|Test Product 4|Overall Study||39
8100665|NCT03233009|19966865|P1|Test Product 3|Overall Study||39
8100666|NCT03233009|19966865|P1|Test Product 2|Overall Study||39
8100667|NCT03233009|19966865|P1|Test Product 1|Overall Study||39
8100668|NCT03233009|19966865|P1|STARTED|Overall Study||40
8100669|NCT03232983|19966908|P4|NOT COMPLETED|Period 4||0
8100670|NCT03232983|19966909|P3|NOT COMPLETED|Period 4||0
8100671|NCT03232983|19966910|P2|NOT COMPLETED|Period 4||0
8100672|NCT03232983|19966911|P1|NOT COMPLETED|Period 4||1
8100673|NCT03232983|19966908|P4|COMPLETED|Period 4||6
8100674|NCT03232983|19966909|P3|COMPLETED|Period 4||5
8100675|NCT03232983|19966910|P2|COMPLETED|Period 4||7
8100676|NCT03232983|19966911|P1|COMPLETED|Period 4||6
8100677|NCT03232983|19966908|P4|STARTED|Period 4||6
8100678|NCT03232983|19966909|P3|STARTED|Period 4||5
8100679|NCT03232983|19966910|P2|STARTED|Period 4||7
8100680|NCT03232983|19966911|P1|STARTED|Period 4||7
8100681|NCT03232983|19966908|P4|NOT COMPLETED|Washout Period 3||0
8100682|NCT03232983|19966909|P3|NOT COMPLETED|Washout Period 3||0
8100683|NCT03232983|19966910|P2|NOT COMPLETED|Washout Period 3||0
8100684|NCT03232983|19966911|P1|NOT COMPLETED|Washout Period 3||0
8100685|NCT03232983|19966908|P4|COMPLETED|Washout Period 3||6
8100686|NCT03232983|19966909|P3|COMPLETED|Washout Period 3||5
8100687|NCT03232983|19966910|P2|COMPLETED|Washout Period 3||7
8100688|NCT03232983|19966911|P1|COMPLETED|Washout Period 3||7
8100689|NCT03232983|19966908|P4|STARTED|Washout Period 3||6
8100690|NCT03232983|19966909|P3|STARTED|Washout Period 3||5
8100691|NCT03232983|19966910|P2|STARTED|Washout Period 3||7
8100692|NCT03232983|19966911|P1|STARTED|Washout Period 3||7
8100693|NCT03232983|19966908|P4|NOT COMPLETED|Period 3||0
8100694|NCT03232983|19966909|P3|NOT COMPLETED|Period 3||0
8100695|NCT03232983|19966910|P2|NOT COMPLETED|Period 3||0
8100696|NCT03232983|19966911|P1|NOT COMPLETED|Period 3||0
8100697|NCT03232983|19966908|P4|COMPLETED|Period 3||6
8100698|NCT03232983|19966909|P3|COMPLETED|Period 3||5
8100699|NCT03232983|19966910|P2|COMPLETED|Period 3||7
8100700|NCT03232983|19966911|P1|COMPLETED|Period 3||7
8100701|NCT03232983|19966908|P4|STARTED|Period 3||6
8100702|NCT03232983|19966909|P3|STARTED|Period 3||5
8100703|NCT03232983|19966910|P2|STARTED|Period 3||7
8100704|NCT03232983|19966911|P1|STARTED|Period 3||7
8100705|NCT03232983|19966908|P4|NOT COMPLETED|Washout Period 2||1
8100706|NCT03232983|19966909|P3|NOT COMPLETED|Washout Period 2||1
8100707|NCT03232983|19966910|P2|NOT COMPLETED|Washout Period 2||0
8100708|NCT03232983|19966911|P1|NOT COMPLETED|Washout Period 2||0
8100709|NCT03232983|19966908|P4|COMPLETED|Washout Period 2||6
8100710|NCT03232983|19966909|P3|COMPLETED|Washout Period 2||5
8100711|NCT03232983|19966910|P2|COMPLETED|Washout Period 2||7
8100712|NCT03232983|19966911|P1|COMPLETED|Washout Period 2||7
8100713|NCT03232983|19966908|P4|STARTED|Washout Period 2||7
8100714|NCT03232983|19966909|P3|STARTED|Washout Period 2||6
8100715|NCT03232983|19966910|P2|STARTED|Washout Period 2||7
8100716|NCT03232983|19966911|P1|STARTED|Washout Period 2||7
8100717|NCT03232983|19966908|P4|NOT COMPLETED|Period 2||0
8100718|NCT03232983|19966909|P3|NOT COMPLETED|Period 2||0
8100719|NCT03232983|19966910|P2|NOT COMPLETED|Period 2||0
8100720|NCT03232983|19966911|P1|NOT COMPLETED|Period 2||0
8100721|NCT03232983|19966908|P4|COMPLETED|Period 2||7
8100722|NCT03232983|19966909|P3|COMPLETED|Period 2||6
8100723|NCT03232983|19966910|P2|COMPLETED|Period 2||7
8100724|NCT03232983|19966911|P1|COMPLETED|Period 2||7
8100725|NCT03232983|19966908|P4|STARTED|Period 2||7
8100726|NCT03232983|19966909|P3|STARTED|Period 2||6
8100727|NCT03232983|19966910|P2|STARTED|Period 2||7
8100728|NCT03232983|19966911|P1|STARTED|Period 2||7
8100729|NCT03232983|19966908|P4|NOT COMPLETED|Washout Period 1||0
8100730|NCT03232983|19966909|P3|NOT COMPLETED|Washout Period 1||0
8100731|NCT03232983|19966910|P2|NOT COMPLETED|Washout Period 1||0
8100732|NCT03232983|19966911|P1|NOT COMPLETED|Washout Period 1||0
8100733|NCT03232983|19966908|P4|COMPLETED|Washout Period 1||7
8100734|NCT03232983|19966909|P3|COMPLETED|Washout Period 1||6
8100735|NCT03232983|19966910|P2|COMPLETED|Washout Period 1||7
8100736|NCT03232983|19966911|P1|COMPLETED|Washout Period 1||7
8100737|NCT03232983|19966908|P4|STARTED|Washout Period 1||7
8100738|NCT03232983|19966909|P3|STARTED|Washout Period 1||6
8100739|NCT03232983|19966910|P2|STARTED|Washout Period 1||7
8100740|NCT03232983|19966911|P1|STARTED|Washout Period 1||7
8100741|NCT03232983|19966908|P4|NOT COMPLETED|Period 1||0
8100742|NCT03232983|19966909|P3|NOT COMPLETED|Period 1||1
8100743|NCT03232983|19966910|P2|NOT COMPLETED|Period 1||0
8100744|NCT03232983|19966911|P1|NOT COMPLETED|Period 1||0
8100745|NCT03232983|19966908|P4|COMPLETED|Period 1||7
8100746|NCT03232983|19966909|P3|COMPLETED|Period 1||6
8100747|NCT03232983|19966910|P2|COMPLETED|Period 1||7
8100748|NCT03232983|19966911|P1|COMPLETED|Period 1||7
8100749|NCT03232983|19966908|P4|Received at Least One Dose of Study Drug|Period 1||7
8100750|NCT03232983|19966909|P3|Received at Least One Dose of Study Drug|Period 1||7
8100751|NCT03232983|19966910|P2|Received at Least One Dose of Study Drug|Period 1||7
8100752|NCT03232983|19966911|P1|Received at Least One Dose of Study Drug|Period 1||7
8100753|NCT03232983|19966908|P4|STARTED|Period 1||7
8100754|NCT03232983|19966909|P3|STARTED|Period 1||7
8100755|NCT03232983|19966910|P2|STARTED|Period 1||7
8100756|NCT03232983|19966911|P1|STARTED|Period 1||7
8100757|NCT03232892|19966924|P1|NOT COMPLETED|Overall Study||0
8100758|NCT03232892|19966924|P1|COMPLETED|Overall Study||1
8100759|NCT03232892|19966924|P1|STARTED|Overall Study||1
8100760|NCT03232827|19966932|P1|NOT COMPLETED|Flavored-very Low Sweetened||0
8100761|NCT03232827|19966932|P1|COMPLETED|Flavored-very Low Sweetened||66
8100762|NCT03232827|19966932|P1|STARTED|Flavored-very Low Sweetened||66
8100763|NCT03232827|19966932|P1|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0
8100764|NCT03232827|19966932|P1|COMPLETED|Unflavored-very Low Sweetened (UU)||66
8100765|NCT03232827|19966932|P1|STARTED|Unflavored-very Low Sweetened (UU)||66
8100766|NCT03232827|19966932|P1|NOT COMPLETED|Unflavored-sweetened (US)||0
8100767|NCT03232827|19966932|P1|COMPLETED|Unflavored-sweetened (US)||86
8100768|NCT03232827|19966932|P1|STARTED|Unflavored-sweetened (US)||86
8100769|NCT03232827|19966932|P1|NOT COMPLETED|Flavored-sweetened (FS)||0
8100770|NCT03232827|19966932|P1|COMPLETED|Flavored-sweetened (FS)||80
8100771|NCT03232827|19966932|P1|STARTED|Flavored-sweetened (FS)||80
8100772|NCT03232580|19966946|P1|NOT COMPLETED|Overall Study||0
8100773|NCT03232580|19966946|P1|COMPLETED|Overall Study||5
8100774|NCT03232580|19966946|P1|STARTED|Overall Study||5
8100775|NCT03232567|19966955|P4|NOT COMPLETED|Overall Study||0
8100776|NCT03232567|19966956|P3|NOT COMPLETED|Overall Study||0
8100777|NCT03232567|19966957|P2|NOT COMPLETED|Overall Study||1
8100778|NCT03232567|19966958|P1|NOT COMPLETED|Overall Study||0
8100779|NCT03232567|19966955|P4|COMPLETED|Overall Study||15
8100780|NCT03232567|19966956|P3|COMPLETED|Overall Study||15
8100781|NCT03232567|19966957|P2|COMPLETED|Overall Study||14
8100782|NCT03232567|19966958|P1|COMPLETED|Overall Study||15
8100783|NCT03232567|19966955|P4|STARTED|Overall Study||15
8100784|NCT03232567|19966956|P3|STARTED|Overall Study||15
8100785|NCT03232567|19966957|P2|STARTED|Overall Study||15
8100786|NCT03232567|19966958|P1|STARTED|Overall Study||15
8100787|NCT03232333|19966980|P1|NOT COMPLETED|Overall Study||15
8100788|NCT03232333|19966980|P1|COMPLETED|Overall Study||38
8100789|NCT03232333|19966980|P1|STARTED|Overall Study||53
8100985|NCT03231917|19967459|P2|NOT COMPLETED|Overall Study||0
8100986|NCT03231917|19967460|P1|NOT COMPLETED|Overall Study||0
8100987|NCT03231917|19967459|P2|COMPLETED|Overall Study||61
8100988|NCT03231917|19967460|P1|COMPLETED|Overall Study||60
8100989|NCT03231917|19967459|P2|STARTED|Overall Study||61
8100990|NCT03231917|19967460|P1|STARTED|Overall Study||60
8100991|NCT03231800|19967472|P2|NOT COMPLETED|Overall Study||3
8100992|NCT03231800|19967473|P1|NOT COMPLETED|Overall Study||3
8100993|NCT03231800|19967472|P2|COMPLETED|Overall Study||44
8100994|NCT03231800|19967473|P1|COMPLETED|Overall Study||45
8100995|NCT03231800|19967472|P2|Safety Population|Overall Study||47
8100996|NCT03231800|19967473|P1|Safety Population|Overall Study||47
8100997|NCT03231800|19967472|P2|STARTED|Overall Study||47
8100998|NCT03231800|19967473|P1|STARTED|Overall Study||48
8100999|NCT03231709|19967489|P2|NOT COMPLETED|Treatment Period 2||1
8101000|NCT03231709|19967490|P1|NOT COMPLETED|Treatment Period 2||0
8101001|NCT03231709|19967489|P2|COMPLETED|Treatment Period 2||28
8101002|NCT03231709|19967490|P1|COMPLETED|Treatment Period 2||30
8101003|NCT03231709|19967489|P2|STARTED|Treatment Period 2||29
8101004|NCT03231709|19967490|P1|STARTED|Treatment Period 2||30
8101005|NCT03231709|19967489|P2|NOT COMPLETED|Treatment Period 1||1
8101006|NCT03231709|19967490|P1|NOT COMPLETED|Treatment Period 1||0
8101007|NCT03231709|19967489|P2|COMPLETED|Treatment Period 1||29
8101008|NCT03231709|19967490|P1|COMPLETED|Treatment Period 1||30
8101009|NCT03231709|19967489|P2|STARTED|Treatment Period 1||30
8101010|NCT03231709|19967490|P1|STARTED|Treatment Period 1||30
8101011|NCT03231371|19967508|P1|NOT COMPLETED|Overall Study||13
8101012|NCT03231371|19967508|P1|COMPLETED|Overall Study||9
8101013|NCT03231371|19967508|P1|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
8101014|NCT03231371|19967508|P1|STARTED|Overall Study||22
8101015|NCT03231345|19967513|P1|NOT COMPLETED|Overall Study||0
8101016|NCT03231345|19967513|P1|COMPLETED|Overall Study||35
8101017|NCT03231345|19967513|P1|STARTED|Overall Study||35
8101018|NCT03231228|19967521|P2|NOT COMPLETED|Overall Study||0
8101019|NCT03231228|19967522|P1|NOT COMPLETED|Overall Study||3
8101020|NCT03231228|19967521|P2|COMPLETED|Overall Study||28
8101021|NCT03231228|19967522|P1|COMPLETED|Overall Study||30
8101022|NCT03231228|19967521|P2|STARTED|Overall Study||28
8101023|NCT03231228|19967522|P1|STARTED|Overall Study||33
8101024|NCT03230864|19967533|P4|NOT COMPLETED|Double Blind Treatment (DBT) Period||2
8101025|NCT03230864|19967534|P3|NOT COMPLETED|Double Blind Treatment (DBT) Period||8
8101026|NCT03230864|19967535|P2|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
8101027|NCT03230864|19967536|P1|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
8101028|NCT03230864|19967533|P4|COMPLETED|Double Blind Treatment (DBT) Period||31
8101029|NCT03230864|19967534|P3|COMPLETED|Double Blind Treatment (DBT) Period||27
8101030|NCT03230864|19967535|P2|COMPLETED|Double Blind Treatment (DBT) Period||0
8101031|NCT03230864|19967536|P1|COMPLETED|Double Blind Treatment (DBT) Period||0
8101032|NCT03230864|19967533|P4|STARTED|Double Blind Treatment (DBT) Period||33
8101033|NCT03230864|19967534|P3|STARTED|Double Blind Treatment (DBT) Period||35
8101034|NCT03230864|19967535|P2|STARTED|Double Blind Treatment (DBT) Period||0
8101035|NCT03230864|19967536|P1|STARTED|Double Blind Treatment (DBT) Period||0
8101036|NCT03230864|19967533|P4|NOT COMPLETED|Prospective Confirmation (PC) Period||0
8101037|NCT03230864|19967534|P3|NOT COMPLETED|Prospective Confirmation (PC) Period||0
8101038|NCT03230864|19967535|P2|NOT COMPLETED|Prospective Confirmation (PC) Period||19
8101039|NCT03230864|19967536|P1|NOT COMPLETED|Prospective Confirmation (PC) Period||32
8101040|NCT03230864|19967533|P4|COMPLETED|Prospective Confirmation (PC) Period||0
8101041|NCT03230864|19967534|P3|COMPLETED|Prospective Confirmation (PC) Period||0
8101042|NCT03230864|19967535|P2|COMPLETED|Prospective Confirmation (PC) Period||32
8101043|NCT03230864|19967536|P1|COMPLETED|Prospective Confirmation (PC) Period||36
8101044|NCT03230864|19967533|P4|STARTED|Prospective Confirmation (PC) Period||0
8101045|NCT03230864|19967534|P3|STARTED|Prospective Confirmation (PC) Period||0
8101046|NCT03230864|19967535|P2|STARTED|Prospective Confirmation (PC) Period||51
8101047|NCT03230864|19967536|P1|STARTED|Prospective Confirmation (PC) Period||68
8101048|NCT03229486|19967554|P2|NOT COMPLETED|Overall Study||1
8101049|NCT03229486|19967555|P1|NOT COMPLETED|Overall Study||0
8101050|NCT03229486|19967554|P2|COMPLETED|Overall Study||19
8101051|NCT03229486|19967555|P1|COMPLETED|Overall Study||20
8101052|NCT03229486|19967554|P2|STARTED|Overall Study||20
8101053|NCT03229486|19967555|P1|STARTED|Overall Study||20
8101054|NCT03229252|19967576|P3|NOT COMPLETED|Overall Study||6
8101055|NCT03229252|19967577|P2|NOT COMPLETED|Overall Study||0
8101056|NCT03229252|19967578|P1|NOT COMPLETED|Overall Study||2
8101057|NCT03229252|19967576|P3|COMPLETED|Overall Study||39
8101058|NCT03229252|19967577|P2|COMPLETED|Overall Study||15
8101059|NCT03229252|19967578|P1|COMPLETED|Overall Study||29
8101060|NCT03229252|19967576|P3|STARTED|Overall Study||45
8101061|NCT03229252|19967577|P2|STARTED|Overall Study||15
8101062|NCT03229252|19967578|P1|STARTED|Overall Study||31
8101063|NCT03229109|19967596|P4|NOT COMPLETED|Overall Study||1
8101064|NCT03229109|19967597|P3|NOT COMPLETED|Overall Study||0
8101065|NCT03229109|19967598|P2|NOT COMPLETED|Overall Study||0
8101066|NCT03229109|19967599|P1|NOT COMPLETED|Overall Study||0
8101067|NCT03229109|19967596|P4|COMPLETED|Overall Study||50
8101068|NCT03229109|19967597|P3|COMPLETED|Overall Study||50
8101069|NCT03229109|19967598|P2|COMPLETED|Overall Study||50
8101070|NCT03229109|19967599|P1|COMPLETED|Overall Study||50
8101071|NCT03229109|19967596|P4|STARTED|Overall Study||51
8101072|NCT03229109|19967597|P3|STARTED|Overall Study||50
8101073|NCT03229109|19967598|P2|STARTED|Overall Study||50
8101074|NCT03229109|19967599|P1|STARTED|Overall Study||50
8101075|NCT03228914|19967609|P2|NOT COMPLETED|Overall Study||0
8101076|NCT03228914|19967610|P1|NOT COMPLETED|Overall Study||0
8101077|NCT03228914|19967609|P2|COMPLETED|Overall Study||20
8101078|NCT03228914|19967610|P1|COMPLETED|Overall Study||20
8101079|NCT03228914|19967609|P2|STARTED|Overall Study||20
8101080|NCT03228914|19967610|P1|STARTED|Overall Study||20
8101081|NCT03228836|19967618|P1|NOT COMPLETED|Overall Study||17
8101082|NCT03228836|19967618|P1|COMPLETED|Overall Study||11
8101083|NCT03228836|19967618|P1|Treated|Overall Study||28
8101084|NCT03228836|19967618|P1|STARTED|Overall Study||28
8101085|NCT03228433|19967630|P6|NOT COMPLETED|Overall Study||0
8101086|NCT03228433|19967631|P5|NOT COMPLETED|Overall Study||0
8101087|NCT03228433|19967632|P4|NOT COMPLETED|Overall Study||1
8101088|NCT03228433|19967633|P3|NOT COMPLETED|Overall Study||0
8101089|NCT03228433|19967634|P2|NOT COMPLETED|Overall Study||0
8101090|NCT03228433|19967635|P1|NOT COMPLETED|Overall Study||1
8101091|NCT03228433|19967630|P6|COMPLETED|Overall Study||6
8101092|NCT03228433|19967631|P5|COMPLETED|Overall Study||6
8101093|NCT03228433|19967632|P4|COMPLETED|Overall Study||5
8101094|NCT03228433|19967633|P3|COMPLETED|Overall Study||6
8101095|NCT03228433|19967634|P2|COMPLETED|Overall Study||6
8101096|NCT03228433|19967635|P1|COMPLETED|Overall Study||9
8101097|NCT03228433|19967630|P6|STARTED|Overall Study||6
8101098|NCT03228433|19967631|P5|STARTED|Overall Study||6
8101099|NCT03228433|19967632|P4|STARTED|Overall Study||6
8101100|NCT03228433|19967633|P3|STARTED|Overall Study||6
8101101|NCT03228433|19967634|P2|STARTED|Overall Study||6
8101102|NCT03228433|19967635|P1|STARTED|Overall Study||10
8101103|NCT03228212|19967710|P2|NOT COMPLETED|Period 3||0
8101104|NCT03228212|19967711|P1|NOT COMPLETED|Period 3||0
8101105|NCT03228212|19967710|P2|COMPLETED|Period 3||64
8101106|NCT03228212|19967711|P1|COMPLETED|Period 3||63
8101107|NCT03228212|19967710|P2|STARTED|Period 3||64
8101108|NCT03228212|19967711|P1|STARTED|Period 3||63
8101109|NCT03228212|19967710|P2|NOT COMPLETED|Period 2||0
8101110|NCT03228212|19967711|P1|NOT COMPLETED|Period 2||1
8101111|NCT03228212|19967710|P2|COMPLETED|Period 2||64
8101112|NCT03228212|19967711|P1|COMPLETED|Period 2||63
8101113|NCT03228212|19967710|P2|STARTED|Period 2||64
8101114|NCT03228212|19967711|P1|STARTED|Period 2||64
8101115|NCT03228212|19967710|P2|NOT COMPLETED|Period 1||1
8101116|NCT03228212|19967711|P1|NOT COMPLETED|Period 1||1
8101117|NCT03228212|19967710|P2|COMPLETED|Period 1||64
8101118|NCT03228212|19967711|P1|COMPLETED|Period 1||64
8101119|NCT03228212|19967710|P2|STARTED|Period 1||65
8101120|NCT03228212|19967711|P1|STARTED|Period 1||65
8101121|NCT03227861|19967727|P1|NOT COMPLETED|Extension Period (Week 48 to Week 96)||80
8101122|NCT03227861|19967727|P1|COMPLETED|Extension Period (Week 48 to Week 96)||0
8101123|NCT03227861|19967727|P1|STARTED|Extension Period (Week 48 to Week 96)|17 participants were not willing to enter extension study and discontinued after main study.|80
8101124|NCT03227861|19967727|P1|NOT COMPLETED|Main Study Period (Week 0 to Week 48)||12
8101125|NCT03227861|19967727|P1|COMPLETED|Main Study Period (Week 0 to Week 48)||97
8101126|NCT03227861|19967727|P1|STARTED|Main Study Period (Week 0 to Week 48)||109
8101127|NCT03227692|19967759|P2|NOT COMPLETED|Overall Study||5
8101128|NCT03227692|19967760|P1|NOT COMPLETED|Overall Study||5
8101129|NCT03227692|19967759|P2|COMPLETED|Overall Study||41
8101130|NCT03227692|19967760|P1|COMPLETED|Overall Study||42
8101131|NCT03227692|19967759|P2|STARTED|Overall Study||46
8101132|NCT03227692|19967760|P1|STARTED|Overall Study||47
8101133|NCT03227445|19967788|P4|NOT COMPLETED|Period 2 (28 Days)||3
8101134|NCT03227445|19967789|P3|NOT COMPLETED|Period 2 (28 Days)||2
8101135|NCT03227445|19967790|P2|NOT COMPLETED|Period 2 (28 Days)||1
8101136|NCT03227445|19967791|P1|NOT COMPLETED|Period 2 (28 Days)||1
8101137|NCT03227445|19967788|P4|COMPLETED|Period 2 (28 Days)||55
8101138|NCT03227445|19967789|P3|COMPLETED|Period 2 (28 Days)||57
8101139|NCT03227445|19967790|P2|COMPLETED|Period 2 (28 Days)||56
8101140|NCT03227445|19967791|P1|COMPLETED|Period 2 (28 Days)||57
8101141|NCT03227445|19967788|P4|STARTED|Period 2 (28 Days)||58
8101142|NCT03227445|19967789|P3|STARTED|Period 2 (28 Days)||59
8101143|NCT03227445|19967790|P2|STARTED|Period 2 (28 Days)||57
8101144|NCT03227445|19967791|P1|STARTED|Period 2 (28 Days)||58
8101145|NCT03227445|19967788|P4|NOT COMPLETED|Period 1 (28 Days)||2
8101146|NCT03227445|19967789|P3|NOT COMPLETED|Period 1 (28 Days)||1
8101147|NCT03227445|19967790|P2|NOT COMPLETED|Period 1 (28 Days)||2
8101148|NCT03227445|19967791|P1|NOT COMPLETED|Period 1 (28 Days)||2
8101149|NCT03227445|19967788|P4|COMPLETED|Period 1 (28 Days)||58
8101150|NCT03227445|19967789|P3|COMPLETED|Period 1 (28 Days)||59
8101151|NCT03227445|19967790|P2|COMPLETED|Period 1 (28 Days)||57
8101152|NCT03227445|19967791|P1|COMPLETED|Period 1 (28 Days)||58
8101153|NCT03227445|19967788|P4|STARTED|Period 1 (28 Days)||60
8101154|NCT03227445|19967789|P3|STARTED|Period 1 (28 Days)||60
8101155|NCT03227445|19967790|P2|STARTED|Period 1 (28 Days)||59
8101156|NCT03227445|19967791|P1|STARTED|Period 1 (28 Days)||60
8101169|NCT03226769|19967863|P2|NOT COMPLETED|Overall Study||1
8101170|NCT03226769|19967864|P1|NOT COMPLETED|Overall Study||0
8101171|NCT03226769|19967863|P2|COMPLETED|Overall Study||27
8101172|NCT03226769|19967864|P1|COMPLETED|Overall Study||29
8101173|NCT03226769|19967863|P2|STARTED|Overall Study||28
8101174|NCT03226769|19967864|P1|STARTED|Overall Study||29
8101175|NCT03226691|19967872|P1|NOT COMPLETED|Overall Study||0
8101176|NCT03226691|19967872|P1|COMPLETED|Overall Study||15
8101177|NCT03226691|19967872|P1|STARTED|Overall Study||15
8101178|NCT03226392|19967878|P2|NOT COMPLETED|Overall Study||8
8101179|NCT03226392|19967879|P1|NOT COMPLETED|Overall Study||11
8101180|NCT03226392|19967878|P2|COMPLETED|Overall Study||344
8101181|NCT03226392|19967879|P1|COMPLETED|Overall Study||341
8101182|NCT03226392|19967878|P2|FAS|Overall Study|"2 patients in the placebo were mis-randomized, not treated, not included due to technical problems"|350
8101183|NCT03226392|19967879|P1|FAS|Overall Study||352
8101184|NCT03226392|19967878|P2|STARTED|Overall Study||352
8101185|NCT03226392|19967879|P1|STARTED|Overall Study||352
8101186|NCT03226366|19967895|P4|NOT COMPLETED|Overall Study||0
8101187|NCT03226366|19967896|P3|NOT COMPLETED|Overall Study||0
8101188|NCT03226366|19967897|P2|NOT COMPLETED|Overall Study||0
8101189|NCT03226366|19967898|P1|NOT COMPLETED|Overall Study||0
8101190|NCT03226366|19967895|P4|COMPLETED|Overall Study||641
8101191|NCT03226366|19967896|P3|COMPLETED|Overall Study||1183
8101192|NCT03226366|19967897|P2|COMPLETED|Overall Study||495
8101193|NCT03226366|19967898|P1|COMPLETED|Overall Study||911
8101194|NCT03226366|19967895|P4|STARTED|Overall Study||641
8101195|NCT03226366|19967896|P3|STARTED|Overall Study||1183
8101196|NCT03226366|19967897|P2|STARTED|Overall Study||495
8101197|NCT03226366|19967898|P1|STARTED|Overall Study||911
8101198|NCT03226353|19967920|P1|NOT COMPLETED|Overall Study||6
8101199|NCT03226353|19967920|P1|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71
8101200|NCT03226353|19967920|P1|Other Habitual Lens Types|Overall Study||75
8101201|NCT03226353|19967920|P1|Habitual Wearers of Proclear 1 Day|Overall Study||2
8101202|NCT03226353|19967920|P1|STARTED|Overall Study||77
8101203|NCT03226275|19967944|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8101204|NCT03226275|19967945|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8101205|NCT03226275|19967946|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8101206|NCT03226275|19967947|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8101207|NCT03226275|19967944|P4|COMPLETED|Treatment Period 2 (8 Days)||7
8101208|NCT03226275|19967945|P3|COMPLETED|Treatment Period 2 (8 Days)||7
8101209|NCT03226275|19967946|P2|COMPLETED|Treatment Period 2 (8 Days)||8
8101210|NCT03226275|19967947|P1|COMPLETED|Treatment Period 2 (8 Days)||8
8101211|NCT03226275|19967944|P4|STARTED|Treatment Period 2 (8 Days)||7
8101212|NCT03226275|19967945|P3|STARTED|Treatment Period 2 (8 Days)||7
8101213|NCT03226275|19967946|P2|STARTED|Treatment Period 2 (8 Days)||8
8101214|NCT03226275|19967947|P1|STARTED|Treatment Period 2 (8 Days)||8
8101215|NCT03226275|19967944|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||1
8101216|NCT03226275|19967945|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||1
8101217|NCT03226275|19967946|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8101218|NCT03226275|19967947|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8101219|NCT03226275|19967944|P4|COMPLETED|Treatment Period 1 (8 Days)||7
8101220|NCT03226275|19967945|P3|COMPLETED|Treatment Period 1 (8 Days)||7
8101221|NCT03226275|19967946|P2|COMPLETED|Treatment Period 1 (8 Days)||8
8101222|NCT03226275|19967947|P1|COMPLETED|Treatment Period 1 (8 Days)||8
8101223|NCT03226275|19967944|P4|STARTED|Treatment Period 1 (8 Days)||8
8101224|NCT03226275|19967945|P3|STARTED|Treatment Period 1 (8 Days)||8
8101225|NCT03226275|19967946|P2|STARTED|Treatment Period 1 (8 Days)||8
8101226|NCT03226275|19967947|P1|STARTED|Treatment Period 1 (8 Days)||8
8101227|NCT03226249|19967993|P1|NOT COMPLETED|Survival Follow-up||30
8101228|NCT03226249|19967993|P1|COMPLETED|Survival Follow-up||0
8101229|NCT03226249|19967993|P1|STARTED|Survival Follow-up|All patients that are treated with one dose of study drug go into follow-up.|30
8101230|NCT03226249|19967993|P1|NOT COMPLETED|PEM Consolidation (1-2 Years)||29
8101231|NCT03226249|19967993|P1|COMPLETED|PEM Consolidation (1-2 Years)||0
8101232|NCT03226249|19967993|P1|STARTED|PEM Consolidation (1-2 Years)||29
8101233|NCT03226249|19967993|P1|NOT COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||1
8101234|NCT03226249|19967993|P1|COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
8101235|NCT03226249|19967993|P1|PET#4|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
8101236|NCT03226249|19967993|P1|2-4 Cycles of AVD +/- Chemo & RT|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
8101237|NCT03226249|19967993|P1|STARTED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||30
8101238|NCT03226249|19967993|P1|NOT COMPLETED|2 Cycles of AVD + PET#3||0
8101239|NCT03226249|19967993|P1|COMPLETED|2 Cycles of AVD + PET#3||30
8101240|NCT03226249|19967993|P1|PET#3|2 Cycles of AVD + PET#3||30
8101241|NCT03226249|19967993|P1|AVD Cycle 2|2 Cycles of AVD + PET#3||30
8101242|NCT03226249|19967993|P1|AVD Cycle 1|2 Cycles of AVD + PET#3||30
8101243|NCT03226249|19967993|P1|STARTED|2 Cycles of AVD + PET#3||30
8101244|NCT03226249|19967993|P1|NOT COMPLETED|PEM Induction Cycles 1-3, and PET#2||0
8101245|NCT03226249|19967993|P1|COMPLETED|PEM Induction Cycles 1-3, and PET#2||30
8101246|NCT03226249|19967993|P1|PET#2|PEM Induction Cycles 1-3, and PET#2||30
8101247|NCT03226249|19967993|P1|PEM Cycle 3|PEM Induction Cycles 1-3, and PET#2||30
8101248|NCT03226249|19967993|P1|PEM Cycle 2|PEM Induction Cycles 1-3, and PET#2||30
8101249|NCT03226249|19967993|P1|PEM Cycle 1|PEM Induction Cycles 1-3, and PET#2||30
8101250|NCT03226249|19967993|P1|STARTED|PEM Induction Cycles 1-3, and PET#2||30
8101251|NCT03226223|19968001|P2|NOT COMPLETED|Overall Study||2
8101252|NCT03226223|19968002|P1|NOT COMPLETED|Overall Study||2
8101253|NCT03226223|19968001|P2|COMPLETED|Overall Study||6
8101254|NCT03226223|19968002|P1|COMPLETED|Overall Study||8
8101255|NCT03226223|19968001|P2|STARTED|Overall Study||8
8101256|NCT03226223|19968002|P1|STARTED|Overall Study||10
8101257|NCT03225599|19968010|P1|NOT COMPLETED|Overall Study||2
8101258|NCT03225599|19968010|P1|COMPLETED|Overall Study||7
8101259|NCT03225599|19968010|P1|STARTED|Overall Study||9
8101260|NCT03225573|19968014|P1|NOT COMPLETED|Overall Study||0
8101261|NCT03225573|19968014|P1|COMPLETED|Overall Study||60
8101262|NCT03225573|19968014|P1|STARTED|Overall Study||60
8101276|NCT03224598|19968063|P3|NOT COMPLETED|Overall Study||0
8101277|NCT03224598|19968064|P2|NOT COMPLETED|Overall Study||3
8101278|NCT03224598|19968065|P1|NOT COMPLETED|Overall Study||0
8101279|NCT03224598|19968063|P3|COMPLETED|Overall Study||13
8101280|NCT03224598|19968064|P2|COMPLETED|Overall Study||14
8101281|NCT03224598|19968065|P1|COMPLETED|Overall Study||9
8101282|NCT03224598|19968063|P3|STARTED|Overall Study||13
8101283|NCT03224598|19968064|P2|STARTED|Overall Study||17
8101284|NCT03224598|19968065|P1|STARTED|Overall Study||9
8101285|NCT03224390|19968075|P2|NOT COMPLETED|Overall Study||35
8101286|NCT03224390|19968076|P1|NOT COMPLETED|Overall Study||27
8101287|NCT03224390|19968075|P2|COMPLETED|Overall Study||21
8101288|NCT03224390|19968076|P1|COMPLETED|Overall Study||29
8101289|NCT03224390|19968075|P2|STARTED|Overall Study||56
8101290|NCT03224390|19968076|P1|STARTED|Overall Study||56
8101312|NCT03224234|19968162|P2|NOT COMPLETED|Pilot||0
8101313|NCT03224234|19968163|P1|NOT COMPLETED|Pilot||0
8101314|NCT03224234|19968162|P2|COMPLETED|Pilot||7
8101315|NCT03224234|19968163|P1|COMPLETED|Pilot||11
8101316|NCT03224234|19968162|P2|STARTED|Pilot||7
8101317|NCT03224234|19968163|P1|STARTED|Pilot||11
8101318|NCT03224234|19968162|P2|NOT COMPLETED|Main Study||5
8101319|NCT03224234|19968163|P1|NOT COMPLETED|Main Study||5
8101320|NCT03224234|19968162|P2|COMPLETED|Main Study||35
8101321|NCT03224234|19968163|P1|COMPLETED|Main Study||35
8101322|NCT03224234|19968162|P2|STARTED|Main Study||40
8101323|NCT03224234|19968163|P1|STARTED|Main Study||40
8101324|NCT03224130|19968211|P2|NOT COMPLETED|Overall Study||1
8101325|NCT03224130|19968212|P1|NOT COMPLETED|Overall Study||0
8101326|NCT03224130|19968211|P2|COMPLETED|Overall Study||482
8101327|NCT03224130|19968212|P1|COMPLETED|Overall Study||483
8101328|NCT03224130|19968211|P2|STARTED|Overall Study||483
8101329|NCT03224130|19968212|P1|STARTED|Overall Study||483
8101330|NCT03223909|19968233|P3|NOT COMPLETED|Overall Study||16
8101331|NCT03223909|19968234|P2|NOT COMPLETED|Overall Study||45
8101332|NCT03223909|19968235|P1|NOT COMPLETED|Overall Study||48
8101333|NCT03223909|19968233|P3|COMPLETED|Overall Study||81
8101334|NCT03223909|19968234|P2|COMPLETED|Overall Study||64
8101335|NCT03223909|19968235|P1|COMPLETED|Overall Study||72
8101336|NCT03223909|19968233|P3|STARTED|Overall Study||97
8101337|NCT03223909|19968234|P2|STARTED|Overall Study||109
8101338|NCT03223909|19968235|P1|STARTED|Overall Study||120
8101339|NCT03223662|19968264|P1|NOT COMPLETED|Overall Study||2
8101340|NCT03223662|19968264|P1|COMPLETED|Overall Study||0
8101341|NCT03223662|19968264|P1|STARTED|Overall Study||2
8101342|NCT03223337|19968278|P4|NOT COMPLETED|Part 2 (Up to 16 Days)||0
8101343|NCT03223337|19968279|P3|NOT COMPLETED|Part 2 (Up to 16 Days)||0
8101344|NCT03223337|19968280|P2|NOT COMPLETED|Part 2 (Up to 16 Days)||0
8101345|NCT03223337|19968281|P1|NOT COMPLETED|Part 2 (Up to 16 Days)||0
8101346|NCT03223337|19968278|P4|COMPLETED|Part 2 (Up to 16 Days)||9
8101347|NCT03223337|19968279|P3|COMPLETED|Part 2 (Up to 16 Days)||12
8101348|NCT03223337|19968280|P2|COMPLETED|Part 2 (Up to 16 Days)||0
8101349|NCT03223337|19968281|P1|COMPLETED|Part 2 (Up to 16 Days)||0
8101350|NCT03223337|19968278|P4|STARTED|Part 2 (Up to 16 Days)||9
8101351|NCT03223337|19968279|P3|STARTED|Part 2 (Up to 16 Days)||12
8101352|NCT03223337|19968280|P2|STARTED|Part 2 (Up to 16 Days)||0
8101353|NCT03223337|19968281|P1|STARTED|Part 2 (Up to 16 Days)||0
8101354|NCT03223337|19968278|P4|NOT COMPLETED|Part 1 (Up to 16 Days)||0
8101355|NCT03223337|19968279|P3|NOT COMPLETED|Part 1 (Up to 16 Days)||0
8101356|NCT03223337|19968280|P2|NOT COMPLETED|Part 1 (Up to 16 Days)||0
8101357|NCT03223337|19968281|P1|NOT COMPLETED|Part 1 (Up to 16 Days)||0
8101358|NCT03223337|19968278|P4|COMPLETED|Part 1 (Up to 16 Days)||0
8101359|NCT03223337|19968279|P3|COMPLETED|Part 1 (Up to 16 Days)||0
8101360|NCT03223337|19968280|P2|COMPLETED|Part 1 (Up to 16 Days)||8
8101361|NCT03223337|19968281|P1|COMPLETED|Part 1 (Up to 16 Days)||8
8101362|NCT03223337|19968278|P4|STARTED|Part 1 (Up to 16 Days)||0
8101363|NCT03223337|19968279|P3|STARTED|Part 1 (Up to 16 Days)||0
8101364|NCT03223337|19968280|P2|STARTED|Part 1 (Up to 16 Days)||8
8101365|NCT03223337|19968281|P1|STARTED|Part 1 (Up to 16 Days)||8
8101366|NCT03223246|19968349|P2|NOT COMPLETED|5-7 Days||31
8101367|NCT03223246|19968350|P1|NOT COMPLETED|5-7 Days||42
8101368|NCT03223246|19968349|P2|COMPLETED|5-7 Days||35
8101369|NCT03223246|19968350|P1|COMPLETED|5-7 Days||41
8101370|NCT03223246|19968349|P2|STARTED|5-7 Days||66
8101371|NCT03223246|19968350|P1|STARTED|5-7 Days||83
8101372|NCT03223246|19968349|P2|NOT COMPLETED|48-72 Hours||31
8101373|NCT03223246|19968350|P1|NOT COMPLETED|48-72 Hours||21
8101374|NCT03223246|19968349|P2|COMPLETED|48-72 Hours||35
8101375|NCT03223246|19968350|P1|COMPLETED|48-72 Hours||62
8101376|NCT03223246|19968349|P2|STARTED|48-72 Hours||66
8101377|NCT03223246|19968350|P1|STARTED|48-72 Hours||83
8101378|NCT03222583|19968368|P2|NOT COMPLETED|Overall Study||6
8101379|NCT03222583|19968369|P1|NOT COMPLETED|Overall Study||5
8101380|NCT03222583|19968368|P2|COMPLETED|Overall Study||177
8101381|NCT03222583|19968369|P1|COMPLETED|Overall Study||358
8101382|NCT03222583|19968368|P2|Completed Open-label Period|Overall Study||181
8101383|NCT03222583|19968369|P1|Completed Open-label Period|Overall Study||0
8101384|NCT03222583|19968368|P2|Entered Open-label Period|Overall Study||182
8101385|NCT03222583|19968369|P1|Entered Open-label Period|Overall Study||0
8101386|NCT03222583|19968368|P2|Completed Double-blind Period|Overall Study||183
8101387|NCT03222583|19968369|P1|Completed Double-blind Period|Overall Study||360
8101388|NCT03222583|19968368|P2|Received Double-blind Treatment|Overall Study||183
8101389|NCT03222583|19968369|P1|Received Double-blind Treatment|Overall Study||362
8101390|NCT03222583|19968368|P2|STARTED|Overall Study||183
8101391|NCT03222583|19968369|P1|STARTED|Overall Study||363
8101392|NCT03222505|19968382|P2|NOT COMPLETED|Overall Study||0
8101393|NCT03222505|19968383|P1|NOT COMPLETED|Overall Study||0
8101394|NCT03222505|19968382|P2|COMPLETED|Overall Study||7
8101395|NCT03222505|19968383|P1|COMPLETED|Overall Study||5
8101396|NCT03222505|19968382|P2|STARTED|Overall Study||7
8101397|NCT03222505|19968383|P1|STARTED|Overall Study||5
8101398|NCT03222427|19968393|P1|NOT COMPLETED|Overall Study||0
8101399|NCT03222427|19968393|P1|COMPLETED|Overall Study||8
8101400|NCT03222427|19968393|P1|Received One Dose of Study Drug|Overall Study||8
8101401|NCT03222427|19968393|P1|STARTED|Overall Study||8
8101402|NCT03222414|19968402|P2|NOT COMPLETED|Overall Study||0
8101403|NCT03222414|19968403|P1|NOT COMPLETED|Overall Study||0
8101404|NCT03222414|19968402|P2|COMPLETED|Overall Study||1
8101405|NCT03222414|19968403|P1|COMPLETED|Overall Study||0
8101406|NCT03222414|19968402|P2|STARTED|Overall Study||1
8101407|NCT03222414|19968403|P1|STARTED|Overall Study||0
8101411|NCT03222128|19968425|P1|NOT COMPLETED|Overall Study||106
8101412|NCT03222128|19968425|P1|COMPLETED|Overall Study||968
8101413|NCT03222128|19968425|P1|Valve-Implanted|Overall Study||1069
8101414|NCT03222128|19968425|P1|STARTED|Overall Study||1074
8101415|NCT03222037|19968430|P2|NOT COMPLETED|Period 2||0
8101416|NCT03222037|19968431|P1|NOT COMPLETED|Period 2||0
8101417|NCT03222037|19968430|P2|COMPLETED|Period 2||22
8101418|NCT03222037|19968431|P1|COMPLETED|Period 2||21
8101419|NCT03222037|19968430|P2|STARTED|Period 2||22
8101420|NCT03222037|19968431|P1|STARTED|Period 2||21
8101421|NCT03222037|19968430|P2|NOT COMPLETED|Period 1||0
8101422|NCT03222037|19968431|P1|NOT COMPLETED|Period 1||0
8101423|NCT03222037|19968430|P2|COMPLETED|Period 1||22
8101424|NCT03222037|19968431|P1|COMPLETED|Period 1||21
8101425|NCT03222037|19968430|P2|STARTED|Period 1||22
8101426|NCT03222037|19968431|P1|STARTED|Period 1||21
8101427|NCT03221764|19968439|P1|NOT COMPLETED|Overall Study||0
8101428|NCT03221764|19968439|P1|COMPLETED|Overall Study||20
8101429|NCT03221764|19968439|P1|STARTED|Overall Study||20
8101430|NCT03221738|19968445|P1|NOT COMPLETED|Overall Study||0
8101431|NCT03221738|19968445|P1|COMPLETED|Overall Study||10
8101432|NCT03221738|19968445|P1|STARTED|Overall Study||10
8101433|NCT03221660|19968451|P1|NOT COMPLETED|Overall Study||0
8101434|NCT03221660|19968451|P1|COMPLETED|Overall Study||50
8101435|NCT03221660|19968451|P1|STARTED|Overall Study||50
8101436|NCT03221192|19968456|P1|NOT COMPLETED|Overall Study||0
8101437|NCT03221192|19968456|P1|COMPLETED|Overall Study||27
8101438|NCT03221192|19968456|P1|STARTED|Overall Study||27
8101439|NCT03220854|19968498|P3|NOT COMPLETED|Overall Study||0
8101440|NCT03220854|19968499|P2|NOT COMPLETED|Overall Study||0
8101441|NCT03220854|19968500|P1|NOT COMPLETED|Overall Study||0
8101442|NCT03220854|19968498|P3|COMPLETED|Overall Study||1
8101443|NCT03220854|19968499|P2|COMPLETED|Overall Study||0
8101444|NCT03220854|19968500|P1|COMPLETED|Overall Study||4
8101445|NCT03220854|19968498|P3|STARTED|Overall Study||1
8101446|NCT03220854|19968499|P2|STARTED|Overall Study||0
8101447|NCT03220854|19968500|P1|STARTED|Overall Study||4
8101448|NCT03220737|19968533|P7|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
8101449|NCT03220737|19968534|P6|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
8101450|NCT03220737|19968535|P5|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
8101451|NCT03220737|19968536|P4|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
8101452|NCT03220737|19968537|P3|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
8101453|NCT03220737|19968538|P2|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
8101454|NCT03220737|19968539|P1|NOT COMPLETED|Long-term Follow-up (Day 365-730)||11
8101455|NCT03220737|19968533|P7|COMPLETED|Long-term Follow-up (Day 365-730)||0
8101456|NCT03220737|19968534|P6|COMPLETED|Long-term Follow-up (Day 365-730)||0
8101457|NCT03220737|19968535|P5|COMPLETED|Long-term Follow-up (Day 365-730)||0
8101458|NCT03220737|19968536|P4|COMPLETED|Long-term Follow-up (Day 365-730)||0
8101459|NCT03220737|19968537|P3|COMPLETED|Long-term Follow-up (Day 365-730)||0
8101460|NCT03220737|19968538|P2|COMPLETED|Long-term Follow-up (Day 365-730)||0
8101461|NCT03220737|19968539|P1|COMPLETED|Long-term Follow-up (Day 365-730)||62
8101462|NCT03220737|19968533|P7|STARTED|Long-term Follow-up (Day 365-730)||0
8101463|NCT03220737|19968534|P6|STARTED|Long-term Follow-up (Day 365-730)||0
8101464|NCT03220737|19968535|P5|STARTED|Long-term Follow-up (Day 365-730)|Cohort 3 subjects were not eligible for the Long-term follow-up study.|0
8101465|NCT03220737|19968536|P4|STARTED|Long-term Follow-up (Day 365-730)||0
8101466|NCT03220737|19968537|P3|STARTED|Long-term Follow-up (Day 365-730)|Cohort 2 subjects were not eligible for the Long-term follow-up study.|0
8101467|NCT03220737|19968538|P2|STARTED|Long-term Follow-up (Day 365-730)||0
8101468|NCT03220737|19968539|P1|STARTED|Long-term Follow-up (Day 365-730)|Cohort 1 subjects from the main study had to opt to be included in the Long-term follow-up study.|73
8101469|NCT03220737|19968533|P7|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
8101470|NCT03220737|19968534|P6|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
8101471|NCT03220737|19968535|P5|NOT COMPLETED|Placebo Crossover (Day 181-365)||2
8101472|NCT03220737|19968536|P4|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
8101473|NCT03220737|19968537|P3|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
8101474|NCT03220737|19968538|P2|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
8101475|NCT03220737|19968539|P1|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
8101476|NCT03220737|19968533|P7|COMPLETED|Placebo Crossover (Day 181-365)||0
8101477|NCT03220737|19968534|P6|COMPLETED|Placebo Crossover (Day 181-365)||0
8101478|NCT03220737|19968535|P5|COMPLETED|Placebo Crossover (Day 181-365)||5
8101479|NCT03220737|19968536|P4|COMPLETED|Placebo Crossover (Day 181-365)||0
8101480|NCT03220737|19968537|P3|COMPLETED|Placebo Crossover (Day 181-365)||11
8101481|NCT03220737|19968538|P2|COMPLETED|Placebo Crossover (Day 181-365)||0
8101482|NCT03220737|19968539|P1|COMPLETED|Placebo Crossover (Day 181-365)||13
8101483|NCT03220737|19968533|P7|STARTED|Placebo Crossover (Day 181-365)||0
8101484|NCT03220737|19968534|P6|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
8101485|NCT03220737|19968535|P5|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|7
8101486|NCT03220737|19968536|P4|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
8101487|NCT03220737|19968537|P3|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|11
8101488|NCT03220737|19968538|P2|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora.|0
8101489|NCT03220737|19968539|P1|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|13
8101490|NCT03220737|19968533|P7|NOT COMPLETED|Main Study (Day 1 - 181)||1
8101491|NCT03220737|19968534|P6|NOT COMPLETED|Main Study (Day 1 - 181)||1
8101492|NCT03220737|19968535|P5|NOT COMPLETED|Main Study (Day 1 - 181)||20
8101493|NCT03220737|19968536|P4|NOT COMPLETED|Main Study (Day 1 - 181)||3
8101494|NCT03220737|19968537|P3|NOT COMPLETED|Main Study (Day 1 - 181)||12
8101495|NCT03220737|19968538|P2|NOT COMPLETED|Main Study (Day 1 - 181)||2
8101496|NCT03220737|19968539|P1|NOT COMPLETED|Main Study (Day 1 - 181)||6
8101497|NCT03220737|19968533|P7|COMPLETED|Main Study (Day 1 - 181)||2687
8101498|NCT03220737|19968534|P6|COMPLETED|Main Study (Day 1 - 181)||25
8101499|NCT03220737|19968535|P5|COMPLETED|Main Study (Day 1 - 181)||130
8101500|NCT03220737|19968536|P4|COMPLETED|Main Study (Day 1 - 181)||24
8101501|NCT03220737|19968537|P3|COMPLETED|Main Study (Day 1 - 181)||146
8101502|NCT03220737|19968538|P2|COMPLETED|Main Study (Day 1 - 181)||24
8101503|NCT03220737|19968539|P1|COMPLETED|Main Study (Day 1 - 181)||157
8101504|NCT03220737|19968533|P7|STARTED|Main Study (Day 1 - 181)||2688
8101505|NCT03220737|19968534|P6|STARTED|Main Study (Day 1 - 181)||26
8101506|NCT03220737|19968535|P5|STARTED|Main Study (Day 1 - 181)||150
8101507|NCT03220737|19968536|P4|STARTED|Main Study (Day 1 - 181)||27
8101508|NCT03220737|19968537|P3|STARTED|Main Study (Day 1 - 181)||158
8101509|NCT03220737|19968538|P2|STARTED|Main Study (Day 1 - 181)||26
8101510|NCT03220737|19968539|P1|STARTED|Main Study (Day 1 - 181)||163
8101511|NCT03220412|19968580|P2|NOT COMPLETED|Overall Study||0
8101512|NCT03220412|19968581|P1|NOT COMPLETED|Overall Study||0
8101513|NCT03220412|19968580|P2|COMPLETED|Overall Study||50
8101514|NCT03220412|19968581|P1|COMPLETED|Overall Study||54
8101515|NCT03220412|19968580|P2|STARTED|Overall Study||50
8101516|NCT03220412|19968581|P1|STARTED|Overall Study||54
8101517|NCT03220230|19968589|P1|NOT COMPLETED|Overall Study||0
8101518|NCT03220230|19968589|P1|COMPLETED|Overall Study||4240
8101519|NCT03220230|19968589|P1|STARTED|Overall Study||4240
8101520|NCT03220217|19968602|P3|NOT COMPLETED|Overall Study||1
8101521|NCT03220217|19968603|P2|NOT COMPLETED|Overall Study||1
8101522|NCT03220217|19968604|P1|NOT COMPLETED|Overall Study||0
8101523|NCT03220217|19968602|P3|COMPLETED|Overall Study||10
8101524|NCT03220217|19968603|P2|COMPLETED|Overall Study||9
8101525|NCT03220217|19968604|P1|COMPLETED|Overall Study||8
8101526|NCT03220217|19968602|P3|STARTED|Overall Study||11
8101527|NCT03220217|19968603|P2|STARTED|Overall Study||10
8101528|NCT03220217|19968604|P1|STARTED|Overall Study||8
8101538|NCT03220048|19968726|P3|NOT COMPLETED|Overall Study||1
8101539|NCT03220048|19968727|P2|NOT COMPLETED|Overall Study||2
8101540|NCT03220048|19968728|P1|NOT COMPLETED|Overall Study||0
8101541|NCT03220048|19968726|P3|COMPLETED|Overall Study||27
8101542|NCT03220048|19968727|P2|COMPLETED|Overall Study||25
8101543|NCT03220048|19968728|P1|COMPLETED|Overall Study||11
8101544|NCT03220048|19968726|P3|STARTED|Overall Study||28
8101545|NCT03220048|19968727|P2|STARTED|Overall Study||27
8101546|NCT03220048|19968728|P1|STARTED|Overall Study||11
8101547|NCT03219723|19968751|P1|NOT COMPLETED|Overall Study||10
8101548|NCT03219723|19968751|P1|COMPLETED|Overall Study||550
8101549|NCT03219723|19968751|P1|STARTED|Overall Study||560
8101550|NCT03219372|19968758|P2|NOT COMPLETED|Overall Study||0
8101551|NCT03219372|19968759|P1|NOT COMPLETED|Overall Study||1
8101552|NCT03219372|19968758|P2|COMPLETED|Overall Study||0
8101553|NCT03219372|19968759|P1|COMPLETED|Overall Study||0
8101554|NCT03219372|19968758|P2|STARTED|Overall Study||0
8101555|NCT03219372|19968759|P1|STARTED|Overall Study||1
8101556|NCT03219320|19968783|P4|NOT COMPLETED|Overall Study||3
8101557|NCT03219320|19968784|P3|NOT COMPLETED|Overall Study||5
8101558|NCT03219320|19968785|P2|NOT COMPLETED|Overall Study||3
8101559|NCT03219320|19968786|P1|NOT COMPLETED|Overall Study||2
8101560|NCT03219320|19968783|P4|COMPLETED|Overall Study||69
8101561|NCT03219320|19968784|P3|COMPLETED|Overall Study||72
8101562|NCT03219320|19968785|P2|COMPLETED|Overall Study||74
8101563|NCT03219320|19968786|P1|COMPLETED|Overall Study||73
8101564|NCT03219320|19968783|P4|STARTED|Overall Study||72
8101565|NCT03219320|19968784|P3|STARTED|Overall Study||77
8101566|NCT03219320|19968785|P2|STARTED|Overall Study||77
8101567|NCT03219320|19968786|P1|STARTED|Overall Study||75
8101568|NCT03219294|19968806|P2|NOT COMPLETED|Overall Study||0
8101569|NCT03219294|19968807|P1|NOT COMPLETED|Overall Study||0
8101570|NCT03219294|19968806|P2|COMPLETED|Overall Study||58
8101571|NCT03219294|19968807|P1|COMPLETED|Overall Study||58
8101572|NCT03219294|19968806|P2|STARTED|Overall Study||58
8101573|NCT03219294|19968807|P1|STARTED|Overall Study||58
8101574|NCT03219216|19968817|P2|NOT COMPLETED|Overall Study||1
8101575|NCT03219216|19968818|P1|NOT COMPLETED|Overall Study||0
8101576|NCT03219216|19968817|P2|COMPLETED|Overall Study||24
8101577|NCT03219216|19968818|P1|COMPLETED|Overall Study||75
8101578|NCT03219216|19968817|P2|STARTED|Overall Study||25
8101579|NCT03219216|19968818|P1|STARTED|Overall Study||75
8101580|NCT03218592|19968827|P3|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
8101581|NCT03218592|19968828|P2|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
8101582|NCT03218592|19968829|P1|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
8101583|NCT03218592|19968827|P3|COMPLETED|Phase 3: 3 Doses Per Week||4
8101584|NCT03218592|19968828|P2|COMPLETED|Phase 3: 3 Doses Per Week||4
8101585|NCT03218592|19968829|P1|COMPLETED|Phase 3: 3 Doses Per Week||4
8101586|NCT03218592|19968827|P3|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
8101587|NCT03218592|19968828|P2|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
8101588|NCT03218592|19968829|P1|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
8101589|NCT03218592|19968827|P3|STARTED|Phase 3: 3 Doses Per Week||4
8101590|NCT03218592|19968828|P2|STARTED|Phase 3: 3 Doses Per Week||4
8101591|NCT03218592|19968829|P1|STARTED|Phase 3: 3 Doses Per Week||4
8101592|NCT03218592|19968827|P3|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
8101593|NCT03218592|19968828|P2|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
8101594|NCT03218592|19968829|P1|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
8101595|NCT03218592|19968827|P3|COMPLETED|Phase 3: 1 Dose Per Period||4
8101596|NCT03218592|19968828|P2|COMPLETED|Phase 3: 1 Dose Per Period||4
8101597|NCT03218592|19968829|P1|COMPLETED|Phase 3: 1 Dose Per Period||4
8101598|NCT03218592|19968827|P3|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
8101599|NCT03218592|19968828|P2|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
8101600|NCT03218592|19968829|P1|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
8101601|NCT03218592|19968827|P3|STARTED|Phase 3: 1 Dose Per Period||4
8101602|NCT03218592|19968828|P2|STARTED|Phase 3: 1 Dose Per Period||4
8101603|NCT03218592|19968829|P1|STARTED|Phase 3: 1 Dose Per Period||4
8101604|NCT03218592|19968827|P3|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
8101605|NCT03218592|19968828|P2|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
8101606|NCT03218592|19968829|P1|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
8101607|NCT03218592|19968827|P3|COMPLETED|Phase 3: 0 Doses Per Week||4
8101608|NCT03218592|19968828|P2|COMPLETED|Phase 3: 0 Doses Per Week||4
8101609|NCT03218592|19968829|P1|COMPLETED|Phase 3: 0 Doses Per Week||4
8101610|NCT03218592|19968827|P3|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
8101611|NCT03218592|19968828|P2|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
8101612|NCT03218592|19968829|P1|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
8101613|NCT03218592|19968827|P3|STARTED|Phase 3: 0 Doses Per Week||4
8101614|NCT03218592|19968828|P2|STARTED|Phase 3: 0 Doses Per Week||4
8101615|NCT03218592|19968829|P1|STARTED|Phase 3: 0 Doses Per Week||4
8101616|NCT03218592|19968827|P3|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
8101617|NCT03218592|19968828|P2|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
8101618|NCT03218592|19968829|P1|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
8101619|NCT03218592|19968827|P3|COMPLETED|Phase 2: Daily Doses x 28 Days||12
8101620|NCT03218592|19968828|P2|COMPLETED|Phase 2: Daily Doses x 28 Days||12
8101621|NCT03218592|19968829|P1|COMPLETED|Phase 2: Daily Doses x 28 Days||12
8101622|NCT03218592|19968827|P3|STARTED|Phase 2: Daily Doses x 28 Days||12
8101623|NCT03218592|19968828|P2|STARTED|Phase 2: Daily Doses x 28 Days||12
8101624|NCT03218592|19968829|P1|STARTED|Phase 2: Daily Doses x 28 Days||12
8101625|NCT03218592|19968827|P3|NOT COMPLETED|Phase 1: 1 Dose||0
8101626|NCT03218592|19968828|P2|NOT COMPLETED|Phase 1: 1 Dose||0
8101627|NCT03218592|19968829|P1|NOT COMPLETED|Phase 1: 1 Dose||0
8101628|NCT03218592|19968827|P3|COMPLETED|Phase 1: 1 Dose||12
8101629|NCT03218592|19968828|P2|COMPLETED|Phase 1: 1 Dose||12
8101630|NCT03218592|19968829|P1|COMPLETED|Phase 1: 1 Dose||12
8101631|NCT03218592|19968827|P3|STARTED|Phase 1: 1 Dose||12
8101632|NCT03218592|19968828|P2|STARTED|Phase 1: 1 Dose||12
8101633|NCT03218592|19968829|P1|STARTED|Phase 1: 1 Dose||12
8101634|NCT03218566|19968849|P1|NOT COMPLETED|Overall Study||9
8101635|NCT03218566|19968849|P1|COMPLETED|Overall Study||110
8101636|NCT03218566|19968849|P1|STARTED|Overall Study||119
8101637|NCT03218397|19968864|P2|NOT COMPLETED|Overall Study||29
8101638|NCT03218397|19968865|P1|NOT COMPLETED|Overall Study||23
8101639|NCT03218397|19968864|P2|COMPLETED|Overall Study||222
8101640|NCT03218397|19968865|P1|COMPLETED|Overall Study||226
8101641|NCT03218397|19968864|P2|STARTED|Overall Study||251
8101642|NCT03218397|19968865|P1|STARTED|Overall Study||249
8101643|NCT03218163|19968893|P1|NOT COMPLETED|Overall Study||0
8101644|NCT03218163|19968893|P1|COMPLETED|Overall Study||0
8101645|NCT03218163|19968893|P1|STARTED|Overall Study||0
8101646|NCT03217968|19968897|P1|NOT COMPLETED|Overall Study||11
8101647|NCT03217968|19968897|P1|COMPLETED|Overall Study||48
8101648|NCT03217968|19968897|P1|STARTED|Overall Study||59
8101649|NCT03217175|19968906|P2|NOT COMPLETED|Overall Study||1
8101650|NCT03217175|19968907|P1|NOT COMPLETED|Overall Study||4
8101651|NCT03217175|19968906|P2|COMPLETED|Overall Study||0
8101652|NCT03217175|19968907|P1|COMPLETED|Overall Study||0
8101653|NCT03217175|19968906|P2|STARTED|Overall Study||1
8101654|NCT03217175|19968907|P1|STARTED|Overall Study||4
8101655|NCT03216954|19968921|P5|NOT COMPLETED|Overall Study||1
8101656|NCT03216954|19968922|P4|NOT COMPLETED|Overall Study||0
8101657|NCT03216954|19968923|P3|NOT COMPLETED|Overall Study||1
8101658|NCT03216954|19968924|P2|NOT COMPLETED|Overall Study||1
8101659|NCT03216954|19968925|P1|NOT COMPLETED|Overall Study||2
8101660|NCT03216954|19968921|P5|COMPLETED|Overall Study||0
8101661|NCT03216954|19968922|P4|COMPLETED|Overall Study||3
8101662|NCT03216954|19968923|P3|COMPLETED|Overall Study||2
8101663|NCT03216954|19968924|P2|COMPLETED|Overall Study||2
8101664|NCT03216954|19968925|P1|COMPLETED|Overall Study||2
8101665|NCT03216954|19968921|P5|STARTED|Overall Study||1
8101666|NCT03216954|19968922|P4|STARTED|Overall Study||3
8101667|NCT03216954|19968923|P3|STARTED|Overall Study||3
8101668|NCT03216954|19968924|P2|STARTED|Overall Study||3
8101669|NCT03216954|19968925|P1|STARTED|Overall Study||4
8101670|NCT03216902|19968939|P6|NOT COMPLETED|Overall Study||3
8101671|NCT03216902|19968940|P5|NOT COMPLETED|Overall Study||1
8101672|NCT03216902|19968941|P4|NOT COMPLETED|Overall Study||0
8101673|NCT03216902|19968942|P3|NOT COMPLETED|Overall Study||1
8101674|NCT03216902|19968943|P2|NOT COMPLETED|Overall Study||1
8101675|NCT03216902|19968944|P1|NOT COMPLETED|Overall Study||2
8101676|NCT03216902|19968939|P6|COMPLETED|Overall Study||42
8101677|NCT03216902|19968940|P5|COMPLETED|Overall Study||43
8101678|NCT03216902|19968941|P4|COMPLETED|Overall Study||43
8101679|NCT03216902|19968942|P3|COMPLETED|Overall Study||42
8101680|NCT03216902|19968943|P2|COMPLETED|Overall Study||43
8101681|NCT03216902|19968944|P1|COMPLETED|Overall Study||20
8101682|NCT03216902|19968939|P6|STARTED|Overall Study||45
8101683|NCT03216902|19968940|P5|STARTED|Overall Study||44
8101684|NCT03216902|19968941|P4|STARTED|Overall Study||43
8101685|NCT03216902|19968942|P3|STARTED|Overall Study||43
8101686|NCT03216902|19968943|P2|STARTED|Overall Study||44
8101687|NCT03216902|19968944|P1|STARTED|Overall Study||22
8101688|NCT03216850|19969014|P1|NOT COMPLETED|Overall Study||6
8101689|NCT03216850|19969014|P1|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9
8101690|NCT03216850|19969014|P1|STARTED|Overall Study||15
8101691|NCT03216746|19969022|P4|NOT COMPLETED|Overall Study||6
8101692|NCT03216746|19969023|P3|NOT COMPLETED|Overall Study||5
8101693|NCT03216746|19969024|P2|NOT COMPLETED|Overall Study||8
8101694|NCT03216746|19969025|P1|NOT COMPLETED|Overall Study||6
8101695|NCT03216746|19969022|P4|COMPLETED|Overall Study||63
8101696|NCT03216746|19969023|P3|COMPLETED|Overall Study||63
8101697|NCT03216746|19969024|P2|COMPLETED|Overall Study||71
8101698|NCT03216746|19969025|P1|COMPLETED|Overall Study||66
8101699|NCT03216746|19969022|P4|STARTED|Overall Study||69
8101700|NCT03216746|19969023|P3|STARTED|Overall Study||68
8101701|NCT03216746|19969024|P2|STARTED|Overall Study||79
8101702|NCT03216746|19969025|P1|STARTED|Overall Study||72
8101703|NCT03216512|19969037|P2|NOT COMPLETED|Overall Study||1
8101704|NCT03216512|19969038|P1|NOT COMPLETED|Overall Study||0
8101705|NCT03216512|19969037|P2|COMPLETED|Overall Study||13
8101706|NCT03216512|19969038|P1|COMPLETED|Overall Study||17
8101707|NCT03216512|19969037|P2|STARTED|Overall Study||14
8101708|NCT03216512|19969038|P1|STARTED|Overall Study||17
8101709|NCT03216499|19969056|P1|NOT COMPLETED|Overall Study||0
8101710|NCT03216499|19969056|P1|COMPLETED|Overall Study||24
8101711|NCT03216499|19969056|P1|STARTED|Overall Study||24
8101712|NCT03216265|19969066|P3|NOT COMPLETED|Overall Study||3
8101713|NCT03216265|19969067|P2|NOT COMPLETED|Overall Study||1
8101714|NCT03216265|19969068|P1|NOT COMPLETED|Overall Study||2
8101715|NCT03216265|19969066|P3|COMPLETED|Overall Study||19
8101716|NCT03216265|19969067|P2|COMPLETED|Overall Study||21
8101717|NCT03216265|19969068|P1|COMPLETED|Overall Study||20
8101718|NCT03216265|19969066|P3|STARTED|Overall Study||22
8101719|NCT03216265|19969067|P2|STARTED|Overall Study||22
8101720|NCT03216265|19969068|P1|STARTED|Overall Study||22
8101721|NCT03216200|19969118|P1|NOT COMPLETED|Overall Study||0
8101722|NCT03216200|19969118|P1|COMPLETED|Overall Study||5
8101723|NCT03216200|19969118|P1|STARTED|Overall Study||5
8101724|NCT03215901|19969126|P3|NOT COMPLETED|Overall Study||0
8101725|NCT03215901|19969127|P2|NOT COMPLETED|Overall Study||0
8101726|NCT03215901|19969128|P1|NOT COMPLETED|Overall Study||0
8101727|NCT03215901|19969126|P3|COMPLETED|Overall Study||116
8101728|NCT03215901|19969127|P2|COMPLETED|Overall Study||112
8101729|NCT03215901|19969128|P1|COMPLETED|Overall Study||199
8101730|NCT03215901|19969126|P3|STARTED|Overall Study||116
8101731|NCT03215901|19969127|P2|STARTED|Overall Study||112
8101732|NCT03215901|19969128|P1|STARTED|Overall Study||199
8101733|NCT03215758|19969159|P2|NOT COMPLETED|Overall Study||8
8101734|NCT03215758|19969160|P1|NOT COMPLETED|Overall Study||5
8101735|NCT03215758|19969159|P2|COMPLETED|Overall Study||328
8101736|NCT03215758|19969160|P1|COMPLETED|Overall Study||334
8101737|NCT03215758|19969159|P2|STARTED|Overall Study||336
8101738|NCT03215758|19969160|P1|STARTED|Overall Study||339
8101751|NCT03215667|19969195|P1|NOT COMPLETED|Overall Study||4
8101752|NCT03215667|19969195|P1|COMPLETED|Overall Study||5
8101753|NCT03215667|19969195|P1|STARTED|Overall Study||9
8101754|NCT03214952|19969200|P1|NOT COMPLETED|Overall Study||58
8101755|NCT03214952|19969200|P1|COMPLETED|Overall Study||3125
8101756|NCT03214952|19969200|P1|STARTED|Overall Study||3183
8101772|NCT03214380|19969299|P6|NOT COMPLETED|Treatment Period||11
8101773|NCT03214380|19969300|P5|NOT COMPLETED|Treatment Period||9
8101774|NCT03214380|19969301|P4|NOT COMPLETED|Treatment Period||0
8101775|NCT03214380|19969302|P3|NOT COMPLETED|Treatment Period||16
8101776|NCT03214380|19969303|P2|NOT COMPLETED|Treatment Period||18
8101777|NCT03214380|19969304|P1|NOT COMPLETED|Treatment Period||0
8101778|NCT03214380|19969299|P6|COMPLETED|Treatment Period||71
8101779|NCT03214380|19969300|P5|COMPLETED|Treatment Period||73
8101780|NCT03214380|19969301|P4|COMPLETED|Treatment Period||0
8101781|NCT03214380|19969302|P3|COMPLETED|Treatment Period||320
8101782|NCT03214380|19969303|P2|COMPLETED|Treatment Period||319
8101783|NCT03214380|19969304|P1|COMPLETED|Treatment Period||0
8101784|NCT03214380|19969299|P6|Received at Least 1 Dose of Study Drug|Treatment Period||82
8101785|NCT03214380|19969300|P5|Received at Least 1 Dose of Study Drug|Treatment Period||82
8101786|NCT03214380|19969301|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
8101787|NCT03214380|19969302|P3|Received at Least 1 Dose of Study Drug|Treatment Period||336
8101788|NCT03214380|19969303|P2|Received at Least 1 Dose of Study Drug|Treatment Period||337
8101789|NCT03214380|19969304|P1|Received at Least 1 Dose of Study Drug|Treatment Period||0
8101790|NCT03214380|19969299|P6|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
8101791|NCT03214380|19969300|P5|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
8101792|NCT03214380|19969301|P4|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
8101793|NCT03214380|19969302|P3|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|336
8101794|NCT03214380|19969303|P2|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|337
8101795|NCT03214380|19969304|P1|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
8101796|NCT03214380|19969299|P6|NOT COMPLETED|Lead-in||0
8101797|NCT03214380|19969300|P5|NOT COMPLETED|Lead-in||0
8101798|NCT03214380|19969301|P4|NOT COMPLETED|Lead-in||19
8101799|NCT03214380|19969302|P3|NOT COMPLETED|Lead-in||0
8101800|NCT03214380|19969303|P2|NOT COMPLETED|Lead-in||0
8101801|NCT03214380|19969304|P1|NOT COMPLETED|Lead-in||77
8101802|NCT03214380|19969299|P6|COMPLETED|Lead-in||0
8101803|NCT03214380|19969300|P5|COMPLETED|Lead-in||0
8101804|NCT03214380|19969301|P4|COMPLETED|Lead-in||164
8101805|NCT03214380|19969302|P3|COMPLETED|Lead-in||0
8101806|NCT03214380|19969303|P2|COMPLETED|Lead-in||0
8101807|NCT03214380|19969304|P1|COMPLETED|Lead-in||673
8101808|NCT03214380|19969299|P6|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
8101809|NCT03214380|19969300|P5|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
8101810|NCT03214380|19969301|P4|Received at Least 1 Dose Lead-in Insulin|Lead-in||183
8101811|NCT03214380|19969302|P3|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
8101812|NCT03214380|19969303|P2|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
8101813|NCT03214380|19969304|P1|Received at Least 1 Dose Lead-in Insulin|Lead-in||750
8101814|NCT03214380|19969299|P6|STARTED|Lead-in||0
8101815|NCT03214380|19969300|P5|STARTED|Lead-in||0
8101816|NCT03214380|19969301|P4|STARTED|Lead-in||183
8101817|NCT03214380|19969302|P3|STARTED|Lead-in||0
8101818|NCT03214380|19969303|P2|STARTED|Lead-in||0
8101819|NCT03214380|19969304|P1|STARTED|Lead-in||750
8101820|NCT03214367|19969340|P8|NOT COMPLETED|Treatment Period||1
8101821|NCT03214367|19969341|P7|NOT COMPLETED|Treatment Period||2
8101822|NCT03214367|19969342|P6|NOT COMPLETED|Treatment Period||3
8101823|NCT03214367|19969343|P5|NOT COMPLETED|Treatment Period||0
8101824|NCT03214367|19969344|P4|NOT COMPLETED|Treatment Period||19
8101825|NCT03214367|19969345|P3|NOT COMPLETED|Treatment Period||33
8101826|NCT03214367|19969346|P2|NOT COMPLETED|Treatment Period||34
8101827|NCT03214367|19969347|P1|NOT COMPLETED|Treatment Period||0
8101828|NCT03214367|19969340|P8|COMPLETED|Treatment Period||21
8101829|NCT03214367|19969341|P7|COMPLETED|Treatment Period||19
8101830|NCT03214367|19969342|P6|COMPLETED|Treatment Period||28
8101831|NCT03214367|19969343|P5|COMPLETED|Treatment Period||0
8101832|NCT03214367|19969344|P4|COMPLETED|Treatment Period||310
8101833|NCT03214367|19969345|P3|COMPLETED|Treatment Period||418
8101834|NCT03214367|19969346|P2|COMPLETED|Treatment Period||408
8101835|NCT03214367|19969347|P1|COMPLETED|Treatment Period||0
8101836|NCT03214367|19969340|P8|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|22
8101837|NCT03214367|19969341|P7|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|21
8101838|NCT03214367|19969342|P6|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|31
8101839|NCT03214367|19969343|P5|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
8101840|NCT03214367|19969344|P4|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|329
8101841|NCT03214367|19969345|P3|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|451
8101842|NCT03214367|19969346|P2|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|442
8101843|NCT03214367|19969347|P1|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
8101844|NCT03214367|19969340|P8|NOT COMPLETED|Lead-in Period||0
8101845|NCT03214367|19969341|P7|NOT COMPLETED|Lead-in Period||0
8101846|NCT03214367|19969342|P6|NOT COMPLETED|Lead-in Period||0
8101847|NCT03214367|19969343|P5|NOT COMPLETED|Lead-in Period||2
8101848|NCT03214367|19969344|P4|NOT COMPLETED|Lead-in Period||0
8101849|NCT03214367|19969345|P3|NOT COMPLETED|Lead-in Period||0
8101850|NCT03214367|19969346|P2|NOT COMPLETED|Lead-in Period||0
8101851|NCT03214367|19969347|P1|NOT COMPLETED|Lead-in Period||94
8101852|NCT03214367|19969340|P8|COMPLETED|Lead-in Period||0
8101853|NCT03214367|19969341|P7|COMPLETED|Lead-in Period||0
8101854|NCT03214367|19969342|P6|COMPLETED|Lead-in Period||0
8101855|NCT03214367|19969343|P5|COMPLETED|Lead-in Period||74
8101856|NCT03214367|19969344|P4|COMPLETED|Lead-in Period||0
8101857|NCT03214367|19969345|P3|COMPLETED|Lead-in Period||0
8101858|NCT03214367|19969346|P2|COMPLETED|Lead-in Period||0
8101859|NCT03214367|19969347|P1|COMPLETED|Lead-in Period||1222
8101860|NCT03214367|19969340|P8|STARTED|Lead-in Period||0
8101861|NCT03214367|19969341|P7|STARTED|Lead-in Period||0
8101862|NCT03214367|19969342|P6|STARTED|Lead-in Period||0
8101863|NCT03214367|19969343|P5|STARTED|Lead-in Period||76
8101864|NCT03214367|19969344|P4|STARTED|Lead-in Period||0
8101865|NCT03214367|19969345|P3|STARTED|Lead-in Period||0
8101866|NCT03214367|19969346|P2|STARTED|Lead-in Period||0
8101867|NCT03214367|19969347|P1|STARTED|Lead-in Period||1316
8101868|NCT03214224|19969392|P1|NOT COMPLETED|Overall Study||9
8101869|NCT03214224|19969392|P1|COMPLETED|Overall Study|3 therapists enrolled. 3 ctrls enrolled (not incl. in analysis). 3 pts enr. but not completed.|40
8101870|NCT03214224|19969392|P1|STARTED|Overall Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49
8101871|NCT03214094|19969401|P1|NOT COMPLETED|Overall Study||60
8101872|NCT03214094|19969401|P1|COMPLETED|Overall Study||1059
8101873|NCT03214094|19969401|P1|STARTED|Overall Study||1119
8101874|NCT03214081|19969409|P1|NOT COMPLETED|Overall Study||63
8101875|NCT03214081|19969409|P1|COMPLETED|Overall Study||1174
8101876|NCT03214081|19969409|P1|STARTED|Overall Study||1237
8101877|NCT03213626|19969424|P1|NOT COMPLETED|Overall Study||7
8101878|NCT03213626|19969424|P1|COMPLETED|Overall Study||0
8101879|NCT03213626|19969424|P1|STARTED|Overall Study||7
8101880|NCT03213509|19969434|P2|NOT COMPLETED|Overall Study||5
8101881|NCT03213509|19969435|P1|NOT COMPLETED|Overall Study||4
8101882|NCT03213509|19969434|P2|COMPLETED|Overall Study||85
8101883|NCT03213509|19969435|P1|COMPLETED|Overall Study||76
8101884|NCT03213509|19969434|P2|STARTED|Overall Study||90
8101885|NCT03213509|19969435|P1|STARTED|Overall Study||80
8101886|NCT03213405|19969450|P4|NOT COMPLETED|Overall Study||0
8101887|NCT03213405|19969451|P3|NOT COMPLETED|Overall Study||0
8101888|NCT03213405|19969452|P2|NOT COMPLETED|Overall Study||0
8101889|NCT03213405|19969453|P1|NOT COMPLETED|Overall Study||0
8101890|NCT03213405|19969450|P4|COMPLETED|Overall Study||6
8101891|NCT03213405|19969451|P3|COMPLETED|Overall Study||6
8101892|NCT03213405|19969452|P2|COMPLETED|Overall Study||6
8101893|NCT03213405|19969453|P1|COMPLETED|Overall Study||6
8101894|NCT03213405|19969450|P4|STARTED|Overall Study||6
8101895|NCT03213405|19969451|P3|STARTED|Overall Study||6
8101896|NCT03213405|19969452|P2|STARTED|Overall Study||6
8101897|NCT03213405|19969453|P1|STARTED|Overall Study||6
8101898|NCT03213366|19969465|P2|NOT COMPLETED|Overall Study||4
8101899|NCT03213366|19969466|P1|NOT COMPLETED|Overall Study||9
8101900|NCT03213366|19969465|P2|COMPLETED|Overall Study||67
8101901|NCT03213366|19969466|P1|COMPLETED|Overall Study||72
8101902|NCT03213366|19969465|P2|STARTED|Overall Study||71
8101903|NCT03213366|19969466|P1|STARTED|Overall Study||81
8101904|NCT03212690|19969492|P1|NOT COMPLETED|Overall Study||1
8101905|NCT03212690|19969492|P1|COMPLETED|Overall Study||56
8101906|NCT03212690|19969492|P1|STARTED|Overall Study||57
8101907|NCT03212638|19969514|P5|NOT COMPLETED|Period 5||0
8101908|NCT03212638|19969515|P4|NOT COMPLETED|Period 5||0
8101909|NCT03212638|19969516|P3|NOT COMPLETED|Period 5||0
8101910|NCT03212638|19969517|P2|NOT COMPLETED|Period 5||0
8101911|NCT03212638|19969518|P1|NOT COMPLETED|Period 5||0
8101912|NCT03212638|19969514|P5|COMPLETED|Period 5||9
8101913|NCT03212638|19969515|P4|COMPLETED|Period 5||9
8101914|NCT03212638|19969516|P3|COMPLETED|Period 5||0
8101915|NCT03212638|19969517|P2|COMPLETED|Period 5||0
8101916|NCT03212638|19969518|P1|COMPLETED|Period 5||0
8101917|NCT03212638|19969514|P5|Received at Least 1 Dose of Study Drug|Period 5||9
8101918|NCT03212638|19969515|P4|Received at Least 1 Dose of Study Drug|Period 5||9
8101919|NCT03212638|19969516|P3|Received at Least 1 Dose of Study Drug|Period 5||0
8101920|NCT03212638|19969517|P2|Received at Least 1 Dose of Study Drug|Period 5||0
8101921|NCT03212638|19969518|P1|Received at Least 1 Dose of Study Drug|Period 5||0
8101922|NCT03212638|19969514|P5|STARTED|Period 5||9
8101923|NCT03212638|19969515|P4|STARTED|Period 5||9
8101924|NCT03212638|19969516|P3|STARTED|Period 5||0
8101925|NCT03212638|19969517|P2|STARTED|Period 5||0
8101926|NCT03212638|19969518|P1|STARTED|Period 5||0
8101927|NCT03212638|19969514|P5|NOT COMPLETED|Period 4||0
8101928|NCT03212638|19969515|P4|NOT COMPLETED|Period 4||0
8101929|NCT03212638|19969516|P3|NOT COMPLETED|Period 4||0
8101930|NCT03212638|19969517|P2|NOT COMPLETED|Period 4||0
8101931|NCT03212638|19969518|P1|NOT COMPLETED|Period 4||0
8101932|NCT03212638|19969514|P5|COMPLETED|Period 4||9
8101933|NCT03212638|19969515|P4|COMPLETED|Period 4||9
8101934|NCT03212638|19969516|P3|COMPLETED|Period 4||0
8101935|NCT03212638|19969517|P2|COMPLETED|Period 4||0
8101936|NCT03212638|19969518|P1|COMPLETED|Period 4||0
8101937|NCT03212638|19969514|P5|Received at Least 1 Dose of Study Drug|Period 4||9
8101938|NCT03212638|19969515|P4|Received at Least 1 Dose of Study Drug|Period 4||9
8101939|NCT03212638|19969516|P3|Received at Least 1 Dose of Study Drug|Period 4||0
8101940|NCT03212638|19969517|P2|Received at Least 1 Dose of Study Drug|Period 4||0
8101941|NCT03212638|19969518|P1|Received at Least 1 Dose of Study Drug|Period 4||0
8101942|NCT03212638|19969514|P5|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
8101943|NCT03212638|19969515|P4|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
8101944|NCT03212638|19969516|P3|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
8101945|NCT03212638|19969517|P2|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
8101946|NCT03212638|19969518|P1|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
8101947|NCT03212638|19969514|P5|NOT COMPLETED|Period 3||0
8101948|NCT03212638|19969515|P4|NOT COMPLETED|Period 3||0
8101949|NCT03212638|19969516|P3|NOT COMPLETED|Period 3||0
8101950|NCT03212638|19969517|P2|NOT COMPLETED|Period 3||0
8101951|NCT03212638|19969518|P1|NOT COMPLETED|Period 3||0
8101952|NCT03212638|19969514|P5|COMPLETED|Period 3||0
8101953|NCT03212638|19969515|P4|COMPLETED|Period 3||0
8101954|NCT03212638|19969516|P3|COMPLETED|Period 3||8
8101955|NCT03212638|19969517|P2|COMPLETED|Period 3||8
8101956|NCT03212638|19969518|P1|COMPLETED|Period 3||8
8101957|NCT03212638|19969514|P5|Received at Least 1 Dose of Study Drug|Period 3||0
8101958|NCT03212638|19969515|P4|Received at Least 1 Dose of Study Drug|Period 3||0
8101959|NCT03212638|19969516|P3|Received at Least 1 Dose of Study Drug|Period 3||8
8101960|NCT03212638|19969517|P2|Received at Least 1 Dose of Study Drug|Period 3||8
8101961|NCT03212638|19969518|P1|Received at Least 1 Dose of Study Drug|Period 3||8
8101962|NCT03212638|19969514|P5|STARTED|Period 3||0
8101963|NCT03212638|19969515|P4|STARTED|Period 3||0
8101964|NCT03212638|19969516|P3|STARTED|Period 3||8
8101965|NCT03212638|19969517|P2|STARTED|Period 3||8
8101966|NCT03212638|19969518|P1|STARTED|Period 3||8
8101967|NCT03212638|19969514|P5|NOT COMPLETED|Period 2||0
8101968|NCT03212638|19969515|P4|NOT COMPLETED|Period 2||0
8101969|NCT03212638|19969516|P3|NOT COMPLETED|Period 2||0
8101970|NCT03212638|19969517|P2|NOT COMPLETED|Period 2||0
8101971|NCT03212638|19969518|P1|NOT COMPLETED|Period 2||0
8101972|NCT03212638|19969514|P5|COMPLETED|Period 2||0
8101973|NCT03212638|19969515|P4|COMPLETED|Period 2||0
8101974|NCT03212638|19969516|P3|COMPLETED|Period 2||8
8101975|NCT03212638|19969517|P2|COMPLETED|Period 2||8
8101976|NCT03212638|19969518|P1|COMPLETED|Period 2||8
8101977|NCT03212638|19969514|P5|Received at Least 1 Dose of Study Drug|Period 2||0
8101978|NCT03212638|19969515|P4|Received at Least 1 Dose of Study Drug|Period 2||0
8101979|NCT03212638|19969516|P3|Received at Least 1 Dose of Study Drug|Period 2||8
8101980|NCT03212638|19969517|P2|Received at Least 1 Dose of Study Drug|Period 2||8
8101981|NCT03212638|19969518|P1|Received at Least 1 Dose of Study Drug|Period 2||8
8101982|NCT03212638|19969514|P5|STARTED|Period 2||0
8101983|NCT03212638|19969515|P4|STARTED|Period 2||0
8101984|NCT03212638|19969516|P3|STARTED|Period 2||8
8101985|NCT03212638|19969517|P2|STARTED|Period 2||8
8101986|NCT03212638|19969518|P1|STARTED|Period 2||8
8101987|NCT03212638|19969514|P5|NOT COMPLETED|Period 1||0
8101988|NCT03212638|19969515|P4|NOT COMPLETED|Period 1||0
8101989|NCT03212638|19969516|P3|NOT COMPLETED|Period 1||0
8101990|NCT03212638|19969517|P2|NOT COMPLETED|Period 1||0
8101991|NCT03212638|19969518|P1|NOT COMPLETED|Period 1||0
8101992|NCT03212638|19969514|P5|COMPLETED|Period 1||0
8101993|NCT03212638|19969515|P4|COMPLETED|Period 1||0
8101994|NCT03212638|19969516|P3|COMPLETED|Period 1||8
8101995|NCT03212638|19969517|P2|COMPLETED|Period 1||8
8101996|NCT03212638|19969518|P1|COMPLETED|Period 1||8
8101997|NCT03212638|19969514|P5|Received at Least 1 Dose of Study Drug|Period 1||0
8101998|NCT03212638|19969515|P4|Received at Least 1 Dose of Study Drug|Period 1||0
8101999|NCT03212638|19969516|P3|Received at Least 1 Dose of Study Drug|Period 1||8
8102000|NCT03212638|19969517|P2|Received at Least 1 Dose of Study Drug|Period 1||8
8102001|NCT03212638|19969518|P1|Received at Least 1 Dose of Study Drug|Period 1||8
8102002|NCT03212638|19969514|P5|STARTED|Period 1||0
8102003|NCT03212638|19969515|P4|STARTED|Period 1||0
8102004|NCT03212638|19969516|P3|STARTED|Period 1||8
8102005|NCT03212638|19969517|P2|STARTED|Period 1||8
8102006|NCT03212638|19969518|P1|STARTED|Period 1||8
8102007|NCT03212521|19969540|P1|NOT COMPLETED|Overall Study||7
8102008|NCT03212521|19969540|P1|COMPLETED|Overall Study||223
8102009|NCT03212521|19969540|P1|STARTED|Overall Study||230
8102010|NCT03212365|19969549|P2|NOT COMPLETED|Overall Study||14
8102011|NCT03212365|19969550|P1|NOT COMPLETED|Overall Study||23
8102012|NCT03212365|19969549|P2|COMPLETED|Overall Study||130
8102013|NCT03212365|19969550|P1|COMPLETED|Overall Study||128
8102014|NCT03212365|19969549|P2|STARTED|Overall Study||144
8102015|NCT03212365|19969550|P1|STARTED|Overall Study||151
8102016|NCT03212326|19969562|P1|NOT COMPLETED|Overall Study||4
8102017|NCT03212326|19969562|P1|COMPLETED|Overall Study||20
8102018|NCT03212326|19969562|P1|STARTED|Overall Study||24
8102019|NCT03212261|19969567|P1|NOT COMPLETED|Overall Study||16
8102020|NCT03212261|19969567|P1|COMPLETED|Overall Study||21
8102021|NCT03212261|19969567|P1|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21
8102022|NCT03212261|19969567|P1|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22
8102023|NCT03212261|19969567|P1|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26
8102024|NCT03212261|19969567|P1|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30
8102025|NCT03212261|19969567|P1|Remained Eligible|Overall Study||35
8102026|NCT03212261|19969567|P1|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37
8102027|NCT03212144|19969575|P2|NOT COMPLETED|Second Sequence (4 Weeks)||1
8102028|NCT03212144|19969576|P1|NOT COMPLETED|Second Sequence (4 Weeks)||1
8102029|NCT03212144|19969575|P2|COMPLETED|Second Sequence (4 Weeks)||0
8102030|NCT03212144|19969576|P1|COMPLETED|Second Sequence (4 Weeks)||0
8102031|NCT03212144|19969575|P2|STARTED|Second Sequence (4 Weeks)||1
8102032|NCT03212144|19969576|P1|STARTED|Second Sequence (4 Weeks)||1
8102033|NCT03212144|19969575|P2|NOT COMPLETED|Washout (4 Weeks)||0
8102034|NCT03212144|19969576|P1|NOT COMPLETED|Washout (4 Weeks)||0
8102035|NCT03212144|19969575|P2|COMPLETED|Washout (4 Weeks)||1
8102036|NCT03212144|19969576|P1|COMPLETED|Washout (4 Weeks)||1
8102037|NCT03212144|19969575|P2|STARTED|Washout (4 Weeks)||1
8102038|NCT03212144|19969576|P1|STARTED|Washout (4 Weeks)||1
8102039|NCT03212144|19969575|P2|NOT COMPLETED|First Sequence (4 Weeks)||0
8102040|NCT03212144|19969576|P1|NOT COMPLETED|First Sequence (4 Weeks)||1
8102041|NCT03212144|19969575|P2|COMPLETED|First Sequence (4 Weeks)||1
8102042|NCT03212144|19969576|P1|COMPLETED|First Sequence (4 Weeks)||1
8102043|NCT03212144|19969575|P2|STARTED|First Sequence (4 Weeks)||1
8102044|NCT03212144|19969576|P1|STARTED|First Sequence (4 Weeks)||2
8102045|NCT03211858|19969584|P2|NOT COMPLETED|Overall Study||33
8102046|NCT03211858|19969585|P1|NOT COMPLETED|Overall Study||37
8102047|NCT03211858|19969584|P2|COMPLETED|Overall Study||263
8102048|NCT03211858|19969585|P1|COMPLETED|Overall Study||264
8102049|NCT03211858|19969584|P2|Treated|Overall Study||296
8102050|NCT03211858|19969585|P1|Treated|Overall Study||301
8102051|NCT03211858|19969584|P2|STARTED|Overall Study||296
8102052|NCT03211858|19969585|P1|STARTED|Overall Study||301
8102053|NCT03211156|19969637|P2|NOT COMPLETED|Overall Study||3
8102054|NCT03211156|19969638|P1|NOT COMPLETED|Overall Study||2
8102055|NCT03211156|19969637|P2|COMPLETED|Overall Study||45
8102056|NCT03211156|19969638|P1|COMPLETED|Overall Study||47
8102057|NCT03211156|19969637|P2|Received Study Drug|Overall Study||45
8102058|NCT03211156|19969638|P1|Received Study Drug|Overall Study||47
8102059|NCT03211156|19969637|P2|STARTED|Overall Study||48
8102060|NCT03211156|19969638|P1|STARTED|Overall Study||49
8102061|NCT03211117|19969646|P2|NOT COMPLETED|Overall Study||0
8102062|NCT03211117|19969647|P1|NOT COMPLETED|Overall Study||0
8102063|NCT03211117|19969646|P2|COMPLETED|Overall Study||3
8102064|NCT03211117|19969647|P1|COMPLETED|Overall Study||0
8102065|NCT03211117|19969646|P2|STARTED|Overall Study||3
8102066|NCT03211117|19969647|P1|STARTED|Overall Study||0
8102067|NCT03210961|19969669|P15|NOT COMPLETED|Overall Study||2
8102068|NCT03210961|19969670|P14|NOT COMPLETED|Overall Study||4
8102069|NCT03210961|19969671|P13|NOT COMPLETED|Overall Study||2
8102070|NCT03210961|19969672|P12|NOT COMPLETED|Overall Study||0
8102071|NCT03210961|19969673|P11|NOT COMPLETED|Overall Study||1
8102072|NCT03210961|19969674|P10|NOT COMPLETED|Overall Study||0
8102073|NCT03210961|19969675|P9|NOT COMPLETED|Overall Study||0
8102074|NCT03210961|19969676|P8|NOT COMPLETED|Overall Study||0
8102075|NCT03210961|19969677|P7|NOT COMPLETED|Overall Study||1
8102076|NCT03210961|19969678|P6|NOT COMPLETED|Overall Study||0
8102077|NCT03210961|19969679|P5|NOT COMPLETED|Overall Study||0
8102078|NCT03210961|19969680|P4|NOT COMPLETED|Overall Study||1
8102079|NCT03210961|19969681|P3|NOT COMPLETED|Overall Study||0
8102080|NCT03210961|19969682|P2|NOT COMPLETED|Overall Study||0
8102081|NCT03210961|19969683|P1|NOT COMPLETED|Overall Study||0
8102082|NCT03210961|19969669|P15|COMPLETED|Overall Study||9
8102083|NCT03210961|19969670|P14|COMPLETED|Overall Study||11
8102084|NCT03210961|19969671|P13|COMPLETED|Overall Study||12
8102085|NCT03210961|19969672|P12|COMPLETED|Overall Study||5
8102086|NCT03210961|19969673|P11|COMPLETED|Overall Study||6
8102087|NCT03210961|19969674|P10|COMPLETED|Overall Study||6
8102088|NCT03210961|19969675|P9|COMPLETED|Overall Study||8
8102089|NCT03210961|19969676|P8|COMPLETED|Overall Study||7
8102090|NCT03210961|19969677|P7|COMPLETED|Overall Study||7
8102091|NCT03210961|19969678|P6|COMPLETED|Overall Study||6
8102092|NCT03210961|19969679|P5|COMPLETED|Overall Study||6
8102093|NCT03210961|19969680|P4|COMPLETED|Overall Study||1
8102094|NCT03210961|19969681|P3|COMPLETED|Overall Study||1
8102095|NCT03210961|19969682|P2|COMPLETED|Overall Study||9
8102096|NCT03210961|19969683|P1|COMPLETED|Overall Study||4
8102097|NCT03210961|19969669|P15|STARTED|Overall Study||11
8102098|NCT03210961|19969670|P14|STARTED|Overall Study||15
8102099|NCT03210961|19969671|P13|STARTED|Overall Study||14
8102100|NCT03210961|19969672|P12|STARTED|Overall Study||5
8102101|NCT03210961|19969673|P11|STARTED|Overall Study||7
8102102|NCT03210961|19969674|P10|STARTED|Overall Study||6
8102103|NCT03210961|19969675|P9|STARTED|Overall Study||8
8102104|NCT03210961|19969676|P8|STARTED|Overall Study||7
8102105|NCT03210961|19969677|P7|STARTED|Overall Study||8
8102106|NCT03210961|19969678|P6|STARTED|Overall Study||6
8102107|NCT03210961|19969679|P5|STARTED|Overall Study||6
8102108|NCT03210961|19969680|P4|STARTED|Overall Study||2
8102109|NCT03210961|19969681|P3|STARTED|Overall Study||1
8102110|NCT03210961|19969682|P2|STARTED|Overall Study||9
8102111|NCT03210961|19969683|P1|STARTED|Overall Study||4
8102112|NCT03210701|19970032|P1|NOT COMPLETED|Overall Study||0
8102113|NCT03210701|19970032|P1|COMPLETED|Overall Study||123
8102114|NCT03210701|19970032|P1|STARTED|Overall Study||123
8102115|NCT03210519|19970042|P2|NOT COMPLETED|Overall Study||0
8102116|NCT03210519|19970043|P1|NOT COMPLETED|Overall Study||2
8102117|NCT03210519|19970042|P2|COMPLETED|Overall Study||10
8102118|NCT03210519|19970043|P1|COMPLETED|Overall Study||9
8102119|NCT03210519|19970042|P2|STARTED|Overall Study||10
8102120|NCT03210519|19970043|P1|STARTED|Overall Study||11
8102121|NCT03210376|19970069|P2|NOT COMPLETED|Overall Study||0
8102122|NCT03210376|19970070|P1|NOT COMPLETED|Overall Study||0
8102123|NCT03210376|19970069|P2|COMPLETED|Overall Study||50
8102124|NCT03210376|19970070|P1|COMPLETED|Overall Study||50
8102125|NCT03210376|19970069|P2|STARTED|Overall Study||50
8102126|NCT03210376|19970070|P1|STARTED|Overall Study||50
8102127|NCT03210337|19970090|P2|NOT COMPLETED|Overall Study||5
8102128|NCT03210337|19970091|P1|NOT COMPLETED|Overall Study||8
8102129|NCT03210337|19970090|P2|COMPLETED|Overall Study||74
8102130|NCT03210337|19970091|P1|COMPLETED|Overall Study||70
8102131|NCT03210337|19970090|P2|STARTED|Overall Study||79
8102132|NCT03210337|19970091|P1|STARTED|Overall Study||78
8102133|NCT03210220|19970099|P2|NOT COMPLETED|Overall Study||0
8102134|NCT03210220|19970100|P1|NOT COMPLETED|Overall Study||1
8102135|NCT03210220|19970099|P2|COMPLETED|Overall Study||20
8102136|NCT03210220|19970100|P1|COMPLETED|Overall Study||19
8102137|NCT03210220|19970099|P2|STARTED|Overall Study||20
8102138|NCT03210220|19970100|P1|STARTED|Overall Study||20
8102139|NCT03210155|19970108|P2|NOT COMPLETED|Overall Study||0
8102140|NCT03210155|19970109|P1|NOT COMPLETED|Overall Study||0
8102141|NCT03210155|19970108|P2|COMPLETED|Overall Study||1
8102142|NCT03210155|19970109|P1|COMPLETED|Overall Study||0
8102143|NCT03210155|19970108|P2|STARTED|Overall Study||1
8102144|NCT03210155|19970109|P1|STARTED|Overall Study||0
8102148|NCT03209570|19970129|P2|NOT COMPLETED|Overall Study||13
8102149|NCT03209570|19970130|P1|NOT COMPLETED|Overall Study||10
8102150|NCT03209570|19970129|P2|COMPLETED|Overall Study||12
8102151|NCT03209570|19970130|P1|COMPLETED|Overall Study||14
8102152|NCT03209570|19970129|P2|STARTED|Overall Study||25
8102153|NCT03209570|19970130|P1|STARTED|Overall Study||24
8102154|NCT03209518|19970140|P1|NOT COMPLETED|Overall Study||2
8102155|NCT03209518|19970140|P1|COMPLETED|Overall Study||310
8102156|NCT03209518|19970140|P1|STARTED|Overall Study||312
8102157|NCT03209492|19970145|P1|NOT COMPLETED|Overall Study||5
8102158|NCT03209492|19970145|P1|COMPLETED|Overall Study||328
8102159|NCT03209492|19970145|P1|STARTED|Overall Study||333
8102160|NCT03208933|19970150|P1|NOT COMPLETED|Overall Study||13
8102161|NCT03208933|19970150|P1|COMPLETED|Overall Study||47
8102162|NCT03208933|19970150|P1|STARTED|Overall Study||60
8102163|NCT03208673|19970159|P1|NOT COMPLETED|Overall Study||0
8102164|NCT03208673|19970159|P1|COMPLETED|Overall Study||32
8102165|NCT03208673|19970159|P1|STARTED|Overall Study||32
8102166|NCT03208192|19970167|P2|NOT COMPLETED|Overall Study||0
8102167|NCT03208192|19970168|P1|NOT COMPLETED|Overall Study||0
8102168|NCT03208192|19970167|P2|COMPLETED|Overall Study||36
8102169|NCT03208192|19970168|P1|COMPLETED|Overall Study||32
8102170|NCT03208192|19970167|P2|STARTED|Overall Study||36
8102171|NCT03208192|19970168|P1|STARTED|Overall Study||32
8102172|NCT03208166|19970188|P2|NOT COMPLETED|Overall Study||0
8102173|NCT03208166|19970189|P1|NOT COMPLETED|Overall Study||0
8102174|NCT03208166|19970188|P2|COMPLETED|Overall Study||1
8102175|NCT03208166|19970189|P1|COMPLETED|Overall Study||1
8102176|NCT03208166|19970188|P2|STARTED|Overall Study||1
8102177|NCT03208166|19970189|P1|STARTED|Overall Study||1
8102178|NCT03208088|19970197|P10|NOT COMPLETED|Period 5||0
8102179|NCT03208088|19970198|P9|NOT COMPLETED|Period 5||0
8102180|NCT03208088|19970199|P8|NOT COMPLETED|Period 5||0
8102181|NCT03208088|19970200|P7|NOT COMPLETED|Period 5||0
8102182|NCT03208088|19970201|P6|NOT COMPLETED|Period 5||0
8102183|NCT03208088|19970202|P5|NOT COMPLETED|Period 5||0
8102184|NCT03208088|19970203|P4|NOT COMPLETED|Period 5||0
8102185|NCT03208088|19970204|P3|NOT COMPLETED|Period 5||0
8102186|NCT03208088|19970205|P2|NOT COMPLETED|Period 5||0
8102187|NCT03208088|19970206|P1|NOT COMPLETED|Period 5||0
8102188|NCT03208088|19970197|P10|COMPLETED|Period 5||9
8102189|NCT03208088|19970198|P9|COMPLETED|Period 5||7
8102190|NCT03208088|19970199|P8|COMPLETED|Period 5||10
8102191|NCT03208088|19970200|P7|COMPLETED|Period 5||8
8102192|NCT03208088|19970201|P6|COMPLETED|Period 5||9
8102193|NCT03208088|19970202|P5|COMPLETED|Period 5||9
8102194|NCT03208088|19970203|P4|COMPLETED|Period 5||7
8102195|NCT03208088|19970204|P3|COMPLETED|Period 5||10
8102196|NCT03208088|19970205|P2|COMPLETED|Period 5||9
8102197|NCT03208088|19970206|P1|COMPLETED|Period 5||10
8102198|NCT03208088|19970197|P10|STARTED|Period 5||9
8102199|NCT03208088|19970198|P9|STARTED|Period 5||7
8102200|NCT03208088|19970199|P8|STARTED|Period 5||10
8102201|NCT03208088|19970200|P7|STARTED|Period 5||8
8102202|NCT03208088|19970201|P6|STARTED|Period 5||9
8102203|NCT03208088|19970202|P5|STARTED|Period 5||9
8102204|NCT03208088|19970203|P4|STARTED|Period 5||7
8102205|NCT03208088|19970204|P3|STARTED|Period 5||10
8102206|NCT03208088|19970205|P2|STARTED|Period 5||9
8102207|NCT03208088|19970206|P1|STARTED|Period 5||10
8102208|NCT03208088|19970197|P10|NOT COMPLETED|Period 4||0
8102209|NCT03208088|19970198|P9|NOT COMPLETED|Period 4||0
8102210|NCT03208088|19970199|P8|NOT COMPLETED|Period 4||0
8102211|NCT03208088|19970200|P7|NOT COMPLETED|Period 4||0
8102212|NCT03208088|19970201|P6|NOT COMPLETED|Period 4||0
8102213|NCT03208088|19970202|P5|NOT COMPLETED|Period 4||0
8102214|NCT03208088|19970203|P4|NOT COMPLETED|Period 4||1
8102215|NCT03208088|19970204|P3|NOT COMPLETED|Period 4||0
8102216|NCT03208088|19970205|P2|NOT COMPLETED|Period 4||0
8102217|NCT03208088|19970206|P1|NOT COMPLETED|Period 4||0
8102218|NCT03208088|19970197|P10|COMPLETED|Period 4||9
8102219|NCT03208088|19970198|P9|COMPLETED|Period 4||7
8102220|NCT03208088|19970199|P8|COMPLETED|Period 4||10
8102221|NCT03208088|19970200|P7|COMPLETED|Period 4||8
8102222|NCT03208088|19970201|P6|COMPLETED|Period 4||9
8102223|NCT03208088|19970202|P5|COMPLETED|Period 4||9
8102224|NCT03208088|19970203|P4|COMPLETED|Period 4||7
8102225|NCT03208088|19970204|P3|COMPLETED|Period 4||10
8102226|NCT03208088|19970205|P2|COMPLETED|Period 4||9
8102227|NCT03208088|19970206|P1|COMPLETED|Period 4||10
8102228|NCT03208088|19970197|P10|STARTED|Period 4||9
8102229|NCT03208088|19970198|P9|STARTED|Period 4||7
8102230|NCT03208088|19970199|P8|STARTED|Period 4||10
8102231|NCT03208088|19970200|P7|STARTED|Period 4||8
8102232|NCT03208088|19970201|P6|STARTED|Period 4||9
8102233|NCT03208088|19970202|P5|STARTED|Period 4||9
8102234|NCT03208088|19970203|P4|STARTED|Period 4||8
8102235|NCT03208088|19970204|P3|STARTED|Period 4||10
8102236|NCT03208088|19970205|P2|STARTED|Period 4||9
8102237|NCT03208088|19970206|P1|STARTED|Period 4||10
8102238|NCT03208088|19970197|P10|NOT COMPLETED|Period 3||0
8102239|NCT03208088|19970198|P9|NOT COMPLETED|Period 3||0
8102240|NCT03208088|19970199|P8|NOT COMPLETED|Period 3||0
8102241|NCT03208088|19970200|P7|NOT COMPLETED|Period 3||0
8102242|NCT03208088|19970201|P6|NOT COMPLETED|Period 3||0
8102243|NCT03208088|19970202|P5|NOT COMPLETED|Period 3||0
8102244|NCT03208088|19970203|P4|NOT COMPLETED|Period 3||1
8102245|NCT03208088|19970204|P3|NOT COMPLETED|Period 3||0
8102246|NCT03208088|19970205|P2|NOT COMPLETED|Period 3||0
8102247|NCT03208088|19970206|P1|NOT COMPLETED|Period 3||0
8102248|NCT03208088|19970197|P10|COMPLETED|Period 3||9
8102249|NCT03208088|19970198|P9|COMPLETED|Period 3||7
8102250|NCT03208088|19970199|P8|COMPLETED|Period 3||10
8102251|NCT03208088|19970200|P7|COMPLETED|Period 3||8
8102252|NCT03208088|19970201|P6|COMPLETED|Period 3||9
8102253|NCT03208088|19970202|P5|COMPLETED|Period 3||9
8102254|NCT03208088|19970203|P4|COMPLETED|Period 3||8
8102255|NCT03208088|19970204|P3|COMPLETED|Period 3||10
8102256|NCT03208088|19970205|P2|COMPLETED|Period 3||9
8102257|NCT03208088|19970206|P1|COMPLETED|Period 3||10
8102258|NCT03208088|19970197|P10|STARTED|Period 3||9
8102259|NCT03208088|19970198|P9|STARTED|Period 3||7
8102260|NCT03208088|19970199|P8|STARTED|Period 3||10
8102261|NCT03208088|19970200|P7|STARTED|Period 3||8
8102262|NCT03208088|19970201|P6|STARTED|Period 3||9
8102263|NCT03208088|19970202|P5|STARTED|Period 3||9
8102264|NCT03208088|19970203|P4|STARTED|Period 3||9
8102265|NCT03208088|19970204|P3|STARTED|Period 3||10
8102266|NCT03208088|19970205|P2|STARTED|Period 3||9
8102267|NCT03208088|19970206|P1|STARTED|Period 3||10
8102268|NCT03208088|19970197|P10|NOT COMPLETED|Period 2||0
8102269|NCT03208088|19970198|P9|NOT COMPLETED|Period 2||1
8102270|NCT03208088|19970199|P8|NOT COMPLETED|Period 2||0
8102271|NCT03208088|19970200|P7|NOT COMPLETED|Period 2||0
8102272|NCT03208088|19970201|P6|NOT COMPLETED|Period 2||0
8102273|NCT03208088|19970202|P5|NOT COMPLETED|Period 2||0
8102274|NCT03208088|19970203|P4|NOT COMPLETED|Period 2||0
8102275|NCT03208088|19970204|P3|NOT COMPLETED|Period 2||0
8102276|NCT03208088|19970205|P2|NOT COMPLETED|Period 2||0
8102277|NCT03208088|19970206|P1|NOT COMPLETED|Period 2||0
8102278|NCT03208088|19970197|P10|COMPLETED|Period 2||9
8102279|NCT03208088|19970198|P9|COMPLETED|Period 2||7
8102280|NCT03208088|19970199|P8|COMPLETED|Period 2||10
8102281|NCT03208088|19970200|P7|COMPLETED|Period 2||8
8102282|NCT03208088|19970201|P6|COMPLETED|Period 2||9
8102283|NCT03208088|19970202|P5|COMPLETED|Period 2||9
8102284|NCT03208088|19970203|P4|COMPLETED|Period 2||9
8102285|NCT03208088|19970204|P3|COMPLETED|Period 2||10
8102286|NCT03208088|19970205|P2|COMPLETED|Period 2||9
8102287|NCT03208088|19970206|P1|COMPLETED|Period 2||10
8102288|NCT03208088|19970197|P10|STARTED|Period 2||9
8102289|NCT03208088|19970198|P9|STARTED|Period 2||8
8102290|NCT03208088|19970199|P8|STARTED|Period 2||10
8102291|NCT03208088|19970200|P7|STARTED|Period 2||8
8102292|NCT03208088|19970201|P6|STARTED|Period 2||9
8102293|NCT03208088|19970202|P5|STARTED|Period 2||9
8102294|NCT03208088|19970203|P4|STARTED|Period 2||9
8102295|NCT03208088|19970204|P3|STARTED|Period 2||10
8102296|NCT03208088|19970205|P2|STARTED|Period 2||9
8102297|NCT03208088|19970206|P1|STARTED|Period 2||10
8102298|NCT03208088|19970197|P10|NOT COMPLETED|Period 1||0
8102299|NCT03208088|19970198|P9|NOT COMPLETED|Period 1||0
8102300|NCT03208088|19970199|P8|NOT COMPLETED|Period 1||0
8102301|NCT03208088|19970200|P7|NOT COMPLETED|Period 1||0
8102302|NCT03208088|19970201|P6|NOT COMPLETED|Period 1||0
8102303|NCT03208088|19970202|P5|NOT COMPLETED|Period 1||0
8102304|NCT03208088|19970203|P4|NOT COMPLETED|Period 1||0
8102305|NCT03208088|19970204|P3|NOT COMPLETED|Period 1||0
8102306|NCT03208088|19970205|P2|NOT COMPLETED|Period 1||0
8102307|NCT03208088|19970206|P1|NOT COMPLETED|Period 1||0
8102308|NCT03208088|19970197|P10|COMPLETED|Period 1||9
8102309|NCT03208088|19970198|P9|COMPLETED|Period 1||8
8102310|NCT03208088|19970199|P8|COMPLETED|Period 1||10
8102311|NCT03208088|19970200|P7|COMPLETED|Period 1||8
8102312|NCT03208088|19970201|P6|COMPLETED|Period 1||9
8102313|NCT03208088|19970202|P5|COMPLETED|Period 1||9
8102314|NCT03208088|19970203|P4|COMPLETED|Period 1||9
8102315|NCT03208088|19970204|P3|COMPLETED|Period 1||10
8102316|NCT03208088|19970205|P2|COMPLETED|Period 1||9
8102317|NCT03208088|19970206|P1|COMPLETED|Period 1||10
8102318|NCT03208088|19970197|P10|STARTED|Period 1||9
8102319|NCT03208088|19970198|P9|STARTED|Period 1||8
8102320|NCT03208088|19970199|P8|STARTED|Period 1||10
8102321|NCT03208088|19970200|P7|STARTED|Period 1||8
8102322|NCT03208088|19970201|P6|STARTED|Period 1||9
8102323|NCT03208088|19970202|P5|STARTED|Period 1||9
8102324|NCT03208088|19970203|P4|STARTED|Period 1||9
8102325|NCT03208088|19970204|P3|STARTED|Period 1||10
8102326|NCT03208088|19970205|P2|STARTED|Period 1||9
8102327|NCT03208088|19970206|P1|STARTED|Period 1||10
8102328|NCT03207776|19970221|P2|NOT COMPLETED|Overall Study||0
8102329|NCT03207776|19970222|P1|NOT COMPLETED|Overall Study||0
8102330|NCT03207776|19970221|P2|COMPLETED|Overall Study||2353
8102331|NCT03207776|19970222|P1|COMPLETED|Overall Study||2479
8102332|NCT03207776|19970221|P2|STARTED|Overall Study||2353
8102333|NCT03207776|19970222|P1|STARTED|Overall Study||2479
8102334|NCT03207763|19970236|P2|NOT COMPLETED|Overall Study||0
8102335|NCT03207763|19970237|P1|NOT COMPLETED|Overall Study||1
8102336|NCT03207763|19970236|P2|COMPLETED|Overall Study||25
8102337|NCT03207763|19970237|P1|COMPLETED|Overall Study||7
8102338|NCT03207763|19970236|P2|Completed Patches 2 and 3 Study|Overall Study||23
8102339|NCT03207763|19970237|P1|Completed Patches 2 and 3 Study|Overall Study||5
8102340|NCT03207763|19970236|P2|Eligible and Opted for Patches 2 and 3|Overall Study||23
8102341|NCT03207763|19970237|P1|Eligible and Opted for Patches 2 and 3|Overall Study||5
8102342|NCT03207763|19970236|P2|STARTED|Overall Study||25
8102343|NCT03207763|19970237|P1|STARTED|Overall Study||8
8102344|NCT03207750|19970263|P2|NOT COMPLETED|Overall Study||66
8102345|NCT03207750|19970264|P1|NOT COMPLETED|Overall Study||58
8102346|NCT03207750|19970263|P2|COMPLETED|Overall Study||574
8102347|NCT03207750|19970264|P1|COMPLETED|Overall Study||574
8102348|NCT03207750|19970263|P2|STARTED|Overall Study||640
8102349|NCT03207750|19970264|P1|STARTED|Overall Study||632
8102350|NCT03207438|19970310|P4|NOT COMPLETED|Overall Study||112
8102351|NCT03207438|19970311|P3|NOT COMPLETED|Overall Study||232
8102352|NCT03207438|19970312|P2|NOT COMPLETED|Overall Study||21
8102353|NCT03207438|19970313|P1|NOT COMPLETED|Overall Study||19
8102354|NCT03207438|19970310|P4|COMPLETED|Overall Study||470
8102355|NCT03207438|19970311|P3|COMPLETED|Overall Study||643
8102356|NCT03207438|19970312|P2|COMPLETED|Overall Study||145
8102357|NCT03207438|19970313|P1|COMPLETED|Overall Study||148
8102358|NCT03207438|19970310|P4|STARTED|Overall Study||582
8102359|NCT03207438|19970311|P3|STARTED|Overall Study||875
8102360|NCT03207438|19970312|P2|STARTED|Overall Study||166
8102361|NCT03207438|19970313|P1|STARTED|Overall Study||167
8102362|NCT03207399|19970330|P1|NOT COMPLETED|Overall Study||0
8102363|NCT03207399|19970330|P1|COMPLETED|Overall Study||1
8102364|NCT03207399|19970330|P1|STARTED|Overall Study||1
8102365|NCT03207243|19970344|P2|NOT COMPLETED|Overall Study||44
8102366|NCT03207243|19970345|P1|NOT COMPLETED|Overall Study||59
8102367|NCT03207243|19970344|P2|COMPLETED|Overall Study||39
8102368|NCT03207243|19970345|P1|COMPLETED|Overall Study||23
8102369|NCT03207243|19970344|P2|STARTED|Overall Study||83
8102370|NCT03207243|19970345|P1|STARTED|Overall Study||82
8102371|NCT03207074|19970452|P1|NOT COMPLETED|Overall Study||0
8102372|NCT03207074|19970452|P1|COMPLETED|Overall Study||150
8102373|NCT03207074|19970452|P1|STARTED|Overall Study||150
8102374|NCT03206970|19970456|P1|NOT COMPLETED|Overall Study||26
8102375|NCT03206970|19970456|P1|COMPLETED|Overall Study||60
8102376|NCT03206970|19970456|P1|STARTED|Overall Study||86
8102380|NCT03206788|19970466|P2|NOT COMPLETED|Overall Study||3
8102381|NCT03206788|19970467|P1|NOT COMPLETED|Overall Study||0
8102382|NCT03206788|19970466|P2|COMPLETED|Overall Study||2
8102383|NCT03206788|19970467|P1|COMPLETED|Overall Study||2
8102384|NCT03206788|19970466|P2|STARTED|Overall Study||5
8102385|NCT03206788|19970467|P1|STARTED|Overall Study||2
8102386|NCT03206216|19970505|P2|NOT COMPLETED|Overall Study||1
8102387|NCT03206216|19970506|P1|NOT COMPLETED|Overall Study||0
8102388|NCT03206216|19970505|P2|COMPLETED|Overall Study||0
8102389|NCT03206216|19970506|P1|COMPLETED|Overall Study||0
8102390|NCT03206216|19970505|P2|STARTED|Overall Study||1
8102391|NCT03206216|19970506|P1|STARTED|Overall Study||0
8102392|NCT03205488|19970517|P3|NOT COMPLETED|Overall Study||5
8102393|NCT03205488|19970518|P2|NOT COMPLETED|Overall Study||2
8102394|NCT03205488|19970519|P1|NOT COMPLETED|Overall Study||1
8102395|NCT03205488|19970517|P3|COMPLETED|Overall Study||21
8102396|NCT03205488|19970518|P2|COMPLETED|Overall Study||23
8102397|NCT03205488|19970519|P1|COMPLETED|Overall Study||24
8102398|NCT03205488|19970517|P3|STARTED|Overall Study||26
8102399|NCT03205488|19970518|P2|STARTED|Overall Study||25
8102400|NCT03205488|19970519|P1|STARTED|Overall Study||25
8102401|NCT03205371|19970545|P12|NOT COMPLETED|Overall Study||1
8102402|NCT03205371|19970546|P11|NOT COMPLETED|Overall Study||0
8102403|NCT03205371|19970547|P10|NOT COMPLETED|Overall Study||0
8102404|NCT03205371|19970548|P9|NOT COMPLETED|Overall Study||5
8102405|NCT03205371|19970549|P8|NOT COMPLETED|Overall Study||3
8102406|NCT03205371|19970550|P7|NOT COMPLETED|Overall Study||10
8102407|NCT03205371|19970551|P6|NOT COMPLETED|Overall Study||0
8102408|NCT03205371|19970552|P5|NOT COMPLETED|Overall Study||0
8102409|NCT03205371|19970553|P4|NOT COMPLETED|Overall Study||0
8102410|NCT03205371|19970554|P3|NOT COMPLETED|Overall Study||0
8102411|NCT03205371|19970555|P2|NOT COMPLETED|Overall Study||1
8102412|NCT03205371|19970556|P1|NOT COMPLETED|Overall Study||4
8102413|NCT03205371|19970545|P12|COMPLETED|Overall Study||99
8102414|NCT03205371|19970546|P11|COMPLETED|Overall Study||100
8102415|NCT03205371|19970547|P10|COMPLETED|Overall Study||200
8102416|NCT03205371|19970548|P9|COMPLETED|Overall Study||95
8102417|NCT03205371|19970549|P8|COMPLETED|Overall Study||97
8102418|NCT03205371|19970550|P7|COMPLETED|Overall Study||190
8102419|NCT03205371|19970551|P6|COMPLETED|Overall Study||42
8102420|NCT03205371|19970552|P5|COMPLETED|Overall Study||42
8102421|NCT03205371|19970553|P4|COMPLETED|Overall Study||86
8102422|NCT03205371|19970554|P3|COMPLETED|Overall Study||53
8102423|NCT03205371|19970555|P2|COMPLETED|Overall Study||52
8102424|NCT03205371|19970556|P1|COMPLETED|Overall Study||103
8102425|NCT03205371|19970545|P12|Per-protocol Analysis Set (PPAS)|Overall Study||92
8102426|NCT03205371|19970546|P11|Per-protocol Analysis Set (PPAS)|Overall Study||96
8102427|NCT03205371|19970547|P10|Per-protocol Analysis Set (PPAS)|Overall Study||196
8102428|NCT03205371|19970548|P9|Per-protocol Analysis Set (PPAS)|Overall Study||68
8102429|NCT03205371|19970549|P8|Per-protocol Analysis Set (PPAS)|Overall Study||79
8102430|NCT03205371|19970550|P7|Per-protocol Analysis Set (PPAS)|Overall Study||155
8102431|NCT03205371|19970551|P6|Per-protocol Analysis Set (PPAS)|Overall Study||42
8102432|NCT03205371|19970552|P5|Per-protocol Analysis Set (PPAS)|Overall Study||42
8102433|NCT03205371|19970553|P4|Per-protocol Analysis Set (PPAS)|Overall Study||85
8102434|NCT03205371|19970554|P3|Per-protocol Analysis Set (PPAS)|Overall Study||50
8102435|NCT03205371|19970555|P2|Per-protocol Analysis Set (PPAS)|Overall Study||45
8102436|NCT03205371|19970556|P1|Per-protocol Analysis Set (PPAS)|Overall Study||92
8102437|NCT03205371|19970545|P12|Safety Analysis Set (SafAS)|Overall Study||99
8102438|NCT03205371|19970546|P11|Safety Analysis Set (SafAS)|Overall Study||100
8102439|NCT03205371|19970547|P10|Safety Analysis Set (SafAS)|Overall Study||200
8102440|NCT03205371|19970548|P9|Safety Analysis Set (SafAS)|Overall Study||100
8102441|NCT03205371|19970549|P8|Safety Analysis Set (SafAS)|Overall Study||100
8102442|NCT03205371|19970550|P7|Safety Analysis Set (SafAS)|Overall Study||200
8102443|NCT03205371|19970551|P6|Safety Analysis Set (SafAS)|Overall Study||42
8102444|NCT03205371|19970552|P5|Safety Analysis Set (SafAS)|Overall Study||42
8102445|NCT03205371|19970553|P4|Safety Analysis Set (SafAS)|Overall Study||86
8102446|NCT03205371|19970554|P3|Safety Analysis Set (SafAS)|Overall Study||53
8102447|NCT03205371|19970555|P2|Safety Analysis Set (SafAS)|Overall Study||52
8102448|NCT03205371|19970556|P1|Safety Analysis Set (SafAS)|Overall Study||103
8102449|NCT03205371|19970545|P12|STARTED|Overall Study||100
8102450|NCT03205371|19970546|P11|STARTED|Overall Study||100
8102451|NCT03205371|19970547|P10|STARTED|Overall Study||200
8102452|NCT03205371|19970548|P9|STARTED|Overall Study||100
8102453|NCT03205371|19970549|P8|STARTED|Overall Study||100
8102454|NCT03205371|19970550|P7|STARTED|Overall Study||200
8102455|NCT03205371|19970551|P6|STARTED|Overall Study||42
8102456|NCT03205371|19970552|P5|STARTED|Overall Study||42
8102457|NCT03205371|19970553|P4|STARTED|Overall Study||86
8102458|NCT03205371|19970554|P3|STARTED|Overall Study||53
8102459|NCT03205371|19970555|P2|STARTED|Overall Study||53
8102460|NCT03205371|19970556|P1|STARTED|Overall Study||107
8102461|NCT03205358|19970636|P2|NOT COMPLETED|Overall Study||0
8102462|NCT03205358|19970637|P1|NOT COMPLETED|Overall Study||0
8102463|NCT03205358|19970636|P2|COMPLETED|Overall Study||94
8102464|NCT03205358|19970637|P1|COMPLETED|Overall Study||94
8102465|NCT03205358|19970636|P2|STARTED|Overall Study||94
8102466|NCT03205358|19970637|P1|STARTED|Overall Study||94
8102467|NCT03205163|19970645|P2|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
8102468|NCT03205163|19970646|P1|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
8102469|NCT03205163|19970645|P2|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9
8102470|NCT03205163|19970646|P1|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6
8102471|NCT03205163|19970645|P2|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9
8102472|NCT03205163|19970646|P1|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6
8102473|NCT03205163|19970645|P2|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9
8102474|NCT03205163|19970646|P1|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6
8102475|NCT03205163|19970645|P2|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0
8102476|NCT03205163|19970646|P1|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1
8102477|NCT03205163|19970645|P2|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9
8102478|NCT03205163|19970646|P1|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6
8102479|NCT03205163|19970645|P2|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9
8102480|NCT03205163|19970646|P1|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7
8102481|NCT03205163|19970645|P2|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9
8102482|NCT03205163|19970646|P1|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7
8102483|NCT03205150|19970697|P3|NOT COMPLETED|Overall Study||2
8102484|NCT03205150|19970698|P2|NOT COMPLETED|Overall Study||7
8102485|NCT03205150|19970699|P1|NOT COMPLETED|Overall Study||2
8102486|NCT03205150|19970697|P3|COMPLETED|Overall Study||19
8102487|NCT03205150|19970698|P2|COMPLETED|Overall Study||36
8102488|NCT03205150|19970699|P1|COMPLETED|Overall Study||41
8102489|NCT03205150|19970697|P3|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|21
8102490|NCT03205150|19970698|P2|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|41
8102491|NCT03205150|19970699|P1|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|43
8102492|NCT03205150|19970697|P3|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
8102493|NCT03205150|19970698|P2|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|36
8102494|NCT03205150|19970699|P1|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|42
8102495|NCT03205150|19970697|P3|Safety Analysis Set|Overall Study||21
8102496|NCT03205150|19970698|P2|Safety Analysis Set|Overall Study||43
8102497|NCT03205150|19970699|P1|Safety Analysis Set|Overall Study||43
8102498|NCT03205150|19970697|P3|STARTED|Overall Study||21
8102499|NCT03205150|19970698|P2|STARTED|Overall Study||43
8102500|NCT03205150|19970699|P1|STARTED|Overall Study||43
8102501|NCT03205046|19970737|P2|NOT COMPLETED|Overall Study||10
8102502|NCT03205046|19970738|P1|NOT COMPLETED|Overall Study||13
8102503|NCT03205046|19970737|P2|COMPLETED|Overall Study||2
8102504|NCT03205046|19970738|P1|COMPLETED|Overall Study||0
8102505|NCT03205046|19970737|P2|STARTED|Overall Study||12
8102506|NCT03205046|19970738|P1|STARTED|Overall Study||13
8102507|NCT03204942|19970747|P3|NOT COMPLETED|Overall Study||0
8102508|NCT03204942|19970748|P2|NOT COMPLETED|Overall Study||0
8102509|NCT03204942|19970749|P1|NOT COMPLETED|Overall Study||0
8102510|NCT03204942|19970747|P3|COMPLETED|Overall Study||23
8102511|NCT03204942|19970748|P2|COMPLETED|Overall Study||23
8102512|NCT03204942|19970749|P1|COMPLETED|Overall Study||23
8102513|NCT03204942|19970747|P3|STARTED|Overall Study||23
8102514|NCT03204942|19970748|P2|STARTED|Overall Study||23
8102515|NCT03204942|19970749|P1|STARTED|Overall Study||23
8102516|NCT03204643|19970777|P2|NOT COMPLETED|Overall Study||0
8102517|NCT03204643|19970778|P1|NOT COMPLETED|Overall Study||0
8102518|NCT03204643|19970777|P2|COMPLETED|Overall Study||314
8102519|NCT03204643|19970778|P1|COMPLETED|Overall Study||323
8102520|NCT03204643|19970777|P2|STARTED|Overall Study||314
8102521|NCT03204643|19970778|P1|STARTED|Overall Study||323
8102522|NCT03204539|19970792|P2|NOT COMPLETED|Overall Study||1
8102523|NCT03204539|19970793|P1|NOT COMPLETED|Overall Study||0
8102524|NCT03204539|19970792|P2|COMPLETED|Overall Study||0
8102525|NCT03204539|19970793|P1|COMPLETED|Overall Study||0
8102526|NCT03204539|19970792|P2|STARTED|Overall Study||1
8102527|NCT03204539|19970793|P1|STARTED|Overall Study||0
8102528|NCT03204279|19970817|P2|NOT COMPLETED|Overall Study||1
8102529|NCT03204279|19970818|P1|NOT COMPLETED|Overall Study||0
8102530|NCT03204279|19970817|P2|COMPLETED|Overall Study||32
8102531|NCT03204279|19970818|P1|COMPLETED|Overall Study||34
8102532|NCT03204279|19970817|P2|STARTED|Overall Study||33
8102533|NCT03204279|19970818|P1|STARTED|Overall Study||34
8102534|NCT03203564|19970833|P4|NOT COMPLETED|Overall Study||0
8102535|NCT03203564|19970834|P3|NOT COMPLETED|Overall Study||0
8102536|NCT03203564|19970835|P2|NOT COMPLETED|Overall Study||0
8102537|NCT03203564|19970836|P1|NOT COMPLETED|Overall Study||0
8102538|NCT03203564|19970833|P4|COMPLETED|Overall Study||9
8102539|NCT03203564|19970834|P3|COMPLETED|Overall Study||8
8102540|NCT03203564|19970835|P2|COMPLETED|Overall Study||8
8102541|NCT03203564|19970836|P1|COMPLETED|Overall Study||8
8102542|NCT03203564|19970833|P4|STARTED|Overall Study||9
8102543|NCT03203564|19970834|P3|STARTED|Overall Study||8
8102544|NCT03203564|19970835|P2|STARTED|Overall Study||8
8102545|NCT03203564|19970836|P1|STARTED|Overall Study||8
8102546|NCT03203291|19970945|P1|NOT COMPLETED|Overall Study||1
8102547|NCT03203291|19970945|P1|COMPLETED|Overall Study||11
8102548|NCT03203291|19970945|P1|STARTED|Overall Study||12
8102549|NCT03202550|19970957|P2|NOT COMPLETED|Overall Study||0
8102550|NCT03202550|19970958|P1|NOT COMPLETED|Overall Study||0
8102551|NCT03202550|19970957|P2|COMPLETED|Overall Study||11
8102552|NCT03202550|19970958|P1|COMPLETED|Overall Study||13
8102553|NCT03202550|19970957|P2|STARTED|Overall Study||11
8102554|NCT03202550|19970958|P1|STARTED|Overall Study||13
8102555|NCT03202472|19970980|P1|NOT COMPLETED|Overall Study||0
8102556|NCT03202472|19970980|P1|COMPLETED|Overall Study||50
8102557|NCT03202472|19970980|P1|STARTED|Overall Study||50
8102565|NCT03201419|19971008|P9|NOT COMPLETED|Overall Study||2
8102566|NCT03201419|19971009|P8|NOT COMPLETED|Overall Study||1
8102567|NCT03201419|19971010|P7|NOT COMPLETED|Overall Study||6
8102568|NCT03201419|19971011|P6|NOT COMPLETED|Overall Study||1
8102569|NCT03201419|19971012|P5|NOT COMPLETED|Overall Study||1
8102570|NCT03201419|19971013|P4|NOT COMPLETED|Overall Study||0
8102571|NCT03201419|19971014|P3|NOT COMPLETED|Overall Study||2
8102572|NCT03201419|19971015|P2|NOT COMPLETED|Overall Study||3
8102573|NCT03201419|19971016|P1|NOT COMPLETED|Overall Study||8
8102574|NCT03201419|19971008|P9|COMPLETED|Overall Study||15
8102575|NCT03201419|19971009|P8|COMPLETED|Overall Study||25
8102576|NCT03201419|19971010|P7|COMPLETED|Overall Study||81
8102577|NCT03201419|19971011|P6|COMPLETED|Overall Study||33
8102578|NCT03201419|19971012|P5|COMPLETED|Overall Study||12
8102579|NCT03201419|19971013|P4|COMPLETED|Overall Study||14
8102580|NCT03201419|19971014|P3|COMPLETED|Overall Study||22
8102581|NCT03201419|19971015|P2|COMPLETED|Overall Study||24
8102582|NCT03201419|19971016|P1|COMPLETED|Overall Study||52
8102583|NCT03201419|19971008|P9|STARTED|Overall Study||17
8102584|NCT03201419|19971009|P8|STARTED|Overall Study||26
8102585|NCT03201419|19971010|P7|STARTED|Overall Study||87
8102586|NCT03201419|19971011|P6|STARTED|Overall Study||34
8102587|NCT03201419|19971012|P5|STARTED|Overall Study||13
8102588|NCT03201419|19971013|P4|STARTED|Overall Study||14
8102589|NCT03201419|19971014|P3|STARTED|Overall Study||24
8102590|NCT03201419|19971015|P2|STARTED|Overall Study||27
8102591|NCT03201419|19971016|P1|STARTED|Overall Study||60
8102592|NCT03200925|19971352|P2|NOT COMPLETED|Overall Study||0
8102593|NCT03200925|19971353|P1|NOT COMPLETED|Overall Study||0
8102594|NCT03200925|19971352|P2|COMPLETED|Overall Study||120
8102595|NCT03200925|19971353|P1|COMPLETED|Overall Study||120
8102596|NCT03200925|19971352|P2|STARTED|Overall Study||120
8102597|NCT03200925|19971353|P1|STARTED|Overall Study||120
8102598|NCT03200912|19971366|P3|NOT COMPLETED|Overall Study||4
8102599|NCT03200912|19971367|P2|NOT COMPLETED|Overall Study||3
8102600|NCT03200912|19971368|P1|NOT COMPLETED|Overall Study||4
8102601|NCT03200912|19971366|P3|COMPLETED|Overall Study||164
8102602|NCT03200912|19971367|P2|COMPLETED|Overall Study||166
8102603|NCT03200912|19971368|P1|COMPLETED|Overall Study||166
8102604|NCT03200912|19971366|P3|STARTED|Overall Study||168
8102605|NCT03200912|19971367|P2|STARTED|Overall Study||169
8102606|NCT03200912|19971368|P1|STARTED|Overall Study||170
8102607|NCT03200860|19971378|P2|NOT COMPLETED|Overall Study||0
8102608|NCT03200860|19971379|P1|NOT COMPLETED|Overall Study||1
8102609|NCT03200860|19971378|P2|COMPLETED|Overall Study||39
8102610|NCT03200860|19971379|P1|COMPLETED|Overall Study||40
8102611|NCT03200860|19971378|P2|STARTED|Overall Study||39
8102612|NCT03200860|19971379|P1|STARTED|Overall Study||41
8102613|NCT03200535|19971403|P4|NOT COMPLETED|Overall Study||0
8102614|NCT03200535|19971404|P3|NOT COMPLETED|Overall Study||0
8102615|NCT03200535|19971405|P2|NOT COMPLETED|Overall Study||0
8102616|NCT03200535|19971406|P1|NOT COMPLETED|Overall Study||0
8102617|NCT03200535|19971403|P4|COMPLETED|Overall Study||1000
8102618|NCT03200535|19971404|P3|COMPLETED|Overall Study||1862
8102619|NCT03200535|19971405|P2|COMPLETED|Overall Study||1863
8102620|NCT03200535|19971406|P1|COMPLETED|Overall Study||1863
8102621|NCT03200535|19971403|P4|STARTED|Overall Study||1000
8102622|NCT03200535|19971404|P3|STARTED|Overall Study||1862
8102623|NCT03200535|19971405|P2|STARTED|Overall Study||1863
8102624|NCT03200535|19971406|P1|STARTED|Overall Study||1863
8102625|NCT03199911|19971422|P2|NOT COMPLETED|Overall Study||6
8102626|NCT03199911|19971423|P1|NOT COMPLETED|Overall Study||7
8102627|NCT03199911|19971422|P2|COMPLETED|Overall Study||187
8102628|NCT03199911|19971423|P1|COMPLETED|Overall Study||201
8102629|NCT03199911|19971422|P2|Primary Outcome Analyzed|Overall Study||187
8102630|NCT03199911|19971423|P1|Primary Outcome Analyzed|Overall Study||201
8102631|NCT03199911|19971422|P2|Lost to Follow-up|Overall Study||5
8102632|NCT03199911|19971423|P1|Lost to Follow-up|Overall Study||5
8102633|NCT03199911|19971422|P2|Received Allocated Treatment|Overall Study||192
8102634|NCT03199911|19971423|P1|Received Allocated Treatment|Overall Study||206
8102635|NCT03199911|19971422|P2|Did Not Proceed With Surgery|Overall Study||1
8102636|NCT03199911|19971423|P1|Did Not Proceed With Surgery|Overall Study||2
8102637|NCT03199911|19971422|P2|STARTED|Overall Study||193
8102638|NCT03199911|19971423|P1|STARTED|Overall Study||208
8102639|NCT03199872|19971435|P1|NOT COMPLETED|Overall Study||0
8102640|NCT03199872|19971435|P1|COMPLETED|Overall Study||22
8102641|NCT03199872|19971435|P1|STARTED|Overall Study||22
8102642|NCT03199079|19971442|P2|NOT COMPLETED|Overall Study||0
8102643|NCT03199079|19971443|P1|NOT COMPLETED|Overall Study||0
8102644|NCT03199079|19971442|P2|COMPLETED|Overall Study||10
8102645|NCT03199079|19971443|P1|COMPLETED|Overall Study||10
8102646|NCT03199079|19971442|P2|STARTED|Overall Study||10
8102647|NCT03199079|19971443|P1|STARTED|Overall Study||10
8102648|NCT03198884|19971451|P1|NOT COMPLETED|Overall Study||0
8102649|NCT03198884|19971451|P1|COMPLETED|Overall Study||20
8102650|NCT03198884|19971451|P1|STARTED|Overall Study||20
8102651|NCT03198767|19971474|P7|NOT COMPLETED|Overall Study||0
8102652|NCT03198767|19971475|P6|NOT COMPLETED|Overall Study||0
8102653|NCT03198767|19971476|P5|NOT COMPLETED|Overall Study||0
8102654|NCT03198767|19971477|P4|NOT COMPLETED|Overall Study||6
8102655|NCT03198767|19971478|P3|NOT COMPLETED|Overall Study||0
8102656|NCT03198767|19971479|P2|NOT COMPLETED|Overall Study||0
8102657|NCT03198767|19971480|P1|NOT COMPLETED|Overall Study||0
8102658|NCT03198767|19971474|P7|COMPLETED|Overall Study||8
8102659|NCT03198767|19971475|P6|COMPLETED|Overall Study||8
8102660|NCT03198767|19971476|P5|COMPLETED|Overall Study||8
8102661|NCT03198767|19971477|P4|COMPLETED|Overall Study||0
8102662|NCT03198767|19971478|P3|COMPLETED|Overall Study||8
8102663|NCT03198767|19971479|P2|COMPLETED|Overall Study||8
8102664|NCT03198767|19971480|P1|COMPLETED|Overall Study||8
8102665|NCT03198767|19971474|P7|STARTED|Overall Study||8
8102666|NCT03198767|19971475|P6|STARTED|Overall Study||8
8102667|NCT03198767|19971476|P5|STARTED|Overall Study||8
8102668|NCT03198767|19971477|P4|STARTED|Overall Study||6
8102669|NCT03198767|19971478|P3|STARTED|Overall Study||8
8102670|NCT03198767|19971479|P2|STARTED|Overall Study||8
8102671|NCT03198767|19971480|P1|STARTED|Overall Study||8
8102672|NCT03198754|19971521|P2|NOT COMPLETED|Overall Study||8
8102673|NCT03198754|19971522|P1|NOT COMPLETED|Overall Study||11
8102674|NCT03198754|19971521|P2|COMPLETED|Overall Study||27
8102675|NCT03198754|19971522|P1|COMPLETED|Overall Study||27
8102676|NCT03198754|19971521|P2|STARTED|Overall Study||35
8102677|NCT03198754|19971522|P1|STARTED|Overall Study||38
8102678|NCT03198520|19971560|P1|NOT COMPLETED|Overall Study||6
8102679|NCT03198520|19971560|P1|COMPLETED|Overall Study||40
8102680|NCT03198520|19971560|P1|STARTED|Overall Study||46
8102681|NCT03198507|19971583|P2|NOT COMPLETED|Overall Study||0
8102682|NCT03198507|19971584|P1|NOT COMPLETED|Overall Study||1
8102683|NCT03198507|19971583|P2|COMPLETED|Overall Study||227
8102684|NCT03198507|19971584|P1|COMPLETED|Overall Study||227
8102685|NCT03198507|19971583|P2|STARTED|Overall Study||227
8102686|NCT03198507|19971584|P1|STARTED|Overall Study||228
8102687|NCT03198000|19971599|P3|NOT COMPLETED|Overall Study||0
8102688|NCT03198000|19971600|P2|NOT COMPLETED|Overall Study||0
8102689|NCT03198000|19971601|P1|NOT COMPLETED|Overall Study||0
8102690|NCT03198000|19971599|P3|COMPLETED|Overall Study||41
8102691|NCT03198000|19971600|P2|COMPLETED|Overall Study||38
8102692|NCT03198000|19971601|P1|COMPLETED|Overall Study||41
8102693|NCT03198000|19971599|P3|STARTED|Overall Study||41
8102694|NCT03198000|19971600|P2|STARTED|Overall Study||38
8102695|NCT03198000|19971601|P1|STARTED|Overall Study||41
8102696|NCT03197883|19971710|P2|NOT COMPLETED|Overall Study||6
8102697|NCT03197883|19971711|P1|NOT COMPLETED|Overall Study||3
8102698|NCT03197883|19971710|P2|COMPLETED|Overall Study||44
8102699|NCT03197883|19971711|P1|COMPLETED|Overall Study||47
8102700|NCT03197883|19971710|P2|STARTED|Overall Study||50
8102701|NCT03197883|19971711|P1|STARTED|Overall Study||50
8102702|NCT03197558|19971741|P1|NOT COMPLETED|Overall Study||1
8102703|NCT03197558|19971741|P1|COMPLETED|Overall Study||29
8102704|NCT03197558|19971741|P1|STARTED|Overall Study||30
8102705|NCT03197376|19971749|P4|NOT COMPLETED|Immune Persistence Phase||5
8102706|NCT03197376|19971750|P3|NOT COMPLETED|Immune Persistence Phase||5
8102707|NCT03197376|19971751|P2|NOT COMPLETED|Immune Persistence Phase||4
8102708|NCT03197376|19971752|P1|NOT COMPLETED|Immune Persistence Phase||5
8102709|NCT03197376|19971749|P4|COMPLETED|Immune Persistence Phase||190
8102710|NCT03197376|19971750|P3|COMPLETED|Immune Persistence Phase||123
8102711|NCT03197376|19971751|P2|COMPLETED|Immune Persistence Phase||129
8102712|NCT03197376|19971752|P1|COMPLETED|Immune Persistence Phase||127
8102713|NCT03197376|19971749|P4|STARTED|Immune Persistence Phase||195
8102714|NCT03197376|19971750|P3|STARTED|Immune Persistence Phase||128
8102715|NCT03197376|19971751|P2|STARTED|Immune Persistence Phase||133
8102716|NCT03197376|19971752|P1|STARTED|Immune Persistence Phase||132
8102717|NCT03197376|19971749|P4|NOT COMPLETED|Primary and Booster Phase||25
8102718|NCT03197376|19971750|P3|NOT COMPLETED|Primary and Booster Phase||20
8102719|NCT03197376|19971751|P2|NOT COMPLETED|Primary and Booster Phase||13
8102720|NCT03197376|19971752|P1|NOT COMPLETED|Primary and Booster Phase||15
8102721|NCT03197376|19971749|P4|COMPLETED|Primary and Booster Phase||722
8102722|NCT03197376|19971750|P3|COMPLETED|Primary and Booster Phase||480
8102723|NCT03197376|19971751|P2|COMPLETED|Primary and Booster Phase||488
8102724|NCT03197376|19971752|P1|COMPLETED|Primary and Booster Phase||487
8102725|NCT03197376|19971749|P4|Received Booster Vaccine|Primary and Booster Phase||213
8102726|NCT03197376|19971750|P3|Received Booster Vaccine|Primary and Booster Phase||139
8102727|NCT03197376|19971751|P2|Received Booster Vaccine|Primary and Booster Phase||144
8102728|NCT03197376|19971752|P1|Received Booster Vaccine|Primary and Booster Phase||145
8102729|NCT03197376|19971749|P4|Booster Cohort|Primary and Booster Phase||224
8102730|NCT03197376|19971750|P3|Booster Cohort|Primary and Booster Phase||150
8102731|NCT03197376|19971751|P2|Booster Cohort|Primary and Booster Phase||151
8102732|NCT03197376|19971752|P1|Booster Cohort|Primary and Booster Phase||150
8102733|NCT03197376|19971749|P4|Primary Reactogenicity Cohort|Primary and Booster Phase||364
8102734|NCT03197376|19971750|P3|Primary Reactogenicity Cohort|Primary and Booster Phase||257
8102735|NCT03197376|19971751|P2|Primary Reactogenicity Cohort|Primary and Booster Phase||243
8102736|NCT03197376|19971752|P1|Primary Reactogenicity Cohort|Primary and Booster Phase||251
8102737|NCT03197376|19971749|P4|Vaccinated-Dose 3|Primary and Booster Phase||731
8102738|NCT03197376|19971750|P3|Vaccinated-Dose 3|Primary and Booster Phase||490
8102739|NCT03197376|19971751|P2|Vaccinated-Dose 3|Primary and Booster Phase||493
8102740|NCT03197376|19971752|P1|Vaccinated-Dose 3|Primary and Booster Phase||492
8102741|NCT03197376|19971749|P4|Vaccinated-Dose 2|Primary and Booster Phase||738
8102742|NCT03197376|19971750|P3|Vaccinated-Dose 2|Primary and Booster Phase||491
8102743|NCT03197376|19971751|P2|Vaccinated-Dose 2|Primary and Booster Phase||495
8102744|NCT03197376|19971752|P1|Vaccinated-Dose 2|Primary and Booster Phase||495
8102745|NCT03197376|19971749|P4|Vaccinated-Dose 1|Primary and Booster Phase||747
8102746|NCT03197376|19971750|P3|Vaccinated-Dose 1|Primary and Booster Phase||500
8102747|NCT03197376|19971751|P2|Vaccinated-Dose 1|Primary and Booster Phase||501
8102748|NCT03197376|19971752|P1|Vaccinated-Dose 1|Primary and Booster Phase||502
8102749|NCT03197376|19971749|P4|STARTED|Primary and Booster Phase||747
8102750|NCT03197376|19971750|P3|STARTED|Primary and Booster Phase||500
8102751|NCT03197376|19971751|P2|STARTED|Primary and Booster Phase||501
8102752|NCT03197376|19971752|P1|STARTED|Primary and Booster Phase||502
8102756|NCT03196635|19971826|P1|NOT COMPLETED|Overall Study||1
8102757|NCT03196635|19971826|P1|COMPLETED|Overall Study||30
8102758|NCT03196635|19971826|P1|STARTED|Overall Study||31
8102759|NCT03196505|19971846|P2|NOT COMPLETED|Overall Study||26
8102760|NCT03196505|19971847|P1|NOT COMPLETED|Overall Study||26
8102761|NCT03196505|19971846|P2|COMPLETED|Overall Study||90
8102762|NCT03196505|19971847|P1|COMPLETED|Overall Study||89
8102763|NCT03196505|19971846|P2|STARTED|Overall Study||116
8102764|NCT03196505|19971847|P1|STARTED|Overall Study||115
8102765|NCT03196349|19971858|P3|NOT COMPLETED|Overall Study||13
8102766|NCT03196349|19971859|P2|NOT COMPLETED|Overall Study||14
8102767|NCT03196349|19971860|P1|NOT COMPLETED|Overall Study||17
8102768|NCT03196349|19971858|P3|COMPLETED|Overall Study||0
8102769|NCT03196349|19971859|P2|COMPLETED|Overall Study||0
8102770|NCT03196349|19971860|P1|COMPLETED|Overall Study||0
8102771|NCT03196349|19971858|P3|STARTED|Overall Study||13
8102772|NCT03196349|19971859|P2|STARTED|Overall Study||14
8102773|NCT03196349|19971860|P1|STARTED|Overall Study||17
8102774|NCT03196232|19971886|P1|NOT COMPLETED|Overall Study||0
8102775|NCT03196232|19971886|P1|COMPLETED|Overall Study||3
8102776|NCT03196232|19971886|P1|STARTED|Overall Study||3
8102777|NCT03196193|19971897|P2|NOT COMPLETED|Overall Study||0
8102778|NCT03196193|19971898|P1|NOT COMPLETED|Overall Study||3
8102779|NCT03196193|19971897|P2|COMPLETED|Overall Study||119
8102780|NCT03196193|19971898|P1|COMPLETED|Overall Study||118
8102781|NCT03196193|19971897|P2|STARTED|Overall Study||119
8102782|NCT03196193|19971898|P1|STARTED|Overall Study||121
8102783|NCT03195517|19971910|P1|NOT COMPLETED|Overall Study||0
8102784|NCT03195517|19971910|P1|COMPLETED|Overall Study||33
8102785|NCT03195517|19971910|P1|STARTED|Overall Study||33
8102786|NCT03195010|19971925|P2|NOT COMPLETED|Overall Study||0
8102787|NCT03195010|19971926|P1|NOT COMPLETED|Overall Study||0
8102788|NCT03195010|19971925|P2|COMPLETED|Overall Study||2
8102789|NCT03195010|19971926|P1|COMPLETED|Overall Study||2
8102790|NCT03195010|19971925|P2|STARTED|Overall Study||2
8102791|NCT03195010|19971926|P1|STARTED|Overall Study||2
8102792|NCT03194776|19971953|P2|NOT COMPLETED|Overall Study||0
8102793|NCT03194776|19971954|P1|NOT COMPLETED|Overall Study||0
8102794|NCT03194776|19971953|P2|COMPLETED|Overall Study||23
8102795|NCT03194776|19971954|P1|COMPLETED|Overall Study||23
8102796|NCT03194776|19971953|P2|STARTED|Overall Study||23
8102797|NCT03194776|19971954|P1|STARTED|Overall Study||23
8102798|NCT03194698|19971972|P2|NOT COMPLETED|Overall Study||0
8102799|NCT03194698|19971973|P1|NOT COMPLETED|Overall Study||0
8102800|NCT03194698|19971972|P2|COMPLETED|Overall Study||10
8102801|NCT03194698|19971973|P1|COMPLETED|Overall Study||10
8102802|NCT03194698|19971972|P2|STARTED|Overall Study||10
8102803|NCT03194698|19971973|P1|STARTED|Overall Study||10
8102810|NCT03194490|19971996|P2|NOT COMPLETED|Overall Study||3
8102811|NCT03194490|19971997|P1|NOT COMPLETED|Overall Study||2
8102812|NCT03194490|19971996|P2|COMPLETED|Overall Study||20
8102813|NCT03194490|19971997|P1|COMPLETED|Overall Study||18
8102814|NCT03194490|19971996|P2|STARTED|Overall Study||23
8102815|NCT03194490|19971997|P1|STARTED|Overall Study||20
8102816|NCT03194464|19972039|P1|NOT COMPLETED|Overall Study||2
8102817|NCT03194464|19972039|P1|COMPLETED|Overall Study||13
8102818|NCT03194464|19972039|P1|STARTED|Overall Study||15
8102822|NCT03194334|19972053|P3|NOT COMPLETED|3-6 Months||0
8102823|NCT03194334|19972054|P2|NOT COMPLETED|3-6 Months||0
8102824|NCT03194334|19972055|P1|NOT COMPLETED|3-6 Months||0
8102825|NCT03194334|19972053|P3|COMPLETED|3-6 Months||14
8102826|NCT03194334|19972054|P2|COMPLETED|3-6 Months||15
8102827|NCT03194334|19972055|P1|COMPLETED|3-6 Months||10
8102828|NCT03194334|19972053|P3|STARTED|3-6 Months||14
8102829|NCT03194334|19972054|P2|STARTED|3-6 Months||15
8102830|NCT03194334|19972055|P1|STARTED|3-6 Months||10
8102831|NCT03194334|19972053|P3|NOT COMPLETED|0-3 Months||1
8102832|NCT03194334|19972054|P2|NOT COMPLETED|0-3 Months||0
8102833|NCT03194334|19972055|P1|NOT COMPLETED|0-3 Months||0
8102834|NCT03194334|19972053|P3|COMPLETED|0-3 Months||14
8102835|NCT03194334|19972054|P2|COMPLETED|0-3 Months||15
8102836|NCT03194334|19972055|P1|COMPLETED|0-3 Months||10
8102837|NCT03194334|19972053|P3|STARTED|0-3 Months||15
8102838|NCT03194334|19972054|P2|STARTED|0-3 Months||15
8102839|NCT03194334|19972055|P1|STARTED|0-3 Months||10
8102840|NCT03194217|19972130|P4|NOT COMPLETED|Overall Study||4
8102841|NCT03194217|19972131|P3|NOT COMPLETED|Overall Study||4
8102842|NCT03194217|19972132|P2|NOT COMPLETED|Overall Study||3
8102843|NCT03194217|19972133|P1|NOT COMPLETED|Overall Study||0
8102844|NCT03194217|19972130|P4|COMPLETED|Overall Study||60
8102845|NCT03194217|19972131|P3|COMPLETED|Overall Study||56
8102846|NCT03194217|19972132|P2|COMPLETED|Overall Study||57
8102847|NCT03194217|19972133|P1|COMPLETED|Overall Study||60
8102848|NCT03194217|19972130|P4|STARTED|Overall Study||64
8102849|NCT03194217|19972131|P3|STARTED|Overall Study||60
8102850|NCT03194217|19972132|P2|STARTED|Overall Study||60
8102851|NCT03194217|19972133|P1|STARTED|Overall Study||60
8102852|NCT03193593|19972150|P7|NOT COMPLETED|Overall Study||4
8102853|NCT03193593|19972151|P6|NOT COMPLETED|Overall Study||3
8102854|NCT03193593|19972152|P5|NOT COMPLETED|Overall Study||1
8102855|NCT03193593|19972153|P4|NOT COMPLETED|Overall Study||0
8102856|NCT03193593|19972154|P3|NOT COMPLETED|Overall Study||1
8102857|NCT03193593|19972155|P2|NOT COMPLETED|Overall Study||1
8102858|NCT03193593|19972156|P1|NOT COMPLETED|Overall Study||4
8102859|NCT03193593|19972150|P7|COMPLETED|Overall Study||8
8102860|NCT03193593|19972151|P6|COMPLETED|Overall Study||13
8102861|NCT03193593|19972152|P5|COMPLETED|Overall Study||7
8102862|NCT03193593|19972153|P4|COMPLETED|Overall Study||4
8102863|NCT03193593|19972154|P3|COMPLETED|Overall Study||3
8102864|NCT03193593|19972155|P2|COMPLETED|Overall Study||3
8102865|NCT03193593|19972156|P1|COMPLETED|Overall Study||14
8102866|NCT03193593|19972150|P7|STARTED|Overall Study||12
8102867|NCT03193593|19972151|P6|STARTED|Overall Study||16
8102868|NCT03193593|19972152|P5|STARTED|Overall Study||8
8102869|NCT03193593|19972153|P4|STARTED|Overall Study||4
8102870|NCT03193593|19972154|P3|STARTED|Overall Study||4
8102871|NCT03193593|19972155|P2|STARTED|Overall Study||4
8102872|NCT03193593|19972156|P1|STARTED|Overall Study||18
8102873|NCT03193047|19972174|P2|NOT COMPLETED|Overall Study||0
8102874|NCT03193047|19972175|P1|NOT COMPLETED|Overall Study||2
8102875|NCT03193047|19972174|P2|COMPLETED|Overall Study||28
8102876|NCT03193047|19972175|P1|COMPLETED|Overall Study||29
8102877|NCT03193047|19972174|P2|STARTED|Overall Study||28
8102878|NCT03193047|19972175|P1|STARTED|Overall Study||31
8102879|NCT03193021|19972195|P2|NOT COMPLETED|Overall Study||1
8102880|NCT03193021|19972196|P1|NOT COMPLETED|Overall Study||1
8102881|NCT03193021|19972195|P2|COMPLETED|Overall Study||103
8102882|NCT03193021|19972196|P1|COMPLETED|Overall Study||99
8102883|NCT03193021|19972195|P2|STARTED|Overall Study||104
8102884|NCT03193021|19972196|P1|STARTED|Overall Study||100
8102891|NCT03192826|19972259|P3|NOT COMPLETED|Overall Study||0
8102892|NCT03192826|19972260|P2|NOT COMPLETED|Overall Study||0
8102893|NCT03192826|19972261|P1|NOT COMPLETED|Overall Study||0
8102894|NCT03192826|19972259|P3|COMPLETED|Overall Study||25
8102895|NCT03192826|19972260|P2|COMPLETED|Overall Study||27
8102896|NCT03192826|19972261|P1|COMPLETED|Overall Study||27
8102897|NCT03192826|19972259|P3|STARTED|Overall Study||25
8102898|NCT03192826|19972260|P2|STARTED|Overall Study||27
8102899|NCT03192826|19972261|P1|STARTED|Overall Study||27
8102900|NCT03192488|19972278|P6|NOT COMPLETED|Third Intervention (d1)||0
8102901|NCT03192488|19972279|P5|NOT COMPLETED|Third Intervention (d1)||1
8102902|NCT03192488|19972280|P4|NOT COMPLETED|Third Intervention (d1)||0
8102903|NCT03192488|19972281|P3|NOT COMPLETED|Third Intervention (d1)||0
8102904|NCT03192488|19972282|P2|NOT COMPLETED|Third Intervention (d1)||0
8102905|NCT03192488|19972283|P1|NOT COMPLETED|Third Intervention (d1)||0
8102906|NCT03192488|19972278|P6|COMPLETED|Third Intervention (d1)||0
8102907|NCT03192488|19972279|P5|COMPLETED|Third Intervention (d1)||0
8102908|NCT03192488|19972280|P4|COMPLETED|Third Intervention (d1)||1
8102909|NCT03192488|19972281|P3|COMPLETED|Third Intervention (d1)||1
8102910|NCT03192488|19972282|P2|COMPLETED|Third Intervention (d1)||5
8102911|NCT03192488|19972283|P1|COMPLETED|Third Intervention (d1)||1
8102912|NCT03192488|19972278|P6|STARTED|Third Intervention (d1)||0
8102913|NCT03192488|19972279|P5|STARTED|Third Intervention (d1)||1
8102914|NCT03192488|19972280|P4|STARTED|Third Intervention (d1)||1
8102915|NCT03192488|19972281|P3|STARTED|Third Intervention (d1)||1
8102916|NCT03192488|19972282|P2|STARTED|Third Intervention (d1)||5
8102917|NCT03192488|19972283|P1|STARTED|Third Intervention (d1)||1
8102918|NCT03192488|19972278|P6|NOT COMPLETED|Second Washout (>6d)||0
8102919|NCT03192488|19972279|P5|NOT COMPLETED|Second Washout (>6d)||0
8102920|NCT03192488|19972280|P4|NOT COMPLETED|Second Washout (>6d)||0
8102921|NCT03192488|19972281|P3|NOT COMPLETED|Second Washout (>6d)||0
8102922|NCT03192488|19972282|P2|NOT COMPLETED|Second Washout (>6d)||0
8102923|NCT03192488|19972283|P1|NOT COMPLETED|Second Washout (>6d)||0
8102924|NCT03192488|19972278|P6|COMPLETED|Second Washout (>6d)||0
8102925|NCT03192488|19972279|P5|COMPLETED|Second Washout (>6d)||1
8102926|NCT03192488|19972280|P4|COMPLETED|Second Washout (>6d)||1
8102927|NCT03192488|19972281|P3|COMPLETED|Second Washout (>6d)||1
8102928|NCT03192488|19972282|P2|COMPLETED|Second Washout (>6d)||5
8102929|NCT03192488|19972283|P1|COMPLETED|Second Washout (>6d)||1
8102930|NCT03192488|19972278|P6|STARTED|Second Washout (>6d)||0
8102931|NCT03192488|19972279|P5|STARTED|Second Washout (>6d)||1
8102932|NCT03192488|19972280|P4|STARTED|Second Washout (>6d)||1
8102933|NCT03192488|19972281|P3|STARTED|Second Washout (>6d)||1
8102934|NCT03192488|19972282|P2|STARTED|Second Washout (>6d)||5
8102935|NCT03192488|19972283|P1|STARTED|Second Washout (>6d)||1
8102936|NCT03192488|19972278|P6|NOT COMPLETED|Second Intervention (d1)||0
8102937|NCT03192488|19972279|P5|NOT COMPLETED|Second Intervention (d1)||0
8102938|NCT03192488|19972280|P4|NOT COMPLETED|Second Intervention (d1)||0
8102939|NCT03192488|19972281|P3|NOT COMPLETED|Second Intervention (d1)||0
8102940|NCT03192488|19972282|P2|NOT COMPLETED|Second Intervention (d1)||0
8102941|NCT03192488|19972283|P1|NOT COMPLETED|Second Intervention (d1)||0
8102942|NCT03192488|19972278|P6|COMPLETED|Second Intervention (d1)||0
8102943|NCT03192488|19972279|P5|COMPLETED|Second Intervention (d1)||1
8102944|NCT03192488|19972280|P4|COMPLETED|Second Intervention (d1)||1
8102945|NCT03192488|19972281|P3|COMPLETED|Second Intervention (d1)||1
8102946|NCT03192488|19972282|P2|COMPLETED|Second Intervention (d1)||5
8102947|NCT03192488|19972283|P1|COMPLETED|Second Intervention (d1)||1
8102948|NCT03192488|19972278|P6|STARTED|Second Intervention (d1)||0
8102949|NCT03192488|19972279|P5|STARTED|Second Intervention (d1)||1
8102950|NCT03192488|19972280|P4|STARTED|Second Intervention (d1)||1
8102951|NCT03192488|19972281|P3|STARTED|Second Intervention (d1)||1
8102952|NCT03192488|19972282|P2|STARTED|Second Intervention (d1)||5
8102953|NCT03192488|19972283|P1|STARTED|Second Intervention (d1)||1
8102954|NCT03192488|19972278|P6|NOT COMPLETED|First Washout (>6d)||1
8102955|NCT03192488|19972279|P5|NOT COMPLETED|First Washout (>6d)||0
8102956|NCT03192488|19972280|P4|NOT COMPLETED|First Washout (>6d)||0
8102957|NCT03192488|19972281|P3|NOT COMPLETED|First Washout (>6d)||1
8102958|NCT03192488|19972282|P2|NOT COMPLETED|First Washout (>6d)||0
8102959|NCT03192488|19972283|P1|NOT COMPLETED|First Washout (>6d)||0
8102960|NCT03192488|19972278|P6|COMPLETED|First Washout (>6d)||0
8102961|NCT03192488|19972279|P5|COMPLETED|First Washout (>6d)||1
8102962|NCT03192488|19972280|P4|COMPLETED|First Washout (>6d)||1
8102963|NCT03192488|19972281|P3|COMPLETED|First Washout (>6d)||1
8102964|NCT03192488|19972282|P2|COMPLETED|First Washout (>6d)||5
8102965|NCT03192488|19972283|P1|COMPLETED|First Washout (>6d)||1
8102966|NCT03192488|19972278|P6|STARTED|First Washout (>6d)||1
8102967|NCT03192488|19972279|P5|STARTED|First Washout (>6d)||1
8102968|NCT03192488|19972280|P4|STARTED|First Washout (>6d)||1
8102969|NCT03192488|19972281|P3|STARTED|First Washout (>6d)||2
8102970|NCT03192488|19972282|P2|STARTED|First Washout (>6d)||5
8102971|NCT03192488|19972283|P1|STARTED|First Washout (>6d)||1
8102972|NCT03192488|19972278|P6|NOT COMPLETED|First Intervention (d1)||0
8102973|NCT03192488|19972279|P5|NOT COMPLETED|First Intervention (d1)||0
8102974|NCT03192488|19972280|P4|NOT COMPLETED|First Intervention (d1)||0
8102975|NCT03192488|19972281|P3|NOT COMPLETED|First Intervention (d1)||0
8102976|NCT03192488|19972282|P2|NOT COMPLETED|First Intervention (d1)||0
8102977|NCT03192488|19972283|P1|NOT COMPLETED|First Intervention (d1)||0
8102978|NCT03192488|19972278|P6|COMPLETED|First Intervention (d1)||1
8102979|NCT03192488|19972279|P5|COMPLETED|First Intervention (d1)||1
8102980|NCT03192488|19972280|P4|COMPLETED|First Intervention (d1)||1
8102981|NCT03192488|19972281|P3|COMPLETED|First Intervention (d1)||2
8102982|NCT03192488|19972282|P2|COMPLETED|First Intervention (d1)||5
8102983|NCT03192488|19972283|P1|COMPLETED|First Intervention (d1)||1
8102984|NCT03192488|19972278|P6|STARTED|First Intervention (d1)||1
8102985|NCT03192488|19972279|P5|STARTED|First Intervention (d1)||1
8102986|NCT03192488|19972280|P4|STARTED|First Intervention (d1)||1
8102987|NCT03192488|19972281|P3|STARTED|First Intervention (d1)||2
8102988|NCT03192488|19972282|P2|STARTED|First Intervention (d1)||5
8102989|NCT03192488|19972283|P1|STARTED|First Intervention (d1)||1
8102990|NCT03192475|19972299|P2|NOT COMPLETED|Overall Study||9
8102991|NCT03192475|19972300|P1|NOT COMPLETED|Overall Study||13
8102992|NCT03192475|19972299|P2|COMPLETED|Overall Study||151
8102993|NCT03192475|19972300|P1|COMPLETED|Overall Study||149
8102994|NCT03192475|19972299|P2|STARTED|Overall Study||160
8102995|NCT03192475|19972300|P1|STARTED|Overall Study||162
8102996|NCT03192306|19972336|P2|NOT COMPLETED|Overall Study||145
8102997|NCT03192306|19972337|P1|NOT COMPLETED|Overall Study||152
8102998|NCT03192306|19972336|P2|COMPLETED|Overall Study||79
8102999|NCT03192306|19972337|P1|COMPLETED|Overall Study||75
8103000|NCT03192306|19972336|P2|Modified Intent to Treat (MITT)|Overall Study||80
8103001|NCT03192306|19972337|P1|Modified Intent to Treat (MITT)|Overall Study||76
8103002|NCT03192306|19972336|P2|STARTED|Overall Study||224
8103003|NCT03192306|19972337|P1|STARTED|Overall Study||227
8103004|NCT03192150|19972357|P2|NOT COMPLETED|Overall Study||54
8103005|NCT03192150|19972358|P1|NOT COMPLETED|Overall Study||55
8103006|NCT03192150|19972357|P2|COMPLETED|Overall Study||29
8103007|NCT03192150|19972358|P1|COMPLETED|Overall Study||108
8103008|NCT03192150|19972357|P2|STARTED|Overall Study||83
8103009|NCT03192150|19972358|P1|STARTED|Overall Study||163
8103016|NCT03191552|19972380|P3|NOT COMPLETED|Overall Study||0
8103017|NCT03191552|19972381|P2|NOT COMPLETED|Overall Study||1
8103018|NCT03191552|19972382|P1|NOT COMPLETED|Overall Study||1
8103019|NCT03191552|19972380|P3|COMPLETED|Overall Study||8
8103020|NCT03191552|19972381|P2|COMPLETED|Overall Study||8
8103021|NCT03191552|19972382|P1|COMPLETED|Overall Study||8
8103022|NCT03191552|19972380|P3|STARTED|Overall Study||8
8103023|NCT03191552|19972381|P2|STARTED|Overall Study||9
8103024|NCT03191552|19972382|P1|STARTED|Overall Study||9
8103025|NCT03191396|19972435|P2|NOT COMPLETED|Overall Study||5
8103026|NCT03191396|19972436|P1|NOT COMPLETED|Overall Study||3
8103027|NCT03191396|19972435|P2|COMPLETED|Overall Study||282
8103028|NCT03191396|19972436|P1|COMPLETED|Overall Study||287
8103029|NCT03191396|19972435|P2|STARTED|Overall Study||287
8103030|NCT03191396|19972436|P1|STARTED|Overall Study||290
8103031|NCT03190993|19972524|P2|NOT COMPLETED|Overall Study||0
8103032|NCT03190993|19972525|P1|NOT COMPLETED|Overall Study||0
8103033|NCT03190993|19972524|P2|COMPLETED|Overall Study||10
8103034|NCT03190993|19972525|P1|COMPLETED|Overall Study||10
8103035|NCT03190993|19972524|P2|STARTED|Overall Study||10
8103036|NCT03190993|19972525|P1|STARTED|Overall Study||10
8103037|NCT03190460|19972533|P2|NOT COMPLETED|Overall Study||18
8103038|NCT03190460|19972534|P1|NOT COMPLETED|Overall Study||37
8103039|NCT03190460|19972533|P2|COMPLETED|Overall Study||2
8103040|NCT03190460|19972534|P1|COMPLETED|Overall Study||3
8103041|NCT03190460|19972533|P2|STARTED|Overall Study||20
8103042|NCT03190460|19972534|P1|STARTED|Overall Study||40
8103043|NCT03190369|19972542|P2|NOT COMPLETED|Overall Study||8
8103044|NCT03190369|19972543|P1|NOT COMPLETED|Overall Study||1
8103045|NCT03190369|19972542|P2|COMPLETED|Overall Study||212
8103046|NCT03190369|19972543|P1|COMPLETED|Overall Study||219
8103047|NCT03190369|19972542|P2|Treated|Overall Study||218
8103048|NCT03190369|19972543|P1|Treated|Overall Study||220
8103049|NCT03190369|19972542|P2|STARTED|Overall Study||220
8103050|NCT03190369|19972543|P1|STARTED|Overall Study||220
8103054|NCT03190083|19972569|P1|NOT COMPLETED|Overall Study||0
8103055|NCT03190083|19972569|P1|COMPLETED|Overall Study||16
8103056|NCT03190083|19972569|P1|STARTED|Overall Study||16
8103057|NCT03190005|19972580|P7|NOT COMPLETED|Overall Study||0
8103058|NCT03190005|19972581|P6|NOT COMPLETED|Overall Study||0
8103059|NCT03190005|19972582|P5|NOT COMPLETED|Overall Study||0
8103060|NCT03190005|19972583|P4|NOT COMPLETED|Overall Study||0
8103061|NCT03190005|19972584|P3|NOT COMPLETED|Overall Study||0
8103062|NCT03190005|19972585|P2|NOT COMPLETED|Overall Study||0
8103063|NCT03190005|19972586|P1|NOT COMPLETED|Overall Study||0
8103064|NCT03190005|19972580|P7|COMPLETED|Overall Study||5
8103065|NCT03190005|19972581|P6|COMPLETED|Overall Study||5
8103066|NCT03190005|19972582|P5|COMPLETED|Overall Study||5
8103067|NCT03190005|19972583|P4|COMPLETED|Overall Study||5
8103068|NCT03190005|19972584|P3|COMPLETED|Overall Study||5
8103069|NCT03190005|19972585|P2|COMPLETED|Overall Study||5
8103070|NCT03190005|19972586|P1|COMPLETED|Overall Study||5
8103071|NCT03190005|19972580|P7|STARTED|Overall Study||5
8103072|NCT03190005|19972581|P6|STARTED|Overall Study||5
8103073|NCT03190005|19972582|P5|STARTED|Overall Study||5
8103074|NCT03190005|19972583|P4|STARTED|Overall Study||5
8103075|NCT03190005|19972584|P3|STARTED|Overall Study||5
8103076|NCT03190005|19972585|P2|STARTED|Overall Study||5
8103077|NCT03190005|19972586|P1|STARTED|Overall Study||5
8103078|NCT03189745|19972604|P2|NOT COMPLETED|Overall Study||1
8103079|NCT03189745|19972605|P1|NOT COMPLETED|Overall Study||1
8103080|NCT03189745|19972604|P2|COMPLETED|Overall Study||58
8103081|NCT03189745|19972605|P1|COMPLETED|Overall Study||169
8103082|NCT03189745|19972604|P2|STARTED|Overall Study||59
8103083|NCT03189745|19972605|P1|STARTED|Overall Study||170
8103084|NCT03189589|19972633|P2|NOT COMPLETED|Overall Study||0
8103085|NCT03189589|19972634|P1|NOT COMPLETED|Overall Study||0
8103086|NCT03189589|19972633|P2|COMPLETED|Overall Study||6
8103087|NCT03189589|19972634|P1|COMPLETED|Overall Study||6
8103088|NCT03189589|19972633|P2|STARTED|Overall Study||6
8103089|NCT03189589|19972634|P1|STARTED|Overall Study||6
8103093|NCT03189134|19972663|P1|NOT COMPLETED|Overall Study||0
8103094|NCT03189134|19972663|P1|COMPLETED|Overall Study||6
8103095|NCT03189134|19972663|P1|STARTED|Overall Study||6
8103096|NCT03188536|19972669|P1|NOT COMPLETED|Overall Study||6
8103097|NCT03188536|19972669|P1|COMPLETED|Overall Study||276
8103098|NCT03188536|19972669|P1|STARTED|Overall Study||282
8103099|NCT03188523|19972683|P4|NOT COMPLETED|Overall Study||0
8103100|NCT03188523|19972684|P3|NOT COMPLETED|Overall Study||0
8103101|NCT03188523|19972685|P2|NOT COMPLETED|Overall Study||0
8103102|NCT03188523|19972686|P1|NOT COMPLETED|Overall Study||0
8103103|NCT03188523|19972683|P4|COMPLETED|Overall Study||0
8103104|NCT03188523|19972684|P3|COMPLETED|Overall Study||0
8103105|NCT03188523|19972685|P2|COMPLETED|Overall Study||6
8103106|NCT03188523|19972686|P1|COMPLETED|Overall Study||6
8103107|NCT03188523|19972683|P4|STARTED|Overall Study||0
8103108|NCT03188523|19972684|P3|STARTED|Overall Study||0
8103109|NCT03188523|19972685|P2|STARTED|Overall Study||6
8103110|NCT03188523|19972686|P1|STARTED|Overall Study||6
8103111|NCT03188263|19972738|P2|NOT COMPLETED|Overall Study||0
8103112|NCT03188263|19972739|P1|NOT COMPLETED|Overall Study||4
8103113|NCT03188263|19972738|P2|COMPLETED|Overall Study||0
8103114|NCT03188263|19972739|P1|COMPLETED|Overall Study||6
8103115|NCT03188263|19972738|P2|STARTED|Overall Study||0
8103116|NCT03188263|19972739|P1|STARTED|Overall Study||10
8103117|NCT03188120|19972747|P1|NOT COMPLETED|Overall Study||47
8103118|NCT03188120|19972747|P1|COMPLETED|Overall Study||146
8103119|NCT03188120|19972747|P1|STARTED|Overall Study||193
8103120|NCT03188055|19972754|P6|NOT COMPLETED|Overall Study||0
8103121|NCT03188055|19972755|P5|NOT COMPLETED|Overall Study||0
8103122|NCT03188055|19972756|P4|NOT COMPLETED|Overall Study||12
8103123|NCT03188055|19972757|P3|NOT COMPLETED|Overall Study||19
8103124|NCT03188055|19972758|P2|NOT COMPLETED|Overall Study||19
8103125|NCT03188055|19972759|P1|NOT COMPLETED|Overall Study||0
8103126|NCT03188055|19972754|P6|COMPLETED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|0
8103127|NCT03188055|19972755|P5|COMPLETED|Overall Study||59
8103128|NCT03188055|19972756|P4|COMPLETED|Overall Study||26
8103129|NCT03188055|19972757|P3|COMPLETED|Overall Study||43
8103130|NCT03188055|19972758|P2|COMPLETED|Overall Study||29
8103131|NCT03188055|19972759|P1|COMPLETED|Overall Study||48
8103132|NCT03188055|19972754|P6|Family Survey 3|Overall Study||0
8103133|NCT03188055|19972755|P5|Family Survey 3|Overall Study||0
8103134|NCT03188055|19972756|P4|Family Survey 3|Overall Study||26
8103135|NCT03188055|19972757|P3|Family Survey 3|Overall Study||0
8103136|NCT03188055|19972758|P2|Family Survey 3|Overall Study||29
8103137|NCT03188055|19972759|P1|Family Survey 3|Overall Study||0
8103138|NCT03188055|19972754|P6|Family Survey 2|Overall Study||0
8103139|NCT03188055|19972755|P5|Family Survey 2|Overall Study||0
8103140|NCT03188055|19972756|P4|Family Survey 2|Overall Study||35
8103141|NCT03188055|19972757|P3|Family Survey 2|Overall Study||0
8103142|NCT03188055|19972758|P2|Family Survey 2|Overall Study||34
8103143|NCT03188055|19972759|P1|Family Survey 2|Overall Study||0
8103144|NCT03188055|19972754|P6|Family Survey 1|Overall Study||0
8103145|NCT03188055|19972755|P5|Family Survey 1|Overall Study||0
8103146|NCT03188055|19972756|P4|Family Survey 1|Overall Study||38
8103147|NCT03188055|19972757|P3|Family Survey 1|Overall Study||0
8103148|NCT03188055|19972758|P2|Family Survey 1|Overall Study||37
8103149|NCT03188055|19972759|P1|Family Survey 1|Overall Study||0
8103150|NCT03188055|19972754|P6|Nurse Survey 1|Overall Study||0
8103151|NCT03188055|19972755|P5|Nurse Survey 1|Overall Study||0
8103152|NCT03188055|19972756|P4|Nurse Survey 1|Overall Study||27
8103153|NCT03188055|19972757|P3|Nurse Survey 1|Overall Study||0
8103154|NCT03188055|19972758|P2|Nurse Survey 1|Overall Study||32
8103155|NCT03188055|19972759|P1|Nurse Survey 1|Overall Study||0
8103156|NCT03188055|19972754|P6|Patient Survey 1|Overall Study||0
8103157|NCT03188055|19972755|P5|Patient Survey 1|Overall Study||0
8103158|NCT03188055|19972756|P4|Patient Survey 1|Overall Study||13
8103159|NCT03188055|19972757|P3|Patient Survey 1|Overall Study||0
8103160|NCT03188055|19972758|P2|Patient Survey 1|Overall Study||16
8103161|NCT03188055|19972759|P1|Patient Survey 1|Overall Study||0
8103162|NCT03188055|19972754|P6|MDS Post-Intervention Survey Responses|Overall Study||134
8103163|NCT03188055|19972755|P5|MDS Post-Intervention Survey Responses|Overall Study||0
8103164|NCT03188055|19972756|P4|MDS Post-Intervention Survey Responses|Overall Study||0
8103165|NCT03188055|19972757|P3|MDS Post-Intervention Survey Responses|Overall Study||0
8103166|NCT03188055|19972758|P2|MDS Post-Intervention Survey Responses|Overall Study||0
8103167|NCT03188055|19972759|P1|MDS Post-Intervention Survey Responses|Overall Study||0
8103168|NCT03188055|19972754|P6|MDS Pre-Intervention Survey Responses|Overall Study||99
8103169|NCT03188055|19972755|P5|MDS Pre-Intervention Survey Responses|Overall Study||0
8103170|NCT03188055|19972756|P4|MDS Pre-Intervention Survey Responses|Overall Study||0
8103171|NCT03188055|19972757|P3|MDS Pre-Intervention Survey Responses|Overall Study||0
8103172|NCT03188055|19972758|P2|MDS Pre-Intervention Survey Responses|Overall Study||0
8103173|NCT03188055|19972759|P1|MDS Pre-Intervention Survey Responses|Overall Study||0
8103174|NCT03188055|19972754|P6|Patients Who Provided Self-Consent|Overall Study||0
8103175|NCT03188055|19972755|P5|Patients Who Provided Self-Consent|Overall Study||0
8103176|NCT03188055|19972756|P4|Patients Who Provided Self-Consent|Overall Study||19
8103177|NCT03188055|19972757|P3|Patients Who Provided Self-Consent|Overall Study||0
8103178|NCT03188055|19972758|P2|Patients Who Provided Self-Consent|Overall Study||24
8103179|NCT03188055|19972759|P1|Patients Who Provided Self-Consent|Overall Study||0
8103180|NCT03188055|19972754|P6|STARTED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|0
8103181|NCT03188055|19972755|P5|STARTED|Overall Study||59
8103182|NCT03188055|19972756|P4|STARTED|Overall Study|Family members consented (19/38 had patient enroll along with them as patient had DMC).|38
8103183|NCT03188055|19972757|P3|STARTED|Overall Study||62
8103184|NCT03188055|19972758|P2|STARTED|Overall Study|Family members consented (24/48 had patient enroll along with them as patient had DMC).|48
8103185|NCT03188055|19972759|P1|STARTED|Overall Study||48
8103186|NCT03187756|19972785|P1|NOT COMPLETED|Overall Study||4
8103187|NCT03187756|19972785|P1|COMPLETED|Overall Study||2
8103188|NCT03187756|19972785|P1|STARTED|Overall Study||6
8103189|NCT03187678|19972795|P1|NOT COMPLETED|Period 3 (Oral Selexipag)||0
8103190|NCT03187678|19972795|P1|COMPLETED|Period 3 (Oral Selexipag)||20
8103191|NCT03187678|19972795|P1|STARTED|Period 3 (Oral Selexipag)||20
8103192|NCT03187678|19972795|P1|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0
8103193|NCT03187678|19972795|P1|COMPLETED|Period 2 (Intravenous Selexipag)||20
8103194|NCT03187678|19972795|P1|STARTED|Period 2 (Intravenous Selexipag)||20
8103195|NCT03187678|19972795|P1|NOT COMPLETED|Period 1 (Oral Selexipag)||0
8103196|NCT03187678|19972795|P1|COMPLETED|Period 1 (Oral Selexipag)||20
8103197|NCT03187678|19972795|P1|STARTED|Period 1 (Oral Selexipag)||20
8103198|NCT03187301|19972803|P7|NOT COMPLETED|Third Intervention||0
8103199|NCT03187301|19972804|P6|NOT COMPLETED|Third Intervention||0
8103200|NCT03187301|19972805|P5|NOT COMPLETED|Third Intervention||0
8103201|NCT03187301|19972806|P4|NOT COMPLETED|Third Intervention||0
8103202|NCT03187301|19972807|P3|NOT COMPLETED|Third Intervention||0
8103203|NCT03187301|19972808|P2|NOT COMPLETED|Third Intervention||0
8103204|NCT03187301|19972809|P1|NOT COMPLETED|Third Intervention||0
8103205|NCT03187301|19972803|P7|COMPLETED|Third Intervention||0
8103206|NCT03187301|19972804|P6|COMPLETED|Third Intervention||7
8103207|NCT03187301|19972805|P5|COMPLETED|Third Intervention||7
8103208|NCT03187301|19972806|P4|COMPLETED|Third Intervention||6
8103209|NCT03187301|19972807|P3|COMPLETED|Third Intervention||7
8103210|NCT03187301|19972808|P2|COMPLETED|Third Intervention||7
8103211|NCT03187301|19972809|P1|COMPLETED|Third Intervention||6
8103212|NCT03187301|19972803|P7|STARTED|Third Intervention||0
8103213|NCT03187301|19972804|P6|STARTED|Third Intervention||7
8103214|NCT03187301|19972805|P5|STARTED|Third Intervention||7
8103215|NCT03187301|19972806|P4|STARTED|Third Intervention||6
8103216|NCT03187301|19972807|P3|STARTED|Third Intervention||7
8103217|NCT03187301|19972808|P2|STARTED|Third Intervention||7
8103218|NCT03187301|19972809|P1|STARTED|Third Intervention||6
8103219|NCT03187301|19972803|P7|NOT COMPLETED|Second Washout||0
8103220|NCT03187301|19972804|P6|NOT COMPLETED|Second Washout||0
8103221|NCT03187301|19972805|P5|NOT COMPLETED|Second Washout||0
8103222|NCT03187301|19972806|P4|NOT COMPLETED|Second Washout||0
8103223|NCT03187301|19972807|P3|NOT COMPLETED|Second Washout||0
8103224|NCT03187301|19972808|P2|NOT COMPLETED|Second Washout||0
8103225|NCT03187301|19972809|P1|NOT COMPLETED|Second Washout||0
8103226|NCT03187301|19972803|P7|COMPLETED|Second Washout||0
8103227|NCT03187301|19972804|P6|COMPLETED|Second Washout||7
8103228|NCT03187301|19972805|P5|COMPLETED|Second Washout||7
8103229|NCT03187301|19972806|P4|COMPLETED|Second Washout||6
8103230|NCT03187301|19972807|P3|COMPLETED|Second Washout||7
8103231|NCT03187301|19972808|P2|COMPLETED|Second Washout||7
8103232|NCT03187301|19972809|P1|COMPLETED|Second Washout||6
8103233|NCT03187301|19972803|P7|STARTED|Second Washout||0
8103234|NCT03187301|19972804|P6|STARTED|Second Washout||7
8103235|NCT03187301|19972805|P5|STARTED|Second Washout||7
8103236|NCT03187301|19972806|P4|STARTED|Second Washout||6
8103237|NCT03187301|19972807|P3|STARTED|Second Washout||7
8103238|NCT03187301|19972808|P2|STARTED|Second Washout||7
8103239|NCT03187301|19972809|P1|STARTED|Second Washout||6
8103240|NCT03187301|19972803|P7|NOT COMPLETED|Second Intervention||0
8103241|NCT03187301|19972804|P6|NOT COMPLETED|Second Intervention||0
8103242|NCT03187301|19972805|P5|NOT COMPLETED|Second Intervention||0
8103243|NCT03187301|19972806|P4|NOT COMPLETED|Second Intervention||0
8103244|NCT03187301|19972807|P3|NOT COMPLETED|Second Intervention||0
8103245|NCT03187301|19972808|P2|NOT COMPLETED|Second Intervention||0
8103246|NCT03187301|19972809|P1|NOT COMPLETED|Second Intervention||0
8103247|NCT03187301|19972803|P7|COMPLETED|Second Intervention||0
8103248|NCT03187301|19972804|P6|COMPLETED|Second Intervention||7
8103249|NCT03187301|19972805|P5|COMPLETED|Second Intervention||7
8103250|NCT03187301|19972806|P4|COMPLETED|Second Intervention||6
8103251|NCT03187301|19972807|P3|COMPLETED|Second Intervention||7
8103252|NCT03187301|19972808|P2|COMPLETED|Second Intervention||7
8103253|NCT03187301|19972809|P1|COMPLETED|Second Intervention||6
8103254|NCT03187301|19972803|P7|STARTED|Second Intervention||0
8103255|NCT03187301|19972804|P6|STARTED|Second Intervention||7
8103256|NCT03187301|19972805|P5|STARTED|Second Intervention||7
8103257|NCT03187301|19972806|P4|STARTED|Second Intervention||6
8103258|NCT03187301|19972807|P3|STARTED|Second Intervention||7
8103259|NCT03187301|19972808|P2|STARTED|Second Intervention||7
8103260|NCT03187301|19972809|P1|STARTED|Second Intervention||6
8103261|NCT03187301|19972803|P7|NOT COMPLETED|First Washout||0
8103262|NCT03187301|19972804|P6|NOT COMPLETED|First Washout||0
8103263|NCT03187301|19972805|P5|NOT COMPLETED|First Washout||0
8103264|NCT03187301|19972806|P4|NOT COMPLETED|First Washout||0
8103265|NCT03187301|19972807|P3|NOT COMPLETED|First Washout||0
8103266|NCT03187301|19972808|P2|NOT COMPLETED|First Washout||0
8103267|NCT03187301|19972809|P1|NOT COMPLETED|First Washout||0
8103268|NCT03187301|19972803|P7|COMPLETED|First Washout||0
8103269|NCT03187301|19972804|P6|COMPLETED|First Washout||7
8103270|NCT03187301|19972805|P5|COMPLETED|First Washout||7
8103271|NCT03187301|19972806|P4|COMPLETED|First Washout||6
8103272|NCT03187301|19972807|P3|COMPLETED|First Washout||7
8103273|NCT03187301|19972808|P2|COMPLETED|First Washout||7
8103274|NCT03187301|19972809|P1|COMPLETED|First Washout||6
8103275|NCT03187301|19972803|P7|STARTED|First Washout||0
8103276|NCT03187301|19972804|P6|STARTED|First Washout||7
8103277|NCT03187301|19972805|P5|STARTED|First Washout||7
8103278|NCT03187301|19972806|P4|STARTED|First Washout||6
8103279|NCT03187301|19972807|P3|STARTED|First Washout||7
8103280|NCT03187301|19972808|P2|STARTED|First Washout||7
8103281|NCT03187301|19972809|P1|STARTED|First Washout||6
8103282|NCT03187301|19972803|P7|NOT COMPLETED|First Intervention||0
8103283|NCT03187301|19972804|P6|NOT COMPLETED|First Intervention||0
8103284|NCT03187301|19972805|P5|NOT COMPLETED|First Intervention||0
8103285|NCT03187301|19972806|P4|NOT COMPLETED|First Intervention||0
8103286|NCT03187301|19972807|P3|NOT COMPLETED|First Intervention||0
8103287|NCT03187301|19972808|P2|NOT COMPLETED|First Intervention||0
8103288|NCT03187301|19972809|P1|NOT COMPLETED|First Intervention||0
8103289|NCT03187301|19972803|P7|COMPLETED|First Intervention||0
8103290|NCT03187301|19972804|P6|COMPLETED|First Intervention||7
8103291|NCT03187301|19972805|P5|COMPLETED|First Intervention||7
8103292|NCT03187301|19972806|P4|COMPLETED|First Intervention||6
8103293|NCT03187301|19972807|P3|COMPLETED|First Intervention||7
8103294|NCT03187301|19972808|P2|COMPLETED|First Intervention||7
8103295|NCT03187301|19972809|P1|COMPLETED|First Intervention||6
8103296|NCT03187301|19972803|P7|STARTED|First Intervention||0
8103297|NCT03187301|19972804|P6|STARTED|First Intervention||7
8103298|NCT03187301|19972805|P5|STARTED|First Intervention||7
8103299|NCT03187301|19972806|P4|STARTED|First Intervention||6
8103300|NCT03187301|19972807|P3|STARTED|First Intervention||7
8103301|NCT03187301|19972808|P2|STARTED|First Intervention||7
8103302|NCT03187301|19972809|P1|STARTED|First Intervention||6
8103303|NCT03187301|19972803|P7|NOT COMPLETED|Pre-Intervention||0
8103304|NCT03187301|19972804|P6|NOT COMPLETED|Pre-Intervention||0
8103305|NCT03187301|19972805|P5|NOT COMPLETED|Pre-Intervention||0
8103306|NCT03187301|19972806|P4|NOT COMPLETED|Pre-Intervention||0
8103307|NCT03187301|19972807|P3|NOT COMPLETED|Pre-Intervention||0
8103308|NCT03187301|19972808|P2|NOT COMPLETED|Pre-Intervention||0
8103309|NCT03187301|19972809|P1|NOT COMPLETED|Pre-Intervention||1
8103310|NCT03187301|19972803|P7|COMPLETED|Pre-Intervention||0
8103311|NCT03187301|19972804|P6|COMPLETED|Pre-Intervention||7
8103312|NCT03187301|19972805|P5|COMPLETED|Pre-Intervention||7
8103313|NCT03187301|19972806|P4|COMPLETED|Pre-Intervention||6
8103314|NCT03187301|19972807|P3|COMPLETED|Pre-Intervention||7
8103315|NCT03187301|19972808|P2|COMPLETED|Pre-Intervention||7
8103316|NCT03187301|19972809|P1|COMPLETED|Pre-Intervention||6
8103317|NCT03187301|19972803|P7|STARTED|Pre-Intervention||0
8103318|NCT03187301|19972804|P6|STARTED|Pre-Intervention||7
8103319|NCT03187301|19972805|P5|STARTED|Pre-Intervention||7
8103320|NCT03187301|19972806|P4|STARTED|Pre-Intervention||6
8103321|NCT03187301|19972807|P3|STARTED|Pre-Intervention||7
8103322|NCT03187301|19972808|P2|STARTED|Pre-Intervention||7
8103323|NCT03187301|19972809|P1|STARTED|Pre-Intervention||7
8103324|NCT03187301|19972803|P7|NOT COMPLETED|Titration Period||7
8103325|NCT03187301|19972804|P6|NOT COMPLETED|Titration Period||0
8103326|NCT03187301|19972805|P5|NOT COMPLETED|Titration Period||0
8103327|NCT03187301|19972806|P4|NOT COMPLETED|Titration Period||0
8103328|NCT03187301|19972807|P3|NOT COMPLETED|Titration Period||0
8103329|NCT03187301|19972808|P2|NOT COMPLETED|Titration Period||0
8103330|NCT03187301|19972809|P1|NOT COMPLETED|Titration Period||0
8103331|NCT03187301|19972803|P7|COMPLETED|Titration Period||0
8103332|NCT03187301|19972804|P6|COMPLETED|Titration Period||7
8103333|NCT03187301|19972805|P5|COMPLETED|Titration Period||7
8103334|NCT03187301|19972806|P4|COMPLETED|Titration Period||6
8103335|NCT03187301|19972807|P3|COMPLETED|Titration Period||7
8103336|NCT03187301|19972808|P2|COMPLETED|Titration Period||7
8103337|NCT03187301|19972809|P1|COMPLETED|Titration Period||7
8103338|NCT03187301|19972803|P7|STARTED|Titration Period||7
8103339|NCT03187301|19972804|P6|STARTED|Titration Period||7
8103340|NCT03187301|19972805|P5|STARTED|Titration Period||7
8103341|NCT03187301|19972806|P4|STARTED|Titration Period||6
8103342|NCT03187301|19972807|P3|STARTED|Titration Period||7
8103343|NCT03187301|19972808|P2|STARTED|Titration Period||7
8103344|NCT03187301|19972809|P1|STARTED|Titration Period||7
8103345|NCT03187197|19972861|P3|NOT COMPLETED|Overall Study||23
8103346|NCT03187197|19972862|P2|NOT COMPLETED|Overall Study||393
8103347|NCT03187197|19972863|P1|NOT COMPLETED|Overall Study||46
8103348|NCT03187197|19972861|P3|COMPLETED|Overall Study||32
8103349|NCT03187197|19972862|P2|COMPLETED|Overall Study||704
8103350|NCT03187197|19972863|P1|COMPLETED|Overall Study||107
8103351|NCT03187197|19972861|P3|Started (Eligible Participants as FAS)|Overall Study||54
8103352|NCT03187197|19972862|P2|Started (Eligible Participants as FAS)|Overall Study||1052
8103353|NCT03187197|19972863|P1|Started (Eligible Participants as FAS)|Overall Study||139
8103354|NCT03187197|19972861|P3|STARTED|Overall Study||55
8103355|NCT03187197|19972862|P2|STARTED|Overall Study||1097
8103356|NCT03187197|19972863|P1|STARTED|Overall Study||153
8103357|NCT03187002|19972876|P2|NOT COMPLETED|Overall Study||0
8103358|NCT03187002|19972877|P1|NOT COMPLETED|Overall Study||0
8103359|NCT03187002|19972876|P2|COMPLETED|Overall Study||54
8103360|NCT03187002|19972877|P1|COMPLETED|Overall Study||55
8103361|NCT03187002|19972876|P2|STARTED|Overall Study||54
8103362|NCT03187002|19972877|P1|STARTED|Overall Study||55
8103393|NCT03186677|19972977|P5|NOT COMPLETED|Period 2||0
8103394|NCT03186677|19972978|P4|NOT COMPLETED|Period 2||0
8103395|NCT03186677|19972979|P3|NOT COMPLETED|Period 2||0
8103396|NCT03186677|19972980|P2|NOT COMPLETED|Period 2||0
8103397|NCT03186677|19972981|P1|NOT COMPLETED|Period 2||0
8103398|NCT03186677|19972977|P5|COMPLETED|Period 2||2
8103399|NCT03186677|19972978|P4|COMPLETED|Period 2||5
8103400|NCT03186677|19972979|P3|COMPLETED|Period 2||0
8103401|NCT03186677|19972980|P2|COMPLETED|Period 2||0
8103402|NCT03186677|19972981|P1|COMPLETED|Period 2||0
8103403|NCT03186677|19972977|P5|STARTED|Period 2||2
8103404|NCT03186677|19972978|P4|STARTED|Period 2||5
8103405|NCT03186677|19972979|P3|STARTED|Period 2||0
8103406|NCT03186677|19972980|P2|STARTED|Period 2||0
8103407|NCT03186677|19972981|P1|STARTED|Period 2||0
8103408|NCT03186677|19972977|P5|NOT COMPLETED|Period 1||0
8103409|NCT03186677|19972978|P4|NOT COMPLETED|Period 1||0
8103410|NCT03186677|19972979|P3|NOT COMPLETED|Period 1||0
8103411|NCT03186677|19972980|P2|NOT COMPLETED|Period 1||0
8103412|NCT03186677|19972981|P1|NOT COMPLETED|Period 1||0
8103413|NCT03186677|19972977|P5|COMPLETED|Period 1||0
8103414|NCT03186677|19972978|P4|COMPLETED|Period 1||0
8103415|NCT03186677|19972979|P3|COMPLETED|Period 1||3
8103416|NCT03186677|19972980|P2|COMPLETED|Period 1||3
8103417|NCT03186677|19972981|P1|COMPLETED|Period 1||3
8103418|NCT03186677|19972977|P5|STARTED|Period 1||0
8103419|NCT03186677|19972978|P4|STARTED|Period 1||0
8103420|NCT03186677|19972979|P3|STARTED|Period 1||3
8103421|NCT03186677|19972980|P2|STARTED|Period 1||3
8103422|NCT03186677|19972981|P1|STARTED|Period 1||3
8103423|NCT03185481|19973003|P1|NOT COMPLETED|Overall Study||5
8103424|NCT03185481|19973003|P1|COMPLETED|Overall Study||0
8103425|NCT03185481|19973003|P1|STARTED|Overall Study||5
8103426|NCT03185455|19973022|P2|NOT COMPLETED|Overall Study||0
8103427|NCT03185455|19973023|P1|NOT COMPLETED|Overall Study||0
8103428|NCT03185455|19973022|P2|COMPLETED|Overall Study||103
8103429|NCT03185455|19973023|P1|COMPLETED|Overall Study||103
8103430|NCT03185455|19973022|P2|STARTED|Overall Study||103
8103431|NCT03185455|19973023|P1|STARTED|Overall Study||103
8103432|NCT03185182|19973037|P1|NOT COMPLETED|Overall Study||0
8103433|NCT03185182|19973037|P1|COMPLETED|Overall Study||5
8103434|NCT03185182|19973037|P1|STARTED|Overall Study||5
8103435|NCT03185065|19973046|P4|NOT COMPLETED|Period 4 (6 Weeks)||1
8103436|NCT03185065|19973047|P3|NOT COMPLETED|Period 4 (6 Weeks)||1
8103437|NCT03185065|19973048|P2|NOT COMPLETED|Period 4 (6 Weeks)||1
8103438|NCT03185065|19973049|P1|NOT COMPLETED|Period 4 (6 Weeks)||0
8103439|NCT03185065|19973046|P4|COMPLETED|Period 4 (6 Weeks)||31
8103440|NCT03185065|19973047|P3|COMPLETED|Period 4 (6 Weeks)||26
8103441|NCT03185065|19973048|P2|COMPLETED|Period 4 (6 Weeks)||27
8103442|NCT03185065|19973049|P1|COMPLETED|Period 4 (6 Weeks)||31
8103443|NCT03185065|19973046|P4|STARTED|Period 4 (6 Weeks)||32
8103444|NCT03185065|19973047|P3|STARTED|Period 4 (6 Weeks)||27
8103445|NCT03185065|19973048|P2|STARTED|Period 4 (6 Weeks)||28
8103446|NCT03185065|19973049|P1|STARTED|Period 4 (6 Weeks)||31
8103447|NCT03185065|19973046|P4|NOT COMPLETED|Washout (2 Weeks)||0
8103448|NCT03185065|19973047|P3|NOT COMPLETED|Washout (2 Weeks)||2
8103449|NCT03185065|19973048|P2|NOT COMPLETED|Washout (2 Weeks)||1
8103450|NCT03185065|19973049|P1|NOT COMPLETED|Washout (2 Weeks)||0
8103451|NCT03185065|19973046|P4|COMPLETED|Washout (2 Weeks)||32
8103452|NCT03185065|19973047|P3|COMPLETED|Washout (2 Weeks)||27
8103453|NCT03185065|19973048|P2|COMPLETED|Washout (2 Weeks)||28
8103454|NCT03185065|19973049|P1|COMPLETED|Washout (2 Weeks)||31
8103455|NCT03185065|19973046|P4|STARTED|Washout (2 Weeks)||32
8103456|NCT03185065|19973047|P3|STARTED|Washout (2 Weeks)||29
8103457|NCT03185065|19973048|P2|STARTED|Washout (2 Weeks)||29
8103458|NCT03185065|19973049|P1|STARTED|Washout (2 Weeks)||31
8103459|NCT03185065|19973046|P4|NOT COMPLETED|Period 3 (6 Weeks)||0
8103460|NCT03185065|19973047|P3|NOT COMPLETED|Period 3 (6 Weeks)||2
8103461|NCT03185065|19973048|P2|NOT COMPLETED|Period 3 (6 Weeks)||0
8103462|NCT03185065|19973049|P1|NOT COMPLETED|Period 3 (6 Weeks)||0
8103463|NCT03185065|19973046|P4|COMPLETED|Period 3 (6 Weeks)||32
8103464|NCT03185065|19973047|P3|COMPLETED|Period 3 (6 Weeks)||29
8103465|NCT03185065|19973048|P2|COMPLETED|Period 3 (6 Weeks)||29
8103466|NCT03185065|19973049|P1|COMPLETED|Period 3 (6 Weeks)||31
8103467|NCT03185065|19973046|P4|STARTED|Period 3 (6 Weeks)||32
8103468|NCT03185065|19973047|P3|STARTED|Period 3 (6 Weeks)||31
8103469|NCT03185065|19973048|P2|STARTED|Period 3 (6 Weeks)||29
8103470|NCT03185065|19973049|P1|STARTED|Period 3 (6 Weeks)||31
8103471|NCT03185065|19973046|P4|NOT COMPLETED|Washout (2 Weeks)||2
8103472|NCT03185065|19973047|P3|NOT COMPLETED|Washout (2 Weeks)||1
8103473|NCT03185065|19973048|P2|NOT COMPLETED|Washout (2 Weeks)||2
8103474|NCT03185065|19973049|P1|NOT COMPLETED|Washout (2 Weeks)||1
8103475|NCT03185065|19973046|P4|COMPLETED|Washout (2 Weeks)||32
8103476|NCT03185065|19973047|P3|COMPLETED|Washout (2 Weeks)||31
8103477|NCT03185065|19973048|P2|COMPLETED|Washout (2 Weeks)||29
8103478|NCT03185065|19973049|P1|COMPLETED|Washout (2 Weeks)||31
8103479|NCT03185065|19973046|P4|STARTED|Washout (2 Weeks)||34
8103480|NCT03185065|19973047|P3|STARTED|Washout (2 Weeks)||32
8103481|NCT03185065|19973048|P2|STARTED|Washout (2 Weeks)||31
8103482|NCT03185065|19973049|P1|STARTED|Washout (2 Weeks)||32
8103483|NCT03185065|19973046|P4|NOT COMPLETED|Period 2 (6 Weeks)||1
8103484|NCT03185065|19973047|P3|NOT COMPLETED|Period 2 (6 Weeks)||0
8103485|NCT03185065|19973048|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
8103486|NCT03185065|19973049|P1|NOT COMPLETED|Period 2 (6 Weeks)||0
8103487|NCT03185065|19973046|P4|COMPLETED|Period 2 (6 Weeks)||34
8103488|NCT03185065|19973047|P3|COMPLETED|Period 2 (6 Weeks)||32
8103489|NCT03185065|19973048|P2|COMPLETED|Period 2 (6 Weeks)||31
8103490|NCT03185065|19973049|P1|COMPLETED|Period 2 (6 Weeks)||32
8103491|NCT03185065|19973046|P4|STARTED|Period 2 (6 Weeks)||35
8103492|NCT03185065|19973047|P3|STARTED|Period 2 (6 Weeks)||32
8103493|NCT03185065|19973048|P2|STARTED|Period 2 (6 Weeks)||31
8103494|NCT03185065|19973049|P1|STARTED|Period 2 (6 Weeks)||32
8103495|NCT03185065|19973046|P4|NOT COMPLETED|Washout (2 Weeks)||1
8103496|NCT03185065|19973047|P3|NOT COMPLETED|Washout (2 Weeks)||0
8103497|NCT03185065|19973048|P2|NOT COMPLETED|Washout (2 Weeks)||2
8103498|NCT03185065|19973049|P1|NOT COMPLETED|Washout (2 Weeks)||0
8103499|NCT03185065|19973046|P4|COMPLETED|Washout (2 Weeks)||35
8103500|NCT03185065|19973047|P3|COMPLETED|Washout (2 Weeks)||32
8103501|NCT03185065|19973048|P2|COMPLETED|Washout (2 Weeks)||31
8103502|NCT03185065|19973049|P1|COMPLETED|Washout (2 Weeks)||32
8103503|NCT03185065|19973046|P4|STARTED|Washout (2 Weeks)||36
8103504|NCT03185065|19973047|P3|STARTED|Washout (2 Weeks)||32
8103505|NCT03185065|19973048|P2|STARTED|Washout (2 Weeks)||33
8103506|NCT03185065|19973049|P1|STARTED|Washout (2 Weeks)||32
8103507|NCT03185065|19973046|P4|NOT COMPLETED|Period 1 (6 Weeks)||1
8103508|NCT03185065|19973047|P3|NOT COMPLETED|Period 1 (6 Weeks)||3
8103509|NCT03185065|19973048|P2|NOT COMPLETED|Period 1 (6 Weeks)||1
8103510|NCT03185065|19973049|P1|NOT COMPLETED|Period 1 (6 Weeks)||3
8103511|NCT03185065|19973046|P4|COMPLETED|Period 1 (6 Weeks)||36
8103512|NCT03185065|19973047|P3|COMPLETED|Period 1 (6 Weeks)||32
8103513|NCT03185065|19973048|P2|COMPLETED|Period 1 (6 Weeks)||33
8103514|NCT03185065|19973049|P1|COMPLETED|Period 1 (6 Weeks)||32
8103515|NCT03185065|19973046|P4|STARTED|Period 1 (6 Weeks)||37
8103516|NCT03185065|19973047|P3|STARTED|Period 1 (6 Weeks)||35
8103517|NCT03185065|19973048|P2|STARTED|Period 1 (6 Weeks)||34
8103518|NCT03185065|19973049|P1|STARTED|Period 1 (6 Weeks)||35
8103519|NCT03184987|19973074|P3|NOT COMPLETED|Overall Study||4
8103520|NCT03184987|19973075|P2|NOT COMPLETED|Overall Study||1
8103521|NCT03184987|19973076|P1|NOT COMPLETED|Overall Study||1
8103522|NCT03184987|19973074|P3|COMPLETED|Overall Study||51
8103523|NCT03184987|19973075|P2|COMPLETED|Overall Study||8
8103524|NCT03184987|19973076|P1|COMPLETED|Overall Study||46
8103525|NCT03184987|19973074|P3|STARTED|Overall Study||55
8103526|NCT03184987|19973075|P2|STARTED|Overall Study||9
8103527|NCT03184987|19973076|P1|STARTED|Overall Study||47
8103528|NCT03184701|19973141|P1|NOT COMPLETED|Overall Study||17
8103529|NCT03184701|19973141|P1|COMPLETED|Overall Study||28
8103530|NCT03184701|19973141|P1|STARTED|Overall Study||45
8103531|NCT03184519|19973145|P1|NOT COMPLETED|Overall Study||27
8103532|NCT03184519|19973145|P1|COMPLETED|Overall Study||129
8103533|NCT03184519|19973145|P1|STARTED|Overall Study||156
8103534|NCT03184441|19973149|P1|NOT COMPLETED|Overall Study||1
8103535|NCT03184441|19973149|P1|COMPLETED|Overall Study|Last subject completed study|10
8103536|NCT03184441|19973149|P1|STARTED|Overall Study||11
8103537|NCT03184428|19973157|P1|NOT COMPLETED|Overall Study||822
8103538|NCT03184428|19973157|P1|COMPLETED|Overall Study||2963
8103539|NCT03184428|19973157|P1|STARTED|Overall Study||3785
8103540|NCT03184077|19973175|P2|NOT COMPLETED|Overall Study||21
8103541|NCT03184077|19973176|P1|NOT COMPLETED|Overall Study||21
8103542|NCT03184077|19973175|P2|COMPLETED|Overall Study||131
8103543|NCT03184077|19973176|P1|COMPLETED|Overall Study||145
8103544|NCT03184077|19973175|P2|STARTED|Overall Study||152
8103545|NCT03184077|19973176|P1|STARTED|Overall Study||166
8103546|NCT03183869|19973188|P2|NOT COMPLETED|Overall Study||5
8103547|NCT03183869|19973189|P1|NOT COMPLETED|Overall Study||4
8103548|NCT03183869|19973188|P2|COMPLETED|Overall Study||2
8103549|NCT03183869|19973189|P1|COMPLETED|Overall Study||0
8103550|NCT03183869|19973188|P2|STARTED|Overall Study||7
8103551|NCT03183869|19973189|P1|STARTED|Overall Study||4
8103552|NCT03183518|19973195|P1|NOT COMPLETED|Overall Study||3
8103553|NCT03183518|19973195|P1|COMPLETED|Overall Study||33
8103554|NCT03183518|19973195|P1|Negative Control|Overall Study||36
8103555|NCT03183518|19973195|P1|Test Product|Overall Study||36
8103556|NCT03183518|19973195|P1|STARTED|Overall Study||36
8103557|NCT03183063|19973229|P3|NOT COMPLETED|Overall Study||4
8103558|NCT03183063|19973230|P2|NOT COMPLETED|Overall Study||4
8103559|NCT03183063|19973231|P1|NOT COMPLETED|Overall Study||5
8103560|NCT03183063|19973229|P3|COMPLETED|Overall Study||111
8103561|NCT03183063|19973230|P2|COMPLETED|Overall Study||0
8103562|NCT03183063|19973231|P1|COMPLETED|Overall Study||15
8103563|NCT03183063|19973229|P3|STARTED|Overall Study||115
8103564|NCT03183063|19973230|P2|STARTED|Overall Study||4
8103565|NCT03183063|19973231|P1|STARTED|Overall Study||20
8103566|NCT03182933|19973256|P2|NOT COMPLETED|Overall Study||0
8103567|NCT03182933|19973257|P1|NOT COMPLETED|Overall Study||1
8103568|NCT03182933|19973256|P2|COMPLETED|Overall Study||32
8103569|NCT03182933|19973257|P1|COMPLETED|Overall Study||31
8103570|NCT03182933|19973256|P2|STARTED|Overall Study||32
8103571|NCT03182933|19973257|P1|STARTED|Overall Study||32
8103572|NCT03182920|19973273|P3|NOT COMPLETED|Period 2||0
8103573|NCT03182920|19973274|P2|NOT COMPLETED|Period 2||0
8103574|NCT03182920|19973275|P1|NOT COMPLETED|Period 2||0
8103575|NCT03182920|19973273|P3|COMPLETED|Period 2||0
8103576|NCT03182920|19973274|P2|COMPLETED|Period 2||9
8103577|NCT03182920|19973275|P1|COMPLETED|Period 2||9
8103578|NCT03182920|19973273|P3|STARTED|Period 2|Young participants on Lasmiditan did not move to study period 2.|0
8103579|NCT03182920|19973274|P2|STARTED|Period 2||9
8103580|NCT03182920|19973275|P1|STARTED|Period 2||9
8103581|NCT03182920|19973273|P3|NOT COMPLETED|Washout Period||0
8103582|NCT03182920|19973274|P2|NOT COMPLETED|Washout Period||0
8103583|NCT03182920|19973275|P1|NOT COMPLETED|Washout Period||0
8103584|NCT03182920|19973273|P3|COMPLETED|Washout Period||0
8103585|NCT03182920|19973274|P2|COMPLETED|Washout Period||9
8103586|NCT03182920|19973275|P1|COMPLETED|Washout Period||9
8103587|NCT03182920|19973273|P3|STARTED|Washout Period||0
8103588|NCT03182920|19973274|P2|STARTED|Washout Period||9
8103589|NCT03182920|19973275|P1|STARTED|Washout Period||9
8103590|NCT03182920|19973273|P3|NOT COMPLETED|Period 1||0
8103591|NCT03182920|19973274|P2|NOT COMPLETED|Period 1||0
8103592|NCT03182920|19973275|P1|NOT COMPLETED|Period 1||0
8103593|NCT03182920|19973273|P3|COMPLETED|Period 1||17
8103594|NCT03182920|19973274|P2|COMPLETED|Period 1||9
8103595|NCT03182920|19973275|P1|COMPLETED|Period 1||9
8103596|NCT03182920|19973273|P3|STARTED|Period 1||17
8103597|NCT03182920|19973274|P2|STARTED|Period 1||9
8103598|NCT03182920|19973275|P1|STARTED|Period 1||9
8103599|NCT03182738|19973286|P2|NOT COMPLETED|Overall Study||5
8103600|NCT03182738|19973287|P1|NOT COMPLETED|Overall Study||9
8103601|NCT03182738|19973286|P2|COMPLETED|Overall Study||45
8103602|NCT03182738|19973287|P1|COMPLETED|Overall Study||41
8103603|NCT03182738|19973286|P2|STARTED|Overall Study||50
8103604|NCT03182738|19973287|P1|STARTED|Overall Study||50
8103605|NCT03182582|19973301|P2|NOT COMPLETED|Treatment 2||0
8103606|NCT03182582|19973302|P1|NOT COMPLETED|Treatment 2||0
8103607|NCT03182582|19973301|P2|COMPLETED|Treatment 2||10
8103608|NCT03182582|19973302|P1|COMPLETED|Treatment 2||12
8103609|NCT03182582|19973301|P2|STARTED|Treatment 2||10
8103610|NCT03182582|19973302|P1|STARTED|Treatment 2||12
8103611|NCT03182582|19973301|P2|NOT COMPLETED|Treatment 1||0
8103612|NCT03182582|19973302|P1|NOT COMPLETED|Treatment 1||0
8103613|NCT03182582|19973301|P2|COMPLETED|Treatment 1||10
8103614|NCT03182582|19973302|P1|COMPLETED|Treatment 1||12
8103615|NCT03182582|19973301|P2|STARTED|Treatment 1||10
8103616|NCT03182582|19973302|P1|STARTED|Treatment 1||12
8103617|NCT03181724|19973319|P2|NOT COMPLETED|Overall Study||0
8103618|NCT03181724|19973320|P1|NOT COMPLETED|Overall Study||0
8103619|NCT03181724|19973319|P2|COMPLETED|Overall Study||45
8103620|NCT03181724|19973320|P1|COMPLETED|Overall Study||45
8103621|NCT03181724|19973319|P2|STARTED|Overall Study||45
8103622|NCT03181724|19973320|P1|STARTED|Overall Study||45
8103628|NCT03181503|19973344|P2|NOT COMPLETED|Overall Study||3
8103629|NCT03181503|19973345|P1|NOT COMPLETED|Overall Study||7
8103630|NCT03181503|19973344|P2|COMPLETED|Overall Study||31
8103631|NCT03181503|19973345|P1|COMPLETED|Overall Study||29
8103632|NCT03181503|19973344|P2|Treated|Overall Study||34
8103633|NCT03181503|19973345|P1|Treated|Overall Study||36
8103634|NCT03181503|19973344|P2|STARTED|Overall Study||34
8103635|NCT03181503|19973345|P1|STARTED|Overall Study||36
8103636|NCT03181451|19973384|P3|NOT COMPLETED|Overall Study||0
8103637|NCT03181451|19973385|P2|NOT COMPLETED|Overall Study||2
8103638|NCT03181451|19973386|P1|NOT COMPLETED|Overall Study||0
8103639|NCT03181451|19973384|P3|COMPLETED|Overall Study||12
8103640|NCT03181451|19973385|P2|COMPLETED|Overall Study||11
8103641|NCT03181451|19973386|P1|COMPLETED|Overall Study||12
8103642|NCT03181451|19973384|P3|STARTED|Overall Study||12
8103643|NCT03181451|19973385|P2|STARTED|Overall Study||13
8103644|NCT03181451|19973386|P1|STARTED|Overall Study||12
8103645|NCT03181308|19973546|P2|NOT COMPLETED|Overall Study||0
8103646|NCT03181308|19973547|P1|NOT COMPLETED|Overall Study||0
8103647|NCT03181308|19973546|P2|COMPLETED|Overall Study||8
8103648|NCT03181308|19973547|P1|COMPLETED|Overall Study||3
8103649|NCT03181308|19973546|P2|STARTED|Overall Study||8
8103650|NCT03181308|19973547|P1|STARTED|Overall Study||3
8103651|NCT03181009|19973563|P2|NOT COMPLETED|Overall Study||2
8103652|NCT03181009|19973564|P1|NOT COMPLETED|Overall Study||0
8103653|NCT03181009|19973563|P2|COMPLETED|Overall Study||28
8103654|NCT03181009|19973564|P1|COMPLETED|Overall Study||30
8103655|NCT03181009|19973563|P2|STARTED|Overall Study||30
8103656|NCT03181009|19973564|P1|STARTED|Overall Study||30
8103657|NCT03180801|19973573|P3|NOT COMPLETED|Overall Study||10
8103658|NCT03180801|19973574|P2|NOT COMPLETED|Overall Study||12
8103659|NCT03180801|19973575|P1|NOT COMPLETED|Overall Study||8
8103660|NCT03180801|19973573|P3|COMPLETED|Overall Study||41
8103661|NCT03180801|19973574|P2|COMPLETED|Overall Study||40
8103662|NCT03180801|19973575|P1|COMPLETED|Overall Study||42
8103663|NCT03180801|19973573|P3|Intention to Treat|Overall Study||41
8103664|NCT03180801|19973574|P2|Intention to Treat|Overall Study||40
8103665|NCT03180801|19973575|P1|Intention to Treat|Overall Study||42
8103666|NCT03180801|19973573|P3|Safety Population|Overall Study||51
8103667|NCT03180801|19973574|P2|Safety Population|Overall Study||52
8103668|NCT03180801|19973575|P1|Safety Population|Overall Study||50
8103669|NCT03180801|19973573|P3|STARTED|Overall Study||51
8103670|NCT03180801|19973574|P2|STARTED|Overall Study||52
8103671|NCT03180801|19973575|P1|STARTED|Overall Study||50
8103672|NCT03180645|19973619|P3|NOT COMPLETED|Overall Study||2
8103673|NCT03180645|19973620|P2|NOT COMPLETED|Overall Study||1
8103674|NCT03180645|19973621|P1|NOT COMPLETED|Overall Study||0
8103675|NCT03180645|19973619|P3|COMPLETED|Overall Study||22
8103676|NCT03180645|19973620|P2|COMPLETED|Overall Study||23
8103677|NCT03180645|19973621|P1|COMPLETED|Overall Study||24
8103678|NCT03180645|19973619|P3|STARTED|Overall Study||24
8103679|NCT03180645|19973620|P2|STARTED|Overall Study||24
8103680|NCT03180645|19973621|P1|STARTED|Overall Study||24
8103693|NCT03180515|19973766|P1|NOT COMPLETED|Aim 3||0
8103694|NCT03180515|19973766|P1|COMPLETED|Aim 3||1
8103695|NCT03180515|19973766|P1|STARTED|Aim 3||1
8103696|NCT03180515|19973766|P1|NOT COMPLETED|Aim 2||0
8103697|NCT03180515|19973766|P1|COMPLETED|Aim 2||12
8103698|NCT03180515|19973766|P1|STARTED|Aim 2||12
8103699|NCT03180515|19973766|P1|NOT COMPLETED|Aim 1||0
8103700|NCT03180515|19973766|P1|COMPLETED|Aim 1||12
8103701|NCT03180515|19973766|P1|STARTED|Aim 1||12
8103702|NCT03180489|19973811|P2|NOT COMPLETED|Overall Study||4
8103703|NCT03180489|19973812|P1|NOT COMPLETED|Overall Study||8
8103704|NCT03180489|19973811|P2|COMPLETED|Overall Study||25
8103705|NCT03180489|19973812|P1|COMPLETED|Overall Study||25
8103706|NCT03180489|19973811|P2|STARTED|Overall Study||29
8103707|NCT03180489|19973812|P1|STARTED|Overall Study||33
8103708|NCT03180385|19973844|P2|NOT COMPLETED|Overall Study||0
8103709|NCT03180385|19973845|P1|NOT COMPLETED|Overall Study||0
8103710|NCT03180385|19973844|P2|COMPLETED|Overall Study||2
8103711|NCT03180385|19973845|P1|COMPLETED|Overall Study||0
8103712|NCT03180385|19973844|P2|STARTED|Overall Study||2
8103713|NCT03180385|19973845|P1|STARTED|Overall Study||0
8103714|NCT03180138|19973872|P3|NOT COMPLETED|Overall Study||24
8103715|NCT03180138|19973873|P2|NOT COMPLETED|Overall Study||13
8103716|NCT03180138|19973874|P1|NOT COMPLETED|Overall Study||22
8103717|NCT03180138|19973872|P3|COMPLETED|Overall Study||179
8103718|NCT03180138|19973873|P2|COMPLETED|Overall Study||188
8103719|NCT03180138|19973874|P1|COMPLETED|Overall Study||182
8103720|NCT03180138|19973872|P3|STARTED|Overall Study||203
8103721|NCT03180138|19973873|P2|STARTED|Overall Study||201
8103722|NCT03180138|19973874|P1|STARTED|Overall Study||204
8103723|NCT03179891|19973885|P2|NOT COMPLETED|Second Intervention (After 14 Days)||0
8103724|NCT03179891|19973886|P1|NOT COMPLETED|Second Intervention (After 14 Days)||0
8103725|NCT03179891|19973885|P2|COMPLETED|Second Intervention (After 14 Days)||20
8103726|NCT03179891|19973886|P1|COMPLETED|Second Intervention (After 14 Days)||11
8103727|NCT03179891|19973885|P2|STARTED|Second Intervention (After 14 Days)||20
8103728|NCT03179891|19973886|P1|STARTED|Second Intervention (After 14 Days)||11
8103729|NCT03179891|19973885|P2|NOT COMPLETED|First Intervention||2
8103730|NCT03179891|19973886|P1|NOT COMPLETED|First Intervention||2
8103731|NCT03179891|19973885|P2|COMPLETED|First Intervention||20
8103732|NCT03179891|19973886|P1|COMPLETED|First Intervention||11
8103733|NCT03179891|19973885|P2|STARTED|First Intervention||22
8103734|NCT03179891|19973886|P1|STARTED|First Intervention||13
8103735|NCT03179345|19973910|P4|NOT COMPLETED|Overall Study||2
8103736|NCT03179345|19973911|P3|NOT COMPLETED|Overall Study||1
8103737|NCT03179345|19973912|P2|NOT COMPLETED|Overall Study||1
8103738|NCT03179345|19973913|P1|NOT COMPLETED|Overall Study||0
8103739|NCT03179345|19973910|P4|COMPLETED|Overall Study||6
8103740|NCT03179345|19973911|P3|COMPLETED|Overall Study||7
8103741|NCT03179345|19973912|P2|COMPLETED|Overall Study||7
8103742|NCT03179345|19973913|P1|COMPLETED|Overall Study||8
8103743|NCT03179345|19973910|P4|Received Placebo|Overall Study||8
8103744|NCT03179345|19973911|P3|Received Placebo|Overall Study||7
8103745|NCT03179345|19973912|P2|Received Placebo|Overall Study||7
8103746|NCT03179345|19973913|P1|Received Placebo|Overall Study||8
8103747|NCT03179345|19973910|P4|Received Lyrica®|Overall Study||8
8103748|NCT03179345|19973911|P3|Received Lyrica®|Overall Study||8
8103749|NCT03179345|19973912|P2|Received Lyrica®|Overall Study||7
8103750|NCT03179345|19973913|P1|Received Lyrica®|Overall Study||8
8103751|NCT03179345|19973910|P4|Received Neurontin®|Overall Study||8
8103752|NCT03179345|19973911|P3|Received Neurontin®|Overall Study||7
8103753|NCT03179345|19973912|P2|Received Neurontin®|Overall Study||8
8103754|NCT03179345|19973913|P1|Received Neurontin®|Overall Study||8
8103755|NCT03179345|19973910|P4|Received Gralise®|Overall Study||6
8103756|NCT03179345|19973911|P3|Received Gralise®|Overall Study||7
8103757|NCT03179345|19973912|P2|Received Gralise®|Overall Study||7
8103758|NCT03179345|19973913|P1|Received Gralise®|Overall Study||8
8103759|NCT03179345|19973910|P4|STARTED|Overall Study||8
8103760|NCT03179345|19973911|P3|STARTED|Overall Study||8
8103761|NCT03179345|19973912|P2|STARTED|Overall Study||8
8103762|NCT03179345|19973913|P1|STARTED|Overall Study||8
8103763|NCT03179319|19973965|P2|NOT COMPLETED|Overall Study||0
8103764|NCT03179319|19973966|P1|NOT COMPLETED|Overall Study||6
8103765|NCT03179319|19973965|P2|COMPLETED|Overall Study||20
8103766|NCT03179319|19973966|P1|COMPLETED|Overall Study||34
8103767|NCT03179319|19973965|P2|3 Month Visit|Overall Study||20
8103768|NCT03179319|19973966|P1|3 Month Visit|Overall Study||37
8103769|NCT03179319|19973965|P2|STARTED|Overall Study||20
8103770|NCT03179319|19973966|P1|STARTED|Overall Study||40
8103771|NCT03178942|19973981|P2|NOT COMPLETED|Overall Study||2
8103772|NCT03178942|19973982|P1|NOT COMPLETED|Overall Study||3
8103773|NCT03178942|19973981|P2|COMPLETED|Overall Study||123
8103774|NCT03178942|19973982|P1|COMPLETED|Overall Study||126
8103775|NCT03178942|19973981|P2|STARTED|Overall Study||125
8103776|NCT03178942|19973982|P1|STARTED|Overall Study||129
8103777|NCT03178851|19973997|P3|NOT COMPLETED|Overall Study||52
8103778|NCT03178851|19973998|P2|NOT COMPLETED|Overall Study||11
8103779|NCT03178851|19973999|P1|NOT COMPLETED|Overall Study||92
8103780|NCT03178851|19973997|P3|COMPLETED|Overall Study||0
8103781|NCT03178851|19973998|P2|COMPLETED|Overall Study||0
8103782|NCT03178851|19973999|P1|COMPLETED|Overall Study||0
8103783|NCT03178851|19973997|P3|STARTED|Overall Study||52
8103784|NCT03178851|19973998|P2|STARTED|Overall Study||11
8103785|NCT03178851|19973999|P1|STARTED|Overall Study||92
8103786|NCT03178344|19974029|P2|NOT COMPLETED|Second Session||0
8103787|NCT03178344|19974030|P1|NOT COMPLETED|Second Session||0
8103788|NCT03178344|19974029|P2|COMPLETED|Second Session||10
8103789|NCT03178344|19974030|P1|COMPLETED|Second Session||10
8103790|NCT03178344|19974029|P2|STARTED|Second Session||10
8103791|NCT03178344|19974030|P1|STARTED|Second Session||10
8103792|NCT03178344|19974029|P2|NOT COMPLETED|Washout Period (5-9 Days)||0
8103793|NCT03178344|19974030|P1|NOT COMPLETED|Washout Period (5-9 Days)||0
8103794|NCT03178344|19974029|P2|COMPLETED|Washout Period (5-9 Days)||10
8103795|NCT03178344|19974030|P1|COMPLETED|Washout Period (5-9 Days)||10
8103796|NCT03178344|19974029|P2|STARTED|Washout Period (5-9 Days)||10
8103797|NCT03178344|19974030|P1|STARTED|Washout Period (5-9 Days)||10
8103798|NCT03178344|19974029|P2|NOT COMPLETED|First Session||0
8103799|NCT03178344|19974030|P1|NOT COMPLETED|First Session||0
8103800|NCT03178344|19974029|P2|COMPLETED|First Session||10
8103801|NCT03178344|19974030|P1|COMPLETED|First Session||10
8103802|NCT03178344|19974029|P2|STARTED|First Session||10
8103803|NCT03178344|19974030|P1|STARTED|First Session||10
8103804|NCT03178266|19974046|P2|NOT COMPLETED|Overall Study||4
8103805|NCT03178266|19974047|P1|NOT COMPLETED|Overall Study||0
8103806|NCT03178266|19974046|P2|COMPLETED|Overall Study||16
8103807|NCT03178266|19974047|P1|COMPLETED|Overall Study||21
8103808|NCT03178266|19974046|P2|STARTED|Overall Study||20
8103809|NCT03178266|19974047|P1|STARTED|Overall Study||21
8103816|NCT03177798|19974085|P2|NOT COMPLETED|Overall Study||0
8103817|NCT03177798|19974086|P1|NOT COMPLETED|Overall Study||0
8103818|NCT03177798|19974085|P2|COMPLETED|Overall Study||6
8103819|NCT03177798|19974086|P1|COMPLETED|Overall Study||5
8103820|NCT03177798|19974085|P2|Intervention 2|Overall Study||6
8103821|NCT03177798|19974086|P1|Intervention 2|Overall Study||5
8103822|NCT03177798|19974085|P2|Washout|Overall Study||6
8103823|NCT03177798|19974086|P1|Washout|Overall Study||5
8103824|NCT03177798|19974085|P2|Intervention 1|Overall Study||6
8103825|NCT03177798|19974086|P1|Intervention 1|Overall Study||5
8103826|NCT03177798|19974085|P2|STARTED|Overall Study||6
8103827|NCT03177798|19974086|P1|STARTED|Overall Study||5
8103828|NCT03177603|19974098|P4|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103829|NCT03177603|19974099|P3|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103830|NCT03177603|19974100|P2|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103831|NCT03177603|19974101|P1|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103832|NCT03177603|19974098|P4|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
8103833|NCT03177603|19974099|P3|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103834|NCT03177603|19974100|P2|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103835|NCT03177603|19974101|P1|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103836|NCT03177603|19974098|P4|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
8103837|NCT03177603|19974099|P3|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103838|NCT03177603|19974100|P2|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103839|NCT03177603|19974101|P1|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
8103840|NCT03177603|19974098|P4|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103841|NCT03177603|19974099|P3|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103842|NCT03177603|19974100|P2|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103843|NCT03177603|19974101|P1|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103844|NCT03177603|19974098|P4|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103845|NCT03177603|19974099|P3|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
8103846|NCT03177603|19974100|P2|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103847|NCT03177603|19974101|P1|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103848|NCT03177603|19974098|P4|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103849|NCT03177603|19974099|P3|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
8103850|NCT03177603|19974100|P2|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103851|NCT03177603|19974101|P1|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
8103852|NCT03177603|19974098|P4|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103853|NCT03177603|19974099|P3|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103854|NCT03177603|19974100|P2|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103855|NCT03177603|19974101|P1|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103856|NCT03177603|19974098|P4|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103857|NCT03177603|19974099|P3|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103858|NCT03177603|19974100|P2|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
8103859|NCT03177603|19974101|P1|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103860|NCT03177603|19974098|P4|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103861|NCT03177603|19974099|P3|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103862|NCT03177603|19974100|P2|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
8103863|NCT03177603|19974101|P1|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
8103864|NCT03177603|19974098|P4|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103865|NCT03177603|19974099|P3|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103866|NCT03177603|19974100|P2|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103867|NCT03177603|19974101|P1|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103868|NCT03177603|19974098|P4|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103869|NCT03177603|19974099|P3|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103870|NCT03177603|19974100|P2|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103871|NCT03177603|19974101|P1|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
8103872|NCT03177603|19974098|P4|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103873|NCT03177603|19974099|P3|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103874|NCT03177603|19974100|P2|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
8103875|NCT03177603|19974101|P1|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
8103876|NCT03177395|19974271|P4|NOT COMPLETED|Overall Study||0
8103877|NCT03177395|19974272|P3|NOT COMPLETED|Overall Study||0
8103878|NCT03177395|19974273|P2|NOT COMPLETED|Overall Study||0
8103879|NCT03177395|19974274|P1|NOT COMPLETED|Overall Study||0
8103880|NCT03177395|19974271|P4|COMPLETED|Overall Study||6
8103881|NCT03177395|19974272|P3|COMPLETED|Overall Study||6
8103882|NCT03177395|19974273|P2|COMPLETED|Overall Study||6
8103883|NCT03177395|19974274|P1|COMPLETED|Overall Study||6
8103884|NCT03177395|19974271|P4|STARTED|Overall Study||6
8103885|NCT03177395|19974272|P3|STARTED|Overall Study||6
8103886|NCT03177395|19974273|P2|STARTED|Overall Study||6
8103887|NCT03177395|19974274|P1|STARTED|Overall Study||6
8103888|NCT03176654|19974378|P2|NOT COMPLETED|Overall Study||0
8103889|NCT03176654|19974379|P1|NOT COMPLETED|Overall Study||0
8103890|NCT03176654|19974378|P2|COMPLETED|Overall Study||15
8103891|NCT03176654|19974379|P1|COMPLETED|Overall Study||13
8103892|NCT03176654|19974378|P2|STARTED|Overall Study||15
8103893|NCT03176654|19974379|P1|STARTED|Overall Study||13
8103894|NCT03176459|19974401|P2|NOT COMPLETED|Overall Study||7
8103895|NCT03176459|19974402|P1|NOT COMPLETED|Overall Study||5
8103896|NCT03176459|19974401|P2|COMPLETED|Overall Study||83
8103897|NCT03176459|19974402|P1|COMPLETED|Overall Study||91
8103898|NCT03176459|19974401|P2|STARTED|Overall Study||90
8103899|NCT03176459|19974402|P1|STARTED|Overall Study||96
8103900|NCT03176407|19974424|P1|NOT COMPLETED|Overall Study||3
8103901|NCT03176407|19974424|P1|COMPLETED|Overall Study||27
8103902|NCT03176407|19974424|P1|STARTED|Overall Study||30
8103903|NCT03176238|19974434|P2|NOT COMPLETED|Overall Study||36
8103904|NCT03176238|19974435|P1|NOT COMPLETED|Overall Study||199
8103905|NCT03176238|19974434|P2|COMPLETED|Overall Study||0
8103906|NCT03176238|19974435|P1|COMPLETED|Overall Study||0
8103907|NCT03176238|19974434|P2|STARTED|Overall Study||36
8103908|NCT03176238|19974435|P1|STARTED|Overall Study||199
8103909|NCT03175562|19974454|P1|NOT COMPLETED|Overall Study||16
8103910|NCT03175562|19974454|P1|COMPLETED|Overall Study||224
8103911|NCT03175562|19974454|P1|Negative Control|Overall Study||240
8103912|NCT03175562|19974454|P1|Test Product|Overall Study||240
8103913|NCT03175562|19974454|P1|STARTED|Overall Study||240
8103914|NCT03175172|19974479|P1|NOT COMPLETED|Overall Study||10
8103915|NCT03175172|19974479|P1|COMPLETED|Overall Study||0
8103916|NCT03175172|19974479|P1|STARTED|Overall Study||10
8103917|NCT03175120|19974489|P2|NOT COMPLETED|Overall Study||12
8103918|NCT03175120|19974490|P1|NOT COMPLETED|Overall Study||12
8103919|NCT03175120|19974489|P2|COMPLETED|Overall Study||139
8103920|NCT03175120|19974490|P1|COMPLETED|Overall Study||290
8103921|NCT03175120|19974489|P2|Safety Analysis Set (SAS)|Overall Study||151
8103922|NCT03175120|19974490|P1|Safety Analysis Set (SAS)|Overall Study||301
8103923|NCT03175120|19974489|P2|Full Analysis Set (FAS)|Overall Study||151
8103924|NCT03175120|19974490|P1|Full Analysis Set (FAS)|Overall Study||302
8103925|NCT03175120|19974489|P2|Treated|Overall Study||151
8103926|NCT03175120|19974490|P1|Treated|Overall Study||301
8103927|NCT03175120|19974489|P2|STARTED|Overall Study||151
8103928|NCT03175120|19974490|P1|STARTED|Overall Study||302
8103929|NCT03174366|19974612|P1|NOT COMPLETED|Overall Study||0
8103930|NCT03174366|19974612|P1|COMPLETED|Overall Study||7
8103931|NCT03174366|19974612|P1|STARTED|Overall Study||7
8103932|NCT03174158|19974621|P4|NOT COMPLETED|Overall Study||1
8103933|NCT03174158|19974622|P3|NOT COMPLETED|Overall Study||2
8103934|NCT03174158|19974623|P2|NOT COMPLETED|Overall Study||2
8103935|NCT03174158|19974624|P1|NOT COMPLETED|Overall Study||4
8103936|NCT03174158|19974621|P4|COMPLETED|Overall Study||38
8103937|NCT03174158|19974622|P3|COMPLETED|Overall Study||34
8103938|NCT03174158|19974623|P2|COMPLETED|Overall Study||37
8103939|NCT03174158|19974624|P1|COMPLETED|Overall Study||35
8103940|NCT03174158|19974621|P4|STARTED|Overall Study||39
8103941|NCT03174158|19974622|P3|STARTED|Overall Study||36
8103942|NCT03174158|19974623|P2|STARTED|Overall Study||39
8103943|NCT03174158|19974624|P1|STARTED|Overall Study||39
8103944|NCT03174132|19974660|P1|NOT COMPLETED|Overall Study||0
8103945|NCT03174132|19974660|P1|COMPLETED|Overall Study||70
8103946|NCT03174132|19974660|P1|STARTED|Overall Study||70
8103947|NCT03173170|19974665|P1|NOT COMPLETED|Intervention Period 2 (9 Days)||0
8103948|NCT03173170|19974665|P1|COMPLETED|Intervention Period 2 (9 Days)||10
8103949|NCT03173170|19974665|P1|STARTED|Intervention Period 2 (9 Days)||10
8103950|NCT03173170|19974665|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8103951|NCT03173170|19974665|P1|COMPLETED|Washout Period (at Least 7 Days)||10
8103952|NCT03173170|19974665|P1|STARTED|Washout Period (at Least 7 Days)||10
8103953|NCT03173170|19974665|P1|NOT COMPLETED|First Intervention Period (6 Days)||0
8103954|NCT03173170|19974665|P1|COMPLETED|First Intervention Period (6 Days)||10
8103955|NCT03173170|19974665|P1|STARTED|First Intervention Period (6 Days)||10
8103956|NCT03172702|19974674|P1|NOT COMPLETED|Overall Study||28
8103957|NCT03172702|19974674|P1|COMPLETED|Overall Study||122
8103958|NCT03172702|19974674|P1|Received Treatment in MP|Overall Study||150
8103959|NCT03172702|19974674|P1|Received Treatment in CP|Overall Study||150
8103960|NCT03172702|19974674|P1|STARTED|Overall Study||150
8103961|NCT03172520|19974695|P1|NOT COMPLETED|Overall Study||10
8103962|NCT03172520|19974695|P1|COMPLETED|Overall Study||0
8103963|NCT03172520|19974695|P1|STARTED|Overall Study||10
8103964|NCT03172494|19974702|P3|NOT COMPLETED|Overall Study||29
8103965|NCT03172494|19974703|P2|NOT COMPLETED|Overall Study||12
8103966|NCT03172494|19974704|P1|NOT COMPLETED|Overall Study||20
8103967|NCT03172494|19974702|P3|COMPLETED|Overall Study||151
8103968|NCT03172494|19974703|P2|COMPLETED|Overall Study||167
8103969|NCT03172494|19974704|P1|COMPLETED|Overall Study||341
8103970|NCT03172494|19974702|P3|Exposed|Overall Study||180
8103971|NCT03172494|19974703|P2|Exposed|Overall Study||175
8103972|NCT03172494|19974704|P1|Exposed|Overall Study||358
8103973|NCT03172494|19974702|P3|Safety Analysis Set (SAS)|Overall Study||180
8103974|NCT03172494|19974703|P2|Safety Analysis Set (SAS)|Overall Study||175
8103975|NCT03172494|19974704|P1|Safety Analysis Set (SAS)|Overall Study||358
8103976|NCT03172494|19974702|P3|Full Analysis Set (FAS)|Overall Study||180
8103977|NCT03172494|19974703|P2|Full Analysis Set (FAS)|Overall Study||179
8103978|NCT03172494|19974704|P1|Full Analysis Set (FAS)|Overall Study||361
8103979|NCT03172494|19974702|P3|STARTED|Overall Study||180
8103980|NCT03172494|19974703|P2|STARTED|Overall Study||179
8103981|NCT03172494|19974704|P1|STARTED|Overall Study||361
8103982|NCT03172481|19974887|P2|NOT COMPLETED|Double-blind||0
8103983|NCT03172481|19974888|P1|NOT COMPLETED|Double-blind||1
8103984|NCT03172481|19974887|P2|COMPLETED|Double-blind||73
8103985|NCT03172481|19974888|P1|COMPLETED|Double-blind||74
8103986|NCT03172481|19974887|P2|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73
8103987|NCT03172481|19974888|P1|STARTED|Double-blind||75
8103988|NCT03172481|19974887|P2|NOT COMPLETED|Open-label||0
8103989|NCT03172481|19974888|P1|NOT COMPLETED|Open-label||8
8103990|NCT03172481|19974887|P2|COMPLETED|Open-label||0
8103991|NCT03172481|19974888|P1|COMPLETED|Open-label||148
8103992|NCT03172481|19974887|P2|STARTED|Open-label||0
8103993|NCT03172481|19974888|P1|STARTED|Open-label||156
8103994|NCT03172364|19974896|P2|NOT COMPLETED|Overall Study||1
8103995|NCT03172364|19974897|P1|NOT COMPLETED|Overall Study||2
8103996|NCT03172364|19974896|P2|COMPLETED|Overall Study||57
8103997|NCT03172364|19974897|P1|COMPLETED|Overall Study||53
8103998|NCT03172364|19974896|P2|STARTED|Overall Study||58
8103999|NCT03172364|19974897|P1|STARTED|Overall Study||55
8104000|NCT03172130|19974915|P2|NOT COMPLETED|Overall Study||1
8104001|NCT03172130|19974916|P1|NOT COMPLETED|Overall Study||3
8104002|NCT03172130|19974915|P2|COMPLETED|Overall Study||9
8104003|NCT03172130|19974916|P1|COMPLETED|Overall Study||9
8104004|NCT03172130|19974915|P2|STARTED|Overall Study||10
8104005|NCT03172130|19974916|P1|STARTED|Overall Study||12
8104006|NCT03171415|19974941|P5|NOT COMPLETED|Overall Study||2
8104007|NCT03171415|19974942|P4|NOT COMPLETED|Overall Study||0
8104008|NCT03171415|19974943|P3|NOT COMPLETED|Overall Study||0
8104009|NCT03171415|19974944|P2|NOT COMPLETED|Overall Study||0
8104010|NCT03171415|19974945|P1|NOT COMPLETED|Overall Study||0
8104011|NCT03171415|19974941|P5|COMPLETED|Overall Study||7
8104012|NCT03171415|19974942|P4|COMPLETED|Overall Study||6
8104013|NCT03171415|19974943|P3|COMPLETED|Overall Study||6
8104014|NCT03171415|19974944|P2|COMPLETED|Overall Study||6
8104015|NCT03171415|19974945|P1|COMPLETED|Overall Study||6
8104016|NCT03171415|19974941|P5|STARTED|Overall Study||9
8104017|NCT03171415|19974942|P4|STARTED|Overall Study||6
8104018|NCT03171415|19974943|P3|STARTED|Overall Study||6
8104019|NCT03171415|19974944|P2|STARTED|Overall Study||6
8104020|NCT03171415|19974945|P1|STARTED|Overall Study||6
8104021|NCT03171051|19975006|P1|NOT COMPLETED|Overall Study||0
8104022|NCT03171051|19975006|P1|COMPLETED|Overall Study||10
8104023|NCT03171051|19975006|P1|STARTED|Overall Study||10
8104024|NCT03170609|19975018|P7|NOT COMPLETED|Overall Study||1
8104025|NCT03170609|19975019|P6|NOT COMPLETED|Overall Study||2
8104026|NCT03170609|19975020|P5|NOT COMPLETED|Overall Study||1
8104027|NCT03170609|19975021|P4|NOT COMPLETED|Overall Study||2
8104028|NCT03170609|19975022|P3|NOT COMPLETED|Overall Study||6
8104029|NCT03170609|19975023|P2|NOT COMPLETED|Overall Study||2
8104030|NCT03170609|19975024|P1|NOT COMPLETED|Overall Study||3
8104031|NCT03170609|19975018|P7|COMPLETED|Overall Study||51
8104032|NCT03170609|19975019|P6|COMPLETED|Overall Study||50
8104033|NCT03170609|19975020|P5|COMPLETED|Overall Study||51
8104034|NCT03170609|19975021|P4|COMPLETED|Overall Study||50
8104035|NCT03170609|19975022|P3|COMPLETED|Overall Study||46
8104036|NCT03170609|19975023|P2|COMPLETED|Overall Study||50
8104037|NCT03170609|19975024|P1|COMPLETED|Overall Study||50
8104038|NCT03170609|19975018|P7|Vaccinated|Overall Study||52
8104039|NCT03170609|19975019|P6|Vaccinated|Overall Study||52
8104040|NCT03170609|19975020|P5|Vaccinated|Overall Study||52
8104041|NCT03170609|19975021|P4|Vaccinated|Overall Study||52
8104042|NCT03170609|19975022|P3|Vaccinated|Overall Study||52
8104043|NCT03170609|19975023|P2|Vaccinated|Overall Study||52
8104044|NCT03170609|19975024|P1|Vaccinated|Overall Study||52
8104045|NCT03170609|19975018|P7|STARTED|Overall Study||52
8104046|NCT03170609|19975019|P6|STARTED|Overall Study||52
8104047|NCT03170609|19975020|P5|STARTED|Overall Study||52
8104048|NCT03170609|19975021|P4|STARTED|Overall Study||52
8104049|NCT03170609|19975022|P3|STARTED|Overall Study||52
8104050|NCT03170609|19975023|P2|STARTED|Overall Study||52
8104051|NCT03170609|19975024|P1|STARTED|Overall Study||53
8104052|NCT03170544|19975094|P12|NOT COMPLETED|Part 4||0
8104053|NCT03170544|19975095|P11|NOT COMPLETED|Part 4||0
8104054|NCT03170544|19975096|P10|NOT COMPLETED|Part 4||0
8104055|NCT03170544|19975097|P9|NOT COMPLETED|Part 4||0
8104056|NCT03170544|19975098|P8|NOT COMPLETED|Part 4||0
8104057|NCT03170544|19975099|P7|NOT COMPLETED|Part 4||0
8104058|NCT03170544|19975100|P6|NOT COMPLETED|Part 4||0
8104059|NCT03170544|19975101|P5|NOT COMPLETED|Part 4||0
8104060|NCT03170544|19975102|P4|NOT COMPLETED|Part 4||0
8104061|NCT03170544|19975103|P3|NOT COMPLETED|Part 4||0
8104062|NCT03170544|19975104|P2|NOT COMPLETED|Part 4||0
8104063|NCT03170544|19975105|P1|NOT COMPLETED|Part 4||0
8104064|NCT03170544|19975094|P12|COMPLETED|Part 4||6
8104065|NCT03170544|19975095|P11|COMPLETED|Part 4||3
8104066|NCT03170544|19975096|P10|COMPLETED|Part 4||0
8104067|NCT03170544|19975097|P9|COMPLETED|Part 4||0
8104068|NCT03170544|19975098|P8|COMPLETED|Part 4||0
8104069|NCT03170544|19975099|P7|COMPLETED|Part 4||0
8104070|NCT03170544|19975100|P6|COMPLETED|Part 4||0
8104071|NCT03170544|19975101|P5|COMPLETED|Part 4||0
8104072|NCT03170544|19975102|P4|COMPLETED|Part 4||0
8104073|NCT03170544|19975103|P3|COMPLETED|Part 4||0
8104074|NCT03170544|19975104|P2|COMPLETED|Part 4||0
8104075|NCT03170544|19975105|P1|COMPLETED|Part 4||0
8104076|NCT03170544|19975094|P12|STARTED|Part 4||6
8104077|NCT03170544|19975095|P11|STARTED|Part 4||3
8104078|NCT03170544|19975096|P10|STARTED|Part 4||0
8104079|NCT03170544|19975097|P9|STARTED|Part 4||0
8104080|NCT03170544|19975098|P8|STARTED|Part 4||0
8104081|NCT03170544|19975099|P7|STARTED|Part 4||0
8104082|NCT03170544|19975100|P6|STARTED|Part 4||0
8104083|NCT03170544|19975101|P5|STARTED|Part 4||0
8104084|NCT03170544|19975102|P4|STARTED|Part 4||0
8104085|NCT03170544|19975103|P3|STARTED|Part 4||0
8104086|NCT03170544|19975104|P2|STARTED|Part 4||0
8104087|NCT03170544|19975105|P1|STARTED|Part 4||0
8104088|NCT03170544|19975094|P12|NOT COMPLETED|Part 3||0
8104089|NCT03170544|19975095|P11|NOT COMPLETED|Part 3||0
8104090|NCT03170544|19975096|P10|NOT COMPLETED|Part 3||0
8104091|NCT03170544|19975097|P9|NOT COMPLETED|Part 3||0
8104092|NCT03170544|19975098|P8|NOT COMPLETED|Part 3||0
8104093|NCT03170544|19975099|P7|NOT COMPLETED|Part 3||0
8104094|NCT03170544|19975100|P6|NOT COMPLETED|Part 3||0
8104095|NCT03170544|19975101|P5|NOT COMPLETED|Part 3||0
8104096|NCT03170544|19975102|P4|NOT COMPLETED|Part 3||0
8104097|NCT03170544|19975103|P3|NOT COMPLETED|Part 3||0
8104098|NCT03170544|19975104|P2|NOT COMPLETED|Part 3||0
8104099|NCT03170544|19975105|P1|NOT COMPLETED|Part 3||0
8104100|NCT03170544|19975094|P12|COMPLETED|Part 3||0
8104101|NCT03170544|19975095|P11|COMPLETED|Part 3||0
8104102|NCT03170544|19975096|P10|COMPLETED|Part 3||6
8104103|NCT03170544|19975097|P9|COMPLETED|Part 3||6
8104104|NCT03170544|19975098|P8|COMPLETED|Part 3||4
8104105|NCT03170544|19975099|P7|COMPLETED|Part 3||0
8104106|NCT03170544|19975100|P6|COMPLETED|Part 3||0
8104107|NCT03170544|19975101|P5|COMPLETED|Part 3||0
8104108|NCT03170544|19975102|P4|COMPLETED|Part 3||0
8104109|NCT03170544|19975103|P3|COMPLETED|Part 3||0
8104110|NCT03170544|19975104|P2|COMPLETED|Part 3||0
8104111|NCT03170544|19975105|P1|COMPLETED|Part 3||0
8104112|NCT03170544|19975094|P12|STARTED|Part 3||0
8104113|NCT03170544|19975095|P11|STARTED|Part 3||0
8104114|NCT03170544|19975096|P10|STARTED|Part 3||6
8104115|NCT03170544|19975097|P9|STARTED|Part 3||6
8104116|NCT03170544|19975098|P8|STARTED|Part 3||4
8104117|NCT03170544|19975099|P7|STARTED|Part 3||0
8104118|NCT03170544|19975100|P6|STARTED|Part 3||0
8104119|NCT03170544|19975101|P5|STARTED|Part 3||0
8104120|NCT03170544|19975102|P4|STARTED|Part 3||0
8104121|NCT03170544|19975103|P3|STARTED|Part 3||0
8104122|NCT03170544|19975104|P2|STARTED|Part 3||0
8104123|NCT03170544|19975105|P1|STARTED|Part 3||0
8104124|NCT03170544|19975094|P12|NOT COMPLETED|Part 2||0
8104125|NCT03170544|19975095|P11|NOT COMPLETED|Part 2||0
8104126|NCT03170544|19975096|P10|NOT COMPLETED|Part 2||0
8104127|NCT03170544|19975097|P9|NOT COMPLETED|Part 2||0
8104128|NCT03170544|19975098|P8|NOT COMPLETED|Part 2||0
8104129|NCT03170544|19975099|P7|NOT COMPLETED|Part 2||0
8104130|NCT03170544|19975100|P6|NOT COMPLETED|Part 2||0
8104131|NCT03170544|19975101|P5|NOT COMPLETED|Part 2||0
8104132|NCT03170544|19975102|P4|NOT COMPLETED|Part 2||0
8104133|NCT03170544|19975103|P3|NOT COMPLETED|Part 2||0
8104134|NCT03170544|19975104|P2|NOT COMPLETED|Part 2||0
8104135|NCT03170544|19975105|P1|NOT COMPLETED|Part 2||0
8104136|NCT03170544|19975094|P12|COMPLETED|Part 2||0
8104137|NCT03170544|19975095|P11|COMPLETED|Part 2||0
8104138|NCT03170544|19975096|P10|COMPLETED|Part 2||0
8104139|NCT03170544|19975097|P9|COMPLETED|Part 2||0
8104140|NCT03170544|19975098|P8|COMPLETED|Part 2||0
8104141|NCT03170544|19975099|P7|COMPLETED|Part 2||4
8104142|NCT03170544|19975100|P6|COMPLETED|Part 2||0
8104143|NCT03170544|19975101|P5|COMPLETED|Part 2||0
8104144|NCT03170544|19975102|P4|COMPLETED|Part 2||0
8104145|NCT03170544|19975103|P3|COMPLETED|Part 2||0
8104146|NCT03170544|19975104|P2|COMPLETED|Part 2||0
8104147|NCT03170544|19975105|P1|COMPLETED|Part 2||0
8104148|NCT03170544|19975094|P12|STARTED|Part 2||0
8104149|NCT03170544|19975095|P11|STARTED|Part 2||0
8104150|NCT03170544|19975096|P10|STARTED|Part 2||0
8104151|NCT03170544|19975097|P9|STARTED|Part 2||0
8104152|NCT03170544|19975098|P8|STARTED|Part 2||0
8104153|NCT03170544|19975099|P7|STARTED|Part 2||4
8104154|NCT03170544|19975100|P6|STARTED|Part 2||0
8104155|NCT03170544|19975101|P5|STARTED|Part 2||0
8104156|NCT03170544|19975102|P4|STARTED|Part 2||0
8104157|NCT03170544|19975103|P3|STARTED|Part 2||0
8104158|NCT03170544|19975104|P2|STARTED|Part 2||0
8104159|NCT03170544|19975105|P1|STARTED|Part 2||0
8104160|NCT03170544|19975094|P12|NOT COMPLETED|Part 1||0
8104161|NCT03170544|19975095|P11|NOT COMPLETED|Part 1||0
8104162|NCT03170544|19975096|P10|NOT COMPLETED|Part 1||0
8104163|NCT03170544|19975097|P9|NOT COMPLETED|Part 1||0
8104164|NCT03170544|19975098|P8|NOT COMPLETED|Part 1||0
8104165|NCT03170544|19975099|P7|NOT COMPLETED|Part 1||0
8104166|NCT03170544|19975100|P6|NOT COMPLETED|Part 1||0
8104167|NCT03170544|19975101|P5|NOT COMPLETED|Part 1||0
8104168|NCT03170544|19975102|P4|NOT COMPLETED|Part 1||1
8104169|NCT03170544|19975103|P3|NOT COMPLETED|Part 1||0
8104170|NCT03170544|19975104|P2|NOT COMPLETED|Part 1||0
8104171|NCT03170544|19975105|P1|NOT COMPLETED|Part 1||1
8104172|NCT03170544|19975094|P12|COMPLETED|Part 1||0
8104173|NCT03170544|19975095|P11|COMPLETED|Part 1||0
8104174|NCT03170544|19975096|P10|COMPLETED|Part 1||0
8104175|NCT03170544|19975097|P9|COMPLETED|Part 1||0
8104176|NCT03170544|19975098|P8|COMPLETED|Part 1||0
8104177|NCT03170544|19975099|P7|COMPLETED|Part 1||0
8104178|NCT03170544|19975100|P6|COMPLETED|Part 1||6
8104179|NCT03170544|19975101|P5|COMPLETED|Part 1||6
8104180|NCT03170544|19975102|P4|COMPLETED|Part 1||6
8104181|NCT03170544|19975103|P3|COMPLETED|Part 1||6
8104182|NCT03170544|19975104|P2|COMPLETED|Part 1||6
8104183|NCT03170544|19975105|P1|COMPLETED|Part 1||9
8104184|NCT03170544|19975094|P12|STARTED|Part 1||0
8104185|NCT03170544|19975095|P11|STARTED|Part 1||0
8104186|NCT03170544|19975096|P10|STARTED|Part 1||0
8104187|NCT03170544|19975097|P9|STARTED|Part 1||0
8104188|NCT03170544|19975098|P8|STARTED|Part 1||0
8104189|NCT03170544|19975099|P7|STARTED|Part 1||0
8104190|NCT03170544|19975100|P6|STARTED|Part 1||6
8104191|NCT03170544|19975101|P5|STARTED|Part 1||6
8104192|NCT03170544|19975102|P4|STARTED|Part 1||7
8104193|NCT03170544|19975103|P3|STARTED|Part 1||6
8104194|NCT03170544|19975104|P2|STARTED|Part 1||6
8104195|NCT03170544|19975105|P1|STARTED|Part 1||10
8104196|NCT03170271|19975269|P2|NOT COMPLETED|Overall Study||11
8104197|NCT03170271|19975270|P1|NOT COMPLETED|Overall Study||33
8104198|NCT03170271|19975269|P2|COMPLETED|Overall Study||218
8104199|NCT03170271|19975270|P1|COMPLETED|Overall Study||398
8104200|NCT03170271|19975269|P2|Received Treatment|Overall Study||229
8104201|NCT03170271|19975270|P1|Received Treatment|Overall Study||427
8104202|NCT03170271|19975269|P2|STARTED|Overall Study||229
8104203|NCT03170271|19975270|P1|STARTED|Overall Study||431
8104204|NCT03170232|19975298|P2|NOT COMPLETED|Overall Study||27
8104205|NCT03170232|19975299|P1|NOT COMPLETED|Overall Study||27
8104206|NCT03170232|19975298|P2|COMPLETED|Overall Study||0
8104207|NCT03170232|19975299|P1|COMPLETED|Overall Study||0
8104208|NCT03170232|19975298|P2|STARTED|Overall Study||27
8104209|NCT03170232|19975299|P1|STARTED|Overall Study||27
8104210|NCT03170219|19975345|P2|NOT COMPLETED|Overall Study||0
8104211|NCT03170219|19975346|P1|NOT COMPLETED|Overall Study||0
8104212|NCT03170219|19975345|P2|COMPLETED|Overall Study||4
8104213|NCT03170219|19975346|P1|COMPLETED|Overall Study||7
8104214|NCT03170219|19975345|P2|STARTED|Overall Study||4
8104215|NCT03170219|19975346|P1|STARTED|Overall Study||7
8104216|NCT03170193|19975377|P7|NOT COMPLETED|Overall Study||0
8104217|NCT03170193|19975378|P6|NOT COMPLETED|Overall Study||0
8104218|NCT03170193|19975379|P5|NOT COMPLETED|Overall Study||0
8104219|NCT03170193|19975380|P4|NOT COMPLETED|Overall Study||1
8104220|NCT03170193|19975381|P3|NOT COMPLETED|Overall Study||0
8104221|NCT03170193|19975382|P2|NOT COMPLETED|Overall Study||1
8104222|NCT03170193|19975383|P1|NOT COMPLETED|Overall Study||1
8104223|NCT03170193|19975377|P7|COMPLETED|Overall Study||6
8104224|NCT03170193|19975378|P6|COMPLETED|Overall Study||6
8104225|NCT03170193|19975379|P5|COMPLETED|Overall Study||6
8104226|NCT03170193|19975380|P4|COMPLETED|Overall Study||5
8104227|NCT03170193|19975381|P3|COMPLETED|Overall Study||6
8104228|NCT03170193|19975382|P2|COMPLETED|Overall Study||5
8104229|NCT03170193|19975383|P1|COMPLETED|Overall Study||11
8104230|NCT03170193|19975377|P7|STARTED|Overall Study||6
8104231|NCT03170193|19975378|P6|STARTED|Overall Study||6
8104232|NCT03170193|19975379|P5|STARTED|Overall Study||6
8104233|NCT03170193|19975380|P4|STARTED|Overall Study||6
8104234|NCT03170193|19975381|P3|STARTED|Overall Study||6
8104235|NCT03170193|19975382|P2|STARTED|Overall Study||6
8104236|NCT03170193|19975383|P1|STARTED|Overall Study||12
8104237|NCT03170154|19975452|P1|NOT COMPLETED|Overall Study||8
8104238|NCT03170154|19975452|P1|COMPLETED|Overall Study||342
8104239|NCT03170154|19975452|P1|Rotational Stability Sub-study|Overall Study||141
8104240|NCT03170154|19975452|P1|STARTED|Overall Study||350
8104241|NCT03169816|19975467|P2|NOT COMPLETED|Overall Study||13
8104242|NCT03169816|19975468|P1|NOT COMPLETED|Overall Study||27
8104243|NCT03169816|19975467|P2|COMPLETED|Overall Study||3
8104244|NCT03169816|19975468|P1|COMPLETED|Overall Study||6
8104245|NCT03169816|19975467|P2|STARTED|Overall Study||16
8104246|NCT03169816|19975468|P1|STARTED|Overall Study||33
8104247|NCT03169530|19975476|P2|NOT COMPLETED|Overall Study||17
8104248|NCT03169530|19975477|P1|NOT COMPLETED|Overall Study||15
8104249|NCT03169530|19975476|P2|COMPLETED|Overall Study||0
8104250|NCT03169530|19975477|P1|COMPLETED|Overall Study||0
8104251|NCT03169530|19975476|P2|STARTED|Overall Study||17
8104252|NCT03169530|19975477|P1|STARTED|Overall Study||15
8104253|NCT03169244|19975497|P2|NOT COMPLETED|Overall Study||4
8104254|NCT03169244|19975498|P1|NOT COMPLETED|Overall Study||5
8104255|NCT03169244|19975497|P2|COMPLETED|Overall Study||16
8104256|NCT03169244|19975498|P1|COMPLETED|Overall Study||17
8104257|NCT03169244|19975497|P2|Received Intervention|Overall Study||18
8104258|NCT03169244|19975498|P1|Received Intervention|Overall Study||22
8104259|NCT03169244|19975497|P2|Randomly Assigned|Overall Study||20
8104260|NCT03169244|19975498|P1|Randomly Assigned|Overall Study||22
8104261|NCT03169244|19975497|P2|STARTED|Overall Study||20
8104262|NCT03169244|19975498|P1|STARTED|Overall Study||22
8104263|NCT03169153|19975508|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
8104264|NCT03169153|19975509|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
8104265|NCT03169153|19975508|P2|COMPLETED|Period 2, Second 30 Days of Wear||32
8104266|NCT03169153|19975509|P1|COMPLETED|Period 2, Second 30 Days of Wear||37
8104267|NCT03169153|19975508|P2|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34
8104268|NCT03169153|19975509|P1|STARTED|Period 2, Second 30 Days of Wear||39
8104269|NCT03169153|19975508|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||4
8104270|NCT03169153|19975509|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
8104271|NCT03169153|19975508|P2|COMPLETED|Period 1, First 30 Days of Wear||35
8104272|NCT03169153|19975509|P1|COMPLETED|Period 1, First 30 Days of Wear||39
8104273|NCT03169153|19975508|P2|STARTED|Period 1, First 30 Days of Wear||39
8104274|NCT03169153|19975509|P1|STARTED|Period 1, First 30 Days of Wear||42
8104275|NCT03169062|19975515|P1|NOT COMPLETED|Overall Study||0
8104276|NCT03169062|19975515|P1|COMPLETED|Overall Study||10
8104277|NCT03169062|19975515|P1|STARTED|Overall Study||10
8104278|NCT03168919|19975520|P1|NOT COMPLETED|Overall Study||2
8104279|NCT03168919|19975520|P1|COMPLETED|Overall Study||3
8104280|NCT03168919|19975520|P1|STARTED|Overall Study||5
8104281|NCT03168906|19975530|P2|NOT COMPLETED|Overall Study||6
8104282|NCT03168906|19975531|P1|NOT COMPLETED|Overall Study||6
8104283|NCT03168906|19975530|P2|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
8104284|NCT03168906|19975531|P1|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
8104285|NCT03168906|19975530|P2|STARTED|Overall Study||6
8104286|NCT03168906|19975531|P1|STARTED|Overall Study||6
8104287|NCT03168841|19975551|P1|NOT COMPLETED|Overall Study||4
8104288|NCT03168841|19975551|P1|COMPLETED|Overall Study||36
8104289|NCT03168841|19975551|P1|STARTED|Overall Study||40
8104290|NCT03168542|19975558|P3|NOT COMPLETED|Overall Study||0
8104291|NCT03168542|19975559|P2|NOT COMPLETED|Overall Study||0
8104292|NCT03168542|19975560|P1|NOT COMPLETED|Overall Study||0
8104293|NCT03168542|19975558|P3|COMPLETED|Overall Study||9
8104294|NCT03168542|19975559|P2|COMPLETED|Overall Study||5
8104295|NCT03168542|19975560|P1|COMPLETED|Overall Study||7
8104296|NCT03168542|19975558|P3|STARTED|Overall Study||9
8104297|NCT03168542|19975559|P2|STARTED|Overall Study||5
8104298|NCT03168542|19975560|P1|STARTED|Overall Study||7
8104299|NCT03168425|19975577|P2|NOT COMPLETED|Overall Study||11
8104300|NCT03168425|19975578|P1|NOT COMPLETED|Overall Study||7
8104301|NCT03168425|19975577|P2|COMPLETED|Overall Study||85
8104302|NCT03168425|19975578|P1|COMPLETED|Overall Study||87
8104303|NCT03168425|19975577|P2|STARTED|Overall Study||96
8104304|NCT03168425|19975578|P1|STARTED|Overall Study||94
8104305|NCT03168308|19975588|P2|NOT COMPLETED|Overall Study||0
8104306|NCT03168308|19975589|P1|NOT COMPLETED|Overall Study||0
8104307|NCT03168308|19975588|P2|COMPLETED|Overall Study||44
8104308|NCT03168308|19975589|P1|COMPLETED|Overall Study||48
8104309|NCT03168308|19975588|P2|STARTED|Overall Study||44
8104310|NCT03168308|19975589|P1|STARTED|Overall Study||48
8104311|NCT03168295|19975602|P5|NOT COMPLETED|Overall Study||0
8104312|NCT03168295|19975603|P4|NOT COMPLETED|Overall Study||0
8104313|NCT03168295|19975604|P3|NOT COMPLETED|Overall Study||0
8104314|NCT03168295|19975605|P2|NOT COMPLETED|Overall Study||0
8104315|NCT03168295|19975606|P1|NOT COMPLETED|Overall Study||0
8104316|NCT03168295|19975602|P5|COMPLETED|Overall Study||20
8104317|NCT03168295|19975603|P4|COMPLETED|Overall Study||4
8104318|NCT03168295|19975604|P3|COMPLETED|Overall Study||4
8104319|NCT03168295|19975605|P2|COMPLETED|Overall Study||3
8104320|NCT03168295|19975606|P1|COMPLETED|Overall Study||3
8104321|NCT03168295|19975602|P5|STARTED|Overall Study||20
8104322|NCT03168295|19975603|P4|STARTED|Overall Study||4
8104323|NCT03168295|19975604|P3|STARTED|Overall Study||4
8104324|NCT03168295|19975605|P2|STARTED|Overall Study||3
8104325|NCT03168295|19975606|P1|STARTED|Overall Study||3
8104326|NCT03168022|19975620|P2|NOT COMPLETED|Overall Study||1
8104327|NCT03168022|19975621|P1|NOT COMPLETED|Overall Study||0
8104328|NCT03168022|19975620|P2|COMPLETED|Overall Study||21
8104329|NCT03168022|19975621|P1|COMPLETED|Overall Study||21
8104330|NCT03168022|19975620|P2|STARTED|Overall Study||22
8104331|NCT03168022|19975621|P1|STARTED|Overall Study||21
8104332|NCT03167541|19975629|P2|NOT COMPLETED|Second Intervention||0
8104333|NCT03167541|19975630|P1|NOT COMPLETED|Second Intervention||0
8104334|NCT03167541|19975629|P2|COMPLETED|Second Intervention||9
8104335|NCT03167541|19975630|P1|COMPLETED|Second Intervention||9
8104336|NCT03167541|19975629|P2|STARTED|Second Intervention||9
8104337|NCT03167541|19975630|P1|STARTED|Second Intervention||9
8104338|NCT03167541|19975629|P2|NOT COMPLETED|Washout: 5-8 Days||0
8104339|NCT03167541|19975630|P1|NOT COMPLETED|Washout: 5-8 Days||0
8104340|NCT03167541|19975629|P2|COMPLETED|Washout: 5-8 Days||9
8104341|NCT03167541|19975630|P1|COMPLETED|Washout: 5-8 Days||9
8104342|NCT03167541|19975629|P2|STARTED|Washout: 5-8 Days||9
8104343|NCT03167541|19975630|P1|STARTED|Washout: 5-8 Days||9
8104344|NCT03167541|19975629|P2|NOT COMPLETED|First Intervention||0
8104345|NCT03167541|19975630|P1|NOT COMPLETED|First Intervention||0
8104346|NCT03167541|19975629|P2|COMPLETED|First Intervention||9
8104347|NCT03167541|19975630|P1|COMPLETED|First Intervention||9
8104348|NCT03167541|19975629|P2|STARTED|First Intervention||9
8104349|NCT03167541|19975630|P1|STARTED|First Intervention||9
8104350|NCT03167151|19975655|P3|NOT COMPLETED|Overall Study||1
8104351|NCT03167151|19975656|P2|NOT COMPLETED|Overall Study||1
8104352|NCT03167151|19975657|P1|NOT COMPLETED|Overall Study||1
8104353|NCT03167151|19975655|P3|COMPLETED|Overall Study||2
8104354|NCT03167151|19975656|P2|COMPLETED|Overall Study||2
8104355|NCT03167151|19975657|P1|COMPLETED|Overall Study||2
8104356|NCT03167151|19975655|P3|STARTED|Overall Study||3
8104357|NCT03167151|19975656|P2|STARTED|Overall Study||3
8104358|NCT03167151|19975657|P1|STARTED|Overall Study||3
8104359|NCT03166735|19975670|P5|NOT COMPLETED|Overall Study||4
8104360|NCT03166735|19975671|P4|NOT COMPLETED|Overall Study||1
8104361|NCT03166735|19975672|P3|NOT COMPLETED|Overall Study||3
8104362|NCT03166735|19975673|P2|NOT COMPLETED|Overall Study||3
8104363|NCT03166735|19975674|P1|NOT COMPLETED|Overall Study||1
8104364|NCT03166735|19975670|P5|COMPLETED|Overall Study||28
8104365|NCT03166735|19975671|P4|COMPLETED|Overall Study||16
8104366|NCT03166735|19975672|P3|COMPLETED|Overall Study||13
8104367|NCT03166735|19975673|P2|COMPLETED|Overall Study||13
8104368|NCT03166735|19975674|P1|COMPLETED|Overall Study||32
8104369|NCT03166735|19975670|P5|Treated|Overall Study||32
8104370|NCT03166735|19975671|P4|Treated|Overall Study||17
8104371|NCT03166735|19975672|P3|Treated|Overall Study||16
8104372|NCT03166735|19975673|P2|Treated|Overall Study||16
8104373|NCT03166735|19975674|P1|Treated|Overall Study||32
8104374|NCT03166735|19975670|P5|STARTED|Overall Study||32
8104375|NCT03166735|19975671|P4|STARTED|Overall Study||17
8104376|NCT03166735|19975672|P3|STARTED|Overall Study||16
8104377|NCT03166735|19975673|P2|STARTED|Overall Study||16
8104378|NCT03166735|19975674|P1|STARTED|Overall Study||33
8104379|NCT03166618|19975724|P2|NOT COMPLETED|Overall Study||1
8104380|NCT03166618|19975725|P1|NOT COMPLETED|Overall Study||0
8104381|NCT03166618|19975724|P2|COMPLETED|Overall Study||0
8104382|NCT03166618|19975725|P1|COMPLETED|Overall Study||0
8104383|NCT03166618|19975724|P2|STARTED|Overall Study||1
8104384|NCT03166618|19975725|P1|STARTED|Overall Study||0
8104385|NCT03166215|19975737|P3|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2
8104386|NCT03166215|19975738|P2|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
8104387|NCT03166215|19975739|P1|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
8104388|NCT03166215|19975737|P3|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14
8104389|NCT03166215|19975738|P2|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
8104390|NCT03166215|19975739|P1|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
8104391|NCT03166215|19975737|P3|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16
8104392|NCT03166215|19975738|P2|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
8104393|NCT03166215|19975739|P1|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
8104394|NCT03166215|19975737|P3|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
8104395|NCT03166215|19975738|P2|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2
8104396|NCT03166215|19975739|P1|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
8104397|NCT03166215|19975737|P3|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
8104398|NCT03166215|19975738|P2|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12
8104399|NCT03166215|19975739|P1|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4
8104400|NCT03166215|19975737|P3|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0
8104401|NCT03166215|19975738|P2|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14
8104402|NCT03166215|19975739|P1|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4
8104403|NCT03166124|19975779|P4|NOT COMPLETED|Treatment Period 2||0
8104404|NCT03166124|19975780|P3|NOT COMPLETED|Treatment Period 2||0
8104405|NCT03166124|19975781|P2|NOT COMPLETED|Treatment Period 2||0
8104406|NCT03166124|19975782|P1|NOT COMPLETED|Treatment Period 2||0
8104407|NCT03166124|19975779|P4|COMPLETED|Treatment Period 2||20
8104408|NCT03166124|19975780|P3|COMPLETED|Treatment Period 2||17
8104409|NCT03166124|19975781|P2|COMPLETED|Treatment Period 2||18
8104410|NCT03166124|19975782|P1|COMPLETED|Treatment Period 2||20
8104411|NCT03166124|19975779|P4|STARTED|Treatment Period 2||20
8104412|NCT03166124|19975780|P3|STARTED|Treatment Period 2||17
8104413|NCT03166124|19975781|P2|STARTED|Treatment Period 2||18
8104414|NCT03166124|19975782|P1|STARTED|Treatment Period 2||20
8104415|NCT03166124|19975779|P4|NOT COMPLETED|Wash-out Period||1
8104416|NCT03166124|19975780|P3|NOT COMPLETED|Wash-out Period||1
8104417|NCT03166124|19975781|P2|NOT COMPLETED|Wash-out Period||2
8104418|NCT03166124|19975782|P1|NOT COMPLETED|Wash-out Period||0
8104419|NCT03166124|19975779|P4|COMPLETED|Wash-out Period||20
8104420|NCT03166124|19975780|P3|COMPLETED|Wash-out Period||17
8104421|NCT03166124|19975781|P2|COMPLETED|Wash-out Period||18
8104422|NCT03166124|19975782|P1|COMPLETED|Wash-out Period||20
8104423|NCT03166124|19975779|P4|STARTED|Wash-out Period||21
8104424|NCT03166124|19975780|P3|STARTED|Wash-out Period||18
8104425|NCT03166124|19975781|P2|STARTED|Wash-out Period||20
8104426|NCT03166124|19975782|P1|STARTED|Wash-out Period||20
8104427|NCT03166124|19975779|P4|NOT COMPLETED|Treatment Period 1||0
8104428|NCT03166124|19975780|P3|NOT COMPLETED|Treatment Period 1||1
8104429|NCT03166124|19975781|P2|NOT COMPLETED|Treatment Period 1||0
8104430|NCT03166124|19975782|P1|NOT COMPLETED|Treatment Period 1||0
8104431|NCT03166124|19975779|P4|COMPLETED|Treatment Period 1||21
8104432|NCT03166124|19975780|P3|COMPLETED|Treatment Period 1||18
8104433|NCT03166124|19975781|P2|COMPLETED|Treatment Period 1||20
8104434|NCT03166124|19975782|P1|COMPLETED|Treatment Period 1||20
8104435|NCT03166124|19975779|P4|Received at Least One Dose of Study Drug|Treatment Period 1||21
8104436|NCT03166124|19975780|P3|Received at Least One Dose of Study Drug|Treatment Period 1||18
8104437|NCT03166124|19975781|P2|Received at Least One Dose of Study Drug|Treatment Period 1||20
8104438|NCT03166124|19975782|P1|Received at Least One Dose of Study Drug|Treatment Period 1||20
8104439|NCT03166124|19975779|P4|STARTED|Treatment Period 1||21
8104440|NCT03166124|19975780|P3|STARTED|Treatment Period 1||19
8104441|NCT03166124|19975781|P2|STARTED|Treatment Period 1||20
8104442|NCT03166124|19975782|P1|STARTED|Treatment Period 1||20
8104443|NCT03165981|19975798|P2|NOT COMPLETED|Overall Study||4
8104444|NCT03165981|19975799|P1|NOT COMPLETED|Overall Study||11
8104445|NCT03165981|19975798|P2|COMPLETED|Overall Study||107
8104446|NCT03165981|19975799|P1|COMPLETED|Overall Study||99
8104447|NCT03165981|19975798|P2|Per Protocol Population|Overall Study||107
8104448|NCT03165981|19975799|P1|Per Protocol Population|Overall Study||99
8104449|NCT03165981|19975798|P2|STARTED|Overall Study||111
8104450|NCT03165981|19975799|P1|STARTED|Overall Study||110
8104457|NCT03165916|19975846|P2|NOT COMPLETED|Overall Study||0
8104458|NCT03165916|19975847|P1|NOT COMPLETED|Overall Study||0
8104459|NCT03165916|19975846|P2|COMPLETED|Overall Study||57
8104460|NCT03165916|19975847|P1|COMPLETED|Overall Study||58
8104461|NCT03165916|19975846|P2|Reconstruction Interventions|Overall Study||57
8104462|NCT03165916|19975847|P1|Reconstruction Interventions|Overall Study||59
8104463|NCT03165916|19975846|P2|STARTED|Overall Study||57
8104464|NCT03165916|19975847|P1|STARTED|Overall Study||58
8104465|NCT03165747|19975857|P2|NOT COMPLETED|Overall Study||0
8104466|NCT03165747|19975858|P1|NOT COMPLETED|Overall Study||0
8104467|NCT03165747|19975857|P2|COMPLETED|Overall Study||0
8104468|NCT03165747|19975858|P1|COMPLETED|Overall Study||0
8104469|NCT03165747|19975857|P2|STARTED|Overall Study||0
8104470|NCT03165747|19975858|P1|STARTED|Overall Study||0
8104471|NCT03165617|19975886|P2|NOT COMPLETED|Overall Study||9
8104472|NCT03165617|19975887|P1|NOT COMPLETED|Overall Study||9
8104473|NCT03165617|19975886|P2|COMPLETED|Overall Study||2247
8104474|NCT03165617|19975887|P1|COMPLETED|Overall Study||2249
8104475|NCT03165617|19975886|P2|STARTED|Overall Study||2256
8104476|NCT03165617|19975887|P1|STARTED|Overall Study||2258
8104477|NCT03165175|19975951|P2|NOT COMPLETED|Baseline to 3-month||0
8104478|NCT03165175|19975952|P1|NOT COMPLETED|Baseline to 3-month||4
8104479|NCT03165175|19975951|P2|COMPLETED|Baseline to 3-month||39
8104480|NCT03165175|19975952|P1|COMPLETED|Baseline to 3-month||31
8104481|NCT03165175|19975951|P2|STARTED|Baseline to 3-month||39
8104482|NCT03165175|19975952|P1|STARTED|Baseline to 3-month||35
8104483|NCT03165175|19975951|P2|NOT COMPLETED|1-month to 3-month||0
8104484|NCT03165175|19975952|P1|NOT COMPLETED|1-month to 3-month||6
8104485|NCT03165175|19975951|P2|COMPLETED|1-month to 3-month||39
8104486|NCT03165175|19975952|P1|COMPLETED|1-month to 3-month||35
8104487|NCT03165175|19975951|P2|STARTED|1-month to 3-month||39
8104488|NCT03165175|19975952|P1|STARTED|1-month to 3-month||41
8104489|NCT03165110|19975966|P1|NOT COMPLETED|Overall Study||1
8104490|NCT03165110|19975966|P1|COMPLETED|Overall Study||46
8104491|NCT03165110|19975966|P1|STARTED|Overall Study||47
8104498|NCT03165045|19975988|P1|NOT COMPLETED|Visit 2||182
8104499|NCT03165045|19975988|P1|COMPLETED|Visit 2||1140
8104500|NCT03165045|19975988|P1|STARTED|Visit 2||1322
8104501|NCT03165045|19975988|P1|NOT COMPLETED|Visit 1||29
8104502|NCT03165045|19975988|P1|COMPLETED|Visit 1||1322
8104503|NCT03165045|19975988|P1|STARTED|Visit 1||1351
8104504|NCT03164629|19975999|P2|NOT COMPLETED|Overall Study||0
8104505|NCT03164629|19976000|P1|NOT COMPLETED|Overall Study||0
8104506|NCT03164629|19975999|P2|COMPLETED|Overall Study||25
8104507|NCT03164629|19976000|P1|COMPLETED|Overall Study||25
8104508|NCT03164629|19975999|P2|STARTED|Overall Study||25
8104509|NCT03164629|19976000|P1|STARTED|Overall Study||25
8104510|NCT03164551|19976008|P2|NOT COMPLETED|Overall Study||16
8104511|NCT03164551|19976009|P1|NOT COMPLETED|Overall Study||29
8104512|NCT03164551|19976008|P2|COMPLETED|Overall Study||192
8104513|NCT03164551|19976009|P1|COMPLETED|Overall Study||171
8104514|NCT03164551|19976008|P2|STARTED|Overall Study||208
8104515|NCT03164551|19976009|P1|STARTED|Overall Study||200
8104516|NCT03163758|19976035|P2|NOT COMPLETED|Overall Study||7
8104517|NCT03163758|19976036|P1|NOT COMPLETED|Overall Study||8
8104518|NCT03163758|19976035|P2|COMPLETED|Overall Study||14
8104519|NCT03163758|19976036|P1|COMPLETED|Overall Study||13
8104520|NCT03163758|19976035|P2|STARTED|Overall Study||21
8104521|NCT03163758|19976036|P1|STARTED|Overall Study||21
8104522|NCT03163342|19976048|P1|NOT COMPLETED|Overall Study||0
8104523|NCT03163342|19976048|P1|COMPLETED|Overall Study||20
8104524|NCT03163342|19976048|P1|STARTED|Overall Study||20
8104525|NCT03163303|19976057|P2|NOT COMPLETED|Overall Study||0
8104526|NCT03163303|19976058|P1|NOT COMPLETED|Overall Study||0
8104527|NCT03163303|19976057|P2|COMPLETED|Overall Study||94
8104528|NCT03163303|19976058|P1|COMPLETED|Overall Study||85
8104529|NCT03163303|19976057|P2|STARTED|Overall Study||94
8104530|NCT03163303|19976058|P1|STARTED|Overall Study||85
8104531|NCT03163134|19976092|P2|NOT COMPLETED|Overall Study||0
8104532|NCT03163134|19976093|P1|NOT COMPLETED|Overall Study||0
8104533|NCT03163134|19976092|P2|COMPLETED|Overall Study||85
8104534|NCT03163134|19976093|P1|COMPLETED|Overall Study||85
8104535|NCT03163134|19976092|P2|STARTED|Overall Study||85
8104536|NCT03163134|19976093|P1|STARTED|Overall Study||85
8104537|NCT03163017|19976101|P1|NOT COMPLETED|Overall Study||0
8104538|NCT03163017|19976101|P1|COMPLETED|Overall Study||30
8104539|NCT03163017|19976101|P1|STARTED|Overall Study||30
8104567|NCT03162614|19976432|P6|NOT COMPLETED|Overall Study||0
8104568|NCT03162614|19976433|P5|NOT COMPLETED|Overall Study||5
8104569|NCT03162614|19976434|P4|NOT COMPLETED|Overall Study||7
8104570|NCT03162614|19976435|P3|NOT COMPLETED|Overall Study||4
8104571|NCT03162614|19976436|P2|NOT COMPLETED|Overall Study||5
8104572|NCT03162614|19976437|P1|NOT COMPLETED|Overall Study||6
8104573|NCT03162614|19976432|P6|COMPLETED|Overall Study||24
8104574|NCT03162614|19976433|P5|COMPLETED|Overall Study||21
8104575|NCT03162614|19976434|P4|COMPLETED|Overall Study||19
8104576|NCT03162614|19976435|P3|COMPLETED|Overall Study||22
8104577|NCT03162614|19976436|P2|COMPLETED|Overall Study||21
8104578|NCT03162614|19976437|P1|COMPLETED|Overall Study||20
8104579|NCT03162614|19976432|P6|STARTED|Overall Study||24
8104580|NCT03162614|19976433|P5|STARTED|Overall Study||26
8104581|NCT03162614|19976434|P4|STARTED|Overall Study||26
8104582|NCT03162614|19976435|P3|STARTED|Overall Study||26
8104583|NCT03162614|19976436|P2|STARTED|Overall Study||26
8104584|NCT03162614|19976437|P1|STARTED|Overall Study||26
8104585|NCT03162458|19976531|P2|NOT COMPLETED|Overall Study||0
8104586|NCT03162458|19976532|P1|NOT COMPLETED|Overall Study||0
8104587|NCT03162458|19976531|P2|COMPLETED|Overall Study||71
8104588|NCT03162458|19976532|P1|COMPLETED|Overall Study||71
8104589|NCT03162458|19976531|P2|STARTED|Overall Study||71
8104590|NCT03162458|19976532|P1|STARTED|Overall Study||71
8104591|NCT03162354|19976558|P2|NOT COMPLETED|Overall Study||0
8104592|NCT03162354|19976559|P1|NOT COMPLETED|Overall Study||0
8104593|NCT03162354|19976558|P2|COMPLETED|Overall Study||237
8104594|NCT03162354|19976559|P1|COMPLETED|Overall Study||183
8104595|NCT03162354|19976558|P2|STARTED|Overall Study||237
8104596|NCT03162354|19976559|P1|STARTED|Overall Study||183
8104615|NCT03162055|19976621|P2|NOT COMPLETED|Overall Study||43
8104616|NCT03162055|19976622|P1|NOT COMPLETED|Overall Study||62
8104617|NCT03162055|19976621|P2|COMPLETED|Overall Study||517
8104618|NCT03162055|19976622|P1|COMPLETED|Overall Study||497
8104619|NCT03162055|19976621|P2|Per Protocol (PP) Analysis Set|Overall Study||510
8104620|NCT03162055|19976622|P1|Per Protocol (PP) Analysis Set|Overall Study||506
8104621|NCT03162055|19976621|P2|Full Analysis Set (FAS)|Overall Study||552
8104622|NCT03162055|19976622|P1|Full Analysis Set (FAS)|Overall Study||552
8104623|NCT03162055|19976621|P2|Safety Analysis Set|Overall Study||552
8104624|NCT03162055|19976622|P1|Safety Analysis Set|Overall Study||552
8104625|NCT03162055|19976621|P2|Received Treatment|Overall Study||560
8104626|NCT03162055|19976622|P1|Received Treatment|Overall Study||557
8104627|NCT03162055|19976621|P2|STARTED|Overall Study||560
8104628|NCT03162055|19976622|P1|STARTED|Overall Study||559
8104629|NCT03161964|19976648|P2|NOT COMPLETED|Overall Study||1
8104630|NCT03161964|19976649|P1|NOT COMPLETED|Overall Study||0
8104631|NCT03161964|19976648|P2|COMPLETED|Overall Study||0
8104632|NCT03161964|19976649|P1|COMPLETED|Overall Study||1
8104633|NCT03161964|19976648|P2|STARTED|Overall Study||1
8104634|NCT03161964|19976649|P1|STARTED|Overall Study||1
8104635|NCT03161938|19976687|P2|NOT COMPLETED|Overall Study||0
8104636|NCT03161938|19976688|P1|NOT COMPLETED|Overall Study||0
8104637|NCT03161938|19976687|P2|COMPLETED|Overall Study||32
8104638|NCT03161938|19976688|P1|COMPLETED|Overall Study||32
8104639|NCT03161938|19976687|P2|STARTED|Overall Study||32
8104640|NCT03161938|19976688|P1|STARTED|Overall Study||32
8104641|NCT03161405|19976714|P1|NOT COMPLETED|Second Intervention Period (6 Days)||1
8104642|NCT03161405|19976714|P1|COMPLETED|Second Intervention Period (6 Days)||11
8104643|NCT03161405|19976714|P1|STARTED|Second Intervention Period (6 Days)||12
8104644|NCT03161405|19976714|P1|NOT COMPLETED|Washout Period (at Least 4 Days)||0
8104645|NCT03161405|19976714|P1|COMPLETED|Washout Period (at Least 4 Days)||12
8104646|NCT03161405|19976714|P1|STARTED|Washout Period (at Least 4 Days)||12
8104647|NCT03161405|19976714|P1|NOT COMPLETED|First Intervention Period (3 Days)||0
8104648|NCT03161405|19976714|P1|COMPLETED|First Intervention Period (3 Days)||12
8104649|NCT03161405|19976714|P1|STARTED|First Intervention Period (3 Days)||12
8104650|NCT03161327|19976725|P1|NOT COMPLETED|Overall Study||0
8104651|NCT03161327|19976725|P1|COMPLETED|Overall Study||238
8104652|NCT03161327|19976725|P1|STARTED|Overall Study||238
8104653|NCT03160898|19976734|P4|NOT COMPLETED|Overall Study||19
8104654|NCT03160898|19976735|P3|NOT COMPLETED|Overall Study||16
8104655|NCT03160898|19976736|P2|NOT COMPLETED|Overall Study||13
8104656|NCT03160898|19976737|P1|NOT COMPLETED|Overall Study||20
8104657|NCT03160898|19976734|P4|COMPLETED|Overall Study||98
8104658|NCT03160898|19976735|P3|COMPLETED|Overall Study||97
8104659|NCT03160898|19976736|P2|COMPLETED|Overall Study||100
8104660|NCT03160898|19976737|P1|COMPLETED|Overall Study||95
8104661|NCT03160898|19976734|P4|STARTED|Overall Study||117
8104662|NCT03160898|19976735|P3|STARTED|Overall Study||113
8104663|NCT03160898|19976736|P2|STARTED|Overall Study|1 patient withdrew consent before study drug dosing and was therefore excluded from safety analysis|113
8104664|NCT03160898|19976737|P1|STARTED|Overall Study||115
8104665|NCT03160885|19976760|P7|NOT COMPLETED|Maintenance Treatment Period||0
8104666|NCT03160885|19976761|P6|NOT COMPLETED|Maintenance Treatment Period||15
8104667|NCT03160885|19976762|P5|NOT COMPLETED|Maintenance Treatment Period||31
8104668|NCT03160885|19976763|P4|NOT COMPLETED|Maintenance Treatment Period||40
8104669|NCT03160885|19976764|P3|NOT COMPLETED|Maintenance Treatment Period||39
8104670|NCT03160885|19976765|P2|NOT COMPLETED|Maintenance Treatment Period||0
8104671|NCT03160885|19976766|P1|NOT COMPLETED|Maintenance Treatment Period||0
8104672|NCT03160885|19976760|P7|COMPLETED|Maintenance Treatment Period||0
8104673|NCT03160885|19976761|P6|COMPLETED|Maintenance Treatment Period||16
8104674|NCT03160885|19976762|P5|COMPLETED|Maintenance Treatment Period||15
8104675|NCT03160885|19976763|P4|COMPLETED|Maintenance Treatment Period||50
8104676|NCT03160885|19976764|P3|COMPLETED|Maintenance Treatment Period||52
8104677|NCT03160885|19976765|P2|COMPLETED|Maintenance Treatment Period||0
8104678|NCT03160885|19976766|P1|COMPLETED|Maintenance Treatment Period||0
8104679|NCT03160885|19976760|P7|STARTED|Maintenance Treatment Period||0
8104680|NCT03160885|19976761|P6|STARTED|Maintenance Treatment Period||31
8104681|NCT03160885|19976762|P5|STARTED|Maintenance Treatment Period||46
8104682|NCT03160885|19976763|P4|STARTED|Maintenance Treatment Period||90
8104683|NCT03160885|19976764|P3|STARTED|Maintenance Treatment Period||91
8104684|NCT03160885|19976765|P2|STARTED|Maintenance Treatment Period||0
8104685|NCT03160885|19976766|P1|STARTED|Maintenance Treatment Period||0
8104686|NCT03160885|19976760|P7|NOT COMPLETED|Open-label Treatment||137
8104687|NCT03160885|19976761|P6|NOT COMPLETED|Open-label Treatment||0
8104688|NCT03160885|19976762|P5|NOT COMPLETED|Open-label Treatment||0
8104689|NCT03160885|19976763|P4|NOT COMPLETED|Open-label Treatment||0
8104690|NCT03160885|19976764|P3|NOT COMPLETED|Open-label Treatment||0
8104691|NCT03160885|19976765|P2|NOT COMPLETED|Open-label Treatment||0
8104692|NCT03160885|19976766|P1|NOT COMPLETED|Open-label Treatment||0
8104693|NCT03160885|19976760|P7|COMPLETED|Open-label Treatment||423
8104694|NCT03160885|19976761|P6|COMPLETED|Open-label Treatment||0
8104695|NCT03160885|19976762|P5|COMPLETED|Open-label Treatment||0
8104696|NCT03160885|19976763|P4|COMPLETED|Open-label Treatment||0
8104697|NCT03160885|19976764|P3|COMPLETED|Open-label Treatment||0
8104698|NCT03160885|19976765|P2|COMPLETED|Open-label Treatment||0
8104699|NCT03160885|19976766|P1|COMPLETED|Open-label Treatment||0
8104700|NCT03160885|19976760|P7|STARTED|Open-label Treatment||560
8104701|NCT03160885|19976761|P6|STARTED|Open-label Treatment||0
8104702|NCT03160885|19976762|P5|STARTED|Open-label Treatment||0
8104703|NCT03160885|19976763|P4|STARTED|Open-label Treatment||0
8104704|NCT03160885|19976764|P3|STARTED|Open-label Treatment||0
8104705|NCT03160885|19976765|P2|STARTED|Open-label Treatment||0
8104706|NCT03160885|19976766|P1|STARTED|Open-label Treatment||0
8104707|NCT03160885|19976760|P7|NOT COMPLETED|Initial Treatment Period||0
8104708|NCT03160885|19976761|P6|NOT COMPLETED|Initial Treatment Period||0
8104709|NCT03160885|19976762|P5|NOT COMPLETED|Initial Treatment Period||0
8104710|NCT03160885|19976763|P4|NOT COMPLETED|Initial Treatment Period||0
8104711|NCT03160885|19976764|P3|NOT COMPLETED|Initial Treatment Period||0
8104712|NCT03160885|19976765|P2|NOT COMPLETED|Initial Treatment Period||22
8104713|NCT03160885|19976766|P1|NOT COMPLETED|Initial Treatment Period||35
8104714|NCT03160885|19976760|P7|COMPLETED|Initial Treatment Period||0
8104715|NCT03160885|19976761|P6|COMPLETED|Initial Treatment Period||0
8104716|NCT03160885|19976762|P5|COMPLETED|Initial Treatment Period||0
8104717|NCT03160885|19976763|P4|COMPLETED|Initial Treatment Period||0
8104718|NCT03160885|19976764|P3|COMPLETED|Initial Treatment Period||0
8104719|NCT03160885|19976765|P2|COMPLETED|Initial Treatment Period||179
8104720|NCT03160885|19976766|P1|COMPLETED|Initial Treatment Period||558
8104721|NCT03160885|19976760|P7|STARTED|Initial Treatment Period||0
8104722|NCT03160885|19976761|P6|STARTED|Initial Treatment Period||0
8104723|NCT03160885|19976762|P5|STARTED|Initial Treatment Period||0
8104724|NCT03160885|19976763|P4|STARTED|Initial Treatment Period||0
8104725|NCT03160885|19976764|P3|STARTED|Initial Treatment Period||0
8104726|NCT03160885|19976765|P2|STARTED|Initial Treatment Period||201
8104727|NCT03160885|19976766|P1|STARTED|Initial Treatment Period||593
8104728|NCT03160716|19976812|P1|NOT COMPLETED|Overall Study||1
8104729|NCT03160716|19976812|P1|COMPLETED|Overall Study||59
8104730|NCT03160716|19976812|P1|STARTED|Overall Study||60
8104731|NCT03160703|19976823|P4|NOT COMPLETED|Overall Study||1
8104732|NCT03160703|19976824|P3|NOT COMPLETED|Overall Study||0
8104733|NCT03160703|19976825|P2|NOT COMPLETED|Overall Study||0
8104734|NCT03160703|19976826|P1|NOT COMPLETED|Overall Study||0
8104735|NCT03160703|19976823|P4|COMPLETED|Overall Study||54
8104736|NCT03160703|19976824|P3|COMPLETED|Overall Study||55
8104737|NCT03160703|19976825|P2|COMPLETED|Overall Study||55
8104738|NCT03160703|19976826|P1|COMPLETED|Overall Study||55
8104739|NCT03160703|19976823|P4|STARTED|Overall Study||55
8104740|NCT03160703|19976824|P3|STARTED|Overall Study||55
8104741|NCT03160703|19976825|P2|STARTED|Overall Study||55
8104742|NCT03160703|19976826|P1|STARTED|Overall Study||55
8104743|NCT03160573|19976840|P4|NOT COMPLETED|Second Sequence (3 Weeks)||0
8104744|NCT03160573|19976841|P3|NOT COMPLETED|Second Sequence (3 Weeks)||0
8104745|NCT03160573|19976842|P2|NOT COMPLETED|Second Sequence (3 Weeks)||0
8104746|NCT03160573|19976843|P1|NOT COMPLETED|Second Sequence (3 Weeks)||0
8104747|NCT03160573|19976840|P4|COMPLETED|Second Sequence (3 Weeks)||23
8104748|NCT03160573|19976841|P3|COMPLETED|Second Sequence (3 Weeks)||23
8104749|NCT03160573|19976842|P2|COMPLETED|Second Sequence (3 Weeks)||23
8104750|NCT03160573|19976843|P1|COMPLETED|Second Sequence (3 Weeks)||22
8104751|NCT03160573|19976840|P4|STARTED|Second Sequence (3 Weeks)||23
8104752|NCT03160573|19976841|P3|STARTED|Second Sequence (3 Weeks)||23
8104753|NCT03160573|19976842|P2|STARTED|Second Sequence (3 Weeks)||23
8104754|NCT03160573|19976843|P1|STARTED|Second Sequence (3 Weeks)||22
8104755|NCT03160573|19976840|P4|NOT COMPLETED|Washout (2 Weeks)||0
8104756|NCT03160573|19976841|P3|NOT COMPLETED|Washout (2 Weeks)||0
8104757|NCT03160573|19976842|P2|NOT COMPLETED|Washout (2 Weeks)||0
8104758|NCT03160573|19976843|P1|NOT COMPLETED|Washout (2 Weeks)||0
8104759|NCT03160573|19976840|P4|COMPLETED|Washout (2 Weeks)||23
8104760|NCT03160573|19976841|P3|COMPLETED|Washout (2 Weeks)||23
8104761|NCT03160573|19976842|P2|COMPLETED|Washout (2 Weeks)||23
8104762|NCT03160573|19976843|P1|COMPLETED|Washout (2 Weeks)||22
8104763|NCT03160573|19976840|P4|STARTED|Washout (2 Weeks)||23
8104764|NCT03160573|19976841|P3|STARTED|Washout (2 Weeks)||23
8104765|NCT03160573|19976842|P2|STARTED|Washout (2 Weeks)||23
8104766|NCT03160573|19976843|P1|STARTED|Washout (2 Weeks)||22
8104767|NCT03160573|19976840|P4|NOT COMPLETED|First Sequence (3 Weeks)||2
8104768|NCT03160573|19976841|P3|NOT COMPLETED|First Sequence (3 Weeks)||2
8104769|NCT03160573|19976842|P2|NOT COMPLETED|First Sequence (3 Weeks)||3
8104770|NCT03160573|19976843|P1|NOT COMPLETED|First Sequence (3 Weeks)||1
8104771|NCT03160573|19976840|P4|COMPLETED|First Sequence (3 Weeks)||23
8104772|NCT03160573|19976841|P3|COMPLETED|First Sequence (3 Weeks)||23
8104773|NCT03160573|19976842|P2|COMPLETED|First Sequence (3 Weeks)||23
8104774|NCT03160573|19976843|P1|COMPLETED|First Sequence (3 Weeks)||22
8104775|NCT03160573|19976840|P4|STARTED|First Sequence (3 Weeks)||25
8104776|NCT03160573|19976841|P3|STARTED|First Sequence (3 Weeks)||25
8104777|NCT03160573|19976842|P2|STARTED|First Sequence (3 Weeks)||26
8104778|NCT03160573|19976843|P1|STARTED|First Sequence (3 Weeks)||23
8104779|NCT03160560|19976857|P4|NOT COMPLETED|Second Intervention (3 Weeks)||0
8104780|NCT03160560|19976858|P3|NOT COMPLETED|Second Intervention (3 Weeks)||0
8104781|NCT03160560|19976859|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8104782|NCT03160560|19976860|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
8104783|NCT03160560|19976857|P4|COMPLETED|Second Intervention (3 Weeks)||25
8104784|NCT03160560|19976858|P3|COMPLETED|Second Intervention (3 Weeks)||24
8104785|NCT03160560|19976859|P2|COMPLETED|Second Intervention (3 Weeks)||24
8104786|NCT03160560|19976860|P1|COMPLETED|Second Intervention (3 Weeks)||22
8104787|NCT03160560|19976857|P4|STARTED|Second Intervention (3 Weeks)||25
8104788|NCT03160560|19976858|P3|STARTED|Second Intervention (3 Weeks)||24
8104789|NCT03160560|19976859|P2|STARTED|Second Intervention (3 Weeks)||24
8104790|NCT03160560|19976860|P1|STARTED|Second Intervention (3 Weeks)||23
8104791|NCT03160560|19976857|P4|NOT COMPLETED|Washout (2 Weeks)||0
8104792|NCT03160560|19976858|P3|NOT COMPLETED|Washout (2 Weeks)||0
8104793|NCT03160560|19976859|P2|NOT COMPLETED|Washout (2 Weeks)||0
8104794|NCT03160560|19976860|P1|NOT COMPLETED|Washout (2 Weeks)||0
8104795|NCT03160560|19976857|P4|COMPLETED|Washout (2 Weeks)||25
8104796|NCT03160560|19976858|P3|COMPLETED|Washout (2 Weeks)||24
8104797|NCT03160560|19976859|P2|COMPLETED|Washout (2 Weeks)||24
8104798|NCT03160560|19976860|P1|COMPLETED|Washout (2 Weeks)||23
8104799|NCT03160560|19976857|P4|STARTED|Washout (2 Weeks)||25
8104800|NCT03160560|19976858|P3|STARTED|Washout (2 Weeks)||24
8104801|NCT03160560|19976859|P2|STARTED|Washout (2 Weeks)||24
8104802|NCT03160560|19976860|P1|STARTED|Washout (2 Weeks)||23
8104803|NCT03160560|19976857|P4|NOT COMPLETED|First Intervention (3 Weeks)||0
8104804|NCT03160560|19976858|P3|NOT COMPLETED|First Intervention (3 Weeks)||1
8104805|NCT03160560|19976859|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
8104806|NCT03160560|19976860|P1|NOT COMPLETED|First Intervention (3 Weeks)||2
8104807|NCT03160560|19976857|P4|COMPLETED|First Intervention (3 Weeks)||25
8104808|NCT03160560|19976858|P3|COMPLETED|First Intervention (3 Weeks)||24
8104809|NCT03160560|19976859|P2|COMPLETED|First Intervention (3 Weeks)||24
8104810|NCT03160560|19976860|P1|COMPLETED|First Intervention (3 Weeks)||23
8104811|NCT03160560|19976857|P4|STARTED|First Intervention (3 Weeks)||25
8104812|NCT03160560|19976858|P3|STARTED|First Intervention (3 Weeks)||25
8104813|NCT03160560|19976859|P2|STARTED|First Intervention (3 Weeks)||25
8104814|NCT03160560|19976860|P1|STARTED|First Intervention (3 Weeks)||25
8104815|NCT03160170|19976872|P2|NOT COMPLETED|Overall Study||0
8104816|NCT03160170|19976873|P1|NOT COMPLETED|Overall Study||0
8104817|NCT03160170|19976872|P2|COMPLETED|Overall Study||10
8104818|NCT03160170|19976873|P1|COMPLETED|Overall Study||10
8104819|NCT03160170|19976872|P2|STARTED|Overall Study||10
8104820|NCT03160170|19976873|P1|STARTED|Overall Study||10
8104821|NCT03160027|19976887|P4|NOT COMPLETED|Overall Study||0
8104822|NCT03160027|19976888|P3|NOT COMPLETED|Overall Study||0
8104823|NCT03160027|19976889|P2|NOT COMPLETED|Overall Study||0
8104824|NCT03160027|19976890|P1|NOT COMPLETED|Overall Study||0
8104825|NCT03160027|19976887|P4|COMPLETED|Overall Study||4
8104826|NCT03160027|19976888|P3|COMPLETED|Overall Study||6
8104827|NCT03160027|19976889|P2|COMPLETED|Overall Study||4
8104828|NCT03160027|19976890|P1|COMPLETED|Overall Study||6
8104829|NCT03160027|19976887|P4|STARTED|Overall Study||4
8104830|NCT03160027|19976888|P3|STARTED|Overall Study||6
8104831|NCT03160027|19976889|P2|STARTED|Overall Study||4
8104832|NCT03160027|19976890|P1|STARTED|Overall Study||6
8104833|NCT03159624|19976925|P2|NOT COMPLETED|Overall Study||1
8104834|NCT03159624|19976926|P1|NOT COMPLETED|Overall Study||0
8104835|NCT03159624|19976925|P2|COMPLETED|Overall Study||25
8104836|NCT03159624|19976926|P1|COMPLETED|Overall Study||21
8104837|NCT03159624|19976925|P2|STARTED|Overall Study||26
8104838|NCT03159624|19976926|P1|STARTED|Overall Study||21
8104839|NCT03159611|19976938|P2|NOT COMPLETED|Overall Study||15
8104840|NCT03159611|19976939|P1|NOT COMPLETED|Overall Study||23
8104841|NCT03159611|19976938|P2|COMPLETED|Overall Study||72
8104842|NCT03159611|19976939|P1|COMPLETED|Overall Study||72
8104843|NCT03159611|19976938|P2|STARTED|Overall Study||87
8104844|NCT03159611|19976939|P1|STARTED|Overall Study||95
8104845|NCT03159468|19976959|P6|NOT COMPLETED|Overall Study||0
8104846|NCT03159468|19976960|P5|NOT COMPLETED|Overall Study||0
8104847|NCT03159468|19976961|P4|NOT COMPLETED|Overall Study||0
8104848|NCT03159468|19976962|P3|NOT COMPLETED|Overall Study||3
8104849|NCT03159468|19976963|P2|NOT COMPLETED|Overall Study||0
8104850|NCT03159468|19976964|P1|NOT COMPLETED|Overall Study||0
8104851|NCT03159468|19976959|P6|COMPLETED|Overall Study||34
8104852|NCT03159468|19976960|P5|COMPLETED|Overall Study||34
8104853|NCT03159468|19976961|P4|COMPLETED|Overall Study||34
8104854|NCT03159468|19976962|P3|COMPLETED|Overall Study||34
8104855|NCT03159468|19976963|P2|COMPLETED|Overall Study||35
8104856|NCT03159468|19976964|P1|COMPLETED|Overall Study||35
8104857|NCT03159468|19976959|P6|STARTED|Overall Study||34
8104858|NCT03159468|19976960|P5|STARTED|Overall Study||34
8104859|NCT03159468|19976961|P4|STARTED|Overall Study||34
8104860|NCT03159468|19976962|P3|STARTED|Overall Study||37
8104861|NCT03159468|19976963|P2|STARTED|Overall Study||35
8104862|NCT03159468|19976964|P1|STARTED|Overall Study||35
8104863|NCT03159299|19976980|P2|NOT COMPLETED|Overall Study||1
8104864|NCT03159299|19976981|P1|NOT COMPLETED|Overall Study||2
8104865|NCT03159299|19976980|P2|COMPLETED|Overall Study||20
8104866|NCT03159299|19976981|P1|COMPLETED|Overall Study||24
8104867|NCT03159299|19976980|P2|STARTED|Overall Study||21
8104868|NCT03159299|19976981|P1|STARTED|Overall Study||26
8104869|NCT03159260|19976989|P2|NOT COMPLETED|Overall Study||4
8104870|NCT03159260|19976990|P1|NOT COMPLETED|Overall Study||3
8104871|NCT03159260|19976989|P2|COMPLETED|Overall Study||25
8104872|NCT03159260|19976990|P1|COMPLETED|Overall Study||25
8104873|NCT03159260|19976989|P2|STARTED|Overall Study||29
8104874|NCT03159260|19976990|P1|STARTED|Overall Study||28
8104875|NCT03159143|19977004|P1|NOT COMPLETED|Overall Study||0
8104876|NCT03159143|19977004|P1|COMPLETED|Overall Study||22
8104877|NCT03159143|19977004|P1|STARTED|Overall Study||22
8104878|NCT03159091|19977013|P2|NOT COMPLETED|Overall Study||4
8104879|NCT03159091|19977014|P1|NOT COMPLETED|Overall Study||5
8104880|NCT03159091|19977013|P2|COMPLETED|Overall Study||113
8104881|NCT03159091|19977014|P1|COMPLETED|Overall Study||116
8104882|NCT03159091|19977013|P2|STARTED|Overall Study||117
8104883|NCT03159091|19977014|P1|STARTED|Overall Study||121
8104892|NCT03158311|19977064|P3|NOT COMPLETED|Overall Study||28
8104893|NCT03158311|19977065|P2|NOT COMPLETED|Overall Study||16
8104894|NCT03158311|19977066|P1|NOT COMPLETED|Overall Study||22
8104895|NCT03158311|19977064|P3|COMPLETED|Overall Study||448
8104896|NCT03158311|19977065|P2|COMPLETED|Overall Study||460
8104897|NCT03158311|19977066|P1|COMPLETED|Overall Study||452
8104898|NCT03158311|19977064|P3|Safety Set (SAF)|Overall Study||475
8104899|NCT03158311|19977065|P2|Safety Set (SAF)|Overall Study||476
8104900|NCT03158311|19977066|P1|Safety Set (SAF)|Overall Study||474
8104901|NCT03158311|19977064|P3|Full Analysis Set (FAS)|Overall Study||475
8104902|NCT03158311|19977065|P2|Full Analysis Set (FAS)|Overall Study||476
8104903|NCT03158311|19977066|P1|Full Analysis Set (FAS)|Overall Study||474
8104904|NCT03158311|19977064|P3|STARTED|Overall Study||476
8104905|NCT03158311|19977065|P2|STARTED|Overall Study||476
8104906|NCT03158311|19977066|P1|STARTED|Overall Study||474
8104907|NCT03158285|19977098|P3|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
8104908|NCT03158285|19977099|P2|NOT COMPLETED|Active Treatment Period: Week 24 - 52||6
8104909|NCT03158285|19977100|P1|NOT COMPLETED|Active Treatment Period: Week 24 - 52||10
8104910|NCT03158285|19977098|P3|COMPLETED|Active Treatment Period: Week 24 - 52||227
8104911|NCT03158285|19977099|P2|COMPLETED|Active Treatment Period: Week 24 - 52||234
8104912|NCT03158285|19977100|P1|COMPLETED|Active Treatment Period: Week 24 - 52||228
8104913|NCT03158285|19977098|P3|STARTED|Active Treatment Period: Week 24 - 52|2 participants who discontinued without receiving study agent at and post Week 24 were not included.|234
8104914|NCT03158285|19977099|P2|STARTED|Active Treatment Period: Week 24 - 52||240
8104915|NCT03158285|19977100|P1|STARTED|Active Treatment Period: Week 24 - 52|2 participants who discontinued without receiving study agent at and post Week 24 were not included.|238
8104916|NCT03158285|19977098|P3|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||9
8104917|NCT03158285|19977099|P2|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||8
8104918|NCT03158285|19977100|P1|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||6
8104919|NCT03158285|19977098|P3|COMPLETED|Placebo-controlled Period: Week 0 - 24||236
8104920|NCT03158285|19977099|P2|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
8104921|NCT03158285|19977100|P1|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
8104922|NCT03158285|19977098|P3|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (159) = 38 (CNTO1959PSA3001) + 121 (CNTO1959PSA3002)|159
8104923|NCT03158285|19977099|P2|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (160) = 49 (CNTO1959PSA3001) + 111 (CNTO1959PSA3002)|160
8104924|NCT03158285|19977100|P1|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (154) = 55 (CNTO1959PSA3001) + 99 (CNTO1959PSA3002)|154
8104925|NCT03158285|19977098|P3|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (243)= 73 (CNTO1959PSA3001) + 170 (CNTO1959PSA3002)|243
8104926|NCT03158285|19977099|P2|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (230)= 72 (CNTO1959PSA3001) + 158 (CNTO1959PSA3002)|230
8104927|NCT03158285|19977100|P1|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (255) = 77 (CNTO1959PSA3001[NCT03162796]) + 178 (CNTO1959PSA3002)|255
8104928|NCT03158285|19977098|P3|STARTED|Placebo-controlled Period: Week 0 - 24||245
8104929|NCT03158285|19977099|P2|STARTED|Placebo-controlled Period: Week 0 - 24||248
8104930|NCT03158285|19977100|P1|STARTED|Placebo-controlled Period: Week 0 - 24||246
8104931|NCT03158272|19977316|P4|NOT COMPLETED|Overall Study||6
8104932|NCT03158272|19977317|P3|NOT COMPLETED|Overall Study||6
8104933|NCT03158272|19977318|P2|NOT COMPLETED|Overall Study||4
8104934|NCT03158272|19977319|P1|NOT COMPLETED|Overall Study||3
8104935|NCT03158272|19977316|P4|COMPLETED|Overall Study||0
8104936|NCT03158272|19977317|P3|COMPLETED|Overall Study||0
8104937|NCT03158272|19977318|P2|COMPLETED|Overall Study||0
8104938|NCT03158272|19977319|P1|COMPLETED|Overall Study||0
8104939|NCT03158272|19977316|P4|STARTED|Overall Study||6
8104940|NCT03158272|19977317|P3|STARTED|Overall Study||6
8104941|NCT03158272|19977318|P2|STARTED|Overall Study||4
8104942|NCT03158272|19977319|P1|STARTED|Overall Study||3
8104943|NCT03158220|19977389|P2|NOT COMPLETED|Overall Study||16
8104944|NCT03158220|19977390|P1|NOT COMPLETED|Overall Study||17
8104945|NCT03158220|19977389|P2|COMPLETED|Overall Study||626
8104946|NCT03158220|19977390|P1|COMPLETED|Overall Study||553
8104947|NCT03158220|19977389|P2|Vaccination 3|Overall Study||629
8104948|NCT03158220|19977390|P1|Vaccination 3|Overall Study||556
8104949|NCT03158220|19977389|P2|Vaccination 2|Overall Study||635
8104950|NCT03158220|19977390|P1|Vaccination 2|Overall Study||563
8104951|NCT03158220|19977389|P2|Vaccination 1|Overall Study||640
8104952|NCT03158220|19977390|P1|Vaccination 1|Overall Study||570
8104953|NCT03158220|19977389|P2|STARTED|Overall Study||642
8104954|NCT03158220|19977390|P1|STARTED|Overall Study||570
8104955|NCT03158038|19977410|P2|NOT COMPLETED|Overall Study||0
8104956|NCT03158038|19977411|P1|NOT COMPLETED|Overall Study||0
8104957|NCT03158038|19977410|P2|COMPLETED|Overall Study||60
8104958|NCT03158038|19977411|P1|COMPLETED|Overall Study||240
8104959|NCT03158038|19977410|P2|STARTED|Overall Study||60
8104960|NCT03158038|19977411|P1|STARTED|Overall Study||240
8104961|NCT03158012|19977427|P2|NOT COMPLETED|Overall Study||1
8104962|NCT03158012|19977428|P1|NOT COMPLETED|Overall Study||0
8104963|NCT03158012|19977427|P2|COMPLETED|Overall Study||6
8104964|NCT03158012|19977428|P1|COMPLETED|Overall Study||8
8104965|NCT03158012|19977427|P2|STARTED|Overall Study||7
8104966|NCT03158012|19977428|P1|STARTED|Overall Study||8
8104967|NCT03157583|19977434|P1|NOT COMPLETED|Overall Study||1
8104968|NCT03157583|19977434|P1|COMPLETED|Overall Study||7
8104969|NCT03157583|19977434|P1|STARTED|Overall Study||8
8104970|NCT03157531|19977452|P1|NOT COMPLETED|Overall Study||6
8104971|NCT03157531|19977452|P1|COMPLETED|Overall Study||91
8104972|NCT03157531|19977452|P1|Analyzed at 30 Days For MAEs|Overall Study||93
8104973|NCT03157531|19977452|P1|STARTED|Overall Study||97
8104974|NCT03157232|19977467|P1|NOT COMPLETED|Overall Study||0
8104975|NCT03157232|19977467|P1|COMPLETED|Overall Study||18
8104976|NCT03157232|19977467|P1|STARTED|Overall Study||18
8104977|NCT03156543|19977473|P2|NOT COMPLETED|Overall Study||0
8104978|NCT03156543|19977474|P1|NOT COMPLETED|Overall Study||1
8104979|NCT03156543|19977473|P2|COMPLETED|Overall Study||23
8104980|NCT03156543|19977474|P1|COMPLETED|Overall Study||8
8104981|NCT03156543|19977473|P2|STARTED|Overall Study||23
8104982|NCT03156543|19977474|P1|STARTED|Overall Study||9
8104983|NCT03155269|19977484|P2|NOT COMPLETED|Overall Study||7
8104984|NCT03155269|19977485|P1|NOT COMPLETED|Overall Study||5
8104985|NCT03155269|19977484|P2|COMPLETED|Overall Study||50
8104986|NCT03155269|19977485|P1|COMPLETED|Overall Study||52
8104987|NCT03155269|19977484|P2|STARTED|Overall Study||57
8104988|NCT03155269|19977485|P1|STARTED|Overall Study||57
8104989|NCT03155178|19977531|P4|NOT COMPLETED|Overall Study||7
8104990|NCT03155178|19977532|P3|NOT COMPLETED|Overall Study||7
8104991|NCT03155178|19977533|P2|NOT COMPLETED|Overall Study||7
8104992|NCT03155178|19977534|P1|NOT COMPLETED|Overall Study||7
8104993|NCT03155178|19977531|P4|COMPLETED|Overall Study||62
8104994|NCT03155178|19977532|P3|COMPLETED|Overall Study||62
8104995|NCT03155178|19977533|P2|COMPLETED|Overall Study||62
8104996|NCT03155178|19977534|P1|COMPLETED|Overall Study||62
8104997|NCT03155178|19977531|P4|STARTED|Overall Study||69
8104998|NCT03155178|19977532|P3|STARTED|Overall Study||69
8104999|NCT03155178|19977533|P2|STARTED|Overall Study||69
8105000|NCT03155178|19977534|P1|STARTED|Overall Study||69
8105001|NCT03154333|19977554|P2|NOT COMPLETED|Overall Study||5
8105002|NCT03154333|19977555|P1|NOT COMPLETED|Overall Study||7
8105003|NCT03154333|19977554|P2|COMPLETED|Overall Study||21
8105004|NCT03154333|19977555|P1|COMPLETED|Overall Study||21
8105005|NCT03154333|19977554|P2|STARTED|Overall Study||26
8105006|NCT03154333|19977555|P1|STARTED|Overall Study||28
8105007|NCT03154086|19977578|P15|NOT COMPLETED|Part B (Up to 25 Days)||0
8105008|NCT03154086|19977579|P14|NOT COMPLETED|Part B (Up to 25 Days)||0
8105009|NCT03154086|19977580|P13|NOT COMPLETED|Part B (Up to 25 Days)||0
8105010|NCT03154086|19977581|P12|NOT COMPLETED|Part B (Up to 25 Days)||0
8105011|NCT03154086|19977582|P11|NOT COMPLETED|Part B (Up to 25 Days)||1
8105012|NCT03154086|19977583|P10|NOT COMPLETED|Part B (Up to 25 Days)||0
8105013|NCT03154086|19977584|P9|NOT COMPLETED|Part B (Up to 25 Days)||0
8105014|NCT03154086|19977585|P8|NOT COMPLETED|Part B (Up to 25 Days)||0
8105015|NCT03154086|19977586|P7|NOT COMPLETED|Part B (Up to 25 Days)||0
8105016|NCT03154086|19977587|P6|NOT COMPLETED|Part B (Up to 25 Days)||0
8105017|NCT03154086|19977588|P5|NOT COMPLETED|Part B (Up to 25 Days)||0
8105018|NCT03154086|19977589|P4|NOT COMPLETED|Part B (Up to 25 Days)||0
8105019|NCT03154086|19977590|P3|NOT COMPLETED|Part B (Up to 25 Days)||0
8105020|NCT03154086|19977591|P2|NOT COMPLETED|Part B (Up to 25 Days)||0
8105021|NCT03154086|19977592|P1|NOT COMPLETED|Part B (Up to 25 Days)||0
8105022|NCT03154086|19977578|P15|COMPLETED|Part B (Up to 25 Days)||6
8105023|NCT03154086|19977579|P14|COMPLETED|Part B (Up to 25 Days)||6
8105024|NCT03154086|19977580|P13|COMPLETED|Part B (Up to 25 Days)||6
8105025|NCT03154086|19977581|P12|COMPLETED|Part B (Up to 25 Days)||6
8105026|NCT03154086|19977582|P11|COMPLETED|Part B (Up to 25 Days)||5
8105027|NCT03154086|19977583|P10|COMPLETED|Part B (Up to 25 Days)||10
8105028|NCT03154086|19977584|P9|COMPLETED|Part B (Up to 25 Days)||0
8105029|NCT03154086|19977585|P8|COMPLETED|Part B (Up to 25 Days)||0
8105030|NCT03154086|19977586|P7|COMPLETED|Part B (Up to 25 Days)||0
8105031|NCT03154086|19977587|P6|COMPLETED|Part B (Up to 25 Days)||0
8105032|NCT03154086|19977588|P5|COMPLETED|Part B (Up to 25 Days)||0
8105033|NCT03154086|19977589|P4|COMPLETED|Part B (Up to 25 Days)||0
8105034|NCT03154086|19977590|P3|COMPLETED|Part B (Up to 25 Days)||0
8105035|NCT03154086|19977591|P2|COMPLETED|Part B (Up to 25 Days)||0
8105036|NCT03154086|19977592|P1|COMPLETED|Part B (Up to 25 Days)||0
8105037|NCT03154086|19977578|P15|STARTED|Part B (Up to 25 Days)||6
8105038|NCT03154086|19977579|P14|STARTED|Part B (Up to 25 Days)||6
8105039|NCT03154086|19977580|P13|STARTED|Part B (Up to 25 Days)||6
8105040|NCT03154086|19977581|P12|STARTED|Part B (Up to 25 Days)||6
8105041|NCT03154086|19977582|P11|STARTED|Part B (Up to 25 Days)||6
8105042|NCT03154086|19977583|P10|STARTED|Part B (Up to 25 Days)||10
8105043|NCT03154086|19977584|P9|STARTED|Part B (Up to 25 Days)||0
8105044|NCT03154086|19977585|P8|STARTED|Part B (Up to 25 Days)||0
8105045|NCT03154086|19977586|P7|STARTED|Part B (Up to 25 Days)||0
8105046|NCT03154086|19977587|P6|STARTED|Part B (Up to 25 Days)||0
8105047|NCT03154086|19977588|P5|STARTED|Part B (Up to 25 Days)||0
8105048|NCT03154086|19977589|P4|STARTED|Part B (Up to 25 Days)||0
8105049|NCT03154086|19977590|P3|STARTED|Part B (Up to 25 Days)||0
8105050|NCT03154086|19977591|P2|STARTED|Part B (Up to 25 Days)||0
8105051|NCT03154086|19977592|P1|STARTED|Part B (Up to 25 Days)||0
8105052|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105053|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105054|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105055|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105056|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105057|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105058|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
8105059|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
8105060|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105061|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105062|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105063|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105064|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105065|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105066|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105067|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105068|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105069|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105070|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105071|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105072|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105073|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4
8105074|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
8105075|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2
8105076|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105077|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105078|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105079|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105080|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105081|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105082|NCT03154086|19977578|P15|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105083|NCT03154086|19977579|P14|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105084|NCT03154086|19977580|P13|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105085|NCT03154086|19977581|P12|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105086|NCT03154086|19977582|P11|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105087|NCT03154086|19977583|P10|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105088|NCT03154086|19977584|P9|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5
8105089|NCT03154086|19977585|P8|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
8105090|NCT03154086|19977586|P7|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
8105091|NCT03154086|19977587|P6|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105092|NCT03154086|19977588|P5|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105093|NCT03154086|19977589|P4|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105094|NCT03154086|19977590|P3|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105095|NCT03154086|19977591|P2|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105096|NCT03154086|19977592|P1|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
8105097|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105098|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105099|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105100|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105101|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105102|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105103|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105104|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105105|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105106|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105107|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105108|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105109|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105110|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105111|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105112|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105113|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105114|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105115|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105116|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105117|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105118|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
8105119|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
8105120|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
8105121|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105122|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105123|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105124|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105125|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105126|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105127|NCT03154086|19977578|P15|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105128|NCT03154086|19977579|P14|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105129|NCT03154086|19977580|P13|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105130|NCT03154086|19977581|P12|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105131|NCT03154086|19977582|P11|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105132|NCT03154086|19977583|P10|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105133|NCT03154086|19977584|P9|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
8105134|NCT03154086|19977585|P8|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
8105135|NCT03154086|19977586|P7|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
8105136|NCT03154086|19977587|P6|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105137|NCT03154086|19977588|P5|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105138|NCT03154086|19977589|P4|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105139|NCT03154086|19977590|P3|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105140|NCT03154086|19977591|P2|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105141|NCT03154086|19977592|P1|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
8105142|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105143|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105144|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105145|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105146|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105147|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105148|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105149|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105150|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105151|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105152|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105153|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105154|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105155|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105156|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105157|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105158|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105159|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105160|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105161|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105162|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105163|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4
8105164|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
8105165|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
8105166|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105167|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105168|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105169|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105170|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105171|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105172|NCT03154086|19977578|P15|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105173|NCT03154086|19977579|P14|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105174|NCT03154086|19977580|P13|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105175|NCT03154086|19977581|P12|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105176|NCT03154086|19977582|P11|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105177|NCT03154086|19977583|P10|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105178|NCT03154086|19977584|P9|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4
8105179|NCT03154086|19977585|P8|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
8105180|NCT03154086|19977586|P7|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
8105181|NCT03154086|19977587|P6|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105182|NCT03154086|19977588|P5|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105183|NCT03154086|19977589|P4|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105184|NCT03154086|19977590|P3|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105185|NCT03154086|19977591|P2|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105186|NCT03154086|19977592|P1|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
8105187|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105188|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105189|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105190|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105191|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105192|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105193|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105194|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105195|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105196|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105197|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105198|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105199|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105200|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105201|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105202|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105203|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105204|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105205|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105206|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105207|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105208|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105209|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105210|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105211|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2
8105212|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6
8105213|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105214|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105215|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105216|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105217|NCT03154086|19977578|P15|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105218|NCT03154086|19977579|P14|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105219|NCT03154086|19977580|P13|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105220|NCT03154086|19977581|P12|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105221|NCT03154086|19977582|P11|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105222|NCT03154086|19977583|P10|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105223|NCT03154086|19977584|P9|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105224|NCT03154086|19977585|P8|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105225|NCT03154086|19977586|P7|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105226|NCT03154086|19977587|P6|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2
8105227|NCT03154086|19977588|P5|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6
8105228|NCT03154086|19977589|P4|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105229|NCT03154086|19977590|P3|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105230|NCT03154086|19977591|P2|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105231|NCT03154086|19977592|P1|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
8105232|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105233|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105234|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105235|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105236|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105237|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105238|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105239|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105240|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105241|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105242|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105243|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105244|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105245|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105246|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105247|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105248|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105249|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105250|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105251|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105252|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105253|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105254|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105255|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105256|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
8105257|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
8105258|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105259|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105260|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105261|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105262|NCT03154086|19977578|P15|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105263|NCT03154086|19977579|P14|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105264|NCT03154086|19977580|P13|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105265|NCT03154086|19977581|P12|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105266|NCT03154086|19977582|P11|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105267|NCT03154086|19977583|P10|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105268|NCT03154086|19977584|P9|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105269|NCT03154086|19977585|P8|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105270|NCT03154086|19977586|P7|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105271|NCT03154086|19977587|P6|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
8105272|NCT03154086|19977588|P5|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
8105273|NCT03154086|19977589|P4|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105274|NCT03154086|19977590|P3|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105275|NCT03154086|19977591|P2|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105276|NCT03154086|19977592|P1|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
8105277|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105278|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105279|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105280|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105281|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105282|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105283|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105284|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105285|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105286|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105287|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105288|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105289|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105290|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105291|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105292|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105293|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105294|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105295|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105296|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105297|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105298|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105299|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105300|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105301|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2
8105302|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6
8105303|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105304|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105305|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105306|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105307|NCT03154086|19977578|P15|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105308|NCT03154086|19977579|P14|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105309|NCT03154086|19977580|P13|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105310|NCT03154086|19977581|P12|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105311|NCT03154086|19977582|P11|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105312|NCT03154086|19977583|P10|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105313|NCT03154086|19977584|P9|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105314|NCT03154086|19977585|P8|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105315|NCT03154086|19977586|P7|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105316|NCT03154086|19977587|P6|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2
8105317|NCT03154086|19977588|P5|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6
8105318|NCT03154086|19977589|P4|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105319|NCT03154086|19977590|P3|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105320|NCT03154086|19977591|P2|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105321|NCT03154086|19977592|P1|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
8105322|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105323|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105324|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105325|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105326|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105327|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105328|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105329|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105330|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105331|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105332|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105333|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105334|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105335|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105336|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
8105337|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105338|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105339|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105340|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105341|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105342|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105343|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105344|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105345|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105346|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105347|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105348|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
8105349|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
8105350|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
8105351|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
8105352|NCT03154086|19977578|P15|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105353|NCT03154086|19977579|P14|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105354|NCT03154086|19977580|P13|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105355|NCT03154086|19977581|P12|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105356|NCT03154086|19977582|P11|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105357|NCT03154086|19977583|P10|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105358|NCT03154086|19977584|P9|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105359|NCT03154086|19977585|P8|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105360|NCT03154086|19977586|P7|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105361|NCT03154086|19977587|P6|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105362|NCT03154086|19977588|P5|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
8105363|NCT03154086|19977589|P4|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
8105364|NCT03154086|19977590|P3|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1
8105365|NCT03154086|19977591|P2|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
8105366|NCT03154086|19977592|P1|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3
8105367|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105368|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105369|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105370|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105371|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105372|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105373|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105374|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105375|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105376|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105377|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105378|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105379|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
8105380|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105381|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105382|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105383|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105384|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105385|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105386|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105387|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105388|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105389|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105390|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105391|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105392|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105393|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
8105394|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
8105395|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
8105396|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
8105397|NCT03154086|19977578|P15|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105398|NCT03154086|19977579|P14|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105399|NCT03154086|19977580|P13|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105400|NCT03154086|19977581|P12|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105401|NCT03154086|19977582|P11|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105402|NCT03154086|19977583|P10|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105403|NCT03154086|19977584|P9|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105404|NCT03154086|19977585|P8|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105405|NCT03154086|19977586|P7|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105406|NCT03154086|19977587|P6|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105407|NCT03154086|19977588|P5|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
8105408|NCT03154086|19977589|P4|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
8105409|NCT03154086|19977590|P3|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
8105410|NCT03154086|19977591|P2|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
8105411|NCT03154086|19977592|P1|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
8105412|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105413|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105414|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105415|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105416|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105417|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105418|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105419|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105420|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105421|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105422|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105423|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105424|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105425|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105426|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105427|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105428|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105429|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105430|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105431|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105432|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105433|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105434|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105435|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105436|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105437|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105438|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8105439|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8105440|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8105441|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8105442|NCT03154086|19977578|P15|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105443|NCT03154086|19977579|P14|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105444|NCT03154086|19977580|P13|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105445|NCT03154086|19977581|P12|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105446|NCT03154086|19977582|P11|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105447|NCT03154086|19977583|P10|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105448|NCT03154086|19977584|P9|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105449|NCT03154086|19977585|P8|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105450|NCT03154086|19977586|P7|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105451|NCT03154086|19977587|P6|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105452|NCT03154086|19977588|P5|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
8105453|NCT03154086|19977589|P4|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8105454|NCT03154086|19977590|P3|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8105455|NCT03154086|19977591|P2|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2
8105456|NCT03154086|19977592|P1|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
8105457|NCT03154086|19977578|P15|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105458|NCT03154086|19977579|P14|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105459|NCT03154086|19977580|P13|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105460|NCT03154086|19977581|P12|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105461|NCT03154086|19977582|P11|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105462|NCT03154086|19977583|P10|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105463|NCT03154086|19977584|P9|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105464|NCT03154086|19977585|P8|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105465|NCT03154086|19977586|P7|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105466|NCT03154086|19977587|P6|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105467|NCT03154086|19977588|P5|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105468|NCT03154086|19977589|P4|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105469|NCT03154086|19977590|P3|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105470|NCT03154086|19977591|P2|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
8105471|NCT03154086|19977592|P1|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105472|NCT03154086|19977578|P15|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105473|NCT03154086|19977579|P14|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105474|NCT03154086|19977580|P13|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105475|NCT03154086|19977581|P12|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105476|NCT03154086|19977582|P11|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105477|NCT03154086|19977583|P10|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105478|NCT03154086|19977584|P9|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105479|NCT03154086|19977585|P8|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105480|NCT03154086|19977586|P7|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105481|NCT03154086|19977587|P6|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105482|NCT03154086|19977588|P5|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105483|NCT03154086|19977589|P4|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
8105484|NCT03154086|19977590|P3|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
8105485|NCT03154086|19977591|P2|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
8105486|NCT03154086|19977592|P1|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
8105487|NCT03154086|19977578|P15|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105488|NCT03154086|19977579|P14|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105489|NCT03154086|19977580|P13|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105490|NCT03154086|19977581|P12|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105491|NCT03154086|19977582|P11|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105492|NCT03154086|19977583|P10|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105493|NCT03154086|19977584|P9|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105494|NCT03154086|19977585|P8|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105495|NCT03154086|19977586|P7|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105496|NCT03154086|19977587|P6|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105497|NCT03154086|19977588|P5|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
8105498|NCT03154086|19977589|P4|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
8105499|NCT03154086|19977590|P3|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
8105500|NCT03154086|19977591|P2|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
8105501|NCT03154086|19977592|P1|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
8105502|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105503|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105504|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105505|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105506|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105507|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105508|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105509|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105510|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105511|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105512|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105513|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105514|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105515|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105516|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105517|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105518|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105519|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105520|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105521|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105522|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105523|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105524|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105525|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105526|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105527|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105528|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
8105529|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
8105530|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
8105531|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
8105532|NCT03154086|19977578|P15|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105533|NCT03154086|19977579|P14|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105534|NCT03154086|19977580|P13|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105535|NCT03154086|19977581|P12|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105536|NCT03154086|19977582|P11|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105537|NCT03154086|19977583|P10|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105538|NCT03154086|19977584|P9|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105539|NCT03154086|19977585|P8|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105540|NCT03154086|19977586|P7|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105541|NCT03154086|19977587|P6|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105542|NCT03154086|19977588|P5|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
8105543|NCT03154086|19977589|P4|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2
8105544|NCT03154086|19977590|P3|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
8105545|NCT03154086|19977591|P2|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
8105546|NCT03154086|19977592|P1|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
8105547|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105548|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105549|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105550|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105551|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105552|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105553|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105554|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105555|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105556|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105557|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105558|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
8105559|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105560|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105561|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105562|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105563|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105564|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105565|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105566|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105567|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105568|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105569|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105570|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105571|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105572|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105573|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
8105574|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
8105575|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
8105576|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
8105577|NCT03154086|19977578|P15|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105578|NCT03154086|19977579|P14|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105579|NCT03154086|19977580|P13|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105580|NCT03154086|19977581|P12|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105581|NCT03154086|19977582|P11|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105582|NCT03154086|19977583|P10|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105583|NCT03154086|19977584|P9|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105584|NCT03154086|19977585|P8|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105585|NCT03154086|19977586|P7|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105586|NCT03154086|19977587|P6|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105587|NCT03154086|19977588|P5|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
8105588|NCT03154086|19977589|P4|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
8105589|NCT03154086|19977590|P3|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
8105590|NCT03154086|19977591|P2|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
8105591|NCT03154086|19977592|P1|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
8105592|NCT03154086|19977578|P15|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105593|NCT03154086|19977579|P14|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105594|NCT03154086|19977580|P13|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105595|NCT03154086|19977581|P12|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105596|NCT03154086|19977582|P11|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105597|NCT03154086|19977583|P10|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105598|NCT03154086|19977584|P9|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105599|NCT03154086|19977585|P8|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105600|NCT03154086|19977586|P7|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105601|NCT03154086|19977587|P6|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105602|NCT03154086|19977588|P5|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105603|NCT03154086|19977589|P4|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105604|NCT03154086|19977590|P3|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105605|NCT03154086|19977591|P2|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105606|NCT03154086|19977592|P1|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105607|NCT03154086|19977578|P15|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105608|NCT03154086|19977579|P14|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105609|NCT03154086|19977580|P13|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105610|NCT03154086|19977581|P12|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105611|NCT03154086|19977582|P11|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105612|NCT03154086|19977583|P10|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105613|NCT03154086|19977584|P9|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105614|NCT03154086|19977585|P8|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105615|NCT03154086|19977586|P7|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105616|NCT03154086|19977587|P6|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105617|NCT03154086|19977588|P5|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105618|NCT03154086|19977589|P4|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105619|NCT03154086|19977590|P3|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105620|NCT03154086|19977591|P2|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105621|NCT03154086|19977592|P1|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105622|NCT03154086|19977578|P15|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105623|NCT03154086|19977579|P14|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105624|NCT03154086|19977580|P13|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105625|NCT03154086|19977581|P12|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105626|NCT03154086|19977582|P11|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105627|NCT03154086|19977583|P10|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105628|NCT03154086|19977584|P9|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105629|NCT03154086|19977585|P8|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105630|NCT03154086|19977586|P7|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105631|NCT03154086|19977587|P6|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105632|NCT03154086|19977588|P5|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
8105633|NCT03154086|19977589|P4|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105634|NCT03154086|19977590|P3|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105635|NCT03154086|19977591|P2|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105636|NCT03154086|19977592|P1|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
8105637|NCT03154047|19977992|P1|NOT COMPLETED|Overall Study||80
8105638|NCT03154047|19977992|P1|COMPLETED|Overall Study||0
8105639|NCT03154047|19977992|P1|Number of Patients Dosed|Overall Study||80
8105640|NCT03154047|19977992|P1|STARTED|Overall Study||80
8105641|NCT03153956|19977998|P2|NOT COMPLETED|Overall Study||0
8105642|NCT03153956|19977999|P1|NOT COMPLETED|Overall Study||0
8105643|NCT03153956|19977998|P2|COMPLETED|Overall Study||38
8105644|NCT03153956|19977999|P1|COMPLETED|Overall Study||39
8105645|NCT03153956|19977998|P2|STARTED|Overall Study||38
8105646|NCT03153956|19977999|P1|STARTED|Overall Study||39
8105647|NCT03152591|19978011|P2|NOT COMPLETED|Overall Study||0
8105648|NCT03152591|19978012|P1|NOT COMPLETED|Overall Study||0
8105649|NCT03152591|19978011|P2|COMPLETED|Overall Study||14
8105650|NCT03152591|19978012|P1|COMPLETED|Overall Study||15
8105651|NCT03152591|19978011|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||14
8105652|NCT03152591|19978012|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||15
8105653|NCT03152591|19978011|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8105654|NCT03152591|19978012|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||14
8105655|NCT03152591|19978011|P2|STARTED|Overall Study||14
8105656|NCT03152591|19978012|P1|STARTED|Overall Study||15
8105657|NCT03152552|19978039|P5|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11
8105658|NCT03152552|19978040|P4|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
8105659|NCT03152552|19978041|P3|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
8105660|NCT03152552|19978042|P2|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5
8105661|NCT03152552|19978043|P1|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6
8105662|NCT03152552|19978039|P5|COMPLETED|Treatment Period 2 (24 Weeks)||0
8105663|NCT03152552|19978040|P4|COMPLETED|Treatment Period 2 (24 Weeks)||0
8105664|NCT03152552|19978041|P3|COMPLETED|Treatment Period 2 (24 Weeks)||0
8105665|NCT03152552|19978042|P2|COMPLETED|Treatment Period 2 (24 Weeks)||0
8105666|NCT03152552|19978043|P1|COMPLETED|Treatment Period 2 (24 Weeks)||1
8105667|NCT03152552|19978039|P5|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11
8105668|NCT03152552|19978040|P4|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
8105669|NCT03152552|19978041|P3|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
8105670|NCT03152552|19978042|P2|STARTED|Treatment Period 2 (24 Weeks)||5
8105671|NCT03152552|19978043|P1|STARTED|Treatment Period 2 (24 Weeks)||7
8105672|NCT03152552|19978039|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
8105673|NCT03152552|19978040|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20
8105674|NCT03152552|19978041|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
8105675|NCT03152552|19978042|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
8105676|NCT03152552|19978043|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
8105677|NCT03152552|19978039|P5|COMPLETED|Treatment Period 1 (12 Weeks)||12
8105678|NCT03152552|19978040|P4|COMPLETED|Treatment Period 1 (12 Weeks)||10
8105679|NCT03152552|19978041|P3|COMPLETED|Treatment Period 1 (12 Weeks)||10
8105680|NCT03152552|19978042|P2|COMPLETED|Treatment Period 1 (12 Weeks)||5
8105681|NCT03152552|19978043|P1|COMPLETED|Treatment Period 1 (12 Weeks)||7
8105682|NCT03152552|19978039|P5|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33
8105683|NCT03152552|19978040|P4|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
8105684|NCT03152552|19978041|P3|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
8105685|NCT03152552|19978042|P2|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16
8105686|NCT03152552|19978043|P1|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15
8105687|NCT03152552|19978039|P5|STARTED|Treatment Period 1 (12 Weeks)||33
8105688|NCT03152552|19978040|P4|STARTED|Treatment Period 1 (12 Weeks)||30
8105689|NCT03152552|19978041|P3|STARTED|Treatment Period 1 (12 Weeks)||31
8105690|NCT03152552|19978042|P2|STARTED|Treatment Period 1 (12 Weeks)||16
8105691|NCT03152552|19978043|P1|STARTED|Treatment Period 1 (12 Weeks)||15
8105692|NCT03152526|19978176|P2|NOT COMPLETED|Overall Study||1
8105693|NCT03152526|19978177|P1|NOT COMPLETED|Overall Study||0
8105694|NCT03152526|19978176|P2|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0
8105695|NCT03152526|19978177|P1|COMPLETED|Overall Study|No participants were enrolled on this arm.|0
8105696|NCT03152526|19978176|P2|STARTED|Overall Study|One participant was enrolled on this arm.|1
8105697|NCT03152526|19978177|P1|STARTED|Overall Study|No participants were enrolled on this arm.|0
8105698|NCT03152136|19978188|P3|NOT COMPLETED|Overall Study||1
8105699|NCT03152136|19978189|P2|NOT COMPLETED|Overall Study||0
8105700|NCT03152136|19978190|P1|NOT COMPLETED|Overall Study||3
8105701|NCT03152136|19978188|P3|COMPLETED|Overall Study||14
8105702|NCT03152136|19978189|P2|COMPLETED|Overall Study||15
8105703|NCT03152136|19978190|P1|COMPLETED|Overall Study||29
8105704|NCT03152136|19978188|P3|STARTED|Overall Study||15
8105705|NCT03152136|19978189|P2|STARTED|Overall Study||15
8105706|NCT03152136|19978190|P1|STARTED|Overall Study||32
8105707|NCT03152110|19978197|P1|NOT COMPLETED|Overall Study||3
8105708|NCT03152110|19978197|P1|COMPLETED|Overall Study||7
8105709|NCT03152110|19978197|P1|STARTED|Overall Study||10
8105710|NCT03152019|19978212|P2|NOT COMPLETED|Overall Study||1
8105711|NCT03152019|19978213|P1|NOT COMPLETED|Overall Study||0
8105712|NCT03152019|19978212|P2|COMPLETED|Overall Study||24
8105713|NCT03152019|19978213|P1|COMPLETED|Overall Study||25
8105714|NCT03152019|19978212|P2|STARTED|Overall Study||25
8105715|NCT03152019|19978213|P1|STARTED|Overall Study||25
8105716|NCT03151551|19978221|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||28
8105717|NCT03151551|19978222|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||25
8105718|NCT03151551|19978221|P2|COMPLETED|Post-Treatment Follow-Up Period||230
8105719|NCT03151551|19978222|P1|COMPLETED|Post-Treatment Follow-Up Period||240
8105720|NCT03151551|19978221|P2|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|258
8105721|NCT03151551|19978222|P1|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|265
8105722|NCT03151551|19978221|P2|NOT COMPLETED|Open-Label Treatment Period||24
8105723|NCT03151551|19978222|P1|NOT COMPLETED|Open-Label Treatment Period||18
8105724|NCT03151551|19978221|P2|COMPLETED|Open-Label Treatment Period||259
8105725|NCT03151551|19978222|P1|COMPLETED|Open-Label Treatment Period||265
8105726|NCT03151551|19978221|P2|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||219
8105727|NCT03151551|19978222|P1|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
8105728|NCT03151551|19978221|P2|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||51
8105729|NCT03151551|19978222|P1|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
8105730|NCT03151551|19978221|P2|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
8105731|NCT03151551|19978222|P1|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period||218
8105732|NCT03151551|19978221|P2|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
8105733|NCT03151551|19978222|P1|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period||49
8105734|NCT03151551|19978221|P2|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
8105735|NCT03151551|19978222|P1|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
8105736|NCT03151551|19978221|P2|STARTED|Open-Label Treatment Period||283
8105737|NCT03151551|19978222|P1|STARTED|Open-Label Treatment Period||283
8105738|NCT03151434|19978289|P3|NOT COMPLETED|Overall Study||7
8105739|NCT03151434|19978290|P2|NOT COMPLETED|Overall Study||7
8105740|NCT03151434|19978291|P1|NOT COMPLETED|Overall Study||13
8105741|NCT03151434|19978289|P3|COMPLETED|Overall Study||40
8105742|NCT03151434|19978290|P2|COMPLETED|Overall Study||40
8105743|NCT03151434|19978291|P1|COMPLETED|Overall Study||40
8105744|NCT03151434|19978289|P3|STARTED|Overall Study||47
8105745|NCT03151434|19978290|P2|STARTED|Overall Study||47
8105746|NCT03151434|19978291|P1|STARTED|Overall Study||53
8105747|NCT03151265|19978319|P2|NOT COMPLETED|Overall Study||0
8105748|NCT03151265|19978320|P1|NOT COMPLETED|Overall Study||0
8105749|NCT03151265|19978319|P2|COMPLETED|Overall Study||20
8105750|NCT03151265|19978320|P1|COMPLETED|Overall Study||20
8105751|NCT03151265|19978319|P2|STARTED|Overall Study||20
8105752|NCT03151265|19978320|P1|STARTED|Overall Study||20
8105753|NCT03151226|19978342|P1|NOT COMPLETED|Overall Study||3
8105754|NCT03151226|19978342|P1|COMPLETED|Overall Study||0
8105755|NCT03151226|19978342|P1|STARTED|Overall Study||3
8105756|NCT03151148|19978348|P2|NOT COMPLETED|Overall Study||0
8105757|NCT03151148|19978349|P1|NOT COMPLETED|Overall Study||2
8105758|NCT03151148|19978348|P2|COMPLETED|Overall Study||18
8105759|NCT03151148|19978349|P1|COMPLETED|Overall Study||34
8105760|NCT03151148|19978348|P2|STARTED|Overall Study||18
8105761|NCT03151148|19978349|P1|STARTED|Overall Study||36
8105762|NCT03151083|19978400|P3|NOT COMPLETED|Overall Study||4
8105763|NCT03151083|19978401|P2|NOT COMPLETED|Overall Study||1
8105764|NCT03151083|19978402|P1|NOT COMPLETED|Overall Study||2
8105765|NCT03151083|19978400|P3|COMPLETED|Overall Study||26
8105766|NCT03151083|19978401|P2|COMPLETED|Overall Study||19
8105767|NCT03151083|19978402|P1|COMPLETED|Overall Study||25
8105768|NCT03151083|19978400|P3|STARTED|Overall Study||30
8105769|NCT03151083|19978401|P2|STARTED|Overall Study||20
8105770|NCT03151083|19978402|P1|STARTED|Overall Study||27
8105771|NCT03150758|19978417|P1|NOT COMPLETED|Overall Study||0
8105772|NCT03150758|19978417|P1|COMPLETED|Overall Study||6
8105773|NCT03150758|19978417|P1|STARTED|Overall Study||6
8105774|NCT03150719|19978423|P2|NOT COMPLETED|Overall Study||2
8105775|NCT03150719|19978424|P1|NOT COMPLETED|Overall Study||1
8105776|NCT03150719|19978423|P2|COMPLETED|Overall Study||48
8105777|NCT03150719|19978424|P1|COMPLETED|Overall Study||46
8105778|NCT03150719|19978423|P2|STARTED|Overall Study||50
8105779|NCT03150719|19978424|P1|STARTED|Overall Study||47
8105780|NCT03150485|19978440|P6|NOT COMPLETED|Overall Study||0
8105781|NCT03150485|19978441|P5|NOT COMPLETED|Overall Study||0
8105782|NCT03150485|19978442|P4|NOT COMPLETED|Overall Study||0
8105783|NCT03150485|19978443|P3|NOT COMPLETED|Overall Study||0
8105784|NCT03150485|19978444|P2|NOT COMPLETED|Overall Study||1
8105785|NCT03150485|19978445|P1|NOT COMPLETED|Overall Study||0
8105786|NCT03150485|19978440|P6|COMPLETED|Overall Study||1
8105787|NCT03150485|19978441|P5|COMPLETED|Overall Study||2
8105788|NCT03150485|19978442|P4|COMPLETED|Overall Study||5
8105789|NCT03150485|19978443|P3|COMPLETED|Overall Study||4
8105790|NCT03150485|19978444|P2|COMPLETED|Overall Study||8
8105791|NCT03150485|19978445|P1|COMPLETED|Overall Study||2
8105792|NCT03150485|19978440|P6|STARTED|Overall Study||1
8105793|NCT03150485|19978441|P5|STARTED|Overall Study||2
8105794|NCT03150485|19978442|P4|STARTED|Overall Study||5
8105795|NCT03150485|19978443|P3|STARTED|Overall Study||4
8105796|NCT03150485|19978444|P2|STARTED|Overall Study||9
8105797|NCT03150485|19978445|P1|STARTED|Overall Study||2
8105798|NCT03150199|19978462|P2|NOT COMPLETED|Overall Study||0
8105799|NCT03150199|19978463|P1|NOT COMPLETED|Overall Study||0
8105800|NCT03150199|19978462|P2|COMPLETED|Overall Study||30
8105801|NCT03150199|19978463|P1|COMPLETED|Overall Study||30
8105802|NCT03150199|19978462|P2|STARTED|Overall Study||30
8105803|NCT03150199|19978463|P1|STARTED|Overall Study||30
8105804|NCT03150160|19978514|P2|NOT COMPLETED|Overall Study||0
8105805|NCT03150160|19978515|P1|NOT COMPLETED|Overall Study||0
8105806|NCT03150160|19978514|P2|COMPLETED|Overall Study||1
8105807|NCT03150160|19978515|P1|COMPLETED|Overall Study||0
8105808|NCT03150160|19978514|P2|STARTED|Overall Study||1
8105809|NCT03150160|19978515|P1|STARTED|Overall Study||0
8105816|NCT03150082|19978622|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
8105817|NCT03150082|19978623|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
8105818|NCT03150082|19978622|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
8105819|NCT03150082|19978623|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
8105820|NCT03150082|19978622|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
8105821|NCT03150082|19978623|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
8105822|NCT03150082|19978622|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
8105823|NCT03150082|19978623|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
8105824|NCT03150082|19978622|P2|COMPLETED|Washout Period (Up to 4 Weeks)||13
8105825|NCT03150082|19978623|P1|COMPLETED|Washout Period (Up to 4 Weeks)||12
8105826|NCT03150082|19978622|P2|STARTED|Washout Period (Up to 4 Weeks)||13
8105827|NCT03150082|19978623|P1|STARTED|Washout Period (Up to 4 Weeks)||12
8105828|NCT03150082|19978622|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
8105829|NCT03150082|19978623|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
8105830|NCT03150082|19978622|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
8105831|NCT03150082|19978623|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
8105832|NCT03150082|19978622|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
8105833|NCT03150082|19978623|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
8105834|NCT03149991|19978679|P2|NOT COMPLETED|Overall Study||2
8105835|NCT03149991|19978680|P1|NOT COMPLETED|Overall Study||4
8105836|NCT03149991|19978679|P2|COMPLETED|Overall Study||24
8105837|NCT03149991|19978680|P1|COMPLETED|Overall Study||21
8105838|NCT03149991|19978679|P2|Exited|Overall Study||2
8105839|NCT03149991|19978680|P1|Exited|Overall Study||4
8105840|NCT03149991|19978679|P2|Completed Primary Endpoint (Day 14)|Overall Study||24
8105841|NCT03149991|19978680|P1|Completed Primary Endpoint (Day 14)|Overall Study||25
8105842|NCT03149991|19978679|P2|STARTED|Overall Study||26
8105843|NCT03149991|19978680|P1|STARTED|Overall Study||25
8105844|NCT03149887|19978708|P2|NOT COMPLETED|Overall Study||0
8105845|NCT03149887|19978709|P1|NOT COMPLETED|Overall Study||0
8105846|NCT03149887|19978708|P2|COMPLETED|Overall Study||27
8105847|NCT03149887|19978709|P1|COMPLETED|Overall Study||27
8105848|NCT03149887|19978708|P2|STARTED|Overall Study||27
8105849|NCT03149887|19978709|P1|STARTED|Overall Study||27
8105850|NCT03149848|19978729|P1|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2
8105851|NCT03149848|19978729|P1|COMPLETED|Period 2 (Day 15 to Day 28)||12
8105852|NCT03149848|19978729|P1|STARTED|Period 2 (Day 15 to Day 28)||14
8105853|NCT03149848|19978729|P1|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1
8105854|NCT03149848|19978729|P1|COMPLETED|Period 1 (Day 1 to Day 14)||14
8105855|NCT03149848|19978729|P1|STARTED|Period 1 (Day 1 to Day 14)||15
8105856|NCT03149172|19978769|P3|NOT COMPLETED|Overall Study||2
8105857|NCT03149172|19978770|P2|NOT COMPLETED|Overall Study||1
8105858|NCT03149172|19978771|P1|NOT COMPLETED|Overall Study||2
8105859|NCT03149172|19978769|P3|COMPLETED|Overall Study||5
8105860|NCT03149172|19978770|P2|COMPLETED|Overall Study||5
8105861|NCT03149172|19978771|P1|COMPLETED|Overall Study||6
8105862|NCT03149172|19978769|P3|STARTED|Overall Study||7
8105863|NCT03149172|19978770|P2|STARTED|Overall Study||6
8105864|NCT03149172|19978771|P1|STARTED|Overall Study||8
8105868|NCT03149042|19978787|P1|NOT COMPLETED|Overall Study||23
8105869|NCT03149042|19978787|P1|COMPLETED|Overall Study||52
8105870|NCT03149042|19978787|P1|STARTED|Overall Study||75
8105871|NCT03148756|19978801|P2|NOT COMPLETED|Overall Study||1
8105872|NCT03148756|19978802|P1|NOT COMPLETED|Overall Study||0
8105873|NCT03148756|19978801|P2|COMPLETED|Overall Study||1
8105874|NCT03148756|19978802|P1|COMPLETED|Overall Study||0
8105875|NCT03148756|19978801|P2|STARTED|Overall Study||2
8105876|NCT03148756|19978802|P1|STARTED|Overall Study||0
8105877|NCT03148691|19978835|P3|NOT COMPLETED|Overall Study||8
8105878|NCT03148691|19978836|P2|NOT COMPLETED|Overall Study||2
8105879|NCT03148691|19978837|P1|NOT COMPLETED|Overall Study||3
8105880|NCT03148691|19978835|P3|COMPLETED|Overall Study||92
8105881|NCT03148691|19978836|P2|COMPLETED|Overall Study||101
8105882|NCT03148691|19978837|P1|COMPLETED|Overall Study||47
8105883|NCT03148691|19978835|P3|STARTED|Overall Study||100
8105884|NCT03148691|19978836|P2|STARTED|Overall Study||103
8105885|NCT03148691|19978837|P1|STARTED|Overall Study||50
8105886|NCT03148470|19978847|P2|NOT COMPLETED|Overall Study||0
8105887|NCT03148470|19978848|P1|NOT COMPLETED|Overall Study||1
8105888|NCT03148470|19978847|P2|COMPLETED|Overall Study|20 Participants completed the Tasks following cTBS-stimulation|20
8105889|NCT03148470|19978848|P1|COMPLETED|Overall Study|20 Participants completed the Tasks following iTBS-stimulation|20
8105890|NCT03148470|19978847|P2|STARTED|Overall Study|20 Participants completed the Tasks following Sham-stimulation|20
8105891|NCT03148470|19978848|P1|STARTED|Overall Study|21 Participants completed the Tasks following Sham-stimulation|21
8105892|NCT03148262|19978864|P2|NOT COMPLETED|Overall Study||1
8105893|NCT03148262|19978865|P1|NOT COMPLETED|Overall Study||3
8105894|NCT03148262|19978864|P2|COMPLETED|Overall Study||31
8105895|NCT03148262|19978865|P1|COMPLETED|Overall Study||28
8105896|NCT03148262|19978864|P2|STARTED|Overall Study||32
8105897|NCT03148262|19978865|P1|STARTED|Overall Study||31
8105898|NCT03148236|19978873|P2|NOT COMPLETED|Overall Study||0
8105899|NCT03148236|19978874|P1|NOT COMPLETED|Overall Study||0
8105900|NCT03148236|19978873|P2|COMPLETED|Overall Study||10
8105901|NCT03148236|19978874|P1|COMPLETED|Overall Study||10
8105902|NCT03148236|19978873|P2|STARTED|Overall Study||10
8105903|NCT03148236|19978874|P1|STARTED|Overall Study||10
8105904|NCT03148067|19978900|P1|NOT COMPLETED|Overall Study||4
8105905|NCT03148067|19978900|P1|COMPLETED|Overall Study||221
8105906|NCT03148067|19978900|P1|STARTED|Overall Study||225
8105910|NCT03147495|19978929|P2|NOT COMPLETED|Overall Study||6
8105911|NCT03147495|19978930|P1|NOT COMPLETED|Overall Study||0
8105912|NCT03147495|19978929|P2|COMPLETED|Overall Study||40
8105913|NCT03147495|19978930|P1|COMPLETED|Overall Study||40
8105914|NCT03147495|19978929|P2|STARTED|Overall Study||46
8105915|NCT03147495|19978930|P1|STARTED|Overall Study||40
8105916|NCT03147248|19978952|P6|NOT COMPLETED|Overall Study||31
8105917|NCT03147248|19978953|P5|NOT COMPLETED|Overall Study||26
8105918|NCT03147248|19978954|P4|NOT COMPLETED|Overall Study||2
8105919|NCT03147248|19978955|P3|NOT COMPLETED|Overall Study||2
8105920|NCT03147248|19978956|P2|NOT COMPLETED|Overall Study||2
8105921|NCT03147248|19978957|P1|NOT COMPLETED|Overall Study||1
8105922|NCT03147248|19978952|P6|COMPLETED|Overall Study||145
8105923|NCT03147248|19978953|P5|COMPLETED|Overall Study||141
8105924|NCT03147248|19978954|P4|COMPLETED|Overall Study||10
8105925|NCT03147248|19978955|P3|COMPLETED|Overall Study||10
8105926|NCT03147248|19978956|P2|COMPLETED|Overall Study||9
8105927|NCT03147248|19978957|P1|COMPLETED|Overall Study||12
8105928|NCT03147248|19978952|P6|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|176
8105929|NCT03147248|19978953|P5|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|167
8105930|NCT03147248|19978954|P4|STARTED|Overall Study|This cohort is only for Part 1.|12
8105931|NCT03147248|19978955|P3|STARTED|Overall Study|This cohort is only for Part 1.|12
8105932|NCT03147248|19978956|P2|STARTED|Overall Study|This cohort is only for Part 1.|11
8105933|NCT03147248|19978957|P1|STARTED|Overall Study|This cohort is only for Part 1.|13
8105937|NCT03146585|19978987|P3|NOT COMPLETED|Overall Study||0
8105938|NCT03146585|19978988|P2|NOT COMPLETED|Overall Study||0
8105939|NCT03146585|19978989|P1|NOT COMPLETED|Overall Study||0
8105940|NCT03146585|19978987|P3|COMPLETED|Overall Study||5
8105941|NCT03146585|19978988|P2|COMPLETED|Overall Study||10
8105942|NCT03146585|19978989|P1|COMPLETED|Overall Study||25
8105943|NCT03146585|19978987|P3|STARTED|Overall Study||5
8105944|NCT03146585|19978988|P2|STARTED|Overall Study||10
8105945|NCT03146585|19978989|P1|STARTED|Overall Study||25
8105946|NCT03146403|19978999|P2|NOT COMPLETED|Overall Study||3
8105947|NCT03146403|19979000|P1|NOT COMPLETED|Overall Study||2
8105948|NCT03146403|19978999|P2|COMPLETED|Overall Study||14
8105949|NCT03146403|19979000|P1|COMPLETED|Overall Study||14
8105950|NCT03146403|19978999|P2|STARTED|Overall Study||17
8105951|NCT03146403|19979000|P1|STARTED|Overall Study||16
8105952|NCT03145818|19979018|P4|NOT COMPLETED|Overall Study||0
8105953|NCT03145818|19979019|P3|NOT COMPLETED|Overall Study||0
8105954|NCT03145818|19979020|P2|NOT COMPLETED|Overall Study||8
8105955|NCT03145818|19979021|P1|NOT COMPLETED|Overall Study||91
8105956|NCT03145818|19979018|P4|COMPLETED|Overall Study||9
8105957|NCT03145818|19979019|P3|COMPLETED|Overall Study||10
8105958|NCT03145818|19979020|P2|COMPLETED|Overall Study||0
8105959|NCT03145818|19979021|P1|COMPLETED|Overall Study||8
8105960|NCT03145818|19979018|P4|STARTED|Overall Study||9
8105961|NCT03145818|19979019|P3|STARTED|Overall Study||10
8105962|NCT03145818|19979020|P2|STARTED|Overall Study||8
8105963|NCT03145818|19979021|P1|STARTED|Overall Study||99
8105964|NCT03145259|19979029|P1|NOT COMPLETED|Overall Study||0
8105965|NCT03145259|19979029|P1|COMPLETED|Overall Study||12
8105966|NCT03145259|19979029|P1|STARTED|Overall Study||12
8105967|NCT03145207|19979036|P1|NOT COMPLETED|Overall Study||2
8105968|NCT03145207|19979036|P1|COMPLETED|Overall Study||12
8105969|NCT03145207|19979036|P1|STARTED|Overall Study|The same 12 volunteers completed each of the seven study sessions.|14
8105970|NCT03144635|19979051|P1|NOT COMPLETED|Overall Study||80
8105971|NCT03144635|19979051|P1|COMPLETED|Overall Study||0
8105972|NCT03144635|19979051|P1|STARTED|Overall Study||80
8105973|NCT03144518|19979063|P2|NOT COMPLETED|16 Week Post-Vaccination||2
8105974|NCT03144518|19979064|P1|NOT COMPLETED|16 Week Post-Vaccination||3
8105975|NCT03144518|19979063|P2|COMPLETED|16 Week Post-Vaccination||49
8105976|NCT03144518|19979064|P1|COMPLETED|16 Week Post-Vaccination||49
8105977|NCT03144518|19979063|P2|STARTED|16 Week Post-Vaccination||51
8105978|NCT03144518|19979064|P1|STARTED|16 Week Post-Vaccination||52
8105979|NCT03144518|19979063|P2|NOT COMPLETED|4 Weeks Post-Vaccination||0
8105980|NCT03144518|19979064|P1|NOT COMPLETED|4 Weeks Post-Vaccination||1
8105981|NCT03144518|19979063|P2|COMPLETED|4 Weeks Post-Vaccination||51
8105982|NCT03144518|19979064|P1|COMPLETED|4 Weeks Post-Vaccination||51
8105983|NCT03144518|19979063|P2|STARTED|4 Weeks Post-Vaccination||51
8105984|NCT03144518|19979064|P1|STARTED|4 Weeks Post-Vaccination||52
8105985|NCT03144518|19979063|P2|NOT COMPLETED|Primary Outcome (Mood)||0
8105986|NCT03144518|19979064|P1|NOT COMPLETED|Primary Outcome (Mood)||0
8105987|NCT03144518|19979063|P2|COMPLETED|Primary Outcome (Mood)||51
8105988|NCT03144518|19979064|P1|COMPLETED|Primary Outcome (Mood)||52
8105989|NCT03144518|19979063|P2|STARTED|Primary Outcome (Mood)||51
8105990|NCT03144518|19979064|P1|STARTED|Primary Outcome (Mood)||52
8105991|NCT03144180|19979081|P2|NOT COMPLETED|Overall Study||6
8105992|NCT03144180|19979082|P1|NOT COMPLETED|Overall Study||2
8105993|NCT03144180|19979081|P2|COMPLETED|Overall Study||10
8105994|NCT03144180|19979082|P1|COMPLETED|Overall Study||14
8105995|NCT03144180|19979081|P2|STARTED|Overall Study||16
8105996|NCT03144180|19979082|P1|STARTED|Overall Study||16
8105997|NCT03143855|19979094|P2|NOT COMPLETED|Overall Study||4
8105998|NCT03143855|19979095|P1|NOT COMPLETED|Overall Study||5
8105999|NCT03143855|19979094|P2|COMPLETED|Overall Study||6
8106000|NCT03143855|19979095|P1|COMPLETED|Overall Study||12
8106001|NCT03143855|19979094|P2|STARTED|Overall Study||10
8106002|NCT03143855|19979095|P1|STARTED|Overall Study||17
8106003|NCT03143569|19979103|P2|NOT COMPLETED|Overall Study||2
8106004|NCT03143569|19979104|P1|NOT COMPLETED|Overall Study||0
8106005|NCT03143569|19979103|P2|COMPLETED|Overall Study||8
8106006|NCT03143569|19979104|P1|COMPLETED|Overall Study||10
8106007|NCT03143569|19979103|P2|STARTED|Overall Study||10
8106008|NCT03143569|19979104|P1|STARTED|Overall Study||10
8106009|NCT03143166|19979126|P1|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1
8106010|NCT03143166|19979126|P1|COMPLETED|Period 2 (Washout of at Least 4 Days)||35
8106011|NCT03143166|19979126|P1|STARTED|Period 2 (Washout of at Least 4 Days)||36
8106012|NCT03143166|19979126|P1|NOT COMPLETED|Period 1||0
8106013|NCT03143166|19979126|P1|COMPLETED|Period 1||36
8106014|NCT03143166|19979126|P1|STARTED|Period 1||36
8106015|NCT03143101|19979145|P3|NOT COMPLETED|Overall Study||0
8106016|NCT03143101|19979146|P2|NOT COMPLETED|Overall Study||3
8106017|NCT03143101|19979147|P1|NOT COMPLETED|Overall Study||2
8106018|NCT03143101|19979145|P3|COMPLETED|Overall Study||67
8106019|NCT03143101|19979146|P2|COMPLETED|Overall Study||63
8106020|NCT03143101|19979147|P1|COMPLETED|Overall Study||65
8106021|NCT03143101|19979145|P3|STARTED|Overall Study||67
8106022|NCT03143101|19979146|P2|STARTED|Overall Study||66
8106023|NCT03143101|19979147|P1|STARTED|Overall Study||67
8106024|NCT03142932|19979202|P2|NOT COMPLETED|Overall Study||11
8106025|NCT03142932|19979203|P1|NOT COMPLETED|Overall Study||2
8106026|NCT03142932|19979202|P2|COMPLETED|Overall Study||39
8106027|NCT03142932|19979203|P1|COMPLETED|Overall Study||50
8106028|NCT03142932|19979202|P2|STARTED|Overall Study||50
8106029|NCT03142932|19979203|P1|STARTED|Overall Study||52
8106030|NCT03142750|19979219|P2|NOT COMPLETED|Overall Study||1
8106031|NCT03142750|19979220|P1|NOT COMPLETED|Overall Study||4
8106032|NCT03142750|19979219|P2|COMPLETED|Overall Study||9
8106033|NCT03142750|19979220|P1|COMPLETED|Overall Study||10
8106034|NCT03142750|19979219|P2|STARTED|Overall Study||10
8106035|NCT03142750|19979220|P1|STARTED|Overall Study||14
8106036|NCT03141931|19979233|P2|NOT COMPLETED|Overall Study||6
8106037|NCT03141931|19979234|P1|NOT COMPLETED|Overall Study||12
8106038|NCT03141931|19979233|P2|COMPLETED|Overall Study||52
8106039|NCT03141931|19979234|P1|COMPLETED|Overall Study||49
8106040|NCT03141931|19979233|P2|STARTED|Overall Study||58
8106041|NCT03141931|19979234|P1|STARTED|Overall Study||61
8106042|NCT03141788|19979254|P1|NOT COMPLETED|Overall Study||8
8106043|NCT03141788|19979254|P1|COMPLETED|Overall Study||44
8106044|NCT03141788|19979254|P1|STARTED|Overall Study||52
8106045|NCT03141528|19979271|P2|NOT COMPLETED|Overall Study||41
8106046|NCT03141528|19979272|P1|NOT COMPLETED|Overall Study||47
8106047|NCT03141528|19979271|P2|COMPLETED|Overall Study||77
8106048|NCT03141528|19979272|P1|COMPLETED|Overall Study||75
8106049|NCT03141528|19979271|P2|STARTED|Overall Study||118
8106050|NCT03141528|19979272|P1|STARTED|Overall Study||122
8106051|NCT03141372|19979314|P2|NOT COMPLETED|Overall Study||2
8106052|NCT03141372|19979315|P1|NOT COMPLETED|Overall Study||0
8106053|NCT03141372|19979314|P2|COMPLETED|Overall Study||40
8106054|NCT03141372|19979315|P1|COMPLETED|Overall Study||42
8106055|NCT03141372|19979314|P2|STARTED|Overall Study||42
8106056|NCT03141372|19979315|P1|STARTED|Overall Study||42
8106057|NCT03141307|19979335|P2|NOT COMPLETED|Follow-Up||54
8106058|NCT03141307|19979336|P1|NOT COMPLETED|Follow-Up||97
8106059|NCT03141307|19979335|P2|COMPLETED|Follow-Up||184
8106060|NCT03141307|19979336|P1|COMPLETED|Follow-Up||370
8106061|NCT03141307|19979335|P2|STARTED|Follow-Up||238
8106062|NCT03141307|19979336|P1|STARTED|Follow-Up||467
8106063|NCT03141307|19979335|P2|NOT COMPLETED|In-Hospital||2
8106064|NCT03141307|19979336|P1|NOT COMPLETED|In-Hospital||4
8106065|NCT03141307|19979335|P2|COMPLETED|In-Hospital||238
8106066|NCT03141307|19979336|P1|COMPLETED|In-Hospital||467
8106067|NCT03141307|19979335|P2|STARTED|In-Hospital||240
8106068|NCT03141307|19979336|P1|STARTED|In-Hospital||471
8106069|NCT03141151|19979354|P2|NOT COMPLETED|Overall Study||4
8106070|NCT03141151|19979355|P1|NOT COMPLETED|Overall Study||6
8106071|NCT03141151|19979354|P2|COMPLETED|Overall Study||54
8106072|NCT03141151|19979355|P1|COMPLETED|Overall Study||53
8106073|NCT03141151|19979354|P2|STARTED|Overall Study||58
8106074|NCT03141151|19979355|P1|STARTED|Overall Study||59
8106075|NCT03141086|19979373|P2|NOT COMPLETED|Overall Study||5
8106076|NCT03141086|19979374|P1|NOT COMPLETED|Overall Study||1
8106077|NCT03141086|19979373|P2|COMPLETED|Overall Study||12
8106078|NCT03141086|19979374|P1|COMPLETED|Overall Study||6
8106079|NCT03141086|19979373|P2|STARTED|Overall Study||17
8106080|NCT03141086|19979374|P1|STARTED|Overall Study||7
8106081|NCT03140631|19979403|P2|NOT COMPLETED|Overall Study||0
8106082|NCT03140631|19979404|P1|NOT COMPLETED|Overall Study||0
8106083|NCT03140631|19979403|P2|COMPLETED|Overall Study||77
8106084|NCT03140631|19979404|P1|COMPLETED|Overall Study||73
8106085|NCT03140631|19979403|P2|STARTED|Overall Study||77
8106086|NCT03140631|19979404|P1|STARTED|Overall Study||73
8106093|NCT03139578|19979427|P4|NOT COMPLETED|Period 2||0
8106094|NCT03139578|19979428|P3|NOT COMPLETED|Period 2||0
8106095|NCT03139578|19979429|P2|NOT COMPLETED|Period 2||0
8106096|NCT03139578|19979430|P1|NOT COMPLETED|Period 2||0
8106097|NCT03139578|19979427|P4|COMPLETED|Period 2||13
8106098|NCT03139578|19979428|P3|COMPLETED|Period 2||12
8106099|NCT03139578|19979429|P2|COMPLETED|Period 2||13
8106100|NCT03139578|19979430|P1|COMPLETED|Period 2||12
8106101|NCT03139578|19979427|P4|Discontinued|Period 2||0
8106102|NCT03139578|19979428|P3|Discontinued|Period 2||0
8106103|NCT03139578|19979429|P2|Discontinued|Period 2||0
8106104|NCT03139578|19979430|P1|Discontinued|Period 2||0
8106105|NCT03139578|19979427|P4|STARTED|Period 2||13
8106106|NCT03139578|19979428|P3|STARTED|Period 2||12
8106107|NCT03139578|19979429|P2|STARTED|Period 2||13
8106108|NCT03139578|19979430|P1|STARTED|Period 2||12
8106109|NCT03139578|19979427|P4|NOT COMPLETED|Period 1||0
8106110|NCT03139578|19979428|P3|NOT COMPLETED|Period 1||0
8106111|NCT03139578|19979429|P2|NOT COMPLETED|Period 1||0
8106112|NCT03139578|19979430|P1|NOT COMPLETED|Period 1||0
8106113|NCT03139578|19979427|P4|COMPLETED|Period 1||13
8106114|NCT03139578|19979428|P3|COMPLETED|Period 1||12
8106115|NCT03139578|19979429|P2|COMPLETED|Period 1||13
8106116|NCT03139578|19979430|P1|COMPLETED|Period 1||12
8106117|NCT03139578|19979427|P4|Discontinued|Period 1||0
8106118|NCT03139578|19979428|P3|Discontinued|Period 1||0
8106119|NCT03139578|19979429|P2|Discontinued|Period 1||0
8106120|NCT03139578|19979430|P1|Discontinued|Period 1||0
8106121|NCT03139578|19979427|P4|STARTED|Period 1||13
8106122|NCT03139578|19979428|P3|STARTED|Period 1||12
8106123|NCT03139578|19979429|P2|STARTED|Period 1||13
8106124|NCT03139578|19979430|P1|STARTED|Period 1||12
8106125|NCT03139552|19979464|P1|NOT COMPLETED|Overall Study||3
8106126|NCT03139552|19979464|P1|COMPLETED|Overall Study||147
8106127|NCT03139552|19979464|P1|STARTED|Overall Study||150
8106128|NCT03139448|19979507|P2|NOT COMPLETED|Overall Study||26
8106129|NCT03139448|19979508|P1|NOT COMPLETED|Overall Study||12
8106130|NCT03139448|19979507|P2|COMPLETED|Overall Study||63
8106131|NCT03139448|19979508|P1|COMPLETED|Overall Study||73
8106132|NCT03139448|19979507|P2|Intervention Started|Overall Study||70
8106133|NCT03139448|19979508|P1|Intervention Started|Overall Study||79
8106134|NCT03139448|19979507|P2|STARTED|Overall Study||89
8106135|NCT03139448|19979508|P1|STARTED|Overall Study||85
8106136|NCT03139279|19979532|P2|NOT COMPLETED|Overall Study||6
8106137|NCT03139279|19979533|P1|NOT COMPLETED|Overall Study||7
8106138|NCT03139279|19979532|P2|COMPLETED|Overall Study||50
8106139|NCT03139279|19979533|P1|COMPLETED|Overall Study||51
8106140|NCT03139279|19979532|P2|STARTED|Overall Study||56
8106141|NCT03139279|19979533|P1|STARTED|Overall Study||58
8106142|NCT03139240|19979551|P4|NOT COMPLETED|Overall Study||0
8106143|NCT03139240|19979552|P3|NOT COMPLETED|Overall Study||1
8106144|NCT03139240|19979553|P2|NOT COMPLETED|Overall Study||1
8106145|NCT03139240|19979554|P1|NOT COMPLETED|Overall Study||0
8106146|NCT03139240|19979551|P4|COMPLETED|Overall Study||38
8106147|NCT03139240|19979552|P3|COMPLETED|Overall Study||37
8106148|NCT03139240|19979553|P2|COMPLETED|Overall Study||47
8106149|NCT03139240|19979554|P1|COMPLETED|Overall Study||48
8106150|NCT03139240|19979551|P4|STARTED|Overall Study||38
8106151|NCT03139240|19979552|P3|STARTED|Overall Study||38
8106152|NCT03139240|19979553|P2|STARTED|Overall Study||48
8106153|NCT03139240|19979554|P1|STARTED|Overall Study||48
8106154|NCT03139032|19979564|P1|NOT COMPLETED|Overall Study||0
8106155|NCT03139032|19979564|P1|COMPLETED|Overall Study||1
8106156|NCT03139032|19979564|P1|STARTED|Overall Study||1
8106157|NCT03138967|19979586|P2|NOT COMPLETED|Overall Study||4
8106158|NCT03138967|19979587|P1|NOT COMPLETED|Overall Study||1
8106159|NCT03138967|19979586|P2|COMPLETED|Overall Study||24
8106160|NCT03138967|19979587|P1|COMPLETED|Overall Study||25
8106161|NCT03138967|19979586|P2|Post-operative Day(POD) 7 Follow-up|Overall Study||24
8106162|NCT03138967|19979587|P1|Post-operative Day(POD) 7 Follow-up|Overall Study||25
8106163|NCT03138967|19979586|P2|Post-operative Day(POD) 1 Follow-up|Overall Study||25
8106164|NCT03138967|19979587|P1|Post-operative Day(POD) 1 Follow-up|Overall Study||25
8106165|NCT03138967|19979586|P2|STARTED|Overall Study||28
8106166|NCT03138967|19979587|P1|STARTED|Overall Study||26
8106167|NCT03138876|19979597|P1|NOT COMPLETED|Overall Study||0
8106168|NCT03138876|19979597|P1|COMPLETED|Overall Study||20
8106169|NCT03138876|19979597|P1|STARTED|Overall Study||20
8106170|NCT03138798|19979606|P2|NOT COMPLETED|Overall Study||4
8106171|NCT03138798|19979607|P1|NOT COMPLETED|Overall Study||6
8106172|NCT03138798|19979606|P2|COMPLETED|Overall Study||171
8106173|NCT03138798|19979607|P1|COMPLETED|Overall Study||167
8106174|NCT03138798|19979606|P2|Randomized But Did Not Meet Eligibility|Overall Study||4
8106175|NCT03138798|19979607|P1|Randomized But Did Not Meet Eligibility|Overall Study||6
8106176|NCT03138798|19979606|P2|STARTED|Overall Study||175
8106177|NCT03138798|19979607|P1|STARTED|Overall Study||173
8106178|NCT03138655|19979638|P8|NOT COMPLETED|Overall Study||2
8106179|NCT03138655|19979639|P7|NOT COMPLETED|Overall Study||3
8106180|NCT03138655|19979640|P6|NOT COMPLETED|Overall Study||5
8106181|NCT03138655|19979641|P5|NOT COMPLETED|Overall Study||2
8106182|NCT03138655|19979642|P4|NOT COMPLETED|Overall Study||3
8106183|NCT03138655|19979643|P3|NOT COMPLETED|Overall Study||2
8106184|NCT03138655|19979644|P2|NOT COMPLETED|Overall Study||2
8106185|NCT03138655|19979645|P1|NOT COMPLETED|Overall Study||3
8106186|NCT03138655|19979638|P8|COMPLETED|Overall Study||10
8106187|NCT03138655|19979639|P7|COMPLETED|Overall Study||9
8106188|NCT03138655|19979640|P6|COMPLETED|Overall Study||7
8106189|NCT03138655|19979641|P5|COMPLETED|Overall Study||11
8106190|NCT03138655|19979642|P4|COMPLETED|Overall Study||7
8106191|NCT03138655|19979643|P3|COMPLETED|Overall Study||9
8106192|NCT03138655|19979644|P2|COMPLETED|Overall Study||7
8106193|NCT03138655|19979645|P1|COMPLETED|Overall Study||7
8106194|NCT03138655|19979638|P8|STARTED|Overall Study||12
8106195|NCT03138655|19979639|P7|STARTED|Overall Study||12
8106196|NCT03138655|19979640|P6|STARTED|Overall Study||12
8106197|NCT03138655|19979641|P5|STARTED|Overall Study||13
8106198|NCT03138655|19979642|P4|STARTED|Overall Study||10
8106199|NCT03138655|19979643|P3|STARTED|Overall Study||11
8106200|NCT03138655|19979644|P2|STARTED|Overall Study||9
8106201|NCT03138655|19979645|P1|STARTED|Overall Study||10
8106202|NCT03138590|19979687|P2|NOT COMPLETED|Overall Study||0
8106203|NCT03138590|19979688|P1|NOT COMPLETED|Overall Study||0
8106204|NCT03138590|19979687|P2|COMPLETED|Overall Study||10
8106205|NCT03138590|19979688|P1|COMPLETED|Overall Study||10
8106206|NCT03138590|19979687|P2|STARTED|Overall Study||10
8106207|NCT03138590|19979688|P1|STARTED|Overall Study||10
8106208|NCT03138577|19979701|P7|NOT COMPLETED|Overall Study||0
8106209|NCT03138577|19979702|P6|NOT COMPLETED|Overall Study||0
8106210|NCT03138577|19979703|P5|NOT COMPLETED|Overall Study||0
8106211|NCT03138577|19979704|P4|NOT COMPLETED|Overall Study||0
8106212|NCT03138577|19979705|P3|NOT COMPLETED|Overall Study||0
8106213|NCT03138577|19979706|P2|NOT COMPLETED|Overall Study||0
8106214|NCT03138577|19979707|P1|NOT COMPLETED|Overall Study||0
8106215|NCT03138577|19979701|P7|COMPLETED|Overall Study||3
8106216|NCT03138577|19979702|P6|COMPLETED|Overall Study||3
8106217|NCT03138577|19979703|P5|COMPLETED|Overall Study||3
8106218|NCT03138577|19979704|P4|COMPLETED|Overall Study||3
8106219|NCT03138577|19979705|P3|COMPLETED|Overall Study||3
8106220|NCT03138577|19979706|P2|COMPLETED|Overall Study||3
8106221|NCT03138577|19979707|P1|COMPLETED|Overall Study||3
8106222|NCT03138577|19979701|P7|STARTED|Overall Study||3
8106223|NCT03138577|19979702|P6|STARTED|Overall Study||3
8106224|NCT03138577|19979703|P5|STARTED|Overall Study||3
8106225|NCT03138577|19979704|P4|STARTED|Overall Study||3
8106226|NCT03138577|19979705|P3|STARTED|Overall Study||3
8106227|NCT03138577|19979706|P2|STARTED|Overall Study||3
8106228|NCT03138577|19979707|P1|STARTED|Overall Study||3
8106229|NCT03138382|19979752|P2|NOT COMPLETED|Overall Study||0
8106230|NCT03138382|19979753|P1|NOT COMPLETED|Overall Study||0
8106231|NCT03138382|19979752|P2|COMPLETED|Overall Study||10
8106232|NCT03138382|19979753|P1|COMPLETED|Overall Study||10
8106233|NCT03138382|19979752|P2|STARTED|Overall Study||10
8106234|NCT03138382|19979753|P1|STARTED|Overall Study||10
8106235|NCT03138330|19979761|P1|NOT COMPLETED|Overall Study||4
8106236|NCT03138330|19979761|P1|COMPLETED|Overall Study||91
8106237|NCT03138330|19979761|P1|STARTED|Overall Study||95
8106238|NCT03137784|19979766|P6|NOT COMPLETED|Overall Study||0
8106239|NCT03137784|19979767|P5|NOT COMPLETED|Overall Study||1
8106240|NCT03137784|19979768|P4|NOT COMPLETED|Overall Study||0
8106241|NCT03137784|19979769|P3|NOT COMPLETED|Overall Study||0
8106242|NCT03137784|19979770|P2|NOT COMPLETED|Overall Study||1
8106243|NCT03137784|19979771|P1|NOT COMPLETED|Overall Study||2
8106244|NCT03137784|19979766|P6|COMPLETED|Overall Study||25
8106245|NCT03137784|19979767|P5|COMPLETED|Overall Study||24
8106246|NCT03137784|19979768|P4|COMPLETED|Overall Study||24
8106247|NCT03137784|19979769|P3|COMPLETED|Overall Study||25
8106248|NCT03137784|19979770|P2|COMPLETED|Overall Study||24
8106249|NCT03137784|19979771|P1|COMPLETED|Overall Study||22
8106250|NCT03137784|19979766|P6|STARTED|Overall Study||25
8106251|NCT03137784|19979767|P5|STARTED|Overall Study||25
8106252|NCT03137784|19979768|P4|STARTED|Overall Study||24
8106253|NCT03137784|19979769|P3|STARTED|Overall Study||25
8106254|NCT03137784|19979770|P2|STARTED|Overall Study||25
8106255|NCT03137784|19979771|P1|STARTED|Overall Study||24
8106259|NCT03137225|19979812|P2|NOT COMPLETED|Second 4 Hour Measurement Period||0
8106260|NCT03137225|19979813|P1|NOT COMPLETED|Second 4 Hour Measurement Period||0
8106261|NCT03137225|19979812|P2|COMPLETED|Second 4 Hour Measurement Period||0
8106262|NCT03137225|19979813|P1|COMPLETED|Second 4 Hour Measurement Period||1
8106263|NCT03137225|19979812|P2|STARTED|Second 4 Hour Measurement Period||0
8106264|NCT03137225|19979813|P1|STARTED|Second 4 Hour Measurement Period||1
8106265|NCT03137225|19979812|P2|NOT COMPLETED|First 4 Hour Measurement Period||0
8106266|NCT03137225|19979813|P1|NOT COMPLETED|First 4 Hour Measurement Period||0
8106267|NCT03137225|19979812|P2|COMPLETED|First 4 Hour Measurement Period||0
8106268|NCT03137225|19979813|P1|COMPLETED|First 4 Hour Measurement Period||1
8106269|NCT03137225|19979812|P2|STARTED|First 4 Hour Measurement Period||0
8106270|NCT03137225|19979813|P1|STARTED|First 4 Hour Measurement Period||1
8106271|NCT03137173|19979827|P2|NOT COMPLETED|Overall Study||36
8106272|NCT03137173|19979828|P1|NOT COMPLETED|Overall Study||26
8106273|NCT03137173|19979827|P2|COMPLETED|Overall Study||308
8106274|NCT03137173|19979828|P1|COMPLETED|Overall Study||309
8106275|NCT03137173|19979827|P2|STARTED|Overall Study||344
8106276|NCT03137173|19979828|P1|STARTED|Overall Study||335
8106277|NCT03137069|19979844|P6|NOT COMPLETED|Overall Study||2
8106278|NCT03137069|19979845|P5|NOT COMPLETED|Overall Study||2
8106279|NCT03137069|19979846|P4|NOT COMPLETED|Overall Study||6
8106280|NCT03137069|19979847|P3|NOT COMPLETED|Overall Study||3
8106281|NCT03137069|19979848|P2|NOT COMPLETED|Overall Study||6
8106282|NCT03137069|19979849|P1|NOT COMPLETED|Overall Study||1
8106283|NCT03137069|19979844|P6|COMPLETED|Overall Study||21
8106284|NCT03137069|19979845|P5|COMPLETED|Overall Study||22
8106285|NCT03137069|19979846|P4|COMPLETED|Overall Study||17
8106286|NCT03137069|19979847|P3|COMPLETED|Overall Study||20
8106287|NCT03137069|19979848|P2|COMPLETED|Overall Study||22
8106288|NCT03137069|19979849|P1|COMPLETED|Overall Study||12
8106289|NCT03137069|19979844|P6|STARTED|Overall Study||23
8106290|NCT03137069|19979845|P5|STARTED|Overall Study||24
8106291|NCT03137069|19979846|P4|STARTED|Overall Study||23
8106292|NCT03137069|19979847|P3|STARTED|Overall Study||23
8106293|NCT03137069|19979848|P2|STARTED|Overall Study||28
8106294|NCT03137069|19979849|P1|STARTED|Overall Study||13
8106295|NCT03136861|19979892|P7|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
8106296|NCT03136861|19979893|P6|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
8106297|NCT03136861|19979894|P5|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
8106298|NCT03136861|19979895|P4|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
8106299|NCT03136861|19979896|P3|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
8106300|NCT03136861|19979897|P2|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
8106301|NCT03136861|19979898|P1|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
8106302|NCT03136861|19979892|P7|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43
8106303|NCT03136861|19979893|P6|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
8106304|NCT03136861|19979894|P5|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92
8106305|NCT03136861|19979895|P4|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93
8106306|NCT03136861|19979896|P3|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88
8106307|NCT03136861|19979897|P2|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
8106308|NCT03136861|19979898|P1|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
8106309|NCT03136861|19979892|P7|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44
8106310|NCT03136861|19979893|P6|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
8106311|NCT03136861|19979894|P5|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
8106312|NCT03136861|19979895|P4|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
8106313|NCT03136861|19979896|P3|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90
8106314|NCT03136861|19979897|P2|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
8106315|NCT03136861|19979898|P1|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
8106316|NCT03136861|19979892|P7|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106317|NCT03136861|19979893|P6|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106318|NCT03136861|19979894|P5|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106319|NCT03136861|19979895|P4|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106320|NCT03136861|19979896|P3|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106321|NCT03136861|19979897|P2|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6
8106322|NCT03136861|19979898|P1|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7
8106323|NCT03136861|19979892|P7|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106324|NCT03136861|19979893|P6|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106325|NCT03136861|19979894|P5|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106326|NCT03136861|19979895|P4|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106327|NCT03136861|19979896|P3|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106328|NCT03136861|19979897|P2|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89
8106329|NCT03136861|19979898|P1|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278
8106330|NCT03136861|19979892|P7|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106331|NCT03136861|19979893|P6|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106332|NCT03136861|19979894|P5|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106333|NCT03136861|19979895|P4|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106334|NCT03136861|19979896|P3|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
8106335|NCT03136861|19979897|P2|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95
8106336|NCT03136861|19979898|P1|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285
8106337|NCT03136484|19979913|P2|NOT COMPLETED|Overall Study||22
8106338|NCT03136484|19979914|P1|NOT COMPLETED|Overall Study||27
8106339|NCT03136484|19979913|P2|COMPLETED|Overall Study||372
8106340|NCT03136484|19979914|P1|COMPLETED|Overall Study||367
8106341|NCT03136484|19979913|P2|Exposed|Overall Study||394
8106342|NCT03136484|19979914|P1|Exposed|Overall Study||392
8106343|NCT03136484|19979913|P2|STARTED|Overall Study||394
8106344|NCT03136484|19979914|P1|STARTED|Overall Study||394
8106345|NCT03136380|19980042|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8106346|NCT03136380|19980043|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8106347|NCT03136380|19980044|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8106348|NCT03136380|19980045|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8106349|NCT03136380|19980046|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8106350|NCT03136380|19980042|P5|COMPLETED|Part 2, Period 2 (3 Days)||8
8106351|NCT03136380|19980043|P4|COMPLETED|Part 2, Period 2 (3 Days)||8
8106352|NCT03136380|19980044|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
8106353|NCT03136380|19980045|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
8106354|NCT03136380|19980046|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
8106355|NCT03136380|19980042|P5|STARTED|Part 2, Period 2 (3 Days)||8
8106356|NCT03136380|19980043|P4|STARTED|Part 2, Period 2 (3 Days)||8
8106357|NCT03136380|19980044|P3|STARTED|Part 2, Period 2 (3 Days)||0
8106358|NCT03136380|19980045|P2|STARTED|Part 2, Period 2 (3 Days)||0
8106359|NCT03136380|19980046|P1|STARTED|Part 2, Period 2 (3 Days)||0
8106360|NCT03136380|19980042|P5|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106361|NCT03136380|19980043|P4|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106362|NCT03136380|19980044|P3|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106363|NCT03136380|19980045|P2|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106364|NCT03136380|19980046|P1|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106365|NCT03136380|19980042|P5|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
8106366|NCT03136380|19980043|P4|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
8106367|NCT03136380|19980044|P3|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106368|NCT03136380|19980045|P2|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106369|NCT03136380|19980046|P1|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
8106370|NCT03136380|19980042|P5|STARTED|Part 2, Washout Period 1 (7 Days)||8
8106371|NCT03136380|19980043|P4|STARTED|Part 2, Washout Period 1 (7 Days)||8
8106372|NCT03136380|19980044|P3|STARTED|Part 2, Washout Period 1 (7 Days)||0
8106373|NCT03136380|19980045|P2|STARTED|Part 2, Washout Period 1 (7 Days)||0
8106374|NCT03136380|19980046|P1|STARTED|Part 2, Washout Period 1 (7 Days)||0
8106375|NCT03136380|19980042|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8106376|NCT03136380|19980043|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8106377|NCT03136380|19980044|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8106378|NCT03136380|19980045|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8106379|NCT03136380|19980046|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8106380|NCT03136380|19980042|P5|COMPLETED|Part 2, Period 1 (3 Days)||8
8106381|NCT03136380|19980043|P4|COMPLETED|Part 2, Period 1 (3 Days)||8
8106382|NCT03136380|19980044|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
8106383|NCT03136380|19980045|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
8106384|NCT03136380|19980046|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
8106385|NCT03136380|19980042|P5|STARTED|Part 2, Period 1 (3 Days)||8
8106386|NCT03136380|19980043|P4|STARTED|Part 2, Period 1 (3 Days)||8
8106387|NCT03136380|19980044|P3|STARTED|Part 2, Period 1 (3 Days)||0
8106388|NCT03136380|19980045|P2|STARTED|Part 2, Period 1 (3 Days)||0
8106389|NCT03136380|19980046|P1|STARTED|Part 2, Period 1 (3 Days)||0
8106390|NCT03136380|19980042|P5|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
8106391|NCT03136380|19980043|P4|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
8106392|NCT03136380|19980044|P3|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
8106393|NCT03136380|19980045|P2|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
8106394|NCT03136380|19980046|P1|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
8106395|NCT03136380|19980042|P5|COMPLETED|Part 1, Period 3 (4 Days)||0
8106396|NCT03136380|19980043|P4|COMPLETED|Part 1, Period 3 (4 Days)||0
8106397|NCT03136380|19980044|P3|COMPLETED|Part 1, Period 3 (4 Days)||6
8106398|NCT03136380|19980045|P2|COMPLETED|Part 1, Period 3 (4 Days)||5
8106399|NCT03136380|19980046|P1|COMPLETED|Part 1, Period 3 (4 Days)||6
8106400|NCT03136380|19980042|P5|STARTED|Part 1, Period 3 (4 Days)||0
8106401|NCT03136380|19980043|P4|STARTED|Part 1, Period 3 (4 Days)||0
8106402|NCT03136380|19980044|P3|STARTED|Part 1, Period 3 (4 Days)||6
8106403|NCT03136380|19980045|P2|STARTED|Part 1, Period 3 (4 Days)||5
8106404|NCT03136380|19980046|P1|STARTED|Part 1, Period 3 (4 Days)||6
8106405|NCT03136380|19980042|P5|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8106406|NCT03136380|19980043|P4|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8106407|NCT03136380|19980044|P3|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8106408|NCT03136380|19980045|P2|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1
8106409|NCT03136380|19980046|P1|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8106410|NCT03136380|19980042|P5|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8106411|NCT03136380|19980043|P4|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8106412|NCT03136380|19980044|P3|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
8106413|NCT03136380|19980045|P2|COMPLETED|Part 1, Washout Period 2 (7 Days)||5
8106414|NCT03136380|19980046|P1|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
8106415|NCT03136380|19980042|P5|STARTED|Part 1, Washout Period 2 (7 Days)||0
8106416|NCT03136380|19980043|P4|STARTED|Part 1, Washout Period 2 (7 Days)||0
8106417|NCT03136380|19980044|P3|STARTED|Part 1, Washout Period 2 (7 Days)||6
8106418|NCT03136380|19980045|P2|STARTED|Part 1, Washout Period 2 (7 Days)||6
8106419|NCT03136380|19980046|P1|STARTED|Part 1, Washout Period 2 (7 Days)||6
8106420|NCT03136380|19980042|P5|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
8106421|NCT03136380|19980043|P4|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
8106422|NCT03136380|19980044|P3|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
8106423|NCT03136380|19980045|P2|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
8106424|NCT03136380|19980046|P1|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
8106425|NCT03136380|19980042|P5|COMPLETED|Part 1, Period 2 (3 Days)||0
8106426|NCT03136380|19980043|P4|COMPLETED|Part 1, Period 2 (3 Days)||0
8106427|NCT03136380|19980044|P3|COMPLETED|Part 1, Period 2 (3 Days)||6
8106428|NCT03136380|19980045|P2|COMPLETED|Part 1, Period 2 (3 Days)||6
8106429|NCT03136380|19980046|P1|COMPLETED|Part 1, Period 2 (3 Days)||6
8106430|NCT03136380|19980042|P5|STARTED|Part 1, Period 2 (3 Days)||0
8106431|NCT03136380|19980043|P4|STARTED|Part 1, Period 2 (3 Days)||0
8106432|NCT03136380|19980044|P3|STARTED|Part 1, Period 2 (3 Days)||6
8106433|NCT03136380|19980045|P2|STARTED|Part 1, Period 2 (3 Days)||6
8106434|NCT03136380|19980046|P1|STARTED|Part 1, Period 2 (3 Days)||6
8106435|NCT03136380|19980042|P5|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8106436|NCT03136380|19980043|P4|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8106437|NCT03136380|19980044|P3|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8106438|NCT03136380|19980045|P2|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8106439|NCT03136380|19980046|P1|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8106440|NCT03136380|19980042|P5|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8106441|NCT03136380|19980043|P4|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8106442|NCT03136380|19980044|P3|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
8106443|NCT03136380|19980045|P2|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
8106444|NCT03136380|19980046|P1|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
8106445|NCT03136380|19980042|P5|STARTED|Part 1, Washout Period 1 (7 Days)||0
8106446|NCT03136380|19980043|P4|STARTED|Part 1, Washout Period 1 (7 Days)||0
8106447|NCT03136380|19980044|P3|STARTED|Part 1, Washout Period 1 (7 Days)||6
8106448|NCT03136380|19980045|P2|STARTED|Part 1, Washout Period 1 (7 Days)||6
8106449|NCT03136380|19980046|P1|STARTED|Part 1, Washout Period 1 (7 Days)||6
8106450|NCT03136380|19980042|P5|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
8106451|NCT03136380|19980043|P4|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
8106452|NCT03136380|19980044|P3|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
8106453|NCT03136380|19980045|P2|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
8106454|NCT03136380|19980046|P1|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
8106455|NCT03136380|19980042|P5|COMPLETED|Part 1, Period 1 (3 Days)||0
8106456|NCT03136380|19980043|P4|COMPLETED|Part 1, Period 1 (3 Days)||0
8106457|NCT03136380|19980044|P3|COMPLETED|Part 1, Period 1 (3 Days)||6
8106458|NCT03136380|19980045|P2|COMPLETED|Part 1, Period 1 (3 Days)||6
8106459|NCT03136380|19980046|P1|COMPLETED|Part 1, Period 1 (3 Days)||6
8106460|NCT03136380|19980042|P5|STARTED|Part 1, Period 1 (3 Days)||0
8106461|NCT03136380|19980043|P4|STARTED|Part 1, Period 1 (3 Days)||0
8106462|NCT03136380|19980044|P3|STARTED|Part 1, Period 1 (3 Days)||6
8106463|NCT03136380|19980045|P2|STARTED|Part 1, Period 1 (3 Days)||6
8106464|NCT03136380|19980046|P1|STARTED|Part 1, Period 1 (3 Days)||6
8106465|NCT03136367|19980222|P3|NOT COMPLETED|T5 1 Year After Surgery||129
8106466|NCT03136367|19980223|P2|NOT COMPLETED|T5 1 Year After Surgery||136
8106467|NCT03136367|19980224|P1|NOT COMPLETED|T5 1 Year After Surgery||36
8106468|NCT03136367|19980222|P3|COMPLETED|T5 1 Year After Surgery||56
8106469|NCT03136367|19980223|P2|COMPLETED|T5 1 Year After Surgery||62
8106470|NCT03136367|19980224|P1|COMPLETED|T5 1 Year After Surgery||13
8106471|NCT03136367|19980222|P3|STARTED|T5 1 Year After Surgery||185
8106472|NCT03136367|19980223|P2|STARTED|T5 1 Year After Surgery||198
8106473|NCT03136367|19980224|P1|STARTED|T5 1 Year After Surgery||49
8106474|NCT03136367|19980222|P3|NOT COMPLETED|T4 12 Weeks After Surgery||9
8106475|NCT03136367|19980223|P2|NOT COMPLETED|T4 12 Weeks After Surgery||5
8106476|NCT03136367|19980224|P1|NOT COMPLETED|T4 12 Weeks After Surgery||2
8106477|NCT03136367|19980222|P3|COMPLETED|T4 12 Weeks After Surgery||185
8106478|NCT03136367|19980223|P2|COMPLETED|T4 12 Weeks After Surgery||198
8106479|NCT03136367|19980224|P1|COMPLETED|T4 12 Weeks After Surgery||49
8106480|NCT03136367|19980222|P3|STARTED|T4 12 Weeks After Surgery||194
8106481|NCT03136367|19980223|P2|STARTED|T4 12 Weeks After Surgery||203
8106482|NCT03136367|19980224|P1|STARTED|T4 12 Weeks After Surgery||51
8106483|NCT03136367|19980222|P3|NOT COMPLETED|T3 1 Week After Surgery||31
8106484|NCT03136367|19980223|P2|NOT COMPLETED|T3 1 Week After Surgery||32
8106485|NCT03136367|19980224|P1|NOT COMPLETED|T3 1 Week After Surgery||10
8106486|NCT03136367|19980222|P3|COMPLETED|T3 1 Week After Surgery||194
8106487|NCT03136367|19980223|P2|COMPLETED|T3 1 Week After Surgery||203
8106488|NCT03136367|19980224|P1|COMPLETED|T3 1 Week After Surgery||51
8106489|NCT03136367|19980222|P3|STARTED|T3 1 Week After Surgery||225
8106490|NCT03136367|19980223|P2|STARTED|T3 1 Week After Surgery||235
8106491|NCT03136367|19980224|P1|STARTED|T3 1 Week After Surgery||61
8106492|NCT03136367|19980222|P3|NOT COMPLETED|T2 Post-consultation||31
8106493|NCT03136367|19980223|P2|NOT COMPLETED|T2 Post-consultation||6
8106494|NCT03136367|19980224|P1|NOT COMPLETED|T2 Post-consultation||3
8106495|NCT03136367|19980222|P3|COMPLETED|T2 Post-consultation||225
8106496|NCT03136367|19980223|P2|COMPLETED|T2 Post-consultation||235
8106497|NCT03136367|19980224|P1|COMPLETED|T2 Post-consultation||61
8106498|NCT03136367|19980222|P3|STARTED|T2 Post-consultation||256
8106499|NCT03136367|19980223|P2|STARTED|T2 Post-consultation||241
8106500|NCT03136367|19980224|P1|STARTED|T2 Post-consultation||64
8106501|NCT03136367|19980222|P3|NOT COMPLETED|T1 Consultation||1
8106502|NCT03136367|19980223|P2|NOT COMPLETED|T1 Consultation||7
8106503|NCT03136367|19980224|P1|NOT COMPLETED|T1 Consultation||2
8106504|NCT03136367|19980222|P3|COMPLETED|T1 Consultation||256
8106505|NCT03136367|19980223|P2|COMPLETED|T1 Consultation||241
8106506|NCT03136367|19980224|P1|COMPLETED|T1 Consultation|received the intervention|64
8106507|NCT03136367|19980222|P3|STARTED|T1 Consultation||257
8106508|NCT03136367|19980223|P2|STARTED|T1 Consultation||248
8106509|NCT03136367|19980224|P1|STARTED|T1 Consultation||66
8106510|NCT03136328|19980261|P1|NOT COMPLETED|Overall Study||0
8106511|NCT03136328|19980261|P1|COMPLETED|Overall Study||11
8106512|NCT03136328|19980261|P1|STARTED|Overall Study||11
8106513|NCT03136198|19980269|P2|NOT COMPLETED|Overall Study||1
8106514|NCT03136198|19980270|P1|NOT COMPLETED|Overall Study||0
8106515|NCT03136198|19980269|P2|COMPLETED|Overall Study||63
8106516|NCT03136198|19980270|P1|COMPLETED|Overall Study||66
8106517|NCT03136198|19980269|P2|STARTED|Overall Study||64
8106518|NCT03136198|19980270|P1|STARTED|Overall Study||66
8106519|NCT03136159|19980278|P2|NOT COMPLETED|Overall Study||0
8106520|NCT03136159|19980279|P1|NOT COMPLETED|Overall Study||5
8106521|NCT03136159|19980278|P2|COMPLETED|Overall Study||190
8106522|NCT03136159|19980279|P1|COMPLETED|Overall Study||185
8106523|NCT03136159|19980278|P2|STARTED|Overall Study||190
8106524|NCT03136159|19980279|P1|STARTED|Overall Study||190
8106525|NCT03136107|19980285|P1|NOT COMPLETED|Overall Study||1
8106526|NCT03136107|19980285|P1|COMPLETED|Overall Study||25
8106527|NCT03136107|19980285|P1|Negative Control|Overall Study||26
8106528|NCT03136107|19980285|P1|Reference Product|Overall Study||26
8106529|NCT03136107|19980285|P1|Test Product|Overall Study||26
8106530|NCT03136107|19980285|P1|STARTED|Overall Study||26
8106531|NCT03136068|19980295|P2|NOT COMPLETED|Overall Study||1
8106532|NCT03136068|19980296|P1|NOT COMPLETED|Overall Study||2
8106533|NCT03136068|19980295|P2|COMPLETED|Overall Study||89
8106534|NCT03136068|19980296|P1|COMPLETED|Overall Study||86
8106535|NCT03136068|19980295|P2|STARTED|Overall Study||90
8106536|NCT03136068|19980296|P1|STARTED|Overall Study||88
8106537|NCT03135899|19980318|P8|NOT COMPLETED|Overall Study||0
8106538|NCT03135899|19980319|P7|NOT COMPLETED|Overall Study||1
8106539|NCT03135899|19980320|P6|NOT COMPLETED|Overall Study||2
8106540|NCT03135899|19980321|P5|NOT COMPLETED|Overall Study||0
8106541|NCT03135899|19980322|P4|NOT COMPLETED|Overall Study||0
8106542|NCT03135899|19980323|P3|NOT COMPLETED|Overall Study||0
8106543|NCT03135899|19980324|P2|NOT COMPLETED|Overall Study||0
8106544|NCT03135899|19980325|P1|NOT COMPLETED|Overall Study||0
8106545|NCT03135899|19980318|P8|COMPLETED|Overall Study||8
8106546|NCT03135899|19980319|P7|COMPLETED|Overall Study||7
8106547|NCT03135899|19980320|P6|COMPLETED|Overall Study||7
8106548|NCT03135899|19980321|P5|COMPLETED|Overall Study||8
8106549|NCT03135899|19980322|P4|COMPLETED|Overall Study||1
8106550|NCT03135899|19980323|P3|COMPLETED|Overall Study||1
8106551|NCT03135899|19980324|P2|COMPLETED|Overall Study||1
8106552|NCT03135899|19980325|P1|COMPLETED|Overall Study||1
8106553|NCT03135899|19980318|P8|STARTED|Overall Study||8
8106554|NCT03135899|19980319|P7|STARTED|Overall Study||8
8106555|NCT03135899|19980320|P6|STARTED|Overall Study||9
8106556|NCT03135899|19980321|P5|STARTED|Overall Study||8
8106557|NCT03135899|19980322|P4|STARTED|Overall Study||1
8106558|NCT03135899|19980323|P3|STARTED|Overall Study||1
8106559|NCT03135899|19980324|P2|STARTED|Overall Study||1
8106560|NCT03135899|19980325|P1|STARTED|Overall Study||1
8106561|NCT03135548|19980358|P3|NOT COMPLETED|Overall Study||3
8106562|NCT03135548|19980359|P2|NOT COMPLETED|Overall Study||4
8106563|NCT03135548|19980360|P1|NOT COMPLETED|Overall Study||5
8106564|NCT03135548|19980358|P3|COMPLETED|Overall Study||18
8106565|NCT03135548|19980359|P2|COMPLETED|Overall Study||15
8106566|NCT03135548|19980360|P1|COMPLETED|Overall Study||14
8106567|NCT03135548|19980358|P3|STARTED|Overall Study||21
8106568|NCT03135548|19980359|P2|STARTED|Overall Study||19
8106569|NCT03135548|19980360|P1|STARTED|Overall Study||19
8106570|NCT03135535|19980380|P1|NOT COMPLETED|Overall Study||0
8106571|NCT03135535|19980380|P1|COMPLETED|Overall Study||30
8106572|NCT03135535|19980380|P1|STARTED|Overall Study||30
8106573|NCT03135522|19980390|P2|NOT COMPLETED|Overall Study||0
8106574|NCT03135522|19980391|P1|NOT COMPLETED|Overall Study||1
8106575|NCT03135522|19980390|P2|COMPLETED|Overall Study||17
8106576|NCT03135522|19980391|P1|COMPLETED|Overall Study||16
8106577|NCT03135522|19980390|P2|STARTED|Overall Study||17
8106578|NCT03135522|19980391|P1|STARTED|Overall Study||17
8106579|NCT03135431|19980405|P2|NOT COMPLETED|Overall Study||0
8106580|NCT03135431|19980406|P1|NOT COMPLETED|Overall Study||2
8106581|NCT03135431|19980405|P2|COMPLETED|Overall Study||20
8106582|NCT03135431|19980406|P1|COMPLETED|Overall Study||18
8106583|NCT03135431|19980405|P2|STARTED|Overall Study||20
8106584|NCT03135431|19980406|P1|STARTED|Overall Study||20
8106585|NCT03135379|19980418|P2|NOT COMPLETED|Overall Study||3
8106586|NCT03135379|19980419|P1|NOT COMPLETED|Overall Study||1
8106587|NCT03135379|19980418|P2|COMPLETED|Overall Study||59
8106588|NCT03135379|19980419|P1|COMPLETED|Overall Study||61
8106589|NCT03135379|19980418|P2|STARTED|Overall Study||62
8106590|NCT03135379|19980419|P1|STARTED|Overall Study||62
8106591|NCT03135028|19980427|P1|NOT COMPLETED|Overall Study||9
8106592|NCT03135028|19980427|P1|COMPLETED|Overall Study||0
8106593|NCT03135028|19980427|P1|STARTED|Overall Study||9
8106594|NCT03135015|19980435|P2|NOT COMPLETED|Overall Study||0
8106595|NCT03135015|19980436|P1|NOT COMPLETED|Overall Study||2
8106596|NCT03135015|19980435|P2|COMPLETED|Overall Study||11
8106597|NCT03135015|19980436|P1|COMPLETED|Overall Study||9
8106598|NCT03135015|19980435|P2|4g Tablets|Overall Study||11
8106599|NCT03135015|19980436|P1|4g Tablets|Overall Study||9
8106600|NCT03135015|19980435|P2|2g Tablets|Overall Study||11
8106601|NCT03135015|19980436|P1|2g Tablets|Overall Study||9
8106602|NCT03135015|19980435|P2|4g Capsules|Overall Study||11
8106603|NCT03135015|19980436|P1|4g Capsules|Overall Study||9
8106604|NCT03135015|19980435|P2|2g Capsules|Overall Study||11
8106605|NCT03135015|19980436|P1|2g Capsules|Overall Study||9
8106606|NCT03135015|19980435|P2|Placebo Capsules|Overall Study||11
8106607|NCT03135015|19980436|P1|Placebo Capsules|Overall Study||9
8106608|NCT03135015|19980435|P2|Water Control|Overall Study||11
8106609|NCT03135015|19980436|P1|Water Control|Overall Study||9
8106610|NCT03135015|19980435|P2|STARTED|Overall Study||11
8106611|NCT03135015|19980436|P1|STARTED|Overall Study||11
8106624|NCT03134911|19980573|P1|NOT COMPLETED|Overall Study||34
8106625|NCT03134911|19980573|P1|COMPLETED|Overall Study||501
8106626|NCT03134911|19980573|P1|STARTED|Overall Study||535
8106627|NCT03134768|19980600|P1|NOT COMPLETED|Overall Study||0
8106628|NCT03134768|19980600|P1|COMPLETED|Overall Study||50
8106629|NCT03134768|19980600|P1|STARTED|Overall Study||50
8106630|NCT03134703|19980608|P2|NOT COMPLETED|Overall Study||2
8106631|NCT03134703|19980609|P1|NOT COMPLETED|Overall Study||6
8106632|NCT03134703|19980608|P2|COMPLETED|Overall Study||3
8106633|NCT03134703|19980609|P1|COMPLETED|Overall Study||0
8106634|NCT03134703|19980608|P2|STARTED|Overall Study||5
8106635|NCT03134703|19980609|P1|STARTED|Overall Study||6
8106636|NCT03134599|19980635|P6|NOT COMPLETED|Week 3||1
8106637|NCT03134599|19980636|P5|NOT COMPLETED|Week 3||0
8106638|NCT03134599|19980637|P4|NOT COMPLETED|Week 3||1
8106639|NCT03134599|19980638|P3|NOT COMPLETED|Week 3||0
8106640|NCT03134599|19980639|P2|NOT COMPLETED|Week 3||0
8106641|NCT03134599|19980640|P1|NOT COMPLETED|Week 3||0
8106642|NCT03134599|19980635|P6|COMPLETED|Week 3||8
8106643|NCT03134599|19980636|P5|COMPLETED|Week 3||8
8106644|NCT03134599|19980637|P4|COMPLETED|Week 3||9
8106645|NCT03134599|19980638|P3|COMPLETED|Week 3||10
8106646|NCT03134599|19980639|P2|COMPLETED|Week 3||10
8106647|NCT03134599|19980640|P1|COMPLETED|Week 3||9
8106648|NCT03134599|19980635|P6|STARTED|Week 3||9
8106649|NCT03134599|19980636|P5|STARTED|Week 3||8
8106650|NCT03134599|19980637|P4|STARTED|Week 3||10
8106651|NCT03134599|19980638|P3|STARTED|Week 3||10
8106652|NCT03134599|19980639|P2|STARTED|Week 3||10
8106653|NCT03134599|19980640|P1|STARTED|Week 3||9
8106654|NCT03134599|19980635|P6|NOT COMPLETED|Week 2||0
8106655|NCT03134599|19980636|P5|NOT COMPLETED|Week 2||1
8106656|NCT03134599|19980637|P4|NOT COMPLETED|Week 2||1
8106657|NCT03134599|19980638|P3|NOT COMPLETED|Week 2||0
8106658|NCT03134599|19980639|P2|NOT COMPLETED|Week 2||0
8106659|NCT03134599|19980640|P1|NOT COMPLETED|Week 2||1
8106660|NCT03134599|19980635|P6|COMPLETED|Week 2||9
8106661|NCT03134599|19980636|P5|COMPLETED|Week 2||8
8106662|NCT03134599|19980637|P4|COMPLETED|Week 2||10
8106663|NCT03134599|19980638|P3|COMPLETED|Week 2||10
8106664|NCT03134599|19980639|P2|COMPLETED|Week 2||10
8106665|NCT03134599|19980640|P1|COMPLETED|Week 2||9
8106666|NCT03134599|19980635|P6|STARTED|Week 2||9
8106667|NCT03134599|19980636|P5|STARTED|Week 2||9
8106668|NCT03134599|19980637|P4|STARTED|Week 2||11
8106669|NCT03134599|19980638|P3|STARTED|Week 2||10
8106670|NCT03134599|19980639|P2|STARTED|Week 2||10
8106671|NCT03134599|19980640|P1|STARTED|Week 2||10
8106672|NCT03134599|19980635|P6|NOT COMPLETED|Week 1||0
8106673|NCT03134599|19980636|P5|NOT COMPLETED|Week 1||1
8106674|NCT03134599|19980637|P4|NOT COMPLETED|Week 1||0
8106675|NCT03134599|19980638|P3|NOT COMPLETED|Week 1||0
8106676|NCT03134599|19980639|P2|NOT COMPLETED|Week 1||0
8106677|NCT03134599|19980640|P1|NOT COMPLETED|Week 1||0
8106678|NCT03134599|19980635|P6|COMPLETED|Week 1||9
8106679|NCT03134599|19980636|P5|COMPLETED|Week 1||9
8106680|NCT03134599|19980637|P4|COMPLETED|Week 1||11
8106681|NCT03134599|19980638|P3|COMPLETED|Week 1||10
8106682|NCT03134599|19980639|P2|COMPLETED|Week 1||10
8106683|NCT03134599|19980640|P1|COMPLETED|Week 1||10
8106684|NCT03134599|19980635|P6|STARTED|Week 1||9
8106685|NCT03134599|19980636|P5|STARTED|Week 1||10
8106686|NCT03134599|19980637|P4|STARTED|Week 1||11
8106687|NCT03134599|19980638|P3|STARTED|Week 1||10
8106688|NCT03134599|19980639|P2|STARTED|Week 1||10
8106689|NCT03134599|19980640|P1|STARTED|Week 1||10
8106690|NCT03134326|19980648|P1|NOT COMPLETED|Overall Study||0
8106691|NCT03134326|19980648|P1|COMPLETED|Overall Study||21
8106692|NCT03134326|19980648|P1|STARTED|Overall Study||21
8106693|NCT03134313|19980652|P1|NOT COMPLETED|Overall Study||0
8106694|NCT03134313|19980652|P1|COMPLETED|Overall Study||25
8106695|NCT03134313|19980652|P1|STARTED|Overall Study||25
8106696|NCT03134248|19980656|P6|NOT COMPLETED|Week 3||0
8106697|NCT03134248|19980657|P5|NOT COMPLETED|Week 3||0
8106698|NCT03134248|19980658|P4|NOT COMPLETED|Week 3||0
8106699|NCT03134248|19980659|P3|NOT COMPLETED|Week 3||0
8106700|NCT03134248|19980660|P2|NOT COMPLETED|Week 3||0
8106701|NCT03134248|19980661|P1|NOT COMPLETED|Week 3||0
8106702|NCT03134248|19980656|P6|COMPLETED|Week 3||9
8106703|NCT03134248|19980657|P5|COMPLETED|Week 3||9
8106704|NCT03134248|19980658|P4|COMPLETED|Week 3||7
8106705|NCT03134248|19980659|P3|COMPLETED|Week 3||9
8106706|NCT03134248|19980660|P2|COMPLETED|Week 3||8
8106707|NCT03134248|19980661|P1|COMPLETED|Week 3||7
8106708|NCT03134248|19980656|P6|STARTED|Week 3||9
8106709|NCT03134248|19980657|P5|STARTED|Week 3||9
8106710|NCT03134248|19980658|P4|STARTED|Week 3||7
8106711|NCT03134248|19980659|P3|STARTED|Week 3||9
8106712|NCT03134248|19980660|P2|STARTED|Week 3||8
8106713|NCT03134248|19980661|P1|STARTED|Week 3||7
8106714|NCT03134248|19980656|P6|NOT COMPLETED|Week 2||0
8106715|NCT03134248|19980657|P5|NOT COMPLETED|Week 2||0
8106716|NCT03134248|19980658|P4|NOT COMPLETED|Week 2||0
8106717|NCT03134248|19980659|P3|NOT COMPLETED|Week 2||0
8106718|NCT03134248|19980660|P2|NOT COMPLETED|Week 2||0
8106719|NCT03134248|19980661|P1|NOT COMPLETED|Week 2||0
8106720|NCT03134248|19980656|P6|COMPLETED|Week 2||9
8106721|NCT03134248|19980657|P5|COMPLETED|Week 2||9
8106722|NCT03134248|19980658|P4|COMPLETED|Week 2||7
8106723|NCT03134248|19980659|P3|COMPLETED|Week 2||9
8106724|NCT03134248|19980660|P2|COMPLETED|Week 2||8
8106725|NCT03134248|19980661|P1|COMPLETED|Week 2||7
8106726|NCT03134248|19980656|P6|STARTED|Week 2||9
8106727|NCT03134248|19980657|P5|STARTED|Week 2||9
8106728|NCT03134248|19980658|P4|STARTED|Week 2||7
8106729|NCT03134248|19980659|P3|STARTED|Week 2||9
8106730|NCT03134248|19980660|P2|STARTED|Week 2||8
8106731|NCT03134248|19980661|P1|STARTED|Week 2||7
8106732|NCT03134248|19980656|P6|NOT COMPLETED|Week 1||0
8106733|NCT03134248|19980657|P5|NOT COMPLETED|Week 1||0
8106734|NCT03134248|19980658|P4|NOT COMPLETED|Week 1||0
8106735|NCT03134248|19980659|P3|NOT COMPLETED|Week 1||0
8106736|NCT03134248|19980660|P2|NOT COMPLETED|Week 1||0
8106737|NCT03134248|19980661|P1|NOT COMPLETED|Week 1||0
8106738|NCT03134248|19980656|P6|COMPLETED|Week 1||9
8106739|NCT03134248|19980657|P5|COMPLETED|Week 1||9
8106740|NCT03134248|19980658|P4|COMPLETED|Week 1||7
8106741|NCT03134248|19980659|P3|COMPLETED|Week 1||9
8106742|NCT03134248|19980660|P2|COMPLETED|Week 1||8
8106743|NCT03134248|19980661|P1|COMPLETED|Week 1||7
8106744|NCT03134248|19980656|P6|STARTED|Week 1||9
8106745|NCT03134248|19980657|P5|STARTED|Week 1||9
8106746|NCT03134248|19980658|P4|STARTED|Week 1||7
8106747|NCT03134248|19980659|P3|STARTED|Week 1||9
8106748|NCT03134248|19980660|P2|STARTED|Week 1||8
8106749|NCT03134248|19980661|P1|STARTED|Week 1||7
8106750|NCT03134222|19980680|P5|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
8106751|NCT03134222|19980681|P4|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
8106752|NCT03134222|19980682|P3|NOT COMPLETED|Treatment Period (Week 12 to 48)||0
8106753|NCT03134222|19980683|P2|NOT COMPLETED|Treatment Period (Week 12 to 48)||3
8106754|NCT03134222|19980684|P1|NOT COMPLETED|Treatment Period (Week 12 to 48)||2
8106755|NCT03134222|19980680|P5|COMPLETED|Treatment Period (Week 12 to 48)||3
8106756|NCT03134222|19980681|P4|COMPLETED|Treatment Period (Week 12 to 48)||3
8106757|NCT03134222|19980682|P3|COMPLETED|Treatment Period (Week 12 to 48)||0
8106758|NCT03134222|19980683|P2|COMPLETED|Treatment Period (Week 12 to 48)||11
8106759|NCT03134222|19980684|P1|COMPLETED|Treatment Period (Week 12 to 48)||12
8106760|NCT03134222|19980680|P5|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
8106761|NCT03134222|19980681|P4|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
8106762|NCT03134222|19980682|P3|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized 1:1 to either Placebo to Lanraplenib or Placebo to Filgotinib arm.|0
8106763|NCT03134222|19980683|P2|STARTED|Treatment Period (Week 12 to 48)||14
8106764|NCT03134222|19980684|P1|STARTED|Treatment Period (Week 12 to 48)||14
8106765|NCT03134222|19980680|P5|NOT COMPLETED|Treatment Period (Up to Week 12)||0
8106766|NCT03134222|19980681|P4|NOT COMPLETED|Treatment Period (Up to Week 12)||0
8106767|NCT03134222|19980682|P3|NOT COMPLETED|Treatment Period (Up to Week 12)||2
8106768|NCT03134222|19980683|P2|NOT COMPLETED|Treatment Period (Up to Week 12)||4
8106769|NCT03134222|19980684|P1|NOT COMPLETED|Treatment Period (Up to Week 12)||5
8106770|NCT03134222|19980680|P5|COMPLETED|Treatment Period (Up to Week 12)||0
8106771|NCT03134222|19980681|P4|COMPLETED|Treatment Period (Up to Week 12)||0
8106772|NCT03134222|19980682|P3|COMPLETED|Treatment Period (Up to Week 12)||8
8106773|NCT03134222|19980683|P2|COMPLETED|Treatment Period (Up to Week 12)||14
8106774|NCT03134222|19980684|P1|COMPLETED|Treatment Period (Up to Week 12)||14
8106775|NCT03134222|19980680|P5|STARTED|Treatment Period (Up to Week 12)||0
8106776|NCT03134222|19980681|P4|STARTED|Treatment Period (Up to Week 12)||0
8106777|NCT03134222|19980682|P3|STARTED|Treatment Period (Up to Week 12)||10
8106778|NCT03134222|19980683|P2|STARTED|Treatment Period (Up to Week 12)||18
8106779|NCT03134222|19980684|P1|STARTED|Treatment Period (Up to Week 12)||19
8106780|NCT03134183|19980706|P2|NOT COMPLETED|Overall Study||1
8106781|NCT03134183|19980707|P1|NOT COMPLETED|Overall Study||1
8106782|NCT03134183|19980706|P2|COMPLETED|Overall Study||33
8106783|NCT03134183|19980707|P1|COMPLETED|Overall Study||35
8106784|NCT03134183|19980706|P2|STARTED|Overall Study||34
8106785|NCT03134183|19980707|P1|STARTED|Overall Study||36
8106786|NCT03134144|19980717|P2|NOT COMPLETED|Overall Study||0
8106787|NCT03134144|19980718|P1|NOT COMPLETED|Overall Study||0
8106788|NCT03134144|19980717|P2|COMPLETED|Overall Study||30
8106789|NCT03134144|19980718|P1|COMPLETED|Overall Study||15
8106790|NCT03134144|19980717|P2|STARTED|Overall Study||30
8106791|NCT03134144|19980718|P1|STARTED|Overall Study||15
8106792|NCT03134092|19980735|P3|NOT COMPLETED|Overall Study||0
8106793|NCT03134092|19980736|P2|NOT COMPLETED|Overall Study||0
8106794|NCT03134092|19980737|P1|NOT COMPLETED|Overall Study||0
8106795|NCT03134092|19980735|P3|COMPLETED|Overall Study||433
8106796|NCT03134092|19980736|P2|COMPLETED|Overall Study||435
8106797|NCT03134092|19980737|P1|COMPLETED|Overall Study||434
8106798|NCT03134092|19980735|P3|STARTED|Overall Study||433
8106799|NCT03134092|19980736|P2|STARTED|Overall Study||435
8106800|NCT03134092|19980737|P1|STARTED|Overall Study||434
8106801|NCT03133767|19980758|P2|NOT COMPLETED|Overall Study||25
8106802|NCT03133767|19980759|P1|NOT COMPLETED|Overall Study||38
8106803|NCT03133767|19980758|P2|COMPLETED|Overall Study||53
8106804|NCT03133767|19980759|P1|COMPLETED|Overall Study||41
8106805|NCT03133767|19980758|P2|STARTED|Overall Study||78
8106806|NCT03133767|19980759|P1|STARTED|Overall Study||79
8106807|NCT03133481|19980775|P2|NOT COMPLETED|Overall Study||4
8106808|NCT03133481|19980776|P1|NOT COMPLETED|Overall Study||0
8106809|NCT03133481|19980775|P2|COMPLETED|Overall Study||45
8106810|NCT03133481|19980776|P1|COMPLETED|Overall Study||45
8106811|NCT03133481|19980775|P2|STARTED|Overall Study||49
8106812|NCT03133481|19980776|P1|STARTED|Overall Study||45
8106813|NCT03132753|19980806|P2|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||2
8106814|NCT03132753|19980807|P1|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||6
8106815|NCT03132753|19980806|P2|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||20
8106816|NCT03132753|19980807|P1|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||13
8106817|NCT03132753|19980806|P2|STARTED|6 Month Follow-Up - 12 Month Follow-Up||22
8106818|NCT03132753|19980807|P1|STARTED|6 Month Follow-Up - 12 Month Follow-Up||19
8106819|NCT03132753|19980806|P2|NOT COMPLETED|Baseline - 6 Month Follow-Up||32
8106820|NCT03132753|19980807|P1|NOT COMPLETED|Baseline - 6 Month Follow-Up||27
8106821|NCT03132753|19980806|P2|COMPLETED|Baseline - 6 Month Follow-Up||22
8106822|NCT03132753|19980807|P1|COMPLETED|Baseline - 6 Month Follow-Up||19
8106823|NCT03132753|19980806|P2|STARTED|Baseline - 6 Month Follow-Up||54
8106824|NCT03132753|19980807|P1|STARTED|Baseline - 6 Month Follow-Up||46
8106825|NCT03132571|19980895|P2|NOT COMPLETED|Overall Study||0
8106826|NCT03132571|19980896|P1|NOT COMPLETED|Overall Study||0
8106827|NCT03132571|19980895|P2|COMPLETED|Overall Study||2
8106828|NCT03132571|19980896|P1|COMPLETED|Overall Study||3
8106829|NCT03132571|19980895|P2|STARTED|Overall Study||2
8106830|NCT03132571|19980896|P1|STARTED|Overall Study||3
8106831|NCT03132298|19980910|P2|NOT COMPLETED|Overall Study||13
8106832|NCT03132298|19980911|P1|NOT COMPLETED|Overall Study||12
8106833|NCT03132298|19980910|P2|COMPLETED|Overall Study||35
8106834|NCT03132298|19980911|P1|COMPLETED|Overall Study||36
8106835|NCT03132298|19980910|P2|STARTED|Overall Study||48
8106836|NCT03132298|19980911|P1|STARTED|Overall Study||48
8106837|NCT03132246|19980941|P1|NOT COMPLETED|Overall Study||104
8106838|NCT03132246|19980941|P1|COMPLETED|Overall Study||156
8106839|NCT03132246|19980941|P1|STARTED|Overall Study||260
8106840|NCT03132220|19980952|P2|NOT COMPLETED|Overall Study||12
8106841|NCT03132220|19980953|P1|NOT COMPLETED|Overall Study||18
8106842|NCT03132220|19980952|P2|COMPLETED|Overall Study||54
8106843|NCT03132220|19980953|P1|COMPLETED|Overall Study||47
8106844|NCT03132220|19980952|P2|Began Study Sessions|Overall Study|66 participants randomized to control arm;8 were lost to f/u prior to study start; 58 began sessions|58
8106845|NCT03132220|19980953|P1|Began Study Sessions|Overall Study|65 participants randomized to intervention arm;17 lost to f/u prior to study start;48 began sessions|48
8106846|NCT03132220|19980952|P2|STARTED|Overall Study||66
8106847|NCT03132220|19980953|P1|STARTED|Overall Study||65
8106848|NCT03131999|19980981|P2|NOT COMPLETED|Overall Study||1
8106849|NCT03131999|19980982|P1|NOT COMPLETED|Overall Study||0
8106850|NCT03131999|19980981|P2|COMPLETED|Overall Study||7
8106851|NCT03131999|19980982|P1|COMPLETED|Overall Study||8
8106852|NCT03131999|19980981|P2|STARTED|Overall Study||8
8106853|NCT03131999|19980982|P1|STARTED|Overall Study||8
8106854|NCT03131895|19980994|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8106855|NCT03131895|19980995|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8106856|NCT03131895|19980996|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||1
8106857|NCT03131895|19980997|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
8106858|NCT03131895|19980994|P4|COMPLETED|Intervention Period 2 (2 Days)||25
8106859|NCT03131895|19980995|P3|COMPLETED|Intervention Period 2 (2 Days)||26
8106860|NCT03131895|19980996|P2|COMPLETED|Intervention Period 2 (2 Days)||22
8106861|NCT03131895|19980997|P1|COMPLETED|Intervention Period 2 (2 Days)||26
8106862|NCT03131895|19980994|P4|STARTED|Intervention Period 2 (2 Days)||25
8106863|NCT03131895|19980995|P3|STARTED|Intervention Period 2 (2 Days)||26
8106864|NCT03131895|19980996|P2|STARTED|Intervention Period 2 (2 Days)||23
8106865|NCT03131895|19980997|P1|STARTED|Intervention Period 2 (2 Days)||27
8106866|NCT03131895|19980994|P4|NOT COMPLETED|Washout Period (at Least 5 Days)||5
8106867|NCT03131895|19980995|P3|NOT COMPLETED|Washout Period (at Least 5 Days)||4
8106868|NCT03131895|19980996|P2|NOT COMPLETED|Washout Period (at Least 5 Days)||5
8106869|NCT03131895|19980997|P1|NOT COMPLETED|Washout Period (at Least 5 Days)||1
8106870|NCT03131895|19980994|P4|COMPLETED|Washout Period (at Least 5 Days)||25
8106871|NCT03131895|19980995|P3|COMPLETED|Washout Period (at Least 5 Days)||26
8106872|NCT03131895|19980996|P2|COMPLETED|Washout Period (at Least 5 Days)||23
8106873|NCT03131895|19980997|P1|COMPLETED|Washout Period (at Least 5 Days)||27
8106874|NCT03131895|19980994|P4|STARTED|Washout Period (at Least 5 Days)||30
8106875|NCT03131895|19980995|P3|STARTED|Washout Period (at Least 5 Days)||30
8106876|NCT03131895|19980996|P2|STARTED|Washout Period (at Least 5 Days)||28
8106877|NCT03131895|19980997|P1|STARTED|Washout Period (at Least 5 Days)||28
8106878|NCT03131895|19980994|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8106879|NCT03131895|19980995|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8106880|NCT03131895|19980996|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8106881|NCT03131895|19980997|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8106882|NCT03131895|19980994|P4|COMPLETED|Intervention Period 1 (2 Days)||30
8106883|NCT03131895|19980995|P3|COMPLETED|Intervention Period 1 (2 Days)||30
8106884|NCT03131895|19980996|P2|COMPLETED|Intervention Period 1 (2 Days)||28
8106885|NCT03131895|19980997|P1|COMPLETED|Intervention Period 1 (2 Days)||28
8106886|NCT03131895|19980994|P4|STARTED|Intervention Period 1 (2 Days)||30
8106887|NCT03131895|19980995|P3|STARTED|Intervention Period 1 (2 Days)||30
8106888|NCT03131895|19980996|P2|STARTED|Intervention Period 1 (2 Days)||28
8106889|NCT03131895|19980997|P1|STARTED|Intervention Period 1 (2 Days)||28
8106890|NCT03131713|19981017|P2|NOT COMPLETED|Overall Study||0
8106891|NCT03131713|19981018|P1|NOT COMPLETED|Overall Study||5
8106892|NCT03131713|19981017|P2|COMPLETED|Overall Study||51
8106893|NCT03131713|19981018|P1|COMPLETED|Overall Study||45
8106894|NCT03131713|19981017|P2|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51
8106895|NCT03131713|19981018|P1|STARTED|Overall Study||50
8106896|NCT03131687|19981042|P6|NOT COMPLETED|Overall Study||5
8106897|NCT03131687|19981043|P5|NOT COMPLETED|Overall Study||8
8106898|NCT03131687|19981044|P4|NOT COMPLETED|Overall Study||4
8106899|NCT03131687|19981045|P3|NOT COMPLETED|Overall Study||3
8106900|NCT03131687|19981046|P2|NOT COMPLETED|Overall Study||9
8106901|NCT03131687|19981047|P1|NOT COMPLETED|Overall Study||6
8106902|NCT03131687|19981042|P6|COMPLETED|Overall Study||49
8106903|NCT03131687|19981043|P5|COMPLETED|Overall Study||45
8106904|NCT03131687|19981044|P4|COMPLETED|Overall Study||48
8106905|NCT03131687|19981045|P3|COMPLETED|Overall Study||52
8106906|NCT03131687|19981046|P2|COMPLETED|Overall Study||44
8106907|NCT03131687|19981047|P1|COMPLETED|Overall Study||45
8106908|NCT03131687|19981042|P6|Received at Least One Dose of Study Drug|Overall Study||54
8106909|NCT03131687|19981043|P5|Received at Least One Dose of Study Drug|Overall Study||53
8106910|NCT03131687|19981044|P4|Received at Least One Dose of Study Drug|Overall Study||51
8106911|NCT03131687|19981045|P3|Received at Least One Dose of Study Drug|Overall Study||55
8106912|NCT03131687|19981046|P2|Received at Least One Dose of Study Drug|Overall Study||52
8106913|NCT03131687|19981047|P1|Received at Least One Dose of Study Drug|Overall Study||51
8106914|NCT03131687|19981042|P6|STARTED|Overall Study||54
8106915|NCT03131687|19981043|P5|STARTED|Overall Study||53
8106916|NCT03131687|19981044|P4|STARTED|Overall Study||52
8106917|NCT03131687|19981045|P3|STARTED|Overall Study||55
8106918|NCT03131687|19981046|P2|STARTED|Overall Study||53
8106919|NCT03131687|19981047|P1|STARTED|Overall Study||51
8106920|NCT03131648|19981157|P8|NOT COMPLETED|Open-label (Short Term Extension)||3
8106921|NCT03131648|19981158|P7|NOT COMPLETED|Open-label (Short Term Extension)||0
8106922|NCT03131648|19981159|P6|NOT COMPLETED|Open-label (Short Term Extension)||0
8106923|NCT03131648|19981160|P5|NOT COMPLETED|Open-label (Short Term Extension)||0
8106924|NCT03131648|19981161|P4|NOT COMPLETED|Open-label (Short Term Extension)||0
8106925|NCT03131648|19981162|P3|NOT COMPLETED|Open-label (Short Term Extension)||0
8106926|NCT03131648|19981163|P2|NOT COMPLETED|Open-label (Short Term Extension)||0
8106927|NCT03131648|19981164|P1|NOT COMPLETED|Open-label (Short Term Extension)||0
8106928|NCT03131648|19981157|P8|COMPLETED|Open-label (Short Term Extension)||62
8106929|NCT03131648|19981158|P7|COMPLETED|Open-label (Short Term Extension)||0
8106930|NCT03131648|19981159|P6|COMPLETED|Open-label (Short Term Extension)||0
8106931|NCT03131648|19981160|P5|COMPLETED|Open-label (Short Term Extension)||0
8106932|NCT03131648|19981161|P4|COMPLETED|Open-label (Short Term Extension)||0
8106933|NCT03131648|19981162|P3|COMPLETED|Open-label (Short Term Extension)||0
8106934|NCT03131648|19981163|P2|COMPLETED|Open-label (Short Term Extension)||0
8106935|NCT03131648|19981164|P1|COMPLETED|Open-label (Short Term Extension)||0
8106936|NCT03131648|19981157|P8|STARTED|Open-label (Short Term Extension)||65
8106937|NCT03131648|19981158|P7|STARTED|Open-label (Short Term Extension)||0
8106938|NCT03131648|19981159|P6|STARTED|Open-label (Short Term Extension)||0
8106939|NCT03131648|19981160|P5|STARTED|Open-label (Short Term Extension)||0
8106940|NCT03131648|19981161|P4|STARTED|Open-label (Short Term Extension)||0
8106941|NCT03131648|19981162|P3|STARTED|Open-label (Short Term Extension)||0
8106942|NCT03131648|19981163|P2|STARTED|Open-label (Short Term Extension)||0
8106943|NCT03131648|19981164|P1|STARTED|Open-label (Short Term Extension)||0
8106944|NCT03131648|19981157|P8|NOT COMPLETED|Maintenance Treatment Period||0
8106945|NCT03131648|19981158|P7|NOT COMPLETED|Maintenance Treatment Period||0
8106946|NCT03131648|19981159|P6|NOT COMPLETED|Maintenance Treatment Period||14
8106947|NCT03131648|19981160|P5|NOT COMPLETED|Maintenance Treatment Period||15
8106948|NCT03131648|19981161|P4|NOT COMPLETED|Maintenance Treatment Period||25
8106949|NCT03131648|19981162|P3|NOT COMPLETED|Maintenance Treatment Period||27
8106950|NCT03131648|19981163|P2|NOT COMPLETED|Maintenance Treatment Period||0
8106951|NCT03131648|19981164|P1|NOT COMPLETED|Maintenance Treatment Period||0
8106952|NCT03131648|19981157|P8|COMPLETED|Maintenance Treatment Period||0
8106953|NCT03131648|19981158|P7|COMPLETED|Maintenance Treatment Period||0
8106954|NCT03131648|19981159|P6|COMPLETED|Maintenance Treatment Period||15
8106955|NCT03131648|19981160|P5|COMPLETED|Maintenance Treatment Period||21
8106956|NCT03131648|19981161|P4|COMPLETED|Maintenance Treatment Period||53
8106957|NCT03131648|19981162|P3|COMPLETED|Maintenance Treatment Period||44
8106958|NCT03131648|19981163|P2|COMPLETED|Maintenance Treatment Period||0
8106959|NCT03131648|19981164|P1|COMPLETED|Maintenance Treatment Period||0
8106960|NCT03131648|19981157|P8|STARTED|Maintenance Treatment Period||0
8106961|NCT03131648|19981158|P7|STARTED|Maintenance Treatment Period||0
8106962|NCT03131648|19981159|P6|STARTED|Maintenance Treatment Period||29
8106963|NCT03131648|19981160|P5|STARTED|Maintenance Treatment Period||36
8106964|NCT03131648|19981161|P4|STARTED|Maintenance Treatment Period||78
8106965|NCT03131648|19981162|P3|STARTED|Maintenance Treatment Period||71
8106966|NCT03131648|19981163|P2|STARTED|Maintenance Treatment Period||0
8106967|NCT03131648|19981164|P1|STARTED|Maintenance Treatment Period||0
8106968|NCT03131648|19981157|P8|NOT COMPLETED|Open-label Treatment||0
8106969|NCT03131648|19981158|P7|NOT COMPLETED|Open-label Treatment||118
8106970|NCT03131648|19981159|P6|NOT COMPLETED|Open-label Treatment||0
8106971|NCT03131648|19981160|P5|NOT COMPLETED|Open-label Treatment||0
8106972|NCT03131648|19981161|P4|NOT COMPLETED|Open-label Treatment||0
8106973|NCT03131648|19981162|P3|NOT COMPLETED|Open-label Treatment||0
8106974|NCT03131648|19981163|P2|NOT COMPLETED|Open-label Treatment||0
8106975|NCT03131648|19981164|P1|NOT COMPLETED|Open-label Treatment||0
8106976|NCT03131648|19981157|P8|COMPLETED|Open-label Treatment||0
8106977|NCT03131648|19981158|P7|COMPLETED|Open-label Treatment||446
8106978|NCT03131648|19981159|P6|COMPLETED|Open-label Treatment||0
8106979|NCT03131648|19981160|P5|COMPLETED|Open-label Treatment||0
8106980|NCT03131648|19981161|P4|COMPLETED|Open-label Treatment||0
8106981|NCT03131648|19981162|P3|COMPLETED|Open-label Treatment||0
8106982|NCT03131648|19981163|P2|COMPLETED|Open-label Treatment||0
8106983|NCT03131648|19981164|P1|COMPLETED|Open-label Treatment||0
8106984|NCT03131648|19981157|P8|STARTED|Open-label Treatment||0
8106985|NCT03131648|19981158|P7|STARTED|Open-label Treatment||564
8106986|NCT03131648|19981159|P6|STARTED|Open-label Treatment||0
8106987|NCT03131648|19981160|P5|STARTED|Open-label Treatment||0
8106988|NCT03131648|19981161|P4|STARTED|Open-label Treatment||0
8106989|NCT03131648|19981162|P3|STARTED|Open-label Treatment||0
8106990|NCT03131648|19981163|P2|STARTED|Open-label Treatment||0
8106991|NCT03131648|19981164|P1|STARTED|Open-label Treatment||0
8106992|NCT03131648|19981157|P8|NOT COMPLETED|Initial Treatment Period||0
8106993|NCT03131648|19981158|P7|NOT COMPLETED|Initial Treatment Period||0
8106994|NCT03131648|19981159|P6|NOT COMPLETED|Initial Treatment Period||0
8106995|NCT03131648|19981160|P5|NOT COMPLETED|Initial Treatment Period||0
8106996|NCT03131648|19981161|P4|NOT COMPLETED|Initial Treatment Period||0
8106997|NCT03131648|19981162|P3|NOT COMPLETED|Initial Treatment Period||0
8106998|NCT03131648|19981163|P2|NOT COMPLETED|Initial Treatment Period||20
8106999|NCT03131648|19981164|P1|NOT COMPLETED|Initial Treatment Period||53
8107000|NCT03131648|19981157|P8|COMPLETED|Initial Treatment Period||0
8107001|NCT03131648|19981158|P7|COMPLETED|Initial Treatment Period||0
8107002|NCT03131648|19981159|P6|COMPLETED|Initial Treatment Period||0
8107003|NCT03131648|19981160|P5|COMPLETED|Initial Treatment Period||0
8107004|NCT03131648|19981161|P4|COMPLETED|Initial Treatment Period||0
8107005|NCT03131648|19981162|P3|COMPLETED|Initial Treatment Period||0
8107006|NCT03131648|19981163|P2|COMPLETED|Initial Treatment Period||179
8107007|NCT03131648|19981164|P1|COMPLETED|Initial Treatment Period||550
8107008|NCT03131648|19981157|P8|STARTED|Initial Treatment Period||0
8107009|NCT03131648|19981158|P7|STARTED|Initial Treatment Period||0
8107010|NCT03131648|19981159|P6|STARTED|Initial Treatment Period||0
8107011|NCT03131648|19981160|P5|STARTED|Initial Treatment Period||0
8107012|NCT03131648|19981161|P4|STARTED|Initial Treatment Period||0
8107013|NCT03131648|19981162|P3|STARTED|Initial Treatment Period||0
8107014|NCT03131648|19981163|P2|STARTED|Initial Treatment Period||199
8107015|NCT03131648|19981164|P1|STARTED|Initial Treatment Period||603
8107016|NCT03131596|19981212|P2|NOT COMPLETED|Overall Study||3
8107017|NCT03131596|19981213|P1|NOT COMPLETED|Overall Study||6
8107018|NCT03131596|19981212|P2|COMPLETED|Overall Study||97
8107019|NCT03131596|19981213|P1|COMPLETED|Overall Study||94
8107020|NCT03131596|19981212|P2|STARTED|Overall Study||100
8107021|NCT03131596|19981213|P1|STARTED|Overall Study||100
8107022|NCT03131479|19981230|P5|NOT COMPLETED|Overall Study||0
8107023|NCT03131479|19981231|P4|NOT COMPLETED|Overall Study||2
8107024|NCT03131479|19981232|P3|NOT COMPLETED|Overall Study||1
8107025|NCT03131479|19981233|P2|NOT COMPLETED|Overall Study||0
8107026|NCT03131479|19981234|P1|NOT COMPLETED|Overall Study||0
8107027|NCT03131479|19981230|P5|COMPLETED|Overall Study||10
8107028|NCT03131479|19981231|P4|COMPLETED|Overall Study||10
8107029|NCT03131479|19981232|P3|COMPLETED|Overall Study||10
8107030|NCT03131479|19981233|P2|COMPLETED|Overall Study||10
8107031|NCT03131479|19981234|P1|COMPLETED|Overall Study||10
8107032|NCT03131479|19981230|P5|Pharcodynamic Analysis Set (PD)|Overall Study||10
8107033|NCT03131479|19981231|P4|Pharcodynamic Analysis Set (PD)|Overall Study||12
8107034|NCT03131479|19981232|P3|Pharcodynamic Analysis Set (PD)|Overall Study||11
8107035|NCT03131479|19981233|P2|Pharcodynamic Analysis Set (PD)|Overall Study||10
8107036|NCT03131479|19981234|P1|Pharcodynamic Analysis Set (PD)|Overall Study||10
8107037|NCT03131479|19981230|P5|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
8107038|NCT03131479|19981231|P4|Pharmacokinetic Analysis Set (PAS)|Overall Study||12
8107039|NCT03131479|19981232|P3|Pharmacokinetic Analysis Set (PAS)|Overall Study||11
8107040|NCT03131479|19981233|P2|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
8107041|NCT03131479|19981234|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
8107042|NCT03131479|19981230|P5|Safety Analysis Set (SS)|Overall Study||10
8107043|NCT03131479|19981231|P4|Safety Analysis Set (SS)|Overall Study||12
8107044|NCT03131479|19981232|P3|Safety Analysis Set (SS)|Overall Study||11
8107045|NCT03131479|19981233|P2|Safety Analysis Set (SS)|Overall Study||10
8107046|NCT03131479|19981234|P1|Safety Analysis Set (SS)|Overall Study||10
8107047|NCT03131479|19981230|P5|STARTED|Overall Study||10
8107048|NCT03131479|19981231|P4|STARTED|Overall Study||12
8107049|NCT03131479|19981232|P3|STARTED|Overall Study||11
8107050|NCT03131479|19981233|P2|STARTED|Overall Study||10
8107051|NCT03131479|19981234|P1|STARTED|Overall Study||10
8107052|NCT03131219|19981293|P2|NOT COMPLETED|Extension Period||10
8107053|NCT03131219|19981294|P1|NOT COMPLETED|Extension Period||17
8107054|NCT03131219|19981293|P2|COMPLETED|Extension Period||0
8107055|NCT03131219|19981294|P1|COMPLETED|Extension Period||0
8107056|NCT03131219|19981293|P2|Ongoing|Extension Period||10
8107057|NCT03131219|19981294|P1|Ongoing|Extension Period||16
8107058|NCT03131219|19981293|P2|Received At Least 1 Dose of Study Drug|Extension Period||10
8107059|NCT03131219|19981294|P1|Received At Least 1 Dose of Study Drug|Extension Period||17
8107060|NCT03131219|19981293|P2|STARTED|Extension Period||10
8107061|NCT03131219|19981294|P1|STARTED|Extension Period||17
8107062|NCT03131219|19981293|P2|NOT COMPLETED|Initial Evaluation Period||0
8107063|NCT03131219|19981294|P1|NOT COMPLETED|Initial Evaluation Period||4
8107064|NCT03131219|19981293|P2|COMPLETED|Initial Evaluation Period||10
8107065|NCT03131219|19981294|P1|COMPLETED|Initial Evaluation Period||17
8107066|NCT03131219|19981293|P2|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||10
8107067|NCT03131219|19981294|P1|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||21
8107068|NCT03131219|19981293|P2|STARTED|Initial Evaluation Period||10
8107069|NCT03131219|19981294|P1|STARTED|Initial Evaluation Period||21
8107070|NCT03131206|19981320|P4|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107071|NCT03131206|19981321|P3|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107072|NCT03131206|19981322|P2|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107073|NCT03131206|19981323|P1|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107074|NCT03131206|19981320|P4|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107075|NCT03131206|19981321|P3|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107076|NCT03131206|19981322|P2|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107077|NCT03131206|19981323|P1|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107078|NCT03131206|19981320|P4|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107079|NCT03131206|19981321|P3|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107080|NCT03131206|19981322|P2|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107081|NCT03131206|19981323|P1|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
8107082|NCT03131206|19981320|P4|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107083|NCT03131206|19981321|P3|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107084|NCT03131206|19981322|P2|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107085|NCT03131206|19981323|P1|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107086|NCT03131206|19981320|P4|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107087|NCT03131206|19981321|P3|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107088|NCT03131206|19981322|P2|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107089|NCT03131206|19981323|P1|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
8107090|NCT03131206|19981320|P4|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107091|NCT03131206|19981321|P3|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107092|NCT03131206|19981322|P2|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
8107093|NCT03131206|19981323|P1|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
8107133|NCT03130738|19981410|P3|NOT COMPLETED|Overall Study||6
8107134|NCT03130738|19981411|P2|NOT COMPLETED|Overall Study||2
8107135|NCT03130738|19981412|P1|NOT COMPLETED|Overall Study||3
8107136|NCT03130738|19981410|P3|COMPLETED|Overall Study||14
8107137|NCT03130738|19981411|P2|COMPLETED|Overall Study||20
8107138|NCT03130738|19981412|P1|COMPLETED|Overall Study||20
8107139|NCT03130738|19981410|P3|STARTED|Overall Study||20
8107140|NCT03130738|19981411|P2|STARTED|Overall Study||22
8107141|NCT03130738|19981412|P1|STARTED|Overall Study||23
8107142|NCT03130257|19981426|P3|NOT COMPLETED|Overall Study||2
8107143|NCT03130257|19981427|P2|NOT COMPLETED|Overall Study||0
8107144|NCT03130257|19981428|P1|NOT COMPLETED|Overall Study||1
8107145|NCT03130257|19981426|P3|COMPLETED|Overall Study||166
8107146|NCT03130257|19981427|P2|COMPLETED|Overall Study||170
8107147|NCT03130257|19981428|P1|COMPLETED|Overall Study||171
8107148|NCT03130257|19981426|P3|STARTED|Overall Study||168
8107149|NCT03130257|19981427|P2|STARTED|Overall Study||170
8107150|NCT03130257|19981428|P1|STARTED|Overall Study||172
8107151|NCT03129321|19981439|P3|NOT COMPLETED|Overall Study||55
8107152|NCT03129321|19981440|P2|NOT COMPLETED|Overall Study||109
8107153|NCT03129321|19981441|P1|NOT COMPLETED|Overall Study||98
8107154|NCT03129321|19981439|P3|COMPLETED|Overall Study||120
8107155|NCT03129321|19981440|P2|COMPLETED|Overall Study||241
8107156|NCT03129321|19981441|P1|COMPLETED|Overall Study||253
8107157|NCT03129321|19981439|P3|STARTED|Overall Study||175
8107158|NCT03129321|19981440|P2|STARTED|Overall Study||350
8107159|NCT03129321|19981441|P1|STARTED|Overall Study||351
8107160|NCT03129178|19981463|P2|NOT COMPLETED|Overall Study||2
8107161|NCT03129178|19981464|P1|NOT COMPLETED|Overall Study||1
8107162|NCT03129178|19981463|P2|COMPLETED|Overall Study||11
8107163|NCT03129178|19981464|P1|COMPLETED|Overall Study||12
8107164|NCT03129178|19981463|P2|STARTED|Overall Study||13
8107165|NCT03129178|19981464|P1|STARTED|Overall Study||13
8107166|NCT03128931|19981482|P1|NOT COMPLETED|Overall Study||4
8107167|NCT03128931|19981482|P1|COMPLETED|Overall Study||41
8107168|NCT03128931|19981482|P1|STARTED|Overall Study||45
8107172|NCT03128723|19981492|P1|NOT COMPLETED|Overall Study||2
8107173|NCT03128723|19981492|P1|COMPLETED|Overall Study||43
8107174|NCT03128723|19981492|P1|STARTED|Overall Study||45
8107267|NCT03126539|19981683|P2|NOT COMPLETED|Overall Study||1
8107182|NCT03128372|19981546|P1|NOT COMPLETED|Overall Study||0
8107183|NCT03128372|19981546|P1|COMPLETED|Overall Study||32
8107184|NCT03128372|19981546|P1|STARTED|Overall Study||32
8107185|NCT03128307|19981550|P1|NOT COMPLETED|Overall Study||34
8107186|NCT03128307|19981550|P1|COMPLETED|Overall Study||570
8107187|NCT03128307|19981550|P1|STARTED|Overall Study||604
8107188|NCT03128099|19981558|P3|NOT COMPLETED|Overall Study||1
8107189|NCT03128099|19981559|P2|NOT COMPLETED|Overall Study||4
8107190|NCT03128099|19981560|P1|NOT COMPLETED|Overall Study||2
8107191|NCT03128099|19981558|P3|COMPLETED|Overall Study||21
8107192|NCT03128099|19981559|P2|COMPLETED|Overall Study|hour 2 training was completed by 0 participants|0
8107193|NCT03128099|19981560|P1|COMPLETED|Overall Study||19
8107194|NCT03128099|19981558|P3|Hour 2 (High Dose) Completed|Overall Study||0
8107195|NCT03128099|19981559|P2|Hour 2 (High Dose) Completed|Overall Study||0
8107196|NCT03128099|19981560|P1|Hour 2 (High Dose) Completed|Overall Study||0
8107197|NCT03128099|19981558|P3|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
8107198|NCT03128099|19981559|P2|Hour 2 (High Dose)Started|Overall Study||4
8107199|NCT03128099|19981560|P1|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
8107200|NCT03128099|19981558|P3|Hour 1 (Low Dose) Completed|Overall Study||21
8107201|NCT03128099|19981559|P2|Hour 1 (Low Dose) Completed|Overall Study||4
8107202|NCT03128099|19981560|P1|Hour 1 (Low Dose) Completed|Overall Study||19
8107203|NCT03128099|19981558|P3|Hour 1 (Low Dose) Started|Overall Study||22
8107204|NCT03128099|19981559|P2|Hour 1 (Low Dose) Started|Overall Study||4
8107205|NCT03128099|19981560|P1|Hour 1 (Low Dose) Started|Overall Study||21
8107206|NCT03128099|19981558|P3|STARTED|Overall Study||22
8107207|NCT03128099|19981559|P2|STARTED|Overall Study||4
8107208|NCT03128099|19981560|P1|STARTED|Overall Study||21
8107209|NCT03128086|19981568|P2|NOT COMPLETED|Overall Study||0
8107210|NCT03128086|19981569|P1|NOT COMPLETED|Overall Study||0
8107211|NCT03128086|19981568|P2|COMPLETED|Overall Study||44
8107212|NCT03128086|19981569|P1|COMPLETED|Overall Study||50
8107213|NCT03128086|19981568|P2|STARTED|Overall Study||44
8107214|NCT03128086|19981569|P1|STARTED|Overall Study||50
8107221|NCT03127943|19981598|P2|NOT COMPLETED|Second Intervention||0
8107222|NCT03127943|19981599|P1|NOT COMPLETED|Second Intervention||0
8107223|NCT03127943|19981598|P2|COMPLETED|Second Intervention||12
8107224|NCT03127943|19981599|P1|COMPLETED|Second Intervention||12
8107225|NCT03127943|19981598|P2|STARTED|Second Intervention||12
8107226|NCT03127943|19981599|P1|STARTED|Second Intervention||12
8107227|NCT03127943|19981598|P2|NOT COMPLETED|Washout (1 Week)||0
8107228|NCT03127943|19981599|P1|NOT COMPLETED|Washout (1 Week)||0
8107229|NCT03127943|19981598|P2|COMPLETED|Washout (1 Week)||12
8107230|NCT03127943|19981599|P1|COMPLETED|Washout (1 Week)||12
8107231|NCT03127943|19981598|P2|STARTED|Washout (1 Week)||12
8107232|NCT03127943|19981599|P1|STARTED|Washout (1 Week)||12
8107233|NCT03127943|19981598|P2|NOT COMPLETED|First Intervention||0
8107234|NCT03127943|19981599|P1|NOT COMPLETED|First Intervention||0
8107235|NCT03127943|19981598|P2|COMPLETED|First Intervention||12
8107236|NCT03127943|19981599|P1|COMPLETED|First Intervention||12
8107237|NCT03127943|19981598|P2|STARTED|First Intervention||12
8107238|NCT03127943|19981599|P1|STARTED|First Intervention||12
8107239|NCT03127644|19981610|P3|NOT COMPLETED|Overall Study||2
8107240|NCT03127644|19981611|P2|NOT COMPLETED|Overall Study||0
8107241|NCT03127644|19981612|P1|NOT COMPLETED|Overall Study||0
8107242|NCT03127644|19981610|P3|COMPLETED|Overall Study||31
8107243|NCT03127644|19981611|P2|COMPLETED|Overall Study||36
8107244|NCT03127644|19981612|P1|COMPLETED|Overall Study||34
8107245|NCT03127644|19981610|P3|STARTED|Overall Study||33
8107246|NCT03127644|19981611|P2|STARTED|Overall Study||36
8107247|NCT03127644|19981612|P1|STARTED|Overall Study||34
8107248|NCT03127384|19981644|P1|NOT COMPLETED|Overall Study||6
8107249|NCT03127384|19981644|P1|COMPLETED|Overall Study||43
8107250|NCT03127384|19981644|P1|Completed 3 Month Visit|Overall Study||47
8107251|NCT03127384|19981644|P1|STARTED|Overall Study||49
8107252|NCT03127228|19981652|P2|NOT COMPLETED|Overall Study||0
8107253|NCT03127228|19981653|P1|NOT COMPLETED|Overall Study||0
8107254|NCT03127228|19981652|P2|COMPLETED|Overall Study||12
8107255|NCT03127228|19981653|P1|COMPLETED|Overall Study||12
8107256|NCT03127228|19981652|P2|STARTED|Overall Study||12
8107257|NCT03127228|19981653|P1|STARTED|Overall Study||12
8107258|NCT03126682|19981667|P2|NOT COMPLETED|Overall Study||0
8107259|NCT03126682|19981668|P1|NOT COMPLETED|Overall Study||0
8107260|NCT03126682|19981667|P2|COMPLETED|Overall Study||5
8107261|NCT03126682|19981668|P1|COMPLETED|Overall Study||5
8107262|NCT03126682|19981667|P2|STARTED|Overall Study||5
8107263|NCT03126682|19981668|P1|STARTED|Overall Study||5
8107264|NCT03126539|19981680|P5|NOT COMPLETED|Overall Study||0
8107265|NCT03126539|19981681|P4|NOT COMPLETED|Overall Study||0
8107266|NCT03126539|19981682|P3|NOT COMPLETED|Overall Study||1
8107268|NCT03126539|19981684|P1|NOT COMPLETED|Overall Study||1
8107269|NCT03126539|19981680|P5|COMPLETED|Overall Study||0
8107270|NCT03126539|19981681|P4|COMPLETED|Overall Study||0
8107271|NCT03126539|19981682|P3|COMPLETED|Overall Study||8
8107272|NCT03126539|19981683|P2|COMPLETED|Overall Study||8
8107273|NCT03126539|19981684|P1|COMPLETED|Overall Study||8
8107274|NCT03126539|19981680|P5|STARTED|Overall Study||0
8107275|NCT03126539|19981681|P4|STARTED|Overall Study|Group B was not done|0
8107276|NCT03126539|19981682|P3|STARTED|Overall Study||9
8107277|NCT03126539|19981683|P2|STARTED|Overall Study||9
8107278|NCT03126539|19981684|P1|STARTED|Overall Study||9
8107279|NCT03126448|19981700|P3|NOT COMPLETED|Overall Study||10
8107280|NCT03126448|19981701|P2|NOT COMPLETED|Overall Study||8
8107281|NCT03126448|19981702|P1|NOT COMPLETED|Overall Study||13
8107282|NCT03126448|19981700|P3|COMPLETED|Overall Study||27
8107283|NCT03126448|19981701|P2|COMPLETED|Overall Study||41
8107284|NCT03126448|19981702|P1|COMPLETED|Overall Study||43
8107285|NCT03126448|19981700|P3|STARTED|Overall Study||37
8107286|NCT03126448|19981701|P2|STARTED|Overall Study||49
8107287|NCT03126448|19981702|P1|STARTED|Overall Study||56
8107288|NCT03126344|19981713|P3|NOT COMPLETED|Overall Study||5
8107289|NCT03126344|19981714|P2|NOT COMPLETED|Overall Study||0
8107290|NCT03126344|19981715|P1|NOT COMPLETED|Overall Study||0
8107291|NCT03126344|19981713|P3|COMPLETED|Overall Study||28
8107292|NCT03126344|19981714|P2|COMPLETED|Overall Study||33
8107293|NCT03126344|19981715|P1|COMPLETED|Overall Study||33
8107294|NCT03126344|19981713|P3|STARTED|Overall Study||33
8107295|NCT03126344|19981714|P2|STARTED|Overall Study||33
8107296|NCT03126344|19981715|P1|STARTED|Overall Study||33
8107297|NCT03125941|19981731|P2|NOT COMPLETED|Overall Study||2
8107298|NCT03125941|19981732|P1|NOT COMPLETED|Overall Study||1
8107299|NCT03125941|19981731|P2|COMPLETED|Overall Study||63
8107300|NCT03125941|19981732|P1|COMPLETED|Overall Study||64
8107301|NCT03125941|19981731|P2|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|2
8107302|NCT03125941|19981732|P1|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|1
8107303|NCT03125941|19981731|P2|STARTED|Overall Study||65
8107304|NCT03125941|19981732|P1|STARTED|Overall Study||65
8107359|NCT03125395|19981837|P1|NOT COMPLETED|Overall Study||10
8107360|NCT03125395|19981837|P1|COMPLETED|Overall Study||47
8107361|NCT03125395|19981837|P1|Study 116 LCI Substudy Set|Overall Study||31
8107362|NCT03125395|19981837|P1|Study 116 FAS|Overall Study||57
8107363|NCT03125395|19981837|P1|Study 115B FAS|Overall Study||60
8107364|NCT03125395|19981837|P1|STARTED|Overall Study||57
8107386|NCT03125031|19982067|P2|NOT COMPLETED|Overall Study||0
8107387|NCT03125031|19982068|P1|NOT COMPLETED|Overall Study||0
8107388|NCT03125031|19982067|P2|COMPLETED|Overall Study||44
8107389|NCT03125031|19982068|P1|COMPLETED|Overall Study||44
8107390|NCT03125031|19982067|P2|STARTED|Overall Study||44
8107391|NCT03125031|19982068|P1|STARTED|Overall Study||44
8107392|NCT03125018|19982073|P1|NOT COMPLETED|Overall Study||0
8107393|NCT03125018|19982073|P1|COMPLETED|Overall Study||13
8107394|NCT03125018|19982073|P1|STARTED|Overall Study||13
8107395|NCT03125005|19982077|P1|NOT COMPLETED|Overall Study||0
8107396|NCT03125005|19982077|P1|COMPLETED|Overall Study||51
8107397|NCT03125005|19982077|P1|STARTED|Overall Study||51
8107398|NCT03124979|19982081|P1|NOT COMPLETED|Overall Study||0
8107399|NCT03124979|19982081|P1|COMPLETED|Overall Study||13
8107400|NCT03124979|19982081|P1|STARTED|Overall Study||13
8107401|NCT03124966|19982085|P1|NOT COMPLETED|Overall Study||0
8107402|NCT03124966|19982085|P1|COMPLETED|Overall Study||118
8107403|NCT03124966|19982085|P1|STARTED|Overall Study||118
8107404|NCT03124927|19982089|P1|NOT COMPLETED|Overall Study||0
8107405|NCT03124927|19982089|P1|COMPLETED|Overall Study||25
8107406|NCT03124927|19982089|P1|STARTED|Overall Study||25
8107407|NCT03124901|19982093|P1|NOT COMPLETED|Overall Study||0
8107408|NCT03124901|19982093|P1|COMPLETED|Overall Study||147
8107409|NCT03124901|19982093|P1|STARTED|Overall Study||147
8107410|NCT03124836|19982097|P1|NOT COMPLETED|Overall Study||0
8107411|NCT03124836|19982097|P1|COMPLETED|Overall Study||28
8107412|NCT03124836|19982097|P1|STARTED|Overall Study||28
8107413|NCT03124823|19982101|P1|NOT COMPLETED|Overall Study||0
8107414|NCT03124823|19982101|P1|COMPLETED|Overall Study||11
8107415|NCT03124823|19982101|P1|STARTED|Overall Study||11
8107416|NCT03124797|19982105|P1|NOT COMPLETED|Overall Study||0
8107417|NCT03124797|19982105|P1|COMPLETED|Overall Study||18
8107418|NCT03124797|19982105|P1|STARTED|Overall Study||18
8107419|NCT03124784|19982109|P1|NOT COMPLETED|Overall Study||2
8107420|NCT03124784|19982109|P1|COMPLETED|Overall Study||25
8107421|NCT03124784|19982109|P1|STARTED|Overall Study||27
8107422|NCT03124771|19982113|P1|NOT COMPLETED|Overall Study||0
8107423|NCT03124771|19982113|P1|COMPLETED|Overall Study||132
8107424|NCT03124771|19982113|P1|STARTED|Overall Study||132
8107425|NCT03124758|19982117|P1|NOT COMPLETED|Overall Study||0
8107426|NCT03124758|19982117|P1|COMPLETED|Overall Study||354
8107427|NCT03124758|19982117|P1|STARTED|Overall Study||354
8107428|NCT03124693|19982121|P1|NOT COMPLETED|Overall Study||0
8107429|NCT03124693|19982121|P1|COMPLETED|Overall Study||90
8107430|NCT03124693|19982121|P1|STARTED|Overall Study||90
8107431|NCT03124602|19982125|P1|NOT COMPLETED|Overall Study||10
8107432|NCT03124602|19982125|P1|COMPLETED|Overall Study||25
8107433|NCT03124602|19982125|P1|STARTED|Overall Study||35
8107434|NCT03124563|19982131|P2|NOT COMPLETED|Overall Study||2
8107435|NCT03124563|19982132|P1|NOT COMPLETED|Overall Study||2
8107436|NCT03124563|19982131|P2|COMPLETED|Overall Study||29
8107437|NCT03124563|19982132|P1|COMPLETED|Overall Study||30
8107438|NCT03124563|19982131|P2|Pre-test|Overall Study||30
8107439|NCT03124563|19982132|P1|Pre-test|Overall Study||30
8107440|NCT03124563|19982131|P2|STARTED|Overall Study||31
8107441|NCT03124563|19982132|P1|STARTED|Overall Study||32
8107442|NCT03124550|19982148|P1|NOT COMPLETED|Overall Study||0
8107443|NCT03124550|19982148|P1|COMPLETED|Overall Study||18
8107444|NCT03124550|19982148|P1|STARTED|Overall Study||18
8107445|NCT03124537|19982157|P2|NOT COMPLETED|Overall Study||13
8107446|NCT03124537|19982158|P1|NOT COMPLETED|Overall Study||10
8107447|NCT03124537|19982157|P2|COMPLETED|Overall Study||32
8107448|NCT03124537|19982158|P1|COMPLETED|Overall Study||31
8107449|NCT03124537|19982157|P2|STARTED|Overall Study||45
8107450|NCT03124537|19982158|P1|STARTED|Overall Study||41
8107451|NCT03124407|19982182|P4|NOT COMPLETED|Overall Study||0
8107452|NCT03124407|19982183|P3|NOT COMPLETED|Overall Study||1
8107453|NCT03124407|19982184|P2|NOT COMPLETED|Overall Study||0
8107454|NCT03124407|19982185|P1|NOT COMPLETED|Overall Study||1
8107455|NCT03124407|19982182|P4|COMPLETED|Overall Study||20
8107456|NCT03124407|19982183|P3|COMPLETED|Overall Study||39
8107457|NCT03124407|19982184|P2|COMPLETED|Overall Study||20
8107458|NCT03124407|19982185|P1|COMPLETED|Overall Study||39
8107459|NCT03124407|19982182|P4|STARTED|Overall Study||20
8107460|NCT03124407|19982183|P3|STARTED|Overall Study||40
8107461|NCT03124407|19982184|P2|STARTED|Overall Study||20
8107462|NCT03124407|19982185|P1|STARTED|Overall Study||40
8107463|NCT03124381|19982205|P2|NOT COMPLETED|Overall Study||6
8107464|NCT03124381|19982206|P1|NOT COMPLETED|Overall Study||9
8107465|NCT03124381|19982205|P2|COMPLETED|Overall Study||55
8107466|NCT03124381|19982206|P1|COMPLETED|Overall Study||56
8107467|NCT03124381|19982205|P2|STARTED|Overall Study||61
8107468|NCT03124381|19982206|P1|STARTED|Overall Study||65
8107469|NCT03124342|19982298|P2|NOT COMPLETED|Overall Study||0
8107470|NCT03124342|19982299|P1|NOT COMPLETED|Overall Study||0
8107471|NCT03124342|19982298|P2|COMPLETED|Overall Study||121
8107472|NCT03124342|19982299|P1|COMPLETED|Overall Study||111
8107473|NCT03124342|19982298|P2|STARTED|Overall Study||121
8107474|NCT03124342|19982299|P1|STARTED|Overall Study||111
8107475|NCT03124199|19982313|P1|NOT COMPLETED|Overall Study||4
8107476|NCT03124199|19982313|P1|COMPLETED|Overall Study||36
8107477|NCT03124199|19982313|P1|STARTED|Overall Study||40
8107478|NCT03124108|19982322|P3|NOT COMPLETED|Overall Study||0
8107479|NCT03124108|19982323|P2|NOT COMPLETED|Overall Study||1
8107480|NCT03124108|19982324|P1|NOT COMPLETED|Overall Study||0
8107481|NCT03124108|19982322|P3|COMPLETED|Overall Study||15
8107482|NCT03124108|19982323|P2|COMPLETED|Overall Study||14
8107483|NCT03124108|19982324|P1|COMPLETED|Overall Study||15
8107484|NCT03124108|19982322|P3|STARTED|Overall Study||15
8107485|NCT03124108|19982323|P2|STARTED|Overall Study||15
8107486|NCT03124108|19982324|P1|STARTED|Overall Study||15
8107487|NCT03123874|19982457|P2|NOT COMPLETED|Overall Study||0
8107488|NCT03123874|19982458|P1|NOT COMPLETED|Overall Study||0
8107489|NCT03123874|19982457|P2|COMPLETED|Overall Study||25
8107490|NCT03123874|19982458|P1|COMPLETED|Overall Study||27
8107491|NCT03123874|19982457|P2|STARTED|Overall Study||25
8107492|NCT03123874|19982458|P1|STARTED|Overall Study||27
8107493|NCT03123861|19982470|P2|NOT COMPLETED|Overall Study||3
8107494|NCT03123861|19982471|P1|NOT COMPLETED|Overall Study||3
8107495|NCT03123861|19982470|P2|COMPLETED|Overall Study||20
8107496|NCT03123861|19982471|P1|COMPLETED|Overall Study||19
8107497|NCT03123861|19982470|P2|Received Intervention|Overall Study||22
8107498|NCT03123861|19982471|P1|Received Intervention|Overall Study||21
8107499|NCT03123861|19982470|P2|STARTED|Overall Study||23
8107500|NCT03123861|19982471|P1|STARTED|Overall Study||22
8107501|NCT03123848|19982483|P1|NOT COMPLETED|Overall Study||0
8107502|NCT03123848|19982483|P1|COMPLETED|Overall Study||8
8107503|NCT03123848|19982483|P1|STARTED|Overall Study||8
8107510|NCT03123471|19982522|P2|NOT COMPLETED|Apremilast Extension Phase||25
8107511|NCT03123471|19982523|P1|NOT COMPLETED|Apremilast Extension Phase||8
8107512|NCT03123471|19982522|P2|COMPLETED|Apremilast Extension Phase||140
8107513|NCT03123471|19982523|P1|COMPLETED|Apremilast Extension Phase||76
8107514|NCT03123471|19982522|P2|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163
8107515|NCT03123471|19982523|P1|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84
8107516|NCT03123471|19982522|P2|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165
8107517|NCT03123471|19982523|P1|STARTED|Apremilast Extension Phase||84
8107518|NCT03123471|19982522|P2|NOT COMPLETED|Placebo-controlled Phase||33
8107519|NCT03123471|19982523|P1|NOT COMPLETED|Placebo-controlled Phase||18
8107520|NCT03123471|19982522|P2|COMPLETED|Placebo-controlled Phase||168
8107521|NCT03123471|19982523|P1|COMPLETED|Placebo-controlled Phase||84
8107522|NCT03123471|19982522|P2|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200
8107523|NCT03123471|19982523|P1|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102
8107524|NCT03123471|19982522|P2|STARTED|Placebo-controlled Phase||201
8107525|NCT03123471|19982523|P1|STARTED|Placebo-controlled Phase||102
8107526|NCT03123393|19982550|P2|NOT COMPLETED|Overall Study||23
8107527|NCT03123393|19982551|P1|NOT COMPLETED|Overall Study||21
8107528|NCT03123393|19982550|P2|COMPLETED|Overall Study||2
8107529|NCT03123393|19982551|P1|COMPLETED|Overall Study||3
8107530|NCT03123393|19982550|P2|STARTED|Overall Study||25
8107531|NCT03123393|19982551|P1|STARTED|Overall Study||24
8107532|NCT03123354|19982579|P1|NOT COMPLETED|Overall Study||6
8107533|NCT03123354|19982579|P1|COMPLETED|Overall Study||38
8107534|NCT03123354|19982579|P1|STARTED|Overall Study||44
8107535|NCT03123263|19982583|P1|NOT COMPLETED|Overall Study||0
8107536|NCT03123263|19982583|P1|COMPLETED|Overall Study||60
8107537|NCT03123263|19982583|P1|STARTED|Overall Study||60
8107538|NCT03123055|19982590|P1|NOT COMPLETED|Overall Study||0
8107539|NCT03123055|19982590|P1|COMPLETED|Overall Study||28
8107540|NCT03123055|19982590|P1|STARTED|Overall Study||28
8107547|NCT03122587|19982614|P3|NOT COMPLETED|Overall Study||1
8107548|NCT03122587|19982615|P2|NOT COMPLETED|Overall Study||2
8107549|NCT03122587|19982616|P1|NOT COMPLETED|Overall Study||2
8107550|NCT03122587|19982614|P3|COMPLETED|Overall Study||12
8107551|NCT03122587|19982615|P2|COMPLETED|Overall Study||10
8107552|NCT03122587|19982616|P1|COMPLETED|Overall Study||11
8107553|NCT03122587|19982614|P3|STARTED|Overall Study||13
8107554|NCT03122587|19982615|P2|STARTED|Overall Study||12
8107555|NCT03122587|19982616|P1|STARTED|Overall Study||13
8107556|NCT03122548|19982627|P1|NOT COMPLETED|Overall Study||5
8107557|NCT03122548|19982627|P1|COMPLETED|Overall Study||0
8107558|NCT03122548|19982627|P1|STARTED|Overall Study||5
8107559|NCT03122457|19982635|P1|NOT COMPLETED|Overall Study||6
8107560|NCT03122457|19982635|P1|COMPLETED|Overall Study||16
8107561|NCT03122457|19982635|P1|STARTED|Overall Study||22
8107582|NCT03122184|19982703|P2|NOT COMPLETED|Overall Study||6
8107583|NCT03122184|19982704|P1|NOT COMPLETED|Overall Study||8
8107584|NCT03122184|19982703|P2|COMPLETED|Overall Study||17
8107585|NCT03122184|19982704|P1|COMPLETED|Overall Study||16
8107586|NCT03122184|19982703|P2|STARTED|Overall Study||23
8107587|NCT03122184|19982704|P1|STARTED|Overall Study||24
8107588|NCT03122171|19982741|P1|NOT COMPLETED|Overall Study||1
8107589|NCT03122171|19982741|P1|COMPLETED|Overall Study||5
8107590|NCT03122171|19982741|P1|STARTED|Overall Study||6
8107591|NCT03122145|19982750|P2|NOT COMPLETED|Overall Study||0
8107592|NCT03122145|19982751|P1|NOT COMPLETED|Overall Study||3
8107593|NCT03122145|19982750|P2|COMPLETED|Overall Study||12
8107594|NCT03122145|19982751|P1|COMPLETED|Overall Study||34
8107595|NCT03122145|19982750|P2|STARTED|Overall Study||12
8107596|NCT03122145|19982751|P1|STARTED|Overall Study|34 participants completed the first sub study under this IRB|37
8107597|NCT03121950|19982761|P2|NOT COMPLETED|Overall Study||2
8107598|NCT03121950|19982762|P1|NOT COMPLETED|Overall Study||11
8107599|NCT03121950|19982761|P2|COMPLETED|Overall Study||1
8107600|NCT03121950|19982762|P1|COMPLETED|Overall Study||6
8107601|NCT03121950|19982761|P2|STARTED|Overall Study||3
8107602|NCT03121950|19982762|P1|STARTED|Overall Study||17
8107603|NCT03121820|19982774|P2|NOT COMPLETED|Second Period (After Washout)||0
8107604|NCT03121820|19982775|P1|NOT COMPLETED|Second Period (After Washout)||0
8107605|NCT03121820|19982774|P2|COMPLETED|Second Period (After Washout)||9
8107606|NCT03121820|19982775|P1|COMPLETED|Second Period (After Washout)||9
8107607|NCT03121820|19982774|P2|STARTED|Second Period (After Washout)||9
8107608|NCT03121820|19982775|P1|STARTED|Second Period (After Washout)||9
8107609|NCT03121820|19982774|P2|NOT COMPLETED|First Period||0
8107610|NCT03121820|19982775|P1|NOT COMPLETED|First Period||0
8107611|NCT03121820|19982774|P2|COMPLETED|First Period||9
8107612|NCT03121820|19982775|P1|COMPLETED|First Period||9
8107613|NCT03121820|19982774|P2|STARTED|First Period||9
8107614|NCT03121820|19982775|P1|STARTED|First Period||9
8107615|NCT03121612|19982785|P2|NOT COMPLETED|Overall Study||0
8107616|NCT03121612|19982786|P1|NOT COMPLETED|Overall Study||0
8107617|NCT03121612|19982785|P2|COMPLETED|Overall Study||25
8107618|NCT03121612|19982786|P1|COMPLETED|Overall Study||26
8107619|NCT03121612|19982785|P2|STARTED|Overall Study||25
8107620|NCT03121612|19982786|P1|STARTED|Overall Study||26
8107621|NCT03121365|19982830|P2|NOT COMPLETED|7 Months||8
8107622|NCT03121365|19982831|P1|NOT COMPLETED|7 Months||10
8107623|NCT03121365|19982830|P2|COMPLETED|7 Months||37
8107624|NCT03121365|19982831|P1|COMPLETED|7 Months||44
8107625|NCT03121365|19982830|P2|STARTED|7 Months||45
8107626|NCT03121365|19982831|P1|STARTED|7 Months||54
8107627|NCT03121365|19982830|P2|NOT COMPLETED|4 Months||1
8107628|NCT03121365|19982831|P1|NOT COMPLETED|4 Months||3
8107629|NCT03121365|19982830|P2|COMPLETED|4 Months||44
8107630|NCT03121365|19982831|P1|COMPLETED|4 Months||51
8107631|NCT03121365|19982830|P2|STARTED|4 Months||45
8107632|NCT03121365|19982831|P1|STARTED|4 Months||54
8107633|NCT03121365|19982830|P2|NOT COMPLETED|1 Months||3
8107634|NCT03121365|19982831|P1|NOT COMPLETED|1 Months||2
8107635|NCT03121365|19982830|P2|COMPLETED|1 Months||45
8107636|NCT03121365|19982831|P1|COMPLETED|1 Months||52
8107637|NCT03121365|19982830|P2|STARTED|1 Months||48
8107638|NCT03121365|19982831|P1|STARTED|1 Months||54
8107639|NCT03121365|19982830|P2|NOT COMPLETED|Baseline||1
8107640|NCT03121365|19982831|P1|NOT COMPLETED|Baseline||1
8107641|NCT03121365|19982830|P2|COMPLETED|Baseline||48
8107642|NCT03121365|19982831|P1|COMPLETED|Baseline||54
8107643|NCT03121365|19982830|P2|STARTED|Baseline||49
8107644|NCT03121365|19982831|P1|STARTED|Baseline||55
8107645|NCT03121144|19982859|P1|NOT COMPLETED|Overall Study||0
8107646|NCT03121144|19982859|P1|COMPLETED|Overall Study||34
8107647|NCT03121144|19982859|P1|STARTED|Overall Study||34
8107648|NCT03120676|19982863|P1|NOT COMPLETED|Overall Study||1
8107649|NCT03120676|19982863|P1|COMPLETED|Overall Study||2
8107650|NCT03120676|19982863|P1|STARTED|Overall Study||3
8107651|NCT03120520|19982871|P4|NOT COMPLETED|Overall Study||3
8107652|NCT03120520|19982872|P3|NOT COMPLETED|Overall Study||4
8107653|NCT03120520|19982873|P2|NOT COMPLETED|Overall Study||4
8107654|NCT03120520|19982874|P1|NOT COMPLETED|Overall Study||4
8107655|NCT03120520|19982871|P4|COMPLETED|Overall Study||29
8107656|NCT03120520|19982872|P3|COMPLETED|Overall Study||26
8107657|NCT03120520|19982873|P2|COMPLETED|Overall Study||27
8107658|NCT03120520|19982874|P1|COMPLETED|Overall Study||27
8107659|NCT03120520|19982871|P4|STARTED|Overall Study||32
8107660|NCT03120520|19982872|P3|STARTED|Overall Study||30
8107661|NCT03120520|19982873|P2|STARTED|Overall Study||31
8107662|NCT03120520|19982874|P1|STARTED|Overall Study||31
8107663|NCT03120351|19982898|P2|NOT COMPLETED|Overall Study||1
8107664|NCT03120351|19982899|P1|NOT COMPLETED|Overall Study||1
8107665|NCT03120351|19982898|P2|COMPLETED|Overall Study||39
8107666|NCT03120351|19982899|P1|COMPLETED|Overall Study||39
8107667|NCT03120351|19982898|P2|STARTED|Overall Study||40
8107668|NCT03120351|19982899|P1|STARTED|Overall Study||40
8107669|NCT03120013|19982905|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8107670|NCT03120013|19982906|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8107671|NCT03120013|19982905|P2|COMPLETED|Second Intervention (2 Weeks)||10
8107672|NCT03120013|19982906|P1|COMPLETED|Second Intervention (2 Weeks)||10
8107673|NCT03120013|19982905|P2|STARTED|Second Intervention (2 Weeks)||10
8107674|NCT03120013|19982906|P1|STARTED|Second Intervention (2 Weeks)||10
8107675|NCT03120013|19982905|P2|NOT COMPLETED|Washout (6 Months)||0
8107676|NCT03120013|19982906|P1|NOT COMPLETED|Washout (6 Months)||0
8107677|NCT03120013|19982905|P2|COMPLETED|Washout (6 Months)||10
8107678|NCT03120013|19982906|P1|COMPLETED|Washout (6 Months)||10
8107679|NCT03120013|19982905|P2|STARTED|Washout (6 Months)||10
8107680|NCT03120013|19982906|P1|STARTED|Washout (6 Months)||10
8107681|NCT03120013|19982905|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
8107682|NCT03120013|19982906|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8107683|NCT03120013|19982905|P2|COMPLETED|First Intervention (2 Weeks)||10
8107684|NCT03120013|19982906|P1|COMPLETED|First Intervention (2 Weeks)||10
8107685|NCT03120013|19982905|P2|Received Intervention|First Intervention (2 Weeks)||11
8107686|NCT03120013|19982906|P1|Received Intervention|First Intervention (2 Weeks)||10
8107687|NCT03120013|19982905|P2|STARTED|First Intervention (2 Weeks)||11
8107688|NCT03120013|19982906|P1|STARTED|First Intervention (2 Weeks)||10
8107689|NCT03119831|19982929|P3|NOT COMPLETED|Overall Study||0
8107690|NCT03119831|19982930|P2|NOT COMPLETED|Overall Study||0
8107691|NCT03119831|19982931|P1|NOT COMPLETED|Overall Study||0
8107692|NCT03119831|19982929|P3|COMPLETED|Overall Study||14
8107693|NCT03119831|19982930|P2|COMPLETED|Overall Study||14
8107694|NCT03119831|19982931|P1|COMPLETED|Overall Study||14
8107695|NCT03119831|19982929|P3|STARTED|Overall Study||14
8107696|NCT03119831|19982930|P2|STARTED|Overall Study||14
8107697|NCT03119831|19982931|P1|STARTED|Overall Study||14
8107698|NCT03119701|19982950|P2|NOT COMPLETED|Mid-term (Final) Follow-up at D90||1
8107699|NCT03119701|19982951|P1|NOT COMPLETED|Mid-term (Final) Follow-up at D90||3
8107700|NCT03119701|19982950|P2|COMPLETED|Mid-term (Final) Follow-up at D90||9
8107701|NCT03119701|19982951|P1|COMPLETED|Mid-term (Final) Follow-up at D90||22
8107702|NCT03119701|19982950|P2|STARTED|Mid-term (Final) Follow-up at D90|2 patients who did not receive 6 doses were also followed up.|10
8107703|NCT03119701|19982951|P1|STARTED|Mid-term (Final) Follow-up at D90|3 patients who discontinued study drug due to adverse events were also followed up.|25
8107704|NCT03119701|19982950|P2|NOT COMPLETED|6-day Dosing||3
8107705|NCT03119701|19982951|P1|NOT COMPLETED|6-day Dosing||7
8107706|NCT03119701|19982950|P2|COMPLETED|6-day Dosing||8
8107707|NCT03119701|19982951|P1|COMPLETED|6-day Dosing||22
8107708|NCT03119701|19982950|P2|STARTED|6-day Dosing||11
8107709|NCT03119701|19982951|P1|STARTED|6-day Dosing||29
8107710|NCT03119688|19982983|P1|NOT COMPLETED|Overall Study||4
8107711|NCT03119688|19982983|P1|COMPLETED|Overall Study||44
8107712|NCT03119688|19982983|P1|STARTED|Overall Study||48
8107713|NCT03119662|19983016|P2|NOT COMPLETED|Overall Study||1
8107714|NCT03119662|19983017|P1|NOT COMPLETED|Overall Study||0
8107715|NCT03119662|19983016|P2|COMPLETED|Overall Study||1
8107716|NCT03119662|19983017|P1|COMPLETED|Overall Study||2
8107717|NCT03119662|19983016|P2|STARTED|Overall Study||2
8107718|NCT03119662|19983017|P1|STARTED|Overall Study||2
8107719|NCT03119649|19983038|P5|NOT COMPLETED|Overall Study||0
8107720|NCT03119649|19983039|P4|NOT COMPLETED|Overall Study||0
8107721|NCT03119649|19983040|P3|NOT COMPLETED|Overall Study||0
8107722|NCT03119649|19983041|P2|NOT COMPLETED|Overall Study||0
8107723|NCT03119649|19983042|P1|NOT COMPLETED|Overall Study||0
8107724|NCT03119649|19983038|P5|COMPLETED|Overall Study||14
8107725|NCT03119649|19983039|P4|COMPLETED|Overall Study||14
8107726|NCT03119649|19983040|P3|COMPLETED|Overall Study||10
8107727|NCT03119649|19983041|P2|COMPLETED|Overall Study||10
8107728|NCT03119649|19983042|P1|COMPLETED|Overall Study||11
8107729|NCT03119649|19983038|P5|STARTED|Overall Study||14
8107730|NCT03119649|19983039|P4|STARTED|Overall Study||14
8107731|NCT03119649|19983040|P3|STARTED|Overall Study||10
8107732|NCT03119649|19983041|P2|STARTED|Overall Study||10
8107733|NCT03119649|19983042|P1|STARTED|Overall Study||11
8107734|NCT03119610|19983087|P2|NOT COMPLETED|Overall Study||1
8107735|NCT03119610|19983088|P1|NOT COMPLETED|Overall Study||1
8107736|NCT03119610|19983087|P2|COMPLETED|Overall Study||9
8107737|NCT03119610|19983088|P1|COMPLETED|Overall Study||12
8107738|NCT03119610|19983087|P2|STARTED|Overall Study||10
8107739|NCT03119610|19983088|P1|STARTED|Overall Study||13
8107740|NCT03119571|19983120|P2|NOT COMPLETED|Overall Study||0
8107741|NCT03119571|19983121|P1|NOT COMPLETED|Overall Study||0
8107742|NCT03119571|19983120|P2|COMPLETED|Overall Study||34
8107743|NCT03119571|19983121|P1|COMPLETED|Overall Study||31
8107744|NCT03119571|19983120|P2|STARTED|Overall Study||34
8107745|NCT03119571|19983121|P1|STARTED|Overall Study||31
8107746|NCT03119389|19983129|P2|NOT COMPLETED|Overall Study||0
8107747|NCT03119389|19983130|P1|NOT COMPLETED|Overall Study||0
8107748|NCT03119389|19983129|P2|COMPLETED|Overall Study||7627
8107749|NCT03119389|19983130|P1|COMPLETED|Overall Study||6791
8107750|NCT03119389|19983129|P2|STARTED|Overall Study||7627
8107751|NCT03119389|19983130|P1|STARTED|Overall Study||6791
8107752|NCT03119181|19983146|P2|NOT COMPLETED|Overall Study||0
8107753|NCT03119181|19983147|P1|NOT COMPLETED|Overall Study||0
8107754|NCT03119181|19983146|P2|COMPLETED|Overall Study||21
8107755|NCT03119181|19983147|P1|COMPLETED|Overall Study||19
8107756|NCT03119181|19983146|P2|STARTED|Overall Study||21
8107757|NCT03119181|19983147|P1|STARTED|Overall Study||19
8107758|NCT03119168|19983155|P2|NOT COMPLETED|Overall Study||0
8107759|NCT03119168|19983156|P1|NOT COMPLETED|Overall Study||0
8107760|NCT03119168|19983155|P2|COMPLETED|Overall Study||139
8107761|NCT03119168|19983156|P1|COMPLETED|Overall Study||129
8107762|NCT03119168|19983155|P2|STARTED|Overall Study||139
8107763|NCT03119168|19983156|P1|STARTED|Overall Study||129
8107764|NCT03119025|19983168|P1|NOT COMPLETED|Overall Study||0
8107765|NCT03119025|19983168|P1|COMPLETED|Overall Study||10
8107766|NCT03119025|19983168|P1|STARTED|Overall Study||10
8107767|NCT03118947|19983175|P1|NOT COMPLETED|Overall Study||29
8107768|NCT03118947|19983175|P1|COMPLETED|Overall Study||49
8107769|NCT03118947|19983175|P1|STARTED|Overall Study||78
8107770|NCT03118934|19983182|P6|NOT COMPLETED|Overall Study||2
8107771|NCT03118934|19983183|P5|NOT COMPLETED|Overall Study||2
8107772|NCT03118934|19983184|P4|NOT COMPLETED|Overall Study||1
8107773|NCT03118934|19983185|P3|NOT COMPLETED|Overall Study||1
8107774|NCT03118934|19983186|P2|NOT COMPLETED|Overall Study||1
8107775|NCT03118934|19983187|P1|NOT COMPLETED|Overall Study||0
8107776|NCT03118934|19983182|P6|COMPLETED|Overall Study||23
8107777|NCT03118934|19983183|P5|COMPLETED|Overall Study||27
8107778|NCT03118934|19983184|P4|COMPLETED|Overall Study||28
8107779|NCT03118934|19983185|P3|COMPLETED|Overall Study||33
8107780|NCT03118934|19983186|P2|COMPLETED|Overall Study||30
8107781|NCT03118934|19983187|P1|COMPLETED|Overall Study||34
8107782|NCT03118934|19983182|P6|Safety Analysis Set|Overall Study||25
8107783|NCT03118934|19983183|P5|Safety Analysis Set|Overall Study||26
8107784|NCT03118934|19983184|P4|Safety Analysis Set|Overall Study||29
8107785|NCT03118934|19983185|P3|Safety Analysis Set|Overall Study||34
8107786|NCT03118934|19983186|P2|Safety Analysis Set|Overall Study||29
8107787|NCT03118934|19983187|P1|Safety Analysis Set|Overall Study||34
8107788|NCT03118934|19983182|P6|STARTED|Overall Study||25
8107789|NCT03118934|19983183|P5|STARTED|Overall Study||29
8107790|NCT03118934|19983184|P4|STARTED|Overall Study||29
8107791|NCT03118934|19983185|P3|STARTED|Overall Study||34
8107792|NCT03118934|19983186|P2|STARTED|Overall Study||31
8107793|NCT03118934|19983187|P1|STARTED|Overall Study||34
8107794|NCT03118843|19983197|P1|NOT COMPLETED|Overall Study||0
8107795|NCT03118843|19983197|P1|COMPLETED|Overall Study||31
8107796|NCT03118843|19983197|P1|STARTED|Overall Study||31
8107797|NCT03118765|19983211|P5|NOT COMPLETED|Overall Study||2
8107798|NCT03118765|19983212|P4|NOT COMPLETED|Overall Study||3
8107799|NCT03118765|19983213|P3|NOT COMPLETED|Overall Study||5
8107800|NCT03118765|19983214|P2|NOT COMPLETED|Overall Study||2
8107801|NCT03118765|19983215|P1|NOT COMPLETED|Overall Study||4
8107802|NCT03118765|19983211|P5|COMPLETED|Overall Study||28
8107803|NCT03118765|19983212|P4|COMPLETED|Overall Study||29
8107804|NCT03118765|19983213|P3|COMPLETED|Overall Study||26
8107805|NCT03118765|19983214|P2|COMPLETED|Overall Study||30
8107806|NCT03118765|19983215|P1|COMPLETED|Overall Study||26
8107807|NCT03118765|19983211|P5|STARTED|Overall Study||30
8107808|NCT03118765|19983212|P4|STARTED|Overall Study||32
8107809|NCT03118765|19983213|P3|STARTED|Overall Study||31
8107810|NCT03118765|19983214|P2|STARTED|Overall Study||32
8107811|NCT03118765|19983215|P1|STARTED|Overall Study||30
8107812|NCT03118739|19983311|P2|NOT COMPLETED|Overall Study||4
8107813|NCT03118739|19983312|P1|NOT COMPLETED|Overall Study||7
8107814|NCT03118739|19983311|P2|COMPLETED|Overall Study||24
8107815|NCT03118739|19983312|P1|COMPLETED|Overall Study||25
8107816|NCT03118739|19983311|P2|Completed 24 Weeks of Treatment|Overall Study||25
8107817|NCT03118739|19983312|P1|Completed 24 Weeks of Treatment|Overall Study||24
8107818|NCT03118739|19983311|P2|Completed 12 Weeks of Treatment|Overall Study||25
8107819|NCT03118739|19983312|P1|Completed 12 Weeks of Treatment|Overall Study||26
8107820|NCT03118739|19983311|P2|STARTED|Overall Study||28
8107821|NCT03118739|19983312|P1|STARTED|Overall Study||32
8107822|NCT03118596|19983404|P2|NOT COMPLETED|Overall Study||4
8107823|NCT03118596|19983405|P1|NOT COMPLETED|Overall Study||0
8107824|NCT03118596|19983404|P2|COMPLETED|Overall Study||86
8107825|NCT03118596|19983405|P1|COMPLETED|Overall Study||90
8107826|NCT03118596|19983404|P2|Failed|Overall Study||4
8107827|NCT03118596|19983405|P1|Failed|Overall Study||0
8107828|NCT03118596|19983404|P2|Treated|Overall Study||0
8107829|NCT03118596|19983405|P1|Treated|Overall Study||2
8107830|NCT03118596|19983404|P2|STARTED|Overall Study||90
8107831|NCT03118596|19983405|P1|STARTED|Overall Study||90
8107832|NCT03118297|19983425|P2|NOT COMPLETED|Overall Study||2
8107833|NCT03118297|19983426|P1|NOT COMPLETED|Overall Study||0
8107834|NCT03118297|19983425|P2|COMPLETED|Overall Study||31
8107835|NCT03118297|19983426|P1|COMPLETED|Overall Study||32
8107836|NCT03118297|19983425|P2|STARTED|Overall Study||33
8107837|NCT03118297|19983426|P1|STARTED|Overall Study||32
8107838|NCT03117569|19983442|P2|NOT COMPLETED|Overall Study||12
8107839|NCT03117569|19983443|P1|NOT COMPLETED|Overall Study||4
8107840|NCT03117569|19983442|P2|COMPLETED|Overall Study||241
8107841|NCT03117569|19983443|P1|COMPLETED|Overall Study||123
8107842|NCT03117569|19983442|P2|STARTED|Overall Study||253
8107843|NCT03117569|19983443|P1|STARTED|Overall Study||127
8107844|NCT03117517|19983467|P2|NOT COMPLETED|Overall Study||4
8107845|NCT03117517|19983468|P1|NOT COMPLETED|Overall Study||5
8107846|NCT03117517|19983467|P2|COMPLETED|Overall Study||49
8107847|NCT03117517|19983468|P1|COMPLETED|Overall Study||48
8107848|NCT03117517|19983467|P2|STARTED|Overall Study||53
8107849|NCT03117517|19983468|P1|STARTED|Overall Study||53
8107850|NCT03117361|19983478|P1|NOT COMPLETED|Overall Study||10
8107851|NCT03117361|19983478|P1|COMPLETED|Overall Study||0
8107852|NCT03117361|19983478|P1|STARTED|Overall Study||10
8107853|NCT03117140|19983505|P4|NOT COMPLETED|Overall Study||0
8107854|NCT03117140|19983506|P3|NOT COMPLETED|Overall Study||0
8107855|NCT03117140|19983507|P2|NOT COMPLETED|Overall Study||0
8107856|NCT03117140|19983508|P1|NOT COMPLETED|Overall Study||0
8107857|NCT03117140|19983505|P4|COMPLETED|Overall Study||40
8107858|NCT03117140|19983506|P3|COMPLETED|Overall Study||40
8107859|NCT03117140|19983507|P2|COMPLETED|Overall Study||40
8107860|NCT03117140|19983508|P1|COMPLETED|Overall Study||40
8107861|NCT03117140|19983505|P4|STARTED|Overall Study||40
8107862|NCT03117140|19983506|P3|STARTED|Overall Study||40
8107863|NCT03117140|19983507|P2|STARTED|Overall Study||40
8107864|NCT03117140|19983508|P1|STARTED|Overall Study||40
8107865|NCT03116841|19983574|P1|NOT COMPLETED|Overall Study||0
8107866|NCT03116841|19983574|P1|COMPLETED|Overall Study||3
8107867|NCT03116841|19983574|P1|STARTED|Overall Study||3
8107868|NCT03116828|19983593|P2|NOT COMPLETED|Overall Study||21
8107869|NCT03116828|19983594|P1|NOT COMPLETED|Overall Study||8
8107870|NCT03116828|19983593|P2|COMPLETED|Overall Study||37
8107871|NCT03116828|19983594|P1|COMPLETED|Overall Study||36
8107872|NCT03116828|19983593|P2|STARTED|Overall Study||58
8107873|NCT03116828|19983594|P1|STARTED|Overall Study||44
8107874|NCT03116698|19983604|P4|NOT COMPLETED|Overall Study||2
8107875|NCT03116698|19983605|P3|NOT COMPLETED|Overall Study||8
8107876|NCT03116698|19983606|P2|NOT COMPLETED|Overall Study||6
8107877|NCT03116698|19983607|P1|NOT COMPLETED|Overall Study||6
8107878|NCT03116698|19983604|P4|COMPLETED|Overall Study||55
8107879|NCT03116698|19983605|P3|COMPLETED|Overall Study||54
8107880|NCT03116698|19983606|P2|COMPLETED|Overall Study||51
8107881|NCT03116698|19983607|P1|COMPLETED|Overall Study||56
8107882|NCT03116698|19983604|P4|STARTED|Overall Study||57
8107883|NCT03116698|19983605|P3|STARTED|Overall Study||62
8107884|NCT03116698|19983606|P2|STARTED|Overall Study||57
8107885|NCT03116698|19983607|P1|STARTED|Overall Study||62
8107894|NCT03115853|19983636|P1|NOT COMPLETED|Overall Study||0
8107895|NCT03115853|19983636|P1|COMPLETED|Overall Study||31
8107896|NCT03115853|19983636|P1|STARTED|Overall Study||31
8107897|NCT03115827|19983654|P1|NOT COMPLETED|Overall Study||3
8107898|NCT03115827|19983654|P1|COMPLETED|Overall Study||12
8107899|NCT03115827|19983654|P1|STARTED|Overall Study||15
8107900|NCT03115580|19983664|P2|NOT COMPLETED|Overall Study||0
8107901|NCT03115580|19983665|P1|NOT COMPLETED|Overall Study||0
8107902|NCT03115580|19983664|P2|COMPLETED|Overall Study||36
8107903|NCT03115580|19983665|P1|COMPLETED|Overall Study||35
8107904|NCT03115580|19983664|P2|STARTED|Overall Study||36
8107905|NCT03115580|19983665|P1|STARTED|Overall Study||35
8107906|NCT03115476|19983684|P3|NOT COMPLETED|LP0084-1369||162
8107907|NCT03115476|19983685|P2|NOT COMPLETED|LP0084-1369||210
8107908|NCT03115476|19983686|P1|NOT COMPLETED|LP0084-1369||191
8107909|NCT03115476|19983684|P3|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
8107910|NCT03115476|19983685|P2|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
8107911|NCT03115476|19983686|P1|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
8107912|NCT03115476|19983684|P3|STARTED|LP0084-1369||162
8107913|NCT03115476|19983685|P2|STARTED|LP0084-1369||210
8107914|NCT03115476|19983686|P1|STARTED|LP0084-1369||191
8107915|NCT03115476|19983684|P3|NOT COMPLETED|Main Trials (LP0084-119x)||0
8107916|NCT03115476|19983685|P2|NOT COMPLETED|Main Trials (LP0084-119x)||0
8107917|NCT03115476|19983686|P1|NOT COMPLETED|Main Trials (LP0084-119x)||0
8107918|NCT03115476|19983684|P3|COMPLETED|Main Trials (LP0084-119x)||409
8107919|NCT03115476|19983685|P2|COMPLETED|Main Trials (LP0084-119x)||418
8107920|NCT03115476|19983686|P1|COMPLETED|Main Trials (LP0084-119x)||407
8107921|NCT03115476|19983684|P3|STARTED|Main Trials (LP0084-119x)||409
8107922|NCT03115476|19983685|P2|STARTED|Main Trials (LP0084-119x)||418
8107923|NCT03115476|19983686|P1|STARTED|Main Trials (LP0084-119x)||407
8107924|NCT03115411|19983697|P1|NOT COMPLETED|Overall Study||0
8107925|NCT03115411|19983697|P1|COMPLETED|Overall Study||23
8107926|NCT03115411|19983697|P1|STARTED|Overall Study||23
8107927|NCT03115177|19983703|P2|NOT COMPLETED|Overall Study||0
8107928|NCT03115177|19983704|P1|NOT COMPLETED|Overall Study||0
8107929|NCT03115177|19983703|P2|COMPLETED|Overall Study||29
8107930|NCT03115177|19983704|P1|COMPLETED|Overall Study||27
8107931|NCT03115177|19983703|P2|STARTED|Overall Study||29
8107932|NCT03115177|19983704|P1|STARTED|Overall Study||27
8107933|NCT03114995|19983713|P3|NOT COMPLETED|Overall Study||0
8107934|NCT03114995|19983714|P2|NOT COMPLETED|Overall Study||1
8107935|NCT03114995|19983715|P1|NOT COMPLETED|Overall Study||1
8107936|NCT03114995|19983713|P3|COMPLETED|Overall Study||78
8107937|NCT03114995|19983714|P2|COMPLETED|Overall Study||30
8107938|NCT03114995|19983715|P1|COMPLETED|Overall Study||30
8107939|NCT03114995|19983713|P3|STARTED|Overall Study||78
8107940|NCT03114995|19983714|P2|STARTED|Overall Study||31
8107941|NCT03114995|19983715|P1|STARTED|Overall Study||31
8107942|NCT03114969|19983735|P9|NOT COMPLETED|Overall Study||2
8107943|NCT03114969|19983736|P8|NOT COMPLETED|Overall Study||0
8107944|NCT03114969|19983737|P7|NOT COMPLETED|Overall Study||1
8107945|NCT03114969|19983738|P6|NOT COMPLETED|Overall Study||1
8107946|NCT03114969|19983739|P5|NOT COMPLETED|Overall Study||0
8107947|NCT03114969|19983740|P4|NOT COMPLETED|Overall Study||2
8107948|NCT03114969|19983741|P3|NOT COMPLETED|Overall Study||4
8107949|NCT03114969|19983742|P2|NOT COMPLETED|Overall Study||0
8107950|NCT03114969|19983743|P1|NOT COMPLETED|Overall Study||0
8107951|NCT03114969|19983735|P9|COMPLETED|Overall Study||48
8107952|NCT03114969|19983736|P8|COMPLETED|Overall Study||50
8107953|NCT03114969|19983737|P7|COMPLETED|Overall Study||49
8107954|NCT03114969|19983738|P6|COMPLETED|Overall Study||48
8107955|NCT03114969|19983739|P5|COMPLETED|Overall Study||51
8107956|NCT03114969|19983740|P4|COMPLETED|Overall Study||48
8107957|NCT03114969|19983741|P3|COMPLETED|Overall Study||46
8107958|NCT03114969|19983742|P2|COMPLETED|Overall Study||50
8107959|NCT03114969|19983743|P1|COMPLETED|Overall Study||50
8107960|NCT03114969|19983735|P9|STARTED|Overall Study||50
8107961|NCT03114969|19983736|P8|STARTED|Overall Study||50
8107962|NCT03114969|19983737|P7|STARTED|Overall Study||50
8107963|NCT03114969|19983738|P6|STARTED|Overall Study||49
8107964|NCT03114969|19983739|P5|STARTED|Overall Study||51
8107965|NCT03114969|19983740|P4|STARTED|Overall Study||50
8107966|NCT03114969|19983741|P3|STARTED|Overall Study||50
8107967|NCT03114969|19983742|P2|STARTED|Overall Study||50
8107968|NCT03114969|19983743|P1|STARTED|Overall Study||50
8107969|NCT03114683|19983838|P1|NOT COMPLETED|Overall Study||44
8107970|NCT03114683|19983838|P1|COMPLETED|Overall Study||52
8107971|NCT03114683|19983838|P1|STARTED|Overall Study||96
8107972|NCT03114657|19983844|P2|NOT COMPLETED|Overall Study||407
8107973|NCT03114657|19983845|P1|NOT COMPLETED|Overall Study||399
8107974|NCT03114657|19983844|P2|COMPLETED|Overall Study||0
8107975|NCT03114657|19983845|P1|COMPLETED|Overall Study||0
8107976|NCT03114657|19983844|P2|STARTED|Overall Study||407
8107977|NCT03114657|19983845|P1|STARTED|Overall Study||399
8107978|NCT03114488|19983890|P2|NOT COMPLETED|Time Period 2||3
8107979|NCT03114488|19983891|P1|NOT COMPLETED|Time Period 2||1
8107980|NCT03114488|19983890|P2|COMPLETED|Time Period 2||19
8107981|NCT03114488|19983891|P1|COMPLETED|Time Period 2||18
8107982|NCT03114488|19983890|P2|STARTED|Time Period 2||22
8107983|NCT03114488|19983891|P1|STARTED|Time Period 2||19
8107984|NCT03114488|19983890|P2|NOT COMPLETED|Time Period 1||0
8107985|NCT03114488|19983891|P1|NOT COMPLETED|Time Period 1||0
8107986|NCT03114488|19983890|P2|COMPLETED|Time Period 1||22
8107987|NCT03114488|19983891|P1|COMPLETED|Time Period 1||19
8107988|NCT03114488|19983890|P2|STARTED|Time Period 1||22
8107989|NCT03114488|19983891|P1|STARTED|Time Period 1||19
8107990|NCT03113916|19983903|P2|NOT COMPLETED|Overall Study||12
8107991|NCT03113916|19983904|P1|NOT COMPLETED|Overall Study||11
8107992|NCT03113916|19983903|P2|COMPLETED|Overall Study||84
8107993|NCT03113916|19983904|P1|COMPLETED|Overall Study||88
8107994|NCT03113916|19983903|P2|STARTED|Overall Study||96
8107995|NCT03113916|19983904|P1|STARTED|Overall Study||99
8107996|NCT03113656|19983935|P2|NOT COMPLETED|Overall Study||0
8107997|NCT03113656|19983936|P1|NOT COMPLETED|Overall Study||0
8107998|NCT03113656|19983935|P2|COMPLETED|Overall Study||7
8107999|NCT03113656|19983936|P1|COMPLETED|Overall Study||9
8108000|NCT03113656|19983935|P2|STARTED|Overall Study||7
8108001|NCT03113656|19983936|P1|STARTED|Overall Study||9
8108002|NCT03112993|19983944|P2|NOT COMPLETED|Overall Study||0
8108003|NCT03112993|19983945|P1|NOT COMPLETED|Overall Study||0
8108004|NCT03112993|19983944|P2|COMPLETED|Overall Study||21
8108005|NCT03112993|19983945|P1|COMPLETED|Overall Study||19
8108006|NCT03112993|19983944|P2|STARTED|Overall Study||21
8108007|NCT03112993|19983945|P1|STARTED|Overall Study||19
8108008|NCT03111550|19983962|P3|NOT COMPLETED|Overall Study||3
8108009|NCT03111550|19983963|P2|NOT COMPLETED|Overall Study||2
8108010|NCT03111550|19983964|P1|NOT COMPLETED|Overall Study||4
8108011|NCT03111550|19983962|P3|COMPLETED|Overall Study||76
8108012|NCT03111550|19983963|P2|COMPLETED|Overall Study||71
8108013|NCT03111550|19983964|P1|COMPLETED|Overall Study||73
8108014|NCT03111550|19983962|P3|STARTED|Overall Study|First eye|79
8108015|NCT03111550|19983963|P2|STARTED|Overall Study|First eye|73
8108016|NCT03111550|19983964|P1|STARTED|Overall Study|First eye|77
8108029|NCT03111108|19984001|P2|NOT COMPLETED|Overall Study||1
8108030|NCT03111108|19984002|P1|NOT COMPLETED|Overall Study||1
8108031|NCT03111108|19984001|P2|COMPLETED|Overall Study||63
8108032|NCT03111108|19984002|P1|COMPLETED|Overall Study||52
8108033|NCT03111108|19984001|P2|STARTED|Overall Study||64
8108034|NCT03111108|19984002|P1|STARTED|Overall Study||53
8108035|NCT03110900|19984020|P2|NOT COMPLETED|Overall Study||1
8108036|NCT03110900|19984021|P1|NOT COMPLETED|Overall Study||1
8108037|NCT03110900|19984020|P2|COMPLETED|Overall Study||0
8108038|NCT03110900|19984021|P1|COMPLETED|Overall Study||0
8108039|NCT03110900|19984020|P2|STARTED|Overall Study||1
8108040|NCT03110900|19984021|P1|STARTED|Overall Study||1
8108071|NCT03110692|19984081|P2|NOT COMPLETED|Overall Study||0
8108072|NCT03110692|19984082|P1|NOT COMPLETED|Overall Study||0
8108073|NCT03110692|19984081|P2|COMPLETED|Overall Study||509
8108074|NCT03110692|19984082|P1|COMPLETED|Overall Study||679
8108075|NCT03110692|19984081|P2|STARTED|Overall Study||509
8108076|NCT03110692|19984082|P1|STARTED|Overall Study||679
8108077|NCT03110601|19984088|P1|NOT COMPLETED|Stimgenics SCS Parameters||3
8108078|NCT03110601|19984088|P1|COMPLETED|Stimgenics SCS Parameters||20
8108079|NCT03110601|19984088|P1|STARTED|Stimgenics SCS Parameters||23
8108080|NCT03110601|19984088|P1|NOT COMPLETED|Washout Period||1
8108081|NCT03110601|19984088|P1|COMPLETED|Washout Period||23
8108082|NCT03110601|19984088|P1|STARTED|Washout Period||24
8108083|NCT03110601|19984088|P1|NOT COMPLETED|Conventional SCS Parameters||1
8108084|NCT03110601|19984088|P1|COMPLETED|Conventional SCS Parameters||24
8108085|NCT03110601|19984088|P1|STARTED|Conventional SCS Parameters||25
8108086|NCT03110471|19984097|P2|NOT COMPLETED|Overall Study||0
8108087|NCT03110471|19984098|P1|NOT COMPLETED|Overall Study||0
8108088|NCT03110471|19984097|P2|COMPLETED|Overall Study||30
8108089|NCT03110471|19984098|P1|COMPLETED|Overall Study||30
8108090|NCT03110471|19984097|P2|STARTED|Overall Study||30
8108091|NCT03110471|19984098|P1|STARTED|Overall Study||30
8108092|NCT03110458|19984110|P3|NOT COMPLETED|Overall Study||3
8108093|NCT03110458|19984111|P2|NOT COMPLETED|Overall Study||4
8108094|NCT03110458|19984112|P1|NOT COMPLETED|Overall Study||6
8108095|NCT03110458|19984110|P3|COMPLETED|Overall Study||31
8108096|NCT03110458|19984111|P2|COMPLETED|Overall Study||32
8108097|NCT03110458|19984112|P1|COMPLETED|Overall Study||31
8108098|NCT03110458|19984110|P3|STARTED|Overall Study||34
8108099|NCT03110458|19984111|P2|STARTED|Overall Study||36
8108100|NCT03110458|19984112|P1|STARTED|Overall Study||37
8108107|NCT03110185|19984153|P2|NOT COMPLETED|Overall Study||31
8108108|NCT03110185|19984154|P1|NOT COMPLETED|Overall Study||10
8108109|NCT03110185|19984153|P2|COMPLETED|Overall Study||33
8108110|NCT03110185|19984154|P1|COMPLETED|Overall Study||17
8108111|NCT03110185|19984153|P2|STARTED|Overall Study||64
8108112|NCT03110185|19984154|P1|STARTED|Overall Study||27
8108116|NCT03110029|19984175|P2|NOT COMPLETED|Overall Study||1
8108117|NCT03110029|19984176|P1|NOT COMPLETED|Overall Study||1
8108118|NCT03110029|19984175|P2|COMPLETED|Overall Study||5
8108119|NCT03110029|19984176|P1|COMPLETED|Overall Study||6
8108120|NCT03110029|19984175|P2|STARTED|Overall Study||6
8108121|NCT03110029|19984176|P1|STARTED|Overall Study||7
8108122|NCT03110003|19984186|P2|NOT COMPLETED|Overall Study||0
8108123|NCT03110003|19984187|P1|NOT COMPLETED|Overall Study||0
8108124|NCT03110003|19984186|P2|COMPLETED|Overall Study||24
8108125|NCT03110003|19984187|P1|COMPLETED|Overall Study||21
8108126|NCT03110003|19984186|P2|STARTED|Overall Study||24
8108127|NCT03110003|19984187|P1|STARTED|Overall Study||21
8108128|NCT03109951|19984203|P1|NOT COMPLETED|Overall Study||0
8108129|NCT03109951|19984203|P1|COMPLETED|Overall Study||187
8108130|NCT03109951|19984203|P1|STARTED|Overall Study||187
8108131|NCT03109873|19984211|P2|NOT COMPLETED|Overall Study||0
8108132|NCT03109873|19984212|P1|NOT COMPLETED|Overall Study||0
8108133|NCT03109873|19984211|P2|COMPLETED|Overall Study||4
8108134|NCT03109873|19984212|P1|COMPLETED|Overall Study||5
8108135|NCT03109873|19984211|P2|STARTED|Overall Study||4
8108136|NCT03109873|19984212|P1|STARTED|Overall Study||5
8108137|NCT03109769|19984228|P2|NOT COMPLETED|Overall Study||0
8108138|NCT03109769|19984229|P1|NOT COMPLETED|Overall Study||0
8108139|NCT03109769|19984228|P2|COMPLETED|Overall Study||22
8108140|NCT03109769|19984229|P1|COMPLETED|Overall Study||22
8108141|NCT03109769|19984228|P2|STARTED|Overall Study||22
8108142|NCT03109769|19984229|P1|STARTED|Overall Study||22
8108143|NCT03109418|19984239|P2|NOT COMPLETED|Overall Study||1
8108144|NCT03109418|19984240|P1|NOT COMPLETED|Overall Study||0
8108145|NCT03109418|19984239|P2|COMPLETED|Overall Study||3
8108146|NCT03109418|19984240|P1|COMPLETED|Overall Study||2
8108147|NCT03109418|19984239|P2|STARTED|Overall Study||4
8108148|NCT03109418|19984240|P1|STARTED|Overall Study||2
8108149|NCT03109184|19984250|P2|NOT COMPLETED|Overall Study||7
8108150|NCT03109184|19984251|P1|NOT COMPLETED|Overall Study||7
8108151|NCT03109184|19984250|P2|COMPLETED|Overall Study||52
8108152|NCT03109184|19984251|P1|COMPLETED|Overall Study||53
8108153|NCT03109184|19984250|P2|STARTED|Overall Study||59
8108154|NCT03109184|19984251|P1|STARTED|Overall Study||60
8108155|NCT03109015|19984271|P2|NOT COMPLETED|Overall Study||0
8108156|NCT03109015|19984272|P1|NOT COMPLETED|Overall Study||0
8108157|NCT03109015|19984271|P2|COMPLETED|Overall Study||3
8108158|NCT03109015|19984272|P1|COMPLETED|Overall Study||4
8108159|NCT03109015|19984271|P2|STARTED|Overall Study||3
8108160|NCT03109015|19984272|P1|STARTED|Overall Study||4
8108161|NCT03108924|19984306|P4|NOT COMPLETED|Overall Study||0
8108162|NCT03108924|19984307|P3|NOT COMPLETED|Overall Study||0
8108163|NCT03108924|19984308|P2|NOT COMPLETED|Overall Study||0
8108164|NCT03108924|19984309|P1|NOT COMPLETED|Overall Study||0
8108165|NCT03108924|19984306|P4|COMPLETED|Overall Study||6
8108166|NCT03108924|19984307|P3|COMPLETED|Overall Study||6
8108167|NCT03108924|19984308|P2|COMPLETED|Overall Study||6
8108168|NCT03108924|19984309|P1|COMPLETED|Overall Study||6
8108169|NCT03108924|19984306|P4|STARTED|Overall Study||6
8108170|NCT03108924|19984307|P3|STARTED|Overall Study||6
8108171|NCT03108924|19984308|P2|STARTED|Overall Study||6
8108172|NCT03108924|19984309|P1|STARTED|Overall Study||6
8108173|NCT03108521|19984405|P2|NOT COMPLETED|Overall Study||0
8108174|NCT03108521|19984406|P1|NOT COMPLETED|Overall Study||12
8108175|NCT03108521|19984405|P2|COMPLETED|Overall Study||36
8108176|NCT03108521|19984406|P1|COMPLETED|Overall Study||71
8108177|NCT03108521|19984405|P2|STARTED|Overall Study||36
8108178|NCT03108521|19984406|P1|STARTED|Overall Study||83
8108179|NCT03108482|19984420|P4|NOT COMPLETED|Overall Study||3
8108180|NCT03108482|19984421|P3|NOT COMPLETED|Overall Study||2
8108181|NCT03108482|19984422|P2|NOT COMPLETED|Overall Study||4
8108182|NCT03108482|19984423|P1|NOT COMPLETED|Overall Study||0
8108183|NCT03108482|19984420|P4|COMPLETED|Overall Study||86
8108184|NCT03108482|19984421|P3|COMPLETED|Overall Study||180
8108185|NCT03108482|19984422|P2|COMPLETED|Overall Study||179
8108186|NCT03108482|19984423|P1|COMPLETED|Overall Study||183
8108187|NCT03108482|19984420|P4|STARTED|Overall Study||89
8108188|NCT03108482|19984421|P3|STARTED|Overall Study||182
8108189|NCT03108482|19984422|P2|STARTED|Overall Study||183
8108190|NCT03108482|19984423|P1|STARTED|Overall Study||183
8108191|NCT03108469|19984435|P2|NOT COMPLETED|Overall Study||4
8108192|NCT03108469|19984436|P1|NOT COMPLETED|Overall Study||4
8108193|NCT03108469|19984435|P2|COMPLETED|Overall Study||11
8108194|NCT03108469|19984436|P1|COMPLETED|Overall Study||11
8108195|NCT03108469|19984435|P2|STARTED|Overall Study||15
8108196|NCT03108469|19984436|P1|STARTED|Overall Study||15
8108197|NCT03108157|19984458|P2|NOT COMPLETED|Overall Study||4
8108198|NCT03108157|19984459|P1|NOT COMPLETED|Overall Study||15
8108199|NCT03108157|19984458|P2|COMPLETED|Overall Study||172
8108200|NCT03108157|19984459|P1|COMPLETED|Overall Study||161
8108201|NCT03108157|19984458|P2|STARTED|Overall Study||176
8108202|NCT03108157|19984459|P1|STARTED|Overall Study||176
8108203|NCT03108027|19984469|P6|NOT COMPLETED|Period 3||0
8108204|NCT03108027|19984470|P5|NOT COMPLETED|Period 3||0
8108205|NCT03108027|19984471|P4|NOT COMPLETED|Period 3||0
8108206|NCT03108027|19984472|P3|NOT COMPLETED|Period 3||0
8108207|NCT03108027|19984473|P2|NOT COMPLETED|Period 3||1
8108208|NCT03108027|19984474|P1|NOT COMPLETED|Period 3||0
8108209|NCT03108027|19984469|P6|COMPLETED|Period 3||6
8108210|NCT03108027|19984470|P5|COMPLETED|Period 3||6
8108211|NCT03108027|19984471|P4|COMPLETED|Period 3||4
8108212|NCT03108027|19984472|P3|COMPLETED|Period 3||6
8108213|NCT03108027|19984473|P2|COMPLETED|Period 3||5
8108214|NCT03108027|19984474|P1|COMPLETED|Period 3||7
8108215|NCT03108027|19984469|P6|STARTED|Period 3||6
8108216|NCT03108027|19984470|P5|STARTED|Period 3||6
8108217|NCT03108027|19984471|P4|STARTED|Period 3||4
8108218|NCT03108027|19984472|P3|STARTED|Period 3||6
8108219|NCT03108027|19984473|P2|STARTED|Period 3||6
8108220|NCT03108027|19984474|P1|STARTED|Period 3||7
8108221|NCT03108027|19984469|P6|NOT COMPLETED|Period 2||0
8108222|NCT03108027|19984470|P5|NOT COMPLETED|Period 2||0
8108223|NCT03108027|19984471|P4|NOT COMPLETED|Period 2||0
8108224|NCT03108027|19984472|P3|NOT COMPLETED|Period 2||0
8108225|NCT03108027|19984473|P2|NOT COMPLETED|Period 2||0
8108226|NCT03108027|19984474|P1|NOT COMPLETED|Period 2||0
8108227|NCT03108027|19984469|P6|COMPLETED|Period 2||6
8108228|NCT03108027|19984470|P5|COMPLETED|Period 2||6
8108229|NCT03108027|19984471|P4|COMPLETED|Period 2||4
8108230|NCT03108027|19984472|P3|COMPLETED|Period 2||6
8108231|NCT03108027|19984473|P2|COMPLETED|Period 2||6
8108232|NCT03108027|19984474|P1|COMPLETED|Period 2||7
8108233|NCT03108027|19984469|P6|STARTED|Period 2||6
8108234|NCT03108027|19984470|P5|STARTED|Period 2||6
8108235|NCT03108027|19984471|P4|STARTED|Period 2||4
8108236|NCT03108027|19984472|P3|STARTED|Period 2||6
8108237|NCT03108027|19984473|P2|STARTED|Period 2||6
8108238|NCT03108027|19984474|P1|STARTED|Period 2||7
8108239|NCT03108027|19984469|P6|NOT COMPLETED|Period 1||0
8108240|NCT03108027|19984470|P5|NOT COMPLETED|Period 1||0
8108241|NCT03108027|19984471|P4|NOT COMPLETED|Period 1||2
8108242|NCT03108027|19984472|P3|NOT COMPLETED|Period 1||0
8108243|NCT03108027|19984473|P2|NOT COMPLETED|Period 1||0
8108244|NCT03108027|19984474|P1|NOT COMPLETED|Period 1||0
8108245|NCT03108027|19984469|P6|COMPLETED|Period 1||6
8108246|NCT03108027|19984470|P5|COMPLETED|Period 1||6
8108247|NCT03108027|19984471|P4|COMPLETED|Period 1||4
8108248|NCT03108027|19984472|P3|COMPLETED|Period 1||6
8108249|NCT03108027|19984473|P2|COMPLETED|Period 1||6
8108250|NCT03108027|19984474|P1|COMPLETED|Period 1||7
8108251|NCT03108027|19984469|P6|STARTED|Period 1||6
8108252|NCT03108027|19984470|P5|STARTED|Period 1||6
8108253|NCT03108027|19984471|P4|STARTED|Period 1||6
8108254|NCT03108027|19984472|P3|STARTED|Period 1||6
8108255|NCT03108027|19984473|P2|STARTED|Period 1||6
8108256|NCT03108027|19984474|P1|STARTED|Period 1||7
8108257|NCT03107754|19984490|P2|NOT COMPLETED|Overall Study||0
8108258|NCT03107754|19984491|P1|NOT COMPLETED|Overall Study||0
8108259|NCT03107754|19984490|P2|COMPLETED|Overall Study||50
8108260|NCT03107754|19984491|P1|COMPLETED|Overall Study||48
8108261|NCT03107754|19984490|P2|STARTED|Overall Study||50
8108262|NCT03107754|19984491|P1|STARTED|Overall Study||48
8108263|NCT03107715|19984501|P2|NOT COMPLETED|Overall Study||7
8108264|NCT03107715|19984502|P1|NOT COMPLETED|Overall Study||4
8108265|NCT03107715|19984501|P2|COMPLETED|Overall Study||104
8108266|NCT03107715|19984502|P1|COMPLETED|Overall Study||128
8108267|NCT03107715|19984501|P2|STARTED|Overall Study||111
8108268|NCT03107715|19984502|P1|STARTED|Overall Study||132
8108269|NCT03107611|19984517|P3|NOT COMPLETED|Overall Study||9
8108270|NCT03107611|19984518|P2|NOT COMPLETED|Overall Study||4
8108271|NCT03107611|19984519|P1|NOT COMPLETED|Overall Study||7
8108272|NCT03107611|19984517|P3|COMPLETED|Overall Study||212
8108273|NCT03107611|19984518|P2|COMPLETED|Overall Study||212
8108274|NCT03107611|19984519|P1|COMPLETED|Overall Study||210
8108275|NCT03107611|19984517|P3|Dosed|Overall Study||220
8108276|NCT03107611|19984518|P2|Dosed|Overall Study||214
8108277|NCT03107611|19984519|P1|Dosed|Overall Study||215
8108278|NCT03107611|19984517|P3|STARTED|Overall Study||221
8108279|NCT03107611|19984518|P2|STARTED|Overall Study||216
8108280|NCT03107611|19984519|P1|STARTED|Overall Study||217
8108281|NCT03107377|19984538|P2|NOT COMPLETED|Overall Study||99
8108282|NCT03107377|19984539|P1|NOT COMPLETED|Overall Study||91
8108283|NCT03107377|19984538|P2|COMPLETED|Overall Study||335
8108284|NCT03107377|19984539|P1|COMPLETED|Overall Study||335
8108285|NCT03107377|19984538|P2|STARTED|Overall Study||434
8108286|NCT03107377|19984539|P1|STARTED|Overall Study||426
8108287|NCT03107052|19984564|P3|NOT COMPLETED|Overall Study||41
8108288|NCT03107052|19984565|P2|NOT COMPLETED|Overall Study||46
8108289|NCT03107052|19984566|P1|NOT COMPLETED|Overall Study||119
8108290|NCT03107052|19984564|P3|COMPLETED|Overall Study||29
8108291|NCT03107052|19984565|P2|COMPLETED|Overall Study||14
8108292|NCT03107052|19984566|P1|COMPLETED|Overall Study||26
8108293|NCT03107052|19984564|P3|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|71
8108294|NCT03107052|19984565|P2|Safety Analysis Set|Overall Study||60
8108295|NCT03107052|19984566|P1|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|144
8108296|NCT03107052|19984564|P3|STARTED|Overall Study||70
8108297|NCT03107052|19984565|P2|STARTED|Overall Study||60
8108298|NCT03107052|19984566|P1|STARTED|Overall Study||145
8108299|NCT03107026|19984610|P3|NOT COMPLETED|Overall Study||56
8108300|NCT03107026|19984611|P2|NOT COMPLETED|Overall Study||38
8108301|NCT03107026|19984612|P1|NOT COMPLETED|Overall Study||32
8108302|NCT03107026|19984610|P3|COMPLETED|Overall Study||106
8108303|NCT03107026|19984611|P2|COMPLETED|Overall Study||123
8108304|NCT03107026|19984612|P1|COMPLETED|Overall Study||131
8108305|NCT03107026|19984610|P3|STARTED|Overall Study||162
8108306|NCT03107026|19984611|P2|STARTED|Overall Study||161
8108307|NCT03107026|19984612|P1|STARTED|Overall Study||163
8108308|NCT03106870|19984661|P2|NOT COMPLETED|Overall Study||0
8108309|NCT03106870|19984662|P1|NOT COMPLETED|Overall Study||0
8108310|NCT03106870|19984661|P2|COMPLETED|Overall Study||31
8108311|NCT03106870|19984662|P1|COMPLETED|Overall Study||31
8108312|NCT03106870|19984661|P2|STARTED|Overall Study||31
8108313|NCT03106870|19984662|P1|STARTED|Overall Study||31
8108317|NCT03106753|19984679|P2|NOT COMPLETED|Overall Study||1
8108318|NCT03106753|19984680|P1|NOT COMPLETED|Overall Study||0
8108319|NCT03106753|19984679|P2|COMPLETED|Overall Study||16
8108320|NCT03106753|19984680|P1|COMPLETED|Overall Study||17
8108321|NCT03106753|19984679|P2|STARTED|Overall Study||17
8108322|NCT03106753|19984680|P1|STARTED|Overall Study||17
8108323|NCT03106636|19984704|P2|NOT COMPLETED|Overall Study||26
8108324|NCT03106636|19984705|P1|NOT COMPLETED|Overall Study||44
8108325|NCT03106636|19984704|P2|COMPLETED|Overall Study||164
8108326|NCT03106636|19984705|P1|COMPLETED|Overall Study||182
8108327|NCT03106636|19984704|P2|STARTED|Overall Study||190
8108328|NCT03106636|19984705|P1|STARTED|Overall Study||226
8108329|NCT03106337|19984741|P1|NOT COMPLETED|Overall Study||0
8108330|NCT03106337|19984741|P1|COMPLETED|Overall Study||35
8108331|NCT03106337|19984741|P1|STARTED|Overall Study||35
8108332|NCT03106077|19984746|P2|NOT COMPLETED|Overall Study||0
8108333|NCT03106077|19984747|P1|NOT COMPLETED|Overall Study||94
8108334|NCT03106077|19984746|P2|COMPLETED|Overall Study||0
8108335|NCT03106077|19984747|P1|COMPLETED|Overall Study||2
8108336|NCT03106077|19984746|P2|STARTED|Overall Study||0
8108337|NCT03106077|19984747|P1|STARTED|Overall Study||96
8108341|NCT03105479|19984762|P7|NOT COMPLETED|Overall Study||0
8108342|NCT03105479|19984763|P6|NOT COMPLETED|Overall Study||0
8108343|NCT03105479|19984764|P5|NOT COMPLETED|Overall Study||0
8108344|NCT03105479|19984765|P4|NOT COMPLETED|Overall Study||0
8108345|NCT03105479|19984766|P3|NOT COMPLETED|Overall Study||0
8108346|NCT03105479|19984767|P2|NOT COMPLETED|Overall Study||0
8108347|NCT03105479|19984768|P1|NOT COMPLETED|Overall Study||0
8108348|NCT03105479|19984762|P7|COMPLETED|Overall Study||0
8108349|NCT03105479|19984763|P6|COMPLETED|Overall Study||0
8108350|NCT03105479|19984764|P5|COMPLETED|Overall Study||0
8108351|NCT03105479|19984765|P4|COMPLETED|Overall Study||0
8108352|NCT03105479|19984766|P3|COMPLETED|Overall Study||0
8108353|NCT03105479|19984767|P2|COMPLETED|Overall Study||0
8108354|NCT03105479|19984768|P1|COMPLETED|Overall Study||1
8108355|NCT03105479|19984762|P7|STARTED|Overall Study||0
8108356|NCT03105479|19984763|P6|STARTED|Overall Study||0
8108357|NCT03105479|19984764|P5|STARTED|Overall Study||0
8108358|NCT03105479|19984765|P4|STARTED|Overall Study||0
8108359|NCT03105479|19984766|P3|STARTED|Overall Study||0
8108360|NCT03105479|19984767|P2|STARTED|Overall Study||0
8108361|NCT03105479|19984768|P1|STARTED|Overall Study||1
8108362|NCT03105362|19984791|P1|NOT COMPLETED|Overall Study||2
8108363|NCT03105362|19984791|P1|COMPLETED|Overall Study||2
8108364|NCT03105362|19984791|P1|Completed 2 Week Questionaire|Overall Study||2
8108365|NCT03105362|19984791|P1|Completed 2 Weeks of Study|Overall Study||3
8108366|NCT03105362|19984791|P1|Completed 1 Week of Study|Overall Study||4
8108367|NCT03105362|19984791|P1|STARTED|Overall Study||4
8108368|NCT03105297|19984798|P1|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8
8108369|NCT03105297|19984798|P1|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48
8108370|NCT03105297|19984798|P1|Treated|Nasal Resistance Phase (Day 30, 31)||55
8108371|NCT03105297|19984798|P1|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56
8108372|NCT03105297|19984798|P1|NOT COMPLETED|Active Phase (Day 2-29)||0
8108373|NCT03105297|19984798|P1|COMPLETED|Active Phase (Day 2-29)||70
8108374|NCT03105297|19984798|P1|STARTED|Active Phase (Day 2-29)||70
8108375|NCT03105297|19984798|P1|NOT COMPLETED|Baseline Phase (Day 1)||21
8108376|NCT03105297|19984798|P1|COMPLETED|Baseline Phase (Day 1)||70
8108377|NCT03105297|19984798|P1|STARTED|Baseline Phase (Day 1)||91
8108378|NCT03104985|19984832|P2|NOT COMPLETED|Overall Study||0
8108379|NCT03104985|19984833|P1|NOT COMPLETED|Overall Study||0
8108380|NCT03104985|19984832|P2|COMPLETED|Overall Study||34
8108381|NCT03104985|19984833|P1|COMPLETED|Overall Study||34
8108382|NCT03104985|19984832|P2|STARTED|Overall Study||34
8108383|NCT03104985|19984833|P1|STARTED|Overall Study||34
8108384|NCT03104816|19984842|P3|NOT COMPLETED|Overall Study||2
8108385|NCT03104816|19984843|P2|NOT COMPLETED|Overall Study||2
8108386|NCT03104816|19984844|P1|NOT COMPLETED|Overall Study||2
8108387|NCT03104816|19984842|P3|COMPLETED|Overall Study||4
8108388|NCT03104816|19984843|P2|COMPLETED|Overall Study||9
8108389|NCT03104816|19984844|P1|COMPLETED|Overall Study||9
8108390|NCT03104816|19984842|P3|STARTED|Overall Study||6
8108391|NCT03104816|19984843|P2|STARTED|Overall Study||11
8108392|NCT03104816|19984844|P1|STARTED|Overall Study||11
8108393|NCT03104738|19984854|P2|NOT COMPLETED|Overall Study||0
8108394|NCT03104738|19984855|P1|NOT COMPLETED|Overall Study||0
8108395|NCT03104738|19984854|P2|COMPLETED|Overall Study||20
8108396|NCT03104738|19984855|P1|COMPLETED|Overall Study||20
8108397|NCT03104738|19984854|P2|STARTED|Overall Study||20
8108398|NCT03104738|19984855|P1|STARTED|Overall Study||20
8108399|NCT03104647|19984881|P1|NOT COMPLETED|Overall Study||0
8108400|NCT03104647|19984881|P1|COMPLETED|Overall Study||20
8108401|NCT03104647|19984881|P1|STARTED|Overall Study||20
8108402|NCT03104322|19984886|P1|NOT COMPLETED|Overall Study||1
8108403|NCT03104322|19984886|P1|COMPLETED|Overall Study||6
8108404|NCT03104322|19984886|P1|STARTED|Overall Study||7
8108405|NCT03104192|19984898|P4|NOT COMPLETED|Overall Study||3
8108406|NCT03104192|19984899|P3|NOT COMPLETED|Overall Study||2
8108407|NCT03104192|19984900|P2|NOT COMPLETED|Overall Study||4
8108408|NCT03104192|19984901|P1|NOT COMPLETED|Overall Study||0
8108409|NCT03104192|19984898|P4|COMPLETED|Overall Study||14
8108410|NCT03104192|19984899|P3|COMPLETED|Overall Study||14
8108411|NCT03104192|19984900|P2|COMPLETED|Overall Study||23
8108412|NCT03104192|19984901|P1|COMPLETED|Overall Study||9
8108413|NCT03104192|19984898|P4|STARTED|Overall Study||17
8108414|NCT03104192|19984899|P3|STARTED|Overall Study||16
8108415|NCT03104192|19984900|P2|STARTED|Overall Study||27
8108416|NCT03104192|19984901|P1|STARTED|Overall Study||9
8108417|NCT03103919|19984952|P2|NOT COMPLETED|Overall Study||2
8108418|NCT03103919|19984953|P1|NOT COMPLETED|Overall Study||2
8108419|NCT03103919|19984952|P2|COMPLETED|Overall Study||17
8108420|NCT03103919|19984953|P1|COMPLETED|Overall Study||18
8108421|NCT03103919|19984952|P2|STARTED|Overall Study||19
8108422|NCT03103919|19984953|P1|STARTED|Overall Study||20
8108423|NCT03103906|19984989|P2|NOT COMPLETED|Overall Study||3
8108424|NCT03103906|19984990|P1|NOT COMPLETED|Overall Study||4
8108425|NCT03103906|19984989|P2|COMPLETED|Overall Study||39
8108426|NCT03103906|19984990|P1|COMPLETED|Overall Study||36
8108427|NCT03103906|19984989|P2|STARTED|Overall Study||42
8108428|NCT03103906|19984990|P1|STARTED|Overall Study||40
8108438|NCT03103503|19985044|P1|NOT COMPLETED|Overall Study||901
8108439|NCT03103503|19985044|P1|COMPLETED|Overall Study||0
8108440|NCT03103503|19985044|P1|STARTED|Overall Study||901
8108441|NCT03103282|19985054|P1|NOT COMPLETED|Overall Study||0
8108442|NCT03103282|19985054|P1|COMPLETED|Overall Study||65
8108443|NCT03103282|19985054|P1|STARTED|Overall Study||65
8108444|NCT03103100|19985069|P3|NOT COMPLETED|Overall Study||2
8108445|NCT03103100|19985070|P2|NOT COMPLETED|Overall Study||0
8108446|NCT03103100|19985071|P1|NOT COMPLETED|Overall Study||2
8108447|NCT03103100|19985069|P3|COMPLETED|Overall Study||23
8108448|NCT03103100|19985070|P2|COMPLETED|Overall Study||25
8108449|NCT03103100|19985071|P1|COMPLETED|Overall Study||23
8108450|NCT03103100|19985069|P3|STARTED|Overall Study||25
8108451|NCT03103100|19985070|P2|STARTED|Overall Study||25
8108452|NCT03103100|19985071|P1|STARTED|Overall Study||25
8108453|NCT03103061|19985088|P1|NOT COMPLETED|Overall Study||0
8108454|NCT03103061|19985088|P1|COMPLETED|Overall Study||24
8108455|NCT03103061|19985088|P1|STARTED|Overall Study||24
8108456|NCT03102918|19985095|P2|NOT COMPLETED|Overall Study||0
8108457|NCT03102918|19985096|P1|NOT COMPLETED|Overall Study||1
8108458|NCT03102918|19985095|P2|COMPLETED|Overall Study||5
8108459|NCT03102918|19985096|P1|COMPLETED|Overall Study||4
8108460|NCT03102918|19985095|P2|STARTED|Overall Study||5
8108461|NCT03102918|19985096|P1|STARTED|Overall Study||5
8108462|NCT03102879|19985104|P2|NOT COMPLETED|Overall Study||0
8108463|NCT03102879|19985105|P1|NOT COMPLETED|Overall Study||0
8108464|NCT03102879|19985104|P2|COMPLETED|Overall Study||18
8108465|NCT03102879|19985105|P1|COMPLETED|Overall Study||18
8108466|NCT03102879|19985104|P2|STARTED|Overall Study||18
8108467|NCT03102879|19985105|P1|STARTED|Overall Study||18
8108468|NCT03102762|19985122|P2|NOT COMPLETED|Overall Study||0
8108469|NCT03102762|19985123|P1|NOT COMPLETED|Overall Study||1
8108470|NCT03102762|19985122|P2|COMPLETED|Overall Study||35
8108471|NCT03102762|19985123|P1|COMPLETED|Overall Study||34
8108472|NCT03102762|19985122|P2|STARTED|Overall Study||35
8108473|NCT03102762|19985123|P1|STARTED|Overall Study||35
8108474|NCT03102736|19985151|P2|NOT COMPLETED|Overall Study||0
8108475|NCT03102736|19985152|P1|NOT COMPLETED|Overall Study||0
8108476|NCT03102736|19985151|P2|COMPLETED|Overall Study||9
8108477|NCT03102736|19985152|P1|COMPLETED|Overall Study||7
8108478|NCT03102736|19985151|P2|STARTED|Overall Study||9
8108479|NCT03102736|19985152|P1|STARTED|Overall Study||7
8108480|NCT03102710|19985167|P3|NOT COMPLETED|Overall Study||0
8108481|NCT03102710|19985168|P2|NOT COMPLETED|Overall Study||3
8108482|NCT03102710|19985169|P1|NOT COMPLETED|Overall Study||1
8108483|NCT03102710|19985167|P3|COMPLETED|Overall Study||27
8108484|NCT03102710|19985168|P2|COMPLETED|Overall Study||27
8108485|NCT03102710|19985169|P1|COMPLETED|Overall Study||27
8108486|NCT03102710|19985167|P3|STARTED|Overall Study||27
8108487|NCT03102710|19985168|P2|STARTED|Overall Study||30
8108488|NCT03102710|19985169|P1|STARTED|Overall Study||28
8108489|NCT03102411|19985183|P1|NOT COMPLETED|Overall Study||163
8108490|NCT03102411|19985183|P1|COMPLETED|Overall Study||1718
8108491|NCT03102411|19985183|P1|STARTED|Overall Study||1881
8108492|NCT03102190|19985188|P1|NOT COMPLETED|Overall Study||0
8108493|NCT03102190|19985188|P1|COMPLETED|Overall Study||6
8108494|NCT03102190|19985188|P1|STARTED|Overall Study||6
8108495|NCT03102034|19985194|P2|NOT COMPLETED|Overall Study||0
8108496|NCT03102034|19985195|P1|NOT COMPLETED|Overall Study||1
8108497|NCT03102034|19985194|P2|COMPLETED|Overall Study||11
8108498|NCT03102034|19985195|P1|COMPLETED|Overall Study||20
8108499|NCT03102034|19985194|P2|STARTED|Overall Study||11
8108500|NCT03102034|19985195|P1|STARTED|Overall Study||21
8108501|NCT03101592|19985224|P3|NOT COMPLETED|Overall Study||118
8108502|NCT03101592|19985225|P2|NOT COMPLETED|Overall Study||170
8108503|NCT03101592|19985226|P1|NOT COMPLETED|Overall Study||111
8108504|NCT03101592|19985224|P3|COMPLETED|Overall Study||2981
8108505|NCT03101592|19985225|P2|COMPLETED|Overall Study||2726
8108506|NCT03101592|19985226|P1|COMPLETED|Overall Study||3012
8108507|NCT03101592|19985224|P3|STARTED|Overall Study||3099
8108508|NCT03101592|19985225|P2|STARTED|Overall Study||2896
8108509|NCT03101592|19985226|P1|STARTED|Overall Study||3123
8108510|NCT03101462|19985245|P2|NOT COMPLETED|Overall Study||1
8108511|NCT03101462|19985246|P1|NOT COMPLETED|Overall Study||1
8108512|NCT03101462|19985245|P2|COMPLETED|Overall Study||18
8108513|NCT03101462|19985246|P1|COMPLETED|Overall Study||18
8108514|NCT03101462|19985245|P2|STARTED|Overall Study||19
8108515|NCT03101462|19985246|P1|STARTED|Overall Study||19
8108516|NCT03101371|19985262|P2|NOT COMPLETED|Overall Study||6
8108517|NCT03101371|19985263|P1|NOT COMPLETED|Overall Study||3
8108518|NCT03101371|19985262|P2|COMPLETED|Overall Study||45
8108519|NCT03101371|19985263|P1|COMPLETED|Overall Study||45
8108520|NCT03101371|19985262|P2|STARTED|Overall Study||51
8108521|NCT03101371|19985263|P1|STARTED|Overall Study||48
8108540|NCT03101267|19985299|P3|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
8108541|NCT03101267|19985300|P2|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
8108542|NCT03101267|19985301|P1|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
8108543|NCT03101267|19985299|P3|COMPLETED|Pollinosis Symptoms Survey Period||47
8108544|NCT03101267|19985300|P2|COMPLETED|Pollinosis Symptoms Survey Period||48
8108545|NCT03101267|19985301|P1|COMPLETED|Pollinosis Symptoms Survey Period||47
8108546|NCT03101267|19985299|P3|STARTED|Pollinosis Symptoms Survey Period||47
8108547|NCT03101267|19985300|P2|STARTED|Pollinosis Symptoms Survey Period||48
8108548|NCT03101267|19985301|P1|STARTED|Pollinosis Symptoms Survey Period||47
8108549|NCT03101267|19985299|P3|NOT COMPLETED|Primary Study Period||3
8108550|NCT03101267|19985300|P2|NOT COMPLETED|Primary Study Period||2
8108551|NCT03101267|19985301|P1|NOT COMPLETED|Primary Study Period||3
8108552|NCT03101267|19985299|P3|COMPLETED|Primary Study Period||47
8108553|NCT03101267|19985300|P2|COMPLETED|Primary Study Period||48
8108554|NCT03101267|19985301|P1|COMPLETED|Primary Study Period||47
8108555|NCT03101267|19985299|P3|STARTED|Primary Study Period||50
8108556|NCT03101267|19985300|P2|STARTED|Primary Study Period||50
8108557|NCT03101267|19985301|P1|STARTED|Primary Study Period||50
8108558|NCT03101150|19985356|P2|NOT COMPLETED|Overall Study||10
8108559|NCT03101150|19985357|P1|NOT COMPLETED|Overall Study||5
8108560|NCT03101150|19985356|P2|COMPLETED|Overall Study||83
8108561|NCT03101150|19985357|P1|COMPLETED|Overall Study||81
8108562|NCT03101150|19985356|P2|STARTED|Overall Study||93
8108563|NCT03101150|19985357|P1|STARTED|Overall Study||86
8108564|NCT03101033|19985369|P2|NOT COMPLETED|Overall Study||9
8108565|NCT03101033|19985370|P1|NOT COMPLETED|Overall Study||5
8108566|NCT03101033|19985369|P2|COMPLETED|Overall Study||51
8108567|NCT03101033|19985370|P1|COMPLETED|Overall Study||27
8108568|NCT03101033|19985369|P2|STARTED|Overall Study||60
8108569|NCT03101033|19985370|P1|STARTED|Overall Study||32
8108570|NCT03101020|19985392|P2|NOT COMPLETED|Overall Study||3
8108571|NCT03101020|19985393|P1|NOT COMPLETED|Overall Study||1
8108572|NCT03101020|19985392|P2|COMPLETED|Overall Study||7
8108573|NCT03101020|19985393|P1|COMPLETED|Overall Study||9
8108574|NCT03101020|19985392|P2|STARTED|Overall Study||10
8108575|NCT03101020|19985393|P1|STARTED|Overall Study||10
8108576|NCT03100968|19985407|P2|NOT COMPLETED|Overall Study||0
8108577|NCT03100968|19985408|P1|NOT COMPLETED|Overall Study||0
8108578|NCT03100968|19985407|P2|COMPLETED|Overall Study||75
8108579|NCT03100968|19985408|P1|COMPLETED|Overall Study||75
8108580|NCT03100968|19985407|P2|STARTED|Overall Study||75
8108581|NCT03100968|19985408|P1|STARTED|Overall Study||75
8108582|NCT03100942|19985428|P7|NOT COMPLETED|Placebo Arm Re-Randomized||1
8108583|NCT03100942|19985429|P6|NOT COMPLETED|Placebo Arm Re-Randomized||0
8108584|NCT03100942|19985430|P5|NOT COMPLETED|Placebo Arm Re-Randomized||0
8108585|NCT03100942|19985431|P4|NOT COMPLETED|Placebo Arm Re-Randomized||0
8108586|NCT03100942|19985432|P3|NOT COMPLETED|Placebo Arm Re-Randomized||0
8108587|NCT03100942|19985433|P2|NOT COMPLETED|Placebo Arm Re-Randomized||0
8108588|NCT03100942|19985434|P1|NOT COMPLETED|Placebo Arm Re-Randomized||0
8108589|NCT03100942|19985428|P7|COMPLETED|Placebo Arm Re-Randomized||9
8108590|NCT03100942|19985429|P6|COMPLETED|Placebo Arm Re-Randomized||12
8108591|NCT03100942|19985430|P5|COMPLETED|Placebo Arm Re-Randomized||10
8108592|NCT03100942|19985431|P4|COMPLETED|Placebo Arm Re-Randomized||0
8108593|NCT03100942|19985432|P3|COMPLETED|Placebo Arm Re-Randomized||0
8108594|NCT03100942|19985433|P2|COMPLETED|Placebo Arm Re-Randomized||0
8108595|NCT03100942|19985434|P1|COMPLETED|Placebo Arm Re-Randomized||0
8108596|NCT03100942|19985428|P7|STARTED|Placebo Arm Re-Randomized||10
8108597|NCT03100942|19985429|P6|STARTED|Placebo Arm Re-Randomized||12
8108598|NCT03100942|19985430|P5|STARTED|Placebo Arm Re-Randomized||10
8108599|NCT03100942|19985431|P4|STARTED|Placebo Arm Re-Randomized||0
8108600|NCT03100942|19985432|P3|STARTED|Placebo Arm Re-Randomized||0
8108601|NCT03100942|19985433|P2|STARTED|Placebo Arm Re-Randomized||0
8108602|NCT03100942|19985434|P1|STARTED|Placebo Arm Re-Randomized||0
8108603|NCT03100942|19985428|P7|NOT COMPLETED|Randomized Treatment Period||0
8108604|NCT03100942|19985429|P6|NOT COMPLETED|Randomized Treatment Period||0
8108605|NCT03100942|19985430|P5|NOT COMPLETED|Randomized Treatment Period||0
8108606|NCT03100942|19985431|P4|NOT COMPLETED|Randomized Treatment Period||5
8108607|NCT03100942|19985432|P3|NOT COMPLETED|Randomized Treatment Period||6
8108608|NCT03100942|19985433|P2|NOT COMPLETED|Randomized Treatment Period||9
8108609|NCT03100942|19985434|P1|NOT COMPLETED|Randomized Treatment Period||12
8108610|NCT03100942|19985428|P7|COMPLETED|Randomized Treatment Period||0
8108611|NCT03100942|19985429|P6|COMPLETED|Randomized Treatment Period||0
8108612|NCT03100942|19985430|P5|COMPLETED|Randomized Treatment Period||0
8108613|NCT03100942|19985431|P4|COMPLETED|Randomized Treatment Period||32
8108614|NCT03100942|19985432|P3|COMPLETED|Randomized Treatment Period||33
8108615|NCT03100942|19985433|P2|COMPLETED|Randomized Treatment Period||29
8108616|NCT03100942|19985434|P1|COMPLETED|Randomized Treatment Period||26
8108617|NCT03100942|19985428|P7|STARTED|Randomized Treatment Period||0
8108618|NCT03100942|19985429|P6|STARTED|Randomized Treatment Period||0
8108619|NCT03100942|19985430|P5|STARTED|Randomized Treatment Period||0
8108620|NCT03100942|19985431|P4|STARTED|Randomized Treatment Period||37
8108621|NCT03100942|19985432|P3|STARTED|Randomized Treatment Period||39
8108622|NCT03100942|19985433|P2|STARTED|Randomized Treatment Period||38
8108623|NCT03100942|19985434|P1|STARTED|Randomized Treatment Period||38
8108624|NCT03100864|19985463|P1|NOT COMPLETED|Overall Study||0
8108625|NCT03100864|19985463|P1|COMPLETED|Overall Study||8
8108626|NCT03100864|19985463|P1|STARTED|Overall Study||8
8108627|NCT03100838|19985472|P4|NOT COMPLETED|Overall Study||1
8108628|NCT03100838|19985473|P3|NOT COMPLETED|Overall Study||2
8108629|NCT03100838|19985474|P2|NOT COMPLETED|Overall Study||2
8108630|NCT03100838|19985475|P1|NOT COMPLETED|Overall Study||2
8108631|NCT03100838|19985472|P4|COMPLETED|Overall Study||15
8108632|NCT03100838|19985473|P3|COMPLETED|Overall Study||14
8108633|NCT03100838|19985474|P2|COMPLETED|Overall Study||14
8108634|NCT03100838|19985475|P1|COMPLETED|Overall Study||14
8108635|NCT03100838|19985472|P4|STARTED|Overall Study||16
8108636|NCT03100838|19985473|P3|STARTED|Overall Study||16
8108637|NCT03100838|19985474|P2|STARTED|Overall Study||16
8108638|NCT03100838|19985475|P1|STARTED|Overall Study||16
8108639|NCT03100825|19985501|P1|NOT COMPLETED|Overall Study||8
8108640|NCT03100825|19985501|P1|COMPLETED|Overall Study||86
8108641|NCT03100825|19985501|P1|STARTED|Overall Study||94
8108642|NCT03100617|19985511|P1|NOT COMPLETED|Overall Study||0
8108643|NCT03100617|19985511|P1|COMPLETED|Overall Study||6
8108644|NCT03100617|19985511|P1|STARTED|Overall Study||6
8108645|NCT03100500|19985515|P1|NOT COMPLETED|Overall Study||0
8108646|NCT03100500|19985515|P1|COMPLETED|Overall Study||51
8108647|NCT03100500|19985515|P1|STARTED|Overall Study||51
8108648|NCT03100344|19985528|P4|NOT COMPLETED|Overall Study||12
8108649|NCT03100344|19985529|P3|NOT COMPLETED|Overall Study||7
8108650|NCT03100344|19985530|P2|NOT COMPLETED|Overall Study||11
8108651|NCT03100344|19985531|P1|NOT COMPLETED|Overall Study||14
8108652|NCT03100344|19985528|P4|COMPLETED|Overall Study||45
8108653|NCT03100344|19985529|P3|COMPLETED|Overall Study||50
8108654|NCT03100344|19985530|P2|COMPLETED|Overall Study||44
8108655|NCT03100344|19985531|P1|COMPLETED|Overall Study||43
8108656|NCT03100344|19985528|P4|STARTED|Overall Study||57
8108657|NCT03100344|19985529|P3|STARTED|Overall Study||57
8108658|NCT03100344|19985530|P2|STARTED|Overall Study||55
8108659|NCT03100344|19985531|P1|STARTED|Overall Study||57
8108660|NCT03100123|19985611|P2|NOT COMPLETED|Overall Study||0
8108661|NCT03100123|19985612|P1|NOT COMPLETED|Overall Study||0
8108662|NCT03100123|19985611|P2|COMPLETED|Overall Study||1
8108663|NCT03100123|19985612|P1|COMPLETED|Overall Study||0
8108664|NCT03100123|19985611|P2|STARTED|Overall Study||1
8108665|NCT03100123|19985612|P1|STARTED|Overall Study||0
8108666|NCT03100058|19985634|P13|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4
8108667|NCT03100058|19985635|P12|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3
8108668|NCT03100058|19985636|P11|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15
8108669|NCT03100058|19985637|P10|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5
8108670|NCT03100058|19985638|P9|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108671|NCT03100058|19985639|P8|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108672|NCT03100058|19985640|P7|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108673|NCT03100058|19985641|P6|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108674|NCT03100058|19985642|P5|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108675|NCT03100058|19985643|P4|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108676|NCT03100058|19985644|P3|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108677|NCT03100058|19985645|P2|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108678|NCT03100058|19985646|P1|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108679|NCT03100058|19985634|P13|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30
8108680|NCT03100058|19985635|P12|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36
8108681|NCT03100058|19985636|P11|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148
8108682|NCT03100058|19985637|P10|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153
8108683|NCT03100058|19985638|P9|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108684|NCT03100058|19985639|P8|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108685|NCT03100058|19985640|P7|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108686|NCT03100058|19985641|P6|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108687|NCT03100058|19985642|P5|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108688|NCT03100058|19985643|P4|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108689|NCT03100058|19985644|P3|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108690|NCT03100058|19985645|P2|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108691|NCT03100058|19985646|P1|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
8108692|NCT03100058|19985634|P13|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34
8108693|NCT03100058|19985635|P12|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39
8108694|NCT03100058|19985636|P11|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163
8108695|NCT03100058|19985637|P10|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158
8108696|NCT03100058|19985638|P9|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108697|NCT03100058|19985639|P8|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108698|NCT03100058|19985640|P7|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108699|NCT03100058|19985641|P6|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108700|NCT03100058|19985642|P5|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108701|NCT03100058|19985643|P4|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108702|NCT03100058|19985644|P3|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108703|NCT03100058|19985645|P2|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108704|NCT03100058|19985646|P1|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
8108705|NCT03100058|19985634|P13|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108706|NCT03100058|19985635|P12|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108707|NCT03100058|19985636|P11|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108708|NCT03100058|19985637|P10|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108709|NCT03100058|19985638|P9|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5
8108710|NCT03100058|19985639|P8|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16
8108711|NCT03100058|19985640|P7|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8
8108712|NCT03100058|19985641|P6|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
8108713|NCT03100058|19985642|P5|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
8108714|NCT03100058|19985643|P4|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14
8108715|NCT03100058|19985644|P3|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9
8108716|NCT03100058|19985645|P2|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7
8108717|NCT03100058|19985646|P1|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3
8108718|NCT03100058|19985634|P13|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108719|NCT03100058|19985635|P12|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108720|NCT03100058|19985636|P11|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108721|NCT03100058|19985637|P10|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
8108722|NCT03100058|19985638|P9|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73
8108723|NCT03100058|19985639|P8|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60
8108724|NCT03100058|19985640|P7|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30
8108725|NCT03100058|19985641|P6|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37
8108726|NCT03100058|19985642|P5|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36
8108727|NCT03100058|19985643|P4|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63
8108728|NCT03100058|19985644|P3|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29
8108729|NCT03100058|19985645|P2|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31
8108730|NCT03100058|19985646|P1|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35
8108731|NCT03100058|19985634|P13|STARTED|Epoch 3 (24 Weeks of Treatment)||0
8108732|NCT03100058|19985635|P12|STARTED|Epoch 3 (24 Weeks of Treatment)||0
8108733|NCT03100058|19985636|P11|STARTED|Epoch 3 (24 Weeks of Treatment)||0
8108734|NCT03100058|19985637|P10|STARTED|Epoch 3 (24 Weeks of Treatment)||0
8108735|NCT03100058|19985638|P9|STARTED|Epoch 3 (24 Weeks of Treatment)||78
8108736|NCT03100058|19985639|P8|STARTED|Epoch 3 (24 Weeks of Treatment)||76
8108737|NCT03100058|19985640|P7|STARTED|Epoch 3 (24 Weeks of Treatment)||38
8108738|NCT03100058|19985641|P6|STARTED|Epoch 3 (24 Weeks of Treatment)||39
8108739|NCT03100058|19985642|P5|STARTED|Epoch 3 (24 Weeks of Treatment)||38
8108740|NCT03100058|19985643|P4|STARTED|Epoch 3 (24 Weeks of Treatment)||77
8108741|NCT03100058|19985644|P3|STARTED|Epoch 3 (24 Weeks of Treatment)||38
8108742|NCT03100058|19985645|P2|STARTED|Epoch 3 (24 Weeks of Treatment)||38
8108743|NCT03100058|19985646|P1|STARTED|Epoch 3 (24 Weeks of Treatment)||38
8108750|NCT03099655|19985882|P1|NOT COMPLETED|Overall Study||61
8108751|NCT03099655|19985882|P1|COMPLETED|Overall Study|6-Month visit with original 4798 lead implanted|379
8108752|NCT03099655|19985882|P1|STARTED|Overall Study||440
8108753|NCT03099538|19985893|P1|NOT COMPLETED|Overall Study||3
8108754|NCT03099538|19985893|P1|COMPLETED|Overall Study||1
8108755|NCT03099538|19985893|P1|STARTED|Overall Study||4
8108756|NCT03099369|19985905|P2|NOT COMPLETED|Overall Study||4
8108757|NCT03099369|19985906|P1|NOT COMPLETED|Overall Study||6
8108758|NCT03099369|19985905|P2|COMPLETED|Overall Study||5
8108759|NCT03099369|19985906|P1|COMPLETED|Overall Study||5
8108760|NCT03099369|19985905|P2|STARTED|Overall Study||9
8108761|NCT03099369|19985906|P1|STARTED|Overall Study||11
8108762|NCT03099187|19985918|P4|NOT COMPLETED|12-month Safety Follow-up||26
8108763|NCT03099187|19985919|P3|NOT COMPLETED|12-month Safety Follow-up||19
8108764|NCT03099187|19985920|P2|NOT COMPLETED|12-month Safety Follow-up||0
8108765|NCT03099187|19985921|P1|NOT COMPLETED|12-month Safety Follow-up||0
8108766|NCT03099187|19985918|P4|COMPLETED|12-month Safety Follow-up||84
8108767|NCT03099187|19985919|P3|COMPLETED|12-month Safety Follow-up||75
8108768|NCT03099187|19985920|P2|COMPLETED|12-month Safety Follow-up||0
8108769|NCT03099187|19985921|P1|COMPLETED|12-month Safety Follow-up||0
8108770|NCT03099187|19985918|P4|STARTED|12-month Safety Follow-up||110
8108771|NCT03099187|19985919|P3|STARTED|12-month Safety Follow-up||94
8108772|NCT03099187|19985920|P2|STARTED|12-month Safety Follow-up||0
8108773|NCT03099187|19985921|P1|STARTED|12-month Safety Follow-up||0
8108774|NCT03099187|19985918|P4|NOT COMPLETED|Double-blind Treatment||0
8108775|NCT03099187|19985919|P3|NOT COMPLETED|Double-blind Treatment||0
8108776|NCT03099187|19985920|P2|NOT COMPLETED|Double-blind Treatment||16
8108777|NCT03099187|19985921|P1|NOT COMPLETED|Double-blind Treatment||33
8108778|NCT03099187|19985918|P4|COMPLETED|Double-blind Treatment||0
8108779|NCT03099187|19985919|P3|COMPLETED|Double-blind Treatment||0
8108780|NCT03099187|19985920|P2|COMPLETED|Double-blind Treatment||110
8108781|NCT03099187|19985921|P1|COMPLETED|Double-blind Treatment||94
8108782|NCT03099187|19985918|P4|STARTED|Double-blind Treatment||0
8108783|NCT03099187|19985919|P3|STARTED|Double-blind Treatment||0
8108784|NCT03099187|19985920|P2|STARTED|Double-blind Treatment||126
8108785|NCT03099187|19985921|P1|STARTED|Double-blind Treatment||127
8108786|NCT03099161|19985976|P3|NOT COMPLETED|Overall Study||3
8108787|NCT03099161|19985977|P2|NOT COMPLETED|Overall Study||4
8108788|NCT03099161|19985978|P1|NOT COMPLETED|Overall Study||3
8108789|NCT03099161|19985976|P3|COMPLETED|Overall Study||0
8108790|NCT03099161|19985977|P2|COMPLETED|Overall Study||0
8108791|NCT03099161|19985978|P1|COMPLETED|Overall Study||0
8108792|NCT03099161|19985976|P3|STARTED|Overall Study||3
8108793|NCT03099161|19985977|P2|STARTED|Overall Study||4
8108794|NCT03099161|19985978|P1|STARTED|Overall Study||3
8108795|NCT03099096|19985995|P1|NOT COMPLETED|Overall Study||2
8108796|NCT03099096|19985995|P1|COMPLETED|Overall Study||157
8108797|NCT03099096|19985995|P1|STARTED|Overall Study||159
8108798|NCT03098979|19986008|P6|NOT COMPLETED|Overall Study||4
8108799|NCT03098979|19986009|P5|NOT COMPLETED|Overall Study||9
8108800|NCT03098979|19986010|P4|NOT COMPLETED|Overall Study||5
8108801|NCT03098979|19986011|P3|NOT COMPLETED|Overall Study||4
8108802|NCT03098979|19986012|P2|NOT COMPLETED|Overall Study||2
8108803|NCT03098979|19986013|P1|NOT COMPLETED|Overall Study||6
8108804|NCT03098979|19986008|P6|COMPLETED|Overall Study||47
8108805|NCT03098979|19986009|P5|COMPLETED|Overall Study||41
8108806|NCT03098979|19986010|P4|COMPLETED|Overall Study||46
8108807|NCT03098979|19986011|P3|COMPLETED|Overall Study||46
8108808|NCT03098979|19986012|P2|COMPLETED|Overall Study||25
8108809|NCT03098979|19986013|P1|COMPLETED|Overall Study||70
8108810|NCT03098979|19986008|P6|STARTED|Overall Study||51
8108811|NCT03098979|19986009|P5|STARTED|Overall Study||50
8108812|NCT03098979|19986010|P4|STARTED|Overall Study||51
8108813|NCT03098979|19986011|P3|STARTED|Overall Study||50
8108814|NCT03098979|19986012|P2|STARTED|Overall Study||27
8108815|NCT03098979|19986013|P1|STARTED|Overall Study||76
8108816|NCT03098966|19986051|P1|NOT COMPLETED|Overall Study||0
8108817|NCT03098966|19986051|P1|COMPLETED|Overall Study||368
8108818|NCT03098966|19986051|P1|STARTED|Overall Study||368
8108819|NCT03098745|19986057|P6|NOT COMPLETED|Day 3||0
8108820|NCT03098745|19986058|P5|NOT COMPLETED|Day 3||0
8108821|NCT03098745|19986059|P4|NOT COMPLETED|Day 3||0
8108822|NCT03098745|19986060|P3|NOT COMPLETED|Day 3||0
8108823|NCT03098745|19986061|P2|NOT COMPLETED|Day 3||0
8108824|NCT03098745|19986062|P1|NOT COMPLETED|Day 3||0
8108825|NCT03098745|19986057|P6|COMPLETED|Day 3||4
8108826|NCT03098745|19986058|P5|COMPLETED|Day 3||10
8108827|NCT03098745|19986059|P4|COMPLETED|Day 3||8
8108828|NCT03098745|19986060|P3|COMPLETED|Day 3||8
8108829|NCT03098745|19986061|P2|COMPLETED|Day 3||3
8108830|NCT03098745|19986062|P1|COMPLETED|Day 3||7
8108831|NCT03098745|19986057|P6|STARTED|Day 3||4
8108832|NCT03098745|19986058|P5|STARTED|Day 3||10
8108833|NCT03098745|19986059|P4|STARTED|Day 3||8
8108834|NCT03098745|19986060|P3|STARTED|Day 3||8
8108835|NCT03098745|19986061|P2|STARTED|Day 3||3
8108836|NCT03098745|19986062|P1|STARTED|Day 3||7
8108837|NCT03098745|19986057|P6|NOT COMPLETED|Day 2||0
8108838|NCT03098745|19986058|P5|NOT COMPLETED|Day 2||0
8108839|NCT03098745|19986059|P4|NOT COMPLETED|Day 2||0
8108840|NCT03098745|19986060|P3|NOT COMPLETED|Day 2||0
8108841|NCT03098745|19986061|P2|NOT COMPLETED|Day 2||0
8108842|NCT03098745|19986062|P1|NOT COMPLETED|Day 2||0
8108843|NCT03098745|19986057|P6|COMPLETED|Day 2||4
8108844|NCT03098745|19986058|P5|COMPLETED|Day 2||10
8108845|NCT03098745|19986059|P4|COMPLETED|Day 2||8
8108846|NCT03098745|19986060|P3|COMPLETED|Day 2||8
8108847|NCT03098745|19986061|P2|COMPLETED|Day 2||3
8108848|NCT03098745|19986062|P1|COMPLETED|Day 2||7
8108849|NCT03098745|19986057|P6|STARTED|Day 2||4
8108850|NCT03098745|19986058|P5|STARTED|Day 2||10
8108851|NCT03098745|19986059|P4|STARTED|Day 2||8
8108852|NCT03098745|19986060|P3|STARTED|Day 2||8
8108853|NCT03098745|19986061|P2|STARTED|Day 2||3
8108854|NCT03098745|19986062|P1|STARTED|Day 2||7
8108855|NCT03098745|19986057|P6|NOT COMPLETED|Day 1||0
8108856|NCT03098745|19986058|P5|NOT COMPLETED|Day 1||0
8108857|NCT03098745|19986059|P4|NOT COMPLETED|Day 1||0
8108858|NCT03098745|19986060|P3|NOT COMPLETED|Day 1||0
8108859|NCT03098745|19986061|P2|NOT COMPLETED|Day 1||0
8108860|NCT03098745|19986062|P1|NOT COMPLETED|Day 1||0
8108861|NCT03098745|19986057|P6|COMPLETED|Day 1||4
8108862|NCT03098745|19986058|P5|COMPLETED|Day 1||10
8108863|NCT03098745|19986059|P4|COMPLETED|Day 1||8
8108864|NCT03098745|19986060|P3|COMPLETED|Day 1||8
8108865|NCT03098745|19986061|P2|COMPLETED|Day 1||3
8108866|NCT03098745|19986062|P1|COMPLETED|Day 1||7
8108867|NCT03098745|19986057|P6|STARTED|Day 1||4
8108868|NCT03098745|19986058|P5|STARTED|Day 1||10
8108869|NCT03098745|19986059|P4|STARTED|Day 1||8
8108870|NCT03098745|19986060|P3|STARTED|Day 1||8
8108871|NCT03098745|19986061|P2|STARTED|Day 1||3
8108872|NCT03098745|19986062|P1|STARTED|Day 1||7
8108873|NCT03098641|19986098|P1|NOT COMPLETED|Overall Study||52
8108874|NCT03098641|19986098|P1|COMPLETED|Overall Study||220
8108875|NCT03098641|19986098|P1|STARTED|Overall Study||272
8108876|NCT03098615|19986116|P1|NOT COMPLETED|Overall Study||2
8108877|NCT03098615|19986116|P1|COMPLETED|Overall Study||17
8108878|NCT03098615|19986116|P1|STARTED|Overall Study||19
8108879|NCT03098173|19986123|P2|NOT COMPLETED|Overall Study||2
8108880|NCT03098173|19986124|P1|NOT COMPLETED|Overall Study||1
8108881|NCT03098173|19986123|P2|COMPLETED|Overall Study||79
8108882|NCT03098173|19986124|P1|COMPLETED|Overall Study||80
8108883|NCT03098173|19986123|P2|STARTED|Overall Study||81
8108884|NCT03098173|19986124|P1|STARTED|Overall Study||81
8108885|NCT03098030|19986156|P4|NOT COMPLETED|Overall Study||85
8108886|NCT03098030|19986157|P3|NOT COMPLETED|Overall Study||166
8108887|NCT03098030|19986158|P2|NOT COMPLETED|Overall Study||163
8108888|NCT03098030|19986159|P1|NOT COMPLETED|Overall Study||10
8108889|NCT03098030|19986156|P4|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|9
8108890|NCT03098030|19986157|P3|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
8108891|NCT03098030|19986158|P2|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
8108892|NCT03098030|19986159|P1|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|2
8108893|NCT03098030|19986156|P4|STARTED|Overall Study||94
8108894|NCT03098030|19986157|P3|STARTED|Overall Study||190
8108895|NCT03098030|19986158|P2|STARTED|Overall Study||187
8108896|NCT03098030|19986159|P1|STARTED|Overall Study||12
8108897|NCT03097861|19986180|P3|NOT COMPLETED|Overall Study||9
8108898|NCT03097861|19986181|P2|NOT COMPLETED|Overall Study||22
8108899|NCT03097861|19986182|P1|NOT COMPLETED|Overall Study||7
8108900|NCT03097861|19986180|P3|COMPLETED|Overall Study||122
8108901|NCT03097861|19986181|P2|COMPLETED|Overall Study||254
8108902|NCT03097861|19986182|P1|COMPLETED|Overall Study||138
8108903|NCT03097861|19986180|P3|Per-protocol Population (PP)|Overall Study||113
8108904|NCT03097861|19986181|P2|Per-protocol Population (PP)|Overall Study||234
8108905|NCT03097861|19986182|P1|Per-protocol Population (PP)|Overall Study||126
8108906|NCT03097861|19986180|P3|Completers|Overall Study||121
8108907|NCT03097861|19986181|P2|Completers|Overall Study||255
8108908|NCT03097861|19986182|P1|Completers|Overall Study||129
8108909|NCT03097861|19986180|P3|Modified Intent to Treat|Overall Study||130
8108910|NCT03097861|19986181|P2|Modified Intent to Treat|Overall Study||275
8108911|NCT03097861|19986182|P1|Modified Intent to Treat|Overall Study||143
8108912|NCT03097861|19986180|P3|Safety Population|Overall Study||130
8108913|NCT03097861|19986181|P2|Safety Population|Overall Study||275
8108914|NCT03097861|19986182|P1|Safety Population|Overall Study||143
8108915|NCT03097861|19986180|P3|STARTED|Overall Study||131
8108916|NCT03097861|19986181|P2|STARTED|Overall Study||276
8108917|NCT03097861|19986182|P1|STARTED|Overall Study||145
8108918|NCT03097614|19986199|P1|NOT COMPLETED|Overall Study||3
8108919|NCT03097614|19986199|P1|COMPLETED|Overall Study||54
8108920|NCT03097614|19986199|P1|STARTED|Overall Study||57
8108921|NCT03097484|19986205|P2|NOT COMPLETED|Overall Study||0
8108922|NCT03097484|19986206|P1|NOT COMPLETED|Overall Study||0
8108923|NCT03097484|19986205|P2|COMPLETED|Overall Study||19
8108924|NCT03097484|19986206|P1|COMPLETED|Overall Study||19
8108925|NCT03097484|19986205|P2|STARTED|Overall Study||19
8108926|NCT03097484|19986206|P1|STARTED|Overall Study||19
8108927|NCT03097341|19986219|P5|NOT COMPLETED|Overall Study||0
8108928|NCT03097341|19986220|P4|NOT COMPLETED|Overall Study||0
8108929|NCT03097341|19986221|P3|NOT COMPLETED|Overall Study||0
8108930|NCT03097341|19986222|P2|NOT COMPLETED|Overall Study||0
8108931|NCT03097341|19986223|P1|NOT COMPLETED|Overall Study||0
8108932|NCT03097341|19986219|P5|COMPLETED|Overall Study||5
8108933|NCT03097341|19986220|P4|COMPLETED|Overall Study||4
8108934|NCT03097341|19986221|P3|COMPLETED|Overall Study||4
8108935|NCT03097341|19986222|P2|COMPLETED|Overall Study||4
8108936|NCT03097341|19986223|P1|COMPLETED|Overall Study||4
8108937|NCT03097341|19986219|P5|STARTED|Overall Study||5
8108938|NCT03097341|19986220|P4|STARTED|Overall Study||4
8108939|NCT03097341|19986221|P3|STARTED|Overall Study||4
8108940|NCT03097341|19986222|P2|STARTED|Overall Study||4
8108941|NCT03097341|19986223|P1|STARTED|Overall Study||4
8108942|NCT03097289|19986301|P1|NOT COMPLETED|Overall Study||6
8108943|NCT03097289|19986301|P1|COMPLETED|Overall Study||26
8108944|NCT03097289|19986301|P1|STARTED|Overall Study||32
8108953|NCT03097029|19986361|P1|NOT COMPLETED|Overall Study||1
8108954|NCT03097029|19986361|P1|COMPLETED|Overall Study||14
8108955|NCT03097029|19986361|P1|STARTED|Overall Study||15
8108956|NCT03096873|19986368|P2|NOT COMPLETED|Overall Study||0
8108957|NCT03096873|19986369|P1|NOT COMPLETED|Overall Study||0
8108958|NCT03096873|19986368|P2|COMPLETED|Overall Study||20
8108959|NCT03096873|19986369|P1|COMPLETED|Overall Study||20
8108960|NCT03096873|19986368|P2|STARTED|Overall Study||20
8108961|NCT03096873|19986369|P1|STARTED|Overall Study||20
8108962|NCT03096483|19986405|P1|NOT COMPLETED|Overall Study||1
8108963|NCT03096483|19986405|P1|COMPLETED|Overall Study||11
8108964|NCT03096483|19986405|P1|STARTED|Overall Study||12
8108965|NCT03096444|19986410|P1|NOT COMPLETED|Overall Study||0
8108966|NCT03096444|19986410|P1|COMPLETED|Overall Study||13
8108967|NCT03096444|19986410|P1|STARTED|Overall Study||13
8108968|NCT03096314|19986434|P2|NOT COMPLETED|Confirmed Vitamin D Deficient||12
8108969|NCT03096314|19986435|P1|NOT COMPLETED|Confirmed Vitamin D Deficient||7
8108970|NCT03096314|19986434|P2|COMPLETED|Confirmed Vitamin D Deficient||528
8108971|NCT03096314|19986435|P1|COMPLETED|Confirmed Vitamin D Deficient||531
8108972|NCT03096314|19986434|P2|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|540
8108973|NCT03096314|19986435|P1|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|538
8108974|NCT03096314|19986434|P2|NOT COMPLETED|Screened Vitamin D Deficient||12
8108975|NCT03096314|19986435|P1|NOT COMPLETED|Screened Vitamin D Deficient||9
8108976|NCT03096314|19986434|P2|COMPLETED|Screened Vitamin D Deficient||656
8108977|NCT03096314|19986435|P1|COMPLETED|Screened Vitamin D Deficient||681
8108978|NCT03096314|19986434|P2|STARTED|Screened Vitamin D Deficient|2 randomized but not included in analysis; 1 treated but inadequate consent and 1 withdrew.|668
8108979|NCT03096314|19986435|P1|STARTED|Screened Vitamin D Deficient||690
8108983|NCT03095651|19986497|P8|NOT COMPLETED|Overall Study||0
8108984|NCT03095651|19986498|P7|NOT COMPLETED|Overall Study||0
8108985|NCT03095651|19986499|P6|NOT COMPLETED|Overall Study||1
8108986|NCT03095651|19986500|P5|NOT COMPLETED|Overall Study||0
8108987|NCT03095651|19986501|P4|NOT COMPLETED|Overall Study||1
8108988|NCT03095651|19986502|P3|NOT COMPLETED|Overall Study||0
8108989|NCT03095651|19986503|P2|NOT COMPLETED|Overall Study||1
8108990|NCT03095651|19986504|P1|NOT COMPLETED|Overall Study||1
8108991|NCT03095651|19986497|P8|COMPLETED|Overall Study||4
8108992|NCT03095651|19986498|P7|COMPLETED|Overall Study||6
8108993|NCT03095651|19986499|P6|COMPLETED|Overall Study||6
8108994|NCT03095651|19986500|P5|COMPLETED|Overall Study||0
8108995|NCT03095651|19986501|P4|COMPLETED|Overall Study||3
8108996|NCT03095651|19986502|P3|COMPLETED|Overall Study||0
8108997|NCT03095651|19986503|P2|COMPLETED|Overall Study||5
8108998|NCT03095651|19986504|P1|COMPLETED|Overall Study||5
8108999|NCT03095651|19986497|P8|STARTED|Overall Study||4
8109000|NCT03095651|19986498|P7|STARTED|Overall Study||6
8109001|NCT03095651|19986499|P6|STARTED|Overall Study||7
8109002|NCT03095651|19986500|P5|STARTED|Overall Study||0
8109003|NCT03095651|19986501|P4|STARTED|Overall Study||4
8109004|NCT03095651|19986502|P3|STARTED|Overall Study||0
8109005|NCT03095651|19986503|P2|STARTED|Overall Study||6
8109006|NCT03095651|19986504|P1|STARTED|Overall Study||6
8109007|NCT03095638|19986628|P8|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109008|NCT03095638|19986629|P7|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109009|NCT03095638|19986630|P6|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109010|NCT03095638|19986631|P5|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109011|NCT03095638|19986632|P4|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109012|NCT03095638|19986633|P3|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109013|NCT03095638|19986634|P2|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109014|NCT03095638|19986635|P1|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109015|NCT03095638|19986628|P8|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
8109016|NCT03095638|19986629|P7|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
8109017|NCT03095638|19986630|P6|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
8109018|NCT03095638|19986631|P5|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
8109019|NCT03095638|19986632|P4|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
8109020|NCT03095638|19986633|P3|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
8109021|NCT03095638|19986634|P2|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109022|NCT03095638|19986635|P1|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
8109023|NCT03095638|19986628|P8|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
8109024|NCT03095638|19986629|P7|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
8109025|NCT03095638|19986630|P6|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
8109026|NCT03095638|19986631|P5|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
8109027|NCT03095638|19986632|P4|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
8109028|NCT03095638|19986633|P3|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
8109029|NCT03095638|19986634|P2|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
8109030|NCT03095638|19986635|P1|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
8109031|NCT03095638|19986628|P8|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109032|NCT03095638|19986629|P7|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109033|NCT03095638|19986630|P6|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109034|NCT03095638|19986631|P5|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109035|NCT03095638|19986632|P4|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109036|NCT03095638|19986633|P3|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109037|NCT03095638|19986634|P2|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109038|NCT03095638|19986635|P1|NOT COMPLETED|P2: Period 3 (4 Days)||0
8109039|NCT03095638|19986628|P8|COMPLETED|P2: Period 3 (4 Days)||4
8109040|NCT03095638|19986629|P7|COMPLETED|P2: Period 3 (4 Days)||4
8109041|NCT03095638|19986630|P6|COMPLETED|P2: Period 3 (4 Days)||4
8109042|NCT03095638|19986631|P5|COMPLETED|P2: Period 3 (4 Days)||4
8109043|NCT03095638|19986632|P4|COMPLETED|P2: Period 3 (4 Days)||4
8109044|NCT03095638|19986633|P3|COMPLETED|P2: Period 3 (4 Days)||4
8109045|NCT03095638|19986634|P2|COMPLETED|P2: Period 3 (4 Days)||0
8109046|NCT03095638|19986635|P1|COMPLETED|P2: Period 3 (4 Days)||0
8109047|NCT03095638|19986628|P8|STARTED|P2: Period 3 (4 Days)||4
8109048|NCT03095638|19986629|P7|STARTED|P2: Period 3 (4 Days)||4
8109049|NCT03095638|19986630|P6|STARTED|P2: Period 3 (4 Days)||4
8109050|NCT03095638|19986631|P5|STARTED|P2: Period 3 (4 Days)||4
8109051|NCT03095638|19986632|P4|STARTED|P2: Period 3 (4 Days)||4
8109052|NCT03095638|19986633|P3|STARTED|P2: Period 3 (4 Days)||4
8109053|NCT03095638|19986634|P2|STARTED|P2: Period 3 (4 Days)||0
8109054|NCT03095638|19986635|P1|STARTED|P2: Period 3 (4 Days)||0
8109055|NCT03095638|19986628|P8|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109056|NCT03095638|19986629|P7|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109057|NCT03095638|19986630|P6|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109058|NCT03095638|19986631|P5|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109059|NCT03095638|19986632|P4|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109060|NCT03095638|19986633|P3|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109061|NCT03095638|19986634|P2|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109062|NCT03095638|19986635|P1|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109063|NCT03095638|19986628|P8|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
8109064|NCT03095638|19986629|P7|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
8109065|NCT03095638|19986630|P6|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
8109066|NCT03095638|19986631|P5|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
8109067|NCT03095638|19986632|P4|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
8109068|NCT03095638|19986633|P3|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
8109069|NCT03095638|19986634|P2|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109070|NCT03095638|19986635|P1|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
8109071|NCT03095638|19986628|P8|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
8109072|NCT03095638|19986629|P7|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
8109073|NCT03095638|19986630|P6|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
8109074|NCT03095638|19986631|P5|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
8109075|NCT03095638|19986632|P4|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
8109076|NCT03095638|19986633|P3|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
8109077|NCT03095638|19986634|P2|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
8109078|NCT03095638|19986635|P1|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
8109079|NCT03095638|19986628|P8|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109080|NCT03095638|19986629|P7|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109081|NCT03095638|19986630|P6|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109082|NCT03095638|19986631|P5|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109083|NCT03095638|19986632|P4|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109084|NCT03095638|19986633|P3|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109085|NCT03095638|19986634|P2|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109086|NCT03095638|19986635|P1|NOT COMPLETED|P2: Period 2 (4 Days)||0
8109087|NCT03095638|19986628|P8|COMPLETED|P2: Period 2 (4 Days)||4
8109088|NCT03095638|19986629|P7|COMPLETED|P2: Period 2 (4 Days)||4
8109089|NCT03095638|19986630|P6|COMPLETED|P2: Period 2 (4 Days)||4
8109090|NCT03095638|19986631|P5|COMPLETED|P2: Period 2 (4 Days)||4
8109091|NCT03095638|19986632|P4|COMPLETED|P2: Period 2 (4 Days)||4
8109092|NCT03095638|19986633|P3|COMPLETED|P2: Period 2 (4 Days)||4
8109093|NCT03095638|19986634|P2|COMPLETED|P2: Period 2 (4 Days)||0
8109094|NCT03095638|19986635|P1|COMPLETED|P2: Period 2 (4 Days)||0
8109095|NCT03095638|19986628|P8|STARTED|P2: Period 2 (4 Days)||4
8109096|NCT03095638|19986629|P7|STARTED|P2: Period 2 (4 Days)||4
8109097|NCT03095638|19986630|P6|STARTED|P2: Period 2 (4 Days)||4
8109098|NCT03095638|19986631|P5|STARTED|P2: Period 2 (4 Days)||4
8109099|NCT03095638|19986632|P4|STARTED|P2: Period 2 (4 Days)||4
8109100|NCT03095638|19986633|P3|STARTED|P2: Period 2 (4 Days)||4
8109101|NCT03095638|19986634|P2|STARTED|P2: Period 2 (4 Days)||0
8109102|NCT03095638|19986635|P1|STARTED|P2: Period 2 (4 Days)||0
8109103|NCT03095638|19986628|P8|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109104|NCT03095638|19986629|P7|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109105|NCT03095638|19986630|P6|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109106|NCT03095638|19986631|P5|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109107|NCT03095638|19986632|P4|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109108|NCT03095638|19986633|P3|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109109|NCT03095638|19986634|P2|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109110|NCT03095638|19986635|P1|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109111|NCT03095638|19986628|P8|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
8109112|NCT03095638|19986629|P7|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
8109113|NCT03095638|19986630|P6|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
8109114|NCT03095638|19986631|P5|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
8109115|NCT03095638|19986632|P4|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
8109116|NCT03095638|19986633|P3|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
8109117|NCT03095638|19986634|P2|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109118|NCT03095638|19986635|P1|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
8109119|NCT03095638|19986628|P8|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
8109120|NCT03095638|19986629|P7|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
8109121|NCT03095638|19986630|P6|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
8109122|NCT03095638|19986631|P5|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
8109123|NCT03095638|19986632|P4|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
8109124|NCT03095638|19986633|P3|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
8109125|NCT03095638|19986634|P2|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
8109126|NCT03095638|19986635|P1|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
8109127|NCT03095638|19986628|P8|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109128|NCT03095638|19986629|P7|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109129|NCT03095638|19986630|P6|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109130|NCT03095638|19986631|P5|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109131|NCT03095638|19986632|P4|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109132|NCT03095638|19986633|P3|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109133|NCT03095638|19986634|P2|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109134|NCT03095638|19986635|P1|NOT COMPLETED|P2: Period 1 (4 Days)||0
8109135|NCT03095638|19986628|P8|COMPLETED|P2: Period 1 (4 Days)||4
8109136|NCT03095638|19986629|P7|COMPLETED|P2: Period 1 (4 Days)||4
8109137|NCT03095638|19986630|P6|COMPLETED|P2: Period 1 (4 Days)||4
8109138|NCT03095638|19986631|P5|COMPLETED|P2: Period 1 (4 Days)||4
8109139|NCT03095638|19986632|P4|COMPLETED|P2: Period 1 (4 Days)||4
8109140|NCT03095638|19986633|P3|COMPLETED|P2: Period 1 (4 Days)||4
8109141|NCT03095638|19986634|P2|COMPLETED|P2: Period 1 (4 Days)||0
8109142|NCT03095638|19986635|P1|COMPLETED|P2: Period 1 (4 Days)||0
8109143|NCT03095638|19986628|P8|STARTED|P2: Period 1 (4 Days)||4
8109144|NCT03095638|19986629|P7|STARTED|P2: Period 1 (4 Days)||4
8109145|NCT03095638|19986630|P6|STARTED|P2: Period 1 (4 Days)||4
8109146|NCT03095638|19986631|P5|STARTED|P2: Period 1 (4 Days)||4
8109147|NCT03095638|19986632|P4|STARTED|P2: Period 1 (4 Days)||4
8109148|NCT03095638|19986633|P3|STARTED|P2: Period 1 (4 Days)||4
8109149|NCT03095638|19986634|P2|STARTED|P2: Period 1 (4 Days)||0
8109150|NCT03095638|19986635|P1|STARTED|P2: Period 1 (4 Days)||0
8109151|NCT03095638|19986628|P8|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109152|NCT03095638|19986629|P7|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109153|NCT03095638|19986630|P6|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109154|NCT03095638|19986631|P5|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109155|NCT03095638|19986632|P4|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109156|NCT03095638|19986633|P3|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109157|NCT03095638|19986634|P2|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109158|NCT03095638|19986635|P1|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109159|NCT03095638|19986628|P8|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109160|NCT03095638|19986629|P7|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109161|NCT03095638|19986630|P6|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109162|NCT03095638|19986631|P5|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109163|NCT03095638|19986632|P4|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109164|NCT03095638|19986633|P3|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
8109165|NCT03095638|19986634|P2|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
8109166|NCT03095638|19986635|P1|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
8109167|NCT03095638|19986628|P8|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
8109168|NCT03095638|19986629|P7|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
8109169|NCT03095638|19986630|P6|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
8109170|NCT03095638|19986631|P5|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
8109171|NCT03095638|19986632|P4|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
8109172|NCT03095638|19986633|P3|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
8109173|NCT03095638|19986634|P2|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
8109174|NCT03095638|19986635|P1|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
8109175|NCT03095638|19986628|P8|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109176|NCT03095638|19986629|P7|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109177|NCT03095638|19986630|P6|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109178|NCT03095638|19986631|P5|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109179|NCT03095638|19986632|P4|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109180|NCT03095638|19986633|P3|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109181|NCT03095638|19986634|P2|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109182|NCT03095638|19986635|P1|NOT COMPLETED|P1: Period 2 (4 Days)||0
8109183|NCT03095638|19986628|P8|COMPLETED|P1: Period 2 (4 Days)||0
8109184|NCT03095638|19986629|P7|COMPLETED|P1: Period 2 (4 Days)||0
8109185|NCT03095638|19986630|P6|COMPLETED|P1: Period 2 (4 Days)||0
8109186|NCT03095638|19986631|P5|COMPLETED|P1: Period 2 (4 Days)||0
8109187|NCT03095638|19986632|P4|COMPLETED|P1: Period 2 (4 Days)||0
8109188|NCT03095638|19986633|P3|COMPLETED|P1: Period 2 (4 Days)||0
8109189|NCT03095638|19986634|P2|COMPLETED|P1: Period 2 (4 Days)||7
8109190|NCT03095638|19986635|P1|COMPLETED|P1: Period 2 (4 Days)||7
8109191|NCT03095638|19986628|P8|STARTED|P1: Period 2 (4 Days)||0
8109192|NCT03095638|19986629|P7|STARTED|P1: Period 2 (4 Days)||0
8109193|NCT03095638|19986630|P6|STARTED|P1: Period 2 (4 Days)||0
8109194|NCT03095638|19986631|P5|STARTED|P1: Period 2 (4 Days)||0
8109195|NCT03095638|19986632|P4|STARTED|P1: Period 2 (4 Days)||0
8109196|NCT03095638|19986633|P3|STARTED|P1: Period 2 (4 Days)||0
8109197|NCT03095638|19986634|P2|STARTED|P1: Period 2 (4 Days)||7
8109198|NCT03095638|19986635|P1|STARTED|P1: Period 2 (4 Days)||7
8109199|NCT03095638|19986628|P8|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109200|NCT03095638|19986629|P7|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109201|NCT03095638|19986630|P6|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109202|NCT03095638|19986631|P5|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109203|NCT03095638|19986632|P4|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109204|NCT03095638|19986633|P3|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109205|NCT03095638|19986634|P2|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109206|NCT03095638|19986635|P1|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109207|NCT03095638|19986628|P8|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109208|NCT03095638|19986629|P7|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109209|NCT03095638|19986630|P6|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109210|NCT03095638|19986631|P5|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109211|NCT03095638|19986632|P4|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109212|NCT03095638|19986633|P3|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
8109213|NCT03095638|19986634|P2|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
8109214|NCT03095638|19986635|P1|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
8109215|NCT03095638|19986628|P8|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
8109216|NCT03095638|19986629|P7|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
8109217|NCT03095638|19986630|P6|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
8109218|NCT03095638|19986631|P5|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
8109219|NCT03095638|19986632|P4|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
8109220|NCT03095638|19986633|P3|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
8109221|NCT03095638|19986634|P2|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
8109222|NCT03095638|19986635|P1|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
8109223|NCT03095638|19986628|P8|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109224|NCT03095638|19986629|P7|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109225|NCT03095638|19986630|P6|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109226|NCT03095638|19986631|P5|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109227|NCT03095638|19986632|P4|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109228|NCT03095638|19986633|P3|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109229|NCT03095638|19986634|P2|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109230|NCT03095638|19986635|P1|NOT COMPLETED|P1: Period 1 (4 Days)||0
8109231|NCT03095638|19986628|P8|COMPLETED|P1: Period 1 (4 Days)||0
8109232|NCT03095638|19986629|P7|COMPLETED|P1: Period 1 (4 Days)||0
8109233|NCT03095638|19986630|P6|COMPLETED|P1: Period 1 (4 Days)||0
8109234|NCT03095638|19986631|P5|COMPLETED|P1: Period 1 (4 Days)||0
8109235|NCT03095638|19986632|P4|COMPLETED|P1: Period 1 (4 Days)||0
8109236|NCT03095638|19986633|P3|COMPLETED|P1: Period 1 (4 Days)||0
8109237|NCT03095638|19986634|P2|COMPLETED|P1: Period 1 (4 Days)||7
8109238|NCT03095638|19986635|P1|COMPLETED|P1: Period 1 (4 Days)||7
8109239|NCT03095638|19986628|P8|STARTED|P1: Period 1 (4 Days)||0
8109240|NCT03095638|19986629|P7|STARTED|P1: Period 1 (4 Days)||0
8109241|NCT03095638|19986630|P6|STARTED|P1: Period 1 (4 Days)||0
8109242|NCT03095638|19986631|P5|STARTED|P1: Period 1 (4 Days)||0
8109243|NCT03095638|19986632|P4|STARTED|P1: Period 1 (4 Days)||0
8109244|NCT03095638|19986633|P3|STARTED|P1: Period 1 (4 Days)||0
8109245|NCT03095638|19986634|P2|STARTED|P1: Period 1 (4 Days)||7
8109246|NCT03095638|19986635|P1|STARTED|P1: Period 1 (4 Days)||7
8109247|NCT03095599|19986783|P2|NOT COMPLETED|Overall Study||0
8109248|NCT03095599|19986784|P1|NOT COMPLETED|Overall Study||3
8109249|NCT03095599|19986783|P2|COMPLETED|Overall Study||148
8109250|NCT03095599|19986784|P1|COMPLETED|Overall Study||738
8109251|NCT03095599|19986783|P2|Vaccinated|Overall Study||148
8109252|NCT03095599|19986784|P1|Vaccinated|Overall Study||740
8109253|NCT03095599|19986783|P2|Withdrawal Before Vaccination|Overall Study||0
8109254|NCT03095599|19986784|P1|Withdrawal Before Vaccination|Overall Study||1
8109255|NCT03095599|19986783|P2|STARTED|Overall Study||148
8109256|NCT03095599|19986784|P1|STARTED|Overall Study||741
8109257|NCT03095521|19986820|P2|NOT COMPLETED|Overall Study||2
8109258|NCT03095521|19986821|P1|NOT COMPLETED|Overall Study||0
8109259|NCT03095521|19986820|P2|COMPLETED|Overall Study||111
8109260|NCT03095521|19986821|P1|COMPLETED|Overall Study||115
8109261|NCT03095521|19986820|P2|Safety Population|Overall Study||113
8109262|NCT03095521|19986821|P1|Safety Population|Overall Study||115
8109263|NCT03095521|19986820|P2|Per Protocol Population PP|Overall Study||107
8109264|NCT03095521|19986821|P1|Per Protocol Population PP|Overall Study||113
8109265|NCT03095521|19986820|P2|Intent to Treat Population ITT|Overall Study||113
8109266|NCT03095521|19986821|P1|Intent to Treat Population ITT|Overall Study||115
8109267|NCT03095521|19986820|P2|STARTED|Overall Study||113
8109268|NCT03095521|19986821|P1|STARTED|Overall Study||115
8109269|NCT03095508|19986839|P2|NOT COMPLETED|Overall Study||1
8109270|NCT03095508|19986840|P1|NOT COMPLETED|Overall Study||0
8109271|NCT03095508|19986839|P2|COMPLETED|Overall Study||114
8109272|NCT03095508|19986840|P1|COMPLETED|Overall Study||114
8109273|NCT03095508|19986839|P2|ITT Population|Overall Study||115
8109274|NCT03095508|19986840|P1|ITT Population|Overall Study||114
8109275|NCT03095508|19986839|P2|Safety Population|Overall Study||115
8109276|NCT03095508|19986840|P1|Safety Population|Overall Study||114
8109277|NCT03095508|19986839|P2|Per Protocol Population|Overall Study||111
8109278|NCT03095508|19986840|P1|Per Protocol Population|Overall Study||112
8109279|NCT03095508|19986839|P2|STARTED|Overall Study||115
8109280|NCT03095508|19986840|P1|STARTED|Overall Study||114
8109287|NCT03095053|19986877|P2|NOT COMPLETED|Overall Study||0
8109288|NCT03095053|19986878|P1|NOT COMPLETED|Overall Study||29
8109289|NCT03095053|19986877|P2|COMPLETED|Overall Study||111
8109290|NCT03095053|19986878|P1|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80
8109291|NCT03095053|19986877|P2|STARTED|Overall Study|All blastocysts scored morphologically|111
8109292|NCT03095053|19986878|P1|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109
8109293|NCT03095027|19986888|P2|NOT COMPLETED|Period 2, Second Week of Wear||0
8109294|NCT03095027|19986889|P1|NOT COMPLETED|Period 2, Second Week of Wear||1
8109295|NCT03095027|19986888|P2|COMPLETED|Period 2, Second Week of Wear||24
8109296|NCT03095027|19986889|P1|COMPLETED|Period 2, Second Week of Wear||26
8109297|NCT03095027|19986888|P2|STARTED|Period 2, Second Week of Wear||24
8109298|NCT03095027|19986889|P1|STARTED|Period 2, Second Week of Wear||27
8109299|NCT03095027|19986888|P2|NOT COMPLETED|Period 1, First Week of Wear||0
8109300|NCT03095027|19986889|P1|NOT COMPLETED|Period 1, First Week of Wear||0
8109301|NCT03095027|19986888|P2|COMPLETED|Period 1, First Week of Wear||24
8109302|NCT03095027|19986889|P1|COMPLETED|Period 1, First Week of Wear||27
8109303|NCT03095027|19986888|P2|STARTED|Period 1, First Week of Wear||24
8109304|NCT03095027|19986889|P1|STARTED|Period 1, First Week of Wear||27
8109305|NCT03094806|19986897|P2|NOT COMPLETED|Overall Study||0
8109306|NCT03094806|19986898|P1|NOT COMPLETED|Overall Study||0
8109307|NCT03094806|19986897|P2|COMPLETED|Overall Study||47
8109308|NCT03094806|19986898|P1|COMPLETED|Overall Study||44
8109309|NCT03094806|19986897|P2|STARTED|Overall Study||47
8109310|NCT03094806|19986898|P1|STARTED|Overall Study||44
8109311|NCT03094325|19986916|P1|NOT COMPLETED|Overall Study||0
8109312|NCT03094325|19986916|P1|COMPLETED|Overall Study||10
8109313|NCT03094325|19986916|P1|OPIE After Cardiopulmonary Bypass|Overall Study||10
8109314|NCT03094325|19986916|P1|TEE After Cardiopulmonary Bypass|Overall Study||10
8109315|NCT03094325|19986916|P1|OPIE Before Cardiopulmonary Bypass|Overall Study||10
8109316|NCT03094325|19986916|P1|TEE Before Cardiopulmonary Bypass|Overall Study||10
8109317|NCT03094325|19986916|P1|STARTED|Overall Study||10
8109318|NCT03094195|19986925|P8|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109319|NCT03094195|19986926|P7|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109320|NCT03094195|19986927|P6|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109321|NCT03094195|19986928|P5|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109322|NCT03094195|19986929|P4|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109323|NCT03094195|19986930|P3|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109324|NCT03094195|19986931|P2|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109325|NCT03094195|19986932|P1|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
8109326|NCT03094195|19986925|P8|COMPLETED|Treatment Withdrawal Period (TW)||26
8109327|NCT03094195|19986926|P7|COMPLETED|Treatment Withdrawal Period (TW)||13
8109328|NCT03094195|19986927|P6|COMPLETED|Treatment Withdrawal Period (TW)||15
8109329|NCT03094195|19986928|P5|COMPLETED|Treatment Withdrawal Period (TW)||13
8109330|NCT03094195|19986929|P4|COMPLETED|Treatment Withdrawal Period (TW)||13
8109331|NCT03094195|19986930|P3|COMPLETED|Treatment Withdrawal Period (TW)||0
8109332|NCT03094195|19986931|P2|COMPLETED|Treatment Withdrawal Period (TW)||0
8109333|NCT03094195|19986932|P1|COMPLETED|Treatment Withdrawal Period (TW)||0
8109334|NCT03094195|19986925|P8|STARTED|Treatment Withdrawal Period (TW)||26
8109335|NCT03094195|19986926|P7|STARTED|Treatment Withdrawal Period (TW)||13
8109336|NCT03094195|19986927|P6|STARTED|Treatment Withdrawal Period (TW)||15
8109337|NCT03094195|19986928|P5|STARTED|Treatment Withdrawal Period (TW)||13
8109338|NCT03094195|19986929|P4|STARTED|Treatment Withdrawal Period (TW)||13
8109339|NCT03094195|19986930|P3|STARTED|Treatment Withdrawal Period (TW)||0
8109340|NCT03094195|19986931|P2|STARTED|Treatment Withdrawal Period (TW)||0
8109341|NCT03094195|19986932|P1|STARTED|Treatment Withdrawal Period (TW)||0
8109342|NCT03094195|19986925|P8|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8109343|NCT03094195|19986926|P7|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8109344|NCT03094195|19986927|P6|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8109345|NCT03094195|19986928|P5|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8109346|NCT03094195|19986929|P4|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
8109347|NCT03094195|19986930|P3|NOT COMPLETED|Double-Blind Treatment Period (DB)||14
8109348|NCT03094195|19986931|P2|NOT COMPLETED|Double-Blind Treatment Period (DB)||13
8109349|NCT03094195|19986932|P1|NOT COMPLETED|Double-Blind Treatment Period (DB)||15
8109350|NCT03094195|19986925|P8|COMPLETED|Double-Blind Treatment Period (DB)||0
8109351|NCT03094195|19986926|P7|COMPLETED|Double-Blind Treatment Period (DB)||0
8109352|NCT03094195|19986927|P6|COMPLETED|Double-Blind Treatment Period (DB)||0
8109353|NCT03094195|19986928|P5|COMPLETED|Double-Blind Treatment Period (DB)||0
8109354|NCT03094195|19986929|P4|COMPLETED|Double-Blind Treatment Period (DB)||0
8109355|NCT03094195|19986930|P3|COMPLETED|Double-Blind Treatment Period (DB)||29
8109356|NCT03094195|19986931|P2|COMPLETED|Double-Blind Treatment Period (DB)||30
8109357|NCT03094195|19986932|P1|COMPLETED|Double-Blind Treatment Period (DB)||28
8109358|NCT03094195|19986925|P8|STARTED|Double-Blind Treatment Period (DB)||0
8109359|NCT03094195|19986926|P7|STARTED|Double-Blind Treatment Period (DB)||0
8109360|NCT03094195|19986927|P6|STARTED|Double-Blind Treatment Period (DB)||0
8109361|NCT03094195|19986928|P5|STARTED|Double-Blind Treatment Period (DB)||0
8109362|NCT03094195|19986929|P4|STARTED|Double-Blind Treatment Period (DB)||0
8109363|NCT03094195|19986930|P3|STARTED|Double-Blind Treatment Period (DB)||43
8109364|NCT03094195|19986931|P2|STARTED|Double-Blind Treatment Period (DB)||43
8109365|NCT03094195|19986932|P1|STARTED|Double-Blind Treatment Period (DB)||43
8109384|NCT03093415|19986990|P3|NOT COMPLETED|Enrollment to SVR12 Results||3
8109385|NCT03093415|19986991|P2|NOT COMPLETED|Enrollment to SVR12 Results||8
8109386|NCT03093415|19986992|P1|NOT COMPLETED|Enrollment to SVR12 Results||1
8109387|NCT03093415|19986990|P3|COMPLETED|Enrollment to SVR12 Results||47
8109388|NCT03093415|19986991|P2|COMPLETED|Enrollment to SVR12 Results||17
8109389|NCT03093415|19986992|P1|COMPLETED|Enrollment to SVR12 Results||24
8109390|NCT03093415|19986990|P3|STARTED|Enrollment to SVR12 Results|Prespecified 50 participants enrolled.|50
8109391|NCT03093415|19986991|P2|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
8109392|NCT03093415|19986992|P1|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
8109393|NCT03093415|19986990|P3|NOT COMPLETED|Assessed for Eligibility --> Enrollment||0
8109394|NCT03093415|19986991|P2|NOT COMPLETED|Assessed for Eligibility --> Enrollment||110
8109395|NCT03093415|19986992|P1|NOT COMPLETED|Assessed for Eligibility --> Enrollment||140
8109396|NCT03093415|19986990|P3|COMPLETED|Assessed for Eligibility --> Enrollment||50
8109397|NCT03093415|19986991|P2|COMPLETED|Assessed for Eligibility --> Enrollment||25
8109398|NCT03093415|19986992|P1|COMPLETED|Assessed for Eligibility --> Enrollment||25
8109399|NCT03093415|19986990|P3|STARTED|Assessed for Eligibility --> Enrollment||50
8109400|NCT03093415|19986991|P2|STARTED|Assessed for Eligibility --> Enrollment||135
8109401|NCT03093415|19986992|P1|STARTED|Assessed for Eligibility --> Enrollment||165
8109406|NCT03093324|19987023|P2|NOT COMPLETED|Overall Study||19
8109407|NCT03093324|19987024|P1|NOT COMPLETED|Overall Study||9
8109408|NCT03093324|19987023|P2|COMPLETED|Overall Study||233
8109409|NCT03093324|19987024|P1|COMPLETED|Overall Study||245
8109410|NCT03093324|19987023|P2|Safety Population|Overall Study||251
8109411|NCT03093324|19987024|P1|Safety Population|Overall Study||253
8109412|NCT03093324|19987023|P2|STARTED|Overall Study||252
8109413|NCT03093324|19987024|P1|STARTED|Overall Study||254
8109414|NCT03093272|19987046|P1|NOT COMPLETED|Overall Study||0
8109415|NCT03093272|19987046|P1|COMPLETED|Overall Study||9
8109416|NCT03093272|19987046|P1|STARTED|Overall Study||9
8109417|NCT03093207|19987057|P2|NOT COMPLETED|Overall Study||0
8109418|NCT03093207|19987058|P1|NOT COMPLETED|Overall Study||0
8109419|NCT03093207|19987057|P2|COMPLETED|Overall Study||17
8109420|NCT03093207|19987058|P1|COMPLETED|Overall Study||17
8109421|NCT03093207|19987057|P2|STARTED|Overall Study||17
8109422|NCT03093207|19987058|P1|STARTED|Overall Study||17
8109423|NCT03093181|19987071|P3|NOT COMPLETED|Overall Study||3
8109424|NCT03093181|19987072|P2|NOT COMPLETED|Overall Study||2
8109425|NCT03093181|19987073|P1|NOT COMPLETED|Overall Study||3
8109426|NCT03093181|19987071|P3|COMPLETED|Overall Study||41
8109427|NCT03093181|19987072|P2|COMPLETED|Overall Study||42
8109428|NCT03093181|19987073|P1|COMPLETED|Overall Study||41
8109429|NCT03093181|19987071|P3|STARTED|Overall Study||44
8109430|NCT03093181|19987072|P2|STARTED|Overall Study||44
8109431|NCT03093181|19987073|P1|STARTED|Overall Study||44
8109432|NCT03093025|19987102|P3|NOT COMPLETED|Overall Study||2
8109433|NCT03093025|19987103|P2|NOT COMPLETED|Overall Study||2
8109434|NCT03093025|19987104|P1|NOT COMPLETED|Overall Study||4
8109435|NCT03093025|19987102|P3|COMPLETED|Overall Study||16
8109436|NCT03093025|19987103|P2|COMPLETED|Overall Study||15
8109437|NCT03093025|19987104|P1|COMPLETED|Overall Study||12
8109438|NCT03093025|19987102|P3|STARTED|Overall Study||18
8109439|NCT03093025|19987103|P2|STARTED|Overall Study|One participant did not take any dose of investigational product after randomization.|17
8109440|NCT03093025|19987104|P1|STARTED|Overall Study||16
8109441|NCT03092791|19987135|P8|NOT COMPLETED|Overall Study||60
8109442|NCT03092791|19987136|P7|NOT COMPLETED|Overall Study||60
8109443|NCT03092791|19987137|P6|NOT COMPLETED|Overall Study||60
8109444|NCT03092791|19987138|P5|NOT COMPLETED|Overall Study||60
8109445|NCT03092791|19987139|P4|NOT COMPLETED|Overall Study||0
8109446|NCT03092791|19987140|P3|NOT COMPLETED|Overall Study||0
8109447|NCT03092791|19987141|P2|NOT COMPLETED|Overall Study||0
8109448|NCT03092791|19987142|P1|NOT COMPLETED|Overall Study||0
8109449|NCT03092791|19987135|P8|COMPLETED|Overall Study||0
8109450|NCT03092791|19987136|P7|COMPLETED|Overall Study||0
8109451|NCT03092791|19987137|P6|COMPLETED|Overall Study||0
8109452|NCT03092791|19987138|P5|COMPLETED|Overall Study||0
8109453|NCT03092791|19987139|P4|COMPLETED|Overall Study||30
8109454|NCT03092791|19987140|P3|COMPLETED|Overall Study||30
8109455|NCT03092791|19987141|P2|COMPLETED|Overall Study||20
8109456|NCT03092791|19987142|P1|COMPLETED|Overall Study||20
8109457|NCT03092791|19987135|P8|STARTED|Overall Study||60
8109458|NCT03092791|19987136|P7|STARTED|Overall Study||60
8109459|NCT03092791|19987137|P6|STARTED|Overall Study||60
8109460|NCT03092791|19987138|P5|STARTED|Overall Study||60
8109461|NCT03092791|19987139|P4|STARTED|Overall Study||30
8109462|NCT03092791|19987140|P3|STARTED|Overall Study||30
8109463|NCT03092791|19987141|P2|STARTED|Overall Study||20
8109464|NCT03092791|19987142|P1|STARTED|Overall Study||20
8109465|NCT03092752|19987257|P1|NOT COMPLETED|Overall Study||361469
8109466|NCT03092752|19987257|P1|COMPLETED|Overall Study||162116
8109467|NCT03092752|19987257|P1|STARTED|Overall Study||523585
8109468|NCT03092726|19987322|P2|NOT COMPLETED|Overall Study||14
8109469|NCT03092726|19987323|P1|NOT COMPLETED|Overall Study||9
8109470|NCT03092726|19987322|P2|COMPLETED|Overall Study||81
8109471|NCT03092726|19987323|P1|COMPLETED|Overall Study||79
8109472|NCT03092726|19987322|P2|Treated|Overall Study||95
8109473|NCT03092726|19987323|P1|Treated|Overall Study||88
8109474|NCT03092726|19987322|P2|STARTED|Overall Study||95
8109475|NCT03092726|19987323|P1|STARTED|Overall Study||88
8109476|NCT03092479|19987349|P2|NOT COMPLETED|Overall Study||2
8109477|NCT03092479|19987350|P1|NOT COMPLETED|Overall Study||7
8109478|NCT03092479|19987349|P2|COMPLETED|Overall Study||24
8109479|NCT03092479|19987350|P1|COMPLETED|Overall Study||17
8109480|NCT03092479|19987349|P2|STARTED|Overall Study||26
8109481|NCT03092479|19987350|P1|STARTED|Overall Study||24
8109482|NCT03092375|19987372|P4|NOT COMPLETED|Overall Study||0
8109483|NCT03092375|19987373|P3|NOT COMPLETED|Overall Study||1
8109484|NCT03092375|19987374|P2|NOT COMPLETED|Overall Study||1
8109485|NCT03092375|19987375|P1|NOT COMPLETED|Overall Study||0
8109486|NCT03092375|19987372|P4|COMPLETED|Overall Study||29
8109487|NCT03092375|19987373|P3|COMPLETED|Overall Study||20
8109488|NCT03092375|19987374|P2|COMPLETED|Overall Study||48
8109489|NCT03092375|19987375|P1|COMPLETED|Overall Study||78
8109490|NCT03092375|19987372|P4|STARTED|Overall Study||29
8109491|NCT03092375|19987373|P3|STARTED|Overall Study||21
8109492|NCT03092375|19987374|P2|STARTED|Overall Study||49
8109493|NCT03092375|19987375|P1|STARTED|Overall Study||78
8109506|NCT03091920|19987448|P3|NOT COMPLETED|Overall Study||0
8109507|NCT03091920|19987449|P2|NOT COMPLETED|Overall Study||1
8109508|NCT03091920|19987450|P1|NOT COMPLETED|Overall Study||0
8109509|NCT03091920|19987448|P3|COMPLETED|Overall Study||10
8109510|NCT03091920|19987449|P2|COMPLETED|Overall Study||9
8109511|NCT03091920|19987450|P1|COMPLETED|Overall Study||6
8109512|NCT03091920|19987448|P3|STARTED|Overall Study||10
8109513|NCT03091920|19987449|P2|STARTED|Overall Study||10
8109514|NCT03091920|19987450|P1|STARTED|Overall Study||6
8109515|NCT03091777|19987597|P3|NOT COMPLETED|Overall Study||37
8109516|NCT03091777|19987598|P2|NOT COMPLETED|Overall Study||33
8109517|NCT03091777|19987599|P1|NOT COMPLETED|Overall Study||32
8109518|NCT03091777|19987597|P3|COMPLETED|Overall Study||257
8109519|NCT03091777|19987598|P2|COMPLETED|Overall Study||255
8109520|NCT03091777|19987599|P1|COMPLETED|Overall Study||257
8109521|NCT03091777|19987597|P3|STARTED|Overall Study||294
8109522|NCT03091777|19987598|P2|STARTED|Overall Study||288
8109523|NCT03091777|19987599|P1|STARTED|Overall Study||289
8109524|NCT03091751|19987607|P1|NOT COMPLETED|Overall Study||0
8109525|NCT03091751|19987607|P1|COMPLETED|Overall Study||22
8109526|NCT03091751|19987607|P1|STARTED|Overall Study||22
8109527|NCT03091673|19987618|P2|NOT COMPLETED|Second Dose||0
8109528|NCT03091673|19987619|P1|NOT COMPLETED|Second Dose||0
8109529|NCT03091673|19987618|P2|COMPLETED|Second Dose||11
8109530|NCT03091673|19987619|P1|COMPLETED|Second Dose||0
8109531|NCT03091673|19987618|P2|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
8109532|NCT03091673|19987619|P1|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
8109533|NCT03091673|19987618|P2|NOT COMPLETED|First Dose||0
8109534|NCT03091673|19987619|P1|NOT COMPLETED|First Dose||0
8109535|NCT03091673|19987618|P2|COMPLETED|First Dose||0
8109536|NCT03091673|19987619|P1|COMPLETED|First Dose||31
8109537|NCT03091673|19987618|P2|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
8109538|NCT03091673|19987619|P1|STARTED|First Dose||31
8109539|NCT03091478|19987639|P1|NOT COMPLETED|Overall Study||0
8109540|NCT03091478|19987639|P1|COMPLETED|Overall Study||13
8109541|NCT03091478|19987639|P1|STARTED|Overall Study||13
8109542|NCT03091439|19987647|P2|NOT COMPLETED|Overall Study||0
8109543|NCT03091439|19987648|P1|NOT COMPLETED|Overall Study||1
8109544|NCT03091439|19987647|P2|COMPLETED|Overall Study||0
8109545|NCT03091439|19987648|P1|COMPLETED|Overall Study||0
8109546|NCT03091439|19987647|P2|STARTED|Overall Study||0
8109547|NCT03091439|19987648|P1|STARTED|Overall Study||1
8109548|NCT03091400|19987672|P2|NOT COMPLETED|Phase 2 - 6 Weeks||0
8109549|NCT03091400|19987673|P1|NOT COMPLETED|Phase 2 - 6 Weeks||0
8109550|NCT03091400|19987672|P2|COMPLETED|Phase 2 - 6 Weeks||6
8109551|NCT03091400|19987673|P1|COMPLETED|Phase 2 - 6 Weeks||4
8109552|NCT03091400|19987672|P2|STARTED|Phase 2 - 6 Weeks||6
8109553|NCT03091400|19987673|P1|STARTED|Phase 2 - 6 Weeks||4
8109554|NCT03091400|19987672|P2|NOT COMPLETED|Washout - 2 Weeks||0
8109555|NCT03091400|19987673|P1|NOT COMPLETED|Washout - 2 Weeks||1
8109556|NCT03091400|19987672|P2|COMPLETED|Washout - 2 Weeks||6
8109557|NCT03091400|19987673|P1|COMPLETED|Washout - 2 Weeks||4
8109558|NCT03091400|19987672|P2|STARTED|Washout - 2 Weeks||6
8109559|NCT03091400|19987673|P1|STARTED|Washout - 2 Weeks||5
8109560|NCT03091400|19987672|P2|NOT COMPLETED|Phase 1 - 6 Weeks||0
8109561|NCT03091400|19987673|P1|NOT COMPLETED|Phase 1 - 6 Weeks||0
8109562|NCT03091400|19987672|P2|COMPLETED|Phase 1 - 6 Weeks||6
8109563|NCT03091400|19987673|P1|COMPLETED|Phase 1 - 6 Weeks||5
8109564|NCT03091400|19987672|P2|STARTED|Phase 1 - 6 Weeks||6
8109565|NCT03091400|19987673|P1|STARTED|Phase 1 - 6 Weeks||5
8109566|NCT03091361|19987689|P1|NOT COMPLETED|Overall Study||0
8109567|NCT03091361|19987689|P1|COMPLETED|Overall Study||30
8109568|NCT03091361|19987689|P1|STARTED|Overall Study||30
8109569|NCT03091348|19987695|P2|NOT COMPLETED|Overall Study||1
8109570|NCT03091348|19987696|P1|NOT COMPLETED|Overall Study||2
8109571|NCT03091348|19987695|P2|COMPLETED|Overall Study||1
8109572|NCT03091348|19987696|P1|COMPLETED|Overall Study||0
8109573|NCT03091348|19987695|P2|STARTED|Overall Study||2
8109574|NCT03091348|19987696|P1|STARTED|Overall Study||2
8109581|NCT03091179|19987741|P2|NOT COMPLETED|Overall Study||0
8109582|NCT03091179|19987742|P1|NOT COMPLETED|Overall Study||0
8109583|NCT03091179|19987741|P2|COMPLETED|Overall Study||10
8109584|NCT03091179|19987742|P1|COMPLETED|Overall Study||10
8109585|NCT03091179|19987741|P2|STARTED|Overall Study||10
8109586|NCT03091179|19987742|P1|STARTED|Overall Study||10
8109587|NCT03090958|19987768|P1|NOT COMPLETED|Overall Study||0
8109588|NCT03090958|19987768|P1|COMPLETED|Overall Study||20
8109589|NCT03090958|19987768|P1|STARTED|Overall Study||20
8109590|NCT03090256|19987780|P1|NOT COMPLETED|Overall Study||0
8109591|NCT03090256|19987780|P1|COMPLETED|Overall Study||68
8109592|NCT03090256|19987780|P1|STARTED|Overall Study||68
8109593|NCT03090100|19987791|P2|NOT COMPLETED|Overall Study||48
8109594|NCT03090100|19987792|P1|NOT COMPLETED|Overall Study||27
8109595|NCT03090100|19987791|P2|COMPLETED|Overall Study||466
8109596|NCT03090100|19987792|P1|COMPLETED|Overall Study||507
8109597|NCT03090100|19987791|P2|Treated|Overall Study||511
8109598|NCT03090100|19987792|P1|Treated|Overall Study||534
8109599|NCT03090100|19987791|P2|STARTED|Overall Study||514
8109600|NCT03090100|19987792|P1|STARTED|Overall Study||534
8109601|NCT03089944|19987832|P1|NOT COMPLETED|Overall Study||12
8109602|NCT03089944|19987832|P1|COMPLETED|Overall Study||331
8109603|NCT03089944|19987832|P1|STARTED|Overall Study||343
8109604|NCT03089879|19987846|P3|NOT COMPLETED|Overall Study||0
8109605|NCT03089879|19987847|P2|NOT COMPLETED|Overall Study||0
8109606|NCT03089879|19987848|P1|NOT COMPLETED|Overall Study||0
8109607|NCT03089879|19987846|P3|COMPLETED|Overall Study||26
8109608|NCT03089879|19987847|P2|COMPLETED|Overall Study||2
8109609|NCT03089879|19987848|P1|COMPLETED|Overall Study||7
8109610|NCT03089879|19987846|P3|STARTED|Overall Study||26
8109611|NCT03089879|19987847|P2|STARTED|Overall Study||2
8109612|NCT03089879|19987848|P1|STARTED|Overall Study||7
8109613|NCT03089853|19987879|P2|NOT COMPLETED|Overall Study||1
8109614|NCT03089853|19987880|P1|NOT COMPLETED|Overall Study||2
8109615|NCT03089853|19987879|P2|COMPLETED|Overall Study||2
8109616|NCT03089853|19987880|P1|COMPLETED|Overall Study||2
8109617|NCT03089853|19987879|P2|STARTED|Overall Study||3
8109618|NCT03089853|19987880|P1|STARTED|Overall Study||4
8109619|NCT03089580|19987902|P1|NOT COMPLETED|Overall Study||2
8109620|NCT03089580|19987902|P1|COMPLETED|Overall Study||12
8109621|NCT03089580|19987902|P1|STARTED|Overall Study||14
8109622|NCT03089216|19987913|P4|NOT COMPLETED|Overall Study||1
8109623|NCT03089216|19987914|P3|NOT COMPLETED|Overall Study||0
8109624|NCT03089216|19987915|P2|NOT COMPLETED|Overall Study||0
8109625|NCT03089216|19987916|P1|NOT COMPLETED|Overall Study||0
8109626|NCT03089216|19987913|P4|COMPLETED|Overall Study||26
8109627|NCT03089216|19987914|P3|COMPLETED|Overall Study||27
8109628|NCT03089216|19987915|P2|COMPLETED|Overall Study||27
8109629|NCT03089216|19987916|P1|COMPLETED|Overall Study||27
8109630|NCT03089216|19987913|P4|STARTED|Overall Study||27
8109631|NCT03089216|19987914|P3|STARTED|Overall Study||27
8109632|NCT03089216|19987915|P2|STARTED|Overall Study||27
8109633|NCT03089216|19987916|P1|STARTED|Overall Study||27
8109634|NCT03089047|19987932|P2|NOT COMPLETED|Overall Study||0
8109635|NCT03089047|19987933|P1|NOT COMPLETED|Overall Study||1
8109636|NCT03089047|19987932|P2|COMPLETED|Overall Study||2
8109637|NCT03089047|19987933|P1|COMPLETED|Overall Study||1
8109638|NCT03089047|19987932|P2|STARTED|Overall Study||2
8109639|NCT03089047|19987933|P1|STARTED|Overall Study||2
8109640|NCT03088917|19987943|P1|NOT COMPLETED|Overall Study||96
8109641|NCT03088917|19987943|P1|COMPLETED|Overall Study||10
8109642|NCT03088917|19987943|P1|STARTED|Overall Study||106
8109643|NCT03088345|19987953|P2|NOT COMPLETED|Overall Study||0
8109644|NCT03088345|19987954|P1|NOT COMPLETED|Overall Study||0
8109645|NCT03088345|19987953|P2|COMPLETED|Overall Study||10
8109646|NCT03088345|19987954|P1|COMPLETED|Overall Study||10
8109647|NCT03088345|19987953|P2|STARTED|Overall Study||10
8109648|NCT03088345|19987954|P1|STARTED|Overall Study||10
8109649|NCT03088267|19987970|P2|NOT COMPLETED|Overall Study||0
8109650|NCT03088267|19987971|P1|NOT COMPLETED|Overall Study||0
8109651|NCT03088267|19987970|P2|COMPLETED|Overall Study||9
8109652|NCT03088267|19987971|P1|COMPLETED|Overall Study||9
8109653|NCT03088267|19987970|P2|STARTED|Overall Study||9
8109654|NCT03088267|19987971|P1|STARTED|Overall Study||9
8109655|NCT03088137|19987982|P2|NOT COMPLETED|Overall Study||0
8109656|NCT03088137|19987983|P1|NOT COMPLETED|Overall Study||0
8109657|NCT03088137|19987982|P2|COMPLETED|Overall Study||55
8109658|NCT03088137|19987983|P1|COMPLETED|Overall Study||55
8109659|NCT03088137|19987982|P2|STARTED|Overall Study||55
8109660|NCT03088137|19987983|P1|STARTED|Overall Study||55
8109670|NCT03087786|19988026|P2|NOT COMPLETED|Overall Study||0
8109671|NCT03087786|19988027|P1|NOT COMPLETED|Overall Study||2
8109672|NCT03087786|19988026|P2|COMPLETED|Overall Study||50
8109673|NCT03087786|19988027|P1|COMPLETED|Overall Study||48
8109674|NCT03087786|19988026|P2|STARTED|Overall Study||50
8109675|NCT03087786|19988027|P1|STARTED|Overall Study||50
8109676|NCT03087643|19988063|P2|NOT COMPLETED|Overall Study||6
8109677|NCT03087643|19988064|P1|NOT COMPLETED|Overall Study||4
8109678|NCT03087643|19988063|P2|COMPLETED|Overall Study||19
8109679|NCT03087643|19988064|P1|COMPLETED|Overall Study||22
8109680|NCT03087643|19988063|P2|STARTED|Overall Study||25
8109681|NCT03087643|19988064|P1|STARTED|Overall Study||26
8109682|NCT03087604|19988080|P2|NOT COMPLETED|Overall Study||0
8109683|NCT03087604|19988081|P1|NOT COMPLETED|Overall Study||0
8109684|NCT03087604|19988080|P2|COMPLETED|Overall Study||50
8109685|NCT03087604|19988081|P1|COMPLETED|Overall Study||50
8109686|NCT03087604|19988080|P2|STARTED|Overall Study||50
8109687|NCT03087604|19988081|P1|STARTED|Overall Study||50
8109688|NCT03087513|19988091|P1|NOT COMPLETED|Second Intervention After 3 hr Washout||2
8109689|NCT03087513|19988091|P1|COMPLETED|Second Intervention After 3 hr Washout||38
8109690|NCT03087513|19988091|P1|STARTED|Second Intervention After 3 hr Washout||40
8109691|NCT03087513|19988091|P1|NOT COMPLETED|First Intervention||0
8109692|NCT03087513|19988091|P1|COMPLETED|First Intervention||40
8109693|NCT03087513|19988091|P1|STARTED|First Intervention||40
8109694|NCT03086707|19988107|P2|NOT COMPLETED|Overall Study||0
8109695|NCT03086707|19988108|P1|NOT COMPLETED|Overall Study||0
8109696|NCT03086707|19988107|P2|COMPLETED|Overall Study||7
8109697|NCT03086707|19988108|P1|COMPLETED|Overall Study||7
8109698|NCT03086707|19988107|P2|STARTED|Overall Study||7
8109699|NCT03086707|19988108|P1|STARTED|Overall Study||7
8109700|NCT03086551|19988138|P2|NOT COMPLETED|Second Intervention||0
8109701|NCT03086551|19988139|P1|NOT COMPLETED|Second Intervention||0
8109702|NCT03086551|19988138|P2|COMPLETED|Second Intervention||1
8109703|NCT03086551|19988139|P1|COMPLETED|Second Intervention||1
8109704|NCT03086551|19988138|P2|STARTED|Second Intervention||1
8109705|NCT03086551|19988139|P1|STARTED|Second Intervention||1
8109706|NCT03086551|19988138|P2|NOT COMPLETED|Washout||3
8109707|NCT03086551|19988139|P1|NOT COMPLETED|Washout||3
8109708|NCT03086551|19988138|P2|COMPLETED|Washout||1
8109709|NCT03086551|19988139|P1|COMPLETED|Washout||1
8109710|NCT03086551|19988138|P2|STARTED|Washout||4
8109711|NCT03086551|19988139|P1|STARTED|Washout||4
8109712|NCT03086551|19988138|P2|NOT COMPLETED|First Intervention||1
8109713|NCT03086551|19988139|P1|NOT COMPLETED|First Intervention||1
8109714|NCT03086551|19988138|P2|COMPLETED|First Intervention||4
8109715|NCT03086551|19988139|P1|COMPLETED|First Intervention||4
8109716|NCT03086551|19988138|P2|STARTED|First Intervention||5
8109717|NCT03086551|19988139|P1|STARTED|First Intervention||5
8109718|NCT03086447|19988155|P2|NOT COMPLETED|Overall Study||20
8109719|NCT03086447|19988156|P1|NOT COMPLETED|Overall Study||11
8109720|NCT03086447|19988155|P2|COMPLETED|Overall Study||110
8109721|NCT03086447|19988156|P1|COMPLETED|Overall Study||121
8109722|NCT03086447|19988155|P2|STARTED|Overall Study||130
8109723|NCT03086447|19988156|P1|STARTED|Overall Study||132
8109724|NCT03086408|19988178|P2|NOT COMPLETED|Overall Study||0
8109725|NCT03086408|19988179|P1|NOT COMPLETED|Overall Study||0
8109726|NCT03086408|19988178|P2|COMPLETED|Overall Study||10
8109727|NCT03086408|19988179|P1|COMPLETED|Overall Study||10
8109728|NCT03086408|19988178|P2|STARTED|Overall Study||10
8109729|NCT03086408|19988179|P1|STARTED|Overall Study||10
8109730|NCT03086356|19988203|P1|NOT COMPLETED|Overall Study||0
8109731|NCT03086356|19988203|P1|COMPLETED|Overall Study||12
8109732|NCT03086356|19988203|P1|STARTED|Overall Study||12
8109747|NCT03086265|19988350|P2|NOT COMPLETED|Overall Study||0
8109748|NCT03086265|19988351|P1|NOT COMPLETED|Overall Study||0
8109749|NCT03086265|19988350|P2|COMPLETED|Overall Study||10
8109750|NCT03086265|19988351|P1|COMPLETED|Overall Study||10
8109751|NCT03086265|19988350|P2|STARTED|Overall Study||10
8109752|NCT03086265|19988351|P1|STARTED|Overall Study||10
8109753|NCT03086213|19988408|P2|NOT COMPLETED|Overall Study||0
8109754|NCT03086213|19988409|P1|NOT COMPLETED|Overall Study||0
8109755|NCT03086213|19988408|P2|COMPLETED|Overall Study||24
8109756|NCT03086213|19988409|P1|COMPLETED|Overall Study||24
8109757|NCT03086213|19988408|P2|STARTED|Overall Study||24
8109758|NCT03086213|19988409|P1|STARTED|Overall Study||24
8109759|NCT03086135|19988425|P1|NOT COMPLETED|Overall Study||3
8109760|NCT03086135|19988425|P1|COMPLETED|Overall Study||48
8109761|NCT03086135|19988425|P1|STARTED|Overall Study||51
8109762|NCT03086018|19988452|P1|NOT COMPLETED|Final Testing for End of Trial||2
8109763|NCT03086018|19988452|P1|COMPLETED|Final Testing for End of Trial||28
8109764|NCT03086018|19988452|P1|STARTED|Final Testing for End of Trial||30
8109765|NCT03086018|19988452|P1|NOT COMPLETED|Field Testing||0
8109766|NCT03086018|19988452|P1|COMPLETED|Field Testing||30
8109767|NCT03086018|19988452|P1|STARTED|Field Testing||30
8109796|NCT03085836|19988506|P3|NOT COMPLETED|Overall Study||0
8109797|NCT03085836|19988507|P2|NOT COMPLETED|Overall Study||0
8109798|NCT03085836|19988508|P1|NOT COMPLETED|Overall Study||0
8109799|NCT03085836|19988506|P3|COMPLETED|Overall Study||10
8109800|NCT03085836|19988507|P2|COMPLETED|Overall Study||11
8109801|NCT03085836|19988508|P1|COMPLETED|Overall Study||12
8109802|NCT03085836|19988506|P3|STARTED|Overall Study||10
8109803|NCT03085836|19988507|P2|STARTED|Overall Study||11
8109804|NCT03085836|19988508|P1|STARTED|Overall Study||12
8109833|NCT03085238|19988580|P1|NOT COMPLETED|Overall Study||4
8109834|NCT03085238|19988580|P1|COMPLETED|Overall Study||19
8109835|NCT03085238|19988580|P1|18 Months|Overall Study||7
8109836|NCT03085238|19988580|P1|15 Months|Overall Study||11
8109837|NCT03085238|19988580|P1|12 Months|Overall Study||14
8109838|NCT03085238|19988580|P1|9 Months|Overall Study||16
8109839|NCT03085238|19988580|P1|6 Months|Overall Study||19
8109840|NCT03085238|19988580|P1|3 Months|Overall Study||22
8109841|NCT03085238|19988580|P1|1 Month|Overall Study||23
8109842|NCT03085238|19988580|P1|STARTED|Overall Study||23
8109855|NCT03083990|19988645|P2|NOT COMPLETED|Overall Study||0
8109856|NCT03083990|19988646|P1|NOT COMPLETED|Overall Study||1
8109857|NCT03083990|19988645|P2|COMPLETED|Overall Study||50
8109858|NCT03083990|19988646|P1|COMPLETED|Overall Study||49
8109859|NCT03083990|19988645|P2|STARTED|Overall Study||50
8109860|NCT03083990|19988646|P1|STARTED|Overall Study||50
8109891|NCT03083769|19988715|P2|NOT COMPLETED|Overall Study||32
8109892|NCT03083769|19988716|P1|NOT COMPLETED|Overall Study||20
8109893|NCT03083769|19988715|P2|COMPLETED|Overall Study||631
8109894|NCT03083769|19988716|P1|COMPLETED|Overall Study||819
8109895|NCT03083769|19988715|P2|STARTED|Overall Study||663
8109896|NCT03083769|19988716|P1|STARTED|Overall Study||839
8109897|NCT03083639|19988728|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||0
8109898|NCT03083639|19988729|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
8109899|NCT03083639|19988728|P2|COMPLETED|Intervention Period 2 (1 Day)||25
8109900|NCT03083639|19988729|P1|COMPLETED|Intervention Period 2 (1 Day)||25
8109901|NCT03083639|19988728|P2|STARTED|Intervention Period 2 (1 Day)||25
8109902|NCT03083639|19988729|P1|STARTED|Intervention Period 2 (1 Day)||25
8109903|NCT03083639|19988728|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||1
8109904|NCT03083639|19988729|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||1
8109905|NCT03083639|19988728|P2|COMPLETED|Washout Period (at Least 6 Days)||25
8109906|NCT03083639|19988729|P1|COMPLETED|Washout Period (at Least 6 Days)||25
8109907|NCT03083639|19988728|P2|STARTED|Washout Period (at Least 6 Days)||26
8109908|NCT03083639|19988729|P1|STARTED|Washout Period (at Least 6 Days)||26
8109909|NCT03083639|19988728|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8109910|NCT03083639|19988729|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8109911|NCT03083639|19988728|P2|COMPLETED|Intervention Period 1 (1 Day)||26
8109912|NCT03083639|19988729|P1|COMPLETED|Intervention Period 1 (1 Day)||26
8109913|NCT03083639|19988728|P2|STARTED|Intervention Period 1 (1 Day)||26
8109914|NCT03083639|19988729|P1|STARTED|Intervention Period 1 (1 Day)||26
8109915|NCT03083483|19988742|P3|NOT COMPLETED|Overall Study||3
8109916|NCT03083483|19988743|P2|NOT COMPLETED|Overall Study||2
8109917|NCT03083483|19988744|P1|NOT COMPLETED|Overall Study||4
8109918|NCT03083483|19988742|P3|COMPLETED|Overall Study||20
8109919|NCT03083483|19988743|P2|COMPLETED|Overall Study||20
8109920|NCT03083483|19988744|P1|COMPLETED|Overall Study||20
8109921|NCT03083483|19988742|P3|STARTED|Overall Study||23
8109922|NCT03083483|19988743|P2|STARTED|Overall Study||22
8109923|NCT03083483|19988744|P1|STARTED|Overall Study||24
8109924|NCT03083470|19988763|P5|NOT COMPLETED|Overall Study||2
8109925|NCT03083470|19988764|P4|NOT COMPLETED|Overall Study||0
8109926|NCT03083470|19988765|P3|NOT COMPLETED|Overall Study||0
8109927|NCT03083470|19988766|P2|NOT COMPLETED|Overall Study||0
8109928|NCT03083470|19988767|P1|NOT COMPLETED|Overall Study||0
8109929|NCT03083470|19988763|P5|COMPLETED|Overall Study||7
8109930|NCT03083470|19988764|P4|COMPLETED|Overall Study||6
8109931|NCT03083470|19988765|P3|COMPLETED|Overall Study||6
8109932|NCT03083470|19988766|P2|COMPLETED|Overall Study||6
8109933|NCT03083470|19988767|P1|COMPLETED|Overall Study||6
8109934|NCT03083470|19988763|P5|STARTED|Overall Study||9
8109935|NCT03083470|19988764|P4|STARTED|Overall Study||6
8109936|NCT03083470|19988765|P3|STARTED|Overall Study||6
8109937|NCT03083470|19988766|P2|STARTED|Overall Study||6
8109938|NCT03083470|19988767|P1|STARTED|Overall Study||6
8109939|NCT03083379|19988806|P2|NOT COMPLETED|Overall Study||0
8109940|NCT03083379|19988807|P1|NOT COMPLETED|Overall Study||0
8109941|NCT03083379|19988806|P2|COMPLETED|Overall Study||15
8109942|NCT03083379|19988807|P1|COMPLETED|Overall Study||15
8109943|NCT03083379|19988806|P2|STARTED|Overall Study||15
8109944|NCT03083379|19988807|P1|STARTED|Overall Study||15
8109945|NCT03082599|19988815|P2|NOT COMPLETED|Overall Study||0
8109946|NCT03082599|19988816|P1|NOT COMPLETED|Overall Study||1
8109947|NCT03082599|19988815|P2|COMPLETED|Overall Study||39
8109948|NCT03082599|19988816|P1|COMPLETED|Overall Study||39
8109949|NCT03082599|19988815|P2|STARTED|Overall Study||39
8109950|NCT03082599|19988816|P1|STARTED|Overall Study||40
8109951|NCT03082586|19988848|P6|NOT COMPLETED|Overall Study||0
8109952|NCT03082586|19988849|P5|NOT COMPLETED|Overall Study||0
8109953|NCT03082586|19988850|P4|NOT COMPLETED|Overall Study||0
8109954|NCT03082586|19988851|P3|NOT COMPLETED|Overall Study||0
8109955|NCT03082586|19988852|P2|NOT COMPLETED|Overall Study||0
8109956|NCT03082586|19988853|P1|NOT COMPLETED|Overall Study||0
8109957|NCT03082586|19988848|P6|COMPLETED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
8109958|NCT03082586|19988849|P5|COMPLETED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
8109959|NCT03082586|19988850|P4|COMPLETED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
8109960|NCT03082586|19988851|P3|COMPLETED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
8109961|NCT03082586|19988852|P2|COMPLETED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
8109962|NCT03082586|19988853|P1|COMPLETED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
8109963|NCT03082586|19988848|P6|STARTED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
8109964|NCT03082586|19988849|P5|STARTED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
8109965|NCT03082586|19988850|P4|STARTED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
8109966|NCT03082586|19988851|P3|STARTED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
8109967|NCT03082586|19988852|P2|STARTED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
8109968|NCT03082586|19988853|P1|STARTED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
8109969|NCT03082196|19988875|P2|NOT COMPLETED|Overall Study||13
8109970|NCT03082196|19988876|P1|NOT COMPLETED|Overall Study||9
8109971|NCT03082196|19988875|P2|COMPLETED|Overall Study||129
8109972|NCT03082196|19988876|P1|COMPLETED|Overall Study||133
8109973|NCT03082196|19988875|P2|STARTED|Overall Study||142
8109974|NCT03082196|19988876|P1|STARTED|Overall Study||142
8109975|NCT03081884|19988888|P1|NOT COMPLETED|Overall Study||4
8109976|NCT03081884|19988888|P1|COMPLETED|Overall Study||57
8109977|NCT03081884|19988888|P1|STARTED|Overall Study||61
8109978|NCT03080961|19988894|P1|NOT COMPLETED|Overall Study||3
8109979|NCT03080961|19988894|P1|COMPLETED|Overall Study||43
8109980|NCT03080961|19988894|P1|STARTED|Overall Study||46
8109981|NCT03080493|19988905|P2|NOT COMPLETED|Overall Study||2
8109982|NCT03080493|19988906|P1|NOT COMPLETED|Overall Study||1
8109983|NCT03080493|19988905|P2|COMPLETED|Overall Study||58
8109984|NCT03080493|19988906|P1|COMPLETED|Overall Study||60
8109985|NCT03080493|19988905|P2|STARTED|Overall Study||60
8109986|NCT03080493|19988906|P1|STARTED|Overall Study||61
8110002|NCT03079531|19988931|P1|NOT COMPLETED|Overall Study||7
8110003|NCT03079531|19988931|P1|COMPLETED|Overall Study||17
8110004|NCT03079531|19988931|P1|Attended ≥1 Post-baseline Visit|Overall Study||23
8110005|NCT03079531|19988931|P1|STARTED|Overall Study||24
8110006|NCT03079375|19988944|P3|NOT COMPLETED|Overall Study||21
8110007|NCT03079375|19988945|P2|NOT COMPLETED|Overall Study||6
8110008|NCT03079375|19988946|P1|NOT COMPLETED|Overall Study||5
8110009|NCT03079375|19988944|P3|COMPLETED|Overall Study||476
8110010|NCT03079375|19988945|P2|COMPLETED|Overall Study||493
8110011|NCT03079375|19988946|P1|COMPLETED|Overall Study||498
8110012|NCT03079375|19988944|P3|STARTED|Overall Study||497
8110013|NCT03079375|19988945|P2|STARTED|Overall Study||499
8110014|NCT03079375|19988946|P1|STARTED|Overall Study||503
8110015|NCT03078946|19988980|P2|NOT COMPLETED|Overall Study||0
8110016|NCT03078946|19988981|P1|NOT COMPLETED|Overall Study||0
8110017|NCT03078946|19988980|P2|COMPLETED|Overall Study||30
8110018|NCT03078946|19988981|P1|COMPLETED|Overall Study||30
8110019|NCT03078946|19988980|P2|STARTED|Overall Study||30
8110020|NCT03078946|19988981|P1|STARTED|Overall Study||30
8110021|NCT03078816|19988989|P1|NOT COMPLETED|Overall Study||1
8110022|NCT03078816|19988989|P1|COMPLETED|Overall Study||4
8110023|NCT03078816|19988989|P1|STARTED|Overall Study||5
8110034|NCT03078647|19989018|P3|NOT COMPLETED|Overall Study||0
8110035|NCT03078647|19989019|P2|NOT COMPLETED|Overall Study||1
8110036|NCT03078647|19989020|P1|NOT COMPLETED|Overall Study||0
8110037|NCT03078647|19989018|P3|COMPLETED|Overall Study||3
8110038|NCT03078647|19989019|P2|COMPLETED|Overall Study||10
8110039|NCT03078647|19989020|P1|COMPLETED|Overall Study||17
8110040|NCT03078647|19989018|P3|STARTED|Overall Study||3
8110041|NCT03078647|19989019|P2|STARTED|Overall Study||11
8110042|NCT03078647|19989020|P1|STARTED|Overall Study||17
8110043|NCT03078595|19989039|P2|NOT COMPLETED|Overall Study||0
8110044|NCT03078595|19989040|P1|NOT COMPLETED|Overall Study||0
8110045|NCT03078595|19989039|P2|COMPLETED|Overall Study||24
8110046|NCT03078595|19989040|P1|COMPLETED|Overall Study||24
8110047|NCT03078595|19989039|P2|STARTED|Overall Study||24
8110048|NCT03078595|19989040|P1|STARTED|Overall Study||24
8110049|NCT03078582|19989050|P2|NOT COMPLETED|Overall Study||8
8110050|NCT03078582|19989051|P1|NOT COMPLETED|Overall Study||0
8110051|NCT03078582|19989050|P2|COMPLETED|Overall Study||8
8110052|NCT03078582|19989051|P1|COMPLETED|Overall Study||10
8110053|NCT03078582|19989050|P2|STARTED|Overall Study||16
8110054|NCT03078582|19989051|P1|STARTED|Overall Study||10
8110055|NCT03078556|19989071|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8110056|NCT03078556|19989072|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8110057|NCT03078556|19989073|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8110058|NCT03078556|19989074|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8110059|NCT03078556|19989071|P4|COMPLETED|Treatment Period 3 (4 Days)||9
8110060|NCT03078556|19989072|P3|COMPLETED|Treatment Period 3 (4 Days)||7
8110061|NCT03078556|19989073|P2|COMPLETED|Treatment Period 3 (4 Days)||7
8110062|NCT03078556|19989074|P1|COMPLETED|Treatment Period 3 (4 Days)||9
8110063|NCT03078556|19989071|P4|STARTED|Treatment Period 3 (4 Days)||9
8110064|NCT03078556|19989072|P3|STARTED|Treatment Period 3 (4 Days)||7
8110065|NCT03078556|19989073|P2|STARTED|Treatment Period 3 (4 Days)||7
8110066|NCT03078556|19989074|P1|STARTED|Treatment Period 3 (4 Days)||9
8110067|NCT03078556|19989071|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8110068|NCT03078556|19989072|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8110069|NCT03078556|19989073|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8110070|NCT03078556|19989074|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8110071|NCT03078556|19989071|P4|COMPLETED|Washout Period 2 (7 Days)||9
8110072|NCT03078556|19989072|P3|COMPLETED|Washout Period 2 (7 Days)||7
8110073|NCT03078556|19989073|P2|COMPLETED|Washout Period 2 (7 Days)||7
8110074|NCT03078556|19989074|P1|COMPLETED|Washout Period 2 (7 Days)||9
8110075|NCT03078556|19989071|P4|STARTED|Washout Period 2 (7 Days)||9
8110076|NCT03078556|19989072|P3|STARTED|Washout Period 2 (7 Days)||7
8110077|NCT03078556|19989073|P2|STARTED|Washout Period 2 (7 Days)||7
8110078|NCT03078556|19989074|P1|STARTED|Washout Period 2 (7 Days)||9
8110079|NCT03078556|19989071|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8110080|NCT03078556|19989072|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8110081|NCT03078556|19989073|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8110082|NCT03078556|19989074|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8110083|NCT03078556|19989071|P4|COMPLETED|Treatment Period 2 (4 Days)||37
8110084|NCT03078556|19989072|P3|COMPLETED|Treatment Period 2 (4 Days)||37
8110085|NCT03078556|19989073|P2|COMPLETED|Treatment Period 2 (4 Days)||36
8110086|NCT03078556|19989074|P1|COMPLETED|Treatment Period 2 (4 Days)||37
8110087|NCT03078556|19989071|P4|STARTED|Treatment Period 2 (4 Days)||37
8110088|NCT03078556|19989072|P3|STARTED|Treatment Period 2 (4 Days)||37
8110089|NCT03078556|19989073|P2|STARTED|Treatment Period 2 (4 Days)||36
8110090|NCT03078556|19989074|P1|STARTED|Treatment Period 2 (4 Days)||37
8110091|NCT03078556|19989071|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
8110092|NCT03078556|19989072|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
8110093|NCT03078556|19989073|P2|NOT COMPLETED|Washout Period 1 (7 Days)||2
8110094|NCT03078556|19989074|P1|NOT COMPLETED|Washout Period 1 (7 Days)||2
8110095|NCT03078556|19989071|P4|COMPLETED|Washout Period 1 (7 Days)||37
8110096|NCT03078556|19989072|P3|COMPLETED|Washout Period 1 (7 Days)||37
8110097|NCT03078556|19989073|P2|COMPLETED|Washout Period 1 (7 Days)||36
8110098|NCT03078556|19989074|P1|COMPLETED|Washout Period 1 (7 Days)||37
8110099|NCT03078556|19989071|P4|STARTED|Washout Period 1 (7 Days)||38
8110100|NCT03078556|19989072|P3|STARTED|Washout Period 1 (7 Days)||38
8110101|NCT03078556|19989073|P2|STARTED|Washout Period 1 (7 Days)||38
8110102|NCT03078556|19989074|P1|STARTED|Washout Period 1 (7 Days)||39
8110103|NCT03078556|19989071|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8110104|NCT03078556|19989072|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8110105|NCT03078556|19989073|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
8110106|NCT03078556|19989074|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8110107|NCT03078556|19989071|P4|COMPLETED|Treatment Period 1 (4 Days)||38
8110108|NCT03078556|19989072|P3|COMPLETED|Treatment Period 1 (4 Days)||38
8110109|NCT03078556|19989073|P2|COMPLETED|Treatment Period 1 (4 Days)||38
8110110|NCT03078556|19989074|P1|COMPLETED|Treatment Period 1 (4 Days)||39
8110111|NCT03078556|19989071|P4|STARTED|Treatment Period 1 (4 Days)||38
8110112|NCT03078556|19989072|P3|STARTED|Treatment Period 1 (4 Days)||38
8110113|NCT03078556|19989073|P2|STARTED|Treatment Period 1 (4 Days)||39
8110114|NCT03078556|19989074|P1|STARTED|Treatment Period 1 (4 Days)||39
8110115|NCT03078504|19989212|P1|NOT COMPLETED|Overall Study||0
8110116|NCT03078504|19989212|P1|COMPLETED|Overall Study||6
8110117|NCT03078504|19989212|P1|STARTED|Overall Study||6
8110118|NCT03078478|19989218|P2|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||27
8110119|NCT03078478|19989219|P1|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||25
8110120|NCT03078478|19989218|P2|COMPLETED|Maintencance Period 2 (36 Weeks)||734
8110121|NCT03078478|19989219|P1|COMPLETED|Maintencance Period 2 (36 Weeks)||733
8110122|NCT03078478|19989218|P2|STARTED|Maintencance Period 2 (36 Weeks)||761
8110123|NCT03078478|19989219|P1|STARTED|Maintencance Period 2 (36 Weeks)||758
8110124|NCT03078478|19989218|P2|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||43
8110125|NCT03078478|19989219|P1|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||47
8110126|NCT03078478|19989218|P2|COMPLETED|Maintenance Period 1 (36 Weeks)||761
8110127|NCT03078478|19989219|P1|COMPLETED|Maintenance Period 1 (36 Weeks)||758
8110128|NCT03078478|19989218|P2|STARTED|Maintenance Period 1 (36 Weeks)||804
8110129|NCT03078478|19989219|P1|STARTED|Maintenance Period 1 (36 Weeks)||805
8110130|NCT03078478|19989218|P2|NOT COMPLETED|Titration Period (16 Weeks)||0
8110131|NCT03078478|19989219|P1|NOT COMPLETED|Titration Period (16 Weeks)||0
8110132|NCT03078478|19989218|P2|COMPLETED|Titration Period (16 Weeks)||804
8110133|NCT03078478|19989219|P1|COMPLETED|Titration Period (16 Weeks)||805
8110134|NCT03078478|19989218|P2|Safety Analysis Set|Titration Period (16 Weeks)||798
8110135|NCT03078478|19989219|P1|Safety Analysis Set|Titration Period (16 Weeks)||802
8110136|NCT03078478|19989218|P2|Full Analysis Set|Titration Period (16 Weeks)||804
8110137|NCT03078478|19989219|P1|Full Analysis Set|Titration Period (16 Weeks)||805
8110138|NCT03078478|19989218|P2|STARTED|Titration Period (16 Weeks)||804
8110139|NCT03078478|19989219|P1|STARTED|Titration Period (16 Weeks)||805
8110140|NCT03078270|19989257|P2|NOT COMPLETED|Overall Study||0
8110141|NCT03078270|19989258|P1|NOT COMPLETED|Overall Study||4
8110142|NCT03078270|19989257|P2|COMPLETED|Overall Study||0
8110143|NCT03078270|19989258|P1|COMPLETED|Overall Study||0
8110144|NCT03078270|19989257|P2|STARTED|Overall Study||0
8110145|NCT03078270|19989258|P1|STARTED|Overall Study||4
8110146|NCT03078127|19989267|P3|NOT COMPLETED|Third Intervention||0
8110147|NCT03078127|19989268|P2|NOT COMPLETED|Third Intervention||0
8110148|NCT03078127|19989269|P1|NOT COMPLETED|Third Intervention||0
8110149|NCT03078127|19989267|P3|COMPLETED|Third Intervention||3
8110150|NCT03078127|19989268|P2|COMPLETED|Third Intervention||3
8110151|NCT03078127|19989269|P1|COMPLETED|Third Intervention||4
8110152|NCT03078127|19989267|P3|STARTED|Third Intervention||3
8110153|NCT03078127|19989268|P2|STARTED|Third Intervention||3
8110154|NCT03078127|19989269|P1|STARTED|Third Intervention||4
8110155|NCT03078127|19989267|P3|NOT COMPLETED|Washout (3-21 Days)||0
8110156|NCT03078127|19989268|P2|NOT COMPLETED|Washout (3-21 Days)||0
8110157|NCT03078127|19989269|P1|NOT COMPLETED|Washout (3-21 Days)||0
8110158|NCT03078127|19989267|P3|COMPLETED|Washout (3-21 Days)||3
8110159|NCT03078127|19989268|P2|COMPLETED|Washout (3-21 Days)||3
8110160|NCT03078127|19989269|P1|COMPLETED|Washout (3-21 Days)||4
8110161|NCT03078127|19989267|P3|STARTED|Washout (3-21 Days)||3
8110162|NCT03078127|19989268|P2|STARTED|Washout (3-21 Days)||3
8110163|NCT03078127|19989269|P1|STARTED|Washout (3-21 Days)||4
8110164|NCT03078127|19989267|P3|NOT COMPLETED|Second Intervention||0
8110165|NCT03078127|19989268|P2|NOT COMPLETED|Second Intervention||0
8110166|NCT03078127|19989269|P1|NOT COMPLETED|Second Intervention||0
8110167|NCT03078127|19989267|P3|COMPLETED|Second Intervention||3
8110168|NCT03078127|19989268|P2|COMPLETED|Second Intervention||3
8110169|NCT03078127|19989269|P1|COMPLETED|Second Intervention||4
8110170|NCT03078127|19989267|P3|STARTED|Second Intervention||3
8110171|NCT03078127|19989268|P2|STARTED|Second Intervention||3
8110172|NCT03078127|19989269|P1|STARTED|Second Intervention||4
8110173|NCT03078127|19989267|P3|NOT COMPLETED|Washout (3-21 Days)||0
8110174|NCT03078127|19989268|P2|NOT COMPLETED|Washout (3-21 Days)||0
8110175|NCT03078127|19989269|P1|NOT COMPLETED|Washout (3-21 Days)||0
8110176|NCT03078127|19989267|P3|COMPLETED|Washout (3-21 Days)||3
8110177|NCT03078127|19989268|P2|COMPLETED|Washout (3-21 Days)||3
8110178|NCT03078127|19989269|P1|COMPLETED|Washout (3-21 Days)||4
8110179|NCT03078127|19989267|P3|STARTED|Washout (3-21 Days)||3
8110180|NCT03078127|19989268|P2|STARTED|Washout (3-21 Days)||3
8110181|NCT03078127|19989269|P1|STARTED|Washout (3-21 Days)||4
8110182|NCT03078127|19989267|P3|NOT COMPLETED|First Intervention||0
8110183|NCT03078127|19989268|P2|NOT COMPLETED|First Intervention||0
8110184|NCT03078127|19989269|P1|NOT COMPLETED|First Intervention||0
8110185|NCT03078127|19989267|P3|COMPLETED|First Intervention||3
8110186|NCT03078127|19989268|P2|COMPLETED|First Intervention||3
8110187|NCT03078127|19989269|P1|COMPLETED|First Intervention||4
8110188|NCT03078127|19989267|P3|STARTED|First Intervention||3
8110189|NCT03078127|19989268|P2|STARTED|First Intervention||3
8110190|NCT03078127|19989269|P1|STARTED|First Intervention||4
8110191|NCT03077919|19989305|P2|NOT COMPLETED|Overall Study||1
8110192|NCT03077919|19989306|P1|NOT COMPLETED|Overall Study||4
8110193|NCT03077919|19989305|P2|COMPLETED|Overall Study||38
8110194|NCT03077919|19989306|P1|COMPLETED|Overall Study||70
8110195|NCT03077919|19989305|P2|Final CAPS|Overall Study||38
8110196|NCT03077919|19989306|P1|Final CAPS|Overall Study||70
8110197|NCT03077919|19989305|P2|Week 8 Visit|Overall Study||38
8110198|NCT03077919|19989306|P1|Week 8 Visit|Overall Study||71
8110199|NCT03077919|19989305|P2|Week 6 Visit|Overall Study||38
8110200|NCT03077919|19989306|P1|Week 6 Visit|Overall Study||73
8110201|NCT03077919|19989305|P2|Week 4 Visit|Overall Study||38
8110202|NCT03077919|19989306|P1|Week 4 Visit|Overall Study||73
8110203|NCT03077919|19989305|P2|Week 2 Visit|Overall Study||39
8110204|NCT03077919|19989306|P1|Week 2 Visit|Overall Study||74
8110205|NCT03077919|19989305|P2|STARTED|Overall Study||39
8110206|NCT03077919|19989306|P1|STARTED|Overall Study||74
8110207|NCT03077893|19989336|P2|NOT COMPLETED|Overall Study||3
8110208|NCT03077893|19989337|P1|NOT COMPLETED|Overall Study||4
8110209|NCT03077893|19989336|P2|COMPLETED|Overall Study||16
8110210|NCT03077893|19989337|P1|COMPLETED|Overall Study||14
8110211|NCT03077893|19989336|P2|STARTED|Overall Study||19
8110212|NCT03077893|19989337|P1|STARTED|Overall Study||18
8110213|NCT03077724|19989366|P2|NOT COMPLETED|Overall Study||2
8110214|NCT03077724|19989367|P1|NOT COMPLETED|Overall Study||8
8110215|NCT03077724|19989366|P2|COMPLETED|Overall Study||12
8110216|NCT03077724|19989367|P1|COMPLETED|Overall Study||6
8110217|NCT03077724|19989366|P2|STARTED|Overall Study||14
8110218|NCT03077724|19989367|P1|STARTED|Overall Study||14
8110219|NCT03077711|19989379|P2|NOT COMPLETED|Overall Study||2
8110220|NCT03077711|19989380|P1|NOT COMPLETED|Overall Study||4
8110221|NCT03077711|19989379|P2|COMPLETED|Overall Study||43
8110222|NCT03077711|19989380|P1|COMPLETED|Overall Study||43
8110223|NCT03077711|19989379|P2|STARTED|Overall Study||45
8110224|NCT03077711|19989380|P1|STARTED|Overall Study||47
8110225|NCT03077659|19989399|P3|NOT COMPLETED|Overall Study||1
8110226|NCT03077659|19989400|P2|NOT COMPLETED|Overall Study||0
8110227|NCT03077659|19989401|P1|NOT COMPLETED|Overall Study||0
8110228|NCT03077659|19989399|P3|COMPLETED|Overall Study||9
8110229|NCT03077659|19989400|P2|COMPLETED|Overall Study||3
8110230|NCT03077659|19989401|P1|COMPLETED|Overall Study||3
8110231|NCT03077659|19989399|P3|STARTED|Overall Study||10
8110232|NCT03077659|19989400|P2|STARTED|Overall Study||3
8110233|NCT03077659|19989401|P1|STARTED|Overall Study||3
8110254|NCT03077438|19989501|P2|NOT COMPLETED|Overall Study||14
8110255|NCT03077438|19989502|P1|NOT COMPLETED|Overall Study||12
8110256|NCT03077438|19989501|P2|COMPLETED|Overall Study||487
8110257|NCT03077438|19989502|P1|COMPLETED|Overall Study||487
8110258|NCT03077438|19989501|P2|Safety Analysis Set (SafAS)|Overall Study||494
8110259|NCT03077438|19989502|P1|Safety Analysis Set (SafAS)|Overall Study||498
8110260|NCT03077438|19989501|P2|STARTED|Overall Study||501
8110261|NCT03077438|19989502|P1|STARTED|Overall Study||499
8110262|NCT03077165|19989524|P6|NOT COMPLETED|Overall Study||0
8110263|NCT03077165|19989525|P5|NOT COMPLETED|Overall Study||3
8110264|NCT03077165|19989526|P4|NOT COMPLETED|Overall Study||0
8110265|NCT03077165|19989527|P3|NOT COMPLETED|Overall Study||0
8110266|NCT03077165|19989528|P2|NOT COMPLETED|Overall Study||0
8110267|NCT03077165|19989529|P1|NOT COMPLETED|Overall Study||1
8110268|NCT03077165|19989524|P6|COMPLETED|Overall Study||20
8110269|NCT03077165|19989525|P5|COMPLETED|Overall Study||16
8110270|NCT03077165|19989526|P4|COMPLETED|Overall Study||19
8110271|NCT03077165|19989527|P3|COMPLETED|Overall Study||20
8110272|NCT03077165|19989528|P2|COMPLETED|Overall Study||22
8110273|NCT03077165|19989529|P1|COMPLETED|Overall Study||20
8110274|NCT03077165|19989524|P6|STARTED|Overall Study||20
8110275|NCT03077165|19989525|P5|STARTED|Overall Study||19
8110276|NCT03077165|19989526|P4|STARTED|Overall Study||19
8110277|NCT03077165|19989527|P3|STARTED|Overall Study||20
8110278|NCT03077165|19989528|P2|STARTED|Overall Study||22
8110279|NCT03077165|19989529|P1|STARTED|Overall Study||21
8110280|NCT03076996|19989543|P1|NOT COMPLETED|Overall Study||6
8110281|NCT03076996|19989543|P1|COMPLETED|Overall Study||35
8110282|NCT03076996|19989543|P1|STARTED|Overall Study||41
8110283|NCT03076983|19989552|P2|NOT COMPLETED|Overall Study||0
8110284|NCT03076983|19989553|P1|NOT COMPLETED|Overall Study||0
8110285|NCT03076983|19989552|P2|COMPLETED|Overall Study||25
8110286|NCT03076983|19989553|P1|COMPLETED|Overall Study||55
8110287|NCT03076983|19989552|P2|STARTED|Overall Study||25
8110288|NCT03076983|19989553|P1|STARTED|Overall Study||55
8110289|NCT03076970|19989569|P6|NOT COMPLETED|Washout Period 3||0
8110290|NCT03076970|19989570|P5|NOT COMPLETED|Washout Period 3||0
8110291|NCT03076970|19989571|P4|NOT COMPLETED|Washout Period 3||0
8110292|NCT03076970|19989572|P3|NOT COMPLETED|Washout Period 3||0
8110293|NCT03076970|19989573|P2|NOT COMPLETED|Washout Period 3||0
8110294|NCT03076970|19989574|P1|NOT COMPLETED|Washout Period 3||0
8110295|NCT03076970|19989569|P6|COMPLETED|Washout Period 3||6
8110296|NCT03076970|19989570|P5|COMPLETED|Washout Period 3||5
8110297|NCT03076970|19989571|P4|COMPLETED|Washout Period 3||7
8110298|NCT03076970|19989572|P3|COMPLETED|Washout Period 3||7
8110299|NCT03076970|19989573|P2|COMPLETED|Washout Period 3||7
8110300|NCT03076970|19989574|P1|COMPLETED|Washout Period 3||7
8110301|NCT03076970|19989569|P6|STARTED|Washout Period 3||6
8110302|NCT03076970|19989570|P5|STARTED|Washout Period 3||5
8110303|NCT03076970|19989571|P4|STARTED|Washout Period 3||7
8110304|NCT03076970|19989572|P3|STARTED|Washout Period 3||7
8110305|NCT03076970|19989573|P2|STARTED|Washout Period 3||7
8110306|NCT03076970|19989574|P1|STARTED|Washout Period 3||7
8110307|NCT03076970|19989569|P6|NOT COMPLETED|Period 3||1
8110308|NCT03076970|19989570|P5|NOT COMPLETED|Period 3||1
8110309|NCT03076970|19989571|P4|NOT COMPLETED|Period 3||0
8110310|NCT03076970|19989572|P3|NOT COMPLETED|Period 3||0
8110311|NCT03076970|19989573|P2|NOT COMPLETED|Period 3||0
8110312|NCT03076970|19989574|P1|NOT COMPLETED|Period 3||0
8110313|NCT03076970|19989569|P6|COMPLETED|Period 3||6
8110314|NCT03076970|19989570|P5|COMPLETED|Period 3||5
8110315|NCT03076970|19989571|P4|COMPLETED|Period 3||7
8110316|NCT03076970|19989572|P3|COMPLETED|Period 3||7
8110317|NCT03076970|19989573|P2|COMPLETED|Period 3||7
8110318|NCT03076970|19989574|P1|COMPLETED|Period 3||7
8110319|NCT03076970|19989569|P6|STARTED|Period 3||7
8110320|NCT03076970|19989570|P5|STARTED|Period 3||6
8110321|NCT03076970|19989571|P4|STARTED|Period 3||7
8110322|NCT03076970|19989572|P3|STARTED|Period 3||7
8110323|NCT03076970|19989573|P2|STARTED|Period 3||7
8110324|NCT03076970|19989574|P1|STARTED|Period 3||7
8110325|NCT03076970|19989569|P6|NOT COMPLETED|Washout Period 2||0
8110326|NCT03076970|19989570|P5|NOT COMPLETED|Washout Period 2||1
8110327|NCT03076970|19989571|P4|NOT COMPLETED|Washout Period 2||0
8110328|NCT03076970|19989572|P3|NOT COMPLETED|Washout Period 2||0
8110329|NCT03076970|19989573|P2|NOT COMPLETED|Washout Period 2||0
8110330|NCT03076970|19989574|P1|NOT COMPLETED|Washout Period 2||0
8110331|NCT03076970|19989569|P6|COMPLETED|Washout Period 2||7
8110332|NCT03076970|19989570|P5|COMPLETED|Washout Period 2||6
8110333|NCT03076970|19989571|P4|COMPLETED|Washout Period 2||7
8110334|NCT03076970|19989572|P3|COMPLETED|Washout Period 2||7
8110335|NCT03076970|19989573|P2|COMPLETED|Washout Period 2||7
8110336|NCT03076970|19989574|P1|COMPLETED|Washout Period 2||7
8110337|NCT03076970|19989569|P6|STARTED|Washout Period 2||7
8110338|NCT03076970|19989570|P5|STARTED|Washout Period 2||7
8110339|NCT03076970|19989571|P4|STARTED|Washout Period 2||7
8110340|NCT03076970|19989572|P3|STARTED|Washout Period 2||7
8110341|NCT03076970|19989573|P2|STARTED|Washout Period 2||7
8110342|NCT03076970|19989574|P1|STARTED|Washout Period 2||7
8110343|NCT03076970|19989569|P6|NOT COMPLETED|Period 2||0
8110344|NCT03076970|19989570|P5|NOT COMPLETED|Period 2||0
8110345|NCT03076970|19989571|P4|NOT COMPLETED|Period 2||0
8110346|NCT03076970|19989572|P3|NOT COMPLETED|Period 2||0
8110347|NCT03076970|19989573|P2|NOT COMPLETED|Period 2||0
8110348|NCT03076970|19989574|P1|NOT COMPLETED|Period 2||0
8110349|NCT03076970|19989569|P6|COMPLETED|Period 2||7
8110350|NCT03076970|19989570|P5|COMPLETED|Period 2||7
8110351|NCT03076970|19989571|P4|COMPLETED|Period 2||7
8110352|NCT03076970|19989572|P3|COMPLETED|Period 2||7
8110353|NCT03076970|19989573|P2|COMPLETED|Period 2||7
8110354|NCT03076970|19989574|P1|COMPLETED|Period 2||7
8110355|NCT03076970|19989569|P6|STARTED|Period 2||7
8110356|NCT03076970|19989570|P5|STARTED|Period 2||7
8110357|NCT03076970|19989571|P4|STARTED|Period 2||7
8110358|NCT03076970|19989572|P3|STARTED|Period 2||7
8110359|NCT03076970|19989573|P2|STARTED|Period 2||7
8110360|NCT03076970|19989574|P1|STARTED|Period 2||7
8110361|NCT03076970|19989569|P6|NOT COMPLETED|Washout Period 1||0
8110362|NCT03076970|19989570|P5|NOT COMPLETED|Washout Period 1||0
8110363|NCT03076970|19989571|P4|NOT COMPLETED|Washout Period 1||0
8110364|NCT03076970|19989572|P3|NOT COMPLETED|Washout Period 1||0
8110365|NCT03076970|19989573|P2|NOT COMPLETED|Washout Period 1||0
8110366|NCT03076970|19989574|P1|NOT COMPLETED|Washout Period 1||0
8110367|NCT03076970|19989569|P6|COMPLETED|Washout Period 1||7
8110368|NCT03076970|19989570|P5|COMPLETED|Washout Period 1||7
8110369|NCT03076970|19989571|P4|COMPLETED|Washout Period 1||7
8110370|NCT03076970|19989572|P3|COMPLETED|Washout Period 1||7
8110371|NCT03076970|19989573|P2|COMPLETED|Washout Period 1||7
8110372|NCT03076970|19989574|P1|COMPLETED|Washout Period 1||7
8110373|NCT03076970|19989569|P6|STARTED|Washout Period 1||7
8110374|NCT03076970|19989570|P5|STARTED|Washout Period 1||7
8110375|NCT03076970|19989571|P4|STARTED|Washout Period 1||7
8110376|NCT03076970|19989572|P3|STARTED|Washout Period 1||7
8110377|NCT03076970|19989573|P2|STARTED|Washout Period 1||7
8110378|NCT03076970|19989574|P1|STARTED|Washout Period 1||7
8110379|NCT03076970|19989569|P6|NOT COMPLETED|Period 1||0
8110380|NCT03076970|19989570|P5|NOT COMPLETED|Period 1||0
8110381|NCT03076970|19989571|P4|NOT COMPLETED|Period 1||0
8110382|NCT03076970|19989572|P3|NOT COMPLETED|Period 1||0
8110383|NCT03076970|19989573|P2|NOT COMPLETED|Period 1||0
8110384|NCT03076970|19989574|P1|NOT COMPLETED|Period 1||0
8110385|NCT03076970|19989569|P6|COMPLETED|Period 1||7
8110386|NCT03076970|19989570|P5|COMPLETED|Period 1||7
8110387|NCT03076970|19989571|P4|COMPLETED|Period 1||7
8110388|NCT03076970|19989572|P3|COMPLETED|Period 1||7
8110389|NCT03076970|19989573|P2|COMPLETED|Period 1||7
8110390|NCT03076970|19989574|P1|COMPLETED|Period 1||7
8110391|NCT03076970|19989569|P6|Received at Least 1 Dose of Study Drug|Period 1||7
8110392|NCT03076970|19989570|P5|Received at Least 1 Dose of Study Drug|Period 1||7
8110393|NCT03076970|19989571|P4|Received at Least 1 Dose of Study Drug|Period 1||7
8110394|NCT03076970|19989572|P3|Received at Least 1 Dose of Study Drug|Period 1||7
8110395|NCT03076970|19989573|P2|Received at Least 1 Dose of Study Drug|Period 1||7
8110396|NCT03076970|19989574|P1|Received at Least 1 Dose of Study Drug|Period 1||7
8110397|NCT03076970|19989569|P6|STARTED|Period 1||7
8110398|NCT03076970|19989570|P5|STARTED|Period 1||7
8110399|NCT03076970|19989571|P4|STARTED|Period 1||7
8110400|NCT03076970|19989572|P3|STARTED|Period 1||7
8110401|NCT03076970|19989573|P2|STARTED|Period 1||7
8110402|NCT03076970|19989574|P1|STARTED|Period 1||7
8110403|NCT03076515|19989626|P2|NOT COMPLETED|Overall Study||29
8110404|NCT03076515|19989627|P1|NOT COMPLETED|Overall Study||25
8110405|NCT03076515|19989626|P2|COMPLETED|Overall Study||33
8110406|NCT03076515|19989627|P1|COMPLETED|Overall Study||33
8110407|NCT03076515|19989626|P2|STARTED|Overall Study||62
8110408|NCT03076515|19989627|P1|STARTED|Overall Study||58
8110409|NCT03076359|19989635|P2|NOT COMPLETED|Overall Study||0
8110410|NCT03076359|19989636|P1|NOT COMPLETED|Overall Study||0
8110411|NCT03076359|19989635|P2|COMPLETED|Overall Study||150
8110412|NCT03076359|19989636|P1|COMPLETED|Overall Study||170
8110413|NCT03076359|19989635|P2|STARTED|Overall Study||150
8110414|NCT03076359|19989636|P1|STARTED|Overall Study||170
8110415|NCT03076190|19989646|P2|NOT COMPLETED|Overall Study||41
8110416|NCT03076190|19989647|P1|NOT COMPLETED|Overall Study||18
8110417|NCT03076190|19989646|P2|COMPLETED|Overall Study||36
8110418|NCT03076190|19989647|P1|COMPLETED|Overall Study||32
8110419|NCT03076190|19989646|P2|STARTED|Overall Study||77
8110420|NCT03076190|19989647|P1|STARTED|Overall Study||50
8110421|NCT03075904|19989660|P1|NOT COMPLETED|Overall Study||4
8110422|NCT03075904|19989660|P1|COMPLETED|Overall Study||4
8110423|NCT03075904|19989660|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8110424|NCT03075904|19989660|P1|STARTED|Overall Study||8
8110431|NCT03075878|19989677|P1|NOT COMPLETED|Overall Study||1
8110432|NCT03075878|19989677|P1|COMPLETED|Overall Study||7
8110433|NCT03075878|19989677|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8110434|NCT03075878|19989677|P1|STARTED|Overall Study||8
8110435|NCT03075839|19989685|P1|NOT COMPLETED|Overall Study||4
8110436|NCT03075839|19989685|P1|COMPLETED|Overall Study||29
8110437|NCT03075839|19989685|P1|STARTED|Overall Study||33
8110438|NCT03075644|19989693|P2|NOT COMPLETED|Overall Study||1
8110439|NCT03075644|19989694|P1|NOT COMPLETED|Overall Study||1
8110440|NCT03075644|19989693|P2|COMPLETED|Overall Study||45
8110441|NCT03075644|19989694|P1|COMPLETED|Overall Study||15
8110442|NCT03075644|19989693|P2|Safety Analysis Set (SAS)|Overall Study||46
8110443|NCT03075644|19989694|P1|Safety Analysis Set (SAS)|Overall Study||16
8110444|NCT03075644|19989693|P2|Full Analysis Set (FAS)|Overall Study||46
8110445|NCT03075644|19989694|P1|Full Analysis Set (FAS)|Overall Study||16
8110446|NCT03075644|19989693|P2|STARTED|Overall Study||46
8110447|NCT03075644|19989694|P1|STARTED|Overall Study||16
8110448|NCT03075553|19989755|P1|NOT COMPLETED|Overall Study||0
8110449|NCT03075553|19989755|P1|COMPLETED|Overall Study||12
8110450|NCT03075553|19989755|P1|STARTED|Overall Study||12
8110454|NCT03075449|19989768|P1|NOT COMPLETED|Overall Study||0
8110455|NCT03075449|19989768|P1|COMPLETED|Overall Study||170
8110456|NCT03075449|19989768|P1|STARTED|Overall Study||170
8110457|NCT03075410|19989788|P9|NOT COMPLETED|Part B (up to 28 Days)||0
8110458|NCT03075410|19989789|P8|NOT COMPLETED|Part B (up to 28 Days)||0
8110459|NCT03075410|19989790|P7|NOT COMPLETED|Part B (up to 28 Days)||0
8110460|NCT03075410|19989791|P6|NOT COMPLETED|Part B (up to 28 Days)||0
8110461|NCT03075410|19989792|P5|NOT COMPLETED|Part B (up to 28 Days)||0
8110462|NCT03075410|19989793|P4|NOT COMPLETED|Part B (up to 28 Days)||0
8110463|NCT03075410|19989794|P3|NOT COMPLETED|Part B (up to 28 Days)||0
8110464|NCT03075410|19989795|P2|NOT COMPLETED|Part B (up to 28 Days)||0
8110465|NCT03075410|19989796|P1|NOT COMPLETED|Part B (up to 28 Days)||0
8110466|NCT03075410|19989788|P9|COMPLETED|Part B (up to 28 Days)||8
8110467|NCT03075410|19989789|P8|COMPLETED|Part B (up to 28 Days)||7
8110468|NCT03075410|19989790|P7|COMPLETED|Part B (up to 28 Days)||4
8110469|NCT03075410|19989791|P6|COMPLETED|Part B (up to 28 Days)||0
8110470|NCT03075410|19989792|P5|COMPLETED|Part B (up to 28 Days)||0
8110471|NCT03075410|19989793|P4|COMPLETED|Part B (up to 28 Days)||0
8110472|NCT03075410|19989794|P3|COMPLETED|Part B (up to 28 Days)||0
8110473|NCT03075410|19989795|P2|COMPLETED|Part B (up to 28 Days)||0
8110474|NCT03075410|19989796|P1|COMPLETED|Part B (up to 28 Days)||0
8110475|NCT03075410|19989788|P9|STARTED|Part B (up to 28 Days)||8
8110476|NCT03075410|19989789|P8|STARTED|Part B (up to 28 Days)||7
8110477|NCT03075410|19989790|P7|STARTED|Part B (up to 28 Days)||4
8110478|NCT03075410|19989791|P6|STARTED|Part B (up to 28 Days)||0
8110479|NCT03075410|19989792|P5|STARTED|Part B (up to 28 Days)||0
8110480|NCT03075410|19989793|P4|STARTED|Part B (up to 28 Days)||0
8110481|NCT03075410|19989794|P3|STARTED|Part B (up to 28 Days)||0
8110482|NCT03075410|19989795|P2|STARTED|Part B (up to 28 Days)||0
8110483|NCT03075410|19989796|P1|STARTED|Part B (up to 28 Days)||0
8110484|NCT03075410|19989788|P9|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110485|NCT03075410|19989789|P8|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110486|NCT03075410|19989790|P7|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110487|NCT03075410|19989791|P6|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110488|NCT03075410|19989792|P5|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110489|NCT03075410|19989793|P4|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110490|NCT03075410|19989794|P3|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110491|NCT03075410|19989795|P2|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110492|NCT03075410|19989796|P1|NOT COMPLETED|Part A-Period 4 (14 Days)||0
8110493|NCT03075410|19989788|P9|COMPLETED|Part A-Period 4 (14 Days)||0
8110494|NCT03075410|19989789|P8|COMPLETED|Part A-Period 4 (14 Days)||0
8110495|NCT03075410|19989790|P7|COMPLETED|Part A-Period 4 (14 Days)||0
8110496|NCT03075410|19989791|P6|COMPLETED|Part A-Period 4 (14 Days)||1
8110497|NCT03075410|19989792|P5|COMPLETED|Part A-Period 4 (14 Days)||2
8110498|NCT03075410|19989793|P4|COMPLETED|Part A-Period 4 (14 Days)||1
8110499|NCT03075410|19989794|P3|COMPLETED|Part A-Period 4 (14 Days)||2
8110500|NCT03075410|19989795|P2|COMPLETED|Part A-Period 4 (14 Days)||1
8110501|NCT03075410|19989796|P1|COMPLETED|Part A-Period 4 (14 Days)||1
8110502|NCT03075410|19989788|P9|STARTED|Part A-Period 4 (14 Days)||0
8110503|NCT03075410|19989789|P8|STARTED|Part A-Period 4 (14 Days)||0
8110504|NCT03075410|19989790|P7|STARTED|Part A-Period 4 (14 Days)||0
8110505|NCT03075410|19989791|P6|STARTED|Part A-Period 4 (14 Days)||1
8110506|NCT03075410|19989792|P5|STARTED|Part A-Period 4 (14 Days)||2
8110507|NCT03075410|19989793|P4|STARTED|Part A-Period 4 (14 Days)||1
8110508|NCT03075410|19989794|P3|STARTED|Part A-Period 4 (14 Days)||2
8110509|NCT03075410|19989795|P2|STARTED|Part A-Period 4 (14 Days)||1
8110510|NCT03075410|19989796|P1|STARTED|Part A-Period 4 (14 Days)||1
8110511|NCT03075410|19989788|P9|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110512|NCT03075410|19989789|P8|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110513|NCT03075410|19989790|P7|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110514|NCT03075410|19989791|P6|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110515|NCT03075410|19989792|P5|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110516|NCT03075410|19989793|P4|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110517|NCT03075410|19989794|P3|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110518|NCT03075410|19989795|P2|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110519|NCT03075410|19989796|P1|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110520|NCT03075410|19989788|P9|COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110521|NCT03075410|19989789|P8|COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110522|NCT03075410|19989790|P7|COMPLETED|Part A-Washout Period 3 (14 Days)||0
8110523|NCT03075410|19989791|P6|COMPLETED|Part A-Washout Period 3 (14 Days)||1
8110524|NCT03075410|19989792|P5|COMPLETED|Part A-Washout Period 3 (14 Days)||2
8110525|NCT03075410|19989793|P4|COMPLETED|Part A-Washout Period 3 (14 Days)||1
8110526|NCT03075410|19989794|P3|COMPLETED|Part A-Washout Period 3 (14 Days)||2
8110527|NCT03075410|19989795|P2|COMPLETED|Part A-Washout Period 3 (14 Days)||1
8110528|NCT03075410|19989796|P1|COMPLETED|Part A-Washout Period 3 (14 Days)||1
8110529|NCT03075410|19989788|P9|STARTED|Part A-Washout Period 3 (14 Days)||0
8110530|NCT03075410|19989789|P8|STARTED|Part A-Washout Period 3 (14 Days)||0
8110531|NCT03075410|19989790|P7|STARTED|Part A-Washout Period 3 (14 Days)||0
8110532|NCT03075410|19989791|P6|STARTED|Part A-Washout Period 3 (14 Days)||1
8110533|NCT03075410|19989792|P5|STARTED|Part A-Washout Period 3 (14 Days)||2
8110534|NCT03075410|19989793|P4|STARTED|Part A-Washout Period 3 (14 Days)||1
8110535|NCT03075410|19989794|P3|STARTED|Part A-Washout Period 3 (14 Days)||2
8110536|NCT03075410|19989795|P2|STARTED|Part A-Washout Period 3 (14 Days)||1
8110537|NCT03075410|19989796|P1|STARTED|Part A-Washout Period 3 (14 Days)||1
8110538|NCT03075410|19989788|P9|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110539|NCT03075410|19989789|P8|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110540|NCT03075410|19989790|P7|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110541|NCT03075410|19989791|P6|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110542|NCT03075410|19989792|P5|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110543|NCT03075410|19989793|P4|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110544|NCT03075410|19989794|P3|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110545|NCT03075410|19989795|P2|NOT COMPLETED|Part A-Period 3 (14 Days)||0
8110546|NCT03075410|19989796|P1|NOT COMPLETED|Part A-Period 3 (14 Days)||1
8110547|NCT03075410|19989788|P9|COMPLETED|Part A-Period 3 (14 Days)||0
8110548|NCT03075410|19989789|P8|COMPLETED|Part A-Period 3 (14 Days)||0
8110549|NCT03075410|19989790|P7|COMPLETED|Part A-Period 3 (14 Days)||0
8110550|NCT03075410|19989791|P6|COMPLETED|Part A-Period 3 (14 Days)||1
8110551|NCT03075410|19989792|P5|COMPLETED|Part A-Period 3 (14 Days)||2
8110552|NCT03075410|19989793|P4|COMPLETED|Part A-Period 3 (14 Days)||1
8110553|NCT03075410|19989794|P3|COMPLETED|Part A-Period 3 (14 Days)||2
8110554|NCT03075410|19989795|P2|COMPLETED|Part A-Period 3 (14 Days)||1
8110555|NCT03075410|19989796|P1|COMPLETED|Part A-Period 3 (14 Days)||1
8110556|NCT03075410|19989788|P9|STARTED|Part A-Period 3 (14 Days)||0
8110557|NCT03075410|19989789|P8|STARTED|Part A-Period 3 (14 Days)||0
8110558|NCT03075410|19989790|P7|STARTED|Part A-Period 3 (14 Days)||0
8110559|NCT03075410|19989791|P6|STARTED|Part A-Period 3 (14 Days)||1
8110560|NCT03075410|19989792|P5|STARTED|Part A-Period 3 (14 Days)||2
8110561|NCT03075410|19989793|P4|STARTED|Part A-Period 3 (14 Days)||1
8110562|NCT03075410|19989794|P3|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
8110563|NCT03075410|19989795|P2|STARTED|Part A-Period 3 (14 Days)||1
8110564|NCT03075410|19989796|P1|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
8110565|NCT03075410|19989788|P9|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110566|NCT03075410|19989789|P8|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110567|NCT03075410|19989790|P7|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110568|NCT03075410|19989791|P6|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110569|NCT03075410|19989792|P5|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110570|NCT03075410|19989793|P4|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110571|NCT03075410|19989794|P3|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110572|NCT03075410|19989795|P2|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110573|NCT03075410|19989796|P1|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110574|NCT03075410|19989788|P9|COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110575|NCT03075410|19989789|P8|COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110576|NCT03075410|19989790|P7|COMPLETED|Part A-Washout Period 2 (14 Days)||0
8110577|NCT03075410|19989791|P6|COMPLETED|Part A-Washout Period 2 (14 Days)||1
8110578|NCT03075410|19989792|P5|COMPLETED|Part A-Washout Period 2 (14 Days)||2
8110579|NCT03075410|19989793|P4|COMPLETED|Part A-Washout Period 2 (14 Days)||1
8110580|NCT03075410|19989794|P3|COMPLETED|Part A-Washout Period 2 (14 Days)||1
8110581|NCT03075410|19989795|P2|COMPLETED|Part A-Washout Period 2 (14 Days)||1
8110582|NCT03075410|19989796|P1|COMPLETED|Part A-Washout Period 2 (14 Days)||1
8110583|NCT03075410|19989788|P9|STARTED|Part A-Washout Period 2 (14 Days)||0
8110584|NCT03075410|19989789|P8|STARTED|Part A-Washout Period 2 (14 Days)||0
8110585|NCT03075410|19989790|P7|STARTED|Part A-Washout Period 2 (14 Days)||0
8110586|NCT03075410|19989791|P6|STARTED|Part A-Washout Period 2 (14 Days)||1
8110587|NCT03075410|19989792|P5|STARTED|Part A-Washout Period 2 (14 Days)||2
8110588|NCT03075410|19989793|P4|STARTED|Part A-Washout Period 2 (14 Days)||1
8110589|NCT03075410|19989794|P3|STARTED|Part A-Washout Period 2 (14 Days)||1
8110590|NCT03075410|19989795|P2|STARTED|Part A-Washout Period 2 (14 Days)||1
8110591|NCT03075410|19989796|P1|STARTED|Part A-Washout Period 2 (14 Days)||1
8110592|NCT03075410|19989788|P9|NOT COMPLETED|Part A-Period 2 (14 Days)||0
8110593|NCT03075410|19989789|P8|NOT COMPLETED|Part A-Period 2 (14 Days)||0
8110594|NCT03075410|19989790|P7|NOT COMPLETED|Part A-Period 2 (14 Days)||0
8110595|NCT03075410|19989791|P6|NOT COMPLETED|Part A-Period 2 (14 Days)||0
8110596|NCT03075410|19989792|P5|NOT COMPLETED|Part A-Period 2 (14 Days)||0
8110597|NCT03075410|19989793|P4|NOT COMPLETED|Part A-Period 2 (14 Days)||0
8110598|NCT03075410|19989794|P3|NOT COMPLETED|Part A-Period 2 (14 Days)||1
8110599|NCT03075410|19989795|P2|NOT COMPLETED|Part A-Period 2 (14 Days)||0
8110600|NCT03075410|19989796|P1|NOT COMPLETED|Part A-Period 2 (14 Days)||1
8110601|NCT03075410|19989788|P9|COMPLETED|Part A-Period 2 (14 Days)||0
8110602|NCT03075410|19989789|P8|COMPLETED|Part A-Period 2 (14 Days)||0
8110603|NCT03075410|19989790|P7|COMPLETED|Part A-Period 2 (14 Days)||0
8110604|NCT03075410|19989791|P6|COMPLETED|Part A-Period 2 (14 Days)||1
8110605|NCT03075410|19989792|P5|COMPLETED|Part A-Period 2 (14 Days)||2
8110606|NCT03075410|19989793|P4|COMPLETED|Part A-Period 2 (14 Days)||1
8110607|NCT03075410|19989794|P3|COMPLETED|Part A-Period 2 (14 Days)||1
8110608|NCT03075410|19989795|P2|COMPLETED|Part A-Period 2 (14 Days)||1
8110609|NCT03075410|19989796|P1|COMPLETED|Part A-Period 2 (14 Days)||1
8110610|NCT03075410|19989788|P9|STARTED|Part A-Period 2 (14 Days)||0
8110611|NCT03075410|19989789|P8|STARTED|Part A-Period 2 (14 Days)||0
8110612|NCT03075410|19989790|P7|STARTED|Part A-Period 2 (14 Days)||0
8110613|NCT03075410|19989791|P6|STARTED|Part A-Period 2 (14 Days)||1
8110614|NCT03075410|19989792|P5|STARTED|Part A-Period 2 (14 Days)||2
8110615|NCT03075410|19989793|P4|STARTED|Part A-Period 2 (14 Days)||1
8110616|NCT03075410|19989794|P3|STARTED|Part A-Period 2 (14 Days)||2
8110617|NCT03075410|19989795|P2|STARTED|Part A-Period 2 (14 Days)||1
8110618|NCT03075410|19989796|P1|STARTED|Part A-Period 2 (14 Days)||2
8110619|NCT03075410|19989788|P9|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110620|NCT03075410|19989789|P8|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110621|NCT03075410|19989790|P7|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110622|NCT03075410|19989791|P6|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110623|NCT03075410|19989792|P5|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110624|NCT03075410|19989793|P4|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110625|NCT03075410|19989794|P3|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110626|NCT03075410|19989795|P2|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110627|NCT03075410|19989796|P1|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110628|NCT03075410|19989788|P9|COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110629|NCT03075410|19989789|P8|COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110630|NCT03075410|19989790|P7|COMPLETED|Part A-Washout Period 1 (14 Days)||0
8110631|NCT03075410|19989791|P6|COMPLETED|Part A-Washout Period 1 (14 Days)||1
8110632|NCT03075410|19989792|P5|COMPLETED|Part A-Washout Period 1 (14 Days)||2
8110633|NCT03075410|19989793|P4|COMPLETED|Part A-Washout Period 1 (14 Days)||1
8110634|NCT03075410|19989794|P3|COMPLETED|Part A-Washout Period 1 (14 Days)||2
8110635|NCT03075410|19989795|P2|COMPLETED|Part A-Washout Period 1 (14 Days)||1
8110636|NCT03075410|19989796|P1|COMPLETED|Part A-Washout Period 1 (14 Days)||2
8110637|NCT03075410|19989788|P9|STARTED|Part A-Washout Period 1 (14 Days)||0
8110638|NCT03075410|19989789|P8|STARTED|Part A-Washout Period 1 (14 Days)||0
8110639|NCT03075410|19989790|P7|STARTED|Part A-Washout Period 1 (14 Days)||0
8110640|NCT03075410|19989791|P6|STARTED|Part A-Washout Period 1 (14 Days)||1
8110641|NCT03075410|19989792|P5|STARTED|Part A-Washout Period 1 (14 Days)||2
8110642|NCT03075410|19989793|P4|STARTED|Part A-Washout Period 1 (14 Days)||1
8110643|NCT03075410|19989794|P3|STARTED|Part A-Washout Period 1 (14 Days)||2
8110644|NCT03075410|19989795|P2|STARTED|Part A-Washout Period 1 (14 Days)||1
8110645|NCT03075410|19989796|P1|STARTED|Part A-Washout Period 1 (14 Days)||2
8110646|NCT03075410|19989788|P9|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110647|NCT03075410|19989789|P8|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110648|NCT03075410|19989790|P7|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110649|NCT03075410|19989791|P6|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110650|NCT03075410|19989792|P5|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110651|NCT03075410|19989793|P4|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110652|NCT03075410|19989794|P3|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110653|NCT03075410|19989795|P2|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110654|NCT03075410|19989796|P1|NOT COMPLETED|Part A-Period 1 (14 Days)||0
8110655|NCT03075410|19989788|P9|COMPLETED|Part A-Period 1 (14 Days)||0
8110656|NCT03075410|19989789|P8|COMPLETED|Part A-Period 1 (14 Days)||0
8110657|NCT03075410|19989790|P7|COMPLETED|Part A-Period 1 (14 Days)||0
8110658|NCT03075410|19989791|P6|COMPLETED|Part A-Period 1 (14 Days)||1
8110659|NCT03075410|19989792|P5|COMPLETED|Part A-Period 1 (14 Days)||2
8110660|NCT03075410|19989793|P4|COMPLETED|Part A-Period 1 (14 Days)||1
8110661|NCT03075410|19989794|P3|COMPLETED|Part A-Period 1 (14 Days)||2
8110662|NCT03075410|19989795|P2|COMPLETED|Part A-Period 1 (14 Days)||1
8110663|NCT03075410|19989796|P1|COMPLETED|Part A-Period 1 (14 Days)||2
8110664|NCT03075410|19989788|P9|STARTED|Part A-Period 1 (14 Days)||0
8110665|NCT03075410|19989789|P8|STARTED|Part A-Period 1 (14 Days)||0
8110666|NCT03075410|19989790|P7|STARTED|Part A-Period 1 (14 Days)||0
8110667|NCT03075410|19989791|P6|STARTED|Part A-Period 1 (14 Days)||1
8110668|NCT03075410|19989792|P5|STARTED|Part A-Period 1 (14 Days)||2
8110669|NCT03075410|19989793|P4|STARTED|Part A-Period 1 (14 Days)||1
8110670|NCT03075410|19989794|P3|STARTED|Part A-Period 1 (14 Days)||2
8110671|NCT03075410|19989795|P2|STARTED|Part A-Period 1 (14 Days)||1
8110672|NCT03075410|19989796|P1|STARTED|Part A-Period 1 (14 Days)||2
8110673|NCT03075267|19989963|P3|NOT COMPLETED|Overall Study||0
8110674|NCT03075267|19989964|P2|NOT COMPLETED|Overall Study||0
8110675|NCT03075267|19989965|P1|NOT COMPLETED|Overall Study||1
8110676|NCT03075267|19989963|P3|COMPLETED|Overall Study||32
8110677|NCT03075267|19989964|P2|COMPLETED|Overall Study||32
8110678|NCT03075267|19989965|P1|COMPLETED|Overall Study||31
8110679|NCT03075267|19989963|P3|STARTED|Overall Study||32
8110680|NCT03075267|19989964|P2|STARTED|Overall Study||32
8110681|NCT03075267|19989965|P1|STARTED|Overall Study||32
8110682|NCT03075163|19990099|P2|NOT COMPLETED|Overall Study||138
8110683|NCT03075163|19990100|P1|NOT COMPLETED|Overall Study||138
8110684|NCT03075163|19990099|P2|COMPLETED|Overall Study||12
8110685|NCT03075163|19990100|P1|COMPLETED|Overall Study||12
8110686|NCT03075163|19990099|P2|STARTED|Overall Study||150
8110687|NCT03075163|19990100|P1|STARTED|Overall Study||150
8110688|NCT03074682|19990109|P3|NOT COMPLETED|Overall Study||0
8110689|NCT03074682|19990110|P2|NOT COMPLETED|Overall Study||0
8110690|NCT03074682|19990111|P1|NOT COMPLETED|Overall Study||0
8110691|NCT03074682|19990109|P3|COMPLETED|Overall Study||18
8110692|NCT03074682|19990110|P2|COMPLETED|Overall Study||18
8110693|NCT03074682|19990111|P1|COMPLETED|Overall Study||18
8110694|NCT03074682|19990109|P3|STARTED|Overall Study||18
8110695|NCT03074682|19990110|P2|STARTED|Overall Study||18
8110696|NCT03074682|19990111|P1|STARTED|Overall Study||18
8110697|NCT03074630|19990128|P1|NOT COMPLETED|Overall Study||1
8110698|NCT03074630|19990128|P1|COMPLETED|Overall Study||11
8110699|NCT03074630|19990128|P1|STARTED|Overall Study||12
8110700|NCT03074500|19990147|P3|NOT COMPLETED|Overall Study||1
8110701|NCT03074500|19990148|P2|NOT COMPLETED|Overall Study||1
8110702|NCT03074500|19990149|P1|NOT COMPLETED|Overall Study||1
8110703|NCT03074500|19990147|P3|COMPLETED|Overall Study||10
8110704|NCT03074500|19990148|P2|COMPLETED|Overall Study||10
8110705|NCT03074500|19990149|P1|COMPLETED|Overall Study||10
8110706|NCT03074500|19990147|P3|STARTED|Overall Study||11
8110707|NCT03074500|19990148|P2|STARTED|Overall Study||11
8110708|NCT03074500|19990149|P1|STARTED|Overall Study||11
8110709|NCT03074409|19990177|P2|NOT COMPLETED|Overall Study||4
8110710|NCT03074409|19990178|P1|NOT COMPLETED|Overall Study||4
8110711|NCT03074409|19990177|P2|COMPLETED|Overall Study||38
8110712|NCT03074409|19990178|P1|COMPLETED|Overall Study||37
8110713|NCT03074409|19990177|P2|STARTED|Overall Study||42
8110714|NCT03074409|19990178|P1|STARTED|Overall Study||41
8110715|NCT03074331|19990186|P1|NOT COMPLETED|Overall Study||7
8110716|NCT03074331|19990186|P1|COMPLETED|Overall Study||123
8110717|NCT03074331|19990186|P1|STARTED|Overall Study||130
8110718|NCT03074162|19990198|P6|NOT COMPLETED|Period 3||0
8110719|NCT03074162|19990199|P5|NOT COMPLETED|Period 3||1
8110720|NCT03074162|19990200|P4|NOT COMPLETED|Period 3||0
8110721|NCT03074162|19990201|P3|NOT COMPLETED|Period 3||0
8110722|NCT03074162|19990202|P2|NOT COMPLETED|Period 3||0
8110723|NCT03074162|19990203|P1|NOT COMPLETED|Period 3||1
8110724|NCT03074162|19990198|P6|COMPLETED|Period 3||7
8110725|NCT03074162|19990199|P5|COMPLETED|Period 3||7
8110726|NCT03074162|19990200|P4|COMPLETED|Period 3||8
8110727|NCT03074162|19990201|P3|COMPLETED|Period 3||6
8110728|NCT03074162|19990202|P2|COMPLETED|Period 3||8
8110729|NCT03074162|19990203|P1|COMPLETED|Period 3||7
8110730|NCT03074162|19990198|P6|STARTED|Period 3||7
8110731|NCT03074162|19990199|P5|STARTED|Period 3||8
8110732|NCT03074162|19990200|P4|STARTED|Period 3||8
8110733|NCT03074162|19990201|P3|STARTED|Period 3||6
8110734|NCT03074162|19990202|P2|STARTED|Period 3||8
8110735|NCT03074162|19990203|P1|STARTED|Period 3||8
8110736|NCT03074162|19990198|P6|NOT COMPLETED|Period 2 Including Washout 2||1
8110737|NCT03074162|19990199|P5|NOT COMPLETED|Period 2 Including Washout 2||0
8110738|NCT03074162|19990200|P4|NOT COMPLETED|Period 2 Including Washout 2||0
8110739|NCT03074162|19990201|P3|NOT COMPLETED|Period 2 Including Washout 2||1
8110740|NCT03074162|19990202|P2|NOT COMPLETED|Period 2 Including Washout 2||0
8110741|NCT03074162|19990203|P1|NOT COMPLETED|Period 2 Including Washout 2||0
8110742|NCT03074162|19990198|P6|COMPLETED|Period 2 Including Washout 2||7
8110743|NCT03074162|19990199|P5|COMPLETED|Period 2 Including Washout 2||8
8110744|NCT03074162|19990200|P4|COMPLETED|Period 2 Including Washout 2||8
8110745|NCT03074162|19990201|P3|COMPLETED|Period 2 Including Washout 2||6
8110746|NCT03074162|19990202|P2|COMPLETED|Period 2 Including Washout 2||8
8110747|NCT03074162|19990203|P1|COMPLETED|Period 2 Including Washout 2||8
8110748|NCT03074162|19990198|P6|STARTED|Period 2 Including Washout 2||8
8110749|NCT03074162|19990199|P5|STARTED|Period 2 Including Washout 2||8
8110750|NCT03074162|19990200|P4|STARTED|Period 2 Including Washout 2||8
8110751|NCT03074162|19990201|P3|STARTED|Period 2 Including Washout 2||7
8110752|NCT03074162|19990202|P2|STARTED|Period 2 Including Washout 2||8
8110753|NCT03074162|19990203|P1|STARTED|Period 2 Including Washout 2||8
8110754|NCT03074162|19990198|P6|NOT COMPLETED|Period 1 Including Washout 1||0
8110755|NCT03074162|19990199|P5|NOT COMPLETED|Period 1 Including Washout 1||0
8110756|NCT03074162|19990200|P4|NOT COMPLETED|Period 1 Including Washout 1||0
8110757|NCT03074162|19990201|P3|NOT COMPLETED|Period 1 Including Washout 1||1
8110758|NCT03074162|19990202|P2|NOT COMPLETED|Period 1 Including Washout 1||0
8110759|NCT03074162|19990203|P1|NOT COMPLETED|Period 1 Including Washout 1||0
8110760|NCT03074162|19990198|P6|COMPLETED|Period 1 Including Washout 1||8
8110761|NCT03074162|19990199|P5|COMPLETED|Period 1 Including Washout 1||8
8110762|NCT03074162|19990200|P4|COMPLETED|Period 1 Including Washout 1||8
8110763|NCT03074162|19990201|P3|COMPLETED|Period 1 Including Washout 1||7
8110764|NCT03074162|19990202|P2|COMPLETED|Period 1 Including Washout 1||8
8110765|NCT03074162|19990203|P1|COMPLETED|Period 1 Including Washout 1||8
8110766|NCT03074162|19990198|P6|STARTED|Period 1 Including Washout 1||8
8110767|NCT03074162|19990199|P5|STARTED|Period 1 Including Washout 1||8
8110768|NCT03074162|19990200|P4|STARTED|Period 1 Including Washout 1||8
8110769|NCT03074162|19990201|P3|STARTED|Period 1 Including Washout 1||8
8110770|NCT03074162|19990202|P2|STARTED|Period 1 Including Washout 1||8
8110771|NCT03074162|19990203|P1|STARTED|Period 1 Including Washout 1||8
8110778|NCT03073798|19990265|P1|NOT COMPLETED|Overall Study||2
8110779|NCT03073798|19990265|P1|COMPLETED|Overall Study||10
8110780|NCT03073798|19990265|P1|STARTED|Overall Study||12
8110781|NCT03073759|19990278|P2|NOT COMPLETED|Overall Study||0
8110782|NCT03073759|19990279|P1|NOT COMPLETED|Overall Study||0
8110783|NCT03073759|19990278|P2|COMPLETED|Overall Study||2
8110784|NCT03073759|19990279|P1|COMPLETED|Overall Study||2
8110785|NCT03073759|19990278|P2|STARTED|Overall Study||2
8110786|NCT03073759|19990279|P1|STARTED|Overall Study||2
8110793|NCT03073213|19990303|P3|NOT COMPLETED|Multiple Dose Period||1
8110794|NCT03073213|19990304|P2|NOT COMPLETED|Multiple Dose Period||0
8110795|NCT03073213|19990305|P1|NOT COMPLETED|Multiple Dose Period||0
8110796|NCT03073213|19990303|P3|COMPLETED|Multiple Dose Period||14
8110797|NCT03073213|19990304|P2|COMPLETED|Multiple Dose Period||14
8110798|NCT03073213|19990305|P1|COMPLETED|Multiple Dose Period||0
8110799|NCT03073213|19990303|P3|Participants Enrolled From Single Dose|Multiple Dose Period||2
8110800|NCT03073213|19990304|P2|Participants Enrolled From Single Dose|Multiple Dose Period||7
8110801|NCT03073213|19990305|P1|Participants Enrolled From Single Dose|Multiple Dose Period||0
8110802|NCT03073213|19990303|P3|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|15
8110803|NCT03073213|19990304|P2|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|14
8110804|NCT03073213|19990305|P1|STARTED|Multiple Dose Period||0
8110805|NCT03073213|19990303|P3|NOT COMPLETED|Single Dose Period||0
8110806|NCT03073213|19990304|P2|NOT COMPLETED|Single Dose Period||0
8110807|NCT03073213|19990305|P1|NOT COMPLETED|Single Dose Period||0
8110808|NCT03073213|19990303|P3|COMPLETED|Single Dose Period||0
8110809|NCT03073213|19990304|P2|COMPLETED|Single Dose Period||0
8110810|NCT03073213|19990305|P1|COMPLETED|Single Dose Period||12
8110811|NCT03073213|19990303|P3|STARTED|Single Dose Period||0
8110812|NCT03073213|19990304|P2|STARTED|Single Dose Period||0
8110813|NCT03073213|19990305|P1|STARTED|Single Dose Period||12
8110826|NCT03073148|19990360|P3|NOT COMPLETED|Overall Study||4
8110827|NCT03073148|19990361|P2|NOT COMPLETED|Overall Study||0
8110828|NCT03073148|19990362|P1|NOT COMPLETED|Overall Study||0
8110829|NCT03073148|19990360|P3|COMPLETED|Overall Study||0
8110830|NCT03073148|19990361|P2|COMPLETED|Overall Study||10
8110831|NCT03073148|19990362|P1|COMPLETED|Overall Study||21
8110832|NCT03073148|19990360|P3|STARTED|Overall Study||4
8110833|NCT03073148|19990361|P2|STARTED|Overall Study||10
8110834|NCT03073148|19990362|P1|STARTED|Overall Study||21
8110835|NCT03073109|19990384|P2|NOT COMPLETED|Overall Study||2
8110836|NCT03073109|19990385|P1|NOT COMPLETED|Overall Study||10
8110837|NCT03073109|19990384|P2|COMPLETED|Overall Study||68
8110838|NCT03073109|19990385|P1|COMPLETED|Overall Study||90
8110839|NCT03073109|19990384|P2|STARTED|Overall Study||70
8110840|NCT03073109|19990385|P1|STARTED|Overall Study||100
8110841|NCT03072875|19990413|P1|NOT COMPLETED|Overall Study||1
8110842|NCT03072875|19990413|P1|COMPLETED|Overall Study||25
8110843|NCT03072875|19990413|P1|STARTED|Overall Study||26
8110844|NCT03072732|19990420|P2|NOT COMPLETED|Overall Study||0
8110845|NCT03072732|19990421|P1|NOT COMPLETED|Overall Study||0
8110846|NCT03072732|19990420|P2|COMPLETED|Overall Study||20
8110847|NCT03072732|19990421|P1|COMPLETED|Overall Study||20
8110848|NCT03072732|19990420|P2|STARTED|Overall Study||20
8110849|NCT03072732|19990421|P1|STARTED|Overall Study||20
8110850|NCT03072719|19990429|P2|NOT COMPLETED|Overall Study||1
8110851|NCT03072719|19990430|P1|NOT COMPLETED|Overall Study||1
8110852|NCT03072719|19990429|P2|COMPLETED|Overall Study||59
8110853|NCT03072719|19990430|P1|COMPLETED|Overall Study||59
8110854|NCT03072719|19990429|P2|STARTED|Overall Study||60
8110855|NCT03072719|19990430|P1|STARTED|Overall Study||60
8110856|NCT03072550|19990440|P1|NOT COMPLETED|Overall Study||2
8110857|NCT03072550|19990440|P1|COMPLETED|Overall Study||24
8110858|NCT03072550|19990440|P1|STARTED|Overall Study||26
8110859|NCT03071887|19990444|P1|NOT COMPLETED|Overall Study||6
8110860|NCT03071887|19990444|P1|COMPLETED|Overall Study||7
8110861|NCT03071887|19990444|P1|STARTED|Overall Study||13
8110862|NCT03071744|19990449|P1|NOT COMPLETED|Overall Study||2
8110863|NCT03071744|19990449|P1|COMPLETED|Overall Study||4
8110864|NCT03071744|19990449|P1|STARTED|Overall Study||6
8110865|NCT03071276|19990455|P1|NOT COMPLETED|Overall Study||15
8110866|NCT03071276|19990455|P1|COMPLETED|Overall Study||22
8110867|NCT03071276|19990455|P1|STARTED|Overall Study||37
8110874|NCT03070964|19990488|P1|NOT COMPLETED|Overall Study||14
8110875|NCT03070964|19990488|P1|COMPLETED|Overall Study||0
8110876|NCT03070964|19990488|P1|STARTED|Overall Study||14
8110877|NCT03070782|19990499|P6|NOT COMPLETED|Overall Study||7
8110878|NCT03070782|19990500|P5|NOT COMPLETED|Overall Study||12
8110879|NCT03070782|19990501|P4|NOT COMPLETED|Overall Study||5
8110880|NCT03070782|19990502|P3|NOT COMPLETED|Overall Study||4
8110881|NCT03070782|19990503|P2|NOT COMPLETED|Overall Study||1
8110882|NCT03070782|19990504|P1|NOT COMPLETED|Overall Study||7
8110883|NCT03070782|19990499|P6|COMPLETED|Overall Study||40
8110884|NCT03070782|19990500|P5|COMPLETED|Overall Study||36
8110885|NCT03070782|19990501|P4|COMPLETED|Overall Study||43
8110886|NCT03070782|19990502|P3|COMPLETED|Overall Study||43
8110887|NCT03070782|19990503|P2|COMPLETED|Overall Study||47
8110888|NCT03070782|19990504|P1|COMPLETED|Overall Study||41
8110889|NCT03070782|19990499|P6|STARTED|Overall Study||47
8110890|NCT03070782|19990500|P5|STARTED|Overall Study||48
8110891|NCT03070782|19990501|P4|STARTED|Overall Study||48
8110892|NCT03070782|19990502|P3|STARTED|Overall Study||47
8110893|NCT03070782|19990503|P2|STARTED|Overall Study||48
8110894|NCT03070782|19990504|P1|STARTED|Overall Study||48
8110895|NCT03070730|19990575|P3|NOT COMPLETED|Overall Study||0
8110896|NCT03070730|19990576|P2|NOT COMPLETED|Overall Study||0
8110897|NCT03070730|19990577|P1|NOT COMPLETED|Overall Study||0
8110898|NCT03070730|19990575|P3|COMPLETED|Overall Study||0
8110899|NCT03070730|19990576|P2|COMPLETED|Overall Study||0
8110900|NCT03070730|19990577|P1|COMPLETED|Overall Study||0
8110901|NCT03070730|19990575|P3|STARTED|Overall Study||0
8110902|NCT03070730|19990576|P2|STARTED|Overall Study||0
8110903|NCT03070730|19990577|P1|STARTED|Overall Study||0
8110904|NCT03070548|19990708|P1|NOT COMPLETED|Overall Study||0
8110905|NCT03070548|19990708|P1|COMPLETED|Overall Study||6
8110906|NCT03070548|19990708|P1|STARTED|Overall Study||6
8110907|NCT03070483|19990744|P1|NOT COMPLETED|Overall Study||2
8110908|NCT03070483|19990744|P1|COMPLETED|Overall Study||3
8110909|NCT03070483|19990744|P1|STARTED|Overall Study||5
8110910|NCT03070470|19990759|P6|NOT COMPLETED|Overall Study||2
8110911|NCT03070470|19990760|P5|NOT COMPLETED|Overall Study||0
8110912|NCT03070470|19990761|P4|NOT COMPLETED|Overall Study||0
8110913|NCT03070470|19990762|P3|NOT COMPLETED|Overall Study||0
8110914|NCT03070470|19990763|P2|NOT COMPLETED|Overall Study||1
8110915|NCT03070470|19990764|P1|NOT COMPLETED|Overall Study||0
8110916|NCT03070470|19990759|P6|COMPLETED|Overall Study||8
8110917|NCT03070470|19990760|P5|COMPLETED|Overall Study||10
8110918|NCT03070470|19990761|P4|COMPLETED|Overall Study||10
8110919|NCT03070470|19990762|P3|COMPLETED|Overall Study||10
8110920|NCT03070470|19990763|P2|COMPLETED|Overall Study||9
8110921|NCT03070470|19990764|P1|COMPLETED|Overall Study||10
8110922|NCT03070470|19990759|P6|STARTED|Overall Study||10
8110923|NCT03070470|19990760|P5|STARTED|Overall Study||10
8110924|NCT03070470|19990761|P4|STARTED|Overall Study||10
8110925|NCT03070470|19990762|P3|STARTED|Overall Study||10
8110926|NCT03070470|19990763|P2|STARTED|Overall Study||10
8110927|NCT03070470|19990764|P1|STARTED|Overall Study||10
8110928|NCT03070431|19990791|P1|NOT COMPLETED|Overall Study||4
8110929|NCT03070431|19990791|P1|COMPLETED|Overall Study||40
8110930|NCT03070431|19990791|P1|STARTED|Overall Study||44
8110936|NCT03070171|19990813|P2|NOT COMPLETED|Treatment Period 4 + Washout||1
8110937|NCT03070171|19990814|P1|NOT COMPLETED|Treatment Period 4 + Washout||0
8110938|NCT03070171|19990813|P2|COMPLETED|Treatment Period 4 + Washout||78
8110939|NCT03070171|19990814|P1|COMPLETED|Treatment Period 4 + Washout||80
8110940|NCT03070171|19990813|P2|STARTED|Treatment Period 4 + Washout||79
8110941|NCT03070171|19990814|P1|STARTED|Treatment Period 4 + Washout||80
8110942|NCT03070171|19990813|P2|NOT COMPLETED|Treatment Period 3 + Washout||0
8110943|NCT03070171|19990814|P1|NOT COMPLETED|Treatment Period 3 + Washout||0
8110944|NCT03070171|19990813|P2|COMPLETED|Treatment Period 3 + Washout||79
8110945|NCT03070171|19990814|P1|COMPLETED|Treatment Period 3 + Washout||80
8110946|NCT03070171|19990813|P2|STARTED|Treatment Period 3 + Washout||79
8110947|NCT03070171|19990814|P1|STARTED|Treatment Period 3 + Washout||80
8110948|NCT03070171|19990813|P2|NOT COMPLETED|Treatment Period 2 + Washout||1
8110949|NCT03070171|19990814|P1|NOT COMPLETED|Treatment Period 2 + Washout||0
8110950|NCT03070171|19990813|P2|COMPLETED|Treatment Period 2 + Washout||79
8110951|NCT03070171|19990814|P1|COMPLETED|Treatment Period 2 + Washout||80
8110952|NCT03070171|19990813|P2|STARTED|Treatment Period 2 + Washout||80
8110953|NCT03070171|19990814|P1|STARTED|Treatment Period 2 + Washout||80
8110954|NCT03070171|19990813|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
8110955|NCT03070171|19990814|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
8110956|NCT03070171|19990813|P2|COMPLETED|Treatment Period 1 + Washout||80
8110957|NCT03070171|19990814|P1|COMPLETED|Treatment Period 1 + Washout||80
8110958|NCT03070171|19990813|P2|STARTED|Treatment Period 1 + Washout||80
8110959|NCT03070171|19990814|P1|STARTED|Treatment Period 1 + Washout||80
8110960|NCT03070002|19990830|P1|NOT COMPLETED|Follow up for 2 Years||1
8110961|NCT03070002|19990830|P1|COMPLETED|Follow up for 2 Years||0
8110962|NCT03070002|19990830|P1|STARTED|Follow up for 2 Years||1
8110963|NCT03070002|19990830|P1|NOT COMPLETED|3 Cycles of Treatment||0
8110964|NCT03070002|19990830|P1|COMPLETED|3 Cycles of Treatment||1
8110965|NCT03070002|19990830|P1|STARTED|3 Cycles of Treatment||1
8110966|NCT03069989|19990838|P2|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0
8110967|NCT03069989|19990839|P1|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1
8110968|NCT03069989|19990838|P2|COMPLETED|Dosing Period 2 (Up to 16 Days)||5
8110969|NCT03069989|19990839|P1|COMPLETED|Dosing Period 2 (Up to 16 Days)||2
8110970|NCT03069989|19990838|P2|STARTED|Dosing Period 2 (Up to 16 Days)||5
8110971|NCT03069989|19990839|P1|STARTED|Dosing Period 2 (Up to 16 Days)||3
8110972|NCT03069989|19990838|P2|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
8110973|NCT03069989|19990839|P1|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
8110974|NCT03069989|19990838|P2|COMPLETED|Wash Out Period (Up to 28 Days))||5
8110975|NCT03069989|19990839|P1|COMPLETED|Wash Out Period (Up to 28 Days))||3
8110976|NCT03069989|19990838|P2|STARTED|Wash Out Period (Up to 28 Days))||5
8110977|NCT03069989|19990839|P1|STARTED|Wash Out Period (Up to 28 Days))||3
8110978|NCT03069989|19990838|P2|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
8110979|NCT03069989|19990839|P1|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
8110980|NCT03069989|19990838|P2|COMPLETED|Dosing Period 1 (Up to 2 Days)||5
8110981|NCT03069989|19990839|P1|COMPLETED|Dosing Period 1 (Up to 2 Days)||3
8110982|NCT03069989|19990838|P2|STARTED|Dosing Period 1 (Up to 2 Days)||5
8110983|NCT03069989|19990839|P1|STARTED|Dosing Period 1 (Up to 2 Days)||3
8110984|NCT03069677|19990927|P2|NOT COMPLETED|Overall Study||3
8110985|NCT03069677|19990928|P1|NOT COMPLETED|Overall Study||3
8110986|NCT03069677|19990927|P2|COMPLETED|Overall Study||77
8110987|NCT03069677|19990928|P1|COMPLETED|Overall Study||77
8110988|NCT03069677|19990927|P2|STARTED|Overall Study||80
8110989|NCT03069677|19990928|P1|STARTED|Overall Study||80
8110990|NCT03069482|19990946|P2|NOT COMPLETED|Overall Study||1
8110991|NCT03069482|19990947|P1|NOT COMPLETED|Overall Study||1
8110992|NCT03069482|19990946|P2|COMPLETED|Overall Study||28
8110993|NCT03069482|19990947|P1|COMPLETED|Overall Study||33
8110994|NCT03069482|19990946|P2|STARTED|Overall Study||29
8110995|NCT03069482|19990947|P1|STARTED|Overall Study||34
8110996|NCT03069365|19991057|P1|NOT COMPLETED|Overall Study||1
8110997|NCT03069365|19991057|P1|COMPLETED|Overall Study||100
8110998|NCT03069365|19991057|P1|STARTED|Overall Study||101
8111007|NCT03069313|19991108|P1|NOT COMPLETED|Overall Study||5
8111008|NCT03069313|19991108|P1|COMPLETED|Overall Study||36
8111009|NCT03069313|19991108|P1|STARTED|Overall Study||41
8111010|NCT03068897|19991119|P4|NOT COMPLETED|Overall Study||6
8111011|NCT03068897|19991120|P3|NOT COMPLETED|Overall Study||1
8111012|NCT03068897|19991121|P2|NOT COMPLETED|Overall Study||4
8111013|NCT03068897|19991122|P1|NOT COMPLETED|Overall Study||4
8111014|NCT03068897|19991119|P4|COMPLETED|Overall Study||74
8111015|NCT03068897|19991120|P3|COMPLETED|Overall Study||79
8111016|NCT03068897|19991121|P2|COMPLETED|Overall Study||76
8111017|NCT03068897|19991122|P1|COMPLETED|Overall Study||76
8111018|NCT03068897|19991119|P4|STARTED|Overall Study||80
8111019|NCT03068897|19991120|P3|STARTED|Overall Study||80
8111020|NCT03068897|19991121|P2|STARTED|Overall Study||80
8111021|NCT03068897|19991122|P1|STARTED|Overall Study||80
8111022|NCT03068767|19991146|P2|NOT COMPLETED|Overall Study||3
8111023|NCT03068767|19991147|P1|NOT COMPLETED|Overall Study||10
8111024|NCT03068767|19991146|P2|COMPLETED|Overall Study|December 2018|71
8111025|NCT03068767|19991147|P1|COMPLETED|Overall Study|December 2018|65
8111026|NCT03068767|19991146|P2|STARTED|Overall Study|from August 2017 to September 2018|74
8111027|NCT03068767|19991147|P1|STARTED|Overall Study|from August 2017 to September 2018|75
8111028|NCT03068754|19991157|P4|NOT COMPLETED|Open Label Extension Period (OLE)||6
8111029|NCT03068754|19991158|P3|NOT COMPLETED|Open Label Extension Period (OLE)||21
8111030|NCT03068754|19991159|P2|NOT COMPLETED|Open Label Extension Period (OLE)||0
8111031|NCT03068754|19991160|P1|NOT COMPLETED|Open Label Extension Period (OLE)||0
8111032|NCT03068754|19991157|P4|COMPLETED|Open Label Extension Period (OLE)||2
8111033|NCT03068754|19991158|P3|COMPLETED|Open Label Extension Period (OLE)||4
8111034|NCT03068754|19991159|P2|COMPLETED|Open Label Extension Period (OLE)||0
8111035|NCT03068754|19991160|P1|COMPLETED|Open Label Extension Period (OLE)||0
8111036|NCT03068754|19991157|P4|Completed Treatment in OLE|Open Label Extension Period (OLE)||2
8111037|NCT03068754|19991158|P3|Completed Treatment in OLE|Open Label Extension Period (OLE)||4
8111038|NCT03068754|19991159|P2|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
8111039|NCT03068754|19991160|P1|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
8111040|NCT03068754|19991157|P4|Completed OLE Period|Open Label Extension Period (OLE)||2
8111041|NCT03068754|19991158|P3|Completed OLE Period|Open Label Extension Period (OLE)||3
8111042|NCT03068754|19991159|P2|Completed OLE Period|Open Label Extension Period (OLE)||0
8111043|NCT03068754|19991160|P1|Completed OLE Period|Open Label Extension Period (OLE)||0
8111044|NCT03068754|19991157|P4|Completed Taper|Open Label Extension Period (OLE)||7
8111045|NCT03068754|19991158|P3|Completed Taper|Open Label Extension Period (OLE)||19
8111046|NCT03068754|19991159|P2|Completed Taper|Open Label Extension Period (OLE)||0
8111047|NCT03068754|19991160|P1|Completed Taper|Open Label Extension Period (OLE)||0
8111048|NCT03068754|19991157|P4|STARTED|Open Label Extension Period (OLE)||8
8111049|NCT03068754|19991158|P3|STARTED|Open Label Extension Period (OLE)||25
8111050|NCT03068754|19991159|P2|STARTED|Open Label Extension Period (OLE)||0
8111051|NCT03068754|19991160|P1|STARTED|Open Label Extension Period (OLE)|RTP arms were not included during the OLE period|0
8111052|NCT03068754|19991157|P4|NOT COMPLETED|Randomized Treatment Period (RTP)||0
8111053|NCT03068754|19991158|P3|NOT COMPLETED|Randomized Treatment Period (RTP)||0
8111054|NCT03068754|19991159|P2|NOT COMPLETED|Randomized Treatment Period (RTP)||39
8111055|NCT03068754|19991160|P1|NOT COMPLETED|Randomized Treatment Period (RTP)||67
8111056|NCT03068754|19991157|P4|COMPLETED|Randomized Treatment Period (RTP)||0
8111057|NCT03068754|19991158|P3|COMPLETED|Randomized Treatment Period (RTP)||0
8111058|NCT03068754|19991159|P2|COMPLETED|Randomized Treatment Period (RTP)||9
8111059|NCT03068754|19991160|P1|COMPLETED|Randomized Treatment Period (RTP)||28
8111060|NCT03068754|19991157|P4|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
8111061|NCT03068754|19991158|P3|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
8111062|NCT03068754|19991159|P2|Enrolled in OLE Period|Randomized Treatment Period (RTP)||8
8111063|NCT03068754|19991160|P1|Enrolled in OLE Period|Randomized Treatment Period (RTP)||25
8111064|NCT03068754|19991157|P4|Completed RTP|Randomized Treatment Period (RTP)||0
8111065|NCT03068754|19991158|P3|Completed RTP|Randomized Treatment Period (RTP)||0
8111066|NCT03068754|19991159|P2|Completed RTP|Randomized Treatment Period (RTP)||9
8111067|NCT03068754|19991160|P1|Completed RTP|Randomized Treatment Period (RTP)||27
8111068|NCT03068754|19991157|P4|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
8111069|NCT03068754|19991158|P3|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
8111070|NCT03068754|19991159|P2|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||9
8111071|NCT03068754|19991160|P1|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||28
8111072|NCT03068754|19991157|P4|Completed Taper|Randomized Treatment Period (RTP)||0
8111073|NCT03068754|19991158|P3|Completed Taper|Randomized Treatment Period (RTP)||0
8111074|NCT03068754|19991159|P2|Completed Taper|Randomized Treatment Period (RTP)||28
8111075|NCT03068754|19991160|P1|Completed Taper|Randomized Treatment Period (RTP)||58
8111076|NCT03068754|19991157|P4|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
8111077|NCT03068754|19991158|P3|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
8111078|NCT03068754|19991159|P2|Modified ITT (mITT)|Randomized Treatment Period (RTP)||46
8111079|NCT03068754|19991160|P1|Modified ITT (mITT)|Randomized Treatment Period (RTP)||93
8111080|NCT03068754|19991157|P4|Safety Population|Randomized Treatment Period (RTP)||0
8111081|NCT03068754|19991158|P3|Safety Population|Randomized Treatment Period (RTP)||0
8111082|NCT03068754|19991159|P2|Safety Population|Randomized Treatment Period (RTP)||47
8111083|NCT03068754|19991160|P1|Safety Population|Randomized Treatment Period (RTP)||95
8111084|NCT03068754|19991157|P4|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
8111085|NCT03068754|19991158|P3|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
8111086|NCT03068754|19991159|P2|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||48
8111087|NCT03068754|19991160|P1|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||95
8111088|NCT03068754|19991157|P4|STARTED|Randomized Treatment Period (RTP)||0
8111089|NCT03068754|19991158|P3|STARTED|Randomized Treatment Period (RTP)|OLE Arms were not included during the RTP|0
8111090|NCT03068754|19991159|P2|STARTED|Randomized Treatment Period (RTP)||48
8111091|NCT03068754|19991160|P1|STARTED|Randomized Treatment Period (RTP)||95
8111092|NCT03068611|19991180|P2|NOT COMPLETED|Overall Study||25
8111093|NCT03068611|19991181|P1|NOT COMPLETED|Overall Study||31
8111094|NCT03068611|19991180|P2|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33
8111095|NCT03068611|19991181|P1|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30
8111096|NCT03068611|19991180|P2|STARTED|Overall Study||58
8111097|NCT03068611|19991181|P1|STARTED|Overall Study||61
8111098|NCT03068468|19991195|P4|NOT COMPLETED|Open-Label Extension Period||276
8111099|NCT03068468|19991196|P3|NOT COMPLETED|Open-Label Extension Period||140
8111100|NCT03068468|19991197|P2|NOT COMPLETED|Open-Label Extension Period||0
8111101|NCT03068468|19991198|P1|NOT COMPLETED|Open-Label Extension Period||0
8111102|NCT03068468|19991195|P4|COMPLETED|Open-Label Extension Period||0
8111103|NCT03068468|19991196|P3|COMPLETED|Open-Label Extension Period||0
8111104|NCT03068468|19991197|P2|COMPLETED|Open-Label Extension Period||0
8111105|NCT03068468|19991198|P1|COMPLETED|Open-Label Extension Period||0
8111106|NCT03068468|19991195|P4|STARTED|Open-Label Extension Period|3 participants did not enter OLE period.|276
8111107|NCT03068468|19991196|P3|STARTED|Open-Label Extension Period|4 participants did not enter OLE period.|140
8111108|NCT03068468|19991197|P2|STARTED|Open-Label Extension Period||0
8111109|NCT03068468|19991198|P1|STARTED|Open-Label Extension Period||0
8111110|NCT03068468|19991195|P4|NOT COMPLETED|Placebo-Controlled Period||0
8111111|NCT03068468|19991196|P3|NOT COMPLETED|Placebo-Controlled Period||0
8111112|NCT03068468|19991197|P2|NOT COMPLETED|Placebo-Controlled Period||45
8111113|NCT03068468|19991198|P1|NOT COMPLETED|Placebo-Controlled Period||22
8111114|NCT03068468|19991195|P4|COMPLETED|Placebo-Controlled Period||0
8111115|NCT03068468|19991196|P3|COMPLETED|Placebo-Controlled Period||0
8111116|NCT03068468|19991197|P2|COMPLETED|Placebo-Controlled Period||279
8111117|NCT03068468|19991198|P1|COMPLETED|Placebo-Controlled Period||144
8111118|NCT03068468|19991195|P4|Treated|Placebo-Controlled Period||0
8111119|NCT03068468|19991196|P3|Treated|Placebo-Controlled Period||0
8111120|NCT03068468|19991197|P2|Treated|Placebo-Controlled Period||321
8111121|NCT03068468|19991198|P1|Treated|Placebo-Controlled Period||165
8111122|NCT03068468|19991195|P4|STARTED|Placebo-Controlled Period||0
8111123|NCT03068468|19991196|P3|STARTED|Placebo-Controlled Period||0
8111124|NCT03068468|19991197|P2|STARTED|Placebo-Controlled Period||324
8111125|NCT03068468|19991198|P1|STARTED|Placebo-Controlled Period||166
8111126|NCT03068312|19991236|P2|NOT COMPLETED|Overall Study||0
8111127|NCT03068312|19991237|P1|NOT COMPLETED|Overall Study||0
8111128|NCT03068312|19991236|P2|COMPLETED|Overall Study||19
8111129|NCT03068312|19991237|P1|COMPLETED|Overall Study||19
8111130|NCT03068312|19991236|P2|STARTED|Overall Study||19
8111131|NCT03068312|19991237|P1|STARTED|Overall Study||19
8111132|NCT03068091|19991243|P1|NOT COMPLETED|Overall Study||1
8111133|NCT03068091|19991243|P1|COMPLETED|Overall Study||24
8111134|NCT03068091|19991243|P1|STARTED|Overall Study||25
8111135|NCT03067987|19991250|P2|NOT COMPLETED|Overall Study||13
8111136|NCT03067987|19991251|P1|NOT COMPLETED|Overall Study||10
8111137|NCT03067987|19991250|P2|COMPLETED|Overall Study||40
8111138|NCT03067987|19991251|P1|COMPLETED|Overall Study||40
8111139|NCT03067987|19991250|P2|STARTED|Overall Study||53
8111140|NCT03067987|19991251|P1|STARTED|Overall Study||50
8111141|NCT03067948|19991263|P1|NOT COMPLETED|Overall Study||0
8111142|NCT03067948|19991263|P1|COMPLETED|Overall Study||32
8111143|NCT03067948|19991263|P1|STARTED|Overall Study||32
8111144|NCT03067506|19991268|P1|NOT COMPLETED|Overall Study||0
8111145|NCT03067506|19991268|P1|COMPLETED|Overall Study||30
8111146|NCT03067506|19991268|P1|STARTED|Overall Study||30
8111153|NCT03066999|19991336|P2|NOT COMPLETED|Overall Study||2
8111154|NCT03066999|19991337|P1|NOT COMPLETED|Overall Study||0
8111155|NCT03066999|19991336|P2|COMPLETED|Overall Study||1
8111156|NCT03066999|19991337|P1|COMPLETED|Overall Study||2
8111157|NCT03066999|19991336|P2|STARTED|Overall Study||3
8111158|NCT03066999|19991337|P1|STARTED|Overall Study||2
8111167|NCT03066622|19991386|P2|NOT COMPLETED|Overall Study||26
8111168|NCT03066622|19991387|P1|NOT COMPLETED|Overall Study||26
8111169|NCT03066622|19991386|P2|COMPLETED|Overall Study||35
8111170|NCT03066622|19991387|P1|COMPLETED|Overall Study||35
8111171|NCT03066622|19991386|P2|STARTED|Overall Study||61
8111172|NCT03066622|19991387|P1|STARTED|Overall Study||61
8111173|NCT03066609|19991400|P4|NOT COMPLETED|OVERALL STUDY||5
8111174|NCT03066609|19991401|P3|NOT COMPLETED|OVERALL STUDY||4
8111175|NCT03066609|19991402|P2|NOT COMPLETED|OVERALL STUDY||8
8111176|NCT03066609|19991403|P1|NOT COMPLETED|OVERALL STUDY||10
8111177|NCT03066609|19991400|P4|COMPLETED|OVERALL STUDY||124
8111178|NCT03066609|19991401|P3|COMPLETED|OVERALL STUDY||2
8111179|NCT03066609|19991402|P2|COMPLETED|OVERALL STUDY||264
8111180|NCT03066609|19991403|P1|COMPLETED|OVERALL STUDY||126
8111181|NCT03066609|19991400|P4|STARTED|OVERALL STUDY||129
8111182|NCT03066609|19991401|P3|STARTED|OVERALL STUDY||6
8111183|NCT03066609|19991402|P2|STARTED|OVERALL STUDY||272
8111184|NCT03066609|19991403|P1|STARTED|OVERALL STUDY||136
8111185|NCT03066609|19991400|P4|NOT COMPLETED|MAINTENANCE||3
8111186|NCT03066609|19991401|P3|NOT COMPLETED|MAINTENANCE||2
8111187|NCT03066609|19991402|P2|NOT COMPLETED|MAINTENANCE||4
8111188|NCT03066609|19991403|P1|NOT COMPLETED|MAINTENANCE||7
8111189|NCT03066609|19991400|P4|COMPLETED|MAINTENANCE||126
8111190|NCT03066609|19991401|P3|COMPLETED|MAINTENANCE||2
8111191|NCT03066609|19991402|P2|COMPLETED|MAINTENANCE||266
8111192|NCT03066609|19991403|P1|COMPLETED|MAINTENANCE||127
8111193|NCT03066609|19991400|P4|STARTED|MAINTENANCE||129
8111194|NCT03066609|19991401|P3|STARTED|MAINTENANCE||4
8111195|NCT03066609|19991402|P2|STARTED|MAINTENANCE||270
8111196|NCT03066609|19991403|P1|STARTED|MAINTENANCE||134
8111197|NCT03066609|19991400|P4|NOT COMPLETED|INDUCTION||0
8111198|NCT03066609|19991401|P3|NOT COMPLETED|INDUCTION||2
8111199|NCT03066609|19991402|P2|NOT COMPLETED|INDUCTION||2
8111200|NCT03066609|19991403|P1|NOT COMPLETED|INDUCTION||2
8111201|NCT03066609|19991400|P4|COMPLETED|INDUCTION||0
8111202|NCT03066609|19991401|P3|COMPLETED|INDUCTION||133
8111203|NCT03066609|19991402|P2|COMPLETED|INDUCTION||270
8111204|NCT03066609|19991403|P1|COMPLETED|INDUCTION||134
8111205|NCT03066609|19991400|P4|STARTED|INDUCTION||0
8111206|NCT03066609|19991401|P3|STARTED|INDUCTION||135
8111207|NCT03066609|19991402|P2|STARTED|INDUCTION||272
8111208|NCT03066609|19991403|P1|STARTED|INDUCTION||136
8111209|NCT03066193|19991433|P1|NOT COMPLETED|Overall Study||1
8111210|NCT03066193|19991433|P1|COMPLETED|Overall Study||16
8111211|NCT03066193|19991433|P1|STARTED|Overall Study||17
8111212|NCT03066102|19991437|P1|NOT COMPLETED|Overall Study||0
8111213|NCT03066102|19991437|P1|COMPLETED|Overall Study||30
8111214|NCT03066102|19991437|P1|STARTED|Overall Study||30
8111215|NCT03065933|19991446|P1|NOT COMPLETED|Overall Study||5
8111216|NCT03065933|19991446|P1|COMPLETED|Overall Study||0
8111217|NCT03065933|19991446|P1|STARTED|Overall Study||5
8111218|NCT03065530|19991454|P4|NOT COMPLETED|Overall Study||2
8111219|NCT03065530|19991455|P3|NOT COMPLETED|Overall Study||1
8111220|NCT03065530|19991456|P2|NOT COMPLETED|Overall Study||1
8111221|NCT03065530|19991457|P1|NOT COMPLETED|Overall Study||2
8111222|NCT03065530|19991454|P4|COMPLETED|Overall Study||28
8111223|NCT03065530|19991455|P3|COMPLETED|Overall Study||29
8111224|NCT03065530|19991456|P2|COMPLETED|Overall Study||29
8111225|NCT03065530|19991457|P1|COMPLETED|Overall Study||28
8111226|NCT03065530|19991454|P4|STARTED|Overall Study||30
8111227|NCT03065530|19991455|P3|STARTED|Overall Study||30
8111228|NCT03065530|19991456|P2|STARTED|Overall Study||30
8111229|NCT03065530|19991457|P1|STARTED|Overall Study||30
8111230|NCT03065283|19991536|P2|NOT COMPLETED|Overall Study||0
8111231|NCT03065283|19991537|P1|NOT COMPLETED|Overall Study||0
8111232|NCT03065283|19991536|P2|COMPLETED|Overall Study||25
8111233|NCT03065283|19991537|P1|COMPLETED|Overall Study||50
8111234|NCT03065283|19991536|P2|STARTED|Overall Study||25
8111235|NCT03065283|19991537|P1|STARTED|Overall Study||50
8111236|NCT03065205|19991543|P1|NOT COMPLETED|Overall Study||12
8111237|NCT03065205|19991543|P1|COMPLETED|Overall Study||53
8111238|NCT03065205|19991543|P1|STARTED|Overall Study||65
8111239|NCT03065075|19991552|P2|NOT COMPLETED|Overall Study||0
8111240|NCT03065075|19991553|P1|NOT COMPLETED|Overall Study||0
8111241|NCT03065075|19991552|P2|COMPLETED|Overall Study||76
8111242|NCT03065075|19991553|P1|COMPLETED|Overall Study||76
8111243|NCT03065075|19991552|P2|As-treated Analysis|Overall Study||77
8111244|NCT03065075|19991553|P1|As-treated Analysis|Overall Study||69
8111245|NCT03065075|19991552|P2|Intent-to-treat Analysis|Overall Study||74
8111246|NCT03065075|19991553|P1|Intent-to-treat Analysis|Overall Study||72
8111247|NCT03065075|19991552|P2|STARTED|Overall Study||76
8111248|NCT03065075|19991553|P1|STARTED|Overall Study||76
8111249|NCT03065023|19991565|P5|NOT COMPLETED|Overall Study||0
8111250|NCT03065023|19991566|P4|NOT COMPLETED|Overall Study||3
8111251|NCT03065023|19991567|P3|NOT COMPLETED|Overall Study||1
8111252|NCT03065023|19991568|P2|NOT COMPLETED|Overall Study||2
8111253|NCT03065023|19991569|P1|NOT COMPLETED|Overall Study||2
8111254|NCT03065023|19991565|P5|COMPLETED|Overall Study||0
8111255|NCT03065023|19991566|P4|COMPLETED|Overall Study||3
8111256|NCT03065023|19991567|P3|COMPLETED|Overall Study||2
8111257|NCT03065023|19991568|P2|COMPLETED|Overall Study||1
8111258|NCT03065023|19991569|P1|COMPLETED|Overall Study||1
8111259|NCT03065023|19991565|P5|STARTED|Overall Study|Group B not started for business reasons.|0
8111260|NCT03065023|19991566|P4|STARTED|Overall Study||6
8111261|NCT03065023|19991567|P3|STARTED|Overall Study||3
8111262|NCT03065023|19991568|P2|STARTED|Overall Study||3
8111263|NCT03065023|19991569|P1|STARTED|Overall Study||3
8111264|NCT03064841|19991635|P1|NOT COMPLETED|Overall Study||17
8111265|NCT03064841|19991635|P1|COMPLETED|Overall Study||1520
8111266|NCT03064841|19991635|P1|STARTED|Overall Study||1537
8111267|NCT03064451|19991650|P1|NOT COMPLETED|Overall Study||14
8111268|NCT03064451|19991650|P1|COMPLETED|Overall Study||46
8111269|NCT03064451|19991650|P1|Safety Population|Overall Study||52
8111270|NCT03064451|19991650|P1|STARTED|Overall Study||60
8111379|NCT03063476|19991757|P1|NOT COMPLETED|Overall Study||0
8111380|NCT03063476|19991757|P1|COMPLETED|Overall Study||2
8111381|NCT03063476|19991757|P1|STARTED|Overall Study||2
8111382|NCT03063437|19991764|P2|NOT COMPLETED|Overall Study||0
8111383|NCT03063437|19991765|P1|NOT COMPLETED|Overall Study||0
8111384|NCT03063437|19991764|P2|COMPLETED|Overall Study||5
8111385|NCT03063437|19991765|P1|COMPLETED|Overall Study||4
8111386|NCT03063437|19991764|P2|STARTED|Overall Study||5
8111387|NCT03063437|19991765|P1|STARTED|Overall Study||4
8111388|NCT03063385|19991793|P2|NOT COMPLETED|Overall Study||76
8111389|NCT03063385|19991794|P1|NOT COMPLETED|Overall Study||87
8111390|NCT03063385|19991793|P2|COMPLETED|Overall Study||254
8111391|NCT03063385|19991794|P1|COMPLETED|Overall Study||243
8111392|NCT03063385|19991793|P2|12-month Follow-up|Overall Study||254
8111393|NCT03063385|19991794|P1|12-month Follow-up|Overall Study||243
8111394|NCT03063385|19991793|P2|6-month Follow-up|Overall Study||259
8111395|NCT03063385|19991794|P1|6-month Follow-up|Overall Study||265
8111396|NCT03063385|19991793|P2|3-month Follow-up|Overall Study||259
8111397|NCT03063385|19991794|P1|3-month Follow-up|Overall Study||257
8111398|NCT03063385|19991793|P2|STARTED|Overall Study||330
8111399|NCT03063385|19991794|P1|STARTED|Overall Study||330
8111400|NCT03063294|19991806|P2|NOT COMPLETED|Overall Study||0
8111401|NCT03063294|19991807|P1|NOT COMPLETED|Overall Study||0
8111402|NCT03063294|19991806|P2|COMPLETED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
8111403|NCT03063294|19991807|P1|COMPLETED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
8111404|NCT03063294|19991806|P2|STARTED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
8111405|NCT03063294|19991807|P1|STARTED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
8111406|NCT03063086|19991813|P6|NOT COMPLETED|Overall Study||1
8111407|NCT03063086|19991814|P5|NOT COMPLETED|Overall Study||0
8111408|NCT03063086|19991815|P4|NOT COMPLETED|Overall Study||3
8111409|NCT03063086|19991816|P3|NOT COMPLETED|Overall Study||1
8111410|NCT03063086|19991817|P2|NOT COMPLETED|Overall Study||1
8111411|NCT03063086|19991818|P1|NOT COMPLETED|Overall Study||3
8111412|NCT03063086|19991813|P6|COMPLETED|Overall Study||18
8111413|NCT03063086|19991814|P5|COMPLETED|Overall Study||20
8111414|NCT03063086|19991815|P4|COMPLETED|Overall Study||17
8111415|NCT03063086|19991816|P3|COMPLETED|Overall Study||17
8111416|NCT03063086|19991817|P2|COMPLETED|Overall Study||19
8111417|NCT03063086|19991818|P1|COMPLETED|Overall Study||16
8111418|NCT03063086|19991813|P6|STARTED|Overall Study||19
8111419|NCT03063086|19991814|P5|STARTED|Overall Study||20
8111420|NCT03063086|19991815|P4|STARTED|Overall Study||20
8111421|NCT03063086|19991816|P3|STARTED|Overall Study||18
8111422|NCT03063086|19991817|P2|STARTED|Overall Study||20
8111423|NCT03063086|19991818|P1|STARTED|Overall Study||19
8111424|NCT03062917|19991846|P5|NOT COMPLETED|Overall Study||0
8111425|NCT03062917|19991847|P4|NOT COMPLETED|Overall Study||0
8111426|NCT03062917|19991848|P3|NOT COMPLETED|Overall Study||0
8111427|NCT03062917|19991849|P2|NOT COMPLETED|Overall Study||0
8111428|NCT03062917|19991850|P1|NOT COMPLETED|Overall Study||0
8111429|NCT03062917|19991846|P5|COMPLETED|Overall Study||0
8111430|NCT03062917|19991847|P4|COMPLETED|Overall Study||20
8111431|NCT03062917|19991848|P3|COMPLETED|Overall Study||49
8111432|NCT03062917|19991849|P2|COMPLETED|Overall Study||51
8111433|NCT03062917|19991850|P1|COMPLETED|Overall Study||32
8111434|NCT03062917|19991846|P5|STARTED|Overall Study||0
8111435|NCT03062917|19991847|P4|STARTED|Overall Study||20
8111436|NCT03062917|19991848|P3|STARTED|Overall Study||49
8111437|NCT03062917|19991849|P2|STARTED|Overall Study||51
8111438|NCT03062917|19991850|P1|STARTED|Overall Study||32
8111439|NCT03062891|19991864|P2|NOT COMPLETED|Overall Study||38
8111440|NCT03062891|19991865|P1|NOT COMPLETED|Overall Study||52
8111441|NCT03062891|19991864|P2|COMPLETED|Overall Study||62
8111442|NCT03062891|19991865|P1|COMPLETED|Overall Study||47
8111443|NCT03062891|19991864|P2|Followup|Overall Study||62
8111444|NCT03062891|19991865|P1|Followup|Overall Study||47
8111445|NCT03062891|19991864|P2|End of Intervention|Overall Study||78
8111446|NCT03062891|19991865|P1|End of Intervention|Overall Study||67
8111447|NCT03062891|19991864|P2|Mid-intervention|Overall Study||74
8111448|NCT03062891|19991865|P1|Mid-intervention|Overall Study||68
8111449|NCT03062891|19991864|P2|STARTED|Overall Study||100
8111450|NCT03062891|19991865|P1|STARTED|Overall Study||99
8111451|NCT03062605|19991910|P2|NOT COMPLETED|Overall Study||10
8111452|NCT03062605|19991911|P1|NOT COMPLETED|Overall Study||11
8111453|NCT03062605|19991910|P2|COMPLETED|Overall Study||13
8111454|NCT03062605|19991911|P1|COMPLETED|Overall Study||14
8111455|NCT03062605|19991910|P2|STARTED|Overall Study||23
8111456|NCT03062605|19991911|P1|STARTED|Overall Study||25
8111457|NCT03062488|19991920|P3|NOT COMPLETED|Overall Study||0
8111458|NCT03062488|19991921|P2|NOT COMPLETED|Overall Study||0
8111459|NCT03062488|19991922|P1|NOT COMPLETED|Overall Study||0
8111460|NCT03062488|19991920|P3|COMPLETED|Overall Study||41
8111461|NCT03062488|19991921|P2|COMPLETED|Overall Study||51
8111462|NCT03062488|19991922|P1|COMPLETED|Overall Study||51
8111463|NCT03062488|19991920|P3|STARTED|Overall Study||41
8111464|NCT03062488|19991921|P2|STARTED|Overall Study||51
8111465|NCT03062488|19991922|P1|STARTED|Overall Study||51
8111466|NCT03062267|19991938|P2|NOT COMPLETED|Overall Study||5
8111467|NCT03062267|19991939|P1|NOT COMPLETED|Overall Study||2
8111468|NCT03062267|19991938|P2|COMPLETED|Overall Study||32
8111469|NCT03062267|19991939|P1|COMPLETED|Overall Study||10
8111470|NCT03062267|19991938|P2|STARTED|Overall Study||37
8111471|NCT03062267|19991939|P1|STARTED|Overall Study||12
8111472|NCT03062228|19991951|P1|NOT COMPLETED|Overall Study||0
8111473|NCT03062228|19991951|P1|COMPLETED|Overall Study||162
8111474|NCT03062228|19991951|P1|STARTED|Overall Study||162
8111475|NCT03061513|19991964|P2|NOT COMPLETED|Overall Study||1
8111476|NCT03061513|19991965|P1|NOT COMPLETED|Overall Study||0
8111477|NCT03061513|19991964|P2|COMPLETED|Overall Study||4
8111478|NCT03061513|19991965|P1|COMPLETED|Overall Study||6
8111479|NCT03061513|19991964|P2|STARTED|Overall Study||5
8111480|NCT03061513|19991965|P1|STARTED|Overall Study||6
8111481|NCT03061331|19991975|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8111482|NCT03061331|19991976|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8111483|NCT03061331|19991975|P2|COMPLETED|Treatment Period 2 (8 Weeks)||9
8111484|NCT03061331|19991976|P1|COMPLETED|Treatment Period 2 (8 Weeks)||8
8111485|NCT03061331|19991975|P2|STARTED|Treatment Period 2 (8 Weeks)||9
8111486|NCT03061331|19991976|P1|STARTED|Treatment Period 2 (8 Weeks)||8
8111487|NCT03061331|19991975|P2|NOT COMPLETED|Washout Period (8 Weeks)||1
8111488|NCT03061331|19991976|P1|NOT COMPLETED|Washout Period (8 Weeks)||2
8111489|NCT03061331|19991975|P2|COMPLETED|Washout Period (8 Weeks)||9
8111490|NCT03061331|19991976|P1|COMPLETED|Washout Period (8 Weeks)||8
8111491|NCT03061331|19991975|P2|STARTED|Washout Period (8 Weeks)||10
8111492|NCT03061331|19991976|P1|STARTED|Washout Period (8 Weeks)||10
8111493|NCT03061331|19991975|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
8111494|NCT03061331|19991976|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
8111495|NCT03061331|19991975|P2|COMPLETED|Treatment Period 1 (8 Weeks)||10
8111496|NCT03061331|19991976|P1|COMPLETED|Treatment Period 1 (8 Weeks)||10
8111497|NCT03061331|19991975|P2|STARTED|Treatment Period 1 (8 Weeks)||10
8111498|NCT03061331|19991976|P1|STARTED|Treatment Period 1 (8 Weeks)||10
8111499|NCT03061279|19991984|P2|NOT COMPLETED|Overall Study||1
8111500|NCT03061279|19991985|P1|NOT COMPLETED|Overall Study||0
8111501|NCT03061279|19991984|P2|COMPLETED|Overall Study||0
8111502|NCT03061279|19991985|P1|COMPLETED|Overall Study||0
8111503|NCT03061279|19991984|P2|STARTED|Overall Study||1
8111504|NCT03061279|19991985|P1|STARTED|Overall Study||0
8111523|NCT03061188|19992234|P4|NOT COMPLETED|On Follow-up for 3 Years||5
8111524|NCT03061188|19992235|P3|NOT COMPLETED|On Follow-up for 3 Years||5
8111525|NCT03061188|19992236|P2|NOT COMPLETED|On Follow-up for 3 Years||3
8111526|NCT03061188|19992237|P1|NOT COMPLETED|On Follow-up for 3 Years||0
8111527|NCT03061188|19992234|P4|COMPLETED|On Follow-up for 3 Years||1
8111528|NCT03061188|19992235|P3|COMPLETED|On Follow-up for 3 Years||1
8111529|NCT03061188|19992236|P2|COMPLETED|On Follow-up for 3 Years||0
8111530|NCT03061188|19992237|P1|COMPLETED|On Follow-up for 3 Years||0
8111531|NCT03061188|19992234|P4|STARTED|On Follow-up for 3 Years|Patients who receive at least one dose of study drug go into follow-up.|6
8111532|NCT03061188|19992235|P3|STARTED|On Follow-up for 3 Years|Patients who received at least one dose of study drug go into follow-up.|6
8111533|NCT03061188|19992236|P2|STARTED|On Follow-up for 3 Years||3
8111534|NCT03061188|19992237|P1|STARTED|On Follow-up for 3 Years||0
8111535|NCT03061188|19992234|P4|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
8111536|NCT03061188|19992235|P3|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
8111537|NCT03061188|19992236|P2|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
8111538|NCT03061188|19992237|P1|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
8111539|NCT03061188|19992234|P4|COMPLETED|Went on to Cycle 2 and Beyond||5
8111540|NCT03061188|19992235|P3|COMPLETED|Went on to Cycle 2 and Beyond||5
8111541|NCT03061188|19992236|P2|COMPLETED|Went on to Cycle 2 and Beyond||3
8111542|NCT03061188|19992237|P1|COMPLETED|Went on to Cycle 2 and Beyond||0
8111543|NCT03061188|19992234|P4|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
8111544|NCT03061188|19992235|P3|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
8111545|NCT03061188|19992236|P2|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||3
8111546|NCT03061188|19992237|P1|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||0
8111547|NCT03061188|19992234|P4|STARTED|Went on to Cycle 2 and Beyond||6
8111548|NCT03061188|19992235|P3|STARTED|Went on to Cycle 2 and Beyond||6
8111549|NCT03061188|19992236|P2|STARTED|Went on to Cycle 2 and Beyond||3
8111550|NCT03061188|19992237|P1|STARTED|Went on to Cycle 2 and Beyond||0
8111551|NCT03061188|19992234|P4|NOT COMPLETED|Completed 1st Cycle||0
8111552|NCT03061188|19992235|P3|NOT COMPLETED|Completed 1st Cycle||0
8111553|NCT03061188|19992236|P2|NOT COMPLETED|Completed 1st Cycle||0
8111554|NCT03061188|19992237|P1|NOT COMPLETED|Completed 1st Cycle||0
8111555|NCT03061188|19992234|P4|COMPLETED|Completed 1st Cycle||6
8111556|NCT03061188|19992235|P3|COMPLETED|Completed 1st Cycle||6
8111557|NCT03061188|19992236|P2|COMPLETED|Completed 1st Cycle||3
8111558|NCT03061188|19992237|P1|COMPLETED|Completed 1st Cycle||0
8111559|NCT03061188|19992234|P4|STARTED|Completed 1st Cycle||6
8111560|NCT03061188|19992235|P3|STARTED|Completed 1st Cycle||6
8111561|NCT03061188|19992236|P2|STARTED|Completed 1st Cycle||3
8111562|NCT03061188|19992237|P1|STARTED|Completed 1st Cycle||0
8111587|NCT03060759|19992299|P2|NOT COMPLETED|Overall Study||3
8111588|NCT03060759|19992300|P1|NOT COMPLETED|Overall Study||5
8111589|NCT03060759|19992299|P2|COMPLETED|Overall Study||12
8111590|NCT03060759|19992300|P1|COMPLETED|Overall Study||15
8111591|NCT03060759|19992299|P2|STARTED|Overall Study||15
8111592|NCT03060759|19992300|P1|STARTED|Overall Study||20
8111593|NCT03060551|19992306|P1|NOT COMPLETED|Overall Study||2
8111594|NCT03060551|19992306|P1|COMPLETED|Overall Study||18
8111595|NCT03060551|19992306|P1|STARTED|Overall Study||20
8111596|NCT03060512|19992327|P2|NOT COMPLETED|Overall Study||9
8111597|NCT03060512|19992328|P1|NOT COMPLETED|Overall Study||7
8111598|NCT03060512|19992327|P2|COMPLETED|Overall Study||130
8111599|NCT03060512|19992328|P1|COMPLETED|Overall Study||130
8111600|NCT03060512|19992327|P2|Treated With PEG 3350|Overall Study||138
8111601|NCT03060512|19992328|P1|Treated With PEG 3350|Overall Study||130
8111602|NCT03060512|19992327|P2|Treated With Movantik|Overall Study||135
8111603|NCT03060512|19992328|P1|Treated With Movantik|Overall Study||136
8111604|NCT03060512|19992327|P2|STARTED|Overall Study||139
8111605|NCT03060512|19992328|P1|STARTED|Overall Study||137
8111606|NCT03060486|19992345|P1|NOT COMPLETED|Overall Study||0
8111607|NCT03060486|19992345|P1|COMPLETED|Overall Study||15
8111608|NCT03060486|19992345|P1|STARTED|Overall Study||15
8111609|NCT03059901|19992351|P2|NOT COMPLETED|Overall Study||2
8111610|NCT03059901|19992352|P1|NOT COMPLETED|Overall Study||4
8111611|NCT03059901|19992351|P2|COMPLETED|Overall Study||28
8111612|NCT03059901|19992352|P1|COMPLETED|Overall Study||26
8111613|NCT03059901|19992351|P2|STARTED|Overall Study||30
8111614|NCT03059901|19992352|P1|STARTED|Overall Study||30
8111615|NCT03059810|19992358|P1|NOT COMPLETED|Overall Study||0
8111616|NCT03059810|19992358|P1|COMPLETED|Overall Study||63
8111617|NCT03059810|19992358|P1|STARTED|Overall Study||63
8111630|NCT03058705|19992393|P1|NOT COMPLETED|Overall Study||4
8111631|NCT03058705|19992393|P1|COMPLETED|Overall Study||6
8111632|NCT03058705|19992393|P1|STARTED|Overall Study||10
8111633|NCT03058692|19992399|P2|NOT COMPLETED|Overall Study||2
8111634|NCT03058692|19992400|P1|NOT COMPLETED|Overall Study||3
8111635|NCT03058692|19992399|P2|COMPLETED|Overall Study||57
8111636|NCT03058692|19992400|P1|COMPLETED|Overall Study||58
8111637|NCT03058692|19992399|P2|STARTED|Overall Study||59
8111638|NCT03058692|19992400|P1|STARTED|Overall Study||61
8111639|NCT03057704|19992514|P2|NOT COMPLETED|Overall Study||0
8111640|NCT03057704|19992515|P1|NOT COMPLETED|Overall Study||0
8111641|NCT03057704|19992514|P2|COMPLETED|Overall Study||25
8111642|NCT03057704|19992515|P1|COMPLETED|Overall Study||25
8111643|NCT03057704|19992514|P2|STARTED|Overall Study||25
8111644|NCT03057704|19992515|P1|STARTED|Overall Study||25
8111645|NCT03057613|19992525|P1|NOT COMPLETED|Overall Study||0
8111646|NCT03057613|19992525|P1|COMPLETED|Overall Study||18
8111647|NCT03057613|19992525|P1|STARTED|Overall Study||18
8111652|NCT03057366|19992537|P3|NOT COMPLETED|Part B||0
8111653|NCT03057366|19992538|P2|NOT COMPLETED|Part B||0
8111654|NCT03057366|19992539|P1|NOT COMPLETED|Part B||0
8111655|NCT03057366|19992537|P3|COMPLETED|Part B||2
8111656|NCT03057366|19992538|P2|COMPLETED|Part B||5
8111657|NCT03057366|19992539|P1|COMPLETED|Part B||0
8111658|NCT03057366|19992537|P3|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2
8111659|NCT03057366|19992538|P2|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5
8111660|NCT03057366|19992539|P1|STARTED|Part B||0
8111661|NCT03057366|19992537|P3|NOT COMPLETED|Part A||0
8111662|NCT03057366|19992538|P2|NOT COMPLETED|Part A||0
8111663|NCT03057366|19992539|P1|NOT COMPLETED|Part A||0
8111664|NCT03057366|19992537|P3|COMPLETED|Part A||0
8111665|NCT03057366|19992538|P2|COMPLETED|Part A||0
8111666|NCT03057366|19992539|P1|COMPLETED|Part A||8
8111667|NCT03057366|19992537|P3|STARTED|Part A||0
8111668|NCT03057366|19992538|P2|STARTED|Part A||0
8111669|NCT03057366|19992539|P1|STARTED|Part A||8
8111670|NCT03057132|19992562|P1|NOT COMPLETED|Overall Study||0
8111671|NCT03057132|19992562|P1|COMPLETED|Overall Study||1
8111672|NCT03057132|19992562|P1|STARTED|Overall Study||1
8111673|NCT03056573|19992569|P2|NOT COMPLETED|Overall Study||5
8111674|NCT03056573|19992570|P1|NOT COMPLETED|Overall Study||5
8111675|NCT03056573|19992569|P2|COMPLETED|Overall Study||14
8111676|NCT03056573|19992570|P1|COMPLETED|Overall Study||40
8111677|NCT03056573|19992569|P2|STARTED|Overall Study||19
8111678|NCT03056573|19992570|P1|STARTED|Overall Study||45
8111679|NCT03056456|19992614|P4|NOT COMPLETED|Period 4||0
8111680|NCT03056456|19992615|P3|NOT COMPLETED|Period 4||0
8111681|NCT03056456|19992616|P2|NOT COMPLETED|Period 4||0
8111682|NCT03056456|19992617|P1|NOT COMPLETED|Period 4||0
8111683|NCT03056456|19992614|P4|COMPLETED|Period 4||5
8111684|NCT03056456|19992615|P3|COMPLETED|Period 4||6
8111685|NCT03056456|19992616|P2|COMPLETED|Period 4||6
8111686|NCT03056456|19992617|P1|COMPLETED|Period 4||6
8111687|NCT03056456|19992614|P4|STARTED|Period 4|Participant deviated from 1 week maximum between consecutive periods and did not start Period 4.|5
8111688|NCT03056456|19992615|P3|STARTED|Period 4||6
8111689|NCT03056456|19992616|P2|STARTED|Period 4||6
8111690|NCT03056456|19992617|P1|STARTED|Period 4||6
8111691|NCT03056456|19992614|P4|NOT COMPLETED|Period 3||0
8111692|NCT03056456|19992615|P3|NOT COMPLETED|Period 3||0
8111693|NCT03056456|19992616|P2|NOT COMPLETED|Period 3||0
8111694|NCT03056456|19992617|P1|NOT COMPLETED|Period 3||0
8111695|NCT03056456|19992614|P4|COMPLETED|Period 3||6
8111696|NCT03056456|19992615|P3|COMPLETED|Period 3||6
8111697|NCT03056456|19992616|P2|COMPLETED|Period 3||6
8111698|NCT03056456|19992617|P1|COMPLETED|Period 3||6
8111699|NCT03056456|19992614|P4|STARTED|Period 3||6
8111700|NCT03056456|19992615|P3|STARTED|Period 3||6
8111701|NCT03056456|19992616|P2|STARTED|Period 3||6
8111702|NCT03056456|19992617|P1|STARTED|Period 3||6
8111703|NCT03056456|19992614|P4|NOT COMPLETED|Period 2||0
8111704|NCT03056456|19992615|P3|NOT COMPLETED|Period 2||0
8111705|NCT03056456|19992616|P2|NOT COMPLETED|Period 2||0
8111706|NCT03056456|19992617|P1|NOT COMPLETED|Period 2||0
8111707|NCT03056456|19992614|P4|COMPLETED|Period 2||6
8111708|NCT03056456|19992615|P3|COMPLETED|Period 2||6
8111709|NCT03056456|19992616|P2|COMPLETED|Period 2||6
8111710|NCT03056456|19992617|P1|COMPLETED|Period 2||6
8111711|NCT03056456|19992614|P4|STARTED|Period 2||6
8111712|NCT03056456|19992615|P3|STARTED|Period 2||6
8111713|NCT03056456|19992616|P2|STARTED|Period 2||6
8111714|NCT03056456|19992617|P1|STARTED|Period 2||6
8111715|NCT03056456|19992614|P4|NOT COMPLETED|Period 1||0
8111716|NCT03056456|19992615|P3|NOT COMPLETED|Period 1||0
8111717|NCT03056456|19992616|P2|NOT COMPLETED|Period 1||0
8111718|NCT03056456|19992617|P1|NOT COMPLETED|Period 1||0
8111719|NCT03056456|19992614|P4|COMPLETED|Period 1||6
8111720|NCT03056456|19992615|P3|COMPLETED|Period 1||6
8111721|NCT03056456|19992616|P2|COMPLETED|Period 1||6
8111722|NCT03056456|19992617|P1|COMPLETED|Period 1||6
8111723|NCT03056456|19992614|P4|Received One Dose of Study Drug|Period 1||6
8111724|NCT03056456|19992615|P3|Received One Dose of Study Drug|Period 1||6
8111725|NCT03056456|19992616|P2|Received One Dose of Study Drug|Period 1||6
8111726|NCT03056456|19992617|P1|Received One Dose of Study Drug|Period 1||6
8111727|NCT03056456|19992614|P4|STARTED|Period 1||6
8111728|NCT03056456|19992615|P3|STARTED|Period 1||6
8111729|NCT03056456|19992616|P2|STARTED|Period 1||6
8111730|NCT03056456|19992617|P1|STARTED|Period 1||6
8111731|NCT03056352|19992630|P1|NOT COMPLETED|Overall Study||1
8111732|NCT03056352|19992630|P1|COMPLETED|Overall Study||20
8111733|NCT03056352|19992630|P1|STARTED|Overall Study||21
8111734|NCT03056300|19992636|P1|NOT COMPLETED|Overall Study||3
8111735|NCT03056300|19992636|P1|COMPLETED|Overall Study||47
8111736|NCT03056300|19992636|P1|STARTED|Overall Study||50
8111737|NCT03056144|19992641|P1|NOT COMPLETED|Overall Study||0
8111738|NCT03056144|19992641|P1|COMPLETED|Overall Study||1
8111739|NCT03056144|19992641|P1|STARTED|Overall Study||1
8111740|NCT03056040|19992653|P2|NOT COMPLETED|Extension Period||95
8111741|NCT03056040|19992654|P1|NOT COMPLETED|Extension Period||96
8111742|NCT03056040|19992653|P2|COMPLETED|Extension Period||0
8111743|NCT03056040|19992654|P1|COMPLETED|Extension Period||0
8111744|NCT03056040|19992653|P2|Received at Least 1 Dose of Ravulizumab|Extension Period||95
8111745|NCT03056040|19992654|P1|Received at Least 1 Dose of Ravulizumab|Extension Period||96
8111746|NCT03056040|19992653|P2|STARTED|Extension Period||95
8111747|NCT03056040|19992654|P1|STARTED|Extension Period||96
8111748|NCT03056040|19992653|P2|NOT COMPLETED|Primary Evaluation Period||3
8111749|NCT03056040|19992654|P1|NOT COMPLETED|Primary Evaluation Period||1
8111750|NCT03056040|19992653|P2|COMPLETED|Primary Evaluation Period||95
8111751|NCT03056040|19992654|P1|COMPLETED|Primary Evaluation Period||96
8111752|NCT03056040|19992653|P2|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98
8111753|NCT03056040|19992654|P1|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97
8111754|NCT03056040|19992653|P2|STARTED|Primary Evaluation Period||98
8111755|NCT03056040|19992654|P1|STARTED|Primary Evaluation Period||97
8111756|NCT03055988|19992668|P2|NOT COMPLETED|Period 2||2
8111757|NCT03055988|19992669|P1|NOT COMPLETED|Period 2||1
8111758|NCT03055988|19992668|P2|COMPLETED|Period 2||31
8111759|NCT03055988|19992669|P1|COMPLETED|Period 2||36
8111760|NCT03055988|19992668|P2|STARTED|Period 2||33
8111761|NCT03055988|19992669|P1|STARTED|Period 2||37
8111762|NCT03055988|19992668|P2|NOT COMPLETED|Period 1||5
8111763|NCT03055988|19992669|P1|NOT COMPLETED|Period 1||1
8111764|NCT03055988|19992668|P2|COMPLETED|Period 1||33
8111765|NCT03055988|19992669|P1|COMPLETED|Period 1||37
8111766|NCT03055988|19992668|P2|STARTED|Period 1||38
8111767|NCT03055988|19992669|P1|STARTED|Period 1||38
8111768|NCT03055897|19992691|P1|NOT COMPLETED|Overall Study||0
8111769|NCT03055897|19992691|P1|COMPLETED|Overall Study||15
8111770|NCT03055897|19992691|P1|STARTED|Overall Study||15
8111771|NCT03055858|19992695|P1|NOT COMPLETED|Overall Study||6
8111772|NCT03055858|19992695|P1|COMPLETED|Overall Study||194
8111773|NCT03055858|19992695|P1|CAP Cohort|Overall Study||150
8111774|NCT03055858|19992695|P1|IDE Cohort|Overall Study||50
8111775|NCT03055858|19992695|P1|STARTED|Overall Study||200
8111776|NCT03055832|19992703|P2|NOT COMPLETED|Week 4||0
8111777|NCT03055832|19992704|P1|NOT COMPLETED|Week 4||0
8111778|NCT03055832|19992703|P2|COMPLETED|Week 4||71
8111779|NCT03055832|19992704|P1|COMPLETED|Week 4||70
8111780|NCT03055832|19992703|P2|STARTED|Week 4||71
8111781|NCT03055832|19992704|P1|STARTED|Week 4||70
8111782|NCT03055832|19992703|P2|NOT COMPLETED|Week 2||0
8111783|NCT03055832|19992704|P1|NOT COMPLETED|Week 2||1
8111784|NCT03055832|19992703|P2|COMPLETED|Week 2||71
8111785|NCT03055832|19992704|P1|COMPLETED|Week 2||70
8111786|NCT03055832|19992703|P2|STARTED|Week 2||71
8111787|NCT03055832|19992704|P1|STARTED|Week 2||71
8111788|NCT03055832|19992703|P2|NOT COMPLETED|Day 1||0
8111789|NCT03055832|19992704|P1|NOT COMPLETED|Day 1||0
8111790|NCT03055832|19992703|P2|COMPLETED|Day 1||71
8111791|NCT03055832|19992704|P1|COMPLETED|Day 1||71
8111792|NCT03055832|19992703|P2|STARTED|Day 1||71
8111793|NCT03055832|19992704|P1|STARTED|Day 1||71
8111794|NCT03055832|19992703|P2|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
8111795|NCT03055832|19992704|P1|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
8111796|NCT03055832|19992703|P2|COMPLETED|Immediately Post-Procedure (Hour 1)||71
8111797|NCT03055832|19992704|P1|COMPLETED|Immediately Post-Procedure (Hour 1)||71
8111798|NCT03055832|19992703|P2|STARTED|Immediately Post-Procedure (Hour 1)||71
8111799|NCT03055832|19992704|P1|STARTED|Immediately Post-Procedure (Hour 1)||71
8111800|NCT03055832|19992703|P2|NOT COMPLETED|Baseline||0
8111801|NCT03055832|19992704|P1|NOT COMPLETED|Baseline||0
8111802|NCT03055832|19992703|P2|COMPLETED|Baseline||71
8111803|NCT03055832|19992704|P1|COMPLETED|Baseline||71
8111804|NCT03055832|19992703|P2|STARTED|Baseline||71
8111805|NCT03055832|19992704|P1|STARTED|Baseline||71
8111806|NCT03055806|19992764|P4|NOT COMPLETED|Overall Study||15
8111807|NCT03055806|19992765|P3|NOT COMPLETED|Overall Study||13
8111808|NCT03055806|19992766|P2|NOT COMPLETED|Overall Study||7
8111809|NCT03055806|19992767|P1|NOT COMPLETED|Overall Study||6
8111810|NCT03055806|19992764|P4|COMPLETED|Overall Study||57
8111811|NCT03055806|19992765|P3|COMPLETED|Overall Study||58
8111812|NCT03055806|19992766|P2|COMPLETED|Overall Study||41
8111813|NCT03055806|19992767|P1|COMPLETED|Overall Study||42
8111814|NCT03055806|19992764|P4|STARTED|Overall Study||72
8111815|NCT03055806|19992765|P3|STARTED|Overall Study||71
8111816|NCT03055806|19992766|P2|STARTED|Overall Study||48
8111817|NCT03055806|19992767|P1|STARTED|Overall Study||48
8111818|NCT03055650|19992809|P1|NOT COMPLETED|Overall Study||0
8111819|NCT03055650|19992809|P1|COMPLETED|Overall Study||30
8111820|NCT03055650|19992809|P1|STARTED|Overall Study||30
8111821|NCT03055624|19992816|P1|NOT COMPLETED|Overall Study||9
8111822|NCT03055624|19992816|P1|COMPLETED|Overall Study||0
8111823|NCT03055624|19992816|P1|STARTED|Overall Study||9
8111824|NCT03055494|19992827|P2|NOT COMPLETED|Overall Study||1
8111825|NCT03055494|19992828|P1|NOT COMPLETED|Overall Study||10
8111826|NCT03055494|19992827|P2|COMPLETED|Overall Study||27
8111827|NCT03055494|19992828|P1|COMPLETED|Overall Study||44
8111828|NCT03055494|19992827|P2|STARTED|Overall Study||28
8111829|NCT03055494|19992828|P1|STARTED|Overall Study||54
8111830|NCT03055338|19992859|P3|NOT COMPLETED|Overall Study||12
8111831|NCT03055338|19992860|P2|NOT COMPLETED|Overall Study||11
8111832|NCT03055338|19992861|P1|NOT COMPLETED|Overall Study||18
8111833|NCT03055338|19992859|P3|COMPLETED|Overall Study||77
8111834|NCT03055338|19992860|P2|COMPLETED|Overall Study||34
8111835|NCT03055338|19992861|P1|COMPLETED|Overall Study||72
8111836|NCT03055338|19992859|P3|STARTED|Overall Study||89
8111837|NCT03055338|19992860|P2|STARTED|Overall Study||45
8111838|NCT03055338|19992861|P1|STARTED|Overall Study||90
8111839|NCT03055260|19992880|P2|NOT COMPLETED|Overall Study||0
8111840|NCT03055260|19992881|P1|NOT COMPLETED|Overall Study||1
8111841|NCT03055260|19992880|P2|COMPLETED|Overall Study||0
8111842|NCT03055260|19992881|P1|COMPLETED|Overall Study||7
8111843|NCT03055260|19992880|P2|STARTED|Overall Study||0
8111844|NCT03055260|19992881|P1|STARTED|Overall Study||8
8111845|NCT03055221|19992889|P1|NOT COMPLETED|Overall Study||16
8111846|NCT03055221|19992889|P1|COMPLETED|Overall Study||0
8111847|NCT03055221|19992889|P1|STARTED|Overall Study||16
8111848|NCT03055195|19992896|P2|NOT COMPLETED|Overall Study||14
8111849|NCT03055195|19992897|P1|NOT COMPLETED|Overall Study||12
8111850|NCT03055195|19992896|P2|COMPLETED|Overall Study||4
8111851|NCT03055195|19992897|P1|COMPLETED|Overall Study||4
8111852|NCT03055195|19992896|P2|STARTED|Overall Study||18
8111853|NCT03055195|19992897|P1|STARTED|Overall Study||16
8111854|NCT03055156|19992951|P2|NOT COMPLETED|Overall Study||0
8111855|NCT03055156|19992952|P1|NOT COMPLETED|Overall Study||0
8111856|NCT03055156|19992951|P2|COMPLETED|Overall Study||273
8111857|NCT03055156|19992952|P1|COMPLETED|Overall Study||281
8111858|NCT03055156|19992951|P2|STARTED|Overall Study||273
8111859|NCT03055156|19992952|P1|STARTED|Overall Study||281
8111860|NCT03055000|19992989|P3|NOT COMPLETED|Overall Study||0
8111861|NCT03055000|19992990|P2|NOT COMPLETED|Overall Study||0
8111862|NCT03055000|19992991|P1|NOT COMPLETED|Overall Study||0
8111863|NCT03055000|19992989|P3|COMPLETED|Overall Study||16
8111864|NCT03055000|19992990|P2|COMPLETED|Overall Study||17
8111865|NCT03055000|19992991|P1|COMPLETED|Overall Study||16
8111866|NCT03055000|19992989|P3|STARTED|Overall Study||16
8111867|NCT03055000|19992990|P2|STARTED|Overall Study||17
8111868|NCT03055000|19992991|P1|STARTED|Overall Study||16
8111869|NCT03054922|19993077|P3|NOT COMPLETED|Overall Study||0
8111870|NCT03054922|19993078|P2|NOT COMPLETED|Overall Study||0
8111871|NCT03054922|19993079|P1|NOT COMPLETED|Overall Study||0
8111872|NCT03054922|19993077|P3|COMPLETED|Overall Study||20
8111873|NCT03054922|19993078|P2|COMPLETED|Overall Study||19
8111874|NCT03054922|19993079|P1|COMPLETED|Overall Study||20
8111875|NCT03054922|19993077|P3|STARTED|Overall Study||20
8111876|NCT03054922|19993078|P2|STARTED|Overall Study||19
8111877|NCT03054922|19993079|P1|STARTED|Overall Study||20
8111878|NCT03054857|19993101|P2|NOT COMPLETED|Overall Study||0
8111879|NCT03054857|19993102|P1|NOT COMPLETED|Overall Study||1
8111880|NCT03054857|19993101|P2|COMPLETED|Overall Study||50
8111881|NCT03054857|19993102|P1|COMPLETED|Overall Study||49
8111882|NCT03054857|19993101|P2|STARTED|Overall Study||50
8111883|NCT03054857|19993102|P1|STARTED|Overall Study||50
8111884|NCT03054844|19993118|P2|NOT COMPLETED|Overall Study||1
8111885|NCT03054844|19993119|P1|NOT COMPLETED|Overall Study||3
8111886|NCT03054844|19993118|P2|COMPLETED|Overall Study||26
8111887|NCT03054844|19993119|P1|COMPLETED|Overall Study||25
8111888|NCT03054844|19993118|P2|STARTED|Overall Study||27
8111889|NCT03054844|19993119|P1|STARTED|Overall Study||28
8111890|NCT03054805|19993138|P3|NOT COMPLETED|Overall Study||2
8111891|NCT03054805|19993139|P2|NOT COMPLETED|Overall Study||10
8111892|NCT03054805|19993140|P1|NOT COMPLETED|Overall Study||16
8111893|NCT03054805|19993138|P3|COMPLETED|Overall Study||42
8111894|NCT03054805|19993139|P2|COMPLETED|Overall Study||41
8111895|NCT03054805|19993140|P1|COMPLETED|Overall Study||42
8111896|NCT03054805|19993138|P3|STARTED|Overall Study||44
8111897|NCT03054805|19993139|P2|STARTED|Overall Study||51
8111898|NCT03054805|19993140|P1|STARTED|Overall Study||58
8111899|NCT03054740|19993150|P2|NOT COMPLETED|Overall Study||0
8111900|NCT03054740|19993151|P1|NOT COMPLETED|Overall Study||0
8111901|NCT03054740|19993150|P2|COMPLETED|Overall Study||15
8111902|NCT03054740|19993151|P1|COMPLETED|Overall Study||15
8111903|NCT03054740|19993150|P2|STARTED|Overall Study||15
8111904|NCT03054740|19993151|P1|STARTED|Overall Study||15
8111905|NCT03054649|19993165|P2|NOT COMPLETED|Overall Study||0
8111906|NCT03054649|19993166|P1|NOT COMPLETED|Overall Study||0
8111907|NCT03054649|19993165|P2|COMPLETED|Overall Study||27
8111908|NCT03054649|19993166|P1|COMPLETED|Overall Study||27
8111909|NCT03054649|19993165|P2|STARTED|Overall Study||27
8111910|NCT03054649|19993166|P1|STARTED|Overall Study||27
8111911|NCT03054506|19993223|P3|NOT COMPLETED|Overall Study||0
8111912|NCT03054506|19993224|P2|NOT COMPLETED|Overall Study||0
8111913|NCT03054506|19993225|P1|NOT COMPLETED|Overall Study||1
8111914|NCT03054506|19993223|P3|COMPLETED|Overall Study||9
8111915|NCT03054506|19993224|P2|COMPLETED|Overall Study||11
8111916|NCT03054506|19993225|P1|COMPLETED|Overall Study||19
8111917|NCT03054506|19993223|P3|STARTED|Overall Study||9
8111918|NCT03054506|19993224|P2|STARTED|Overall Study||11
8111919|NCT03054506|19993225|P1|STARTED|Overall Study||20
8111920|NCT03054428|19993269|P3|NOT COMPLETED|Overall Study||79
8111921|NCT03054428|19993270|P2|NOT COMPLETED|Overall Study||80
8111922|NCT03054428|19993271|P1|NOT COMPLETED|Overall Study||83
8111923|NCT03054428|19993269|P3|COMPLETED|Overall Study||3
8111924|NCT03054428|19993270|P2|COMPLETED|Overall Study||4
8111925|NCT03054428|19993271|P1|COMPLETED|Overall Study||2
8111926|NCT03054428|19993269|P3|Completed Week 28 (End of Study)|Overall Study||3
8111927|NCT03054428|19993270|P2|Completed Week 28 (End of Study)|Overall Study||4
8111928|NCT03054428|19993271|P1|Completed Week 28 (End of Study)|Overall Study||2
8111929|NCT03054428|19993269|P3|Completed Wk 16 End of Treatment (EOT)|Overall Study||79
8111930|NCT03054428|19993270|P2|Completed Wk 16 End of Treatment (EOT)|Overall Study||81
8111931|NCT03054428|19993271|P1|Completed Wk 16 End of Treatment (EOT)|Overall Study||80
8111932|NCT03054428|19993269|P3|STARTED|Overall Study||82
8111933|NCT03054428|19993270|P2|STARTED|Overall Study||84
8111934|NCT03054428|19993271|P1|STARTED|Overall Study||85
8111935|NCT03054103|19993339|P3|NOT COMPLETED|Overall Study||0
8111936|NCT03054103|19993340|P2|NOT COMPLETED|Overall Study||0
8111937|NCT03054103|19993341|P1|NOT COMPLETED|Overall Study||0
8111938|NCT03054103|19993339|P3|COMPLETED|Overall Study||35
8111939|NCT03054103|19993340|P2|COMPLETED|Overall Study||29
8111940|NCT03054103|19993341|P1|COMPLETED|Overall Study||41
8111941|NCT03054103|19993339|P3|STARTED|Overall Study||35
8111942|NCT03054103|19993340|P2|STARTED|Overall Study||29
8111943|NCT03054103|19993341|P1|STARTED|Overall Study||41
8111944|NCT03054077|19993360|P2|NOT COMPLETED|Overall Study||0
8111945|NCT03054077|19993361|P1|NOT COMPLETED|Overall Study||0
8111946|NCT03054077|19993360|P2|COMPLETED|Overall Study||12
8111947|NCT03054077|19993361|P1|COMPLETED|Overall Study||12
8111948|NCT03054077|19993360|P2|STARTED|Overall Study||12
8111949|NCT03054077|19993361|P1|STARTED|Overall Study||12
8111950|NCT03054064|19993367|P1|NOT COMPLETED|Overall Study||6
8111951|NCT03054064|19993367|P1|COMPLETED|Overall Study||42
8111952|NCT03054064|19993367|P1|Screen Failure|Overall Study||2
8111953|NCT03054064|19993367|P1|STARTED|Overall Study||48
8111954|NCT03054051|19993377|P2|NOT COMPLETED|Overall Study||0
8111955|NCT03054051|19993378|P1|NOT COMPLETED|Overall Study||0
8111956|NCT03054051|19993377|P2|COMPLETED|Overall Study||30
8111957|NCT03054051|19993378|P1|COMPLETED|Overall Study||30
8111958|NCT03054051|19993377|P2|STARTED|Overall Study||30
8111959|NCT03054051|19993378|P1|STARTED|Overall Study||30
8111960|NCT03053960|19993407|P1|NOT COMPLETED|Overall Study||0
8111961|NCT03053960|19993407|P1|COMPLETED|Overall Study||8
8111962|NCT03053960|19993407|P1|STARTED|Overall Study||8
8111963|NCT03053518|19993412|P1|NOT COMPLETED|Overall Study||10
8111964|NCT03053518|19993412|P1|COMPLETED|Overall Study||12
8111965|NCT03053518|19993412|P1|STARTED|Overall Study||22
8111966|NCT03053492|19993418|P2|NOT COMPLETED|Overall Study||6
8111967|NCT03053492|19993419|P1|NOT COMPLETED|Overall Study||8
8111968|NCT03053492|19993418|P2|COMPLETED|Overall Study||27
8111969|NCT03053492|19993419|P1|COMPLETED|Overall Study||25
8111970|NCT03053492|19993418|P2|STARTED|Overall Study||33
8111971|NCT03053492|19993419|P1|STARTED|Overall Study||33
8111972|NCT03053427|19993433|P2|NOT COMPLETED|Overall Study||16
8111973|NCT03053427|19993434|P1|NOT COMPLETED|Overall Study||13
8111974|NCT03053427|19993433|P2|COMPLETED|Overall Study||173
8111975|NCT03053427|19993434|P1|COMPLETED|Overall Study||173
8111976|NCT03053427|19993433|P2|STARTED|Overall Study||189
8111977|NCT03053427|19993434|P1|STARTED|Overall Study||186
8111978|NCT03053401|19993458|P2|NOT COMPLETED|Overall Study||0
8111979|NCT03053401|19993459|P1|NOT COMPLETED|Overall Study||0
8111980|NCT03053401|19993458|P2|COMPLETED|Overall Study||26
8111981|NCT03053401|19993459|P1|COMPLETED|Overall Study||26
8111982|NCT03053401|19993458|P2|STARTED|Overall Study||26
8111983|NCT03053401|19993459|P1|STARTED|Overall Study||26
8111984|NCT03053180|19993469|P1|NOT COMPLETED|Overall Study||1
8111985|NCT03053180|19993469|P1|COMPLETED|Overall Study||59
8111986|NCT03053180|19993469|P1|STARTED|Overall Study||60
8111987|NCT03053063|19993481|P4|NOT COMPLETED|Open-Label Phase||23
8111988|NCT03053063|19993482|P3|NOT COMPLETED|Open-Label Phase||0
8111989|NCT03053063|19993483|P2|NOT COMPLETED|Open-Label Phase||0
8111990|NCT03053063|19993484|P1|NOT COMPLETED|Open-Label Phase||0
8111991|NCT03053063|19993481|P4|COMPLETED|Open-Label Phase||0
8111992|NCT03053063|19993482|P3|COMPLETED|Open-Label Phase||0
8111993|NCT03053063|19993483|P2|COMPLETED|Open-Label Phase||0
8111994|NCT03053063|19993484|P1|COMPLETED|Open-Label Phase||0
8111995|NCT03053063|19993481|P4|STARTED|Open-Label Phase|Participants who experienced a hepatic clinical event had the option to roll over into the OL Phase.|23
8111996|NCT03053063|19993482|P3|STARTED|Open-Label Phase||0
8111997|NCT03053063|19993483|P2|STARTED|Open-Label Phase||0
8111998|NCT03053063|19993484|P1|STARTED|Open-Label Phase||0
8111999|NCT03053063|19993481|P4|NOT COMPLETED|Randomized Phase||0
8112000|NCT03053063|19993482|P3|NOT COMPLETED|Randomized Phase||174
8112001|NCT03053063|19993483|P2|NOT COMPLETED|Randomized Phase||354
8112002|NCT03053063|19993484|P1|NOT COMPLETED|Randomized Phase||355
8112003|NCT03053063|19993481|P4|COMPLETED|Randomized Phase||0
8112004|NCT03053063|19993482|P3|COMPLETED|Randomized Phase||0
8112005|NCT03053063|19993483|P2|COMPLETED|Randomized Phase||0
8112006|NCT03053063|19993484|P1|COMPLETED|Randomized Phase||0
8112007|NCT03053063|19993481|P4|STARTED|Randomized Phase||0
8112008|NCT03053063|19993482|P3|STARTED|Randomized Phase||174
8112009|NCT03053063|19993483|P2|STARTED|Randomized Phase||354
8112010|NCT03053063|19993484|P1|STARTED|Randomized Phase||355
8112011|NCT03053050|19993514|P4|NOT COMPLETED|Open-label Phase||99
8112012|NCT03053050|19993515|P3|NOT COMPLETED|Open-label Phase||0
8112013|NCT03053050|19993516|P2|NOT COMPLETED|Open-label Phase||0
8112014|NCT03053050|19993517|P1|NOT COMPLETED|Open-label Phase||0
8112015|NCT03053050|19993514|P4|COMPLETED|Open-label Phase||0
8112016|NCT03053050|19993515|P3|COMPLETED|Open-label Phase||0
8112017|NCT03053050|19993516|P2|COMPLETED|Open-label Phase||0
8112018|NCT03053050|19993517|P1|COMPLETED|Open-label Phase||0
8112019|NCT03053050|19993514|P4|STARTED|Open-label Phase|Participants with hepatic clinical event or progression to cirrhosis had option to go into OL Phase.|99
8112020|NCT03053050|19993515|P3|STARTED|Open-label Phase||0
8112021|NCT03053050|19993516|P2|STARTED|Open-label Phase||0
8112022|NCT03053050|19993517|P1|STARTED|Open-label Phase||0
8112023|NCT03053050|19993514|P4|NOT COMPLETED|Randomized Phase||0
8112024|NCT03053050|19993515|P3|NOT COMPLETED|Randomized Phase||161
8112025|NCT03053050|19993516|P2|NOT COMPLETED|Randomized Phase||323
8112026|NCT03053050|19993517|P1|NOT COMPLETED|Randomized Phase||324
8112027|NCT03053050|19993514|P4|COMPLETED|Randomized Phase||0
8112028|NCT03053050|19993515|P3|COMPLETED|Randomized Phase||0
8112029|NCT03053050|19993516|P2|COMPLETED|Randomized Phase||0
8112030|NCT03053050|19993517|P1|COMPLETED|Randomized Phase||0
8112031|NCT03053050|19993514|P4|STARTED|Randomized Phase||0
8112032|NCT03053050|19993515|P3|STARTED|Randomized Phase||161
8112033|NCT03053050|19993516|P2|STARTED|Randomized Phase||323
8112034|NCT03053050|19993517|P1|STARTED|Randomized Phase||324
8112035|NCT03052972|19993549|P2|NOT COMPLETED|Overall Study||0
8112036|NCT03052972|19993550|P1|NOT COMPLETED|Overall Study||0
8112037|NCT03052972|19993549|P2|COMPLETED|Overall Study||5
8112038|NCT03052972|19993550|P1|COMPLETED|Overall Study||18
8112039|NCT03052972|19993549|P2|STARTED|Overall Study||5
8112040|NCT03052972|19993550|P1|STARTED|Overall Study||18
8112041|NCT03052764|19993561|P2|NOT COMPLETED|Open-Label Re-Treatment Period||0
8112042|NCT03052764|19993562|P1|NOT COMPLETED|Open-Label Re-Treatment Period||0
8112043|NCT03052764|19993561|P2|COMPLETED|Open-Label Re-Treatment Period||33
8112044|NCT03052764|19993562|P1|COMPLETED|Open-Label Re-Treatment Period||58
8112045|NCT03052764|19993561|P2|STARTED|Open-Label Re-Treatment Period||33
8112046|NCT03052764|19993562|P1|STARTED|Open-Label Re-Treatment Period||58
8112047|NCT03052764|19993561|P2|NOT COMPLETED|Double-Blind Treatment Period||3
8112048|NCT03052764|19993562|P1|NOT COMPLETED|Double-Blind Treatment Period||10
8112049|NCT03052764|19993561|P2|COMPLETED|Double-Blind Treatment Period||37
8112050|NCT03052764|19993562|P1|COMPLETED|Double-Blind Treatment Period||70
8112051|NCT03052764|19993561|P2|mITT|Double-Blind Treatment Period||39
8112052|NCT03052764|19993562|P1|mITT|Double-Blind Treatment Period||78
8112053|NCT03052764|19993561|P2|STARTED|Double-Blind Treatment Period||40
8112054|NCT03052764|19993562|P1|STARTED|Double-Blind Treatment Period||80
8112055|NCT03052725|19993582|P2|NOT COMPLETED|Overall Study||150
8112056|NCT03052725|19993583|P1|NOT COMPLETED|Overall Study||148
8112057|NCT03052725|19993582|P2|COMPLETED|Overall Study||47
8112058|NCT03052725|19993583|P1|COMPLETED|Overall Study||46
8112059|NCT03052725|19993582|P2|Safety Analysis Set|Overall Study||196
8112060|NCT03052725|19993583|P1|Safety Analysis Set|Overall Study||194
8112061|NCT03052725|19993582|P2|STARTED|Overall Study||197
8112062|NCT03052725|19993583|P1|STARTED|Overall Study||194
8112063|NCT03052530|19993620|P1|NOT COMPLETED|Overall Study||0
8112064|NCT03052530|19993620|P1|COMPLETED|Overall Study||61
8112065|NCT03052530|19993620|P1|STARTED|Overall Study||61
8112066|NCT03052517|19993630|P3|NOT COMPLETED|Overall Study||328
8112067|NCT03052517|19993631|P2|NOT COMPLETED|Overall Study||1014
8112068|NCT03052517|19993632|P1|NOT COMPLETED|Overall Study||1017
8112069|NCT03052517|19993630|P3|COMPLETED|Overall Study||32
8112070|NCT03052517|19993631|P2|COMPLETED|Overall Study||71
8112071|NCT03052517|19993632|P1|COMPLETED|Overall Study||76
8112072|NCT03052517|19993630|P3|Safety Set (SAF)|Overall Study|One patient in QAW039 150 mg group received placebo and was included in the placebo group in the SAF|361
8112073|NCT03052517|19993631|P2|Safety Set (SAF)|Overall Study|One patient had no treatment administered and thus was excluded from the SAF|1084
8112074|NCT03052517|19993632|P1|Safety Set (SAF)|Overall Study|One patient received placebo. This patient was not included in QAW039 150 mg group in the SAF|1092
8112075|NCT03052517|19993630|P3|STARTED|Overall Study||360
8112076|NCT03052517|19993631|P2|STARTED|Overall Study||1085
8112077|NCT03052517|19993632|P1|STARTED|Overall Study||1093
8112078|NCT03052426|19993676|P3|NOT COMPLETED|Overall Study||1
8112079|NCT03052426|19993677|P2|NOT COMPLETED|Overall Study||1
8112080|NCT03052426|19993678|P1|NOT COMPLETED|Overall Study||2
8112081|NCT03052426|19993676|P3|COMPLETED|Overall Study||5
8112082|NCT03052426|19993677|P2|COMPLETED|Overall Study||5
8112083|NCT03052426|19993678|P1|COMPLETED|Overall Study||4
8112084|NCT03052426|19993676|P3|STARTED|Overall Study||6
8112085|NCT03052426|19993677|P2|STARTED|Overall Study||6
8112086|NCT03052426|19993678|P1|STARTED|Overall Study||6
8112087|NCT03052322|19993693|P2|NOT COMPLETED|Overall Study||32
8112088|NCT03052322|19993694|P1|NOT COMPLETED|Overall Study||21
8112089|NCT03052322|19993693|P2|COMPLETED|Overall Study||113
8112090|NCT03052322|19993694|P1|COMPLETED|Overall Study||122
8112091|NCT03052322|19993693|P2|STARTED|Overall Study||145
8112092|NCT03052322|19993694|P1|STARTED|Overall Study||143
8112099|NCT03051646|19993755|P2|NOT COMPLETED|Overall Study||0
8112100|NCT03051646|19993756|P1|NOT COMPLETED|Overall Study||0
8112101|NCT03051646|19993755|P2|COMPLETED|Overall Study||6
8112102|NCT03051646|19993756|P1|COMPLETED|Overall Study||6
8112103|NCT03051646|19993755|P2|STARTED|Overall Study||6
8112104|NCT03051646|19993756|P1|STARTED|Overall Study||6
8112105|NCT03051633|19993766|P2|NOT COMPLETED|Overall Study||7
8112106|NCT03051633|19993767|P1|NOT COMPLETED|Overall Study||93
8112107|NCT03051633|19993766|P2|COMPLETED|Overall Study||179
8112108|NCT03051633|19993767|P1|COMPLETED|Overall Study||249
8112109|NCT03051633|19993766|P2|STARTED|Overall Study||186
8112110|NCT03051633|19993767|P1|STARTED|Overall Study||342
8112111|NCT03051607|19993777|P1|NOT COMPLETED|Overall Study||66
8112112|NCT03051607|19993777|P1|COMPLETED|Overall Study||0
8112113|NCT03051607|19993777|P1|STARTED|Overall Study||66
8112114|NCT03051217|19993787|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1
8112115|NCT03051217|19993788|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2
8112116|NCT03051217|19993789|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
8112117|NCT03051217|19993790|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
8112118|NCT03051217|19993791|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8112119|NCT03051217|19993792|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8112120|NCT03051217|19993793|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8112121|NCT03051217|19993787|P7|COMPLETED|Maintenance Period (Week 16 to Week 52)||19
8112122|NCT03051217|19993788|P6|COMPLETED|Maintenance Period (Week 16 to Week 52)||24
8112123|NCT03051217|19993789|P5|COMPLETED|Maintenance Period (Week 16 to Week 52)||48
8112124|NCT03051217|19993790|P4|COMPLETED|Maintenance Period (Week 16 to Week 52)||20
8112125|NCT03051217|19993791|P3|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8112126|NCT03051217|19993792|P2|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8112127|NCT03051217|19993793|P1|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
8112128|NCT03051217|19993787|P7|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
8112129|NCT03051217|19993788|P6|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7
8112130|NCT03051217|19993789|P5|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
8112131|NCT03051217|19993790|P4|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21
8112132|NCT03051217|19993791|P3|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
8112133|NCT03051217|19993792|P2|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
8112134|NCT03051217|19993793|P1|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
8112135|NCT03051217|19993787|P7|STARTED|Maintenance Period (Week 16 to Week 52)||20
8112136|NCT03051217|19993788|P6|STARTED|Maintenance Period (Week 16 to Week 52)||26
8112137|NCT03051217|19993789|P5|STARTED|Maintenance Period (Week 16 to Week 52)||51
8112138|NCT03051217|19993790|P4|STARTED|Maintenance Period (Week 16 to Week 52)||23
8112139|NCT03051217|19993791|P3|STARTED|Maintenance Period (Week 16 to Week 52)||0
8112140|NCT03051217|19993792|P2|STARTED|Maintenance Period (Week 16 to Week 52)||0
8112141|NCT03051217|19993793|P1|STARTED|Maintenance Period (Week 16 to Week 52)||0
8112142|NCT03051217|19993787|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8112143|NCT03051217|19993788|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8112144|NCT03051217|19993789|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8112145|NCT03051217|19993790|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8112146|NCT03051217|19993791|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
8112147|NCT03051217|19993792|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
8112148|NCT03051217|19993793|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
8112149|NCT03051217|19993787|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
8112150|NCT03051217|19993788|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
8112151|NCT03051217|19993789|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
8112152|NCT03051217|19993790|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
8112153|NCT03051217|19993791|P3|COMPLETED|Initial Period (Week 0 to Week 16)||51
8112154|NCT03051217|19993792|P2|COMPLETED|Initial Period (Week 0 to Week 16)||46
8112155|NCT03051217|19993793|P1|COMPLETED|Initial Period (Week 0 to Week 16)||23
8112156|NCT03051217|19993787|P7|STARTED|Initial Period (Week 0 to Week 16)||0
8112157|NCT03051217|19993788|P6|STARTED|Initial Period (Week 0 to Week 16)||0
8112158|NCT03051217|19993789|P5|STARTED|Initial Period (Week 0 to Week 16)||0
8112159|NCT03051217|19993790|P4|STARTED|Initial Period (Week 0 to Week 16)||0
8112160|NCT03051217|19993791|P3|STARTED|Initial Period (Week 0 to Week 16)||53
8112161|NCT03051217|19993792|P2|STARTED|Initial Period (Week 0 to Week 16)||48
8112162|NCT03051217|19993793|P1|STARTED|Initial Period (Week 0 to Week 16)||26
8112163|NCT03051165|19993822|P1|NOT COMPLETED|Overall Study||13
8112164|NCT03051165|19993822|P1|COMPLETED|Overall Study||0
8112165|NCT03051165|19993822|P1|Completed Some Day 137 Assessments|Overall Study||0
8112166|NCT03051165|19993822|P1|Began HGNS Treatment Withdrawal|Overall Study||0
8112167|NCT03051165|19993822|P1|Completed Some Day 105 Assessments|Overall Study||1
8112168|NCT03051165|19993822|P1|Completed Some Baseline Assessments|Overall Study||1
8112169|NCT03051165|19993822|P1|STARTED|Overall Study||13
8112170|NCT03051100|19993836|P2|NOT COMPLETED|Overall Study||0
8112171|NCT03051100|19993837|P1|NOT COMPLETED|Overall Study||1
8112172|NCT03051100|19993836|P2|COMPLETED|Overall Study||43
8112173|NCT03051100|19993837|P1|COMPLETED|Overall Study||19
8112174|NCT03051100|19993836|P2|STARTED|Overall Study||43
8112175|NCT03051100|19993837|P1|STARTED|Overall Study||20
8112176|NCT03050918|19993853|P2|NOT COMPLETED|Overall Study||0
8112177|NCT03050918|19993854|P1|NOT COMPLETED|Overall Study||0
8112178|NCT03050918|19993853|P2|COMPLETED|Overall Study||1520
8112179|NCT03050918|19993854|P1|COMPLETED|Overall Study||1534
8112180|NCT03050918|19993853|P2|STARTED|Overall Study||1520
8112181|NCT03050918|19993854|P1|STARTED|Overall Study||1534
8112182|NCT03050775|19993876|P2|NOT COMPLETED|Overall Study||0
8112183|NCT03050775|19993877|P1|NOT COMPLETED|Overall Study||0
8112184|NCT03050775|19993876|P2|COMPLETED|Overall Study||35
8112185|NCT03050775|19993877|P1|COMPLETED|Overall Study||35
8112186|NCT03050775|19993876|P2|STARTED|Overall Study||35
8112187|NCT03050775|19993877|P1|STARTED|Overall Study||35
8112188|NCT03050697|19993895|P1|NOT COMPLETED|Overall Study||0
8112189|NCT03050697|19993895|P1|COMPLETED|Overall Study||12
8112190|NCT03050697|19993895|P1|STARTED|Overall Study||12
8112191|NCT03050619|19993932|P6|NOT COMPLETED|Overall Study||0
8112192|NCT03050619|19993933|P5|NOT COMPLETED|Overall Study||0
8112193|NCT03050619|19993934|P4|NOT COMPLETED|Overall Study||0
8112194|NCT03050619|19993935|P3|NOT COMPLETED|Overall Study||0
8112195|NCT03050619|19993936|P2|NOT COMPLETED|Overall Study||0
8112196|NCT03050619|19993937|P1|NOT COMPLETED|Overall Study||0
8112197|NCT03050619|19993932|P6|COMPLETED|Overall Study||1351
8112198|NCT03050619|19993933|P5|COMPLETED|Overall Study||6079
8112199|NCT03050619|19993934|P4|COMPLETED|Overall Study||14007
8112200|NCT03050619|19993935|P3|COMPLETED|Overall Study||6416
8112201|NCT03050619|19993936|P2|COMPLETED|Overall Study||3926
8112202|NCT03050619|19993937|P1|COMPLETED|Overall Study||129
8112203|NCT03050619|19993932|P6|STARTED|Overall Study||1351
8112204|NCT03050619|19993933|P5|STARTED|Overall Study||6079
8112205|NCT03050619|19993934|P4|STARTED|Overall Study||14007
8112206|NCT03050619|19993935|P3|STARTED|Overall Study||6416
8112207|NCT03050619|19993936|P2|STARTED|Overall Study||3926
8112208|NCT03050619|19993937|P1|STARTED|Overall Study||129
8112209|NCT03050541|19994074|P3|NOT COMPLETED|Overall Study||8
8112210|NCT03050541|19994075|P2|NOT COMPLETED|Overall Study||8
8112211|NCT03050541|19994076|P1|NOT COMPLETED|Overall Study||8
8112212|NCT03050541|19994074|P3|COMPLETED|Overall Study||20
8112213|NCT03050541|19994075|P2|COMPLETED|Overall Study||20
8112214|NCT03050541|19994076|P1|COMPLETED|Overall Study||20
8112215|NCT03050541|19994074|P3|STARTED|Overall Study||28
8112216|NCT03050541|19994075|P2|STARTED|Overall Study||28
8112217|NCT03050541|19994076|P1|STARTED|Overall Study||28
8112218|NCT03050398|19994087|P1|NOT COMPLETED|Overall Study||8
8112219|NCT03050398|19994087|P1|COMPLETED|Overall Study||0
8112220|NCT03050398|19994087|P1|STARTED|Overall Study||8
8112221|NCT03050372|19994092|P2|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1
8112222|NCT03050372|19994093|P1|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0
8112223|NCT03050372|19994092|P2|COMPLETED|Second Intervention (Nights #4 and #5)|N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study|5
8112224|NCT03050372|19994093|P1|COMPLETED|Second Intervention (Nights #4 and #5)||5
8112225|NCT03050372|19994092|P2|STARTED|Second Intervention (Nights #4 and #5)||6
8112226|NCT03050372|19994093|P1|STARTED|Second Intervention (Nights #4 and #5)||5
8112227|NCT03050372|19994092|P2|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
8112228|NCT03050372|19994093|P1|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
8112229|NCT03050372|19994092|P2|COMPLETED|First Intervention (Nights #2 and #3)||6
8112230|NCT03050372|19994093|P1|COMPLETED|First Intervention (Nights #2 and #3)||5
8112231|NCT03050372|19994092|P2|STARTED|First Intervention (Nights #2 and #3)||6
8112232|NCT03050372|19994093|P1|STARTED|First Intervention (Nights #2 and #3)||5
8112233|NCT03050372|19994092|P2|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0
8112234|NCT03050372|19994093|P1|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1
8112235|NCT03050372|19994092|P2|COMPLETED|Adaptation Night (Night #1 PSG)||6
8112236|NCT03050372|19994093|P1|COMPLETED|Adaptation Night (Night #1 PSG)|N=1 subject removed from study due to mild sleep apnea during adaptation night|5
8112237|NCT03050372|19994092|P2|STARTED|Adaptation Night (Night #1 PSG)||6
8112238|NCT03050372|19994093|P1|STARTED|Adaptation Night (Night #1 PSG)||6
8112239|NCT03050359|19994116|P2|NOT COMPLETED|Overall Study||20
8112240|NCT03050359|19994117|P1|NOT COMPLETED|Overall Study||17
8112241|NCT03050359|19994116|P2|COMPLETED|Overall Study||248
8112242|NCT03050359|19994117|P1|COMPLETED|Overall Study||248
8112243|NCT03050359|19994116|P2|STARTED|Overall Study||268
8112244|NCT03050359|19994117|P1|STARTED|Overall Study||265
8112245|NCT03050320|19994131|P2|NOT COMPLETED|Overall Study||1
8112246|NCT03050320|19994132|P1|NOT COMPLETED|Overall Study||1
8112247|NCT03050320|19994131|P2|COMPLETED|Overall Study||21
8112248|NCT03050320|19994132|P1|COMPLETED|Overall Study||20
8112249|NCT03050320|19994131|P2|STARTED|Overall Study||22
8112250|NCT03050320|19994132|P1|STARTED|Overall Study||21
8112251|NCT03050294|19994166|P4|NOT COMPLETED|Overall Study||0
8112252|NCT03050294|19994167|P3|NOT COMPLETED|Overall Study||0
8112253|NCT03050294|19994168|P2|NOT COMPLETED|Overall Study||0
8112254|NCT03050294|19994169|P1|NOT COMPLETED|Overall Study||0
8112255|NCT03050294|19994166|P4|COMPLETED|Overall Study||6
8112256|NCT03050294|19994167|P3|COMPLETED|Overall Study||6
8112257|NCT03050294|19994168|P2|COMPLETED|Overall Study||6
8112258|NCT03050294|19994169|P1|COMPLETED|Overall Study||6
8112259|NCT03050294|19994166|P4|STARTED|Overall Study||6
8112260|NCT03050294|19994167|P3|STARTED|Overall Study||6
8112261|NCT03050294|19994168|P2|STARTED|Overall Study||6
8112262|NCT03050294|19994169|P1|STARTED|Overall Study||6
8112263|NCT03050216|19994191|P1|NOT COMPLETED|Overall Study||0
8112264|NCT03050216|19994191|P1|COMPLETED|Overall Study||8
8112265|NCT03050216|19994191|P1|STARTED|Overall Study||8
8112266|NCT03050203|19994203|P2|NOT COMPLETED|Overall Study||0
8112267|NCT03050203|19994204|P1|NOT COMPLETED|Overall Study||0
8112268|NCT03050203|19994203|P2|COMPLETED|Overall Study||18
8112269|NCT03050203|19994204|P1|COMPLETED|Overall Study||19
8112270|NCT03050203|19994203|P2|STARTED|Overall Study||18
8112271|NCT03050203|19994204|P1|STARTED|Overall Study||19
8112272|NCT03049852|19994213|P3|NOT COMPLETED|Overall Study||0
8112273|NCT03049852|19994214|P2|NOT COMPLETED|Overall Study||1
8112274|NCT03049852|19994215|P1|NOT COMPLETED|Overall Study||0
8112275|NCT03049852|19994213|P3|COMPLETED|Overall Study||26
8112276|NCT03049852|19994214|P2|COMPLETED|Overall Study||24
8112277|NCT03049852|19994215|P1|COMPLETED|Overall Study||24
8112278|NCT03049852|19994213|P3|STARTED|Overall Study||26
8112279|NCT03049852|19994214|P2|STARTED|Overall Study||25
8112280|NCT03049852|19994215|P1|STARTED|Overall Study||24
8112281|NCT03049748|19994227|P2|NOT COMPLETED|Overall Study||6
8112282|NCT03049748|19994228|P1|NOT COMPLETED|Overall Study||4
8112283|NCT03049748|19994227|P2|COMPLETED|Overall Study||14
8112284|NCT03049748|19994228|P1|COMPLETED|Overall Study||16
8112285|NCT03049748|19994227|P2|STARTED|Overall Study||20
8112286|NCT03049748|19994228|P1|STARTED|Overall Study||20
8112287|NCT03049501|19994246|P2|NOT COMPLETED|Overall Study||29
8112288|NCT03049501|19994247|P1|NOT COMPLETED|Overall Study||22
8112289|NCT03049501|19994246|P2|COMPLETED|Overall Study||92
8112290|NCT03049501|19994247|P1|COMPLETED|Overall Study||101
8112291|NCT03049501|19994246|P2|12 Month Follow up|Overall Study||92
8112292|NCT03049501|19994247|P1|12 Month Follow up|Overall Study||101
8112293|NCT03049501|19994246|P2|6 Month Follow up|Overall Study||91
8112294|NCT03049501|19994247|P1|6 Month Follow up|Overall Study||107
8112295|NCT03049501|19994246|P2|STARTED|Overall Study||121
8112296|NCT03049501|19994247|P1|STARTED|Overall Study||123
8112297|NCT03049488|19994269|P6|NOT COMPLETED|Overall Study||0
8112298|NCT03049488|19994270|P5|NOT COMPLETED|Overall Study||2
8112299|NCT03049488|19994271|P4|NOT COMPLETED|Overall Study||2
8112300|NCT03049488|19994272|P3|NOT COMPLETED|Overall Study||0
8112301|NCT03049488|19994273|P2|NOT COMPLETED|Overall Study||2
8112302|NCT03049488|19994274|P1|NOT COMPLETED|Overall Study||2
8112303|NCT03049488|19994269|P6|COMPLETED|Overall Study||15
8112304|NCT03049488|19994270|P5|COMPLETED|Overall Study||13
8112305|NCT03049488|19994271|P4|COMPLETED|Overall Study||13
8112306|NCT03049488|19994272|P3|COMPLETED|Overall Study||20
8112307|NCT03049488|19994273|P2|COMPLETED|Overall Study||13
8112308|NCT03049488|19994274|P1|COMPLETED|Overall Study||13
8112309|NCT03049488|19994269|P6|Received Optional Second Dose|Overall Study||10
8112310|NCT03049488|19994270|P5|Received Optional Second Dose|Overall Study||11
8112311|NCT03049488|19994271|P4|Received Optional Second Dose|Overall Study||9
8112312|NCT03049488|19994272|P3|Received Optional Second Dose|Overall Study||11
8112313|NCT03049488|19994273|P2|Received Optional Second Dose|Overall Study||11
8112314|NCT03049488|19994274|P1|Received Optional Second Dose|Overall Study||10
8112315|NCT03049488|19994269|P6|Received First Product Administration|Overall Study||15
8112316|NCT03049488|19994270|P5|Received First Product Administration|Overall Study||15
8112317|NCT03049488|19994271|P4|Received First Product Administration|Overall Study||15
8112318|NCT03049488|19994272|P3|Received First Product Administration|Overall Study||20
8112319|NCT03049488|19994273|P2|Received First Product Administration|Overall Study||15
8112320|NCT03049488|19994274|P1|Received First Product Administration|Overall Study||15
8112321|NCT03049488|19994269|P6|STARTED|Overall Study||15
8112322|NCT03049488|19994270|P5|STARTED|Overall Study||15
8112323|NCT03049488|19994271|P4|STARTED|Overall Study||15
8112324|NCT03049488|19994272|P3|STARTED|Overall Study||20
8112325|NCT03049488|19994273|P2|STARTED|Overall Study||15
8112326|NCT03049488|19994274|P1|STARTED|Overall Study||15
8112327|NCT03049280|19994357|P1|NOT COMPLETED|Overall Study||1
8112328|NCT03049280|19994357|P1|COMPLETED|Overall Study||32
8112329|NCT03049280|19994357|P1|STARTED|Overall Study||33
8112330|NCT03048747|19994363|P1|NOT COMPLETED|Overall Study||5
8112331|NCT03048747|19994363|P1|COMPLETED|Overall Study||11
8112332|NCT03048747|19994363|P1|STARTED|Overall Study||16
8112333|NCT03048500|19994368|P1|NOT COMPLETED|Follow up for 3 Years||16
8112334|NCT03048500|19994368|P1|COMPLETED|Follow up for 3 Years||0
8112335|NCT03048500|19994368|P1|STARTED|Follow up for 3 Years|1 patient died whilst on study.|16
8112336|NCT03048500|19994368|P1|NOT COMPLETED|Reached 1st Response/Continued Treatment||7
8112337|NCT03048500|19994368|P1|COMPLETED|Reached 1st Response/Continued Treatment||9
8112338|NCT03048500|19994368|P1|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||9
8112339|NCT03048500|19994368|P1|Assessed for First Response|Reached 1st Response/Continued Treatment||16
8112340|NCT03048500|19994368|P1|STARTED|Reached 1st Response/Continued Treatment||16
8112341|NCT03048500|19994368|P1|NOT COMPLETED|2 Cycles of Treatment||1
8112342|NCT03048500|19994368|P1|COMPLETED|2 Cycles of Treatment||16
8112343|NCT03048500|19994368|P1|Attempted 2nd Cycle|2 Cycles of Treatment||16
8112344|NCT03048500|19994368|P1|Attempted 1st Cycle|2 Cycles of Treatment||17
8112345|NCT03048500|19994368|P1|STARTED|2 Cycles of Treatment||17
8112346|NCT03048383|19994376|P3|NOT COMPLETED|Overall Study||12
8112347|NCT03048383|19994377|P2|NOT COMPLETED|Overall Study||8
8112348|NCT03048383|19994378|P1|NOT COMPLETED|Overall Study||13
8112349|NCT03048383|19994376|P3|COMPLETED|Overall Study||10
8112350|NCT03048383|19994377|P2|COMPLETED|Overall Study||13
8112351|NCT03048383|19994378|P1|COMPLETED|Overall Study||15
8112352|NCT03048383|19994376|P3|STARTED|Overall Study||22
8112353|NCT03048383|19994377|P2|STARTED|Overall Study||21
8112354|NCT03048383|19994378|P1|STARTED|Overall Study||28
8112355|NCT03048058|19994391|P2|NOT COMPLETED|Overall Study||4
8112356|NCT03048058|19994392|P1|NOT COMPLETED|Overall Study||4
8112357|NCT03048058|19994391|P2|COMPLETED|Overall Study||6
8112358|NCT03048058|19994392|P1|COMPLETED|Overall Study||6
8112359|NCT03048058|19994391|P2|STARTED|Overall Study||10
8112360|NCT03048058|19994392|P1|STARTED|Overall Study||10
8112361|NCT03048006|19994410|P1|NOT COMPLETED|Overall Study||0
8112362|NCT03048006|19994410|P1|COMPLETED|Overall Study||44456
8112363|NCT03048006|19994410|P1|STARTED|Overall Study||44456
8112364|NCT03047720|19994418|P2|NOT COMPLETED|Second Intervention (6weeks)||0
8112365|NCT03047720|19994419|P1|NOT COMPLETED|Second Intervention (6weeks)||0
8112366|NCT03047720|19994418|P2|COMPLETED|Second Intervention (6weeks)||0
8112367|NCT03047720|19994419|P1|COMPLETED|Second Intervention (6weeks)||0
8112368|NCT03047720|19994418|P2|STARTED|Second Intervention (6weeks)||0
8112369|NCT03047720|19994419|P1|STARTED|Second Intervention (6weeks)||0
8112370|NCT03047720|19994418|P2|NOT COMPLETED|First Intervention (6weeks)||0
8112371|NCT03047720|19994419|P1|NOT COMPLETED|First Intervention (6weeks)||7
8112372|NCT03047720|19994418|P2|COMPLETED|First Intervention (6weeks)||0
8112373|NCT03047720|19994419|P1|COMPLETED|First Intervention (6weeks)||5
8112374|NCT03047720|19994418|P2|STARTED|First Intervention (6weeks)||0
8112375|NCT03047720|19994419|P1|STARTED|First Intervention (6weeks)||12
8112376|NCT03047551|19994433|P2|NOT COMPLETED|Overall Study||3
8112377|NCT03047551|19994434|P1|NOT COMPLETED|Overall Study||2
8112378|NCT03047551|19994433|P2|COMPLETED|Overall Study||312
8112379|NCT03047551|19994434|P1|COMPLETED|Overall Study||317
8112380|NCT03047551|19994433|P2|STARTED|Overall Study||315
8112381|NCT03047551|19994434|P1|STARTED|Overall Study||319
8112382|NCT03047447|19994445|P3|NOT COMPLETED|Overall Study||0
8112383|NCT03047447|19994446|P2|NOT COMPLETED|Overall Study||0
8112384|NCT03047447|19994447|P1|NOT COMPLETED|Overall Study||0
8112385|NCT03047447|19994445|P3|COMPLETED|Overall Study||10
8112386|NCT03047447|19994446|P2|COMPLETED|Overall Study||10
8112387|NCT03047447|19994447|P1|COMPLETED|Overall Study||10
8112388|NCT03047447|19994445|P3|STARTED|Overall Study||10
8112389|NCT03047447|19994446|P2|STARTED|Overall Study||10
8112390|NCT03047447|19994447|P1|STARTED|Overall Study||10
8112391|NCT03047174|19994469|P2|NOT COMPLETED|Overall Study||2
8112392|NCT03047174|19994470|P1|NOT COMPLETED|Overall Study||19
8112393|NCT03047174|19994469|P2|COMPLETED|Overall Study||27
8112394|NCT03047174|19994470|P1|COMPLETED|Overall Study||9
8112395|NCT03047174|19994469|P2|STARTED|Overall Study||29
8112396|NCT03047174|19994470|P1|STARTED|Overall Study||28
8112397|NCT03046472|19994500|P2|NOT COMPLETED|Overall Study||0
8112398|NCT03046472|19994501|P1|NOT COMPLETED|Overall Study||0
8112399|NCT03046472|19994500|P2|COMPLETED|Overall Study||17
8112400|NCT03046472|19994501|P1|COMPLETED|Overall Study||33
8112401|NCT03046472|19994500|P2|STARTED|Overall Study||17
8112402|NCT03046472|19994501|P1|STARTED|Overall Study||33
8112403|NCT03046446|19994511|P1|NOT COMPLETED|Overall Study||59
8112404|NCT03046446|19994511|P1|COMPLETED|Overall Study||149
8112405|NCT03046446|19994511|P1|Completed at Week 52|Overall Study||133
8112406|NCT03046446|19994511|P1|Completed at Week 24|Overall Study||6
8112407|NCT03046446|19994511|P1|Completed at Week 12|Overall Study||10
8112408|NCT03046446|19994511|P1|Second Injection|Overall Study||179
8112409|NCT03046446|19994511|P1|STARTED|Overall Study||208
8112410|NCT03046225|19994521|P2|NOT COMPLETED|Overall Study||0
8112411|NCT03046225|19994522|P1|NOT COMPLETED|Overall Study||0
8112412|NCT03046225|19994521|P2|COMPLETED|Overall Study||13
8112413|NCT03046225|19994522|P1|COMPLETED|Overall Study||13
8112414|NCT03046225|19994521|P2|STARTED|Overall Study||13
8112415|NCT03046225|19994522|P1|STARTED|Overall Study||13
8112416|NCT03046212|19994534|P2|NOT COMPLETED|Overall Study||0
8112417|NCT03046212|19994535|P1|NOT COMPLETED|Overall Study||0
8112418|NCT03046212|19994534|P2|COMPLETED|Overall Study||15
8112419|NCT03046212|19994535|P1|COMPLETED|Overall Study||15
8112420|NCT03046212|19994534|P2|STARTED|Overall Study||15
8112421|NCT03046212|19994535|P1|STARTED|Overall Study||15
8112422|NCT03045926|19994545|P1|NOT COMPLETED|Overall Study||0
8112423|NCT03045926|19994545|P1|COMPLETED|Overall Study||35
8112424|NCT03045926|19994545|P1|STARTED|Overall Study||35
8112425|NCT03045887|19994574|P10|NOT COMPLETED|Part B (14 Days)||0
8112426|NCT03045887|19994575|P9|NOT COMPLETED|Part B (14 Days)||0
8112427|NCT03045887|19994576|P8|NOT COMPLETED|Part B (14 Days)||0
8112428|NCT03045887|19994577|P7|NOT COMPLETED|Part B (14 Days)||0
8112429|NCT03045887|19994578|P6|NOT COMPLETED|Part B (14 Days)||0
8112430|NCT03045887|19994579|P5|NOT COMPLETED|Part B (14 Days)||0
8112431|NCT03045887|19994580|P4|NOT COMPLETED|Part B (14 Days)||0
8112432|NCT03045887|19994581|P3|NOT COMPLETED|Part B (14 Days)||0
8112433|NCT03045887|19994582|P2|NOT COMPLETED|Part B (14 Days)||0
8112434|NCT03045887|19994583|P1|NOT COMPLETED|Part B (14 Days)||0
8112435|NCT03045887|19994574|P10|COMPLETED|Part B (14 Days)||9
8112436|NCT03045887|19994575|P9|COMPLETED|Part B (14 Days)||3
8112437|NCT03045887|19994576|P8|COMPLETED|Part B (14 Days)||0
8112438|NCT03045887|19994577|P7|COMPLETED|Part B (14 Days)||0
8112439|NCT03045887|19994578|P6|COMPLETED|Part B (14 Days)||0
8112440|NCT03045887|19994579|P5|COMPLETED|Part B (14 Days)||0
8112441|NCT03045887|19994580|P4|COMPLETED|Part B (14 Days)||0
8112442|NCT03045887|19994581|P3|COMPLETED|Part B (14 Days)||0
8112443|NCT03045887|19994582|P2|COMPLETED|Part B (14 Days)||0
8112444|NCT03045887|19994583|P1|COMPLETED|Part B (14 Days)||0
8112445|NCT03045887|19994574|P10|STARTED|Part B (14 Days)||9
8112446|NCT03045887|19994575|P9|STARTED|Part B (14 Days)||3
8112447|NCT03045887|19994576|P8|STARTED|Part B (14 Days)||0
8112448|NCT03045887|19994577|P7|STARTED|Part B (14 Days)||0
8112449|NCT03045887|19994578|P6|STARTED|Part B (14 Days)||0
8112450|NCT03045887|19994579|P5|STARTED|Part B (14 Days)||0
8112451|NCT03045887|19994580|P4|STARTED|Part B (14 Days)||0
8112452|NCT03045887|19994581|P3|STARTED|Part B (14 Days)||0
8112453|NCT03045887|19994582|P2|STARTED|Part B (14 Days)||0
8112454|NCT03045887|19994583|P1|STARTED|Part B (14 Days)||0
8112455|NCT03045887|19994574|P10|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112456|NCT03045887|19994575|P9|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112457|NCT03045887|19994576|P8|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112458|NCT03045887|19994577|P7|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112459|NCT03045887|19994578|P6|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112460|NCT03045887|19994579|P5|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112461|NCT03045887|19994580|P4|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112462|NCT03045887|19994581|P3|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112463|NCT03045887|19994582|P2|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112464|NCT03045887|19994583|P1|NOT COMPLETED|Part A, Period 3 (1 Day)||0
8112465|NCT03045887|19994574|P10|COMPLETED|Part A, Period 3 (1 Day)||0
8112466|NCT03045887|19994575|P9|COMPLETED|Part A, Period 3 (1 Day)||0
8112467|NCT03045887|19994576|P8|COMPLETED|Part A, Period 3 (1 Day)||4
8112468|NCT03045887|19994577|P7|COMPLETED|Part A, Period 3 (1 Day)||4
8112469|NCT03045887|19994578|P6|COMPLETED|Part A, Period 3 (1 Day)||4
8112470|NCT03045887|19994579|P5|COMPLETED|Part A, Period 3 (1 Day)||4
8112471|NCT03045887|19994580|P4|COMPLETED|Part A, Period 3 (1 Day)||2
8112472|NCT03045887|19994581|P3|COMPLETED|Part A, Period 3 (1 Day)||4
8112473|NCT03045887|19994582|P2|COMPLETED|Part A, Period 3 (1 Day)||4
8112474|NCT03045887|19994583|P1|COMPLETED|Part A, Period 3 (1 Day)||3
8112475|NCT03045887|19994574|P10|STARTED|Part A, Period 3 (1 Day)||0
8112476|NCT03045887|19994575|P9|STARTED|Part A, Period 3 (1 Day)||0
8112477|NCT03045887|19994576|P8|STARTED|Part A, Period 3 (1 Day)||4
8112478|NCT03045887|19994577|P7|STARTED|Part A, Period 3 (1 Day)||4
8112479|NCT03045887|19994578|P6|STARTED|Part A, Period 3 (1 Day)||4
8112480|NCT03045887|19994579|P5|STARTED|Part A, Period 3 (1 Day)||4
8112481|NCT03045887|19994580|P4|STARTED|Part A, Period 3 (1 Day)||2
8112482|NCT03045887|19994581|P3|STARTED|Part A, Period 3 (1 Day)||4
8112483|NCT03045887|19994582|P2|STARTED|Part A, Period 3 (1 Day)||4
8112484|NCT03045887|19994583|P1|STARTED|Part A, Period 3 (1 Day)||3
8112485|NCT03045887|19994574|P10|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112486|NCT03045887|19994575|P9|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112487|NCT03045887|19994576|P8|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112488|NCT03045887|19994577|P7|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112489|NCT03045887|19994578|P6|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112490|NCT03045887|19994579|P5|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112491|NCT03045887|19994580|P4|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
8112492|NCT03045887|19994581|P3|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1
8112493|NCT03045887|19994582|P2|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112494|NCT03045887|19994583|P1|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112495|NCT03045887|19994574|P10|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112496|NCT03045887|19994575|P9|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
8112497|NCT03045887|19994576|P8|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
8112498|NCT03045887|19994577|P7|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
8112499|NCT03045887|19994578|P6|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
8112500|NCT03045887|19994579|P5|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
8112501|NCT03045887|19994580|P4|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
8112502|NCT03045887|19994581|P3|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
8112503|NCT03045887|19994582|P2|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
8112504|NCT03045887|19994583|P1|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3
8112505|NCT03045887|19994574|P10|STARTED|Part A,Washout Period 2 (4 Weeks)||0
8112506|NCT03045887|19994575|P9|STARTED|Part A,Washout Period 2 (4 Weeks)||0
8112507|NCT03045887|19994576|P8|STARTED|Part A,Washout Period 2 (4 Weeks)||4
8112508|NCT03045887|19994577|P7|STARTED|Part A,Washout Period 2 (4 Weeks)||4
8112509|NCT03045887|19994578|P6|STARTED|Part A,Washout Period 2 (4 Weeks)||4
8112510|NCT03045887|19994579|P5|STARTED|Part A,Washout Period 2 (4 Weeks)||4
8112511|NCT03045887|19994580|P4|STARTED|Part A,Washout Period 2 (4 Weeks)||4
8112512|NCT03045887|19994581|P3|STARTED|Part A,Washout Period 2 (4 Weeks)||5
8112513|NCT03045887|19994582|P2|STARTED|Part A,Washout Period 2 (4 Weeks)||4
8112514|NCT03045887|19994583|P1|STARTED|Part A,Washout Period 2 (4 Weeks)||3
8112515|NCT03045887|19994574|P10|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112516|NCT03045887|19994575|P9|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112517|NCT03045887|19994576|P8|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112518|NCT03045887|19994577|P7|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112519|NCT03045887|19994578|P6|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112520|NCT03045887|19994579|P5|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112521|NCT03045887|19994580|P4|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112522|NCT03045887|19994581|P3|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112523|NCT03045887|19994582|P2|NOT COMPLETED|Part A, Period 2 (1 Day)||0
8112524|NCT03045887|19994583|P1|NOT COMPLETED|Part A, Period 2 (1 Day)||1
8112525|NCT03045887|19994574|P10|COMPLETED|Part A, Period 2 (1 Day)||0
8112526|NCT03045887|19994575|P9|COMPLETED|Part A, Period 2 (1 Day)||0
8112527|NCT03045887|19994576|P8|COMPLETED|Part A, Period 2 (1 Day)||4
8112528|NCT03045887|19994577|P7|COMPLETED|Part A, Period 2 (1 Day)||4
8112529|NCT03045887|19994578|P6|COMPLETED|Part A, Period 2 (1 Day)||4
8112530|NCT03045887|19994579|P5|COMPLETED|Part A, Period 2 (1 Day)||4
8112531|NCT03045887|19994580|P4|COMPLETED|Part A, Period 2 (1 Day)||4
8112532|NCT03045887|19994581|P3|COMPLETED|Part A, Period 2 (1 Day)||5
8112533|NCT03045887|19994582|P2|COMPLETED|Part A, Period 2 (1 Day)||4
8112534|NCT03045887|19994583|P1|COMPLETED|Part A, Period 2 (1 Day)||3
8112535|NCT03045887|19994574|P10|STARTED|Part A, Period 2 (1 Day)||0
8112536|NCT03045887|19994575|P9|STARTED|Part A, Period 2 (1 Day)||0
8112537|NCT03045887|19994576|P8|STARTED|Part A, Period 2 (1 Day)||4
8112538|NCT03045887|19994577|P7|STARTED|Part A, Period 2 (1 Day)||4
8112539|NCT03045887|19994578|P6|STARTED|Part A, Period 2 (1 Day)||4
8112540|NCT03045887|19994579|P5|STARTED|Part A, Period 2 (1 Day)||4
8112541|NCT03045887|19994580|P4|STARTED|Part A, Period 2 (1 Day)||4
8112542|NCT03045887|19994581|P3|STARTED|Part A, Period 2 (1 Day)||5
8112543|NCT03045887|19994582|P2|STARTED|Part A, Period 2 (1 Day)||4
8112544|NCT03045887|19994583|P1|STARTED|Part A, Period 2 (1 Day)||4
8112545|NCT03045887|19994574|P10|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112546|NCT03045887|19994575|P9|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112547|NCT03045887|19994576|P8|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112548|NCT03045887|19994577|P7|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112549|NCT03045887|19994578|P6|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112550|NCT03045887|19994579|P5|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112551|NCT03045887|19994580|P4|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1
8112552|NCT03045887|19994581|P3|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112553|NCT03045887|19994582|P2|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112554|NCT03045887|19994583|P1|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3
8112555|NCT03045887|19994574|P10|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112556|NCT03045887|19994575|P9|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
8112557|NCT03045887|19994576|P8|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
8112558|NCT03045887|19994577|P7|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
8112559|NCT03045887|19994578|P6|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
8112560|NCT03045887|19994579|P5|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
8112561|NCT03045887|19994580|P4|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
8112562|NCT03045887|19994581|P3|COMPLETED|Part A,Washout Period 1(4 Weeks)||5
8112563|NCT03045887|19994582|P2|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
8112564|NCT03045887|19994583|P1|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
8112565|NCT03045887|19994574|P10|STARTED|Part A,Washout Period 1(4 Weeks)||0
8112566|NCT03045887|19994575|P9|STARTED|Part A,Washout Period 1(4 Weeks)||0
8112567|NCT03045887|19994576|P8|STARTED|Part A,Washout Period 1(4 Weeks)||4
8112568|NCT03045887|19994577|P7|STARTED|Part A,Washout Period 1(4 Weeks)||4
8112569|NCT03045887|19994578|P6|STARTED|Part A,Washout Period 1(4 Weeks)||4
8112570|NCT03045887|19994579|P5|STARTED|Part A,Washout Period 1(4 Weeks)||4
8112571|NCT03045887|19994580|P4|STARTED|Part A,Washout Period 1(4 Weeks)||5
8112572|NCT03045887|19994581|P3|STARTED|Part A,Washout Period 1(4 Weeks)||5
8112573|NCT03045887|19994582|P2|STARTED|Part A,Washout Period 1(4 Weeks)||4
8112574|NCT03045887|19994583|P1|STARTED|Part A,Washout Period 1(4 Weeks)||7
8112575|NCT03045887|19994574|P10|NOT COMPLETED|Part A, Period (1 Day)||0
8112576|NCT03045887|19994575|P9|NOT COMPLETED|Part A, Period (1 Day)||0
8112577|NCT03045887|19994576|P8|NOT COMPLETED|Part A, Period (1 Day)||0
8112578|NCT03045887|19994577|P7|NOT COMPLETED|Part A, Period (1 Day)||0
8112579|NCT03045887|19994578|P6|NOT COMPLETED|Part A, Period (1 Day)||0
8112580|NCT03045887|19994579|P5|NOT COMPLETED|Part A, Period (1 Day)||0
8112581|NCT03045887|19994580|P4|NOT COMPLETED|Part A, Period (1 Day)||0
8112582|NCT03045887|19994581|P3|NOT COMPLETED|Part A, Period (1 Day)||0
8112583|NCT03045887|19994582|P2|NOT COMPLETED|Part A, Period (1 Day)||0
8112584|NCT03045887|19994583|P1|NOT COMPLETED|Part A, Period (1 Day)||0
8112585|NCT03045887|19994574|P10|COMPLETED|Part A, Period (1 Day)||0
8112586|NCT03045887|19994575|P9|COMPLETED|Part A, Period (1 Day)||0
8112587|NCT03045887|19994576|P8|COMPLETED|Part A, Period (1 Day)||4
8112588|NCT03045887|19994577|P7|COMPLETED|Part A, Period (1 Day)||4
8112589|NCT03045887|19994578|P6|COMPLETED|Part A, Period (1 Day)||4
8112590|NCT03045887|19994579|P5|COMPLETED|Part A, Period (1 Day)||4
8112591|NCT03045887|19994580|P4|COMPLETED|Part A, Period (1 Day)||5
8112592|NCT03045887|19994581|P3|COMPLETED|Part A, Period (1 Day)||5
8112593|NCT03045887|19994582|P2|COMPLETED|Part A, Period (1 Day)||4
8112594|NCT03045887|19994583|P1|COMPLETED|Part A, Period (1 Day)||7
8112595|NCT03045887|19994574|P10|STARTED|Part A, Period (1 Day)||0
8112596|NCT03045887|19994575|P9|STARTED|Part A, Period (1 Day)||0
8112597|NCT03045887|19994576|P8|STARTED|Part A, Period (1 Day)||4
8112598|NCT03045887|19994577|P7|STARTED|Part A, Period (1 Day)||4
8112599|NCT03045887|19994578|P6|STARTED|Part A, Period (1 Day)||4
8112600|NCT03045887|19994579|P5|STARTED|Part A, Period (1 Day)||4
8112601|NCT03045887|19994580|P4|STARTED|Part A, Period (1 Day)||5
8112602|NCT03045887|19994581|P3|STARTED|Part A, Period (1 Day)||5
8112603|NCT03045887|19994582|P2|STARTED|Part A, Period (1 Day)||4
8112604|NCT03045887|19994583|P1|STARTED|Part A, Period (1 Day)||7
8112605|NCT03045861|19994725|P4|NOT COMPLETED|Part B (Up to 10 Days)||0
8112606|NCT03045861|19994726|P3|NOT COMPLETED|Part B (Up to 10 Days)||0
8112607|NCT03045861|19994727|P2|NOT COMPLETED|Part B (Up to 10 Days)||0
8112608|NCT03045861|19994728|P1|NOT COMPLETED|Part B (Up to 10 Days)||0
8112609|NCT03045861|19994725|P4|COMPLETED|Part B (Up to 10 Days)||8
8112610|NCT03045861|19994726|P3|COMPLETED|Part B (Up to 10 Days)||0
8112611|NCT03045861|19994727|P2|COMPLETED|Part B (Up to 10 Days)||8
8112612|NCT03045861|19994728|P1|COMPLETED|Part B (Up to 10 Days)||7
8112613|NCT03045861|19994725|P4|STARTED|Part B (Up to 10 Days)||8
8112614|NCT03045861|19994726|P3|STARTED|Part B (Up to 10 Days)||0
8112615|NCT03045861|19994727|P2|STARTED|Part B (Up to 10 Days)||8
8112616|NCT03045861|19994728|P1|STARTED|Part B (Up to 10 Days)||7
8112617|NCT03045861|19994725|P4|NOT COMPLETED|Part A (Up to 10 Days)||0
8112618|NCT03045861|19994726|P3|NOT COMPLETED|Part A (Up to 10 Days)||0
8112619|NCT03045861|19994727|P2|NOT COMPLETED|Part A (Up to 10 Days)||0
8112620|NCT03045861|19994728|P1|NOT COMPLETED|Part A (Up to 10 Days)||0
8112621|NCT03045861|19994725|P4|COMPLETED|Part A (Up to 10 Days)||0
8112622|NCT03045861|19994726|P3|COMPLETED|Part A (Up to 10 Days)||10
8112623|NCT03045861|19994727|P2|COMPLETED|Part A (Up to 10 Days)||0
8112624|NCT03045861|19994728|P1|COMPLETED|Part A (Up to 10 Days)||0
8112625|NCT03045861|19994725|P4|STARTED|Part A (Up to 10 Days)||0
8112626|NCT03045861|19994726|P3|STARTED|Part A (Up to 10 Days)||10
8112627|NCT03045861|19994727|P2|STARTED|Part A (Up to 10 Days)||0
8112628|NCT03045861|19994728|P1|STARTED|Part A (Up to 10 Days)||0
8112629|NCT03045809|19994854|P1|NOT COMPLETED|Overall Study||0
8112630|NCT03045809|19994854|P1|COMPLETED|Overall Study||705
8112631|NCT03045809|19994854|P1|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51
8112632|NCT03045809|19994854|P1|STARTED|Overall Study||705
8112636|NCT03045302|19994865|P1|NOT COMPLETED|Overall Study||1
8112637|NCT03045302|19994865|P1|COMPLETED|Overall Study||3
8112638|NCT03045302|19994865|P1|STARTED|Overall Study||4
8112639|NCT03045081|19994871|P2|NOT COMPLETED|Overall Study||11
8112640|NCT03045081|19994872|P1|NOT COMPLETED|Overall Study||6
8112641|NCT03045081|19994871|P2|COMPLETED|Overall Study||37
8112642|NCT03045081|19994872|P1|COMPLETED|Overall Study||45
8112643|NCT03045081|19994871|P2|STARTED|Overall Study||48
8112644|NCT03045081|19994872|P1|STARTED|Overall Study||51
8112645|NCT03044886|19994891|P3|NOT COMPLETED|Overall Study||12
8112646|NCT03044886|19994892|P2|NOT COMPLETED|Overall Study||10
8112647|NCT03044886|19994893|P1|NOT COMPLETED|Overall Study||15
8112648|NCT03044886|19994891|P3|COMPLETED|Overall Study||108
8112649|NCT03044886|19994892|P2|COMPLETED|Overall Study||110
8112650|NCT03044886|19994893|P1|COMPLETED|Overall Study||105
8112651|NCT03044886|19994891|P3|STARTED|Overall Study||120
8112652|NCT03044886|19994892|P2|STARTED|Overall Study||120
8112653|NCT03044886|19994893|P1|STARTED|Overall Study||120
8112654|NCT03044730|19994934|P1|NOT COMPLETED|On Follow-up for 2 Years||25
8112655|NCT03044730|19994934|P1|COMPLETED|On Follow-up for 2 Years||4
8112656|NCT03044730|19994934|P1|STARTED|On Follow-up for 2 Years||29
8112657|NCT03044730|19994934|P1|NOT COMPLETED|Cycles 4 and Beyond||10
8112658|NCT03044730|19994934|P1|COMPLETED|Cycles 4 and Beyond||16
8112659|NCT03044730|19994934|P1|Went on to Cycle 5 and Beyond|Cycles 4 and Beyond||16
8112660|NCT03044730|19994934|P1|Started Cycle 4|Cycles 4 and Beyond||20
8112661|NCT03044730|19994934|P1|Assessed for Cycle 4|Cycles 4 and Beyond||26
8112662|NCT03044730|19994934|P1|STARTED|Cycles 4 and Beyond||26
8112663|NCT03044730|19994934|P1|NOT COMPLETED|3 Cycles of Pembro + Capecitab||4
8112664|NCT03044730|19994934|P1|COMPLETED|3 Cycles of Pembro + Capecitab||26
8112665|NCT03044730|19994934|P1|Attempted Cycle 3|3 Cycles of Pembro + Capecitab||26
8112666|NCT03044730|19994934|P1|Attempted Cycle 2|3 Cycles of Pembro + Capecitab||28
8112667|NCT03044730|19994934|P1|Attempted Cycle 1|3 Cycles of Pembro + Capecitab||30
8112668|NCT03044730|19994934|P1|STARTED|3 Cycles of Pembro + Capecitab||30
8112669|NCT03044691|19994945|P2|NOT COMPLETED|Overall Study||0
8112670|NCT03044691|19994946|P1|NOT COMPLETED|Overall Study||0
8112671|NCT03044691|19994945|P2|COMPLETED|Overall Study||84
8112672|NCT03044691|19994946|P1|COMPLETED|Overall Study||0
8112673|NCT03044691|19994945|P2|STARTED|Overall Study||84
8112674|NCT03044691|19994946|P1|STARTED|Overall Study||0
8112687|NCT03044431|19994981|P1|NOT COMPLETED|Overall Study||59
8112688|NCT03044431|19994981|P1|COMPLETED|Overall Study||148
8112689|NCT03044431|19994981|P1|STARTED|Overall Study||207
8112690|NCT03044353|19994994|P3|NOT COMPLETED|Overall Study||0
8112691|NCT03044353|19994995|P2|NOT COMPLETED|Overall Study||1
8112692|NCT03044353|19994996|P1|NOT COMPLETED|Overall Study||0
8112693|NCT03044353|19994994|P3|COMPLETED|Overall Study||0
8112694|NCT03044353|19994995|P2|COMPLETED|Overall Study||0
8112695|NCT03044353|19994996|P1|COMPLETED|Overall Study||6
8112696|NCT03044353|19994994|P3|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0
8112697|NCT03044353|19994995|P2|STARTED|Overall Study||1
8112698|NCT03044353|19994996|P1|STARTED|Overall Study||6
8112699|NCT03044197|19995079|P2|NOT COMPLETED|Overall Study||1
8112700|NCT03044197|19995080|P1|NOT COMPLETED|Overall Study||3
8112701|NCT03044197|19995079|P2|COMPLETED|Overall Study||11
8112702|NCT03044197|19995080|P1|COMPLETED|Overall Study||9
8112703|NCT03044197|19995079|P2|STARTED|Overall Study||12
8112704|NCT03044197|19995080|P1|STARTED|Overall Study||12
8112705|NCT03044106|19995090|P2|NOT COMPLETED|Visit 2||0
8112706|NCT03044106|19995091|P1|NOT COMPLETED|Visit 2||0
8112707|NCT03044106|19995090|P2|COMPLETED|Visit 2||20
8112708|NCT03044106|19995091|P1|COMPLETED|Visit 2||22
8112709|NCT03044106|19995090|P2|STARTED|Visit 2||20
8112710|NCT03044106|19995091|P1|STARTED|Visit 2||22
8112711|NCT03044106|19995090|P2|NOT COMPLETED|Washout (1 Week)||2
8112712|NCT03044106|19995091|P1|NOT COMPLETED|Washout (1 Week)||0
8112713|NCT03044106|19995090|P2|COMPLETED|Washout (1 Week)||20
8112714|NCT03044106|19995091|P1|COMPLETED|Washout (1 Week)||22
8112715|NCT03044106|19995090|P2|STARTED|Washout (1 Week)||22
8112716|NCT03044106|19995091|P1|STARTED|Washout (1 Week)||22
8112717|NCT03044106|19995090|P2|NOT COMPLETED|Visit 1||0
8112718|NCT03044106|19995091|P1|NOT COMPLETED|Visit 1||0
8112719|NCT03044106|19995090|P2|COMPLETED|Visit 1||22
8112720|NCT03044106|19995091|P1|COMPLETED|Visit 1||22
8112721|NCT03044106|19995090|P2|STARTED|Visit 1||22
8112722|NCT03044106|19995091|P1|STARTED|Visit 1||22
8112723|NCT03044028|19995108|P3|NOT COMPLETED|Overall Study||0
8112724|NCT03044028|19995109|P2|NOT COMPLETED|Overall Study||10
8112725|NCT03044028|19995110|P1|NOT COMPLETED|Overall Study||10
8112726|NCT03044028|19995108|P3|COMPLETED|Overall Study||22
8112727|NCT03044028|19995109|P2|COMPLETED|Overall Study||12
8112728|NCT03044028|19995110|P1|COMPLETED|Overall Study||12
8112729|NCT03044028|19995108|P3|STARTED|Overall Study||22
8112730|NCT03044028|19995109|P2|STARTED|Overall Study||22
8112731|NCT03044028|19995110|P1|STARTED|Overall Study||22
8112732|NCT03043885|19995146|P4|NOT COMPLETED|Overall Study||0
8112733|NCT03043885|19995147|P3|NOT COMPLETED|Overall Study||0
8112734|NCT03043885|19995148|P2|NOT COMPLETED|Overall Study||0
8112735|NCT03043885|19995149|P1|NOT COMPLETED|Overall Study||0
8112736|NCT03043885|19995146|P4|COMPLETED|Overall Study||10
8112737|NCT03043885|19995147|P3|COMPLETED|Overall Study||10
8112738|NCT03043885|19995148|P2|COMPLETED|Overall Study||10
8112739|NCT03043885|19995149|P1|COMPLETED|Overall Study||10
8112740|NCT03043885|19995146|P4|STARTED|Overall Study||10
8112741|NCT03043885|19995147|P3|STARTED|Overall Study||10
8112742|NCT03043885|19995148|P2|STARTED|Overall Study||10
8112743|NCT03043885|19995149|P1|STARTED|Overall Study||10
8112744|NCT03043651|19995163|P1|NOT COMPLETED|Overall Study||48
8112745|NCT03043651|19995163|P1|COMPLETED|Overall Study||0
8112746|NCT03043651|19995163|P1|STARTED|Overall Study||48
8112750|NCT03043560|19995175|P2|NOT COMPLETED|Overall Study||3
8112751|NCT03043560|19995176|P1|NOT COMPLETED|Overall Study||1
8112752|NCT03043560|19995175|P2|COMPLETED|Overall Study||21
8112753|NCT03043560|19995176|P1|COMPLETED|Overall Study||20
8112754|NCT03043560|19995175|P2|STARTED|Overall Study||24
8112755|NCT03043560|19995176|P1|STARTED|Overall Study||21
8112756|NCT03043534|19995200|P2|NOT COMPLETED|Overall Study||0
8112757|NCT03043534|19995201|P1|NOT COMPLETED|Overall Study||0
8112758|NCT03043534|19995200|P2|COMPLETED|Overall Study||14
8112759|NCT03043534|19995201|P1|COMPLETED|Overall Study||15
8112760|NCT03043534|19995200|P2|STARTED|Overall Study||14
8112761|NCT03043534|19995201|P1|STARTED|Overall Study||15
8112762|NCT03043365|19995217|P2|NOT COMPLETED|Week 16 to Week 24||0
8112763|NCT03043365|19995218|P1|NOT COMPLETED|Week 16 to Week 24||0
8112764|NCT03043365|19995217|P2|COMPLETED|Week 16 to Week 24||14
8112765|NCT03043365|19995218|P1|COMPLETED|Week 16 to Week 24||16
8112766|NCT03043365|19995217|P2|STARTED|Week 16 to Week 24||14
8112767|NCT03043365|19995218|P1|STARTED|Week 16 to Week 24||16
8112768|NCT03043365|19995217|P2|NOT COMPLETED|Week 8 to Week 16 - Washout Period||0
8112769|NCT03043365|19995218|P1|NOT COMPLETED|Week 8 to Week 16 - Washout Period||1
8112770|NCT03043365|19995217|P2|COMPLETED|Week 8 to Week 16 - Washout Period||14
8112771|NCT03043365|19995218|P1|COMPLETED|Week 8 to Week 16 - Washout Period||16
8112772|NCT03043365|19995217|P2|STARTED|Week 8 to Week 16 - Washout Period||14
8112773|NCT03043365|19995218|P1|STARTED|Week 8 to Week 16 - Washout Period||17
8112774|NCT03043365|19995217|P2|NOT COMPLETED|Weeks 0 to Week 8||3
8112775|NCT03043365|19995218|P1|NOT COMPLETED|Weeks 0 to Week 8||3
8112776|NCT03043365|19995217|P2|COMPLETED|Weeks 0 to Week 8||14
8112777|NCT03043365|19995218|P1|COMPLETED|Weeks 0 to Week 8||17
8112778|NCT03043365|19995217|P2|STARTED|Weeks 0 to Week 8||17
8112779|NCT03043365|19995218|P1|STARTED|Weeks 0 to Week 8||20
8112780|NCT03043274|19995231|P2|NOT COMPLETED|Overall Study||1
8112781|NCT03043274|19995232|P1|NOT COMPLETED|Overall Study||0
8112782|NCT03043274|19995231|P2|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|9
8112783|NCT03043274|19995232|P1|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|13
8112784|NCT03043274|19995231|P2|STARTED|Overall Study||10
8112785|NCT03043274|19995232|P1|STARTED|Overall Study||13
8112786|NCT03043105|19995248|P1|NOT COMPLETED|Overall Study||0
8112787|NCT03043105|19995248|P1|COMPLETED|Overall Study||25
8112788|NCT03043105|19995248|P1|STARTED|Overall Study||25
8112789|NCT03043079|19995260|P3|NOT COMPLETED|Overall Study||0
8112790|NCT03043079|19995261|P2|NOT COMPLETED|Overall Study||0
8112791|NCT03043079|19995262|P1|NOT COMPLETED|Overall Study||0
8112792|NCT03043079|19995260|P3|COMPLETED|Overall Study||10
8112793|NCT03043079|19995261|P2|COMPLETED|Overall Study||14
8112794|NCT03043079|19995262|P1|COMPLETED|Overall Study||21
8112795|NCT03043079|19995260|P3|STARTED|Overall Study||10
8112796|NCT03043079|19995261|P2|STARTED|Overall Study||14
8112797|NCT03043079|19995262|P1|STARTED|Overall Study||21
8112798|NCT03042910|19995272|P1|NOT COMPLETED|Overall Study||7
8112799|NCT03042910|19995272|P1|COMPLETED|Overall Study||31
8112800|NCT03042910|19995272|P1|Treated|Overall Study||37
8112801|NCT03042910|19995272|P1|STARTED|Overall Study||38
8112802|NCT03042780|19995295|P1|NOT COMPLETED|Overall Study||0
8112803|NCT03042780|19995295|P1|COMPLETED|Overall Study||2
8112804|NCT03042780|19995295|P1|STARTED|Overall Study||2
8112811|NCT03042715|19995330|P1|NOT COMPLETED|Overall Study||1
8112812|NCT03042715|19995330|P1|COMPLETED|Overall Study||5
8112813|NCT03042715|19995330|P1|STARTED|Overall Study||6
8112814|NCT03042702|19995334|P1|NOT COMPLETED|Overall Study||0
8112815|NCT03042702|19995334|P1|COMPLETED|Overall Study||2
8112816|NCT03042702|19995334|P1|STARTED|Overall Study||2
8112817|NCT03042559|19995345|P2|NOT COMPLETED|Overall Study||1
8112818|NCT03042559|19995346|P1|NOT COMPLETED|Overall Study||1
8112819|NCT03042559|19995345|P2|COMPLETED|Overall Study||20
8112820|NCT03042559|19995346|P1|COMPLETED|Overall Study||21
8112821|NCT03042559|19995345|P2|STARTED|Overall Study||21
8112822|NCT03042559|19995346|P1|STARTED|Overall Study||22
8112823|NCT03042299|19995408|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8112824|NCT03042299|19995409|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8112825|NCT03042299|19995408|P2|COMPLETED|Intervention Period 2 (6 Days)||7
8112826|NCT03042299|19995409|P1|COMPLETED|Intervention Period 2 (6 Days)||7
8112827|NCT03042299|19995408|P2|STARTED|Intervention Period 2 (6 Days)||7
8112828|NCT03042299|19995409|P1|STARTED|Intervention Period 2 (6 Days)||7
8112829|NCT03042299|19995408|P2|NOT COMPLETED|Washout Period (at Least 6 Days)||0
8112830|NCT03042299|19995409|P1|NOT COMPLETED|Washout Period (at Least 6 Days)||0
8112831|NCT03042299|19995408|P2|COMPLETED|Washout Period (at Least 6 Days)||7
8112832|NCT03042299|19995409|P1|COMPLETED|Washout Period (at Least 6 Days)||7
8112833|NCT03042299|19995408|P2|STARTED|Washout Period (at Least 6 Days)||7
8112834|NCT03042299|19995409|P1|STARTED|Washout Period (at Least 6 Days)||7
8112835|NCT03042299|19995408|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8112836|NCT03042299|19995409|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8112837|NCT03042299|19995408|P2|COMPLETED|Intervention Period 1 (6 Days)||7
8112838|NCT03042299|19995409|P1|COMPLETED|Intervention Period 1 (6 Days)||7
8112839|NCT03042299|19995408|P2|STARTED|Intervention Period 1 (6 Days)||7
8112840|NCT03042299|19995409|P1|STARTED|Intervention Period 1 (6 Days)||7
8112841|NCT03041909|19995438|P3|NOT COMPLETED|Overall Study||0
8112842|NCT03041909|19995439|P2|NOT COMPLETED|Overall Study||0
8112843|NCT03041909|19995440|P1|NOT COMPLETED|Overall Study||0
8112844|NCT03041909|19995438|P3|COMPLETED|Overall Study||1
8112845|NCT03041909|19995439|P2|COMPLETED|Overall Study||1
8112846|NCT03041909|19995440|P1|COMPLETED|Overall Study||3
8112847|NCT03041909|19995438|P3|STARTED|Overall Study||1
8112848|NCT03041909|19995439|P2|STARTED|Overall Study||1
8112849|NCT03041909|19995440|P1|STARTED|Overall Study||3
8112850|NCT03041896|19995461|P4|NOT COMPLETED|Overall Study||3
8112851|NCT03041896|19995462|P3|NOT COMPLETED|Overall Study||63
8112852|NCT03041896|19995463|P2|NOT COMPLETED|Overall Study||0
8112853|NCT03041896|19995464|P1|NOT COMPLETED|Overall Study||0
8112854|NCT03041896|19995461|P4|COMPLETED|Overall Study||253
8112855|NCT03041896|19995462|P3|COMPLETED|Overall Study||2236
8112856|NCT03041896|19995463|P2|COMPLETED|Overall Study||1009
8112857|NCT03041896|19995464|P1|COMPLETED|Overall Study||1486
8112858|NCT03041896|19995461|P4|STARTED|Overall Study||256
8112859|NCT03041896|19995462|P3|STARTED|Overall Study||2299
8112860|NCT03041896|19995463|P2|STARTED|Overall Study||1009
8112861|NCT03041896|19995464|P1|STARTED|Overall Study||1486
8112862|NCT03041792|19995481|P2|NOT COMPLETED|Overall Study||3
8112863|NCT03041792|19995482|P1|NOT COMPLETED|Overall Study||4
8112864|NCT03041792|19995481|P2|COMPLETED|Overall Study||26
8112865|NCT03041792|19995482|P1|COMPLETED|Overall Study||28
8112866|NCT03041792|19995481|P2|Received Treatment|Overall Study||28
8112867|NCT03041792|19995482|P1|Received Treatment|Overall Study||32
8112868|NCT03041792|19995481|P2|STARTED|Overall Study||29
8112869|NCT03041792|19995482|P1|STARTED|Overall Study||32
8112876|NCT03041441|19995537|P1|NOT COMPLETED|Overall Study||2
8112877|NCT03041441|19995537|P1|COMPLETED|Overall Study||3
8112878|NCT03041441|19995537|P1|STARTED|Overall Study||5
8112879|NCT03041298|19995545|P1|NOT COMPLETED|Overall Study||0
8112880|NCT03041298|19995545|P1|COMPLETED|Overall Study||1537
8112881|NCT03041298|19995545|P1|STARTED|Overall Study||1537
8112882|NCT03041181|19995555|P2|NOT COMPLETED|Overall Study||2
8112883|NCT03041181|19995556|P1|NOT COMPLETED|Overall Study||1
8112884|NCT03041181|19995555|P2|COMPLETED|Overall Study||0
8112885|NCT03041181|19995556|P1|COMPLETED|Overall Study||0
8112886|NCT03041181|19995555|P2|STARTED|Overall Study||2
8112887|NCT03041181|19995556|P1|STARTED|Overall Study||1
8112888|NCT03041116|19995572|P2|NOT COMPLETED|Open-label||37
8112889|NCT03041116|19995573|P1|NOT COMPLETED|Open-label||41
8112890|NCT03041116|19995572|P2|COMPLETED|Open-label||0
8112891|NCT03041116|19995573|P1|COMPLETED|Open-label||0
8112892|NCT03041116|19995572|P2|Received At Least 1 Dose of Study Drug|Open-label||37
8112893|NCT03041116|19995573|P1|Received At Least 1 Dose of Study Drug|Open-label||41
8112894|NCT03041116|19995572|P2|STARTED|Open-label||37
8112895|NCT03041116|19995573|P1|STARTED|Open-label||41
8112896|NCT03041116|19995572|P2|NOT COMPLETED|Double-blind||6
8112897|NCT03041116|19995573|P1|NOT COMPLETED|Double-blind||0
8112898|NCT03041116|19995572|P2|COMPLETED|Double-blind||37
8112899|NCT03041116|19995573|P1|COMPLETED|Double-blind||41
8112900|NCT03041116|19995572|P2|Received at Least 1 Dose of Study Drug|Double-blind||43
8112901|NCT03041116|19995573|P1|Received at Least 1 Dose of Study Drug|Double-blind||41
8112902|NCT03041116|19995572|P2|STARTED|Double-blind||43
8112903|NCT03041116|19995573|P1|STARTED|Double-blind||41
8112904|NCT03041090|19995589|P2|NOT COMPLETED|Overall Study||3
8112905|NCT03041090|19995590|P1|NOT COMPLETED|Overall Study||0
8112906|NCT03041090|19995589|P2|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21
8112907|NCT03041090|19995590|P1|COMPLETED|Overall Study||109
8112908|NCT03041090|19995589|P2|STARTED|Overall Study||24
8112909|NCT03041090|19995590|P1|STARTED|Overall Study||109
8112916|NCT03040713|19995642|P1|NOT COMPLETED|Overall Study||3
8112917|NCT03040713|19995642|P1|COMPLETED|Overall Study||13
8112918|NCT03040713|19995642|P1|STARTED|Overall Study||16
8112919|NCT03040687|19995650|P3|NOT COMPLETED|Overall Study||0
8112920|NCT03040687|19995651|P2|NOT COMPLETED|Overall Study||0
8112921|NCT03040687|19995652|P1|NOT COMPLETED|Overall Study||1
8112922|NCT03040687|19995650|P3|COMPLETED|Overall Study||20
8112923|NCT03040687|19995651|P2|COMPLETED|Overall Study||20
8112924|NCT03040687|19995652|P1|COMPLETED|Overall Study||19
8112925|NCT03040687|19995650|P3|STARTED|Overall Study||20
8112926|NCT03040687|19995651|P2|STARTED|Overall Study||20
8112927|NCT03040687|19995652|P1|STARTED|Overall Study||20
8112928|NCT03040479|19995666|P3|NOT COMPLETED|Overall Study||0
8112929|NCT03040479|19995667|P2|NOT COMPLETED|Overall Study||0
8112930|NCT03040479|19995668|P1|NOT COMPLETED|Overall Study||0
8112931|NCT03040479|19995666|P3|COMPLETED|Overall Study||8
8112932|NCT03040479|19995667|P2|COMPLETED|Overall Study||8
8112933|NCT03040479|19995668|P1|COMPLETED|Overall Study||8
8112934|NCT03040479|19995666|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
8112935|NCT03040479|19995667|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8112936|NCT03040479|19995668|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8112937|NCT03040479|19995666|P3|STARTED|Overall Study||8
8112938|NCT03040479|19995667|P2|STARTED|Overall Study||8
8112939|NCT03040479|19995668|P1|STARTED|Overall Study||8
8112940|NCT03040466|19995696|P2|NOT COMPLETED|Overall Study||0
8112941|NCT03040466|19995697|P1|NOT COMPLETED|Overall Study||0
8112942|NCT03040466|19995696|P2|COMPLETED|Overall Study||115
8112943|NCT03040466|19995697|P1|COMPLETED|Overall Study||65
8112944|NCT03040466|19995696|P2|STARTED|Overall Study||115
8112945|NCT03040466|19995697|P1|STARTED|Overall Study||65
8112946|NCT03040362|19995707|P1|NOT COMPLETED|Overall Study||0
8112947|NCT03040362|19995707|P1|COMPLETED|Overall Study||8
8112948|NCT03040362|19995707|P1|Received at Least 1dose of Study Drug|Overall Study||8
8112949|NCT03040362|19995707|P1|STARTED|Overall Study||8
8112950|NCT03040336|19995721|P2|NOT COMPLETED|Overall Study||3
8112951|NCT03040336|19995722|P1|NOT COMPLETED|Overall Study||3
8112952|NCT03040336|19995721|P2|COMPLETED|Overall Study||4
8112953|NCT03040336|19995722|P1|COMPLETED|Overall Study||7
8112954|NCT03040336|19995721|P2|STARTED|Overall Study||7
8112955|NCT03040336|19995722|P1|STARTED|Overall Study||10
8112956|NCT03040323|19995754|P2|NOT COMPLETED|Overall Study||0
8112957|NCT03040323|19995755|P1|NOT COMPLETED|Overall Study||0
8112958|NCT03040323|19995754|P2|COMPLETED|Overall Study||0
8112959|NCT03040323|19995755|P1|COMPLETED|Overall Study||0
8112960|NCT03040323|19995754|P2|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
8112961|NCT03040323|19995755|P1|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
8112962|NCT03040011|19995766|P3|NOT COMPLETED|Primary Outcome Follow Up||1
8112963|NCT03040011|19995767|P2|NOT COMPLETED|Primary Outcome Follow Up||1
8112964|NCT03040011|19995768|P1|NOT COMPLETED|Primary Outcome Follow Up||4
8112965|NCT03040011|19995766|P3|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
8112966|NCT03040011|19995767|P2|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
8112967|NCT03040011|19995768|P1|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for four patients|21
8112968|NCT03040011|19995766|P3|STARTED|Primary Outcome Follow Up||25
8112969|NCT03040011|19995767|P2|STARTED|Primary Outcome Follow Up||25
8112970|NCT03040011|19995768|P1|STARTED|Primary Outcome Follow Up||25
8112971|NCT03040011|19995766|P3|NOT COMPLETED|Received Randomized Study Intervention||0
8112972|NCT03040011|19995767|P2|NOT COMPLETED|Received Randomized Study Intervention||0
8112973|NCT03040011|19995768|P1|NOT COMPLETED|Received Randomized Study Intervention||0
8112974|NCT03040011|19995766|P3|COMPLETED|Received Randomized Study Intervention||25
8112975|NCT03040011|19995767|P2|COMPLETED|Received Randomized Study Intervention||25
8112976|NCT03040011|19995768|P1|COMPLETED|Received Randomized Study Intervention||25
8112977|NCT03040011|19995766|P3|STARTED|Received Randomized Study Intervention||25
8112978|NCT03040011|19995767|P2|STARTED|Received Randomized Study Intervention||25
8112979|NCT03040011|19995768|P1|STARTED|Received Randomized Study Intervention||25
8112980|NCT03039738|19995835|P2|NOT COMPLETED|Overall Study||0
8112981|NCT03039738|19995836|P1|NOT COMPLETED|Overall Study||54
8112982|NCT03039738|19995835|P2|COMPLETED|Overall Study||0
8112983|NCT03039738|19995836|P1|COMPLETED|Overall Study||152
8112984|NCT03039738|19995835|P2|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0
8112985|NCT03039738|19995836|P1|STARTED|Overall Study||206
8112986|NCT03039699|19995858|P2|NOT COMPLETED|Overall Study||35
8112987|NCT03039699|19995859|P1|NOT COMPLETED|Overall Study||22
8112988|NCT03039699|19995858|P2|COMPLETED|Overall Study||97
8112989|NCT03039699|19995859|P1|COMPLETED|Overall Study||105
8112990|NCT03039699|19995858|P2|STARTED|Overall Study||132
8112991|NCT03039699|19995859|P1|STARTED|Overall Study||127
8112992|NCT03039686|19995882|P3|NOT COMPLETED|Open Label Period||42
8112993|NCT03039686|19995883|P2|NOT COMPLETED|Open Label Period||38
8112994|NCT03039686|19995884|P1|NOT COMPLETED|Open Label Period||0
8112995|NCT03039686|19995882|P3|COMPLETED|Open Label Period||0
8112996|NCT03039686|19995883|P2|COMPLETED|Open Label Period||0
8112997|NCT03039686|19995884|P1|COMPLETED|Open Label Period||0
8112998|NCT03039686|19995882|P3|Completed DB, Did Not Start OL|Open Label Period||3
8112999|NCT03039686|19995883|P2|Completed DB, Did Not Start OL|Open Label Period||2
8113000|NCT03039686|19995884|P1|Completed DB, Did Not Start OL|Open Label Period||2
8113001|NCT03039686|19995882|P3|STARTED|Open Label Period|13 DB placebo participants switched to the RO High Dose for the open-label phase.|42
8113002|NCT03039686|19995883|P2|STARTED|Open Label Period|14 DB placebo participants switched to the RO Low Dose for the open-label phase.|38
8113003|NCT03039686|19995884|P1|STARTED|Open Label Period|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
8113004|NCT03039686|19995882|P3|NOT COMPLETED|Double-blind Period||23
8113005|NCT03039686|19995883|P2|NOT COMPLETED|Double-blind Period||29
8113006|NCT03039686|19995884|P1|NOT COMPLETED|Double-blind Period||27
8113007|NCT03039686|19995882|P3|COMPLETED|Double-blind Period||32
8113008|NCT03039686|19995883|P2|COMPLETED|Double-blind Period||26
8113009|NCT03039686|19995884|P1|COMPLETED|Double-blind Period||29
8113010|NCT03039686|19995882|P3|STARTED|Double-blind Period||55
8113011|NCT03039686|19995883|P2|STARTED|Double-blind Period||55
8113012|NCT03039686|19995884|P1|STARTED|Double-blind Period||56
8113019|NCT03039569|19995975|P2|NOT COMPLETED|Overall Study||4
8113020|NCT03039569|19995976|P1|NOT COMPLETED|Overall Study||5
8113021|NCT03039569|19995975|P2|COMPLETED|Overall Study||35
8113022|NCT03039569|19995976|P1|COMPLETED|Overall Study||35
8113023|NCT03039569|19995975|P2|STARTED|Overall Study||39
8113024|NCT03039569|19995976|P1|STARTED|Overall Study||40
8113025|NCT03039543|19996006|P2|NOT COMPLETED|Overall Study||3
8113026|NCT03039543|19996007|P1|NOT COMPLETED|Overall Study||1
8113027|NCT03039543|19996006|P2|COMPLETED|Overall Study||51
8113028|NCT03039543|19996007|P1|COMPLETED|Overall Study||53
8113029|NCT03039543|19996006|P2|STARTED|Overall Study||54
8113030|NCT03039543|19996007|P1|STARTED|Overall Study||54
8113031|NCT03039283|19996021|P1|NOT COMPLETED|Overall Study||2
8113032|NCT03039283|19996021|P1|COMPLETED|Overall Study||160
8113033|NCT03039283|19996021|P1|STARTED|Overall Study||162
8113034|NCT03039192|19996032|P2|NOT COMPLETED|Overall Study||30
8113035|NCT03039192|19996033|P1|NOT COMPLETED|Overall Study||32
8113036|NCT03039192|19996032|P2|COMPLETED|Overall Study||84
8113037|NCT03039192|19996033|P1|COMPLETED|Overall Study||80
8113038|NCT03039192|19996032|P2|Treated|Overall Study||113
8113039|NCT03039192|19996033|P1|Treated|Overall Study||112
8113040|NCT03039192|19996032|P2|STARTED|Overall Study||114
8113041|NCT03039192|19996033|P1|STARTED|Overall Study||112
8113042|NCT03039179|19996085|P2|NOT COMPLETED|Overall Study||0
8113043|NCT03039179|19996086|P1|NOT COMPLETED|Overall Study||0
8113044|NCT03039179|19996085|P2|COMPLETED|Overall Study||42
8113045|NCT03039179|19996086|P1|COMPLETED|Overall Study||38
8113046|NCT03039179|19996085|P2|STARTED|Overall Study||42
8113047|NCT03039179|19996086|P1|STARTED|Overall Study||38
8113048|NCT03039088|19996096|P2|NOT COMPLETED|Overall Study||0
8113049|NCT03039088|19996097|P1|NOT COMPLETED|Overall Study||0
8113050|NCT03039088|19996096|P2|COMPLETED|Overall Study||316
8113051|NCT03039088|19996097|P1|COMPLETED|Overall Study||192
8113052|NCT03039088|19996096|P2|STARTED|Overall Study||316
8113053|NCT03039088|19996097|P1|STARTED|Overall Study||192
8113054|NCT03038880|19996106|P3|NOT COMPLETED|Overall Study||0
8113055|NCT03038880|19996107|P2|NOT COMPLETED|Overall Study||3
8113056|NCT03038880|19996108|P1|NOT COMPLETED|Overall Study||3
8113057|NCT03038880|19996106|P3|COMPLETED|Overall Study||16
8113058|NCT03038880|19996107|P2|COMPLETED|Overall Study||28
8113059|NCT03038880|19996108|P1|COMPLETED|Overall Study||21
8113060|NCT03038880|19996106|P3|STARTED|Overall Study||16
8113061|NCT03038880|19996107|P2|STARTED|Overall Study||31
8113062|NCT03038880|19996108|P1|STARTED|Overall Study||24
8113063|NCT03038867|19996171|P2|NOT COMPLETED|Overall Study||0
8113064|NCT03038867|19996172|P1|NOT COMPLETED|Overall Study||0
8113065|NCT03038867|19996171|P2|COMPLETED|Overall Study||32
8113066|NCT03038867|19996172|P1|COMPLETED|Overall Study||37
8113067|NCT03038867|19996171|P2|STARTED|Overall Study||32
8113068|NCT03038867|19996172|P1|STARTED|Overall Study||37
8113069|NCT03038815|19996288|P2|NOT COMPLETED|Intervention 2, 1 Hour||0
8113070|NCT03038815|19996289|P1|NOT COMPLETED|Intervention 2, 1 Hour||0
8113071|NCT03038815|19996288|P2|COMPLETED|Intervention 2, 1 Hour||10
8113072|NCT03038815|19996289|P1|COMPLETED|Intervention 2, 1 Hour||10
8113073|NCT03038815|19996288|P2|STARTED|Intervention 2, 1 Hour||10
8113074|NCT03038815|19996289|P1|STARTED|Intervention 2, 1 Hour||10
8113075|NCT03038815|19996288|P2|NOT COMPLETED|Intervention 1, 1 Hour||0
8113076|NCT03038815|19996289|P1|NOT COMPLETED|Intervention 1, 1 Hour||0
8113077|NCT03038815|19996288|P2|COMPLETED|Intervention 1, 1 Hour||10
8113078|NCT03038815|19996289|P1|COMPLETED|Intervention 1, 1 Hour||10
8113079|NCT03038815|19996288|P2|STARTED|Intervention 1, 1 Hour||10
8113080|NCT03038815|19996289|P1|STARTED|Intervention 1, 1 Hour||10
8113081|NCT03038815|19996288|P2|NOT COMPLETED|Controll Condition, 1 Hour||0
8113082|NCT03038815|19996289|P1|NOT COMPLETED|Controll Condition, 1 Hour||0
8113083|NCT03038815|19996288|P2|COMPLETED|Controll Condition, 1 Hour||10
8113084|NCT03038815|19996289|P1|COMPLETED|Controll Condition, 1 Hour||10
8113085|NCT03038815|19996288|P2|STARTED|Controll Condition, 1 Hour||10
8113086|NCT03038815|19996289|P1|STARTED|Controll Condition, 1 Hour||10
8113087|NCT03038126|19996301|P2|NOT COMPLETED|Overall Study||4
8113088|NCT03038126|19996302|P1|NOT COMPLETED|Overall Study||9
8113089|NCT03038126|19996301|P2|COMPLETED|Overall Study||51
8113090|NCT03038126|19996302|P1|COMPLETED|Overall Study||54
8113091|NCT03038126|19996301|P2|STARTED|Overall Study||55
8113092|NCT03038126|19996302|P1|STARTED|Overall Study||63
8113093|NCT03038113|19996326|P14|NOT COMPLETED|Overall Study||1
8113094|NCT03038113|19996327|P13|NOT COMPLETED|Overall Study||0
8113095|NCT03038113|19996328|P12|NOT COMPLETED|Overall Study||0
8113096|NCT03038113|19996329|P11|NOT COMPLETED|Overall Study||0
8113097|NCT03038113|19996330|P10|NOT COMPLETED|Overall Study||0
8113098|NCT03038113|19996331|P9|NOT COMPLETED|Overall Study||0
8113099|NCT03038113|19996332|P8|NOT COMPLETED|Overall Study||0
8113100|NCT03038113|19996333|P7|NOT COMPLETED|Overall Study||1
8113101|NCT03038113|19996334|P6|NOT COMPLETED|Overall Study||0
8113102|NCT03038113|19996335|P5|NOT COMPLETED|Overall Study||0
8113103|NCT03038113|19996336|P4|NOT COMPLETED|Overall Study||0
8113104|NCT03038113|19996337|P3|NOT COMPLETED|Overall Study||1
8113105|NCT03038113|19996338|P2|NOT COMPLETED|Overall Study||0
8113106|NCT03038113|19996339|P1|NOT COMPLETED|Overall Study||0
8113107|NCT03038113|19996326|P14|COMPLETED|Overall Study||14
8113108|NCT03038113|19996327|P13|COMPLETED|Overall Study||4
8113109|NCT03038113|19996328|P12|COMPLETED|Overall Study||7
8113110|NCT03038113|19996329|P11|COMPLETED|Overall Study||14
8113111|NCT03038113|19996330|P10|COMPLETED|Overall Study||6
8113112|NCT03038113|19996331|P9|COMPLETED|Overall Study||7
8113113|NCT03038113|19996332|P8|COMPLETED|Overall Study||6
8113114|NCT03038113|19996333|P7|COMPLETED|Overall Study||11
8113115|NCT03038113|19996334|P6|COMPLETED|Overall Study||8
8113116|NCT03038113|19996335|P5|COMPLETED|Overall Study||8
8113117|NCT03038113|19996336|P4|COMPLETED|Overall Study||8
8113118|NCT03038113|19996337|P3|COMPLETED|Overall Study||7
8113119|NCT03038113|19996338|P2|COMPLETED|Overall Study||8
8113120|NCT03038113|19996339|P1|COMPLETED|Overall Study||8
8113121|NCT03038113|19996326|P14|STARTED|Overall Study||15
8113122|NCT03038113|19996327|P13|STARTED|Overall Study||4
8113123|NCT03038113|19996328|P12|STARTED|Overall Study||7
8113124|NCT03038113|19996329|P11|STARTED|Overall Study||14
8113125|NCT03038113|19996330|P10|STARTED|Overall Study||6
8113126|NCT03038113|19996331|P9|STARTED|Overall Study||7
8113127|NCT03038113|19996332|P8|STARTED|Overall Study||6
8113128|NCT03038113|19996333|P7|STARTED|Overall Study||12
8113129|NCT03038113|19996334|P6|STARTED|Overall Study||8
8113130|NCT03038113|19996335|P5|STARTED|Overall Study||8
8113131|NCT03038113|19996336|P4|STARTED|Overall Study||8
8113132|NCT03038113|19996337|P3|STARTED|Overall Study||8
8113133|NCT03038113|19996338|P2|STARTED|Overall Study||8
8113134|NCT03038113|19996339|P1|STARTED|Overall Study||8
8113135|NCT03037983|19996550|P2|NOT COMPLETED|Overall Study||0
8113136|NCT03037983|19996551|P1|NOT COMPLETED|Overall Study||0
8113137|NCT03037983|19996550|P2|COMPLETED|Overall Study||4
8113138|NCT03037983|19996551|P1|COMPLETED|Overall Study||5
8113139|NCT03037983|19996550|P2|STARTED|Overall Study||4
8113140|NCT03037983|19996551|P1|STARTED|Overall Study||5
8113141|NCT03037905|19996565|P2|NOT COMPLETED|Overall Study||0
8113142|NCT03037905|19996566|P1|NOT COMPLETED|Overall Study||0
8113143|NCT03037905|19996565|P2|COMPLETED|Overall Study||50
8113144|NCT03037905|19996566|P1|COMPLETED|Overall Study||50
8113145|NCT03037905|19996565|P2|STARTED|Overall Study||50
8113146|NCT03037905|19996566|P1|STARTED|Overall Study||50
8113147|NCT03037619|19996580|P2|NOT COMPLETED|Overall Study||1
8113148|NCT03037619|19996581|P1|NOT COMPLETED|Overall Study||0
8113149|NCT03037619|19996580|P2|COMPLETED|Overall Study|7 participants and 7 buddies|14
8113150|NCT03037619|19996581|P1|COMPLETED|Overall Study||8
8113151|NCT03037619|19996580|P2|STARTED|Overall Study|8 participants and 7 buddies|15
8113152|NCT03037619|19996581|P1|STARTED|Overall Study||8
8113153|NCT03037580|19996595|P2|NOT COMPLETED|Overall Study||16
8113154|NCT03037580|19996596|P1|NOT COMPLETED|Overall Study||16
8113155|NCT03037580|19996595|P2|COMPLETED|Overall Study||27
8113156|NCT03037580|19996596|P1|COMPLETED|Overall Study||25
8113157|NCT03037580|19996595|P2|STARTED|Overall Study||43
8113158|NCT03037580|19996596|P1|STARTED|Overall Study||41
8113159|NCT03037541|19996610|P2|NOT COMPLETED|Overall Study||0
8113160|NCT03037541|19996611|P1|NOT COMPLETED|Overall Study||0
8113161|NCT03037541|19996610|P2|COMPLETED|Overall Study||30
8113162|NCT03037541|19996611|P1|COMPLETED|Overall Study||30
8113163|NCT03037541|19996610|P2|STARTED|Overall Study||30
8113164|NCT03037541|19996611|P1|STARTED|Overall Study||30
8113165|NCT03037489|19996621|P2|NOT COMPLETED|Overall Study||0
8113166|NCT03037489|19996622|P1|NOT COMPLETED|Overall Study||7
8113167|NCT03037489|19996621|P2|COMPLETED|Overall Study||4
8113168|NCT03037489|19996622|P1|COMPLETED|Overall Study||39
8113169|NCT03037489|19996621|P2|STARTED|Overall Study||4
8113170|NCT03037489|19996622|P1|STARTED|Overall Study||46
8113171|NCT03037307|19996628|P6|NOT COMPLETED|Period 3||0
8113172|NCT03037307|19996629|P5|NOT COMPLETED|Period 3||0
8113173|NCT03037307|19996630|P4|NOT COMPLETED|Period 3||0
8113174|NCT03037307|19996631|P3|NOT COMPLETED|Period 3||0
8113175|NCT03037307|19996632|P2|NOT COMPLETED|Period 3||0
8113176|NCT03037307|19996633|P1|NOT COMPLETED|Period 3||0
8113177|NCT03037307|19996628|P6|COMPLETED|Period 3||8
8113178|NCT03037307|19996629|P5|COMPLETED|Period 3||7
8113179|NCT03037307|19996630|P4|COMPLETED|Period 3||6
8113180|NCT03037307|19996631|P3|COMPLETED|Period 3||8
8113181|NCT03037307|19996632|P2|COMPLETED|Period 3||7
8113182|NCT03037307|19996633|P1|COMPLETED|Period 3||7
8113183|NCT03037307|19996628|P6|STARTED|Period 3||8
8113184|NCT03037307|19996629|P5|STARTED|Period 3||7
8113185|NCT03037307|19996630|P4|STARTED|Period 3||6
8113186|NCT03037307|19996631|P3|STARTED|Period 3||8
8113187|NCT03037307|19996632|P2|STARTED|Period 3||7
8113188|NCT03037307|19996633|P1|STARTED|Period 3||7
8113189|NCT03037307|19996628|P6|NOT COMPLETED|Wash Out Period 2||0
8113190|NCT03037307|19996629|P5|NOT COMPLETED|Wash Out Period 2||0
8113191|NCT03037307|19996630|P4|NOT COMPLETED|Wash Out Period 2||0
8113192|NCT03037307|19996631|P3|NOT COMPLETED|Wash Out Period 2||0
8113193|NCT03037307|19996632|P2|NOT COMPLETED|Wash Out Period 2||0
8113194|NCT03037307|19996633|P1|NOT COMPLETED|Wash Out Period 2||0
8113195|NCT03037307|19996628|P6|COMPLETED|Wash Out Period 2||8
8113196|NCT03037307|19996629|P5|COMPLETED|Wash Out Period 2||7
8113197|NCT03037307|19996630|P4|COMPLETED|Wash Out Period 2||6
8113198|NCT03037307|19996631|P3|COMPLETED|Wash Out Period 2||8
8113199|NCT03037307|19996632|P2|COMPLETED|Wash Out Period 2||7
8113200|NCT03037307|19996633|P1|COMPLETED|Wash Out Period 2||7
8113201|NCT03037307|19996628|P6|STARTED|Wash Out Period 2||8
8113202|NCT03037307|19996629|P5|STARTED|Wash Out Period 2||7
8113203|NCT03037307|19996630|P4|STARTED|Wash Out Period 2||6
8113204|NCT03037307|19996631|P3|STARTED|Wash Out Period 2||8
8113205|NCT03037307|19996632|P2|STARTED|Wash Out Period 2||7
8113206|NCT03037307|19996633|P1|STARTED|Wash Out Period 2||7
8113207|NCT03037307|19996628|P6|NOT COMPLETED|Period 2||0
8113208|NCT03037307|19996629|P5|NOT COMPLETED|Period 2||0
8113209|NCT03037307|19996630|P4|NOT COMPLETED|Period 2||0
8113210|NCT03037307|19996631|P3|NOT COMPLETED|Period 2||0
8113211|NCT03037307|19996632|P2|NOT COMPLETED|Period 2||0
8113212|NCT03037307|19996633|P1|NOT COMPLETED|Period 2||0
8113213|NCT03037307|19996628|P6|COMPLETED|Period 2||8
8113214|NCT03037307|19996629|P5|COMPLETED|Period 2||7
8113215|NCT03037307|19996630|P4|COMPLETED|Period 2||6
8113216|NCT03037307|19996631|P3|COMPLETED|Period 2||8
8113217|NCT03037307|19996632|P2|COMPLETED|Period 2||7
8113218|NCT03037307|19996633|P1|COMPLETED|Period 2||7
8113219|NCT03037307|19996628|P6|STARTED|Period 2||8
8113220|NCT03037307|19996629|P5|STARTED|Period 2||7
8113221|NCT03037307|19996630|P4|STARTED|Period 2||6
8113222|NCT03037307|19996631|P3|STARTED|Period 2||8
8113223|NCT03037307|19996632|P2|STARTED|Period 2||7
8113224|NCT03037307|19996633|P1|STARTED|Period 2||7
8113225|NCT03037307|19996628|P6|NOT COMPLETED|Wash Out Period 1||0
8113226|NCT03037307|19996629|P5|NOT COMPLETED|Wash Out Period 1||0
8113227|NCT03037307|19996630|P4|NOT COMPLETED|Wash Out Period 1||0
8113228|NCT03037307|19996631|P3|NOT COMPLETED|Wash Out Period 1||0
8113229|NCT03037307|19996632|P2|NOT COMPLETED|Wash Out Period 1||0
8113230|NCT03037307|19996633|P1|NOT COMPLETED|Wash Out Period 1||0
8113231|NCT03037307|19996628|P6|COMPLETED|Wash Out Period 1||8
8113232|NCT03037307|19996629|P5|COMPLETED|Wash Out Period 1||7
8113233|NCT03037307|19996630|P4|COMPLETED|Wash Out Period 1||6
8113234|NCT03037307|19996631|P3|COMPLETED|Wash Out Period 1||8
8113235|NCT03037307|19996632|P2|COMPLETED|Wash Out Period 1||7
8113236|NCT03037307|19996633|P1|COMPLETED|Wash Out Period 1||7
8113237|NCT03037307|19996628|P6|STARTED|Wash Out Period 1||8
8113238|NCT03037307|19996629|P5|STARTED|Wash Out Period 1||7
8113239|NCT03037307|19996630|P4|STARTED|Wash Out Period 1||6
8113240|NCT03037307|19996631|P3|STARTED|Wash Out Period 1||8
8113241|NCT03037307|19996632|P2|STARTED|Wash Out Period 1||7
8113242|NCT03037307|19996633|P1|STARTED|Wash Out Period 1||7
8113243|NCT03037307|19996628|P6|NOT COMPLETED|Period 1||0
8113244|NCT03037307|19996629|P5|NOT COMPLETED|Period 1||0
8113245|NCT03037307|19996630|P4|NOT COMPLETED|Period 1||1
8113246|NCT03037307|19996631|P3|NOT COMPLETED|Period 1||0
8113247|NCT03037307|19996632|P2|NOT COMPLETED|Period 1||0
8113248|NCT03037307|19996633|P1|NOT COMPLETED|Period 1||0
8113249|NCT03037307|19996628|P6|COMPLETED|Period 1||8
8113250|NCT03037307|19996629|P5|COMPLETED|Period 1||7
8113251|NCT03037307|19996630|P4|COMPLETED|Period 1||6
8113252|NCT03037307|19996631|P3|COMPLETED|Period 1||8
8113253|NCT03037307|19996632|P2|COMPLETED|Period 1||7
8113254|NCT03037307|19996633|P1|COMPLETED|Period 1||7
8113255|NCT03037307|19996628|P6|STARTED|Period 1||8
8113256|NCT03037307|19996629|P5|STARTED|Period 1||7
8113257|NCT03037307|19996630|P4|STARTED|Period 1||7
8113258|NCT03037307|19996631|P3|STARTED|Period 1||8
8113259|NCT03037307|19996632|P2|STARTED|Period 1||7
8113260|NCT03037307|19996633|P1|STARTED|Period 1||7
8113261|NCT03037281|19996645|P2|NOT COMPLETED|Overall Study||0
8113262|NCT03037281|19996646|P1|NOT COMPLETED|Overall Study||0
8113263|NCT03037281|19996645|P2|COMPLETED|Overall Study||8
8113264|NCT03037281|19996646|P1|COMPLETED|Overall Study||6
8113265|NCT03037281|19996645|P2|STARTED|Overall Study||8
8113266|NCT03037281|19996646|P1|STARTED|Overall Study||6
8113267|NCT03037203|19996667|P3|NOT COMPLETED|Overall Study||1
8113268|NCT03037203|19996668|P2|NOT COMPLETED|Overall Study||2
8113269|NCT03037203|19996669|P1|NOT COMPLETED|Overall Study||1
8113270|NCT03037203|19996667|P3|COMPLETED|Overall Study||9
8113271|NCT03037203|19996668|P2|COMPLETED|Overall Study||26
8113272|NCT03037203|19996669|P1|COMPLETED|Overall Study||27
8113273|NCT03037203|19996667|P3|STARTED|Overall Study||10
8113274|NCT03037203|19996668|P2|STARTED|Overall Study||28
8113275|NCT03037203|19996669|P1|STARTED|Overall Study||28
8113276|NCT03036852|19996693|P1|NOT COMPLETED|Overall Study||6
8113277|NCT03036852|19996693|P1|COMPLETED|Overall Study||53
8113278|NCT03036852|19996693|P1|STARTED|Overall Study||59
8113279|NCT03036839|19996750|P3|NOT COMPLETED|Overall Study||5
8113280|NCT03036839|19996751|P2|NOT COMPLETED|Overall Study||0
8113281|NCT03036839|19996752|P1|NOT COMPLETED|Overall Study||3
8113282|NCT03036839|19996750|P3|COMPLETED|Overall Study||14
8113283|NCT03036839|19996751|P2|COMPLETED|Overall Study||31
8113284|NCT03036839|19996752|P1|COMPLETED|Overall Study||42
8113285|NCT03036839|19996750|P3|STARTED|Overall Study||19
8113286|NCT03036839|19996751|P2|STARTED|Overall Study||31
8113287|NCT03036839|19996752|P1|STARTED|Overall Study||45
8113288|NCT03036813|19996805|P3|NOT COMPLETED|Overall Study||26
8113289|NCT03036813|19996806|P2|NOT COMPLETED|Overall Study||27
8113290|NCT03036813|19996807|P1|NOT COMPLETED|Overall Study||22
8113291|NCT03036813|19996805|P3|COMPLETED|Overall Study||66
8113292|NCT03036813|19996806|P2|COMPLETED|Overall Study||63
8113293|NCT03036813|19996807|P1|COMPLETED|Overall Study||70
8113294|NCT03036813|19996805|P3|STARTED|Overall Study||92
8113295|NCT03036813|19996806|P2|STARTED|Overall Study||90
8113296|NCT03036813|19996807|P1|STARTED|Overall Study||92
8113297|NCT03036735|19996830|P1|NOT COMPLETED|Overall Study||10
8113298|NCT03036735|19996830|P1|COMPLETED|Overall Study||0
8113299|NCT03036735|19996830|P1|STARTED|Overall Study||10
8113300|NCT03036384|19996838|P10|NOT COMPLETED|Overall Study||0
8113301|NCT03036384|19996839|P9|NOT COMPLETED|Overall Study||0
8113302|NCT03036384|19996840|P8|NOT COMPLETED|Overall Study||0
8113303|NCT03036384|19996841|P7|NOT COMPLETED|Overall Study||0
8113304|NCT03036384|19996842|P6|NOT COMPLETED|Overall Study||0
8113305|NCT03036384|19996843|P5|NOT COMPLETED|Overall Study||0
8113306|NCT03036384|19996844|P4|NOT COMPLETED|Overall Study||0
8113307|NCT03036384|19996845|P3|NOT COMPLETED|Overall Study||0
8113308|NCT03036384|19996846|P2|NOT COMPLETED|Overall Study||0
8113309|NCT03036384|19996847|P1|NOT COMPLETED|Overall Study||0
8113310|NCT03036384|19996838|P10|COMPLETED|Overall Study||4
8113311|NCT03036384|19996839|P9|COMPLETED|Overall Study||4
8113312|NCT03036384|19996840|P8|COMPLETED|Overall Study||4
8113313|NCT03036384|19996841|P7|COMPLETED|Overall Study||4
8113314|NCT03036384|19996842|P6|COMPLETED|Overall Study||4
8113315|NCT03036384|19996843|P5|COMPLETED|Overall Study||4
8113316|NCT03036384|19996844|P4|COMPLETED|Overall Study||4
8113317|NCT03036384|19996845|P3|COMPLETED|Overall Study||4
8113318|NCT03036384|19996846|P2|COMPLETED|Overall Study||4
8113319|NCT03036384|19996847|P1|COMPLETED|Overall Study||4
8113320|NCT03036384|19996838|P10|STARTED|Overall Study||4
8113321|NCT03036384|19996839|P9|STARTED|Overall Study||4
8113322|NCT03036384|19996840|P8|STARTED|Overall Study||4
8113323|NCT03036384|19996841|P7|STARTED|Overall Study||4
8113324|NCT03036384|19996842|P6|STARTED|Overall Study||4
8113325|NCT03036384|19996843|P5|STARTED|Overall Study||4
8113326|NCT03036384|19996844|P4|STARTED|Overall Study||4
8113327|NCT03036384|19996845|P3|STARTED|Overall Study||4
8113328|NCT03036384|19996846|P2|STARTED|Overall Study||4
8113329|NCT03036384|19996847|P1|STARTED|Overall Study||4
8113330|NCT03036293|19996893|P4|NOT COMPLETED|Overall Study||1
8113331|NCT03036293|19996894|P3|NOT COMPLETED|Overall Study||1
8113332|NCT03036293|19996895|P2|NOT COMPLETED|Overall Study||3
8113333|NCT03036293|19996896|P1|NOT COMPLETED|Overall Study||1
8113334|NCT03036293|19996893|P4|COMPLETED|Overall Study||64
8113335|NCT03036293|19996894|P3|COMPLETED|Overall Study||130
8113336|NCT03036293|19996895|P2|COMPLETED|Overall Study||64
8113337|NCT03036293|19996896|P1|COMPLETED|Overall Study||126
8113338|NCT03036293|19996893|P4|STARTED|Overall Study||65
8113339|NCT03036293|19996894|P3|STARTED|Overall Study||131
8113340|NCT03036293|19996895|P2|STARTED|Overall Study||67
8113341|NCT03036293|19996896|P1|STARTED|Overall Study||127
8113342|NCT03036215|19996924|P2|NOT COMPLETED|Overall Study||3
8113343|NCT03036215|19996925|P1|NOT COMPLETED|Overall Study||2
8113344|NCT03036215|19996924|P2|COMPLETED|Overall Study||36
8113345|NCT03036215|19996925|P1|COMPLETED|Overall Study||39
8113346|NCT03036215|19996924|P2|STARTED|Overall Study||39
8113347|NCT03036215|19996925|P1|STARTED|Overall Study||41
8113348|NCT03036163|19996942|P7|NOT COMPLETED|Overall Study||0
8113349|NCT03036163|19996943|P6|NOT COMPLETED|Overall Study||0
8113350|NCT03036163|19996944|P5|NOT COMPLETED|Overall Study||0
8113351|NCT03036163|19996945|P4|NOT COMPLETED|Overall Study||0
8113352|NCT03036163|19996946|P3|NOT COMPLETED|Overall Study||0
8113353|NCT03036163|19996947|P2|NOT COMPLETED|Overall Study||0
8113354|NCT03036163|19996948|P1|NOT COMPLETED|Overall Study||0
8113355|NCT03036163|19996942|P7|COMPLETED|Overall Study||5
8113356|NCT03036163|19996943|P6|COMPLETED|Overall Study||5
8113357|NCT03036163|19996944|P5|COMPLETED|Overall Study||6
8113358|NCT03036163|19996945|P4|COMPLETED|Overall Study||6
8113359|NCT03036163|19996946|P3|COMPLETED|Overall Study||6
8113360|NCT03036163|19996947|P2|COMPLETED|Overall Study||6
8113361|NCT03036163|19996948|P1|COMPLETED|Overall Study||6
8113362|NCT03036163|19996942|P7|STARTED|Overall Study||5
8113363|NCT03036163|19996943|P6|STARTED|Overall Study||5
8113364|NCT03036163|19996944|P5|STARTED|Overall Study||6
8113365|NCT03036163|19996945|P4|STARTED|Overall Study||6
8113366|NCT03036163|19996946|P3|STARTED|Overall Study||6
8113367|NCT03036163|19996947|P2|STARTED|Overall Study||6
8113368|NCT03036163|19996948|P1|STARTED|Overall Study||6
8113369|NCT03036124|19997039|P2|NOT COMPLETED|Overall Study||6
8113370|NCT03036124|19997040|P1|NOT COMPLETED|Overall Study||5
8113371|NCT03036124|19997039|P2|COMPLETED|Overall Study||2365
8113372|NCT03036124|19997040|P1|COMPLETED|Overall Study||2368
8113373|NCT03036124|19997039|P2|STARTED|Overall Study||2371
8113374|NCT03036124|19997040|P1|STARTED|Overall Study||2373
8113375|NCT03036072|19997058|P2|NOT COMPLETED|Overall Study||3
8113376|NCT03036072|19997059|P1|NOT COMPLETED|Overall Study||0
8113377|NCT03036072|19997058|P2|COMPLETED|Overall Study||10
8113378|NCT03036072|19997059|P1|COMPLETED|Overall Study||12
8113379|NCT03036072|19997058|P2|STARTED|Overall Study||13
8113380|NCT03036072|19997059|P1|STARTED|Overall Study||12
8113381|NCT03035955|19997069|P2|NOT COMPLETED|Overall Study||1
8113382|NCT03035955|19997070|P1|NOT COMPLETED|Overall Study||1
8113383|NCT03035955|19997069|P2|COMPLETED|Overall Study||9
8113384|NCT03035955|19997070|P1|COMPLETED|Overall Study||9
8113385|NCT03035955|19997069|P2|STARTED|Overall Study||10
8113386|NCT03035955|19997070|P1|STARTED|Overall Study||10
8113387|NCT03035942|19997079|P3|NOT COMPLETED|Overall Study||5
8113388|NCT03035942|19997080|P2|NOT COMPLETED|Overall Study||4
8113389|NCT03035942|19997081|P1|NOT COMPLETED|Overall Study||8
8113390|NCT03035942|19997079|P3|COMPLETED|Overall Study||40
8113391|NCT03035942|19997080|P2|COMPLETED|Overall Study||41
8113392|NCT03035942|19997081|P1|COMPLETED|Overall Study||37
8113393|NCT03035942|19997079|P3|STARTED|Overall Study||45
8113394|NCT03035942|19997080|P2|STARTED|Overall Study||45
8113395|NCT03035942|19997081|P1|STARTED|Overall Study||45
8113396|NCT03035929|19997098|P1|NOT COMPLETED|Overall Study||0
8113397|NCT03035929|19997098|P1|COMPLETED|Overall Study||10
8113398|NCT03035929|19997098|P1|STARTED|Overall Study||10
8113399|NCT03035916|19997110|P3|NOT COMPLETED|Overall Study||0
8113400|NCT03035916|19997111|P2|NOT COMPLETED|Overall Study||2
8113401|NCT03035916|19997112|P1|NOT COMPLETED|Overall Study||0
8113402|NCT03035916|19997110|P3|COMPLETED|Overall Study||31
8113403|NCT03035916|19997111|P2|COMPLETED|Overall Study||28
8113404|NCT03035916|19997112|P1|COMPLETED|Overall Study||30
8113405|NCT03035916|19997110|P3|STARTED|Overall Study||31
8113406|NCT03035916|19997111|P2|STARTED|Overall Study||30
8113407|NCT03035916|19997112|P1|STARTED|Overall Study||30
8113408|NCT03035864|19997161|P2|NOT COMPLETED|Follow-up Period||4
8113409|NCT03035864|19997162|P1|NOT COMPLETED|Follow-up Period||11
8113410|NCT03035864|19997161|P2|COMPLETED|Follow-up Period||55
8113411|NCT03035864|19997162|P1|COMPLETED|Follow-up Period||105
8113412|NCT03035864|19997161|P2|STARTED|Follow-up Period||59
8113413|NCT03035864|19997162|P1|STARTED|Follow-up Period||116
8113414|NCT03035864|19997161|P2|NOT COMPLETED|Treatment Period||1
8113415|NCT03035864|19997162|P1|NOT COMPLETED|Treatment Period||4
8113416|NCT03035864|19997161|P2|COMPLETED|Treatment Period||59
8113417|NCT03035864|19997162|P1|COMPLETED|Treatment Period||116
8113418|NCT03035864|19997161|P2|STARTED|Treatment Period||60
8113419|NCT03035864|19997162|P1|STARTED|Treatment Period||120
8113420|NCT03035760|19997183|P5|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
8113421|NCT03035760|19997184|P4|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
8113422|NCT03035760|19997185|P3|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
8113423|NCT03035760|19997186|P2|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
8113424|NCT03035760|19997187|P1|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
8113425|NCT03035760|19997183|P5|COMPLETED|Second Intervention - 7 Days Follow-up||6
8113426|NCT03035760|19997184|P4|COMPLETED|Second Intervention - 7 Days Follow-up||6
8113427|NCT03035760|19997185|P3|COMPLETED|Second Intervention - 7 Days Follow-up||0
8113428|NCT03035760|19997186|P2|COMPLETED|Second Intervention - 7 Days Follow-up||0
8113429|NCT03035760|19997187|P1|COMPLETED|Second Intervention - 7 Days Follow-up||0
8113430|NCT03035760|19997183|P5|STARTED|Second Intervention - 7 Days Follow-up||6
8113431|NCT03035760|19997184|P4|STARTED|Second Intervention - 7 Days Follow-up||6
8113432|NCT03035760|19997185|P3|STARTED|Second Intervention - 7 Days Follow-up||0
8113433|NCT03035760|19997186|P2|STARTED|Second Intervention - 7 Days Follow-up||0
8113434|NCT03035760|19997187|P1|STARTED|Second Intervention - 7 Days Follow-up||0
8113435|NCT03035760|19997183|P5|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
8113436|NCT03035760|19997184|P4|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
8113437|NCT03035760|19997185|P3|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
8113438|NCT03035760|19997186|P2|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
8113439|NCT03035760|19997187|P1|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
8113440|NCT03035760|19997183|P5|COMPLETED|First Intervention - 10/7 Days Follow-up||6
8113441|NCT03035760|19997184|P4|COMPLETED|First Intervention - 10/7 Days Follow-up||6
8113442|NCT03035760|19997185|P3|COMPLETED|First Intervention - 10/7 Days Follow-up||8
8113443|NCT03035760|19997186|P2|COMPLETED|First Intervention - 10/7 Days Follow-up||8
8113444|NCT03035760|19997187|P1|COMPLETED|First Intervention - 10/7 Days Follow-up||8
8113445|NCT03035760|19997183|P5|STARTED|First Intervention - 10/7 Days Follow-up||6
8113446|NCT03035760|19997184|P4|STARTED|First Intervention - 10/7 Days Follow-up||6
8113447|NCT03035760|19997185|P3|STARTED|First Intervention - 10/7 Days Follow-up||8
8113448|NCT03035760|19997186|P2|STARTED|First Intervention - 10/7 Days Follow-up||8
8113449|NCT03035760|19997187|P1|STARTED|First Intervention - 10/7 Days Follow-up||8
8113450|NCT03035708|19997217|P2|NOT COMPLETED|Overall Study||11
8113451|NCT03035708|19997218|P1|NOT COMPLETED|Overall Study||4
8113452|NCT03035708|19997217|P2|COMPLETED|Overall Study||13
8113453|NCT03035708|19997218|P1|COMPLETED|Overall Study||19
8113454|NCT03035708|19997217|P2|STARTED|Overall Study||24
8113455|NCT03035708|19997218|P1|STARTED|Overall Study||23
8113456|NCT03035487|19997232|P1|NOT COMPLETED|Overall Study||0
8113457|NCT03035487|19997232|P1|COMPLETED|Overall Study||9
8113458|NCT03035487|19997232|P1|STARTED|Overall Study||9
8113459|NCT03035032|19997236|P1|NOT COMPLETED|Overall Study||43
8113460|NCT03035032|19997236|P1|COMPLETED|Overall Study||64
8113461|NCT03035032|19997236|P1|STARTED|Overall Study||107
8113462|NCT03034967|19997257|P6|NOT COMPLETED|Overall Study||15
8113463|NCT03034967|19997258|P5|NOT COMPLETED|Overall Study||14
8113464|NCT03034967|19997259|P4|NOT COMPLETED|Overall Study||11
8113465|NCT03034967|19997260|P3|NOT COMPLETED|Overall Study||13
8113466|NCT03034967|19997261|P2|NOT COMPLETED|Overall Study||5
8113467|NCT03034967|19997262|P1|NOT COMPLETED|Overall Study||14
8113468|NCT03034967|19997257|P6|COMPLETED|Overall Study||87
8113469|NCT03034967|19997258|P5|COMPLETED|Overall Study||88
8113470|NCT03034967|19997259|P4|COMPLETED|Overall Study||92
8113471|NCT03034967|19997260|P3|COMPLETED|Overall Study||90
8113472|NCT03034967|19997261|P2|COMPLETED|Overall Study||97
8113473|NCT03034967|19997262|P1|COMPLETED|Overall Study||88
8113474|NCT03034967|19997257|P6|STARTED|Overall Study||102
8113475|NCT03034967|19997258|P5|STARTED|Overall Study||102
8113476|NCT03034967|19997259|P4|STARTED|Overall Study||103
8113477|NCT03034967|19997260|P3|STARTED|Overall Study||103
8113478|NCT03034967|19997261|P2|STARTED|Overall Study||102
8113479|NCT03034967|19997262|P1|STARTED|Overall Study||102
8113480|NCT03034954|19997460|P2|NOT COMPLETED|Overall Study||0
8113481|NCT03034954|19997461|P1|NOT COMPLETED|Overall Study||1
8113482|NCT03034954|19997460|P2|COMPLETED|Overall Study||21
8113483|NCT03034954|19997461|P1|COMPLETED|Overall Study||20
8113484|NCT03034954|19997460|P2|STARTED|Overall Study||21
8113485|NCT03034954|19997461|P1|STARTED|Overall Study||21
8113486|NCT03034928|19997513|P4|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
8113487|NCT03034928|19997514|P3|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
8113488|NCT03034928|19997515|P2|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
8113489|NCT03034928|19997516|P1|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
8113490|NCT03034928|19997513|P4|COMPLETED|Period 2, Second 2 Hours of Wear||8
8113491|NCT03034928|19997514|P3|COMPLETED|Period 2, Second 2 Hours of Wear||9
8113492|NCT03034928|19997515|P2|COMPLETED|Period 2, Second 2 Hours of Wear||8
8113493|NCT03034928|19997516|P1|COMPLETED|Period 2, Second 2 Hours of Wear||8
8113494|NCT03034928|19997513|P4|STARTED|Period 2, Second 2 Hours of Wear||8
8113495|NCT03034928|19997514|P3|STARTED|Period 2, Second 2 Hours of Wear||9
8113496|NCT03034928|19997515|P2|STARTED|Period 2, Second 2 Hours of Wear||8
8113497|NCT03034928|19997516|P1|STARTED|Period 2, Second 2 Hours of Wear||8
8113498|NCT03034928|19997513|P4|NOT COMPLETED|Washout Period Between Lens Wear||0
8113499|NCT03034928|19997514|P3|NOT COMPLETED|Washout Period Between Lens Wear||0
8113500|NCT03034928|19997515|P2|NOT COMPLETED|Washout Period Between Lens Wear||0
8113501|NCT03034928|19997516|P1|NOT COMPLETED|Washout Period Between Lens Wear||0
8113502|NCT03034928|19997513|P4|COMPLETED|Washout Period Between Lens Wear||8
8113503|NCT03034928|19997514|P3|COMPLETED|Washout Period Between Lens Wear||9
8113504|NCT03034928|19997515|P2|COMPLETED|Washout Period Between Lens Wear||8
8113505|NCT03034928|19997516|P1|COMPLETED|Washout Period Between Lens Wear||8
8113506|NCT03034928|19997513|P4|STARTED|Washout Period Between Lens Wear||8
8113507|NCT03034928|19997514|P3|STARTED|Washout Period Between Lens Wear||9
8113508|NCT03034928|19997515|P2|STARTED|Washout Period Between Lens Wear||8
8113509|NCT03034928|19997516|P1|STARTED|Washout Period Between Lens Wear||8
8113510|NCT03034928|19997513|P4|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
8113511|NCT03034928|19997514|P3|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
8113512|NCT03034928|19997515|P2|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
8113513|NCT03034928|19997516|P1|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
8113514|NCT03034928|19997513|P4|COMPLETED|Period 1, First 2 Hours of Wear||8
8113515|NCT03034928|19997514|P3|COMPLETED|Period 1, First 2 Hours of Wear||9
8113516|NCT03034928|19997515|P2|COMPLETED|Period 1, First 2 Hours of Wear||8
8113517|NCT03034928|19997516|P1|COMPLETED|Period 1, First 2 Hours of Wear||8
8113518|NCT03034928|19997513|P4|STARTED|Period 1, First 2 Hours of Wear||8
8113519|NCT03034928|19997514|P3|STARTED|Period 1, First 2 Hours of Wear||9
8113520|NCT03034928|19997515|P2|STARTED|Period 1, First 2 Hours of Wear||8
8113521|NCT03034928|19997516|P1|STARTED|Period 1, First 2 Hours of Wear||8
8113522|NCT03034915|19997528|P3|NOT COMPLETED|Overall Study||126
8113523|NCT03034915|19997529|P2|NOT COMPLETED|Overall Study||154
8113524|NCT03034915|19997530|P1|NOT COMPLETED|Overall Study||95
8113525|NCT03034915|19997528|P3|COMPLETED|Overall Study||683
8113526|NCT03034915|19997529|P2|COMPLETED|Overall Study||650
8113527|NCT03034915|19997530|P1|COMPLETED|Overall Study||717
8113528|NCT03034915|19997528|P3|STARTED|Overall Study||809
8113529|NCT03034915|19997529|P2|STARTED|Overall Study||804
8113530|NCT03034915|19997530|P1|STARTED|Overall Study||812
8113531|NCT03034772|19997570|P2|NOT COMPLETED|Overall Study||2
8113532|NCT03034772|19997571|P1|NOT COMPLETED|Overall Study||0
8113533|NCT03034772|19997570|P2|COMPLETED|Overall Study||23
8113534|NCT03034772|19997571|P1|COMPLETED|Overall Study||27
8113535|NCT03034772|19997570|P2|STARTED|Overall Study||25
8113536|NCT03034772|19997571|P1|STARTED|Overall Study||27
8113537|NCT03034577|19997587|P2|NOT COMPLETED|Overall Study||35
8113538|NCT03034577|19997588|P1|NOT COMPLETED|Overall Study||31
8113539|NCT03034577|19997587|P2|COMPLETED|Overall Study||140
8113540|NCT03034577|19997588|P1|COMPLETED|Overall Study||144
8113541|NCT03034577|19997587|P2|STARTED|Overall Study||175
8113542|NCT03034577|19997588|P1|STARTED|Overall Study||175
8113543|NCT03034460|19997606|P2|NOT COMPLETED|Overall Study||3
8113544|NCT03034460|19997607|P1|NOT COMPLETED|Overall Study||3
8113545|NCT03034460|19997606|P2|COMPLETED|Overall Study||19
8113546|NCT03034460|19997607|P1|COMPLETED|Overall Study||45
8113547|NCT03034460|19997606|P2|STARTED|Overall Study||22
8113548|NCT03034460|19997607|P1|STARTED|Overall Study||48
8113549|NCT03034057|19997649|P1|NOT COMPLETED|Overall Study||55
8113550|NCT03034057|19997649|P1|COMPLETED|Overall Study||114
8113551|NCT03034057|19997649|P1|STARTED|Overall Study||169
8113552|NCT03034044|19997655|P1|NOT COMPLETED|Overall Study||1
8113553|NCT03034044|19997655|P1|COMPLETED|Overall Study||105
8113554|NCT03034044|19997655|P1|Received Xyntha|Overall Study||105
8113555|NCT03034044|19997655|P1|STARTED|Overall Study||106
8113556|NCT03033784|19997677|P13|NOT COMPLETED|Overall Study||2
8113557|NCT03033784|19997678|P12|NOT COMPLETED|Overall Study||0
8113558|NCT03033784|19997679|P11|NOT COMPLETED|Overall Study||0
8113559|NCT03033784|19997680|P10|NOT COMPLETED|Overall Study||0
8113560|NCT03033784|19997681|P9|NOT COMPLETED|Overall Study||0
8113561|NCT03033784|19997682|P8|NOT COMPLETED|Overall Study||0
8113562|NCT03033784|19997683|P7|NOT COMPLETED|Overall Study||0
8113563|NCT03033784|19997684|P6|NOT COMPLETED|Overall Study||0
8113564|NCT03033784|19997685|P5|NOT COMPLETED|Overall Study||0
8113565|NCT03033784|19997686|P4|NOT COMPLETED|Overall Study||0
8113566|NCT03033784|19997687|P3|NOT COMPLETED|Overall Study||0
8113567|NCT03033784|19997688|P2|NOT COMPLETED|Overall Study||1
8113568|NCT03033784|19997689|P1|NOT COMPLETED|Overall Study||0
8113569|NCT03033784|19997677|P13|COMPLETED|Overall Study||17
8113570|NCT03033784|19997678|P12|COMPLETED|Overall Study||1
8113571|NCT03033784|19997679|P11|COMPLETED|Overall Study||1
8113572|NCT03033784|19997680|P10|COMPLETED|Overall Study||1
8113573|NCT03033784|19997681|P9|COMPLETED|Overall Study||1
8113574|NCT03033784|19997682|P8|COMPLETED|Overall Study||2
8113575|NCT03033784|19997683|P7|COMPLETED|Overall Study||2
8113576|NCT03033784|19997684|P6|COMPLETED|Overall Study||2
8113577|NCT03033784|19997685|P5|COMPLETED|Overall Study||3
8113578|NCT03033784|19997686|P4|COMPLETED|Overall Study||4
8113579|NCT03033784|19997687|P3|COMPLETED|Overall Study||4
8113580|NCT03033784|19997688|P2|COMPLETED|Overall Study||1
8113581|NCT03033784|19997689|P1|COMPLETED|Overall Study||9
8113582|NCT03033784|19997677|P13|Clinical Visit 4|Overall Study||0
8113583|NCT03033784|19997678|P12|Clinical Visit 4|Overall Study||1
8113584|NCT03033784|19997679|P11|Clinical Visit 4|Overall Study||1
8113585|NCT03033784|19997680|P10|Clinical Visit 4|Overall Study||1
8113586|NCT03033784|19997681|P9|Clinical Visit 4|Overall Study||1
8113587|NCT03033784|19997682|P8|Clinical Visit 4|Overall Study||2
8113588|NCT03033784|19997683|P7|Clinical Visit 4|Overall Study||2
8113589|NCT03033784|19997684|P6|Clinical Visit 4|Overall Study||2
8113590|NCT03033784|19997685|P5|Clinical Visit 4|Overall Study||3
8113591|NCT03033784|19997686|P4|Clinical Visit 4|Overall Study||4
8113592|NCT03033784|19997687|P3|Clinical Visit 4|Overall Study||4
8113593|NCT03033784|19997688|P2|Clinical Visit 4|Overall Study||1
8113594|NCT03033784|19997689|P1|Clinical Visit 4|Overall Study||9
8113595|NCT03033784|19997677|P13|Clinical Visit 3|Overall Study||0
8113596|NCT03033784|19997678|P12|Clinical Visit 3|Overall Study||1
8113597|NCT03033784|19997679|P11|Clinical Visit 3|Overall Study||1
8113598|NCT03033784|19997680|P10|Clinical Visit 3|Overall Study||1
8113599|NCT03033784|19997681|P9|Clinical Visit 3|Overall Study||1
8113600|NCT03033784|19997682|P8|Clinical Visit 3|Overall Study||2
8113601|NCT03033784|19997683|P7|Clinical Visit 3|Overall Study||2
8113602|NCT03033784|19997684|P6|Clinical Visit 3|Overall Study||2
8113603|NCT03033784|19997685|P5|Clinical Visit 3|Overall Study||3
8113604|NCT03033784|19997686|P4|Clinical Visit 3|Overall Study||4
8113605|NCT03033784|19997687|P3|Clinical Visit 3|Overall Study||4
8113606|NCT03033784|19997688|P2|Clinical Visit 3|Overall Study||1
8113607|NCT03033784|19997689|P1|Clinical Visit 3|Overall Study||9
8113608|NCT03033784|19997677|P13|Clinical Visit 2|Overall Study||17
8113609|NCT03033784|19997678|P12|Clinical Visit 2|Overall Study||1
8113610|NCT03033784|19997679|P11|Clinical Visit 2|Overall Study||1
8113611|NCT03033784|19997680|P10|Clinical Visit 2|Overall Study||1
8113612|NCT03033784|19997681|P9|Clinical Visit 2|Overall Study||1
8113613|NCT03033784|19997682|P8|Clinical Visit 2|Overall Study||2
8113614|NCT03033784|19997683|P7|Clinical Visit 2|Overall Study||2
8113615|NCT03033784|19997684|P6|Clinical Visit 2|Overall Study||2
8113616|NCT03033784|19997685|P5|Clinical Visit 2|Overall Study||3
8113617|NCT03033784|19997686|P4|Clinical Visit 2|Overall Study||4
8113618|NCT03033784|19997687|P3|Clinical Visit 2|Overall Study||4
8113619|NCT03033784|19997688|P2|Clinical Visit 2|Overall Study||2
8113620|NCT03033784|19997689|P1|Clinical Visit 2|Overall Study||9
8113621|NCT03033784|19997677|P13|STARTED|Overall Study||19
8113622|NCT03033784|19997678|P12|STARTED|Overall Study||1
8113623|NCT03033784|19997679|P11|STARTED|Overall Study||1
8113624|NCT03033784|19997680|P10|STARTED|Overall Study||1
8113625|NCT03033784|19997681|P9|STARTED|Overall Study||1
8113626|NCT03033784|19997682|P8|STARTED|Overall Study||2
8113627|NCT03033784|19997683|P7|STARTED|Overall Study||2
8113628|NCT03033784|19997684|P6|STARTED|Overall Study||2
8113629|NCT03033784|19997685|P5|STARTED|Overall Study||3
8113630|NCT03033784|19997686|P4|STARTED|Overall Study||4
8113631|NCT03033784|19997687|P3|STARTED|Overall Study||4
8113632|NCT03033784|19997688|P2|STARTED|Overall Study||2
8113633|NCT03033784|19997689|P1|STARTED|Overall Study||9
8113634|NCT03033745|19997730|P3|NOT COMPLETED|Overall Study||2
8113635|NCT03033745|19997731|P2|NOT COMPLETED|Overall Study||1
8113636|NCT03033745|19997732|P1|NOT COMPLETED|Overall Study||1
8113637|NCT03033745|19997730|P3|COMPLETED|Overall Study||14
8113638|NCT03033745|19997731|P2|COMPLETED|Overall Study||17
8113639|NCT03033745|19997732|P1|COMPLETED|Overall Study||14
8113640|NCT03033745|19997730|P3|STARTED|Overall Study||16
8113641|NCT03033745|19997731|P2|STARTED|Overall Study||18
8113642|NCT03033745|19997732|P1|STARTED|Overall Study||15
8113649|NCT03033134|19997780|P2|NOT COMPLETED|Overall Study||12
8113650|NCT03033134|19997781|P1|NOT COMPLETED|Overall Study||42
8113651|NCT03033134|19997780|P2|COMPLETED|Overall Study||0
8113652|NCT03033134|19997781|P1|COMPLETED|Overall Study||0
8113653|NCT03033134|19997780|P2|6-month Primary Endpoints|Overall Study||12
8113654|NCT03033134|19997781|P1|6-month Primary Endpoints|Overall Study||42
8113655|NCT03033134|19997780|P2|STARTED|Overall Study||12
8113656|NCT03033134|19997781|P1|STARTED|Overall Study||42
8113657|NCT03032965|19997803|P2|NOT COMPLETED|Overall Study||0
8113658|NCT03032965|19997804|P1|NOT COMPLETED|Overall Study||0
8113659|NCT03032965|19997803|P2|COMPLETED|Overall Study||68
8113660|NCT03032965|19997804|P1|COMPLETED|Overall Study||61
8113661|NCT03032965|19997803|P2|STARTED|Overall Study||68
8113662|NCT03032965|19997804|P1|STARTED|Overall Study||61
8113663|NCT03032523|19997828|P2|NOT COMPLETED|Overall Study||2
8113664|NCT03032523|19997829|P1|NOT COMPLETED|Overall Study||3
8113665|NCT03032523|19997828|P2|COMPLETED|Overall Study||4
8113666|NCT03032523|19997829|P1|COMPLETED|Overall Study||12
8113667|NCT03032523|19997828|P2|STARTED|Overall Study||6
8113668|NCT03032523|19997829|P1|STARTED|Overall Study||15
8113669|NCT03032510|19997841|P2|NOT COMPLETED|Overall Study||18
8113670|NCT03032510|19997842|P1|NOT COMPLETED|Overall Study||27
8113671|NCT03032510|19997841|P2|COMPLETED|Overall Study||584
8113672|NCT03032510|19997842|P1|COMPLETED|Overall Study||576
8113673|NCT03032510|19997841|P2|STARTED|Overall Study||602
8113674|NCT03032510|19997842|P1|STARTED|Overall Study||603
8113675|NCT03032393|19997854|P2|NOT COMPLETED|Overall Study||0
8113676|NCT03032393|19997855|P1|NOT COMPLETED|Overall Study||0
8113677|NCT03032393|19997854|P2|COMPLETED|Overall Study||15
8113678|NCT03032393|19997855|P1|COMPLETED|Overall Study||15
8113679|NCT03032393|19997854|P2|STARTED|Overall Study||15
8113680|NCT03032393|19997855|P1|STARTED|Overall Study||15
8113681|NCT03032380|19997863|P2|NOT COMPLETED|Overall Study||40
8113682|NCT03032380|19997864|P1|NOT COMPLETED|Overall Study||42
8113683|NCT03032380|19997863|P2|COMPLETED|Overall Study||112
8113684|NCT03032380|19997864|P1|COMPLETED|Overall Study||106
8113685|NCT03032380|19997863|P2|Received Treatment|Overall Study||150
8113686|NCT03032380|19997864|P1|Received Treatment|Overall Study||148
8113687|NCT03032380|19997863|P2|STARTED|Overall Study||152
8113688|NCT03032380|19997864|P1|STARTED|Overall Study||148
8113689|NCT03032263|19997896|P2|NOT COMPLETED|Overall Study||0
8113690|NCT03032263|19997897|P1|NOT COMPLETED|Overall Study||0
8113691|NCT03032263|19997896|P2|COMPLETED|Overall Study||6
8113692|NCT03032263|19997897|P1|COMPLETED|Overall Study||6
8113693|NCT03032263|19997896|P2|STARTED|Overall Study||6
8113694|NCT03032263|19997897|P1|STARTED|Overall Study||6
8113695|NCT03031899|19997911|P1|NOT COMPLETED|Overall Study||2
8113696|NCT03031899|19997911|P1|COMPLETED|Overall Study||25
8113697|NCT03031899|19997911|P1|STARTED|Overall Study||27
8113698|NCT03031795|19997921|P2|NOT COMPLETED|Overall Study||1
8113699|NCT03031795|19997922|P1|NOT COMPLETED|Overall Study||0
8113700|NCT03031795|19997921|P2|COMPLETED|Overall Study||35
8113701|NCT03031795|19997922|P1|COMPLETED|Overall Study||35
8113702|NCT03031795|19997921|P2|STARTED|Overall Study||36
8113703|NCT03031795|19997922|P1|STARTED|Overall Study||35
8113704|NCT03031678|19997928|P1|NOT COMPLETED|Overall Study||1
8113705|NCT03031678|19997928|P1|COMPLETED|Overall Study||49
8113706|NCT03031678|19997928|P1|CI Alone Test Condition Complete|Overall Study||10
8113707|NCT03031678|19997928|P1|EAS Test Condition Complete|Overall Study||39
8113708|NCT03031678|19997928|P1|STARTED|Overall Study||50
8113721|NCT03031431|19997974|P1|NOT COMPLETED|Overall Study||1
8113722|NCT03031431|19997974|P1|COMPLETED|Overall Study||129
8113723|NCT03031431|19997974|P1|STARTED|Overall Study||130
8113724|NCT03031340|19997983|P2|NOT COMPLETED|Overall Study||1
8113725|NCT03031340|19997984|P1|NOT COMPLETED|Overall Study||2
8113726|NCT03031340|19997983|P2|COMPLETED|Overall Study||0
8113727|NCT03031340|19997984|P1|COMPLETED|Overall Study||0
8113728|NCT03031340|19997983|P2|STARTED|Overall Study||1
8113729|NCT03031340|19997984|P1|STARTED|Overall Study||2
8113730|NCT03030989|19998002|P2|NOT COMPLETED|Overall Study||14
8113731|NCT03030989|19998003|P1|NOT COMPLETED|Overall Study||12
8113732|NCT03030989|19998002|P2|COMPLETED|Overall Study||15
8113733|NCT03030989|19998003|P1|COMPLETED|Overall Study||9
8113734|NCT03030989|19998002|P2|STARTED|Overall Study||29
8113735|NCT03030989|19998003|P1|STARTED|Overall Study||21
8113736|NCT03030638|19998019|P8|NOT COMPLETED|Overall Study||0
8113737|NCT03030638|19998020|P7|NOT COMPLETED|Overall Study||0
8113738|NCT03030638|19998021|P6|NOT COMPLETED|Overall Study||0
8113739|NCT03030638|19998022|P5|NOT COMPLETED|Overall Study||0
8113740|NCT03030638|19998023|P4|NOT COMPLETED|Overall Study||0
8113741|NCT03030638|19998024|P3|NOT COMPLETED|Overall Study||0
8113742|NCT03030638|19998025|P2|NOT COMPLETED|Overall Study||0
8113743|NCT03030638|19998026|P1|NOT COMPLETED|Overall Study||0
8113744|NCT03030638|19998019|P8|COMPLETED|Overall Study||127
8113745|NCT03030638|19998020|P7|COMPLETED|Overall Study||364
8113746|NCT03030638|19998021|P6|COMPLETED|Overall Study||1592
8113747|NCT03030638|19998022|P5|COMPLETED|Overall Study||696
8113748|NCT03030638|19998023|P4|COMPLETED|Overall Study||6406
8113749|NCT03030638|19998024|P3|COMPLETED|Overall Study||1712
8113750|NCT03030638|19998025|P2|COMPLETED|Overall Study||1841
8113751|NCT03030638|19998026|P1|COMPLETED|Overall Study||1386
8113752|NCT03030638|19998019|P8|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
8113753|NCT03030638|19998020|P7|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
8113754|NCT03030638|19998021|P6|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
8113755|NCT03030638|19998022|P5|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
8113756|NCT03030638|19998023|P4|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
8113757|NCT03030638|19998024|P3|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
8113758|NCT03030638|19998025|P2|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636
8113759|NCT03030638|19998026|P1|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372
8113760|NCT03030638|19998019|P8|STARTED|Overall Study||127
8113761|NCT03030638|19998020|P7|STARTED|Overall Study||364
8113762|NCT03030638|19998021|P6|STARTED|Overall Study||1592
8113763|NCT03030638|19998022|P5|STARTED|Overall Study||696
8113764|NCT03030638|19998023|P4|STARTED|Overall Study||6406
8113765|NCT03030638|19998024|P3|STARTED|Overall Study||1712
8113766|NCT03030638|19998025|P2|STARTED|Overall Study||1841
8113767|NCT03030638|19998026|P1|STARTED|Overall Study||1386
8113768|NCT03030599|19998056|P3|NOT COMPLETED|Open-label Extension||0
8113769|NCT03030599|19998057|P2|NOT COMPLETED|Open-label Extension||0
8113770|NCT03030599|19998058|P1|NOT COMPLETED|Open-label Extension||7
8113771|NCT03030599|19998056|P3|COMPLETED|Open-label Extension||0
8113772|NCT03030599|19998057|P2|COMPLETED|Open-label Extension||0
8113773|NCT03030599|19998058|P1|COMPLETED|Open-label Extension||67
8113774|NCT03030599|19998056|P3|STARTED|Open-label Extension||0
8113775|NCT03030599|19998057|P2|STARTED|Open-label Extension||0
8113776|NCT03030599|19998058|P1|STARTED|Open-label Extension||74
8113777|NCT03030599|19998056|P3|NOT COMPLETED|Double Blind Randomized Withdrawal||8
8113778|NCT03030599|19998057|P2|NOT COMPLETED|Double Blind Randomized Withdrawal||0
8113779|NCT03030599|19998058|P1|NOT COMPLETED|Double Blind Randomized Withdrawal||0
8113780|NCT03030599|19998056|P3|COMPLETED|Double Blind Randomized Withdrawal||59
8113781|NCT03030599|19998057|P2|COMPLETED|Double Blind Randomized Withdrawal||69
8113782|NCT03030599|19998058|P1|COMPLETED|Double Blind Randomized Withdrawal||0
8113783|NCT03030599|19998056|P3|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|67
8113784|NCT03030599|19998057|P2|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|69
8113785|NCT03030599|19998058|P1|STARTED|Double Blind Randomized Withdrawal||0
8113786|NCT03030599|19998056|P3|NOT COMPLETED|Stable Dose||0
8113787|NCT03030599|19998057|P2|NOT COMPLETED|Stable Dose||0
8113788|NCT03030599|19998058|P1|NOT COMPLETED|Stable Dose||5
8113789|NCT03030599|19998056|P3|COMPLETED|Stable Dose||0
8113790|NCT03030599|19998057|P2|COMPLETED|Stable Dose||0
8113791|NCT03030599|19998058|P1|COMPLETED|Stable Dose||144
8113792|NCT03030599|19998056|P3|STARTED|Stable Dose||0
8113793|NCT03030599|19998057|P2|STARTED|Stable Dose||0
8113794|NCT03030599|19998058|P1|STARTED|Stable Dose|149 subjects of the 201 entered the Stable Dose Period. Of those subjects, 136 were randomized.|149
8113795|NCT03030599|19998056|P3|NOT COMPLETED|Open Label Treatment and Titration||0
8113796|NCT03030599|19998057|P2|NOT COMPLETED|Open Label Treatment and Titration||0
8113797|NCT03030599|19998058|P1|NOT COMPLETED|Open Label Treatment and Titration||46
8113798|NCT03030599|19998056|P3|COMPLETED|Open Label Treatment and Titration||0
8113799|NCT03030599|19998057|P2|COMPLETED|Open Label Treatment and Titration||0
8113800|NCT03030599|19998058|P1|COMPLETED|Open Label Treatment and Titration||155
8113801|NCT03030599|19998056|P3|STARTED|Open Label Treatment and Titration||0
8113802|NCT03030599|19998057|P2|STARTED|Open Label Treatment and Titration||0
8113803|NCT03030599|19998058|P1|STARTED|Open Label Treatment and Titration||201
8113804|NCT03030183|19998074|P1|NOT COMPLETED|Overall Study||0
8113805|NCT03030183|19998074|P1|COMPLETED|Overall Study||3
8113806|NCT03030183|19998074|P1|STARTED|Overall Study||3
8113807|NCT03029988|19998084|P1|NOT COMPLETED|Overall Study||0
8113808|NCT03029988|19998084|P1|COMPLETED|Overall Study||3
8113809|NCT03029988|19998084|P1|STARTED|Overall Study||3
8113810|NCT03029832|19998091|P2|NOT COMPLETED|Overall Study||1
8113811|NCT03029832|19998092|P1|NOT COMPLETED|Overall Study||4
8113812|NCT03029832|19998091|P2|COMPLETED|Overall Study||0
8113813|NCT03029832|19998092|P1|COMPLETED|Overall Study||0
8113814|NCT03029832|19998091|P2|STARTED|Overall Study||1
8113815|NCT03029832|19998092|P1|STARTED|Overall Study||4
8113816|NCT03029819|19998122|P2|NOT COMPLETED|Overall Study||6
8113817|NCT03029819|19998123|P1|NOT COMPLETED|Overall Study||3
8113818|NCT03029819|19998122|P2|COMPLETED|Overall Study||33
8113819|NCT03029819|19998123|P1|COMPLETED|Overall Study||30
8113820|NCT03029819|19998122|P2|STARTED|Overall Study||39
8113821|NCT03029819|19998123|P1|STARTED|Overall Study||33
8113822|NCT03029780|19998137|P2|NOT COMPLETED|Overall Study||11
8113823|NCT03029780|19998138|P1|NOT COMPLETED|Overall Study||6
8113824|NCT03029780|19998137|P2|COMPLETED|Overall Study||41
8113825|NCT03029780|19998138|P1|COMPLETED|Overall Study||46
8113826|NCT03029780|19998137|P2|STARTED|Overall Study||52
8113827|NCT03029780|19998138|P1|STARTED|Overall Study||52
8113828|NCT03029715|19998152|P2|NOT COMPLETED|Overall Study||0
8113829|NCT03029715|19998153|P1|NOT COMPLETED|Overall Study||0
8113830|NCT03029715|19998152|P2|COMPLETED|Overall Study||50
8113831|NCT03029715|19998153|P1|COMPLETED|Overall Study||50
8113832|NCT03029715|19998152|P2|STARTED|Overall Study||50
8113833|NCT03029715|19998153|P1|STARTED|Overall Study||50
8113834|NCT03029650|19998161|P2|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
8113835|NCT03029650|19998162|P1|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
8113836|NCT03029650|19998161|P2|COMPLETED|2nd Intervention (3 - 6 Days)||10
8113837|NCT03029650|19998162|P1|COMPLETED|2nd Intervention (3 - 6 Days)||13
8113838|NCT03029650|19998161|P2|STARTED|2nd Intervention (3 - 6 Days)||10
8113839|NCT03029650|19998162|P1|STARTED|2nd Intervention (3 - 6 Days)||13
8113840|NCT03029650|19998161|P2|NOT COMPLETED|Washout (1 Week)||2
8113841|NCT03029650|19998162|P1|NOT COMPLETED|Washout (1 Week)||1
8113842|NCT03029650|19998161|P2|COMPLETED|Washout (1 Week)||10
8113843|NCT03029650|19998162|P1|COMPLETED|Washout (1 Week)||13
8113844|NCT03029650|19998161|P2|STARTED|Washout (1 Week)||12
8113845|NCT03029650|19998162|P1|STARTED|Washout (1 Week)||14
8113846|NCT03029650|19998161|P2|NOT COMPLETED|First Intervention (3 - 6 Days)||0
8113847|NCT03029650|19998162|P1|NOT COMPLETED|First Intervention (3 - 6 Days)||0
8113848|NCT03029650|19998161|P2|COMPLETED|First Intervention (3 - 6 Days)||12
8113849|NCT03029650|19998162|P1|COMPLETED|First Intervention (3 - 6 Days)||14
8113850|NCT03029650|19998161|P2|STARTED|First Intervention (3 - 6 Days)||12
8113851|NCT03029650|19998162|P1|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
8113852|NCT03029624|19998177|P1|NOT COMPLETED|Overall Study||5
8113853|NCT03029624|19998177|P1|COMPLETED|Overall Study||41
8113854|NCT03029624|19998177|P1|Primary Endpoint (3 Months)|Overall Study||44
8113855|NCT03029624|19998177|P1|STARTED|Overall Study||46
8113860|NCT03029091|19998211|P2|NOT COMPLETED|Overall Study||0
8113861|NCT03029091|19998212|P1|NOT COMPLETED|Overall Study||0
8113862|NCT03029091|19998211|P2|COMPLETED|Overall Study||7
8113863|NCT03029091|19998212|P1|COMPLETED|Overall Study||8
8113864|NCT03029091|19998211|P2|STARTED|Overall Study||7
8113865|NCT03029091|19998212|P1|STARTED|Overall Study||8
8113866|NCT03029000|19998238|P1|NOT COMPLETED|Overall Study||0
8113867|NCT03029000|19998238|P1|COMPLETED|Overall Study||1
8113868|NCT03029000|19998238|P1|STARTED|Overall Study||1
8113869|NCT03028987|19998251|P2|NOT COMPLETED|Overall Study||0
8113870|NCT03028987|19998252|P1|NOT COMPLETED|Overall Study||0
8113871|NCT03028987|19998251|P2|COMPLETED|Overall Study||5
8113872|NCT03028987|19998252|P1|COMPLETED|Overall Study||5
8113873|NCT03028987|19998251|P2|STARTED|Overall Study||5
8113874|NCT03028987|19998252|P1|STARTED|Overall Study||5
8113875|NCT03028974|19998265|P7|NOT COMPLETED|2017-2018||0
8113876|NCT03028974|19998266|P6|NOT COMPLETED|2017-2018||0
8113877|NCT03028974|19998267|P5|NOT COMPLETED|2017-2018||0
8113878|NCT03028974|19998268|P4|NOT COMPLETED|2017-2018||0
8113879|NCT03028974|19998269|P3|NOT COMPLETED|2017-2018||0
8113880|NCT03028974|19998270|P2|NOT COMPLETED|2017-2018||0
8113881|NCT03028974|19998271|P1|NOT COMPLETED|2017-2018||0
8113882|NCT03028974|19998265|P7|COMPLETED|2017-2018||5
8113883|NCT03028974|19998266|P6|COMPLETED|2017-2018||0
8113884|NCT03028974|19998267|P5|COMPLETED|2017-2018||0
8113885|NCT03028974|19998268|P4|COMPLETED|2017-2018||5
8113886|NCT03028974|19998269|P3|COMPLETED|2017-2018||0
8113887|NCT03028974|19998270|P2|COMPLETED|2017-2018||0
8113888|NCT03028974|19998271|P1|COMPLETED|2017-2018||0
8113889|NCT03028974|19998265|P7|STARTED|2017-2018|5 new participants were enrolled.|5
8113890|NCT03028974|19998266|P6|STARTED|2017-2018||0
8113891|NCT03028974|19998267|P5|STARTED|2017-2018||0
8113892|NCT03028974|19998268|P4|STARTED|2017-2018||5
8113893|NCT03028974|19998269|P3|STARTED|2017-2018||0
8113894|NCT03028974|19998270|P2|STARTED|2017-2018||0
8113895|NCT03028974|19998271|P1|STARTED|2017-2018||0
8113896|NCT03028974|19998265|P7|NOT COMPLETED|2016-2017||0
8113897|NCT03028974|19998266|P6|NOT COMPLETED|2016-2017||0
8113898|NCT03028974|19998267|P5|NOT COMPLETED|2016-2017||0
8113899|NCT03028974|19998268|P4|NOT COMPLETED|2016-2017||0
8113900|NCT03028974|19998269|P3|NOT COMPLETED|2016-2017||0
8113901|NCT03028974|19998270|P2|NOT COMPLETED|2016-2017||0
8113902|NCT03028974|19998271|P1|NOT COMPLETED|2016-2017||0
8113903|NCT03028974|19998265|P7|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
8113904|NCT03028974|19998266|P6|COMPLETED|2016-2017||0
8113905|NCT03028974|19998267|P5|COMPLETED|2016-2017|2 participants did not continue to the next period|2
8113906|NCT03028974|19998268|P4|COMPLETED|2016-2017||4
8113907|NCT03028974|19998269|P3|COMPLETED|2016-2017||0
8113908|NCT03028974|19998270|P2|COMPLETED|2016-2017||0
8113909|NCT03028974|19998271|P1|COMPLETED|2016-2017||0
8113910|NCT03028974|19998265|P7|STARTED|2016-2017|18 new participants were enrolled.|18
8113911|NCT03028974|19998266|P6|STARTED|2016-2017||0
8113912|NCT03028974|19998267|P5|STARTED|2016-2017|2 new participants were enrolled.|2
8113913|NCT03028974|19998268|P4|STARTED|2016-2017|1 new participant was enrolled.|4
8113914|NCT03028974|19998269|P3|STARTED|2016-2017||0
8113915|NCT03028974|19998270|P2|STARTED|2016-2017||0
8113916|NCT03028974|19998271|P1|STARTED|2016-2017||0
8113917|NCT03028974|19998265|P7|NOT COMPLETED|2015-2016||0
8113918|NCT03028974|19998266|P6|NOT COMPLETED|2015-2016||0
8113919|NCT03028974|19998267|P5|NOT COMPLETED|2015-2016||0
8113920|NCT03028974|19998268|P4|NOT COMPLETED|2015-2016||0
8113921|NCT03028974|19998269|P3|NOT COMPLETED|2015-2016||0
8113922|NCT03028974|19998270|P2|NOT COMPLETED|2015-2016||0
8113923|NCT03028974|19998271|P1|NOT COMPLETED|2015-2016||0
8113924|NCT03028974|19998265|P7|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
8113925|NCT03028974|19998266|P6|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
8113926|NCT03028974|19998267|P5|COMPLETED|2015-2016||0
8113927|NCT03028974|19998268|P4|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
8113928|NCT03028974|19998269|P3|COMPLETED|2015-2016||0
8113929|NCT03028974|19998270|P2|COMPLETED|2015-2016||0
8113930|NCT03028974|19998271|P1|COMPLETED|2015-2016||0
8113931|NCT03028974|19998265|P7|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
8113932|NCT03028974|19998266|P6|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
8113933|NCT03028974|19998267|P5|STARTED|2015-2016||0
8113934|NCT03028974|19998268|P4|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
8113935|NCT03028974|19998269|P3|STARTED|2015-2016||0
8113936|NCT03028974|19998270|P2|STARTED|2015-2016||0
8113937|NCT03028974|19998271|P1|STARTED|2015-2016||0
8113938|NCT03028974|19998265|P7|NOT COMPLETED|2014-2015||0
8113939|NCT03028974|19998266|P6|NOT COMPLETED|2014-2015||0
8113940|NCT03028974|19998267|P5|NOT COMPLETED|2014-2015||0
8113941|NCT03028974|19998268|P4|NOT COMPLETED|2014-2015||0
8113942|NCT03028974|19998269|P3|NOT COMPLETED|2014-2015||0
8113943|NCT03028974|19998270|P2|NOT COMPLETED|2014-2015||0
8113944|NCT03028974|19998271|P1|NOT COMPLETED|2014-2015||0
8113945|NCT03028974|19998265|P7|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
8113946|NCT03028974|19998266|P6|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
8113947|NCT03028974|19998267|P5|COMPLETED|2014-2015||0
8113948|NCT03028974|19998268|P4|COMPLETED|2014-2015||3
8113949|NCT03028974|19998269|P3|COMPLETED|2014-2015||0
8113950|NCT03028974|19998270|P2|COMPLETED|2014-2015||0
8113951|NCT03028974|19998271|P1|COMPLETED|2014-2015||1
8113952|NCT03028974|19998265|P7|STARTED|2014-2015||13
8113953|NCT03028974|19998266|P6|STARTED|2014-2015||11
8113954|NCT03028974|19998267|P5|STARTED|2014-2015||0
8113955|NCT03028974|19998268|P4|STARTED|2014-2015||3
8113956|NCT03028974|19998269|P3|STARTED|2014-2015||0
8113957|NCT03028974|19998270|P2|STARTED|2014-2015||0
8113958|NCT03028974|19998271|P1|STARTED|2014-2015||1
8113965|NCT03028870|19998307|P4|NOT COMPLETED|Overall Study||9
8113966|NCT03028870|19998308|P3|NOT COMPLETED|Overall Study||16
8113967|NCT03028870|19998309|P2|NOT COMPLETED|Overall Study||10
8113968|NCT03028870|19998310|P1|NOT COMPLETED|Overall Study||17
8113969|NCT03028870|19998307|P4|COMPLETED|Overall Study||65
8113970|NCT03028870|19998308|P3|COMPLETED|Overall Study||60
8113971|NCT03028870|19998309|P2|COMPLETED|Overall Study||57
8113972|NCT03028870|19998310|P1|COMPLETED|Overall Study||57
8113973|NCT03028870|19998307|P4|STARTED|Overall Study||74
8113974|NCT03028870|19998308|P3|STARTED|Overall Study||76
8113975|NCT03028870|19998309|P2|STARTED|Overall Study||67
8113976|NCT03028870|19998310|P1|STARTED|Overall Study||74
8113977|NCT03028636|19998388|P1|NOT COMPLETED|Overall Study||6
8113978|NCT03028636|19998388|P1|COMPLETED|Overall Study||11
8113979|NCT03028636|19998388|P1|STARTED|Overall Study||17
8113980|NCT03028467|19998401|P4|NOT COMPLETED|Overall Study||0
8113981|NCT03028467|19998402|P3|NOT COMPLETED|Overall Study||0
8113982|NCT03028467|19998403|P2|NOT COMPLETED|Overall Study||0
8113983|NCT03028467|19998404|P1|NOT COMPLETED|Overall Study||0
8113984|NCT03028467|19998401|P4|COMPLETED|Overall Study||4
8113985|NCT03028467|19998402|P3|COMPLETED|Overall Study||4
8113986|NCT03028467|19998403|P2|COMPLETED|Overall Study||3
8113987|NCT03028467|19998404|P1|COMPLETED|Overall Study||4
8113988|NCT03028467|19998401|P4|STARTED|Overall Study||4
8113989|NCT03028467|19998402|P3|STARTED|Overall Study||4
8113990|NCT03028467|19998403|P2|STARTED|Overall Study||3
8113991|NCT03028467|19998404|P1|STARTED|Overall Study||4
8113998|NCT03028324|19998479|P1|NOT COMPLETED|Overall Study||0
8113999|NCT03028324|19998479|P1|COMPLETED|Overall Study||4
8114000|NCT03028324|19998479|P1|STARTED|Overall Study||4
8114001|NCT03028220|19998486|P2|NOT COMPLETED|Overall Study||0
8114002|NCT03028220|19998487|P1|NOT COMPLETED|Overall Study||0
8114003|NCT03028220|19998486|P2|COMPLETED|Overall Study||20
8114004|NCT03028220|19998487|P1|COMPLETED|Overall Study||20
8114005|NCT03028220|19998486|P2|STARTED|Overall Study||20
8114006|NCT03028220|19998487|P1|STARTED|Overall Study||20
8114007|NCT03028142|19998515|P6|NOT COMPLETED|Overall Study||1
8114008|NCT03028142|19998516|P5|NOT COMPLETED|Overall Study||1
8114009|NCT03028142|19998517|P4|NOT COMPLETED|Overall Study||0
8114010|NCT03028142|19998518|P3|NOT COMPLETED|Overall Study||0
8114011|NCT03028142|19998519|P2|NOT COMPLETED|Overall Study||1
8114012|NCT03028142|19998520|P1|NOT COMPLETED|Overall Study||1
8114013|NCT03028142|19998515|P6|COMPLETED|Overall Study||3
8114014|NCT03028142|19998516|P5|COMPLETED|Overall Study||5
8114015|NCT03028142|19998517|P4|COMPLETED|Overall Study||4
8114016|NCT03028142|19998518|P3|COMPLETED|Overall Study||6
8114017|NCT03028142|19998519|P2|COMPLETED|Overall Study||4
8114018|NCT03028142|19998520|P1|COMPLETED|Overall Study||4
8114019|NCT03028142|19998515|P6|STARTED|Overall Study||4
8114020|NCT03028142|19998516|P5|STARTED|Overall Study||6
8114021|NCT03028142|19998517|P4|STARTED|Overall Study||4
8114022|NCT03028142|19998518|P3|STARTED|Overall Study||6
8114023|NCT03028142|19998519|P2|STARTED|Overall Study||5
8114024|NCT03028142|19998520|P1|STARTED|Overall Study||5
8114025|NCT03028129|19998539|P2|NOT COMPLETED|Overall Study||87
8114026|NCT03028129|19998540|P1|NOT COMPLETED|Overall Study||126
8114027|NCT03028129|19998539|P2|COMPLETED|Overall Study||122
8114028|NCT03028129|19998540|P1|COMPLETED|Overall Study||132
8114029|NCT03028129|19998539|P2|STARTED|Overall Study||209
8114030|NCT03028129|19998540|P1|STARTED|Overall Study||258
8114037|NCT03028012|19998560|P3|NOT COMPLETED|Overall Study||3
8114038|NCT03028012|19998561|P2|NOT COMPLETED|Overall Study||3
8114039|NCT03028012|19998562|P1|NOT COMPLETED|Overall Study||2
8114040|NCT03028012|19998560|P3|COMPLETED|Overall Study||0
8114041|NCT03028012|19998561|P2|COMPLETED|Overall Study||0
8114042|NCT03028012|19998562|P1|COMPLETED|Overall Study||2
8114043|NCT03028012|19998560|P3|STARTED|Overall Study||3
8114044|NCT03028012|19998561|P2|STARTED|Overall Study||3
8114045|NCT03028012|19998562|P1|STARTED|Overall Study||4
8114046|NCT03027661|19998578|P2|NOT COMPLETED|Overall Study||0
8114047|NCT03027661|19998579|P1|NOT COMPLETED|Overall Study||0
8114048|NCT03027661|19998578|P2|COMPLETED|Overall Study||21
8114049|NCT03027661|19998579|P1|COMPLETED|Overall Study||20
8114050|NCT03027661|19998578|P2|STARTED|Overall Study||21
8114051|NCT03027661|19998579|P1|STARTED|Overall Study||20
8114052|NCT03026803|19998587|P1|NOT COMPLETED|Overall Study||0
8114053|NCT03026803|19998587|P1|COMPLETED|Overall Study||4
8114054|NCT03026803|19998587|P1|STARTED|Overall Study||4
8114055|NCT03026777|19998593|P2|NOT COMPLETED|Overall Study||0
8114056|NCT03026777|19998594|P1|NOT COMPLETED|Overall Study||0
8114057|NCT03026777|19998593|P2|COMPLETED|Overall Study||169
8114058|NCT03026777|19998594|P1|COMPLETED|Overall Study||168
8114059|NCT03026777|19998593|P2|STARTED|Overall Study||169
8114060|NCT03026777|19998594|P1|STARTED|Overall Study||168
8114061|NCT03026556|19998615|P3|NOT COMPLETED|Overall Study||0
8114062|NCT03026556|19998616|P2|NOT COMPLETED|Overall Study||0
8114063|NCT03026556|19998617|P1|NOT COMPLETED|Overall Study||0
8114064|NCT03026556|19998615|P3|COMPLETED|Overall Study||12594
8114065|NCT03026556|19998616|P2|COMPLETED|Overall Study||17177
8114066|NCT03026556|19998617|P1|COMPLETED|Overall Study||12763
8114067|NCT03026556|19998615|P3|STARTED|Overall Study||12594
8114068|NCT03026556|19998616|P2|STARTED|Overall Study||17177
8114069|NCT03026556|19998617|P1|STARTED|Overall Study||12763
8114070|NCT03026530|19998676|P2|NOT COMPLETED|Overall Study||29
8114071|NCT03026530|19998677|P1|NOT COMPLETED|Overall Study||21
8114072|NCT03026530|19998676|P2|COMPLETED|Overall Study||71
8114073|NCT03026530|19998677|P1|COMPLETED|Overall Study||79
8114074|NCT03026530|19998676|P2|STARTED|Overall Study||100
8114075|NCT03026530|19998677|P1|STARTED|Overall Study||100
8114172|NCT03026257|19998713|P6|NOT COMPLETED|Overall Study||0
8114173|NCT03026257|19998714|P5|NOT COMPLETED|Overall Study||1
8114174|NCT03026257|19998715|P4|NOT COMPLETED|Overall Study||1
8114175|NCT03026257|19998716|P3|NOT COMPLETED|Overall Study||0
8114176|NCT03026257|19998717|P2|NOT COMPLETED|Overall Study||1
8114177|NCT03026257|19998718|P1|NOT COMPLETED|Overall Study||6
8114178|NCT03026257|19998713|P6|COMPLETED|Overall Study||46
8114179|NCT03026257|19998714|P5|COMPLETED|Overall Study||22
8114180|NCT03026257|19998715|P4|COMPLETED|Overall Study||24
8114181|NCT03026257|19998716|P3|COMPLETED|Overall Study||34
8114182|NCT03026257|19998717|P2|COMPLETED|Overall Study||63
8114183|NCT03026257|19998718|P1|COMPLETED|Overall Study||54
8114184|NCT03026257|19998713|P6|Treated|Overall Study||47
8114185|NCT03026257|19998714|P5|Treated|Overall Study||23
8114186|NCT03026257|19998715|P4|Treated|Overall Study||24
8114187|NCT03026257|19998716|P3|Treated|Overall Study||35
8114188|NCT03026257|19998717|P2|Treated|Overall Study||65
8114189|NCT03026257|19998718|P1|Treated|Overall Study||58
8114190|NCT03026257|19998713|P6|STARTED|Overall Study||46
8114191|NCT03026257|19998714|P5|STARTED|Overall Study||23
8114192|NCT03026257|19998715|P4|STARTED|Overall Study||25
8114193|NCT03026257|19998716|P3|STARTED|Overall Study||34
8114194|NCT03026257|19998717|P2|STARTED|Overall Study||64
8114195|NCT03026257|19998718|P1|STARTED|Overall Study||60
8114196|NCT03026166|19998734|P2|NOT COMPLETED|Overall Study||12
8114197|NCT03026166|19998735|P1|NOT COMPLETED|Overall Study||30
8114198|NCT03026166|19998734|P2|COMPLETED|Overall Study||0
8114199|NCT03026166|19998735|P1|COMPLETED|Overall Study||0
8114200|NCT03026166|19998734|P2|STARTED|Overall Study||12
8114201|NCT03026166|19998735|P1|STARTED|Overall Study||30
8114202|NCT03026088|19998751|P1|NOT COMPLETED|Overall Study||20
8114203|NCT03026088|19998751|P1|COMPLETED|Overall Study||0
8114204|NCT03026088|19998751|P1|STARTED|Overall Study||20
8114205|NCT03026075|19998775|P1|NOT COMPLETED|Overall Study||1
8114206|NCT03026075|19998775|P1|COMPLETED|Overall Study||46
8114207|NCT03026075|19998775|P1|STARTED|Overall Study||47
8114208|NCT03025945|19998781|P2|NOT COMPLETED|Overall Study||0
8114209|NCT03025945|19998782|P1|NOT COMPLETED|Overall Study||0
8114210|NCT03025945|19998781|P2|COMPLETED|Overall Study||331
8114211|NCT03025945|19998782|P1|COMPLETED|Overall Study||331
8114212|NCT03025945|19998781|P2|STARTED|Overall Study||331
8114213|NCT03025945|19998782|P1|STARTED|Overall Study||331
8114214|NCT03025542|19998790|P2|NOT COMPLETED|Overall Study||2
8114215|NCT03025542|19998791|P1|NOT COMPLETED|Overall Study||2
8114216|NCT03025542|19998790|P2|COMPLETED|Overall Study||15
8114217|NCT03025542|19998791|P1|COMPLETED|Overall Study||30
8114218|NCT03025542|19998790|P2|STARTED|Overall Study||17
8114219|NCT03025542|19998791|P1|STARTED|Overall Study||32
8114220|NCT03025217|19998831|P1|NOT COMPLETED|Overall Study||4
8114221|NCT03025217|19998831|P1|COMPLETED|Overall Study||27
8114222|NCT03025217|19998831|P1|STARTED|Overall Study||31
8114223|NCT03024970|19998836|P2|NOT COMPLETED|Second Intervention||0
8114224|NCT03024970|19998837|P1|NOT COMPLETED|Second Intervention||1
8114225|NCT03024970|19998836|P2|COMPLETED|Second Intervention||38
8114226|NCT03024970|19998837|P1|COMPLETED|Second Intervention||32
8114227|NCT03024970|19998836|P2|STARTED|Second Intervention||38
8114228|NCT03024970|19998837|P1|STARTED|Second Intervention||33
8114229|NCT03024970|19998836|P2|NOT COMPLETED|First Intervention||0
8114230|NCT03024970|19998837|P1|NOT COMPLETED|First Intervention||1
8114231|NCT03024970|19998836|P2|COMPLETED|First Intervention||38
8114232|NCT03024970|19998837|P1|COMPLETED|First Intervention||33
8114233|NCT03024970|19998836|P2|STARTED|First Intervention||38
8114234|NCT03024970|19998837|P1|STARTED|First Intervention||34
8114235|NCT03024606|19998915|P2|NOT COMPLETED|Overall Study||10
8114236|NCT03024606|19998916|P1|NOT COMPLETED|Overall Study||9
8114237|NCT03024606|19998915|P2|COMPLETED|Overall Study||16
8114238|NCT03024606|19998916|P1|COMPLETED|Overall Study||14
8114239|NCT03024606|19998915|P2|STARTED|Overall Study||26
8114240|NCT03024606|19998916|P1|STARTED|Overall Study||23
8114241|NCT03024112|19998924|P2|NOT COMPLETED|Overall Study||0
8114242|NCT03024112|19998925|P1|NOT COMPLETED|Overall Study||7
8114243|NCT03024112|19998924|P2|COMPLETED|Overall Study||26
8114244|NCT03024112|19998925|P1|COMPLETED|Overall Study||18
8114245|NCT03024112|19998924|P2|STARTED|Overall Study||26
8114246|NCT03024112|19998925|P1|STARTED|Overall Study||25
8114247|NCT03023891|19998937|P1|NOT COMPLETED|Overall Study||0
8114248|NCT03023891|19998937|P1|COMPLETED|Overall Study||18
8114249|NCT03023891|19998937|P1|STARTED|Overall Study||18
8114250|NCT03023878|19998944|P1|NOT COMPLETED|Long Term Follow-Up Period||2
8114251|NCT03023878|19998944|P1|COMPLETED|Long Term Follow-Up Period||26
8114252|NCT03023878|19998944|P1|STARTED|Long Term Follow-Up Period||28
8114253|NCT03023878|19998944|P1|NOT COMPLETED|Treatment Period||3
8114254|NCT03023878|19998944|P1|COMPLETED|Treatment Period||25
8114255|NCT03023878|19998944|P1|Started Cycle 2|Treatment Period||11
8114256|NCT03023878|19998944|P1|Started Cycle 1|Treatment Period||28
8114257|NCT03023878|19998944|P1|STARTED|Treatment Period||28
8114258|NCT03023878|19998944|P1|NOT COMPLETED|Between Run-In and Treatment Periods||2
8114259|NCT03023878|19998944|P1|COMPLETED|Between Run-In and Treatment Periods||28
8114260|NCT03023878|19998944|P1|STARTED|Between Run-In and Treatment Periods||30
8114261|NCT03023878|19998944|P1|NOT COMPLETED|Pre-Study Run-In Period||17
8114262|NCT03023878|19998944|P1|COMPLETED|Pre-Study Run-In Period||30
8114263|NCT03023878|19998944|P1|STARTED|Pre-Study Run-In Period||47
8114264|NCT03023722|19998957|P1|NOT COMPLETED|Overall Study||4
8114265|NCT03023722|19998957|P1|COMPLETED|Overall Study||14
8114266|NCT03023722|19998957|P1|STARTED|Overall Study||18
8114267|NCT03023709|19998965|P2|NOT COMPLETED|Overall Study||0
8114268|NCT03023709|19998966|P1|NOT COMPLETED|Overall Study||0
8114269|NCT03023709|19998965|P2|COMPLETED|Overall Study||0
8114270|NCT03023709|19998966|P1|COMPLETED|Overall Study||3
8114271|NCT03023709|19998965|P2|STARTED|Overall Study||0
8114272|NCT03023709|19998966|P1|STARTED|Overall Study||3
8114273|NCT03023683|19998976|P2|NOT COMPLETED|Overall Study||1
8114274|NCT03023683|19998977|P1|NOT COMPLETED|Overall Study||0
8114275|NCT03023683|19998976|P2|COMPLETED|Overall Study||17
8114276|NCT03023683|19998977|P1|COMPLETED|Overall Study||0
8114277|NCT03023683|19998976|P2|STARTED|Overall Study||18
8114278|NCT03023683|19998977|P1|STARTED|Overall Study||0
8114279|NCT03023553|19998987|P2|NOT COMPLETED|Overall Study||1
8114280|NCT03023553|19998988|P1|NOT COMPLETED|Overall Study||0
8114281|NCT03023553|19998987|P2|COMPLETED|Overall Study||8
8114282|NCT03023553|19998988|P1|COMPLETED|Overall Study||4
8114283|NCT03023553|19998987|P2|STARTED|Overall Study||9
8114284|NCT03023553|19998988|P1|STARTED|Overall Study||4
8114285|NCT03023488|19998996|P1|NOT COMPLETED|Overall Study||0
8114286|NCT03023488|19998996|P1|COMPLETED|Overall Study||46
8114287|NCT03023488|19998996|P1|STARTED|Overall Study||46
8114288|NCT03023423|19999012|P3|NOT COMPLETED|Overall Study||46
8114289|NCT03023423|19999013|P2|NOT COMPLETED|Overall Study||46
8114290|NCT03023423|19999014|P1|NOT COMPLETED|Overall Study||7
8114291|NCT03023423|19999012|P3|COMPLETED|Overall Study||0
8114292|NCT03023423|19999013|P2|COMPLETED|Overall Study||0
8114293|NCT03023423|19999014|P1|COMPLETED|Overall Study||0
8114294|NCT03023423|19999012|P3|Crossover From Atezo to Dara + Atezo|Overall Study||0
8114295|NCT03023423|19999013|P2|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8
8114296|NCT03023423|19999014|P1|Crossover From Atezo to Dara + Atezo|Overall Study||0
8114297|NCT03023423|19999012|P3|Treated|Overall Study||44
8114298|NCT03023423|19999013|P2|Treated|Overall Study||44
8114299|NCT03023423|19999014|P1|Treated|Overall Study||7
8114300|NCT03023423|19999012|P3|STARTED|Overall Study||46
8114301|NCT03023423|19999013|P2|STARTED|Overall Study||46
8114302|NCT03023423|19999014|P1|STARTED|Overall Study||7
8114303|NCT03023176|19999044|P1|NOT COMPLETED|Overall Study||0
8114304|NCT03023176|19999044|P1|COMPLETED|Overall Study||20
8114305|NCT03023176|19999044|P1|STARTED|Overall Study||20
8114306|NCT03023137|19999051|P2|NOT COMPLETED|Overall Study||9
8114307|NCT03023137|19999052|P1|NOT COMPLETED|Overall Study||4
8114308|NCT03023137|19999051|P2|COMPLETED|Overall Study||162
8114309|NCT03023137|19999052|P1|COMPLETED|Overall Study||174
8114310|NCT03023137|19999051|P2|STARTED|Overall Study||171
8114311|NCT03023137|19999052|P1|STARTED|Overall Study||178
8114312|NCT03022981|19999081|P3|NOT COMPLETED|Overall Study||6
8114313|NCT03022981|19999082|P2|NOT COMPLETED|Overall Study||4
8114314|NCT03022981|19999083|P1|NOT COMPLETED|Overall Study||6
8114315|NCT03022981|19999081|P3|COMPLETED|Overall Study||35
8114316|NCT03022981|19999082|P2|COMPLETED|Overall Study||69
8114317|NCT03022981|19999083|P1|COMPLETED|Overall Study||96
8114318|NCT03022981|19999081|P3|Participated in PK Lead-in (PKL) Phase|Overall Study|All 19 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|19
8114319|NCT03022981|19999082|P2|Participated in PK Lead-in (PKL) Phase|Overall Study|All 20 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|20
8114320|NCT03022981|19999083|P1|Participated in PK Lead-in (PKL) Phase|Overall Study|All 17 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|17
8114321|NCT03022981|19999081|P3|STARTED|Overall Study||41
8114322|NCT03022981|19999082|P2|STARTED|Overall Study||73
8114323|NCT03022981|19999083|P1|STARTED|Overall Study||102
8114324|NCT03022916|19999159|P4|NOT COMPLETED|Overall Study||0
8114325|NCT03022916|19999160|P3|NOT COMPLETED|Overall Study||0
8114326|NCT03022916|19999161|P2|NOT COMPLETED|Overall Study||0
8114327|NCT03022916|19999162|P1|NOT COMPLETED|Overall Study||0
8114328|NCT03022916|19999159|P4|COMPLETED|Overall Study||5
8114329|NCT03022916|19999160|P3|COMPLETED|Overall Study||5
8114330|NCT03022916|19999161|P2|COMPLETED|Overall Study||5
8114331|NCT03022916|19999162|P1|COMPLETED|Overall Study||5
8114332|NCT03022916|19999159|P4|Nail Polish, Top Coat|Overall Study||5
8114333|NCT03022916|19999160|P3|Nail Polish, Top Coat|Overall Study||5
8114334|NCT03022916|19999161|P2|Nail Polish, Top Coat|Overall Study||5
8114335|NCT03022916|19999162|P1|Nail Polish, Top Coat|Overall Study||5
8114336|NCT03022916|19999159|P4|Nail Polish, Base Coat|Overall Study||5
8114337|NCT03022916|19999160|P3|Nail Polish, Base Coat|Overall Study||5
8114338|NCT03022916|19999161|P2|Nail Polish, Base Coat|Overall Study||5
8114339|NCT03022916|19999162|P1|Nail Polish, Base Coat|Overall Study||5
8114340|NCT03022916|19999159|P4|Nail Polish|Overall Study||5
8114341|NCT03022916|19999160|P3|Nail Polish|Overall Study||5
8114342|NCT03022916|19999161|P2|Nail Polish|Overall Study||5
8114343|NCT03022916|19999162|P1|Nail Polish|Overall Study||5
8114344|NCT03022916|19999159|P4|STARTED|Overall Study||5
8114345|NCT03022916|19999160|P3|STARTED|Overall Study||5
8114346|NCT03022916|19999161|P2|STARTED|Overall Study||5
8114347|NCT03022916|19999162|P1|STARTED|Overall Study||5
8114348|NCT03022799|19999182|P13|NOT COMPLETED|Overall Study||0
8114349|NCT03022799|19999183|P12|NOT COMPLETED|Overall Study||0
8114350|NCT03022799|19999184|P11|NOT COMPLETED|Overall Study||1
8114351|NCT03022799|19999185|P10|NOT COMPLETED|Overall Study||1
8114352|NCT03022799|19999186|P9|NOT COMPLETED|Overall Study||0
8114353|NCT03022799|19999187|P8|NOT COMPLETED|Overall Study||0
8114354|NCT03022799|19999188|P7|NOT COMPLETED|Overall Study||0
8114355|NCT03022799|19999189|P6|NOT COMPLETED|Overall Study||0
8114356|NCT03022799|19999190|P5|NOT COMPLETED|Overall Study||0
8114357|NCT03022799|19999191|P4|NOT COMPLETED|Overall Study||0
8114358|NCT03022799|19999192|P3|NOT COMPLETED|Overall Study||0
8114359|NCT03022799|19999193|P2|NOT COMPLETED|Overall Study||0
8114360|NCT03022799|19999194|P1|NOT COMPLETED|Overall Study||0
8114361|NCT03022799|19999182|P13|COMPLETED|Overall Study||10
8114362|NCT03022799|19999183|P12|COMPLETED|Overall Study||6
8114363|NCT03022799|19999184|P11|COMPLETED|Overall Study||5
8114364|NCT03022799|19999185|P10|COMPLETED|Overall Study||5
8114365|NCT03022799|19999186|P9|COMPLETED|Overall Study||6
8114366|NCT03022799|19999187|P8|COMPLETED|Overall Study||6
8114367|NCT03022799|19999188|P7|COMPLETED|Overall Study||12
8114368|NCT03022799|19999189|P6|COMPLETED|Overall Study||6
8114369|NCT03022799|19999190|P5|COMPLETED|Overall Study||6
8114370|NCT03022799|19999191|P4|COMPLETED|Overall Study||6
8114371|NCT03022799|19999192|P3|COMPLETED|Overall Study||6
8114372|NCT03022799|19999193|P2|COMPLETED|Overall Study||6
8114373|NCT03022799|19999194|P1|COMPLETED|Overall Study||6
8114374|NCT03022799|19999182|P13|STARTED|Overall Study||10
8114375|NCT03022799|19999183|P12|STARTED|Overall Study||6
8114376|NCT03022799|19999184|P11|STARTED|Overall Study||6
8114377|NCT03022799|19999185|P10|STARTED|Overall Study||6
8114378|NCT03022799|19999186|P9|STARTED|Overall Study||6
8114379|NCT03022799|19999187|P8|STARTED|Overall Study||6
8114380|NCT03022799|19999188|P7|STARTED|Overall Study||12
8114381|NCT03022799|19999189|P6|STARTED|Overall Study||6
8114382|NCT03022799|19999190|P5|STARTED|Overall Study||6
8114383|NCT03022799|19999191|P4|STARTED|Overall Study||6
8114384|NCT03022799|19999192|P3|STARTED|Overall Study||6
8114385|NCT03022799|19999193|P2|STARTED|Overall Study||6
8114386|NCT03022799|19999194|P1|STARTED|Overall Study||6
8114387|NCT03022630|19999391|P2|NOT COMPLETED|Overall Study||12
8114388|NCT03022630|19999392|P1|NOT COMPLETED|Overall Study||9
8114389|NCT03022630|19999391|P2|COMPLETED|Overall Study||20
8114390|NCT03022630|19999392|P1|COMPLETED|Overall Study||22
8114391|NCT03022630|19999391|P2|STARTED|Overall Study||32
8114392|NCT03022630|19999392|P1|STARTED|Overall Study||31
8114393|NCT03022526|19999442|P2|NOT COMPLETED|Overall Study||5
8114394|NCT03022526|19999443|P1|NOT COMPLETED|Overall Study||10
8114395|NCT03022526|19999442|P2|COMPLETED|Overall Study||25
8114396|NCT03022526|19999443|P1|COMPLETED|Overall Study||21
8114397|NCT03022526|19999442|P2|STARTED|Overall Study||30
8114398|NCT03022526|19999443|P1|STARTED|Overall Study||31
8114399|NCT03022435|19999482|P5|NOT COMPLETED|Overall Study||0
8114400|NCT03022435|19999483|P4|NOT COMPLETED|Overall Study||0
8114401|NCT03022435|19999484|P3|NOT COMPLETED|Overall Study||0
8114402|NCT03022435|19999485|P2|NOT COMPLETED|Overall Study||0
8114403|NCT03022435|19999486|P1|NOT COMPLETED|Overall Study||0
8114404|NCT03022435|19999482|P5|COMPLETED|Overall Study||3
8114405|NCT03022435|19999483|P4|COMPLETED|Overall Study||3
8114406|NCT03022435|19999484|P3|COMPLETED|Overall Study||6
8114407|NCT03022435|19999485|P2|COMPLETED|Overall Study||5
8114408|NCT03022435|19999486|P1|COMPLETED|Overall Study||5
8114409|NCT03022435|19999482|P5|STARTED|Overall Study||3
8114410|NCT03022435|19999483|P4|STARTED|Overall Study||3
8114411|NCT03022435|19999484|P3|STARTED|Overall Study||6
8114412|NCT03022435|19999485|P2|STARTED|Overall Study||5
8114413|NCT03022435|19999486|P1|STARTED|Overall Study||5
8114414|NCT03022422|19999509|P6|NOT COMPLETED|Overall Study||0
8114415|NCT03022422|19999510|P5|NOT COMPLETED|Overall Study||0
8114416|NCT03022422|19999511|P4|NOT COMPLETED|Overall Study||0
8114417|NCT03022422|19999512|P3|NOT COMPLETED|Overall Study||3
8114418|NCT03022422|19999513|P2|NOT COMPLETED|Overall Study||0
8114419|NCT03022422|19999514|P1|NOT COMPLETED|Overall Study||0
8114420|NCT03022422|19999509|P6|COMPLETED|Overall Study||5
8114421|NCT03022422|19999510|P5|COMPLETED|Overall Study||5
8114422|NCT03022422|19999511|P4|COMPLETED|Overall Study||12
8114423|NCT03022422|19999512|P3|COMPLETED|Overall Study||20
8114424|NCT03022422|19999513|P2|COMPLETED|Overall Study||10
8114425|NCT03022422|19999514|P1|COMPLETED|Overall Study||8
8114426|NCT03022422|19999509|P6|STARTED|Overall Study||5
8114427|NCT03022422|19999510|P5|STARTED|Overall Study||5
8114428|NCT03022422|19999511|P4|STARTED|Overall Study||12
8114429|NCT03022422|19999512|P3|STARTED|Overall Study||23
8114430|NCT03022422|19999513|P2|STARTED|Overall Study||10
8114431|NCT03022422|19999514|P1|STARTED|Overall Study||8
8114432|NCT03022396|19999540|P6|NOT COMPLETED|Overall Study||0
8114433|NCT03022396|19999541|P5|NOT COMPLETED|Overall Study||0
8114434|NCT03022396|19999542|P4|NOT COMPLETED|Overall Study||0
8114435|NCT03022396|19999543|P3|NOT COMPLETED|Overall Study||0
8114436|NCT03022396|19999544|P2|NOT COMPLETED|Overall Study||0
8114437|NCT03022396|19999545|P1|NOT COMPLETED|Overall Study||0
8114438|NCT03022396|19999540|P6|COMPLETED|Overall Study||8
8114439|NCT03022396|19999541|P5|COMPLETED|Overall Study||14
8114440|NCT03022396|19999542|P4|COMPLETED|Overall Study||20
8114441|NCT03022396|19999543|P3|COMPLETED|Overall Study||10
8114442|NCT03022396|19999544|P2|COMPLETED|Overall Study||14
8114443|NCT03022396|19999545|P1|COMPLETED|Overall Study||16
8114444|NCT03022396|19999540|P6|STARTED|Overall Study||8
8114445|NCT03022396|19999541|P5|STARTED|Overall Study||14
8114446|NCT03022396|19999542|P4|STARTED|Overall Study||20
8114447|NCT03022396|19999543|P3|STARTED|Overall Study||10
8114448|NCT03022396|19999544|P2|STARTED|Overall Study||14
8114449|NCT03022396|19999545|P1|STARTED|Overall Study||16
8114450|NCT03022370|19999569|P2|NOT COMPLETED|Overall Study||121
8114451|NCT03022370|19999570|P1|NOT COMPLETED|Overall Study||180
8114452|NCT03022370|19999569|P2|COMPLETED|Overall Study||553
8114453|NCT03022370|19999570|P1|COMPLETED|Overall Study||497
8114454|NCT03022370|19999569|P2|STARTED|Overall Study||674
8114455|NCT03022370|19999570|P1|STARTED|Overall Study||677
8114456|NCT03022084|19999646|P2|NOT COMPLETED|Overall Study||3
8114457|NCT03022084|19999647|P1|NOT COMPLETED|Overall Study||2
8114458|NCT03022084|19999646|P2|COMPLETED|Overall Study||29
8114459|NCT03022084|19999647|P1|COMPLETED|Overall Study||27
8114460|NCT03022084|19999646|P2|STARTED|Overall Study||32
8114461|NCT03022084|19999647|P1|STARTED|Overall Study||29
8114462|NCT03022045|19999655|P2|NOT COMPLETED|Overall Study||2
8114463|NCT03022045|19999656|P1|NOT COMPLETED|Overall Study||1
8114464|NCT03022045|19999655|P2|COMPLETED|Overall Study||6
8114465|NCT03022045|19999656|P1|COMPLETED|Overall Study||8
8114466|NCT03022045|19999655|P2|STARTED|Overall Study||8
8114467|NCT03022045|19999656|P1|STARTED|Overall Study||9
8114468|NCT03021759|19999673|P3|NOT COMPLETED|Overall Study||0
8114469|NCT03021759|19999674|P2|NOT COMPLETED|Overall Study||0
8114470|NCT03021759|19999675|P1|NOT COMPLETED|Overall Study||0
8114471|NCT03021759|19999673|P3|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465
8114472|NCT03021759|19999674|P2|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743
8114473|NCT03021759|19999675|P1|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566
8114474|NCT03021759|19999673|P3|STARTED|Overall Study||1465
8114475|NCT03021759|19999674|P2|STARTED|Overall Study||1743
8114476|NCT03021759|19999675|P1|STARTED|Overall Study||1566
8114477|NCT03021668|19999685|P2|NOT COMPLETED|Overall Study||1
8114478|NCT03021668|19999686|P1|NOT COMPLETED|Overall Study||0
8114479|NCT03021668|19999685|P2|COMPLETED|Overall Study||61
8114480|NCT03021668|19999686|P1|COMPLETED|Overall Study||62
8114481|NCT03021668|19999685|P2|STARTED|Overall Study||62
8114482|NCT03021668|19999686|P1|STARTED|Overall Study||62
8114483|NCT03021642|19999698|P2|NOT COMPLETED|Treatment Period 2 (Day 22)||0
8114484|NCT03021642|19999699|P1|NOT COMPLETED|Treatment Period 2 (Day 22)||0
8114485|NCT03021642|19999698|P2|COMPLETED|Treatment Period 2 (Day 22)||11
8114486|NCT03021642|19999699|P1|COMPLETED|Treatment Period 2 (Day 22)||11
8114487|NCT03021642|19999698|P2|STARTED|Treatment Period 2 (Day 22)||11
8114488|NCT03021642|19999699|P1|STARTED|Treatment Period 2 (Day 22)||11
8114489|NCT03021642|19999698|P2|NOT COMPLETED|Washout Period (21 Days)||1
8114490|NCT03021642|19999699|P1|NOT COMPLETED|Washout Period (21 Days)||1
8114491|NCT03021642|19999698|P2|COMPLETED|Washout Period (21 Days)||11
8114492|NCT03021642|19999699|P1|COMPLETED|Washout Period (21 Days)||11
8114493|NCT03021642|19999698|P2|STARTED|Washout Period (21 Days)||12
8114494|NCT03021642|19999699|P1|STARTED|Washout Period (21 Days)||12
8114495|NCT03021642|19999698|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8114496|NCT03021642|19999699|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8114497|NCT03021642|19999698|P2|COMPLETED|Treatment Period 1 (Day 1)||12
8114498|NCT03021642|19999699|P1|COMPLETED|Treatment Period 1 (Day 1)||12
8114499|NCT03021642|19999698|P2|STARTED|Treatment Period 1 (Day 1)||12
8114500|NCT03021642|19999699|P1|STARTED|Treatment Period 1 (Day 1)||12
8114501|NCT03021564|19999739|P2|NOT COMPLETED|Overall Study||468
8114502|NCT03021564|19999740|P1|NOT COMPLETED|Overall Study||84
8114503|NCT03021564|19999739|P2|COMPLETED|Overall Study||89
8114504|NCT03021564|19999740|P1|COMPLETED|Overall Study||36
8114505|NCT03021564|19999739|P2|STARTED|Overall Study||557
8114506|NCT03021564|19999740|P1|STARTED|Overall Study||120
8114507|NCT03021538|19999766|P2|NOT COMPLETED|Overall Study||0
8114508|NCT03021538|19999767|P1|NOT COMPLETED|Overall Study||0
8114509|NCT03021538|19999766|P2|COMPLETED|Overall Study||7
8114510|NCT03021538|19999767|P1|COMPLETED|Overall Study||6
8114511|NCT03021538|19999766|P2|STARTED|Overall Study||7
8114512|NCT03021538|19999767|P1|STARTED|Overall Study||6
8114513|NCT03021343|19999775|P2|NOT COMPLETED|Overall Study||7
8114514|NCT03021343|19999776|P1|NOT COMPLETED|Overall Study||5
8114515|NCT03021343|19999775|P2|COMPLETED|Overall Study||174
8114516|NCT03021343|19999776|P1|COMPLETED|Overall Study||174
8114517|NCT03021343|19999775|P2|STARTED|Overall Study||181
8114518|NCT03021343|19999776|P1|STARTED|Overall Study||179
8114519|NCT03021304|19999784|P1|NOT COMPLETED|Overall Study||1
8114520|NCT03021304|19999784|P1|COMPLETED|Overall Study||55
8114521|NCT03021304|19999784|P1|STARTED|Overall Study||56
8114522|NCT03021265|19999789|P1|NOT COMPLETED|Overall Study||122
8114523|NCT03021265|19999789|P1|COMPLETED|Overall Study||554
8114524|NCT03021265|19999789|P1|STARTED|Overall Study||676
8114525|NCT03021187|19999799|P4|NOT COMPLETED|Overall Study||9
8114526|NCT03021187|19999800|P3|NOT COMPLETED|Overall Study||6
8114527|NCT03021187|19999801|P2|NOT COMPLETED|Overall Study||9
8114528|NCT03021187|19999802|P1|NOT COMPLETED|Overall Study||10
8114529|NCT03021187|19999799|P4|COMPLETED|Overall Study||175
8114530|NCT03021187|19999800|P3|COMPLETED|Overall Study||175
8114531|NCT03021187|19999801|P2|COMPLETED|Overall Study||173
8114532|NCT03021187|19999802|P1|COMPLETED|Overall Study||174
8114533|NCT03021187|19999799|P4|Safety Analysis Set (SAS)|Overall Study||184
8114534|NCT03021187|19999800|P3|Safety Analysis Set (SAS)|Overall Study||181
8114535|NCT03021187|19999801|P2|Safety Analysis Set (SAS)|Overall Study||181
8114536|NCT03021187|19999802|P1|Safety Analysis Set (SAS)|Overall Study||184
8114537|NCT03021187|19999799|P4|Full Analysis Set (FAS)|Overall Study||184
8114538|NCT03021187|19999800|P3|Full Analysis Set (FAS)|Overall Study||181
8114539|NCT03021187|19999801|P2|Full Analysis Set (FAS)|Overall Study||182
8114540|NCT03021187|19999802|P1|Full Analysis Set (FAS)|Overall Study||184
8114541|NCT03021187|19999799|P4|Exposed|Overall Study||184
8114542|NCT03021187|19999800|P3|Exposed|Overall Study||181
8114543|NCT03021187|19999801|P2|Exposed|Overall Study||181
8114544|NCT03021187|19999802|P1|Exposed|Overall Study||184
8114545|NCT03021187|19999799|P4|STARTED|Overall Study||184
8114546|NCT03021187|19999800|P3|STARTED|Overall Study||181
8114547|NCT03021187|19999801|P2|STARTED|Overall Study||182
8114548|NCT03021187|19999802|P1|STARTED|Overall Study||184
8114549|NCT03021018|19999958|P3|NOT COMPLETED|Overall Study||0
8114550|NCT03021018|19999959|P2|NOT COMPLETED|Overall Study||0
8114551|NCT03021018|19999960|P1|NOT COMPLETED|Overall Study||2
8114552|NCT03021018|19999958|P3|COMPLETED|Overall Study||15
8114553|NCT03021018|19999959|P2|COMPLETED|Overall Study||15
8114554|NCT03021018|19999960|P1|COMPLETED|Overall Study||14
8114555|NCT03021018|19999958|P3|STARTED|Overall Study||15
8114556|NCT03021018|19999959|P2|STARTED|Overall Study||15
8114557|NCT03021018|19999960|P1|STARTED|Overall Study||16
8114558|NCT03021005|19999991|P2|NOT COMPLETED|Overall Study||26
8114559|NCT03021005|19999992|P1|NOT COMPLETED|Overall Study||39
8114560|NCT03021005|19999991|P2|COMPLETED|Overall Study||72
8114561|NCT03021005|19999992|P1|COMPLETED|Overall Study||63
8114562|NCT03021005|19999991|P2|STARTED|Overall Study||98
8114563|NCT03021005|19999992|P1|STARTED|Overall Study||102
8114570|NCT03020745|20000052|P10|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114571|NCT03020745|20000053|P9|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||3
8114572|NCT03020745|20000054|P8|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114573|NCT03020745|20000055|P7|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114574|NCT03020745|20000056|P6|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||1
8114575|NCT03020745|20000057|P5|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114576|NCT03020745|20000058|P4|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114577|NCT03020745|20000059|P3|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114578|NCT03020745|20000060|P2|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114579|NCT03020745|20000061|P1|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114580|NCT03020745|20000052|P10|COMPLETED|Part 2:Optional FU (Up to 450 Days)||15
8114581|NCT03020745|20000053|P9|COMPLETED|Part 2:Optional FU (Up to 450 Days)||10
8114582|NCT03020745|20000054|P8|COMPLETED|Part 2:Optional FU (Up to 450 Days)||17
8114583|NCT03020745|20000055|P7|COMPLETED|Part 2:Optional FU (Up to 450 Days)||5
8114584|NCT03020745|20000056|P6|COMPLETED|Part 2:Optional FU (Up to 450 Days)||9
8114585|NCT03020745|20000057|P5|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114586|NCT03020745|20000058|P4|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114587|NCT03020745|20000059|P3|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114588|NCT03020745|20000060|P2|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114589|NCT03020745|20000061|P1|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
8114590|NCT03020745|20000052|P10|STARTED|Part 2:Optional FU (Up to 450 Days)||15
8114591|NCT03020745|20000053|P9|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant did not enter into optional follow-up period|13
8114592|NCT03020745|20000054|P8|STARTED|Part 2:Optional FU (Up to 450 Days)|2 participants didn't enter into optional follow-up period.|17
8114593|NCT03020745|20000055|P7|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant didn't enter into optional follow-up period.|5
8114594|NCT03020745|20000056|P6|STARTED|Part 2:Optional FU (Up to 450 Days)||10
8114595|NCT03020745|20000057|P5|STARTED|Part 2:Optional FU (Up to 450 Days)||0
8114596|NCT03020745|20000058|P4|STARTED|Part 2:Optional FU (Up to 450 Days)||0
8114597|NCT03020745|20000059|P3|STARTED|Part 2:Optional FU (Up to 450 Days)||0
8114598|NCT03020745|20000060|P2|STARTED|Part 2:Optional FU (Up to 450 Days)||0
8114599|NCT03020745|20000061|P1|STARTED|Part 2:Optional FU (Up to 450 Days)||0
8114600|NCT03020745|20000052|P10|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114601|NCT03020745|20000053|P9|NOT COMPLETED|Part 2 (Up to 169 Days)||1
8114602|NCT03020745|20000054|P8|NOT COMPLETED|Part 2 (Up to 169 Days)||1
8114603|NCT03020745|20000055|P7|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114604|NCT03020745|20000056|P6|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114605|NCT03020745|20000057|P5|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114606|NCT03020745|20000058|P4|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114607|NCT03020745|20000059|P3|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114608|NCT03020745|20000060|P2|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114609|NCT03020745|20000061|P1|NOT COMPLETED|Part 2 (Up to 169 Days)||0
8114610|NCT03020745|20000052|P10|COMPLETED|Part 2 (Up to 169 Days)||15
8114611|NCT03020745|20000053|P9|COMPLETED|Part 2 (Up to 169 Days)||14
8114612|NCT03020745|20000054|P8|COMPLETED|Part 2 (Up to 169 Days)||19
8114613|NCT03020745|20000055|P7|COMPLETED|Part 2 (Up to 169 Days)||6
8114614|NCT03020745|20000056|P6|COMPLETED|Part 2 (Up to 169 Days)||10
8114615|NCT03020745|20000057|P5|COMPLETED|Part 2 (Up to 169 Days)||0
8114616|NCT03020745|20000058|P4|COMPLETED|Part 2 (Up to 169 Days)||0
8114617|NCT03020745|20000059|P3|COMPLETED|Part 2 (Up to 169 Days)||0
8114618|NCT03020745|20000060|P2|COMPLETED|Part 2 (Up to 169 Days)||0
8114619|NCT03020745|20000061|P1|COMPLETED|Part 2 (Up to 169 Days)||0
8114620|NCT03020745|20000052|P10|STARTED|Part 2 (Up to 169 Days)||15
8114621|NCT03020745|20000053|P9|STARTED|Part 2 (Up to 169 Days)||15
8114622|NCT03020745|20000054|P8|STARTED|Part 2 (Up to 169 Days)||20
8114623|NCT03020745|20000055|P7|STARTED|Part 2 (Up to 169 Days)||6
8114624|NCT03020745|20000056|P6|STARTED|Part 2 (Up to 169 Days)||10
8114625|NCT03020745|20000057|P5|STARTED|Part 2 (Up to 169 Days)||0
8114626|NCT03020745|20000058|P4|STARTED|Part 2 (Up to 169 Days)||0
8114627|NCT03020745|20000059|P3|STARTED|Part 2 (Up to 169 Days)||0
8114628|NCT03020745|20000060|P2|STARTED|Part 2 (Up to 169 Days)||0
8114629|NCT03020745|20000061|P1|STARTED|Part 2 (Up to 169 Days)||0
8114630|NCT03020745|20000052|P10|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114631|NCT03020745|20000053|P9|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114632|NCT03020745|20000054|P8|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114633|NCT03020745|20000055|P7|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114634|NCT03020745|20000056|P6|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114635|NCT03020745|20000057|P5|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114636|NCT03020745|20000058|P4|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114637|NCT03020745|20000059|P3|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114638|NCT03020745|20000060|P2|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114639|NCT03020745|20000061|P1|NOT COMPLETED|Part 1 (Up to 60 Days)||0
8114640|NCT03020745|20000052|P10|COMPLETED|Part 1 (Up to 60 Days)||0
8114641|NCT03020745|20000053|P9|COMPLETED|Part 1 (Up to 60 Days)||0
8114642|NCT03020745|20000054|P8|COMPLETED|Part 1 (Up to 60 Days)||0
8114643|NCT03020745|20000055|P7|COMPLETED|Part 1 (Up to 60 Days)||0
8114644|NCT03020745|20000056|P6|COMPLETED|Part 1 (Up to 60 Days)||0
8114645|NCT03020745|20000057|P5|COMPLETED|Part 1 (Up to 60 Days)||0
8114646|NCT03020745|20000058|P4|COMPLETED|Part 1 (Up to 60 Days)||6
8114647|NCT03020745|20000059|P3|COMPLETED|Part 1 (Up to 60 Days)||0
8114648|NCT03020745|20000060|P2|COMPLETED|Part 1 (Up to 60 Days)||3
8114649|NCT03020745|20000061|P1|COMPLETED|Part 1 (Up to 60 Days)||3
8114650|NCT03020745|20000052|P10|STARTED|Part 1 (Up to 60 Days)||0
8114651|NCT03020745|20000053|P9|STARTED|Part 1 (Up to 60 Days)||0
8114652|NCT03020745|20000054|P8|STARTED|Part 1 (Up to 60 Days)||0
8114653|NCT03020745|20000055|P7|STARTED|Part 1 (Up to 60 Days)||0
8114654|NCT03020745|20000056|P6|STARTED|Part 1 (Up to 60 Days)||0
8114655|NCT03020745|20000057|P5|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
8114656|NCT03020745|20000058|P4|STARTED|Part 1 (Up to 60 Days)||6
8114657|NCT03020745|20000059|P3|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
8114658|NCT03020745|20000060|P2|STARTED|Part 1 (Up to 60 Days)||3
8114659|NCT03020745|20000061|P1|STARTED|Part 1 (Up to 60 Days)||3
8114660|NCT03020719|20000401|P2|NOT COMPLETED|Overall Study||2
8114661|NCT03020719|20000402|P1|NOT COMPLETED|Overall Study||0
8114662|NCT03020719|20000401|P2|COMPLETED|Overall Study||28
8114663|NCT03020719|20000402|P1|COMPLETED|Overall Study||30
8114664|NCT03020719|20000401|P2|STARTED|Overall Study||30
8114665|NCT03020719|20000402|P1|STARTED|Overall Study||30
8114666|NCT03020576|20000422|P2|NOT COMPLETED|Overall Study||2
8114667|NCT03020576|20000423|P1|NOT COMPLETED|Overall Study||1
8114668|NCT03020576|20000422|P2|COMPLETED|Overall Study||14
8114669|NCT03020576|20000423|P1|COMPLETED|Overall Study||14
8114670|NCT03020576|20000422|P2|STARTED|Overall Study||16
8114671|NCT03020576|20000423|P1|STARTED|Overall Study||15
8114672|NCT03020550|20000445|P2|NOT COMPLETED|Overall Study||0
8114673|NCT03020550|20000446|P1|NOT COMPLETED|Overall Study||0
8114674|NCT03020550|20000445|P2|COMPLETED|Overall Study||16
8114675|NCT03020550|20000446|P1|COMPLETED|Overall Study||8
8114676|NCT03020550|20000445|P2|STARTED|Overall Study||16
8114677|NCT03020550|20000446|P1|STARTED|Overall Study||8
8114678|NCT03020537|20000462|P2|NOT COMPLETED|Overall Study||0
8114679|NCT03020537|20000463|P1|NOT COMPLETED|Overall Study||0
8114680|NCT03020537|20000462|P2|COMPLETED|Overall Study||7
8114681|NCT03020537|20000463|P1|COMPLETED|Overall Study||1
8114682|NCT03020537|20000462|P2|STARTED|Overall Study||7
8114683|NCT03020537|20000463|P1|STARTED|Overall Study||1
8114684|NCT03020524|20000474|P3|NOT COMPLETED|Overall Study||0
8114685|NCT03020524|20000475|P2|NOT COMPLETED|Overall Study||0
8114686|NCT03020524|20000476|P1|NOT COMPLETED|Overall Study||0
8114687|NCT03020524|20000474|P3|COMPLETED|Overall Study||3
8114688|NCT03020524|20000475|P2|COMPLETED|Overall Study||3
8114689|NCT03020524|20000476|P1|COMPLETED|Overall Study||3
8114690|NCT03020524|20000474|P3|STARTED|Overall Study||3
8114691|NCT03020524|20000475|P2|STARTED|Overall Study||3
8114692|NCT03020524|20000476|P1|STARTED|Overall Study||3
8114693|NCT03020498|20000487|P3|NOT COMPLETED|Overall Study||0
8114694|NCT03020498|20000488|P2|NOT COMPLETED|Overall Study||3
8114695|NCT03020498|20000489|P1|NOT COMPLETED|Overall Study||0
8114696|NCT03020498|20000487|P3|COMPLETED|Overall Study||36
8114697|NCT03020498|20000488|P2|COMPLETED|Overall Study||38
8114698|NCT03020498|20000489|P1|COMPLETED|Overall Study||14
8114699|NCT03020498|20000487|P3|STARTED|Overall Study||36
8114700|NCT03020498|20000488|P2|STARTED|Overall Study||41
8114701|NCT03020498|20000489|P1|STARTED|Overall Study||14
8114702|NCT03020472|20000500|P1|NOT COMPLETED|Overall Study||0
8114703|NCT03020472|20000500|P1|COMPLETED|Overall Study||6
8114704|NCT03020472|20000500|P1|STARTED|Overall Study||6
8114705|NCT03020446|20000506|P1|NOT COMPLETED|Overall Study||3
8114706|NCT03020446|20000506|P1|COMPLETED|Overall Study||0
8114707|NCT03020446|20000506|P1|STARTED|Overall Study||3
8114716|NCT03020095|20000568|P1|NOT COMPLETED|Overall Study||1
8114717|NCT03020095|20000568|P1|COMPLETED|Overall Study||37
8114718|NCT03020095|20000568|P1|STARTED|Overall Study||38
8114719|NCT03020069|20000574|P2|NOT COMPLETED|Overall Study||1
8114720|NCT03020069|20000575|P1|NOT COMPLETED|Overall Study||0
8114721|NCT03020069|20000574|P2|COMPLETED|Overall Study||3
8114722|NCT03020069|20000575|P1|COMPLETED|Overall Study||9
8114723|NCT03020069|20000574|P2|STARTED|Overall Study||4
8114724|NCT03020069|20000575|P1|STARTED|Overall Study||9
8114725|NCT03020004|20000587|P1|NOT COMPLETED|Overall Study||1
8114726|NCT03020004|20000587|P1|COMPLETED|Overall Study||69
8114727|NCT03020004|20000587|P1|STARTED|Overall Study||70
8114728|NCT03019783|20000593|P2|NOT COMPLETED|Overall Study||0
8114729|NCT03019783|20000594|P1|NOT COMPLETED|Overall Study||0
8114730|NCT03019783|20000593|P2|COMPLETED|Overall Study||31
8114731|NCT03019783|20000594|P1|COMPLETED|Overall Study||29
8114732|NCT03019783|20000593|P2|STARTED|Overall Study||31
8114733|NCT03019783|20000594|P1|STARTED|Overall Study||29
8114734|NCT03019744|20000604|P2|NOT COMPLETED|Overall Study||8
8114735|NCT03019744|20000605|P1|NOT COMPLETED|Overall Study||6
8114736|NCT03019744|20000604|P2|COMPLETED|Overall Study||36
8114737|NCT03019744|20000605|P1|COMPLETED|Overall Study||32
8114738|NCT03019744|20000604|P2|STARTED|Overall Study||44
8114739|NCT03019744|20000605|P1|STARTED|Overall Study||38
8114740|NCT03019627|20000621|P2|NOT COMPLETED|Overall Study||8
8114741|NCT03019627|20000622|P1|NOT COMPLETED|Overall Study||15
8114742|NCT03019627|20000621|P2|COMPLETED|Overall Study||42
8114743|NCT03019627|20000622|P1|COMPLETED|Overall Study||85
8114744|NCT03019627|20000621|P2|STARTED|Overall Study||50
8114745|NCT03019627|20000622|P1|STARTED|Overall Study||100
8114746|NCT03019549|20000638|P1|NOT COMPLETED|Period 2||5
8114747|NCT03019549|20000638|P1|COMPLETED|Period 2||26
8114748|NCT03019549|20000638|P1|Received at Least 1 Dose of Study Drug|Period 2||29
8114749|NCT03019549|20000638|P1|STARTED|Period 2||31
8114750|NCT03019549|20000638|P1|NOT COMPLETED|Washout||11
8114751|NCT03019549|20000638|P1|COMPLETED|Washout||31
8114752|NCT03019549|20000638|P1|STARTED|Washout||42
8114753|NCT03019549|20000638|P1|NOT COMPLETED|Period 1||0
8114754|NCT03019549|20000638|P1|COMPLETED|Period 1||42
8114755|NCT03019549|20000638|P1|Received 1 Dose of Study Drug|Period 1||42
8114756|NCT03019549|20000638|P1|STARTED|Period 1||42
8114757|NCT03019458|20000651|P2|NOT COMPLETED|Overall Study||1
8114758|NCT03019458|20000652|P1|NOT COMPLETED|Overall Study||0
8114759|NCT03019458|20000651|P2|COMPLETED|Overall Study||25
8114760|NCT03019458|20000652|P1|COMPLETED|Overall Study||24
8114761|NCT03019458|20000651|P2|STARTED|Overall Study||26
8114762|NCT03019458|20000652|P1|STARTED|Overall Study||24
8114763|NCT03018938|20000666|P2|NOT COMPLETED|Overall Study||85
8114764|NCT03018938|20000667|P1|NOT COMPLETED|Overall Study||66
8114765|NCT03018938|20000666|P2|COMPLETED|Overall Study||325
8114766|NCT03018938|20000667|P1|COMPLETED|Overall Study||338
8114767|NCT03018938|20000666|P2|Received at Least 1 Dose of Study Drug|Overall Study||410
8114768|NCT03018938|20000667|P1|Received at Least 1 Dose of Study Drug|Overall Study||404
8114769|NCT03018938|20000666|P2|STARTED|Overall Study||410
8114770|NCT03018938|20000667|P1|STARTED|Overall Study||404
8114771|NCT03018691|20000706|P3|NOT COMPLETED|Overall Study||7
8114772|NCT03018691|20000707|P2|NOT COMPLETED|Overall Study||1
8114773|NCT03018691|20000708|P1|NOT COMPLETED|Overall Study||2
8114774|NCT03018691|20000706|P3|COMPLETED|Overall Study||17
8114775|NCT03018691|20000707|P2|COMPLETED|Overall Study||24
8114776|NCT03018691|20000708|P1|COMPLETED|Overall Study||22
8114777|NCT03018691|20000706|P3|STARTED|Overall Study||24
8114778|NCT03018691|20000707|P2|STARTED|Overall Study||25
8114779|NCT03018691|20000708|P1|STARTED|Overall Study||24
8114780|NCT03018340|20000744|P2|NOT COMPLETED|Overall Study||30
8114781|NCT03018340|20000745|P1|NOT COMPLETED|Overall Study||8
8114782|NCT03018340|20000744|P2|COMPLETED|Overall Study||125
8114783|NCT03018340|20000745|P1|COMPLETED|Overall Study||44
8114784|NCT03018340|20000744|P2|STARTED|Overall Study||155
8114785|NCT03018340|20000745|P1|STARTED|Overall Study||52
8114789|NCT03018106|20000804|P2|NOT COMPLETED|Overall Study||1
8114790|NCT03018106|20000805|P1|NOT COMPLETED|Overall Study||0
8114791|NCT03018106|20000804|P2|COMPLETED|Overall Study||0
8114792|NCT03018106|20000805|P1|COMPLETED|Overall Study||0
8114793|NCT03018106|20000804|P2|STARTED|Overall Study||1
8114794|NCT03018106|20000805|P1|STARTED|Overall Study||0
8114795|NCT03018028|20000818|P5|NOT COMPLETED|Overall Study||0
8114796|NCT03018028|20000819|P4|NOT COMPLETED|Overall Study||2
8114797|NCT03018028|20000820|P3|NOT COMPLETED|Overall Study||1
8114798|NCT03018028|20000821|P2|NOT COMPLETED|Overall Study||0
8114799|NCT03018028|20000822|P1|NOT COMPLETED|Overall Study||3
8114800|NCT03018028|20000818|P5|COMPLETED|Overall Study||49
8114801|NCT03018028|20000819|P4|COMPLETED|Overall Study||46
8114802|NCT03018028|20000820|P3|COMPLETED|Overall Study||47
8114803|NCT03018028|20000821|P2|COMPLETED|Overall Study||49
8114804|NCT03018028|20000822|P1|COMPLETED|Overall Study||46
8114805|NCT03018028|20000818|P5|Safety Analysis Set (SAS)|Overall Study||49
8114806|NCT03018028|20000819|P4|Safety Analysis Set (SAS)|Overall Study||48
8114807|NCT03018028|20000820|P3|Safety Analysis Set (SAS)|Overall Study||48
8114808|NCT03018028|20000821|P2|Safety Analysis Set (SAS)|Overall Study||49
8114809|NCT03018028|20000822|P1|Safety Analysis Set (SAS)|Overall Study||49
8114810|NCT03018028|20000818|P5|Full Analysis Set (FAS)|Overall Study||49
8114811|NCT03018028|20000819|P4|Full Analysis Set (FAS)|Overall Study||48
8114812|NCT03018028|20000820|P3|Full Analysis Set (FAS)|Overall Study||48
8114813|NCT03018028|20000821|P2|Full Analysis Set (FAS)|Overall Study||49
8114814|NCT03018028|20000822|P1|Full Analysis Set (FAS)|Overall Study||49
8114815|NCT03018028|20000818|P5|STARTED|Overall Study||49
8114816|NCT03018028|20000819|P4|STARTED|Overall Study||48
8114817|NCT03018028|20000820|P3|STARTED|Overall Study||48
8114818|NCT03018028|20000821|P2|STARTED|Overall Study||49
8114819|NCT03018028|20000822|P1|STARTED|Overall Study||49
8114820|NCT03017937|20001067|P1|NOT COMPLETED|Overall Study||0
8114821|NCT03017937|20001067|P1|COMPLETED|Overall Study||155
8114822|NCT03017937|20001067|P1|STARTED|Overall Study||155
8114823|NCT03017846|20001072|P1|NOT COMPLETED|Overall Study||5
8114824|NCT03017846|20001072|P1|COMPLETED|Overall Study||25
8114825|NCT03017846|20001072|P1|STARTED|Overall Study||30
8114826|NCT03017612|20001080|P1|NOT COMPLETED|Overall Study||2
8114827|NCT03017612|20001080|P1|COMPLETED|Overall Study||11
8114828|NCT03017612|20001080|P1|STARTED|Overall Study||13
8114829|NCT03017261|20001088|P1|NOT COMPLETED|12 Month Follow up||47
8114830|NCT03017261|20001088|P1|COMPLETED|12 Month Follow up|1 failed to compete 12M imaging so only 58 have 12M data for KSS Objective Score.|59
8114831|NCT03017261|20001088|P1|STARTED|12 Month Follow up||106
8114832|NCT03017261|20001088|P1|NOT COMPLETED|6 Month Follow up||9
8114833|NCT03017261|20001088|P1|COMPLETED|6 Month Follow up||106
8114834|NCT03017261|20001088|P1|STARTED|6 Month Follow up||115
8114835|NCT03017261|20001088|P1|NOT COMPLETED|3 Month Follow up||0
8114836|NCT03017261|20001088|P1|COMPLETED|3 Month Follow up|1 failed to compete 3M imaging so only 114 have 3M data for tibial slope and KSS Objective Score.|115
8114837|NCT03017261|20001088|P1|STARTED|3 Month Follow up||115
8114838|NCT03017261|20001088|P1|NOT COMPLETED|6 Week Follow up||0
8114839|NCT03017261|20001088|P1|COMPLETED|6 Week Follow up||115
8114840|NCT03017261|20001088|P1|STARTED|6 Week Follow up||115
8114841|NCT03017235|20001125|P2|NOT COMPLETED|Overall Study||14
8114842|NCT03017235|20001126|P1|NOT COMPLETED|Overall Study||12
8114843|NCT03017235|20001125|P2|COMPLETED|Overall Study||447
8114844|NCT03017235|20001126|P1|COMPLETED|Overall Study||444
8114845|NCT03017235|20001125|P2|STARTED|Overall Study||461
8114846|NCT03017235|20001126|P1|STARTED|Overall Study||456
8114847|NCT03017040|20001176|P2|NOT COMPLETED|Overall Study||1
8114848|NCT03017040|20001177|P1|NOT COMPLETED|Overall Study||1
8114849|NCT03017040|20001176|P2|COMPLETED|Overall Study||0
8114850|NCT03017040|20001177|P1|COMPLETED|Overall Study||0
8114851|NCT03017040|20001176|P2|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
8114852|NCT03017040|20001177|P1|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
8114853|NCT03016325|20001195|P8|NOT COMPLETED|182-Day Follow-Up Period||5
8114854|NCT03016325|20001196|P7|NOT COMPLETED|182-Day Follow-Up Period||4
8114855|NCT03016325|20001197|P6|NOT COMPLETED|182-Day Follow-Up Period||5
8114856|NCT03016325|20001198|P5|NOT COMPLETED|182-Day Follow-Up Period||12
8114857|NCT03016325|20001199|P4|NOT COMPLETED|182-Day Follow-Up Period||13
8114858|NCT03016325|20001200|P3|NOT COMPLETED|182-Day Follow-Up Period||11
8114859|NCT03016325|20001201|P2|NOT COMPLETED|182-Day Follow-Up Period||4
8114860|NCT03016325|20001202|P1|NOT COMPLETED|182-Day Follow-Up Period||4
8114861|NCT03016325|20001195|P8|COMPLETED|182-Day Follow-Up Period||1
8114862|NCT03016325|20001196|P7|COMPLETED|182-Day Follow-Up Period||2
8114863|NCT03016325|20001197|P6|COMPLETED|182-Day Follow-Up Period||1
8114864|NCT03016325|20001198|P5|COMPLETED|182-Day Follow-Up Period||60
8114865|NCT03016325|20001199|P4|COMPLETED|182-Day Follow-Up Period||58
8114866|NCT03016325|20001200|P3|COMPLETED|182-Day Follow-Up Period||60
8114867|NCT03016325|20001201|P2|COMPLETED|182-Day Follow-Up Period||45
8114868|NCT03016325|20001202|P1|COMPLETED|182-Day Follow-Up Period||44
8114869|NCT03016325|20001195|P8|STARTED|182-Day Follow-Up Period||6
8114870|NCT03016325|20001196|P7|STARTED|182-Day Follow-Up Period||6
8114871|NCT03016325|20001197|P6|STARTED|182-Day Follow-Up Period||6
8114872|NCT03016325|20001198|P5|STARTED|182-Day Follow-Up Period||72
8114873|NCT03016325|20001199|P4|STARTED|182-Day Follow-Up Period||71
8114874|NCT03016325|20001200|P3|STARTED|182-Day Follow-Up Period||71
8114875|NCT03016325|20001201|P2|STARTED|182-Day Follow-Up Period||49
8114876|NCT03016325|20001202|P1|STARTED|182-Day Follow-Up Period||48
8114877|NCT03016325|20001195|P8|NOT COMPLETED|32-Day Follow-Up Period||0
8114878|NCT03016325|20001196|P7|NOT COMPLETED|32-Day Follow-Up Period||1
8114879|NCT03016325|20001197|P6|NOT COMPLETED|32-Day Follow-Up Period||0
8114880|NCT03016325|20001198|P5|NOT COMPLETED|32-Day Follow-Up Period||8
8114881|NCT03016325|20001199|P4|NOT COMPLETED|32-Day Follow-Up Period||8
8114882|NCT03016325|20001200|P3|NOT COMPLETED|32-Day Follow-Up Period||9
8114883|NCT03016325|20001201|P2|NOT COMPLETED|32-Day Follow-Up Period||2
8114884|NCT03016325|20001202|P1|NOT COMPLETED|32-Day Follow-Up Period||4
8114885|NCT03016325|20001195|P8|COMPLETED|32-Day Follow-Up Period||6
8114886|NCT03016325|20001196|P7|COMPLETED|32-Day Follow-Up Period||5
8114887|NCT03016325|20001197|P6|COMPLETED|32-Day Follow-Up Period||6
8114888|NCT03016325|20001198|P5|COMPLETED|32-Day Follow-Up Period||64
8114889|NCT03016325|20001199|P4|COMPLETED|32-Day Follow-Up Period||63
8114890|NCT03016325|20001200|P3|COMPLETED|32-Day Follow-Up Period||62
8114891|NCT03016325|20001201|P2|COMPLETED|32-Day Follow-Up Period||47
8114892|NCT03016325|20001202|P1|COMPLETED|32-Day Follow-Up Period||44
8114893|NCT03016325|20001195|P8|STARTED|32-Day Follow-Up Period||6
8114894|NCT03016325|20001196|P7|STARTED|32-Day Follow-Up Period||6
8114895|NCT03016325|20001197|P6|STARTED|32-Day Follow-Up Period||6
8114896|NCT03016325|20001198|P5|STARTED|32-Day Follow-Up Period||72
8114897|NCT03016325|20001199|P4|STARTED|32-Day Follow-Up Period||71
8114898|NCT03016325|20001200|P3|STARTED|32-Day Follow-Up Period||71
8114899|NCT03016325|20001201|P2|STARTED|32-Day Follow-Up Period||49
8114900|NCT03016325|20001202|P1|STARTED|32-Day Follow-Up Period||48
8114901|NCT03016325|20001195|P8|NOT COMPLETED|Treatment Period||0
8114902|NCT03016325|20001196|P7|NOT COMPLETED|Treatment Period||0
8114903|NCT03016325|20001197|P6|NOT COMPLETED|Treatment Period||0
8114904|NCT03016325|20001198|P5|NOT COMPLETED|Treatment Period||2
8114905|NCT03016325|20001199|P4|NOT COMPLETED|Treatment Period||0
8114906|NCT03016325|20001200|P3|NOT COMPLETED|Treatment Period||1
8114907|NCT03016325|20001201|P2|NOT COMPLETED|Treatment Period||1
8114908|NCT03016325|20001202|P1|NOT COMPLETED|Treatment Period||0
8114909|NCT03016325|20001195|P8|COMPLETED|Treatment Period||6
8114910|NCT03016325|20001196|P7|COMPLETED|Treatment Period||6
8114911|NCT03016325|20001197|P6|COMPLETED|Treatment Period||6
8114912|NCT03016325|20001198|P5|COMPLETED|Treatment Period||70
8114913|NCT03016325|20001199|P4|COMPLETED|Treatment Period||71
8114914|NCT03016325|20001200|P3|COMPLETED|Treatment Period||70
8114915|NCT03016325|20001201|P2|COMPLETED|Treatment Period||48
8114916|NCT03016325|20001202|P1|COMPLETED|Treatment Period||48
8114917|NCT03016325|20001195|P8|STARTED|Treatment Period||6
8114918|NCT03016325|20001196|P7|STARTED|Treatment Period||6
8114919|NCT03016325|20001197|P6|STARTED|Treatment Period||6
8114920|NCT03016325|20001198|P5|STARTED|Treatment Period||72
8114921|NCT03016325|20001199|P4|STARTED|Treatment Period||71
8114922|NCT03016325|20001200|P3|STARTED|Treatment Period||71
8114923|NCT03016325|20001201|P2|STARTED|Treatment Period||49
8114924|NCT03016325|20001202|P1|STARTED|Treatment Period||48
8114925|NCT03016078|20001425|P1|NOT COMPLETED|Overall Study||2
8114926|NCT03016078|20001425|P1|COMPLETED|Overall Study||19
8114927|NCT03016078|20001425|P1|STARTED|Overall Study||21
8114928|NCT03015649|20001436|P1|NOT COMPLETED|Overall Study||0
8114929|NCT03015649|20001436|P1|COMPLETED|Overall Study||34
8114930|NCT03015649|20001436|P1|STARTED|Overall Study||34
8114951|NCT03015181|20001592|P7|NOT COMPLETED|Overall Study||1
8114952|NCT03015181|20001593|P6|NOT COMPLETED|Overall Study||1
8114953|NCT03015181|20001594|P5|NOT COMPLETED|Overall Study||0
8114954|NCT03015181|20001595|P4|NOT COMPLETED|Overall Study||0
8114955|NCT03015181|20001596|P3|NOT COMPLETED|Overall Study||0
8114956|NCT03015181|20001597|P2|NOT COMPLETED|Overall Study||0
8114957|NCT03015181|20001598|P1|NOT COMPLETED|Overall Study||1
8114958|NCT03015181|20001592|P7|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4
8114959|NCT03015181|20001593|P6|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4
8114960|NCT03015181|20001594|P5|COMPLETED|Overall Study||3
8114961|NCT03015181|20001595|P4|COMPLETED|Overall Study||3
8114962|NCT03015181|20001596|P3|COMPLETED|Overall Study||3
8114963|NCT03015181|20001597|P2|COMPLETED|Overall Study||3
8114964|NCT03015181|20001598|P1|COMPLETED|Overall Study||3
8114965|NCT03015181|20001592|P7|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1
8114966|NCT03015181|20001593|P6|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1
8114967|NCT03015181|20001594|P5|Discontinued VRC07-523LS Administrations|Overall Study||0
8114968|NCT03015181|20001595|P4|Discontinued VRC07-523LS Administrations|Overall Study||0
8114969|NCT03015181|20001596|P3|Discontinued VRC07-523LS Administrations|Overall Study||0
8114970|NCT03015181|20001597|P2|Discontinued VRC07-523LS Administrations|Overall Study||0
8114971|NCT03015181|20001598|P1|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1
8114972|NCT03015181|20001592|P7|Received VRC07-523LS Per Protocol|Overall Study||4
8114973|NCT03015181|20001593|P6|Received VRC07-523LS Per Protocol|Overall Study||4
8114974|NCT03015181|20001594|P5|Received VRC07-523LS Per Protocol|Overall Study||3
8114975|NCT03015181|20001595|P4|Received VRC07-523LS Per Protocol|Overall Study||3
8114976|NCT03015181|20001596|P3|Received VRC07-523LS Per Protocol|Overall Study||3
8114977|NCT03015181|20001597|P2|Received VRC07-523LS Per Protocol|Overall Study||3
8114978|NCT03015181|20001598|P1|Received VRC07-523LS Per Protocol|Overall Study||3
8114979|NCT03015181|20001592|P7|STARTED|Overall Study||5
8114980|NCT03015181|20001593|P6|STARTED|Overall Study||5
8114981|NCT03015181|20001594|P5|STARTED|Overall Study||3
8114982|NCT03015181|20001595|P4|STARTED|Overall Study||3
8114983|NCT03015181|20001596|P3|STARTED|Overall Study||3
8114984|NCT03015181|20001597|P2|STARTED|Overall Study||3
8114985|NCT03015181|20001598|P1|STARTED|Overall Study||4
8114986|NCT03015142|20001709|P1|NOT COMPLETED|Overall Study||1
8114987|NCT03015142|20001709|P1|COMPLETED|Overall Study||20
8114988|NCT03015142|20001709|P1|STARTED|Overall Study||21
8114989|NCT03014700|20001724|P2|NOT COMPLETED|Overall Study||1
8114990|NCT03014700|20001725|P1|NOT COMPLETED|Overall Study||5
8114991|NCT03014700|20001724|P2|COMPLETED|Overall Study||29
8114992|NCT03014700|20001725|P1|COMPLETED|Overall Study||25
8114993|NCT03014700|20001724|P2|STARTED|Overall Study||30
8114994|NCT03014700|20001725|P1|STARTED|Overall Study||30
8114995|NCT03014674|20001744|P3|NOT COMPLETED|Overall Study||0
8114996|NCT03014674|20001745|P2|NOT COMPLETED|Overall Study||0
8114997|NCT03014674|20001746|P1|NOT COMPLETED|Overall Study||1
8114998|NCT03014674|20001744|P3|COMPLETED|Overall Study||80
8114999|NCT03014674|20001745|P2|COMPLETED|Overall Study||79
8115000|NCT03014674|20001746|P1|COMPLETED|Overall Study||84
8115001|NCT03014674|20001744|P3|STARTED|Overall Study||80
8115002|NCT03014674|20001745|P2|STARTED|Overall Study||79
8115003|NCT03014674|20001746|P1|STARTED|Overall Study||85
8115004|NCT03014492|20001810|P2|NOT COMPLETED|Overall Study||0
8115005|NCT03014492|20001811|P1|NOT COMPLETED|Overall Study||0
8115006|NCT03014492|20001810|P2|COMPLETED|Overall Study||28
8115007|NCT03014492|20001811|P1|COMPLETED|Overall Study||44
8115008|NCT03014492|20001810|P2|STARTED|Overall Study||28
8115009|NCT03014492|20001811|P1|STARTED|Overall Study||44
8115010|NCT03014479|20001821|P2|NOT COMPLETED|Overall Study||4
8115011|NCT03014479|20001822|P1|NOT COMPLETED|Overall Study||0
8115012|NCT03014479|20001821|P2|COMPLETED|Overall Study||105
8115013|NCT03014479|20001822|P1|COMPLETED|Overall Study||110
8115014|NCT03014479|20001821|P2|STARTED|Overall Study||109
8115015|NCT03014479|20001822|P1|STARTED|Overall Study||110
8115016|NCT03014453|20001868|P1|NOT COMPLETED|Overall Study||71
8115017|NCT03014453|20001868|P1|COMPLETED|Overall Study||116
8115018|NCT03014453|20001868|P1|STARTED|Overall Study||187
8115019|NCT03014206|20001872|P1|NOT COMPLETED|Overall Study||12
8115020|NCT03014206|20001872|P1|COMPLETED|Overall Study||684
8115021|NCT03014206|20001872|P1|STARTED|Overall Study||696
8115022|NCT03014180|20001876|P1|NOT COMPLETED|Overall Study||2
8115023|NCT03014180|20001876|P1|COMPLETED|Overall Study||58
8115024|NCT03014180|20001876|P1|STARTED|Overall Study||60
8115025|NCT03014011|20001885|P2|NOT COMPLETED|Second Intervention||0
8115026|NCT03014011|20001886|P1|NOT COMPLETED|Second Intervention||0
8115027|NCT03014011|20001885|P2|COMPLETED|Second Intervention||13
8115028|NCT03014011|20001886|P1|COMPLETED|Second Intervention||12
8115029|NCT03014011|20001885|P2|STARTED|Second Intervention||13
8115030|NCT03014011|20001886|P1|STARTED|Second Intervention||12
8115031|NCT03014011|20001885|P2|NOT COMPLETED|Washout||0
8115032|NCT03014011|20001886|P1|NOT COMPLETED|Washout||1
8115033|NCT03014011|20001885|P2|COMPLETED|Washout||13
8115034|NCT03014011|20001886|P1|COMPLETED|Washout||12
8115035|NCT03014011|20001885|P2|STARTED|Washout||13
8115036|NCT03014011|20001886|P1|STARTED|Washout||13
8115037|NCT03014011|20001885|P2|NOT COMPLETED|First Intervention||0
8115038|NCT03014011|20001886|P1|NOT COMPLETED|First Intervention||1
8115039|NCT03014011|20001885|P2|COMPLETED|First Intervention||13
8115040|NCT03014011|20001886|P1|COMPLETED|First Intervention||13
8115041|NCT03014011|20001885|P2|STARTED|First Intervention||13
8115042|NCT03014011|20001886|P1|STARTED|First Intervention||14
8115043|NCT03013985|20001894|P2|NOT COMPLETED|Overall Study||19
8115044|NCT03013985|20001895|P1|NOT COMPLETED|Overall Study||16
8115045|NCT03013985|20001894|P2|COMPLETED|Overall Study||84
8115046|NCT03013985|20001895|P1|COMPLETED|Overall Study||92
8115047|NCT03013985|20001894|P2|STARTED|Overall Study||103
8115048|NCT03013985|20001895|P1|STARTED|Overall Study||108
8115049|NCT03012841|20001927|P2|NOT COMPLETED|Overall Study||21
8115050|NCT03012841|20001928|P1|NOT COMPLETED|Overall Study||20
8115051|NCT03012841|20001927|P2|COMPLETED|Overall Study||0
8115052|NCT03012841|20001928|P1|COMPLETED|Overall Study||145
8115053|NCT03012841|20001927|P2|STARTED|Overall Study||21
8115054|NCT03012841|20001928|P1|STARTED|Overall Study||165
8115055|NCT03012828|20001942|P6|NOT COMPLETED|Overall Study||2
8115056|NCT03012828|20001943|P5|NOT COMPLETED|Overall Study||2
8115057|NCT03012828|20001944|P4|NOT COMPLETED|Overall Study||0
8115058|NCT03012828|20001945|P3|NOT COMPLETED|Overall Study||2
8115059|NCT03012828|20001946|P2|NOT COMPLETED|Overall Study||0
8115060|NCT03012828|20001947|P1|NOT COMPLETED|Overall Study||1
8115061|NCT03012828|20001942|P6|COMPLETED|Overall Study||8
8115062|NCT03012828|20001943|P5|COMPLETED|Overall Study||8
8115063|NCT03012828|20001944|P4|COMPLETED|Overall Study||10
8115064|NCT03012828|20001945|P3|COMPLETED|Overall Study||8
8115065|NCT03012828|20001946|P2|COMPLETED|Overall Study||10
8115066|NCT03012828|20001947|P1|COMPLETED|Overall Study||9
8115067|NCT03012828|20001942|P6|STARTED|Overall Study||10
8115068|NCT03012828|20001943|P5|STARTED|Overall Study||10
8115069|NCT03012828|20001944|P4|STARTED|Overall Study||10
8115070|NCT03012828|20001945|P3|STARTED|Overall Study||10
8115071|NCT03012828|20001946|P2|STARTED|Overall Study||10
8115072|NCT03012828|20001947|P1|STARTED|Overall Study||10
8115073|NCT03012594|20001980|P1|NOT COMPLETED|Overall Study||3
8115074|NCT03012594|20001980|P1|COMPLETED|Overall Study||9
8115075|NCT03012594|20001980|P1|STARTED|Overall Study||12
8115076|NCT03012334|20001995|P10|NOT COMPLETED|Period 5||0
8115077|NCT03012334|20001996|P9|NOT COMPLETED|Period 5||0
8115078|NCT03012334|20001997|P8|NOT COMPLETED|Period 5||0
8115079|NCT03012334|20001998|P7|NOT COMPLETED|Period 5||0
8115080|NCT03012334|20001999|P6|NOT COMPLETED|Period 5||0
8115081|NCT03012334|20002000|P5|NOT COMPLETED|Period 5||0
8115082|NCT03012334|20002001|P4|NOT COMPLETED|Period 5||0
8115083|NCT03012334|20002002|P3|NOT COMPLETED|Period 5||0
8115084|NCT03012334|20002003|P2|NOT COMPLETED|Period 5||0
8115085|NCT03012334|20002004|P1|NOT COMPLETED|Period 5||0
8115086|NCT03012334|20001995|P10|COMPLETED|Period 5||8
8115087|NCT03012334|20001996|P9|COMPLETED|Period 5||8
8115088|NCT03012334|20001997|P8|COMPLETED|Period 5||8
8115089|NCT03012334|20001998|P7|COMPLETED|Period 5||8
8115090|NCT03012334|20001999|P6|COMPLETED|Period 5||9
8115091|NCT03012334|20002000|P5|COMPLETED|Period 5||9
8115092|NCT03012334|20002001|P4|COMPLETED|Period 5||9
8115093|NCT03012334|20002002|P3|COMPLETED|Period 5||8
8115094|NCT03012334|20002003|P2|COMPLETED|Period 5||8
8115095|NCT03012334|20002004|P1|COMPLETED|Period 5||9
8115096|NCT03012334|20001995|P10|STARTED|Period 5||8
8115097|NCT03012334|20001996|P9|STARTED|Period 5||8
8115098|NCT03012334|20001997|P8|STARTED|Period 5||8
8115099|NCT03012334|20001998|P7|STARTED|Period 5||8
8115100|NCT03012334|20001999|P6|STARTED|Period 5||9
8115101|NCT03012334|20002000|P5|STARTED|Period 5||9
8115102|NCT03012334|20002001|P4|STARTED|Period 5||9
8115103|NCT03012334|20002002|P3|STARTED|Period 5||8
8115104|NCT03012334|20002003|P2|STARTED|Period 5||8
8115105|NCT03012334|20002004|P1|STARTED|Period 5||9
8115106|NCT03012334|20001995|P10|NOT COMPLETED|Period 4||0
8115107|NCT03012334|20001996|P9|NOT COMPLETED|Period 4||1
8115108|NCT03012334|20001997|P8|NOT COMPLETED|Period 4||0
8115109|NCT03012334|20001998|P7|NOT COMPLETED|Period 4||1
8115110|NCT03012334|20001999|P6|NOT COMPLETED|Period 4||0
8115111|NCT03012334|20002000|P5|NOT COMPLETED|Period 4||0
8115112|NCT03012334|20002001|P4|NOT COMPLETED|Period 4||0
8115113|NCT03012334|20002002|P3|NOT COMPLETED|Period 4||0
8115114|NCT03012334|20002003|P2|NOT COMPLETED|Period 4||0
8115115|NCT03012334|20002004|P1|NOT COMPLETED|Period 4||0
8115116|NCT03012334|20001995|P10|COMPLETED|Period 4||8
8115117|NCT03012334|20001996|P9|COMPLETED|Period 4||8
8115118|NCT03012334|20001997|P8|COMPLETED|Period 4||8
8115119|NCT03012334|20001998|P7|COMPLETED|Period 4||8
8115120|NCT03012334|20001999|P6|COMPLETED|Period 4||9
8115121|NCT03012334|20002000|P5|COMPLETED|Period 4||9
8115122|NCT03012334|20002001|P4|COMPLETED|Period 4||9
8115123|NCT03012334|20002002|P3|COMPLETED|Period 4||8
8115124|NCT03012334|20002003|P2|COMPLETED|Period 4||8
8115125|NCT03012334|20002004|P1|COMPLETED|Period 4||9
8115126|NCT03012334|20001995|P10|STARTED|Period 4||8
8115127|NCT03012334|20001996|P9|STARTED|Period 4||9
8115128|NCT03012334|20001997|P8|STARTED|Period 4||8
8115129|NCT03012334|20001998|P7|STARTED|Period 4||9
8115130|NCT03012334|20001999|P6|STARTED|Period 4||9
8115131|NCT03012334|20002000|P5|STARTED|Period 4||9
8115132|NCT03012334|20002001|P4|STARTED|Period 4||9
8115133|NCT03012334|20002002|P3|STARTED|Period 4||8
8115134|NCT03012334|20002003|P2|STARTED|Period 4||8
8115135|NCT03012334|20002004|P1|STARTED|Period 4||9
8115136|NCT03012334|20001995|P10|NOT COMPLETED|Period 3||0
8115137|NCT03012334|20001996|P9|NOT COMPLETED|Period 3||0
8115138|NCT03012334|20001997|P8|NOT COMPLETED|Period 3||0
8115139|NCT03012334|20001998|P7|NOT COMPLETED|Period 3||0
8115140|NCT03012334|20001999|P6|NOT COMPLETED|Period 3||0
8115141|NCT03012334|20002000|P5|NOT COMPLETED|Period 3||0
8115142|NCT03012334|20002001|P4|NOT COMPLETED|Period 3||0
8115143|NCT03012334|20002002|P3|NOT COMPLETED|Period 3||0
8115144|NCT03012334|20002003|P2|NOT COMPLETED|Period 3||0
8115145|NCT03012334|20002004|P1|NOT COMPLETED|Period 3||0
8115146|NCT03012334|20001995|P10|COMPLETED|Period 3||8
8115147|NCT03012334|20001996|P9|COMPLETED|Period 3||9
8115148|NCT03012334|20001997|P8|COMPLETED|Period 3||8
8115149|NCT03012334|20001998|P7|COMPLETED|Period 3||9
8115150|NCT03012334|20001999|P6|COMPLETED|Period 3||9
8115151|NCT03012334|20002000|P5|COMPLETED|Period 3||9
8115152|NCT03012334|20002001|P4|COMPLETED|Period 3||9
8115153|NCT03012334|20002002|P3|COMPLETED|Period 3||8
8115154|NCT03012334|20002003|P2|COMPLETED|Period 3||8
8115155|NCT03012334|20002004|P1|COMPLETED|Period 3||9
8115156|NCT03012334|20001995|P10|STARTED|Period 3||8
8115157|NCT03012334|20001996|P9|STARTED|Period 3||9
8115158|NCT03012334|20001997|P8|STARTED|Period 3||8
8115159|NCT03012334|20001998|P7|STARTED|Period 3||9
8115160|NCT03012334|20001999|P6|STARTED|Period 3||9
8115161|NCT03012334|20002000|P5|STARTED|Period 3||9
8115162|NCT03012334|20002001|P4|STARTED|Period 3||9
8115163|NCT03012334|20002002|P3|STARTED|Period 3||8
8115164|NCT03012334|20002003|P2|STARTED|Period 3||8
8115165|NCT03012334|20002004|P1|STARTED|Period 3||9
8115166|NCT03012334|20001995|P10|NOT COMPLETED|Period 2||0
8115167|NCT03012334|20001996|P9|NOT COMPLETED|Period 2||0
8115168|NCT03012334|20001997|P8|NOT COMPLETED|Period 2||1
8115169|NCT03012334|20001998|P7|NOT COMPLETED|Period 2||0
8115170|NCT03012334|20001999|P6|NOT COMPLETED|Period 2||0
8115171|NCT03012334|20002000|P5|NOT COMPLETED|Period 2||0
8115172|NCT03012334|20002001|P4|NOT COMPLETED|Period 2||0
8115173|NCT03012334|20002002|P3|NOT COMPLETED|Period 2||1
8115174|NCT03012334|20002003|P2|NOT COMPLETED|Period 2||1
8115175|NCT03012334|20002004|P1|NOT COMPLETED|Period 2||0
8115176|NCT03012334|20001995|P10|COMPLETED|Period 2||8
8115177|NCT03012334|20001996|P9|COMPLETED|Period 2||9
8115178|NCT03012334|20001997|P8|COMPLETED|Period 2||8
8115179|NCT03012334|20001998|P7|COMPLETED|Period 2||9
8115180|NCT03012334|20001999|P6|COMPLETED|Period 2||9
8115181|NCT03012334|20002000|P5|COMPLETED|Period 2||9
8115182|NCT03012334|20002001|P4|COMPLETED|Period 2||9
8115183|NCT03012334|20002002|P3|COMPLETED|Period 2||8
8115184|NCT03012334|20002003|P2|COMPLETED|Period 2||8
8115185|NCT03012334|20002004|P1|COMPLETED|Period 2||9
8115186|NCT03012334|20001995|P10|STARTED|Period 2||8
8115187|NCT03012334|20001996|P9|STARTED|Period 2||9
8115188|NCT03012334|20001997|P8|STARTED|Period 2||9
8115189|NCT03012334|20001998|P7|STARTED|Period 2||9
8115190|NCT03012334|20001999|P6|STARTED|Period 2||9
8115191|NCT03012334|20002000|P5|STARTED|Period 2||9
8115192|NCT03012334|20002001|P4|STARTED|Period 2||9
8115193|NCT03012334|20002002|P3|STARTED|Period 2||9
8115194|NCT03012334|20002003|P2|STARTED|Period 2||9
8115195|NCT03012334|20002004|P1|STARTED|Period 2||9
8115196|NCT03012334|20001995|P10|NOT COMPLETED|Period 1||1
8115197|NCT03012334|20001996|P9|NOT COMPLETED|Period 1||0
8115198|NCT03012334|20001997|P8|NOT COMPLETED|Period 1||0
8115199|NCT03012334|20001998|P7|NOT COMPLETED|Period 1||0
8115200|NCT03012334|20001999|P6|NOT COMPLETED|Period 1||0
8115201|NCT03012334|20002000|P5|NOT COMPLETED|Period 1||0
8115202|NCT03012334|20002001|P4|NOT COMPLETED|Period 1||0
8115203|NCT03012334|20002002|P3|NOT COMPLETED|Period 1||0
8115204|NCT03012334|20002003|P2|NOT COMPLETED|Period 1||0
8115205|NCT03012334|20002004|P1|NOT COMPLETED|Period 1||0
8115206|NCT03012334|20001995|P10|COMPLETED|Period 1||8
8115207|NCT03012334|20001996|P9|COMPLETED|Period 1||9
8115208|NCT03012334|20001997|P8|COMPLETED|Period 1||9
8115209|NCT03012334|20001998|P7|COMPLETED|Period 1||9
8115210|NCT03012334|20001999|P6|COMPLETED|Period 1||9
8115211|NCT03012334|20002000|P5|COMPLETED|Period 1||9
8115212|NCT03012334|20002001|P4|COMPLETED|Period 1||9
8115213|NCT03012334|20002002|P3|COMPLETED|Period 1||9
8115214|NCT03012334|20002003|P2|COMPLETED|Period 1||9
8115215|NCT03012334|20002004|P1|COMPLETED|Period 1||9
8115216|NCT03012334|20001995|P10|STARTED|Period 1||9
8115217|NCT03012334|20001996|P9|STARTED|Period 1||9
8115218|NCT03012334|20001997|P8|STARTED|Period 1||9
8115219|NCT03012334|20001998|P7|STARTED|Period 1||9
8115220|NCT03012334|20001999|P6|STARTED|Period 1||9
8115221|NCT03012334|20002000|P5|STARTED|Period 1||9
8115222|NCT03012334|20002001|P4|STARTED|Period 1||9
8115223|NCT03012334|20002002|P3|STARTED|Period 1||9
8115224|NCT03012334|20002003|P2|STARTED|Period 1||9
8115225|NCT03012334|20002004|P1|STARTED|Period 1||9
8115226|NCT03012191|20002054|P3|NOT COMPLETED|Overall Study||0
8115227|NCT03012191|20002055|P2|NOT COMPLETED|Overall Study||0
8115228|NCT03012191|20002056|P1|NOT COMPLETED|Overall Study||0
8115229|NCT03012191|20002054|P3|COMPLETED|Overall Study||2
8115230|NCT03012191|20002055|P2|COMPLETED|Overall Study||2
8115231|NCT03012191|20002056|P1|COMPLETED|Overall Study||2
8115232|NCT03012191|20002054|P3|STARTED|Overall Study||2
8115233|NCT03012191|20002055|P2|STARTED|Overall Study||2
8115234|NCT03012191|20002056|P1|STARTED|Overall Study||2
8115235|NCT03012061|20002074|P3|NOT COMPLETED|Overall Study||8
8115236|NCT03012061|20002075|P2|NOT COMPLETED|Overall Study||9
8115237|NCT03012061|20002076|P1|NOT COMPLETED|Overall Study||6
8115238|NCT03012061|20002074|P3|COMPLETED|Overall Study||131
8115239|NCT03012061|20002075|P2|COMPLETED|Overall Study||130
8115240|NCT03012061|20002076|P1|COMPLETED|Overall Study||137
8115241|NCT03012061|20002074|P3|STARTED|Overall Study||139
8115242|NCT03012061|20002075|P2|STARTED|Overall Study||139
8115243|NCT03012061|20002076|P1|STARTED|Overall Study||143
8115244|NCT03011840|20002101|P2|NOT COMPLETED|Overall Study||21
8115245|NCT03011840|20002102|P1|NOT COMPLETED|Overall Study||0
8115246|NCT03011840|20002101|P2|COMPLETED|Overall Study||196
8115247|NCT03011840|20002102|P1|COMPLETED|Overall Study||232
8115248|NCT03011840|20002101|P2|STARTED|Overall Study||217
8115249|NCT03011840|20002102|P1|STARTED|Overall Study||232
8115250|NCT03011099|20002112|P2|NOT COMPLETED|Overall Study||2
8115251|NCT03011099|20002113|P1|NOT COMPLETED|Overall Study||0
8115252|NCT03011099|20002112|P2|COMPLETED|Overall Study||3
8115253|NCT03011099|20002113|P1|COMPLETED|Overall Study||6
8115254|NCT03011099|20002112|P2|STARTED|Overall Study||5
8115255|NCT03011099|20002113|P1|STARTED|Overall Study||6
8115262|NCT03010800|20002170|P2|NOT COMPLETED|Cross Over||0
8115263|NCT03010800|20002171|P1|NOT COMPLETED|Cross Over||0
8115264|NCT03010800|20002170|P2|COMPLETED|Cross Over||4
8115265|NCT03010800|20002171|P1|COMPLETED|Cross Over||4
8115266|NCT03010800|20002170|P2|STARTED|Cross Over||4
8115267|NCT03010800|20002171|P1|STARTED|Cross Over||4
8115268|NCT03010800|20002170|P2|NOT COMPLETED|Initial Assignment||0
8115269|NCT03010800|20002171|P1|NOT COMPLETED|Initial Assignment||0
8115270|NCT03010800|20002170|P2|COMPLETED|Initial Assignment||4
8115271|NCT03010800|20002171|P1|COMPLETED|Initial Assignment||4
8115272|NCT03010800|20002170|P2|STARTED|Initial Assignment||4
8115273|NCT03010800|20002171|P1|STARTED|Initial Assignment||4
8115274|NCT03010631|20002181|P4|NOT COMPLETED|Cohort 2||0
8115275|NCT03010631|20002182|P3|NOT COMPLETED|Cohort 2||0
8115276|NCT03010631|20002183|P2|NOT COMPLETED|Cohort 2||0
8115277|NCT03010631|20002184|P1|NOT COMPLETED|Cohort 2||0
8115278|NCT03010631|20002181|P4|COMPLETED|Cohort 2||7
8115279|NCT03010631|20002182|P3|COMPLETED|Cohort 2||7
8115280|NCT03010631|20002183|P2|COMPLETED|Cohort 2||0
8115281|NCT03010631|20002184|P1|COMPLETED|Cohort 2||0
8115282|NCT03010631|20002181|P4|STARTED|Cohort 2||7
8115283|NCT03010631|20002182|P3|STARTED|Cohort 2|New participants were enrolled for Cohort 2|7
8115284|NCT03010631|20002183|P2|STARTED|Cohort 2||0
8115285|NCT03010631|20002184|P1|STARTED|Cohort 2||0
8115286|NCT03010631|20002181|P4|NOT COMPLETED|Cohort 1||0
8115287|NCT03010631|20002182|P3|NOT COMPLETED|Cohort 1||0
8115288|NCT03010631|20002183|P2|NOT COMPLETED|Cohort 1||0
8115289|NCT03010631|20002184|P1|NOT COMPLETED|Cohort 1||4
8115290|NCT03010631|20002181|P4|COMPLETED|Cohort 1||0
8115291|NCT03010631|20002182|P3|COMPLETED|Cohort 1||0
8115292|NCT03010631|20002183|P2|COMPLETED|Cohort 1||17
8115293|NCT03010631|20002184|P1|COMPLETED|Cohort 1||14
8115294|NCT03010631|20002181|P4|STARTED|Cohort 1||0
8115295|NCT03010631|20002182|P3|STARTED|Cohort 1||0
8115296|NCT03010631|20002183|P2|STARTED|Cohort 1||17
8115297|NCT03010631|20002184|P1|STARTED|Cohort 1||18
8115298|NCT03010501|20002202|P6|NOT COMPLETED|Study Week 3||0
8115299|NCT03010501|20002203|P5|NOT COMPLETED|Study Week 3||0
8115300|NCT03010501|20002204|P4|NOT COMPLETED|Study Week 3||1
8115301|NCT03010501|20002205|P3|NOT COMPLETED|Study Week 3||0
8115302|NCT03010501|20002206|P2|NOT COMPLETED|Study Week 3||0
8115303|NCT03010501|20002207|P1|NOT COMPLETED|Study Week 3||0
8115304|NCT03010501|20002202|P6|COMPLETED|Study Week 3||11
8115305|NCT03010501|20002203|P5|COMPLETED|Study Week 3||7
8115306|NCT03010501|20002204|P4|COMPLETED|Study Week 3||4
8115307|NCT03010501|20002205|P3|COMPLETED|Study Week 3||7
8115308|NCT03010501|20002206|P2|COMPLETED|Study Week 3||14
8115309|NCT03010501|20002207|P1|COMPLETED|Study Week 3||7
8115310|NCT03010501|20002202|P6|STARTED|Study Week 3||11
8115311|NCT03010501|20002203|P5|STARTED|Study Week 3||7
8115312|NCT03010501|20002204|P4|STARTED|Study Week 3||5
8115313|NCT03010501|20002205|P3|STARTED|Study Week 3||7
8115314|NCT03010501|20002206|P2|STARTED|Study Week 3||14
8115315|NCT03010501|20002207|P1|STARTED|Study Week 3||7
8115316|NCT03010501|20002202|P6|NOT COMPLETED|Study Week 2||0
8115317|NCT03010501|20002203|P5|NOT COMPLETED|Study Week 2||0
8115318|NCT03010501|20002204|P4|NOT COMPLETED|Study Week 2||0
8115319|NCT03010501|20002205|P3|NOT COMPLETED|Study Week 2||0
8115320|NCT03010501|20002206|P2|NOT COMPLETED|Study Week 2||0
8115321|NCT03010501|20002207|P1|NOT COMPLETED|Study Week 2||0
8115322|NCT03010501|20002202|P6|COMPLETED|Study Week 2||11
8115323|NCT03010501|20002203|P5|COMPLETED|Study Week 2||7
8115324|NCT03010501|20002204|P4|COMPLETED|Study Week 2||5
8115325|NCT03010501|20002205|P3|COMPLETED|Study Week 2||7
8115326|NCT03010501|20002206|P2|COMPLETED|Study Week 2||14
8115327|NCT03010501|20002207|P1|COMPLETED|Study Week 2||7
8115328|NCT03010501|20002202|P6|STARTED|Study Week 2||11
8115329|NCT03010501|20002203|P5|STARTED|Study Week 2||7
8115330|NCT03010501|20002204|P4|STARTED|Study Week 2||5
8115331|NCT03010501|20002205|P3|STARTED|Study Week 2||7
8115332|NCT03010501|20002206|P2|STARTED|Study Week 2||14
8115333|NCT03010501|20002207|P1|STARTED|Study Week 2||7
8115334|NCT03010501|20002202|P6|NOT COMPLETED|Study Week 1||0
8115335|NCT03010501|20002203|P5|NOT COMPLETED|Study Week 1||0
8115336|NCT03010501|20002204|P4|NOT COMPLETED|Study Week 1||2
8115337|NCT03010501|20002205|P3|NOT COMPLETED|Study Week 1||0
8115338|NCT03010501|20002206|P2|NOT COMPLETED|Study Week 1||1
8115339|NCT03010501|20002207|P1|NOT COMPLETED|Study Week 1||2
8115340|NCT03010501|20002202|P6|COMPLETED|Study Week 1||11
8115341|NCT03010501|20002203|P5|COMPLETED|Study Week 1||7
8115342|NCT03010501|20002204|P4|COMPLETED|Study Week 1||5
8115343|NCT03010501|20002205|P3|COMPLETED|Study Week 1||7
8115344|NCT03010501|20002206|P2|COMPLETED|Study Week 1||14
8115345|NCT03010501|20002207|P1|COMPLETED|Study Week 1||7
8115346|NCT03010501|20002202|P6|STARTED|Study Week 1||11
8115347|NCT03010501|20002203|P5|STARTED|Study Week 1||7
8115348|NCT03010501|20002204|P4|STARTED|Study Week 1||7
8115349|NCT03010501|20002205|P3|STARTED|Study Week 1||7
8115350|NCT03010501|20002206|P2|STARTED|Study Week 1||15
8115351|NCT03010501|20002207|P1|STARTED|Study Week 1||9
8115352|NCT03010423|20002221|P1|NOT COMPLETED|Overall Study||8
8115353|NCT03010423|20002221|P1|COMPLETED|Overall Study||0
8115354|NCT03010423|20002221|P1|STARTED|Overall Study||8
8115355|NCT03010254|20002234|P2|NOT COMPLETED|Overall Study||5
8115356|NCT03010254|20002235|P1|NOT COMPLETED|Overall Study||7
8115357|NCT03010254|20002234|P2|COMPLETED|Overall Study||118
8115358|NCT03010254|20002235|P1|COMPLETED|Overall Study||152
8115359|NCT03010254|20002234|P2|Successful Implantation|Overall Study||120
8115360|NCT03010254|20002235|P1|Successful Implantation|Overall Study||156
8115361|NCT03010254|20002234|P2|Attempted Implantation|Overall Study||120
8115362|NCT03010254|20002235|P1|Attempted Implantation|Overall Study||156
8115363|NCT03010254|20002234|P2|STARTED|Overall Study||123
8115364|NCT03010254|20002235|P1|STARTED|Overall Study||159
8115365|NCT03010137|20002262|P2|NOT COMPLETED|Overall Study||0
8115366|NCT03010137|20002263|P1|NOT COMPLETED|Overall Study||0
8115367|NCT03010137|20002262|P2|COMPLETED|Overall Study||15
8115368|NCT03010137|20002263|P1|COMPLETED|Overall Study||15
8115369|NCT03010137|20002262|P2|STARTED|Overall Study||15
8115370|NCT03010137|20002263|P1|STARTED|Overall Study||15
8115371|NCT03009162|20002279|P2|NOT COMPLETED|Overall Study||0
8115372|NCT03009162|20002280|P1|NOT COMPLETED|Overall Study||0
8115373|NCT03009162|20002279|P2|COMPLETED|Overall Study||8
8115374|NCT03009162|20002280|P1|COMPLETED|Overall Study||8
8115375|NCT03009162|20002279|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8115376|NCT03009162|20002280|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8115377|NCT03009162|20002279|P2|STARTED|Overall Study||8
8115378|NCT03009162|20002280|P1|STARTED|Overall Study||8
8115379|NCT03008889|20002302|P2|NOT COMPLETED|Overall Study||0
8115380|NCT03008889|20002303|P1|NOT COMPLETED|Overall Study||0
8115381|NCT03008889|20002302|P2|COMPLETED|Overall Study||1
8115382|NCT03008889|20002303|P1|COMPLETED|Overall Study||1
8115383|NCT03008889|20002302|P2|STARTED|Overall Study||1
8115384|NCT03008889|20002303|P1|STARTED|Overall Study||1
8115385|NCT03008837|20002328|P2|NOT COMPLETED|Overall Study||4
8115386|NCT03008837|20002329|P1|NOT COMPLETED|Overall Study||3
8115387|NCT03008837|20002328|P2|COMPLETED|Overall Study||5
8115388|NCT03008837|20002329|P1|COMPLETED|Overall Study||9
8115389|NCT03008837|20002328|P2|STARTED|Overall Study||9
8115390|NCT03008837|20002329|P1|STARTED|Overall Study||12
8115391|NCT03008707|20002347|P2|NOT COMPLETED|Overall Study||0
8115392|NCT03008707|20002348|P1|NOT COMPLETED|Overall Study||0
8115393|NCT03008707|20002347|P2|COMPLETED|Overall Study||38
8115394|NCT03008707|20002348|P1|COMPLETED|Overall Study||28
8115395|NCT03008707|20002347|P2|STARTED|Overall Study||38
8115396|NCT03008707|20002348|P1|STARTED|Overall Study||28
8115397|NCT03008213|20002368|P1|NOT COMPLETED|Overall Study||0
8115398|NCT03008213|20002368|P1|COMPLETED|Overall Study||1
8115399|NCT03008213|20002368|P1|STARTED|Overall Study||1
8115400|NCT03008174|20002374|P2|NOT COMPLETED|Overall Study||4
8115401|NCT03008174|20002375|P1|NOT COMPLETED|Overall Study||3
8115402|NCT03008174|20002374|P2|COMPLETED|Overall Study||6
8115403|NCT03008174|20002375|P1|COMPLETED|Overall Study||7
8115404|NCT03008174|20002374|P2|STARTED|Overall Study||10
8115405|NCT03008174|20002375|P1|STARTED|Overall Study||10
8115406|NCT03007966|20002403|P2|NOT COMPLETED|Overall Study||0
8115407|NCT03007966|20002404|P1|NOT COMPLETED|Overall Study||1
8115408|NCT03007966|20002403|P2|COMPLETED|Overall Study||30
8115409|NCT03007966|20002404|P1|COMPLETED|Overall Study||29
8115410|NCT03007966|20002403|P2|STARTED|Overall Study||30
8115411|NCT03007966|20002404|P1|STARTED|Overall Study||30
8115412|NCT03007719|20002436|P2|NOT COMPLETED|Overall Study||0
8115413|NCT03007719|20002437|P1|NOT COMPLETED|Overall Study||0
8115414|NCT03007719|20002436|P2|COMPLETED|Overall Study||4
8115415|NCT03007719|20002437|P1|COMPLETED|Overall Study||0
8115416|NCT03007719|20002436|P2|STARTED|Overall Study||4
8115417|NCT03007719|20002437|P1|STARTED|Overall Study||0
8115418|NCT03007472|20002445|P1|NOT COMPLETED|Overall Study||5
8115419|NCT03007472|20002445|P1|COMPLETED|Overall Study||91
8115420|NCT03007472|20002445|P1|STARTED|Overall Study||96
8115421|NCT03007394|20002453|P2|NOT COMPLETED|Overall Study||63
8115422|NCT03007394|20002454|P1|NOT COMPLETED|Overall Study||27
8115423|NCT03007394|20002453|P2|COMPLETED|Overall Study||91
8115424|NCT03007394|20002454|P1|COMPLETED|Overall Study||91
8115425|NCT03007394|20002453|P2|STARTED|Overall Study||154
8115426|NCT03007394|20002454|P1|STARTED|Overall Study||118
8115427|NCT03007225|20002464|P2|NOT COMPLETED|Overall Study||0
8115428|NCT03007225|20002465|P1|NOT COMPLETED|Overall Study||0
8115429|NCT03007225|20002464|P2|COMPLETED|Overall Study||25
8115430|NCT03007225|20002465|P1|COMPLETED|Overall Study||25
8115431|NCT03007225|20002464|P2|STARTED|Overall Study|followed up for at least 6 months after TACE|25
8115432|NCT03007225|20002465|P1|STARTED|Overall Study|Followed up for at least 6 months after DEB TACE|25
8115433|NCT03006926|20002473|P2|NOT COMPLETED|Overall Study||98
8115434|NCT03006926|20002474|P1|NOT COMPLETED|Overall Study||0
8115435|NCT03006926|20002473|P2|COMPLETED|Overall Study||0
8115436|NCT03006926|20002474|P1|COMPLETED|Overall Study||6
8115437|NCT03006926|20002473|P2|STARTED|Overall Study||98
8115438|NCT03006926|20002474|P1|STARTED|Overall Study||6
8115439|NCT03006562|20002494|P2|NOT COMPLETED|Overall Study||1
8115440|NCT03006562|20002495|P1|NOT COMPLETED|Overall Study||0
8115441|NCT03006562|20002494|P2|COMPLETED|Overall Study||249
8115442|NCT03006562|20002495|P1|COMPLETED|Overall Study||251
8115443|NCT03006562|20002494|P2|Voluntary Ultrasound at 30 Days|Overall Study||137
8115444|NCT03006562|20002495|P1|Voluntary Ultrasound at 30 Days|Overall Study||141
8115445|NCT03006562|20002494|P2|STARTED|Overall Study||250
8115446|NCT03006562|20002495|P1|STARTED|Overall Study||251
8115447|NCT03006471|20002515|P2|NOT COMPLETED|Overall Study||2
8115448|NCT03006471|20002516|P1|NOT COMPLETED|Overall Study||2
8115449|NCT03006471|20002515|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
8115450|NCT03006471|20002516|P1|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
8115451|NCT03006471|20002515|P2|STARTED|Overall Study||15
8115452|NCT03006471|20002516|P1|STARTED|Overall Study||15
8115453|NCT03006458|20002586|P2|NOT COMPLETED|Second Intervention||0
8115454|NCT03006458|20002587|P1|NOT COMPLETED|Second Intervention||0
8115455|NCT03006458|20002586|P2|COMPLETED|Second Intervention||10
8115456|NCT03006458|20002587|P1|COMPLETED|Second Intervention||14
8115457|NCT03006458|20002586|P2|STARTED|Second Intervention||10
8115458|NCT03006458|20002587|P1|STARTED|Second Intervention||14
8115459|NCT03006458|20002586|P2|NOT COMPLETED|First Intervention||3
8115460|NCT03006458|20002587|P1|NOT COMPLETED|First Intervention||0
8115461|NCT03006458|20002586|P2|COMPLETED|First Intervention||7
8115462|NCT03006458|20002587|P1|COMPLETED|First Intervention||14
8115463|NCT03006458|20002586|P2|STARTED|First Intervention||10
8115464|NCT03006458|20002587|P1|STARTED|First Intervention||14
8115465|NCT03006341|20002629|P4|NOT COMPLETED|Overall Study||10685
8115466|NCT03006341|20002630|P3|NOT COMPLETED|Overall Study||30993
8115467|NCT03006341|20002631|P2|NOT COMPLETED|Overall Study||67505
8115468|NCT03006341|20002632|P1|NOT COMPLETED|Overall Study||25069
8115469|NCT03006341|20002629|P4|COMPLETED|Overall Study||637
8115470|NCT03006341|20002630|P3|COMPLETED|Overall Study||1602
8115471|NCT03006341|20002631|P2|COMPLETED|Overall Study||2566
8115472|NCT03006341|20002632|P1|COMPLETED|Overall Study||1130
8115473|NCT03006341|20002629|P4|STARTED|Overall Study||11322
8115474|NCT03006341|20002630|P3|STARTED|Overall Study||32595
8115475|NCT03006341|20002631|P2|STARTED|Overall Study||70071
8115476|NCT03006341|20002632|P1|STARTED|Overall Study||26199
8115477|NCT03005288|20002676|P2|NOT COMPLETED|Overall Study||8
8115478|NCT03005288|20002677|P1|NOT COMPLETED|Overall Study||12
8115479|NCT03005288|20002676|P2|COMPLETED|Overall Study||31
8115480|NCT03005288|20002677|P1|COMPLETED|Overall Study||27
8115481|NCT03005288|20002676|P2|Pharmacodynamics (PD) Analysis Set|Overall Study|Two subjects were excluded due to protocol deviations.|36
8115482|NCT03005288|20002677|P1|Pharmacodynamics (PD) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
8115483|NCT03005288|20002676|P2|Pharmacokinetics (PK) Analysis Set|Overall Study|PK samples were only obtained and evaluated for subjects treated with BYM338.|0
8115484|NCT03005288|20002677|P1|Pharmacokinetics (PK) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
8115485|NCT03005288|20002676|P2|Safety Analysis Set|Overall Study||38
8115486|NCT03005288|20002677|P1|Safety Analysis Set|Overall Study||37
8115487|NCT03005288|20002676|P2|STARTED|Overall Study||39
8115488|NCT03005288|20002677|P1|STARTED|Overall Study||39
8115489|NCT03005067|20002709|P2|NOT COMPLETED|Overall Study||7
8115490|NCT03005067|20002710|P1|NOT COMPLETED|Overall Study||10
8115491|NCT03005067|20002709|P2|COMPLETED|Overall Study||74
8115492|NCT03005067|20002710|P1|COMPLETED|Overall Study||80
8115493|NCT03005067|20002709|P2|STARTED|Overall Study||81
8115494|NCT03005067|20002710|P1|STARTED|Overall Study||90
8115495|NCT03005041|20002722|P2|NOT COMPLETED|Period 2||0
8115496|NCT03005041|20002723|P1|NOT COMPLETED|Period 2||0
8115497|NCT03005041|20002722|P2|COMPLETED|Period 2||27
8115498|NCT03005041|20002723|P1|COMPLETED|Period 2||28
8115499|NCT03005041|20002722|P2|STARTED|Period 2||27
8115500|NCT03005041|20002723|P1|STARTED|Period 2||28
8115501|NCT03005041|20002722|P2|NOT COMPLETED|Washout Period 1||0
8115502|NCT03005041|20002723|P1|NOT COMPLETED|Washout Period 1||0
8115503|NCT03005041|20002722|P2|COMPLETED|Washout Period 1||27
8115504|NCT03005041|20002723|P1|COMPLETED|Washout Period 1||28
8115505|NCT03005041|20002722|P2|STARTED|Washout Period 1||27
8115506|NCT03005041|20002723|P1|STARTED|Washout Period 1||28
8115507|NCT03005041|20002722|P2|NOT COMPLETED|Period 1||0
8115508|NCT03005041|20002723|P1|NOT COMPLETED|Period 1||0
8115509|NCT03005041|20002722|P2|COMPLETED|Period 1||27
8115510|NCT03005041|20002723|P1|COMPLETED|Period 1||28
8115511|NCT03005041|20002722|P2|STARTED|Period 1||27
8115512|NCT03005041|20002723|P1|STARTED|Period 1||28
8115522|NCT03004911|20002792|P2|NOT COMPLETED|Overall Study||3
8115523|NCT03004911|20002793|P1|NOT COMPLETED|Overall Study||1
8115524|NCT03004911|20002792|P2|COMPLETED|Overall Study||17
8115525|NCT03004911|20002793|P1|COMPLETED|Overall Study||19
8115526|NCT03004911|20002792|P2|STARTED|Overall Study||20
8115527|NCT03004911|20002793|P1|STARTED|Overall Study||20
8115528|NCT03004846|20002811|P3|NOT COMPLETED|Part B (Up to 14 Weeks)||0
8115529|NCT03004846|20002812|P2|NOT COMPLETED|Part B (Up to 14 Weeks)||0
8115530|NCT03004846|20002813|P1|NOT COMPLETED|Part B (Up to 14 Weeks)||0
8115531|NCT03004846|20002811|P3|COMPLETED|Part B (Up to 14 Weeks)||0
8115532|NCT03004846|20002812|P2|COMPLETED|Part B (Up to 14 Weeks)||0
8115533|NCT03004846|20002813|P1|COMPLETED|Part B (Up to 14 Weeks)||0
8115534|NCT03004846|20002811|P3|STARTED|Part B (Up to 14 Weeks)||0
8115535|NCT03004846|20002812|P2|STARTED|Part B (Up to 14 Weeks)||0
8115536|NCT03004846|20002813|P1|STARTED|Part B (Up to 14 Weeks)||0
8115537|NCT03004846|20002811|P3|NOT COMPLETED|Part A (Up to 14 Weeks)||0
8115538|NCT03004846|20002812|P2|NOT COMPLETED|Part A (Up to 14 Weeks)||0
8115539|NCT03004846|20002813|P1|NOT COMPLETED|Part A (Up to 14 Weeks)||0
8115540|NCT03004846|20002811|P3|COMPLETED|Part A (Up to 14 Weeks)||0
8115541|NCT03004846|20002812|P2|COMPLETED|Part A (Up to 14 Weeks)||0
8115542|NCT03004846|20002813|P1|COMPLETED|Part A (Up to 14 Weeks)||8
8115543|NCT03004846|20002811|P3|STARTED|Part A (Up to 14 Weeks)||0
8115544|NCT03004846|20002812|P2|STARTED|Part A (Up to 14 Weeks)||0
8115545|NCT03004846|20002813|P1|STARTED|Part A (Up to 14 Weeks)||8
8115546|NCT03004638|20002865|P6|NOT COMPLETED|Overall Study||0
8115547|NCT03004638|20002866|P5|NOT COMPLETED|Overall Study||0
8115548|NCT03004638|20002867|P4|NOT COMPLETED|Overall Study||0
8115549|NCT03004638|20002868|P3|NOT COMPLETED|Overall Study||0
8115550|NCT03004638|20002869|P2|NOT COMPLETED|Overall Study||0
8115551|NCT03004638|20002870|P1|NOT COMPLETED|Overall Study||0
8115552|NCT03004638|20002865|P6|COMPLETED|Overall Study||7
8115553|NCT03004638|20002866|P5|COMPLETED|Overall Study||1
8115554|NCT03004638|20002867|P4|COMPLETED|Overall Study||6
8115555|NCT03004638|20002868|P3|COMPLETED|Overall Study||6
8115556|NCT03004638|20002869|P2|COMPLETED|Overall Study||6
8115557|NCT03004638|20002870|P1|COMPLETED|Overall Study||6
8115558|NCT03004638|20002865|P6|STARTED|Overall Study||7
8115559|NCT03004638|20002866|P5|STARTED|Overall Study||1
8115560|NCT03004638|20002867|P4|STARTED|Overall Study||6
8115561|NCT03004638|20002868|P3|STARTED|Overall Study||6
8115562|NCT03004638|20002869|P2|STARTED|Overall Study||6
8115563|NCT03004638|20002870|P1|STARTED|Overall Study||6
8115564|NCT03004534|20002976|P1|NOT COMPLETED|Overall Study||0
8115565|NCT03004534|20002976|P1|COMPLETED|Overall Study||36
8115566|NCT03004534|20002976|P1|STARTED|Overall Study||36
8115567|NCT03004469|20002984|P3|NOT COMPLETED|Overall Study||25
8115568|NCT03004469|20002985|P2|NOT COMPLETED|Overall Study||49
8115569|NCT03004469|20002986|P1|NOT COMPLETED|Overall Study||61
8115570|NCT03004469|20002984|P3|COMPLETED|Overall Study||60
8115571|NCT03004469|20002985|P2|COMPLETED|Overall Study||135
8115572|NCT03004469|20002986|P1|COMPLETED|Overall Study||128
8115573|NCT03004469|20002984|P3|STARTED|Overall Study||85
8115574|NCT03004469|20002985|P2|STARTED|Overall Study||184
8115575|NCT03004469|20002986|P1|STARTED|Overall Study||189
8115576|NCT03003793|20003020|P2|NOT COMPLETED|Overall Study||0
8115577|NCT03003793|20003021|P1|NOT COMPLETED|Overall Study||0
8115578|NCT03003793|20003020|P2|COMPLETED|Overall Study||16
8115579|NCT03003793|20003021|P1|COMPLETED|Overall Study||16
8115580|NCT03003793|20003020|P2|STARTED|Overall Study||16
8115581|NCT03003793|20003021|P1|STARTED|Overall Study||16
8115582|NCT03003520|20003029|P2|NOT COMPLETED|Follow-up||3
8115583|NCT03003520|20003030|P1|NOT COMPLETED|Follow-up||14
8115584|NCT03003520|20003029|P2|COMPLETED|Follow-up||0
8115585|NCT03003520|20003030|P1|COMPLETED|Follow-up||0
8115586|NCT03003520|20003029|P2|STARTED|Follow-up||3
8115587|NCT03003520|20003030|P1|STARTED|Follow-up||14
8115588|NCT03003520|20003029|P2|NOT COMPLETED|Consolidation||1
8115589|NCT03003520|20003030|P1|NOT COMPLETED|Consolidation||24
8115590|NCT03003520|20003029|P2|COMPLETED|Consolidation||2
8115591|NCT03003520|20003030|P1|COMPLETED|Consolidation||1
8115592|NCT03003520|20003029|P2|STARTED|Consolidation||3
8115593|NCT03003520|20003030|P1|STARTED|Consolidation||25
8115594|NCT03003520|20003029|P2|NOT COMPLETED|Induction||0
8115595|NCT03003520|20003030|P1|NOT COMPLETED|Induction||13
8115596|NCT03003520|20003029|P2|COMPLETED|Induction||3
8115597|NCT03003520|20003030|P1|COMPLETED|Induction||30
8115598|NCT03003520|20003029|P2|Efficacy Evaluable Population|Induction||3
8115599|NCT03003520|20003030|P1|Efficacy Evaluable Population|Induction||37
8115600|NCT03003520|20003029|P2|Safety Population|Induction||3
8115601|NCT03003520|20003030|P1|Safety Population|Induction||43
8115602|NCT03003520|20003029|P2|STARTED|Induction||3
8115603|NCT03003520|20003030|P1|STARTED|Induction||43
8115604|NCT03003494|20003048|P1|NOT COMPLETED|Overall Study||28
8115605|NCT03003494|20003048|P1|COMPLETED|Overall Study||278
8115606|NCT03003494|20003048|P1|STARTED|Overall Study||306
8115607|NCT03003390|20003059|P2|NOT COMPLETED|Overall Study||0
8115608|NCT03003390|20003060|P1|NOT COMPLETED|Overall Study||4
8115609|NCT03003390|20003059|P2|COMPLETED|Overall Study||24
8115610|NCT03003390|20003060|P1|COMPLETED|Overall Study||23
8115611|NCT03003390|20003059|P2|STARTED|Overall Study||24
8115612|NCT03003390|20003060|P1|STARTED|Overall Study||27
8115613|NCT03003000|20003088|P3|NOT COMPLETED|Overall Study||5
8115614|NCT03003000|20003089|P2|NOT COMPLETED|Overall Study||4
8115615|NCT03003000|20003090|P1|NOT COMPLETED|Overall Study||5
8115616|NCT03003000|20003088|P3|COMPLETED|Overall Study||251
8115617|NCT03003000|20003089|P2|COMPLETED|Overall Study||249
8115618|NCT03003000|20003090|P1|COMPLETED|Overall Study||121
8115619|NCT03003000|20003088|P3|STARTED|Overall Study||256
8115620|NCT03003000|20003089|P2|STARTED|Overall Study||253
8115621|NCT03003000|20003090|P1|STARTED|Overall Study||126
8115622|NCT03002974|20003119|P3|NOT COMPLETED|Overall Study||18
8115623|NCT03002974|20003120|P2|NOT COMPLETED|Overall Study||16
8115624|NCT03002974|20003121|P1|NOT COMPLETED|Overall Study||20
8115625|NCT03002974|20003119|P3|COMPLETED|Overall Study||36
8115626|NCT03002974|20003120|P2|COMPLETED|Overall Study||40
8115627|NCT03002974|20003121|P1|COMPLETED|Overall Study||35
8115628|NCT03002974|20003119|P3|Safety Population|Overall Study||52
8115629|NCT03002974|20003120|P2|Safety Population|Overall Study||55
8115630|NCT03002974|20003121|P1|Safety Population|Overall Study||54
8115631|NCT03002974|20003119|P3|Intention To Treat Populatio|Overall Study||54
8115632|NCT03002974|20003120|P2|Intention To Treat Populatio|Overall Study||56
8115633|NCT03002974|20003121|P1|Intention To Treat Populatio|Overall Study||55
8115634|NCT03002974|20003119|P3|STARTED|Overall Study||54
8115635|NCT03002974|20003120|P2|STARTED|Overall Study||56
8115636|NCT03002974|20003121|P1|STARTED|Overall Study||55
8115637|NCT03002818|20003192|P1|NOT COMPLETED|Overall Study||1
8115638|NCT03002818|20003192|P1|COMPLETED|Overall Study||40
8115639|NCT03002818|20003192|P1|STARTED|Overall Study||41
8115640|NCT03002753|20003206|P3|NOT COMPLETED|Second Randomization (Re-randomization)||0
8115641|NCT03002753|20003207|P2|NOT COMPLETED|Second Randomization (Re-randomization)||1
8115642|NCT03002753|20003208|P1|NOT COMPLETED|Second Randomization (Re-randomization)||0
8115643|NCT03002753|20003206|P3|COMPLETED|Second Randomization (Re-randomization)||0
8115644|NCT03002753|20003207|P2|COMPLETED|Second Randomization (Re-randomization)||9
8115645|NCT03002753|20003208|P1|COMPLETED|Second Randomization (Re-randomization)||11
8115646|NCT03002753|20003206|P3|STARTED|Second Randomization (Re-randomization)||0
8115647|NCT03002753|20003207|P2|STARTED|Second Randomization (Re-randomization)||10
8115648|NCT03002753|20003208|P1|STARTED|Second Randomization (Re-randomization)||11
8115649|NCT03002753|20003206|P3|NOT COMPLETED|First Randomization||0
8115650|NCT03002753|20003207|P2|NOT COMPLETED|First Randomization||1
8115651|NCT03002753|20003208|P1|NOT COMPLETED|First Randomization||1
8115652|NCT03002753|20003206|P3|COMPLETED|First Randomization||21
8115653|NCT03002753|20003207|P2|COMPLETED|First Randomization||11
8115654|NCT03002753|20003208|P1|COMPLETED|First Randomization||9
8115655|NCT03002753|20003206|P3|STARTED|First Randomization||21
8115656|NCT03002753|20003207|P2|STARTED|First Randomization||12
8115657|NCT03002753|20003208|P1|STARTED|First Randomization||10
8115658|NCT03002623|20003218|P2|NOT COMPLETED|Overall Study||1
8115659|NCT03002623|20003219|P1|NOT COMPLETED|Overall Study||2
8115660|NCT03002623|20003218|P2|COMPLETED|Overall Study||2
8115661|NCT03002623|20003219|P1|COMPLETED|Overall Study||2
8115662|NCT03002623|20003218|P2|STARTED|Overall Study||3
8115663|NCT03002623|20003219|P1|STARTED|Overall Study||4
8115664|NCT03002610|20003236|P3|NOT COMPLETED|Overall Study||13
8115665|NCT03002610|20003237|P2|NOT COMPLETED|Overall Study||25
8115666|NCT03002610|20003238|P1|NOT COMPLETED|Overall Study||6
8115667|NCT03002610|20003236|P3|COMPLETED|Overall Study||21
8115668|NCT03002610|20003237|P2|COMPLETED|Overall Study||25
8115669|NCT03002610|20003238|P1|COMPLETED|Overall Study||18
8115670|NCT03002610|20003236|P3|STARTED|Overall Study||34
8115671|NCT03002610|20003237|P2|STARTED|Overall Study||50
8115672|NCT03002610|20003238|P1|STARTED|Overall Study||24
8115673|NCT03002454|20003255|P1|NOT COMPLETED|Overall Study||0
8115674|NCT03002454|20003255|P1|COMPLETED|Overall Study||4
8115675|NCT03002454|20003255|P1|STARTED|Overall Study||4
8115676|NCT03002311|20003262|P2|NOT COMPLETED|Overall Study||30
8115677|NCT03002311|20003263|P1|NOT COMPLETED|Overall Study||19
8115678|NCT03002311|20003262|P2|COMPLETED|Overall Study||150
8115679|NCT03002311|20003263|P1|COMPLETED|Overall Study||128
8115680|NCT03002311|20003262|P2|STARTED|Overall Study||180
8115681|NCT03002311|20003263|P1|STARTED|Overall Study||147
8115682|NCT03002194|20003271|P1|NOT COMPLETED|Overall Study||10
8115683|NCT03002194|20003271|P1|COMPLETED|Overall Study||38
8115684|NCT03002194|20003271|P1|STARTED|Overall Study||48
8115685|NCT03002077|20003277|P1|NOT COMPLETED|Overall Study||438
8115686|NCT03002077|20003277|P1|COMPLETED|Overall Study||179
8115687|NCT03002077|20003277|P1|STARTED|Overall Study||617
8115688|NCT03002038|20003285|P2|NOT COMPLETED|Overall Study||7
8115689|NCT03002038|20003286|P1|NOT COMPLETED|Overall Study||11
8115690|NCT03002038|20003285|P2|COMPLETED|Overall Study||33
8115691|NCT03002038|20003286|P1|COMPLETED|Overall Study||35
8115692|NCT03002038|20003285|P2|STARTED|Overall Study||40
8115693|NCT03002038|20003286|P1|STARTED|Overall Study||46
8115694|NCT03002012|20003298|P2|NOT COMPLETED|Overall Study||0
8115695|NCT03002012|20003299|P1|NOT COMPLETED|Overall Study||0
8115696|NCT03002012|20003298|P2|COMPLETED|Overall Study||11
8115697|NCT03002012|20003299|P1|COMPLETED|Overall Study||11
8115698|NCT03002012|20003298|P2|STARTED|Overall Study||11
8115699|NCT03002012|20003299|P1|STARTED|Overall Study||11
8115700|NCT03001778|20003321|P2|NOT COMPLETED|Overall Study||0
8115701|NCT03001778|20003322|P1|NOT COMPLETED|Overall Study||0
8115702|NCT03001778|20003321|P2|COMPLETED|Overall Study||46
8115703|NCT03001778|20003322|P1|COMPLETED|Overall Study||21
8115704|NCT03001778|20003321|P2|STARTED|Overall Study||46
8115705|NCT03001778|20003322|P1|STARTED|Overall Study||21
8115706|NCT03001674|20003330|P2|NOT COMPLETED|Overall Study||0
8115707|NCT03001674|20003331|P1|NOT COMPLETED|Overall Study||0
8115708|NCT03001674|20003330|P2|COMPLETED|Overall Study||5
8115709|NCT03001674|20003331|P1|COMPLETED|Overall Study||10
8115710|NCT03001674|20003330|P2|STARTED|Overall Study||5
8115711|NCT03001674|20003331|P1|STARTED|Overall Study||10
8115732|NCT03001453|20003615|P2|NOT COMPLETED|Overall Study||0
8115733|NCT03001453|20003616|P1|NOT COMPLETED|Overall Study||0
8115734|NCT03001453|20003615|P2|COMPLETED|Overall Study||57
8115735|NCT03001453|20003616|P1|COMPLETED|Overall Study||50
8115736|NCT03001453|20003615|P2|STARTED|Overall Study||57
8115737|NCT03001453|20003616|P1|STARTED|Overall Study||50
8115738|NCT03001258|20003633|P3|NOT COMPLETED|Overall Study||0
8115739|NCT03001258|20003634|P2|NOT COMPLETED|Overall Study||0
8115740|NCT03001258|20003635|P1|NOT COMPLETED|Overall Study||0
8115741|NCT03001258|20003633|P3|COMPLETED|Overall Study||485
8115742|NCT03001258|20003634|P2|COMPLETED|Overall Study||751
8115743|NCT03001258|20003635|P1|COMPLETED|Overall Study||765
8115744|NCT03001258|20003633|P3|STARTED|Overall Study||485
8115745|NCT03001258|20003634|P2|STARTED|Overall Study||751
8115746|NCT03001258|20003635|P1|STARTED|Overall Study||765
8115747|NCT03001219|20003645|P2|NOT COMPLETED|Extension Period Analysis||45
8115748|NCT03001219|20003646|P1|NOT COMPLETED|Extension Period Analysis||5
8115749|NCT03001219|20003645|P2|COMPLETED|Extension Period Analysis||52
8115750|NCT03001219|20003646|P1|COMPLETED|Extension Period Analysis||4
8115751|NCT03001219|20003645|P2|STARTED|Extension Period Analysis||97
8115752|NCT03001219|20003646|P1|STARTED|Extension Period Analysis||9
8115753|NCT03001219|20003645|P2|NOT COMPLETED|Proof of Concept||7
8115754|NCT03001219|20003646|P1|NOT COMPLETED|Proof of Concept||2
8115755|NCT03001219|20003645|P2|COMPLETED|Proof of Concept||65
8115756|NCT03001219|20003646|P1|COMPLETED|Proof of Concept||35
8115757|NCT03001219|20003645|P2|STARTED|Proof of Concept||72
8115758|NCT03001219|20003646|P1|STARTED|Proof of Concept||37
8115759|NCT03001076|20003707|P2|NOT COMPLETED|Overall Study||5
8115760|NCT03001076|20003708|P1|NOT COMPLETED|Overall Study||7
8115761|NCT03001076|20003707|P2|COMPLETED|Overall Study||176
8115762|NCT03001076|20003708|P1|COMPLETED|Overall Study||81
8115763|NCT03001076|20003707|P2|STARTED|Overall Study||181
8115764|NCT03001076|20003708|P1|STARTED|Overall Study||88
8115765|NCT03001011|20003742|P2|NOT COMPLETED|Overall Study||21
8115766|NCT03001011|20003743|P1|NOT COMPLETED|Overall Study||27
8115767|NCT03001011|20003742|P2|COMPLETED|Overall Study||80
8115768|NCT03001011|20003743|P1|COMPLETED|Overall Study||74
8115769|NCT03001011|20003742|P2|STARTED|Overall Study||101
8115770|NCT03001011|20003743|P1|STARTED|Overall Study||101
8115771|NCT03000686|20003777|P4|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8115772|NCT03000686|20003778|P3|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8115773|NCT03000686|20003779|P2|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8115774|NCT03000686|20003780|P1|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8115775|NCT03000686|20003777|P4|COMPLETED|Part 2, Period 2 (1 Day)||3
8115776|NCT03000686|20003778|P3|COMPLETED|Part 2, Period 2 (1 Day)||3
8115777|NCT03000686|20003779|P2|COMPLETED|Part 2, Period 2 (1 Day)||0
8115778|NCT03000686|20003780|P1|COMPLETED|Part 2, Period 2 (1 Day)||0
8115779|NCT03000686|20003777|P4|STARTED|Part 2, Period 2 (1 Day)||3
8115780|NCT03000686|20003778|P3|STARTED|Part 2, Period 2 (1 Day)||3
8115781|NCT03000686|20003779|P2|STARTED|Part 2, Period 2 (1 Day)||0
8115782|NCT03000686|20003780|P1|STARTED|Part 2, Period 2 (1 Day)||0
8115783|NCT03000686|20003777|P4|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
8115784|NCT03000686|20003778|P3|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
8115785|NCT03000686|20003779|P2|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
8115786|NCT03000686|20003780|P1|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
8115787|NCT03000686|20003777|P4|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
8115788|NCT03000686|20003778|P3|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
8115789|NCT03000686|20003779|P2|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
8115790|NCT03000686|20003780|P1|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
8115791|NCT03000686|20003777|P4|STARTED|Part 2, Wash-out (Up to 14 Days)||3
8115792|NCT03000686|20003778|P3|STARTED|Part 2, Wash-out (Up to 14 Days)||3
8115793|NCT03000686|20003779|P2|STARTED|Part 2, Wash-out (Up to 14 Days)||0
8115794|NCT03000686|20003780|P1|STARTED|Part 2, Wash-out (Up to 14 Days)||0
8115795|NCT03000686|20003777|P4|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8115796|NCT03000686|20003778|P3|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8115797|NCT03000686|20003779|P2|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8115798|NCT03000686|20003780|P1|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8115799|NCT03000686|20003777|P4|COMPLETED|Part 2, Period 1 (1 Day)||3
8115800|NCT03000686|20003778|P3|COMPLETED|Part 2, Period 1 (1 Day)||3
8115801|NCT03000686|20003779|P2|COMPLETED|Part 2, Period 1 (1 Day)||0
8115802|NCT03000686|20003780|P1|COMPLETED|Part 2, Period 1 (1 Day)||0
8115803|NCT03000686|20003777|P4|STARTED|Part 2, Period 1 (1 Day)||3
8115804|NCT03000686|20003778|P3|STARTED|Part 2, Period 1 (1 Day)||3
8115805|NCT03000686|20003779|P2|STARTED|Part 2, Period 1 (1 Day)||0
8115806|NCT03000686|20003780|P1|STARTED|Part 2, Period 1 (1 Day)||0
8115807|NCT03000686|20003777|P4|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8115808|NCT03000686|20003778|P3|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8115809|NCT03000686|20003779|P2|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8115810|NCT03000686|20003780|P1|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8115811|NCT03000686|20003777|P4|COMPLETED|Part 1, Period 2 (1 Day)||0
8115812|NCT03000686|20003778|P3|COMPLETED|Part 1, Period 2 (1 Day)||0
8115813|NCT03000686|20003779|P2|COMPLETED|Part 1, Period 2 (1 Day)||5
8115814|NCT03000686|20003780|P1|COMPLETED|Part 1, Period 2 (1 Day)||5
8115815|NCT03000686|20003777|P4|STARTED|Part 1, Period 2 (1 Day)||0
8115816|NCT03000686|20003778|P3|STARTED|Part 1, Period 2 (1 Day)||0
8115817|NCT03000686|20003779|P2|STARTED|Part 1, Period 2 (1 Day)||5
8115818|NCT03000686|20003780|P1|STARTED|Part 1, Period 2 (1 Day)||5
8115819|NCT03000686|20003777|P4|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
8115820|NCT03000686|20003778|P3|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
8115821|NCT03000686|20003779|P2|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
8115822|NCT03000686|20003780|P1|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
8115823|NCT03000686|20003777|P4|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
8115824|NCT03000686|20003778|P3|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
8115825|NCT03000686|20003779|P2|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
8115826|NCT03000686|20003780|P1|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
8115827|NCT03000686|20003777|P4|STARTED|Part 1, Wash-out (Up to 14 Days)||0
8115828|NCT03000686|20003778|P3|STARTED|Part 1, Wash-out (Up to 14 Days)||0
8115829|NCT03000686|20003779|P2|STARTED|Part 1, Wash-out (Up to 14 Days)||5
8115830|NCT03000686|20003780|P1|STARTED|Part 1, Wash-out (Up to 14 Days)||5
8115831|NCT03000686|20003777|P4|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
8115832|NCT03000686|20003778|P3|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
8115833|NCT03000686|20003779|P2|NOT COMPLETED|Part 1, Period 1 (1 Day)||1
8115834|NCT03000686|20003780|P1|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
8115835|NCT03000686|20003777|P4|COMPLETED|Part 1, Period 1 (1 Day)||0
8115836|NCT03000686|20003778|P3|COMPLETED|Part 1, Period 1 (1 Day)||0
8115837|NCT03000686|20003779|P2|COMPLETED|Part 1, Period 1 (1 Day)||5
8115838|NCT03000686|20003780|P1|COMPLETED|Part 1, Period 1 (1 Day)||5
8115839|NCT03000686|20003777|P4|STARTED|Part 1, Period 1 (1 Day)||0
8115840|NCT03000686|20003778|P3|STARTED|Part 1, Period 1 (1 Day)||0
8115841|NCT03000686|20003779|P2|STARTED|Part 1, Period 1 (1 Day)||6
8115842|NCT03000686|20003780|P1|STARTED|Part 1, Period 1 (1 Day)||5
8115843|NCT03000673|20003850|P4|NOT COMPLETED|Overall Study||0
8115844|NCT03000673|20003851|P3|NOT COMPLETED|Overall Study||0
8115845|NCT03000673|20003852|P2|NOT COMPLETED|Overall Study||0
8115846|NCT03000673|20003853|P1|NOT COMPLETED|Overall Study||1
8115847|NCT03000673|20003850|P4|COMPLETED|Overall Study||9
8115848|NCT03000673|20003851|P3|COMPLETED|Overall Study||7
8115849|NCT03000673|20003852|P2|COMPLETED|Overall Study||9
8115850|NCT03000673|20003853|P1|COMPLETED|Overall Study||6
8115851|NCT03000673|20003850|P4|STARTED|Overall Study||9
8115852|NCT03000673|20003851|P3|STARTED|Overall Study||7
8115853|NCT03000673|20003852|P2|STARTED|Overall Study||9
8115854|NCT03000673|20003853|P1|STARTED|Overall Study||7
8115855|NCT03000608|20003935|P2|NOT COMPLETED|Overall Study||4
8115856|NCT03000608|20003936|P1|NOT COMPLETED|Overall Study||6
8115857|NCT03000608|20003935|P2|COMPLETED|Overall Study||19
8115858|NCT03000608|20003936|P1|COMPLETED|Overall Study||40
8115859|NCT03000608|20003935|P2|STARTED|Overall Study||23
8115860|NCT03000608|20003936|P1|STARTED|Overall Study||46
8115861|NCT03000569|20003946|P2|NOT COMPLETED|Overall Study||0
8115862|NCT03000569|20003947|P1|NOT COMPLETED|Overall Study||1
8115863|NCT03000569|20003946|P2|COMPLETED|Overall Study||14
8115864|NCT03000569|20003947|P1|COMPLETED|Overall Study||14
8115865|NCT03000569|20003946|P2|STARTED|Overall Study||14
8115866|NCT03000569|20003947|P1|STARTED|Overall Study||15
8115867|NCT03000530|20004082|P3|NOT COMPLETED|Overall Study||4
8115868|NCT03000530|20004083|P2|NOT COMPLETED|Overall Study||5
8115869|NCT03000530|20004084|P1|NOT COMPLETED|Overall Study||0
8115870|NCT03000530|20004082|P3|COMPLETED|Overall Study||41
8115871|NCT03000530|20004083|P2|COMPLETED|Overall Study||39
8115872|NCT03000530|20004084|P1|COMPLETED|Overall Study||13
8115873|NCT03000530|20004082|P3|STARTED|Overall Study||45
8115874|NCT03000530|20004083|P2|STARTED|Overall Study||44
8115875|NCT03000530|20004084|P1|STARTED|Overall Study||13
8115876|NCT03000452|20004282|P1|NOT COMPLETED|Follow-Up Period||7
8115877|NCT03000452|20004282|P1|COMPLETED|Follow-Up Period||10
8115878|NCT03000452|20004282|P1|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
8115879|NCT03000452|20004282|P1|NOT COMPLETED|Treatment Period||18
8115880|NCT03000452|20004282|P1|COMPLETED|Treatment Period||0
8115881|NCT03000452|20004282|P1|STARTED|Treatment Period||18
8115882|NCT03000309|20004298|P1|NOT COMPLETED|Overall Study||1
8115883|NCT03000309|20004298|P1|COMPLETED|Overall Study||19
8115884|NCT03000309|20004298|P1|STARTED|Overall Study||20
8115885|NCT03000283|20004318|P1|NOT COMPLETED|Overall Study||0
8115886|NCT03000283|20004318|P1|COMPLETED|Overall Study||7
8115887|NCT03000283|20004318|P1|STARTED|Overall Study||7
8115888|NCT03000088|20004329|P2|NOT COMPLETED|Overall Study||0
8115889|NCT03000088|20004330|P1|NOT COMPLETED|Overall Study||0
8115890|NCT03000088|20004329|P2|COMPLETED|Overall Study||70
8115891|NCT03000088|20004330|P1|COMPLETED|Overall Study||70
8115892|NCT03000088|20004329|P2|STARTED|Overall Study||70
8115893|NCT03000088|20004330|P1|STARTED|Overall Study||70
8115894|NCT03000075|20004339|P7|NOT COMPLETED|Part B||1
8115895|NCT03000075|20004340|P6|NOT COMPLETED|Part B||2
8115896|NCT03000075|20004341|P5|NOT COMPLETED|Part B||1
8115897|NCT03000075|20004342|P4|NOT COMPLETED|Part B||0
8115898|NCT03000075|20004343|P3|NOT COMPLETED|Part B||0
8115899|NCT03000075|20004344|P2|NOT COMPLETED|Part B||0
8115900|NCT03000075|20004345|P1|NOT COMPLETED|Part B||0
8115901|NCT03000075|20004339|P7|COMPLETED|Part B||54
8115902|NCT03000075|20004340|P6|COMPLETED|Part B||56
8115903|NCT03000075|20004341|P5|COMPLETED|Part B||26
8115904|NCT03000075|20004342|P4|COMPLETED|Part B||27
8115905|NCT03000075|20004343|P3|COMPLETED|Part B||0
8115906|NCT03000075|20004344|P2|COMPLETED|Part B||0
8115907|NCT03000075|20004345|P1|COMPLETED|Part B||0
8115908|NCT03000075|20004339|P7|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55
8115909|NCT03000075|20004340|P6|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58
8115910|NCT03000075|20004341|P5|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27
8115911|NCT03000075|20004342|P4|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27
8115912|NCT03000075|20004343|P3|STARTED|Part B||0
8115913|NCT03000075|20004344|P2|STARTED|Part B||0
8115914|NCT03000075|20004345|P1|STARTED|Part B||0
8115915|NCT03000075|20004339|P7|NOT COMPLETED|Part A||0
8115916|NCT03000075|20004340|P6|NOT COMPLETED|Part A||0
8115917|NCT03000075|20004341|P5|NOT COMPLETED|Part A||0
8115918|NCT03000075|20004342|P4|NOT COMPLETED|Part A||0
8115919|NCT03000075|20004343|P3|NOT COMPLETED|Part A||0
8115920|NCT03000075|20004344|P2|NOT COMPLETED|Part A||0
8115921|NCT03000075|20004345|P1|NOT COMPLETED|Part A||4
8115922|NCT03000075|20004339|P7|COMPLETED|Part A||0
8115923|NCT03000075|20004340|P6|COMPLETED|Part A||0
8115924|NCT03000075|20004341|P5|COMPLETED|Part A||0
8115925|NCT03000075|20004342|P4|COMPLETED|Part A||0
8115926|NCT03000075|20004343|P3|COMPLETED|Part A||55
8115927|NCT03000075|20004344|P2|COMPLETED|Part A||58
8115928|NCT03000075|20004345|P1|COMPLETED|Part A||54
8115929|NCT03000075|20004339|P7|STARTED|Part A||0
8115930|NCT03000075|20004340|P6|STARTED|Part A||0
8115931|NCT03000075|20004341|P5|STARTED|Part A||0
8115932|NCT03000075|20004342|P4|STARTED|Part A||0
8115933|NCT03000075|20004343|P3|STARTED|Part A||55
8115934|NCT03000075|20004344|P2|STARTED|Part A||58
8115935|NCT03000075|20004345|P1|STARTED|Part A||58
8115936|NCT02999763|20004389|P1|NOT COMPLETED|Overall Study||12
8115937|NCT02999763|20004389|P1|COMPLETED|Overall Study||58
8115938|NCT02999763|20004389|P1|STARTED|Overall Study||70
8115939|NCT02999672|20004398|P2|NOT COMPLETED|Overall Study||7
8115940|NCT02999672|20004399|P1|NOT COMPLETED|Overall Study||13
8115941|NCT02999672|20004398|P2|COMPLETED|Overall Study||0
8115942|NCT02999672|20004399|P1|COMPLETED|Overall Study||0
8115943|NCT02999672|20004398|P2|STARTED|Overall Study||7
8115944|NCT02999672|20004399|P1|STARTED|Overall Study||13
8115945|NCT02999633|20004415|P1|NOT COMPLETED|Overall Study||14
8115946|NCT02999633|20004415|P1|COMPLETED|Overall Study||0
8115947|NCT02999633|20004415|P1|STARTED|Overall Study||14
8115948|NCT02999178|20004425|P2|NOT COMPLETED|Overall Study||100
8115949|NCT02999178|20004426|P1|NOT COMPLETED|Overall Study||114
8115950|NCT02999178|20004425|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|231
8115951|NCT02999178|20004426|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|218
8115952|NCT02999178|20004425|P2|STARTED|Overall Study||331
8115953|NCT02999178|20004426|P1|STARTED|Overall Study||332
8115954|NCT02999100|20004476|P6|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115955|NCT02999100|20004477|P5|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115956|NCT02999100|20004478|P4|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115957|NCT02999100|20004479|P3|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115958|NCT02999100|20004480|P2|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115959|NCT02999100|20004481|P1|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115960|NCT02999100|20004476|P6|COMPLETED|Part 2 (Day 14): Dosing Session 2||2
8115961|NCT02999100|20004477|P5|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
8115962|NCT02999100|20004478|P4|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
8115963|NCT02999100|20004479|P3|COMPLETED|Part 2 (Day 14): Dosing Session 2||4
8115964|NCT02999100|20004480|P2|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115965|NCT02999100|20004481|P1|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
8115966|NCT02999100|20004476|P6|STARTED|Part 2 (Day 14): Dosing Session 2||2
8115967|NCT02999100|20004477|P5|STARTED|Part 2 (Day 14): Dosing Session 2||3
8115968|NCT02999100|20004478|P4|STARTED|Part 2 (Day 14): Dosing Session 2||3
8115969|NCT02999100|20004479|P3|STARTED|Part 2 (Day 14): Dosing Session 2||4
8115970|NCT02999100|20004480|P2|STARTED|Part 2 (Day 14): Dosing Session 2||0
8115971|NCT02999100|20004481|P1|STARTED|Part 2 (Day 14): Dosing Session 2||0
8115972|NCT02999100|20004476|P6|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
8115973|NCT02999100|20004477|P5|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
8115974|NCT02999100|20004478|P4|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
8115975|NCT02999100|20004479|P3|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
8115976|NCT02999100|20004480|P2|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
8115977|NCT02999100|20004481|P1|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
8115978|NCT02999100|20004476|P6|COMPLETED|Part 2 (Day 1): Dosing Session 1||2
8115979|NCT02999100|20004477|P5|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
8115980|NCT02999100|20004478|P4|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
8115981|NCT02999100|20004479|P3|COMPLETED|Part 2 (Day 1): Dosing Session 1||4
8115982|NCT02999100|20004480|P2|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
8115983|NCT02999100|20004481|P1|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
8115984|NCT02999100|20004476|P6|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
8115985|NCT02999100|20004477|P5|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
8115986|NCT02999100|20004478|P4|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
8115987|NCT02999100|20004479|P3|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|5
8115988|NCT02999100|20004480|P2|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
8115989|NCT02999100|20004481|P1|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
8115990|NCT02999100|20004476|P6|NOT COMPLETED|Part 1 (up to 15 Days)||0
8115991|NCT02999100|20004477|P5|NOT COMPLETED|Part 1 (up to 15 Days)||0
8115992|NCT02999100|20004478|P4|NOT COMPLETED|Part 1 (up to 15 Days)||0
8115993|NCT02999100|20004479|P3|NOT COMPLETED|Part 1 (up to 15 Days)||0
8115994|NCT02999100|20004480|P2|NOT COMPLETED|Part 1 (up to 15 Days)||1
8115995|NCT02999100|20004481|P1|NOT COMPLETED|Part 1 (up to 15 Days)||0
8115996|NCT02999100|20004476|P6|COMPLETED|Part 1 (up to 15 Days)||0
8115997|NCT02999100|20004477|P5|COMPLETED|Part 1 (up to 15 Days)||0
8115998|NCT02999100|20004478|P4|COMPLETED|Part 1 (up to 15 Days)||0
8115999|NCT02999100|20004479|P3|COMPLETED|Part 1 (up to 15 Days)||0
8116000|NCT02999100|20004480|P2|COMPLETED|Part 1 (up to 15 Days)||7
8116001|NCT02999100|20004481|P1|COMPLETED|Part 1 (up to 15 Days)||9
8116002|NCT02999100|20004476|P6|STARTED|Part 1 (up to 15 Days)||0
8116003|NCT02999100|20004477|P5|STARTED|Part 1 (up to 15 Days)||0
8116004|NCT02999100|20004478|P4|STARTED|Part 1 (up to 15 Days)||0
8116005|NCT02999100|20004479|P3|STARTED|Part 1 (up to 15 Days)||0
8116006|NCT02999100|20004480|P2|STARTED|Part 1 (up to 15 Days)||8
8116007|NCT02999100|20004481|P1|STARTED|Part 1 (up to 15 Days)||9
8116008|NCT02998996|20004649|P6|NOT COMPLETED|Overall Study||0
8116009|NCT02998996|20004650|P5|NOT COMPLETED|Overall Study||1
8116010|NCT02998996|20004651|P4|NOT COMPLETED|Overall Study||0
8116011|NCT02998996|20004652|P3|NOT COMPLETED|Overall Study||1
8116012|NCT02998996|20004653|P2|NOT COMPLETED|Overall Study||1
8116013|NCT02998996|20004654|P1|NOT COMPLETED|Overall Study||0
8116014|NCT02998996|20004649|P6|COMPLETED|Overall Study||19
8116015|NCT02998996|20004650|P5|COMPLETED|Overall Study||17
8116016|NCT02998996|20004651|P4|COMPLETED|Overall Study||18
8116017|NCT02998996|20004652|P3|COMPLETED|Overall Study||35
8116018|NCT02998996|20004653|P2|COMPLETED|Overall Study||34
8116019|NCT02998996|20004654|P1|COMPLETED|Overall Study||36
8116020|NCT02998996|20004649|P6|STARTED|Overall Study||19
8116021|NCT02998996|20004650|P5|STARTED|Overall Study||18
8116022|NCT02998996|20004651|P4|STARTED|Overall Study||18
8116023|NCT02998996|20004652|P3|STARTED|Overall Study||36
8116024|NCT02998996|20004653|P2|STARTED|Overall Study||35
8116025|NCT02998996|20004654|P1|STARTED|Overall Study||36
8116026|NCT02998684|20004674|P2|NOT COMPLETED|Overall Study||1
8116027|NCT02998684|20004675|P1|NOT COMPLETED|Overall Study||3
8116028|NCT02998684|20004674|P2|COMPLETED|Overall Study||6
8116029|NCT02998684|20004675|P1|COMPLETED|Overall Study||4
8116030|NCT02998684|20004674|P2|STARTED|Overall Study||7
8116031|NCT02998684|20004675|P1|STARTED|Overall Study||7
8116032|NCT02998671|20004688|P5|NOT COMPLETED|Period 2||0
8116033|NCT02998671|20004689|P4|NOT COMPLETED|Period 2||4
8116034|NCT02998671|20004690|P3|NOT COMPLETED|Period 2||1
8116035|NCT02998671|20004691|P2|NOT COMPLETED|Period 2||7
8116036|NCT02998671|20004692|P1|NOT COMPLETED|Period 2||3
8116037|NCT02998671|20004688|P5|COMPLETED|Period 2||0
8116038|NCT02998671|20004689|P4|COMPLETED|Period 2||4
8116039|NCT02998671|20004690|P3|COMPLETED|Period 2||5
8116040|NCT02998671|20004691|P2|COMPLETED|Period 2||3
8116041|NCT02998671|20004692|P1|COMPLETED|Period 2||14
8116042|NCT02998671|20004688|P5|STARTED|Period 2||0
8116043|NCT02998671|20004689|P4|STARTED|Period 2||8
8116044|NCT02998671|20004690|P3|STARTED|Period 2||6
8116045|NCT02998671|20004691|P2|STARTED|Period 2||10
8116046|NCT02998671|20004692|P1|STARTED|Period 2||17
8116047|NCT02998671|20004688|P5|NOT COMPLETED|Period 1||4
8116048|NCT02998671|20004689|P4|NOT COMPLETED|Period 1||0
8116049|NCT02998671|20004690|P3|NOT COMPLETED|Period 1||0
8116050|NCT02998671|20004691|P2|NOT COMPLETED|Period 1||3
8116051|NCT02998671|20004692|P1|NOT COMPLETED|Period 1||4
8116052|NCT02998671|20004688|P5|COMPLETED|Period 1||0
8116053|NCT02998671|20004689|P4|COMPLETED|Period 1||8
8116054|NCT02998671|20004690|P3|COMPLETED|Period 1||6
8116055|NCT02998671|20004691|P2|COMPLETED|Period 1||10
8116056|NCT02998671|20004692|P1|COMPLETED|Period 1||17
8116057|NCT02998671|20004688|P5|STARTED|Period 1||4
8116058|NCT02998671|20004689|P4|STARTED|Period 1||8
8116059|NCT02998671|20004690|P3|STARTED|Period 1||6
8116060|NCT02998671|20004691|P2|STARTED|Period 1||13
8116061|NCT02998671|20004692|P1|STARTED|Period 1||21
8116083|NCT02998021|20004837|P2|NOT COMPLETED|Overall Study||2
8116084|NCT02998021|20004838|P1|NOT COMPLETED|Overall Study||3
8116085|NCT02998021|20004837|P2|COMPLETED|Overall Study||0
8116086|NCT02998021|20004838|P1|COMPLETED|Overall Study||5
8116087|NCT02998021|20004837|P2|STARTED|Overall Study||2
8116088|NCT02998021|20004838|P1|STARTED|Overall Study||8
8116089|NCT02997904|20004864|P2|NOT COMPLETED|Overall Study||0
8116090|NCT02997904|20004865|P1|NOT COMPLETED|Overall Study||0
8116091|NCT02997904|20004864|P2|COMPLETED|Overall Study||49
8116092|NCT02997904|20004865|P1|COMPLETED|Overall Study||51
8116093|NCT02997904|20004864|P2|STARTED|Overall Study||49
8116094|NCT02997904|20004865|P1|STARTED|Overall Study||51
8116095|NCT02997735|20004877|P2|NOT COMPLETED|Overall Study||0
8116096|NCT02997735|20004878|P1|NOT COMPLETED|Overall Study||0
8116097|NCT02997735|20004877|P2|COMPLETED|Overall Study||251
8116098|NCT02997735|20004878|P1|COMPLETED|Overall Study||233
8116099|NCT02997735|20004877|P2|STARTED|Overall Study||251
8116100|NCT02997735|20004878|P1|STARTED|Overall Study||233
8116101|NCT02997722|20004902|P2|NOT COMPLETED|Overall Study||0
8116102|NCT02997722|20004903|P1|NOT COMPLETED|Overall Study||0
8116103|NCT02997722|20004902|P2|COMPLETED|Overall Study||1
8116104|NCT02997722|20004903|P1|COMPLETED|Overall Study||3
8116105|NCT02997722|20004902|P2|STARTED|Overall Study||1
8116106|NCT02997722|20004903|P1|STARTED|Overall Study||3
8116107|NCT02997163|20004913|P4|NOT COMPLETED|Overall Study||1
8116108|NCT02997163|20004914|P3|NOT COMPLETED|Overall Study||0
8116109|NCT02997163|20004915|P2|NOT COMPLETED|Overall Study||0
8116110|NCT02997163|20004916|P1|NOT COMPLETED|Overall Study||1
8116111|NCT02997163|20004913|P4|COMPLETED|Overall Study||7
8116112|NCT02997163|20004914|P3|COMPLETED|Overall Study||8
8116113|NCT02997163|20004915|P2|COMPLETED|Overall Study||9
8116114|NCT02997163|20004916|P1|COMPLETED|Overall Study||8
8116115|NCT02997163|20004913|P4|STARTED|Overall Study||8
8116116|NCT02997163|20004914|P3|STARTED|Overall Study||8
8116117|NCT02997163|20004915|P2|STARTED|Overall Study||9
8116118|NCT02997163|20004916|P1|STARTED|Overall Study||9
8116119|NCT02996968|20005048|P2|NOT COMPLETED|Overall Study||0
8116120|NCT02996968|20005049|P1|NOT COMPLETED|Overall Study||1
8116121|NCT02996968|20005048|P2|COMPLETED|Overall Study||79
8116122|NCT02996968|20005049|P1|COMPLETED|Overall Study||78
8116123|NCT02996968|20005048|P2|STARTED|Overall Study||79
8116124|NCT02996968|20005049|P1|STARTED|Overall Study||79
8116125|NCT02996682|20005057|P2|NOT COMPLETED|Overall Study||3
8116126|NCT02996682|20005058|P1|NOT COMPLETED|Overall Study||0
8116127|NCT02996682|20005057|P2|COMPLETED|Overall Study||48
8116128|NCT02996682|20005058|P1|COMPLETED|Overall Study||51
8116129|NCT02996682|20005057|P2|STARTED|Overall Study||51
8116130|NCT02996682|20005058|P1|STARTED|Overall Study||51
8116131|NCT02996591|20005082|P2|NOT COMPLETED|Overall Study||0
8116132|NCT02996591|20005083|P1|NOT COMPLETED|Overall Study||0
8116133|NCT02996591|20005082|P2|COMPLETED|Overall Study||18
8116134|NCT02996591|20005083|P1|COMPLETED|Overall Study||18
8116135|NCT02996591|20005082|P2|STARTED|Overall Study||18
8116136|NCT02996591|20005083|P1|STARTED|Overall Study||18
8116137|NCT02996500|20005137|P6|NOT COMPLETED|Overall Study||4
8116138|NCT02996500|20005138|P5|NOT COMPLETED|Overall Study||5
8116139|NCT02996500|20005139|P4|NOT COMPLETED|Overall Study||4
8116140|NCT02996500|20005140|P3|NOT COMPLETED|Overall Study||10
8116141|NCT02996500|20005141|P2|NOT COMPLETED|Overall Study||1
8116142|NCT02996500|20005142|P1|NOT COMPLETED|Overall Study||8
8116143|NCT02996500|20005137|P6|COMPLETED|Overall Study||44
8116144|NCT02996500|20005138|P5|COMPLETED|Overall Study||45
8116145|NCT02996500|20005139|P4|COMPLETED|Overall Study||46
8116146|NCT02996500|20005140|P3|COMPLETED|Overall Study||29
8116147|NCT02996500|20005141|P2|COMPLETED|Overall Study||42
8116148|NCT02996500|20005142|P1|COMPLETED|Overall Study||31
8116149|NCT02996500|20005137|P6|STARTED|Overall Study||48
8116150|NCT02996500|20005138|P5|STARTED|Overall Study||50
8116151|NCT02996500|20005139|P4|STARTED|Overall Study||50
8116152|NCT02996500|20005140|P3|STARTED|Overall Study||39
8116153|NCT02996500|20005141|P2|STARTED|Overall Study||43
8116154|NCT02996500|20005142|P1|STARTED|Overall Study||39
8116155|NCT02996474|20005325|P1|NOT COMPLETED|Overall Study||5
8116156|NCT02996474|20005325|P1|COMPLETED|Overall Study||5
8116157|NCT02996474|20005325|P1|STARTED|Overall Study||10
8116158|NCT02996448|20005329|P1|NOT COMPLETED|Overall Study||3
8116159|NCT02996448|20005329|P1|COMPLETED|Overall Study||0
8116160|NCT02996448|20005329|P1|STARTED|Overall Study||3
8116161|NCT02996097|20005335|P2|NOT COMPLETED|Overall Study||11
8116162|NCT02996097|20005336|P1|NOT COMPLETED|Overall Study||11
8116163|NCT02996097|20005335|P2|COMPLETED|Overall Study||19
8116164|NCT02996097|20005336|P1|COMPLETED|Overall Study||19
8116165|NCT02996097|20005335|P2|Per Protocol Population|Overall Study||22
8116166|NCT02996097|20005336|P1|Per Protocol Population|Overall Study||22
8116167|NCT02996097|20005335|P2|STARTED|Overall Study||30
8116168|NCT02996097|20005336|P1|STARTED|Overall Study||30
8116169|NCT02995980|20005343|P1|NOT COMPLETED|Overall Study||14
8116170|NCT02995980|20005343|P1|COMPLETED|Overall Study||114
8116171|NCT02995980|20005343|P1|STARTED|Overall Study||128
8116172|NCT02995967|20005354|P2|NOT COMPLETED|Overall Study||0
8116173|NCT02995967|20005355|P1|NOT COMPLETED|Overall Study||0
8116174|NCT02995967|20005354|P2|COMPLETED|Overall Study||2
8116175|NCT02995967|20005355|P1|COMPLETED|Overall Study||1
8116176|NCT02995967|20005354|P2|STARTED|Overall Study||2
8116177|NCT02995967|20005355|P1|STARTED|Overall Study||1
8116178|NCT02994979|20005381|P2|NOT COMPLETED|Overall Study||0
8116179|NCT02994979|20005382|P1|NOT COMPLETED|Overall Study||0
8116180|NCT02994979|20005381|P2|COMPLETED|Overall Study||105
8116181|NCT02994979|20005382|P1|COMPLETED|Overall Study||114
8116182|NCT02994979|20005381|P2|STARTED|Overall Study||105
8116183|NCT02994979|20005382|P1|STARTED|Overall Study||114
8116184|NCT02994732|20005394|P1|NOT COMPLETED|Overall Study||0
8116185|NCT02994732|20005394|P1|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6
8116186|NCT02994732|20005394|P1|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6
8116187|NCT02994251|20005408|P1|NOT COMPLETED|Overall Study||0
8116188|NCT02994251|20005408|P1|COMPLETED|Overall Study||0
8116189|NCT02994251|20005408|P1|STARTED|Overall Study||0
8116190|NCT02994108|20005420|P2|NOT COMPLETED|Phase 2 Assessment||7
8116191|NCT02994108|20005421|P1|NOT COMPLETED|Phase 2 Assessment||9
8116192|NCT02994108|20005420|P2|COMPLETED|Phase 2 Assessment||69
8116193|NCT02994108|20005421|P1|COMPLETED|Phase 2 Assessment||63
8116194|NCT02994108|20005420|P2|STARTED|Phase 2 Assessment||76
8116195|NCT02994108|20005421|P1|STARTED|Phase 2 Assessment||72
8116196|NCT02994108|20005420|P2|NOT COMPLETED|Phase 1 Assessment||3
8116197|NCT02994108|20005421|P1|NOT COMPLETED|Phase 1 Assessment||5
8116198|NCT02994108|20005420|P2|COMPLETED|Phase 1 Assessment||73
8116199|NCT02994108|20005421|P1|COMPLETED|Phase 1 Assessment||67
8116200|NCT02994108|20005420|P2|STARTED|Phase 1 Assessment||76
8116201|NCT02994108|20005421|P1|STARTED|Phase 1 Assessment||72
8116202|NCT02994108|20005420|P2|NOT COMPLETED|Intervention Messages||0
8116203|NCT02994108|20005421|P1|NOT COMPLETED|Intervention Messages||2
8116204|NCT02994108|20005420|P2|COMPLETED|Intervention Messages||76
8116205|NCT02994108|20005421|P1|COMPLETED|Intervention Messages||72
8116206|NCT02994108|20005420|P2|STARTED|Intervention Messages||76
8116207|NCT02994108|20005421|P1|STARTED|Intervention Messages||74
8116208|NCT02994056|20005453|P1|NOT COMPLETED|Overall Study||9
8116209|NCT02994056|20005453|P1|COMPLETED|Overall Study||23
8116210|NCT02994056|20005453|P1|STARTED|Overall Study||32
8116211|NCT02993926|20005487|P3|NOT COMPLETED|Follow-Up Phase||0
8116212|NCT02993926|20005488|P2|NOT COMPLETED|Follow-Up Phase||0
8116213|NCT02993926|20005489|P1|NOT COMPLETED|Follow-Up Phase||0
8116214|NCT02993926|20005487|P3|COMPLETED|Follow-Up Phase||26
8116215|NCT02993926|20005488|P2|COMPLETED|Follow-Up Phase||44
8116216|NCT02993926|20005489|P1|COMPLETED|Follow-Up Phase||0
8116217|NCT02993926|20005487|P3|STARTED|Follow-Up Phase||26
8116218|NCT02993926|20005488|P2|STARTED|Follow-Up Phase||44
8116219|NCT02993926|20005489|P1|STARTED|Follow-Up Phase||0
8116220|NCT02993926|20005487|P3|NOT COMPLETED|Enantone Treatment Phase||0
8116221|NCT02993926|20005488|P2|NOT COMPLETED|Enantone Treatment Phase||0
8116222|NCT02993926|20005489|P1|NOT COMPLETED|Enantone Treatment Phase||32
8116223|NCT02993926|20005487|P3|COMPLETED|Enantone Treatment Phase||0
8116224|NCT02993926|20005488|P2|COMPLETED|Enantone Treatment Phase||0
8116225|NCT02993926|20005489|P1|COMPLETED|Enantone Treatment Phase||76
8116226|NCT02993926|20005487|P3|STARTED|Enantone Treatment Phase||0
8116227|NCT02993926|20005488|P2|STARTED|Enantone Treatment Phase||0
8116228|NCT02993926|20005489|P1|STARTED|Enantone Treatment Phase||108
8116229|NCT02993783|20005521|P2|NOT COMPLETED|Overall Study||9
8116230|NCT02993783|20005522|P1|NOT COMPLETED|Overall Study||6
8116231|NCT02993783|20005521|P2|COMPLETED|Overall Study||0
8116232|NCT02993783|20005522|P1|COMPLETED|Overall Study||2
8116233|NCT02993783|20005521|P2|STARTED|Overall Study||9
8116234|NCT02993783|20005522|P1|STARTED|Overall Study||8
8116235|NCT02993757|20005554|P2|NOT COMPLETED|Overall Study||178
8116236|NCT02993757|20005555|P1|NOT COMPLETED|Overall Study||164
8116237|NCT02993757|20005554|P2|COMPLETED|Overall Study||84
8116238|NCT02993757|20005555|P1|COMPLETED|Overall Study||102
8116239|NCT02993757|20005554|P2|Safety Analysis Set (SafAS)|Overall Study||260
8116240|NCT02993757|20005555|P1|Safety Analysis Set (SafAS)|Overall Study||263
8116241|NCT02993757|20005554|P2|STARTED|Overall Study||262
8116242|NCT02993757|20005555|P1|STARTED|Overall Study||266
8116243|NCT02993471|20005587|P1|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2
8116244|NCT02993471|20005587|P1|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26
8116245|NCT02993471|20005587|P1|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27
8116246|NCT02993471|20005587|P1|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28
8116247|NCT02993471|20005587|P1|NOT COMPLETED|Period 1 (Drug Cocktail)||0
8116248|NCT02993471|20005587|P1|COMPLETED|Period 1 (Drug Cocktail)||28
8116249|NCT02993471|20005587|P1|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28
8116250|NCT02993471|20005587|P1|STARTED|Period 1 (Drug Cocktail)||28
8116251|NCT02993445|20005623|P2|NOT COMPLETED|Second Intervention (5 Mins)||0
8116252|NCT02993445|20005624|P1|NOT COMPLETED|Second Intervention (5 Mins)||0
8116253|NCT02993445|20005623|P2|COMPLETED|Second Intervention (5 Mins)||5
8116254|NCT02993445|20005624|P1|COMPLETED|Second Intervention (5 Mins)||6
8116255|NCT02993445|20005623|P2|STARTED|Second Intervention (5 Mins)||5
8116256|NCT02993445|20005624|P1|STARTED|Second Intervention (5 Mins)||6
8116257|NCT02993445|20005623|P2|NOT COMPLETED|Washout (2 Weeks)||0
8116258|NCT02993445|20005624|P1|NOT COMPLETED|Washout (2 Weeks)||0
8116259|NCT02993445|20005623|P2|COMPLETED|Washout (2 Weeks)||5
8116260|NCT02993445|20005624|P1|COMPLETED|Washout (2 Weeks)||6
8116261|NCT02993445|20005623|P2|STARTED|Washout (2 Weeks)||5
8116262|NCT02993445|20005624|P1|STARTED|Washout (2 Weeks)||6
8116263|NCT02993445|20005623|P2|NOT COMPLETED|First Intervention (5 Minutes)||0
8116264|NCT02993445|20005624|P1|NOT COMPLETED|First Intervention (5 Minutes)||0
8116265|NCT02993445|20005623|P2|COMPLETED|First Intervention (5 Minutes)||5
8116266|NCT02993445|20005624|P1|COMPLETED|First Intervention (5 Minutes)||6
8116267|NCT02993445|20005623|P2|STARTED|First Intervention (5 Minutes)||5
8116268|NCT02993445|20005624|P1|STARTED|First Intervention (5 Minutes)||6
8116269|NCT02993302|20005634|P2|NOT COMPLETED|Overall Study||0
8116270|NCT02993302|20005635|P1|NOT COMPLETED|Overall Study||0
8116271|NCT02993302|20005634|P2|COMPLETED|Overall Study||12
8116272|NCT02993302|20005635|P1|COMPLETED|Overall Study||13
8116273|NCT02993302|20005634|P2|STARTED|Overall Study||12
8116274|NCT02993302|20005635|P1|STARTED|Overall Study||13
8116275|NCT02993250|20005649|P2|NOT COMPLETED|Overall Study||1
8116276|NCT02993250|20005650|P1|NOT COMPLETED|Overall Study||0
8116277|NCT02993250|20005649|P2|COMPLETED|Overall Study||10
8116278|NCT02993250|20005650|P1|COMPLETED|Overall Study||22
8116279|NCT02993250|20005649|P2|STARTED|Overall Study||11
8116280|NCT02993250|20005650|P1|STARTED|Overall Study||22
8116281|NCT02992691|20005670|P1|NOT COMPLETED|Overall Study||3
8116282|NCT02992691|20005670|P1|COMPLETED|Overall Study||53
8116283|NCT02992691|20005670|P1|Received Negative Control|Overall Study||55
8116284|NCT02992691|20005670|P1|Received Positive Control|Overall Study||55
8116285|NCT02992691|20005670|P1|Received Test Product 3|Overall Study||52
8116286|NCT02992691|20005670|P1|Received Test Product 2|Overall Study||55
8116287|NCT02992691|20005670|P1|Received Test Product 1|Overall Study||55
8116288|NCT02992691|20005670|P1|STARTED|Overall Study||56
8116289|NCT02992418|20005689|P2|NOT COMPLETED|Overall Study||342
8116290|NCT02992418|20005690|P1|NOT COMPLETED|Overall Study||346
8116291|NCT02992418|20005689|P2|COMPLETED|Overall Study||0
8116292|NCT02992418|20005690|P1|COMPLETED|Overall Study||0
8116293|NCT02992418|20005689|P2|Safety Analysis Set (SafAS)|Overall Study||342
8116294|NCT02992418|20005690|P1|Safety Analysis Set (SafAS)|Overall Study||338
8116295|NCT02992418|20005689|P2|STARTED|Overall Study||342
8116296|NCT02992418|20005690|P1|STARTED|Overall Study||346
8116297|NCT02992288|20005730|P6|NOT COMPLETED|Overall Study||13
8116298|NCT02992288|20005731|P5|NOT COMPLETED|Overall Study||8
8116299|NCT02992288|20005732|P4|NOT COMPLETED|Overall Study||9
8116300|NCT02992288|20005733|P3|NOT COMPLETED|Overall Study||7
8116301|NCT02992288|20005734|P2|NOT COMPLETED|Overall Study||5
8116302|NCT02992288|20005735|P1|NOT COMPLETED|Overall Study||17
8116303|NCT02992288|20005730|P6|COMPLETED|Overall Study||59
8116304|NCT02992288|20005731|P5|COMPLETED|Overall Study||61
8116305|NCT02992288|20005732|P4|COMPLETED|Overall Study||64
8116306|NCT02992288|20005733|P3|COMPLETED|Overall Study||63
8116307|NCT02992288|20005734|P2|COMPLETED|Overall Study||32
8116308|NCT02992288|20005735|P1|COMPLETED|Overall Study||89
8116309|NCT02992288|20005730|P6|Treated|Overall Study||72
8116310|NCT02992288|20005731|P5|Treated|Overall Study||69
8116311|NCT02992288|20005732|P4|Treated|Overall Study||72
8116312|NCT02992288|20005733|P3|Treated|Overall Study||70
8116313|NCT02992288|20005734|P2|Treated|Overall Study||37
8116314|NCT02992288|20005735|P1|Treated|Overall Study||106
8116315|NCT02992288|20005730|P6|STARTED|Overall Study||72
8116316|NCT02992288|20005731|P5|STARTED|Overall Study||69
8116317|NCT02992288|20005732|P4|STARTED|Overall Study||73
8116318|NCT02992288|20005733|P3|STARTED|Overall Study||70
8116319|NCT02992288|20005734|P2|STARTED|Overall Study||37
8116320|NCT02992288|20005735|P1|STARTED|Overall Study||106
8116321|NCT02992236|20005793|P2|NOT COMPLETED|Overall Study||0
8116322|NCT02992236|20005794|P1|NOT COMPLETED|Overall Study||0
8116323|NCT02992236|20005793|P2|COMPLETED|Overall Study||8
8116324|NCT02992236|20005794|P1|COMPLETED|Overall Study||8
8116325|NCT02992236|20005793|P2|STARTED|Overall Study||8
8116326|NCT02992236|20005794|P1|STARTED|Overall Study||8
8116327|NCT02992197|20005806|P2|NOT COMPLETED|Overall Study||7
8116328|NCT02992197|20005807|P1|NOT COMPLETED|Overall Study||11
8116329|NCT02992197|20005806|P2|COMPLETED|Overall Study||103
8116330|NCT02992197|20005807|P1|COMPLETED|Overall Study||99
8116331|NCT02992197|20005806|P2|STARTED|Overall Study||110
8116332|NCT02992197|20005807|P1|STARTED|Overall Study||110
8116333|NCT02992132|20005820|P3|NOT COMPLETED|Overall Study||7
8116334|NCT02992132|20005821|P2|NOT COMPLETED|Overall Study||8
8116335|NCT02992132|20005822|P1|NOT COMPLETED|Overall Study||13
8116336|NCT02992132|20005820|P3|COMPLETED|Overall Study||29
8116337|NCT02992132|20005821|P2|COMPLETED|Overall Study||27
8116338|NCT02992132|20005822|P1|COMPLETED|Overall Study||27
8116339|NCT02992132|20005820|P3|STARTED|Overall Study||36
8116340|NCT02992132|20005821|P2|STARTED|Overall Study||35
8116341|NCT02992132|20005822|P1|STARTED|Overall Study||40
8116342|NCT02992119|20005840|P7|NOT COMPLETED|Overall Study||3
8116343|NCT02992119|20005841|P6|NOT COMPLETED|Overall Study||0
8116344|NCT02992119|20005842|P5|NOT COMPLETED|Overall Study||0
8116345|NCT02992119|20005843|P4|NOT COMPLETED|Overall Study||0
8116346|NCT02992119|20005844|P3|NOT COMPLETED|Overall Study||1
8116347|NCT02992119|20005845|P2|NOT COMPLETED|Overall Study||1
8116348|NCT02992119|20005846|P1|NOT COMPLETED|Overall Study||2
8116349|NCT02992119|20005840|P7|COMPLETED|Overall Study||28
8116350|NCT02992119|20005841|P6|COMPLETED|Overall Study||30
8116351|NCT02992119|20005842|P5|COMPLETED|Overall Study||30
8116352|NCT02992119|20005843|P4|COMPLETED|Overall Study||30
8116353|NCT02992119|20005844|P3|COMPLETED|Overall Study||29
8116354|NCT02992119|20005845|P2|COMPLETED|Overall Study||20
8116355|NCT02992119|20005846|P1|COMPLETED|Overall Study||19
8116356|NCT02992119|20005840|P7|STARTED|Overall Study||31
8116357|NCT02992119|20005841|P6|STARTED|Overall Study||30
8116358|NCT02992119|20005842|P5|STARTED|Overall Study||30
8116359|NCT02992119|20005843|P4|STARTED|Overall Study||30
8116360|NCT02992119|20005844|P3|STARTED|Overall Study||30
8116361|NCT02992119|20005845|P2|STARTED|Overall Study||21
8116362|NCT02992119|20005846|P1|STARTED|Overall Study||21
8116363|NCT02992067|20005897|P1|NOT COMPLETED|Overall Study||0
8116364|NCT02992067|20005897|P1|COMPLETED|Overall Study||359
8116365|NCT02992067|20005897|P1|STARTED|Overall Study||359
8116366|NCT02991898|20005901|P1|NOT COMPLETED|Overall Study||0
8116367|NCT02991898|20005901|P1|COMPLETED|Overall Study||3
8116368|NCT02991898|20005901|P1|STARTED|Overall Study||3
8116369|NCT02991859|20005935|P17|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116370|NCT02991859|20005936|P16|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116371|NCT02991859|20005937|P15|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116372|NCT02991859|20005938|P14|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116373|NCT02991859|20005939|P13|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116374|NCT02991859|20005940|P12|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116375|NCT02991859|20005941|P11|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116376|NCT02991859|20005942|P10|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116377|NCT02991859|20005943|P9|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116378|NCT02991859|20005944|P8|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116379|NCT02991859|20005945|P7|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116380|NCT02991859|20005946|P6|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116381|NCT02991859|20005947|P5|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116382|NCT02991859|20005948|P4|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116383|NCT02991859|20005949|P3|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116384|NCT02991859|20005950|P2|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116385|NCT02991859|20005951|P1|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116386|NCT02991859|20005935|P17|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116387|NCT02991859|20005936|P16|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116388|NCT02991859|20005937|P15|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116389|NCT02991859|20005938|P14|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116390|NCT02991859|20005939|P13|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
8116391|NCT02991859|20005940|P12|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116392|NCT02991859|20005941|P11|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116393|NCT02991859|20005942|P10|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116394|NCT02991859|20005943|P9|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
8116395|NCT02991859|20005944|P8|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116396|NCT02991859|20005945|P7|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116397|NCT02991859|20005946|P6|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
8116398|NCT02991859|20005947|P5|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116399|NCT02991859|20005948|P4|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116400|NCT02991859|20005949|P3|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116401|NCT02991859|20005950|P2|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116402|NCT02991859|20005951|P1|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
8116403|NCT02991859|20005935|P17|STARTED|Period2,Escalation Phase5,Upto Day 112||0
8116404|NCT02991859|20005936|P16|STARTED|Period2,Escalation Phase5,Upto Day 112||0
8116405|NCT02991859|20005937|P15|STARTED|Period2,Escalation Phase5,Upto Day 112||0
8116406|NCT02991859|20005938|P14|STARTED|Period2,Escalation Phase5,Upto Day 112||0
8116407|NCT02991859|20005939|P13|STARTED|Period2,Escalation Phase5,Upto Day 112||0
8116408|NCT02991859|20005940|P12|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116409|NCT02991859|20005941|P11|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116410|NCT02991859|20005942|P10|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116411|NCT02991859|20005943|P9|STARTED|Period2,Escalation Phase5,Upto Day 112||1
8116412|NCT02991859|20005944|P8|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116413|NCT02991859|20005945|P7|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116414|NCT02991859|20005946|P6|STARTED|Period2,Escalation Phase5,Upto Day 112||1
8116415|NCT02991859|20005947|P5|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116416|NCT02991859|20005948|P4|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116417|NCT02991859|20005949|P3|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116418|NCT02991859|20005950|P2|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116419|NCT02991859|20005951|P1|STARTED|Period2,Escalation Phase5,Upto Day 112||2
8116420|NCT02991859|20005935|P17|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116421|NCT02991859|20005936|P16|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116422|NCT02991859|20005937|P15|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116423|NCT02991859|20005938|P14|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116424|NCT02991859|20005939|P13|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116425|NCT02991859|20005940|P12|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116426|NCT02991859|20005941|P11|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116427|NCT02991859|20005942|P10|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116428|NCT02991859|20005943|P9|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
8116429|NCT02991859|20005944|P8|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116430|NCT02991859|20005945|P7|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116431|NCT02991859|20005946|P6|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116432|NCT02991859|20005947|P5|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116433|NCT02991859|20005948|P4|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116434|NCT02991859|20005949|P3|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116435|NCT02991859|20005950|P2|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116436|NCT02991859|20005951|P1|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116437|NCT02991859|20005935|P17|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116438|NCT02991859|20005936|P16|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116439|NCT02991859|20005937|P15|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116440|NCT02991859|20005938|P14|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116441|NCT02991859|20005939|P13|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
8116442|NCT02991859|20005940|P12|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116443|NCT02991859|20005941|P11|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116444|NCT02991859|20005942|P10|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116445|NCT02991859|20005943|P9|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
8116446|NCT02991859|20005944|P8|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116447|NCT02991859|20005945|P7|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116448|NCT02991859|20005946|P6|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
8116449|NCT02991859|20005947|P5|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116450|NCT02991859|20005948|P4|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116451|NCT02991859|20005949|P3|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116452|NCT02991859|20005950|P2|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116453|NCT02991859|20005951|P1|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
8116454|NCT02991859|20005935|P17|STARTED|Period2, Escalation Phase4, Upto Day 105||0
8116455|NCT02991859|20005936|P16|STARTED|Period2, Escalation Phase4, Upto Day 105||0
8116456|NCT02991859|20005937|P15|STARTED|Period2, Escalation Phase4, Upto Day 105||0
8116457|NCT02991859|20005938|P14|STARTED|Period2, Escalation Phase4, Upto Day 105||0
8116458|NCT02991859|20005939|P13|STARTED|Period2, Escalation Phase4, Upto Day 105||0
8116459|NCT02991859|20005940|P12|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116460|NCT02991859|20005941|P11|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116461|NCT02991859|20005942|P10|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116462|NCT02991859|20005943|P9|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116463|NCT02991859|20005944|P8|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116464|NCT02991859|20005945|P7|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116465|NCT02991859|20005946|P6|STARTED|Period2, Escalation Phase4, Upto Day 105||1
8116466|NCT02991859|20005947|P5|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116467|NCT02991859|20005948|P4|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116468|NCT02991859|20005949|P3|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116469|NCT02991859|20005950|P2|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116470|NCT02991859|20005951|P1|STARTED|Period2, Escalation Phase4, Upto Day 105||2
8116471|NCT02991859|20005935|P17|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116472|NCT02991859|20005936|P16|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116473|NCT02991859|20005937|P15|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116474|NCT02991859|20005938|P14|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116475|NCT02991859|20005939|P13|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116476|NCT02991859|20005940|P12|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116477|NCT02991859|20005941|P11|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116478|NCT02991859|20005942|P10|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116479|NCT02991859|20005943|P9|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116480|NCT02991859|20005944|P8|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116481|NCT02991859|20005945|P7|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116482|NCT02991859|20005946|P6|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116483|NCT02991859|20005947|P5|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116484|NCT02991859|20005948|P4|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116485|NCT02991859|20005949|P3|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116486|NCT02991859|20005950|P2|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116487|NCT02991859|20005951|P1|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116488|NCT02991859|20005935|P17|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116489|NCT02991859|20005936|P16|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116490|NCT02991859|20005937|P15|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116491|NCT02991859|20005938|P14|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116492|NCT02991859|20005939|P13|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
8116493|NCT02991859|20005940|P12|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116494|NCT02991859|20005941|P11|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116495|NCT02991859|20005942|P10|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116496|NCT02991859|20005943|P9|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116497|NCT02991859|20005944|P8|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116498|NCT02991859|20005945|P7|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116499|NCT02991859|20005946|P6|COMPLETED|Period2, Escalation Phase3, Upto Day 98||1
8116500|NCT02991859|20005947|P5|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116501|NCT02991859|20005948|P4|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116502|NCT02991859|20005949|P3|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116503|NCT02991859|20005950|P2|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116504|NCT02991859|20005951|P1|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
8116505|NCT02991859|20005935|P17|STARTED|Period2, Escalation Phase3, Upto Day 98||0
8116506|NCT02991859|20005936|P16|STARTED|Period2, Escalation Phase3, Upto Day 98||0
8116507|NCT02991859|20005937|P15|STARTED|Period2, Escalation Phase3, Upto Day 98||0
8116508|NCT02991859|20005938|P14|STARTED|Period2, Escalation Phase3, Upto Day 98||0
8116509|NCT02991859|20005939|P13|STARTED|Period2, Escalation Phase3, Upto Day 98||0
8116510|NCT02991859|20005940|P12|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116511|NCT02991859|20005941|P11|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116512|NCT02991859|20005942|P10|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116513|NCT02991859|20005943|P9|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116514|NCT02991859|20005944|P8|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116515|NCT02991859|20005945|P7|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116516|NCT02991859|20005946|P6|STARTED|Period2, Escalation Phase3, Upto Day 98||1
8116517|NCT02991859|20005947|P5|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116518|NCT02991859|20005948|P4|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116519|NCT02991859|20005949|P3|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116520|NCT02991859|20005950|P2|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116521|NCT02991859|20005951|P1|STARTED|Period2, Escalation Phase3, Upto Day 98||2
8116522|NCT02991859|20005935|P17|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116523|NCT02991859|20005936|P16|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116524|NCT02991859|20005937|P15|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116525|NCT02991859|20005938|P14|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116526|NCT02991859|20005939|P13|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116527|NCT02991859|20005940|P12|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116528|NCT02991859|20005941|P11|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116529|NCT02991859|20005942|P10|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116530|NCT02991859|20005943|P9|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116531|NCT02991859|20005944|P8|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116532|NCT02991859|20005945|P7|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116533|NCT02991859|20005946|P6|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116534|NCT02991859|20005947|P5|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116535|NCT02991859|20005948|P4|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116536|NCT02991859|20005949|P3|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116537|NCT02991859|20005950|P2|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116538|NCT02991859|20005951|P1|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116539|NCT02991859|20005935|P17|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116540|NCT02991859|20005936|P16|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116541|NCT02991859|20005937|P15|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116542|NCT02991859|20005938|P14|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116543|NCT02991859|20005939|P13|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
8116544|NCT02991859|20005940|P12|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116545|NCT02991859|20005941|P11|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116546|NCT02991859|20005942|P10|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116547|NCT02991859|20005943|P9|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116548|NCT02991859|20005944|P8|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116549|NCT02991859|20005945|P7|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116550|NCT02991859|20005946|P6|COMPLETED|Period2, Escalation Phase2, Upto Day 91||1
8116551|NCT02991859|20005947|P5|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116552|NCT02991859|20005948|P4|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116553|NCT02991859|20005949|P3|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116554|NCT02991859|20005950|P2|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116555|NCT02991859|20005951|P1|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
8116556|NCT02991859|20005935|P17|STARTED|Period2, Escalation Phase2, Upto Day 91||0
8116557|NCT02991859|20005936|P16|STARTED|Period2, Escalation Phase2, Upto Day 91||0
8116558|NCT02991859|20005937|P15|STARTED|Period2, Escalation Phase2, Upto Day 91||0
8116559|NCT02991859|20005938|P14|STARTED|Period2, Escalation Phase2, Upto Day 91||0
8116560|NCT02991859|20005939|P13|STARTED|Period2, Escalation Phase2, Upto Day 91||0
8116561|NCT02991859|20005940|P12|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116562|NCT02991859|20005941|P11|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116563|NCT02991859|20005942|P10|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116564|NCT02991859|20005943|P9|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116565|NCT02991859|20005944|P8|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116566|NCT02991859|20005945|P7|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116567|NCT02991859|20005946|P6|STARTED|Period2, Escalation Phase2, Upto Day 91||1
8116568|NCT02991859|20005947|P5|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116569|NCT02991859|20005948|P4|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116570|NCT02991859|20005949|P3|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116571|NCT02991859|20005950|P2|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116572|NCT02991859|20005951|P1|STARTED|Period2, Escalation Phase2, Upto Day 91||2
8116573|NCT02991859|20005935|P17|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116574|NCT02991859|20005936|P16|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116575|NCT02991859|20005937|P15|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116576|NCT02991859|20005938|P14|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116577|NCT02991859|20005939|P13|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116578|NCT02991859|20005940|P12|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116579|NCT02991859|20005941|P11|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116580|NCT02991859|20005942|P10|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116581|NCT02991859|20005943|P9|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116582|NCT02991859|20005944|P8|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116583|NCT02991859|20005945|P7|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116584|NCT02991859|20005946|P6|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116585|NCT02991859|20005947|P5|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116586|NCT02991859|20005948|P4|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116587|NCT02991859|20005949|P3|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116588|NCT02991859|20005950|P2|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116589|NCT02991859|20005951|P1|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116590|NCT02991859|20005935|P17|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116591|NCT02991859|20005936|P16|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116592|NCT02991859|20005937|P15|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116593|NCT02991859|20005938|P14|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116594|NCT02991859|20005939|P13|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
8116595|NCT02991859|20005940|P12|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116596|NCT02991859|20005941|P11|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116597|NCT02991859|20005942|P10|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116598|NCT02991859|20005943|P9|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116599|NCT02991859|20005944|P8|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116600|NCT02991859|20005945|P7|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116601|NCT02991859|20005946|P6|COMPLETED|Period2, Escalation Phase1, Upto Day 84||1
8116602|NCT02991859|20005947|P5|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116603|NCT02991859|20005948|P4|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116604|NCT02991859|20005949|P3|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116605|NCT02991859|20005950|P2|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116606|NCT02991859|20005951|P1|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
8116607|NCT02991859|20005935|P17|STARTED|Period2, Escalation Phase1, Upto Day 84||0
8116608|NCT02991859|20005936|P16|STARTED|Period2, Escalation Phase1, Upto Day 84||0
8116609|NCT02991859|20005937|P15|STARTED|Period2, Escalation Phase1, Upto Day 84||0
8116610|NCT02991859|20005938|P14|STARTED|Period2, Escalation Phase1, Upto Day 84||0
8116611|NCT02991859|20005939|P13|STARTED|Period2, Escalation Phase1, Upto Day 84||0
8116612|NCT02991859|20005940|P12|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116613|NCT02991859|20005941|P11|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par cont in P2 Esc 1 insteadP1 Esc 5, was not withdrawn|2
8116614|NCT02991859|20005942|P10|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par directly entered into Period 2, Esc 1|2
8116615|NCT02991859|20005943|P9|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116616|NCT02991859|20005944|P8|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116617|NCT02991859|20005945|P7|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116618|NCT02991859|20005946|P6|STARTED|Period2, Escalation Phase1, Upto Day 84||1
8116619|NCT02991859|20005947|P5|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116620|NCT02991859|20005948|P4|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116621|NCT02991859|20005949|P3|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116622|NCT02991859|20005950|P2|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116623|NCT02991859|20005951|P1|STARTED|Period2, Escalation Phase1, Upto Day 84||2
8116624|NCT02991859|20005935|P17|NOT COMPLETED|Wash Out, Up to Day 77||0
8116625|NCT02991859|20005936|P16|NOT COMPLETED|Wash Out, Up to Day 77||0
8116626|NCT02991859|20005937|P15|NOT COMPLETED|Wash Out, Up to Day 77||0
8116627|NCT02991859|20005938|P14|NOT COMPLETED|Wash Out, Up to Day 77||0
8116628|NCT02991859|20005939|P13|NOT COMPLETED|Wash Out, Up to Day 77||0
8116629|NCT02991859|20005940|P12|NOT COMPLETED|Wash Out, Up to Day 77||0
8116630|NCT02991859|20005941|P11|NOT COMPLETED|Wash Out, Up to Day 77||0
8116631|NCT02991859|20005942|P10|NOT COMPLETED|Wash Out, Up to Day 77||1
8116632|NCT02991859|20005943|P9|NOT COMPLETED|Wash Out, Up to Day 77||0
8116633|NCT02991859|20005944|P8|NOT COMPLETED|Wash Out, Up to Day 77||0
8116634|NCT02991859|20005945|P7|NOT COMPLETED|Wash Out, Up to Day 77||0
8116635|NCT02991859|20005946|P6|NOT COMPLETED|Wash Out, Up to Day 77||1
8116636|NCT02991859|20005947|P5|NOT COMPLETED|Wash Out, Up to Day 77||0
8116637|NCT02991859|20005948|P4|NOT COMPLETED|Wash Out, Up to Day 77||0
8116638|NCT02991859|20005949|P3|NOT COMPLETED|Wash Out, Up to Day 77||0
8116639|NCT02991859|20005950|P2|NOT COMPLETED|Wash Out, Up to Day 77||0
8116640|NCT02991859|20005951|P1|NOT COMPLETED|Wash Out, Up to Day 77||0
8116641|NCT02991859|20005935|P17|COMPLETED|Wash Out, Up to Day 77||0
8116642|NCT02991859|20005936|P16|COMPLETED|Wash Out, Up to Day 77||0
8116643|NCT02991859|20005937|P15|COMPLETED|Wash Out, Up to Day 77||0
8116644|NCT02991859|20005938|P14|COMPLETED|Wash Out, Up to Day 77||0
8116645|NCT02991859|20005939|P13|COMPLETED|Wash Out, Up to Day 77||0
8116646|NCT02991859|20005940|P12|COMPLETED|Wash Out, Up to Day 77||2
8116647|NCT02991859|20005941|P11|COMPLETED|Wash Out, Up to Day 77||1
8116648|NCT02991859|20005942|P10|COMPLETED|Wash Out, Up to Day 77||1
8116649|NCT02991859|20005943|P9|COMPLETED|Wash Out, Up to Day 77||2
8116650|NCT02991859|20005944|P8|COMPLETED|Wash Out, Up to Day 77||2
8116651|NCT02991859|20005945|P7|COMPLETED|Wash Out, Up to Day 77||2
8116652|NCT02991859|20005946|P6|COMPLETED|Wash Out, Up to Day 77||1
8116653|NCT02991859|20005947|P5|COMPLETED|Wash Out, Up to Day 77||2
8116654|NCT02991859|20005948|P4|COMPLETED|Wash Out, Up to Day 77||2
8116655|NCT02991859|20005949|P3|COMPLETED|Wash Out, Up to Day 77||2
8116656|NCT02991859|20005950|P2|COMPLETED|Wash Out, Up to Day 77||2
8116657|NCT02991859|20005951|P1|COMPLETED|Wash Out, Up to Day 77||2
8116658|NCT02991859|20005935|P17|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
8116659|NCT02991859|20005936|P16|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
8116660|NCT02991859|20005937|P15|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
8116661|NCT02991859|20005938|P14|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
8116662|NCT02991859|20005939|P13|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
8116663|NCT02991859|20005940|P12|STARTED|Wash Out, Up to Day 77||2
8116664|NCT02991859|20005941|P11|STARTED|Wash Out, Up to Day 77||1
8116665|NCT02991859|20005942|P10|STARTED|Wash Out, Up to Day 77||2
8116666|NCT02991859|20005943|P9|STARTED|Wash Out, Up to Day 77||2
8116667|NCT02991859|20005944|P8|STARTED|Wash Out, Up to Day 77||2
8116668|NCT02991859|20005945|P7|STARTED|Wash Out, Up to Day 77||2
8116669|NCT02991859|20005946|P6|STARTED|Wash Out, Up to Day 77||2
8116670|NCT02991859|20005947|P5|STARTED|Wash Out, Up to Day 77||2
8116671|NCT02991859|20005948|P4|STARTED|Wash Out, Up to Day 77||2
8116672|NCT02991859|20005949|P3|STARTED|Wash Out, Up to Day 77||2
8116673|NCT02991859|20005950|P2|STARTED|Wash Out, Up to Day 77||2
8116674|NCT02991859|20005951|P1|STARTED|Wash Out, Up to Day 77||2
8116675|NCT02991859|20005935|P17|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116676|NCT02991859|20005936|P16|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116677|NCT02991859|20005937|P15|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116678|NCT02991859|20005938|P14|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116679|NCT02991859|20005939|P13|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116680|NCT02991859|20005940|P12|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116681|NCT02991859|20005941|P11|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116682|NCT02991859|20005942|P10|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116683|NCT02991859|20005943|P9|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116684|NCT02991859|20005944|P8|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116685|NCT02991859|20005945|P7|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116686|NCT02991859|20005946|P6|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116687|NCT02991859|20005947|P5|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116688|NCT02991859|20005948|P4|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116689|NCT02991859|20005949|P3|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116690|NCT02991859|20005950|P2|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116691|NCT02991859|20005951|P1|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
8116692|NCT02991859|20005935|P17|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
8116693|NCT02991859|20005936|P16|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
8116694|NCT02991859|20005937|P15|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
8116695|NCT02991859|20005938|P14|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
8116696|NCT02991859|20005939|P13|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
8116697|NCT02991859|20005940|P12|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116698|NCT02991859|20005941|P11|COMPLETED|Period1, Escalation Phase5, Upto Day35||1
8116699|NCT02991859|20005942|P10|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116700|NCT02991859|20005943|P9|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116701|NCT02991859|20005944|P8|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116702|NCT02991859|20005945|P7|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116703|NCT02991859|20005946|P6|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116704|NCT02991859|20005947|P5|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116705|NCT02991859|20005948|P4|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116706|NCT02991859|20005949|P3|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116707|NCT02991859|20005950|P2|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116708|NCT02991859|20005951|P1|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
8116709|NCT02991859|20005935|P17|STARTED|Period1, Escalation Phase5, Upto Day35||3
8116710|NCT02991859|20005936|P16|STARTED|Period1, Escalation Phase5, Upto Day35||3
8116711|NCT02991859|20005937|P15|STARTED|Period1, Escalation Phase5, Upto Day35||6
8116712|NCT02991859|20005938|P14|STARTED|Period1, Escalation Phase5, Upto Day35||6
8116713|NCT02991859|20005939|P13|STARTED|Period1, Escalation Phase5, Upto Day35||6
8116714|NCT02991859|20005940|P12|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116715|NCT02991859|20005941|P11|STARTED|Period1, Escalation Phase5, Upto Day35|1 participant did not enter Esc Phase 5, and was not withdrawn|1
8116716|NCT02991859|20005942|P10|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116717|NCT02991859|20005943|P9|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116718|NCT02991859|20005944|P8|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116719|NCT02991859|20005945|P7|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116720|NCT02991859|20005946|P6|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116721|NCT02991859|20005947|P5|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116722|NCT02991859|20005948|P4|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116723|NCT02991859|20005949|P3|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116724|NCT02991859|20005950|P2|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116725|NCT02991859|20005951|P1|STARTED|Period1, Escalation Phase5, Upto Day35||2
8116726|NCT02991859|20005935|P17|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116727|NCT02991859|20005936|P16|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116728|NCT02991859|20005937|P15|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116729|NCT02991859|20005938|P14|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116730|NCT02991859|20005939|P13|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116731|NCT02991859|20005940|P12|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116732|NCT02991859|20005941|P11|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116733|NCT02991859|20005942|P10|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116734|NCT02991859|20005943|P9|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116735|NCT02991859|20005944|P8|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116736|NCT02991859|20005945|P7|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116737|NCT02991859|20005946|P6|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116738|NCT02991859|20005947|P5|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116739|NCT02991859|20005948|P4|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116740|NCT02991859|20005949|P3|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116741|NCT02991859|20005950|P2|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116742|NCT02991859|20005951|P1|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
8116743|NCT02991859|20005935|P17|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
8116744|NCT02991859|20005936|P16|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
8116745|NCT02991859|20005937|P15|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
8116746|NCT02991859|20005938|P14|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
8116747|NCT02991859|20005939|P13|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
8116748|NCT02991859|20005940|P12|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116749|NCT02991859|20005941|P11|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116750|NCT02991859|20005942|P10|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116751|NCT02991859|20005943|P9|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116752|NCT02991859|20005944|P8|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116753|NCT02991859|20005945|P7|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116754|NCT02991859|20005946|P6|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116755|NCT02991859|20005947|P5|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116756|NCT02991859|20005948|P4|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116757|NCT02991859|20005949|P3|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116758|NCT02991859|20005950|P2|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116759|NCT02991859|20005951|P1|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
8116760|NCT02991859|20005935|P17|STARTED|Period1, Escalation Phase4, Upto Day28||3
8116761|NCT02991859|20005936|P16|STARTED|Period1, Escalation Phase4, Upto Day28||3
8116762|NCT02991859|20005937|P15|STARTED|Period1, Escalation Phase4, Upto Day28||6
8116763|NCT02991859|20005938|P14|STARTED|Period1, Escalation Phase4, Upto Day28||6
8116764|NCT02991859|20005939|P13|STARTED|Period1, Escalation Phase4, Upto Day28||6
8116765|NCT02991859|20005940|P12|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116766|NCT02991859|20005941|P11|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116767|NCT02991859|20005942|P10|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116768|NCT02991859|20005943|P9|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116769|NCT02991859|20005944|P8|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116770|NCT02991859|20005945|P7|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116771|NCT02991859|20005946|P6|STARTED|Period1, Escalation Phase4, Upto Day28|1 Par completed Phase 3 did not enter Phase 4|2
8116772|NCT02991859|20005947|P5|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116773|NCT02991859|20005948|P4|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116774|NCT02991859|20005949|P3|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116775|NCT02991859|20005950|P2|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116776|NCT02991859|20005951|P1|STARTED|Period1, Escalation Phase4, Upto Day28||2
8116777|NCT02991859|20005935|P17|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116778|NCT02991859|20005936|P16|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116779|NCT02991859|20005937|P15|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116780|NCT02991859|20005938|P14|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
8116781|NCT02991859|20005939|P13|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
8116782|NCT02991859|20005940|P12|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116783|NCT02991859|20005941|P11|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116784|NCT02991859|20005942|P10|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116785|NCT02991859|20005943|P9|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116786|NCT02991859|20005944|P8|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116787|NCT02991859|20005945|P7|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116788|NCT02991859|20005946|P6|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116789|NCT02991859|20005947|P5|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116790|NCT02991859|20005948|P4|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116791|NCT02991859|20005949|P3|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116792|NCT02991859|20005950|P2|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116793|NCT02991859|20005951|P1|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
8116794|NCT02991859|20005935|P17|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
8116795|NCT02991859|20005936|P16|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
8116796|NCT02991859|20005937|P15|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
8116797|NCT02991859|20005938|P14|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
8116798|NCT02991859|20005939|P13|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
8116799|NCT02991859|20005940|P12|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116800|NCT02991859|20005941|P11|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116801|NCT02991859|20005942|P10|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116802|NCT02991859|20005943|P9|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116803|NCT02991859|20005944|P8|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116804|NCT02991859|20005945|P7|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116805|NCT02991859|20005946|P6|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
8116806|NCT02991859|20005947|P5|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116807|NCT02991859|20005948|P4|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116808|NCT02991859|20005949|P3|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116809|NCT02991859|20005950|P2|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116810|NCT02991859|20005951|P1|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
8116811|NCT02991859|20005935|P17|STARTED|Period1, Escalation Phase3, Upto Day21||3
8116812|NCT02991859|20005936|P16|STARTED|Period1, Escalation Phase3, Upto Day21||3
8116813|NCT02991859|20005937|P15|STARTED|Period1, Escalation Phase3, Upto Day21||6
8116814|NCT02991859|20005938|P14|STARTED|Period1, Escalation Phase3, Upto Day21||7
8116815|NCT02991859|20005939|P13|STARTED|Period1, Escalation Phase3, Upto Day21||7
8116816|NCT02991859|20005940|P12|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116817|NCT02991859|20005941|P11|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116818|NCT02991859|20005942|P10|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116819|NCT02991859|20005943|P9|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116820|NCT02991859|20005944|P8|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116821|NCT02991859|20005945|P7|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116822|NCT02991859|20005946|P6|STARTED|Period1, Escalation Phase3, Upto Day21||3
8116823|NCT02991859|20005947|P5|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116824|NCT02991859|20005948|P4|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116825|NCT02991859|20005949|P3|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116826|NCT02991859|20005950|P2|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116827|NCT02991859|20005951|P1|STARTED|Period1, Escalation Phase3, Upto Day21||2
8116828|NCT02991859|20005935|P17|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116829|NCT02991859|20005936|P16|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116830|NCT02991859|20005937|P15|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116831|NCT02991859|20005938|P14|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116832|NCT02991859|20005939|P13|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116833|NCT02991859|20005940|P12|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116834|NCT02991859|20005941|P11|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116835|NCT02991859|20005942|P10|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116836|NCT02991859|20005943|P9|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116837|NCT02991859|20005944|P8|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116838|NCT02991859|20005945|P7|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116839|NCT02991859|20005946|P6|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116840|NCT02991859|20005947|P5|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116841|NCT02991859|20005948|P4|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116842|NCT02991859|20005949|P3|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116843|NCT02991859|20005950|P2|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116844|NCT02991859|20005951|P1|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
8116845|NCT02991859|20005935|P17|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
8116846|NCT02991859|20005936|P16|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
8116847|NCT02991859|20005937|P15|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||6
8116848|NCT02991859|20005938|P14|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
8116849|NCT02991859|20005939|P13|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
8116850|NCT02991859|20005940|P12|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116851|NCT02991859|20005941|P11|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116852|NCT02991859|20005942|P10|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116853|NCT02991859|20005943|P9|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116854|NCT02991859|20005944|P8|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116855|NCT02991859|20005945|P7|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116856|NCT02991859|20005946|P6|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
8116857|NCT02991859|20005947|P5|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116858|NCT02991859|20005948|P4|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116859|NCT02991859|20005949|P3|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116860|NCT02991859|20005950|P2|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116861|NCT02991859|20005951|P1|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
8116862|NCT02991859|20005935|P17|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
8116863|NCT02991859|20005936|P16|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
8116864|NCT02991859|20005937|P15|STARTED|Period 1,Escalation Phase2,Upto Day 14||6
8116865|NCT02991859|20005938|P14|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
8116866|NCT02991859|20005939|P13|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
8116867|NCT02991859|20005940|P12|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116868|NCT02991859|20005941|P11|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116869|NCT02991859|20005942|P10|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116870|NCT02991859|20005943|P9|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116871|NCT02991859|20005944|P8|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116872|NCT02991859|20005945|P7|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116873|NCT02991859|20005946|P6|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
8116874|NCT02991859|20005947|P5|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116875|NCT02991859|20005948|P4|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116876|NCT02991859|20005949|P3|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116877|NCT02991859|20005950|P2|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116878|NCT02991859|20005951|P1|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
8116879|NCT02991859|20005935|P17|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116880|NCT02991859|20005936|P16|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116881|NCT02991859|20005937|P15|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116882|NCT02991859|20005938|P14|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116883|NCT02991859|20005939|P13|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116884|NCT02991859|20005940|P12|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116885|NCT02991859|20005941|P11|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116886|NCT02991859|20005942|P10|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116887|NCT02991859|20005943|P9|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116888|NCT02991859|20005944|P8|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116889|NCT02991859|20005945|P7|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116890|NCT02991859|20005946|P6|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116891|NCT02991859|20005947|P5|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
8116892|NCT02991859|20005948|P4|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116893|NCT02991859|20005949|P3|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116894|NCT02991859|20005950|P2|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
8116895|NCT02991859|20005951|P1|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
8116896|NCT02991859|20005935|P17|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
8116897|NCT02991859|20005936|P16|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
8116898|NCT02991859|20005937|P15|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||6
8116899|NCT02991859|20005938|P14|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
8116900|NCT02991859|20005939|P13|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
8116901|NCT02991859|20005940|P12|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116902|NCT02991859|20005941|P11|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116903|NCT02991859|20005942|P10|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116904|NCT02991859|20005943|P9|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116905|NCT02991859|20005944|P8|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116906|NCT02991859|20005945|P7|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116907|NCT02991859|20005946|P6|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
8116908|NCT02991859|20005947|P5|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116909|NCT02991859|20005948|P4|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116910|NCT02991859|20005949|P3|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116911|NCT02991859|20005950|P2|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116912|NCT02991859|20005951|P1|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
8116913|NCT02991859|20005935|P17|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
8116914|NCT02991859|20005936|P16|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
8116915|NCT02991859|20005937|P15|STARTED|Period 1,Escalation Phase 1,Upto Day 7||6
8116916|NCT02991859|20005938|P14|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
8116917|NCT02991859|20005939|P13|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
8116918|NCT02991859|20005940|P12|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116919|NCT02991859|20005941|P11|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116920|NCT02991859|20005942|P10|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116921|NCT02991859|20005943|P9|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116922|NCT02991859|20005944|P8|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116923|NCT02991859|20005945|P7|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116924|NCT02991859|20005946|P6|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
8116925|NCT02991859|20005947|P5|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
8116926|NCT02991859|20005948|P4|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116927|NCT02991859|20005949|P3|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116928|NCT02991859|20005950|P2|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
8116929|NCT02991859|20005951|P1|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
8116930|NCT02991820|20006196|P2|NOT COMPLETED|Overall Study||0
8116931|NCT02991820|20006197|P1|NOT COMPLETED|Overall Study||0
8116932|NCT02991820|20006196|P2|COMPLETED|Overall Study||31
8116933|NCT02991820|20006197|P1|COMPLETED|Overall Study||12
8116934|NCT02991820|20006196|P2|STARTED|Overall Study||31
8116935|NCT02991820|20006197|P1|STARTED|Overall Study||12
8116936|NCT02991729|20006207|P2|NOT COMPLETED|Overall Study||0
8116937|NCT02991729|20006208|P1|NOT COMPLETED|Overall Study||0
8116938|NCT02991729|20006207|P2|COMPLETED|Overall Study||92
8116939|NCT02991729|20006208|P1|COMPLETED|Overall Study||105
8116940|NCT02991729|20006207|P2|STARTED|Overall Study||92
8116941|NCT02991729|20006208|P1|STARTED|Overall Study||105
8116942|NCT02991599|20006222|P2|NOT COMPLETED|Overall Study||37
8116943|NCT02991599|20006223|P1|NOT COMPLETED|Overall Study||38
8116944|NCT02991599|20006222|P2|COMPLETED|Overall Study||61
8116945|NCT02991599|20006223|P1|COMPLETED|Overall Study||60
8116946|NCT02991599|20006222|P2|STARTED|Overall Study||98
8116947|NCT02991599|20006223|P1|STARTED|Overall Study||98
8116948|NCT02991430|20006246|P3|NOT COMPLETED|Post-treatment Observation Period||5
8116949|NCT02991430|20006247|P2|NOT COMPLETED|Post-treatment Observation Period||6
8116950|NCT02991430|20006248|P1|NOT COMPLETED|Post-treatment Observation Period||3
8116951|NCT02991430|20006246|P3|COMPLETED|Post-treatment Observation Period||5
8116952|NCT02991430|20006247|P2|COMPLETED|Post-treatment Observation Period||2
8116953|NCT02991430|20006248|P1|COMPLETED|Post-treatment Observation Period||4
8116954|NCT02991430|20006246|P3|STARTED|Post-treatment Observation Period||10
8116955|NCT02991430|20006247|P2|STARTED|Post-treatment Observation Period||8
8116956|NCT02991430|20006248|P1|STARTED|Post-treatment Observation Period||7
8116957|NCT02991430|20006246|P3|NOT COMPLETED|Treatment Period 2||4
8116958|NCT02991430|20006247|P2|NOT COMPLETED|Treatment Period 2||3
8116959|NCT02991430|20006248|P1|NOT COMPLETED|Treatment Period 2||6
8116960|NCT02991430|20006246|P3|COMPLETED|Treatment Period 2||10
8116961|NCT02991430|20006247|P2|COMPLETED|Treatment Period 2||8
8116962|NCT02991430|20006248|P1|COMPLETED|Treatment Period 2||7
8116963|NCT02991430|20006246|P3|STARTED|Treatment Period 2||14
8116964|NCT02991430|20006247|P2|STARTED|Treatment Period 2||11
8116965|NCT02991430|20006248|P1|STARTED|Treatment Period 2||13
8116966|NCT02991430|20006246|P3|NOT COMPLETED|Treatment Period 1||2
8116967|NCT02991430|20006247|P2|NOT COMPLETED|Treatment Period 1||4
8116968|NCT02991430|20006248|P1|NOT COMPLETED|Treatment Period 1||1
8116969|NCT02991430|20006246|P3|COMPLETED|Treatment Period 1||14
8116970|NCT02991430|20006247|P2|COMPLETED|Treatment Period 1||11
8116971|NCT02991430|20006248|P1|COMPLETED|Treatment Period 1||13
8116972|NCT02991430|20006246|P3|STARTED|Treatment Period 1||16
8116973|NCT02991430|20006247|P2|STARTED|Treatment Period 1||15
8116974|NCT02991430|20006248|P1|STARTED|Treatment Period 1||14
8116975|NCT02991118|20006285|P2|NOT COMPLETED|Overall Study||32
8116976|NCT02991118|20006286|P1|NOT COMPLETED|Overall Study||7
8116977|NCT02991118|20006285|P2|COMPLETED|Overall Study||490
8116978|NCT02991118|20006286|P1|COMPLETED|Overall Study||250
8116979|NCT02991118|20006285|P2|STARTED|Overall Study||522
8116980|NCT02991118|20006286|P1|STARTED|Overall Study||257
8116981|NCT02991040|20006330|P1|NOT COMPLETED|Overall Study||4
8116982|NCT02991040|20006330|P1|COMPLETED|Overall Study||96
8116983|NCT02991040|20006330|P1|STARTED|Overall Study||100
8116984|NCT02990910|20006345|P2|NOT COMPLETED|Overall Study||10
8116985|NCT02990910|20006346|P1|NOT COMPLETED|Overall Study||6
8116986|NCT02990910|20006345|P2|COMPLETED|Overall Study||130
8116987|NCT02990910|20006346|P1|COMPLETED|Overall Study||134
8116988|NCT02990910|20006345|P2|STARTED|Overall Study||140
8116989|NCT02990910|20006346|P1|STARTED|Overall Study||140
8117000|NCT02990000|20006405|P2|NOT COMPLETED|Overall Study||34
8117001|NCT02990000|20006406|P1|NOT COMPLETED|Overall Study||36
8117002|NCT02990000|20006405|P2|COMPLETED|Overall Study|99 patients provided naturalistic treatment data and were included in analyses|99
8117003|NCT02990000|20006406|P1|COMPLETED|Overall Study|119 patients provided naturalistic treatment data and were included in analyses|119
8117004|NCT02990000|20006405|P2|Begin Treatment|Overall Study|99 Scientifically Matched patients actually began treatment (attended at least one session)|99
8117005|NCT02990000|20006406|P1|Begin Treatment|Overall Study|119 Pragmatic Match patients actually began treatment (attended at least 1 session)|119
8117006|NCT02990000|20006405|P2|STARTED|Overall Study|133 patients were randomly assigned to the Scientific Match condition|133
8117007|NCT02990000|20006406|P1|STARTED|Overall Study|155 patients were randomly assigned to the Pragmatic Match condition|155
8117008|NCT02989805|20006426|P2|NOT COMPLETED|Overall Study||4
8117009|NCT02989805|20006427|P1|NOT COMPLETED|Overall Study||6
8117010|NCT02989805|20006426|P2|COMPLETED|Overall Study||162
8117011|NCT02989805|20006427|P1|COMPLETED|Overall Study||154
8117012|NCT02989805|20006426|P2|STARTED|Overall Study||166
8117013|NCT02989805|20006427|P1|STARTED|Overall Study||160
8117014|NCT02989727|20006443|P4|NOT COMPLETED|Overall Study||0
8117015|NCT02989727|20006444|P3|NOT COMPLETED|Overall Study||0
8117016|NCT02989727|20006445|P2|NOT COMPLETED|Overall Study||0
8117017|NCT02989727|20006446|P1|NOT COMPLETED|Overall Study||0
8117018|NCT02989727|20006443|P4|COMPLETED|Overall Study||30
8117019|NCT02989727|20006444|P3|COMPLETED|Overall Study||30
8117020|NCT02989727|20006445|P2|COMPLETED|Overall Study||44
8117021|NCT02989727|20006446|P1|COMPLETED|Overall Study||46
8117022|NCT02989727|20006443|P4|STARTED|Overall Study||30
8117023|NCT02989727|20006444|P3|STARTED|Overall Study||30
8117024|NCT02989727|20006445|P2|STARTED|Overall Study||44
8117025|NCT02989727|20006446|P1|STARTED|Overall Study||46
8117030|NCT02989649|20006528|P1|NOT COMPLETED|Overall Study||420
8117031|NCT02989649|20006528|P1|COMPLETED|Overall Study||173
8117032|NCT02989649|20006528|P1|Eligible to Enter Into Treatment Period|Overall Study||509
8117033|NCT02989649|20006528|P1|Started But Not Treated|Overall Study||84
8117034|NCT02989649|20006528|P1|STARTED|Overall Study||593
8117035|NCT02989610|20006540|P1|NOT COMPLETED|Overall Study||39
8117036|NCT02989610|20006540|P1|COMPLETED|Overall Study||195
8117037|NCT02989610|20006540|P1|STARTED|Overall Study||234
8117038|NCT02989545|20006546|P1|NOT COMPLETED|Treatment Period - Anal Tape Provided||0
8117039|NCT02989545|20006546|P1|COMPLETED|Treatment Period - Anal Tape Provided||20
8117040|NCT02989545|20006546|P1|STARTED|Treatment Period - Anal Tape Provided||20
8117041|NCT02989545|20006546|P1|NOT COMPLETED|Control Period - no Intervention||0
8117042|NCT02989545|20006546|P1|COMPLETED|Control Period - no Intervention||20
8117043|NCT02989545|20006546|P1|STARTED|Control Period - no Intervention||20
8117044|NCT02989389|20006570|P10|NOT COMPLETED|Period 3||0
8117045|NCT02989389|20006571|P9|NOT COMPLETED|Period 3||0
8117046|NCT02989389|20006572|P8|NOT COMPLETED|Period 3||0
8117047|NCT02989389|20006573|P7|NOT COMPLETED|Period 3||0
8117048|NCT02989389|20006574|P6|NOT COMPLETED|Period 3||0
8117049|NCT02989389|20006575|P5|NOT COMPLETED|Period 3||0
8117050|NCT02989389|20006576|P4|NOT COMPLETED|Period 3||0
8117051|NCT02989389|20006577|P3|NOT COMPLETED|Period 3||0
8117052|NCT02989389|20006578|P2|NOT COMPLETED|Period 3||0
8117053|NCT02989389|20006579|P1|NOT COMPLETED|Period 3||0
8117054|NCT02989389|20006570|P10|COMPLETED|Period 3||0
8117055|NCT02989389|20006571|P9|COMPLETED|Period 3||0
8117056|NCT02989389|20006572|P8|COMPLETED|Period 3||0
8117057|NCT02989389|20006573|P7|COMPLETED|Period 3||0
8117058|NCT02989389|20006574|P6|COMPLETED|Period 3||3
8117059|NCT02989389|20006575|P5|COMPLETED|Period 3||3
8117060|NCT02989389|20006576|P4|COMPLETED|Period 3||3
8117061|NCT02989389|20006577|P3|COMPLETED|Period 3||3
8117062|NCT02989389|20006578|P2|COMPLETED|Period 3||3
8117063|NCT02989389|20006579|P1|COMPLETED|Period 3||3
8117064|NCT02989389|20006570|P10|STARTED|Period 3||0
8117065|NCT02989389|20006571|P9|STARTED|Period 3||0
8117066|NCT02989389|20006572|P8|STARTED|Period 3||0
8117067|NCT02989389|20006573|P7|STARTED|Period 3||0
8117068|NCT02989389|20006574|P6|STARTED|Period 3||3
8117069|NCT02989389|20006575|P5|STARTED|Period 3||3
8117070|NCT02989389|20006576|P4|STARTED|Period 3||3
8117071|NCT02989389|20006577|P3|STARTED|Period 3||3
8117072|NCT02989389|20006578|P2|STARTED|Period 3||3
8117073|NCT02989389|20006579|P1|STARTED|Period 3||3
8117074|NCT02989389|20006570|P10|NOT COMPLETED|Period 2||0
8117075|NCT02989389|20006571|P9|NOT COMPLETED|Period 2||0
8117076|NCT02989389|20006572|P8|NOT COMPLETED|Period 2||0
8117077|NCT02989389|20006573|P7|NOT COMPLETED|Period 2||0
8117078|NCT02989389|20006574|P6|NOT COMPLETED|Period 2||0
8117079|NCT02989389|20006575|P5|NOT COMPLETED|Period 2||0
8117080|NCT02989389|20006576|P4|NOT COMPLETED|Period 2||0
8117081|NCT02989389|20006577|P3|NOT COMPLETED|Period 2||0
8117082|NCT02989389|20006578|P2|NOT COMPLETED|Period 2||0
8117083|NCT02989389|20006579|P1|NOT COMPLETED|Period 2||0
8117084|NCT02989389|20006570|P10|COMPLETED|Period 2||0
8117085|NCT02989389|20006571|P9|COMPLETED|Period 2||0
8117086|NCT02989389|20006572|P8|COMPLETED|Period 2||0
8117087|NCT02989389|20006573|P7|COMPLETED|Period 2||0
8117088|NCT02989389|20006574|P6|COMPLETED|Period 2||3
8117089|NCT02989389|20006575|P5|COMPLETED|Period 2||3
8117090|NCT02989389|20006576|P4|COMPLETED|Period 2||3
8117091|NCT02989389|20006577|P3|COMPLETED|Period 2||3
8117092|NCT02989389|20006578|P2|COMPLETED|Period 2||3
8117093|NCT02989389|20006579|P1|COMPLETED|Period 2||3
8117094|NCT02989389|20006570|P10|STARTED|Period 2|Part B was planned as a single period study.|0
8117095|NCT02989389|20006571|P9|STARTED|Period 2|Part B was planned as a single period study.|0
8117096|NCT02989389|20006572|P8|STARTED|Period 2|Part B was planned as a single period study.|0
8117097|NCT02989389|20006573|P7|STARTED|Period 2|Part B was planned as a single period study.|0
8117098|NCT02989389|20006574|P6|STARTED|Period 2||3
8117099|NCT02989389|20006575|P5|STARTED|Period 2||3
8117100|NCT02989389|20006576|P4|STARTED|Period 2||3
8117101|NCT02989389|20006577|P3|STARTED|Period 2||3
8117102|NCT02989389|20006578|P2|STARTED|Period 2||3
8117103|NCT02989389|20006579|P1|STARTED|Period 2||3
8117104|NCT02989389|20006570|P10|NOT COMPLETED|Period 1||0
8117105|NCT02989389|20006571|P9|NOT COMPLETED|Period 1||1
8117106|NCT02989389|20006572|P8|NOT COMPLETED|Period 1||0
8117107|NCT02989389|20006573|P7|NOT COMPLETED|Period 1||0
8117108|NCT02989389|20006574|P6|NOT COMPLETED|Period 1||0
8117109|NCT02989389|20006575|P5|NOT COMPLETED|Period 1||0
8117110|NCT02989389|20006576|P4|NOT COMPLETED|Period 1||0
8117111|NCT02989389|20006577|P3|NOT COMPLETED|Period 1||0
8117112|NCT02989389|20006578|P2|NOT COMPLETED|Period 1||1
8117113|NCT02989389|20006579|P1|NOT COMPLETED|Period 1||0
8117114|NCT02989389|20006570|P10|COMPLETED|Period 1||6
8117115|NCT02989389|20006571|P9|COMPLETED|Period 1||5
8117116|NCT02989389|20006572|P8|COMPLETED|Period 1||5
8117117|NCT02989389|20006573|P7|COMPLETED|Period 1||6
8117118|NCT02989389|20006574|P6|COMPLETED|Period 1||3
8117119|NCT02989389|20006575|P5|COMPLETED|Period 1||3
8117120|NCT02989389|20006576|P4|COMPLETED|Period 1||3
8117121|NCT02989389|20006577|P3|COMPLETED|Period 1||3
8117122|NCT02989389|20006578|P2|COMPLETED|Period 1||3
8117123|NCT02989389|20006579|P1|COMPLETED|Period 1||3
8117124|NCT02989389|20006570|P10|Received at Least 1 Dose of Study Drug|Period 1||6
8117125|NCT02989389|20006571|P9|Received at Least 1 Dose of Study Drug|Period 1||6
8117126|NCT02989389|20006572|P8|Received at Least 1 Dose of Study Drug|Period 1||5
8117127|NCT02989389|20006573|P7|Received at Least 1 Dose of Study Drug|Period 1||6
8117128|NCT02989389|20006574|P6|Received at Least 1 Dose of Study Drug|Period 1||3
8117129|NCT02989389|20006575|P5|Received at Least 1 Dose of Study Drug|Period 1||3
8117130|NCT02989389|20006576|P4|Received at Least 1 Dose of Study Drug|Period 1||3
8117131|NCT02989389|20006577|P3|Received at Least 1 Dose of Study Drug|Period 1||3
8117132|NCT02989389|20006578|P2|Received at Least 1 Dose of Study Drug|Period 1||4
8117133|NCT02989389|20006579|P1|Received at Least 1 Dose of Study Drug|Period 1||3
8117134|NCT02989389|20006570|P10|STARTED|Period 1||6
8117135|NCT02989389|20006571|P9|STARTED|Period 1||6
8117136|NCT02989389|20006572|P8|STARTED|Period 1||5
8117137|NCT02989389|20006573|P7|STARTED|Period 1||6
8117138|NCT02989389|20006574|P6|STARTED|Period 1||3
8117139|NCT02989389|20006575|P5|STARTED|Period 1||3
8117140|NCT02989389|20006576|P4|STARTED|Period 1||3
8117141|NCT02989389|20006577|P3|STARTED|Period 1||3
8117142|NCT02989389|20006578|P2|STARTED|Period 1||4
8117143|NCT02989389|20006579|P1|STARTED|Period 1||3
8117144|NCT02989168|20006645|P2|NOT COMPLETED|Overall Study||3
8117145|NCT02989168|20006646|P1|NOT COMPLETED|Overall Study||4
8117146|NCT02989168|20006645|P2|COMPLETED|Overall Study||0
8117147|NCT02989168|20006646|P1|COMPLETED|Overall Study||7
8117148|NCT02989168|20006645|P2|STARTED|Overall Study||3
8117149|NCT02989168|20006646|P1|STARTED|Overall Study||11
8117150|NCT02988882|20006668|P2|NOT COMPLETED|Overall Study||2
8117151|NCT02988882|20006669|P1|NOT COMPLETED|Overall Study||3
8117152|NCT02988882|20006668|P2|COMPLETED|Overall Study||40
8117153|NCT02988882|20006669|P1|COMPLETED|Overall Study||41
8117154|NCT02988882|20006668|P2|STARTED|Overall Study||42
8117155|NCT02988882|20006669|P1|STARTED|Overall Study||44
8117156|NCT02988856|20006679|P1|NOT COMPLETED|Overall Study||3
8117157|NCT02988856|20006679|P1|COMPLETED|Overall Study||8
8117158|NCT02988856|20006679|P1|STARTED|Overall Study||11
8117159|NCT02988843|20006685|P1|NOT COMPLETED|Overall Study||0
8117160|NCT02988843|20006685|P1|COMPLETED|Overall Study||1
8117161|NCT02988843|20006685|P1|STARTED|Overall Study||1
8117162|NCT02988622|20006692|P1|NOT COMPLETED|Overall Study||17
8117163|NCT02988622|20006692|P1|COMPLETED|Overall Study||83
8117164|NCT02988622|20006692|P1|STARTED|Overall Study||100
8117165|NCT02988349|20006716|P2|NOT COMPLETED|Overall Study||0
8117166|NCT02988349|20006717|P1|NOT COMPLETED|Overall Study||0
8117167|NCT02988349|20006716|P2|COMPLETED|Overall Study||21
8117168|NCT02988349|20006717|P1|COMPLETED|Overall Study||21
8117169|NCT02988349|20006716|P2|STARTED|Overall Study||21
8117170|NCT02988349|20006717|P1|STARTED|Overall Study||21
8117171|NCT02988219|20006727|P2|NOT COMPLETED|Overall Study||3
8117172|NCT02988219|20006728|P1|NOT COMPLETED|Overall Study||1
8117173|NCT02988219|20006727|P2|COMPLETED|Overall Study||22
8117174|NCT02988219|20006728|P1|COMPLETED|Overall Study||24
8117175|NCT02988219|20006727|P2|STARTED|Overall Study||25
8117176|NCT02988219|20006728|P1|STARTED|Overall Study||25
8117177|NCT02988193|20006738|P2|NOT COMPLETED|Overall Study||0
8117178|NCT02988193|20006739|P1|NOT COMPLETED|Overall Study||0
8117179|NCT02988193|20006738|P2|COMPLETED|Overall Study||16
8117180|NCT02988193|20006739|P1|COMPLETED|Overall Study||12
8117181|NCT02988193|20006738|P2|STARTED|Overall Study||16
8117182|NCT02988193|20006739|P1|STARTED|Overall Study||12
8117183|NCT02988115|20006747|P2|NOT COMPLETED|Overall Study||4
8117184|NCT02988115|20006748|P1|NOT COMPLETED|Overall Study||14
8117185|NCT02988115|20006747|P2|COMPLETED|Overall Study||107
8117186|NCT02988115|20006748|P1|COMPLETED|Overall Study||220
8117187|NCT02988115|20006747|P2|STARTED|Overall Study||111
8117188|NCT02988115|20006748|P1|STARTED|Overall Study||234
8117189|NCT02988050|20006764|P2|NOT COMPLETED|Overall Study||0
8117190|NCT02988050|20006765|P1|NOT COMPLETED|Overall Study||0
8117191|NCT02988050|20006764|P2|COMPLETED|Overall Study||30
8117192|NCT02988050|20006765|P1|COMPLETED|Overall Study||30
8117193|NCT02988050|20006764|P2|STARTED|Overall Study||30
8117194|NCT02988050|20006765|P1|STARTED|Overall Study||30
8117195|NCT02987972|20006774|P3|NOT COMPLETED|Overall Study||42
8117196|NCT02987972|20006775|P2|NOT COMPLETED|Overall Study||45
8117197|NCT02987972|20006776|P1|NOT COMPLETED|Overall Study||43
8117198|NCT02987972|20006774|P3|COMPLETED|Overall Study||308
8117199|NCT02987972|20006775|P2|COMPLETED|Overall Study||305
8117200|NCT02987972|20006776|P1|COMPLETED|Overall Study||308
8117201|NCT02987972|20006774|P3|Vaccination 4|Overall Study||311
8117202|NCT02987972|20006775|P2|Vaccination 4|Overall Study||306
8117203|NCT02987972|20006776|P1|Vaccination 4|Overall Study||310
8117204|NCT02987972|20006774|P3|Vaccination 3|Overall Study||332
8117205|NCT02987972|20006775|P2|Vaccination 3|Overall Study||331
8117206|NCT02987972|20006776|P1|Vaccination 3|Overall Study||330
8117207|NCT02987972|20006774|P3|Vaccination 2|Overall Study||335
8117208|NCT02987972|20006775|P2|Vaccination 2|Overall Study||335
8117209|NCT02987972|20006776|P1|Vaccination 2|Overall Study||333
8117210|NCT02987972|20006774|P3|Vaccination 1|Overall Study||347
8117211|NCT02987972|20006775|P2|Vaccination 1|Overall Study||347
8117212|NCT02987972|20006776|P1|Vaccination 1|Overall Study||350
8117213|NCT02987972|20006774|P3|STARTED|Overall Study||350
8117214|NCT02987972|20006775|P2|STARTED|Overall Study||350
8117215|NCT02987972|20006776|P1|STARTED|Overall Study||351
8117216|NCT02987868|20006805|P2|NOT COMPLETED|Second Intervention||0
8117217|NCT02987868|20006806|P1|NOT COMPLETED|Second Intervention||0
8117218|NCT02987868|20006805|P2|COMPLETED|Second Intervention||8
8117219|NCT02987868|20006806|P1|COMPLETED|Second Intervention||8
8117220|NCT02987868|20006805|P2|STARTED|Second Intervention||8
8117221|NCT02987868|20006806|P1|STARTED|Second Intervention||8
8117222|NCT02987868|20006805|P2|NOT COMPLETED|Wash Out Period 1 Week||0
8117223|NCT02987868|20006806|P1|NOT COMPLETED|Wash Out Period 1 Week||0
8117224|NCT02987868|20006805|P2|COMPLETED|Wash Out Period 1 Week||8
8117225|NCT02987868|20006806|P1|COMPLETED|Wash Out Period 1 Week||8
8117226|NCT02987868|20006805|P2|STARTED|Wash Out Period 1 Week||8
8117227|NCT02987868|20006806|P1|STARTED|Wash Out Period 1 Week||8
8117228|NCT02987868|20006805|P2|NOT COMPLETED|First Intervention||0
8117229|NCT02987868|20006806|P1|NOT COMPLETED|First Intervention||0
8117230|NCT02987868|20006805|P2|COMPLETED|First Intervention||8
8117231|NCT02987868|20006806|P1|COMPLETED|First Intervention||8
8117232|NCT02987868|20006805|P2|STARTED|First Intervention||8
8117233|NCT02987868|20006806|P1|STARTED|First Intervention||8
8117234|NCT02987660|20006814|P2|NOT COMPLETED|Overall Study||10
8117235|NCT02987660|20006815|P1|NOT COMPLETED|Overall Study||10
8117236|NCT02987660|20006814|P2|COMPLETED|Overall Study||0
8117237|NCT02987660|20006815|P1|COMPLETED|Overall Study||0
8117238|NCT02987660|20006814|P2|STARTED|Overall Study||10
8117239|NCT02987660|20006815|P1|STARTED|Overall Study||10
8117240|NCT02987621|20006825|P2|NOT COMPLETED|Overall Study||0
8117241|NCT02987621|20006826|P1|NOT COMPLETED|Overall Study||0
8117242|NCT02987621|20006825|P2|COMPLETED|Overall Study||7
8117243|NCT02987621|20006826|P1|COMPLETED|Overall Study||7
8117244|NCT02987621|20006825|P2|STARTED|Overall Study||7
8117245|NCT02987621|20006826|P1|STARTED|Overall Study||7
8117258|NCT02987374|20006856|P1|NOT COMPLETED|Overall Study||0
8117259|NCT02987374|20006856|P1|COMPLETED|Overall Study||10
8117260|NCT02987374|20006856|P1|STARTED|Overall Study||10
8117261|NCT02987231|20006863|P2|NOT COMPLETED|Overall Study||0
8117262|NCT02987231|20006864|P1|NOT COMPLETED|Overall Study||0
8117263|NCT02987231|20006863|P2|COMPLETED|Overall Study||30
8117264|NCT02987231|20006864|P1|COMPLETED|Overall Study||30
8117265|NCT02987231|20006863|P2|STARTED|Overall Study||30
8117266|NCT02987231|20006864|P1|STARTED|Overall Study||30
8117267|NCT02987205|20006872|P1|NOT COMPLETED|Overall Study||4
8117268|NCT02987205|20006872|P1|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
8117269|NCT02987205|20006872|P1|Treated - Bilateral NLF Injection|Overall Study||163
8117270|NCT02987205|20006872|P1|STARTED|Overall Study||163
8117271|NCT02986958|20006882|P2|NOT COMPLETED|Overall Study||0
8117272|NCT02986958|20006883|P1|NOT COMPLETED|Overall Study||0
8117273|NCT02986958|20006882|P2|COMPLETED|Overall Study||44
8117274|NCT02986958|20006883|P1|COMPLETED|Overall Study||49
8117275|NCT02986958|20006882|P2|STARTED|Overall Study||44
8117276|NCT02986958|20006883|P1|STARTED|Overall Study||49
8117277|NCT02986854|20006906|P3|NOT COMPLETED|Overall Study||3
8117278|NCT02986854|20006907|P2|NOT COMPLETED|Overall Study||12
8117279|NCT02986854|20006908|P1|NOT COMPLETED|Overall Study||3
8117280|NCT02986854|20006906|P3|COMPLETED|Overall Study||97
8117281|NCT02986854|20006907|P2|COMPLETED|Overall Study||288
8117282|NCT02986854|20006908|P1|COMPLETED|Overall Study||298
8117283|NCT02986854|20006906|P3|STARTED|Overall Study||100
8117284|NCT02986854|20006907|P2|STARTED|Overall Study||300
8117285|NCT02986854|20006908|P1|STARTED|Overall Study||301
8117286|NCT02986711|20006983|P2|NOT COMPLETED|Overall Study||10
8117287|NCT02986711|20006984|P1|NOT COMPLETED|Overall Study||8
8117288|NCT02986711|20006983|P2|COMPLETED|Overall Study||70
8117289|NCT02986711|20006984|P1|COMPLETED|Overall Study||70
8117290|NCT02986711|20006983|P2|STARTED|Overall Study||80
8117291|NCT02986711|20006984|P1|STARTED|Overall Study||78
8117292|NCT02986373|20006992|P1|NOT COMPLETED|Overall Study||39
8117293|NCT02986373|20006992|P1|COMPLETED|Overall Study||106
8117294|NCT02986373|20006992|P1|STARTED|Overall Study||145
8117295|NCT02986282|20007027|P1|NOT COMPLETED|Overall Study||16
8117296|NCT02986282|20007027|P1|COMPLETED|Overall Study||99
8117297|NCT02986282|20007027|P1|STARTED|Overall Study||115
8117298|NCT02986139|20007034|P2|NOT COMPLETED|Overall Study||4
8117299|NCT02986139|20007035|P1|NOT COMPLETED|Overall Study||1
8117300|NCT02986139|20007034|P2|COMPLETED|Overall Study||51
8117301|NCT02986139|20007035|P1|COMPLETED|Overall Study||55
8117302|NCT02986139|20007034|P2|Received Etanercept|Overall Study||53
8117303|NCT02986139|20007035|P1|Received Etanercept|Overall Study||56
8117304|NCT02986139|20007034|P2|STARTED|Overall Study||55
8117305|NCT02986139|20007035|P1|STARTED|Overall Study||56
8117306|NCT02985996|20007052|P5|NOT COMPLETED|Overall Study||0
8117307|NCT02985996|20007053|P4|NOT COMPLETED|Overall Study||0
8117308|NCT02985996|20007054|P3|NOT COMPLETED|Overall Study||1
8117309|NCT02985996|20007055|P2|NOT COMPLETED|Overall Study||1
8117310|NCT02985996|20007056|P1|NOT COMPLETED|Overall Study||0
8117311|NCT02985996|20007052|P5|COMPLETED|Overall Study||9
8117312|NCT02985996|20007053|P4|COMPLETED|Overall Study||7
8117313|NCT02985996|20007054|P3|COMPLETED|Overall Study||9
8117314|NCT02985996|20007055|P2|COMPLETED|Overall Study||7
8117315|NCT02985996|20007056|P1|COMPLETED|Overall Study||5
8117316|NCT02985996|20007052|P5|STARTED|Overall Study||9
8117317|NCT02985996|20007053|P4|STARTED|Overall Study||7
8117318|NCT02985996|20007054|P3|STARTED|Overall Study||10
8117319|NCT02985996|20007055|P2|STARTED|Overall Study||8
8117320|NCT02985996|20007056|P1|STARTED|Overall Study||5
8117321|NCT02985840|20007170|P2|NOT COMPLETED|Overall Study||0
8117322|NCT02985840|20007171|P1|NOT COMPLETED|Overall Study||0
8117323|NCT02985840|20007170|P2|COMPLETED|Overall Study||63
8117324|NCT02985840|20007171|P1|COMPLETED|Overall Study||64
8117325|NCT02985840|20007170|P2|STARTED|Overall Study||63
8117326|NCT02985840|20007171|P1|STARTED|Overall Study||64
8117327|NCT02985827|20007181|P2|NOT COMPLETED|Overall Study||0
8117328|NCT02985827|20007182|P1|NOT COMPLETED|Overall Study||0
8117329|NCT02985827|20007181|P2|COMPLETED|Overall Study||15
8117330|NCT02985827|20007182|P1|COMPLETED|Overall Study||33
8117331|NCT02985827|20007181|P2|STARTED|Overall Study||15
8117332|NCT02985827|20007182|P1|STARTED|Overall Study||33
8117333|NCT02985684|20007190|P1|NOT COMPLETED|6-Month Closure Success Evaluation||8
8117334|NCT02985684|20007190|P1|COMPLETED|6-Month Closure Success Evaluation||112
8117335|NCT02985684|20007190|P1|STARTED|6-Month Closure Success Evaluation||120
8117336|NCT02985684|20007190|P1|NOT COMPLETED|6-Month Clinical Success Evaluation||5
8117337|NCT02985684|20007190|P1|COMPLETED|6-Month Clinical Success Evaluation||120
8117338|NCT02985684|20007190|P1|STARTED|6-Month Clinical Success Evaluation||125
8117339|NCT02985398|20007201|P1|NOT COMPLETED|Overall Study||22
8117340|NCT02985398|20007201|P1|COMPLETED|Overall Study||106
8117341|NCT02985398|20007201|P1|Participants Treated|Overall Study||128
8117342|NCT02985398|20007201|P1|STARTED|Overall Study||128
8117343|NCT02984995|20007219|P2|NOT COMPLETED|Overall Study||3
8117344|NCT02984995|20007220|P1|NOT COMPLETED|Overall Study||25
8117345|NCT02984995|20007219|P2|COMPLETED|Overall Study||0
8117346|NCT02984995|20007220|P1|COMPLETED|Overall Study||9
8117347|NCT02984995|20007219|P2|STARTED|Overall Study||3
8117348|NCT02984995|20007220|P1|STARTED|Overall Study||34
8117349|NCT02984982|20007267|P2|NOT COMPLETED|Overall Study||10
8117350|NCT02984982|20007268|P1|NOT COMPLETED|Overall Study||8
8117351|NCT02984982|20007267|P2|COMPLETED|Overall Study||94
8117352|NCT02984982|20007268|P1|COMPLETED|Overall Study||94
8117353|NCT02984982|20007267|P2|Treated|Overall Study||103
8117354|NCT02984982|20007268|P1|Treated|Overall Study||102
8117355|NCT02984982|20007267|P2|STARTED|Overall Study||104
8117356|NCT02984982|20007268|P1|STARTED|Overall Study||102
8117357|NCT02984943|20007320|P1|NOT COMPLETED|Overall Study||4
8117358|NCT02984943|20007320|P1|COMPLETED|Overall Study||10
8117359|NCT02984943|20007320|P1|STARTED|Overall Study||14
8117360|NCT02984878|20007365|P2|NOT COMPLETED|Overall Study||0
8117361|NCT02984878|20007366|P1|NOT COMPLETED|Overall Study||0
8117362|NCT02984878|20007365|P2|COMPLETED|Overall Study||41
8117363|NCT02984878|20007366|P1|COMPLETED|Overall Study||30
8117364|NCT02984878|20007365|P2|STARTED|Overall Study||41
8117365|NCT02984878|20007366|P1|STARTED|Overall Study||30
8117366|NCT02984709|20007378|P2|NOT COMPLETED|Overall Study||0
8117367|NCT02984709|20007379|P1|NOT COMPLETED|Overall Study||0
8117368|NCT02984709|20007378|P2|COMPLETED|Overall Study||24
8117369|NCT02984709|20007379|P1|COMPLETED|Overall Study||24
8117370|NCT02984709|20007378|P2|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
8117371|NCT02984709|20007379|P1|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
8117372|NCT02984644|20007403|P2|NOT COMPLETED|Overall Study||0
8117373|NCT02984644|20007404|P1|NOT COMPLETED|Overall Study||0
8117374|NCT02984644|20007403|P2|COMPLETED|Overall Study||10
8117375|NCT02984644|20007404|P1|COMPLETED|Overall Study||20
8117376|NCT02984644|20007403|P2|STARTED|Overall Study||10
8117377|NCT02984644|20007404|P1|STARTED|Overall Study||20
8117378|NCT02984267|20007434|P2|NOT COMPLETED|Overall Study||1
8117379|NCT02984267|20007435|P1|NOT COMPLETED|Overall Study||1
8117380|NCT02984267|20007434|P2|COMPLETED|Overall Study||9
8117381|NCT02984267|20007435|P1|COMPLETED|Overall Study||7
8117382|NCT02984267|20007434|P2|STARTED|Overall Study||10
8117383|NCT02984267|20007435|P1|STARTED|Overall Study||8
8117384|NCT02983981|20007459|P1|NOT COMPLETED|Overall Study||0
8117385|NCT02983981|20007459|P1|COMPLETED|Overall Study||20
8117386|NCT02983981|20007459|P1|STARTED|Overall Study||20
8117387|NCT02983877|20007466|P1|NOT COMPLETED|Overall Study||0
8117388|NCT02983877|20007466|P1|COMPLETED|Overall Study||38
8117389|NCT02983877|20007466|P1|STARTED|Overall Study||38
8117393|NCT02983617|20007480|P2|NOT COMPLETED|Overall Study||30
8117394|NCT02983617|20007481|P1|NOT COMPLETED|Overall Study||6
8117395|NCT02983617|20007480|P2|COMPLETED|Overall Study||0
8117396|NCT02983617|20007481|P1|COMPLETED|Overall Study||0
8117397|NCT02983617|20007480|P2|STARTED|Overall Study||30
8117398|NCT02983617|20007481|P1|STARTED|Overall Study||6
8117399|NCT02983604|20007499|P4|NOT COMPLETED|Overall Study||0
8117400|NCT02983604|20007500|P3|NOT COMPLETED|Overall Study||1
8117401|NCT02983604|20007501|P2|NOT COMPLETED|Overall Study||0
8117402|NCT02983604|20007502|P1|NOT COMPLETED|Overall Study||0
8117403|NCT02983604|20007499|P4|COMPLETED|Overall Study||3
8117404|NCT02983604|20007500|P3|COMPLETED|Overall Study||3
8117405|NCT02983604|20007501|P2|COMPLETED|Overall Study||3
8117406|NCT02983604|20007502|P1|COMPLETED|Overall Study||4
8117407|NCT02983604|20007499|P4|STARTED|Overall Study||3
8117408|NCT02983604|20007500|P3|STARTED|Overall Study||4
8117409|NCT02983604|20007501|P2|STARTED|Overall Study||3
8117410|NCT02983604|20007502|P1|STARTED|Overall Study||4
8117411|NCT02983448|20007540|P2|NOT COMPLETED|Overall Study||0
8117412|NCT02983448|20007541|P1|NOT COMPLETED|Overall Study||0
8117413|NCT02983448|20007540|P2|COMPLETED|Overall Study||12
8117414|NCT02983448|20007541|P1|COMPLETED|Overall Study||12
8117415|NCT02983448|20007540|P2|STARTED|Overall Study||12
8117416|NCT02983448|20007541|P1|STARTED|Overall Study||12
8117417|NCT02983305|20007551|P2|NOT COMPLETED|Overall Study||0
8117418|NCT02983305|20007552|P1|NOT COMPLETED|Overall Study||2
8117419|NCT02983305|20007551|P2|COMPLETED|Overall Study||10
8117420|NCT02983305|20007552|P1|COMPLETED|Overall Study||10
8117421|NCT02983305|20007551|P2|STARTED|Overall Study||10
8117422|NCT02983305|20007552|P1|STARTED|Overall Study||12
8117423|NCT02983227|20007562|P2|NOT COMPLETED|Overall Study||14
8117424|NCT02983227|20007563|P1|NOT COMPLETED|Overall Study||59
8117425|NCT02983227|20007562|P2|COMPLETED|Overall Study||72
8117426|NCT02983227|20007563|P1|COMPLETED|Overall Study||351
8117427|NCT02983227|20007562|P2|STARTED|Overall Study||86
8117428|NCT02983227|20007563|P1|STARTED|Overall Study||410
8117429|NCT02983058|20007623|P2|NOT COMPLETED|Overall Study||3
8117430|NCT02983058|20007624|P1|NOT COMPLETED|Overall Study||5
8117431|NCT02983058|20007623|P2|COMPLETED|Overall Study||2
8117432|NCT02983058|20007624|P1|COMPLETED|Overall Study||2
8117433|NCT02983058|20007623|P2|STARTED|Overall Study||5
8117434|NCT02983058|20007624|P1|STARTED|Overall Study||7
8117435|NCT02982928|20007634|P1|NOT COMPLETED|Overall Study||0
8117436|NCT02982928|20007634|P1|COMPLETED|Overall Study||11
8117437|NCT02982928|20007634|P1|STARTED|Overall Study||11
8117438|NCT02982863|20007643|P5|NOT COMPLETED|Overall Study||492
8117439|NCT02982863|20007644|P4|NOT COMPLETED|Overall Study||1400
8117440|NCT02982863|20007645|P3|NOT COMPLETED|Overall Study||1852
8117441|NCT02982863|20007646|P2|NOT COMPLETED|Overall Study||4261
8117442|NCT02982863|20007647|P1|NOT COMPLETED|Overall Study||809
8117443|NCT02982863|20007643|P5|COMPLETED|Overall Study||2268
8117444|NCT02982863|20007644|P4|COMPLETED|Overall Study||8758
8117445|NCT02982863|20007645|P3|COMPLETED|Overall Study||11386
8117446|NCT02982863|20007646|P2|COMPLETED|Overall Study||12484
8117447|NCT02982863|20007647|P1|COMPLETED|Overall Study||4936
8117448|NCT02982863|20007643|P5|STARTED|Overall Study||2760
8117449|NCT02982863|20007644|P4|STARTED|Overall Study||10158
8117450|NCT02982863|20007645|P3|STARTED|Overall Study||13238
8117451|NCT02982863|20007646|P2|STARTED|Overall Study||16745
8117452|NCT02982863|20007647|P1|STARTED|Overall Study||5745
8117453|NCT02982720|20007704|P1|NOT COMPLETED|Overall Study||4
8117454|NCT02982720|20007704|P1|COMPLETED|Overall Study||0
8117455|NCT02982720|20007704|P1|STARTED|Overall Study||4
8117456|NCT02982239|20007714|P2|NOT COMPLETED|Overall Study||2
8117457|NCT02982239|20007715|P1|NOT COMPLETED|Overall Study||3
8117458|NCT02982239|20007714|P2|COMPLETED|Overall Study||18
8117459|NCT02982239|20007715|P1|COMPLETED|Overall Study||17
8117460|NCT02982239|20007714|P2|STARTED|Overall Study||20
8117461|NCT02982239|20007715|P1|STARTED|Overall Study||20
8117462|NCT02982213|20007731|P2|NOT COMPLETED|Overall Study||1
8117463|NCT02982213|20007732|P1|NOT COMPLETED|Overall Study||5
8117464|NCT02982213|20007731|P2|COMPLETED|Overall Study||74
8117465|NCT02982213|20007732|P1|COMPLETED|Overall Study||70
8117466|NCT02982213|20007731|P2|STARTED|Overall Study||75
8117467|NCT02982213|20007732|P1|STARTED|Overall Study||75
8117468|NCT02982187|20007748|P8|NOT COMPLETED|Overall Study||0
8117469|NCT02982187|20007749|P7|NOT COMPLETED|Overall Study||1
8117470|NCT02982187|20007750|P6|NOT COMPLETED|Overall Study||0
8117471|NCT02982187|20007751|P5|NOT COMPLETED|Overall Study||0
8117472|NCT02982187|20007752|P4|NOT COMPLETED|Overall Study||0
8117473|NCT02982187|20007753|P3|NOT COMPLETED|Overall Study||0
8117474|NCT02982187|20007754|P2|NOT COMPLETED|Overall Study||0
8117475|NCT02982187|20007755|P1|NOT COMPLETED|Overall Study||0
8117476|NCT02982187|20007748|P8|COMPLETED|Overall Study||20
8117477|NCT02982187|20007749|P7|COMPLETED|Overall Study||19
8117478|NCT02982187|20007750|P6|COMPLETED|Overall Study||20
8117479|NCT02982187|20007751|P5|COMPLETED|Overall Study||20
8117480|NCT02982187|20007752|P4|COMPLETED|Overall Study||20
8117481|NCT02982187|20007753|P3|COMPLETED|Overall Study||20
8117482|NCT02982187|20007754|P2|COMPLETED|Overall Study||20
8117483|NCT02982187|20007755|P1|COMPLETED|Overall Study||20
8117484|NCT02982187|20007748|P8|STARTED|Overall Study||20
8117485|NCT02982187|20007749|P7|STARTED|Overall Study||20
8117486|NCT02982187|20007750|P6|STARTED|Overall Study||20
8117487|NCT02982187|20007751|P5|STARTED|Overall Study||20
8117488|NCT02982187|20007752|P4|STARTED|Overall Study||20
8117489|NCT02982187|20007753|P3|STARTED|Overall Study||20
8117490|NCT02982187|20007754|P2|STARTED|Overall Study||20
8117491|NCT02982187|20007755|P1|STARTED|Overall Study||20
8117492|NCT02982018|20007805|P2|NOT COMPLETED|Overall Study||3
8117493|NCT02982018|20007806|P1|NOT COMPLETED|Overall Study||5
8117494|NCT02982018|20007805|P2|COMPLETED|Overall Study||61
8117495|NCT02982018|20007806|P1|COMPLETED|Overall Study||62
8117496|NCT02982018|20007805|P2|STARTED|Overall Study||64
8117497|NCT02982018|20007806|P1|STARTED|Overall Study||67
8117516|NCT02981342|20008021|P4|NOT COMPLETED|Overall Study||14
8117517|NCT02981342|20008022|P3|NOT COMPLETED|Overall Study||13
8117518|NCT02981342|20008023|P2|NOT COMPLETED|Overall Study||11
8117519|NCT02981342|20008024|P1|NOT COMPLETED|Overall Study||0
8117520|NCT02981342|20008021|P4|COMPLETED|Overall Study||19
8117521|NCT02981342|20008022|P3|COMPLETED|Overall Study||20
8117522|NCT02981342|20008023|P2|COMPLETED|Overall Study||22
8117523|NCT02981342|20008024|P1|COMPLETED|Overall Study||7
8117524|NCT02981342|20008021|P4|Received at Least One Dose of Study Drug|Overall Study||26
8117525|NCT02981342|20008022|P3|Received at Least One Dose of Study Drug|Overall Study||33
8117526|NCT02981342|20008023|P2|Received at Least One Dose of Study Drug|Overall Study||32
8117527|NCT02981342|20008024|P1|Received at Least One Dose of Study Drug|Overall Study||7
8117528|NCT02981342|20008021|P4|STARTED|Overall Study||33
8117529|NCT02981342|20008022|P3|STARTED|Overall Study||33
8117530|NCT02981342|20008023|P2|STARTED|Overall Study||33
8117531|NCT02981342|20008024|P1|STARTED|Overall Study||7
8117532|NCT02980978|20008067|P2|NOT COMPLETED|Overall Study||8
8117533|NCT02980978|20008068|P1|NOT COMPLETED|Overall Study||6
8117534|NCT02980978|20008067|P2|COMPLETED|Overall Study||50
8117535|NCT02980978|20008068|P1|COMPLETED|Overall Study||54
8117536|NCT02980978|20008067|P2|STARTED|Overall Study||58
8117537|NCT02980978|20008068|P1|STARTED|Overall Study||60
8117538|NCT02980783|20008082|P1|NOT COMPLETED|Overall Study||1
8117539|NCT02980783|20008082|P1|COMPLETED|Overall Study||52
8117540|NCT02980783|20008082|P1|STARTED|Overall Study||53
8117541|NCT02980601|20008095|P2|NOT COMPLETED|Overall Study||3
8117542|NCT02980601|20008096|P1|NOT COMPLETED|Overall Study||5
8117543|NCT02980601|20008095|P2|COMPLETED|Overall Study||1
8117544|NCT02980601|20008096|P1|COMPLETED|Overall Study||1
8117545|NCT02980601|20008095|P2|STARTED|Overall Study||4
8117546|NCT02980601|20008096|P1|STARTED|Overall Study||6
8117547|NCT02980523|20008189|P5|NOT COMPLETED|Overall Study||10
8117548|NCT02980523|20008190|P4|NOT COMPLETED|Overall Study||9
8117549|NCT02980523|20008191|P3|NOT COMPLETED|Overall Study||6
8117550|NCT02980523|20008192|P2|NOT COMPLETED|Overall Study||11
8117551|NCT02980523|20008193|P1|NOT COMPLETED|Overall Study||3
8117552|NCT02980523|20008189|P5|COMPLETED|Overall Study||20
8117553|NCT02980523|20008190|P4|COMPLETED|Overall Study||21
8117554|NCT02980523|20008191|P3|COMPLETED|Overall Study||24
8117555|NCT02980523|20008192|P2|COMPLETED|Overall Study||19
8117556|NCT02980523|20008193|P1|COMPLETED|Overall Study||27
8117557|NCT02980523|20008189|P5|STARTED|Overall Study||30
8117558|NCT02980523|20008190|P4|STARTED|Overall Study||30
8117559|NCT02980523|20008191|P3|STARTED|Overall Study||30
8117560|NCT02980523|20008192|P2|STARTED|Overall Study||30
8117561|NCT02980523|20008193|P1|STARTED|Overall Study||30
8117562|NCT02980224|20008237|P2|NOT COMPLETED|Overall Study||3
8117563|NCT02980224|20008238|P1|NOT COMPLETED|Overall Study||4
8117564|NCT02980224|20008237|P2|COMPLETED|Overall Study||88
8117565|NCT02980224|20008238|P1|COMPLETED|Overall Study||85
8117566|NCT02980224|20008237|P2|STARTED|Overall Study||91
8117567|NCT02980224|20008238|P1|STARTED|Overall Study||89
8117568|NCT02980211|20008248|P1|NOT COMPLETED|Overall Study||0
8117569|NCT02980211|20008248|P1|COMPLETED|Overall Study||17
8117570|NCT02980211|20008248|P1|STARTED|Overall Study||17
8117571|NCT02980133|20008256|P4|NOT COMPLETED|Overall Study||6
8117572|NCT02980133|20008257|P3|NOT COMPLETED|Overall Study||7
8117573|NCT02980133|20008258|P2|NOT COMPLETED|Overall Study||5
8117574|NCT02980133|20008259|P1|NOT COMPLETED|Overall Study||7
8117575|NCT02980133|20008256|P4|COMPLETED|Overall Study||205
8117576|NCT02980133|20008257|P3|COMPLETED|Overall Study||203
8117577|NCT02980133|20008258|P2|COMPLETED|Overall Study||206
8117578|NCT02980133|20008259|P1|COMPLETED|Overall Study||202
8117579|NCT02980133|20008256|P4|Received at Least 1 Dose of Study Drug|Overall Study||211
8117580|NCT02980133|20008257|P3|Received at Least 1 Dose of Study Drug|Overall Study||208
8117581|NCT02980133|20008258|P2|Received at Least 1 Dose of Study Drug|Overall Study||211
8117582|NCT02980133|20008259|P1|Received at Least 1 Dose of Study Drug|Overall Study||209
8117583|NCT02980133|20008256|P4|STARTED|Overall Study||211
8117584|NCT02980133|20008257|P3|STARTED|Overall Study||210
8117585|NCT02980133|20008258|P2|STARTED|Overall Study||211
8117586|NCT02980133|20008259|P1|STARTED|Overall Study||209
8117587|NCT02980107|20008297|P2|NOT COMPLETED|Overall Study||62
8117588|NCT02980107|20008298|P1|NOT COMPLETED|Overall Study||51
8117589|NCT02980107|20008297|P2|COMPLETED|Overall Study||45
8117590|NCT02980107|20008298|P1|COMPLETED|Overall Study||54
8117591|NCT02980107|20008297|P2|STARTED|Overall Study||107
8117592|NCT02980107|20008298|P1|STARTED|Overall Study||105
8117599|NCT02979899|20008332|P2|NOT COMPLETED|Overall Study||0
8117600|NCT02979899|20008333|P1|NOT COMPLETED|Overall Study||0
8117601|NCT02979899|20008332|P2|COMPLETED|Overall Study||64
8117602|NCT02979899|20008333|P1|COMPLETED|Overall Study||64
8117603|NCT02979899|20008332|P2|STARTED|Overall Study||64
8117604|NCT02979899|20008333|P1|STARTED|Overall Study||64
8117605|NCT02979639|20008345|P1|NOT COMPLETED|Overall Study||14
8117606|NCT02979639|20008345|P1|COMPLETED|Overall Study||387
8117607|NCT02979639|20008345|P1|STARTED|Overall Study||401
8117608|NCT02979613|20008377|P2|NOT COMPLETED|Open-Label Extension (OLE) Phase||6
8117609|NCT02979613|20008378|P1|NOT COMPLETED|Open-Label Extension (OLE) Phase||3
8117610|NCT02979613|20008377|P2|COMPLETED|Open-Label Extension (OLE) Phase||231
8117611|NCT02979613|20008378|P1|COMPLETED|Open-Label Extension (OLE) Phase||232
8117612|NCT02979613|20008377|P2|STARTED|Open-Label Extension (OLE) Phase||237
8117613|NCT02979613|20008378|P1|STARTED|Open-Label Extension (OLE) Phase||235
8117614|NCT02979613|20008377|P2|NOT COMPLETED|Double-Blind Phase||8
8117615|NCT02979613|20008378|P1|NOT COMPLETED|Double-Blind Phase||10
8117616|NCT02979613|20008377|P2|COMPLETED|Double-Blind Phase||237
8117617|NCT02979613|20008378|P1|COMPLETED|Double-Blind Phase||235
8117618|NCT02979613|20008377|P2|STARTED|Double-Blind Phase||245
8117619|NCT02979613|20008378|P1|STARTED|Double-Blind Phase||245
8117620|NCT02979535|20008438|P2|NOT COMPLETED|Overall Study||101
8117621|NCT02979535|20008439|P1|NOT COMPLETED|Overall Study||95
8117622|NCT02979535|20008438|P2|COMPLETED|Overall Study||140
8117623|NCT02979535|20008439|P1|COMPLETED|Overall Study||144
8117624|NCT02979535|20008438|P2|Safety Analysis Set|Overall Study||241
8117625|NCT02979535|20008439|P1|Safety Analysis Set|Overall Study||237
8117626|NCT02979535|20008438|P2|STARTED|Overall Study||241
8117627|NCT02979535|20008439|P1|STARTED|Overall Study||239
8117628|NCT02979444|20008476|P3|NOT COMPLETED|Overall Study||10
8117629|NCT02979444|20008477|P2|NOT COMPLETED|Overall Study||17
8117630|NCT02979444|20008478|P1|NOT COMPLETED|Overall Study||23
8117631|NCT02979444|20008476|P3|COMPLETED|Overall Study||149
8117632|NCT02979444|20008477|P2|COMPLETED|Overall Study||293
8117633|NCT02979444|20008478|P1|COMPLETED|Overall Study||382
8117634|NCT02979444|20008476|P3|STARTED|Overall Study||159
8117635|NCT02979444|20008477|P2|STARTED|Overall Study||310
8117636|NCT02979444|20008478|P1|STARTED|Overall Study||405
8117637|NCT02979431|20008502|P4|NOT COMPLETED|Overall Study||1
8117638|NCT02979431|20008503|P3|NOT COMPLETED|Overall Study||2
8117639|NCT02979431|20008504|P2|NOT COMPLETED|Overall Study||2
8117640|NCT02979431|20008505|P1|NOT COMPLETED|Overall Study||4
8117641|NCT02979431|20008502|P4|COMPLETED|Overall Study||44
8117642|NCT02979431|20008503|P3|COMPLETED|Overall Study||43
8117643|NCT02979431|20008504|P2|COMPLETED|Overall Study||44
8117644|NCT02979431|20008505|P1|COMPLETED|Overall Study||40
8117645|NCT02979431|20008502|P4|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46
8117646|NCT02979431|20008503|P3|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44
8117647|NCT02979431|20008504|P2|Included in the Safety Population|Overall Study||45
8117648|NCT02979431|20008505|P1|Included in the Safety Population|Overall Study||40
8117649|NCT02979431|20008502|P4|Included in the mITT Population|Overall Study||45
8117650|NCT02979431|20008503|P3|Included in the mITT Population|Overall Study||43
8117651|NCT02979431|20008504|P2|Included in the mITT Population|Overall Study||45
8117652|NCT02979431|20008505|P1|Included in the mITT Population|Overall Study||42
8117653|NCT02979431|20008502|P4|STARTED|Overall Study||45
8117654|NCT02979431|20008503|P3|STARTED|Overall Study||45
8117655|NCT02979431|20008504|P2|STARTED|Overall Study||46
8117656|NCT02979431|20008505|P1|STARTED|Overall Study||44
8117657|NCT02979301|20008557|P2|NOT COMPLETED|Overall Study||0
8117658|NCT02979301|20008558|P1|NOT COMPLETED|Overall Study||1
8117659|NCT02979301|20008557|P2|COMPLETED|Overall Study||11
8117660|NCT02979301|20008558|P1|COMPLETED|Overall Study||10
8117661|NCT02979301|20008557|P2|STARTED|Overall Study||11
8117662|NCT02979301|20008558|P1|STARTED|Overall Study||11
8117663|NCT02979262|20008566|P2|NOT COMPLETED|Overall Study||9
8117664|NCT02979262|20008567|P1|NOT COMPLETED|Overall Study||12
8117665|NCT02979262|20008566|P2|COMPLETED|Overall Study||20
8117666|NCT02979262|20008567|P1|COMPLETED|Overall Study||21
8117667|NCT02979262|20008566|P2|Received Allocated Intervention|Overall Study||27
8117668|NCT02979262|20008567|P1|Received Allocated Intervention|Overall Study||30
8117669|NCT02979262|20008566|P2|STARTED|Overall Study||29
8117670|NCT02979262|20008567|P1|STARTED|Overall Study||33
8117671|NCT02979249|20008583|P1|NOT COMPLETED|Overall Study||6
8117672|NCT02979249|20008583|P1|COMPLETED|Overall Study||10
8117673|NCT02979249|20008583|P1|STARTED|Overall Study||16
8117674|NCT02979197|20008591|P3|NOT COMPLETED|Overall Study||0
8117675|NCT02979197|20008592|P2|NOT COMPLETED|Overall Study||4
8117676|NCT02979197|20008593|P1|NOT COMPLETED|Overall Study||4
8117677|NCT02979197|20008591|P3|COMPLETED|Overall Study||8
8117678|NCT02979197|20008592|P2|COMPLETED|Overall Study||45
8117679|NCT02979197|20008593|P1|COMPLETED|Overall Study||44
8117680|NCT02979197|20008591|P3|STARTED|Overall Study||8
8117681|NCT02979197|20008592|P2|STARTED|Overall Study||49
8117682|NCT02979197|20008593|P1|STARTED|Overall Study||48
8117683|NCT02979054|20008621|P2|NOT COMPLETED|Overall Study||0
8117684|NCT02979054|20008622|P1|NOT COMPLETED|Overall Study||0
8117685|NCT02979054|20008621|P2|COMPLETED|Overall Study||64
8117686|NCT02979054|20008622|P1|COMPLETED|Overall Study||71
8117687|NCT02979054|20008621|P2|STARTED|Overall Study||64
8117688|NCT02979054|20008622|P1|STARTED|Overall Study||71
8117689|NCT02978833|20008636|P2|NOT COMPLETED|Overall Study||1
8117690|NCT02978833|20008637|P1|NOT COMPLETED|Overall Study||1
8117691|NCT02978833|20008636|P2|COMPLETED|Overall Study||0
8117692|NCT02978833|20008637|P1|COMPLETED|Overall Study||0
8117693|NCT02978833|20008636|P2|STARTED|Overall Study||1
8117694|NCT02978833|20008637|P1|STARTED|Overall Study||1
8117695|NCT02978508|20008655|P2|NOT COMPLETED|Overall Study||0
8117696|NCT02978508|20008656|P1|NOT COMPLETED|Overall Study||0
8117697|NCT02978508|20008655|P2|COMPLETED|Overall Study||70
8117698|NCT02978508|20008656|P1|COMPLETED|Overall Study||70
8117699|NCT02978508|20008655|P2|STARTED|Overall Study||70
8117700|NCT02978508|20008656|P1|STARTED|Overall Study||70
8117701|NCT02978417|20008666|P2|NOT COMPLETED|Overall Study||2
8117702|NCT02978417|20008667|P1|NOT COMPLETED|Overall Study||2
8117703|NCT02978417|20008666|P2|COMPLETED|Overall Study||3
8117704|NCT02978417|20008667|P1|COMPLETED|Overall Study||3
8117705|NCT02978417|20008666|P2|STARTED|Overall Study||5
8117706|NCT02978417|20008667|P1|STARTED|Overall Study||5
8117707|NCT02978339|20008701|P1|NOT COMPLETED|Overall Study||0
8117708|NCT02978339|20008701|P1|COMPLETED|Overall Study||15
8117709|NCT02978339|20008701|P1|STARTED|Overall Study||15
8117710|NCT02978157|20008713|P2|NOT COMPLETED|Overall Study||0
8117711|NCT02978157|20008714|P1|NOT COMPLETED|Overall Study||0
8117712|NCT02978157|20008713|P2|COMPLETED|Overall Study||50
8117713|NCT02978157|20008714|P1|COMPLETED|Overall Study||52
8117714|NCT02978157|20008713|P2|STARTED|Overall Study||50
8117715|NCT02978157|20008714|P1|STARTED|Overall Study||52
8117716|NCT02977572|20008722|P2|NOT COMPLETED|Overall Study||2
8117717|NCT02977572|20008723|P1|NOT COMPLETED|Overall Study||2
8117718|NCT02977572|20008722|P2|COMPLETED|Overall Study||54
8117719|NCT02977572|20008723|P1|COMPLETED|Overall Study||56
8117720|NCT02977572|20008722|P2|STARTED|Overall Study||56
8117721|NCT02977572|20008723|P1|STARTED|Overall Study||58
8117722|NCT02977507|20008745|P2|NOT COMPLETED|Overall Study||0
8117723|NCT02977507|20008746|P1|NOT COMPLETED|Overall Study||2
8117724|NCT02977507|20008745|P2|COMPLETED|Overall Study||10
8117725|NCT02977507|20008746|P1|COMPLETED|Overall Study||6
8117726|NCT02977507|20008745|P2|STARTED|Overall Study||10
8117727|NCT02977507|20008746|P1|STARTED|Overall Study||8
8117728|NCT02976519|20008776|P7|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1
8117729|NCT02976519|20008777|P6|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117730|NCT02976519|20008778|P5|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117731|NCT02976519|20008779|P4|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117732|NCT02976519|20008780|P3|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117733|NCT02976519|20008781|P2|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117734|NCT02976519|20008782|P1|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117735|NCT02976519|20008776|P7|COMPLETED|Treatment Period 2 (Part 2 Only)||9
8117736|NCT02976519|20008777|P6|COMPLETED|Treatment Period 2 (Part 2 Only)||12
8117737|NCT02976519|20008778|P5|COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117738|NCT02976519|20008779|P4|COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117739|NCT02976519|20008780|P3|COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117740|NCT02976519|20008781|P2|COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117741|NCT02976519|20008782|P1|COMPLETED|Treatment Period 2 (Part 2 Only)||0
8117742|NCT02976519|20008776|P7|STARTED|Treatment Period 2 (Part 2 Only)||10
8117743|NCT02976519|20008777|P6|STARTED|Treatment Period 2 (Part 2 Only)||12
8117744|NCT02976519|20008778|P5|STARTED|Treatment Period 2 (Part 2 Only)||0
8117745|NCT02976519|20008779|P4|STARTED|Treatment Period 2 (Part 2 Only)||0
8117746|NCT02976519|20008780|P3|STARTED|Treatment Period 2 (Part 2 Only)||0
8117747|NCT02976519|20008781|P2|STARTED|Treatment Period 2 (Part 2 Only)||0
8117748|NCT02976519|20008782|P1|STARTED|Treatment Period 2 (Part 2 Only)||0
8117749|NCT02976519|20008776|P7|NOT COMPLETED|Wash-out Period (Part 2 Only)||2
8117750|NCT02976519|20008777|P6|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
8117751|NCT02976519|20008778|P5|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
8117752|NCT02976519|20008779|P4|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
8117753|NCT02976519|20008780|P3|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
8117754|NCT02976519|20008781|P2|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
8117755|NCT02976519|20008782|P1|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
8117756|NCT02976519|20008776|P7|COMPLETED|Wash-out Period (Part 2 Only)||10
8117757|NCT02976519|20008777|P6|COMPLETED|Wash-out Period (Part 2 Only)||12
8117758|NCT02976519|20008778|P5|COMPLETED|Wash-out Period (Part 2 Only)||0
8117759|NCT02976519|20008779|P4|COMPLETED|Wash-out Period (Part 2 Only)||0
8117760|NCT02976519|20008780|P3|COMPLETED|Wash-out Period (Part 2 Only)||0
8117761|NCT02976519|20008781|P2|COMPLETED|Wash-out Period (Part 2 Only)||0
8117762|NCT02976519|20008782|P1|COMPLETED|Wash-out Period (Part 2 Only)||0
8117763|NCT02976519|20008776|P7|STARTED|Wash-out Period (Part 2 Only)||12
8117764|NCT02976519|20008777|P6|STARTED|Wash-out Period (Part 2 Only)||12
8117765|NCT02976519|20008778|P5|STARTED|Wash-out Period (Part 2 Only)||0
8117766|NCT02976519|20008779|P4|STARTED|Wash-out Period (Part 2 Only)||0
8117767|NCT02976519|20008780|P3|STARTED|Wash-out Period (Part 2 Only)||0
8117768|NCT02976519|20008781|P2|STARTED|Wash-out Period (Part 2 Only)||0
8117769|NCT02976519|20008782|P1|STARTED|Wash-out Period (Part 2 Only)||0
8117770|NCT02976519|20008776|P7|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
8117771|NCT02976519|20008777|P6|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
8117772|NCT02976519|20008778|P5|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
8117773|NCT02976519|20008779|P4|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
8117774|NCT02976519|20008780|P3|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
8117775|NCT02976519|20008781|P2|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
8117776|NCT02976519|20008782|P1|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
8117777|NCT02976519|20008776|P7|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
8117778|NCT02976519|20008777|P6|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
8117779|NCT02976519|20008778|P5|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
8117780|NCT02976519|20008779|P4|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
8117781|NCT02976519|20008780|P3|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
8117782|NCT02976519|20008781|P2|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
8117783|NCT02976519|20008782|P1|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
8117784|NCT02976519|20008776|P7|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
8117785|NCT02976519|20008777|P6|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
8117786|NCT02976519|20008778|P5|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
8117787|NCT02976519|20008779|P4|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
8117788|NCT02976519|20008780|P3|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
8117789|NCT02976519|20008781|P2|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
8117790|NCT02976519|20008782|P1|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
8117791|NCT02976181|20008806|P1|NOT COMPLETED|Overall Study||1
8117792|NCT02976181|20008806|P1|COMPLETED|Overall Study||112
8117793|NCT02976181|20008806|P1|STARTED|Overall Study||113
8117794|NCT02976103|20008813|P2|NOT COMPLETED|Overall Study||8
8117795|NCT02976103|20008814|P1|NOT COMPLETED|Overall Study||13
8117796|NCT02976103|20008813|P2|COMPLETED|Overall Study|64 participants answered final (T3 questionnaire)|64
8117797|NCT02976103|20008814|P1|COMPLETED|Overall Study|54 participants answered final (T3) questionnaire|54
8117798|NCT02976103|20008813|P2|STARTED|Overall Study||72
8117799|NCT02976103|20008814|P1|STARTED|Overall Study||67
8117800|NCT02975973|20008869|P4|NOT COMPLETED|Overall Study||0
8117801|NCT02975973|20008870|P3|NOT COMPLETED|Overall Study||1
8117802|NCT02975973|20008871|P2|NOT COMPLETED|Overall Study||1
8117803|NCT02975973|20008872|P1|NOT COMPLETED|Overall Study||1
8117804|NCT02975973|20008869|P4|COMPLETED|Overall Study||4
8117805|NCT02975973|20008870|P3|COMPLETED|Overall Study||0
8117806|NCT02975973|20008871|P2|COMPLETED|Overall Study||1
8117807|NCT02975973|20008872|P1|COMPLETED|Overall Study||0
8117808|NCT02975973|20008869|P4|STARTED|Overall Study||4
8117809|NCT02975973|20008870|P3|STARTED|Overall Study||1
8117810|NCT02975973|20008871|P2|STARTED|Overall Study||2
8117811|NCT02975973|20008872|P1|STARTED|Overall Study||1
8117812|NCT02975804|20008896|P2|NOT COMPLETED|Overall Study||0
8117813|NCT02975804|20008897|P1|NOT COMPLETED|Overall Study||0
8117814|NCT02975804|20008896|P2|COMPLETED|Overall Study||9
8117815|NCT02975804|20008897|P1|COMPLETED|Overall Study||9
8117816|NCT02975804|20008896|P2|STARTED|Overall Study||9
8117817|NCT02975804|20008897|P1|STARTED|Overall Study||9
8117821|NCT02975557|20008956|P3|NOT COMPLETED|Overall Study||1
8117822|NCT02975557|20008957|P2|NOT COMPLETED|Overall Study||3
8117823|NCT02975557|20008958|P1|NOT COMPLETED|Overall Study||1
8117824|NCT02975557|20008956|P3|COMPLETED|Overall Study||5
8117825|NCT02975557|20008957|P2|COMPLETED|Overall Study||2
8117826|NCT02975557|20008958|P1|COMPLETED|Overall Study||3
8117827|NCT02975557|20008956|P3|STARTED|Overall Study||6
8117828|NCT02975557|20008957|P2|STARTED|Overall Study||5
8117829|NCT02975557|20008958|P1|STARTED|Overall Study||4
8117851|NCT02974868|20009225|P4|NOT COMPLETED|Cross-Over Extension (COE) Period||0
8117852|NCT02974868|20009226|P3|NOT COMPLETED|Cross-Over Extension (COE) Period||3
8117853|NCT02974868|20009227|P2|NOT COMPLETED|Cross-Over Extension (COE) Period||1
8117854|NCT02974868|20009228|P1|NOT COMPLETED|Cross-Over Extension (COE) Period||2
8117855|NCT02974868|20009225|P4|COMPLETED|Cross-Over Extension (COE) Period||3
8117856|NCT02974868|20009226|P3|COMPLETED|Cross-Over Extension (COE) Period||8
8117857|NCT02974868|20009227|P2|COMPLETED|Cross-Over Extension (COE) Period||1
8117858|NCT02974868|20009228|P1|COMPLETED|Cross-Over Extension (COE) Period||5
8117859|NCT02974868|20009225|P4|STARTED|Cross-Over Extension (COE) Period||3
8117860|NCT02974868|20009226|P3|STARTED|Cross-Over Extension (COE) Period||11
8117861|NCT02974868|20009227|P2|STARTED|Cross-Over Extension (COE) Period||2
8117862|NCT02974868|20009228|P1|STARTED|Cross-Over Extension (COE) Period||7
8117863|NCT02974868|20009225|P4|NOT COMPLETED|Single-Blind Extension (SBE) Period||6
8117864|NCT02974868|20009226|P3|NOT COMPLETED|Single-Blind Extension (SBE) Period||11
8117865|NCT02974868|20009227|P2|NOT COMPLETED|Single-Blind Extension (SBE) Period||1
8117866|NCT02974868|20009228|P1|NOT COMPLETED|Single-Blind Extension (SBE) Period||2
8117867|NCT02974868|20009225|P4|COMPLETED|Single-Blind Extension (SBE) Period||23
8117868|NCT02974868|20009226|P3|COMPLETED|Single-Blind Extension (SBE) Period||27
8117869|NCT02974868|20009227|P2|COMPLETED|Single-Blind Extension (SBE) Period||11
8117870|NCT02974868|20009228|P1|COMPLETED|Single-Blind Extension (SBE) Period||15
8117871|NCT02974868|20009225|P4|STARTED|Single-Blind Extension (SBE) Period||29
8117872|NCT02974868|20009226|P3|STARTED|Single-Blind Extension (SBE) Period||38
8117873|NCT02974868|20009227|P2|STARTED|Single-Blind Extension (SBE) Period||12
8117874|NCT02974868|20009228|P1|STARTED|Single-Blind Extension (SBE) Period||17
8117875|NCT02974868|20009225|P4|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||12
8117876|NCT02974868|20009226|P3|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||3
8117877|NCT02974868|20009227|P2|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||9
8117878|NCT02974868|20009228|P1|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||4
8117879|NCT02974868|20009225|P4|COMPLETED|Initial 24-Week Treatment Period (TP)||35
8117880|NCT02974868|20009226|P3|COMPLETED|Initial 24-Week Treatment Period (TP)||45
8117881|NCT02974868|20009227|P2|COMPLETED|Initial 24-Week Treatment Period (TP)||14
8117882|NCT02974868|20009228|P1|COMPLETED|Initial 24-Week Treatment Period (TP)||20
8117883|NCT02974868|20009225|P4|STARTED|Initial 24-Week Treatment Period (TP)||47
8117884|NCT02974868|20009226|P3|STARTED|Initial 24-Week Treatment Period (TP)||48
8117885|NCT02974868|20009227|P2|STARTED|Initial 24-Week Treatment Period (TP)||23
8117886|NCT02974868|20009228|P1|STARTED|Initial 24-Week Treatment Period (TP)||24
8117887|NCT02974855|20009350|P4|NOT COMPLETED|Overall Study||1
8117888|NCT02974855|20009351|P3|NOT COMPLETED|Overall Study||0
8117889|NCT02974855|20009352|P2|NOT COMPLETED|Overall Study||1
8117890|NCT02974855|20009353|P1|NOT COMPLETED|Overall Study||0
8117891|NCT02974855|20009350|P4|COMPLETED|Overall Study||6
8117892|NCT02974855|20009351|P3|COMPLETED|Overall Study||6
8117893|NCT02974855|20009352|P2|COMPLETED|Overall Study||5
8117894|NCT02974855|20009353|P1|COMPLETED|Overall Study||7
8117895|NCT02974855|20009350|P4|STARTED|Overall Study||7
8117896|NCT02974855|20009351|P3|STARTED|Overall Study||6
8117897|NCT02974855|20009352|P2|STARTED|Overall Study||6
8117898|NCT02974855|20009353|P1|STARTED|Overall Study||7
8117899|NCT02974842|20009539|P1|NOT COMPLETED|Overall Study||8
8117900|NCT02974842|20009539|P1|COMPLETED|Overall Study||42
8117901|NCT02974842|20009539|P1|STARTED|Overall Study|Participants|50
8117902|NCT02974686|20009545|P2|NOT COMPLETED|Overall Study||0
8117903|NCT02974686|20009546|P1|NOT COMPLETED|Overall Study||0
8117904|NCT02974686|20009545|P2|COMPLETED|Overall Study||0
8117905|NCT02974686|20009546|P1|COMPLETED|Overall Study||0
8117906|NCT02974686|20009545|P2|STARTED|Overall Study||0
8117907|NCT02974686|20009546|P1|STARTED|Overall Study||0
8117908|NCT02974634|20009558|P2|NOT COMPLETED|Overall Study||21
8117909|NCT02974634|20009559|P1|NOT COMPLETED|Overall Study||28
8117910|NCT02974634|20009558|P2|COMPLETED|Overall Study||89
8117911|NCT02974634|20009559|P1|COMPLETED|Overall Study||78
8117912|NCT02974634|20009558|P2|STARTED|Overall Study||110
8117913|NCT02974634|20009559|P1|STARTED|Overall Study||106
8117914|NCT02974543|20009569|P2|NOT COMPLETED|Overall Study||0
8117915|NCT02974543|20009570|P1|NOT COMPLETED|Overall Study||1
8117916|NCT02974543|20009569|P2|COMPLETED|Overall Study||10
8117917|NCT02974543|20009570|P1|COMPLETED|Overall Study||10
8117918|NCT02974543|20009569|P2|Began Crossover Assignment|Overall Study||10
8117919|NCT02974543|20009570|P1|Began Crossover Assignment|Overall Study||10
8117920|NCT02974543|20009569|P2|Began Washout Period|Overall Study||10
8117921|NCT02974543|20009570|P1|Began Washout Period|Overall Study||10
8117922|NCT02974543|20009569|P2|STARTED|Overall Study||10
8117923|NCT02974543|20009570|P1|STARTED|Overall Study||11
8117924|NCT02974296|20009592|P2|NOT COMPLETED|Overall Study||1
8117925|NCT02974296|20009593|P1|NOT COMPLETED|Overall Study||0
8117926|NCT02974296|20009592|P2|COMPLETED|Overall Study||22
8117927|NCT02974296|20009593|P1|COMPLETED|Overall Study||10
8117928|NCT02974296|20009592|P2|STARTED|Overall Study||23
8117929|NCT02974296|20009593|P1|STARTED|Overall Study||10
8117930|NCT02974153|20009604|P3|NOT COMPLETED|Overall Study||50
8117931|NCT02974153|20009605|P2|NOT COMPLETED|Overall Study||48
8117932|NCT02974153|20009606|P1|NOT COMPLETED|Overall Study||52
8117933|NCT02974153|20009604|P3|COMPLETED|Overall Study||325
8117934|NCT02974153|20009605|P2|COMPLETED|Overall Study||324
8117935|NCT02974153|20009606|P1|COMPLETED|Overall Study||322
8117936|NCT02974153|20009604|P3|Participants Treated|Overall Study||366
8117937|NCT02974153|20009605|P2|Participants Treated|Overall Study||356
8117938|NCT02974153|20009606|P1|Participants Treated|Overall Study||350
8117939|NCT02974153|20009604|P3|STARTED|Overall Study||375
8117940|NCT02974153|20009605|P2|STARTED|Overall Study||372
8117941|NCT02974153|20009606|P1|STARTED|Overall Study||374
8117942|NCT02974140|20009692|P1|NOT COMPLETED|Overall Study||39
8117943|NCT02974140|20009692|P1|COMPLETED|Overall Study||0
8117944|NCT02974140|20009692|P1|Manual (Fellow Eye)|Overall Study||38
8117945|NCT02974140|20009692|P1|CRS (Left or Right Eye)|Overall Study||38
8117946|NCT02974140|20009692|P1|STARTED|Overall Study||39
8117947|NCT02974114|20009708|P3|NOT COMPLETED|Overall Study||2
8117948|NCT02974114|20009709|P2|NOT COMPLETED|Overall Study||1
8117949|NCT02974114|20009710|P1|NOT COMPLETED|Overall Study||0
8117950|NCT02974114|20009708|P3|COMPLETED|Overall Study||6
8117951|NCT02974114|20009709|P2|COMPLETED|Overall Study||6
8117952|NCT02974114|20009710|P1|COMPLETED|Overall Study||6
8117953|NCT02974114|20009708|P3|STARTED|Overall Study||8
8117954|NCT02974114|20009709|P2|STARTED|Overall Study||7
8117955|NCT02974114|20009710|P1|STARTED|Overall Study||6
8117956|NCT02974088|20009753|P2|NOT COMPLETED|Overall Study||3
8117957|NCT02974088|20009754|P1|NOT COMPLETED|Overall Study||0
8117958|NCT02974088|20009753|P2|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21
8117959|NCT02974088|20009754|P1|COMPLETED|Overall Study||23
8117960|NCT02974088|20009753|P2|STARTED|Overall Study||24
8117961|NCT02974088|20009754|P1|STARTED|Overall Study||23
8117962|NCT02973802|20009760|P1|NOT COMPLETED|Overall Study||2
8117963|NCT02973802|20009760|P1|COMPLETED|Overall Study||10
8117964|NCT02973802|20009760|P1|STARTED|Overall Study||12
8117965|NCT02973503|20009774|P1|NOT COMPLETED|Overall Study||0
8117966|NCT02973503|20009774|P1|COMPLETED|Overall Study||117
8117967|NCT02973503|20009774|P1|STARTED|Overall Study||117
8117968|NCT02973477|20009787|P2|NOT COMPLETED|Second Intervention||0
8117969|NCT02973477|20009788|P1|NOT COMPLETED|Second Intervention||1
8117970|NCT02973477|20009787|P2|COMPLETED|Second Intervention||24
8117971|NCT02973477|20009788|P1|COMPLETED|Second Intervention||17
8117972|NCT02973477|20009787|P2|STARTED|Second Intervention||24
8117973|NCT02973477|20009788|P1|STARTED|Second Intervention||18
8117974|NCT02973477|20009787|P2|NOT COMPLETED|Washout||0
8117975|NCT02973477|20009788|P1|NOT COMPLETED|Washout||1
8117976|NCT02973477|20009787|P2|COMPLETED|Washout||24
8117977|NCT02973477|20009788|P1|COMPLETED|Washout||18
8117978|NCT02973477|20009787|P2|STARTED|Washout||24
8117979|NCT02973477|20009788|P1|STARTED|Washout||19
8117980|NCT02973477|20009787|P2|NOT COMPLETED|First Intervention||2
8117981|NCT02973477|20009788|P1|NOT COMPLETED|First Intervention||0
8117982|NCT02973477|20009787|P2|COMPLETED|First Intervention||24
8117983|NCT02973477|20009788|P1|COMPLETED|First Intervention||19
8117984|NCT02973477|20009787|P2|STARTED|First Intervention||26
8117985|NCT02973477|20009788|P1|STARTED|First Intervention||19
8117986|NCT02973438|20009805|P4|NOT COMPLETED|Second Treatment Session (4 Days)||0
8117987|NCT02973438|20009806|P3|NOT COMPLETED|Second Treatment Session (4 Days)||0
8117988|NCT02973438|20009807|P2|NOT COMPLETED|Second Treatment Session (4 Days)||0
8117989|NCT02973438|20009808|P1|NOT COMPLETED|Second Treatment Session (4 Days)||0
8117990|NCT02973438|20009805|P4|COMPLETED|Second Treatment Session (4 Days)||1
8117991|NCT02973438|20009806|P3|COMPLETED|Second Treatment Session (4 Days)||2
8117992|NCT02973438|20009807|P2|COMPLETED|Second Treatment Session (4 Days)||1
8117993|NCT02973438|20009808|P1|COMPLETED|Second Treatment Session (4 Days)||2
8117994|NCT02973438|20009805|P4|STARTED|Second Treatment Session (4 Days)||1
8117995|NCT02973438|20009806|P3|STARTED|Second Treatment Session (4 Days)||2
8117996|NCT02973438|20009807|P2|STARTED|Second Treatment Session (4 Days)||1
8117997|NCT02973438|20009808|P1|STARTED|Second Treatment Session (4 Days)||2
8117998|NCT02973438|20009805|P4|NOT COMPLETED|Washout (Three Weeks)||0
8117999|NCT02973438|20009806|P3|NOT COMPLETED|Washout (Three Weeks)||0
8118000|NCT02973438|20009807|P2|NOT COMPLETED|Washout (Three Weeks)||0
8118001|NCT02973438|20009808|P1|NOT COMPLETED|Washout (Three Weeks)||0
8118002|NCT02973438|20009805|P4|COMPLETED|Washout (Three Weeks)||1
8118003|NCT02973438|20009806|P3|COMPLETED|Washout (Three Weeks)||2
8118004|NCT02973438|20009807|P2|COMPLETED|Washout (Three Weeks)||1
8118005|NCT02973438|20009808|P1|COMPLETED|Washout (Three Weeks)||2
8118006|NCT02973438|20009805|P4|STARTED|Washout (Three Weeks)||1
8118007|NCT02973438|20009806|P3|STARTED|Washout (Three Weeks)||2
8118008|NCT02973438|20009807|P2|STARTED|Washout (Three Weeks)||1
8118009|NCT02973438|20009808|P1|STARTED|Washout (Three Weeks)||2
8118010|NCT02973438|20009805|P4|NOT COMPLETED|First Treatment Session (4 Days)||0
8118011|NCT02973438|20009806|P3|NOT COMPLETED|First Treatment Session (4 Days)||0
8118012|NCT02973438|20009807|P2|NOT COMPLETED|First Treatment Session (4 Days)||0
8118013|NCT02973438|20009808|P1|NOT COMPLETED|First Treatment Session (4 Days)||0
8118014|NCT02973438|20009805|P4|COMPLETED|First Treatment Session (4 Days)||1
8118015|NCT02973438|20009806|P3|COMPLETED|First Treatment Session (4 Days)||2
8118016|NCT02973438|20009807|P2|COMPLETED|First Treatment Session (4 Days)||1
8118017|NCT02973438|20009808|P1|COMPLETED|First Treatment Session (4 Days)||2
8118018|NCT02973438|20009805|P4|STARTED|First Treatment Session (4 Days)||1
8118019|NCT02973438|20009806|P3|STARTED|First Treatment Session (4 Days)||2
8118020|NCT02973438|20009807|P2|STARTED|First Treatment Session (4 Days)||1
8118021|NCT02973438|20009808|P1|STARTED|First Treatment Session (4 Days)||2
8118022|NCT02973100|20009826|P4|NOT COMPLETED|Overall Study||7
8118023|NCT02973100|20009827|P3|NOT COMPLETED|Overall Study||4
8118024|NCT02973100|20009828|P2|NOT COMPLETED|Overall Study||8
8118025|NCT02973100|20009829|P1|NOT COMPLETED|Overall Study||7
8118026|NCT02973100|20009826|P4|COMPLETED|Overall Study||69
8118027|NCT02973100|20009827|P3|COMPLETED|Overall Study||75
8118028|NCT02973100|20009828|P2|COMPLETED|Overall Study||73
8118029|NCT02973100|20009829|P1|COMPLETED|Overall Study||75
8118030|NCT02973100|20009826|P4|Received at Least 1 Dose of Study Drug|Overall Study||76
8118031|NCT02973100|20009827|P3|Received at Least 1 Dose of Study Drug|Overall Study||79
8118032|NCT02973100|20009828|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
8118033|NCT02973100|20009829|P1|Received at Least 1 Dose of Study Drug|Overall Study||81
8118034|NCT02973100|20009826|P4|STARTED|Overall Study||76
8118035|NCT02973100|20009827|P3|STARTED|Overall Study||79
8118036|NCT02973100|20009828|P2|STARTED|Overall Study||81
8118037|NCT02973100|20009829|P1|STARTED|Overall Study||82
8118038|NCT02973048|20009867|P2|NOT COMPLETED|Overall Study||3
8118039|NCT02973048|20009868|P1|NOT COMPLETED|Overall Study||1
8118040|NCT02973048|20009867|P2|COMPLETED|Overall Study||17
8118041|NCT02973048|20009868|P1|COMPLETED|Overall Study||19
8118042|NCT02973048|20009867|P2|STARTED|Overall Study||20
8118043|NCT02973048|20009868|P1|STARTED|Overall Study||20
8118044|NCT02972658|20009920|P4|NOT COMPLETED|Overall Study||131
8118045|NCT02972658|20009921|P3|NOT COMPLETED|Overall Study||75
8118046|NCT02972658|20009922|P2|NOT COMPLETED|Overall Study||138
8118047|NCT02972658|20009923|P1|NOT COMPLETED|Overall Study||76
8118048|NCT02972658|20009920|P4|COMPLETED|Overall Study||0
8118049|NCT02972658|20009921|P3|COMPLETED|Overall Study||0
8118050|NCT02972658|20009922|P2|COMPLETED|Overall Study|"1 participant was incorrectly marked as Completed rather than study terminated by Sponsor."|1
8118051|NCT02972658|20009923|P1|COMPLETED|Overall Study||0
8118052|NCT02972658|20009920|P4|Received at Least 1 Dose of Study Drug|Overall Study||131
8118053|NCT02972658|20009921|P3|Received at Least 1 Dose of Study Drug|Overall Study||74
8118054|NCT02972658|20009922|P2|Received at Least 1 Dose of Study Drug|Overall Study||139
8118055|NCT02972658|20009923|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
8118056|NCT02972658|20009920|P4|STARTED|Overall Study||131
8118057|NCT02972658|20009921|P3|STARTED|Overall Study||75
8118058|NCT02972658|20009922|P2|STARTED|Overall Study||139
8118059|NCT02972658|20009923|P1|STARTED|Overall Study||76
8118060|NCT02972632|20009953|P1|NOT COMPLETED|Overall Study||17
8118061|NCT02972632|20009953|P1|COMPLETED|Overall Study||106
8118062|NCT02972632|20009953|P1|Safety Analysis Set|Overall Study||122
8118063|NCT02972632|20009953|P1|STARTED|Overall Study||123
8118064|NCT02972554|20009966|P2|NOT COMPLETED|Overall Study||0
8118065|NCT02972554|20009967|P1|NOT COMPLETED|Overall Study||0
8118066|NCT02972554|20009966|P2|COMPLETED|Overall Study||48
8118067|NCT02972554|20009967|P1|COMPLETED|Overall Study||44
8118068|NCT02972554|20009966|P2|STARTED|Overall Study||48
8118069|NCT02972554|20009967|P1|STARTED|Overall Study||44
8118070|NCT02972515|20009983|P1|NOT COMPLETED|Overall Study||78
8118071|NCT02972515|20009983|P1|COMPLETED|Overall Study||88
8118072|NCT02972515|20009983|P1|STARTED|Overall Study||166
8118073|NCT02972502|20009992|P2|NOT COMPLETED|Overall Study||2
8118074|NCT02972502|20009993|P1|NOT COMPLETED|Overall Study||4
8118075|NCT02972502|20009992|P2|COMPLETED|Overall Study||29
8118076|NCT02972502|20009993|P1|COMPLETED|Overall Study||31
8118077|NCT02972502|20009992|P2|STARTED|Overall Study||31
8118078|NCT02972502|20009993|P1|STARTED|Overall Study||35
8118079|NCT02972359|20010003|P1|NOT COMPLETED|Overall Study||71
8118080|NCT02972359|20010003|P1|COMPLETED|Overall Study||247
8118081|NCT02972359|20010003|P1|STARTED|Overall Study||318
8118082|NCT02972242|20010016|P2|NOT COMPLETED|Overall Study||0
8118083|NCT02972242|20010017|P1|NOT COMPLETED|Overall Study||1
8118084|NCT02972242|20010016|P2|COMPLETED|Overall Study||93
8118085|NCT02972242|20010017|P1|COMPLETED|Overall Study||81
8118086|NCT02972242|20010016|P2|STARTED|Overall Study||93
8118087|NCT02972242|20010017|P1|STARTED|Overall Study||82
8118088|NCT02971839|20010044|P5|NOT COMPLETED|Overall Study||0
8118089|NCT02971839|20010045|P4|NOT COMPLETED|Overall Study||0
8118090|NCT02971839|20010046|P3|NOT COMPLETED|Overall Study||0
8118091|NCT02971839|20010047|P2|NOT COMPLETED|Overall Study||0
8118092|NCT02971839|20010048|P1|NOT COMPLETED|Overall Study||0
8118093|NCT02971839|20010044|P5|COMPLETED|Overall Study||3
8118094|NCT02971839|20010045|P4|COMPLETED|Overall Study||2
8118095|NCT02971839|20010046|P3|COMPLETED|Overall Study||2
8118096|NCT02971839|20010047|P2|COMPLETED|Overall Study||2
8118097|NCT02971839|20010048|P1|COMPLETED|Overall Study||2
8118098|NCT02971839|20010044|P5|STARTED|Overall Study||3
8118099|NCT02971839|20010045|P4|STARTED|Overall Study||2
8118100|NCT02971839|20010046|P3|STARTED|Overall Study||2
8118101|NCT02971839|20010047|P2|STARTED|Overall Study||2
8118102|NCT02971839|20010048|P1|STARTED|Overall Study||2
8118103|NCT02971670|20010074|P4|NOT COMPLETED|Overall Study||2
8118104|NCT02971670|20010075|P3|NOT COMPLETED|Overall Study||1
8118105|NCT02971670|20010076|P2|NOT COMPLETED|Overall Study||1
8118106|NCT02971670|20010077|P1|NOT COMPLETED|Overall Study||4
8118107|NCT02971670|20010074|P4|COMPLETED|Overall Study||1
8118108|NCT02971670|20010075|P3|COMPLETED|Overall Study||4
8118109|NCT02971670|20010076|P2|COMPLETED|Overall Study||1
8118110|NCT02971670|20010077|P1|COMPLETED|Overall Study||9
8118111|NCT02971670|20010074|P4|STARTED|Overall Study||3
8118112|NCT02971670|20010075|P3|STARTED|Overall Study||5
8118113|NCT02971670|20010076|P2|STARTED|Overall Study||2
8118114|NCT02971670|20010077|P1|STARTED|Overall Study||13
8118115|NCT02971631|20010095|P2|NOT COMPLETED|Second Intervention - One Day||0
8118116|NCT02971631|20010096|P1|NOT COMPLETED|Second Intervention - One Day||0
8118117|NCT02971631|20010095|P2|COMPLETED|Second Intervention - One Day||2
8118118|NCT02971631|20010096|P1|COMPLETED|Second Intervention - One Day||3
8118119|NCT02971631|20010095|P2|STARTED|Second Intervention - One Day||2
8118120|NCT02971631|20010096|P1|STARTED|Second Intervention - One Day||3
8118121|NCT02971631|20010095|P2|NOT COMPLETED|First Intervention - One Day||0
8118122|NCT02971631|20010096|P1|NOT COMPLETED|First Intervention - One Day||0
8118123|NCT02971631|20010095|P2|COMPLETED|First Intervention - One Day||2
8118124|NCT02971631|20010096|P1|COMPLETED|First Intervention - One Day||3
8118125|NCT02971631|20010095|P2|STARTED|First Intervention - One Day||2
8118126|NCT02971631|20010096|P1|STARTED|First Intervention - One Day||3
8118127|NCT02971605|20010116|P1|NOT COMPLETED|Overall Study||1
8118128|NCT02971605|20010116|P1|COMPLETED|Overall Study||12
8118129|NCT02971605|20010116|P1|STARTED|Overall Study||13
8118130|NCT02971488|20010131|P1|NOT COMPLETED|Overall Study||0
8118131|NCT02971488|20010131|P1|COMPLETED|Overall Study||529
8118132|NCT02971488|20010131|P1|STARTED|Overall Study||529
8118133|NCT02971293|20010141|P1|NOT COMPLETED|Overall Study||11
8118134|NCT02971293|20010141|P1|COMPLETED|Overall Study||31
8118135|NCT02971293|20010141|P1|STARTED|Overall Study||42
8118136|NCT02971202|20010230|P3|NOT COMPLETED|Overall Study||1
8118137|NCT02971202|20010231|P2|NOT COMPLETED|Overall Study||0
8118138|NCT02971202|20010232|P1|NOT COMPLETED|Overall Study||2
8118139|NCT02971202|20010230|P3|COMPLETED|Overall Study||10
8118140|NCT02971202|20010231|P2|COMPLETED|Overall Study||10
8118141|NCT02971202|20010232|P1|COMPLETED|Overall Study||10
8118142|NCT02971202|20010230|P3|Started Study|Overall Study||10
8118143|NCT02971202|20010231|P2|Started Study|Overall Study||10
8118144|NCT02971202|20010232|P1|Started Study|Overall Study||11
8118145|NCT02971202|20010230|P3|STARTED|Overall Study||11
8118146|NCT02971202|20010231|P2|STARTED|Overall Study||10
8118147|NCT02971202|20010232|P1|STARTED|Overall Study||12
8118148|NCT02971163|20010248|P2|NOT COMPLETED|Overall Study||2
8118149|NCT02971163|20010249|P1|NOT COMPLETED|Overall Study||4
8118150|NCT02971163|20010248|P2|COMPLETED|Overall Study||24
8118151|NCT02971163|20010249|P1|COMPLETED|Overall Study||20
8118152|NCT02971163|20010248|P2|STARTED|Overall Study||26
8118153|NCT02971163|20010249|P1|STARTED|Overall Study||24
8118154|NCT02971007|20010272|P3|NOT COMPLETED|Overall Study||1
8118155|NCT02971007|20010273|P2|NOT COMPLETED|Overall Study||3
8118156|NCT02971007|20010274|P1|NOT COMPLETED|Overall Study||2
8118157|NCT02971007|20010272|P3|COMPLETED|Overall Study||45
8118158|NCT02971007|20010273|P2|COMPLETED|Overall Study||42
8118159|NCT02971007|20010274|P1|COMPLETED|Overall Study||44
8118160|NCT02971007|20010272|P3|STARTED|Overall Study||46
8118161|NCT02971007|20010273|P2|STARTED|Overall Study||45
8118162|NCT02971007|20010274|P1|STARTED|Overall Study||46
8118172|NCT02970669|20010306|P2|NOT COMPLETED|Open-label Period||2
8118173|NCT02970669|20010307|P1|NOT COMPLETED|Open-label Period||4
8118174|NCT02970669|20010306|P2|COMPLETED|Open-label Period||62
8118175|NCT02970669|20010307|P1|COMPLETED|Open-label Period||58
8118176|NCT02970669|20010306|P2|STARTED|Open-label Period||64
8118177|NCT02970669|20010307|P1|STARTED|Open-label Period||62
8118178|NCT02970669|20010306|P2|NOT COMPLETED|Double-blind Period||6
8118179|NCT02970669|20010307|P1|NOT COMPLETED|Double-blind Period||8
8118180|NCT02970669|20010306|P2|COMPLETED|Double-blind Period||64
8118181|NCT02970669|20010307|P1|COMPLETED|Double-blind Period||62
8118182|NCT02970669|20010306|P2|STARTED|Double-blind Period||70
8118183|NCT02970669|20010307|P1|STARTED|Double-blind Period||70
8118184|NCT02970552|20010327|P2|NOT COMPLETED|Overall Study||3
8118185|NCT02970552|20010328|P1|NOT COMPLETED|Overall Study||3
8118186|NCT02970552|20010327|P2|COMPLETED|Overall Study||67
8118187|NCT02970552|20010328|P1|COMPLETED|Overall Study||67
8118188|NCT02970552|20010327|P2|STARTED|Overall Study||70
8118189|NCT02970552|20010328|P1|STARTED|Overall Study||70
8118190|NCT02970422|20010356|P1|NOT COMPLETED|Overall Study||0
8118191|NCT02970422|20010356|P1|COMPLETED|Overall Study||200
8118192|NCT02970422|20010356|P1|STARTED|Overall Study||200
8118193|NCT02970305|20010461|P2|NOT COMPLETED|Overall Study||28
8118194|NCT02970305|20010462|P1|NOT COMPLETED|Overall Study||29
8118195|NCT02970305|20010461|P2|COMPLETED|Overall Study||174
8118196|NCT02970305|20010462|P1|COMPLETED|Overall Study||172
8118197|NCT02970305|20010461|P2|STARTED|Overall Study||202
8118198|NCT02970305|20010462|P1|STARTED|Overall Study||201
8118199|NCT02970292|20010494|P2|NOT COMPLETED|Overall Study||8
8118200|NCT02970292|20010495|P1|NOT COMPLETED|Overall Study||24
8118201|NCT02970292|20010494|P2|COMPLETED|Overall Study||190
8118202|NCT02970292|20010495|P1|COMPLETED|Overall Study||174
8118203|NCT02970292|20010494|P2|STARTED|Overall Study||198
8118204|NCT02970292|20010495|P1|STARTED|Overall Study||198
8118205|NCT02970162|20010519|P2|NOT COMPLETED|Overall Study||0
8118206|NCT02970162|20010520|P1|NOT COMPLETED|Overall Study||0
8118207|NCT02970162|20010519|P2|COMPLETED|Overall Study||13
8118208|NCT02970162|20010520|P1|COMPLETED|Overall Study||13
8118209|NCT02970162|20010519|P2|STARTED|Overall Study||13
8118210|NCT02970162|20010520|P1|STARTED|Overall Study||13
8118211|NCT02970032|20010532|P1|NOT COMPLETED|Real Time Heparin Dose Adjustment||0
8118212|NCT02970032|20010532|P1|COMPLETED|Real Time Heparin Dose Adjustment||20
8118213|NCT02970032|20010532|P1|STARTED|Real Time Heparin Dose Adjustment||20
8118214|NCT02970032|20010532|P1|NOT COMPLETED|Standard Heparin Dose||0
8118215|NCT02970032|20010532|P1|COMPLETED|Standard Heparin Dose||20
8118216|NCT02970032|20010532|P1|STARTED|Standard Heparin Dose||20
8118217|NCT02969928|20010540|P2|NOT COMPLETED|Overall Study||0
8118218|NCT02969928|20010541|P1|NOT COMPLETED|Overall Study||0
8118219|NCT02969928|20010540|P2|COMPLETED|Overall Study||23
8118220|NCT02969928|20010541|P1|COMPLETED|Overall Study||23
8118221|NCT02969928|20010540|P2|STARTED|Overall Study||23
8118222|NCT02969928|20010541|P1|STARTED|Overall Study||23
8118223|NCT02969876|20010555|P1|NOT COMPLETED|Overall Study||0
8118224|NCT02969876|20010555|P1|COMPLETED|Overall Study||2
8118225|NCT02969876|20010555|P1|STARTED|Overall Study||2
8118226|NCT02969863|20010561|P6|NOT COMPLETED|Overall Study||0
8118227|NCT02969863|20010562|P5|NOT COMPLETED|Overall Study||0
8118228|NCT02969863|20010563|P4|NOT COMPLETED|Overall Study||0
8118229|NCT02969863|20010564|P3|NOT COMPLETED|Overall Study||0
8118230|NCT02969863|20010565|P2|NOT COMPLETED|Overall Study||0
8118231|NCT02969863|20010566|P1|NOT COMPLETED|Overall Study||1
8118232|NCT02969863|20010561|P6|COMPLETED|Overall Study||4
8118233|NCT02969863|20010562|P5|COMPLETED|Overall Study||4
8118234|NCT02969863|20010563|P4|COMPLETED|Overall Study||4
8118235|NCT02969863|20010564|P3|COMPLETED|Overall Study||4
8118236|NCT02969863|20010565|P2|COMPLETED|Overall Study||4
8118237|NCT02969863|20010566|P1|COMPLETED|Overall Study||3
8118238|NCT02969863|20010561|P6|STARTED|Overall Study||4
8118239|NCT02969863|20010562|P5|STARTED|Overall Study||4
8118240|NCT02969863|20010563|P4|STARTED|Overall Study||4
8118241|NCT02969863|20010564|P3|STARTED|Overall Study||4
8118242|NCT02969863|20010565|P2|STARTED|Overall Study||4
8118243|NCT02969863|20010566|P1|STARTED|Overall Study||4
8118244|NCT02969655|20010582|P2|NOT COMPLETED|Overall Study||15
8118245|NCT02969655|20010583|P1|NOT COMPLETED|Overall Study||21
8118246|NCT02969655|20010582|P2|COMPLETED|Overall Study||120
8118247|NCT02969655|20010583|P1|COMPLETED|Overall Study||115
8118248|NCT02969655|20010582|P2|STARTED|Overall Study||135
8118249|NCT02969655|20010583|P1|STARTED|Overall Study||136
8118250|NCT02969590|20010618|P3|NOT COMPLETED|Treatment Period 2||0
8118251|NCT02969590|20010619|P2|NOT COMPLETED|Treatment Period 2||0
8118252|NCT02969590|20010620|P1|NOT COMPLETED|Treatment Period 2||0
8118253|NCT02969590|20010618|P3|COMPLETED|Treatment Period 2||2
8118254|NCT02969590|20010619|P2|COMPLETED|Treatment Period 2||2
8118255|NCT02969590|20010620|P1|COMPLETED|Treatment Period 2||0
8118256|NCT02969590|20010618|P3|STARTED|Treatment Period 2||2
8118257|NCT02969590|20010619|P2|STARTED|Treatment Period 2||2
8118258|NCT02969590|20010620|P1|STARTED|Treatment Period 2||0
8118259|NCT02969590|20010618|P3|NOT COMPLETED|Treatment Period 1||0
8118260|NCT02969590|20010619|P2|NOT COMPLETED|Treatment Period 1||0
8118261|NCT02969590|20010620|P1|NOT COMPLETED|Treatment Period 1||0
8118262|NCT02969590|20010618|P3|COMPLETED|Treatment Period 1||2
8118263|NCT02969590|20010619|P2|COMPLETED|Treatment Period 1||2
8118264|NCT02969590|20010620|P1|COMPLETED|Treatment Period 1||0
8118265|NCT02969590|20010618|P3|STARTED|Treatment Period 1||2
8118266|NCT02969590|20010619|P2|STARTED|Treatment Period 1||2
8118267|NCT02969590|20010620|P1|STARTED|Treatment Period 1||0
8118268|NCT02969590|20010618|P3|NOT COMPLETED|Screening Period||0
8118269|NCT02969590|20010619|P2|NOT COMPLETED|Screening Period||0
8118270|NCT02969590|20010620|P1|NOT COMPLETED|Screening Period||1
8118271|NCT02969590|20010618|P3|COMPLETED|Screening Period||0
8118272|NCT02969590|20010619|P2|COMPLETED|Screening Period||0
8118273|NCT02969590|20010620|P1|COMPLETED|Screening Period||4
8118274|NCT02969590|20010618|P3|STARTED|Screening Period||0
8118275|NCT02969590|20010619|P2|STARTED|Screening Period||0
8118276|NCT02969590|20010620|P1|STARTED|Screening Period||5
8118277|NCT02969525|20010643|P12|NOT COMPLETED|Dose-Blind Period||2
8118278|NCT02969525|20010644|P11|NOT COMPLETED|Dose-Blind Period||2
8118279|NCT02969525|20010645|P10|NOT COMPLETED|Dose-Blind Period||3
8118280|NCT02969525|20010646|P9|NOT COMPLETED|Dose-Blind Period||1
8118281|NCT02969525|20010647|P8|NOT COMPLETED|Dose-Blind Period||0
8118282|NCT02969525|20010648|P7|NOT COMPLETED|Dose-Blind Period||2
8118283|NCT02969525|20010649|P6|NOT COMPLETED|Dose-Blind Period||0
8118284|NCT02969525|20010650|P5|NOT COMPLETED|Dose-Blind Period||0
8118285|NCT02969525|20010651|P4|NOT COMPLETED|Dose-Blind Period||0
8118286|NCT02969525|20010652|P3|NOT COMPLETED|Dose-Blind Period||0
8118287|NCT02969525|20010653|P2|NOT COMPLETED|Dose-Blind Period||0
8118288|NCT02969525|20010654|P1|NOT COMPLETED|Dose-Blind Period||0
8118289|NCT02969525|20010643|P12|COMPLETED|Dose-Blind Period||39
8118290|NCT02969525|20010644|P11|COMPLETED|Dose-Blind Period||38
8118291|NCT02969525|20010645|P10|COMPLETED|Dose-Blind Period||34
8118292|NCT02969525|20010646|P9|COMPLETED|Dose-Blind Period||18
8118293|NCT02969525|20010647|P8|COMPLETED|Dose-Blind Period||22
8118294|NCT02969525|20010648|P7|COMPLETED|Dose-Blind Period||18
8118295|NCT02969525|20010649|P6|COMPLETED|Dose-Blind Period||20
8118296|NCT02969525|20010650|P5|COMPLETED|Dose-Blind Period||0
8118297|NCT02969525|20010651|P4|COMPLETED|Dose-Blind Period||0
8118298|NCT02969525|20010652|P3|COMPLETED|Dose-Blind Period||0
8118299|NCT02969525|20010653|P2|COMPLETED|Dose-Blind Period||0
8118300|NCT02969525|20010654|P1|COMPLETED|Dose-Blind Period||0
8118301|NCT02969525|20010643|P12|STARTED|Dose-Blind Period||41
8118302|NCT02969525|20010644|P11|STARTED|Dose-Blind Period||40
8118303|NCT02969525|20010645|P10|STARTED|Dose-Blind Period||37
8118304|NCT02969525|20010646|P9|STARTED|Dose-Blind Period||19
8118305|NCT02969525|20010647|P8|STARTED|Dose-Blind Period||22
8118306|NCT02969525|20010648|P7|STARTED|Dose-Blind Period||20
8118307|NCT02969525|20010649|P6|STARTED|Dose-Blind Period||20
8118308|NCT02969525|20010650|P5|STARTED|Dose-Blind Period||0
8118309|NCT02969525|20010651|P4|STARTED|Dose-Blind Period||0
8118310|NCT02969525|20010652|P3|STARTED|Dose-Blind Period||0
8118311|NCT02969525|20010653|P2|STARTED|Dose-Blind Period||0
8118312|NCT02969525|20010654|P1|STARTED|Dose-Blind Period||0
8118313|NCT02969525|20010643|P12|NOT COMPLETED|Double-Blind Period||0
8118314|NCT02969525|20010644|P11|NOT COMPLETED|Double-Blind Period||0
8118315|NCT02969525|20010645|P10|NOT COMPLETED|Double-Blind Period||0
8118316|NCT02969525|20010646|P9|NOT COMPLETED|Double-Blind Period||0
8118317|NCT02969525|20010647|P8|NOT COMPLETED|Double-Blind Period||0
8118318|NCT02969525|20010648|P7|NOT COMPLETED|Double-Blind Period||0
8118319|NCT02969525|20010649|P6|NOT COMPLETED|Double-Blind Period||0
8118320|NCT02969525|20010650|P5|NOT COMPLETED|Double-Blind Period||0
8118321|NCT02969525|20010651|P4|NOT COMPLETED|Double-Blind Period||4
8118322|NCT02969525|20010652|P3|NOT COMPLETED|Double-Blind Period||1
8118323|NCT02969525|20010653|P2|NOT COMPLETED|Double-Blind Period||0
8118324|NCT02969525|20010654|P1|NOT COMPLETED|Double-Blind Period||2
8118325|NCT02969525|20010643|P12|COMPLETED|Double-Blind Period||0
8118326|NCT02969525|20010644|P11|COMPLETED|Double-Blind Period||0
8118327|NCT02969525|20010645|P10|COMPLETED|Double-Blind Period||0
8118328|NCT02969525|20010646|P9|COMPLETED|Double-Blind Period||0
8118329|NCT02969525|20010647|P8|COMPLETED|Double-Blind Period||0
8118330|NCT02969525|20010648|P7|COMPLETED|Double-Blind Period||0
8118331|NCT02969525|20010649|P6|COMPLETED|Double-Blind Period||0
8118332|NCT02969525|20010650|P5|COMPLETED|Double-Blind Period||41
8118333|NCT02969525|20010651|P4|COMPLETED|Double-Blind Period||37
8118334|NCT02969525|20010652|P3|COMPLETED|Double-Blind Period||40
8118335|NCT02969525|20010653|P2|COMPLETED|Double-Blind Period||41
8118336|NCT02969525|20010654|P1|COMPLETED|Double-Blind Period||40
8118337|NCT02969525|20010643|P12|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
8118338|NCT02969525|20010644|P11|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
8118339|NCT02969525|20010645|P10|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
8118340|NCT02969525|20010646|P9|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
8118341|NCT02969525|20010647|P8|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
8118342|NCT02969525|20010648|P7|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
8118343|NCT02969525|20010649|P6|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
8118344|NCT02969525|20010650|P5|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
8118345|NCT02969525|20010651|P4|Completed Wk12 and Started Dose-Blind|Double-Blind Period||37
8118346|NCT02969525|20010652|P3|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
8118347|NCT02969525|20010653|P2|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
8118348|NCT02969525|20010654|P1|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
8118349|NCT02969525|20010643|P12|Completed Double-Blind Period|Double-Blind Period||0
8118350|NCT02969525|20010644|P11|Completed Double-Blind Period|Double-Blind Period||0
8118351|NCT02969525|20010645|P10|Completed Double-Blind Period|Double-Blind Period||0
8118352|NCT02969525|20010646|P9|Completed Double-Blind Period|Double-Blind Period||0
8118353|NCT02969525|20010647|P8|Completed Double-Blind Period|Double-Blind Period||0
8118354|NCT02969525|20010648|P7|Completed Double-Blind Period|Double-Blind Period||0
8118355|NCT02969525|20010649|P6|Completed Double-Blind Period|Double-Blind Period||0
8118356|NCT02969525|20010650|P5|Completed Double-Blind Period|Double-Blind Period||41
8118357|NCT02969525|20010651|P4|Completed Double-Blind Period|Double-Blind Period||39
8118358|NCT02969525|20010652|P3|Completed Double-Blind Period|Double-Blind Period||40
8118359|NCT02969525|20010653|P2|Completed Double-Blind Period|Double-Blind Period||41
8118360|NCT02969525|20010654|P1|Completed Double-Blind Period|Double-Blind Period||42
8118361|NCT02969525|20010643|P12|STARTED|Double-Blind Period||0
8118362|NCT02969525|20010644|P11|STARTED|Double-Blind Period||0
8118363|NCT02969525|20010645|P10|STARTED|Double-Blind Period||0
8118364|NCT02969525|20010646|P9|STARTED|Double-Blind Period||0
8118365|NCT02969525|20010647|P8|STARTED|Double-Blind Period||0
8118366|NCT02969525|20010648|P7|STARTED|Double-Blind Period||0
8118367|NCT02969525|20010649|P6|STARTED|Double-Blind Period||0
8118368|NCT02969525|20010650|P5|STARTED|Double-Blind Period||41
8118369|NCT02969525|20010651|P4|STARTED|Double-Blind Period||41
8118370|NCT02969525|20010652|P3|STARTED|Double-Blind Period||41
8118371|NCT02969525|20010653|P2|STARTED|Double-Blind Period||41
8118372|NCT02969525|20010654|P1|STARTED|Double-Blind Period||42
8118373|NCT02969421|20010794|P2|NOT COMPLETED|Overall Study||0
8118374|NCT02969421|20010795|P1|NOT COMPLETED|Overall Study||0
8118375|NCT02969421|20010794|P2|COMPLETED|Overall Study||33
8118376|NCT02969421|20010795|P1|COMPLETED|Overall Study||33
8118377|NCT02969421|20010794|P2|STARTED|Overall Study||33
8118378|NCT02969421|20010795|P1|STARTED|Overall Study||33
8118379|NCT02969408|20010805|P1|NOT COMPLETED|Overall Study||16
8118380|NCT02969408|20010805|P1|COMPLETED|Overall Study||381
8118381|NCT02969408|20010805|P1|Used ABS eMDPI at Least Once|Overall Study||370
8118382|NCT02969408|20010805|P1|STARTED|Overall Study||397
8118383|NCT02969356|20010813|P1|NOT COMPLETED|Overall Study||23
8118384|NCT02969356|20010813|P1|COMPLETED|Overall Study||134
8118385|NCT02969356|20010813|P1|Intent-to-Treat (ITT) Population|Overall Study||153
8118386|NCT02969356|20010813|P1|STARTED|Overall Study||157
8118387|NCT02969317|20010831|P1|NOT COMPLETED|Overall Study||0
8118388|NCT02969317|20010831|P1|COMPLETED|Overall Study||12
8118389|NCT02969317|20010831|P1|STARTED|Overall Study||12
8118390|NCT02969187|20010856|P2|NOT COMPLETED|Overall Study||13
8118391|NCT02969187|20010857|P1|NOT COMPLETED|Overall Study||12
8118392|NCT02969187|20010856|P2|COMPLETED|Overall Study||50
8118393|NCT02969187|20010857|P1|COMPLETED|Overall Study||51
8118394|NCT02969187|20010856|P2|STARTED|Overall Study||63
8118395|NCT02969187|20010857|P1|STARTED|Overall Study||63
8118396|NCT02969044|20010869|P2|NOT COMPLETED|Overall Study||6
8118397|NCT02969044|20010870|P1|NOT COMPLETED|Overall Study||5
8118398|NCT02969044|20010869|P2|COMPLETED|Overall Study||22
8118399|NCT02969044|20010870|P1|COMPLETED|Overall Study||37
8118400|NCT02969044|20010869|P2|STARTED|Overall Study||28
8118401|NCT02969044|20010870|P1|STARTED|Overall Study||42
8118402|NCT02969031|20010912|P2|NOT COMPLETED|Completed and Analyzed||0
8118403|NCT02969031|20010913|P1|NOT COMPLETED|Completed and Analyzed||0
8118404|NCT02969031|20010912|P2|COMPLETED|Completed and Analyzed||12
8118405|NCT02969031|20010913|P1|COMPLETED|Completed and Analyzed||15
8118406|NCT02969031|20010912|P2|STARTED|Completed and Analyzed||12
8118407|NCT02969031|20010913|P1|STARTED|Completed and Analyzed||15
8118408|NCT02969031|20010912|P2|NOT COMPLETED|Collection of Follow-Up Recordings||0
8118409|NCT02969031|20010913|P1|NOT COMPLETED|Collection of Follow-Up Recordings||0
8118410|NCT02969031|20010912|P2|COMPLETED|Collection of Follow-Up Recordings||12
8118411|NCT02969031|20010913|P1|COMPLETED|Collection of Follow-Up Recordings||15
8118412|NCT02969031|20010912|P2|STARTED|Collection of Follow-Up Recordings||12
8118413|NCT02969031|20010913|P1|STARTED|Collection of Follow-Up Recordings||15
8118414|NCT02969031|20010912|P2|NOT COMPLETED|Collection of Follow-Up Surveys||2
8118415|NCT02969031|20010913|P1|NOT COMPLETED|Collection of Follow-Up Surveys||0
8118416|NCT02969031|20010912|P2|COMPLETED|Collection of Follow-Up Surveys||12
8118417|NCT02969031|20010913|P1|COMPLETED|Collection of Follow-Up Surveys||15
8118418|NCT02969031|20010912|P2|STARTED|Collection of Follow-Up Surveys||14
8118419|NCT02969031|20010913|P1|STARTED|Collection of Follow-Up Surveys||15
8118420|NCT02969031|20010912|P2|NOT COMPLETED|Completed Intervention||4
8118421|NCT02969031|20010913|P1|NOT COMPLETED|Completed Intervention||7
8118422|NCT02969031|20010912|P2|COMPLETED|Completed Intervention||14
8118423|NCT02969031|20010913|P1|COMPLETED|Completed Intervention||15
8118424|NCT02969031|20010912|P2|STARTED|Completed Intervention||18
8118425|NCT02969031|20010913|P1|STARTED|Completed Intervention||22
8118426|NCT02969031|20010912|P2|NOT COMPLETED|Collection of Baseline Recordings||5
8118427|NCT02969031|20010913|P1|NOT COMPLETED|Collection of Baseline Recordings||12
8118428|NCT02969031|20010912|P2|COMPLETED|Collection of Baseline Recordings||18
8118429|NCT02969031|20010913|P1|COMPLETED|Collection of Baseline Recordings||22
8118430|NCT02969031|20010912|P2|STARTED|Collection of Baseline Recordings||23
8118431|NCT02969031|20010913|P1|STARTED|Collection of Baseline Recordings||34
8118432|NCT02969031|20010912|P2|NOT COMPLETED|Collection of Baseline Surveys||52
8118433|NCT02969031|20010913|P1|NOT COMPLETED|Collection of Baseline Surveys||39
8118434|NCT02969031|20010912|P2|COMPLETED|Collection of Baseline Surveys||23
8118435|NCT02969031|20010913|P1|COMPLETED|Collection of Baseline Surveys||34
8118436|NCT02969031|20010912|P2|STARTED|Collection of Baseline Surveys||75
8118437|NCT02969031|20010913|P1|STARTED|Collection of Baseline Surveys||73
8118438|NCT02969031|20010912|P2|NOT COMPLETED|Enrolled and Randomized||0
8118439|NCT02969031|20010913|P1|NOT COMPLETED|Enrolled and Randomized||0
8118440|NCT02969031|20010912|P2|COMPLETED|Enrolled and Randomized||75
8118441|NCT02969031|20010913|P1|COMPLETED|Enrolled and Randomized||73
8118442|NCT02969031|20010912|P2|STARTED|Enrolled and Randomized||75
8118443|NCT02969031|20010913|P1|STARTED|Enrolled and Randomized||73
8118444|NCT02969018|20010929|P8|NOT COMPLETED|Overall Study||7
8118445|NCT02969018|20010930|P7|NOT COMPLETED|Overall Study||8
8118446|NCT02969018|20010931|P6|NOT COMPLETED|Overall Study||8
8118447|NCT02969018|20010932|P5|NOT COMPLETED|Overall Study||2
8118448|NCT02969018|20010933|P4|NOT COMPLETED|Overall Study||5
8118449|NCT02969018|20010934|P3|NOT COMPLETED|Overall Study||6
8118450|NCT02969018|20010935|P2|NOT COMPLETED|Overall Study||8
8118451|NCT02969018|20010936|P1|NOT COMPLETED|Overall Study||4
8118452|NCT02969018|20010929|P8|COMPLETED|Overall Study||16
8118453|NCT02969018|20010930|P7|COMPLETED|Overall Study||22
8118454|NCT02969018|20010931|P6|COMPLETED|Overall Study||17
8118455|NCT02969018|20010932|P5|COMPLETED|Overall Study||27
8118456|NCT02969018|20010933|P4|COMPLETED|Overall Study||20
8118457|NCT02969018|20010934|P3|COMPLETED|Overall Study||20
8118458|NCT02969018|20010935|P2|COMPLETED|Overall Study||21
8118459|NCT02969018|20010936|P1|COMPLETED|Overall Study||21
8118460|NCT02969018|20010929|P8|STARTED|Overall Study||23
8118461|NCT02969018|20010930|P7|STARTED|Overall Study||30
8118462|NCT02969018|20010931|P6|STARTED|Overall Study||25
8118463|NCT02969018|20010932|P5|STARTED|Overall Study||29
8118464|NCT02969018|20010933|P4|STARTED|Overall Study||25
8118465|NCT02969018|20010934|P3|STARTED|Overall Study||26
8118466|NCT02969018|20010935|P2|STARTED|Overall Study||29
8118467|NCT02969018|20010936|P1|STARTED|Overall Study||25
8118468|NCT02968992|20011055|P2|NOT COMPLETED|Overall Study||1
8118469|NCT02968992|20011056|P1|NOT COMPLETED|Overall Study||0
8118470|NCT02968992|20011055|P2|COMPLETED|Overall Study||17
8118471|NCT02968992|20011056|P1|COMPLETED|Overall Study||18
8118472|NCT02968992|20011055|P2|STARTED|Overall Study||18
8118473|NCT02968992|20011056|P1|STARTED|Overall Study||18
8118474|NCT02968979|20011076|P1|NOT COMPLETED|Overall Study||8
8118475|NCT02968979|20011076|P1|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531
8118476|NCT02968979|20011076|P1|STARTED|Overall Study||539
8118477|NCT02968914|20011164|P2|NOT COMPLETED|Overall Study||0
8118478|NCT02968914|20011165|P1|NOT COMPLETED|Overall Study||0
8118479|NCT02968914|20011164|P2|COMPLETED|Overall Study||90
8118480|NCT02968914|20011165|P1|COMPLETED|Overall Study||90
8118481|NCT02968914|20011164|P2|STARTED|Overall Study||90
8118482|NCT02968914|20011165|P1|STARTED|Overall Study||90
8118489|NCT02968576|20011201|P2|NOT COMPLETED|Overall Study||1
8118490|NCT02968576|20011202|P1|NOT COMPLETED|Overall Study||0
8118491|NCT02968576|20011201|P2|COMPLETED|Overall Study||13
8118492|NCT02968576|20011202|P1|COMPLETED|Overall Study||11
8118493|NCT02968576|20011201|P2|STARTED|Overall Study||14
8118494|NCT02968576|20011202|P1|STARTED|Overall Study||11
8118501|NCT02968433|20011224|P1|NOT COMPLETED|Overall Study||1
8118502|NCT02968433|20011224|P1|COMPLETED|Overall Study||15
8118503|NCT02968433|20011224|P1|STARTED|Overall Study||16
8118504|NCT02968381|20011239|P2|NOT COMPLETED|Overall Study||10
8118505|NCT02968381|20011240|P1|NOT COMPLETED|Overall Study||5
8118506|NCT02968381|20011239|P2|COMPLETED|Overall Study||50
8118507|NCT02968381|20011240|P1|COMPLETED|Overall Study||56
8118508|NCT02968381|20011239|P2|STARTED|Overall Study||60
8118509|NCT02968381|20011240|P1|STARTED|Overall Study||61
8118510|NCT02968368|20011256|P2|NOT COMPLETED|Open Label Phase||14
8118511|NCT02968368|20011257|P1|NOT COMPLETED|Open Label Phase||19
8118512|NCT02968368|20011256|P2|COMPLETED|Open Label Phase||25
8118513|NCT02968368|20011257|P1|COMPLETED|Open Label Phase||67
8118514|NCT02968368|20011256|P2|STARTED|Open Label Phase||39
8118515|NCT02968368|20011257|P1|STARTED|Open Label Phase||86
8118516|NCT02968368|20011256|P2|NOT COMPLETED|Double Blind Phase||17
8118517|NCT02968368|20011257|P1|NOT COMPLETED|Double Blind Phase||21
8118518|NCT02968368|20011256|P2|COMPLETED|Double Blind Phase||39
8118519|NCT02968368|20011257|P1|COMPLETED|Double Blind Phase||90
8118520|NCT02968368|20011256|P2|STARTED|Double Blind Phase||56
8118521|NCT02968368|20011257|P1|STARTED|Double Blind Phase||111
8118522|NCT02968277|20011290|P3|NOT COMPLETED|Overall Study||0
8118523|NCT02968277|20011291|P2|NOT COMPLETED|Overall Study||0
8118524|NCT02968277|20011292|P1|NOT COMPLETED|Overall Study||0
8118525|NCT02968277|20011290|P3|COMPLETED|Overall Study||13
8118526|NCT02968277|20011291|P2|COMPLETED|Overall Study||7
8118527|NCT02968277|20011292|P1|COMPLETED|Overall Study||10
8118528|NCT02968277|20011290|P3|STARTED|Overall Study||13
8118529|NCT02968277|20011291|P2|STARTED|Overall Study||7
8118530|NCT02968277|20011292|P1|STARTED|Overall Study||10
8118531|NCT02968173|20011318|P1|NOT COMPLETED|Overall Study||1
8118532|NCT02968173|20011318|P1|COMPLETED|Overall Study||49
8118533|NCT02968173|20011318|P1|STARTED|Overall Study||50
8118534|NCT02968134|20011330|P1|NOT COMPLETED|Overall Study||0
8118535|NCT02968134|20011330|P1|COMPLETED|Overall Study||8
8118536|NCT02968134|20011330|P1|STARTED|Overall Study||8
8118537|NCT02967991|20011335|P2|NOT COMPLETED|Overall Study||0
8118538|NCT02967991|20011336|P1|NOT COMPLETED|Overall Study||0
8118539|NCT02967991|20011335|P2|COMPLETED|Overall Study||10
8118540|NCT02967991|20011336|P1|COMPLETED|Overall Study||10
8118541|NCT02967991|20011335|P2|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
8118542|NCT02967991|20011336|P1|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
8118543|NCT02967679|20011355|P1|NOT COMPLETED|Overall Study||1
8118544|NCT02967679|20011355|P1|COMPLETED|Overall Study||14
8118545|NCT02967679|20011355|P1|STARTED|Overall Study||15
8118546|NCT02967562|20011376|P2|NOT COMPLETED|Overall Study||1
8118547|NCT02967562|20011377|P1|NOT COMPLETED|Overall Study||2
8118548|NCT02967562|20011376|P2|COMPLETED|Overall Study||30
8118549|NCT02967562|20011377|P1|COMPLETED|Overall Study||30
8118550|NCT02967562|20011376|P2|STARTED|Overall Study||31
8118551|NCT02967562|20011377|P1|STARTED|Overall Study||32
8118552|NCT02967510|20011391|P4|NOT COMPLETED|Overall Study||8
8118553|NCT02967510|20011392|P3|NOT COMPLETED|Overall Study||7
8118554|NCT02967510|20011393|P2|NOT COMPLETED|Overall Study||3
8118555|NCT02967510|20011394|P1|NOT COMPLETED|Overall Study||4
8118556|NCT02967510|20011391|P4|COMPLETED|Overall Study||63
8118557|NCT02967510|20011392|P3|COMPLETED|Overall Study||65
8118558|NCT02967510|20011393|P2|COMPLETED|Overall Study||67
8118559|NCT02967510|20011394|P1|COMPLETED|Overall Study||66
8118560|NCT02967510|20011391|P4|STARTED|Overall Study||71
8118561|NCT02967510|20011392|P3|STARTED|Overall Study||72
8118562|NCT02967510|20011393|P2|STARTED|Overall Study||70
8118563|NCT02967510|20011394|P1|STARTED|Overall Study||70
8118564|NCT02967458|20011520|P1|NOT COMPLETED|Overall Study||0
8118565|NCT02967458|20011520|P1|COMPLETED|Overall Study||55
8118566|NCT02967458|20011520|P1|STARTED|Overall Study||55
8118567|NCT02967393|20011528|P2|NOT COMPLETED|Overall Study||0
8118568|NCT02967393|20011529|P1|NOT COMPLETED|Overall Study||0
8118569|NCT02967393|20011528|P2|COMPLETED|Overall Study||20
8118570|NCT02967393|20011529|P1|COMPLETED|Overall Study||20
8118571|NCT02967393|20011528|P2|STARTED|Overall Study||20
8118572|NCT02967393|20011529|P1|STARTED|Overall Study||20
8118573|NCT02967367|20011554|P1|NOT COMPLETED|Overall Study||14
8118574|NCT02967367|20011554|P1|COMPLETED|Overall Study||22
8118575|NCT02967367|20011554|P1|STARTED|Overall Study||36
8118576|NCT02967354|20011567|P5|NOT COMPLETED|Overall Study||0
8118577|NCT02967354|20011568|P4|NOT COMPLETED|Overall Study||0
8118578|NCT02967354|20011569|P3|NOT COMPLETED|Overall Study||0
8118579|NCT02967354|20011570|P2|NOT COMPLETED|Overall Study||0
8118580|NCT02967354|20011571|P1|NOT COMPLETED|Overall Study||0
8118581|NCT02967354|20011567|P5|COMPLETED|Overall Study||8
8118582|NCT02967354|20011568|P4|COMPLETED|Overall Study||7
8118583|NCT02967354|20011569|P3|COMPLETED|Overall Study||9
8118584|NCT02967354|20011570|P2|COMPLETED|Overall Study||7
8118585|NCT02967354|20011571|P1|COMPLETED|Overall Study||8
8118586|NCT02967354|20011567|P5|STARTED|Overall Study||8
8118587|NCT02967354|20011568|P4|STARTED|Overall Study||7
8118588|NCT02967354|20011569|P3|STARTED|Overall Study||9
8118589|NCT02967354|20011570|P2|STARTED|Overall Study||7
8118590|NCT02967354|20011571|P1|STARTED|Overall Study||8
8118591|NCT02967055|20011603|P1|NOT COMPLETED|Overall Study||49
8118592|NCT02967055|20011603|P1|COMPLETED|Overall Study||5
8118593|NCT02967055|20011603|P1|Completed 4 Week Follow-up Visit|Overall Study||8
8118594|NCT02967055|20011603|P1|Enrolled|Overall Study|Enrolled|9
8118595|NCT02967055|20011603|P1|In-person Screening|Overall Study||14
8118596|NCT02967055|20011603|P1|STARTED|Overall Study|Assessed for eligibility|54
8118597|NCT02967016|20011611|P2|NOT COMPLETED|Overall Study||0
8118598|NCT02967016|20011612|P1|NOT COMPLETED|Overall Study||0
8118599|NCT02967016|20011611|P2|COMPLETED|Overall Study||25
8118600|NCT02967016|20011612|P1|COMPLETED|Overall Study||25
8118601|NCT02967016|20011611|P2|STARTED|Overall Study||25
8118602|NCT02967016|20011612|P1|STARTED|Overall Study||25
8118609|NCT02966509|20011636|P2|NOT COMPLETED|End of Life Utilization and Cost 15month||48
8118610|NCT02966509|20011637|P1|NOT COMPLETED|End of Life Utilization and Cost 15month||45
8118611|NCT02966509|20011636|P2|COMPLETED|End of Life Utilization and Cost 15month||60
8118612|NCT02966509|20011637|P1|COMPLETED|End of Life Utilization and Cost 15month||60
8118613|NCT02966509|20011636|P2|STARTED|End of Life Utilization and Cost 15month||108
8118614|NCT02966509|20011637|P1|STARTED|End of Life Utilization and Cost 15month||105
8118615|NCT02966509|20011636|P2|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
8118616|NCT02966509|20011637|P1|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
8118617|NCT02966509|20011636|P2|COMPLETED|End of Life Utilization and Cost 6 Month||33
8118618|NCT02966509|20011637|P1|COMPLETED|End of Life Utilization and Cost 6 Month||36
8118619|NCT02966509|20011636|P2|STARTED|End of Life Utilization and Cost 6 Month||108
8118620|NCT02966509|20011637|P1|STARTED|End of Life Utilization and Cost 6 Month||105
8118621|NCT02966509|20011636|P2|NOT COMPLETED|15-Month Utilization and Cost||0
8118622|NCT02966509|20011637|P1|NOT COMPLETED|15-Month Utilization and Cost||0
8118623|NCT02966509|20011636|P2|COMPLETED|15-Month Utilization and Cost||108
8118624|NCT02966509|20011637|P1|COMPLETED|15-Month Utilization and Cost||105
8118625|NCT02966509|20011636|P2|STARTED|15-Month Utilization and Cost||108
8118626|NCT02966509|20011637|P1|STARTED|15-Month Utilization and Cost||105
8118627|NCT02966509|20011636|P2|NOT COMPLETED|6-Month Utilization and Cost||0
8118628|NCT02966509|20011637|P1|NOT COMPLETED|6-Month Utilization and Cost||0
8118629|NCT02966509|20011636|P2|COMPLETED|6-Month Utilization and Cost||108
8118630|NCT02966509|20011637|P1|COMPLETED|6-Month Utilization and Cost||105
8118631|NCT02966509|20011636|P2|STARTED|6-Month Utilization and Cost||108
8118632|NCT02966509|20011637|P1|STARTED|6-Month Utilization and Cost||105
8118633|NCT02966509|20011636|P2|NOT COMPLETED|6 Month Satisfaction Survey||48
8118634|NCT02966509|20011637|P1|NOT COMPLETED|6 Month Satisfaction Survey||47
8118635|NCT02966509|20011636|P2|COMPLETED|6 Month Satisfaction Survey||60
8118636|NCT02966509|20011637|P1|COMPLETED|6 Month Satisfaction Survey||58
8118637|NCT02966509|20011636|P2|STARTED|6 Month Satisfaction Survey||108
8118638|NCT02966509|20011637|P1|STARTED|6 Month Satisfaction Survey||105
8118639|NCT02966509|20011636|P2|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
8118640|NCT02966509|20011637|P1|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
8118641|NCT02966509|20011636|P2|COMPLETED|6 Month Satisfaction Decision Survey||77
8118642|NCT02966509|20011637|P1|COMPLETED|6 Month Satisfaction Decision Survey||80
8118643|NCT02966509|20011636|P2|STARTED|6 Month Satisfaction Decision Survey||108
8118644|NCT02966509|20011637|P1|STARTED|6 Month Satisfaction Decision Survey||105
8118645|NCT02966509|20011636|P2|NOT COMPLETED|Baseline Satisfaction Survey||7
8118646|NCT02966509|20011637|P1|NOT COMPLETED|Baseline Satisfaction Survey||4
8118647|NCT02966509|20011636|P2|COMPLETED|Baseline Satisfaction Survey||101
8118648|NCT02966509|20011637|P1|COMPLETED|Baseline Satisfaction Survey||101
8118649|NCT02966509|20011636|P2|STARTED|Baseline Satisfaction Survey||108
8118650|NCT02966509|20011637|P1|STARTED|Baseline Satisfaction Survey||105
8118651|NCT02966353|20011661|P1|NOT COMPLETED|Overall Study||22
8118652|NCT02966353|20011661|P1|COMPLETED|Overall Study||29
8118653|NCT02966353|20011661|P1|Completed After Data Cutoff|Overall Study||1
8118654|NCT02966353|20011661|P1|STARTED|Overall Study||51
8118655|NCT02966340|20011670|P2|NOT COMPLETED|Overall Study||3
8118656|NCT02966340|20011671|P1|NOT COMPLETED|Overall Study||3
8118657|NCT02966340|20011670|P2|COMPLETED|Overall Study||30
8118658|NCT02966340|20011671|P1|COMPLETED|Overall Study||34
8118659|NCT02966340|20011670|P2|STARTED|Overall Study||33
8118660|NCT02966340|20011671|P1|STARTED|Overall Study||37
8118661|NCT02966275|20011679|P1|NOT COMPLETED|Overall Study||0
8118662|NCT02966275|20011679|P1|COMPLETED|Overall Study||10
8118663|NCT02966275|20011679|P1|STARTED|Overall Study||10
8118664|NCT02966223|20011714|P1|NOT COMPLETED|Overall Study||15
8118665|NCT02966223|20011714|P1|COMPLETED|Overall Study||5
8118666|NCT02966223|20011714|P1|STARTED|Overall Study||20
8118667|NCT02966015|20011722|P2|NOT COMPLETED|Test Period||0
8118668|NCT02966015|20011723|P1|NOT COMPLETED|Test Period||0
8118669|NCT02966015|20011722|P2|COMPLETED|Test Period||55
8118670|NCT02966015|20011723|P1|COMPLETED|Test Period||87
8118671|NCT02966015|20011722|P2|STARTED|Test Period||55
8118672|NCT02966015|20011723|P1|STARTED|Test Period||87
8118673|NCT02966015|20011722|P2|NOT COMPLETED|Inclusion Visit||3
8118674|NCT02966015|20011723|P1|NOT COMPLETED|Inclusion Visit||8
8118675|NCT02966015|20011722|P2|COMPLETED|Inclusion Visit||55
8118676|NCT02966015|20011723|P1|COMPLETED|Inclusion Visit||87
8118677|NCT02966015|20011722|P2|STARTED|Inclusion Visit||58
8118678|NCT02966015|20011723|P1|STARTED|Inclusion Visit||95
8118679|NCT02966002|20011729|P1|NOT COMPLETED|Overall Study||4
8118680|NCT02966002|20011729|P1|COMPLETED|Overall Study||5
8118681|NCT02966002|20011729|P1|STARTED|Overall Study||9
8118682|NCT02965924|20011736|P1|NOT COMPLETED|Overall Study||0
8118683|NCT02965924|20011736|P1|COMPLETED|Overall Study||20
8118684|NCT02965924|20011736|P1|STARTED|Overall Study||20
8118685|NCT02965846|20011744|P3|NOT COMPLETED|Overall Study||33
8118686|NCT02965846|20011745|P2|NOT COMPLETED|Overall Study||5
8118687|NCT02965846|20011746|P1|NOT COMPLETED|Overall Study||5
8118688|NCT02965846|20011744|P3|COMPLETED|Overall Study||0
8118689|NCT02965846|20011745|P2|COMPLETED|Overall Study||0
8118690|NCT02965846|20011746|P1|COMPLETED|Overall Study||0
8118691|NCT02965846|20011744|P3|STARTED|Overall Study||33
8118692|NCT02965846|20011745|P2|STARTED|Overall Study||5
8118693|NCT02965846|20011746|P1|STARTED|Overall Study||5
8118694|NCT02965833|20011754|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
8118695|NCT02965833|20011755|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
8118696|NCT02965833|20011754|P2|COMPLETED|Period 2, Second 30 Days of Wear||52
8118697|NCT02965833|20011755|P1|COMPLETED|Period 2, Second 30 Days of Wear||62
8118698|NCT02965833|20011754|P2|STARTED|Period 2, Second 30 Days of Wear||52
8118699|NCT02965833|20011755|P1|STARTED|Period 2, Second 30 Days of Wear||64
8118700|NCT02965833|20011754|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||2
8118701|NCT02965833|20011755|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||3
8118702|NCT02965833|20011754|P2|COMPLETED|Period 1, First 30 Days of Wear||52
8118703|NCT02965833|20011755|P1|COMPLETED|Period 1, First 30 Days of Wear||64
8118704|NCT02965833|20011754|P2|STARTED|Period 1, First 30 Days of Wear||54
8118705|NCT02965833|20011755|P1|STARTED|Period 1, First 30 Days of Wear||67
8118706|NCT02965820|20011761|P2|NOT COMPLETED|Period 2, Second 30 Days||1
8118707|NCT02965820|20011762|P1|NOT COMPLETED|Period 2, Second 30 Days||1
8118708|NCT02965820|20011761|P2|COMPLETED|Period 2, Second 30 Days||61
8118709|NCT02965820|20011762|P1|COMPLETED|Period 2, Second 30 Days||57
8118710|NCT02965820|20011761|P2|STARTED|Period 2, Second 30 Days||62
8118711|NCT02965820|20011762|P1|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
8118712|NCT02965820|20011761|P2|NOT COMPLETED|Period 1, First 30 Days||0
8118713|NCT02965820|20011762|P1|NOT COMPLETED|Period 1, First 30 Days||0
8118714|NCT02965820|20011761|P2|COMPLETED|Period 1, First 30 Days||62
8118715|NCT02965820|20011762|P1|COMPLETED|Period 1, First 30 Days||59
8118716|NCT02965820|20011761|P2|STARTED|Period 1, First 30 Days||62
8118717|NCT02965820|20011762|P1|STARTED|Period 1, First 30 Days||59
8118718|NCT02965729|20011771|P3|NOT COMPLETED|Overall Study||11
8118719|NCT02965729|20011772|P2|NOT COMPLETED|Overall Study||3
8118720|NCT02965729|20011773|P1|NOT COMPLETED|Overall Study||7
8118721|NCT02965729|20011771|P3|COMPLETED|Overall Study||45
8118722|NCT02965729|20011772|P2|COMPLETED|Overall Study||22
8118723|NCT02965729|20011773|P1|COMPLETED|Overall Study||17
8118724|NCT02965729|20011771|P3|STARTED|Overall Study||56
8118725|NCT02965729|20011772|P2|STARTED|Overall Study||25
8118726|NCT02965729|20011773|P1|STARTED|Overall Study||24
8118727|NCT02965599|20011801|P2|NOT COMPLETED|Overall Study||0
8118728|NCT02965599|20011802|P1|NOT COMPLETED|Overall Study||1
8118729|NCT02965599|20011801|P2|COMPLETED|Overall Study||1
8118730|NCT02965599|20011802|P1|COMPLETED|Overall Study||1
8118731|NCT02965599|20011801|P2|STARTED|Overall Study||1
8118732|NCT02965599|20011802|P1|STARTED|Overall Study||2
8118733|NCT02965573|20011866|P2|NOT COMPLETED|Overall Study||0
8118734|NCT02965573|20011867|P1|NOT COMPLETED|Overall Study||1
8118735|NCT02965573|20011866|P2|COMPLETED|Overall Study||12
8118736|NCT02965573|20011867|P1|COMPLETED|Overall Study||11
8118737|NCT02965573|20011866|P2|STARTED|Overall Study||12
8118738|NCT02965573|20011867|P1|STARTED|Overall Study||12
8118739|NCT02965534|20011911|P2|NOT COMPLETED|Overall Study||0
8118740|NCT02965534|20011912|P1|NOT COMPLETED|Overall Study||0
8118741|NCT02965534|20011911|P2|COMPLETED|Overall Study||55
8118742|NCT02965534|20011912|P1|COMPLETED|Overall Study||45
8118743|NCT02965534|20011911|P2|STARTED|Overall Study|test period: 14 days with each test glasses|55
8118744|NCT02965534|20011912|P1|STARTED|Overall Study|test period: 14 days with each test glasses|45
8118745|NCT02965456|20011928|P2|NOT COMPLETED|Overall Study||43
8118746|NCT02965456|20011929|P1|NOT COMPLETED|Overall Study||71
8118747|NCT02965456|20011928|P2|COMPLETED|Overall Study||364
8118748|NCT02965456|20011929|P1|COMPLETED|Overall Study||342
8118749|NCT02965456|20011928|P2|Safety Population|Overall Study||398
8118750|NCT02965456|20011929|P1|Safety Population|Overall Study||389
8118751|NCT02965456|20011928|P2|Intent-to-treat (ITT) Population|Overall Study||407
8118752|NCT02965456|20011929|P1|Intent-to-treat (ITT) Population|Overall Study||413
8118753|NCT02965456|20011928|P2|STARTED|Overall Study||407
8118754|NCT02965456|20011929|P1|STARTED|Overall Study||413
8118755|NCT02965144|20011943|P1|NOT COMPLETED|Overall Study||0
8118756|NCT02965144|20011943|P1|COMPLETED|Overall Study||13
8118757|NCT02965144|20011943|P1|STARTED|Overall Study||13
8118758|NCT02964910|20011953|P2|NOT COMPLETED|Overall Study||44
8118759|NCT02964910|20011954|P1|NOT COMPLETED|Overall Study||43
8118760|NCT02964910|20011953|P2|COMPLETED|Overall Study||196
8118761|NCT02964910|20011954|P1|COMPLETED|Overall Study||192
8118762|NCT02964910|20011953|P2|STARTED|Overall Study||240
8118763|NCT02964910|20011954|P1|STARTED|Overall Study||235
8118764|NCT02964767|20011980|P2|NOT COMPLETED|Overall Study||0
8118765|NCT02964767|20011981|P1|NOT COMPLETED|Overall Study||0
8118766|NCT02964767|20011980|P2|COMPLETED|Overall Study||48
8118767|NCT02964767|20011981|P1|COMPLETED|Overall Study||171
8118768|NCT02964767|20011980|P2|STARTED|Overall Study||48
8118769|NCT02964767|20011981|P1|STARTED|Overall Study||171
8118770|NCT02964416|20011990|P2|NOT COMPLETED|Overall Study||0
8118771|NCT02964416|20011991|P1|NOT COMPLETED|Overall Study||1
8118772|NCT02964416|20011990|P2|COMPLETED|Overall Study||41
8118773|NCT02964416|20011991|P1|COMPLETED|Overall Study||38
8118774|NCT02964416|20011990|P2|STARTED|Overall Study||41
8118775|NCT02964416|20011991|P1|STARTED|Overall Study||39
8118791|NCT02964312|20012066|P1|NOT COMPLETED|Overall Study||64
8118792|NCT02964312|20012066|P1|COMPLETED|Overall Study||102
8118793|NCT02964312|20012066|P1|24-Month Follow-up|Overall Study||102
8118794|NCT02964312|20012066|P1|18-Month Follow-up|Overall Study||112
8118795|NCT02964312|20012066|P1|12-Month Follow-up|Overall Study||139
8118796|NCT02964312|20012066|P1|6-Month Follow-up|Overall Study||152
8118797|NCT02964312|20012066|P1|3-Month Follow-up|Overall Study||159
8118798|NCT02964312|20012066|P1|1-Month Follow-up|Overall Study||164
8118799|NCT02964312|20012066|P1|STARTED|Overall Study||166
8118800|NCT02964247|20012077|P2|NOT COMPLETED|Overall Study||2
8118801|NCT02964247|20012078|P1|NOT COMPLETED|Overall Study||3
8118802|NCT02964247|20012077|P2|COMPLETED|Overall Study||98
8118803|NCT02964247|20012078|P1|COMPLETED|Overall Study||200
8118804|NCT02964247|20012077|P2|Exposed to Trial Product|Overall Study||100
8118805|NCT02964247|20012078|P1|Exposed to Trial Product|Overall Study||202
8118806|NCT02964247|20012077|P2|STARTED|Overall Study||100
8118807|NCT02964247|20012078|P1|STARTED|Overall Study||203
8118808|NCT02964234|20012136|P2|NOT COMPLETED|Overall Study||13
8118809|NCT02964234|20012137|P1|NOT COMPLETED|Overall Study||22
8118810|NCT02964234|20012136|P2|COMPLETED|Overall Study||56
8118811|NCT02964234|20012137|P1|COMPLETED|Overall Study||54
8118812|NCT02964234|20012136|P2|STARTED|Overall Study||69
8118813|NCT02964234|20012137|P1|STARTED|Overall Study||76
8118817|NCT02963987|20012153|P2|NOT COMPLETED|Second Intervention Period||0
8118818|NCT02963987|20012154|P1|NOT COMPLETED|Second Intervention Period||0
8118819|NCT02963987|20012153|P2|COMPLETED|Second Intervention Period||19
8118820|NCT02963987|20012154|P1|COMPLETED|Second Intervention Period||31
8118821|NCT02963987|20012153|P2|STARTED|Second Intervention Period||19
8118822|NCT02963987|20012154|P1|STARTED|Second Intervention Period||31
8118823|NCT02963987|20012153|P2|NOT COMPLETED|First Intervention Period||0
8118824|NCT02963987|20012154|P1|NOT COMPLETED|First Intervention Period||0
8118825|NCT02963987|20012153|P2|COMPLETED|First Intervention Period||19
8118826|NCT02963987|20012154|P1|COMPLETED|First Intervention Period||31
8118827|NCT02963987|20012153|P2|STARTED|First Intervention Period||19
8118828|NCT02963987|20012154|P1|STARTED|First Intervention Period||31
8118829|NCT02963935|20012166|P2|NOT COMPLETED|Overall Study||37
8118830|NCT02963935|20012167|P1|NOT COMPLETED|Overall Study||28
8118831|NCT02963935|20012166|P2|COMPLETED|Overall Study||103
8118832|NCT02963935|20012167|P1|COMPLETED|Overall Study||114
8118833|NCT02963935|20012166|P2|STARTED|Overall Study||140
8118834|NCT02963935|20012167|P1|STARTED|Overall Study||142
8118835|NCT02963922|20012275|P2|NOT COMPLETED|Overall Study||30
8118836|NCT02963922|20012276|P1|NOT COMPLETED|Overall Study||32
8118837|NCT02963922|20012275|P2|COMPLETED|Overall Study||168
8118838|NCT02963922|20012276|P1|COMPLETED|Overall Study||166
8118839|NCT02963922|20012275|P2|STARTED|Overall Study||198
8118840|NCT02963922|20012276|P1|STARTED|Overall Study||198
8118841|NCT02963701|20012374|P2|NOT COMPLETED|Period 2 (2 Days)||0
8118842|NCT02963701|20012375|P1|NOT COMPLETED|Period 2 (2 Days)||0
8118843|NCT02963701|20012374|P2|COMPLETED|Period 2 (2 Days)||28
8118844|NCT02963701|20012375|P1|COMPLETED|Period 2 (2 Days)||27
8118845|NCT02963701|20012374|P2|STARTED|Period 2 (2 Days)||28
8118846|NCT02963701|20012375|P1|STARTED|Period 2 (2 Days)||27
8118847|NCT02963701|20012374|P2|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
8118848|NCT02963701|20012375|P1|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
8119023|NCT02962609|20012740|P2|NOT COMPLETED|Overall Study||0
8118849|NCT02963701|20012374|P2|COMPLETED|Period 1 (Including Washout) (2 Days)||28
8118850|NCT02963701|20012375|P1|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
8118851|NCT02963701|20012374|P2|STARTED|Period 1 (Including Washout) (2 Days)||28
8118852|NCT02963701|20012375|P1|STARTED|Period 1 (Including Washout) (2 Days)||28
8118853|NCT02963597|20012407|P2|NOT COMPLETED|Overall Study||0
8118854|NCT02963597|20012408|P1|NOT COMPLETED|Overall Study||0
8118855|NCT02963597|20012407|P2|COMPLETED|Overall Study||11
8118856|NCT02963597|20012408|P1|COMPLETED|Overall Study||10
8118857|NCT02963597|20012407|P2|STARTED|Overall Study||11
8118858|NCT02963597|20012408|P1|STARTED|Overall Study||10
8118859|NCT02963506|20012435|P13|NOT COMPLETED|Dose-Blind Period||7
8118860|NCT02963506|20012436|P12|NOT COMPLETED|Dose-Blind Period||2
8118861|NCT02963506|20012437|P11|NOT COMPLETED|Dose-Blind Period||1
8118862|NCT02963506|20012438|P10|NOT COMPLETED|Dose-Blind Period||4
8118863|NCT02963506|20012439|P9|NOT COMPLETED|Dose-Blind Period||3
8118864|NCT02963506|20012440|P8|NOT COMPLETED|Dose-Blind Period||5
8118865|NCT02963506|20012441|P7|NOT COMPLETED|Dose-Blind Period||5
8118866|NCT02963506|20012442|P6|NOT COMPLETED|Dose-Blind Period||4
8118867|NCT02963506|20012443|P5|NOT COMPLETED|Dose-Blind Period||0
8118868|NCT02963506|20012444|P4|NOT COMPLETED|Dose-Blind Period||0
8118869|NCT02963506|20012445|P3|NOT COMPLETED|Dose-Blind Period||0
8118870|NCT02963506|20012446|P2|NOT COMPLETED|Dose-Blind Period||0
8118871|NCT02963506|20012447|P1|NOT COMPLETED|Dose-Blind Period||0
8118872|NCT02963506|20012435|P13|COMPLETED|Dose-Blind Period||54
8118873|NCT02963506|20012436|P12|COMPLETED|Dose-Blind Period||56
8118874|NCT02963506|20012437|P11|COMPLETED|Dose-Blind Period||24
8118875|NCT02963506|20012438|P10|COMPLETED|Dose-Blind Period||30
8118876|NCT02963506|20012439|P9|COMPLETED|Dose-Blind Period||24
8118877|NCT02963506|20012440|P8|COMPLETED|Dose-Blind Period||26
8118878|NCT02963506|20012441|P7|COMPLETED|Dose-Blind Period||31
8118879|NCT02963506|20012442|P6|COMPLETED|Dose-Blind Period||20
8118880|NCT02963506|20012443|P5|COMPLETED|Dose-Blind Period||0
8118881|NCT02963506|20012444|P4|COMPLETED|Dose-Blind Period||0
8118882|NCT02963506|20012445|P3|COMPLETED|Dose-Blind Period||0
8118883|NCT02963506|20012446|P2|COMPLETED|Dose-Blind Period||0
8118884|NCT02963506|20012447|P1|COMPLETED|Dose-Blind Period||0
8118885|NCT02963506|20012435|P13|STARTED|Dose-Blind Period||61
8118886|NCT02963506|20012436|P12|STARTED|Dose-Blind Period||58
8118887|NCT02963506|20012437|P11|STARTED|Dose-Blind Period||25
8118888|NCT02963506|20012438|P10|STARTED|Dose-Blind Period||34
8118889|NCT02963506|20012439|P9|STARTED|Dose-Blind Period||27
8118890|NCT02963506|20012440|P8|STARTED|Dose-Blind Period||31
8118891|NCT02963506|20012441|P7|STARTED|Dose-Blind Period||36
8118892|NCT02963506|20012442|P6|STARTED|Dose-Blind Period||24
8118893|NCT02963506|20012443|P5|STARTED|Dose-Blind Period||0
8118894|NCT02963506|20012444|P4|STARTED|Dose-Blind Period||0
8118895|NCT02963506|20012445|P3|STARTED|Dose-Blind Period||0
8118896|NCT02963506|20012446|P2|STARTED|Dose-Blind Period||0
8118897|NCT02963506|20012447|P1|STARTED|Dose-Blind Period||0
8118898|NCT02963506|20012435|P13|NOT COMPLETED|Double-Blind Period||0
8118899|NCT02963506|20012436|P12|NOT COMPLETED|Double-Blind Period||0
8118900|NCT02963506|20012437|P11|NOT COMPLETED|Double-Blind Period||0
8118901|NCT02963506|20012438|P10|NOT COMPLETED|Double-Blind Period||0
8118902|NCT02963506|20012439|P9|NOT COMPLETED|Double-Blind Period||0
8118903|NCT02963506|20012440|P8|NOT COMPLETED|Double-Blind Period||0
8118904|NCT02963506|20012441|P7|NOT COMPLETED|Double-Blind Period||0
8118905|NCT02963506|20012442|P6|NOT COMPLETED|Double-Blind Period||0
8118906|NCT02963506|20012443|P5|NOT COMPLETED|Double-Blind Period||0
8118907|NCT02963506|20012444|P4|NOT COMPLETED|Double-Blind Period||2
8118908|NCT02963506|20012445|P3|NOT COMPLETED|Double-Blind Period||2
8118909|NCT02963506|20012446|P2|NOT COMPLETED|Double-Blind Period||3
8118910|NCT02963506|20012447|P1|NOT COMPLETED|Double-Blind Period||0
8118911|NCT02963506|20012435|P13|COMPLETED|Double-Blind Period||0
8118912|NCT02963506|20012436|P12|COMPLETED|Double-Blind Period||0
8118913|NCT02963506|20012437|P11|COMPLETED|Double-Blind Period||0
8118914|NCT02963506|20012438|P10|COMPLETED|Double-Blind Period||0
8118915|NCT02963506|20012439|P9|COMPLETED|Double-Blind Period||0
8118916|NCT02963506|20012440|P8|COMPLETED|Double-Blind Period||0
8118917|NCT02963506|20012441|P7|COMPLETED|Double-Blind Period||0
8118918|NCT02963506|20012442|P6|COMPLETED|Double-Blind Period||0
8118919|NCT02963506|20012443|P5|COMPLETED|Double-Blind Period||61
8118920|NCT02963506|20012444|P4|COMPLETED|Double-Blind Period||58
8118921|NCT02963506|20012445|P3|COMPLETED|Double-Blind Period||59
8118922|NCT02963506|20012446|P2|COMPLETED|Double-Blind Period||58
8118923|NCT02963506|20012447|P1|COMPLETED|Double-Blind Period||60
8118924|NCT02963506|20012435|P13|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118925|NCT02963506|20012436|P12|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118926|NCT02963506|20012437|P11|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118927|NCT02963506|20012438|P10|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118928|NCT02963506|20012439|P9|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118929|NCT02963506|20012440|P8|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118930|NCT02963506|20012441|P7|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118931|NCT02963506|20012442|P6|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
8118932|NCT02963506|20012443|P5|Completed Week 12 - Started Dose-Blind|Double-Blind Period||61
8118933|NCT02963506|20012444|P4|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
8118934|NCT02963506|20012445|P3|Completed Week 12 - Started Dose-Blind|Double-Blind Period||59
8119024|NCT02962609|20012741|P1|NOT COMPLETED|Overall Study||0
8118935|NCT02963506|20012446|P2|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
8118936|NCT02963506|20012447|P1|Completed Week 12 - Started Dose-Blind|Double-Blind Period||60
8118937|NCT02963506|20012435|P13|Completed Double-Blind Period|Double-Blind Period||0
8118938|NCT02963506|20012436|P12|Completed Double-Blind Period|Double-Blind Period||0
8118939|NCT02963506|20012437|P11|Completed Double-Blind Period|Double-Blind Period||0
8118940|NCT02963506|20012438|P10|Completed Double-Blind Period|Double-Blind Period||0
8118941|NCT02963506|20012439|P9|Completed Double-Blind Period|Double-Blind Period||0
8118942|NCT02963506|20012440|P8|Completed Double-Blind Period|Double-Blind Period||0
8118943|NCT02963506|20012441|P7|Completed Double-Blind Period|Double-Blind Period||0
8118944|NCT02963506|20012442|P6|Completed Double-Blind Period|Double-Blind Period||0
8118945|NCT02963506|20012443|P5|Completed Double-Blind Period|Double-Blind Period||61
8118946|NCT02963506|20012444|P4|Completed Double-Blind Period|Double-Blind Period||58
8118947|NCT02963506|20012445|P3|Completed Double-Blind Period|Double-Blind Period||59
8118948|NCT02963506|20012446|P2|Completed Double-Blind Period|Double-Blind Period||59
8118949|NCT02963506|20012447|P1|Completed Double-Blind Period|Double-Blind Period||60
8118950|NCT02963506|20012435|P13|STARTED|Double-Blind Period||0
8118951|NCT02963506|20012436|P12|STARTED|Double-Blind Period||0
8118952|NCT02963506|20012437|P11|STARTED|Double-Blind Period||0
8118953|NCT02963506|20012438|P10|STARTED|Double-Blind Period||0
8118954|NCT02963506|20012439|P9|STARTED|Double-Blind Period||0
8118955|NCT02963506|20012440|P8|STARTED|Double-Blind Period||0
8118956|NCT02963506|20012441|P7|STARTED|Double-Blind Period||0
8118957|NCT02963506|20012442|P6|STARTED|Double-Blind Period||0
8118958|NCT02963506|20012443|P5|STARTED|Double-Blind Period||61
8118959|NCT02963506|20012444|P4|STARTED|Double-Blind Period||60
8118960|NCT02963506|20012445|P3|STARTED|Double-Blind Period||61
8118961|NCT02963506|20012446|P2|STARTED|Double-Blind Period||61
8118962|NCT02963506|20012447|P1|STARTED|Double-Blind Period||60
8118963|NCT02963311|20012499|P1|NOT COMPLETED|Overall Study||5
8118964|NCT02963311|20012499|P1|COMPLETED|Overall Study||4
8118965|NCT02963311|20012499|P1|STARTED|Overall Study||9
8118966|NCT02962960|20012526|P3|NOT COMPLETED|Overall Study||0
8118967|NCT02962960|20012527|P2|NOT COMPLETED|Overall Study||2
8118968|NCT02962960|20012528|P1|NOT COMPLETED|Overall Study||3
8118969|NCT02962960|20012526|P3|COMPLETED|Overall Study||9
8118970|NCT02962960|20012527|P2|COMPLETED|Overall Study||11
8118971|NCT02962960|20012528|P1|COMPLETED|Overall Study||11
8118972|NCT02962960|20012526|P3|STARTED|Overall Study||9
8118973|NCT02962960|20012527|P2|STARTED|Overall Study||13
8118974|NCT02962960|20012528|P1|STARTED|Overall Study||14
8118975|NCT02962934|20012601|P2|NOT COMPLETED|Overall Study||0
8118976|NCT02962934|20012602|P1|NOT COMPLETED|Overall Study||0
8118977|NCT02962934|20012601|P2|COMPLETED|Overall Study||6
8118978|NCT02962934|20012602|P1|COMPLETED|Overall Study||12
8118979|NCT02962934|20012601|P2|STARTED|Overall Study||6
8118980|NCT02962934|20012602|P1|STARTED|Overall Study||12
8118981|NCT02962908|20012612|P4|NOT COMPLETED|Overall Study||3
8118982|NCT02962908|20012613|P3|NOT COMPLETED|Overall Study||0
8118983|NCT02962908|20012614|P2|NOT COMPLETED|Overall Study||8
8118984|NCT02962908|20012615|P1|NOT COMPLETED|Overall Study||0
8118985|NCT02962908|20012612|P4|COMPLETED|Overall Study||24
8118986|NCT02962908|20012613|P3|COMPLETED|Overall Study||32
8118987|NCT02962908|20012614|P2|COMPLETED|Overall Study||50
8118988|NCT02962908|20012615|P1|COMPLETED|Overall Study||58
8118989|NCT02962908|20012612|P4|STARTED|Overall Study||27
8118990|NCT02962908|20012613|P3|STARTED|Overall Study||32
8118991|NCT02962908|20012614|P2|STARTED|Overall Study||58
8118992|NCT02962908|20012615|P1|STARTED|Overall Study||58
8118993|NCT02962882|20012679|P1|NOT COMPLETED|Overall Study||36
8118994|NCT02962882|20012679|P1|COMPLETED|Overall Study||14
8118995|NCT02962882|20012679|P1|STARTED|Overall Study||50
8118996|NCT02962739|20012688|P6|NOT COMPLETED|Overall Study||0
8118997|NCT02962739|20012689|P5|NOT COMPLETED|Overall Study||1
8118998|NCT02962739|20012690|P4|NOT COMPLETED|Overall Study||0
8118999|NCT02962739|20012691|P3|NOT COMPLETED|Overall Study||1
8119000|NCT02962739|20012692|P2|NOT COMPLETED|Overall Study||1
8119001|NCT02962739|20012693|P1|NOT COMPLETED|Overall Study||0
8119002|NCT02962739|20012688|P6|COMPLETED|Overall Study||6
8119003|NCT02962739|20012689|P5|COMPLETED|Overall Study||5
8119004|NCT02962739|20012690|P4|COMPLETED|Overall Study||6
8119005|NCT02962739|20012691|P3|COMPLETED|Overall Study||6
8119006|NCT02962739|20012692|P2|COMPLETED|Overall Study||6
8119007|NCT02962739|20012693|P1|COMPLETED|Overall Study||6
8119008|NCT02962739|20012688|P6|STARTED|Overall Study||6
8119009|NCT02962739|20012689|P5|STARTED|Overall Study||6
8119010|NCT02962739|20012690|P4|STARTED|Overall Study||6
8119011|NCT02962739|20012691|P3|STARTED|Overall Study||7
8119012|NCT02962739|20012692|P2|STARTED|Overall Study||7
8119013|NCT02962739|20012693|P1|STARTED|Overall Study||6
8119014|NCT02962687|20012701|P2|NOT COMPLETED|Overall Study||8
8119015|NCT02962687|20012702|P1|NOT COMPLETED|Overall Study||10
8119016|NCT02962687|20012701|P2|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32
8119017|NCT02962687|20012702|P1|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30
8119018|NCT02962687|20012701|P2|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
8119019|NCT02962687|20012702|P1|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
8119020|NCT02962648|20012726|P1|NOT COMPLETED|Overall Study||9
8119021|NCT02962648|20012726|P1|COMPLETED|Overall Study||94
8119022|NCT02962648|20012726|P1|STARTED|Overall Study||103
8119025|NCT02962609|20012740|P2|COMPLETED|Overall Study||42
8119026|NCT02962609|20012741|P1|COMPLETED|Overall Study||38
8119027|NCT02962609|20012740|P2|STARTED|Overall Study||42
8119028|NCT02962609|20012741|P1|STARTED|Overall Study||38
8119029|NCT02962427|20012753|P2|NOT COMPLETED|Overall Study||0
8119030|NCT02962427|20012754|P1|NOT COMPLETED|Overall Study||0
8119031|NCT02962427|20012753|P2|COMPLETED|Overall Study||1
8119032|NCT02962427|20012754|P1|COMPLETED|Overall Study||3
8119033|NCT02962427|20012753|P2|STARTED|Overall Study||1
8119034|NCT02962427|20012754|P1|STARTED|Overall Study||3
8119035|NCT02962284|20012764|P2|NOT COMPLETED|Overall Study||3
8119036|NCT02962284|20012765|P1|NOT COMPLETED|Overall Study||5
8119037|NCT02962284|20012764|P2|COMPLETED|Overall Study||8
8119038|NCT02962284|20012765|P1|COMPLETED|Overall Study||4
8119039|NCT02962284|20012764|P2|STARTED|Overall Study||11
8119040|NCT02962284|20012765|P1|STARTED|Overall Study||9
8119041|NCT02961946|20012784|P3|NOT COMPLETED|Overall Study||0
8119042|NCT02961946|20012785|P2|NOT COMPLETED|Overall Study||0
8119043|NCT02961946|20012786|P1|NOT COMPLETED|Overall Study||0
8119044|NCT02961946|20012784|P3|COMPLETED|Overall Study||66
8119045|NCT02961946|20012785|P2|COMPLETED|Overall Study||66
8119046|NCT02961946|20012786|P1|COMPLETED|Overall Study||66
8119047|NCT02961946|20012784|P3|STARTED|Overall Study||66
8119048|NCT02961946|20012785|P2|STARTED|Overall Study||66
8119049|NCT02961946|20012786|P1|STARTED|Overall Study||66
8119050|NCT02961920|20012796|P2|NOT COMPLETED|Overall Study||1
8119051|NCT02961920|20012797|P1|NOT COMPLETED|Overall Study||1
8119052|NCT02961920|20012796|P2|COMPLETED|Overall Study||24
8119053|NCT02961920|20012797|P1|COMPLETED|Overall Study||24
8119054|NCT02961920|20012796|P2|STARTED|Overall Study||25
8119055|NCT02961920|20012797|P1|STARTED|Overall Study||25
8119056|NCT02961894|20012803|P1|NOT COMPLETED|Overall Study||0
8119057|NCT02961894|20012803|P1|COMPLETED|Overall Study||121
8119058|NCT02961894|20012803|P1|STARTED|Overall Study||121
8119059|NCT02961790|20012825|P4|NOT COMPLETED|Overall Study||5
8119060|NCT02961790|20012826|P3|NOT COMPLETED|Overall Study||6
8119061|NCT02961790|20012827|P2|NOT COMPLETED|Overall Study||11
8119062|NCT02961790|20012828|P1|NOT COMPLETED|Overall Study||15
8119063|NCT02961790|20012825|P4|COMPLETED|Overall Study||20
8119064|NCT02961790|20012826|P3|COMPLETED|Overall Study||18
8119065|NCT02961790|20012827|P2|COMPLETED|Overall Study||40
8119066|NCT02961790|20012828|P1|COMPLETED|Overall Study||35
8119067|NCT02961790|20012825|P4|STARTED|Overall Study||25
8119068|NCT02961790|20012826|P3|STARTED|Overall Study||24
8119069|NCT02961790|20012827|P2|STARTED|Overall Study||51
8119070|NCT02961790|20012828|P1|STARTED|Overall Study||50
8119071|NCT02961764|20012851|P2|NOT COMPLETED|Overall Study||25
8119072|NCT02961764|20012852|P1|NOT COMPLETED|Overall Study||39
8119073|NCT02961764|20012851|P2|COMPLETED|Overall Study||128
8119074|NCT02961764|20012852|P1|COMPLETED|Overall Study||121
8119075|NCT02961764|20012851|P2|STARTED|Overall Study||153
8119076|NCT02961764|20012852|P1|STARTED|Overall Study||160
8119077|NCT02961751|20012926|P1|NOT COMPLETED|Overall Study||15
8119078|NCT02961751|20012926|P1|COMPLETED|Overall Study||196
8119079|NCT02961751|20012926|P1|STARTED|Overall Study||211
8119080|NCT02961244|20012939|P2|NOT COMPLETED|Overall Study||9
8119081|NCT02961244|20012940|P1|NOT COMPLETED|Overall Study||1
8119082|NCT02961244|20012939|P2|COMPLETED|Overall Study||55
8119083|NCT02961244|20012940|P1|COMPLETED|Overall Study||63
8119084|NCT02961244|20012939|P2|Patients Excluded During Randomization|Overall Study||1
8119085|NCT02961244|20012940|P1|Patients Excluded During Randomization|Overall Study||0
8119086|NCT02961244|20012939|P2|STARTED|Overall Study||64
8119087|NCT02961244|20012940|P1|STARTED|Overall Study||64
8119088|NCT02961218|20012950|P2|NOT COMPLETED|Overall Study||5
8119089|NCT02961218|20012951|P1|NOT COMPLETED|Overall Study||3
8119090|NCT02961218|20012950|P2|COMPLETED|Overall Study||19
8119091|NCT02961218|20012951|P1|COMPLETED|Overall Study||22
8119092|NCT02961218|20012950|P2|Primary PD Analysis Set|Overall Study||24
8119093|NCT02961218|20012951|P1|Primary PD Analysis Set|Overall Study||25
8119094|NCT02961218|20012950|P2|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
8119095|NCT02961218|20012951|P1|Pharmacokinetics (PK) Analysis Set|Overall Study||25
8119096|NCT02961218|20012950|P2|Safety Analysis Set|Overall Study||24
8119097|NCT02961218|20012951|P1|Safety Analysis Set|Overall Study||25
8119098|NCT02961218|20012950|P2|STARTED|Overall Study||24
8119099|NCT02961218|20012951|P1|STARTED|Overall Study||25
8119100|NCT02961062|20012988|P2|NOT COMPLETED|Overall Study||0
8119101|NCT02961062|20012989|P1|NOT COMPLETED|Overall Study||0
8119102|NCT02961062|20012988|P2|COMPLETED|Overall Study||20
8119103|NCT02961062|20012989|P1|COMPLETED|Overall Study||20
8119104|NCT02961062|20012988|P2|STARTED|Overall Study||20
8119105|NCT02961062|20012989|P1|STARTED|Overall Study||20
8119106|NCT02960997|20013005|P2|NOT COMPLETED|Follow-up Period, 4 Weeks||0
8119107|NCT02960997|20013006|P1|NOT COMPLETED|Follow-up Period, 4 Weeks||0
8119108|NCT02960997|20013005|P2|COMPLETED|Follow-up Period, 4 Weeks||4
8119109|NCT02960997|20013006|P1|COMPLETED|Follow-up Period, 4 Weeks||4
8119110|NCT02960997|20013005|P2|STARTED|Follow-up Period, 4 Weeks||4
8119111|NCT02960997|20013006|P1|STARTED|Follow-up Period, 4 Weeks||4
8119112|NCT02960997|20013005|P2|NOT COMPLETED|Second Treatment, 12 Weeks||0
8119113|NCT02960997|20013006|P1|NOT COMPLETED|Second Treatment, 12 Weeks||0
8119114|NCT02960997|20013005|P2|COMPLETED|Second Treatment, 12 Weeks||4
8119115|NCT02960997|20013006|P1|COMPLETED|Second Treatment, 12 Weeks||4
8119116|NCT02960997|20013005|P2|STARTED|Second Treatment, 12 Weeks||4
8119117|NCT02960997|20013006|P1|STARTED|Second Treatment, 12 Weeks||4
8119118|NCT02960997|20013005|P2|NOT COMPLETED|Washout Period, 4 Weeks||0
8119119|NCT02960997|20013006|P1|NOT COMPLETED|Washout Period, 4 Weeks||0
8119120|NCT02960997|20013005|P2|COMPLETED|Washout Period, 4 Weeks||4
8119121|NCT02960997|20013006|P1|COMPLETED|Washout Period, 4 Weeks||4
8119122|NCT02960997|20013005|P2|STARTED|Washout Period, 4 Weeks||4
8119123|NCT02960997|20013006|P1|STARTED|Washout Period, 4 Weeks||4
8119124|NCT02960997|20013005|P2|NOT COMPLETED|First Intervention, 12 Weeks||0
8119125|NCT02960997|20013006|P1|NOT COMPLETED|First Intervention, 12 Weeks||0
8119126|NCT02960997|20013005|P2|COMPLETED|First Intervention, 12 Weeks||4
8119127|NCT02960997|20013006|P1|COMPLETED|First Intervention, 12 Weeks||4
8119128|NCT02960997|20013005|P2|STARTED|First Intervention, 12 Weeks||4
8119129|NCT02960997|20013006|P1|STARTED|First Intervention, 12 Weeks||4
8119142|NCT02960854|20013050|P2|NOT COMPLETED|Overall Study||9
8119143|NCT02960854|20013051|P1|NOT COMPLETED|Overall Study||7
8119144|NCT02960854|20013050|P2|COMPLETED|Overall Study||7
8119145|NCT02960854|20013051|P1|COMPLETED|Overall Study||8
8119146|NCT02960854|20013050|P2|STARTED|Overall Study||16
8119147|NCT02960854|20013051|P1|STARTED|Overall Study||15
8119148|NCT02960295|20013081|P1|NOT COMPLETED|Overall Study||0
8119149|NCT02960295|20013081|P1|COMPLETED|Overall Study||10
8119150|NCT02960295|20013081|P1|STARTED|Overall Study||10
8119151|NCT02960217|20013090|P2|NOT COMPLETED|Open-Label Extension Phase||13
8119152|NCT02960217|20013091|P1|NOT COMPLETED|Open-Label Extension Phase||20
8119153|NCT02960217|20013090|P2|COMPLETED|Open-Label Extension Phase||0
8119154|NCT02960217|20013091|P1|COMPLETED|Open-Label Extension Phase||0
8119155|NCT02960217|20013090|P2|STARTED|Open-Label Extension Phase|5 participants completed the double blind period but did not continue in the open label period.|13
8119156|NCT02960217|20013091|P1|STARTED|Open-Label Extension Phase||20
8119157|NCT02960217|20013090|P2|NOT COMPLETED|Maintenance Phase: Treatment Period 2||3
8119158|NCT02960217|20013091|P1|NOT COMPLETED|Maintenance Phase: Treatment Period 2||1
8119159|NCT02960217|20013090|P2|COMPLETED|Maintenance Phase: Treatment Period 2||18
8119160|NCT02960217|20013091|P1|COMPLETED|Maintenance Phase: Treatment Period 2||20
8119161|NCT02960217|20013090|P2|STARTED|Maintenance Phase: Treatment Period 2||21
8119162|NCT02960217|20013091|P1|STARTED|Maintenance Phase: Treatment Period 2||21
8119163|NCT02960217|20013090|P2|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
8119164|NCT02960217|20013091|P1|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
8119165|NCT02960217|20013090|P2|COMPLETED|Maintenance Phase: Crossover Washout||21
8119166|NCT02960217|20013091|P1|COMPLETED|Maintenance Phase: Crossover Washout||21
8119167|NCT02960217|20013090|P2|STARTED|Maintenance Phase: Crossover Washout||21
8119168|NCT02960217|20013091|P1|STARTED|Maintenance Phase: Crossover Washout||21
8119169|NCT02960217|20013090|P2|NOT COMPLETED|Maintenance Phase: Treatment Period 1||0
8119170|NCT02960217|20013091|P1|NOT COMPLETED|Maintenance Phase: Treatment Period 1||1
8119171|NCT02960217|20013090|P2|COMPLETED|Maintenance Phase: Treatment Period 1||21
8119172|NCT02960217|20013091|P1|COMPLETED|Maintenance Phase: Treatment Period 1||21
8119173|NCT02960217|20013090|P2|STARTED|Maintenance Phase: Treatment Period 1||21
8119174|NCT02960217|20013091|P1|STARTED|Maintenance Phase: Treatment Period 1||22
8119175|NCT02959996|20013145|P2|NOT COMPLETED|Overall Study||0
8119176|NCT02959996|20013146|P1|NOT COMPLETED|Overall Study||0
8119177|NCT02959996|20013145|P2|COMPLETED|Overall Study||39
8119178|NCT02959996|20013146|P1|COMPLETED|Overall Study||40
8119179|NCT02959996|20013145|P2|STARTED|Overall Study||39
8119180|NCT02959996|20013146|P1|STARTED|Overall Study||40
8119181|NCT02959983|20013170|P2|NOT COMPLETED|Overall Study||25
8119182|NCT02959983|20013171|P1|NOT COMPLETED|Overall Study||26
8119183|NCT02959983|20013170|P2|COMPLETED|Overall Study||149
8119184|NCT02959983|20013171|P1|COMPLETED|Overall Study||146
8119185|NCT02959983|20013170|P2|STARTED|Overall Study||174
8119186|NCT02959983|20013171|P1|STARTED|Overall Study||172
8119187|NCT02959970|20013185|P2|NOT COMPLETED|Overall Study||7
8119188|NCT02959970|20013186|P1|NOT COMPLETED|Overall Study||2
8119189|NCT02959970|20013185|P2|COMPLETED|Overall Study||76
8119190|NCT02959970|20013186|P1|COMPLETED|Overall Study||15
8119191|NCT02959970|20013185|P2|STARTED|Overall Study||83
8119192|NCT02959970|20013186|P1|STARTED|Overall Study||17
8119199|NCT02959866|20013229|P1|NOT COMPLETED|Overall Study||1
8119200|NCT02959866|20013229|P1|COMPLETED|Overall Study||58
8119201|NCT02959866|20013229|P1|Telephone Interview at 1 Month Follow-up|Overall Study||59
8119202|NCT02959866|20013229|P1|STARTED|Overall Study||59
8119203|NCT02959853|20013236|P2|NOT COMPLETED|Overall Study||2
8119204|NCT02959853|20013237|P1|NOT COMPLETED|Overall Study||4
8119205|NCT02959853|20013236|P2|COMPLETED|Overall Study||10
8119206|NCT02959853|20013237|P1|COMPLETED|Overall Study||7
8119207|NCT02959853|20013236|P2|STARTED|Overall Study||12
8119208|NCT02959853|20013237|P1|STARTED|Overall Study||11
8119209|NCT02959840|20013256|P3|NOT COMPLETED|Overall Study||0
8119210|NCT02959840|20013257|P2|NOT COMPLETED|Overall Study||0
8119211|NCT02959840|20013258|P1|NOT COMPLETED|Overall Study||0
8119212|NCT02959840|20013256|P3|COMPLETED|Overall Study||60
8119213|NCT02959840|20013257|P2|COMPLETED|Overall Study||60
8119214|NCT02959840|20013258|P1|COMPLETED|Overall Study||60
8119215|NCT02959840|20013256|P3|STARTED|Overall Study||60
8119216|NCT02959840|20013257|P2|STARTED|Overall Study||60
8119217|NCT02959840|20013258|P1|STARTED|Overall Study||60
8119218|NCT02959827|20013299|P1|NOT COMPLETED|Overall Study||0
8119219|NCT02959827|20013299|P1|COMPLETED|Overall Study||2320
8119220|NCT02959827|20013299|P1|STARTED|Overall Study||2320
8119221|NCT02959814|20013318|P1|NOT COMPLETED|Overall Study||57
8119222|NCT02959814|20013318|P1|COMPLETED|Overall Study|17-10-2017|272
8119223|NCT02959814|20013318|P1|STARTED|Overall Study|22-02-2017|329
8119224|NCT02959671|20013337|P1|NOT COMPLETED|Overall Study||5
8119225|NCT02959671|20013337|P1|COMPLETED|Overall Study||29
8119226|NCT02959671|20013337|P1|STARTED|Overall Study||34
8119239|NCT02959307|20013366|P2|NOT COMPLETED|Phase 2||0
8119240|NCT02959307|20013367|P1|NOT COMPLETED|Phase 2||2
8119241|NCT02959307|20013366|P2|COMPLETED|Phase 2||10
8119242|NCT02959307|20013367|P1|COMPLETED|Phase 2||26
8119243|NCT02959307|20013366|P2|STARTED|Phase 2|This group is decreased as those in sham were re-randomized to sham or NIR.|10
8119244|NCT02959307|20013367|P1|STARTED|Phase 2|This group is increased as those in sham were re-randomized to sham or NIR.|28
8119245|NCT02959307|20013366|P2|NOT COMPLETED|Phase 1||8
8119246|NCT02959307|20013367|P1|NOT COMPLETED|Phase 1||3
8119247|NCT02959307|20013366|P2|COMPLETED|Phase 1||23
8119248|NCT02959307|20013367|P1|COMPLETED|Phase 1||15
8119249|NCT02959307|20013366|P2|STARTED|Phase 1||31
8119250|NCT02959307|20013367|P1|STARTED|Phase 1||18
8119251|NCT02959190|20013385|P4|NOT COMPLETED|Post Treatment Follow Up||0
8119252|NCT02959190|20013386|P3|NOT COMPLETED|Post Treatment Follow Up||1
8119253|NCT02959190|20013387|P2|NOT COMPLETED|Post Treatment Follow Up||1
8119254|NCT02959190|20013388|P1|NOT COMPLETED|Post Treatment Follow Up||3
8119255|NCT02959190|20013385|P4|COMPLETED|Post Treatment Follow Up||32
8119256|NCT02959190|20013386|P3|COMPLETED|Post Treatment Follow Up||31
8119257|NCT02959190|20013387|P2|COMPLETED|Post Treatment Follow Up||119
8119258|NCT02959190|20013388|P1|COMPLETED|Post Treatment Follow Up||114
8119259|NCT02959190|20013385|P4|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
8119260|NCT02959190|20013386|P3|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
8119261|NCT02959190|20013387|P2|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|120
8119262|NCT02959190|20013388|P1|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|117
8119263|NCT02959190|20013385|P4|NOT COMPLETED|Open Label||6
8119264|NCT02959190|20013386|P3|NOT COMPLETED|Open Label||4
8119265|NCT02959190|20013387|P2|NOT COMPLETED|Open Label||16
8119266|NCT02959190|20013388|P1|NOT COMPLETED|Open Label||7
8119267|NCT02959190|20013385|P4|COMPLETED|Open Label||27
8119268|NCT02959190|20013386|P3|COMPLETED|Open Label||28
8119269|NCT02959190|20013387|P2|COMPLETED|Open Label||110
8119270|NCT02959190|20013388|P1|COMPLETED|Open Label||113
8119271|NCT02959190|20013385|P4|Placebo/ 240mg Galcanezumab - EM|Open Label||0
8119272|NCT02959190|20013386|P3|Placebo/ 240mg Galcanezumab - EM|Open Label||0
8119273|NCT02959190|20013387|P2|Placebo/ 240mg Galcanezumab - EM|Open Label||64
8119274|NCT02959190|20013388|P1|Placebo/ 240mg Galcanezumab - EM|Open Label||0
8119275|NCT02959190|20013385|P4|Placebo/ 120mg Galcanezumab - EM|Open Label||0
8119276|NCT02959190|20013386|P3|Placebo/ 120mg Galcanezumab - EM|Open Label||0
8119277|NCT02959190|20013387|P2|Placebo/ 120mg Galcanezumab - EM|Open Label||0
8119278|NCT02959190|20013388|P1|Placebo/ 120mg Galcanezumab - EM|Open Label||62
8119279|NCT02959190|20013385|P4|240mg/240mg Galcanezumab - EM|Open Label||0
8119280|NCT02959190|20013386|P3|240mg/240mg Galcanezumab - EM|Open Label||0
8119281|NCT02959190|20013387|P2|240mg/240mg Galcanezumab - EM|Open Label||62
8119282|NCT02959190|20013388|P1|240mg/240mg Galcanezumab - EM|Open Label||0
8119283|NCT02959190|20013385|P4|120mg/120mg Galcanezumab - EM|Open Label||0
8119284|NCT02959190|20013386|P3|120mg/120mg Galcanezumab - EM|Open Label||0
8119285|NCT02959190|20013387|P2|120mg/120mg Galcanezumab - EM|Open Label||0
8119286|NCT02959190|20013388|P1|120mg/120mg Galcanezumab - EM|Open Label||58
8119287|NCT02959190|20013385|P4|Received at Least 1 Dose of Study Drug|Open Label||33
8119288|NCT02959190|20013386|P3|Received at Least 1 Dose of Study Drug|Open Label||32
8119289|NCT02959190|20013387|P2|Received at Least 1 Dose of Study Drug|Open Label||126
8119290|NCT02959190|20013388|P1|Received at Least 1 Dose of Study Drug|Open Label||120
8119291|NCT02959190|20013385|P4|STARTED|Open Label||33
8119292|NCT02959190|20013386|P3|STARTED|Open Label||32
8119293|NCT02959190|20013387|P2|STARTED|Open Label||126
8119294|NCT02959190|20013388|P1|STARTED|Open Label||120
8119316|NCT02959138|20013538|P3|NOT COMPLETED|Overall Study||0
8119317|NCT02959138|20013539|P2|NOT COMPLETED|Overall Study||1
8119318|NCT02959138|20013540|P1|NOT COMPLETED|Overall Study||0
8119319|NCT02959138|20013538|P3|COMPLETED|Overall Study||16
8119320|NCT02959138|20013539|P2|COMPLETED|Overall Study||9
8119321|NCT02959138|20013540|P1|COMPLETED|Overall Study||10
8119322|NCT02959138|20013538|P3|STARTED|Overall Study||16
8119323|NCT02959138|20013539|P2|STARTED|Overall Study||10
8119324|NCT02959138|20013540|P1|STARTED|Overall Study||10
8119325|NCT02958995|20013565|P2|NOT COMPLETED|Overall Study||0
8119326|NCT02958995|20013566|P1|NOT COMPLETED|Overall Study||0
8119327|NCT02958995|20013565|P2|COMPLETED|Overall Study||107495
8119328|NCT02958995|20013566|P1|COMPLETED|Overall Study||2630666
8119329|NCT02958995|20013565|P2|STARTED|Overall Study||107495
8119330|NCT02958995|20013566|P1|STARTED|Overall Study||2630666
8119331|NCT02958982|20013585|P11|NOT COMPLETED|Proof of Concept Study||0
8119332|NCT02958982|20013586|P10|NOT COMPLETED|Proof of Concept Study||0
8119333|NCT02958982|20013587|P9|NOT COMPLETED|Proof of Concept Study||0
8119334|NCT02958982|20013588|P8|NOT COMPLETED|Proof of Concept Study||0
8119335|NCT02958982|20013589|P7|NOT COMPLETED|Proof of Concept Study||0
8119336|NCT02958982|20013590|P6|NOT COMPLETED|Proof of Concept Study||0
8119337|NCT02958982|20013591|P5|NOT COMPLETED|Proof of Concept Study||0
8119338|NCT02958982|20013592|P4|NOT COMPLETED|Proof of Concept Study||0
8119339|NCT02958982|20013593|P3|NOT COMPLETED|Proof of Concept Study||0
8119340|NCT02958982|20013594|P2|NOT COMPLETED|Proof of Concept Study||0
8119341|NCT02958982|20013595|P1|NOT COMPLETED|Proof of Concept Study||0
8119342|NCT02958982|20013585|P11|COMPLETED|Proof of Concept Study||1
8119343|NCT02958982|20013586|P10|COMPLETED|Proof of Concept Study||0
8119344|NCT02958982|20013587|P9|COMPLETED|Proof of Concept Study||0
8119345|NCT02958982|20013588|P8|COMPLETED|Proof of Concept Study||0
8119346|NCT02958982|20013589|P7|COMPLETED|Proof of Concept Study||0
8119347|NCT02958982|20013590|P6|COMPLETED|Proof of Concept Study||0
8119348|NCT02958982|20013591|P5|COMPLETED|Proof of Concept Study||0
8119349|NCT02958982|20013592|P4|COMPLETED|Proof of Concept Study||0
8119350|NCT02958982|20013593|P3|COMPLETED|Proof of Concept Study||0
8119351|NCT02958982|20013594|P2|COMPLETED|Proof of Concept Study||0
8119352|NCT02958982|20013595|P1|COMPLETED|Proof of Concept Study||0
8119353|NCT02958982|20013585|P11|STARTED|Proof of Concept Study||1
8119354|NCT02958982|20013586|P10|STARTED|Proof of Concept Study||0
8119355|NCT02958982|20013587|P9|STARTED|Proof of Concept Study||0
8119356|NCT02958982|20013588|P8|STARTED|Proof of Concept Study||0
8119357|NCT02958982|20013589|P7|STARTED|Proof of Concept Study||0
8119358|NCT02958982|20013590|P6|STARTED|Proof of Concept Study||0
8119359|NCT02958982|20013591|P5|STARTED|Proof of Concept Study||0
8119360|NCT02958982|20013592|P4|STARTED|Proof of Concept Study||0
8119361|NCT02958982|20013593|P3|STARTED|Proof of Concept Study||0
8119362|NCT02958982|20013594|P2|STARTED|Proof of Concept Study||0
8119363|NCT02958982|20013595|P1|STARTED|Proof of Concept Study||0
8119364|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119365|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119366|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119367|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119368|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119369|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119370|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119371|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119372|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119373|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119374|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119375|NCT02958982|20013585|P11|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119376|NCT02958982|20013586|P10|COMPLETED|Cohort 3: 400 mg in MAD Study||6
8119377|NCT02958982|20013587|P9|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119378|NCT02958982|20013588|P8|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119379|NCT02958982|20013589|P7|COMPLETED|Cohort 3: 400 mg in MAD Study||2
8119380|NCT02958982|20013590|P6|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119381|NCT02958982|20013591|P5|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119382|NCT02958982|20013592|P4|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119383|NCT02958982|20013593|P3|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119384|NCT02958982|20013594|P2|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119385|NCT02958982|20013595|P1|COMPLETED|Cohort 3: 400 mg in MAD Study||0
8119386|NCT02958982|20013585|P11|STARTED|Cohort 3: 400 mg in MAD Study||0
8119387|NCT02958982|20013586|P10|STARTED|Cohort 3: 400 mg in MAD Study||6
8119388|NCT02958982|20013587|P9|STARTED|Cohort 3: 400 mg in MAD Study||0
8119389|NCT02958982|20013588|P8|STARTED|Cohort 3: 400 mg in MAD Study||0
8119390|NCT02958982|20013589|P7|STARTED|Cohort 3: 400 mg in MAD Study||2
8119391|NCT02958982|20013590|P6|STARTED|Cohort 3: 400 mg in MAD Study||0
8119392|NCT02958982|20013591|P5|STARTED|Cohort 3: 400 mg in MAD Study||0
8119393|NCT02958982|20013592|P4|STARTED|Cohort 3: 400 mg in MAD Study||0
8119394|NCT02958982|20013593|P3|STARTED|Cohort 3: 400 mg in MAD Study||0
8119395|NCT02958982|20013594|P2|STARTED|Cohort 3: 400 mg in MAD Study||0
8119396|NCT02958982|20013595|P1|STARTED|Cohort 3: 400 mg in MAD Study||0
8119397|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119398|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119399|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119400|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119401|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119402|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119403|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119404|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119405|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119406|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119407|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119408|NCT02958982|20013585|P11|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119409|NCT02958982|20013586|P10|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119410|NCT02958982|20013587|P9|COMPLETED|Cohort 2: 100 mg in MAD Study||6
8119411|NCT02958982|20013588|P8|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119412|NCT02958982|20013589|P7|COMPLETED|Cohort 2: 100 mg in MAD Study||2
8119413|NCT02958982|20013590|P6|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119414|NCT02958982|20013591|P5|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119415|NCT02958982|20013592|P4|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119416|NCT02958982|20013593|P3|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119417|NCT02958982|20013594|P2|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119418|NCT02958982|20013595|P1|COMPLETED|Cohort 2: 100 mg in MAD Study||0
8119419|NCT02958982|20013585|P11|STARTED|Cohort 2: 100 mg in MAD Study||0
8119420|NCT02958982|20013586|P10|STARTED|Cohort 2: 100 mg in MAD Study||0
8119421|NCT02958982|20013587|P9|STARTED|Cohort 2: 100 mg in MAD Study||6
8119422|NCT02958982|20013588|P8|STARTED|Cohort 2: 100 mg in MAD Study||0
8119423|NCT02958982|20013589|P7|STARTED|Cohort 2: 100 mg in MAD Study||2
8119424|NCT02958982|20013590|P6|STARTED|Cohort 2: 100 mg in MAD Study||0
8119425|NCT02958982|20013591|P5|STARTED|Cohort 2: 100 mg in MAD Study||0
8119426|NCT02958982|20013592|P4|STARTED|Cohort 2: 100 mg in MAD Study||0
8119427|NCT02958982|20013593|P3|STARTED|Cohort 2: 100 mg in MAD Study||0
8119428|NCT02958982|20013594|P2|STARTED|Cohort 2: 100 mg in MAD Study||0
8119429|NCT02958982|20013595|P1|STARTED|Cohort 2: 100 mg in MAD Study||0
8119430|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119431|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119432|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119433|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119434|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119435|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119436|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119437|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119438|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119439|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119440|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119441|NCT02958982|20013585|P11|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119442|NCT02958982|20013586|P10|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119443|NCT02958982|20013587|P9|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119444|NCT02958982|20013588|P8|COMPLETED|Cohort 1 : 25 mg in MAD Study||6
8119445|NCT02958982|20013589|P7|COMPLETED|Cohort 1 : 25 mg in MAD Study||2
8119446|NCT02958982|20013590|P6|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119447|NCT02958982|20013591|P5|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119448|NCT02958982|20013592|P4|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119449|NCT02958982|20013593|P3|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119450|NCT02958982|20013594|P2|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119451|NCT02958982|20013595|P1|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
8119452|NCT02958982|20013585|P11|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119453|NCT02958982|20013586|P10|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119454|NCT02958982|20013587|P9|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119455|NCT02958982|20013588|P8|STARTED|Cohort 1 : 25 mg in MAD Study||6
8119456|NCT02958982|20013589|P7|STARTED|Cohort 1 : 25 mg in MAD Study||2
8119457|NCT02958982|20013590|P6|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119458|NCT02958982|20013591|P5|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119459|NCT02958982|20013592|P4|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119460|NCT02958982|20013593|P3|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119461|NCT02958982|20013594|P2|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119462|NCT02958982|20013595|P1|STARTED|Cohort 1 : 25 mg in MAD Study||0
8119463|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119464|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119465|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119466|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119467|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119468|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119469|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119470|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119471|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119472|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119473|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119474|NCT02958982|20013585|P11|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119475|NCT02958982|20013586|P10|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119476|NCT02958982|20013587|P9|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119477|NCT02958982|20013588|P8|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119478|NCT02958982|20013589|P7|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119479|NCT02958982|20013590|P6|COMPLETED|Cohort 5: 400 mg in SAD Study||6
8119480|NCT02958982|20013591|P5|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119481|NCT02958982|20013592|P4|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119482|NCT02958982|20013593|P3|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119483|NCT02958982|20013594|P2|COMPLETED|Cohort 5: 400 mg in SAD Study||0
8119484|NCT02958982|20013595|P1|COMPLETED|Cohort 5: 400 mg in SAD Study||2
8119485|NCT02958982|20013585|P11|STARTED|Cohort 5: 400 mg in SAD Study||0
8119486|NCT02958982|20013586|P10|STARTED|Cohort 5: 400 mg in SAD Study||0
8119487|NCT02958982|20013587|P9|STARTED|Cohort 5: 400 mg in SAD Study||0
8119488|NCT02958982|20013588|P8|STARTED|Cohort 5: 400 mg in SAD Study||0
8119489|NCT02958982|20013589|P7|STARTED|Cohort 5: 400 mg in SAD Study||0
8119490|NCT02958982|20013590|P6|STARTED|Cohort 5: 400 mg in SAD Study||6
8119491|NCT02958982|20013591|P5|STARTED|Cohort 5: 400 mg in SAD Study||0
8119492|NCT02958982|20013592|P4|STARTED|Cohort 5: 400 mg in SAD Study||0
8119493|NCT02958982|20013593|P3|STARTED|Cohort 5: 400 mg in SAD Study||0
8119494|NCT02958982|20013594|P2|STARTED|Cohort 5: 400 mg in SAD Study||0
8119495|NCT02958982|20013595|P1|STARTED|Cohort 5: 400 mg in SAD Study||2
8119496|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119497|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119498|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119499|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119500|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119501|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119502|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119503|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119504|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119505|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119506|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119507|NCT02958982|20013585|P11|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119508|NCT02958982|20013586|P10|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119509|NCT02958982|20013587|P9|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119510|NCT02958982|20013588|P8|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119511|NCT02958982|20013589|P7|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119512|NCT02958982|20013590|P6|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119513|NCT02958982|20013591|P5|COMPLETED|Cohort 4: 200 mg in SAD Study||6
8119514|NCT02958982|20013592|P4|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119515|NCT02958982|20013593|P3|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119516|NCT02958982|20013594|P2|COMPLETED|Cohort 4: 200 mg in SAD Study||0
8119517|NCT02958982|20013595|P1|COMPLETED|Cohort 4: 200 mg in SAD Study||2
8119518|NCT02958982|20013585|P11|STARTED|Cohort 4: 200 mg in SAD Study||0
8119519|NCT02958982|20013586|P10|STARTED|Cohort 4: 200 mg in SAD Study||0
8119520|NCT02958982|20013587|P9|STARTED|Cohort 4: 200 mg in SAD Study||0
8119521|NCT02958982|20013588|P8|STARTED|Cohort 4: 200 mg in SAD Study||0
8119522|NCT02958982|20013589|P7|STARTED|Cohort 4: 200 mg in SAD Study||0
8119523|NCT02958982|20013590|P6|STARTED|Cohort 4: 200 mg in SAD Study||0
8119524|NCT02958982|20013591|P5|STARTED|Cohort 4: 200 mg in SAD Study||6
8119525|NCT02958982|20013592|P4|STARTED|Cohort 4: 200 mg in SAD Study||0
8119526|NCT02958982|20013593|P3|STARTED|Cohort 4: 200 mg in SAD Study||0
8119527|NCT02958982|20013594|P2|STARTED|Cohort 4: 200 mg in SAD Study||0
8119528|NCT02958982|20013595|P1|STARTED|Cohort 4: 200 mg in SAD Study||2
8119529|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119530|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119531|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119532|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119533|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119534|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119535|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119536|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119537|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119538|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119539|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119540|NCT02958982|20013585|P11|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119541|NCT02958982|20013586|P10|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119542|NCT02958982|20013587|P9|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119543|NCT02958982|20013588|P8|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119544|NCT02958982|20013589|P7|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119545|NCT02958982|20013590|P6|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119546|NCT02958982|20013591|P5|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119547|NCT02958982|20013592|P4|COMPLETED|Cohort 3: 100 mg in SAD Study||4
8119548|NCT02958982|20013593|P3|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119549|NCT02958982|20013594|P2|COMPLETED|Cohort 3: 100 mg in SAD Study||0
8119550|NCT02958982|20013595|P1|COMPLETED|Cohort 3: 100 mg in SAD Study||2
8119551|NCT02958982|20013585|P11|STARTED|Cohort 3: 100 mg in SAD Study||0
8119552|NCT02958982|20013586|P10|STARTED|Cohort 3: 100 mg in SAD Study||0
8119553|NCT02958982|20013587|P9|STARTED|Cohort 3: 100 mg in SAD Study||0
8119554|NCT02958982|20013588|P8|STARTED|Cohort 3: 100 mg in SAD Study||0
8119555|NCT02958982|20013589|P7|STARTED|Cohort 3: 100 mg in SAD Study||0
8119556|NCT02958982|20013590|P6|STARTED|Cohort 3: 100 mg in SAD Study||0
8119557|NCT02958982|20013591|P5|STARTED|Cohort 3: 100 mg in SAD Study||0
8119558|NCT02958982|20013592|P4|STARTED|Cohort 3: 100 mg in SAD Study||4
8119559|NCT02958982|20013593|P3|STARTED|Cohort 3: 100 mg in SAD Study||0
8119560|NCT02958982|20013594|P2|STARTED|Cohort 3: 100 mg in SAD Study||0
8119561|NCT02958982|20013595|P1|STARTED|Cohort 3: 100 mg in SAD Study||2
8119562|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119563|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119564|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119565|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119566|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119567|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119568|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119569|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119570|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119571|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119572|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119573|NCT02958982|20013585|P11|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119574|NCT02958982|20013586|P10|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119575|NCT02958982|20013587|P9|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119576|NCT02958982|20013588|P8|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119577|NCT02958982|20013589|P7|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119578|NCT02958982|20013590|P6|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119579|NCT02958982|20013591|P5|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119580|NCT02958982|20013592|P4|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119581|NCT02958982|20013593|P3|COMPLETED|Cohort 2: 50 mg in SAD Study||4
8119582|NCT02958982|20013594|P2|COMPLETED|Cohort 2: 50 mg in SAD Study||0
8119583|NCT02958982|20013595|P1|COMPLETED|Cohort 2: 50 mg in SAD Study||2
8119584|NCT02958982|20013585|P11|STARTED|Cohort 2: 50 mg in SAD Study||0
8119585|NCT02958982|20013586|P10|STARTED|Cohort 2: 50 mg in SAD Study||0
8119586|NCT02958982|20013587|P9|STARTED|Cohort 2: 50 mg in SAD Study||0
8119587|NCT02958982|20013588|P8|STARTED|Cohort 2: 50 mg in SAD Study||0
8119588|NCT02958982|20013589|P7|STARTED|Cohort 2: 50 mg in SAD Study||0
8119589|NCT02958982|20013590|P6|STARTED|Cohort 2: 50 mg in SAD Study||0
8119590|NCT02958982|20013591|P5|STARTED|Cohort 2: 50 mg in SAD Study||0
8119591|NCT02958982|20013592|P4|STARTED|Cohort 2: 50 mg in SAD Study||0
8119592|NCT02958982|20013593|P3|STARTED|Cohort 2: 50 mg in SAD Study||4
8119593|NCT02958982|20013594|P2|STARTED|Cohort 2: 50 mg in SAD Study||0
8119594|NCT02958982|20013595|P1|STARTED|Cohort 2: 50 mg in SAD Study||2
8119595|NCT02958982|20013585|P11|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119596|NCT02958982|20013586|P10|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119597|NCT02958982|20013587|P9|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119598|NCT02958982|20013588|P8|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119599|NCT02958982|20013589|P7|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119600|NCT02958982|20013590|P6|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119601|NCT02958982|20013591|P5|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119602|NCT02958982|20013592|P4|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119603|NCT02958982|20013593|P3|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119604|NCT02958982|20013594|P2|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119605|NCT02958982|20013595|P1|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119606|NCT02958982|20013585|P11|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119607|NCT02958982|20013586|P10|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119608|NCT02958982|20013587|P9|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119609|NCT02958982|20013588|P8|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119610|NCT02958982|20013589|P7|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119611|NCT02958982|20013590|P6|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119612|NCT02958982|20013591|P5|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119613|NCT02958982|20013592|P4|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119614|NCT02958982|20013593|P3|COMPLETED|Cohort 1: 25 mg in SAD Study||0
8119615|NCT02958982|20013594|P2|COMPLETED|Cohort 1: 25 mg in SAD Study||3
8119616|NCT02958982|20013595|P1|COMPLETED|Cohort 1: 25 mg in SAD Study||1
8119617|NCT02958982|20013585|P11|STARTED|Cohort 1: 25 mg in SAD Study||0
8119618|NCT02958982|20013586|P10|STARTED|Cohort 1: 25 mg in SAD Study||0
8119619|NCT02958982|20013587|P9|STARTED|Cohort 1: 25 mg in SAD Study||0
8119620|NCT02958982|20013588|P8|STARTED|Cohort 1: 25 mg in SAD Study||0
8119621|NCT02958982|20013589|P7|STARTED|Cohort 1: 25 mg in SAD Study||0
8119622|NCT02958982|20013590|P6|STARTED|Cohort 1: 25 mg in SAD Study||0
8119623|NCT02958982|20013591|P5|STARTED|Cohort 1: 25 mg in SAD Study||0
8119624|NCT02958982|20013592|P4|STARTED|Cohort 1: 25 mg in SAD Study||0
8119625|NCT02958982|20013593|P3|STARTED|Cohort 1: 25 mg in SAD Study||0
8119626|NCT02958982|20013594|P2|STARTED|Cohort 1: 25 mg in SAD Study||3
8119627|NCT02958982|20013595|P1|STARTED|Cohort 1: 25 mg in SAD Study||1
8119628|NCT02958969|20013641|P1|NOT COMPLETED|Overall Study||0
8119629|NCT02958969|20013641|P1|COMPLETED|Overall Study||50
8119630|NCT02958969|20013641|P1|STARTED|Overall Study||50
8119631|NCT02958956|20013650|P2|NOT COMPLETED|Overall Study||0
8119632|NCT02958956|20013651|P1|NOT COMPLETED|Overall Study||0
8119633|NCT02958956|20013650|P2|COMPLETED|Overall Study||198317
8119634|NCT02958956|20013651|P1|COMPLETED|Overall Study||38190
8119635|NCT02958956|20013650|P2|STARTED|Overall Study||198317
8119636|NCT02958956|20013651|P1|STARTED|Overall Study||38190
8119637|NCT02958826|20013666|P2|NOT COMPLETED|Overall Study||0
8119638|NCT02958826|20013667|P1|NOT COMPLETED|Overall Study||0
8119639|NCT02958826|20013666|P2|COMPLETED|Overall Study||80
8119640|NCT02958826|20013667|P1|COMPLETED|Overall Study||80
8119641|NCT02958826|20013666|P2|STARTED|Overall Study||80
8119642|NCT02958826|20013667|P1|STARTED|Overall Study||80
8119643|NCT02958787|20013677|P1|NOT COMPLETED|Overall Study||0
8119644|NCT02958787|20013677|P1|COMPLETED|Overall Study||135
8119645|NCT02958787|20013677|P1|STARTED|Overall Study||135
8119646|NCT02958553|20013681|P1|NOT COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||0
8119647|NCT02958553|20013681|P1|COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||2
8119648|NCT02958553|20013681|P1|STARTED|Phase II, 7th Visit -12 Month emPOWER FU||2
8119649|NCT02958553|20013681|P1|NOT COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
8119650|NCT02958553|20013681|P1|COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
8119651|NCT02958553|20013681|P1|STARTED|Phase II, 6th Visit -6 Month emPOWER FU||4
8119652|NCT02958553|20013681|P1|NOT COMPLETED|Phase II, 5th Visit -Crossover Visit||0
8119653|NCT02958553|20013681|P1|COMPLETED|Phase II, 5th Visit -Crossover Visit||4
8119654|NCT02958553|20013681|P1|STARTED|Phase II, 5th Visit -Crossover Visit||4
8119655|NCT02958553|20013681|P1|NOT COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||3
8119656|NCT02958553|20013681|P1|COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||4
8119657|NCT02958553|20013681|P1|STARTED|Phase II, 4th Visit -3 Month emPOWER FU|Only 4 subjects started Phase II of the study. Phase II was optional per protocol.|7
8119658|NCT02958553|20013681|P1|NOT COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||1
8119659|NCT02958553|20013681|P1|COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||7
8119660|NCT02958553|20013681|P1|STARTED|Phase I, 3rd Visit -2 Week emPOWER FU||8
8119661|NCT02958553|20013681|P1|NOT COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||0
8119662|NCT02958553|20013681|P1|COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||8
8119663|NCT02958553|20013681|P1|STARTED|Phase I, 2nd Visit -Fitted With emPOWER||8
8119664|NCT02958553|20013681|P1|NOT COMPLETED|Phase I, 1st Visit -Passive Prosthesis||0
8119665|NCT02958553|20013681|P1|COMPLETED|Phase I, 1st Visit -Passive Prosthesis||8
8119666|NCT02958553|20013681|P1|STARTED|Phase I, 1st Visit -Passive Prosthesis||8
8119667|NCT02958345|20013704|P2|NOT COMPLETED|Overall Study||1
8119668|NCT02958345|20013705|P1|NOT COMPLETED|Overall Study||1
8119669|NCT02958345|20013704|P2|COMPLETED|Overall Study||13
8119670|NCT02958345|20013705|P1|COMPLETED|Overall Study||13
8119671|NCT02958345|20013704|P2|STARTED|Overall Study||14
8119672|NCT02958345|20013705|P1|STARTED|Overall Study||14
8119673|NCT02958267|20013715|P2|NOT COMPLETED|Follow-up Visits||1
8119674|NCT02958267|20013716|P1|NOT COMPLETED|Follow-up Visits||2
8119675|NCT02958267|20013715|P2|COMPLETED|Follow-up Visits||14
8119676|NCT02958267|20013716|P1|COMPLETED|Follow-up Visits||13
8119677|NCT02958267|20013715|P2|12 Month Follow-up|Follow-up Visits||14
8119678|NCT02958267|20013716|P1|12 Month Follow-up|Follow-up Visits||13
8119679|NCT02958267|20013715|P2|6 Month Follow-up|Follow-up Visits||14
8119680|NCT02958267|20013716|P1|6 Month Follow-up|Follow-up Visits||14
8119681|NCT02958267|20013715|P2|3 Month Follow-up|Follow-up Visits||15
8119682|NCT02958267|20013716|P1|3 Month Follow-up|Follow-up Visits||15
8119683|NCT02958267|20013715|P2|STARTED|Follow-up Visits||15
8119684|NCT02958267|20013716|P1|STARTED|Follow-up Visits||15
8119685|NCT02958267|20013715|P2|NOT COMPLETED|Enrollment to Actual Treatment Complete||0
8119686|NCT02958267|20013716|P1|NOT COMPLETED|Enrollment to Actual Treatment Complete||2
8119687|NCT02958267|20013715|P2|COMPLETED|Enrollment to Actual Treatment Complete||15
8119688|NCT02958267|20013716|P1|COMPLETED|Enrollment to Actual Treatment Complete||15
8119689|NCT02958267|20013715|P2|STARTED|Enrollment to Actual Treatment Complete||15
8119690|NCT02958267|20013716|P1|STARTED|Enrollment to Actual Treatment Complete||17
8119691|NCT02958267|20013715|P2|NOT COMPLETED|Enrollment||0
8119692|NCT02958267|20013716|P1|NOT COMPLETED|Enrollment||0
8119693|NCT02958267|20013715|P2|COMPLETED|Enrollment||15
8119694|NCT02958267|20013716|P1|COMPLETED|Enrollment||17
8119695|NCT02958267|20013715|P2|STARTED|Enrollment||15
8119696|NCT02958267|20013716|P1|STARTED|Enrollment||17
8119697|NCT02957942|20013728|P2|NOT COMPLETED|Overall Study||7
8119698|NCT02957942|20013729|P1|NOT COMPLETED|Overall Study||0
8119699|NCT02957942|20013728|P2|COMPLETED|Overall Study||6
8119700|NCT02957942|20013729|P1|COMPLETED|Overall Study||7
8119701|NCT02957942|20013728|P2|STARTED|Overall Study|7 healthy individuals were recruited as control; 6 were recruited for practicing experiment details.|13
8119702|NCT02957942|20013729|P1|STARTED|Overall Study||7
8119703|NCT02957747|20013745|P2|NOT COMPLETED|Overall Study||8
8119704|NCT02957747|20013746|P1|NOT COMPLETED|Overall Study||10
8119705|NCT02957747|20013745|P2|COMPLETED|Overall Study||69
8119706|NCT02957747|20013746|P1|COMPLETED|Overall Study||66
8119707|NCT02957747|20013745|P2|STARTED|Overall Study||77
8119708|NCT02957747|20013746|P1|STARTED|Overall Study||76
8119709|NCT02957331|20013782|P2|NOT COMPLETED|Overall Study||0
8119710|NCT02957331|20013783|P1|NOT COMPLETED|Overall Study||1
8119711|NCT02957331|20013782|P2|COMPLETED|Overall Study||12
8119712|NCT02957331|20013783|P1|COMPLETED|Overall Study||13
8119713|NCT02957331|20013782|P2|STARTED|Overall Study||12
8119714|NCT02957331|20013783|P1|STARTED|Overall Study||14
8119721|NCT02956967|20013802|P1|NOT COMPLETED|Overall Study||48
8119722|NCT02956967|20013802|P1|COMPLETED|Overall Study||123
8119723|NCT02956967|20013802|P1|STARTED|Overall Study||171
8119724|NCT02956837|20013829|P4|NOT COMPLETED|Overall Study||3
8119725|NCT02956837|20013830|P3|NOT COMPLETED|Overall Study||2
8119726|NCT02956837|20013831|P2|NOT COMPLETED|Overall Study||3
8119727|NCT02956837|20013832|P1|NOT COMPLETED|Overall Study||0
8119728|NCT02956837|20013829|P4|COMPLETED|Overall Study||99
8119729|NCT02956837|20013830|P3|COMPLETED|Overall Study||97
8119730|NCT02956837|20013831|P2|COMPLETED|Overall Study||96
8119731|NCT02956837|20013832|P1|COMPLETED|Overall Study||100
8119732|NCT02956837|20013829|P4|STARTED|Overall Study||102
8119733|NCT02956837|20013830|P3|STARTED|Overall Study||99
8119734|NCT02956837|20013831|P2|STARTED|Overall Study||99
8119735|NCT02956837|20013832|P1|STARTED|Overall Study||100
8119736|NCT02956746|20013926|P4|NOT COMPLETED|Overall Study||4
8119737|NCT02956746|20013927|P3|NOT COMPLETED|Overall Study||6
8119738|NCT02956746|20013928|P2|NOT COMPLETED|Overall Study||3
8119739|NCT02956746|20013929|P1|NOT COMPLETED|Overall Study||2
8119740|NCT02956746|20013926|P4|COMPLETED|Overall Study||38
8119741|NCT02956746|20013927|P3|COMPLETED|Overall Study||36
8119742|NCT02956746|20013928|P2|COMPLETED|Overall Study||37
8119743|NCT02956746|20013929|P1|COMPLETED|Overall Study||38
8119744|NCT02956746|20013926|P4|STARTED|Overall Study||42
8119745|NCT02956746|20013927|P3|STARTED|Overall Study||42
8119746|NCT02956746|20013928|P2|STARTED|Overall Study||40
8119747|NCT02956746|20013929|P1|STARTED|Overall Study||40
8119766|NCT02956616|20014036|P2|NOT COMPLETED|Overall Study||0
8119767|NCT02956616|20014037|P1|NOT COMPLETED|Overall Study||0
8119768|NCT02956616|20014036|P2|COMPLETED|Overall Study||60
8119769|NCT02956616|20014037|P1|COMPLETED|Overall Study||58
8119770|NCT02956616|20014036|P2|STARTED|Overall Study||60
8119771|NCT02956616|20014037|P1|STARTED|Overall Study||58
8119772|NCT02956460|20014051|P2|NOT COMPLETED|Lens 2||0
8119773|NCT02956460|20014052|P1|NOT COMPLETED|Lens 2||0
8119774|NCT02956460|20014051|P2|COMPLETED|Lens 2||34
8119775|NCT02956460|20014052|P1|COMPLETED|Lens 2||29
8119776|NCT02956460|20014051|P2|STARTED|Lens 2||34
8119777|NCT02956460|20014052|P1|STARTED|Lens 2||29
8119778|NCT02956460|20014051|P2|NOT COMPLETED|Lens 1||0
8119779|NCT02956460|20014052|P1|NOT COMPLETED|Lens 1||1
8119780|NCT02956460|20014051|P2|COMPLETED|Lens 1||34
8119781|NCT02956460|20014052|P1|COMPLETED|Lens 1||29
8119782|NCT02956460|20014051|P2|STARTED|Lens 1||34
8119783|NCT02956460|20014052|P1|STARTED|Lens 1||30
8119784|NCT02956278|20014081|P3|NOT COMPLETED|Overall Study||0
8119785|NCT02956278|20014082|P2|NOT COMPLETED|Overall Study||2
8119786|NCT02956278|20014083|P1|NOT COMPLETED|Overall Study||6
8119787|NCT02956278|20014081|P3|COMPLETED|Overall Study||3
8119788|NCT02956278|20014082|P2|COMPLETED|Overall Study||7
8119789|NCT02956278|20014083|P1|COMPLETED|Overall Study||9
8119790|NCT02956278|20014081|P3|STARTED|Overall Study||3
8119791|NCT02956278|20014082|P2|STARTED|Overall Study||9
8119792|NCT02956278|20014083|P1|STARTED|Overall Study||15
8119793|NCT02956122|20014097|P1|NOT COMPLETED|Overall Study||0
8119794|NCT02956122|20014097|P1|COMPLETED|Overall Study||1
8119795|NCT02956122|20014097|P1|STARTED|Overall Study||1
8119796|NCT02956070|20014150|P2|NOT COMPLETED|Overall Study||0
8119797|NCT02956070|20014151|P1|NOT COMPLETED|Overall Study||0
8119798|NCT02956070|20014150|P2|COMPLETED|Overall Study||35
8119799|NCT02956070|20014151|P1|COMPLETED|Overall Study||35
8119800|NCT02956070|20014150|P2|STARTED|Overall Study||35
8119801|NCT02956070|20014151|P1|STARTED|Overall Study||35
8119802|NCT02956057|20014167|P6|NOT COMPLETED|Overall Study||17
8119803|NCT02956057|20014168|P5|NOT COMPLETED|Overall Study||5
8119804|NCT02956057|20014169|P4|NOT COMPLETED|Overall Study||15
8119805|NCT02956057|20014170|P3|NOT COMPLETED|Overall Study||8
8119806|NCT02956057|20014171|P2|NOT COMPLETED|Overall Study||12
8119807|NCT02956057|20014172|P1|NOT COMPLETED|Overall Study||14
8119808|NCT02956057|20014167|P6|COMPLETED|Overall Study||157
8119809|NCT02956057|20014168|P5|COMPLETED|Overall Study||169
8119810|NCT02956057|20014169|P4|COMPLETED|Overall Study||159
8119811|NCT02956057|20014170|P3|COMPLETED|Overall Study||166
8119812|NCT02956057|20014171|P2|COMPLETED|Overall Study||162
8119813|NCT02956057|20014172|P1|COMPLETED|Overall Study||160
8119814|NCT02956057|20014167|P6|STARTED|Overall Study||174
8119815|NCT02956057|20014168|P5|STARTED|Overall Study||174
8119816|NCT02956057|20014169|P4|STARTED|Overall Study||174
8119817|NCT02956057|20014170|P3|STARTED|Overall Study||174
8119818|NCT02956057|20014171|P2|STARTED|Overall Study||174
8119819|NCT02956057|20014172|P1|STARTED|Overall Study||174
8119820|NCT02956005|20014192|P1|NOT COMPLETED|Overall Study||16
8119821|NCT02956005|20014192|P1|COMPLETED|Overall Study||2
8119822|NCT02956005|20014192|P1|STARTED|Overall Study||18
8119823|NCT02955797|20014201|P4|NOT COMPLETED|Overall Study||2
8119824|NCT02955797|20014202|P3|NOT COMPLETED|Overall Study||0
8119825|NCT02955797|20014203|P2|NOT COMPLETED|Overall Study||3
8119826|NCT02955797|20014204|P1|NOT COMPLETED|Overall Study||3
8119827|NCT02955797|20014201|P4|COMPLETED|Overall Study||101
8119828|NCT02955797|20014202|P3|COMPLETED|Overall Study||203
8119829|NCT02955797|20014203|P2|COMPLETED|Overall Study||303
8119830|NCT02955797|20014204|P1|COMPLETED|Overall Study||303
8119831|NCT02955797|20014201|P4|Per Protocol Analysis Set (PPAS)|Overall Study||99
8119832|NCT02955797|20014202|P3|Per Protocol Analysis Set (PPAS)|Overall Study||198
8119833|NCT02955797|20014203|P2|Per Protocol Analysis Set (PPAS)|Overall Study||296
8119834|NCT02955797|20014204|P1|Per Protocol Analysis Set (PPAS)|Overall Study||293
8119835|NCT02955797|20014201|P4|Safety Analysis Set (SafAS)|Overall Study||102
8119836|NCT02955797|20014202|P3|Safety Analysis Set (SafAS)|Overall Study||203
8119837|NCT02955797|20014203|P2|Safety Analysis Set (SafAS)|Overall Study||306
8119838|NCT02955797|20014204|P1|Safety Analysis Set (SafAS)|Overall Study||303
8119839|NCT02955797|20014201|P4|STARTED|Overall Study||103
8119840|NCT02955797|20014202|P3|STARTED|Overall Study||203
8119841|NCT02955797|20014203|P2|STARTED|Overall Study||306
8119842|NCT02955797|20014204|P1|STARTED|Overall Study||306
8119843|NCT02955212|20014222|P2|NOT COMPLETED|Overall Study||12
8119844|NCT02955212|20014223|P1|NOT COMPLETED|Overall Study||16
8119845|NCT02955212|20014222|P2|COMPLETED|Overall Study||157
8119846|NCT02955212|20014223|P1|COMPLETED|Overall Study||153
8119847|NCT02955212|20014222|P2|STARTED|Overall Study||169
8119848|NCT02955212|20014223|P1|STARTED|Overall Study||169
8119849|NCT02955186|20014249|P2|NOT COMPLETED|Overall Study||2
8119850|NCT02955186|20014250|P1|NOT COMPLETED|Overall Study||7
8119851|NCT02955186|20014249|P2|COMPLETED|Overall Study||15
8119852|NCT02955186|20014250|P1|COMPLETED|Overall Study||26
8119853|NCT02955186|20014249|P2|STARTED|Overall Study||17
8119854|NCT02955186|20014250|P1|STARTED|Overall Study||33
8119855|NCT02955147|20014262|P1|NOT COMPLETED|Overall Study||0
8119856|NCT02955147|20014262|P1|COMPLETED|Overall Study||13
8119857|NCT02955147|20014262|P1|STARTED|Overall Study||13
8119858|NCT02954952|20014272|P3|NOT COMPLETED|Overall Study||0
8119859|NCT02954952|20014273|P2|NOT COMPLETED|Overall Study||1
8119860|NCT02954952|20014274|P1|NOT COMPLETED|Overall Study||1
8119861|NCT02954952|20014272|P3|COMPLETED|Overall Study||3
8119862|NCT02954952|20014273|P2|COMPLETED|Overall Study||4
8119863|NCT02954952|20014274|P1|COMPLETED|Overall Study||35
8119864|NCT02954952|20014272|P3|STARTED|Overall Study||3
8119865|NCT02954952|20014273|P2|STARTED|Overall Study||5
8119866|NCT02954952|20014274|P1|STARTED|Overall Study||36
8119867|NCT02954887|20014282|P1|NOT COMPLETED|Overall Study||7
8119868|NCT02954887|20014282|P1|COMPLETED|Overall Study||2
8119869|NCT02954887|20014282|P1|STARTED|Overall Study||9
8119870|NCT02954848|20014311|P2|NOT COMPLETED|Overall Study||5
8119871|NCT02954848|20014312|P1|NOT COMPLETED|Overall Study||2
8119872|NCT02954848|20014311|P2|COMPLETED|Overall Study||234
8119873|NCT02954848|20014312|P1|COMPLETED|Overall Study||243
8119874|NCT02954848|20014311|P2|Treated|Overall Study||238
8119875|NCT02954848|20014312|P1|Treated|Overall Study||245
8119876|NCT02954848|20014311|P2|STARTED|Overall Study||239
8119877|NCT02954848|20014312|P1|STARTED|Overall Study||245
8119878|NCT02954653|20014372|P9|NOT COMPLETED|Overall Study||0
8119879|NCT02954653|20014373|P8|NOT COMPLETED|Overall Study||0
8119880|NCT02954653|20014374|P7|NOT COMPLETED|Overall Study||0
8119881|NCT02954653|20014375|P6|NOT COMPLETED|Overall Study||0
8119882|NCT02954653|20014376|P5|NOT COMPLETED|Overall Study||0
8119883|NCT02954653|20014377|P4|NOT COMPLETED|Overall Study||0
8119884|NCT02954653|20014378|P3|NOT COMPLETED|Overall Study||0
8119885|NCT02954653|20014379|P2|NOT COMPLETED|Overall Study||3
8119886|NCT02954653|20014380|P1|NOT COMPLETED|Overall Study||4
8119887|NCT02954653|20014372|P9|COMPLETED|Overall Study||0
8119888|NCT02954653|20014373|P8|COMPLETED|Overall Study||0
8119889|NCT02954653|20014374|P7|COMPLETED|Overall Study||0
8119890|NCT02954653|20014375|P6|COMPLETED|Overall Study||0
8119891|NCT02954653|20014376|P5|COMPLETED|Overall Study||0
8119892|NCT02954653|20014377|P4|COMPLETED|Overall Study||0
8119893|NCT02954653|20014378|P3|COMPLETED|Overall Study||0
8119894|NCT02954653|20014379|P2|COMPLETED|Overall Study||1
8119895|NCT02954653|20014380|P1|COMPLETED|Overall Study||0
8119896|NCT02954653|20014372|P9|Received Treatment|Overall Study||0
8119897|NCT02954653|20014373|P8|Received Treatment|Overall Study||0
8119898|NCT02954653|20014374|P7|Received Treatment|Overall Study||0
8119899|NCT02954653|20014375|P6|Received Treatment|Overall Study||0
8119900|NCT02954653|20014376|P5|Received Treatment|Overall Study||0
8119901|NCT02954653|20014377|P4|Received Treatment|Overall Study||0
8119902|NCT02954653|20014378|P3|Received Treatment|Overall Study||0
8119903|NCT02954653|20014379|P2|Received Treatment|Overall Study||4
8119904|NCT02954653|20014380|P1|Received Treatment|Overall Study||3
8119905|NCT02954653|20014372|P9|STARTED|Overall Study|No participants were enrolled in this arm.|0
8119906|NCT02954653|20014373|P8|STARTED|Overall Study|No participants were enrolled in this arm.|0
8119907|NCT02954653|20014374|P7|STARTED|Overall Study|No participants were enrolled in this arm.|0
8119908|NCT02954653|20014375|P6|STARTED|Overall Study|No participants were enrolled in this arm.|0
8119909|NCT02954653|20014376|P5|STARTED|Overall Study|No participants were enrolled in this arm.|0
8119910|NCT02954653|20014377|P4|STARTED|Overall Study|No participants were enrolled in this arm.|0
8119911|NCT02954653|20014378|P3|STARTED|Overall Study|No participants were enrolled in this arm.|0
8119912|NCT02954653|20014379|P2|STARTED|Overall Study||4
8119913|NCT02954653|20014380|P1|STARTED|Overall Study||4
8119914|NCT02954601|20014499|P4|NOT COMPLETED|Third Intervention (Five Days)||0
8119915|NCT02954601|20014500|P3|NOT COMPLETED|Third Intervention (Five Days)||0
8119916|NCT02954601|20014501|P2|NOT COMPLETED|Third Intervention (Five Days)||0
8119917|NCT02954601|20014502|P1|NOT COMPLETED|Third Intervention (Five Days)||0
8119918|NCT02954601|20014499|P4|COMPLETED|Third Intervention (Five Days)||8
8119919|NCT02954601|20014500|P3|COMPLETED|Third Intervention (Five Days)||6
8119920|NCT02954601|20014501|P2|COMPLETED|Third Intervention (Five Days)||8
8119921|NCT02954601|20014502|P1|COMPLETED|Third Intervention (Five Days)||9
8119922|NCT02954601|20014499|P4|STARTED|Third Intervention (Five Days)||8
8119923|NCT02954601|20014500|P3|STARTED|Third Intervention (Five Days)||6
8119924|NCT02954601|20014501|P2|STARTED|Third Intervention (Five Days)||8
8119925|NCT02954601|20014502|P1|STARTED|Third Intervention (Five Days)||9
8119926|NCT02954601|20014499|P4|NOT COMPLETED|Second Intervention (Five Days)||0
8119927|NCT02954601|20014500|P3|NOT COMPLETED|Second Intervention (Five Days)||0
8119928|NCT02954601|20014501|P2|NOT COMPLETED|Second Intervention (Five Days)||0
8119929|NCT02954601|20014502|P1|NOT COMPLETED|Second Intervention (Five Days)||0
8119930|NCT02954601|20014499|P4|COMPLETED|Second Intervention (Five Days)||6
8119931|NCT02954601|20014500|P3|COMPLETED|Second Intervention (Five Days)||8
8119932|NCT02954601|20014501|P2|COMPLETED|Second Intervention (Five Days)||6
8119933|NCT02954601|20014502|P1|COMPLETED|Second Intervention (Five Days)||11
8119934|NCT02954601|20014499|P4|STARTED|Second Intervention (Five Days)||6
8119935|NCT02954601|20014500|P3|STARTED|Second Intervention (Five Days)||8
8119936|NCT02954601|20014501|P2|STARTED|Second Intervention (Five Days)||6
8119937|NCT02954601|20014502|P1|STARTED|Second Intervention (Five Days)||11
8119938|NCT02954601|20014499|P4|NOT COMPLETED|First Intervention (Five Days)||0
8119939|NCT02954601|20014500|P3|NOT COMPLETED|First Intervention (Five Days)||1
8119940|NCT02954601|20014501|P2|NOT COMPLETED|First Intervention (Five Days)||0
8119941|NCT02954601|20014502|P1|NOT COMPLETED|First Intervention (Five Days)||0
8119942|NCT02954601|20014499|P4|COMPLETED|First Intervention (Five Days)||7
8119943|NCT02954601|20014500|P3|COMPLETED|First Intervention (Five Days)||7
8119944|NCT02954601|20014501|P2|COMPLETED|First Intervention (Five Days)||6
8119945|NCT02954601|20014502|P1|COMPLETED|First Intervention (Five Days)||11
8119946|NCT02954601|20014499|P4|STARTED|First Intervention (Five Days)||7
8119947|NCT02954601|20014500|P3|STARTED|First Intervention (Five Days)||8
8119948|NCT02954601|20014501|P2|STARTED|First Intervention (Five Days)||6
8119949|NCT02954601|20014502|P1|STARTED|First Intervention (Five Days)||11
8119950|NCT02954575|20014524|P1|NOT COMPLETED|Overall Study||3
8119951|NCT02954575|20014524|P1|COMPLETED|Overall Study||54
8119952|NCT02954575|20014524|P1|SURG Population|Overall Study||1
8119953|NCT02954575|20014524|P1|PK Population|Overall Study||21
8119954|NCT02954575|20014524|P1|PP Population|Overall Study||52
8119955|NCT02954575|20014524|P1|FAS Population|Overall Study||55
8119956|NCT02954575|20014524|P1|SAF Population|Overall Study||55
8119957|NCT02954575|20014524|P1|Received Treatment|Overall Study||55
8119958|NCT02954575|20014524|P1|STARTED|Overall Study||57
8119959|NCT02954354|20014544|P3|NOT COMPLETED|Overall Study||16
8119960|NCT02954354|20014545|P2|NOT COMPLETED|Overall Study||20
8119961|NCT02954354|20014546|P1|NOT COMPLETED|Overall Study||34
8119962|NCT02954354|20014544|P3|COMPLETED|Overall Study||498
8119963|NCT02954354|20014545|P2|COMPLETED|Overall Study||290
8119964|NCT02954354|20014546|P1|COMPLETED|Overall Study||578
8119965|NCT02954354|20014544|P3|Intention to Treat Infected Population|Overall Study||377
8119966|NCT02954354|20014545|P2|Intention to Treat Infected Population|Overall Study||231
8119967|NCT02954354|20014546|P1|Intention to Treat Infected Population|Overall Study||456
8119968|NCT02954354|20014544|P3|Received Study Drug|Overall Study||513
8119969|NCT02954354|20014545|P2|Received Study Drug|Overall Study||309
8119970|NCT02954354|20014546|P1|Received Study Drug|Overall Study||610
8119971|NCT02954354|20014544|P3|STARTED|Overall Study||514
8119972|NCT02954354|20014545|P2|STARTED|Overall Study||310
8119973|NCT02954354|20014546|P1|STARTED|Overall Study||612
8119974|NCT02954198|20014632|P2|NOT COMPLETED|Overall Study||0
8119975|NCT02954198|20014633|P1|NOT COMPLETED|Overall Study||0
8119976|NCT02954198|20014632|P2|COMPLETED|Overall Study||20
8119977|NCT02954198|20014633|P1|COMPLETED|Overall Study||20
8119978|NCT02954198|20014632|P2|STARTED|Overall Study||20
8119979|NCT02954198|20014633|P1|STARTED|Overall Study||20
8119980|NCT02954172|20014647|P2|NOT COMPLETED|Overall Study||3
8119981|NCT02954172|20014648|P1|NOT COMPLETED|Overall Study||6
8119982|NCT02954172|20014647|P2|COMPLETED|Overall Study||221
8119983|NCT02954172|20014648|P1|COMPLETED|Overall Study||220
8119984|NCT02954172|20014647|P2|STARTED|Overall Study||224
8119985|NCT02954172|20014648|P1|STARTED|Overall Study||226
8119986|NCT02954159|20014660|P2|NOT COMPLETED|Overall Study||1
8119987|NCT02954159|20014661|P1|NOT COMPLETED|Overall Study||1
8119988|NCT02954159|20014660|P2|COMPLETED|Overall Study||1
8119989|NCT02954159|20014661|P1|COMPLETED|Overall Study||1
8119990|NCT02954159|20014660|P2|STARTED|Overall Study||2
8119991|NCT02954159|20014661|P1|STARTED|Overall Study||2
8119992|NCT02953938|20014675|P2|NOT COMPLETED|Overall Study||2
8119993|NCT02953938|20014676|P1|NOT COMPLETED|Overall Study||1
8119994|NCT02953938|20014675|P2|COMPLETED|Overall Study||28
8119995|NCT02953938|20014676|P1|COMPLETED|Overall Study||28
8119996|NCT02953938|20014675|P2|STARTED|Overall Study||30
8119997|NCT02953938|20014676|P1|STARTED|Overall Study||29
8119998|NCT02953886|20014691|P1|NOT COMPLETED|Overall Study||0
8119999|NCT02953886|20014691|P1|COMPLETED|Overall Study||20
8120000|NCT02953886|20014691|P1|STARTED|Overall Study||20
8120001|NCT02953873|20014697|P1|NOT COMPLETED|Overall Study||0
8120002|NCT02953873|20014697|P1|COMPLETED|Overall Study||25
8120003|NCT02953873|20014697|P1|STARTED|Overall Study||25
8120004|NCT02953821|20014707|P2|NOT COMPLETED|Overall Study||13
8120005|NCT02953821|20014708|P1|NOT COMPLETED|Overall Study||15
8120006|NCT02953821|20014707|P2|COMPLETED|Overall Study||73
8120007|NCT02953821|20014708|P1|COMPLETED|Overall Study||71
8120008|NCT02953821|20014707|P2|Completed Study Treatment (Week 24)|Overall Study||76
8120009|NCT02953821|20014708|P1|Completed Study Treatment (Week 24)|Overall Study||73
8120010|NCT02953821|20014707|P2|Completed Week 16 Visit|Overall Study||77
8120011|NCT02953821|20014708|P1|Completed Week 16 Visit|Overall Study||76
8120012|NCT02953821|20014707|P2|Per Protocol (PP) Population|Overall Study||75
8120013|NCT02953821|20014708|P1|Per Protocol (PP) Population|Overall Study||72
8120014|NCT02953821|20014707|P2|Modified Intent to Treat (mITT) Populati|Overall Study||84
8120015|NCT02953821|20014708|P1|Modified Intent to Treat (mITT) Populati|Overall Study||85
8120016|NCT02953821|20014707|P2|Safety Population|Overall Study||86
8120017|NCT02953821|20014708|P1|Safety Population|Overall Study||86
8120018|NCT02953821|20014707|P2|STARTED|Overall Study||86
8120019|NCT02953821|20014708|P1|STARTED|Overall Study||86
8120025|NCT02953561|20014735|P1|NOT COMPLETED|Overall Study||0
8120026|NCT02953561|20014735|P1|COMPLETED|Overall Study||19
8120027|NCT02953561|20014735|P1|STARTED|Overall Study||19
8120028|NCT02953548|20014742|P2|NOT COMPLETED|Overall Study||0
8120029|NCT02953548|20014743|P1|NOT COMPLETED|Overall Study||0
8120030|NCT02953548|20014742|P2|COMPLETED|Overall Study||4
8120031|NCT02953548|20014743|P1|COMPLETED|Overall Study||5
8120032|NCT02953548|20014742|P2|STARTED|Overall Study||4
8120033|NCT02953548|20014743|P1|STARTED|Overall Study||5
8120034|NCT02953418|20014765|P1|NOT COMPLETED|Overall Study||0
8120035|NCT02953418|20014765|P1|COMPLETED|Overall Study||34
8120036|NCT02953418|20014765|P1|STARTED|Overall Study||34
8120037|NCT02953314|20014774|P2|NOT COMPLETED|Overall Study||3
8120038|NCT02953314|20014775|P1|NOT COMPLETED|Overall Study||0
8120039|NCT02953314|20014774|P2|COMPLETED|Overall Study||67
8120040|NCT02953314|20014775|P1|COMPLETED|Overall Study||13
8120041|NCT02953314|20014774|P2|STARTED|Overall Study||70
8120042|NCT02953314|20014775|P1|STARTED|Overall Study||13
8120043|NCT02952898|20014801|P3|NOT COMPLETED|Overall Study||15
8120044|NCT02952898|20014802|P2|NOT COMPLETED|Overall Study||19
8120045|NCT02952898|20014803|P1|NOT COMPLETED|Overall Study||22
8120046|NCT02952898|20014801|P3|COMPLETED|Overall Study||209
8120047|NCT02952898|20014802|P2|COMPLETED|Overall Study||202
8120048|NCT02952898|20014803|P1|COMPLETED|Overall Study||198
8120049|NCT02952898|20014801|P3|STARTED|Overall Study||224
8120050|NCT02952898|20014802|P2|STARTED|Overall Study||221
8120051|NCT02952898|20014803|P1|STARTED|Overall Study||220
8120052|NCT02952872|20014827|P16|NOT COMPLETED|Overall Study||0
8120053|NCT02952872|20014828|P15|NOT COMPLETED|Overall Study||0
8120054|NCT02952872|20014829|P14|NOT COMPLETED|Overall Study||0
8120055|NCT02952872|20014830|P13|NOT COMPLETED|Overall Study||0
8120056|NCT02952872|20014831|P12|NOT COMPLETED|Overall Study||0
8120057|NCT02952872|20014832|P11|NOT COMPLETED|Overall Study||0
8120058|NCT02952872|20014833|P10|NOT COMPLETED|Overall Study||0
8120059|NCT02952872|20014834|P9|NOT COMPLETED|Overall Study||0
8120060|NCT02952872|20014835|P8|NOT COMPLETED|Overall Study||0
8120061|NCT02952872|20014836|P7|NOT COMPLETED|Overall Study||0
8120062|NCT02952872|20014837|P6|NOT COMPLETED|Overall Study||0
8120063|NCT02952872|20014838|P5|NOT COMPLETED|Overall Study||0
8120064|NCT02952872|20014839|P4|NOT COMPLETED|Overall Study||0
8120065|NCT02952872|20014840|P3|NOT COMPLETED|Overall Study||0
8120066|NCT02952872|20014841|P2|NOT COMPLETED|Overall Study||0
8120067|NCT02952872|20014842|P1|NOT COMPLETED|Overall Study||0
8120068|NCT02952872|20014827|P16|COMPLETED|Overall Study||23
8120069|NCT02952872|20014828|P15|COMPLETED|Overall Study||22
8120070|NCT02952872|20014829|P14|COMPLETED|Overall Study||22
8120071|NCT02952872|20014830|P13|COMPLETED|Overall Study||22
8120072|NCT02952872|20014831|P12|COMPLETED|Overall Study||22
8120073|NCT02952872|20014832|P11|COMPLETED|Overall Study||23
8120074|NCT02952872|20014833|P10|COMPLETED|Overall Study||22
8120075|NCT02952872|20014834|P9|COMPLETED|Overall Study||22
8120076|NCT02952872|20014835|P8|COMPLETED|Overall Study||21
8120077|NCT02952872|20014836|P7|COMPLETED|Overall Study||22
8120078|NCT02952872|20014837|P6|COMPLETED|Overall Study||21
8120079|NCT02952872|20014838|P5|COMPLETED|Overall Study||22
8120080|NCT02952872|20014839|P4|COMPLETED|Overall Study||22
8120081|NCT02952872|20014840|P3|COMPLETED|Overall Study||22
8120082|NCT02952872|20014841|P2|COMPLETED|Overall Study||22
8120083|NCT02952872|20014842|P1|COMPLETED|Overall Study||22
8120084|NCT02952872|20014827|P16|STARTED|Overall Study||23
8120085|NCT02952872|20014828|P15|STARTED|Overall Study||22
8120086|NCT02952872|20014829|P14|STARTED|Overall Study||22
8120087|NCT02952872|20014830|P13|STARTED|Overall Study||22
8120088|NCT02952872|20014831|P12|STARTED|Overall Study||22
8120089|NCT02952872|20014832|P11|STARTED|Overall Study||23
8120090|NCT02952872|20014833|P10|STARTED|Overall Study||22
8120091|NCT02952872|20014834|P9|STARTED|Overall Study||22
8120092|NCT02952872|20014835|P8|STARTED|Overall Study||21
8120093|NCT02952872|20014836|P7|STARTED|Overall Study||22
8120094|NCT02952872|20014837|P6|STARTED|Overall Study||21
8120095|NCT02952872|20014838|P5|STARTED|Overall Study||22
8120096|NCT02952872|20014839|P4|STARTED|Overall Study||22
8120097|NCT02952872|20014840|P3|STARTED|Overall Study||22
8120098|NCT02952872|20014841|P2|STARTED|Overall Study||22
8120099|NCT02952872|20014842|P1|STARTED|Overall Study||22
8120100|NCT02952820|20014927|P3|NOT COMPLETED|Active Treatment Period (6 Months)||31
8120101|NCT02952820|20014928|P2|NOT COMPLETED|Active Treatment Period (6 Months)||38
8120102|NCT02952820|20014929|P1|NOT COMPLETED|Active Treatment Period (6 Months)||0
8120103|NCT02952820|20014927|P3|COMPLETED|Active Treatment Period (6 Months)||321
8120104|NCT02952820|20014928|P2|COMPLETED|Active Treatment Period (6 Months)||346
8120105|NCT02952820|20014929|P1|COMPLETED|Active Treatment Period (6 Months)||0
8120106|NCT02952820|20014927|P3|STARTED|Active Treatment Period (6 Months)||352
8120107|NCT02952820|20014928|P2|STARTED|Active Treatment Period (6 Months)||384
8120108|NCT02952820|20014929|P1|STARTED|Active Treatment Period (6 Months)|Participants from Placebo were re-randomized to Lemborexant 5 mg and Lemborexant 10 mg.|0
8120109|NCT02952820|20014927|P3|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88
8120110|NCT02952820|20014928|P2|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69
8120111|NCT02952820|20014929|P1|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64
8120112|NCT02952820|20014927|P3|COMPLETED|Placebo-Controlled Treatment (6 Months)||235
8120113|NCT02952820|20014928|P2|COMPLETED|Placebo-Controlled Treatment (6 Months)||254
8120114|NCT02952820|20014929|P1|COMPLETED|Placebo-Controlled Treatment (6 Months)||261
8120115|NCT02952820|20014927|P3|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
8120116|NCT02952820|20014928|P2|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
8120117|NCT02952820|20014929|P1|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319
8120118|NCT02952820|20014927|P3|Treated|Placebo-Controlled Treatment (6 Months)||319
8120119|NCT02952820|20014928|P2|Treated|Placebo-Controlled Treatment (6 Months)||319
8120120|NCT02952820|20014929|P1|Treated|Placebo-Controlled Treatment (6 Months)||321
8120121|NCT02952820|20014927|P3|STARTED|Placebo-Controlled Treatment (6 Months)||323
8120122|NCT02952820|20014928|P2|STARTED|Placebo-Controlled Treatment (6 Months)||323
8120123|NCT02952820|20014929|P1|STARTED|Placebo-Controlled Treatment (6 Months)||325
8120124|NCT02952313|20014989|P1|NOT COMPLETED|Long-term Follow-up||32
8120125|NCT02952313|20014989|P1|COMPLETED|Long-term Follow-up||75
8120126|NCT02952313|20014989|P1|18-Month|Long-term Follow-up||79
8120127|NCT02952313|20014989|P1|12-Month|Long-term Follow-up||93
8120128|NCT02952313|20014989|P1|STARTED|Long-term Follow-up||107
8120129|NCT02952313|20014989|P1|NOT COMPLETED|Primary Endpoint||7
8120130|NCT02952313|20014989|P1|COMPLETED|Primary Endpoint||106
8120131|NCT02952313|20014989|P1|6 Months|Primary Endpoint||106
8120132|NCT02952313|20014989|P1|STARTED|Primary Endpoint||113
8120133|NCT02952261|20015000|P2|NOT COMPLETED|Overall Study||5
8120134|NCT02952261|20015001|P1|NOT COMPLETED|Overall Study||5
8120135|NCT02952261|20015000|P2|COMPLETED|Overall Study||95
8120136|NCT02952261|20015001|P1|COMPLETED|Overall Study||95
8120137|NCT02952261|20015000|P2|STARTED|Overall Study||100
8120138|NCT02952261|20015001|P1|STARTED|Overall Study||100
8120139|NCT02951988|20015016|P4|NOT COMPLETED|Double-Blind Treatment Period||115
8120140|NCT02951988|20015017|P3|NOT COMPLETED|Double-Blind Treatment Period||101
8120141|NCT02951988|20015018|P2|NOT COMPLETED|Double-Blind Treatment Period||101
8120142|NCT02951988|20015019|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8120143|NCT02951988|20015016|P4|COMPLETED|Double-Blind Treatment Period||85
8120144|NCT02951988|20015017|P3|COMPLETED|Double-Blind Treatment Period||101
8120145|NCT02951988|20015018|P2|COMPLETED|Double-Blind Treatment Period||101
8120146|NCT02951988|20015019|P1|COMPLETED|Double-Blind Treatment Period||0
8120147|NCT02951988|20015016|P4|STARTED|Double-Blind Treatment Period||200
8120148|NCT02951988|20015017|P3|STARTED|Double-Blind Treatment Period||202
8120149|NCT02951988|20015018|P2|STARTED|Double-Blind Treatment Period||202
8120150|NCT02951988|20015019|P1|STARTED|Double-Blind Treatment Period||0
8120151|NCT02951988|20015016|P4|NOT COMPLETED|Open-Label Treatment Period||0
8120152|NCT02951988|20015017|P3|NOT COMPLETED|Open-Label Treatment Period||0
8120153|NCT02951988|20015018|P2|NOT COMPLETED|Open-Label Treatment Period||0
8120154|NCT02951988|20015019|P1|NOT COMPLETED|Open-Label Treatment Period||248
8120155|NCT02951988|20015016|P4|COMPLETED|Open-Label Treatment Period||0
8120156|NCT02951988|20015017|P3|COMPLETED|Open-Label Treatment Period||0
8120157|NCT02951988|20015018|P2|COMPLETED|Open-Label Treatment Period||0
8120158|NCT02951988|20015019|P1|COMPLETED|Open-Label Treatment Period||1056
8120159|NCT02951988|20015016|P4|STARTED|Open-Label Treatment Period||0
8120160|NCT02951988|20015017|P3|STARTED|Open-Label Treatment Period||0
8120161|NCT02951988|20015018|P2|STARTED|Open-Label Treatment Period||0
8120162|NCT02951988|20015019|P1|STARTED|Open-Label Treatment Period||1304
8120163|NCT02951884|20015037|P3|NOT COMPLETED|Overall Study||0
8120164|NCT02951884|20015038|P2|NOT COMPLETED|Overall Study||0
8120165|NCT02951884|20015039|P1|NOT COMPLETED|Overall Study||0
8120166|NCT02951884|20015037|P3|COMPLETED|Overall Study||1
8120167|NCT02951884|20015038|P2|COMPLETED|Overall Study||1
8120168|NCT02951884|20015039|P1|COMPLETED|Overall Study||0
8120169|NCT02951884|20015037|P3|STARTED|Overall Study||1
8120170|NCT02951884|20015038|P2|STARTED|Overall Study||1
8120171|NCT02951884|20015039|P1|STARTED|Overall Study||0
8120172|NCT02951819|20015052|P2|NOT COMPLETED|Overall Study||14
8120173|NCT02951819|20015053|P1|NOT COMPLETED|Overall Study||87
8120174|NCT02951819|20015052|P2|COMPLETED|Overall Study||0
8120175|NCT02951819|20015053|P1|COMPLETED|Overall Study||0
8120176|NCT02951819|20015052|P2|Treated|Overall Study||14
8120177|NCT02951819|20015053|P1|Treated|Overall Study||86
8120178|NCT02951819|20015052|P2|STARTED|Overall Study||14
8120179|NCT02951819|20015053|P1|STARTED|Overall Study||87
8120180|NCT02951780|20015084|P9|NOT COMPLETED|Period 3||0
8120181|NCT02951780|20015085|P8|NOT COMPLETED|Period 3||0
8120182|NCT02951780|20015086|P7|NOT COMPLETED|Period 3||0
8120183|NCT02951780|20015087|P6|NOT COMPLETED|Period 3||0
8120184|NCT02951780|20015088|P5|NOT COMPLETED|Period 3||0
8120185|NCT02951780|20015089|P4|NOT COMPLETED|Period 3||0
8120186|NCT02951780|20015090|P3|NOT COMPLETED|Period 3||0
8120187|NCT02951780|20015091|P2|NOT COMPLETED|Period 3||0
8120188|NCT02951780|20015092|P1|NOT COMPLETED|Period 3||0
8120189|NCT02951780|20015084|P9|COMPLETED|Period 3||2
8120190|NCT02951780|20015085|P8|COMPLETED|Period 3||1
8120191|NCT02951780|20015086|P7|COMPLETED|Period 3||2
8120192|NCT02951780|20015087|P6|COMPLETED|Period 3||3
8120193|NCT02951780|20015088|P5|COMPLETED|Period 3||2
8120194|NCT02951780|20015089|P4|COMPLETED|Period 3||2
8120195|NCT02951780|20015090|P3|COMPLETED|Period 3||3
8120196|NCT02951780|20015091|P2|COMPLETED|Period 3||2
8120197|NCT02951780|20015092|P1|COMPLETED|Period 3||3
8120198|NCT02951780|20015084|P9|STARTED|Period 3||2
8120199|NCT02951780|20015085|P8|STARTED|Period 3||1
8120200|NCT02951780|20015086|P7|STARTED|Period 3||2
8120201|NCT02951780|20015087|P6|STARTED|Period 3||3
8120202|NCT02951780|20015088|P5|STARTED|Period 3||2
8120203|NCT02951780|20015089|P4|STARTED|Period 3||2
8120204|NCT02951780|20015090|P3|STARTED|Period 3||3
8120205|NCT02951780|20015091|P2|STARTED|Period 3||2
8120206|NCT02951780|20015092|P1|STARTED|Period 3||3
8120207|NCT02951780|20015084|P9|NOT COMPLETED|Period 2||0
8120208|NCT02951780|20015085|P8|NOT COMPLETED|Period 2||1
8120209|NCT02951780|20015086|P7|NOT COMPLETED|Period 2||0
8120210|NCT02951780|20015087|P6|NOT COMPLETED|Period 2||0
8120211|NCT02951780|20015088|P5|NOT COMPLETED|Period 2||0
8120212|NCT02951780|20015089|P4|NOT COMPLETED|Period 2||0
8120213|NCT02951780|20015090|P3|NOT COMPLETED|Period 2||0
8120214|NCT02951780|20015091|P2|NOT COMPLETED|Period 2||0
8120215|NCT02951780|20015092|P1|NOT COMPLETED|Period 2||0
8120216|NCT02951780|20015084|P9|COMPLETED|Period 2||2
8120217|NCT02951780|20015085|P8|COMPLETED|Period 2||1
8120218|NCT02951780|20015086|P7|COMPLETED|Period 2||2
8120219|NCT02951780|20015087|P6|COMPLETED|Period 2||3
8120220|NCT02951780|20015088|P5|COMPLETED|Period 2||2
8120221|NCT02951780|20015089|P4|COMPLETED|Period 2||2
8120222|NCT02951780|20015090|P3|COMPLETED|Period 2||3
8120223|NCT02951780|20015091|P2|COMPLETED|Period 2||2
8120224|NCT02951780|20015092|P1|COMPLETED|Period 2||3
8120225|NCT02951780|20015084|P9|STARTED|Period 2||2
8120226|NCT02951780|20015085|P8|STARTED|Period 2||2
8120227|NCT02951780|20015086|P7|STARTED|Period 2||2
8120228|NCT02951780|20015087|P6|STARTED|Period 2||3
8120229|NCT02951780|20015088|P5|STARTED|Period 2||2
8120230|NCT02951780|20015089|P4|STARTED|Period 2||2
8120231|NCT02951780|20015090|P3|STARTED|Period 2||3
8120232|NCT02951780|20015091|P2|STARTED|Period 2||2
8120233|NCT02951780|20015092|P1|STARTED|Period 2||3
8120234|NCT02951780|20015084|P9|NOT COMPLETED|Period 1||0
8120235|NCT02951780|20015085|P8|NOT COMPLETED|Period 1||1
8120236|NCT02951780|20015086|P7|NOT COMPLETED|Period 1||0
8120237|NCT02951780|20015087|P6|NOT COMPLETED|Period 1||0
8120238|NCT02951780|20015088|P5|NOT COMPLETED|Period 1||0
8120239|NCT02951780|20015089|P4|NOT COMPLETED|Period 1||1
8120240|NCT02951780|20015090|P3|NOT COMPLETED|Period 1||0
8120241|NCT02951780|20015091|P2|NOT COMPLETED|Period 1||0
8120242|NCT02951780|20015092|P1|NOT COMPLETED|Period 1||0
8120243|NCT02951780|20015084|P9|COMPLETED|Period 1||2
8120244|NCT02951780|20015085|P8|COMPLETED|Period 1||2
8120245|NCT02951780|20015086|P7|COMPLETED|Period 1||2
8120246|NCT02951780|20015087|P6|COMPLETED|Period 1||3
8120247|NCT02951780|20015088|P5|COMPLETED|Period 1||2
8120248|NCT02951780|20015089|P4|COMPLETED|Period 1||2
8120249|NCT02951780|20015090|P3|COMPLETED|Period 1||3
8120250|NCT02951780|20015091|P2|COMPLETED|Period 1||2
8120251|NCT02951780|20015092|P1|COMPLETED|Period 1||3
8120252|NCT02951780|20015084|P9|STARTED|Period 1||2
8120253|NCT02951780|20015085|P8|STARTED|Period 1||3
8120254|NCT02951780|20015086|P7|STARTED|Period 1||2
8120255|NCT02951780|20015087|P6|STARTED|Period 1||3
8120256|NCT02951780|20015088|P5|STARTED|Period 1||2
8120257|NCT02951780|20015089|P4|STARTED|Period 1||3
8120258|NCT02951780|20015090|P3|STARTED|Period 1||3
8120259|NCT02951780|20015091|P2|STARTED|Period 1||2
8120260|NCT02951780|20015092|P1|STARTED|Period 1||3
8120264|NCT02951702|20015176|P2|NOT COMPLETED|Overall Study||0
8120265|NCT02951702|20015177|P1|NOT COMPLETED|Overall Study||0
8120266|NCT02951702|20015176|P2|COMPLETED|Overall Study||17
8120267|NCT02951702|20015177|P1|COMPLETED|Overall Study||34
8120268|NCT02951702|20015176|P2|STARTED|Overall Study||17
8120269|NCT02951702|20015177|P1|STARTED|Overall Study||34
8120270|NCT02951533|20015189|P3|NOT COMPLETED|Part III (Week 64 Through Week 100)||2
8120271|NCT02951533|20015190|P2|NOT COMPLETED|Part III (Week 64 Through Week 100)||0
8120272|NCT02951533|20015191|P1|NOT COMPLETED|Part III (Week 64 Through Week 100)||4
8120273|NCT02951533|20015189|P3|COMPLETED|Part III (Week 64 Through Week 100)||10
8120274|NCT02951533|20015190|P2|COMPLETED|Part III (Week 64 Through Week 100)||0
8120275|NCT02951533|20015191|P1|COMPLETED|Part III (Week 64 Through Week 100)||32
8120276|NCT02951533|20015189|P3|STARTED|Part III (Week 64 Through Week 100)|8 participants were not eligible to enter Part III.|12
8120277|NCT02951533|20015190|P2|STARTED|Part III (Week 64 Through Week 100)|10 participants in the FAE group were not eligible to enter Part III.|0
8120278|NCT02951533|20015191|P1|STARTED|Part III (Week 64 Through Week 100)|18 participants were not eligible to enter Part III.|36
8120279|NCT02951533|20015189|P3|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0
8120280|NCT02951533|20015190|P2|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4
8120281|NCT02951533|20015191|P1|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1
8120282|NCT02951533|20015189|P3|COMPLETED|Part IIb (Week 32 Through Week 56)||20
8120283|NCT02951533|20015190|P2|COMPLETED|Part IIb (Week 32 Through Week 56)||10
8120284|NCT02951533|20015191|P1|COMPLETED|Part IIb (Week 32 Through Week 56)||54
8120285|NCT02951533|20015189|P3|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in FAE group, 20 PASI 75 non-responders switched to GUS group.|20
8120286|NCT02951533|20015190|P2|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in the FAE group, 14 PASI 75 responders remained on FAE treatment.|14
8120287|NCT02951533|20015191|P1|STARTED|Part IIb (Week 32 Through Week 56)||55
8120288|NCT02951533|20015189|P3|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0
8120289|NCT02951533|20015190|P2|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
8120290|NCT02951533|20015191|P1|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
8120291|NCT02951533|20015189|P3|COMPLETED|Part IIa (Week 24 Through Week 32)||0
8120292|NCT02951533|20015190|P2|COMPLETED|Part IIa (Week 24 Through Week 32)||34
8120293|NCT02951533|20015191|P1|COMPLETED|Part IIa (Week 24 Through Week 32)||55
8120294|NCT02951533|20015189|P3|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0
8120295|NCT02951533|20015190|P2|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20
8120296|NCT02951533|20015191|P1|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1
8120297|NCT02951533|20015189|P3|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0
8120298|NCT02951533|20015190|P2|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14
8120299|NCT02951533|20015191|P1|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54
8120300|NCT02951533|20015189|P3|STARTED|Part IIa (Week 24 Through Week 32)||0
8120301|NCT02951533|20015190|P2|STARTED|Part IIa (Week 24 Through Week 32)|1 participant did not sign informed consent form (ICF) for Study Part II but completed Study Part I.|35
8120302|NCT02951533|20015191|P1|STARTED|Part IIa (Week 24 Through Week 32)||56
8120303|NCT02951533|20015189|P3|NOT COMPLETED|Part I (Week 0 Through Week 24)||0
8120304|NCT02951533|20015190|P2|NOT COMPLETED|Part I (Week 0 Through Week 24)||23
8120305|NCT02951533|20015191|P1|NOT COMPLETED|Part I (Week 0 Through Week 24)||4
8120306|NCT02951533|20015189|P3|COMPLETED|Part I (Week 0 Through Week 24)||0
8120307|NCT02951533|20015190|P2|COMPLETED|Part I (Week 0 Through Week 24)||36
8120308|NCT02951533|20015191|P1|COMPLETED|Part I (Week 0 Through Week 24)||56
8120309|NCT02951533|20015189|P3|Treated|Part I (Week 0 Through Week 24)||0
8120310|NCT02951533|20015190|P2|Treated|Part I (Week 0 Through Week 24)||58
8120311|NCT02951533|20015191|P1|Treated|Part I (Week 0 Through Week 24)||60
8120312|NCT02951533|20015189|P3|STARTED|Part I (Week 0 Through Week 24)||0
8120313|NCT02951533|20015190|P2|STARTED|Part I (Week 0 Through Week 24)||59
8120314|NCT02951533|20015191|P1|STARTED|Part I (Week 0 Through Week 24)||60
8120315|NCT02951481|20015290|P2|NOT COMPLETED|Overall Study||0
8120316|NCT02951481|20015291|P1|NOT COMPLETED|Overall Study||0
8120317|NCT02951481|20015290|P2|COMPLETED|Overall Study||172
8120318|NCT02951481|20015291|P1|COMPLETED|Overall Study||231
8120319|NCT02951481|20015290|P2|STARTED|Overall Study||172
8120320|NCT02951481|20015291|P1|STARTED|Overall Study||231
8120321|NCT02951429|20015313|P2|NOT COMPLETED|Overall Study||83
8120322|NCT02951429|20015314|P1|NOT COMPLETED|Overall Study||72
8120323|NCT02951429|20015313|P2|COMPLETED|Overall Study||6
8120324|NCT02951429|20015314|P1|COMPLETED|Overall Study||16
8120325|NCT02951429|20015313|P2|STARTED|Overall Study||89
8120326|NCT02951429|20015314|P1|STARTED|Overall Study||88
8120327|NCT02951351|20015374|P2|NOT COMPLETED|Overall Study||0
8120328|NCT02951351|20015375|P1|NOT COMPLETED|Overall Study||0
8120329|NCT02951351|20015374|P2|COMPLETED|Overall Study||17
8120330|NCT02951351|20015375|P1|COMPLETED|Overall Study||19
8120331|NCT02951351|20015374|P2|STARTED|Overall Study||17
8120332|NCT02951351|20015375|P1|STARTED|Overall Study||19
8120333|NCT02951312|20015399|P4|NOT COMPLETED|Study Part 2||0
8120334|NCT02951312|20015400|P3|NOT COMPLETED|Study Part 2||0
8120335|NCT02951312|20015401|P2|NOT COMPLETED|Study Part 2||0
8120336|NCT02951312|20015402|P1|NOT COMPLETED|Study Part 2||0
8120337|NCT02951312|20015399|P4|COMPLETED|Study Part 2||6
8120338|NCT02951312|20015400|P3|COMPLETED|Study Part 2||6
8120339|NCT02951312|20015401|P2|COMPLETED|Study Part 2||0
8120340|NCT02951312|20015402|P1|COMPLETED|Study Part 2||0
8120341|NCT02951312|20015399|P4|STARTED|Study Part 2||6
8120342|NCT02951312|20015400|P3|STARTED|Study Part 2||6
8120343|NCT02951312|20015401|P2|STARTED|Study Part 2||0
8120344|NCT02951312|20015402|P1|STARTED|Study Part 2||0
8120345|NCT02951312|20015399|P4|NOT COMPLETED|Study Part 1||0
8120346|NCT02951312|20015400|P3|NOT COMPLETED|Study Part 1||0
8120347|NCT02951312|20015401|P2|NOT COMPLETED|Study Part 1||0
8120348|NCT02951312|20015402|P1|NOT COMPLETED|Study Part 1||0
8120349|NCT02951312|20015399|P4|COMPLETED|Study Part 1||0
8120350|NCT02951312|20015400|P3|COMPLETED|Study Part 1||0
8120351|NCT02951312|20015401|P2|COMPLETED|Study Part 1||6
8120352|NCT02951312|20015402|P1|COMPLETED|Study Part 1||6
8120353|NCT02951312|20015399|P4|STARTED|Study Part 1||0
8120354|NCT02951312|20015400|P3|STARTED|Study Part 1||0
8120355|NCT02951312|20015401|P2|STARTED|Study Part 1||6
8120356|NCT02951312|20015402|P1|STARTED|Study Part 1||6
8120357|NCT02951273|20015522|P1|NOT COMPLETED|Overall Study||3
8120358|NCT02951273|20015522|P1|COMPLETED|Overall Study||27
8120359|NCT02951273|20015522|P1|STARTED|Overall Study||30
8120360|NCT02951182|20015543|P6|NOT COMPLETED|Overall Study||0
8120361|NCT02951182|20015544|P5|NOT COMPLETED|Overall Study||0
8120362|NCT02951182|20015545|P4|NOT COMPLETED|Overall Study||0
8120363|NCT02951182|20015546|P3|NOT COMPLETED|Overall Study||0
8120364|NCT02951182|20015547|P2|NOT COMPLETED|Overall Study||0
8120365|NCT02951182|20015548|P1|NOT COMPLETED|Overall Study||0
8120366|NCT02951182|20015543|P6|COMPLETED|Overall Study||20
8120367|NCT02951182|20015544|P5|COMPLETED|Overall Study||6
8120368|NCT02951182|20015545|P4|COMPLETED|Overall Study||18
8120369|NCT02951182|20015546|P3|COMPLETED|Overall Study||9
8120370|NCT02951182|20015547|P2|COMPLETED|Overall Study||9
8120371|NCT02951182|20015548|P1|COMPLETED|Overall Study||11
8120372|NCT02951182|20015543|P6|STARTED|Overall Study||20
8120373|NCT02951182|20015544|P5|STARTED|Overall Study||6
8120374|NCT02951182|20015545|P4|STARTED|Overall Study||18
8120375|NCT02951182|20015546|P3|STARTED|Overall Study||9
8120376|NCT02951182|20015547|P2|STARTED|Overall Study||9
8120377|NCT02951182|20015548|P1|STARTED|Overall Study||11
8120378|NCT02951156|20015590|P3|NOT COMPLETED|Overall Study||10
8120379|NCT02951156|20015591|P2|NOT COMPLETED|Overall Study||9
8120380|NCT02951156|20015592|P1|NOT COMPLETED|Overall Study||9
8120381|NCT02951156|20015590|P3|COMPLETED|Overall Study||1
8120382|NCT02951156|20015591|P2|COMPLETED|Overall Study||0
8120383|NCT02951156|20015592|P1|COMPLETED|Overall Study||0
8120384|NCT02951156|20015590|P3|STARTED|Overall Study||11
8120385|NCT02951156|20015591|P2|STARTED|Overall Study||9
8120386|NCT02951156|20015592|P1|STARTED|Overall Study||9
8120393|NCT02950896|20015817|P1|NOT COMPLETED|Overall Study||0
8120394|NCT02950896|20015817|P1|COMPLETED|Overall Study||4
8120395|NCT02950896|20015817|P1|STARTED|Overall Study||4
8120396|NCT02950831|20015821|P1|NOT COMPLETED|Overall Study||9
8120397|NCT02950831|20015821|P1|COMPLETED|Overall Study||18
8120398|NCT02950831|20015821|P1|8 Weeks Follow up|Overall Study||19
8120399|NCT02950831|20015821|P1|4 Week Follow up|Overall Study||20
8120400|NCT02950831|20015821|P1|Permanent Implant|Overall Study||20
8120401|NCT02950831|20015821|P1|Complete Trial|Overall Study||26
8120402|NCT02950831|20015821|P1|STARTED|Overall Study||27
8120403|NCT02950753|20015846|P2|NOT COMPLETED|Overall Study||0
8120404|NCT02950753|20015847|P1|NOT COMPLETED|Overall Study||0
8120405|NCT02950753|20015846|P2|COMPLETED|Overall Study||15
8120406|NCT02950753|20015847|P1|COMPLETED|Overall Study||15
8120407|NCT02950753|20015846|P2|STARTED|Overall Study||15
8120408|NCT02950753|20015847|P1|STARTED|Overall Study||15
8120409|NCT02950545|20015863|P6|NOT COMPLETED|Session 3 (70 Minutes)||1
8120410|NCT02950545|20015864|P5|NOT COMPLETED|Session 3 (70 Minutes)||0
8120411|NCT02950545|20015865|P4|NOT COMPLETED|Session 3 (70 Minutes)||0
8120412|NCT02950545|20015866|P3|NOT COMPLETED|Session 3 (70 Minutes)||0
8120413|NCT02950545|20015867|P2|NOT COMPLETED|Session 3 (70 Minutes)||0
8120414|NCT02950545|20015868|P1|NOT COMPLETED|Session 3 (70 Minutes)||0
8120415|NCT02950545|20015863|P6|COMPLETED|Session 3 (70 Minutes)||7
8120416|NCT02950545|20015864|P5|COMPLETED|Session 3 (70 Minutes)||7
8120417|NCT02950545|20015865|P4|COMPLETED|Session 3 (70 Minutes)||7
8120418|NCT02950545|20015866|P3|COMPLETED|Session 3 (70 Minutes)||7
8120419|NCT02950545|20015867|P2|COMPLETED|Session 3 (70 Minutes)||9
8120420|NCT02950545|20015868|P1|COMPLETED|Session 3 (70 Minutes)||7
8120421|NCT02950545|20015863|P6|STARTED|Session 3 (70 Minutes)||8
8120422|NCT02950545|20015864|P5|STARTED|Session 3 (70 Minutes)||7
8120423|NCT02950545|20015865|P4|STARTED|Session 3 (70 Minutes)||7
8120424|NCT02950545|20015866|P3|STARTED|Session 3 (70 Minutes)||7
8120425|NCT02950545|20015867|P2|STARTED|Session 3 (70 Minutes)||9
8120426|NCT02950545|20015868|P1|STARTED|Session 3 (70 Minutes)||7
8120427|NCT02950545|20015863|P6|NOT COMPLETED|Washout 2 (5 Minutes)||0
8120428|NCT02950545|20015864|P5|NOT COMPLETED|Washout 2 (5 Minutes)||0
8120429|NCT02950545|20015865|P4|NOT COMPLETED|Washout 2 (5 Minutes)||0
8120430|NCT02950545|20015866|P3|NOT COMPLETED|Washout 2 (5 Minutes)||0
8120431|NCT02950545|20015867|P2|NOT COMPLETED|Washout 2 (5 Minutes)||0
8120432|NCT02950545|20015868|P1|NOT COMPLETED|Washout 2 (5 Minutes)||1
8120433|NCT02950545|20015863|P6|COMPLETED|Washout 2 (5 Minutes)||8
8120434|NCT02950545|20015864|P5|COMPLETED|Washout 2 (5 Minutes)||7
8120435|NCT02950545|20015865|P4|COMPLETED|Washout 2 (5 Minutes)||7
8120436|NCT02950545|20015866|P3|COMPLETED|Washout 2 (5 Minutes)||7
8120437|NCT02950545|20015867|P2|COMPLETED|Washout 2 (5 Minutes)||9
8120438|NCT02950545|20015868|P1|COMPLETED|Washout 2 (5 Minutes)||7
8120439|NCT02950545|20015863|P6|STARTED|Washout 2 (5 Minutes)||8
8120440|NCT02950545|20015864|P5|STARTED|Washout 2 (5 Minutes)||7
8120441|NCT02950545|20015865|P4|STARTED|Washout 2 (5 Minutes)||7
8120442|NCT02950545|20015866|P3|STARTED|Washout 2 (5 Minutes)||7
8120443|NCT02950545|20015867|P2|STARTED|Washout 2 (5 Minutes)||9
8120444|NCT02950545|20015868|P1|STARTED|Washout 2 (5 Minutes)||8
8120445|NCT02950545|20015863|P6|NOT COMPLETED|Session 2 (70 Minutes)||0
8120446|NCT02950545|20015864|P5|NOT COMPLETED|Session 2 (70 Minutes)||1
8120447|NCT02950545|20015865|P4|NOT COMPLETED|Session 2 (70 Minutes)||0
8120448|NCT02950545|20015866|P3|NOT COMPLETED|Session 2 (70 Minutes)||0
8120449|NCT02950545|20015867|P2|NOT COMPLETED|Session 2 (70 Minutes)||0
8120450|NCT02950545|20015868|P1|NOT COMPLETED|Session 2 (70 Minutes)||0
8120451|NCT02950545|20015863|P6|COMPLETED|Session 2 (70 Minutes)||8
8120452|NCT02950545|20015864|P5|COMPLETED|Session 2 (70 Minutes)||7
8120453|NCT02950545|20015865|P4|COMPLETED|Session 2 (70 Minutes)||7
8120454|NCT02950545|20015866|P3|COMPLETED|Session 2 (70 Minutes)||7
8120455|NCT02950545|20015867|P2|COMPLETED|Session 2 (70 Minutes)||9
8120456|NCT02950545|20015868|P1|COMPLETED|Session 2 (70 Minutes)||8
8120457|NCT02950545|20015863|P6|STARTED|Session 2 (70 Minutes)||8
8120458|NCT02950545|20015864|P5|STARTED|Session 2 (70 Minutes)||8
8120459|NCT02950545|20015865|P4|STARTED|Session 2 (70 Minutes)||7
8120460|NCT02950545|20015866|P3|STARTED|Session 2 (70 Minutes)||7
8120461|NCT02950545|20015867|P2|STARTED|Session 2 (70 Minutes)||9
8120462|NCT02950545|20015868|P1|STARTED|Session 2 (70 Minutes)||8
8120463|NCT02950545|20015863|P6|NOT COMPLETED|Washout 1 (5 Minutes)||1
8120464|NCT02950545|20015864|P5|NOT COMPLETED|Washout 1 (5 Minutes)||0
8120465|NCT02950545|20015865|P4|NOT COMPLETED|Washout 1 (5 Minutes)||1
8120466|NCT02950545|20015866|P3|NOT COMPLETED|Washout 1 (5 Minutes)||0
8120467|NCT02950545|20015867|P2|NOT COMPLETED|Washout 1 (5 Minutes)||0
8120468|NCT02950545|20015868|P1|NOT COMPLETED|Washout 1 (5 Minutes)||1
8120469|NCT02950545|20015863|P6|COMPLETED|Washout 1 (5 Minutes)||8
8120470|NCT02950545|20015864|P5|COMPLETED|Washout 1 (5 Minutes)||8
8120471|NCT02950545|20015865|P4|COMPLETED|Washout 1 (5 Minutes)||7
8120472|NCT02950545|20015866|P3|COMPLETED|Washout 1 (5 Minutes)||7
8120473|NCT02950545|20015867|P2|COMPLETED|Washout 1 (5 Minutes)||9
8120474|NCT02950545|20015868|P1|COMPLETED|Washout 1 (5 Minutes)||8
8120475|NCT02950545|20015863|P6|STARTED|Washout 1 (5 Minutes)||9
8120476|NCT02950545|20015864|P5|STARTED|Washout 1 (5 Minutes)||8
8120477|NCT02950545|20015865|P4|STARTED|Washout 1 (5 Minutes)||8
8120478|NCT02950545|20015866|P3|STARTED|Washout 1 (5 Minutes)||7
8120479|NCT02950545|20015867|P2|STARTED|Washout 1 (5 Minutes)||9
8120480|NCT02950545|20015868|P1|STARTED|Washout 1 (5 Minutes)||9
8120481|NCT02950545|20015863|P6|NOT COMPLETED|Session 1 (70 Minutes)||1
8120482|NCT02950545|20015864|P5|NOT COMPLETED|Session 1 (70 Minutes)||0
8120483|NCT02950545|20015865|P4|NOT COMPLETED|Session 1 (70 Minutes)||0
8120484|NCT02950545|20015866|P3|NOT COMPLETED|Session 1 (70 Minutes)||0
8120485|NCT02950545|20015867|P2|NOT COMPLETED|Session 1 (70 Minutes)||0
8120486|NCT02950545|20015868|P1|NOT COMPLETED|Session 1 (70 Minutes)||0
8120487|NCT02950545|20015863|P6|COMPLETED|Session 1 (70 Minutes)||9
8120488|NCT02950545|20015864|P5|COMPLETED|Session 1 (70 Minutes)||8
8120489|NCT02950545|20015865|P4|COMPLETED|Session 1 (70 Minutes)||8
8120490|NCT02950545|20015866|P3|COMPLETED|Session 1 (70 Minutes)||7
8120491|NCT02950545|20015867|P2|COMPLETED|Session 1 (70 Minutes)||9
8120492|NCT02950545|20015868|P1|COMPLETED|Session 1 (70 Minutes)||9
8120493|NCT02950545|20015863|P6|STARTED|Session 1 (70 Minutes)||10
8120494|NCT02950545|20015864|P5|STARTED|Session 1 (70 Minutes)||8
8120495|NCT02950545|20015865|P4|STARTED|Session 1 (70 Minutes)||8
8120496|NCT02950545|20015866|P3|STARTED|Session 1 (70 Minutes)||7
8120497|NCT02950545|20015867|P2|STARTED|Session 1 (70 Minutes)||9
8120498|NCT02950545|20015868|P1|STARTED|Session 1 (70 Minutes)||9
8120499|NCT02950480|20015877|P2|NOT COMPLETED|Overall Study||0
8120500|NCT02950480|20015878|P1|NOT COMPLETED|Overall Study||1
8120501|NCT02950480|20015877|P2|COMPLETED|Overall Study||2
8120502|NCT02950480|20015878|P1|COMPLETED|Overall Study||1
8120503|NCT02950480|20015877|P2|STARTED|Overall Study||2
8120504|NCT02950480|20015878|P1|STARTED|Overall Study||2
8120505|NCT02950467|20015888|P1|NOT COMPLETED|3-month Follow-up||0
8120506|NCT02950467|20015888|P1|COMPLETED|3-month Follow-up|All participants completed the safety follow-up assessment, but not all completed outcomes measures.|18
8120507|NCT02950467|20015888|P1|STARTED|3-month Follow-up||18
8120508|NCT02950467|20015888|P1|NOT COMPLETED|Open-label Treatment||0
8120509|NCT02950467|20015888|P1|COMPLETED|Open-label Treatment|1 participant completed study period but missed some visits due to an adverse event (AE).|18
8120510|NCT02950467|20015888|P1|STARTED|Open-label Treatment||18
8120511|NCT02950025|20015918|P2|NOT COMPLETED|Overall Study||0
8120512|NCT02950025|20015919|P1|NOT COMPLETED|Overall Study||0
8120513|NCT02950025|20015918|P2|COMPLETED|Overall Study||3
8120514|NCT02950025|20015919|P1|COMPLETED|Overall Study||2
8120515|NCT02950025|20015918|P2|STARTED|Overall Study||3
8120516|NCT02950025|20015919|P1|STARTED|Overall Study||2
8120517|NCT02949947|20015939|P2|NOT COMPLETED|Overall Study||1
8120518|NCT02949947|20015940|P1|NOT COMPLETED|Overall Study||1
8120519|NCT02949947|20015939|P2|COMPLETED|Overall Study||1
8120520|NCT02949947|20015940|P1|COMPLETED|Overall Study||0
8120521|NCT02949947|20015939|P2|STARTED|Overall Study||2
8120522|NCT02949947|20015940|P1|STARTED|Overall Study||1
8120523|NCT02949921|20015948|P2|NOT COMPLETED|Overall Study||0
8120524|NCT02949921|20015949|P1|NOT COMPLETED|Overall Study||0
8120525|NCT02949921|20015948|P2|COMPLETED|Overall Study||10
8120526|NCT02949921|20015949|P1|COMPLETED|Overall Study||10
8120527|NCT02949921|20015948|P2|STARTED|Overall Study||10
8120528|NCT02949921|20015949|P1|STARTED|Overall Study||10
8120529|NCT02949908|20015973|P1|NOT COMPLETED|Overall Study||2
8120530|NCT02949908|20015973|P1|COMPLETED|Overall Study||0
8120531|NCT02949908|20015973|P1|STARTED|Overall Study||2
8120532|NCT02949674|20015996|P3|NOT COMPLETED|Overall Study||0
8120533|NCT02949674|20015997|P2|NOT COMPLETED|Overall Study||0
8120534|NCT02949674|20015998|P1|NOT COMPLETED|Overall Study||0
8120535|NCT02949674|20015996|P3|COMPLETED|Overall Study||31
8120536|NCT02949674|20015997|P2|COMPLETED|Overall Study||31
8120537|NCT02949674|20015998|P1|COMPLETED|Overall Study||31
8120538|NCT02949674|20015996|P3|STARTED|Overall Study||31
8120539|NCT02949674|20015997|P2|STARTED|Overall Study||31
8120540|NCT02949674|20015998|P1|STARTED|Overall Study||31
8120541|NCT02949518|20016008|P2|NOT COMPLETED|Overall Study||2
8120542|NCT02949518|20016009|P1|NOT COMPLETED|Overall Study||3
8120543|NCT02949518|20016008|P2|COMPLETED|Overall Study||26
8120544|NCT02949518|20016009|P1|COMPLETED|Overall Study||25
8120545|NCT02949518|20016008|P2|STARTED|Overall Study||28
8120546|NCT02949518|20016009|P1|STARTED|Overall Study||28
8120547|NCT02949271|20016037|P2|NOT COMPLETED|Overall Study||30
8120548|NCT02949271|20016038|P1|NOT COMPLETED|Overall Study||29
8120549|NCT02949271|20016037|P2|COMPLETED|Overall Study||59
8120550|NCT02949271|20016038|P1|COMPLETED|Overall Study||61
8120551|NCT02949271|20016037|P2|STARTED|Overall Study||89
8120552|NCT02949271|20016038|P1|STARTED|Overall Study||90
8120556|NCT02949141|20016071|P1|NOT COMPLETED|Overall Study||0
8120557|NCT02949141|20016071|P1|COMPLETED|Overall Study||62
8120558|NCT02949141|20016071|P1|STARTED|Overall Study||62
8120559|NCT02949128|20016078|P1|NOT COMPLETED|Extension Period||2
8120560|NCT02949128|20016078|P1|COMPLETED|Extension Period||47
8120561|NCT02949128|20016078|P1|Received At Least 1 Dose of Study Drug|Extension Period||47
8120562|NCT02949128|20016078|P1|STARTED|Extension Period||49
8120563|NCT02949128|20016078|P1|NOT COMPLETED|Initial Evaluation Period||9
8120564|NCT02949128|20016078|P1|COMPLETED|Initial Evaluation Period||49
8120565|NCT02949128|20016078|P1|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||58
8120566|NCT02949128|20016078|P1|STARTED|Initial Evaluation Period||58
8120567|NCT02949011|20016095|P3|NOT COMPLETED|Overall Study||42
8120568|NCT02949011|20016096|P2|NOT COMPLETED|Overall Study||34
8120569|NCT02949011|20016097|P1|NOT COMPLETED|Overall Study||33
8120570|NCT02949011|20016095|P3|COMPLETED|Overall Study||683
8120571|NCT02949011|20016096|P2|COMPLETED|Overall Study||695
8120572|NCT02949011|20016097|P1|COMPLETED|Overall Study||697
8120573|NCT02949011|20016095|P3|Intention to Treat Infected Population|Overall Study||389
8120574|NCT02949011|20016096|P2|Intention to Treat Infected Population|Overall Study||386
8120575|NCT02949011|20016097|P1|Intention to Treat Infected Population|Overall Study||388
8120576|NCT02949011|20016095|P3|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722
8120577|NCT02949011|20016096|P2|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728
8120578|NCT02949011|20016097|P1|Received Study Drug|Overall Study||728
8120579|NCT02949011|20016095|P3|STARTED|Overall Study||725
8120580|NCT02949011|20016096|P2|STARTED|Overall Study||729
8120581|NCT02949011|20016097|P1|STARTED|Overall Study||730
8120582|NCT02948634|20016167|P2|NOT COMPLETED|Overall Study||2
8120583|NCT02948634|20016168|P1|NOT COMPLETED|Overall Study||10
8120584|NCT02948634|20016167|P2|COMPLETED|Overall Study||9
8120585|NCT02948634|20016168|P1|COMPLETED|Overall Study||7
8120586|NCT02948634|20016167|P2|STARTED|Overall Study||11
8120587|NCT02948634|20016168|P1|STARTED|Overall Study||17
8120588|NCT02948582|20016178|P6|NOT COMPLETED|Wshout Period 6||0
8120589|NCT02948582|20016179|P5|NOT COMPLETED|Wshout Period 6||0
8120590|NCT02948582|20016180|P4|NOT COMPLETED|Wshout Period 6||0
8120591|NCT02948582|20016181|P3|NOT COMPLETED|Wshout Period 6||0
8120592|NCT02948582|20016182|P2|NOT COMPLETED|Wshout Period 6||0
8120593|NCT02948582|20016183|P1|NOT COMPLETED|Wshout Period 6||0
8120594|NCT02948582|20016178|P6|COMPLETED|Wshout Period 6||6
8120595|NCT02948582|20016179|P5|COMPLETED|Wshout Period 6||7
8120596|NCT02948582|20016180|P4|COMPLETED|Wshout Period 6||6
8120597|NCT02948582|20016181|P3|COMPLETED|Wshout Period 6||6
8120598|NCT02948582|20016182|P2|COMPLETED|Wshout Period 6||4
8120599|NCT02948582|20016183|P1|COMPLETED|Wshout Period 6||6
8120600|NCT02948582|20016178|P6|STARTED|Wshout Period 6||6
8120601|NCT02948582|20016179|P5|STARTED|Wshout Period 6||7
8120602|NCT02948582|20016180|P4|STARTED|Wshout Period 6||6
8120603|NCT02948582|20016181|P3|STARTED|Wshout Period 6||6
8120604|NCT02948582|20016182|P2|STARTED|Wshout Period 6||4
8120605|NCT02948582|20016183|P1|STARTED|Wshout Period 6||6
8120606|NCT02948582|20016178|P6|NOT COMPLETED|Treatment Period 6||0
8120607|NCT02948582|20016179|P5|NOT COMPLETED|Treatment Period 6||0
8120608|NCT02948582|20016180|P4|NOT COMPLETED|Treatment Period 6||0
8120609|NCT02948582|20016181|P3|NOT COMPLETED|Treatment Period 6||0
8120610|NCT02948582|20016182|P2|NOT COMPLETED|Treatment Period 6||0
8120611|NCT02948582|20016183|P1|NOT COMPLETED|Treatment Period 6||0
8120612|NCT02948582|20016178|P6|COMPLETED|Treatment Period 6||6
8120613|NCT02948582|20016179|P5|COMPLETED|Treatment Period 6||7
8120614|NCT02948582|20016180|P4|COMPLETED|Treatment Period 6||6
8120615|NCT02948582|20016181|P3|COMPLETED|Treatment Period 6||6
8120616|NCT02948582|20016182|P2|COMPLETED|Treatment Period 6||4
8120617|NCT02948582|20016183|P1|COMPLETED|Treatment Period 6||6
8120618|NCT02948582|20016178|P6|STARTED|Treatment Period 6||6
8120619|NCT02948582|20016179|P5|STARTED|Treatment Period 6||7
8120620|NCT02948582|20016180|P4|STARTED|Treatment Period 6||6
8120621|NCT02948582|20016181|P3|STARTED|Treatment Period 6||6
8120622|NCT02948582|20016182|P2|STARTED|Treatment Period 6||4
8120623|NCT02948582|20016183|P1|STARTED|Treatment Period 6||6
8120624|NCT02948582|20016178|P6|NOT COMPLETED|Washout Period 5||0
8120625|NCT02948582|20016179|P5|NOT COMPLETED|Washout Period 5||0
8120626|NCT02948582|20016180|P4|NOT COMPLETED|Washout Period 5||0
8120627|NCT02948582|20016181|P3|NOT COMPLETED|Washout Period 5||0
8120628|NCT02948582|20016182|P2|NOT COMPLETED|Washout Period 5||0
8120629|NCT02948582|20016183|P1|NOT COMPLETED|Washout Period 5||0
8120630|NCT02948582|20016178|P6|COMPLETED|Washout Period 5||6
8120631|NCT02948582|20016179|P5|COMPLETED|Washout Period 5||7
8120632|NCT02948582|20016180|P4|COMPLETED|Washout Period 5||6
8120633|NCT02948582|20016181|P3|COMPLETED|Washout Period 5||6
8120634|NCT02948582|20016182|P2|COMPLETED|Washout Period 5||4
8120635|NCT02948582|20016183|P1|COMPLETED|Washout Period 5||6
8120636|NCT02948582|20016178|P6|STARTED|Washout Period 5||6
8120637|NCT02948582|20016179|P5|STARTED|Washout Period 5||7
8120638|NCT02948582|20016180|P4|STARTED|Washout Period 5||6
8120639|NCT02948582|20016181|P3|STARTED|Washout Period 5||6
8120640|NCT02948582|20016182|P2|STARTED|Washout Period 5||4
8120641|NCT02948582|20016183|P1|STARTED|Washout Period 5||6
8120642|NCT02948582|20016178|P6|NOT COMPLETED|Treatment Period 5||0
8120643|NCT02948582|20016179|P5|NOT COMPLETED|Treatment Period 5||0
8120644|NCT02948582|20016180|P4|NOT COMPLETED|Treatment Period 5||0
8120645|NCT02948582|20016181|P3|NOT COMPLETED|Treatment Period 5||0
8120646|NCT02948582|20016182|P2|NOT COMPLETED|Treatment Period 5||0
8120647|NCT02948582|20016183|P1|NOT COMPLETED|Treatment Period 5||0
8120648|NCT02948582|20016178|P6|COMPLETED|Treatment Period 5||6
8120649|NCT02948582|20016179|P5|COMPLETED|Treatment Period 5||7
8120650|NCT02948582|20016180|P4|COMPLETED|Treatment Period 5||6
8120651|NCT02948582|20016181|P3|COMPLETED|Treatment Period 5||6
8120652|NCT02948582|20016182|P2|COMPLETED|Treatment Period 5||4
8120653|NCT02948582|20016183|P1|COMPLETED|Treatment Period 5||6
8120654|NCT02948582|20016178|P6|STARTED|Treatment Period 5||6
8120655|NCT02948582|20016179|P5|STARTED|Treatment Period 5||7
8120656|NCT02948582|20016180|P4|STARTED|Treatment Period 5||6
8120657|NCT02948582|20016181|P3|STARTED|Treatment Period 5||6
8120658|NCT02948582|20016182|P2|STARTED|Treatment Period 5||4
8120659|NCT02948582|20016183|P1|STARTED|Treatment Period 5||6
8120660|NCT02948582|20016178|P6|NOT COMPLETED|Washout Period 4||0
8120661|NCT02948582|20016179|P5|NOT COMPLETED|Washout Period 4||0
8120662|NCT02948582|20016180|P4|NOT COMPLETED|Washout Period 4||0
8120663|NCT02948582|20016181|P3|NOT COMPLETED|Washout Period 4||1
8120664|NCT02948582|20016182|P2|NOT COMPLETED|Washout Period 4||0
8120665|NCT02948582|20016183|P1|NOT COMPLETED|Washout Period 4||1
8120666|NCT02948582|20016178|P6|COMPLETED|Washout Period 4||6
8120667|NCT02948582|20016179|P5|COMPLETED|Washout Period 4||7
8120668|NCT02948582|20016180|P4|COMPLETED|Washout Period 4||6
8120669|NCT02948582|20016181|P3|COMPLETED|Washout Period 4||6
8120670|NCT02948582|20016182|P2|COMPLETED|Washout Period 4||4
8120671|NCT02948582|20016183|P1|COMPLETED|Washout Period 4||6
8120672|NCT02948582|20016178|P6|STARTED|Washout Period 4||6
8120673|NCT02948582|20016179|P5|STARTED|Washout Period 4||7
8120674|NCT02948582|20016180|P4|STARTED|Washout Period 4||6
8120675|NCT02948582|20016181|P3|STARTED|Washout Period 4||7
8120676|NCT02948582|20016182|P2|STARTED|Washout Period 4||4
8120677|NCT02948582|20016183|P1|STARTED|Washout Period 4||7
8120678|NCT02948582|20016178|P6|NOT COMPLETED|Treatment Period 4||0
8120679|NCT02948582|20016179|P5|NOT COMPLETED|Treatment Period 4||0
8120680|NCT02948582|20016180|P4|NOT COMPLETED|Treatment Period 4||0
8120681|NCT02948582|20016181|P3|NOT COMPLETED|Treatment Period 4||0
8120682|NCT02948582|20016182|P2|NOT COMPLETED|Treatment Period 4||0
8120683|NCT02948582|20016183|P1|NOT COMPLETED|Treatment Period 4||0
8120684|NCT02948582|20016178|P6|COMPLETED|Treatment Period 4||6
8120685|NCT02948582|20016179|P5|COMPLETED|Treatment Period 4||7
8120686|NCT02948582|20016180|P4|COMPLETED|Treatment Period 4||6
8120687|NCT02948582|20016181|P3|COMPLETED|Treatment Period 4||7
8120688|NCT02948582|20016182|P2|COMPLETED|Treatment Period 4||4
8120689|NCT02948582|20016183|P1|COMPLETED|Treatment Period 4||7
8120690|NCT02948582|20016178|P6|STARTED|Treatment Period 4||6
8120691|NCT02948582|20016179|P5|STARTED|Treatment Period 4||7
8120692|NCT02948582|20016180|P4|STARTED|Treatment Period 4||6
8120693|NCT02948582|20016181|P3|STARTED|Treatment Period 4||7
8120694|NCT02948582|20016182|P2|STARTED|Treatment Period 4||4
8120695|NCT02948582|20016183|P1|STARTED|Treatment Period 4||7
8120696|NCT02948582|20016178|P6|NOT COMPLETED|Washout Period 3||0
8120697|NCT02948582|20016179|P5|NOT COMPLETED|Washout Period 3||0
8120698|NCT02948582|20016180|P4|NOT COMPLETED|Washout Period 3||0
8120699|NCT02948582|20016181|P3|NOT COMPLETED|Washout Period 3||0
8120700|NCT02948582|20016182|P2|NOT COMPLETED|Washout Period 3||0
8120701|NCT02948582|20016183|P1|NOT COMPLETED|Washout Period 3||0
8120702|NCT02948582|20016178|P6|COMPLETED|Washout Period 3||6
8120703|NCT02948582|20016179|P5|COMPLETED|Washout Period 3||7
8120704|NCT02948582|20016180|P4|COMPLETED|Washout Period 3||6
8120705|NCT02948582|20016181|P3|COMPLETED|Washout Period 3||7
8120706|NCT02948582|20016182|P2|COMPLETED|Washout Period 3||4
8120707|NCT02948582|20016183|P1|COMPLETED|Washout Period 3||7
8120708|NCT02948582|20016178|P6|STARTED|Washout Period 3||6
8120709|NCT02948582|20016179|P5|STARTED|Washout Period 3||7
8120710|NCT02948582|20016180|P4|STARTED|Washout Period 3||6
8120711|NCT02948582|20016181|P3|STARTED|Washout Period 3||7
8120712|NCT02948582|20016182|P2|STARTED|Washout Period 3||4
8120713|NCT02948582|20016183|P1|STARTED|Washout Period 3||7
8120714|NCT02948582|20016178|P6|NOT COMPLETED|Treatment Period 3||0
8120715|NCT02948582|20016179|P5|NOT COMPLETED|Treatment Period 3||0
8120716|NCT02948582|20016180|P4|NOT COMPLETED|Treatment Period 3||0
8120717|NCT02948582|20016181|P3|NOT COMPLETED|Treatment Period 3||0
8120718|NCT02948582|20016182|P2|NOT COMPLETED|Treatment Period 3||0
8120719|NCT02948582|20016183|P1|NOT COMPLETED|Treatment Period 3||0
8120720|NCT02948582|20016178|P6|COMPLETED|Treatment Period 3||6
8120721|NCT02948582|20016179|P5|COMPLETED|Treatment Period 3||7
8120722|NCT02948582|20016180|P4|COMPLETED|Treatment Period 3||6
8120723|NCT02948582|20016181|P3|COMPLETED|Treatment Period 3||7
8120724|NCT02948582|20016182|P2|COMPLETED|Treatment Period 3||4
8120725|NCT02948582|20016183|P1|COMPLETED|Treatment Period 3||7
8120726|NCT02948582|20016178|P6|STARTED|Treatment Period 3||6
8120727|NCT02948582|20016179|P5|STARTED|Treatment Period 3||7
8120728|NCT02948582|20016180|P4|STARTED|Treatment Period 3||6
8120729|NCT02948582|20016181|P3|STARTED|Treatment Period 3||7
8120730|NCT02948582|20016182|P2|STARTED|Treatment Period 3||4
8120731|NCT02948582|20016183|P1|STARTED|Treatment Period 3||7
8120732|NCT02948582|20016178|P6|NOT COMPLETED|Washout Period 2||0
8120733|NCT02948582|20016179|P5|NOT COMPLETED|Washout Period 2||0
8120734|NCT02948582|20016180|P4|NOT COMPLETED|Washout Period 2||1
8120735|NCT02948582|20016181|P3|NOT COMPLETED|Washout Period 2||0
8120736|NCT02948582|20016182|P2|NOT COMPLETED|Washout Period 2||1
8120737|NCT02948582|20016183|P1|NOT COMPLETED|Washout Period 2||0
8120738|NCT02948582|20016178|P6|COMPLETED|Washout Period 2||6
8120739|NCT02948582|20016179|P5|COMPLETED|Washout Period 2||7
8120740|NCT02948582|20016180|P4|COMPLETED|Washout Period 2||6
8120741|NCT02948582|20016181|P3|COMPLETED|Washout Period 2||7
8120742|NCT02948582|20016182|P2|COMPLETED|Washout Period 2||4
8120743|NCT02948582|20016183|P1|COMPLETED|Washout Period 2||7
8120744|NCT02948582|20016178|P6|STARTED|Washout Period 2||6
8120745|NCT02948582|20016179|P5|STARTED|Washout Period 2||7
8120746|NCT02948582|20016180|P4|STARTED|Washout Period 2||7
8120747|NCT02948582|20016181|P3|STARTED|Washout Period 2||7
8120748|NCT02948582|20016182|P2|STARTED|Washout Period 2||5
8120749|NCT02948582|20016183|P1|STARTED|Washout Period 2||7
8120750|NCT02948582|20016178|P6|NOT COMPLETED|Treatment Period 2||0
8120751|NCT02948582|20016179|P5|NOT COMPLETED|Treatment Period 2||0
8120752|NCT02948582|20016180|P4|NOT COMPLETED|Treatment Period 2||0
8120753|NCT02948582|20016181|P3|NOT COMPLETED|Treatment Period 2||0
8120754|NCT02948582|20016182|P2|NOT COMPLETED|Treatment Period 2||0
8120755|NCT02948582|20016183|P1|NOT COMPLETED|Treatment Period 2||0
8120756|NCT02948582|20016178|P6|COMPLETED|Treatment Period 2||6
8120757|NCT02948582|20016179|P5|COMPLETED|Treatment Period 2||7
8120758|NCT02948582|20016180|P4|COMPLETED|Treatment Period 2||7
8120759|NCT02948582|20016181|P3|COMPLETED|Treatment Period 2||7
8120760|NCT02948582|20016182|P2|COMPLETED|Treatment Period 2||5
8120761|NCT02948582|20016183|P1|COMPLETED|Treatment Period 2||7
8120762|NCT02948582|20016178|P6|STARTED|Treatment Period 2||6
8120763|NCT02948582|20016179|P5|STARTED|Treatment Period 2||7
8120764|NCT02948582|20016180|P4|STARTED|Treatment Period 2||7
8120765|NCT02948582|20016181|P3|STARTED|Treatment Period 2||7
8120766|NCT02948582|20016182|P2|STARTED|Treatment Period 2||5
8120767|NCT02948582|20016183|P1|STARTED|Treatment Period 2||7
8120768|NCT02948582|20016178|P6|NOT COMPLETED|Washout Period 1||1
8120769|NCT02948582|20016179|P5|NOT COMPLETED|Washout Period 1||0
8120770|NCT02948582|20016180|P4|NOT COMPLETED|Washout Period 1||0
8120771|NCT02948582|20016181|P3|NOT COMPLETED|Washout Period 1||0
8120772|NCT02948582|20016182|P2|NOT COMPLETED|Washout Period 1||2
8120773|NCT02948582|20016183|P1|NOT COMPLETED|Washout Period 1||0
8120774|NCT02948582|20016178|P6|COMPLETED|Washout Period 1||6
8120775|NCT02948582|20016179|P5|COMPLETED|Washout Period 1||7
8120776|NCT02948582|20016180|P4|COMPLETED|Washout Period 1||7
8120777|NCT02948582|20016181|P3|COMPLETED|Washout Period 1||7
8120778|NCT02948582|20016182|P2|COMPLETED|Washout Period 1||5
8120779|NCT02948582|20016183|P1|COMPLETED|Washout Period 1||7
8120780|NCT02948582|20016178|P6|STARTED|Washout Period 1||7
8120781|NCT02948582|20016179|P5|STARTED|Washout Period 1||7
8120782|NCT02948582|20016180|P4|STARTED|Washout Period 1||7
8120783|NCT02948582|20016181|P3|STARTED|Washout Period 1||7
8120784|NCT02948582|20016182|P2|STARTED|Washout Period 1||7
8120785|NCT02948582|20016183|P1|STARTED|Washout Period 1||7
8120786|NCT02948582|20016178|P6|NOT COMPLETED|Treatment Period 1||0
8120787|NCT02948582|20016179|P5|NOT COMPLETED|Treatment Period 1||0
8120788|NCT02948582|20016180|P4|NOT COMPLETED|Treatment Period 1||0
8120789|NCT02948582|20016181|P3|NOT COMPLETED|Treatment Period 1||0
8120790|NCT02948582|20016182|P2|NOT COMPLETED|Treatment Period 1||0
8120791|NCT02948582|20016183|P1|NOT COMPLETED|Treatment Period 1||0
8120792|NCT02948582|20016178|P6|COMPLETED|Treatment Period 1||7
8120793|NCT02948582|20016179|P5|COMPLETED|Treatment Period 1||7
8120794|NCT02948582|20016180|P4|COMPLETED|Treatment Period 1||7
8120795|NCT02948582|20016181|P3|COMPLETED|Treatment Period 1||7
8120796|NCT02948582|20016182|P2|COMPLETED|Treatment Period 1||7
8120797|NCT02948582|20016183|P1|COMPLETED|Treatment Period 1||7
8120798|NCT02948582|20016178|P6|STARTED|Treatment Period 1||7
8120799|NCT02948582|20016179|P5|STARTED|Treatment Period 1||7
8120800|NCT02948582|20016180|P4|STARTED|Treatment Period 1||7
8120801|NCT02948582|20016181|P3|STARTED|Treatment Period 1||7
8120802|NCT02948582|20016182|P2|STARTED|Treatment Period 1||7
8120803|NCT02948582|20016183|P1|STARTED|Treatment Period 1||7
8120804|NCT02948257|20016276|P1|NOT COMPLETED|Overall Study||0
8120805|NCT02948257|20016276|P1|COMPLETED|Overall Study||52
8120806|NCT02948257|20016276|P1|STARTED|Overall Study||52
8120807|NCT02947997|20016286|P1|NOT COMPLETED|Overall Study||0
8120808|NCT02947997|20016286|P1|COMPLETED|Overall Study||4
8120809|NCT02947997|20016286|P1|STARTED|Overall Study||4
8120810|NCT02947984|20016292|P2|NOT COMPLETED|Overall Study||0
8120811|NCT02947984|20016293|P1|NOT COMPLETED|Overall Study||0
8120812|NCT02947984|20016292|P2|COMPLETED|Overall Study||22
8120813|NCT02947984|20016293|P1|COMPLETED|Overall Study||22
8120814|NCT02947984|20016292|P2|STARTED|Overall Study||22
8120815|NCT02947984|20016293|P1|STARTED|Overall Study||22
8120816|NCT02947100|20016305|P1|NOT COMPLETED|Overall Study||4
8120817|NCT02947100|20016305|P1|COMPLETED|Overall Study||0
8120818|NCT02947100|20016305|P1|STARTED|Overall Study||4
8120819|NCT02947022|20016313|P1|NOT COMPLETED|Overall Study||1
8120820|NCT02947022|20016313|P1|COMPLETED|Overall Study||0
8120821|NCT02947022|20016313|P1|STARTED|Overall Study||1
8120822|NCT02946918|20016334|P2|NOT COMPLETED|Overall Study||3
8120823|NCT02946918|20016335|P1|NOT COMPLETED|Overall Study||1
8120824|NCT02946918|20016334|P2|COMPLETED|Overall Study||5
8120825|NCT02946918|20016335|P1|COMPLETED|Overall Study||5
8120826|NCT02946918|20016334|P2|STARTED|Overall Study||8
8120827|NCT02946918|20016335|P1|STARTED|Overall Study||6
8120828|NCT02946892|20016347|P2|NOT COMPLETED|Second Intervention||0
8120829|NCT02946892|20016348|P1|NOT COMPLETED|Second Intervention||0
8120830|NCT02946892|20016347|P2|COMPLETED|Second Intervention||14
8120831|NCT02946892|20016348|P1|COMPLETED|Second Intervention||9
8120832|NCT02946892|20016347|P2|STARTED|Second Intervention||14
8120833|NCT02946892|20016348|P1|STARTED|Second Intervention||9
8120834|NCT02946892|20016347|P2|NOT COMPLETED|Washout (6 Weeks)||0
8120835|NCT02946892|20016348|P1|NOT COMPLETED|Washout (6 Weeks)||2
8120836|NCT02946892|20016347|P2|COMPLETED|Washout (6 Weeks)||14
8120837|NCT02946892|20016348|P1|COMPLETED|Washout (6 Weeks)||9
8120838|NCT02946892|20016347|P2|STARTED|Washout (6 Weeks)||14
8120839|NCT02946892|20016348|P1|STARTED|Washout (6 Weeks)||11
8120840|NCT02946892|20016347|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
8120841|NCT02946892|20016348|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
8120842|NCT02946892|20016347|P2|COMPLETED|First Intervention (12 Weeks)||14
8120843|NCT02946892|20016348|P1|COMPLETED|First Intervention (12 Weeks)||11
8120844|NCT02946892|20016347|P2|STARTED|First Intervention (12 Weeks)||15
8120845|NCT02946892|20016348|P1|STARTED|First Intervention (12 Weeks)||11
8120846|NCT02946580|20016360|P2|NOT COMPLETED|Overall Study||5
8120847|NCT02946580|20016361|P1|NOT COMPLETED|Overall Study||1
8120848|NCT02946580|20016360|P2|COMPLETED|Overall Study||20
8120849|NCT02946580|20016361|P1|COMPLETED|Overall Study||27
8120850|NCT02946580|20016360|P2|STARTED|Overall Study||25
8120851|NCT02946580|20016361|P1|STARTED|Overall Study||28
8120852|NCT02946515|20016379|P2|NOT COMPLETED|Overall Study||1
8120853|NCT02946515|20016380|P1|NOT COMPLETED|Overall Study||2
8120854|NCT02946515|20016379|P2|COMPLETED|Overall Study||21
8120855|NCT02946515|20016380|P1|COMPLETED|Overall Study||20
8120856|NCT02946515|20016379|P2|STARTED|Overall Study||22
8120857|NCT02946515|20016380|P1|STARTED|Overall Study||22
8120858|NCT02946489|20016386|P1|NOT COMPLETED|Overall Study||0
8120859|NCT02946489|20016386|P1|COMPLETED|Overall Study||8
8120860|NCT02946489|20016386|P1|STARTED|Overall Study||8
8120861|NCT02946463|20016393|P2|NOT COMPLETED|Extension Period||119
8120862|NCT02946463|20016394|P1|NOT COMPLETED|Extension Period||124
8120863|NCT02946463|20016393|P2|COMPLETED|Extension Period||0
8120864|NCT02946463|20016394|P1|COMPLETED|Extension Period||0
8120865|NCT02946463|20016393|P2|Received at Least 1 Dose of Ravulizumab|Extension Period||119
8120866|NCT02946463|20016394|P1|Received at Least 1 Dose of Ravulizumab|Extension Period||124
8120867|NCT02946463|20016393|P2|STARTED|Extension Period||119
8120868|NCT02946463|20016394|P1|STARTED|Extension Period||124
8120869|NCT02946463|20016393|P2|NOT COMPLETED|Primary Evaluation Period||2
8120870|NCT02946463|20016394|P1|NOT COMPLETED|Primary Evaluation Period||0
8120871|NCT02946463|20016393|P2|COMPLETED|Primary Evaluation Period||119
8120872|NCT02946463|20016394|P1|COMPLETED|Primary Evaluation Period||125
8120873|NCT02946463|20016393|P2|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121
8120874|NCT02946463|20016394|P1|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125
8120875|NCT02946463|20016393|P2|STARTED|Primary Evaluation Period||121
8120876|NCT02946463|20016394|P1|STARTED|Primary Evaluation Period||125
8120877|NCT02946385|20016416|P6|NOT COMPLETED|Overall Study||1
8120878|NCT02946385|20016417|P5|NOT COMPLETED|Overall Study||2
8120879|NCT02946385|20016418|P4|NOT COMPLETED|Overall Study||0
8120880|NCT02946385|20016419|P3|NOT COMPLETED|Overall Study||3
8120881|NCT02946385|20016420|P2|NOT COMPLETED|Overall Study||0
8120882|NCT02946385|20016421|P1|NOT COMPLETED|Overall Study||0
8120883|NCT02946385|20016416|P6|COMPLETED|Overall Study||76
8120884|NCT02946385|20016417|P5|COMPLETED|Overall Study||99
8120885|NCT02946385|20016418|P4|COMPLETED|Overall Study||74
8120886|NCT02946385|20016419|P3|COMPLETED|Overall Study||96
8120887|NCT02946385|20016420|P2|COMPLETED|Overall Study||127
8120888|NCT02946385|20016421|P1|COMPLETED|Overall Study||126
8120889|NCT02946385|20016416|P6|STARTED|Overall Study||77
8120890|NCT02946385|20016417|P5|STARTED|Overall Study||101
8120891|NCT02946385|20016418|P4|STARTED|Overall Study||74
8120892|NCT02946385|20016419|P3|STARTED|Overall Study||99
8120893|NCT02946385|20016420|P2|STARTED|Overall Study||127
8120894|NCT02946385|20016421|P1|STARTED|Overall Study||126
8120895|NCT02946229|20016505|P1|NOT COMPLETED|Overall Study||0
8120896|NCT02946229|20016505|P1|COMPLETED|Overall Study||142
8120897|NCT02946229|20016505|P1|STARTED|Overall Study||142
8120898|NCT02946021|20016511|P2|NOT COMPLETED|Overall Study||0
8120899|NCT02946021|20016512|P1|NOT COMPLETED|Overall Study||0
8120900|NCT02946021|20016511|P2|COMPLETED|Overall Study||5
8120901|NCT02946021|20016512|P1|COMPLETED|Overall Study||6
8120902|NCT02946021|20016511|P2|STARTED|Overall Study||5
8120903|NCT02946021|20016512|P1|STARTED|Overall Study||6
8120904|NCT02945657|20016524|P1|NOT COMPLETED|Overall Study||4
8120905|NCT02945657|20016524|P1|COMPLETED|Overall Study||28
8120906|NCT02945657|20016524|P1|STARTED|Overall Study||32
8120907|NCT02945553|20016543|P2|NOT COMPLETED|Overall Study||2
8120908|NCT02945553|20016544|P1|NOT COMPLETED|Overall Study||3
8120909|NCT02945553|20016543|P2|COMPLETED|Overall Study|Included in analysis for primary aim.|9
8120910|NCT02945553|20016544|P1|COMPLETED|Overall Study|Included in analysis for primary aim.|11
8120911|NCT02945553|20016543|P2|STARTED|Overall Study||11
8120912|NCT02945553|20016544|P1|STARTED|Overall Study||14
8120913|NCT02945410|20016566|P6|NOT COMPLETED|Intervention 3 (5 Days)||0
8120914|NCT02945410|20016567|P5|NOT COMPLETED|Intervention 3 (5 Days)||0
8120915|NCT02945410|20016568|P4|NOT COMPLETED|Intervention 3 (5 Days)||0
8120916|NCT02945410|20016569|P3|NOT COMPLETED|Intervention 3 (5 Days)||0
8120917|NCT02945410|20016570|P2|NOT COMPLETED|Intervention 3 (5 Days)||0
8120918|NCT02945410|20016571|P1|NOT COMPLETED|Intervention 3 (5 Days)||0
8120919|NCT02945410|20016566|P6|COMPLETED|Intervention 3 (5 Days)||0
8120920|NCT02945410|20016567|P5|COMPLETED|Intervention 3 (5 Days)||1
8120921|NCT02945410|20016568|P4|COMPLETED|Intervention 3 (5 Days)||3
8120922|NCT02945410|20016569|P3|COMPLETED|Intervention 3 (5 Days)||0
8120923|NCT02945410|20016570|P2|COMPLETED|Intervention 3 (5 Days)||1
8120924|NCT02945410|20016571|P1|COMPLETED|Intervention 3 (5 Days)||2
8120925|NCT02945410|20016566|P6|STARTED|Intervention 3 (5 Days)||0
8120926|NCT02945410|20016567|P5|STARTED|Intervention 3 (5 Days)||1
8120927|NCT02945410|20016568|P4|STARTED|Intervention 3 (5 Days)||3
8120928|NCT02945410|20016569|P3|STARTED|Intervention 3 (5 Days)||0
8120929|NCT02945410|20016570|P2|STARTED|Intervention 3 (5 Days)||1
8120930|NCT02945410|20016571|P1|STARTED|Intervention 3 (5 Days)||2
8120931|NCT02945410|20016566|P6|NOT COMPLETED|Washout 2 (14 Days)||0
8120932|NCT02945410|20016567|P5|NOT COMPLETED|Washout 2 (14 Days)||0
8120933|NCT02945410|20016568|P4|NOT COMPLETED|Washout 2 (14 Days)||0
8120934|NCT02945410|20016569|P3|NOT COMPLETED|Washout 2 (14 Days)||0
8120935|NCT02945410|20016570|P2|NOT COMPLETED|Washout 2 (14 Days)||0
8120936|NCT02945410|20016571|P1|NOT COMPLETED|Washout 2 (14 Days)||0
8120937|NCT02945410|20016566|P6|COMPLETED|Washout 2 (14 Days)||0
8120938|NCT02945410|20016567|P5|COMPLETED|Washout 2 (14 Days)||1
8120939|NCT02945410|20016568|P4|COMPLETED|Washout 2 (14 Days)||3
8120940|NCT02945410|20016569|P3|COMPLETED|Washout 2 (14 Days)||0
8120941|NCT02945410|20016570|P2|COMPLETED|Washout 2 (14 Days)||1
8120942|NCT02945410|20016571|P1|COMPLETED|Washout 2 (14 Days)||2
8120943|NCT02945410|20016566|P6|STARTED|Washout 2 (14 Days)||0
8120944|NCT02945410|20016567|P5|STARTED|Washout 2 (14 Days)||1
8120945|NCT02945410|20016568|P4|STARTED|Washout 2 (14 Days)||3
8120946|NCT02945410|20016569|P3|STARTED|Washout 2 (14 Days)||0
8120947|NCT02945410|20016570|P2|STARTED|Washout 2 (14 Days)||1
8120948|NCT02945410|20016571|P1|STARTED|Washout 2 (14 Days)||2
8120949|NCT02945410|20016566|P6|NOT COMPLETED|Intervention 2 (5 Days)||0
8120950|NCT02945410|20016567|P5|NOT COMPLETED|Intervention 2 (5 Days)||0
8120951|NCT02945410|20016568|P4|NOT COMPLETED|Intervention 2 (5 Days)||0
8120952|NCT02945410|20016569|P3|NOT COMPLETED|Intervention 2 (5 Days)||0
8120953|NCT02945410|20016570|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
8120954|NCT02945410|20016571|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
8120955|NCT02945410|20016566|P6|COMPLETED|Intervention 2 (5 Days)||0
8120956|NCT02945410|20016567|P5|COMPLETED|Intervention 2 (5 Days)||1
8120957|NCT02945410|20016568|P4|COMPLETED|Intervention 2 (5 Days)||3
8120958|NCT02945410|20016569|P3|COMPLETED|Intervention 2 (5 Days)||0
8120959|NCT02945410|20016570|P2|COMPLETED|Intervention 2 (5 Days)||1
8120960|NCT02945410|20016571|P1|COMPLETED|Intervention 2 (5 Days)||2
8120961|NCT02945410|20016566|P6|STARTED|Intervention 2 (5 Days)||0
8120962|NCT02945410|20016567|P5|STARTED|Intervention 2 (5 Days)||1
8120963|NCT02945410|20016568|P4|STARTED|Intervention 2 (5 Days)||3
8120964|NCT02945410|20016569|P3|STARTED|Intervention 2 (5 Days)||0
8120965|NCT02945410|20016570|P2|STARTED|Intervention 2 (5 Days)||1
8120966|NCT02945410|20016571|P1|STARTED|Intervention 2 (5 Days)||2
8120967|NCT02945410|20016566|P6|NOT COMPLETED|Washout 1 (14 Days)||0
8120968|NCT02945410|20016567|P5|NOT COMPLETED|Washout 1 (14 Days)||1
8120969|NCT02945410|20016568|P4|NOT COMPLETED|Washout 1 (14 Days)||0
8120970|NCT02945410|20016569|P3|NOT COMPLETED|Washout 1 (14 Days)||2
8120971|NCT02945410|20016570|P2|NOT COMPLETED|Washout 1 (14 Days)||0
8120972|NCT02945410|20016571|P1|NOT COMPLETED|Washout 1 (14 Days)||0
8120973|NCT02945410|20016566|P6|COMPLETED|Washout 1 (14 Days)||0
8120974|NCT02945410|20016567|P5|COMPLETED|Washout 1 (14 Days)||1
8120975|NCT02945410|20016568|P4|COMPLETED|Washout 1 (14 Days)||3
8120976|NCT02945410|20016569|P3|COMPLETED|Washout 1 (14 Days)||0
8120977|NCT02945410|20016570|P2|COMPLETED|Washout 1 (14 Days)||1
8120978|NCT02945410|20016571|P1|COMPLETED|Washout 1 (14 Days)||2
8120979|NCT02945410|20016566|P6|STARTED|Washout 1 (14 Days)||0
8120980|NCT02945410|20016567|P5|STARTED|Washout 1 (14 Days)||2
8120981|NCT02945410|20016568|P4|STARTED|Washout 1 (14 Days)||3
8120982|NCT02945410|20016569|P3|STARTED|Washout 1 (14 Days)||2
8120983|NCT02945410|20016570|P2|STARTED|Washout 1 (14 Days)||1
8120984|NCT02945410|20016571|P1|STARTED|Washout 1 (14 Days)||2
8120985|NCT02945410|20016566|P6|NOT COMPLETED|Intervention 1 (5 Days)||1
8120986|NCT02945410|20016567|P5|NOT COMPLETED|Intervention 1 (5 Days)||0
8120987|NCT02945410|20016568|P4|NOT COMPLETED|Intervention 1 (5 Days)||0
8120988|NCT02945410|20016569|P3|NOT COMPLETED|Intervention 1 (5 Days)||0
8120989|NCT02945410|20016570|P2|NOT COMPLETED|Intervention 1 (5 Days)||3
8120990|NCT02945410|20016571|P1|NOT COMPLETED|Intervention 1 (5 Days)||1
8120991|NCT02945410|20016566|P6|COMPLETED|Intervention 1 (5 Days)||0
8120992|NCT02945410|20016567|P5|COMPLETED|Intervention 1 (5 Days)||2
8120993|NCT02945410|20016568|P4|COMPLETED|Intervention 1 (5 Days)||3
8120994|NCT02945410|20016569|P3|COMPLETED|Intervention 1 (5 Days)||2
8120995|NCT02945410|20016570|P2|COMPLETED|Intervention 1 (5 Days)||1
8120996|NCT02945410|20016571|P1|COMPLETED|Intervention 1 (5 Days)||2
8120997|NCT02945410|20016566|P6|STARTED|Intervention 1 (5 Days)||1
8120998|NCT02945410|20016567|P5|STARTED|Intervention 1 (5 Days)||2
8120999|NCT02945410|20016568|P4|STARTED|Intervention 1 (5 Days)||3
8121000|NCT02945410|20016569|P3|STARTED|Intervention 1 (5 Days)||2
8121001|NCT02945410|20016570|P2|STARTED|Intervention 1 (5 Days)||4
8121002|NCT02945410|20016571|P1|STARTED|Intervention 1 (5 Days)||3
8121003|NCT02945254|20016602|P2|NOT COMPLETED|Overall Study||0
8121004|NCT02945254|20016603|P1|NOT COMPLETED|Overall Study||2
8121005|NCT02945254|20016602|P2|COMPLETED|Overall Study||10
8121006|NCT02945254|20016603|P1|COMPLETED|Overall Study||8
8121007|NCT02945254|20016602|P2|STARTED|Overall Study||10
8121008|NCT02945254|20016603|P1|STARTED|Overall Study||10
8121009|NCT02945150|20016611|P1|NOT COMPLETED|Overall Study||0
8121010|NCT02945150|20016611|P1|COMPLETED|Overall Study||8
8121011|NCT02945150|20016611|P1|SVR12|Overall Study||8
8121012|NCT02945150|20016611|P1|STARTED|Overall Study||8
8121013|NCT02945046|20016619|P3|NOT COMPLETED|Overall Study||15
8121014|NCT02945046|20016620|P2|NOT COMPLETED|Overall Study||13
8121015|NCT02945046|20016621|P1|NOT COMPLETED|Overall Study||13
8121016|NCT02945046|20016619|P3|COMPLETED|Overall Study||40
8121017|NCT02945046|20016620|P2|COMPLETED|Overall Study||42
8121018|NCT02945046|20016621|P1|COMPLETED|Overall Study||46
8121019|NCT02945046|20016619|P3|Full Analysis Set|Overall Study||55
8121020|NCT02945046|20016620|P2|Full Analysis Set|Overall Study||53
8121021|NCT02945046|20016621|P1|Full Analysis Set|Overall Study||57
8121022|NCT02945046|20016619|P3|Safety Analysis Set|Overall Study||55
8121023|NCT02945046|20016620|P2|Safety Analysis Set|Overall Study||55
8121024|NCT02945046|20016621|P1|Safety Analysis Set|Overall Study||59
8121025|NCT02945046|20016619|P3|STARTED|Overall Study||55
8121026|NCT02945046|20016620|P2|STARTED|Overall Study||55
8121027|NCT02945046|20016621|P1|STARTED|Overall Study||59
8121028|NCT02944968|20016674|P1|NOT COMPLETED|Overall Study||3
8121029|NCT02944968|20016674|P1|COMPLETED|Overall Study||48
8121030|NCT02944968|20016674|P1|STARTED|Overall Study||51
8121031|NCT02944656|20016681|P2|NOT COMPLETED|Overall Study||10
8121032|NCT02944656|20016682|P1|NOT COMPLETED|Overall Study||10
8121033|NCT02944656|20016681|P2|COMPLETED|Overall Study||47
8121034|NCT02944656|20016682|P1|COMPLETED|Overall Study||47
8121035|NCT02944656|20016681|P2|Completed Day 1 Follow up|Overall Study||47
8121036|NCT02944656|20016682|P1|Completed Day 1 Follow up|Overall Study||47
8121037|NCT02944656|20016681|P2|Completed Procedure Day|Overall Study||57
8121038|NCT02944656|20016682|P1|Completed Procedure Day|Overall Study||54
8121039|NCT02944656|20016681|P2|STARTED|Overall Study||57
8121040|NCT02944656|20016682|P1|STARTED|Overall Study||57
8121041|NCT02944565|20016710|P1|NOT COMPLETED|Overall Study||0
8121042|NCT02944565|20016710|P1|COMPLETED|Overall Study||28
8121043|NCT02944565|20016710|P1|STARTED|Overall Study||28
8121044|NCT02944513|20016718|P2|NOT COMPLETED|Overall Study||1
8121045|NCT02944513|20016719|P1|NOT COMPLETED|Overall Study||4
8121046|NCT02944513|20016718|P2|COMPLETED|Overall Study||32
8121047|NCT02944513|20016719|P1|COMPLETED|Overall Study||31
8121048|NCT02944513|20016718|P2|STARTED|Overall Study||33
8121049|NCT02944513|20016719|P1|STARTED|Overall Study||35
8121050|NCT02944461|20016735|P1|NOT COMPLETED|Overall Study||5
8121051|NCT02944461|20016735|P1|COMPLETED|Overall Study||15
8121052|NCT02944461|20016735|P1|STARTED|Overall Study||20
8121053|NCT02944448|20016744|P2|NOT COMPLETED|Overall Study||24
8121054|NCT02944448|20016745|P1|NOT COMPLETED|Overall Study||89
8121055|NCT02944448|20016744|P2|COMPLETED|Overall Study||136
8121056|NCT02944448|20016745|P1|COMPLETED|Overall Study||227
8121057|NCT02944448|20016744|P2|STARTED|Overall Study||160
8121058|NCT02944448|20016745|P1|STARTED|Overall Study||316
8121059|NCT02944383|20016772|P3|NOT COMPLETED|Overall Study||1
8121060|NCT02944383|20016773|P2|NOT COMPLETED|Overall Study||0
8121061|NCT02944383|20016774|P1|NOT COMPLETED|Overall Study||1
8121062|NCT02944383|20016772|P3|COMPLETED|Overall Study||30
8121063|NCT02944383|20016773|P2|COMPLETED|Overall Study||30
8121064|NCT02944383|20016774|P1|COMPLETED|Overall Study||29
8121065|NCT02944383|20016772|P3|STARTED|Overall Study||31
8121066|NCT02944383|20016773|P2|STARTED|Overall Study||30
8121067|NCT02944383|20016774|P1|STARTED|Overall Study||30
8121068|NCT02943941|20016929|P1|NOT COMPLETED|Overall Study||0
8121069|NCT02943941|20016929|P1|COMPLETED|Overall Study||16
8121070|NCT02943941|20016929|P1|STARTED|Overall Study||16
8121071|NCT02943668|20016935|P1|NOT COMPLETED|Overall Study||1
8121072|NCT02943668|20016935|P1|COMPLETED|Overall Study||1
8121073|NCT02943668|20016935|P1|STARTED|Overall Study||2
8121074|NCT02943577|20016946|P2|NOT COMPLETED|Overall Study||5
8121075|NCT02943577|20016947|P1|NOT COMPLETED|Overall Study||5
8121076|NCT02943577|20016946|P2|COMPLETED|Overall Study||201
8121077|NCT02943577|20016947|P1|COMPLETED|Overall Study||204
8121078|NCT02943577|20016946|P2|STARTED|Overall Study||206
8121079|NCT02943577|20016947|P1|STARTED|Overall Study||209
8121080|NCT02943564|20016962|P3|NOT COMPLETED|Overall Study||9
8121081|NCT02943564|20016963|P2|NOT COMPLETED|Overall Study||13
8121082|NCT02943564|20016964|P1|NOT COMPLETED|Overall Study||10
8121083|NCT02943564|20016962|P3|COMPLETED|Overall Study||201
8121084|NCT02943564|20016963|P2|COMPLETED|Overall Study||198
8121085|NCT02943564|20016964|P1|COMPLETED|Overall Study||207
8121086|NCT02943564|20016962|P3|Non-Responder|Overall Study||133
8121087|NCT02943564|20016963|P2|Non-Responder|Overall Study||134
8121088|NCT02943564|20016964|P1|Non-Responder|Overall Study||134
8121089|NCT02943564|20016962|P3|Responder|Overall Study||77
8121090|NCT02943564|20016963|P2|Responder|Overall Study||77
8121091|NCT02943564|20016964|P1|Responder|Overall Study||83
8121092|NCT02943564|20016962|P3|STARTED|Overall Study||210
8121093|NCT02943564|20016963|P2|STARTED|Overall Study||211
8121094|NCT02943564|20016964|P1|STARTED|Overall Study||217
8121095|NCT02943499|20016977|P2|NOT COMPLETED|Overall Study||5
8121096|NCT02943499|20016978|P1|NOT COMPLETED|Overall Study||7
8121097|NCT02943499|20016977|P2|COMPLETED|Overall Study||34
8121098|NCT02943499|20016978|P1|COMPLETED|Overall Study||34
8121099|NCT02943499|20016977|P2|STARTED|Overall Study||39
8121100|NCT02943499|20016978|P1|STARTED|Overall Study||41
8121101|NCT02943473|20016984|P1|NOT COMPLETED|Overall Study||6
8121102|NCT02943473|20016984|P1|COMPLETED|Overall Study||3
8121103|NCT02943473|20016984|P1|STARTED|Overall Study||9
8121122|NCT02943447|20017011|P3|NOT COMPLETED|Open-Label Extension Phase||10
8121123|NCT02943447|20017012|P2|NOT COMPLETED|Open-Label Extension Phase||25
8121124|NCT02943447|20017013|P1|NOT COMPLETED|Open-Label Extension Phase||18
8121125|NCT02943447|20017011|P3|COMPLETED|Open-Label Extension Phase||2
8121126|NCT02943447|20017012|P2|COMPLETED|Open-Label Extension Phase||3
8121127|NCT02943447|20017013|P1|COMPLETED|Open-Label Extension Phase||5
8121128|NCT02943447|20017011|P3|STARTED|Open-Label Extension Phase||12
8121129|NCT02943447|20017012|P2|STARTED|Open-Label Extension Phase||28
8121130|NCT02943447|20017013|P1|STARTED|Open-Label Extension Phase||23
8121131|NCT02943447|20017011|P3|NOT COMPLETED|Blinded Study Phase||1
8121132|NCT02943447|20017012|P2|NOT COMPLETED|Blinded Study Phase||2
8121133|NCT02943447|20017013|P1|NOT COMPLETED|Blinded Study Phase||5
8121134|NCT02943447|20017011|P3|COMPLETED|Blinded Study Phase||12
8121135|NCT02943447|20017012|P2|COMPLETED|Blinded Study Phase||28
8121136|NCT02943447|20017013|P1|COMPLETED|Blinded Study Phase||23
8121137|NCT02943447|20017011|P3|STARTED|Blinded Study Phase||13
8121138|NCT02943447|20017012|P2|STARTED|Blinded Study Phase||30
8121139|NCT02943447|20017013|P1|STARTED|Blinded Study Phase||28
8121140|NCT02943226|20017035|P2|NOT COMPLETED|Overall Study||0
8121141|NCT02943226|20017036|P1|NOT COMPLETED|Overall Study||0
8121142|NCT02943226|20017035|P2|COMPLETED|Overall Study||30
8121143|NCT02943226|20017036|P1|COMPLETED|Overall Study||31
8121144|NCT02943226|20017035|P2|STARTED|Overall Study||30
8121145|NCT02943226|20017036|P1|STARTED|Overall Study||31
8121146|NCT02943213|20017052|P1|NOT COMPLETED|Treatment Period 2||0
8121147|NCT02943213|20017052|P1|COMPLETED|Treatment Period 2||20
8121148|NCT02943213|20017052|P1|STARTED|Treatment Period 2||20
8121149|NCT02943213|20017052|P1|NOT COMPLETED|Treatment Period 1||0
8121150|NCT02943213|20017052|P1|COMPLETED|Treatment Period 1||20
8121151|NCT02943213|20017052|P1|STARTED|Treatment Period 1||20
8121152|NCT02943096|20017082|P2|NOT COMPLETED|Overall Study||1
8121153|NCT02943096|20017083|P1|NOT COMPLETED|Overall Study||0
8121154|NCT02943096|20017082|P2|COMPLETED|Overall Study||2
8121155|NCT02943096|20017083|P1|COMPLETED|Overall Study||3
8121156|NCT02943096|20017082|P2|STARTED|Overall Study||3
8121157|NCT02943096|20017083|P1|STARTED|Overall Study||3
8121158|NCT02942771|20017102|P5|NOT COMPLETED|Overall Study||4
8121159|NCT02942771|20017103|P4|NOT COMPLETED|Overall Study||0
8121160|NCT02942771|20017104|P3|NOT COMPLETED|Overall Study||0
8121161|NCT02942771|20017105|P2|NOT COMPLETED|Overall Study||0
8121162|NCT02942771|20017106|P1|NOT COMPLETED|Overall Study||3
8121163|NCT02942771|20017102|P5|COMPLETED|Overall Study||4
8121164|NCT02942771|20017103|P4|COMPLETED|Overall Study||6
8121165|NCT02942771|20017104|P3|COMPLETED|Overall Study||6
8121166|NCT02942771|20017105|P2|COMPLETED|Overall Study||6
8121167|NCT02942771|20017106|P1|COMPLETED|Overall Study||6
8121168|NCT02942771|20017102|P5|STARTED|Overall Study||8
8121169|NCT02942771|20017103|P4|STARTED|Overall Study||6
8121170|NCT02942771|20017104|P3|STARTED|Overall Study||6
8121171|NCT02942771|20017105|P2|STARTED|Overall Study||6
8121172|NCT02942771|20017106|P1|STARTED|Overall Study||9
8121173|NCT02942654|20017148|P2|NOT COMPLETED|Period 2||0
8121174|NCT02942654|20017149|P1|NOT COMPLETED|Period 2||0
8121175|NCT02942654|20017148|P2|COMPLETED|Period 2||16
8121176|NCT02942654|20017149|P1|COMPLETED|Period 2||16
8121177|NCT02942654|20017148|P2|STARTED|Period 2||16
8121178|NCT02942654|20017149|P1|STARTED|Period 2||16
8121179|NCT02942654|20017148|P2|NOT COMPLETED|Washout||0
8121180|NCT02942654|20017149|P1|NOT COMPLETED|Washout||0
8121181|NCT02942654|20017148|P2|COMPLETED|Washout||16
8121182|NCT02942654|20017149|P1|COMPLETED|Washout||16
8121183|NCT02942654|20017148|P2|STARTED|Washout||16
8121184|NCT02942654|20017149|P1|STARTED|Washout||16
8121185|NCT02942654|20017148|P2|NOT COMPLETED|Period 1||0
8121186|NCT02942654|20017149|P1|NOT COMPLETED|Period 1||0
8121187|NCT02942654|20017148|P2|COMPLETED|Period 1||16
8121188|NCT02942654|20017149|P1|COMPLETED|Period 1||16
8121189|NCT02942654|20017148|P2|Received at Least 1 Dose of Study Drug|Period 1||16
8121190|NCT02942654|20017149|P1|Received at Least 1 Dose of Study Drug|Period 1||16
8121191|NCT02942654|20017148|P2|STARTED|Period 1||16
8121192|NCT02942654|20017149|P1|STARTED|Period 1||16
8121193|NCT02942576|20017159|P2|NOT COMPLETED|Overall Study||23
8121194|NCT02942576|20017160|P1|NOT COMPLETED|Overall Study||46
8121195|NCT02942576|20017159|P2|COMPLETED|Overall Study||174
8121196|NCT02942576|20017160|P1|COMPLETED|Overall Study||359
8121197|NCT02942576|20017159|P2|STARTED|Overall Study||197
8121198|NCT02942576|20017160|P1|STARTED|Overall Study||405
8121199|NCT02942485|20017174|P2|NOT COMPLETED|Overall Study||0
8121200|NCT02942485|20017175|P1|NOT COMPLETED|Overall Study||1
8121201|NCT02942485|20017174|P2|COMPLETED|Overall Study||1
8121202|NCT02942485|20017175|P1|COMPLETED|Overall Study||6
8121203|NCT02942485|20017174|P2|STARTED|Overall Study||1
8121204|NCT02942485|20017175|P1|STARTED|Overall Study||7
8121205|NCT02942407|20017187|P2|NOT COMPLETED|Overall Study||24
8121206|NCT02942407|20017188|P1|NOT COMPLETED|Overall Study||26
8121207|NCT02942407|20017187|P2|COMPLETED|Overall Study||48
8121208|NCT02942407|20017188|P1|COMPLETED|Overall Study||56
8121209|NCT02942407|20017187|P2|STARTED|Overall Study||72
8121210|NCT02942407|20017188|P1|STARTED|Overall Study||82
8121211|NCT02942160|20017216|P1|NOT COMPLETED|Overall Study||103
8121212|NCT02942160|20017216|P1|COMPLETED|Overall Study|EN3835 Treated Participants in EN3835-202 Completed|156
8121213|NCT02942160|20017216|P1|EN3835 Treated Subjects in EN3835-202|Overall Study|EN3835 Treated Participants in EN3835-202 Started|200
8121214|NCT02942160|20017216|P1|EN3835-202 Participants|Overall Study|Observation Phase Completed|222
8121215|NCT02942160|20017216|P1|STARTED|Overall Study|Observation Phase prior to open-label treatment phase|259
8121216|NCT02942017|20017250|P2|NOT COMPLETED|Overall Study||6
8121217|NCT02942017|20017251|P1|NOT COMPLETED|Overall Study||2
8121218|NCT02942017|20017250|P2|COMPLETED|Overall Study||48
8121219|NCT02942017|20017251|P1|COMPLETED|Overall Study||52
8121220|NCT02942017|20017250|P2|Treated|Overall Study||51
8121221|NCT02942017|20017251|P1|Treated|Overall Study||53
8121222|NCT02942017|20017250|P2|STARTED|Overall Study||54
8121223|NCT02942017|20017251|P1|STARTED|Overall Study||54
8121224|NCT02942004|20017282|P3|NOT COMPLETED|Overall Study||9
8121225|NCT02942004|20017283|P2|NOT COMPLETED|Overall Study||12
8121226|NCT02942004|20017284|P1|NOT COMPLETED|Overall Study||4
8121227|NCT02942004|20017282|P3|COMPLETED|Overall Study||36
8121228|NCT02942004|20017283|P2|COMPLETED|Overall Study||35
8121229|NCT02942004|20017284|P1|COMPLETED|Overall Study||42
8121230|NCT02942004|20017282|P3|Participants Who Received Study Drug|Overall Study||41
8121231|NCT02942004|20017283|P2|Participants Who Received Study Drug|Overall Study||38
8121232|NCT02942004|20017284|P1|Participants Who Received Study Drug|Overall Study||43
8121233|NCT02942004|20017282|P3|STARTED|Overall Study||45
8121234|NCT02942004|20017283|P2|STARTED|Overall Study||47
8121235|NCT02942004|20017284|P1|STARTED|Overall Study||46
8121236|NCT02941692|20017327|P2|NOT COMPLETED|Overall Study||0
8121237|NCT02941692|20017328|P1|NOT COMPLETED|Overall Study||0
8121238|NCT02941692|20017327|P2|COMPLETED|Overall Study||34
8121239|NCT02941692|20017328|P1|COMPLETED|Overall Study||32
8121240|NCT02941692|20017327|P2|STARTED|Overall Study||34
8121241|NCT02941692|20017328|P1|STARTED|Overall Study||32
8121242|NCT02941640|20017340|P4|NOT COMPLETED|Overall Study||0
8121243|NCT02941640|20017341|P3|NOT COMPLETED|Overall Study||0
8121244|NCT02941640|20017342|P2|NOT COMPLETED|Overall Study||0
8121245|NCT02941640|20017343|P1|NOT COMPLETED|Overall Study||0
8121246|NCT02941640|20017340|P4|COMPLETED|Overall Study||30
8121247|NCT02941640|20017341|P3|COMPLETED|Overall Study||30
8121248|NCT02941640|20017342|P2|COMPLETED|Overall Study||30
8121249|NCT02941640|20017343|P1|COMPLETED|Overall Study||30
8121250|NCT02941640|20017340|P4|STARTED|Overall Study||30
8121251|NCT02941640|20017341|P3|STARTED|Overall Study||30
8121252|NCT02941640|20017342|P2|STARTED|Overall Study||30
8121253|NCT02941640|20017343|P1|STARTED|Overall Study||30
8121254|NCT02941614|20017375|P2|NOT COMPLETED|Overall Study||246
8121255|NCT02941614|20017376|P1|NOT COMPLETED|Overall Study||141
8121256|NCT02941614|20017375|P2|COMPLETED|Overall Study||446
8121257|NCT02941614|20017376|P1|COMPLETED|Overall Study||603
8121258|NCT02941614|20017375|P2|STARTED|Overall Study||692
8121259|NCT02941614|20017376|P1|STARTED|Overall Study||744
8121260|NCT02941146|20017396|P1|NOT COMPLETED|Overall Study||0
8121261|NCT02941146|20017396|P1|COMPLETED|Overall Study||15
8121262|NCT02941146|20017396|P1|STARTED|Overall Study||15
8121263|NCT02940886|20017404|P2|NOT COMPLETED|Overall Study||54
8121264|NCT02940886|20017405|P1|NOT COMPLETED|Overall Study||102
8121265|NCT02940886|20017404|P2|COMPLETED|Overall Study||449
8121266|NCT02940886|20017405|P1|COMPLETED|Overall Study||907
8121267|NCT02940886|20017404|P2|Safety Analysis Set|Overall Study||494
8121268|NCT02940886|20017405|P1|Safety Analysis Set|Overall Study||989
8121269|NCT02940886|20017404|P2|STARTED|Overall Study|Intention-to-treat analysis set included 503 subjects, safety analysis set included 494 subjects.|503
8121270|NCT02940886|20017405|P1|STARTED|Overall Study|Intention-to-treat analysis set included 1009 subjects, safety analysis set included 989 subjects.|1009
8121271|NCT02940860|20017451|P2|NOT COMPLETED|Overall Study||35
8121272|NCT02940860|20017452|P1|NOT COMPLETED|Overall Study||56
8121273|NCT02940860|20017451|P2|COMPLETED|Overall Study||476
8121274|NCT02940860|20017452|P1|COMPLETED|Overall Study||971
8121275|NCT02940860|20017451|P2|STARTED|Overall Study||511
8121276|NCT02940860|20017452|P1|STARTED|Overall Study||1027
8121277|NCT02940691|20017496|P1|NOT COMPLETED|Overall Study||6
8121278|NCT02940691|20017496|P1|COMPLETED|Overall Study||26
8121279|NCT02940691|20017496|P1|STARTED|Overall Study||32
8121280|NCT02940626|20017505|P2|NOT COMPLETED|Overall Study||35
8121281|NCT02940626|20017506|P1|NOT COMPLETED|Overall Study||47
8121282|NCT02940626|20017505|P2|COMPLETED|Overall Study||43
8121283|NCT02940626|20017506|P1|COMPLETED|Overall Study||30
8121284|NCT02940626|20017505|P2|Completed Through Study Day 22|Overall Study||49
8121285|NCT02940626|20017506|P1|Completed Through Study Day 22|Overall Study||42
8121286|NCT02940626|20017505|P2|Received Study Treatment|Overall Study||77
8121287|NCT02940626|20017506|P1|Received Study Treatment|Overall Study||77
8121288|NCT02940626|20017505|P2|Randomized Into Treatment Sub-study|Overall Study||1
8121289|NCT02940626|20017506|P1|Randomized Into Treatment Sub-study|Overall Study||0
8121290|NCT02940626|20017505|P2|Randomized Into Primary Prevention Study|Overall Study||77
8121291|NCT02940626|20017506|P1|Randomized Into Primary Prevention Study|Overall Study||77
8121292|NCT02940626|20017505|P2|STARTED|Overall Study||78
8121293|NCT02940626|20017506|P1|STARTED|Overall Study||77
8121306|NCT02940522|20017567|P2|NOT COMPLETED|Overall Study||2
8121307|NCT02940522|20017568|P1|NOT COMPLETED|Overall Study||2
8121308|NCT02940522|20017567|P2|COMPLETED|Overall Study||59
8121309|NCT02940522|20017568|P1|COMPLETED|Overall Study||57
8121310|NCT02940522|20017567|P2|STARTED|Overall Study||61
8121311|NCT02940522|20017568|P1|STARTED|Overall Study||59
8121312|NCT02940327|20017584|P1|NOT COMPLETED|Overall Study||0
8121313|NCT02940327|20017584|P1|COMPLETED|Overall Study||24
8121314|NCT02940327|20017584|P1|STARTED|Overall Study||24
8121315|NCT02940249|20017647|P1|NOT COMPLETED|Overall Study||4
8121316|NCT02940249|20017647|P1|COMPLETED|Overall Study||30
8121317|NCT02940249|20017647|P1|STARTED|Overall Study||34
8121318|NCT02939950|20017659|P2|NOT COMPLETED|Overall Study||81
8121319|NCT02939950|20017660|P1|NOT COMPLETED|Overall Study||66
8121320|NCT02939950|20017659|P2|COMPLETED|Overall Study||329
8121321|NCT02939950|20017660|P1|COMPLETED|Overall Study||340
8121322|NCT02939950|20017659|P2|Eligible at Baseline|Overall Study||402
8121323|NCT02939950|20017660|P1|Eligible at Baseline|Overall Study||403
8121324|NCT02939950|20017659|P2|Dispensed the Assigned Lenses|Overall Study||410
8121325|NCT02939950|20017660|P1|Dispensed the Assigned Lenses|Overall Study||405
8121326|NCT02939950|20017659|P2|STARTED|Overall Study||410
8121327|NCT02939950|20017660|P1|STARTED|Overall Study||406
8121328|NCT02939937|20017670|P2|NOT COMPLETED|Overall Study||3
8121329|NCT02939937|20017671|P1|NOT COMPLETED|Overall Study||6
8121330|NCT02939937|20017670|P2|COMPLETED|Overall Study||47
8121331|NCT02939937|20017671|P1|COMPLETED|Overall Study||15
8121332|NCT02939937|20017670|P2|STARTED|Overall Study|3 patients excluded from study|50
8121333|NCT02939937|20017671|P1|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21
8121334|NCT02939716|20017685|P6|NOT COMPLETED|Overall Study||1
8121335|NCT02939716|20017686|P5|NOT COMPLETED|Overall Study||1
8121336|NCT02939716|20017687|P4|NOT COMPLETED|Overall Study||1
8121337|NCT02939716|20017688|P3|NOT COMPLETED|Overall Study||0
8121338|NCT02939716|20017689|P2|NOT COMPLETED|Overall Study||0
8121339|NCT02939716|20017690|P1|NOT COMPLETED|Overall Study||0
8121340|NCT02939716|20017685|P6|COMPLETED|Overall Study||2
8121341|NCT02939716|20017686|P5|COMPLETED|Overall Study||2
8121342|NCT02939716|20017687|P4|COMPLETED|Overall Study||2
8121343|NCT02939716|20017688|P3|COMPLETED|Overall Study||3
8121344|NCT02939716|20017689|P2|COMPLETED|Overall Study||3
8121345|NCT02939716|20017690|P1|COMPLETED|Overall Study||3
8121346|NCT02939716|20017685|P6|STARTED|Overall Study||3
8121347|NCT02939716|20017686|P5|STARTED|Overall Study||3
8121348|NCT02939716|20017687|P4|STARTED|Overall Study||3
8121349|NCT02939716|20017688|P3|STARTED|Overall Study||3
8121350|NCT02939716|20017689|P2|STARTED|Overall Study||3
8121351|NCT02939716|20017690|P1|STARTED|Overall Study||3
8121352|NCT02939599|20017715|P2|NOT COMPLETED|Overall Study||2
8121353|NCT02939599|20017716|P1|NOT COMPLETED|Overall Study||3
8121354|NCT02939599|20017715|P2|COMPLETED|Overall Study||0
8121355|NCT02939599|20017716|P1|COMPLETED|Overall Study||0
8121356|NCT02939599|20017715|P2|STARTED|Overall Study||2
8121357|NCT02939599|20017716|P1|STARTED|Overall Study||3
8121358|NCT02939560|20017730|P1|NOT COMPLETED|Overall Study||3
8121359|NCT02939560|20017730|P1|COMPLETED|Overall Study||10
8121360|NCT02939560|20017730|P1|STARTED|Overall Study||13
8121361|NCT02939326|20017747|P8|NOT COMPLETED|Overall Study||0
8121362|NCT02939326|20017748|P7|NOT COMPLETED|Overall Study||0
8121363|NCT02939326|20017749|P6|NOT COMPLETED|Overall Study||0
8121364|NCT02939326|20017750|P5|NOT COMPLETED|Overall Study||0
8121365|NCT02939326|20017751|P4|NOT COMPLETED|Overall Study||0
8121366|NCT02939326|20017752|P3|NOT COMPLETED|Overall Study||0
8121367|NCT02939326|20017753|P2|NOT COMPLETED|Overall Study||0
8121368|NCT02939326|20017754|P1|NOT COMPLETED|Overall Study||0
8121369|NCT02939326|20017747|P8|COMPLETED|Overall Study||5
8121370|NCT02939326|20017748|P7|COMPLETED|Overall Study||5
8121371|NCT02939326|20017749|P6|COMPLETED|Overall Study||5
8121372|NCT02939326|20017750|P5|COMPLETED|Overall Study||5
8121373|NCT02939326|20017751|P4|COMPLETED|Overall Study||5
8121374|NCT02939326|20017752|P3|COMPLETED|Overall Study||5
8121375|NCT02939326|20017753|P2|COMPLETED|Overall Study||5
8121376|NCT02939326|20017754|P1|COMPLETED|Overall Study||7
8121377|NCT02939326|20017747|P8|STARTED|Overall Study||5
8121378|NCT02939326|20017748|P7|STARTED|Overall Study||5
8121379|NCT02939326|20017749|P6|STARTED|Overall Study||5
8121380|NCT02939326|20017750|P5|STARTED|Overall Study||5
8121381|NCT02939326|20017751|P4|STARTED|Overall Study||5
8121382|NCT02939326|20017752|P3|STARTED|Overall Study||5
8121383|NCT02939326|20017753|P2|STARTED|Overall Study||5
8121384|NCT02939326|20017754|P1|STARTED|Overall Study||7
8121385|NCT02939170|20017774|P2|NOT COMPLETED|Overall Study||0
8121386|NCT02939170|20017775|P1|NOT COMPLETED|Overall Study||0
8121387|NCT02939170|20017774|P2|COMPLETED|Overall Study||40
8121388|NCT02939170|20017775|P1|COMPLETED|Overall Study||40
8121389|NCT02939170|20017774|P2|STARTED|Overall Study||40
8121390|NCT02939170|20017775|P1|STARTED|Overall Study||40
8121399|NCT02939079|20017807|P2|NOT COMPLETED|Overall Study||5
8121400|NCT02939079|20017808|P1|NOT COMPLETED|Overall Study||4
8121401|NCT02939079|20017807|P2|COMPLETED|Overall Study||20
8121402|NCT02939079|20017808|P1|COMPLETED|Overall Study||21
8121403|NCT02939079|20017807|P2|STARTED|Overall Study||25
8121404|NCT02939079|20017808|P1|STARTED|Overall Study||25
8121411|NCT02938949|20017868|P2|NOT COMPLETED|Overall Study||0
8121412|NCT02938949|20017869|P1|NOT COMPLETED|Overall Study||0
8121413|NCT02938949|20017868|P2|COMPLETED|Overall Study||10
8121414|NCT02938949|20017869|P1|COMPLETED|Overall Study||10
8121415|NCT02938949|20017868|P2|STARTED|Overall Study||10
8121416|NCT02938949|20017869|P1|STARTED|Overall Study||10
8121417|NCT02938585|20017883|P4|NOT COMPLETED|Overall Study||5
8121418|NCT02938585|20017884|P3|NOT COMPLETED|Overall Study||0
8121419|NCT02938585|20017885|P2|NOT COMPLETED|Overall Study||1
8121420|NCT02938585|20017886|P1|NOT COMPLETED|Overall Study||0
8121421|NCT02938585|20017883|P4|COMPLETED|Overall Study||10
8121422|NCT02938585|20017884|P3|COMPLETED|Overall Study||11
8121423|NCT02938585|20017885|P2|COMPLETED|Overall Study||32
8121424|NCT02938585|20017886|P1|COMPLETED|Overall Study||9
8121425|NCT02938585|20017883|P4|Exposed to On-demand Regimen|Overall Study||8
8121426|NCT02938585|20017884|P3|Exposed to On-demand Regimen|Overall Study||1
8121427|NCT02938585|20017885|P2|Exposed to On-demand Regimen|Overall Study||7
8121428|NCT02938585|20017886|P1|Exposed to On-demand Regimen|Overall Study||1
8121429|NCT02938585|20017883|P4|Exposed to Prophylaxis Regimen|Overall Study||12
8121430|NCT02938585|20017884|P3|Exposed to Prophylaxis Regimen|Overall Study||11
8121431|NCT02938585|20017885|P2|Exposed to Prophylaxis Regimen|Overall Study||31
8121432|NCT02938585|20017886|P1|Exposed to Prophylaxis Regimen|Overall Study||9
8121433|NCT02938585|20017883|P4|STARTED|Overall Study||15
8121434|NCT02938585|20017884|P3|STARTED|Overall Study||11
8121435|NCT02938585|20017885|P2|STARTED|Overall Study||33
8121436|NCT02938585|20017886|P1|STARTED|Overall Study||9
8121443|NCT02938494|20018180|P4|NOT COMPLETED|Overall Study||4
8121444|NCT02938494|20018181|P3|NOT COMPLETED|Overall Study||4
8121445|NCT02938494|20018182|P2|NOT COMPLETED|Overall Study||9
8121446|NCT02938494|20018183|P1|NOT COMPLETED|Overall Study||4
8121447|NCT02938494|20018180|P4|COMPLETED|Overall Study||31
8121448|NCT02938494|20018181|P3|COMPLETED|Overall Study||30
8121449|NCT02938494|20018182|P2|COMPLETED|Overall Study||63
8121450|NCT02938494|20018183|P1|COMPLETED|Overall Study||65
8121451|NCT02938494|20018180|P4|STARTED|Overall Study||35
8121452|NCT02938494|20018181|P3|STARTED|Overall Study||34
8121453|NCT02938494|20018182|P2|STARTED|Overall Study||72
8121454|NCT02938494|20018183|P1|STARTED|Overall Study||69
8121455|NCT02938169|20018202|P4|NOT COMPLETED|Overall Study||3
8121456|NCT02938169|20018203|P3|NOT COMPLETED|Overall Study||5
8121457|NCT02938169|20018204|P2|NOT COMPLETED|Overall Study||2
8121458|NCT02938169|20018205|P1|NOT COMPLETED|Overall Study||2
8121459|NCT02938169|20018202|P4|COMPLETED|Overall Study||12
8121460|NCT02938169|20018203|P3|COMPLETED|Overall Study||10
8121461|NCT02938169|20018204|P2|COMPLETED|Overall Study||13
8121462|NCT02938169|20018205|P1|COMPLETED|Overall Study||13
8121463|NCT02938169|20018202|P4|STARTED|Overall Study||15
8121464|NCT02938169|20018203|P3|STARTED|Overall Study||15
8121465|NCT02938169|20018204|P2|STARTED|Overall Study||15
8121466|NCT02938169|20018205|P1|STARTED|Overall Study||15
8121467|NCT02938052|20018231|P1|NOT COMPLETED|Overall Study||0
8121468|NCT02938052|20018231|P1|COMPLETED|Overall Study||10
8121469|NCT02938052|20018231|P1|STARTED|Overall Study||10
8121470|NCT02938013|20018254|P3|NOT COMPLETED|Overall Study||0
8121471|NCT02938013|20018255|P2|NOT COMPLETED|Overall Study||0
8121472|NCT02938013|20018256|P1|NOT COMPLETED|Overall Study||0
8121473|NCT02938013|20018254|P3|COMPLETED|Overall Study||5
8121474|NCT02938013|20018255|P2|COMPLETED|Overall Study||5
8121475|NCT02938013|20018256|P1|COMPLETED|Overall Study||5
8121476|NCT02938013|20018254|P3|STARTED|Overall Study||5
8121477|NCT02938013|20018255|P2|STARTED|Overall Study||5
8121478|NCT02938013|20018256|P1|STARTED|Overall Study||5
8121479|NCT02937870|20018273|P1|NOT COMPLETED|Overall Study||3
8121480|NCT02937870|20018273|P1|COMPLETED|Overall Study||20
8121481|NCT02937870|20018273|P1|Received no Adhesive|Overall Study||20
8121482|NCT02937870|20018273|P1|Received Positive Control Adhesive|Overall Study||21
8121483|NCT02937870|20018273|P1|Received Test Adhesive 2|Overall Study||22
8121484|NCT02937870|20018273|P1|Received Test Adhesive 1|Overall Study||21
8121485|NCT02937870|20018273|P1|STARTED|Overall Study||23
8121486|NCT02937766|20018291|P2|NOT COMPLETED|Overall Study||0
8121487|NCT02937766|20018292|P1|NOT COMPLETED|Overall Study||7
8121488|NCT02937766|20018291|P2|COMPLETED|Overall Study||30
8121489|NCT02937766|20018292|P1|COMPLETED|Overall Study||23
8121490|NCT02937766|20018291|P2|STARTED|Overall Study||30
8121491|NCT02937766|20018292|P1|STARTED|Overall Study||30
8121492|NCT02937740|20018304|P2|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2
8121493|NCT02937740|20018305|P1|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1
8121494|NCT02937740|20018304|P2|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15
8121495|NCT02937740|20018305|P1|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12
8121496|NCT02937740|20018304|P2|STARTED|Uptitrated to TID on Day 90 for 30 Days||17
8121497|NCT02937740|20018305|P1|STARTED|Uptitrated to TID on Day 90 for 30 Days||13
8121498|NCT02937740|20018304|P2|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31
8121499|NCT02937740|20018305|P1|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5
8121500|NCT02937740|20018304|P2|COMPLETED|BID for 90 Days, 22 mg/Day||62
8121501|NCT02937740|20018305|P1|COMPLETED|BID for 90 Days, 22 mg/Day||19
8121502|NCT02937740|20018304|P2|STARTED|BID for 90 Days, 22 mg/Day||93
8121503|NCT02937740|20018305|P1|STARTED|BID for 90 Days, 22 mg/Day||24
8121504|NCT02937701|20018321|P5|NOT COMPLETED|Week 22 to Week 50||9
8121505|NCT02937701|20018322|P4|NOT COMPLETED|Week 22 to Week 50||8
8121506|NCT02937701|20018323|P3|NOT COMPLETED|Week 22 to Week 50||32
8121507|NCT02937701|20018324|P2|NOT COMPLETED|Week 22 to Week 50||0
8121508|NCT02937701|20018325|P1|NOT COMPLETED|Week 22 to Week 50||0
8121509|NCT02937701|20018321|P5|COMPLETED|Week 22 to Week 50||110
8121510|NCT02937701|20018322|P4|COMPLETED|Week 22 to Week 50||113
8121511|NCT02937701|20018323|P3|COMPLETED|Week 22 to Week 50||212
8121512|NCT02937701|20018324|P2|COMPLETED|Week 22 to Week 50||0
8121513|NCT02937701|20018325|P1|COMPLETED|Week 22 to Week 50||0
8121514|NCT02937701|20018321|P5|STARTED|Week 22 to Week 50||119
8121515|NCT02937701|20018322|P4|STARTED|Week 22 to Week 50||121
8121516|NCT02937701|20018323|P3|STARTED|Week 22 to Week 50||244
8121517|NCT02937701|20018324|P2|STARTED|Week 22 to Week 50||0
8121518|NCT02937701|20018325|P1|STARTED|Week 22 to Week 50||0
8121519|NCT02937701|20018321|P5|NOT COMPLETED|Day 1 to Week 22||0
8121520|NCT02937701|20018322|P4|NOT COMPLETED|Day 1 to Week 22||0
8121521|NCT02937701|20018323|P3|NOT COMPLETED|Day 1 to Week 22||0
8121522|NCT02937701|20018324|P2|NOT COMPLETED|Day 1 to Week 22||39
8121523|NCT02937701|20018325|P1|NOT COMPLETED|Day 1 to Week 22||35
8121524|NCT02937701|20018321|P5|COMPLETED|Day 1 to Week 22||0
8121525|NCT02937701|20018322|P4|COMPLETED|Day 1 to Week 22||0
8121526|NCT02937701|20018323|P3|COMPLETED|Day 1 to Week 22||0
8121527|NCT02937701|20018324|P2|COMPLETED|Day 1 to Week 22||240
8121528|NCT02937701|20018325|P1|COMPLETED|Day 1 to Week 22||244
8121529|NCT02937701|20018321|P5|Received Treatment|Day 1 to Week 22||0
8121530|NCT02937701|20018322|P4|Received Treatment|Day 1 to Week 22||0
8121531|NCT02937701|20018323|P3|Received Treatment|Day 1 to Week 22||0
8121532|NCT02937701|20018324|P2|Received Treatment|Day 1 to Week 22||278
8121533|NCT02937701|20018325|P1|Received Treatment|Day 1 to Week 22||278
8121534|NCT02937701|20018321|P5|STARTED|Day 1 to Week 22||0
8121535|NCT02937701|20018322|P4|STARTED|Day 1 to Week 22||0
8121536|NCT02937701|20018323|P3|STARTED|Day 1 to Week 22||0
8121537|NCT02937701|20018324|P2|STARTED|Day 1 to Week 22||279
8121538|NCT02937701|20018325|P1|STARTED|Day 1 to Week 22||279
8121539|NCT02937636|20018356|P2|NOT COMPLETED|Overall Study||2
8121540|NCT02937636|20018357|P1|NOT COMPLETED|Overall Study||3
8121541|NCT02937636|20018356|P2|COMPLETED|Overall Study||63
8121542|NCT02937636|20018357|P1|COMPLETED|Overall Study||60
8121543|NCT02937636|20018356|P2|STARTED|Overall Study||65
8121544|NCT02937636|20018357|P1|STARTED|Overall Study||63
8121545|NCT02937623|20018371|P2|NOT COMPLETED|Overall Study||0
8121546|NCT02937623|20018372|P1|NOT COMPLETED|Overall Study||0
8121547|NCT02937623|20018371|P2|COMPLETED|Overall Study||60
8121548|NCT02937623|20018372|P1|COMPLETED|Overall Study||60
8121549|NCT02937623|20018371|P2|STARTED|Overall Study||60
8121550|NCT02937623|20018372|P1|STARTED|Overall Study||60
8121551|NCT02937584|20018384|P2|NOT COMPLETED|Period 2||0
8121552|NCT02937584|20018385|P1|NOT COMPLETED|Period 2||0
8121553|NCT02937584|20018384|P2|COMPLETED|Period 2||9
8121554|NCT02937584|20018385|P1|COMPLETED|Period 2||10
8121555|NCT02937584|20018384|P2|STARTED|Period 2||9
8121556|NCT02937584|20018385|P1|STARTED|Period 2||10
8121557|NCT02937584|20018384|P2|NOT COMPLETED|Washout||1
8121558|NCT02937584|20018385|P1|NOT COMPLETED|Washout||0
8121559|NCT02937584|20018384|P2|COMPLETED|Washout||9
8121560|NCT02937584|20018385|P1|COMPLETED|Washout||10
8121561|NCT02937584|20018384|P2|STARTED|Washout||10
8121562|NCT02937584|20018385|P1|STARTED|Washout||10
8121563|NCT02937584|20018384|P2|NOT COMPLETED|Period 1||2
8121564|NCT02937584|20018385|P1|NOT COMPLETED|Period 1||1
8121565|NCT02937584|20018384|P2|COMPLETED|Period 1||10
8121566|NCT02937584|20018385|P1|COMPLETED|Period 1||10
8121567|NCT02937584|20018384|P2|STARTED|Period 1||12
8121568|NCT02937584|20018385|P1|STARTED|Period 1||11
8121569|NCT02937558|20018403|P2|NOT COMPLETED|Open-label Phase||0
8121570|NCT02937558|20018404|P1|NOT COMPLETED|Open-label Phase||0
8121571|NCT02937558|20018403|P2|COMPLETED|Open-label Phase||0
8121572|NCT02937558|20018404|P1|COMPLETED|Open-label Phase||5
8121573|NCT02937558|20018403|P2|STARTED|Open-label Phase||0
8121574|NCT02937558|20018404|P1|STARTED|Open-label Phase||5
8121575|NCT02937558|20018403|P2|NOT COMPLETED|Double-blind Phase||0
8121576|NCT02937558|20018404|P1|NOT COMPLETED|Double-blind Phase||0
8121577|NCT02937558|20018403|P2|COMPLETED|Double-blind Phase||2
8121578|NCT02937558|20018404|P1|COMPLETED|Double-blind Phase||3
8121579|NCT02937558|20018403|P2|STARTED|Double-blind Phase||2
8121580|NCT02937558|20018404|P1|STARTED|Double-blind Phase||3
8121581|NCT02937506|20018419|P2|NOT COMPLETED|Overall Study||0
8121582|NCT02937506|20018420|P1|NOT COMPLETED|Overall Study||0
8121583|NCT02937506|20018419|P2|COMPLETED|Overall Study||300
8121584|NCT02937506|20018420|P1|COMPLETED|Overall Study||300
8121585|NCT02937506|20018419|P2|STARTED|Overall Study||300
8121586|NCT02937506|20018420|P1|STARTED|Overall Study||300
8121587|NCT02937168|20018426|P3|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
8121588|NCT02937168|20018427|P2|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
8121589|NCT02937168|20018428|P1|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
8121590|NCT02937168|20018426|P3|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
8121591|NCT02937168|20018427|P2|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
8121592|NCT02937168|20018428|P1|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
8121593|NCT02937168|20018426|P3|STARTED|Double-Blind Treatment Period (6 Weeks)||0
8121594|NCT02937168|20018427|P2|STARTED|Double-Blind Treatment Period (6 Weeks)||0
8121595|NCT02937168|20018428|P1|STARTED|Double-Blind Treatment Period (6 Weeks)||0
8121596|NCT02937168|20018426|P3|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
8121597|NCT02937168|20018427|P2|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
8121598|NCT02937168|20018428|P1|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
8121599|NCT02937168|20018426|P3|COMPLETED|PET/CT Screening Period (21 Days)||0
8121600|NCT02937168|20018427|P2|COMPLETED|PET/CT Screening Period (21 Days)||0
8121601|NCT02937168|20018428|P1|COMPLETED|PET/CT Screening Period (21 Days)||5
8121602|NCT02937168|20018426|P3|STARTED|PET/CT Screening Period (21 Days)||0
8121603|NCT02937168|20018427|P2|STARTED|PET/CT Screening Period (21 Days)||0
8121604|NCT02937168|20018428|P1|STARTED|PET/CT Screening Period (21 Days)||5
8121605|NCT02936999|20018446|P1|NOT COMPLETED|Overall Study||0
8121606|NCT02936999|20018446|P1|COMPLETED|Overall Study||8
8121607|NCT02936999|20018446|P1|STARTED|Overall Study||8
8121608|NCT02936869|20018456|P2|NOT COMPLETED|Overall Study||5
8121609|NCT02936869|20018457|P1|NOT COMPLETED|Overall Study||2
8121610|NCT02936869|20018456|P2|COMPLETED|Overall Study||98
8121611|NCT02936869|20018457|P1|COMPLETED|Overall Study||102
8121612|NCT02936869|20018456|P2|STARTED|Overall Study||103
8121613|NCT02936869|20018457|P1|STARTED|Overall Study||104
8121614|NCT02936648|20018465|P1|NOT COMPLETED|Overall Study||0
8121615|NCT02936648|20018465|P1|COMPLETED|Overall Study||2209
8121616|NCT02936648|20018465|P1|STARTED|Overall Study||2209
8121617|NCT02936479|20018469|P1|NOT COMPLETED|Overall Study||0
8121618|NCT02936479|20018469|P1|COMPLETED|Overall Study||1
8121619|NCT02936479|20018469|P1|STARTED|Overall Study||1
8121626|NCT02936037|20018490|P2|NOT COMPLETED|Open Label Extension||10
8121627|NCT02936037|20018491|P1|NOT COMPLETED|Open Label Extension||0
8121628|NCT02936037|20018490|P2|COMPLETED|Open Label Extension||518
8121629|NCT02936037|20018491|P1|COMPLETED|Open Label Extension||0
8121630|NCT02936037|20018490|P2|STARTED|Open Label Extension||528
8121631|NCT02936037|20018491|P1|STARTED|Open Label Extension||0
8121632|NCT02936037|20018490|P2|NOT COMPLETED|Double-Blind Treatment Period||65
8121633|NCT02936037|20018491|P1|NOT COMPLETED|Double-Blind Treatment Period||49
8121634|NCT02936037|20018490|P2|COMPLETED|Double-Blind Treatment Period||261
8121635|NCT02936037|20018491|P1|COMPLETED|Double-Blind Treatment Period||267
8121636|NCT02936037|20018490|P2|STARTED|Double-Blind Treatment Period||326
8121637|NCT02936037|20018491|P1|STARTED|Double-Blind Treatment Period||316
8121638|NCT02935894|20018497|P1|NOT COMPLETED|Overall Study||1
8121639|NCT02935894|20018497|P1|COMPLETED|Overall Study||13
8121640|NCT02935894|20018497|P1|STARTED|Overall Study||14
8121641|NCT02935842|20018512|P4|NOT COMPLETED|Testing and Therapy Period 3||1
8121642|NCT02935842|20018513|P3|NOT COMPLETED|Testing and Therapy Period 3||5
8121643|NCT02935842|20018514|P2|NOT COMPLETED|Testing and Therapy Period 3||4
8121644|NCT02935842|20018515|P1|NOT COMPLETED|Testing and Therapy Period 3||3
8121645|NCT02935842|20018512|P4|COMPLETED|Testing and Therapy Period 3||17
8121646|NCT02935842|20018513|P3|COMPLETED|Testing and Therapy Period 3||1
8121647|NCT02935842|20018514|P2|COMPLETED|Testing and Therapy Period 3||2
8121648|NCT02935842|20018515|P1|COMPLETED|Testing and Therapy Period 3||3
8121649|NCT02935842|20018512|P4|STARTED|Testing and Therapy Period 3|HC received no interventions. They have only been tested at BL, 4 Weeks and 6 Months.|18
8121650|NCT02935842|20018513|P3|STARTED|Testing and Therapy Period 3||6
8121651|NCT02935842|20018514|P2|STARTED|Testing and Therapy Period 3||6
8121652|NCT02935842|20018515|P1|STARTED|Testing and Therapy Period 3||6
8121653|NCT02935842|20018512|P4|NOT COMPLETED|Testing and Therapy Period 2||0
8121654|NCT02935842|20018513|P3|NOT COMPLETED|Testing and Therapy Period 2||0
8121655|NCT02935842|20018514|P2|NOT COMPLETED|Testing and Therapy Period 2||0
8121656|NCT02935842|20018515|P1|NOT COMPLETED|Testing and Therapy Period 2||2
8121657|NCT02935842|20018512|P4|COMPLETED|Testing and Therapy Period 2||0
8121658|NCT02935842|20018513|P3|COMPLETED|Testing and Therapy Period 2||6
8121659|NCT02935842|20018514|P2|COMPLETED|Testing and Therapy Period 2||6
8121660|NCT02935842|20018515|P1|COMPLETED|Testing and Therapy Period 2||6
8121661|NCT02935842|20018512|P4|STARTED|Testing and Therapy Period 2|Due to limited staff capacity, HC have only been included in the final tranche.|0
8121662|NCT02935842|20018513|P3|STARTED|Testing and Therapy Period 2||6
8121663|NCT02935842|20018514|P2|STARTED|Testing and Therapy Period 2||6
8121664|NCT02935842|20018515|P1|STARTED|Testing and Therapy Period 2||8
8121665|NCT02935842|20018512|P4|NOT COMPLETED|Testing and Therapy Period 1||0
8121666|NCT02935842|20018513|P3|NOT COMPLETED|Testing and Therapy Period 1||0
8121667|NCT02935842|20018514|P2|NOT COMPLETED|Testing and Therapy Period 1||0
8121668|NCT02935842|20018515|P1|NOT COMPLETED|Testing and Therapy Period 1||0
8121669|NCT02935842|20018512|P4|COMPLETED|Testing and Therapy Period 1||0
8121670|NCT02935842|20018513|P3|COMPLETED|Testing and Therapy Period 1||6
8121671|NCT02935842|20018514|P2|COMPLETED|Testing and Therapy Period 1||6
8121672|NCT02935842|20018515|P1|COMPLETED|Testing and Therapy Period 1||8
8121673|NCT02935842|20018512|P4|STARTED|Testing and Therapy Period 1|Due to limited staff capacity, HC have only been included in the final tranche.|0
8121674|NCT02935842|20018513|P3|STARTED|Testing and Therapy Period 1||6
8121675|NCT02935842|20018514|P2|STARTED|Testing and Therapy Period 1||6
8121676|NCT02935842|20018515|P1|STARTED|Testing and Therapy Period 1||8
8121677|NCT02935738|20018553|P4|NOT COMPLETED|Overall Study||5
8121678|NCT02935738|20018554|P3|NOT COMPLETED|Overall Study||1
8121679|NCT02935738|20018555|P2|NOT COMPLETED|Overall Study||21
8121680|NCT02935738|20018556|P1|NOT COMPLETED|Overall Study||17
8121681|NCT02935738|20018553|P4|COMPLETED|Overall Study||48
8121682|NCT02935738|20018554|P3|COMPLETED|Overall Study||46
8121683|NCT02935738|20018555|P2|COMPLETED|Overall Study||53
8121684|NCT02935738|20018556|P1|COMPLETED|Overall Study||50
8121685|NCT02935738|20018553|P4|STARTED|Overall Study||53
8121686|NCT02935738|20018554|P3|STARTED|Overall Study||47
8121687|NCT02935738|20018555|P2|STARTED|Overall Study||74
8121688|NCT02935738|20018556|P1|STARTED|Overall Study||67
8121689|NCT02935699|20018568|P2|NOT COMPLETED|Overall Study||0
8121690|NCT02935699|20018569|P1|NOT COMPLETED|Overall Study||0
8121691|NCT02935699|20018568|P2|COMPLETED|Overall Study||135
8121692|NCT02935699|20018569|P1|COMPLETED|Overall Study||127
8121693|NCT02935699|20018568|P2|STARTED|Overall Study||135
8121694|NCT02935699|20018569|P1|STARTED|Overall Study||127
8121695|NCT02935673|20018584|P3|NOT COMPLETED|Overall Study||0
8121696|NCT02935673|20018585|P2|NOT COMPLETED|Overall Study||3
8121697|NCT02935673|20018586|P1|NOT COMPLETED|Overall Study||1
8121698|NCT02935673|20018584|P3|COMPLETED|Overall Study||6
8121699|NCT02935673|20018585|P2|COMPLETED|Overall Study||24
8121700|NCT02935673|20018586|P1|COMPLETED|Overall Study||15
8121701|NCT02935673|20018584|P3|STARTED|Overall Study||6
8121702|NCT02935673|20018585|P2|STARTED|Overall Study||27
8121703|NCT02935673|20018586|P1|STARTED|Overall Study||16
8121704|NCT02935595|20018708|P1|NOT COMPLETED|Overall Study||1
8121705|NCT02935595|20018708|P1|COMPLETED|Overall Study||4
8121706|NCT02935595|20018708|P1|STARTED|Overall Study||5
8121707|NCT02935543|20018719|P1|NOT COMPLETED|Overall Study||0
8121708|NCT02935543|20018719|P1|COMPLETED|Overall Study||1
8121709|NCT02935543|20018719|P1|STARTED|Overall Study||1
8121710|NCT02935192|20018731|P2|NOT COMPLETED|Overall Study||4
8121711|NCT02935192|20018732|P1|NOT COMPLETED|Overall Study||8
8121712|NCT02935192|20018731|P2|COMPLETED|Overall Study||156
8121713|NCT02935192|20018732|P1|COMPLETED|Overall Study||312
8121714|NCT02935192|20018731|P2|Received Vaccine/Placebo|Overall Study||156
8121715|NCT02935192|20018732|P1|Received Vaccine/Placebo|Overall Study||312
8121716|NCT02935192|20018731|P2|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160
8121717|NCT02935192|20018732|P1|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320
8121718|NCT02935179|20018756|P2|NOT COMPLETED|Overall Study||1
8121719|NCT02935179|20018757|P1|NOT COMPLETED|Overall Study||1
8121720|NCT02935179|20018756|P2|COMPLETED|Overall Study||29
8121721|NCT02935179|20018757|P1|COMPLETED|Overall Study||29
8121722|NCT02935179|20018756|P2|STARTED|Overall Study||30
8121723|NCT02935179|20018757|P1|STARTED|Overall Study||30
8121724|NCT02935088|20018765|P1|NOT COMPLETED|Overall Study||102
8121725|NCT02935088|20018765|P1|COMPLETED|Overall Study||2115
8121726|NCT02935088|20018765|P1|STARTED|Overall Study||2217
8121727|NCT02935062|20018780|P3|NOT COMPLETED|Overall Study||0
8121728|NCT02935062|20018781|P2|NOT COMPLETED|Overall Study||0
8121729|NCT02935062|20018782|P1|NOT COMPLETED|Overall Study||0
8121730|NCT02935062|20018780|P3|COMPLETED|Overall Study||8
8121731|NCT02935062|20018781|P2|COMPLETED|Overall Study||8
8121732|NCT02935062|20018782|P1|COMPLETED|Overall Study||8
8121733|NCT02935062|20018780|P3|STARTED|Overall Study||8
8121734|NCT02935062|20018781|P2|STARTED|Overall Study||8
8121735|NCT02935062|20018782|P1|STARTED|Overall Study||8
8121736|NCT02935036|20018795|P2|NOT COMPLETED|Overall Study||11
8121737|NCT02935036|20018796|P1|NOT COMPLETED|Overall Study||10
8121738|NCT02935036|20018795|P2|COMPLETED|Overall Study||136
8121739|NCT02935036|20018796|P1|COMPLETED|Overall Study||137
8121740|NCT02935036|20018795|P2|STARTED|Overall Study||147
8121741|NCT02935036|20018796|P1|STARTED|Overall Study||147
8121742|NCT02934932|20018806|P1|NOT COMPLETED|Overall Study||3
8121743|NCT02934932|20018806|P1|COMPLETED|Overall Study||6
8121744|NCT02934932|20018806|P1|STARTED|Overall Study||9
8121745|NCT02934698|20018815|P1|NOT COMPLETED|Overall Study||0
8121746|NCT02934698|20018815|P1|COMPLETED|Overall Study||2
8121747|NCT02934698|20018815|P1|STARTED|Overall Study||2
8121748|NCT02934347|20018823|P2|NOT COMPLETED|Overall Study||0
8121749|NCT02934347|20018824|P1|NOT COMPLETED|Overall Study||0
8121750|NCT02934347|20018823|P2|COMPLETED|Overall Study||407
8121751|NCT02934347|20018824|P1|COMPLETED|Overall Study||374
8121752|NCT02934347|20018823|P2|STARTED|Overall Study||407
8121753|NCT02934347|20018824|P1|STARTED|Overall Study||374
8121754|NCT02934191|20018838|P2|NOT COMPLETED|Overall Study||0
8121755|NCT02934191|20018839|P1|NOT COMPLETED|Overall Study||0
8121756|NCT02934191|20018838|P2|COMPLETED|Overall Study||85
8121757|NCT02934191|20018839|P1|COMPLETED|Overall Study||87
8121758|NCT02934191|20018838|P2|STARTED|Overall Study||85
8121759|NCT02934191|20018839|P1|STARTED|Overall Study||87
8121760|NCT02934178|20018849|P2|NOT COMPLETED|Received Vaccination 3||0
8121761|NCT02934178|20018850|P1|NOT COMPLETED|Received Vaccination 3||1
8121762|NCT02934178|20018849|P2|COMPLETED|Received Vaccination 3||3
8121763|NCT02934178|20018850|P1|COMPLETED|Received Vaccination 3||11
8121764|NCT02934178|20018849|P2|STARTED|Received Vaccination 3||3
8121765|NCT02934178|20018850|P1|STARTED|Received Vaccination 3||12
8121766|NCT02934178|20018849|P2|NOT COMPLETED|Received Vaccination 2||1
8121767|NCT02934178|20018850|P1|NOT COMPLETED|Received Vaccination 2||0
8121768|NCT02934178|20018849|P2|COMPLETED|Received Vaccination 2||3
8121769|NCT02934178|20018850|P1|COMPLETED|Received Vaccination 2||12
8121770|NCT02934178|20018849|P2|STARTED|Received Vaccination 2||4
8121771|NCT02934178|20018850|P1|STARTED|Received Vaccination 2||12
8121772|NCT02934178|20018849|P2|NOT COMPLETED|Received Vaccination 1||0
8121773|NCT02934178|20018850|P1|NOT COMPLETED|Received Vaccination 1||0
8121774|NCT02934178|20018849|P2|COMPLETED|Received Vaccination 1||4
8121775|NCT02934178|20018850|P1|COMPLETED|Received Vaccination 1||12
8121776|NCT02934178|20018849|P2|STARTED|Received Vaccination 1||4
8121777|NCT02934178|20018850|P1|STARTED|Received Vaccination 1||12
8121778|NCT02933879|20018945|P3|NOT COMPLETED|Overall Study||17
8121779|NCT02933879|20018946|P2|NOT COMPLETED|Overall Study||14
8121780|NCT02933879|20018947|P1|NOT COMPLETED|Overall Study||16
8121781|NCT02933879|20018945|P3|COMPLETED|Overall Study||41
8121782|NCT02933879|20018946|P2|COMPLETED|Overall Study||48
8121783|NCT02933879|20018947|P1|COMPLETED|Overall Study||48
8121784|NCT02933879|20018945|P3|STARTED|Overall Study||58
8121785|NCT02933879|20018946|P2|STARTED|Overall Study||62
8121786|NCT02933879|20018947|P1|STARTED|Overall Study||64
8121787|NCT02933866|20018983|P2|NOT COMPLETED|Overall Study||9
8121788|NCT02933866|20018984|P1|NOT COMPLETED|Overall Study||12
8121789|NCT02933866|20018983|P2|COMPLETED|Overall Study||176
8121790|NCT02933866|20018984|P1|COMPLETED|Overall Study||174
8121791|NCT02933866|20018983|P2|STARTED|Overall Study||185
8121792|NCT02933866|20018984|P1|STARTED|Overall Study||186
8121793|NCT02933528|20018990|P1|NOT COMPLETED|Overall Study||2
8121794|NCT02933528|20018990|P1|COMPLETED|Overall Study||22
8121795|NCT02933528|20018990|P1|STARTED|Overall Study||24
8121796|NCT02933502|20018994|P1|NOT COMPLETED|Overall Study||0
8121797|NCT02933502|20018994|P1|COMPLETED|Overall Study||3
8121798|NCT02933502|20018994|P1|STARTED|Overall Study||3
8121799|NCT02933476|20018998|P1|NOT COMPLETED|Overall Study||0
8121800|NCT02933476|20018998|P1|COMPLETED|Overall Study||5
8121801|NCT02933476|20018998|P1|STARTED|Overall Study||5
8121802|NCT02933450|20019007|P2|NOT COMPLETED|Overall Study||8
8121803|NCT02933450|20019008|P1|NOT COMPLETED|Overall Study||5
8121804|NCT02933450|20019007|P2|COMPLETED|Overall Study||15
8121805|NCT02933450|20019008|P1|COMPLETED|Overall Study||15
8121806|NCT02933450|20019007|P2|STARTED|Overall Study||23
8121807|NCT02933450|20019008|P1|STARTED|Overall Study||20
8121808|NCT02933060|20019018|P2|NOT COMPLETED|Overall Study||1
8121809|NCT02933060|20019019|P1|NOT COMPLETED|Overall Study||0
8121810|NCT02933060|20019018|P2|COMPLETED|Overall Study||24
8121811|NCT02933060|20019019|P1|COMPLETED|Overall Study||25
8121812|NCT02933060|20019018|P2|STARTED|Overall Study||25
8121813|NCT02933060|20019019|P1|STARTED|Overall Study||25
8121814|NCT02933034|20019043|P1|NOT COMPLETED|Overall Study||9
8121815|NCT02933034|20019043|P1|COMPLETED|Overall Study||24
8121816|NCT02933034|20019043|P1|Received Both MEMRI and DEMRI Scans|Overall Study||24
8121817|NCT02933034|20019043|P1|STARTED|Overall Study||33
8121818|NCT02932943|20019060|P2|NOT COMPLETED|Overall Study||7
8121819|NCT02932943|20019061|P1|NOT COMPLETED|Overall Study||5
8121820|NCT02932943|20019060|P2|COMPLETED|Overall Study||224
8121821|NCT02932943|20019061|P1|COMPLETED|Overall Study||222
8121822|NCT02932943|20019060|P2|STARTED|Overall Study||231
8121823|NCT02932943|20019061|P1|STARTED|Overall Study||227
8121824|NCT02932904|20019077|P4|NOT COMPLETED|Overall Study||14
8121825|NCT02932904|20019078|P3|NOT COMPLETED|Overall Study||23
8121826|NCT02932904|20019079|P2|NOT COMPLETED|Overall Study||18
8121827|NCT02932904|20019080|P1|NOT COMPLETED|Overall Study||16
8121828|NCT02932904|20019077|P4|COMPLETED|Overall Study||79
8121829|NCT02932904|20019078|P3|COMPLETED|Overall Study||68
8121830|NCT02932904|20019079|P2|COMPLETED|Overall Study||67
8121831|NCT02932904|20019080|P1|COMPLETED|Overall Study||76
8121832|NCT02932904|20019077|P4|Treated|Overall Study||91
8121833|NCT02932904|20019078|P3|Treated|Overall Study||91
8121834|NCT02932904|20019079|P2|Treated|Overall Study||84
8121835|NCT02932904|20019080|P1|Treated|Overall Study||91
8121836|NCT02932904|20019077|P4|STARTED|Overall Study||93
8121837|NCT02932904|20019078|P3|STARTED|Overall Study||91
8121838|NCT02932904|20019079|P2|STARTED|Overall Study||85
8121839|NCT02932904|20019080|P1|STARTED|Overall Study||92
8121840|NCT02932891|20019115|P1|NOT COMPLETED|Overall Study||4
8121841|NCT02932891|20019115|P1|COMPLETED|Overall Study||24
8121842|NCT02932891|20019115|P1|STARTED|Overall Study||28
8121843|NCT02932878|20019121|P2|NOT COMPLETED|Overall Study||1
8121844|NCT02932878|20019122|P1|NOT COMPLETED|Overall Study||2
8121845|NCT02932878|20019121|P2|COMPLETED|Overall Study||0
8121846|NCT02932878|20019122|P1|COMPLETED|Overall Study||13
8121847|NCT02932878|20019121|P2|STARTED|Overall Study||1
8121848|NCT02932878|20019122|P1|STARTED|Overall Study||15
8121849|NCT02932787|20019130|P2|NOT COMPLETED|Overall Study||0
8121850|NCT02932787|20019131|P1|NOT COMPLETED|Overall Study||0
8121851|NCT02932787|20019130|P2|COMPLETED|Overall Study||9
8121852|NCT02932787|20019131|P1|COMPLETED|Overall Study||22
8121853|NCT02932787|20019130|P2|STARTED|Overall Study||9
8121854|NCT02932787|20019131|P1|STARTED|Overall Study||22
8121855|NCT02932462|20019143|P2|NOT COMPLETED|Overall Study||13
8121856|NCT02932462|20019144|P1|NOT COMPLETED|Overall Study||7
8121857|NCT02932462|20019143|P2|COMPLETED|Overall Study||176
8121858|NCT02932462|20019144|P1|COMPLETED|Overall Study||177
8121859|NCT02932462|20019143|P2|STARTED|Overall Study||189
8121860|NCT02932462|20019144|P1|STARTED|Overall Study||184
8121861|NCT02932306|20019156|P2|NOT COMPLETED|Overall Study||77
8121862|NCT02932306|20019157|P1|NOT COMPLETED|Overall Study||68
8121863|NCT02932306|20019156|P2|COMPLETED|Overall Study||337
8121864|NCT02932306|20019157|P1|COMPLETED|Overall Study||338
8121865|NCT02932306|20019156|P2|Safety Population|Overall Study||385
8121866|NCT02932306|20019157|P1|Safety Population|Overall Study||378
8121867|NCT02932306|20019156|P2|Intent-to-treat (ITT) Population|Overall Study||414
8121868|NCT02932306|20019157|P1|Intent-to-treat (ITT) Population|Overall Study||406
8121869|NCT02932306|20019156|P2|STARTED|Overall Study||414
8121870|NCT02932306|20019157|P1|STARTED|Overall Study||406
8121874|NCT02932228|20019177|P2|NOT COMPLETED|Overall Study||28
8121875|NCT02932228|20019178|P1|NOT COMPLETED|Overall Study||10
8121876|NCT02932228|20019177|P2|COMPLETED|Overall Study||405
8121877|NCT02932228|20019178|P1|COMPLETED|Overall Study||140
8121878|NCT02932228|20019177|P2|STARTED|Overall Study||433
8121879|NCT02932228|20019178|P1|STARTED|Overall Study||150
8121880|NCT02931838|20019203|P6|NOT COMPLETED|Overall Study||2
8121881|NCT02931838|20019204|P5|NOT COMPLETED|Overall Study||6
8121882|NCT02931838|20019205|P4|NOT COMPLETED|Overall Study||3
8121883|NCT02931838|20019206|P3|NOT COMPLETED|Overall Study||8
8121884|NCT02931838|20019207|P2|NOT COMPLETED|Overall Study||10
8121885|NCT02931838|20019208|P1|NOT COMPLETED|Overall Study||14
8121886|NCT02931838|20019203|P6|COMPLETED|Overall Study||42
8121887|NCT02931838|20019204|P5|COMPLETED|Overall Study||39
8121888|NCT02931838|20019205|P4|COMPLETED|Overall Study||42
8121889|NCT02931838|20019206|P3|COMPLETED|Overall Study||36
8121890|NCT02931838|20019207|P2|COMPLETED|Overall Study||34
8121891|NCT02931838|20019208|P1|COMPLETED|Overall Study||31
8121892|NCT02931838|20019203|P6|STARTED|Overall Study||44
8121893|NCT02931838|20019204|P5|STARTED|Overall Study||45
8121894|NCT02931838|20019205|P4|STARTED|Overall Study||45
8121895|NCT02931838|20019206|P3|STARTED|Overall Study||44
8121896|NCT02931838|20019207|P2|STARTED|Overall Study||44
8121897|NCT02931838|20019208|P1|STARTED|Overall Study||45
8121898|NCT02931396|20019259|P2|NOT COMPLETED|Overall Study||0
8121899|NCT02931396|20019260|P1|NOT COMPLETED|Overall Study||5
8121900|NCT02931396|20019259|P2|COMPLETED|Overall Study||10
8121901|NCT02931396|20019260|P1|COMPLETED|Overall Study||5
8121902|NCT02931396|20019259|P2|STARTED|Overall Study||10
8121903|NCT02931396|20019260|P1|STARTED|Overall Study||10
8121904|NCT02931253|20019272|P2|NOT COMPLETED|Overall Study||0
8121905|NCT02931253|20019273|P1|NOT COMPLETED|Overall Study||0
8121906|NCT02931253|20019272|P2|COMPLETED|Overall Study||4
8121907|NCT02931253|20019273|P1|COMPLETED|Overall Study||2
8121908|NCT02931253|20019272|P2|STARTED|Overall Study||4
8121909|NCT02931253|20019273|P1|STARTED|Overall Study||2
8121910|NCT02931045|20019295|P2|NOT COMPLETED|Overall Study||2
8121911|NCT02931045|20019296|P1|NOT COMPLETED|Overall Study||3
8121912|NCT02931045|20019295|P2|COMPLETED|Overall Study||28
8121913|NCT02931045|20019296|P1|COMPLETED|Overall Study||27
8121914|NCT02931045|20019295|P2|STARTED|Overall Study||30
8121915|NCT02931045|20019296|P1|STARTED|Overall Study||30
8121916|NCT02930980|20019302|P1|NOT COMPLETED|Overall Study||0
8121917|NCT02930980|20019302|P1|COMPLETED|Overall Study||43
8121918|NCT02930980|20019302|P1|STARTED|Overall Study||43
8121919|NCT02930837|20019306|P1|NOT COMPLETED|Overall Study||12
8121920|NCT02930837|20019306|P1|COMPLETED|Overall Study|Completed the trial|108
8121921|NCT02930837|20019306|P1|STARTED|Overall Study|Started are treated patients|120
8121922|NCT02930590|20019316|P6|NOT COMPLETED|Third Intervention (2 Hours)||0
8121923|NCT02930590|20019317|P5|NOT COMPLETED|Third Intervention (2 Hours)||0
8121924|NCT02930590|20019318|P4|NOT COMPLETED|Third Intervention (2 Hours)||0
8121925|NCT02930590|20019319|P3|NOT COMPLETED|Third Intervention (2 Hours)||0
8121926|NCT02930590|20019320|P2|NOT COMPLETED|Third Intervention (2 Hours)||0
8121927|NCT02930590|20019321|P1|NOT COMPLETED|Third Intervention (2 Hours)||0
8121928|NCT02930590|20019316|P6|COMPLETED|Third Intervention (2 Hours)||2
8121929|NCT02930590|20019317|P5|COMPLETED|Third Intervention (2 Hours)||2
8121930|NCT02930590|20019318|P4|COMPLETED|Third Intervention (2 Hours)||2
8121931|NCT02930590|20019319|P3|COMPLETED|Third Intervention (2 Hours)||3
8121932|NCT02930590|20019320|P2|COMPLETED|Third Intervention (2 Hours)||3
8121933|NCT02930590|20019321|P1|COMPLETED|Third Intervention (2 Hours)||3
8121934|NCT02930590|20019316|P6|STARTED|Third Intervention (2 Hours)||2
8121935|NCT02930590|20019317|P5|STARTED|Third Intervention (2 Hours)||2
8121936|NCT02930590|20019318|P4|STARTED|Third Intervention (2 Hours)||2
8121937|NCT02930590|20019319|P3|STARTED|Third Intervention (2 Hours)||3
8121938|NCT02930590|20019320|P2|STARTED|Third Intervention (2 Hours)||3
8121939|NCT02930590|20019321|P1|STARTED|Third Intervention (2 Hours)||3
8121940|NCT02930590|20019316|P6|NOT COMPLETED|Second Intervention (2 Hours)||0
8121941|NCT02930590|20019317|P5|NOT COMPLETED|Second Intervention (2 Hours)||0
8121942|NCT02930590|20019318|P4|NOT COMPLETED|Second Intervention (2 Hours)||0
8121943|NCT02930590|20019319|P3|NOT COMPLETED|Second Intervention (2 Hours)||0
8121944|NCT02930590|20019320|P2|NOT COMPLETED|Second Intervention (2 Hours)||0
8121945|NCT02930590|20019321|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
8121946|NCT02930590|20019316|P6|COMPLETED|Second Intervention (2 Hours)||2
8121947|NCT02930590|20019317|P5|COMPLETED|Second Intervention (2 Hours)||2
8121948|NCT02930590|20019318|P4|COMPLETED|Second Intervention (2 Hours)||2
8121949|NCT02930590|20019319|P3|COMPLETED|Second Intervention (2 Hours)||3
8121950|NCT02930590|20019320|P2|COMPLETED|Second Intervention (2 Hours)||3
8121951|NCT02930590|20019321|P1|COMPLETED|Second Intervention (2 Hours)||3
8121952|NCT02930590|20019316|P6|STARTED|Second Intervention (2 Hours)||2
8121953|NCT02930590|20019317|P5|STARTED|Second Intervention (2 Hours)||2
8121954|NCT02930590|20019318|P4|STARTED|Second Intervention (2 Hours)||2
8121955|NCT02930590|20019319|P3|STARTED|Second Intervention (2 Hours)||3
8121956|NCT02930590|20019320|P2|STARTED|Second Intervention (2 Hours)||3
8121957|NCT02930590|20019321|P1|STARTED|Second Intervention (2 Hours)||3
8121958|NCT02930590|20019316|P6|NOT COMPLETED|First Intervention (2 Hours)||0
8121959|NCT02930590|20019317|P5|NOT COMPLETED|First Intervention (2 Hours)||0
8121960|NCT02930590|20019318|P4|NOT COMPLETED|First Intervention (2 Hours)||0
8121961|NCT02930590|20019319|P3|NOT COMPLETED|First Intervention (2 Hours)||0
8121962|NCT02930590|20019320|P2|NOT COMPLETED|First Intervention (2 Hours)||0
8121963|NCT02930590|20019321|P1|NOT COMPLETED|First Intervention (2 Hours)||0
8121964|NCT02930590|20019316|P6|COMPLETED|First Intervention (2 Hours)||2
8121965|NCT02930590|20019317|P5|COMPLETED|First Intervention (2 Hours)||2
8121966|NCT02930590|20019318|P4|COMPLETED|First Intervention (2 Hours)||2
8121967|NCT02930590|20019319|P3|COMPLETED|First Intervention (2 Hours)||3
8121968|NCT02930590|20019320|P2|COMPLETED|First Intervention (2 Hours)||3
8121969|NCT02930590|20019321|P1|COMPLETED|First Intervention (2 Hours)||3
8121970|NCT02930590|20019316|P6|STARTED|First Intervention (2 Hours)||2
8121971|NCT02930590|20019317|P5|STARTED|First Intervention (2 Hours)||2
8121972|NCT02930590|20019318|P4|STARTED|First Intervention (2 Hours)||2
8121973|NCT02930590|20019319|P3|STARTED|First Intervention (2 Hours)||3
8121974|NCT02930590|20019320|P2|STARTED|First Intervention (2 Hours)||3
8121975|NCT02930590|20019321|P1|STARTED|First Intervention (2 Hours)||3
8121994|NCT02930174|20019643|P2|NOT COMPLETED|Overall Study||0
8121995|NCT02930174|20019644|P1|NOT COMPLETED|Overall Study||0
8121996|NCT02930174|20019643|P2|COMPLETED|Overall Study||8
8121997|NCT02930174|20019644|P1|COMPLETED|Overall Study||12
8121998|NCT02930174|20019643|P2|STARTED|Overall Study||8
8121999|NCT02930174|20019644|P1|STARTED|Overall Study||12
8122000|NCT02930018|20019661|P2|NOT COMPLETED|Overall Study||3
8122001|NCT02930018|20019662|P1|NOT COMPLETED|Overall Study||6
8122002|NCT02930018|20019661|P2|COMPLETED|Overall Study||546
8122003|NCT02930018|20019662|P1|COMPLETED|Overall Study||550
8122004|NCT02930018|20019661|P2|STARTED|Overall Study||549
8122005|NCT02930018|20019662|P1|STARTED|Overall Study||556
8122006|NCT02930005|20019686|P2|NOT COMPLETED|Overall Study||5
8122007|NCT02930005|20019687|P1|NOT COMPLETED|Overall Study||1
8122008|NCT02930005|20019686|P2|COMPLETED|Overall Study||1
8122009|NCT02930005|20019687|P1|COMPLETED|Overall Study||1
8122010|NCT02930005|20019686|P2|Completed 2 Weeks|Overall Study||2
8122011|NCT02930005|20019687|P1|Completed 2 Weeks|Overall Study||2
8122012|NCT02930005|20019686|P2|STARTED|Overall Study||6
8122013|NCT02930005|20019687|P1|STARTED|Overall Study||2
8122023|NCT02929667|20019710|P2|NOT COMPLETED|Overall Study||0
8122024|NCT02929667|20019711|P1|NOT COMPLETED|Overall Study||0
8122025|NCT02929667|20019710|P2|COMPLETED|Overall Study||11
8122026|NCT02929667|20019711|P1|COMPLETED|Overall Study||11
8122027|NCT02929667|20019710|P2|STARTED|Overall Study||11
8122028|NCT02929667|20019711|P1|STARTED|Overall Study||11
8122029|NCT02929498|20019727|P3|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122030|NCT02929498|20019728|P2|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122031|NCT02929498|20019729|P1|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122032|NCT02929498|20019727|P3|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122033|NCT02929498|20019728|P2|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122034|NCT02929498|20019729|P1|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122035|NCT02929498|20019727|P3|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122036|NCT02929498|20019728|P2|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122037|NCT02929498|20019729|P1|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
8122038|NCT02929498|20019727|P3|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
8122039|NCT02929498|20019728|P2|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
8122040|NCT02929498|20019729|P1|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5
8122041|NCT02929498|20019727|P3|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
8122042|NCT02929498|20019728|P2|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
8122043|NCT02929498|20019729|P1|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
8122044|NCT02929498|20019727|P3|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
8122045|NCT02929498|20019728|P2|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
8122046|NCT02929498|20019729|P1|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5
8122047|NCT02929407|20019823|P1|NOT COMPLETED|Overall Study||1
8122048|NCT02929407|20019823|P1|COMPLETED|Overall Study||3
8122049|NCT02929407|20019823|P1|STARTED|Overall Study||4
8122050|NCT02928770|20019838|P1|NOT COMPLETED|Overall Study||2
8122051|NCT02928770|20019838|P1|COMPLETED|Overall Study||30
8122052|NCT02928770|20019838|P1|STARTED|Overall Study||32
8122053|NCT02928536|20019842|P1|NOT COMPLETED|Overall Study||0
8122054|NCT02928536|20019842|P1|COMPLETED|Overall Study||11902
8122055|NCT02928536|20019842|P1|STARTED|Overall Study||11902
8122056|NCT02928380|20019849|P6|NOT COMPLETED|Period 3||0
8122057|NCT02928380|20019850|P5|NOT COMPLETED|Period 3||0
8122058|NCT02928380|20019851|P4|NOT COMPLETED|Period 3||0
8122059|NCT02928380|20019852|P3|NOT COMPLETED|Period 3||0
8122060|NCT02928380|20019853|P2|NOT COMPLETED|Period 3||0
8122061|NCT02928380|20019854|P1|NOT COMPLETED|Period 3||0
8122062|NCT02928380|20019849|P6|COMPLETED|Period 3||14
8122063|NCT02928380|20019850|P5|COMPLETED|Period 3||14
8122064|NCT02928380|20019851|P4|COMPLETED|Period 3||14
8122065|NCT02928380|20019852|P3|COMPLETED|Period 3||14
8122066|NCT02928380|20019853|P2|COMPLETED|Period 3||14
8122067|NCT02928380|20019854|P1|COMPLETED|Period 3||13
8122068|NCT02928380|20019849|P6|STARTED|Period 3||14
8122069|NCT02928380|20019850|P5|STARTED|Period 3||14
8122070|NCT02928380|20019851|P4|STARTED|Period 3||14
8122071|NCT02928380|20019852|P3|STARTED|Period 3||14
8122072|NCT02928380|20019853|P2|STARTED|Period 3||14
8122073|NCT02928380|20019854|P1|STARTED|Period 3||13
8122074|NCT02928380|20019849|P6|NOT COMPLETED|Wash Out Period 2||0
8122075|NCT02928380|20019850|P5|NOT COMPLETED|Wash Out Period 2||0
8122076|NCT02928380|20019851|P4|NOT COMPLETED|Wash Out Period 2||0
8122077|NCT02928380|20019852|P3|NOT COMPLETED|Wash Out Period 2||0
8122078|NCT02928380|20019853|P2|NOT COMPLETED|Wash Out Period 2||0
8122079|NCT02928380|20019854|P1|NOT COMPLETED|Wash Out Period 2||0
8122080|NCT02928380|20019849|P6|COMPLETED|Wash Out Period 2||14
8122081|NCT02928380|20019850|P5|COMPLETED|Wash Out Period 2||14
8122082|NCT02928380|20019851|P4|COMPLETED|Wash Out Period 2||14
8122083|NCT02928380|20019852|P3|COMPLETED|Wash Out Period 2||14
8122084|NCT02928380|20019853|P2|COMPLETED|Wash Out Period 2||14
8122085|NCT02928380|20019854|P1|COMPLETED|Wash Out Period 2||13
8122086|NCT02928380|20019849|P6|STARTED|Wash Out Period 2||14
8122087|NCT02928380|20019850|P5|STARTED|Wash Out Period 2||14
8122088|NCT02928380|20019851|P4|STARTED|Wash Out Period 2||14
8122089|NCT02928380|20019852|P3|STARTED|Wash Out Period 2||14
8122090|NCT02928380|20019853|P2|STARTED|Wash Out Period 2||14
8122091|NCT02928380|20019854|P1|STARTED|Wash Out Period 2||13
8122092|NCT02928380|20019849|P6|NOT COMPLETED|Period 2||0
8122093|NCT02928380|20019850|P5|NOT COMPLETED|Period 2||0
8122094|NCT02928380|20019851|P4|NOT COMPLETED|Period 2||0
8122095|NCT02928380|20019852|P3|NOT COMPLETED|Period 2||0
8122096|NCT02928380|20019853|P2|NOT COMPLETED|Period 2||0
8122097|NCT02928380|20019854|P1|NOT COMPLETED|Period 2||0
8122098|NCT02928380|20019849|P6|COMPLETED|Period 2||14
8122099|NCT02928380|20019850|P5|COMPLETED|Period 2||14
8122100|NCT02928380|20019851|P4|COMPLETED|Period 2||14
8122101|NCT02928380|20019852|P3|COMPLETED|Period 2||14
8122102|NCT02928380|20019853|P2|COMPLETED|Period 2||14
8122103|NCT02928380|20019854|P1|COMPLETED|Period 2||13
8122104|NCT02928380|20019849|P6|STARTED|Period 2||14
8122105|NCT02928380|20019850|P5|STARTED|Period 2||14
8122106|NCT02928380|20019851|P4|STARTED|Period 2||14
8122107|NCT02928380|20019852|P3|STARTED|Period 2||14
8122108|NCT02928380|20019853|P2|STARTED|Period 2||14
8122109|NCT02928380|20019854|P1|STARTED|Period 2||13
8122110|NCT02928380|20019849|P6|NOT COMPLETED|Wash Out Period 1||0
8122111|NCT02928380|20019850|P5|NOT COMPLETED|Wash Out Period 1||0
8122112|NCT02928380|20019851|P4|NOT COMPLETED|Wash Out Period 1||0
8122113|NCT02928380|20019852|P3|NOT COMPLETED|Wash Out Period 1||0
8122114|NCT02928380|20019853|P2|NOT COMPLETED|Wash Out Period 1||0
8122115|NCT02928380|20019854|P1|NOT COMPLETED|Wash Out Period 1||0
8122116|NCT02928380|20019849|P6|COMPLETED|Wash Out Period 1||14
8122117|NCT02928380|20019850|P5|COMPLETED|Wash Out Period 1||14
8122118|NCT02928380|20019851|P4|COMPLETED|Wash Out Period 1||14
8122119|NCT02928380|20019852|P3|COMPLETED|Wash Out Period 1||14
8122120|NCT02928380|20019853|P2|COMPLETED|Wash Out Period 1||14
8122121|NCT02928380|20019854|P1|COMPLETED|Wash Out Period 1||13
8122122|NCT02928380|20019849|P6|STARTED|Wash Out Period 1||14
8122123|NCT02928380|20019850|P5|STARTED|Wash Out Period 1||14
8122124|NCT02928380|20019851|P4|STARTED|Wash Out Period 1||14
8122125|NCT02928380|20019852|P3|STARTED|Wash Out Period 1||14
8122126|NCT02928380|20019853|P2|STARTED|Wash Out Period 1||14
8122127|NCT02928380|20019854|P1|STARTED|Wash Out Period 1||13
8122128|NCT02928380|20019849|P6|NOT COMPLETED|Period 1||0
8122129|NCT02928380|20019850|P5|NOT COMPLETED|Period 1||0
8122130|NCT02928380|20019851|P4|NOT COMPLETED|Period 1||0
8122131|NCT02928380|20019852|P3|NOT COMPLETED|Period 1||0
8122132|NCT02928380|20019853|P2|NOT COMPLETED|Period 1||0
8122133|NCT02928380|20019854|P1|NOT COMPLETED|Period 1||0
8122134|NCT02928380|20019849|P6|COMPLETED|Period 1||14
8122135|NCT02928380|20019850|P5|COMPLETED|Period 1||14
8122136|NCT02928380|20019851|P4|COMPLETED|Period 1||14
8122137|NCT02928380|20019852|P3|COMPLETED|Period 1||14
8122138|NCT02928380|20019853|P2|COMPLETED|Period 1||14
8122139|NCT02928380|20019854|P1|COMPLETED|Period 1||13
8122140|NCT02928380|20019849|P6|STARTED|Period 1||14
8122141|NCT02928380|20019850|P5|STARTED|Period 1||14
8122142|NCT02928380|20019851|P4|STARTED|Period 1||14
8122143|NCT02928380|20019852|P3|STARTED|Period 1||14
8122144|NCT02928380|20019853|P2|STARTED|Period 1||14
8122145|NCT02928380|20019854|P1|STARTED|Period 1||13
8122158|NCT02928029|20019985|P2|NOT COMPLETED|Overall Study||4
8122159|NCT02928029|20019986|P1|NOT COMPLETED|Overall Study||3
8122160|NCT02928029|20019985|P2|COMPLETED|Overall Study||0
8122161|NCT02928029|20019986|P1|COMPLETED|Overall Study||0
8122162|NCT02928029|20019985|P2|STARTED|Overall Study||4
8122163|NCT02928029|20019986|P1|STARTED|Overall Study||3
8122164|NCT02927938|20020000|P4|NOT COMPLETED|Overall Study||7
8122165|NCT02927938|20020001|P3|NOT COMPLETED|Overall Study||4
8122166|NCT02927938|20020002|P2|NOT COMPLETED|Overall Study||6
8122167|NCT02927938|20020003|P1|NOT COMPLETED|Overall Study||1
8122168|NCT02927938|20020000|P4|COMPLETED|Overall Study||0
8122169|NCT02927938|20020001|P3|COMPLETED|Overall Study||0
8122170|NCT02927938|20020002|P2|COMPLETED|Overall Study||0
8122171|NCT02927938|20020003|P1|COMPLETED|Overall Study||0
8122172|NCT02927938|20020000|P4|STARTED|Overall Study||7
8122173|NCT02927938|20020001|P3|STARTED|Overall Study||4
8122174|NCT02927938|20020002|P2|STARTED|Overall Study||6
8122175|NCT02927938|20020003|P1|STARTED|Overall Study||1
8122176|NCT02927925|20020011|P1|NOT COMPLETED|Overall Study||32
8122177|NCT02927925|20020011|P1|COMPLETED|Overall Study||0
8122178|NCT02927925|20020011|P1|STARTED|Overall Study||32
8122179|NCT02927834|20020028|P3|NOT COMPLETED|Overall Study||2
8122180|NCT02927834|20020029|P2|NOT COMPLETED|Overall Study||2
8122181|NCT02927834|20020030|P1|NOT COMPLETED|Overall Study||1
8122182|NCT02927834|20020028|P3|COMPLETED|Overall Study||6
8122183|NCT02927834|20020029|P2|COMPLETED|Overall Study||6
8122184|NCT02927834|20020030|P1|COMPLETED|Overall Study||7
8122185|NCT02927834|20020028|P3|STARTED|Overall Study||8
8122186|NCT02927834|20020029|P2|STARTED|Overall Study||8
8122187|NCT02927834|20020030|P1|STARTED|Overall Study||8
8122188|NCT02927795|20020044|P1|NOT COMPLETED|Overall Study||23
8122189|NCT02927795|20020044|P1|COMPLETED|Overall Study||234
8122190|NCT02927795|20020044|P1|Treated|Overall Study||253
8122191|NCT02927795|20020044|P1|STARTED|Overall Study||257
8122204|NCT02927431|20020100|P3|NOT COMPLETED|Overall Study||1
8122205|NCT02927431|20020101|P2|NOT COMPLETED|Overall Study||0
8122206|NCT02927431|20020102|P1|NOT COMPLETED|Overall Study||0
8122207|NCT02927431|20020100|P3|COMPLETED|Overall Study||3
8122208|NCT02927431|20020101|P2|COMPLETED|Overall Study||4
8122209|NCT02927431|20020102|P1|COMPLETED|Overall Study||2
8122210|NCT02927431|20020100|P3|STARTED|Overall Study||4
8122211|NCT02927431|20020101|P2|STARTED|Overall Study||4
8122212|NCT02927431|20020102|P1|STARTED|Overall Study||2
8122213|NCT02927366|20020180|P2|NOT COMPLETED|Overall Study||0
8122214|NCT02927366|20020181|P1|NOT COMPLETED|Overall Study||2
8122215|NCT02927366|20020180|P2|COMPLETED|Overall Study||2
8122216|NCT02927366|20020181|P1|COMPLETED|Overall Study||4
8122217|NCT02927366|20020180|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8122218|NCT02927366|20020181|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||4
8122219|NCT02927366|20020180|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||2
8122220|NCT02927366|20020181|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||6
8122221|NCT02927366|20020180|P2|STARTED|Overall Study||2
8122222|NCT02927366|20020181|P1|STARTED|Overall Study||6
8122223|NCT02927327|20020215|P2|NOT COMPLETED|Overall Study||0
8122224|NCT02927327|20020216|P1|NOT COMPLETED|Overall Study||0
8122225|NCT02927327|20020215|P2|COMPLETED|Overall Study||31
8122226|NCT02927327|20020216|P1|COMPLETED|Overall Study||30
8122227|NCT02927327|20020215|P2|STARTED|Overall Study||31
8122228|NCT02927327|20020216|P1|STARTED|Overall Study||30
8122229|NCT02927223|20020228|P1|NOT COMPLETED|Overall Study||0
8122230|NCT02927223|20020228|P1|COMPLETED|Overall Study||6
8122231|NCT02927223|20020228|P1|STARTED|Overall Study||6
8122232|NCT02927171|20020236|P2|NOT COMPLETED|Overall Study||1
8122233|NCT02927171|20020237|P1|NOT COMPLETED|Overall Study||0
8122234|NCT02927171|20020236|P2|COMPLETED|Overall Study||50
8122235|NCT02927171|20020237|P1|COMPLETED|Overall Study||53
8122236|NCT02927171|20020236|P2|STARTED|Overall Study||51
8122237|NCT02927171|20020237|P1|STARTED|Overall Study||53
8122250|NCT02926638|20020310|P2|NOT COMPLETED|Overall Study||5
8122251|NCT02926638|20020311|P1|NOT COMPLETED|Overall Study||4
8122252|NCT02926638|20020310|P2|COMPLETED|Overall Study||0
8122253|NCT02926638|20020311|P1|COMPLETED|Overall Study||0
8122254|NCT02926638|20020310|P2|Eligible|Overall Study||5
8122255|NCT02926638|20020311|P1|Eligible|Overall Study||3
8122256|NCT02926638|20020310|P2|STARTED|Overall Study||5
8122257|NCT02926638|20020311|P1|STARTED|Overall Study||4
8122258|NCT02926573|20020325|P2|NOT COMPLETED|Overall Study||9
8122259|NCT02926573|20020326|P1|NOT COMPLETED|Overall Study||11
8122260|NCT02926573|20020325|P2|COMPLETED|Overall Study||46
8122261|NCT02926573|20020326|P1|COMPLETED|Overall Study||44
8122262|NCT02926573|20020325|P2|STARTED|Overall Study||55
8122263|NCT02926573|20020326|P1|STARTED|Overall Study||55
8122264|NCT02926209|20020344|P2|NOT COMPLETED|Training Cohort - First Patients||0
8122265|NCT02926209|20020345|P1|NOT COMPLETED|Training Cohort - First Patients||0
8122266|NCT02926209|20020344|P2|COMPLETED|Training Cohort - First Patients||0
8122267|NCT02926209|20020345|P1|COMPLETED|Training Cohort - First Patients||20
8122268|NCT02926209|20020344|P2|STARTED|Training Cohort - First Patients||0
8122269|NCT02926209|20020345|P1|STARTED|Training Cohort - First Patients||20
8122270|NCT02926209|20020344|P2|NOT COMPLETED|Study Cohort||0
8122271|NCT02926209|20020345|P1|NOT COMPLETED|Study Cohort||1
8122272|NCT02926209|20020344|P2|COMPLETED|Study Cohort||37
8122273|NCT02926209|20020345|P1|COMPLETED|Study Cohort||41
8122274|NCT02926209|20020344|P2|STARTED|Study Cohort||37
8122275|NCT02926209|20020345|P1|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42
8122276|NCT02925923|20020358|P2|NOT COMPLETED|Overall Study||2
8122277|NCT02925923|20020359|P1|NOT COMPLETED|Overall Study||0
8122278|NCT02925923|20020358|P2|COMPLETED|Overall Study||48
8122279|NCT02925923|20020359|P1|COMPLETED|Overall Study||50
8122280|NCT02925923|20020358|P2|STARTED|Overall Study||50
8122281|NCT02925923|20020359|P1|STARTED|Overall Study||50
8122282|NCT02925858|20020389|P2|NOT COMPLETED|Overall Study||0
8122283|NCT02925858|20020390|P1|NOT COMPLETED|Overall Study||0
8122284|NCT02925858|20020389|P2|COMPLETED|Overall Study||38
8122285|NCT02925858|20020390|P1|COMPLETED|Overall Study||42
8122286|NCT02925858|20020389|P2|STARTED|Overall Study||38
8122287|NCT02925858|20020390|P1|STARTED|Overall Study||42
8122288|NCT02925741|20020416|P2|NOT COMPLETED|Overall Study||0
8122289|NCT02925741|20020417|P1|NOT COMPLETED|Overall Study||11
8122290|NCT02925741|20020416|P2|COMPLETED|Overall Study||1706
8122291|NCT02925741|20020417|P1|COMPLETED|Overall Study||1626
8122292|NCT02925741|20020416|P2|STARTED|Overall Study||1706
8122293|NCT02925741|20020417|P1|STARTED|Overall Study||1637
8122294|NCT02925611|20020429|P2|NOT COMPLETED|Overall Study||0
8122295|NCT02925611|20020430|P1|NOT COMPLETED|Overall Study||0
8122296|NCT02925611|20020429|P2|COMPLETED|Overall Study||30
8122297|NCT02925611|20020430|P1|COMPLETED|Overall Study||30
8122298|NCT02925611|20020429|P2|STARTED|Overall Study||30
8122299|NCT02925611|20020430|P1|STARTED|Overall Study||30
8122324|NCT02925403|20020481|P2|NOT COMPLETED|Overall Study||1
8122325|NCT02925403|20020482|P1|NOT COMPLETED|Overall Study||0
8122326|NCT02925403|20020481|P2|COMPLETED|Overall Study||4
8122327|NCT02925403|20020482|P1|COMPLETED|Overall Study||8
8122328|NCT02925403|20020481|P2|STARTED|Overall Study||5
8122329|NCT02925403|20020482|P1|STARTED|Overall Study||8
8122330|NCT02925312|20020496|P2|NOT COMPLETED|Overall Study||0
8122331|NCT02925312|20020497|P1|NOT COMPLETED|Overall Study||27
8122332|NCT02925312|20020496|P2|COMPLETED|Overall Study||294
8122333|NCT02925312|20020497|P1|COMPLETED|Overall Study||98
8122334|NCT02925312|20020496|P2|STARTED|Overall Study||294
8122335|NCT02925312|20020497|P1|STARTED|Overall Study||125
8122336|NCT02925117|20020513|P12|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
8122337|NCT02925117|20020514|P11|NOT COMPLETED|Period 2 (Weeks 16 - 88)||8
8122338|NCT02925117|20020515|P10|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
8122339|NCT02925117|20020516|P9|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
8122340|NCT02925117|20020517|P8|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
8122341|NCT02925117|20020518|P7|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
8122342|NCT02925117|20020519|P6|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
8122343|NCT02925117|20020520|P5|NOT COMPLETED|Period 2 (Weeks 16 - 88)||2
8122344|NCT02925117|20020521|P4|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
8122345|NCT02925117|20020522|P3|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
8122346|NCT02925117|20020523|P2|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
8122347|NCT02925117|20020524|P1|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
8122348|NCT02925117|20020513|P12|COMPLETED|Period 2 (Weeks 16 - 88)||14
8122349|NCT02925117|20020514|P11|COMPLETED|Period 2 (Weeks 16 - 88)||11
8122350|NCT02925117|20020515|P10|COMPLETED|Period 2 (Weeks 16 - 88)||12
8122351|NCT02925117|20020516|P9|COMPLETED|Period 2 (Weeks 16 - 88)||13
8122352|NCT02925117|20020517|P8|COMPLETED|Period 2 (Weeks 16 - 88)||11
8122353|NCT02925117|20020518|P7|COMPLETED|Period 2 (Weeks 16 - 88)||9
8122354|NCT02925117|20020519|P6|COMPLETED|Period 2 (Weeks 16 - 88)||5
8122355|NCT02925117|20020520|P5|COMPLETED|Period 2 (Weeks 16 - 88)||8
8122356|NCT02925117|20020521|P4|COMPLETED|Period 2 (Weeks 16 - 88)||0
8122357|NCT02925117|20020522|P3|COMPLETED|Period 2 (Weeks 16 - 88)||0
8122358|NCT02925117|20020523|P2|COMPLETED|Period 2 (Weeks 16 - 88)||0
8122359|NCT02925117|20020524|P1|COMPLETED|Period 2 (Weeks 16 - 88)||0
8122360|NCT02925117|20020513|P12|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||4
8122361|NCT02925117|20020514|P11|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||14
8122362|NCT02925117|20020515|P10|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
8122363|NCT02925117|20020516|P9|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||17
8122364|NCT02925117|20020517|P8|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
8122365|NCT02925117|20020518|P7|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||13
8122366|NCT02925117|20020519|P6|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||1
8122367|NCT02925117|20020520|P5|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||8
8122368|NCT02925117|20020521|P4|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
8122369|NCT02925117|20020522|P3|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
8122370|NCT02925117|20020523|P2|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
8122371|NCT02925117|20020524|P1|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
8122372|NCT02925117|20020513|P12|STARTED|Period 2 (Weeks 16 - 88)||19
8122373|NCT02925117|20020514|P11|STARTED|Period 2 (Weeks 16 - 88)||19
8122374|NCT02925117|20020515|P10|STARTED|Period 2 (Weeks 16 - 88)||18
8122375|NCT02925117|20020516|P9|STARTED|Period 2 (Weeks 16 - 88)||19
8122376|NCT02925117|20020517|P8|STARTED|Period 2 (Weeks 16 - 88)||16
8122377|NCT02925117|20020518|P7|STARTED|Period 2 (Weeks 16 - 88)||15
8122378|NCT02925117|20020519|P6|STARTED|Period 2 (Weeks 16 - 88)||10
8122379|NCT02925117|20020520|P5|STARTED|Period 2 (Weeks 16 - 88)||10
8122380|NCT02925117|20020521|P4|STARTED|Period 2 (Weeks 16 - 88)||0
8122381|NCT02925117|20020522|P3|STARTED|Period 2 (Weeks 16 - 88)||0
8122382|NCT02925117|20020523|P2|STARTED|Period 2 (Weeks 16 - 88)||0
8122383|NCT02925117|20020524|P1|STARTED|Period 2 (Weeks 16 - 88)||0
8122384|NCT02925117|20020513|P12|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122385|NCT02925117|20020514|P11|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122386|NCT02925117|20020515|P10|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122387|NCT02925117|20020516|P9|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122388|NCT02925117|20020517|P8|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122389|NCT02925117|20020518|P7|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122390|NCT02925117|20020519|P6|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122391|NCT02925117|20020520|P5|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
8122392|NCT02925117|20020521|P4|NOT COMPLETED|Period 1 (Weeks 0 - 16)||3
8122393|NCT02925117|20020522|P3|NOT COMPLETED|Period 1 (Weeks 0 - 16)||5
8122394|NCT02925117|20020523|P2|NOT COMPLETED|Period 1 (Weeks 0 - 16)||11
8122395|NCT02925117|20020524|P1|NOT COMPLETED|Period 1 (Weeks 0 - 16)||18
8122396|NCT02925117|20020513|P12|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122397|NCT02925117|20020514|P11|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122398|NCT02925117|20020515|P10|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122399|NCT02925117|20020516|P9|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122400|NCT02925117|20020517|P8|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122401|NCT02925117|20020518|P7|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122402|NCT02925117|20020519|P6|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122403|NCT02925117|20020520|P5|COMPLETED|Period 1 (Weeks 0 - 16)||0
8122404|NCT02925117|20020521|P4|COMPLETED|Period 1 (Weeks 0 - 16)||39
8122405|NCT02925117|20020522|P3|COMPLETED|Period 1 (Weeks 0 - 16)||37
8122406|NCT02925117|20020523|P2|COMPLETED|Period 1 (Weeks 0 - 16)||31
8122407|NCT02925117|20020524|P1|COMPLETED|Period 1 (Weeks 0 - 16)||23
8122408|NCT02925117|20020513|P12|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122409|NCT02925117|20020514|P11|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122410|NCT02925117|20020515|P10|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122411|NCT02925117|20020516|P9|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122412|NCT02925117|20020517|P8|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122413|NCT02925117|20020518|P7|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122414|NCT02925117|20020519|P6|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122415|NCT02925117|20020520|P5|Received Treatment|Period 1 (Weeks 0 - 16)||0
8122416|NCT02925117|20020521|P4|Received Treatment|Period 1 (Weeks 0 - 16)||42
8122417|NCT02925117|20020522|P3|Received Treatment|Period 1 (Weeks 0 - 16)||42
8122418|NCT02925117|20020523|P2|Received Treatment|Period 1 (Weeks 0 - 16)||42
8122419|NCT02925117|20020524|P1|Received Treatment|Period 1 (Weeks 0 - 16)||40
8122420|NCT02925117|20020513|P12|STARTED|Period 1 (Weeks 0 - 16)||0
8122421|NCT02925117|20020514|P11|STARTED|Period 1 (Weeks 0 - 16)||0
8122422|NCT02925117|20020515|P10|STARTED|Period 1 (Weeks 0 - 16)||0
8122423|NCT02925117|20020516|P9|STARTED|Period 1 (Weeks 0 - 16)||0
8122424|NCT02925117|20020517|P8|STARTED|Period 1 (Weeks 0 - 16)||0
8122425|NCT02925117|20020518|P7|STARTED|Period 1 (Weeks 0 - 16)||0
8122426|NCT02925117|20020519|P6|STARTED|Period 1 (Weeks 0 - 16)||0
8122427|NCT02925117|20020520|P5|STARTED|Period 1 (Weeks 0 - 16)||0
8122428|NCT02925117|20020521|P4|STARTED|Period 1 (Weeks 0 - 16)||42
8122429|NCT02925117|20020522|P3|STARTED|Period 1 (Weeks 0 - 16)||42
8122430|NCT02925117|20020523|P2|STARTED|Period 1 (Weeks 0 - 16)||42
8122431|NCT02925117|20020524|P1|STARTED|Period 1 (Weeks 0 - 16)||41
8122432|NCT02925078|20020624|P2|NOT COMPLETED|Overall Study||3
8122433|NCT02925078|20020625|P1|NOT COMPLETED|Overall Study||1
8122434|NCT02925078|20020624|P2|COMPLETED|Overall Study||13
8122435|NCT02925078|20020625|P1|COMPLETED|Overall Study||13
8122436|NCT02925078|20020624|P2|STARTED|Overall Study||16
8122437|NCT02925078|20020625|P1|STARTED|Overall Study||14
8122462|NCT02924428|20020736|P2|NOT COMPLETED|Overall Study||5
8122463|NCT02924428|20020737|P1|NOT COMPLETED|Overall Study||4
8122464|NCT02924428|20020736|P2|COMPLETED|Overall Study||14
8122465|NCT02924428|20020737|P1|COMPLETED|Overall Study||16
8122466|NCT02924428|20020736|P2|STARTED|Overall Study||19
8122467|NCT02924428|20020737|P1|STARTED|Overall Study||20
8122468|NCT02924350|20020759|P2|NOT COMPLETED|Overall Study||2
8122469|NCT02924350|20020760|P1|NOT COMPLETED|Overall Study||0
8122470|NCT02924350|20020759|P2|COMPLETED|Overall Study||100
8122471|NCT02924350|20020760|P1|COMPLETED|Overall Study||102
8122472|NCT02924350|20020759|P2|STARTED|Overall Study||102
8122473|NCT02924350|20020760|P1|STARTED|Overall Study||102
8122474|NCT02924051|20020772|P2|NOT COMPLETED|Overall Study||9
8122475|NCT02924051|20020773|P1|NOT COMPLETED|Overall Study||1
8122476|NCT02924051|20020772|P2|COMPLETED|Overall Study||97
8122477|NCT02924051|20020773|P1|COMPLETED|Overall Study||81
8122478|NCT02924051|20020772|P2|STARTED|Overall Study||106
8122479|NCT02924051|20020773|P1|STARTED|Overall Study||82
8122480|NCT02923921|20020785|P2|NOT COMPLETED|Overall Study||57
8122481|NCT02923921|20020786|P1|NOT COMPLETED|Overall Study||53
8122482|NCT02923921|20020785|P2|COMPLETED|Overall Study||227
8122483|NCT02923921|20020786|P1|COMPLETED|Overall Study||230
8122484|NCT02923921|20020785|P2|Safety Population|Overall Study||251
8122485|NCT02923921|20020786|P1|Safety Population|Overall Study||278
8122486|NCT02923921|20020785|P2|Received at Least 1 Dose of Study Drug|Overall Study||251
8122487|NCT02923921|20020786|P1|Received at Least 1 Dose of Study Drug|Overall Study||278
8122488|NCT02923921|20020785|P2|STARTED|Overall Study||284
8122489|NCT02923921|20020786|P1|STARTED|Overall Study||283
8122490|NCT02923895|20020804|P2|NOT COMPLETED|Overall Study||0
8122491|NCT02923895|20020805|P1|NOT COMPLETED|Overall Study||0
8122492|NCT02923895|20020804|P2|COMPLETED|Overall Study||95
8122493|NCT02923895|20020805|P1|COMPLETED|Overall Study||97
8122494|NCT02923895|20020804|P2|STARTED|Overall Study||95
8122495|NCT02923895|20020805|P1|STARTED|Overall Study||97
8122496|NCT02923830|20020819|P2|NOT COMPLETED|Overall Study||15
8122497|NCT02923830|20020820|P1|NOT COMPLETED|Overall Study||13
8122498|NCT02923830|20020819|P2|COMPLETED|Overall Study|Study terminated|0
8122499|NCT02923830|20020820|P1|COMPLETED|Overall Study|Study terminated|0
8122500|NCT02923830|20020819|P2|STARTED|Overall Study||15
8122501|NCT02923830|20020820|P1|STARTED|Overall Study||13
8122502|NCT02923427|20020840|P2|NOT COMPLETED|Overall Study||2
8122503|NCT02923427|20020841|P1|NOT COMPLETED|Overall Study||4
8122504|NCT02923427|20020840|P2|COMPLETED|Overall Study|"The reasons:
~n = 2 Convert to Laparotomy"|55
8122505|NCT02923427|20020841|P1|COMPLETED|Overall Study|"The reasons:
~n= 2 Convert to Laparotomy n=1 Desaturation n=1 LMA-S can not be placed"|51
8122506|NCT02923427|20020840|P2|STARTED|Overall Study||57
8122507|NCT02923427|20020841|P1|STARTED|Overall Study||55
8122508|NCT02923349|20020868|P7|NOT COMPLETED|Overall Study||3
8122509|NCT02923349|20020869|P6|NOT COMPLETED|Overall Study||7
8122510|NCT02923349|20020870|P5|NOT COMPLETED|Overall Study||19
8122511|NCT02923349|20020871|P4|NOT COMPLETED|Overall Study||16
8122512|NCT02923349|20020872|P3|NOT COMPLETED|Overall Study||17
8122513|NCT02923349|20020873|P2|NOT COMPLETED|Overall Study||4
8122514|NCT02923349|20020874|P1|NOT COMPLETED|Overall Study||4
8122515|NCT02923349|20020868|P7|COMPLETED|Overall Study||1
8122516|NCT02923349|20020869|P6|COMPLETED|Overall Study||5
8122517|NCT02923349|20020870|P5|COMPLETED|Overall Study||4
8122518|NCT02923349|20020871|P4|COMPLETED|Overall Study||2
8122519|NCT02923349|20020872|P3|COMPLETED|Overall Study||5
8122520|NCT02923349|20020873|P2|COMPLETED|Overall Study||0
8122521|NCT02923349|20020874|P1|COMPLETED|Overall Study||0
8122522|NCT02923349|20020868|P7|STARTED|Overall Study||4
8122523|NCT02923349|20020869|P6|STARTED|Overall Study||12
8122524|NCT02923349|20020870|P5|STARTED|Overall Study||23
8122525|NCT02923349|20020871|P4|STARTED|Overall Study||18
8122526|NCT02923349|20020872|P3|STARTED|Overall Study||22
8122527|NCT02923349|20020873|P2|STARTED|Overall Study||4
8122528|NCT02923349|20020874|P1|STARTED|Overall Study||4
8122529|NCT02923271|20020948|P2|NOT COMPLETED|Overall Study||2
8122530|NCT02923271|20020949|P1|NOT COMPLETED|Overall Study||8
8122531|NCT02923271|20020948|P2|COMPLETED|Overall Study||14
8122532|NCT02923271|20020949|P1|COMPLETED|Overall Study||10
8122533|NCT02923271|20020948|P2|STARTED|Overall Study||16
8122534|NCT02923271|20020949|P1|STARTED|Overall Study||18
8122535|NCT02923245|20020959|P2|NOT COMPLETED|Overall Study||1
8122536|NCT02923245|20020960|P1|NOT COMPLETED|Overall Study||2
8122537|NCT02923245|20020959|P2|COMPLETED|Overall Study||59
8122538|NCT02923245|20020960|P1|COMPLETED|Overall Study||58
8122539|NCT02923245|20020959|P2|STARTED|Overall Study||60
8122540|NCT02923245|20020960|P1|STARTED|Overall Study||60
8122541|NCT02923115|20020983|P6|NOT COMPLETED|Overall Study||0
8122542|NCT02923115|20020984|P5|NOT COMPLETED|Overall Study||5
8122543|NCT02923115|20020985|P4|NOT COMPLETED|Overall Study||2
8122544|NCT02923115|20020986|P3|NOT COMPLETED|Overall Study||3
8122545|NCT02923115|20020987|P2|NOT COMPLETED|Overall Study||1
8122546|NCT02923115|20020988|P1|NOT COMPLETED|Overall Study||0
8122547|NCT02923115|20020983|P6|COMPLETED|Overall Study||38
8122548|NCT02923115|20020984|P5|COMPLETED|Overall Study||17
8122549|NCT02923115|20020985|P4|COMPLETED|Overall Study||21
8122550|NCT02923115|20020986|P3|COMPLETED|Overall Study||20
8122551|NCT02923115|20020987|P2|COMPLETED|Overall Study||15
8122552|NCT02923115|20020988|P1|COMPLETED|Overall Study||12
8122553|NCT02923115|20020983|P6|Treated|Overall Study||38
8122554|NCT02923115|20020984|P5|Treated|Overall Study||17
8122555|NCT02923115|20020985|P4|Treated|Overall Study||22
8122556|NCT02923115|20020986|P3|Treated|Overall Study||20
8122557|NCT02923115|20020987|P2|Treated|Overall Study||16
8122558|NCT02923115|20020988|P1|Treated|Overall Study||12
8122559|NCT02923115|20020983|P6|STARTED|Overall Study||38
8122560|NCT02923115|20020984|P5|STARTED|Overall Study||22
8122561|NCT02923115|20020985|P4|STARTED|Overall Study||23
8122562|NCT02923115|20020986|P3|STARTED|Overall Study||23
8122563|NCT02923115|20020987|P2|STARTED|Overall Study||16
8122564|NCT02923115|20020988|P1|STARTED|Overall Study||12
8122565|NCT02922985|20021031|P2|NOT COMPLETED|Overall Study||0
8122566|NCT02922985|20021032|P1|NOT COMPLETED|Overall Study||0
8122567|NCT02922985|20021031|P2|COMPLETED|Overall Study||60
8122568|NCT02922985|20021032|P1|COMPLETED|Overall Study||60
8122569|NCT02922985|20021031|P2|STARTED|Overall Study||60
8122570|NCT02922985|20021032|P1|STARTED|Overall Study||60
8122571|NCT02922959|20021058|P2|NOT COMPLETED|Overall Study||17
8122572|NCT02922959|20021059|P1|NOT COMPLETED|Overall Study||19
8122573|NCT02922959|20021058|P2|COMPLETED|Overall Study||23
8122574|NCT02922959|20021059|P1|COMPLETED|Overall Study||21
8122575|NCT02922959|20021058|P2|12 Months|Overall Study|n=23 (57.5%)|23
8122576|NCT02922959|20021059|P1|12 Months|Overall Study|n=21 (52.5%)|21
8122577|NCT02922959|20021058|P2|6 Months|Overall Study|n=30 (75.0%)|30
8122578|NCT02922959|20021059|P1|6 Months|Overall Study|n=28 (70.0%)|28
8122579|NCT02922959|20021058|P2|3 Months|Overall Study|n=31 (77.5%)|31
8122580|NCT02922959|20021059|P1|3 Months|Overall Study|n=35 (87.5%)|35
8122581|NCT02922959|20021058|P2|3 Weeks|Overall Study|n=36 (90.0%)|36
8122582|NCT02922959|20021059|P1|3 Weeks|Overall Study|n=38 (95.0%)|38
8122583|NCT02922959|20021058|P2|STARTED|Overall Study||40
8122584|NCT02922959|20021059|P1|STARTED|Overall Study||40
8122585|NCT02922868|20021073|P2|NOT COMPLETED|Overall Study||0
8122586|NCT02922868|20021074|P1|NOT COMPLETED|Overall Study||0
8122587|NCT02922868|20021073|P2|COMPLETED|Overall Study||30
8122588|NCT02922868|20021074|P1|COMPLETED|Overall Study||30
8122589|NCT02922868|20021073|P2|STARTED|Overall Study||30
8122590|NCT02922868|20021074|P1|STARTED|Overall Study||30
8122591|NCT02922738|20021094|P2|NOT COMPLETED|Overall Study||0
8122592|NCT02922738|20021095|P1|NOT COMPLETED|Overall Study||0
8122593|NCT02922738|20021094|P2|COMPLETED|Overall Study||290
8122594|NCT02922738|20021095|P1|COMPLETED|Overall Study||175
8122595|NCT02922738|20021094|P2|STARTED|Overall Study|275 patients and 15 providers|290
8122596|NCT02922738|20021095|P1|STARTED|Overall Study|158 patients and 17 providers|175
8122597|NCT02922582|20021107|P4|NOT COMPLETED|Overall Study||0
8122598|NCT02922582|20021108|P3|NOT COMPLETED|Overall Study||0
8122599|NCT02922582|20021109|P2|NOT COMPLETED|Overall Study||1
8122600|NCT02922582|20021110|P1|NOT COMPLETED|Overall Study||0
8122601|NCT02922582|20021107|P4|COMPLETED|Overall Study||4
8122602|NCT02922582|20021108|P3|COMPLETED|Overall Study||4
8122603|NCT02922582|20021109|P2|COMPLETED|Overall Study||3
8122604|NCT02922582|20021110|P1|COMPLETED|Overall Study||4
8122605|NCT02922582|20021107|P4|STARTED|Overall Study||4
8122606|NCT02922582|20021108|P3|STARTED|Overall Study||4
8122607|NCT02922582|20021109|P2|STARTED|Overall Study||4
8122608|NCT02922582|20021110|P1|STARTED|Overall Study||4
8122609|NCT02922153|20021170|P2|NOT COMPLETED|Overall Study||2
8122610|NCT02922153|20021171|P1|NOT COMPLETED|Overall Study||10
8122611|NCT02922153|20021170|P2|COMPLETED|Overall Study||17
8122612|NCT02922153|20021171|P1|COMPLETED|Overall Study||55
8122613|NCT02922153|20021170|P2|STARTED|Overall Study||19
8122614|NCT02922153|20021171|P1|STARTED|Overall Study||65
8122615|NCT02921841|20021195|P2|NOT COMPLETED|Overall Study||13
8122616|NCT02921841|20021196|P1|NOT COMPLETED|Overall Study||16
8122617|NCT02921841|20021195|P2|COMPLETED|Overall Study||44
8122618|NCT02921841|20021196|P1|COMPLETED|Overall Study||52
8122619|NCT02921841|20021195|P2|STARTED|Overall Study||57
8122620|NCT02921841|20021196|P1|STARTED|Overall Study||68
8122621|NCT02921750|20021230|P2|NOT COMPLETED|Overall Study||11
8122622|NCT02921750|20021231|P1|NOT COMPLETED|Overall Study||9
8122623|NCT02921750|20021230|P2|COMPLETED|Overall Study||113
8122624|NCT02921750|20021231|P1|COMPLETED|Overall Study||115
8122625|NCT02921750|20021230|P2|Subgroup Followed for 24 Weeks (PP)|Overall Study||36
8122626|NCT02921750|20021231|P1|Subgroup Followed for 24 Weeks (PP)|Overall Study||19
8122627|NCT02921750|20021230|P2|Subgroup Followed for 24 Weeks (ITT)|Overall Study||40
8122628|NCT02921750|20021231|P1|Subgroup Followed for 24 Weeks (ITT)|Overall Study||35
8122629|NCT02921750|20021230|P2|Completed 6 Weeks Follow-up (PP)|Overall Study||104
8122630|NCT02921750|20021231|P1|Completed 6 Weeks Follow-up (PP)|Overall Study||97
8122631|NCT02921750|20021230|P2|Per Protocol (PP)|Overall Study||107
8122632|NCT02921750|20021231|P1|Per Protocol (PP)|Overall Study||100
8122633|NCT02921750|20021230|P2|Intention to Treat (ITT)|Overall Study||123
8122634|NCT02921750|20021231|P1|Intention to Treat (ITT)|Overall Study||122
8122635|NCT02921750|20021230|P2|STARTED|Overall Study||124
8122636|NCT02921750|20021231|P1|STARTED|Overall Study||124
8122637|NCT02921490|20021251|P1|NOT COMPLETED|Overall Study||0
8122638|NCT02921490|20021251|P1|COMPLETED|Overall Study||10
8122639|NCT02921490|20021251|P1|STARTED|Overall Study||10
8122640|NCT02921425|20021262|P1|NOT COMPLETED|Overall Study||9
8122641|NCT02921425|20021262|P1|COMPLETED|Overall Study||38
8122642|NCT02921425|20021262|P1|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
8122643|NCT02921425|20021262|P1|STARTED|Overall Study||47
8122644|NCT02921412|20021276|P1|NOT COMPLETED|Overall Study||0
8122645|NCT02921412|20021276|P1|COMPLETED|Overall Study||36
8122646|NCT02921412|20021276|P1|STARTED|Overall Study||36
8122647|NCT02921386|20021299|P1|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
8122648|NCT02921386|20021299|P1|COMPLETED|Sequence E: FDA High Fat Breakfast||18
8122649|NCT02921386|20021299|P1|STARTED|Sequence E: FDA High Fat Breakfast||18
8122650|NCT02921386|20021299|P1|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
8122651|NCT02921386|20021299|P1|COMPLETED|Sequence D: 45 g Fat Breakfast||18
8122652|NCT02921386|20021299|P1|STARTED|Sequence D: 45 g Fat Breakfast||18
8122653|NCT02921386|20021299|P1|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
8122654|NCT02921386|20021299|P1|COMPLETED|Sequence C: 30 g Fat Breakfast||18
8122655|NCT02921386|20021299|P1|STARTED|Sequence C: 30 g Fat Breakfast||18
8122656|NCT02921386|20021299|P1|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
8122657|NCT02921386|20021299|P1|COMPLETED|Sequence B: 15 g Fat Breakfast||18
8122658|NCT02921386|20021299|P1|STARTED|Sequence B: 15 g Fat Breakfast||18
8122659|NCT02921386|20021299|P1|NOT COMPLETED|Sequence A: Fasting||0
8122660|NCT02921386|20021299|P1|COMPLETED|Sequence A: Fasting||18
8122661|NCT02921386|20021299|P1|STARTED|Sequence A: Fasting||18
8122662|NCT02921295|20021322|P1|NOT COMPLETED|Conventional Prostheses||0
8122663|NCT02921295|20021322|P1|COMPLETED|Conventional Prostheses||1
8122664|NCT02921295|20021322|P1|STARTED|Conventional Prostheses||1
8122665|NCT02921295|20021322|P1|NOT COMPLETED|Sidekicks||0
8122666|NCT02921295|20021322|P1|COMPLETED|Sidekicks||1
8122667|NCT02921295|20021322|P1|STARTED|Sidekicks||1
8122668|NCT02921087|20021334|P2|NOT COMPLETED|Overall Study||1
8122669|NCT02921087|20021335|P1|NOT COMPLETED|Overall Study||0
8122670|NCT02921087|20021334|P2|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10
8122671|NCT02921087|20021335|P1|COMPLETED|Overall Study||12
8122672|NCT02921087|20021334|P2|STARTED|Overall Study||11
8122673|NCT02921087|20021335|P1|STARTED|Overall Study||12
8122674|NCT02921061|20021355|P1|NOT COMPLETED|Overall Study||0
8122675|NCT02921061|20021355|P1|COMPLETED|Overall Study||28
8122676|NCT02921061|20021355|P1|STARTED|Overall Study||28
8122677|NCT02920983|20021364|P6|NOT COMPLETED|Dispense 3||0
8122678|NCT02920983|20021365|P5|NOT COMPLETED|Dispense 3||1
8122679|NCT02920983|20021366|P4|NOT COMPLETED|Dispense 3||0
8122680|NCT02920983|20021367|P3|NOT COMPLETED|Dispense 3||0
8122681|NCT02920983|20021368|P2|NOT COMPLETED|Dispense 3||1
8122682|NCT02920983|20021369|P1|NOT COMPLETED|Dispense 3||1
8122683|NCT02920983|20021364|P6|COMPLETED|Dispense 3||7
8122684|NCT02920983|20021365|P5|COMPLETED|Dispense 3||12
8122685|NCT02920983|20021366|P4|COMPLETED|Dispense 3||6
8122686|NCT02920983|20021367|P3|COMPLETED|Dispense 3||7
8122687|NCT02920983|20021368|P2|COMPLETED|Dispense 3||9
8122688|NCT02920983|20021369|P1|COMPLETED|Dispense 3||7
8122689|NCT02920983|20021364|P6|STARTED|Dispense 3||7
8122690|NCT02920983|20021365|P5|STARTED|Dispense 3||13
8122691|NCT02920983|20021366|P4|STARTED|Dispense 3||6
8122692|NCT02920983|20021367|P3|STARTED|Dispense 3||7
8122693|NCT02920983|20021368|P2|STARTED|Dispense 3||10
8122694|NCT02920983|20021369|P1|STARTED|Dispense 3||8
8122695|NCT02920983|20021364|P6|NOT COMPLETED|Dispense 2||0
8122696|NCT02920983|20021365|P5|NOT COMPLETED|Dispense 2||1
8122697|NCT02920983|20021366|P4|NOT COMPLETED|Dispense 2||0
8122698|NCT02920983|20021367|P3|NOT COMPLETED|Dispense 2||0
8122699|NCT02920983|20021368|P2|NOT COMPLETED|Dispense 2||0
8122700|NCT02920983|20021369|P1|NOT COMPLETED|Dispense 2||1
8122701|NCT02920983|20021364|P6|COMPLETED|Dispense 2||7
8122702|NCT02920983|20021365|P5|COMPLETED|Dispense 2||12
8122703|NCT02920983|20021366|P4|COMPLETED|Dispense 2||6
8122704|NCT02920983|20021367|P3|COMPLETED|Dispense 2||7
8122705|NCT02920983|20021368|P2|COMPLETED|Dispense 2||10
8122706|NCT02920983|20021369|P1|COMPLETED|Dispense 2||7
8122707|NCT02920983|20021364|P6|STARTED|Dispense 2||7
8122708|NCT02920983|20021365|P5|STARTED|Dispense 2||13
8122709|NCT02920983|20021366|P4|STARTED|Dispense 2||6
8122710|NCT02920983|20021367|P3|STARTED|Dispense 2||7
8122711|NCT02920983|20021368|P2|STARTED|Dispense 2||10
8122712|NCT02920983|20021369|P1|STARTED|Dispense 2||8
8122713|NCT02920983|20021364|P6|NOT COMPLETED|Dispense 1||0
8122714|NCT02920983|20021365|P5|NOT COMPLETED|Dispense 1||1
8122715|NCT02920983|20021366|P4|NOT COMPLETED|Dispense 1||0
8122716|NCT02920983|20021367|P3|NOT COMPLETED|Dispense 1||0
8122717|NCT02920983|20021368|P2|NOT COMPLETED|Dispense 1||0
8122718|NCT02920983|20021369|P1|NOT COMPLETED|Dispense 1||0
8122719|NCT02920983|20021364|P6|COMPLETED|Dispense 1||7
8122720|NCT02920983|20021365|P5|COMPLETED|Dispense 1||12
8122721|NCT02920983|20021366|P4|COMPLETED|Dispense 1||6
8122722|NCT02920983|20021367|P3|COMPLETED|Dispense 1||7
8122723|NCT02920983|20021368|P2|COMPLETED|Dispense 1||10
8122724|NCT02920983|20021369|P1|COMPLETED|Dispense 1||8
8122725|NCT02920983|20021364|P6|STARTED|Dispense 1||7
8122726|NCT02920983|20021365|P5|STARTED|Dispense 1||13
8122727|NCT02920983|20021366|P4|STARTED|Dispense 1||6
8122728|NCT02920983|20021367|P3|STARTED|Dispense 1||7
8122729|NCT02920983|20021368|P2|STARTED|Dispense 1||10
8122730|NCT02920983|20021369|P1|STARTED|Dispense 1||8
8122731|NCT02920970|20021398|P2|NOT COMPLETED|Second Intervention||0
8122732|NCT02920970|20021399|P1|NOT COMPLETED|Second Intervention||1
8122733|NCT02920970|20021398|P2|COMPLETED|Second Intervention||30
8122734|NCT02920970|20021399|P1|COMPLETED|Second Intervention||37
8122735|NCT02920970|20021398|P2|STARTED|Second Intervention||30
8122736|NCT02920970|20021399|P1|STARTED|Second Intervention||38
8122737|NCT02920970|20021398|P2|NOT COMPLETED|First Intervention||2
8122738|NCT02920970|20021399|P1|NOT COMPLETED|First Intervention||0
8122739|NCT02920970|20021398|P2|COMPLETED|First Intervention||30
8122740|NCT02920970|20021399|P1|COMPLETED|First Intervention||38
8122741|NCT02920970|20021398|P2|STARTED|First Intervention||32
8122742|NCT02920970|20021399|P1|STARTED|First Intervention||38
8122743|NCT02920957|20021425|P2|NOT COMPLETED|Second Intervention: 1 Month||1
8122744|NCT02920957|20021426|P1|NOT COMPLETED|Second Intervention: 1 Month||0
8122745|NCT02920957|20021425|P2|COMPLETED|Second Intervention: 1 Month||40
8122746|NCT02920957|20021426|P1|COMPLETED|Second Intervention: 1 Month||42
8122747|NCT02920957|20021425|P2|STARTED|Second Intervention: 1 Month||41
8122748|NCT02920957|20021426|P1|STARTED|Second Intervention: 1 Month||42
8122749|NCT02920957|20021425|P2|NOT COMPLETED|First Intervention : 1 Month||0
8122750|NCT02920957|20021426|P1|NOT COMPLETED|First Intervention : 1 Month||4
8122751|NCT02920957|20021425|P2|COMPLETED|First Intervention : 1 Month||41
8122752|NCT02920957|20021426|P1|COMPLETED|First Intervention : 1 Month||42
8122753|NCT02920957|20021425|P2|STARTED|First Intervention : 1 Month||41
8122754|NCT02920957|20021426|P1|STARTED|First Intervention : 1 Month||46
8122755|NCT02920918|20021480|P2|NOT COMPLETED|Overall Study||0
8122756|NCT02920918|20021481|P1|NOT COMPLETED|Overall Study||0
8122757|NCT02920918|20021480|P2|COMPLETED|Overall Study||19
8122758|NCT02920918|20021481|P1|COMPLETED|Overall Study||17
8122759|NCT02920918|20021480|P2|STARTED|Overall Study||19
8122760|NCT02920918|20021481|P1|STARTED|Overall Study||17
8122761|NCT02920749|20021493|P4|NOT COMPLETED|Overall Study||0
8122762|NCT02920749|20021494|P3|NOT COMPLETED|Overall Study||0
8122763|NCT02920749|20021495|P2|NOT COMPLETED|Overall Study||0
8122764|NCT02920749|20021496|P1|NOT COMPLETED|Overall Study||0
8122765|NCT02920749|20021493|P4|COMPLETED|Overall Study||30
8122766|NCT02920749|20021494|P3|COMPLETED|Overall Study||30
8122767|NCT02920749|20021495|P2|COMPLETED|Overall Study||30
8122768|NCT02920749|20021496|P1|COMPLETED|Overall Study||30
8122769|NCT02920749|20021493|P4|STARTED|Overall Study||30
8122770|NCT02920749|20021494|P3|STARTED|Overall Study||30
8122771|NCT02920749|20021495|P2|STARTED|Overall Study||30
8122772|NCT02920749|20021496|P1|STARTED|Overall Study||30
8122776|NCT02920450|20021515|P4|NOT COMPLETED|Overall Study||0
8122777|NCT02920450|20021516|P3|NOT COMPLETED|Overall Study||0
8122778|NCT02920450|20021517|P2|NOT COMPLETED|Overall Study||0
8122779|NCT02920450|20021518|P1|NOT COMPLETED|Overall Study||2
8122780|NCT02920450|20021515|P4|COMPLETED|Overall Study||0
8122781|NCT02920450|20021516|P3|COMPLETED|Overall Study||0
8122782|NCT02920450|20021517|P2|COMPLETED|Overall Study||0
8122783|NCT02920450|20021518|P1|COMPLETED|Overall Study||1
8122784|NCT02920450|20021515|P4|STARTED|Overall Study||0
8122785|NCT02920450|20021516|P3|STARTED|Overall Study||0
8122786|NCT02920450|20021517|P2|STARTED|Overall Study||0
8122787|NCT02920450|20021518|P1|STARTED|Overall Study||3
8122788|NCT02920242|20021529|P3|NOT COMPLETED|Overall Study||1
8122789|NCT02920242|20021530|P2|NOT COMPLETED|Overall Study||0
8122790|NCT02920242|20021531|P1|NOT COMPLETED|Overall Study||2
8122791|NCT02920242|20021529|P3|COMPLETED|Overall Study||3
8122792|NCT02920242|20021530|P2|COMPLETED|Overall Study||11
8122793|NCT02920242|20021531|P1|COMPLETED|Overall Study||11
8122794|NCT02920242|20021529|P3|Safety Set|Overall Study||4
8122795|NCT02920242|20021530|P2|Safety Set|Overall Study||11
8122796|NCT02920242|20021531|P1|Safety Set|Overall Study||12
8122797|NCT02920242|20021529|P3|STARTED|Overall Study||4
8122798|NCT02920242|20021530|P2|STARTED|Overall Study||11
8122799|NCT02920242|20021531|P1|STARTED|Overall Study||13
8122800|NCT02920177|20021559|P2|NOT COMPLETED|Overall Study||2
8122801|NCT02920177|20021560|P1|NOT COMPLETED|Overall Study||2
8122802|NCT02920177|20021559|P2|COMPLETED|Overall Study||0
8122803|NCT02920177|20021560|P1|COMPLETED|Overall Study||0
8122804|NCT02920177|20021559|P2|STARTED|Overall Study||2
8122805|NCT02920177|20021560|P1|STARTED|Overall Study||2
8122806|NCT02919995|20021580|P6|NOT COMPLETED|Overall Study||1
8122807|NCT02919995|20021581|P5|NOT COMPLETED|Overall Study||0
8122808|NCT02919995|20021582|P4|NOT COMPLETED|Overall Study||0
8122809|NCT02919995|20021583|P3|NOT COMPLETED|Overall Study||0
8122810|NCT02919995|20021584|P2|NOT COMPLETED|Overall Study||0
8122811|NCT02919995|20021585|P1|NOT COMPLETED|Overall Study||0
8122812|NCT02919995|20021580|P6|COMPLETED|Overall Study||1
8122813|NCT02919995|20021581|P5|COMPLETED|Overall Study||1
8122814|NCT02919995|20021582|P4|COMPLETED|Overall Study||2
8122815|NCT02919995|20021583|P3|COMPLETED|Overall Study||2
8122816|NCT02919995|20021584|P2|COMPLETED|Overall Study||2
8122817|NCT02919995|20021585|P1|COMPLETED|Overall Study||1
8122818|NCT02919995|20021580|P6|STARTED|Overall Study||2
8122819|NCT02919995|20021581|P5|STARTED|Overall Study||1
8122820|NCT02919995|20021582|P4|STARTED|Overall Study||2
8122821|NCT02919995|20021583|P3|STARTED|Overall Study||2
8122822|NCT02919995|20021584|P2|STARTED|Overall Study||2
8122823|NCT02919995|20021585|P1|STARTED|Overall Study||1
8122824|NCT02919826|20021612|P2|NOT COMPLETED|Overall Study||2
8122825|NCT02919826|20021613|P1|NOT COMPLETED|Overall Study||0
8122826|NCT02919826|20021612|P2|COMPLETED|Overall Study||8
8122827|NCT02919826|20021613|P1|COMPLETED|Overall Study||10
8122828|NCT02919826|20021612|P2|STARTED|Overall Study||10
8122829|NCT02919826|20021613|P1|STARTED|Overall Study||10
8122830|NCT02919813|20021629|P2|NOT COMPLETED|Overall Study||0
8122831|NCT02919813|20021630|P1|NOT COMPLETED|Overall Study||0
8122832|NCT02919813|20021629|P2|COMPLETED|Overall Study||17
8122833|NCT02919813|20021630|P1|COMPLETED|Overall Study||14
8122834|NCT02919813|20021629|P2|STARTED|Overall Study||17
8122835|NCT02919813|20021630|P1|STARTED|Overall Study||14
8122836|NCT02919761|20021648|P3|NOT COMPLETED|Part 2: Double-blind||21
8122837|NCT02919761|20021649|P2|NOT COMPLETED|Part 2: Double-blind||6
8122838|NCT02919761|20021650|P1|NOT COMPLETED|Part 2: Double-blind||0
8122839|NCT02919761|20021648|P3|COMPLETED|Part 2: Double-blind||56
8122840|NCT02919761|20021649|P2|COMPLETED|Part 2: Double-blind||71
8122841|NCT02919761|20021650|P1|COMPLETED|Part 2: Double-blind||0
8122842|NCT02919761|20021648|P3|Per Protocol Population|Part 2: Double-blind||73
8122843|NCT02919761|20021649|P2|Per Protocol Population|Part 2: Double-blind||76
8122844|NCT02919761|20021650|P1|Per Protocol Population|Part 2: Double-blind||0
8122845|NCT02919761|20021648|P3|mITT Population|Part 2: Double-blind||76
8122846|NCT02919761|20021649|P2|mITT Population|Part 2: Double-blind||77
8122847|NCT02919761|20021650|P1|mITT Population|Part 2: Double-blind||0
8122848|NCT02919761|20021648|P3|Safety Population|Part 2: Double-blind||77
8122849|NCT02919761|20021649|P2|Safety Population|Part 2: Double-blind||77
8122850|NCT02919761|20021650|P1|Safety Population|Part 2: Double-blind||0
8122851|NCT02919761|20021648|P3|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive placebo for an additional 12 weeks in Part 2|77
8122852|NCT02919761|20021649|P2|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive Acthar for an additional 12 weeks in Part 2|77
8122853|NCT02919761|20021650|P1|STARTED|Part 2: Double-blind|154 of the original Part 1 participants continued to Part 2, randomized to Acthar or placebo|0
8122854|NCT02919761|20021648|P3|NOT COMPLETED|Part 1: Open Label||0
8122855|NCT02919761|20021649|P2|NOT COMPLETED|Part 1: Open Label||0
8122856|NCT02919761|20021650|P1|NOT COMPLETED|Part 1: Open Label||24
8122857|NCT02919761|20021648|P3|COMPLETED|Part 1: Open Label||0
8122858|NCT02919761|20021649|P2|COMPLETED|Part 1: Open Label||0
8122859|NCT02919761|20021650|P1|COMPLETED|Part 1: Open Label||235
8122860|NCT02919761|20021648|P3|Per Protocol Population|Part 1: Open Label||0
8122861|NCT02919761|20021649|P2|Per Protocol Population|Part 1: Open Label||0
8122862|NCT02919761|20021650|P1|Per Protocol Population|Part 1: Open Label||236
8122863|NCT02919761|20021648|P3|Safety Population|Part 1: Open Label||0
8122864|NCT02919761|20021649|P2|Safety Population|Part 1: Open Label||0
8122865|NCT02919761|20021650|P1|Safety Population|Part 1: Open Label||259
8122866|NCT02919761|20021648|P3|mITT Population|Part 1: Open Label||0
8122867|NCT02919761|20021649|P2|mITT Population|Part 1: Open Label||0
8122868|NCT02919761|20021650|P1|mITT Population|Part 1: Open Label||259
8122869|NCT02919761|20021648|P3|STARTED|Part 1: Open Label||0
8122870|NCT02919761|20021649|P2|STARTED|Part 1: Open Label|Part 2 Blinded groups were not evaluated as such during Part 1|0
8122871|NCT02919761|20021650|P1|STARTED|Part 1: Open Label||259
8122872|NCT02919696|20021678|P2|NOT COMPLETED|Overall Study||5
8122873|NCT02919696|20021679|P1|NOT COMPLETED|Overall Study||4
8122874|NCT02919696|20021678|P2|COMPLETED|Overall Study||9
8122875|NCT02919696|20021679|P1|COMPLETED|Overall Study||8
8122876|NCT02919696|20021678|P2|Progressive Disease|Overall Study||9
8122877|NCT02919696|20021679|P1|Progressive Disease|Overall Study||7
8122878|NCT02919696|20021678|P2|Death On Treatment|Overall Study||0
8122879|NCT02919696|20021679|P1|Death On Treatment|Overall Study||1
8122880|NCT02919696|20021678|P2|PK 150 mg Abemaciclib Dose|Overall Study||2
8122881|NCT02919696|20021679|P1|PK 150 mg Abemaciclib Dose|Overall Study||0
8122882|NCT02919696|20021678|P2|PK 100 mg Abemaciclib Dose|Overall Study||0
8122883|NCT02919696|20021679|P1|PK 100 mg Abemaciclib Dose|Overall Study||5
8122884|NCT02919696|20021678|P2|Received at Least One Dose of Study Drug|Overall Study||13
8122885|NCT02919696|20021679|P1|Received at Least One Dose of Study Drug|Overall Study||12
8122886|NCT02919696|20021678|P2|STARTED|Overall Study||14
8122887|NCT02919696|20021679|P1|STARTED|Overall Study||12
8122900|NCT02919657|20021708|P2|NOT COMPLETED|Overall Study||0
8122901|NCT02919657|20021709|P1|NOT COMPLETED|Overall Study||0
8122902|NCT02919657|20021708|P2|COMPLETED|Overall Study|completed with the same initial 10 participants|10
8122903|NCT02919657|20021709|P1|COMPLETED|Overall Study|completed with the same initial 10 participants|10
8122904|NCT02919657|20021708|P2|STARTED|Overall Study|10 Participants|10
8122905|NCT02919657|20021709|P1|STARTED|Overall Study|10 Participants|10
8122906|NCT02919618|20021715|P1|NOT COMPLETED|Overall Study||1
8122907|NCT02919618|20021715|P1|COMPLETED|Overall Study||18
8122908|NCT02919618|20021715|P1|Primary Efficacy Endpoint (6 Months)|Overall Study||18
8122909|NCT02919618|20021715|P1|Primary Safety Endpoint (</=90 Days)|Overall Study||19
8122910|NCT02919618|20021715|P1|STARTED|Overall Study||19
8122911|NCT02919423|20021734|P2|NOT COMPLETED|Overall Study||9
8122912|NCT02919423|20021735|P1|NOT COMPLETED|Overall Study||2
8122913|NCT02919423|20021734|P2|COMPLETED|Overall Study||16
8122914|NCT02919423|20021735|P1|COMPLETED|Overall Study||4
8122915|NCT02919423|20021734|P2|STARTED|Overall Study||25
8122916|NCT02919423|20021735|P1|STARTED|Overall Study||6
8122917|NCT02919267|20021745|P4|NOT COMPLETED|Overall Study||4
8122918|NCT02919267|20021746|P3|NOT COMPLETED|Overall Study||3
8122919|NCT02919267|20021747|P2|NOT COMPLETED|Overall Study||3
8122920|NCT02919267|20021748|P1|NOT COMPLETED|Overall Study||0
8122921|NCT02919267|20021745|P4|COMPLETED|Overall Study||10
8122922|NCT02919267|20021746|P3|COMPLETED|Overall Study||10
8122923|NCT02919267|20021747|P2|COMPLETED|Overall Study||9
8122924|NCT02919267|20021748|P1|COMPLETED|Overall Study||10
8122925|NCT02919267|20021745|P4|STARTED|Overall Study||14
8122926|NCT02919267|20021746|P3|STARTED|Overall Study||13
8122927|NCT02919267|20021747|P2|STARTED|Overall Study||12
8122928|NCT02919267|20021748|P1|STARTED|Overall Study||10
8122929|NCT02919111|20021758|P1|NOT COMPLETED|Overall Study||0
8122930|NCT02919111|20021758|P1|COMPLETED|Overall Study||299
8122931|NCT02919111|20021758|P1|STARTED|Overall Study||299
8122932|NCT02919007|20021778|P1|NOT COMPLETED|Overall Study||0
8122933|NCT02919007|20021778|P1|COMPLETED|Overall Study||25
8122934|NCT02919007|20021778|P1|STARTED|Overall Study||25
8122935|NCT02918773|20021784|P2|NOT COMPLETED|Overall Study||0
8122936|NCT02918773|20021785|P1|NOT COMPLETED|Overall Study||0
8122937|NCT02918773|20021784|P2|COMPLETED|Overall Study||11
8122938|NCT02918773|20021785|P1|COMPLETED|Overall Study||11
8122939|NCT02918773|20021784|P2|STARTED|Overall Study||11
8122940|NCT02918773|20021785|P1|STARTED|Overall Study||11
8122941|NCT02918721|20021796|P1|NOT COMPLETED|Overall Study||0
8122942|NCT02918721|20021796|P1|COMPLETED|Overall Study||70
8122943|NCT02918721|20021796|P1|STARTED|Overall Study||70
8122944|NCT02918669|20021801|P1|NOT COMPLETED|Overall Study||4
8122945|NCT02918669|20021801|P1|COMPLETED|Overall Study||8
8122946|NCT02918669|20021801|P1|STARTED|Overall Study||12
8122947|NCT02918656|20021811|P3|NOT COMPLETED|Overall Study||0
8122948|NCT02918656|20021812|P2|NOT COMPLETED|Overall Study||0
8122949|NCT02918656|20021813|P1|NOT COMPLETED|Overall Study||0
8122950|NCT02918656|20021811|P3|COMPLETED|Overall Study||57
8122951|NCT02918656|20021812|P2|COMPLETED|Overall Study||60
8122952|NCT02918656|20021813|P1|COMPLETED|Overall Study||54
8122953|NCT02918656|20021811|P3|STARTED|Overall Study||57
8122954|NCT02918656|20021812|P2|STARTED|Overall Study||60
8122955|NCT02918656|20021813|P1|STARTED|Overall Study||54
8122956|NCT02918630|20021832|P2|NOT COMPLETED|Overall Study||0
8122957|NCT02918630|20021833|P1|NOT COMPLETED|Overall Study||0
8122958|NCT02918630|20021832|P2|COMPLETED|Overall Study||3
8122959|NCT02918630|20021833|P1|COMPLETED|Overall Study||4
8122960|NCT02918630|20021832|P2|STARTED|Overall Study||3
8122961|NCT02918630|20021833|P1|STARTED|Overall Study||4
8122962|NCT02918617|20021856|P9|NOT COMPLETED|Overall Study||0
8122963|NCT02918617|20021857|P8|NOT COMPLETED|Overall Study||1
8122964|NCT02918617|20021858|P7|NOT COMPLETED|Overall Study||0
8122965|NCT02918617|20021859|P6|NOT COMPLETED|Overall Study||0
8122966|NCT02918617|20021860|P5|NOT COMPLETED|Overall Study||0
8122967|NCT02918617|20021861|P4|NOT COMPLETED|Overall Study||0
8122968|NCT02918617|20021862|P3|NOT COMPLETED|Overall Study||3
8122969|NCT02918617|20021863|P2|NOT COMPLETED|Overall Study||0
8122970|NCT02918617|20021864|P1|NOT COMPLETED|Overall Study||1
8122971|NCT02918617|20021856|P9|COMPLETED|Overall Study||26
8122972|NCT02918617|20021857|P8|COMPLETED|Overall Study||25
8122973|NCT02918617|20021858|P7|COMPLETED|Overall Study||22
8122974|NCT02918617|20021859|P6|COMPLETED|Overall Study||20
8122975|NCT02918617|20021860|P5|COMPLETED|Overall Study||24
8122976|NCT02918617|20021861|P4|COMPLETED|Overall Study||22
8122977|NCT02918617|20021862|P3|COMPLETED|Overall Study||19
8122978|NCT02918617|20021863|P2|COMPLETED|Overall Study||20
8122979|NCT02918617|20021864|P1|COMPLETED|Overall Study||20
8122980|NCT02918617|20021856|P9|STARTED|Overall Study||26
8122981|NCT02918617|20021857|P8|STARTED|Overall Study||26
8122982|NCT02918617|20021858|P7|STARTED|Overall Study||22
8122983|NCT02918617|20021859|P6|STARTED|Overall Study||20
8122984|NCT02918617|20021860|P5|STARTED|Overall Study||24
8122985|NCT02918617|20021861|P4|STARTED|Overall Study||22
8122986|NCT02918617|20021862|P3|STARTED|Overall Study||22
8122987|NCT02918617|20021863|P2|STARTED|Overall Study||20
8122988|NCT02918617|20021864|P1|STARTED|Overall Study||21
8122989|NCT02918552|20021913|P2|NOT COMPLETED|Overall Study||2
8122990|NCT02918552|20021914|P1|NOT COMPLETED|Overall Study||1
8122991|NCT02918552|20021913|P2|COMPLETED|Overall Study||6
8122992|NCT02918552|20021914|P1|COMPLETED|Overall Study||6
8122993|NCT02918552|20021913|P2|STARTED|Overall Study||8
8122994|NCT02918552|20021914|P1|STARTED|Overall Study||7
8122995|NCT02918396|20021951|P3|NOT COMPLETED|Overall Study||0
8122996|NCT02918396|20021952|P2|NOT COMPLETED|Overall Study||0
8122997|NCT02918396|20021953|P1|NOT COMPLETED|Overall Study||0
8122998|NCT02918396|20021951|P3|COMPLETED|Overall Study||2
8122999|NCT02918396|20021952|P2|COMPLETED|Overall Study||1
8123000|NCT02918396|20021953|P1|COMPLETED|Overall Study||2
8123001|NCT02918396|20021951|P3|STARTED|Overall Study||2
8123002|NCT02918396|20021952|P2|STARTED|Overall Study||1
8123003|NCT02918396|20021953|P1|STARTED|Overall Study||2
8123004|NCT02918357|20021961|P1|NOT COMPLETED|Overall Study||0
8123005|NCT02918357|20021961|P1|COMPLETED|Overall Study||385
8123006|NCT02918357|20021961|P1|PET/CT Scan|Overall Study||385
8123007|NCT02918357|20021961|P1|Investigational Drug Administration|Overall Study||385
8123008|NCT02918357|20021961|P1|STARTED|Overall Study||385
8123009|NCT02918318|20021990|P5|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||1
8123010|NCT02918318|20021991|P4|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123011|NCT02918318|20021992|P3|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123012|NCT02918318|20021993|P2|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123013|NCT02918318|20021994|P1|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123014|NCT02918318|20021990|P5|COMPLETED|Open Label Follow-up Phase: 4 Weeks||47
8123015|NCT02918318|20021991|P4|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123016|NCT02918318|20021992|P3|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123017|NCT02918318|20021993|P2|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123018|NCT02918318|20021994|P1|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
8123019|NCT02918318|20021990|P5|STARTED|Open Label Follow-up Phase: 4 Weeks||48
8123020|NCT02918318|20021991|P4|STARTED|Open Label Follow-up Phase: 4 Weeks||0
8123021|NCT02918318|20021992|P3|STARTED|Open Label Follow-up Phase: 4 Weeks||0
8123022|NCT02918318|20021993|P2|STARTED|Open Label Follow-up Phase: 4 Weeks||0
8123023|NCT02918318|20021994|P1|STARTED|Open Label Follow-up Phase: 4 Weeks||0
8123024|NCT02918318|20021990|P5|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||1
8123025|NCT02918318|20021991|P4|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123026|NCT02918318|20021992|P3|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123027|NCT02918318|20021993|P2|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123028|NCT02918318|20021994|P1|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123029|NCT02918318|20021990|P5|COMPLETED|Open Label Treatment Phase: 4 Weeks||47
8123030|NCT02918318|20021991|P4|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123031|NCT02918318|20021992|P3|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123032|NCT02918318|20021993|P2|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123033|NCT02918318|20021994|P1|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
8123034|NCT02918318|20021990|P5|STARTED|Open Label Treatment Phase: 4 Weeks||48
8123035|NCT02918318|20021991|P4|STARTED|Open Label Treatment Phase: 4 Weeks||0
8123036|NCT02918318|20021992|P3|STARTED|Open Label Treatment Phase: 4 Weeks||0
8123037|NCT02918318|20021993|P2|STARTED|Open Label Treatment Phase: 4 Weeks||0
8123038|NCT02918318|20021994|P1|STARTED|Open Label Treatment Phase: 4 Weeks||0
8123039|NCT02918318|20021990|P5|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
8123040|NCT02918318|20021991|P4|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||2
8123041|NCT02918318|20021992|P3|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
8123042|NCT02918318|20021993|P2|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||3
8123043|NCT02918318|20021994|P1|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
8123044|NCT02918318|20021990|P5|COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
8123045|NCT02918318|20021991|P4|COMPLETED|Posttreatment Phase: Up to 24 Weeks||25
8123046|NCT02918318|20021992|P3|COMPLETED|Posttreatment Phase: Up to 24 Weeks||16
8123047|NCT02918318|20021993|P2|COMPLETED|Posttreatment Phase: Up to 24 Weeks||8
8123048|NCT02918318|20021994|P1|COMPLETED|Posttreatment Phase: Up to 24 Weeks||12
8123049|NCT02918318|20021990|P5|STARTED|Posttreatment Phase: Up to 24 Weeks||0
8123050|NCT02918318|20021991|P4|STARTED|Posttreatment Phase: Up to 24 Weeks||27
8123051|NCT02918318|20021992|P3|STARTED|Posttreatment Phase: Up to 24 Weeks||17
8123052|NCT02918318|20021993|P2|STARTED|Posttreatment Phase: Up to 24 Weeks||11
8123053|NCT02918318|20021994|P1|STARTED|Posttreatment Phase: Up to 24 Weeks||13
8123054|NCT02918318|20021990|P5|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
8123055|NCT02918318|20021991|P4|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||3
8123056|NCT02918318|20021992|P3|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
8123057|NCT02918318|20021993|P2|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
8123058|NCT02918318|20021994|P1|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
8123059|NCT02918318|20021990|P5|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
8123060|NCT02918318|20021991|P4|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||50
8123061|NCT02918318|20021992|P3|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||23
8123062|NCT02918318|20021993|P2|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||28
8123063|NCT02918318|20021994|P1|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||26
8123064|NCT02918318|20021990|P5|STARTED|Double-blind Follow-up Phase: 4 Weeks||0
8123065|NCT02918318|20021991|P4|STARTED|Double-blind Follow-up Phase: 4 Weeks||53
8123066|NCT02918318|20021992|P3|STARTED|Double-blind Follow-up Phase: 4 Weeks||24
8123067|NCT02918318|20021993|P2|STARTED|Double-blind Follow-up Phase: 4 Weeks||28
8123068|NCT02918318|20021994|P1|STARTED|Double-blind Follow-up Phase: 4 Weeks||27
8123069|NCT02918318|20021990|P5|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||0
8123070|NCT02918318|20021991|P4|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||8
8123071|NCT02918318|20021992|P3|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
8123072|NCT02918318|20021993|P2|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||7
8123073|NCT02918318|20021994|P1|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
8123074|NCT02918318|20021990|P5|COMPLETED|Double-blind Induction Phase: 4 Weeks||0
8123075|NCT02918318|20021991|P4|COMPLETED|Double-blind Induction Phase: 4 Weeks||72
8123076|NCT02918318|20021992|P3|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
8123077|NCT02918318|20021993|P2|COMPLETED|Double-blind Induction Phase: 4 Weeks||33
8123078|NCT02918318|20021994|P1|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
8123079|NCT02918318|20021990|P5|Responders|Double-blind Induction Phase: 4 Weeks||0
8123080|NCT02918318|20021991|P4|Responders|Double-blind Induction Phase: 4 Weeks||27
8123081|NCT02918318|20021992|P3|Responders|Double-blind Induction Phase: 4 Weeks||17
8123082|NCT02918318|20021993|P2|Responders|Double-blind Induction Phase: 4 Weeks||11
8123083|NCT02918318|20021994|P1|Responders|Double-blind Induction Phase: 4 Weeks||13
8123084|NCT02918318|20021990|P5|STARTED|Double-blind Induction Phase: 4 Weeks||0
8123085|NCT02918318|20021991|P4|STARTED|Double-blind Induction Phase: 4 Weeks||80
8123086|NCT02918318|20021992|P3|STARTED|Double-blind Induction Phase: 4 Weeks||41
8123087|NCT02918318|20021993|P2|STARTED|Double-blind Induction Phase: 4 Weeks||40
8123088|NCT02918318|20021994|P1|STARTED|Double-blind Induction Phase: 4 Weeks||41
8123089|NCT02918279|20022055|P2|NOT COMPLETED|Overall Study||23
8123090|NCT02918279|20022056|P1|NOT COMPLETED|Overall Study||13
8123091|NCT02918279|20022055|P2|COMPLETED|Overall Study||103
8123092|NCT02918279|20022056|P1|COMPLETED|Overall Study||112
8123093|NCT02918279|20022055|P2|Safety Analysis Set|Overall Study||126
8123094|NCT02918279|20022056|P1|Safety Analysis Set|Overall Study||125
8123095|NCT02918279|20022055|P2|Full Analysis Set|Overall Study||126
8123096|NCT02918279|20022056|P1|Full Analysis Set|Overall Study||125
8123097|NCT02918279|20022055|P2|STARTED|Overall Study||126
8123098|NCT02918279|20022056|P1|STARTED|Overall Study||125
8123099|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123100|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123101|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123102|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123103|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123104|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123105|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123106|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123107|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123108|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123109|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123110|NCT02918266|20022192|P11|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123111|NCT02918266|20022193|P10|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123112|NCT02918266|20022194|P9|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123113|NCT02918266|20022195|P8|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123114|NCT02918266|20022196|P7|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123115|NCT02918266|20022197|P6|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123116|NCT02918266|20022198|P5|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123117|NCT02918266|20022199|P4|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123118|NCT02918266|20022200|P3|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123119|NCT02918266|20022201|P2|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123120|NCT02918266|20022202|P1|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
8123121|NCT02918266|20022192|P11|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123122|NCT02918266|20022193|P10|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123123|NCT02918266|20022194|P9|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123124|NCT02918266|20022195|P8|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123125|NCT02918266|20022196|P7|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123126|NCT02918266|20022197|P6|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123127|NCT02918266|20022198|P5|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123128|NCT02918266|20022199|P4|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123129|NCT02918266|20022200|P3|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123130|NCT02918266|20022201|P2|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123131|NCT02918266|20022202|P1|STARTED|Part 2: Intervention Period 5 (2 Days)||0
8123132|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123133|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123134|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123135|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123136|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123137|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123138|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123139|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123140|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123141|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123142|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123143|NCT02918266|20022192|P11|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123144|NCT02918266|20022193|P10|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123145|NCT02918266|20022194|P9|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123146|NCT02918266|20022195|P8|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123147|NCT02918266|20022196|P7|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123148|NCT02918266|20022197|P6|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123149|NCT02918266|20022198|P5|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123150|NCT02918266|20022199|P4|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123151|NCT02918266|20022200|P3|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123152|NCT02918266|20022201|P2|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123153|NCT02918266|20022202|P1|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
8123154|NCT02918266|20022192|P11|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123155|NCT02918266|20022193|P10|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123156|NCT02918266|20022194|P9|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123157|NCT02918266|20022195|P8|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123158|NCT02918266|20022196|P7|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123159|NCT02918266|20022197|P6|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123160|NCT02918266|20022198|P5|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123161|NCT02918266|20022199|P4|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123162|NCT02918266|20022200|P3|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123163|NCT02918266|20022201|P2|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123164|NCT02918266|20022202|P1|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
8123165|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123166|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123167|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123168|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123169|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123170|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123171|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123172|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123173|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123174|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123175|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123176|NCT02918266|20022192|P11|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123177|NCT02918266|20022193|P10|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123178|NCT02918266|20022194|P9|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123179|NCT02918266|20022195|P8|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123180|NCT02918266|20022196|P7|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123181|NCT02918266|20022197|P6|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123182|NCT02918266|20022198|P5|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123183|NCT02918266|20022199|P4|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123184|NCT02918266|20022200|P3|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123185|NCT02918266|20022201|P2|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123186|NCT02918266|20022202|P1|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
8123187|NCT02918266|20022192|P11|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123188|NCT02918266|20022193|P10|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123189|NCT02918266|20022194|P9|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123190|NCT02918266|20022195|P8|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123191|NCT02918266|20022196|P7|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123192|NCT02918266|20022197|P6|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123193|NCT02918266|20022198|P5|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123194|NCT02918266|20022199|P4|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123195|NCT02918266|20022200|P3|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123196|NCT02918266|20022201|P2|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123197|NCT02918266|20022202|P1|STARTED|Part 2: Intervention Period 4 (2 Days)||0
8123198|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123199|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123200|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123201|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123202|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123203|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123204|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123205|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123206|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123207|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123208|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123209|NCT02918266|20022192|P11|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123210|NCT02918266|20022193|P10|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123211|NCT02918266|20022194|P9|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123212|NCT02918266|20022195|P8|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123213|NCT02918266|20022196|P7|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123214|NCT02918266|20022197|P6|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123215|NCT02918266|20022198|P5|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123216|NCT02918266|20022199|P4|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123217|NCT02918266|20022200|P3|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123218|NCT02918266|20022201|P2|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123219|NCT02918266|20022202|P1|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
8123220|NCT02918266|20022192|P11|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123221|NCT02918266|20022193|P10|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123222|NCT02918266|20022194|P9|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123223|NCT02918266|20022195|P8|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123224|NCT02918266|20022196|P7|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123225|NCT02918266|20022197|P6|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123226|NCT02918266|20022198|P5|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123227|NCT02918266|20022199|P4|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123228|NCT02918266|20022200|P3|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123229|NCT02918266|20022201|P2|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123230|NCT02918266|20022202|P1|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
8123231|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123232|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123233|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123234|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123235|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123236|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123237|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123238|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123239|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123240|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123241|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123242|NCT02918266|20022192|P11|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123243|NCT02918266|20022193|P10|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123244|NCT02918266|20022194|P9|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123245|NCT02918266|20022195|P8|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123246|NCT02918266|20022196|P7|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123247|NCT02918266|20022197|P6|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123248|NCT02918266|20022198|P5|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123249|NCT02918266|20022199|P4|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123250|NCT02918266|20022200|P3|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123251|NCT02918266|20022201|P2|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123252|NCT02918266|20022202|P1|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
8123253|NCT02918266|20022192|P11|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123254|NCT02918266|20022193|P10|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123255|NCT02918266|20022194|P9|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123256|NCT02918266|20022195|P8|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123257|NCT02918266|20022196|P7|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123258|NCT02918266|20022197|P6|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123259|NCT02918266|20022198|P5|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123260|NCT02918266|20022199|P4|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123261|NCT02918266|20022200|P3|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123262|NCT02918266|20022201|P2|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123263|NCT02918266|20022202|P1|STARTED|Part 2: Intervention Period 3 (2 Days)||0
8123264|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123265|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123266|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123267|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123268|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123269|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123270|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123271|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123272|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123273|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123274|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123275|NCT02918266|20022192|P11|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123276|NCT02918266|20022193|P10|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123277|NCT02918266|20022194|P9|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123278|NCT02918266|20022195|P8|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123279|NCT02918266|20022196|P7|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123280|NCT02918266|20022197|P6|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123281|NCT02918266|20022198|P5|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123282|NCT02918266|20022199|P4|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123283|NCT02918266|20022200|P3|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123284|NCT02918266|20022201|P2|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123285|NCT02918266|20022202|P1|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
8123286|NCT02918266|20022192|P11|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123287|NCT02918266|20022193|P10|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123288|NCT02918266|20022194|P9|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123289|NCT02918266|20022195|P8|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123290|NCT02918266|20022196|P7|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123291|NCT02918266|20022197|P6|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123292|NCT02918266|20022198|P5|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123293|NCT02918266|20022199|P4|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123294|NCT02918266|20022200|P3|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123295|NCT02918266|20022201|P2|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123296|NCT02918266|20022202|P1|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
8123297|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123298|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123299|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123300|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123301|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123302|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123303|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123304|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123305|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123306|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123307|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123308|NCT02918266|20022192|P11|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123309|NCT02918266|20022193|P10|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123310|NCT02918266|20022194|P9|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123311|NCT02918266|20022195|P8|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123312|NCT02918266|20022196|P7|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123313|NCT02918266|20022197|P6|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123314|NCT02918266|20022198|P5|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123315|NCT02918266|20022199|P4|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123316|NCT02918266|20022200|P3|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123317|NCT02918266|20022201|P2|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123318|NCT02918266|20022202|P1|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
8123319|NCT02918266|20022192|P11|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123320|NCT02918266|20022193|P10|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123321|NCT02918266|20022194|P9|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123322|NCT02918266|20022195|P8|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123323|NCT02918266|20022196|P7|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123324|NCT02918266|20022197|P6|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123325|NCT02918266|20022198|P5|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123326|NCT02918266|20022199|P4|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123327|NCT02918266|20022200|P3|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123328|NCT02918266|20022201|P2|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123329|NCT02918266|20022202|P1|STARTED|Part 2: Intervention Period 2 (2 Days)||0
8123330|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123331|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123332|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123333|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123334|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123335|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123336|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123337|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123338|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123339|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123340|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123341|NCT02918266|20022192|P11|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123342|NCT02918266|20022193|P10|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123343|NCT02918266|20022194|P9|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123344|NCT02918266|20022195|P8|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123345|NCT02918266|20022196|P7|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123346|NCT02918266|20022197|P6|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123347|NCT02918266|20022198|P5|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123348|NCT02918266|20022199|P4|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123349|NCT02918266|20022200|P3|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123350|NCT02918266|20022201|P2|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123351|NCT02918266|20022202|P1|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
8123352|NCT02918266|20022192|P11|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123353|NCT02918266|20022193|P10|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123354|NCT02918266|20022194|P9|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123355|NCT02918266|20022195|P8|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123356|NCT02918266|20022196|P7|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123357|NCT02918266|20022197|P6|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123358|NCT02918266|20022198|P5|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123359|NCT02918266|20022199|P4|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123360|NCT02918266|20022200|P3|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123361|NCT02918266|20022201|P2|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123362|NCT02918266|20022202|P1|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
8123363|NCT02918266|20022192|P11|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123364|NCT02918266|20022193|P10|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123365|NCT02918266|20022194|P9|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
8123366|NCT02918266|20022195|P8|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123367|NCT02918266|20022196|P7|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
8123368|NCT02918266|20022197|P6|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123369|NCT02918266|20022198|P5|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123370|NCT02918266|20022199|P4|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123371|NCT02918266|20022200|P3|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123372|NCT02918266|20022201|P2|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
8123373|NCT02918266|20022202|P1|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123374|NCT02918266|20022192|P11|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123375|NCT02918266|20022193|P10|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123376|NCT02918266|20022194|P9|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123377|NCT02918266|20022195|P8|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123378|NCT02918266|20022196|P7|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123379|NCT02918266|20022197|P6|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123380|NCT02918266|20022198|P5|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123381|NCT02918266|20022199|P4|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123382|NCT02918266|20022200|P3|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123383|NCT02918266|20022201|P2|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123384|NCT02918266|20022202|P1|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
8123385|NCT02918266|20022192|P11|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123386|NCT02918266|20022193|P10|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123387|NCT02918266|20022194|P9|STARTED|Part 2: Intervention Period 1 (2 Days)||2
8123388|NCT02918266|20022195|P8|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123389|NCT02918266|20022196|P7|STARTED|Part 2: Intervention Period 1 (2 Days)||2
8123390|NCT02918266|20022197|P6|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123391|NCT02918266|20022198|P5|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123392|NCT02918266|20022199|P4|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123393|NCT02918266|20022200|P3|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123394|NCT02918266|20022201|P2|STARTED|Part 2: Intervention Period 1 (2 Days)||1
8123395|NCT02918266|20022202|P1|STARTED|Part 2: Intervention Period 1 (2 Days)||0
8123396|NCT02918266|20022192|P11|NOT COMPLETED|Part 1||0
8123397|NCT02918266|20022193|P10|NOT COMPLETED|Part 1||0
8123398|NCT02918266|20022194|P9|NOT COMPLETED|Part 1||0
8123399|NCT02918266|20022195|P8|NOT COMPLETED|Part 1||0
8123400|NCT02918266|20022196|P7|NOT COMPLETED|Part 1||0
8123401|NCT02918266|20022197|P6|NOT COMPLETED|Part 1||0
8123402|NCT02918266|20022198|P5|NOT COMPLETED|Part 1||0
8123403|NCT02918266|20022199|P4|NOT COMPLETED|Part 1||0
8123404|NCT02918266|20022200|P3|NOT COMPLETED|Part 1||0
8123405|NCT02918266|20022201|P2|NOT COMPLETED|Part 1||0
8123406|NCT02918266|20022202|P1|NOT COMPLETED|Part 1||0
8123407|NCT02918266|20022192|P11|COMPLETED|Part 1||0
8123408|NCT02918266|20022193|P10|COMPLETED|Part 1||0
8123409|NCT02918266|20022194|P9|COMPLETED|Part 1||0
8123410|NCT02918266|20022195|P8|COMPLETED|Part 1||0
8123411|NCT02918266|20022196|P7|COMPLETED|Part 1||0
8123412|NCT02918266|20022197|P6|COMPLETED|Part 1||0
8123413|NCT02918266|20022198|P5|COMPLETED|Part 1||0
8123414|NCT02918266|20022199|P4|COMPLETED|Part 1||0
8123415|NCT02918266|20022200|P3|COMPLETED|Part 1||0
8123416|NCT02918266|20022201|P2|COMPLETED|Part 1||0
8123417|NCT02918266|20022202|P1|COMPLETED|Part 1||6
8123418|NCT02918266|20022192|P11|STARTED|Part 1||0
8123419|NCT02918266|20022193|P10|STARTED|Part 1||0
8123420|NCT02918266|20022194|P9|STARTED|Part 1||0
8123421|NCT02918266|20022195|P8|STARTED|Part 1||0
8123422|NCT02918266|20022196|P7|STARTED|Part 1||0
8123423|NCT02918266|20022197|P6|STARTED|Part 1||0
8123424|NCT02918266|20022198|P5|STARTED|Part 1||0
8123425|NCT02918266|20022199|P4|STARTED|Part 1||0
8123426|NCT02918266|20022200|P3|STARTED|Part 1||0
8123427|NCT02918266|20022201|P2|STARTED|Part 1||0
8123428|NCT02918266|20022202|P1|STARTED|Part 1||6
8123429|NCT02918097|20022301|P1|NOT COMPLETED|Overall Study||20
8123430|NCT02918097|20022301|P1|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|58
8123431|NCT02918097|20022301|P1|STARTED|Overall Study||78
8123432|NCT02918071|20022307|P1|NOT COMPLETED|Overall Study||3
8123433|NCT02918071|20022307|P1|COMPLETED|Overall Study||118
8123434|NCT02918071|20022307|P1|STARTED|Overall Study||121
8123435|NCT02917941|20022317|P1|NOT COMPLETED|Survival Follow-up Period||5
8123436|NCT02917941|20022317|P1|COMPLETED|Survival Follow-up Period||26
8123437|NCT02917941|20022317|P1|STARTED|Survival Follow-up Period||31
8123438|NCT02917941|20022317|P1|NOT COMPLETED|Treatment Period||24
8123439|NCT02917941|20022317|P1|COMPLETED|Treatment Period||10
8123440|NCT02917941|20022317|P1|STARTED|Treatment Period||34
8123441|NCT02917642|20022331|P2|NOT COMPLETED|Overall Study||0
8123442|NCT02917642|20022332|P1|NOT COMPLETED|Overall Study||0
8123443|NCT02917642|20022331|P2|COMPLETED|Overall Study||25
8123444|NCT02917642|20022332|P1|COMPLETED|Overall Study||25
8123445|NCT02917642|20022331|P2|STARTED|Overall Study||25
8123446|NCT02917642|20022332|P1|STARTED|Overall Study||25
8123447|NCT02917603|20022342|P2|NOT COMPLETED|Overall Study||4
8123448|NCT02917603|20022343|P1|NOT COMPLETED|Overall Study||1
8123449|NCT02917603|20022342|P2|COMPLETED|Overall Study||16
8123450|NCT02917603|20022343|P1|COMPLETED|Overall Study||19
8123451|NCT02917603|20022342|P2|STARTED|Overall Study||20
8123452|NCT02917603|20022343|P1|STARTED|Overall Study||20
8123453|NCT02917447|20022357|P2|NOT COMPLETED|Overall Study||3
8123454|NCT02917447|20022358|P1|NOT COMPLETED|Overall Study||7
8123455|NCT02917447|20022357|P2|COMPLETED|Overall Study||48
8123456|NCT02917447|20022358|P1|COMPLETED|Overall Study||44
8123457|NCT02917447|20022357|P2|STARTED|Overall Study||51
8123458|NCT02917447|20022358|P1|STARTED|Overall Study||51
8123459|NCT02917265|20022370|P2|NOT COMPLETED|Overall Study||0
8123460|NCT02917265|20022371|P1|NOT COMPLETED|Overall Study||2
8123461|NCT02917265|20022370|P2|COMPLETED|Overall Study||2
8123462|NCT02917265|20022371|P1|COMPLETED|Overall Study||3
8123463|NCT02917265|20022370|P2|STARTED|Overall Study||2
8123464|NCT02917265|20022371|P1|STARTED|Overall Study||5
8123465|NCT02916927|20022387|P2|NOT COMPLETED|Overall Study||3
8123466|NCT02916927|20022388|P1|NOT COMPLETED|Overall Study||1
8123467|NCT02916927|20022387|P2|COMPLETED|Overall Study|1 participant was in radiology for the 45 and 60 minute time points.|28
8123468|NCT02916927|20022388|P1|COMPLETED|Overall Study||30
8123469|NCT02916927|20022387|P2|Received Study Drug|Overall Study||29
8123470|NCT02916927|20022388|P1|Received Study Drug|Overall Study||31
8123471|NCT02916927|20022387|P2|STARTED|Overall Study||31
8123472|NCT02916927|20022388|P1|STARTED|Overall Study||31
8123473|NCT02916745|20022402|P1|NOT COMPLETED|Overall Study||0
8123474|NCT02916745|20022402|P1|COMPLETED|Overall Study||5
8123475|NCT02916745|20022402|P1|STARTED|Overall Study||5
8123476|NCT02916693|20022432|P1|NOT COMPLETED|Overall Study||7
8123477|NCT02916693|20022432|P1|COMPLETED|Overall Study||13
8123478|NCT02916693|20022432|P1|STARTED|Overall Study||20
8123479|NCT02916563|20022445|P1|NOT COMPLETED|Overall Study||0
8123480|NCT02916563|20022445|P1|COMPLETED|Overall Study||50
8123481|NCT02916563|20022445|P1|STARTED|Overall Study||50
8123482|NCT02916433|20022451|P2|NOT COMPLETED|Overall Study||0
8123483|NCT02916433|20022452|P1|NOT COMPLETED|Overall Study||2
8123484|NCT02916433|20022451|P2|COMPLETED|Overall Study||2
8123485|NCT02916433|20022452|P1|COMPLETED|Overall Study||1
8123486|NCT02916433|20022451|P2|STARTED|Overall Study||2
8123487|NCT02916433|20022452|P1|STARTED|Overall Study||3
8123488|NCT02916407|20022463|P2|NOT COMPLETED|Overall Study||0
8123489|NCT02916407|20022464|P1|NOT COMPLETED|Overall Study||0
8123490|NCT02916407|20022463|P2|COMPLETED|Overall Study||28
8123491|NCT02916407|20022464|P1|COMPLETED|Overall Study||28
8123492|NCT02916407|20022463|P2|STARTED|Overall Study||28
8123493|NCT02916407|20022464|P1|STARTED|Overall Study||28
8123494|NCT02915978|20022475|P3|NOT COMPLETED|Overall Study||0
8123495|NCT02915978|20022476|P2|NOT COMPLETED|Overall Study||1
8123496|NCT02915978|20022477|P1|NOT COMPLETED|Overall Study||2
8123497|NCT02915978|20022475|P3|COMPLETED|Overall Study||15
8123498|NCT02915978|20022476|P2|COMPLETED|Overall Study||14
8123499|NCT02915978|20022477|P1|COMPLETED|Overall Study||13
8123500|NCT02915978|20022475|P3|STARTED|Overall Study||15
8123501|NCT02915978|20022476|P2|STARTED|Overall Study||15
8123502|NCT02915978|20022477|P1|STARTED|Overall Study||15
8123503|NCT02915874|20022529|P2|NOT COMPLETED|Overall Study||6
8123504|NCT02915874|20022530|P1|NOT COMPLETED|Overall Study||6
8123505|NCT02915874|20022529|P2|COMPLETED|Overall Study||22
8123506|NCT02915874|20022530|P1|COMPLETED|Overall Study||38
8123507|NCT02915874|20022529|P2|Week 6 Follow Up|Overall Study||26
8123508|NCT02915874|20022530|P1|Week 6 Follow Up|Overall Study||41
8123509|NCT02915874|20022529|P2|STARTED|Overall Study||28
8123510|NCT02915874|20022530|P1|STARTED|Overall Study||44
8123511|NCT02915835|20022550|P2|NOT COMPLETED|Overall Study||1
8123512|NCT02915835|20022551|P1|NOT COMPLETED|Overall Study||1
8123513|NCT02915835|20022550|P2|COMPLETED|Overall Study||7
8123514|NCT02915835|20022551|P1|COMPLETED|Overall Study||8
8123515|NCT02915835|20022550|P2|STARTED|Overall Study||8
8123516|NCT02915835|20022551|P1|STARTED|Overall Study||9
8123520|NCT02915705|20022683|P2|NOT COMPLETED|Long Term Extension Period||0
8123521|NCT02915705|20022684|P1|NOT COMPLETED|Long Term Extension Period||0
8123522|NCT02915705|20022683|P2|COMPLETED|Long Term Extension Period||25
8123523|NCT02915705|20022684|P1|COMPLETED|Long Term Extension Period||26
8123524|NCT02915705|20022683|P2|STARTED|Long Term Extension Period|4 participants did not enter the extension period|25
8123525|NCT02915705|20022684|P1|STARTED|Long Term Extension Period|6 participants did not enter the extension period|26
8123526|NCT02915705|20022683|P2|NOT COMPLETED|Treatment Period||0
8123527|NCT02915705|20022684|P1|NOT COMPLETED|Treatment Period||0
8123528|NCT02915705|20022683|P2|COMPLETED|Treatment Period||29
8123529|NCT02915705|20022684|P1|COMPLETED|Treatment Period||32
8123530|NCT02915705|20022683|P2|Completed Week 64|Treatment Period||29
8123531|NCT02915705|20022684|P1|Completed Week 64|Treatment Period||32
8123532|NCT02915705|20022683|P2|Completed Week 40|Treatment Period||29
8123533|NCT02915705|20022684|P1|Completed Week 40|Treatment Period||32
8123534|NCT02915705|20022683|P2|STARTED|Treatment Period||29
8123535|NCT02915705|20022684|P1|STARTED|Treatment Period||32
8123536|NCT02915302|20022757|P2|NOT COMPLETED|Overall Study||78
8123537|NCT02915302|20022758|P1|NOT COMPLETED|Overall Study||65
8123538|NCT02915302|20022757|P2|COMPLETED|Overall Study||917
8123539|NCT02915302|20022758|P1|COMPLETED|Overall Study||890
8123540|NCT02915302|20022757|P2|Vaccinated (Safety Analysis Set)|Overall Study||992
8123541|NCT02915302|20022758|P1|Vaccinated (Safety Analysis Set)|Overall Study||949
8123542|NCT02915302|20022757|P2|STARTED|Overall Study||995
8123543|NCT02915302|20022758|P1|STARTED|Overall Study||955
8123544|NCT02915159|20022770|P2|NOT COMPLETED|Overall Study||8
8123545|NCT02915159|20022771|P1|NOT COMPLETED|Overall Study||11
8123546|NCT02915159|20022770|P2|COMPLETED|Overall Study||87
8123547|NCT02915159|20022771|P1|COMPLETED|Overall Study||81
8123548|NCT02915159|20022770|P2|STARTED|Overall Study||95
8123549|NCT02915159|20022771|P1|STARTED|Overall Study||92
8123550|NCT02915029|20022857|P2|NOT COMPLETED|Overall Study||14
8123551|NCT02915029|20022858|P1|NOT COMPLETED|Overall Study||13
8123552|NCT02915029|20022857|P2|COMPLETED|Overall Study||48
8123553|NCT02915029|20022858|P1|COMPLETED|Overall Study||50
8123554|NCT02915029|20022857|P2|STARTED|Overall Study||62
8123555|NCT02915029|20022858|P1|STARTED|Overall Study||63
8123588|NCT02914795|20023129|P2|NOT COMPLETED|Overall Study||0
8123589|NCT02914795|20023130|P1|NOT COMPLETED|Overall Study||0
8123590|NCT02914795|20023129|P2|COMPLETED|Overall Study||22
8123591|NCT02914795|20023130|P1|COMPLETED|Overall Study||77
8123592|NCT02914795|20023129|P2|STARTED|Overall Study||22
8123593|NCT02914795|20023130|P1|STARTED|Overall Study||77
8123594|NCT02914548|20023141|P3|NOT COMPLETED|Overall Study||20
8123595|NCT02914548|20023142|P2|NOT COMPLETED|Overall Study||14
8123596|NCT02914548|20023143|P1|NOT COMPLETED|Overall Study||21
8123597|NCT02914548|20023141|P3|COMPLETED|Overall Study||46
8123598|NCT02914548|20023142|P2|COMPLETED|Overall Study||53
8123599|NCT02914548|20023143|P1|COMPLETED|Overall Study||46
8123600|NCT02914548|20023141|P3|STARTED|Overall Study||66
8123601|NCT02914548|20023142|P2|STARTED|Overall Study||67
8123602|NCT02914548|20023143|P1|STARTED|Overall Study||67
8123603|NCT02914457|20023174|P1|NOT COMPLETED|Overall Study||6
8123604|NCT02914457|20023174|P1|COMPLETED|Overall Study|Subjects who completed electrophysiological study with analyzable data|25
8123605|NCT02914457|20023174|P1|STARTED|Overall Study||31
8123606|NCT02914275|20023184|P2|NOT COMPLETED|Overall Study||42
8123607|NCT02914275|20023185|P1|NOT COMPLETED|Overall Study||121
8123608|NCT02914275|20023184|P2|COMPLETED|Overall Study||521
8123609|NCT02914275|20023185|P1|COMPLETED|Overall Study||1566
8123610|NCT02914275|20023184|P2|Included in Clinical Database / FAS|Overall Study||563
8123611|NCT02914275|20023185|P1|Included in Clinical Database / FAS|Overall Study||1684
8123612|NCT02914275|20023184|P2|STARTED|Overall Study||563
8123613|NCT02914275|20023185|P1|STARTED|Overall Study||1687
8123614|NCT02914236|20023217|P1|NOT COMPLETED|Overall Study||1
8123615|NCT02914236|20023217|P1|COMPLETED|Overall Study||49
8123616|NCT02914236|20023217|P1|26-week Follow-up Visit|Overall Study||49
8123617|NCT02914236|20023217|P1|12-week Follow-up Visit|Overall Study||50
8123618|NCT02914236|20023217|P1|4-week Follow-up Visit|Overall Study||50
8123619|NCT02914236|20023217|P1|STARTED|Overall Study||50
8123620|NCT02914210|20023227|P2|NOT COMPLETED|Overall Study||9
8123621|NCT02914210|20023228|P1|NOT COMPLETED|Overall Study||10
8123622|NCT02914210|20023227|P2|COMPLETED|Overall Study||144
8123623|NCT02914210|20023228|P1|COMPLETED|Overall Study||143
8123624|NCT02914210|20023227|P2|STARTED|Overall Study||153
8123625|NCT02914210|20023228|P1|STARTED|Overall Study||153
8123626|NCT02914184|20023263|P4|NOT COMPLETED|Overall Study||11
8123627|NCT02914184|20023264|P3|NOT COMPLETED|Overall Study||17
8123628|NCT02914184|20023265|P2|NOT COMPLETED|Overall Study||13
8123629|NCT02914184|20023266|P1|NOT COMPLETED|Overall Study||14
8123630|NCT02914184|20023263|P4|COMPLETED|Overall Study||391
8123631|NCT02914184|20023264|P3|COMPLETED|Overall Study||385
8123632|NCT02914184|20023265|P2|COMPLETED|Overall Study||383
8123633|NCT02914184|20023266|P1|COMPLETED|Overall Study||386
8123634|NCT02914184|20023263|P4|STARTED|Overall Study||402
8123635|NCT02914184|20023264|P3|STARTED|Overall Study||402
8123636|NCT02914184|20023265|P2|STARTED|Overall Study||396
8123637|NCT02914184|20023266|P1|STARTED|Overall Study||400
8123638|NCT02914132|20023305|P1|NOT COMPLETED|Overall Study||0
8123639|NCT02914132|20023305|P1|COMPLETED|Overall Study||15
8123640|NCT02914132|20023305|P1|STARTED|Overall Study||15
8123641|NCT02914119|20023310|P1|NOT COMPLETED|Overall Study||0
8123642|NCT02914119|20023310|P1|COMPLETED|Overall Study||30430
8123643|NCT02914119|20023310|P1|STARTED|Overall Study||30430
8123653|NCT02913326|20023359|P2|NOT COMPLETED|Overall Study||2
8123654|NCT02913326|20023360|P1|NOT COMPLETED|Overall Study||1
8123655|NCT02913326|20023359|P2|COMPLETED|Overall Study||58
8123656|NCT02913326|20023360|P1|COMPLETED|Overall Study||59
8123657|NCT02913326|20023359|P2|STARTED|Overall Study||60
8123658|NCT02913326|20023360|P1|STARTED|Overall Study||60
8123659|NCT02913105|20023383|P3|NOT COMPLETED|Overall Study||7
8123660|NCT02913105|20023384|P2|NOT COMPLETED|Overall Study||5
8123661|NCT02913105|20023385|P1|NOT COMPLETED|Overall Study||15
8123662|NCT02913105|20023383|P3|COMPLETED|Overall Study||33
8123663|NCT02913105|20023384|P2|COMPLETED|Overall Study||39
8123664|NCT02913105|20023385|P1|COMPLETED|Overall Study||22
8123665|NCT02913105|20023383|P3|STARTED|Overall Study||40
8123666|NCT02913105|20023384|P2|STARTED|Overall Study||44
8123667|NCT02913105|20023385|P1|STARTED|Overall Study||37
8123668|NCT02912650|20023438|P4|NOT COMPLETED|Overall Study||5
8123669|NCT02912650|20023439|P3|NOT COMPLETED|Overall Study||2
8123670|NCT02912650|20023440|P2|NOT COMPLETED|Overall Study||0
8123671|NCT02912650|20023441|P1|NOT COMPLETED|Overall Study||1
8123672|NCT02912650|20023438|P4|COMPLETED|Overall Study||160
8123673|NCT02912650|20023439|P3|COMPLETED|Overall Study||173
8123674|NCT02912650|20023440|P2|COMPLETED|Overall Study||172
8123675|NCT02912650|20023441|P1|COMPLETED|Overall Study||55
8123676|NCT02912650|20023438|P4|STARTED|Overall Study||165
8123677|NCT02912650|20023439|P3|STARTED|Overall Study||175
8123678|NCT02912650|20023440|P2|STARTED|Overall Study||172
8123679|NCT02912650|20023441|P1|STARTED|Overall Study||56
8123680|NCT02912468|20023525|P2|NOT COMPLETED|Overall Study||5
8123681|NCT02912468|20023526|P1|NOT COMPLETED|Overall Study||9
8123682|NCT02912468|20023525|P2|COMPLETED|Overall Study||138
8123683|NCT02912468|20023526|P1|COMPLETED|Overall Study||124
8123684|NCT02912468|20023525|P2|Safety Population|Overall Study||143
8123685|NCT02912468|20023526|P1|Safety Population|Overall Study||132
8123686|NCT02912468|20023525|P2|Treated|Overall Study||142
8123687|NCT02912468|20023526|P1|Treated|Overall Study||133
8123688|NCT02912468|20023525|P2|STARTED|Overall Study||143
8123689|NCT02912468|20023526|P1|STARTED|Overall Study||133
8123690|NCT02912455|20023605|P2|NOT COMPLETED|Overall Study||3
8123691|NCT02912455|20023606|P1|NOT COMPLETED|Overall Study||2
8123692|NCT02912455|20023605|P2|COMPLETED|Overall Study||2
8123693|NCT02912455|20023606|P1|COMPLETED|Overall Study||9
8123694|NCT02912455|20023605|P2|STARTED|Overall Study||5
8123695|NCT02912455|20023606|P1|STARTED|Overall Study||11
8123696|NCT02912364|20023644|P2|NOT COMPLETED|Treatment 2||0
8123697|NCT02912364|20023645|P1|NOT COMPLETED|Treatment 2||1
8123698|NCT02912364|20023644|P2|COMPLETED|Treatment 2||11
8123699|NCT02912364|20023645|P1|COMPLETED|Treatment 2||12
8123700|NCT02912364|20023644|P2|Received Intervention|Treatment 2||11
8123701|NCT02912364|20023645|P1|Received Intervention|Treatment 2||12
8123702|NCT02912364|20023644|P2|STARTED|Treatment 2||11
8123703|NCT02912364|20023645|P1|STARTED|Treatment 2||13
8123704|NCT02912364|20023644|P2|NOT COMPLETED|Washout Period||0
8123705|NCT02912364|20023645|P1|NOT COMPLETED|Washout Period||0
8123706|NCT02912364|20023644|P2|COMPLETED|Washout Period||11
8123707|NCT02912364|20023645|P1|COMPLETED|Washout Period||13
8123708|NCT02912364|20023644|P2|STARTED|Washout Period||11
8123709|NCT02912364|20023645|P1|STARTED|Washout Period||13
8123710|NCT02912364|20023644|P2|NOT COMPLETED|Treatment 1||12
8123711|NCT02912364|20023645|P1|NOT COMPLETED|Treatment 1||10
8123712|NCT02912364|20023644|P2|COMPLETED|Treatment 1||11
8123713|NCT02912364|20023645|P1|COMPLETED|Treatment 1||13
8123714|NCT02912364|20023644|P2|Received Intervention|Treatment 1||18
8123715|NCT02912364|20023645|P1|Received Intervention|Treatment 1||18
8123716|NCT02912364|20023644|P2|STARTED|Treatment 1||23
8123717|NCT02912364|20023645|P1|STARTED|Treatment 1||23
8123718|NCT02912195|20023664|P2|NOT COMPLETED|Overall Study||0
8123719|NCT02912195|20023665|P1|NOT COMPLETED|Overall Study||0
8123720|NCT02912195|20023664|P2|COMPLETED|Overall Study||16
8123721|NCT02912195|20023665|P1|COMPLETED|Overall Study||16
8123722|NCT02912195|20023664|P2|STARTED|Overall Study||16
8123723|NCT02912195|20023665|P1|STARTED|Overall Study||16
8123730|NCT02911922|20023764|P2|NOT COMPLETED|Overall Study||0
8123731|NCT02911922|20023765|P1|NOT COMPLETED|Overall Study||0
8123732|NCT02911922|20023764|P2|COMPLETED|Overall Study||0
8123733|NCT02911922|20023765|P1|COMPLETED|Overall Study||1
8123734|NCT02911922|20023764|P2|STARTED|Overall Study||0
8123735|NCT02911922|20023765|P1|STARTED|Overall Study||1
8123736|NCT02911909|20023785|P2|NOT COMPLETED|Overall Study||3
8123737|NCT02911909|20023786|P1|NOT COMPLETED|Overall Study||2
8123738|NCT02911909|20023785|P2|COMPLETED|Overall Study|No Data was obtained in the study group.|0
8123739|NCT02911909|20023786|P1|COMPLETED|Overall Study||2
8123740|NCT02911909|20023785|P2|STARTED|Overall Study||3
8123741|NCT02911909|20023786|P1|STARTED|Overall Study||4
8123742|NCT02911857|20023815|P3|NOT COMPLETED|Overall Study||0
8123743|NCT02911857|20023816|P2|NOT COMPLETED|Overall Study||0
8123744|NCT02911857|20023817|P1|NOT COMPLETED|Overall Study||0
8123745|NCT02911857|20023815|P3|COMPLETED|Overall Study||1
8123746|NCT02911857|20023816|P2|COMPLETED|Overall Study||1
8123747|NCT02911857|20023817|P1|COMPLETED|Overall Study||2
8123748|NCT02911857|20023815|P3|STARTED|Overall Study||1
8123749|NCT02911857|20023816|P2|STARTED|Overall Study||1
8123750|NCT02911857|20023817|P1|STARTED|Overall Study||2
8123751|NCT02911844|20023825|P1|NOT COMPLETED|Overall Study||0
8123752|NCT02911844|20023825|P1|COMPLETED|Overall Study||5
8123753|NCT02911844|20023825|P1|STARTED|Overall Study||5
8123754|NCT02911818|20023835|P5|NOT COMPLETED|12 Week Extension Study||1
8123755|NCT02911818|20023836|P4|NOT COMPLETED|12 Week Extension Study||0
8123756|NCT02911818|20023837|P3|NOT COMPLETED|12 Week Extension Study||0
8123757|NCT02911818|20023838|P2|NOT COMPLETED|12 Week Extension Study||0
8123758|NCT02911818|20023839|P1|NOT COMPLETED|12 Week Extension Study||0
8123759|NCT02911818|20023835|P5|COMPLETED|12 Week Extension Study||22
8123760|NCT02911818|20023836|P4|COMPLETED|12 Week Extension Study||22
8123761|NCT02911818|20023837|P3|COMPLETED|12 Week Extension Study||0
8123762|NCT02911818|20023838|P2|COMPLETED|12 Week Extension Study||0
8123763|NCT02911818|20023839|P1|COMPLETED|12 Week Extension Study||0
8123764|NCT02911818|20023835|P5|STARTED|12 Week Extension Study||23
8123765|NCT02911818|20023836|P4|STARTED|12 Week Extension Study||22
8123766|NCT02911818|20023837|P3|STARTED|12 Week Extension Study||0
8123767|NCT02911818|20023838|P2|STARTED|12 Week Extension Study||0
8123768|NCT02911818|20023839|P1|STARTED|12 Week Extension Study||0
8123769|NCT02911818|20023835|P5|NOT COMPLETED|52 Week Study||0
8123770|NCT02911818|20023836|P4|NOT COMPLETED|52 Week Study||0
8123771|NCT02911818|20023837|P3|NOT COMPLETED|52 Week Study||4
8123772|NCT02911818|20023838|P2|NOT COMPLETED|52 Week Study||5
8123773|NCT02911818|20023839|P1|NOT COMPLETED|52 Week Study||4
8123774|NCT02911818|20023835|P5|COMPLETED|52 Week Study||0
8123775|NCT02911818|20023836|P4|COMPLETED|52 Week Study||0
8123776|NCT02911818|20023837|P3|COMPLETED|52 Week Study||46
8123777|NCT02911818|20023838|P2|COMPLETED|52 Week Study||45
8123778|NCT02911818|20023839|P1|COMPLETED|52 Week Study||46
8123779|NCT02911818|20023835|P5|STARTED|52 Week Study||0
8123780|NCT02911818|20023836|P4|STARTED|52 Week Study||0
8123781|NCT02911818|20023837|P3|STARTED|52 Week Study||50
8123782|NCT02911818|20023838|P2|STARTED|52 Week Study||50
8123783|NCT02911818|20023839|P1|STARTED|52 Week Study||50
8123784|NCT02911753|20023934|P3|NOT COMPLETED|Overall Study||0
8123785|NCT02911753|20023935|P2|NOT COMPLETED|Overall Study||3
8123786|NCT02911753|20023936|P1|NOT COMPLETED|Overall Study||3
8123787|NCT02911753|20023934|P3|COMPLETED|Overall Study||10
8123788|NCT02911753|20023935|P2|COMPLETED|Overall Study||16
8123789|NCT02911753|20023936|P1|COMPLETED|Overall Study||18
8123790|NCT02911753|20023934|P3|STARTED|Overall Study||10
8123791|NCT02911753|20023935|P2|STARTED|Overall Study||19
8123792|NCT02911753|20023936|P1|STARTED|Overall Study||21
8123793|NCT02911688|20023964|P2|NOT COMPLETED|Second Intervention||0
8123794|NCT02911688|20023965|P1|NOT COMPLETED|Second Intervention||0
8123795|NCT02911688|20023964|P2|COMPLETED|Second Intervention||7
8123796|NCT02911688|20023965|P1|COMPLETED|Second Intervention||8
8123797|NCT02911688|20023964|P2|STARTED|Second Intervention||7
8123798|NCT02911688|20023965|P1|STARTED|Second Intervention||8
8123799|NCT02911688|20023964|P2|NOT COMPLETED|Washout||2
8123800|NCT02911688|20023965|P1|NOT COMPLETED|Washout||1
8123801|NCT02911688|20023964|P2|COMPLETED|Washout||7
8123802|NCT02911688|20023965|P1|COMPLETED|Washout||8
8123803|NCT02911688|20023964|P2|STARTED|Washout||9
8123804|NCT02911688|20023965|P1|STARTED|Washout||9
8123805|NCT02911688|20023964|P2|NOT COMPLETED|First Intervention||0
8123806|NCT02911688|20023965|P1|NOT COMPLETED|First Intervention||0
8123807|NCT02911688|20023964|P2|COMPLETED|First Intervention||9
8123808|NCT02911688|20023965|P1|COMPLETED|First Intervention||9
8123809|NCT02911688|20023964|P2|Received Intervention|First Intervention||9
8123810|NCT02911688|20023965|P1|Received Intervention|First Intervention||9
8123811|NCT02911688|20023964|P2|STARTED|First Intervention||9
8123812|NCT02911688|20023965|P1|STARTED|First Intervention||9
8123813|NCT02911519|20023989|P2|NOT COMPLETED|Overall Study||4
8123814|NCT02911519|20023990|P1|NOT COMPLETED|Overall Study||2
8123815|NCT02911519|20023989|P2|COMPLETED|Overall Study||82
8123816|NCT02911519|20023990|P1|COMPLETED|Overall Study||88
8123817|NCT02911519|20023989|P2|STARTED|Overall Study||86
8123818|NCT02911519|20023990|P1|STARTED|Overall Study||90
8123819|NCT02911324|20024012|P2|NOT COMPLETED|Overall Study||1
8123820|NCT02911324|20024013|P1|NOT COMPLETED|Overall Study||3
8123821|NCT02911324|20024012|P2|COMPLETED|Overall Study||6
8123822|NCT02911324|20024013|P1|COMPLETED|Overall Study||6
8123823|NCT02911324|20024012|P2|STARTED|Overall Study||7
8123824|NCT02911324|20024013|P1|STARTED|Overall Study||9
8123825|NCT02910739|20024022|P4|NOT COMPLETED|Overall Study||0
8123826|NCT02910739|20024023|P3|NOT COMPLETED|Overall Study||0
8123827|NCT02910739|20024024|P2|NOT COMPLETED|Overall Study||0
8123828|NCT02910739|20024025|P1|NOT COMPLETED|Overall Study||1
8123829|NCT02910739|20024022|P4|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
8123830|NCT02910739|20024023|P3|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
8123831|NCT02910739|20024024|P2|COMPLETED|Overall Study||8
8123832|NCT02910739|20024025|P1|COMPLETED|Overall Study||7
8123833|NCT02910739|20024022|P4|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
8123834|NCT02910739|20024023|P3|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
8123835|NCT02910739|20024024|P2|STARTED|Overall Study||8
8123836|NCT02910739|20024025|P1|STARTED|Overall Study||8
8123837|NCT02910713|20024051|P1|NOT COMPLETED|Overall Study||42
8123838|NCT02910713|20024051|P1|COMPLETED|Overall Study|Completed=Completed both Intranasal and Extranasal applications.|143
8123839|NCT02910713|20024051|P1|Safety Population: Entered CAE|Overall Study||171
8123840|NCT02910713|20024051|P1|STARTED|Overall Study||185
8123841|NCT02910362|20024060|P2|NOT COMPLETED|Overall Study||0
8123842|NCT02910362|20024061|P1|NOT COMPLETED|Overall Study||0
8123843|NCT02910362|20024060|P2|COMPLETED|Overall Study||7
8123844|NCT02910362|20024061|P1|COMPLETED|Overall Study||8
8123845|NCT02910362|20024060|P2|STARTED|Overall Study||7
8123846|NCT02910362|20024061|P1|STARTED|Overall Study||8
8123847|NCT02910167|20024067|P1|NOT COMPLETED|Overall Study||19
8123848|NCT02910167|20024067|P1|COMPLETED|Overall Study||341
8123849|NCT02910167|20024067|P1|STARTED|Overall Study||360
8123850|NCT02910102|20024077|P2|NOT COMPLETED|Overall Study||0
8123851|NCT02910102|20024078|P1|NOT COMPLETED|Overall Study||0
8123852|NCT02910102|20024077|P2|COMPLETED|Overall Study||17
8123853|NCT02910102|20024078|P1|COMPLETED|Overall Study||21
8123854|NCT02910102|20024077|P2|Per-Protocol Population|Overall Study||17
8123855|NCT02910102|20024078|P1|Per-Protocol Population|Overall Study||20
8123856|NCT02910102|20024077|P2|Intent to Treat (ITT) Population|Overall Study||17
8123857|NCT02910102|20024078|P1|Intent to Treat (ITT) Population|Overall Study||21
8123858|NCT02910102|20024077|P2|Safety Population|Overall Study||17
8123859|NCT02910102|20024078|P1|Safety Population|Overall Study||21
8123860|NCT02910102|20024077|P2|STARTED|Overall Study||17
8123861|NCT02910102|20024078|P1|STARTED|Overall Study||21
8123862|NCT02910089|20024092|P2|NOT COMPLETED|Overall Study||16
8123863|NCT02910089|20024093|P1|NOT COMPLETED|Overall Study||22
8123864|NCT02910089|20024092|P2|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684
8123865|NCT02910089|20024093|P1|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678
8123866|NCT02910089|20024092|P2|STARTED|Overall Study|Patients allocated to control|700
8123867|NCT02910089|20024093|P1|STARTED|Overall Study|Patients allocated to intervention|700
8123868|NCT02910063|20024105|P3|NOT COMPLETED|Phase 3||0
8123869|NCT02910063|20024106|P2|NOT COMPLETED|Phase 3||0
8123870|NCT02910063|20024107|P1|NOT COMPLETED|Phase 3||0
8123871|NCT02910063|20024105|P3|COMPLETED|Phase 3||0
8123872|NCT02910063|20024106|P2|COMPLETED|Phase 3||0
8123873|NCT02910063|20024107|P1|COMPLETED|Phase 3||0
8123874|NCT02910063|20024105|P3|STARTED|Phase 3||0
8123875|NCT02910063|20024106|P2|STARTED|Phase 3||0
8123876|NCT02910063|20024107|P1|STARTED|Phase 3|Participants in this Phase 2 arm were not included in the Phase 3 period.|0
8123877|NCT02910063|20024105|P3|NOT COMPLETED|Phase 2||0
8123878|NCT02910063|20024106|P2|NOT COMPLETED|Phase 2||0
8123879|NCT02910063|20024107|P1|NOT COMPLETED|Phase 2||28
8123880|NCT02910063|20024105|P3|COMPLETED|Phase 2||0
8123881|NCT02910063|20024106|P2|COMPLETED|Phase 2||0
8123882|NCT02910063|20024107|P1|COMPLETED|Phase 2||13
8123883|NCT02910063|20024105|P3|Started Optional Cycle 2|Phase 2||0
8123884|NCT02910063|20024106|P2|Started Optional Cycle 2|Phase 2||0
8123885|NCT02910063|20024107|P1|Started Optional Cycle 2|Phase 2||4
8123886|NCT02910063|20024105|P3|Started Cycle 1|Phase 2||0
8123887|NCT02910063|20024106|P2|Started Cycle 1|Phase 2||0
8123888|NCT02910063|20024107|P1|Started Cycle 1|Phase 2||41
8123889|NCT02910063|20024105|P3|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
8123890|NCT02910063|20024106|P2|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
8123891|NCT02910063|20024107|P1|STARTED|Phase 2||41
8123892|NCT02910011|20024148|P1|NOT COMPLETED|Overall Study||2
8123893|NCT02910011|20024148|P1|COMPLETED|Overall Study||13
8123894|NCT02910011|20024148|P1|STARTED|Overall Study||15
8123895|NCT02909959|20024156|P2|NOT COMPLETED|Overall Study||0
8123896|NCT02909959|20024157|P1|NOT COMPLETED|Overall Study||0
8123897|NCT02909959|20024156|P2|COMPLETED|Overall Study||24
8123898|NCT02909959|20024157|P1|COMPLETED|Overall Study||24
8123899|NCT02909959|20024156|P2|STARTED|Overall Study||24
8123900|NCT02909959|20024157|P1|STARTED|Overall Study||24
8123901|NCT02909907|20024257|P2|NOT COMPLETED|Overall Study||1
8123902|NCT02909907|20024258|P1|NOT COMPLETED|Overall Study||0
8123903|NCT02909907|20024257|P2|COMPLETED|Overall Study||9
8123904|NCT02909907|20024258|P1|COMPLETED|Overall Study||10
8123905|NCT02909907|20024257|P2|STARTED|Overall Study||10
8123906|NCT02909907|20024258|P1|STARTED|Overall Study||10
8123907|NCT02909764|20024282|P2|NOT COMPLETED|Overall Study||0
8123908|NCT02909764|20024283|P1|NOT COMPLETED|Overall Study||0
8123909|NCT02909764|20024282|P2|COMPLETED|Overall Study||20
8123910|NCT02909764|20024283|P1|COMPLETED|Overall Study||19
8123911|NCT02909764|20024282|P2|STARTED|Overall Study||20
8123912|NCT02909764|20024283|P1|STARTED|Overall Study||19
8123913|NCT02909504|20024299|P1|NOT COMPLETED|Overall Study||12
8123914|NCT02909504|20024299|P1|COMPLETED|Overall Study||12
8123915|NCT02909504|20024299|P1|STARTED|Overall Study||24
8123916|NCT02909439|20024306|P2|NOT COMPLETED|Overall Study||0
8123917|NCT02909439|20024307|P1|NOT COMPLETED|Overall Study||0
8123918|NCT02909439|20024306|P2|COMPLETED|Overall Study||31
8123919|NCT02909439|20024307|P1|COMPLETED|Overall Study||31
8123920|NCT02909439|20024306|P2|STARTED|Overall Study||31
8123921|NCT02909439|20024307|P1|STARTED|Overall Study||31
8123922|NCT02909153|20024336|P5|NOT COMPLETED|Overall Study||0
8123923|NCT02909153|20024337|P4|NOT COMPLETED|Overall Study||0
8123924|NCT02909153|20024338|P3|NOT COMPLETED|Overall Study||0
8123925|NCT02909153|20024339|P2|NOT COMPLETED|Overall Study||1
8123926|NCT02909153|20024340|P1|NOT COMPLETED|Overall Study||0
8123927|NCT02909153|20024336|P5|COMPLETED|Overall Study||6
8123928|NCT02909153|20024337|P4|COMPLETED|Overall Study||6
8123929|NCT02909153|20024338|P3|COMPLETED|Overall Study||6
8123930|NCT02909153|20024339|P2|COMPLETED|Overall Study||5
8123931|NCT02909153|20024340|P1|COMPLETED|Overall Study||6
8123932|NCT02909153|20024336|P5|Triferic in Extraneal PD Solution|Overall Study||6
8123933|NCT02909153|20024337|P4|Triferic in Extraneal PD Solution|Overall Study||6
8123934|NCT02909153|20024338|P3|Triferic in Extraneal PD Solution|Overall Study||0
8123935|NCT02909153|20024339|P2|Triferic in Extraneal PD Solution|Overall Study||0
8123936|NCT02909153|20024340|P1|Triferic in Extraneal PD Solution|Overall Study||0
8123937|NCT02909153|20024336|P5|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
8123938|NCT02909153|20024337|P4|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
8123939|NCT02909153|20024338|P3|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
8123940|NCT02909153|20024339|P2|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5
8123941|NCT02909153|20024340|P1|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
8123942|NCT02909153|20024336|P5|Triferic in Dianeal PD Solution|Overall Study||0
8123943|NCT02909153|20024337|P4|Triferic in Dianeal PD Solution|Overall Study||0
8123944|NCT02909153|20024338|P3|Triferic in Dianeal PD Solution|Overall Study||6
8123945|NCT02909153|20024339|P2|Triferic in Dianeal PD Solution|Overall Study||6
8123946|NCT02909153|20024340|P1|Triferic in Dianeal PD Solution|Overall Study||6
8123947|NCT02909153|20024336|P5|STARTED|Overall Study||6
8123948|NCT02909153|20024337|P4|STARTED|Overall Study||6
8123949|NCT02909153|20024338|P3|STARTED|Overall Study||6
8123950|NCT02909153|20024339|P2|STARTED|Overall Study||6
8123951|NCT02909153|20024340|P1|STARTED|Overall Study||6
8123952|NCT02909140|20024385|P3|NOT COMPLETED|Overall Study||0
8123953|NCT02909140|20024386|P2|NOT COMPLETED|Overall Study||0
8123954|NCT02909140|20024387|P1|NOT COMPLETED|Overall Study||0
8123955|NCT02909140|20024385|P3|COMPLETED|Overall Study||0
8123956|NCT02909140|20024386|P2|COMPLETED|Overall Study||2
8123957|NCT02909140|20024387|P1|COMPLETED|Overall Study||0
8123958|NCT02909140|20024385|P3|STARTED|Overall Study||0
8123959|NCT02909140|20024386|P2|STARTED|Overall Study||2
8123960|NCT02909140|20024387|P1|STARTED|Overall Study||0
8123961|NCT02909101|20024430|P2|NOT COMPLETED|Overall Study||1
8123962|NCT02909101|20024431|P1|NOT COMPLETED|Overall Study||1
8123963|NCT02909101|20024430|P2|COMPLETED|Overall Study||28
8123964|NCT02909101|20024431|P1|COMPLETED|Overall Study||28
8123965|NCT02909101|20024430|P2|STARTED|Overall Study||29
8123966|NCT02909101|20024431|P1|STARTED|Overall Study||29
8123967|NCT02908880|20024449|P1|NOT COMPLETED|Overall Study||27
8123968|NCT02908880|20024449|P1|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236
8123969|NCT02908880|20024449|P1|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263
8123976|NCT02908672|20024478|P2|NOT COMPLETED|Overall Study||256
8123977|NCT02908672|20024479|P1|NOT COMPLETED|Overall Study||258
8123978|NCT02908672|20024478|P2|COMPLETED|Overall Study||0
8123979|NCT02908672|20024479|P1|COMPLETED|Overall Study||0
8123980|NCT02908672|20024478|P2|STARTED|Overall Study||256
8123981|NCT02908672|20024479|P1|STARTED|Overall Study||258
8123982|NCT02908620|20024515|P4|NOT COMPLETED|Overall Study||0
8123983|NCT02908620|20024516|P3|NOT COMPLETED|Overall Study||0
8123984|NCT02908620|20024517|P2|NOT COMPLETED|Overall Study||0
8123985|NCT02908620|20024518|P1|NOT COMPLETED|Overall Study||0
8123986|NCT02908620|20024515|P4|COMPLETED|Overall Study||10
8123987|NCT02908620|20024516|P3|COMPLETED|Overall Study||10
8123988|NCT02908620|20024517|P2|COMPLETED|Overall Study||10
8123989|NCT02908620|20024518|P1|COMPLETED|Overall Study||10
8123990|NCT02908620|20024515|P4|STARTED|Overall Study||10
8123991|NCT02908620|20024516|P3|STARTED|Overall Study||10
8123992|NCT02908620|20024517|P2|STARTED|Overall Study||10
8123993|NCT02908620|20024518|P1|STARTED|Overall Study||10
8123994|NCT02908529|20024552|P2|NOT COMPLETED|Overall Study||2
8123995|NCT02908529|20024553|P1|NOT COMPLETED|Overall Study||0
8123996|NCT02908529|20024552|P2|COMPLETED|Overall Study||10
8123997|NCT02908529|20024553|P1|COMPLETED|Overall Study||10
8123998|NCT02908529|20024552|P2|STARTED|Overall Study||12
8123999|NCT02908529|20024553|P1|STARTED|Overall Study||10
8124000|NCT02908516|20024563|P2|NOT COMPLETED|Overall Study||3
8124001|NCT02908516|20024564|P1|NOT COMPLETED|Overall Study||3
8124002|NCT02908516|20024563|P2|COMPLETED|Overall Study||0
8124003|NCT02908516|20024564|P1|COMPLETED|Overall Study||0
8124004|NCT02908516|20024563|P2|STARTED|Overall Study||3
8124005|NCT02908516|20024564|P1|STARTED|Overall Study||3
8124006|NCT02908464|20024580|P2|NOT COMPLETED|Overall Study||3
8124007|NCT02908464|20024581|P1|NOT COMPLETED|Overall Study||2
8124008|NCT02908464|20024580|P2|COMPLETED|Overall Study||20
8124009|NCT02908464|20024581|P1|COMPLETED|Overall Study||20
8124010|NCT02908464|20024580|P2|STARTED|Overall Study||23
8124011|NCT02908464|20024581|P1|STARTED|Overall Study||22
8124012|NCT02908347|20024602|P2|NOT COMPLETED|Overall Study||1
8124013|NCT02908347|20024603|P1|NOT COMPLETED|Overall Study||1
8124014|NCT02908347|20024602|P2|COMPLETED|Overall Study||22
8124015|NCT02908347|20024603|P1|COMPLETED|Overall Study||22
8124016|NCT02908347|20024602|P2|STARTED|Overall Study||23
8124017|NCT02908347|20024603|P1|STARTED|Overall Study||23
8124018|NCT02908269|20024654|P3|NOT COMPLETED|Overall Study||0
8124019|NCT02908269|20024655|P2|NOT COMPLETED|Overall Study||0
8124020|NCT02908269|20024656|P1|NOT COMPLETED|Overall Study||0
8124021|NCT02908269|20024654|P3|COMPLETED|Overall Study||60
8124022|NCT02908269|20024655|P2|COMPLETED|Overall Study||60
8124023|NCT02908269|20024656|P1|COMPLETED|Overall Study||60
8124024|NCT02908269|20024654|P3|STARTED|Overall Study||60
8124025|NCT02908269|20024655|P2|STARTED|Overall Study||60
8124026|NCT02908269|20024656|P1|STARTED|Overall Study||60
8124027|NCT02908178|20024674|P4|NOT COMPLETED|Overall Study||6819
8124028|NCT02908178|20024675|P3|NOT COMPLETED|Overall Study||0
8124029|NCT02908178|20024676|P2|NOT COMPLETED|Overall Study||8388
8124030|NCT02908178|20024677|P1|NOT COMPLETED|Overall Study||0
8124031|NCT02908178|20024674|P4|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965
8124032|NCT02908178|20024675|P3|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992
8124033|NCT02908178|20024676|P2|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718
8124034|NCT02908178|20024677|P1|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409
8124035|NCT02908178|20024674|P4|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784
8124036|NCT02908178|20024675|P3|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992
8124037|NCT02908178|20024676|P2|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106
8124038|NCT02908178|20024677|P1|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409
8124039|NCT02908100|20024699|P3|NOT COMPLETED|Overall Study||21
8124040|NCT02908100|20024700|P2|NOT COMPLETED|Overall Study||21
8124041|NCT02908100|20024701|P1|NOT COMPLETED|Overall Study||23
8124042|NCT02908100|20024699|P3|COMPLETED|Overall Study||66
8124043|NCT02908100|20024700|P2|COMPLETED|Overall Study||66
8124044|NCT02908100|20024701|P1|COMPLETED|Overall Study||63
8124045|NCT02908100|20024699|P3|STARTED|Overall Study||87
8124046|NCT02908100|20024700|P2|STARTED|Overall Study||87
8124047|NCT02908100|20024701|P1|STARTED|Overall Study||86
8124048|NCT02907892|20024737|P2|NOT COMPLETED|Overall Study||40
8124049|NCT02907892|20024738|P1|NOT COMPLETED|Overall Study||27
8124050|NCT02907892|20024737|P2|COMPLETED|Overall Study||236
8124051|NCT02907892|20024738|P1|COMPLETED|Overall Study||250
8124052|NCT02907892|20024737|P2|STARTED|Overall Study||276
8124053|NCT02907892|20024738|P1|STARTED|Overall Study||277
8124054|NCT02907814|20024746|P2|NOT COMPLETED|Overall Study||0
8124055|NCT02907814|20024747|P1|NOT COMPLETED|Overall Study||6
8124056|NCT02907814|20024746|P2|COMPLETED|Overall Study||0
8124057|NCT02907814|20024747|P1|COMPLETED|Overall Study||0
8124058|NCT02907814|20024746|P2|STARTED|Overall Study||0
8124059|NCT02907814|20024747|P1|STARTED|Overall Study||6
8124060|NCT02907619|20024758|P3|NOT COMPLETED|Overall Study||20
8124061|NCT02907619|20024759|P2|NOT COMPLETED|Overall Study||20
8124062|NCT02907619|20024760|P1|NOT COMPLETED|Overall Study||19
8124063|NCT02907619|20024758|P3|COMPLETED|Overall Study||0
8124064|NCT02907619|20024759|P2|COMPLETED|Overall Study||0
8124065|NCT02907619|20024760|P1|COMPLETED|Overall Study||0
8124066|NCT02907619|20024758|P3|Received Treatment|Overall Study||20
8124067|NCT02907619|20024759|P2|Received Treatment|Overall Study||20
8124068|NCT02907619|20024760|P1|Received Treatment|Overall Study||19
8124069|NCT02907619|20024758|P3|STARTED|Overall Study||20
8124070|NCT02907619|20024759|P2|STARTED|Overall Study||20
8124071|NCT02907619|20024760|P1|STARTED|Overall Study||19
8124072|NCT02907489|20024967|P2|NOT COMPLETED|Overall Study||1
8124073|NCT02907489|20024968|P1|NOT COMPLETED|Overall Study||2
8124074|NCT02907489|20024967|P2|COMPLETED|Overall Study||41
8124075|NCT02907489|20024968|P1|COMPLETED|Overall Study||40
8124076|NCT02907489|20024967|P2|STARTED|Overall Study||42
8124077|NCT02907489|20024968|P1|STARTED|Overall Study||42
8124078|NCT02907463|20024976|P1|NOT COMPLETED|Overall Study||37
8124079|NCT02907463|20024976|P1|COMPLETED|Overall Study||243
8124080|NCT02907463|20024976|P1|Per Protocol Cohort|Overall Study||276
8124081|NCT02907463|20024976|P1|Enrolled Cohort|Overall Study||280
8124082|NCT02907463|20024976|P1|STARTED|Overall Study||280
8124083|NCT02907268|20025048|P2|NOT COMPLETED|Overall Study||0
8124084|NCT02907268|20025049|P1|NOT COMPLETED|Overall Study||0
8124085|NCT02907268|20025048|P2|COMPLETED|Overall Study||5
8124086|NCT02907268|20025049|P1|COMPLETED|Overall Study||5
8124087|NCT02907268|20025048|P2|STARTED|Overall Study||5
8124088|NCT02907268|20025049|P1|STARTED|Overall Study||5
8124089|NCT02907216|20025058|P2|NOT COMPLETED|Overall Study||1
8124090|NCT02907216|20025059|P1|NOT COMPLETED|Overall Study||1
8124091|NCT02907216|20025058|P2|COMPLETED|Overall Study||144
8124092|NCT02907216|20025059|P1|COMPLETED|Overall Study||146
8124093|NCT02907216|20025058|P2|STARTED|Overall Study||145
8124094|NCT02907216|20025059|P1|STARTED|Overall Study||147
8124095|NCT02907073|20025094|P3|NOT COMPLETED|Overall Study||0
8124096|NCT02907073|20025095|P2|NOT COMPLETED|Overall Study||0
8124097|NCT02907073|20025096|P1|NOT COMPLETED|Overall Study||0
8124098|NCT02907073|20025094|P3|COMPLETED|Overall Study||0
8124099|NCT02907073|20025095|P2|COMPLETED|Overall Study||0
8124100|NCT02907073|20025096|P1|COMPLETED|Overall Study||8
8124101|NCT02907073|20025094|P3|STARTED|Overall Study||0
8124102|NCT02907073|20025095|P2|STARTED|Overall Study||0
8124103|NCT02907073|20025096|P1|STARTED|Overall Study||8
8124104|NCT02906930|20025111|P4|NOT COMPLETED|Overall Study||8
8124105|NCT02906930|20025112|P3|NOT COMPLETED|Overall Study||12
8124106|NCT02906930|20025113|P2|NOT COMPLETED|Overall Study||14
8124107|NCT02906930|20025114|P1|NOT COMPLETED|Overall Study||6
8124108|NCT02906930|20025111|P4|COMPLETED|Overall Study||170
8124109|NCT02906930|20025112|P3|COMPLETED|Overall Study||163
8124110|NCT02906930|20025113|P2|COMPLETED|Overall Study||161
8124111|NCT02906930|20025114|P1|COMPLETED|Overall Study||169
8124112|NCT02906930|20025111|P4|Safety Analysis Set (SAS)|Overall Study||178
8124113|NCT02906930|20025112|P3|Safety Analysis Set (SAS)|Overall Study||175
8124114|NCT02906930|20025113|P2|Safety Analysis Set (SAS)|Overall Study||175
8124115|NCT02906930|20025114|P1|Safety Analysis Set (SAS)|Overall Study||175
8124116|NCT02906930|20025111|P4|Full Analysis Set (FAS)|Overall Study||178
8124117|NCT02906930|20025112|P3|Full Analysis Set (FAS)|Overall Study||175
8124118|NCT02906930|20025113|P2|Full Analysis Set (FAS)|Overall Study||175
8124119|NCT02906930|20025114|P1|Full Analysis Set (FAS)|Overall Study||175
8124120|NCT02906930|20025111|P4|STARTED|Overall Study||178
8124121|NCT02906930|20025112|P3|STARTED|Overall Study||175
8124122|NCT02906930|20025113|P2|STARTED|Overall Study||175
8124123|NCT02906930|20025114|P1|STARTED|Overall Study||175
8124124|NCT02906917|20025307|P2|NOT COMPLETED|Intensification Period (Week 26-38)||7
8124125|NCT02906917|20025308|P1|NOT COMPLETED|Intensification Period (Week 26-38)||9
8124126|NCT02906917|20025307|P2|COMPLETED|Intensification Period (Week 26-38)||247
8124127|NCT02906917|20025308|P1|COMPLETED|Intensification Period (Week 26-38)||252
8124128|NCT02906917|20025307|P2|STARTED|Intensification Period (Week 26-38)||254
8124129|NCT02906917|20025308|P1|STARTED|Intensification Period (Week 26-38)||261
8124130|NCT02906917|20025307|P2|NOT COMPLETED|Initiation Period (Week 0-26)||11
8124131|NCT02906917|20025308|P1|NOT COMPLETED|Initiation Period (Week 0-26)||6
8124132|NCT02906917|20025307|P2|COMPLETED|Initiation Period (Week 0-26)||254
8124133|NCT02906917|20025308|P1|COMPLETED|Initiation Period (Week 0-26)||261
8124134|NCT02906917|20025307|P2|Exposed|Initiation Period (Week 0-26)||263
8124135|NCT02906917|20025308|P1|Exposed|Initiation Period (Week 0-26)||265
8124136|NCT02906917|20025307|P2|STARTED|Initiation Period (Week 0-26)||265
8124137|NCT02906917|20025308|P1|STARTED|Initiation Period (Week 0-26)||267
8124138|NCT02906813|20025339|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8124139|NCT02906813|20025340|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8124140|NCT02906813|20025341|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8124141|NCT02906813|20025339|P3|COMPLETED|Intervention Period 3 (3 Days)||3
8124142|NCT02906813|20025340|P2|COMPLETED|Intervention Period 3 (3 Days)||3
8124143|NCT02906813|20025341|P1|COMPLETED|Intervention Period 3 (3 Days)||3
8124144|NCT02906813|20025339|P3|STARTED|Intervention Period 3 (3 Days)||3
8124145|NCT02906813|20025340|P2|STARTED|Intervention Period 3 (3 Days)||3
8124146|NCT02906813|20025341|P1|STARTED|Intervention Period 3 (3 Days)||3
8124147|NCT02906813|20025339|P3|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
8124148|NCT02906813|20025340|P2|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
8124149|NCT02906813|20025341|P1|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
8124150|NCT02906813|20025339|P3|COMPLETED|Washout Period 2 (at Least 3 Days)||3
8124151|NCT02906813|20025340|P2|COMPLETED|Washout Period 2 (at Least 3 Days)||3
8124152|NCT02906813|20025341|P1|COMPLETED|Washout Period 2 (at Least 3 Days)||3
8124153|NCT02906813|20025339|P3|STARTED|Washout Period 2 (at Least 3 Days)||3
8124154|NCT02906813|20025340|P2|STARTED|Washout Period 2 (at Least 3 Days)||3
8124155|NCT02906813|20025341|P1|STARTED|Washout Period 2 (at Least 3 Days)||3
8124156|NCT02906813|20025339|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8124157|NCT02906813|20025340|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8124158|NCT02906813|20025341|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8124159|NCT02906813|20025339|P3|COMPLETED|Intervention Period 2 (3 Days)||3
8124160|NCT02906813|20025340|P2|COMPLETED|Intervention Period 2 (3 Days)||3
8124161|NCT02906813|20025341|P1|COMPLETED|Intervention Period 2 (3 Days)||3
8124162|NCT02906813|20025339|P3|STARTED|Intervention Period 2 (3 Days)||3
8124163|NCT02906813|20025340|P2|STARTED|Intervention Period 2 (3 Days)||3
8124164|NCT02906813|20025341|P1|STARTED|Intervention Period 2 (3 Days)||3
8124165|NCT02906813|20025339|P3|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
8124166|NCT02906813|20025340|P2|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
8124167|NCT02906813|20025341|P1|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
8124168|NCT02906813|20025339|P3|COMPLETED|Washout Period 1 (at Least 3 Days)||3
8124169|NCT02906813|20025340|P2|COMPLETED|Washout Period 1 (at Least 3 Days)||3
8124170|NCT02906813|20025341|P1|COMPLETED|Washout Period 1 (at Least 3 Days)||3
8124171|NCT02906813|20025339|P3|STARTED|Washout Period 1 (at Least 3 Days)||3
8124172|NCT02906813|20025340|P2|STARTED|Washout Period 1 (at Least 3 Days)||3
8124173|NCT02906813|20025341|P1|STARTED|Washout Period 1 (at Least 3 Days)||3
8124174|NCT02906813|20025339|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8124175|NCT02906813|20025340|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8124176|NCT02906813|20025341|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8124177|NCT02906813|20025339|P3|COMPLETED|Intervention Period 1 (3 Days)||3
8124178|NCT02906813|20025340|P2|COMPLETED|Intervention Period 1 (3 Days)||3
8124179|NCT02906813|20025341|P1|COMPLETED|Intervention Period 1 (3 Days)||3
8124180|NCT02906813|20025339|P3|STARTED|Intervention Period 1 (3 Days)||3
8124181|NCT02906813|20025340|P2|STARTED|Intervention Period 1 (3 Days)||3
8124182|NCT02906813|20025341|P1|STARTED|Intervention Period 1 (3 Days)||3
8124183|NCT02906709|20025369|P2|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0
8124184|NCT02906709|20025370|P1|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5
8124185|NCT02906709|20025369|P2|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58
8124186|NCT02906709|20025370|P1|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117
8124187|NCT02906709|20025369|P2|STARTED|Phase B (Extension, Week 17 to Week 52)||58
8124188|NCT02906709|20025370|P1|STARTED|Phase B (Extension, Week 17 to Week 52)||122
8124189|NCT02906709|20025369|P2|NOT COMPLETED|Phase A (Week 0 to Week 16)||3
8124190|NCT02906709|20025370|P1|NOT COMPLETED|Phase A (Week 0 to Week 16)||1
8124191|NCT02906709|20025369|P2|COMPLETED|Phase A (Week 0 to Week 16)||58
8124192|NCT02906709|20025370|P1|COMPLETED|Phase A (Week 0 to Week 16)||122
8124193|NCT02906709|20025369|P2|STARTED|Phase A (Week 0 to Week 16)||61
8124194|NCT02906709|20025370|P1|STARTED|Phase A (Week 0 to Week 16)||123
8124195|NCT02906696|20025402|P1|NOT COMPLETED|Overall Study||0
8124196|NCT02906696|20025402|P1|COMPLETED|Overall Study||8
8124197|NCT02906696|20025402|P1|STARTED|Overall Study||8
8124198|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 5P, QW||0
8124199|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 5P, QW||0
8124200|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 5P, QW||0
8124201|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 5P, QW||0
8124202|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 5P, QW||0
8124203|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 5P, QW||3
8124204|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 5P, QW||0
8124205|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 5P, QW||0
8124206|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 5P, QW||0
8124207|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 5P, QW||0
8124208|NCT02906670|20025424|P10|COMPLETED|Cohort 5P, QW||0
8124209|NCT02906670|20025425|P9|COMPLETED|Cohort 5P, QW||0
8124210|NCT02906670|20025426|P8|COMPLETED|Cohort 5P, QW||0
8124211|NCT02906670|20025427|P7|COMPLETED|Cohort 5P, QW||0
8124212|NCT02906670|20025428|P6|COMPLETED|Cohort 5P, QW||0
8124213|NCT02906670|20025429|P5|COMPLETED|Cohort 5P, QW||0
8124214|NCT02906670|20025430|P4|COMPLETED|Cohort 5P, QW||0
8124215|NCT02906670|20025431|P3|COMPLETED|Cohort 5P, QW||0
8124216|NCT02906670|20025432|P2|COMPLETED|Cohort 5P, QW||0
8124217|NCT02906670|20025433|P1|COMPLETED|Cohort 5P, QW||0
8124218|NCT02906670|20025424|P10|STARTED|Cohort 5P, QW||0
8124219|NCT02906670|20025425|P9|STARTED|Cohort 5P, QW||0
8124220|NCT02906670|20025426|P8|STARTED|Cohort 5P, QW||0
8124221|NCT02906670|20025427|P7|STARTED|Cohort 5P, QW||0
8124222|NCT02906670|20025428|P6|STARTED|Cohort 5P, QW||0
8124223|NCT02906670|20025429|P5|STARTED|Cohort 5P, QW||3
8124224|NCT02906670|20025430|P4|STARTED|Cohort 5P, QW||0
8124225|NCT02906670|20025431|P3|STARTED|Cohort 5P, QW||0
8124226|NCT02906670|20025432|P2|STARTED|Cohort 5P, QW||0
8124227|NCT02906670|20025433|P1|STARTED|Cohort 5P, QW||0
8124228|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 7P, Q2W||3
8124229|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 7P, Q2W||0
8124230|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 7P, Q2W||0
8124231|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 7P, Q2W||0
8124232|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 7P, Q2W||0
8124233|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 7P, Q2W||0
8124234|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 7P, Q2W||0
8124235|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 7P, Q2W||0
8124236|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 7P, Q2W||0
8124237|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 7P, Q2W||0
8124238|NCT02906670|20025424|P10|COMPLETED|Cohort 7P, Q2W||0
8124239|NCT02906670|20025425|P9|COMPLETED|Cohort 7P, Q2W||0
8124240|NCT02906670|20025426|P8|COMPLETED|Cohort 7P, Q2W||0
8124241|NCT02906670|20025427|P7|COMPLETED|Cohort 7P, Q2W||0
8124242|NCT02906670|20025428|P6|COMPLETED|Cohort 7P, Q2W||0
8124243|NCT02906670|20025429|P5|COMPLETED|Cohort 7P, Q2W||0
8124244|NCT02906670|20025430|P4|COMPLETED|Cohort 7P, Q2W||0
8124245|NCT02906670|20025431|P3|COMPLETED|Cohort 7P, Q2W||0
8124246|NCT02906670|20025432|P2|COMPLETED|Cohort 7P, Q2W||0
8124247|NCT02906670|20025433|P1|COMPLETED|Cohort 7P, Q2W||0
8124248|NCT02906670|20025424|P10|STARTED|Cohort 7P, Q2W||3
8124249|NCT02906670|20025425|P9|STARTED|Cohort 7P, Q2W||0
8124250|NCT02906670|20025426|P8|STARTED|Cohort 7P, Q2W||0
8124251|NCT02906670|20025427|P7|STARTED|Cohort 7P, Q2W||0
8124252|NCT02906670|20025428|P6|STARTED|Cohort 7P, Q2W||0
8124253|NCT02906670|20025429|P5|STARTED|Cohort 7P, Q2W||0
8124254|NCT02906670|20025430|P4|STARTED|Cohort 7P, Q2W||0
8124255|NCT02906670|20025431|P3|STARTED|Cohort 7P, Q2W||0
8124256|NCT02906670|20025432|P2|STARTED|Cohort 7P, Q2W||0
8124257|NCT02906670|20025433|P1|STARTED|Cohort 7P, Q2W||0
8124258|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 4P, QW||0
8124259|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 4P, QW||0
8124260|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 4P, QW||0
8124261|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 4P, QW||0
8124262|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 4P, QW||0
8124263|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 4P, QW||0
8124264|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 4P, QW||3
8124265|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 4P, QW||0
8124266|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 4P, QW||0
8124267|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 4P, QW||0
8124268|NCT02906670|20025424|P10|COMPLETED|Cohort 4P, QW||0
8124269|NCT02906670|20025425|P9|COMPLETED|Cohort 4P, QW||0
8124270|NCT02906670|20025426|P8|COMPLETED|Cohort 4P, QW||0
8124271|NCT02906670|20025427|P7|COMPLETED|Cohort 4P, QW||0
8124272|NCT02906670|20025428|P6|COMPLETED|Cohort 4P, QW||0
8124273|NCT02906670|20025429|P5|COMPLETED|Cohort 4P, QW||0
8124274|NCT02906670|20025430|P4|COMPLETED|Cohort 4P, QW||0
8124275|NCT02906670|20025431|P3|COMPLETED|Cohort 4P, QW||0
8124276|NCT02906670|20025432|P2|COMPLETED|Cohort 4P, QW||0
8124277|NCT02906670|20025433|P1|COMPLETED|Cohort 4P, QW||0
8124278|NCT02906670|20025424|P10|STARTED|Cohort 4P, QW||0
8124279|NCT02906670|20025425|P9|STARTED|Cohort 4P, QW||0
8124280|NCT02906670|20025426|P8|STARTED|Cohort 4P, QW||0
8124281|NCT02906670|20025427|P7|STARTED|Cohort 4P, QW||0
8124282|NCT02906670|20025428|P6|STARTED|Cohort 4P, QW||0
8124283|NCT02906670|20025429|P5|STARTED|Cohort 4P, QW||0
8124284|NCT02906670|20025430|P4|STARTED|Cohort 4P, QW||3
8124285|NCT02906670|20025431|P3|STARTED|Cohort 4P, QW||0
8124286|NCT02906670|20025432|P2|STARTED|Cohort 4P, QW||0
8124287|NCT02906670|20025433|P1|STARTED|Cohort 4P, QW||0
8124288|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 6P, Q2W||0
8124289|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 6P, Q2W||4
8124290|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 6P, Q2W||0
8124291|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 6P, Q2W||0
8124292|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 6P, Q2W||0
8124293|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 6P, Q2W||0
8124294|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 6P, Q2W||0
8124295|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 6P, Q2W||0
8124296|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 6P, Q2W||0
8124297|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 6P, Q2W||0
8124298|NCT02906670|20025424|P10|COMPLETED|Cohort 6P, Q2W||0
8124299|NCT02906670|20025425|P9|COMPLETED|Cohort 6P, Q2W||0
8124300|NCT02906670|20025426|P8|COMPLETED|Cohort 6P, Q2W||0
8124301|NCT02906670|20025427|P7|COMPLETED|Cohort 6P, Q2W||0
8124302|NCT02906670|20025428|P6|COMPLETED|Cohort 6P, Q2W||0
8124303|NCT02906670|20025429|P5|COMPLETED|Cohort 6P, Q2W||0
8124304|NCT02906670|20025430|P4|COMPLETED|Cohort 6P, Q2W||0
8124305|NCT02906670|20025431|P3|COMPLETED|Cohort 6P, Q2W||0
8124306|NCT02906670|20025432|P2|COMPLETED|Cohort 6P, Q2W||0
8124307|NCT02906670|20025433|P1|COMPLETED|Cohort 6P, Q2W||0
8124308|NCT02906670|20025424|P10|STARTED|Cohort 6P, Q2W||0
8124309|NCT02906670|20025425|P9|STARTED|Cohort 6P, Q2W||4
8124310|NCT02906670|20025426|P8|STARTED|Cohort 6P, Q2W||0
8124311|NCT02906670|20025427|P7|STARTED|Cohort 6P, Q2W||0
8124312|NCT02906670|20025428|P6|STARTED|Cohort 6P, Q2W||0
8124313|NCT02906670|20025429|P5|STARTED|Cohort 6P, Q2W||0
8124314|NCT02906670|20025430|P4|STARTED|Cohort 6P, Q2W||0
8124315|NCT02906670|20025431|P3|STARTED|Cohort 6P, Q2W||0
8124316|NCT02906670|20025432|P2|STARTED|Cohort 6P, Q2W||0
8124317|NCT02906670|20025433|P1|STARTED|Cohort 6P, Q2W||0
8124318|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 5P, Q2W||0
8124319|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 5P, Q2W||0
8124320|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 5P, Q2W||3
8124321|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 5P, Q2W||0
8124322|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 5P, Q2W||0
8124323|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 5P, Q2W||0
8124324|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 5P, Q2W||0
8124325|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 5P, Q2W||0
8124326|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 5P, Q2W||0
8124327|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 5P, Q2W||0
8124328|NCT02906670|20025424|P10|COMPLETED|Cohort 5P, Q2W||0
8124329|NCT02906670|20025425|P9|COMPLETED|Cohort 5P, Q2W||0
8124330|NCT02906670|20025426|P8|COMPLETED|Cohort 5P, Q2W||0
8124331|NCT02906670|20025427|P7|COMPLETED|Cohort 5P, Q2W||0
8124332|NCT02906670|20025428|P6|COMPLETED|Cohort 5P, Q2W||0
8124333|NCT02906670|20025429|P5|COMPLETED|Cohort 5P, Q2W||0
8124334|NCT02906670|20025430|P4|COMPLETED|Cohort 5P, Q2W||0
8124335|NCT02906670|20025431|P3|COMPLETED|Cohort 5P, Q2W||0
8124336|NCT02906670|20025432|P2|COMPLETED|Cohort 5P, Q2W||0
8124337|NCT02906670|20025433|P1|COMPLETED|Cohort 5P, Q2W||0
8124338|NCT02906670|20025424|P10|STARTED|Cohort 5P, Q2W||0
8124339|NCT02906670|20025425|P9|STARTED|Cohort 5P, Q2W||0
8124340|NCT02906670|20025426|P8|STARTED|Cohort 5P, Q2W||3
8124341|NCT02906670|20025427|P7|STARTED|Cohort 5P, Q2W||0
8124342|NCT02906670|20025428|P6|STARTED|Cohort 5P, Q2W||0
8124343|NCT02906670|20025429|P5|STARTED|Cohort 5P, Q2W||0
8124344|NCT02906670|20025430|P4|STARTED|Cohort 5P, Q2W||0
8124345|NCT02906670|20025431|P3|STARTED|Cohort 5P, Q2W||0
8124346|NCT02906670|20025432|P2|STARTED|Cohort 5P, Q2W||0
8124347|NCT02906670|20025433|P1|STARTED|Cohort 5P, Q2W||0
8124348|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 5, Q2W||0
8124349|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 5, Q2W||0
8124350|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 5, Q2W||0
8124351|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 5, Q2W||7
8124352|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 5, Q2W||0
8124353|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 5, Q2W||0
8124354|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 5, Q2W||0
8124355|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 5, Q2W||0
8124356|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 5, Q2W||0
8124357|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 5, Q2W||0
8124358|NCT02906670|20025424|P10|COMPLETED|Cohort 5, Q2W||0
8124359|NCT02906670|20025425|P9|COMPLETED|Cohort 5, Q2W||0
8124360|NCT02906670|20025426|P8|COMPLETED|Cohort 5, Q2W||0
8124361|NCT02906670|20025427|P7|COMPLETED|Cohort 5, Q2W||0
8124362|NCT02906670|20025428|P6|COMPLETED|Cohort 5, Q2W||0
8124363|NCT02906670|20025429|P5|COMPLETED|Cohort 5, Q2W||0
8124364|NCT02906670|20025430|P4|COMPLETED|Cohort 5, Q2W||0
8124365|NCT02906670|20025431|P3|COMPLETED|Cohort 5, Q2W||0
8124366|NCT02906670|20025432|P2|COMPLETED|Cohort 5, Q2W||0
8124367|NCT02906670|20025433|P1|COMPLETED|Cohort 5, Q2W||0
8124368|NCT02906670|20025424|P10|STARTED|Cohort 5, Q2W||0
8124369|NCT02906670|20025425|P9|STARTED|Cohort 5, Q2W||0
8124370|NCT02906670|20025426|P8|STARTED|Cohort 5, Q2W||0
8124371|NCT02906670|20025427|P7|STARTED|Cohort 5, Q2W||7
8124372|NCT02906670|20025428|P6|STARTED|Cohort 5, Q2W||0
8124373|NCT02906670|20025429|P5|STARTED|Cohort 5, Q2W||0
8124374|NCT02906670|20025430|P4|STARTED|Cohort 5, Q2W||0
8124375|NCT02906670|20025431|P3|STARTED|Cohort 5, Q2W||0
8124376|NCT02906670|20025432|P2|STARTED|Cohort 5, Q2W||0
8124377|NCT02906670|20025433|P1|STARTED|Cohort 5, Q2W||0
8124378|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 4, Q2W||0
8124379|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 4, Q2W||0
8124380|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 4, Q2W||0
8124381|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 4, Q2W||0
8124382|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 4, Q2W||3
8124383|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 4, Q2W||0
8124384|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 4, Q2W||0
8124385|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 4, Q2W||0
8124386|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 4, Q2W||0
8124387|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 4, Q2W||0
8124388|NCT02906670|20025424|P10|COMPLETED|Cohort 4, Q2W||0
8124389|NCT02906670|20025425|P9|COMPLETED|Cohort 4, Q2W||0
8124390|NCT02906670|20025426|P8|COMPLETED|Cohort 4, Q2W||0
8124391|NCT02906670|20025427|P7|COMPLETED|Cohort 4, Q2W||0
8124392|NCT02906670|20025428|P6|COMPLETED|Cohort 4, Q2W||0
8124393|NCT02906670|20025429|P5|COMPLETED|Cohort 4, Q2W||0
8124394|NCT02906670|20025430|P4|COMPLETED|Cohort 4, Q2W||0
8124395|NCT02906670|20025431|P3|COMPLETED|Cohort 4, Q2W||0
8124396|NCT02906670|20025432|P2|COMPLETED|Cohort 4, Q2W||0
8124397|NCT02906670|20025433|P1|COMPLETED|Cohort 4, Q2W||0
8124398|NCT02906670|20025424|P10|STARTED|Cohort 4, Q2W||0
8124399|NCT02906670|20025425|P9|STARTED|Cohort 4, Q2W||0
8124400|NCT02906670|20025426|P8|STARTED|Cohort 4, Q2W||0
8124401|NCT02906670|20025427|P7|STARTED|Cohort 4, Q2W||0
8124402|NCT02906670|20025428|P6|STARTED|Cohort 4, Q2W||3
8124403|NCT02906670|20025429|P5|STARTED|Cohort 4, Q2W||0
8124404|NCT02906670|20025430|P4|STARTED|Cohort 4, Q2W||0
8124405|NCT02906670|20025431|P3|STARTED|Cohort 4, Q2W||0
8124406|NCT02906670|20025432|P2|STARTED|Cohort 4, Q2W||0
8124407|NCT02906670|20025433|P1|STARTED|Cohort 4, Q2W||0
8124408|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 3, QW||0
8124409|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 3, QW||0
8124410|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 3, QW||0
8124411|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 3, QW||0
8124412|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 3, QW||0
8124413|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 3, QW||0
8124414|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 3, QW||0
8124415|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 3, QW||4
8124416|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 3, QW||0
8124417|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 3, QW||0
8124418|NCT02906670|20025424|P10|COMPLETED|Cohort 3, QW||0
8124419|NCT02906670|20025425|P9|COMPLETED|Cohort 3, QW||0
8124420|NCT02906670|20025426|P8|COMPLETED|Cohort 3, QW||0
8124421|NCT02906670|20025427|P7|COMPLETED|Cohort 3, QW||0
8124422|NCT02906670|20025428|P6|COMPLETED|Cohort 3, QW||0
8124423|NCT02906670|20025429|P5|COMPLETED|Cohort 3, QW||0
8124424|NCT02906670|20025430|P4|COMPLETED|Cohort 3, QW||0
8124425|NCT02906670|20025431|P3|COMPLETED|Cohort 3, QW||0
8124426|NCT02906670|20025432|P2|COMPLETED|Cohort 3, QW||0
8124427|NCT02906670|20025433|P1|COMPLETED|Cohort 3, QW||0
8124428|NCT02906670|20025424|P10|STARTED|Cohort 3, QW||0
8124429|NCT02906670|20025425|P9|STARTED|Cohort 3, QW||0
8124430|NCT02906670|20025426|P8|STARTED|Cohort 3, QW||0
8124431|NCT02906670|20025427|P7|STARTED|Cohort 3, QW||0
8124432|NCT02906670|20025428|P6|STARTED|Cohort 3, QW||0
8124433|NCT02906670|20025429|P5|STARTED|Cohort 3, QW||0
8124434|NCT02906670|20025430|P4|STARTED|Cohort 3, QW||0
8124435|NCT02906670|20025431|P3|STARTED|Cohort 3, QW||4
8124436|NCT02906670|20025432|P2|STARTED|Cohort 3, QW||0
8124437|NCT02906670|20025433|P1|STARTED|Cohort 3, QW||0
8124438|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 2, QW||0
8124439|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 2, QW||0
8124440|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 2, QW||0
8124441|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 2, QW||0
8124442|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 2, QW||0
8124443|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 2, QW||0
8124444|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 2, QW||0
8124445|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 2, QW||0
8124446|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 2, QW||1
8124447|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 2, QW||0
8124448|NCT02906670|20025424|P10|COMPLETED|Cohort 2, QW||0
8124449|NCT02906670|20025425|P9|COMPLETED|Cohort 2, QW||0
8124450|NCT02906670|20025426|P8|COMPLETED|Cohort 2, QW||0
8124451|NCT02906670|20025427|P7|COMPLETED|Cohort 2, QW||0
8124452|NCT02906670|20025428|P6|COMPLETED|Cohort 2, QW||0
8124453|NCT02906670|20025429|P5|COMPLETED|Cohort 2, QW||0
8124454|NCT02906670|20025430|P4|COMPLETED|Cohort 2, QW||0
8124455|NCT02906670|20025431|P3|COMPLETED|Cohort 2, QW||0
8124456|NCT02906670|20025432|P2|COMPLETED|Cohort 2, QW||0
8124457|NCT02906670|20025433|P1|COMPLETED|Cohort 2, QW||0
8124458|NCT02906670|20025424|P10|STARTED|Cohort 2, QW||0
8124459|NCT02906670|20025425|P9|STARTED|Cohort 2, QW||0
8124460|NCT02906670|20025426|P8|STARTED|Cohort 2, QW||0
8124461|NCT02906670|20025427|P7|STARTED|Cohort 2, QW||0
8124462|NCT02906670|20025428|P6|STARTED|Cohort 2, QW||0
8124463|NCT02906670|20025429|P5|STARTED|Cohort 2, QW||0
8124464|NCT02906670|20025430|P4|STARTED|Cohort 2, QW||0
8124465|NCT02906670|20025431|P3|STARTED|Cohort 2, QW||0
8124466|NCT02906670|20025432|P2|STARTED|Cohort 2, QW||1
8124467|NCT02906670|20025433|P1|STARTED|Cohort 2, QW||0
8124468|NCT02906670|20025424|P10|NOT COMPLETED|Cohort 1, QW||0
8124469|NCT02906670|20025425|P9|NOT COMPLETED|Cohort 1, QW||0
8124470|NCT02906670|20025426|P8|NOT COMPLETED|Cohort 1, QW||0
8124471|NCT02906670|20025427|P7|NOT COMPLETED|Cohort 1, QW||0
8124472|NCT02906670|20025428|P6|NOT COMPLETED|Cohort 1, QW||0
8124473|NCT02906670|20025429|P5|NOT COMPLETED|Cohort 1, QW||0
8124474|NCT02906670|20025430|P4|NOT COMPLETED|Cohort 1, QW||0
8124475|NCT02906670|20025431|P3|NOT COMPLETED|Cohort 1, QW||0
8124476|NCT02906670|20025432|P2|NOT COMPLETED|Cohort 1, QW||0
8124477|NCT02906670|20025433|P1|NOT COMPLETED|Cohort 1, QW||1
8124478|NCT02906670|20025424|P10|COMPLETED|Cohort 1, QW||0
8124479|NCT02906670|20025425|P9|COMPLETED|Cohort 1, QW||0
8124480|NCT02906670|20025426|P8|COMPLETED|Cohort 1, QW||0
8124481|NCT02906670|20025427|P7|COMPLETED|Cohort 1, QW||0
8124482|NCT02906670|20025428|P6|COMPLETED|Cohort 1, QW||0
8124483|NCT02906670|20025429|P5|COMPLETED|Cohort 1, QW||0
8124484|NCT02906670|20025430|P4|COMPLETED|Cohort 1, QW||0
8124485|NCT02906670|20025431|P3|COMPLETED|Cohort 1, QW||0
8124486|NCT02906670|20025432|P2|COMPLETED|Cohort 1, QW||0
8124487|NCT02906670|20025433|P1|COMPLETED|Cohort 1, QW||0
8124488|NCT02906670|20025424|P10|STARTED|Cohort 1, QW||0
8124489|NCT02906670|20025425|P9|STARTED|Cohort 1, QW||0
8124490|NCT02906670|20025426|P8|STARTED|Cohort 1, QW||0
8124491|NCT02906670|20025427|P7|STARTED|Cohort 1, QW||0
8124492|NCT02906670|20025428|P6|STARTED|Cohort 1, QW||0
8124493|NCT02906670|20025429|P5|STARTED|Cohort 1, QW||0
8124494|NCT02906670|20025430|P4|STARTED|Cohort 1, QW||0
8124495|NCT02906670|20025431|P3|STARTED|Cohort 1, QW||0
8124496|NCT02906670|20025432|P2|STARTED|Cohort 1, QW||0
8124497|NCT02906670|20025433|P1|STARTED|Cohort 1, QW||1
8124498|NCT02906644|20025550|P2|NOT COMPLETED|Weeks 3 to 14||11
8124499|NCT02906644|20025551|P1|NOT COMPLETED|Weeks 3 to 14||16
8124500|NCT02906644|20025550|P2|COMPLETED|Weeks 3 to 14||16
8124501|NCT02906644|20025551|P1|COMPLETED|Weeks 3 to 14||14
8124502|NCT02906644|20025550|P2|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16
8124503|NCT02906644|20025551|P1|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14
8124504|NCT02906644|20025550|P2|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20
8124505|NCT02906644|20025551|P1|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17
8124506|NCT02906644|20025550|P2|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27
8124507|NCT02906644|20025551|P1|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30
8124508|NCT02906644|20025550|P2|NOT COMPLETED|First 2 Weeks||3
8124509|NCT02906644|20025551|P1|NOT COMPLETED|First 2 Weeks||1
8124510|NCT02906644|20025550|P2|COMPLETED|First 2 Weeks||27
8124511|NCT02906644|20025551|P1|COMPLETED|First 2 Weeks||30
8124512|NCT02906644|20025550|P2|STARTED|First 2 Weeks||30
8124513|NCT02906644|20025551|P1|STARTED|First 2 Weeks||31
8124514|NCT02906579|20025567|P1|NOT COMPLETED|Overall Study||2
8124515|NCT02906579|20025567|P1|COMPLETED|Overall Study||9
8124516|NCT02906579|20025567|P1|Completed Cycle 6 (50 mg IW-1973)|Overall Study||9
8124517|NCT02906579|20025567|P1|Completed Cycle 5 (40 mg IW-1973)|Overall Study||9
8124518|NCT02906579|20025567|P1|Completed Cycle 4 (30 mg IW-1973)|Overall Study||10
8124519|NCT02906579|20025567|P1|Completed Cycle 3 (20 mg IW-1973)|Overall Study||11
8124520|NCT02906579|20025567|P1|Completed Cycle 2 (10 mg IW-1973)|Overall Study||11
8124521|NCT02906579|20025567|P1|Completed Cycle 1 (Placebo)|Overall Study||11
8124522|NCT02906579|20025567|P1|STARTED|Overall Study||11
8124523|NCT02906566|20025754|P2|NOT COMPLETED|Overall Study||0
8124524|NCT02906566|20025755|P1|NOT COMPLETED|Overall Study||3
8124525|NCT02906566|20025754|P2|COMPLETED|Overall Study||10
8124526|NCT02906566|20025755|P1|COMPLETED|Overall Study||21
8124527|NCT02906566|20025754|P2|STARTED|Overall Study||10
8124528|NCT02906566|20025755|P1|STARTED|Overall Study||24
8124529|NCT02906358|20025771|P2|NOT COMPLETED|Overall Study||22
8124530|NCT02906358|20025772|P1|NOT COMPLETED|Overall Study||22
8124531|NCT02906358|20025771|P2|COMPLETED|Overall Study||31
8124532|NCT02906358|20025772|P1|COMPLETED|Overall Study||36
8124533|NCT02906358|20025771|P2|Completed 3 Month Measures|Overall Study||33
8124534|NCT02906358|20025772|P1|Completed 3 Month Measures|Overall Study||36
8124535|NCT02906358|20025771|P2|STARTED|Overall Study||53
8124536|NCT02906358|20025772|P1|STARTED|Overall Study||58
8124537|NCT02905981|20025800|P1|NOT COMPLETED|Overall Study||1
8124538|NCT02905981|20025800|P1|COMPLETED|Overall Study||0
8124539|NCT02905981|20025800|P1|STARTED|Overall Study||1
8124540|NCT02905825|20025806|P1|NOT COMPLETED|Overall Study||12
8124541|NCT02905825|20025806|P1|COMPLETED|Overall Study||41
8124542|NCT02905825|20025806|P1|STARTED|Overall Study||53
8124543|NCT02905331|20025814|P3|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
8124544|NCT02905331|20025815|P2|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
8124545|NCT02905331|20025816|P1|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
8124546|NCT02905331|20025814|P3|COMPLETED|Active Treatment and Follow up (wk16-40)||13
8124547|NCT02905331|20025815|P2|COMPLETED|Active Treatment and Follow up (wk16-40)||53
8124548|NCT02905331|20025816|P1|COMPLETED|Active Treatment and Follow up (wk16-40)||0
8124549|NCT02905331|20025814|P3|STARTED|Active Treatment and Follow up (wk16-40)||13
8124550|NCT02905331|20025815|P2|STARTED|Active Treatment and Follow up (wk16-40)||61
8124551|NCT02905331|20025816|P1|STARTED|Active Treatment and Follow up (wk16-40)||0
8124552|NCT02905331|20025814|P3|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
8124553|NCT02905331|20025815|P2|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
8124554|NCT02905331|20025816|P1|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
8124555|NCT02905331|20025814|P3|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
8124556|NCT02905331|20025815|P2|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
8124557|NCT02905331|20025816|P1|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
8124558|NCT02905331|20025814|P3|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
8124559|NCT02905331|20025815|P2|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
8124560|NCT02905331|20025816|P1|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
8124561|NCT02905266|20025844|P2|NOT COMPLETED|Maintenance Phase Part 2||8
8124562|NCT02905266|20025845|P1|NOT COMPLETED|Maintenance Phase Part 2||12
8124563|NCT02905266|20025844|P2|COMPLETED|Maintenance Phase Part 2||14
8124564|NCT02905266|20025845|P1|COMPLETED|Maintenance Phase Part 2||8
8124565|NCT02905266|20025844|P2|STARTED|Maintenance Phase Part 2||22
8124566|NCT02905266|20025845|P1|STARTED|Maintenance Phase Part 2||20
8124567|NCT02905266|20025844|P2|NOT COMPLETED|Transition From Part 1 to Part 2||8
8124568|NCT02905266|20025845|P1|NOT COMPLETED|Transition From Part 1 to Part 2||4
8124569|NCT02905266|20025844|P2|COMPLETED|Transition From Part 1 to Part 2||22
8124570|NCT02905266|20025845|P1|COMPLETED|Transition From Part 1 to Part 2||20
8124571|NCT02905266|20025844|P2|STARTED|Transition From Part 1 to Part 2||30
8124572|NCT02905266|20025845|P1|STARTED|Transition From Part 1 to Part 2||24
8124573|NCT02905266|20025844|P2|NOT COMPLETED|Treatment Phase Part 1||23
8124574|NCT02905266|20025845|P1|NOT COMPLETED|Treatment Phase Part 1||29
8124575|NCT02905266|20025844|P2|COMPLETED|Treatment Phase Part 1||30
8124576|NCT02905266|20025845|P1|COMPLETED|Treatment Phase Part 1||24
8124577|NCT02905266|20025844|P2|STARTED|Treatment Phase Part 1||53
8124578|NCT02905266|20025845|P1|STARTED|Treatment Phase Part 1||53
8124579|NCT02905149|20025873|P2|NOT COMPLETED|Overall Study||0
8124580|NCT02905149|20025874|P1|NOT COMPLETED|Overall Study||2
8124581|NCT02905149|20025873|P2|COMPLETED|Overall Study||30
8124582|NCT02905149|20025874|P1|COMPLETED|Overall Study||28
8124583|NCT02905149|20025873|P2|STARTED|Overall Study||30
8124584|NCT02905149|20025874|P1|STARTED|Overall Study||30
8124585|NCT02905006|20025892|P6|NOT COMPLETED|Overall Study||4
8124586|NCT02905006|20025893|P5|NOT COMPLETED|Overall Study||3
8124587|NCT02905006|20025894|P4|NOT COMPLETED|Overall Study||6
8124588|NCT02905006|20025895|P3|NOT COMPLETED|Overall Study||5
8124589|NCT02905006|20025896|P2|NOT COMPLETED|Overall Study||3
8124590|NCT02905006|20025897|P1|NOT COMPLETED|Overall Study||5
8124591|NCT02905006|20025892|P6|COMPLETED|Overall Study||39
8124592|NCT02905006|20025893|P5|COMPLETED|Overall Study||40
8124593|NCT02905006|20025894|P4|COMPLETED|Overall Study||34
8124594|NCT02905006|20025895|P3|COMPLETED|Overall Study||38
8124595|NCT02905006|20025896|P2|COMPLETED|Overall Study||36
8124596|NCT02905006|20025897|P1|COMPLETED|Overall Study||37
8124597|NCT02905006|20025892|P6|Entered Safety Follow-up Period|Overall Study||3
8124598|NCT02905006|20025893|P5|Entered Safety Follow-up Period|Overall Study||1
8124599|NCT02905006|20025894|P4|Entered Safety Follow-up Period|Overall Study||2
8124600|NCT02905006|20025895|P3|Entered Safety Follow-up Period|Overall Study||4
8124601|NCT02905006|20025896|P2|Entered Safety Follow-up Period|Overall Study||4
8124602|NCT02905006|20025897|P1|Entered Safety Follow-up Period|Overall Study||4
8124603|NCT02905006|20025892|P6|Enrolled in Extension Study (PS0011)|Overall Study||40
8124604|NCT02905006|20025893|P5|Enrolled in Extension Study (PS0011)|Overall Study||42
8124605|NCT02905006|20025894|P4|Enrolled in Extension Study (PS0011)|Overall Study||38
8124606|NCT02905006|20025895|P3|Enrolled in Extension Study (PS0011)|Overall Study||39
8124607|NCT02905006|20025896|P2|Enrolled in Extension Study (PS0011)|Overall Study||35
8124608|NCT02905006|20025897|P1|Enrolled in Extension Study (PS0011)|Overall Study||38
8124609|NCT02905006|20025892|P6|Completed Treatment Period|Overall Study||39
8124610|NCT02905006|20025893|P5|Completed Treatment Period|Overall Study||40
8124611|NCT02905006|20025894|P4|Completed Treatment Period|Overall Study||34
8124612|NCT02905006|20025895|P3|Completed Treatment Period|Overall Study||38
8124613|NCT02905006|20025896|P2|Completed Treatment Period|Overall Study||36
8124614|NCT02905006|20025897|P1|Completed Treatment Period|Overall Study||37
8124615|NCT02905006|20025892|P6|STARTED|Overall Study||43
8124616|NCT02905006|20025893|P5|STARTED|Overall Study||43
8124617|NCT02905006|20025894|P4|STARTED|Overall Study||40
8124618|NCT02905006|20025895|P3|STARTED|Overall Study||43
8124619|NCT02905006|20025896|P2|STARTED|Overall Study||39
8124620|NCT02905006|20025897|P1|STARTED|Overall Study||42
8124621|NCT02904915|20026113|P2|NOT COMPLETED|Overall Study||0
8124622|NCT02904915|20026114|P1|NOT COMPLETED|Overall Study||0
8124623|NCT02904915|20026113|P2|COMPLETED|Overall Study||25
8124624|NCT02904915|20026114|P1|COMPLETED|Overall Study||25
8124625|NCT02904915|20026113|P2|STARTED|Overall Study||25
8124626|NCT02904915|20026114|P1|STARTED|Overall Study||25
8124627|NCT02904902|20026124|P1|NOT COMPLETED|Overall Study||1
8124628|NCT02904902|20026124|P1|COMPLETED|Overall Study||14
8124629|NCT02904902|20026124|P1|STARTED|Overall Study||15
8124630|NCT02904356|20026131|P1|NOT COMPLETED|Overall Study||0
8124631|NCT02904356|20026131|P1|COMPLETED|Overall Study||2
8124632|NCT02904356|20026131|P1|STARTED|Overall Study||2
8124633|NCT02904265|20026137|P2|NOT COMPLETED|Overall Study||2
8124634|NCT02904265|20026138|P1|NOT COMPLETED|Overall Study||1
8124635|NCT02904265|20026137|P2|COMPLETED|Overall Study||0
8124636|NCT02904265|20026138|P1|COMPLETED|Overall Study||0
8124637|NCT02904265|20026137|P2|STARTED|Overall Study|Study closed due to only 3 participants recruited|2
8124638|NCT02904265|20026138|P1|STARTED|Overall Study|Study closed due to only 3 participants recruited|1
8124639|NCT02904096|20026146|P2|NOT COMPLETED|Overall Study||21
8124640|NCT02904096|20026147|P1|NOT COMPLETED|Overall Study||19
8124641|NCT02904096|20026146|P2|COMPLETED|Overall Study||105
8124642|NCT02904096|20026147|P1|COMPLETED|Overall Study||111
8124643|NCT02904096|20026146|P2|STARTED|Overall Study||126
8124644|NCT02904096|20026147|P1|STARTED|Overall Study||130
8124645|NCT02904057|20026173|P2|NOT COMPLETED|Overall Study||0
8124646|NCT02904057|20026174|P1|NOT COMPLETED|Overall Study||0
8124647|NCT02904057|20026173|P2|COMPLETED|Overall Study||10
8124648|NCT02904057|20026174|P1|COMPLETED|Overall Study||19
8124649|NCT02904057|20026173|P2|STARTED|Overall Study||10
8124650|NCT02904057|20026174|P1|STARTED|Overall Study||19
8124651|NCT02903966|20026183|P2|NOT COMPLETED|Part B (Day 44 to 112)||2
8124652|NCT02903966|20026184|P1|NOT COMPLETED|Part B (Day 44 to 112)||0
8124653|NCT02903966|20026183|P2|COMPLETED|Part B (Day 44 to 112)||22
8124654|NCT02903966|20026184|P1|COMPLETED|Part B (Day 44 to 112)||11
8124655|NCT02903966|20026183|P2|STARTED|Part B (Day 44 to 112)||24
8124656|NCT02903966|20026184|P1|STARTED|Part B (Day 44 to 112)||11
8124657|NCT02903966|20026183|P2|NOT COMPLETED|Part A (Day 1 to 43)||0
8124658|NCT02903966|20026184|P1|NOT COMPLETED|Part A (Day 1 to 43)||1
8124659|NCT02903966|20026183|P2|COMPLETED|Part A (Day 1 to 43)||24
8124660|NCT02903966|20026184|P1|COMPLETED|Part A (Day 1 to 43)||11
8124661|NCT02903966|20026183|P2|STARTED|Part A (Day 1 to 43)||24
8124662|NCT02903966|20026184|P1|STARTED|Part A (Day 1 to 43)||12
8124663|NCT02903836|20026253|P3|NOT COMPLETED|Overall Study||4
8124664|NCT02903836|20026254|P2|NOT COMPLETED|Overall Study||4
8124665|NCT02903836|20026255|P1|NOT COMPLETED|Overall Study||3
8124666|NCT02903836|20026253|P3|COMPLETED|Overall Study||73
8124667|NCT02903836|20026254|P2|COMPLETED|Overall Study||69
8124668|NCT02903836|20026255|P1|COMPLETED|Overall Study||71
8124669|NCT02903836|20026253|P3|STARTED|Overall Study||77
8124670|NCT02903836|20026254|P2|STARTED|Overall Study||73
8124671|NCT02903836|20026255|P1|STARTED|Overall Study||74
8124672|NCT02903420|20026266|P1|NOT COMPLETED|Overall Study||3
8124673|NCT02903420|20026266|P1|COMPLETED|Overall Study||25
8124674|NCT02903420|20026266|P1|STARTED|Overall Study||28
8124675|NCT02903407|20026274|P2|NOT COMPLETED|Overall Study||0
8124676|NCT02903407|20026275|P1|NOT COMPLETED|Overall Study||0
8124677|NCT02903407|20026274|P2|COMPLETED|Overall Study||3
8124678|NCT02903407|20026275|P1|COMPLETED|Overall Study||4
8124679|NCT02903407|20026274|P2|STARTED|Overall Study||3
8124680|NCT02903407|20026275|P1|STARTED|Overall Study||4
8124681|NCT02903394|20026307|P2|NOT COMPLETED|Overall Study||0
8124682|NCT02903394|20026308|P1|NOT COMPLETED|Overall Study||0
8124683|NCT02903394|20026307|P2|COMPLETED|Overall Study||50
8124684|NCT02903394|20026308|P1|COMPLETED|Overall Study||5
8124685|NCT02903394|20026307|P2|STARTED|Overall Study||50
8124686|NCT02903394|20026308|P1|STARTED|Overall Study||5
8124687|NCT02903238|20026318|P1|NOT COMPLETED|Overall Study||4
8124688|NCT02903238|20026318|P1|COMPLETED|Overall Study||17
8124689|NCT02903238|20026318|P1|STARTED|Overall Study||21
8124690|NCT02903121|20026329|P2|NOT COMPLETED|Overall Study||14
8124691|NCT02903121|20026330|P1|NOT COMPLETED|Overall Study||23
8124692|NCT02903121|20026329|P2|COMPLETED|Overall Study||38
8124693|NCT02903121|20026330|P1|COMPLETED|Overall Study||34
8124694|NCT02903121|20026329|P2|STARTED|Overall Study||52
8124695|NCT02903121|20026330|P1|STARTED|Overall Study||57
8124696|NCT02903030|20026344|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
8124697|NCT02903030|20026345|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
8124698|NCT02903030|20026344|P2|COMPLETED|Second Intervention (8 Weeks)||4
8124699|NCT02903030|20026345|P1|COMPLETED|Second Intervention (8 Weeks)||6
8124700|NCT02903030|20026344|P2|STARTED|Second Intervention (8 Weeks)||4
8124701|NCT02903030|20026345|P1|STARTED|Second Intervention (8 Weeks)||6
8124702|NCT02903030|20026344|P2|NOT COMPLETED|Washout (3 Weeks)||0
8124703|NCT02903030|20026345|P1|NOT COMPLETED|Washout (3 Weeks)||0
8124704|NCT02903030|20026344|P2|COMPLETED|Washout (3 Weeks)||4
8124705|NCT02903030|20026345|P1|COMPLETED|Washout (3 Weeks)||6
8124706|NCT02903030|20026344|P2|STARTED|Washout (3 Weeks)||4
8124707|NCT02903030|20026345|P1|STARTED|Washout (3 Weeks)||6
8124708|NCT02903030|20026344|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
8124709|NCT02903030|20026345|P1|NOT COMPLETED|First Intervention (8 Weeks)||2
8124710|NCT02903030|20026344|P2|COMPLETED|First Intervention (8 Weeks)||4
8124711|NCT02903030|20026345|P1|COMPLETED|First Intervention (8 Weeks)||6
8124712|NCT02903030|20026344|P2|Received Intervention|First Intervention (8 Weeks)||4
8124713|NCT02903030|20026345|P1|Received Intervention|First Intervention (8 Weeks)||6
8124714|NCT02903030|20026344|P2|STARTED|First Intervention (8 Weeks)||5
8124715|NCT02903030|20026345|P1|STARTED|First Intervention (8 Weeks)||8
8124716|NCT02902965|20026363|P1|NOT COMPLETED|Overall Study||10
8124717|NCT02902965|20026363|P1|COMPLETED|Overall Study||64
8124718|NCT02902965|20026363|P1|STARTED|Overall Study||74
8124729|NCT02902809|20026381|P1|NOT COMPLETED|Overall Study||28
8124730|NCT02902809|20026381|P1|COMPLETED|Overall Study||0
8124731|NCT02902809|20026381|P1|Treatment Completed|Overall Study||2
8124732|NCT02902809|20026381|P1|Treatment Received|Overall Study||28
8124733|NCT02902809|20026381|P1|STARTED|Overall Study||28
8124734|NCT02902770|20026392|P3|NOT COMPLETED|Overall Study||0
8124735|NCT02902770|20026393|P2|NOT COMPLETED|Overall Study||0
8124736|NCT02902770|20026394|P1|NOT COMPLETED|Overall Study||0
8124737|NCT02902770|20026392|P3|COMPLETED|Overall Study||50
8124738|NCT02902770|20026393|P2|COMPLETED|Overall Study||50
8124739|NCT02902770|20026394|P1|COMPLETED|Overall Study||50
8124740|NCT02902770|20026392|P3|STARTED|Overall Study||50
8124741|NCT02902770|20026393|P2|STARTED|Overall Study||50
8124742|NCT02902770|20026394|P1|STARTED|Overall Study||50
8124743|NCT02902237|20026402|P1|NOT COMPLETED|Overall Study||0
8124744|NCT02902237|20026402|P1|COMPLETED|Overall Study|STUDY INITIATION: 2017 03 29, 1st Patient In, STUDY COMPLETION: 2019 11 05, Date of Study End|17
8124745|NCT02902237|20026402|P1|STARTED|Overall Study||17
8124746|NCT02902172|20026415|P2|NOT COMPLETED|Overall Study||0
8124747|NCT02902172|20026416|P1|NOT COMPLETED|Overall Study||0
8124748|NCT02902172|20026415|P2|COMPLETED|Overall Study||20
8124749|NCT02902172|20026416|P1|COMPLETED|Overall Study||16
8124750|NCT02902172|20026415|P2|STARTED|Overall Study||20
8124751|NCT02902172|20026416|P1|STARTED|Overall Study||16
8124752|NCT02902146|20026426|P2|NOT COMPLETED|Overall Study||0
8124753|NCT02902146|20026427|P1|NOT COMPLETED|Overall Study||0
8124754|NCT02902146|20026426|P2|COMPLETED|Overall Study||376
8124755|NCT02902146|20026427|P1|COMPLETED|Overall Study||381
8124756|NCT02902146|20026426|P2|STARTED|Overall Study||376
8124757|NCT02902146|20026427|P1|STARTED|Overall Study||381
8124758|NCT02902081|20026441|P1|NOT COMPLETED|Overall Study||0
8124759|NCT02902081|20026441|P1|COMPLETED|Overall Study||38
8124760|NCT02902081|20026441|P1|STARTED|Overall Study||38
8124761|NCT02901951|20026449|P1|NOT COMPLETED|Overall Study||0
8124762|NCT02901951|20026449|P1|COMPLETED|Overall Study||103
8124763|NCT02901951|20026449|P1|STARTED|Overall Study||103
8124764|NCT02901249|20026460|P1|NOT COMPLETED|Overall Study||25
8124765|NCT02901249|20026460|P1|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|43
8124766|NCT02901249|20026460|P1|STARTED|Overall Study||68
8124770|NCT02901054|20026473|P1|NOT COMPLETED|Overall Study||4
8124771|NCT02901054|20026473|P1|COMPLETED|Overall Study||15
8124772|NCT02901054|20026473|P1|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
8124773|NCT02900781|20026479|P2|NOT COMPLETED|Overall Study||5
8124774|NCT02900781|20026480|P1|NOT COMPLETED|Overall Study||4
8124775|NCT02900781|20026479|P2|COMPLETED|Overall Study||0
8124776|NCT02900781|20026480|P1|COMPLETED|Overall Study||0
8124777|NCT02900781|20026479|P2|STARTED|Overall Study||5
8124778|NCT02900781|20026480|P1|STARTED|Overall Study||4
8124779|NCT02900378|20026488|P2|NOT COMPLETED|Treatment Phase||0
8124780|NCT02900378|20026489|P1|NOT COMPLETED|Treatment Phase||0
8124781|NCT02900378|20026488|P2|COMPLETED|Treatment Phase||310
8124782|NCT02900378|20026489|P1|COMPLETED|Treatment Phase||309
8124783|NCT02900378|20026488|P2|Full Analysis Set|Treatment Phase||302
8124784|NCT02900378|20026489|P1|Full Analysis Set|Treatment Phase||302
8124785|NCT02900378|20026488|P2|STARTED|Treatment Phase||310
8124786|NCT02900378|20026489|P1|STARTED|Treatment Phase||309
8124787|NCT02900378|20026488|P2|NOT COMPLETED|Randomization (Visit 2)||28
8124788|NCT02900378|20026489|P1|NOT COMPLETED|Randomization (Visit 2)||23
8124789|NCT02900378|20026488|P2|COMPLETED|Randomization (Visit 2)||283
8124790|NCT02900378|20026489|P1|COMPLETED|Randomization (Visit 2)||287
8124791|NCT02900378|20026488|P2|STARTED|Randomization (Visit 2)||311
8124792|NCT02900378|20026489|P1|STARTED|Randomization (Visit 2)||310
8124793|NCT02900170|20026533|P1|NOT COMPLETED|Overall Study||8
8124794|NCT02900170|20026533|P1|COMPLETED|Overall Study||0
8124795|NCT02900170|20026533|P1|STARTED|Overall Study||8
8124796|NCT02900092|20026537|P1|NOT COMPLETED|Overall Study||1
8124797|NCT02900092|20026537|P1|COMPLETED|Overall Study||9
8124798|NCT02900092|20026537|P1|STARTED|Overall Study||10
8124799|NCT02899988|20026545|P11|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124800|NCT02899988|20026546|P10|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124801|NCT02899988|20026547|P9|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124802|NCT02899988|20026548|P8|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124803|NCT02899988|20026549|P7|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124804|NCT02899988|20026550|P6|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124805|NCT02899988|20026551|P5|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124806|NCT02899988|20026552|P4|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124807|NCT02899988|20026553|P3|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124808|NCT02899988|20026554|P2|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124809|NCT02899988|20026555|P1|NOT COMPLETED|Follow-Up (16 Weeks)||0
8124810|NCT02899988|20026545|P11|COMPLETED|Follow-Up (16 Weeks)||0
8124811|NCT02899988|20026546|P10|COMPLETED|Follow-Up (16 Weeks)||2
8124812|NCT02899988|20026547|P9|COMPLETED|Follow-Up (16 Weeks)||6
8124813|NCT02899988|20026548|P8|COMPLETED|Follow-Up (16 Weeks)||3
8124814|NCT02899988|20026549|P7|COMPLETED|Follow-Up (16 Weeks)||3
8124815|NCT02899988|20026550|P6|COMPLETED|Follow-Up (16 Weeks)||4
8124816|NCT02899988|20026551|P5|COMPLETED|Follow-Up (16 Weeks)||2
8124817|NCT02899988|20026552|P4|COMPLETED|Follow-Up (16 Weeks)||0
8124818|NCT02899988|20026553|P3|COMPLETED|Follow-Up (16 Weeks)||0
8124819|NCT02899988|20026554|P2|COMPLETED|Follow-Up (16 Weeks)||0
8124820|NCT02899988|20026555|P1|COMPLETED|Follow-Up (16 Weeks)||0
8124821|NCT02899988|20026545|P11|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|0
8124822|NCT02899988|20026546|P10|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
8124823|NCT02899988|20026547|P9|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|6
8124824|NCT02899988|20026548|P8|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
8124825|NCT02899988|20026549|P7|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
8124826|NCT02899988|20026550|P6|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|4
8124827|NCT02899988|20026551|P5|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
8124828|NCT02899988|20026552|P4|STARTED|Follow-Up (16 Weeks)||0
8124829|NCT02899988|20026553|P3|STARTED|Follow-Up (16 Weeks)||0
8124830|NCT02899988|20026554|P2|STARTED|Follow-Up (16 Weeks)||0
8124831|NCT02899988|20026555|P1|STARTED|Follow-Up (16 Weeks)||0
8124832|NCT02899988|20026545|P11|NOT COMPLETED|Maintenance Period (88 Weeks)||2
8124833|NCT02899988|20026546|P10|NOT COMPLETED|Maintenance Period (88 Weeks)||2
8124834|NCT02899988|20026547|P9|NOT COMPLETED|Maintenance Period (88 Weeks)||4
8124835|NCT02899988|20026548|P8|NOT COMPLETED|Maintenance Period (88 Weeks)||5
8124836|NCT02899988|20026549|P7|NOT COMPLETED|Maintenance Period (88 Weeks)||4
8124837|NCT02899988|20026550|P6|NOT COMPLETED|Maintenance Period (88 Weeks)||3
8124838|NCT02899988|20026551|P5|NOT COMPLETED|Maintenance Period (88 Weeks)||2
8124839|NCT02899988|20026552|P4|NOT COMPLETED|Maintenance Period (88 Weeks)||0
8124840|NCT02899988|20026553|P3|NOT COMPLETED|Maintenance Period (88 Weeks)||0
8124841|NCT02899988|20026554|P2|NOT COMPLETED|Maintenance Period (88 Weeks)||0
8124842|NCT02899988|20026555|P1|NOT COMPLETED|Maintenance Period (88 Weeks)||0
8124843|NCT02899988|20026545|P11|COMPLETED|Maintenance Period (88 Weeks)||13
8124844|NCT02899988|20026546|P10|COMPLETED|Maintenance Period (88 Weeks)||19
8124845|NCT02899988|20026547|P9|COMPLETED|Maintenance Period (88 Weeks)||30
8124846|NCT02899988|20026548|P8|COMPLETED|Maintenance Period (88 Weeks)||45
8124847|NCT02899988|20026549|P7|COMPLETED|Maintenance Period (88 Weeks)||30
8124848|NCT02899988|20026550|P6|COMPLETED|Maintenance Period (88 Weeks)||27
8124849|NCT02899988|20026551|P5|COMPLETED|Maintenance Period (88 Weeks)||13
8124850|NCT02899988|20026552|P4|COMPLETED|Maintenance Period (88 Weeks)||0
8124851|NCT02899988|20026553|P3|COMPLETED|Maintenance Period (88 Weeks)||0
8124852|NCT02899988|20026554|P2|COMPLETED|Maintenance Period (88 Weeks)||0
8124853|NCT02899988|20026555|P1|COMPLETED|Maintenance Period (88 Weeks)||0
8124854|NCT02899988|20026545|P11|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
8124855|NCT02899988|20026546|P10|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||17
8124856|NCT02899988|20026547|P9|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||24
8124857|NCT02899988|20026548|P8|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||42
8124858|NCT02899988|20026549|P7|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||26
8124859|NCT02899988|20026550|P6|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||18
8124860|NCT02899988|20026551|P5|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||9
8124861|NCT02899988|20026552|P4|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||13
8124862|NCT02899988|20026553|P3|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
8124863|NCT02899988|20026554|P2|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
8124864|NCT02899988|20026555|P1|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
8124865|NCT02899988|20026545|P11|Rescue Participants|Maintenance Period (88 Weeks)||0
8124866|NCT02899988|20026546|P10|Rescue Participants|Maintenance Period (88 Weeks)||0
8124867|NCT02899988|20026547|P9|Rescue Participants|Maintenance Period (88 Weeks)||0
8124868|NCT02899988|20026548|P8|Rescue Participants|Maintenance Period (88 Weeks)||0
8124869|NCT02899988|20026549|P7|Rescue Participants|Maintenance Period (88 Weeks)||0
8124870|NCT02899988|20026550|P6|Rescue Participants|Maintenance Period (88 Weeks)||0
8124871|NCT02899988|20026551|P5|Rescue Participants|Maintenance Period (88 Weeks)||0
8124872|NCT02899988|20026552|P4|Rescue Participants|Maintenance Period (88 Weeks)|In PRN not regaining ≥ PASI 90 after 3 consecutive doses of drug or have < PASI 50 after 1 dose.|10
8124873|NCT02899988|20026553|P3|Rescue Participants|Maintenance Period (88 Weeks)||0
8124874|NCT02899988|20026554|P2|Rescue Participants|Maintenance Period (88 Weeks)||0
8124875|NCT02899988|20026555|P1|Rescue Participants|Maintenance Period (88 Weeks)||0
8124876|NCT02899988|20026545|P11|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction arm.|15
8124877|NCT02899988|20026546|P10|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction arm.|21
8124878|NCT02899988|20026547|P9|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction arm.|34
8124879|NCT02899988|20026548|P8|STARTED|Maintenance Period (88 Weeks)|Participants received placebo during induction period.|50
8124880|NCT02899988|20026549|P7|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction period.|34
8124881|NCT02899988|20026550|P6|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction period.|30
8124882|NCT02899988|20026551|P5|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction period.|15
8124883|NCT02899988|20026552|P4|STARTED|Maintenance Period (88 Weeks)||0
8124884|NCT02899988|20026553|P3|STARTED|Maintenance Period (88 Weeks)|No participants received 100 mg mirikizumab Q8W in both induction and maintenance.|0
8124885|NCT02899988|20026554|P2|STARTED|Maintenance Period (88 Weeks)|No participants received 30 mg mirikizumab Q8W in both induction and maintenance.|0
8124886|NCT02899988|20026555|P1|STARTED|Maintenance Period (88 Weeks)|No participants received placebo during maintenance period.|0
8124887|NCT02899988|20026545|P11|NOT COMPLETED|Induction Period (16 Weeks)||0
8124888|NCT02899988|20026546|P10|NOT COMPLETED|Induction Period (16 Weeks)||0
8124889|NCT02899988|20026547|P9|NOT COMPLETED|Induction Period (16 Weeks)||0
8124890|NCT02899988|20026548|P8|NOT COMPLETED|Induction Period (16 Weeks)||0
8124891|NCT02899988|20026549|P7|NOT COMPLETED|Induction Period (16 Weeks)||0
8124892|NCT02899988|20026550|P6|NOT COMPLETED|Induction Period (16 Weeks)||0
8124893|NCT02899988|20026551|P5|NOT COMPLETED|Induction Period (16 Weeks)||0
8124894|NCT02899988|20026552|P4|NOT COMPLETED|Induction Period (16 Weeks)||2
8124895|NCT02899988|20026553|P3|NOT COMPLETED|Induction Period (16 Weeks)||0
8124896|NCT02899988|20026554|P2|NOT COMPLETED|Induction Period (16 Weeks)||2
8124897|NCT02899988|20026555|P1|NOT COMPLETED|Induction Period (16 Weeks)||2
8124898|NCT02899988|20026545|P11|COMPLETED|Induction Period (16 Weeks)||0
8124899|NCT02899988|20026546|P10|COMPLETED|Induction Period (16 Weeks)||0
8124900|NCT02899988|20026547|P9|COMPLETED|Induction Period (16 Weeks)||0
8124901|NCT02899988|20026548|P8|COMPLETED|Induction Period (16 Weeks)||0
8124902|NCT02899988|20026549|P7|COMPLETED|Induction Period (16 Weeks)||0
8124903|NCT02899988|20026550|P6|COMPLETED|Induction Period (16 Weeks)||0
8124904|NCT02899988|20026551|P5|COMPLETED|Induction Period (16 Weeks)||0
8124905|NCT02899988|20026552|P4|COMPLETED|Induction Period (16 Weeks)||49
8124906|NCT02899988|20026553|P3|COMPLETED|Induction Period (16 Weeks)||51
8124907|NCT02899988|20026554|P2|COMPLETED|Induction Period (16 Weeks)||49
8124908|NCT02899988|20026555|P1|COMPLETED|Induction Period (16 Weeks)||50
8124909|NCT02899988|20026545|P11|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8124910|NCT02899988|20026546|P10|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8124911|NCT02899988|20026547|P9|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8124912|NCT02899988|20026548|P8|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8124913|NCT02899988|20026549|P7|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8124914|NCT02899988|20026550|P6|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8124915|NCT02899988|20026551|P5|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8124916|NCT02899988|20026552|P4|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
8124917|NCT02899988|20026553|P3|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
8124918|NCT02899988|20026554|P2|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
8124919|NCT02899988|20026555|P1|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||52
8124920|NCT02899988|20026545|P11|STARTED|Induction Period (16 Weeks)||0
8124921|NCT02899988|20026546|P10|STARTED|Induction Period (16 Weeks)||0
8124922|NCT02899988|20026547|P9|STARTED|Induction Period (16 Weeks)||0
8124923|NCT02899988|20026548|P8|STARTED|Induction Period (16 Weeks)||0
8124924|NCT02899988|20026549|P7|STARTED|Induction Period (16 Weeks)||0
8124925|NCT02899988|20026550|P6|STARTED|Induction Period (16 Weeks)||0
8124926|NCT02899988|20026551|P5|STARTED|Induction Period (16 Weeks)||0
8124927|NCT02899988|20026552|P4|STARTED|Induction Period (16 Weeks)||51
8124928|NCT02899988|20026553|P3|STARTED|Induction Period (16 Weeks)||51
8124929|NCT02899988|20026554|P2|STARTED|Induction Period (16 Weeks)||51
8124930|NCT02899988|20026555|P1|STARTED|Induction Period (16 Weeks)||52
8124931|NCT02899962|20026614|P3|NOT COMPLETED|Maintenance Phase||153
8124932|NCT02899962|20026615|P2|NOT COMPLETED|Maintenance Phase||141
8124933|NCT02899962|20026616|P1|NOT COMPLETED|Maintenance Phase||0
8124934|NCT02899962|20026614|P3|COMPLETED|Maintenance Phase||120
8124935|NCT02899962|20026615|P2|COMPLETED|Maintenance Phase||131
8124936|NCT02899962|20026616|P1|COMPLETED|Maintenance Phase||0
8124937|NCT02899962|20026614|P3|STARTED|Maintenance Phase||273
8124938|NCT02899962|20026615|P2|STARTED|Maintenance Phase||272
8124939|NCT02899962|20026616|P1|STARTED|Maintenance Phase||0
8124940|NCT02899962|20026614|P3|NOT COMPLETED|Open-label Phase||0
8124941|NCT02899962|20026615|P2|NOT COMPLETED|Open-label Phase||0
8124942|NCT02899962|20026616|P1|NOT COMPLETED|Open-label Phase||27
8124943|NCT02899962|20026614|P3|COMPLETED|Open-label Phase||0
8124944|NCT02899962|20026615|P2|COMPLETED|Open-label Phase||0
8124945|NCT02899962|20026616|P1|COMPLETED|Open-label Phase||623
8124946|NCT02899962|20026614|P3|STARTED|Open-label Phase||0
8124947|NCT02899962|20026615|P2|STARTED|Open-label Phase||0
8124948|NCT02899962|20026616|P1|STARTED|Open-label Phase||650
8124949|NCT02899884|20026627|P1|NOT COMPLETED|Overall Study||0
8124950|NCT02899884|20026627|P1|COMPLETED|Overall Study||3765
8124951|NCT02899884|20026627|P1|STARTED|Overall Study||3765
8124952|NCT02899689|20026641|P2|NOT COMPLETED|Overall Study||2
8124953|NCT02899689|20026642|P1|NOT COMPLETED|Overall Study||0
8124954|NCT02899689|20026641|P2|COMPLETED|Overall Study||208
8124955|NCT02899689|20026642|P1|COMPLETED|Overall Study||209
8124956|NCT02899689|20026641|P2|STARTED|Overall Study||210
8124957|NCT02899689|20026642|P1|STARTED|Overall Study||209
8124958|NCT02899650|20026667|P4|NOT COMPLETED|Overall Study||0
8124959|NCT02899650|20026668|P3|NOT COMPLETED|Overall Study||0
8124960|NCT02899650|20026669|P2|NOT COMPLETED|Overall Study||0
8124961|NCT02899650|20026670|P1|NOT COMPLETED|Overall Study||0
8124962|NCT02899650|20026667|P4|COMPLETED|Overall Study||0
8124963|NCT02899650|20026668|P3|COMPLETED|Overall Study||14
8124964|NCT02899650|20026669|P2|COMPLETED|Overall Study||10
8124965|NCT02899650|20026670|P1|COMPLETED|Overall Study||15
8124966|NCT02899650|20026667|P4|STARTED|Overall Study|We were not able to recruit older unfit adults so this group was dropped from the study.|0
8124967|NCT02899650|20026668|P3|STARTED|Overall Study||14
8124968|NCT02899650|20026669|P2|STARTED|Overall Study||10
8124969|NCT02899650|20026670|P1|STARTED|Overall Study||15
8124970|NCT02899377|20026684|P2|NOT COMPLETED|Overall Study||0
8124971|NCT02899377|20026685|P1|NOT COMPLETED|Overall Study||1
8124972|NCT02899377|20026684|P2|COMPLETED|Overall Study||12
8124973|NCT02899377|20026685|P1|COMPLETED|Overall Study||12
8124974|NCT02899377|20026684|P2|STARTED|Overall Study||12
8124975|NCT02899377|20026685|P1|STARTED|Overall Study||13
8124976|NCT02899338|20026718|P2|NOT COMPLETED|Overall Study||2
8124977|NCT02899338|20026719|P1|NOT COMPLETED|Overall Study||3
8124978|NCT02899338|20026718|P2|COMPLETED|Overall Study||79
8124979|NCT02899338|20026719|P1|COMPLETED|Overall Study||78
8124980|NCT02899338|20026718|P2|STARTED|Overall Study||81
8124981|NCT02899338|20026719|P1|STARTED|Overall Study||81
8124982|NCT02899156|20026733|P2|NOT COMPLETED|Overall Study||1
8124983|NCT02899156|20026734|P1|NOT COMPLETED|Overall Study||1
8124984|NCT02899156|20026733|P2|COMPLETED|Overall Study||10
8124985|NCT02899156|20026734|P1|COMPLETED|Overall Study||10
8124986|NCT02899156|20026733|P2|STARTED|Overall Study||11
8124987|NCT02899156|20026734|P1|STARTED|Overall Study||11
8124988|NCT02898974|20026754|P2|NOT COMPLETED|Overall Study||0
8124989|NCT02898974|20026755|P1|NOT COMPLETED|Overall Study||0
8124990|NCT02898974|20026754|P2|COMPLETED|Overall Study||9
8124991|NCT02898974|20026755|P1|COMPLETED|Overall Study||13
8124992|NCT02898974|20026754|P2|STARTED|Overall Study||9
8124993|NCT02898974|20026755|P1|STARTED|Overall Study||13
8124994|NCT02898740|20026767|P2|NOT COMPLETED|Overall Study||0
8124995|NCT02898740|20026768|P1|NOT COMPLETED|Overall Study||0
8124996|NCT02898740|20026767|P2|COMPLETED|Overall Study||19
8124997|NCT02898740|20026768|P1|COMPLETED|Overall Study||21
8124998|NCT02898740|20026767|P2|STARTED|Overall Study||19
8124999|NCT02898740|20026768|P1|STARTED|Overall Study||21
8125000|NCT02898662|20026776|P2|NOT COMPLETED|Overall Study||28
8125001|NCT02898662|20026777|P1|NOT COMPLETED|Overall Study||29
8125002|NCT02898662|20026776|P2|COMPLETED|Overall Study||13
8125003|NCT02898662|20026777|P1|COMPLETED|Overall Study||11
8125004|NCT02898662|20026776|P2|Completed Treatment|Overall Study||29
8125005|NCT02898662|20026777|P1|Completed Treatment|Overall Study||25
8125006|NCT02898662|20026776|P2|STARTED|Overall Study||41
8125007|NCT02898662|20026777|P1|STARTED|Overall Study||40
8125008|NCT02898597|20026801|P2|NOT COMPLETED|Overall Study||12
8125009|NCT02898597|20026802|P1|NOT COMPLETED|Overall Study||4
8125010|NCT02898597|20026801|P2|COMPLETED|Overall Study||12
8125011|NCT02898597|20026802|P1|COMPLETED|Overall Study||21
8125012|NCT02898597|20026801|P2|STARTED|Overall Study||24
8125013|NCT02898597|20026802|P1|STARTED|Overall Study||25
8125014|NCT02898454|20026811|P3|NOT COMPLETED|Overall Study||6
8125015|NCT02898454|20026812|P2|NOT COMPLETED|Overall Study||5
8125016|NCT02898454|20026813|P1|NOT COMPLETED|Overall Study||17
8125017|NCT02898454|20026811|P3|COMPLETED|Overall Study||144
8125018|NCT02898454|20026812|P2|COMPLETED|Overall Study||140
8125019|NCT02898454|20026813|P1|COMPLETED|Overall Study||136
8125020|NCT02898454|20026811|P3|Safety Population|Overall Study||149
8125021|NCT02898454|20026812|P2|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148
8125022|NCT02898454|20026813|P1|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150
8125023|NCT02898454|20026811|P3|Treated|Overall Study||150
8125024|NCT02898454|20026812|P2|Treated|Overall Study||145
8125025|NCT02898454|20026813|P1|Treated|Overall Study||152
8125026|NCT02898454|20026811|P3|Intent-to-Treat (ITT) Population|Overall Study||150
8125027|NCT02898454|20026812|P2|Intent-to-Treat (ITT) Population|Overall Study||145
8125028|NCT02898454|20026813|P1|Intent-to-Treat (ITT) Population|Overall Study||153
8125029|NCT02898454|20026811|P3|STARTED|Overall Study||150
8125030|NCT02898454|20026812|P2|STARTED|Overall Study||145
8125031|NCT02898454|20026813|P1|STARTED|Overall Study||153
8125032|NCT02898259|20026931|P5|NOT COMPLETED|Overall Study||0
8125033|NCT02898259|20026932|P4|NOT COMPLETED|Overall Study||1
8125034|NCT02898259|20026933|P3|NOT COMPLETED|Overall Study||5
8125035|NCT02898259|20026934|P2|NOT COMPLETED|Overall Study||1
8125036|NCT02898259|20026935|P1|NOT COMPLETED|Overall Study||1
8125037|NCT02898259|20026931|P5|COMPLETED|Overall Study||0
8125038|NCT02898259|20026932|P4|COMPLETED|Overall Study||6
8125039|NCT02898259|20026933|P3|COMPLETED|Overall Study||1
8125040|NCT02898259|20026934|P2|COMPLETED|Overall Study||2
8125041|NCT02898259|20026935|P1|COMPLETED|Overall Study||2
8125042|NCT02898259|20026931|P5|STARTED|Overall Study||0
8125043|NCT02898259|20026932|P4|STARTED|Overall Study||7
8125044|NCT02898259|20026933|P3|STARTED|Overall Study||6
8125045|NCT02898259|20026934|P2|STARTED|Overall Study||3
8125046|NCT02898259|20026935|P1|STARTED|Overall Study||3
8125047|NCT02898116|20026943|P1|NOT COMPLETED|Overall Study||2
8125048|NCT02898116|20026943|P1|COMPLETED|Overall Study||0
8125049|NCT02898116|20026943|P1|STARTED|Overall Study||2
8125050|NCT02897349|20026951|P2|NOT COMPLETED|Overall Study||6
8125051|NCT02897349|20026952|P1|NOT COMPLETED|Overall Study||5
8125052|NCT02897349|20026951|P2|COMPLETED|Overall Study||98
8125053|NCT02897349|20026952|P1|COMPLETED|Overall Study||97
8125054|NCT02897349|20026951|P2|STARTED|Overall Study||104
8125055|NCT02897349|20026952|P1|STARTED|Overall Study||102
8125056|NCT02897141|20026974|P2|NOT COMPLETED|Overall Study||1
8125057|NCT02897141|20026975|P1|NOT COMPLETED|Overall Study||2
8125058|NCT02897141|20026974|P2|COMPLETED|Overall Study||39
8125059|NCT02897141|20026975|P1|COMPLETED|Overall Study||38
8125060|NCT02897141|20026974|P2|STARTED|Overall Study||40
8125061|NCT02897141|20026975|P1|STARTED|Overall Study||40
8125062|NCT02897115|20026994|P2|NOT COMPLETED|Overall Study||8
8125063|NCT02897115|20026995|P1|NOT COMPLETED|Overall Study||11
8125064|NCT02897115|20026994|P2|COMPLETED|Overall Study||0
8125065|NCT02897115|20026995|P1|COMPLETED|Overall Study||3
8125066|NCT02897115|20026994|P2|STARTED|Overall Study||8
8125067|NCT02897115|20026995|P1|STARTED|Overall Study||14
8125068|NCT02896907|20027065|P1|NOT COMPLETED|Overall Study||0
8125069|NCT02896907|20027065|P1|COMPLETED|Overall Study||8
8125070|NCT02896907|20027065|P1|STARTED|Overall Study||8
8125079|NCT02896595|20027105|P2|NOT COMPLETED|Overall Study||0
8125080|NCT02896595|20027106|P1|NOT COMPLETED|Overall Study||0
8125081|NCT02896595|20027105|P2|COMPLETED|Overall Study||50
8125082|NCT02896595|20027106|P1|COMPLETED|Overall Study||50
8125083|NCT02896595|20027105|P2|STARTED|Overall Study||50
8125084|NCT02896595|20027106|P1|STARTED|Overall Study||50
8125085|NCT02896569|20027156|P2|NOT COMPLETED|Overall Study||5
8125086|NCT02896569|20027157|P1|NOT COMPLETED|Overall Study||4
8125087|NCT02896569|20027156|P2|COMPLETED|Overall Study||19
8125088|NCT02896569|20027157|P1|COMPLETED|Overall Study||21
8125089|NCT02896569|20027156|P2|STARTED|Overall Study||24
8125090|NCT02896569|20027157|P1|STARTED|Overall Study||25
8125091|NCT02896400|20027191|P16|NOT COMPLETED|Biochemical Verification at 3 Months||57
8125092|NCT02896400|20027192|P15|NOT COMPLETED|Biochemical Verification at 3 Months||55
8125093|NCT02896400|20027193|P14|NOT COMPLETED|Biochemical Verification at 3 Months||48
8125094|NCT02896400|20027194|P13|NOT COMPLETED|Biochemical Verification at 3 Months||53
8125095|NCT02896400|20027195|P12|NOT COMPLETED|Biochemical Verification at 3 Months||41
8125096|NCT02896400|20027196|P11|NOT COMPLETED|Biochemical Verification at 3 Months||55
8125097|NCT02896400|20027197|P10|NOT COMPLETED|Biochemical Verification at 3 Months||53
8125098|NCT02896400|20027198|P9|NOT COMPLETED|Biochemical Verification at 3 Months||45
8125099|NCT02896400|20027199|P8|NOT COMPLETED|Biochemical Verification at 3 Months||49
8125100|NCT02896400|20027200|P7|NOT COMPLETED|Biochemical Verification at 3 Months||51
8125101|NCT02896400|20027201|P6|NOT COMPLETED|Biochemical Verification at 3 Months||49
8125102|NCT02896400|20027202|P5|NOT COMPLETED|Biochemical Verification at 3 Months||45
8125103|NCT02896400|20027203|P4|NOT COMPLETED|Biochemical Verification at 3 Months||41
8125104|NCT02896400|20027204|P3|NOT COMPLETED|Biochemical Verification at 3 Months||47
8125105|NCT02896400|20027205|P2|NOT COMPLETED|Biochemical Verification at 3 Months||48
8125106|NCT02896400|20027206|P1|NOT COMPLETED|Biochemical Verification at 3 Months||46
8125107|NCT02896400|20027191|P16|COMPLETED|Biochemical Verification at 3 Months||6
8125108|NCT02896400|20027192|P15|COMPLETED|Biochemical Verification at 3 Months||7
8125109|NCT02896400|20027193|P14|COMPLETED|Biochemical Verification at 3 Months||12
8125110|NCT02896400|20027194|P13|COMPLETED|Biochemical Verification at 3 Months||10
8125111|NCT02896400|20027195|P12|COMPLETED|Biochemical Verification at 3 Months||19
8125112|NCT02896400|20027196|P11|COMPLETED|Biochemical Verification at 3 Months||5
8125113|NCT02896400|20027197|P10|COMPLETED|Biochemical Verification at 3 Months||8
8125114|NCT02896400|20027198|P9|COMPLETED|Biochemical Verification at 3 Months||15
8125115|NCT02896400|20027199|P8|COMPLETED|Biochemical Verification at 3 Months||14
8125116|NCT02896400|20027200|P7|COMPLETED|Biochemical Verification at 3 Months||11
8125117|NCT02896400|20027201|P6|COMPLETED|Biochemical Verification at 3 Months||11
8125118|NCT02896400|20027202|P5|COMPLETED|Biochemical Verification at 3 Months||9
8125119|NCT02896400|20027203|P4|COMPLETED|Biochemical Verification at 3 Months||14
8125120|NCT02896400|20027204|P3|COMPLETED|Biochemical Verification at 3 Months||13
8125121|NCT02896400|20027205|P2|COMPLETED|Biochemical Verification at 3 Months||15
8125122|NCT02896400|20027206|P1|COMPLETED|Biochemical Verification at 3 Months||14
8125123|NCT02896400|20027191|P16|STARTED|Biochemical Verification at 3 Months||63
8125124|NCT02896400|20027192|P15|STARTED|Biochemical Verification at 3 Months||62
8125125|NCT02896400|20027193|P14|STARTED|Biochemical Verification at 3 Months||60
8125126|NCT02896400|20027194|P13|STARTED|Biochemical Verification at 3 Months||63
8125127|NCT02896400|20027195|P12|STARTED|Biochemical Verification at 3 Months||60
8125128|NCT02896400|20027196|P11|STARTED|Biochemical Verification at 3 Months||60
8125129|NCT02896400|20027197|P10|STARTED|Biochemical Verification at 3 Months||61
8125130|NCT02896400|20027198|P9|STARTED|Biochemical Verification at 3 Months||60
8125131|NCT02896400|20027199|P8|STARTED|Biochemical Verification at 3 Months||63
8125132|NCT02896400|20027200|P7|STARTED|Biochemical Verification at 3 Months||62
8125133|NCT02896400|20027201|P6|STARTED|Biochemical Verification at 3 Months||60
8125134|NCT02896400|20027202|P5|STARTED|Biochemical Verification at 3 Months||54
8125135|NCT02896400|20027203|P4|STARTED|Biochemical Verification at 3 Months||55
8125136|NCT02896400|20027204|P3|STARTED|Biochemical Verification at 3 Months||60
8125137|NCT02896400|20027205|P2|STARTED|Biochemical Verification at 3 Months||63
8125138|NCT02896400|20027206|P1|STARTED|Biochemical Verification at 3 Months||60
8125139|NCT02896400|20027191|P16|NOT COMPLETED|3 Month Follow-up||2
8125140|NCT02896400|20027192|P15|NOT COMPLETED|3 Month Follow-up||4
8125141|NCT02896400|20027193|P14|NOT COMPLETED|3 Month Follow-up||6
8125142|NCT02896400|20027194|P13|NOT COMPLETED|3 Month Follow-up||3
8125143|NCT02896400|20027195|P12|NOT COMPLETED|3 Month Follow-up||6
8125144|NCT02896400|20027196|P11|NOT COMPLETED|3 Month Follow-up||6
8125145|NCT02896400|20027197|P10|NOT COMPLETED|3 Month Follow-up||5
8125146|NCT02896400|20027198|P9|NOT COMPLETED|3 Month Follow-up||6
8125147|NCT02896400|20027199|P8|NOT COMPLETED|3 Month Follow-up||3
8125148|NCT02896400|20027200|P7|NOT COMPLETED|3 Month Follow-up||4
8125149|NCT02896400|20027201|P6|NOT COMPLETED|3 Month Follow-up||6
8125150|NCT02896400|20027202|P5|NOT COMPLETED|3 Month Follow-up||12
8125151|NCT02896400|20027203|P4|NOT COMPLETED|3 Month Follow-up||11
8125152|NCT02896400|20027204|P3|NOT COMPLETED|3 Month Follow-up||6
8125153|NCT02896400|20027205|P2|NOT COMPLETED|3 Month Follow-up||3
8125154|NCT02896400|20027206|P1|NOT COMPLETED|3 Month Follow-up||6
8125155|NCT02896400|20027191|P16|COMPLETED|3 Month Follow-up||63
8125156|NCT02896400|20027192|P15|COMPLETED|3 Month Follow-up||62
8125157|NCT02896400|20027193|P14|COMPLETED|3 Month Follow-up||60
8125158|NCT02896400|20027194|P13|COMPLETED|3 Month Follow-up||63
8125159|NCT02896400|20027195|P12|COMPLETED|3 Month Follow-up||60
8125160|NCT02896400|20027196|P11|COMPLETED|3 Month Follow-up||60
8125161|NCT02896400|20027197|P10|COMPLETED|3 Month Follow-up||61
8125162|NCT02896400|20027198|P9|COMPLETED|3 Month Follow-up||60
8125163|NCT02896400|20027199|P8|COMPLETED|3 Month Follow-up||63
8125164|NCT02896400|20027200|P7|COMPLETED|3 Month Follow-up||62
8125165|NCT02896400|20027201|P6|COMPLETED|3 Month Follow-up||60
8125166|NCT02896400|20027202|P5|COMPLETED|3 Month Follow-up||54
8125167|NCT02896400|20027203|P4|COMPLETED|3 Month Follow-up||55
8125168|NCT02896400|20027204|P3|COMPLETED|3 Month Follow-up||60
8125169|NCT02896400|20027205|P2|COMPLETED|3 Month Follow-up||63
8125170|NCT02896400|20027206|P1|COMPLETED|3 Month Follow-up||60
8125171|NCT02896400|20027191|P16|STARTED|3 Month Follow-up||65
8125172|NCT02896400|20027192|P15|STARTED|3 Month Follow-up||66
8125173|NCT02896400|20027193|P14|STARTED|3 Month Follow-up||66
8125174|NCT02896400|20027194|P13|STARTED|3 Month Follow-up||66
8125175|NCT02896400|20027195|P12|STARTED|3 Month Follow-up||66
8125176|NCT02896400|20027196|P11|STARTED|3 Month Follow-up||66
8125177|NCT02896400|20027197|P10|STARTED|3 Month Follow-up||66
8125178|NCT02896400|20027198|P9|STARTED|3 Month Follow-up||66
8125179|NCT02896400|20027199|P8|STARTED|3 Month Follow-up||66
8125180|NCT02896400|20027200|P7|STARTED|3 Month Follow-up||66
8125181|NCT02896400|20027201|P6|STARTED|3 Month Follow-up||66
8125182|NCT02896400|20027202|P5|STARTED|3 Month Follow-up||66
8125183|NCT02896400|20027203|P4|STARTED|3 Month Follow-up||66
8125184|NCT02896400|20027204|P3|STARTED|3 Month Follow-up||66
8125185|NCT02896400|20027205|P2|STARTED|3 Month Follow-up||66
8125186|NCT02896400|20027206|P1|STARTED|3 Month Follow-up||66
8125187|NCT02896400|20027191|P16|NOT COMPLETED|1 Month Follow-up||3
8125188|NCT02896400|20027192|P15|NOT COMPLETED|1 Month Follow-up||1
8125189|NCT02896400|20027193|P14|NOT COMPLETED|1 Month Follow-up||4
8125190|NCT02896400|20027194|P13|NOT COMPLETED|1 Month Follow-up||3
8125191|NCT02896400|20027195|P12|NOT COMPLETED|1 Month Follow-up||5
8125192|NCT02896400|20027196|P11|NOT COMPLETED|1 Month Follow-up||5
8125193|NCT02896400|20027197|P10|NOT COMPLETED|1 Month Follow-up||7
8125194|NCT02896400|20027198|P9|NOT COMPLETED|1 Month Follow-up||4
8125195|NCT02896400|20027199|P8|NOT COMPLETED|1 Month Follow-up||6
8125196|NCT02896400|20027200|P7|NOT COMPLETED|1 Month Follow-up||5
8125197|NCT02896400|20027201|P6|NOT COMPLETED|1 Month Follow-up||6
8125198|NCT02896400|20027202|P5|NOT COMPLETED|1 Month Follow-up||9
8125199|NCT02896400|20027203|P4|NOT COMPLETED|1 Month Follow-up||8
8125200|NCT02896400|20027204|P3|NOT COMPLETED|1 Month Follow-up||5
8125201|NCT02896400|20027205|P2|NOT COMPLETED|1 Month Follow-up||7
8125202|NCT02896400|20027206|P1|NOT COMPLETED|1 Month Follow-up||7
8125203|NCT02896400|20027191|P16|COMPLETED|1 Month Follow-up||63
8125204|NCT02896400|20027192|P15|COMPLETED|1 Month Follow-up||65
8125205|NCT02896400|20027193|P14|COMPLETED|1 Month Follow-up||62
8125206|NCT02896400|20027194|P13|COMPLETED|1 Month Follow-up||63
8125207|NCT02896400|20027195|P12|COMPLETED|1 Month Follow-up||61
8125208|NCT02896400|20027196|P11|COMPLETED|1 Month Follow-up||61
8125209|NCT02896400|20027197|P10|COMPLETED|1 Month Follow-up||59
8125210|NCT02896400|20027198|P9|COMPLETED|1 Month Follow-up||62
8125211|NCT02896400|20027199|P8|COMPLETED|1 Month Follow-up||60
8125212|NCT02896400|20027200|P7|COMPLETED|1 Month Follow-up||61
8125213|NCT02896400|20027201|P6|COMPLETED|1 Month Follow-up||60
8125214|NCT02896400|20027202|P5|COMPLETED|1 Month Follow-up||57
8125215|NCT02896400|20027203|P4|COMPLETED|1 Month Follow-up||58
8125216|NCT02896400|20027204|P3|COMPLETED|1 Month Follow-up||61
8125217|NCT02896400|20027205|P2|COMPLETED|1 Month Follow-up||59
8125218|NCT02896400|20027206|P1|COMPLETED|1 Month Follow-up||59
8125219|NCT02896400|20027191|P16|STARTED|1 Month Follow-up||66
8125220|NCT02896400|20027192|P15|STARTED|1 Month Follow-up||66
8125221|NCT02896400|20027193|P14|STARTED|1 Month Follow-up||66
8125222|NCT02896400|20027194|P13|STARTED|1 Month Follow-up||66
8125223|NCT02896400|20027195|P12|STARTED|1 Month Follow-up||66
8125224|NCT02896400|20027196|P11|STARTED|1 Month Follow-up||66
8125225|NCT02896400|20027197|P10|STARTED|1 Month Follow-up||66
8125226|NCT02896400|20027198|P9|STARTED|1 Month Follow-up||66
8125227|NCT02896400|20027199|P8|STARTED|1 Month Follow-up||66
8125228|NCT02896400|20027200|P7|STARTED|1 Month Follow-up||66
8125229|NCT02896400|20027201|P6|STARTED|1 Month Follow-up||66
8125230|NCT02896400|20027202|P5|STARTED|1 Month Follow-up||66
8125231|NCT02896400|20027203|P4|STARTED|1 Month Follow-up||66
8125232|NCT02896400|20027204|P3|STARTED|1 Month Follow-up||66
8125233|NCT02896400|20027205|P2|STARTED|1 Month Follow-up||66
8125234|NCT02896400|20027206|P1|STARTED|1 Month Follow-up||66
8125235|NCT02896400|20027191|P16|NOT COMPLETED|Baseline||0
8125236|NCT02896400|20027192|P15|NOT COMPLETED|Baseline||0
8125237|NCT02896400|20027193|P14|NOT COMPLETED|Baseline||0
8125238|NCT02896400|20027194|P13|NOT COMPLETED|Baseline||0
8125239|NCT02896400|20027195|P12|NOT COMPLETED|Baseline||0
8125240|NCT02896400|20027196|P11|NOT COMPLETED|Baseline||0
8125241|NCT02896400|20027197|P10|NOT COMPLETED|Baseline||0
8125242|NCT02896400|20027198|P9|NOT COMPLETED|Baseline||0
8125243|NCT02896400|20027199|P8|NOT COMPLETED|Baseline||0
8125244|NCT02896400|20027200|P7|NOT COMPLETED|Baseline||0
8125245|NCT02896400|20027201|P6|NOT COMPLETED|Baseline||0
8125246|NCT02896400|20027202|P5|NOT COMPLETED|Baseline||0
8125247|NCT02896400|20027203|P4|NOT COMPLETED|Baseline||0
8125248|NCT02896400|20027204|P3|NOT COMPLETED|Baseline||0
8125249|NCT02896400|20027205|P2|NOT COMPLETED|Baseline||0
8125250|NCT02896400|20027206|P1|NOT COMPLETED|Baseline||0
8125251|NCT02896400|20027191|P16|COMPLETED|Baseline||66
8125252|NCT02896400|20027192|P15|COMPLETED|Baseline||66
8125253|NCT02896400|20027193|P14|COMPLETED|Baseline||66
8125254|NCT02896400|20027194|P13|COMPLETED|Baseline||66
8125255|NCT02896400|20027195|P12|COMPLETED|Baseline||66
8125256|NCT02896400|20027196|P11|COMPLETED|Baseline||66
8125257|NCT02896400|20027197|P10|COMPLETED|Baseline||66
8125258|NCT02896400|20027198|P9|COMPLETED|Baseline||66
8125259|NCT02896400|20027199|P8|COMPLETED|Baseline||66
8125260|NCT02896400|20027200|P7|COMPLETED|Baseline||66
8125261|NCT02896400|20027201|P6|COMPLETED|Baseline||66
8125262|NCT02896400|20027202|P5|COMPLETED|Baseline||66
8125263|NCT02896400|20027203|P4|COMPLETED|Baseline||66
8125264|NCT02896400|20027204|P3|COMPLETED|Baseline||66
8125265|NCT02896400|20027205|P2|COMPLETED|Baseline||66
8125266|NCT02896400|20027206|P1|COMPLETED|Baseline||66
8125267|NCT02896400|20027191|P16|STARTED|Baseline||66
8125268|NCT02896400|20027192|P15|STARTED|Baseline||66
8125269|NCT02896400|20027193|P14|STARTED|Baseline||66
8125270|NCT02896400|20027194|P13|STARTED|Baseline||66
8125271|NCT02896400|20027195|P12|STARTED|Baseline||66
8125272|NCT02896400|20027196|P11|STARTED|Baseline||66
8125273|NCT02896400|20027197|P10|STARTED|Baseline||66
8125274|NCT02896400|20027198|P9|STARTED|Baseline||66
8125275|NCT02896400|20027199|P8|STARTED|Baseline||66
8125276|NCT02896400|20027200|P7|STARTED|Baseline||66
8125277|NCT02896400|20027201|P6|STARTED|Baseline||66
8125278|NCT02896400|20027202|P5|STARTED|Baseline||66
8125279|NCT02896400|20027203|P4|STARTED|Baseline||66
8125280|NCT02896400|20027204|P3|STARTED|Baseline||66
8125281|NCT02896400|20027205|P2|STARTED|Baseline||66
8125282|NCT02896400|20027206|P1|STARTED|Baseline||66
8125283|NCT02896361|20027232|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
8125284|NCT02896361|20027233|P2|NOT COMPLETED|Third Intervention (2 Weeks)||1
8125285|NCT02896361|20027234|P1|NOT COMPLETED|Third Intervention (2 Weeks)||1
8125286|NCT02896361|20027232|P3|COMPLETED|Third Intervention (2 Weeks)||8
8125287|NCT02896361|20027233|P2|COMPLETED|Third Intervention (2 Weeks)||9
8125288|NCT02896361|20027234|P1|COMPLETED|Third Intervention (2 Weeks)||8
8125289|NCT02896361|20027232|P3|STARTED|Third Intervention (2 Weeks)||8
8125290|NCT02896361|20027233|P2|STARTED|Third Intervention (2 Weeks)||10
8125291|NCT02896361|20027234|P1|STARTED|Third Intervention (2 Weeks)||9
8125292|NCT02896361|20027232|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
8125293|NCT02896361|20027233|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8125294|NCT02896361|20027234|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8125295|NCT02896361|20027232|P3|COMPLETED|Second Intervention (2 Weeks)||8
8125296|NCT02896361|20027233|P2|COMPLETED|Second Intervention (2 Weeks)||10
8125297|NCT02896361|20027234|P1|COMPLETED|Second Intervention (2 Weeks)||9
8125298|NCT02896361|20027232|P3|STARTED|Second Intervention (2 Weeks)||8
8125299|NCT02896361|20027233|P2|STARTED|Second Intervention (2 Weeks)||10
8125300|NCT02896361|20027234|P1|STARTED|Second Intervention (2 Weeks)||9
8125301|NCT02896361|20027232|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
8125302|NCT02896361|20027233|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
8125303|NCT02896361|20027234|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8125304|NCT02896361|20027232|P3|COMPLETED|First Intervention (2 Weeks)||8
8125305|NCT02896361|20027233|P2|COMPLETED|First Intervention (2 Weeks)||10
8125306|NCT02896361|20027234|P1|COMPLETED|First Intervention (2 Weeks)||9
8125307|NCT02896361|20027232|P3|STARTED|First Intervention (2 Weeks)||8
8125308|NCT02896361|20027233|P2|STARTED|First Intervention (2 Weeks)||10
8125309|NCT02896361|20027234|P1|STARTED|First Intervention (2 Weeks)||9
8125310|NCT02896296|20027252|P1|NOT COMPLETED|Overall Study||42
8125311|NCT02896296|20027252|P1|COMPLETED|Overall Study||166
8125312|NCT02896296|20027252|P1|STARTED|Overall Study||208
8125313|NCT02896127|20027260|P2|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||5
8125314|NCT02896127|20027261|P1|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||4
8125315|NCT02896127|20027260|P2|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|134
8125316|NCT02896127|20027261|P1|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|276
8125317|NCT02896127|20027260|P2|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|139
8125318|NCT02896127|20027261|P1|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|280
8125319|NCT02896127|20027260|P2|NOT COMPLETED|COMPLETED WEEK 52||11
8125320|NCT02896127|20027261|P1|NOT COMPLETED|COMPLETED WEEK 52||27
8125321|NCT02896127|20027260|P2|COMPLETED|COMPLETED WEEK 52||142
8125322|NCT02896127|20027261|P1|COMPLETED|COMPLETED WEEK 52||278
8125323|NCT02896127|20027260|P2|STARTED|COMPLETED WEEK 52|Includes participants originally assigned to placebo and switched to AIN457150 mg after Wk 16.|153
8125324|NCT02896127|20027261|P1|STARTED|COMPLETED WEEK 52||305
8125325|NCT02895347|20027283|P2|NOT COMPLETED|Overall Study||1
8125326|NCT02895347|20027284|P1|NOT COMPLETED|Overall Study||3
8125327|NCT02895347|20027283|P2|COMPLETED|Overall Study||19
8125328|NCT02895347|20027284|P1|COMPLETED|Overall Study||17
8125329|NCT02895347|20027283|P2|STARTED|Overall Study||20
8125330|NCT02895347|20027284|P1|STARTED|Overall Study||20
8125331|NCT02895295|20027296|P3|NOT COMPLETED|Overall Study||92
8125332|NCT02895295|20027297|P2|NOT COMPLETED|Overall Study||94
8125333|NCT02895295|20027298|P1|NOT COMPLETED|Overall Study||71
8125334|NCT02895295|20027296|P3|COMPLETED|Overall Study||299
8125335|NCT02895295|20027297|P2|COMPLETED|Overall Study||316
8125336|NCT02895295|20027298|P1|COMPLETED|Overall Study||313
8125337|NCT02895295|20027296|P3|STARTED|Overall Study||391
8125338|NCT02895295|20027297|P2|STARTED|Overall Study||410
8125339|NCT02895295|20027298|P1|STARTED|Overall Study||384
8125340|NCT02895035|20027315|P2|NOT COMPLETED|Overall Study||12
8125341|NCT02895035|20027316|P1|NOT COMPLETED|Overall Study||5
8125342|NCT02895035|20027315|P2|COMPLETED|Overall Study||24
8125343|NCT02895035|20027316|P1|COMPLETED|Overall Study||18
8125344|NCT02895035|20027315|P2|STARTED|Overall Study||36
8125345|NCT02895035|20027316|P1|STARTED|Overall Study||23
8125346|NCT02894840|20027332|P4|NOT COMPLETED|Overall Study||0
8125347|NCT02894840|20027333|P3|NOT COMPLETED|Overall Study||3
8125348|NCT02894840|20027334|P2|NOT COMPLETED|Overall Study||0
8125349|NCT02894840|20027335|P1|NOT COMPLETED|Overall Study||1
8125350|NCT02894840|20027332|P4|COMPLETED|Overall Study||100
8125351|NCT02894840|20027333|P3|COMPLETED|Overall Study||197
8125352|NCT02894840|20027334|P2|COMPLETED|Overall Study||20
8125353|NCT02894840|20027335|P1|COMPLETED|Overall Study||19
8125354|NCT02894840|20027332|P4|STARTED|Overall Study||100
8125355|NCT02894840|20027333|P3|STARTED|Overall Study||200
8125356|NCT02894840|20027334|P2|STARTED|Overall Study||20
8125357|NCT02894840|20027335|P1|STARTED|Overall Study||20
8125358|NCT02893878|20027360|P3|NOT COMPLETED|Overall Study||0
8125359|NCT02893878|20027361|P2|NOT COMPLETED|Overall Study||0
8125360|NCT02893878|20027362|P1|NOT COMPLETED|Overall Study||0
8125361|NCT02893878|20027360|P3|COMPLETED|Overall Study||3178
8125362|NCT02893878|20027361|P2|COMPLETED|Overall Study||2295
8125363|NCT02893878|20027362|P1|COMPLETED|Overall Study||13861
8125364|NCT02893878|20027360|P3|STARTED|Overall Study||3178
8125365|NCT02893878|20027361|P2|STARTED|Overall Study||2295
8125366|NCT02893878|20027362|P1|STARTED|Overall Study||13861
8125367|NCT02892734|20027607|P1|NOT COMPLETED|Follow up for 2 Years||3
8125368|NCT02892734|20027607|P1|COMPLETED|Follow up for 2 Years||0
8125369|NCT02892734|20027607|P1|STARTED|Follow up for 2 Years||3
8125370|NCT02892734|20027607|P1|NOT COMPLETED|Treatment on Study||2
8125371|NCT02892734|20027607|P1|COMPLETED|Treatment on Study||1
8125372|NCT02892734|20027607|P1|Went on to Start Cycle 2|Treatment on Study||1
8125373|NCT02892734|20027607|P1|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1
8125374|NCT02892734|20027607|P1|STARTED|Treatment on Study||3
8125375|NCT02892513|20027617|P2|NOT COMPLETED|Overall Study||1
8125376|NCT02892513|20027618|P1|NOT COMPLETED|Overall Study||0
8125377|NCT02892513|20027617|P2|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24
8125378|NCT02892513|20027618|P1|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28
8125379|NCT02892513|20027617|P2|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25
8125380|NCT02892513|20027618|P1|STARTED|Overall Study||28
8125381|NCT02892500|20027626|P2|NOT COMPLETED|Overall Study||0
8125382|NCT02892500|20027627|P1|NOT COMPLETED|Overall Study||0
8125383|NCT02892500|20027626|P2|COMPLETED|Overall Study||0
8125384|NCT02892500|20027627|P1|COMPLETED|Overall Study||0
8125385|NCT02892500|20027626|P2|STARTED|Overall Study||0
8125386|NCT02892500|20027627|P1|STARTED|Overall Study||0
8125387|NCT02892448|20027638|P3|NOT COMPLETED|Overall Study||1
8125388|NCT02892448|20027639|P2|NOT COMPLETED|Overall Study||2
8125389|NCT02892448|20027640|P1|NOT COMPLETED|Overall Study||2
8125390|NCT02892448|20027638|P3|COMPLETED|Overall Study||10
8125391|NCT02892448|20027639|P2|COMPLETED|Overall Study||10
8125392|NCT02892448|20027640|P1|COMPLETED|Overall Study||10
8125393|NCT02892448|20027638|P3|STARTED|Overall Study||11
8125394|NCT02892448|20027639|P2|STARTED|Overall Study||12
8125395|NCT02892448|20027640|P1|STARTED|Overall Study||12
8125396|NCT02892422|20027660|P1|NOT COMPLETED|Overall Study||210
8125397|NCT02892422|20027660|P1|COMPLETED|Overall Study||318
8125398|NCT02892422|20027660|P1|STARTED|Overall Study|528 participants were enrolled, 524 from study 16159A and 4 from study 16323A|528
8125399|NCT02892409|20027666|P2|NOT COMPLETED|Overall Study||1
8125400|NCT02892409|20027667|P1|NOT COMPLETED|Overall Study||3
8125401|NCT02892409|20027666|P2|COMPLETED|Overall Study||14
8125402|NCT02892409|20027667|P1|COMPLETED|Overall Study||12
8125403|NCT02892409|20027666|P2|STARTED|Overall Study||15
8125404|NCT02892409|20027667|P1|STARTED|Overall Study||15
8125405|NCT02892344|20027689|P2|NOT COMPLETED|Overall Study||21
8125406|NCT02892344|20027690|P1|NOT COMPLETED|Overall Study||4
8125407|NCT02892344|20027689|P2|COMPLETED|Overall Study||383
8125408|NCT02892344|20027690|P1|COMPLETED|Overall Study||394
8125409|NCT02892344|20027689|P2|Full Analysis Set|Overall Study||399
8125410|NCT02892344|20027690|P1|Full Analysis Set|Overall Study||395
8125411|NCT02892344|20027689|P2|STARTED|Overall Study||404
8125412|NCT02892344|20027690|P1|STARTED|Overall Study||398
8125413|NCT02892110|20027726|P2|NOT COMPLETED|Overall Study||12
8125414|NCT02892110|20027727|P1|NOT COMPLETED|Overall Study||13
8125415|NCT02892110|20027726|P2|COMPLETED|Overall Study||25
8125416|NCT02892110|20027727|P1|COMPLETED|Overall Study||22
8125417|NCT02892110|20027726|P2|STARTED|Overall Study||37
8125418|NCT02892110|20027727|P1|STARTED|Overall Study||35
8125419|NCT02892019|20027739|P2|NOT COMPLETED|Overall Study||3
8125420|NCT02892019|20027740|P1|NOT COMPLETED|Overall Study||1
8125421|NCT02892019|20027739|P2|COMPLETED|Overall Study||36
8125422|NCT02892019|20027740|P1|COMPLETED|Overall Study||40
8125423|NCT02892019|20027739|P2|STARTED|Overall Study||39
8125424|NCT02892019|20027740|P1|STARTED|Overall Study||41
8125425|NCT02891863|20027762|P1|NOT COMPLETED|Overall Study||0
8125426|NCT02891863|20027762|P1|COMPLETED|Overall Study||9
8125427|NCT02891863|20027762|P1|STARTED|Overall Study||9
8125434|NCT02891629|20027786|P2|NOT COMPLETED|Overall Study||1
8125435|NCT02891629|20027787|P1|NOT COMPLETED|Overall Study||0
8125436|NCT02891629|20027786|P2|COMPLETED|Overall Study||4
8125437|NCT02891629|20027787|P1|COMPLETED|Overall Study||10
8125438|NCT02891629|20027786|P2|STARTED|Overall Study||5
8125439|NCT02891629|20027787|P1|STARTED|Overall Study||10
8125440|NCT02891408|20027802|P7|NOT COMPLETED|Overall Study||0
8125441|NCT02891408|20027803|P6|NOT COMPLETED|Overall Study||0
8125442|NCT02891408|20027804|P5|NOT COMPLETED|Overall Study||0
8125443|NCT02891408|20027805|P4|NOT COMPLETED|Overall Study||0
8125444|NCT02891408|20027806|P3|NOT COMPLETED|Overall Study||1
8125445|NCT02891408|20027807|P2|NOT COMPLETED|Overall Study||0
8125446|NCT02891408|20027808|P1|NOT COMPLETED|Overall Study||0
8125447|NCT02891408|20027802|P7|COMPLETED|Overall Study||10
8125448|NCT02891408|20027803|P6|COMPLETED|Overall Study||10
8125449|NCT02891408|20027804|P5|COMPLETED|Overall Study||10
8125450|NCT02891408|20027805|P4|COMPLETED|Overall Study||10
8125451|NCT02891408|20027806|P3|COMPLETED|Overall Study||13
8125452|NCT02891408|20027807|P2|COMPLETED|Overall Study||10
8125453|NCT02891408|20027808|P1|COMPLETED|Overall Study||10
8125454|NCT02891408|20027802|P7|STARTED|Overall Study||10
8125455|NCT02891408|20027803|P6|STARTED|Overall Study||10
8125456|NCT02891408|20027804|P5|STARTED|Overall Study||10
8125457|NCT02891408|20027805|P4|STARTED|Overall Study||10
8125458|NCT02891408|20027806|P3|STARTED|Overall Study||14
8125459|NCT02891408|20027807|P2|STARTED|Overall Study||10
8125460|NCT02891408|20027808|P1|STARTED|Overall Study||10
8125461|NCT02891200|20027921|P2|NOT COMPLETED|Overall Study||49
8125462|NCT02891200|20027922|P1|NOT COMPLETED|Overall Study||42
8125463|NCT02891200|20027921|P2|COMPLETED|Overall Study||98
8125464|NCT02891200|20027922|P1|COMPLETED|Overall Study||103
8125465|NCT02891200|20027921|P2|STARTED|Overall Study||147
8125466|NCT02891200|20027922|P1|STARTED|Overall Study||145
8125467|NCT02891174|20027950|P2|NOT COMPLETED|Second Intervention (24 Hours)||7
8125468|NCT02891174|20027951|P1|NOT COMPLETED|Second Intervention (24 Hours)||6
8125469|NCT02891174|20027950|P2|COMPLETED|Second Intervention (24 Hours)||3
8125470|NCT02891174|20027951|P1|COMPLETED|Second Intervention (24 Hours)||11
8125471|NCT02891174|20027950|P2|STARTED|Second Intervention (24 Hours)||10
8125472|NCT02891174|20027951|P1|STARTED|Second Intervention (24 Hours)||17
8125473|NCT02891174|20027950|P2|NOT COMPLETED|First Intervention (24 Hours)||13
8125474|NCT02891174|20027951|P1|NOT COMPLETED|First Intervention (24 Hours)||3
8125475|NCT02891174|20027950|P2|COMPLETED|First Intervention (24 Hours)||10
8125476|NCT02891174|20027951|P1|COMPLETED|First Intervention (24 Hours)||17
8125477|NCT02891174|20027950|P2|Received First Intervention|First Intervention (24 Hours)||18
8125478|NCT02891174|20027951|P1|Received First Intervention|First Intervention (24 Hours)||19
8125479|NCT02891174|20027950|P2|STARTED|First Intervention (24 Hours)||23
8125480|NCT02891174|20027951|P1|STARTED|First Intervention (24 Hours)||20
8125481|NCT02891070|20027965|P2|NOT COMPLETED|Overall Study||8
8125482|NCT02891070|20027966|P1|NOT COMPLETED|Overall Study||10
8125483|NCT02891070|20027965|P2|COMPLETED|Overall Study||106
8125484|NCT02891070|20027966|P1|COMPLETED|Overall Study||100
8125485|NCT02891070|20027965|P2|STARTED|Overall Study||114
8125486|NCT02891070|20027966|P1|STARTED|Overall Study||110
8125487|NCT02890992|20027992|P8|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
8125488|NCT02890992|20027993|P7|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
8125489|NCT02890992|20027994|P6|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
8125490|NCT02890992|20027995|P5|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
8125491|NCT02890992|20027996|P4|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
8125492|NCT02890992|20027997|P3|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
8125493|NCT02890992|20027998|P2|NOT COMPLETED|130 Weeks Open-Label Extension Period||3
8125494|NCT02890992|20027999|P1|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
8125495|NCT02890992|20027992|P8|COMPLETED|130 Weeks Open-Label Extension Period||4
8125496|NCT02890992|20027993|P7|COMPLETED|130 Weeks Open-Label Extension Period||5
8125497|NCT02890992|20027994|P6|COMPLETED|130 Weeks Open-Label Extension Period||5
8125498|NCT02890992|20027995|P5|COMPLETED|130 Weeks Open-Label Extension Period||6
8125499|NCT02890992|20027996|P4|COMPLETED|130 Weeks Open-Label Extension Period||6
8125500|NCT02890992|20027997|P3|COMPLETED|130 Weeks Open-Label Extension Period||4
8125501|NCT02890992|20027998|P2|COMPLETED|130 Weeks Open-Label Extension Period||3
8125502|NCT02890992|20027999|P1|COMPLETED|130 Weeks Open-Label Extension Period||3
8125503|NCT02890992|20027992|P8|Treated|130 Weeks Open-Label Extension Period||4
8125504|NCT02890992|20027993|P7|Treated|130 Weeks Open-Label Extension Period||5
8125505|NCT02890992|20027994|P6|Treated|130 Weeks Open-Label Extension Period||5
8125506|NCT02890992|20027995|P5|Treated|130 Weeks Open-Label Extension Period||6
8125507|NCT02890992|20027996|P4|Treated|130 Weeks Open-Label Extension Period||6
8125508|NCT02890992|20027997|P3|Treated|130 Weeks Open-Label Extension Period||4
8125509|NCT02890992|20027998|P2|Treated|130 Weeks Open-Label Extension Period||6
8125510|NCT02890992|20027999|P1|Treated|130 Weeks Open-Label Extension Period||3
8125511|NCT02890992|20027992|P8|STARTED|130 Weeks Open-Label Extension Period||5
8125512|NCT02890992|20027993|P7|STARTED|130 Weeks Open-Label Extension Period||6
8125513|NCT02890992|20027994|P6|STARTED|130 Weeks Open-Label Extension Period||5
8125514|NCT02890992|20027995|P5|STARTED|130 Weeks Open-Label Extension Period||6
8125515|NCT02890992|20027996|P4|STARTED|130 Weeks Open-Label Extension Period||6
8125516|NCT02890992|20027997|P3|STARTED|130 Weeks Open-Label Extension Period||4
8125517|NCT02890992|20027998|P2|STARTED|130 Weeks Open-Label Extension Period||6
8125518|NCT02890992|20027999|P1|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3
8125519|NCT02890992|20027992|P8|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125520|NCT02890992|20027993|P7|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125521|NCT02890992|20027994|P6|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125522|NCT02890992|20027995|P5|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125523|NCT02890992|20027996|P4|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125524|NCT02890992|20027997|P3|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125525|NCT02890992|20027998|P2|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125526|NCT02890992|20027999|P1|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
8125527|NCT02890992|20027992|P8|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
8125528|NCT02890992|20027993|P7|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
8125529|NCT02890992|20027994|P6|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
8125530|NCT02890992|20027995|P5|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
8125531|NCT02890992|20027996|P4|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
8125532|NCT02890992|20027997|P3|COMPLETED|12 Weeks Open-Label Dose Finding Period||4
8125533|NCT02890992|20027998|P2|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
8125534|NCT02890992|20027999|P1|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4
8125535|NCT02890992|20027992|P8|Treated|12 Weeks Open-Label Dose Finding Period||5
8125536|NCT02890992|20027993|P7|Treated|12 Weeks Open-Label Dose Finding Period||6
8125537|NCT02890992|20027994|P6|Treated|12 Weeks Open-Label Dose Finding Period||5
8125538|NCT02890992|20027995|P5|Treated|12 Weeks Open-Label Dose Finding Period||6
8125539|NCT02890992|20027996|P4|Treated|12 Weeks Open-Label Dose Finding Period||6
8125540|NCT02890992|20027997|P3|Treated|12 Weeks Open-Label Dose Finding Period||4
8125541|NCT02890992|20027998|P2|Treated|12 Weeks Open-Label Dose Finding Period||6
8125542|NCT02890992|20027999|P1|Treated|12 Weeks Open-Label Dose Finding Period||4
8125543|NCT02890992|20027992|P8|STARTED|12 Weeks Open-Label Dose Finding Period||5
8125544|NCT02890992|20027993|P7|STARTED|12 Weeks Open-Label Dose Finding Period||6
8125545|NCT02890992|20027994|P6|STARTED|12 Weeks Open-Label Dose Finding Period||5
8125546|NCT02890992|20027995|P5|STARTED|12 Weeks Open-Label Dose Finding Period||6
8125547|NCT02890992|20027996|P4|STARTED|12 Weeks Open-Label Dose Finding Period||6
8125548|NCT02890992|20027997|P3|STARTED|12 Weeks Open-Label Dose Finding Period||4
8125549|NCT02890992|20027998|P2|STARTED|12 Weeks Open-Label Dose Finding Period||6
8125550|NCT02890992|20027999|P1|STARTED|12 Weeks Open-Label Dose Finding Period||4
8125551|NCT02890381|20028167|P2|NOT COMPLETED|Overall Study||0
8125552|NCT02890381|20028168|P1|NOT COMPLETED|Overall Study||0
8125553|NCT02890381|20028167|P2|COMPLETED|Overall Study||6
8125554|NCT02890381|20028168|P1|COMPLETED|Overall Study||11
8125555|NCT02890381|20028167|P2|STARTED|Overall Study||6
8125556|NCT02890381|20028168|P1|STARTED|Overall Study||11
8125565|NCT02890303|20028213|P1|NOT COMPLETED|Overall Study||0
8125566|NCT02890303|20028213|P1|COMPLETED|Overall Study||100
8125567|NCT02890303|20028213|P1|STARTED|Overall Study||100
8125572|NCT02889861|20028229|P1|NOT COMPLETED|Overall Study||2
8125573|NCT02889861|20028229|P1|COMPLETED|Overall Study||1
8125574|NCT02889861|20028229|P1|STARTED|Overall Study||3
8125593|NCT02889562|20028626|P2|NOT COMPLETED|Overall Study||2
8125594|NCT02889562|20028627|P1|NOT COMPLETED|Overall Study||0
8125595|NCT02889562|20028626|P2|COMPLETED|Overall Study||26
8125596|NCT02889562|20028627|P1|COMPLETED|Overall Study||28
8125597|NCT02889562|20028626|P2|STARTED|Overall Study||28
8125598|NCT02889562|20028627|P1|STARTED|Overall Study||28
8125599|NCT02889289|20028641|P1|NOT COMPLETED|Overall Study||0
8125600|NCT02889289|20028641|P1|COMPLETED|Overall Study||1
8125601|NCT02889289|20028641|P1|STARTED|Overall Study||1
8125602|NCT02888756|20028653|P3|NOT COMPLETED|Analytical Treatment Interruption||5
8125603|NCT02888756|20028654|P2|NOT COMPLETED|Analytical Treatment Interruption||6
8125604|NCT02888756|20028655|P1|NOT COMPLETED|Analytical Treatment Interruption||10
8125605|NCT02888756|20028653|P3|COMPLETED|Analytical Treatment Interruption||3
8125606|NCT02888756|20028654|P2|COMPLETED|Analytical Treatment Interruption||3
8125607|NCT02888756|20028655|P1|COMPLETED|Analytical Treatment Interruption||5
8125608|NCT02888756|20028653|P3|STARTED|Analytical Treatment Interruption||8
8125609|NCT02888756|20028654|P2|STARTED|Analytical Treatment Interruption||9
8125610|NCT02888756|20028655|P1|STARTED|Analytical Treatment Interruption||15
8125611|NCT02888756|20028653|P3|NOT COMPLETED|Vaccination Period||0
8125612|NCT02888756|20028654|P2|NOT COMPLETED|Vaccination Period||0
8125613|NCT02888756|20028655|P1|NOT COMPLETED|Vaccination Period||0
8125614|NCT02888756|20028653|P3|COMPLETED|Vaccination Period||8
8125615|NCT02888756|20028654|P2|COMPLETED|Vaccination Period||9
8125616|NCT02888756|20028655|P1|COMPLETED|Vaccination Period||16
8125617|NCT02888756|20028653|P3|STARTED|Vaccination Period||8
8125618|NCT02888756|20028654|P2|STARTED|Vaccination Period||9
8125619|NCT02888756|20028655|P1|STARTED|Vaccination Period||16
8125620|NCT02888691|20028696|P2|NOT COMPLETED|Second Intervention Period||2
8125621|NCT02888691|20028697|P1|NOT COMPLETED|Second Intervention Period||0
8125622|NCT02888691|20028696|P2|COMPLETED|Second Intervention Period||3
8125623|NCT02888691|20028697|P1|COMPLETED|Second Intervention Period||7
8125624|NCT02888691|20028696|P2|STARTED|Second Intervention Period||5
8125625|NCT02888691|20028697|P1|STARTED|Second Intervention Period|This is a cross-over study. Therefore starters does not necessarily equal completers of period 1.|7
8125626|NCT02888691|20028696|P2|NOT COMPLETED|First Intervention Period||0
8125627|NCT02888691|20028697|P1|NOT COMPLETED|First Intervention Period||1
8125628|NCT02888691|20028696|P2|COMPLETED|First Intervention Period||7
8125629|NCT02888691|20028697|P1|COMPLETED|First Intervention Period||6
8125630|NCT02888691|20028696|P2|STARTED|First Intervention Period||7
8125631|NCT02888691|20028697|P1|STARTED|First Intervention Period||7
8125632|NCT02888171|20028795|P2|NOT COMPLETED|Overall Study||4
8125633|NCT02888171|20028796|P1|NOT COMPLETED|Overall Study||5
8125634|NCT02888171|20028795|P2|COMPLETED|Overall Study||26
8125635|NCT02888171|20028796|P1|COMPLETED|Overall Study||25
8125636|NCT02888171|20028795|P2|STARTED|Overall Study||30
8125637|NCT02888171|20028796|P1|STARTED|Overall Study||30
8125638|NCT02888093|20028812|P2|NOT COMPLETED|Overall Study||2
8125639|NCT02888093|20028813|P1|NOT COMPLETED|Overall Study||2
8125640|NCT02888093|20028812|P2|COMPLETED|Overall Study||20
8125641|NCT02888093|20028813|P1|COMPLETED|Overall Study||20
8125642|NCT02888093|20028812|P2|STARTED|Overall Study||22
8125643|NCT02888093|20028813|P1|STARTED|Overall Study||22
8125644|NCT02888080|20028825|P2|NOT COMPLETED|Overall Study||5
8125645|NCT02888080|20028826|P1|NOT COMPLETED|Overall Study||2
8125646|NCT02888080|20028825|P2|COMPLETED|Overall Study||15
8125647|NCT02888080|20028826|P1|COMPLETED|Overall Study||18
8125648|NCT02888080|20028825|P2|STARTED|Overall Study||20
8125649|NCT02888080|20028826|P1|STARTED|Overall Study||20
8125650|NCT02887989|20028852|P2|NOT COMPLETED|Overall Study||11
8125651|NCT02887989|20028853|P1|NOT COMPLETED|Overall Study||9
8125652|NCT02887989|20028852|P2|COMPLETED|Overall Study||59
8125653|NCT02887989|20028853|P1|COMPLETED|Overall Study||61
8125654|NCT02887989|20028852|P2|STARTED|Overall Study||70
8125655|NCT02887989|20028853|P1|STARTED|Overall Study||70
8125656|NCT02887521|20028865|P2|NOT COMPLETED|Overall Study||3
8125657|NCT02887521|20028866|P1|NOT COMPLETED|Overall Study||0
8125658|NCT02887521|20028865|P2|COMPLETED|Overall Study||2
8125659|NCT02887521|20028866|P1|COMPLETED|Overall Study||4
8125660|NCT02887521|20028865|P2|STARTED|Overall Study||5
8125661|NCT02887521|20028866|P1|STARTED|Overall Study||4
8125662|NCT02887404|20028880|P2|NOT COMPLETED|Overall Study||0
8125663|NCT02887404|20028881|P1|NOT COMPLETED|Overall Study||0
8125664|NCT02887404|20028880|P2|COMPLETED|Overall Study||149
8125665|NCT02887404|20028881|P1|COMPLETED|Overall Study||150
8125666|NCT02887404|20028880|P2|STARTED|Overall Study||149
8125667|NCT02887404|20028881|P1|STARTED|Overall Study||150
8125668|NCT02887183|20028929|P1|NOT COMPLETED|Overall Study||141
8125669|NCT02887183|20028929|P1|COMPLETED|Overall Study||654
8125670|NCT02887183|20028929|P1|Full Analysis Set|Overall Study||794
8125671|NCT02887183|20028929|P1|STARTED|Overall Study||795
8125672|NCT02886923|20028942|P2|NOT COMPLETED|Period 2||0
8125673|NCT02886923|20028943|P1|NOT COMPLETED|Period 2||0
8125674|NCT02886923|20028942|P2|COMPLETED|Period 2||11
8125675|NCT02886923|20028943|P1|COMPLETED|Period 2||12
8125676|NCT02886923|20028942|P2|STARTED|Period 2||11
8125677|NCT02886923|20028943|P1|STARTED|Period 2||12
8125678|NCT02886923|20028942|P2|NOT COMPLETED|Period 1||0
8125679|NCT02886923|20028943|P1|NOT COMPLETED|Period 1||0
8125680|NCT02886923|20028942|P2|COMPLETED|Period 1||11
8125681|NCT02886923|20028943|P1|COMPLETED|Period 1||12
8125682|NCT02886923|20028942|P2|STARTED|Period 1||11
8125683|NCT02886923|20028943|P1|STARTED|Period 1||12
8125696|NCT02886715|20029141|P3|NOT COMPLETED|Overall Study||20
8125697|NCT02886715|20029142|P2|NOT COMPLETED|Overall Study||55
8125698|NCT02886715|20029143|P1|NOT COMPLETED|Overall Study||64
8125699|NCT02886715|20029141|P3|COMPLETED|Overall Study||203
8125700|NCT02886715|20029142|P2|COMPLETED|Overall Study||390
8125701|NCT02886715|20029143|P1|COMPLETED|Overall Study||378
8125702|NCT02886715|20029141|P3|Per Protocol (PP) Population|Overall Study||176
8125703|NCT02886715|20029142|P2|Per Protocol (PP) Population|Overall Study||351
8125704|NCT02886715|20029143|P1|Per Protocol (PP) Population|Overall Study||346
8125705|NCT02886715|20029141|P3|Modified ITT (mITT)|Overall Study||217
8125706|NCT02886715|20029142|P2|Modified ITT (mITT)|Overall Study||418
8125707|NCT02886715|20029143|P1|Modified ITT (mITT)|Overall Study||421
8125708|NCT02886715|20029141|P3|STARTED|Overall Study||223
8125709|NCT02886715|20029142|P2|STARTED|Overall Study||445
8125710|NCT02886715|20029143|P1|STARTED|Overall Study||442
8125711|NCT02886702|20029160|P3|NOT COMPLETED|Overall Study||53
8125712|NCT02886702|20029161|P2|NOT COMPLETED|Overall Study||51
8125713|NCT02886702|20029162|P1|NOT COMPLETED|Overall Study||48
8125714|NCT02886702|20029160|P3|COMPLETED|Overall Study||232
8125715|NCT02886702|20029161|P2|COMPLETED|Overall Study||235
8125716|NCT02886702|20029162|P1|COMPLETED|Overall Study||236
8125717|NCT02886702|20029160|P3|Per-Protocol Population (PP)|Overall Study||201
8125718|NCT02886702|20029161|P2|Per-Protocol Population (PP)|Overall Study||209
8125719|NCT02886702|20029162|P1|Per-Protocol Population (PP)|Overall Study||208
8125720|NCT02886702|20029160|P3|Modified Intent-to Treat (mITT)|Overall Study||275
8125721|NCT02886702|20029161|P2|Modified Intent-to Treat (mITT)|Overall Study||266
8125722|NCT02886702|20029162|P1|Modified Intent-to Treat (mITT)|Overall Study||263
8125723|NCT02886702|20029160|P3|STARTED|Overall Study||285
8125724|NCT02886702|20029161|P2|STARTED|Overall Study||286
8125725|NCT02886702|20029162|P1|STARTED|Overall Study||284
8125726|NCT02886624|20029176|P1|NOT COMPLETED|48-week Post Treatment Follow-up||1
8125727|NCT02886624|20029176|P1|COMPLETED|48-week Post Treatment Follow-up||28
8125728|NCT02886624|20029176|P1|STARTED|48-week Post Treatment Follow-up||29
8125729|NCT02886624|20029176|P1|NOT COMPLETED|12-week Post Treatment Follow-up||1
8125730|NCT02886624|20029176|P1|COMPLETED|12-week Post Treatment Follow-up||29
8125731|NCT02886624|20029176|P1|STARTED|12-week Post Treatment Follow-up||30
8125732|NCT02886624|20029176|P1|NOT COMPLETED|8-week Treatment||0
8125733|NCT02886624|20029176|P1|COMPLETED|8-week Treatment||30
8125734|NCT02886624|20029176|P1|STARTED|8-week Treatment||30
8125735|NCT02886338|20029185|P1|NOT COMPLETED|Overall Study||1
8125736|NCT02886338|20029185|P1|COMPLETED|Overall Study||9
8125737|NCT02886338|20029185|P1|STARTED|Overall Study||10
8125738|NCT02886234|20029191|P2|NOT COMPLETED|Overall Study||2
8125739|NCT02886234|20029192|P1|NOT COMPLETED|Overall Study||0
8125740|NCT02886234|20029191|P2|COMPLETED|Overall Study||22
8125741|NCT02886234|20029192|P1|COMPLETED|Overall Study||20
8125742|NCT02886234|20029191|P2|STARTED|Overall Study||24
8125743|NCT02886234|20029192|P1|STARTED|Overall Study||20
8125744|NCT02885636|20029214|P2|NOT COMPLETED|Overall Study||0
8125745|NCT02885636|20029215|P1|NOT COMPLETED|Overall Study||0
8125746|NCT02885636|20029214|P2|COMPLETED|Overall Study||15
8125747|NCT02885636|20029215|P1|COMPLETED|Overall Study||15
8125748|NCT02885636|20029214|P2|STARTED|Overall Study||15
8125749|NCT02885636|20029215|P1|STARTED|Overall Study||15
8125750|NCT02885506|20029257|P10|NOT COMPLETED|Part B||0
8125751|NCT02885506|20029258|P9|NOT COMPLETED|Part B||0
8125752|NCT02885506|20029259|P8|NOT COMPLETED|Part B||0
8125753|NCT02885506|20029260|P7|NOT COMPLETED|Part B||0
8125754|NCT02885506|20029261|P6|NOT COMPLETED|Part B||0
8125755|NCT02885506|20029262|P5|NOT COMPLETED|Part B||0
8125756|NCT02885506|20029263|P4|NOT COMPLETED|Part B||0
8125757|NCT02885506|20029264|P3|NOT COMPLETED|Part B||0
8125758|NCT02885506|20029265|P2|NOT COMPLETED|Part B||0
8125759|NCT02885506|20029266|P1|NOT COMPLETED|Part B||0
8125760|NCT02885506|20029257|P10|COMPLETED|Part B||4
8125761|NCT02885506|20029258|P9|COMPLETED|Part B||4
8125762|NCT02885506|20029259|P8|COMPLETED|Part B||0
8125763|NCT02885506|20029260|P7|COMPLETED|Part B||0
8125764|NCT02885506|20029261|P6|COMPLETED|Part B||0
8125765|NCT02885506|20029262|P5|COMPLETED|Part B||0
8125766|NCT02885506|20029263|P4|COMPLETED|Part B||0
8125767|NCT02885506|20029264|P3|COMPLETED|Part B||0
8125768|NCT02885506|20029265|P2|COMPLETED|Part B||0
8125769|NCT02885506|20029266|P1|COMPLETED|Part B||0
8125770|NCT02885506|20029257|P10|STARTED|Part B||4
8125771|NCT02885506|20029258|P9|STARTED|Part B||4
8125772|NCT02885506|20029259|P8|STARTED|Part B||0
8125773|NCT02885506|20029260|P7|STARTED|Part B||0
8125774|NCT02885506|20029261|P6|STARTED|Part B||0
8125775|NCT02885506|20029262|P5|STARTED|Part B||0
8125776|NCT02885506|20029263|P4|STARTED|Part B||0
8125777|NCT02885506|20029264|P3|STARTED|Part B||0
8125778|NCT02885506|20029265|P2|STARTED|Part B||0
8125779|NCT02885506|20029266|P1|STARTED|Part B||0
8125780|NCT02885506|20029257|P10|NOT COMPLETED|Part A||0
8125781|NCT02885506|20029258|P9|NOT COMPLETED|Part A||0
8125782|NCT02885506|20029259|P8|NOT COMPLETED|Part A||0
8125783|NCT02885506|20029260|P7|NOT COMPLETED|Part A||0
8125784|NCT02885506|20029261|P6|NOT COMPLETED|Part A||0
8125785|NCT02885506|20029262|P5|NOT COMPLETED|Part A||0
8125786|NCT02885506|20029263|P4|NOT COMPLETED|Part A||0
8125787|NCT02885506|20029264|P3|NOT COMPLETED|Part A||0
8125788|NCT02885506|20029265|P2|NOT COMPLETED|Part A||0
8125789|NCT02885506|20029266|P1|NOT COMPLETED|Part A||0
8125790|NCT02885506|20029257|P10|COMPLETED|Part A||0
8125791|NCT02885506|20029258|P9|COMPLETED|Part A||0
8125792|NCT02885506|20029259|P8|COMPLETED|Part A||14
8125793|NCT02885506|20029260|P7|COMPLETED|Part A||6
8125794|NCT02885506|20029261|P6|COMPLETED|Part A||6
8125795|NCT02885506|20029262|P5|COMPLETED|Part A||6
8125796|NCT02885506|20029263|P4|COMPLETED|Part A||6
8125797|NCT02885506|20029264|P3|COMPLETED|Part A||6
8125798|NCT02885506|20029265|P2|COMPLETED|Part A||6
8125799|NCT02885506|20029266|P1|COMPLETED|Part A||6
8125800|NCT02885506|20029257|P10|STARTED|Part A||0
8125801|NCT02885506|20029258|P9|STARTED|Part A||0
8125802|NCT02885506|20029259|P8|STARTED|Part A||14
8125803|NCT02885506|20029260|P7|STARTED|Part A||6
8125804|NCT02885506|20029261|P6|STARTED|Part A||6
8125805|NCT02885506|20029262|P5|STARTED|Part A||6
8125806|NCT02885506|20029263|P4|STARTED|Part A||6
8125807|NCT02885506|20029264|P3|STARTED|Part A||6
8125808|NCT02885506|20029265|P2|STARTED|Part A||6
8125809|NCT02885506|20029266|P1|STARTED|Part A||6
8125810|NCT02885246|20029358|P1|NOT COMPLETED|Overall Study||0
8125811|NCT02885246|20029358|P1|COMPLETED|Overall Study||1839
8125812|NCT02885246|20029358|P1|STARTED|Overall Study||1839
8125813|NCT02885181|20029374|P4|NOT COMPLETED|Overall Study||3
8125814|NCT02885181|20029375|P3|NOT COMPLETED|Overall Study||0
8125815|NCT02885181|20029376|P2|NOT COMPLETED|Overall Study||1
8125816|NCT02885181|20029377|P1|NOT COMPLETED|Overall Study||0
8125817|NCT02885181|20029374|P4|COMPLETED|Overall Study||19
8125818|NCT02885181|20029375|P3|COMPLETED|Overall Study||21
8125819|NCT02885181|20029376|P2|COMPLETED|Overall Study||19
8125820|NCT02885181|20029377|P1|COMPLETED|Overall Study||20
8125821|NCT02885181|20029374|P4|STARTED|Overall Study||22
8125822|NCT02885181|20029375|P3|STARTED|Overall Study||21
8125823|NCT02885181|20029376|P2|STARTED|Overall Study||20
8125824|NCT02885181|20029377|P1|STARTED|Overall Study||20
8125825|NCT02885025|20029407|P4|NOT COMPLETED|Overall Study||0
8125826|NCT02885025|20029408|P3|NOT COMPLETED|Overall Study||0
8125827|NCT02885025|20029409|P2|NOT COMPLETED|Overall Study||2
8125828|NCT02885025|20029410|P1|NOT COMPLETED|Overall Study||0
8125829|NCT02885025|20029407|P4|COMPLETED|Overall Study||8
8125830|NCT02885025|20029408|P3|COMPLETED|Overall Study||9
8125831|NCT02885025|20029409|P2|COMPLETED|Overall Study||12
8125832|NCT02885025|20029410|P1|COMPLETED|Overall Study||16
8125833|NCT02885025|20029407|P4|STARTED|Overall Study||8
8125834|NCT02885025|20029408|P3|STARTED|Overall Study||9
8125835|NCT02885025|20029409|P2|STARTED|Overall Study||14
8125836|NCT02885025|20029410|P1|STARTED|Overall Study||16
8125837|NCT02885012|20029450|P2|NOT COMPLETED|Overall Study||0
8125838|NCT02885012|20029451|P1|NOT COMPLETED|Overall Study||0
8125839|NCT02885012|20029450|P2|COMPLETED|Overall Study||2
8125840|NCT02885012|20029451|P1|COMPLETED|Overall Study||1
8125841|NCT02885012|20029450|P2|STARTED|Overall Study||2
8125842|NCT02885012|20029451|P1|STARTED|Overall Study||1
8125843|NCT02884492|20029463|P2|NOT COMPLETED|Overall Study||0
8125844|NCT02884492|20029464|P1|NOT COMPLETED|Overall Study||0
8125845|NCT02884492|20029463|P2|COMPLETED|Overall Study||10
8125846|NCT02884492|20029464|P1|COMPLETED|Overall Study||7
8125847|NCT02884492|20029463|P2|STARTED|Overall Study||10
8125848|NCT02884492|20029464|P1|STARTED|Overall Study||7
8125849|NCT02884427|20029473|P3|NOT COMPLETED|Overall Study||0
8125850|NCT02884427|20029474|P2|NOT COMPLETED|Overall Study||0
8125851|NCT02884427|20029475|P1|NOT COMPLETED|Overall Study||0
8125852|NCT02884427|20029473|P3|COMPLETED|Overall Study||50
8125853|NCT02884427|20029474|P2|COMPLETED|Overall Study||52
8125854|NCT02884427|20029475|P1|COMPLETED|Overall Study||48
8125855|NCT02884427|20029473|P3|STARTED|Overall Study||50
8125856|NCT02884427|20029474|P2|STARTED|Overall Study||52
8125857|NCT02884427|20029475|P1|STARTED|Overall Study||48
8125858|NCT02884414|20029489|P1|NOT COMPLETED|Overall Study||0
8125859|NCT02884414|20029489|P1|COMPLETED|Overall Study||56
8125860|NCT02884414|20029489|P1|STARTED|Overall Study||56
8125861|NCT02884089|20029493|P4|NOT COMPLETED|Follow-up Visit||1
8125862|NCT02884089|20029494|P3|NOT COMPLETED|Follow-up Visit||0
8125863|NCT02884089|20029495|P2|NOT COMPLETED|Follow-up Visit||0
8125864|NCT02884089|20029496|P1|NOT COMPLETED|Follow-up Visit||1
8125865|NCT02884089|20029493|P4|COMPLETED|Follow-up Visit||6
8125866|NCT02884089|20029494|P3|COMPLETED|Follow-up Visit||7
8125867|NCT02884089|20029495|P2|COMPLETED|Follow-up Visit||6
8125868|NCT02884089|20029496|P1|COMPLETED|Follow-up Visit||6
8125869|NCT02884089|20029493|P4|STARTED|Follow-up Visit||7
8125870|NCT02884089|20029494|P3|STARTED|Follow-up Visit||7
8125871|NCT02884089|20029495|P2|STARTED|Follow-up Visit||6
8125872|NCT02884089|20029496|P1|STARTED|Follow-up Visit||7
8125873|NCT02884089|20029493|P4|NOT COMPLETED|Period 4||0
8125874|NCT02884089|20029494|P3|NOT COMPLETED|Period 4||0
8125875|NCT02884089|20029495|P2|NOT COMPLETED|Period 4||1
8125876|NCT02884089|20029496|P1|NOT COMPLETED|Period 4||1
8125877|NCT02884089|20029493|P4|COMPLETED|Period 4||7
8125878|NCT02884089|20029494|P3|COMPLETED|Period 4||7
8125879|NCT02884089|20029495|P2|COMPLETED|Period 4||6
8125880|NCT02884089|20029496|P1|COMPLETED|Period 4||7
8125881|NCT02884089|20029493|P4|STARTED|Period 4||7
8125882|NCT02884089|20029494|P3|STARTED|Period 4||7
8125883|NCT02884089|20029495|P2|STARTED|Period 4||7
8125884|NCT02884089|20029496|P1|STARTED|Period 4||8
8125885|NCT02884089|20029493|P4|NOT COMPLETED|Washout Period 3||1
8125886|NCT02884089|20029494|P3|NOT COMPLETED|Washout Period 3||1
8125887|NCT02884089|20029495|P2|NOT COMPLETED|Washout Period 3||0
8125888|NCT02884089|20029496|P1|NOT COMPLETED|Washout Period 3||0
8125889|NCT02884089|20029493|P4|COMPLETED|Washout Period 3||7
8125890|NCT02884089|20029494|P3|COMPLETED|Washout Period 3||7
8125891|NCT02884089|20029495|P2|COMPLETED|Washout Period 3||7
8125892|NCT02884089|20029496|P1|COMPLETED|Washout Period 3||8
8125893|NCT02884089|20029493|P4|STARTED|Washout Period 3||8
8125894|NCT02884089|20029494|P3|STARTED|Washout Period 3||8
8125895|NCT02884089|20029495|P2|STARTED|Washout Period 3||7
8125896|NCT02884089|20029496|P1|STARTED|Washout Period 3||8
8125897|NCT02884089|20029493|P4|NOT COMPLETED|Period 3||0
8125898|NCT02884089|20029494|P3|NOT COMPLETED|Period 3||1
8125899|NCT02884089|20029495|P2|NOT COMPLETED|Period 3||0
8125900|NCT02884089|20029496|P1|NOT COMPLETED|Period 3||0
8125901|NCT02884089|20029493|P4|COMPLETED|Period 3||8
8125902|NCT02884089|20029494|P3|COMPLETED|Period 3||8
8125903|NCT02884089|20029495|P2|COMPLETED|Period 3||7
8125904|NCT02884089|20029496|P1|COMPLETED|Period 3||8
8125905|NCT02884089|20029493|P4|STARTED|Period 3||8
8125906|NCT02884089|20029494|P3|STARTED|Period 3||9
8125907|NCT02884089|20029495|P2|STARTED|Period 3||7
8125908|NCT02884089|20029496|P1|STARTED|Period 3||8
8125909|NCT02884089|20029493|P4|NOT COMPLETED|Washout Period 2||0
8125910|NCT02884089|20029494|P3|NOT COMPLETED|Washout Period 2||0
8125911|NCT02884089|20029495|P2|NOT COMPLETED|Washout Period 2||0
8125912|NCT02884089|20029496|P1|NOT COMPLETED|Washout Period 2||0
8125913|NCT02884089|20029493|P4|COMPLETED|Washout Period 2||8
8125914|NCT02884089|20029494|P3|COMPLETED|Washout Period 2||9
8125915|NCT02884089|20029495|P2|COMPLETED|Washout Period 2||7
8125916|NCT02884089|20029496|P1|COMPLETED|Washout Period 2||8
8125917|NCT02884089|20029493|P4|STARTED|Washout Period 2||8
8125918|NCT02884089|20029494|P3|STARTED|Washout Period 2||9
8125919|NCT02884089|20029495|P2|STARTED|Washout Period 2||7
8125920|NCT02884089|20029496|P1|STARTED|Washout Period 2||8
8125921|NCT02884089|20029493|P4|NOT COMPLETED|Period 2||0
8125922|NCT02884089|20029494|P3|NOT COMPLETED|Period 2||0
8125923|NCT02884089|20029495|P2|NOT COMPLETED|Period 2||0
8125924|NCT02884089|20029496|P1|NOT COMPLETED|Period 2||1
8125925|NCT02884089|20029493|P4|COMPLETED|Period 2||8
8125926|NCT02884089|20029494|P3|COMPLETED|Period 2||9
8125927|NCT02884089|20029495|P2|COMPLETED|Period 2||7
8125928|NCT02884089|20029496|P1|COMPLETED|Period 2||8
8125929|NCT02884089|20029493|P4|STARTED|Period 2||8
8125930|NCT02884089|20029494|P3|STARTED|Period 2||9
8125931|NCT02884089|20029495|P2|STARTED|Period 2||7
8125932|NCT02884089|20029496|P1|STARTED|Period 2||9
8125933|NCT02884089|20029493|P4|NOT COMPLETED|Washout Period 1||1
8125934|NCT02884089|20029494|P3|NOT COMPLETED|Washout Period 1||0
8125935|NCT02884089|20029495|P2|NOT COMPLETED|Washout Period 1||2
8125936|NCT02884089|20029496|P1|NOT COMPLETED|Washout Period 1||0
8125937|NCT02884089|20029493|P4|COMPLETED|Washout Period 1||8
8125938|NCT02884089|20029494|P3|COMPLETED|Washout Period 1||9
8125939|NCT02884089|20029495|P2|COMPLETED|Washout Period 1||7
8125940|NCT02884089|20029496|P1|COMPLETED|Washout Period 1||9
8125941|NCT02884089|20029493|P4|STARTED|Washout Period 1||9
8125942|NCT02884089|20029494|P3|STARTED|Washout Period 1||9
8125943|NCT02884089|20029495|P2|STARTED|Washout Period 1||9
8125944|NCT02884089|20029496|P1|STARTED|Washout Period 1||9
8125945|NCT02884089|20029493|P4|NOT COMPLETED|Period 1||0
8125946|NCT02884089|20029494|P3|NOT COMPLETED|Period 1||0
8125947|NCT02884089|20029495|P2|NOT COMPLETED|Period 1||2
8125948|NCT02884089|20029496|P1|NOT COMPLETED|Period 1||2
8125949|NCT02884089|20029493|P4|COMPLETED|Period 1||9
8125950|NCT02884089|20029494|P3|COMPLETED|Period 1||9
8125951|NCT02884089|20029495|P2|COMPLETED|Period 1||9
8125952|NCT02884089|20029496|P1|COMPLETED|Period 1||9
8125953|NCT02884089|20029493|P4|Received at Least One Dose of Study Drug|Period 1||9
8125954|NCT02884089|20029494|P3|Received at Least One Dose of Study Drug|Period 1||9
8125955|NCT02884089|20029495|P2|Received at Least One Dose of Study Drug|Period 1||11
8125956|NCT02884089|20029496|P1|Received at Least One Dose of Study Drug|Period 1||11
8125957|NCT02884089|20029493|P4|STARTED|Period 1||9
8125958|NCT02884089|20029494|P3|STARTED|Period 1||9
8125959|NCT02884089|20029495|P2|STARTED|Period 1||11
8125960|NCT02884089|20029496|P1|STARTED|Period 1||11
8125961|NCT02883452|20029516|P6|NOT COMPLETED|Overall Study||15
8125962|NCT02883452|20029517|P5|NOT COMPLETED|Overall Study||11
8125963|NCT02883452|20029518|P4|NOT COMPLETED|Overall Study||2
8125964|NCT02883452|20029519|P3|NOT COMPLETED|Overall Study||5
8125965|NCT02883452|20029520|P2|NOT COMPLETED|Overall Study||2
8125966|NCT02883452|20029521|P1|NOT COMPLETED|Overall Study||5
8125967|NCT02883452|20029516|P6|COMPLETED|Overall Study||50
8125968|NCT02883452|20029517|P5|COMPLETED|Overall Study||55
8125969|NCT02883452|20029518|P4|COMPLETED|Overall Study||6
8125970|NCT02883452|20029519|P3|COMPLETED|Overall Study||7
8125971|NCT02883452|20029520|P2|COMPLETED|Overall Study||9
8125972|NCT02883452|20029521|P1|COMPLETED|Overall Study||8
8125973|NCT02883452|20029516|P6|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|65
8125974|NCT02883452|20029517|P5|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|66
8125975|NCT02883452|20029518|P4|STARTED|Overall Study|This cohort is only for Part 1.|8
8125976|NCT02883452|20029519|P3|STARTED|Overall Study|This cohort is only for Part 1.|12
8125977|NCT02883452|20029520|P2|STARTED|Overall Study|This cohort is only for Part 1.|11
8125978|NCT02883452|20029521|P1|STARTED|Overall Study|This cohort is only for Part 1.|13
8125979|NCT02883244|20029549|P2|NOT COMPLETED|Overall Study||1
8125980|NCT02883244|20029550|P1|NOT COMPLETED|Overall Study||0
8125981|NCT02883244|20029549|P2|COMPLETED|Overall Study||25
8125982|NCT02883244|20029550|P1|COMPLETED|Overall Study||24
8125983|NCT02883244|20029549|P2|STARTED|Overall Study||26
8125984|NCT02883244|20029550|P1|STARTED|Overall Study||24
8125985|NCT02882854|20029568|P2|NOT COMPLETED|Overall Study||3
8125986|NCT02882854|20029569|P1|NOT COMPLETED|Overall Study||1
8125987|NCT02882854|20029568|P2|COMPLETED|Overall Study||41
8125988|NCT02882854|20029569|P1|COMPLETED|Overall Study||39
8125989|NCT02882854|20029568|P2|STARTED|Overall Study||44
8125990|NCT02882854|20029569|P1|STARTED|Overall Study||40
8125991|NCT02882711|20029591|P1|NOT COMPLETED|Overall Study||4
8125992|NCT02882711|20029591|P1|COMPLETED|Overall Study||2
8125993|NCT02882711|20029591|P1|STARTED|Overall Study||6
8125994|NCT02882633|20029599|P2|NOT COMPLETED|Overall Study||0
8125995|NCT02882633|20029600|P1|NOT COMPLETED|Overall Study||2
8125996|NCT02882633|20029599|P2|COMPLETED|Overall Study||25
8125997|NCT02882633|20029600|P1|COMPLETED|Overall Study||23
8125998|NCT02882633|20029599|P2|STARTED|Overall Study||25
8125999|NCT02882633|20029600|P1|STARTED|Overall Study||25
8126000|NCT02882178|20029610|P1|NOT COMPLETED|Overall Study||0
8126001|NCT02882178|20029610|P1|COMPLETED|Overall Study||18
8126002|NCT02882178|20029610|P1|STARTED|Overall Study||18
8126003|NCT02882152|20029616|P2|NOT COMPLETED|Overall Study||0
8126004|NCT02882152|20029617|P1|NOT COMPLETED|Overall Study||1
8126005|NCT02882152|20029616|P2|COMPLETED|Overall Study||20
8126006|NCT02882152|20029617|P1|COMPLETED|Overall Study||19
8126007|NCT02882152|20029616|P2|STARTED|Overall Study||20
8126008|NCT02882152|20029617|P1|STARTED|Overall Study||20
8126009|NCT02881996|20029627|P2|NOT COMPLETED|Overall Study||2
8126010|NCT02881996|20029628|P1|NOT COMPLETED|Overall Study||6
8126011|NCT02881996|20029627|P2|COMPLETED|Overall Study||43
8126012|NCT02881996|20029628|P1|COMPLETED|Overall Study||39
8126013|NCT02881996|20029627|P2|STARTED|Overall Study||45
8126014|NCT02881996|20029628|P1|STARTED|Overall Study||45
8126015|NCT02881957|20029638|P2|NOT COMPLETED|Overall Study||4
8126016|NCT02881957|20029639|P1|NOT COMPLETED|Overall Study||3
8126017|NCT02881957|20029638|P2|COMPLETED|Overall Study||134
8126018|NCT02881957|20029639|P1|COMPLETED|Overall Study||133
8126019|NCT02881957|20029638|P2|STARTED|Overall Study||138
8126020|NCT02881957|20029639|P1|STARTED|Overall Study||136
8126021|NCT02881840|20029663|P1|NOT COMPLETED|Overall Study||0
8126022|NCT02881840|20029663|P1|COMPLETED|Overall Study||6
8126023|NCT02881840|20029663|P1|STARTED|Overall Study||6
8126024|NCT02881775|20029667|P2|NOT COMPLETED|Second Intervention (1-Hour Session)||0
8126025|NCT02881775|20029668|P1|NOT COMPLETED|Second Intervention (1-Hour Session)||0
8126026|NCT02881775|20029667|P2|COMPLETED|Second Intervention (1-Hour Session)||7
8126027|NCT02881775|20029668|P1|COMPLETED|Second Intervention (1-Hour Session)||9
8126028|NCT02881775|20029667|P2|STARTED|Second Intervention (1-Hour Session)||7
8126029|NCT02881775|20029668|P1|STARTED|Second Intervention (1-Hour Session)||9
8126030|NCT02881775|20029667|P2|NOT COMPLETED|Washout (1 Week)||0
8126031|NCT02881775|20029668|P1|NOT COMPLETED|Washout (1 Week)||0
8126032|NCT02881775|20029667|P2|COMPLETED|Washout (1 Week)||7
8126033|NCT02881775|20029668|P1|COMPLETED|Washout (1 Week)||9
8126034|NCT02881775|20029667|P2|STARTED|Washout (1 Week)||7
8126035|NCT02881775|20029668|P1|STARTED|Washout (1 Week)||9
8126036|NCT02881775|20029667|P2|NOT COMPLETED|First Intervention (1-hr Session)||0
8126037|NCT02881775|20029668|P1|NOT COMPLETED|First Intervention (1-hr Session)||0
8126038|NCT02881775|20029667|P2|COMPLETED|First Intervention (1-hr Session)||7
8126039|NCT02881775|20029668|P1|COMPLETED|First Intervention (1-hr Session)||9
8126040|NCT02881775|20029667|P2|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7
8126041|NCT02881775|20029668|P1|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9
8126042|NCT02881775|20029667|P2|NOT COMPLETED|Baseline||0
8126043|NCT02881775|20029668|P1|NOT COMPLETED|Baseline||0
8126044|NCT02881775|20029667|P2|COMPLETED|Baseline||9
8126045|NCT02881775|20029668|P1|COMPLETED|Baseline||11
8126046|NCT02881775|20029667|P2|STARTED|Baseline||9
8126047|NCT02881775|20029668|P1|STARTED|Baseline||11
8126048|NCT02881658|20029690|P2|NOT COMPLETED|Overall Study||5
8126049|NCT02881658|20029691|P1|NOT COMPLETED|Overall Study||2
8126050|NCT02881658|20029690|P2|COMPLETED|Overall Study||96
8126051|NCT02881658|20029691|P1|COMPLETED|Overall Study||98
8126052|NCT02881658|20029690|P2|STARTED|Overall Study||101
8126053|NCT02881658|20029691|P1|STARTED|Overall Study||100
8126054|NCT02881567|20029725|P1|NOT COMPLETED|Overall Study||18
8126055|NCT02881567|20029725|P1|COMPLETED|Overall Study||23
8126056|NCT02881567|20029725|P1|STARTED|Overall Study||41
8126057|NCT02881112|20029737|P1|NOT COMPLETED|Overall Study||28
8126058|NCT02881112|20029737|P1|COMPLETED|Overall Study||152
8126059|NCT02881112|20029737|P1|STARTED|Overall Study||180
8126060|NCT02881047|20029741|P1|NOT COMPLETED|Overall Study||2
8126061|NCT02881047|20029741|P1|COMPLETED|Overall Study||6
8126062|NCT02881047|20029741|P1|STARTED|Overall Study||8
8126063|NCT02881008|20029753|P6|NOT COMPLETED|Overall Study||0
8126064|NCT02881008|20029754|P5|NOT COMPLETED|Overall Study||0
8126065|NCT02881008|20029755|P4|NOT COMPLETED|Overall Study||0
8126066|NCT02881008|20029756|P3|NOT COMPLETED|Overall Study||0
8126067|NCT02881008|20029757|P2|NOT COMPLETED|Overall Study||0
8126068|NCT02881008|20029758|P1|NOT COMPLETED|Overall Study||0
8126069|NCT02881008|20029753|P6|COMPLETED|Overall Study||8
8126070|NCT02881008|20029754|P5|COMPLETED|Overall Study||8
8126071|NCT02881008|20029755|P4|COMPLETED|Overall Study||8
8126072|NCT02881008|20029756|P3|COMPLETED|Overall Study||8
8126073|NCT02881008|20029757|P2|COMPLETED|Overall Study||8
8126074|NCT02881008|20029758|P1|COMPLETED|Overall Study||8
8126075|NCT02881008|20029753|P6|STARTED|Overall Study||8
8126076|NCT02881008|20029754|P5|STARTED|Overall Study||8
8126077|NCT02881008|20029755|P4|STARTED|Overall Study||8
8126078|NCT02881008|20029756|P3|STARTED|Overall Study||8
8126079|NCT02881008|20029757|P2|STARTED|Overall Study||8
8126080|NCT02881008|20029758|P1|STARTED|Overall Study||8
8126081|NCT02880865|20029793|P2|NOT COMPLETED|Overall Study||3
8126082|NCT02880865|20029794|P1|NOT COMPLETED|Overall Study||1
8126083|NCT02880865|20029793|P2|COMPLETED|Overall Study||311
8126084|NCT02880865|20029794|P1|COMPLETED|Overall Study||313
8126085|NCT02880865|20029793|P2|Received MMR Dose 2|Overall Study||311
8126086|NCT02880865|20029794|P1|Received MMR Dose 2|Overall Study||313
8126087|NCT02880865|20029793|P2|Received CD-JEV|Overall Study||309
8126088|NCT02880865|20029794|P1|Received CD-JEV|Overall Study||314
8126089|NCT02880865|20029793|P2|Received MMR Dose 1|Overall Study||314
8126090|NCT02880865|20029794|P1|Received MMR Dose 1|Overall Study||314
8126091|NCT02880865|20029793|P2|STARTED|Overall Study||314
8126092|NCT02880865|20029794|P1|STARTED|Overall Study||314
8126093|NCT02880852|20029849|P1|NOT COMPLETED|Overall Study||0
8126094|NCT02880852|20029849|P1|COMPLETED|Overall Study||20
8126095|NCT02880852|20029849|P1|STARTED|Overall Study||20
8126096|NCT02880761|20029877|P2|NOT COMPLETED|Overall Study||21
8126097|NCT02880761|20029878|P1|NOT COMPLETED|Overall Study||16
8126098|NCT02880761|20029877|P2|COMPLETED|Overall Study||85
8126099|NCT02880761|20029878|P1|COMPLETED|Overall Study||87
8126100|NCT02880761|20029877|P2|STARTED|Overall Study||106
8126101|NCT02880761|20029878|P1|STARTED|Overall Study||103
8126102|NCT02880514|20029888|P2|NOT COMPLETED|Overall Study||0
8126103|NCT02880514|20029889|P1|NOT COMPLETED|Overall Study||0
8126104|NCT02880514|20029888|P2|COMPLETED|Overall Study||50
8126105|NCT02880514|20029889|P1|COMPLETED|Overall Study||50
8126106|NCT02880514|20029888|P2|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
8126107|NCT02880514|20029889|P1|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
8126108|NCT02880475|20029898|P2|NOT COMPLETED|Overall Study||0
8126109|NCT02880475|20029899|P1|NOT COMPLETED|Overall Study||0
8126110|NCT02880475|20029898|P2|COMPLETED|Overall Study||17
8126111|NCT02880475|20029899|P1|COMPLETED|Overall Study||13
8126112|NCT02880475|20029898|P2|STARTED|Overall Study||17
8126113|NCT02880475|20029899|P1|STARTED|Overall Study||13
8126114|NCT02880254|20030033|P2|NOT COMPLETED|Overall Study||10
8126115|NCT02880254|20030034|P1|NOT COMPLETED|Overall Study||9
8126116|NCT02880254|20030033|P2|COMPLETED|Overall Study||4
8126117|NCT02880254|20030034|P1|COMPLETED|Overall Study||4
8126118|NCT02880254|20030033|P2|STARTED|Overall Study||14
8126119|NCT02880254|20030034|P1|STARTED|Overall Study||13
8126120|NCT02880228|20030042|P1|NOT COMPLETED|Overall Study||0
8126121|NCT02880228|20030042|P1|COMPLETED|Overall Study||11
8126122|NCT02880228|20030042|P1|STARTED|Overall Study||11
8126123|NCT02880189|20030050|P1|NOT COMPLETED|Overall Study||0
8126124|NCT02880189|20030050|P1|COMPLETED|Overall Study||21
8126125|NCT02880189|20030050|P1|STARTED|Overall Study||21
8126126|NCT02880137|20030055|P1|NOT COMPLETED|Overall Study||0
8126127|NCT02880137|20030055|P1|COMPLETED|Overall Study||36
8126128|NCT02880137|20030055|P1|STARTED|Overall Study||36
8126129|NCT02879812|20030061|P2|NOT COMPLETED|Overall Study||1451
8126130|NCT02879812|20030062|P1|NOT COMPLETED|Overall Study||1217
8126131|NCT02879812|20030061|P2|COMPLETED|Overall Study||21029
8126132|NCT02879812|20030062|P1|COMPLETED|Overall Study||22153
8126133|NCT02879812|20030061|P2|STARTED|Overall Study||22480
8126134|NCT02879812|20030062|P1|STARTED|Overall Study||23370
8126135|NCT02879747|20030081|P3|NOT COMPLETED|Overall Study||2
8126136|NCT02879747|20030082|P2|NOT COMPLETED|Overall Study||6
8126137|NCT02879747|20030083|P1|NOT COMPLETED|Overall Study||4
8126138|NCT02879747|20030081|P3|COMPLETED|Overall Study||31
8126139|NCT02879747|20030082|P2|COMPLETED|Overall Study||32
8126140|NCT02879747|20030083|P1|COMPLETED|Overall Study||23
8126141|NCT02879747|20030081|P3|STARTED|Overall Study||33
8126142|NCT02879747|20030082|P2|STARTED|Overall Study||38
8126143|NCT02879747|20030083|P1|STARTED|Overall Study||27
8126144|NCT02879032|20030100|P1|NOT COMPLETED|Overall Study||0
8126145|NCT02879032|20030100|P1|COMPLETED|Overall Study||130
8126146|NCT02879032|20030100|P1|STARTED|Overall Study||130
8126147|NCT02878590|20030106|P1|NOT COMPLETED|Overall Study||2
8126148|NCT02878590|20030106|P1|COMPLETED|Overall Study||10
8126149|NCT02878590|20030106|P1|STARTED|Overall Study||12
8126150|NCT02878486|20030112|P2|NOT COMPLETED|Overall Study||0
8126151|NCT02878486|20030113|P1|NOT COMPLETED|Overall Study||0
8126152|NCT02878486|20030112|P2|COMPLETED|Overall Study||3
8126153|NCT02878486|20030113|P1|COMPLETED|Overall Study||3
8126154|NCT02878486|20030112|P2|STARTED|Overall Study||3
8126155|NCT02878486|20030113|P1|STARTED|Overall Study||3
8126156|NCT02878382|20030129|P2|NOT COMPLETED|Overall Study||0
8126157|NCT02878382|20030130|P1|NOT COMPLETED|Overall Study||0
8126158|NCT02878382|20030129|P2|COMPLETED|Overall Study||20
8126159|NCT02878382|20030130|P1|COMPLETED|Overall Study||20
8126160|NCT02878382|20030129|P2|STARTED|Overall Study|otal 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
8126161|NCT02878382|20030130|P1|STARTED|Overall Study|total 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
8126162|NCT02878330|20030144|P2|NOT COMPLETED|Overall Study||56
8126163|NCT02878330|20030145|P1|NOT COMPLETED|Overall Study||29
8126164|NCT02878330|20030144|P2|COMPLETED|Overall Study||913
8126165|NCT02878330|20030145|P1|COMPLETED|Overall Study||455
8126166|NCT02878330|20030144|P2|STARTED|Overall Study||969
8126167|NCT02878330|20030145|P1|STARTED|Overall Study||484
8126168|NCT02878213|20030161|P1|NOT COMPLETED|Overall Study||3
8126169|NCT02878213|20030161|P1|COMPLETED|Overall Study||36
8126170|NCT02878213|20030161|P1|STARTED|Overall Study||39
8126171|NCT02878057|20030166|P1|NOT COMPLETED|Overall Study||4
8126172|NCT02878057|20030166|P1|COMPLETED|Overall Study||26
8126173|NCT02878057|20030166|P1|STARTED|Overall Study||30
8126174|NCT02877927|20030176|P2|NOT COMPLETED|Overall Study||57
8126175|NCT02877927|20030177|P1|NOT COMPLETED|Overall Study||54
8126176|NCT02877927|20030176|P2|COMPLETED|Overall Study||310
8126177|NCT02877927|20030177|P1|COMPLETED|Overall Study||314
8126178|NCT02877927|20030176|P2|STARTED|Overall Study||367
8126179|NCT02877927|20030177|P1|STARTED|Overall Study||368
8126180|NCT02877732|20030189|P2|NOT COMPLETED|Overall Study||6
8126181|NCT02877732|20030190|P1|NOT COMPLETED|Overall Study||6
8126182|NCT02877732|20030189|P2|COMPLETED|Overall Study||0
8126183|NCT02877732|20030190|P1|COMPLETED|Overall Study||0
8126184|NCT02877732|20030189|P2|STARTED|Overall Study||6
8126185|NCT02877732|20030190|P1|STARTED|Overall Study||6
8126186|NCT02877680|20030208|P2|NOT COMPLETED|Overall Study||1
8126187|NCT02877680|20030209|P1|NOT COMPLETED|Overall Study||1
8126188|NCT02877680|20030208|P2|COMPLETED|Overall Study||24
8126189|NCT02877680|20030209|P1|COMPLETED|Overall Study||54
8126190|NCT02877680|20030208|P2|STARTED|Overall Study||25
8126191|NCT02877680|20030209|P1|STARTED|Overall Study||55
8126192|NCT02877485|20030250|P2|NOT COMPLETED|Overall Study||0
8126193|NCT02877485|20030251|P1|NOT COMPLETED|Overall Study||0
8126194|NCT02877485|20030250|P2|COMPLETED|Overall Study||20
8126195|NCT02877485|20030251|P1|COMPLETED|Overall Study||22
8126196|NCT02877485|20030250|P2|STARTED|Overall Study||20
8126197|NCT02877485|20030251|P1|STARTED|Overall Study||22
8126198|NCT02877095|20030260|P2|NOT COMPLETED|Overall Study||0
8126199|NCT02877095|20030261|P1|NOT COMPLETED|Overall Study||0
8126200|NCT02877095|20030260|P2|COMPLETED|Overall Study||20
8126201|NCT02877095|20030261|P1|COMPLETED|Overall Study||20
8126202|NCT02877095|20030260|P2|STARTED|Overall Study||20
8126203|NCT02877095|20030261|P1|STARTED|Overall Study|First patient enrolled 1/9/17.|20
8126204|NCT02877082|20030267|P1|NOT COMPLETED|Overall Study||5
8126205|NCT02877082|20030267|P1|COMPLETED|Overall Study||0
8126206|NCT02877082|20030267|P1|STARTED|Overall Study||5
8126207|NCT02877004|20030278|P3|NOT COMPLETED|Overall Study||1
8126208|NCT02877004|20030279|P2|NOT COMPLETED|Overall Study||0
8126209|NCT02877004|20030280|P1|NOT COMPLETED|Overall Study||0
8126210|NCT02877004|20030278|P3|COMPLETED|Overall Study||19
8126211|NCT02877004|20030279|P2|COMPLETED|Overall Study||20
8126212|NCT02877004|20030280|P1|COMPLETED|Overall Study||20
8126213|NCT02877004|20030278|P3|STARTED|Overall Study||20
8126214|NCT02877004|20030279|P2|STARTED|Overall Study||20
8126215|NCT02877004|20030280|P1|STARTED|Overall Study||20
8126216|NCT02876926|20030294|P3|NOT COMPLETED|Overall Study||20
8126217|NCT02876926|20030295|P2|NOT COMPLETED|Overall Study||19
8126218|NCT02876926|20030296|P1|NOT COMPLETED|Overall Study||18
8126219|NCT02876926|20030294|P3|COMPLETED|Overall Study||2
8126220|NCT02876926|20030295|P2|COMPLETED|Overall Study||3
8126221|NCT02876926|20030296|P1|COMPLETED|Overall Study||3
8126222|NCT02876926|20030294|P3|STARTED|Overall Study||22
8126223|NCT02876926|20030295|P2|STARTED|Overall Study||22
8126224|NCT02876926|20030296|P1|STARTED|Overall Study||21
8126225|NCT02876900|20030313|P3|NOT COMPLETED|Overall Study||44
8126226|NCT02876900|20030314|P2|NOT COMPLETED|Overall Study||48
8126227|NCT02876900|20030315|P1|NOT COMPLETED|Overall Study||39
8126228|NCT02876900|20030313|P3|COMPLETED|Overall Study||162
8126229|NCT02876900|20030314|P2|COMPLETED|Overall Study||158
8126230|NCT02876900|20030315|P1|COMPLETED|Overall Study||166
8126231|NCT02876900|20030313|P3|STARTED|Overall Study||206
8126232|NCT02876900|20030314|P2|STARTED|Overall Study||206
8126233|NCT02876900|20030315|P1|STARTED|Overall Study||205
8126234|NCT02876887|20030328|P2|NOT COMPLETED|Overall Study||0
8126235|NCT02876887|20030329|P1|NOT COMPLETED|Overall Study||4
8126236|NCT02876887|20030328|P2|COMPLETED|Overall Study||21
8126237|NCT02876887|20030329|P1|COMPLETED|Overall Study||19
8126238|NCT02876887|20030328|P2|STARTED|Overall Study||21
8126239|NCT02876887|20030329|P1|STARTED|Overall Study||23
8126240|NCT02876757|20030349|P2|NOT COMPLETED|Overall Study||0
8126241|NCT02876757|20030350|P1|NOT COMPLETED|Overall Study||0
8126242|NCT02876757|20030349|P2|COMPLETED|Overall Study||93197
8126243|NCT02876757|20030350|P1|COMPLETED|Overall Study||93197
8126244|NCT02876757|20030349|P2|STARTED|Overall Study||93197
8126245|NCT02876757|20030350|P1|STARTED|Overall Study||93197
8126246|NCT02876601|20030364|P4|NOT COMPLETED|Second Intervention (24 Hours)||0
8126247|NCT02876601|20030365|P3|NOT COMPLETED|Second Intervention (24 Hours)||0
8126248|NCT02876601|20030366|P2|NOT COMPLETED|Second Intervention (24 Hours)||0
8126249|NCT02876601|20030367|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
8126250|NCT02876601|20030364|P4|COMPLETED|Second Intervention (24 Hours)||2
8126251|NCT02876601|20030365|P3|COMPLETED|Second Intervention (24 Hours)||1
8126252|NCT02876601|20030366|P2|COMPLETED|Second Intervention (24 Hours)||8
8126253|NCT02876601|20030367|P1|COMPLETED|Second Intervention (24 Hours)||8
8126254|NCT02876601|20030364|P4|STARTED|Second Intervention (24 Hours)||2
8126255|NCT02876601|20030365|P3|STARTED|Second Intervention (24 Hours)||1
8126256|NCT02876601|20030366|P2|STARTED|Second Intervention (24 Hours)||8
8126257|NCT02876601|20030367|P1|STARTED|Second Intervention (24 Hours)||8
8126258|NCT02876601|20030364|P4|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
8126259|NCT02876601|20030365|P3|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1
8126260|NCT02876601|20030366|P2|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
8126261|NCT02876601|20030367|P1|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
8126262|NCT02876601|20030364|P4|COMPLETED|Washout (Minimum of 6 Weeks)||2
8126263|NCT02876601|20030365|P3|COMPLETED|Washout (Minimum of 6 Weeks)||1
8126264|NCT02876601|20030366|P2|COMPLETED|Washout (Minimum of 6 Weeks)||8
8126265|NCT02876601|20030367|P1|COMPLETED|Washout (Minimum of 6 Weeks)||8
8126266|NCT02876601|20030364|P4|STARTED|Washout (Minimum of 6 Weeks)||2
8126267|NCT02876601|20030365|P3|STARTED|Washout (Minimum of 6 Weeks)||2
8126268|NCT02876601|20030366|P2|STARTED|Washout (Minimum of 6 Weeks)||8
8126269|NCT02876601|20030367|P1|STARTED|Washout (Minimum of 6 Weeks)||8
8126270|NCT02876601|20030364|P4|NOT COMPLETED|First Intervention (24 Hours)||0
8126271|NCT02876601|20030365|P3|NOT COMPLETED|First Intervention (24 Hours)||0
8126272|NCT02876601|20030366|P2|NOT COMPLETED|First Intervention (24 Hours)||0
8126273|NCT02876601|20030367|P1|NOT COMPLETED|First Intervention (24 Hours)||0
8126274|NCT02876601|20030364|P4|COMPLETED|First Intervention (24 Hours)||2
8126275|NCT02876601|20030365|P3|COMPLETED|First Intervention (24 Hours)||2
8126276|NCT02876601|20030366|P2|COMPLETED|First Intervention (24 Hours)||8
8126277|NCT02876601|20030367|P1|COMPLETED|First Intervention (24 Hours)||8
8126278|NCT02876601|20030364|P4|STARTED|First Intervention (24 Hours)||2
8126279|NCT02876601|20030365|P3|STARTED|First Intervention (24 Hours)||2
8126280|NCT02876601|20030366|P2|STARTED|First Intervention (24 Hours)||8
8126281|NCT02876601|20030367|P1|STARTED|First Intervention (24 Hours)||8
8126282|NCT02876575|20030417|P1|NOT COMPLETED|Overall Study||0
8126283|NCT02876575|20030417|P1|COMPLETED|Overall Study||48
8126284|NCT02876575|20030417|P1|STARTED|Overall Study||48
8126285|NCT02876159|20030433|P2|NOT COMPLETED|Overall Study||0
8126286|NCT02876159|20030434|P1|NOT COMPLETED|Overall Study||0
8126287|NCT02876159|20030433|P2|COMPLETED|Overall Study||10
8126288|NCT02876159|20030434|P1|COMPLETED|Overall Study||10
8126289|NCT02876159|20030433|P2|STARTED|Overall Study||10
8126290|NCT02876159|20030434|P1|STARTED|Overall Study||10
8126291|NCT02876055|20030453|P3|NOT COMPLETED|Overall Study||0
8126292|NCT02876055|20030454|P2|NOT COMPLETED|Overall Study||0
8126293|NCT02876055|20030455|P1|NOT COMPLETED|Overall Study||0
8126294|NCT02876055|20030453|P3|COMPLETED|Overall Study||42
8126295|NCT02876055|20030454|P2|COMPLETED|Overall Study||41
8126296|NCT02876055|20030455|P1|COMPLETED|Overall Study||42
8126297|NCT02876055|20030453|P3|STARTED|Overall Study||42
8126298|NCT02876055|20030454|P2|STARTED|Overall Study||41
8126299|NCT02876055|20030455|P1|STARTED|Overall Study||42
8126300|NCT02875977|20030465|P2|NOT COMPLETED|Overall Study||29
8126301|NCT02875977|20030466|P1|NOT COMPLETED|Overall Study||42
8126302|NCT02875977|20030465|P2|COMPLETED|Overall Study||71
8126303|NCT02875977|20030466|P1|COMPLETED|Overall Study||58
8126304|NCT02875977|20030465|P2|STARTED|Overall Study||100
8126305|NCT02875977|20030466|P1|STARTED|Overall Study||100
8126306|NCT02875834|20030484|P4|NOT COMPLETED|Randomized Treatment Phase||9
8126307|NCT02875834|20030485|P3|NOT COMPLETED|Randomized Treatment Phase||11
8126308|NCT02875834|20030486|P2|NOT COMPLETED|Randomized Treatment Phase||14
8126309|NCT02875834|20030487|P1|NOT COMPLETED|Randomized Treatment Phase||0
8126310|NCT02875834|20030484|P4|COMPLETED|Randomized Treatment Phase||41
8126311|NCT02875834|20030485|P3|COMPLETED|Randomized Treatment Phase||88
8126312|NCT02875834|20030486|P2|COMPLETED|Randomized Treatment Phase||85
8126313|NCT02875834|20030487|P1|COMPLETED|Randomized Treatment Phase||0
8126314|NCT02875834|20030484|P4|STARTED|Randomized Treatment Phase|50 subjects were randomized in placebo group in RTP.|50
8126406|NCT02874066|20030812|P1|COMPLETED|Overall Study||46
8126315|NCT02875834|20030485|P3|STARTED|Randomized Treatment Phase|99 subjects were randomized in 10g QD group in RTP.|99
8126316|NCT02875834|20030486|P2|STARTED|Randomized Treatment Phase|99 subjects were randomized in 5g QD group in RTP.|99
8126317|NCT02875834|20030487|P1|STARTED|Randomized Treatment Phase|No subjects were randomized in 10g TID group in RTP.|0
8126318|NCT02875834|20030484|P4|NOT COMPLETED|Open-label Phase||0
8126319|NCT02875834|20030485|P3|NOT COMPLETED|Open-label Phase||0
8126320|NCT02875834|20030486|P2|NOT COMPLETED|Open-label Phase||0
8126321|NCT02875834|20030487|P1|NOT COMPLETED|Open-label Phase||7
8126322|NCT02875834|20030484|P4|COMPLETED|Open-label Phase||0
8126323|NCT02875834|20030485|P3|COMPLETED|Open-label Phase||0
8126324|NCT02875834|20030486|P2|COMPLETED|Open-label Phase||0
8126325|NCT02875834|20030487|P1|COMPLETED|Open-label Phase||260
8126326|NCT02875834|20030484|P4|STARTED|Open-label Phase||0
8126327|NCT02875834|20030485|P3|STARTED|Open-label Phase||0
8126328|NCT02875834|20030486|P2|STARTED|Open-label Phase||0
8126329|NCT02875834|20030487|P1|STARTED|Open-label Phase||267
8126330|NCT02875613|20030545|P1|NOT COMPLETED|Overall Study||1
8126331|NCT02875613|20030545|P1|COMPLETED|Overall Study||4
8126332|NCT02875613|20030545|P1|STARTED|Overall Study||5
8126333|NCT02875366|20030551|P2|NOT COMPLETED|Overall Study||3
8126334|NCT02875366|20030552|P1|NOT COMPLETED|Overall Study||0
8126335|NCT02875366|20030551|P2|COMPLETED|Overall Study||31
8126336|NCT02875366|20030552|P1|COMPLETED|Overall Study||36
8126337|NCT02875366|20030551|P2|STARTED|Overall Study||34
8126338|NCT02875366|20030552|P1|STARTED|Overall Study||36
8126339|NCT02875340|20030604|P1|NOT COMPLETED|Overall Study||8
8126340|NCT02875340|20030604|P1|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
8126341|NCT02875340|20030604|P1|STARTED|Overall Study||8
8126342|NCT02875067|20030626|P1|NOT COMPLETED|Overall Study||6
8126343|NCT02875067|20030626|P1|COMPLETED|Overall Study||0
8126344|NCT02875067|20030626|P1|STARTED|Overall Study||6
8126345|NCT02875028|20030641|P2|NOT COMPLETED|Second Intervention (24 Hours)||0
8126346|NCT02875028|20030642|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
8126347|NCT02875028|20030641|P2|COMPLETED|Second Intervention (24 Hours)||7
8126348|NCT02875028|20030642|P1|COMPLETED|Second Intervention (24 Hours)||8
8126349|NCT02875028|20030641|P2|STARTED|Second Intervention (24 Hours)||7
8126350|NCT02875028|20030642|P1|STARTED|Second Intervention (24 Hours)||8
8126351|NCT02875028|20030641|P2|NOT COMPLETED|Washout Period||1
8126352|NCT02875028|20030642|P1|NOT COMPLETED|Washout Period||0
8126353|NCT02875028|20030641|P2|COMPLETED|Washout Period||7
8126354|NCT02875028|20030642|P1|COMPLETED|Washout Period||8
8126355|NCT02875028|20030641|P2|STARTED|Washout Period||8
8126356|NCT02875028|20030642|P1|STARTED|Washout Period||8
8126357|NCT02875028|20030641|P2|NOT COMPLETED|First Intervention (24 Hours)||0
8126358|NCT02875028|20030642|P1|NOT COMPLETED|First Intervention (24 Hours)||0
8126359|NCT02875028|20030641|P2|COMPLETED|First Intervention (24 Hours)||8
8126360|NCT02875028|20030642|P1|COMPLETED|First Intervention (24 Hours)||8
8126361|NCT02875028|20030641|P2|STARTED|First Intervention (24 Hours)||8
8126362|NCT02875028|20030642|P1|STARTED|First Intervention (24 Hours)||8
8126363|NCT02874924|20030673|P3|NOT COMPLETED|Overall Study||0
8126364|NCT02874924|20030674|P2|NOT COMPLETED|Overall Study||0
8126365|NCT02874924|20030675|P1|NOT COMPLETED|Overall Study||3
8126366|NCT02874924|20030673|P3|COMPLETED|Overall Study||6
8126367|NCT02874924|20030674|P2|COMPLETED|Overall Study||14
8126368|NCT02874924|20030675|P1|COMPLETED|Overall Study||11
8126369|NCT02874924|20030673|P3|STARTED|Overall Study||6
8126370|NCT02874924|20030674|P2|STARTED|Overall Study||14
8126371|NCT02874924|20030675|P1|STARTED|Overall Study||14
8126372|NCT02874846|20030697|P2|NOT COMPLETED|Overall Study||0
8126373|NCT02874846|20030698|P1|NOT COMPLETED|Overall Study||0
8126374|NCT02874846|20030697|P2|COMPLETED|Overall Study||4
8126375|NCT02874846|20030698|P1|COMPLETED|Overall Study||8
8126376|NCT02874846|20030697|P2|STARTED|Overall Study||4
8126377|NCT02874846|20030698|P1|STARTED|Overall Study||8
8126378|NCT02874794|20030708|P2|NOT COMPLETED|Overall Study||11
8126379|NCT02874794|20030709|P1|NOT COMPLETED|Overall Study||7
8126380|NCT02874794|20030708|P2|COMPLETED|Overall Study||221
8126381|NCT02874794|20030709|P1|COMPLETED|Overall Study||226
8126382|NCT02874794|20030708|P2|STARTED|Overall Study||232
8126383|NCT02874794|20030709|P1|STARTED|Overall Study||233
8126396|NCT02874534|20030797|P2|NOT COMPLETED|Overall Study||11
8126397|NCT02874534|20030798|P1|NOT COMPLETED|Overall Study||8
8126398|NCT02874534|20030797|P2|COMPLETED|Overall Study||15
8126399|NCT02874534|20030798|P1|COMPLETED|Overall Study||23
8126400|NCT02874534|20030797|P2|STARTED|Overall Study||26
8126401|NCT02874534|20030798|P1|STARTED|Overall Study||31
8126402|NCT02874404|20030806|P1|NOT COMPLETED|Overall Study||0
8126403|NCT02874404|20030806|P1|COMPLETED|Overall Study||13
8126404|NCT02874404|20030806|P1|STARTED|Overall Study||13
8126405|NCT02874066|20030812|P1|NOT COMPLETED|Overall Study||0
8126407|NCT02874066|20030812|P1|STARTED|Overall Study||46
8126417|NCT02873923|20030953|P1|NOT COMPLETED|Overall Study||0
8126418|NCT02873923|20030953|P1|COMPLETED|Overall Study||2846
8126419|NCT02873923|20030953|P1|STARTED|Overall Study||2846
8126420|NCT02873754|20030960|P1|NOT COMPLETED|Overall Study||6
8126421|NCT02873754|20030960|P1|COMPLETED|Overall Study||5
8126422|NCT02873754|20030960|P1|STARTED|Overall Study||11
8126423|NCT02873702|20030977|P4|NOT COMPLETED|Maintenance Period (up to Month 6)||2
8126424|NCT02873702|20030978|P3|NOT COMPLETED|Maintenance Period (up to Month 6)||7
8126425|NCT02873702|20030979|P2|NOT COMPLETED|Maintenance Period (up to Month 6)||0
8126426|NCT02873702|20030980|P1|NOT COMPLETED|Maintenance Period (up to Month 6)||0
8126427|NCT02873702|20030977|P4|COMPLETED|Maintenance Period (up to Month 6)||6
8126428|NCT02873702|20030978|P3|COMPLETED|Maintenance Period (up to Month 6)||1
8126429|NCT02873702|20030979|P2|COMPLETED|Maintenance Period (up to Month 6)||0
8126430|NCT02873702|20030980|P1|COMPLETED|Maintenance Period (up to Month 6)||0
8126431|NCT02873702|20030977|P4|STARTED|Maintenance Period (up to Month 6)||8
8126432|NCT02873702|20030978|P3|STARTED|Maintenance Period (up to Month 6)||8
8126433|NCT02873702|20030979|P2|STARTED|Maintenance Period (up to Month 6)||0
8126434|NCT02873702|20030980|P1|STARTED|Maintenance Period (up to Month 6)||0
8126435|NCT02873702|20030977|P4|NOT COMPLETED|Healing Period (up to Week 8)||0
8126436|NCT02873702|20030978|P3|NOT COMPLETED|Healing Period (up to Week 8)||0
8126437|NCT02873702|20030979|P2|NOT COMPLETED|Healing Period (up to Week 8)||1
8126438|NCT02873702|20030980|P1|NOT COMPLETED|Healing Period (up to Week 8)||1
8126439|NCT02873702|20030977|P4|COMPLETED|Healing Period (up to Week 8)||0
8126440|NCT02873702|20030978|P3|COMPLETED|Healing Period (up to Week 8)||0
8126441|NCT02873702|20030979|P2|COMPLETED|Healing Period (up to Week 8)||16
8126442|NCT02873702|20030980|P1|COMPLETED|Healing Period (up to Week 8)||19
8126443|NCT02873702|20030977|P4|STARTED|Healing Period (up to Week 8)||0
8126444|NCT02873702|20030978|P3|STARTED|Healing Period (up to Week 8)||0
8126445|NCT02873702|20030979|P2|STARTED|Healing Period (up to Week 8)||17
8126446|NCT02873702|20030980|P1|STARTED|Healing Period (up to Week 8)||20
8126447|NCT02873689|20030992|P2|NOT COMPLETED|Overall Study||5
8126448|NCT02873689|20030993|P1|NOT COMPLETED|Overall Study||7
8126449|NCT02873689|20030992|P2|COMPLETED|Overall Study||103
8126450|NCT02873689|20030993|P1|COMPLETED|Overall Study||102
8126451|NCT02873689|20030992|P2|Treated|Overall Study||107
8126452|NCT02873689|20030993|P1|Treated|Overall Study||108
8126453|NCT02873689|20030992|P2|STARTED|Overall Study||108
8126454|NCT02873689|20030993|P1|STARTED|Overall Study||109
8126455|NCT02873585|20031001|P1|NOT COMPLETED|Overall Study||0
8126456|NCT02873585|20031001|P1|COMPLETED|Overall Study||32
8126457|NCT02873585|20031001|P1|STARTED|Overall Study||32
8126458|NCT02873481|20031016|P2|NOT COMPLETED|Overall Study||0
8126459|NCT02873481|20031017|P1|NOT COMPLETED|Overall Study||0
8126460|NCT02873481|20031016|P2|COMPLETED|Overall Study||17
8126461|NCT02873481|20031017|P1|COMPLETED|Overall Study||15
8126462|NCT02873481|20031016|P2|STARTED|Overall Study||17
8126463|NCT02873481|20031017|P1|STARTED|Overall Study||15
8126464|NCT02873429|20031034|P2|NOT COMPLETED|16 Weeks||2
8126465|NCT02873429|20031035|P1|NOT COMPLETED|16 Weeks||5
8126466|NCT02873429|20031034|P2|COMPLETED|16 Weeks||96
8126467|NCT02873429|20031035|P1|COMPLETED|16 Weeks||100
8126468|NCT02873429|20031034|P2|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
8126469|NCT02873429|20031035|P1|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
8126470|NCT02873429|20031034|P2|NOT COMPLETED|6-8 Weeks||1
8126471|NCT02873429|20031035|P1|NOT COMPLETED|6-8 Weeks||10
8126472|NCT02873429|20031034|P2|COMPLETED|6-8 Weeks||97
8126473|NCT02873429|20031035|P1|COMPLETED|6-8 Weeks||95
8126474|NCT02873429|20031034|P2|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
8126475|NCT02873429|20031035|P1|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
8126476|NCT02873429|20031034|P2|NOT COMPLETED|Baseline||0
8126477|NCT02873429|20031035|P1|NOT COMPLETED|Baseline||0
8126478|NCT02873429|20031034|P2|COMPLETED|Baseline||100
8126479|NCT02873429|20031035|P1|COMPLETED|Baseline||109
8126480|NCT02873429|20031034|P2|STARTED|Baseline||100
8126481|NCT02873429|20031035|P1|STARTED|Baseline||109
8126482|NCT02873377|20031047|P2|NOT COMPLETED|Period Title 3: 6 Months Follow up||23
8126483|NCT02873377|20031048|P1|NOT COMPLETED|Period Title 3: 6 Months Follow up||15
8126484|NCT02873377|20031047|P2|COMPLETED|Period Title 3: 6 Months Follow up||46
8126485|NCT02873377|20031048|P1|COMPLETED|Period Title 3: 6 Months Follow up||50
8126486|NCT02873377|20031047|P2|STARTED|Period Title 3: 6 Months Follow up||69
8126487|NCT02873377|20031048|P1|STARTED|Period Title 3: 6 Months Follow up||65
8126488|NCT02873377|20031047|P2|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
8126489|NCT02873377|20031048|P1|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
8126490|NCT02873377|20031047|P2|COMPLETED|Period Title 2: 3 Months Follow up||47
8126491|NCT02873377|20031048|P1|COMPLETED|Period Title 2: 3 Months Follow up||43
8126492|NCT02873377|20031047|P2|STARTED|Period Title 2: 3 Months Follow up||69
8126493|NCT02873377|20031048|P1|STARTED|Period Title 2: 3 Months Follow up||65
8126494|NCT02873377|20031047|P2|NOT COMPLETED|Period 1: Enrollment||0
8126495|NCT02873377|20031048|P1|NOT COMPLETED|Period 1: Enrollment||0
8126496|NCT02873377|20031047|P2|COMPLETED|Period 1: Enrollment||69
8126497|NCT02873377|20031048|P1|COMPLETED|Period 1: Enrollment||65
8126498|NCT02873377|20031047|P2|STARTED|Period 1: Enrollment||69
8126499|NCT02873377|20031048|P1|STARTED|Period 1: Enrollment||65
8126500|NCT02873286|20031072|P5|NOT COMPLETED|Booster Substudy||0
8126501|NCT02873286|20031073|P4|NOT COMPLETED|Booster Substudy||0
8126502|NCT02873286|20031074|P3|NOT COMPLETED|Booster Substudy||0
8126503|NCT02873286|20031075|P2|NOT COMPLETED|Booster Substudy||0
8126504|NCT02873286|20031076|P1|NOT COMPLETED|Booster Substudy||0
8126505|NCT02873286|20031072|P5|COMPLETED|Booster Substudy||0
8126506|NCT02873286|20031073|P4|COMPLETED|Booster Substudy||0
8126507|NCT02873286|20031074|P3|COMPLETED|Booster Substudy||45
8126508|NCT02873286|20031075|P2|COMPLETED|Booster Substudy||0
8126509|NCT02873286|20031076|P1|COMPLETED|Booster Substudy||43
8126510|NCT02873286|20031072|P5|STARTED|Booster Substudy||0
8126511|NCT02873286|20031073|P4|STARTED|Booster Substudy||0
8126512|NCT02873286|20031074|P3|STARTED|Booster Substudy||45
8126513|NCT02873286|20031075|P2|STARTED|Booster Substudy||0
8126514|NCT02873286|20031076|P1|STARTED|Booster Substudy||43
8126515|NCT02873286|20031072|P5|NOT COMPLETED|Main Study||2
8126516|NCT02873286|20031073|P4|NOT COMPLETED|Main Study||1
8126517|NCT02873286|20031074|P3|NOT COMPLETED|Main Study||2
8126518|NCT02873286|20031075|P2|NOT COMPLETED|Main Study||5
8126519|NCT02873286|20031076|P1|NOT COMPLETED|Main Study||2
8126520|NCT02873286|20031072|P5|COMPLETED|Main Study||81
8126521|NCT02873286|20031073|P4|COMPLETED|Main Study||89
8126522|NCT02873286|20031074|P3|COMPLETED|Main Study||78
8126523|NCT02873286|20031075|P2|COMPLETED|Main Study||84
8126524|NCT02873286|20031076|P1|COMPLETED|Main Study||76
8126525|NCT02873286|20031072|P5|STARTED|Main Study||83
8126526|NCT02873286|20031073|P4|STARTED|Main Study||90
8126527|NCT02873286|20031074|P3|STARTED|Main Study||80
8126528|NCT02873286|20031075|P2|STARTED|Main Study||89
8126529|NCT02873286|20031076|P1|STARTED|Main Study||78
8126530|NCT02873221|20031306|P3|NOT COMPLETED|Safety Follow-up Period||14
8126531|NCT02873221|20031307|P2|NOT COMPLETED|Safety Follow-up Period||17
8126532|NCT02873221|20031308|P1|NOT COMPLETED|Safety Follow-up Period||7
8126533|NCT02873221|20031306|P3|COMPLETED|Safety Follow-up Period||350
8126534|NCT02873221|20031307|P2|COMPLETED|Safety Follow-up Period||339
8126535|NCT02873221|20031308|P1|COMPLETED|Safety Follow-up Period||343
8126536|NCT02873221|20031306|P3|STARTED|Safety Follow-up Period||364
8126537|NCT02873221|20031307|P2|STARTED|Safety Follow-up Period||356
8126538|NCT02873221|20031308|P1|STARTED|Safety Follow-up Period||350
8126539|NCT02873221|20031306|P3|NOT COMPLETED|Treatment Period||105
8126540|NCT02873221|20031307|P2|NOT COMPLETED|Treatment Period||126
8126541|NCT02873221|20031308|P1|NOT COMPLETED|Treatment Period||88
8126542|NCT02873221|20031306|P3|COMPLETED|Treatment Period||315
8126543|NCT02873221|20031307|P2|COMPLETED|Treatment Period||291
8126544|NCT02873221|20031308|P1|COMPLETED|Treatment Period||329
8126545|NCT02873221|20031306|P3|Safety Population: Received Study Drug|Treatment Period||409
8126546|NCT02873221|20031307|P2|Safety Population: Received Study Drug|Treatment Period||404
8126547|NCT02873221|20031308|P1|Safety Population: Received Study Drug|Treatment Period||417
8126548|NCT02873221|20031306|P3|STARTED|Treatment Period||420
8126549|NCT02873221|20031307|P2|STARTED|Treatment Period||417
8126550|NCT02873221|20031308|P1|STARTED|Treatment Period||417
8126559|NCT02873104|20031345|P2|NOT COMPLETED|Overall Study||0
8126560|NCT02873104|20031346|P1|NOT COMPLETED|Overall Study||1
8126561|NCT02873104|20031345|P2|COMPLETED|Overall Study||23
8126562|NCT02873104|20031346|P1|COMPLETED|Overall Study||46
8126563|NCT02873104|20031345|P2|STARTED|Overall Study||23
8126564|NCT02873104|20031346|P1|STARTED|Overall Study||47
8126565|NCT02872935|20031360|P2|NOT COMPLETED|Overall Study||1
8126566|NCT02872935|20031361|P1|NOT COMPLETED|Overall Study||0
8126567|NCT02872935|20031360|P2|COMPLETED|Overall Study|One subject consented but did no proceed with the study.|10
8126568|NCT02872935|20031361|P1|COMPLETED|Overall Study||11
8126569|NCT02872935|20031360|P2|STARTED|Overall Study||11
8126570|NCT02872935|20031361|P1|STARTED|Overall Study||11
8126571|NCT02872909|20031371|P2|NOT COMPLETED|Overall Study||0
8126572|NCT02872909|20031372|P1|NOT COMPLETED|Overall Study||0
8126573|NCT02872909|20031371|P2|COMPLETED|Overall Study||18
8126574|NCT02872909|20031372|P1|COMPLETED|Overall Study||32
8126575|NCT02872909|20031371|P2|STARTED|Overall Study||18
8126576|NCT02872909|20031372|P1|STARTED|Overall Study||32
8126577|NCT02872311|20031389|P5|NOT COMPLETED|Overall Study||0
8126578|NCT02872311|20031390|P4|NOT COMPLETED|Overall Study||0
8126579|NCT02872311|20031391|P3|NOT COMPLETED|Overall Study||1
8126580|NCT02872311|20031392|P2|NOT COMPLETED|Overall Study||2
8126581|NCT02872311|20031393|P1|NOT COMPLETED|Overall Study||4
8126582|NCT02872311|20031389|P5|COMPLETED|Overall Study||20
8126583|NCT02872311|20031390|P4|COMPLETED|Overall Study||20
8126584|NCT02872311|20031391|P3|COMPLETED|Overall Study||19
8126585|NCT02872311|20031392|P2|COMPLETED|Overall Study||58
8126586|NCT02872311|20031393|P1|COMPLETED|Overall Study||55
8126587|NCT02872311|20031389|P5|STARTED|Overall Study||20
8126588|NCT02872311|20031390|P4|STARTED|Overall Study||20
8126589|NCT02872311|20031391|P3|STARTED|Overall Study||20
8126590|NCT02872311|20031392|P2|STARTED|Overall Study||60
8126591|NCT02872311|20031393|P1|STARTED|Overall Study||59
8126592|NCT02872285|20031454|P2|NOT COMPLETED|Overall Study||2
8126593|NCT02872285|20031455|P1|NOT COMPLETED|Overall Study||5
8126594|NCT02872285|20031454|P2|COMPLETED|Overall Study||9
8126595|NCT02872285|20031455|P1|COMPLETED|Overall Study||17
8126596|NCT02872285|20031454|P2|STARTED|Overall Study||11
8126597|NCT02872285|20031455|P1|STARTED|Overall Study||22
8126610|NCT02872012|20031501|P5|NOT COMPLETED|Overall Study||0
8126611|NCT02872012|20031502|P4|NOT COMPLETED|Overall Study||0
8126612|NCT02872012|20031503|P3|NOT COMPLETED|Overall Study||0
8126613|NCT02872012|20031504|P2|NOT COMPLETED|Overall Study||0
8126614|NCT02872012|20031505|P1|NOT COMPLETED|Overall Study||1
8126615|NCT02872012|20031501|P5|COMPLETED|Overall Study||5
8126616|NCT02872012|20031502|P4|COMPLETED|Overall Study||3
8126617|NCT02872012|20031503|P3|COMPLETED|Overall Study||4
8126618|NCT02872012|20031504|P2|COMPLETED|Overall Study||7
8126619|NCT02872012|20031505|P1|COMPLETED|Overall Study||3
8126620|NCT02872012|20031501|P5|STARTED|Overall Study||5
8126621|NCT02872012|20031502|P4|STARTED|Overall Study||3
8126622|NCT02872012|20031503|P3|STARTED|Overall Study||4
8126623|NCT02872012|20031504|P2|STARTED|Overall Study||7
8126624|NCT02872012|20031505|P1|STARTED|Overall Study||4
8126625|NCT02871739|20031523|P4|NOT COMPLETED|Overall Study||2
8126626|NCT02871739|20031524|P3|NOT COMPLETED|Overall Study||0
8126627|NCT02871739|20031525|P2|NOT COMPLETED|Overall Study||2
8126628|NCT02871739|20031526|P1|NOT COMPLETED|Overall Study||3
8126629|NCT02871739|20031523|P4|COMPLETED|Overall Study||5
8126630|NCT02871739|20031524|P3|COMPLETED|Overall Study||4
8126631|NCT02871739|20031525|P2|COMPLETED|Overall Study||4
8126632|NCT02871739|20031526|P1|COMPLETED|Overall Study||3
8126633|NCT02871739|20031523|P4|Complete Final Survey|Overall Study||5
8126634|NCT02871739|20031524|P3|Complete Final Survey|Overall Study||4
8126635|NCT02871739|20031525|P2|Complete Final Survey|Overall Study||4
8126636|NCT02871739|20031526|P1|Complete Final Survey|Overall Study||3
8126637|NCT02871739|20031523|P4|Completed Second SPI|Overall Study||5
8126638|NCT02871739|20031524|P3|Completed Second SPI|Overall Study||4
8126639|NCT02871739|20031525|P2|Completed Second SPI|Overall Study||4
8126640|NCT02871739|20031526|P1|Completed Second SPI|Overall Study||3
8126641|NCT02871739|20031523|P4|Completed First SPI|Overall Study||6
8126642|NCT02871739|20031524|P3|Completed First SPI|Overall Study||4
8126643|NCT02871739|20031525|P2|Completed First SPI|Overall Study||5
8126644|NCT02871739|20031526|P1|Completed First SPI|Overall Study||3
8126645|NCT02871739|20031523|P4|STARTED|Overall Study||7
8126646|NCT02871739|20031524|P3|STARTED|Overall Study||4
8126647|NCT02871739|20031525|P2|STARTED|Overall Study||6
8126648|NCT02871739|20031526|P1|STARTED|Overall Study||6
8126649|NCT02871635|20031538|P2|NOT COMPLETED|Overall Study||19
8126650|NCT02871635|20031539|P1|NOT COMPLETED|Overall Study||18
8126651|NCT02871635|20031538|P2|COMPLETED|Overall Study||56
8126652|NCT02871635|20031539|P1|COMPLETED|Overall Study||54
8126653|NCT02871635|20031538|P2|STARTED|Overall Study||75
8126654|NCT02871635|20031539|P1|STARTED|Overall Study||72
8126655|NCT02871570|20031565|P2|NOT COMPLETED|Overall Study||0
8126656|NCT02871570|20031566|P1|NOT COMPLETED|Overall Study||0
8126657|NCT02871570|20031565|P2|COMPLETED|Overall Study||8
8126658|NCT02871570|20031566|P1|COMPLETED|Overall Study||8
8126659|NCT02871570|20031565|P2|STARTED|Overall Study||8
8126660|NCT02871570|20031566|P1|STARTED|Overall Study||8
8126661|NCT02871479|20031597|P3|NOT COMPLETED|Overall Study||0
8126662|NCT02871479|20031598|P2|NOT COMPLETED|Overall Study||3
8126663|NCT02871479|20031599|P1|NOT COMPLETED|Overall Study||3
8126664|NCT02871479|20031597|P3|COMPLETED|Overall Study||11
8126665|NCT02871479|20031598|P2|COMPLETED|Overall Study||21
8126666|NCT02871479|20031599|P1|COMPLETED|Overall Study||33
8126667|NCT02871479|20031597|P3|STARTED|Overall Study||11
8126668|NCT02871479|20031598|P2|STARTED|Overall Study||24
8126669|NCT02871479|20031599|P1|STARTED|Overall Study||36
8126670|NCT02871440|20031613|P3|NOT COMPLETED|Overall Study||0
8126671|NCT02871440|20031614|P2|NOT COMPLETED|Overall Study||0
8126672|NCT02871440|20031615|P1|NOT COMPLETED|Overall Study||0
8126673|NCT02871440|20031613|P3|COMPLETED|Overall Study||15
8126674|NCT02871440|20031614|P2|COMPLETED|Overall Study||13
8126675|NCT02871440|20031615|P1|COMPLETED|Overall Study||12
8126676|NCT02871440|20031613|P3|STARTED|Overall Study||15
8126677|NCT02871440|20031614|P2|STARTED|Overall Study||13
8126678|NCT02871440|20031615|P1|STARTED|Overall Study||12
8126679|NCT02871375|20031629|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
8126774|NCT02868242|20031901|P1|STARTED|Overall Study||19
8126680|NCT02871375|20031630|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
8126681|NCT02871375|20031629|P2|COMPLETED|Period 2, Second 14 Days of Wear||76
8126682|NCT02871375|20031630|P1|COMPLETED|Period 2, Second 14 Days of Wear||89
8126683|NCT02871375|20031629|P2|STARTED|Period 2, Second 14 Days of Wear||76
8126684|NCT02871375|20031630|P1|STARTED|Period 2, Second 14 Days of Wear||89
8126685|NCT02871375|20031629|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
8126686|NCT02871375|20031630|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||0
8126687|NCT02871375|20031629|P2|COMPLETED|Period 1, First 14 Days of Wear||76
8126688|NCT02871375|20031630|P1|COMPLETED|Period 1, First 14 Days of Wear||89
8126689|NCT02871375|20031629|P2|STARTED|Period 1, First 14 Days of Wear||77
8126690|NCT02871375|20031630|P1|STARTED|Period 1, First 14 Days of Wear||89
8126700|NCT02871011|20031657|P2|NOT COMPLETED|Overall Study||0
8126701|NCT02871011|20031658|P1|NOT COMPLETED|Overall Study||0
8126702|NCT02871011|20031657|P2|COMPLETED|Overall Study||13
8126703|NCT02871011|20031658|P1|COMPLETED|Overall Study||7
8126704|NCT02871011|20031657|P2|STARTED|Overall Study||13
8126705|NCT02871011|20031658|P1|STARTED|Overall Study||7
8126706|NCT02870933|20031676|P2|NOT COMPLETED|Overall Study||2
8126707|NCT02870933|20031677|P1|NOT COMPLETED|Overall Study||2
8126708|NCT02870933|20031676|P2|COMPLETED|Overall Study||13
8126709|NCT02870933|20031677|P1|COMPLETED|Overall Study||13
8126710|NCT02870933|20031676|P2|STARTED|Overall Study||15
8126711|NCT02870933|20031677|P1|STARTED|Overall Study||15
8126712|NCT02870920|20031701|P2|NOT COMPLETED|Overall Study||0
8126713|NCT02870920|20031702|P1|NOT COMPLETED|Overall Study||0
8126714|NCT02870920|20031701|P2|COMPLETED|Overall Study||119
8126715|NCT02870920|20031702|P1|COMPLETED|Overall Study||61
8126716|NCT02870920|20031701|P2|STARTED|Overall Study||119
8126717|NCT02870920|20031702|P1|STARTED|Overall Study||61
8126718|NCT02870283|20031715|P3|NOT COMPLETED|Overall Study||19
8126719|NCT02870283|20031716|P2|NOT COMPLETED|Overall Study||9
8126720|NCT02870283|20031717|P1|NOT COMPLETED|Overall Study||3
8126721|NCT02870283|20031715|P3|COMPLETED|Overall Study||15
8126722|NCT02870283|20031716|P2|COMPLETED|Overall Study||26
8126723|NCT02870283|20031717|P1|COMPLETED|Overall Study||35
8126724|NCT02870283|20031715|P3|STARTED|Overall Study||34
8126725|NCT02870283|20031716|P2|STARTED|Overall Study||35
8126726|NCT02870283|20031717|P1|STARTED|Overall Study||38
8126727|NCT02870205|20031735|P4|NOT COMPLETED|Overall Study||7
8126728|NCT02870205|20031736|P3|NOT COMPLETED|Overall Study||7
8126729|NCT02870205|20031737|P2|NOT COMPLETED|Overall Study||5
8126730|NCT02870205|20031738|P1|NOT COMPLETED|Overall Study||10
8126731|NCT02870205|20031735|P4|COMPLETED|Overall Study||287
8126732|NCT02870205|20031736|P3|COMPLETED|Overall Study||287
8126733|NCT02870205|20031737|P2|COMPLETED|Overall Study||289
8126734|NCT02870205|20031738|P1|COMPLETED|Overall Study||284
8126735|NCT02870205|20031735|P4|STARTED|Overall Study||294
8126736|NCT02870205|20031736|P3|STARTED|Overall Study||294
8126737|NCT02870205|20031737|P2|STARTED|Overall Study||294
8126738|NCT02870205|20031738|P1|STARTED|Overall Study||294
8126739|NCT02870101|20031748|P1|NOT COMPLETED|Overall Study||169
8126740|NCT02870101|20031748|P1|COMPLETED|Overall Study||2598
8126741|NCT02870101|20031748|P1|STARTED|Overall Study||2767
8126742|NCT02869893|20031763|P1|NOT COMPLETED|Overall Study||7
8126743|NCT02869893|20031763|P1|COMPLETED|Overall Study||50
8126744|NCT02869893|20031763|P1|STARTED|Overall Study||57
8126745|NCT02869451|20031769|P1|NOT COMPLETED|Overall Study||0
8126746|NCT02869451|20031769|P1|COMPLETED|Overall Study||5
8126747|NCT02869451|20031769|P1|STARTED|Overall Study||5
8126748|NCT02869438|20031793|P2|NOT COMPLETED|Overall Study||2
8126749|NCT02869438|20031794|P1|NOT COMPLETED|Overall Study||3
8126750|NCT02869438|20031793|P2|COMPLETED|Overall Study||113
8126751|NCT02869438|20031794|P1|COMPLETED|Overall Study||115
8126752|NCT02869438|20031793|P2|STARTED|Overall Study||115
8126753|NCT02869438|20031794|P1|STARTED|Overall Study||118
8126754|NCT02868892|20031842|P1|NOT COMPLETED|Overall Study||6
8126755|NCT02868892|20031842|P1|COMPLETED|Overall Study||0
8126756|NCT02868892|20031842|P1|STARTED|Overall Study||6
8126757|NCT02868554|20031851|P3|NOT COMPLETED|Overall Study||1
8126758|NCT02868554|20031852|P2|NOT COMPLETED|Overall Study||0
8126759|NCT02868554|20031853|P1|NOT COMPLETED|Overall Study||3
8126760|NCT02868554|20031851|P3|COMPLETED|Overall Study||11
8126761|NCT02868554|20031852|P2|COMPLETED|Overall Study||12
8126762|NCT02868554|20031853|P1|COMPLETED|Overall Study||7
8126763|NCT02868554|20031851|P3|STARTED|Overall Study||12
8126764|NCT02868554|20031852|P2|STARTED|Overall Study||12
8126765|NCT02868554|20031853|P1|STARTED|Overall Study||10
8126772|NCT02868242|20031901|P1|NOT COMPLETED|Overall Study||0
8126773|NCT02868242|20031901|P1|COMPLETED|Overall Study||19
8126775|NCT02868216|20031913|P2|NOT COMPLETED|Overall Study||6
8126776|NCT02868216|20031914|P1|NOT COMPLETED|Overall Study||8
8126777|NCT02868216|20031913|P2|COMPLETED|Overall Study||41
8126778|NCT02868216|20031914|P1|COMPLETED|Overall Study||35
8126779|NCT02868216|20031913|P2|STARTED|Overall Study||47
8126780|NCT02868216|20031914|P1|STARTED|Overall Study||43
8126781|NCT02867995|20031922|P2|NOT COMPLETED|Overall Study||3
8126782|NCT02867995|20031923|P1|NOT COMPLETED|Overall Study||0
8126783|NCT02867995|20031922|P2|COMPLETED|Overall Study|Total patients completed|27
8126784|NCT02867995|20031923|P1|COMPLETED|Overall Study|Total patients completed|9
8126785|NCT02867995|20031922|P2|STARTED|Overall Study|Total patients consented|30
8126786|NCT02867995|20031923|P1|STARTED|Overall Study|Total patients consented|9
8126787|NCT02867709|20031942|P3|NOT COMPLETED|Safety Follow-up Period||14
8126788|NCT02867709|20031943|P2|NOT COMPLETED|Safety Follow-up Period||15
8126789|NCT02867709|20031944|P1|NOT COMPLETED|Safety Follow-up Period||11
8126790|NCT02867709|20031942|P3|COMPLETED|Safety Follow-up Period||473
8126791|NCT02867709|20031943|P2|COMPLETED|Safety Follow-up Period||459
8126792|NCT02867709|20031944|P1|COMPLETED|Safety Follow-up Period||482
8126793|NCT02867709|20031942|P3|STARTED|Safety Follow-up Period||487
8126794|NCT02867709|20031943|P2|STARTED|Safety Follow-up Period||474
8126795|NCT02867709|20031944|P1|STARTED|Safety Follow-up Period||493
8126796|NCT02867709|20031942|P3|NOT COMPLETED|Treatment Period||75
8126797|NCT02867709|20031943|P2|NOT COMPLETED|Treatment Period||87
8126798|NCT02867709|20031944|P1|NOT COMPLETED|Treatment Period||70
8126799|NCT02867709|20031942|P3|COMPLETED|Treatment Period||487
8126800|NCT02867709|20031943|P2|COMPLETED|Treatment Period||474
8126801|NCT02867709|20031944|P1|COMPLETED|Treatment Period||493
8126802|NCT02867709|20031942|P3|Safety Population: Received Study Drug|Treatment Period||488
8126803|NCT02867709|20031943|P2|Safety Population: Received Study Drug|Treatment Period||478
8126804|NCT02867709|20031944|P1|Safety Population: Received Study Drug|Treatment Period||499
8126805|NCT02867709|20031942|P3|STARTED|Treatment Period||562
8126806|NCT02867709|20031943|P2|STARTED|Treatment Period||561
8126807|NCT02867709|20031944|P1|STARTED|Treatment Period||563
8126808|NCT02867605|20031973|P1|NOT COMPLETED|Overall Study||0
8126809|NCT02867605|20031973|P1|COMPLETED|Overall Study||20
8126810|NCT02867605|20031973|P1|STARTED|Overall Study||20
8126811|NCT02867202|20032025|P2|NOT COMPLETED|Overall Study||32
8126812|NCT02867202|20032026|P1|NOT COMPLETED|Overall Study||21
8126813|NCT02867202|20032025|P2|COMPLETED|Overall Study||56
8126814|NCT02867202|20032026|P1|COMPLETED|Overall Study||62
8126815|NCT02867202|20032025|P2|STARTED|Overall Study||88
8126816|NCT02867202|20032026|P1|STARTED|Overall Study||83
8126817|NCT02867163|20032032|P1|NOT COMPLETED|Overall Study||0
8126818|NCT02867163|20032032|P1|COMPLETED|Overall Study||25
8126819|NCT02867163|20032032|P1|STARTED|Overall Study||25
8126820|NCT02867150|20032036|P1|NOT COMPLETED|Overall Study||0
8126821|NCT02867150|20032036|P1|COMPLETED|Overall Study||58
8126822|NCT02867150|20032036|P1|STARTED|Overall Study||58
8126823|NCT02867059|20032042|P2|NOT COMPLETED|Overall Study||2
8126824|NCT02867059|20032043|P1|NOT COMPLETED|Overall Study||0
8126825|NCT02867059|20032042|P2|COMPLETED|Overall Study||8
8126826|NCT02867059|20032043|P1|COMPLETED|Overall Study||7
8126827|NCT02867059|20032042|P2|STARTED|Overall Study||10
8126828|NCT02867059|20032043|P1|STARTED|Overall Study||7
8126829|NCT02866942|20032051|P1|NOT COMPLETED|Overall Study||1
8126830|NCT02866942|20032051|P1|COMPLETED|Overall Study||478
8126831|NCT02866942|20032051|P1|STARTED|Overall Study||479
8126832|NCT02866695|20032056|P1|NOT COMPLETED|Overall Study||2
8126833|NCT02866695|20032056|P1|COMPLETED|Overall Study||18
8126834|NCT02866695|20032056|P1|STARTED|Overall Study||20
8126845|NCT02866175|20032073|P2|NOT COMPLETED|Overall Study||175
8126846|NCT02866175|20032074|P1|NOT COMPLETED|Overall Study||135
8126847|NCT02866175|20032073|P2|COMPLETED|Overall Study||580
8126848|NCT02866175|20032074|P1|COMPLETED|Overall Study||616
8126849|NCT02866175|20032073|P2|STARTED|Overall Study||755
8126850|NCT02866175|20032074|P1|STARTED|Overall Study||751
8126863|NCT02865590|20032131|P2|NOT COMPLETED|Overall Study||0
8126864|NCT02865590|20032132|P1|NOT COMPLETED|Overall Study||0
8126865|NCT02865590|20032131|P2|COMPLETED|Overall Study||8
8126866|NCT02865590|20032132|P1|COMPLETED|Overall Study||8
8126867|NCT02865590|20032131|P2|STARTED|Overall Study||8
8126868|NCT02865590|20032132|P1|STARTED|Overall Study||8
8126869|NCT02865499|20032138|P1|NOT COMPLETED|12 Weeks||0
8126870|NCT02865499|20032138|P1|COMPLETED|12 Weeks||6
8126871|NCT02865499|20032138|P1|STARTED|12 Weeks||6
8126872|NCT02865499|20032138|P1|NOT COMPLETED|8 Weeks||0
8126873|NCT02865499|20032138|P1|COMPLETED|8 Weeks||6
8126874|NCT02865499|20032138|P1|STARTED|8 Weeks||6
8126875|NCT02865499|20032138|P1|NOT COMPLETED|Baseline||2
8126876|NCT02865499|20032138|P1|COMPLETED|Baseline||6
8126877|NCT02865499|20032138|P1|STARTED|Baseline||8
8126878|NCT02865395|20032145|P3|NOT COMPLETED|Overall Study||7
8126879|NCT02865395|20032146|P2|NOT COMPLETED|Overall Study||10
8126880|NCT02865395|20032147|P1|NOT COMPLETED|Overall Study||6
8126881|NCT02865395|20032145|P3|COMPLETED|Overall Study|Data Not Collected|0
8126882|NCT02865395|20032146|P2|COMPLETED|Overall Study|Data Not Collected|0
8126883|NCT02865395|20032147|P1|COMPLETED|Overall Study|Data Not Collected|0
8126884|NCT02865395|20032145|P3|STARTED|Overall Study||7
8126885|NCT02865395|20032146|P2|STARTED|Overall Study||10
8126886|NCT02865395|20032147|P1|STARTED|Overall Study||6
8126887|NCT02865343|20032160|P2|NOT COMPLETED|Overall Study||2
8126888|NCT02865343|20032161|P1|NOT COMPLETED|Overall Study||0
8126889|NCT02865343|20032160|P2|COMPLETED|Overall Study||3
8126890|NCT02865343|20032161|P1|COMPLETED|Overall Study||6
8126891|NCT02865343|20032160|P2|STARTED|Overall Study||5
8126892|NCT02865343|20032161|P1|STARTED|Overall Study||6
8126893|NCT02865083|20032173|P2|NOT COMPLETED|Overall Study||1
8126894|NCT02865083|20032174|P1|NOT COMPLETED|Overall Study||3
8126895|NCT02865083|20032173|P2|COMPLETED|Overall Study||0
8126896|NCT02865083|20032174|P1|COMPLETED|Overall Study||0
8126897|NCT02865083|20032173|P2|STARTED|Overall Study||1
8126898|NCT02865083|20032174|P1|STARTED|Overall Study||3
8126899|NCT02864732|20032194|P2|NOT COMPLETED|Overall Study||2
8126900|NCT02864732|20032195|P1|NOT COMPLETED|Overall Study||2
8126901|NCT02864732|20032194|P2|COMPLETED|Overall Study||13
8126902|NCT02864732|20032195|P1|COMPLETED|Overall Study||13
8126903|NCT02864732|20032194|P2|STARTED|Overall Study||15
8126904|NCT02864732|20032195|P1|STARTED|Overall Study||15
8126905|NCT02864706|20032212|P2|NOT COMPLETED|Overall Study||0
8126906|NCT02864706|20032213|P1|NOT COMPLETED|Overall Study||0
8126907|NCT02864706|20032212|P2|COMPLETED|Overall Study||47
8126908|NCT02864706|20032213|P1|COMPLETED|Overall Study||48
8126909|NCT02864706|20032212|P2|Intent to Treat|Overall Study||47
8126910|NCT02864706|20032213|P1|Intent to Treat|Overall Study||46
8126911|NCT02864706|20032212|P2|Safety Set|Overall Study||47
8126912|NCT02864706|20032213|P1|Safety Set|Overall Study||48
8126913|NCT02864706|20032212|P2|STARTED|Overall Study||47
8126914|NCT02864706|20032213|P1|STARTED|Overall Study||48
8126923|NCT02864381|20032262|P2|NOT COMPLETED|Overall Study||72
8126924|NCT02864381|20032263|P1|NOT COMPLETED|Overall Study||72
8126925|NCT02864381|20032262|P2|COMPLETED|Overall Study||0
8126926|NCT02864381|20032263|P1|COMPLETED|Overall Study||0
8126927|NCT02864381|20032262|P2|STARTED|Overall Study||72
8126928|NCT02864381|20032263|P1|STARTED|Overall Study||72
8126929|NCT02864342|20032281|P2|NOT COMPLETED|Overall Study||19
8126930|NCT02864342|20032282|P1|NOT COMPLETED|Overall Study||15
8126931|NCT02864342|20032281|P2|COMPLETED|Overall Study||49
8126932|NCT02864342|20032282|P1|COMPLETED|Overall Study||55
8126933|NCT02864342|20032281|P2|Full Analysis Set (FAS)|Overall Study||67
8126934|NCT02864342|20032282|P1|Full Analysis Set (FAS)|Overall Study||70
8126935|NCT02864342|20032281|P2|STARTED|Overall Study||68
8126936|NCT02864342|20032282|P1|STARTED|Overall Study||70
8126937|NCT02864316|20032299|P2|NOT COMPLETED|Overall Study||2
8126938|NCT02864316|20032300|P1|NOT COMPLETED|Overall Study||2
8126939|NCT02864316|20032299|P2|COMPLETED|Overall Study||0
8126940|NCT02864316|20032300|P1|COMPLETED|Overall Study||0
8126941|NCT02864316|20032299|P2|STARTED|Overall Study||2
8126942|NCT02864316|20032300|P1|STARTED|Overall Study||2
8126943|NCT02864069|20032319|P3|NOT COMPLETED|Overall Study||8
8126944|NCT02864069|20032320|P2|NOT COMPLETED|Overall Study||8
8126945|NCT02864069|20032321|P1|NOT COMPLETED|Overall Study||6
8126946|NCT02864069|20032319|P3|COMPLETED|Overall Study||13
8126947|NCT02864069|20032320|P2|COMPLETED|Overall Study||5
8126948|NCT02864069|20032321|P1|COMPLETED|Overall Study||12
8126949|NCT02864069|20032319|P3|STARTED|Overall Study||21
8126950|NCT02864069|20032320|P2|STARTED|Overall Study||13
8126951|NCT02864069|20032321|P1|STARTED|Overall Study||18
8126952|NCT02863575|20032338|P3|NOT COMPLETED|Overall Study||1
8126953|NCT02863575|20032339|P2|NOT COMPLETED|Overall Study||2
8126954|NCT02863575|20032340|P1|NOT COMPLETED|Overall Study||1
8126955|NCT02863575|20032338|P3|COMPLETED|Overall Study||51
8126956|NCT02863575|20032339|P2|COMPLETED|Overall Study||159
8126957|NCT02863575|20032340|P1|COMPLETED|Overall Study||160
8126958|NCT02863575|20032338|P3|STARTED|Overall Study||52
8126959|NCT02863575|20032339|P2|STARTED|Overall Study||161
8126960|NCT02863575|20032340|P1|STARTED|Overall Study||161
8126961|NCT02863419|20032392|P3|NOT COMPLETED|Overall Study||8
8126962|NCT02863419|20032393|P2|NOT COMPLETED|Overall Study||10
8126963|NCT02863419|20032394|P1|NOT COMPLETED|Overall Study||8
8126964|NCT02863419|20032392|P3|COMPLETED|Overall Study||134
8126965|NCT02863419|20032393|P2|COMPLETED|Overall Study||274
8126966|NCT02863419|20032394|P1|COMPLETED|Overall Study||277
8126967|NCT02863419|20032392|P3|Safety Analysis Set (SAS)|Overall Study||142
8126968|NCT02863419|20032393|P2|Safety Analysis Set (SAS)|Overall Study||284
8126969|NCT02863419|20032394|P1|Safety Analysis Set (SAS)|Overall Study||285
8126970|NCT02863419|20032392|P3|Full Analysis Set (FAS)|Overall Study||142
8126971|NCT02863419|20032393|P2|Full Analysis Set (FAS)|Overall Study||284
8126972|NCT02863419|20032394|P1|Full Analysis Set (FAS)|Overall Study||285
8126973|NCT02863419|20032392|P3|STARTED|Overall Study||142
8126974|NCT02863419|20032393|P2|STARTED|Overall Study||284
8126975|NCT02863419|20032394|P1|STARTED|Overall Study||285
8126976|NCT02863328|20032511|P2|NOT COMPLETED|Overall Study||23
8126977|NCT02863328|20032512|P1|NOT COMPLETED|Overall Study||11
8126978|NCT02863328|20032511|P2|COMPLETED|Overall Study||387
8126979|NCT02863328|20032512|P1|COMPLETED|Overall Study||400
8126980|NCT02863328|20032511|P2|Safety Analysis Set (SAS)|Overall Study||409
8126981|NCT02863328|20032512|P1|Safety Analysis Set (SAS)|Overall Study||410
8126982|NCT02863328|20032511|P2|Full Analysis Set (FAS)|Overall Study||410
8126983|NCT02863328|20032512|P1|Full Analysis Set (FAS)|Overall Study||411
8126984|NCT02863328|20032511|P2|STARTED|Overall Study||410
8126985|NCT02863328|20032512|P1|STARTED|Overall Study||411
8126986|NCT02863289|20032609|P1|NOT COMPLETED|Overall Study||83
8126987|NCT02863289|20032609|P1|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35
8126988|NCT02863289|20032609|P1|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118
8126989|NCT02863263|20032616|P2|NOT COMPLETED|Overall Study||1
8126990|NCT02863263|20032617|P1|NOT COMPLETED|Overall Study||1
8126991|NCT02863263|20032616|P2|COMPLETED|Overall Study||1
8126992|NCT02863263|20032617|P1|COMPLETED|Overall Study||2
8126993|NCT02863263|20032616|P2|STARTED|Overall Study||2
8126994|NCT02863263|20032617|P1|STARTED|Overall Study||3
8126995|NCT02863198|20032639|P2|NOT COMPLETED|Overall Study||0
8126996|NCT02863198|20032640|P1|NOT COMPLETED|Overall Study||0
8126997|NCT02863198|20032639|P2|COMPLETED|Overall Study||60
8126998|NCT02863198|20032640|P1|COMPLETED|Overall Study||60
8126999|NCT02863198|20032639|P2|STARTED|Overall Study||60
8127000|NCT02863198|20032640|P1|STARTED|Overall Study||60
8127001|NCT02862912|20032658|P2|NOT COMPLETED|Overall Study||0
8127002|NCT02862912|20032659|P1|NOT COMPLETED|Overall Study||1
8127003|NCT02862912|20032658|P2|COMPLETED|Overall Study||20
8127004|NCT02862912|20032659|P1|COMPLETED|Overall Study||22
8127005|NCT02862912|20032658|P2|STARTED|Overall Study||20
8127006|NCT02862912|20032659|P1|STARTED|Overall Study||23
8127007|NCT02862730|20032669|P7|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8127008|NCT02862730|20032670|P6|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8127009|NCT02862730|20032671|P5|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8127010|NCT02862730|20032672|P4|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8127011|NCT02862730|20032673|P3|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8127012|NCT02862730|20032674|P2|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8127013|NCT02862730|20032675|P1|NOT COMPLETED|Fourth Intervention (84 Hours)||0
8127014|NCT02862730|20032669|P7|COMPLETED|Fourth Intervention (84 Hours)||1
8127015|NCT02862730|20032670|P6|COMPLETED|Fourth Intervention (84 Hours)||1
8127016|NCT02862730|20032671|P5|COMPLETED|Fourth Intervention (84 Hours)||4
8127017|NCT02862730|20032672|P4|COMPLETED|Fourth Intervention (84 Hours)||4
8127018|NCT02862730|20032673|P3|COMPLETED|Fourth Intervention (84 Hours)||6
8127019|NCT02862730|20032674|P2|COMPLETED|Fourth Intervention (84 Hours)||1
8127020|NCT02862730|20032675|P1|COMPLETED|Fourth Intervention (84 Hours)||3
8127021|NCT02862730|20032669|P7|STARTED|Fourth Intervention (84 Hours)||1
8127022|NCT02862730|20032670|P6|STARTED|Fourth Intervention (84 Hours)||1
8127023|NCT02862730|20032671|P5|STARTED|Fourth Intervention (84 Hours)||4
8127024|NCT02862730|20032672|P4|STARTED|Fourth Intervention (84 Hours)||4
8127025|NCT02862730|20032673|P3|STARTED|Fourth Intervention (84 Hours)||6
8127026|NCT02862730|20032674|P2|STARTED|Fourth Intervention (84 Hours)||1
8127027|NCT02862730|20032675|P1|STARTED|Fourth Intervention (84 Hours)||3
8127028|NCT02862730|20032669|P7|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8127029|NCT02862730|20032670|P6|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8127030|NCT02862730|20032671|P5|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8127031|NCT02862730|20032672|P4|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8127032|NCT02862730|20032673|P3|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8127033|NCT02862730|20032674|P2|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8127034|NCT02862730|20032675|P1|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
8127035|NCT02862730|20032669|P7|COMPLETED|Fourth Rest Period (7-45 Days)||1
8127036|NCT02862730|20032670|P6|COMPLETED|Fourth Rest Period (7-45 Days)||1
8127037|NCT02862730|20032671|P5|COMPLETED|Fourth Rest Period (7-45 Days)||4
8127038|NCT02862730|20032672|P4|COMPLETED|Fourth Rest Period (7-45 Days)||4
8127039|NCT02862730|20032673|P3|COMPLETED|Fourth Rest Period (7-45 Days)||6
8127040|NCT02862730|20032674|P2|COMPLETED|Fourth Rest Period (7-45 Days)||1
8127041|NCT02862730|20032675|P1|COMPLETED|Fourth Rest Period (7-45 Days)||3
8127042|NCT02862730|20032669|P7|STARTED|Fourth Rest Period (7-45 Days)||1
8127043|NCT02862730|20032670|P6|STARTED|Fourth Rest Period (7-45 Days)||1
8127044|NCT02862730|20032671|P5|STARTED|Fourth Rest Period (7-45 Days)||4
8127045|NCT02862730|20032672|P4|STARTED|Fourth Rest Period (7-45 Days)||4
8127046|NCT02862730|20032673|P3|STARTED|Fourth Rest Period (7-45 Days)||6
8127047|NCT02862730|20032674|P2|STARTED|Fourth Rest Period (7-45 Days)||1
8127048|NCT02862730|20032675|P1|STARTED|Fourth Rest Period (7-45 Days)||3
8127049|NCT02862730|20032669|P7|NOT COMPLETED|Third Intervention (84 Hours)||0
8127050|NCT02862730|20032670|P6|NOT COMPLETED|Third Intervention (84 Hours)||0
8127051|NCT02862730|20032671|P5|NOT COMPLETED|Third Intervention (84 Hours)||0
8127052|NCT02862730|20032672|P4|NOT COMPLETED|Third Intervention (84 Hours)||1
8127053|NCT02862730|20032673|P3|NOT COMPLETED|Third Intervention (84 Hours)||0
8127054|NCT02862730|20032674|P2|NOT COMPLETED|Third Intervention (84 Hours)||0
8127055|NCT02862730|20032675|P1|NOT COMPLETED|Third Intervention (84 Hours)||0
8127056|NCT02862730|20032669|P7|COMPLETED|Third Intervention (84 Hours)||1
8127057|NCT02862730|20032670|P6|COMPLETED|Third Intervention (84 Hours)||1
8127058|NCT02862730|20032671|P5|COMPLETED|Third Intervention (84 Hours)||4
8127059|NCT02862730|20032672|P4|COMPLETED|Third Intervention (84 Hours)||4
8127060|NCT02862730|20032673|P3|COMPLETED|Third Intervention (84 Hours)||6
8127061|NCT02862730|20032674|P2|COMPLETED|Third Intervention (84 Hours)||1
8127062|NCT02862730|20032675|P1|COMPLETED|Third Intervention (84 Hours)||3
8127063|NCT02862730|20032669|P7|STARTED|Third Intervention (84 Hours)||1
8127064|NCT02862730|20032670|P6|STARTED|Third Intervention (84 Hours)||1
8127065|NCT02862730|20032671|P5|STARTED|Third Intervention (84 Hours)||4
8127066|NCT02862730|20032672|P4|STARTED|Third Intervention (84 Hours)||5
8127067|NCT02862730|20032673|P3|STARTED|Third Intervention (84 Hours)||6
8127068|NCT02862730|20032674|P2|STARTED|Third Intervention (84 Hours)||1
8127069|NCT02862730|20032675|P1|STARTED|Third Intervention (84 Hours)||3
8127070|NCT02862730|20032669|P7|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8127071|NCT02862730|20032670|P6|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8127072|NCT02862730|20032671|P5|NOT COMPLETED|Third Rest Period (7-45 Days)||1
8127073|NCT02862730|20032672|P4|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8127074|NCT02862730|20032673|P3|NOT COMPLETED|Third Rest Period (7-45 Days)||1
8127075|NCT02862730|20032674|P2|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8127076|NCT02862730|20032675|P1|NOT COMPLETED|Third Rest Period (7-45 Days)||0
8127077|NCT02862730|20032669|P7|COMPLETED|Third Rest Period (7-45 Days)||1
8127078|NCT02862730|20032670|P6|COMPLETED|Third Rest Period (7-45 Days)||1
8127079|NCT02862730|20032671|P5|COMPLETED|Third Rest Period (7-45 Days)||4
8127080|NCT02862730|20032672|P4|COMPLETED|Third Rest Period (7-45 Days)||5
8127081|NCT02862730|20032673|P3|COMPLETED|Third Rest Period (7-45 Days)||6
8127082|NCT02862730|20032674|P2|COMPLETED|Third Rest Period (7-45 Days)||1
8127083|NCT02862730|20032675|P1|COMPLETED|Third Rest Period (7-45 Days)||3
8127084|NCT02862730|20032669|P7|STARTED|Third Rest Period (7-45 Days)||1
8127085|NCT02862730|20032670|P6|STARTED|Third Rest Period (7-45 Days)||1
8127086|NCT02862730|20032671|P5|STARTED|Third Rest Period (7-45 Days)||5
8127087|NCT02862730|20032672|P4|STARTED|Third Rest Period (7-45 Days)||5
8127088|NCT02862730|20032673|P3|STARTED|Third Rest Period (7-45 Days)||7
8127089|NCT02862730|20032674|P2|STARTED|Third Rest Period (7-45 Days)||1
8127090|NCT02862730|20032675|P1|STARTED|Third Rest Period (7-45 Days)||3
8127091|NCT02862730|20032669|P7|NOT COMPLETED|Second Intervention (84 Hours)||0
8127092|NCT02862730|20032670|P6|NOT COMPLETED|Second Intervention (84 Hours)||0
8127093|NCT02862730|20032671|P5|NOT COMPLETED|Second Intervention (84 Hours)||0
8127094|NCT02862730|20032672|P4|NOT COMPLETED|Second Intervention (84 Hours)||0
8127095|NCT02862730|20032673|P3|NOT COMPLETED|Second Intervention (84 Hours)||0
8127096|NCT02862730|20032674|P2|NOT COMPLETED|Second Intervention (84 Hours)||0
8127097|NCT02862730|20032675|P1|NOT COMPLETED|Second Intervention (84 Hours)||1
8127098|NCT02862730|20032669|P7|COMPLETED|Second Intervention (84 Hours)||1
8127099|NCT02862730|20032670|P6|COMPLETED|Second Intervention (84 Hours)||1
8127100|NCT02862730|20032671|P5|COMPLETED|Second Intervention (84 Hours)||5
8127101|NCT02862730|20032672|P4|COMPLETED|Second Intervention (84 Hours)||5
8127102|NCT02862730|20032673|P3|COMPLETED|Second Intervention (84 Hours)||7
8127103|NCT02862730|20032674|P2|COMPLETED|Second Intervention (84 Hours)||1
8127104|NCT02862730|20032675|P1|COMPLETED|Second Intervention (84 Hours)||3
8127105|NCT02862730|20032669|P7|STARTED|Second Intervention (84 Hours)||1
8127106|NCT02862730|20032670|P6|STARTED|Second Intervention (84 Hours)||1
8127107|NCT02862730|20032671|P5|STARTED|Second Intervention (84 Hours)||5
8127108|NCT02862730|20032672|P4|STARTED|Second Intervention (84 Hours)||5
8127109|NCT02862730|20032673|P3|STARTED|Second Intervention (84 Hours)||7
8127110|NCT02862730|20032674|P2|STARTED|Second Intervention (84 Hours)||1
8127111|NCT02862730|20032675|P1|STARTED|Second Intervention (84 Hours)||4
8127112|NCT02862730|20032669|P7|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8127113|NCT02862730|20032670|P6|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8127114|NCT02862730|20032671|P5|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8127115|NCT02862730|20032672|P4|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8127116|NCT02862730|20032673|P3|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8127117|NCT02862730|20032674|P2|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8127118|NCT02862730|20032675|P1|NOT COMPLETED|Second Rest Period (7-45 Days)||0
8127119|NCT02862730|20032669|P7|COMPLETED|Second Rest Period (7-45 Days)||1
8127120|NCT02862730|20032670|P6|COMPLETED|Second Rest Period (7-45 Days)||1
8127121|NCT02862730|20032671|P5|COMPLETED|Second Rest Period (7-45 Days)||5
8127122|NCT02862730|20032672|P4|COMPLETED|Second Rest Period (7-45 Days)||5
8127123|NCT02862730|20032673|P3|COMPLETED|Second Rest Period (7-45 Days)||7
8127124|NCT02862730|20032674|P2|COMPLETED|Second Rest Period (7-45 Days)||1
8127125|NCT02862730|20032675|P1|COMPLETED|Second Rest Period (7-45 Days)||4
8127126|NCT02862730|20032669|P7|STARTED|Second Rest Period (7-45 Days)||1
8127127|NCT02862730|20032670|P6|STARTED|Second Rest Period (7-45 Days)||1
8127128|NCT02862730|20032671|P5|STARTED|Second Rest Period (7-45 Days)||5
8127129|NCT02862730|20032672|P4|STARTED|Second Rest Period (7-45 Days)||5
8127130|NCT02862730|20032673|P3|STARTED|Second Rest Period (7-45 Days)||7
8127131|NCT02862730|20032674|P2|STARTED|Second Rest Period (7-45 Days)||1
8127132|NCT02862730|20032675|P1|STARTED|Second Rest Period (7-45 Days)||4
8127133|NCT02862730|20032669|P7|NOT COMPLETED|First Intervention (84 Hours)||0
8127134|NCT02862730|20032670|P6|NOT COMPLETED|First Intervention (84 Hours)||0
8127135|NCT02862730|20032671|P5|NOT COMPLETED|First Intervention (84 Hours)||0
8127136|NCT02862730|20032672|P4|NOT COMPLETED|First Intervention (84 Hours)||0
8127137|NCT02862730|20032673|P3|NOT COMPLETED|First Intervention (84 Hours)||0
8127138|NCT02862730|20032674|P2|NOT COMPLETED|First Intervention (84 Hours)||0
8127139|NCT02862730|20032675|P1|NOT COMPLETED|First Intervention (84 Hours)||0
8127140|NCT02862730|20032669|P7|COMPLETED|First Intervention (84 Hours)||1
8127141|NCT02862730|20032670|P6|COMPLETED|First Intervention (84 Hours)||1
8127142|NCT02862730|20032671|P5|COMPLETED|First Intervention (84 Hours)||5
8127143|NCT02862730|20032672|P4|COMPLETED|First Intervention (84 Hours)||5
8127144|NCT02862730|20032673|P3|COMPLETED|First Intervention (84 Hours)||7
8127145|NCT02862730|20032674|P2|COMPLETED|First Intervention (84 Hours)||1
8127146|NCT02862730|20032675|P1|COMPLETED|First Intervention (84 Hours)||4
8127147|NCT02862730|20032669|P7|STARTED|First Intervention (84 Hours)||1
8127148|NCT02862730|20032670|P6|STARTED|First Intervention (84 Hours)||1
8127149|NCT02862730|20032671|P5|STARTED|First Intervention (84 Hours)||5
8127150|NCT02862730|20032672|P4|STARTED|First Intervention (84 Hours)||5
8127151|NCT02862730|20032673|P3|STARTED|First Intervention (84 Hours)||7
8127152|NCT02862730|20032674|P2|STARTED|First Intervention (84 Hours)||1
8127153|NCT02862730|20032675|P1|STARTED|First Intervention (84 Hours)||4
8127154|NCT02862730|20032669|P7|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8127155|NCT02862730|20032670|P6|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8127156|NCT02862730|20032671|P5|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8127157|NCT02862730|20032672|P4|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8127158|NCT02862730|20032673|P3|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8127159|NCT02862730|20032674|P2|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8127160|NCT02862730|20032675|P1|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
8127161|NCT02862730|20032669|P7|COMPLETED|First Rest Period (1-12 Weeks)||1
8127162|NCT02862730|20032670|P6|COMPLETED|First Rest Period (1-12 Weeks)||1
8127163|NCT02862730|20032671|P5|COMPLETED|First Rest Period (1-12 Weeks)||5
8127164|NCT02862730|20032672|P4|COMPLETED|First Rest Period (1-12 Weeks)||5
8127165|NCT02862730|20032673|P3|COMPLETED|First Rest Period (1-12 Weeks)||7
8127166|NCT02862730|20032674|P2|COMPLETED|First Rest Period (1-12 Weeks)||1
8127167|NCT02862730|20032675|P1|COMPLETED|First Rest Period (1-12 Weeks)||4
8127168|NCT02862730|20032669|P7|STARTED|First Rest Period (1-12 Weeks)||1
8127169|NCT02862730|20032670|P6|STARTED|First Rest Period (1-12 Weeks)||1
8127170|NCT02862730|20032671|P5|STARTED|First Rest Period (1-12 Weeks)||5
8127171|NCT02862730|20032672|P4|STARTED|First Rest Period (1-12 Weeks)||5
8127172|NCT02862730|20032673|P3|STARTED|First Rest Period (1-12 Weeks)||7
8127173|NCT02862730|20032674|P2|STARTED|First Rest Period (1-12 Weeks)||1
8127174|NCT02862730|20032675|P1|STARTED|First Rest Period (1-12 Weeks)||4
8127175|NCT02862730|20032669|P7|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8127176|NCT02862730|20032670|P6|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8127177|NCT02862730|20032671|P5|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8127178|NCT02862730|20032672|P4|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8127179|NCT02862730|20032673|P3|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
8127180|NCT02862730|20032674|P2|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8127181|NCT02862730|20032675|P1|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
8127182|NCT02862730|20032669|P7|COMPLETED|Tslim Training Visit (2 Weeks)||1
8127183|NCT02862730|20032670|P6|COMPLETED|Tslim Training Visit (2 Weeks)||1
8127184|NCT02862730|20032671|P5|COMPLETED|Tslim Training Visit (2 Weeks)||5
8127185|NCT02862730|20032672|P4|COMPLETED|Tslim Training Visit (2 Weeks)||5
8127186|NCT02862730|20032673|P3|COMPLETED|Tslim Training Visit (2 Weeks)||7
8127187|NCT02862730|20032674|P2|COMPLETED|Tslim Training Visit (2 Weeks)||1
8127188|NCT02862730|20032675|P1|COMPLETED|Tslim Training Visit (2 Weeks)||4
8127189|NCT02862730|20032669|P7|STARTED|Tslim Training Visit (2 Weeks)||1
8127190|NCT02862730|20032670|P6|STARTED|Tslim Training Visit (2 Weeks)||1
8127191|NCT02862730|20032671|P5|STARTED|Tslim Training Visit (2 Weeks)||5
8127192|NCT02862730|20032672|P4|STARTED|Tslim Training Visit (2 Weeks)||5
8127193|NCT02862730|20032673|P3|STARTED|Tslim Training Visit (2 Weeks)||8
8127194|NCT02862730|20032674|P2|STARTED|Tslim Training Visit (2 Weeks)||1
8127195|NCT02862730|20032675|P1|STARTED|Tslim Training Visit (2 Weeks)||4
8127196|NCT02862600|20032730|P1|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
8127197|NCT02862600|20032730|P1|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
8127198|NCT02862600|20032730|P1|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
8127199|NCT02862600|20032730|P1|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
8127200|NCT02862600|20032730|P1|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
8127201|NCT02862600|20032730|P1|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
8127202|NCT02862574|20032740|P3|NOT COMPLETED|Open-Label Treatment Period||1
8127203|NCT02862574|20032741|P2|NOT COMPLETED|Open-Label Treatment Period||3
8127204|NCT02862574|20032742|P1|NOT COMPLETED|Open-Label Treatment Period||2
8127205|NCT02862574|20032740|P3|COMPLETED|Open-Label Treatment Period||0
8127206|NCT02862574|20032741|P2|COMPLETED|Open-Label Treatment Period||0
8127207|NCT02862574|20032742|P1|COMPLETED|Open-Label Treatment Period||0
8127208|NCT02862574|20032740|P3|STARTED|Open-Label Treatment Period||1
8127209|NCT02862574|20032741|P2|STARTED|Open-Label Treatment Period||3
8127210|NCT02862574|20032742|P1|STARTED|Open-Label Treatment Period||2
8127211|NCT02862574|20032740|P3|NOT COMPLETED|Double-Blind Treatment Period||4
8127212|NCT02862574|20032741|P2|NOT COMPLETED|Double-Blind Treatment Period||2
8127213|NCT02862574|20032742|P1|NOT COMPLETED|Double-Blind Treatment Period||3
8127214|NCT02862574|20032740|P3|COMPLETED|Double-Blind Treatment Period||1
8127215|NCT02862574|20032741|P2|COMPLETED|Double-Blind Treatment Period||3
8127216|NCT02862574|20032742|P1|COMPLETED|Double-Blind Treatment Period||2
8127217|NCT02862574|20032740|P3|STARTED|Double-Blind Treatment Period||5
8127218|NCT02862574|20032741|P2|STARTED|Double-Blind Treatment Period||5
8127219|NCT02862574|20032742|P1|STARTED|Double-Blind Treatment Period||5
8127232|NCT02862535|20032791|P4|NOT COMPLETED|Overall Study||11
8127233|NCT02862535|20032792|P3|NOT COMPLETED|Overall Study||10
8127234|NCT02862535|20032793|P2|NOT COMPLETED|Overall Study||6
8127235|NCT02862535|20032794|P1|NOT COMPLETED|Overall Study||9
8127236|NCT02862535|20032791|P4|COMPLETED|Overall Study||0
8127237|NCT02862535|20032792|P3|COMPLETED|Overall Study||0
8127238|NCT02862535|20032793|P2|COMPLETED|Overall Study||0
8127239|NCT02862535|20032794|P1|COMPLETED|Overall Study||0
8127240|NCT02862535|20032791|P4|STARTED|Overall Study||11
8127241|NCT02862535|20032792|P3|STARTED|Overall Study||10
8127242|NCT02862535|20032793|P2|STARTED|Overall Study||6
8127243|NCT02862535|20032794|P1|STARTED|Overall Study||9
8127244|NCT02862106|20032822|P2|NOT COMPLETED|Overall Study||6
8127245|NCT02862106|20032823|P1|NOT COMPLETED|Overall Study||38
8127246|NCT02862106|20032822|P2|COMPLETED|Overall Study||20
8127247|NCT02862106|20032823|P1|COMPLETED|Overall Study||145
8127248|NCT02862106|20032822|P2|STARTED|Overall Study||26
8127249|NCT02862106|20032823|P1|STARTED|Overall Study||183
8127250|NCT02862080|20032883|P4|NOT COMPLETED|Intervention 1 Again (1 Week)||0
8127251|NCT02862080|20032884|P3|NOT COMPLETED|Intervention 1 Again (1 Week)||0
8127252|NCT02862080|20032885|P2|NOT COMPLETED|Intervention 1 Again (1 Week)||0
8127253|NCT02862080|20032886|P1|NOT COMPLETED|Intervention 1 Again (1 Week)||0
8127254|NCT02862080|20032883|P4|COMPLETED|Intervention 1 Again (1 Week)||1
8127255|NCT02862080|20032884|P3|COMPLETED|Intervention 1 Again (1 Week)||1
8127256|NCT02862080|20032885|P2|COMPLETED|Intervention 1 Again (1 Week)||1
8127257|NCT02862080|20032886|P1|COMPLETED|Intervention 1 Again (1 Week)||1
8127258|NCT02862080|20032883|P4|STARTED|Intervention 1 Again (1 Week)||1
8127259|NCT02862080|20032884|P3|STARTED|Intervention 1 Again (1 Week)||1
8127260|NCT02862080|20032885|P2|STARTED|Intervention 1 Again (1 Week)||1
8127261|NCT02862080|20032886|P1|STARTED|Intervention 1 Again (1 Week)||1
8127262|NCT02862080|20032883|P4|NOT COMPLETED|Washout (1 Week)||0
8127263|NCT02862080|20032884|P3|NOT COMPLETED|Washout (1 Week)||0
8127264|NCT02862080|20032885|P2|NOT COMPLETED|Washout (1 Week)||0
8127265|NCT02862080|20032886|P1|NOT COMPLETED|Washout (1 Week)||0
8127266|NCT02862080|20032883|P4|COMPLETED|Washout (1 Week)||1
8127267|NCT02862080|20032884|P3|COMPLETED|Washout (1 Week)||1
8127268|NCT02862080|20032885|P2|COMPLETED|Washout (1 Week)||1
8127269|NCT02862080|20032886|P1|COMPLETED|Washout (1 Week)||1
8127270|NCT02862080|20032883|P4|STARTED|Washout (1 Week)||1
8127271|NCT02862080|20032884|P3|STARTED|Washout (1 Week)||1
8127272|NCT02862080|20032885|P2|STARTED|Washout (1 Week)||1
8127273|NCT02862080|20032886|P1|STARTED|Washout (1 Week)||1
8127274|NCT02862080|20032883|P4|NOT COMPLETED|Intervention 2 (1 Week)||0
8127275|NCT02862080|20032884|P3|NOT COMPLETED|Intervention 2 (1 Week)||0
8127276|NCT02862080|20032885|P2|NOT COMPLETED|Intervention 2 (1 Week)||0
8127277|NCT02862080|20032886|P1|NOT COMPLETED|Intervention 2 (1 Week)||0
8127278|NCT02862080|20032883|P4|COMPLETED|Intervention 2 (1 Week)||1
8127279|NCT02862080|20032884|P3|COMPLETED|Intervention 2 (1 Week)||1
8127280|NCT02862080|20032885|P2|COMPLETED|Intervention 2 (1 Week)||1
8127281|NCT02862080|20032886|P1|COMPLETED|Intervention 2 (1 Week)||1
8127282|NCT02862080|20032883|P4|STARTED|Intervention 2 (1 Week)||1
8127283|NCT02862080|20032884|P3|STARTED|Intervention 2 (1 Week)||1
8127284|NCT02862080|20032885|P2|STARTED|Intervention 2 (1 Week)||1
8127285|NCT02862080|20032886|P1|STARTED|Intervention 2 (1 Week)||1
8127286|NCT02862080|20032883|P4|NOT COMPLETED|Washout (1 Week)||0
8127287|NCT02862080|20032884|P3|NOT COMPLETED|Washout (1 Week)||0
8127288|NCT02862080|20032885|P2|NOT COMPLETED|Washout (1 Week)||0
8127289|NCT02862080|20032886|P1|NOT COMPLETED|Washout (1 Week)||0
8127290|NCT02862080|20032883|P4|COMPLETED|Washout (1 Week)||1
8127291|NCT02862080|20032884|P3|COMPLETED|Washout (1 Week)||1
8127292|NCT02862080|20032885|P2|COMPLETED|Washout (1 Week)||1
8127293|NCT02862080|20032886|P1|COMPLETED|Washout (1 Week)||1
8127294|NCT02862080|20032883|P4|STARTED|Washout (1 Week)||1
8127295|NCT02862080|20032884|P3|STARTED|Washout (1 Week)||1
8127296|NCT02862080|20032885|P2|STARTED|Washout (1 Week)||1
8127297|NCT02862080|20032886|P1|STARTED|Washout (1 Week)||1
8127298|NCT02862080|20032883|P4|NOT COMPLETED|Intervention 1 (1 Week)||0
8127299|NCT02862080|20032884|P3|NOT COMPLETED|Intervention 1 (1 Week)||0
8127300|NCT02862080|20032885|P2|NOT COMPLETED|Intervention 1 (1 Week)||0
8127301|NCT02862080|20032886|P1|NOT COMPLETED|Intervention 1 (1 Week)||0
8127302|NCT02862080|20032883|P4|COMPLETED|Intervention 1 (1 Week)||1
8127303|NCT02862080|20032884|P3|COMPLETED|Intervention 1 (1 Week)||1
8127304|NCT02862080|20032885|P2|COMPLETED|Intervention 1 (1 Week)||1
8127305|NCT02862080|20032886|P1|COMPLETED|Intervention 1 (1 Week)||1
8127306|NCT02862080|20032883|P4|STARTED|Intervention 1 (1 Week)||1
8127307|NCT02862080|20032884|P3|STARTED|Intervention 1 (1 Week)||1
8127308|NCT02862080|20032885|P2|STARTED|Intervention 1 (1 Week)||1
8127309|NCT02862080|20032886|P1|STARTED|Intervention 1 (1 Week)||1
8127310|NCT02862080|20032883|P4|NOT COMPLETED|3 Days Before Any Intervention||0
8127311|NCT02862080|20032884|P3|NOT COMPLETED|3 Days Before Any Intervention||0
8127312|NCT02862080|20032885|P2|NOT COMPLETED|3 Days Before Any Intervention||0
8127313|NCT02862080|20032886|P1|NOT COMPLETED|3 Days Before Any Intervention||0
8127314|NCT02862080|20032883|P4|COMPLETED|3 Days Before Any Intervention||1
8127315|NCT02862080|20032884|P3|COMPLETED|3 Days Before Any Intervention||1
8127316|NCT02862080|20032885|P2|COMPLETED|3 Days Before Any Intervention||1
8127317|NCT02862080|20032886|P1|COMPLETED|3 Days Before Any Intervention||1
8127318|NCT02862080|20032883|P4|STARTED|3 Days Before Any Intervention||1
8127319|NCT02862080|20032884|P3|STARTED|3 Days Before Any Intervention||1
8127320|NCT02862080|20032885|P2|STARTED|3 Days Before Any Intervention||1
8127321|NCT02862080|20032886|P1|STARTED|3 Days Before Any Intervention||1
8127322|NCT02862080|20032883|P4|NOT COMPLETED|7 Days Before Any Intervention||0
8127323|NCT02862080|20032884|P3|NOT COMPLETED|7 Days Before Any Intervention||0
8127324|NCT02862080|20032885|P2|NOT COMPLETED|7 Days Before Any Intervention||0
8127325|NCT02862080|20032886|P1|NOT COMPLETED|7 Days Before Any Intervention||0
8127326|NCT02862080|20032883|P4|COMPLETED|7 Days Before Any Intervention||1
8127327|NCT02862080|20032884|P3|COMPLETED|7 Days Before Any Intervention||1
8127328|NCT02862080|20032885|P2|COMPLETED|7 Days Before Any Intervention||1
8127329|NCT02862080|20032886|P1|COMPLETED|7 Days Before Any Intervention||1
8127330|NCT02862080|20032883|P4|STARTED|7 Days Before Any Intervention||1
8127331|NCT02862080|20032884|P3|STARTED|7 Days Before Any Intervention||1
8127332|NCT02862080|20032885|P2|STARTED|7 Days Before Any Intervention||1
8127333|NCT02862080|20032886|P1|STARTED|7 Days Before Any Intervention||1
8127334|NCT02861937|20032920|P3|NOT COMPLETED|Overall Study||0
8127335|NCT02861937|20032921|P2|NOT COMPLETED|Overall Study||0
8127336|NCT02861937|20032922|P1|NOT COMPLETED|Overall Study||0
8127337|NCT02861937|20032920|P3|COMPLETED|Overall Study||12
8127338|NCT02861937|20032921|P2|COMPLETED|Overall Study||12
8127339|NCT02861937|20032922|P1|COMPLETED|Overall Study||10
8127340|NCT02861937|20032920|P3|STARTED|Overall Study||12
8127341|NCT02861937|20032921|P2|STARTED|Overall Study||12
8127342|NCT02861937|20032922|P1|STARTED|Overall Study||10
8127343|NCT02861807|20032944|P2|NOT COMPLETED|Overall Study||14
8127344|NCT02861807|20032945|P1|NOT COMPLETED|Overall Study||12
8127345|NCT02861807|20032944|P2|COMPLETED|Overall Study||23
8127346|NCT02861807|20032945|P1|COMPLETED|Overall Study||35
8127347|NCT02861807|20032944|P2|Attended 2-month Follow-up|Overall Study||20
8127348|NCT02861807|20032945|P1|Attended 2-month Follow-up|Overall Study||32
8127349|NCT02861807|20032944|P2|Attended Post-treatment Assessment|Overall Study||18
8127350|NCT02861807|20032945|P1|Attended Post-treatment Assessment|Overall Study||34
8127351|NCT02861807|20032944|P2|STARTED|Overall Study||37
8127352|NCT02861807|20032945|P1|STARTED|Overall Study||47
8127353|NCT02861664|20032961|P2|NOT COMPLETED|Overall Study||1
8127354|NCT02861664|20032962|P1|NOT COMPLETED|Overall Study||0
8127355|NCT02861664|20032961|P2|COMPLETED|Overall Study||67
8127356|NCT02861664|20032962|P1|COMPLETED|Overall Study||67
8127357|NCT02861664|20032961|P2|STARTED|Overall Study||68
8127358|NCT02861664|20032962|P1|STARTED|Overall Study||67
8127359|NCT02861534|20032974|P2|NOT COMPLETED|Overall Study||587
8127360|NCT02861534|20032975|P1|NOT COMPLETED|Overall Study||574
8127361|NCT02861534|20032974|P2|COMPLETED|Overall Study||1937
8127362|NCT02861534|20032975|P1|COMPLETED|Overall Study||1952
8127363|NCT02861534|20032974|P2|Treated|Overall Study||2515
8127364|NCT02861534|20032975|P1|Treated|Overall Study||2519
8127365|NCT02861534|20032974|P2|STARTED|Overall Study||2524
8127366|NCT02861534|20032975|P1|STARTED|Overall Study||2526
8127367|NCT02861131|20033001|P2|NOT COMPLETED|Overall Study||0
8127368|NCT02861131|20033002|P1|NOT COMPLETED|Overall Study||0
8127369|NCT02861131|20033001|P2|COMPLETED|Overall Study||100
8127370|NCT02861131|20033002|P1|COMPLETED|Overall Study||100
8127371|NCT02861131|20033001|P2|STARTED|Overall Study||100
8127372|NCT02861131|20033002|P1|STARTED|Overall Study||100
8127373|NCT02861118|20033020|P2|NOT COMPLETED|Overall Study||0
8127374|NCT02861118|20033021|P1|NOT COMPLETED|Overall Study||0
8127375|NCT02861118|20033020|P2|COMPLETED|Overall Study||116
8127376|NCT02861118|20033021|P1|COMPLETED|Overall Study||194
8127377|NCT02861118|20033020|P2|STARTED|Overall Study||116
8127378|NCT02861118|20033021|P1|STARTED|Overall Study||194
8127379|NCT02860845|20033035|P2|NOT COMPLETED|Overall Study||1
8127380|NCT02860845|20033036|P1|NOT COMPLETED|Overall Study||2
8127381|NCT02860845|20033035|P2|COMPLETED|Overall Study||23
8127382|NCT02860845|20033036|P1|COMPLETED|Overall Study||22
8127383|NCT02860845|20033035|P2|Analyzed Patients|Overall Study||23
8127384|NCT02860845|20033036|P1|Analyzed Patients|Overall Study||22
8127385|NCT02860845|20033035|P2|STARTED|Overall Study||24
8127386|NCT02860845|20033036|P1|STARTED|Overall Study||24
8127387|NCT02860507|20033052|P2|NOT COMPLETED|Overall Study||0
8127388|NCT02860507|20033053|P1|NOT COMPLETED|Overall Study||0
8127389|NCT02860507|20033052|P2|COMPLETED|Overall Study||25
8127390|NCT02860507|20033053|P1|COMPLETED|Overall Study||25
8127391|NCT02860507|20033052|P2|STARTED|Overall Study||25
8127392|NCT02860507|20033053|P1|STARTED|Overall Study||25
8127393|NCT02860169|20033063|P1|NOT COMPLETED|Part C||1
8127394|NCT02860169|20033063|P1|COMPLETED|Part C||47
8127395|NCT02860169|20033063|P1|Participants With Cold and Flu|Part C||42
8127396|NCT02860169|20033063|P1|Healthy Participants|Part C||6
8127397|NCT02860169|20033063|P1|STARTED|Part C||48
8127398|NCT02860169|20033063|P1|NOT COMPLETED|Part B||11
8127399|NCT02860169|20033063|P1|COMPLETED|Part B||9
8127400|NCT02860169|20033063|P1|Participants With Cold and Flu|Part B||10
8127401|NCT02860169|20033063|P1|Healthy Participants|Part B||10
8127402|NCT02860169|20033063|P1|STARTED|Part B||20
8127403|NCT02860169|20033063|P1|NOT COMPLETED|Part A||11
8127404|NCT02860169|20033063|P1|COMPLETED|Part A||35
8127405|NCT02860169|20033063|P1|Participants With Cold and Flu|Part A||0
8127406|NCT02860169|20033063|P1|Healthy Participants|Part A||46
8127407|NCT02860169|20033063|P1|STARTED|Part A||46
8127408|NCT02860130|20033081|P2|NOT COMPLETED|Overall Study||9
8127409|NCT02860130|20033082|P1|NOT COMPLETED|Overall Study||7
8127410|NCT02860130|20033081|P2|COMPLETED|Overall Study||8
8127411|NCT02860130|20033082|P1|COMPLETED|Overall Study||10
8127412|NCT02860130|20033081|P2|STARTED|Overall Study||17
8127413|NCT02860130|20033082|P1|STARTED|Overall Study||17
8127414|NCT02859597|20033136|P2|NOT COMPLETED|Overall Study||0
8127415|NCT02859597|20033137|P1|NOT COMPLETED|Overall Study||0
8127416|NCT02859597|20033136|P2|COMPLETED|Overall Study|September 2018|19
8127417|NCT02859597|20033137|P1|COMPLETED|Overall Study|September 2018|22
8127418|NCT02859597|20033136|P2|STARTED|Overall Study|Started Dec 2016|19
8127419|NCT02859597|20033137|P1|STARTED|Overall Study|started Dec 2016|22
8127423|NCT02859441|20033158|P1|NOT COMPLETED|Overall Study||0
8127424|NCT02859441|20033158|P1|COMPLETED|Overall Study||3
8127425|NCT02859441|20033158|P1|STARTED|Overall Study||3
8127426|NCT02859246|20033203|P1|NOT COMPLETED|Overall Study||5
8127427|NCT02859246|20033203|P1|COMPLETED|Overall Study|10 subjects completed the study|10
8127428|NCT02859246|20033203|P1|STARTED|Overall Study|15 subjects were enrolled into study|15
8127429|NCT02858726|20033212|P4|NOT COMPLETED|Overall Study||3
8127430|NCT02858726|20033213|P3|NOT COMPLETED|Overall Study||11
8127431|NCT02858726|20033214|P2|NOT COMPLETED|Overall Study||7
8127432|NCT02858726|20033215|P1|NOT COMPLETED|Overall Study||5
8127433|NCT02858726|20033212|P4|COMPLETED|Overall Study||42
8127434|NCT02858726|20033213|P3|COMPLETED|Overall Study||33
8127435|NCT02858726|20033214|P2|COMPLETED|Overall Study||35
8127436|NCT02858726|20033215|P1|COMPLETED|Overall Study||39
8127437|NCT02858726|20033212|P4|STARTED|Overall Study||45
8127438|NCT02858726|20033213|P3|STARTED|Overall Study||44
8127439|NCT02858726|20033214|P2|STARTED|Overall Study||42
8127440|NCT02858726|20033215|P1|STARTED|Overall Study||44
8127441|NCT02858713|20033231|P2|NOT COMPLETED|Overall Study||5
8127442|NCT02858713|20033232|P1|NOT COMPLETED|Overall Study||7
8127443|NCT02858713|20033231|P2|COMPLETED|Overall Study||61
8127444|NCT02858713|20033232|P1|COMPLETED|Overall Study||61
8127445|NCT02858713|20033231|P2|STARTED|Overall Study||66
8127446|NCT02858713|20033232|P1|STARTED|Overall Study||68
8127459|NCT02858440|20033425|P1|NOT COMPLETED|Overall Study||12
8127460|NCT02858440|20033425|P1|COMPLETED|Overall Study||223
8127461|NCT02858440|20033425|P1|STARTED|Overall Study||235
8127462|NCT02858401|20033458|P7|NOT COMPLETED|Overall Study||0
8127463|NCT02858401|20033459|P6|NOT COMPLETED|Overall Study||1
8127464|NCT02858401|20033460|P5|NOT COMPLETED|Overall Study||0
8127465|NCT02858401|20033461|P4|NOT COMPLETED|Overall Study||0
8127466|NCT02858401|20033462|P3|NOT COMPLETED|Overall Study||0
8127467|NCT02858401|20033463|P2|NOT COMPLETED|Overall Study||1
8127468|NCT02858401|20033464|P1|NOT COMPLETED|Overall Study||0
8127469|NCT02858401|20033458|P7|COMPLETED|Overall Study||12
8127470|NCT02858401|20033459|P6|COMPLETED|Overall Study||5
8127471|NCT02858401|20033460|P5|COMPLETED|Overall Study||6
8127472|NCT02858401|20033461|P4|COMPLETED|Overall Study||6
8127473|NCT02858401|20033462|P3|COMPLETED|Overall Study||6
8127474|NCT02858401|20033463|P2|COMPLETED|Overall Study||5
8127475|NCT02858401|20033464|P1|COMPLETED|Overall Study||6
8127476|NCT02858401|20033458|P7|STARTED|Overall Study||12
8127477|NCT02858401|20033459|P6|STARTED|Overall Study||6
8127478|NCT02858401|20033460|P5|STARTED|Overall Study||6
8127479|NCT02858401|20033461|P4|STARTED|Overall Study||6
8127480|NCT02858401|20033462|P3|STARTED|Overall Study||6
8127481|NCT02858401|20033463|P2|STARTED|Overall Study||6
8127482|NCT02858401|20033464|P1|STARTED|Overall Study||6
8127483|NCT02858362|20033875|P3|NOT COMPLETED|Overall Study||3
8127484|NCT02858362|20033876|P2|NOT COMPLETED|Overall Study||1
8127485|NCT02858362|20033877|P1|NOT COMPLETED|Overall Study||2
8127486|NCT02858362|20033875|P3|COMPLETED|Overall Study||0
8127487|NCT02858362|20033876|P2|COMPLETED|Overall Study||9
8127488|NCT02858362|20033877|P1|COMPLETED|Overall Study||28
8127489|NCT02858362|20033875|P3|Did Not Enter Extension Phase|Overall Study||0
8127490|NCT02858362|20033876|P2|Did Not Enter Extension Phase|Overall Study||2
8127491|NCT02858362|20033877|P1|Did Not Enter Extension Phase|Overall Study||1
8127492|NCT02858362|20033875|P3|STARTED|Overall Study||3
8127493|NCT02858362|20033876|P2|STARTED|Overall Study||10
8127494|NCT02858362|20033877|P1|STARTED|Overall Study||30
8127495|NCT02858349|20033912|P1|NOT COMPLETED|Overall Study||0
8127496|NCT02858349|20033912|P1|COMPLETED|Overall Study||10
8127497|NCT02858349|20033912|P1|STARTED|Overall Study||10
8127498|NCT02858180|20033918|P2|NOT COMPLETED|Overall Study||2
8127499|NCT02858180|20033919|P1|NOT COMPLETED|Overall Study||0
8127500|NCT02858180|20033918|P2|COMPLETED|Overall Study|Completed a 12-week course of therapy.|3
8127501|NCT02858180|20033919|P1|COMPLETED|Overall Study|Completed a 12-week course of therapy.|10
8127502|NCT02858180|20033918|P2|STARTED|Overall Study||5
8127503|NCT02858180|20033919|P1|STARTED|Overall Study||10
8127510|NCT02858050|20033972|P2|NOT COMPLETED|Overall Study||0
8127511|NCT02858050|20033973|P1|NOT COMPLETED|Overall Study||0
8127512|NCT02858050|20033972|P2|COMPLETED|Overall Study||20
8127513|NCT02858050|20033973|P1|COMPLETED|Overall Study||20
8127514|NCT02858050|20033972|P2|STARTED|Overall Study||20
8127515|NCT02858050|20033973|P1|STARTED|Overall Study||20
8127516|NCT02857816|20033979|P1|NOT COMPLETED|Overall Study||38
8127517|NCT02857816|20033979|P1|COMPLETED|Overall Study||116
8127518|NCT02857816|20033979|P1|Subjects Qualified and Treated With PTNM|Overall Study||120
8127519|NCT02857816|20033979|P1|STARTED|Overall Study||154
8127520|NCT02857426|20033987|P2|NOT COMPLETED|Follow-up||6
8127521|NCT02857426|20033988|P1|NOT COMPLETED|Follow-up||10
8127522|NCT02857426|20033987|P2|COMPLETED|Follow-up||13
8127523|NCT02857426|20033988|P1|COMPLETED|Follow-up||37
8127524|NCT02857426|20033987|P2|STARTED|Follow-up||19
8127525|NCT02857426|20033988|P1|STARTED|Follow-up||47
8127526|NCT02857426|20033987|P2|NOT COMPLETED|Treatment||17
8127527|NCT02857426|20033988|P1|NOT COMPLETED|Treatment||46
8127528|NCT02857426|20033987|P2|COMPLETED|Treatment||2
8127529|NCT02857426|20033988|P1|COMPLETED|Treatment||1
8127530|NCT02857426|20033987|P2|STARTED|Treatment||19
8127531|NCT02857426|20033988|P1|STARTED|Treatment||47
8127550|NCT02856880|20034039|P1|NOT COMPLETED|Overall Study||1
8127551|NCT02856880|20034039|P1|COMPLETED|Overall Study||44
8127552|NCT02856880|20034039|P1|Received SLS Negative Control|Overall Study||44
8127553|NCT02856880|20034039|P1|Received Non-SLS Negative Control|Overall Study||44
8127554|NCT02856880|20034039|P1|Received Positive Control|Overall Study||45
8127555|NCT02856880|20034039|P1|Received Test Zinc Non-IPMP|Overall Study||44
8127556|NCT02856880|20034039|P1|Received Test Zinc-IPMP|Overall Study||44
8127557|NCT02856880|20034039|P1|STARTED|Overall Study||45
8127558|NCT02856828|20034065|P2|NOT COMPLETED|Overall Study||0
8127559|NCT02856828|20034066|P1|NOT COMPLETED|Overall Study||0
8127560|NCT02856828|20034065|P2|COMPLETED|Overall Study||3
8127561|NCT02856828|20034066|P1|COMPLETED|Overall Study||2
8127562|NCT02856828|20034065|P2|STARTED|Overall Study||3
8127563|NCT02856828|20034066|P1|STARTED|Overall Study||2
8127564|NCT02856555|20034083|P3|NOT COMPLETED|Overall Study||0
8127565|NCT02856555|20034084|P2|NOT COMPLETED|Overall Study||4
8127566|NCT02856555|20034085|P1|NOT COMPLETED|Overall Study||5
8127567|NCT02856555|20034083|P3|COMPLETED|Overall Study||26
8127568|NCT02856555|20034084|P2|COMPLETED|Overall Study||46
8127569|NCT02856555|20034085|P1|COMPLETED|Overall Study||46
8127570|NCT02856555|20034083|P3|STARTED|Overall Study||26
8127571|NCT02856555|20034084|P2|STARTED|Overall Study||50
8127572|NCT02856555|20034085|P1|STARTED|Overall Study||51
8127573|NCT02856282|20034093|P1|NOT COMPLETED|Overall Study||1
8127574|NCT02856282|20034093|P1|COMPLETED|Overall Study||45
8127575|NCT02856282|20034093|P1|STARTED|Overall Study||46
8127576|NCT02856035|20034103|P1|NOT COMPLETED|Overall Study||0
8127577|NCT02856035|20034103|P1|COMPLETED|Overall Study||4
8127578|NCT02856035|20034103|P1|STARTED|Overall Study||4
8127579|NCT02855567|20034110|P2|NOT COMPLETED|Overall Study||0
8127580|NCT02855567|20034111|P1|NOT COMPLETED|Overall Study||0
8127581|NCT02855567|20034110|P2|COMPLETED|Overall Study||56
8127582|NCT02855567|20034111|P1|COMPLETED|Overall Study||54
8127583|NCT02855567|20034110|P2|STARTED|Overall Study||56
8127584|NCT02855567|20034111|P1|STARTED|Overall Study||54
8127585|NCT02855541|20034125|P1|NOT COMPLETED|Overall Study||4
8127586|NCT02855541|20034125|P1|COMPLETED|Overall Study||21
8127587|NCT02855541|20034125|P1|STARTED|Overall Study||25
8127588|NCT02855450|20034138|P2|NOT COMPLETED|Overall Study||0
8127589|NCT02855450|20034139|P1|NOT COMPLETED|Overall Study||5
8127590|NCT02855450|20034138|P2|COMPLETED|Overall Study||20
8127591|NCT02855450|20034139|P1|COMPLETED|Overall Study||35
8127592|NCT02855450|20034138|P2|STARTED|Overall Study||20
8127593|NCT02855450|20034139|P1|STARTED|Overall Study||40
8127594|NCT02855437|20034147|P2|NOT COMPLETED|Phase 2||1
8127595|NCT02855437|20034148|P1|NOT COMPLETED|Phase 2||1
8127596|NCT02855437|20034147|P2|COMPLETED|Phase 2||18
8127597|NCT02855437|20034148|P1|COMPLETED|Phase 2||20
8127598|NCT02855437|20034147|P2|STARTED|Phase 2||19
8127599|NCT02855437|20034148|P1|STARTED|Phase 2||21
8127600|NCT02855437|20034147|P2|NOT COMPLETED|Crossover Period (Same Day)||0
8127601|NCT02855437|20034148|P1|NOT COMPLETED|Crossover Period (Same Day)||0
8127602|NCT02855437|20034147|P2|COMPLETED|Crossover Period (Same Day)||19
8127603|NCT02855437|20034148|P1|COMPLETED|Crossover Period (Same Day)||21
8127604|NCT02855437|20034147|P2|STARTED|Crossover Period (Same Day)||19
8127605|NCT02855437|20034148|P1|STARTED|Crossover Period (Same Day)||21
8127606|NCT02855437|20034147|P2|NOT COMPLETED|Phase 1||2
8127607|NCT02855437|20034148|P1|NOT COMPLETED|Phase 1||2
8127608|NCT02855437|20034147|P2|COMPLETED|Phase 1||19
8127609|NCT02855437|20034148|P1|COMPLETED|Phase 1||21
8127610|NCT02855437|20034147|P2|STARTED|Phase 1||21
8127611|NCT02855437|20034148|P1|STARTED|Phase 1||23
8127612|NCT02855411|20034156|P1|NOT COMPLETED|Overall Study||35
8127613|NCT02855411|20034156|P1|COMPLETED|Overall Study||0
8127614|NCT02855411|20034156|P1|Assigned to Study Treatment|Overall Study||0
8127615|NCT02855411|20034156|P1|STARTED|Overall Study||35
8127616|NCT02855359|20034178|P4|NOT COMPLETED|Overall Study||0
8127617|NCT02855359|20034179|P3|NOT COMPLETED|Overall Study||0
8127618|NCT02855359|20034180|P2|NOT COMPLETED|Overall Study||13
8127619|NCT02855359|20034181|P1|NOT COMPLETED|Overall Study||11
8127620|NCT02855359|20034178|P4|COMPLETED|Overall Study||0
8127621|NCT02855359|20034179|P3|COMPLETED|Overall Study||0
8127622|NCT02855359|20034180|P2|COMPLETED|Overall Study||0
8127623|NCT02855359|20034181|P1|COMPLETED|Overall Study||0
8127624|NCT02855359|20034178|P4|STARTED|Overall Study||0
8127625|NCT02855359|20034179|P3|STARTED|Overall Study||0
8127626|NCT02855359|20034180|P2|STARTED|Overall Study||13
8127627|NCT02855359|20034181|P1|STARTED|Overall Study||11
8127628|NCT02855086|20034215|P2|NOT COMPLETED|Overall Study||0
8127629|NCT02855086|20034216|P1|NOT COMPLETED|Overall Study||0
8127630|NCT02855086|20034215|P2|COMPLETED|Overall Study||1
8127631|NCT02855086|20034216|P1|COMPLETED|Overall Study||2
8127632|NCT02855086|20034215|P2|STARTED|Overall Study||1
8127633|NCT02855086|20034216|P1|STARTED|Overall Study||2
8127634|NCT02854800|20034227|P3|NOT COMPLETED|Overall Study||6
8127635|NCT02854800|20034228|P2|NOT COMPLETED|Overall Study||13
8127636|NCT02854800|20034229|P1|NOT COMPLETED|Overall Study||20
8127637|NCT02854800|20034227|P3|COMPLETED|Overall Study||8
8127638|NCT02854800|20034228|P2|COMPLETED|Overall Study||15
8127639|NCT02854800|20034229|P1|COMPLETED|Overall Study||12
8127640|NCT02854800|20034227|P3|STARTED|Overall Study||14
8127641|NCT02854800|20034228|P2|STARTED|Overall Study||28
8127642|NCT02854800|20034229|P1|STARTED|Overall Study||32
8127643|NCT02854631|20034269|P2|NOT COMPLETED|Overall Study||15
8127644|NCT02854631|20034270|P1|NOT COMPLETED|Overall Study||26
8127645|NCT02854631|20034269|P2|COMPLETED|Overall Study||37
8127646|NCT02854631|20034270|P1|COMPLETED|Overall Study||26
8127647|NCT02854631|20034269|P2|STARTED|Overall Study||52
8127648|NCT02854631|20034270|P1|STARTED|Overall Study||52
8127649|NCT02854605|20034331|P3|NOT COMPLETED|Overall Study||4
8127650|NCT02854605|20034332|P2|NOT COMPLETED|Overall Study||7
8127651|NCT02854605|20034333|P1|NOT COMPLETED|Overall Study||3
8127652|NCT02854605|20034331|P3|COMPLETED|Overall Study||24
8127653|NCT02854605|20034332|P2|COMPLETED|Overall Study||49
8127654|NCT02854605|20034333|P1|COMPLETED|Overall Study||53
8127655|NCT02854605|20034331|P3|STARTED|Overall Study||28
8127656|NCT02854605|20034332|P2|STARTED|Overall Study||56
8127657|NCT02854605|20034333|P1|STARTED|Overall Study||56
8127658|NCT02854540|20034344|P1|NOT COMPLETED|Overall Study||2
8127659|NCT02854540|20034344|P1|COMPLETED|Overall Study||11
8127660|NCT02854540|20034344|P1|STARTED|Overall Study||13
8127661|NCT02854527|20034363|P10|NOT COMPLETED|Overall Study||0
8127662|NCT02854527|20034364|P9|NOT COMPLETED|Overall Study||0
8127663|NCT02854527|20034365|P8|NOT COMPLETED|Overall Study||0
8127664|NCT02854527|20034366|P7|NOT COMPLETED|Overall Study||0
8127665|NCT02854527|20034367|P6|NOT COMPLETED|Overall Study||0
8127666|NCT02854527|20034368|P5|NOT COMPLETED|Overall Study||1
8127667|NCT02854527|20034369|P4|NOT COMPLETED|Overall Study||1
8127668|NCT02854527|20034370|P3|NOT COMPLETED|Overall Study||0
8127669|NCT02854527|20034371|P2|NOT COMPLETED|Overall Study||0
8127670|NCT02854527|20034372|P1|NOT COMPLETED|Overall Study||0
8127671|NCT02854527|20034363|P10|COMPLETED|Overall Study||3
8127672|NCT02854527|20034364|P9|COMPLETED|Overall Study||3
8127673|NCT02854527|20034365|P8|COMPLETED|Overall Study||3
8127674|NCT02854527|20034366|P7|COMPLETED|Overall Study||3
8127675|NCT02854527|20034367|P6|COMPLETED|Overall Study||3
8127676|NCT02854527|20034368|P5|COMPLETED|Overall Study||2
8127677|NCT02854527|20034369|P4|COMPLETED|Overall Study||2
8127678|NCT02854527|20034370|P3|COMPLETED|Overall Study||3
8127679|NCT02854527|20034371|P2|COMPLETED|Overall Study||3
8127680|NCT02854527|20034372|P1|COMPLETED|Overall Study||3
8127681|NCT02854527|20034363|P10|Received T|Overall Study||3
8127682|NCT02854527|20034364|P9|Received T|Overall Study||3
8127683|NCT02854527|20034365|P8|Received T|Overall Study||3
8127684|NCT02854527|20034366|P7|Received T|Overall Study||3
8127685|NCT02854527|20034367|P6|Received T|Overall Study||3
8127686|NCT02854527|20034368|P5|Received T|Overall Study||2
8127687|NCT02854527|20034369|P4|Received T|Overall Study||2
8127688|NCT02854527|20034370|P3|Received T|Overall Study||3
8127689|NCT02854527|20034371|P2|Received T|Overall Study||3
8127690|NCT02854527|20034372|P1|Received T|Overall Study||3
8127691|NCT02854527|20034363|P10|Received R4|Overall Study||3
8127692|NCT02854527|20034364|P9|Received R4|Overall Study||3
8127693|NCT02854527|20034365|P8|Received R4|Overall Study||3
8127694|NCT02854527|20034366|P7|Received R4|Overall Study||3
8127695|NCT02854527|20034367|P6|Received R4|Overall Study||3
8127696|NCT02854527|20034368|P5|Received R4|Overall Study||3
8127697|NCT02854527|20034369|P4|Received R4|Overall Study||2
8127698|NCT02854527|20034370|P3|Received R4|Overall Study||3
8127699|NCT02854527|20034371|P2|Received R4|Overall Study||3
8127700|NCT02854527|20034372|P1|Received R4|Overall Study||3
8127701|NCT02854527|20034363|P10|Received R3|Overall Study||3
8127702|NCT02854527|20034364|P9|Received R3|Overall Study||3
8127703|NCT02854527|20034365|P8|Received R3|Overall Study||3
8127704|NCT02854527|20034366|P7|Received R3|Overall Study||3
8127705|NCT02854527|20034367|P6|Received R3|Overall Study||3
8127706|NCT02854527|20034368|P5|Received R3|Overall Study||3
8127707|NCT02854527|20034369|P4|Received R3|Overall Study||2
8127708|NCT02854527|20034370|P3|Received R3|Overall Study||3
8127709|NCT02854527|20034371|P2|Received R3|Overall Study||3
8127710|NCT02854527|20034372|P1|Received R3|Overall Study||3
8127711|NCT02854527|20034363|P10|Received R2|Overall Study||3
8127712|NCT02854527|20034364|P9|Received R2|Overall Study||3
8127713|NCT02854527|20034365|P8|Received R2|Overall Study||3
8127714|NCT02854527|20034366|P7|Received R2|Overall Study||3
8127715|NCT02854527|20034367|P6|Received R2|Overall Study||3
8127716|NCT02854527|20034368|P5|Received R2|Overall Study||3
8127717|NCT02854527|20034369|P4|Received R2|Overall Study||3
8127718|NCT02854527|20034370|P3|Received R2|Overall Study||3
8127719|NCT02854527|20034371|P2|Received R2|Overall Study||3
8127720|NCT02854527|20034372|P1|Received R2|Overall Study||3
8127721|NCT02854527|20034363|P10|Received R1|Overall Study||3
8127722|NCT02854527|20034364|P9|Received R1|Overall Study||3
8127723|NCT02854527|20034365|P8|Received R1|Overall Study||3
8127724|NCT02854527|20034366|P7|Received R1|Overall Study||3
8127725|NCT02854527|20034367|P6|Received R1|Overall Study||3
8127726|NCT02854527|20034368|P5|Received R1|Overall Study||2
8127727|NCT02854527|20034369|P4|Received R1|Overall Study||2
8127728|NCT02854527|20034370|P3|Received R1|Overall Study||3
8127729|NCT02854527|20034371|P2|Received R1|Overall Study||3
8127730|NCT02854527|20034372|P1|Received R1|Overall Study||3
8127731|NCT02854527|20034363|P10|STARTED|Overall Study||3
8127732|NCT02854527|20034364|P9|STARTED|Overall Study||3
8127733|NCT02854527|20034365|P8|STARTED|Overall Study||3
8127734|NCT02854527|20034366|P7|STARTED|Overall Study||3
8127735|NCT02854527|20034367|P6|STARTED|Overall Study||3
8127736|NCT02854527|20034368|P5|STARTED|Overall Study||3
8127737|NCT02854527|20034369|P4|STARTED|Overall Study||3
8127738|NCT02854527|20034370|P3|STARTED|Overall Study||3
8127739|NCT02854527|20034371|P2|STARTED|Overall Study||3
8127740|NCT02854527|20034372|P1|STARTED|Overall Study||3
8127741|NCT02854059|20034405|P2|NOT COMPLETED|Overall Study||0
8127742|NCT02854059|20034406|P1|NOT COMPLETED|Overall Study||0
8127743|NCT02854059|20034405|P2|COMPLETED|Overall Study||0
8127744|NCT02854059|20034406|P1|COMPLETED|Overall Study||2
8127745|NCT02854059|20034405|P2|STARTED|Overall Study||0
8127746|NCT02854059|20034406|P1|STARTED|Overall Study||2
8127747|NCT02853929|20034430|P2|NOT COMPLETED|Overall Study||4
8127748|NCT02853929|20034431|P1|NOT COMPLETED|Overall Study||11
8127749|NCT02853929|20034430|P2|COMPLETED|Overall Study||277
8127750|NCT02853929|20034431|P1|COMPLETED|Overall Study||259
8127751|NCT02853929|20034430|P2|Vaccinated|Overall Study||277
8127752|NCT02853929|20034431|P1|Vaccinated|Overall Study||263
8127753|NCT02853929|20034430|P2|STARTED|Overall Study||281
8127754|NCT02853929|20034431|P1|STARTED|Overall Study||270
8127755|NCT02853760|20034469|P6|NOT COMPLETED|Third Intervention (3 Hours)||0
8127756|NCT02853760|20034470|P5|NOT COMPLETED|Third Intervention (3 Hours)||0
8127757|NCT02853760|20034471|P4|NOT COMPLETED|Third Intervention (3 Hours)||0
8127758|NCT02853760|20034472|P3|NOT COMPLETED|Third Intervention (3 Hours)||0
8127759|NCT02853760|20034473|P2|NOT COMPLETED|Third Intervention (3 Hours)||0
8127760|NCT02853760|20034474|P1|NOT COMPLETED|Third Intervention (3 Hours)||0
8127761|NCT02853760|20034469|P6|COMPLETED|Third Intervention (3 Hours)||5
8127762|NCT02853760|20034470|P5|COMPLETED|Third Intervention (3 Hours)||8
8127763|NCT02853760|20034471|P4|COMPLETED|Third Intervention (3 Hours)||6
8127764|NCT02853760|20034472|P3|COMPLETED|Third Intervention (3 Hours)||6
8127765|NCT02853760|20034473|P2|COMPLETED|Third Intervention (3 Hours)||10
8127766|NCT02853760|20034474|P1|COMPLETED|Third Intervention (3 Hours)||7
8127767|NCT02853760|20034469|P6|STARTED|Third Intervention (3 Hours)||5
8127768|NCT02853760|20034470|P5|STARTED|Third Intervention (3 Hours)||8
8127769|NCT02853760|20034471|P4|STARTED|Third Intervention (3 Hours)||6
8127770|NCT02853760|20034472|P3|STARTED|Third Intervention (3 Hours)||6
8127771|NCT02853760|20034473|P2|STARTED|Third Intervention (3 Hours)||10
8127772|NCT02853760|20034474|P1|STARTED|Third Intervention (3 Hours)||7
8127773|NCT02853760|20034469|P6|NOT COMPLETED|Washout (1 Week)||0
8127774|NCT02853760|20034470|P5|NOT COMPLETED|Washout (1 Week)||0
8127775|NCT02853760|20034471|P4|NOT COMPLETED|Washout (1 Week)||0
8127776|NCT02853760|20034472|P3|NOT COMPLETED|Washout (1 Week)||0
8127777|NCT02853760|20034473|P2|NOT COMPLETED|Washout (1 Week)||0
8127778|NCT02853760|20034474|P1|NOT COMPLETED|Washout (1 Week)||0
8127779|NCT02853760|20034469|P6|COMPLETED|Washout (1 Week)||5
8127780|NCT02853760|20034470|P5|COMPLETED|Washout (1 Week)||8
8127781|NCT02853760|20034471|P4|COMPLETED|Washout (1 Week)||6
8127782|NCT02853760|20034472|P3|COMPLETED|Washout (1 Week)||6
8127783|NCT02853760|20034473|P2|COMPLETED|Washout (1 Week)||10
8127784|NCT02853760|20034474|P1|COMPLETED|Washout (1 Week)||7
8127785|NCT02853760|20034469|P6|STARTED|Washout (1 Week)||5
8127786|NCT02853760|20034470|P5|STARTED|Washout (1 Week)||8
8127787|NCT02853760|20034471|P4|STARTED|Washout (1 Week)||6
8127788|NCT02853760|20034472|P3|STARTED|Washout (1 Week)||6
8127789|NCT02853760|20034473|P2|STARTED|Washout (1 Week)||10
8127790|NCT02853760|20034474|P1|STARTED|Washout (1 Week)||7
8127791|NCT02853760|20034469|P6|NOT COMPLETED|Second Intervention (3 Hours)||0
8127792|NCT02853760|20034470|P5|NOT COMPLETED|Second Intervention (3 Hours)||0
8127793|NCT02853760|20034471|P4|NOT COMPLETED|Second Intervention (3 Hours)||0
8127794|NCT02853760|20034472|P3|NOT COMPLETED|Second Intervention (3 Hours)||0
8127795|NCT02853760|20034473|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
8127796|NCT02853760|20034474|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
8127797|NCT02853760|20034469|P6|COMPLETED|Second Intervention (3 Hours)||5
8127798|NCT02853760|20034470|P5|COMPLETED|Second Intervention (3 Hours)||8
8127799|NCT02853760|20034471|P4|COMPLETED|Second Intervention (3 Hours)||6
8127800|NCT02853760|20034472|P3|COMPLETED|Second Intervention (3 Hours)||6
8127801|NCT02853760|20034473|P2|COMPLETED|Second Intervention (3 Hours)||10
8127802|NCT02853760|20034474|P1|COMPLETED|Second Intervention (3 Hours)||7
8127803|NCT02853760|20034469|P6|STARTED|Second Intervention (3 Hours)||5
8127804|NCT02853760|20034470|P5|STARTED|Second Intervention (3 Hours)||8
8127805|NCT02853760|20034471|P4|STARTED|Second Intervention (3 Hours)||6
8127806|NCT02853760|20034472|P3|STARTED|Second Intervention (3 Hours)||6
8127807|NCT02853760|20034473|P2|STARTED|Second Intervention (3 Hours)||10
8127808|NCT02853760|20034474|P1|STARTED|Second Intervention (3 Hours)||7
8127809|NCT02853760|20034469|P6|NOT COMPLETED|Washout (1 Week)||2
8127810|NCT02853760|20034470|P5|NOT COMPLETED|Washout (1 Week)||0
8127811|NCT02853760|20034471|P4|NOT COMPLETED|Washout (1 Week)||2
8127812|NCT02853760|20034472|P3|NOT COMPLETED|Washout (1 Week)||1
8127813|NCT02853760|20034473|P2|NOT COMPLETED|Washout (1 Week)||0
8127814|NCT02853760|20034474|P1|NOT COMPLETED|Washout (1 Week)||0
8127815|NCT02853760|20034469|P6|COMPLETED|Washout (1 Week)||5
8127816|NCT02853760|20034470|P5|COMPLETED|Washout (1 Week)||8
8127817|NCT02853760|20034471|P4|COMPLETED|Washout (1 Week)||6
8127818|NCT02853760|20034472|P3|COMPLETED|Washout (1 Week)||6
8127819|NCT02853760|20034473|P2|COMPLETED|Washout (1 Week)||10
8127820|NCT02853760|20034474|P1|COMPLETED|Washout (1 Week)||7
8127821|NCT02853760|20034469|P6|STARTED|Washout (1 Week)||7
8127822|NCT02853760|20034470|P5|STARTED|Washout (1 Week)||8
8127823|NCT02853760|20034471|P4|STARTED|Washout (1 Week)||8
8127824|NCT02853760|20034472|P3|STARTED|Washout (1 Week)||7
8127825|NCT02853760|20034473|P2|STARTED|Washout (1 Week)||10
8127826|NCT02853760|20034474|P1|STARTED|Washout (1 Week)||7
8127827|NCT02853760|20034469|P6|NOT COMPLETED|First Intervention (3 Hours)||0
8127828|NCT02853760|20034470|P5|NOT COMPLETED|First Intervention (3 Hours)||0
8127829|NCT02853760|20034471|P4|NOT COMPLETED|First Intervention (3 Hours)||0
8127830|NCT02853760|20034472|P3|NOT COMPLETED|First Intervention (3 Hours)||0
8127831|NCT02853760|20034473|P2|NOT COMPLETED|First Intervention (3 Hours)||0
8127832|NCT02853760|20034474|P1|NOT COMPLETED|First Intervention (3 Hours)||0
8127833|NCT02853760|20034469|P6|COMPLETED|First Intervention (3 Hours)||7
8127834|NCT02853760|20034470|P5|COMPLETED|First Intervention (3 Hours)||8
8127835|NCT02853760|20034471|P4|COMPLETED|First Intervention (3 Hours)||8
8127836|NCT02853760|20034472|P3|COMPLETED|First Intervention (3 Hours)||7
8127837|NCT02853760|20034473|P2|COMPLETED|First Intervention (3 Hours)||10
8127838|NCT02853760|20034474|P1|COMPLETED|First Intervention (3 Hours)||7
8127839|NCT02853760|20034469|P6|STARTED|First Intervention (3 Hours)||7
8127840|NCT02853760|20034470|P5|STARTED|First Intervention (3 Hours)||8
8127841|NCT02853760|20034471|P4|STARTED|First Intervention (3 Hours)||8
8127842|NCT02853760|20034472|P3|STARTED|First Intervention (3 Hours)||7
8127843|NCT02853760|20034473|P2|STARTED|First Intervention (3 Hours)||10
8127844|NCT02853760|20034474|P1|STARTED|First Intervention (3 Hours)||7
8127845|NCT02853435|20034500|P6|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8127846|NCT02853435|20034501|P5|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8127847|NCT02853435|20034502|P4|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8127848|NCT02853435|20034503|P3|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8127849|NCT02853435|20034504|P2|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8127850|NCT02853435|20034505|P1|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
8127851|NCT02853435|20034500|P6|COMPLETED|Part 3, Period 3 (3 Days)||2
8127852|NCT02853435|20034501|P5|COMPLETED|Part 3, Period 3 (3 Days)||9
8127853|NCT02853435|20034502|P4|COMPLETED|Part 3, Period 3 (3 Days)||0
8127854|NCT02853435|20034503|P3|COMPLETED|Part 3, Period 3 (3 Days)||0
8127855|NCT02853435|20034504|P2|COMPLETED|Part 3, Period 3 (3 Days)||0
8127856|NCT02853435|20034505|P1|COMPLETED|Part 3, Period 3 (3 Days)||0
8127857|NCT02853435|20034500|P6|STARTED|Part 3, Period 3 (3 Days)||2
8127858|NCT02853435|20034501|P5|STARTED|Part 3, Period 3 (3 Days)||9
8127859|NCT02853435|20034502|P4|STARTED|Part 3, Period 3 (3 Days)||0
8127860|NCT02853435|20034503|P3|STARTED|Part 3, Period 3 (3 Days)||0
8127861|NCT02853435|20034504|P2|STARTED|Part 3, Period 3 (3 Days)||0
8127862|NCT02853435|20034505|P1|STARTED|Part 3, Period 3 (3 Days)||0
8127863|NCT02853435|20034500|P6|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127864|NCT02853435|20034501|P5|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
8127865|NCT02853435|20034502|P4|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127866|NCT02853435|20034503|P3|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127867|NCT02853435|20034504|P2|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127868|NCT02853435|20034505|P1|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127869|NCT02853435|20034500|P6|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
8127870|NCT02853435|20034501|P5|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
8127871|NCT02853435|20034502|P4|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127872|NCT02853435|20034503|P3|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127873|NCT02853435|20034504|P2|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127874|NCT02853435|20034505|P1|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
8127875|NCT02853435|20034500|P6|STARTED|Part 3, Washout Period 2 (3 Days)||2
8127876|NCT02853435|20034501|P5|STARTED|Part 3, Washout Period 2 (3 Days)||10
8127877|NCT02853435|20034502|P4|STARTED|Part 3, Washout Period 2 (3 Days)||0
8127878|NCT02853435|20034503|P3|STARTED|Part 3, Washout Period 2 (3 Days)||0
8127879|NCT02853435|20034504|P2|STARTED|Part 3, Washout Period 2 (3 Days)||0
8127880|NCT02853435|20034505|P1|STARTED|Part 3, Washout Period 2 (3 Days)||0
8127881|NCT02853435|20034500|P6|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8127882|NCT02853435|20034501|P5|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8127883|NCT02853435|20034502|P4|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8127884|NCT02853435|20034503|P3|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8127885|NCT02853435|20034504|P2|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8127886|NCT02853435|20034505|P1|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
8127887|NCT02853435|20034500|P6|COMPLETED|Part 3, Period 2 (3 Days)||2
8127888|NCT02853435|20034501|P5|COMPLETED|Part 3, Period 2 (3 Days)||10
8127889|NCT02853435|20034502|P4|COMPLETED|Part 3, Period 2 (3 Days)||0
8127890|NCT02853435|20034503|P3|COMPLETED|Part 3, Period 2 (3 Days)||0
8127891|NCT02853435|20034504|P2|COMPLETED|Part 3, Period 2 (3 Days)||0
8127892|NCT02853435|20034505|P1|COMPLETED|Part 3, Period 2 (3 Days)||0
8127893|NCT02853435|20034500|P6|STARTED|Part 3, Period 2 (3 Days)||2
8127894|NCT02853435|20034501|P5|STARTED|Part 3, Period 2 (3 Days)||10
8127895|NCT02853435|20034502|P4|STARTED|Part 3, Period 2 (3 Days)||0
8127896|NCT02853435|20034503|P3|STARTED|Part 3, Period 2 (3 Days)||0
8127897|NCT02853435|20034504|P2|STARTED|Part 3, Period 2 (3 Days)||0
8127898|NCT02853435|20034505|P1|STARTED|Part 3, Period 2 (3 Days)||0
8127899|NCT02853435|20034500|P6|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127900|NCT02853435|20034501|P5|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127901|NCT02853435|20034502|P4|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127902|NCT02853435|20034503|P3|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127903|NCT02853435|20034504|P2|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127904|NCT02853435|20034505|P1|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127905|NCT02853435|20034500|P6|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
8127906|NCT02853435|20034501|P5|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
8127907|NCT02853435|20034502|P4|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127908|NCT02853435|20034503|P3|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127909|NCT02853435|20034504|P2|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127910|NCT02853435|20034505|P1|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
8127911|NCT02853435|20034500|P6|STARTED|Part 3, Washout Period 1 (3 Days)||2
8127912|NCT02853435|20034501|P5|STARTED|Part 3, Washout Period 1 (3 Days)||10
8127913|NCT02853435|20034502|P4|STARTED|Part 3, Washout Period 1 (3 Days)||0
8127914|NCT02853435|20034503|P3|STARTED|Part 3, Washout Period 1 (3 Days)||0
8127915|NCT02853435|20034504|P2|STARTED|Part 3, Washout Period 1 (3 Days)||0
8127916|NCT02853435|20034505|P1|STARTED|Part 3, Washout Period 1 (3 Days)||0
8127917|NCT02853435|20034500|P6|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8127918|NCT02853435|20034501|P5|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8127919|NCT02853435|20034502|P4|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8127920|NCT02853435|20034503|P3|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8127921|NCT02853435|20034504|P2|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8127922|NCT02853435|20034505|P1|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
8127923|NCT02853435|20034500|P6|COMPLETED|Part 3, Period 1 (3 Days)||2
8127924|NCT02853435|20034501|P5|COMPLETED|Part 3, Period 1 (3 Days)||10
8127925|NCT02853435|20034502|P4|COMPLETED|Part 3, Period 1 (3 Days)||0
8127926|NCT02853435|20034503|P3|COMPLETED|Part 3, Period 1 (3 Days)||0
8127927|NCT02853435|20034504|P2|COMPLETED|Part 3, Period 1 (3 Days)||0
8127928|NCT02853435|20034505|P1|COMPLETED|Part 3, Period 1 (3 Days)||0
8127929|NCT02853435|20034500|P6|STARTED|Part 3, Period 1 (3 Days)||2
8127930|NCT02853435|20034501|P5|STARTED|Part 3, Period 1 (3 Days)||10
8127931|NCT02853435|20034502|P4|STARTED|Part 3, Period 1 (3 Days)||0
8127932|NCT02853435|20034503|P3|STARTED|Part 3, Period 1 (3 Days)||0
8127933|NCT02853435|20034504|P2|STARTED|Part 3, Period 1 (3 Days)||0
8127934|NCT02853435|20034505|P1|STARTED|Part 3, Period 1 (3 Days)||0
8127935|NCT02853435|20034500|P6|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8127936|NCT02853435|20034501|P5|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8127937|NCT02853435|20034502|P4|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8127938|NCT02853435|20034503|P3|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8127939|NCT02853435|20034504|P2|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8127940|NCT02853435|20034505|P1|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
8127941|NCT02853435|20034500|P6|COMPLETED|Part 2, Period 2 (3 Days)||0
8127942|NCT02853435|20034501|P5|COMPLETED|Part 2, Period 2 (3 Days)||0
8127943|NCT02853435|20034502|P4|COMPLETED|Part 2, Period 2 (3 Days)||10
8127944|NCT02853435|20034503|P3|COMPLETED|Part 2, Period 2 (3 Days)||0
8127945|NCT02853435|20034504|P2|COMPLETED|Part 2, Period 2 (3 Days)||0
8127946|NCT02853435|20034505|P1|COMPLETED|Part 2, Period 2 (3 Days)||0
8127947|NCT02853435|20034500|P6|STARTED|Part 2, Period 2 (3 Days)||0
8127948|NCT02853435|20034501|P5|STARTED|Part 2, Period 2 (3 Days)||0
8127949|NCT02853435|20034502|P4|STARTED|Part 2, Period 2 (3 Days)||10
8127950|NCT02853435|20034503|P3|STARTED|Part 2, Period 2 (3 Days)||0
8127951|NCT02853435|20034504|P2|STARTED|Part 2, Period 2 (3 Days)||0
8127952|NCT02853435|20034505|P1|STARTED|Part 2, Period 2 (3 Days)||0
8127953|NCT02853435|20034500|P6|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127954|NCT02853435|20034501|P5|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127955|NCT02853435|20034502|P4|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127956|NCT02853435|20034503|P3|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127957|NCT02853435|20034504|P2|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127958|NCT02853435|20034505|P1|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127959|NCT02853435|20034500|P6|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127960|NCT02853435|20034501|P5|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127961|NCT02853435|20034502|P4|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
8127962|NCT02853435|20034503|P3|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127963|NCT02853435|20034504|P2|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127964|NCT02853435|20034505|P1|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
8127965|NCT02853435|20034500|P6|STARTED|Part 2, Washout Period 1 (3 Days)||0
8127966|NCT02853435|20034501|P5|STARTED|Part 2, Washout Period 1 (3 Days)||0
8127967|NCT02853435|20034502|P4|STARTED|Part 2, Washout Period 1 (3 Days)||10
8127968|NCT02853435|20034503|P3|STARTED|Part 2, Washout Period 1 (3 Days)||0
8127969|NCT02853435|20034504|P2|STARTED|Part 2, Washout Period 1 (3 Days)||0
8127970|NCT02853435|20034505|P1|STARTED|Part 2, Washout Period 1 (3 Days)||0
8127971|NCT02853435|20034500|P6|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8127972|NCT02853435|20034501|P5|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8127973|NCT02853435|20034502|P4|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8127974|NCT02853435|20034503|P3|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8127975|NCT02853435|20034504|P2|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8127976|NCT02853435|20034505|P1|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
8127977|NCT02853435|20034500|P6|COMPLETED|Part 2, Period 1 (3 Days)||0
8127978|NCT02853435|20034501|P5|COMPLETED|Part 2, Period 1 (3 Days)||0
8127979|NCT02853435|20034502|P4|COMPLETED|Part 2, Period 1 (3 Days)||10
8127980|NCT02853435|20034503|P3|COMPLETED|Part 2, Period 1 (3 Days)||0
8127981|NCT02853435|20034504|P2|COMPLETED|Part 2, Period 1 (3 Days)||0
8127982|NCT02853435|20034505|P1|COMPLETED|Part 2, Period 1 (3 Days)||0
8127983|NCT02853435|20034500|P6|STARTED|Part 2, Period 1 (3 Days)||0
8127984|NCT02853435|20034501|P5|STARTED|Part 2, Period 1 (3 Days)||0
8127985|NCT02853435|20034502|P4|STARTED|Part 2, Period 1 (3 Days)||10
8127986|NCT02853435|20034503|P3|STARTED|Part 2, Period 1 (3 Days)||0
8127987|NCT02853435|20034504|P2|STARTED|Part 2, Period 1 (3 Days)||0
8127988|NCT02853435|20034505|P1|STARTED|Part 2, Period 1 (3 Days)||0
8127989|NCT02853435|20034500|P6|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8127990|NCT02853435|20034501|P5|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8127991|NCT02853435|20034502|P4|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8127992|NCT02853435|20034503|P3|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8127993|NCT02853435|20034504|P2|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8127994|NCT02853435|20034505|P1|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
8127995|NCT02853435|20034500|P6|COMPLETED|Part 1a, Period 3 (3 Days)||0
8127996|NCT02853435|20034501|P5|COMPLETED|Part 1a, Period 3 (3 Days)||0
8127997|NCT02853435|20034502|P4|COMPLETED|Part 1a, Period 3 (3 Days)||0
8127998|NCT02853435|20034503|P3|COMPLETED|Part 1a, Period 3 (3 Days)||8
8127999|NCT02853435|20034504|P2|COMPLETED|Part 1a, Period 3 (3 Days)||9
8128000|NCT02853435|20034505|P1|COMPLETED|Part 1a, Period 3 (3 Days)||9
8128001|NCT02853435|20034500|P6|STARTED|Part 1a, Period 3 (3 Days)||0
8128002|NCT02853435|20034501|P5|STARTED|Part 1a, Period 3 (3 Days)||0
8128003|NCT02853435|20034502|P4|STARTED|Part 1a, Period 3 (3 Days)||0
8128004|NCT02853435|20034503|P3|STARTED|Part 1a, Period 3 (3 Days)||8
8128005|NCT02853435|20034504|P2|STARTED|Part 1a, Period 3 (3 Days)||9
8128006|NCT02853435|20034505|P1|STARTED|Part 1a, Period 3 (3 Days)||9
8128007|NCT02853435|20034500|P6|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128008|NCT02853435|20034501|P5|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128009|NCT02853435|20034502|P4|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128010|NCT02853435|20034503|P3|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128011|NCT02853435|20034504|P2|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128012|NCT02853435|20034505|P1|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128013|NCT02853435|20034500|P6|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128014|NCT02853435|20034501|P5|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128015|NCT02853435|20034502|P4|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
8128016|NCT02853435|20034503|P3|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
8128017|NCT02853435|20034504|P2|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
8128018|NCT02853435|20034505|P1|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
8128019|NCT02853435|20034500|P6|STARTED|Part 1a, Washout Period 2 (3 Days)||0
8128020|NCT02853435|20034501|P5|STARTED|Part 1a, Washout Period 2 (3 Days)||0
8128021|NCT02853435|20034502|P4|STARTED|Part 1a, Washout Period 2 (3 Days)||0
8128022|NCT02853435|20034503|P3|STARTED|Part 1a, Washout Period 2 (3 Days)||8
8128023|NCT02853435|20034504|P2|STARTED|Part 1a, Washout Period 2 (3 Days)||9
8128024|NCT02853435|20034505|P1|STARTED|Part 1a, Washout Period 2 (3 Days)||9
8128025|NCT02853435|20034500|P6|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8128026|NCT02853435|20034501|P5|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8128027|NCT02853435|20034502|P4|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8128028|NCT02853435|20034503|P3|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8128029|NCT02853435|20034504|P2|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8128030|NCT02853435|20034505|P1|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
8128031|NCT02853435|20034500|P6|COMPLETED|Part 1a, Period 2 (3 Days)||0
8128032|NCT02853435|20034501|P5|COMPLETED|Part 1a, Period 2 (3 Days)||0
8128033|NCT02853435|20034502|P4|COMPLETED|Part 1a, Period 2 (3 Days)||0
8128034|NCT02853435|20034503|P3|COMPLETED|Part 1a, Period 2 (3 Days)||8
8128035|NCT02853435|20034504|P2|COMPLETED|Part 1a, Period 2 (3 Days)||9
8128036|NCT02853435|20034505|P1|COMPLETED|Part 1a, Period 2 (3 Days)||9
8128037|NCT02853435|20034500|P6|STARTED|Part 1a, Period 2 (3 Days)||0
8128038|NCT02853435|20034501|P5|STARTED|Part 1a, Period 2 (3 Days)||0
8128039|NCT02853435|20034502|P4|STARTED|Part 1a, Period 2 (3 Days)||0
8128040|NCT02853435|20034503|P3|STARTED|Part 1a, Period 2 (3 Days)||8
8128041|NCT02853435|20034504|P2|STARTED|Part 1a, Period 2 (3 Days)||9
8128042|NCT02853435|20034505|P1|STARTED|Part 1a, Period 2 (3 Days)||9
8128043|NCT02853435|20034500|P6|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128044|NCT02853435|20034501|P5|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128045|NCT02853435|20034502|P4|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128046|NCT02853435|20034503|P3|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128047|NCT02853435|20034504|P2|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128048|NCT02853435|20034505|P1|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128049|NCT02853435|20034500|P6|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128050|NCT02853435|20034501|P5|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128051|NCT02853435|20034502|P4|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
8128052|NCT02853435|20034503|P3|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
8128053|NCT02853435|20034504|P2|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
8128054|NCT02853435|20034505|P1|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
8128055|NCT02853435|20034500|P6|STARTED|Part 1a, Washout Period 1 (3 Days)||0
8128056|NCT02853435|20034501|P5|STARTED|Part 1a, Washout Period 1 (3 Days)||0
8128057|NCT02853435|20034502|P4|STARTED|Part 1a, Washout Period 1 (3 Days)||0
8128058|NCT02853435|20034503|P3|STARTED|Part 1a, Washout Period 1 (3 Days)||8
8128059|NCT02853435|20034504|P2|STARTED|Part 1a, Washout Period 1 (3 Days)||9
8128060|NCT02853435|20034505|P1|STARTED|Part 1a, Washout Period 1 (3 Days)||9
8128061|NCT02853435|20034500|P6|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8128062|NCT02853435|20034501|P5|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8128063|NCT02853435|20034502|P4|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8128064|NCT02853435|20034503|P3|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8128065|NCT02853435|20034504|P2|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8128066|NCT02853435|20034505|P1|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
8128067|NCT02853435|20034500|P6|COMPLETED|Part 1a, Period 1 (3 Days)||0
8128068|NCT02853435|20034501|P5|COMPLETED|Part 1a, Period 1 (3 Days)||0
8128069|NCT02853435|20034502|P4|COMPLETED|Part 1a, Period 1 (3 Days)||0
8128070|NCT02853435|20034503|P3|COMPLETED|Part 1a, Period 1 (3 Days)||8
8128071|NCT02853435|20034504|P2|COMPLETED|Part 1a, Period 1 (3 Days)||9
8128072|NCT02853435|20034505|P1|COMPLETED|Part 1a, Period 1 (3 Days)||9
8128073|NCT02853435|20034500|P6|STARTED|Part 1a, Period 1 (3 Days)||0
8128074|NCT02853435|20034501|P5|STARTED|Part 1a, Period 1 (3 Days)||0
8128075|NCT02853435|20034502|P4|STARTED|Part 1a, Period 1 (3 Days)||0
8128076|NCT02853435|20034503|P3|STARTED|Part 1a, Period 1 (3 Days)||8
8128077|NCT02853435|20034504|P2|STARTED|Part 1a, Period 1 (3 Days)||9
8128078|NCT02853435|20034505|P1|STARTED|Part 1a, Period 1 (3 Days)||9
8128079|NCT02853331|20034815|P2|NOT COMPLETED|Overall Study||429
8128080|NCT02853331|20034816|P1|NOT COMPLETED|Overall Study||432
8128081|NCT02853331|20034815|P2|COMPLETED|Overall Study||0
8128082|NCT02853331|20034816|P1|COMPLETED|Overall Study||0
8128083|NCT02853331|20034815|P2|Treated|Overall Study||425
8128084|NCT02853331|20034816|P1|Treated|Overall Study||429
8128085|NCT02853331|20034815|P2|STARTED|Overall Study||429
8128086|NCT02853331|20034816|P1|STARTED|Overall Study||432
8128087|NCT02853318|20034848|P1|NOT COMPLETED|Overall Study||1
8128088|NCT02853318|20034848|P1|COMPLETED|Overall Study||39
8128089|NCT02853318|20034848|P1|STARTED|Overall Study||40
8128090|NCT02853123|20034856|P2|NOT COMPLETED|Treatment Period 2||0
8128091|NCT02853123|20034857|P1|NOT COMPLETED|Treatment Period 2||0
8128092|NCT02853123|20034856|P2|COMPLETED|Treatment Period 2||48
8128093|NCT02853123|20034857|P1|COMPLETED|Treatment Period 2||51
8128094|NCT02853123|20034856|P2|STARTED|Treatment Period 2||48
8128095|NCT02853123|20034857|P1|STARTED|Treatment Period 2||51
8128096|NCT02853123|20034856|P2|NOT COMPLETED|Washout Period||3
8128097|NCT02853123|20034857|P1|NOT COMPLETED|Washout Period||1
8128098|NCT02853123|20034856|P2|COMPLETED|Washout Period||48
8128099|NCT02853123|20034857|P1|COMPLETED|Washout Period||51
8128100|NCT02853123|20034856|P2|STARTED|Washout Period||51
8128101|NCT02853123|20034857|P1|STARTED|Washout Period||52
8128102|NCT02853123|20034856|P2|NOT COMPLETED|Treatment Period 1||3
8128103|NCT02853123|20034857|P1|NOT COMPLETED|Treatment Period 1||0
8128104|NCT02853123|20034856|P2|COMPLETED|Treatment Period 1||51
8128105|NCT02853123|20034857|P1|COMPLETED|Treatment Period 1||52
8128106|NCT02853123|20034856|P2|STARTED|Treatment Period 1||54
8128107|NCT02853123|20034857|P1|STARTED|Treatment Period 1||52
8128108|NCT02853032|20034880|P2|NOT COMPLETED|Overall Study||3
8128109|NCT02853032|20034881|P1|NOT COMPLETED|Overall Study||9
8128110|NCT02853032|20034880|P2|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|56
8128111|NCT02853032|20034881|P1|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|51
8128112|NCT02853032|20034880|P2|STARTED|Overall Study||59
8128113|NCT02853032|20034881|P1|STARTED|Overall Study||60
8128114|NCT02852434|20034957|P2|NOT COMPLETED|Overall Study||1
8128115|NCT02852434|20034958|P1|NOT COMPLETED|Overall Study||2
8128116|NCT02852434|20034957|P2|COMPLETED|Overall Study||35
8128117|NCT02852434|20034958|P1|COMPLETED|Overall Study||34
8128118|NCT02852434|20034957|P2|STARTED|Overall Study||36
8128119|NCT02852434|20034958|P1|STARTED|Overall Study||36
8128120|NCT02852265|20034974|P2|NOT COMPLETED|6-month Follow-up||0
8128121|NCT02852265|20034975|P1|NOT COMPLETED|6-month Follow-up||0
8128122|NCT02852265|20034974|P2|COMPLETED|6-month Follow-up||9
8128123|NCT02852265|20034975|P1|COMPLETED|6-month Follow-up||9
8128124|NCT02852265|20034974|P2|STARTED|6-month Follow-up||9
8128125|NCT02852265|20034975|P1|STARTED|6-month Follow-up||9
8128126|NCT02852265|20034974|P2|NOT COMPLETED|3-month Follow-up||1
8128127|NCT02852265|20034975|P1|NOT COMPLETED|3-month Follow-up||1
8128128|NCT02852265|20034974|P2|COMPLETED|3-month Follow-up||9
8128129|NCT02852265|20034975|P1|COMPLETED|3-month Follow-up||9
8128130|NCT02852265|20034974|P2|STARTED|3-month Follow-up||10
8128131|NCT02852265|20034975|P1|STARTED|3-month Follow-up||10
8128132|NCT02852265|20034974|P2|NOT COMPLETED|1-month Follow-up||0
8128133|NCT02852265|20034975|P1|NOT COMPLETED|1-month Follow-up||0
8128134|NCT02852265|20034974|P2|COMPLETED|1-month Follow-up||10
8128135|NCT02852265|20034975|P1|COMPLETED|1-month Follow-up||10
8128136|NCT02852265|20034974|P2|STARTED|1-month Follow-up||10
8128137|NCT02852265|20034975|P1|STARTED|1-month Follow-up||10
8128138|NCT02851823|20034991|P1|NOT COMPLETED|Overall Study||0
8128139|NCT02851823|20034991|P1|COMPLETED|Overall Study||25
8128140|NCT02851823|20034991|P1|3 Months|Overall Study||25
8128141|NCT02851823|20034991|P1|1 Month|Overall Study||25
8128142|NCT02851823|20034991|P1|STARTED|Overall Study||25
8128143|NCT02851108|20035001|P2|NOT COMPLETED|Overall Study||1
8128144|NCT02851108|20035002|P1|NOT COMPLETED|Overall Study||8
8128145|NCT02851108|20035001|P2|COMPLETED|Overall Study||49
8128146|NCT02851108|20035002|P1|COMPLETED|Overall Study||42
8128147|NCT02851108|20035001|P2|STARTED|Overall Study||50
8128148|NCT02851108|20035002|P1|STARTED|Overall Study||50
8128149|NCT02851069|20035008|P1|NOT COMPLETED|Overall Study||6
8128150|NCT02851069|20035008|P1|COMPLETED|Overall Study||59
8128151|NCT02851069|20035008|P1|STARTED|Overall Study||65
8128152|NCT02850978|20035030|P1|NOT COMPLETED|Overall Study||426
8128153|NCT02850978|20035030|P1|COMPLETED|Overall Study||909
8128154|NCT02850978|20035030|P1|Treated|Overall Study||1308
8128155|NCT02850978|20035030|P1|Case Report Form (CRF) Collected|Overall Study||1308
8128156|NCT02850978|20035030|P1|STARTED|Overall Study||1335
8128157|NCT02850965|20035037|P2|NOT COMPLETED|Overall Study||25
8128158|NCT02850965|20035038|P1|NOT COMPLETED|Overall Study||18
8128159|NCT02850965|20035037|P2|COMPLETED|Overall Study||134
8128160|NCT02850965|20035038|P1|COMPLETED|Overall Study||141
8128161|NCT02850965|20035037|P2|Treated|Overall Study||158
8128162|NCT02850965|20035038|P1|Treated|Overall Study||159
8128163|NCT02850965|20035037|P2|STARTED|Overall Study||159
8128164|NCT02850965|20035038|P1|STARTED|Overall Study||159
8128165|NCT02850276|20035054|P1|NOT COMPLETED|Overall Study||61
8128166|NCT02850276|20035054|P1|COMPLETED|Overall Study||15
8128167|NCT02850276|20035054|P1|STARTED|Overall Study||76
8128168|NCT02850159|20035067|P2|NOT COMPLETED|Overall Study||0
8128169|NCT02850159|20035068|P1|NOT COMPLETED|Overall Study||0
8128170|NCT02850159|20035067|P2|COMPLETED|Overall Study||16
8128171|NCT02850159|20035068|P1|COMPLETED|Overall Study||16
8128172|NCT02850159|20035067|P2|STARTED|Overall Study||16
8128173|NCT02850159|20035068|P1|STARTED|Overall Study||16
8128174|NCT02850068|20035074|P1|NOT COMPLETED|Overall Study||20
8128175|NCT02850068|20035074|P1|COMPLETED|Overall Study||0
8128176|NCT02850068|20035074|P1|STARTED|Overall Study||20
8128177|NCT02849990|20035081|P1|NOT COMPLETED|Overall Study||2
8128178|NCT02849990|20035081|P1|COMPLETED|Overall Study||20
8128179|NCT02849990|20035081|P1|STARTED|Overall Study||22
8128180|NCT02849938|20035093|P2|NOT COMPLETED|Overall Study||0
8128181|NCT02849938|20035094|P1|NOT COMPLETED|Overall Study||0
8128182|NCT02849938|20035093|P2|COMPLETED|Overall Study||15
8128183|NCT02849938|20035094|P1|COMPLETED|Overall Study||9
8128184|NCT02849938|20035093|P2|STARTED|Overall Study||15
8128185|NCT02849938|20035094|P1|STARTED|Overall Study||9
8128186|NCT02849704|20035106|P2|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
8128187|NCT02849704|20035107|P1|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3
8128188|NCT02849704|20035106|P2|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
8128189|NCT02849704|20035107|P1|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21
8128190|NCT02849704|20035106|P2|STARTED|Assessment on PERT - CP Subj - 16 Days||0
8128191|NCT02849704|20035107|P1|STARTED|Assessment on PERT - CP Subj - 16 Days||24
8128192|NCT02849704|20035106|P2|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
8128193|NCT02849704|20035107|P1|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
8128194|NCT02849704|20035106|P2|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
8128195|NCT02849704|20035107|P1|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
8128196|NCT02849704|20035106|P2|STARTED|Baseline Assessments - All Subj - 7 Days||24
8128197|NCT02849704|20035107|P1|STARTED|Baseline Assessments - All Subj - 7 Days||24
8128198|NCT02849704|20035106|P2|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
8128199|NCT02849704|20035107|P1|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
8128200|NCT02849704|20035106|P2|COMPLETED|Washout Period - CP Subj on PERT - 3days||0
8128201|NCT02849704|20035107|P1|COMPLETED|Washout Period - CP Subj on PERT - 3days||11
8128202|NCT02849704|20035106|P2|STARTED|Washout Period - CP Subj on PERT - 3days||0
8128203|NCT02849704|20035107|P1|STARTED|Washout Period - CP Subj on PERT - 3days||11
8128204|NCT02849678|20035122|P2|NOT COMPLETED|Overall Study||6
8128205|NCT02849678|20035123|P1|NOT COMPLETED|Overall Study||3
8128206|NCT02849678|20035122|P2|COMPLETED|Overall Study||18
8128207|NCT02849678|20035123|P1|COMPLETED|Overall Study||17
8128208|NCT02849678|20035122|P2|STARTED|Overall Study||24
8128209|NCT02849678|20035123|P1|STARTED|Overall Study||20
8128222|NCT02849509|20035207|P3|NOT COMPLETED|Overall Study||85
8128223|NCT02849509|20035208|P2|NOT COMPLETED|Overall Study||166
8128224|NCT02849509|20035209|P1|NOT COMPLETED|Overall Study||90
8128225|NCT02849509|20035207|P3|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258
8128226|NCT02849509|20035208|P2|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425
8128227|NCT02849509|20035209|P1|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289
8128228|NCT02849509|20035207|P3|STARTED|Overall Study||343
8128229|NCT02849509|20035208|P2|STARTED|Overall Study||591
8128230|NCT02849509|20035209|P1|STARTED|Overall Study||379
8128285|NCT02849184|20035393|P2|NOT COMPLETED|Overall Study||0
8128286|NCT02849184|20035394|P1|NOT COMPLETED|Overall Study||0
8128287|NCT02849184|20035393|P2|COMPLETED|Overall Study||42
8128288|NCT02849184|20035394|P1|COMPLETED|Overall Study||40
8128289|NCT02849184|20035393|P2|STARTED|Overall Study||42
8128290|NCT02849184|20035394|P1|STARTED|Overall Study||40
8128291|NCT02849080|20035416|P4|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
8128292|NCT02849080|20035417|P3|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||1
8128293|NCT02849080|20035418|P2|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
8128294|NCT02849080|20035419|P1|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||3
8128295|NCT02849080|20035416|P4|COMPLETED|Extension Phase: 53 - 104 Weeks||98
8128296|NCT02849080|20035417|P3|COMPLETED|Extension Phase: 53 - 104 Weeks||99
8128297|NCT02849080|20035418|P2|COMPLETED|Extension Phase: 53 - 104 Weeks||0
8128298|NCT02849080|20035419|P1|COMPLETED|Extension Phase: 53 - 104 Weeks||182
8128299|NCT02849080|20035416|P4|Exposed|Extension Phase: 53 - 104 Weeks||97
8128300|NCT02849080|20035417|P3|Exposed|Extension Phase: 53 - 104 Weeks||100
8128301|NCT02849080|20035418|P2|Exposed|Extension Phase: 53 - 104 Weeks||0
8128302|NCT02849080|20035419|P1|Exposed|Extension Phase: 53 - 104 Weeks||184
8128303|NCT02849080|20035416|P4|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|98
8128304|NCT02849080|20035417|P3|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|100
8128305|NCT02849080|20035418|P2|STARTED|Extension Phase: 53 - 104 Weeks||0
8128306|NCT02849080|20035419|P1|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|185
8128307|NCT02849080|20035416|P4|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
8128308|NCT02849080|20035417|P3|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
8128309|NCT02849080|20035418|P2|NOT COMPLETED|Main Phase: 0 - 52 Weeks||7
8128310|NCT02849080|20035419|P1|NOT COMPLETED|Main Phase: 0 - 52 Weeks||12
8128311|NCT02849080|20035416|P4|COMPLETED|Main Phase: 0 - 52 Weeks||0
8128312|NCT02849080|20035417|P3|COMPLETED|Main Phase: 0 - 52 Weeks||0
8128313|NCT02849080|20035418|P2|COMPLETED|Main Phase: 0 - 52 Weeks||244
8128314|NCT02849080|20035419|P1|COMPLETED|Main Phase: 0 - 52 Weeks||241
8128315|NCT02849080|20035416|P4|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
8128316|NCT02849080|20035417|P3|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
8128317|NCT02849080|20035418|P2|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||250
8128318|NCT02849080|20035419|P1|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||253
8128319|NCT02849080|20035416|P4|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
8128320|NCT02849080|20035417|P3|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
8128321|NCT02849080|20035418|P2|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||251
8128322|NCT02849080|20035419|P1|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||253
8128323|NCT02849080|20035416|P4|Exposed|Main Phase: 0 - 52 Weeks||0
8128324|NCT02849080|20035417|P3|Exposed|Main Phase: 0 - 52 Weeks||0
8128325|NCT02849080|20035418|P2|Exposed|Main Phase: 0 - 52 Weeks||250
8128326|NCT02849080|20035419|P1|Exposed|Main Phase: 0 - 52 Weeks||253
8128327|NCT02849080|20035416|P4|STARTED|Main Phase: 0 - 52 Weeks||0
8128328|NCT02849080|20035417|P3|STARTED|Main Phase: 0 - 52 Weeks||0
8128329|NCT02849080|20035418|P2|STARTED|Main Phase: 0 - 52 Weeks||251
8128330|NCT02849080|20035419|P1|STARTED|Main Phase: 0 - 52 Weeks||253
8128331|NCT02848729|20035546|P2|NOT COMPLETED|Overall Study||11
8128332|NCT02848729|20035547|P1|NOT COMPLETED|Overall Study||16
8128333|NCT02848729|20035546|P2|COMPLETED|Overall Study||12
8128334|NCT02848729|20035547|P1|COMPLETED|Overall Study||11
8128335|NCT02848729|20035546|P2|Safety Population|Overall Study||23
8128336|NCT02848729|20035547|P1|Safety Population|Overall Study||27
8128337|NCT02848729|20035546|P2|Per Protocol Population|Overall Study||11
8128338|NCT02848729|20035547|P1|Per Protocol Population|Overall Study||11
8128339|NCT02848729|20035546|P2|STARTED|Overall Study||23
8128340|NCT02848729|20035547|P1|STARTED|Overall Study||27
8128341|NCT02848664|20035564|P1|NOT COMPLETED|Overall Study||4
8128342|NCT02848664|20035564|P1|COMPLETED|Overall Study||7
8128343|NCT02848664|20035564|P1|STARTED|Overall Study||11
8128344|NCT02848651|20035572|P1|NOT COMPLETED|Overall Study||106
8128345|NCT02848651|20035572|P1|COMPLETED|Overall Study||47
8128346|NCT02848651|20035572|P1|Received Treatment|Overall Study||152
8128347|NCT02848651|20035572|P1|STARTED|Overall Study||153
8128348|NCT02848599|20035601|P2|NOT COMPLETED|Overall Study||9
8128349|NCT02848599|20035602|P1|NOT COMPLETED|Overall Study||7
8128350|NCT02848599|20035601|P2|COMPLETED|Overall Study||35
8128351|NCT02848599|20035602|P1|COMPLETED|Overall Study||35
8128352|NCT02848599|20035601|P2|STARTED|Overall Study||44
8128353|NCT02848599|20035602|P1|STARTED|Overall Study||42
8128354|NCT02848326|20035624|P6|NOT COMPLETED|Safety Follow-up Period||5
8128355|NCT02848326|20035625|P5|NOT COMPLETED|Safety Follow-up Period||1
8128356|NCT02848326|20035626|P4|NOT COMPLETED|Safety Follow-up Period||0
8128357|NCT02848326|20035627|P3|NOT COMPLETED|Safety Follow-up Period||3
8128358|NCT02848326|20035628|P2|NOT COMPLETED|Safety Follow-up Period||1
8128359|NCT02848326|20035629|P1|NOT COMPLETED|Safety Follow-up Period||4
8128360|NCT02848326|20035624|P6|COMPLETED|Safety Follow-up Period||77
8128361|NCT02848326|20035625|P5|COMPLETED|Safety Follow-up Period||76
8128362|NCT02848326|20035626|P4|COMPLETED|Safety Follow-up Period||169
8128363|NCT02848326|20035627|P3|COMPLETED|Safety Follow-up Period||153
8128364|NCT02848326|20035628|P2|COMPLETED|Safety Follow-up Period||83
8128365|NCT02848326|20035629|P1|COMPLETED|Safety Follow-up Period||157
8128366|NCT02848326|20035624|P6|STARTED|Safety Follow-up Period||82
8128367|NCT02848326|20035625|P5|STARTED|Safety Follow-up Period||77
8128368|NCT02848326|20035626|P4|STARTED|Safety Follow-up Period||169
8128369|NCT02848326|20035627|P3|STARTED|Safety Follow-up Period||156
8128370|NCT02848326|20035628|P2|STARTED|Safety Follow-up Period||84
8128371|NCT02848326|20035629|P1|STARTED|Safety Follow-up Period||161
8128372|NCT02848326|20035624|P6|NOT COMPLETED|Treatment Period||20
8128373|NCT02848326|20035625|P5|NOT COMPLETED|Treatment Period||19
8128374|NCT02848326|20035626|P4|NOT COMPLETED|Treatment Period||23
8128375|NCT02848326|20035627|P3|NOT COMPLETED|Treatment Period||36
8128376|NCT02848326|20035628|P2|NOT COMPLETED|Treatment Period||14
8128377|NCT02848326|20035629|P1|NOT COMPLETED|Treatment Period||38
8128378|NCT02848326|20035624|P6|COMPLETED|Treatment Period||73
8128379|NCT02848326|20035625|P5|COMPLETED|Treatment Period||70
8128380|NCT02848326|20035626|P4|COMPLETED|Treatment Period||164
8128381|NCT02848326|20035627|P3|COMPLETED|Treatment Period||149
8128382|NCT02848326|20035628|P2|COMPLETED|Treatment Period||80
8128383|NCT02848326|20035629|P1|COMPLETED|Treatment Period||148
8128384|NCT02848326|20035624|P6|Safety Population: Received Study Drug|Treatment Period||91
8128385|NCT02848326|20035625|P5|Safety Population: Received Study Drug|Treatment Period||86
8128386|NCT02848326|20035626|P4|Safety Population: Received Study Drug|Treatment Period||186
8128387|NCT02848326|20035627|P3|Safety Population: Received Study Drug|Treatment Period||183
8128388|NCT02848326|20035628|P2|Safety Population: Received Study Drug|Treatment Period||93
8128389|NCT02848326|20035629|P1|Safety Population: Received Study Drug|Treatment Period||186
8128390|NCT02848326|20035624|P6|STARTED|Treatment Period||93
8128391|NCT02848326|20035625|P5|STARTED|Treatment Period||89
8128392|NCT02848326|20035626|P4|STARTED|Treatment Period||187
8128393|NCT02848326|20035627|P3|STARTED|Treatment Period||185
8128394|NCT02848326|20035628|P2|STARTED|Treatment Period||94
8128395|NCT02848326|20035629|P1|STARTED|Treatment Period||186
8128396|NCT02848313|20035663|P2|NOT COMPLETED|Overall Study||4
8128397|NCT02848313|20035664|P1|NOT COMPLETED|Overall Study||3
8128398|NCT02848313|20035663|P2|COMPLETED|Overall Study||15
8128399|NCT02848313|20035664|P1|COMPLETED|Overall Study||18
8128400|NCT02848313|20035663|P2|STARTED|Overall Study||19
8128401|NCT02848313|20035664|P1|STARTED|Overall Study||21
8128402|NCT02848222|20035699|P3|NOT COMPLETED|Overall Study||0
8128403|NCT02848222|20035700|P2|NOT COMPLETED|Overall Study||1
8128404|NCT02848222|20035701|P1|NOT COMPLETED|Overall Study||7
8128405|NCT02848222|20035699|P3|COMPLETED|Overall Study||17
8128406|NCT02848222|20035700|P2|COMPLETED|Overall Study||17
8128407|NCT02848222|20035701|P1|COMPLETED|Overall Study||18
8128408|NCT02848222|20035699|P3|STARTED|Overall Study||17
8128409|NCT02848222|20035700|P2|STARTED|Overall Study||18
8128410|NCT02848222|20035701|P1|STARTED|Overall Study||25
8128411|NCT02847858|20035711|P2|NOT COMPLETED|Overall Study||269
8128412|NCT02847858|20035712|P1|NOT COMPLETED|Overall Study||401
8128413|NCT02847858|20035711|P2|COMPLETED|Overall Study||398
8128414|NCT02847858|20035712|P1|COMPLETED|Overall Study||292
8128415|NCT02847858|20035711|P2|STARTED|Overall Study||667
8128416|NCT02847858|20035712|P1|STARTED|Overall Study||693
8128417|NCT02847650|20035738|P2|NOT COMPLETED|Overall Study||6
8128418|NCT02847650|20035739|P1|NOT COMPLETED|Overall Study||4
8128419|NCT02847650|20035738|P2|COMPLETED|Overall Study||22
8128420|NCT02847650|20035739|P1|COMPLETED|Overall Study||25
8128421|NCT02847650|20035738|P2|STARTED|Overall Study||28
8128422|NCT02847650|20035739|P1|STARTED|Overall Study||29
8128447|NCT02847494|20035880|P2|NOT COMPLETED|Overall Study||5
8128448|NCT02847494|20035881|P1|NOT COMPLETED|Overall Study||8
8128449|NCT02847494|20035880|P2|COMPLETED|Overall Study||106
8128450|NCT02847494|20035881|P1|COMPLETED|Overall Study||101
8128451|NCT02847494|20035880|P2|STARTED|Overall Study||111
8128452|NCT02847494|20035881|P1|STARTED|Overall Study||109
8128453|NCT02847260|20035891|P1|NOT COMPLETED|Overall Study||7
8128454|NCT02847260|20035891|P1|COMPLETED|Overall Study||32
8128455|NCT02847260|20035891|P1|STARTED|Overall Study||39
8128456|NCT02847182|20035905|P2|NOT COMPLETED|Overall Study||1
8128457|NCT02847182|20035906|P1|NOT COMPLETED|Overall Study||0
8128458|NCT02847182|20035905|P2|COMPLETED|Overall Study||60
8128459|NCT02847182|20035906|P1|COMPLETED|Overall Study||119
8128460|NCT02847182|20035905|P2|Second Intervention (6 Months)|Overall Study||119
8128461|NCT02847182|20035906|P1|Second Intervention (6 Months)|Overall Study||61
8128462|NCT02847182|20035905|P2|First Intervention (6 Months)|Overall Study||61
8128463|NCT02847182|20035906|P1|First Intervention (6 Months)|Overall Study||119
8128464|NCT02847182|20035905|P2|STARTED|Overall Study||61
8128465|NCT02847182|20035906|P1|STARTED|Overall Study||119
8128466|NCT02847169|20035982|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8128467|NCT02847169|20035983|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8128468|NCT02847169|20035982|P2|COMPLETED|Second Intervention (1 Week)||15
8128469|NCT02847169|20035983|P1|COMPLETED|Second Intervention (1 Week)||15
8128470|NCT02847169|20035982|P2|STARTED|Second Intervention (1 Week)||15
8128471|NCT02847169|20035983|P1|STARTED|Second Intervention (1 Week)||15
8128472|NCT02847169|20035982|P2|NOT COMPLETED|First Intervention (1 Week)||0
8128473|NCT02847169|20035983|P1|NOT COMPLETED|First Intervention (1 Week)||0
8128474|NCT02847169|20035982|P2|COMPLETED|First Intervention (1 Week)||15
8128475|NCT02847169|20035983|P1|COMPLETED|First Intervention (1 Week)||15
8128476|NCT02847169|20035982|P2|STARTED|First Intervention (1 Week)||15
8128477|NCT02847169|20035983|P1|STARTED|First Intervention (1 Week)||15
8128478|NCT02846792|20036017|P1|NOT COMPLETED|Overall Study||0
8128479|NCT02846792|20036017|P1|COMPLETED|Overall Study||5
8128480|NCT02846792|20036017|P1|STARTED|Overall Study||5
8128481|NCT02846779|20036030|P3|NOT COMPLETED|Overall Study||138
8128482|NCT02846779|20036031|P2|NOT COMPLETED|Overall Study||127
8128483|NCT02846779|20036032|P1|NOT COMPLETED|Overall Study||139
8128484|NCT02846779|20036030|P3|COMPLETED|Overall Study||1862
8128485|NCT02846779|20036031|P2|COMPLETED|Overall Study||1873
8128486|NCT02846779|20036032|P1|COMPLETED|Overall Study||1861
8128487|NCT02846779|20036030|P3|STARTED|Overall Study||2000
8128488|NCT02846779|20036031|P2|STARTED|Overall Study||2000
8128489|NCT02846779|20036032|P1|STARTED|Overall Study||2000
8128490|NCT02846740|20036057|P2|NOT COMPLETED|Overall Study||1
8128491|NCT02846740|20036058|P1|NOT COMPLETED|Overall Study||0
8128492|NCT02846740|20036057|P2|COMPLETED|Overall Study||14
8128493|NCT02846740|20036058|P1|COMPLETED|Overall Study||15
8128494|NCT02846740|20036057|P2|STARTED|Overall Study||15
8128495|NCT02846740|20036058|P1|STARTED|Overall Study||15
8128496|NCT02846714|20036068|P1|NOT COMPLETED|Overall Study||6
8128497|NCT02846714|20036068|P1|COMPLETED|Overall Study||36
8128498|NCT02846714|20036068|P1|STARTED|Overall Study||42
8128499|NCT02846558|20036088|P4|NOT COMPLETED|Overall Study||2
8128500|NCT02846558|20036089|P3|NOT COMPLETED|Overall Study||2
8128501|NCT02846558|20036090|P2|NOT COMPLETED|Overall Study||4
8128502|NCT02846558|20036091|P1|NOT COMPLETED|Overall Study||8
8128503|NCT02846558|20036088|P4|COMPLETED|Overall Study||11
8128504|NCT02846558|20036089|P3|COMPLETED|Overall Study||12
8128505|NCT02846558|20036090|P2|COMPLETED|Overall Study||8
8128506|NCT02846558|20036091|P1|COMPLETED|Overall Study||7
8128507|NCT02846558|20036088|P4|3 Month Study Visit|Overall Study||11
8128508|NCT02846558|20036089|P3|3 Month Study Visit|Overall Study||12
8128509|NCT02846558|20036090|P2|3 Month Study Visit|Overall Study||8
8128510|NCT02846558|20036091|P1|3 Month Study Visit|Overall Study||7
8128511|NCT02846558|20036088|P4|Baseline Study Visit|Overall Study||12
8128512|NCT02846558|20036089|P3|Baseline Study Visit|Overall Study||14
8128513|NCT02846558|20036090|P2|Baseline Study Visit|Overall Study||9
8128514|NCT02846558|20036091|P1|Baseline Study Visit|Overall Study||10
8128515|NCT02846558|20036088|P4|STARTED|Overall Study||13
8128516|NCT02846558|20036089|P3|STARTED|Overall Study||14
8128517|NCT02846558|20036090|P2|STARTED|Overall Study||12
8128518|NCT02846558|20036091|P1|STARTED|Overall Study||15
8128519|NCT02846415|20036129|P2|NOT COMPLETED|Overall Study||1
8128520|NCT02846415|20036130|P1|NOT COMPLETED|Overall Study||3
8128521|NCT02846415|20036129|P2|COMPLETED|Overall Study||11
8128522|NCT02846415|20036130|P1|COMPLETED|Overall Study||15
8128523|NCT02846415|20036129|P2|STARTED|Overall Study||12
8128524|NCT02846415|20036130|P1|STARTED|Overall Study||18
8128525|NCT02846324|20036144|P4|NOT COMPLETED|Overall Study||0
8128526|NCT02846324|20036145|P3|NOT COMPLETED|Overall Study||4
8128527|NCT02846324|20036146|P2|NOT COMPLETED|Overall Study||0
8128528|NCT02846324|20036147|P1|NOT COMPLETED|Overall Study||2
8128529|NCT02846324|20036144|P4|COMPLETED|Overall Study||10
8128530|NCT02846324|20036145|P3|COMPLETED|Overall Study||10
8128531|NCT02846324|20036146|P2|COMPLETED|Overall Study||6
8128532|NCT02846324|20036147|P1|COMPLETED|Overall Study||7
8128533|NCT02846324|20036144|P4|Completed Study Treatment|Overall Study||10
8128534|NCT02846324|20036145|P3|Completed Study Treatment|Overall Study||11
8128535|NCT02846324|20036146|P2|Completed Study Treatment|Overall Study||5
8128536|NCT02846324|20036147|P1|Completed Study Treatment|Overall Study||7
8128537|NCT02846324|20036144|P4|STARTED|Overall Study||10
8128538|NCT02846324|20036145|P3|STARTED|Overall Study||14
8128539|NCT02846324|20036146|P2|STARTED|Overall Study||6
8128540|NCT02846324|20036147|P1|STARTED|Overall Study||9
8128541|NCT02846233|20036179|P2|NOT COMPLETED|Overall Study||2
8128542|NCT02846233|20036180|P1|NOT COMPLETED|Overall Study||2
8128543|NCT02846233|20036179|P2|COMPLETED|Overall Study||8
8128544|NCT02846233|20036180|P1|COMPLETED|Overall Study||10
8128545|NCT02846233|20036179|P2|STARTED|Overall Study||10
8128546|NCT02846233|20036180|P1|STARTED|Overall Study||12
8128547|NCT02845752|20036202|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8128548|NCT02845752|20036203|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8128549|NCT02845752|20036202|P2|COMPLETED|Second Intervention (7 Days)||7
8128550|NCT02845752|20036203|P1|COMPLETED|Second Intervention (7 Days)||7
8128551|NCT02845752|20036202|P2|STARTED|Second Intervention (7 Days)||7
8128552|NCT02845752|20036203|P1|STARTED|Second Intervention (7 Days)||7
8128553|NCT02845752|20036202|P2|NOT COMPLETED|Washout (14 Days)||0
8128554|NCT02845752|20036203|P1|NOT COMPLETED|Washout (14 Days)||0
8128555|NCT02845752|20036202|P2|COMPLETED|Washout (14 Days)||7
8128556|NCT02845752|20036203|P1|COMPLETED|Washout (14 Days)||7
8128557|NCT02845752|20036202|P2|STARTED|Washout (14 Days)||7
8128558|NCT02845752|20036203|P1|STARTED|Washout (14 Days)||7
8128559|NCT02845752|20036202|P2|NOT COMPLETED|First Intervention (7 Days)||0
8128560|NCT02845752|20036203|P1|NOT COMPLETED|First Intervention (7 Days)||0
8128561|NCT02845752|20036202|P2|COMPLETED|First Intervention (7 Days)||7
8128562|NCT02845752|20036203|P1|COMPLETED|First Intervention (7 Days)||7
8128563|NCT02845752|20036202|P2|STARTED|First Intervention (7 Days)||7
8128564|NCT02845752|20036203|P1|STARTED|First Intervention (7 Days)||7
8128565|NCT02845700|20036237|P2|NOT COMPLETED|Month 1 Follow-Up||0
8128566|NCT02845700|20036238|P1|NOT COMPLETED|Month 1 Follow-Up||0
8128567|NCT02845700|20036237|P2|COMPLETED|Month 1 Follow-Up||4
8128568|NCT02845700|20036238|P1|COMPLETED|Month 1 Follow-Up||2
8128569|NCT02845700|20036237|P2|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4
8128570|NCT02845700|20036238|P1|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2
8128571|NCT02845700|20036237|P2|NOT COMPLETED|Intervention Session 2||0
8128572|NCT02845700|20036238|P1|NOT COMPLETED|Intervention Session 2||0
8128573|NCT02845700|20036237|P2|COMPLETED|Intervention Session 2||6
8128574|NCT02845700|20036238|P1|COMPLETED|Intervention Session 2||5
8128575|NCT02845700|20036237|P2|STARTED|Intervention Session 2||6
8128576|NCT02845700|20036238|P1|STARTED|Intervention Session 2||5
8128577|NCT02845700|20036237|P2|NOT COMPLETED|Intervention Session 1||0
8128578|NCT02845700|20036238|P1|NOT COMPLETED|Intervention Session 1||0
8128579|NCT02845700|20036237|P2|COMPLETED|Intervention Session 1||6
8128580|NCT02845700|20036238|P1|COMPLETED|Intervention Session 1||5
8128581|NCT02845700|20036237|P2|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6
8128582|NCT02845700|20036238|P1|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5
8128583|NCT02845700|20036237|P2|NOT COMPLETED|Baseline Appointment||0
8128584|NCT02845700|20036238|P1|NOT COMPLETED|Baseline Appointment||0
8128585|NCT02845700|20036237|P2|COMPLETED|Baseline Appointment||7
8128586|NCT02845700|20036238|P1|COMPLETED|Baseline Appointment||6
8128587|NCT02845700|20036237|P2|STARTED|Baseline Appointment||7
8128588|NCT02845700|20036238|P1|STARTED|Baseline Appointment||6
8128589|NCT02845674|20036254|P2|NOT COMPLETED|Overall Study||50
8128590|NCT02845674|20036255|P1|NOT COMPLETED|Overall Study||18
8128591|NCT02845674|20036254|P2|COMPLETED|Overall Study||79
8128592|NCT02845674|20036255|P1|COMPLETED|Overall Study||111
8128593|NCT02845674|20036254|P2|STARTED|Overall Study||129
8128594|NCT02845674|20036255|P1|STARTED|Overall Study||129
8128595|NCT02845375|20036264|P3|NOT COMPLETED|Overall Study||1
8128596|NCT02845375|20036265|P2|NOT COMPLETED|Overall Study||2
8128597|NCT02845375|20036266|P1|NOT COMPLETED|Overall Study||1
8128598|NCT02845375|20036264|P3|COMPLETED|Overall Study||12
8128599|NCT02845375|20036265|P2|COMPLETED|Overall Study||12
8128600|NCT02845375|20036266|P1|COMPLETED|Overall Study||12
8128601|NCT02845375|20036264|P3|STARTED|Overall Study||13
8128602|NCT02845375|20036265|P2|STARTED|Overall Study||14
8128603|NCT02845375|20036266|P1|STARTED|Overall Study||13
8128604|NCT02845336|20036279|P2|NOT COMPLETED|Overall Study||1
8128605|NCT02845336|20036280|P1|NOT COMPLETED|Overall Study||5
8128606|NCT02845336|20036279|P2|COMPLETED|Overall Study||0
8128607|NCT02845336|20036280|P1|COMPLETED|Overall Study||1
8128608|NCT02845336|20036279|P2|STARTED|Overall Study||1
8128609|NCT02845336|20036280|P1|STARTED|Overall Study||6
8128610|NCT02844998|20036307|P3|NOT COMPLETED|Overall Study||4
8128611|NCT02844998|20036308|P2|NOT COMPLETED|Overall Study||4
8128612|NCT02844998|20036309|P1|NOT COMPLETED|Overall Study||7
8128613|NCT02844998|20036307|P3|COMPLETED|Overall Study||35
8128614|NCT02844998|20036308|P2|COMPLETED|Overall Study||35
8128615|NCT02844998|20036309|P1|COMPLETED|Overall Study||35
8128616|NCT02844998|20036307|P3|STARTED|Overall Study||39
8128617|NCT02844998|20036308|P2|STARTED|Overall Study||39
8128618|NCT02844998|20036309|P1|STARTED|Overall Study||42
8128619|NCT02844946|20036322|P2|NOT COMPLETED|Overall Study||0
8128620|NCT02844946|20036323|P1|NOT COMPLETED|Overall Study||7
8128621|NCT02844946|20036322|P2|COMPLETED|Overall Study||12
8128622|NCT02844946|20036323|P1|COMPLETED|Overall Study||20
8128623|NCT02844946|20036322|P2|STARTED|Overall Study||12
8128624|NCT02844946|20036323|P1|STARTED|Overall Study||27
8128625|NCT02844920|20036341|P1|NOT COMPLETED|Overall Study||2
8128626|NCT02844920|20036341|P1|COMPLETED|Overall Study|Participants with completed the follow-up|35
8128627|NCT02844920|20036341|P1|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6
8128628|NCT02844920|20036341|P1|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34
8128629|NCT02844920|20036341|P1|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1
8128630|NCT02844920|20036341|P1|STARTED|Overall Study||37
8128631|NCT02844582|20036346|P1|NOT COMPLETED|Overall Study||0
8128632|NCT02844582|20036346|P1|COMPLETED|Overall Study||2
8128633|NCT02844582|20036346|P1|STARTED|Overall Study||2
8128634|NCT02844569|20036356|P2|NOT COMPLETED|Overall Study||0
8128635|NCT02844569|20036357|P1|NOT COMPLETED|Overall Study||0
8128636|NCT02844569|20036356|P2|COMPLETED|Overall Study||12
8128637|NCT02844569|20036357|P1|COMPLETED|Overall Study||12
8128638|NCT02844569|20036356|P2|STARTED|Overall Study||12
8128639|NCT02844569|20036357|P1|STARTED|Overall Study||12
8128640|NCT02844543|20036367|P1|NOT COMPLETED|Overall Study||5
8128641|NCT02844543|20036367|P1|COMPLETED|Overall Study||150
8128642|NCT02844543|20036367|P1|STARTED|Overall Study||155
8128643|NCT02843659|20036377|P3|NOT COMPLETED|Overall Study||5
8128644|NCT02843659|20036378|P2|NOT COMPLETED|Overall Study||6
8128645|NCT02843659|20036379|P1|NOT COMPLETED|Overall Study||4
8128646|NCT02843659|20036377|P3|COMPLETED|Overall Study||2
8128647|NCT02843659|20036378|P2|COMPLETED|Overall Study||0
8128648|NCT02843659|20036379|P1|COMPLETED|Overall Study||1
8128649|NCT02843659|20036377|P3|STARTED|Overall Study||7
8128650|NCT02843659|20036378|P2|STARTED|Overall Study||6
8128651|NCT02843659|20036379|P1|STARTED|Overall Study||5
8128652|NCT02843529|20036446|P2|NOT COMPLETED|Overall Study||21
8128653|NCT02843529|20036447|P1|NOT COMPLETED|Overall Study||31
8128654|NCT02843529|20036446|P2|COMPLETED|Overall Study||283
8128655|NCT02843529|20036447|P1|COMPLETED|Overall Study||213
8128656|NCT02843529|20036446|P2|STARTED|Overall Study||304
8128657|NCT02843529|20036447|P1|STARTED|Overall Study||244
8128658|NCT02843178|20036457|P4|NOT COMPLETED|Overall Study||4
8128659|NCT02843178|20036458|P3|NOT COMPLETED|Overall Study||7
8128660|NCT02843178|20036459|P2|NOT COMPLETED|Overall Study||8
8128661|NCT02843178|20036460|P1|NOT COMPLETED|Overall Study||8
8128662|NCT02843178|20036457|P4|COMPLETED|Overall Study||87
8128663|NCT02843178|20036458|P3|COMPLETED|Overall Study||85
8128664|NCT02843178|20036459|P2|COMPLETED|Overall Study||82
8128665|NCT02843178|20036460|P1|COMPLETED|Overall Study||78
8128666|NCT02843178|20036457|P4|STARTED|Overall Study||91
8128667|NCT02843178|20036458|P3|STARTED|Overall Study||92
8128668|NCT02843178|20036459|P2|STARTED|Overall Study||90
8128669|NCT02843178|20036460|P1|STARTED|Overall Study||86
8128670|NCT02842866|20036500|P2|NOT COMPLETED|Overall Study||3
8128671|NCT02842866|20036501|P1|NOT COMPLETED|Overall Study||7
8128672|NCT02842866|20036500|P2|COMPLETED|Overall Study||452
8128673|NCT02842866|20036501|P1|COMPLETED|Overall Study||444
8128674|NCT02842866|20036500|P2|Vaccinated|Overall Study||453
8128675|NCT02842866|20036501|P1|Vaccinated|Overall Study||448
8128676|NCT02842866|20036500|P2|STARTED|Overall Study||455
8128677|NCT02842866|20036501|P1|STARTED|Overall Study||451
8128678|NCT02842853|20036513|P4|NOT COMPLETED|Overall Study||24
8128679|NCT02842853|20036514|P3|NOT COMPLETED|Overall Study||21
8128680|NCT02842853|20036515|P2|NOT COMPLETED|Overall Study||34
8128681|NCT02842853|20036516|P1|NOT COMPLETED|Overall Study||23
8128682|NCT02842853|20036513|P4|COMPLETED|Overall Study||617
8128683|NCT02842853|20036514|P3|COMPLETED|Overall Study||885
8128684|NCT02842853|20036515|P2|COMPLETED|Overall Study||861
8128685|NCT02842853|20036516|P1|COMPLETED|Overall Study||879
8128686|NCT02842853|20036513|P4|Safety Analysis Set (SafAS)|Overall Study||635
8128687|NCT02842853|20036514|P3|Safety Analysis Set (SafAS)|Overall Study||898
8128688|NCT02842853|20036515|P2|Safety Analysis Set (SafAS)|Overall Study||883
8128689|NCT02842853|20036516|P1|Safety Analysis Set (SafAS)|Overall Study||895
8128690|NCT02842853|20036513|P4|Vaccinated|Overall Study||636
8128691|NCT02842853|20036514|P3|Vaccinated|Overall Study||900
8128692|NCT02842853|20036515|P2|Vaccinated|Overall Study||886
8128693|NCT02842853|20036516|P1|Vaccinated|Overall Study||895
8128694|NCT02842853|20036513|P4|STARTED|Overall Study||641
8128695|NCT02842853|20036514|P3|STARTED|Overall Study||906
8128696|NCT02842853|20036515|P2|STARTED|Overall Study||895
8128697|NCT02842853|20036516|P1|STARTED|Overall Study||902
8128698|NCT02842736|20036536|P1|NOT COMPLETED|Overall Study||41
8128699|NCT02842736|20036536|P1|COMPLETED|Overall Study|36 Month Visit Completed|201
8128700|NCT02842736|20036536|P1|24 Month Visit Performed|Overall Study||210
8128701|NCT02842736|20036536|P1|Known Month 12 Outcome|Overall Study||230
8128702|NCT02842736|20036536|P1|STARTED|Overall Study|Treated|242
8128709|NCT02842151|20036579|P1|NOT COMPLETED|Overall Study||2
8128710|NCT02842151|20036579|P1|COMPLETED|Overall Study||148
8128711|NCT02842151|20036579|P1|STARTED|Overall Study||150
8128718|NCT02842073|20036624|P1|NOT COMPLETED|Overall Study||1
8128719|NCT02842073|20036624|P1|COMPLETED|Overall Study||11
8128720|NCT02842073|20036624|P1|STARTED|Overall Study||12
8128721|NCT02842060|20036634|P2|NOT COMPLETED|Overall Study||0
8128722|NCT02842060|20036635|P1|NOT COMPLETED|Overall Study||0
8128723|NCT02842060|20036634|P2|COMPLETED|Overall Study||60
8128724|NCT02842060|20036635|P1|COMPLETED|Overall Study||120
8128725|NCT02842060|20036634|P2|STARTED|Overall Study||60
8128726|NCT02842060|20036635|P1|STARTED|Overall Study||120
8128727|NCT02841787|20036650|P3|NOT COMPLETED|Overall Study||0
8128728|NCT02841787|20036651|P2|NOT COMPLETED|Overall Study||4
8128729|NCT02841787|20036652|P1|NOT COMPLETED|Overall Study||3
8128730|NCT02841787|20036650|P3|COMPLETED|Overall Study||12
8128731|NCT02841787|20036651|P2|COMPLETED|Overall Study||19
8128732|NCT02841787|20036652|P1|COMPLETED|Overall Study||9
8128733|NCT02841787|20036650|P3|STARTED|Overall Study||12
8128734|NCT02841787|20036651|P2|STARTED|Overall Study||23
8128735|NCT02841787|20036652|P1|STARTED|Overall Study||12
8128736|NCT02841709|20036666|P5|NOT COMPLETED|5th Intervention||2
8128737|NCT02841709|20036667|P4|NOT COMPLETED|5th Intervention||0
8128738|NCT02841709|20036668|P3|NOT COMPLETED|5th Intervention||0
8128739|NCT02841709|20036669|P2|NOT COMPLETED|5th Intervention||0
8128740|NCT02841709|20036670|P1|NOT COMPLETED|5th Intervention||2
8128741|NCT02841709|20036666|P5|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 5.|9
8128742|NCT02841709|20036667|P4|COMPLETED|5th Intervention||12
8128743|NCT02841709|20036668|P3|COMPLETED|5th Intervention||12
8128744|NCT02841709|20036669|P2|COMPLETED|5th Intervention||11
8128745|NCT02841709|20036670|P1|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 1.|10
8128746|NCT02841709|20036666|P5|STARTED|5th Intervention||11
8128747|NCT02841709|20036667|P4|STARTED|5th Intervention||12
8128748|NCT02841709|20036668|P3|STARTED|5th Intervention||12
8128749|NCT02841709|20036669|P2|STARTED|5th Intervention||11
8128750|NCT02841709|20036670|P1|STARTED|5th Intervention||12
8128751|NCT02841709|20036666|P5|NOT COMPLETED|Washout Period 4||0
8128752|NCT02841709|20036667|P4|NOT COMPLETED|Washout Period 4||0
8128753|NCT02841709|20036668|P3|NOT COMPLETED|Washout Period 4||0
8128754|NCT02841709|20036669|P2|NOT COMPLETED|Washout Period 4||0
8128755|NCT02841709|20036670|P1|NOT COMPLETED|Washout Period 4||0
8128756|NCT02841709|20036666|P5|COMPLETED|Washout Period 4||11
8128757|NCT02841709|20036667|P4|COMPLETED|Washout Period 4||12
8128758|NCT02841709|20036668|P3|COMPLETED|Washout Period 4||12
8128759|NCT02841709|20036669|P2|COMPLETED|Washout Period 4||11
8128760|NCT02841709|20036670|P1|COMPLETED|Washout Period 4||12
8128761|NCT02841709|20036666|P5|STARTED|Washout Period 4||11
8128762|NCT02841709|20036667|P4|STARTED|Washout Period 4||12
8128763|NCT02841709|20036668|P3|STARTED|Washout Period 4||12
8128764|NCT02841709|20036669|P2|STARTED|Washout Period 4||11
8128765|NCT02841709|20036670|P1|STARTED|Washout Period 4||12
8128766|NCT02841709|20036666|P5|NOT COMPLETED|4th Intervention||0
8128767|NCT02841709|20036667|P4|NOT COMPLETED|4th Intervention||0
8128768|NCT02841709|20036668|P3|NOT COMPLETED|4th Intervention||0
8128769|NCT02841709|20036669|P2|NOT COMPLETED|4th Intervention||0
8128770|NCT02841709|20036670|P1|NOT COMPLETED|4th Intervention||0
8128771|NCT02841709|20036666|P5|COMPLETED|4th Intervention||11
8128772|NCT02841709|20036667|P4|COMPLETED|4th Intervention||12
8128773|NCT02841709|20036668|P3|COMPLETED|4th Intervention||12
8128774|NCT02841709|20036669|P2|COMPLETED|4th Intervention||11
8128775|NCT02841709|20036670|P1|COMPLETED|4th Intervention||12
8128776|NCT02841709|20036666|P5|STARTED|4th Intervention||11
8128777|NCT02841709|20036667|P4|STARTED|4th Intervention||12
8128778|NCT02841709|20036668|P3|STARTED|4th Intervention||12
8128779|NCT02841709|20036669|P2|STARTED|4th Intervention||11
8128780|NCT02841709|20036670|P1|STARTED|4th Intervention||12
8128781|NCT02841709|20036666|P5|NOT COMPLETED|Washout Period 3||0
8128782|NCT02841709|20036667|P4|NOT COMPLETED|Washout Period 3||0
8128783|NCT02841709|20036668|P3|NOT COMPLETED|Washout Period 3||0
8128784|NCT02841709|20036669|P2|NOT COMPLETED|Washout Period 3||0
8128785|NCT02841709|20036670|P1|NOT COMPLETED|Washout Period 3||0
8128786|NCT02841709|20036666|P5|COMPLETED|Washout Period 3||11
8128787|NCT02841709|20036667|P4|COMPLETED|Washout Period 3||12
8128788|NCT02841709|20036668|P3|COMPLETED|Washout Period 3||12
8128789|NCT02841709|20036669|P2|COMPLETED|Washout Period 3||11
8128790|NCT02841709|20036670|P1|COMPLETED|Washout Period 3||12
8128791|NCT02841709|20036666|P5|STARTED|Washout Period 3||11
8128792|NCT02841709|20036667|P4|STARTED|Washout Period 3||12
8128793|NCT02841709|20036668|P3|STARTED|Washout Period 3||12
8128794|NCT02841709|20036669|P2|STARTED|Washout Period 3||11
8128795|NCT02841709|20036670|P1|STARTED|Washout Period 3||12
8128796|NCT02841709|20036666|P5|NOT COMPLETED|3rd Intervention||0
8128797|NCT02841709|20036667|P4|NOT COMPLETED|3rd Intervention||0
8128798|NCT02841709|20036668|P3|NOT COMPLETED|3rd Intervention||0
8128799|NCT02841709|20036669|P2|NOT COMPLETED|3rd Intervention||0
8128800|NCT02841709|20036670|P1|NOT COMPLETED|3rd Intervention||0
8128801|NCT02841709|20036666|P5|COMPLETED|3rd Intervention||11
8128802|NCT02841709|20036667|P4|COMPLETED|3rd Intervention||12
8128803|NCT02841709|20036668|P3|COMPLETED|3rd Intervention||12
8128804|NCT02841709|20036669|P2|COMPLETED|3rd Intervention||11
8128805|NCT02841709|20036670|P1|COMPLETED|3rd Intervention||12
8128806|NCT02841709|20036666|P5|STARTED|3rd Intervention||11
8128807|NCT02841709|20036667|P4|STARTED|3rd Intervention||12
8128808|NCT02841709|20036668|P3|STARTED|3rd Intervention||12
8128809|NCT02841709|20036669|P2|STARTED|3rd Intervention||11
8128810|NCT02841709|20036670|P1|STARTED|3rd Intervention||12
8128811|NCT02841709|20036666|P5|NOT COMPLETED|Washout Period 2||0
8128812|NCT02841709|20036667|P4|NOT COMPLETED|Washout Period 2||0
8128813|NCT02841709|20036668|P3|NOT COMPLETED|Washout Period 2||0
8128814|NCT02841709|20036669|P2|NOT COMPLETED|Washout Period 2||0
8128815|NCT02841709|20036670|P1|NOT COMPLETED|Washout Period 2||0
8128816|NCT02841709|20036666|P5|COMPLETED|Washout Period 2||11
8128817|NCT02841709|20036667|P4|COMPLETED|Washout Period 2||12
8128818|NCT02841709|20036668|P3|COMPLETED|Washout Period 2||12
8128819|NCT02841709|20036669|P2|COMPLETED|Washout Period 2||11
8128820|NCT02841709|20036670|P1|COMPLETED|Washout Period 2||12
8128821|NCT02841709|20036666|P5|STARTED|Washout Period 2||11
8128822|NCT02841709|20036667|P4|STARTED|Washout Period 2||12
8128823|NCT02841709|20036668|P3|STARTED|Washout Period 2||12
8128824|NCT02841709|20036669|P2|STARTED|Washout Period 2||11
8128825|NCT02841709|20036670|P1|STARTED|Washout Period 2||12
8128826|NCT02841709|20036666|P5|NOT COMPLETED|2nd Intervention||0
8128827|NCT02841709|20036667|P4|NOT COMPLETED|2nd Intervention||0
8128828|NCT02841709|20036668|P3|NOT COMPLETED|2nd Intervention||0
8128829|NCT02841709|20036669|P2|NOT COMPLETED|2nd Intervention||0
8128830|NCT02841709|20036670|P1|NOT COMPLETED|2nd Intervention||0
8128831|NCT02841709|20036666|P5|COMPLETED|2nd Intervention||11
8128832|NCT02841709|20036667|P4|COMPLETED|2nd Intervention||12
8128833|NCT02841709|20036668|P3|COMPLETED|2nd Intervention||12
8128834|NCT02841709|20036669|P2|COMPLETED|2nd Intervention||11
8128835|NCT02841709|20036670|P1|COMPLETED|2nd Intervention||12
8128836|NCT02841709|20036666|P5|STARTED|2nd Intervention||11
8128837|NCT02841709|20036667|P4|STARTED|2nd Intervention||12
8128838|NCT02841709|20036668|P3|STARTED|2nd Intervention||12
8128839|NCT02841709|20036669|P2|STARTED|2nd Intervention||11
8128840|NCT02841709|20036670|P1|STARTED|2nd Intervention||12
8128841|NCT02841709|20036666|P5|NOT COMPLETED|Washout Period 1||0
8128842|NCT02841709|20036667|P4|NOT COMPLETED|Washout Period 1||0
8128843|NCT02841709|20036668|P3|NOT COMPLETED|Washout Period 1||0
8128844|NCT02841709|20036669|P2|NOT COMPLETED|Washout Period 1||0
8128845|NCT02841709|20036670|P1|NOT COMPLETED|Washout Period 1||0
8128846|NCT02841709|20036666|P5|COMPLETED|Washout Period 1||11
8128847|NCT02841709|20036667|P4|COMPLETED|Washout Period 1||12
8128848|NCT02841709|20036668|P3|COMPLETED|Washout Period 1||12
8128849|NCT02841709|20036669|P2|COMPLETED|Washout Period 1||11
8128850|NCT02841709|20036670|P1|COMPLETED|Washout Period 1||12
8128851|NCT02841709|20036666|P5|STARTED|Washout Period 1||11
8128852|NCT02841709|20036667|P4|STARTED|Washout Period 1||12
8128853|NCT02841709|20036668|P3|STARTED|Washout Period 1||12
8128854|NCT02841709|20036669|P2|STARTED|Washout Period 1||11
8128855|NCT02841709|20036670|P1|STARTED|Washout Period 1||12
8128856|NCT02841709|20036666|P5|NOT COMPLETED|1st Intervention||0
8128857|NCT02841709|20036667|P4|NOT COMPLETED|1st Intervention||0
8128858|NCT02841709|20036668|P3|NOT COMPLETED|1st Intervention||0
8128859|NCT02841709|20036669|P2|NOT COMPLETED|1st Intervention||0
8128860|NCT02841709|20036670|P1|NOT COMPLETED|1st Intervention||0
8128861|NCT02841709|20036666|P5|COMPLETED|1st Intervention||11
8128862|NCT02841709|20036667|P4|COMPLETED|1st Intervention||12
8128863|NCT02841709|20036668|P3|COMPLETED|1st Intervention||12
8128864|NCT02841709|20036669|P2|COMPLETED|1st Intervention||11
8128865|NCT02841709|20036670|P1|COMPLETED|1st Intervention||12
8128866|NCT02841709|20036666|P5|STARTED|1st Intervention||11
8128867|NCT02841709|20036667|P4|STARTED|1st Intervention||12
8128868|NCT02841709|20036668|P3|STARTED|1st Intervention||12
8128869|NCT02841709|20036669|P2|STARTED|1st Intervention||11
8128870|NCT02841709|20036670|P1|STARTED|1st Intervention||12
8128871|NCT02841449|20036690|P2|NOT COMPLETED|Overall Study||0
8128872|NCT02841449|20036691|P1|NOT COMPLETED|Overall Study||0
8128873|NCT02841449|20036690|P2|COMPLETED|Overall Study||9
8128874|NCT02841449|20036691|P1|COMPLETED|Overall Study||7
8128875|NCT02841449|20036690|P2|STARTED|Overall Study||9
8128876|NCT02841449|20036691|P1|STARTED|Overall Study||7
8128877|NCT02841267|20036718|P3|NOT COMPLETED|Extension Study||0
8128878|NCT02841267|20036719|P2|NOT COMPLETED|Extension Study||0
8128879|NCT02841267|20036720|P1|NOT COMPLETED|Extension Study||0
8128880|NCT02841267|20036718|P3|COMPLETED|Extension Study||6
8128881|NCT02841267|20036719|P2|COMPLETED|Extension Study||6
8128882|NCT02841267|20036720|P1|COMPLETED|Extension Study||4
8128883|NCT02841267|20036718|P3|STARTED|Extension Study|Cohort 3 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 24 weeks.|6
8128884|NCT02841267|20036719|P2|STARTED|Extension Study|Cohort 2 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 40 weeks.|6
8128885|NCT02841267|20036720|P1|STARTED|Extension Study|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
8128886|NCT02841267|20036718|P3|NOT COMPLETED|Treatment Period||0
8128887|NCT02841267|20036719|P2|NOT COMPLETED|Treatment Period||0
8128888|NCT02841267|20036720|P1|NOT COMPLETED|Treatment Period||0
8128889|NCT02841267|20036718|P3|COMPLETED|Treatment Period||8
8128890|NCT02841267|20036719|P2|COMPLETED|Treatment Period||7
8128891|NCT02841267|20036720|P1|COMPLETED|Treatment Period||4
8128892|NCT02841267|20036718|P3|STARTED|Treatment Period||8
8128893|NCT02841267|20036719|P2|STARTED|Treatment Period||7
8128894|NCT02841267|20036720|P1|STARTED|Treatment Period|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
8128895|NCT02841267|20036718|P3|NOT COMPLETED|Lead-in (Untreated)||0
8128896|NCT02841267|20036719|P2|NOT COMPLETED|Lead-in (Untreated)||0
8128897|NCT02841267|20036720|P1|NOT COMPLETED|Lead-in (Untreated)||0
8128898|NCT02841267|20036718|P3|COMPLETED|Lead-in (Untreated)||8
8128899|NCT02841267|20036719|P2|COMPLETED|Lead-in (Untreated)||7
8128900|NCT02841267|20036720|P1|COMPLETED|Lead-in (Untreated)||4
8128901|NCT02841267|20036718|P3|STARTED|Lead-in (Untreated)||8
8128902|NCT02841267|20036719|P2|STARTED|Lead-in (Untreated)||7
8128903|NCT02841267|20036720|P1|STARTED|Lead-in (Untreated)||4
8128904|NCT02841241|20036763|P1|NOT COMPLETED|Overall Study||0
8128905|NCT02841241|20036763|P1|COMPLETED|Overall Study||7
8128906|NCT02841241|20036763|P1|STARTED|Overall Study||7
8128907|NCT02841189|20036774|P1|NOT COMPLETED|Overall Study||35
8128908|NCT02841189|20036774|P1|COMPLETED|Overall Study||65
8128909|NCT02841189|20036774|P1|STARTED|Overall Study||100
8128910|NCT02841046|20036780|P2|NOT COMPLETED|Overall Study||0
8128911|NCT02841046|20036781|P1|NOT COMPLETED|Overall Study||0
8128912|NCT02841046|20036780|P2|COMPLETED|Overall Study||25
8128913|NCT02841046|20036781|P1|COMPLETED|Overall Study||25
8128914|NCT02841046|20036780|P2|STARTED|Overall Study||25
8128915|NCT02841046|20036781|P1|STARTED|Overall Study||25
8128916|NCT02840916|20036789|P2|NOT COMPLETED|Overall Study||3
8128917|NCT02840916|20036790|P1|NOT COMPLETED|Overall Study||1
8128918|NCT02840916|20036789|P2|COMPLETED|Overall Study||30
8128919|NCT02840916|20036790|P1|COMPLETED|Overall Study||32
8128920|NCT02840916|20036789|P2|STARTED|Overall Study||33
8128921|NCT02840916|20036790|P1|STARTED|Overall Study||33
8128922|NCT02840721|20036800|P1|NOT COMPLETED|Follow-Up||7
8128923|NCT02840721|20036800|P1|COMPLETED|Follow-Up||42
8128924|NCT02840721|20036800|P1|STARTED|Follow-Up||49
8128925|NCT02840721|20036800|P1|NOT COMPLETED|Treatment Period||1
8128926|NCT02840721|20036800|P1|COMPLETED|Treatment Period||49
8128927|NCT02840721|20036800|P1|STARTED|Treatment Period||50
8128928|NCT02840461|20036822|P3|NOT COMPLETED|Overall Study||14
8128929|NCT02840461|20036823|P2|NOT COMPLETED|Overall Study||22
8128930|NCT02840461|20036824|P1|NOT COMPLETED|Overall Study||23
8128931|NCT02840461|20036822|P3|COMPLETED|Overall Study||100
8128932|NCT02840461|20036823|P2|COMPLETED|Overall Study||235
8128933|NCT02840461|20036824|P1|COMPLETED|Overall Study||236
8128934|NCT02840461|20036822|P3|STARTED|Overall Study||114
8128935|NCT02840461|20036823|P2|STARTED|Overall Study||257
8128936|NCT02840461|20036824|P1|STARTED|Overall Study||259
8128937|NCT02840253|20036835|P1|NOT COMPLETED|Overall Study||4
8128938|NCT02840253|20036835|P1|COMPLETED|Overall Study||19
8128939|NCT02840253|20036835|P1|STARTED|Overall Study||23
8128940|NCT02839902|20036842|P2|NOT COMPLETED|Overall Study||0
8128941|NCT02839902|20036843|P1|NOT COMPLETED|Overall Study||0
8128942|NCT02839902|20036842|P2|COMPLETED|Overall Study||29
8128943|NCT02839902|20036843|P1|COMPLETED|Overall Study||24
8128944|NCT02839902|20036842|P2|STARTED|Overall Study||29
8128945|NCT02839902|20036843|P1|STARTED|Overall Study||24
8128946|NCT02839889|20036881|P2|NOT COMPLETED|Open-Label Period||1
8128947|NCT02839889|20036882|P1|NOT COMPLETED|Open-Label Period||0
8128948|NCT02839889|20036881|P2|COMPLETED|Open-Label Period||4
8128949|NCT02839889|20036882|P1|COMPLETED|Open-Label Period||0
8128950|NCT02839889|20036881|P2|STARTED|Open-Label Period||5
8128951|NCT02839889|20036882|P1|STARTED|Open-Label Period||0
8128952|NCT02839889|20036881|P2|NOT COMPLETED|Randomization Period||0
8128953|NCT02839889|20036882|P1|NOT COMPLETED|Randomization Period||0
8128954|NCT02839889|20036881|P2|COMPLETED|Randomization Period||3
8128955|NCT02839889|20036882|P1|COMPLETED|Randomization Period||2
8128956|NCT02839889|20036881|P2|STARTED|Randomization Period||3
8128957|NCT02839889|20036882|P1|STARTED|Randomization Period||2
8128964|NCT02839798|20036983|P1|NOT COMPLETED|Overall Study||2
8128965|NCT02839798|20036983|P1|COMPLETED|Overall Study||4
8128966|NCT02839798|20036983|P1|STARTED|Overall Study||6
8128967|NCT02839772|20036991|P2|NOT COMPLETED|Overall Study||0
8128968|NCT02839772|20036992|P1|NOT COMPLETED|Overall Study||1
8128969|NCT02839772|20036991|P2|COMPLETED|Overall Study||96
8128970|NCT02839772|20036992|P1|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
8128971|NCT02839772|20036991|P2|STARTED|Overall Study||96
8128972|NCT02839772|20036992|P1|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
8128973|NCT02839746|20037029|P1|NOT COMPLETED|Overall Study||12
8128974|NCT02839746|20037029|P1|COMPLETED|Overall Study||659
8128975|NCT02839746|20037029|P1|STARTED|Overall Study||671
8128976|NCT02839681|20037043|P1|NOT COMPLETED|Overall Study||2
8128977|NCT02839681|20037043|P1|COMPLETED|Overall Study||0
8128978|NCT02839681|20037043|P1|STARTED|Overall Study||2
8128979|NCT02839330|20037056|P4|NOT COMPLETED|Overall Study||51
8128980|NCT02839330|20037057|P3|NOT COMPLETED|Overall Study||48
8128981|NCT02839330|20037058|P2|NOT COMPLETED|Overall Study||58
8128982|NCT02839330|20037059|P1|NOT COMPLETED|Overall Study||58
8128983|NCT02839330|20037056|P4|COMPLETED|Overall Study||747
8128984|NCT02839330|20037057|P3|COMPLETED|Overall Study||747
8128985|NCT02839330|20037058|P2|COMPLETED|Overall Study||741
8128986|NCT02839330|20037059|P1|COMPLETED|Overall Study||746
8128987|NCT02839330|20037056|P4|Exposed|Overall Study||797
8128988|NCT02839330|20037057|P3|Exposed|Overall Study||793
8128989|NCT02839330|20037058|P2|Exposed|Overall Study||797
8128990|NCT02839330|20037059|P1|Exposed|Overall Study||804
8128991|NCT02839330|20037056|P4|STARTED|Overall Study||798
8128992|NCT02839330|20037057|P3|STARTED|Overall Study||795
8128993|NCT02839330|20037058|P2|STARTED|Overall Study||799
8128994|NCT02839330|20037059|P1|STARTED|Overall Study||804
8128995|NCT02839200|20037094|P6|NOT COMPLETED|Overall Study||1
8128996|NCT02839200|20037095|P5|NOT COMPLETED|Overall Study||2
8128997|NCT02839200|20037096|P4|NOT COMPLETED|Overall Study||0
8128998|NCT02839200|20037097|P3|NOT COMPLETED|Overall Study||1
8128999|NCT02839200|20037098|P2|NOT COMPLETED|Overall Study||1
8129000|NCT02839200|20037099|P1|NOT COMPLETED|Overall Study||4
8129001|NCT02839200|20037094|P6|COMPLETED|Overall Study||59
8129002|NCT02839200|20037095|P5|COMPLETED|Overall Study||58
8129003|NCT02839200|20037096|P4|COMPLETED|Overall Study||61
8129004|NCT02839200|20037097|P3|COMPLETED|Overall Study||59
8129005|NCT02839200|20037098|P2|COMPLETED|Overall Study||58
8129006|NCT02839200|20037099|P1|COMPLETED|Overall Study||56
8129007|NCT02839200|20037094|P6|STARTED|Overall Study||60
8129008|NCT02839200|20037095|P5|STARTED|Overall Study||60
8129009|NCT02839200|20037096|P4|STARTED|Overall Study||61
8129010|NCT02839200|20037097|P3|STARTED|Overall Study||60
8129011|NCT02839200|20037098|P2|STARTED|Overall Study||59
8129012|NCT02839200|20037099|P1|STARTED|Overall Study||60
8129013|NCT02838901|20037133|P2|NOT COMPLETED|Overall Study||2
8129014|NCT02838901|20037134|P1|NOT COMPLETED|Overall Study||2
8129015|NCT02838901|20037133|P2|COMPLETED|Overall Study||7
8129016|NCT02838901|20037134|P1|COMPLETED|Overall Study||7
8129017|NCT02838901|20037133|P2|STARTED|Overall Study||9
8129018|NCT02838901|20037134|P1|STARTED|Overall Study||9
8129019|NCT02838420|20037164|P2|NOT COMPLETED|Overall Study||62
8129020|NCT02838420|20037165|P1|NOT COMPLETED|Overall Study||125
8129021|NCT02838420|20037164|P2|COMPLETED|Overall Study||0
8129022|NCT02838420|20037165|P1|COMPLETED|Overall Study||0
8129023|NCT02838420|20037164|P2|STARTED|Overall Study||62
8129024|NCT02838420|20037165|P1|STARTED|Overall Study||125
8129025|NCT02838407|20037179|P1|NOT COMPLETED|Overall Study||0
8129026|NCT02838407|20037179|P1|COMPLETED|Overall Study||197
8129027|NCT02838407|20037179|P1|STARTED|Overall Study||197
8129028|NCT02838134|20037228|P2|NOT COMPLETED|Overall Study||3
8129029|NCT02838134|20037229|P1|NOT COMPLETED|Overall Study||2
8129030|NCT02838134|20037228|P2|COMPLETED|Overall Study||48
8129031|NCT02838134|20037229|P1|COMPLETED|Overall Study||48
8129032|NCT02838134|20037228|P2|STARTED|Overall Study||51
8129033|NCT02838134|20037229|P1|STARTED|Overall Study||50
8129034|NCT02838017|20037261|P2|NOT COMPLETED|Overall Study||11
8129035|NCT02838017|20037262|P1|NOT COMPLETED|Overall Study||14
8129036|NCT02838017|20037261|P2|COMPLETED|Overall Study||241
8129037|NCT02838017|20037262|P1|COMPLETED|Overall Study||238
8129038|NCT02838017|20037261|P2|STARTED|Overall Study||252
8129039|NCT02838017|20037262|P1|STARTED|Overall Study||252
8129040|NCT02837952|20037280|P2|NOT COMPLETED|Overall Study||6
8129041|NCT02837952|20037281|P1|NOT COMPLETED|Overall Study||5
8129042|NCT02837952|20037280|P2|COMPLETED|Overall Study||76
8129043|NCT02837952|20037281|P1|COMPLETED|Overall Study||36
8129044|NCT02837952|20037280|P2|STARTED|Overall Study||82
8129045|NCT02837952|20037281|P1|STARTED|Overall Study||41
8129046|NCT02837913|20037295|P2|NOT COMPLETED|Overall Study||0
8129047|NCT02837913|20037296|P1|NOT COMPLETED|Overall Study||0
8129048|NCT02837913|20037295|P2|COMPLETED|Overall Study||9
8129049|NCT02837913|20037296|P1|COMPLETED|Overall Study||10
8129050|NCT02837913|20037295|P2|STARTED|Overall Study||9
8129051|NCT02837913|20037296|P1|STARTED|Overall Study||10
8129052|NCT02837731|20037318|P2|NOT COMPLETED|Analysis||0
8129053|NCT02837731|20037319|P1|NOT COMPLETED|Analysis||0
8129054|NCT02837731|20037318|P2|COMPLETED|Analysis||41
8129055|NCT02837731|20037319|P1|COMPLETED|Analysis||83
8129056|NCT02837731|20037318|P2|STARTED|Analysis||41
8129057|NCT02837731|20037319|P1|STARTED|Analysis||83
8129058|NCT02837731|20037318|P2|NOT COMPLETED|Follow-up||0
8129059|NCT02837731|20037319|P1|NOT COMPLETED|Follow-up||0
8129060|NCT02837731|20037318|P2|COMPLETED|Follow-up||41
8129061|NCT02837731|20037319|P1|COMPLETED|Follow-up||83
8129062|NCT02837731|20037318|P2|STARTED|Follow-up||41
8129063|NCT02837731|20037319|P1|STARTED|Follow-up||83
8129064|NCT02837731|20037318|P2|NOT COMPLETED|Allocation||7
8129065|NCT02837731|20037319|P1|NOT COMPLETED|Allocation||19
8129066|NCT02837731|20037318|P2|COMPLETED|Allocation||41
8129067|NCT02837731|20037319|P1|COMPLETED|Allocation||83
8129068|NCT02837731|20037318|P2|STARTED|Allocation||48
8129069|NCT02837731|20037319|P1|STARTED|Allocation||102
8129070|NCT02837328|20037351|P2|NOT COMPLETED|Overall Study||0
8129071|NCT02837328|20037352|P1|NOT COMPLETED|Overall Study||0
8129072|NCT02837328|20037351|P2|COMPLETED|Overall Study||30
8129073|NCT02837328|20037352|P1|COMPLETED|Overall Study||29
8129074|NCT02837328|20037351|P2|STARTED|Overall Study||30
8129075|NCT02837328|20037352|P1|STARTED|Overall Study||29
8129076|NCT02837237|20037360|P1|NOT COMPLETED|Overall Study||0
8129077|NCT02837237|20037360|P1|COMPLETED|Overall Study||11
8129078|NCT02837237|20037360|P1|STARTED|Overall Study||11
8129079|NCT02837029|20037367|P3|NOT COMPLETED|2 Year Follow-up||0
8129080|NCT02837029|20037368|P2|NOT COMPLETED|2 Year Follow-up||7
8129081|NCT02837029|20037369|P1|NOT COMPLETED|2 Year Follow-up||6
8129082|NCT02837029|20037367|P3|COMPLETED|2 Year Follow-up||0
8129083|NCT02837029|20037368|P2|COMPLETED|2 Year Follow-up||0
8129084|NCT02837029|20037369|P1|COMPLETED|2 Year Follow-up||0
8129085|NCT02837029|20037367|P3|STARTED|2 Year Follow-up||0
8129086|NCT02837029|20037368|P2|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|7
8129087|NCT02837029|20037369|P1|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|6
8129088|NCT02837029|20037367|P3|NOT COMPLETED|Cycle 2 and Beyond||0
8129089|NCT02837029|20037368|P2|NOT COMPLETED|Cycle 2 and Beyond||0
8129090|NCT02837029|20037369|P1|NOT COMPLETED|Cycle 2 and Beyond||1
8129091|NCT02837029|20037367|P3|COMPLETED|Cycle 2 and Beyond||0
8129092|NCT02837029|20037368|P2|COMPLETED|Cycle 2 and Beyond||6
8129093|NCT02837029|20037369|P1|COMPLETED|Cycle 2 and Beyond||5
8129094|NCT02837029|20037367|P3|STARTED|Cycle 2 and Beyond||0
8129095|NCT02837029|20037368|P2|STARTED|Cycle 2 and Beyond||6
8129096|NCT02837029|20037369|P1|STARTED|Cycle 2 and Beyond||6
8129097|NCT02837029|20037367|P3|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||0
8129098|NCT02837029|20037368|P2|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||3
8129099|NCT02837029|20037369|P1|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||2
8129100|NCT02837029|20037367|P3|COMPLETED|Cycle 1 (DLT Monitoring Period)||0
8129101|NCT02837029|20037368|P2|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
8129102|NCT02837029|20037369|P1|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
8129103|NCT02837029|20037367|P3|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||0
8129104|NCT02837029|20037368|P2|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||7
8129105|NCT02837029|20037369|P1|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||6
8129106|NCT02837029|20037367|P3|STARTED|Cycle 1 (DLT Monitoring Period)||0
8129107|NCT02837029|20037368|P2|STARTED|Cycle 1 (DLT Monitoring Period)||9
8129108|NCT02837029|20037369|P1|STARTED|Cycle 1 (DLT Monitoring Period)||8
8129109|NCT02837029|20037367|P3|NOT COMPLETED|Induction Treatment With Y90||0
8129110|NCT02837029|20037368|P2|NOT COMPLETED|Induction Treatment With Y90||0
8129111|NCT02837029|20037369|P1|NOT COMPLETED|Induction Treatment With Y90||0
8129112|NCT02837029|20037367|P3|COMPLETED|Induction Treatment With Y90||0
8129113|NCT02837029|20037368|P2|COMPLETED|Induction Treatment With Y90||9
8129114|NCT02837029|20037369|P1|COMPLETED|Induction Treatment With Y90||8
8129115|NCT02837029|20037367|P3|STARTED|Induction Treatment With Y90||0
8129116|NCT02837029|20037368|P2|STARTED|Induction Treatment With Y90||9
8129117|NCT02837029|20037369|P1|STARTED|Induction Treatment With Y90||8
8129118|NCT02837029|20037367|P3|NOT COMPLETED|Screening||0
8129119|NCT02837029|20037368|P2|NOT COMPLETED|Screening||3
8129120|NCT02837029|20037369|P1|NOT COMPLETED|Screening||7
8129121|NCT02837029|20037367|P3|COMPLETED|Screening||0
8129122|NCT02837029|20037368|P2|COMPLETED|Screening||9
8129123|NCT02837029|20037369|P1|COMPLETED|Screening||8
8129124|NCT02837029|20037367|P3|STARTED|Screening||0
8129125|NCT02837029|20037368|P2|STARTED|Screening||12
8129126|NCT02837029|20037369|P1|STARTED|Screening||15
8129127|NCT02836990|20037378|P2|NOT COMPLETED|Overall Study||0
8129128|NCT02836990|20037379|P1|NOT COMPLETED|Overall Study||0
8129129|NCT02836990|20037378|P2|COMPLETED|Overall Study||55
8129130|NCT02836990|20037379|P1|COMPLETED|Overall Study||50
8129131|NCT02836990|20037378|P2|STARTED|Overall Study||55
8129132|NCT02836990|20037379|P1|STARTED|Overall Study||50
8129133|NCT02836652|20037391|P2|NOT COMPLETED|Overall Study||19
8129134|NCT02836652|20037392|P1|NOT COMPLETED|Overall Study||18
8129135|NCT02836652|20037391|P2|COMPLETED|Overall Study||18
8129136|NCT02836652|20037392|P1|COMPLETED|Overall Study||17
8129137|NCT02836652|20037391|P2|As-treated Population|Overall Study||34
8129138|NCT02836652|20037392|P1|As-treated Population|Overall Study||31
8129139|NCT02836652|20037391|P2|STARTED|Overall Study||37
8129140|NCT02836652|20037392|P1|STARTED|Overall Study||35
8129141|NCT02836613|20037406|P2|NOT COMPLETED|Overall Study||3
8129142|NCT02836613|20037407|P1|NOT COMPLETED|Overall Study||1
8129143|NCT02836613|20037406|P2|COMPLETED|Overall Study||77
8129144|NCT02836613|20037407|P1|COMPLETED|Overall Study||79
8129145|NCT02836613|20037406|P2|STARTED|Overall Study||80
8129146|NCT02836613|20037407|P1|STARTED|Overall Study||80
8129147|NCT02836496|20037421|P2|NOT COMPLETED|Overall Study||2
8129148|NCT02836496|20037422|P1|NOT COMPLETED|Overall Study||2
8129149|NCT02836496|20037421|P2|COMPLETED|Overall Study||52
8129150|NCT02836496|20037422|P1|COMPLETED|Overall Study||52
8129151|NCT02836496|20037421|P2|STARTED|Overall Study||54
8129152|NCT02836496|20037422|P1|STARTED|Overall Study||54
8129165|NCT02835820|20037474|P2|NOT COMPLETED|Overall Study||3
8129166|NCT02835820|20037475|P1|NOT COMPLETED|Overall Study||0
8129167|NCT02835820|20037474|P2|COMPLETED|Overall Study||7
8129168|NCT02835820|20037475|P1|COMPLETED|Overall Study||7
8129169|NCT02835820|20037474|P2|Baseline Screen (OGTT)|Overall Study||7
8129170|NCT02835820|20037475|P1|Baseline Screen (OGTT)|Overall Study||7
8129171|NCT02835820|20037474|P2|STARTED|Overall Study||10
8129172|NCT02835820|20037475|P1|STARTED|Overall Study||7
8129185|NCT02835677|20037577|P1|NOT COMPLETED|Overall Study||0
8129186|NCT02835677|20037577|P1|COMPLETED|Overall Study||25
8129187|NCT02835677|20037577|P1|STARTED|Overall Study||25
8129194|NCT02835495|20037607|P2|NOT COMPLETED|Overall Study||2
8129195|NCT02835495|20037608|P1|NOT COMPLETED|Overall Study||5
8129196|NCT02835495|20037607|P2|COMPLETED|Overall Study||23
8129197|NCT02835495|20037608|P1|COMPLETED|Overall Study||21
8129198|NCT02835495|20037607|P2|Intervention Start|Overall Study||25
8129199|NCT02835495|20037608|P1|Intervention Start|Overall Study||25
8129200|NCT02835495|20037607|P2|STARTED|Overall Study||25
8129201|NCT02835495|20037608|P1|STARTED|Overall Study|26 randomized, however, one had to withdraw pre-intervention initiation due to cancer diagnosis.|26
8129202|NCT02835339|20037634|P2|NOT COMPLETED|Overall Study||16
8129203|NCT02835339|20037635|P1|NOT COMPLETED|Overall Study||13
8129204|NCT02835339|20037634|P2|COMPLETED|Overall Study||19
8129205|NCT02835339|20037635|P1|COMPLETED|Overall Study||18
8129206|NCT02835339|20037634|P2|STARTED|Overall Study||35
8129207|NCT02835339|20037635|P1|STARTED|Overall Study||31
8129208|NCT02835274|20037647|P2|NOT COMPLETED|Overall Study||0
8129209|NCT02835274|20037648|P1|NOT COMPLETED|Overall Study||0
8129210|NCT02835274|20037647|P2|COMPLETED|Overall Study||6
8129211|NCT02835274|20037648|P1|COMPLETED|Overall Study||6
8129212|NCT02835274|20037647|P2|STARTED|Overall Study||6
8129213|NCT02835274|20037648|P1|STARTED|Overall Study||6
8129214|NCT02835092|20037657|P3|NOT COMPLETED|Overall Study||3
8129215|NCT02835092|20037658|P2|NOT COMPLETED|Overall Study||8
8129216|NCT02835092|20037659|P1|NOT COMPLETED|Overall Study||3
8129217|NCT02835092|20037657|P3|COMPLETED|Overall Study||64
8129218|NCT02835092|20037658|P2|COMPLETED|Overall Study||57
8129219|NCT02835092|20037659|P1|COMPLETED|Overall Study||63
8129220|NCT02835092|20037657|P3|STARTED|Overall Study||67
8129221|NCT02835092|20037658|P2|STARTED|Overall Study||65
8129222|NCT02835092|20037659|P1|STARTED|Overall Study||66
8129223|NCT02834819|20037669|P2|NOT COMPLETED|Overall Study||0
8129224|NCT02834819|20037670|P1|NOT COMPLETED|Overall Study||5
8129225|NCT02834819|20037669|P2|COMPLETED|Overall Study||9
8129226|NCT02834819|20037670|P1|COMPLETED|Overall Study||4
8129227|NCT02834819|20037669|P2|STARTED|Overall Study||9
8129228|NCT02834819|20037670|P1|STARTED|Overall Study||9
8129229|NCT02834806|20037690|P1|NOT COMPLETED|Overall Study||0
8129230|NCT02834806|20037690|P1|COMPLETED|Overall Study||58
8129231|NCT02834806|20037690|P1|STARTED|Overall Study||58
8129232|NCT02834663|20037694|P1|NOT COMPLETED|Overall Study||0
8129233|NCT02834663|20037694|P1|COMPLETED|Overall Study|Unit means the eye. One eye was included per patient|25
8129234|NCT02834663|20037694|P1|STARTED|Overall Study|Unit means the eye. One eye was included per patient|25
8129235|NCT02834624|20037714|P2|NOT COMPLETED|Overall Study||0
8129236|NCT02834624|20037715|P1|NOT COMPLETED|Overall Study||0
8129237|NCT02834624|20037714|P2|COMPLETED|Overall Study||15
8129238|NCT02834624|20037715|P1|COMPLETED|Overall Study||15
8129239|NCT02834624|20037714|P2|STARTED|Overall Study||15
8129240|NCT02834624|20037715|P1|STARTED|Overall Study||15
8129241|NCT02834247|20037729|P4|NOT COMPLETED|Dose Expansion Phase||17
8129242|NCT02834247|20037730|P3|NOT COMPLETED|Dose Expansion Phase||0
8129243|NCT02834247|20037731|P2|NOT COMPLETED|Dose Expansion Phase||0
8129244|NCT02834247|20037732|P1|NOT COMPLETED|Dose Expansion Phase||0
8129245|NCT02834247|20037729|P4|COMPLETED|Dose Expansion Phase||0
8129246|NCT02834247|20037730|P3|COMPLETED|Dose Expansion Phase||0
8129247|NCT02834247|20037731|P2|COMPLETED|Dose Expansion Phase||0
8129248|NCT02834247|20037732|P1|COMPLETED|Dose Expansion Phase||0
8129249|NCT02834247|20037729|P4|STARTED|Dose Expansion Phase||17
8129250|NCT02834247|20037730|P3|STARTED|Dose Expansion Phase||0
8129251|NCT02834247|20037731|P2|STARTED|Dose Expansion Phase||0
8129252|NCT02834247|20037732|P1|STARTED|Dose Expansion Phase||0
8129253|NCT02834247|20037729|P4|NOT COMPLETED|Dose Escalation Phase||0
8129254|NCT02834247|20037730|P3|NOT COMPLETED|Dose Escalation Phase||5
8129255|NCT02834247|20037731|P2|NOT COMPLETED|Dose Escalation Phase||11
8129256|NCT02834247|20037732|P1|NOT COMPLETED|Dose Escalation Phase||8
8129257|NCT02834247|20037729|P4|COMPLETED|Dose Escalation Phase||0
8129258|NCT02834247|20037730|P3|COMPLETED|Dose Escalation Phase||0
8129259|NCT02834247|20037731|P2|COMPLETED|Dose Escalation Phase||0
8129260|NCT02834247|20037732|P1|COMPLETED|Dose Escalation Phase||0
8129261|NCT02834247|20037729|P4|STARTED|Dose Escalation Phase||0
8129262|NCT02834247|20037730|P3|STARTED|Dose Escalation Phase||5
8129263|NCT02834247|20037731|P2|STARTED|Dose Escalation Phase||11
8129264|NCT02834247|20037732|P1|STARTED|Dose Escalation Phase||8
8129271|NCT02833948|20037788|P2|NOT COMPLETED|Overall Study||18
8129272|NCT02833948|20037789|P1|NOT COMPLETED|Overall Study||15
8129273|NCT02833948|20037788|P2|COMPLETED|Overall Study||97
8129274|NCT02833948|20037789|P1|COMPLETED|Overall Study||101
8129275|NCT02833948|20037788|P2|STARTED|Overall Study||115
8129276|NCT02833948|20037789|P1|STARTED|Overall Study||116
8129277|NCT02833922|20037813|P1|NOT COMPLETED|Overall Study||382
8129278|NCT02833922|20037813|P1|COMPLETED|Overall Study||336
8129279|NCT02833922|20037813|P1|STARTED|Overall Study||718
8129280|NCT02833857|20037821|P1|NOT COMPLETED|Overall Study||0
8129281|NCT02833857|20037821|P1|COMPLETED|Overall Study||11
8129282|NCT02833857|20037821|P1|STARTED|Overall Study||11
8129283|NCT02833415|20037848|P2|NOT COMPLETED|Overall Study||3
8129284|NCT02833415|20037849|P1|NOT COMPLETED|Overall Study||2
8129285|NCT02833415|20037848|P2|COMPLETED|Overall Study||17
8129286|NCT02833415|20037849|P1|COMPLETED|Overall Study||18
8129287|NCT02833415|20037848|P2|STARTED|Overall Study||20
8129288|NCT02833415|20037849|P1|STARTED|Overall Study||20
8129289|NCT02833350|20037862|P7|NOT COMPLETED|Overall Study||5
8129290|NCT02833350|20037863|P6|NOT COMPLETED|Overall Study||1
8129291|NCT02833350|20037864|P5|NOT COMPLETED|Overall Study||3
8129292|NCT02833350|20037865|P4|NOT COMPLETED|Overall Study||8
8129293|NCT02833350|20037866|P3|NOT COMPLETED|Overall Study||8
8129294|NCT02833350|20037867|P2|NOT COMPLETED|Overall Study||9
8129295|NCT02833350|20037868|P1|NOT COMPLETED|Overall Study||3
8129296|NCT02833350|20037862|P7|COMPLETED|Overall Study||44
8129297|NCT02833350|20037863|P6|COMPLETED|Overall Study||48
8129298|NCT02833350|20037864|P5|COMPLETED|Overall Study||108
8129299|NCT02833350|20037865|P4|COMPLETED|Overall Study||102
8129300|NCT02833350|20037866|P3|COMPLETED|Overall Study||102
8129301|NCT02833350|20037867|P2|COMPLETED|Overall Study||100
8129302|NCT02833350|20037868|P1|COMPLETED|Overall Study||37
8129303|NCT02833350|20037862|P7|Randomized|Overall Study||50
8129304|NCT02833350|20037863|P6|Randomized|Overall Study||48
8129305|NCT02833350|20037864|P5|Randomized|Overall Study||111
8129306|NCT02833350|20037865|P4|Randomized|Overall Study||110
8129307|NCT02833350|20037866|P3|Randomized|Overall Study||110
8129308|NCT02833350|20037867|P2|Randomized|Overall Study||109
8129309|NCT02833350|20037868|P1|Randomized|Overall Study||40
8129310|NCT02833350|20037862|P7|STARTED|Overall Study||49
8129311|NCT02833350|20037863|P6|STARTED|Overall Study||49
8129312|NCT02833350|20037864|P5|STARTED|Overall Study||111
8129313|NCT02833350|20037865|P4|STARTED|Overall Study||110
8129314|NCT02833350|20037866|P3|STARTED|Overall Study||110
8129315|NCT02833350|20037867|P2|STARTED|Overall Study||109
8129316|NCT02833350|20037868|P1|STARTED|Overall Study||40
8129317|NCT02833337|20038069|P1|NOT COMPLETED|Overall Study||0
8129318|NCT02833337|20038069|P1|COMPLETED|Overall Study||180
8129319|NCT02833337|20038069|P1|STARTED|Overall Study||180
8129320|NCT02833077|20038075|P2|NOT COMPLETED|Overall Study||8
8129321|NCT02833077|20038076|P1|NOT COMPLETED|Overall Study||17
8129322|NCT02833077|20038075|P2|COMPLETED|Overall Study|Includes participants who completed the study but did not receive the optional treatment.|40
8129323|NCT02833077|20038076|P1|COMPLETED|Overall Study||127
8129324|NCT02833077|20038075|P2|Participants Treated|Overall Study||38
8129325|NCT02833077|20038076|P1|Participants Treated|Overall Study||144
8129326|NCT02833077|20038075|P2|STARTED|Overall Study||48
8129327|NCT02833077|20038076|P1|STARTED|Overall Study||144
8129328|NCT02832674|20038088|P1|NOT COMPLETED|Overall Study||5
8129329|NCT02832674|20038088|P1|COMPLETED|Overall Study||67
8129330|NCT02832674|20038088|P1|STARTED|Overall Study||72
8129331|NCT02832375|20038099|P2|NOT COMPLETED|Overall Study||0
8129332|NCT02832375|20038100|P1|NOT COMPLETED|Overall Study||2
8129333|NCT02832375|20038099|P2|COMPLETED|Overall Study||121
8129334|NCT02832375|20038100|P1|COMPLETED|Overall Study||119
8129335|NCT02832375|20038099|P2|STARTED|Overall Study||121
8129336|NCT02832375|20038100|P1|STARTED|Overall Study||121
8129340|NCT02832167|20038118|P1|NOT COMPLETED|Treatment Period 2||83
8129341|NCT02832167|20038118|P1|COMPLETED|Treatment Period 2||20
8129342|NCT02832167|20038118|P1|STARTED|Treatment Period 2||103
8129343|NCT02832167|20038118|P1|NOT COMPLETED|Transition From Period 1 to Period 2||7
8129344|NCT02832167|20038118|P1|COMPLETED|Transition From Period 1 to Period 2||103
8129345|NCT02832167|20038118|P1|STARTED|Transition From Period 1 to Period 2||110
8129346|NCT02832167|20038118|P1|NOT COMPLETED|Treatment Period 1||129
8129347|NCT02832167|20038118|P1|COMPLETED|Treatment Period 1||110
8129348|NCT02832167|20038118|P1|STARTED|Treatment Period 1||239
8129349|NCT02832154|20038129|P1|NOT COMPLETED|Overall Study||0
8129350|NCT02832154|20038129|P1|COMPLETED|Overall Study||43
8129351|NCT02832154|20038129|P1|STARTED|Overall Study||43
8129352|NCT02832115|20038144|P2|NOT COMPLETED|Overall Study||0
8129353|NCT02832115|20038145|P1|NOT COMPLETED|Overall Study||0
8129354|NCT02832115|20038144|P2|COMPLETED|Overall Study||52
8129355|NCT02832115|20038145|P1|COMPLETED|Overall Study||48
8129356|NCT02832115|20038144|P2|STARTED|Overall Study||52
8129357|NCT02832115|20038145|P1|STARTED|Overall Study||48
8129358|NCT02831855|20038159|P3|NOT COMPLETED|Double Blind Phase (24 Weeks)||19
8129359|NCT02831855|20038160|P2|NOT COMPLETED|Double Blind Phase (24 Weeks)||29
8129360|NCT02831855|20038161|P1|NOT COMPLETED|Double Blind Phase (24 Weeks)||0
8129361|NCT02831855|20038159|P3|COMPLETED|Double Blind Phase (24 Weeks)||247
8129362|NCT02831855|20038160|P2|COMPLETED|Double Blind Phase (24 Weeks)||238
8129363|NCT02831855|20038161|P1|COMPLETED|Double Blind Phase (24 Weeks)||0
8129364|NCT02831855|20038159|P3|Treated|Double Blind Phase (24 Weeks)||266
8129365|NCT02831855|20038160|P2|Treated|Double Blind Phase (24 Weeks)||264
8129366|NCT02831855|20038161|P1|Treated|Double Blind Phase (24 Weeks)||0
8129367|NCT02831855|20038159|P3|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase. .|266
8129368|NCT02831855|20038160|P2|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase.|267
8129369|NCT02831855|20038161|P1|STARTED|Double Blind Phase (24 Weeks)||0
8129370|NCT02831855|20038159|P3|NOT COMPLETED|Open Label Phase (24 Weeks)||0
8129371|NCT02831855|20038160|P2|NOT COMPLETED|Open Label Phase (24 Weeks)||0
8129372|NCT02831855|20038161|P1|NOT COMPLETED|Open Label Phase (24 Weeks)||71
8129373|NCT02831855|20038159|P3|COMPLETED|Open Label Phase (24 Weeks)||0
8129374|NCT02831855|20038160|P2|COMPLETED|Open Label Phase (24 Weeks)||0
8129375|NCT02831855|20038161|P1|COMPLETED|Open Label Phase (24 Weeks)||623
8129376|NCT02831855|20038159|P3|STARTED|Open Label Phase (24 Weeks)||0
8129377|NCT02831855|20038160|P2|STARTED|Open Label Phase (24 Weeks)||0
8129378|NCT02831855|20038161|P1|STARTED|Open Label Phase (24 Weeks)||694
8129391|NCT02831660|20038350|P1|NOT COMPLETED|Overall Study||0
8129392|NCT02831660|20038350|P1|COMPLETED|Overall Study||1
8129393|NCT02831660|20038350|P1|STARTED|Overall Study||1
8129394|NCT02831569|20038354|P1|NOT COMPLETED|Overall Study||0
8129395|NCT02831569|20038354|P1|COMPLETED|Overall Study||80
8129396|NCT02831569|20038354|P1|STARTED|Overall Study||80
8129397|NCT02831387|20038361|P2|NOT COMPLETED|Overall Study||2
8129398|NCT02831387|20038362|P1|NOT COMPLETED|Overall Study||1
8129399|NCT02831387|20038361|P2|COMPLETED|Overall Study||22
8129400|NCT02831387|20038362|P1|COMPLETED|Overall Study||22
8129401|NCT02831387|20038361|P2|STARTED|Overall Study||24
8129402|NCT02831387|20038362|P1|STARTED|Overall Study||23
8129403|NCT02831257|20038380|P1|NOT COMPLETED|Overall Study||12
8129404|NCT02831257|20038380|P1|COMPLETED|Overall Study||6
8129405|NCT02831257|20038380|P1|STARTED|Overall Study||18
8129406|NCT02830893|20038394|P2|NOT COMPLETED|Overall Study||3
8129407|NCT02830893|20038395|P1|NOT COMPLETED|Overall Study||1
8129408|NCT02830893|20038394|P2|COMPLETED|Overall Study||8
8129409|NCT02830893|20038395|P1|COMPLETED|Overall Study||11
8129410|NCT02830893|20038394|P2|STARTED|Overall Study||11
8129411|NCT02830893|20038395|P1|STARTED|Overall Study||12
8129412|NCT02830880|20038407|P1|NOT COMPLETED|Overall Study||3
8129413|NCT02830880|20038407|P1|COMPLETED|Overall Study||4
8129414|NCT02830880|20038407|P1|Completed Visit After Cyle 1|Overall Study||7
8129415|NCT02830880|20038407|P1|STARTED|Overall Study||7
8129416|NCT02830438|20038416|P1|NOT COMPLETED|Overall Study||0
8129417|NCT02830438|20038416|P1|COMPLETED|Overall Study||8
8129418|NCT02830438|20038416|P1|STARTED|Overall Study||8
8129419|NCT02830087|20038426|P6|NOT COMPLETED|Overall Study||3
8129420|NCT02830087|20038427|P5|NOT COMPLETED|Overall Study||3
8129421|NCT02830087|20038428|P4|NOT COMPLETED|Overall Study||3
8129422|NCT02830087|20038429|P3|NOT COMPLETED|Overall Study||4
8129423|NCT02830087|20038430|P2|NOT COMPLETED|Overall Study||4
8129424|NCT02830087|20038431|P1|NOT COMPLETED|Overall Study||4
8129425|NCT02830087|20038426|P6|COMPLETED|Overall Study||0
8129426|NCT02830087|20038427|P5|COMPLETED|Overall Study||0
8129427|NCT02830087|20038428|P4|COMPLETED|Overall Study||0
8129428|NCT02830087|20038429|P3|COMPLETED|Overall Study||0
8129429|NCT02830087|20038430|P2|COMPLETED|Overall Study||0
8129430|NCT02830087|20038431|P1|COMPLETED|Overall Study||0
8129431|NCT02830087|20038426|P6|STARTED|Overall Study||3
8129432|NCT02830087|20038427|P5|STARTED|Overall Study||3
8129433|NCT02830087|20038428|P4|STARTED|Overall Study||3
8129434|NCT02830087|20038429|P3|STARTED|Overall Study||4
8129435|NCT02830087|20038430|P2|STARTED|Overall Study||4
8129436|NCT02830087|20038431|P1|STARTED|Overall Study||4
8129437|NCT02829996|20038498|P5|NOT COMPLETED|Overall Study||0
8129438|NCT02829996|20038499|P4|NOT COMPLETED|Overall Study||0
8129439|NCT02829996|20038500|P3|NOT COMPLETED|Overall Study||0
8129440|NCT02829996|20038501|P2|NOT COMPLETED|Overall Study||0
8129441|NCT02829996|20038502|P1|NOT COMPLETED|Overall Study||1
8129442|NCT02829996|20038498|P5|COMPLETED|Overall Study||42
8129443|NCT02829996|20038499|P4|COMPLETED|Overall Study||41
8129444|NCT02829996|20038500|P3|COMPLETED|Overall Study||40
8129445|NCT02829996|20038501|P2|COMPLETED|Overall Study||39
8129446|NCT02829996|20038502|P1|COMPLETED|Overall Study||38
8129447|NCT02829996|20038498|P5|STARTED|Overall Study||42
8129448|NCT02829996|20038499|P4|STARTED|Overall Study||41
8129449|NCT02829996|20038500|P3|STARTED|Overall Study||40
8129450|NCT02829996|20038501|P2|STARTED|Overall Study||39
8129451|NCT02829996|20038502|P1|STARTED|Overall Study||39
8129452|NCT02829983|20038516|P2|NOT COMPLETED|Overall Study||0
8129453|NCT02829983|20038517|P1|NOT COMPLETED|Overall Study||0
8129454|NCT02829983|20038516|P2|COMPLETED|Overall Study||20
8129455|NCT02829983|20038517|P1|COMPLETED|Overall Study||20
8129456|NCT02829983|20038516|P2|STARTED|Overall Study||20
8129457|NCT02829983|20038517|P1|STARTED|Overall Study||20
8129458|NCT02829944|20038527|P2|NOT COMPLETED|Overall Study||7
8129459|NCT02829944|20038528|P1|NOT COMPLETED|Overall Study||6
8129460|NCT02829944|20038527|P2|COMPLETED|Overall Study||33
8129461|NCT02829944|20038528|P1|COMPLETED|Overall Study||38
8129462|NCT02829944|20038527|P2|STARTED|Overall Study||40
8129463|NCT02829944|20038528|P1|STARTED|Overall Study||44
8129467|NCT02829775|20038583|P1|NOT COMPLETED|Overall Study||5
8129468|NCT02829775|20038583|P1|COMPLETED|Overall Study||4
8129469|NCT02829775|20038583|P1|STARTED|Overall Study||9
8129470|NCT02829463|20038590|P2|NOT COMPLETED|Overall Study||0
8129471|NCT02829463|20038591|P1|NOT COMPLETED|Overall Study||0
8129472|NCT02829463|20038590|P2|COMPLETED|Overall Study||62
8129473|NCT02829463|20038591|P1|COMPLETED|Overall Study||59
8129474|NCT02829463|20038590|P2|STARTED|Overall Study||62
8129475|NCT02829463|20038591|P1|STARTED|Overall Study||59
8129476|NCT02829320|20038597|P1|NOT COMPLETED|Overall Study||0
8129477|NCT02829320|20038597|P1|COMPLETED|Overall Study||28
8129478|NCT02829320|20038597|P1|STARTED|Overall Study||28
8129479|NCT02829307|20038634|P1|NOT COMPLETED|Overall Study||0
8129480|NCT02829307|20038634|P1|COMPLETED|Overall Study||8
8129481|NCT02829307|20038634|P1|STARTED|Overall Study||8
8129482|NCT02829294|20038657|P1|NOT COMPLETED|Overall Study||0
8129483|NCT02829294|20038657|P1|COMPLETED|Overall Study||19
8129484|NCT02829294|20038657|P1|STARTED|Overall Study||19
8129485|NCT02829138|20038665|P2|NOT COMPLETED|Overall Study||0
8129486|NCT02829138|20038666|P1|NOT COMPLETED|Overall Study||1
8129487|NCT02829138|20038665|P2|COMPLETED|Overall Study||28
8129488|NCT02829138|20038666|P1|COMPLETED|Overall Study||28
8129489|NCT02829138|20038665|P2|STARTED|Overall Study||28
8129490|NCT02829138|20038666|P1|STARTED|Overall Study||29
8129491|NCT02829034|20038678|P2|NOT COMPLETED|Overall Study||2
8129492|NCT02829034|20038679|P1|NOT COMPLETED|Overall Study||5
8129493|NCT02829034|20038678|P2|COMPLETED|Overall Study||6
8129494|NCT02829034|20038679|P1|COMPLETED|Overall Study||9
8129495|NCT02829034|20038678|P2|STARTED|Overall Study||8
8129496|NCT02829034|20038679|P1|STARTED|Overall Study||14
8129497|NCT02828982|20038689|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8129498|NCT02828982|20038690|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8129499|NCT02828982|20038689|P2|COMPLETED|Second Intervention (3 Weeks)||6
8129500|NCT02828982|20038690|P1|COMPLETED|Second Intervention (3 Weeks)||4
8129501|NCT02828982|20038689|P2|Received Intervention|Second Intervention (3 Weeks)||6
8129502|NCT02828982|20038690|P1|Received Intervention|Second Intervention (3 Weeks)||4
8129503|NCT02828982|20038689|P2|STARTED|Second Intervention (3 Weeks)||6
8129504|NCT02828982|20038690|P1|STARTED|Second Intervention (3 Weeks)||4
8129505|NCT02828982|20038689|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
8129506|NCT02828982|20038690|P1|NOT COMPLETED|First Intervention (3 Weeks)||1
8129507|NCT02828982|20038689|P2|COMPLETED|First Intervention (3 Weeks)||6
8129508|NCT02828982|20038690|P1|COMPLETED|First Intervention (3 Weeks)||4
8129509|NCT02828982|20038689|P2|Received Intervention|First Intervention (3 Weeks)||7
8129510|NCT02828982|20038690|P1|Received Intervention|First Intervention (3 Weeks)||5
8129511|NCT02828982|20038689|P2|STARTED|First Intervention (3 Weeks)||7
8129512|NCT02828982|20038690|P1|STARTED|First Intervention (3 Weeks)||5
8129513|NCT02828917|20038706|P1|NOT COMPLETED|Overall Study||0
8129514|NCT02828917|20038706|P1|COMPLETED|Overall Study||104
8129515|NCT02828917|20038706|P1|STARTED|Overall Study||104
8129516|NCT02828644|20038712|P2|NOT COMPLETED|Overall Study||22
8129517|NCT02828644|20038713|P1|NOT COMPLETED|Overall Study||23
8129518|NCT02828644|20038712|P2|COMPLETED|Overall Study||65
8129519|NCT02828644|20038713|P1|COMPLETED|Overall Study||65
8129520|NCT02828644|20038712|P2|STARTED|Overall Study||87
8129521|NCT02828644|20038713|P1|STARTED|Overall Study||88
8129522|NCT02828436|20038720|P2|NOT COMPLETED|Period 2||0
8129523|NCT02828436|20038721|P1|NOT COMPLETED|Period 2||8
8129524|NCT02828436|20038720|P2|COMPLETED|Period 2||0
8129525|NCT02828436|20038721|P1|COMPLETED|Period 2||1
8129526|NCT02828436|20038720|P2|STARTED|Period 2||0
8129527|NCT02828436|20038721|P1|STARTED|Period 2||9
8129528|NCT02828436|20038720|P2|NOT COMPLETED|Period 1||4
8129529|NCT02828436|20038721|P1|NOT COMPLETED|Period 1||0
8129530|NCT02828436|20038720|P2|COMPLETED|Period 1||5
8129531|NCT02828436|20038721|P1|COMPLETED|Period 1||0
8129532|NCT02828436|20038720|P2|STARTED|Period 1||9
8129533|NCT02828436|20038721|P1|STARTED|Period 1||0
8129534|NCT02828241|20038729|P2|NOT COMPLETED|Overall Study||2
8129535|NCT02828241|20038730|P1|NOT COMPLETED|Overall Study||8
8129536|NCT02828241|20038729|P2|COMPLETED|Overall Study||21
8129537|NCT02828241|20038730|P1|COMPLETED|Overall Study||30
8129538|NCT02828241|20038729|P2|STARTED|Overall Study||23
8129539|NCT02828241|20038730|P1|STARTED|Overall Study||38
8129540|NCT02828137|20038743|P3|NOT COMPLETED|Overall Study||0
8129541|NCT02828137|20038744|P2|NOT COMPLETED|Overall Study||0
8129542|NCT02828137|20038745|P1|NOT COMPLETED|Overall Study||0
8129543|NCT02828137|20038743|P3|COMPLETED|Overall Study||41
8129544|NCT02828137|20038744|P2|COMPLETED|Overall Study||41
8129545|NCT02828137|20038745|P1|COMPLETED|Overall Study||41
8129546|NCT02828137|20038743|P3|STARTED|Overall Study||41
8129547|NCT02828137|20038744|P2|STARTED|Overall Study||41
8129548|NCT02828137|20038745|P1|STARTED|Overall Study||41
8129549|NCT02828124|20038757|P4|NOT COMPLETED|Overall Study||6
8129550|NCT02828124|20038758|P3|NOT COMPLETED|Overall Study||1
8129551|NCT02828124|20038759|P2|NOT COMPLETED|Overall Study||2
8129552|NCT02828124|20038760|P1|NOT COMPLETED|Overall Study||1
8129553|NCT02828124|20038757|P4|COMPLETED|Overall Study||0
8129554|NCT02828124|20038758|P3|COMPLETED|Overall Study||0
8129555|NCT02828124|20038759|P2|COMPLETED|Overall Study||0
8129556|NCT02828124|20038760|P1|COMPLETED|Overall Study||0
8129557|NCT02828124|20038757|P4|STARTED|Overall Study||6
8129558|NCT02828124|20038758|P3|STARTED|Overall Study||1
8129559|NCT02828124|20038759|P2|STARTED|Overall Study||2
8129560|NCT02828124|20038760|P1|STARTED|Overall Study||1
8129561|NCT02828111|20038875|P5|NOT COMPLETED|Overall Study||1
8129562|NCT02828111|20038876|P4|NOT COMPLETED|Overall Study||1
8129563|NCT02828111|20038877|P3|NOT COMPLETED|Overall Study||2
8129564|NCT02828111|20038878|P2|NOT COMPLETED|Overall Study||0
8129565|NCT02828111|20038879|P1|NOT COMPLETED|Overall Study||0
8129566|NCT02828111|20038875|P5|COMPLETED|Overall Study||11
8129567|NCT02828111|20038876|P4|COMPLETED|Overall Study||5
8129568|NCT02828111|20038877|P3|COMPLETED|Overall Study||4
8129569|NCT02828111|20038878|P2|COMPLETED|Overall Study||6
8129570|NCT02828111|20038879|P1|COMPLETED|Overall Study||6
8129571|NCT02828111|20038875|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
8129572|NCT02828111|20038876|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8129573|NCT02828111|20038877|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8129574|NCT02828111|20038878|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8129575|NCT02828111|20038879|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8129576|NCT02828111|20038875|P5|STARTED|Overall Study||12
8129577|NCT02828111|20038876|P4|STARTED|Overall Study||6
8129578|NCT02828111|20038877|P3|STARTED|Overall Study||6
8129579|NCT02828111|20038878|P2|STARTED|Overall Study||6
8129580|NCT02828111|20038879|P1|STARTED|Overall Study||6
8129581|NCT02828020|20038940|P3|NOT COMPLETED|Safety Follow-up Period||19
8129582|NCT02828020|20038941|P2|NOT COMPLETED|Safety Follow-up Period||18
8129583|NCT02828020|20038942|P1|NOT COMPLETED|Safety Follow-up Period||20
8129584|NCT02828020|20038940|P3|COMPLETED|Safety Follow-up Period||461
8129585|NCT02828020|20038941|P2|COMPLETED|Safety Follow-up Period||440
8129586|NCT02828020|20038942|P1|COMPLETED|Safety Follow-up Period||460
8129587|NCT02828020|20038940|P3|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
8129588|NCT02828020|20038941|P2|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458
8129589|NCT02828020|20038942|P1|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
8129590|NCT02828020|20038940|P3|NOT COMPLETED|Treatment Period||78
8129591|NCT02828020|20038941|P2|NOT COMPLETED|Treatment Period||99
8129592|NCT02828020|20038942|P1|NOT COMPLETED|Treatment Period||80
8129593|NCT02828020|20038940|P3|COMPLETED|Treatment Period||479
8129594|NCT02828020|20038941|P2|COMPLETED|Treatment Period||457
8129595|NCT02828020|20038942|P1|COMPLETED|Treatment Period||479
8129596|NCT02828020|20038940|P3|Safety Population: Received Study Drug|Treatment Period||485
8129597|NCT02828020|20038941|P2|Safety Population: Received Study Drug|Treatment Period||466
8129598|NCT02828020|20038942|P1|Safety Population: Received Study Drug|Treatment Period||485
8129599|NCT02828020|20038940|P3|STARTED|Treatment Period||557
8129600|NCT02828020|20038941|P2|STARTED|Treatment Period||556
8129601|NCT02828020|20038942|P1|STARTED|Treatment Period||559
8129602|NCT02827708|20038973|P2|NOT COMPLETED|Overall Study||5
8129603|NCT02827708|20038974|P1|NOT COMPLETED|Overall Study||5
8129604|NCT02827708|20038973|P2|COMPLETED|Overall Study||156
8129605|NCT02827708|20038974|P1|COMPLETED|Overall Study||158
8129606|NCT02827708|20038973|P2|Safety Analysis Set (SAS)|Overall Study||161
8129607|NCT02827708|20038974|P1|Safety Analysis Set (SAS)|Overall Study||163
8129608|NCT02827708|20038973|P2|Full Analysis Set (FAS)|Overall Study||161
8129609|NCT02827708|20038974|P1|Full Analysis Set (FAS)|Overall Study||163
8129610|NCT02827708|20038973|P2|STARTED|Overall Study||161
8129611|NCT02827708|20038974|P1|STARTED|Overall Study||163
8129612|NCT02827500|20039053|P2|NOT COMPLETED|Overall Study||7
8129613|NCT02827500|20039054|P1|NOT COMPLETED|Overall Study||19
8129614|NCT02827500|20039053|P2|COMPLETED|Overall Study||45
8129615|NCT02827500|20039054|P1|COMPLETED|Overall Study||33
8129616|NCT02827500|20039053|P2|STARTED|Overall Study||52
8129617|NCT02827500|20039054|P1|STARTED|Overall Study||52
8129618|NCT02826798|20039075|P5|NOT COMPLETED|Overall Study||0
8129619|NCT02826798|20039076|P4|NOT COMPLETED|Overall Study||1
8129620|NCT02826798|20039077|P3|NOT COMPLETED|Overall Study||0
8129621|NCT02826798|20039078|P2|NOT COMPLETED|Overall Study||1
8129622|NCT02826798|20039079|P1|NOT COMPLETED|Overall Study||0
8129623|NCT02826798|20039075|P5|COMPLETED|Overall Study||26
8129624|NCT02826798|20039076|P4|COMPLETED|Overall Study||24
8129625|NCT02826798|20039077|P3|COMPLETED|Overall Study||26
8129626|NCT02826798|20039078|P2|COMPLETED|Overall Study||25
8129627|NCT02826798|20039079|P1|COMPLETED|Overall Study||25
8129628|NCT02826798|20039075|P5|STARTED|Overall Study||26
8129629|NCT02826798|20039076|P4|STARTED|Overall Study||25
8129630|NCT02826798|20039077|P3|STARTED|Overall Study||26
8129631|NCT02826798|20039078|P2|STARTED|Overall Study||26
8129632|NCT02826798|20039079|P1|STARTED|Overall Study||25
8129633|NCT02826694|20039128|P2|NOT COMPLETED|Overall Study||0
8129634|NCT02826694|20039129|P1|NOT COMPLETED|Overall Study||0
8129635|NCT02826694|20039128|P2|COMPLETED|Overall Study||45
8129636|NCT02826694|20039129|P1|COMPLETED|Overall Study||61
8129637|NCT02826694|20039128|P2|Control Group|Overall Study||15
8129638|NCT02826694|20039129|P1|Control Group|Overall Study||20
8129639|NCT02826694|20039128|P2|Decision Group|Overall Study||30
8129640|NCT02826694|20039129|P1|Decision Group|Overall Study||41
8129641|NCT02826694|20039128|P2|STARTED|Overall Study||45
8129642|NCT02826694|20039129|P1|STARTED|Overall Study||61
8129643|NCT02826603|20039141|P2|NOT COMPLETED|Overall Study||64
8129644|NCT02826603|20039142|P1|NOT COMPLETED|Overall Study||61
8129645|NCT02826603|20039141|P2|COMPLETED|Overall Study||488
8129646|NCT02826603|20039142|P1|COMPLETED|Overall Study||489
8129647|NCT02826603|20039141|P2|STARTED|Overall Study||552
8129648|NCT02826603|20039142|P1|STARTED|Overall Study||550
8129649|NCT02826551|20039169|P2|NOT COMPLETED|Overall Study||0
8129650|NCT02826551|20039170|P1|NOT COMPLETED|Overall Study||0
8129651|NCT02826551|20039169|P2|COMPLETED|Overall Study||12
8129652|NCT02826551|20039170|P1|COMPLETED|Overall Study||11
8129653|NCT02826551|20039169|P2|STARTED|Overall Study||12
8129654|NCT02826551|20039170|P1|STARTED|Overall Study||11
8129655|NCT02826421|20039182|P4|NOT COMPLETED|Overall Study||2
8129656|NCT02826421|20039183|P3|NOT COMPLETED|Overall Study||2
8129657|NCT02826421|20039184|P2|NOT COMPLETED|Overall Study||3
8129658|NCT02826421|20039185|P1|NOT COMPLETED|Overall Study||3
8129659|NCT02826421|20039182|P4|COMPLETED|Overall Study||28
8129660|NCT02826421|20039183|P3|COMPLETED|Overall Study||26
8129661|NCT02826421|20039184|P2|COMPLETED|Overall Study||26
8129662|NCT02826421|20039185|P1|COMPLETED|Overall Study||19
8129663|NCT02826421|20039182|P4|Treated|Overall Study||28
8129664|NCT02826421|20039183|P3|Treated|Overall Study||26
8129665|NCT02826421|20039184|P2|Treated|Overall Study||26
8129666|NCT02826421|20039185|P1|Treated|Overall Study||19
8129667|NCT02826421|20039182|P4|STARTED|Overall Study||30
8129668|NCT02826421|20039183|P3|STARTED|Overall Study||28
8129669|NCT02826421|20039184|P2|STARTED|Overall Study||29
8129670|NCT02826421|20039185|P1|STARTED|Overall Study||22
8129671|NCT02825992|20039197|P1|NOT COMPLETED|Overall Study||8
8129672|NCT02825992|20039197|P1|COMPLETED|Overall Study||121
8129673|NCT02825992|20039197|P1|STARTED|Overall Study|The procedure was terminated for clinical reasons in 2 patients, therefore only 127 were treated.|129
8129674|NCT02825966|20039209|P1|NOT COMPLETED|Overall Study||0
8129675|NCT02825966|20039209|P1|COMPLETED|Overall Study||35
8129676|NCT02825966|20039209|P1|STARTED|Overall Study||35
8129677|NCT02825680|20039218|P2|NOT COMPLETED|Overall Study||16
8129678|NCT02825680|20039219|P1|NOT COMPLETED|Overall Study||0
8129679|NCT02825680|20039218|P2|COMPLETED|Overall Study||39
8129680|NCT02825680|20039219|P1|COMPLETED|Overall Study||82
8129681|NCT02825680|20039218|P2|STARTED|Overall Study||55
8129682|NCT02825680|20039219|P1|STARTED|Overall Study||82
8129683|NCT02825550|20039225|P1|NOT COMPLETED|Overall Study||1
8129684|NCT02825550|20039225|P1|COMPLETED|Overall Study||12
8129685|NCT02825550|20039225|P1|STARTED|Overall Study||13
8129686|NCT02825251|20039233|P2|NOT COMPLETED|Overall Study||6
8129687|NCT02825251|20039234|P1|NOT COMPLETED|Overall Study||3
8129688|NCT02825251|20039233|P2|COMPLETED|Overall Study||230
8129689|NCT02825251|20039234|P1|COMPLETED|Overall Study||233
8129690|NCT02825251|20039233|P2|STARTED|Overall Study||236
8129691|NCT02825251|20039234|P1|STARTED|Overall Study||236
8129692|NCT02825212|20039420|P1|NOT COMPLETED|Overall Study||0
8129693|NCT02825212|20039420|P1|COMPLETED|Overall Study||10
8129694|NCT02825212|20039420|P1|STARTED|Overall Study||10
8129695|NCT02825043|20039425|P1|NOT COMPLETED|Overall Study||4
8129696|NCT02825043|20039425|P1|COMPLETED|Overall Study||2
8129697|NCT02825043|20039425|P1|STARTED|Overall Study||6
8129698|NCT02824913|20039432|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8129699|NCT02824913|20039433|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8129700|NCT02824913|20039432|P2|COMPLETED|Second Intervention (1 Day)||0
8129701|NCT02824913|20039433|P1|COMPLETED|Second Intervention (1 Day)||1
8129702|NCT02824913|20039432|P2|STARTED|Second Intervention (1 Day)||0
8129703|NCT02824913|20039433|P1|STARTED|Second Intervention (1 Day)||1
8129704|NCT02824913|20039432|P2|NOT COMPLETED|Washout (7-14 Days)||0
8129705|NCT02824913|20039433|P1|NOT COMPLETED|Washout (7-14 Days)||0
8129706|NCT02824913|20039432|P2|COMPLETED|Washout (7-14 Days)||0
8129707|NCT02824913|20039433|P1|COMPLETED|Washout (7-14 Days)||1
8129708|NCT02824913|20039432|P2|STARTED|Washout (7-14 Days)||0
8129709|NCT02824913|20039433|P1|STARTED|Washout (7-14 Days)||1
8129710|NCT02824913|20039432|P2|NOT COMPLETED|First Intervention (1 Day)||0
8129711|NCT02824913|20039433|P1|NOT COMPLETED|First Intervention (1 Day)||0
8129712|NCT02824913|20039432|P2|COMPLETED|First Intervention (1 Day)||0
8129713|NCT02824913|20039433|P1|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
8129714|NCT02824913|20039432|P2|STARTED|First Intervention (1 Day)||0
8129715|NCT02824913|20039433|P1|STARTED|First Intervention (1 Day)||1
8129716|NCT02824562|20039447|P2|NOT COMPLETED|Overall Study||5
8129717|NCT02824562|20039448|P1|NOT COMPLETED|Overall Study||3
8129718|NCT02824562|20039447|P2|COMPLETED|Overall Study||17
8129719|NCT02824562|20039448|P1|COMPLETED|Overall Study||19
8129720|NCT02824562|20039447|P2|STARTED|Overall Study||22
8129721|NCT02824562|20039448|P1|STARTED|Overall Study||22
8129722|NCT02824432|20039457|P2|NOT COMPLETED|Overall Study||0
8129723|NCT02824432|20039458|P1|NOT COMPLETED|Overall Study||1
8129724|NCT02824432|20039457|P2|COMPLETED|Overall Study||19
8129725|NCT02824432|20039458|P1|COMPLETED|Overall Study||17
8129726|NCT02824432|20039457|P2|STARTED|Overall Study||19
8129727|NCT02824432|20039458|P1|STARTED|Overall Study||18
8129728|NCT02824224|20039534|P2|NOT COMPLETED|Overall Study||1
8129729|NCT02824224|20039535|P1|NOT COMPLETED|Overall Study||2
8129730|NCT02824224|20039534|P2|COMPLETED|Overall Study||17
8129731|NCT02824224|20039535|P1|COMPLETED|Overall Study||17
8129732|NCT02824224|20039534|P2|STARTED|Overall Study||18
8129733|NCT02824224|20039535|P1|STARTED|Overall Study||19
8129734|NCT02824198|20039555|P2|NOT COMPLETED|Overall Study||3
8129735|NCT02824198|20039556|P1|NOT COMPLETED|Overall Study||15
8129736|NCT02824198|20039555|P2|COMPLETED|Overall Study||26
8129737|NCT02824198|20039556|P1|COMPLETED|Overall Study||74
8129738|NCT02824198|20039555|P2|STARTED|Overall Study||29
8129739|NCT02824198|20039556|P1|STARTED|Overall Study||89
8129740|NCT02823964|20039586|P1|NOT COMPLETED|Overall Study||5
8129741|NCT02823964|20039586|P1|COMPLETED|Overall Study||20
8129742|NCT02823964|20039586|P1|STARTED|Overall Study||25
8129743|NCT02823600|20039590|P1|NOT COMPLETED|Overall Study||0
8129744|NCT02823600|20039590|P1|COMPLETED|Overall Study||68
8129745|NCT02823600|20039590|P1|STARTED|Overall Study||68
8129746|NCT02823470|20039600|P2|NOT COMPLETED|Overall Study||15
8129747|NCT02823470|20039601|P1|NOT COMPLETED|Overall Study||9
8129748|NCT02823470|20039600|P2|COMPLETED|Overall Study||0
8129749|NCT02823470|20039601|P1|COMPLETED|Overall Study||0
8129750|NCT02823470|20039600|P2|STARTED|Overall Study||15
8129751|NCT02823470|20039601|P1|STARTED|Overall Study||9
8129752|NCT02823457|20039613|P1|NOT COMPLETED|Overall Study||5
8129753|NCT02823457|20039613|P1|COMPLETED|Overall Study||15
8129754|NCT02823457|20039613|P1|STARTED|Overall Study||20
8129755|NCT02823431|20039620|P2|NOT COMPLETED|Overall Study||0
8129756|NCT02823431|20039621|P1|NOT COMPLETED|Overall Study||0
8129757|NCT02823431|20039620|P2|COMPLETED|Overall Study||12
8129758|NCT02823431|20039621|P1|COMPLETED|Overall Study||11
8129759|NCT02823431|20039620|P2|STARTED|Overall Study||12
8129760|NCT02823431|20039621|P1|STARTED|Overall Study||11
8129761|NCT02823080|20039635|P2|NOT COMPLETED|Overall Study||0
8129762|NCT02823080|20039636|P1|NOT COMPLETED|Overall Study||0
8129763|NCT02823080|20039635|P2|COMPLETED|Overall Study||24
8129764|NCT02823080|20039636|P1|COMPLETED|Overall Study||24
8129765|NCT02823080|20039635|P2|STARTED|Overall Study||24
8129766|NCT02823080|20039636|P1|STARTED|Overall Study||24
8129767|NCT02822950|20039654|P1|NOT COMPLETED|Overall Study||0
8129768|NCT02822950|20039654|P1|COMPLETED|Overall Study||10
8129769|NCT02822950|20039654|P1|STARTED|Overall Study||10
8129770|NCT02822885|20039662|P1|NOT COMPLETED|Overall Study||0
8129771|NCT02822885|20039662|P1|COMPLETED|Overall Study||70
8129772|NCT02822885|20039662|P1|STARTED|Overall Study||70
8129773|NCT02822794|20039674|P2|NOT COMPLETED|Overall Study||0
8129774|NCT02822794|20039675|P1|NOT COMPLETED|Overall Study||1
8129775|NCT02822794|20039674|P2|COMPLETED|Overall Study||60
8129776|NCT02822794|20039675|P1|COMPLETED|Overall Study||56
8129777|NCT02822794|20039674|P2|STARTED|Overall Study||60
8129778|NCT02822794|20039675|P1|STARTED|Overall Study||57
8129779|NCT02822612|20039738|P5|NOT COMPLETED|Overall Study||0
8129780|NCT02822612|20039739|P4|NOT COMPLETED|Overall Study||0
8129781|NCT02822612|20039740|P3|NOT COMPLETED|Overall Study||0
8129782|NCT02822612|20039741|P2|NOT COMPLETED|Overall Study||0
8129783|NCT02822612|20039742|P1|NOT COMPLETED|Overall Study||0
8129784|NCT02822612|20039738|P5|COMPLETED|Overall Study||15
8129785|NCT02822612|20039739|P4|COMPLETED|Overall Study||4
8129786|NCT02822612|20039740|P3|COMPLETED|Overall Study||14
8129787|NCT02822612|20039741|P2|COMPLETED|Overall Study||13
8129788|NCT02822612|20039742|P1|COMPLETED|Overall Study||14
8129789|NCT02822612|20039738|P5|STARTED|Overall Study||15
8129790|NCT02822612|20039739|P4|STARTED|Overall Study||4
8129791|NCT02822612|20039740|P3|STARTED|Overall Study||14
8129792|NCT02822612|20039741|P2|STARTED|Overall Study||13
8129793|NCT02822612|20039742|P1|STARTED|Overall Study||14
8129794|NCT02822287|20039764|P1|NOT COMPLETED|Overall Study||0
8129795|NCT02822287|20039764|P1|COMPLETED|Overall Study||57
8129796|NCT02822287|20039764|P1|STARTED|Overall Study||57
8129797|NCT02822235|20039776|P2|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2
8129798|NCT02822235|20039777|P1|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11
8129799|NCT02822235|20039776|P2|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34
8129800|NCT02822235|20039777|P1|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107
8129801|NCT02822235|20039776|P2|STARTED|Prospective Phase (Day 1 up to Month 12)||36
8129802|NCT02822235|20039777|P1|STARTED|Prospective Phase (Day 1 up to Month 12)||118
8129803|NCT02822235|20039776|P2|NOT COMPLETED|Cross-sectional Phase (Day 1)||107
8129804|NCT02822235|20039777|P1|NOT COMPLETED|Cross-sectional Phase (Day 1)||146
8129805|NCT02822235|20039776|P2|COMPLETED|Cross-sectional Phase (Day 1)||36
8129806|NCT02822235|20039777|P1|COMPLETED|Cross-sectional Phase (Day 1)||118
8129807|NCT02822235|20039776|P2|STARTED|Cross-sectional Phase (Day 1)||143
8129808|NCT02822235|20039777|P1|STARTED|Cross-sectional Phase (Day 1)||264
8129809|NCT02822222|20039832|P2|NOT COMPLETED|Overall Study||0
8129810|NCT02822222|20039833|P1|NOT COMPLETED|Overall Study||1
8129811|NCT02822222|20039832|P2|COMPLETED|Overall Study||6
8129812|NCT02822222|20039833|P1|COMPLETED|Overall Study||15
8129813|NCT02822222|20039832|P2|STARTED|Overall Study||6
8129814|NCT02822222|20039833|P1|STARTED|Overall Study||16
8129815|NCT02821962|20039883|P2|NOT COMPLETED|Overall Study||0
8129816|NCT02821962|20039884|P1|NOT COMPLETED|Overall Study||2
8129817|NCT02821962|20039883|P2|COMPLETED|Overall Study||21
8129818|NCT02821962|20039884|P1|COMPLETED|Overall Study||17
8129819|NCT02821962|20039883|P2|STARTED|Overall Study||21
8129820|NCT02821962|20039884|P1|STARTED|Overall Study||19
8129821|NCT02821910|20039928|P6|NOT COMPLETED|Overall Study||1
8129822|NCT02821910|20039929|P5|NOT COMPLETED|Overall Study||0
8129823|NCT02821910|20039930|P4|NOT COMPLETED|Overall Study||0
8129824|NCT02821910|20039931|P3|NOT COMPLETED|Overall Study||2
8129825|NCT02821910|20039932|P2|NOT COMPLETED|Overall Study||0
8129826|NCT02821910|20039933|P1|NOT COMPLETED|Overall Study||1
8129827|NCT02821910|20039928|P6|COMPLETED|Overall Study||7
8129828|NCT02821910|20039929|P5|COMPLETED|Overall Study||7
8129829|NCT02821910|20039930|P4|COMPLETED|Overall Study||10
8129830|NCT02821910|20039931|P3|COMPLETED|Overall Study||8
8129831|NCT02821910|20039932|P2|COMPLETED|Overall Study||8
8129832|NCT02821910|20039933|P1|COMPLETED|Overall Study||6
8129833|NCT02821910|20039928|P6|STARTED|Overall Study||8
8129834|NCT02821910|20039929|P5|STARTED|Overall Study||7
8129835|NCT02821910|20039930|P4|STARTED|Overall Study||10
8129836|NCT02821910|20039931|P3|STARTED|Overall Study||10
8129837|NCT02821910|20039932|P2|STARTED|Overall Study||8
8129838|NCT02821910|20039933|P1|STARTED|Overall Study||7
8129839|NCT02821819|20039995|P1|NOT COMPLETED|Overall Study||1
8129840|NCT02821819|20039995|P1|COMPLETED|Overall Study||14
8129841|NCT02821819|20039995|P1|STARTED|Overall Study||15
8129842|NCT02821715|20040000|P6|NOT COMPLETED|Overall Study||0
8129843|NCT02821715|20040001|P5|NOT COMPLETED|Overall Study||0
8129844|NCT02821715|20040002|P4|NOT COMPLETED|Overall Study||0
8129845|NCT02821715|20040003|P3|NOT COMPLETED|Overall Study||0
8129846|NCT02821715|20040004|P2|NOT COMPLETED|Overall Study||0
8129847|NCT02821715|20040005|P1|NOT COMPLETED|Overall Study||1
8129848|NCT02821715|20040000|P6|COMPLETED|Overall Study||9
8129849|NCT02821715|20040001|P5|COMPLETED|Overall Study||6
8129850|NCT02821715|20040002|P4|COMPLETED|Overall Study||9
8129851|NCT02821715|20040003|P3|COMPLETED|Overall Study||8
8129852|NCT02821715|20040004|P2|COMPLETED|Overall Study||8
8129853|NCT02821715|20040005|P1|COMPLETED|Overall Study||7
8129854|NCT02821715|20040000|P6|STARTED|Overall Study||9
8129855|NCT02821715|20040001|P5|STARTED|Overall Study||6
8129856|NCT02821715|20040002|P4|STARTED|Overall Study||9
8129857|NCT02821715|20040003|P3|STARTED|Overall Study||8
8129858|NCT02821715|20040004|P2|STARTED|Overall Study||8
8129859|NCT02821715|20040005|P1|STARTED|Overall Study||8
8129860|NCT02821455|20040049|P1|NOT COMPLETED|Overall Study||0
8129861|NCT02821455|20040049|P1|COMPLETED|Overall Study||19
8129862|NCT02821455|20040049|P1|STARTED|Overall Study||19
8129863|NCT02821416|20040056|P2|NOT COMPLETED|Overall Study||1
8129864|NCT02821416|20040057|P1|NOT COMPLETED|Overall Study||3
8129865|NCT02821416|20040056|P2|COMPLETED|Overall Study||22
8129866|NCT02821416|20040057|P1|COMPLETED|Overall Study||20
8129867|NCT02821416|20040056|P2|STARTED|Overall Study||23
8129868|NCT02821416|20040057|P1|STARTED|Overall Study||23
8129869|NCT02821403|20040067|P2|NOT COMPLETED|"Third Intervention (1 Month)"||0
8129870|NCT02821403|20040068|P1|NOT COMPLETED|"Third Intervention (1 Month)"||0
8129871|NCT02821403|20040067|P2|COMPLETED|"Third Intervention (1 Month)"||40
8129872|NCT02821403|20040068|P1|COMPLETED|"Third Intervention (1 Month)"||40
8129873|NCT02821403|20040067|P2|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
8129874|NCT02821403|20040068|P1|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
8129875|NCT02821403|20040067|P2|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
8129876|NCT02821403|20040068|P1|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
8129877|NCT02821403|20040067|P2|Used Clear Lens|"Third Intervention (1 Month)"||13
8129878|NCT02821403|20040068|P1|Used Clear Lens|"Third Intervention (1 Month)"||14
8129879|NCT02821403|20040067|P2|STARTED|"Third Intervention (1 Month)"||40
8129880|NCT02821403|20040068|P1|STARTED|"Third Intervention (1 Month)"||40
8129881|NCT02821403|20040067|P2|NOT COMPLETED|"Second Intervention (1 Month)"||0
8129882|NCT02821403|20040068|P1|NOT COMPLETED|"Second Intervention (1 Month)"||0
8129883|NCT02821403|20040067|P2|COMPLETED|"Second Intervention (1 Month)"||40
8129884|NCT02821403|20040068|P1|COMPLETED|"Second Intervention (1 Month)"||40
8129885|NCT02821403|20040067|P2|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
8129886|NCT02821403|20040068|P1|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
8129887|NCT02821403|20040067|P2|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
8129888|NCT02821403|20040068|P1|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
8129889|NCT02821403|20040067|P2|Used Clear Lens|"Second Intervention (1 Month)"||14
8129890|NCT02821403|20040068|P1|Used Clear Lens|"Second Intervention (1 Month)"||13
8129891|NCT02821403|20040067|P2|STARTED|"Second Intervention (1 Month)"||40
8129892|NCT02821403|20040068|P1|STARTED|"Second Intervention (1 Month)"||40
8129893|NCT02821403|20040067|P2|NOT COMPLETED|"First Intervention (1 Month)"||0
8129894|NCT02821403|20040068|P1|NOT COMPLETED|"First Intervention (1 Month)"||0
8129895|NCT02821403|20040067|P2|COMPLETED|"First Intervention (1 Month)"||40
8129896|NCT02821403|20040068|P1|COMPLETED|"First Intervention (1 Month)"||40
8129897|NCT02821403|20040067|P2|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
8129898|NCT02821403|20040068|P1|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
8129899|NCT02821403|20040067|P2|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
8129900|NCT02821403|20040068|P1|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
8129901|NCT02821403|20040067|P2|Used Clear Lens|"First Intervention (1 Month)"||13
8129902|NCT02821403|20040068|P1|Used Clear Lens|"First Intervention (1 Month)"||13
8129903|NCT02821403|20040067|P2|STARTED|"First Intervention (1 Month)"||40
8129904|NCT02821403|20040068|P1|STARTED|"First Intervention (1 Month)"||40
8129905|NCT02821338|20040086|P2|NOT COMPLETED|Overall Study||2
8129906|NCT02821338|20040087|P1|NOT COMPLETED|Overall Study||3
8129907|NCT02821338|20040086|P2|COMPLETED|Overall Study|13 out of 15 subjects assigned to Sequence 2 completed the study, and provided two data points.|13
8129908|NCT02821338|20040087|P1|COMPLETED|Overall Study|12 out of 15 subjects assigned to Sequence 1 completed the study, and provided two data points.|12
8129909|NCT02821338|20040086|P2|STARTED|Overall Study||15
8129910|NCT02821338|20040087|P1|STARTED|Overall Study||15
8129911|NCT02821000|20040103|P1|NOT COMPLETED|Overall Study||103
8129912|NCT02821000|20040103|P1|COMPLETED|Overall Study||0
8129913|NCT02821000|20040103|P1|Treated|Overall Study||103
8129914|NCT02821000|20040103|P1|STARTED|Overall Study||103
8129915|NCT02820870|20040128|P2|NOT COMPLETED|Post Intervention||0
8129916|NCT02820870|20040129|P1|NOT COMPLETED|Post Intervention||0
8129917|NCT02820870|20040128|P2|COMPLETED|Post Intervention||28
8129918|NCT02820870|20040129|P1|COMPLETED|Post Intervention||15
8129919|NCT02820870|20040128|P2|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
8129920|NCT02820870|20040129|P1|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
8129921|NCT02820870|20040128|P2|NOT COMPLETED|Intervention||0
8129922|NCT02820870|20040129|P1|NOT COMPLETED|Intervention||0
8129923|NCT02820870|20040128|P2|COMPLETED|Intervention||28
8129924|NCT02820870|20040129|P1|COMPLETED|Intervention||15
8129925|NCT02820870|20040128|P2|STARTED|Intervention||28
8129926|NCT02820870|20040129|P1|STARTED|Intervention||15
8129927|NCT02820870|20040128|P2|NOT COMPLETED|Before Intervention||0
8129928|NCT02820870|20040129|P1|NOT COMPLETED|Before Intervention||0
8129929|NCT02820870|20040128|P2|COMPLETED|Before Intervention||28
8129930|NCT02820870|20040129|P1|COMPLETED|Before Intervention||15
8129931|NCT02820870|20040128|P2|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
8129932|NCT02820870|20040129|P1|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
8129933|NCT02820844|20040141|P6|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1
8129934|NCT02820844|20040142|P5|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2
8129935|NCT02820844|20040143|P4|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129936|NCT02820844|20040144|P3|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129937|NCT02820844|20040145|P2|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129938|NCT02820844|20040146|P1|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129939|NCT02820844|20040141|P6|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42
8129940|NCT02820844|20040142|P5|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54
8129941|NCT02820844|20040143|P4|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129942|NCT02820844|20040144|P3|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129943|NCT02820844|20040145|P2|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129944|NCT02820844|20040146|P1|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129945|NCT02820844|20040141|P6|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43
8129946|NCT02820844|20040142|P5|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56
8129947|NCT02820844|20040143|P4|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129948|NCT02820844|20040144|P3|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129949|NCT02820844|20040145|P2|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129950|NCT02820844|20040146|P1|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
8129951|NCT02820844|20040141|P6|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129952|NCT02820844|20040142|P5|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129953|NCT02820844|20040143|P4|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4
8129954|NCT02820844|20040144|P3|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9
8129955|NCT02820844|20040145|P2|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129956|NCT02820844|20040146|P1|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129957|NCT02820844|20040141|P6|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129958|NCT02820844|20040142|P5|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129959|NCT02820844|20040143|P4|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84
8129960|NCT02820844|20040144|P3|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99
8129961|NCT02820844|20040145|P2|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129962|NCT02820844|20040146|P1|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129963|NCT02820844|20040141|P6|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129964|NCT02820844|20040142|P5|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129965|NCT02820844|20040143|P4|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88
8129966|NCT02820844|20040144|P3|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108
8129967|NCT02820844|20040145|P2|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129968|NCT02820844|20040146|P1|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
8129969|NCT02820844|20040141|P6|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129970|NCT02820844|20040142|P5|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129971|NCT02820844|20040143|P4|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129972|NCT02820844|20040144|P3|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129973|NCT02820844|20040145|P2|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9
8129974|NCT02820844|20040146|P1|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5
8129975|NCT02820844|20040141|P6|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129976|NCT02820844|20040142|P5|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129977|NCT02820844|20040143|P4|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129978|NCT02820844|20040144|P3|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8129979|NCT02820844|20040145|P2|COMPLETED|Double-blinded (Up to 48 Weeks)||115
8129980|NCT02820844|20040146|P1|COMPLETED|Double-blinded (Up to 48 Weeks)||119
8129981|NCT02820844|20040141|P6|STARTED|Double-blinded (Up to 48 Weeks)||0
8129982|NCT02820844|20040142|P5|STARTED|Double-blinded (Up to 48 Weeks)||0
8129983|NCT02820844|20040143|P4|STARTED|Double-blinded (Up to 48 Weeks)||0
8129984|NCT02820844|20040144|P3|STARTED|Double-blinded (Up to 48 Weeks)||0
8129985|NCT02820844|20040145|P2|STARTED|Double-blinded (Up to 48 Weeks)||124
8129986|NCT02820844|20040146|P1|STARTED|Double-blinded (Up to 48 Weeks)||124
8129987|NCT02820597|20040360|P1|NOT COMPLETED|Overall Study||12
8129988|NCT02820597|20040360|P1|COMPLETED|Overall Study|12 participants were lost to follow-up.|15
8129989|NCT02820597|20040360|P1|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21
8129990|NCT02820597|20040360|P1|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24
8129991|NCT02820597|20040360|P1|30-day Post Treatment|Overall Study||27
8129992|NCT02820597|20040360|P1|7-day Post Treatment|Overall Study||27
8129993|NCT02820597|20040360|P1|1-day Post Treatment|Overall Study||27
8129994|NCT02820597|20040360|P1|STARTED|Overall Study||27
8129995|NCT02820324|20040373|P5|NOT COMPLETED|Overall Study||3
8129996|NCT02820324|20040374|P4|NOT COMPLETED|Overall Study||3
8129997|NCT02820324|20040375|P3|NOT COMPLETED|Overall Study||3
8129998|NCT02820324|20040376|P2|NOT COMPLETED|Overall Study||3
8129999|NCT02820324|20040377|P1|NOT COMPLETED|Overall Study||2
8130000|NCT02820324|20040373|P5|COMPLETED|Overall Study||80
8130001|NCT02820324|20040374|P4|COMPLETED|Overall Study||79
8130002|NCT02820324|20040375|P3|COMPLETED|Overall Study||79
8130003|NCT02820324|20040376|P2|COMPLETED|Overall Study||79
8130004|NCT02820324|20040377|P1|COMPLETED|Overall Study||76
8130005|NCT02820324|20040373|P5|Treated With Study Medication|Overall Study||83
8130006|NCT02820324|20040374|P4|Treated With Study Medication|Overall Study||81
8130007|NCT02820324|20040375|P3|Treated With Study Medication|Overall Study||80
8130008|NCT02820324|20040376|P2|Treated With Study Medication|Overall Study||80
8130009|NCT02820324|20040377|P1|Treated With Study Medication|Overall Study||77
8130010|NCT02820324|20040373|P5|STARTED|Overall Study||83
8130011|NCT02820324|20040374|P4|STARTED|Overall Study||82
8130012|NCT02820324|20040375|P3|STARTED|Overall Study||82
8130013|NCT02820324|20040376|P2|STARTED|Overall Study||82
8130014|NCT02820324|20040377|P1|STARTED|Overall Study||78
8130015|NCT02820038|20040411|P4|NOT COMPLETED|Overall Study||22
8130016|NCT02820038|20040412|P3|NOT COMPLETED|Overall Study||5
8130017|NCT02820038|20040413|P2|NOT COMPLETED|Overall Study||25
8130018|NCT02820038|20040414|P1|NOT COMPLETED|Overall Study||10
8130019|NCT02820038|20040411|P4|COMPLETED|Overall Study||44
8130020|NCT02820038|20040412|P3|COMPLETED|Overall Study||60
8130021|NCT02820038|20040413|P2|COMPLETED|Overall Study||52
8130022|NCT02820038|20040414|P1|COMPLETED|Overall Study||68
8130023|NCT02820038|20040411|P4|STARTED|Overall Study||66
8130024|NCT02820038|20040412|P3|STARTED|Overall Study||65
8130025|NCT02820038|20040413|P2|STARTED|Overall Study||77
8130026|NCT02820038|20040414|P1|STARTED|Overall Study||78
8130027|NCT02819908|20040518|P2|NOT COMPLETED|Overall Study||0
8130028|NCT02819908|20040519|P1|NOT COMPLETED|Overall Study||0
8130029|NCT02819908|20040518|P2|COMPLETED|Overall Study||13
8130030|NCT02819908|20040519|P1|COMPLETED|Overall Study||12
8130031|NCT02819908|20040518|P2|STARTED|Overall Study||13
8130032|NCT02819908|20040519|P1|STARTED|Overall Study||12
8130033|NCT02819804|20040541|P1|NOT COMPLETED|Follow-up for 1 Year||0
8130034|NCT02819804|20040541|P1|COMPLETED|Follow-up for 1 Year||1
8130035|NCT02819804|20040541|P1|STARTED|Follow-up for 1 Year||1
8130036|NCT02819804|20040541|P1|NOT COMPLETED|Start Cycle 2 and Beyond||0
8130037|NCT02819804|20040541|P1|COMPLETED|Start Cycle 2 and Beyond||0
8130038|NCT02819804|20040541|P1|STARTED|Start Cycle 2 and Beyond||0
8130039|NCT02819804|20040541|P1|NOT COMPLETED|Complete Cycle 1 (28 Days)||1
8130040|NCT02819804|20040541|P1|COMPLETED|Complete Cycle 1 (28 Days)||0
8130041|NCT02819804|20040541|P1|STARTED|Complete Cycle 1 (28 Days)||1
8130042|NCT02819726|20040548|P4|NOT COMPLETED|Part B (All Participants)||2
8130043|NCT02819726|20040549|P3|NOT COMPLETED|Part B (All Participants)||4
8130044|NCT02819726|20040550|P2|NOT COMPLETED|Part B (All Participants)||2
8130045|NCT02819726|20040551|P1|NOT COMPLETED|Part B (All Participants)||3
8130046|NCT02819726|20040548|P4|COMPLETED|Part B (All Participants)||36
8130047|NCT02819726|20040549|P3|COMPLETED|Part B (All Participants)||35
8130048|NCT02819726|20040550|P2|COMPLETED|Part B (All Participants)||68
8130049|NCT02819726|20040551|P1|COMPLETED|Part B (All Participants)||70
8130050|NCT02819726|20040548|P4|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|38
8130051|NCT02819726|20040549|P3|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|39
8130052|NCT02819726|20040550|P2|STARTED|Part B (All Participants)|18 participants completing Part A were not eligible for Part B|70
8130053|NCT02819726|20040551|P1|STARTED|Part B (All Participants)|19 participants who completed Part A were not eligible for Part B|73
8130054|NCT02819726|20040548|P4|NOT COMPLETED|Part A (All Participants)||0
8130055|NCT02819726|20040549|P3|NOT COMPLETED|Part A (All Participants)||11
8130056|NCT02819726|20040550|P2|NOT COMPLETED|Part A (All Participants)||10
8130057|NCT02819726|20040551|P1|NOT COMPLETED|Part A (All Participants)||6
8130058|NCT02819726|20040548|P4|COMPLETED|Part A (All Participants)||0
8130059|NCT02819726|20040549|P3|COMPLETED|Part A (All Participants)||87
8130060|NCT02819726|20040550|P2|COMPLETED|Part A (All Participants)||88
8130061|NCT02819726|20040551|P1|COMPLETED|Part A (All Participants)||92
8130062|NCT02819726|20040548|P4|STARTED|Part A (All Participants)||0
8130063|NCT02819726|20040549|P3|STARTED|Part A (All Participants)||98
8130064|NCT02819726|20040550|P2|STARTED|Part A (All Participants)||98
8130065|NCT02819726|20040551|P1|STARTED|Part A (All Participants)||98
8130066|NCT02819557|20040661|P1|NOT COMPLETED|Overall Study||0
8130067|NCT02819557|20040661|P1|COMPLETED|Overall Study||14
8130068|NCT02819557|20040661|P1|Evaluable Population|Overall Study||14
8130069|NCT02819557|20040661|P1|Pharmacokinetics (PK) Population|Overall Study||14
8130070|NCT02819557|20040661|P1|Safety Population|Overall Study||14
8130071|NCT02819557|20040661|P1|STARTED|Overall Study||14
8130072|NCT02819310|20040678|P1|NOT COMPLETED|Overall Study||109
8130073|NCT02819310|20040678|P1|COMPLETED|Overall Study||221
8130074|NCT02819310|20040678|P1|STARTED|Overall Study||330
8130075|NCT02819297|20040684|P2|NOT COMPLETED|Overall Study||52
8130076|NCT02819297|20040685|P1|NOT COMPLETED|Overall Study||60
8130077|NCT02819297|20040684|P2|COMPLETED|Overall Study||252
8130078|NCT02819297|20040685|P1|COMPLETED|Overall Study||239
8130079|NCT02819297|20040684|P2|STARTED|Overall Study||304
8130080|NCT02819297|20040685|P1|STARTED|Overall Study||299
8130081|NCT02819284|20040693|P2|NOT COMPLETED|Overall Study||5
8130082|NCT02819284|20040694|P1|NOT COMPLETED|Overall Study||5
8130083|NCT02819284|20040693|P2|COMPLETED|Overall Study||448
8130084|NCT02819284|20040694|P1|COMPLETED|Overall Study||447
8130085|NCT02819284|20040693|P2|STARTED|Overall Study||453
8130086|NCT02819284|20040694|P1|STARTED|Overall Study||452
8130087|NCT02819011|20040728|P2|NOT COMPLETED|Overall Study||5
8130088|NCT02819011|20040729|P1|NOT COMPLETED|Overall Study||7
8130089|NCT02819011|20040728|P2|COMPLETED|Overall Study||17
8130090|NCT02819011|20040729|P1|COMPLETED|Overall Study||15
8130091|NCT02819011|20040728|P2|STARTED|Overall Study||22
8130092|NCT02819011|20040729|P1|STARTED|Overall Study||22
8130093|NCT02818998|20040759|P3|NOT COMPLETED|Overall Study||18
8130094|NCT02818998|20040760|P2|NOT COMPLETED|Overall Study||16
8130095|NCT02818998|20040761|P1|NOT COMPLETED|Overall Study||18
8130096|NCT02818998|20040759|P3|COMPLETED|Overall Study||136
8130097|NCT02818998|20040760|P2|COMPLETED|Overall Study||138
8130098|NCT02818998|20040761|P1|COMPLETED|Overall Study||137
8130099|NCT02818998|20040759|P3|Completed Week 52 Visit|Overall Study||140
8130100|NCT02818998|20040760|P2|Completed Week 52 Visit|Overall Study||146
8130101|NCT02818998|20040761|P1|Completed Week 52 Visit|Overall Study||144
8130102|NCT02818998|20040759|P3|STARTED|Overall Study||154
8130103|NCT02818998|20040760|P2|STARTED|Overall Study||154
8130104|NCT02818998|20040761|P1|STARTED|Overall Study||155
8130105|NCT02818946|20040787|P1|NOT COMPLETED|Overall Study||0
8130106|NCT02818946|20040787|P1|COMPLETED|Overall Study||30
8130107|NCT02818946|20040787|P1|STARTED|Overall Study||30
8130113|NCT02818777|20040798|P1|NOT COMPLETED|Overall Study||3
8130114|NCT02818777|20040798|P1|COMPLETED|Overall Study||10
8130115|NCT02818777|20040798|P1|STARTED|Overall Study|The number of baseline participants was 13.|13
8130116|NCT02818569|20040826|P2|NOT COMPLETED|Overall Study||0
8130117|NCT02818569|20040827|P1|NOT COMPLETED|Overall Study||0
8130118|NCT02818569|20040826|P2|COMPLETED|Overall Study||7
8130119|NCT02818569|20040827|P1|COMPLETED|Overall Study||8
8130120|NCT02818569|20040826|P2|STARTED|Overall Study||7
8130121|NCT02818569|20040827|P1|STARTED|Overall Study||8
8130122|NCT02818244|20040845|P4|NOT COMPLETED|Overall Study||0
8130123|NCT02818244|20040846|P3|NOT COMPLETED|Overall Study||0
8130124|NCT02818244|20040847|P2|NOT COMPLETED|Overall Study||0
8130125|NCT02818244|20040848|P1|NOT COMPLETED|Overall Study||0
8130126|NCT02818244|20040845|P4|COMPLETED|Overall Study||25
8130127|NCT02818244|20040846|P3|COMPLETED|Overall Study||25
8130128|NCT02818244|20040847|P2|COMPLETED|Overall Study||25
8130129|NCT02818244|20040848|P1|COMPLETED|Overall Study||25
8130130|NCT02818244|20040845|P4|STARTED|Overall Study||25
8130131|NCT02818244|20040846|P3|STARTED|Overall Study||25
8130132|NCT02818244|20040847|P2|STARTED|Overall Study||25
8130133|NCT02818244|20040848|P1|STARTED|Overall Study||25
8130134|NCT02818114|20040858|P1|NOT COMPLETED|Overall Study||1
8130135|NCT02818114|20040858|P1|COMPLETED|Overall Study||7
8130136|NCT02818114|20040858|P1|STARTED|Overall Study||8
8130137|NCT02818036|20040865|P2|NOT COMPLETED|Overall Study||0
8130138|NCT02818036|20040866|P1|NOT COMPLETED|Overall Study||2
8130139|NCT02818036|20040865|P2|COMPLETED|Overall Study||40
8130140|NCT02818036|20040866|P1|COMPLETED|Overall Study||40
8130141|NCT02818036|20040865|P2|STARTED|Overall Study||40
8130142|NCT02818036|20040866|P1|STARTED|Overall Study||42
8130143|NCT02817841|20040874|P1|NOT COMPLETED|Overall Study||848
8130144|NCT02817841|20040874|P1|COMPLETED|Overall Study||1016
8130145|NCT02817841|20040874|P1|STARTED|Overall Study||1864
8130146|NCT02817828|20040901|P1|NOT COMPLETED|Overall Study||335
8130147|NCT02817828|20040901|P1|COMPLETED|Overall Study||1218
8130148|NCT02817828|20040901|P1|STARTED|Overall Study||1553
8130149|NCT02817776|20040925|P1|NOT COMPLETED|Overall Study||88
8130150|NCT02817776|20040925|P1|COMPLETED|Overall Study||293
8130244|NCT02815735|20041204|P2|STARTED|First Intervention (4 Weeks)||38
8130151|NCT02817776|20040925|P1|STARTED|Overall Study|33 excluded prior to procedure. 348 had study catheter inserted (Safety Population)|381
8130152|NCT02817763|20040937|P2|NOT COMPLETED|Overall Study||0
8130153|NCT02817763|20040938|P1|NOT COMPLETED|Overall Study||0
8130154|NCT02817763|20040937|P2|COMPLETED|Overall Study||20
8130155|NCT02817763|20040938|P1|COMPLETED|Overall Study||20
8130156|NCT02817763|20040937|P2|STARTED|Overall Study||20
8130157|NCT02817763|20040938|P1|STARTED|Overall Study||20
8130158|NCT02817594|20040946|P1|NOT COMPLETED|Overall Study||3
8130159|NCT02817594|20040946|P1|COMPLETED|Overall Study||48
8130160|NCT02817594|20040946|P1|Received Treatment|Overall Study||50
8130161|NCT02817594|20040946|P1|STARTED|Overall Study||51
8130162|NCT02817555|20040967|P2|NOT COMPLETED|Overall Study||5
8130163|NCT02817555|20040968|P1|NOT COMPLETED|Overall Study||3
8130164|NCT02817555|20040967|P2|COMPLETED|Overall Study||21
8130165|NCT02817555|20040968|P1|COMPLETED|Overall Study||21
8130166|NCT02817555|20040967|P2|STARTED|Overall Study||26
8130167|NCT02817555|20040968|P1|STARTED|Overall Study||24
8130168|NCT02817516|20040988|P4|NOT COMPLETED|Overall Study||0
8130169|NCT02817516|20040989|P3|NOT COMPLETED|Overall Study||1
8130170|NCT02817516|20040990|P2|NOT COMPLETED|Overall Study||0
8130171|NCT02817516|20040991|P1|NOT COMPLETED|Overall Study||0
8130172|NCT02817516|20040988|P4|COMPLETED|Overall Study||6
8130173|NCT02817516|20040989|P3|COMPLETED|Overall Study||5
8130174|NCT02817516|20040990|P2|COMPLETED|Overall Study||6
8130175|NCT02817516|20040991|P1|COMPLETED|Overall Study||6
8130176|NCT02817516|20040988|P4|STARTED|Overall Study||6
8130177|NCT02817516|20040989|P3|STARTED|Overall Study||6
8130178|NCT02817516|20040990|P2|STARTED|Overall Study||6
8130179|NCT02817516|20040991|P1|STARTED|Overall Study||6
8130180|NCT02817087|20041028|P2|NOT COMPLETED|Overall Study||0
8130181|NCT02817087|20041029|P1|NOT COMPLETED|Overall Study||2
8130182|NCT02817087|20041028|P2|COMPLETED|Overall Study||15
8130183|NCT02817087|20041029|P1|COMPLETED|Overall Study|1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns|14
8130184|NCT02817087|20041028|P2|STARTED|Overall Study||15
8130185|NCT02817087|20041029|P1|STARTED|Overall Study||16
8130186|NCT02816723|20041049|P2|NOT COMPLETED|Overall Study||2
8130187|NCT02816723|20041050|P1|NOT COMPLETED|Overall Study||6
8130188|NCT02816723|20041049|P2|COMPLETED|Overall Study||28
8130189|NCT02816723|20041050|P1|COMPLETED|Overall Study||24
8130190|NCT02816723|20041049|P2|STARTED|Overall Study||30
8130191|NCT02816723|20041050|P1|STARTED|Overall Study||30
8130192|NCT02816710|20041063|P3|NOT COMPLETED|Overall Study||7
8130193|NCT02816710|20041064|P2|NOT COMPLETED|Overall Study||3
8130194|NCT02816710|20041065|P1|NOT COMPLETED|Overall Study||4
8130195|NCT02816710|20041063|P3|COMPLETED|Overall Study||29
8130196|NCT02816710|20041064|P2|COMPLETED|Overall Study||35
8130197|NCT02816710|20041065|P1|COMPLETED|Overall Study||34
8130198|NCT02816710|20041063|P3|STARTED|Overall Study||36
8130199|NCT02816710|20041064|P2|STARTED|Overall Study||38
8130200|NCT02816710|20041065|P1|STARTED|Overall Study||38
8130204|NCT02816346|20041112|P5|NOT COMPLETED|Overall Study||0
8130205|NCT02816346|20041113|P4|NOT COMPLETED|Overall Study||0
8130206|NCT02816346|20041114|P3|NOT COMPLETED|Overall Study||0
8130207|NCT02816346|20041115|P2|NOT COMPLETED|Overall Study||0
8130208|NCT02816346|20041116|P1|NOT COMPLETED|Overall Study||0
8130209|NCT02816346|20041112|P5|COMPLETED|Overall Study||16
8130210|NCT02816346|20041113|P4|COMPLETED|Overall Study||10
8130211|NCT02816346|20041114|P3|COMPLETED|Overall Study||10
8130212|NCT02816346|20041115|P2|COMPLETED|Overall Study||10
8130213|NCT02816346|20041116|P1|COMPLETED|Overall Study||10
8130214|NCT02816346|20041112|P5|STARTED|Overall Study||16
8130215|NCT02816346|20041113|P4|STARTED|Overall Study||10
8130216|NCT02816346|20041114|P3|STARTED|Overall Study||10
8130217|NCT02816346|20041115|P2|STARTED|Overall Study||10
8130218|NCT02816346|20041116|P1|STARTED|Overall Study||10
8130219|NCT02816138|20041158|P1|NOT COMPLETED|Overall Study||1
8130220|NCT02816138|20041158|P1|COMPLETED|Overall Study||14
8130221|NCT02816138|20041158|P1|STARTED|Overall Study||15
8130222|NCT02815982|20041175|P4|NOT COMPLETED|Overall Study||0
8130223|NCT02815982|20041176|P3|NOT COMPLETED|Overall Study||0
8130224|NCT02815982|20041177|P2|NOT COMPLETED|Overall Study||0
8130225|NCT02815982|20041178|P1|NOT COMPLETED|Overall Study||0
8130226|NCT02815982|20041175|P4|COMPLETED|Overall Study||26
8130227|NCT02815982|20041176|P3|COMPLETED|Overall Study||27
8130228|NCT02815982|20041177|P2|COMPLETED|Overall Study||26
8130229|NCT02815982|20041178|P1|COMPLETED|Overall Study||27
8130230|NCT02815982|20041175|P4|STARTED|Overall Study||26
8130231|NCT02815982|20041176|P3|STARTED|Overall Study||27
8130232|NCT02815982|20041177|P2|STARTED|Overall Study||26
8130233|NCT02815982|20041178|P1|STARTED|Overall Study||27
8130234|NCT02815735|20041204|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
8130235|NCT02815735|20041205|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
8130236|NCT02815735|20041204|P2|COMPLETED|Second Intervention (4 Weeks)||37
8130237|NCT02815735|20041205|P1|COMPLETED|Second Intervention (4 Weeks)||33
8130238|NCT02815735|20041204|P2|STARTED|Second Intervention (4 Weeks)||37
8130239|NCT02815735|20041205|P1|STARTED|Second Intervention (4 Weeks)||34
8130240|NCT02815735|20041204|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
8130241|NCT02815735|20041205|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
8130242|NCT02815735|20041204|P2|COMPLETED|First Intervention (4 Weeks)||37
8130243|NCT02815735|20041205|P1|COMPLETED|First Intervention (4 Weeks)||34
8130245|NCT02815735|20041205|P1|STARTED|First Intervention (4 Weeks)||36
8130246|NCT02815709|20041225|P5|NOT COMPLETED|Overall Study||10
8130247|NCT02815709|20041226|P4|NOT COMPLETED|Overall Study||8
8130248|NCT02815709|20041227|P3|NOT COMPLETED|Overall Study||7
8130249|NCT02815709|20041228|P2|NOT COMPLETED|Overall Study||8
8130250|NCT02815709|20041229|P1|NOT COMPLETED|Overall Study||7
8130251|NCT02815709|20041225|P5|COMPLETED|Overall Study|Completed Study|74
8130252|NCT02815709|20041226|P4|COMPLETED|Overall Study|Completed Study|76
8130253|NCT02815709|20041227|P3|COMPLETED|Overall Study|Completed Study|75
8130254|NCT02815709|20041228|P2|COMPLETED|Overall Study|Completed Study|78
8130255|NCT02815709|20041229|P1|COMPLETED|Overall Study|Completed Study|75
8130256|NCT02815709|20041225|P5|Treated With Study Medication|Overall Study||76
8130257|NCT02815709|20041226|P4|Treated With Study Medication|Overall Study||79
8130258|NCT02815709|20041227|P3|Treated With Study Medication|Overall Study||79
8130259|NCT02815709|20041228|P2|Treated With Study Medication|Overall Study||79
8130260|NCT02815709|20041229|P1|Treated With Study Medication|Overall Study||76
8130261|NCT02815709|20041225|P5|STARTED|Overall Study||84
8130262|NCT02815709|20041226|P4|STARTED|Overall Study||84
8130263|NCT02815709|20041227|P3|STARTED|Overall Study||82
8130264|NCT02815709|20041228|P2|STARTED|Overall Study||86
8130265|NCT02815709|20041229|P1|STARTED|Overall Study||82
8130266|NCT02815670|20041259|P1|NOT COMPLETED|Overall Study||1
8130267|NCT02815670|20041259|P1|COMPLETED|Overall Study||0
8130268|NCT02815670|20041259|P1|STARTED|Overall Study||1
8130269|NCT02815644|20041272|P2|NOT COMPLETED|Treatment Period 2||0
8130270|NCT02815644|20041273|P1|NOT COMPLETED|Treatment Period 2||0
8130271|NCT02815644|20041272|P2|COMPLETED|Treatment Period 2||11
8130272|NCT02815644|20041273|P1|COMPLETED|Treatment Period 2||11
8130273|NCT02815644|20041272|P2|STARTED|Treatment Period 2||11
8130274|NCT02815644|20041273|P1|STARTED|Treatment Period 2||11
8130275|NCT02815644|20041272|P2|NOT COMPLETED|Treatment Period 1 + Washout||0
8130276|NCT02815644|20041273|P1|NOT COMPLETED|Treatment Period 1 + Washout||0
8130277|NCT02815644|20041272|P2|COMPLETED|Treatment Period 1 + Washout||11
8130278|NCT02815644|20041273|P1|COMPLETED|Treatment Period 1 + Washout||11
8130279|NCT02815644|20041272|P2|STARTED|Treatment Period 1 + Washout||11
8130280|NCT02815644|20041273|P1|STARTED|Treatment Period 1 + Washout||11
8130281|NCT02815397|20041291|P1|NOT COMPLETED|Overall Study||2
8130282|NCT02815397|20041291|P1|COMPLETED|Overall Study||0
8130283|NCT02815397|20041291|P1|STARTED|Overall Study||2
8130284|NCT02815293|20041301|P3|NOT COMPLETED|Overall Study||18
8130285|NCT02815293|20041302|P2|NOT COMPLETED|Overall Study||8
8130286|NCT02815293|20041303|P1|NOT COMPLETED|Overall Study||10
8130287|NCT02815293|20041301|P3|COMPLETED|Overall Study||0
8130288|NCT02815293|20041302|P2|COMPLETED|Overall Study||0
8130289|NCT02815293|20041303|P1|COMPLETED|Overall Study||0
8130290|NCT02815293|20041301|P3|STARTED|Overall Study||18
8130291|NCT02815293|20041302|P2|STARTED|Overall Study||8
8130292|NCT02815293|20041303|P1|STARTED|Overall Study||10
8130293|NCT02815280|20041313|P2|NOT COMPLETED|Open-Label Phase||44
8130294|NCT02815280|20041314|P1|NOT COMPLETED|Open-Label Phase||87
8130295|NCT02815280|20041313|P2|COMPLETED|Open-Label Phase||73
8130296|NCT02815280|20041314|P1|COMPLETED|Open-Label Phase||169
8130297|NCT02815280|20041313|P2|STARTED|Open-Label Phase||117
8130298|NCT02815280|20041314|P1|STARTED|Open-Label Phase||256
8130299|NCT02815280|20041313|P2|NOT COMPLETED|Double-Blind Phase||25
8130300|NCT02815280|20041314|P1|NOT COMPLETED|Double-Blind Phase||36
8130301|NCT02815280|20041313|P2|COMPLETED|Double-Blind Phase||137
8130302|NCT02815280|20041314|P1|COMPLETED|Double-Blind Phase||297
8130303|NCT02815280|20041313|P2|STARTED|Double-Blind Phase||162
8130304|NCT02815280|20041314|P1|STARTED|Double-Blind Phase||333
8130305|NCT02815267|20041334|P2|NOT COMPLETED|Open-Label Phase||41
8130306|NCT02815267|20041335|P1|NOT COMPLETED|Open-Label Phase||71
8130307|NCT02815267|20041334|P2|COMPLETED|Open-Label Phase||50
8130308|NCT02815267|20041335|P1|COMPLETED|Open-Label Phase||122
8130309|NCT02815267|20041334|P2|STARTED|Open-Label Phase||91
8130310|NCT02815267|20041335|P1|STARTED|Open-Label Phase||193
8130311|NCT02815267|20041334|P2|NOT COMPLETED|Double-Blind Phase||31
8130312|NCT02815267|20041335|P1|NOT COMPLETED|Double-Blind Phase||33
8130313|NCT02815267|20041334|P2|COMPLETED|Double-Blind Phase||128
8130314|NCT02815267|20041335|P1|COMPLETED|Double-Blind Phase||274
8130315|NCT02815267|20041334|P2|STARTED|Double-Blind Phase||159
8130316|NCT02815267|20041335|P1|STARTED|Double-Blind Phase||307
8130317|NCT02814890|20041355|P2|NOT COMPLETED|Overall Study||2
8130318|NCT02814890|20041356|P1|NOT COMPLETED|Overall Study||3
8130319|NCT02814890|20041355|P2|COMPLETED|Overall Study||30
8130320|NCT02814890|20041356|P1|COMPLETED|Overall Study||30
8130321|NCT02814890|20041355|P2|STARTED|Overall Study||32
8130322|NCT02814890|20041356|P1|STARTED|Overall Study||33
8130323|NCT02814838|20041370|P2|NOT COMPLETED|Overall Study||1
8130324|NCT02814838|20041371|P1|NOT COMPLETED|Overall Study||2
8130325|NCT02814838|20041370|P2|COMPLETED|Overall Study||25
8130326|NCT02814838|20041371|P1|COMPLETED|Overall Study||48
8130327|NCT02814838|20041370|P2|STARTED|Overall Study||26
8130328|NCT02814838|20041371|P1|STARTED|Overall Study||50
8130329|NCT02814656|20041407|P4|NOT COMPLETED|Overall Study||0
8130330|NCT02814656|20041408|P3|NOT COMPLETED|Overall Study||0
8130331|NCT02814656|20041409|P2|NOT COMPLETED|Overall Study||0
8130332|NCT02814656|20041410|P1|NOT COMPLETED|Overall Study||0
8130333|NCT02814656|20041407|P4|COMPLETED|Overall Study||6
8130334|NCT02814656|20041408|P3|COMPLETED|Overall Study||6
8130335|NCT02814656|20041409|P2|COMPLETED|Overall Study||6
8130336|NCT02814656|20041410|P1|COMPLETED|Overall Study||6
8130337|NCT02814656|20041407|P4|STARTED|Overall Study||6
8130338|NCT02814656|20041408|P3|STARTED|Overall Study||6
8130339|NCT02814656|20041409|P2|STARTED|Overall Study||6
8130340|NCT02814656|20041410|P1|STARTED|Overall Study||6
8130341|NCT02814643|20041510|P2|NOT COMPLETED|Overall Study||3
8130342|NCT02814643|20041511|P1|NOT COMPLETED|Overall Study||1
8130343|NCT02814643|20041510|P2|COMPLETED|Overall Study||49
8130344|NCT02814643|20041511|P1|COMPLETED|Overall Study||50
8130345|NCT02814643|20041510|P2|STARTED|Overall Study||52
8130346|NCT02814643|20041511|P1|STARTED|Overall Study||51
8130347|NCT02814565|20041535|P2|NOT COMPLETED|Overall Study||2
8130348|NCT02814565|20041536|P1|NOT COMPLETED|Overall Study||1
8130349|NCT02814565|20041535|P2|COMPLETED|Overall Study||88
8130350|NCT02814565|20041536|P1|COMPLETED|Overall Study||89
8130351|NCT02814565|20041535|P2|STARTED|Overall Study||90
8130352|NCT02814565|20041536|P1|STARTED|Overall Study||90
8130353|NCT02814448|20041565|P5|NOT COMPLETED|Overall Study||2
8130354|NCT02814448|20041566|P4|NOT COMPLETED|Overall Study||0
8130355|NCT02814448|20041567|P3|NOT COMPLETED|Overall Study||1
8130356|NCT02814448|20041568|P2|NOT COMPLETED|Overall Study||0
8130357|NCT02814448|20041569|P1|NOT COMPLETED|Overall Study||0
8130358|NCT02814448|20041565|P5|COMPLETED|Overall Study||26
8130359|NCT02814448|20041566|P4|COMPLETED|Overall Study||25
8130360|NCT02814448|20041567|P3|COMPLETED|Overall Study||25
8130361|NCT02814448|20041568|P2|COMPLETED|Overall Study||24
8130362|NCT02814448|20041569|P1|COMPLETED|Overall Study||27
8130363|NCT02814448|20041565|P5|STARTED|Overall Study||28
8130364|NCT02814448|20041566|P4|STARTED|Overall Study||25
8130365|NCT02814448|20041567|P3|STARTED|Overall Study||26
8130366|NCT02814448|20041568|P2|STARTED|Overall Study||24
8130367|NCT02814448|20041569|P1|STARTED|Overall Study||27
8130368|NCT02814279|20041588|P2|NOT COMPLETED|Overall Study||0
8130369|NCT02814279|20041589|P1|NOT COMPLETED|Overall Study||0
8130370|NCT02814279|20041588|P2|COMPLETED|Overall Study||21
8130371|NCT02814279|20041589|P1|COMPLETED|Overall Study||21
8130372|NCT02814279|20041588|P2|STARTED|Overall Study||21
8130373|NCT02814279|20041589|P1|STARTED|Overall Study||21
8130374|NCT02814227|20041597|P1|NOT COMPLETED|Overall Study||0
8130375|NCT02814227|20041597|P1|COMPLETED|Overall Study||52
8130376|NCT02814227|20041597|P1|STARTED|Overall Study||52
8130377|NCT02814175|20041606|P6|NOT COMPLETED|Part 2||6
8130378|NCT02814175|20041607|P5|NOT COMPLETED|Part 2||2
8130379|NCT02814175|20041608|P4|NOT COMPLETED|Part 2||4
8130380|NCT02814175|20041609|P3|NOT COMPLETED|Part 2||0
8130381|NCT02814175|20041610|P2|NOT COMPLETED|Part 2||0
8130382|NCT02814175|20041611|P1|NOT COMPLETED|Part 2||0
8130383|NCT02814175|20041606|P6|COMPLETED|Part 2||57
8130384|NCT02814175|20041607|P5|COMPLETED|Part 2||52
8130385|NCT02814175|20041608|P4|COMPLETED|Part 2||91
8130386|NCT02814175|20041609|P3|COMPLETED|Part 2||15
8130387|NCT02814175|20041610|P2|COMPLETED|Part 2||0
8130388|NCT02814175|20041611|P1|COMPLETED|Part 2||0
8130389|NCT02814175|20041606|P6|STARTED|Part 2||63
8130390|NCT02814175|20041607|P5|STARTED|Part 2||54
8130391|NCT02814175|20041608|P4|STARTED|Part 2||95
8130392|NCT02814175|20041609|P3|STARTED|Part 2||15
8130393|NCT02814175|20041610|P2|STARTED|Part 2||0
8130394|NCT02814175|20041611|P1|STARTED|Part 2||0
8130395|NCT02814175|20041606|P6|NOT COMPLETED|Part 1||0
8130396|NCT02814175|20041607|P5|NOT COMPLETED|Part 1||0
8130397|NCT02814175|20041608|P4|NOT COMPLETED|Part 1||0
8130398|NCT02814175|20041609|P3|NOT COMPLETED|Part 1||0
8130399|NCT02814175|20041610|P2|NOT COMPLETED|Part 1||6
8130400|NCT02814175|20041611|P1|NOT COMPLETED|Part 1||12
8130401|NCT02814175|20041606|P6|COMPLETED|Part 1||0
8130402|NCT02814175|20041607|P5|COMPLETED|Part 1||0
8130403|NCT02814175|20041608|P4|COMPLETED|Part 1||0
8130404|NCT02814175|20041609|P3|COMPLETED|Part 1||0
8130405|NCT02814175|20041610|P2|COMPLETED|Part 1||117
8130406|NCT02814175|20041611|P1|COMPLETED|Part 1||110
8130407|NCT02814175|20041606|P6|STARTED|Part 1||0
8130408|NCT02814175|20041607|P5|STARTED|Part 1||0
8130409|NCT02814175|20041608|P4|STARTED|Part 1||0
8130410|NCT02814175|20041609|P3|STARTED|Part 1||0
8130411|NCT02814175|20041610|P2|STARTED|Part 1||123
8130412|NCT02814175|20041611|P1|STARTED|Part 1||122
8130413|NCT02813694|20041649|P2|NOT COMPLETED|Overall Study||14
8130414|NCT02813694|20041650|P1|NOT COMPLETED|Overall Study||17
8130415|NCT02813694|20041649|P2|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354
8130416|NCT02813694|20041650|P1|COMPLETED|Overall Study||353
8130417|NCT02813694|20041649|P2|STARTED|Overall Study|Intent to Treat Analysis Set|368
8130418|NCT02813694|20041650|P1|STARTED|Overall Study|Intent to Treat Analysis Set|370
8130419|NCT02813681|20041663|P3|NOT COMPLETED|Overall Study||0
8130420|NCT02813681|20041664|P2|NOT COMPLETED|Overall Study||6
8130421|NCT02813681|20041665|P1|NOT COMPLETED|Overall Study||5
8130422|NCT02813681|20041663|P3|COMPLETED|Overall Study||19
8130423|NCT02813681|20041664|P2|COMPLETED|Overall Study||28
8130424|NCT02813681|20041665|P1|COMPLETED|Overall Study||22
8130425|NCT02813681|20041663|P3|STARTED|Overall Study||19
8130426|NCT02813681|20041664|P2|STARTED|Overall Study||34
8130427|NCT02813681|20041665|P1|STARTED|Overall Study||27
8130428|NCT02813577|20041686|P1|NOT COMPLETED|Overall Study||4
8130429|NCT02813577|20041686|P1|COMPLETED|Overall Study|Study was terminated and only some results at 1 month follow up are available.|0
8130430|NCT02813577|20041686|P1|STARTED|Overall Study||4
8130431|NCT02813551|20041704|P2|NOT COMPLETED|Overall Study||2
8130432|NCT02813551|20041705|P1|NOT COMPLETED|Overall Study||1
8130433|NCT02813551|20041704|P2|COMPLETED|Overall Study||57
8130434|NCT02813551|20041705|P1|COMPLETED|Overall Study||58
8130435|NCT02813551|20041704|P2|STARTED|Overall Study||59
8130436|NCT02813551|20041705|P1|STARTED|Overall Study||59
8130437|NCT02813473|20041731|P1|NOT COMPLETED|Overall Study||0
8130438|NCT02813473|20041731|P1|COMPLETED|Overall Study||223
8130439|NCT02813473|20041731|P1|STARTED|Overall Study||223
8130446|NCT02813070|20041771|P3|NOT COMPLETED|Overall Study||11
8130447|NCT02813070|20041772|P2|NOT COMPLETED|Overall Study||3
8130448|NCT02813070|20041773|P1|NOT COMPLETED|Overall Study||3
8130449|NCT02813070|20041771|P3|COMPLETED|Overall Study||25
8130450|NCT02813070|20041772|P2|COMPLETED|Overall Study||20
8130451|NCT02813070|20041773|P1|COMPLETED|Overall Study||25
8130452|NCT02813070|20041771|P3|Treated (Safety Population)|Overall Study||25
8130453|NCT02813070|20041772|P2|Treated (Safety Population)|Overall Study||20
8130454|NCT02813070|20041773|P1|Treated (Safety Population)|Overall Study||25
8130455|NCT02813070|20041771|P3|STARTED|Overall Study||36
8130456|NCT02813070|20041772|P2|STARTED|Overall Study||23
8130457|NCT02813070|20041773|P1|STARTED|Overall Study||28
8130458|NCT02812342|20041782|P1|NOT COMPLETED|Overall Study||0
8130459|NCT02812342|20041782|P1|COMPLETED|Overall Study||10
8130460|NCT02812342|20041782|P1|STARTED|Overall Study||10
8130461|NCT02812238|20041787|P2|NOT COMPLETED|Second Intervention||1
8130462|NCT02812238|20041788|P1|NOT COMPLETED|Second Intervention||0
8130463|NCT02812238|20041787|P2|COMPLETED|Second Intervention||18
8130464|NCT02812238|20041788|P1|COMPLETED|Second Intervention||18
8130465|NCT02812238|20041787|P2|STARTED|Second Intervention||19
8130466|NCT02812238|20041788|P1|STARTED|Second Intervention||18
8130467|NCT02812238|20041787|P2|NOT COMPLETED|First Intervention||0
8130468|NCT02812238|20041788|P1|NOT COMPLETED|First Intervention||1
8130469|NCT02812238|20041787|P2|COMPLETED|First Intervention||19
8130470|NCT02812238|20041788|P1|COMPLETED|First Intervention||18
8130471|NCT02812238|20041787|P2|STARTED|First Intervention||19
8130472|NCT02812238|20041788|P1|STARTED|First Intervention||19
8130473|NCT02812186|20041796|P2|NOT COMPLETED|Period 2||0
8130474|NCT02812186|20041797|P1|NOT COMPLETED|Period 2||0
8130475|NCT02812186|20041796|P2|COMPLETED|Period 2||24
8130476|NCT02812186|20041797|P1|COMPLETED|Period 2||29
8130477|NCT02812186|20041796|P2|STARTED|Period 2||24
8130478|NCT02812186|20041797|P1|STARTED|Period 2||29
8130479|NCT02812186|20041796|P2|NOT COMPLETED|Period 1||15
8130480|NCT02812186|20041797|P1|NOT COMPLETED|Period 1||11
8130481|NCT02812186|20041796|P2|COMPLETED|Period 1||24
8130482|NCT02812186|20041797|P1|COMPLETED|Period 1||29
8130483|NCT02812186|20041796|P2|STARTED|Period 1||39
8130484|NCT02812186|20041797|P1|STARTED|Period 1||40
8130485|NCT02811965|20041807|P1|NOT COMPLETED|Overall Study||0
8130486|NCT02811965|20041807|P1|COMPLETED|Overall Study||21
8130487|NCT02811965|20041807|P1|STARTED|Overall Study||21
8130491|NCT02811640|20041841|P1|NOT COMPLETED|Overall Study||2
8130492|NCT02811640|20041841|P1|COMPLETED|Overall Study||10
8130493|NCT02811640|20041841|P1|STARTED|Overall Study||12
8130494|NCT02811445|20041847|P2|NOT COMPLETED|Overall Study||0
8130495|NCT02811445|20041848|P1|NOT COMPLETED|Overall Study||0
8130496|NCT02811445|20041847|P2|COMPLETED|Overall Study||11
8130497|NCT02811445|20041848|P1|COMPLETED|Overall Study||18
8130498|NCT02811445|20041847|P2|STARTED|Overall Study||11
8130499|NCT02811445|20041848|P1|STARTED|Overall Study||18
8130500|NCT02811419|20041862|P2|NOT COMPLETED|Overall Study||13
8130501|NCT02811419|20041863|P1|NOT COMPLETED|Overall Study||12
8130502|NCT02811419|20041862|P2|COMPLETED|Overall Study||358
8130503|NCT02811419|20041863|P1|COMPLETED|Overall Study||357
8130504|NCT02811419|20041862|P2|STARTED|Overall Study||371
8130505|NCT02811419|20041863|P1|STARTED|Overall Study||369
8130506|NCT02811302|20041871|P1|NOT COMPLETED|Overall Study||213
8130507|NCT02811302|20041871|P1|COMPLETED|Overall Study||1282
8130508|NCT02811302|20041871|P1|STARTED|Overall Study||1495
8130509|NCT02811159|20041876|P1|NOT COMPLETED|Treatment Course 2||0
8130510|NCT02811159|20041876|P1|COMPLETED|Treatment Course 2||4
8130511|NCT02811159|20041876|P1|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4
8130512|NCT02811159|20041876|P1|NOT COMPLETED|Treatment Course 1||1
8130513|NCT02811159|20041876|P1|COMPLETED|Treatment Course 1||19
8130514|NCT02811159|20041876|P1|STARTED|Treatment Course 1||20
8130515|NCT02810873|20041893|P2|NOT COMPLETED|Overall Study||0
8130516|NCT02810873|20041894|P1|NOT COMPLETED|Overall Study||0
8130517|NCT02810873|20041893|P2|COMPLETED|Overall Study||13
8130518|NCT02810873|20041894|P1|COMPLETED|Overall Study||6
8130519|NCT02810873|20041893|P2|STARTED|Overall Study||13
8130520|NCT02810873|20041894|P1|STARTED|Overall Study||6
8130521|NCT02810509|20041904|P2|NOT COMPLETED|Overall Study||0
8130522|NCT02810509|20041905|P1|NOT COMPLETED|Overall Study||0
8130523|NCT02810509|20041904|P2|COMPLETED|Overall Study||1230
8130524|NCT02810509|20041905|P1|COMPLETED|Overall Study||584
8130525|NCT02810509|20041904|P2|STARTED|Overall Study||1230
8130526|NCT02810509|20041905|P1|STARTED|Overall Study||584
8130533|NCT02810327|20041938|P2|NOT COMPLETED|Overall Study||7
8130534|NCT02810327|20041939|P1|NOT COMPLETED|Overall Study||7
8130535|NCT02810327|20041938|P2|COMPLETED|Overall Study||34
8130536|NCT02810327|20041939|P1|COMPLETED|Overall Study||69
8130537|NCT02810327|20041938|P2|STARTED|Overall Study||41
8130538|NCT02810327|20041939|P1|STARTED|Overall Study||76
8130539|NCT02809976|20041945|P1|NOT COMPLETED|Overall Study||2
8130540|NCT02809976|20041945|P1|COMPLETED|Overall Study||9
8130541|NCT02809976|20041945|P1|STARTED|Overall Study||11
8130542|NCT02809911|20041957|P2|NOT COMPLETED|Overall Study||0
8130543|NCT02809911|20041958|P1|NOT COMPLETED|Overall Study||0
8130544|NCT02809911|20041957|P2|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
8130545|NCT02809911|20041958|P1|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
8130546|NCT02809911|20041957|P2|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
8130547|NCT02809911|20041958|P1|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
8130548|NCT02809859|20041966|P1|NOT COMPLETED|Overall Study||14
8130549|NCT02809859|20041966|P1|COMPLETED|Overall Study||125
8130550|NCT02809859|20041966|P1|STARTED|Overall Study||139
8130551|NCT02809846|20041976|P2|NOT COMPLETED|Overall Study||7
8130552|NCT02809846|20041977|P1|NOT COMPLETED|Overall Study||9
8130553|NCT02809846|20041976|P2|COMPLETED|Overall Study||9
8130554|NCT02809846|20041977|P1|COMPLETED|Overall Study||8
8130555|NCT02809846|20041976|P2|STARTED|Overall Study||16
8130556|NCT02809846|20041977|P1|STARTED|Overall Study||17
8130557|NCT02809833|20041983|P1|NOT COMPLETED|Overall Study||300
8130558|NCT02809833|20041983|P1|COMPLETED|Overall Study||550
8130559|NCT02809833|20041983|P1|STARTED|Overall Study||850
8130560|NCT02809430|20042057|P1|NOT COMPLETED|Overall Study||38
8130561|NCT02809430|20042057|P1|COMPLETED|Overall Study||52
8130562|NCT02809430|20042057|P1|Stopped CPAP During Inpatient Rehabilitation|Overall Study|10 of 62 participants stopped CPAP after the run-in and prior to discharge from IPR|10
8130563|NCT02809430|20042057|P1|Failed 3-night run-in Because no Evidence of Obstructive Sleep Apnea|Overall Study|14 with CPAP < 3 hours, 5 without evidence of OSA, 9 with evidence of central or complex sleep apnea|28
8130564|NCT02809430|20042057|P1|STARTED|Overall Study||90
8130565|NCT02809183|20042073|P6|NOT COMPLETED|Overall Study||0
8130566|NCT02809183|20042074|P5|NOT COMPLETED|Overall Study||0
8130567|NCT02809183|20042075|P4|NOT COMPLETED|Overall Study||0
8130568|NCT02809183|20042076|P3|NOT COMPLETED|Overall Study||0
8130569|NCT02809183|20042077|P2|NOT COMPLETED|Overall Study||0
8130570|NCT02809183|20042078|P1|NOT COMPLETED|Overall Study||0
8130571|NCT02809183|20042073|P6|COMPLETED|Overall Study||28
8130572|NCT02809183|20042074|P5|COMPLETED|Overall Study||6
8130573|NCT02809183|20042075|P4|COMPLETED|Overall Study||26
8130574|NCT02809183|20042076|P3|COMPLETED|Overall Study||25
8130575|NCT02809183|20042077|P2|COMPLETED|Overall Study||25
8130576|NCT02809183|20042078|P1|COMPLETED|Overall Study||25
8130577|NCT02809183|20042073|P6|STARTED|Overall Study||28
8130578|NCT02809183|20042074|P5|STARTED|Overall Study||6
8130579|NCT02809183|20042075|P4|STARTED|Overall Study||26
8130580|NCT02809183|20042076|P3|STARTED|Overall Study||25
8130581|NCT02809183|20042077|P2|STARTED|Overall Study||25
8130582|NCT02809183|20042078|P1|STARTED|Overall Study||25
8130583|NCT02809118|20042115|P3|NOT COMPLETED|Overall Study||1
8130584|NCT02809118|20042116|P2|NOT COMPLETED|Overall Study||1
8130585|NCT02809118|20042117|P1|NOT COMPLETED|Overall Study||0
8130586|NCT02809118|20042115|P3|COMPLETED|Overall Study||18
8130587|NCT02809118|20042116|P2|COMPLETED|Overall Study||18
8130588|NCT02809118|20042117|P1|COMPLETED|Overall Study||18
8130589|NCT02809118|20042115|P3|STARTED|Overall Study||19
8130590|NCT02809118|20042116|P2|STARTED|Overall Study||19
8130591|NCT02809118|20042117|P1|STARTED|Overall Study||18
8130592|NCT02809053|20042130|P2|NOT COMPLETED|Overall Study||6
8130593|NCT02809053|20042131|P1|NOT COMPLETED|Overall Study||7
8130594|NCT02809053|20042130|P2|COMPLETED|Overall Study||152
8130595|NCT02809053|20042131|P1|COMPLETED|Overall Study||150
8130596|NCT02809053|20042130|P2|Completed Treatment|Overall Study||156
8130597|NCT02809053|20042131|P1|Completed Treatment|Overall Study||156
8130598|NCT02809053|20042130|P2|STARTED|Overall Study||158
8130599|NCT02809053|20042131|P1|STARTED|Overall Study||157
8130600|NCT02808975|20042177|P2|NOT COMPLETED|Overall Study||19
8130601|NCT02808975|20042178|P1|NOT COMPLETED|Overall Study||22
8130602|NCT02808975|20042177|P2|COMPLETED|Overall Study||84
8130603|NCT02808975|20042178|P1|COMPLETED|Overall Study||81
8130604|NCT02808975|20042177|P2|STARTED|Overall Study||103
8130605|NCT02808975|20042178|P1|STARTED|Overall Study||103
8130606|NCT02808390|20042195|P3|NOT COMPLETED|Overall Study||3
8130607|NCT02808390|20042196|P2|NOT COMPLETED|Overall Study||6
8130608|NCT02808390|20042197|P1|NOT COMPLETED|Overall Study||2
8130609|NCT02808390|20042195|P3|COMPLETED|Overall Study||4
8130610|NCT02808390|20042196|P2|COMPLETED|Overall Study||2
8130611|NCT02808390|20042197|P1|COMPLETED|Overall Study||2
8130612|NCT02808390|20042195|P3|STARTED|Overall Study||7
8130613|NCT02808390|20042196|P2|STARTED|Overall Study||8
8130614|NCT02808390|20042197|P1|STARTED|Overall Study||4
8130615|NCT02808338|20042205|P1|NOT COMPLETED|Take Home Period||0
8130616|NCT02808338|20042205|P1|COMPLETED|Take Home Period||13
8130617|NCT02808338|20042205|P1|STARTED|Take Home Period||13
8130618|NCT02808338|20042205|P1|NOT COMPLETED|Overnight In-lab Polysomonography||2
8130619|NCT02808338|20042205|P1|COMPLETED|Overnight In-lab Polysomonography||13
8130620|NCT02808338|20042205|P1|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12
8130621|NCT02808338|20042205|P1|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12
8130622|NCT02808338|20042205|P1|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13
8130623|NCT02808338|20042205|P1|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13
8130624|NCT02808338|20042205|P1|STARTED|Overnight In-lab Polysomonography||15
8130625|NCT02808338|20042205|P1|NOT COMPLETED|Screening||10
8130626|NCT02808338|20042205|P1|COMPLETED|Screening||15
8130627|NCT02808338|20042205|P1|STARTED|Screening||25
8130628|NCT02808312|20042221|P5|NOT COMPLETED|Overall Study||0
8130629|NCT02808312|20042222|P4|NOT COMPLETED|Overall Study||0
8130630|NCT02808312|20042223|P3|NOT COMPLETED|Overall Study||1
8130631|NCT02808312|20042224|P2|NOT COMPLETED|Overall Study||0
8130632|NCT02808312|20042225|P1|NOT COMPLETED|Overall Study||0
8130633|NCT02808312|20042221|P5|COMPLETED|Overall Study||10
8130634|NCT02808312|20042222|P4|COMPLETED|Overall Study||10
8130635|NCT02808312|20042223|P3|COMPLETED|Overall Study||16
8130636|NCT02808312|20042224|P2|COMPLETED|Overall Study||10
8130637|NCT02808312|20042225|P1|COMPLETED|Overall Study||10
8130638|NCT02808312|20042221|P5|STARTED|Overall Study||10
8130639|NCT02808312|20042222|P4|STARTED|Overall Study||10
8130640|NCT02808312|20042223|P3|STARTED|Overall Study||17
8130641|NCT02808312|20042224|P2|STARTED|Overall Study||10
8130642|NCT02808312|20042225|P1|STARTED|Overall Study||10
8130643|NCT02808130|20042338|P6|NOT COMPLETED|Overall Study||0
8130644|NCT02808130|20042339|P5|NOT COMPLETED|Overall Study||0
8130645|NCT02808130|20042340|P4|NOT COMPLETED|Overall Study||0
8130646|NCT02808130|20042341|P3|NOT COMPLETED|Overall Study||0
8130647|NCT02808130|20042342|P2|NOT COMPLETED|Overall Study||0
8130648|NCT02808130|20042343|P1|NOT COMPLETED|Overall Study||0
8130649|NCT02808130|20042338|P6|COMPLETED|Overall Study||15
8130650|NCT02808130|20042339|P5|COMPLETED|Overall Study||15
8130651|NCT02808130|20042340|P4|COMPLETED|Overall Study||15
8130652|NCT02808130|20042341|P3|COMPLETED|Overall Study||15
8130653|NCT02808130|20042342|P2|COMPLETED|Overall Study||15
8130654|NCT02808130|20042343|P1|COMPLETED|Overall Study||15
8130655|NCT02808130|20042338|P6|STARTED|Overall Study||15
8130656|NCT02808130|20042339|P5|STARTED|Overall Study||15
8130657|NCT02808130|20042340|P4|STARTED|Overall Study||15
8130658|NCT02808130|20042341|P3|STARTED|Overall Study||15
8130659|NCT02808130|20042342|P2|STARTED|Overall Study||15
8130660|NCT02808130|20042343|P1|STARTED|Overall Study||15
8130661|NCT02808052|20042372|P3|NOT COMPLETED|Overall Study||0
8130662|NCT02808052|20042373|P2|NOT COMPLETED|Overall Study||0
8130663|NCT02808052|20042374|P1|NOT COMPLETED|Overall Study||0
8130664|NCT02808052|20042372|P3|COMPLETED|Overall Study||2
8130665|NCT02808052|20042373|P2|COMPLETED|Overall Study||3
8130666|NCT02808052|20042374|P1|COMPLETED|Overall Study||4
8130667|NCT02808052|20042372|P3|STARTED|Overall Study||2
8130668|NCT02808052|20042373|P2|STARTED|Overall Study||3
8130669|NCT02808052|20042374|P1|STARTED|Overall Study||4
8130670|NCT02807948|20042382|P2|NOT COMPLETED|Overall Study||0
8130671|NCT02807948|20042383|P1|NOT COMPLETED|Overall Study||1
8130672|NCT02807948|20042382|P2|COMPLETED|Overall Study||57
8130673|NCT02807948|20042383|P1|COMPLETED|Overall Study||131
8130674|NCT02807948|20042382|P2|STARTED|Overall Study||57
8130675|NCT02807948|20042383|P1|STARTED|Overall Study||132
8130682|NCT02807623|20042437|P3|NOT COMPLETED|Overall Study||23
8130683|NCT02807623|20042438|P2|NOT COMPLETED|Overall Study||21
8130684|NCT02807623|20042439|P1|NOT COMPLETED|Overall Study||23
8130685|NCT02807623|20042437|P3|COMPLETED|Overall Study||79
8130686|NCT02807623|20042438|P2|COMPLETED|Overall Study||79
8130687|NCT02807623|20042439|P1|COMPLETED|Overall Study||75
8130688|NCT02807623|20042437|P3|STARTED|Overall Study||102
8130689|NCT02807623|20042438|P2|STARTED|Overall Study||100
8130690|NCT02807623|20042439|P1|STARTED|Overall Study||98
8130691|NCT02807402|20042466|P1|NOT COMPLETED|Overall Study||6
8130692|NCT02807402|20042466|P1|COMPLETED|Overall Study||516
8130693|NCT02807402|20042466|P1|STARTED|Overall Study||522
8130694|NCT02807376|20042504|P2|NOT COMPLETED|Overall Study||1
8130695|NCT02807376|20042505|P1|NOT COMPLETED|Overall Study||3
8130696|NCT02807376|20042504|P2|COMPLETED|Overall Study||130
8130697|NCT02807376|20042505|P1|COMPLETED|Overall Study||136
8130698|NCT02807376|20042504|P2|STARTED|Overall Study||131
8130699|NCT02807376|20042505|P1|STARTED|Overall Study||139
8130700|NCT02807259|20042515|P2|NOT COMPLETED|Endline (3 Months)||87
8130701|NCT02807259|20042516|P1|NOT COMPLETED|Endline (3 Months)||35
8130702|NCT02807259|20042515|P2|COMPLETED|Endline (3 Months)||259
8130703|NCT02807259|20042516|P1|COMPLETED|Endline (3 Months)||288
8130704|NCT02807259|20042515|P2|STARTED|Endline (3 Months)||346
8130705|NCT02807259|20042516|P1|STARTED|Endline (3 Months)||323
8130706|NCT02807259|20042515|P2|NOT COMPLETED|Midline (3 Months)||34
8130707|NCT02807259|20042516|P1|NOT COMPLETED|Midline (3 Months)||30
8130708|NCT02807259|20042515|P2|COMPLETED|Midline (3 Months)||189
8130709|NCT02807259|20042516|P1|COMPLETED|Midline (3 Months)||322
8130710|NCT02807259|20042515|P2|STARTED|Midline (3 Months)||223
8130711|NCT02807259|20042516|P1|STARTED|Midline (3 Months)||352
8130712|NCT02807259|20042515|P2|NOT COMPLETED|Baseline (3 Months)||112
8130713|NCT02807259|20042516|P1|NOT COMPLETED|Baseline (3 Months)||77
8130714|NCT02807259|20042515|P2|COMPLETED|Baseline (3 Months)||292
8130715|NCT02807259|20042516|P1|COMPLETED|Baseline (3 Months)||328
8130716|NCT02807259|20042515|P2|STARTED|Baseline (3 Months)||404
8130717|NCT02807259|20042516|P1|STARTED|Baseline (3 Months)||405
8130718|NCT02806986|20042534|P1|NOT COMPLETED|Treatment Stage 2||5
8130719|NCT02806986|20042534|P1|COMPLETED|Treatment Stage 2||55
8130720|NCT02806986|20042534|P1|STARTED|Treatment Stage 2||60
8130721|NCT02806986|20042534|P1|NOT COMPLETED|Treatment Stage 1||1
8130722|NCT02806986|20042534|P1|COMPLETED|Treatment Stage 1||60
8130723|NCT02806986|20042534|P1|STARTED|Treatment Stage 1||61
8130724|NCT02806973|20042554|P4|NOT COMPLETED|Period 4||0
8130725|NCT02806973|20042555|P3|NOT COMPLETED|Period 4||0
8130726|NCT02806973|20042556|P2|NOT COMPLETED|Period 4||0
8130727|NCT02806973|20042557|P1|NOT COMPLETED|Period 4||0
8130728|NCT02806973|20042554|P4|COMPLETED|Period 4||3
8130729|NCT02806973|20042555|P3|COMPLETED|Period 4||6
8130730|NCT02806973|20042556|P2|COMPLETED|Period 4||6
8130731|NCT02806973|20042557|P1|COMPLETED|Period 4||8
8130732|NCT02806973|20042554|P4|STARTED|Period 4||3
8130733|NCT02806973|20042555|P3|STARTED|Period 4||6
8130734|NCT02806973|20042556|P2|STARTED|Period 4||6
8130735|NCT02806973|20042557|P1|STARTED|Period 4||8
8130736|NCT02806973|20042554|P4|NOT COMPLETED|Period 3||3
8130737|NCT02806973|20042555|P3|NOT COMPLETED|Period 3||1
8130738|NCT02806973|20042556|P2|NOT COMPLETED|Period 3||0
8130739|NCT02806973|20042557|P1|NOT COMPLETED|Period 3||0
8130740|NCT02806973|20042554|P4|COMPLETED|Period 3||3
8130741|NCT02806973|20042555|P3|COMPLETED|Period 3||6
8130742|NCT02806973|20042556|P2|COMPLETED|Period 3||6
8130743|NCT02806973|20042557|P1|COMPLETED|Period 3||8
8130744|NCT02806973|20042554|P4|STARTED|Period 3||6
8130745|NCT02806973|20042555|P3|STARTED|Period 3||7
8130746|NCT02806973|20042556|P2|STARTED|Period 3||6
8130747|NCT02806973|20042557|P1|STARTED|Period 3||8
8130748|NCT02806973|20042554|P4|NOT COMPLETED|Period 2||0
8130749|NCT02806973|20042555|P3|NOT COMPLETED|Period 2||0
8130750|NCT02806973|20042556|P2|NOT COMPLETED|Period 2||0
8130751|NCT02806973|20042557|P1|NOT COMPLETED|Period 2||0
8130752|NCT02806973|20042554|P4|COMPLETED|Period 2||6
8130753|NCT02806973|20042555|P3|COMPLETED|Period 2||7
8130754|NCT02806973|20042556|P2|COMPLETED|Period 2||6
8130755|NCT02806973|20042557|P1|COMPLETED|Period 2||8
8130756|NCT02806973|20042554|P4|STARTED|Period 2||6
8130757|NCT02806973|20042555|P3|STARTED|Period 2||7
8130758|NCT02806973|20042556|P2|STARTED|Period 2||6
8130759|NCT02806973|20042557|P1|STARTED|Period 2||8
8130760|NCT02806973|20042554|P4|NOT COMPLETED|Period 1||2
8130761|NCT02806973|20042555|P3|NOT COMPLETED|Period 1||1
8130762|NCT02806973|20042556|P2|NOT COMPLETED|Period 1||2
8130763|NCT02806973|20042557|P1|NOT COMPLETED|Period 1||0
8130764|NCT02806973|20042554|P4|COMPLETED|Period 1||6
8130765|NCT02806973|20042555|P3|COMPLETED|Period 1||7
8130766|NCT02806973|20042556|P2|COMPLETED|Period 1||6
8130767|NCT02806973|20042557|P1|COMPLETED|Period 1||8
8130768|NCT02806973|20042554|P4|STARTED|Period 1||8
8130769|NCT02806973|20042555|P3|STARTED|Period 1||8
8130770|NCT02806973|20042556|P2|STARTED|Period 1||8
8130771|NCT02806973|20042557|P1|STARTED|Period 1||8
8130772|NCT02806960|20042591|P4|NOT COMPLETED|Period 4||0
8130773|NCT02806960|20042592|P3|NOT COMPLETED|Period 4||0
8130774|NCT02806960|20042593|P2|NOT COMPLETED|Period 4||0
8130775|NCT02806960|20042594|P1|NOT COMPLETED|Period 4||0
8130776|NCT02806960|20042591|P4|COMPLETED|Period 4||0
8130777|NCT02806960|20042592|P3|COMPLETED|Period 4||0
8130778|NCT02806960|20042593|P2|COMPLETED|Period 4||0
8130779|NCT02806960|20042594|P1|COMPLETED|Period 4||0
8130780|NCT02806960|20042591|P4|STARTED|Period 4||0
8130781|NCT02806960|20042592|P3|STARTED|Period 4||0
8130782|NCT02806960|20042593|P2|STARTED|Period 4||0
8130783|NCT02806960|20042594|P1|STARTED|Period 4||0
8130784|NCT02806960|20042591|P4|NOT COMPLETED|Period 3||0
8130785|NCT02806960|20042592|P3|NOT COMPLETED|Period 3||0
8130786|NCT02806960|20042593|P2|NOT COMPLETED|Period 3||0
8130787|NCT02806960|20042594|P1|NOT COMPLETED|Period 3||0
8130788|NCT02806960|20042591|P4|COMPLETED|Period 3||0
8130789|NCT02806960|20042592|P3|COMPLETED|Period 3||0
8130790|NCT02806960|20042593|P2|COMPLETED|Period 3||0
8130791|NCT02806960|20042594|P1|COMPLETED|Period 3||0
8130792|NCT02806960|20042591|P4|STARTED|Period 3||0
8130793|NCT02806960|20042592|P3|STARTED|Period 3||0
8130794|NCT02806960|20042593|P2|STARTED|Period 3||0
8130795|NCT02806960|20042594|P1|STARTED|Period 3||0
8130796|NCT02806960|20042591|P4|NOT COMPLETED|Period 2||0
8130797|NCT02806960|20042592|P3|NOT COMPLETED|Period 2||0
8130798|NCT02806960|20042593|P2|NOT COMPLETED|Period 2||0
8130799|NCT02806960|20042594|P1|NOT COMPLETED|Period 2||0
8130800|NCT02806960|20042591|P4|COMPLETED|Period 2||0
8130801|NCT02806960|20042592|P3|COMPLETED|Period 2||0
8130802|NCT02806960|20042593|P2|COMPLETED|Period 2||0
8130803|NCT02806960|20042594|P1|COMPLETED|Period 2||0
8130804|NCT02806960|20042591|P4|STARTED|Period 2||0
8130805|NCT02806960|20042592|P3|STARTED|Period 2||0
8130806|NCT02806960|20042593|P2|STARTED|Period 2||0
8130807|NCT02806960|20042594|P1|STARTED|Period 2||0
8130808|NCT02806960|20042591|P4|NOT COMPLETED|Period 1||3
8130809|NCT02806960|20042592|P3|NOT COMPLETED|Period 1||3
8130810|NCT02806960|20042593|P2|NOT COMPLETED|Period 1||3
8130811|NCT02806960|20042594|P1|NOT COMPLETED|Period 1||3
8130812|NCT02806960|20042591|P4|COMPLETED|Period 1||0
8130813|NCT02806960|20042592|P3|COMPLETED|Period 1||0
8130814|NCT02806960|20042593|P2|COMPLETED|Period 1||0
8130815|NCT02806960|20042594|P1|COMPLETED|Period 1||0
8130816|NCT02806960|20042591|P4|STARTED|Period 1||3
8130817|NCT02806960|20042592|P3|STARTED|Period 1||3
8130818|NCT02806960|20042593|P2|STARTED|Period 1||3
8130819|NCT02806960|20042594|P1|STARTED|Period 1||3
8130820|NCT02806947|20042630|P2|NOT COMPLETED|Overall Study||1
8130821|NCT02806947|20042631|P1|NOT COMPLETED|Overall Study||5
8130822|NCT02806947|20042630|P2|COMPLETED|Overall Study||63
8130823|NCT02806947|20042631|P1|COMPLETED|Overall Study||53
8130824|NCT02806947|20042630|P2|STARTED|Overall Study||64
8130825|NCT02806947|20042631|P1|STARTED|Overall Study||58
8130826|NCT02806908|20042661|P2|NOT COMPLETED|Overall Study||1
8130827|NCT02806908|20042662|P1|NOT COMPLETED|Overall Study||1
8130828|NCT02806908|20042661|P2|COMPLETED|Overall Study||12
8130829|NCT02806908|20042662|P1|COMPLETED|Overall Study||10
8130830|NCT02806908|20042661|P2|STARTED|Overall Study||13
8130831|NCT02806908|20042662|P1|STARTED|Overall Study||11
8130832|NCT02806895|20042710|P2|NOT COMPLETED|Overall Study||0
8130833|NCT02806895|20042711|P1|NOT COMPLETED|Overall Study||1
8130834|NCT02806895|20042710|P2|COMPLETED|Overall Study||17
8130835|NCT02806895|20042711|P1|COMPLETED|Overall Study||16
8130836|NCT02806895|20042710|P2|STARTED|Overall Study||17
8130837|NCT02806895|20042711|P1|STARTED|Overall Study||17
8130838|NCT02806869|20042759|P2|NOT COMPLETED|Second Intervention (1 Day)||2
8130839|NCT02806869|20042760|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8130840|NCT02806869|20042759|P2|COMPLETED|Second Intervention (1 Day)||5
8130841|NCT02806869|20042760|P1|COMPLETED|Second Intervention (1 Day)||7
8130842|NCT02806869|20042759|P2|STARTED|Second Intervention (1 Day)||7
8130843|NCT02806869|20042760|P1|STARTED|Second Intervention (1 Day)||7
8130844|NCT02806869|20042759|P2|NOT COMPLETED|Washout (7 Days)||0
8130845|NCT02806869|20042760|P1|NOT COMPLETED|Washout (7 Days)||0
8130846|NCT02806869|20042759|P2|COMPLETED|Washout (7 Days)||7
8130847|NCT02806869|20042760|P1|COMPLETED|Washout (7 Days)||7
8130848|NCT02806869|20042759|P2|STARTED|Washout (7 Days)||7
8130849|NCT02806869|20042760|P1|STARTED|Washout (7 Days)||7
8130850|NCT02806869|20042759|P2|NOT COMPLETED|First Intervention (1 Day)||12
8130851|NCT02806869|20042760|P1|NOT COMPLETED|First Intervention (1 Day)||11
8130852|NCT02806869|20042759|P2|COMPLETED|First Intervention (1 Day)||12
8130853|NCT02806869|20042760|P1|COMPLETED|First Intervention (1 Day)||13
8130854|NCT02806869|20042759|P2|STARTED|First Intervention (1 Day)||24
8130855|NCT02806869|20042760|P1|STARTED|First Intervention (1 Day)||24
8130856|NCT02806726|20042770|P1|NOT COMPLETED|Overall Study||1
8130857|NCT02806726|20042770|P1|COMPLETED|Overall Study|Subjects were treated contralaterally|6
8130858|NCT02806726|20042770|P1|STARTED|Overall Study|Subjects were treated contralaterally|7
8130859|NCT02806713|20042779|P2|NOT COMPLETED|Overall Study||2
8130860|NCT02806713|20042780|P1|NOT COMPLETED|Overall Study||2
8130861|NCT02806713|20042779|P2|COMPLETED|Overall Study||44
8130862|NCT02806713|20042780|P1|COMPLETED|Overall Study||44
8130863|NCT02806713|20042779|P2|STARTED|Overall Study||46
8130864|NCT02806713|20042780|P1|STARTED|Overall Study||46
8130865|NCT02806544|20042788|P1|NOT COMPLETED|Overall Study||4
8130866|NCT02806544|20042788|P1|COMPLETED|Overall Study||31
8130867|NCT02806544|20042788|P1|STARTED|Overall Study||35
8130868|NCT02806505|20042799|P2|NOT COMPLETED|Overall Study||11
8130869|NCT02806505|20042800|P1|NOT COMPLETED|Overall Study||10
8130870|NCT02806505|20042799|P2|COMPLETED|Overall Study||32
8130871|NCT02806505|20042800|P1|COMPLETED|Overall Study||28
8130872|NCT02806505|20042799|P2|STARTED|Overall Study||43
8130873|NCT02806505|20042800|P1|STARTED|Overall Study||38
8130874|NCT02806414|20042810|P1|NOT COMPLETED|Overall Study||2
8130875|NCT02806414|20042810|P1|COMPLETED|Overall Study||13
8130876|NCT02806414|20042810|P1|STARTED|Overall Study||15
8130877|NCT02806232|20042824|P9|NOT COMPLETED|Overall Study||0
8130878|NCT02806232|20042825|P8|NOT COMPLETED|Overall Study||0
8130879|NCT02806232|20042826|P7|NOT COMPLETED|Overall Study||0
8130880|NCT02806232|20042827|P6|NOT COMPLETED|Overall Study||2
8130881|NCT02806232|20042828|P5|NOT COMPLETED|Overall Study||2
8130882|NCT02806232|20042829|P4|NOT COMPLETED|Overall Study||0
8130883|NCT02806232|20042830|P3|NOT COMPLETED|Overall Study||1
8130884|NCT02806232|20042831|P2|NOT COMPLETED|Overall Study||4
8130885|NCT02806232|20042832|P1|NOT COMPLETED|Overall Study||1
8130886|NCT02806232|20042824|P9|COMPLETED|Overall Study||4
8130887|NCT02806232|20042825|P8|COMPLETED|Overall Study||20
8130888|NCT02806232|20042826|P7|COMPLETED|Overall Study||60
8130889|NCT02806232|20042827|P6|COMPLETED|Overall Study||58
8130890|NCT02806232|20042828|P5|COMPLETED|Overall Study||58
8130891|NCT02806232|20042829|P4|COMPLETED|Overall Study||60
8130892|NCT02806232|20042830|P3|COMPLETED|Overall Study||59
8130893|NCT02806232|20042831|P2|COMPLETED|Overall Study||56
8130894|NCT02806232|20042832|P1|COMPLETED|Overall Study||59
8130895|NCT02806232|20042824|P9|STARTED|Overall Study||4
8130896|NCT02806232|20042825|P8|STARTED|Overall Study||20
8130897|NCT02806232|20042826|P7|STARTED|Overall Study||60
8130898|NCT02806232|20042827|P6|STARTED|Overall Study||60
8130899|NCT02806232|20042828|P5|STARTED|Overall Study||60
8130900|NCT02806232|20042829|P4|STARTED|Overall Study||60
8130901|NCT02806232|20042830|P3|STARTED|Overall Study||60
8130902|NCT02806232|20042831|P2|STARTED|Overall Study||60
8130903|NCT02806232|20042832|P1|STARTED|Overall Study||60
8130904|NCT02806024|20042872|P2|NOT COMPLETED|Overall Study||2
8130905|NCT02806024|20042873|P1|NOT COMPLETED|Overall Study||1
8130906|NCT02806024|20042872|P2|COMPLETED|Overall Study||5
8130907|NCT02806024|20042873|P1|COMPLETED|Overall Study||6
8130908|NCT02806024|20042872|P2|STARTED|Overall Study||7
8130909|NCT02806024|20042873|P1|STARTED|Overall Study||7
8130910|NCT02805907|20042883|P2|NOT COMPLETED|Overall Study||3
8130911|NCT02805907|20042884|P1|NOT COMPLETED|Overall Study||3
8130912|NCT02805907|20042883|P2|COMPLETED|Overall Study||53
8130913|NCT02805907|20042884|P1|COMPLETED|Overall Study||53
8130914|NCT02805907|20042883|P2|STARTED|Overall Study||56
8130915|NCT02805907|20042884|P1|STARTED|Overall Study||56
8130916|NCT02805790|20042898|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
8130917|NCT02805790|20042899|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8130918|NCT02805790|20042898|P2|COMPLETED|Second Intervention (4 Weeks)||15
8130919|NCT02805790|20042899|P1|COMPLETED|Second Intervention (4 Weeks)||14
8130920|NCT02805790|20042898|P2|STARTED|Second Intervention (4 Weeks)||16
8130921|NCT02805790|20042899|P1|STARTED|Second Intervention (4 Weeks)||14
8130922|NCT02805790|20042898|P2|NOT COMPLETED|Washout (4 Weeks)||0
8130923|NCT02805790|20042899|P1|NOT COMPLETED|Washout (4 Weeks)||0
8130924|NCT02805790|20042898|P2|COMPLETED|Washout (4 Weeks)||16
8130925|NCT02805790|20042899|P1|COMPLETED|Washout (4 Weeks)||14
8130926|NCT02805790|20042898|P2|STARTED|Washout (4 Weeks)||16
8130927|NCT02805790|20042899|P1|STARTED|Washout (4 Weeks)||14
8130928|NCT02805790|20042898|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8130929|NCT02805790|20042899|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8130930|NCT02805790|20042898|P2|COMPLETED|First Intervention (4 Weeks)||16
8130931|NCT02805790|20042899|P1|COMPLETED|First Intervention (4 Weeks)||14
8130932|NCT02805790|20042898|P2|STARTED|First Intervention (4 Weeks)||16
8130933|NCT02805790|20042899|P1|STARTED|First Intervention (4 Weeks)||14
8130934|NCT02805647|20042925|P2|NOT COMPLETED|Overall Study||0
8130935|NCT02805647|20042926|P1|NOT COMPLETED|Overall Study||0
8130936|NCT02805647|20042925|P2|COMPLETED|Overall Study|after laboratory tests|122
8130937|NCT02805647|20042926|P1|COMPLETED|Overall Study|after laboratory tests|100
8130938|NCT02805647|20042925|P2|STARTED|Overall Study|at the moment of submision|122
8130939|NCT02805647|20042926|P1|STARTED|Overall Study|at the moment of submision|100
8130940|NCT02804750|20042934|P2|NOT COMPLETED|Period 4||5
8130941|NCT02804750|20042935|P1|NOT COMPLETED|Period 4||0
8130942|NCT02804750|20042934|P2|COMPLETED|Period 4||7
8130943|NCT02804750|20042935|P1|COMPLETED|Period 4||0
8130944|NCT02804750|20042934|P2|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12
8130945|NCT02804750|20042935|P1|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0
8130946|NCT02804750|20042934|P2|NOT COMPLETED|Period 3||2
8130947|NCT02804750|20042935|P1|NOT COMPLETED|Period 3||0
8130948|NCT02804750|20042934|P2|COMPLETED|Period 3||13
8130949|NCT02804750|20042935|P1|COMPLETED|Period 3||16
8130950|NCT02804750|20042934|P2|STARTED|Period 3||15
8130951|NCT02804750|20042935|P1|STARTED|Period 3||16
8130952|NCT02804750|20042934|P2|NOT COMPLETED|Period 2||0
8130953|NCT02804750|20042935|P1|NOT COMPLETED|Period 2||1
8130954|NCT02804750|20042934|P2|COMPLETED|Period 2||15
8130955|NCT02804750|20042935|P1|COMPLETED|Period 2||16
8130956|NCT02804750|20042934|P2|STARTED|Period 2||15
8130957|NCT02804750|20042935|P1|STARTED|Period 2||17
8130958|NCT02804750|20042934|P2|NOT COMPLETED|Period 1||3
8130959|NCT02804750|20042935|P1|NOT COMPLETED|Period 1||0
8130960|NCT02804750|20042934|P2|COMPLETED|Period 1||15
8130961|NCT02804750|20042935|P1|COMPLETED|Period 1||17
8130962|NCT02804750|20042934|P2|STARTED|Period 1||18
8130963|NCT02804750|20042935|P1|STARTED|Period 1||17
8130970|NCT02804399|20042962|P2|NOT COMPLETED|Period 2||1
8130971|NCT02804399|20042963|P1|NOT COMPLETED|Period 2||0
8130972|NCT02804399|20042962|P2|COMPLETED|Period 2||11
8130973|NCT02804399|20042963|P1|COMPLETED|Period 2||0
8130974|NCT02804399|20042962|P2|STARTED|Period 2||12
8130975|NCT02804399|20042963|P1|STARTED|Period 2||0
8130976|NCT02804399|20042962|P2|NOT COMPLETED|Washout Period at Least 10 Days||0
8130977|NCT02804399|20042963|P1|NOT COMPLETED|Washout Period at Least 10 Days||0
8130978|NCT02804399|20042962|P2|COMPLETED|Washout Period at Least 10 Days||0
8130979|NCT02804399|20042963|P1|COMPLETED|Washout Period at Least 10 Days||12
8130980|NCT02804399|20042962|P2|STARTED|Washout Period at Least 10 Days||0
8130981|NCT02804399|20042963|P1|STARTED|Washout Period at Least 10 Days||12
8130982|NCT02804399|20042962|P2|NOT COMPLETED|Period 1||0
8130983|NCT02804399|20042963|P1|NOT COMPLETED|Period 1||0
8130984|NCT02804399|20042962|P2|COMPLETED|Period 1||0
8130985|NCT02804399|20042963|P1|COMPLETED|Period 1||12
8130986|NCT02804399|20042962|P2|STARTED|Period 1||0
8130987|NCT02804399|20042963|P1|STARTED|Period 1||12
8130988|NCT02803749|20043014|P2|NOT COMPLETED|Overall Study||0
8130989|NCT02803749|20043015|P1|NOT COMPLETED|Overall Study||5
8130990|NCT02803749|20043014|P2|COMPLETED|Overall Study||4
8130991|NCT02803749|20043015|P1|COMPLETED|Overall Study||12
8130992|NCT02803749|20043014|P2|STARTED|Overall Study||4
8130993|NCT02803749|20043015|P1|STARTED|Overall Study||17
8130994|NCT02803580|20043035|P1|NOT COMPLETED|Overall Study||36
8130995|NCT02803580|20043035|P1|COMPLETED|Overall Study||173
8130996|NCT02803580|20043035|P1|STARTED|Overall Study||209
8130997|NCT02803138|20043074|P1|NOT COMPLETED|Overall Study||70
8130998|NCT02803138|20043074|P1|COMPLETED|Overall Study||166
8130999|NCT02803138|20043074|P1|STARTED|Overall Study||236
8131000|NCT02802878|20043090|P2|NOT COMPLETED|Overall Study||3
8131001|NCT02802878|20043091|P1|NOT COMPLETED|Overall Study||4
8131002|NCT02802878|20043090|P2|COMPLETED|Overall Study||18
8131003|NCT02802878|20043091|P1|COMPLETED|Overall Study||17
8131004|NCT02802878|20043090|P2|STARTED|Overall Study||21
8131005|NCT02802878|20043091|P1|STARTED|Overall Study||21
8131006|NCT02802865|20043107|P2|NOT COMPLETED|Overall Study||2
8131007|NCT02802865|20043108|P1|NOT COMPLETED|Overall Study||1
8131008|NCT02802865|20043107|P2|COMPLETED|Overall Study||33
8131009|NCT02802865|20043108|P1|COMPLETED|Overall Study||34
8131010|NCT02802865|20043107|P2|STARTED|Overall Study||35
8131011|NCT02802865|20043108|P1|STARTED|Overall Study||35
8131012|NCT02802592|20043130|P1|NOT COMPLETED|Overall Study||4
8131013|NCT02802592|20043130|P1|COMPLETED|Overall Study||0
8131014|NCT02802592|20043130|P1|STARTED|Overall Study||4
8131015|NCT02802514|20043141|P4|NOT COMPLETED|Session 2 (Up to Day 8)||0
8131016|NCT02802514|20043142|P3|NOT COMPLETED|Session 2 (Up to Day 8)||0
8131017|NCT02802514|20043143|P2|NOT COMPLETED|Session 2 (Up to Day 8)||0
8131018|NCT02802514|20043144|P1|NOT COMPLETED|Session 2 (Up to Day 8)||0
8131019|NCT02802514|20043141|P4|COMPLETED|Session 2 (Up to Day 8)||1
8131020|NCT02802514|20043142|P3|COMPLETED|Session 2 (Up to Day 8)||1
8131021|NCT02802514|20043143|P2|COMPLETED|Session 2 (Up to Day 8)||1
8131022|NCT02802514|20043144|P1|COMPLETED|Session 2 (Up to Day 8)||1
8131023|NCT02802514|20043141|P4|STARTED|Session 2 (Up to Day 8)||1
8131024|NCT02802514|20043142|P3|STARTED|Session 2 (Up to Day 8)||1
8131025|NCT02802514|20043143|P2|STARTED|Session 2 (Up to Day 8)||1
8131026|NCT02802514|20043144|P1|STARTED|Session 2 (Up to Day 8)||1
8131027|NCT02802514|20043141|P4|NOT COMPLETED|Wash Out Period (up to Week 9)||0
8131028|NCT02802514|20043142|P3|NOT COMPLETED|Wash Out Period (up to Week 9)||0
8131029|NCT02802514|20043143|P2|NOT COMPLETED|Wash Out Period (up to Week 9)||0
8131030|NCT02802514|20043144|P1|NOT COMPLETED|Wash Out Period (up to Week 9)||0
8131031|NCT02802514|20043141|P4|COMPLETED|Wash Out Period (up to Week 9)||1
8131032|NCT02802514|20043142|P3|COMPLETED|Wash Out Period (up to Week 9)||1
8131033|NCT02802514|20043143|P2|COMPLETED|Wash Out Period (up to Week 9)||1
8131034|NCT02802514|20043144|P1|COMPLETED|Wash Out Period (up to Week 9)||1
8131035|NCT02802514|20043141|P4|STARTED|Wash Out Period (up to Week 9)||1
8131036|NCT02802514|20043142|P3|STARTED|Wash Out Period (up to Week 9)||1
8131037|NCT02802514|20043143|P2|STARTED|Wash Out Period (up to Week 9)||1
8131038|NCT02802514|20043144|P1|STARTED|Wash Out Period (up to Week 9)||1
8131039|NCT02802514|20043141|P4|NOT COMPLETED|Session 1 (up to Day 8)||0
8131040|NCT02802514|20043142|P3|NOT COMPLETED|Session 1 (up to Day 8)||0
8131041|NCT02802514|20043143|P2|NOT COMPLETED|Session 1 (up to Day 8)||0
8131042|NCT02802514|20043144|P1|NOT COMPLETED|Session 1 (up to Day 8)||0
8131043|NCT02802514|20043141|P4|COMPLETED|Session 1 (up to Day 8)||1
8131044|NCT02802514|20043142|P3|COMPLETED|Session 1 (up to Day 8)||1
8131045|NCT02802514|20043143|P2|COMPLETED|Session 1 (up to Day 8)||1
8131046|NCT02802514|20043144|P1|COMPLETED|Session 1 (up to Day 8)||1
8131047|NCT02802514|20043141|P4|STARTED|Session 1 (up to Day 8)||1
8131048|NCT02802514|20043142|P3|STARTED|Session 1 (up to Day 8)||1
8131049|NCT02802514|20043143|P2|STARTED|Session 1 (up to Day 8)||1
8131050|NCT02802514|20043144|P1|STARTED|Session 1 (up to Day 8)||1
8131051|NCT02802501|20043220|P3|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
8131052|NCT02802501|20043221|P2|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
8131053|NCT02802501|20043222|P1|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
8131054|NCT02802501|20043220|P3|COMPLETED|Open-Label (Day 180 to Day 195)||26
8131055|NCT02802501|20043221|P2|COMPLETED|Open-Label (Day 180 to Day 195)||12
8131056|NCT02802501|20043222|P1|COMPLETED|Open-Label (Day 180 to Day 195)||6
8131057|NCT02802501|20043220|P3|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|26
8131058|NCT02802501|20043221|P2|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|12
8131059|NCT02802501|20043222|P1|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|6
8131060|NCT02802501|20043220|P3|NOT COMPLETED|Double-blind (Up to Day 180)||0
8131061|NCT02802501|20043221|P2|NOT COMPLETED|Double-blind (Up to Day 180)||0
8131062|NCT02802501|20043222|P1|NOT COMPLETED|Double-blind (Up to Day 180)||0
8131063|NCT02802501|20043220|P3|COMPLETED|Double-blind (Up to Day 180)||50
8131064|NCT02802501|20043221|P2|COMPLETED|Double-blind (Up to Day 180)||50
8131065|NCT02802501|20043222|P1|COMPLETED|Double-blind (Up to Day 180)||50
8131066|NCT02802501|20043220|P3|STARTED|Double-blind (Up to Day 180)||50
8131067|NCT02802501|20043221|P2|STARTED|Double-blind (Up to Day 180)||50
8131068|NCT02802501|20043222|P1|STARTED|Double-blind (Up to Day 180)||50
8131069|NCT02802449|20043288|P2|NOT COMPLETED|Overall Study||17
8131070|NCT02802449|20043289|P1|NOT COMPLETED|Overall Study||9
8131071|NCT02802449|20043288|P2|COMPLETED|Overall Study||202
8131072|NCT02802449|20043289|P1|COMPLETED|Overall Study||102
8131073|NCT02802449|20043288|P2|STARTED|Overall Study||219
8131074|NCT02802449|20043289|P1|STARTED|Overall Study||111
8131075|NCT02802345|20043307|P2|NOT COMPLETED|Overall Study||30
8131076|NCT02802345|20043308|P1|NOT COMPLETED|Overall Study||32
8131077|NCT02802345|20043307|P2|COMPLETED|Overall Study||108
8131078|NCT02802345|20043308|P1|COMPLETED|Overall Study||104
8131079|NCT02802345|20043307|P2|Treated|Overall Study||137
8131080|NCT02802345|20043308|P1|Treated|Overall Study||136
8131081|NCT02802345|20043307|P2|STARTED|Overall Study||138
8131082|NCT02802345|20043308|P1|STARTED|Overall Study||136
8131083|NCT02802319|20043324|P2|NOT COMPLETED|Overall Study||5
8131084|NCT02802319|20043325|P1|NOT COMPLETED|Overall Study||2
8131085|NCT02802319|20043324|P2|COMPLETED|Overall Study||17
8131086|NCT02802319|20043325|P1|COMPLETED|Overall Study||20
8131087|NCT02802319|20043324|P2|STARTED|Overall Study||22
8131088|NCT02802319|20043325|P1|STARTED|Overall Study||22
8131089|NCT02802241|20043337|P4|NOT COMPLETED|Overall Study||26
8131090|NCT02802241|20043338|P3|NOT COMPLETED|Overall Study||48
8131091|NCT02802241|20043339|P2|NOT COMPLETED|Overall Study||26
8131092|NCT02802241|20043340|P1|NOT COMPLETED|Overall Study||29
8131093|NCT02802241|20043337|P4|COMPLETED|Overall Study||72
8131094|NCT02802241|20043338|P3|COMPLETED|Overall Study|Not included in primary analysis|0
8131095|NCT02802241|20043339|P2|COMPLETED|Overall Study||71
8131096|NCT02802241|20043340|P1|COMPLETED|Overall Study||68
8131097|NCT02802241|20043337|P4|Planned Analysis|Overall Study||87
8131098|NCT02802241|20043338|P3|Planned Analysis|Overall Study|Not included in primary analysis|0
8131099|NCT02802241|20043339|P2|Planned Analysis|Overall Study||86
8131100|NCT02802241|20043340|P1|Planned Analysis|Overall Study||89
8131101|NCT02802241|20043337|P4|STARTED|Overall Study||98
8131102|NCT02802241|20043338|P3|STARTED|Overall Study||48
8131103|NCT02802241|20043339|P2|STARTED|Overall Study||97
8131104|NCT02802241|20043340|P1|STARTED|Overall Study||97
8131105|NCT02802111|20043352|P2|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
8131106|NCT02802111|20043353|P1|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
8131107|NCT02802111|20043352|P2|COMPLETED|Second Intervention (5 Min of Drug)||12
8131108|NCT02802111|20043353|P1|COMPLETED|Second Intervention (5 Min of Drug)||12
8131109|NCT02802111|20043352|P2|STARTED|Second Intervention (5 Min of Drug)||12
8131110|NCT02802111|20043353|P1|STARTED|Second Intervention (5 Min of Drug)||12
8131111|NCT02802111|20043352|P2|NOT COMPLETED|Washout (4 Hours)||0
8131112|NCT02802111|20043353|P1|NOT COMPLETED|Washout (4 Hours)||0
8131113|NCT02802111|20043352|P2|COMPLETED|Washout (4 Hours)||12
8131114|NCT02802111|20043353|P1|COMPLETED|Washout (4 Hours)||12
8131115|NCT02802111|20043352|P2|STARTED|Washout (4 Hours)||12
8131116|NCT02802111|20043353|P1|STARTED|Washout (4 Hours)||12
8131117|NCT02802111|20043352|P2|NOT COMPLETED|First Intervention (5 Min of Drug)||0
8131118|NCT02802111|20043353|P1|NOT COMPLETED|First Intervention (5 Min of Drug)||0
8131119|NCT02802111|20043352|P2|COMPLETED|First Intervention (5 Min of Drug)||12
8131120|NCT02802111|20043353|P1|COMPLETED|First Intervention (5 Min of Drug)||12
8131121|NCT02802111|20043352|P2|STARTED|First Intervention (5 Min of Drug)||12
8131122|NCT02802111|20043353|P1|STARTED|First Intervention (5 Min of Drug)||12
8131123|NCT02801942|20043363|P2|NOT COMPLETED|Overall Study||0
8131124|NCT02801942|20043364|P1|NOT COMPLETED|Overall Study||0
8131125|NCT02801942|20043363|P2|COMPLETED|Overall Study||10
8131126|NCT02801942|20043364|P1|COMPLETED|Overall Study||12
8131127|NCT02801942|20043363|P2|STARTED|Overall Study||10
8131128|NCT02801942|20043364|P1|STARTED|Overall Study||12
8131129|NCT02801877|20043488|P4|NOT COMPLETED|Overall Study||0
8131130|NCT02801877|20043489|P3|NOT COMPLETED|Overall Study||6
8131131|NCT02801877|20043490|P2|NOT COMPLETED|Overall Study||1
8131132|NCT02801877|20043491|P1|NOT COMPLETED|Overall Study||3
8131133|NCT02801877|20043488|P4|COMPLETED|Overall Study||76
8131134|NCT02801877|20043489|P3|COMPLETED|Overall Study||70
8131135|NCT02801877|20043490|P2|COMPLETED|Overall Study||74
8131136|NCT02801877|20043491|P1|COMPLETED|Overall Study||71
8131137|NCT02801877|20043488|P4|STARTED|Overall Study||76
8131138|NCT02801877|20043489|P3|STARTED|Overall Study||76
8131139|NCT02801877|20043490|P2|STARTED|Overall Study||75
8131140|NCT02801877|20043491|P1|STARTED|Overall Study||74
8131141|NCT02801669|20043511|P2|NOT COMPLETED|Overall Study||152
8131142|NCT02801669|20043512|P1|NOT COMPLETED|Overall Study||151
8131143|NCT02801669|20043511|P2|COMPLETED|Overall Study||340
8131144|NCT02801669|20043512|P1|COMPLETED|Overall Study||341
8131145|NCT02801669|20043511|P2|Received at Least 1 Dose of Study Drug|Overall Study||490
8131146|NCT02801669|20043512|P1|Received at Least 1 Dose of Study Drug|Overall Study||492
8131147|NCT02801669|20043511|P2|STARTED|Overall Study||492
8131148|NCT02801669|20043512|P1|STARTED|Overall Study||492
8131149|NCT02801617|20043539|P2|NOT COMPLETED|Overall Study||6
8131150|NCT02801617|20043540|P1|NOT COMPLETED|Overall Study||2
8131151|NCT02801617|20043539|P2|COMPLETED|Overall Study||50
8131152|NCT02801617|20043540|P1|COMPLETED|Overall Study||49
8131153|NCT02801617|20043539|P2|STARTED|Overall Study||56
8131154|NCT02801617|20043540|P1|STARTED|Overall Study||51
8131155|NCT02801578|20043558|P1|NOT COMPLETED|Overall Study||2
8131156|NCT02801578|20043558|P1|COMPLETED|Overall Study||9
8131157|NCT02801578|20043558|P1|STARTED|Overall Study||11
8131158|NCT02801396|20043562|P6|NOT COMPLETED|Period 3||0
8131159|NCT02801396|20043563|P5|NOT COMPLETED|Period 3||0
8131160|NCT02801396|20043564|P4|NOT COMPLETED|Period 3||0
8131161|NCT02801396|20043565|P3|NOT COMPLETED|Period 3||0
8131162|NCT02801396|20043566|P2|NOT COMPLETED|Period 3||0
8131163|NCT02801396|20043567|P1|NOT COMPLETED|Period 3||0
8131164|NCT02801396|20043562|P6|COMPLETED|Period 3||17
8131165|NCT02801396|20043563|P5|COMPLETED|Period 3||16
8131166|NCT02801396|20043564|P4|COMPLETED|Period 3||16
8131167|NCT02801396|20043565|P3|COMPLETED|Period 3||17
8131168|NCT02801396|20043566|P2|COMPLETED|Period 3||17
8131169|NCT02801396|20043567|P1|COMPLETED|Period 3||17
8131170|NCT02801396|20043562|P6|STARTED|Period 3||17
8131171|NCT02801396|20043563|P5|STARTED|Period 3||16
8131172|NCT02801396|20043564|P4|STARTED|Period 3||16
8131173|NCT02801396|20043565|P3|STARTED|Period 3||17
8131174|NCT02801396|20043566|P2|STARTED|Period 3||17
8131175|NCT02801396|20043567|P1|STARTED|Period 3||17
8131176|NCT02801396|20043562|P6|NOT COMPLETED|Period 2||0
8131177|NCT02801396|20043563|P5|NOT COMPLETED|Period 2||0
8131178|NCT02801396|20043564|P4|NOT COMPLETED|Period 2||0
8131179|NCT02801396|20043565|P3|NOT COMPLETED|Period 2||0
8131180|NCT02801396|20043566|P2|NOT COMPLETED|Period 2||0
8131181|NCT02801396|20043567|P1|NOT COMPLETED|Period 2||0
8131182|NCT02801396|20043562|P6|COMPLETED|Period 2||17
8131183|NCT02801396|20043563|P5|COMPLETED|Period 2||16
8131184|NCT02801396|20043564|P4|COMPLETED|Period 2||16
8131185|NCT02801396|20043565|P3|COMPLETED|Period 2||17
8131186|NCT02801396|20043566|P2|COMPLETED|Period 2||17
8131187|NCT02801396|20043567|P1|COMPLETED|Period 2||17
8131188|NCT02801396|20043562|P6|STARTED|Period 2||17
8131189|NCT02801396|20043563|P5|STARTED|Period 2||16
8131190|NCT02801396|20043564|P4|STARTED|Period 2||16
8131191|NCT02801396|20043565|P3|STARTED|Period 2||17
8131192|NCT02801396|20043566|P2|STARTED|Period 2||17
8131193|NCT02801396|20043567|P1|STARTED|Period 2||17
8131194|NCT02801396|20043562|P6|NOT COMPLETED|Period 1||0
8131195|NCT02801396|20043563|P5|NOT COMPLETED|Period 1||1
8131196|NCT02801396|20043564|P4|NOT COMPLETED|Period 1||0
8131197|NCT02801396|20043565|P3|NOT COMPLETED|Period 1||0
8131198|NCT02801396|20043566|P2|NOT COMPLETED|Period 1||0
8131199|NCT02801396|20043567|P1|NOT COMPLETED|Period 1||0
8131200|NCT02801396|20043562|P6|COMPLETED|Period 1||17
8131201|NCT02801396|20043563|P5|COMPLETED|Period 1||16
8131202|NCT02801396|20043564|P4|COMPLETED|Period 1||16
8131203|NCT02801396|20043565|P3|COMPLETED|Period 1||17
8131204|NCT02801396|20043566|P2|COMPLETED|Period 1||17
8131205|NCT02801396|20043567|P1|COMPLETED|Period 1||17
8131206|NCT02801396|20043562|P6|STARTED|Period 1||17
8131207|NCT02801396|20043563|P5|STARTED|Period 1||17
8131208|NCT02801396|20043564|P4|STARTED|Period 1||16
8131209|NCT02801396|20043565|P3|STARTED|Period 1||17
8131210|NCT02801396|20043566|P2|STARTED|Period 1||17
8131211|NCT02801396|20043567|P1|STARTED|Period 1||17
8131212|NCT02801370|20043586|P2|NOT COMPLETED|Overall Study||0
8131213|NCT02801370|20043587|P1|NOT COMPLETED|Overall Study||7
8131214|NCT02801370|20043586|P2|COMPLETED|Overall Study||132
8131215|NCT02801370|20043587|P1|COMPLETED|Overall Study||123
8131216|NCT02801370|20043586|P2|STARTED|Overall Study||132
8131217|NCT02801370|20043587|P1|STARTED|Overall Study||130
8131218|NCT02801006|20043595|P2|NOT COMPLETED|Lens 2||0
8131219|NCT02801006|20043596|P1|NOT COMPLETED|Lens 2||0
8131220|NCT02801006|20043595|P2|COMPLETED|Lens 2||19
8131221|NCT02801006|20043596|P1|COMPLETED|Lens 2||22
8131222|NCT02801006|20043595|P2|STARTED|Lens 2||19
8131223|NCT02801006|20043596|P1|STARTED|Lens 2||22
8131224|NCT02801006|20043595|P2|NOT COMPLETED|Lens 1||0
8131225|NCT02801006|20043596|P1|NOT COMPLETED|Lens 1||0
8131226|NCT02801006|20043595|P2|COMPLETED|Lens 1||19
8131227|NCT02801006|20043596|P1|COMPLETED|Lens 1||22
8131228|NCT02801006|20043595|P2|STARTED|Lens 1||19
8131229|NCT02801006|20043596|P1|STARTED|Lens 1||22
8131230|NCT02800928|20043612|P2|NOT COMPLETED|Overall Study||2
8131231|NCT02800928|20043613|P1|NOT COMPLETED|Overall Study||2
8131232|NCT02800928|20043612|P2|COMPLETED|Overall Study||6
8131233|NCT02800928|20043613|P1|COMPLETED|Overall Study||7
8131234|NCT02800928|20043612|P2|STARTED|Overall Study||8
8131235|NCT02800928|20043613|P1|STARTED|Overall Study||9
8131236|NCT02800642|20043621|P1|NOT COMPLETED|Overall Study||25
8131237|NCT02800642|20043621|P1|COMPLETED|Overall Study||137
8131238|NCT02800642|20043621|P1|STARTED|Overall Study||162
8131239|NCT02800356|20043634|P1|NOT COMPLETED|Overall Study||0
8131240|NCT02800356|20043634|P1|COMPLETED|Overall Study||20
8131241|NCT02800356|20043634|P1|STARTED|Overall Study||20
8131242|NCT02800213|20043645|P2|NOT COMPLETED|Second Intervention||0
8131243|NCT02800213|20043646|P1|NOT COMPLETED|Second Intervention||0
8131244|NCT02800213|20043645|P2|COMPLETED|Second Intervention||35
8131245|NCT02800213|20043646|P1|COMPLETED|Second Intervention||35
8131246|NCT02800213|20043645|P2|STARTED|Second Intervention||35
8131247|NCT02800213|20043646|P1|STARTED|Second Intervention||35
8131248|NCT02800213|20043645|P2|NOT COMPLETED|First Intervention||0
8131249|NCT02800213|20043646|P1|NOT COMPLETED|First Intervention||0
8131250|NCT02800213|20043645|P2|COMPLETED|First Intervention||35
8131251|NCT02800213|20043646|P1|COMPLETED|First Intervention||35
8131252|NCT02800213|20043645|P2|STARTED|First Intervention||35
8131253|NCT02800213|20043646|P1|STARTED|First Intervention||35
8131254|NCT02800148|20043655|P3|NOT COMPLETED|Overall Study||25
8131255|NCT02800148|20043656|P2|NOT COMPLETED|Overall Study||20
8131256|NCT02800148|20043657|P1|NOT COMPLETED|Overall Study||25
8131257|NCT02800148|20043655|P3|COMPLETED|Overall Study||194
8131258|NCT02800148|20043656|P2|COMPLETED|Overall Study||204
8131259|NCT02800148|20043657|P1|COMPLETED|Overall Study||199
8131260|NCT02800148|20043655|P3|STARTED|Overall Study||219
8131261|NCT02800148|20043656|P2|STARTED|Overall Study||224
8131262|NCT02800148|20043657|P1|STARTED|Overall Study||224
8131263|NCT02799784|20043665|P2|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
8131264|NCT02799784|20043666|P1|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
8131265|NCT02799784|20043665|P2|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
8131266|NCT02799784|20043666|P1|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
8131267|NCT02799784|20043665|P2|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
8131268|NCT02799784|20043666|P1|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
8131269|NCT02799784|20043665|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
8131270|NCT02799784|20043666|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
8131271|NCT02799784|20043665|P2|COMPLETED|Washout Period (3 Weeks)||118
8131272|NCT02799784|20043666|P1|COMPLETED|Washout Period (3 Weeks)||111
8131273|NCT02799784|20043665|P2|STARTED|Washout Period (3 Weeks)||118
8131274|NCT02799784|20043666|P1|STARTED|Washout Period (3 Weeks)||111
8131275|NCT02799784|20043665|P2|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
8131276|NCT02799784|20043666|P1|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
8131277|NCT02799784|20043665|P2|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
8131278|NCT02799784|20043666|P1|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
8131279|NCT02799784|20043665|P2|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
8131280|NCT02799784|20043666|P1|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
8131281|NCT02799472|20043674|P2|NOT COMPLETED|Overall Study||5
8131282|NCT02799472|20043675|P1|NOT COMPLETED|Overall Study||4
8131283|NCT02799472|20043674|P2|COMPLETED|Overall Study||23
8131284|NCT02799472|20043675|P1|COMPLETED|Overall Study||7
8131285|NCT02799472|20043674|P2|STARTED|Overall Study||28
8131286|NCT02799472|20043675|P1|STARTED|Overall Study||11
8131287|NCT02799381|20043735|P2|NOT COMPLETED|Overall Study||3
8131288|NCT02799381|20043736|P1|NOT COMPLETED|Overall Study||4
8131289|NCT02799381|20043735|P2|COMPLETED|Overall Study||25
8131290|NCT02799381|20043736|P1|COMPLETED|Overall Study||29
8131291|NCT02799381|20043735|P2|STARTED|Overall Study||28
8131292|NCT02799381|20043736|P1|STARTED|Overall Study||33
8131293|NCT02799290|20043757|P3|NOT COMPLETED|Overall Study||0
8131294|NCT02799290|20043758|P2|NOT COMPLETED|Overall Study||0
8131295|NCT02799290|20043759|P1|NOT COMPLETED|Overall Study||0
8131296|NCT02799290|20043757|P3|COMPLETED|Overall Study||11
8131297|NCT02799290|20043758|P2|COMPLETED|Overall Study||13
8131298|NCT02799290|20043759|P1|COMPLETED|Overall Study||24
8131299|NCT02799290|20043757|P3|STARTED|Overall Study||11
8131300|NCT02799290|20043758|P2|STARTED|Overall Study||13
8131301|NCT02799290|20043759|P1|STARTED|Overall Study||24
8131302|NCT02799082|20043781|P2|NOT COMPLETED|Overall Study||4
8131303|NCT02799082|20043782|P1|NOT COMPLETED|Overall Study||4
8131304|NCT02799082|20043781|P2|COMPLETED|Overall Study||77
8131305|NCT02799082|20043782|P1|COMPLETED|Overall Study||37
8131306|NCT02799082|20043781|P2|STARTED|Overall Study||81
8131307|NCT02799082|20043782|P1|STARTED|Overall Study||41
8131308|NCT02799069|20043819|P3|NOT COMPLETED|Overall Study||7
8131309|NCT02799069|20043820|P2|NOT COMPLETED|Overall Study||7
8131310|NCT02799069|20043821|P1|NOT COMPLETED|Overall Study||8
8131311|NCT02799069|20043819|P3|COMPLETED|Overall Study||240
8131312|NCT02799069|20043820|P2|COMPLETED|Overall Study||241
8131313|NCT02799069|20043821|P1|COMPLETED|Overall Study||68
8131314|NCT02799069|20043819|P3|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
8131315|NCT02799069|20043820|P2|ITT/Safety|Overall Study||248
8131316|NCT02799069|20043821|P1|ITT/Safety|Overall Study||76
8131317|NCT02799069|20043819|P3|STARTED|Overall Study||247
8131318|NCT02799069|20043820|P2|STARTED|Overall Study||248
8131319|NCT02799069|20043821|P1|STARTED|Overall Study||76
8131320|NCT02798978|20043938|P7|NOT COMPLETED|Part 2 (45 Days)||0
8131321|NCT02798978|20043939|P6|NOT COMPLETED|Part 2 (45 Days)||0
8131322|NCT02798978|20043940|P5|NOT COMPLETED|Part 2 (45 Days)||0
8131323|NCT02798978|20043941|P4|NOT COMPLETED|Part 2 (45 Days)||0
8131324|NCT02798978|20043942|P3|NOT COMPLETED|Part 2 (45 Days)||0
8131325|NCT02798978|20043943|P2|NOT COMPLETED|Part 2 (45 Days)||0
8131326|NCT02798978|20043944|P1|NOT COMPLETED|Part 2 (45 Days)||0
8131327|NCT02798978|20043938|P7|COMPLETED|Part 2 (45 Days)||0
8131328|NCT02798978|20043939|P6|COMPLETED|Part 2 (45 Days)||0
8131329|NCT02798978|20043940|P5|COMPLETED|Part 2 (45 Days)||0
8131330|NCT02798978|20043941|P4|COMPLETED|Part 2 (45 Days)||0
8131331|NCT02798978|20043942|P3|COMPLETED|Part 2 (45 Days)||0
8131332|NCT02798978|20043943|P2|COMPLETED|Part 2 (45 Days)||0
8131333|NCT02798978|20043944|P1|COMPLETED|Part 2 (45 Days)||0
8131334|NCT02798978|20043938|P7|STARTED|Part 2 (45 Days)||0
8131335|NCT02798978|20043939|P6|STARTED|Part 2 (45 Days)||0
8131336|NCT02798978|20043940|P5|STARTED|Part 2 (45 Days)||0
8131337|NCT02798978|20043941|P4|STARTED|Part 2 (45 Days)||0
8131338|NCT02798978|20043942|P3|STARTED|Part 2 (45 Days)||0
8131339|NCT02798978|20043943|P2|STARTED|Part 2 (45 Days)||0
8131340|NCT02798978|20043944|P1|STARTED|Part 2 (45 Days)||0
8131341|NCT02798978|20043938|P7|NOT COMPLETED|Part 1 (30 Days)||0
8131342|NCT02798978|20043939|P6|NOT COMPLETED|Part 1 (30 Days)||0
8131343|NCT02798978|20043940|P5|NOT COMPLETED|Part 1 (30 Days)||0
8131344|NCT02798978|20043941|P4|NOT COMPLETED|Part 1 (30 Days)||0
8131345|NCT02798978|20043942|P3|NOT COMPLETED|Part 1 (30 Days)||0
8131346|NCT02798978|20043943|P2|NOT COMPLETED|Part 1 (30 Days)||0
8131347|NCT02798978|20043944|P1|NOT COMPLETED|Part 1 (30 Days)||0
8131348|NCT02798978|20043938|P7|COMPLETED|Part 1 (30 Days)||0
8131349|NCT02798978|20043939|P6|COMPLETED|Part 1 (30 Days)||6
8131350|NCT02798978|20043940|P5|COMPLETED|Part 1 (30 Days)||6
8131351|NCT02798978|20043941|P4|COMPLETED|Part 1 (30 Days)||6
8131352|NCT02798978|20043942|P3|COMPLETED|Part 1 (30 Days)||6
8131353|NCT02798978|20043943|P2|COMPLETED|Part 1 (30 Days)||6
8131354|NCT02798978|20043944|P1|COMPLETED|Part 1 (30 Days)||10
8131355|NCT02798978|20043938|P7|STARTED|Part 1 (30 Days)||0
8131356|NCT02798978|20043939|P6|STARTED|Part 1 (30 Days)||6
8131357|NCT02798978|20043940|P5|STARTED|Part 1 (30 Days)||6
8131358|NCT02798978|20043941|P4|STARTED|Part 1 (30 Days)||6
8131359|NCT02798978|20043942|P3|STARTED|Part 1 (30 Days)||6
8131360|NCT02798978|20043943|P2|STARTED|Part 1 (30 Days)||6
8131361|NCT02798978|20043944|P1|STARTED|Part 1 (30 Days)||10
8131362|NCT02798952|20044147|P1|NOT COMPLETED|Overall Study||0
8131363|NCT02798952|20044147|P1|COMPLETED|Overall Study||302
8131364|NCT02798952|20044147|P1|STARTED|Overall Study||302
8131365|NCT02798861|20044159|P1|NOT COMPLETED|Overall Study||23
8131366|NCT02798861|20044159|P1|COMPLETED|Overall Study||137
8131367|NCT02798861|20044159|P1|STARTED|Overall Study||160
8131368|NCT02798835|20044167|P3|NOT COMPLETED|Overall Study||3
8131369|NCT02798835|20044168|P2|NOT COMPLETED|Overall Study||0
8131370|NCT02798835|20044169|P1|NOT COMPLETED|Overall Study||0
8131371|NCT02798835|20044167|P3|COMPLETED|Overall Study||57
8131372|NCT02798835|20044168|P2|COMPLETED|Overall Study||60
8131373|NCT02798835|20044169|P1|COMPLETED|Overall Study||60
8131374|NCT02798835|20044167|P3|STARTED|Overall Study||60
8131375|NCT02798835|20044168|P2|STARTED|Overall Study||60
8131376|NCT02798835|20044169|P1|STARTED|Overall Study||60
8131377|NCT02798380|20044204|P1|NOT COMPLETED|Overall Study||0
8131378|NCT02798380|20044204|P1|COMPLETED|Overall Study||30
8131379|NCT02798380|20044204|P1|STARTED|Overall Study||30
8131380|NCT02798354|20044211|P3|NOT COMPLETED|Third Intervention Period||0
8131381|NCT02798354|20044212|P2|NOT COMPLETED|Third Intervention Period||0
8131382|NCT02798354|20044213|P1|NOT COMPLETED|Third Intervention Period||0
8131383|NCT02798354|20044211|P3|COMPLETED|Third Intervention Period||2715
8131384|NCT02798354|20044212|P2|COMPLETED|Third Intervention Period||1010
8131385|NCT02798354|20044213|P1|COMPLETED|Third Intervention Period||746
8131386|NCT02798354|20044211|P3|Intervention Data Error 3|Third Intervention Period||1248
8131387|NCT02798354|20044212|P2|Intervention Data Error 3|Third Intervention Period||390
8131388|NCT02798354|20044213|P1|Intervention Data Error 3|Third Intervention Period||327
8131389|NCT02798354|20044211|P3|Control Data Error 3|Third Intervention Period||1467
8131390|NCT02798354|20044212|P2|Control Data Error 3|Third Intervention Period||620
8131391|NCT02798354|20044213|P1|Control Data Error 3|Third Intervention Period||419
8131392|NCT02798354|20044211|P3|STARTED|Third Intervention Period||2715
8131393|NCT02798354|20044212|P2|STARTED|Third Intervention Period||1010
8131394|NCT02798354|20044213|P1|STARTED|Third Intervention Period||746
8131395|NCT02798354|20044211|P3|NOT COMPLETED|Second Intervention Period||0
8131396|NCT02798354|20044212|P2|NOT COMPLETED|Second Intervention Period||0
8131397|NCT02798354|20044213|P1|NOT COMPLETED|Second Intervention Period||0
8131398|NCT02798354|20044211|P3|COMPLETED|Second Intervention Period||1368
8131399|NCT02798354|20044212|P2|COMPLETED|Second Intervention Period||1047
8131400|NCT02798354|20044213|P1|COMPLETED|Second Intervention Period||2617
8131401|NCT02798354|20044211|P3|Intervention Data Error 2|Second Intervention Period||700
8131402|NCT02798354|20044212|P2|Intervention Data Error 2|Second Intervention Period||454
8131403|NCT02798354|20044213|P1|Intervention Data Error 2|Second Intervention Period||1239
8131404|NCT02798354|20044211|P3|Control Data Error 2|Second Intervention Period||668
8131405|NCT02798354|20044212|P2|Control Data Error 2|Second Intervention Period||593
8131406|NCT02798354|20044213|P1|Control Data Error 2|Second Intervention Period||1378
8131407|NCT02798354|20044211|P3|STARTED|Second Intervention Period||1368
8131408|NCT02798354|20044212|P2|STARTED|Second Intervention Period||1047
8131409|NCT02798354|20044213|P1|STARTED|Second Intervention Period||2617
8131410|NCT02798354|20044211|P3|NOT COMPLETED|First Intervention Period||0
8131411|NCT02798354|20044212|P2|NOT COMPLETED|First Intervention Period||0
8131412|NCT02798354|20044213|P1|NOT COMPLETED|First Intervention Period||0
8131413|NCT02798354|20044211|P3|COMPLETED|First Intervention Period||990
8131414|NCT02798354|20044212|P2|COMPLETED|First Intervention Period||2176
8131415|NCT02798354|20044213|P1|COMPLETED|First Intervention Period||1184
8131416|NCT02798354|20044211|P3|Intervention Data Error 1|First Intervention Period||645
8131417|NCT02798354|20044212|P2|Intervention Data Error 1|First Intervention Period||1627
8131418|NCT02798354|20044213|P1|Intervention Data Error 1|First Intervention Period||744
8131419|NCT02798354|20044211|P3|Control Data Error 1|First Intervention Period||345
8131420|NCT02798354|20044212|P2|Control Data Error 1|First Intervention Period||549
8131421|NCT02798354|20044213|P1|Control Data Error 1|First Intervention Period||440
8131422|NCT02798354|20044211|P3|STARTED|First Intervention Period||990
8131423|NCT02798354|20044212|P2|STARTED|First Intervention Period||2176
8131424|NCT02798354|20044213|P1|STARTED|First Intervention Period||1184
8131425|NCT02798315|20044235|P1|NOT COMPLETED|Overall Study||1
8131426|NCT02798315|20044235|P1|COMPLETED|Overall Study||39
8131427|NCT02798315|20044235|P1|STARTED|Overall Study||40
8131428|NCT02798289|20044249|P1|NOT COMPLETED|Overall Study||0
8131429|NCT02798289|20044249|P1|COMPLETED|Overall Study||55
8131430|NCT02798289|20044249|P1|STARTED|Overall Study||55
8131431|NCT02797821|20044256|P3|NOT COMPLETED|Overall Study||0
8131432|NCT02797821|20044257|P2|NOT COMPLETED|Overall Study||0
8131433|NCT02797821|20044258|P1|NOT COMPLETED|Overall Study||0
8131434|NCT02797821|20044256|P3|COMPLETED|Overall Study||9
8131435|NCT02797821|20044257|P2|COMPLETED|Overall Study||10
8131436|NCT02797821|20044258|P1|COMPLETED|Overall Study||8
8131437|NCT02797821|20044256|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
8131438|NCT02797821|20044257|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
8131439|NCT02797821|20044258|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8131440|NCT02797821|20044256|P3|STARTED|Overall Study||9
8131441|NCT02797821|20044257|P2|STARTED|Overall Study||10
8131442|NCT02797821|20044258|P1|STARTED|Overall Study||8
8131443|NCT02797808|20044271|P2|NOT COMPLETED|Overall Study||3
8131444|NCT02797808|20044272|P1|NOT COMPLETED|Overall Study||7
8131445|NCT02797808|20044271|P2|COMPLETED|Overall Study||15
8131446|NCT02797808|20044272|P1|COMPLETED|Overall Study||16
8131447|NCT02797808|20044271|P2|STARTED|Overall Study||18
8131448|NCT02797808|20044272|P1|STARTED|Overall Study||23
8131449|NCT02797678|20044280|P4|NOT COMPLETED|Sub-Study||0
8131450|NCT02797678|20044281|P3|NOT COMPLETED|Sub-Study||0
8131451|NCT02797678|20044282|P2|NOT COMPLETED|Sub-Study||0
8131452|NCT02797678|20044283|P1|NOT COMPLETED|Sub-Study||0
8131453|NCT02797678|20044280|P4|COMPLETED|Sub-Study||9
8131454|NCT02797678|20044281|P3|COMPLETED|Sub-Study||0
8131455|NCT02797678|20044282|P2|COMPLETED|Sub-Study||0
8131456|NCT02797678|20044283|P1|COMPLETED|Sub-Study||0
8131457|NCT02797678|20044280|P4|STARTED|Sub-Study||9
8131458|NCT02797678|20044281|P3|STARTED|Sub-Study||0
8131459|NCT02797678|20044282|P2|STARTED|Sub-Study||0
8131460|NCT02797678|20044283|P1|STARTED|Sub-Study||0
8131461|NCT02797678|20044280|P4|NOT COMPLETED|Second Intervention (5 Nights)||0
8131462|NCT02797678|20044281|P3|NOT COMPLETED|Second Intervention (5 Nights)||1
8131463|NCT02797678|20044282|P2|NOT COMPLETED|Second Intervention (5 Nights)||0
8131464|NCT02797678|20044283|P1|NOT COMPLETED|Second Intervention (5 Nights)||0
8131465|NCT02797678|20044280|P4|COMPLETED|Second Intervention (5 Nights)||0
8131466|NCT02797678|20044281|P3|COMPLETED|Second Intervention (5 Nights)||16
8131467|NCT02797678|20044282|P2|COMPLETED|Second Intervention (5 Nights)||19
8131468|NCT02797678|20044283|P1|COMPLETED|Second Intervention (5 Nights)||0
8131469|NCT02797678|20044280|P4|STARTED|Second Intervention (5 Nights)||0
8131470|NCT02797678|20044281|P3|STARTED|Second Intervention (5 Nights)||17
8131471|NCT02797678|20044282|P2|STARTED|Second Intervention (5 Nights)||19
8131472|NCT02797678|20044283|P1|STARTED|Second Intervention (5 Nights)||0
8131473|NCT02797678|20044280|P4|NOT COMPLETED|Washout||0
8131474|NCT02797678|20044281|P3|NOT COMPLETED|Washout||0
8131475|NCT02797678|20044282|P2|NOT COMPLETED|Washout||0
8131476|NCT02797678|20044283|P1|NOT COMPLETED|Washout||0
8131477|NCT02797678|20044280|P4|COMPLETED|Washout||0
8131478|NCT02797678|20044281|P3|COMPLETED|Washout||17
8131479|NCT02797678|20044282|P2|COMPLETED|Washout||19
8131480|NCT02797678|20044283|P1|COMPLETED|Washout||0
8131481|NCT02797678|20044280|P4|STARTED|Washout||0
8131482|NCT02797678|20044281|P3|STARTED|Washout||17
8131483|NCT02797678|20044282|P2|STARTED|Washout||19
8131484|NCT02797678|20044283|P1|STARTED|Washout||0
8131485|NCT02797678|20044280|P4|NOT COMPLETED|First Intervention (5 Nights)||0
8131486|NCT02797678|20044281|P3|NOT COMPLETED|First Intervention (5 Nights)||0
8131487|NCT02797678|20044282|P2|NOT COMPLETED|First Intervention (5 Nights)||1
8131488|NCT02797678|20044283|P1|NOT COMPLETED|First Intervention (5 Nights)||0
8131489|NCT02797678|20044280|P4|COMPLETED|First Intervention (5 Nights)||0
8131490|NCT02797678|20044281|P3|COMPLETED|First Intervention (5 Nights)||17
8131491|NCT02797678|20044282|P2|COMPLETED|First Intervention (5 Nights)||19
8131492|NCT02797678|20044283|P1|COMPLETED|First Intervention (5 Nights)||0
8131493|NCT02797678|20044280|P4|STARTED|First Intervention (5 Nights)||0
8131494|NCT02797678|20044281|P3|STARTED|First Intervention (5 Nights)||17
8131495|NCT02797678|20044282|P2|STARTED|First Intervention (5 Nights)||20
8131496|NCT02797678|20044283|P1|STARTED|First Intervention (5 Nights)||0
8131497|NCT02797678|20044280|P4|NOT COMPLETED|Screening Phase||0
8131498|NCT02797678|20044281|P3|NOT COMPLETED|Screening Phase||0
8131499|NCT02797678|20044282|P2|NOT COMPLETED|Screening Phase||0
8131500|NCT02797678|20044283|P1|NOT COMPLETED|Screening Phase||25
8131501|NCT02797678|20044280|P4|COMPLETED|Screening Phase||0
8131502|NCT02797678|20044281|P3|COMPLETED|Screening Phase||0
8131503|NCT02797678|20044282|P2|COMPLETED|Screening Phase||0
8131504|NCT02797678|20044283|P1|COMPLETED|Screening Phase||37
8131505|NCT02797678|20044280|P4|STARTED|Screening Phase||0
8131506|NCT02797678|20044281|P3|STARTED|Screening Phase||0
8131507|NCT02797678|20044282|P2|STARTED|Screening Phase||0
8131508|NCT02797678|20044283|P1|STARTED|Screening Phase||62
8131509|NCT02797613|20044300|P2|NOT COMPLETED|Overall Study||0
8131510|NCT02797613|20044301|P1|NOT COMPLETED|Overall Study||0
8131511|NCT02797613|20044300|P2|COMPLETED|Overall Study||55
8131512|NCT02797613|20044301|P1|COMPLETED|Overall Study||55
8131513|NCT02797613|20044300|P2|STARTED|Overall Study||55
8131514|NCT02797613|20044301|P1|STARTED|Overall Study||55
8131515|NCT02797522|20044318|P11|NOT COMPLETED|Overall Study||1
8131516|NCT02797522|20044319|P10|NOT COMPLETED|Overall Study||4
8131517|NCT02797522|20044320|P9|NOT COMPLETED|Overall Study||2
8131518|NCT02797522|20044321|P8|NOT COMPLETED|Overall Study||4
8131519|NCT02797522|20044322|P7|NOT COMPLETED|Overall Study||0
8131520|NCT02797522|20044323|P6|NOT COMPLETED|Overall Study||0
8131521|NCT02797522|20044324|P5|NOT COMPLETED|Overall Study||0
8131522|NCT02797522|20044325|P4|NOT COMPLETED|Overall Study||0
8131523|NCT02797522|20044326|P3|NOT COMPLETED|Overall Study||0
8131524|NCT02797522|20044327|P2|NOT COMPLETED|Overall Study||0
8131525|NCT02797522|20044328|P1|NOT COMPLETED|Overall Study||0
8131526|NCT02797522|20044318|P11|COMPLETED|Overall Study||0
8131527|NCT02797522|20044319|P10|COMPLETED|Overall Study||0
8131528|NCT02797522|20044320|P9|COMPLETED|Overall Study||0
8131529|NCT02797522|20044321|P8|COMPLETED|Overall Study||0
8131530|NCT02797522|20044322|P7|COMPLETED|Overall Study||12
8131531|NCT02797522|20044323|P6|COMPLETED|Overall Study||4
8131532|NCT02797522|20044324|P5|COMPLETED|Overall Study||4
8131533|NCT02797522|20044325|P4|COMPLETED|Overall Study||4
8131534|NCT02797522|20044326|P3|COMPLETED|Overall Study||4
8131535|NCT02797522|20044327|P2|COMPLETED|Overall Study||4
8131536|NCT02797522|20044328|P1|COMPLETED|Overall Study||4
8131537|NCT02797522|20044318|P11|STARTED|Overall Study||1
8131538|NCT02797522|20044319|P10|STARTED|Overall Study||4
8131539|NCT02797522|20044320|P9|STARTED|Overall Study||2
8131540|NCT02797522|20044321|P8|STARTED|Overall Study||4
8131541|NCT02797522|20044322|P7|STARTED|Overall Study||12
8131542|NCT02797522|20044323|P6|STARTED|Overall Study||4
8131543|NCT02797522|20044324|P5|STARTED|Overall Study||4
8131544|NCT02797522|20044325|P4|STARTED|Overall Study||4
8131545|NCT02797522|20044326|P3|STARTED|Overall Study||4
8131546|NCT02797522|20044327|P2|STARTED|Overall Study||4
8131547|NCT02797522|20044328|P1|STARTED|Overall Study||4
8131572|NCT02797132|20044507|P1|NOT COMPLETED|Part B (24 Weeks)||3
8131573|NCT02797132|20044507|P1|COMPLETED|Part B (24 Weeks)||57
8131574|NCT02797132|20044507|P1|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
8131575|NCT02797132|20044507|P1|Part B (<14 kg Weight)|Part B (24 Weeks)||19
8131576|NCT02797132|20044507|P1|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
8131577|NCT02797132|20044507|P1|NOT COMPLETED|Part A (15 Days)||1
8131578|NCT02797132|20044507|P1|COMPLETED|Part A (15 Days)||11
8131579|NCT02797132|20044507|P1|Part A (>=14 kg Weight)|Part A (15 Days)||8
8131580|NCT02797132|20044507|P1|Part A (<14 kg Weight)|Part A (15 Days)||4
8131581|NCT02797132|20044507|P1|STARTED|Part A (15 Days)||12
8131582|NCT02797080|20044559|P1|NOT COMPLETED|Overall Study||2
8131583|NCT02797080|20044559|P1|COMPLETED|Overall Study||36
8131584|NCT02797080|20044559|P1|STARTED|Overall Study||38
8131585|NCT02797054|20044566|P3|NOT COMPLETED|Follow-up||285
8131586|NCT02797054|20044567|P2|NOT COMPLETED|Follow-up||228
8131587|NCT02797054|20044568|P1|NOT COMPLETED|Follow-up||209
8131588|NCT02797054|20044566|P3|COMPLETED|Follow-up||150
8131589|NCT02797054|20044567|P2|COMPLETED|Follow-up||155
8131590|NCT02797054|20044568|P1|COMPLETED|Follow-up||178
8131591|NCT02797054|20044566|P3|STARTED|Follow-up||435
8131592|NCT02797054|20044567|P2|STARTED|Follow-up||383
8131593|NCT02797054|20044568|P1|STARTED|Follow-up||387
8131594|NCT02797054|20044566|P3|NOT COMPLETED|Post-test||348
8131595|NCT02797054|20044567|P2|NOT COMPLETED|Post-test||11
8131596|NCT02797054|20044568|P1|NOT COMPLETED|Post-test||7
8131597|NCT02797054|20044566|P3|COMPLETED|Post-test||87
8131598|NCT02797054|20044567|P2|COMPLETED|Post-test||372
8131599|NCT02797054|20044568|P1|COMPLETED|Post-test||380
8131600|NCT02797054|20044566|P3|STARTED|Post-test||435
8131601|NCT02797054|20044567|P2|STARTED|Post-test||383
8131602|NCT02797054|20044568|P1|STARTED|Post-test||387
8131603|NCT02796963|20044601|P4|NOT COMPLETED|Overall Study||72
8131604|NCT02796963|20044602|P3|NOT COMPLETED|Overall Study||69
8131605|NCT02796963|20044603|P2|NOT COMPLETED|Overall Study||76
8131606|NCT02796963|20044604|P1|NOT COMPLETED|Overall Study||89
8131607|NCT02796963|20044601|P4|COMPLETED|Overall Study||282
8131608|NCT02796963|20044602|P3|COMPLETED|Overall Study||247
8131609|NCT02796963|20044603|P2|COMPLETED|Overall Study||252
8131610|NCT02796963|20044604|P1|COMPLETED|Overall Study||294
8131611|NCT02796963|20044601|P4|HIV Sero Converted|Overall Study||19
8131612|NCT02796963|20044602|P3|HIV Sero Converted|Overall Study||11
8131613|NCT02796963|20044603|P2|HIV Sero Converted|Overall Study||19
8131614|NCT02796963|20044604|P1|HIV Sero Converted|Overall Study||19
8131615|NCT02796963|20044601|P4|Fourth Follow up|Overall Study||263
8131616|NCT02796963|20044602|P3|Fourth Follow up|Overall Study||236
8131617|NCT02796963|20044603|P2|Fourth Follow up|Overall Study||233
8131618|NCT02796963|20044604|P1|Fourth Follow up|Overall Study||275
8131619|NCT02796963|20044601|P4|Third Follow up|Overall Study||286
8131620|NCT02796963|20044602|P3|Third Follow up|Overall Study||245
8131621|NCT02796963|20044603|P2|Third Follow up|Overall Study||237
8131622|NCT02796963|20044604|P1|Third Follow up|Overall Study||276
8131623|NCT02796963|20044601|P4|Second Follow up|Overall Study||293
8131624|NCT02796963|20044602|P3|Second Follow up|Overall Study||255
8131625|NCT02796963|20044603|P2|Second Follow up|Overall Study||260
8131626|NCT02796963|20044604|P1|Second Follow up|Overall Study||280
8131627|NCT02796963|20044601|P4|First Follow up|Overall Study||291
8131628|NCT02796963|20044602|P3|First Follow up|Overall Study||257
8131629|NCT02796963|20044603|P2|First Follow up|Overall Study||279
8131630|NCT02796963|20044604|P1|First Follow up|Overall Study||293
8131631|NCT02796963|20044601|P4|STARTED|Overall Study||354
8131632|NCT02796963|20044602|P3|STARTED|Overall Study||316
8131633|NCT02796963|20044603|P2|STARTED|Overall Study||328
8131634|NCT02796963|20044604|P1|STARTED|Overall Study||383
8131635|NCT02796924|20044666|P1|NOT COMPLETED|Overall Study||0
8131636|NCT02796924|20044666|P1|COMPLETED|Overall Study||10
8131637|NCT02796924|20044666|P1|STARTED|Overall Study||10
8131638|NCT02796677|20044674|P4|NOT COMPLETED|Overall Study||74
8131639|NCT02796677|20044675|P3|NOT COMPLETED|Overall Study||53
8131640|NCT02796677|20044676|P2|NOT COMPLETED|Overall Study||73
8131641|NCT02796677|20044677|P1|NOT COMPLETED|Overall Study||38
8131642|NCT02796677|20044674|P4|COMPLETED|Overall Study||405
8131643|NCT02796677|20044675|P3|COMPLETED|Overall Study||267
8131644|NCT02796677|20044676|P2|COMPLETED|Overall Study||405
8131645|NCT02796677|20044677|P1|COMPLETED|Overall Study||279
8131646|NCT02796677|20044674|P4|Completed Treatment and Follow-up|Overall Study||403
8131647|NCT02796677|20044675|P3|Completed Treatment and Follow-up|Overall Study||267
8131648|NCT02796677|20044676|P2|Completed Treatment and Follow-up|Overall Study||405
8131649|NCT02796677|20044677|P1|Completed Treatment and Follow-up|Overall Study||279
8131650|NCT02796677|20044674|P4|STARTED|Overall Study||479
8131651|NCT02796677|20044675|P3|STARTED|Overall Study||320
8131652|NCT02796677|20044676|P2|STARTED|Overall Study||478
8131653|NCT02796677|20044677|P1|STARTED|Overall Study||317
8131654|NCT02796651|20044701|P1|NOT COMPLETED|Overall Study||26
8131655|NCT02796651|20044701|P1|COMPLETED|Overall Study||106
8131656|NCT02796651|20044701|P1|Placebo (Lactose Monohydrate)|Overall Study||38
8131657|NCT02796651|20044701|P1|Perforomist 40 μg|Overall Study||108
8131658|NCT02796651|20044701|P1|Perforomist 20 μg|Overall Study||118
8131659|NCT02796651|20044701|P1|Formoterol Fumarate (FF) 24 μg|Overall Study||105
8131660|NCT02796651|20044701|P1|Formoterol Fumarate (FF) 12 μg|Overall Study||121
8131661|NCT02796651|20044701|P1|Formoterol Fumarate (FF) 6 μg|Overall Study||107
8131662|NCT02796651|20044701|P1|STARTED|Overall Study||132
8131663|NCT02796560|20044732|P2|NOT COMPLETED|Overall Study||2
8131664|NCT02796560|20044733|P1|NOT COMPLETED|Overall Study||4
8131665|NCT02796560|20044732|P2|COMPLETED|Overall Study||36
8131666|NCT02796560|20044733|P1|COMPLETED|Overall Study||34
8131667|NCT02796560|20044732|P2|STARTED|Overall Study||38
8131668|NCT02796560|20044733|P1|STARTED|Overall Study||38
8131669|NCT02796352|20044741|P1|NOT COMPLETED|Overall Study||0
8131670|NCT02796352|20044741|P1|COMPLETED|Overall Study||1
8131671|NCT02796352|20044741|P1|STARTED|Overall Study||1
8131672|NCT02796300|20044750|P2|NOT COMPLETED|Overall Study||0
8131673|NCT02796300|20044751|P1|NOT COMPLETED|Overall Study||0
8131674|NCT02796300|20044750|P2|COMPLETED|Overall Study||22
8131675|NCT02796300|20044751|P1|COMPLETED|Overall Study||10
8131676|NCT02796300|20044750|P2|STARTED|Overall Study||22
8131677|NCT02796300|20044751|P1|STARTED|Overall Study||10
8131678|NCT02796274|20044763|P1|NOT COMPLETED|Overall Study||0
8131679|NCT02796274|20044763|P1|COMPLETED|Overall Study||219
8131680|NCT02796274|20044763|P1|STARTED|Overall Study||219
8131681|NCT02796092|20044769|P2|NOT COMPLETED|Overall Study||0
8131682|NCT02796092|20044770|P1|NOT COMPLETED|Overall Study||0
8131683|NCT02796092|20044769|P2|COMPLETED|Overall Study||50
8131684|NCT02796092|20044770|P1|COMPLETED|Overall Study||50
8131685|NCT02796092|20044769|P2|STARTED|Overall Study||50
8131686|NCT02796092|20044770|P1|STARTED|Overall Study||50
8131687|NCT02795832|20044808|P6|NOT COMPLETED|Overall Study||3
8131688|NCT02795832|20044809|P5|NOT COMPLETED|Overall Study||0
8131689|NCT02795832|20044810|P4|NOT COMPLETED|Overall Study||0
8131690|NCT02795832|20044811|P3|NOT COMPLETED|Overall Study||0
8131691|NCT02795832|20044812|P2|NOT COMPLETED|Overall Study||0
8131692|NCT02795832|20044813|P1|NOT COMPLETED|Overall Study||0
8131693|NCT02795832|20044808|P6|COMPLETED|Overall Study||7
8131694|NCT02795832|20044809|P5|COMPLETED|Overall Study||20
8131695|NCT02795832|20044810|P4|COMPLETED|Overall Study||3
8131696|NCT02795832|20044811|P3|COMPLETED|Overall Study||8
8131697|NCT02795832|20044812|P2|COMPLETED|Overall Study||4
8131698|NCT02795832|20044813|P1|COMPLETED|Overall Study||8
8131699|NCT02795832|20044808|P6|STARTED|Overall Study||10
8131700|NCT02795832|20044809|P5|STARTED|Overall Study||20
8131701|NCT02795832|20044810|P4|STARTED|Overall Study||3
8131702|NCT02795832|20044811|P3|STARTED|Overall Study||8
8131703|NCT02795832|20044812|P2|STARTED|Overall Study||4
8131704|NCT02795832|20044813|P1|STARTED|Overall Study||8
8131705|NCT02795819|20044847|P7|NOT COMPLETED|Overall Study||0
8131706|NCT02795819|20044848|P6|NOT COMPLETED|Overall Study||0
8131707|NCT02795819|20044849|P5|NOT COMPLETED|Overall Study||0
8131708|NCT02795819|20044850|P4|NOT COMPLETED|Overall Study||0
8131709|NCT02795819|20044851|P3|NOT COMPLETED|Overall Study||0
8131710|NCT02795819|20044852|P2|NOT COMPLETED|Overall Study||0
8131711|NCT02795819|20044853|P1|NOT COMPLETED|Overall Study||0
8131712|NCT02795819|20044847|P7|COMPLETED|Overall Study||0
8131713|NCT02795819|20044848|P6|COMPLETED|Overall Study||0
8131714|NCT02795819|20044849|P5|COMPLETED|Overall Study||0
8131715|NCT02795819|20044850|P4|COMPLETED|Overall Study||0
8131716|NCT02795819|20044851|P3|COMPLETED|Overall Study||0
8131717|NCT02795819|20044852|P2|COMPLETED|Overall Study||6
8131718|NCT02795819|20044853|P1|COMPLETED|Overall Study||0
8131719|NCT02795819|20044847|P7|STARTED|Overall Study||0
8131720|NCT02795819|20044848|P6|STARTED|Overall Study||0
8131721|NCT02795819|20044849|P5|STARTED|Overall Study||0
8131722|NCT02795819|20044850|P4|STARTED|Overall Study||0
8131723|NCT02795819|20044851|P3|STARTED|Overall Study||0
8131724|NCT02795819|20044852|P2|STARTED|Overall Study||6
8131725|NCT02795819|20044853|P1|STARTED|Overall Study||0
8131726|NCT02795780|20044879|P2|NOT COMPLETED|Overall Study||0
8131727|NCT02795780|20044880|P1|NOT COMPLETED|Overall Study||0
8131728|NCT02795780|20044879|P2|COMPLETED|Overall Study||54
8131729|NCT02795780|20044880|P1|COMPLETED|Overall Study||25
8131730|NCT02795780|20044879|P2|STARTED|Overall Study||54
8131731|NCT02795780|20044880|P1|STARTED|Overall Study||25
8131750|NCT02795117|20045015|P3|NOT COMPLETED|Overall Study||12
8131751|NCT02795117|20045016|P2|NOT COMPLETED|Overall Study||27
8131752|NCT02795117|20045017|P1|NOT COMPLETED|Overall Study||18
8131753|NCT02795117|20045015|P3|COMPLETED|Overall Study||88
8131754|NCT02795117|20045016|P2|COMPLETED|Overall Study||166
8131755|NCT02795117|20045017|P1|COMPLETED|Overall Study||175
8131756|NCT02795117|20045015|P3|STARTED|Overall Study||100
8131757|NCT02795117|20045016|P2|STARTED|Overall Study||193
8131758|NCT02795117|20045017|P1|STARTED|Overall Study||193
8131759|NCT02794974|20045030|P2|NOT COMPLETED|Overall Study||1
8131760|NCT02794974|20045031|P1|NOT COMPLETED|Overall Study||0
8131761|NCT02794974|20045030|P2|COMPLETED|Overall Study||14
8131762|NCT02794974|20045031|P1|COMPLETED|Overall Study||14
8131763|NCT02794974|20045030|P2|STARTED|Overall Study||15
8131764|NCT02794974|20045031|P1|STARTED|Overall Study||14
8131765|NCT02794870|20045047|P2|NOT COMPLETED|Overall Study||0
8131766|NCT02794870|20045048|P1|NOT COMPLETED|Overall Study||2
8131767|NCT02794870|20045047|P2|COMPLETED|Overall Study||11
8131768|NCT02794870|20045048|P1|COMPLETED|Overall Study||20
8131769|NCT02794870|20045047|P2|Received Inoculation|Overall Study||11
8131770|NCT02794870|20045048|P1|Received Inoculation|Overall Study||21
8131771|NCT02794870|20045047|P2|STARTED|Overall Study||11
8131772|NCT02794870|20045048|P1|STARTED|Overall Study||22
8131773|NCT02794844|20045074|P1|NOT COMPLETED|Overall Study||5
8131774|NCT02794844|20045074|P1|COMPLETED|Overall Study||23
8131775|NCT02794844|20045074|P1|STARTED|Overall Study||28
8131776|NCT02794766|20045085|P3|NOT COMPLETED|Overall Study||1
8131777|NCT02794766|20045086|P2|NOT COMPLETED|Overall Study||0
8131778|NCT02794766|20045087|P1|NOT COMPLETED|Overall Study||0
8131779|NCT02794766|20045085|P3|COMPLETED|Overall Study||14
8131780|NCT02794766|20045086|P2|COMPLETED|Overall Study||15
8131781|NCT02794766|20045087|P1|COMPLETED|Overall Study||15
8131782|NCT02794766|20045085|P3|STARTED|Overall Study||15
8131783|NCT02794766|20045086|P2|STARTED|Overall Study||15
8131784|NCT02794766|20045087|P1|STARTED|Overall Study||15
8131785|NCT02794727|20045107|P3|NOT COMPLETED|Overall Study||1
8131786|NCT02794727|20045108|P2|NOT COMPLETED|Overall Study||0
8131787|NCT02794727|20045109|P1|NOT COMPLETED|Overall Study||0
8131788|NCT02794727|20045107|P3|COMPLETED|Overall Study||44
8131789|NCT02794727|20045108|P2|COMPLETED|Overall Study||46
8131790|NCT02794727|20045109|P1|COMPLETED|Overall Study||44
8131791|NCT02794727|20045107|P3|STARTED|Overall Study||45
8131792|NCT02794727|20045108|P2|STARTED|Overall Study||46
8131793|NCT02794727|20045109|P1|STARTED|Overall Study||44
8131794|NCT02794597|20045118|P2|NOT COMPLETED|Overall Study||0
8131795|NCT02794597|20045119|P1|NOT COMPLETED|Overall Study||0
8131796|NCT02794597|20045118|P2|COMPLETED|Overall Study||56
8131797|NCT02794597|20045119|P1|COMPLETED|Overall Study||63
8131798|NCT02794597|20045118|P2|STARTED|Overall Study||56
8131799|NCT02794597|20045119|P1|STARTED|Overall Study||63
8131800|NCT02794480|20045145|P4|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
8131801|NCT02794480|20045146|P3|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
8131802|NCT02794480|20045147|P2|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
8131803|NCT02794480|20045148|P1|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
8131804|NCT02794480|20045145|P4|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
8131805|NCT02794480|20045146|P3|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
8131806|NCT02794480|20045147|P2|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
8131807|NCT02794480|20045148|P1|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
8131808|NCT02794480|20045145|P4|STARTED|Period 2: Treatment Period 2 (28 Days)||78
8131809|NCT02794480|20045146|P3|STARTED|Period 2: Treatment Period 2 (28 Days)||79
8131810|NCT02794480|20045147|P2|STARTED|Period 2: Treatment Period 2 (28 Days)||80
8131811|NCT02794480|20045148|P1|STARTED|Period 2: Treatment Period 2 (28 Days)||80
8131812|NCT02794480|20045145|P4|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
8131813|NCT02794480|20045146|P3|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
8131814|NCT02794480|20045147|P2|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
8131815|NCT02794480|20045148|P1|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
8131816|NCT02794480|20045145|P4|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
8131817|NCT02794480|20045146|P3|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
8131818|NCT02794480|20045147|P2|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
8131819|NCT02794480|20045148|P1|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
8131820|NCT02794480|20045145|P4|STARTED|Period 1: Treatment Period 1 (28 Days)||81
8131821|NCT02794480|20045146|P3|STARTED|Period 1: Treatment Period 1 (28 Days)||81
8131822|NCT02794480|20045147|P2|STARTED|Period 1: Treatment Period 1 (28 Days)||82
8131823|NCT02794480|20045148|P1|STARTED|Period 1: Treatment Period 1 (28 Days)||80
8131824|NCT02794441|20045168|P2|NOT COMPLETED|Overall Study||0
8131825|NCT02794441|20045169|P1|NOT COMPLETED|Overall Study||1
8131826|NCT02794441|20045168|P2|COMPLETED|Overall Study||5
8131827|NCT02794441|20045169|P1|COMPLETED|Overall Study||6
8131828|NCT02794441|20045168|P2|STARTED|Overall Study||5
8131829|NCT02794441|20045169|P1|STARTED|Overall Study||7
8131830|NCT02794246|20045191|P1|NOT COMPLETED|Overall Study||6
8131831|NCT02794246|20045191|P1|COMPLETED|Overall Study||0
8131832|NCT02794246|20045191|P1|Treated|Overall Study||3
8131833|NCT02794246|20045191|P1|STARTED|Overall Study||6
8131834|NCT02794207|20045197|P2|NOT COMPLETED|Overall Study||0
8131835|NCT02794207|20045198|P1|NOT COMPLETED|Overall Study||0
8131836|NCT02794207|20045197|P2|COMPLETED|Overall Study||54
8131837|NCT02794207|20045198|P1|COMPLETED|Overall Study||32
8131838|NCT02794207|20045197|P2|STARTED|Overall Study||54
8131839|NCT02794207|20045198|P1|STARTED|Overall Study||32
8131840|NCT02794103|20045203|P1|NOT COMPLETED|Overall Study||3
8131841|NCT02794103|20045203|P1|COMPLETED|Overall Study||15
8131842|NCT02794103|20045203|P1|STARTED|Overall Study||18
8131843|NCT02793947|20045214|P2|NOT COMPLETED|Overall Study||5
8131844|NCT02793947|20045215|P1|NOT COMPLETED|Overall Study||2
8131845|NCT02793947|20045214|P2|COMPLETED|Overall Study||50
8131846|NCT02793947|20045215|P1|COMPLETED|Overall Study||45
8131847|NCT02793947|20045214|P2|STARTED|Overall Study||55
8131848|NCT02793947|20045215|P1|STARTED|Overall Study||47
8131849|NCT02793856|20045229|P4|NOT COMPLETED|Overall Study||0
8131850|NCT02793856|20045230|P3|NOT COMPLETED|Overall Study||0
8131851|NCT02793856|20045231|P2|NOT COMPLETED|Overall Study||0
8131852|NCT02793856|20045232|P1|NOT COMPLETED|Overall Study||0
8131853|NCT02793856|20045229|P4|COMPLETED|Overall Study||3
8131854|NCT02793856|20045230|P3|COMPLETED|Overall Study||3
8131855|NCT02793856|20045231|P2|COMPLETED|Overall Study||4
8131856|NCT02793856|20045232|P1|COMPLETED|Overall Study||2
8131857|NCT02793856|20045229|P4|STARTED|Overall Study||3
8131858|NCT02793856|20045230|P3|STARTED|Overall Study||3
8131859|NCT02793856|20045231|P2|STARTED|Overall Study||4
8131860|NCT02793856|20045232|P1|STARTED|Overall Study||2
8131861|NCT02793817|20045276|P2|NOT COMPLETED|Overall Study||5
8131862|NCT02793817|20045277|P1|NOT COMPLETED|Overall Study||3
8131863|NCT02793817|20045276|P2|COMPLETED|Overall Study||254
8131864|NCT02793817|20045277|P1|COMPLETED|Overall Study||258
8131865|NCT02793817|20045276|P2|STARTED|Overall Study||259
8131866|NCT02793817|20045277|P1|STARTED|Overall Study||261
8131873|NCT02793232|20045319|P9|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131874|NCT02793232|20045320|P8|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131875|NCT02793232|20045321|P7|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131876|NCT02793232|20045322|P6|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131877|NCT02793232|20045323|P5|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131878|NCT02793232|20045324|P4|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131879|NCT02793232|20045325|P3|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131880|NCT02793232|20045326|P2|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131881|NCT02793232|20045327|P1|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
8131882|NCT02793232|20045319|P9|COMPLETED|Period 4 (Part A: 5 Days)||0
8131883|NCT02793232|20045320|P8|COMPLETED|Period 4 (Part A: 5 Days)||0
8131884|NCT02793232|20045321|P7|COMPLETED|Period 4 (Part A: 5 Days)||0
8131885|NCT02793232|20045322|P6|COMPLETED|Period 4 (Part A: 5 Days)||0
8131886|NCT02793232|20045323|P5|COMPLETED|Period 4 (Part A: 5 Days)||0
8131887|NCT02793232|20045324|P4|COMPLETED|Period 4 (Part A: 5 Days)||2
8131888|NCT02793232|20045325|P3|COMPLETED|Period 4 (Part A: 5 Days)||2
8131889|NCT02793232|20045326|P2|COMPLETED|Period 4 (Part A: 5 Days)||2
8131890|NCT02793232|20045327|P1|COMPLETED|Period 4 (Part A: 5 Days)||2
8131891|NCT02793232|20045319|P9|STARTED|Period 4 (Part A: 5 Days)||0
8131892|NCT02793232|20045320|P8|STARTED|Period 4 (Part A: 5 Days)||0
8131893|NCT02793232|20045321|P7|STARTED|Period 4 (Part A: 5 Days)||0
8131894|NCT02793232|20045322|P6|STARTED|Period 4 (Part A: 5 Days)||0
8131895|NCT02793232|20045323|P5|STARTED|Period 4 (Part A: 5 Days)||0
8131896|NCT02793232|20045324|P4|STARTED|Period 4 (Part A: 5 Days)||2
8131897|NCT02793232|20045325|P3|STARTED|Period 4 (Part A: 5 Days)||2
8131898|NCT02793232|20045326|P2|STARTED|Period 4 (Part A: 5 Days)||2
8131899|NCT02793232|20045327|P1|STARTED|Period 4 (Part A: 5 Days)||2
8131900|NCT02793232|20045319|P9|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131901|NCT02793232|20045320|P8|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131902|NCT02793232|20045321|P7|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131903|NCT02793232|20045322|P6|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131904|NCT02793232|20045323|P5|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131905|NCT02793232|20045324|P4|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131906|NCT02793232|20045325|P3|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131907|NCT02793232|20045326|P2|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131908|NCT02793232|20045327|P1|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131909|NCT02793232|20045319|P9|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131910|NCT02793232|20045320|P8|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131911|NCT02793232|20045321|P7|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131912|NCT02793232|20045322|P6|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131913|NCT02793232|20045323|P5|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
8131914|NCT02793232|20045324|P4|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
8131915|NCT02793232|20045325|P3|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
8131916|NCT02793232|20045326|P2|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
8131917|NCT02793232|20045327|P1|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
8131918|NCT02793232|20045319|P9|STARTED|Washout Period 3(Part A:at Least 10days)||0
8131919|NCT02793232|20045320|P8|STARTED|Washout Period 3(Part A:at Least 10days)||0
8131920|NCT02793232|20045321|P7|STARTED|Washout Period 3(Part A:at Least 10days)||0
8131921|NCT02793232|20045322|P6|STARTED|Washout Period 3(Part A:at Least 10days)||0
8131922|NCT02793232|20045323|P5|STARTED|Washout Period 3(Part A:at Least 10days)||0
8131923|NCT02793232|20045324|P4|STARTED|Washout Period 3(Part A:at Least 10days)||2
8131924|NCT02793232|20045325|P3|STARTED|Washout Period 3(Part A:at Least 10days)||2
8131925|NCT02793232|20045326|P2|STARTED|Washout Period 3(Part A:at Least 10days)||2
8131926|NCT02793232|20045327|P1|STARTED|Washout Period 3(Part A:at Least 10days)||2
8131927|NCT02793232|20045319|P9|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131928|NCT02793232|20045320|P8|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131929|NCT02793232|20045321|P7|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131930|NCT02793232|20045322|P6|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131931|NCT02793232|20045323|P5|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131932|NCT02793232|20045324|P4|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131933|NCT02793232|20045325|P3|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131934|NCT02793232|20045326|P2|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131935|NCT02793232|20045327|P1|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
8131936|NCT02793232|20045319|P9|COMPLETED|Period 3 (Part A: 5 Days)||0
8131937|NCT02793232|20045320|P8|COMPLETED|Period 3 (Part A: 5 Days)||0
8131938|NCT02793232|20045321|P7|COMPLETED|Period 3 (Part A: 5 Days)||0
8131939|NCT02793232|20045322|P6|COMPLETED|Period 3 (Part A: 5 Days)||0
8131940|NCT02793232|20045323|P5|COMPLETED|Period 3 (Part A: 5 Days)||0
8131941|NCT02793232|20045324|P4|COMPLETED|Period 3 (Part A: 5 Days)||2
8131942|NCT02793232|20045325|P3|COMPLETED|Period 3 (Part A: 5 Days)||2
8131943|NCT02793232|20045326|P2|COMPLETED|Period 3 (Part A: 5 Days)||2
8131944|NCT02793232|20045327|P1|COMPLETED|Period 3 (Part A: 5 Days)||2
8131945|NCT02793232|20045319|P9|STARTED|Period 3 (Part A: 5 Days)||0
8131946|NCT02793232|20045320|P8|STARTED|Period 3 (Part A: 5 Days)||0
8131947|NCT02793232|20045321|P7|STARTED|Period 3 (Part A: 5 Days)||0
8131948|NCT02793232|20045322|P6|STARTED|Period 3 (Part A: 5 Days)||0
8131949|NCT02793232|20045323|P5|STARTED|Period 3 (Part A: 5 Days)||0
8131950|NCT02793232|20045324|P4|STARTED|Period 3 (Part A: 5 Days)||2
8131951|NCT02793232|20045325|P3|STARTED|Period 3 (Part A: 5 Days)||2
8131952|NCT02793232|20045326|P2|STARTED|Period 3 (Part A: 5 Days)||2
8131953|NCT02793232|20045327|P1|STARTED|Period 3 (Part A: 5 Days)||2
8131954|NCT02793232|20045319|P9|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131955|NCT02793232|20045320|P8|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131956|NCT02793232|20045321|P7|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131957|NCT02793232|20045322|P6|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131958|NCT02793232|20045323|P5|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131959|NCT02793232|20045324|P4|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131960|NCT02793232|20045325|P3|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131961|NCT02793232|20045326|P2|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131962|NCT02793232|20045327|P1|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131963|NCT02793232|20045319|P9|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131964|NCT02793232|20045320|P8|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131965|NCT02793232|20045321|P7|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131966|NCT02793232|20045322|P6|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131967|NCT02793232|20045323|P5|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
8131968|NCT02793232|20045324|P4|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
8131969|NCT02793232|20045325|P3|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
8131970|NCT02793232|20045326|P2|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
8131971|NCT02793232|20045327|P1|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
8131972|NCT02793232|20045319|P9|STARTED|Washout Period 2(Part A:at Least 10days)||0
8131973|NCT02793232|20045320|P8|STARTED|Washout Period 2(Part A:at Least 10days)||0
8131974|NCT02793232|20045321|P7|STARTED|Washout Period 2(Part A:at Least 10days)||0
8131975|NCT02793232|20045322|P6|STARTED|Washout Period 2(Part A:at Least 10days)||0
8131976|NCT02793232|20045323|P5|STARTED|Washout Period 2(Part A:at Least 10days)||0
8131977|NCT02793232|20045324|P4|STARTED|Washout Period 2(Part A:at Least 10days)||2
8131978|NCT02793232|20045325|P3|STARTED|Washout Period 2(Part A:at Least 10days)||2
8131979|NCT02793232|20045326|P2|STARTED|Washout Period 2(Part A:at Least 10days)||2
8131980|NCT02793232|20045327|P1|STARTED|Washout Period 2(Part A:at Least 10days)||2
8131981|NCT02793232|20045319|P9|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131982|NCT02793232|20045320|P8|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131983|NCT02793232|20045321|P7|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131984|NCT02793232|20045322|P6|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131985|NCT02793232|20045323|P5|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131986|NCT02793232|20045324|P4|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131987|NCT02793232|20045325|P3|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131988|NCT02793232|20045326|P2|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131989|NCT02793232|20045327|P1|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
8131990|NCT02793232|20045319|P9|COMPLETED|Period 2 (Part A: 5 Days)||0
8131991|NCT02793232|20045320|P8|COMPLETED|Period 2 (Part A: 5 Days)||0
8131992|NCT02793232|20045321|P7|COMPLETED|Period 2 (Part A: 5 Days)||0
8131993|NCT02793232|20045322|P6|COMPLETED|Period 2 (Part A: 5 Days)||0
8131994|NCT02793232|20045323|P5|COMPLETED|Period 2 (Part A: 5 Days)||0
8131995|NCT02793232|20045324|P4|COMPLETED|Period 2 (Part A: 5 Days)||2
8131996|NCT02793232|20045325|P3|COMPLETED|Period 2 (Part A: 5 Days)||2
8131997|NCT02793232|20045326|P2|COMPLETED|Period 2 (Part A: 5 Days)||2
8131998|NCT02793232|20045327|P1|COMPLETED|Period 2 (Part A: 5 Days)||2
8131999|NCT02793232|20045319|P9|STARTED|Period 2 (Part A: 5 Days)||0
8132000|NCT02793232|20045320|P8|STARTED|Period 2 (Part A: 5 Days)||0
8132001|NCT02793232|20045321|P7|STARTED|Period 2 (Part A: 5 Days)||0
8132002|NCT02793232|20045322|P6|STARTED|Period 2 (Part A: 5 Days)||0
8132003|NCT02793232|20045323|P5|STARTED|Period 2 (Part A: 5 Days)||0
8132004|NCT02793232|20045324|P4|STARTED|Period 2 (Part A: 5 Days)||2
8132005|NCT02793232|20045325|P3|STARTED|Period 2 (Part A: 5 Days)||2
8132006|NCT02793232|20045326|P2|STARTED|Period 2 (Part A: 5 Days)||2
8132007|NCT02793232|20045327|P1|STARTED|Period 2 (Part A: 5 Days)||2
8132008|NCT02793232|20045319|P9|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132009|NCT02793232|20045320|P8|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132010|NCT02793232|20045321|P7|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132011|NCT02793232|20045322|P6|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132012|NCT02793232|20045323|P5|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132013|NCT02793232|20045324|P4|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132014|NCT02793232|20045325|P3|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132015|NCT02793232|20045326|P2|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132016|NCT02793232|20045327|P1|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132017|NCT02793232|20045319|P9|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132018|NCT02793232|20045320|P8|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132019|NCT02793232|20045321|P7|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132020|NCT02793232|20045322|P6|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132021|NCT02793232|20045323|P5|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
8132022|NCT02793232|20045324|P4|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
8132023|NCT02793232|20045325|P3|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
8132024|NCT02793232|20045326|P2|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
8132025|NCT02793232|20045327|P1|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
8132026|NCT02793232|20045319|P9|STARTED|Washout Period 1(Part A:at Least 10days)||0
8132027|NCT02793232|20045320|P8|STARTED|Washout Period 1(Part A:at Least 10days)||0
8132028|NCT02793232|20045321|P7|STARTED|Washout Period 1(Part A:at Least 10days)||0
8132029|NCT02793232|20045322|P6|STARTED|Washout Period 1(Part A:at Least 10days)||0
8132030|NCT02793232|20045323|P5|STARTED|Washout Period 1(Part A:at Least 10days)||0
8132031|NCT02793232|20045324|P4|STARTED|Washout Period 1(Part A:at Least 10days)||2
8132032|NCT02793232|20045325|P3|STARTED|Washout Period 1(Part A:at Least 10days)||2
8132033|NCT02793232|20045326|P2|STARTED|Washout Period 1(Part A:at Least 10days)||2
8132034|NCT02793232|20045327|P1|STARTED|Washout Period 1(Part A:at Least 10days)||2
8132035|NCT02793232|20045319|P9|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8132036|NCT02793232|20045320|P8|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8132037|NCT02793232|20045321|P7|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
8132038|NCT02793232|20045322|P6|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8132039|NCT02793232|20045323|P5|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
8132040|NCT02793232|20045324|P4|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8132041|NCT02793232|20045325|P3|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8132042|NCT02793232|20045326|P2|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8132043|NCT02793232|20045327|P1|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
8132044|NCT02793232|20045319|P9|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
8132045|NCT02793232|20045320|P8|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132046|NCT02793232|20045321|P7|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
8132047|NCT02793232|20045322|P6|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
8132048|NCT02793232|20045323|P5|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
8132049|NCT02793232|20045324|P4|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132050|NCT02793232|20045325|P3|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132051|NCT02793232|20045326|P2|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132052|NCT02793232|20045327|P1|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132053|NCT02793232|20045319|P9|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
8132054|NCT02793232|20045320|P8|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132055|NCT02793232|20045321|P7|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
8132056|NCT02793232|20045322|P6|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
8132057|NCT02793232|20045323|P5|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
8132058|NCT02793232|20045324|P4|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132059|NCT02793232|20045325|P3|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132060|NCT02793232|20045326|P2|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132061|NCT02793232|20045327|P1|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
8132062|NCT02793154|20045512|P3|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8132063|NCT02793154|20045513|P2|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8132064|NCT02793154|20045514|P1|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8132065|NCT02793154|20045512|P3|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8132066|NCT02793154|20045513|P2|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8132067|NCT02793154|20045514|P1|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
8132068|NCT02793154|20045512|P3|STARTED|Part B (Parallel Group-up to 84 Days)||0
8132069|NCT02793154|20045513|P2|STARTED|Part B (Parallel Group-up to 84 Days)||0
8132070|NCT02793154|20045514|P1|STARTED|Part B (Parallel Group-up to 84 Days)||0
8132071|NCT02793154|20045512|P3|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
8132072|NCT02793154|20045513|P2|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
8132073|NCT02793154|20045514|P1|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
8132074|NCT02793154|20045512|P3|COMPLETED|Part A (Single Group-up to 12 Days)||0
8132075|NCT02793154|20045513|P2|COMPLETED|Part A (Single Group-up to 12 Days)||0
8132076|NCT02793154|20045514|P1|COMPLETED|Part A (Single Group-up to 12 Days)||4
8132077|NCT02793154|20045512|P3|STARTED|Part A (Single Group-up to 12 Days)||0
8132078|NCT02793154|20045513|P2|STARTED|Part A (Single Group-up to 12 Days)||0
8132079|NCT02793154|20045514|P1|STARTED|Part A (Single Group-up to 12 Days)||4
8132080|NCT02793128|20045580|P1|NOT COMPLETED|Overall Study||9
8132081|NCT02793128|20045580|P1|COMPLETED|Overall Study||62
8132082|NCT02793128|20045580|P1|STARTED|Overall Study||71
8132083|NCT02792829|20045602|P8|NOT COMPLETED|Treatment Period 2||2
8132084|NCT02792829|20045603|P7|NOT COMPLETED|Treatment Period 2||1
8132085|NCT02792829|20045604|P6|NOT COMPLETED|Treatment Period 2||0
8132086|NCT02792829|20045605|P5|NOT COMPLETED|Treatment Period 2||1
8132087|NCT02792829|20045606|P4|NOT COMPLETED|Treatment Period 2||0
8132088|NCT02792829|20045607|P3|NOT COMPLETED|Treatment Period 2||0
8132089|NCT02792829|20045608|P2|NOT COMPLETED|Treatment Period 2||1
8132090|NCT02792829|20045609|P1|NOT COMPLETED|Treatment Period 2||0
8132091|NCT02792829|20045602|P8|COMPLETED|Treatment Period 2||8
8132092|NCT02792829|20045603|P7|COMPLETED|Treatment Period 2||9
8132093|NCT02792829|20045604|P6|COMPLETED|Treatment Period 2||5
8132094|NCT02792829|20045605|P5|COMPLETED|Treatment Period 2||4
8132095|NCT02792829|20045606|P4|COMPLETED|Treatment Period 2||5
8132096|NCT02792829|20045607|P3|COMPLETED|Treatment Period 2||5
8132097|NCT02792829|20045608|P2|COMPLETED|Treatment Period 2||9
8132098|NCT02792829|20045609|P1|COMPLETED|Treatment Period 2||10
8132099|NCT02792829|20045602|P8|STARTED|Treatment Period 2||10
8132100|NCT02792829|20045603|P7|STARTED|Treatment Period 2||10
8132101|NCT02792829|20045604|P6|STARTED|Treatment Period 2||5
8132102|NCT02792829|20045605|P5|STARTED|Treatment Period 2||5
8132103|NCT02792829|20045606|P4|STARTED|Treatment Period 2||5
8132104|NCT02792829|20045607|P3|STARTED|Treatment Period 2||5
8132105|NCT02792829|20045608|P2|STARTED|Treatment Period 2||10
8132106|NCT02792829|20045609|P1|STARTED|Treatment Period 2||10
8132107|NCT02792829|20045602|P8|NOT COMPLETED|Wash Out Period||0
8132108|NCT02792829|20045603|P7|NOT COMPLETED|Wash Out Period||0
8132109|NCT02792829|20045604|P6|NOT COMPLETED|Wash Out Period||0
8132110|NCT02792829|20045605|P5|NOT COMPLETED|Wash Out Period||0
8132111|NCT02792829|20045606|P4|NOT COMPLETED|Wash Out Period||0
8132112|NCT02792829|20045607|P3|NOT COMPLETED|Wash Out Period||0
8132113|NCT02792829|20045608|P2|NOT COMPLETED|Wash Out Period||0
8132114|NCT02792829|20045609|P1|NOT COMPLETED|Wash Out Period||0
8132115|NCT02792829|20045602|P8|COMPLETED|Wash Out Period||10
8132116|NCT02792829|20045603|P7|COMPLETED|Wash Out Period||10
8132117|NCT02792829|20045604|P6|COMPLETED|Wash Out Period||5
8132118|NCT02792829|20045605|P5|COMPLETED|Wash Out Period||5
8132119|NCT02792829|20045606|P4|COMPLETED|Wash Out Period||5
8132120|NCT02792829|20045607|P3|COMPLETED|Wash Out Period||5
8132121|NCT02792829|20045608|P2|COMPLETED|Wash Out Period||10
8132122|NCT02792829|20045609|P1|COMPLETED|Wash Out Period||10
8132123|NCT02792829|20045602|P8|STARTED|Wash Out Period||10
8132124|NCT02792829|20045603|P7|STARTED|Wash Out Period||10
8132125|NCT02792829|20045604|P6|STARTED|Wash Out Period||5
8132126|NCT02792829|20045605|P5|STARTED|Wash Out Period||5
8132127|NCT02792829|20045606|P4|STARTED|Wash Out Period||5
8132128|NCT02792829|20045607|P3|STARTED|Wash Out Period||5
8132129|NCT02792829|20045608|P2|STARTED|Wash Out Period||10
8132130|NCT02792829|20045609|P1|STARTED|Wash Out Period||10
8132131|NCT02792829|20045602|P8|NOT COMPLETED|Treatment Period 1||0
8132132|NCT02792829|20045603|P7|NOT COMPLETED|Treatment Period 1||0
8132133|NCT02792829|20045604|P6|NOT COMPLETED|Treatment Period 1||0
8132134|NCT02792829|20045605|P5|NOT COMPLETED|Treatment Period 1||0
8132135|NCT02792829|20045606|P4|NOT COMPLETED|Treatment Period 1||0
8132136|NCT02792829|20045607|P3|NOT COMPLETED|Treatment Period 1||0
8132137|NCT02792829|20045608|P2|NOT COMPLETED|Treatment Period 1||0
8132138|NCT02792829|20045609|P1|NOT COMPLETED|Treatment Period 1||0
8132139|NCT02792829|20045602|P8|COMPLETED|Treatment Period 1||10
8132140|NCT02792829|20045603|P7|COMPLETED|Treatment Period 1||10
8132141|NCT02792829|20045604|P6|COMPLETED|Treatment Period 1||5
8132142|NCT02792829|20045605|P5|COMPLETED|Treatment Period 1||5
8132143|NCT02792829|20045606|P4|COMPLETED|Treatment Period 1||5
8132144|NCT02792829|20045607|P3|COMPLETED|Treatment Period 1||5
8132145|NCT02792829|20045608|P2|COMPLETED|Treatment Period 1||10
8132146|NCT02792829|20045609|P1|COMPLETED|Treatment Period 1||10
8132147|NCT02792829|20045602|P8|STARTED|Treatment Period 1||10
8132148|NCT02792829|20045603|P7|STARTED|Treatment Period 1||10
8132149|NCT02792829|20045604|P6|STARTED|Treatment Period 1||5
8132150|NCT02792829|20045605|P5|STARTED|Treatment Period 1||5
8132151|NCT02792829|20045606|P4|STARTED|Treatment Period 1||5
8132152|NCT02792829|20045607|P3|STARTED|Treatment Period 1||5
8132153|NCT02792829|20045608|P2|STARTED|Treatment Period 1||10
8132154|NCT02792829|20045609|P1|STARTED|Treatment Period 1||10
8132155|NCT02792777|20045717|P2|NOT COMPLETED|Overall Study||0
8132156|NCT02792777|20045718|P1|NOT COMPLETED|Overall Study||7
8132157|NCT02792777|20045717|P2|COMPLETED|Overall Study||52
8132158|NCT02792777|20045718|P1|COMPLETED|Overall Study||89
8132159|NCT02792777|20045717|P2|STARTED|Overall Study||52
8132160|NCT02792777|20045718|P1|STARTED|Overall Study||96
8132161|NCT02792699|20045734|P3|NOT COMPLETED|Overall Study||10
8132162|NCT02792699|20045735|P2|NOT COMPLETED|Overall Study||10
8132163|NCT02792699|20045736|P1|NOT COMPLETED|Overall Study||9
8132164|NCT02792699|20045734|P3|COMPLETED|Overall Study||93
8132165|NCT02792699|20045735|P2|COMPLETED|Overall Study||94
8132166|NCT02792699|20045736|P1|COMPLETED|Overall Study||95
8132167|NCT02792699|20045734|P3|Received Second Infusion of Second Dose|Overall Study||93
8132168|NCT02792699|20045735|P2|Received Second Infusion of Second Dose|Overall Study||99
8132169|NCT02792699|20045736|P1|Received Second Infusion of Second Dose|Overall Study||97
8132170|NCT02792699|20045734|P3|Received First Infusion of Second Dose|Overall Study||95
8132171|NCT02792699|20045735|P2|Received First Infusion of Second Dose|Overall Study||99
8132172|NCT02792699|20045736|P1|Received First Infusion of Second Dose|Overall Study||97
8132173|NCT02792699|20045734|P3|Received Second Infusion of First Dose|Overall Study||99
8132174|NCT02792699|20045735|P2|Received Second Infusion of First Dose|Overall Study||103
8132175|NCT02792699|20045736|P1|Received Second Infusion of First Dose|Overall Study||102
8132176|NCT02792699|20045734|P3|Received First Infusion of First Dose|Overall Study||103
8132177|NCT02792699|20045735|P2|Received First Infusion of First Dose|Overall Study||104
8132178|NCT02792699|20045736|P1|Received First Infusion of First Dose|Overall Study||104
8132179|NCT02792699|20045734|P3|STARTED|Overall Study||103
8132180|NCT02792699|20045735|P2|STARTED|Overall Study||104
8132181|NCT02792699|20045736|P1|STARTED|Overall Study||104
8132182|NCT02792517|20045817|P1|NOT COMPLETED|Overall Study||20
8132183|NCT02792517|20045817|P1|COMPLETED|Overall Study||21
8132184|NCT02792517|20045817|P1|Received Erenumab|Overall Study||24
8132185|NCT02792517|20045817|P1|STARTED|Overall Study||41
8132206|NCT02792062|20045883|P6|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8132207|NCT02792062|20045884|P5|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8132208|NCT02792062|20045885|P4|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8132209|NCT02792062|20045886|P3|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8132210|NCT02792062|20045887|P2|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8132211|NCT02792062|20045888|P1|NOT COMPLETED|Intervention Period 3 (6 Days)||0
8132212|NCT02792062|20045883|P6|COMPLETED|Intervention Period 3 (6 Days)||2
8132213|NCT02792062|20045884|P5|COMPLETED|Intervention Period 3 (6 Days)||2
8132214|NCT02792062|20045885|P4|COMPLETED|Intervention Period 3 (6 Days)||2
8132215|NCT02792062|20045886|P3|COMPLETED|Intervention Period 3 (6 Days)||2
8132216|NCT02792062|20045887|P2|COMPLETED|Intervention Period 3 (6 Days)||2
8132217|NCT02792062|20045888|P1|COMPLETED|Intervention Period 3 (6 Days)||1
8132218|NCT02792062|20045883|P6|STARTED|Intervention Period 3 (6 Days)||2
8132219|NCT02792062|20045884|P5|STARTED|Intervention Period 3 (6 Days)||2
8132220|NCT02792062|20045885|P4|STARTED|Intervention Period 3 (6 Days)||2
8132221|NCT02792062|20045886|P3|STARTED|Intervention Period 3 (6 Days)||2
8132222|NCT02792062|20045887|P2|STARTED|Intervention Period 3 (6 Days)||2
8132223|NCT02792062|20045888|P1|STARTED|Intervention Period 3 (6 Days)||1
8132224|NCT02792062|20045883|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132225|NCT02792062|20045884|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132226|NCT02792062|20045885|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132227|NCT02792062|20045886|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132228|NCT02792062|20045887|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132229|NCT02792062|20045888|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||1
8132230|NCT02792062|20045883|P6|COMPLETED|Washout Period (at Least 14 Days)||2
8132231|NCT02792062|20045884|P5|COMPLETED|Washout Period (at Least 14 Days)||2
8132232|NCT02792062|20045885|P4|COMPLETED|Washout Period (at Least 14 Days)||2
8132233|NCT02792062|20045886|P3|COMPLETED|Washout Period (at Least 14 Days)||2
8132234|NCT02792062|20045887|P2|COMPLETED|Washout Period (at Least 14 Days)||2
8132235|NCT02792062|20045888|P1|COMPLETED|Washout Period (at Least 14 Days)||1
8132236|NCT02792062|20045883|P6|STARTED|Washout Period (at Least 14 Days)||2
8132237|NCT02792062|20045884|P5|STARTED|Washout Period (at Least 14 Days)||2
8132238|NCT02792062|20045885|P4|STARTED|Washout Period (at Least 14 Days)||2
8132239|NCT02792062|20045886|P3|STARTED|Washout Period (at Least 14 Days)||2
8132240|NCT02792062|20045887|P2|STARTED|Washout Period (at Least 14 Days)||2
8132241|NCT02792062|20045888|P1|STARTED|Washout Period (at Least 14 Days)||2
8132242|NCT02792062|20045883|P6|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8132243|NCT02792062|20045884|P5|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8132244|NCT02792062|20045885|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8132245|NCT02792062|20045886|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8132246|NCT02792062|20045887|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8132247|NCT02792062|20045888|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8132248|NCT02792062|20045883|P6|COMPLETED|Intervention Period 2 (6 Days)||2
8132249|NCT02792062|20045884|P5|COMPLETED|Intervention Period 2 (6 Days)||2
8132250|NCT02792062|20045885|P4|COMPLETED|Intervention Period 2 (6 Days)||2
8132251|NCT02792062|20045886|P3|COMPLETED|Intervention Period 2 (6 Days)||2
8132252|NCT02792062|20045887|P2|COMPLETED|Intervention Period 2 (6 Days)||2
8132253|NCT02792062|20045888|P1|COMPLETED|Intervention Period 2 (6 Days)||2
8132254|NCT02792062|20045883|P6|STARTED|Intervention Period 2 (6 Days)||2
8132255|NCT02792062|20045884|P5|STARTED|Intervention Period 2 (6 Days)||2
8132256|NCT02792062|20045885|P4|STARTED|Intervention Period 2 (6 Days)||2
8132257|NCT02792062|20045886|P3|STARTED|Intervention Period 2 (6 Days)||2
8132258|NCT02792062|20045887|P2|STARTED|Intervention Period 2 (6 Days)||2
8132259|NCT02792062|20045888|P1|STARTED|Intervention Period 2 (6 Days)||2
8132260|NCT02792062|20045883|P6|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132261|NCT02792062|20045884|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132262|NCT02792062|20045885|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132263|NCT02792062|20045886|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132264|NCT02792062|20045887|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132265|NCT02792062|20045888|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8132266|NCT02792062|20045883|P6|COMPLETED|Washout Period (at Least 14 Days)||2
8132267|NCT02792062|20045884|P5|COMPLETED|Washout Period (at Least 14 Days)||2
8132268|NCT02792062|20045885|P4|COMPLETED|Washout Period (at Least 14 Days)||2
8132269|NCT02792062|20045886|P3|COMPLETED|Washout Period (at Least 14 Days)||2
8132270|NCT02792062|20045887|P2|COMPLETED|Washout Period (at Least 14 Days)||2
8132271|NCT02792062|20045888|P1|COMPLETED|Washout Period (at Least 14 Days)||2
8132272|NCT02792062|20045883|P6|STARTED|Washout Period (at Least 14 Days)||2
8132273|NCT02792062|20045884|P5|STARTED|Washout Period (at Least 14 Days)||2
8132274|NCT02792062|20045885|P4|STARTED|Washout Period (at Least 14 Days)||2
8132275|NCT02792062|20045886|P3|STARTED|Washout Period (at Least 14 Days)||2
8132276|NCT02792062|20045887|P2|STARTED|Washout Period (at Least 14 Days)||2
8132277|NCT02792062|20045888|P1|STARTED|Washout Period (at Least 14 Days)||2
8132278|NCT02792062|20045883|P6|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8132279|NCT02792062|20045884|P5|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8132280|NCT02792062|20045885|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8132281|NCT02792062|20045886|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8132282|NCT02792062|20045887|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8132283|NCT02792062|20045888|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8132284|NCT02792062|20045883|P6|COMPLETED|Intervention Period 1 (6 Days)||2
8132285|NCT02792062|20045884|P5|COMPLETED|Intervention Period 1 (6 Days)||2
8132286|NCT02792062|20045885|P4|COMPLETED|Intervention Period 1 (6 Days)||2
8132287|NCT02792062|20045886|P3|COMPLETED|Intervention Period 1 (6 Days)||2
8132288|NCT02792062|20045887|P2|COMPLETED|Intervention Period 1 (6 Days)||2
8132289|NCT02792062|20045888|P1|COMPLETED|Intervention Period 1 (6 Days)||2
8132290|NCT02792062|20045883|P6|STARTED|Intervention Period 1 (6 Days)||2
8132291|NCT02792062|20045884|P5|STARTED|Intervention Period 1 (6 Days)||2
8132292|NCT02792062|20045885|P4|STARTED|Intervention Period 1 (6 Days)||2
8132293|NCT02792062|20045886|P3|STARTED|Intervention Period 1 (6 Days)||2
8132294|NCT02792062|20045887|P2|STARTED|Intervention Period 1 (6 Days)||2
8132295|NCT02792062|20045888|P1|STARTED|Intervention Period 1 (6 Days)||2
8132296|NCT02792049|20045922|P2|NOT COMPLETED|Overall Study||0
8132297|NCT02792049|20045923|P1|NOT COMPLETED|Overall Study||0
8132298|NCT02792049|20045922|P2|COMPLETED|Overall Study||35
8132299|NCT02792049|20045923|P1|COMPLETED|Overall Study||35
8132300|NCT02792049|20045922|P2|STARTED|Overall Study||35
8132301|NCT02792049|20045923|P1|STARTED|Overall Study||35
8132308|NCT02791906|20045952|P2|NOT COMPLETED|Overall Study||1
8132309|NCT02791906|20045953|P1|NOT COMPLETED|Overall Study||2
8132310|NCT02791906|20045952|P2|COMPLETED|Overall Study||2
8132311|NCT02791906|20045953|P1|COMPLETED|Overall Study||2
8132312|NCT02791906|20045952|P2|STARTED|Overall Study||3
8132313|NCT02791906|20045953|P1|STARTED|Overall Study||4
8132323|NCT02791659|20046091|P2|NOT COMPLETED|Overall Study||1
8132324|NCT02791659|20046092|P1|NOT COMPLETED|Overall Study||0
8132325|NCT02791659|20046091|P2|COMPLETED|Overall Study||27
8132326|NCT02791659|20046092|P1|COMPLETED|Overall Study||27
8132327|NCT02791659|20046091|P2|STARTED|Overall Study||28
8132328|NCT02791659|20046092|P1|STARTED|Overall Study||27
8132329|NCT02791516|20046100|P2|NOT COMPLETED|Overall Study||1
8132330|NCT02791516|20046101|P1|NOT COMPLETED|Overall Study||1
8132331|NCT02791516|20046100|P2|COMPLETED|Overall Study||33
8132332|NCT02791516|20046101|P1|COMPLETED|Overall Study||32
8132333|NCT02791516|20046100|P2|Completed 6-month Treatment Period|Overall Study||33
8132334|NCT02791516|20046101|P1|Completed 6-month Treatment Period|Overall Study||33
8132335|NCT02791516|20046100|P2|STARTED|Overall Study||34
8132336|NCT02791516|20046101|P1|STARTED|Overall Study||33
8132337|NCT02791490|20046113|P2|NOT COMPLETED|Overall Study||8
8132338|NCT02791490|20046114|P1|NOT COMPLETED|Overall Study||3
8132339|NCT02791490|20046113|P2|COMPLETED|Overall Study||221
8132340|NCT02791490|20046114|P1|COMPLETED|Overall Study||226
8132341|NCT02791490|20046113|P2|STARTED|Overall Study||229
8132342|NCT02791490|20046114|P1|STARTED|Overall Study||229
8132343|NCT02791438|20046134|P2|NOT COMPLETED|Treatment Period||1
8132344|NCT02791438|20046135|P1|NOT COMPLETED|Treatment Period||3
8132345|NCT02791438|20046134|P2|COMPLETED|Treatment Period||4
8132346|NCT02791438|20046135|P1|COMPLETED|Treatment Period||19
8132347|NCT02791438|20046134|P2|STARTED|Treatment Period||5
8132348|NCT02791438|20046135|P1|STARTED|Treatment Period||22
8132349|NCT02791438|20046134|P2|NOT COMPLETED|Run-In Period||0
8132350|NCT02791438|20046135|P1|NOT COMPLETED|Run-In Period||0
8132351|NCT02791438|20046134|P2|COMPLETED|Run-In Period||5
8132352|NCT02791438|20046135|P1|COMPLETED|Run-In Period||22
8132353|NCT02791438|20046134|P2|STARTED|Run-In Period||5
8132354|NCT02791438|20046135|P1|STARTED|Run-In Period||22
8132355|NCT02791308|20046164|P3|NOT COMPLETED|Overall Study||17
8132356|NCT02791308|20046165|P2|NOT COMPLETED|Overall Study||9
8132357|NCT02791308|20046166|P1|NOT COMPLETED|Overall Study||10
8132358|NCT02791308|20046164|P3|COMPLETED|Overall Study||179
8132359|NCT02791308|20046165|P2|COMPLETED|Overall Study||187
8132360|NCT02791308|20046166|P1|COMPLETED|Overall Study||185
8132361|NCT02791308|20046164|P3|STARTED|Overall Study||196
8132362|NCT02791308|20046165|P2|STARTED|Overall Study||196
8132363|NCT02791308|20046166|P1|STARTED|Overall Study||195
8132364|NCT02791269|20046176|P2|NOT COMPLETED|Overall Study||1
8132365|NCT02791269|20046177|P1|NOT COMPLETED|Overall Study||0
8132366|NCT02791269|20046176|P2|COMPLETED|Overall Study||19
8132367|NCT02791269|20046177|P1|COMPLETED|Overall Study||4
8132368|NCT02791269|20046176|P2|STARTED|Overall Study||20
8132369|NCT02791269|20046177|P1|STARTED|Overall Study||4
8132376|NCT02790736|20046246|P2|NOT COMPLETED|Overall Study||0
8132377|NCT02790736|20046247|P1|NOT COMPLETED|Overall Study||0
8132378|NCT02790736|20046246|P2|COMPLETED|Overall Study||1
8132379|NCT02790736|20046247|P1|COMPLETED|Overall Study||5
8132380|NCT02790736|20046246|P2|STARTED|Overall Study||1
8132381|NCT02790736|20046247|P1|STARTED|Overall Study||5
8132382|NCT02790606|20046255|P1|NOT COMPLETED|Overall Study||35
8132383|NCT02790606|20046255|P1|COMPLETED|Overall Study||75
8132384|NCT02790606|20046255|P1|STARTED|Overall Study||110
8132385|NCT02790463|20046272|P2|NOT COMPLETED|Overall Study||309
8132386|NCT02790463|20046273|P1|NOT COMPLETED|Overall Study||0
8132387|NCT02790463|20046272|P2|COMPLETED|Overall Study||372
8132388|NCT02790463|20046273|P1|COMPLETED|Overall Study||782
8132389|NCT02790463|20046272|P2|STARTED|Overall Study||681
8132390|NCT02790463|20046273|P1|STARTED|Overall Study||782
8132391|NCT02790281|20046281|P1|NOT COMPLETED|Overall Study||0
8132392|NCT02790281|20046281|P1|COMPLETED|Overall Study||33
8132393|NCT02790281|20046281|P1|STARTED|Overall Study||33
8132394|NCT02790073|20046287|P1|NOT COMPLETED|Overall Study||3
8132395|NCT02790073|20046287|P1|COMPLETED|Overall Study||11
8132396|NCT02790073|20046287|P1|STARTED|Overall Study||14
8132397|NCT02789410|20046295|P2|NOT COMPLETED|Overall Study||0
8132398|NCT02789410|20046296|P1|NOT COMPLETED|Overall Study||0
8132399|NCT02789410|20046295|P2|COMPLETED|Overall Study||68
8132400|NCT02789410|20046296|P1|COMPLETED|Overall Study||66
8132401|NCT02789410|20046295|P2|STARTED|Overall Study||68
8132402|NCT02789410|20046296|P1|STARTED|Overall Study||66
8132403|NCT02789176|20046310|P4|NOT COMPLETED|Overall Study||1
8132404|NCT02789176|20046311|P3|NOT COMPLETED|Overall Study||10
8132405|NCT02789176|20046312|P2|NOT COMPLETED|Overall Study||2
8132406|NCT02789176|20046313|P1|NOT COMPLETED|Overall Study||8
8132407|NCT02789176|20046310|P4|COMPLETED|Overall Study||53
8132408|NCT02789176|20046311|P3|COMPLETED|Overall Study||85
8132409|NCT02789176|20046312|P2|COMPLETED|Overall Study||53
8132410|NCT02789176|20046313|P1|COMPLETED|Overall Study||91
8132411|NCT02789176|20046310|P4|STARTED|Overall Study||54
8132412|NCT02789176|20046311|P3|STARTED|Overall Study||95
8132413|NCT02789176|20046312|P2|STARTED|Overall Study||55
8132414|NCT02789176|20046313|P1|STARTED|Overall Study||99
8132415|NCT02789111|20046337|P2|NOT COMPLETED|Overall Study||4
8132416|NCT02789111|20046338|P1|NOT COMPLETED|Overall Study||1
8132417|NCT02789111|20046337|P2|COMPLETED|Overall Study||21
8132418|NCT02789111|20046338|P1|COMPLETED|Overall Study||23
8132419|NCT02789111|20046337|P2|STARTED|Overall Study||25
8132420|NCT02789111|20046338|P1|STARTED|Overall Study||24
8132421|NCT02789033|20046350|P4|NOT COMPLETED|Overall Study||2
8132422|NCT02789033|20046351|P3|NOT COMPLETED|Overall Study||1
8132423|NCT02789033|20046352|P2|NOT COMPLETED|Overall Study||2
8132424|NCT02789033|20046353|P1|NOT COMPLETED|Overall Study||2
8132425|NCT02789033|20046350|P4|COMPLETED|Overall Study||15
8132426|NCT02789033|20046351|P3|COMPLETED|Overall Study||16
8132427|NCT02789033|20046352|P2|COMPLETED|Overall Study||15
8132428|NCT02789033|20046353|P1|COMPLETED|Overall Study||15
8132429|NCT02789033|20046350|P4|STARTED|Overall Study||17
8132430|NCT02789033|20046351|P3|STARTED|Overall Study||17
8132431|NCT02789033|20046352|P2|STARTED|Overall Study||17
8132432|NCT02789033|20046353|P1|STARTED|Overall Study||17
8132433|NCT02788747|20046366|P3|NOT COMPLETED|Overall Study||0
8132434|NCT02788747|20046367|P2|NOT COMPLETED|Overall Study||0
8132435|NCT02788747|20046368|P1|NOT COMPLETED|Overall Study||1
8132436|NCT02788747|20046366|P3|COMPLETED|Overall Study||24
8132437|NCT02788747|20046367|P2|COMPLETED|Overall Study||24
8132438|NCT02788747|20046368|P1|COMPLETED|Overall Study||22
8132439|NCT02788747|20046366|P3|STARTED|Overall Study||24
8132440|NCT02788747|20046367|P2|STARTED|Overall Study||24
8132441|NCT02788747|20046368|P1|STARTED|Overall Study||23
8132442|NCT02788656|20046438|P2|NOT COMPLETED|Overall Study||0
8132443|NCT02788656|20046439|P1|NOT COMPLETED|Overall Study||1
8132444|NCT02788656|20046438|P2|COMPLETED|Overall Study||2
8132445|NCT02788656|20046439|P1|COMPLETED|Overall Study||1
8132446|NCT02788656|20046438|P2|STARTED|Overall Study||2
8132447|NCT02788656|20046439|P1|STARTED|Overall Study||2
8132448|NCT02788513|20046464|P5|NOT COMPLETED|Overall Study||5
8132449|NCT02788513|20046465|P4|NOT COMPLETED|Overall Study||6
8132450|NCT02788513|20046466|P3|NOT COMPLETED|Overall Study||8
8132451|NCT02788513|20046467|P2|NOT COMPLETED|Overall Study||8
8132452|NCT02788513|20046468|P1|NOT COMPLETED|Overall Study||9
8132453|NCT02788513|20046464|P5|COMPLETED|Overall Study||115
8132454|NCT02788513|20046465|P4|COMPLETED|Overall Study||117
8132455|NCT02788513|20046466|P3|COMPLETED|Overall Study||114
8132456|NCT02788513|20046467|P2|COMPLETED|Overall Study||114
8132457|NCT02788513|20046468|P1|COMPLETED|Overall Study||114
8132458|NCT02788513|20046464|P5|STARTED|Overall Study||120
8132459|NCT02788513|20046465|P4|STARTED|Overall Study||123
8132460|NCT02788513|20046466|P3|STARTED|Overall Study||122
8132461|NCT02788513|20046467|P2|STARTED|Overall Study||122
8132462|NCT02788513|20046468|P1|STARTED|Overall Study||123
8132463|NCT02788474|20046492|P2|NOT COMPLETED|Open Label Treatment Period||12
8132464|NCT02788474|20046493|P1|NOT COMPLETED|Open Label Treatment Period||32
8132465|NCT02788474|20046492|P2|COMPLETED|Open Label Treatment Period||100
8132466|NCT02788474|20046493|P1|COMPLETED|Open Label Treatment Period||189
8132467|NCT02788474|20046492|P2|STARTED|Open Label Treatment Period||112
8132468|NCT02788474|20046493|P1|STARTED|Open Label Treatment Period||221
8132469|NCT02788474|20046492|P2|NOT COMPLETED|Double Blind Treatment Period||4
8132470|NCT02788474|20046493|P1|NOT COMPLETED|Double Blind Treatment Period||10
8132471|NCT02788474|20046492|P2|COMPLETED|Double Blind Treatment Period||112
8132472|NCT02788474|20046493|P1|COMPLETED|Double Blind Treatment Period||221
8132473|NCT02788474|20046492|P2|Treated|Double Blind Treatment Period||116
8132474|NCT02788474|20046493|P1|Treated|Double Blind Treatment Period||230
8132475|NCT02788474|20046492|P2|STARTED|Double Blind Treatment Period||116
8132476|NCT02788474|20046493|P1|STARTED|Double Blind Treatment Period||231
8132477|NCT02788357|20046508|P2|NOT COMPLETED|Overall Study||0
8132478|NCT02788357|20046509|P1|NOT COMPLETED|Overall Study||3
8132479|NCT02788357|20046508|P2|COMPLETED|Overall Study||6
8132480|NCT02788357|20046509|P1|COMPLETED|Overall Study||3
8132481|NCT02788357|20046508|P2|STARTED|Overall Study||6
8132482|NCT02788357|20046509|P1|STARTED|Overall Study||6
8132483|NCT02788279|20046524|P3|NOT COMPLETED|Overall Study||90
8132484|NCT02788279|20046525|P2|NOT COMPLETED|Overall Study||183
8132485|NCT02788279|20046526|P1|NOT COMPLETED|Overall Study||90
8132486|NCT02788279|20046524|P3|COMPLETED|Overall Study||0
8132487|NCT02788279|20046525|P2|COMPLETED|Overall Study||0
8132488|NCT02788279|20046526|P1|COMPLETED|Overall Study||0
8132489|NCT02788279|20046524|P3|Modified ITT Population|Overall Study||61
8132490|NCT02788279|20046525|P2|Modified ITT Population|Overall Study||125
8132491|NCT02788279|20046526|P1|Modified ITT Population|Overall Study||57
8132492|NCT02788279|20046524|P3|Received Treatment (Safety Population)|Overall Study||90
8132493|NCT02788279|20046525|P2|Received Treatment (Safety Population)|Overall Study||179
8132494|NCT02788279|20046526|P1|Received Treatment (Safety Population)|Overall Study||80
8132495|NCT02788279|20046524|P3|STARTED|Overall Study||90
8132496|NCT02788279|20046525|P2|STARTED|Overall Study||183
8132497|NCT02788279|20046526|P1|STARTED|Overall Study||90
8132498|NCT02788201|20046563|P6|NOT COMPLETED|Overall Study||3
8132499|NCT02788201|20046564|P5|NOT COMPLETED|Overall Study||0
8132500|NCT02788201|20046565|P4|NOT COMPLETED|Overall Study||1
8132501|NCT02788201|20046566|P3|NOT COMPLETED|Overall Study||1
8132502|NCT02788201|20046567|P2|NOT COMPLETED|Overall Study||1
8132503|NCT02788201|20046568|P1|NOT COMPLETED|Overall Study||1
8132504|NCT02788201|20046563|P6|COMPLETED|Overall Study||0
8132505|NCT02788201|20046564|P5|COMPLETED|Overall Study||1
8132506|NCT02788201|20046565|P4|COMPLETED|Overall Study||0
8132507|NCT02788201|20046566|P3|COMPLETED|Overall Study||0
8132508|NCT02788201|20046567|P2|COMPLETED|Overall Study||0
8132509|NCT02788201|20046568|P1|COMPLETED|Overall Study||0
8132510|NCT02788201|20046563|P6|Did Not Start Treatment|Overall Study||3
8132511|NCT02788201|20046564|P5|Did Not Start Treatment|Overall Study||0
8132512|NCT02788201|20046565|P4|Did Not Start Treatment|Overall Study||0
8132513|NCT02788201|20046566|P3|Did Not Start Treatment|Overall Study||0
8132514|NCT02788201|20046567|P2|Did Not Start Treatment|Overall Study||0
8132515|NCT02788201|20046568|P1|Did Not Start Treatment|Overall Study||0
8132516|NCT02788201|20046563|P6|STARTED|Overall Study||3
8132517|NCT02788201|20046564|P5|STARTED|Overall Study||1
8132518|NCT02788201|20046565|P4|STARTED|Overall Study||1
8132519|NCT02788201|20046566|P3|STARTED|Overall Study||1
8132520|NCT02788201|20046567|P2|STARTED|Overall Study||1
8132521|NCT02788201|20046568|P1|STARTED|Overall Study||1
8132522|NCT02788188|20046599|P7|NOT COMPLETED|Overall Study||0
8132523|NCT02788188|20046600|P6|NOT COMPLETED|Overall Study||0
8132524|NCT02788188|20046601|P5|NOT COMPLETED|Overall Study||0
8132525|NCT02788188|20046602|P4|NOT COMPLETED|Overall Study||0
8132526|NCT02788188|20046603|P3|NOT COMPLETED|Overall Study||0
8132527|NCT02788188|20046604|P2|NOT COMPLETED|Overall Study||0
8132528|NCT02788188|20046605|P1|NOT COMPLETED|Overall Study||0
8132529|NCT02788188|20046599|P7|COMPLETED|Overall Study||10
8132530|NCT02788188|20046600|P6|COMPLETED|Overall Study||8
8132531|NCT02788188|20046601|P5|COMPLETED|Overall Study||8
8132532|NCT02788188|20046602|P4|COMPLETED|Overall Study||4
8132533|NCT02788188|20046603|P3|COMPLETED|Overall Study||4
8132534|NCT02788188|20046604|P2|COMPLETED|Overall Study||2
8132535|NCT02788188|20046605|P1|COMPLETED|Overall Study||2
8132536|NCT02788188|20046599|P7|STARTED|Overall Study||10
8132537|NCT02788188|20046600|P6|STARTED|Overall Study||8
8132538|NCT02788188|20046601|P5|STARTED|Overall Study||8
8132539|NCT02788188|20046602|P4|STARTED|Overall Study||4
8132540|NCT02788188|20046603|P3|STARTED|Overall Study||4
8132541|NCT02788188|20046604|P2|STARTED|Overall Study||2
8132542|NCT02788188|20046605|P1|STARTED|Overall Study||2
8132543|NCT02788175|20046621|P1|NOT COMPLETED|Overall Study||13
8132544|NCT02788175|20046621|P1|COMPLETED|Overall Study||13
8132545|NCT02788175|20046621|P1|Received Study Agent|Overall Study||20
8132546|NCT02788175|20046621|P1|STARTED|Overall Study||26
8132547|NCT02788097|20046628|P2|NOT COMPLETED|Overall Study||0
8132548|NCT02788097|20046629|P1|NOT COMPLETED|Overall Study||0
8132549|NCT02788097|20046628|P2|COMPLETED|Overall Study||69
8132550|NCT02788097|20046629|P1|COMPLETED|Overall Study||61
8132551|NCT02788097|20046628|P2|STARTED|Overall Study||69
8132552|NCT02788097|20046629|P1|STARTED|Overall Study||61
8132553|NCT02787863|20046643|P8|NOT COMPLETED|Overall Study||0
8132554|NCT02787863|20046644|P7|NOT COMPLETED|Overall Study||0
8132555|NCT02787863|20046645|P6|NOT COMPLETED|Overall Study||0
8132556|NCT02787863|20046646|P5|NOT COMPLETED|Overall Study||0
8132557|NCT02787863|20046647|P4|NOT COMPLETED|Overall Study||0
8132558|NCT02787863|20046648|P3|NOT COMPLETED|Overall Study||2
8132559|NCT02787863|20046649|P2|NOT COMPLETED|Overall Study||1
8132560|NCT02787863|20046650|P1|NOT COMPLETED|Overall Study||1
8132561|NCT02787863|20046643|P8|COMPLETED|Overall Study||27
8132562|NCT02787863|20046644|P7|COMPLETED|Overall Study||25
8132563|NCT02787863|20046645|P6|COMPLETED|Overall Study||18
8132564|NCT02787863|20046646|P5|COMPLETED|Overall Study||32
8132565|NCT02787863|20046647|P4|COMPLETED|Overall Study||25
8132566|NCT02787863|20046648|P3|COMPLETED|Overall Study||23
8132567|NCT02787863|20046649|P2|COMPLETED|Overall Study||33
8132568|NCT02787863|20046650|P1|COMPLETED|Overall Study||32
8132569|NCT02787863|20046643|P8|4 Years After Vaccination|Overall Study||27
8132570|NCT02787863|20046644|P7|4 Years After Vaccination|Overall Study||25
8132571|NCT02787863|20046645|P6|4 Years After Vaccination|Overall Study||18
8132572|NCT02787863|20046646|P5|4 Years After Vaccination|Overall Study||32
8132573|NCT02787863|20046647|P4|4 Years After Vaccination|Overall Study||25
8132574|NCT02787863|20046648|P3|4 Years After Vaccination|Overall Study||23
8132575|NCT02787863|20046649|P2|4 Years After Vaccination|Overall Study||33
8132576|NCT02787863|20046650|P1|4 Years After Vaccination|Overall Study||32
8132577|NCT02787863|20046643|P8|1 Year After Vaccination|Overall Study||27
8132578|NCT02787863|20046644|P7|1 Year After Vaccination|Overall Study||25
8132579|NCT02787863|20046645|P6|1 Year After Vaccination|Overall Study||18
8132580|NCT02787863|20046646|P5|1 Year After Vaccination|Overall Study||32
8132581|NCT02787863|20046647|P4|1 Year After Vaccination|Overall Study||25
8132582|NCT02787863|20046648|P3|1 Year After Vaccination|Overall Study||23
8132583|NCT02787863|20046649|P2|1 Year After Vaccination|Overall Study||33
8132584|NCT02787863|20046650|P1|1 Year After Vaccination|Overall Study||32
8132585|NCT02787863|20046643|P8|STARTED|Overall Study||27
8132586|NCT02787863|20046644|P7|STARTED|Overall Study||25
8132587|NCT02787863|20046645|P6|STARTED|Overall Study||18
8132588|NCT02787863|20046646|P5|STARTED|Overall Study||32
8132589|NCT02787863|20046647|P4|STARTED|Overall Study||25
8132590|NCT02787863|20046648|P3|STARTED|Overall Study||25
8132591|NCT02787863|20046649|P2|STARTED|Overall Study||34
8132592|NCT02787863|20046650|P1|STARTED|Overall Study||33
8132593|NCT02787694|20046710|P1|NOT COMPLETED|Overall Study||5
8132594|NCT02787694|20046710|P1|COMPLETED|Overall Study||17
8132595|NCT02787694|20046710|P1|STARTED|Overall Study||22
8132596|NCT02787681|20046714|P1|NOT COMPLETED|Overall Study||2
8132597|NCT02787681|20046714|P1|COMPLETED|Overall Study||69
8132598|NCT02787681|20046714|P1|STARTED|Overall Study||71
8132599|NCT02787655|20046720|P2|NOT COMPLETED|Overall Study||12
8132600|NCT02787655|20046721|P1|NOT COMPLETED|Overall Study||11
8132601|NCT02787655|20046720|P2|COMPLETED|Overall Study||26
8132602|NCT02787655|20046721|P1|COMPLETED|Overall Study||29
8132603|NCT02787655|20046720|P2|STARTED|Overall Study||38
8132604|NCT02787655|20046721|P1|STARTED|Overall Study||40
8132605|NCT02787564|20046729|P2|NOT COMPLETED|Overall Study||2
8132606|NCT02787564|20046730|P1|NOT COMPLETED|Overall Study||7
8132607|NCT02787564|20046729|P2|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
8132608|NCT02787564|20046730|P1|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
8132609|NCT02787564|20046729|P2|STARTED|Overall Study||29
8132610|NCT02787564|20046730|P1|STARTED|Overall Study||32
8132611|NCT02787551|20046748|P2|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
8132612|NCT02787551|20046749|P1|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9
8132613|NCT02787551|20046748|P2|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
8132614|NCT02787551|20046749|P1|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197
8132615|NCT02787551|20046748|P2|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0
8132616|NCT02787551|20046749|P1|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206
8132617|NCT02787551|20046748|P2|NOT COMPLETED|Core Period: 26 Weeks||11
8132618|NCT02787551|20046749|P1|NOT COMPLETED|Core Period: 26 Weeks||27
8132619|NCT02787551|20046748|P2|COMPLETED|Core Period: 26 Weeks||246
8132620|NCT02787551|20046749|P1|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230
8132621|NCT02787551|20046748|P2|Treated|Core Period: 26 Weeks||256
8132622|NCT02787551|20046749|P1|Treated|Core Period: 26 Weeks||255
8132623|NCT02787551|20046748|P2|STARTED|Core Period: 26 Weeks||257
8132624|NCT02787551|20046749|P1|STARTED|Core Period: 26 Weeks||257
8132625|NCT02787304|20046785|P4|NOT COMPLETED|Overall Study||34
8132626|NCT02787304|20046786|P3|NOT COMPLETED|Overall Study||41
8132627|NCT02787304|20046787|P2|NOT COMPLETED|Overall Study||38
8132628|NCT02787304|20046788|P1|NOT COMPLETED|Overall Study||36
8132629|NCT02787304|20046785|P4|COMPLETED|Overall Study||15
8132630|NCT02787304|20046786|P3|COMPLETED|Overall Study||8
8132631|NCT02787304|20046787|P2|COMPLETED|Overall Study||12
8132632|NCT02787304|20046788|P1|COMPLETED|Overall Study||13
8132633|NCT02787304|20046785|P4|STARTED|Overall Study||49
8132634|NCT02787304|20046786|P3|STARTED|Overall Study||49
8132635|NCT02787304|20046787|P2|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50
8132636|NCT02787304|20046788|P1|STARTED|Overall Study||49
8132637|NCT02787291|20046834|P1|NOT COMPLETED|Overall Study||0
8132638|NCT02787291|20046834|P1|COMPLETED|Overall Study||227
8132639|NCT02787291|20046834|P1|STARTED|Overall Study||227
8132640|NCT02787083|20046842|P2|NOT COMPLETED|Overall Study||2
8132641|NCT02787083|20046843|P1|NOT COMPLETED|Overall Study||3
8132642|NCT02787083|20046842|P2|COMPLETED|Overall Study||3
8132643|NCT02787083|20046843|P1|COMPLETED|Overall Study||1
8132644|NCT02787083|20046842|P2|STARTED|Overall Study||5
8132645|NCT02787083|20046843|P1|STARTED|Overall Study||4
8132646|NCT02787057|20046853|P2|NOT COMPLETED|Overall Study||0
8132647|NCT02787057|20046854|P1|NOT COMPLETED|Overall Study||0
8132648|NCT02787057|20046853|P2|COMPLETED|Overall Study||40
8132649|NCT02787057|20046854|P1|COMPLETED|Overall Study||40
8132650|NCT02787057|20046853|P2|STARTED|Overall Study||40
8132651|NCT02787057|20046854|P1|STARTED|Overall Study||40
8132652|NCT02786953|20046868|P2|NOT COMPLETED|Overall Study||1
8132653|NCT02786953|20046869|P1|NOT COMPLETED|Overall Study||3
8132654|NCT02786953|20046868|P2|COMPLETED|Overall Study||18
8132655|NCT02786953|20046869|P1|COMPLETED|Overall Study||17
8132656|NCT02786953|20046868|P2|A1C 3 Month|Overall Study||17
8132657|NCT02786953|20046869|P1|A1C 3 Month|Overall Study||15
8132658|NCT02786953|20046868|P2|3 Month Parent Survey Completed|Overall Study||18
8132659|NCT02786953|20046869|P1|3 Month Parent Survey Completed|Overall Study||17
8132660|NCT02786953|20046868|P2|3 Month Teen Survey Completed|Overall Study||18
8132661|NCT02786953|20046869|P1|3 Month Teen Survey Completed|Overall Study||17
8132662|NCT02786953|20046868|P2|Session 3 Completed|Overall Study||0
8132663|NCT02786953|20046869|P1|Session 3 Completed|Overall Study||16
8132664|NCT02786953|20046868|P2|Session 2 Completed|Overall Study||0
8132665|NCT02786953|20046869|P1|Session 2 Completed|Overall Study||16
8132666|NCT02786953|20046868|P2|Session 1 Completed|Overall Study||0
8132667|NCT02786953|20046869|P1|Session 1 Completed|Overall Study||17
8132668|NCT02786953|20046868|P2|A1C Data Baseline|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
8132669|NCT02786953|20046869|P1|A1C Data Baseline|Overall Study||20
8132670|NCT02786953|20046868|P2|Actigraph Data Complete|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|17
8132671|NCT02786953|20046869|P1|Actigraph Data Complete|Overall Study||14
8132672|NCT02786953|20046868|P2|Baseline Parent Survey Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
8132673|NCT02786953|20046869|P1|Baseline Parent Survey Completed|Overall Study||20
8132674|NCT02786953|20046868|P2|Baseline Teen Survey Data Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
8132675|NCT02786953|20046869|P1|Baseline Teen Survey Data Completed|Overall Study||20
8132676|NCT02786953|20046868|P2|STARTED|Overall Study||19
8132677|NCT02786953|20046869|P1|STARTED|Overall Study||20
8132678|NCT02786927|20046891|P1|NOT COMPLETED|Overall Study||5
8132679|NCT02786927|20046891|P1|COMPLETED|Overall Study||207
8132680|NCT02786927|20046891|P1|STARTED|Overall Study||212
8132681|NCT02786901|20046901|P3|NOT COMPLETED|Overall Study||41
8132682|NCT02786901|20046902|P2|NOT COMPLETED|Overall Study||56
8132683|NCT02786901|20046903|P1|NOT COMPLETED|Overall Study||77
8132684|NCT02786901|20046901|P3|COMPLETED|Overall Study||159
8132685|NCT02786901|20046902|P2|COMPLETED|Overall Study||145
8132686|NCT02786901|20046903|P1|COMPLETED|Overall Study||122
8132687|NCT02786901|20046901|P3|STARTED|Overall Study||200
8132688|NCT02786901|20046902|P2|STARTED|Overall Study||201
8132689|NCT02786901|20046903|P1|STARTED|Overall Study||199
8132690|NCT02786836|20046932|P1|NOT COMPLETED|Overall Study||14
8132691|NCT02786836|20046932|P1|COMPLETED|Overall Study||62
8132692|NCT02786836|20046932|P1|Eligible Patients Enrolled Into the Stud|Overall Study||76
8132693|NCT02786836|20046932|P1|STARTED|Overall Study||76
8132694|NCT02786810|20046938|P1|NOT COMPLETED|Overall Study||0
8132695|NCT02786810|20046938|P1|COMPLETED|Overall Study||10
8132696|NCT02786810|20046938|P1|STARTED|Overall Study||10
8132697|NCT02786771|20046945|P2|NOT COMPLETED|Overall Study||6
8132698|NCT02786771|20046946|P1|NOT COMPLETED|Overall Study||10
8132699|NCT02786771|20046945|P2|COMPLETED|Overall Study||56
8132700|NCT02786771|20046946|P1|COMPLETED|Overall Study||53
8132701|NCT02786771|20046945|P2|STARTED|Overall Study||62
8132702|NCT02786771|20046946|P1|STARTED|Overall Study||63
8132703|NCT02786719|20046952|P1|NOT COMPLETED|Overall Study||1
8132704|NCT02786719|20046952|P1|COMPLETED|Overall Study||12
8132705|NCT02786719|20046952|P1|STARTED|Overall Study||13
8132742|NCT02786355|20047017|P1|NOT COMPLETED|Overall Study||0
8132743|NCT02786355|20047017|P1|COMPLETED|Overall Study||35
8132744|NCT02786355|20047017|P1|STARTED|Overall Study||35
8132745|NCT02786134|20047026|P2|NOT COMPLETED|Overall Study||0
8132746|NCT02786134|20047027|P1|NOT COMPLETED|Overall Study||0
8132747|NCT02786134|20047026|P2|COMPLETED|Overall Study||25
8132748|NCT02786134|20047027|P1|COMPLETED|Overall Study||25
8132749|NCT02786134|20047026|P2|STARTED|Overall Study||25
8132750|NCT02786134|20047027|P1|STARTED|Overall Study||25
8132751|NCT02786004|20047035|P2|NOT COMPLETED|Overall Study||1
8132752|NCT02786004|20047036|P1|NOT COMPLETED|Overall Study||0
8132753|NCT02786004|20047035|P2|COMPLETED|Overall Study||9
8132754|NCT02786004|20047036|P1|COMPLETED|Overall Study||14
8132755|NCT02786004|20047035|P2|STARTED|Overall Study||10
8132756|NCT02786004|20047036|P1|STARTED|Overall Study||14
8132757|NCT02785913|20047044|P1|NOT COMPLETED|Overall Study||26
8132758|NCT02785913|20047044|P1|COMPLETED|Overall Study||0
8132759|NCT02785913|20047044|P1|STARTED|Overall Study||26
8132760|NCT02785900|20047055|P2|NOT COMPLETED|Overall Study||123
8132761|NCT02785900|20047056|P1|NOT COMPLETED|Overall Study||117
8132762|NCT02785900|20047055|P2|COMPLETED|Overall Study||0
8132763|NCT02785900|20047056|P1|COMPLETED|Overall Study||0
8132764|NCT02785900|20047055|P2|STARTED|Overall Study||123
8132765|NCT02785900|20047056|P1|STARTED|Overall Study||117
8132766|NCT02785770|20047080|P4|NOT COMPLETED|Intervention Period 4 (1 Day)||0
8132767|NCT02785770|20047081|P3|NOT COMPLETED|Intervention Period 4 (1 Day)||0
8132768|NCT02785770|20047082|P2|NOT COMPLETED|Intervention Period 4 (1 Day)||0
8132769|NCT02785770|20047083|P1|NOT COMPLETED|Intervention Period 4 (1 Day)||0
8132770|NCT02785770|20047080|P4|COMPLETED|Intervention Period 4 (1 Day)||10
8132771|NCT02785770|20047081|P3|COMPLETED|Intervention Period 4 (1 Day)||10
8132772|NCT02785770|20047082|P2|COMPLETED|Intervention Period 4 (1 Day)||10
8132773|NCT02785770|20047083|P1|COMPLETED|Intervention Period 4 (1 Day)||11
8132774|NCT02785770|20047080|P4|STARTED|Intervention Period 4 (1 Day)||10
8132775|NCT02785770|20047081|P3|STARTED|Intervention Period 4 (1 Day)||10
8132776|NCT02785770|20047082|P2|STARTED|Intervention Period 4 (1 Day)||10
8132777|NCT02785770|20047083|P1|STARTED|Intervention Period 4 (1 Day)||11
8132778|NCT02785770|20047080|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8132779|NCT02785770|20047081|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8132780|NCT02785770|20047082|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8132781|NCT02785770|20047083|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8132782|NCT02785770|20047080|P4|COMPLETED|Washout Period 3 (7 Days)||10
8132783|NCT02785770|20047081|P3|COMPLETED|Washout Period 3 (7 Days)||10
8132784|NCT02785770|20047082|P2|COMPLETED|Washout Period 3 (7 Days)||10
8132785|NCT02785770|20047083|P1|COMPLETED|Washout Period 3 (7 Days)||11
8132786|NCT02785770|20047080|P4|STARTED|Washout Period 3 (7 Days)||10
8132787|NCT02785770|20047081|P3|STARTED|Washout Period 3 (7 Days)||10
8132788|NCT02785770|20047082|P2|STARTED|Washout Period 3 (7 Days)||10
8132789|NCT02785770|20047083|P1|STARTED|Washout Period 3 (7 Days)||11
8132790|NCT02785770|20047080|P4|NOT COMPLETED|Intervention Period 3 (1 Day)||1
8132791|NCT02785770|20047081|P3|NOT COMPLETED|Intervention Period 3 (1 Day)||0
8132792|NCT02785770|20047082|P2|NOT COMPLETED|Intervention Period 3 (1 Day)||0
8132793|NCT02785770|20047083|P1|NOT COMPLETED|Intervention Period 3 (1 Day)||0
8132794|NCT02785770|20047080|P4|COMPLETED|Intervention Period 3 (1 Day)||10
8132795|NCT02785770|20047081|P3|COMPLETED|Intervention Period 3 (1 Day)||10
8132796|NCT02785770|20047082|P2|COMPLETED|Intervention Period 3 (1 Day)||10
8132797|NCT02785770|20047083|P1|COMPLETED|Intervention Period 3 (1 Day)||11
8132798|NCT02785770|20047080|P4|STARTED|Intervention Period 3 (1 Day)||11
8132799|NCT02785770|20047081|P3|STARTED|Intervention Period 3 (1 Day)||10
8132800|NCT02785770|20047082|P2|STARTED|Intervention Period 3 (1 Day)||10
8132801|NCT02785770|20047083|P1|STARTED|Intervention Period 3 (1 Day)||11
8132802|NCT02785770|20047080|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8132803|NCT02785770|20047081|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8132804|NCT02785770|20047082|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8132805|NCT02785770|20047083|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8132806|NCT02785770|20047080|P4|COMPLETED|Washout Period 2 (7 Days)||11
8132807|NCT02785770|20047081|P3|COMPLETED|Washout Period 2 (7 Days)||10
8132808|NCT02785770|20047082|P2|COMPLETED|Washout Period 2 (7 Days)||10
8132809|NCT02785770|20047083|P1|COMPLETED|Washout Period 2 (7 Days)||11
8132810|NCT02785770|20047080|P4|STARTED|Washout Period 2 (7 Days)||11
8132811|NCT02785770|20047081|P3|STARTED|Washout Period 2 (7 Days)||10
8132812|NCT02785770|20047082|P2|STARTED|Washout Period 2 (7 Days)||10
8132813|NCT02785770|20047083|P1|STARTED|Washout Period 2 (7 Days)||11
8132814|NCT02785770|20047080|P4|NOT COMPLETED|Intervention Period 2 (1 Day)||0
8132815|NCT02785770|20047081|P3|NOT COMPLETED|Intervention Period 2 (1 Day)||1
8132816|NCT02785770|20047082|P2|NOT COMPLETED|Intervention Period 2 (1 Day)||1
8132817|NCT02785770|20047083|P1|NOT COMPLETED|Intervention Period 2 (1 Day)||0
8132818|NCT02785770|20047080|P4|COMPLETED|Intervention Period 2 (1 Day)||11
8132819|NCT02785770|20047081|P3|COMPLETED|Intervention Period 2 (1 Day)||10
8132820|NCT02785770|20047082|P2|COMPLETED|Intervention Period 2 (1 Day)||10
8132821|NCT02785770|20047083|P1|COMPLETED|Intervention Period 2 (1 Day)||11
8132822|NCT02785770|20047080|P4|STARTED|Intervention Period 2 (1 Day)||11
8132823|NCT02785770|20047081|P3|STARTED|Intervention Period 2 (1 Day)||11
8132824|NCT02785770|20047082|P2|STARTED|Intervention Period 2 (1 Day)||11
8132825|NCT02785770|20047083|P1|STARTED|Intervention Period 2 (1 Day)||11
8132826|NCT02785770|20047080|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8132827|NCT02785770|20047081|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8132828|NCT02785770|20047082|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8132829|NCT02785770|20047083|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8132830|NCT02785770|20047080|P4|COMPLETED|Washout Period 1 (7 Days)||11
8132831|NCT02785770|20047081|P3|COMPLETED|Washout Period 1 (7 Days)||11
8132832|NCT02785770|20047082|P2|COMPLETED|Washout Period 1 (7 Days)||11
8132833|NCT02785770|20047083|P1|COMPLETED|Washout Period 1 (7 Days)||11
8132834|NCT02785770|20047080|P4|STARTED|Washout Period 1 (7 Days)||11
8132835|NCT02785770|20047081|P3|STARTED|Washout Period 1 (7 Days)||11
8132836|NCT02785770|20047082|P2|STARTED|Washout Period 1 (7 Days)||11
8132837|NCT02785770|20047083|P1|STARTED|Washout Period 1 (7 Days)||11
8132838|NCT02785770|20047080|P4|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8132839|NCT02785770|20047081|P3|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8132840|NCT02785770|20047082|P2|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8132841|NCT02785770|20047083|P1|NOT COMPLETED|Intervention Period 1 (1 Day)||0
8132842|NCT02785770|20047080|P4|COMPLETED|Intervention Period 1 (1 Day)||11
8132843|NCT02785770|20047081|P3|COMPLETED|Intervention Period 1 (1 Day)||11
8132844|NCT02785770|20047082|P2|COMPLETED|Intervention Period 1 (1 Day)||11
8132845|NCT02785770|20047083|P1|COMPLETED|Intervention Period 1 (1 Day)||11
8132846|NCT02785770|20047080|P4|STARTED|Intervention Period 1 (1 Day)||11
8132847|NCT02785770|20047081|P3|STARTED|Intervention Period 1 (1 Day)||11
8132848|NCT02785770|20047082|P2|STARTED|Intervention Period 1 (1 Day)||11
8132849|NCT02785770|20047083|P1|STARTED|Intervention Period 1 (1 Day)||11
8132850|NCT02785588|20047150|P1|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0
8132851|NCT02785588|20047150|P1|COMPLETED|Phase2 Controlled Image &Data Collection||5
8132852|NCT02785588|20047150|P1|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5
8132853|NCT02785588|20047150|P1|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2
8132854|NCT02785588|20047150|P1|COMPLETED|Phase 1: Initial Feasibility Assessment||47
8132855|NCT02785588|20047150|P1|STARTED|Phase 1: Initial Feasibility Assessment||49
8132856|NCT02785458|20047166|P2|NOT COMPLETED|3 Months||111
8132857|NCT02785458|20047167|P1|NOT COMPLETED|3 Months||128
8132858|NCT02785458|20047166|P2|COMPLETED|3 Months||293
8132859|NCT02785458|20047167|P1|COMPLETED|3 Months||315
8132860|NCT02785458|20047166|P2|STARTED|3 Months||404
8132861|NCT02785458|20047167|P1|STARTED|3 Months||443
8132862|NCT02785458|20047166|P2|NOT COMPLETED|1 Month||75
8132863|NCT02785458|20047167|P1|NOT COMPLETED|1 Month||83
8132864|NCT02785458|20047166|P2|COMPLETED|1 Month||404
8132865|NCT02785458|20047167|P1|COMPLETED|1 Month||443
8132866|NCT02785458|20047166|P2|STARTED|1 Month||479
8132867|NCT02785458|20047167|P1|STARTED|1 Month||526
8132868|NCT02785458|20047166|P2|NOT COMPLETED|Baseline||0
8132869|NCT02785458|20047167|P1|NOT COMPLETED|Baseline||0
8132870|NCT02785458|20047166|P2|COMPLETED|Baseline||479
8132871|NCT02785458|20047167|P1|COMPLETED|Baseline||526
8132872|NCT02785458|20047166|P2|STARTED|Baseline||479
8132873|NCT02785458|20047167|P1|STARTED|Baseline||526
8132874|NCT02785432|20047177|P2|NOT COMPLETED|Overall Study||0
8132875|NCT02785432|20047178|P1|NOT COMPLETED|Overall Study||0
8132876|NCT02785432|20047177|P2|COMPLETED|Overall Study||7
8132877|NCT02785432|20047178|P1|COMPLETED|Overall Study||4
8132878|NCT02785432|20047177|P2|STARTED|Overall Study||7
8132879|NCT02785432|20047178|P1|STARTED|Overall Study||4
8132880|NCT02785406|20047192|P2|NOT COMPLETED|Overall Study||0
8132881|NCT02785406|20047193|P1|NOT COMPLETED|Overall Study||0
8132882|NCT02785406|20047192|P2|COMPLETED|Overall Study||10
8132883|NCT02785406|20047193|P1|COMPLETED|Overall Study||10
8132884|NCT02785406|20047192|P2|Completed Second Week|Overall Study||10
8132885|NCT02785406|20047193|P1|Completed Second Week|Overall Study||10
8132886|NCT02785406|20047192|P2|Completed First Week|Overall Study||10
8132887|NCT02785406|20047193|P1|Completed First Week|Overall Study||10
8132888|NCT02785406|20047192|P2|STARTED|Overall Study||10
8132889|NCT02785406|20047193|P1|STARTED|Overall Study||10
8132890|NCT02785354|20047268|P3|NOT COMPLETED|Overall Study||0
8132891|NCT02785354|20047269|P2|NOT COMPLETED|Overall Study||0
8132892|NCT02785354|20047270|P1|NOT COMPLETED|Overall Study||0
8132893|NCT02785354|20047268|P3|COMPLETED|Overall Study||44653
8132894|NCT02785354|20047269|P2|COMPLETED|Overall Study||31388
8132895|NCT02785354|20047270|P1|COMPLETED|Overall Study||27060
8132896|NCT02785354|20047268|P3|STARTED|Overall Study||44653
8132897|NCT02785354|20047269|P2|STARTED|Overall Study||31388
8132898|NCT02785354|20047270|P1|STARTED|Overall Study||27060
8132899|NCT02785185|20047303|P4|NOT COMPLETED|Overall Study||0
8132900|NCT02785185|20047304|P3|NOT COMPLETED|Overall Study||2
8132901|NCT02785185|20047305|P2|NOT COMPLETED|Overall Study||1
8132902|NCT02785185|20047306|P1|NOT COMPLETED|Overall Study||1
8132903|NCT02785185|20047303|P4|COMPLETED|Overall Study||16
8132904|NCT02785185|20047304|P3|COMPLETED|Overall Study||15
8132905|NCT02785185|20047305|P2|COMPLETED|Overall Study||56
8132906|NCT02785185|20047306|P1|COMPLETED|Overall Study||59
8132907|NCT02785185|20047303|P4|STARTED|Overall Study||16
8132908|NCT02785185|20047304|P3|STARTED|Overall Study||17
8132909|NCT02785185|20047305|P2|STARTED|Overall Study||57
8132910|NCT02785185|20047306|P1|STARTED|Overall Study||60
8132911|NCT02785172|20047320|P4|NOT COMPLETED|Overall Study||0
8132912|NCT02785172|20047321|P3|NOT COMPLETED|Overall Study||1
8132913|NCT02785172|20047322|P2|NOT COMPLETED|Overall Study||1
8132914|NCT02785172|20047323|P1|NOT COMPLETED|Overall Study||0
8132915|NCT02785172|20047320|P4|COMPLETED|Overall Study||14
8132916|NCT02785172|20047321|P3|COMPLETED|Overall Study||15
8132917|NCT02785172|20047322|P2|COMPLETED|Overall Study||62
8132918|NCT02785172|20047323|P1|COMPLETED|Overall Study||61
8132919|NCT02785172|20047320|P4|STARTED|Overall Study||14
8132920|NCT02785172|20047321|P3|STARTED|Overall Study||16
8132921|NCT02785172|20047322|P2|STARTED|Overall Study||63
8132922|NCT02785172|20047323|P1|STARTED|Overall Study||61
8132923|NCT02785159|20047337|P4|NOT COMPLETED|Overall Study||3
8132924|NCT02785159|20047338|P3|NOT COMPLETED|Overall Study||3
8132925|NCT02785159|20047339|P2|NOT COMPLETED|Overall Study||13
8132926|NCT02785159|20047340|P1|NOT COMPLETED|Overall Study||11
8132927|NCT02785159|20047337|P4|COMPLETED|Overall Study||14
8132928|NCT02785159|20047338|P3|COMPLETED|Overall Study||12
8132929|NCT02785159|20047339|P2|COMPLETED|Overall Study||45
8132930|NCT02785159|20047340|P1|COMPLETED|Overall Study||51
8132931|NCT02785159|20047337|P4|STARTED|Overall Study||17
8132932|NCT02785159|20047338|P3|STARTED|Overall Study||15
8132933|NCT02785159|20047339|P2|STARTED|Overall Study||58
8132934|NCT02785159|20047340|P1|STARTED|Overall Study||62
8132935|NCT02784925|20047350|P1|NOT COMPLETED|Overall Study||0
8132936|NCT02784925|20047350|P1|COMPLETED|Overall Study||30
8132937|NCT02784925|20047350|P1|STARTED|Overall Study||30
8132938|NCT02784834|20047354|P1|NOT COMPLETED|Overall Study||1
8132939|NCT02784834|20047354|P1|COMPLETED|Overall Study||1
8132940|NCT02784834|20047354|P1|STARTED|Overall Study||2
8132941|NCT02784704|20047360|P2|NOT COMPLETED|Overall Study||9
8132942|NCT02784704|20047361|P1|NOT COMPLETED|Overall Study||13
8132943|NCT02784704|20047360|P2|COMPLETED|Overall Study||241
8132944|NCT02784704|20047361|P1|COMPLETED|Overall Study||237
8132945|NCT02784704|20047360|P2|Treated|Overall Study||249
8132946|NCT02784704|20047361|P1|Treated|Overall Study||250
8132947|NCT02784704|20047360|P2|STARTED|Overall Study||250
8132948|NCT02784704|20047361|P1|STARTED|Overall Study||250
8132949|NCT02784613|20047371|P1|NOT COMPLETED|Overall Study||2
8132950|NCT02784613|20047371|P1|COMPLETED|Overall Study||8
8132951|NCT02784613|20047371|P1|STARTED|Overall Study||10
8132952|NCT02784587|20047377|P1|NOT COMPLETED|Overall Study||0
8132953|NCT02784587|20047377|P1|COMPLETED|Overall Study||25
8132954|NCT02784587|20047377|P1|STARTED|Overall Study||25
8132955|NCT02784548|20047381|P1|NOT COMPLETED|Overall Study||0
8132956|NCT02784548|20047381|P1|COMPLETED|Overall Study||15
8132957|NCT02784548|20047381|P1|STARTED|Overall Study||15
8132958|NCT02784444|20047390|P4|NOT COMPLETED|Overall Study||13
8132959|NCT02784444|20047391|P3|NOT COMPLETED|Overall Study||12
8132960|NCT02784444|20047392|P2|NOT COMPLETED|Overall Study||9
8132961|NCT02784444|20047393|P1|NOT COMPLETED|Overall Study||16
8132962|NCT02784444|20047390|P4|COMPLETED|Overall Study||88
8132963|NCT02784444|20047391|P3|COMPLETED|Overall Study||86
8132964|NCT02784444|20047392|P2|COMPLETED|Overall Study||90
8132965|NCT02784444|20047393|P1|COMPLETED|Overall Study||78
8132966|NCT02784444|20047390|P4|STARTED|Overall Study||101
8132967|NCT02784444|20047391|P3|STARTED|Overall Study||98
8132968|NCT02784444|20047392|P2|STARTED|Overall Study||99
8132969|NCT02784444|20047393|P1|STARTED|Overall Study||94
8132970|NCT02784275|20047435|P4|NOT COMPLETED|Overall Study||1
8132971|NCT02784275|20047436|P3|NOT COMPLETED|Overall Study||1
8132972|NCT02784275|20047437|P2|NOT COMPLETED|Overall Study||0
8132973|NCT02784275|20047438|P1|NOT COMPLETED|Overall Study||1
8132974|NCT02784275|20047435|P4|COMPLETED|Overall Study||14
8132975|NCT02784275|20047436|P3|COMPLETED|Overall Study||16
8132976|NCT02784275|20047437|P2|COMPLETED|Overall Study||16
8132977|NCT02784275|20047438|P1|COMPLETED|Overall Study||15
8132978|NCT02784275|20047435|P4|STARTED|Overall Study||15
8132979|NCT02784275|20047436|P3|STARTED|Overall Study||17
8132980|NCT02784275|20047437|P2|STARTED|Overall Study||16
8132981|NCT02784275|20047438|P1|STARTED|Overall Study||16
8132982|NCT02784106|20047482|P4|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
8132983|NCT02784106|20047483|P3|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
8132984|NCT02784106|20047484|P2|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
8132985|NCT02784106|20047485|P1|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
8132986|NCT02784106|20047482|P4|COMPLETED|Open-Label Extension Period (26 Weeks)||19
8132987|NCT02784106|20047483|P3|COMPLETED|Open-Label Extension Period (26 Weeks)||15
8132988|NCT02784106|20047484|P2|COMPLETED|Open-Label Extension Period (26 Weeks)||0
8132989|NCT02784106|20047485|P1|COMPLETED|Open-Label Extension Period (26 Weeks)||0
8132990|NCT02784106|20047482|P4|STARTED|Open-Label Extension Period (26 Weeks)||21
8132991|NCT02784106|20047483|P3|STARTED|Open-Label Extension Period (26 Weeks)||18
8132992|NCT02784106|20047484|P2|STARTED|Open-Label Extension Period (26 Weeks)||0
8132993|NCT02784106|20047485|P1|STARTED|Open-Label Extension Period (26 Weeks)||0
8132994|NCT02784106|20047482|P4|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
8132995|NCT02784106|20047483|P3|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
8132996|NCT02784106|20047484|P2|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
8132997|NCT02784106|20047485|P1|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
8132998|NCT02784106|20047482|P4|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
8132999|NCT02784106|20047483|P3|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
8133000|NCT02784106|20047484|P2|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
8133001|NCT02784106|20047485|P1|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
8133002|NCT02784106|20047482|P4|STARTED|Double-Blind Treatment Period (12 Weeks)||0
8133003|NCT02784106|20047483|P3|STARTED|Double-Blind Treatment Period (12 Weeks)||0
8133004|NCT02784106|20047484|P2|STARTED|Double-Blind Treatment Period (12 Weeks)||33
8133005|NCT02784106|20047485|P1|STARTED|Double-Blind Treatment Period (12 Weeks)||32
8133006|NCT02783898|20047548|P2|NOT COMPLETED|Overall Study||1
8133007|NCT02783898|20047549|P1|NOT COMPLETED|Overall Study||1
8133008|NCT02783898|20047548|P2|COMPLETED|Overall Study||116
8133009|NCT02783898|20047549|P1|COMPLETED|Overall Study||124
8133010|NCT02783898|20047548|P2|STARTED|Overall Study||117
8133011|NCT02783898|20047549|P1|STARTED|Overall Study||125
8133012|NCT02783820|20047573|P4|NOT COMPLETED|Overall Study||0
8133013|NCT02783820|20047574|P3|NOT COMPLETED|Overall Study||0
8133014|NCT02783820|20047575|P2|NOT COMPLETED|Overall Study||0
8133015|NCT02783820|20047576|P1|NOT COMPLETED|Overall Study||0
8133016|NCT02783820|20047573|P4|COMPLETED|Overall Study||6
8133017|NCT02783820|20047574|P3|COMPLETED|Overall Study||6
8133018|NCT02783820|20047575|P2|COMPLETED|Overall Study||6
8133019|NCT02783820|20047576|P1|COMPLETED|Overall Study||6
8133020|NCT02783820|20047573|P4|STARTED|Overall Study||6
8133021|NCT02783820|20047574|P3|STARTED|Overall Study||6
8133022|NCT02783820|20047575|P2|STARTED|Overall Study||6
8133023|NCT02783820|20047576|P1|STARTED|Overall Study||6
8133024|NCT02783768|20047586|P2|NOT COMPLETED|Overall Study||0
8133025|NCT02783768|20047587|P1|NOT COMPLETED|Overall Study||1
8133026|NCT02783768|20047586|P2|COMPLETED|Overall Study||5
8133027|NCT02783768|20047587|P1|COMPLETED|Overall Study||5
8133028|NCT02783768|20047586|P2|STARTED|Overall Study||5
8133029|NCT02783768|20047587|P1|STARTED|Overall Study||6
8133030|NCT02783729|20047609|P4|NOT COMPLETED|Overall Study||9
8133031|NCT02783729|20047610|P3|NOT COMPLETED|Overall Study||8
8133032|NCT02783729|20047611|P2|NOT COMPLETED|Overall Study||17
8133033|NCT02783729|20047612|P1|NOT COMPLETED|Overall Study||10
8133034|NCT02783729|20047609|P4|COMPLETED|Overall Study||260
8133035|NCT02783729|20047610|P3|COMPLETED|Overall Study||258
8133036|NCT02783729|20047611|P2|COMPLETED|Overall Study||246
8133037|NCT02783729|20047612|P1|COMPLETED|Overall Study||198
8133038|NCT02783729|20047609|P4|STARTED|Overall Study||269
8133039|NCT02783729|20047610|P3|STARTED|Overall Study||266
8133040|NCT02783729|20047611|P2|STARTED|Overall Study||263
8133041|NCT02783729|20047612|P1|STARTED|Overall Study||208
8133042|NCT02783599|20047678|P1|NOT COMPLETED|Overall Study||40
8133043|NCT02783599|20047678|P1|COMPLETED|Overall Study||11
8133044|NCT02783599|20047678|P1|Received At Least One Dose of Study Drug|Overall Study||51
8133045|NCT02783599|20047678|P1|STARTED|Overall Study||51
8133046|NCT02783573|20047694|P3|NOT COMPLETED|Delayed-Start Period||12
8133047|NCT02783573|20047695|P2|NOT COMPLETED|Delayed-Start Period||17
8133048|NCT02783573|20047696|P1|NOT COMPLETED|Delayed-Start Period||0
8133049|NCT02783573|20047694|P3|COMPLETED|Delayed-Start Period||0
8133050|NCT02783573|20047695|P2|COMPLETED|Delayed-Start Period||0
8133051|NCT02783573|20047696|P1|COMPLETED|Delayed-Start Period||0
8133052|NCT02783573|20047694|P3|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12
8133053|NCT02783573|20047695|P2|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14
8133054|NCT02783573|20047696|P1|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0
8133055|NCT02783573|20047694|P3|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12
8133056|NCT02783573|20047695|P2|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17
8133057|NCT02783573|20047696|P1|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0
8133058|NCT02783573|20047694|P3|NOT COMPLETED|Placebo-Controlled Treatment Period||548
8133059|NCT02783573|20047695|P2|NOT COMPLETED|Placebo-Controlled Treatment Period||562
8133060|NCT02783573|20047696|P1|NOT COMPLETED|Placebo-Controlled Treatment Period||536
8133061|NCT02783573|20047694|P3|COMPLETED|Placebo-Controlled Treatment Period||22
8133062|NCT02783573|20047695|P2|COMPLETED|Placebo-Controlled Treatment Period||28
8133063|NCT02783573|20047696|P1|COMPLETED|Placebo-Controlled Treatment Period||26
8133064|NCT02783573|20047694|P3|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568
8133065|NCT02783573|20047695|P2|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588
8133066|NCT02783573|20047696|P1|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558
8133067|NCT02783573|20047694|P3|STARTED|Placebo-Controlled Treatment Period||570
8133068|NCT02783573|20047695|P2|STARTED|Placebo-Controlled Treatment Period||590
8133069|NCT02783573|20047696|P1|STARTED|Placebo-Controlled Treatment Period||562
8133070|NCT02783443|20047752|P2|NOT COMPLETED|Overall Study||0
8133071|NCT02783443|20047753|P1|NOT COMPLETED|Overall Study||0
8133072|NCT02783443|20047752|P2|COMPLETED|Overall Study||30
8133073|NCT02783443|20047753|P1|COMPLETED|Overall Study||30
8133074|NCT02783443|20047752|P2|STARTED|Overall Study||30
8133075|NCT02783443|20047753|P1|STARTED|Overall Study||30
8133076|NCT02783170|20047761|P2|NOT COMPLETED|Overall Study||0
8133077|NCT02783170|20047762|P1|NOT COMPLETED|Overall Study||1
8133078|NCT02783170|20047761|P2|COMPLETED|Overall Study||38
8133079|NCT02783170|20047762|P1|COMPLETED|Overall Study||42
8133080|NCT02783170|20047761|P2|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38
8133081|NCT02783170|20047762|P1|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42
8133082|NCT02783170|20047761|P2|STARTED|Overall Study||38
8133083|NCT02783170|20047762|P1|STARTED|Overall Study||43
8133084|NCT02783066|20047803|P1|NOT COMPLETED|Overall Study||13
8133085|NCT02783066|20047803|P1|COMPLETED|Overall Study|complete 4-week pulseflow offloading wearing test|3
8133086|NCT02783066|20047803|P1|STARTED|Overall Study||16
8133087|NCT02783027|20047819|P2|NOT COMPLETED|Overall Study||17
8133088|NCT02783027|20047820|P1|NOT COMPLETED|Overall Study||23
8133089|NCT02783027|20047819|P2|COMPLETED|Overall Study||27
8133090|NCT02783027|20047820|P1|COMPLETED|Overall Study||16
8133091|NCT02783027|20047819|P2|STARTED|Overall Study||44
8133092|NCT02783027|20047820|P1|STARTED|Overall Study||39
8133093|NCT02782923|20047834|P1|NOT COMPLETED|Overall Study||15
8133094|NCT02782923|20047834|P1|COMPLETED|Overall Study||4
8133095|NCT02782923|20047834|P1|STARTED|Overall Study||19
8133102|NCT02782676|20047871|P2|NOT COMPLETED|Overall Study||1
8133103|NCT02782676|20047872|P1|NOT COMPLETED|Overall Study||0
8133104|NCT02782676|20047871|P2|COMPLETED|Overall Study||209
8133105|NCT02782676|20047872|P1|COMPLETED|Overall Study||211
8133106|NCT02782676|20047871|P2|STARTED|Overall Study||210
8133107|NCT02782676|20047872|P1|STARTED|Overall Study||211
8133108|NCT02782377|20047900|P1|NOT COMPLETED|Overall Study||5
8133109|NCT02782377|20047900|P1|COMPLETED|Overall Study|data from five of the patients were excluded due to interpretation difficulties|35
8133110|NCT02782377|20047900|P1|STARTED|Overall Study||40
8133111|NCT02782364|20047913|P2|NOT COMPLETED|Overall Study||0
8133112|NCT02782364|20047914|P1|NOT COMPLETED|Overall Study||0
8133113|NCT02782364|20047913|P2|COMPLETED|Overall Study||18
8133114|NCT02782364|20047914|P1|COMPLETED|Overall Study||18
8133115|NCT02782364|20047913|P2|STARTED|Overall Study||18
8133116|NCT02782364|20047914|P1|STARTED|Overall Study||18
8133117|NCT02782325|20047935|P3|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4
8133118|NCT02782325|20047936|P2|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
8133119|NCT02782325|20047937|P1|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
8133120|NCT02782325|20047935|P3|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1
8133121|NCT02782325|20047936|P2|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
8133122|NCT02782325|20047937|P1|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
8133123|NCT02782325|20047935|P3|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5
8133124|NCT02782325|20047936|P2|STARTED|Open Label FMT Period (up to 24 Weeks)||0
8133125|NCT02782325|20047937|P1|STARTED|Open Label FMT Period (up to 24 Weeks)||0
8133126|NCT02782325|20047935|P3|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
8133127|NCT02782325|20047936|P2|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2
8133128|NCT02782325|20047937|P1|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4
8133129|NCT02782325|20047935|P3|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
8133130|NCT02782325|20047936|P2|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
8133131|NCT02782325|20047937|P1|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
8133132|NCT02782325|20047935|P3|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0
8133133|NCT02782325|20047936|P2|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2
8133134|NCT02782325|20047937|P1|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4
8133135|NCT02782169|20047965|P2|NOT COMPLETED|Overall Study||2
8133136|NCT02782169|20047966|P1|NOT COMPLETED|Overall Study||1
8133137|NCT02782169|20047965|P2|COMPLETED|Overall Study||52
8133138|NCT02782169|20047966|P1|COMPLETED|Overall Study||55
8133139|NCT02782169|20047965|P2|STARTED|Overall Study||54
8133140|NCT02782169|20047966|P1|STARTED|Overall Study||56
8133189|NCT02781818|20048124|P3|NOT COMPLETED|Overall Study||1
8133190|NCT02781818|20048125|P2|NOT COMPLETED|Overall Study||2
8133191|NCT02781818|20048126|P1|NOT COMPLETED|Overall Study||4
8133192|NCT02781818|20048124|P3|COMPLETED|Overall Study||16
8133193|NCT02781818|20048125|P2|COMPLETED|Overall Study||16
8133194|NCT02781818|20048126|P1|COMPLETED|Overall Study||16
8133195|NCT02781818|20048124|P3|STARTED|Overall Study||17
8133196|NCT02781818|20048125|P2|STARTED|Overall Study||18
8133197|NCT02781818|20048126|P1|STARTED|Overall Study||20
8133198|NCT02781649|20048143|P3|NOT COMPLETED|Overall Study||0
8133199|NCT02781649|20048144|P2|NOT COMPLETED|Overall Study||0
8133200|NCT02781649|20048145|P1|NOT COMPLETED|Overall Study||0
8133201|NCT02781649|20048143|P3|COMPLETED|Overall Study||3
8133202|NCT02781649|20048144|P2|COMPLETED|Overall Study||0
8133203|NCT02781649|20048145|P1|COMPLETED|Overall Study||7
8133204|NCT02781649|20048143|P3|STARTED|Overall Study||3
8133205|NCT02781649|20048144|P2|STARTED|Overall Study||0
8133206|NCT02781649|20048145|P1|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
8133207|NCT02781571|20048171|P1|NOT COMPLETED|Overall Study||0
8133208|NCT02781571|20048171|P1|COMPLETED|Overall Study||79
8133209|NCT02781571|20048171|P1|STARTED|Overall Study||79
8133210|NCT02781558|20048192|P2|NOT COMPLETED|Overall Study||2
8133211|NCT02781558|20048193|P1|NOT COMPLETED|Overall Study||3
8133212|NCT02781558|20048192|P2|COMPLETED|Overall Study||101
8133213|NCT02781558|20048193|P1|COMPLETED|Overall Study||98
8133214|NCT02781558|20048192|P2|STARTED|Overall Study||103
8133215|NCT02781558|20048193|P1|STARTED|Overall Study||101
8133216|NCT02781454|20048232|P3|NOT COMPLETED|Overall Study||1
8133217|NCT02781454|20048233|P2|NOT COMPLETED|Overall Study||0
8133218|NCT02781454|20048234|P1|NOT COMPLETED|Overall Study||0
8133219|NCT02781454|20048232|P3|COMPLETED|Overall Study||5
8133220|NCT02781454|20048233|P2|COMPLETED|Overall Study||6
8133221|NCT02781454|20048234|P1|COMPLETED|Overall Study||8
8133222|NCT02781454|20048232|P3|STARTED|Overall Study||6
8133223|NCT02781454|20048233|P2|STARTED|Overall Study||6
8133224|NCT02781454|20048234|P1|STARTED|Overall Study||8
8133225|NCT02781324|20048280|P2|NOT COMPLETED|Overall Study||2
8133226|NCT02781324|20048281|P1|NOT COMPLETED|Overall Study||2
8133227|NCT02781324|20048280|P2|COMPLETED|Overall Study||31
8133228|NCT02781324|20048281|P1|COMPLETED|Overall Study||31
8133229|NCT02781324|20048280|P2|STARTED|Overall Study||33
8133230|NCT02781324|20048281|P1|STARTED|Overall Study||33
8133231|NCT02781311|20048310|P3|NOT COMPLETED|Overall Study||4
8133232|NCT02781311|20048311|P2|NOT COMPLETED|Overall Study||26
8133233|NCT02781311|20048312|P1|NOT COMPLETED|Overall Study||26
8133234|NCT02781311|20048310|P3|COMPLETED|Overall Study||8
8133235|NCT02781311|20048311|P2|COMPLETED|Overall Study||57
8133236|NCT02781311|20048312|P1|COMPLETED|Overall Study||48
8133237|NCT02781311|20048310|P3|mITT Population|Overall Study||11
8133238|NCT02781311|20048311|P2|mITT Population|Overall Study||78
8133239|NCT02781311|20048312|P1|mITT Population|Overall Study||70
8133240|NCT02781311|20048310|P3|Safety Population (Treated)|Overall Study||12
8133241|NCT02781311|20048311|P2|Safety Population (Treated)|Overall Study||81
8133242|NCT02781311|20048312|P1|Safety Population (Treated)|Overall Study||73
8133243|NCT02781311|20048310|P3|STARTED|Overall Study||12
8133244|NCT02781311|20048311|P2|STARTED|Overall Study||83
8133245|NCT02781311|20048312|P1|STARTED|Overall Study||74
8133246|NCT02781051|20048321|P1|NOT COMPLETED|Overall Study||2
8133247|NCT02781051|20048321|P1|COMPLETED|Overall Study||14
8133248|NCT02781051|20048321|P1|STARTED|Overall Study||16
8133249|NCT02780869|20048328|P2|NOT COMPLETED|Overall Study||9
8133250|NCT02780869|20048329|P1|NOT COMPLETED|Overall Study||13
8133251|NCT02780869|20048328|P2|COMPLETED|Overall Study||74
8133252|NCT02780869|20048329|P1|COMPLETED|Overall Study||162
8133253|NCT02780869|20048328|P2|STARTED|Overall Study||83
8133254|NCT02780869|20048329|P1|STARTED|Overall Study||175
8133255|NCT02780856|20048339|P1|NOT COMPLETED|Overall Study||1
8133256|NCT02780856|20048339|P1|COMPLETED|Overall Study||109
8133257|NCT02780856|20048339|P1|STARTED|Overall Study||110
8133258|NCT02780765|20048349|P2|NOT COMPLETED|Overall Study||0
8133259|NCT02780765|20048350|P1|NOT COMPLETED|Overall Study||0
8133260|NCT02780765|20048349|P2|COMPLETED|Overall Study||30
8133261|NCT02780765|20048350|P1|COMPLETED|Overall Study||30
8133262|NCT02780765|20048349|P2|STARTED|Overall Study||30
8133263|NCT02780765|20048350|P1|STARTED|Overall Study||30
8133264|NCT02780700|20048358|P1|NOT COMPLETED|Overall Study||1
8133265|NCT02780700|20048358|P1|COMPLETED|Overall Study||0
8133266|NCT02780700|20048358|P1|STARTED|Overall Study||1
8133267|NCT02780687|20048368|P2|NOT COMPLETED|Overall Study||8
8133268|NCT02780687|20048369|P1|NOT COMPLETED|Overall Study||34
8133269|NCT02780687|20048368|P2|COMPLETED|Overall Study||0
8133270|NCT02780687|20048369|P1|COMPLETED|Overall Study||0
8133271|NCT02780687|20048368|P2|STARTED|Overall Study||8
8133272|NCT02780687|20048369|P1|STARTED|Overall Study||34
8133273|NCT02780661|20048380|P2|NOT COMPLETED|Period 2||0
8133274|NCT02780661|20048381|P1|NOT COMPLETED|Period 2||0
8133275|NCT02780661|20048380|P2|COMPLETED|Period 2||9
8133276|NCT02780661|20048381|P1|COMPLETED|Period 2||10
8133277|NCT02780661|20048380|P2|STARTED|Period 2||9
8133278|NCT02780661|20048381|P1|STARTED|Period 2||10
8133279|NCT02780661|20048380|P2|NOT COMPLETED|Wash Out Period||0
8133280|NCT02780661|20048381|P1|NOT COMPLETED|Wash Out Period||0
8133281|NCT02780661|20048380|P2|COMPLETED|Wash Out Period||9
8133282|NCT02780661|20048381|P1|COMPLETED|Wash Out Period||10
8133283|NCT02780661|20048380|P2|STARTED|Wash Out Period||9
8133284|NCT02780661|20048381|P1|STARTED|Wash Out Period||10
8133285|NCT02780661|20048380|P2|NOT COMPLETED|Period 1||0
8133286|NCT02780661|20048381|P1|NOT COMPLETED|Period 1||0
8133287|NCT02780661|20048380|P2|COMPLETED|Period 1||9
8133288|NCT02780661|20048381|P1|COMPLETED|Period 1||10
8133289|NCT02780661|20048380|P2|STARTED|Period 1||9
8133290|NCT02780661|20048381|P1|STARTED|Period 1||10
8133291|NCT02780622|20048397|P2|NOT COMPLETED|Treatment Period 2||0
8133292|NCT02780622|20048398|P1|NOT COMPLETED|Treatment Period 2||0
8133293|NCT02780622|20048397|P2|COMPLETED|Treatment Period 2||10
8133294|NCT02780622|20048398|P1|COMPLETED|Treatment Period 2||10
8133295|NCT02780622|20048397|P2|STARTED|Treatment Period 2||10
8133296|NCT02780622|20048398|P1|STARTED|Treatment Period 2||10
8133297|NCT02780622|20048397|P2|NOT COMPLETED|Treatment Period 1||0
8133298|NCT02780622|20048398|P1|NOT COMPLETED|Treatment Period 1||0
8133299|NCT02780622|20048397|P2|COMPLETED|Treatment Period 1||10
8133300|NCT02780622|20048398|P1|COMPLETED|Treatment Period 1||10
8133301|NCT02780622|20048397|P2|STARTED|Treatment Period 1||10
8133302|NCT02780622|20048398|P1|STARTED|Treatment Period 1||10
8133303|NCT02780388|20048441|P5|NOT COMPLETED|Overall Study||0
8133304|NCT02780388|20048442|P4|NOT COMPLETED|Overall Study||0
8133305|NCT02780388|20048443|P3|NOT COMPLETED|Overall Study||0
8133306|NCT02780388|20048444|P2|NOT COMPLETED|Overall Study||2
8133307|NCT02780388|20048445|P1|NOT COMPLETED|Overall Study||1
8133308|NCT02780388|20048441|P5|COMPLETED|Overall Study||12
8133309|NCT02780388|20048442|P4|COMPLETED|Overall Study||12
8133310|NCT02780388|20048443|P3|COMPLETED|Overall Study||10
8133311|NCT02780388|20048444|P2|COMPLETED|Overall Study||6
8133312|NCT02780388|20048445|P1|COMPLETED|Overall Study||14
8133313|NCT02780388|20048441|P5|STARTED|Overall Study||12
8133314|NCT02780388|20048442|P4|STARTED|Overall Study||12
8133315|NCT02780388|20048443|P3|STARTED|Overall Study||10
8133316|NCT02780388|20048444|P2|STARTED|Overall Study||8
8133317|NCT02780388|20048445|P1|STARTED|Overall Study||15
8133318|NCT02780349|20048502|P1|NOT COMPLETED|Overall Study||2
8133319|NCT02780349|20048502|P1|COMPLETED|Overall Study||101
8133320|NCT02780349|20048502|P1|STARTED|Overall Study||103
8133321|NCT02780167|20048511|P5|NOT COMPLETED|Overall Study||17
8133322|NCT02780167|20048512|P4|NOT COMPLETED|Overall Study||19
8133323|NCT02780167|20048513|P3|NOT COMPLETED|Overall Study||24
8133324|NCT02780167|20048514|P2|NOT COMPLETED|Overall Study||22
8133325|NCT02780167|20048515|P1|NOT COMPLETED|Overall Study||28
8133326|NCT02780167|20048511|P5|COMPLETED|Overall Study||38
8133327|NCT02780167|20048512|P4|COMPLETED|Overall Study||37
8133328|NCT02780167|20048513|P3|COMPLETED|Overall Study||27
8133329|NCT02780167|20048514|P2|COMPLETED|Overall Study||27
8133330|NCT02780167|20048515|P1|COMPLETED|Overall Study||28
8133331|NCT02780167|20048511|P5|STARTED|Overall Study||55
8133332|NCT02780167|20048512|P4|STARTED|Overall Study||56
8133333|NCT02780167|20048513|P3|STARTED|Overall Study||51
8133334|NCT02780167|20048514|P2|STARTED|Overall Study||49
8133335|NCT02780167|20048515|P1|STARTED|Overall Study||56
8133336|NCT02780115|20048652|P5|NOT COMPLETED|Overall Study||1
8133337|NCT02780115|20048653|P4|NOT COMPLETED|Overall Study||1
8133338|NCT02780115|20048654|P3|NOT COMPLETED|Overall Study||1
8133339|NCT02780115|20048655|P2|NOT COMPLETED|Overall Study||1
8133340|NCT02780115|20048656|P1|NOT COMPLETED|Overall Study||0
8133341|NCT02780115|20048652|P5|COMPLETED|Overall Study||30
8133342|NCT02780115|20048653|P4|COMPLETED|Overall Study||31
8133343|NCT02780115|20048654|P3|COMPLETED|Overall Study||29
8133344|NCT02780115|20048655|P2|COMPLETED|Overall Study||29
8133345|NCT02780115|20048656|P1|COMPLETED|Overall Study||28
8133346|NCT02780115|20048652|P5|STARTED|Overall Study||31
8133347|NCT02780115|20048653|P4|STARTED|Overall Study||32
8133348|NCT02780115|20048654|P3|STARTED|Overall Study||30
8133349|NCT02780115|20048655|P2|STARTED|Overall Study||30
8133350|NCT02780115|20048656|P1|STARTED|Overall Study||28
8133351|NCT02779543|20048675|P2|NOT COMPLETED|Overall Study||0
8133352|NCT02779543|20048676|P1|NOT COMPLETED|Overall Study||0
8133353|NCT02779543|20048675|P2|COMPLETED|Overall Study||100
8133354|NCT02779543|20048676|P1|COMPLETED|Overall Study||100
8133355|NCT02779543|20048675|P2|STARTED|Overall Study||100
8133356|NCT02779543|20048676|P1|STARTED|Overall Study||100
8133357|NCT02779491|20048692|P4|NOT COMPLETED|Overall Study||2
8133358|NCT02779491|20048693|P3|NOT COMPLETED|Overall Study||1
8133359|NCT02779491|20048694|P2|NOT COMPLETED|Overall Study||1
8133360|NCT02779491|20048695|P1|NOT COMPLETED|Overall Study||0
8133361|NCT02779491|20048692|P4|COMPLETED|Overall Study||15
8133362|NCT02779491|20048693|P3|COMPLETED|Overall Study||17
8133363|NCT02779491|20048694|P2|COMPLETED|Overall Study||26
8133364|NCT02779491|20048695|P1|COMPLETED|Overall Study||32
8133365|NCT02779491|20048692|P4|STARTED|Overall Study||17
8133366|NCT02779491|20048693|P3|STARTED|Overall Study||18
8133367|NCT02779491|20048694|P2|STARTED|Overall Study||27
8133368|NCT02779491|20048695|P1|STARTED|Overall Study||32
8133369|NCT02779166|20048715|P2|NOT COMPLETED|Overall Study||0
8133370|NCT02779166|20048716|P1|NOT COMPLETED|Overall Study||0
8133371|NCT02779166|20048715|P2|COMPLETED|Overall Study||48
8133372|NCT02779166|20048716|P1|COMPLETED|Overall Study||50
8133373|NCT02779166|20048715|P2|STARTED|Overall Study||48
8133374|NCT02779166|20048716|P1|STARTED|Overall Study||50
8133375|NCT02779075|20048726|P2|NOT COMPLETED|Overall Study||3
8133376|NCT02779075|20048727|P1|NOT COMPLETED|Overall Study||2
8133377|NCT02779075|20048726|P2|COMPLETED|Overall Study||10
8133378|NCT02779075|20048727|P1|COMPLETED|Overall Study||14
8133379|NCT02779075|20048726|P2|STARTED|Overall Study||13
8133380|NCT02779075|20048727|P1|STARTED|Overall Study||16
8133381|NCT02778880|20048737|P2|NOT COMPLETED|Overall Study||3
8133382|NCT02778880|20048738|P1|NOT COMPLETED|Overall Study||1
8133383|NCT02778880|20048737|P2|COMPLETED|Overall Study||42
8133384|NCT02778880|20048738|P1|COMPLETED|Overall Study||44
8133385|NCT02778880|20048737|P2|STARTED|Overall Study||45
8133386|NCT02778880|20048738|P1|STARTED|Overall Study||45
8133387|NCT02778867|20048790|P4|NOT COMPLETED|Phase 2||2
8133388|NCT02778867|20048791|P3|NOT COMPLETED|Phase 2||1
8133389|NCT02778867|20048792|P2|NOT COMPLETED|Phase 2||0
8133390|NCT02778867|20048793|P1|NOT COMPLETED|Phase 2||0
8133391|NCT02778867|20048790|P4|COMPLETED|Phase 2||9
8133392|NCT02778867|20048791|P3|COMPLETED|Phase 2||20
8133393|NCT02778867|20048792|P2|COMPLETED|Phase 2||0
8133394|NCT02778867|20048793|P1|COMPLETED|Phase 2||0
8133395|NCT02778867|20048790|P4|STARTED|Phase 2|Optional phase for 6FED non-responders|11
8133396|NCT02778867|20048791|P3|STARTED|Phase 2|Optional phase for 1FED non-responders|21
8133397|NCT02778867|20048792|P2|STARTED|Phase 2|6FED non-responders from Phase 1 have the option to undergo SGC in Phase 2|0
8133398|NCT02778867|20048793|P1|STARTED|Phase 2|1FED non-responders from Phase 1 have the option to undergo 6FED in Phase 2|0
8133399|NCT02778867|20048790|P4|NOT COMPLETED|Phase 1||0
8133400|NCT02778867|20048791|P3|NOT COMPLETED|Phase 1||0
8133401|NCT02778867|20048792|P2|NOT COMPLETED|Phase 1||3
8133402|NCT02778867|20048793|P1|NOT COMPLETED|Phase 1||2
8133403|NCT02778867|20048790|P4|COMPLETED|Phase 1||0
8133404|NCT02778867|20048791|P3|COMPLETED|Phase 1||0
8133405|NCT02778867|20048792|P2|COMPLETED|Phase 1||59
8133406|NCT02778867|20048793|P1|COMPLETED|Phase 1||65
8133407|NCT02778867|20048790|P4|STARTED|Phase 1||0
8133408|NCT02778867|20048791|P3|STARTED|Phase 1||0
8133409|NCT02778867|20048792|P2|STARTED|Phase 1||62
8133410|NCT02778867|20048793|P1|STARTED|Phase 1||67
8133411|NCT02778555|20048814|P3|NOT COMPLETED|Overall Study||107
8133412|NCT02778555|20048815|P2|NOT COMPLETED|Overall Study||32
8133413|NCT02778555|20048816|P1|NOT COMPLETED|Overall Study||55
8133414|NCT02778555|20048814|P3|COMPLETED|Overall Study||211
8133415|NCT02778555|20048815|P2|COMPLETED|Overall Study||177
8133416|NCT02778555|20048816|P1|COMPLETED|Overall Study||131
8133417|NCT02778555|20048814|P3|STARTED|Overall Study||318
8133418|NCT02778555|20048815|P2|STARTED|Overall Study||209
8133419|NCT02778555|20048816|P1|STARTED|Overall Study||186
8133420|NCT02778204|20048828|P4|NOT COMPLETED|Overall Study||4
8133421|NCT02778204|20048829|P3|NOT COMPLETED|Overall Study||4
8133422|NCT02778204|20048830|P2|NOT COMPLETED|Overall Study||0
8133423|NCT02778204|20048831|P1|NOT COMPLETED|Overall Study||2
8133424|NCT02778204|20048828|P4|COMPLETED|Overall Study||12
8133425|NCT02778204|20048829|P3|COMPLETED|Overall Study||12
8133426|NCT02778204|20048830|P2|COMPLETED|Overall Study||7
8133427|NCT02778204|20048831|P1|COMPLETED|Overall Study||6
8133428|NCT02778204|20048828|P4|STARTED|Overall Study||16
8133429|NCT02778204|20048829|P3|STARTED|Overall Study||16
8133430|NCT02778204|20048830|P2|STARTED|Overall Study||7
8133431|NCT02778204|20048831|P1|STARTED|Overall Study||8
8133432|NCT02778152|20048875|P1|NOT COMPLETED|Overall Study||0
8133433|NCT02778152|20048875|P1|COMPLETED|Overall Study||13
8133434|NCT02778152|20048875|P1|STARTED|Overall Study||13
8133435|NCT02778113|20048880|P4|NOT COMPLETED|Study Period Four||0
8133436|NCT02778113|20048881|P3|NOT COMPLETED|Study Period Four||0
8133437|NCT02778113|20048882|P2|NOT COMPLETED|Study Period Four||0
8133438|NCT02778113|20048883|P1|NOT COMPLETED|Study Period Four||0
8133439|NCT02778113|20048880|P4|COMPLETED|Study Period Four||4
8133440|NCT02778113|20048881|P3|COMPLETED|Study Period Four||2
8133441|NCT02778113|20048882|P2|COMPLETED|Study Period Four||4
8133442|NCT02778113|20048883|P1|COMPLETED|Study Period Four||3
8133443|NCT02778113|20048880|P4|Received Study Drug|Study Period Four||4
8133444|NCT02778113|20048881|P3|Received Study Drug|Study Period Four||2
8133445|NCT02778113|20048882|P2|Received Study Drug|Study Period Four||4
8133446|NCT02778113|20048883|P1|Received Study Drug|Study Period Four||3
8133447|NCT02778113|20048880|P4|STARTED|Study Period Four||4
8133448|NCT02778113|20048881|P3|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2
8133449|NCT02778113|20048882|P2|STARTED|Study Period Four||4
8133450|NCT02778113|20048883|P1|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3
8133451|NCT02778113|20048880|P4|NOT COMPLETED|Study Period Three||0
8133452|NCT02778113|20048881|P3|NOT COMPLETED|Study Period Three||0
8133453|NCT02778113|20048882|P2|NOT COMPLETED|Study Period Three||0
8133454|NCT02778113|20048883|P1|NOT COMPLETED|Study Period Three||0
8133455|NCT02778113|20048880|P4|COMPLETED|Study Period Three||4
8133456|NCT02778113|20048881|P3|COMPLETED|Study Period Three||3
8133457|NCT02778113|20048882|P2|COMPLETED|Study Period Three||4
8133458|NCT02778113|20048883|P1|COMPLETED|Study Period Three||4
8133459|NCT02778113|20048880|P4|Received Study Drug|Study Period Three||4
8133460|NCT02778113|20048881|P3|Received Study Drug|Study Period Three||3
8133461|NCT02778113|20048882|P2|Received Study Drug|Study Period Three||4
8133462|NCT02778113|20048883|P1|Received Study Drug|Study Period Three||4
8133463|NCT02778113|20048880|P4|STARTED|Study Period Three||4
8133464|NCT02778113|20048881|P3|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3
8133465|NCT02778113|20048882|P2|STARTED|Study Period Three||4
8133466|NCT02778113|20048883|P1|STARTED|Study Period Three||4
8133467|NCT02778113|20048880|P4|NOT COMPLETED|Study Period Two||0
8133468|NCT02778113|20048881|P3|NOT COMPLETED|Study Period Two||0
8133469|NCT02778113|20048882|P2|NOT COMPLETED|Study Period Two||0
8133470|NCT02778113|20048883|P1|NOT COMPLETED|Study Period Two||0
8133471|NCT02778113|20048880|P4|COMPLETED|Study Period Two||4
8133472|NCT02778113|20048881|P3|COMPLETED|Study Period Two||4
8133473|NCT02778113|20048882|P2|COMPLETED|Study Period Two||4
8133474|NCT02778113|20048883|P1|COMPLETED|Study Period Two||4
8133475|NCT02778113|20048880|P4|Received Study Drug|Study Period Two||4
8133476|NCT02778113|20048881|P3|Received Study Drug|Study Period Two||4
8133477|NCT02778113|20048882|P2|Received Study Drug|Study Period Two||4
8133478|NCT02778113|20048883|P1|Received Study Drug|Study Period Two||4
8133479|NCT02778113|20048880|P4|STARTED|Study Period Two||4
8133480|NCT02778113|20048881|P3|STARTED|Study Period Two||4
8133481|NCT02778113|20048882|P2|STARTED|Study Period Two||4
8133482|NCT02778113|20048883|P1|STARTED|Study Period Two||4
8133483|NCT02778113|20048880|P4|NOT COMPLETED|Study Period One||0
8133484|NCT02778113|20048881|P3|NOT COMPLETED|Study Period One||0
8133485|NCT02778113|20048882|P2|NOT COMPLETED|Study Period One||0
8133486|NCT02778113|20048883|P1|NOT COMPLETED|Study Period One||0
8133487|NCT02778113|20048880|P4|COMPLETED|Study Period One||4
8133488|NCT02778113|20048881|P3|COMPLETED|Study Period One||4
8133489|NCT02778113|20048882|P2|COMPLETED|Study Period One||4
8133490|NCT02778113|20048883|P1|COMPLETED|Study Period One||4
8133491|NCT02778113|20048880|P4|Received Study Drug|Study Period One||4
8133492|NCT02778113|20048881|P3|Received Study Drug|Study Period One||4
8133493|NCT02778113|20048882|P2|Received Study Drug|Study Period One||4
8133494|NCT02778113|20048883|P1|Received Study Drug|Study Period One||4
8133495|NCT02778113|20048880|P4|STARTED|Study Period One||4
8133496|NCT02778113|20048881|P3|STARTED|Study Period One||4
8133497|NCT02778113|20048882|P2|STARTED|Study Period One||4
8133498|NCT02778113|20048883|P1|STARTED|Study Period One||4
8133499|NCT02778100|20048923|P2|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
8133500|NCT02778100|20048924|P1|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
8133501|NCT02778100|20048923|P2|COMPLETED|Period 2 (No Cold Symptoms)||0
8133502|NCT02778100|20048924|P1|COMPLETED|Period 2 (No Cold Symptoms)||17
8133503|NCT02778100|20048923|P2|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0
8133504|NCT02778100|20048924|P1|STARTED|Period 2 (No Cold Symptoms)||17
8133505|NCT02778100|20048923|P2|NOT COMPLETED|Period 1 (Common Cold)||0
8133506|NCT02778100|20048924|P1|NOT COMPLETED|Period 1 (Common Cold)||1
8133507|NCT02778100|20048923|P2|COMPLETED|Period 1 (Common Cold)||18
8133508|NCT02778100|20048924|P1|COMPLETED|Period 1 (Common Cold)||17
8133509|NCT02778100|20048923|P2|STARTED|Period 1 (Common Cold)||18
8133510|NCT02778100|20048924|P1|STARTED|Period 1 (Common Cold)||18
8133511|NCT02778074|20048955|P2|NOT COMPLETED|Overall Study||10
8133512|NCT02778074|20048956|P1|NOT COMPLETED|Overall Study||7
8133513|NCT02778074|20048955|P2|COMPLETED|Overall Study||62
8133514|NCT02778074|20048956|P1|COMPLETED|Overall Study||65
8133515|NCT02778074|20048955|P2|STARTED|Overall Study||72
8133516|NCT02778074|20048956|P1|STARTED|Overall Study||72
8133517|NCT02777944|20048964|P2|NOT COMPLETED|Overall Study||0
8133518|NCT02777944|20048965|P1|NOT COMPLETED|Overall Study||0
8133519|NCT02777944|20048964|P2|COMPLETED|Overall Study||156
8133520|NCT02777944|20048965|P1|COMPLETED|Overall Study||157
8133521|NCT02777944|20048964|P2|STARTED|Overall Study||156
8133522|NCT02777944|20048965|P1|STARTED|Overall Study||157
8133533|NCT02777918|20048988|P2|NOT COMPLETED|Overall Study||4
8133534|NCT02777918|20048989|P1|NOT COMPLETED|Overall Study||3
8133535|NCT02777918|20048988|P2|COMPLETED|Overall Study||43
8133536|NCT02777918|20048989|P1|COMPLETED|Overall Study||50
8133537|NCT02777918|20048988|P2|STARTED|Overall Study||47
8133538|NCT02777918|20048989|P1|STARTED|Overall Study||53
8133539|NCT02777827|20049007|P6|NOT COMPLETED|Treatment Period 6||0
8133540|NCT02777827|20049008|P5|NOT COMPLETED|Treatment Period 6||0
8133541|NCT02777827|20049009|P4|NOT COMPLETED|Treatment Period 6||0
8133542|NCT02777827|20049010|P3|NOT COMPLETED|Treatment Period 6||0
8133543|NCT02777827|20049011|P2|NOT COMPLETED|Treatment Period 6||0
8133544|NCT02777827|20049012|P1|NOT COMPLETED|Treatment Period 6||0
8133545|NCT02777827|20049007|P6|COMPLETED|Treatment Period 6||6
8133546|NCT02777827|20049008|P5|COMPLETED|Treatment Period 6||4
8133547|NCT02777827|20049009|P4|COMPLETED|Treatment Period 6||5
8133548|NCT02777827|20049010|P3|COMPLETED|Treatment Period 6||4
8133549|NCT02777827|20049011|P2|COMPLETED|Treatment Period 6||5
8133550|NCT02777827|20049012|P1|COMPLETED|Treatment Period 6||5
8133551|NCT02777827|20049007|P6|STARTED|Treatment Period 6||6
8133552|NCT02777827|20049008|P5|STARTED|Treatment Period 6||4
8133553|NCT02777827|20049009|P4|STARTED|Treatment Period 6||5
8133554|NCT02777827|20049010|P3|STARTED|Treatment Period 6||4
8133555|NCT02777827|20049011|P2|STARTED|Treatment Period 6||5
8133556|NCT02777827|20049012|P1|STARTED|Treatment Period 6||5
8133557|NCT02777827|20049007|P6|NOT COMPLETED|Washout Between Periods 5 and 6||0
8133558|NCT02777827|20049008|P5|NOT COMPLETED|Washout Between Periods 5 and 6||0
8133559|NCT02777827|20049009|P4|NOT COMPLETED|Washout Between Periods 5 and 6||0
8133560|NCT02777827|20049010|P3|NOT COMPLETED|Washout Between Periods 5 and 6||0
8133561|NCT02777827|20049011|P2|NOT COMPLETED|Washout Between Periods 5 and 6||0
8133562|NCT02777827|20049012|P1|NOT COMPLETED|Washout Between Periods 5 and 6||0
8133563|NCT02777827|20049007|P6|COMPLETED|Washout Between Periods 5 and 6||6
8133564|NCT02777827|20049008|P5|COMPLETED|Washout Between Periods 5 and 6||4
8133565|NCT02777827|20049009|P4|COMPLETED|Washout Between Periods 5 and 6||5
8133566|NCT02777827|20049010|P3|COMPLETED|Washout Between Periods 5 and 6||4
8133567|NCT02777827|20049011|P2|COMPLETED|Washout Between Periods 5 and 6||5
8133568|NCT02777827|20049012|P1|COMPLETED|Washout Between Periods 5 and 6||5
8133569|NCT02777827|20049007|P6|STARTED|Washout Between Periods 5 and 6||6
8133570|NCT02777827|20049008|P5|STARTED|Washout Between Periods 5 and 6||4
8133571|NCT02777827|20049009|P4|STARTED|Washout Between Periods 5 and 6||5
8133572|NCT02777827|20049010|P3|STARTED|Washout Between Periods 5 and 6||4
8133573|NCT02777827|20049011|P2|STARTED|Washout Between Periods 5 and 6||5
8133574|NCT02777827|20049012|P1|STARTED|Washout Between Periods 5 and 6||5
8133575|NCT02777827|20049007|P6|NOT COMPLETED|Treatment Period 5||0
8133576|NCT02777827|20049008|P5|NOT COMPLETED|Treatment Period 5||0
8133577|NCT02777827|20049009|P4|NOT COMPLETED|Treatment Period 5||0
8133578|NCT02777827|20049010|P3|NOT COMPLETED|Treatment Period 5||0
8133579|NCT02777827|20049011|P2|NOT COMPLETED|Treatment Period 5||0
8133580|NCT02777827|20049012|P1|NOT COMPLETED|Treatment Period 5||0
8133581|NCT02777827|20049007|P6|COMPLETED|Treatment Period 5||6
8133582|NCT02777827|20049008|P5|COMPLETED|Treatment Period 5||4
8133583|NCT02777827|20049009|P4|COMPLETED|Treatment Period 5||5
8133584|NCT02777827|20049010|P3|COMPLETED|Treatment Period 5||4
8133585|NCT02777827|20049011|P2|COMPLETED|Treatment Period 5||5
8133586|NCT02777827|20049012|P1|COMPLETED|Treatment Period 5||5
8133587|NCT02777827|20049007|P6|STARTED|Treatment Period 5||6
8133588|NCT02777827|20049008|P5|STARTED|Treatment Period 5||4
8133589|NCT02777827|20049009|P4|STARTED|Treatment Period 5||5
8133590|NCT02777827|20049010|P3|STARTED|Treatment Period 5||4
8133591|NCT02777827|20049011|P2|STARTED|Treatment Period 5||5
8133592|NCT02777827|20049012|P1|STARTED|Treatment Period 5||5
8133593|NCT02777827|20049007|P6|NOT COMPLETED|Washout Between Periods 4 and 5||0
8133594|NCT02777827|20049008|P5|NOT COMPLETED|Washout Between Periods 4 and 5||0
8133595|NCT02777827|20049009|P4|NOT COMPLETED|Washout Between Periods 4 and 5||0
8133596|NCT02777827|20049010|P3|NOT COMPLETED|Washout Between Periods 4 and 5||0
8133597|NCT02777827|20049011|P2|NOT COMPLETED|Washout Between Periods 4 and 5||0
8133598|NCT02777827|20049012|P1|NOT COMPLETED|Washout Between Periods 4 and 5||0
8133599|NCT02777827|20049007|P6|COMPLETED|Washout Between Periods 4 and 5||6
8133600|NCT02777827|20049008|P5|COMPLETED|Washout Between Periods 4 and 5||4
8133601|NCT02777827|20049009|P4|COMPLETED|Washout Between Periods 4 and 5||5
8133602|NCT02777827|20049010|P3|COMPLETED|Washout Between Periods 4 and 5||4
8133603|NCT02777827|20049011|P2|COMPLETED|Washout Between Periods 4 and 5||5
8133604|NCT02777827|20049012|P1|COMPLETED|Washout Between Periods 4 and 5||5
8133605|NCT02777827|20049007|P6|STARTED|Washout Between Periods 4 and 5||6
8133606|NCT02777827|20049008|P5|STARTED|Washout Between Periods 4 and 5||4
8133607|NCT02777827|20049009|P4|STARTED|Washout Between Periods 4 and 5||5
8133608|NCT02777827|20049010|P3|STARTED|Washout Between Periods 4 and 5||4
8133609|NCT02777827|20049011|P2|STARTED|Washout Between Periods 4 and 5||5
8133610|NCT02777827|20049012|P1|STARTED|Washout Between Periods 4 and 5||5
8133611|NCT02777827|20049007|P6|NOT COMPLETED|Treatment Period 4||0
8133612|NCT02777827|20049008|P5|NOT COMPLETED|Treatment Period 4||0
8133613|NCT02777827|20049009|P4|NOT COMPLETED|Treatment Period 4||0
8133614|NCT02777827|20049010|P3|NOT COMPLETED|Treatment Period 4||0
8133615|NCT02777827|20049011|P2|NOT COMPLETED|Treatment Period 4||0
8133616|NCT02777827|20049012|P1|NOT COMPLETED|Treatment Period 4||0
8133617|NCT02777827|20049007|P6|COMPLETED|Treatment Period 4||6
8133618|NCT02777827|20049008|P5|COMPLETED|Treatment Period 4||4
8133619|NCT02777827|20049009|P4|COMPLETED|Treatment Period 4||5
8133620|NCT02777827|20049010|P3|COMPLETED|Treatment Period 4||4
8133621|NCT02777827|20049011|P2|COMPLETED|Treatment Period 4||5
8133622|NCT02777827|20049012|P1|COMPLETED|Treatment Period 4||5
8133623|NCT02777827|20049007|P6|STARTED|Treatment Period 4||6
8133624|NCT02777827|20049008|P5|STARTED|Treatment Period 4||4
8133625|NCT02777827|20049009|P4|STARTED|Treatment Period 4||5
8133626|NCT02777827|20049010|P3|STARTED|Treatment Period 4||4
8133627|NCT02777827|20049011|P2|STARTED|Treatment Period 4||5
8133628|NCT02777827|20049012|P1|STARTED|Treatment Period 4||5
8133629|NCT02777827|20049007|P6|NOT COMPLETED|Washout Between Periods 3 and 4||0
8133630|NCT02777827|20049008|P5|NOT COMPLETED|Washout Between Periods 3 and 4||0
8133631|NCT02777827|20049009|P4|NOT COMPLETED|Washout Between Periods 3 and 4||0
8133632|NCT02777827|20049010|P3|NOT COMPLETED|Washout Between Periods 3 and 4||1
8133633|NCT02777827|20049011|P2|NOT COMPLETED|Washout Between Periods 3 and 4||0
8133634|NCT02777827|20049012|P1|NOT COMPLETED|Washout Between Periods 3 and 4||0
8133635|NCT02777827|20049007|P6|COMPLETED|Washout Between Periods 3 and 4||6
8133636|NCT02777827|20049008|P5|COMPLETED|Washout Between Periods 3 and 4||4
8133637|NCT02777827|20049009|P4|COMPLETED|Washout Between Periods 3 and 4||5
8133638|NCT02777827|20049010|P3|COMPLETED|Washout Between Periods 3 and 4||4
8133639|NCT02777827|20049011|P2|COMPLETED|Washout Between Periods 3 and 4||5
8133640|NCT02777827|20049012|P1|COMPLETED|Washout Between Periods 3 and 4||5
8133641|NCT02777827|20049007|P6|STARTED|Washout Between Periods 3 and 4||6
8133642|NCT02777827|20049008|P5|STARTED|Washout Between Periods 3 and 4||4
8133643|NCT02777827|20049009|P4|STARTED|Washout Between Periods 3 and 4||5
8133644|NCT02777827|20049010|P3|STARTED|Washout Between Periods 3 and 4||5
8133645|NCT02777827|20049011|P2|STARTED|Washout Between Periods 3 and 4||5
8133646|NCT02777827|20049012|P1|STARTED|Washout Between Periods 3 and 4||5
8133647|NCT02777827|20049007|P6|NOT COMPLETED|Treatment Period 3||0
8133648|NCT02777827|20049008|P5|NOT COMPLETED|Treatment Period 3||0
8133649|NCT02777827|20049009|P4|NOT COMPLETED|Treatment Period 3||0
8133650|NCT02777827|20049010|P3|NOT COMPLETED|Treatment Period 3||0
8133651|NCT02777827|20049011|P2|NOT COMPLETED|Treatment Period 3||0
8133652|NCT02777827|20049012|P1|NOT COMPLETED|Treatment Period 3||0
8133653|NCT02777827|20049007|P6|COMPLETED|Treatment Period 3||6
8133654|NCT02777827|20049008|P5|COMPLETED|Treatment Period 3||4
8133655|NCT02777827|20049009|P4|COMPLETED|Treatment Period 3||5
8133656|NCT02777827|20049010|P3|COMPLETED|Treatment Period 3||5
8133657|NCT02777827|20049011|P2|COMPLETED|Treatment Period 3||5
8133658|NCT02777827|20049012|P1|COMPLETED|Treatment Period 3||5
8133659|NCT02777827|20049007|P6|STARTED|Treatment Period 3||6
8133660|NCT02777827|20049008|P5|STARTED|Treatment Period 3||4
8133661|NCT02777827|20049009|P4|STARTED|Treatment Period 3||5
8133662|NCT02777827|20049010|P3|STARTED|Treatment Period 3||5
8133663|NCT02777827|20049011|P2|STARTED|Treatment Period 3||5
8133664|NCT02777827|20049012|P1|STARTED|Treatment Period 3||5
8133665|NCT02777827|20049007|P6|NOT COMPLETED|Washout Between Periods 2 and 3||0
8133666|NCT02777827|20049008|P5|NOT COMPLETED|Washout Between Periods 2 and 3||0
8133667|NCT02777827|20049009|P4|NOT COMPLETED|Washout Between Periods 2 and 3||0
8133668|NCT02777827|20049010|P3|NOT COMPLETED|Washout Between Periods 2 and 3||0
8133669|NCT02777827|20049011|P2|NOT COMPLETED|Washout Between Periods 2 and 3||0
8133670|NCT02777827|20049012|P1|NOT COMPLETED|Washout Between Periods 2 and 3||0
8133671|NCT02777827|20049007|P6|COMPLETED|Washout Between Periods 2 and 3||6
8133672|NCT02777827|20049008|P5|COMPLETED|Washout Between Periods 2 and 3||4
8133673|NCT02777827|20049009|P4|COMPLETED|Washout Between Periods 2 and 3||5
8133674|NCT02777827|20049010|P3|COMPLETED|Washout Between Periods 2 and 3||5
8133675|NCT02777827|20049011|P2|COMPLETED|Washout Between Periods 2 and 3||5
8133676|NCT02777827|20049012|P1|COMPLETED|Washout Between Periods 2 and 3||5
8133677|NCT02777827|20049007|P6|STARTED|Washout Between Periods 2 and 3||6
8133678|NCT02777827|20049008|P5|STARTED|Washout Between Periods 2 and 3||4
8133679|NCT02777827|20049009|P4|STARTED|Washout Between Periods 2 and 3||5
8133680|NCT02777827|20049010|P3|STARTED|Washout Between Periods 2 and 3||5
8133681|NCT02777827|20049011|P2|STARTED|Washout Between Periods 2 and 3||5
8133682|NCT02777827|20049012|P1|STARTED|Washout Between Periods 2 and 3||5
8133683|NCT02777827|20049007|P6|NOT COMPLETED|Treatment Period 2||0
8133684|NCT02777827|20049008|P5|NOT COMPLETED|Treatment Period 2||0
8133685|NCT02777827|20049009|P4|NOT COMPLETED|Treatment Period 2||0
8133686|NCT02777827|20049010|P3|NOT COMPLETED|Treatment Period 2||0
8133687|NCT02777827|20049011|P2|NOT COMPLETED|Treatment Period 2||0
8133688|NCT02777827|20049012|P1|NOT COMPLETED|Treatment Period 2||0
8133689|NCT02777827|20049007|P6|COMPLETED|Treatment Period 2||6
8133690|NCT02777827|20049008|P5|COMPLETED|Treatment Period 2||4
8133691|NCT02777827|20049009|P4|COMPLETED|Treatment Period 2||5
8133692|NCT02777827|20049010|P3|COMPLETED|Treatment Period 2||5
8133693|NCT02777827|20049011|P2|COMPLETED|Treatment Period 2||5
8133694|NCT02777827|20049012|P1|COMPLETED|Treatment Period 2||5
8133695|NCT02777827|20049007|P6|STARTED|Treatment Period 2||6
8133696|NCT02777827|20049008|P5|STARTED|Treatment Period 2||4
8133697|NCT02777827|20049009|P4|STARTED|Treatment Period 2||5
8133698|NCT02777827|20049010|P3|STARTED|Treatment Period 2||5
8133699|NCT02777827|20049011|P2|STARTED|Treatment Period 2||5
8133700|NCT02777827|20049012|P1|STARTED|Treatment Period 2||5
8133701|NCT02777827|20049007|P6|NOT COMPLETED|Washout Between Periods 1 and 2||0
8133702|NCT02777827|20049008|P5|NOT COMPLETED|Washout Between Periods 1 and 2||0
8133703|NCT02777827|20049009|P4|NOT COMPLETED|Washout Between Periods 1 and 2||0
8133704|NCT02777827|20049010|P3|NOT COMPLETED|Washout Between Periods 1 and 2||0
8133705|NCT02777827|20049011|P2|NOT COMPLETED|Washout Between Periods 1 and 2||0
8133706|NCT02777827|20049012|P1|NOT COMPLETED|Washout Between Periods 1 and 2||0
8133707|NCT02777827|20049007|P6|COMPLETED|Washout Between Periods 1 and 2||6
8133708|NCT02777827|20049008|P5|COMPLETED|Washout Between Periods 1 and 2||4
8133709|NCT02777827|20049009|P4|COMPLETED|Washout Between Periods 1 and 2||5
8133710|NCT02777827|20049010|P3|COMPLETED|Washout Between Periods 1 and 2||5
8133711|NCT02777827|20049011|P2|COMPLETED|Washout Between Periods 1 and 2||5
8133712|NCT02777827|20049012|P1|COMPLETED|Washout Between Periods 1 and 2||5
8133713|NCT02777827|20049007|P6|STARTED|Washout Between Periods 1 and 2||6
8133714|NCT02777827|20049008|P5|STARTED|Washout Between Periods 1 and 2||4
8133715|NCT02777827|20049009|P4|STARTED|Washout Between Periods 1 and 2||5
8133716|NCT02777827|20049010|P3|STARTED|Washout Between Periods 1 and 2||5
8133717|NCT02777827|20049011|P2|STARTED|Washout Between Periods 1 and 2||5
8133718|NCT02777827|20049012|P1|STARTED|Washout Between Periods 1 and 2||5
8133719|NCT02777827|20049007|P6|NOT COMPLETED|Treatment Period 1||0
8133720|NCT02777827|20049008|P5|NOT COMPLETED|Treatment Period 1||0
8133721|NCT02777827|20049009|P4|NOT COMPLETED|Treatment Period 1||0
8133722|NCT02777827|20049010|P3|NOT COMPLETED|Treatment Period 1||0
8133723|NCT02777827|20049011|P2|NOT COMPLETED|Treatment Period 1||0
8133724|NCT02777827|20049012|P1|NOT COMPLETED|Treatment Period 1||0
8133725|NCT02777827|20049007|P6|COMPLETED|Treatment Period 1||6
8133726|NCT02777827|20049008|P5|COMPLETED|Treatment Period 1||4
8133727|NCT02777827|20049009|P4|COMPLETED|Treatment Period 1||5
8133728|NCT02777827|20049010|P3|COMPLETED|Treatment Period 1||5
8133729|NCT02777827|20049011|P2|COMPLETED|Treatment Period 1||5
8133730|NCT02777827|20049012|P1|COMPLETED|Treatment Period 1||5
8133731|NCT02777827|20049007|P6|STARTED|Treatment Period 1||6
8133732|NCT02777827|20049008|P5|STARTED|Treatment Period 1||4
8133733|NCT02777827|20049009|P4|STARTED|Treatment Period 1||5
8133734|NCT02777827|20049010|P3|STARTED|Treatment Period 1||5
8133735|NCT02777827|20049011|P2|STARTED|Treatment Period 1||5
8133736|NCT02777827|20049012|P1|STARTED|Treatment Period 1||5
8133737|NCT02777749|20049167|P3|NOT COMPLETED|Overall Study||0
8133738|NCT02777749|20049168|P2|NOT COMPLETED|Overall Study||0
8133739|NCT02777749|20049169|P1|NOT COMPLETED|Overall Study||0
8133740|NCT02777749|20049167|P3|COMPLETED|Overall Study||51
8133741|NCT02777749|20049168|P2|COMPLETED|Overall Study||51
8133742|NCT02777749|20049169|P1|COMPLETED|Overall Study||53
8133743|NCT02777749|20049167|P3|STARTED|Overall Study||51
8133744|NCT02777749|20049168|P2|STARTED|Overall Study||51
8133745|NCT02777749|20049169|P1|STARTED|Overall Study||53
8133746|NCT02777268|20049189|P1|NOT COMPLETED|Overall Study||0
8133747|NCT02777268|20049189|P1|COMPLETED|Overall Study||16
8133748|NCT02777268|20049189|P1|STARTED|Overall Study||16
8133749|NCT02777242|20049215|P1|NOT COMPLETED|Overall Study||6
8133750|NCT02777242|20049215|P1|COMPLETED|Overall Study||59
8133751|NCT02777242|20049215|P1|STARTED|Overall Study||65
8133752|NCT02777125|20049221|P2|NOT COMPLETED|Overall Study||47
8133753|NCT02777125|20049222|P1|NOT COMPLETED|Overall Study||43
8133754|NCT02777125|20049221|P2|COMPLETED|Overall Study||445
8133755|NCT02777125|20049222|P1|COMPLETED|Overall Study||445
8133756|NCT02777125|20049221|P2|STARTED|Overall Study||492
8133757|NCT02777125|20049222|P1|STARTED|Overall Study||488
8133758|NCT02777086|20049238|P2|NOT COMPLETED|Overall Study||99
8133759|NCT02777086|20049239|P1|NOT COMPLETED|Overall Study||96
8133760|NCT02777086|20049238|P2|COMPLETED|Overall Study||151
8133761|NCT02777086|20049239|P1|COMPLETED|Overall Study||165
8133762|NCT02777086|20049238|P2|STARTED|Overall Study||250
8133763|NCT02777086|20049239|P1|STARTED|Overall Study||261
8133764|NCT02777021|20049253|P2|NOT COMPLETED|Overall Study||17
8133765|NCT02777021|20049254|P1|NOT COMPLETED|Overall Study||17
8133766|NCT02777021|20049253|P2|COMPLETED|Overall Study||77
8133767|NCT02777021|20049254|P1|COMPLETED|Overall Study||43
8133768|NCT02777021|20049253|P2|STARTED|Overall Study||94
8133769|NCT02777021|20049254|P1|STARTED|Overall Study||60
8133770|NCT02776904|20049262|P2|NOT COMPLETED|Overall Study||0
8133771|NCT02776904|20049263|P1|NOT COMPLETED|Overall Study||0
8133772|NCT02776904|20049262|P2|COMPLETED|Overall Study||46
8133773|NCT02776904|20049263|P1|COMPLETED|Overall Study||281
8133774|NCT02776904|20049262|P2|ImPACT|Overall Study|ImPACT testing for the concussed subjects was completed for the clinical assessment (not research).|46
8133775|NCT02776904|20049263|P1|ImPACT|Overall Study||21
8133776|NCT02776904|20049262|P2|Gait Assessment|Overall Study||32
8133777|NCT02776904|20049263|P1|Gait Assessment|Overall Study||178
8133778|NCT02776904|20049262|P2|STARTED|Overall Study||46
8133779|NCT02776904|20049263|P1|STARTED|Overall Study||281
8133780|NCT02776774|20049277|P1|NOT COMPLETED|Overall Study||0
8133781|NCT02776774|20049277|P1|COMPLETED|Overall Study|Total after data cleaning|91
8133782|NCT02776774|20049277|P1|STARTED|Overall Study||91
8133783|NCT02776683|20049282|P2|NOT COMPLETED|Post-switch Period||43
8133784|NCT02776683|20049283|P1|NOT COMPLETED|Post-switch Period||0
8133785|NCT02776683|20049282|P2|COMPLETED|Post-switch Period||0
8133786|NCT02776683|20049283|P1|COMPLETED|Post-switch Period||0
8133787|NCT02776683|20049282|P2|STARTED|Post-switch Period|Entered into Switch Set|43
8133788|NCT02776683|20049283|P1|STARTED|Post-switch Period||0
8133789|NCT02776683|20049282|P2|NOT COMPLETED|Pre-switch Period||0
8133790|NCT02776683|20049283|P1|NOT COMPLETED|Pre-switch Period||80
8133791|NCT02776683|20049282|P2|COMPLETED|Pre-switch Period||0
8133792|NCT02776683|20049283|P1|COMPLETED|Pre-switch Period|Entered into Switch Set|43
8133793|NCT02776683|20049282|P2|STARTED|Pre-switch Period||0
8133794|NCT02776683|20049283|P1|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123
8133795|NCT02776670|20049294|P2|NOT COMPLETED|Overall Study||6
8133796|NCT02776670|20049295|P1|NOT COMPLETED|Overall Study||0
8133797|NCT02776670|20049294|P2|COMPLETED|Overall Study||108
8133798|NCT02776670|20049295|P1|COMPLETED|Overall Study||117
8133799|NCT02776670|20049294|P2|Safety Analysis Set|Overall Study||114
8133800|NCT02776670|20049295|P1|Safety Analysis Set|Overall Study||117
8133801|NCT02776670|20049294|P2|Per Protocol Analysis Set (PPS)|Overall Study||113
8133802|NCT02776670|20049295|P1|Per Protocol Analysis Set (PPS)|Overall Study||115
8133803|NCT02776670|20049294|P2|Full Analysis Set (FAS)|Overall Study||114
8133804|NCT02776670|20049295|P1|Full Analysis Set (FAS)|Overall Study||117
8133805|NCT02776670|20049294|P2|STARTED|Overall Study||114
8133806|NCT02776670|20049295|P1|STARTED|Overall Study||117
8133807|NCT02776644|20049309|P2|NOT COMPLETED|Overall Study||0
8133808|NCT02776644|20049310|P1|NOT COMPLETED|Overall Study||0
8133809|NCT02776644|20049309|P2|COMPLETED|Overall Study||126
8133810|NCT02776644|20049310|P1|COMPLETED|Overall Study||1223
8133811|NCT02776644|20049309|P2|STARTED|Overall Study||126
8133812|NCT02776644|20049310|P1|STARTED|Overall Study||1223
8133813|NCT02776553|20049352|P2|NOT COMPLETED|Overall Study||3
8133814|NCT02776553|20049353|P1|NOT COMPLETED|Overall Study||3
8133815|NCT02776553|20049352|P2|COMPLETED|Overall Study||5
8133816|NCT02776553|20049353|P1|COMPLETED|Overall Study||6
8133817|NCT02776553|20049352|P2|STARTED|Overall Study|Two subjects were eliminated for repeated hospitalizations.|8
8133818|NCT02776553|20049353|P1|STARTED|Overall Study|One subject was eliminated for repeated hospitalizations.|9
8133819|NCT02776033|20049366|P3|NOT COMPLETED|Overall Study||2
8133820|NCT02776033|20049367|P2|NOT COMPLETED|Overall Study||2
8133821|NCT02776033|20049368|P1|NOT COMPLETED|Overall Study||4
8133822|NCT02776033|20049366|P3|COMPLETED|Overall Study||22
8133823|NCT02776033|20049367|P2|COMPLETED|Overall Study||21
8133824|NCT02776033|20049368|P1|COMPLETED|Overall Study||14
8133825|NCT02776033|20049366|P3|STARTED|Overall Study||24
8133826|NCT02776033|20049367|P2|STARTED|Overall Study||23
8133827|NCT02776033|20049368|P1|STARTED|Overall Study||18
8133828|NCT02775916|20049433|P2|NOT COMPLETED|Overall Study||0
8133829|NCT02775916|20049434|P1|NOT COMPLETED|Overall Study||3
8133830|NCT02775916|20049433|P2|COMPLETED|Overall Study||10
8133831|NCT02775916|20049434|P1|COMPLETED|Overall Study||17
8133832|NCT02775916|20049433|P2|STARTED|Overall Study||10
8133833|NCT02775916|20049434|P1|STARTED|Overall Study||20
8133850|NCT02775864|20049511|P4|NOT COMPLETED|Overall Study||2084
8133851|NCT02775864|20049512|P3|NOT COMPLETED|Overall Study||1860
8133852|NCT02775864|20049513|P2|NOT COMPLETED|Overall Study||4899
8133853|NCT02775864|20049514|P1|NOT COMPLETED|Overall Study||3242
8133854|NCT02775864|20049511|P4|COMPLETED|Overall Study||10765
8133855|NCT02775864|20049512|P3|COMPLETED|Overall Study||10081
8133856|NCT02775864|20049513|P2|COMPLETED|Overall Study||26218
8133857|NCT02775864|20049514|P1|COMPLETED|Overall Study||22772
8133858|NCT02775864|20049511|P4|STARTED|Overall Study||12849
8133859|NCT02775864|20049512|P3|STARTED|Overall Study||11941
8133860|NCT02775864|20049513|P2|STARTED|Overall Study||31117
8133861|NCT02775864|20049514|P1|STARTED|Overall Study||26014
8133862|NCT02775617|20049534|P2|NOT COMPLETED|Overall Study||160
8133863|NCT02775617|20049535|P1|NOT COMPLETED|Overall Study||48
8133864|NCT02775617|20049534|P2|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478
8133865|NCT02775617|20049535|P1|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605
8133866|NCT02775617|20049534|P2|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638
8133867|NCT02775617|20049535|P1|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653
8133868|NCT02775435|20049547|P2|NOT COMPLETED|Overall Study||281
8133869|NCT02775435|20049548|P1|NOT COMPLETED|Overall Study||278
8133870|NCT02775435|20049547|P2|COMPLETED|Overall Study||0
8133871|NCT02775435|20049548|P1|COMPLETED|Overall Study||0
8133872|NCT02775435|20049547|P2|Switched to Pembrolizumab+Chemotherapy|Overall Study||75
8133873|NCT02775435|20049548|P1|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
8133874|NCT02775435|20049547|P2|Treated|Overall Study||280
8133875|NCT02775435|20049548|P1|Treated|Overall Study||278
8133876|NCT02775435|20049547|P2|STARTED|Overall Study||281
8133877|NCT02775435|20049548|P1|STARTED|Overall Study||278
8133878|NCT02775344|20049566|P2|NOT COMPLETED|Overall Study||2
8133879|NCT02775344|20049567|P1|NOT COMPLETED|Overall Study||3
8133880|NCT02775344|20049566|P2|COMPLETED|Overall Study||38
8133881|NCT02775344|20049567|P1|COMPLETED|Overall Study||37
8133882|NCT02775344|20049566|P2|STARTED|Overall Study||40
8133883|NCT02775344|20049567|P1|STARTED|Overall Study||40
8133889|NCT02774941|20049650|P2|NOT COMPLETED|Overall Study||2
8133890|NCT02774941|20049651|P1|NOT COMPLETED|Overall Study||1
8133891|NCT02774941|20049650|P2|COMPLETED|Overall Study||108
8133892|NCT02774941|20049651|P1|COMPLETED|Overall Study||109
8133893|NCT02774941|20049650|P2|Subjects Excluded|Overall Study||2
8133894|NCT02774941|20049651|P1|Subjects Excluded|Overall Study||1
8133895|NCT02774941|20049650|P2|STARTED|Overall Study||110
8133896|NCT02774941|20049651|P1|STARTED|Overall Study||110
8133897|NCT02774850|20049661|P1|NOT COMPLETED|Overall Study||35
8133898|NCT02774850|20049661|P1|COMPLETED|Overall Study||575
8133899|NCT02774850|20049661|P1|Early Discharge Eligible at Int III|Overall Study|7 of these patients were managed as outpatients. 37 were managed as inpatients.|44
8133900|NCT02774850|20049661|P1|Intensification III|Overall Study||48
8133901|NCT02774850|20049661|P1|Early Discharge Eligible at Int II|Overall Study|56 of these patients were managed as outpatients. 229 were managed as inpatients.|285
8133902|NCT02774850|20049661|P1|Intensification II|Overall Study||342
8133903|NCT02774850|20049661|P1|Early Discharge Eligible at Int I|Overall Study|104 of these patients were managed as outpatients. 270 were managed as inpatients.|374
8133904|NCT02774850|20049661|P1|Intensification I|Overall Study||476
8133905|NCT02774850|20049661|P1|Early Discharge Eligible at Induction II|Overall Study|114 of these patients were managed as outpatients. 379 were managed as inpatients.|493
8133906|NCT02774850|20049661|P1|Induction II|Overall Study||564
8133907|NCT02774850|20049661|P1|Early Discharge Eligible at Induction I|Overall Study|24 of these patients were managed as outpatients. 252 were managed as inpatients.|276
8133908|NCT02774850|20049661|P1|Induction I|Overall Study||585
8133909|NCT02774850|20049661|P1|STARTED|Overall Study||610
8133910|NCT02774798|20049672|P3|NOT COMPLETED|Overall Study||0
8133911|NCT02774798|20049673|P2|NOT COMPLETED|Overall Study||0
8133912|NCT02774798|20049674|P1|NOT COMPLETED|Overall Study||0
8133913|NCT02774798|20049672|P3|COMPLETED|Overall Study||7
8133914|NCT02774798|20049673|P2|COMPLETED|Overall Study||17
8133915|NCT02774798|20049674|P1|COMPLETED|Overall Study||7
8133916|NCT02774798|20049672|P3|STARTED|Overall Study||7
8133917|NCT02774798|20049673|P2|STARTED|Overall Study||17
8133918|NCT02774798|20049674|P1|STARTED|Overall Study||7
8133919|NCT02774681|20049700|P1|NOT COMPLETED|Follow-Up for 3 Years||12
8133920|NCT02774681|20049700|P1|COMPLETED|Follow-Up for 3 Years||0
8133921|NCT02774681|20049700|P1|STARTED|Follow-Up for 3 Years||12
8133922|NCT02774681|20049700|P1|NOT COMPLETED|Treatment on Study||7
8133923|NCT02774681|20049700|P1|COMPLETED|Treatment on Study||5
8133924|NCT02774681|20049700|P1|Went on to Start Cycle 3|Treatment on Study||5
8133925|NCT02774681|20049700|P1|Reached 1st Response/2 Cycles|Treatment on Study||10
8133926|NCT02774681|20049700|P1|STARTED|Treatment on Study||12
8133927|NCT02774616|20049712|P3|NOT COMPLETED|Overall Study||3
8133928|NCT02774616|20049713|P2|NOT COMPLETED|Overall Study||11
8133929|NCT02774616|20049714|P1|NOT COMPLETED|Overall Study||15
8133930|NCT02774616|20049712|P3|COMPLETED|Overall Study||13
8133931|NCT02774616|20049713|P2|COMPLETED|Overall Study||156
8133932|NCT02774616|20049714|P1|COMPLETED|Overall Study||80
8133933|NCT02774616|20049712|P3|Other|Overall Study||1
8133934|NCT02774616|20049713|P2|Other|Overall Study||4
8133935|NCT02774616|20049714|P1|Other|Overall Study||2
8133936|NCT02774616|20049712|P3|Device Explanted|Overall Study||1
8133937|NCT02774616|20049713|P2|Device Explanted|Overall Study||1
8133938|NCT02774616|20049714|P1|Device Explanted|Overall Study||2
8133939|NCT02774616|20049712|P3|Lost to FU|Overall Study||0
8133940|NCT02774616|20049713|P2|Lost to FU|Overall Study||0
8133941|NCT02774616|20049714|P1|Lost to FU|Overall Study||2
8133942|NCT02774616|20049712|P3|Withdrew Consent|Overall Study||0
8133943|NCT02774616|20049713|P2|Withdrew Consent|Overall Study||3
8133944|NCT02774616|20049714|P1|Withdrew Consent|Overall Study||3
8133945|NCT02774616|20049712|P3|Died|Overall Study||1
8133946|NCT02774616|20049713|P2|Died|Overall Study||3
8133947|NCT02774616|20049714|P1|Died|Overall Study||6
8133948|NCT02774616|20049712|P3|STARTED|Overall Study||16
8133949|NCT02774616|20049713|P2|STARTED|Overall Study||167
8133950|NCT02774616|20049714|P1|STARTED|Overall Study||95
8133951|NCT02774343|20049727|P2|NOT COMPLETED|Overall Study||3
8133952|NCT02774343|20049728|P1|NOT COMPLETED|Overall Study||6
8133953|NCT02774343|20049727|P2|COMPLETED|Overall Study||12
8133954|NCT02774343|20049728|P1|COMPLETED|Overall Study||9
8133955|NCT02774343|20049727|P2|Received at Least One Capsule|Overall Study||14
8133956|NCT02774343|20049728|P1|Received at Least One Capsule|Overall Study||12
8133957|NCT02774343|20049727|P2|STARTED|Overall Study||15
8133958|NCT02774343|20049728|P1|STARTED|Overall Study||15
8133959|NCT02774278|20049764|P1|NOT COMPLETED|Overall Study||264
8133960|NCT02774278|20049764|P1|COMPLETED|Overall Study||0
8133961|NCT02774278|20049764|P1|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
8133962|NCT02774278|20049764|P1|STARTED|Overall Study||264
8133963|NCT02774265|20049774|P2|NOT COMPLETED|Overall Study||6
8133964|NCT02774265|20049775|P1|NOT COMPLETED|Overall Study||13
8133965|NCT02774265|20049774|P2|COMPLETED|Overall Study||159
8133966|NCT02774265|20049775|P1|COMPLETED|Overall Study||151
8133967|NCT02774265|20049774|P2|STARTED|Overall Study||165
8133968|NCT02774265|20049775|P1|STARTED|Overall Study||164
8133969|NCT02774213|20049785|P1|NOT COMPLETED|Overall Study||19
8133970|NCT02774213|20049785|P1|COMPLETED|Overall Study||55
8133971|NCT02774213|20049785|P1|STARTED|Overall Study||74
8133972|NCT02774148|20049798|P2|NOT COMPLETED|Overall Study||0
8133973|NCT02774148|20049799|P1|NOT COMPLETED|Overall Study||0
8133974|NCT02774148|20049798|P2|COMPLETED|Overall Study||0
8133975|NCT02774148|20049799|P1|COMPLETED|Overall Study||0
8133976|NCT02774148|20049798|P2|STARTED|Overall Study||0
8133977|NCT02774148|20049799|P1|STARTED|Overall Study||0
8133978|NCT02773836|20049819|P6|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8133979|NCT02773836|20049820|P5|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8133980|NCT02773836|20049821|P4|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8133981|NCT02773836|20049822|P3|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8133982|NCT02773836|20049823|P2|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8133983|NCT02773836|20049824|P1|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
8133984|NCT02773836|20049819|P6|COMPLETED|Wave 2- Post-TPD Implementation||998
8133985|NCT02773836|20049820|P5|COMPLETED|Wave 2- Post-TPD Implementation||1002
8133986|NCT02773836|20049821|P4|COMPLETED|Wave 2- Post-TPD Implementation||1010
8133987|NCT02773836|20049822|P3|COMPLETED|Wave 2- Post-TPD Implementation||1003
8133988|NCT02773836|20049823|P2|COMPLETED|Wave 2- Post-TPD Implementation||1013
8133989|NCT02773836|20049824|P1|COMPLETED|Wave 2- Post-TPD Implementation||1010
8133990|NCT02773836|20049819|P6|STARTED|Wave 2- Post-TPD Implementation||998
8133991|NCT02773836|20049820|P5|STARTED|Wave 2- Post-TPD Implementation||1002
8133992|NCT02773836|20049821|P4|STARTED|Wave 2- Post-TPD Implementation||1010
8133993|NCT02773836|20049822|P3|STARTED|Wave 2- Post-TPD Implementation||1003
8133994|NCT02773836|20049823|P2|STARTED|Wave 2- Post-TPD Implementation||1013
8133995|NCT02773836|20049824|P1|STARTED|Wave 2- Post-TPD Implementation||1010
8133996|NCT02773836|20049819|P6|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8133997|NCT02773836|20049820|P5|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8133998|NCT02773836|20049821|P4|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8133999|NCT02773836|20049822|P3|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8134000|NCT02773836|20049823|P2|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8134001|NCT02773836|20049824|P1|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
8134002|NCT02773836|20049819|P6|COMPLETED|Wave 1- Pre-TPD Implementation||1006
8134003|NCT02773836|20049820|P5|COMPLETED|Wave 1- Pre-TPD Implementation||1000
8134004|NCT02773836|20049821|P4|COMPLETED|Wave 1- Pre-TPD Implementation||1001
8134005|NCT02773836|20049822|P3|COMPLETED|Wave 1- Pre-TPD Implementation||1001
8134006|NCT02773836|20049823|P2|COMPLETED|Wave 1- Pre-TPD Implementation||1003
8134007|NCT02773836|20049824|P1|COMPLETED|Wave 1- Pre-TPD Implementation||1000
8134008|NCT02773836|20049819|P6|STARTED|Wave 1- Pre-TPD Implementation||1006
8134009|NCT02773836|20049820|P5|STARTED|Wave 1- Pre-TPD Implementation||1000
8134010|NCT02773836|20049821|P4|STARTED|Wave 1- Pre-TPD Implementation||1001
8134011|NCT02773836|20049822|P3|STARTED|Wave 1- Pre-TPD Implementation||1001
8134012|NCT02773836|20049823|P2|STARTED|Wave 1- Pre-TPD Implementation||1003
8134013|NCT02773836|20049824|P1|STARTED|Wave 1- Pre-TPD Implementation||1000
8134014|NCT02773758|20049912|P2|NOT COMPLETED|Overall Study||0
8134015|NCT02773758|20049913|P1|NOT COMPLETED|Overall Study||0
8134016|NCT02773758|20049912|P2|COMPLETED|Overall Study||70
8134017|NCT02773758|20049913|P1|COMPLETED|Overall Study||71
8134018|NCT02773758|20049912|P2|STARTED|Overall Study||70
8134019|NCT02773758|20049913|P1|STARTED|Overall Study||71
8134020|NCT02773576|20049925|P2|NOT COMPLETED|Overall Study||0
8134021|NCT02773576|20049926|P1|NOT COMPLETED|Overall Study||0
8134022|NCT02773576|20049925|P2|COMPLETED|Overall Study||0
8134023|NCT02773576|20049926|P1|COMPLETED|Overall Study||0
8134024|NCT02773576|20049925|P2|STARTED|Overall Study||0
8134025|NCT02773576|20049926|P1|STARTED|Overall Study||0
8134026|NCT02773537|20049939|P3|NOT COMPLETED|Overall Study||4
8134027|NCT02773537|20049940|P2|NOT COMPLETED|Overall Study||1
8134028|NCT02773537|20049941|P1|NOT COMPLETED|Overall Study||0
8134029|NCT02773537|20049939|P3|COMPLETED|Overall Study||21
8134030|NCT02773537|20049940|P2|COMPLETED|Overall Study||24
8134031|NCT02773537|20049941|P1|COMPLETED|Overall Study||25
8134032|NCT02773537|20049939|P3|STARTED|Overall Study||25
8134033|NCT02773537|20049940|P2|STARTED|Overall Study||25
8134034|NCT02773537|20049941|P1|STARTED|Overall Study||25
8134035|NCT02773446|20049976|P6|NOT COMPLETED|Second Admission||0
8134036|NCT02773446|20049977|P5|NOT COMPLETED|Second Admission||0
8134037|NCT02773446|20049978|P4|NOT COMPLETED|Second Admission||0
8134038|NCT02773446|20049979|P3|NOT COMPLETED|Second Admission||0
8134039|NCT02773446|20049980|P2|NOT COMPLETED|Second Admission||0
8134040|NCT02773446|20049981|P1|NOT COMPLETED|Second Admission||0
8134041|NCT02773446|20049976|P6|COMPLETED|Second Admission||19
8134042|NCT02773446|20049977|P5|COMPLETED|Second Admission||11
8134043|NCT02773446|20049978|P4|COMPLETED|Second Admission||0
8134044|NCT02773446|20049979|P3|COMPLETED|Second Admission||0
8134045|NCT02773446|20049980|P2|COMPLETED|Second Admission||0
8134046|NCT02773446|20049981|P1|COMPLETED|Second Admission||0
8134047|NCT02773446|20049976|P6|STARTED|Second Admission||19
8134048|NCT02773446|20049977|P5|STARTED|Second Admission||11
8134049|NCT02773446|20049978|P4|STARTED|Second Admission||0
8134050|NCT02773446|20049979|P3|STARTED|Second Admission||0
8134051|NCT02773446|20049980|P2|STARTED|Second Admission||0
8134052|NCT02773446|20049981|P1|STARTED|Second Admission||0
8134053|NCT02773446|20049976|P6|NOT COMPLETED|First Admission||0
8134054|NCT02773446|20049977|P5|NOT COMPLETED|First Admission||0
8134055|NCT02773446|20049978|P4|NOT COMPLETED|First Admission||1
8134056|NCT02773446|20049979|P3|NOT COMPLETED|First Admission||0
8134057|NCT02773446|20049980|P2|NOT COMPLETED|First Admission||0
8134058|NCT02773446|20049981|P1|NOT COMPLETED|First Admission||1
8134059|NCT02773446|20049976|P6|COMPLETED|First Admission||0
8134060|NCT02773446|20049977|P5|COMPLETED|First Admission||0
8134061|NCT02773446|20049978|P4|COMPLETED|First Admission||6
8134062|NCT02773446|20049979|P3|COMPLETED|First Admission||7
8134063|NCT02773446|20049980|P2|COMPLETED|First Admission||7
8134064|NCT02773446|20049981|P1|COMPLETED|First Admission||6
8134065|NCT02773446|20049976|P6|STARTED|First Admission||0
8134066|NCT02773446|20049977|P5|STARTED|First Admission||0
8134067|NCT02773446|20049978|P4|STARTED|First Admission||7
8134068|NCT02773446|20049979|P3|STARTED|First Admission||7
8134069|NCT02773446|20049980|P2|STARTED|First Admission||7
8134070|NCT02773446|20049981|P1|STARTED|First Admission||7
8134071|NCT02773368|20050022|P2|NOT COMPLETED|Overall Study||4
8134072|NCT02773368|20050023|P1|NOT COMPLETED|Overall Study||10
8134073|NCT02773368|20050022|P2|COMPLETED|Overall Study||206
8134074|NCT02773368|20050023|P1|COMPLETED|Overall Study||200
8134075|NCT02773368|20050022|P2|Exposed|Overall Study||210
8134076|NCT02773368|20050023|P1|Exposed|Overall Study||209
8134077|NCT02773368|20050022|P2|STARTED|Overall Study||210
8134078|NCT02773368|20050023|P1|STARTED|Overall Study||210
8134079|NCT02772809|20050093|P1|NOT COMPLETED|Overall Study||6
8134080|NCT02772809|20050093|P1|COMPLETED|Overall Study||17
8134081|NCT02772809|20050093|P1|STARTED|Overall Study||23
8134082|NCT02772757|20050105|P3|NOT COMPLETED|Overall Study||5
8134083|NCT02772757|20050106|P2|NOT COMPLETED|Overall Study||3
8134084|NCT02772757|20050107|P1|NOT COMPLETED|Overall Study||1
8134085|NCT02772757|20050105|P3|COMPLETED|Overall Study||21
8134086|NCT02772757|20050106|P2|COMPLETED|Overall Study||21
8134087|NCT02772757|20050107|P1|COMPLETED|Overall Study||21
8134088|NCT02772757|20050105|P3|STARTED|Overall Study||26
8134089|NCT02772757|20050106|P2|STARTED|Overall Study||24
8134090|NCT02772757|20050107|P1|STARTED|Overall Study||22
8134091|NCT02772666|20050124|P1|NOT COMPLETED|SFT Then O-Glass||0
8134092|NCT02772666|20050124|P1|COMPLETED|SFT Then O-Glass||44
8134093|NCT02772666|20050124|P1|STARTED|SFT Then O-Glass||44
8134094|NCT02772666|20050124|P1|NOT COMPLETED|O-Glas Then SFT||0
8134095|NCT02772666|20050124|P1|COMPLETED|O-Glas Then SFT||44
8134096|NCT02772666|20050124|P1|STARTED|O-Glas Then SFT||44
8134097|NCT02772432|20050131|P2|NOT COMPLETED|Overall Study||1
8134098|NCT02772432|20050132|P1|NOT COMPLETED|Overall Study||12
8134099|NCT02772432|20050131|P2|COMPLETED|Overall Study||21
8134100|NCT02772432|20050132|P1|COMPLETED|Overall Study||19
8134101|NCT02772432|20050131|P2|STARTED|Overall Study||22
8134102|NCT02772432|20050132|P1|STARTED|Overall Study||31
8134103|NCT02771574|20050147|P5|NOT COMPLETED|Liq Avexitide (3 Days)||0
8134104|NCT02771574|20050148|P4|NOT COMPLETED|Liq Avexitide (3 Days)||0
8134105|NCT02771574|20050149|P3|NOT COMPLETED|Liq Avexitide (3 Days)||0
8134106|NCT02771574|20050150|P2|NOT COMPLETED|Liq Avexitide (3 Days)||0
8134107|NCT02771574|20050151|P1|NOT COMPLETED|Liq Avexitide (3 Days)||0
8134108|NCT02771574|20050147|P5|COMPLETED|Liq Avexitide (3 Days)||5
8134109|NCT02771574|20050148|P4|COMPLETED|Liq Avexitide (3 Days)||0
8134110|NCT02771574|20050149|P3|COMPLETED|Liq Avexitide (3 Days)||0
8134111|NCT02771574|20050150|P2|COMPLETED|Liq Avexitide (3 Days)||0
8134112|NCT02771574|20050151|P1|COMPLETED|Liq Avexitide (3 Days)||0
8134113|NCT02771574|20050147|P5|STARTED|Liq Avexitide (3 Days)||5
8134114|NCT02771574|20050148|P4|STARTED|Liq Avexitide (3 Days)||0
8134115|NCT02771574|20050149|P3|STARTED|Liq Avexitide (3 Days)||0
8134116|NCT02771574|20050150|P2|STARTED|Liq Avexitide (3 Days)||0
8134117|NCT02771574|20050151|P1|STARTED|Liq Avexitide (3 Days)||0
8134118|NCT02771574|20050147|P5|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134119|NCT02771574|20050148|P4|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134120|NCT02771574|20050149|P3|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134121|NCT02771574|20050150|P2|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134122|NCT02771574|20050151|P1|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134123|NCT02771574|20050147|P5|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134124|NCT02771574|20050148|P4|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||3
8134125|NCT02771574|20050149|P3|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134126|NCT02771574|20050150|P2|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134127|NCT02771574|20050151|P1|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134128|NCT02771574|20050147|P5|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134129|NCT02771574|20050148|P4|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||3
8134130|NCT02771574|20050149|P3|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134131|NCT02771574|20050150|P2|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134132|NCT02771574|20050151|P1|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
8134133|NCT02771574|20050147|P5|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134134|NCT02771574|20050148|P4|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134135|NCT02771574|20050149|P3|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134136|NCT02771574|20050150|P2|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134137|NCT02771574|20050151|P1|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134138|NCT02771574|20050147|P5|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134139|NCT02771574|20050148|P4|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134140|NCT02771574|20050149|P3|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||3
8134141|NCT02771574|20050150|P2|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134142|NCT02771574|20050151|P1|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134143|NCT02771574|20050147|P5|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134144|NCT02771574|20050148|P4|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134145|NCT02771574|20050149|P3|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||3
8134146|NCT02771574|20050150|P2|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134147|NCT02771574|20050151|P1|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
8134148|NCT02771574|20050147|P5|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134149|NCT02771574|20050148|P4|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134150|NCT02771574|20050149|P3|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134151|NCT02771574|20050150|P2|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134152|NCT02771574|20050151|P1|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134153|NCT02771574|20050147|P5|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134154|NCT02771574|20050148|P4|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134155|NCT02771574|20050149|P3|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134156|NCT02771574|20050150|P2|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||5
8134157|NCT02771574|20050151|P1|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134158|NCT02771574|20050147|P5|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134159|NCT02771574|20050148|P4|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134160|NCT02771574|20050149|P3|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134161|NCT02771574|20050150|P2|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||5
8134162|NCT02771574|20050151|P1|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
8134163|NCT02771574|20050147|P5|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134164|NCT02771574|20050148|P4|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134165|NCT02771574|20050149|P3|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134166|NCT02771574|20050150|P2|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134167|NCT02771574|20050151|P1|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134168|NCT02771574|20050147|P5|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134169|NCT02771574|20050148|P4|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134170|NCT02771574|20050149|P3|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134171|NCT02771574|20050150|P2|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134172|NCT02771574|20050151|P1|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||3
8134173|NCT02771574|20050147|P5|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134174|NCT02771574|20050148|P4|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134175|NCT02771574|20050149|P3|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134176|NCT02771574|20050150|P2|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
8134177|NCT02771574|20050151|P1|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||3
8134178|NCT02771522|20050190|P1|NOT COMPLETED|Overall Study||8
8134179|NCT02771522|20050190|P1|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22
8134180|NCT02771522|20050190|P1|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30
8134181|NCT02771366|20050201|P2|NOT COMPLETED|Period 2 (Crossover)||0
8134182|NCT02771366|20050202|P1|NOT COMPLETED|Period 2 (Crossover)||2
8134183|NCT02771366|20050201|P2|COMPLETED|Period 2 (Crossover)||13
8134184|NCT02771366|20050202|P1|COMPLETED|Period 2 (Crossover)||13
8134185|NCT02771366|20050201|P2|STARTED|Period 2 (Crossover)||13
8134186|NCT02771366|20050202|P1|STARTED|Period 2 (Crossover)||15
8134187|NCT02771366|20050201|P2|NOT COMPLETED|Period 1||2
8134188|NCT02771366|20050202|P1|NOT COMPLETED|Period 1||0
8134189|NCT02771366|20050201|P2|COMPLETED|Period 1||13
8134190|NCT02771366|20050202|P1|COMPLETED|Period 1||15
8134191|NCT02771366|20050201|P2|STARTED|Period 1||15
8134192|NCT02771366|20050202|P1|STARTED|Period 1||15
8134193|NCT02771340|20050212|P3|NOT COMPLETED|Overall Study||0
8134194|NCT02771340|20050213|P2|NOT COMPLETED|Overall Study||0
8134195|NCT02771340|20050214|P1|NOT COMPLETED|Overall Study||0
8134196|NCT02771340|20050212|P3|COMPLETED|Overall Study||5
8134197|NCT02771340|20050213|P2|COMPLETED|Overall Study||3
8134198|NCT02771340|20050214|P1|COMPLETED|Overall Study||2
8134199|NCT02771340|20050212|P3|STARTED|Overall Study||5
8134200|NCT02771340|20050213|P2|STARTED|Overall Study||3
8134201|NCT02771340|20050214|P1|STARTED|Overall Study||2
8134202|NCT02771275|20050228|P1|NOT COMPLETED|Overall Study||13
8134203|NCT02771275|20050228|P1|COMPLETED|Overall Study||0
8134204|NCT02771275|20050228|P1|STARTED|Overall Study||13
8134217|NCT02771145|20050265|P1|NOT COMPLETED|Overall Study||4
8134218|NCT02771145|20050265|P1|COMPLETED|Overall Study||86
8134219|NCT02771145|20050265|P1|STARTED|Overall Study||90
8134220|NCT02771093|20050306|P2|NOT COMPLETED|Overall Study||0
8134221|NCT02771093|20050307|P1|NOT COMPLETED|Overall Study||0
8134222|NCT02771093|20050306|P2|COMPLETED|Overall Study||14
8134223|NCT02771093|20050307|P1|COMPLETED|Overall Study||13
8134224|NCT02771093|20050306|P2|STARTED|Overall Study||14
8134225|NCT02771093|20050307|P1|STARTED|Overall Study||13
8134226|NCT02770846|20050361|P2|NOT COMPLETED|Overall Study||0
8134227|NCT02770846|20050362|P1|NOT COMPLETED|Overall Study||0
8134228|NCT02770846|20050361|P2|COMPLETED|Overall Study||25
8134229|NCT02770846|20050362|P1|COMPLETED|Overall Study||25
8134230|NCT02770846|20050361|P2|STARTED|Overall Study||25
8134231|NCT02770846|20050362|P1|STARTED|Overall Study||25
8134232|NCT02770625|20050386|P1|NOT COMPLETED|Overall Study||0
8134233|NCT02770625|20050386|P1|COMPLETED|Overall Study||8
8134234|NCT02770625|20050386|P1|STARTED|Overall Study||8
8134235|NCT02770612|20050399|P1|NOT COMPLETED|Overall Study||1
8134236|NCT02770612|20050399|P1|COMPLETED|Overall Study||50
8134237|NCT02770612|20050399|P1|STARTED|Overall Study||51
8134238|NCT02770547|20050405|P2|NOT COMPLETED|Overall Study||1
8134239|NCT02770547|20050406|P1|NOT COMPLETED|Overall Study||1
8134240|NCT02770547|20050405|P2|COMPLETED|Overall Study||15
8134241|NCT02770547|20050406|P1|COMPLETED|Overall Study||15
8134242|NCT02770547|20050405|P2|STARTED|Overall Study||16
8134243|NCT02770547|20050406|P1|STARTED|Overall Study||16
8134244|NCT02770521|20050428|P6|NOT COMPLETED|Period Three||0
8134245|NCT02770521|20050429|P5|NOT COMPLETED|Period Three||0
8134246|NCT02770521|20050430|P4|NOT COMPLETED|Period Three||0
8134247|NCT02770521|20050431|P3|NOT COMPLETED|Period Three||0
8134248|NCT02770521|20050432|P2|NOT COMPLETED|Period Three||0
8134249|NCT02770521|20050433|P1|NOT COMPLETED|Period Three||0
8134250|NCT02770521|20050428|P6|COMPLETED|Period Three||9
8134251|NCT02770521|20050429|P5|COMPLETED|Period Three||2
8134252|NCT02770521|20050430|P4|COMPLETED|Period Three||2
8134253|NCT02770521|20050431|P3|COMPLETED|Period Three||2
8134254|NCT02770521|20050432|P2|COMPLETED|Period Three||0
8134255|NCT02770521|20050433|P1|COMPLETED|Period Three||0
8134256|NCT02770521|20050428|P6|Received Study Drug|Period Three||9
8134257|NCT02770521|20050429|P5|Received Study Drug|Period Three||2
8134258|NCT02770521|20050430|P4|Received Study Drug|Period Three||2
8134259|NCT02770521|20050431|P3|Received Study Drug|Period Three||2
8134260|NCT02770521|20050432|P2|Received Study Drug|Period Three||0
8134261|NCT02770521|20050433|P1|Received Study Drug|Period Three||0
8134262|NCT02770521|20050428|P6|STARTED|Period Three||9
8134263|NCT02770521|20050429|P5|STARTED|Period Three||2
8134264|NCT02770521|20050430|P4|STARTED|Period Three||2
8134265|NCT02770521|20050431|P3|STARTED|Period Three||2
8134266|NCT02770521|20050432|P2|STARTED|Period Three|Not applicable. Part A only had two periods.|0
8134267|NCT02770521|20050433|P1|STARTED|Period Three|Not applicable. Part A only had two periods.|0
8134268|NCT02770521|20050428|P6|NOT COMPLETED|Period Two||0
8134269|NCT02770521|20050429|P5|NOT COMPLETED|Period Two||0
8134270|NCT02770521|20050430|P4|NOT COMPLETED|Period Two||0
8134271|NCT02770521|20050431|P3|NOT COMPLETED|Period Two||0
8134272|NCT02770521|20050432|P2|NOT COMPLETED|Period Two||0
8134273|NCT02770521|20050433|P1|NOT COMPLETED|Period Two||0
8134274|NCT02770521|20050428|P6|COMPLETED|Period Two||9
8134275|NCT02770521|20050429|P5|COMPLETED|Period Two||2
8134276|NCT02770521|20050430|P4|COMPLETED|Period Two||2
8134277|NCT02770521|20050431|P3|COMPLETED|Period Two||2
8134278|NCT02770521|20050432|P2|COMPLETED|Period Two||4
8134279|NCT02770521|20050433|P1|COMPLETED|Period Two||4
8134280|NCT02770521|20050428|P6|Received Study Drug|Period Two||9
8134281|NCT02770521|20050429|P5|Received Study Drug|Period Two||2
8134282|NCT02770521|20050430|P4|Received Study Drug|Period Two||2
8134283|NCT02770521|20050431|P3|Received Study Drug|Period Two||2
8134284|NCT02770521|20050432|P2|Received Study Drug|Period Two||4
8134285|NCT02770521|20050433|P1|Received Study Drug|Period Two||4
8134286|NCT02770521|20050428|P6|STARTED|Period Two||9
8134287|NCT02770521|20050429|P5|STARTED|Period Two||2
8134288|NCT02770521|20050430|P4|STARTED|Period Two||2
8134289|NCT02770521|20050431|P3|STARTED|Period Two||2
8134290|NCT02770521|20050432|P2|STARTED|Period Two||4
8134291|NCT02770521|20050433|P1|STARTED|Period Two||4
8134292|NCT02770521|20050428|P6|NOT COMPLETED|Period One||0
8134293|NCT02770521|20050429|P5|NOT COMPLETED|Period One||0
8134294|NCT02770521|20050430|P4|NOT COMPLETED|Period One||0
8134295|NCT02770521|20050431|P3|NOT COMPLETED|Period One||0
8134296|NCT02770521|20050432|P2|NOT COMPLETED|Period One||0
8134297|NCT02770521|20050433|P1|NOT COMPLETED|Period One||0
8134298|NCT02770521|20050428|P6|COMPLETED|Period One||9
8134299|NCT02770521|20050429|P5|COMPLETED|Period One||2
8134300|NCT02770521|20050430|P4|COMPLETED|Period One||2
8134301|NCT02770521|20050431|P3|COMPLETED|Period One||2
8134302|NCT02770521|20050432|P2|COMPLETED|Period One||4
8134303|NCT02770521|20050433|P1|COMPLETED|Period One||4
8134304|NCT02770521|20050428|P6|Received Study Drug|Period One||9
8134305|NCT02770521|20050429|P5|Received Study Drug|Period One||2
8134306|NCT02770521|20050430|P4|Received Study Drug|Period One||2
8134307|NCT02770521|20050431|P3|Received Study Drug|Period One||2
8134308|NCT02770521|20050432|P2|Received Study Drug|Period One||4
8134309|NCT02770521|20050433|P1|Received Study Drug|Period One||4
8134310|NCT02770521|20050428|P6|STARTED|Period One||9
8134311|NCT02770521|20050429|P5|STARTED|Period One||2
8134312|NCT02770521|20050430|P4|STARTED|Period One||2
8134313|NCT02770521|20050431|P3|STARTED|Period One||2
8134314|NCT02770521|20050432|P2|STARTED|Period One||4
8134315|NCT02770521|20050433|P1|STARTED|Period One||4
8134316|NCT02770365|20050458|P3|NOT COMPLETED|Overall Study||0
8134317|NCT02770365|20050459|P2|NOT COMPLETED|Overall Study||4
8134318|NCT02770365|20050460|P1|NOT COMPLETED|Overall Study||5
8134319|NCT02770365|20050458|P3|COMPLETED|Overall Study||139
8134320|NCT02770365|20050459|P2|COMPLETED|Overall Study||275
8134321|NCT02770365|20050460|P1|COMPLETED|Overall Study||272
8134322|NCT02770365|20050458|P3|STARTED|Overall Study||139
8134323|NCT02770365|20050459|P2|STARTED|Overall Study||279
8134324|NCT02770365|20050460|P1|STARTED|Overall Study||277
8134325|NCT02770287|20050470|P1|NOT COMPLETED|Overall Study||0
8134326|NCT02770287|20050470|P1|COMPLETED|Overall Study||11
8134327|NCT02770287|20050470|P1|STARTED|Overall Study||11
8134328|NCT02770248|20050479|P2|NOT COMPLETED|Overall Study||2
8134329|NCT02770248|20050480|P1|NOT COMPLETED|Overall Study||0
8134330|NCT02770248|20050479|P2|COMPLETED|Overall Study||61
8134331|NCT02770248|20050480|P1|COMPLETED|Overall Study||62
8134332|NCT02770248|20050479|P2|STARTED|Overall Study||63
8134333|NCT02770248|20050480|P1|STARTED|Overall Study||62
8134334|NCT02770014|20050492|P1|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5
8134335|NCT02770014|20050492|P1|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6
8134336|NCT02770014|20050492|P1|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11
8134337|NCT02770014|20050492|P1|NOT COMPLETED|Plasma Genotyping||0
8134338|NCT02770014|20050492|P1|COMPLETED|Plasma Genotyping||43
8134339|NCT02770014|20050492|P1|STARTED|Plasma Genotyping||43
8134343|NCT02769702|20050504|P1|NOT COMPLETED|Overall Study||0
8134344|NCT02769702|20050504|P1|COMPLETED|Overall Study||2
8134345|NCT02769702|20050504|P1|STARTED|Overall Study||2
8134346|NCT02769624|20050509|P2|NOT COMPLETED|Overall Study||1
8134347|NCT02769624|20050510|P1|NOT COMPLETED|Overall Study||0
8134348|NCT02769624|20050509|P2|COMPLETED|Overall Study||7
8134349|NCT02769624|20050510|P1|COMPLETED|Overall Study||7
8134350|NCT02769624|20050509|P2|STARTED|Overall Study||8
8134351|NCT02769624|20050510|P1|STARTED|Overall Study||7
8134352|NCT02769442|20050528|P2|NOT COMPLETED|Overall Study||0
8134353|NCT02769442|20050529|P1|NOT COMPLETED|Overall Study||0
8134354|NCT02769442|20050528|P2|COMPLETED|Overall Study||291
8134355|NCT02769442|20050529|P1|COMPLETED|Overall Study||309
8134356|NCT02769442|20050528|P2|STARTED|Overall Study||291
8134357|NCT02769442|20050529|P1|STARTED|Overall Study||309
8134358|NCT02769312|20050539|P2|NOT COMPLETED|Follow-up||1
8134359|NCT02769312|20050540|P1|NOT COMPLETED|Follow-up||1
8134360|NCT02769312|20050539|P2|COMPLETED|Follow-up||23
8134361|NCT02769312|20050540|P1|COMPLETED|Follow-up||22
8134362|NCT02769312|20050539|P2|STARTED|Follow-up||24
8134363|NCT02769312|20050540|P1|STARTED|Follow-up||23
8134364|NCT02769312|20050539|P2|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
8134365|NCT02769312|20050540|P1|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
8134366|NCT02769312|20050539|P2|COMPLETED|Unblinded (Optional 2-4 Weeks)||23
8134367|NCT02769312|20050540|P1|COMPLETED|Unblinded (Optional 2-4 Weeks)||20
8134368|NCT02769312|20050539|P2|STARTED|Unblinded (Optional 2-4 Weeks)||24
8134369|NCT02769312|20050540|P1|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21
8134370|NCT02769312|20050539|P2|NOT COMPLETED|Double-Blind (0-2 Weeks)||1
8134371|NCT02769312|20050540|P1|NOT COMPLETED|Double-Blind (0-2 Weeks)||2
8134372|NCT02769312|20050539|P2|COMPLETED|Double-Blind (0-2 Weeks)||24
8134373|NCT02769312|20050540|P1|COMPLETED|Double-Blind (0-2 Weeks)||23
8134374|NCT02769312|20050539|P2|STARTED|Double-Blind (0-2 Weeks)||25
8134375|NCT02769312|20050540|P1|STARTED|Double-Blind (0-2 Weeks)||25
8134376|NCT02769247|20050557|P4|NOT COMPLETED|Overall Study||1
8134377|NCT02769247|20050558|P3|NOT COMPLETED|Overall Study||1
8134378|NCT02769247|20050559|P2|NOT COMPLETED|Overall Study||0
8134379|NCT02769247|20050560|P1|NOT COMPLETED|Overall Study||2
8134380|NCT02769247|20050557|P4|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
8134381|NCT02769247|20050558|P3|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
8134382|NCT02769247|20050559|P2|COMPLETED|Overall Study||40
8134383|NCT02769247|20050560|P1|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
8134384|NCT02769247|20050557|P4|STARTED|Overall Study||40
8134385|NCT02769247|20050558|P3|STARTED|Overall Study||40
8134386|NCT02769247|20050559|P2|STARTED|Overall Study||40
8134387|NCT02769247|20050560|P1|STARTED|Overall Study||40
8134388|NCT02769065|20050628|P30|NOT COMPLETED|Overall Study||0
8134389|NCT02769065|20050629|P29|NOT COMPLETED|Overall Study||0
8134390|NCT02769065|20050630|P28|NOT COMPLETED|Overall Study||0
8134391|NCT02769065|20050631|P27|NOT COMPLETED|Overall Study||0
8134392|NCT02769065|20050632|P26|NOT COMPLETED|Overall Study||0
8134393|NCT02769065|20050633|P25|NOT COMPLETED|Overall Study||0
8134394|NCT02769065|20050634|P24|NOT COMPLETED|Overall Study||0
8134395|NCT02769065|20050635|P23|NOT COMPLETED|Overall Study||0
8134396|NCT02769065|20050636|P22|NOT COMPLETED|Overall Study||0
8134397|NCT02769065|20050637|P21|NOT COMPLETED|Overall Study||0
8134398|NCT02769065|20050638|P20|NOT COMPLETED|Overall Study||0
8134399|NCT02769065|20050639|P19|NOT COMPLETED|Overall Study||0
8134400|NCT02769065|20050640|P18|NOT COMPLETED|Overall Study||0
8134401|NCT02769065|20050641|P17|NOT COMPLETED|Overall Study||0
8134402|NCT02769065|20050642|P16|NOT COMPLETED|Overall Study||0
8134403|NCT02769065|20050643|P15|NOT COMPLETED|Overall Study||0
8134404|NCT02769065|20050644|P14|NOT COMPLETED|Overall Study||0
8134405|NCT02769065|20050645|P13|NOT COMPLETED|Overall Study||0
8134406|NCT02769065|20050646|P12|NOT COMPLETED|Overall Study||0
8134407|NCT02769065|20050647|P11|NOT COMPLETED|Overall Study||1
8134408|NCT02769065|20050648|P10|NOT COMPLETED|Overall Study||0
8134409|NCT02769065|20050649|P9|NOT COMPLETED|Overall Study||0
8134410|NCT02769065|20050650|P8|NOT COMPLETED|Overall Study||0
8134411|NCT02769065|20050651|P7|NOT COMPLETED|Overall Study||1
8134412|NCT02769065|20050652|P6|NOT COMPLETED|Overall Study||0
8134413|NCT02769065|20050653|P5|NOT COMPLETED|Overall Study||0
8134414|NCT02769065|20050654|P4|NOT COMPLETED|Overall Study||0
8134415|NCT02769065|20050655|P3|NOT COMPLETED|Overall Study||0
8134416|NCT02769065|20050656|P2|NOT COMPLETED|Overall Study||0
8134417|NCT02769065|20050657|P1|NOT COMPLETED|Overall Study||1
8134418|NCT02769065|20050628|P30|COMPLETED|Overall Study||6
8134419|NCT02769065|20050629|P29|COMPLETED|Overall Study||6
8134420|NCT02769065|20050630|P28|COMPLETED|Overall Study||5
8134421|NCT02769065|20050631|P27|COMPLETED|Overall Study||9
8134422|NCT02769065|20050632|P26|COMPLETED|Overall Study||9
8134423|NCT02769065|20050633|P25|COMPLETED|Overall Study||6
8134424|NCT02769065|20050634|P24|COMPLETED|Overall Study||6
8134425|NCT02769065|20050635|P23|COMPLETED|Overall Study||4
8134426|NCT02769065|20050636|P22|COMPLETED|Overall Study||4
8134427|NCT02769065|20050637|P21|COMPLETED|Overall Study||4
8134428|NCT02769065|20050638|P20|COMPLETED|Overall Study||0
8134429|NCT02769065|20050639|P19|COMPLETED|Overall Study||5
8134430|NCT02769065|20050640|P18|COMPLETED|Overall Study||5
8134431|NCT02769065|20050641|P17|COMPLETED|Overall Study||5
8134432|NCT02769065|20050642|P16|COMPLETED|Overall Study||3
8134433|NCT02769065|20050643|P15|COMPLETED|Overall Study||6
8134434|NCT02769065|20050644|P14|COMPLETED|Overall Study||6
8134435|NCT02769065|20050645|P13|COMPLETED|Overall Study||6
8134436|NCT02769065|20050646|P12|COMPLETED|Overall Study||6
8134437|NCT02769065|20050647|P11|COMPLETED|Overall Study||5
8134438|NCT02769065|20050648|P10|COMPLETED|Overall Study||6
8134439|NCT02769065|20050649|P9|COMPLETED|Overall Study||6
8134440|NCT02769065|20050650|P8|COMPLETED|Overall Study||6
8134441|NCT02769065|20050651|P7|COMPLETED|Overall Study||6
8134442|NCT02769065|20050652|P6|COMPLETED|Overall Study||6
8134443|NCT02769065|20050653|P5|COMPLETED|Overall Study||6
8134444|NCT02769065|20050654|P4|COMPLETED|Overall Study||6
8134445|NCT02769065|20050655|P3|COMPLETED|Overall Study||6
8134446|NCT02769065|20050656|P2|COMPLETED|Overall Study||6
8134447|NCT02769065|20050657|P1|COMPLETED|Overall Study||16
8134448|NCT02769065|20050628|P30|STARTED|Overall Study||6
8134449|NCT02769065|20050629|P29|STARTED|Overall Study||6
8134450|NCT02769065|20050630|P28|STARTED|Overall Study||5
8134451|NCT02769065|20050631|P27|STARTED|Overall Study||9
8134452|NCT02769065|20050632|P26|STARTED|Overall Study||9
8134453|NCT02769065|20050633|P25|STARTED|Overall Study||6
8134454|NCT02769065|20050634|P24|STARTED|Overall Study||6
8134455|NCT02769065|20050635|P23|STARTED|Overall Study||4
8134456|NCT02769065|20050636|P22|STARTED|Overall Study||4
8134457|NCT02769065|20050637|P21|STARTED|Overall Study||4
8134458|NCT02769065|20050638|P20|STARTED|Overall Study||0
8134459|NCT02769065|20050639|P19|STARTED|Overall Study||5
8134460|NCT02769065|20050640|P18|STARTED|Overall Study||5
8134461|NCT02769065|20050641|P17|STARTED|Overall Study||5
8134462|NCT02769065|20050642|P16|STARTED|Overall Study||3
8134463|NCT02769065|20050643|P15|STARTED|Overall Study||6
8134464|NCT02769065|20050644|P14|STARTED|Overall Study||6
8134465|NCT02769065|20050645|P13|STARTED|Overall Study||6
8134466|NCT02769065|20050646|P12|STARTED|Overall Study||6
8134467|NCT02769065|20050647|P11|STARTED|Overall Study||6
8134468|NCT02769065|20050648|P10|STARTED|Overall Study||6
8134469|NCT02769065|20050649|P9|STARTED|Overall Study||6
8134470|NCT02769065|20050650|P8|STARTED|Overall Study||6
8134471|NCT02769065|20050651|P7|STARTED|Overall Study||7
8134472|NCT02769065|20050652|P6|STARTED|Overall Study||6
8134473|NCT02769065|20050653|P5|STARTED|Overall Study||6
8134474|NCT02769065|20050654|P4|STARTED|Overall Study||6
8134475|NCT02769065|20050655|P3|STARTED|Overall Study||6
8134476|NCT02769065|20050656|P2|STARTED|Overall Study||6
8134477|NCT02769065|20050657|P1|STARTED|Overall Study||17
8134478|NCT02768870|20051067|P1|NOT COMPLETED|Overall Study||26
8134479|NCT02768870|20051067|P1|COMPLETED|Overall Study||0
8134480|NCT02768870|20051067|P1|Implanted With Device|Overall Study||24
8134481|NCT02768870|20051067|P1|STARTED|Overall Study||26
8134482|NCT02768753|20051077|P2|NOT COMPLETED|Overall Study||0
8134483|NCT02768753|20051078|P1|NOT COMPLETED|Overall Study||0
8134484|NCT02768753|20051077|P2|COMPLETED|Overall Study||30
8134485|NCT02768753|20051078|P1|COMPLETED|Overall Study||30
8134486|NCT02768753|20051077|P2|STARTED|Overall Study||30
8134487|NCT02768753|20051078|P1|STARTED|Overall Study||30
8134496|NCT02768298|20051111|P2|NOT COMPLETED|Overall Study||7
8134497|NCT02768298|20051112|P1|NOT COMPLETED|Overall Study||4
8134498|NCT02768298|20051111|P2|COMPLETED|Overall Study||91
8134499|NCT02768298|20051112|P1|COMPLETED|Overall Study||99
8134500|NCT02768298|20051111|P2|STARTED|Overall Study||98
8134501|NCT02768298|20051112|P1|STARTED|Overall Study||103
8134502|NCT02768194|20051126|P6|NOT COMPLETED|Period 3||0
8134503|NCT02768194|20051127|P5|NOT COMPLETED|Period 3||0
8134504|NCT02768194|20051128|P4|NOT COMPLETED|Period 3||0
8134505|NCT02768194|20051129|P3|NOT COMPLETED|Period 3||0
8134506|NCT02768194|20051130|P2|NOT COMPLETED|Period 3||1
8134507|NCT02768194|20051131|P1|NOT COMPLETED|Period 3||0
8134508|NCT02768194|20051126|P6|COMPLETED|Period 3||4
8134509|NCT02768194|20051127|P5|COMPLETED|Period 3||4
8134510|NCT02768194|20051128|P4|COMPLETED|Period 3||3
8134511|NCT02768194|20051129|P3|COMPLETED|Period 3||4
8134512|NCT02768194|20051130|P2|COMPLETED|Period 3||3
8134513|NCT02768194|20051131|P1|COMPLETED|Period 3||3
8134514|NCT02768194|20051126|P6|STARTED|Period 3||4
8134515|NCT02768194|20051127|P5|STARTED|Period 3||4
8134516|NCT02768194|20051128|P4|STARTED|Period 3||3
8134517|NCT02768194|20051129|P3|STARTED|Period 3||4
8134518|NCT02768194|20051130|P2|STARTED|Period 3||4
8134519|NCT02768194|20051131|P1|STARTED|Period 3||3
8134520|NCT02768194|20051126|P6|NOT COMPLETED|Period 2||0
8134521|NCT02768194|20051127|P5|NOT COMPLETED|Period 2||0
8134522|NCT02768194|20051128|P4|NOT COMPLETED|Period 2||0
8134523|NCT02768194|20051129|P3|NOT COMPLETED|Period 2||0
8134524|NCT02768194|20051130|P2|NOT COMPLETED|Period 2||0
8134525|NCT02768194|20051131|P1|NOT COMPLETED|Period 2||1
8134526|NCT02768194|20051126|P6|COMPLETED|Period 2||4
8134527|NCT02768194|20051127|P5|COMPLETED|Period 2||4
8134528|NCT02768194|20051128|P4|COMPLETED|Period 2||3
8134529|NCT02768194|20051129|P3|COMPLETED|Period 2||4
8134530|NCT02768194|20051130|P2|COMPLETED|Period 2||4
8134531|NCT02768194|20051131|P1|COMPLETED|Period 2||3
8134532|NCT02768194|20051126|P6|STARTED|Period 2||4
8134533|NCT02768194|20051127|P5|STARTED|Period 2||4
8134534|NCT02768194|20051128|P4|STARTED|Period 2||3
8134535|NCT02768194|20051129|P3|STARTED|Period 2||4
8134536|NCT02768194|20051130|P2|STARTED|Period 2||4
8134537|NCT02768194|20051131|P1|STARTED|Period 2||4
8134538|NCT02768194|20051126|P6|NOT COMPLETED|Period 1||0
8134539|NCT02768194|20051127|P5|NOT COMPLETED|Period 1||0
8134540|NCT02768194|20051128|P4|NOT COMPLETED|Period 1||1
8134541|NCT02768194|20051129|P3|NOT COMPLETED|Period 1||0
8134542|NCT02768194|20051130|P2|NOT COMPLETED|Period 1||0
8134543|NCT02768194|20051131|P1|NOT COMPLETED|Period 1||0
8134544|NCT02768194|20051126|P6|COMPLETED|Period 1||4
8134545|NCT02768194|20051127|P5|COMPLETED|Period 1||4
8134546|NCT02768194|20051128|P4|COMPLETED|Period 1||3
8134547|NCT02768194|20051129|P3|COMPLETED|Period 1||4
8134548|NCT02768194|20051130|P2|COMPLETED|Period 1||4
8134549|NCT02768194|20051131|P1|COMPLETED|Period 1||4
8134550|NCT02768194|20051126|P6|STARTED|Period 1||4
8134551|NCT02768194|20051127|P5|STARTED|Period 1||4
8134552|NCT02768194|20051128|P4|STARTED|Period 1||4
8134553|NCT02768194|20051129|P3|STARTED|Period 1||4
8134554|NCT02768194|20051130|P2|STARTED|Period 1||4
8134555|NCT02768194|20051131|P1|STARTED|Period 1||4
8134556|NCT02768129|20051144|P2|NOT COMPLETED|Overall Study||0
8134557|NCT02768129|20051145|P1|NOT COMPLETED|Overall Study||0
8134558|NCT02768129|20051144|P2|COMPLETED|Overall Study||10
8134559|NCT02768129|20051145|P1|COMPLETED|Overall Study||11
8134560|NCT02768129|20051144|P2|STARTED|Overall Study||10
8134561|NCT02768129|20051145|P1|STARTED|Overall Study||11
8134562|NCT02768103|20051153|P1|NOT COMPLETED|Overall Study||1
8134563|NCT02768103|20051153|P1|COMPLETED|Overall Study||4
8134564|NCT02768103|20051153|P1|STARTED|Overall Study||5
8134565|NCT02767947|20051160|P2|NOT COMPLETED|Overall Study||0
8134566|NCT02767947|20051161|P1|NOT COMPLETED|Overall Study||0
8134567|NCT02767947|20051160|P2|COMPLETED|Overall Study||15
8134568|NCT02767947|20051161|P1|COMPLETED|Overall Study||60
8134569|NCT02767947|20051160|P2|Pharmacokinetic (PK) Population|Overall Study||3
8134570|NCT02767947|20051161|P1|Pharmacokinetic (PK) Population|Overall Study||12
8134571|NCT02767947|20051160|P2|Safety Population|Overall Study||15
8134572|NCT02767947|20051161|P1|Safety Population|Overall Study||60
8134573|NCT02767947|20051160|P2|STARTED|Overall Study||15
8134574|NCT02767947|20051161|P1|STARTED|Overall Study||60
8134575|NCT02767934|20051169|P1|NOT COMPLETED|Overall Study||0
8134576|NCT02767934|20051169|P1|COMPLETED|Overall Study||12
8134577|NCT02767934|20051169|P1|STARTED|Overall Study||12
8134578|NCT02767869|20051177|P2|NOT COMPLETED|Overall Study||0
8134579|NCT02767869|20051178|P1|NOT COMPLETED|Overall Study||0
8134580|NCT02767869|20051177|P2|COMPLETED|Overall Study||12
8134581|NCT02767869|20051178|P1|COMPLETED|Overall Study||12
8134582|NCT02767869|20051177|P2|STARTED|Overall Study||12
8134583|NCT02767869|20051178|P1|STARTED|Overall Study||12
8134584|NCT02767843|20051208|P1|NOT COMPLETED|Overall Study||0
8134585|NCT02767843|20051208|P1|COMPLETED|Overall Study||4
8134586|NCT02767843|20051208|P1|STARTED|Overall Study||4
8134587|NCT02767765|20051214|P1|NOT COMPLETED|Overall Study||11
8134588|NCT02767765|20051214|P1|COMPLETED|Overall Study||50
8134589|NCT02767765|20051214|P1|STARTED|Overall Study||61
8134590|NCT02767609|20051223|P1|NOT COMPLETED|Overall Study||0
8134591|NCT02767609|20051223|P1|COMPLETED|Overall Study||1
8134592|NCT02767609|20051223|P1|STARTED|Overall Study||1
8134617|NCT02767427|20051236|P2|NOT COMPLETED|Overall Study||0
8134618|NCT02767427|20051237|P1|NOT COMPLETED|Overall Study||0
8134619|NCT02767427|20051236|P2|COMPLETED|Overall Study||19
8134620|NCT02767427|20051237|P1|COMPLETED|Overall Study||21
8134621|NCT02767427|20051236|P2|STARTED|Overall Study||19
8134622|NCT02767427|20051237|P1|STARTED|Overall Study||21
8134623|NCT02767388|20051246|P3|NOT COMPLETED|Overall Study||3
8134624|NCT02767388|20051247|P2|NOT COMPLETED|Overall Study||5
8134625|NCT02767388|20051248|P1|NOT COMPLETED|Overall Study||7
8134626|NCT02767388|20051246|P3|COMPLETED|Overall Study||12
8134627|NCT02767388|20051247|P2|COMPLETED|Overall Study||10
8134628|NCT02767388|20051248|P1|COMPLETED|Overall Study||8
8134629|NCT02767388|20051246|P3|STARTED|Overall Study||15
8134630|NCT02767388|20051247|P2|STARTED|Overall Study||15
8134631|NCT02767388|20051248|P1|STARTED|Overall Study||15
8134632|NCT02767271|20051267|P2|NOT COMPLETED|Overall Study||0
8134633|NCT02767271|20051268|P1|NOT COMPLETED|Overall Study||0
8134634|NCT02767271|20051267|P2|COMPLETED|Overall Study||15
8134635|NCT02767271|20051268|P1|COMPLETED|Overall Study||15
8134636|NCT02767271|20051267|P2|Pharmacokinetic Cruris (PKC) Population|Overall Study||15
8134637|NCT02767271|20051268|P1|Pharmacokinetic Cruris (PKC) Population|Overall Study||0
8134638|NCT02767271|20051267|P2|Pharmacokinetic Pedis (PKP) Population|Overall Study||0
8134639|NCT02767271|20051268|P1|Pharmacokinetic Pedis (PKP) Population|Overall Study||15
8134640|NCT02767271|20051267|P2|Safety Population|Overall Study||15
8134641|NCT02767271|20051268|P1|Safety Population|Overall Study||15
8134642|NCT02767271|20051267|P2|STARTED|Overall Study||15
8134643|NCT02767271|20051268|P1|STARTED|Overall Study||15
8134644|NCT02767128|20051278|P1|NOT COMPLETED|Overall Study||0
8134645|NCT02767128|20051278|P1|COMPLETED|Overall Study||14
8134646|NCT02767128|20051278|P1|Shohl's + Triferic Immediately|Overall Study||14
8134647|NCT02767128|20051278|P1|Shohl's + Triferic After 10 Min|Overall Study||14
8134648|NCT02767128|20051278|P1|Triferic|Overall Study||14
8134649|NCT02767128|20051278|P1|Shohl's + Fer-In-Sol|Overall Study||14
8134650|NCT02767128|20051278|P1|Fer-In-Sol|Overall Study||14
8134651|NCT02767128|20051278|P1|Baseline|Overall Study||14
8134652|NCT02767128|20051278|P1|STARTED|Overall Study||14
8134653|NCT02767011|20051306|P2|NOT COMPLETED|Overall Study||0
8134654|NCT02767011|20051307|P1|NOT COMPLETED|Overall Study||0
8134655|NCT02767011|20051306|P2|COMPLETED|Overall Study||14
8134656|NCT02767011|20051307|P1|COMPLETED|Overall Study||16
8134657|NCT02767011|20051306|P2|STARTED|Overall Study||14
8134658|NCT02767011|20051307|P1|STARTED|Overall Study||16
8134659|NCT02766907|20051331|P2|NOT COMPLETED|Overall Study||1
8134660|NCT02766907|20051332|P1|NOT COMPLETED|Overall Study||1
8134661|NCT02766907|20051331|P2|COMPLETED|Overall Study||9
8134662|NCT02766907|20051332|P1|COMPLETED|Overall Study||9
8134663|NCT02766907|20051331|P2|STARTED|Overall Study||10
8134664|NCT02766907|20051332|P1|STARTED|Overall Study||10
8134665|NCT02766777|20051340|P1|NOT COMPLETED|Overall Study||34
8134666|NCT02766777|20051340|P1|COMPLETED|Overall Study||53
8134667|NCT02766777|20051340|P1|Treated (Safety [SAF] Population)|Overall Study||87
8134668|NCT02766777|20051340|P1|STARTED|Overall Study||87
8134669|NCT02766673|20051344|P6|NOT COMPLETED|Overall Study||1
8134670|NCT02766673|20051345|P5|NOT COMPLETED|Overall Study||0
8134671|NCT02766673|20051346|P4|NOT COMPLETED|Overall Study||0
8134672|NCT02766673|20051347|P3|NOT COMPLETED|Overall Study||0
8134673|NCT02766673|20051348|P2|NOT COMPLETED|Overall Study||0
8134674|NCT02766673|20051349|P1|NOT COMPLETED|Overall Study||1
8134675|NCT02766673|20051344|P6|COMPLETED|Overall Study||3
8134676|NCT02766673|20051345|P5|COMPLETED|Overall Study||4
8134677|NCT02766673|20051346|P4|COMPLETED|Overall Study||4
8134678|NCT02766673|20051347|P3|COMPLETED|Overall Study||4
8134679|NCT02766673|20051348|P2|COMPLETED|Overall Study||4
8134680|NCT02766673|20051349|P1|COMPLETED|Overall Study||3
8134681|NCT02766673|20051344|P6|STARTED|Overall Study||4
8134682|NCT02766673|20051345|P5|STARTED|Overall Study||4
8134683|NCT02766673|20051346|P4|STARTED|Overall Study||4
8134684|NCT02766673|20051347|P3|STARTED|Overall Study||4
8134685|NCT02766673|20051348|P2|STARTED|Overall Study||4
8134686|NCT02766673|20051349|P1|STARTED|Overall Study||4
8134687|NCT02766608|20051365|P5|NOT COMPLETED|Overall Study||29
8134688|NCT02766608|20051366|P4|NOT COMPLETED|Overall Study||37
8134689|NCT02766608|20051367|P3|NOT COMPLETED|Overall Study||90
8134690|NCT02766608|20051368|P2|NOT COMPLETED|Overall Study||70
8134691|NCT02766608|20051369|P1|NOT COMPLETED|Overall Study||79
8134692|NCT02766608|20051365|P5|COMPLETED|Overall Study||190
8134693|NCT02766608|20051366|P4|COMPLETED|Overall Study||169
8134694|NCT02766608|20051367|P3|COMPLETED|Overall Study||554
8134695|NCT02766608|20051368|P2|COMPLETED|Overall Study||567
8134696|NCT02766608|20051369|P1|COMPLETED|Overall Study||576
8134697|NCT02766608|20051365|P5|STARTED|Overall Study||219
8134698|NCT02766608|20051366|P4|STARTED|Overall Study||206
8134699|NCT02766608|20051367|P3|STARTED|Overall Study||644
8134700|NCT02766608|20051368|P2|STARTED|Overall Study||637
8134701|NCT02766608|20051369|P1|STARTED|Overall Study||655
8134702|NCT02766517|20051446|P3|NOT COMPLETED|Overall Study||0
8134703|NCT02766517|20051447|P2|NOT COMPLETED|Overall Study||0
8134704|NCT02766517|20051448|P1|NOT COMPLETED|Overall Study||0
8134705|NCT02766517|20051446|P3|COMPLETED|Overall Study||9
8134706|NCT02766517|20051447|P2|COMPLETED|Overall Study||9
8134707|NCT02766517|20051448|P1|COMPLETED|Overall Study||19
8134708|NCT02766517|20051446|P3|STARTED|Overall Study||9
8134709|NCT02766517|20051447|P2|STARTED|Overall Study||9
8134710|NCT02766517|20051448|P1|STARTED|Overall Study||19
8134711|NCT02766400|20051461|P2|NOT COMPLETED|Overall Study||2
8134712|NCT02766400|20051462|P1|NOT COMPLETED|Overall Study||2
8134713|NCT02766400|20051461|P2|COMPLETED|Overall Study||20
8134714|NCT02766400|20051462|P1|COMPLETED|Overall Study||19
8134715|NCT02766400|20051461|P2|STARTED|Overall Study||22
8134716|NCT02766400|20051462|P1|STARTED|Overall Study||21
8134717|NCT02766374|20051470|P2|NOT COMPLETED|Overall Study||3
8134718|NCT02766374|20051471|P1|NOT COMPLETED|Overall Study||10
8134719|NCT02766374|20051470|P2|COMPLETED|Overall Study||30
8134720|NCT02766374|20051471|P1|COMPLETED|Overall Study||25
8134721|NCT02766374|20051470|P2|STARTED|Overall Study||33
8134722|NCT02766374|20051471|P1|STARTED|Overall Study||35
8134723|NCT02766283|20051477|P1|NOT COMPLETED|Overall Study||27
8134724|NCT02766283|20051477|P1|COMPLETED|Overall Study||816
8134725|NCT02766283|20051477|P1|STARTED|Overall Study||843
8134726|NCT02766244|20051501|P1|NOT COMPLETED|Overall Study||0
8134727|NCT02766244|20051501|P1|COMPLETED|Overall Study||3
8134728|NCT02766244|20051501|P1|STARTED|Overall Study||3
8134729|NCT02766088|20051510|P1|NOT COMPLETED|Overall Study||506
8134730|NCT02766088|20051510|P1|COMPLETED|Overall Study||344
8134731|NCT02766088|20051510|P1|STARTED|Overall Study||850
8134732|NCT02766023|20051525|P2|NOT COMPLETED|Overall Study||17
8134733|NCT02766023|20051526|P1|NOT COMPLETED|Overall Study||30
8134734|NCT02766023|20051525|P2|COMPLETED|Overall Study||59
8134735|NCT02766023|20051526|P1|COMPLETED|Overall Study||122
8134736|NCT02766023|20051525|P2|STARTED|Overall Study||76
8134737|NCT02766023|20051526|P1|STARTED|Overall Study||152
8134738|NCT02765490|20051576|P2|NOT COMPLETED|Overall Study||3
8134739|NCT02765490|20051577|P1|NOT COMPLETED|Overall Study||1
8134740|NCT02765490|20051576|P2|COMPLETED|Overall Study||179
8134741|NCT02765490|20051577|P1|COMPLETED|Overall Study||182
8134742|NCT02765490|20051576|P2|STARTED|Overall Study||182
8134743|NCT02765490|20051577|P1|STARTED|Overall Study||183
8134744|NCT02765269|20051595|P2|NOT COMPLETED|Overall Study||0
8134745|NCT02765269|20051596|P1|NOT COMPLETED|Overall Study||0
8134746|NCT02765269|20051595|P2|COMPLETED|Overall Study||21
8134747|NCT02765269|20051596|P1|COMPLETED|Overall Study||25
8134748|NCT02765269|20051595|P2|STARTED|Overall Study||21
8134749|NCT02765269|20051596|P1|STARTED|Overall Study||25
8134750|NCT02765100|20051610|P2|NOT COMPLETED|Overall Study||2
8134751|NCT02765100|20051611|P1|NOT COMPLETED|Overall Study||1
8134752|NCT02765100|20051610|P2|COMPLETED|Overall Study||10
8134753|NCT02765100|20051611|P1|COMPLETED|Overall Study||8
8134754|NCT02765100|20051610|P2|STARTED|Overall Study||12
8134755|NCT02765100|20051611|P1|STARTED|Overall Study||9
8134756|NCT02764970|20051619|P2|NOT COMPLETED|Overall Study||0
8134757|NCT02764970|20051620|P1|NOT COMPLETED|Overall Study||0
8134758|NCT02764970|20051619|P2|COMPLETED|Overall Study||47
8134759|NCT02764970|20051620|P1|COMPLETED|Overall Study||65
8134760|NCT02764970|20051619|P2|STARTED|Overall Study||47
8134761|NCT02764970|20051620|P1|STARTED|Overall Study||65
8134762|NCT02764775|20051632|P1|NOT COMPLETED|Overall Study||6
8134763|NCT02764775|20051632|P1|COMPLETED|Overall Study||8
8134764|NCT02764775|20051632|P1|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14
8134765|NCT02764697|20051636|P1|NOT COMPLETED|Overall Study||3
8134766|NCT02764697|20051636|P1|COMPLETED|Overall Study||2
8134767|NCT02764697|20051636|P1|STARTED|Overall Study||5
8134768|NCT02764229|20051641|P1|NOT COMPLETED|Overall Study||102
8134769|NCT02764229|20051641|P1|COMPLETED|Overall Study||10
8134770|NCT02764229|20051641|P1|STARTED|Overall Study||112
8134771|NCT02764190|20051647|P2|NOT COMPLETED|Overall Study||13
8134772|NCT02764190|20051648|P1|NOT COMPLETED|Overall Study||17
8134773|NCT02764190|20051647|P2|COMPLETED|Overall Study||122
8134774|NCT02764190|20051648|P1|COMPLETED|Overall Study||150
8134775|NCT02764190|20051647|P2|12 Month Follow-up|Overall Study||122
8134776|NCT02764190|20051648|P1|12 Month Follow-up|Overall Study||150
8134777|NCT02764190|20051647|P2|6 Month Follow-up|Overall Study||128
8134778|NCT02764190|20051648|P1|6 Month Follow-up|Overall Study||155
8134779|NCT02764190|20051647|P2|3 Month Follow-up|Overall Study||128
8134780|NCT02764190|20051648|P1|3 Month Follow-up|Overall Study||156
8134781|NCT02764190|20051647|P2|1 Day Follow-up|Overall Study||131
8134782|NCT02764190|20051648|P1|1 Day Follow-up|Overall Study||161
8134783|NCT02764190|20051647|P2|STARTED|Overall Study||135
8134784|NCT02764190|20051648|P1|STARTED|Overall Study||167
8134788|NCT02764151|20051702|P4|NOT COMPLETED|Overall Study||3
8134789|NCT02764151|20051703|P3|NOT COMPLETED|Overall Study||0
8134790|NCT02764151|20051704|P2|NOT COMPLETED|Overall Study||0
8134791|NCT02764151|20051705|P1|NOT COMPLETED|Overall Study||0
8134792|NCT02764151|20051702|P4|COMPLETED|Overall Study||5
8134793|NCT02764151|20051703|P3|COMPLETED|Overall Study||3
8134794|NCT02764151|20051704|P2|COMPLETED|Overall Study||4
8134795|NCT02764151|20051705|P1|COMPLETED|Overall Study||2
8134796|NCT02764151|20051702|P4|STARTED|Overall Study||8
8134797|NCT02764151|20051703|P3|STARTED|Overall Study||3
8134798|NCT02764151|20051704|P2|STARTED|Overall Study||4
8134799|NCT02764151|20051705|P1|STARTED|Overall Study||2
8134800|NCT02763865|20051829|P2|NOT COMPLETED|Overall Study||0
8134801|NCT02763865|20051830|P1|NOT COMPLETED|Overall Study||0
8134802|NCT02763865|20051829|P2|COMPLETED|Overall Study||5
8134803|NCT02763865|20051830|P1|COMPLETED|Overall Study||5
8134804|NCT02763865|20051829|P2|STARTED|Overall Study||5
8134805|NCT02763865|20051830|P1|STARTED|Overall Study||5
8134806|NCT02763644|20051844|P2|NOT COMPLETED|Overall Study||2
8134807|NCT02763644|20051845|P1|NOT COMPLETED|Overall Study||3
8134808|NCT02763644|20051844|P2|COMPLETED|Overall Study||2
8134809|NCT02763644|20051845|P1|COMPLETED|Overall Study||0
8134810|NCT02763644|20051844|P2|STARTED|Overall Study||4
8134811|NCT02763644|20051845|P1|STARTED|Overall Study||3
8134830|NCT02763254|20051909|P1|NOT COMPLETED|Overall Study||1
8134831|NCT02763254|20051909|P1|COMPLETED|Overall Study||0
8134832|NCT02763254|20051909|P1|STARTED|Overall Study||1
8134833|NCT02763215|20051914|P1|NOT COMPLETED|Overall Study||7
8134834|NCT02763215|20051914|P1|COMPLETED|Overall Study||57
8134835|NCT02763215|20051914|P1|STARTED|Overall Study||64
8134836|NCT02763189|20051937|P2|NOT COMPLETED|Overall Study||2
8134837|NCT02763189|20051938|P1|NOT COMPLETED|Overall Study||0
8134838|NCT02763189|20051937|P2|COMPLETED|Overall Study||2
8134839|NCT02763189|20051938|P1|COMPLETED|Overall Study||4
8134840|NCT02763189|20051937|P2|STARTED|Overall Study||4
8134841|NCT02763189|20051938|P1|STARTED|Overall Study||4
8134842|NCT02763124|20051946|P1|NOT COMPLETED|Overall Study||0
8134843|NCT02763124|20051946|P1|COMPLETED|Overall Study||18
8134844|NCT02763124|20051946|P1|STARTED|Overall Study||18
8134845|NCT02763046|20051956|P3|NOT COMPLETED|Overall Study||8
8134846|NCT02763046|20051957|P2|NOT COMPLETED|Overall Study||5
8134847|NCT02763046|20051958|P1|NOT COMPLETED|Overall Study||9
8134848|NCT02763046|20051956|P3|COMPLETED|Overall Study||62
8134849|NCT02763046|20051957|P2|COMPLETED|Overall Study||65
8134850|NCT02763046|20051958|P1|COMPLETED|Overall Study||62
8134851|NCT02763046|20051956|P3|STARTED|Overall Study||70
8134852|NCT02763046|20051957|P2|STARTED|Overall Study||70
8134853|NCT02763046|20051958|P1|STARTED|Overall Study||71
8134854|NCT02762877|20051987|P2|NOT COMPLETED|Overall Study||0
8134855|NCT02762877|20051988|P1|NOT COMPLETED|Overall Study||0
8134856|NCT02762877|20051987|P2|COMPLETED|Overall Study||19
8134857|NCT02762877|20051988|P1|COMPLETED|Overall Study||121
8134858|NCT02762877|20051987|P2|STARTED|Overall Study||19
8134859|NCT02762877|20051988|P1|STARTED|Overall Study||121
8134860|NCT02762799|20051999|P4|NOT COMPLETED|Overall Study||0
8134861|NCT02762799|20052000|P3|NOT COMPLETED|Overall Study||1
8134862|NCT02762799|20052001|P2|NOT COMPLETED|Overall Study||0
8134863|NCT02762799|20052002|P1|NOT COMPLETED|Overall Study||0
8134864|NCT02762799|20051999|P4|COMPLETED|Overall Study||12
8134865|NCT02762799|20052000|P3|COMPLETED|Overall Study||11
8134866|NCT02762799|20052001|P2|COMPLETED|Overall Study||18
8134867|NCT02762799|20052002|P1|COMPLETED|Overall Study||18
8134868|NCT02762799|20051999|P4|STARTED|Overall Study||12
8134869|NCT02762799|20052000|P3|STARTED|Overall Study||12
8134870|NCT02762799|20052001|P2|STARTED|Overall Study||18
8134871|NCT02762799|20052002|P1|STARTED|Overall Study||18
8134872|NCT02762578|20052074|P2|NOT COMPLETED|Overall Study||10
8134873|NCT02762578|20052075|P1|NOT COMPLETED|Overall Study||15
8134874|NCT02762578|20052074|P2|COMPLETED|Overall Study||172
8134875|NCT02762578|20052075|P1|COMPLETED|Overall Study||346
8134876|NCT02762578|20052074|P2|Exposed|Overall Study||181
8134877|NCT02762578|20052075|P1|Exposed|Overall Study||360
8134878|NCT02762578|20052074|P2|STARTED|Overall Study||182
8134879|NCT02762578|20052075|P1|STARTED|Overall Study||361
8134880|NCT02762500|20052177|P2|NOT COMPLETED|Overall Study||3
8134881|NCT02762500|20052178|P1|NOT COMPLETED|Overall Study||2
8134882|NCT02762500|20052177|P2|COMPLETED|Overall Study||59
8134883|NCT02762500|20052178|P1|COMPLETED|Overall Study||60
8134884|NCT02762500|20052177|P2|STARTED|Overall Study||62
8134885|NCT02762500|20052178|P1|STARTED|Overall Study||62
8134886|NCT02762370|20052198|P2|NOT COMPLETED|Overall Study||0
8134887|NCT02762370|20052199|P1|NOT COMPLETED|Overall Study||1
8134888|NCT02762370|20052198|P2|COMPLETED|Overall Study||15
8134889|NCT02762370|20052199|P1|COMPLETED|Overall Study||17
8134890|NCT02762370|20052198|P2|STARTED|Overall Study||15
8134891|NCT02762370|20052199|P1|STARTED|Overall Study||18
8134892|NCT02762331|20052219|P2|NOT COMPLETED|Overall Study||0
8134893|NCT02762331|20052220|P1|NOT COMPLETED|Overall Study||0
8134894|NCT02762331|20052219|P2|COMPLETED|Overall Study||2
8134895|NCT02762331|20052220|P1|COMPLETED|Overall Study||4
8134896|NCT02762331|20052219|P2|STARTED|Overall Study||2
8134897|NCT02762331|20052220|P1|STARTED|Overall Study||4
8134898|NCT02762084|20052239|P3|NOT COMPLETED|Overall Study||1
8134899|NCT02762084|20052240|P2|NOT COMPLETED|Overall Study||0
8134900|NCT02762084|20052241|P1|NOT COMPLETED|Overall Study||1
8134901|NCT02762084|20052239|P3|COMPLETED|Overall Study||4
8134902|NCT02762084|20052240|P2|COMPLETED|Overall Study||6
8134903|NCT02762084|20052241|P1|COMPLETED|Overall Study||5
8134904|NCT02762084|20052239|P3|By Tumor Per Protocol Population (PP)|Overall Study||4
8134905|NCT02762084|20052240|P2|By Tumor Per Protocol Population (PP)|Overall Study||6
8134906|NCT02762084|20052241|P1|By Tumor Per Protocol Population (PP)|Overall Study||6
8134907|NCT02762084|20052239|P3|Received at Least 1 Dose of Study Drug|Overall Study||5
8134908|NCT02762084|20052240|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8134909|NCT02762084|20052241|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8134910|NCT02762084|20052239|P3|STARTED|Overall Study||5
8134911|NCT02762084|20052240|P2|STARTED|Overall Study||6
8134912|NCT02762084|20052241|P1|STARTED|Overall Study||6
8134913|NCT02762071|20052281|P2|NOT COMPLETED|Overall Study||0
8134914|NCT02762071|20052282|P1|NOT COMPLETED|Overall Study||0
8134915|NCT02762071|20052281|P2|COMPLETED|Overall Study||54
8134916|NCT02762071|20052282|P1|COMPLETED|Overall Study||54
8134917|NCT02762071|20052281|P2|STARTED|Overall Study||54
8134918|NCT02762071|20052282|P1|STARTED|Overall Study||54
8134919|NCT02761980|20052302|P4|NOT COMPLETED|Overall Study||6
8134920|NCT02761980|20052303|P3|NOT COMPLETED|Overall Study||6
8134921|NCT02761980|20052304|P2|NOT COMPLETED|Overall Study||7
8134922|NCT02761980|20052305|P1|NOT COMPLETED|Overall Study||4
8134923|NCT02761980|20052302|P4|COMPLETED|Overall Study||81
8134924|NCT02761980|20052303|P3|COMPLETED|Overall Study||81
8134925|NCT02761980|20052304|P2|COMPLETED|Overall Study||80
8134926|NCT02761980|20052305|P1|COMPLETED|Overall Study||25
8134927|NCT02761980|20052302|P4|STARTED|Overall Study||87
8134928|NCT02761980|20052303|P3|STARTED|Overall Study||87
8134929|NCT02761980|20052304|P2|STARTED|Overall Study||87
8134930|NCT02761980|20052305|P1|STARTED|Overall Study||29
8134931|NCT02761967|20052337|P2|NOT COMPLETED|Overall Study||6
8134932|NCT02761967|20052338|P1|NOT COMPLETED|Overall Study||5
8134933|NCT02761967|20052337|P2|COMPLETED|Overall Study||64
8134934|NCT02761967|20052338|P1|COMPLETED|Overall Study||65
8134935|NCT02761967|20052337|P2|STARTED|Overall Study||70
8134936|NCT02761967|20052338|P1|STARTED|Overall Study||70
8134937|NCT02761733|20052352|P4|NOT COMPLETED|Overall Study||15
8134938|NCT02761733|20052353|P3|NOT COMPLETED|Overall Study||27
8134939|NCT02761733|20052354|P2|NOT COMPLETED|Overall Study||21
8134940|NCT02761733|20052355|P1|NOT COMPLETED|Overall Study||30
8134941|NCT02761733|20052352|P4|COMPLETED|Overall Study||45
8134942|NCT02761733|20052353|P3|COMPLETED|Overall Study||33
8134943|NCT02761733|20052354|P2|COMPLETED|Overall Study||39
8134944|NCT02761733|20052355|P1|COMPLETED|Overall Study||30
8134945|NCT02761733|20052352|P4|9/30/2015|Overall Study||50
8134946|NCT02761733|20052353|P3|9/30/2015|Overall Study||33
8134947|NCT02761733|20052354|P2|9/30/2015|Overall Study||44
8134948|NCT02761733|20052355|P1|9/30/2015|Overall Study||40
8134949|NCT02761733|20052352|P4|3/31/2015|Overall Study||50
8134950|NCT02761733|20052353|P3|3/31/2015|Overall Study||43
8134951|NCT02761733|20052354|P2|3/31/2015|Overall Study||47
8134952|NCT02761733|20052355|P1|3/31/2015|Overall Study||48
8134953|NCT02761733|20052352|P4|9/30/2014|Overall Study||55
8134954|NCT02761733|20052353|P3|9/30/2014|Overall Study||48
8134955|NCT02761733|20052354|P2|9/30/2014|Overall Study||56
8134956|NCT02761733|20052355|P1|9/30/2014|Overall Study||53
8134957|NCT02761733|20052352|P4|STARTED|Overall Study||60
8134958|NCT02761733|20052353|P3|STARTED|Overall Study||60
8134959|NCT02761733|20052354|P2|STARTED|Overall Study||60
8134960|NCT02761733|20052355|P1|STARTED|Overall Study||60
8134961|NCT02761642|20052385|P1|NOT COMPLETED|Overall Study||70
8134962|NCT02761642|20052385|P1|COMPLETED|Overall Study||130
8134963|NCT02761642|20052385|P1|Treated|Overall Study||197
8134964|NCT02761642|20052385|P1|STARTED|Overall Study||200
8134965|NCT02761629|20052398|P2|NOT COMPLETED|Overall Study||32
8134966|NCT02761629|20052399|P1|NOT COMPLETED|Overall Study||27
8134967|NCT02761629|20052398|P2|COMPLETED|Overall Study||58
8134968|NCT02761629|20052399|P1|COMPLETED|Overall Study||63
8134969|NCT02761629|20052398|P2|Treated|Overall Study||86
8134970|NCT02761629|20052399|P1|Treated|Overall Study||82
8134971|NCT02761629|20052398|P2|STARTED|Overall Study||90
8134972|NCT02761629|20052399|P1|STARTED|Overall Study||90
8134973|NCT02761252|20052422|P3|NOT COMPLETED|Overall Study||14
8134974|NCT02761252|20052423|P2|NOT COMPLETED|Overall Study||8
8134975|NCT02761252|20052424|P1|NOT COMPLETED|Overall Study||10
8134976|NCT02761252|20052422|P3|COMPLETED|Overall Study||123
8134977|NCT02761252|20052423|P2|COMPLETED|Overall Study||132
8134978|NCT02761252|20052424|P1|COMPLETED|Overall Study||133
8134979|NCT02761252|20052422|P3|STARTED|Overall Study||137
8134980|NCT02761252|20052423|P2|STARTED|Overall Study||140
8134981|NCT02761252|20052424|P1|STARTED|Overall Study||143
8134982|NCT02760927|20052446|P1|NOT COMPLETED|Overall Study||1
8134983|NCT02760927|20052446|P1|COMPLETED|Overall Study||3
8134984|NCT02760927|20052446|P1|STARTED|Overall Study||4
8134985|NCT02760862|20052456|P2|NOT COMPLETED|Overall Study||0
8134986|NCT02760862|20052457|P1|NOT COMPLETED|Overall Study||0
8134987|NCT02760862|20052456|P2|COMPLETED|Overall Study||25
8134988|NCT02760862|20052457|P1|COMPLETED|Overall Study||25
8134989|NCT02760862|20052456|P2|STARTED|Overall Study||25
8134990|NCT02760862|20052457|P1|STARTED|Overall Study||25
8134991|NCT02760810|20052463|P1|NOT COMPLETED|Overall Study||1
8134992|NCT02760810|20052463|P1|COMPLETED|Overall Study||29
8134993|NCT02760810|20052463|P1|STARTED|Overall Study||30
8134994|NCT02760654|20052471|P2|NOT COMPLETED|Overall Study||6
8134995|NCT02760654|20052472|P1|NOT COMPLETED|Overall Study||7
8134996|NCT02760654|20052471|P2|COMPLETED|Overall Study||24
8134997|NCT02760654|20052472|P1|COMPLETED|Overall Study||23
8134998|NCT02760654|20052471|P2|STARTED|Overall Study||30
8134999|NCT02760654|20052472|P1|STARTED|Overall Study||30
8135000|NCT02760602|20052498|P2|NOT COMPLETED|Overall Study||13
8135001|NCT02760602|20052499|P1|NOT COMPLETED|Overall Study||13
8135002|NCT02760602|20052498|P2|COMPLETED|Overall Study||0
8135003|NCT02760602|20052499|P1|COMPLETED|Overall Study||0
8135004|NCT02760602|20052498|P2|STARTED|Overall Study||13
8135005|NCT02760602|20052499|P1|STARTED|Overall Study||13
8135006|NCT02760368|20052540|P3|NOT COMPLETED|Overall Study||11
8135007|NCT02760368|20052541|P2|NOT COMPLETED|Overall Study||8
8135008|NCT02760368|20052542|P1|NOT COMPLETED|Overall Study||13
8135009|NCT02760368|20052540|P3|COMPLETED|Overall Study||132
8135010|NCT02760368|20052541|P2|COMPLETED|Overall Study||134
8135011|NCT02760368|20052542|P1|COMPLETED|Overall Study||130
8135012|NCT02760368|20052540|P3|STARTED|Overall Study||143
8135013|NCT02760368|20052541|P2|STARTED|Overall Study||142
8135014|NCT02760368|20052542|P1|STARTED|Overall Study||143
8135015|NCT02760277|20052566|P4|NOT COMPLETED|6.0 mg/kg/Day||0
8135016|NCT02760277|20052567|P3|NOT COMPLETED|6.0 mg/kg/Day||0
8135017|NCT02760277|20052568|P2|NOT COMPLETED|6.0 mg/kg/Day||0
8135018|NCT02760277|20052569|P1|NOT COMPLETED|6.0 mg/kg/Day||0
8135019|NCT02760277|20052566|P4|COMPLETED|6.0 mg/kg/Day||12
8135020|NCT02760277|20052567|P3|COMPLETED|6.0 mg/kg/Day||0
8135021|NCT02760277|20052568|P2|COMPLETED|6.0 mg/kg/Day||0
8135022|NCT02760277|20052569|P1|COMPLETED|6.0 mg/kg/Day||0
8135023|NCT02760277|20052566|P4|STARTED|6.0 mg/kg/Day||12
8135024|NCT02760277|20052567|P3|STARTED|6.0 mg/kg/Day||0
8135025|NCT02760277|20052568|P2|STARTED|6.0 mg/kg/Day||0
8135026|NCT02760277|20052569|P1|STARTED|6.0 mg/kg/Day||0
8135027|NCT02760277|20052566|P4|NOT COMPLETED|2.0 mg/kg/Day||0
8135028|NCT02760277|20052567|P3|NOT COMPLETED|2.0 mg/kg/Day||0
8135029|NCT02760277|20052568|P2|NOT COMPLETED|2.0 mg/kg/Day||0
8135030|NCT02760277|20052569|P1|NOT COMPLETED|2.0 mg/kg/Day||0
8135031|NCT02760277|20052566|P4|COMPLETED|2.0 mg/kg/Day||0
8135032|NCT02760277|20052567|P3|COMPLETED|2.0 mg/kg/Day||12
8135033|NCT02760277|20052568|P2|COMPLETED|2.0 mg/kg/Day||0
8135034|NCT02760277|20052569|P1|COMPLETED|2.0 mg/kg/Day||0
8135035|NCT02760277|20052566|P4|STARTED|2.0 mg/kg/Day||0
8135036|NCT02760277|20052567|P3|STARTED|2.0 mg/kg/Day||12
8135037|NCT02760277|20052568|P2|STARTED|2.0 mg/kg/Day||0
8135038|NCT02760277|20052569|P1|STARTED|2.0 mg/kg/Day||0
8135039|NCT02760277|20052566|P4|NOT COMPLETED|0.75 mg/kg/Day||0
8135040|NCT02760277|20052567|P3|NOT COMPLETED|0.75 mg/kg/Day||0
8135041|NCT02760277|20052568|P2|NOT COMPLETED|0.75 mg/kg/Day||0
8135042|NCT02760277|20052569|P1|NOT COMPLETED|0.75 mg/kg/Day||0
8135043|NCT02760277|20052566|P4|COMPLETED|0.75 mg/kg/Day||0
8135044|NCT02760277|20052567|P3|COMPLETED|0.75 mg/kg/Day||0
8135045|NCT02760277|20052568|P2|COMPLETED|0.75 mg/kg/Day||12
8135046|NCT02760277|20052569|P1|COMPLETED|0.75 mg/kg/Day||0
8135047|NCT02760277|20052566|P4|STARTED|0.75 mg/kg/Day||0
8135048|NCT02760277|20052567|P3|STARTED|0.75 mg/kg/Day||0
8135049|NCT02760277|20052568|P2|STARTED|0.75 mg/kg/Day||12
8135050|NCT02760277|20052569|P1|STARTED|0.75 mg/kg/Day||0
8135051|NCT02760277|20052566|P4|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8135052|NCT02760277|20052567|P3|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8135053|NCT02760277|20052568|P2|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8135054|NCT02760277|20052569|P1|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8135055|NCT02760277|20052566|P4|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8135056|NCT02760277|20052567|P3|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8135057|NCT02760277|20052568|P2|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
8135058|NCT02760277|20052569|P1|COMPLETED|Vamorolone 0.25 mg/kg/Day||12
8135059|NCT02760277|20052566|P4|STARTED|Vamorolone 0.25 mg/kg/Day||0
8135060|NCT02760277|20052567|P3|STARTED|Vamorolone 0.25 mg/kg/Day||0
8135061|NCT02760277|20052568|P2|STARTED|Vamorolone 0.25 mg/kg/Day||0
8135062|NCT02760277|20052569|P1|STARTED|Vamorolone 0.25 mg/kg/Day||12
8135063|NCT02760264|20052643|P4|NOT COMPLETED|6.0 mg/kg/Day||0
8135064|NCT02760264|20052644|P3|NOT COMPLETED|6.0 mg/kg/Day||0
8135065|NCT02760264|20052645|P2|NOT COMPLETED|6.0 mg/kg/Day||0
8135066|NCT02760264|20052646|P1|NOT COMPLETED|6.0 mg/kg/Day||0
8135067|NCT02760264|20052643|P4|COMPLETED|6.0 mg/kg/Day||12
8135068|NCT02760264|20052644|P3|COMPLETED|6.0 mg/kg/Day||0
8135069|NCT02760264|20052645|P2|COMPLETED|6.0 mg/kg/Day||0
8135070|NCT02760264|20052646|P1|COMPLETED|6.0 mg/kg/Day||0
8135071|NCT02760264|20052643|P4|STARTED|6.0 mg/kg/Day||12
8135072|NCT02760264|20052644|P3|STARTED|6.0 mg/kg/Day||0
8135073|NCT02760264|20052645|P2|STARTED|6.0 mg/kg/Day||0
8135074|NCT02760264|20052646|P1|STARTED|6.0 mg/kg/Day||0
8135075|NCT02760264|20052643|P4|NOT COMPLETED|2.0 mg/kg/Day||0
8135076|NCT02760264|20052644|P3|NOT COMPLETED|2.0 mg/kg/Day||0
8135077|NCT02760264|20052645|P2|NOT COMPLETED|2.0 mg/kg/Day||0
8135078|NCT02760264|20052646|P1|NOT COMPLETED|2.0 mg/kg/Day||0
8135079|NCT02760264|20052643|P4|COMPLETED|2.0 mg/kg/Day||0
8135080|NCT02760264|20052644|P3|COMPLETED|2.0 mg/kg/Day||12
8135081|NCT02760264|20052645|P2|COMPLETED|2.0 mg/kg/Day||0
8135082|NCT02760264|20052646|P1|COMPLETED|2.0 mg/kg/Day||0
8135083|NCT02760264|20052643|P4|STARTED|2.0 mg/kg/Day||0
8135084|NCT02760264|20052644|P3|STARTED|2.0 mg/kg/Day||12
8135085|NCT02760264|20052645|P2|STARTED|2.0 mg/kg/Day||0
8135086|NCT02760264|20052646|P1|STARTED|2.0 mg/kg/Day||0
8135087|NCT02760264|20052643|P4|NOT COMPLETED|0.75 mg/kg/Day||0
8135088|NCT02760264|20052644|P3|NOT COMPLETED|0.75 mg/kg/Day||0
8135089|NCT02760264|20052645|P2|NOT COMPLETED|0.75 mg/kg/Day||0
8135090|NCT02760264|20052646|P1|NOT COMPLETED|0.75 mg/kg/Day||0
8135091|NCT02760264|20052643|P4|COMPLETED|0.75 mg/kg/Day||0
8135092|NCT02760264|20052644|P3|COMPLETED|0.75 mg/kg/Day||0
8135093|NCT02760264|20052645|P2|COMPLETED|0.75 mg/kg/Day||12
8135094|NCT02760264|20052646|P1|COMPLETED|0.75 mg/kg/Day||0
8135095|NCT02760264|20052643|P4|STARTED|0.75 mg/kg/Day||0
8135096|NCT02760264|20052644|P3|STARTED|0.75 mg/kg/Day||0
8135097|NCT02760264|20052645|P2|STARTED|0.75 mg/kg/Day||12
8135098|NCT02760264|20052646|P1|STARTED|0.75 mg/kg/Day||0
8135099|NCT02760264|20052643|P4|NOT COMPLETED|0.25 mg/kg/Day||0
8135100|NCT02760264|20052644|P3|NOT COMPLETED|0.25 mg/kg/Day||0
8135101|NCT02760264|20052645|P2|NOT COMPLETED|0.25 mg/kg/Day||0
8135102|NCT02760264|20052646|P1|NOT COMPLETED|0.25 mg/kg/Day||0
8135103|NCT02760264|20052643|P4|COMPLETED|0.25 mg/kg/Day||0
8135104|NCT02760264|20052644|P3|COMPLETED|0.25 mg/kg/Day||0
8135105|NCT02760264|20052645|P2|COMPLETED|0.25 mg/kg/Day||0
8135106|NCT02760264|20052646|P1|COMPLETED|0.25 mg/kg/Day||12
8135107|NCT02760264|20052643|P4|STARTED|0.25 mg/kg/Day||0
8135108|NCT02760264|20052644|P3|STARTED|0.25 mg/kg/Day||0
8135109|NCT02760264|20052645|P2|STARTED|0.25 mg/kg/Day||0
8135110|NCT02760264|20052646|P1|STARTED|0.25 mg/kg/Day||12
8135111|NCT02760069|20052724|P3|NOT COMPLETED|Overall Study||1
8135112|NCT02760069|20052725|P2|NOT COMPLETED|Overall Study||1
8135113|NCT02760069|20052726|P1|NOT COMPLETED|Overall Study||0
8135114|NCT02760069|20052724|P3|COMPLETED|Overall Study||40
8135115|NCT02760069|20052725|P2|COMPLETED|Overall Study||40
8135116|NCT02760069|20052726|P1|COMPLETED|Overall Study||40
8135117|NCT02760069|20052724|P3|STARTED|Overall Study||41
8135118|NCT02760069|20052725|P2|STARTED|Overall Study||41
8135119|NCT02760069|20052726|P1|STARTED|Overall Study||40
8135120|NCT02760056|20052739|P2|NOT COMPLETED|Overall Study||0
8135121|NCT02760056|20052740|P1|NOT COMPLETED|Overall Study||0
8135122|NCT02760056|20052739|P2|COMPLETED|Overall Study||5
8135123|NCT02760056|20052740|P1|COMPLETED|Overall Study||10
8135124|NCT02760056|20052739|P2|STARTED|Overall Study||5
8135125|NCT02760056|20052740|P1|STARTED|Overall Study||10
8135126|NCT02759939|20052752|P4|NOT COMPLETED|Overall Study||1043
8135127|NCT02759939|20052753|P3|NOT COMPLETED|Overall Study||1154
8135128|NCT02759939|20052754|P2|NOT COMPLETED|Overall Study||972
8135129|NCT02759939|20052755|P1|NOT COMPLETED|Overall Study||1056
8135130|NCT02759939|20052752|P4|COMPLETED|Overall Study||203
8135131|NCT02759939|20052753|P3|COMPLETED|Overall Study||239
8135132|NCT02759939|20052754|P2|COMPLETED|Overall Study||171
8135133|NCT02759939|20052755|P1|COMPLETED|Overall Study||200
8135134|NCT02759939|20052752|P4|Consented to T2 and T3|Overall Study||564
8135135|NCT02759939|20052753|P3|Consented to T2 and T3|Overall Study||702
8135136|NCT02759939|20052754|P2|Consented to T2 and T3|Overall Study||626
8135137|NCT02759939|20052755|P1|Consented to T2 and T3|Overall Study||579
8135138|NCT02759939|20052752|P4|Analyzed at T2 and/or T3|Overall Study||304
8135139|NCT02759939|20052753|P3|Analyzed at T2 and/or T3|Overall Study||373
8135140|NCT02759939|20052754|P2|Analyzed at T2 and/or T3|Overall Study||278
8135141|NCT02759939|20052755|P1|Analyzed at T2 and/or T3|Overall Study||303
8135142|NCT02759939|20052752|P4|Eligible for T2 and T3|Overall Study||853
8135143|NCT02759939|20052753|P3|Eligible for T2 and T3|Overall Study||1022
8135144|NCT02759939|20052754|P2|Eligible for T2 and T3|Overall Study||962
8135145|NCT02759939|20052755|P1|Eligible for T2 and T3|Overall Study||935
8135146|NCT02759939|20052752|P4|Analyzed at T1|Overall Study||1244
8135147|NCT02759939|20052753|P3|Analyzed at T1|Overall Study||1388
8135148|NCT02759939|20052754|P2|Analyzed at T1|Overall Study||1141
8135149|NCT02759939|20052755|P1|Analyzed at T1|Overall Study||1245
8135150|NCT02759939|20052752|P4|STARTED|Overall Study||1246
8135151|NCT02759939|20052753|P3|STARTED|Overall Study||1393
8135152|NCT02759939|20052754|P2|STARTED|Overall Study||1143
8135153|NCT02759939|20052755|P1|STARTED|Overall Study||1256
8135154|NCT02759692|20052765|P2|NOT COMPLETED|Period 3||0
8135155|NCT02759692|20052766|P1|NOT COMPLETED|Period 3||0
8135156|NCT02759692|20052765|P2|COMPLETED|Period 3||139
8135157|NCT02759692|20052766|P1|COMPLETED|Period 3||137
8135158|NCT02759692|20052765|P2|STARTED|Period 3||139
8135159|NCT02759692|20052766|P1|STARTED|Period 3||137
8135160|NCT02759692|20052765|P2|NOT COMPLETED|Period 2||1
8135161|NCT02759692|20052766|P1|NOT COMPLETED|Period 2||1
8135162|NCT02759692|20052765|P2|COMPLETED|Period 2||139
8135163|NCT02759692|20052766|P1|COMPLETED|Period 2||137
8135164|NCT02759692|20052765|P2|STARTED|Period 2||140
8135165|NCT02759692|20052766|P1|STARTED|Period 2||138
8135166|NCT02759692|20052765|P2|NOT COMPLETED|Period 1||2
8135167|NCT02759692|20052766|P1|NOT COMPLETED|Period 1||3
8135168|NCT02759692|20052765|P2|COMPLETED|Period 1||140
8135169|NCT02759692|20052766|P1|COMPLETED|Period 1||138
8135170|NCT02759692|20052765|P2|STARTED|Period 1||142
8135171|NCT02759692|20052766|P1|STARTED|Period 1||141
8135172|NCT02759562|20052784|P2|NOT COMPLETED|Open-Label Treatment Period||2
8135173|NCT02759562|20052785|P1|NOT COMPLETED|Open-Label Treatment Period||2
8135174|NCT02759562|20052784|P2|COMPLETED|Open-Label Treatment Period||0
8135175|NCT02759562|20052785|P1|COMPLETED|Open-Label Treatment Period||0
8135176|NCT02759562|20052784|P2|STARTED|Open-Label Treatment Period||2
8135177|NCT02759562|20052785|P1|STARTED|Open-Label Treatment Period||2
8135178|NCT02759562|20052784|P2|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
8135179|NCT02759562|20052785|P1|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
8135180|NCT02759562|20052784|P2|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
8135181|NCT02759562|20052785|P1|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
8135182|NCT02759562|20052784|P2|STARTED|Double-Blind Treatment Period (8 Weeks)||3
8135183|NCT02759562|20052785|P1|STARTED|Double-Blind Treatment Period (8 Weeks)||3
8135184|NCT02759471|20052798|P1|NOT COMPLETED|Overall Study||2
8135185|NCT02759471|20052798|P1|COMPLETED|Overall Study||52
8135186|NCT02759471|20052798|P1|STARTED|Overall Study||54
8135187|NCT02759354|20052812|P4|NOT COMPLETED|Overall Study||0
8135188|NCT02759354|20052813|P3|NOT COMPLETED|Overall Study||0
8135189|NCT02759354|20052814|P2|NOT COMPLETED|Overall Study||0
8135190|NCT02759354|20052815|P1|NOT COMPLETED|Overall Study||0
8135191|NCT02759354|20052812|P4|COMPLETED|Overall Study||191
8135192|NCT02759354|20052813|P3|COMPLETED|Overall Study||181
8135193|NCT02759354|20052814|P2|COMPLETED|Overall Study||190
8135194|NCT02759354|20052815|P1|COMPLETED|Overall Study||192
8135195|NCT02759354|20052812|P4|STARTED|Overall Study||191
8135196|NCT02759354|20052813|P3|STARTED|Overall Study||181
8135197|NCT02759354|20052814|P2|STARTED|Overall Study||190
8135198|NCT02759354|20052815|P1|STARTED|Overall Study||192
8135199|NCT02759315|20052854|P5|NOT COMPLETED|Overall Study||1
8135200|NCT02759315|20052855|P4|NOT COMPLETED|Overall Study||1
8135201|NCT02759315|20052856|P3|NOT COMPLETED|Overall Study||10
8135202|NCT02759315|20052857|P2|NOT COMPLETED|Overall Study||1
8135203|NCT02759315|20052858|P1|NOT COMPLETED|Overall Study||4
8135204|NCT02759315|20052854|P5|COMPLETED|Overall Study||2
8135205|NCT02759315|20052855|P4|COMPLETED|Overall Study||19
8135206|NCT02759315|20052856|P3|COMPLETED|Overall Study||29
8135207|NCT02759315|20052857|P2|COMPLETED|Overall Study||28
8135208|NCT02759315|20052858|P1|COMPLETED|Overall Study||65
8135209|NCT02759315|20052854|P5|STARTED|Overall Study||3
8135210|NCT02759315|20052855|P4|STARTED|Overall Study||20
8135211|NCT02759315|20052856|P3|STARTED|Overall Study||39
8135212|NCT02759315|20052857|P2|STARTED|Overall Study||29
8135213|NCT02759315|20052858|P1|STARTED|Overall Study||69
8135214|NCT02759146|20052908|P7|NOT COMPLETED|Week 5-8||6
8135215|NCT02759146|20052909|P6|NOT COMPLETED|Week 5-8||6
8135216|NCT02759146|20052910|P5|NOT COMPLETED|Week 5-8||5
8135217|NCT02759146|20052911|P4|NOT COMPLETED|Week 5-8||7
8135218|NCT02759146|20052912|P3|NOT COMPLETED|Week 5-8||10
8135219|NCT02759146|20052913|P2|NOT COMPLETED|Week 5-8||5
8135220|NCT02759146|20052914|P1|NOT COMPLETED|Week 5-8||10
8135221|NCT02759146|20052908|P7|COMPLETED|Week 5-8||20
8135222|NCT02759146|20052909|P6|COMPLETED|Week 5-8||23
8135223|NCT02759146|20052910|P5|COMPLETED|Week 5-8||44
8135224|NCT02759146|20052911|P4|COMPLETED|Week 5-8||37
8135225|NCT02759146|20052912|P3|COMPLETED|Week 5-8||22
8135226|NCT02759146|20052913|P2|COMPLETED|Week 5-8||29
8135227|NCT02759146|20052914|P1|COMPLETED|Week 5-8||46
8135228|NCT02759146|20052908|P7|STARTED|Week 5-8||26
8135229|NCT02759146|20052909|P6|STARTED|Week 5-8||29
8135230|NCT02759146|20052910|P5|STARTED|Week 5-8||49
8135231|NCT02759146|20052911|P4|STARTED|Week 5-8||44
8135232|NCT02759146|20052912|P3|STARTED|Week 5-8||32
8135233|NCT02759146|20052913|P2|STARTED|Week 5-8||34
8135234|NCT02759146|20052914|P1|STARTED|Week 5-8||56
8135235|NCT02759146|20052908|P7|NOT COMPLETED|Week 1-4||1
8135236|NCT02759146|20052909|P6|NOT COMPLETED|Week 1-4||1
8135237|NCT02759146|20052910|P5|NOT COMPLETED|Week 1-4||0
8135238|NCT02759146|20052911|P4|NOT COMPLETED|Week 1-4||0
8135239|NCT02759146|20052912|P3|NOT COMPLETED|Week 1-4||1
8135240|NCT02759146|20052913|P2|NOT COMPLETED|Week 1-4||2
8135241|NCT02759146|20052914|P1|NOT COMPLETED|Week 1-4||1
8135242|NCT02759146|20052908|P7|COMPLETED|Week 1-4||26
8135243|NCT02759146|20052909|P6|COMPLETED|Week 1-4||29
8135244|NCT02759146|20052910|P5|COMPLETED|Week 1-4||49
8135245|NCT02759146|20052911|P4|COMPLETED|Week 1-4||44
8135246|NCT02759146|20052912|P3|COMPLETED|Week 1-4||32
8135247|NCT02759146|20052913|P2|COMPLETED|Week 1-4||34
8135248|NCT02759146|20052914|P1|COMPLETED|Week 1-4||56
8135249|NCT02759146|20052908|P7|STARTED|Week 1-4||27
8135250|NCT02759146|20052909|P6|STARTED|Week 1-4||30
8135251|NCT02759146|20052910|P5|STARTED|Week 1-4||49
8135252|NCT02759146|20052911|P4|STARTED|Week 1-4|One control participant could continue without the other after baseline.|44
8135253|NCT02759146|20052912|P3|STARTED|Week 1-4||33
8135254|NCT02759146|20052913|P2|STARTED|Week 1-4||36
8135255|NCT02759146|20052914|P1|STARTED|Week 1-4||57
8135256|NCT02759016|20052961|P2|NOT COMPLETED|Overall Study||3
8135257|NCT02759016|20052962|P1|NOT COMPLETED|Overall Study||4
8135258|NCT02759016|20052961|P2|COMPLETED|Overall Study||0
8135259|NCT02759016|20052962|P1|COMPLETED|Overall Study||0
8135260|NCT02759016|20052961|P2|Treated With BI 836826 and Ibrutinib|Overall Study||3
8135261|NCT02759016|20052962|P1|Treated With BI 836826 and Ibrutinib|Overall Study||3
8135262|NCT02759016|20052961|P2|STARTED|Overall Study||3
8135263|NCT02759016|20052962|P1|STARTED|Overall Study||4
8135270|NCT02758717|20052981|P1|NOT COMPLETED|Overall Study||0
8135271|NCT02758717|20052981|P1|COMPLETED|Overall Study||46
8135272|NCT02758717|20052981|P1|STARTED|Overall Study||46
8135273|NCT02758613|20052991|P4|NOT COMPLETED|Follow-up||0
8135274|NCT02758613|20052992|P3|NOT COMPLETED|Follow-up||0
8135275|NCT02758613|20052993|P2|NOT COMPLETED|Follow-up||0
8135276|NCT02758613|20052994|P1|NOT COMPLETED|Follow-up||0
8135277|NCT02758613|20052991|P4|COMPLETED|Follow-up||8
8135278|NCT02758613|20052992|P3|COMPLETED|Follow-up||8
8135279|NCT02758613|20052993|P2|COMPLETED|Follow-up||8
8135280|NCT02758613|20052994|P1|COMPLETED|Follow-up||6
8135281|NCT02758613|20052991|P4|STARTED|Follow-up||8
8135282|NCT02758613|20052992|P3|STARTED|Follow-up||8
8135283|NCT02758613|20052993|P2|STARTED|Follow-up||8
8135284|NCT02758613|20052994|P1|STARTED|Follow-up||6
8135285|NCT02758613|20052991|P4|NOT COMPLETED|Treatment||0
8135286|NCT02758613|20052992|P3|NOT COMPLETED|Treatment||1
8135287|NCT02758613|20052993|P2|NOT COMPLETED|Treatment||0
8135288|NCT02758613|20052994|P1|NOT COMPLETED|Treatment||2
8135289|NCT02758613|20052991|P4|COMPLETED|Treatment||8
8135290|NCT02758613|20052992|P3|COMPLETED|Treatment||8
8135291|NCT02758613|20052993|P2|COMPLETED|Treatment||8
8135292|NCT02758613|20052994|P1|COMPLETED|Treatment||6
8135293|NCT02758613|20052991|P4|Received at Least One Dose of Study Drug|Treatment||8
8135294|NCT02758613|20052992|P3|Received at Least One Dose of Study Drug|Treatment||9
8135295|NCT02758613|20052993|P2|Received at Least One Dose of Study Drug|Treatment||8
8135296|NCT02758613|20052994|P1|Received at Least One Dose of Study Drug|Treatment||8
8135297|NCT02758613|20052991|P4|STARTED|Treatment||8
8135298|NCT02758613|20052992|P3|STARTED|Treatment||9
8135299|NCT02758613|20052993|P2|STARTED|Treatment||8
8135300|NCT02758613|20052994|P1|STARTED|Treatment||8
8135301|NCT02758301|20053012|P2|NOT COMPLETED|Overall Study||8
8135302|NCT02758301|20053013|P1|NOT COMPLETED|Overall Study||34
8135303|NCT02758301|20053012|P2|COMPLETED|Overall Study||0
8135304|NCT02758301|20053013|P1|COMPLETED|Overall Study||70
8135305|NCT02758301|20053012|P2|STARTED|Overall Study||8
8135306|NCT02758301|20053013|P1|STARTED|Overall Study||104
8135307|NCT02758210|20053021|P1|NOT COMPLETED|Overall Study||0
8135308|NCT02758210|20053021|P1|COMPLETED|Overall Study||20
8135309|NCT02758210|20053021|P1|STARTED|Overall Study||20
8135310|NCT02758171|20053032|P2|NOT COMPLETED|Treatment Period 2||0
8135311|NCT02758171|20053033|P1|NOT COMPLETED|Treatment Period 2||0
8135312|NCT02758171|20053032|P2|COMPLETED|Treatment Period 2||28
8135313|NCT02758171|20053033|P1|COMPLETED|Treatment Period 2||26
8135314|NCT02758171|20053032|P2|STARTED|Treatment Period 2||28
8135315|NCT02758171|20053033|P1|STARTED|Treatment Period 2||26
8135316|NCT02758171|20053032|P2|NOT COMPLETED|Wash-out||0
8135317|NCT02758171|20053033|P1|NOT COMPLETED|Wash-out||2
8135318|NCT02758171|20053032|P2|COMPLETED|Wash-out||28
8135319|NCT02758171|20053033|P1|COMPLETED|Wash-out||26
8135320|NCT02758171|20053032|P2|STARTED|Wash-out||28
8135321|NCT02758171|20053033|P1|STARTED|Wash-out||28
8135322|NCT02758171|20053032|P2|NOT COMPLETED|Treatment Period 1||0
8135323|NCT02758171|20053033|P1|NOT COMPLETED|Treatment Period 1||0
8135324|NCT02758171|20053032|P2|COMPLETED|Treatment Period 1||28
8135325|NCT02758171|20053033|P1|COMPLETED|Treatment Period 1||28
8135326|NCT02758171|20053032|P2|STARTED|Treatment Period 1||28
8135327|NCT02758171|20053033|P1|STARTED|Treatment Period 1||28
8135328|NCT02758132|20053051|P2|NOT COMPLETED|Overall Study||1
8135329|NCT02758132|20053052|P1|NOT COMPLETED|Overall Study||0
8135330|NCT02758132|20053051|P2|COMPLETED|Overall Study||0
8135331|NCT02758132|20053052|P1|COMPLETED|Overall Study||0
8135332|NCT02758132|20053051|P2|STARTED|Overall Study||1
8135333|NCT02758132|20053052|P1|STARTED|Overall Study||0
8135334|NCT02758119|20053074|P2|NOT COMPLETED|Overall Study||1
8135335|NCT02758119|20053075|P1|NOT COMPLETED|Overall Study||2
8135336|NCT02758119|20053074|P2|COMPLETED|Overall Study||40
8135337|NCT02758119|20053075|P1|COMPLETED|Overall Study||39
8135338|NCT02758119|20053074|P2|STARTED|Overall Study||41
8135339|NCT02758119|20053075|P1|STARTED|Overall Study||41
8135340|NCT02757963|20053087|P1|NOT COMPLETED|Overall Study||1097
8135341|NCT02757963|20053087|P1|COMPLETED|Overall Study||561
8135342|NCT02757963|20053087|P1|STARTED|Overall Study||1658
8135343|NCT02757950|20053105|P2|NOT COMPLETED|Overall Study||11
8135344|NCT02757950|20053106|P1|NOT COMPLETED|Overall Study||4
8135345|NCT02757950|20053105|P2|COMPLETED|Overall Study||1248
8135346|NCT02757950|20053106|P1|COMPLETED|Overall Study||1199
8135347|NCT02757950|20053105|P2|STARTED|Overall Study||1259
8135348|NCT02757950|20053106|P1|STARTED|Overall Study||1203
8135349|NCT02757768|20053127|P2|NOT COMPLETED|Overall Study||28
8135350|NCT02757768|20053128|P1|NOT COMPLETED|Overall Study||33
8135351|NCT02757768|20053127|P2|COMPLETED|Overall Study||331
8135352|NCT02757768|20053128|P1|COMPLETED|Overall Study||323
8135353|NCT02757768|20053127|P2|Treated|Overall Study||354
8135354|NCT02757768|20053128|P1|Treated|Overall Study||352
8135355|NCT02757768|20053127|P2|STARTED|Overall Study||359
8135356|NCT02757768|20053128|P1|STARTED|Overall Study||356
8135357|NCT02757625|20053178|P4|NOT COMPLETED|Overall Study||0
8135358|NCT02757625|20053179|P3|NOT COMPLETED|Overall Study||2
8135359|NCT02757625|20053180|P2|NOT COMPLETED|Overall Study||0
8135360|NCT02757625|20053181|P1|NOT COMPLETED|Overall Study||0
8135361|NCT02757625|20053178|P4|COMPLETED|Overall Study||12
8135362|NCT02757625|20053179|P3|COMPLETED|Overall Study||17
8135363|NCT02757625|20053180|P2|COMPLETED|Overall Study||18
8135364|NCT02757625|20053181|P1|COMPLETED|Overall Study||14
8135365|NCT02757625|20053178|P4|STARTED|Overall Study||12
8135366|NCT02757625|20053179|P3|STARTED|Overall Study||19
8135367|NCT02757625|20053180|P2|STARTED|Overall Study||18
8135368|NCT02757625|20053181|P1|STARTED|Overall Study||14
8135369|NCT02757547|20053333|P1|NOT COMPLETED|Overall Study||0
8135370|NCT02757547|20053333|P1|COMPLETED|Overall Study||2
8135371|NCT02757547|20053333|P1|STARTED|Overall Study||2
8135372|NCT02757521|20053340|P2|NOT COMPLETED|Overall Study||0
8135373|NCT02757521|20053341|P1|NOT COMPLETED|Overall Study||1
8135374|NCT02757521|20053340|P2|COMPLETED|Overall Study||0
8135375|NCT02757521|20053341|P1|COMPLETED|Overall Study||0
8135376|NCT02757521|20053340|P2|STARTED|Overall Study||0
8135377|NCT02757521|20053341|P1|STARTED|Overall Study||1
8135378|NCT02757430|20053347|P1|NOT COMPLETED|Overall Study||12
8135379|NCT02757430|20053347|P1|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503
8135380|NCT02757430|20053347|P1|EP Mapping/Ablation Procedure|Overall Study||503
8135381|NCT02757430|20053347|P1|Baseline Visits|Overall Study||503
8135382|NCT02757430|20053347|P1|STARTED|Overall Study||515
8135383|NCT02757352|20053366|P10|NOT COMPLETED|Follow-Up Period||3
8135384|NCT02757352|20053367|P9|NOT COMPLETED|Follow-Up Period||10
8135385|NCT02757352|20053368|P8|NOT COMPLETED|Follow-Up Period||1
8135386|NCT02757352|20053369|P7|NOT COMPLETED|Follow-Up Period||1
8135387|NCT02757352|20053370|P6|NOT COMPLETED|Follow-Up Period||0
8135388|NCT02757352|20053371|P5|NOT COMPLETED|Follow-Up Period||0
8135389|NCT02757352|20053372|P4|NOT COMPLETED|Follow-Up Period||0
8135390|NCT02757352|20053373|P3|NOT COMPLETED|Follow-Up Period||0
8135391|NCT02757352|20053374|P2|NOT COMPLETED|Follow-Up Period||0
8135392|NCT02757352|20053375|P1|NOT COMPLETED|Follow-Up Period||0
8135393|NCT02757352|20053366|P10|COMPLETED|Follow-Up Period||2
8135394|NCT02757352|20053367|P9|COMPLETED|Follow-Up Period||18
8135395|NCT02757352|20053368|P8|COMPLETED|Follow-Up Period||4
8135396|NCT02757352|20053369|P7|COMPLETED|Follow-Up Period||2
8135397|NCT02757352|20053370|P6|COMPLETED|Follow-Up Period||0
8135398|NCT02757352|20053371|P5|COMPLETED|Follow-Up Period||0
8135399|NCT02757352|20053372|P4|COMPLETED|Follow-Up Period||0
8135400|NCT02757352|20053373|P3|COMPLETED|Follow-Up Period||0
8135401|NCT02757352|20053374|P2|COMPLETED|Follow-Up Period||0
8135402|NCT02757352|20053375|P1|COMPLETED|Follow-Up Period||0
8135403|NCT02757352|20053366|P10|STARTED|Follow-Up Period||5
8135404|NCT02757352|20053367|P9|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|28
8135405|NCT02757352|20053368|P8|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|5
8135406|NCT02757352|20053369|P7|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|3
8135407|NCT02757352|20053370|P6|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
8135408|NCT02757352|20053371|P5|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
8135409|NCT02757352|20053372|P4|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
8135410|NCT02757352|20053373|P3|STARTED|Follow-Up Period||0
8135411|NCT02757352|20053374|P2|STARTED|Follow-Up Period||0
8135412|NCT02757352|20053375|P1|STARTED|Follow-Up Period||0
8135413|NCT02757352|20053366|P10|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135414|NCT02757352|20053367|P9|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135415|NCT02757352|20053368|P8|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135416|NCT02757352|20053369|P7|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135417|NCT02757352|20053370|P6|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
8135418|NCT02757352|20053371|P5|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||3
8135419|NCT02757352|20053372|P4|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
8135420|NCT02757352|20053373|P3|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135421|NCT02757352|20053374|P2|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135422|NCT02757352|20053375|P1|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135423|NCT02757352|20053366|P10|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135424|NCT02757352|20053367|P9|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135425|NCT02757352|20053368|P8|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135426|NCT02757352|20053369|P7|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135427|NCT02757352|20053370|P6|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||35
8135428|NCT02757352|20053371|P5|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||37
8135429|NCT02757352|20053372|P4|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||55
8135430|NCT02757352|20053373|P3|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135431|NCT02757352|20053374|P2|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135432|NCT02757352|20053375|P1|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
8135433|NCT02757352|20053366|P10|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135434|NCT02757352|20053367|P9|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135435|NCT02757352|20053368|P8|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135436|NCT02757352|20053369|P7|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135437|NCT02757352|20053370|P6|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||3
8135438|NCT02757352|20053371|P5|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135439|NCT02757352|20053372|P4|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||2
8135440|NCT02757352|20053373|P3|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135441|NCT02757352|20053374|P2|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135442|NCT02757352|20053375|P1|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
8135443|NCT02757352|20053366|P10|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
8135444|NCT02757352|20053367|P9|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
8135445|NCT02757352|20053368|P8|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
8135446|NCT02757352|20053369|P7|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
8135447|NCT02757352|20053370|P6|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|42
8135448|NCT02757352|20053371|P5|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|40
8135449|NCT02757352|20053372|P4|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|62
8135450|NCT02757352|20053373|P3|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
8135451|NCT02757352|20053374|P2|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
8135452|NCT02757352|20053375|P1|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
8135453|NCT02757352|20053366|P10|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135454|NCT02757352|20053367|P9|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135455|NCT02757352|20053368|P8|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135456|NCT02757352|20053369|P7|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135457|NCT02757352|20053370|P6|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135458|NCT02757352|20053371|P5|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135459|NCT02757352|20053372|P4|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135460|NCT02757352|20053373|P3|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||46
8135461|NCT02757352|20053374|P2|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||43
8135462|NCT02757352|20053375|P1|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||63
8135463|NCT02757352|20053366|P10|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135464|NCT02757352|20053367|P9|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135465|NCT02757352|20053368|P8|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135466|NCT02757352|20053369|P7|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135467|NCT02757352|20053370|P6|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135468|NCT02757352|20053371|P5|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135469|NCT02757352|20053372|P4|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
8135470|NCT02757352|20053373|P3|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
8135471|NCT02757352|20053374|P2|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
8135472|NCT02757352|20053375|P1|COMPLETED|Double-Blind Period (Week 16 - Week 52)||34
8135473|NCT02757352|20053366|P10|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8135474|NCT02757352|20053367|P9|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8135475|NCT02757352|20053368|P8|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8135476|NCT02757352|20053369|P7|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8135477|NCT02757352|20053370|P6|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8135478|NCT02757352|20053371|P5|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8135479|NCT02757352|20053372|P4|STARTED|Double-Blind Period (Week 16 - Week 52)||0
8135480|NCT02757352|20053373|P3|STARTED|Double-Blind Period (Week 16 - Week 52)||98
8135481|NCT02757352|20053374|P2|STARTED|Double-Blind Period (Week 16 - Week 52)||95
8135482|NCT02757352|20053375|P1|STARTED|Double-Blind Period (Week 16 - Week 52)||97
8135483|NCT02757352|20053366|P10|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135484|NCT02757352|20053367|P9|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135485|NCT02757352|20053368|P8|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135486|NCT02757352|20053369|P7|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135487|NCT02757352|20053370|P6|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135488|NCT02757352|20053371|P5|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135489|NCT02757352|20053372|P4|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135490|NCT02757352|20053373|P3|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||4
8135491|NCT02757352|20053374|P2|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||1
8135492|NCT02757352|20053375|P1|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||8
8135493|NCT02757352|20053366|P10|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135494|NCT02757352|20053367|P9|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135495|NCT02757352|20053368|P8|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135496|NCT02757352|20053369|P7|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135497|NCT02757352|20053370|P6|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135498|NCT02757352|20053371|P5|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135499|NCT02757352|20053372|P4|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
8135500|NCT02757352|20053373|P3|COMPLETED|Double-Blind Period (Week 0 - Week 16)||98
8135501|NCT02757352|20053374|P2|COMPLETED|Double-Blind Period (Week 0 - Week 16)||95
8135502|NCT02757352|20053375|P1|COMPLETED|Double-Blind Period (Week 0 - Week 16)||97
8135503|NCT02757352|20053366|P10|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8135504|NCT02757352|20053367|P9|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8135505|NCT02757352|20053368|P8|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8135506|NCT02757352|20053369|P7|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8135507|NCT02757352|20053370|P6|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8135508|NCT02757352|20053371|P5|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8135509|NCT02757352|20053372|P4|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
8135510|NCT02757352|20053373|P3|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||102
8135511|NCT02757352|20053374|P2|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||96
8135512|NCT02757352|20053375|P1|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||104
8135513|NCT02757352|20053366|P10|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8135514|NCT02757352|20053367|P9|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8135515|NCT02757352|20053368|P8|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8135516|NCT02757352|20053369|P7|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8135517|NCT02757352|20053370|P6|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8135518|NCT02757352|20053371|P5|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8135519|NCT02757352|20053372|P4|STARTED|Double-Blind Period (Week 0 - Week 16)||0
8135520|NCT02757352|20053373|P3|STARTED|Double-Blind Period (Week 0 - Week 16)||102
8135521|NCT02757352|20053374|P2|STARTED|Double-Blind Period (Week 0 - Week 16)||96
8135522|NCT02757352|20053375|P1|STARTED|Double-Blind Period (Week 0 - Week 16)||105
8135523|NCT02757105|20053484|P2|NOT COMPLETED|Overall Study||11
8135524|NCT02757105|20053485|P1|NOT COMPLETED|Overall Study||12
8135525|NCT02757105|20053484|P2|COMPLETED|Overall Study||41
8135526|NCT02757105|20053485|P1|COMPLETED|Overall Study||63
8135527|NCT02757105|20053484|P2|Treated|Overall Study||51
8135528|NCT02757105|20053485|P1|Treated|Overall Study||75
8135529|NCT02757105|20053484|P2|STARTED|Overall Study||52
8135530|NCT02757105|20053485|P1|STARTED|Overall Study||75
8135531|NCT02757092|20053507|P2|NOT COMPLETED|Overall Study||0
8135532|NCT02757092|20053508|P1|NOT COMPLETED|Overall Study||0
8135533|NCT02757092|20053507|P2|COMPLETED|Overall Study|All subjects completed the study|18
8135534|NCT02757092|20053508|P1|COMPLETED|Overall Study|All subjects completed the study|18
8135535|NCT02757092|20053507|P2|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
8135536|NCT02757092|20053508|P1|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
8135537|NCT02757053|20053574|P2|NOT COMPLETED|Overall Study||5
8135538|NCT02757053|20053575|P1|NOT COMPLETED|Overall Study||3
8135539|NCT02757053|20053574|P2|COMPLETED|Overall Study||0
8135540|NCT02757053|20053575|P1|COMPLETED|Overall Study||0
8135541|NCT02757053|20053574|P2|STARTED|Overall Study||5
8135542|NCT02757053|20053575|P1|STARTED|Overall Study||3
8135543|NCT02756949|20053589|P2|NOT COMPLETED|Overall Study||8
8135544|NCT02756949|20053590|P1|NOT COMPLETED|Overall Study||0
8135545|NCT02756949|20053589|P2|COMPLETED|Overall Study||164
8135546|NCT02756949|20053590|P1|COMPLETED|Overall Study||181
8135547|NCT02756949|20053589|P2|STARTED|Overall Study||172
8135548|NCT02756949|20053590|P1|STARTED|Overall Study||181
8135549|NCT02756832|20053598|P1|NOT COMPLETED|Overall Study||53
8135550|NCT02756832|20053598|P1|COMPLETED|Overall Study||1356
8135551|NCT02756832|20053598|P1|Included in Efficacy and Safety Analysis|Overall Study||1399
8135552|NCT02756832|20053598|P1|Received Therapy|Overall Study||1393
8135553|NCT02756832|20053598|P1|STARTED|Overall Study||1409
8135554|NCT02756819|20053612|P1|NOT COMPLETED|Overall Study||52
8135555|NCT02756819|20053612|P1|COMPLETED|Overall Study||1893
8135556|NCT02756819|20053612|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934
8135557|NCT02756819|20053612|P1|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724
8135558|NCT02756819|20053612|P1|STARTED|Overall Study||1945
8135559|NCT02756689|20053624|P2|NOT COMPLETED|Overall Study||0
8135560|NCT02756689|20053625|P1|NOT COMPLETED|Overall Study||0
8135561|NCT02756689|20053624|P2|COMPLETED|Overall Study||65
8135562|NCT02756689|20053625|P1|COMPLETED|Overall Study||64
8135563|NCT02756689|20053624|P2|STARTED|Overall Study||65
8135564|NCT02756689|20053625|P1|STARTED|Overall Study||64
8135565|NCT02756650|20053711|P1|NOT COMPLETED|Overall Study||2
8135566|NCT02756650|20053711|P1|COMPLETED|Overall Study||6
8135567|NCT02756650|20053711|P1|STARTED|Overall Study||8
8135568|NCT02756637|20053734|P2|NOT COMPLETED|Overall Study||54
8135569|NCT02756637|20053735|P1|NOT COMPLETED|Overall Study||87
8135570|NCT02756637|20053734|P2|COMPLETED|Overall Study||263
8135571|NCT02756637|20053735|P1|COMPLETED|Overall Study||230
8135572|NCT02756637|20053734|P2|Completed Curative Treatment|Overall Study||0
8135573|NCT02756637|20053735|P1|Completed Curative Treatment|Overall Study||230
8135574|NCT02756637|20053734|P2|Had NLR Value|Overall Study||263
8135575|NCT02756637|20053735|P1|Had NLR Value|Overall Study||263
8135576|NCT02756637|20053734|P2|Eligible for SWOG 8710|Overall Study||307
8135577|NCT02756637|20053735|P1|Eligible for SWOG 8710|Overall Study||307
8135578|NCT02756637|20053734|P2|STARTED|Overall Study||317
8135579|NCT02756637|20053735|P1|STARTED|Overall Study||317
8135580|NCT02756624|20053743|P2|NOT COMPLETED|Overall Study||7
8135581|NCT02756624|20053744|P1|NOT COMPLETED|Overall Study||16
8135582|NCT02756624|20053743|P2|COMPLETED|Overall Study||166
8135583|NCT02756624|20053744|P1|COMPLETED|Overall Study||327
8135584|NCT02756624|20053743|P2|STARTED|Overall Study||173
8135585|NCT02756624|20053744|P1|STARTED|Overall Study||343
8135586|NCT02756611|20053756|P1|NOT COMPLETED|Overall Study||256
8135587|NCT02756611|20053756|P1|COMPLETED|Overall Study||2
8135588|NCT02756611|20053756|P1|STARTED|Overall Study||258
8135589|NCT02756364|20053770|P3|NOT COMPLETED|Overall Study||48
8135590|NCT02756364|20053771|P2|NOT COMPLETED|Overall Study||47
8135591|NCT02756364|20053772|P1|NOT COMPLETED|Overall Study||46
8135592|NCT02756364|20053770|P3|COMPLETED|Overall Study||0
8135593|NCT02756364|20053771|P2|COMPLETED|Overall Study||0
8135594|NCT02756364|20053772|P1|COMPLETED|Overall Study||0
8135595|NCT02756364|20053770|P3|Treated Participants|Overall Study||47
8135596|NCT02756364|20053771|P2|Treated Participants|Overall Study||47
8135597|NCT02756364|20053772|P1|Treated Participants|Overall Study||46
8135598|NCT02756364|20053770|P3|STARTED|Overall Study||48
8135599|NCT02756364|20053771|P2|STARTED|Overall Study||47
8135600|NCT02756364|20053772|P1|STARTED|Overall Study||46
8135601|NCT02756351|20053797|P2|NOT COMPLETED|Overall Study||0
8135602|NCT02756351|20053798|P1|NOT COMPLETED|Overall Study||0
8135603|NCT02756351|20053797|P2|COMPLETED|Overall Study||24
8135604|NCT02756351|20053798|P1|COMPLETED|Overall Study||24
8135605|NCT02756351|20053797|P2|STARTED|Overall Study||24
8135606|NCT02756351|20053798|P1|STARTED|Overall Study||24
8135607|NCT02756338|20053806|P1|NOT COMPLETED|Overall Study||5
8135608|NCT02756338|20053806|P1|COMPLETED|Overall Study||72
8135609|NCT02756338|20053806|P1|STARTED|Overall Study||77
8135610|NCT02756182|20053815|P1|NOT COMPLETED|Overall Study||4
8135611|NCT02756182|20053815|P1|COMPLETED|Overall Study||21
8135612|NCT02756182|20053815|P1|STARTED|Overall Study||25
8135613|NCT02756078|20053830|P2|NOT COMPLETED|Period 2||7
8135614|NCT02756078|20053831|P1|NOT COMPLETED|Period 2||6
8135615|NCT02756078|20053830|P2|COMPLETED|Period 2||57
8135616|NCT02756078|20053831|P1|COMPLETED|Period 2||70
8135617|NCT02756078|20053830|P2|STARTED|Period 2||64
8135618|NCT02756078|20053831|P1|STARTED|Period 2||76
8135619|NCT02756078|20053830|P2|NOT COMPLETED|Period 1||22
8135620|NCT02756078|20053831|P1|NOT COMPLETED|Period 1||9
8135621|NCT02756078|20053830|P2|COMPLETED|Period 1||64
8135622|NCT02756078|20053831|P1|COMPLETED|Period 1||76
8135623|NCT02756078|20053830|P2|STARTED|Period 1||86
8135624|NCT02756078|20053831|P1|STARTED|Period 1||85
8135625|NCT02756013|20053849|P1|NOT COMPLETED|Overall Study||2
8135626|NCT02756013|20053849|P1|COMPLETED|Overall Study||1
8135627|NCT02756013|20053849|P1|STARTED|Overall Study||3
8135628|NCT02755935|20053854|P1|NOT COMPLETED|Overall Study||2
8135629|NCT02755935|20053854|P1|COMPLETED|Overall Study||22
8135630|NCT02755935|20053854|P1|STARTED|Overall Study||24
8135631|NCT02755831|20053861|P2|NOT COMPLETED|Overall Study||3
8135632|NCT02755831|20053862|P1|NOT COMPLETED|Overall Study||3
8135633|NCT02755831|20053861|P2|COMPLETED|Overall Study||90
8135634|NCT02755831|20053862|P1|COMPLETED|Overall Study||97
8135635|NCT02755831|20053861|P2|STARTED|Overall Study||93
8135636|NCT02755831|20053862|P1|STARTED|Overall Study||100
8135649|NCT02755805|20053917|P2|NOT COMPLETED|Overall Study||4
8135650|NCT02755805|20053918|P1|NOT COMPLETED|Overall Study||2
8135651|NCT02755805|20053917|P2|COMPLETED|Overall Study||11
8135652|NCT02755805|20053918|P1|COMPLETED|Overall Study||13
8135653|NCT02755805|20053917|P2|STARTED|Overall Study||15
8135654|NCT02755805|20053918|P1|STARTED|Overall Study||15
8135655|NCT02755649|20053933|P3|NOT COMPLETED|Overall Study||102
8135656|NCT02755649|20053934|P2|NOT COMPLETED|Overall Study||99
8135657|NCT02755649|20053935|P1|NOT COMPLETED|Overall Study||101
8135658|NCT02755649|20053933|P3|COMPLETED|Overall Study||8
8135659|NCT02755649|20053934|P2|COMPLETED|Overall Study||8
8135660|NCT02755649|20053935|P1|COMPLETED|Overall Study||7
8135661|NCT02755649|20053933|P3|Completed Study (Week 28)|Overall Study||8
8135662|NCT02755649|20053934|P2|Completed Study (Week 28)|Overall Study||8
8135663|NCT02755649|20053935|P1|Completed Study (Week 28)|Overall Study||7
8135664|NCT02755649|20053933|P3|Completed Treatment (Week 16)|Overall Study||109
8135665|NCT02755649|20053934|P2|Completed Treatment (Week 16)|Overall Study||106
8135666|NCT02755649|20053935|P1|Completed Treatment (Week 16)|Overall Study||107
8135667|NCT02755649|20053933|P3|STARTED|Overall Study||110
8135668|NCT02755649|20053934|P2|STARTED|Overall Study||107
8135669|NCT02755649|20053935|P1|STARTED|Overall Study||108
8135670|NCT02755285|20053997|P1|NOT COMPLETED|Overall Study||0
8135671|NCT02755285|20053997|P1|COMPLETED|Overall Study||20
8135672|NCT02755285|20053997|P1|STARTED|Overall Study||20
8135673|NCT02755129|20054001|P1|NOT COMPLETED|Overall Study||0
8135674|NCT02755129|20054001|P1|COMPLETED|Overall Study||15
8135675|NCT02755129|20054001|P1|STARTED|Overall Study||15
8135676|NCT02755116|20054010|P2|NOT COMPLETED|Overall Study||1
8135677|NCT02755116|20054011|P1|NOT COMPLETED|Overall Study||3
8135678|NCT02755116|20054010|P2|COMPLETED|Overall Study||69
8135679|NCT02755116|20054011|P1|COMPLETED|Overall Study||71
8135680|NCT02755116|20054010|P2|STARTED|Overall Study||70
8135681|NCT02755116|20054011|P1|STARTED|Overall Study||74
8135682|NCT02755090|20054027|P2|NOT COMPLETED|Overall Study||0
8135683|NCT02755090|20054028|P1|NOT COMPLETED|Overall Study||1
8135684|NCT02755090|20054027|P2|COMPLETED|Overall Study||20
8135685|NCT02755090|20054028|P1|COMPLETED|Overall Study||18
8135686|NCT02755090|20054027|P2|STARTED|Overall Study||20
8135687|NCT02755090|20054028|P1|STARTED|Overall Study||19
8135688|NCT02754674|20054038|P2|NOT COMPLETED|Overall Study||7
8135689|NCT02754674|20054039|P1|NOT COMPLETED|Overall Study||6
8135690|NCT02754674|20054038|P2|COMPLETED|Overall Study||26
8135691|NCT02754674|20054039|P1|COMPLETED|Overall Study||28
8135692|NCT02754674|20054038|P2|STARTED|Overall Study||33
8135693|NCT02754674|20054039|P1|STARTED|Overall Study||34
8135694|NCT02754661|20054055|P2|NOT COMPLETED|Overall Study||19
8135695|NCT02754661|20054056|P1|NOT COMPLETED|Overall Study||15
8135696|NCT02754661|20054055|P2|COMPLETED|Overall Study||141
8135697|NCT02754661|20054056|P1|COMPLETED|Overall Study||145
8135698|NCT02754661|20054055|P2|STARTED|Overall Study||160
8135699|NCT02754661|20054056|P1|STARTED|Overall Study||160
8135700|NCT02754570|20054070|P1|NOT COMPLETED|Overall Study||0
8135701|NCT02754570|20054070|P1|COMPLETED|Overall Study||27
8135702|NCT02754570|20054070|P1|Visit 3 (PGA + Pilocarpine)|Overall Study||27
8135703|NCT02754570|20054070|P1|Visits 1 and 2 (PGA Only)|Overall Study||27
8135704|NCT02754570|20054070|P1|STARTED|Overall Study||27
8135705|NCT02754492|20054080|P4|NOT COMPLETED|Overall Study||23
8135706|NCT02754492|20054081|P3|NOT COMPLETED|Overall Study||2
8135707|NCT02754492|20054082|P2|NOT COMPLETED|Overall Study||2
8135708|NCT02754492|20054083|P1|NOT COMPLETED|Overall Study||4
8135709|NCT02754492|20054080|P4|COMPLETED|Overall Study||0
8135710|NCT02754492|20054081|P3|COMPLETED|Overall Study||93
8135711|NCT02754492|20054082|P2|COMPLETED|Overall Study||93
8135712|NCT02754492|20054083|P1|COMPLETED|Overall Study||93
8135713|NCT02754492|20054080|P4|STARTED|Overall Study||23
8135714|NCT02754492|20054081|P3|STARTED|Overall Study||95
8135715|NCT02754492|20054082|P2|STARTED|Overall Study||95
8135716|NCT02754492|20054083|P1|STARTED|Overall Study||97
8135717|NCT02754440|20054099|P4|NOT COMPLETED|Overall Study||35
8135718|NCT02754440|20054100|P3|NOT COMPLETED|Overall Study||7
8135719|NCT02754440|20054101|P2|NOT COMPLETED|Overall Study||8
8135720|NCT02754440|20054102|P1|NOT COMPLETED|Overall Study||6
8135721|NCT02754440|20054099|P4|COMPLETED|Overall Study||0
8135722|NCT02754440|20054100|P3|COMPLETED|Overall Study||93
8135723|NCT02754440|20054101|P2|COMPLETED|Overall Study||93
8135724|NCT02754440|20054102|P1|COMPLETED|Overall Study||93
8135725|NCT02754440|20054099|P4|STARTED|Overall Study||35
8135726|NCT02754440|20054100|P3|STARTED|Overall Study||100
8135727|NCT02754440|20054101|P2|STARTED|Overall Study||101
8135728|NCT02754440|20054102|P1|STARTED|Overall Study||99
8135729|NCT02754427|20054116|P2|NOT COMPLETED|Overall Study||1
8135730|NCT02754427|20054117|P1|NOT COMPLETED|Overall Study||0
8135731|NCT02754427|20054116|P2|COMPLETED|Overall Study||19
8135732|NCT02754427|20054117|P1|COMPLETED|Overall Study||21
8135733|NCT02754427|20054116|P2|STARTED|Overall Study||20
8135734|NCT02754427|20054117|P1|STARTED|Overall Study||21
8135735|NCT02754310|20054131|P2|NOT COMPLETED|Overall Study||0
8135736|NCT02754310|20054132|P1|NOT COMPLETED|Overall Study||0
8135737|NCT02754310|20054131|P2|COMPLETED|Overall Study||43
8135738|NCT02754310|20054132|P1|COMPLETED|Overall Study||42
8135739|NCT02754310|20054131|P2|STARTED|Overall Study||43
8135740|NCT02754310|20054132|P1|STARTED|Overall Study||42
8135741|NCT02753946|20054154|P2|NOT COMPLETED|Overall Study||9
8135742|NCT02753946|20054155|P1|NOT COMPLETED|Overall Study||14
8135743|NCT02753946|20054154|P2|COMPLETED|Overall Study||222
8135744|NCT02753946|20054155|P1|COMPLETED|Overall Study||219
8135745|NCT02753946|20054154|P2|STARTED|Overall Study||231
8135746|NCT02753946|20054155|P1|STARTED|Overall Study||233
8135747|NCT02753920|20054167|P2|NOT COMPLETED|Overall Study||0
8135748|NCT02753920|20054168|P1|NOT COMPLETED|Overall Study||0
8135749|NCT02753920|20054167|P2|COMPLETED|Overall Study||86
8135750|NCT02753920|20054168|P1|COMPLETED|Overall Study||87
8135751|NCT02753920|20054167|P2|STARTED|Overall Study||86
8135752|NCT02753920|20054168|P1|STARTED|Overall Study||87
8135753|NCT02753881|20054181|P3|NOT COMPLETED|Overall Study||0
8135754|NCT02753881|20054182|P2|NOT COMPLETED|Overall Study||0
8135755|NCT02753881|20054183|P1|NOT COMPLETED|Overall Study||0
8135756|NCT02753881|20054181|P3|COMPLETED|Overall Study||10
8135757|NCT02753881|20054182|P2|COMPLETED|Overall Study||10
8135758|NCT02753881|20054183|P1|COMPLETED|Overall Study||10
8135759|NCT02753881|20054181|P3|STARTED|Overall Study||10
8135760|NCT02753881|20054182|P2|STARTED|Overall Study||10
8135761|NCT02753881|20054183|P1|STARTED|Overall Study||10
8135762|NCT02753842|20054215|P6|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
8135763|NCT02753842|20054216|P5|NOT COMPLETED|Third Follow-Up (Set of Condoms)||4
8135764|NCT02753842|20054217|P4|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
8135765|NCT02753842|20054218|P3|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
8135766|NCT02753842|20054219|P2|NOT COMPLETED|Third Follow-Up (Set of Condoms)||5
8135767|NCT02753842|20054220|P1|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
8135768|NCT02753842|20054215|P6|COMPLETED|Third Follow-Up (Set of Condoms)||69
8135769|NCT02753842|20054216|P5|COMPLETED|Third Follow-Up (Set of Condoms)||71
8135770|NCT02753842|20054217|P4|COMPLETED|Third Follow-Up (Set of Condoms)||70
8135771|NCT02753842|20054218|P3|COMPLETED|Third Follow-Up (Set of Condoms)||68
8135772|NCT02753842|20054219|P2|COMPLETED|Third Follow-Up (Set of Condoms)||66
8135773|NCT02753842|20054220|P1|COMPLETED|Third Follow-Up (Set of Condoms)||65
8135774|NCT02753842|20054215|P6|STARTED|Third Follow-Up (Set of Condoms)||72
8135775|NCT02753842|20054216|P5|STARTED|Third Follow-Up (Set of Condoms)||75
8135776|NCT02753842|20054217|P4|STARTED|Third Follow-Up (Set of Condoms)||76
8135777|NCT02753842|20054218|P3|STARTED|Third Follow-Up (Set of Condoms)||71
8135778|NCT02753842|20054219|P2|STARTED|Third Follow-Up (Set of Condoms)||71
8135779|NCT02753842|20054220|P1|STARTED|Third Follow-Up (Set of Condoms)||71
8135780|NCT02753842|20054215|P6|NOT COMPLETED|Second Follow-Up (Set of Condoms)||7
8135781|NCT02753842|20054216|P5|NOT COMPLETED|Second Follow-Up (Set of Condoms)||1
8135782|NCT02753842|20054217|P4|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
8135783|NCT02753842|20054218|P3|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
8135784|NCT02753842|20054219|P2|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
8135785|NCT02753842|20054220|P1|NOT COMPLETED|Second Follow-Up (Set of Condoms)||4
8135786|NCT02753842|20054215|P6|COMPLETED|Second Follow-Up (Set of Condoms)||72
8135787|NCT02753842|20054216|P5|COMPLETED|Second Follow-Up (Set of Condoms)||75
8135788|NCT02753842|20054217|P4|COMPLETED|Second Follow-Up (Set of Condoms)||76
8135789|NCT02753842|20054218|P3|COMPLETED|Second Follow-Up (Set of Condoms)||71
8135790|NCT02753842|20054219|P2|COMPLETED|Second Follow-Up (Set of Condoms)||71
8135791|NCT02753842|20054220|P1|COMPLETED|Second Follow-Up (Set of Condoms)||71
8135792|NCT02753842|20054215|P6|STARTED|Second Follow-Up (Set of Condoms)||79
8135793|NCT02753842|20054216|P5|STARTED|Second Follow-Up (Set of Condoms)||76
8135794|NCT02753842|20054217|P4|STARTED|Second Follow-Up (Set of Condoms)||81
8135795|NCT02753842|20054218|P3|STARTED|Second Follow-Up (Set of Condoms)||76
8135796|NCT02753842|20054219|P2|STARTED|Second Follow-Up (Set of Condoms)||76
8135797|NCT02753842|20054220|P1|STARTED|Second Follow-Up (Set of Condoms)||75
8135798|NCT02753842|20054215|P6|NOT COMPLETED|First Follow-Up (Set of Condoms)||5
8135799|NCT02753842|20054216|P5|NOT COMPLETED|First Follow-Up (Set of Condoms)||7
8135800|NCT02753842|20054217|P4|NOT COMPLETED|First Follow-Up (Set of Condoms)||2
8135801|NCT02753842|20054218|P3|NOT COMPLETED|First Follow-Up (Set of Condoms)||9
8135802|NCT02753842|20054219|P2|NOT COMPLETED|First Follow-Up (Set of Condoms)||8
8135803|NCT02753842|20054220|P1|NOT COMPLETED|First Follow-Up (Set of Condoms)||10
8135804|NCT02753842|20054215|P6|COMPLETED|First Follow-Up (Set of Condoms)||79
8135805|NCT02753842|20054216|P5|COMPLETED|First Follow-Up (Set of Condoms)||76
8135806|NCT02753842|20054217|P4|COMPLETED|First Follow-Up (Set of Condoms)||81
8135807|NCT02753842|20054218|P3|COMPLETED|First Follow-Up (Set of Condoms)||76
8135808|NCT02753842|20054219|P2|COMPLETED|First Follow-Up (Set of Condoms)||76
8135809|NCT02753842|20054220|P1|COMPLETED|First Follow-Up (Set of Condoms)||75
8135810|NCT02753842|20054215|P6|STARTED|First Follow-Up (Set of Condoms)||84
8135811|NCT02753842|20054216|P5|STARTED|First Follow-Up (Set of Condoms)||83
8135812|NCT02753842|20054217|P4|STARTED|First Follow-Up (Set of Condoms)||83
8135813|NCT02753842|20054218|P3|STARTED|First Follow-Up (Set of Condoms)||85
8135814|NCT02753842|20054219|P2|STARTED|First Follow-Up (Set of Condoms)||84
8135815|NCT02753842|20054220|P1|STARTED|First Follow-Up (Set of Condoms)||85
8135816|NCT02753699|20054238|P3|NOT COMPLETED|Overall Study||23
8135817|NCT02753699|20054239|P2|NOT COMPLETED|Overall Study||43
8135818|NCT02753699|20054240|P1|NOT COMPLETED|Overall Study||14
8135819|NCT02753699|20054238|P3|COMPLETED|Overall Study||139
8135820|NCT02753699|20054239|P2|COMPLETED|Overall Study||354
8135821|NCT02753699|20054240|P1|COMPLETED|Overall Study||150
8135822|NCT02753699|20054238|P3|STARTED|Overall Study||162
8135823|NCT02753699|20054239|P2|STARTED|Overall Study||397
8135824|NCT02753699|20054240|P1|STARTED|Overall Study||164
8135825|NCT02753595|20054256|P2|NOT COMPLETED|Overall Study||2
8135826|NCT02753595|20054257|P1|NOT COMPLETED|Overall Study||2
8135827|NCT02753595|20054256|P2|COMPLETED|Overall Study||7
8135828|NCT02753595|20054257|P1|COMPLETED|Overall Study||3
8135829|NCT02753595|20054256|P2|STARTED|Overall Study||9
8135830|NCT02753595|20054257|P1|STARTED|Overall Study||5
8135831|NCT02753413|20054265|P2|NOT COMPLETED|Overall Study||0
8135832|NCT02753413|20054266|P1|NOT COMPLETED|Overall Study||0
8135833|NCT02753413|20054265|P2|COMPLETED|Overall Study||51
8135834|NCT02753413|20054266|P1|COMPLETED|Overall Study||49
8135835|NCT02753413|20054265|P2|STARTED|Overall Study||51
8135836|NCT02753413|20054266|P1|STARTED|Overall Study||49
8135837|NCT02753075|20054301|P3|NOT COMPLETED|Overall Study||3
8135838|NCT02753075|20054302|P2|NOT COMPLETED|Overall Study||3
8135839|NCT02753075|20054303|P1|NOT COMPLETED|Overall Study||8
8135840|NCT02753075|20054301|P3|COMPLETED|Overall Study||78
8135841|NCT02753075|20054302|P2|COMPLETED|Overall Study||77
8135842|NCT02753075|20054303|P1|COMPLETED|Overall Study||71
8135843|NCT02753075|20054301|P3|STARTED|Overall Study||81
8135844|NCT02753075|20054302|P2|STARTED|Overall Study||80
8135845|NCT02753075|20054303|P1|STARTED|Overall Study||79
8135846|NCT02752958|20054328|P1|NOT COMPLETED|Overall Study||9
8135847|NCT02752958|20054328|P1|COMPLETED|Overall Study||66
8135848|NCT02752958|20054328|P1|STARTED|Overall Study||75
8135849|NCT02752906|20054399|P2|NOT COMPLETED|Overall Study||5
8135850|NCT02752906|20054400|P1|NOT COMPLETED|Overall Study||7
8135851|NCT02752906|20054399|P2|COMPLETED|Overall Study||402
8135852|NCT02752906|20054400|P1|COMPLETED|Overall Study||396
8135853|NCT02752906|20054399|P2|Vaccinated|Overall Study||407
8135854|NCT02752906|20054400|P1|Vaccinated|Overall Study||402
8135855|NCT02752906|20054399|P2|STARTED|Overall Study||407
8135856|NCT02752906|20054400|P1|STARTED|Overall Study||403
8135857|NCT02752880|20054414|P2|NOT COMPLETED|Overall Study||3
8135858|NCT02752880|20054415|P1|NOT COMPLETED|Overall Study||2
8135859|NCT02752880|20054414|P2|COMPLETED|Overall Study||20
8135860|NCT02752880|20054415|P1|COMPLETED|Overall Study||21
8135861|NCT02752880|20054414|P2|STARTED|Overall Study||23
8135862|NCT02752880|20054415|P1|STARTED|Overall Study||23
8135863|NCT02752802|20054425|P2|NOT COMPLETED|Overall Study||0
8135864|NCT02752802|20054426|P1|NOT COMPLETED|Overall Study||1
8135865|NCT02752802|20054425|P2|COMPLETED|Overall Study||48
8135866|NCT02752802|20054426|P1|COMPLETED|Overall Study||47
8135867|NCT02752802|20054425|P2|STARTED|Overall Study||48
8135868|NCT02752802|20054426|P1|STARTED|Overall Study||48
8135869|NCT02752776|20054438|P3|NOT COMPLETED|Overall Study||48
8135870|NCT02752776|20054439|P2|NOT COMPLETED|Overall Study||76
8135871|NCT02752776|20054440|P1|NOT COMPLETED|Overall Study||52
8135872|NCT02752776|20054438|P3|COMPLETED|Overall Study||276
8135873|NCT02752776|20054439|P2|COMPLETED|Overall Study||597
8135874|NCT02752776|20054440|P1|COMPLETED|Overall Study||611
8135875|NCT02752776|20054438|P3|STARTED|Overall Study||324
8135876|NCT02752776|20054439|P2|STARTED|Overall Study||673
8135877|NCT02752776|20054440|P1|STARTED|Overall Study||663
8135878|NCT02752633|20054486|P1|NOT COMPLETED|Overall Study||1
8135879|NCT02752633|20054486|P1|COMPLETED|Overall Study||8
8135880|NCT02752633|20054486|P1|STARTED|Overall Study||9
8135881|NCT02752490|20054492|P2|NOT COMPLETED|Overall Study||0
8135882|NCT02752490|20054493|P1|NOT COMPLETED|Overall Study||0
8135883|NCT02752490|20054492|P2|COMPLETED|Overall Study||435
8135884|NCT02752490|20054493|P1|COMPLETED|Overall Study||409
8135885|NCT02752490|20054492|P2|STARTED|Overall Study||435
8135886|NCT02752490|20054493|P1|STARTED|Overall Study||409
8135887|NCT02752256|20054515|P2|NOT COMPLETED|Overall Study||0
8135888|NCT02752256|20054516|P1|NOT COMPLETED|Overall Study||0
8135889|NCT02752256|20054515|P2|COMPLETED|Overall Study||41
8135890|NCT02752256|20054516|P1|COMPLETED|Overall Study||35
8135891|NCT02752256|20054515|P2|STARTED|Overall Study||41
8135892|NCT02752256|20054516|P1|STARTED|Overall Study||35
8135893|NCT02752087|20054524|P2|NOT COMPLETED|Follow-up||0
8135894|NCT02752087|20054525|P1|NOT COMPLETED|Follow-up||0
8135895|NCT02752087|20054524|P2|COMPLETED|Follow-up||12
8135896|NCT02752087|20054525|P1|COMPLETED|Follow-up||11
8135897|NCT02752087|20054524|P2|STARTED|Follow-up||12
8135898|NCT02752087|20054525|P1|STARTED|Follow-up||11
8135899|NCT02752087|20054524|P2|NOT COMPLETED|Study Period 4||0
8135900|NCT02752087|20054525|P1|NOT COMPLETED|Study Period 4||0
8135901|NCT02752087|20054524|P2|COMPLETED|Study Period 4||12
8135902|NCT02752087|20054525|P1|COMPLETED|Study Period 4||11
8135903|NCT02752087|20054524|P2|Received Study Drug|Study Period 4||12
8135904|NCT02752087|20054525|P1|Received Study Drug|Study Period 4||11
8135905|NCT02752087|20054524|P2|STARTED|Study Period 4||12
8135906|NCT02752087|20054525|P1|STARTED|Study Period 4||11
8135907|NCT02752087|20054524|P2|NOT COMPLETED|Washout||0
8135908|NCT02752087|20054525|P1|NOT COMPLETED|Washout||0
8135909|NCT02752087|20054524|P2|COMPLETED|Washout||12
8135910|NCT02752087|20054525|P1|COMPLETED|Washout||11
8135911|NCT02752087|20054524|P2|STARTED|Washout||12
8135912|NCT02752087|20054525|P1|STARTED|Washout||11
8135913|NCT02752087|20054524|P2|NOT COMPLETED|Study Period 3||0
8135914|NCT02752087|20054525|P1|NOT COMPLETED|Study Period 3||0
8135915|NCT02752087|20054524|P2|COMPLETED|Study Period 3||12
8135916|NCT02752087|20054525|P1|COMPLETED|Study Period 3||11
8135917|NCT02752087|20054524|P2|Received Study Drug|Study Period 3||12
8135918|NCT02752087|20054525|P1|Received Study Drug|Study Period 3||11
8135919|NCT02752087|20054524|P2|STARTED|Study Period 3||12
8135920|NCT02752087|20054525|P1|STARTED|Study Period 3||11
8135921|NCT02752087|20054524|P2|NOT COMPLETED|Washout||0
8135922|NCT02752087|20054525|P1|NOT COMPLETED|Washout||0
8135923|NCT02752087|20054524|P2|COMPLETED|Washout||12
8135924|NCT02752087|20054525|P1|COMPLETED|Washout||11
8135925|NCT02752087|20054524|P2|STARTED|Washout||12
8135926|NCT02752087|20054525|P1|STARTED|Washout||11
8135927|NCT02752087|20054524|P2|NOT COMPLETED|Study Period 2||0
8135928|NCT02752087|20054525|P1|NOT COMPLETED|Study Period 2||0
8135929|NCT02752087|20054524|P2|COMPLETED|Study Period 2||12
8135930|NCT02752087|20054525|P1|COMPLETED|Study Period 2||11
8135931|NCT02752087|20054524|P2|Received Study Drug|Study Period 2||12
8135932|NCT02752087|20054525|P1|Received Study Drug|Study Period 2||11
8135933|NCT02752087|20054524|P2|STARTED|Study Period 2||12
8135934|NCT02752087|20054525|P1|STARTED|Study Period 2||11
8135935|NCT02752087|20054524|P2|NOT COMPLETED|Washout||0
8135936|NCT02752087|20054525|P1|NOT COMPLETED|Washout||1
8135937|NCT02752087|20054524|P2|COMPLETED|Washout||12
8135938|NCT02752087|20054525|P1|COMPLETED|Washout||11
8135939|NCT02752087|20054524|P2|STARTED|Washout||12
8135940|NCT02752087|20054525|P1|STARTED|Washout||12
8135941|NCT02752087|20054524|P2|NOT COMPLETED|Study Period 1||0
8135942|NCT02752087|20054525|P1|NOT COMPLETED|Study Period 1||0
8135943|NCT02752087|20054524|P2|COMPLETED|Study Period 1||12
8135944|NCT02752087|20054525|P1|COMPLETED|Study Period 1||12
8135945|NCT02752087|20054524|P2|Received Study Drug|Study Period 1||12
8135946|NCT02752087|20054525|P1|Received Study Drug|Study Period 1||12
8135947|NCT02752087|20054524|P2|STARTED|Study Period 1||12
8135948|NCT02752087|20054525|P1|STARTED|Study Period 1||12
8135949|NCT02752074|20054535|P2|NOT COMPLETED|Overall Study||143
8135950|NCT02752074|20054536|P1|NOT COMPLETED|Overall Study||156
8135951|NCT02752074|20054535|P2|COMPLETED|Overall Study||209
8135952|NCT02752074|20054536|P1|COMPLETED|Overall Study||198
8135953|NCT02752074|20054535|P2|Treated|Overall Study||352
8135954|NCT02752074|20054536|P1|Treated|Overall Study||353
8135955|NCT02752074|20054535|P2|STARTED|Overall Study||352
8135956|NCT02752074|20054536|P1|STARTED|Overall Study||354
8135957|NCT02752048|20054561|P3|NOT COMPLETED|Overall Study||3
8135958|NCT02752048|20054562|P2|NOT COMPLETED|Overall Study||0
8135959|NCT02752048|20054563|P1|NOT COMPLETED|Overall Study||0
8135960|NCT02752048|20054561|P3|COMPLETED|Overall Study||10
8135961|NCT02752048|20054562|P2|COMPLETED|Overall Study||12
8135962|NCT02752048|20054563|P1|COMPLETED|Overall Study||11
8135963|NCT02752048|20054561|P3|STARTED|Overall Study||13
8135964|NCT02752048|20054562|P2|STARTED|Overall Study||12
8135965|NCT02752048|20054563|P1|STARTED|Overall Study||11
8135966|NCT02751983|20054582|P2|NOT COMPLETED|Three-Month Follow-Up Assessments||16
8135967|NCT02751983|20054583|P1|NOT COMPLETED|Three-Month Follow-Up Assessments||12
8135968|NCT02751983|20054582|P2|COMPLETED|Three-Month Follow-Up Assessments||19
8135969|NCT02751983|20054583|P1|COMPLETED|Three-Month Follow-Up Assessments||23
8135970|NCT02751983|20054582|P2|STARTED|Three-Month Follow-Up Assessments||35
8135971|NCT02751983|20054583|P1|STARTED|Three-Month Follow-Up Assessments||35
8135972|NCT02751983|20054582|P2|NOT COMPLETED|One-Month Follow-Up Assessments||12
8135973|NCT02751983|20054583|P1|NOT COMPLETED|One-Month Follow-Up Assessments||14
8135974|NCT02751983|20054582|P2|COMPLETED|One-Month Follow-Up Assessments||23
8135975|NCT02751983|20054583|P1|COMPLETED|One-Month Follow-Up Assessments||21
8135976|NCT02751983|20054582|P2|STARTED|One-Month Follow-Up Assessments||35
8135977|NCT02751983|20054583|P1|STARTED|One-Month Follow-Up Assessments||35
8135978|NCT02751983|20054582|P2|NOT COMPLETED|Post-Treatment Assessment||0
8135979|NCT02751983|20054583|P1|NOT COMPLETED|Post-Treatment Assessment||5
8135980|NCT02751983|20054582|P2|COMPLETED|Post-Treatment Assessment||0
8135981|NCT02751983|20054583|P1|COMPLETED|Post-Treatment Assessment||30
8135982|NCT02751983|20054582|P2|STARTED|Post-Treatment Assessment||0
8135983|NCT02751983|20054583|P1|STARTED|Post-Treatment Assessment||35
8135984|NCT02751983|20054582|P2|NOT COMPLETED|Treatment||0
8135985|NCT02751983|20054583|P1|NOT COMPLETED|Treatment||4
8135986|NCT02751983|20054582|P2|COMPLETED|Treatment||35
8135987|NCT02751983|20054583|P1|COMPLETED|Treatment||31
8135988|NCT02751983|20054582|P2|STARTED|Treatment||35
8135989|NCT02751983|20054583|P1|STARTED|Treatment||35
8135990|NCT02751983|20054582|P2|NOT COMPLETED|Baseline and Randomization||0
8135991|NCT02751983|20054583|P1|NOT COMPLETED|Baseline and Randomization||0
8135992|NCT02751983|20054582|P2|COMPLETED|Baseline and Randomization||35
8135993|NCT02751983|20054583|P1|COMPLETED|Baseline and Randomization||35
8135994|NCT02751983|20054582|P2|STARTED|Baseline and Randomization||35
8135995|NCT02751983|20054583|P1|STARTED|Baseline and Randomization||35
8136004|NCT02751879|20054679|P2|NOT COMPLETED|Overall Study||0
8136005|NCT02751879|20054680|P1|NOT COMPLETED|Overall Study||0
8136006|NCT02751879|20054679|P2|COMPLETED|Overall Study||71
8136007|NCT02751879|20054680|P1|COMPLETED|Overall Study||157
8136008|NCT02751879|20054679|P2|On Treatment at Study Completion|Overall Study||41
8136009|NCT02751879|20054680|P1|On Treatment at Study Completion|Overall Study||81
8136010|NCT02751879|20054679|P2|STARTED|Overall Study||71
8136011|NCT02751879|20054680|P1|STARTED|Overall Study||157
8136012|NCT02751580|20054693|P1|NOT COMPLETED|Overall Study||6
8136013|NCT02751580|20054693|P1|COMPLETED|Overall Study||31
8136014|NCT02751580|20054693|P1|STARTED|Overall Study||37
8136015|NCT02751450|20054706|P2|NOT COMPLETED|Overall Study||0
8136016|NCT02751450|20054707|P1|NOT COMPLETED|Overall Study||1
8136017|NCT02751450|20054706|P2|COMPLETED|Overall Study||116
8136018|NCT02751450|20054707|P1|COMPLETED|Overall Study||116
8136019|NCT02751450|20054706|P2|STARTED|Overall Study||116
8136020|NCT02751450|20054707|P1|STARTED|Overall Study||117
8136021|NCT02751424|20054728|P9|NOT COMPLETED|Part 2||0
8136022|NCT02751424|20054729|P8|NOT COMPLETED|Part 2||5
8136023|NCT02751424|20054730|P7|NOT COMPLETED|Part 2||0
8136024|NCT02751424|20054731|P6|NOT COMPLETED|Part 2||0
8136025|NCT02751424|20054732|P5|NOT COMPLETED|Part 2||0
8136026|NCT02751424|20054733|P4|NOT COMPLETED|Part 2||0
8136027|NCT02751424|20054734|P3|NOT COMPLETED|Part 2||0
8136028|NCT02751424|20054735|P2|NOT COMPLETED|Part 2||0
8136029|NCT02751424|20054736|P1|NOT COMPLETED|Part 2||0
8136030|NCT02751424|20054728|P9|COMPLETED|Part 2||3
8136031|NCT02751424|20054729|P8|COMPLETED|Part 2||6
8136032|NCT02751424|20054730|P7|COMPLETED|Part 2||0
8136033|NCT02751424|20054731|P6|COMPLETED|Part 2||0
8136034|NCT02751424|20054732|P5|COMPLETED|Part 2||0
8136035|NCT02751424|20054733|P4|COMPLETED|Part 2||0
8136036|NCT02751424|20054734|P3|COMPLETED|Part 2||0
8136037|NCT02751424|20054735|P2|COMPLETED|Part 2||0
8136038|NCT02751424|20054736|P1|COMPLETED|Part 2||0
8136039|NCT02751424|20054728|P9|STARTED|Part 2||3
8136040|NCT02751424|20054729|P8|STARTED|Part 2||11
8136041|NCT02751424|20054730|P7|STARTED|Part 2||0
8136042|NCT02751424|20054731|P6|STARTED|Part 2||0
8136043|NCT02751424|20054732|P5|STARTED|Part 2||0
8136044|NCT02751424|20054733|P4|STARTED|Part 2||0
8136045|NCT02751424|20054734|P3|STARTED|Part 2||0
8136046|NCT02751424|20054735|P2|STARTED|Part 2||0
8136047|NCT02751424|20054736|P1|STARTED|Part 2||0
8136048|NCT02751424|20054728|P9|NOT COMPLETED|Part 1||0
8136049|NCT02751424|20054729|P8|NOT COMPLETED|Part 1||0
8136050|NCT02751424|20054730|P7|NOT COMPLETED|Part 1||0
8136051|NCT02751424|20054731|P6|NOT COMPLETED|Part 1||0
8136052|NCT02751424|20054732|P5|NOT COMPLETED|Part 1||0
8136053|NCT02751424|20054733|P4|NOT COMPLETED|Part 1||0
8136054|NCT02751424|20054734|P3|NOT COMPLETED|Part 1||0
8136055|NCT02751424|20054735|P2|NOT COMPLETED|Part 1||0
8136056|NCT02751424|20054736|P1|NOT COMPLETED|Part 1||0
8136057|NCT02751424|20054728|P9|COMPLETED|Part 1||0
8136058|NCT02751424|20054729|P8|COMPLETED|Part 1||0
8136059|NCT02751424|20054730|P7|COMPLETED|Part 1||12
8136060|NCT02751424|20054731|P6|COMPLETED|Part 1||6
8136061|NCT02751424|20054732|P5|COMPLETED|Part 1||6
8136062|NCT02751424|20054733|P4|COMPLETED|Part 1||6
8136063|NCT02751424|20054734|P3|COMPLETED|Part 1||6
8136064|NCT02751424|20054735|P2|COMPLETED|Part 1||6
8136065|NCT02751424|20054736|P1|COMPLETED|Part 1||6
8136066|NCT02751424|20054728|P9|STARTED|Part 1||0
8136067|NCT02751424|20054729|P8|STARTED|Part 1||0
8136068|NCT02751424|20054730|P7|STARTED|Part 1||12
8136069|NCT02751424|20054731|P6|STARTED|Part 1||6
8136070|NCT02751424|20054732|P5|STARTED|Part 1||6
8136071|NCT02751424|20054733|P4|STARTED|Part 1||6
8136072|NCT02751424|20054734|P3|STARTED|Part 1||6
8136073|NCT02751424|20054735|P2|STARTED|Part 1||6
8136074|NCT02751424|20054736|P1|STARTED|Part 1||6
8136075|NCT02751385|20054879|P2|NOT COMPLETED|Period 2||0
8136076|NCT02751385|20054880|P1|NOT COMPLETED|Period 2||0
8136077|NCT02751385|20054879|P2|COMPLETED|Period 2||2
8136078|NCT02751385|20054880|P1|COMPLETED|Period 2||0
8136079|NCT02751385|20054879|P2|STARTED|Period 2||2
8136080|NCT02751385|20054880|P1|STARTED|Period 2||0
8136081|NCT02751385|20054879|P2|NOT COMPLETED|Period 1||0
8136082|NCT02751385|20054880|P1|NOT COMPLETED|Period 1||0
8136083|NCT02751385|20054879|P2|COMPLETED|Period 1||0
8136084|NCT02751385|20054880|P1|COMPLETED|Period 1||2
8136085|NCT02751385|20054879|P2|STARTED|Period 1||0
8136086|NCT02751385|20054880|P1|STARTED|Period 1||2
8136087|NCT02751320|20054892|P1|NOT COMPLETED|Overall Study||3
8136088|NCT02751320|20054892|P1|COMPLETED|Overall Study||42
8136089|NCT02751320|20054892|P1|Received Reference Product 3|Overall Study||28
8136090|NCT02751320|20054892|P1|Received Reference Product 2|Overall Study||28
8136091|NCT02751320|20054892|P1|Received Reference Product 1|Overall Study||29
8136092|NCT02751320|20054892|P1|Received Test Prodcut 3|Overall Study||28
8136093|NCT02751320|20054892|P1|Received Test Prodcut 2|Overall Study||28
8136094|NCT02751320|20054892|P1|Received Test Product 1|Overall Study||29
8136095|NCT02751320|20054892|P1|STARTED|Overall Study||45
8136096|NCT02750943|20054930|P2|NOT COMPLETED|Overall Study||9
8136097|NCT02750943|20054931|P1|NOT COMPLETED|Overall Study||6
8136098|NCT02750943|20054930|P2|COMPLETED|Overall Study||119
8136099|NCT02750943|20054931|P1|COMPLETED|Overall Study||119
8136100|NCT02750943|20054930|P2|STARTED|Overall Study||128
8136101|NCT02750943|20054931|P1|STARTED|Overall Study||125
8136102|NCT02750930|20054945|P1|NOT COMPLETED|Overall Study||8
8136103|NCT02750930|20054945|P1|COMPLETED|Overall Study||0
8136104|NCT02750930|20054945|P1|STARTED|Overall Study||8
8136105|NCT02750813|20054957|P2|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
8136106|NCT02750813|20054958|P1|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
8136107|NCT02750813|20054957|P2|COMPLETED|Period 2, Second 14 Days of Wear||120
8136108|NCT02750813|20054958|P1|COMPLETED|Period 2, Second 14 Days of Wear||124
8136109|NCT02750813|20054957|P2|STARTED|Period 2, Second 14 Days of Wear||120
8136110|NCT02750813|20054958|P1|STARTED|Period 2, Second 14 Days of Wear||124
8136111|NCT02750813|20054957|P2|NOT COMPLETED|Period 1, First 14 Days of Wear||1
8136112|NCT02750813|20054958|P1|NOT COMPLETED|Period 1, First 14 Days of Wear||1
8136113|NCT02750813|20054957|P2|COMPLETED|Period 1, First 14 Days of Wear||120
8136114|NCT02750813|20054958|P1|COMPLETED|Period 1, First 14 Days of Wear||124
8136115|NCT02750813|20054957|P2|STARTED|Period 1, First 14 Days of Wear||121
8136116|NCT02750813|20054958|P1|STARTED|Period 1, First 14 Days of Wear||125
8136117|NCT02750800|20054973|P1|NOT COMPLETED|Overall Study||98
8136118|NCT02750800|20054973|P1|COMPLETED|Overall Study||314
8136119|NCT02750800|20054973|P1|STARTED|Overall Study||412
8136120|NCT02750761|20055078|P6|NOT COMPLETED|Overall Study||0
8136121|NCT02750761|20055079|P5|NOT COMPLETED|Overall Study||0
8136122|NCT02750761|20055080|P4|NOT COMPLETED|Overall Study||0
8136123|NCT02750761|20055081|P3|NOT COMPLETED|Overall Study||1
8136124|NCT02750761|20055082|P2|NOT COMPLETED|Overall Study||0
8136125|NCT02750761|20055083|P1|NOT COMPLETED|Overall Study||0
8136126|NCT02750761|20055078|P6|COMPLETED|Overall Study||6
8136127|NCT02750761|20055079|P5|COMPLETED|Overall Study||6
8136128|NCT02750761|20055080|P4|COMPLETED|Overall Study||5
8136129|NCT02750761|20055081|P3|COMPLETED|Overall Study||4
8136130|NCT02750761|20055082|P2|COMPLETED|Overall Study||5
8136131|NCT02750761|20055083|P1|COMPLETED|Overall Study||5
8136132|NCT02750761|20055078|P6|STARTED|Overall Study||6
8136133|NCT02750761|20055079|P5|STARTED|Overall Study||6
8136134|NCT02750761|20055080|P4|STARTED|Overall Study||5
8136135|NCT02750761|20055081|P3|STARTED|Overall Study||5
8136136|NCT02750761|20055082|P2|STARTED|Overall Study||5
8136137|NCT02750761|20055083|P1|STARTED|Overall Study||5
8136138|NCT02750709|20055179|P6|NOT COMPLETED|Treatment Period 3||0
8136139|NCT02750709|20055180|P5|NOT COMPLETED|Treatment Period 3||0
8136140|NCT02750709|20055181|P4|NOT COMPLETED|Treatment Period 3||0
8136141|NCT02750709|20055182|P3|NOT COMPLETED|Treatment Period 3||0
8136142|NCT02750709|20055183|P2|NOT COMPLETED|Treatment Period 3||0
8136143|NCT02750709|20055184|P1|NOT COMPLETED|Treatment Period 3||0
8136144|NCT02750709|20055179|P6|COMPLETED|Treatment Period 3||3
8136145|NCT02750709|20055180|P5|COMPLETED|Treatment Period 3||4
8136146|NCT02750709|20055181|P4|COMPLETED|Treatment Period 3||4
8136147|NCT02750709|20055182|P3|COMPLETED|Treatment Period 3||4
8136148|NCT02750709|20055183|P2|COMPLETED|Treatment Period 3||4
8136149|NCT02750709|20055184|P1|COMPLETED|Treatment Period 3||4
8136150|NCT02750709|20055179|P6|STARTED|Treatment Period 3||3
8136151|NCT02750709|20055180|P5|STARTED|Treatment Period 3||4
8136152|NCT02750709|20055181|P4|STARTED|Treatment Period 3||4
8136153|NCT02750709|20055182|P3|STARTED|Treatment Period 3||4
8136154|NCT02750709|20055183|P2|STARTED|Treatment Period 3||4
8136155|NCT02750709|20055184|P1|STARTED|Treatment Period 3||4
8136156|NCT02750709|20055179|P6|NOT COMPLETED|Treatment Period 2||0
8136157|NCT02750709|20055180|P5|NOT COMPLETED|Treatment Period 2||0
8136158|NCT02750709|20055181|P4|NOT COMPLETED|Treatment Period 2||0
8136159|NCT02750709|20055182|P3|NOT COMPLETED|Treatment Period 2||0
8136160|NCT02750709|20055183|P2|NOT COMPLETED|Treatment Period 2||0
8136161|NCT02750709|20055184|P1|NOT COMPLETED|Treatment Period 2||0
8136162|NCT02750709|20055179|P6|COMPLETED|Treatment Period 2||3
8136163|NCT02750709|20055180|P5|COMPLETED|Treatment Period 2||4
8136164|NCT02750709|20055181|P4|COMPLETED|Treatment Period 2||4
8136165|NCT02750709|20055182|P3|COMPLETED|Treatment Period 2||4
8136166|NCT02750709|20055183|P2|COMPLETED|Treatment Period 2||4
8136167|NCT02750709|20055184|P1|COMPLETED|Treatment Period 2||4
8136168|NCT02750709|20055179|P6|STARTED|Treatment Period 2||3
8136169|NCT02750709|20055180|P5|STARTED|Treatment Period 2||4
8136170|NCT02750709|20055181|P4|STARTED|Treatment Period 2||4
8136171|NCT02750709|20055182|P3|STARTED|Treatment Period 2||4
8136172|NCT02750709|20055183|P2|STARTED|Treatment Period 2||4
8136173|NCT02750709|20055184|P1|STARTED|Treatment Period 2||4
8136174|NCT02750709|20055179|P6|NOT COMPLETED|Treatment Period 1||1
8136175|NCT02750709|20055180|P5|NOT COMPLETED|Treatment Period 1||0
8136176|NCT02750709|20055181|P4|NOT COMPLETED|Treatment Period 1||0
8136177|NCT02750709|20055182|P3|NOT COMPLETED|Treatment Period 1||0
8136178|NCT02750709|20055183|P2|NOT COMPLETED|Treatment Period 1||0
8136179|NCT02750709|20055184|P1|NOT COMPLETED|Treatment Period 1||0
8136180|NCT02750709|20055179|P6|COMPLETED|Treatment Period 1||3
8136181|NCT02750709|20055180|P5|COMPLETED|Treatment Period 1||4
8136182|NCT02750709|20055181|P4|COMPLETED|Treatment Period 1||4
8136183|NCT02750709|20055182|P3|COMPLETED|Treatment Period 1||4
8136184|NCT02750709|20055183|P2|COMPLETED|Treatment Period 1||4
8136185|NCT02750709|20055184|P1|COMPLETED|Treatment Period 1||4
8136186|NCT02750709|20055179|P6|STARTED|Treatment Period 1||4
8136187|NCT02750709|20055180|P5|STARTED|Treatment Period 1||4
8136188|NCT02750709|20055181|P4|STARTED|Treatment Period 1||4
8136189|NCT02750709|20055182|P3|STARTED|Treatment Period 1||4
8136190|NCT02750709|20055183|P2|STARTED|Treatment Period 1||4
8136191|NCT02750709|20055184|P1|STARTED|Treatment Period 1||4
8136192|NCT02750618|20055210|P1|NOT COMPLETED|Overall Study||1
8136193|NCT02750618|20055210|P1|COMPLETED|Overall Study||12
8136194|NCT02750618|20055210|P1|Completed Week 64|Overall Study||13
8136195|NCT02750618|20055210|P1|Completed Week 40|Overall Study||13
8136196|NCT02750618|20055210|P1|STARTED|Overall Study||13
8136197|NCT02750592|20055226|P1|NOT COMPLETED|Overall Study||5
8136198|NCT02750592|20055226|P1|COMPLETED|Overall Study||25
8136199|NCT02750592|20055226|P1|STARTED|Overall Study||30
8136200|NCT02750501|20055245|P1|NOT COMPLETED|Overall Study||8
8136201|NCT02750501|20055245|P1|COMPLETED|Overall Study||36
8136202|NCT02750501|20055245|P1|Treated|Overall Study||39
8136203|NCT02750501|20055245|P1|Enrolled|Overall Study||44
8136204|NCT02750501|20055245|P1|STARTED|Overall Study||44
8136205|NCT02750410|20055259|P2|NOT COMPLETED|Open-Label Extension Period||6
8136206|NCT02750410|20055260|P1|NOT COMPLETED|Open-Label Extension Period||6
8136207|NCT02750410|20055259|P2|COMPLETED|Open-Label Extension Period||111
8136208|NCT02750410|20055260|P1|COMPLETED|Open-Label Extension Period||31
8136209|NCT02750410|20055259|P2|STARTED|Open-Label Extension Period||117
8136210|NCT02750410|20055260|P1|STARTED|Open-Label Extension Period||37
8136211|NCT02750410|20055259|P2|NOT COMPLETED|Double-Blind Treatment Period||3
8136212|NCT02750410|20055260|P1|NOT COMPLETED|Double-Blind Treatment Period||2
8136213|NCT02750410|20055259|P2|COMPLETED|Double-Blind Treatment Period||117
8136214|NCT02750410|20055260|P1|COMPLETED|Double-Blind Treatment Period||37
8136215|NCT02750410|20055259|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120
8136216|NCT02750410|20055260|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39
8136217|NCT02750410|20055259|P2|STARTED|Double-Blind Treatment Period||120
8136218|NCT02750410|20055260|P1|STARTED|Double-Blind Treatment Period||39
8136219|NCT02750345|20055278|P6|NOT COMPLETED|Intervention 3||0
8136220|NCT02750345|20055279|P5|NOT COMPLETED|Intervention 3||0
8136221|NCT02750345|20055280|P4|NOT COMPLETED|Intervention 3||0
8136222|NCT02750345|20055281|P3|NOT COMPLETED|Intervention 3||0
8136223|NCT02750345|20055282|P2|NOT COMPLETED|Intervention 3||0
8136224|NCT02750345|20055283|P1|NOT COMPLETED|Intervention 3||0
8136225|NCT02750345|20055278|P6|COMPLETED|Intervention 3||4
8136226|NCT02750345|20055279|P5|COMPLETED|Intervention 3||3
8136227|NCT02750345|20055280|P4|COMPLETED|Intervention 3||4
8136228|NCT02750345|20055281|P3|COMPLETED|Intervention 3||4
8136229|NCT02750345|20055282|P2|COMPLETED|Intervention 3||4
8136230|NCT02750345|20055283|P1|COMPLETED|Intervention 3||4
8136231|NCT02750345|20055278|P6|STARTED|Intervention 3||4
8136232|NCT02750345|20055279|P5|STARTED|Intervention 3||3
8136233|NCT02750345|20055280|P4|STARTED|Intervention 3||4
8136234|NCT02750345|20055281|P3|STARTED|Intervention 3||4
8136235|NCT02750345|20055282|P2|STARTED|Intervention 3||4
8136236|NCT02750345|20055283|P1|STARTED|Intervention 3||4
8136237|NCT02750345|20055278|P6|NOT COMPLETED|Intervention 2||0
8136238|NCT02750345|20055279|P5|NOT COMPLETED|Intervention 2||0
8136239|NCT02750345|20055280|P4|NOT COMPLETED|Intervention 2||0
8136240|NCT02750345|20055281|P3|NOT COMPLETED|Intervention 2||0
8136241|NCT02750345|20055282|P2|NOT COMPLETED|Intervention 2||0
8136242|NCT02750345|20055283|P1|NOT COMPLETED|Intervention 2||0
8136243|NCT02750345|20055278|P6|COMPLETED|Intervention 2||4
8136244|NCT02750345|20055279|P5|COMPLETED|Intervention 2||3
8136245|NCT02750345|20055280|P4|COMPLETED|Intervention 2||4
8136246|NCT02750345|20055281|P3|COMPLETED|Intervention 2||4
8136247|NCT02750345|20055282|P2|COMPLETED|Intervention 2||4
8136248|NCT02750345|20055283|P1|COMPLETED|Intervention 2||4
8136249|NCT02750345|20055278|P6|STARTED|Intervention 2||4
8136250|NCT02750345|20055279|P5|STARTED|Intervention 2||3
8136251|NCT02750345|20055280|P4|STARTED|Intervention 2||4
8136252|NCT02750345|20055281|P3|STARTED|Intervention 2||4
8136253|NCT02750345|20055282|P2|STARTED|Intervention 2||4
8136254|NCT02750345|20055283|P1|STARTED|Intervention 2||4
8136255|NCT02750345|20055278|P6|NOT COMPLETED|Intervention 1||0
8136256|NCT02750345|20055279|P5|NOT COMPLETED|Intervention 1||1
8136257|NCT02750345|20055280|P4|NOT COMPLETED|Intervention 1||0
8136258|NCT02750345|20055281|P3|NOT COMPLETED|Intervention 1||0
8136259|NCT02750345|20055282|P2|NOT COMPLETED|Intervention 1||0
8136260|NCT02750345|20055283|P1|NOT COMPLETED|Intervention 1||0
8136261|NCT02750345|20055278|P6|COMPLETED|Intervention 1||4
8136262|NCT02750345|20055279|P5|COMPLETED|Intervention 1||3
8136263|NCT02750345|20055280|P4|COMPLETED|Intervention 1||4
8136264|NCT02750345|20055281|P3|COMPLETED|Intervention 1||4
8136265|NCT02750345|20055282|P2|COMPLETED|Intervention 1||4
8136266|NCT02750345|20055283|P1|COMPLETED|Intervention 1||4
8136267|NCT02750345|20055278|P6|STARTED|Intervention 1||4
8136268|NCT02750345|20055279|P5|STARTED|Intervention 1||4
8136269|NCT02750345|20055280|P4|STARTED|Intervention 1||4
8136270|NCT02750345|20055281|P3|STARTED|Intervention 1||4
8136271|NCT02750345|20055282|P2|STARTED|Intervention 1||4
8136272|NCT02750345|20055283|P1|STARTED|Intervention 1||4
8136273|NCT02750332|20055309|P2|NOT COMPLETED|Treatment Period 2||0
8136274|NCT02750332|20055310|P1|NOT COMPLETED|Treatment Period 2||0
8136275|NCT02750332|20055309|P2|COMPLETED|Treatment Period 2||9
8136276|NCT02750332|20055310|P1|COMPLETED|Treatment Period 2||10
8136277|NCT02750332|20055309|P2|STARTED|Treatment Period 2||9
8136278|NCT02750332|20055310|P1|STARTED|Treatment Period 2||10
8136279|NCT02750332|20055309|P2|NOT COMPLETED|Treatment Period 1||1
8136280|NCT02750332|20055310|P1|NOT COMPLETED|Treatment Period 1||0
8136281|NCT02750332|20055309|P2|COMPLETED|Treatment Period 1||9
8136282|NCT02750332|20055310|P1|COMPLETED|Treatment Period 1||10
8136283|NCT02750332|20055309|P2|STARTED|Treatment Period 1||10
8136284|NCT02750332|20055310|P1|STARTED|Treatment Period 1||10
8136285|NCT02750306|20055330|P2|NOT COMPLETED|Overall Study||2
8136286|NCT02750306|20055331|P1|NOT COMPLETED|Overall Study||6
8136287|NCT02750306|20055330|P2|COMPLETED|Overall Study||141
8136288|NCT02750306|20055331|P1|COMPLETED|Overall Study||136
8136289|NCT02750306|20055330|P2|STARTED|Overall Study||143
8136290|NCT02750306|20055331|P1|STARTED|Overall Study||142
8136291|NCT02750267|20055345|P2|NOT COMPLETED|Overall Study||0
8136292|NCT02750267|20055346|P1|NOT COMPLETED|Overall Study||0
8136293|NCT02750267|20055345|P2|COMPLETED|Overall Study||6
8136294|NCT02750267|20055346|P1|COMPLETED|Overall Study||6
8136295|NCT02750267|20055345|P2|STARTED|Overall Study||6
8136296|NCT02750267|20055346|P1|STARTED|Overall Study||6
8136297|NCT02749903|20055384|P1|NOT COMPLETED|Overall Study||0
8136298|NCT02749903|20055384|P1|COMPLETED|Overall Study||46
8136299|NCT02749903|20055384|P1|STARTED|Overall Study||46
8136303|NCT02749370|20055396|P1|NOT COMPLETED|Overall Study||14
8136304|NCT02749370|20055396|P1|COMPLETED|Overall Study||66
8136305|NCT02749370|20055396|P1|STARTED|Overall Study||80
8136309|NCT02748928|20055427|P1|NOT COMPLETED|Overall Study||0
8136310|NCT02748928|20055427|P1|COMPLETED|Overall Study||62
8136311|NCT02748928|20055427|P1|STARTED|Overall Study||62
8136312|NCT02748889|20055438|P2|NOT COMPLETED|Overall Study||0
8136313|NCT02748889|20055439|P1|NOT COMPLETED|Overall Study||0
8136314|NCT02748889|20055438|P2|COMPLETED|Overall Study||1
8136315|NCT02748889|20055439|P1|COMPLETED|Overall Study||0
8136316|NCT02748889|20055438|P2|STARTED|Overall Study||1
8136317|NCT02748889|20055439|P1|STARTED|Overall Study||0
8136318|NCT02748863|20055446|P5|NOT COMPLETED|Treatment Period 2||1
8136319|NCT02748863|20055447|P4|NOT COMPLETED|Treatment Period 2||2
8136320|NCT02748863|20055448|P3|NOT COMPLETED|Treatment Period 2||0
8136321|NCT02748863|20055449|P2|NOT COMPLETED|Treatment Period 2||3
8136322|NCT02748863|20055450|P1|NOT COMPLETED|Treatment Period 2||5
8136323|NCT02748863|20055446|P5|COMPLETED|Treatment Period 2||33
8136324|NCT02748863|20055447|P4|COMPLETED|Treatment Period 2||32
8136325|NCT02748863|20055448|P3|COMPLETED|Treatment Period 2||0
8136326|NCT02748863|20055449|P2|COMPLETED|Treatment Period 2||66
8136327|NCT02748863|20055450|P1|COMPLETED|Treatment Period 2||67
8136328|NCT02748863|20055446|P5|STARTED|Treatment Period 2||34
8136329|NCT02748863|20055447|P4|STARTED|Treatment Period 2||34
8136330|NCT02748863|20055448|P3|STARTED|Treatment Period 2||0
8136331|NCT02748863|20055449|P2|STARTED|Treatment Period 2||69
8136332|NCT02748863|20055450|P1|STARTED|Treatment Period 2||72
8136333|NCT02748863|20055446|P5|NOT COMPLETED|Treatment Period 1||0
8136334|NCT02748863|20055447|P4|NOT COMPLETED|Treatment Period 1||0
8136335|NCT02748863|20055448|P3|NOT COMPLETED|Treatment Period 1||2
8136336|NCT02748863|20055449|P2|NOT COMPLETED|Treatment Period 1||2
8136337|NCT02748863|20055450|P1|NOT COMPLETED|Treatment Period 1||0
8136338|NCT02748863|20055446|P5|COMPLETED|Treatment Period 1||0
8136339|NCT02748863|20055447|P4|COMPLETED|Treatment Period 1||0
8136340|NCT02748863|20055448|P3|COMPLETED|Treatment Period 1||69
8136341|NCT02748863|20055449|P2|COMPLETED|Treatment Period 1||69
8136342|NCT02748863|20055450|P1|COMPLETED|Treatment Period 1||72
8136343|NCT02748863|20055446|P5|STARTED|Treatment Period 1|Not applicable for this period|0
8136344|NCT02748863|20055447|P4|STARTED|Treatment Period 1|Not applicable for this period|0
8136345|NCT02748863|20055448|P3|STARTED|Treatment Period 1||71
8136346|NCT02748863|20055449|P2|STARTED|Treatment Period 1||71
8136347|NCT02748863|20055450|P1|STARTED|Treatment Period 1||72
8136348|NCT02748785|20055476|P4|NOT COMPLETED|Visit 3- Visit 4||2
8136349|NCT02748785|20055477|P3|NOT COMPLETED|Visit 3- Visit 4||2
8136350|NCT02748785|20055478|P2|NOT COMPLETED|Visit 3- Visit 4||1
8136351|NCT02748785|20055479|P1|NOT COMPLETED|Visit 3- Visit 4||1
8136352|NCT02748785|20055476|P4|COMPLETED|Visit 3- Visit 4||50
8136353|NCT02748785|20055477|P3|COMPLETED|Visit 3- Visit 4||47
8136354|NCT02748785|20055478|P2|COMPLETED|Visit 3- Visit 4||43
8136355|NCT02748785|20055479|P1|COMPLETED|Visit 3- Visit 4||53
8136356|NCT02748785|20055476|P4|STARTED|Visit 3- Visit 4||52
8136357|NCT02748785|20055477|P3|STARTED|Visit 3- Visit 4||49
8136358|NCT02748785|20055478|P2|STARTED|Visit 3- Visit 4||44
8136359|NCT02748785|20055479|P1|STARTED|Visit 3- Visit 4||54
8136360|NCT02748785|20055476|P4|NOT COMPLETED|Visit 2-Visit 3||11
8136361|NCT02748785|20055477|P3|NOT COMPLETED|Visit 2-Visit 3||8
8136362|NCT02748785|20055478|P2|NOT COMPLETED|Visit 2-Visit 3||5
8136363|NCT02748785|20055479|P1|NOT COMPLETED|Visit 2-Visit 3||5
8136364|NCT02748785|20055476|P4|COMPLETED|Visit 2-Visit 3||52
8136365|NCT02748785|20055477|P3|COMPLETED|Visit 2-Visit 3||49
8136366|NCT02748785|20055478|P2|COMPLETED|Visit 2-Visit 3||44
8136367|NCT02748785|20055479|P1|COMPLETED|Visit 2-Visit 3||54
8136368|NCT02748785|20055476|P4|STARTED|Visit 2-Visit 3||63
8136369|NCT02748785|20055477|P3|STARTED|Visit 2-Visit 3||57
8136370|NCT02748785|20055478|P2|STARTED|Visit 2-Visit 3||49
8136371|NCT02748785|20055479|P1|STARTED|Visit 2-Visit 3||59
8136372|NCT02748785|20055476|P4|NOT COMPLETED|Visit 1- Visit 2||6
8136373|NCT02748785|20055477|P3|NOT COMPLETED|Visit 1- Visit 2||14
8136374|NCT02748785|20055478|P2|NOT COMPLETED|Visit 1- Visit 2||19
8136375|NCT02748785|20055479|P1|NOT COMPLETED|Visit 1- Visit 2||10
8136376|NCT02748785|20055476|P4|COMPLETED|Visit 1- Visit 2||63
8136377|NCT02748785|20055477|P3|COMPLETED|Visit 1- Visit 2||57
8136378|NCT02748785|20055478|P2|COMPLETED|Visit 1- Visit 2||49
8136379|NCT02748785|20055479|P1|COMPLETED|Visit 1- Visit 2||59
8136380|NCT02748785|20055476|P4|STARTED|Visit 1- Visit 2||69
8136381|NCT02748785|20055477|P3|STARTED|Visit 1- Visit 2||71
8136382|NCT02748785|20055478|P2|STARTED|Visit 1- Visit 2||68
8136383|NCT02748785|20055479|P1|STARTED|Visit 1- Visit 2||69
8136384|NCT02748525|20055525|P1|NOT COMPLETED|Overall Study||11
8136385|NCT02748525|20055525|P1|COMPLETED|Overall Study|Completed 6 months follow up|39
8136386|NCT02748525|20055525|P1|Completed Study Intervention|Overall Study||50
8136387|NCT02748525|20055525|P1|STARTED|Overall Study||50
8136388|NCT02748512|20055534|P2|NOT COMPLETED|Overall Study||1
8136389|NCT02748512|20055535|P1|NOT COMPLETED|Overall Study||1
8136390|NCT02748512|20055534|P2|COMPLETED|Overall Study||11
8136391|NCT02748512|20055535|P1|COMPLETED|Overall Study||13
8136392|NCT02748512|20055534|P2|STARTED|Overall Study||12
8136393|NCT02748512|20055535|P1|STARTED|Overall Study||14
8136394|NCT02748356|20055543|P1|NOT COMPLETED|Overall Study||1
8136395|NCT02748356|20055543|P1|COMPLETED|Overall Study||6
8136396|NCT02748356|20055543|P1|STARTED|Overall Study||7
8136397|NCT02748317|20055548|P1|NOT COMPLETED|Overall Study||23
8136398|NCT02748317|20055548|P1|COMPLETED|Overall Study||73
8136399|NCT02748317|20055548|P1|STARTED|Overall Study||96
8136400|NCT02748213|20055555|P2|NOT COMPLETED|Overall Study||112
8136401|NCT02748213|20055556|P1|NOT COMPLETED|Overall Study||113
8136402|NCT02748213|20055555|P2|COMPLETED|Overall Study||0
8136403|NCT02748213|20055556|P1|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
8136404|NCT02748213|20055555|P2|Treated|Overall Study||110
8136405|NCT02748213|20055556|P1|Treated|Overall Study||112
8136406|NCT02748213|20055555|P2|STARTED|Overall Study||112
8136407|NCT02748213|20055556|P1|STARTED|Overall Study||113
8136408|NCT02748070|20055574|P2|NOT COMPLETED|Overall Study||1
8136409|NCT02748070|20055575|P1|NOT COMPLETED|Overall Study||8
8136410|NCT02748070|20055574|P2|COMPLETED|Overall Study||39
8136411|NCT02748070|20055575|P1|COMPLETED|Overall Study||33
8136412|NCT02748070|20055574|P2|Randomized and Treated|Overall Study||40
8136413|NCT02748070|20055575|P1|Randomized and Treated|Overall Study||40
8136414|NCT02748070|20055574|P2|STARTED|Overall Study||40
8136415|NCT02748070|20055575|P1|STARTED|Overall Study||41
8136416|NCT02748057|20055585|P2|NOT COMPLETED|Overall Study||2
8136417|NCT02748057|20055586|P1|NOT COMPLETED|Overall Study||5
8136418|NCT02748057|20055585|P2|COMPLETED|Overall Study||19
8136419|NCT02748057|20055586|P1|COMPLETED|Overall Study||109
8136420|NCT02748057|20055585|P2|STARTED|Overall Study||21
8136421|NCT02748057|20055586|P1|STARTED|Overall Study||114
8136422|NCT02747628|20055599|P3|NOT COMPLETED|Overall Study||0
8136423|NCT02747628|20055600|P2|NOT COMPLETED|Overall Study||0
8136424|NCT02747628|20055601|P1|NOT COMPLETED|Overall Study||0
8136425|NCT02747628|20055599|P3|COMPLETED|Overall Study||20
8136426|NCT02747628|20055600|P2|COMPLETED|Overall Study||20
8136427|NCT02747628|20055601|P1|COMPLETED|Overall Study||20
8136428|NCT02747628|20055599|P3|STARTED|Overall Study||20
8136429|NCT02747628|20055600|P2|STARTED|Overall Study||20
8136430|NCT02747628|20055601|P1|STARTED|Overall Study||20
8136431|NCT02747615|20055611|P2|NOT COMPLETED|Overall Study||0
8136432|NCT02747615|20055612|P1|NOT COMPLETED|Overall Study||0
8136433|NCT02747615|20055611|P2|COMPLETED|Overall Study||30
8136434|NCT02747615|20055612|P1|COMPLETED|Overall Study||30
8136435|NCT02747615|20055611|P2|STARTED|Overall Study||30
8136436|NCT02747615|20055612|P1|STARTED|Overall Study||30
8136437|NCT02747433|20055622|P2|NOT COMPLETED|Overall Study||0
8136438|NCT02747433|20055623|P1|NOT COMPLETED|Overall Study||0
8136439|NCT02747433|20055622|P2|COMPLETED|Overall Study||5
8136440|NCT02747433|20055623|P1|COMPLETED|Overall Study||5
8136441|NCT02747433|20055622|P2|STARTED|Overall Study||5
8136442|NCT02747433|20055623|P1|STARTED|Overall Study||5
8136443|NCT02747420|20055655|P2|NOT COMPLETED|Overall Study||4
8136444|NCT02747420|20055656|P1|NOT COMPLETED|Overall Study||7
8136445|NCT02747420|20055655|P2|COMPLETED|Overall Study||18
8136446|NCT02747420|20055656|P1|COMPLETED|Overall Study||11
8136447|NCT02747420|20055655|P2|STARTED|Overall Study||22
8136448|NCT02747420|20055656|P1|STARTED|Overall Study||18
8136449|NCT02747186|20055662|P2|NOT COMPLETED|Second Intervention||0
8136450|NCT02747186|20055663|P1|NOT COMPLETED|Second Intervention||0
8136451|NCT02747186|20055662|P2|COMPLETED|Second Intervention||12
8136452|NCT02747186|20055663|P1|COMPLETED|Second Intervention||12
8136453|NCT02747186|20055662|P2|STARTED|Second Intervention||12
8136454|NCT02747186|20055663|P1|STARTED|Second Intervention||12
8136455|NCT02747186|20055662|P2|NOT COMPLETED|Washout (1 Week)||0
8136456|NCT02747186|20055663|P1|NOT COMPLETED|Washout (1 Week)||0
8136457|NCT02747186|20055662|P2|COMPLETED|Washout (1 Week)||12
8136458|NCT02747186|20055663|P1|COMPLETED|Washout (1 Week)||12
8136459|NCT02747186|20055662|P2|STARTED|Washout (1 Week)||12
8136460|NCT02747186|20055663|P1|STARTED|Washout (1 Week)||12
8136461|NCT02747186|20055662|P2|NOT COMPLETED|First Intervention||0
8136462|NCT02747186|20055663|P1|NOT COMPLETED|First Intervention||0
8136463|NCT02747186|20055662|P2|COMPLETED|First Intervention||12
8136464|NCT02747186|20055663|P1|COMPLETED|First Intervention||12
8136465|NCT02747186|20055662|P2|STARTED|First Intervention||12
8136466|NCT02747186|20055663|P1|STARTED|First Intervention||12
8136467|NCT02747108|20055673|P2|NOT COMPLETED|Overall Study||2
8136468|NCT02747108|20055674|P1|NOT COMPLETED|Overall Study||5
8136469|NCT02747108|20055673|P2|COMPLETED|Overall Study||60
8136470|NCT02747108|20055674|P1|COMPLETED|Overall Study||248
8136471|NCT02747108|20055673|P2|STARTED|Overall Study||62
8136472|NCT02747108|20055674|P1|STARTED|Overall Study||253
8136473|NCT02747043|20055716|P2|NOT COMPLETED|Overall Study||5
8136474|NCT02747043|20055717|P1|NOT COMPLETED|Overall Study||10
8136475|NCT02747043|20055716|P2|COMPLETED|Overall Study||123
8136476|NCT02747043|20055717|P1|COMPLETED|Overall Study||118
8136477|NCT02747043|20055716|P2|Treated|Overall Study||126
8136478|NCT02747043|20055717|P1|Treated|Overall Study||128
8136479|NCT02747043|20055716|P2|STARTED|Overall Study||128
8136480|NCT02747043|20055717|P1|STARTED|Overall Study||128
8136493|NCT02746991|20055778|P2|NOT COMPLETED|Overall Study||34
8136494|NCT02746991|20055779|P1|NOT COMPLETED|Overall Study||28
8136495|NCT02746991|20055778|P2|COMPLETED|Overall Study||67
8136496|NCT02746991|20055779|P1|COMPLETED|Overall Study||24
8136497|NCT02746991|20055778|P2|STARTED|Overall Study||101
8136498|NCT02746991|20055779|P1|STARTED|Overall Study||52
8136505|NCT02746705|20055807|P2|NOT COMPLETED|Overall Study||2
8136506|NCT02746705|20055808|P1|NOT COMPLETED|Overall Study||2
8136507|NCT02746705|20055807|P2|COMPLETED|Overall Study||12
8136508|NCT02746705|20055808|P1|COMPLETED|Overall Study||15
8136509|NCT02746705|20055807|P2|STARTED|Overall Study||14
8136510|NCT02746705|20055808|P1|STARTED|Overall Study||17
8136511|NCT02746679|20055822|P2|NOT COMPLETED|Overall Study||6
8136512|NCT02746679|20055823|P1|NOT COMPLETED|Overall Study||4
8136513|NCT02746679|20055822|P2|COMPLETED|Overall Study||75
8136514|NCT02746679|20055823|P1|COMPLETED|Overall Study||76
8136515|NCT02746679|20055822|P2|STARTED|Overall Study||81
8136516|NCT02746679|20055823|P1|STARTED|Overall Study||80
8136517|NCT02746627|20055856|P3|NOT COMPLETED|Overall Study||1
8136518|NCT02746627|20055857|P2|NOT COMPLETED|Overall Study||1
8136519|NCT02746627|20055858|P1|NOT COMPLETED|Overall Study||1
8136520|NCT02746627|20055856|P3|COMPLETED|Overall Study||29
8136521|NCT02746627|20055857|P2|COMPLETED|Overall Study||29
8136522|NCT02746627|20055858|P1|COMPLETED|Overall Study||59
8136523|NCT02746627|20055856|P3|STARTED|Overall Study||30
8136524|NCT02746627|20055857|P2|STARTED|Overall Study||30
8136525|NCT02746627|20055858|P1|STARTED|Overall Study||60
8136526|NCT02746575|20055881|P1|NOT COMPLETED|Overall Study||50
8136527|NCT02746575|20055881|P1|COMPLETED|Overall Study||20
8136528|NCT02746575|20055881|P1|STARTED|Overall Study||70
8136529|NCT02746406|20055885|P1|NOT COMPLETED|Overall Study||0
8136530|NCT02746406|20055885|P1|COMPLETED|Overall Study||5
8136531|NCT02746406|20055885|P1|STARTED|Overall Study||5
8136532|NCT02746263|20055891|P2|NOT COMPLETED|Overall Study||0
8136533|NCT02746263|20055892|P1|NOT COMPLETED|Overall Study||0
8136534|NCT02746263|20055891|P2|COMPLETED|Overall Study||1
8136535|NCT02746263|20055892|P1|COMPLETED|Overall Study||0
8136536|NCT02746263|20055891|P2|Per Protocol Analysis Set|Overall Study||0
8136537|NCT02746263|20055892|P1|Per Protocol Analysis Set|Overall Study||0
8136538|NCT02746263|20055891|P2|STARTED|Overall Study||1
8136539|NCT02746263|20055892|P1|STARTED|Overall Study||0
8136540|NCT02746107|20055898|P1|NOT COMPLETED|Overall Study||0
8136541|NCT02746107|20055898|P1|COMPLETED|Overall Study||968
8136542|NCT02746107|20055898|P1|CHA2DS2-VASC Score = 5|Overall Study||192
8136543|NCT02746107|20055898|P1|CHA2DS2-VASC Score = 4|Overall Study||197
8136544|NCT02746107|20055898|P1|CHA2DS2-VASC Score = 3|Overall Study||195
8136545|NCT02746107|20055898|P1|CHA2DS2-VASC Score = 2|Overall Study||189
8136546|NCT02746107|20055898|P1|CHA2DS2-VASC Score = 1|Overall Study||195
8136547|NCT02746107|20055898|P1|Target=Physician|Overall Study||482
8136548|NCT02746107|20055898|P1|Target=Patient|Overall Study||486
8136549|NCT02746107|20055898|P1|5year Risk Estimate|Overall Study||485
8136550|NCT02746107|20055898|P1|1year Risk Estimate|Overall Study||483
8136551|NCT02746107|20055898|P1|1 Diagram DA|Overall Study||486
8136552|NCT02746107|20055898|P1|2 Diagrams DA|Overall Study||482
8136553|NCT02746107|20055898|P1|STARTED|Overall Study||968
8136554|NCT02745626|20055916|P3|NOT COMPLETED|Overall Study||3
8136555|NCT02745626|20055917|P2|NOT COMPLETED|Overall Study||6
8136556|NCT02745626|20055918|P1|NOT COMPLETED|Overall Study||3
8136557|NCT02745626|20055916|P3|COMPLETED|Overall Study||19
8136558|NCT02745626|20055917|P2|COMPLETED|Overall Study||16
8136559|NCT02745626|20055918|P1|COMPLETED|Overall Study||21
8136560|NCT02745626|20055916|P3|STARTED|Overall Study||22
8136561|NCT02745626|20055917|P2|STARTED|Overall Study||22
8136562|NCT02745626|20055918|P1|STARTED|Overall Study||24
8136563|NCT02745535|20055944|P1|NOT COMPLETED|Overall Study||6
8136564|NCT02745535|20055944|P1|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71
8136565|NCT02745535|20055944|P1|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70
8136566|NCT02745535|20055944|P1|STARTED|Overall Study||77
8136567|NCT02745392|20055956|P4|NOT COMPLETED|Overall Study||0
8136568|NCT02745392|20055957|P3|NOT COMPLETED|Overall Study||0
8136569|NCT02745392|20055958|P2|NOT COMPLETED|Overall Study||1
8136570|NCT02745392|20055959|P1|NOT COMPLETED|Overall Study||0
8136571|NCT02745392|20055956|P4|COMPLETED|Overall Study||92
8136572|NCT02745392|20055957|P3|COMPLETED|Overall Study||92
8136573|NCT02745392|20055958|P2|COMPLETED|Overall Study||89
8136574|NCT02745392|20055959|P1|COMPLETED|Overall Study||91
8136575|NCT02745392|20055956|P4|STARTED|Overall Study||92
8136576|NCT02745392|20055957|P3|STARTED|Overall Study||92
8136577|NCT02745392|20055958|P2|STARTED|Overall Study||90
8136578|NCT02745392|20055959|P1|STARTED|Overall Study||91
8136579|NCT02745353|20055975|P2|NOT COMPLETED|Second Intervention (2 Weeks)||1
8136580|NCT02745353|20055976|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8136581|NCT02745353|20055975|P2|COMPLETED|Second Intervention (2 Weeks)||0
8136582|NCT02745353|20055976|P1|COMPLETED|Second Intervention (2 Weeks)||1
8136583|NCT02745353|20055975|P2|STARTED|Second Intervention (2 Weeks)||1
8136584|NCT02745353|20055976|P1|STARTED|Second Intervention (2 Weeks)||1
8136585|NCT02745353|20055975|P2|NOT COMPLETED|Washout (3 Days)||0
8136586|NCT02745353|20055976|P1|NOT COMPLETED|Washout (3 Days)||0
8136587|NCT02745353|20055975|P2|COMPLETED|Washout (3 Days)||1
8136588|NCT02745353|20055976|P1|COMPLETED|Washout (3 Days)||1
8136589|NCT02745353|20055975|P2|STARTED|Washout (3 Days)||1
8136590|NCT02745353|20055976|P1|STARTED|Washout (3 Days)||1
8136591|NCT02745353|20055975|P2|NOT COMPLETED|First Intervention (2 Weeks)||2
8136592|NCT02745353|20055976|P1|NOT COMPLETED|First Intervention (2 Weeks)||3
8136593|NCT02745353|20055975|P2|COMPLETED|First Intervention (2 Weeks)||1
8136594|NCT02745353|20055976|P1|COMPLETED|First Intervention (2 Weeks)||1
8136595|NCT02745353|20055975|P2|STARTED|First Intervention (2 Weeks)||3
8136596|NCT02745353|20055976|P1|STARTED|First Intervention (2 Weeks)||4
8136597|NCT02745210|20055984|P2|NOT COMPLETED|Overall Study||0
8136598|NCT02745210|20055985|P1|NOT COMPLETED|Overall Study||0
8136599|NCT02745210|20055984|P2|COMPLETED|Overall Study||9
8136600|NCT02745210|20055985|P1|COMPLETED|Overall Study||0
8136601|NCT02745210|20055984|P2|STARTED|Overall Study||9
8136602|NCT02745210|20055985|P1|STARTED|Overall Study||0
8136603|NCT02745145|20055992|P3|NOT COMPLETED|Overall Study||9
8136604|NCT02745145|20055993|P2|NOT COMPLETED|Overall Study||5
8136605|NCT02745145|20055994|P1|NOT COMPLETED|Overall Study||10
8136606|NCT02745145|20055992|P3|COMPLETED|Overall Study||0
8136607|NCT02745145|20055993|P2|COMPLETED|Overall Study||0
8136608|NCT02745145|20055994|P1|COMPLETED|Overall Study||0
8136609|NCT02745145|20055992|P3|STARTED|Overall Study||9
8136610|NCT02745145|20055993|P2|STARTED|Overall Study||5
8136611|NCT02745145|20055994|P1|STARTED|Overall Study||10
8136612|NCT02745119|20056033|P4|NOT COMPLETED|Overall Study||277
8136613|NCT02745119|20056034|P3|NOT COMPLETED|Overall Study||146
8136614|NCT02745119|20056035|P2|NOT COMPLETED|Overall Study||274
8136615|NCT02745119|20056036|P1|NOT COMPLETED|Overall Study||145
8136616|NCT02745119|20056033|P4|COMPLETED|Overall Study||0
8136617|NCT02745119|20056034|P3|COMPLETED|Overall Study||0
8136618|NCT02745119|20056035|P2|COMPLETED|Overall Study||0
8136619|NCT02745119|20056036|P1|COMPLETED|Overall Study||0
8136620|NCT02745119|20056033|P4|STARTED|Overall Study||277
8136621|NCT02745119|20056034|P3|STARTED|Overall Study||146
8136622|NCT02745119|20056035|P2|STARTED|Overall Study||274
8136623|NCT02745119|20056036|P1|STARTED|Overall Study||145
8136624|NCT02745080|20056060|P2|NOT COMPLETED|Overall Study||89
8136625|NCT02745080|20056061|P1|NOT COMPLETED|Overall Study||55
8136626|NCT02745080|20056060|P2|COMPLETED|Overall Study||338
8136627|NCT02745080|20056061|P1|COMPLETED|Overall Study||371
8136628|NCT02745080|20056060|P2|STARTED|Overall Study||427
8136629|NCT02745080|20056061|P1|STARTED|Overall Study||426
8136633|NCT02744846|20056080|P1|NOT COMPLETED|10 Year Outcome Assessment||305820
8136634|NCT02744846|20056080|P1|COMPLETED|10 Year Outcome Assessment||56730
8136635|NCT02744846|20056080|P1|Exclude Ineligible Patients|10 Year Outcome Assessment|Loss to follow-up, patients not yet 9 years, or systems that only had data from 2009 to 2016 or less|305820
8136636|NCT02744846|20056080|P1|STARTED|10 Year Outcome Assessment||362550
8136637|NCT02744846|20056080|P1|NOT COMPLETED|5 Year Outcome Assessment||319189
8136638|NCT02744846|20056080|P1|COMPLETED|5 Year Outcome Assessment|Number of patients that meet eligibility criteria|362550
8136639|NCT02744846|20056080|P1|Excluded Ineligible Patients|5 Year Outcome Assessment|Includes lost to follow-up and patients that had not reached age 4 years by end of study period|319189
8136640|NCT02744846|20056080|P1|STARTED|5 Year Outcome Assessment||681739
8136641|NCT02744755|20056090|P2|NOT COMPLETED|Study Period 2||8
8136642|NCT02744755|20056091|P1|NOT COMPLETED|Study Period 2||14
8136643|NCT02744755|20056090|P2|COMPLETED|Study Period 2||158
8136644|NCT02744755|20056091|P1|COMPLETED|Study Period 2||145
8136645|NCT02744755|20056090|P2|STARTED|Study Period 2||166
8136646|NCT02744755|20056091|P1|STARTED|Study Period 2||159
8136647|NCT02744755|20056090|P2|NOT COMPLETED|Study Period 1||8
8136648|NCT02744755|20056091|P1|NOT COMPLETED|Study Period 1||14
8136649|NCT02744755|20056090|P2|COMPLETED|Study Period 1||168
8136650|NCT02744755|20056091|P1|COMPLETED|Study Period 1||163
8136651|NCT02744755|20056090|P2|STARTED|Study Period 1||176
8136652|NCT02744755|20056091|P1|STARTED|Study Period 1||177
8136653|NCT02744534|20056145|P1|NOT COMPLETED|Overall Study||0
8136654|NCT02744534|20056145|P1|COMPLETED|Overall Study||21
8136655|NCT02744534|20056145|P1|STARTED|Overall Study||21
8136656|NCT02744391|20056151|P1|NOT COMPLETED|Overall Study||14
8136657|NCT02744391|20056151|P1|COMPLETED|Overall Study||33
8136658|NCT02744391|20056151|P1|STARTED|Overall Study||47
8136659|NCT02744352|20056175|P2|NOT COMPLETED|Overall Study||0
8136660|NCT02744352|20056176|P1|NOT COMPLETED|Overall Study||0
8136661|NCT02744352|20056175|P2|COMPLETED|Overall Study||4
8136662|NCT02744352|20056176|P1|COMPLETED|Overall Study||4
8136663|NCT02744352|20056175|P2|STARTED|Overall Study||4
8136664|NCT02744352|20056176|P1|STARTED|Overall Study||4
8136665|NCT02744066|20056192|P2|NOT COMPLETED|Overall Study||5
8136666|NCT02744066|20056193|P1|NOT COMPLETED|Overall Study||0
8136667|NCT02744066|20056192|P2|COMPLETED|Overall Study||25
8136668|NCT02744066|20056193|P1|COMPLETED|Overall Study||25
8136669|NCT02744066|20056192|P2|STARTED|Overall Study||30
8136670|NCT02744066|20056193|P1|STARTED|Overall Study||25
8136671|NCT02743962|20056203|P2|NOT COMPLETED|Overall Study||0
8136672|NCT02743962|20056204|P1|NOT COMPLETED|Overall Study||1
8136673|NCT02743962|20056203|P2|COMPLETED|Overall Study||5
8136674|NCT02743962|20056204|P1|COMPLETED|Overall Study||4
8136675|NCT02743962|20056203|P2|STARTED|Overall Study||5
8136676|NCT02743962|20056204|P1|STARTED|Overall Study||5
8136677|NCT02743949|20056226|P3|NOT COMPLETED|Overall Study||3
8136678|NCT02743949|20056227|P2|NOT COMPLETED|Overall Study||1
8136679|NCT02743949|20056228|P1|NOT COMPLETED|Overall Study||4
8136680|NCT02743949|20056226|P3|COMPLETED|Overall Study||82
8136681|NCT02743949|20056227|P2|COMPLETED|Overall Study||84
8136682|NCT02743949|20056228|P1|COMPLETED|Overall Study||82
8136683|NCT02743949|20056226|P3|STARTED|Overall Study||85
8136684|NCT02743949|20056227|P2|STARTED|Overall Study||85
8136685|NCT02743949|20056228|P1|STARTED|Overall Study||86
8136686|NCT02743936|20056241|P2|NOT COMPLETED|Overall Study||0
8136687|NCT02743936|20056242|P1|NOT COMPLETED|Overall Study||0
8136688|NCT02743936|20056241|P2|COMPLETED|Overall Study||32
8136689|NCT02743936|20056242|P1|COMPLETED|Overall Study||32
8136690|NCT02743936|20056241|P2|STARTED|Overall Study||32
8136691|NCT02743936|20056242|P1|STARTED|Overall Study||32
8136692|NCT02743780|20056255|P5|NOT COMPLETED|Part 3 (7 Days)||0
8136693|NCT02743780|20056256|P4|NOT COMPLETED|Part 3 (7 Days)||0
8136694|NCT02743780|20056257|P3|NOT COMPLETED|Part 3 (7 Days)||1
8136695|NCT02743780|20056258|P2|NOT COMPLETED|Part 3 (7 Days)||0
8136696|NCT02743780|20056259|P1|NOT COMPLETED|Part 3 (7 Days)||0
8136697|NCT02743780|20056255|P5|COMPLETED|Part 3 (7 Days)||25
8136698|NCT02743780|20056256|P4|COMPLETED|Part 3 (7 Days)||0
8136699|NCT02743780|20056257|P3|COMPLETED|Part 3 (7 Days)||24
8136700|NCT02743780|20056258|P2|COMPLETED|Part 3 (7 Days)||0
8136701|NCT02743780|20056259|P1|COMPLETED|Part 3 (7 Days)||0
8136702|NCT02743780|20056255|P5|STARTED|Part 3 (7 Days)||25
8136703|NCT02743780|20056256|P4|STARTED|Part 3 (7 Days)||0
8136704|NCT02743780|20056257|P3|STARTED|Part 3 (7 Days)||25
8136705|NCT02743780|20056258|P2|STARTED|Part 3 (7 Days)||0
8136706|NCT02743780|20056259|P1|STARTED|Part 3 (7 Days)||0
8136707|NCT02743780|20056255|P5|NOT COMPLETED|Part 2 (8 Days)||0
8136708|NCT02743780|20056256|P4|NOT COMPLETED|Part 2 (8 Days)||0
8136709|NCT02743780|20056257|P3|NOT COMPLETED|Part 2 (8 Days)||0
8136710|NCT02743780|20056258|P2|NOT COMPLETED|Part 2 (8 Days)||0
8136711|NCT02743780|20056259|P1|NOT COMPLETED|Part 2 (8 Days)||0
8136712|NCT02743780|20056255|P5|COMPLETED|Part 2 (8 Days)||4
8136713|NCT02743780|20056256|P4|COMPLETED|Part 2 (8 Days)||0
8136714|NCT02743780|20056257|P3|COMPLETED|Part 2 (8 Days)||6
8136715|NCT02743780|20056258|P2|COMPLETED|Part 2 (8 Days)||6
8136716|NCT02743780|20056259|P1|COMPLETED|Part 2 (8 Days)||0
8136717|NCT02743780|20056255|P5|STARTED|Part 2 (8 Days)||4
8136718|NCT02743780|20056256|P4|STARTED|Part 2 (8 Days)||0
8136719|NCT02743780|20056257|P3|STARTED|Part 2 (8 Days)||6
8136720|NCT02743780|20056258|P2|STARTED|Part 2 (8 Days)||6
8136721|NCT02743780|20056259|P1|STARTED|Part 2 (8 Days)||0
8136722|NCT02743780|20056255|P5|NOT COMPLETED|Part 1 (3 Days)||0
8136723|NCT02743780|20056256|P4|NOT COMPLETED|Part 1 (3 Days)||0
8136724|NCT02743780|20056257|P3|NOT COMPLETED|Part 1 (3 Days)||0
8136725|NCT02743780|20056258|P2|NOT COMPLETED|Part 1 (3 Days)||0
8136726|NCT02743780|20056259|P1|NOT COMPLETED|Part 1 (3 Days)||0
8136727|NCT02743780|20056255|P5|COMPLETED|Part 1 (3 Days)||8
8136728|NCT02743780|20056256|P4|COMPLETED|Part 1 (3 Days)||6
8136729|NCT02743780|20056257|P3|COMPLETED|Part 1 (3 Days)||6
8136730|NCT02743780|20056258|P2|COMPLETED|Part 1 (3 Days)||6
8136731|NCT02743780|20056259|P1|COMPLETED|Part 1 (3 Days)||6
8136732|NCT02743780|20056255|P5|STARTED|Part 1 (3 Days)||8
8136733|NCT02743780|20056256|P4|STARTED|Part 1 (3 Days)||6
8136734|NCT02743780|20056257|P3|STARTED|Part 1 (3 Days)||6
8136735|NCT02743780|20056258|P2|STARTED|Part 1 (3 Days)||6
8136736|NCT02743780|20056259|P1|STARTED|Part 1 (3 Days)||6
8136737|NCT02743702|20056306|P2|NOT COMPLETED|Overall Study||0
8136738|NCT02743702|20056307|P1|NOT COMPLETED|Overall Study||0
8136739|NCT02743702|20056306|P2|COMPLETED|Overall Study||10
8136740|NCT02743702|20056307|P1|COMPLETED|Overall Study||11
8136741|NCT02743702|20056306|P2|STARTED|Overall Study||10
8136742|NCT02743702|20056307|P1|STARTED|Overall Study||11
8136743|NCT02743520|20056313|P1|NOT COMPLETED|Overall Study||1
8136744|NCT02743520|20056313|P1|COMPLETED|Overall Study||85
8136745|NCT02743520|20056313|P1|STARTED|Overall Study||86
8136746|NCT02743377|20056323|P2|NOT COMPLETED|Overall Study||0
8136747|NCT02743377|20056324|P1|NOT COMPLETED|Overall Study||2
8136748|NCT02743377|20056323|P2|COMPLETED|Overall Study||6
8136749|NCT02743377|20056324|P1|COMPLETED|Overall Study||7
8136750|NCT02743377|20056323|P2|Whole Body PET Baseline & Blocked|Overall Study||2
8136751|NCT02743377|20056324|P1|Whole Body PET Baseline & Blocked|Overall Study||0
8136752|NCT02743377|20056323|P2|Whole Body PET Baseline With 11C Rolipra|Overall Study||4
8136753|NCT02743377|20056324|P1|Whole Body PET Baseline With 11C Rolipra|Overall Study||5
8136754|NCT02743377|20056323|P2|Brain PET With 11C Rolipram|Overall Study||3
8136755|NCT02743377|20056324|P1|Brain PET With 11C Rolipram|Overall Study||8
8136756|NCT02743377|20056323|P2|STARTED|Overall Study||6
8136757|NCT02743377|20056324|P1|STARTED|Overall Study||9
8136758|NCT02743312|20056352|P2|NOT COMPLETED|Overall Study||0
8136759|NCT02743312|20056353|P1|NOT COMPLETED|Overall Study||0
8136760|NCT02743312|20056352|P2|COMPLETED|Overall Study||2
8136761|NCT02743312|20056353|P1|COMPLETED|Overall Study||3
8136762|NCT02743312|20056352|P2|STARTED|Overall Study||2
8136763|NCT02743312|20056353|P1|STARTED|Overall Study||3
8136770|NCT02743117|20056403|P2|NOT COMPLETED|Overall Study||1
8136771|NCT02743117|20056404|P1|NOT COMPLETED|Overall Study||1
8136772|NCT02743117|20056403|P2|COMPLETED|Overall Study||240
8136773|NCT02743117|20056404|P1|COMPLETED|Overall Study||59
8136774|NCT02743117|20056403|P2|Treated|Overall Study||241
8136775|NCT02743117|20056404|P1|Treated|Overall Study||59
8136776|NCT02743117|20056403|P2|STARTED|Overall Study||241
8136777|NCT02743117|20056404|P1|STARTED|Overall Study||60
8136783|NCT02742987|20056428|P2|NOT COMPLETED|Overall Study||0
8136784|NCT02742987|20056429|P1|NOT COMPLETED|Overall Study||0
8136785|NCT02742987|20056428|P2|COMPLETED|Overall Study||21
8136786|NCT02742987|20056429|P1|COMPLETED|Overall Study||21
8136787|NCT02742987|20056428|P2|STARTED|Overall Study||21
8136788|NCT02742987|20056429|P1|STARTED|Overall Study||21
8136789|NCT02742818|20056437|P2|NOT COMPLETED|Overall Study||2
8136790|NCT02742818|20056438|P1|NOT COMPLETED|Overall Study||0
8136791|NCT02742818|20056437|P2|COMPLETED|Overall Study||23
8136792|NCT02742818|20056438|P1|COMPLETED|Overall Study||25
8136793|NCT02742818|20056437|P2|STARTED|Overall Study||25
8136794|NCT02742818|20056438|P1|STARTED|Overall Study||25
8136795|NCT02742766|20056471|P19|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136796|NCT02742766|20056472|P18|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136797|NCT02742766|20056473|P17|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136798|NCT02742766|20056474|P16|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136799|NCT02742766|20056475|P15|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136800|NCT02742766|20056476|P14|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136801|NCT02742766|20056477|P13|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136802|NCT02742766|20056478|P12|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136803|NCT02742766|20056479|P11|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136804|NCT02742766|20056480|P10|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136805|NCT02742766|20056481|P9|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136806|NCT02742766|20056482|P8|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136807|NCT02742766|20056483|P7|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136808|NCT02742766|20056484|P6|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136809|NCT02742766|20056485|P5|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136810|NCT02742766|20056486|P4|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136811|NCT02742766|20056487|P3|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136812|NCT02742766|20056488|P2|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136813|NCT02742766|20056489|P1|NOT COMPLETED|Part 3 (Up to 36 Days)||0
8136814|NCT02742766|20056471|P19|COMPLETED|Part 3 (Up to 36 Days)||0
8136815|NCT02742766|20056472|P18|COMPLETED|Part 3 (Up to 36 Days)||0
8136816|NCT02742766|20056473|P17|COMPLETED|Part 3 (Up to 36 Days)||0
8136817|NCT02742766|20056474|P16|COMPLETED|Part 3 (Up to 36 Days)||0
8136818|NCT02742766|20056475|P15|COMPLETED|Part 3 (Up to 36 Days)||0
8136819|NCT02742766|20056476|P14|COMPLETED|Part 3 (Up to 36 Days)||0
8136820|NCT02742766|20056477|P13|COMPLETED|Part 3 (Up to 36 Days)||0
8136821|NCT02742766|20056478|P12|COMPLETED|Part 3 (Up to 36 Days)||0
8136822|NCT02742766|20056479|P11|COMPLETED|Part 3 (Up to 36 Days)||0
8136823|NCT02742766|20056480|P10|COMPLETED|Part 3 (Up to 36 Days)||0
8136824|NCT02742766|20056481|P9|COMPLETED|Part 3 (Up to 36 Days)||0
8136825|NCT02742766|20056482|P8|COMPLETED|Part 3 (Up to 36 Days)||0
8136826|NCT02742766|20056483|P7|COMPLETED|Part 3 (Up to 36 Days)||0
8136827|NCT02742766|20056484|P6|COMPLETED|Part 3 (Up to 36 Days)||0
8136828|NCT02742766|20056485|P5|COMPLETED|Part 3 (Up to 36 Days)||0
8136829|NCT02742766|20056486|P4|COMPLETED|Part 3 (Up to 36 Days)||0
8136830|NCT02742766|20056487|P3|COMPLETED|Part 3 (Up to 36 Days)||0
8136831|NCT02742766|20056488|P2|COMPLETED|Part 3 (Up to 36 Days)||0
8136832|NCT02742766|20056489|P1|COMPLETED|Part 3 (Up to 36 Days)||0
8136833|NCT02742766|20056471|P19|STARTED|Part 3 (Up to 36 Days)||0
8136834|NCT02742766|20056472|P18|STARTED|Part 3 (Up to 36 Days)||0
8136835|NCT02742766|20056473|P17|STARTED|Part 3 (Up to 36 Days)||0
8136836|NCT02742766|20056474|P16|STARTED|Part 3 (Up to 36 Days)||0
8136837|NCT02742766|20056475|P15|STARTED|Part 3 (Up to 36 Days)||0
8136838|NCT02742766|20056476|P14|STARTED|Part 3 (Up to 36 Days)||0
8136839|NCT02742766|20056477|P13|STARTED|Part 3 (Up to 36 Days)||0
8136840|NCT02742766|20056478|P12|STARTED|Part 3 (Up to 36 Days)||0
8136841|NCT02742766|20056479|P11|STARTED|Part 3 (Up to 36 Days)||0
8136842|NCT02742766|20056480|P10|STARTED|Part 3 (Up to 36 Days)||0
8136843|NCT02742766|20056481|P9|STARTED|Part 3 (Up to 36 Days)||0
8136844|NCT02742766|20056482|P8|STARTED|Part 3 (Up to 36 Days)||0
8136845|NCT02742766|20056483|P7|STARTED|Part 3 (Up to 36 Days)||0
8136846|NCT02742766|20056484|P6|STARTED|Part 3 (Up to 36 Days)||0
8136847|NCT02742766|20056485|P5|STARTED|Part 3 (Up to 36 Days)||0
8136848|NCT02742766|20056486|P4|STARTED|Part 3 (Up to 36 Days)||0
8136849|NCT02742766|20056487|P3|STARTED|Part 3 (Up to 36 Days)||0
8136850|NCT02742766|20056488|P2|STARTED|Part 3 (Up to 36 Days)||0
8136851|NCT02742766|20056489|P1|STARTED|Part 3 (Up to 36 Days)||0
8136852|NCT02742766|20056471|P19|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136853|NCT02742766|20056472|P18|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136854|NCT02742766|20056473|P17|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136855|NCT02742766|20056474|P16|NOT COMPLETED|Part 2 (Up to 22 Days)||1
8136856|NCT02742766|20056475|P15|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136857|NCT02742766|20056476|P14|NOT COMPLETED|Part 2 (Up to 22 Days)||6
8136858|NCT02742766|20056477|P13|NOT COMPLETED|Part 2 (Up to 22 Days)||2
8136859|NCT02742766|20056478|P12|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136860|NCT02742766|20056479|P11|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136861|NCT02742766|20056480|P10|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136862|NCT02742766|20056481|P9|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136863|NCT02742766|20056482|P8|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136864|NCT02742766|20056483|P7|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136865|NCT02742766|20056484|P6|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136866|NCT02742766|20056485|P5|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136867|NCT02742766|20056486|P4|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136868|NCT02742766|20056487|P3|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136869|NCT02742766|20056488|P2|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136870|NCT02742766|20056489|P1|NOT COMPLETED|Part 2 (Up to 22 Days)||0
8136871|NCT02742766|20056471|P19|COMPLETED|Part 2 (Up to 22 Days)||0
8136872|NCT02742766|20056472|P18|COMPLETED|Part 2 (Up to 22 Days)||0
8136873|NCT02742766|20056473|P17|COMPLETED|Part 2 (Up to 22 Days)||0
8136874|NCT02742766|20056474|P16|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5
8136875|NCT02742766|20056475|P15|COMPLETED|Part 2 (Up to 22 Days)||6
8136876|NCT02742766|20056476|P14|COMPLETED|Part 2 (Up to 22 Days)||0
8136877|NCT02742766|20056477|P13|COMPLETED|Part 2 (Up to 22 Days)||4
8136878|NCT02742766|20056478|P12|COMPLETED|Part 2 (Up to 22 Days)||0
8136879|NCT02742766|20056479|P11|COMPLETED|Part 2 (Up to 22 Days)||0
8136880|NCT02742766|20056480|P10|COMPLETED|Part 2 (Up to 22 Days)||0
8136881|NCT02742766|20056481|P9|COMPLETED|Part 2 (Up to 22 Days)||0
8136882|NCT02742766|20056482|P8|COMPLETED|Part 2 (Up to 22 Days)||0
8136883|NCT02742766|20056483|P7|COMPLETED|Part 2 (Up to 22 Days)||0
8136884|NCT02742766|20056484|P6|COMPLETED|Part 2 (Up to 22 Days)||0
8136885|NCT02742766|20056485|P5|COMPLETED|Part 2 (Up to 22 Days)||0
8136886|NCT02742766|20056486|P4|COMPLETED|Part 2 (Up to 22 Days)||0
8136887|NCT02742766|20056487|P3|COMPLETED|Part 2 (Up to 22 Days)||0
8136888|NCT02742766|20056488|P2|COMPLETED|Part 2 (Up to 22 Days)||0
8136889|NCT02742766|20056489|P1|COMPLETED|Part 2 (Up to 22 Days)||0
8136890|NCT02742766|20056471|P19|STARTED|Part 2 (Up to 22 Days)||0
8136891|NCT02742766|20056472|P18|STARTED|Part 2 (Up to 22 Days)||0
8136892|NCT02742766|20056473|P17|STARTED|Part 2 (Up to 22 Days)||0
8136893|NCT02742766|20056474|P16|STARTED|Part 2 (Up to 22 Days)||6
8136894|NCT02742766|20056475|P15|STARTED|Part 2 (Up to 22 Days)||6
8136895|NCT02742766|20056476|P14|STARTED|Part 2 (Up to 22 Days)||6
8136896|NCT02742766|20056477|P13|STARTED|Part 2 (Up to 22 Days)||6
8136897|NCT02742766|20056478|P12|STARTED|Part 2 (Up to 22 Days)||0
8136898|NCT02742766|20056479|P11|STARTED|Part 2 (Up to 22 Days)||0
8136899|NCT02742766|20056480|P10|STARTED|Part 2 (Up to 22 Days)||0
8136900|NCT02742766|20056481|P9|STARTED|Part 2 (Up to 22 Days)||0
8136901|NCT02742766|20056482|P8|STARTED|Part 2 (Up to 22 Days)||0
8136902|NCT02742766|20056483|P7|STARTED|Part 2 (Up to 22 Days)||0
8136903|NCT02742766|20056484|P6|STARTED|Part 2 (Up to 22 Days)||0
8136904|NCT02742766|20056485|P5|STARTED|Part 2 (Up to 22 Days)||0
8136905|NCT02742766|20056486|P4|STARTED|Part 2 (Up to 22 Days)||0
8136906|NCT02742766|20056487|P3|STARTED|Part 2 (Up to 22 Days)||0
8136907|NCT02742766|20056488|P2|STARTED|Part 2 (Up to 22 Days)||0
8136908|NCT02742766|20056489|P1|STARTED|Part 2 (Up to 22 Days)||0
8136909|NCT02742766|20056471|P19|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136910|NCT02742766|20056472|P18|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136911|NCT02742766|20056473|P17|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136912|NCT02742766|20056474|P16|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136913|NCT02742766|20056475|P15|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136914|NCT02742766|20056476|P14|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136915|NCT02742766|20056477|P13|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136916|NCT02742766|20056478|P12|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136917|NCT02742766|20056479|P11|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136918|NCT02742766|20056480|P10|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136919|NCT02742766|20056481|P9|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136920|NCT02742766|20056482|P8|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136921|NCT02742766|20056483|P7|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136922|NCT02742766|20056484|P6|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136923|NCT02742766|20056485|P5|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136924|NCT02742766|20056486|P4|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136925|NCT02742766|20056487|P3|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136926|NCT02742766|20056488|P2|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136927|NCT02742766|20056489|P1|NOT COMPLETED|Part 1 (Up to 8 Days)||0
8136928|NCT02742766|20056471|P19|COMPLETED|Part 1 (Up to 8 Days)||0
8136929|NCT02742766|20056472|P18|COMPLETED|Part 1 (Up to 8 Days)||0
8136930|NCT02742766|20056473|P17|COMPLETED|Part 1 (Up to 8 Days)||0
8136931|NCT02742766|20056474|P16|COMPLETED|Part 1 (Up to 8 Days)||0
8136932|NCT02742766|20056475|P15|COMPLETED|Part 1 (Up to 8 Days)||0
8136933|NCT02742766|20056476|P14|COMPLETED|Part 1 (Up to 8 Days)||0
8136934|NCT02742766|20056477|P13|COMPLETED|Part 1 (Up to 8 Days)||0
8136935|NCT02742766|20056478|P12|COMPLETED|Part 1 (Up to 8 Days)||6
8136936|NCT02742766|20056479|P11|COMPLETED|Part 1 (Up to 8 Days)||6
8136937|NCT02742766|20056480|P10|COMPLETED|Part 1 (Up to 8 Days)||0
8136938|NCT02742766|20056481|P9|COMPLETED|Part 1 (Up to 8 Days)||6
8136939|NCT02742766|20056482|P8|COMPLETED|Part 1 (Up to 8 Days)||6
8136940|NCT02742766|20056483|P7|COMPLETED|Part 1 (Up to 8 Days)||6
8136941|NCT02742766|20056484|P6|COMPLETED|Part 1 (Up to 8 Days)||6
8136942|NCT02742766|20056485|P5|COMPLETED|Part 1 (Up to 8 Days)||6
8136943|NCT02742766|20056486|P4|COMPLETED|Part 1 (Up to 8 Days)||6
8136944|NCT02742766|20056487|P3|COMPLETED|Part 1 (Up to 8 Days)||6
8136945|NCT02742766|20056488|P2|COMPLETED|Part 1 (Up to 8 Days)||6
8136946|NCT02742766|20056489|P1|COMPLETED|Part 1 (Up to 8 Days)||20
8136947|NCT02742766|20056471|P19|STARTED|Part 1 (Up to 8 Days)||0
8136948|NCT02742766|20056472|P18|STARTED|Part 1 (Up to 8 Days)||0
8136949|NCT02742766|20056473|P17|STARTED|Part 1 (Up to 8 Days)||0
8136950|NCT02742766|20056474|P16|STARTED|Part 1 (Up to 8 Days)||0
8136951|NCT02742766|20056475|P15|STARTED|Part 1 (Up to 8 Days)||0
8136952|NCT02742766|20056476|P14|STARTED|Part 1 (Up to 8 Days)||0
8136953|NCT02742766|20056477|P13|STARTED|Part 1 (Up to 8 Days)||0
8136954|NCT02742766|20056478|P12|STARTED|Part 1 (Up to 8 Days)||6
8136955|NCT02742766|20056479|P11|STARTED|Part 1 (Up to 8 Days)||6
8136956|NCT02742766|20056480|P10|STARTED|Part 1 (Up to 8 Days)||0
8136957|NCT02742766|20056481|P9|STARTED|Part 1 (Up to 8 Days)||6
8136958|NCT02742766|20056482|P8|STARTED|Part 1 (Up to 8 Days)||6
8136959|NCT02742766|20056483|P7|STARTED|Part 1 (Up to 8 Days)||6
8136960|NCT02742766|20056484|P6|STARTED|Part 1 (Up to 8 Days)||6
8136961|NCT02742766|20056485|P5|STARTED|Part 1 (Up to 8 Days)||6
8136962|NCT02742766|20056486|P4|STARTED|Part 1 (Up to 8 Days)||6
8136963|NCT02742766|20056487|P3|STARTED|Part 1 (Up to 8 Days)||6
8136964|NCT02742766|20056488|P2|STARTED|Part 1 (Up to 8 Days)||6
8136965|NCT02742766|20056489|P1|STARTED|Part 1 (Up to 8 Days)||20
8136966|NCT02742649|20056749|P5|NOT COMPLETED|Open-Label Period||1
8136967|NCT02742649|20056750|P4|NOT COMPLETED|Open-Label Period||0
8136968|NCT02742649|20056751|P3|NOT COMPLETED|Open-Label Period||0
8136969|NCT02742649|20056752|P2|NOT COMPLETED|Open-Label Period||0
8136970|NCT02742649|20056753|P1|NOT COMPLETED|Open-Label Period||0
8136971|NCT02742649|20056749|P5|COMPLETED|Open-Label Period||48
8136972|NCT02742649|20056750|P4|COMPLETED|Open-Label Period||0
8136973|NCT02742649|20056751|P3|COMPLETED|Open-Label Period||0
8136974|NCT02742649|20056752|P2|COMPLETED|Open-Label Period||0
8136975|NCT02742649|20056753|P1|COMPLETED|Open-Label Period||0
8136976|NCT02742649|20056749|P5|STARTED|Open-Label Period||49
8136977|NCT02742649|20056750|P4|STARTED|Open-Label Period||0
8136978|NCT02742649|20056751|P3|STARTED|Open-Label Period||0
8136979|NCT02742649|20056752|P2|STARTED|Open-Label Period||0
8136980|NCT02742649|20056753|P1|STARTED|Open-Label Period||0
8136981|NCT02742649|20056749|P5|NOT COMPLETED|Double-Blind Treatment Period||0
8136982|NCT02742649|20056750|P4|NOT COMPLETED|Double-Blind Treatment Period||0
8136983|NCT02742649|20056751|P3|NOT COMPLETED|Double-Blind Treatment Period||0
8136984|NCT02742649|20056752|P2|NOT COMPLETED|Double-Blind Treatment Period||1
8136985|NCT02742649|20056753|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8136986|NCT02742649|20056749|P5|COMPLETED|Double-Blind Treatment Period||0
8136987|NCT02742649|20056750|P4|COMPLETED|Double-Blind Treatment Period||16
8136988|NCT02742649|20056751|P3|COMPLETED|Double-Blind Treatment Period||17
8136989|NCT02742649|20056752|P2|COMPLETED|Double-Blind Treatment Period||16
8136990|NCT02742649|20056753|P1|COMPLETED|Double-Blind Treatment Period||0
8136991|NCT02742649|20056749|P5|STARTED|Double-Blind Treatment Period||0
8136992|NCT02742649|20056750|P4|STARTED|Double-Blind Treatment Period||16
8136993|NCT02742649|20056751|P3|STARTED|Double-Blind Treatment Period||17
8136994|NCT02742649|20056752|P2|STARTED|Double-Blind Treatment Period||17
8136995|NCT02742649|20056753|P1|STARTED|Double-Blind Treatment Period||0
8136996|NCT02742649|20056749|P5|NOT COMPLETED|Pre-Randomization Washout Period||0
8136997|NCT02742649|20056750|P4|NOT COMPLETED|Pre-Randomization Washout Period||0
8136998|NCT02742649|20056751|P3|NOT COMPLETED|Pre-Randomization Washout Period||0
8136999|NCT02742649|20056752|P2|NOT COMPLETED|Pre-Randomization Washout Period||0
8137000|NCT02742649|20056753|P1|NOT COMPLETED|Pre-Randomization Washout Period||5
8137001|NCT02742649|20056749|P5|COMPLETED|Pre-Randomization Washout Period||0
8137002|NCT02742649|20056750|P4|COMPLETED|Pre-Randomization Washout Period||0
8137003|NCT02742649|20056751|P3|COMPLETED|Pre-Randomization Washout Period||0
8137004|NCT02742649|20056752|P2|COMPLETED|Pre-Randomization Washout Period||0
8137005|NCT02742649|20056753|P1|COMPLETED|Pre-Randomization Washout Period||50
8137006|NCT02742649|20056749|P5|STARTED|Pre-Randomization Washout Period||0
8137007|NCT02742649|20056750|P4|STARTED|Pre-Randomization Washout Period||0
8137008|NCT02742649|20056751|P3|STARTED|Pre-Randomization Washout Period||0
8137009|NCT02742649|20056752|P2|STARTED|Pre-Randomization Washout Period||0
8137010|NCT02742649|20056753|P1|STARTED|Pre-Randomization Washout Period||55
8137011|NCT02742532|20056781|P2|NOT COMPLETED|Overall Study||1
8137012|NCT02742532|20056782|P1|NOT COMPLETED|Overall Study||3
8137013|NCT02742532|20056781|P2|COMPLETED|Overall Study||31
8137014|NCT02742532|20056782|P1|COMPLETED|Overall Study||28
8137015|NCT02742532|20056781|P2|STARTED|Overall Study||32
8137016|NCT02742532|20056782|P1|STARTED|Overall Study||31
8137017|NCT02742519|20056792|P3|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
8137018|NCT02742519|20056793|P2|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8137019|NCT02742519|20056794|P1|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8137020|NCT02742519|20056792|P3|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8137021|NCT02742519|20056793|P2|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8137022|NCT02742519|20056794|P1|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
8137114|NCT02741271|20057035|P1|NOT COMPLETED|Overall Study||2
8137115|NCT02741271|20057034|P2|COMPLETED|Overall Study||88
8137023|NCT02742519|20056792|P3|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
8137024|NCT02742519|20056793|P2|STARTED|Part 2 Open Label Period (32 Weeks)||0
8137025|NCT02742519|20056794|P1|STARTED|Part 2 Open Label Period (32 Weeks)||0
8137026|NCT02742519|20056792|P3|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
8137027|NCT02742519|20056793|P2|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
8137028|NCT02742519|20056794|P1|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
8137029|NCT02742519|20056792|P3|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
8137030|NCT02742519|20056793|P2|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
8137031|NCT02742519|20056794|P1|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
8137032|NCT02742519|20056792|P3|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
8137033|NCT02742519|20056793|P2|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
8137034|NCT02742519|20056794|P1|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
8137035|NCT02742519|20056792|P3|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
8137036|NCT02742519|20056793|P2|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
8137037|NCT02742519|20056794|P1|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
8137038|NCT02742519|20056792|P3|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
8137039|NCT02742519|20056793|P2|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
8137040|NCT02742519|20056794|P1|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
8137041|NCT02742519|20056792|P3|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
8137042|NCT02742519|20056793|P2|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
8137043|NCT02742519|20056794|P1|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
8137044|NCT02742441|20056814|P2|NOT COMPLETED|Overall Study||8
8137045|NCT02742441|20056815|P1|NOT COMPLETED|Overall Study||6
8137046|NCT02742441|20056814|P2|COMPLETED|Overall Study||196
8137047|NCT02742441|20056815|P1|COMPLETED|Overall Study||199
8137048|NCT02742441|20056814|P2|STARTED|Overall Study||204
8137049|NCT02742441|20056815|P1|STARTED|Overall Study||205
8137050|NCT02742129|20056833|P2|NOT COMPLETED|Phase 2||2
8137051|NCT02742129|20056834|P1|NOT COMPLETED|Phase 2||1
8137052|NCT02742129|20056833|P2|COMPLETED|Phase 2||48
8137053|NCT02742129|20056834|P1|COMPLETED|Phase 2||50
8137054|NCT02742129|20056833|P2|STARTED|Phase 2||50
8137055|NCT02742129|20056834|P1|STARTED|Phase 2||51
8137056|NCT02742129|20056833|P2|NOT COMPLETED|Phase 1||2
8137057|NCT02742129|20056834|P1|NOT COMPLETED|Phase 1||2
8137058|NCT02742129|20056833|P2|COMPLETED|Phase 1||50
8137059|NCT02742129|20056834|P1|COMPLETED|Phase 1||51
8137060|NCT02742129|20056833|P2|STARTED|Phase 1||52
8137061|NCT02742129|20056834|P1|STARTED|Phase 1||53
8137062|NCT02742103|20056862|P2|NOT COMPLETED|Overall Study||5
8137063|NCT02742103|20056863|P1|NOT COMPLETED|Overall Study||9
8137064|NCT02742103|20056862|P2|COMPLETED|Overall Study||23
8137065|NCT02742103|20056863|P1|COMPLETED|Overall Study||46
8137066|NCT02742103|20056862|P2|STARTED|Overall Study||28
8137067|NCT02742103|20056863|P1|STARTED|Overall Study||55
8137068|NCT02742077|20056900|P1|NOT COMPLETED|Overall Study||0
8137069|NCT02742077|20056900|P1|COMPLETED|Overall Study||20
8137070|NCT02742077|20056900|P1|STARTED|Overall Study||20
8137071|NCT02741713|20056909|P2|NOT COMPLETED|Overall Study||1
8137072|NCT02741713|20056910|P1|NOT COMPLETED|Overall Study||2
8137073|NCT02741713|20056909|P2|COMPLETED|Overall Study||19
8137074|NCT02741713|20056910|P1|COMPLETED|Overall Study||18
8137075|NCT02741713|20056909|P2|STARTED|Overall Study||20
8137076|NCT02741713|20056910|P1|STARTED|Overall Study||20
8137077|NCT02741687|20056925|P2|NOT COMPLETED|Overall Study||0
8137078|NCT02741687|20056926|P1|NOT COMPLETED|Overall Study||0
8137079|NCT02741687|20056925|P2|COMPLETED|Overall Study||44
8137080|NCT02741687|20056926|P1|COMPLETED|Overall Study||36
8137081|NCT02741687|20056925|P2|STARTED|Overall Study||44
8137082|NCT02741687|20056926|P1|STARTED|Overall Study||36
8137083|NCT02741635|20056950|P1|NOT COMPLETED|Overall Study||1
8137084|NCT02741635|20056950|P1|COMPLETED|Overall Study||14
8137085|NCT02741635|20056950|P1|STARTED|Overall Study||15
8137092|NCT02741518|20056977|P2|NOT COMPLETED|Overall Study||1
8137093|NCT02741518|20056978|P1|NOT COMPLETED|Overall Study||1
8137094|NCT02741518|20056977|P2|COMPLETED|Overall Study||10
8137095|NCT02741518|20056978|P1|COMPLETED|Overall Study||10
8137096|NCT02741518|20056977|P2|STARTED|Overall Study||11
8137097|NCT02741518|20056978|P1|STARTED|Overall Study||11
8137098|NCT02741310|20056988|P2|NOT COMPLETED|Overall Study||2
8137099|NCT02741310|20056989|P1|NOT COMPLETED|Overall Study||2
8137100|NCT02741310|20056988|P2|COMPLETED|Overall Study||20
8137101|NCT02741310|20056989|P1|COMPLETED|Overall Study||10
8137102|NCT02741310|20056988|P2|STARTED|Overall Study||22
8137103|NCT02741310|20056989|P1|STARTED|Overall Study||12
8137104|NCT02741297|20057009|P1|NOT COMPLETED|Overall Study||14
8137105|NCT02741297|20057009|P1|COMPLETED|Overall Study||59
8137106|NCT02741297|20057009|P1|STARTED|Overall Study||73
8137113|NCT02741271|20057034|P2|NOT COMPLETED|Overall Study||2
8137116|NCT02741271|20057035|P1|COMPLETED|Overall Study||89
8137117|NCT02741271|20057034|P2|STARTED|Overall Study||90
8137118|NCT02741271|20057035|P1|STARTED|Overall Study||91
8137119|NCT02741245|20057068|P5|NOT COMPLETED|Overall Study||2
8137120|NCT02741245|20057069|P4|NOT COMPLETED|Overall Study||4
8137121|NCT02741245|20057070|P3|NOT COMPLETED|Overall Study||0
8137122|NCT02741245|20057071|P2|NOT COMPLETED|Overall Study||1
8137123|NCT02741245|20057072|P1|NOT COMPLETED|Overall Study||0
8137124|NCT02741245|20057068|P5|COMPLETED|Overall Study||70
8137125|NCT02741245|20057069|P4|COMPLETED|Overall Study||67
8137126|NCT02741245|20057070|P3|COMPLETED|Overall Study||71
8137127|NCT02741245|20057071|P2|COMPLETED|Overall Study||71
8137128|NCT02741245|20057072|P1|COMPLETED|Overall Study||35
8137129|NCT02741245|20057068|P5|STARTED|Overall Study||72
8137130|NCT02741245|20057069|P4|STARTED|Overall Study||71
8137131|NCT02741245|20057070|P3|STARTED|Overall Study||71
8137132|NCT02741245|20057071|P2|STARTED|Overall Study||72
8137133|NCT02741245|20057072|P1|STARTED|Overall Study||35
8137134|NCT02741076|20057178|P4|NOT COMPLETED|Overall Study||2
8137135|NCT02741076|20057179|P3|NOT COMPLETED|Overall Study||2
8137136|NCT02741076|20057180|P2|NOT COMPLETED|Overall Study||5
8137137|NCT02741076|20057181|P1|NOT COMPLETED|Overall Study||3
8137138|NCT02741076|20057178|P4|COMPLETED|Overall Study||2
8137139|NCT02741076|20057179|P3|COMPLETED|Overall Study||1
8137140|NCT02741076|20057180|P2|COMPLETED|Overall Study||7
8137141|NCT02741076|20057181|P1|COMPLETED|Overall Study||10
8137142|NCT02741076|20057178|P4|STARTED|Overall Study||4
8137143|NCT02741076|20057179|P3|STARTED|Overall Study||3
8137144|NCT02741076|20057180|P2|STARTED|Overall Study||12
8137145|NCT02741076|20057181|P1|STARTED|Overall Study||13
8137146|NCT02740920|20057239|P1|NOT COMPLETED|Overall Study||0
8137147|NCT02740920|20057239|P1|COMPLETED|Overall Study||9
8137148|NCT02740920|20057239|P1|STARTED|Overall Study||9
8137149|NCT02740660|20057246|P2|NOT COMPLETED|Overall Study||0
8137150|NCT02740660|20057247|P1|NOT COMPLETED|Overall Study||0
8137151|NCT02740660|20057246|P2|COMPLETED|Overall Study||6
8137152|NCT02740660|20057247|P1|COMPLETED|Overall Study||6
8137153|NCT02740660|20057246|P2|STARTED|Overall Study||6
8137154|NCT02740660|20057247|P1|STARTED|Overall Study||6
8137155|NCT02740582|20057261|P2|NOT COMPLETED|Second Intervention||3
8137156|NCT02740582|20057262|P1|NOT COMPLETED|Second Intervention||1
8137157|NCT02740582|20057261|P2|COMPLETED|Second Intervention||28
8137158|NCT02740582|20057262|P1|COMPLETED|Second Intervention||23
8137159|NCT02740582|20057261|P2|STARTED|Second Intervention||31
8137160|NCT02740582|20057262|P1|STARTED|Second Intervention||24
8137161|NCT02740582|20057261|P2|NOT COMPLETED|Washout||0
8137162|NCT02740582|20057262|P1|NOT COMPLETED|Washout||0
8137163|NCT02740582|20057261|P2|COMPLETED|Washout||31
8137164|NCT02740582|20057262|P1|COMPLETED|Washout||24
8137165|NCT02740582|20057261|P2|STARTED|Washout||31
8137166|NCT02740582|20057262|P1|STARTED|Washout||24
8137167|NCT02740582|20057261|P2|NOT COMPLETED|First Intervention||2
8137168|NCT02740582|20057262|P1|NOT COMPLETED|First Intervention||5
8137169|NCT02740582|20057261|P2|COMPLETED|First Intervention||31
8137170|NCT02740582|20057262|P1|COMPLETED|First Intervention||24
8137171|NCT02740582|20057261|P2|STARTED|First Intervention||33
8137172|NCT02740582|20057262|P1|STARTED|First Intervention||29
8137173|NCT02740413|20057268|P1|NOT COMPLETED|Overall Study||0
8137174|NCT02740413|20057268|P1|COMPLETED|Overall Study||86
8137175|NCT02740413|20057268|P1|STARTED|Overall Study||86
8137176|NCT02740153|20057308|P2|NOT COMPLETED|Overall Study||0
8137177|NCT02740153|20057309|P1|NOT COMPLETED|Overall Study||0
8137178|NCT02740153|20057308|P2|COMPLETED|Overall Study||86
8137179|NCT02740153|20057309|P1|COMPLETED|Overall Study||101
8137180|NCT02740153|20057308|P2|STARTED|Overall Study||86
8137181|NCT02740153|20057309|P1|STARTED|Overall Study||101
8137182|NCT02740049|20057319|P1|NOT COMPLETED|Overall Study||1
8137183|NCT02740049|20057319|P1|COMPLETED|Overall Study||8
8137184|NCT02740049|20057319|P1|STARTED|Overall Study||9
8137185|NCT02739997|20057325|P1|NOT COMPLETED|Overall Study||2
8137186|NCT02739997|20057325|P1|COMPLETED|Overall Study||98
8137187|NCT02739997|20057325|P1|STARTED|Overall Study||100
8137188|NCT02739984|20057339|P2|NOT COMPLETED|Overall Study||2
8137189|NCT02739984|20057340|P1|NOT COMPLETED|Overall Study||5
8137190|NCT02739984|20057339|P2|COMPLETED|Overall Study||279
8137191|NCT02739984|20057340|P1|COMPLETED|Overall Study||138
8137192|NCT02739984|20057339|P2|Received Study Drug|Overall Study||280
8137193|NCT02739984|20057340|P1|Received Study Drug|Overall Study||141
8137194|NCT02739984|20057339|P2|STARTED|Overall Study||281
8137195|NCT02739984|20057340|P1|STARTED|Overall Study||143
8137196|NCT02739828|20057388|P1|NOT COMPLETED|Overall Study||5
8137197|NCT02739828|20057388|P1|COMPLETED|Overall Study||19
8137198|NCT02739828|20057388|P1|STARTED|Overall Study||24
8137199|NCT02739789|20057424|P2|NOT COMPLETED|Second fMRI Scan||0
8137200|NCT02739789|20057425|P1|NOT COMPLETED|Second fMRI Scan||0
8137201|NCT02739789|20057424|P2|COMPLETED|Second fMRI Scan||7
8137202|NCT02739789|20057425|P1|COMPLETED|Second fMRI Scan||9
8137203|NCT02739789|20057424|P2|STARTED|Second fMRI Scan||7
8137204|NCT02739789|20057425|P1|STARTED|Second fMRI Scan||9
8137205|NCT02739789|20057424|P2|NOT COMPLETED|~1 Week Waiting Period||3
8137206|NCT02739789|20057425|P1|NOT COMPLETED|~1 Week Waiting Period||0
8137207|NCT02739789|20057424|P2|COMPLETED|~1 Week Waiting Period||7
8137208|NCT02739789|20057425|P1|COMPLETED|~1 Week Waiting Period||9
8137209|NCT02739789|20057424|P2|STARTED|~1 Week Waiting Period||10
8137210|NCT02739789|20057425|P1|STARTED|~1 Week Waiting Period||9
8137211|NCT02739789|20057424|P2|NOT COMPLETED|First fMRI Scan||0
8137212|NCT02739789|20057425|P1|NOT COMPLETED|First fMRI Scan||0
8137213|NCT02739789|20057424|P2|COMPLETED|First fMRI Scan||10
8137214|NCT02739789|20057425|P1|COMPLETED|First fMRI Scan||9
8137215|NCT02739789|20057424|P2|STARTED|First fMRI Scan||10
8137216|NCT02739789|20057425|P1|STARTED|First fMRI Scan||9
8137217|NCT02739698|20057439|P2|NOT COMPLETED|Overall Study||5
8137218|NCT02739698|20057440|P1|NOT COMPLETED|Overall Study||6
8137219|NCT02739698|20057439|P2|COMPLETED|Overall Study||16
8137220|NCT02739698|20057440|P1|COMPLETED|Overall Study||16
8137221|NCT02739698|20057439|P2|STARTED|Overall Study||21
8137222|NCT02739698|20057440|P1|STARTED|Overall Study||22
8137223|NCT02739594|20057448|P2|NOT COMPLETED|Overall Study||28
8137224|NCT02739594|20057449|P1|NOT COMPLETED|Overall Study||25
8137225|NCT02739594|20057448|P2|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
8137226|NCT02739594|20057449|P1|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
8137227|NCT02739594|20057448|P2|Completed at Week 96|Overall Study||10
8137228|NCT02739594|20057449|P1|Completed at Week 96|Overall Study||10
8137229|NCT02739594|20057448|P2|Completed at Week 44|Overall Study||5
8137230|NCT02739594|20057449|P1|Completed at Week 44|Overall Study||11
8137231|NCT02739594|20057448|P2|STARTED|Overall Study||43
8137232|NCT02739594|20057449|P1|STARTED|Overall Study||46
8137233|NCT02739360|20057479|P1|NOT COMPLETED|Overall Study||3
8137234|NCT02739360|20057479|P1|COMPLETED|Overall Study||0
8137235|NCT02739360|20057479|P1|STARTED|Overall Study||3
8137236|NCT02739321|20057485|P2|NOT COMPLETED|Overall Study||4
8137237|NCT02739321|20057486|P1|NOT COMPLETED|Overall Study||3
8137238|NCT02739321|20057485|P2|COMPLETED|Overall Study||18
8137239|NCT02739321|20057486|P1|COMPLETED|Overall Study||20
8137240|NCT02739321|20057485|P2|STARTED|Overall Study||22
8137241|NCT02739321|20057486|P1|STARTED|Overall Study||23
8137242|NCT02739269|20057532|P2|NOT COMPLETED|Overall Study||4
8137243|NCT02739269|20057533|P1|NOT COMPLETED|Overall Study||7
8137244|NCT02739269|20057532|P2|COMPLETED|Overall Study||96
8137245|NCT02739269|20057533|P1|COMPLETED|Overall Study||93
8137246|NCT02739269|20057532|P2|STARTED|Overall Study||100
8137247|NCT02739269|20057533|P1|STARTED|Overall Study||100
8137248|NCT02739100|20057541|P1|NOT COMPLETED|Overall Study||0
8137249|NCT02739100|20057541|P1|COMPLETED|Overall Study||13
8137250|NCT02739100|20057541|P1|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13
8137251|NCT02739100|20057541|P1|Triferic 6.6 mg IV Predialyzer|Overall Study||13
8137252|NCT02739100|20057541|P1|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13
8137253|NCT02739100|20057541|P1|STARTED|Overall Study||13
8137254|NCT02738879|20057560|P2|NOT COMPLETED|Overall Study||25
8137255|NCT02738879|20057561|P1|NOT COMPLETED|Overall Study||13
8137256|NCT02738879|20057560|P2|COMPLETED|Overall Study||347
8137257|NCT02738879|20057561|P1|COMPLETED|Overall Study||361
8137258|NCT02738879|20057560|P2|Treated|Overall Study||370
8137259|NCT02738879|20057561|P1|Treated|Overall Study||373
8137260|NCT02738879|20057560|P2|STARTED|Overall Study||372
8137261|NCT02738879|20057561|P1|STARTED|Overall Study||374
8137268|NCT02738801|20057613|P2|NOT COMPLETED|Overall Study||2
8137269|NCT02738801|20057614|P1|NOT COMPLETED|Overall Study||1
8137270|NCT02738801|20057613|P2|COMPLETED|Overall Study||15
8137271|NCT02738801|20057614|P1|COMPLETED|Overall Study||5
8137272|NCT02738801|20057613|P2|STARTED|Overall Study||17
8137273|NCT02738801|20057614|P1|STARTED|Overall Study||6
8137274|NCT02738580|20057630|P2|NOT COMPLETED|Overall Study||4
8137275|NCT02738580|20057631|P1|NOT COMPLETED|Overall Study||4
8137276|NCT02738580|20057630|P2|COMPLETED|Overall Study|"2 cycles cancelled due to por response to stimullation
~1 patient withdrawal
~1 excluded"|52
8137277|NCT02738580|20057631|P1|COMPLETED|Overall Study|"3 cycles cancelled due to por response to stimullation.
~1 cycle cancelled due to SAE."|52
8137278|NCT02738580|20057630|P2|STARTED|Overall Study||56
8137279|NCT02738580|20057631|P1|STARTED|Overall Study|56 patients were assigned to this arms.|56
8137280|NCT02738333|20057642|P3|NOT COMPLETED|Overall Study||0
8137281|NCT02738333|20057643|P2|NOT COMPLETED|Overall Study||0
8137282|NCT02738333|20057644|P1|NOT COMPLETED|Overall Study||2
8137283|NCT02738333|20057642|P3|COMPLETED|Overall Study||25
8137284|NCT02738333|20057643|P2|COMPLETED|Overall Study||108
8137285|NCT02738333|20057644|P1|COMPLETED|Overall Study||104
8137286|NCT02738333|20057642|P3|STARTED|Overall Study||25
8137287|NCT02738333|20057643|P2|STARTED|Overall Study||108
8137288|NCT02738333|20057644|P1|STARTED|Overall Study||106
8137289|NCT02738255|20057720|P2|NOT COMPLETED|Overall Study||1
8137290|NCT02738255|20057721|P1|NOT COMPLETED|Overall Study||0
8137291|NCT02738255|20057720|P2|COMPLETED|Overall Study||14
8137292|NCT02738255|20057721|P1|COMPLETED|Overall Study||11
8137293|NCT02738255|20057720|P2|STARTED|Overall Study||15
8137294|NCT02738255|20057721|P1|STARTED|Overall Study||11
8137295|NCT02738203|20057733|P2|NOT COMPLETED|Overall Study||3
8137296|NCT02738203|20057734|P1|NOT COMPLETED|Overall Study||2
8137297|NCT02738203|20057733|P2|COMPLETED|Overall Study||107
8137298|NCT02738203|20057734|P1|COMPLETED|Overall Study||108
8137299|NCT02738203|20057733|P2|STARTED|Overall Study||110
8137300|NCT02738203|20057734|P1|STARTED|Overall Study||110
8137301|NCT02738151|20057750|P2|NOT COMPLETED|Overall Study||31
8137302|NCT02738151|20057751|P1|NOT COMPLETED|Overall Study||23
8137303|NCT02738151|20057750|P2|COMPLETED|Overall Study||432
8137304|NCT02738151|20057751|P1|COMPLETED|Overall Study||443
8137305|NCT02738151|20057750|P2|Treated|Overall Study||462
8137306|NCT02738151|20057751|P1|Treated|Overall Study||462
8137307|NCT02738151|20057750|P2|STARTED|Overall Study||463
8137308|NCT02738151|20057751|P1|STARTED|Overall Study||466
8137315|NCT02738086|20057805|P2|NOT COMPLETED|Overall Study||2
8137316|NCT02738086|20057806|P1|NOT COMPLETED|Overall Study||2
8137317|NCT02738086|20057805|P2|COMPLETED|Overall Study||13
8137318|NCT02738086|20057806|P1|COMPLETED|Overall Study||14
8137319|NCT02738086|20057805|P2|STARTED|Overall Study||15
8137320|NCT02738086|20057806|P1|STARTED|Overall Study||16
8137321|NCT02738008|20057833|P3|NOT COMPLETED|Overall Study||5
8137322|NCT02738008|20057834|P2|NOT COMPLETED|Overall Study||6
8137323|NCT02738008|20057835|P1|NOT COMPLETED|Overall Study||1
8137324|NCT02738008|20057833|P3|COMPLETED|Overall Study||0
8137325|NCT02738008|20057834|P2|COMPLETED|Overall Study||0
8137326|NCT02738008|20057835|P1|COMPLETED|Overall Study||0
8137327|NCT02738008|20057833|P3|STARTED|Overall Study||5
8137328|NCT02738008|20057834|P2|STARTED|Overall Study||6
8137329|NCT02738008|20057835|P1|STARTED|Overall Study||1
8137330|NCT02737917|20057851|P2|NOT COMPLETED|Overall Study||3
8137331|NCT02737917|20057852|P1|NOT COMPLETED|Overall Study||3
8137332|NCT02737917|20057851|P2|COMPLETED|Overall Study||100
8137333|NCT02737917|20057852|P1|COMPLETED|Overall Study||100
8137334|NCT02737917|20057851|P2|STARTED|Overall Study||103
8137335|NCT02737917|20057852|P1|STARTED|Overall Study||103
8137336|NCT02737891|20057862|P2|NOT COMPLETED|Overall Study||2
8137337|NCT02737891|20057863|P1|NOT COMPLETED|Overall Study||0
8137338|NCT02737891|20057862|P2|COMPLETED|Overall Study||28
8137339|NCT02737891|20057863|P1|COMPLETED|Overall Study||30
8137340|NCT02737891|20057862|P2|STARTED|Overall Study||30
8137341|NCT02737891|20057863|P1|STARTED|Overall Study||30
8137342|NCT02737852|20057873|P1|NOT COMPLETED|Overall Study||2
8137343|NCT02737852|20057873|P1|COMPLETED|Overall Study||30
8137344|NCT02737852|20057873|P1|STARTED|Overall Study||32
8137345|NCT02737722|20057882|P4|NOT COMPLETED|Overall Study||0
8137346|NCT02737722|20057883|P3|NOT COMPLETED|Overall Study||1
8137347|NCT02737722|20057884|P2|NOT COMPLETED|Overall Study||0
8137348|NCT02737722|20057885|P1|NOT COMPLETED|Overall Study||0
8137349|NCT02737722|20057882|P4|COMPLETED|Overall Study||6
8137350|NCT02737722|20057883|P3|COMPLETED|Overall Study||7
8137351|NCT02737722|20057884|P2|COMPLETED|Overall Study||8
8137352|NCT02737722|20057885|P1|COMPLETED|Overall Study||8
8137353|NCT02737722|20057882|P4|STARTED|Overall Study||6
8137354|NCT02737722|20057883|P3|STARTED|Overall Study||8
8137355|NCT02737722|20057884|P2|STARTED|Overall Study||8
8137356|NCT02737722|20057885|P1|STARTED|Overall Study||8
8137360|NCT02737618|20057936|P1|NOT COMPLETED|Overall Study||9
8137361|NCT02737618|20057936|P1|COMPLETED|Overall Study||34
8137362|NCT02737618|20057936|P1|STARTED|Overall Study||43
8137363|NCT02737592|20057941|P1|NOT COMPLETED|Overall Study||1
8137364|NCT02737592|20057941|P1|COMPLETED|Overall Study||33
8137365|NCT02737592|20057941|P1|STARTED|Overall Study||34
8137366|NCT02737397|20057946|P1|NOT COMPLETED|Overall Study||0
8137367|NCT02737397|20057946|P1|COMPLETED|Overall Study||13
8137368|NCT02737397|20057946|P1|Placebo|Overall Study||13
8137369|NCT02737397|20057946|P1|SJP-223|Overall Study||13
8137370|NCT02737397|20057946|P1|SJP-304|Overall Study||12
8137371|NCT02737397|20057946|P1|JMI-001|Overall Study||13
8137372|NCT02737397|20057946|P1|STARTED|Overall Study||13
8137373|NCT02737358|20057962|P2|NOT COMPLETED|Overall Study||15
8137374|NCT02737358|20057963|P1|NOT COMPLETED|Overall Study||9
8137375|NCT02737358|20057962|P2|COMPLETED|Overall Study||44
8137376|NCT02737358|20057963|P1|COMPLETED|Overall Study||46
8137377|NCT02737358|20057962|P2|STARTED|Overall Study||59
8137378|NCT02737358|20057963|P1|STARTED|Overall Study||55
8137385|NCT02737163|20057998|P1|NOT COMPLETED|Overall Study||0
8137386|NCT02737163|20057998|P1|COMPLETED|Overall Study||95
8137387|NCT02737163|20057998|P1|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95
8137388|NCT02737072|20058008|P3|NOT COMPLETED|Overall Study||0
8137389|NCT02737072|20058009|P2|NOT COMPLETED|Overall Study||0
8137390|NCT02737072|20058010|P1|NOT COMPLETED|Overall Study||0
8137391|NCT02737072|20058008|P3|COMPLETED|Overall Study||3
8137392|NCT02737072|20058009|P2|COMPLETED|Overall Study||3
8137393|NCT02737072|20058010|P1|COMPLETED|Overall Study||3
8137394|NCT02737072|20058008|P3|Received at Least One Dose of Drug|Overall Study||3
8137395|NCT02737072|20058009|P2|Received at Least One Dose of Drug|Overall Study||3
8137396|NCT02737072|20058010|P1|Received at Least One Dose of Drug|Overall Study||3
8137397|NCT02737072|20058008|P3|STARTED|Overall Study||3
8137398|NCT02737072|20058009|P2|STARTED|Overall Study||3
8137399|NCT02737072|20058010|P1|STARTED|Overall Study||3
8137400|NCT02736955|20058034|P3|NOT COMPLETED|Overall Study||2
8137401|NCT02736955|20058035|P2|NOT COMPLETED|Overall Study||14
8137402|NCT02736955|20058036|P1|NOT COMPLETED|Overall Study||7
8137403|NCT02736955|20058034|P3|COMPLETED|Overall Study||6
8137404|NCT02736955|20058035|P2|COMPLETED|Overall Study||103
8137405|NCT02736955|20058036|P1|COMPLETED|Overall Study||29
8137406|NCT02736955|20058034|P3|STARTED|Overall Study||8
8137407|NCT02736955|20058035|P2|STARTED|Overall Study||117
8137408|NCT02736955|20058036|P1|STARTED|Overall Study||36
8137409|NCT02736890|20058052|P2|NOT COMPLETED|Crossover Next 12 Weeks||2
8137410|NCT02736890|20058053|P1|NOT COMPLETED|Crossover Next 12 Weeks||2
8137411|NCT02736890|20058052|P2|COMPLETED|Crossover Next 12 Weeks||1
8137412|NCT02736890|20058053|P1|COMPLETED|Crossover Next 12 Weeks||3
8137413|NCT02736890|20058052|P2|STARTED|Crossover Next 12 Weeks||3
8137414|NCT02736890|20058053|P1|STARTED|Crossover Next 12 Weeks||5
8137415|NCT02736890|20058052|P2|NOT COMPLETED|First 12 Weeks||0
8137416|NCT02736890|20058053|P1|NOT COMPLETED|First 12 Weeks||0
8137417|NCT02736890|20058052|P2|COMPLETED|First 12 Weeks||3
8137418|NCT02736890|20058053|P1|COMPLETED|First 12 Weeks||5
8137419|NCT02736890|20058052|P2|STARTED|First 12 Weeks||3
8137420|NCT02736890|20058053|P1|STARTED|First 12 Weeks||5
8137421|NCT02736825|20058075|P2|NOT COMPLETED|Overall Study||12
8137422|NCT02736825|20058076|P1|NOT COMPLETED|Overall Study||10
8137423|NCT02736825|20058075|P2|COMPLETED|Overall Study||123
8137424|NCT02736825|20058076|P1|COMPLETED|Overall Study||117
8137425|NCT02736825|20058075|P2|STARTED|Overall Study||135
8137426|NCT02736825|20058076|P1|STARTED|Overall Study||127
8137427|NCT02736721|20058116|P1|NOT COMPLETED|Overall Study||16
8137428|NCT02736721|20058116|P1|COMPLETED|Overall Study||25
8137429|NCT02736721|20058116|P1|STARTED|Overall Study||41
8137430|NCT02736578|20058127|P2|NOT COMPLETED|Overall Study||0
8137431|NCT02736578|20058128|P1|NOT COMPLETED|Overall Study||1
8137432|NCT02736578|20058127|P2|COMPLETED|Overall Study||2
8137433|NCT02736578|20058128|P1|COMPLETED|Overall Study||5
8137434|NCT02736578|20058127|P2|STARTED|Overall Study||2
8137435|NCT02736578|20058128|P1|STARTED|Overall Study||6
8137436|NCT02736409|20058150|P4|NOT COMPLETED|Overall Study||12
8137437|NCT02736409|20058151|P3|NOT COMPLETED|Overall Study||26
8137438|NCT02736409|20058152|P2|NOT COMPLETED|Overall Study||3
8137439|NCT02736409|20058153|P1|NOT COMPLETED|Overall Study||4
8137440|NCT02736409|20058150|P4|COMPLETED|Overall Study||53
8137441|NCT02736409|20058151|P3|COMPLETED|Overall Study||80
8137442|NCT02736409|20058152|P2|COMPLETED|Overall Study||22
8137443|NCT02736409|20058153|P1|COMPLETED|Overall Study||19
8137444|NCT02736409|20058150|P4|STARTED|Overall Study||65
8137445|NCT02736409|20058151|P3|STARTED|Overall Study||106
8137446|NCT02736409|20058152|P2|STARTED|Overall Study||25
8137447|NCT02736409|20058153|P1|STARTED|Overall Study||23
8137448|NCT02736188|20058293|P1|NOT COMPLETED|Overall Study||142
8137449|NCT02736188|20058293|P1|COMPLETED|Overall Study||0
8137450|NCT02736188|20058293|P1|STARTED|Overall Study||142
8137451|NCT02736175|20058319|P2|NOT COMPLETED|Overall Study||1
8137452|NCT02736175|20058320|P1|NOT COMPLETED|Overall Study||2
8137453|NCT02736175|20058319|P2|COMPLETED|Overall Study||221
8137454|NCT02736175|20058320|P1|COMPLETED|Overall Study||214
8137455|NCT02736175|20058319|P2|STARTED|Overall Study||222
8137456|NCT02736175|20058320|P1|STARTED|Overall Study||216
8137457|NCT02735980|20058331|P3|NOT COMPLETED|Overall Study||1
8137458|NCT02735980|20058332|P2|NOT COMPLETED|Overall Study||11
8137459|NCT02735980|20058333|P1|NOT COMPLETED|Overall Study||10
8137460|NCT02735980|20058331|P3|COMPLETED|Overall Study||14
8137461|NCT02735980|20058332|P2|COMPLETED|Overall Study||49
8137462|NCT02735980|20058333|P1|COMPLETED|Overall Study||48
8137463|NCT02735980|20058331|P3|Received at Least 1 Dose of Study Drug|Overall Study||15
8137464|NCT02735980|20058332|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
8137465|NCT02735980|20058333|P1|Received at Least 1 Dose of Study Drug|Overall Study||56
8137466|NCT02735980|20058331|P3|STARTED|Overall Study||15
8137467|NCT02735980|20058332|P2|STARTED|Overall Study||60
8137468|NCT02735980|20058333|P1|STARTED|Overall Study||58
8137469|NCT02735915|20058362|P1|NOT COMPLETED|Overall Study||11
8137470|NCT02735915|20058362|P1|COMPLETED|Overall Study||59
8137471|NCT02735915|20058362|P1|Vaccinated|Overall Study||62
8137472|NCT02735915|20058362|P1|STARTED|Overall Study||70
8137473|NCT02735642|20058383|P2|NOT COMPLETED|Overall Study||0
8137474|NCT02735642|20058384|P1|NOT COMPLETED|Overall Study||0
8137475|NCT02735642|20058383|P2|COMPLETED|Overall Study||152
8137476|NCT02735642|20058384|P1|COMPLETED|Overall Study||1046
8137477|NCT02735642|20058383|P2|STARTED|Overall Study||152
8137478|NCT02735642|20058384|P1|STARTED|Overall Study||1046
8137479|NCT02735577|20058394|P1|NOT COMPLETED|Optional 28 Days of Disulfiram Treatment||2
8137480|NCT02735577|20058394|P1|COMPLETED|Optional 28 Days of Disulfiram Treatment||4
8137481|NCT02735577|20058394|P1|STARTED|Optional 28 Days of Disulfiram Treatment||6
8137482|NCT02735577|20058394|P1|NOT COMPLETED|Disulfiram Treatment||1
8137483|NCT02735577|20058394|P1|COMPLETED|Disulfiram Treatment||6
8137484|NCT02735577|20058394|P1|STARTED|Disulfiram Treatment||7
8137485|NCT02735551|20058401|P3|NOT COMPLETED|Overall Study||0
8137486|NCT02735551|20058402|P2|NOT COMPLETED|Overall Study||0
8137487|NCT02735551|20058403|P1|NOT COMPLETED|Overall Study||0
8137488|NCT02735551|20058401|P3|COMPLETED|Overall Study||0
8137489|NCT02735551|20058402|P2|COMPLETED|Overall Study||0
8137490|NCT02735551|20058403|P1|COMPLETED|Overall Study||3
8137491|NCT02735551|20058401|P3|STARTED|Overall Study||0
8137492|NCT02735551|20058402|P2|STARTED|Overall Study||0
8137493|NCT02735551|20058403|P1|STARTED|Overall Study||3
8137497|NCT02735382|20058422|P4|NOT COMPLETED|Overall Study||0
8137498|NCT02735382|20058423|P3|NOT COMPLETED|Overall Study||0
8137499|NCT02735382|20058424|P2|NOT COMPLETED|Overall Study||0
8137500|NCT02735382|20058425|P1|NOT COMPLETED|Overall Study||0
8137501|NCT02735382|20058422|P4|COMPLETED|Overall Study||110
8137502|NCT02735382|20058423|P3|COMPLETED|Overall Study||184
8137503|NCT02735382|20058424|P2|COMPLETED|Overall Study||7155
8137504|NCT02735382|20058425|P1|COMPLETED|Overall Study||7481
8137505|NCT02735382|20058422|P4|STARTED|Overall Study||110
8137506|NCT02735382|20058423|P3|STARTED|Overall Study||184
8137507|NCT02735382|20058424|P2|STARTED|Overall Study||7155
8137508|NCT02735382|20058425|P1|STARTED|Overall Study||7481
8137509|NCT02735200|20058441|P2|NOT COMPLETED|Overall Study||5
8137510|NCT02735200|20058442|P1|NOT COMPLETED|Overall Study||8
8137511|NCT02735200|20058441|P2|COMPLETED|Overall Study||345
8137512|NCT02735200|20058442|P1|COMPLETED|Overall Study||192
8137513|NCT02735200|20058441|P2|STARTED|Overall Study||350
8137514|NCT02735200|20058442|P1|STARTED|Overall Study||200
8137515|NCT02735187|20058450|P2|NOT COMPLETED|Overall Study||1
8137516|NCT02735187|20058451|P1|NOT COMPLETED|Overall Study||4
8137517|NCT02735187|20058450|P2|COMPLETED|Overall Study||25
8137518|NCT02735187|20058451|P1|COMPLETED|Overall Study||21
8137519|NCT02735187|20058450|P2|STARTED|Overall Study||26
8137520|NCT02735187|20058451|P1|STARTED|Overall Study||25
8137521|NCT02735174|20058481|P1|NOT COMPLETED|Overall Study||0
8137522|NCT02735174|20058481|P1|COMPLETED|Overall Study||21
8137523|NCT02735174|20058481|P1|STARTED|Overall Study||21
8137524|NCT02735096|20058485|P1|NOT COMPLETED|Overall Study||1
8137525|NCT02735096|20058485|P1|COMPLETED|Overall Study||3
8137526|NCT02735096|20058485|P1|STARTED|Overall Study||4
8137527|NCT02735044|20058494|P2|NOT COMPLETED|Overall Study||23
8137528|NCT02735044|20058495|P1|NOT COMPLETED|Overall Study||16
8137529|NCT02735044|20058494|P2|COMPLETED|Overall Study||207
8137530|NCT02735044|20058495|P1|COMPLETED|Overall Study||217
8137531|NCT02735044|20058494|P2|Treated|Overall Study||228
8137532|NCT02735044|20058495|P1|Treated|Overall Study||233
8137533|NCT02735044|20058494|P2|STARTED|Overall Study||230
8137534|NCT02735044|20058495|P1|STARTED|Overall Study||233
8137535|NCT02734953|20058521|P1|NOT COMPLETED|Overall Study||0
8137536|NCT02734953|20058521|P1|COMPLETED|Overall Study||10
8137537|NCT02734953|20058521|P1|STARTED|Overall Study||10
8137538|NCT02734940|20058538|P2|NOT COMPLETED|Overall Study||0
8137539|NCT02734940|20058539|P1|NOT COMPLETED|Overall Study||0
8137540|NCT02734940|20058538|P2|COMPLETED|Overall Study||0
8137541|NCT02734940|20058539|P1|COMPLETED|Overall Study||0
8137542|NCT02734940|20058538|P2|STARTED|Overall Study||0
8137543|NCT02734940|20058539|P1|STARTED|Overall Study||0
8137544|NCT02734862|20058564|P3|NOT COMPLETED|Part B||5
8137545|NCT02734862|20058565|P2|NOT COMPLETED|Part B||7
8137546|NCT02734862|20058566|P1|NOT COMPLETED|Part B||13
8137547|NCT02734862|20058564|P3|COMPLETED|Part B||28
8137548|NCT02734862|20058565|P2|COMPLETED|Part B||14
8137549|NCT02734862|20058566|P1|COMPLETED|Part B||33
8137550|NCT02734862|20058564|P3|STARTED|Part B||33
8137551|NCT02734862|20058565|P2|STARTED|Part B||21
8137552|NCT02734862|20058566|P1|STARTED|Part B||46
8137553|NCT02734862|20058564|P3|NOT COMPLETED|Part A||14
8137554|NCT02734862|20058565|P2|NOT COMPLETED|Part A||8
8137555|NCT02734862|20058566|P1|NOT COMPLETED|Part A||12
8137556|NCT02734862|20058564|P3|COMPLETED|Part A||22
8137557|NCT02734862|20058565|P2|COMPLETED|Part A||28
8137558|NCT02734862|20058566|P1|COMPLETED|Part A||23
8137559|NCT02734862|20058564|P3|STARTED|Part A||36
8137560|NCT02734862|20058565|P2|STARTED|Part A||36
8137561|NCT02734862|20058566|P1|STARTED|Part A||35
8137562|NCT02734849|20058595|P3|NOT COMPLETED|Overall Study||1
8137563|NCT02734849|20058596|P2|NOT COMPLETED|Overall Study||0
8137564|NCT02734849|20058597|P1|NOT COMPLETED|Overall Study||4
8137565|NCT02734849|20058595|P3|COMPLETED|Overall Study||9
8137566|NCT02734849|20058596|P2|COMPLETED|Overall Study||14
8137567|NCT02734849|20058597|P1|COMPLETED|Overall Study||12
8137568|NCT02734849|20058595|P3|STARTED|Overall Study||10
8137569|NCT02734849|20058596|P2|STARTED|Overall Study||14
8137570|NCT02734849|20058597|P1|STARTED|Overall Study|One patient was randomized but never received study treatment and excluded from all analysis sets.|16
8137571|NCT02734810|20058607|P2|NOT COMPLETED|Overall Study||0
8137572|NCT02734810|20058608|P1|NOT COMPLETED|Overall Study||2
8137573|NCT02734810|20058607|P2|COMPLETED|Overall Study||0
8137574|NCT02734810|20058608|P1|COMPLETED|Overall Study||13
8137575|NCT02734810|20058607|P2|STARTED|Overall Study||0
8137576|NCT02734810|20058608|P1|STARTED|Overall Study||15
8137577|NCT02734693|20058617|P3|NOT COMPLETED|Overall Study||3
8137578|NCT02734693|20058618|P2|NOT COMPLETED|Overall Study||3
8137579|NCT02734693|20058619|P1|NOT COMPLETED|Overall Study||6
8137580|NCT02734693|20058617|P3|COMPLETED|Overall Study||17
8137581|NCT02734693|20058618|P2|COMPLETED|Overall Study||53
8137582|NCT02734693|20058619|P1|COMPLETED|Overall Study||50
8137583|NCT02734693|20058617|P3|STARTED|Overall Study||20
8137584|NCT02734693|20058618|P2|STARTED|Overall Study||56
8137585|NCT02734693|20058619|P1|STARTED|Overall Study||56
8137586|NCT02734498|20058639|P3|NOT COMPLETED|Overall Study||0
8137587|NCT02734498|20058640|P2|NOT COMPLETED|Overall Study||0
8137588|NCT02734498|20058641|P1|NOT COMPLETED|Overall Study||0
8137589|NCT02734498|20058639|P3|COMPLETED|Overall Study||0
8137590|NCT02734498|20058640|P2|COMPLETED|Overall Study||0
8137591|NCT02734498|20058641|P1|COMPLETED|Overall Study||2
8137592|NCT02734498|20058639|P3|STARTED|Overall Study||0
8137593|NCT02734498|20058640|P2|STARTED|Overall Study||0
8137594|NCT02734498|20058641|P1|STARTED|Overall Study||2
8137601|NCT02734355|20058695|P2|NOT COMPLETED|Overall Study||0
8137602|NCT02734355|20058696|P1|NOT COMPLETED|Overall Study||0
8137603|NCT02734355|20058695|P2|COMPLETED|Overall Study||30
8137604|NCT02734355|20058696|P1|COMPLETED|Overall Study||34
8137605|NCT02734355|20058695|P2|STARTED|Overall Study||30
8137606|NCT02734355|20058696|P1|STARTED|Overall Study||34
8137607|NCT02734238|20058728|P2|NOT COMPLETED|Overall Study||0
8137608|NCT02734238|20058729|P1|NOT COMPLETED|Overall Study||0
8137609|NCT02734238|20058728|P2|COMPLETED|Overall Study||24
8137610|NCT02734238|20058729|P1|COMPLETED|Overall Study||26
8137611|NCT02734238|20058728|P2|STARTED|Overall Study||24
8137612|NCT02734238|20058729|P1|STARTED|Overall Study||26
8137613|NCT02734212|20058737|P2|NOT COMPLETED|Overall Study||10
8137614|NCT02734212|20058738|P1|NOT COMPLETED|Overall Study||5
8137615|NCT02734212|20058737|P2|COMPLETED|Overall Study||18
8137616|NCT02734212|20058738|P1|COMPLETED|Overall Study||24
8137617|NCT02734212|20058737|P2|STARTED|Overall Study||28
8137618|NCT02734212|20058738|P1|STARTED|Overall Study||29
8137619|NCT02734056|20058750|P2|NOT COMPLETED|Overall Study||1
8137620|NCT02734056|20058751|P1|NOT COMPLETED|Overall Study||0
8137621|NCT02734056|20058750|P2|COMPLETED|Overall Study||49
8137622|NCT02734056|20058751|P1|COMPLETED|Overall Study||50
8137623|NCT02734056|20058750|P2|STARTED|Overall Study||50
8137624|NCT02734056|20058751|P1|STARTED|Overall Study||50
8137625|NCT02733991|20058759|P2|NOT COMPLETED|Overall Study||5
8137626|NCT02733991|20058760|P1|NOT COMPLETED|Overall Study||1
8137627|NCT02733991|20058759|P2|COMPLETED|Overall Study||72
8137628|NCT02733991|20058760|P1|COMPLETED|Overall Study||75
8137629|NCT02733991|20058759|P2|STARTED|Overall Study||77
8137630|NCT02733991|20058760|P1|STARTED|Overall Study||76
8137631|NCT02733757|20058774|P4|NOT COMPLETED|Overall Study||0
8137632|NCT02733757|20058775|P3|NOT COMPLETED|Overall Study||0
8137633|NCT02733757|20058776|P2|NOT COMPLETED|Overall Study||0
8137634|NCT02733757|20058777|P1|NOT COMPLETED|Overall Study||0
8137635|NCT02733757|20058774|P4|COMPLETED|Overall Study||20
8137636|NCT02733757|20058775|P3|COMPLETED|Overall Study||20
8137637|NCT02733757|20058776|P2|COMPLETED|Overall Study||20
8137638|NCT02733757|20058777|P1|COMPLETED|Overall Study||20
8137639|NCT02733757|20058774|P4|STARTED|Overall Study||20
8137640|NCT02733757|20058775|P3|STARTED|Overall Study||20
8137641|NCT02733757|20058776|P2|STARTED|Overall Study||20
8137642|NCT02733757|20058777|P1|STARTED|Overall Study||20
8137643|NCT02733653|20058787|P1|NOT COMPLETED|Overall Study||1
8137644|NCT02733653|20058787|P1|COMPLETED|Overall Study||49
8137645|NCT02733653|20058787|P1|STARTED|Overall Study||50
8137646|NCT02733588|20058793|P1|NOT COMPLETED|Overall Study||0
8137647|NCT02733588|20058793|P1|COMPLETED|Overall Study||7
8137648|NCT02733588|20058793|P1|STARTED|Overall Study||7
8137649|NCT02733367|20058800|P1|NOT COMPLETED|Overall Study||6
8137650|NCT02733367|20058800|P1|COMPLETED|Overall Study||12
8137651|NCT02733367|20058800|P1|STARTED|Overall Study||18
8137652|NCT02733042|20058826|P19|NOT COMPLETED|Follow-up Period||2
8137653|NCT02733042|20058827|P18|NOT COMPLETED|Follow-up Period||2
8137654|NCT02733042|20058828|P17|NOT COMPLETED|Follow-up Period||0
8137655|NCT02733042|20058829|P16|NOT COMPLETED|Follow-up Period||5
8137656|NCT02733042|20058830|P15|NOT COMPLETED|Follow-up Period||1
8137657|NCT02733042|20058831|P14|NOT COMPLETED|Follow-up Period||4
8137658|NCT02733042|20058832|P13|NOT COMPLETED|Follow-up Period||9
8137659|NCT02733042|20058833|P12|NOT COMPLETED|Follow-up Period||9
8137660|NCT02733042|20058834|P11|NOT COMPLETED|Follow-up Period||5
8137661|NCT02733042|20058835|P10|NOT COMPLETED|Follow-up Period||2
8137662|NCT02733042|20058836|P9|NOT COMPLETED|Follow-up Period||4
8137663|NCT02733042|20058837|P8|NOT COMPLETED|Follow-up Period||4
8137664|NCT02733042|20058838|P7|NOT COMPLETED|Follow-up Period||0
8137665|NCT02733042|20058839|P6|NOT COMPLETED|Follow-up Period||2
8137666|NCT02733042|20058840|P5|NOT COMPLETED|Follow-up Period||1
8137667|NCT02733042|20058841|P4|NOT COMPLETED|Follow-up Period||3
8137668|NCT02733042|20058842|P3|NOT COMPLETED|Follow-up Period||6
8137669|NCT02733042|20058843|P2|NOT COMPLETED|Follow-up Period||3
8137670|NCT02733042|20058844|P1|NOT COMPLETED|Follow-up Period||3
8137671|NCT02733042|20058826|P19|COMPLETED|Follow-up Period||0
8137672|NCT02733042|20058827|P18|COMPLETED|Follow-up Period||1
8137673|NCT02733042|20058828|P17|COMPLETED|Follow-up Period||0
8137674|NCT02733042|20058829|P16|COMPLETED|Follow-up Period||0
8137675|NCT02733042|20058830|P15|COMPLETED|Follow-up Period||0
8137676|NCT02733042|20058831|P14|COMPLETED|Follow-up Period||0
8137677|NCT02733042|20058832|P13|COMPLETED|Follow-up Period||0
8137678|NCT02733042|20058833|P12|COMPLETED|Follow-up Period||0
8137679|NCT02733042|20058834|P11|COMPLETED|Follow-up Period||0
8137680|NCT02733042|20058835|P10|COMPLETED|Follow-up Period||0
8137681|NCT02733042|20058836|P9|COMPLETED|Follow-up Period||0
8137682|NCT02733042|20058837|P8|COMPLETED|Follow-up Period||0
8137683|NCT02733042|20058838|P7|COMPLETED|Follow-up Period||0
8137684|NCT02733042|20058839|P6|COMPLETED|Follow-up Period||0
8137685|NCT02733042|20058840|P5|COMPLETED|Follow-up Period||0
8137686|NCT02733042|20058841|P4|COMPLETED|Follow-up Period||0
8137687|NCT02733042|20058842|P3|COMPLETED|Follow-up Period||0
8137688|NCT02733042|20058843|P2|COMPLETED|Follow-up Period||0
8137689|NCT02733042|20058844|P1|COMPLETED|Follow-up Period||0
8137690|NCT02733042|20058826|P19|STARTED|Follow-up Period||2
8137691|NCT02733042|20058827|P18|STARTED|Follow-up Period||3
8137692|NCT02733042|20058828|P17|STARTED|Follow-up Period||0
8137693|NCT02733042|20058829|P16|STARTED|Follow-up Period||5
8137694|NCT02733042|20058830|P15|STARTED|Follow-up Period||1
8137695|NCT02733042|20058831|P14|STARTED|Follow-up Period||4
8137696|NCT02733042|20058832|P13|STARTED|Follow-up Period||9
8137697|NCT02733042|20058833|P12|STARTED|Follow-up Period||9
8137698|NCT02733042|20058834|P11|STARTED|Follow-up Period||5
8137699|NCT02733042|20058835|P10|STARTED|Follow-up Period||2
8137700|NCT02733042|20058836|P9|STARTED|Follow-up Period||4
8137701|NCT02733042|20058837|P8|STARTED|Follow-up Period||4
8137702|NCT02733042|20058838|P7|STARTED|Follow-up Period||0
8137703|NCT02733042|20058839|P6|STARTED|Follow-up Period||2
8137704|NCT02733042|20058840|P5|STARTED|Follow-up Period||1
8137705|NCT02733042|20058841|P4|STARTED|Follow-up Period||3
8137706|NCT02733042|20058842|P3|STARTED|Follow-up Period||6
8137707|NCT02733042|20058843|P2|STARTED|Follow-up Period||3
8137708|NCT02733042|20058844|P1|STARTED|Follow-up Period||3
8137709|NCT02733042|20058826|P19|NOT COMPLETED|Treatment Period||5
8137710|NCT02733042|20058827|P18|NOT COMPLETED|Treatment Period||5
8137711|NCT02733042|20058828|P17|NOT COMPLETED|Treatment Period||2
8137712|NCT02733042|20058829|P16|NOT COMPLETED|Treatment Period||10
8137713|NCT02733042|20058830|P15|NOT COMPLETED|Treatment Period||5
8137714|NCT02733042|20058831|P14|NOT COMPLETED|Treatment Period||4
8137715|NCT02733042|20058832|P13|NOT COMPLETED|Treatment Period||9
8137716|NCT02733042|20058833|P12|NOT COMPLETED|Treatment Period||6
8137717|NCT02733042|20058834|P11|NOT COMPLETED|Treatment Period||10
8137718|NCT02733042|20058835|P10|NOT COMPLETED|Treatment Period||10
8137719|NCT02733042|20058836|P9|NOT COMPLETED|Treatment Period||5
8137720|NCT02733042|20058837|P8|NOT COMPLETED|Treatment Period||3
8137721|NCT02733042|20058838|P7|NOT COMPLETED|Treatment Period||1
8137722|NCT02733042|20058839|P6|NOT COMPLETED|Treatment Period||3
8137723|NCT02733042|20058840|P5|NOT COMPLETED|Treatment Period||4
8137724|NCT02733042|20058841|P4|NOT COMPLETED|Treatment Period||3
8137725|NCT02733042|20058842|P3|NOT COMPLETED|Treatment Period||7
8137726|NCT02733042|20058843|P2|NOT COMPLETED|Treatment Period||2
8137727|NCT02733042|20058844|P1|NOT COMPLETED|Treatment Period||3
8137728|NCT02733042|20058826|P19|COMPLETED|Treatment Period||0
8137729|NCT02733042|20058827|P18|COMPLETED|Treatment Period||0
8137730|NCT02733042|20058828|P17|COMPLETED|Treatment Period||0
8137731|NCT02733042|20058829|P16|COMPLETED|Treatment Period||0
8137732|NCT02733042|20058830|P15|COMPLETED|Treatment Period||0
8137733|NCT02733042|20058831|P14|COMPLETED|Treatment Period||1
8137734|NCT02733042|20058832|P13|COMPLETED|Treatment Period||1
8137735|NCT02733042|20058833|P12|COMPLETED|Treatment Period||4
8137736|NCT02733042|20058834|P11|COMPLETED|Treatment Period||0
8137737|NCT02733042|20058835|P10|COMPLETED|Treatment Period||0
8137738|NCT02733042|20058836|P9|COMPLETED|Treatment Period||0
8137739|NCT02733042|20058837|P8|COMPLETED|Treatment Period||1
8137740|NCT02733042|20058838|P7|COMPLETED|Treatment Period||0
8137741|NCT02733042|20058839|P6|COMPLETED|Treatment Period||0
8137742|NCT02733042|20058840|P5|COMPLETED|Treatment Period||0
8137743|NCT02733042|20058841|P4|COMPLETED|Treatment Period||0
8137744|NCT02733042|20058842|P3|COMPLETED|Treatment Period||1
8137745|NCT02733042|20058843|P2|COMPLETED|Treatment Period||1
8137746|NCT02733042|20058844|P1|COMPLETED|Treatment Period||0
8137747|NCT02733042|20058826|P19|STARTED|Treatment Period||5
8137748|NCT02733042|20058827|P18|STARTED|Treatment Period||5
8137749|NCT02733042|20058828|P17|STARTED|Treatment Period||2
8137750|NCT02733042|20058829|P16|STARTED|Treatment Period||10
8137751|NCT02733042|20058830|P15|STARTED|Treatment Period||5
8137752|NCT02733042|20058831|P14|STARTED|Treatment Period||5
8137753|NCT02733042|20058832|P13|STARTED|Treatment Period||10
8137754|NCT02733042|20058833|P12|STARTED|Treatment Period||10
8137755|NCT02733042|20058834|P11|STARTED|Treatment Period||10
8137756|NCT02733042|20058835|P10|STARTED|Treatment Period||10
8137757|NCT02733042|20058836|P9|STARTED|Treatment Period||5
8137758|NCT02733042|20058837|P8|STARTED|Treatment Period||4
8137759|NCT02733042|20058838|P7|STARTED|Treatment Period||1
8137760|NCT02733042|20058839|P6|STARTED|Treatment Period||3
8137761|NCT02733042|20058840|P5|STARTED|Treatment Period||4
8137762|NCT02733042|20058841|P4|STARTED|Treatment Period||3
8137763|NCT02733042|20058842|P3|STARTED|Treatment Period||8
8137764|NCT02733042|20058843|P2|STARTED|Treatment Period||3
8137765|NCT02733042|20058844|P1|STARTED|Treatment Period||3
8137766|NCT02732951|20059049|P2|NOT COMPLETED|Overall Study||6
8137767|NCT02732951|20059050|P1|NOT COMPLETED|Overall Study||5
8137768|NCT02732951|20059049|P2|COMPLETED|Overall Study||46
8137769|NCT02732951|20059050|P1|COMPLETED|Overall Study||48
8137770|NCT02732951|20059049|P2|STARTED|Overall Study||52
8137771|NCT02732951|20059050|P1|STARTED|Overall Study||53
8137772|NCT02732938|20059060|P3|NOT COMPLETED|Overall Study||0
8137773|NCT02732938|20059061|P2|NOT COMPLETED|Overall Study||18
8137774|NCT02732938|20059062|P1|NOT COMPLETED|Overall Study||4
8137775|NCT02732938|20059060|P3|COMPLETED|Overall Study||0
8137776|NCT02732938|20059061|P2|COMPLETED|Overall Study||0
8137777|NCT02732938|20059062|P1|COMPLETED|Overall Study||0
8137778|NCT02732938|20059060|P3|Received Treatment|Overall Study||0
8137779|NCT02732938|20059061|P2|Received Treatment|Overall Study||17
8137780|NCT02732938|20059062|P1|Received Treatment|Overall Study||4
8137781|NCT02732938|20059060|P3|STARTED|Overall Study||0
8137782|NCT02732938|20059061|P2|STARTED|Overall Study||18
8137783|NCT02732938|20059062|P1|STARTED|Overall Study||4
8137784|NCT02732912|20059108|P2|NOT COMPLETED|Overall Study||18
8137785|NCT02732912|20059109|P1|NOT COMPLETED|Overall Study||10
8137786|NCT02732912|20059108|P2|COMPLETED|Overall Study||91
8137787|NCT02732912|20059109|P1|COMPLETED|Overall Study||87
8137788|NCT02732912|20059108|P2|STARTED|Overall Study||109
8137789|NCT02732912|20059109|P1|STARTED|Overall Study||97
8137790|NCT02732899|20059125|P2|NOT COMPLETED|Overall Study||0
8137791|NCT02732899|20059126|P1|NOT COMPLETED|Overall Study||0
8137792|NCT02732899|20059125|P2|COMPLETED|Overall Study||10
8137793|NCT02732899|20059126|P1|COMPLETED|Overall Study||10
8137794|NCT02732899|20059125|P2|STARTED|Overall Study||10
8137795|NCT02732899|20059126|P1|STARTED|Overall Study||10
8137796|NCT02732639|20059134|P1|NOT COMPLETED|Overall Study||1
8137797|NCT02732639|20059134|P1|COMPLETED|Overall Study||30
8137798|NCT02732639|20059134|P1|STARTED|Overall Study||31
8137809|NCT02732587|20059154|P1|NOT COMPLETED|Overall Study||0
8137810|NCT02732587|20059154|P1|COMPLETED|Overall Study||5
8137811|NCT02732587|20059154|P1|STARTED|Overall Study||5
8137812|NCT02732561|20059160|P2|NOT COMPLETED|Overall Study||1
8137813|NCT02732561|20059161|P1|NOT COMPLETED|Overall Study||2
8137814|NCT02732561|20059160|P2|COMPLETED|Overall Study||4
8137815|NCT02732561|20059161|P1|COMPLETED|Overall Study||3
8137816|NCT02732561|20059160|P2|STARTED|Overall Study||5
8137817|NCT02732561|20059161|P1|STARTED|Overall Study||5
8137818|NCT02732366|20059171|P2|NOT COMPLETED|Overall Study||2
8137819|NCT02732366|20059172|P1|NOT COMPLETED|Overall Study||5
8137820|NCT02732366|20059171|P2|COMPLETED|Overall Study||21
8137821|NCT02732366|20059172|P1|COMPLETED|Overall Study||18
8137822|NCT02732366|20059171|P2|Withdrawal by Participant|Overall Study||2
8137823|NCT02732366|20059172|P1|Withdrawal by Participant|Overall Study||5
8137824|NCT02732366|20059171|P2|STARTED|Overall Study||23
8137825|NCT02732366|20059172|P1|STARTED|Overall Study||23
8137826|NCT02732327|20059187|P2|NOT COMPLETED|Overall Study||1
8137827|NCT02732327|20059188|P1|NOT COMPLETED|Overall Study||0
8137828|NCT02732327|20059187|P2|COMPLETED|Overall Study||1
8137829|NCT02732327|20059188|P1|COMPLETED|Overall Study||0
8137830|NCT02732327|20059187|P2|STARTED|Overall Study||2
8137831|NCT02732327|20059188|P1|STARTED|Overall Study||0
8137832|NCT02732210|20059196|P2|NOT COMPLETED|Overall Study||294
8137833|NCT02732210|20059197|P1|NOT COMPLETED|Overall Study||85
8137834|NCT02732210|20059196|P2|COMPLETED|Overall Study||338
8137835|NCT02732210|20059197|P1|COMPLETED|Overall Study||218
8137836|NCT02732210|20059196|P2|STARTED|Overall Study||632
8137837|NCT02732210|20059197|P1|STARTED|Overall Study||303
8137838|NCT02732145|20059217|P4|NOT COMPLETED|Overall Study||0
8137839|NCT02732145|20059218|P3|NOT COMPLETED|Overall Study||0
8137840|NCT02732145|20059219|P2|NOT COMPLETED|Overall Study||0
8137841|NCT02732145|20059220|P1|NOT COMPLETED|Overall Study||0
8137842|NCT02732145|20059217|P4|COMPLETED|Overall Study||82
8137843|NCT02732145|20059218|P3|COMPLETED|Overall Study||82
8137844|NCT02732145|20059219|P2|COMPLETED|Overall Study||82
8137845|NCT02732145|20059220|P1|COMPLETED|Overall Study||82
8137846|NCT02732145|20059217|P4|STARTED|Overall Study||82
8137847|NCT02732145|20059218|P3|STARTED|Overall Study||82
8137848|NCT02732145|20059219|P2|STARTED|Overall Study||82
8137849|NCT02732145|20059220|P1|STARTED|Overall Study||82
8137850|NCT02731833|20059348|P2|NOT COMPLETED|Overall Study||0
8137851|NCT02731833|20059349|P1|NOT COMPLETED|Overall Study||0
8137852|NCT02731833|20059348|P2|COMPLETED|Overall Study||111
8137853|NCT02731833|20059349|P1|COMPLETED|Overall Study||111
8137854|NCT02731833|20059348|P2|STARTED|Overall Study||111
8137855|NCT02731833|20059349|P1|STARTED|Overall Study||111
8137856|NCT02731820|20059363|P2|NOT COMPLETED|Overall Study||2
8137857|NCT02731820|20059364|P1|NOT COMPLETED|Overall Study||3
8137858|NCT02731820|20059363|P2|COMPLETED|Overall Study||18
8137859|NCT02731820|20059364|P1|COMPLETED|Overall Study||17
8137860|NCT02731820|20059363|P2|STARTED|Overall Study||20
8137861|NCT02731820|20059364|P1|STARTED|Overall Study||20
8137862|NCT02731755|20059376|P2|NOT COMPLETED|Second Intervention||0
8137863|NCT02731755|20059377|P1|NOT COMPLETED|Second Intervention||0
8137864|NCT02731755|20059376|P2|COMPLETED|Second Intervention||8
8137865|NCT02731755|20059377|P1|COMPLETED|Second Intervention||8
8137866|NCT02731755|20059376|P2|STARTED|Second Intervention||8
8137867|NCT02731755|20059377|P1|STARTED|Second Intervention||8
8137868|NCT02731755|20059376|P2|NOT COMPLETED|First Intervention||2
8137869|NCT02731755|20059377|P1|NOT COMPLETED|First Intervention||0
8137870|NCT02731755|20059376|P2|COMPLETED|First Intervention||8
8137871|NCT02731755|20059377|P1|COMPLETED|First Intervention||8
8137872|NCT02731755|20059376|P2|STARTED|First Intervention||10
8137873|NCT02731755|20059377|P1|STARTED|First Intervention||8
8137874|NCT02731742|20059401|P4|NOT COMPLETED|Overall Study||2
8137875|NCT02731742|20059402|P3|NOT COMPLETED|Overall Study||6
8137876|NCT02731742|20059403|P2|NOT COMPLETED|Overall Study||3
8137877|NCT02731742|20059404|P1|NOT COMPLETED|Overall Study||3
8137878|NCT02731742|20059401|P4|COMPLETED|Overall Study||0
8137879|NCT02731742|20059402|P3|COMPLETED|Overall Study||0
8137880|NCT02731742|20059403|P2|COMPLETED|Overall Study||0
8137881|NCT02731742|20059404|P1|COMPLETED|Overall Study||0
8137882|NCT02731742|20059401|P4|STARTED|Overall Study||2
8137883|NCT02731742|20059402|P3|STARTED|Overall Study||6
8137884|NCT02731742|20059403|P2|STARTED|Overall Study||3
8137885|NCT02731742|20059404|P1|STARTED|Overall Study||3
8137886|NCT02731690|20059422|P1|NOT COMPLETED|Overall Study||30
8137887|NCT02731690|20059422|P1|COMPLETED|Overall Study||12
8137888|NCT02731690|20059422|P1|STARTED|Overall Study||42
8137889|NCT02731638|20059442|P2|NOT COMPLETED|Overall Study||9
8137890|NCT02731638|20059443|P1|NOT COMPLETED|Overall Study||6
8137891|NCT02731638|20059442|P2|COMPLETED|Overall Study||26
8137892|NCT02731638|20059443|P1|COMPLETED|Overall Study||29
8137893|NCT02731638|20059442|P2|STARTED|Overall Study||35
8137894|NCT02731638|20059443|P1|STARTED|Overall Study||35
8137895|NCT02731469|20059468|P11|NOT COMPLETED|Overall Study||0
8137896|NCT02731469|20059469|P10|NOT COMPLETED|Overall Study||0
8137897|NCT02731469|20059470|P9|NOT COMPLETED|Overall Study||0
8137898|NCT02731469|20059471|P8|NOT COMPLETED|Overall Study||0
8137899|NCT02731469|20059472|P7|NOT COMPLETED|Overall Study||0
8137900|NCT02731469|20059473|P6|NOT COMPLETED|Overall Study||0
8137901|NCT02731469|20059474|P5|NOT COMPLETED|Overall Study||0
8137902|NCT02731469|20059475|P4|NOT COMPLETED|Overall Study||0
8137903|NCT02731469|20059476|P3|NOT COMPLETED|Overall Study||0
8137904|NCT02731469|20059477|P2|NOT COMPLETED|Overall Study||0
8137905|NCT02731469|20059478|P1|NOT COMPLETED|Overall Study||0
8137906|NCT02731469|20059468|P11|COMPLETED|Overall Study||6
8137907|NCT02731469|20059469|P10|COMPLETED|Overall Study||6
8137908|NCT02731469|20059470|P9|COMPLETED|Overall Study||6
8137909|NCT02731469|20059471|P8|COMPLETED|Overall Study||6
8137910|NCT02731469|20059472|P7|COMPLETED|Overall Study||3
8137911|NCT02731469|20059473|P6|COMPLETED|Overall Study||3
8137912|NCT02731469|20059474|P5|COMPLETED|Overall Study||3
8137913|NCT02731469|20059475|P4|COMPLETED|Overall Study||3
8137914|NCT02731469|20059476|P3|COMPLETED|Overall Study||3
8137915|NCT02731469|20059477|P2|COMPLETED|Overall Study||3
8137916|NCT02731469|20059478|P1|COMPLETED|Overall Study||3
8137917|NCT02731469|20059468|P11|STARTED|Overall Study||6
8137918|NCT02731469|20059469|P10|STARTED|Overall Study||6
8137919|NCT02731469|20059470|P9|STARTED|Overall Study||6
8137920|NCT02731469|20059471|P8|STARTED|Overall Study||6
8137921|NCT02731469|20059472|P7|STARTED|Overall Study||3
8137922|NCT02731469|20059473|P6|STARTED|Overall Study||3
8137923|NCT02731469|20059474|P5|STARTED|Overall Study||3
8137924|NCT02731469|20059475|P4|STARTED|Overall Study||3
8137925|NCT02731469|20059476|P3|STARTED|Overall Study||3
8137926|NCT02731469|20059477|P2|STARTED|Overall Study||3
8137927|NCT02731469|20059478|P1|STARTED|Overall Study||3
8137928|NCT02731313|20059667|P1|NOT COMPLETED|Overall Study||0
8137929|NCT02731313|20059667|P1|COMPLETED|Overall Study||367
8137930|NCT02731313|20059667|P1|STARTED|Overall Study||367
8137931|NCT02731300|20059677|P2|NOT COMPLETED|Overall Study||0
8137932|NCT02731300|20059678|P1|NOT COMPLETED|Overall Study||0
8137933|NCT02731300|20059677|P2|COMPLETED|Overall Study||7
8137934|NCT02731300|20059678|P1|COMPLETED|Overall Study||15
8137935|NCT02731300|20059677|P2|STARTED|Overall Study||7
8137936|NCT02731300|20059678|P1|STARTED|Overall Study||15
8137937|NCT02731157|20059686|P1|NOT COMPLETED|Third Standard RCE||0
8137938|NCT02731157|20059686|P1|COMPLETED|Third Standard RCE||3
8137939|NCT02731157|20059686|P1|STARTED|Third Standard RCE||3
8137940|NCT02731157|20059686|P1|NOT COMPLETED|Second Standard RCE||0
8137941|NCT02731157|20059686|P1|COMPLETED|Second Standard RCE||3
8137942|NCT02731157|20059686|P1|STARTED|Second Standard RCE||3
8137943|NCT02731157|20059686|P1|NOT COMPLETED|Third Rejuvenated RCE||0
8137944|NCT02731157|20059686|P1|COMPLETED|Third Rejuvenated RCE||3
8137945|NCT02731157|20059686|P1|STARTED|Third Rejuvenated RCE||3
8137946|NCT02731157|20059686|P1|NOT COMPLETED|Second Rejuvenated RCE||0
8137947|NCT02731157|20059686|P1|COMPLETED|Second Rejuvenated RCE||3
8137948|NCT02731157|20059686|P1|STARTED|Second Rejuvenated RCE||3
8137949|NCT02731157|20059686|P1|NOT COMPLETED|First Rejuvenated RCE||1
8137950|NCT02731157|20059686|P1|COMPLETED|First Rejuvenated RCE||3
8137951|NCT02731157|20059686|P1|STARTED|First Rejuvenated RCE||4
8137952|NCT02731157|20059686|P1|NOT COMPLETED|First Standard RCE||0
8137953|NCT02731157|20059686|P1|COMPLETED|First Standard RCE||4
8137954|NCT02731157|20059686|P1|STARTED|First Standard RCE||4
8137955|NCT02731131|20059704|P2|NOT COMPLETED|Overall Study||2
8137956|NCT02731131|20059705|P1|NOT COMPLETED|Overall Study||0
8137957|NCT02731131|20059704|P2|COMPLETED|Overall Study||4
8137958|NCT02731131|20059705|P1|COMPLETED|Overall Study||6
8137959|NCT02731131|20059704|P2|STARTED|Overall Study||6
8137960|NCT02731131|20059705|P1|STARTED|Overall Study||6
8137961|NCT02730988|20059723|P2|NOT COMPLETED|Overall Study||10
8137962|NCT02730988|20059724|P1|NOT COMPLETED|Overall Study||4
8137963|NCT02730988|20059723|P2|COMPLETED|Overall Study||39
8137964|NCT02730988|20059724|P1|COMPLETED|Overall Study||43
8137965|NCT02730988|20059723|P2|STARTED|Overall Study||49
8137966|NCT02730988|20059724|P1|STARTED|Overall Study||47
8137967|NCT02730962|20059734|P2|NOT COMPLETED|Overall Study||0
8137968|NCT02730962|20059735|P1|NOT COMPLETED|Overall Study||0
8137969|NCT02730962|20059734|P2|COMPLETED|Overall Study||5
8137970|NCT02730962|20059735|P1|COMPLETED|Overall Study||7
8137971|NCT02730962|20059734|P2|STARTED|Overall Study||5
8137972|NCT02730962|20059735|P1|STARTED|Overall Study||7
8137973|NCT02730884|20059747|P1|NOT COMPLETED|Overall Study||0
8137974|NCT02730884|20059747|P1|COMPLETED|Overall Study||3
8137975|NCT02730884|20059747|P1|STARTED|Overall Study||3
8137976|NCT02730871|20059755|P2|NOT COMPLETED|Overall Study||0
8137977|NCT02730871|20059756|P1|NOT COMPLETED|Overall Study||6
8137978|NCT02730871|20059755|P2|COMPLETED|Overall Study||67
8137979|NCT02730871|20059756|P1|COMPLETED|Overall Study||61
8137980|NCT02730871|20059755|P2|Safety Analysis Set|Overall Study||67
8137981|NCT02730871|20059756|P1|Safety Analysis Set|Overall Study||67
8137982|NCT02730871|20059755|P2|Full Analysis Set (FAS)|Overall Study||67
8137983|NCT02730871|20059756|P1|Full Analysis Set (FAS)|Overall Study||67
8137984|NCT02730871|20059755|P2|STARTED|Overall Study||67
8137985|NCT02730871|20059756|P1|STARTED|Overall Study||67
8137986|NCT02730819|20059770|P1|NOT COMPLETED|Overall Study||9
8137987|NCT02730819|20059770|P1|COMPLETED|Overall Study||10
8137988|NCT02730819|20059770|P1|Follow-up Week 20|Overall Study||10
8137989|NCT02730819|20059770|P1|Follow-up Week 16|Overall Study||11
8137990|NCT02730819|20059770|P1|Follow-up Week 12|Overall Study||11
8137991|NCT02730819|20059770|P1|Follow-up Week 8|Overall Study||14
8137992|NCT02730819|20059770|P1|Follow-up Week 4|Overall Study||16
8137993|NCT02730819|20059770|P1|Follow-up Week 2|Overall Study||15
8137994|NCT02730819|20059770|P1|STARTED|Overall Study||19
8137995|NCT02730728|20059779|P3|NOT COMPLETED|Overall Study||1
8137996|NCT02730728|20059780|P2|NOT COMPLETED|Overall Study||2
8137997|NCT02730728|20059781|P1|NOT COMPLETED|Overall Study||0
8137998|NCT02730728|20059779|P3|COMPLETED|Overall Study||52
8137999|NCT02730728|20059780|P2|COMPLETED|Overall Study||51
8138000|NCT02730728|20059781|P1|COMPLETED|Overall Study||53
8138001|NCT02730728|20059779|P3|STARTED|Overall Study||53
8138002|NCT02730728|20059780|P2|STARTED|Overall Study||53
8138003|NCT02730728|20059781|P1|STARTED|Overall Study||53
8138004|NCT02730663|20059798|P1|NOT COMPLETED|Overall Study||1
8138005|NCT02730663|20059798|P1|COMPLETED|Overall Study||35
8138006|NCT02730663|20059798|P1|STARTED|Overall Study||36
8138007|NCT02730598|20059810|P2|NOT COMPLETED|Overall Study||4
8138008|NCT02730598|20059811|P1|NOT COMPLETED|Overall Study||4
8138009|NCT02730598|20059810|P2|COMPLETED|Overall Study||10
8138010|NCT02730598|20059811|P1|COMPLETED|Overall Study||10
8138011|NCT02730598|20059810|P2|STARTED|Overall Study||14
8138012|NCT02730598|20059811|P1|STARTED|Overall Study||14
8138013|NCT02730455|20059834|P3|NOT COMPLETED|Overall Study||11
8138014|NCT02730455|20059835|P2|NOT COMPLETED|Overall Study||14
8138015|NCT02730455|20059836|P1|NOT COMPLETED|Overall Study||13
8138016|NCT02730455|20059834|P3|COMPLETED|Overall Study||81
8138017|NCT02730455|20059835|P2|COMPLETED|Overall Study||77
8138018|NCT02730455|20059836|P1|COMPLETED|Overall Study||81
8138019|NCT02730455|20059834|P3|Who Received Total Volume of Study Drug|Overall Study||89
8138020|NCT02730455|20059835|P2|Who Received Total Volume of Study Drug|Overall Study||88
8138021|NCT02730455|20059836|P1|Who Received Total Volume of Study Drug|Overall Study||90
8138022|NCT02730455|20059834|P3|Participants Dosed|Overall Study||91
8138023|NCT02730455|20059835|P2|Participants Dosed|Overall Study||88
8138024|NCT02730455|20059836|P1|Participants Dosed|Overall Study||91
8138025|NCT02730455|20059834|P3|Safety Population|Overall Study||89
8138026|NCT02730455|20059835|P2|Safety Population|Overall Study||90
8138027|NCT02730455|20059836|P1|Safety Population|Overall Study||91
8138028|NCT02730455|20059834|P3|STARTED|Overall Study||92
8138029|NCT02730455|20059835|P2|STARTED|Overall Study||91
8138030|NCT02730455|20059836|P1|STARTED|Overall Study||94
8138031|NCT02730403|20059868|P1|NOT COMPLETED|Overall Study||54
8138032|NCT02730403|20059868|P1|COMPLETED|Overall Study||157
8138033|NCT02730403|20059868|P1|STARTED|Overall Study||211
8138034|NCT02730377|20059886|P2|NOT COMPLETED|Overall Study||633
8138035|NCT02730377|20059887|P1|NOT COMPLETED|Overall Study||550
8138036|NCT02730377|20059886|P2|COMPLETED|Overall Study||362
8138037|NCT02730377|20059887|P1|COMPLETED|Overall Study||446
8138038|NCT02730377|20059886|P2|Safety Analysis Set (SAS)|Overall Study||984
8138039|NCT02730377|20059887|P1|Safety Analysis Set (SAS)|Overall Study||980
8138040|NCT02730377|20059886|P2|Full Analysis Set (FAS)|Overall Study||995
8138041|NCT02730377|20059887|P1|Full Analysis Set (FAS)|Overall Study||996
8138042|NCT02730377|20059886|P2|Treated|Overall Study||984
8138043|NCT02730377|20059887|P1|Treated|Overall Study||980
8138044|NCT02730377|20059886|P2|STARTED|Overall Study||995
8138045|NCT02730377|20059887|P1|STARTED|Overall Study||996
8138046|NCT02730351|20059937|P2|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
8138047|NCT02730351|20059938|P1|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
8138048|NCT02730351|20059937|P2|COMPLETED|Treatment Period 2 (2 Weeks)||36
8138049|NCT02730351|20059938|P1|COMPLETED|Treatment Period 2 (2 Weeks)||33
8138050|NCT02730351|20059937|P2|STARTED|Treatment Period 2 (2 Weeks)||36
8138051|NCT02730351|20059938|P1|STARTED|Treatment Period 2 (2 Weeks)||35
8138052|NCT02730351|20059937|P2|NOT COMPLETED|Wash-out Period (2 Weeks)||1
8138053|NCT02730351|20059938|P1|NOT COMPLETED|Wash-out Period (2 Weeks)||1
8138054|NCT02730351|20059937|P2|COMPLETED|Wash-out Period (2 Weeks)||36
8138055|NCT02730351|20059938|P1|COMPLETED|Wash-out Period (2 Weeks)||35
8138056|NCT02730351|20059937|P2|STARTED|Wash-out Period (2 Weeks)||37
8138057|NCT02730351|20059938|P1|STARTED|Wash-out Period (2 Weeks)||36
8138058|NCT02730351|20059937|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
8138059|NCT02730351|20059938|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
8138060|NCT02730351|20059937|P2|COMPLETED|Treatment Period 1 (2 Weeks)||37
8138061|NCT02730351|20059938|P1|COMPLETED|Treatment Period 1 (2 Weeks)||36
8138062|NCT02730351|20059937|P2|STARTED|Treatment Period 1 (2 Weeks)||37
8138063|NCT02730351|20059938|P1|STARTED|Treatment Period 1 (2 Weeks)||37
8138064|NCT02730260|20059952|P2|NOT COMPLETED|Overall Study||75
8138065|NCT02730260|20059953|P1|NOT COMPLETED|Overall Study||82
8138066|NCT02730260|20059952|P2|COMPLETED|Overall Study||185
8138067|NCT02730260|20059953|P1|COMPLETED|Overall Study||176
8138068|NCT02730260|20059952|P2|STARTED|Overall Study||260
8138069|NCT02730260|20059953|P1|STARTED|Overall Study||258
8138070|NCT02730247|20059959|P1|NOT COMPLETED|Overall Study||0
8138071|NCT02730247|20059959|P1|COMPLETED|Overall Study||7
8138072|NCT02730247|20059959|P1|STARTED|Overall Study||7
8138073|NCT02730208|20059972|P2|NOT COMPLETED|Overall Study||1
8138074|NCT02730208|20059973|P1|NOT COMPLETED|Overall Study||0
8138075|NCT02730208|20059972|P2|COMPLETED|Overall Study||20
8138076|NCT02730208|20059973|P1|COMPLETED|Overall Study||20
8138077|NCT02730208|20059972|P2|STARTED|Overall Study||21
8138078|NCT02730208|20059973|P1|STARTED|Overall Study||20
8138079|NCT02730195|20059981|P1|NOT COMPLETED|Overall Study||1
8138080|NCT02730195|20059981|P1|COMPLETED|Overall Study||8
8138081|NCT02730195|20059981|P1|STARTED|Overall Study||9
8138082|NCT02730169|20059991|P4|NOT COMPLETED|Overall Study||16
8138083|NCT02730169|20059992|P3|NOT COMPLETED|Overall Study||17
8138084|NCT02730169|20059993|P2|NOT COMPLETED|Overall Study||21
8138085|NCT02730169|20059994|P1|NOT COMPLETED|Overall Study||14
8138086|NCT02730169|20059991|P4|COMPLETED|Overall Study||55
8138087|NCT02730169|20059992|P3|COMPLETED|Overall Study||50
8138088|NCT02730169|20059993|P2|COMPLETED|Overall Study||45
8138089|NCT02730169|20059994|P1|COMPLETED|Overall Study||53
8138090|NCT02730169|20059991|P4|STARTED|Overall Study||71
8138091|NCT02730169|20059992|P3|STARTED|Overall Study||67
8138092|NCT02730169|20059993|P2|STARTED|Overall Study||66
8138093|NCT02730169|20059994|P1|STARTED|Overall Study||67
8138097|NCT02729909|20060062|P2|NOT COMPLETED|Overall Study||5
8138098|NCT02729909|20060063|P1|NOT COMPLETED|Overall Study||1
8138099|NCT02729909|20060062|P2|COMPLETED|Overall Study||101
8138100|NCT02729909|20060063|P1|COMPLETED|Overall Study||104
8138101|NCT02729909|20060062|P2|STARTED|Overall Study||106
8138102|NCT02729909|20060063|P1|STARTED|Overall Study||105
8138103|NCT02729896|20060082|P3|NOT COMPLETED|Overall Study||22
8138104|NCT02729896|20060083|P2|NOT COMPLETED|Overall Study||9
8138105|NCT02729896|20060084|P1|NOT COMPLETED|Overall Study||2
8138106|NCT02729896|20060082|P3|COMPLETED|Overall Study||1
8138107|NCT02729896|20060083|P2|COMPLETED|Overall Study||1
8138108|NCT02729896|20060084|P1|COMPLETED|Overall Study||1
8138109|NCT02729896|20060082|P3|STARTED|Overall Study||23
8138110|NCT02729896|20060083|P2|STARTED|Overall Study||10
8138111|NCT02729896|20060084|P1|STARTED|Overall Study||3
8138112|NCT02729831|20060129|P4|NOT COMPLETED|6 Month Follow-up||43
8138113|NCT02729831|20060130|P3|NOT COMPLETED|6 Month Follow-up||48
8138114|NCT02729831|20060131|P2|NOT COMPLETED|6 Month Follow-up||54
8138115|NCT02729831|20060132|P1|NOT COMPLETED|6 Month Follow-up||55
8138116|NCT02729831|20060129|P4|COMPLETED|6 Month Follow-up||232
8138117|NCT02729831|20060130|P3|COMPLETED|6 Month Follow-up||227
8138118|NCT02729831|20060131|P2|COMPLETED|6 Month Follow-up||238
8138119|NCT02729831|20060132|P1|COMPLETED|6 Month Follow-up||227
8138120|NCT02729831|20060129|P4|STARTED|6 Month Follow-up||275
8138121|NCT02729831|20060130|P3|STARTED|6 Month Follow-up||275
8138122|NCT02729831|20060131|P2|STARTED|6 Month Follow-up||292
8138123|NCT02729831|20060132|P1|STARTED|6 Month Follow-up||282
8138124|NCT02729831|20060129|P4|NOT COMPLETED|1 Week Post-visit||36
8138125|NCT02729831|20060130|P3|NOT COMPLETED|1 Week Post-visit||38
8138126|NCT02729831|20060131|P2|NOT COMPLETED|1 Week Post-visit||40
8138127|NCT02729831|20060132|P1|NOT COMPLETED|1 Week Post-visit||43
8138128|NCT02729831|20060129|P4|COMPLETED|1 Week Post-visit||239
8138129|NCT02729831|20060130|P3|COMPLETED|1 Week Post-visit||237
8138130|NCT02729831|20060131|P2|COMPLETED|1 Week Post-visit||252
8138131|NCT02729831|20060132|P1|COMPLETED|1 Week Post-visit||239
8138132|NCT02729831|20060129|P4|STARTED|1 Week Post-visit||275
8138133|NCT02729831|20060130|P3|STARTED|1 Week Post-visit||275
8138134|NCT02729831|20060131|P2|STARTED|1 Week Post-visit||292
8138135|NCT02729831|20060132|P1|STARTED|1 Week Post-visit||282
8138136|NCT02729831|20060129|P4|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17
8138137|NCT02729831|20060130|P3|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18
8138138|NCT02729831|20060131|P2|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23
8138139|NCT02729831|20060132|P1|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38
8138140|NCT02729831|20060129|P4|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
8138141|NCT02729831|20060130|P3|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
8138142|NCT02729831|20060131|P2|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292
8138143|NCT02729831|20060132|P1|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282
8138144|NCT02729831|20060129|P4|STARTED|Baseline (Post Decision Aid, Pre-visit)||292
8138145|NCT02729831|20060130|P3|STARTED|Baseline (Post Decision Aid, Pre-visit)||293
8138146|NCT02729831|20060131|P2|STARTED|Baseline (Post Decision Aid, Pre-visit)||315
8138147|NCT02729831|20060132|P1|STARTED|Baseline (Post Decision Aid, Pre-visit)||320
8138148|NCT02729753|20060160|P2|NOT COMPLETED|Overall Study||1
8138149|NCT02729753|20060161|P1|NOT COMPLETED|Overall Study||0
8138150|NCT02729753|20060160|P2|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
8138151|NCT02729753|20060161|P1|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
8138152|NCT02729753|20060160|P2|STARTED|Overall Study|First patient enrolled April 2016|7
8138153|NCT02729753|20060161|P1|STARTED|Overall Study|First patient enrolled April 2016|3
8138154|NCT02729545|20060175|P2|NOT COMPLETED|Overall Study||5
8138155|NCT02729545|20060176|P1|NOT COMPLETED|Overall Study||3
8138156|NCT02729545|20060175|P2|COMPLETED|Overall Study||25
8138157|NCT02729545|20060176|P1|COMPLETED|Overall Study||27
8138158|NCT02729545|20060175|P2|STARTED|Overall Study||30
8138159|NCT02729545|20060176|P1|STARTED|Overall Study||30
8138160|NCT02729194|20060198|P1|NOT COMPLETED|Overall Study||3
8138161|NCT02729194|20060198|P1|COMPLETED|Overall Study||13
8138162|NCT02729194|20060198|P1|STARTED|Overall Study||16
8138163|NCT02729051|20060210|P2|NOT COMPLETED|Overall Study||32
8138164|NCT02729051|20060211|P1|NOT COMPLETED|Overall Study||30
8138165|NCT02729051|20060210|P2|COMPLETED|Overall Study||496
8138166|NCT02729051|20060211|P1|COMPLETED|Overall Study||497
8138167|NCT02729051|20060210|P2|STARTED|Overall Study||528
8138168|NCT02729051|20060211|P1|STARTED|Overall Study||527
8138169|NCT02729038|20060231|P4|NOT COMPLETED|Part 2 (Up to 50 Days)||0
8138170|NCT02729038|20060232|P3|NOT COMPLETED|Part 2 (Up to 50 Days)||0
8138171|NCT02729038|20060233|P2|NOT COMPLETED|Part 2 (Up to 50 Days)||0
8138172|NCT02729038|20060234|P1|NOT COMPLETED|Part 2 (Up to 50 Days)||0
8138173|NCT02729038|20060231|P4|COMPLETED|Part 2 (Up to 50 Days)||8
8138174|NCT02729038|20060232|P3|COMPLETED|Part 2 (Up to 50 Days)||0
8138175|NCT02729038|20060233|P2|COMPLETED|Part 2 (Up to 50 Days)||0
8138176|NCT02729038|20060234|P1|COMPLETED|Part 2 (Up to 50 Days)||0
8138177|NCT02729038|20060231|P4|STARTED|Part 2 (Up to 50 Days)||8
8138178|NCT02729038|20060232|P3|STARTED|Part 2 (Up to 50 Days)||0
8138179|NCT02729038|20060233|P2|STARTED|Part 2 (Up to 50 Days)||0
8138180|NCT02729038|20060234|P1|STARTED|Part 2 (Up to 50 Days)||0
8138181|NCT02729038|20060231|P4|NOT COMPLETED|Part 1 (Up to 44 Days)||0
8138182|NCT02729038|20060232|P3|NOT COMPLETED|Part 1 (Up to 44 Days)||0
8138183|NCT02729038|20060233|P2|NOT COMPLETED|Part 1 (Up to 44 Days)||0
8138184|NCT02729038|20060234|P1|NOT COMPLETED|Part 1 (Up to 44 Days)||0
8138185|NCT02729038|20060231|P4|COMPLETED|Part 1 (Up to 44 Days)||0
8138186|NCT02729038|20060232|P3|COMPLETED|Part 1 (Up to 44 Days)||8
8138187|NCT02729038|20060233|P2|COMPLETED|Part 1 (Up to 44 Days)||8
8138188|NCT02729038|20060234|P1|COMPLETED|Part 1 (Up to 44 Days)||8
8138189|NCT02729038|20060231|P4|STARTED|Part 1 (Up to 44 Days)||0
8138190|NCT02729038|20060232|P3|STARTED|Part 1 (Up to 44 Days)||8
8138191|NCT02729038|20060233|P2|STARTED|Part 1 (Up to 44 Days)||8
8138192|NCT02729038|20060234|P1|STARTED|Part 1 (Up to 44 Days)||8
8138193|NCT02729025|20060355|P2|NOT COMPLETED|Overall Study||1
8138194|NCT02729025|20060356|P1|NOT COMPLETED|Overall Study||0
8138195|NCT02729025|20060355|P2|COMPLETED|Overall Study||64
8138196|NCT02729025|20060356|P1|COMPLETED|Overall Study||64
8138197|NCT02729025|20060355|P2|STARTED|Overall Study||65
8138198|NCT02729025|20060356|P1|STARTED|Overall Study||64
8138199|NCT02728895|20060370|P2|NOT COMPLETED|Overall Study||5
8138200|NCT02728895|20060371|P1|NOT COMPLETED|Overall Study||1
8138201|NCT02728895|20060370|P2|COMPLETED|Overall Study||16
8138202|NCT02728895|20060371|P1|COMPLETED|Overall Study||2
8138203|NCT02728895|20060370|P2|STARTED|Overall Study||21
8138204|NCT02728895|20060371|P1|STARTED|Overall Study||3
8138208|NCT02728206|20060398|P1|NOT COMPLETED|Overall Study||1
8138209|NCT02728206|20060398|P1|COMPLETED|Overall Study||8
8138210|NCT02728206|20060398|P1|STARTED|Overall Study||9
8138211|NCT02728089|20060406|P1|NOT COMPLETED|Overall Study||3
8138212|NCT02728089|20060406|P1|COMPLETED|Overall Study||112
8138213|NCT02728089|20060406|P1|Treated|Overall Study||114
8138214|NCT02728089|20060406|P1|STARTED|Overall Study||115
8138215|NCT02727894|20060423|P2|NOT COMPLETED|Overall Study||0
8138216|NCT02727894|20060424|P1|NOT COMPLETED|Overall Study||0
8138217|NCT02727894|20060423|P2|COMPLETED|Overall Study|September 2015|192
8138218|NCT02727894|20060424|P1|COMPLETED|Overall Study|September 2015|73
8138219|NCT02727894|20060423|P2|STARTED|Overall Study|March 2013|192
8138220|NCT02727894|20060424|P1|STARTED|Overall Study|March 2013|73
8138221|NCT02727842|20060440|P1|NOT COMPLETED|Overall Study||0
8138222|NCT02727842|20060440|P1|COMPLETED|Overall Study||30
8138223|NCT02727842|20060440|P1|STARTED|Overall Study||30
8138224|NCT02727816|20060444|P1|NOT COMPLETED|Overall Study||0
8138225|NCT02727816|20060444|P1|COMPLETED|Overall Study||35
8138226|NCT02727816|20060444|P1|STARTED|Overall Study||35
8138227|NCT02727777|20060494|P3|NOT COMPLETED|Overall Study||0
8138228|NCT02727777|20060495|P2|NOT COMPLETED|Overall Study||0
8138229|NCT02727777|20060496|P1|NOT COMPLETED|Overall Study||4
8138230|NCT02727777|20060494|P3|COMPLETED|Overall Study||0
8138231|NCT02727777|20060495|P2|COMPLETED|Overall Study||0
8138232|NCT02727777|20060496|P1|COMPLETED|Overall Study||0
8138233|NCT02727777|20060494|P3|STARTED|Overall Study||0
8138234|NCT02727777|20060495|P2|STARTED|Overall Study||0
8138235|NCT02727777|20060496|P1|STARTED|Overall Study||4
8138236|NCT02727751|20060510|P1|NOT COMPLETED|Overall Study||50
8138237|NCT02727751|20060510|P1|COMPLETED|Overall Study||262
8138238|NCT02727751|20060510|P1|STARTED|Overall Study||312
8138239|NCT02727660|20060517|P3|NOT COMPLETED|Overall Study||165
8138240|NCT02727660|20060518|P2|NOT COMPLETED|Overall Study||116
8138241|NCT02727660|20060519|P1|NOT COMPLETED|Overall Study||116
8138242|NCT02727660|20060517|P3|COMPLETED|Overall Study||442
8138243|NCT02727660|20060518|P2|COMPLETED|Overall Study||501
8138244|NCT02727660|20060519|P1|COMPLETED|Overall Study||503
8138245|NCT02727660|20060517|P3|STARTED|Overall Study||607
8138246|NCT02727660|20060518|P2|STARTED|Overall Study||617
8138247|NCT02727660|20060519|P1|STARTED|Overall Study||619
8138248|NCT02727322|20060538|P2|NOT COMPLETED|Overall Study||1
8138249|NCT02727322|20060539|P1|NOT COMPLETED|Overall Study||2
8138250|NCT02727322|20060538|P2|COMPLETED|Overall Study||76
8138251|NCT02727322|20060539|P1|COMPLETED|Overall Study||75
8138252|NCT02727322|20060538|P2|STARTED|Overall Study||77
8138253|NCT02727322|20060539|P1|STARTED|Overall Study||77
8138254|NCT02726971|20060551|P2|NOT COMPLETED|Overall Study||9
8138255|NCT02726971|20060552|P1|NOT COMPLETED|Overall Study||11
8138256|NCT02726971|20060551|P2|COMPLETED|Overall Study||62
8138257|NCT02726971|20060552|P1|COMPLETED|Overall Study||59
8138258|NCT02726971|20060551|P2|STARTED|Overall Study||71
8138259|NCT02726971|20060552|P1|STARTED|Overall Study||70
8138260|NCT02726945|20060565|P3|NOT COMPLETED|Overall Study||1
8138261|NCT02726945|20060566|P2|NOT COMPLETED|Overall Study||1
8138262|NCT02726945|20060567|P1|NOT COMPLETED|Overall Study||0
8138263|NCT02726945|20060565|P3|COMPLETED|Overall Study||12
8138264|NCT02726945|20060566|P2|COMPLETED|Overall Study||12
8138265|NCT02726945|20060567|P1|COMPLETED|Overall Study||13
8138266|NCT02726945|20060565|P3|STARTED|Overall Study||13
8138267|NCT02726945|20060566|P2|STARTED|Overall Study||13
8138268|NCT02726945|20060567|P1|STARTED|Overall Study||13
8138269|NCT02726789|20060578|P1|NOT COMPLETED|Overall Study||0
8138270|NCT02726789|20060578|P1|COMPLETED|Overall Study||5
8138271|NCT02726789|20060578|P1|STARTED|Overall Study||5
8138272|NCT02726620|20060587|P2|NOT COMPLETED|Through End of Study: All Interventions||0
8138273|NCT02726620|20060588|P1|NOT COMPLETED|Through End of Study: All Interventions||0
8138274|NCT02726620|20060587|P2|COMPLETED|Through End of Study: All Interventions||3234
8138275|NCT02726620|20060588|P1|COMPLETED|Through End of Study: All Interventions||0
8138276|NCT02726620|20060587|P2|Correct IOH Notifications|Through End of Study: All Interventions||2072
8138277|NCT02726620|20060588|P1|Correct IOH Notifications|Through End of Study: All Interventions||0
8138278|NCT02726620|20060587|P2|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793
8138279|NCT02726620|20060588|P1|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0
8138280|NCT02726620|20060587|P2|STARTED|Through End of Study: All Interventions||3234
8138281|NCT02726620|20060588|P1|STARTED|Through End of Study: All Interventions||0
8138282|NCT02726620|20060587|P2|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
8138283|NCT02726620|20060588|P1|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
8138284|NCT02726620|20060587|P2|COMPLETED|Months 2-3: In-room Providers Randomized||1253
8138285|NCT02726620|20060588|P1|COMPLETED|Months 2-3: In-room Providers Randomized||0
8138286|NCT02726620|20060587|P2|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825
8138287|NCT02726620|20060588|P1|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0
8138288|NCT02726620|20060587|P2|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103
8138289|NCT02726620|20060588|P1|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0
8138290|NCT02726620|20060587|P2|STARTED|Months 2-3: In-room Providers Randomized||1253
8138291|NCT02726620|20060588|P1|STARTED|Months 2-3: In-room Providers Randomized||0
8138292|NCT02726620|20060587|P2|NOT COMPLETED|Month 1: Attending Randomization||0
8138293|NCT02726620|20060588|P1|NOT COMPLETED|Month 1: Attending Randomization||0
8138294|NCT02726620|20060587|P2|COMPLETED|Month 1: Attending Randomization||485
8138295|NCT02726620|20060588|P1|COMPLETED|Month 1: Attending Randomization||0
8138296|NCT02726620|20060587|P2|Correct IOH Notifications|Month 1: Attending Randomization||313
8138297|NCT02726620|20060588|P1|Correct IOH Notifications|Month 1: Attending Randomization||0
8138298|NCT02726620|20060587|P2|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432
8138299|NCT02726620|20060588|P1|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0
8138300|NCT02726620|20060587|P2|STARTED|Month 1: Attending Randomization||485
8138301|NCT02726620|20060588|P1|STARTED|Month 1: Attending Randomization||0
8138302|NCT02726620|20060587|P2|NOT COMPLETED|Historic Cohort - Three Years||0
8138303|NCT02726620|20060588|P1|NOT COMPLETED|Historic Cohort - Three Years||0
8138304|NCT02726620|20060587|P2|COMPLETED|Historic Cohort - Three Years||0
8138305|NCT02726620|20060588|P1|COMPLETED|Historic Cohort - Three Years||17463
8138306|NCT02726620|20060587|P2|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0
8138307|NCT02726620|20060588|P1|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624
8138308|NCT02726620|20060587|P2|STARTED|Historic Cohort - Three Years||0
8138309|NCT02726620|20060588|P1|STARTED|Historic Cohort - Three Years||17463
8138310|NCT02726451|20060686|P2|NOT COMPLETED|Overall Study||0
8138311|NCT02726451|20060687|P1|NOT COMPLETED|Overall Study||0
8138312|NCT02726451|20060686|P2|COMPLETED|Overall Study||10
8138313|NCT02726451|20060687|P1|COMPLETED|Overall Study||10
8138314|NCT02726451|20060686|P2|STARTED|Overall Study||10
8138315|NCT02726451|20060687|P1|STARTED|Overall Study||10
8138316|NCT02726399|20060701|P1|NOT COMPLETED|Overall Study||7
8138317|NCT02726399|20060701|P1|COMPLETED|Overall Study||0
8138318|NCT02726399|20060701|P1|STARTED|Overall Study||7
8138319|NCT02726178|20060707|P2|NOT COMPLETED|Overall Study||0
8138320|NCT02726178|20060708|P1|NOT COMPLETED|Overall Study||0
8138321|NCT02726178|20060707|P2|COMPLETED|Overall Study||28
8138322|NCT02726178|20060708|P1|COMPLETED|Overall Study||28
8138323|NCT02726178|20060707|P2|STARTED|Overall Study||28
8138324|NCT02726178|20060708|P1|STARTED|Overall Study||28
8138325|NCT02726113|20060718|P2|NOT COMPLETED|Genomic Analysis||2
8138326|NCT02726113|20060719|P1|NOT COMPLETED|Genomic Analysis||4
8138327|NCT02726113|20060718|P2|COMPLETED|Genomic Analysis||12
8138328|NCT02726113|20060719|P1|COMPLETED|Genomic Analysis||15
8138329|NCT02726113|20060718|P2|STARTED|Genomic Analysis||14
8138330|NCT02726113|20060719|P1|STARTED|Genomic Analysis||19
8138331|NCT02726113|20060718|P2|NOT COMPLETED|Total Enrollment||3
8138332|NCT02726113|20060719|P1|NOT COMPLETED|Total Enrollment||4
8138333|NCT02726113|20060718|P2|COMPLETED|Total Enrollment||19
8138334|NCT02726113|20060719|P1|COMPLETED|Total Enrollment||24
8138335|NCT02726113|20060718|P2|STARTED|Total Enrollment||22
8138336|NCT02726113|20060719|P1|STARTED|Total Enrollment||28
8138337|NCT02726074|20060726|P1|NOT COMPLETED|Overall Study||26
8138338|NCT02726074|20060726|P1|COMPLETED|Overall Study||80
8138339|NCT02726074|20060726|P1|Treated|Overall Study||102
8138340|NCT02726074|20060726|P1|STARTED|Overall Study||106
8138341|NCT02726022|20060738|P1|NOT COMPLETED|Overall Study||36
8138342|NCT02726022|20060738|P1|COMPLETED|Overall Study||78
8138343|NCT02726022|20060738|P1|STARTED|Overall Study||114
8138344|NCT02725866|20060747|P1|NOT COMPLETED|Overall Study||14
8138345|NCT02725866|20060747|P1|COMPLETED|Overall Study||202
8138346|NCT02725866|20060747|P1|STARTED|Overall Study||216
8138347|NCT02725801|20060760|P2|NOT COMPLETED|Overall Study||0
8138348|NCT02725801|20060761|P1|NOT COMPLETED|Overall Study||0
8138349|NCT02725801|20060760|P2|COMPLETED|Overall Study||12
8138350|NCT02725801|20060761|P1|COMPLETED|Overall Study||8
8138351|NCT02725801|20060760|P2|STARTED|Overall Study||12
8138352|NCT02725801|20060761|P1|STARTED|Overall Study||8
8138353|NCT02725788|20060771|P2|NOT COMPLETED|Overall Study||2
8138354|NCT02725788|20060772|P1|NOT COMPLETED|Overall Study||1
8138355|NCT02725788|20060771|P2|COMPLETED|Overall Study||122
8138356|NCT02725788|20060772|P1|COMPLETED|Overall Study||122
8138357|NCT02725788|20060771|P2|STARTED|Overall Study||124
8138358|NCT02725788|20060772|P1|STARTED|Overall Study||123
8138359|NCT02725710|20060780|P2|NOT COMPLETED|Overall Study||0
8138360|NCT02725710|20060781|P1|NOT COMPLETED|Overall Study||1
8138361|NCT02725710|20060780|P2|COMPLETED|Overall Study||47
8138362|NCT02725710|20060781|P1|COMPLETED|Overall Study||47
8138363|NCT02725710|20060780|P2|STARTED|Overall Study||47
8138364|NCT02725710|20060781|P1|STARTED|Overall Study||48
8138365|NCT02725671|20060809|P1|NOT COMPLETED|Overall Study||1
8138366|NCT02725671|20060809|P1|COMPLETED|Overall Study||1
8138367|NCT02725671|20060809|P1|STARTED|Overall Study||2
8138368|NCT02725645|20060818|P1|NOT COMPLETED|Overall Study||0
8138369|NCT02725645|20060818|P1|COMPLETED|Overall Study||14
8138370|NCT02725645|20060818|P1|STARTED|Overall Study||14
8138385|NCT02725515|20060839|P2|NOT COMPLETED|Overall Study||35
8138386|NCT02725515|20060840|P1|NOT COMPLETED|Overall Study||25
8138387|NCT02725515|20060839|P2|COMPLETED|Overall Study||17
8138388|NCT02725515|20060840|P1|COMPLETED|Overall Study||28
8138389|NCT02725515|20060839|P2|STARTED|Overall Study||52
8138390|NCT02725515|20060840|P1|STARTED|Overall Study||53
8138391|NCT02725476|20060852|P2|NOT COMPLETED|Overall Study||1
8138392|NCT02725476|20060853|P1|NOT COMPLETED|Overall Study||3
8138393|NCT02725476|20060852|P2|COMPLETED|Overall Study||4
8138394|NCT02725476|20060853|P1|COMPLETED|Overall Study||12
8138395|NCT02725476|20060852|P2|STARTED|Overall Study||5
8138396|NCT02725476|20060853|P1|STARTED|Overall Study||15
8138397|NCT02725411|20060864|P3|NOT COMPLETED|Follow-up Period (24 Weeks)||5
8138398|NCT02725411|20060865|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||11
8138399|NCT02725411|20060866|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||4
8138400|NCT02725411|20060864|P3|COMPLETED|Follow-up Period (24 Weeks)||87
8138401|NCT02725411|20060865|P2|COMPLETED|Follow-up Period (24 Weeks)||82
8138402|NCT02725411|20060866|P1|COMPLETED|Follow-up Period (24 Weeks)||88
8138403|NCT02725411|20060864|P3|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
8138404|NCT02725411|20060865|P2|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|93
8138405|NCT02725411|20060866|P1|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
8138406|NCT02725411|20060864|P3|NOT COMPLETED|Treatment Period (56 Weeks)||49
8138407|NCT02725411|20060865|P2|NOT COMPLETED|Treatment Period (56 Weeks)||50
8138408|NCT02725411|20060866|P1|NOT COMPLETED|Treatment Period (56 Weeks)||30
8138409|NCT02725411|20060864|P3|COMPLETED|Treatment Period (56 Weeks)||43
8138410|NCT02725411|20060865|P2|COMPLETED|Treatment Period (56 Weeks)||43
8138411|NCT02725411|20060866|P1|COMPLETED|Treatment Period (56 Weeks)||62
8138412|NCT02725411|20060864|P3|Treated|Treatment Period (56 Weeks)||92
8138413|NCT02725411|20060865|P2|Treated|Treatment Period (56 Weeks)||93
8138414|NCT02725411|20060866|P1|Treated|Treatment Period (56 Weeks)||92
8138415|NCT02725411|20060864|P3|STARTED|Treatment Period (56 Weeks)||92
8138416|NCT02725411|20060865|P2|STARTED|Treatment Period (56 Weeks)||93
8138417|NCT02725411|20060866|P1|STARTED|Treatment Period (56 Weeks)||92
8138418|NCT02725268|20061082|P4|NOT COMPLETED|Overall Study||17
8138419|NCT02725268|20061083|P3|NOT COMPLETED|Overall Study||37
8138420|NCT02725268|20061084|P2|NOT COMPLETED|Overall Study||59
8138421|NCT02725268|20061085|P1|NOT COMPLETED|Overall Study||59
8138422|NCT02725268|20061082|P4|COMPLETED|Overall Study||3
8138423|NCT02725268|20061083|P3|COMPLETED|Overall Study||4
8138424|NCT02725268|20061084|P2|COMPLETED|Overall Study||31
8138425|NCT02725268|20061085|P1|COMPLETED|Overall Study||31
8138426|NCT02725268|20061082|P4|STARTED|Overall Study||20
8138427|NCT02725268|20061083|P3|STARTED|Overall Study||41
8138428|NCT02725268|20061084|P2|STARTED|Overall Study||90
8138429|NCT02725268|20061085|P1|STARTED|Overall Study||90
8138430|NCT02725008|20061121|P2|NOT COMPLETED|Overall Study||12
8138431|NCT02725008|20061122|P1|NOT COMPLETED|Overall Study||9
8138432|NCT02725008|20061121|P2|COMPLETED|Overall Study||39
8138433|NCT02725008|20061122|P1|COMPLETED|Overall Study||37
8138434|NCT02725008|20061121|P2|STARTED|Overall Study||51
8138435|NCT02725008|20061122|P1|STARTED|Overall Study||46
8138436|NCT02724839|20061133|P3|NOT COMPLETED|Overall Study||5
8138437|NCT02724839|20061134|P2|NOT COMPLETED|Overall Study||4
8138438|NCT02724839|20061135|P1|NOT COMPLETED|Overall Study||1
8138439|NCT02724839|20061133|P3|COMPLETED|Overall Study||6
8138440|NCT02724839|20061134|P2|COMPLETED|Overall Study||8
8138441|NCT02724839|20061135|P1|COMPLETED|Overall Study||12
8138442|NCT02724839|20061133|P3|STARTED|Overall Study||11
8138443|NCT02724839|20061134|P2|STARTED|Overall Study||12
8138444|NCT02724839|20061135|P1|STARTED|Overall Study||13
8138445|NCT02724800|20061169|P2|NOT COMPLETED|Overall Study||9
8138446|NCT02724800|20061170|P1|NOT COMPLETED|Overall Study||17
8138447|NCT02724800|20061169|P2|COMPLETED|Overall Study||22
8138448|NCT02724800|20061170|P1|COMPLETED|Overall Study||15
8138449|NCT02724800|20061169|P2|STARTED|Overall Study||31
8138450|NCT02724800|20061170|P1|STARTED|Overall Study||32
8138451|NCT02724787|20061202|P1|NOT COMPLETED|Overall Study||2
8138452|NCT02724787|20061202|P1|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22
8138453|NCT02724787|20061202|P1|STARTED|Overall Study||24
8138454|NCT02724644|20061212|P2|NOT COMPLETED|Overall Study||4
8138455|NCT02724644|20061213|P1|NOT COMPLETED|Overall Study||21
8138456|NCT02724644|20061212|P2|COMPLETED|Overall Study||182
8138457|NCT02724644|20061213|P1|COMPLETED|Overall Study||168
8138458|NCT02724644|20061212|P2|STARTED|Overall Study||186
8138459|NCT02724644|20061213|P1|STARTED|Overall Study||189
8138460|NCT02724462|20061243|P2|NOT COMPLETED|12 Month Follow-up Survey||182
8138461|NCT02724462|20061244|P1|NOT COMPLETED|12 Month Follow-up Survey||214
8138462|NCT02724462|20061243|P2|COMPLETED|12 Month Follow-up Survey||1067
8138463|NCT02724462|20061244|P1|COMPLETED|12 Month Follow-up Survey||1040
8138464|NCT02724462|20061243|P2|STARTED|12 Month Follow-up Survey||1249
8138465|NCT02724462|20061244|P1|STARTED|12 Month Follow-up Survey||1254
8138466|NCT02724462|20061243|P2|NOT COMPLETED|6 Month Follow-up Survey||171
8138467|NCT02724462|20061244|P1|NOT COMPLETED|6 Month Follow-up Survey||196
8138468|NCT02724462|20061243|P2|COMPLETED|6 Month Follow-up Survey||1078
8138469|NCT02724462|20061244|P1|COMPLETED|6 Month Follow-up Survey||1058
8138470|NCT02724462|20061243|P2|STARTED|6 Month Follow-up Survey||1249
8138471|NCT02724462|20061244|P1|STARTED|6 Month Follow-up Survey||1254
8138472|NCT02724462|20061243|P2|NOT COMPLETED|3 Month Follow-up Survey||199
8138473|NCT02724462|20061244|P1|NOT COMPLETED|3 Month Follow-up Survey||211
8138474|NCT02724462|20061243|P2|COMPLETED|3 Month Follow-up Survey||1050
8138475|NCT02724462|20061244|P1|COMPLETED|3 Month Follow-up Survey||1043
8138476|NCT02724462|20061243|P2|STARTED|3 Month Follow-up Survey||1249
8138477|NCT02724462|20061244|P1|STARTED|3 Month Follow-up Survey||1254
8138478|NCT02724449|20061252|P1|NOT COMPLETED|Overall Study||0
8138479|NCT02724449|20061252|P1|COMPLETED|Overall Study||16
8138480|NCT02724449|20061252|P1|STARTED|Overall Study||16
8138481|NCT02724111|20061258|P2|NOT COMPLETED|Overall Study||5
8138482|NCT02724111|20061259|P1|NOT COMPLETED|Overall Study||2
8138483|NCT02724111|20061258|P2|COMPLETED|Overall Study||40
8138484|NCT02724111|20061259|P1|COMPLETED|Overall Study||43
8138485|NCT02724111|20061258|P2|STARTED|Overall Study||45
8138486|NCT02724111|20061259|P1|STARTED|Overall Study||45
8138487|NCT02724033|20061282|P3|NOT COMPLETED|Overall Study||0
8138488|NCT02724033|20061283|P2|NOT COMPLETED|Overall Study||0
8138489|NCT02724033|20061284|P1|NOT COMPLETED|Overall Study||0
8138490|NCT02724033|20061282|P3|COMPLETED|Overall Study||12
8138491|NCT02724033|20061283|P2|COMPLETED|Overall Study||14
8138492|NCT02724033|20061284|P1|COMPLETED|Overall Study||11
8138493|NCT02724033|20061282|P3|STARTED|Overall Study||12
8138494|NCT02724033|20061283|P2|STARTED|Overall Study||14
8138495|NCT02724033|20061284|P1|STARTED|Overall Study||11
8138496|NCT02723916|20061294|P2|NOT COMPLETED|Overall Study||6
8138497|NCT02723916|20061295|P1|NOT COMPLETED|Overall Study||9
8138498|NCT02723916|20061294|P2|COMPLETED|Overall Study||137
8138499|NCT02723916|20061295|P1|COMPLETED|Overall Study||135
8138500|NCT02723916|20061294|P2|STARTED|Overall Study||143
8138501|NCT02723916|20061295|P1|STARTED|Overall Study||144
8138502|NCT02723786|20061311|P1|NOT COMPLETED|Overall Study||1
8138503|NCT02723786|20061311|P1|COMPLETED|Overall Study||6
8138504|NCT02723786|20061311|P1|STARTED|Overall Study||7
8138505|NCT02723630|20061339|P6|NOT COMPLETED|Intervention Period 3||0
8138506|NCT02723630|20061340|P5|NOT COMPLETED|Intervention Period 3||0
8138507|NCT02723630|20061341|P4|NOT COMPLETED|Intervention Period 3||0
8138508|NCT02723630|20061342|P3|NOT COMPLETED|Intervention Period 3||0
8138509|NCT02723630|20061343|P2|NOT COMPLETED|Intervention Period 3||1
8138510|NCT02723630|20061344|P1|NOT COMPLETED|Intervention Period 3||0
8138511|NCT02723630|20061339|P6|COMPLETED|Intervention Period 3||10
8138512|NCT02723630|20061340|P5|COMPLETED|Intervention Period 3||10
8138513|NCT02723630|20061341|P4|COMPLETED|Intervention Period 3||10
8138514|NCT02723630|20061342|P3|COMPLETED|Intervention Period 3||10
8138515|NCT02723630|20061343|P2|COMPLETED|Intervention Period 3||9
8138516|NCT02723630|20061344|P1|COMPLETED|Intervention Period 3||9
8138517|NCT02723630|20061339|P6|STARTED|Intervention Period 3||10
8138518|NCT02723630|20061340|P5|STARTED|Intervention Period 3||10
8138519|NCT02723630|20061341|P4|STARTED|Intervention Period 3||10
8138520|NCT02723630|20061342|P3|STARTED|Intervention Period 3||10
8138521|NCT02723630|20061343|P2|STARTED|Intervention Period 3||10
8138522|NCT02723630|20061344|P1|STARTED|Intervention Period 3||9
8138523|NCT02723630|20061339|P6|NOT COMPLETED|Intervention Period 2||0
8138524|NCT02723630|20061340|P5|NOT COMPLETED|Intervention Period 2||0
8138525|NCT02723630|20061341|P4|NOT COMPLETED|Intervention Period 2||0
8138526|NCT02723630|20061342|P3|NOT COMPLETED|Intervention Period 2||0
8138527|NCT02723630|20061343|P2|NOT COMPLETED|Intervention Period 2||0
8138528|NCT02723630|20061344|P1|NOT COMPLETED|Intervention Period 2||0
8138529|NCT02723630|20061339|P6|COMPLETED|Intervention Period 2||10
8138530|NCT02723630|20061340|P5|COMPLETED|Intervention Period 2||10
8138531|NCT02723630|20061341|P4|COMPLETED|Intervention Period 2||10
8138532|NCT02723630|20061342|P3|COMPLETED|Intervention Period 2||10
8138533|NCT02723630|20061343|P2|COMPLETED|Intervention Period 2||10
8138534|NCT02723630|20061344|P1|COMPLETED|Intervention Period 2||9
8138535|NCT02723630|20061339|P6|STARTED|Intervention Period 2||10
8138536|NCT02723630|20061340|P5|STARTED|Intervention Period 2||10
8138537|NCT02723630|20061341|P4|STARTED|Intervention Period 2||10
8138538|NCT02723630|20061342|P3|STARTED|Intervention Period 2||10
8138539|NCT02723630|20061343|P2|STARTED|Intervention Period 2||10
8138540|NCT02723630|20061344|P1|STARTED|Intervention Period 2||9
8138541|NCT02723630|20061339|P6|NOT COMPLETED|Intervention Period 1||0
8138542|NCT02723630|20061340|P5|NOT COMPLETED|Intervention Period 1||0
8138543|NCT02723630|20061341|P4|NOT COMPLETED|Intervention Period 1||0
8138544|NCT02723630|20061342|P3|NOT COMPLETED|Intervention Period 1||0
8138545|NCT02723630|20061343|P2|NOT COMPLETED|Intervention Period 1||0
8138546|NCT02723630|20061344|P1|NOT COMPLETED|Intervention Period 1||1
8138547|NCT02723630|20061339|P6|COMPLETED|Intervention Period 1||10
8138548|NCT02723630|20061340|P5|COMPLETED|Intervention Period 1||10
8138549|NCT02723630|20061341|P4|COMPLETED|Intervention Period 1||10
8138550|NCT02723630|20061342|P3|COMPLETED|Intervention Period 1||10
8138551|NCT02723630|20061343|P2|COMPLETED|Intervention Period 1||10
8138552|NCT02723630|20061344|P1|COMPLETED|Intervention Period 1||9
8138553|NCT02723630|20061339|P6|STARTED|Intervention Period 1||10
8138554|NCT02723630|20061340|P5|STARTED|Intervention Period 1||10
8138555|NCT02723630|20061341|P4|STARTED|Intervention Period 1||10
8138556|NCT02723630|20061342|P3|STARTED|Intervention Period 1||10
8138557|NCT02723630|20061343|P2|STARTED|Intervention Period 1||10
8138558|NCT02723630|20061344|P1|STARTED|Intervention Period 1||10
8138559|NCT02723591|20061375|P2|NOT COMPLETED|Overall Study||101
8138560|NCT02723591|20061376|P1|NOT COMPLETED|Overall Study||96
8138561|NCT02723591|20061375|P2|COMPLETED|Overall Study||198
8138562|NCT02723591|20061376|P1|COMPLETED|Overall Study||204
8138563|NCT02723591|20061375|P2|STARTED|Overall Study||299
8138564|NCT02723591|20061376|P1|STARTED|Overall Study||300
8138565|NCT02723344|20061504|P2|NOT COMPLETED|Overall Study||4
8138566|NCT02723344|20061505|P1|NOT COMPLETED|Overall Study||0
8138567|NCT02723344|20061504|P2|COMPLETED|Overall Study||12
8138568|NCT02723344|20061505|P1|COMPLETED|Overall Study||15
8138569|NCT02723344|20061504|P2|STARTED|Overall Study||16
8138570|NCT02723344|20061505|P1|STARTED|Overall Study||15
8138571|NCT02723201|20061528|P3|NOT COMPLETED|Fourth Intervention Period||0
8138572|NCT02723201|20061529|P2|NOT COMPLETED|Fourth Intervention Period||0
8138573|NCT02723201|20061530|P1|NOT COMPLETED|Fourth Intervention Period||0
8138574|NCT02723201|20061528|P3|COMPLETED|Fourth Intervention Period||0
8138575|NCT02723201|20061529|P2|COMPLETED|Fourth Intervention Period||0
8138576|NCT02723201|20061530|P1|COMPLETED|Fourth Intervention Period||9
8138577|NCT02723201|20061528|P3|STARTED|Fourth Intervention Period||0
8138578|NCT02723201|20061529|P2|STARTED|Fourth Intervention Period||0
8138579|NCT02723201|20061530|P1|STARTED|Fourth Intervention Period||9
8138580|NCT02723201|20061528|P3|NOT COMPLETED|Washout Period 3||0
8138581|NCT02723201|20061529|P2|NOT COMPLETED|Washout Period 3||0
8138582|NCT02723201|20061530|P1|NOT COMPLETED|Washout Period 3||0
8138583|NCT02723201|20061528|P3|COMPLETED|Washout Period 3||0
8138584|NCT02723201|20061529|P2|COMPLETED|Washout Period 3||0
8138585|NCT02723201|20061530|P1|COMPLETED|Washout Period 3||9
8138586|NCT02723201|20061528|P3|STARTED|Washout Period 3||0
8138587|NCT02723201|20061529|P2|STARTED|Washout Period 3||0
8138588|NCT02723201|20061530|P1|STARTED|Washout Period 3||9
8138589|NCT02723201|20061528|P3|NOT COMPLETED|Third Intervention Period||0
8138590|NCT02723201|20061529|P2|NOT COMPLETED|Third Intervention Period||0
8138591|NCT02723201|20061530|P1|NOT COMPLETED|Third Intervention Period||0
8138592|NCT02723201|20061528|P3|COMPLETED|Third Intervention Period||0
8138593|NCT02723201|20061529|P2|COMPLETED|Third Intervention Period||0
8138594|NCT02723201|20061530|P1|COMPLETED|Third Intervention Period||9
8138595|NCT02723201|20061528|P3|STARTED|Third Intervention Period||0
8138596|NCT02723201|20061529|P2|STARTED|Third Intervention Period||0
8138597|NCT02723201|20061530|P1|STARTED|Third Intervention Period||9
8138598|NCT02723201|20061528|P3|NOT COMPLETED|Washout Period 2||0
8138599|NCT02723201|20061529|P2|NOT COMPLETED|Washout Period 2||0
8138600|NCT02723201|20061530|P1|NOT COMPLETED|Washout Period 2||0
8138601|NCT02723201|20061528|P3|COMPLETED|Washout Period 2||0
8138602|NCT02723201|20061529|P2|COMPLETED|Washout Period 2||0
8138603|NCT02723201|20061530|P1|COMPLETED|Washout Period 2||9
8138604|NCT02723201|20061528|P3|STARTED|Washout Period 2||0
8138605|NCT02723201|20061529|P2|STARTED|Washout Period 2||0
8138606|NCT02723201|20061530|P1|STARTED|Washout Period 2||9
8138607|NCT02723201|20061528|P3|NOT COMPLETED|Second Intervention Period||0
8138608|NCT02723201|20061529|P2|NOT COMPLETED|Second Intervention Period||0
8138609|NCT02723201|20061530|P1|NOT COMPLETED|Second Intervention Period||2
8138610|NCT02723201|20061528|P3|COMPLETED|Second Intervention Period||7
8138611|NCT02723201|20061529|P2|COMPLETED|Second Intervention Period||7
8138612|NCT02723201|20061530|P1|COMPLETED|Second Intervention Period||9
8138613|NCT02723201|20061528|P3|STARTED|Second Intervention Period||7
8138614|NCT02723201|20061529|P2|STARTED|Second Intervention Period||7
8138615|NCT02723201|20061530|P1|STARTED|Second Intervention Period||11
8138616|NCT02723201|20061528|P3|NOT COMPLETED|Washout Period 1||0
8138617|NCT02723201|20061529|P2|NOT COMPLETED|Washout Period 1||0
8138618|NCT02723201|20061530|P1|NOT COMPLETED|Washout Period 1||0
8138619|NCT02723201|20061528|P3|COMPLETED|Washout Period 1||7
8138620|NCT02723201|20061529|P2|COMPLETED|Washout Period 1||7
8138621|NCT02723201|20061530|P1|COMPLETED|Washout Period 1||11
8138622|NCT02723201|20061528|P3|STARTED|Washout Period 1||7
8138623|NCT02723201|20061529|P2|STARTED|Washout Period 1||7
8138624|NCT02723201|20061530|P1|STARTED|Washout Period 1||11
8138625|NCT02723201|20061528|P3|NOT COMPLETED|First Intervention Period||0
8138626|NCT02723201|20061529|P2|NOT COMPLETED|First Intervention Period||0
8138627|NCT02723201|20061530|P1|NOT COMPLETED|First Intervention Period||0
8138628|NCT02723201|20061528|P3|COMPLETED|First Intervention Period||7
8138629|NCT02723201|20061529|P2|COMPLETED|First Intervention Period||7
8138630|NCT02723201|20061530|P1|COMPLETED|First Intervention Period||11
8138631|NCT02723201|20061528|P3|STARTED|First Intervention Period||7
8138632|NCT02723201|20061529|P2|STARTED|First Intervention Period||7
8138633|NCT02723201|20061530|P1|STARTED|First Intervention Period||11
8138634|NCT02723188|20061589|P3|NOT COMPLETED|Overall Study||0
8138635|NCT02723188|20061590|P2|NOT COMPLETED|Overall Study||0
8138636|NCT02723188|20061591|P1|NOT COMPLETED|Overall Study||1
8138637|NCT02723188|20061589|P3|COMPLETED|Overall Study||15
8138638|NCT02723188|20061590|P2|COMPLETED|Overall Study||15
8138639|NCT02723188|20061591|P1|COMPLETED|Overall Study||14
8138640|NCT02723188|20061589|P3|STARTED|Overall Study||15
8138641|NCT02723188|20061590|P2|STARTED|Overall Study||15
8138642|NCT02723188|20061591|P1|STARTED|Overall Study||15
8138643|NCT02723175|20061604|P2|NOT COMPLETED|Overall Study||3
8138644|NCT02723175|20061605|P1|NOT COMPLETED|Overall Study||4
8138645|NCT02723175|20061604|P2|COMPLETED|Overall Study||4
8138646|NCT02723175|20061605|P1|COMPLETED|Overall Study||4
8138647|NCT02723175|20061604|P2|STARTED|Overall Study||7
8138648|NCT02723175|20061605|P1|STARTED|Overall Study||8
8138655|NCT02722967|20061662|P3|NOT COMPLETED|Overall Study||4
8138656|NCT02722967|20061663|P2|NOT COMPLETED|Overall Study||2
8138657|NCT02722967|20061664|P1|NOT COMPLETED|Overall Study||5
8138658|NCT02722967|20061662|P3|COMPLETED|Overall Study||11
8138659|NCT02722967|20061663|P2|COMPLETED|Overall Study||10
8138660|NCT02722967|20061664|P1|COMPLETED|Overall Study||17
8138661|NCT02722967|20061662|P3|STARTED|Overall Study||15
8138662|NCT02722967|20061663|P2|STARTED|Overall Study||12
8138663|NCT02722967|20061664|P1|STARTED|Overall Study||22
8138664|NCT02722928|20061674|P2|NOT COMPLETED|Overall Study||20
8138665|NCT02722928|20061675|P1|NOT COMPLETED|Overall Study||10
8138666|NCT02722928|20061674|P2|COMPLETED|Overall Study||31
8138667|NCT02722928|20061675|P1|COMPLETED|Overall Study||39
8138668|NCT02722928|20061674|P2|STARTED|Overall Study||51
8138669|NCT02722928|20061675|P1|STARTED|Overall Study||49
8138670|NCT02722863|20061689|P1|NOT COMPLETED|Overall Study||0
8138671|NCT02722863|20061689|P1|COMPLETED|Overall Study||908
8138672|NCT02722863|20061689|P1|STARTED|Overall Study||908
8138673|NCT02722837|20061694|P1|NOT COMPLETED|Overall Study||0
8138674|NCT02722837|20061694|P1|COMPLETED|Overall Study||119
8138675|NCT02722837|20061694|P1|STARTED|Overall Study||119
8138676|NCT02722577|20061712|P1|NOT COMPLETED|Overall Study||0
8138677|NCT02722577|20061712|P1|COMPLETED|Overall Study||20
8138678|NCT02722577|20061712|P1|STARTED|Overall Study||20
8138679|NCT02722564|20061716|P1|NOT COMPLETED|Overall Study||0
8138680|NCT02722564|20061716|P1|COMPLETED|Overall Study||55
8138681|NCT02722564|20061716|P1|STARTED|Overall Study||55
8138682|NCT02722408|20061720|P1|NOT COMPLETED|Overall Study||0
8138683|NCT02722408|20061720|P1|COMPLETED|Overall Study||8
8138684|NCT02722408|20061720|P1|STARTED|Overall Study||8
8138685|NCT02722330|20061774|P1|NOT COMPLETED|Overall Study||0
8138686|NCT02722330|20061774|P1|COMPLETED|Overall Study||23
8138687|NCT02722330|20061774|P1|STARTED|Overall Study||23
8138708|NCT02722278|20061861|P2|NOT COMPLETED|Overall Study||7
8138709|NCT02722278|20061862|P1|NOT COMPLETED|Overall Study||12
8138710|NCT02722278|20061861|P2|COMPLETED|Overall Study||49
8138711|NCT02722278|20061862|P1|COMPLETED|Overall Study||154
8138712|NCT02722278|20061861|P2|STARTED|Overall Study||56
8138713|NCT02722278|20061862|P1|STARTED|Overall Study||166
8138714|NCT02722239|20061872|P2|NOT COMPLETED|Overall Study||0
8138715|NCT02722239|20061873|P1|NOT COMPLETED|Overall Study||0
8138716|NCT02722239|20061872|P2|COMPLETED|Overall Study||20
8138717|NCT02722239|20061873|P1|COMPLETED|Overall Study||20
8138718|NCT02722239|20061872|P2|Second Intervention (1 Day)|Overall Study||20
8138719|NCT02722239|20061873|P1|Second Intervention (1 Day)|Overall Study||20
8138720|NCT02722239|20061872|P2|Washout (7 Days)|Overall Study||20
8138721|NCT02722239|20061873|P1|Washout (7 Days)|Overall Study||20
8138722|NCT02722239|20061872|P2|First Intervention (1 Day)|Overall Study||20
8138723|NCT02722239|20061873|P1|First Intervention (1 Day)|Overall Study||20
8138724|NCT02722239|20061872|P2|STARTED|Overall Study||20
8138725|NCT02722239|20061873|P1|STARTED|Overall Study||20
8138726|NCT02722148|20061886|P1|NOT COMPLETED|Overall Study||5
8138727|NCT02722148|20061886|P1|COMPLETED|Overall Study||19
8138728|NCT02722148|20061886|P1|STARTED|Overall Study||24
8138729|NCT02722044|20061893|P1|NOT COMPLETED|Overall Study||5
8138730|NCT02722044|20061893|P1|COMPLETED|Overall Study||28
8138731|NCT02722044|20061893|P1|STARTED|Overall Study||33
8138732|NCT02721966|20061923|P5|NOT COMPLETED|Overall Study||5
8138733|NCT02721966|20061924|P4|NOT COMPLETED|Overall Study||7
8138734|NCT02721966|20061925|P3|NOT COMPLETED|Overall Study||9
8138735|NCT02721966|20061926|P2|NOT COMPLETED|Overall Study||23
8138736|NCT02721966|20061927|P1|NOT COMPLETED|Overall Study||29
8138737|NCT02721966|20061923|P5|COMPLETED|Overall Study||0
8138738|NCT02721966|20061924|P4|COMPLETED|Overall Study||73
8138739|NCT02721966|20061925|P3|COMPLETED|Overall Study||72
8138740|NCT02721966|20061926|P2|COMPLETED|Overall Study||142
8138741|NCT02721966|20061927|P1|COMPLETED|Overall Study||138
8138742|NCT02721966|20061923|P5|Completed Period 1 & Went to Period 2|Overall Study||0
8138743|NCT02721966|20061924|P4|Completed Period 1 & Went to Period 2|Overall Study||80
8138744|NCT02721966|20061925|P3|Completed Period 1 & Went to Period 2|Overall Study||81
8138745|NCT02721966|20061926|P2|Completed Period 1 & Went to Period 2|Overall Study||153
8138746|NCT02721966|20061927|P1|Completed Period 1 & Went to Period 2|Overall Study||162
8138747|NCT02721966|20061923|P5|STARTED|Overall Study||5
8138748|NCT02721966|20061924|P4|STARTED|Overall Study||80
8138749|NCT02721966|20061925|P3|STARTED|Overall Study||81
8138750|NCT02721966|20061926|P2|STARTED|Overall Study||165
8138751|NCT02721966|20061927|P1|STARTED|Overall Study||167
8138752|NCT02721875|20061967|P2|NOT COMPLETED|Overall Study||0
8138753|NCT02721875|20061968|P1|NOT COMPLETED|Overall Study||1
8138754|NCT02721875|20061967|P2|COMPLETED|Overall Study||0
8138755|NCT02721875|20061968|P1|COMPLETED|Overall Study||0
8138756|NCT02721875|20061967|P2|STARTED|Overall Study||0
8138757|NCT02721875|20061968|P1|STARTED|Overall Study||1
8138758|NCT02721641|20061981|P1|NOT COMPLETED|Overall Study||0
8138759|NCT02721641|20061981|P1|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
8138760|NCT02721641|20061981|P1|STARTED|Overall Study||69
8138761|NCT02721277|20061987|P1|NOT COMPLETED|Overall Study||0
8138762|NCT02721277|20061987|P1|COMPLETED|Overall Study||2
8138763|NCT02721277|20061987|P1|STARTED|Overall Study||2
8138764|NCT02721147|20062019|P3|NOT COMPLETED|Overall Study||0
8138765|NCT02721147|20062020|P2|NOT COMPLETED|Overall Study||0
8138766|NCT02721147|20062021|P1|NOT COMPLETED|Overall Study||2
8138767|NCT02721147|20062019|P3|COMPLETED|Overall Study||31
8138768|NCT02721147|20062020|P2|COMPLETED|Overall Study||18
8138769|NCT02721147|20062021|P1|COMPLETED|Overall Study||38
8138770|NCT02721147|20062019|P3|STARTED|Overall Study||31
8138771|NCT02721147|20062020|P2|STARTED|Overall Study||18
8138772|NCT02721147|20062021|P1|STARTED|Overall Study||40
8138773|NCT02720952|20062056|P1|NOT COMPLETED|Overall Study||0
8138774|NCT02720952|20062056|P1|COMPLETED|Overall Study||24
8138775|NCT02720952|20062056|P1|STARTED|Overall Study||24
8138776|NCT02720757|20062065|P1|NOT COMPLETED|Overall Study||18
8138777|NCT02720757|20062065|P1|COMPLETED|Overall Study||114
8138778|NCT02720757|20062065|P1|STARTED|Overall Study||132
8138779|NCT02720627|20062074|P1|NOT COMPLETED|Overall Study||0
8138780|NCT02720627|20062074|P1|COMPLETED|Overall Study||27
8138781|NCT02720627|20062074|P1|STARTED|Overall Study||27
8138782|NCT02720536|20062079|P1|NOT COMPLETED|Overall Study||19
8138783|NCT02720536|20062079|P1|COMPLETED|Overall Study||34
8138784|NCT02720536|20062079|P1|STARTED|Overall Study||53
8138827|NCT02720510|20062179|P2|NOT COMPLETED|Overall Study||3
8138828|NCT02720510|20062180|P1|NOT COMPLETED|Overall Study||3
8138829|NCT02720510|20062179|P2|COMPLETED|Overall Study||0
8138830|NCT02720510|20062180|P1|COMPLETED|Overall Study||0
8138831|NCT02720510|20062179|P2|STARTED|Overall Study||3
8138832|NCT02720510|20062180|P1|STARTED|Overall Study||3
8138833|NCT02720484|20062198|P1|NOT COMPLETED|Follow Up for 2 Years||6
8138834|NCT02720484|20062198|P1|COMPLETED|Follow Up for 2 Years||1
8138835|NCT02720484|20062198|P1|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7
8138836|NCT02720484|20062198|P1|NOT COMPLETED|Treatment on Study||6
8138837|NCT02720484|20062198|P1|COMPLETED|Treatment on Study||4
8138838|NCT02720484|20062198|P1|Treated Cycle 3|Treatment on Study||4
8138839|NCT02720484|20062198|P1|Reached 1st Response/2 Cycles|Treatment on Study||7
8138840|NCT02720484|20062198|P1|STARTED|Treatment on Study||10
8138841|NCT02720224|20062206|P1|NOT COMPLETED|Overall Study||0
8138842|NCT02720224|20062206|P1|COMPLETED|Overall Study||6
8138843|NCT02720224|20062206|P1|STARTED|Overall Study||6
8138844|NCT02720198|20062230|P2|NOT COMPLETED|Overall Study||1
8138845|NCT02720198|20062231|P1|NOT COMPLETED|Overall Study||0
8138846|NCT02720198|20062230|P2|COMPLETED|Overall Study||30
8138847|NCT02720198|20062231|P1|COMPLETED|Overall Study||29
8138848|NCT02720198|20062230|P2|STARTED|Overall Study||31
8138849|NCT02720198|20062231|P1|STARTED|Overall Study||29
8138850|NCT02720107|20062257|P1|NOT COMPLETED|Overall Study||0
8138851|NCT02720107|20062257|P1|COMPLETED|Overall Study||130
8138852|NCT02720107|20062257|P1|STARTED|Overall Study||130
8138853|NCT02720081|20062266|P2|NOT COMPLETED|Overall Study||4
8138854|NCT02720081|20062267|P1|NOT COMPLETED|Overall Study||4
8138855|NCT02720081|20062266|P2|COMPLETED|Overall Study||66
8138856|NCT02720081|20062267|P1|COMPLETED|Overall Study||68
8138857|NCT02720081|20062266|P2|Treated|Overall Study||69
8138858|NCT02720081|20062267|P1|Treated|Overall Study||70
8138859|NCT02720081|20062266|P2|STARTED|Overall Study||70
8138860|NCT02720081|20062267|P1|STARTED|Overall Study||72
8138861|NCT02720042|20062323|P1|NOT COMPLETED|Overall Study||15
8138862|NCT02720042|20062323|P1|COMPLETED|Overall Study||69
8138863|NCT02720042|20062323|P1|STARTED|Overall Study||84
8138864|NCT02719938|20062340|P2|NOT COMPLETED|Overall Study||1
8138865|NCT02719938|20062341|P1|NOT COMPLETED|Overall Study||4
8138866|NCT02719938|20062340|P2|COMPLETED|Overall Study||31
8138867|NCT02719938|20062341|P1|COMPLETED|Overall Study||26
8138868|NCT02719938|20062340|P2|STARTED|Overall Study||32
8138869|NCT02719938|20062341|P1|STARTED|Overall Study||30
8138870|NCT02719743|20062364|P5|NOT COMPLETED|Overall Study||2
8138871|NCT02719743|20062365|P4|NOT COMPLETED|Overall Study||1
8138872|NCT02719743|20062366|P3|NOT COMPLETED|Overall Study||0
8138873|NCT02719743|20062367|P2|NOT COMPLETED|Overall Study||3
8138874|NCT02719743|20062368|P1|NOT COMPLETED|Overall Study||1
8138875|NCT02719743|20062364|P5|COMPLETED|Overall Study||33
8138876|NCT02719743|20062365|P4|COMPLETED|Overall Study||36
8138877|NCT02719743|20062366|P3|COMPLETED|Overall Study||38
8138878|NCT02719743|20062367|P2|COMPLETED|Overall Study||34
8138879|NCT02719743|20062368|P1|COMPLETED|Overall Study||37
8138880|NCT02719743|20062364|P5|STARTED|Overall Study||35
8138881|NCT02719743|20062365|P4|STARTED|Overall Study||37
8138882|NCT02719743|20062366|P3|STARTED|Overall Study||38
8138883|NCT02719743|20062367|P2|STARTED|Overall Study||37
8138884|NCT02719743|20062368|P1|STARTED|Overall Study||38
8138885|NCT02719639|20062495|P1|NOT COMPLETED|Overall Study||0
8138886|NCT02719639|20062495|P1|COMPLETED|Overall Study||7443
8138887|NCT02719639|20062495|P1|STARTED|Overall Study||7443
8138888|NCT02719535|20062504|P1|NOT COMPLETED|Overall Study||22
8138889|NCT02719535|20062504|P1|COMPLETED|Overall Study||37
8138890|NCT02719535|20062504|P1|STARTED|Overall Study||59
8138891|NCT02719522|20062509|P1|NOT COMPLETED|Overall Study||11
8138892|NCT02719522|20062509|P1|COMPLETED|Overall Study||193
8138893|NCT02719522|20062509|P1|STARTED|Overall Study|In 1 consented subject, device deployment was not attempted due to significant arterial stenosis.|204
8138894|NCT02719366|20062517|P2|NOT COMPLETED|Second Intervention||0
8138895|NCT02719366|20062518|P1|NOT COMPLETED|Second Intervention||0
8138896|NCT02719366|20062517|P2|COMPLETED|Second Intervention||6
8138897|NCT02719366|20062518|P1|COMPLETED|Second Intervention||6
8138898|NCT02719366|20062517|P2|STARTED|Second Intervention||6
8138899|NCT02719366|20062518|P1|STARTED|Second Intervention||6
8138900|NCT02719366|20062517|P2|NOT COMPLETED|First Intervention||0
8138901|NCT02719366|20062518|P1|NOT COMPLETED|First Intervention||0
8138902|NCT02719366|20062517|P2|COMPLETED|First Intervention||6
8138903|NCT02719366|20062518|P1|COMPLETED|First Intervention||6
8138904|NCT02719366|20062517|P2|STARTED|First Intervention||6
8138905|NCT02719366|20062518|P1|STARTED|First Intervention||6
8138906|NCT02719353|20062551|P2|NOT COMPLETED|Second Intervention||0
8138907|NCT02719353|20062552|P1|NOT COMPLETED|Second Intervention||0
8138908|NCT02719353|20062551|P2|COMPLETED|Second Intervention||6
8138909|NCT02719353|20062552|P1|COMPLETED|Second Intervention||7
8138910|NCT02719353|20062551|P2|STARTED|Second Intervention||6
8138911|NCT02719353|20062552|P1|STARTED|Second Intervention||7
8138912|NCT02719353|20062551|P2|NOT COMPLETED|First Intervention||1
8138913|NCT02719353|20062552|P1|NOT COMPLETED|First Intervention||0
8138914|NCT02719353|20062551|P2|COMPLETED|First Intervention||6
8138915|NCT02719353|20062552|P1|COMPLETED|First Intervention||7
8138916|NCT02719353|20062551|P2|STARTED|First Intervention||7
8138917|NCT02719353|20062552|P1|STARTED|First Intervention||7
8138918|NCT02719171|20062591|P5|NOT COMPLETED|Overall Study||2
8138919|NCT02719171|20062592|P4|NOT COMPLETED|Overall Study||2
8138920|NCT02719171|20062593|P3|NOT COMPLETED|Overall Study||3
8138921|NCT02719171|20062594|P2|NOT COMPLETED|Overall Study||4
8138922|NCT02719171|20062595|P1|NOT COMPLETED|Overall Study||1
8138923|NCT02719171|20062591|P5|COMPLETED|Overall Study||18
8138924|NCT02719171|20062592|P4|COMPLETED|Overall Study||37
8138925|NCT02719171|20062593|P3|COMPLETED|Overall Study||39
8138926|NCT02719171|20062594|P2|COMPLETED|Overall Study||38
8138927|NCT02719171|20062595|P1|COMPLETED|Overall Study||41
8138928|NCT02719171|20062591|P5|STARTED|Overall Study||20
8138929|NCT02719171|20062592|P4|STARTED|Overall Study||39
8138930|NCT02719171|20062593|P3|STARTED|Overall Study||42
8138931|NCT02719171|20062594|P2|STARTED|Overall Study||42
8138932|NCT02719171|20062595|P1|STARTED|Overall Study||42
8138933|NCT02719158|20062689|P3|NOT COMPLETED|Overall Study||1
8138934|NCT02719158|20062690|P2|NOT COMPLETED|Overall Study||0
8138935|NCT02719158|20062691|P1|NOT COMPLETED|Overall Study||0
8138936|NCT02719158|20062689|P3|COMPLETED|Overall Study||18
8138937|NCT02719158|20062690|P2|COMPLETED|Overall Study||38
8138938|NCT02719158|20062691|P1|COMPLETED|Overall Study||38
8138939|NCT02719158|20062689|P3|STARTED|Overall Study||19
8138940|NCT02719158|20062690|P2|STARTED|Overall Study||38
8138941|NCT02719158|20062691|P1|STARTED|Overall Study||38
8138942|NCT02719028|20062712|P4|NOT COMPLETED|Overall Study||10
8138943|NCT02719028|20062713|P3|NOT COMPLETED|Overall Study||6
8138944|NCT02719028|20062714|P2|NOT COMPLETED|Overall Study||2
8138945|NCT02719028|20062715|P1|NOT COMPLETED|Overall Study||2
8138946|NCT02719028|20062712|P4|COMPLETED|Overall Study||20
8138947|NCT02719028|20062713|P3|COMPLETED|Overall Study||24
8138948|NCT02719028|20062714|P2|COMPLETED|Overall Study||28
8138949|NCT02719028|20062715|P1|COMPLETED|Overall Study||28
8138950|NCT02719028|20062712|P4|STARTED|Overall Study||30
8138951|NCT02719028|20062713|P3|STARTED|Overall Study||30
8138952|NCT02719028|20062714|P2|STARTED|Overall Study||30
8138953|NCT02719028|20062715|P1|STARTED|Overall Study||30
8138954|NCT02718963|20062739|P2|NOT COMPLETED|Overall Study||1
8138955|NCT02718963|20062740|P1|NOT COMPLETED|Overall Study||1
8138956|NCT02718963|20062739|P2|COMPLETED|Overall Study||9
8138957|NCT02718963|20062740|P1|COMPLETED|Overall Study||9
8138958|NCT02718963|20062739|P2|STARTED|Overall Study||10
8138959|NCT02718963|20062740|P1|STARTED|Overall Study||10
8138960|NCT02718898|20062748|P7|NOT COMPLETED|Post Treatment Follow-up Period||5
8138961|NCT02718898|20062749|P6|NOT COMPLETED|Post Treatment Follow-up Period||11
8138962|NCT02718898|20062750|P5|NOT COMPLETED|Post Treatment Follow-up Period||1
8138963|NCT02718898|20062751|P4|NOT COMPLETED|Post Treatment Follow-up Period||0
8138964|NCT02718898|20062752|P3|NOT COMPLETED|Post Treatment Follow-up Period||0
8138965|NCT02718898|20062753|P2|NOT COMPLETED|Post Treatment Follow-up Period||0
8138966|NCT02718898|20062754|P1|NOT COMPLETED|Post Treatment Follow-up Period||0
8138967|NCT02718898|20062748|P7|COMPLETED|Post Treatment Follow-up Period||44
8138968|NCT02718898|20062749|P6|COMPLETED|Post Treatment Follow-up Period||67
8138969|NCT02718898|20062750|P5|COMPLETED|Post Treatment Follow-up Period||0
8138970|NCT02718898|20062751|P4|COMPLETED|Post Treatment Follow-up Period||0
8138971|NCT02718898|20062752|P3|COMPLETED|Post Treatment Follow-up Period||0
8138972|NCT02718898|20062753|P2|COMPLETED|Post Treatment Follow-up Period||0
8138973|NCT02718898|20062754|P1|COMPLETED|Post Treatment Follow-up Period||0
8138974|NCT02718898|20062748|P7|STARTED|Post Treatment Follow-up Period||49
8138975|NCT02718898|20062749|P6|STARTED|Post Treatment Follow-up Period||78
8138976|NCT02718898|20062750|P5|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1
8138977|NCT02718898|20062751|P4|STARTED|Post Treatment Follow-up Period||0
8138978|NCT02718898|20062752|P3|STARTED|Post Treatment Follow-up Period||0
8138979|NCT02718898|20062753|P2|STARTED|Post Treatment Follow-up Period||0
8138980|NCT02718898|20062754|P1|STARTED|Post Treatment Follow-up Period||0
8138981|NCT02718898|20062748|P7|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8138982|NCT02718898|20062749|P6|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8138983|NCT02718898|20062750|P5|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8138984|NCT02718898|20062751|P4|NOT COMPLETED|Open Label Treatment Period (OLTP)||10
8138985|NCT02718898|20062752|P3|NOT COMPLETED|Open Label Treatment Period (OLTP)||3
8138986|NCT02718898|20062753|P2|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8138987|NCT02718898|20062754|P1|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
8138988|NCT02718898|20062748|P7|COMPLETED|Open Label Treatment Period (OLTP)||0
8138989|NCT02718898|20062749|P6|COMPLETED|Open Label Treatment Period (OLTP)||0
8138990|NCT02718898|20062750|P5|COMPLETED|Open Label Treatment Period (OLTP)||0
8138991|NCT02718898|20062751|P4|COMPLETED|Open Label Treatment Period (OLTP)||64
8138992|NCT02718898|20062752|P3|COMPLETED|Open Label Treatment Period (OLTP)||62
8138993|NCT02718898|20062753|P2|COMPLETED|Open Label Treatment Period (OLTP)||0
8138994|NCT02718898|20062754|P1|COMPLETED|Open Label Treatment Period (OLTP)||0
8138995|NCT02718898|20062748|P7|STARTED|Open Label Treatment Period (OLTP)||0
8138996|NCT02718898|20062749|P6|STARTED|Open Label Treatment Period (OLTP)||0
8138997|NCT02718898|20062750|P5|STARTED|Open Label Treatment Period (OLTP)||0
8138998|NCT02718898|20062751|P4|STARTED|Open Label Treatment Period (OLTP)||74
8138999|NCT02718898|20062752|P3|STARTED|Open Label Treatment Period (OLTP)||65
8139000|NCT02718898|20062753|P2|STARTED|Open Label Treatment Period (OLTP)||0
8139001|NCT02718898|20062754|P1|STARTED|Open Label Treatment Period (OLTP)||0
8139002|NCT02718898|20062748|P7|NOT COMPLETED|Blinded Treatment Period||0
8139003|NCT02718898|20062749|P6|NOT COMPLETED|Blinded Treatment Period||0
8139004|NCT02718898|20062750|P5|NOT COMPLETED|Blinded Treatment Period||0
8139005|NCT02718898|20062751|P4|NOT COMPLETED|Blinded Treatment Period||0
8139006|NCT02718898|20062752|P3|NOT COMPLETED|Blinded Treatment Period||0
8139007|NCT02718898|20062753|P2|NOT COMPLETED|Blinded Treatment Period||1
8139008|NCT02718898|20062754|P1|NOT COMPLETED|Blinded Treatment Period||9
8139009|NCT02718898|20062748|P7|COMPLETED|Blinded Treatment Period||0
8139010|NCT02718898|20062749|P6|COMPLETED|Blinded Treatment Period||0
8139011|NCT02718898|20062750|P5|COMPLETED|Blinded Treatment Period||0
8139012|NCT02718898|20062751|P4|COMPLETED|Blinded Treatment Period||0
8139013|NCT02718898|20062752|P3|COMPLETED|Blinded Treatment Period||0
8139014|NCT02718898|20062753|P2|COMPLETED|Blinded Treatment Period||74
8139015|NCT02718898|20062754|P1|COMPLETED|Blinded Treatment Period||65
8139016|NCT02718898|20062748|P7|STARTED|Blinded Treatment Period||0
8139017|NCT02718898|20062749|P6|STARTED|Blinded Treatment Period||0
8139018|NCT02718898|20062750|P5|STARTED|Blinded Treatment Period||0
8139019|NCT02718898|20062751|P4|STARTED|Blinded Treatment Period||0
8139020|NCT02718898|20062752|P3|STARTED|Blinded Treatment Period||0
8139021|NCT02718898|20062753|P2|STARTED|Blinded Treatment Period||75
8139022|NCT02718898|20062754|P1|STARTED|Blinded Treatment Period||74
8139023|NCT02718625|20062789|P2|NOT COMPLETED|Overall Study||2
8139024|NCT02718625|20062790|P1|NOT COMPLETED|Overall Study||0
8139025|NCT02718625|20062789|P2|COMPLETED|Overall Study||0
8139026|NCT02718625|20062790|P1|COMPLETED|Overall Study||1
8139027|NCT02718625|20062789|P2|STARTED|Overall Study||2
8139028|NCT02718625|20062790|P1|STARTED|Overall Study||1
8139029|NCT02718417|20062809|P3|NOT COMPLETED|Long-term Follow-up Phase||135
8139030|NCT02718417|20062810|P2|NOT COMPLETED|Long-term Follow-up Phase||112
8139031|NCT02718417|20062811|P1|NOT COMPLETED|Long-term Follow-up Phase||139
8139032|NCT02718417|20062809|P3|COMPLETED|Long-term Follow-up Phase||0
8139033|NCT02718417|20062810|P2|COMPLETED|Long-term Follow-up Phase||0
8139034|NCT02718417|20062811|P1|COMPLETED|Long-term Follow-up Phase||0
8139035|NCT02718417|20062809|P3|STARTED|Long-term Follow-up Phase|Participants not completing follow-up could also start this phase.|135
8139036|NCT02718417|20062810|P2|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|112
8139037|NCT02718417|20062811|P1|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|139
8139038|NCT02718417|20062809|P3|NOT COMPLETED|Follow-up Phase||19
8139039|NCT02718417|20062810|P2|NOT COMPLETED|Follow-up Phase||172
8139040|NCT02718417|20062811|P1|NOT COMPLETED|Follow-up Phase||135
8139041|NCT02718417|20062809|P3|COMPLETED|Follow-up Phase||20
8139042|NCT02718417|20062810|P2|COMPLETED|Follow-up Phase||91
8139043|NCT02718417|20062811|P1|COMPLETED|Follow-up Phase||103
8139044|NCT02718417|20062809|P3|STARTED|Follow-up Phase|Participants not completing OP could also start this phase.|39
8139045|NCT02718417|20062810|P2|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|263
8139046|NCT02718417|20062811|P1|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|238
8139047|NCT02718417|20062809|P3|NOT COMPLETED|Observation Phase (OP)||282
8139048|NCT02718417|20062810|P2|NOT COMPLETED|Observation Phase (OP)||0
8139049|NCT02718417|20062811|P1|NOT COMPLETED|Observation Phase (OP)||0
8139050|NCT02718417|20062809|P3|COMPLETED|Observation Phase (OP)||2
8139051|NCT02718417|20062810|P2|COMPLETED|Observation Phase (OP)||0
8139052|NCT02718417|20062811|P1|COMPLETED|Observation Phase (OP)||0
8139053|NCT02718417|20062809|P3|STARTED|Observation Phase (OP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|284
8139054|NCT02718417|20062810|P2|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
8139055|NCT02718417|20062811|P1|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
8139056|NCT02718417|20062809|P3|NOT COMPLETED|Maintenance Phase (MP)||0
8139057|NCT02718417|20062810|P2|NOT COMPLETED|Maintenance Phase (MP)||287
8139058|NCT02718417|20062811|P1|NOT COMPLETED|Maintenance Phase (MP)||266
8139059|NCT02718417|20062809|P3|COMPLETED|Maintenance Phase (MP)||0
8139060|NCT02718417|20062810|P2|COMPLETED|Maintenance Phase (MP)||1
8139061|NCT02718417|20062811|P1|COMPLETED|Maintenance Phase (MP)||1
8139062|NCT02718417|20062809|P3|STARTED|Maintenance Phase (MP)|After completing CP, participants moved to observation phase. MP was not applicable for this arm.|0
8139063|NCT02718417|20062810|P2|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|288
8139064|NCT02718417|20062811|P1|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|267
8139065|NCT02718417|20062809|P3|NOT COMPLETED|Chemotherapy Phase (CP)||46
8139066|NCT02718417|20062810|P2|NOT COMPLETED|Chemotherapy Phase (CP)||37
8139067|NCT02718417|20062811|P1|NOT COMPLETED|Chemotherapy Phase (CP)||52
8139068|NCT02718417|20062809|P3|COMPLETED|Chemotherapy Phase (CP)||289
8139069|NCT02718417|20062810|P2|COMPLETED|Chemotherapy Phase (CP)||294
8139070|NCT02718417|20062811|P1|COMPLETED|Chemotherapy Phase (CP)||280
8139071|NCT02718417|20062809|P3|Safety Population|Chemotherapy Phase (CP)||334
8139072|NCT02718417|20062810|P2|Safety Population|Chemotherapy Phase (CP)||329
8139073|NCT02718417|20062811|P1|Safety Population|Chemotherapy Phase (CP)||328
8139074|NCT02718417|20062809|P3|STARTED|Chemotherapy Phase (CP)||335
8139075|NCT02718417|20062810|P2|STARTED|Chemotherapy Phase (CP)||331
8139076|NCT02718417|20062811|P1|STARTED|Chemotherapy Phase (CP)||332
8139077|NCT02718326|20062917|P3|NOT COMPLETED|Overall Study||22
8139078|NCT02718326|20062918|P2|NOT COMPLETED|Overall Study||24
8139079|NCT02718326|20062919|P1|NOT COMPLETED|Overall Study||36
8139080|NCT02718326|20062917|P3|COMPLETED|Overall Study||112
8139081|NCT02718326|20062918|P2|COMPLETED|Overall Study||111
8139082|NCT02718326|20062919|P1|COMPLETED|Overall Study||97
8139083|NCT02718326|20062917|P3|Completed Week 52|Overall Study||124
8139084|NCT02718326|20062918|P2|Completed Week 52|Overall Study||122
8139085|NCT02718326|20062919|P1|Completed Week 52|Overall Study||109
8139086|NCT02718326|20062917|P3|STARTED|Overall Study||134
8139087|NCT02718326|20062918|P2|STARTED|Overall Study||135
8139088|NCT02718326|20062919|P1|STARTED|Overall Study||133
8139089|NCT02718248|20062950|P1|NOT COMPLETED|Overall Study||0
8139090|NCT02718248|20062950|P1|COMPLETED|Overall Study||7
8139091|NCT02718248|20062950|P1|STARTED|Overall Study||7
8139095|NCT02718118|20062975|P2|NOT COMPLETED|Overall Study||1
8139096|NCT02718118|20062976|P1|NOT COMPLETED|Overall Study||2
8139097|NCT02718118|20062975|P2|COMPLETED|Overall Study||29
8139098|NCT02718118|20062976|P1|COMPLETED|Overall Study||28
8139099|NCT02718118|20062975|P2|STARTED|Overall Study||30
8139100|NCT02718118|20062976|P1|STARTED|Overall Study||30
8139101|NCT02718040|20063010|P1|NOT COMPLETED|Overall Study||0
8139102|NCT02718040|20063010|P1|COMPLETED|Overall Study||30
8139103|NCT02718040|20063010|P1|STARTED|Overall Study||30
8139104|NCT02717949|20063025|P2|NOT COMPLETED|Overall Study||0
8139105|NCT02717949|20063026|P1|NOT COMPLETED|Overall Study||0
8139106|NCT02717949|20063025|P2|COMPLETED|Overall Study||0
8139107|NCT02717949|20063026|P1|COMPLETED|Overall Study||0
8139108|NCT02717949|20063025|P2|STARTED|Overall Study||0
8139109|NCT02717949|20063026|P1|STARTED|Overall Study||0
8139110|NCT02717754|20063040|P6|NOT COMPLETED|Overall Study||20
8139111|NCT02717754|20063041|P5|NOT COMPLETED|Overall Study||20
8139112|NCT02717754|20063042|P4|NOT COMPLETED|Overall Study||10
8139113|NCT02717754|20063043|P3|NOT COMPLETED|Overall Study||0
8139114|NCT02717754|20063044|P2|NOT COMPLETED|Overall Study||0
8139115|NCT02717754|20063045|P1|NOT COMPLETED|Overall Study||0
8139116|NCT02717754|20063040|P6|COMPLETED|Overall Study||0
8139117|NCT02717754|20063041|P5|COMPLETED|Overall Study||0
8139118|NCT02717754|20063042|P4|COMPLETED|Overall Study||0
8139119|NCT02717754|20063043|P3|COMPLETED|Overall Study||20
8139120|NCT02717754|20063044|P2|COMPLETED|Overall Study||19
8139121|NCT02717754|20063045|P1|COMPLETED|Overall Study||10
8139122|NCT02717754|20063040|P6|STARTED|Overall Study||20
8139123|NCT02717754|20063041|P5|STARTED|Overall Study||20
8139124|NCT02717754|20063042|P4|STARTED|Overall Study||10
8139125|NCT02717754|20063043|P3|STARTED|Overall Study||20
8139126|NCT02717754|20063044|P2|STARTED|Overall Study||19
8139127|NCT02717754|20063045|P1|STARTED|Overall Study||10
8139128|NCT02717494|20063076|P3|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4
8139129|NCT02717494|20063077|P2|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
8139130|NCT02717494|20063078|P1|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
8139131|NCT02717494|20063076|P3|COMPLETED|Second Intervention (Step 2 or Step 3)||106
8139132|NCT02717494|20063077|P2|COMPLETED|Second Intervention (Step 2 or Step 3)||0
8139133|NCT02717494|20063078|P1|COMPLETED|Second Intervention (Step 2 or Step 3)||0
8139134|NCT02717494|20063076|P3|Completed Step 3|Second Intervention (Step 2 or Step 3)||4
8139135|NCT02717494|20063077|P2|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
8139136|NCT02717494|20063078|P1|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
8139137|NCT02717494|20063076|P3|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50
8139138|NCT02717494|20063077|P2|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
8139139|NCT02717494|20063078|P1|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
8139140|NCT02717494|20063076|P3|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52
8139141|NCT02717494|20063077|P2|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
8139142|NCT02717494|20063078|P1|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
8139143|NCT02717494|20063076|P3|STARTED|Second Intervention (Step 2 or Step 3)|One participant who completed Step 1 did not enroll in Step 2.|110
8139144|NCT02717494|20063077|P2|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
8139145|NCT02717494|20063078|P1|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
8139146|NCT02717494|20063076|P3|NOT COMPLETED|First Intervention (Step 1)||5
8139147|NCT02717494|20063077|P2|NOT COMPLETED|First Intervention (Step 1)||7
8139148|NCT02717494|20063078|P1|NOT COMPLETED|First Intervention (Step 1)||6
8139149|NCT02717494|20063076|P3|COMPLETED|First Intervention (Step 1)||111
8139150|NCT02717494|20063077|P2|COMPLETED|First Intervention (Step 1)||108
8139151|NCT02717494|20063078|P1|COMPLETED|First Intervention (Step 1)||109
8139152|NCT02717494|20063076|P3|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4
8139153|NCT02717494|20063077|P2|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
8139154|NCT02717494|20063078|P1|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
8139155|NCT02717494|20063076|P3|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53
8139156|NCT02717494|20063077|P2|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
8139157|NCT02717494|20063078|P1|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
8139158|NCT02717494|20063076|P3|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53
8139159|NCT02717494|20063077|P2|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
8139160|NCT02717494|20063078|P1|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
8139161|NCT02717494|20063076|P3|STARTED|First Intervention (Step 1)||116
8139162|NCT02717494|20063077|P2|STARTED|First Intervention (Step 1)||115
8139163|NCT02717494|20063078|P1|STARTED|First Intervention (Step 1)||115
8139164|NCT02717273|20063117|P2|NOT COMPLETED|Overall Study||2
8139165|NCT02717273|20063118|P1|NOT COMPLETED|Overall Study||3
8139166|NCT02717273|20063117|P2|COMPLETED|Overall Study||48
8139167|NCT02717273|20063118|P1|COMPLETED|Overall Study||49
8139168|NCT02717273|20063117|P2|STARTED|Overall Study||50
8139169|NCT02717273|20063118|P1|STARTED|Overall Study||52
8139170|NCT02717195|20063140|P5|NOT COMPLETED|Double-blind Treatment (DBT) Period||30
8139171|NCT02717195|20063141|P4|NOT COMPLETED|Double-blind Treatment (DBT) Period||44
8139172|NCT02717195|20063142|P3|NOT COMPLETED|Double-blind Treatment (DBT) Period||37
8139173|NCT02717195|20063143|P2|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
8139174|NCT02717195|20063144|P1|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
8139175|NCT02717195|20063140|P5|COMPLETED|Double-blind Treatment (DBT) Period||200
8139176|NCT02717195|20063141|P4|COMPLETED|Double-blind Treatment (DBT) Period||188
8139177|NCT02717195|20063142|P3|COMPLETED|Double-blind Treatment (DBT) Period||198
8139178|NCT02717195|20063143|P2|COMPLETED|Double-blind Treatment (DBT) Period||0
8139179|NCT02717195|20063144|P1|COMPLETED|Double-blind Treatment (DBT) Period||0
8139180|NCT02717195|20063140|P5|STARTED|Double-blind Treatment (DBT) Period||230
8139181|NCT02717195|20063141|P4|STARTED|Double-blind Treatment (DBT) Period||232
8139182|NCT02717195|20063142|P3|STARTED|Double-blind Treatment (DBT) Period||235
8139183|NCT02717195|20063143|P2|STARTED|Double-blind Treatment (DBT) Period||0
8139184|NCT02717195|20063144|P1|STARTED|Double-blind Treatment (DBT) Period||0
8139185|NCT02717195|20063140|P5|NOT COMPLETED|Prospective Confirmation (PC) Period||0
8139186|NCT02717195|20063141|P4|NOT COMPLETED|Prospective Confirmation (PC) Period||0
8139187|NCT02717195|20063142|P3|NOT COMPLETED|Prospective Confirmation (PC) Period||0
8139188|NCT02717195|20063143|P2|NOT COMPLETED|Prospective Confirmation (PC) Period||111
8139189|NCT02717195|20063144|P1|NOT COMPLETED|Prospective Confirmation (PC) Period||290
8139190|NCT02717195|20063140|P5|COMPLETED|Prospective Confirmation (PC) Period||0
8139191|NCT02717195|20063141|P4|COMPLETED|Prospective Confirmation (PC) Period||0
8139192|NCT02717195|20063142|P3|COMPLETED|Prospective Confirmation (PC) Period||0
8139193|NCT02717195|20063143|P2|COMPLETED|Prospective Confirmation (PC) Period||276
8139194|NCT02717195|20063144|P1|COMPLETED|Prospective Confirmation (PC) Period||421
8139195|NCT02717195|20063140|P5|STARTED|Prospective Confirmation (PC) Period||0
8139196|NCT02717195|20063141|P4|STARTED|Prospective Confirmation (PC) Period||0
8139197|NCT02717195|20063142|P3|STARTED|Prospective Confirmation (PC) Period||0
8139198|NCT02717195|20063143|P2|STARTED|Prospective Confirmation (PC) Period||387
8139199|NCT02717195|20063144|P1|STARTED|Prospective Confirmation (PC) Period||711
8139200|NCT02717130|20063175|P1|NOT COMPLETED|Overall Study||7
8139201|NCT02717130|20063175|P1|COMPLETED|Overall Study||1
8139202|NCT02717130|20063175|P1|STARTED|Overall Study|Of the nine enrolled subjects, eight received study drug.|8
8139221|NCT02716896|20063256|P2|NOT COMPLETED|Overall Study||1
8139222|NCT02716896|20063257|P1|NOT COMPLETED|Overall Study||0
8139223|NCT02716896|20063256|P2|COMPLETED|Overall Study||0
8139224|NCT02716896|20063257|P1|COMPLETED|Overall Study||1
8139225|NCT02716896|20063256|P2|STARTED|Overall Study||1
8139226|NCT02716896|20063257|P1|STARTED|Overall Study||1
8139233|NCT02716805|20063308|P4|NOT COMPLETED|Overall Study||0
8139234|NCT02716805|20063309|P3|NOT COMPLETED|Overall Study||0
8139235|NCT02716805|20063310|P2|NOT COMPLETED|Overall Study||0
8139236|NCT02716805|20063311|P1|NOT COMPLETED|Overall Study||2
8139237|NCT02716805|20063308|P4|COMPLETED|Overall Study||0
8139238|NCT02716805|20063309|P3|COMPLETED|Overall Study||0
8139239|NCT02716805|20063310|P2|COMPLETED|Overall Study||0
8139240|NCT02716805|20063311|P1|COMPLETED|Overall Study||4
8139241|NCT02716805|20063308|P4|STARTED|Overall Study||0
8139242|NCT02716805|20063309|P3|STARTED|Overall Study||0
8139243|NCT02716805|20063310|P2|STARTED|Overall Study||0
8139244|NCT02716805|20063311|P1|STARTED|Overall Study||6
8139245|NCT02716779|20063319|P3|NOT COMPLETED|Combination Therapy||1
8139246|NCT02716779|20063320|P2|NOT COMPLETED|Combination Therapy||2
8139247|NCT02716779|20063321|P1|NOT COMPLETED|Combination Therapy||0
8139248|NCT02716779|20063319|P3|COMPLETED|Combination Therapy||25
8139249|NCT02716779|20063320|P2|COMPLETED|Combination Therapy||23
8139250|NCT02716779|20063321|P1|COMPLETED|Combination Therapy||14
8139251|NCT02716779|20063319|P3|STARTED|Combination Therapy||26
8139252|NCT02716779|20063320|P2|STARTED|Combination Therapy||25
8139253|NCT02716779|20063321|P1|STARTED|Combination Therapy||14
8139254|NCT02716779|20063319|P3|NOT COMPLETED|Monotherapy||1
8139255|NCT02716779|20063320|P2|NOT COMPLETED|Monotherapy||1
8139256|NCT02716779|20063321|P1|NOT COMPLETED|Monotherapy||0
8139257|NCT02716779|20063319|P3|COMPLETED|Monotherapy||26
8139258|NCT02716779|20063320|P2|COMPLETED|Monotherapy||25
8139259|NCT02716779|20063321|P1|COMPLETED|Monotherapy||14
8139260|NCT02716779|20063319|P3|STARTED|Monotherapy||27
8139261|NCT02716779|20063320|P2|STARTED|Monotherapy||26
8139262|NCT02716779|20063321|P1|STARTED|Monotherapy||14
8139263|NCT02716727|20063367|P2|NOT COMPLETED|Overall Study||0
8139264|NCT02716727|20063368|P1|NOT COMPLETED|Overall Study||0
8139265|NCT02716727|20063367|P2|COMPLETED|Overall Study||9
8139266|NCT02716727|20063368|P1|COMPLETED|Overall Study||7
8139267|NCT02716727|20063367|P2|STARTED|Overall Study||9
8139268|NCT02716727|20063368|P1|STARTED|Overall Study||7
8139269|NCT02716714|20063392|P2|NOT COMPLETED|Overall Study||2
8139270|NCT02716714|20063393|P1|NOT COMPLETED|Overall Study||12
8139271|NCT02716714|20063392|P2|COMPLETED|Overall Study||8
8139272|NCT02716714|20063393|P1|COMPLETED|Overall Study||55
8139273|NCT02716714|20063392|P2|STARTED|Overall Study||10
8139274|NCT02716714|20063393|P1|STARTED|Overall Study||67
8139275|NCT02716584|20063421|P2|NOT COMPLETED|Overall Study||5
8139276|NCT02716584|20063422|P1|NOT COMPLETED|Overall Study||8
8139277|NCT02716584|20063421|P2|COMPLETED|Overall Study||13
8139278|NCT02716584|20063422|P1|COMPLETED|Overall Study||27
8139279|NCT02716584|20063421|P2|STARTED|Overall Study||18
8139280|NCT02716584|20063422|P1|STARTED|Overall Study||35
8139281|NCT02716506|20063446|P1|NOT COMPLETED|Overall Study||1164
8139282|NCT02716506|20063446|P1|COMPLETED|Overall Study||2351
8139283|NCT02716506|20063446|P1|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351
8139284|NCT02716506|20063446|P1|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528
8139285|NCT02716506|20063446|P1|STARTED|Overall Study||3515
8139286|NCT02716324|20063453|P2|NOT COMPLETED|Overall Study||11
8139287|NCT02716324|20063454|P1|NOT COMPLETED|Overall Study||19
8139288|NCT02716324|20063453|P2|COMPLETED|Overall Study||143
8139289|NCT02716324|20063454|P1|COMPLETED|Overall Study||130
8139290|NCT02716324|20063453|P2|STARTED|Overall Study||154
8139291|NCT02716324|20063454|P1|STARTED|Overall Study||149
8139292|NCT02716298|20063478|P2|NOT COMPLETED|Second Intervention (1 Month)||0
8139293|NCT02716298|20063479|P1|NOT COMPLETED|Second Intervention (1 Month)||0
8139294|NCT02716298|20063478|P2|COMPLETED|Second Intervention (1 Month)||23
8139295|NCT02716298|20063479|P1|COMPLETED|Second Intervention (1 Month)||24
8139296|NCT02716298|20063478|P2|STARTED|Second Intervention (1 Month)||23
8139297|NCT02716298|20063479|P1|STARTED|Second Intervention (1 Month)||24
8139298|NCT02716298|20063478|P2|NOT COMPLETED|First Intervention (1 Month)||1
8139299|NCT02716298|20063479|P1|NOT COMPLETED|First Intervention (1 Month)||1
8139300|NCT02716298|20063478|P2|COMPLETED|First Intervention (1 Month)||23
8139301|NCT02716298|20063479|P1|COMPLETED|First Intervention (1 Month)||24
8139302|NCT02716298|20063478|P2|STARTED|First Intervention (1 Month)||24
8139303|NCT02716298|20063479|P1|STARTED|First Intervention (1 Month)||25
8139322|NCT02715804|20063579|P2|NOT COMPLETED|Overall Study||113
8139323|NCT02715804|20063580|P1|NOT COMPLETED|Overall Study||229
8139324|NCT02715804|20063579|P2|COMPLETED|Overall Study||52
8139325|NCT02715804|20063580|P1|COMPLETED|Overall Study||98
8139326|NCT02715804|20063579|P2|Safety Population|Overall Study|1 participant randomized to PAG but received AG|156
8139327|NCT02715804|20063580|P1|Safety Population|Overall Study|3 participants randomized to AG but received PAG|325
8139328|NCT02715804|20063579|P2|Received at Least 1 Dose of Study Drug|Overall Study||158
8139329|NCT02715804|20063580|P1|Received at Least 1 Dose of Study Drug|Overall Study||323
8139330|NCT02715804|20063579|P2|STARTED|Overall Study||165
8139331|NCT02715804|20063580|P1|STARTED|Overall Study||327
8139332|NCT02715765|20063603|P3|NOT COMPLETED|Overall Study||0
8139333|NCT02715765|20063604|P2|NOT COMPLETED|Overall Study||0
8139334|NCT02715765|20063605|P1|NOT COMPLETED|Overall Study||3
8139335|NCT02715765|20063603|P3|COMPLETED|Overall Study||0
8139336|NCT02715765|20063604|P2|COMPLETED|Overall Study||0
8139337|NCT02715765|20063605|P1|COMPLETED|Overall Study||0
8139338|NCT02715765|20063603|P3|STARTED|Overall Study||0
8139339|NCT02715765|20063604|P2|STARTED|Overall Study||0
8139340|NCT02715765|20063605|P1|STARTED|Overall Study||3
8139341|NCT02715726|20063618|P2|NOT COMPLETED|Overall Study||27
8139342|NCT02715726|20063619|P1|NOT COMPLETED|Overall Study||18
8139343|NCT02715726|20063618|P2|COMPLETED|Overall Study||380
8139344|NCT02715726|20063619|P1|COMPLETED|Overall Study||190
8139345|NCT02715726|20063618|P2|Safety Population|Overall Study||406
8139346|NCT02715726|20063619|P1|Safety Population|Overall Study||206
8139347|NCT02715726|20063618|P2|Treated|Overall Study||405
8139348|NCT02715726|20063619|P1|Treated|Overall Study||207
8139349|NCT02715726|20063618|P2|STARTED|Overall Study|Randomized|407
8139350|NCT02715726|20063619|P1|STARTED|Overall Study|Randomized|208
8139351|NCT02715700|20063667|P1|NOT COMPLETED|Overall Study||0
8139352|NCT02715700|20063667|P1|COMPLETED|Overall Study||14
8139353|NCT02715700|20063667|P1|STARTED|Overall Study||14
8139354|NCT02714868|20063699|P2|NOT COMPLETED|Overall Study||0
8139355|NCT02714868|20063700|P1|NOT COMPLETED|Overall Study||5
8139356|NCT02714868|20063699|P2|COMPLETED|Overall Study||35
8139357|NCT02714868|20063700|P1|COMPLETED|Overall Study||42
8139358|NCT02714868|20063699|P2|STARTED|Overall Study||35
8139359|NCT02714868|20063700|P1|STARTED|Overall Study||47
8139360|NCT02714595|20063718|P2|NOT COMPLETED|Overall Study||13
8139361|NCT02714595|20063719|P1|NOT COMPLETED|Overall Study||32
8139362|NCT02714595|20063718|P2|COMPLETED|Overall Study||38
8139363|NCT02714595|20063719|P1|COMPLETED|Overall Study||69
8139364|NCT02714595|20063718|P2|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||38
8139365|NCT02714595|20063719|P1|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||80
8139366|NCT02714595|20063718|P2|Received Treatment|Overall Study||49
8139367|NCT02714595|20063719|P1|Received Treatment|Overall Study||101
8139368|NCT02714595|20063718|P2|STARTED|Overall Study||51
8139369|NCT02714595|20063719|P1|STARTED|Overall Study||101
8139370|NCT02714504|20063967|P2|NOT COMPLETED|Overall Study||0
8139371|NCT02714504|20063968|P1|NOT COMPLETED|Overall Study||0
8139372|NCT02714504|20063967|P2|COMPLETED|Overall Study||178
8139373|NCT02714504|20063968|P1|COMPLETED|Overall Study||61
8139374|NCT02714504|20063967|P2|STARTED|Overall Study||178
8139375|NCT02714504|20063968|P1|STARTED|Overall Study||61
8139376|NCT02714426|20063976|P2|NOT COMPLETED|Overall Study||2
8139377|NCT02714426|20063977|P1|NOT COMPLETED|Overall Study||2
8139378|NCT02714426|20063976|P2|COMPLETED|Overall Study||19
8139379|NCT02714426|20063977|P1|COMPLETED|Overall Study||19
8139380|NCT02714426|20063976|P2|STARTED|Overall Study||21
8139381|NCT02714426|20063977|P1|STARTED|Overall Study||21
8139382|NCT02714400|20063993|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8139383|NCT02714400|20063994|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8139384|NCT02714400|20063993|P2|COMPLETED|Second Intervention (1 Day)||8
8139385|NCT02714400|20063994|P1|COMPLETED|Second Intervention (1 Day)||12
8139386|NCT02714400|20063993|P2|STARTED|Second Intervention (1 Day)||8
8139387|NCT02714400|20063994|P1|STARTED|Second Intervention (1 Day)||12
8139388|NCT02714400|20063993|P2|NOT COMPLETED|Washout (>4 Days)||0
8139389|NCT02714400|20063994|P1|NOT COMPLETED|Washout (>4 Days)||0
8139390|NCT02714400|20063993|P2|COMPLETED|Washout (>4 Days)||8
8139391|NCT02714400|20063994|P1|COMPLETED|Washout (>4 Days)||12
8139392|NCT02714400|20063993|P2|STARTED|Washout (>4 Days)||8
8139393|NCT02714400|20063994|P1|STARTED|Washout (>4 Days)||12
8139394|NCT02714400|20063993|P2|NOT COMPLETED|First Intervention (1 Day)||0
8139395|NCT02714400|20063994|P1|NOT COMPLETED|First Intervention (1 Day)||0
8139396|NCT02714400|20063993|P2|COMPLETED|First Intervention (1 Day)||8
8139397|NCT02714400|20063994|P1|COMPLETED|First Intervention (1 Day)||12
8139398|NCT02714400|20063993|P2|STARTED|First Intervention (1 Day)||8
8139399|NCT02714400|20063994|P1|STARTED|First Intervention (1 Day)||12
8139400|NCT02714283|20064010|P2|NOT COMPLETED|Overall Study||0
8139401|NCT02714283|20064011|P1|NOT COMPLETED|Overall Study||0
8139402|NCT02714283|20064010|P2|COMPLETED|Overall Study||6500
8139403|NCT02714283|20064011|P1|COMPLETED|Overall Study||83589
8139404|NCT02714283|20064010|P2|STARTED|Overall Study||6500
8139405|NCT02714283|20064011|P1|STARTED|Overall Study||83589
8139406|NCT02714218|20064038|P3|NOT COMPLETED|Overall Study||19
8139407|NCT02714218|20064039|P2|NOT COMPLETED|Overall Study||143
8139408|NCT02714218|20064040|P1|NOT COMPLETED|Overall Study||130
8139409|NCT02714218|20064038|P3|COMPLETED|Overall Study||8
8139410|NCT02714218|20064039|P2|COMPLETED|Overall Study||35
8139411|NCT02714218|20064040|P1|COMPLETED|Overall Study||50
8139412|NCT02714218|20064038|P3|STARTED|Overall Study||27
8139413|NCT02714218|20064039|P2|STARTED|Overall Study||178
8139414|NCT02714218|20064040|P1|STARTED|Overall Study||180
8139415|NCT02714062|20064090|P3|NOT COMPLETED|Overall Study||3
8139416|NCT02714062|20064091|P2|NOT COMPLETED|Overall Study||1
8139417|NCT02714062|20064092|P1|NOT COMPLETED|Overall Study||1
8139418|NCT02714062|20064090|P3|COMPLETED|Overall Study||10
8139419|NCT02714062|20064091|P2|COMPLETED|Overall Study||14
8139420|NCT02714062|20064092|P1|COMPLETED|Overall Study||13
8139421|NCT02714062|20064090|P3|STARTED|Overall Study||13
8139422|NCT02714062|20064091|P2|STARTED|Overall Study||15
8139423|NCT02714062|20064092|P1|STARTED|Overall Study||14
8139424|NCT02713867|20064138|P2|NOT COMPLETED|Treatment Period||150
8139425|NCT02713867|20064139|P1|NOT COMPLETED|Treatment Period||147
8139426|NCT02713867|20064138|P2|COMPLETED|Treatment Period||30
8139427|NCT02713867|20064139|P1|COMPLETED|Treatment Period||31
8139428|NCT02713867|20064138|P2|STARTED|Treatment Period||180
8139429|NCT02713867|20064139|P1|STARTED|Treatment Period||178
8139430|NCT02713867|20064138|P2|NOT COMPLETED|Randomization||3
8139431|NCT02713867|20064139|P1|NOT COMPLETED|Randomization||2
8139432|NCT02713867|20064138|P2|COMPLETED|Randomization||180
8139433|NCT02713867|20064139|P1|COMPLETED|Randomization||178
8139434|NCT02713867|20064138|P2|STARTED|Randomization||183
8139435|NCT02713867|20064139|P1|STARTED|Randomization||180
8139436|NCT02713828|20064177|P2|NOT COMPLETED|Overall Study||0
8139437|NCT02713828|20064178|P1|NOT COMPLETED|Overall Study||5
8139438|NCT02713828|20064177|P2|COMPLETED|Overall Study||0
8139439|NCT02713828|20064178|P1|COMPLETED|Overall Study||8
8139440|NCT02713828|20064177|P2|STARTED|Overall Study||0
8139441|NCT02713828|20064178|P1|STARTED|Overall Study||13
8139442|NCT02713789|20064190|P3|NOT COMPLETED|Overall Study||1
8139443|NCT02713789|20064191|P2|NOT COMPLETED|Overall Study||1
8139444|NCT02713789|20064192|P1|NOT COMPLETED|Overall Study||0
8139445|NCT02713789|20064190|P3|COMPLETED|Overall Study||7
8139446|NCT02713789|20064191|P2|COMPLETED|Overall Study||9
8139447|NCT02713789|20064192|P1|COMPLETED|Overall Study||8
8139448|NCT02713789|20064190|P3|STARTED|Overall Study||8
8139449|NCT02713789|20064191|P2|STARTED|Overall Study||10
8139450|NCT02713789|20064192|P1|STARTED|Overall Study||8
8139451|NCT02713698|20064230|P3|NOT COMPLETED|Overall Study||0
8139452|NCT02713698|20064231|P2|NOT COMPLETED|Overall Study||0
8139453|NCT02713698|20064232|P1|NOT COMPLETED|Overall Study||0
8139454|NCT02713698|20064230|P3|COMPLETED|Overall Study||20
8139455|NCT02713698|20064231|P2|COMPLETED|Overall Study||20
8139456|NCT02713698|20064232|P1|COMPLETED|Overall Study||20
8139457|NCT02713698|20064230|P3|STARTED|Overall Study||20
8139458|NCT02713698|20064231|P2|STARTED|Overall Study||20
8139459|NCT02713698|20064232|P1|STARTED|Overall Study||20
8139460|NCT02713659|20064242|P2|NOT COMPLETED|24 Month Study Visit||8
8139461|NCT02713659|20064243|P1|NOT COMPLETED|24 Month Study Visit||8
8139462|NCT02713659|20064242|P2|COMPLETED|24 Month Study Visit||44
8139463|NCT02713659|20064243|P1|COMPLETED|24 Month Study Visit||49
8139464|NCT02713659|20064242|P2|STARTED|24 Month Study Visit||52
8139465|NCT02713659|20064243|P1|STARTED|24 Month Study Visit||57
8139466|NCT02713659|20064242|P2|NOT COMPLETED|18 Month Study Visit||3
8139467|NCT02713659|20064243|P1|NOT COMPLETED|18 Month Study Visit||8
8139468|NCT02713659|20064242|P2|COMPLETED|18 Month Study Visit||50
8139469|NCT02713659|20064243|P1|COMPLETED|18 Month Study Visit||50
8139470|NCT02713659|20064242|P2|STARTED|18 Month Study Visit||53
8139471|NCT02713659|20064243|P1|STARTED|18 Month Study Visit||58
8139472|NCT02713659|20064242|P2|NOT COMPLETED|12 Month Study Visit||3
8139473|NCT02713659|20064243|P1|NOT COMPLETED|12 Month Study Visit||3
8139474|NCT02713659|20064242|P2|COMPLETED|12 Month Study Visit||52
8139475|NCT02713659|20064243|P1|COMPLETED|12 Month Study Visit||54
8139476|NCT02713659|20064242|P2|STARTED|12 Month Study Visit||55
8139477|NCT02713659|20064243|P1|STARTED|12 Month Study Visit||57
8139478|NCT02713659|20064242|P2|NOT COMPLETED|6 Month Study Visit||13
8139479|NCT02713659|20064243|P1|NOT COMPLETED|6 Month Study Visit||7
8139480|NCT02713659|20064242|P2|COMPLETED|6 Month Study Visit||47
8139481|NCT02713659|20064243|P1|COMPLETED|6 Month Study Visit||53
8139482|NCT02713659|20064242|P2|STARTED|6 Month Study Visit||60
8139483|NCT02713659|20064243|P1|STARTED|6 Month Study Visit||60
8139484|NCT02713659|20064242|P2|NOT COMPLETED|Baseline||0
8139485|NCT02713659|20064243|P1|NOT COMPLETED|Baseline||0
8139486|NCT02713659|20064242|P2|COMPLETED|Baseline||60
8139487|NCT02713659|20064243|P1|COMPLETED|Baseline||60
8139488|NCT02713659|20064242|P2|STARTED|Baseline||60
8139489|NCT02713659|20064243|P1|STARTED|Baseline||60
8139490|NCT02713594|20064255|P2|NOT COMPLETED|Overall Study||396
8139491|NCT02713594|20064256|P1|NOT COMPLETED|Overall Study||390
8139492|NCT02713594|20064255|P2|COMPLETED|Overall Study||552
8139493|NCT02713594|20064256|P1|COMPLETED|Overall Study||562
8139494|NCT02713594|20064255|P2|STARTED|Overall Study||948
8139495|NCT02713594|20064256|P1|STARTED|Overall Study||952
8139496|NCT02713542|20064268|P2|NOT COMPLETED|Overall Study||6
8139497|NCT02713542|20064269|P1|NOT COMPLETED|Overall Study||18
8139498|NCT02713542|20064268|P2|COMPLETED|Overall Study||24
8139499|NCT02713542|20064269|P1|COMPLETED|Overall Study||42
8139500|NCT02713542|20064268|P2|STARTED|Overall Study||30
8139501|NCT02713542|20064269|P1|STARTED|Overall Study||60
8139502|NCT02713529|20064282|P7|NOT COMPLETED|Overall Study||4
8139503|NCT02713529|20064283|P6|NOT COMPLETED|Overall Study||14
8139504|NCT02713529|20064284|P5|NOT COMPLETED|Overall Study||3
8139505|NCT02713529|20064285|P4|NOT COMPLETED|Overall Study||29
8139506|NCT02713529|20064286|P3|NOT COMPLETED|Overall Study||31
8139507|NCT02713529|20064287|P2|NOT COMPLETED|Overall Study||4
8139508|NCT02713529|20064288|P1|NOT COMPLETED|Overall Study||7
8139509|NCT02713529|20064282|P7|COMPLETED|Overall Study||2
8139510|NCT02713529|20064283|P6|COMPLETED|Overall Study||5
8139511|NCT02713529|20064284|P5|COMPLETED|Overall Study||1
8139512|NCT02713529|20064285|P4|COMPLETED|Overall Study||2
8139513|NCT02713529|20064286|P3|COMPLETED|Overall Study||11
8139514|NCT02713529|20064287|P2|COMPLETED|Overall Study||3
8139515|NCT02713529|20064288|P1|COMPLETED|Overall Study||1
8139516|NCT02713529|20064282|P7|STARTED|Overall Study||6
8139517|NCT02713529|20064283|P6|STARTED|Overall Study||19
8139518|NCT02713529|20064284|P5|STARTED|Overall Study||4
8139519|NCT02713529|20064285|P4|STARTED|Overall Study||31
8139520|NCT02713529|20064286|P3|STARTED|Overall Study||42
8139521|NCT02713529|20064287|P2|STARTED|Overall Study||7
8139522|NCT02713529|20064288|P1|STARTED|Overall Study||8
8139523|NCT02713490|20064370|P2|NOT COMPLETED|Overall Study||2
8139524|NCT02713490|20064371|P1|NOT COMPLETED|Overall Study||3
8139525|NCT02713490|20064370|P2|COMPLETED|Overall Study||67
8139526|NCT02713490|20064371|P1|COMPLETED|Overall Study||68
8139527|NCT02713490|20064370|P2|STARTED|Overall Study||69
8139528|NCT02713490|20064371|P1|STARTED|Overall Study||71
8139529|NCT02713425|20064385|P1|NOT COMPLETED|Overall Study||0
8139530|NCT02713425|20064385|P1|COMPLETED|Overall Study||20
8139531|NCT02713425|20064385|P1|STARTED|Overall Study||20
8139532|NCT02713256|20064390|P1|NOT COMPLETED|Overall Study||0
8139533|NCT02713256|20064390|P1|COMPLETED|Overall Study||15
8139534|NCT02713256|20064390|P1|STARTED|Overall Study||15
8139535|NCT02713243|20064398|P2|NOT COMPLETED|Overall Study||2
8139536|NCT02713243|20064399|P1|NOT COMPLETED|Overall Study||1
8139537|NCT02713243|20064398|P2|COMPLETED|Overall Study||8
8139538|NCT02713243|20064399|P1|COMPLETED|Overall Study||9
8139539|NCT02713243|20064398|P2|PK Analysis Set|Overall Study||9
8139540|NCT02713243|20064399|P1|PK Analysis Set|Overall Study||8
8139541|NCT02713243|20064398|P2|PD Analysis Set|Overall Study||10
8139542|NCT02713243|20064399|P1|PD Analysis Set|Overall Study||9
8139543|NCT02713243|20064398|P2|STARTED|Overall Study||10
8139544|NCT02713243|20064399|P1|STARTED|Overall Study||10
8139545|NCT02713230|20064417|P3|NOT COMPLETED|Overall Study||0
8139546|NCT02713230|20064418|P2|NOT COMPLETED|Overall Study||0
8139547|NCT02713230|20064419|P1|NOT COMPLETED|Overall Study||1
8139548|NCT02713230|20064417|P3|COMPLETED|Overall Study||71
8139549|NCT02713230|20064418|P2|COMPLETED|Overall Study||15
8139550|NCT02713230|20064419|P1|COMPLETED|Overall Study||68
8139551|NCT02713230|20064417|P3|STARTED|Overall Study||71
8139552|NCT02713230|20064418|P2|STARTED|Overall Study||15
8139553|NCT02713230|20064419|P1|STARTED|Overall Study||69
8139554|NCT02713204|20064435|P8|NOT COMPLETED|From Week 12 up to Week 36||4
8139555|NCT02713204|20064436|P7|NOT COMPLETED|From Week 12 up to Week 36||2
8139556|NCT02713204|20064437|P6|NOT COMPLETED|From Week 12 up to Week 36||1
8139557|NCT02713204|20064438|P5|NOT COMPLETED|From Week 12 up to Week 36||2
8139558|NCT02713204|20064439|P4|NOT COMPLETED|From Week 12 up to Week 36||4
8139559|NCT02713204|20064440|P3|NOT COMPLETED|From Week 12 up to Week 36||0
8139560|NCT02713204|20064441|P2|NOT COMPLETED|From Week 12 up to Week 36||0
8139561|NCT02713204|20064442|P1|NOT COMPLETED|From Week 12 up to Week 36||1
8139562|NCT02713204|20064435|P8|COMPLETED|From Week 12 up to Week 36||54
8139563|NCT02713204|20064436|P7|COMPLETED|From Week 12 up to Week 36||60
8139564|NCT02713204|20064437|P6|COMPLETED|From Week 12 up to Week 36||59
8139565|NCT02713204|20064438|P5|COMPLETED|From Week 12 up to Week 36||60
8139566|NCT02713204|20064439|P4|COMPLETED|From Week 12 up to Week 36||53
8139567|NCT02713204|20064440|P3|COMPLETED|From Week 12 up to Week 36||0
8139568|NCT02713204|20064441|P2|COMPLETED|From Week 12 up to Week 36||0
8139569|NCT02713204|20064442|P1|COMPLETED|From Week 12 up to Week 36||57
8139570|NCT02713204|20064435|P8|STARTED|From Week 12 up to Week 36||58
8139571|NCT02713204|20064436|P7|STARTED|From Week 12 up to Week 36||62
8139572|NCT02713204|20064437|P6|STARTED|From Week 12 up to Week 36||60
8139573|NCT02713204|20064438|P5|STARTED|From Week 12 up to Week 36||62
8139574|NCT02713204|20064439|P4|STARTED|From Week 12 up to Week 36||57
8139575|NCT02713204|20064440|P3|STARTED|From Week 12 up to Week 36||0
8139576|NCT02713204|20064441|P2|STARTED|From Week 12 up to Week 36||0
8139577|NCT02713204|20064442|P1|STARTED|From Week 12 up to Week 36||58
8139578|NCT02713204|20064435|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139579|NCT02713204|20064436|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139580|NCT02713204|20064437|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139581|NCT02713204|20064438|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139582|NCT02713204|20064439|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139583|NCT02713204|20064440|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||2
8139584|NCT02713204|20064441|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
8139585|NCT02713204|20064442|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
8139586|NCT02713204|20064435|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
8139587|NCT02713204|20064436|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
8139588|NCT02713204|20064437|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
8139589|NCT02713204|20064438|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
8139590|NCT02713204|20064439|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
8139591|NCT02713204|20064440|P3|COMPLETED|Baseline (Day 1) up to Week 12||181
8139592|NCT02713204|20064441|P2|COMPLETED|Baseline (Day 1) up to Week 12||121
8139593|NCT02713204|20064442|P1|COMPLETED|Baseline (Day 1) up to Week 12||59
8139594|NCT02713204|20064435|P8|STARTED|Baseline (Day 1) up to Week 12||0
8139595|NCT02713204|20064436|P7|STARTED|Baseline (Day 1) up to Week 12||0
8139596|NCT02713204|20064437|P6|STARTED|Baseline (Day 1) up to Week 12||0
8139597|NCT02713204|20064438|P5|STARTED|Baseline (Day 1) up to Week 12||0
8139598|NCT02713204|20064439|P4|STARTED|Baseline (Day 1) up to Week 12||0
8139599|NCT02713204|20064440|P3|STARTED|Baseline (Day 1) up to Week 12||183
8139600|NCT02713204|20064441|P2|STARTED|Baseline (Day 1) up to Week 12||122
8139601|NCT02713204|20064442|P1|STARTED|Baseline (Day 1) up to Week 12||60
8139602|NCT02713178|20064502|P3|NOT COMPLETED|Overall Study||5
8139603|NCT02713178|20064503|P2|NOT COMPLETED|Overall Study||4
8139604|NCT02713178|20064504|P1|NOT COMPLETED|Overall Study||1
8139605|NCT02713178|20064502|P3|COMPLETED|Overall Study||74
8139606|NCT02713178|20064503|P2|COMPLETED|Overall Study||73
8139607|NCT02713178|20064504|P1|COMPLETED|Overall Study||75
8139608|NCT02713178|20064502|P3|STARTED|Overall Study||79
8139609|NCT02713178|20064503|P2|STARTED|Overall Study||77
8139610|NCT02713178|20064504|P1|STARTED|Overall Study||76
8139611|NCT02712996|20064523|P2|NOT COMPLETED|Second Intervention (Study Days 43-84)||1
8139612|NCT02712996|20064524|P1|NOT COMPLETED|Second Intervention (Study Days 43-84)||0
8139613|NCT02712996|20064523|P2|COMPLETED|Second Intervention (Study Days 43-84)||8
8139614|NCT02712996|20064524|P1|COMPLETED|Second Intervention (Study Days 43-84)||8
8139615|NCT02712996|20064523|P2|STARTED|Second Intervention (Study Days 43-84)||9
8139616|NCT02712996|20064524|P1|STARTED|Second Intervention (Study Days 43-84)||8
8139617|NCT02712996|20064523|P2|NOT COMPLETED|First Intervention (Study Days 1-42)||0
8139618|NCT02712996|20064524|P1|NOT COMPLETED|First Intervention (Study Days 1-42)||0
8139619|NCT02712996|20064523|P2|COMPLETED|First Intervention (Study Days 1-42)||9
8139620|NCT02712996|20064524|P1|COMPLETED|First Intervention (Study Days 1-42)||8
8139621|NCT02712996|20064523|P2|STARTED|First Intervention (Study Days 1-42)||9
8139622|NCT02712996|20064524|P1|STARTED|First Intervention (Study Days 1-42)||8
8139623|NCT02712983|20064583|P9|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139624|NCT02712983|20064584|P8|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||3
8139625|NCT02712983|20064585|P7|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
8139626|NCT02712983|20064586|P6|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
8139627|NCT02712983|20064587|P5|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
8139628|NCT02712983|20064588|P4|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
8139629|NCT02712983|20064589|P3|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139630|NCT02712983|20064590|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
8139631|NCT02712983|20064591|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139632|NCT02712983|20064583|P9|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139633|NCT02712983|20064584|P8|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139634|NCT02712983|20064585|P7|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139635|NCT02712983|20064586|P6|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139636|NCT02712983|20064587|P5|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139637|NCT02712983|20064588|P4|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139638|NCT02712983|20064589|P3|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139639|NCT02712983|20064590|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139640|NCT02712983|20064591|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8139641|NCT02712983|20064583|P9|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
8139722|NCT02712359|20064971|P3|STARTED|Epoch 002: Persistence at Year 10||299
8139642|NCT02712983|20064584|P8|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|3
8139643|NCT02712983|20064585|P7|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
8139644|NCT02712983|20064586|P6|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
8139645|NCT02712983|20064587|P5|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
8139646|NCT02712983|20064588|P4|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
8139647|NCT02712983|20064589|P3|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
8139648|NCT02712983|20064590|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
8139649|NCT02712983|20064591|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
8139650|NCT02712983|20064583|P9|NOT COMPLETED|Treatment Phase||2
8139651|NCT02712983|20064584|P8|NOT COMPLETED|Treatment Phase||9
8139652|NCT02712983|20064585|P7|NOT COMPLETED|Treatment Phase||9
8139653|NCT02712983|20064586|P6|NOT COMPLETED|Treatment Phase||0
8139654|NCT02712983|20064587|P5|NOT COMPLETED|Treatment Phase||4
8139655|NCT02712983|20064588|P4|NOT COMPLETED|Treatment Phase||8
8139656|NCT02712983|20064589|P3|NOT COMPLETED|Treatment Phase||1
8139657|NCT02712983|20064590|P2|NOT COMPLETED|Treatment Phase||1
8139658|NCT02712983|20064591|P1|NOT COMPLETED|Treatment Phase||5
8139659|NCT02712983|20064583|P9|COMPLETED|Treatment Phase||5
8139660|NCT02712983|20064584|P8|COMPLETED|Treatment Phase||6
8139661|NCT02712983|20064585|P7|COMPLETED|Treatment Phase||6
8139662|NCT02712983|20064586|P6|COMPLETED|Treatment Phase||7
8139663|NCT02712983|20064587|P5|COMPLETED|Treatment Phase||10
8139664|NCT02712983|20064588|P4|COMPLETED|Treatment Phase||7
8139665|NCT02712983|20064589|P3|COMPLETED|Treatment Phase||6
8139666|NCT02712983|20064590|P2|COMPLETED|Treatment Phase||12
8139667|NCT02712983|20064591|P1|COMPLETED|Treatment Phase||9
8139668|NCT02712983|20064583|P9|Pharmacokinetic Analysis Set|Treatment Phase||0
8139669|NCT02712983|20064584|P8|Pharmacokinetic Analysis Set|Treatment Phase||14
8139670|NCT02712983|20064585|P7|Pharmacokinetic Analysis Set|Treatment Phase||15
8139671|NCT02712983|20064586|P6|Pharmacokinetic Analysis Set|Treatment Phase||0
8139672|NCT02712983|20064587|P5|Pharmacokinetic Analysis Set|Treatment Phase||14
8139673|NCT02712983|20064588|P4|Pharmacokinetic Analysis Set|Treatment Phase||15
8139674|NCT02712983|20064589|P3|Pharmacokinetic Analysis Set|Treatment Phase||0
8139675|NCT02712983|20064590|P2|Pharmacokinetic Analysis Set|Treatment Phase||13
8139676|NCT02712983|20064591|P1|Pharmacokinetic Analysis Set|Treatment Phase||14
8139677|NCT02712983|20064583|P9|STARTED|Treatment Phase||7
8139678|NCT02712983|20064584|P8|STARTED|Treatment Phase||15
8139679|NCT02712983|20064585|P7|STARTED|Treatment Phase||15
8139680|NCT02712983|20064586|P6|STARTED|Treatment Phase||7
8139681|NCT02712983|20064587|P5|STARTED|Treatment Phase||14
8139682|NCT02712983|20064588|P4|STARTED|Treatment Phase||15
8139683|NCT02712983|20064589|P3|STARTED|Treatment Phase||7
8139684|NCT02712983|20064590|P2|STARTED|Treatment Phase||13
8139685|NCT02712983|20064591|P1|STARTED|Treatment Phase||14
8139686|NCT02712788|20064823|P2|NOT COMPLETED|Overall Study||0
8139687|NCT02712788|20064824|P1|NOT COMPLETED|Overall Study||2
8139688|NCT02712788|20064823|P2|COMPLETED|Overall Study||2
8139689|NCT02712788|20064824|P1|COMPLETED|Overall Study||0
8139690|NCT02712788|20064823|P2|STARTED|Overall Study||2
8139691|NCT02712788|20064824|P1|STARTED|Overall Study||2
8139692|NCT02712554|20064834|P2|NOT COMPLETED|Part B: Treatment Phase||3
8139693|NCT02712554|20064835|P1|NOT COMPLETED|Part B: Treatment Phase||0
8139694|NCT02712554|20064834|P2|COMPLETED|Part B: Treatment Phase||37
8139695|NCT02712554|20064835|P1|COMPLETED|Part B: Treatment Phase||0
8139696|NCT02712554|20064834|P2|STARTED|Part B: Treatment Phase||40
8139697|NCT02712554|20064835|P1|STARTED|Part B: Treatment Phase||0
8139698|NCT02712554|20064834|P2|NOT COMPLETED|Part B: Qualification Phase||21
8139699|NCT02712554|20064835|P1|NOT COMPLETED|Part B: Qualification Phase||0
8139700|NCT02712554|20064834|P2|COMPLETED|Part B: Qualification Phase||40
8139701|NCT02712554|20064835|P1|COMPLETED|Part B: Qualification Phase||0
8139702|NCT02712554|20064834|P2|STARTED|Part B: Qualification Phase||61
8139703|NCT02712554|20064835|P1|STARTED|Part B: Qualification Phase||0
8139704|NCT02712554|20064834|P2|NOT COMPLETED|Part A: Dose Selection Phase||0
8139705|NCT02712554|20064835|P1|NOT COMPLETED|Part A: Dose Selection Phase||0
8139706|NCT02712554|20064834|P2|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0
8139707|NCT02712554|20064835|P1|COMPLETED|Part A: Dose Selection Phase||12
8139708|NCT02712554|20064834|P2|STARTED|Part A: Dose Selection Phase||0
8139709|NCT02712554|20064835|P1|STARTED|Part A: Dose Selection Phase||12
8139710|NCT02712398|20064953|P1|NOT COMPLETED|Overall Study||37
8139711|NCT02712398|20064953|P1|COMPLETED|Overall Study||83
8139712|NCT02712398|20064953|P1|STARTED|Overall Study||120
8139713|NCT02712359|20064970|P4|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
8139714|NCT02712359|20064971|P3|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
8139715|NCT02712359|20064972|P2|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
8139716|NCT02712359|20064973|P1|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
8139717|NCT02712359|20064970|P4|COMPLETED|Epoch 002: Persistence at Year 10||300
8139718|NCT02712359|20064971|P3|COMPLETED|Epoch 002: Persistence at Year 10||299
8139719|NCT02712359|20064972|P2|COMPLETED|Epoch 002: Persistence at Year 10||0
8139720|NCT02712359|20064973|P1|COMPLETED|Epoch 002: Persistence at Year 10||0
8139721|NCT02712359|20064970|P4|STARTED|Epoch 002: Persistence at Year 10||300
8139723|NCT02712359|20064972|P2|STARTED|Epoch 002: Persistence at Year 10||0
8139724|NCT02712359|20064973|P1|STARTED|Epoch 002: Persistence at Year 10||0
8139725|NCT02712359|20064970|P4|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
8139726|NCT02712359|20064971|P3|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
8139727|NCT02712359|20064972|P2|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
8139728|NCT02712359|20064973|P1|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
8139729|NCT02712359|20064970|P4|COMPLETED|Epoch 001: Persistence at Year 8||0
8139730|NCT02712359|20064971|P3|COMPLETED|Epoch 001: Persistence at Year 8||0
8139731|NCT02712359|20064972|P2|COMPLETED|Epoch 001: Persistence at Year 8||300
8139732|NCT02712359|20064973|P1|COMPLETED|Epoch 001: Persistence at Year 8||300
8139733|NCT02712359|20064970|P4|STARTED|Epoch 001: Persistence at Year 8||0
8139734|NCT02712359|20064971|P3|STARTED|Epoch 001: Persistence at Year 8||0
8139735|NCT02712359|20064972|P2|STARTED|Epoch 001: Persistence at Year 8||300
8139736|NCT02712359|20064973|P1|STARTED|Epoch 001: Persistence at Year 8||300
8139737|NCT02712333|20064993|P2|NOT COMPLETED|Second Period||0
8139738|NCT02712333|20064994|P1|NOT COMPLETED|Second Period||0
8139739|NCT02712333|20064993|P2|COMPLETED|Second Period||24
8139740|NCT02712333|20064994|P1|COMPLETED|Second Period||31
8139741|NCT02712333|20064993|P2|STARTED|Second Period||24
8139742|NCT02712333|20064994|P1|STARTED|Second Period||31
8139743|NCT02712333|20064993|P2|NOT COMPLETED|First Period||2
8139744|NCT02712333|20064994|P1|NOT COMPLETED|First Period||3
8139745|NCT02712333|20064993|P2|COMPLETED|First Period||24
8139746|NCT02712333|20064994|P1|COMPLETED|First Period||31
8139747|NCT02712333|20064993|P2|STARTED|First Period||26
8139748|NCT02712333|20064994|P1|STARTED|First Period||34
8139749|NCT02712320|20065012|P1|NOT COMPLETED|Overall Study||5
8139750|NCT02712320|20065012|P1|COMPLETED|Overall Study||25
8139751|NCT02712320|20065012|P1|STARTED|Overall Study||30
8139752|NCT02712099|20065022|P2|NOT COMPLETED|Overall Study||0
8139753|NCT02712099|20065023|P1|NOT COMPLETED|Overall Study||0
8139754|NCT02712099|20065022|P2|COMPLETED|Overall Study||20
8139755|NCT02712099|20065023|P1|COMPLETED|Overall Study||30
8139756|NCT02712099|20065022|P2|STARTED|Overall Study||20
8139757|NCT02712099|20065023|P1|STARTED|Overall Study||30
8139758|NCT02712047|20065039|P2|NOT COMPLETED|Treatment Period 2 (35 Days)||0
8139759|NCT02712047|20065040|P1|NOT COMPLETED|Treatment Period 2 (35 Days)||0
8139760|NCT02712047|20065039|P2|COMPLETED|Treatment Period 2 (35 Days)||13
8139761|NCT02712047|20065040|P1|COMPLETED|Treatment Period 2 (35 Days)||14
8139762|NCT02712047|20065039|P2|STARTED|Treatment Period 2 (35 Days)||13
8139763|NCT02712047|20065040|P1|STARTED|Treatment Period 2 (35 Days)||14
8139764|NCT02712047|20065039|P2|NOT COMPLETED|Washout Period (21 Days)||0
8139765|NCT02712047|20065040|P1|NOT COMPLETED|Washout Period (21 Days)||0
8139766|NCT02712047|20065039|P2|COMPLETED|Washout Period (21 Days)||13
8139767|NCT02712047|20065040|P1|COMPLETED|Washout Period (21 Days)||14
8139768|NCT02712047|20065039|P2|STARTED|Washout Period (21 Days)||13
8139769|NCT02712047|20065040|P1|STARTED|Washout Period (21 Days)||14
8139770|NCT02712047|20065039|P2|NOT COMPLETED|Treatment Period 1 (35 Days)||0
8139771|NCT02712047|20065040|P1|NOT COMPLETED|Treatment Period 1 (35 Days)||0
8139772|NCT02712047|20065039|P2|COMPLETED|Treatment Period 1 (35 Days)||13
8139773|NCT02712047|20065040|P1|COMPLETED|Treatment Period 1 (35 Days)||14
8139774|NCT02712047|20065039|P2|STARTED|Treatment Period 1 (35 Days)||13
8139775|NCT02712047|20065040|P1|STARTED|Treatment Period 1 (35 Days)||14
8139776|NCT02712008|20065055|P8|NOT COMPLETED|From Week 12 up to Week 36||4
8139777|NCT02712008|20065056|P7|NOT COMPLETED|From Week 12 up to Week 36||5
8139778|NCT02712008|20065057|P6|NOT COMPLETED|From Week 12 up to Week 36||0
8139779|NCT02712008|20065058|P5|NOT COMPLETED|From Week 12 up to Week 36||2
8139780|NCT02712008|20065059|P4|NOT COMPLETED|From Week 12 up to Week 36||2
8139781|NCT02712008|20065060|P3|NOT COMPLETED|From Week 12 up to Week 36||0
8139782|NCT02712008|20065061|P2|NOT COMPLETED|From Week 12 up to Week 36||0
8139783|NCT02712008|20065062|P1|NOT COMPLETED|From Week 12 up to Week 36||1
8139784|NCT02712008|20065055|P8|COMPLETED|From Week 12 up to Week 36||45
8139785|NCT02712008|20065056|P7|COMPLETED|From Week 12 up to Week 36||43
8139786|NCT02712008|20065057|P6|COMPLETED|From Week 12 up to Week 36||46
8139787|NCT02712008|20065058|P5|COMPLETED|From Week 12 up to Week 36||50
8139788|NCT02712008|20065059|P4|COMPLETED|From Week 12 up to Week 36||42
8139789|NCT02712008|20065060|P3|COMPLETED|From Week 12 up to Week 36||0
8139790|NCT02712008|20065061|P2|COMPLETED|From Week 12 up to Week 36||0
8139791|NCT02712008|20065062|P1|COMPLETED|From Week 12 up to Week 36||44
8139792|NCT02712008|20065055|P8|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
8139793|NCT02712008|20065056|P7|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
8139794|NCT02712008|20065057|P6|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
8139795|NCT02712008|20065058|P5|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
8139796|NCT02712008|20065059|P4|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
8139797|NCT02712008|20065060|P3|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
8139798|NCT02712008|20065061|P2|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
8139799|NCT02712008|20065062|P1|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
8139800|NCT02712008|20065055|P8|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139801|NCT02712008|20065056|P7|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139802|NCT02712008|20065057|P6|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139803|NCT02712008|20065058|P5|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139804|NCT02712008|20065059|P4|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
8139805|NCT02712008|20065060|P3|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
8139806|NCT02712008|20065061|P2|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
8139807|NCT02712008|20065062|P1|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
8139808|NCT02712008|20065055|P8|COMPLETED|Baseline (Day 1) up to Week 12||0
8139809|NCT02712008|20065056|P7|COMPLETED|Baseline (Day 1) up to Week 12||0
8139810|NCT02712008|20065057|P6|COMPLETED|Baseline (Day 1) up to Week 12||0
8139811|NCT02712008|20065058|P5|COMPLETED|Baseline (Day 1) up to Week 12||0
8139812|NCT02712008|20065059|P4|COMPLETED|Baseline (Day 1) up to Week 12||0
8139813|NCT02712008|20065060|P3|COMPLETED|Baseline (Day 1) up to Week 12||148
8139814|NCT02712008|20065061|P2|COMPLETED|Baseline (Day 1) up to Week 12||97
8139815|NCT02712008|20065062|P1|COMPLETED|Baseline (Day 1) up to Week 12||46
8139816|NCT02712008|20065055|P8|STARTED|Baseline (Day 1) up to Week 12||0
8139817|NCT02712008|20065056|P7|STARTED|Baseline (Day 1) up to Week 12||0
8139818|NCT02712008|20065057|P6|STARTED|Baseline (Day 1) up to Week 12||0
8139819|NCT02712008|20065058|P5|STARTED|Baseline (Day 1) up to Week 12||0
8139820|NCT02712008|20065059|P4|STARTED|Baseline (Day 1) up to Week 12||0
8139821|NCT02712008|20065060|P3|STARTED|Baseline (Day 1) up to Week 12||152
8139822|NCT02712008|20065061|P2|STARTED|Baseline (Day 1) up to Week 12||100
8139823|NCT02712008|20065062|P1|STARTED|Baseline (Day 1) up to Week 12||50
8139824|NCT02711995|20065094|P1|NOT COMPLETED|Second Intervention (30 Days)||0
8139825|NCT02711995|20065094|P1|COMPLETED|Second Intervention (30 Days)||7
8139826|NCT02711995|20065094|P1|STARTED|Second Intervention (30 Days)||7
8139827|NCT02711995|20065094|P1|NOT COMPLETED|Washout (90 Days)||1
8139828|NCT02711995|20065094|P1|COMPLETED|Washout (90 Days)||7
8139829|NCT02711995|20065094|P1|STARTED|Washout (90 Days)||8
8139830|NCT02711995|20065094|P1|NOT COMPLETED|First Intervention (30 Days)||0
8139831|NCT02711995|20065094|P1|COMPLETED|First Intervention (30 Days)||8
8139832|NCT02711995|20065094|P1|STARTED|First Intervention (30 Days)||8
8139833|NCT02711839|20065118|P2|NOT COMPLETED|Overall Study||10
8139834|NCT02711839|20065119|P1|NOT COMPLETED|Overall Study||4
8139835|NCT02711839|20065118|P2|COMPLETED|Overall Study||24
8139836|NCT02711839|20065119|P1|COMPLETED|Overall Study||16
8139837|NCT02711839|20065118|P2|STARTED|Overall Study||34
8139838|NCT02711839|20065119|P1|STARTED|Overall Study||20
8139839|NCT02711800|20065133|P1|NOT COMPLETED|Overall Study||2
8139840|NCT02711800|20065133|P1|COMPLETED|Overall Study||7
8139841|NCT02711800|20065133|P1|STARTED|Overall Study||9
8139842|NCT02711345|20065152|P10|NOT COMPLETED|Overall Study||12
8139843|NCT02711345|20065153|P9|NOT COMPLETED|Overall Study||6
8139844|NCT02711345|20065154|P8|NOT COMPLETED|Overall Study||6
8139845|NCT02711345|20065155|P7|NOT COMPLETED|Overall Study||12
8139846|NCT02711345|20065156|P6|NOT COMPLETED|Overall Study||6
8139847|NCT02711345|20065157|P5|NOT COMPLETED|Overall Study||8
8139848|NCT02711345|20065158|P4|NOT COMPLETED|Overall Study||4
8139849|NCT02711345|20065159|P3|NOT COMPLETED|Overall Study||6
8139850|NCT02711345|20065160|P2|NOT COMPLETED|Overall Study||3
8139851|NCT02711345|20065161|P1|NOT COMPLETED|Overall Study||2
8139852|NCT02711345|20065152|P10|COMPLETED|Overall Study||0
8139853|NCT02711345|20065153|P9|COMPLETED|Overall Study||0
8139854|NCT02711345|20065154|P8|COMPLETED|Overall Study||0
8139855|NCT02711345|20065155|P7|COMPLETED|Overall Study||0
8139856|NCT02711345|20065156|P6|COMPLETED|Overall Study||0
8139857|NCT02711345|20065157|P5|COMPLETED|Overall Study||0
8139858|NCT02711345|20065158|P4|COMPLETED|Overall Study||0
8139859|NCT02711345|20065159|P3|COMPLETED|Overall Study||0
8139860|NCT02711345|20065160|P2|COMPLETED|Overall Study||0
8139861|NCT02711345|20065161|P1|COMPLETED|Overall Study||0
8139862|NCT02711345|20065152|P10|STARTED|Overall Study||12
8139863|NCT02711345|20065153|P9|STARTED|Overall Study||6
8139864|NCT02711345|20065154|P8|STARTED|Overall Study||6
8139865|NCT02711345|20065155|P7|STARTED|Overall Study||12
8139866|NCT02711345|20065156|P6|STARTED|Overall Study||6
8139867|NCT02711345|20065157|P5|STARTED|Overall Study||8
8139868|NCT02711345|20065158|P4|STARTED|Overall Study||4
8139869|NCT02711345|20065159|P3|STARTED|Overall Study||6
8139870|NCT02711345|20065160|P2|STARTED|Overall Study||3
8139871|NCT02711345|20065161|P1|STARTED|Overall Study||2
8139872|NCT02711306|20065347|P2|NOT COMPLETED|Overall Study||2
8139873|NCT02711306|20065348|P1|NOT COMPLETED|Overall Study||2
8139874|NCT02711306|20065347|P2|COMPLETED|Overall Study||16
8139875|NCT02711306|20065348|P1|COMPLETED|Overall Study||16
8139876|NCT02711306|20065347|P2|STARTED|Overall Study||18
8139877|NCT02711306|20065348|P1|STARTED|Overall Study||18
8139878|NCT02710981|20065360|P2|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||5
8139879|NCT02710981|20065361|P1|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
8139880|NCT02710981|20065360|P2|COMPLETED|7th Ovulation Induction Cycle (5 Days)||36
8139881|NCT02710981|20065361|P1|COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
8139882|NCT02710981|20065360|P2|STARTED|7th Ovulation Induction Cycle (5 Days)||41
8139883|NCT02710981|20065361|P1|STARTED|7th Ovulation Induction Cycle (5 Days)||0
8139884|NCT02710981|20065360|P2|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
8139885|NCT02710981|20065361|P1|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||1
8139886|NCT02710981|20065360|P2|COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
8139887|NCT02710981|20065361|P1|COMPLETED|6th Ovulation Induction Cycle (5 Days)||41
8139888|NCT02710981|20065360|P2|STARTED|6th Ovulation Induction Cycle (5 Days)||0
8139889|NCT02710981|20065361|P1|STARTED|6th Ovulation Induction Cycle (5 Days)||42
8139890|NCT02710890|20065373|P2|NOT COMPLETED|Overall Study||0
8139891|NCT02710890|20065374|P1|NOT COMPLETED|Overall Study||0
8139892|NCT02710890|20065373|P2|COMPLETED|Overall Study||55
8139893|NCT02710890|20065374|P1|COMPLETED|Overall Study||48
8139894|NCT02710890|20065373|P2|STARTED|Overall Study||55
8139895|NCT02710890|20065374|P1|STARTED|Overall Study||48
8139896|NCT02710630|20065387|P5|NOT COMPLETED|Period 6||0
8139897|NCT02710630|20065388|P4|NOT COMPLETED|Period 6||0
8139898|NCT02710630|20065389|P3|NOT COMPLETED|Period 6||0
8139899|NCT02710630|20065390|P2|NOT COMPLETED|Period 6||0
8139900|NCT02710630|20065391|P1|NOT COMPLETED|Period 6||0
8139901|NCT02710630|20065387|P5|COMPLETED|Period 6||7
8139902|NCT02710630|20065388|P4|COMPLETED|Period 6||7
8139903|NCT02710630|20065389|P3|COMPLETED|Period 6||7
8139904|NCT02710630|20065390|P2|COMPLETED|Period 6||7
8139905|NCT02710630|20065391|P1|COMPLETED|Period 6||7
8139906|NCT02710630|20065387|P5|STARTED|Period 6||7
8139907|NCT02710630|20065388|P4|STARTED|Period 6||7
8139908|NCT02710630|20065389|P3|STARTED|Period 6||7
8139909|NCT02710630|20065390|P2|STARTED|Period 6||7
8139910|NCT02710630|20065391|P1|STARTED|Period 6||7
8139911|NCT02710630|20065387|P5|NOT COMPLETED|Period 5||0
8139912|NCT02710630|20065388|P4|NOT COMPLETED|Period 5||0
8139913|NCT02710630|20065389|P3|NOT COMPLETED|Period 5||0
8139914|NCT02710630|20065390|P2|NOT COMPLETED|Period 5||0
8139915|NCT02710630|20065391|P1|NOT COMPLETED|Period 5||0
8139916|NCT02710630|20065387|P5|COMPLETED|Period 5||7
8139917|NCT02710630|20065388|P4|COMPLETED|Period 5||7
8139918|NCT02710630|20065389|P3|COMPLETED|Period 5||7
8139919|NCT02710630|20065390|P2|COMPLETED|Period 5||7
8139920|NCT02710630|20065391|P1|COMPLETED|Period 5||7
8139921|NCT02710630|20065387|P5|STARTED|Period 5||7
8139922|NCT02710630|20065388|P4|STARTED|Period 5||7
8139923|NCT02710630|20065389|P3|STARTED|Period 5||7
8139924|NCT02710630|20065390|P2|STARTED|Period 5||7
8139925|NCT02710630|20065391|P1|STARTED|Period 5||7
8139926|NCT02710630|20065387|P5|NOT COMPLETED|Period 4||0
8139927|NCT02710630|20065388|P4|NOT COMPLETED|Period 4||0
8139928|NCT02710630|20065389|P3|NOT COMPLETED|Period 4||0
8139929|NCT02710630|20065390|P2|NOT COMPLETED|Period 4||0
8139930|NCT02710630|20065391|P1|NOT COMPLETED|Period 4||0
8139931|NCT02710630|20065387|P5|COMPLETED|Period 4||7
8139932|NCT02710630|20065388|P4|COMPLETED|Period 4||7
8139933|NCT02710630|20065389|P3|COMPLETED|Period 4||7
8139934|NCT02710630|20065390|P2|COMPLETED|Period 4||7
8139935|NCT02710630|20065391|P1|COMPLETED|Period 4||7
8139936|NCT02710630|20065387|P5|STARTED|Period 4||7
8139937|NCT02710630|20065388|P4|STARTED|Period 4||7
8139938|NCT02710630|20065389|P3|STARTED|Period 4||7
8139939|NCT02710630|20065390|P2|STARTED|Period 4||7
8139940|NCT02710630|20065391|P1|STARTED|Period 4||7
8139941|NCT02710630|20065387|P5|NOT COMPLETED|Period 3||0
8139942|NCT02710630|20065388|P4|NOT COMPLETED|Period 3||0
8139943|NCT02710630|20065389|P3|NOT COMPLETED|Period 3||0
8139944|NCT02710630|20065390|P2|NOT COMPLETED|Period 3||0
8139945|NCT02710630|20065391|P1|NOT COMPLETED|Period 3||0
8139946|NCT02710630|20065387|P5|COMPLETED|Period 3||7
8139947|NCT02710630|20065388|P4|COMPLETED|Period 3||7
8139948|NCT02710630|20065389|P3|COMPLETED|Period 3||7
8139949|NCT02710630|20065390|P2|COMPLETED|Period 3||7
8139950|NCT02710630|20065391|P1|COMPLETED|Period 3||7
8139951|NCT02710630|20065387|P5|STARTED|Period 3||7
8139952|NCT02710630|20065388|P4|STARTED|Period 3||7
8139953|NCT02710630|20065389|P3|STARTED|Period 3||7
8139954|NCT02710630|20065390|P2|STARTED|Period 3||7
8139955|NCT02710630|20065391|P1|STARTED|Period 3||7
8139956|NCT02710630|20065387|P5|NOT COMPLETED|Period 2||0
8139957|NCT02710630|20065388|P4|NOT COMPLETED|Period 2||0
8139958|NCT02710630|20065389|P3|NOT COMPLETED|Period 2||0
8139959|NCT02710630|20065390|P2|NOT COMPLETED|Period 2||0
8139960|NCT02710630|20065391|P1|NOT COMPLETED|Period 2||0
8139961|NCT02710630|20065387|P5|COMPLETED|Period 2||7
8139962|NCT02710630|20065388|P4|COMPLETED|Period 2||7
8139963|NCT02710630|20065389|P3|COMPLETED|Period 2||7
8139964|NCT02710630|20065390|P2|COMPLETED|Period 2||7
8139965|NCT02710630|20065391|P1|COMPLETED|Period 2||7
8139966|NCT02710630|20065387|P5|Not Treated|Period 2||0
8139967|NCT02710630|20065388|P4|Not Treated|Period 2||0
8139968|NCT02710630|20065389|P3|Not Treated|Period 2||0
8139969|NCT02710630|20065390|P2|Not Treated|Period 2||0
8139970|NCT02710630|20065391|P1|Not Treated|Period 2||1
8139971|NCT02710630|20065387|P5|STARTED|Period 2||7
8139972|NCT02710630|20065388|P4|STARTED|Period 2||7
8139973|NCT02710630|20065389|P3|STARTED|Period 2||7
8139974|NCT02710630|20065390|P2|STARTED|Period 2||7
8139975|NCT02710630|20065391|P1|STARTED|Period 2||7
8139976|NCT02710630|20065387|P5|NOT COMPLETED|Period 1||0
8139977|NCT02710630|20065388|P4|NOT COMPLETED|Period 1||0
8139978|NCT02710630|20065389|P3|NOT COMPLETED|Period 1||0
8139979|NCT02710630|20065390|P2|NOT COMPLETED|Period 1||0
8139980|NCT02710630|20065391|P1|NOT COMPLETED|Period 1||0
8139981|NCT02710630|20065387|P5|COMPLETED|Period 1||7
8139982|NCT02710630|20065388|P4|COMPLETED|Period 1||7
8139983|NCT02710630|20065389|P3|COMPLETED|Period 1||7
8139984|NCT02710630|20065390|P2|COMPLETED|Period 1||7
8139985|NCT02710630|20065391|P1|COMPLETED|Period 1||7
8139986|NCT02710630|20065387|P5|STARTED|Period 1||7
8139987|NCT02710630|20065388|P4|STARTED|Period 1||7
8139988|NCT02710630|20065389|P3|STARTED|Period 1||7
8139989|NCT02710630|20065390|P2|STARTED|Period 1||7
8139990|NCT02710630|20065391|P1|STARTED|Period 1||7
8139991|NCT02710591|20065439|P4|NOT COMPLETED|Overall Study||0
8139992|NCT02710591|20065440|P3|NOT COMPLETED|Overall Study||0
8139993|NCT02710591|20065441|P2|NOT COMPLETED|Overall Study||0
8139994|NCT02710591|20065442|P1|NOT COMPLETED|Overall Study||0
8139995|NCT02710591|20065439|P4|COMPLETED|Overall Study||5
8139996|NCT02710591|20065440|P3|COMPLETED|Overall Study||5
8139997|NCT02710591|20065441|P2|COMPLETED|Overall Study||5
8139998|NCT02710591|20065442|P1|COMPLETED|Overall Study||5
8139999|NCT02710591|20065439|P4|STARTED|Overall Study||5
8140000|NCT02710591|20065440|P3|STARTED|Overall Study||5
8140001|NCT02710591|20065441|P2|STARTED|Overall Study||5
8140002|NCT02710591|20065442|P1|STARTED|Overall Study||5
8140003|NCT02710526|20065459|P3|NOT COMPLETED|Safety Extension||0
8140004|NCT02710526|20065460|P2|NOT COMPLETED|Safety Extension||0
8140005|NCT02710526|20065461|P1|NOT COMPLETED|Safety Extension||1
8140006|NCT02710526|20065459|P3|COMPLETED|Safety Extension||0
8140007|NCT02710526|20065460|P2|COMPLETED|Safety Extension||12
8140008|NCT02710526|20065461|P1|COMPLETED|Safety Extension||14
8140009|NCT02710526|20065459|P3|STARTED|Safety Extension||0
8140010|NCT02710526|20065460|P2|STARTED|Safety Extension||12
8140011|NCT02710526|20065461|P1|STARTED|Safety Extension||15
8140012|NCT02710526|20065459|P3|NOT COMPLETED|Treatment Phase||6
8140013|NCT02710526|20065460|P2|NOT COMPLETED|Treatment Phase||4
8140014|NCT02710526|20065461|P1|NOT COMPLETED|Treatment Phase||6
8140015|NCT02710526|20065459|P3|COMPLETED|Treatment Phase||12
8140016|NCT02710526|20065460|P2|COMPLETED|Treatment Phase||16
8140017|NCT02710526|20065461|P1|COMPLETED|Treatment Phase||22
8140018|NCT02710526|20065459|P3|STARTED|Treatment Phase||18
8140019|NCT02710526|20065460|P2|STARTED|Treatment Phase||20
8140020|NCT02710526|20065461|P1|STARTED|Treatment Phase||28
8140021|NCT02710422|20065541|P2|NOT COMPLETED|Overall Study||9
8140022|NCT02710422|20065542|P1|NOT COMPLETED|Overall Study||9
8140023|NCT02710422|20065541|P2|COMPLETED|Overall Study||3
8140024|NCT02710422|20065542|P1|COMPLETED|Overall Study||3
8140025|NCT02710422|20065541|P2|12 Month Visit|Overall Study||3
8140026|NCT02710422|20065542|P1|12 Month Visit|Overall Study||3
8140027|NCT02710422|20065541|P2|9 Month Visit|Overall Study||5
8140028|NCT02710422|20065542|P1|9 Month Visit|Overall Study||5
8140029|NCT02710422|20065541|P2|6 Month Visit|Overall Study||8
8140030|NCT02710422|20065542|P1|6 Month Visit|Overall Study||7
8140031|NCT02710422|20065541|P2|3 Month Visit|Overall Study||11
8140032|NCT02710422|20065542|P1|3 Month Visit|Overall Study||9
8140033|NCT02710422|20065541|P2|STARTED|Overall Study||12
8140034|NCT02710422|20065542|P1|STARTED|Overall Study||12
8140035|NCT02710292|20065558|P2|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
8140036|NCT02710292|20065559|P1|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
8140037|NCT02710292|20065558|P2|COMPLETED|Period 2, Second 10 Days of Wear||49
8140038|NCT02710292|20065559|P1|COMPLETED|Period 2, Second 10 Days of Wear||46
8140039|NCT02710292|20065558|P2|STARTED|Period 2, Second 10 Days of Wear||49
8140040|NCT02710292|20065559|P1|STARTED|Period 2, Second 10 Days of Wear||46
8140041|NCT02710292|20065558|P2|NOT COMPLETED|Period 1, First 10 Days of Wear||3
8140042|NCT02710292|20065559|P1|NOT COMPLETED|Period 1, First 10 Days of Wear||1
8140043|NCT02710292|20065558|P2|COMPLETED|Period 1, First 10 Days of Wear||49
8140044|NCT02710292|20065559|P1|COMPLETED|Period 1, First 10 Days of Wear||46
8140045|NCT02710292|20065558|P2|STARTED|Period 1, First 10 Days of Wear||52
8140046|NCT02710292|20065559|P1|STARTED|Period 1, First 10 Days of Wear||47
8140047|NCT02710214|20065568|P2|NOT COMPLETED|Overall Study||2
8140048|NCT02710214|20065569|P1|NOT COMPLETED|Overall Study||1
8140049|NCT02710214|20065568|P2|COMPLETED|Overall Study||10
8140050|NCT02710214|20065569|P1|COMPLETED|Overall Study||11
8140051|NCT02710214|20065568|P2|STARTED|Overall Study||12
8140052|NCT02710214|20065569|P1|STARTED|Overall Study||12
8140053|NCT02710136|20065603|P2|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
8140054|NCT02710136|20065604|P1|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
8140055|NCT02710136|20065603|P2|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
8140056|NCT02710136|20065604|P1|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
8140057|NCT02710136|20065603|P2|STARTED|Phase 2 [Refer to Arm/Group Description]||25
8140058|NCT02710136|20065604|P1|STARTED|Phase 2 [Refer to Arm/Group Description]||0
8140059|NCT02710136|20065603|P2|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
8140060|NCT02710136|20065604|P1|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
8140061|NCT02710136|20065603|P2|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
8140062|NCT02710136|20065604|P1|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
8140063|NCT02710136|20065603|P2|STARTED|Phase 1b[Refer to Arm/Group Description]||0
8140064|NCT02710136|20065604|P1|STARTED|Phase 1b[Refer to Arm/Group Description]||4
8140065|NCT02710136|20065603|P2|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
8140066|NCT02710136|20065604|P1|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
8140067|NCT02710136|20065603|P2|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
8140068|NCT02710136|20065604|P1|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
8140069|NCT02710136|20065603|P2|STARTED|Phase 1a[Refer to Arm/Group Description]||0
8140070|NCT02710136|20065604|P1|STARTED|Phase 1a[Refer to Arm/Group Description]||10
8140071|NCT02710136|20065603|P2|NOT COMPLETED|Study Enrollment||0
8140072|NCT02710136|20065604|P1|NOT COMPLETED|Study Enrollment||0
8140073|NCT02710136|20065603|P2|COMPLETED|Study Enrollment||25
8140074|NCT02710136|20065604|P1|COMPLETED|Study Enrollment||10
8140075|NCT02710136|20065603|P2|STARTED|Study Enrollment||25
8140076|NCT02710136|20065604|P1|STARTED|Study Enrollment||10
8140077|NCT02710071|20065629|P2|NOT COMPLETED|Second Intervention (6 Weeks).||2
8140078|NCT02710071|20065630|P1|NOT COMPLETED|Second Intervention (6 Weeks).||1
8140079|NCT02710071|20065629|P2|COMPLETED|Second Intervention (6 Weeks).||14
8140080|NCT02710071|20065630|P1|COMPLETED|Second Intervention (6 Weeks).||17
8140081|NCT02710071|20065629|P2|STARTED|Second Intervention (6 Weeks).||16
8140082|NCT02710071|20065630|P1|STARTED|Second Intervention (6 Weeks).||18
8140083|NCT02710071|20065629|P2|NOT COMPLETED|First Intervention (6 Weeks).||4
8140084|NCT02710071|20065630|P1|NOT COMPLETED|First Intervention (6 Weeks).||3
8140085|NCT02710071|20065629|P2|COMPLETED|First Intervention (6 Weeks).||16
8140086|NCT02710071|20065630|P1|COMPLETED|First Intervention (6 Weeks).||18
8140087|NCT02710071|20065629|P2|STARTED|First Intervention (6 Weeks).||20
8140088|NCT02710071|20065630|P1|STARTED|First Intervention (6 Weeks).||21
8140089|NCT02710071|20065629|P2|NOT COMPLETED|Placebo (2 Weeks).||0
8140090|NCT02710071|20065630|P1|NOT COMPLETED|Placebo (2 Weeks).||0
8140091|NCT02710071|20065629|P2|COMPLETED|Placebo (2 Weeks).||20
8140092|NCT02710071|20065630|P1|COMPLETED|Placebo (2 Weeks).||21
8140093|NCT02710071|20065629|P2|STARTED|Placebo (2 Weeks).||20
8140094|NCT02710071|20065630|P1|STARTED|Placebo (2 Weeks).||21
8140095|NCT02710045|20065640|P3|NOT COMPLETED|Overall Study||13
8140096|NCT02710045|20065641|P2|NOT COMPLETED|Overall Study||17
8140097|NCT02710045|20065642|P1|NOT COMPLETED|Overall Study||11
8140098|NCT02710045|20065640|P3|COMPLETED|Overall Study||68
8140099|NCT02710045|20065641|P2|COMPLETED|Overall Study||98
8140100|NCT02710045|20065642|P1|COMPLETED|Overall Study||95
8140101|NCT02710045|20065640|P3|STARTED|Overall Study||81
8140102|NCT02710045|20065641|P2|STARTED|Overall Study||115
8140103|NCT02710045|20065642|P1|STARTED|Overall Study||106
8140104|NCT02709889|20065676|P4|NOT COMPLETED|Overall Study||88
8140105|NCT02709889|20065677|P3|NOT COMPLETED|Overall Study||12
8140106|NCT02709889|20065678|P2|NOT COMPLETED|Overall Study||57
8140107|NCT02709889|20065679|P1|NOT COMPLETED|Overall Study||43
8140108|NCT02709889|20065676|P4|COMPLETED|Overall Study||0
8140109|NCT02709889|20065677|P3|COMPLETED|Overall Study||0
8140110|NCT02709889|20065678|P2|COMPLETED|Overall Study||0
8140111|NCT02709889|20065679|P1|COMPLETED|Overall Study||0
8140112|NCT02709889|20065676|P4|Other Solid Tumors|Overall Study||15
8140113|NCT02709889|20065677|P3|Other Solid Tumors|Overall Study||3
8140114|NCT02709889|20065678|P2|Other Solid Tumors|Overall Study||16
8140115|NCT02709889|20065679|P1|Other Solid Tumors|Overall Study||9
8140116|NCT02709889|20065676|P4|Glioblastoma|Overall Study||14
8140117|NCT02709889|20065677|P3|Glioblastoma|Overall Study||1
8140118|NCT02709889|20065678|P2|Glioblastoma|Overall Study||4
8140119|NCT02709889|20065679|P1|Glioblastoma|Overall Study||4
8140120|NCT02709889|20065676|P4|Medullary Thyroid Cancer|Overall Study||7
8140121|NCT02709889|20065677|P3|Medullary Thyroid Cancer|Overall Study||0
8140122|NCT02709889|20065678|P2|Medullary Thyroid Cancer|Overall Study||3
8140123|NCT02709889|20065679|P1|Medullary Thyroid Cancer|Overall Study||3
8140124|NCT02709889|20065676|P4|Malignant Melanoma|Overall Study||11
8140125|NCT02709889|20065677|P3|Malignant Melanoma|Overall Study||0
8140126|NCT02709889|20065678|P2|Malignant Melanoma|Overall Study||6
8140127|NCT02709889|20065679|P1|Malignant Melanoma|Overall Study||3
8140128|NCT02709889|20065676|P4|Other NEC|Overall Study||7
8140129|NCT02709889|20065677|P3|Other NEC|Overall Study||1
8140130|NCT02709889|20065678|P2|Other NEC|Overall Study||12
8140131|NCT02709889|20065679|P1|Other NEC|Overall Study||11
8140132|NCT02709889|20065676|P4|Gastroenteropancreatic NEC|Overall Study||23
8140133|NCT02709889|20065677|P3|Gastroenteropancreatic NEC|Overall Study||2
8140134|NCT02709889|20065678|P2|Gastroenteropancreatic NEC|Overall Study||5
8140135|NCT02709889|20065679|P1|Gastroenteropancreatic NEC|Overall Study||6
8140136|NCT02709889|20065676|P4|Neuroendocrine Prostate Cancer|Overall Study||7
8140137|NCT02709889|20065677|P3|Neuroendocrine Prostate Cancer|Overall Study||3
8140138|NCT02709889|20065678|P2|Neuroendocrine Prostate Cancer|Overall Study||7
8140139|NCT02709889|20065679|P1|Neuroendocrine Prostate Cancer|Overall Study||4
8140140|NCT02709889|20065676|P4|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
8140141|NCT02709889|20065677|P3|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||2
8140142|NCT02709889|20065678|P2|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
8140143|NCT02709889|20065679|P1|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||3
8140144|NCT02709889|20065676|P4|STARTED|Overall Study||88
8140145|NCT02709889|20065677|P3|STARTED|Overall Study||12
8140146|NCT02709889|20065678|P2|STARTED|Overall Study||57
8140147|NCT02709889|20065679|P1|STARTED|Overall Study||43
8140148|NCT02709785|20065760|P3|NOT COMPLETED|Overall Study||1
8140149|NCT02709785|20065761|P2|NOT COMPLETED|Overall Study||2
8140150|NCT02709785|20065762|P1|NOT COMPLETED|Overall Study||1
8140151|NCT02709785|20065760|P3|COMPLETED|Overall Study||27
8140152|NCT02709785|20065761|P2|COMPLETED|Overall Study||26
8140153|NCT02709785|20065762|P1|COMPLETED|Overall Study||23
8140154|NCT02709785|20065760|P3|6 Weeks|Overall Study||27
8140155|NCT02709785|20065761|P2|6 Weeks|Overall Study||26
8140156|NCT02709785|20065762|P1|6 Weeks|Overall Study||23
8140157|NCT02709785|20065760|P3|3 Weeks|Overall Study||27
8140158|NCT02709785|20065761|P2|3 Weeks|Overall Study||27
8140159|NCT02709785|20065762|P1|3 Weeks|Overall Study||23
8140160|NCT02709785|20065760|P3|STARTED|Overall Study||28
8140161|NCT02709785|20065761|P2|STARTED|Overall Study||28
8140162|NCT02709785|20065762|P1|STARTED|Overall Study||24
8140163|NCT02709746|20065787|P5|NOT COMPLETED|Phase B (Double-blind Treatment Period)||16
8140164|NCT02709746|20065788|P4|NOT COMPLETED|Phase B (Double-blind Treatment Period)||15
8140165|NCT02709746|20065789|P3|NOT COMPLETED|Phase B (Double-blind Treatment Period)||22
8140166|NCT02709746|20065790|P2|NOT COMPLETED|Phase B (Double-blind Treatment Period)||21
8140167|NCT02709746|20065791|P1|NOT COMPLETED|Phase B (Double-blind Treatment Period)||0
8140168|NCT02709746|20065787|P5|COMPLETED|Phase B (Double-blind Treatment Period)||138
8140169|NCT02709746|20065788|P4|COMPLETED|Phase B (Double-blind Treatment Period)||138
8140170|NCT02709746|20065789|P3|COMPLETED|Phase B (Double-blind Treatment Period)||140
8140171|NCT02709746|20065790|P2|COMPLETED|Phase B (Double-blind Treatment Period)||126
8140172|NCT02709746|20065791|P1|COMPLETED|Phase B (Double-blind Treatment Period)||0
8140173|NCT02709746|20065787|P5|STARTED|Phase B (Double-blind Treatment Period)||154
8140174|NCT02709746|20065788|P4|STARTED|Phase B (Double-blind Treatment Period)||153
8140175|NCT02709746|20065789|P3|STARTED|Phase B (Double-blind Treatment Period)||162
8140176|NCT02709746|20065790|P2|STARTED|Phase B (Double-blind Treatment Period)||147
8140177|NCT02709746|20065791|P1|STARTED|Phase B (Double-blind Treatment Period)||0
8140178|NCT02709746|20065787|P5|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
8140179|NCT02709746|20065788|P4|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
8140180|NCT02709746|20065789|P3|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
8140181|NCT02709746|20065790|P2|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
8140182|NCT02709746|20065791|P1|NOT COMPLETED|Phase A (Single-blind Treatment Period)||168
8140183|NCT02709746|20065787|P5|COMPLETED|Phase A (Single-blind Treatment Period)||0
8140184|NCT02709746|20065788|P4|COMPLETED|Phase A (Single-blind Treatment Period)||0
8140185|NCT02709746|20065789|P3|COMPLETED|Phase A (Single-blind Treatment Period)||0
8140186|NCT02709746|20065790|P2|COMPLETED|Phase A (Single-blind Treatment Period)||0
8140187|NCT02709746|20065791|P1|COMPLETED|Phase A (Single-blind Treatment Period)||616
8140188|NCT02709746|20065787|P5|STARTED|Phase A (Single-blind Treatment Period)||0
8140189|NCT02709746|20065788|P4|STARTED|Phase A (Single-blind Treatment Period)||0
8140190|NCT02709746|20065789|P3|STARTED|Phase A (Single-blind Treatment Period)||0
8140191|NCT02709746|20065790|P2|STARTED|Phase A (Single-blind Treatment Period)||0
8140192|NCT02709746|20065791|P1|STARTED|Phase A (Single-blind Treatment Period)||784
8140193|NCT02709577|20065913|P4|NOT COMPLETED|Overall Study||0
8140194|NCT02709577|20065914|P3|NOT COMPLETED|Overall Study||2
8140195|NCT02709577|20065915|P2|NOT COMPLETED|Overall Study||5
8140196|NCT02709577|20065916|P1|NOT COMPLETED|Overall Study||2
8140197|NCT02709577|20065913|P4|COMPLETED|Overall Study||5
8140198|NCT02709577|20065914|P3|COMPLETED|Overall Study||4
8140199|NCT02709577|20065915|P2|COMPLETED|Overall Study||8
8140200|NCT02709577|20065916|P1|COMPLETED|Overall Study||10
8140201|NCT02709577|20065913|P4|STARTED|Overall Study||5
8140202|NCT02709577|20065914|P3|STARTED|Overall Study||6
8140203|NCT02709577|20065915|P2|STARTED|Overall Study||13
8140204|NCT02709577|20065916|P1|STARTED|Overall Study||12
8140205|NCT02709538|20065931|P3|NOT COMPLETED|Overall Study||20
8140206|NCT02709538|20065932|P2|NOT COMPLETED|Overall Study||28
8140207|NCT02709538|20065933|P1|NOT COMPLETED|Overall Study||113
8140208|NCT02709538|20065931|P3|COMPLETED|Overall Study||81
8140209|NCT02709538|20065932|P2|COMPLETED|Overall Study||72
8140210|NCT02709538|20065933|P1|COMPLETED|Overall Study||287
8140211|NCT02709538|20065931|P3|STARTED|Overall Study||101
8140212|NCT02709538|20065932|P2|STARTED|Overall Study||100
8140213|NCT02709538|20065933|P1|STARTED|Overall Study||400
8140214|NCT02709486|20065944|P3|NOT COMPLETED|Overall Study||45
8140215|NCT02709486|20065945|P2|NOT COMPLETED|Overall Study||34
8140216|NCT02709486|20065946|P1|NOT COMPLETED|Overall Study||44
8140217|NCT02709486|20065944|P3|COMPLETED|Overall Study||239
8140218|NCT02709486|20065945|P2|COMPLETED|Overall Study||249
8140219|NCT02709486|20065946|P1|COMPLETED|Overall Study||238
8140220|NCT02709486|20065944|P3|STARTED|Overall Study||284
8140221|NCT02709486|20065945|P2|STARTED|Overall Study||283
8140222|NCT02709486|20065946|P1|STARTED|Overall Study||282
8140223|NCT02709369|20066137|P1|NOT COMPLETED|Overall Study||27
8140224|NCT02709369|20066137|P1|COMPLETED|Overall Study||273
8140225|NCT02709369|20066137|P1|STARTED|Overall Study||300
8140226|NCT02709330|20066171|P2|NOT COMPLETED|Overall Study||0
8140227|NCT02709330|20066172|P1|NOT COMPLETED|Overall Study||13
8140228|NCT02709330|20066171|P2|COMPLETED|Overall Study||10
8140229|NCT02709330|20066172|P1|COMPLETED|Overall Study||37
8140230|NCT02709330|20066171|P2|STARTED|Overall Study||10
8140231|NCT02709330|20066172|P1|STARTED|Overall Study||50
8140232|NCT02709096|20066186|P2|NOT COMPLETED|Overall Study||1
8140233|NCT02709096|20066187|P1|NOT COMPLETED|Overall Study||1
8140234|NCT02709096|20066186|P2|COMPLETED|Overall Study||10
8140235|NCT02709096|20066187|P1|COMPLETED|Overall Study||21
8140236|NCT02709096|20066186|P2|STARTED|Overall Study||11
8140237|NCT02709096|20066187|P1|STARTED|Overall Study||22
8140238|NCT02709083|20066193|P1|NOT COMPLETED|Overall Study||7
8140239|NCT02709083|20066193|P1|COMPLETED|Overall Study||0
8140240|NCT02709083|20066193|P1|STARTED|Overall Study||7
8140241|NCT02709005|20066206|P2|NOT COMPLETED|Overall Study||1
8140242|NCT02709005|20066207|P1|NOT COMPLETED|Overall Study||4
8140243|NCT02709005|20066206|P2|COMPLETED|Overall Study||35
8140244|NCT02709005|20066207|P1|COMPLETED|Overall Study||69
8140245|NCT02709005|20066206|P2|STARTED|Overall Study||36
8140246|NCT02709005|20066207|P1|STARTED|Overall Study||73
8140253|NCT02708862|20066280|P1|NOT COMPLETED|Overall Study||0
8140254|NCT02708862|20066280|P1|COMPLETED|Overall Study||26
8140255|NCT02708862|20066280|P1|STARTED|Overall Study||26
8140256|NCT02708849|20066289|P2|NOT COMPLETED|Overall Study||0
8140257|NCT02708849|20066290|P1|NOT COMPLETED|Overall Study||1
8140258|NCT02708849|20066289|P2|COMPLETED|Overall Study||1
8140259|NCT02708849|20066290|P1|COMPLETED|Overall Study||1
8140260|NCT02708849|20066289|P2|STARTED|Overall Study||1
8140261|NCT02708849|20066290|P1|STARTED|Overall Study||2
8140262|NCT02708745|20066302|P4|NOT COMPLETED|Overall Study||82
8140263|NCT02708745|20066303|P3|NOT COMPLETED|Overall Study||83
8140264|NCT02708745|20066304|P2|NOT COMPLETED|Overall Study||4
8140265|NCT02708745|20066305|P1|NOT COMPLETED|Overall Study||0
8140266|NCT02708745|20066302|P4|COMPLETED|Overall Study||116
8140267|NCT02708745|20066303|P3|COMPLETED|Overall Study||121
8140268|NCT02708745|20066304|P2|COMPLETED|Overall Study||65
8140269|NCT02708745|20066305|P1|COMPLETED|Overall Study||91
8140270|NCT02708745|20066302|P4|STARTED|Overall Study||198
8140271|NCT02708745|20066303|P3|STARTED|Overall Study||204
8140272|NCT02708745|20066304|P2|STARTED|Overall Study||69
8140273|NCT02708745|20066305|P1|STARTED|Overall Study||91
8140274|NCT02708524|20066321|P4|NOT COMPLETED|Overall Study||0
8140275|NCT02708524|20066322|P3|NOT COMPLETED|Overall Study||3
8140276|NCT02708524|20066323|P2|NOT COMPLETED|Overall Study||6
8140277|NCT02708524|20066324|P1|NOT COMPLETED|Overall Study||4
8140278|NCT02708524|20066321|P4|COMPLETED|Overall Study||136
8140279|NCT02708524|20066322|P3|COMPLETED|Overall Study||134
8140280|NCT02708524|20066323|P2|COMPLETED|Overall Study||130
8140281|NCT02708524|20066324|P1|COMPLETED|Overall Study||135
8140282|NCT02708524|20066321|P4|STARTED|Overall Study||136
8140283|NCT02708524|20066322|P3|STARTED|Overall Study||137
8140284|NCT02708524|20066323|P2|STARTED|Overall Study||136
8140285|NCT02708524|20066324|P1|STARTED|Overall Study||139
8140286|NCT02708498|20066378|P8|NOT COMPLETED|Overall Study||0
8140287|NCT02708498|20066379|P7|NOT COMPLETED|Overall Study||0
8140288|NCT02708498|20066380|P6|NOT COMPLETED|Overall Study||132
8140289|NCT02708498|20066381|P5|NOT COMPLETED|Overall Study||196
8140290|NCT02708498|20066382|P4|NOT COMPLETED|Overall Study||51
8140291|NCT02708498|20066383|P3|NOT COMPLETED|Overall Study||62
8140292|NCT02708498|20066384|P2|NOT COMPLETED|Overall Study||19
8140293|NCT02708498|20066385|P1|NOT COMPLETED|Overall Study||20
8140294|NCT02708498|20066378|P8|COMPLETED|Overall Study||48
8140295|NCT02708498|20066379|P7|COMPLETED|Overall Study||20
8140296|NCT02708498|20066380|P6|COMPLETED|Overall Study||198
8140297|NCT02708498|20066381|P5|COMPLETED|Overall Study||167
8140298|NCT02708498|20066382|P4|COMPLETED|Overall Study||105
8140299|NCT02708498|20066383|P3|COMPLETED|Overall Study||90
8140300|NCT02708498|20066384|P2|COMPLETED|Overall Study||21
8140301|NCT02708498|20066385|P1|COMPLETED|Overall Study||22
8140302|NCT02708498|20066378|P8|STARTED|Overall Study||48
8140303|NCT02708498|20066379|P7|STARTED|Overall Study||20
8140304|NCT02708498|20066380|P6|STARTED|Overall Study||330
8140305|NCT02708498|20066381|P5|STARTED|Overall Study||363
8140306|NCT02708498|20066382|P4|STARTED|Overall Study||156
8140307|NCT02708498|20066383|P3|STARTED|Overall Study||152
8140308|NCT02708498|20066384|P2|STARTED|Overall Study||40
8140309|NCT02708498|20066385|P1|STARTED|Overall Study||42
8140310|NCT02708485|20066413|P2|NOT COMPLETED|Overall Study||2
8140311|NCT02708485|20066414|P1|NOT COMPLETED|Overall Study||3
8140312|NCT02708485|20066413|P2|COMPLETED|Overall Study||10
8140313|NCT02708485|20066414|P1|COMPLETED|Overall Study||0
8140314|NCT02708485|20066413|P2|STARTED|Overall Study||12
8140315|NCT02708485|20066414|P1|STARTED|Overall Study||3
8140316|NCT02708433|20066422|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
8140317|NCT02708433|20066423|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
8140318|NCT02708433|20066422|P2|COMPLETED|Second Intervention (Visit 2)||11
8140319|NCT02708433|20066423|P1|COMPLETED|Second Intervention (Visit 2)||12
8140320|NCT02708433|20066422|P2|STARTED|Second Intervention (Visit 2)||11
8140321|NCT02708433|20066423|P1|STARTED|Second Intervention (Visit 2)||12
8140322|NCT02708433|20066422|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
8140323|NCT02708433|20066423|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
8140324|NCT02708433|20066422|P2|COMPLETED|Washout (at Least 1 Week)||11
8140325|NCT02708433|20066423|P1|COMPLETED|Washout (at Least 1 Week)||12
8140326|NCT02708433|20066422|P2|STARTED|Washout (at Least 1 Week)||11
8140327|NCT02708433|20066423|P1|STARTED|Washout (at Least 1 Week)||12
8140328|NCT02708433|20066422|P2|NOT COMPLETED|First Intervention (Visit 1)||0
8140329|NCT02708433|20066423|P1|NOT COMPLETED|First Intervention (Visit 1)||0
8140330|NCT02708433|20066422|P2|COMPLETED|First Intervention (Visit 1)||11
8140331|NCT02708433|20066423|P1|COMPLETED|First Intervention (Visit 1)||12
8140332|NCT02708433|20066422|P2|STARTED|First Intervention (Visit 1)||11
8140333|NCT02708433|20066423|P1|STARTED|First Intervention (Visit 1)||12
8140334|NCT02708355|20066434|P3|NOT COMPLETED|Overall Study||0
8140335|NCT02708355|20066435|P2|NOT COMPLETED|Overall Study||0
8140336|NCT02708355|20066436|P1|NOT COMPLETED|Overall Study||1
8140337|NCT02708355|20066434|P3|COMPLETED|Overall Study||12
8140338|NCT02708355|20066435|P2|COMPLETED|Overall Study||22
8140339|NCT02708355|20066436|P1|COMPLETED|Overall Study||20
8140340|NCT02708355|20066434|P3|STARTED|Overall Study||12
8140341|NCT02708355|20066435|P2|STARTED|Overall Study||22
8140342|NCT02708355|20066436|P1|STARTED|Overall Study||21
8140343|NCT02708290|20066449|P2|NOT COMPLETED|Overall Study||0
8140344|NCT02708290|20066450|P1|NOT COMPLETED|Overall Study||0
8140345|NCT02708290|20066449|P2|COMPLETED|Overall Study||1009
8140346|NCT02708290|20066450|P1|COMPLETED|Overall Study||1009
8140347|NCT02708290|20066449|P2|STARTED|Overall Study||1009
8140348|NCT02708290|20066450|P1|STARTED|Overall Study||1009
8140349|NCT02708277|20066458|P2|NOT COMPLETED|Overall Study||4
8140350|NCT02708277|20066459|P1|NOT COMPLETED|Overall Study||7
8140351|NCT02708277|20066458|P2|COMPLETED|Overall Study||39
8140352|NCT02708277|20066459|P1|COMPLETED|Overall Study||43
8140353|NCT02708277|20066458|P2|STARTED|Overall Study||43
8140354|NCT02708277|20066459|P1|STARTED|Overall Study||50
8140355|NCT02708238|20066474|P3|NOT COMPLETED|Overall Study||3
8140356|NCT02708238|20066475|P2|NOT COMPLETED|Overall Study||1
8140357|NCT02708238|20066476|P1|NOT COMPLETED|Overall Study||0
8140358|NCT02708238|20066474|P3|COMPLETED|Overall Study||57
8140359|NCT02708238|20066475|P2|COMPLETED|Overall Study||59
8140360|NCT02708238|20066476|P1|COMPLETED|Overall Study||60
8140361|NCT02708238|20066474|P3|STARTED|Overall Study||60
8140362|NCT02708238|20066475|P2|STARTED|Overall Study||60
8140363|NCT02708238|20066476|P1|STARTED|Overall Study||60
8140364|NCT02708212|20066489|P2|NOT COMPLETED|Overall Study||0
8140365|NCT02708212|20066490|P1|NOT COMPLETED|Overall Study||0
8140366|NCT02708212|20066489|P2|COMPLETED|Overall Study||60
8140367|NCT02708212|20066490|P1|COMPLETED|Overall Study||60
8140368|NCT02708212|20066489|P2|STARTED|Overall Study||60
8140369|NCT02708212|20066490|P1|STARTED|Overall Study||60
8140370|NCT02708186|20066502|P2|NOT COMPLETED|Overall Study||2
8140371|NCT02708186|20066503|P1|NOT COMPLETED|Overall Study||2
8140372|NCT02708186|20066502|P2|COMPLETED|Overall Study||16
8140373|NCT02708186|20066503|P1|COMPLETED|Overall Study||14
8140374|NCT02708186|20066502|P2|STARTED|Overall Study||18
8140375|NCT02708186|20066503|P1|STARTED|Overall Study||16
8140376|NCT02708121|20066511|P2|NOT COMPLETED|Overall Study||5
8140377|NCT02708121|20066512|P1|NOT COMPLETED|Overall Study||1
8140378|NCT02708121|20066511|P2|COMPLETED|Overall Study||26
8140379|NCT02708121|20066512|P1|COMPLETED|Overall Study||34
8140380|NCT02708121|20066511|P2|6 Month Weight Data Via EHR|Overall Study||13
8140381|NCT02708121|20066512|P1|6 Month Weight Data Via EHR|Overall Study||14
8140382|NCT02708121|20066511|P2|6 Month In-Person Follow Up Data|Overall Study||19
8140383|NCT02708121|20066512|P1|6 Month In-Person Follow Up Data|Overall Study||22
8140384|NCT02708121|20066511|P2|Treatment Program Use Data Available|Overall Study||24
8140385|NCT02708121|20066512|P1|Treatment Program Use Data Available|Overall Study||34
8140386|NCT02708121|20066511|P2|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0
8140387|NCT02708121|20066512|P1|Provided Acceptability Data|Overall Study||20
8140388|NCT02708121|20066511|P2|STARTED|Overall Study||31
8140389|NCT02708121|20066512|P1|STARTED|Overall Study||35
8140390|NCT02708095|20066524|P3|NOT COMPLETED|Overall Study||18
8140391|NCT02708095|20066525|P2|NOT COMPLETED|Overall Study||19
8140392|NCT02708095|20066526|P1|NOT COMPLETED|Overall Study||22
8140393|NCT02708095|20066524|P3|COMPLETED|Overall Study||86
8140394|NCT02708095|20066525|P2|COMPLETED|Overall Study||86
8140395|NCT02708095|20066526|P1|COMPLETED|Overall Study||83
8140396|NCT02708095|20066524|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
8140397|NCT02708095|20066525|P2|Received at Least 1 Dose of Study Drug|Overall Study||105
8140398|NCT02708095|20066526|P1|Received at Least 1 Dose of Study Drug|Overall Study||105
8140399|NCT02708095|20066524|P3|STARTED|Overall Study||104
8140400|NCT02708095|20066525|P2|STARTED|Overall Study||105
8140401|NCT02708095|20066526|P1|STARTED|Overall Study||105
8140402|NCT02707991|20066549|P2|NOT COMPLETED|Overall Study||1
8140403|NCT02707991|20066550|P1|NOT COMPLETED|Overall Study||1
8140404|NCT02707991|20066549|P2|COMPLETED|Overall Study||34
8140405|NCT02707991|20066550|P1|COMPLETED|Overall Study||32
8140406|NCT02707991|20066549|P2|Month 6 Data Collection|Overall Study||34
8140407|NCT02707991|20066550|P1|Month 6 Data Collection|Overall Study||32
8140408|NCT02707991|20066549|P2|Day 60 Data Collectio|Overall Study||34
8140409|NCT02707991|20066550|P1|Day 60 Data Collectio|Overall Study||32
8140410|NCT02707991|20066549|P2|STARTED|Overall Study||35
8140411|NCT02707991|20066550|P1|STARTED|Overall Study||33
8140412|NCT02707965|20066567|P16|NOT COMPLETED|Overall Study||0
8140413|NCT02707965|20066568|P15|NOT COMPLETED|Overall Study||2
8140414|NCT02707965|20066569|P14|NOT COMPLETED|Overall Study||0
8140415|NCT02707965|20066570|P13|NOT COMPLETED|Overall Study||0
8140416|NCT02707965|20066571|P12|NOT COMPLETED|Overall Study||0
8140417|NCT02707965|20066572|P11|NOT COMPLETED|Overall Study||0
8140418|NCT02707965|20066573|P10|NOT COMPLETED|Overall Study||0
8140419|NCT02707965|20066574|P9|NOT COMPLETED|Overall Study||0
8140420|NCT02707965|20066575|P8|NOT COMPLETED|Overall Study||3
8140421|NCT02707965|20066576|P7|NOT COMPLETED|Overall Study||0
8140422|NCT02707965|20066577|P6|NOT COMPLETED|Overall Study||0
8140423|NCT02707965|20066578|P5|NOT COMPLETED|Overall Study||0
8140424|NCT02707965|20066579|P4|NOT COMPLETED|Overall Study||0
8140425|NCT02707965|20066580|P3|NOT COMPLETED|Overall Study||1
8140426|NCT02707965|20066581|P2|NOT COMPLETED|Overall Study||1
8140427|NCT02707965|20066582|P1|NOT COMPLETED|Overall Study||1
8140428|NCT02707965|20066567|P16|COMPLETED|Overall Study||0
8140429|NCT02707965|20066568|P15|COMPLETED|Overall Study||0
8140430|NCT02707965|20066569|P14|COMPLETED|Overall Study||2
8140431|NCT02707965|20066570|P13|COMPLETED|Overall Study||0
8140432|NCT02707965|20066571|P12|COMPLETED|Overall Study||0
8140433|NCT02707965|20066572|P11|COMPLETED|Overall Study||1
8140434|NCT02707965|20066573|P10|COMPLETED|Overall Study||0
8140435|NCT02707965|20066574|P9|COMPLETED|Overall Study||1
8140436|NCT02707965|20066575|P8|COMPLETED|Overall Study||0
8140437|NCT02707965|20066576|P7|COMPLETED|Overall Study||0
8140438|NCT02707965|20066577|P6|COMPLETED|Overall Study||1
8140439|NCT02707965|20066578|P5|COMPLETED|Overall Study||2
8140440|NCT02707965|20066579|P4|COMPLETED|Overall Study||0
8140441|NCT02707965|20066580|P3|COMPLETED|Overall Study||3
8140442|NCT02707965|20066581|P2|COMPLETED|Overall Study||1
8140443|NCT02707965|20066582|P1|COMPLETED|Overall Study||2
8140444|NCT02707965|20066567|P16|STARTED|Overall Study||0
8140445|NCT02707965|20066568|P15|STARTED|Overall Study||2
8140446|NCT02707965|20066569|P14|STARTED|Overall Study||2
8140447|NCT02707965|20066570|P13|STARTED|Overall Study||0
8140448|NCT02707965|20066571|P12|STARTED|Overall Study||0
8140449|NCT02707965|20066572|P11|STARTED|Overall Study||1
8140450|NCT02707965|20066573|P10|STARTED|Overall Study||0
8140451|NCT02707965|20066574|P9|STARTED|Overall Study||1
8140452|NCT02707965|20066575|P8|STARTED|Overall Study||3
8140453|NCT02707965|20066576|P7|STARTED|Overall Study||0
8140454|NCT02707965|20066577|P6|STARTED|Overall Study||1
8140455|NCT02707965|20066578|P5|STARTED|Overall Study||2
8140456|NCT02707965|20066579|P4|STARTED|Overall Study||0
8140457|NCT02707965|20066580|P3|STARTED|Overall Study||4
8140458|NCT02707965|20066581|P2|STARTED|Overall Study||2
8140459|NCT02707965|20066582|P1|STARTED|Overall Study||3
8140476|NCT02707640|20066658|P2|NOT COMPLETED|Overall Study||7
8140477|NCT02707640|20066659|P1|NOT COMPLETED|Overall Study||9
8140478|NCT02707640|20066658|P2|COMPLETED|Overall Study||55
8140479|NCT02707640|20066659|P1|COMPLETED|Overall Study||52
8140480|NCT02707640|20066658|P2|STARTED|Overall Study||62
8140481|NCT02707640|20066659|P1|STARTED|Overall Study||61
8140482|NCT02707601|20066679|P2|NOT COMPLETED|Overall Study||4
8140483|NCT02707601|20066680|P1|NOT COMPLETED|Overall Study||4
8140484|NCT02707601|20066679|P2|COMPLETED|Overall Study||70
8140485|NCT02707601|20066680|P1|COMPLETED|Overall Study||72
8140486|NCT02707601|20066679|P2|STARTED|Overall Study||74
8140487|NCT02707601|20066680|P1|STARTED|Overall Study||76
8140488|NCT02707523|20066697|P3|NOT COMPLETED|Overall Study||0
8140489|NCT02707523|20066698|P2|NOT COMPLETED|Overall Study||0
8140490|NCT02707523|20066699|P1|NOT COMPLETED|Overall Study||0
8140491|NCT02707523|20066697|P3|COMPLETED|Overall Study||16
8140492|NCT02707523|20066698|P2|COMPLETED|Overall Study||16
8140493|NCT02707523|20066699|P1|COMPLETED|Overall Study||16
8140494|NCT02707523|20066697|P3|STARTED|Overall Study||16
8140495|NCT02707523|20066698|P2|STARTED|Overall Study||16
8140496|NCT02707523|20066699|P1|STARTED|Overall Study||16
8140497|NCT02707432|20066739|P2|NOT COMPLETED|Overall Study||20
8140498|NCT02707432|20066740|P1|NOT COMPLETED|Overall Study||15
8140499|NCT02707432|20066739|P2|COMPLETED|Overall Study||51
8140500|NCT02707432|20066740|P1|COMPLETED|Overall Study||57
8140501|NCT02707432|20066739|P2|STARTED|Overall Study||71
8140502|NCT02707432|20066740|P1|STARTED|Overall Study||72
8140503|NCT02707172|20066750|P1|NOT COMPLETED|2nd Set of Experiment||0
8140504|NCT02707172|20066750|P1|COMPLETED|2nd Set of Experiment||28
8140505|NCT02707172|20066750|P1|STARTED|2nd Set of Experiment||28
8140506|NCT02707172|20066750|P1|NOT COMPLETED|Wash Out||0
8140507|NCT02707172|20066750|P1|COMPLETED|Wash Out||28
8140508|NCT02707172|20066750|P1|STARTED|Wash Out||28
8140509|NCT02707172|20066750|P1|NOT COMPLETED|1st Set of Experiment||0
8140510|NCT02707172|20066750|P1|COMPLETED|1st Set of Experiment||28
8140511|NCT02707172|20066750|P1|STARTED|1st Set of Experiment||28
8140512|NCT02707146|20066757|P2|NOT COMPLETED|Overall Study||3
8140513|NCT02707146|20066758|P1|NOT COMPLETED|Overall Study||0
8140514|NCT02707146|20066757|P2|COMPLETED|Overall Study||388
8140515|NCT02707146|20066758|P1|COMPLETED|Overall Study||359
8140516|NCT02707146|20066757|P2|STARTED|Overall Study||391
8140517|NCT02707146|20066758|P1|STARTED|Overall Study||359
8140527|NCT02706938|20066805|P2|NOT COMPLETED|Second Period, 6 Weeks||10
8140528|NCT02706938|20066806|P1|NOT COMPLETED|Second Period, 6 Weeks||0
8140529|NCT02706938|20066805|P2|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21
8140530|NCT02706938|20066806|P1|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21
8140531|NCT02706938|20066805|P2|STARTED|Second Period, 6 Weeks||31
8140532|NCT02706938|20066806|P1|STARTED|Second Period, 6 Weeks||21
8140533|NCT02706938|20066805|P2|NOT COMPLETED|First Period, 6 Weeks||2
8140534|NCT02706938|20066806|P1|NOT COMPLETED|First Period, 6 Weeks||11
8140535|NCT02706938|20066805|P2|COMPLETED|First Period, 6 Weeks||31
8140536|NCT02706938|20066806|P1|COMPLETED|First Period, 6 Weeks||21
8140537|NCT02706938|20066805|P2|STARTED|First Period, 6 Weeks||33
8140538|NCT02706938|20066806|P1|STARTED|First Period, 6 Weeks||32
8140539|NCT02706925|20066824|P9|NOT COMPLETED|Overall Study||0
8140540|NCT02706925|20066825|P8|NOT COMPLETED|Overall Study||0
8140541|NCT02706925|20066826|P7|NOT COMPLETED|Overall Study||0
8140542|NCT02706925|20066827|P6|NOT COMPLETED|Overall Study||0
8140543|NCT02706925|20066828|P5|NOT COMPLETED|Overall Study||0
8140544|NCT02706925|20066829|P4|NOT COMPLETED|Overall Study||0
8140545|NCT02706925|20066830|P3|NOT COMPLETED|Overall Study||0
8140546|NCT02706925|20066831|P2|NOT COMPLETED|Overall Study||0
8140547|NCT02706925|20066832|P1|NOT COMPLETED|Overall Study||0
8140548|NCT02706925|20066824|P9|COMPLETED|Overall Study||6
8140549|NCT02706925|20066825|P8|COMPLETED|Overall Study||6
8140550|NCT02706925|20066826|P7|COMPLETED|Overall Study||6
8140551|NCT02706925|20066827|P6|COMPLETED|Overall Study||5
8140552|NCT02706925|20066828|P5|COMPLETED|Overall Study||6
8140553|NCT02706925|20066829|P4|COMPLETED|Overall Study||6
8140554|NCT02706925|20066830|P3|COMPLETED|Overall Study||6
8140555|NCT02706925|20066831|P2|COMPLETED|Overall Study||6
8140556|NCT02706925|20066832|P1|COMPLETED|Overall Study||16
8140557|NCT02706925|20066824|P9|STARTED|Overall Study||6
8140558|NCT02706925|20066825|P8|STARTED|Overall Study||6
8140559|NCT02706925|20066826|P7|STARTED|Overall Study||6
8140560|NCT02706925|20066827|P6|STARTED|Overall Study||5
8140561|NCT02706925|20066828|P5|STARTED|Overall Study||6
8140562|NCT02706925|20066829|P4|STARTED|Overall Study||6
8140563|NCT02706925|20066830|P3|STARTED|Overall Study||6
8140564|NCT02706925|20066831|P2|STARTED|Overall Study||6
8140565|NCT02706925|20066832|P1|STARTED|Overall Study||16
8140566|NCT02706899|20066870|P2|NOT COMPLETED|Overall Study||6
8140567|NCT02706899|20066871|P1|NOT COMPLETED|Overall Study||13
8140568|NCT02706899|20066870|P2|COMPLETED|Overall Study||0
8140569|NCT02706899|20066871|P1|COMPLETED|Overall Study||0
8140570|NCT02706899|20066870|P2|STARTED|Overall Study||6
8140571|NCT02706899|20066871|P1|STARTED|Overall Study||13
8140572|NCT02706886|20066902|P9|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140573|NCT02706886|20066903|P8|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140574|NCT02706886|20066904|P7|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140575|NCT02706886|20066905|P6|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140576|NCT02706886|20066906|P5|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140577|NCT02706886|20066907|P4|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140578|NCT02706886|20066908|P3|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140579|NCT02706886|20066909|P2|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140580|NCT02706886|20066910|P1|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140581|NCT02706886|20066902|P9|COMPLETED|Part B: MAD Study Day 85-End of Study||4
8140582|NCT02706886|20066903|P8|COMPLETED|Part B: MAD Study Day 85-End of Study||8
8140583|NCT02706886|20066904|P7|COMPLETED|Part B: MAD Study Day 85-End of Study||8
8140584|NCT02706886|20066905|P6|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140585|NCT02706886|20066906|P5|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140586|NCT02706886|20066907|P4|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140587|NCT02706886|20066908|P3|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140588|NCT02706886|20066909|P2|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140589|NCT02706886|20066910|P1|COMPLETED|Part B: MAD Study Day 85-End of Study||0
8140590|NCT02706886|20066902|P9|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|4
8140591|NCT02706886|20066903|P8|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
8140592|NCT02706886|20066904|P7|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
8140593|NCT02706886|20066905|P6|STARTED|Part B: MAD Study Day 85-End of Study||0
8140594|NCT02706886|20066906|P5|STARTED|Part B: MAD Study Day 85-End of Study||0
8140595|NCT02706886|20066907|P4|STARTED|Part B: MAD Study Day 85-End of Study||0
8140596|NCT02706886|20066908|P3|STARTED|Part B: MAD Study Day 85-End of Study||0
8140597|NCT02706886|20066909|P2|STARTED|Part B: MAD Study Day 85-End of Study||0
8140598|NCT02706886|20066910|P1|STARTED|Part B: MAD Study Day 85-End of Study||0
8140599|NCT02706886|20066902|P9|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140600|NCT02706886|20066903|P8|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140601|NCT02706886|20066904|P7|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140602|NCT02706886|20066905|P6|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140603|NCT02706886|20066906|P5|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140604|NCT02706886|20066907|P4|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140605|NCT02706886|20066908|P3|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140606|NCT02706886|20066909|P2|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140607|NCT02706886|20066910|P1|NOT COMPLETED|Part B: MAD Study Days 1-85||0
8140608|NCT02706886|20066902|P9|COMPLETED|Part B: MAD Study Days 1-85||3
8140609|NCT02706886|20066903|P8|COMPLETED|Part B: MAD Study Days 1-85||7
8140610|NCT02706886|20066904|P7|COMPLETED|Part B: MAD Study Days 1-85||7
8140611|NCT02706886|20066905|P6|COMPLETED|Part B: MAD Study Days 1-85||3
8140612|NCT02706886|20066906|P5|COMPLETED|Part B: MAD Study Days 1-85||0
8140613|NCT02706886|20066907|P4|COMPLETED|Part B: MAD Study Days 1-85||0
8140614|NCT02706886|20066908|P3|COMPLETED|Part B: MAD Study Days 1-85||0
8140615|NCT02706886|20066909|P2|COMPLETED|Part B: MAD Study Days 1-85||0
8140616|NCT02706886|20066910|P1|COMPLETED|Part B: MAD Study Days 1-85||0
8140617|NCT02706886|20066902|P9|STARTED|Part B: MAD Study Days 1-85||3
8140618|NCT02706886|20066903|P8|STARTED|Part B: MAD Study Days 1-85||7
8140619|NCT02706886|20066904|P7|STARTED|Part B: MAD Study Days 1-85||7
8140620|NCT02706886|20066905|P6|STARTED|Part B: MAD Study Days 1-85||3
8140621|NCT02706886|20066906|P5|STARTED|Part B: MAD Study Days 1-85||0
8140622|NCT02706886|20066907|P4|STARTED|Part B: MAD Study Days 1-85||0
8140623|NCT02706886|20066908|P3|STARTED|Part B: MAD Study Days 1-85||0
8140624|NCT02706886|20066909|P2|STARTED|Part B: MAD Study Days 1-85||0
8140625|NCT02706886|20066910|P1|STARTED|Part B: MAD Study Days 1-85||0
8140626|NCT02706886|20066902|P9|NOT COMPLETED|Part A: SAD Period||0
8140627|NCT02706886|20066903|P8|NOT COMPLETED|Part A: SAD Period||0
8140628|NCT02706886|20066904|P7|NOT COMPLETED|Part A: SAD Period||0
8140629|NCT02706886|20066905|P6|NOT COMPLETED|Part A: SAD Period||0
8140630|NCT02706886|20066906|P5|NOT COMPLETED|Part A: SAD Period||0
8140631|NCT02706886|20066907|P4|NOT COMPLETED|Part A: SAD Period||2
8140632|NCT02706886|20066908|P3|NOT COMPLETED|Part A: SAD Period||0
8140633|NCT02706886|20066909|P2|NOT COMPLETED|Part A: SAD Period||0
8140634|NCT02706886|20066910|P1|NOT COMPLETED|Part A: SAD Period||0
8140635|NCT02706886|20066902|P9|COMPLETED|Part A: SAD Period||0
8140636|NCT02706886|20066903|P8|COMPLETED|Part A: SAD Period||0
8140637|NCT02706886|20066904|P7|COMPLETED|Part A: SAD Period||0
8140638|NCT02706886|20066905|P6|COMPLETED|Part A: SAD Period||0
8140639|NCT02706886|20066906|P5|COMPLETED|Part A: SAD Period||6
8140640|NCT02706886|20066907|P4|COMPLETED|Part A: SAD Period||4
8140641|NCT02706886|20066908|P3|COMPLETED|Part A: SAD Period||6
8140642|NCT02706886|20066909|P2|COMPLETED|Part A: SAD Period||6
8140643|NCT02706886|20066910|P1|COMPLETED|Part A: SAD Period||8
8140644|NCT02706886|20066902|P9|STARTED|Part A: SAD Period||0
8140645|NCT02706886|20066903|P8|STARTED|Part A: SAD Period||0
8140646|NCT02706886|20066904|P7|STARTED|Part A: SAD Period||0
8140647|NCT02706886|20066905|P6|STARTED|Part A: SAD Period||0
8140648|NCT02706886|20066906|P5|STARTED|Part A: SAD Period||6
8140649|NCT02706886|20066907|P4|STARTED|Part A: SAD Period||6
8140650|NCT02706886|20066908|P3|STARTED|Part A: SAD Period||6
8140651|NCT02706886|20066909|P2|STARTED|Part A: SAD Period||6
8140652|NCT02706886|20066910|P1|STARTED|Part A: SAD Period||8
8140709|NCT02706834|20067175|P11|NOT COMPLETED|Overall Study||1
8140710|NCT02706834|20067176|P10|NOT COMPLETED|Overall Study||1
8140711|NCT02706834|20067177|P9|NOT COMPLETED|Overall Study||0
8140712|NCT02706834|20067178|P8|NOT COMPLETED|Overall Study||0
8140713|NCT02706834|20067179|P7|NOT COMPLETED|Overall Study||0
8140714|NCT02706834|20067180|P6|NOT COMPLETED|Overall Study||0
8140715|NCT02706834|20067181|P5|NOT COMPLETED|Overall Study||1
8140716|NCT02706834|20067182|P4|NOT COMPLETED|Overall Study||0
8140717|NCT02706834|20067183|P3|NOT COMPLETED|Overall Study||1
8140718|NCT02706834|20067184|P2|NOT COMPLETED|Overall Study||1
8140719|NCT02706834|20067185|P1|NOT COMPLETED|Overall Study||2
8140720|NCT02706834|20067175|P11|COMPLETED|Overall Study||3
8140721|NCT02706834|20067176|P10|COMPLETED|Overall Study||3
8140722|NCT02706834|20067177|P9|COMPLETED|Overall Study||4
8140723|NCT02706834|20067178|P8|COMPLETED|Overall Study||3
8140724|NCT02706834|20067179|P7|COMPLETED|Overall Study||3
8140725|NCT02706834|20067180|P6|COMPLETED|Overall Study||3
8140726|NCT02706834|20067181|P5|COMPLETED|Overall Study||2
8140727|NCT02706834|20067182|P4|COMPLETED|Overall Study||3
8140728|NCT02706834|20067183|P3|COMPLETED|Overall Study||2
8140729|NCT02706834|20067184|P2|COMPLETED|Overall Study||2
8140730|NCT02706834|20067185|P1|COMPLETED|Overall Study|Completed = completed study drug|1
8140731|NCT02706834|20067175|P11|STARTED|Overall Study||4
8140732|NCT02706834|20067176|P10|STARTED|Overall Study||4
8140733|NCT02706834|20067177|P9|STARTED|Overall Study||4
8140734|NCT02706834|20067178|P8|STARTED|Overall Study||3
8140735|NCT02706834|20067179|P7|STARTED|Overall Study||3
8140736|NCT02706834|20067180|P6|STARTED|Overall Study||3
8140737|NCT02706834|20067181|P5|STARTED|Overall Study||3
8140738|NCT02706834|20067182|P4|STARTED|Overall Study||3
8140739|NCT02706834|20067183|P3|STARTED|Overall Study||3
8140740|NCT02706834|20067184|P2|STARTED|Overall Study||3
8140741|NCT02706834|20067185|P1|STARTED|Overall Study||3
8140742|NCT02706717|20067329|P2|NOT COMPLETED|Overall Study||11
8140743|NCT02706717|20067330|P1|NOT COMPLETED|Overall Study||1
8140744|NCT02706717|20067329|P2|COMPLETED|Overall Study||35
8140745|NCT02706717|20067330|P1|COMPLETED|Overall Study||46
8140746|NCT02706717|20067329|P2|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
8140747|NCT02706717|20067330|P1|STARTED|Overall Study||47
8140748|NCT02706691|20067394|P1|NOT COMPLETED|Overall Study||1
8140749|NCT02706691|20067394|P1|COMPLETED|Overall Study||0
8140750|NCT02706691|20067394|P1|STARTED|Overall Study||1
8140751|NCT02706483|20067401|P1|NOT COMPLETED|Overall Study||430
8140752|NCT02706483|20067401|P1|COMPLETED|Overall Study||1842
8140753|NCT02706483|20067401|P1|STARTED|Overall Study||2272
8140754|NCT02706327|20067408|P3|NOT COMPLETED|Overall Study||2
8140755|NCT02706327|20067409|P2|NOT COMPLETED|Overall Study||1
8140756|NCT02706327|20067410|P1|NOT COMPLETED|Overall Study||1
8140757|NCT02706327|20067408|P3|COMPLETED|Overall Study||21
8140758|NCT02706327|20067409|P2|COMPLETED|Overall Study||21
8140759|NCT02706327|20067410|P1|COMPLETED|Overall Study||21
8140760|NCT02706327|20067408|P3|STARTED|Overall Study||23
8140761|NCT02706327|20067409|P2|STARTED|Overall Study||22
8140762|NCT02706327|20067410|P1|STARTED|Overall Study||22
8140763|NCT02705807|20067430|P1|NOT COMPLETED|Overall Study||0
8140764|NCT02705807|20067430|P1|COMPLETED|Overall Study||10
8140765|NCT02705807|20067430|P1|STARTED|Overall Study||10
8140766|NCT02705716|20067462|P2|NOT COMPLETED|Overall Study||2
8140767|NCT02705716|20067463|P1|NOT COMPLETED|Overall Study||4
8140768|NCT02705716|20067462|P2|COMPLETED|Overall Study||68
8140769|NCT02705716|20067463|P1|COMPLETED|Overall Study||68
8140770|NCT02705716|20067462|P2|STARTED|Overall Study||70
8140771|NCT02705716|20067463|P1|STARTED|Overall Study||72
8140772|NCT02705625|20067476|P3|NOT COMPLETED|Overall Study||11
8140773|NCT02705625|20067477|P2|NOT COMPLETED|Overall Study||10
8140774|NCT02705625|20067478|P1|NOT COMPLETED|Overall Study||8
8140775|NCT02705625|20067476|P3|COMPLETED|Overall Study||69
8140776|NCT02705625|20067477|P2|COMPLETED|Overall Study||72
8140777|NCT02705625|20067478|P1|COMPLETED|Overall Study||74
8140778|NCT02705625|20067476|P3|STARTED|Overall Study||80
8140779|NCT02705625|20067477|P2|STARTED|Overall Study||82
8140780|NCT02705625|20067478|P1|STARTED|Overall Study||82
8140781|NCT02705586|20067507|P1|NOT COMPLETED|Overall Study||8
8140782|NCT02705586|20067507|P1|COMPLETED|Overall Study||5
8140783|NCT02705586|20067507|P1|STARTED|Overall Study||13
8140784|NCT02705365|20067513|P2|NOT COMPLETED|Overall Study||0
8140785|NCT02705365|20067514|P1|NOT COMPLETED|Overall Study||0
8140786|NCT02705365|20067513|P2|COMPLETED|Overall Study||800
8140787|NCT02705365|20067514|P1|COMPLETED|Overall Study||400
8140788|NCT02705365|20067513|P2|STARTED|Overall Study||800
8140789|NCT02705365|20067514|P1|STARTED|Overall Study||400
8140790|NCT02705352|20067524|P2|NOT COMPLETED|Overall Study||0
8140791|NCT02705352|20067525|P1|NOT COMPLETED|Overall Study||0
8140792|NCT02705352|20067524|P2|COMPLETED|Overall Study||0
8140793|NCT02705352|20067525|P1|COMPLETED|Overall Study||1
8140794|NCT02705352|20067524|P2|STARTED|Overall Study||0
8140795|NCT02705352|20067525|P1|STARTED|Overall Study||1
8140796|NCT02705105|20067545|P2|NOT COMPLETED|Follow-Up||110
8140797|NCT02705105|20067546|P1|NOT COMPLETED|Follow-Up||4
8140798|NCT02705105|20067545|P2|COMPLETED|Follow-Up||0
8140799|NCT02705105|20067546|P1|COMPLETED|Follow-Up||0
8140800|NCT02705105|20067545|P2|STARTED|Follow-Up||110
8140801|NCT02705105|20067546|P1|STARTED|Follow-Up||4
8140802|NCT02705105|20067545|P2|NOT COMPLETED|Treatment||109
8140803|NCT02705105|20067546|P1|NOT COMPLETED|Treatment||4
8140804|NCT02705105|20067545|P2|COMPLETED|Treatment||1
8140805|NCT02705105|20067546|P1|COMPLETED|Treatment||0
8140806|NCT02705105|20067545|P2|D/C From Follow-Up|Treatment||110
8140807|NCT02705105|20067546|P1|D/C From Follow-Up|Treatment||4
8140808|NCT02705105|20067545|P2|D/C From Treatment Phase|Treatment||107
8140809|NCT02705105|20067546|P1|D/C From Treatment Phase|Treatment||4
8140810|NCT02705105|20067545|P2|Subjects Who Were Replaced|Treatment||0
8140811|NCT02705105|20067546|P1|Subjects Who Were Replaced|Treatment||1
8140812|NCT02705105|20067545|P2|STARTED|Treatment||110
8140813|NCT02705105|20067546|P1|STARTED|Treatment||4
8140814|NCT02704702|20067572|P6|NOT COMPLETED|Overall Study||2
8140815|NCT02704702|20067573|P5|NOT COMPLETED|Overall Study||2
8140816|NCT02704702|20067574|P4|NOT COMPLETED|Overall Study||1
8140817|NCT02704702|20067575|P3|NOT COMPLETED|Overall Study||0
8140818|NCT02704702|20067576|P2|NOT COMPLETED|Overall Study||0
8140819|NCT02704702|20067577|P1|NOT COMPLETED|Overall Study||1
8140820|NCT02704702|20067572|P6|COMPLETED|Overall Study||4
8140821|NCT02704702|20067573|P5|COMPLETED|Overall Study||4
8140822|NCT02704702|20067574|P4|COMPLETED|Overall Study||5
8140823|NCT02704702|20067575|P3|COMPLETED|Overall Study||6
8140824|NCT02704702|20067576|P2|COMPLETED|Overall Study||6
8140825|NCT02704702|20067577|P1|COMPLETED|Overall Study||5
8140826|NCT02704702|20067572|P6|STARTED|Overall Study||6
8140827|NCT02704702|20067573|P5|STARTED|Overall Study||6
8140828|NCT02704702|20067574|P4|STARTED|Overall Study||6
8140829|NCT02704702|20067575|P3|STARTED|Overall Study||6
8140830|NCT02704702|20067576|P2|STARTED|Overall Study||6
8140831|NCT02704702|20067577|P1|STARTED|Overall Study||6
8140832|NCT02704689|20067609|P1|NOT COMPLETED|Overall Study||3
8140833|NCT02704689|20067609|P1|COMPLETED|Overall Study||6
8140834|NCT02704689|20067609|P1|STARTED|Overall Study||9
8140835|NCT02704143|20067626|P1|NOT COMPLETED|Overall Study||10
8140836|NCT02704143|20067626|P1|COMPLETED|Overall Study||53
8140837|NCT02704143|20067626|P1|STARTED|Overall Study||63
8140838|NCT02704104|20067635|P1|NOT COMPLETED|Overall Study||0
8140839|NCT02704104|20067635|P1|COMPLETED|Overall Study||46
8140840|NCT02704104|20067635|P1|STARTED|Overall Study||46
8140841|NCT02704091|20067651|P2|NOT COMPLETED|Overall Study||23
8140842|NCT02704091|20067652|P1|NOT COMPLETED|Overall Study||28
8140843|NCT02704091|20067651|P2|COMPLETED|Overall Study||400
8140844|NCT02704091|20067652|P1|COMPLETED|Overall Study||402
8140845|NCT02704091|20067651|P2|STARTED|Overall Study||423
8140846|NCT02704091|20067652|P1|STARTED|Overall Study||430
8140847|NCT02703987|20067674|P2|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
8140848|NCT02703987|20067675|P1|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
8140849|NCT02703987|20067674|P2|COMPLETED|Visit 4 Intervention (1 Day)||10
8140850|NCT02703987|20067675|P1|COMPLETED|Visit 4 Intervention (1 Day)||12
8140851|NCT02703987|20067674|P2|STARTED|Visit 4 Intervention (1 Day)||11
8140852|NCT02703987|20067675|P1|STARTED|Visit 4 Intervention (1 Day)||13
8140853|NCT02703987|20067674|P2|NOT COMPLETED|Washout (Minimum 5 Days)||0
8140854|NCT02703987|20067675|P1|NOT COMPLETED|Washout (Minimum 5 Days)||0
8140855|NCT02703987|20067674|P2|COMPLETED|Washout (Minimum 5 Days)||11
8140856|NCT02703987|20067675|P1|COMPLETED|Washout (Minimum 5 Days)||13
8140857|NCT02703987|20067674|P2|STARTED|Washout (Minimum 5 Days)||11
8140858|NCT02703987|20067675|P1|STARTED|Washout (Minimum 5 Days)||13
8140859|NCT02703987|20067674|P2|NOT COMPLETED|Visit 3 Intervention (1 Day)||3
8140860|NCT02703987|20067675|P1|NOT COMPLETED|Visit 3 Intervention (1 Day)||1
8140861|NCT02703987|20067674|P2|COMPLETED|Visit 3 Intervention (1 Day)||11
8140862|NCT02703987|20067675|P1|COMPLETED|Visit 3 Intervention (1 Day)||13
8140863|NCT02703987|20067674|P2|STARTED|Visit 3 Intervention (1 Day)||14
8140864|NCT02703987|20067675|P1|STARTED|Visit 3 Intervention (1 Day)||14
8140865|NCT02703948|20067685|P1|NOT COMPLETED|Overall Study||3
8140866|NCT02703948|20067685|P1|COMPLETED|Overall Study||57
8140867|NCT02703948|20067685|P1|STARTED|Overall Study||60
8140868|NCT02703909|20067693|P4|NOT COMPLETED|Overall Study||0
8140869|NCT02703909|20067694|P3|NOT COMPLETED|Overall Study||0
8140870|NCT02703909|20067695|P2|NOT COMPLETED|Overall Study||0
8140871|NCT02703909|20067696|P1|NOT COMPLETED|Overall Study||0
8140872|NCT02703909|20067693|P4|COMPLETED|Overall Study||35
8140873|NCT02703909|20067694|P3|COMPLETED|Overall Study||36
8140874|NCT02703909|20067695|P2|COMPLETED|Overall Study||37
8140875|NCT02703909|20067696|P1|COMPLETED|Overall Study||36
8140876|NCT02703909|20067693|P4|STARTED|Overall Study||35
8140877|NCT02703909|20067694|P3|STARTED|Overall Study||36
8140878|NCT02703909|20067695|P2|STARTED|Overall Study||37
8140879|NCT02703909|20067696|P1|STARTED|Overall Study||36
8140880|NCT02703636|20067712|P1|NOT COMPLETED|Overall Study||16
8140881|NCT02703636|20067712|P1|COMPLETED|Overall Study||102
8140882|NCT02703636|20067712|P1|STARTED|Overall Study||118
8140883|NCT02703532|20067727|P4|NOT COMPLETED|Overall Study||1
8140884|NCT02703532|20067728|P3|NOT COMPLETED|Overall Study||2
8140885|NCT02703532|20067729|P2|NOT COMPLETED|Overall Study||1
8140886|NCT02703532|20067730|P1|NOT COMPLETED|Overall Study||2
8140887|NCT02703532|20067727|P4|COMPLETED|Overall Study||10
8140888|NCT02703532|20067728|P3|COMPLETED|Overall Study||19
8140889|NCT02703532|20067729|P2|COMPLETED|Overall Study||10
8140890|NCT02703532|20067730|P1|COMPLETED|Overall Study||19
8140891|NCT02703532|20067727|P4|STARTED|Overall Study||11
8140892|NCT02703532|20067728|P3|STARTED|Overall Study||21
8140893|NCT02703532|20067729|P2|STARTED|Overall Study||11
8140894|NCT02703532|20067730|P1|STARTED|Overall Study||21
8140895|NCT02703467|20067768|P3|NOT COMPLETED|Overall Study||0
8140896|NCT02703467|20067769|P2|NOT COMPLETED|Overall Study||0
8140897|NCT02703467|20067770|P1|NOT COMPLETED|Overall Study||0
8140898|NCT02703467|20067768|P3|COMPLETED|Overall Study||45
8140899|NCT02703467|20067769|P2|COMPLETED|Overall Study||5
8140900|NCT02703467|20067770|P1|COMPLETED|Overall Study||20
8140901|NCT02703467|20067768|P3|STARTED|Overall Study||45
8140902|NCT02703467|20067769|P2|STARTED|Overall Study||5
8140903|NCT02703467|20067770|P1|STARTED|Overall Study||20
8140904|NCT02703454|20067792|P2|NOT COMPLETED|Overall Study||16
8140905|NCT02703454|20067793|P1|NOT COMPLETED|Overall Study||11
8140906|NCT02703454|20067792|P2|COMPLETED|Overall Study||11
8140907|NCT02703454|20067793|P1|COMPLETED|Overall Study||13
8140908|NCT02703454|20067792|P2|Treated|Overall Study||24
8140909|NCT02703454|20067793|P1|Treated|Overall Study||23
8140910|NCT02703454|20067792|P2|STARTED|Overall Study||27
8140911|NCT02703454|20067793|P1|STARTED|Overall Study||24
8140912|NCT02703350|20067801|P8|NOT COMPLETED|Part B||0
8140913|NCT02703350|20067802|P7|NOT COMPLETED|Part B||0
8140914|NCT02703350|20067803|P6|NOT COMPLETED|Part B||0
8140915|NCT02703350|20067804|P5|NOT COMPLETED|Part B||0
8140916|NCT02703350|20067805|P4|NOT COMPLETED|Part B||0
8140917|NCT02703350|20067806|P3|NOT COMPLETED|Part B||0
8140918|NCT02703350|20067807|P2|NOT COMPLETED|Part B||0
8140919|NCT02703350|20067808|P1|NOT COMPLETED|Part B||0
8140920|NCT02703350|20067801|P8|COMPLETED|Part B||15
8140921|NCT02703350|20067802|P7|COMPLETED|Part B||15
8140922|NCT02703350|20067803|P6|COMPLETED|Part B||0
8140923|NCT02703350|20067804|P5|COMPLETED|Part B||0
8140924|NCT02703350|20067805|P4|COMPLETED|Part B||0
8140925|NCT02703350|20067806|P3|COMPLETED|Part B||0
8140926|NCT02703350|20067807|P2|COMPLETED|Part B||0
8140927|NCT02703350|20067808|P1|COMPLETED|Part B||0
8140928|NCT02703350|20067801|P8|Received Study Drug|Part B||15
8140929|NCT02703350|20067802|P7|Received Study Drug|Part B||15
8140930|NCT02703350|20067803|P6|Received Study Drug|Part B||0
8140931|NCT02703350|20067804|P5|Received Study Drug|Part B||0
8140932|NCT02703350|20067805|P4|Received Study Drug|Part B||0
8140933|NCT02703350|20067806|P3|Received Study Drug|Part B||0
8140934|NCT02703350|20067807|P2|Received Study Drug|Part B||0
8140935|NCT02703350|20067808|P1|Received Study Drug|Part B||0
8140936|NCT02703350|20067801|P8|STARTED|Part B||15
8140937|NCT02703350|20067802|P7|STARTED|Part B||15
8140938|NCT02703350|20067803|P6|STARTED|Part B||0
8140939|NCT02703350|20067804|P5|STARTED|Part B||0
8140940|NCT02703350|20067805|P4|STARTED|Part B||0
8140941|NCT02703350|20067806|P3|STARTED|Part B||0
8140942|NCT02703350|20067807|P2|STARTED|Part B||0
8140943|NCT02703350|20067808|P1|STARTED|Part B||0
8140944|NCT02703350|20067801|P8|NOT COMPLETED|Period Six (Part A)||0
8140945|NCT02703350|20067802|P7|NOT COMPLETED|Period Six (Part A)||0
8140946|NCT02703350|20067803|P6|NOT COMPLETED|Period Six (Part A)||0
8140947|NCT02703350|20067804|P5|NOT COMPLETED|Period Six (Part A)||0
8140948|NCT02703350|20067805|P4|NOT COMPLETED|Period Six (Part A)||0
8140949|NCT02703350|20067806|P3|NOT COMPLETED|Period Six (Part A)||0
8140950|NCT02703350|20067807|P2|NOT COMPLETED|Period Six (Part A)||0
8140951|NCT02703350|20067808|P1|NOT COMPLETED|Period Six (Part A)||0
8140952|NCT02703350|20067801|P8|COMPLETED|Period Six (Part A)||0
8140953|NCT02703350|20067802|P7|COMPLETED|Period Six (Part A)||0
8140954|NCT02703350|20067803|P6|COMPLETED|Period Six (Part A)||5
8140955|NCT02703350|20067804|P5|COMPLETED|Period Six (Part A)||5
8140956|NCT02703350|20067805|P4|COMPLETED|Period Six (Part A)||5
8140957|NCT02703350|20067806|P3|COMPLETED|Period Six (Part A)||5
8140958|NCT02703350|20067807|P2|COMPLETED|Period Six (Part A)||5
8140959|NCT02703350|20067808|P1|COMPLETED|Period Six (Part A)||5
8140960|NCT02703350|20067801|P8|Received Study Drug|Period Six (Part A)||0
8140961|NCT02703350|20067802|P7|Received Study Drug|Period Six (Part A)||0
8140962|NCT02703350|20067803|P6|Received Study Drug|Period Six (Part A)||5
8140963|NCT02703350|20067804|P5|Received Study Drug|Period Six (Part A)||5
8140964|NCT02703350|20067805|P4|Received Study Drug|Period Six (Part A)||5
8140965|NCT02703350|20067806|P3|Received Study Drug|Period Six (Part A)||5
8140966|NCT02703350|20067807|P2|Received Study Drug|Period Six (Part A)||5
8140967|NCT02703350|20067808|P1|Received Study Drug|Period Six (Part A)||5
8140968|NCT02703350|20067801|P8|STARTED|Period Six (Part A)||0
8140969|NCT02703350|20067802|P7|STARTED|Period Six (Part A)||0
8140970|NCT02703350|20067803|P6|STARTED|Period Six (Part A)||5
8140971|NCT02703350|20067804|P5|STARTED|Period Six (Part A)||5
8140972|NCT02703350|20067805|P4|STARTED|Period Six (Part A)||5
8140973|NCT02703350|20067806|P3|STARTED|Period Six (Part A)||5
8140974|NCT02703350|20067807|P2|STARTED|Period Six (Part A)||5
8140975|NCT02703350|20067808|P1|STARTED|Period Six (Part A)||5
8140976|NCT02703350|20067801|P8|NOT COMPLETED|Period Five (Part A)||0
8140977|NCT02703350|20067802|P7|NOT COMPLETED|Period Five (Part A)||0
8140978|NCT02703350|20067803|P6|NOT COMPLETED|Period Five (Part A)||0
8140979|NCT02703350|20067804|P5|NOT COMPLETED|Period Five (Part A)||0
8140980|NCT02703350|20067805|P4|NOT COMPLETED|Period Five (Part A)||0
8140981|NCT02703350|20067806|P3|NOT COMPLETED|Period Five (Part A)||0
8140982|NCT02703350|20067807|P2|NOT COMPLETED|Period Five (Part A)||0
8140983|NCT02703350|20067808|P1|NOT COMPLETED|Period Five (Part A)||0
8140984|NCT02703350|20067801|P8|COMPLETED|Period Five (Part A)||0
8140985|NCT02703350|20067802|P7|COMPLETED|Period Five (Part A)||0
8140986|NCT02703350|20067803|P6|COMPLETED|Period Five (Part A)||5
8140987|NCT02703350|20067804|P5|COMPLETED|Period Five (Part A)||5
8140988|NCT02703350|20067805|P4|COMPLETED|Period Five (Part A)||5
8140989|NCT02703350|20067806|P3|COMPLETED|Period Five (Part A)||5
8140990|NCT02703350|20067807|P2|COMPLETED|Period Five (Part A)||5
8140991|NCT02703350|20067808|P1|COMPLETED|Period Five (Part A)||5
8140992|NCT02703350|20067801|P8|Received Study Drug|Period Five (Part A)||0
8140993|NCT02703350|20067802|P7|Received Study Drug|Period Five (Part A)||0
8140994|NCT02703350|20067803|P6|Received Study Drug|Period Five (Part A)||5
8140995|NCT02703350|20067804|P5|Received Study Drug|Period Five (Part A)||5
8140996|NCT02703350|20067805|P4|Received Study Drug|Period Five (Part A)||5
8140997|NCT02703350|20067806|P3|Received Study Drug|Period Five (Part A)||5
8140998|NCT02703350|20067807|P2|Received Study Drug|Period Five (Part A)||5
8140999|NCT02703350|20067808|P1|Received Study Drug|Period Five (Part A)||5
8141000|NCT02703350|20067801|P8|STARTED|Period Five (Part A)||0
8141001|NCT02703350|20067802|P7|STARTED|Period Five (Part A)||0
8141002|NCT02703350|20067803|P6|STARTED|Period Five (Part A)||5
8141003|NCT02703350|20067804|P5|STARTED|Period Five (Part A)||5
8141004|NCT02703350|20067805|P4|STARTED|Period Five (Part A)||5
8141005|NCT02703350|20067806|P3|STARTED|Period Five (Part A)||5
8141006|NCT02703350|20067807|P2|STARTED|Period Five (Part A)||5
8141007|NCT02703350|20067808|P1|STARTED|Period Five (Part A)||5
8141008|NCT02703350|20067801|P8|NOT COMPLETED|Period Four (Part A)||0
8141009|NCT02703350|20067802|P7|NOT COMPLETED|Period Four (Part A)||0
8141010|NCT02703350|20067803|P6|NOT COMPLETED|Period Four (Part A)||0
8141011|NCT02703350|20067804|P5|NOT COMPLETED|Period Four (Part A)||0
8141012|NCT02703350|20067805|P4|NOT COMPLETED|Period Four (Part A)||0
8141013|NCT02703350|20067806|P3|NOT COMPLETED|Period Four (Part A)||0
8141014|NCT02703350|20067807|P2|NOT COMPLETED|Period Four (Part A)||0
8141015|NCT02703350|20067808|P1|NOT COMPLETED|Period Four (Part A)||0
8141016|NCT02703350|20067801|P8|COMPLETED|Period Four (Part A)||0
8141017|NCT02703350|20067802|P7|COMPLETED|Period Four (Part A)||0
8141018|NCT02703350|20067803|P6|COMPLETED|Period Four (Part A)||5
8141019|NCT02703350|20067804|P5|COMPLETED|Period Four (Part A)||5
8141020|NCT02703350|20067805|P4|COMPLETED|Period Four (Part A)||5
8141021|NCT02703350|20067806|P3|COMPLETED|Period Four (Part A)||5
8141022|NCT02703350|20067807|P2|COMPLETED|Period Four (Part A)||5
8141023|NCT02703350|20067808|P1|COMPLETED|Period Four (Part A)||5
8141024|NCT02703350|20067801|P8|Received Study Drug|Period Four (Part A)||0
8141025|NCT02703350|20067802|P7|Received Study Drug|Period Four (Part A)||0
8141026|NCT02703350|20067803|P6|Received Study Drug|Period Four (Part A)||5
8141027|NCT02703350|20067804|P5|Received Study Drug|Period Four (Part A)||5
8141028|NCT02703350|20067805|P4|Received Study Drug|Period Four (Part A)||5
8141029|NCT02703350|20067806|P3|Received Study Drug|Period Four (Part A)||5
8141030|NCT02703350|20067807|P2|Received Study Drug|Period Four (Part A)||5
8141031|NCT02703350|20067808|P1|Received Study Drug|Period Four (Part A)||5
8141032|NCT02703350|20067801|P8|STARTED|Period Four (Part A)||0
8141033|NCT02703350|20067802|P7|STARTED|Period Four (Part A)||0
8141034|NCT02703350|20067803|P6|STARTED|Period Four (Part A)||5
8141035|NCT02703350|20067804|P5|STARTED|Period Four (Part A)||5
8141036|NCT02703350|20067805|P4|STARTED|Period Four (Part A)||5
8141037|NCT02703350|20067806|P3|STARTED|Period Four (Part A)||5
8141038|NCT02703350|20067807|P2|STARTED|Period Four (Part A)||5
8141039|NCT02703350|20067808|P1|STARTED|Period Four (Part A)||5
8141040|NCT02703350|20067801|P8|NOT COMPLETED|Period Three (Part A)||0
8141041|NCT02703350|20067802|P7|NOT COMPLETED|Period Three (Part A)||0
8141042|NCT02703350|20067803|P6|NOT COMPLETED|Period Three (Part A)||0
8141043|NCT02703350|20067804|P5|NOT COMPLETED|Period Three (Part A)||0
8141044|NCT02703350|20067805|P4|NOT COMPLETED|Period Three (Part A)||0
8141045|NCT02703350|20067806|P3|NOT COMPLETED|Period Three (Part A)||0
8141046|NCT02703350|20067807|P2|NOT COMPLETED|Period Three (Part A)||0
8141047|NCT02703350|20067808|P1|NOT COMPLETED|Period Three (Part A)||0
8141048|NCT02703350|20067801|P8|COMPLETED|Period Three (Part A)||0
8141049|NCT02703350|20067802|P7|COMPLETED|Period Three (Part A)||0
8141050|NCT02703350|20067803|P6|COMPLETED|Period Three (Part A)||5
8141051|NCT02703350|20067804|P5|COMPLETED|Period Three (Part A)||5
8141052|NCT02703350|20067805|P4|COMPLETED|Period Three (Part A)||5
8141053|NCT02703350|20067806|P3|COMPLETED|Period Three (Part A)||5
8141054|NCT02703350|20067807|P2|COMPLETED|Period Three (Part A)||5
8141055|NCT02703350|20067808|P1|COMPLETED|Period Three (Part A)||5
8141056|NCT02703350|20067801|P8|Received Study Drug|Period Three (Part A)||0
8141057|NCT02703350|20067802|P7|Received Study Drug|Period Three (Part A)||0
8141058|NCT02703350|20067803|P6|Received Study Drug|Period Three (Part A)||5
8141059|NCT02703350|20067804|P5|Received Study Drug|Period Three (Part A)||5
8141060|NCT02703350|20067805|P4|Received Study Drug|Period Three (Part A)||5
8141061|NCT02703350|20067806|P3|Received Study Drug|Period Three (Part A)||5
8141062|NCT02703350|20067807|P2|Received Study Drug|Period Three (Part A)||5
8141063|NCT02703350|20067808|P1|Received Study Drug|Period Three (Part A)||5
8141064|NCT02703350|20067801|P8|STARTED|Period Three (Part A)||0
8141065|NCT02703350|20067802|P7|STARTED|Period Three (Part A)||0
8141066|NCT02703350|20067803|P6|STARTED|Period Three (Part A)||5
8141067|NCT02703350|20067804|P5|STARTED|Period Three (Part A)||5
8141068|NCT02703350|20067805|P4|STARTED|Period Three (Part A)||5
8141069|NCT02703350|20067806|P3|STARTED|Period Three (Part A)||5
8141070|NCT02703350|20067807|P2|STARTED|Period Three (Part A)||5
8141071|NCT02703350|20067808|P1|STARTED|Period Three (Part A)||5
8141072|NCT02703350|20067801|P8|NOT COMPLETED|Period Two (Part A)||0
8141073|NCT02703350|20067802|P7|NOT COMPLETED|Period Two (Part A)||0
8141074|NCT02703350|20067803|P6|NOT COMPLETED|Period Two (Part A)||0
8141075|NCT02703350|20067804|P5|NOT COMPLETED|Period Two (Part A)||0
8141076|NCT02703350|20067805|P4|NOT COMPLETED|Period Two (Part A)||0
8141077|NCT02703350|20067806|P3|NOT COMPLETED|Period Two (Part A)||0
8141078|NCT02703350|20067807|P2|NOT COMPLETED|Period Two (Part A)||0
8141079|NCT02703350|20067808|P1|NOT COMPLETED|Period Two (Part A)||0
8141080|NCT02703350|20067801|P8|COMPLETED|Period Two (Part A)||0
8141081|NCT02703350|20067802|P7|COMPLETED|Period Two (Part A)||0
8141082|NCT02703350|20067803|P6|COMPLETED|Period Two (Part A)||5
8141083|NCT02703350|20067804|P5|COMPLETED|Period Two (Part A)||5
8141084|NCT02703350|20067805|P4|COMPLETED|Period Two (Part A)||5
8141085|NCT02703350|20067806|P3|COMPLETED|Period Two (Part A)||5
8141086|NCT02703350|20067807|P2|COMPLETED|Period Two (Part A)||5
8141087|NCT02703350|20067808|P1|COMPLETED|Period Two (Part A)||5
8141088|NCT02703350|20067801|P8|Received Study Drug|Period Two (Part A)||0
8141089|NCT02703350|20067802|P7|Received Study Drug|Period Two (Part A)||0
8141090|NCT02703350|20067803|P6|Received Study Drug|Period Two (Part A)||5
8141091|NCT02703350|20067804|P5|Received Study Drug|Period Two (Part A)||5
8141092|NCT02703350|20067805|P4|Received Study Drug|Period Two (Part A)||5
8141093|NCT02703350|20067806|P3|Received Study Drug|Period Two (Part A)||5
8141094|NCT02703350|20067807|P2|Received Study Drug|Period Two (Part A)||5
8141095|NCT02703350|20067808|P1|Received Study Drug|Period Two (Part A)||5
8141096|NCT02703350|20067801|P8|STARTED|Period Two (Part A)||0
8141097|NCT02703350|20067802|P7|STARTED|Period Two (Part A)||0
8141098|NCT02703350|20067803|P6|STARTED|Period Two (Part A)||5
8141099|NCT02703350|20067804|P5|STARTED|Period Two (Part A)||5
8141100|NCT02703350|20067805|P4|STARTED|Period Two (Part A)||5
8141101|NCT02703350|20067806|P3|STARTED|Period Two (Part A)||5
8141102|NCT02703350|20067807|P2|STARTED|Period Two (Part A)||5
8141103|NCT02703350|20067808|P1|STARTED|Period Two (Part A)||5
8141104|NCT02703350|20067801|P8|NOT COMPLETED|Period One (Part A)||0
8141105|NCT02703350|20067802|P7|NOT COMPLETED|Period One (Part A)||0
8141106|NCT02703350|20067803|P6|NOT COMPLETED|Period One (Part A)||0
8141107|NCT02703350|20067804|P5|NOT COMPLETED|Period One (Part A)||0
8141108|NCT02703350|20067805|P4|NOT COMPLETED|Period One (Part A)||0
8141109|NCT02703350|20067806|P3|NOT COMPLETED|Period One (Part A)||0
8141110|NCT02703350|20067807|P2|NOT COMPLETED|Period One (Part A)||0
8141111|NCT02703350|20067808|P1|NOT COMPLETED|Period One (Part A)||0
8141112|NCT02703350|20067801|P8|COMPLETED|Period One (Part A)||0
8141113|NCT02703350|20067802|P7|COMPLETED|Period One (Part A)||0
8141114|NCT02703350|20067803|P6|COMPLETED|Period One (Part A)||5
8141115|NCT02703350|20067804|P5|COMPLETED|Period One (Part A)||5
8141116|NCT02703350|20067805|P4|COMPLETED|Period One (Part A)||5
8141117|NCT02703350|20067806|P3|COMPLETED|Period One (Part A)||5
8141118|NCT02703350|20067807|P2|COMPLETED|Period One (Part A)||5
8141119|NCT02703350|20067808|P1|COMPLETED|Period One (Part A)||5
8141120|NCT02703350|20067801|P8|Received Study Drug|Period One (Part A)||0
8141121|NCT02703350|20067802|P7|Received Study Drug|Period One (Part A)||0
8141122|NCT02703350|20067803|P6|Received Study Drug|Period One (Part A)||5
8141123|NCT02703350|20067804|P5|Received Study Drug|Period One (Part A)||5
8141124|NCT02703350|20067805|P4|Received Study Drug|Period One (Part A)||5
8141125|NCT02703350|20067806|P3|Received Study Drug|Period One (Part A)||5
8141126|NCT02703350|20067807|P2|Received Study Drug|Period One (Part A)||5
8141127|NCT02703350|20067808|P1|Received Study Drug|Period One (Part A)||5
8141128|NCT02703350|20067801|P8|STARTED|Period One (Part A)||0
8141129|NCT02703350|20067802|P7|STARTED|Period One (Part A)||0
8141130|NCT02703350|20067803|P6|STARTED|Period One (Part A)||5
8141131|NCT02703350|20067804|P5|STARTED|Period One (Part A)||5
8141132|NCT02703350|20067805|P4|STARTED|Period One (Part A)||5
8141133|NCT02703350|20067806|P3|STARTED|Period One (Part A)||5
8141134|NCT02703350|20067807|P2|STARTED|Period One (Part A)||5
8141135|NCT02703350|20067808|P1|STARTED|Period One (Part A)||5
8141136|NCT02703337|20067828|P8|NOT COMPLETED|Part B||0
8141137|NCT02703337|20067829|P7|NOT COMPLETED|Part B||0
8141138|NCT02703337|20067830|P6|NOT COMPLETED|Part B||0
8141139|NCT02703337|20067831|P5|NOT COMPLETED|Part B||0
8141140|NCT02703337|20067832|P4|NOT COMPLETED|Part B||0
8141141|NCT02703337|20067833|P3|NOT COMPLETED|Part B||0
8141142|NCT02703337|20067834|P2|NOT COMPLETED|Part B||0
8141143|NCT02703337|20067835|P1|NOT COMPLETED|Part B||0
8141144|NCT02703337|20067828|P8|COMPLETED|Part B||14
8141145|NCT02703337|20067829|P7|COMPLETED|Part B||15
8141146|NCT02703337|20067830|P6|COMPLETED|Part B||0
8141147|NCT02703337|20067831|P5|COMPLETED|Part B||0
8141148|NCT02703337|20067832|P4|COMPLETED|Part B||0
8141149|NCT02703337|20067833|P3|COMPLETED|Part B||0
8141150|NCT02703337|20067834|P2|COMPLETED|Part B||0
8141151|NCT02703337|20067835|P1|COMPLETED|Part B||0
8141152|NCT02703337|20067828|P8|Received Study Drug|Part B||14
8141153|NCT02703337|20067829|P7|Received Study Drug|Part B||15
8141154|NCT02703337|20067830|P6|Received Study Drug|Part B||0
8141155|NCT02703337|20067831|P5|Received Study Drug|Part B||0
8141156|NCT02703337|20067832|P4|Received Study Drug|Part B||0
8141157|NCT02703337|20067833|P3|Received Study Drug|Part B||0
8141158|NCT02703337|20067834|P2|Received Study Drug|Part B||0
8141159|NCT02703337|20067835|P1|Received Study Drug|Part B||0
8141160|NCT02703337|20067828|P8|STARTED|Part B||14
8141161|NCT02703337|20067829|P7|STARTED|Part B||15
8141162|NCT02703337|20067830|P6|STARTED|Part B||0
8141163|NCT02703337|20067831|P5|STARTED|Part B||0
8141164|NCT02703337|20067832|P4|STARTED|Part B||0
8141165|NCT02703337|20067833|P3|STARTED|Part B||0
8141166|NCT02703337|20067834|P2|STARTED|Part B||0
8141167|NCT02703337|20067835|P1|STARTED|Part B||0
8141168|NCT02703337|20067828|P8|NOT COMPLETED|Period Six (Part A)||0
8141169|NCT02703337|20067829|P7|NOT COMPLETED|Period Six (Part A)||0
8141170|NCT02703337|20067830|P6|NOT COMPLETED|Period Six (Part A)||0
8141171|NCT02703337|20067831|P5|NOT COMPLETED|Period Six (Part A)||0
8141172|NCT02703337|20067832|P4|NOT COMPLETED|Period Six (Part A)||0
8141173|NCT02703337|20067833|P3|NOT COMPLETED|Period Six (Part A)||0
8141174|NCT02703337|20067834|P2|NOT COMPLETED|Period Six (Part A)||0
8141175|NCT02703337|20067835|P1|NOT COMPLETED|Period Six (Part A)||0
8141176|NCT02703337|20067828|P8|COMPLETED|Period Six (Part A)||0
8141177|NCT02703337|20067829|P7|COMPLETED|Period Six (Part A)||0
8141178|NCT02703337|20067830|P6|COMPLETED|Period Six (Part A)||5
8141179|NCT02703337|20067831|P5|COMPLETED|Period Six (Part A)||4
8141180|NCT02703337|20067832|P4|COMPLETED|Period Six (Part A)||5
8141181|NCT02703337|20067833|P3|COMPLETED|Period Six (Part A)||5
8141182|NCT02703337|20067834|P2|COMPLETED|Period Six (Part A)||5
8141183|NCT02703337|20067835|P1|COMPLETED|Period Six (Part A)||5
8141184|NCT02703337|20067828|P8|Received Study Drug|Period Six (Part A)||0
8141185|NCT02703337|20067829|P7|Received Study Drug|Period Six (Part A)||0
8141186|NCT02703337|20067830|P6|Received Study Drug|Period Six (Part A)||5
8141187|NCT02703337|20067831|P5|Received Study Drug|Period Six (Part A)||4
8141188|NCT02703337|20067832|P4|Received Study Drug|Period Six (Part A)||5
8141189|NCT02703337|20067833|P3|Received Study Drug|Period Six (Part A)||5
8141190|NCT02703337|20067834|P2|Received Study Drug|Period Six (Part A)||5
8141191|NCT02703337|20067835|P1|Received Study Drug|Period Six (Part A)||5
8141192|NCT02703337|20067828|P8|STARTED|Period Six (Part A)||0
8141193|NCT02703337|20067829|P7|STARTED|Period Six (Part A)||0
8141194|NCT02703337|20067830|P6|STARTED|Period Six (Part A)||5
8141195|NCT02703337|20067831|P5|STARTED|Period Six (Part A)||4
8141196|NCT02703337|20067832|P4|STARTED|Period Six (Part A)||5
8141197|NCT02703337|20067833|P3|STARTED|Period Six (Part A)||5
8141198|NCT02703337|20067834|P2|STARTED|Period Six (Part A)||5
8141199|NCT02703337|20067835|P1|STARTED|Period Six (Part A)||5
8141200|NCT02703337|20067828|P8|NOT COMPLETED|Period Five (Part A)||0
8141201|NCT02703337|20067829|P7|NOT COMPLETED|Period Five (Part A)||0
8141202|NCT02703337|20067830|P6|NOT COMPLETED|Period Five (Part A)||0
8141203|NCT02703337|20067831|P5|NOT COMPLETED|Period Five (Part A)||0
8141204|NCT02703337|20067832|P4|NOT COMPLETED|Period Five (Part A)||0
8141205|NCT02703337|20067833|P3|NOT COMPLETED|Period Five (Part A)||0
8141206|NCT02703337|20067834|P2|NOT COMPLETED|Period Five (Part A)||0
8141207|NCT02703337|20067835|P1|NOT COMPLETED|Period Five (Part A)||0
8141208|NCT02703337|20067828|P8|COMPLETED|Period Five (Part A)||0
8141209|NCT02703337|20067829|P7|COMPLETED|Period Five (Part A)||0
8141210|NCT02703337|20067830|P6|COMPLETED|Period Five (Part A)||5
8141211|NCT02703337|20067831|P5|COMPLETED|Period Five (Part A)||4
8141212|NCT02703337|20067832|P4|COMPLETED|Period Five (Part A)||5
8141213|NCT02703337|20067833|P3|COMPLETED|Period Five (Part A)||5
8141214|NCT02703337|20067834|P2|COMPLETED|Period Five (Part A)||5
8141215|NCT02703337|20067835|P1|COMPLETED|Period Five (Part A)||5
8141216|NCT02703337|20067828|P8|Received Study Drug|Period Five (Part A)||0
8141217|NCT02703337|20067829|P7|Received Study Drug|Period Five (Part A)||0
8141218|NCT02703337|20067830|P6|Received Study Drug|Period Five (Part A)||5
8141219|NCT02703337|20067831|P5|Received Study Drug|Period Five (Part A)||4
8141220|NCT02703337|20067832|P4|Received Study Drug|Period Five (Part A)||5
8141221|NCT02703337|20067833|P3|Received Study Drug|Period Five (Part A)||5
8141222|NCT02703337|20067834|P2|Received Study Drug|Period Five (Part A)||5
8141223|NCT02703337|20067835|P1|Received Study Drug|Period Five (Part A)||5
8141224|NCT02703337|20067828|P8|STARTED|Period Five (Part A)||0
8141225|NCT02703337|20067829|P7|STARTED|Period Five (Part A)||0
8141226|NCT02703337|20067830|P6|STARTED|Period Five (Part A)||5
8141227|NCT02703337|20067831|P5|STARTED|Period Five (Part A)||4
8141228|NCT02703337|20067832|P4|STARTED|Period Five (Part A)||5
8141229|NCT02703337|20067833|P3|STARTED|Period Five (Part A)||5
8141230|NCT02703337|20067834|P2|STARTED|Period Five (Part A)||5
8141231|NCT02703337|20067835|P1|STARTED|Period Five (Part A)||5
8141232|NCT02703337|20067828|P8|NOT COMPLETED|Period Four (Part A)||0
8141233|NCT02703337|20067829|P7|NOT COMPLETED|Period Four (Part A)||0
8141234|NCT02703337|20067830|P6|NOT COMPLETED|Period Four (Part A)||0
8141235|NCT02703337|20067831|P5|NOT COMPLETED|Period Four (Part A)||0
8141236|NCT02703337|20067832|P4|NOT COMPLETED|Period Four (Part A)||0
8141237|NCT02703337|20067833|P3|NOT COMPLETED|Period Four (Part A)||0
8141238|NCT02703337|20067834|P2|NOT COMPLETED|Period Four (Part A)||0
8141239|NCT02703337|20067835|P1|NOT COMPLETED|Period Four (Part A)||0
8141240|NCT02703337|20067828|P8|COMPLETED|Period Four (Part A)||0
8141241|NCT02703337|20067829|P7|COMPLETED|Period Four (Part A)||0
8141242|NCT02703337|20067830|P6|COMPLETED|Period Four (Part A)||5
8141243|NCT02703337|20067831|P5|COMPLETED|Period Four (Part A)||4
8141244|NCT02703337|20067832|P4|COMPLETED|Period Four (Part A)||5
8141245|NCT02703337|20067833|P3|COMPLETED|Period Four (Part A)||5
8141246|NCT02703337|20067834|P2|COMPLETED|Period Four (Part A)||5
8141247|NCT02703337|20067835|P1|COMPLETED|Period Four (Part A)||5
8141248|NCT02703337|20067828|P8|Received Study Drug|Period Four (Part A)||0
8141249|NCT02703337|20067829|P7|Received Study Drug|Period Four (Part A)||0
8141250|NCT02703337|20067830|P6|Received Study Drug|Period Four (Part A)||5
8141251|NCT02703337|20067831|P5|Received Study Drug|Period Four (Part A)||4
8141252|NCT02703337|20067832|P4|Received Study Drug|Period Four (Part A)||5
8141253|NCT02703337|20067833|P3|Received Study Drug|Period Four (Part A)||5
8141254|NCT02703337|20067834|P2|Received Study Drug|Period Four (Part A)||5
8141255|NCT02703337|20067835|P1|Received Study Drug|Period Four (Part A)||5
8141256|NCT02703337|20067828|P8|STARTED|Period Four (Part A)||0
8141257|NCT02703337|20067829|P7|STARTED|Period Four (Part A)||0
8141258|NCT02703337|20067830|P6|STARTED|Period Four (Part A)||5
8141259|NCT02703337|20067831|P5|STARTED|Period Four (Part A)||4
8141260|NCT02703337|20067832|P4|STARTED|Period Four (Part A)||5
8141261|NCT02703337|20067833|P3|STARTED|Period Four (Part A)||5
8141262|NCT02703337|20067834|P2|STARTED|Period Four (Part A)||5
8141263|NCT02703337|20067835|P1|STARTED|Period Four (Part A)||5
8141264|NCT02703337|20067828|P8|NOT COMPLETED|Period Three (Part A)||0
8141265|NCT02703337|20067829|P7|NOT COMPLETED|Period Three (Part A)||0
8141266|NCT02703337|20067830|P6|NOT COMPLETED|Period Three (Part A)||0
8141267|NCT02703337|20067831|P5|NOT COMPLETED|Period Three (Part A)||0
8141268|NCT02703337|20067832|P4|NOT COMPLETED|Period Three (Part A)||0
8141269|NCT02703337|20067833|P3|NOT COMPLETED|Period Three (Part A)||0
8141270|NCT02703337|20067834|P2|NOT COMPLETED|Period Three (Part A)||0
8141271|NCT02703337|20067835|P1|NOT COMPLETED|Period Three (Part A)||0
8141272|NCT02703337|20067828|P8|COMPLETED|Period Three (Part A)||0
8141273|NCT02703337|20067829|P7|COMPLETED|Period Three (Part A)||0
8141274|NCT02703337|20067830|P6|COMPLETED|Period Three (Part A)||5
8141275|NCT02703337|20067831|P5|COMPLETED|Period Three (Part A)||4
8141276|NCT02703337|20067832|P4|COMPLETED|Period Three (Part A)||5
8141277|NCT02703337|20067833|P3|COMPLETED|Period Three (Part A)||5
8141278|NCT02703337|20067834|P2|COMPLETED|Period Three (Part A)||5
8141279|NCT02703337|20067835|P1|COMPLETED|Period Three (Part A)||5
8141280|NCT02703337|20067828|P8|Received Study Drug|Period Three (Part A)||0
8141281|NCT02703337|20067829|P7|Received Study Drug|Period Three (Part A)||0
8141282|NCT02703337|20067830|P6|Received Study Drug|Period Three (Part A)||5
8141283|NCT02703337|20067831|P5|Received Study Drug|Period Three (Part A)||4
8141284|NCT02703337|20067832|P4|Received Study Drug|Period Three (Part A)||5
8141285|NCT02703337|20067833|P3|Received Study Drug|Period Three (Part A)||5
8141286|NCT02703337|20067834|P2|Received Study Drug|Period Three (Part A)||5
8141287|NCT02703337|20067835|P1|Received Study Drug|Period Three (Part A)||5
8141288|NCT02703337|20067828|P8|STARTED|Period Three (Part A)||0
8141289|NCT02703337|20067829|P7|STARTED|Period Three (Part A)||0
8141290|NCT02703337|20067830|P6|STARTED|Period Three (Part A)||5
8141291|NCT02703337|20067831|P5|STARTED|Period Three (Part A)||4
8141292|NCT02703337|20067832|P4|STARTED|Period Three (Part A)||5
8141293|NCT02703337|20067833|P3|STARTED|Period Three (Part A)||5
8141294|NCT02703337|20067834|P2|STARTED|Period Three (Part A)||5
8141295|NCT02703337|20067835|P1|STARTED|Period Three (Part A)||5
8141296|NCT02703337|20067828|P8|NOT COMPLETED|Period Two (Part A)||0
8141297|NCT02703337|20067829|P7|NOT COMPLETED|Period Two (Part A)||0
8141298|NCT02703337|20067830|P6|NOT COMPLETED|Period Two (Part A)||0
8141299|NCT02703337|20067831|P5|NOT COMPLETED|Period Two (Part A)||0
8141300|NCT02703337|20067832|P4|NOT COMPLETED|Period Two (Part A)||0
8141301|NCT02703337|20067833|P3|NOT COMPLETED|Period Two (Part A)||0
8141302|NCT02703337|20067834|P2|NOT COMPLETED|Period Two (Part A)||0
8141303|NCT02703337|20067835|P1|NOT COMPLETED|Period Two (Part A)||0
8141304|NCT02703337|20067828|P8|COMPLETED|Period Two (Part A)||0
8141305|NCT02703337|20067829|P7|COMPLETED|Period Two (Part A)||0
8141306|NCT02703337|20067830|P6|COMPLETED|Period Two (Part A)||5
8141307|NCT02703337|20067831|P5|COMPLETED|Period Two (Part A)||4
8141308|NCT02703337|20067832|P4|COMPLETED|Period Two (Part A)||5
8141309|NCT02703337|20067833|P3|COMPLETED|Period Two (Part A)||5
8141310|NCT02703337|20067834|P2|COMPLETED|Period Two (Part A)||5
8141311|NCT02703337|20067835|P1|COMPLETED|Period Two (Part A)||5
8141312|NCT02703337|20067828|P8|Received Study Drug|Period Two (Part A)||0
8141313|NCT02703337|20067829|P7|Received Study Drug|Period Two (Part A)||0
8141314|NCT02703337|20067830|P6|Received Study Drug|Period Two (Part A)||5
8141315|NCT02703337|20067831|P5|Received Study Drug|Period Two (Part A)||4
8141316|NCT02703337|20067832|P4|Received Study Drug|Period Two (Part A)||5
8141317|NCT02703337|20067833|P3|Received Study Drug|Period Two (Part A)||5
8141318|NCT02703337|20067834|P2|Received Study Drug|Period Two (Part A)||5
8141319|NCT02703337|20067835|P1|Received Study Drug|Period Two (Part A)||5
8141320|NCT02703337|20067828|P8|STARTED|Period Two (Part A)||0
8141321|NCT02703337|20067829|P7|STARTED|Period Two (Part A)||0
8141322|NCT02703337|20067830|P6|STARTED|Period Two (Part A)||5
8141323|NCT02703337|20067831|P5|STARTED|Period Two (Part A)||4
8141324|NCT02703337|20067832|P4|STARTED|Period Two (Part A)||5
8141325|NCT02703337|20067833|P3|STARTED|Period Two (Part A)||5
8141326|NCT02703337|20067834|P2|STARTED|Period Two (Part A)||5
8141327|NCT02703337|20067835|P1|STARTED|Period Two (Part A)||5
8141328|NCT02703337|20067828|P8|NOT COMPLETED|Period One (Part A)||0
8141329|NCT02703337|20067829|P7|NOT COMPLETED|Period One (Part A)||0
8141330|NCT02703337|20067830|P6|NOT COMPLETED|Period One (Part A)||0
8141331|NCT02703337|20067831|P5|NOT COMPLETED|Period One (Part A)||1
8141332|NCT02703337|20067832|P4|NOT COMPLETED|Period One (Part A)||0
8141333|NCT02703337|20067833|P3|NOT COMPLETED|Period One (Part A)||0
8141334|NCT02703337|20067834|P2|NOT COMPLETED|Period One (Part A)||0
8141335|NCT02703337|20067835|P1|NOT COMPLETED|Period One (Part A)||0
8141336|NCT02703337|20067828|P8|COMPLETED|Period One (Part A)||0
8141337|NCT02703337|20067829|P7|COMPLETED|Period One (Part A)||0
8141338|NCT02703337|20067830|P6|COMPLETED|Period One (Part A)||5
8141339|NCT02703337|20067831|P5|COMPLETED|Period One (Part A)||4
8141340|NCT02703337|20067832|P4|COMPLETED|Period One (Part A)||5
8141341|NCT02703337|20067833|P3|COMPLETED|Period One (Part A)||5
8141342|NCT02703337|20067834|P2|COMPLETED|Period One (Part A)||5
8141343|NCT02703337|20067835|P1|COMPLETED|Period One (Part A)||5
8141344|NCT02703337|20067828|P8|Received Study Drug|Period One (Part A)||0
8141345|NCT02703337|20067829|P7|Received Study Drug|Period One (Part A)||0
8141346|NCT02703337|20067830|P6|Received Study Drug|Period One (Part A)||5
8141347|NCT02703337|20067831|P5|Received Study Drug|Period One (Part A)||5
8141348|NCT02703337|20067832|P4|Received Study Drug|Period One (Part A)||5
8141349|NCT02703337|20067833|P3|Received Study Drug|Period One (Part A)||5
8141350|NCT02703337|20067834|P2|Received Study Drug|Period One (Part A)||5
8141351|NCT02703337|20067835|P1|Received Study Drug|Period One (Part A)||5
8141352|NCT02703337|20067828|P8|STARTED|Period One (Part A)||0
8141353|NCT02703337|20067829|P7|STARTED|Period One (Part A)||0
8141354|NCT02703337|20067830|P6|STARTED|Period One (Part A)||5
8141355|NCT02703337|20067831|P5|STARTED|Period One (Part A)||5
8141356|NCT02703337|20067832|P4|STARTED|Period One (Part A)||5
8141357|NCT02703337|20067833|P3|STARTED|Period One (Part A)||5
8141358|NCT02703337|20067834|P2|STARTED|Period One (Part A)||5
8141359|NCT02703337|20067835|P1|STARTED|Period One (Part A)||5
8141360|NCT02703324|20067855|P6|NOT COMPLETED|Period Four||0
8141361|NCT02703324|20067856|P5|NOT COMPLETED|Period Four||0
8141362|NCT02703324|20067857|P4|NOT COMPLETED|Period Four||0
8141363|NCT02703324|20067858|P3|NOT COMPLETED|Period Four||0
8141364|NCT02703324|20067859|P2|NOT COMPLETED|Period Four||0
8141365|NCT02703324|20067860|P1|NOT COMPLETED|Period Four||0
8141366|NCT02703324|20067855|P6|COMPLETED|Period Four||5
8141367|NCT02703324|20067856|P5|COMPLETED|Period Four||5
8141368|NCT02703324|20067857|P4|COMPLETED|Period Four||5
8141369|NCT02703324|20067858|P3|COMPLETED|Period Four||4
8141370|NCT02703324|20067859|P2|COMPLETED|Period Four||4
8141371|NCT02703324|20067860|P1|COMPLETED|Period Four||5
8141372|NCT02703324|20067855|P6|Received Study Drug|Period Four||5
8141373|NCT02703324|20067856|P5|Received Study Drug|Period Four||5
8141374|NCT02703324|20067857|P4|Received Study Drug|Period Four||5
8141375|NCT02703324|20067858|P3|Received Study Drug|Period Four||4
8141376|NCT02703324|20067859|P2|Received Study Drug|Period Four||4
8141377|NCT02703324|20067860|P1|Received Study Drug|Period Four||5
8141378|NCT02703324|20067855|P6|STARTED|Period Four||5
8141379|NCT02703324|20067856|P5|STARTED|Period Four||5
8141380|NCT02703324|20067857|P4|STARTED|Period Four||5
8141381|NCT02703324|20067858|P3|STARTED|Period Four||4
8141382|NCT02703324|20067859|P2|STARTED|Period Four|One participant discontinued after Period 3. Did not enter Period 4.|4
8141383|NCT02703324|20067860|P1|STARTED|Period Four||5
8141384|NCT02703324|20067855|P6|NOT COMPLETED|Period Three||0
8141385|NCT02703324|20067856|P5|NOT COMPLETED|Period Three||0
8141386|NCT02703324|20067857|P4|NOT COMPLETED|Period Three||0
8141387|NCT02703324|20067858|P3|NOT COMPLETED|Period Three||0
8141388|NCT02703324|20067859|P2|NOT COMPLETED|Period Three||0
8141389|NCT02703324|20067860|P1|NOT COMPLETED|Period Three||0
8141390|NCT02703324|20067855|P6|COMPLETED|Period Three||5
8141391|NCT02703324|20067856|P5|COMPLETED|Period Three||5
8141392|NCT02703324|20067857|P4|COMPLETED|Period Three||5
8141393|NCT02703324|20067858|P3|COMPLETED|Period Three||4
8141394|NCT02703324|20067859|P2|COMPLETED|Period Three|One participant discontinued after Period 3. Did not enter Period 4.|5
8141395|NCT02703324|20067860|P1|COMPLETED|Period Three||5
8141396|NCT02703324|20067855|P6|Received Study Drug|Period Three||5
8141397|NCT02703324|20067856|P5|Received Study Drug|Period Three||5
8141398|NCT02703324|20067857|P4|Received Study Drug|Period Three||5
8141399|NCT02703324|20067858|P3|Received Study Drug|Period Three||4
8141400|NCT02703324|20067859|P2|Received Study Drug|Period Three||5
8141401|NCT02703324|20067860|P1|Received Study Drug|Period Three||5
8141402|NCT02703324|20067855|P6|STARTED|Period Three||5
8141403|NCT02703324|20067856|P5|STARTED|Period Three||5
8141404|NCT02703324|20067857|P4|STARTED|Period Three||5
8141405|NCT02703324|20067858|P3|STARTED|Period Three||4
8141406|NCT02703324|20067859|P2|STARTED|Period Three||5
8141407|NCT02703324|20067860|P1|STARTED|Period Three||5
8141408|NCT02703324|20067855|P6|NOT COMPLETED|Period Two||0
8141409|NCT02703324|20067856|P5|NOT COMPLETED|Period Two||0
8141410|NCT02703324|20067857|P4|NOT COMPLETED|Period Two||0
8141411|NCT02703324|20067858|P3|NOT COMPLETED|Period Two||1
8141412|NCT02703324|20067859|P2|NOT COMPLETED|Period Two||0
8141413|NCT02703324|20067860|P1|NOT COMPLETED|Period Two||0
8141414|NCT02703324|20067855|P6|COMPLETED|Period Two||5
8141415|NCT02703324|20067856|P5|COMPLETED|Period Two||5
8141416|NCT02703324|20067857|P4|COMPLETED|Period Two||5
8141417|NCT02703324|20067858|P3|COMPLETED|Period Two||4
8141418|NCT02703324|20067859|P2|COMPLETED|Period Two||5
8141419|NCT02703324|20067860|P1|COMPLETED|Period Two||5
8141420|NCT02703324|20067855|P6|Received Study Drug|Period Two||5
8141421|NCT02703324|20067856|P5|Received Study Drug|Period Two||5
8141422|NCT02703324|20067857|P4|Received Study Drug|Period Two||5
8141423|NCT02703324|20067858|P3|Received Study Drug|Period Two||5
8141424|NCT02703324|20067859|P2|Received Study Drug|Period Two||5
8141425|NCT02703324|20067860|P1|Received Study Drug|Period Two||5
8141426|NCT02703324|20067855|P6|STARTED|Period Two||5
8141427|NCT02703324|20067856|P5|STARTED|Period Two||5
8141428|NCT02703324|20067857|P4|STARTED|Period Two||5
8141429|NCT02703324|20067858|P3|STARTED|Period Two||5
8141430|NCT02703324|20067859|P2|STARTED|Period Two||5
8141431|NCT02703324|20067860|P1|STARTED|Period Two||5
8141432|NCT02703324|20067855|P6|NOT COMPLETED|Period One||0
8141433|NCT02703324|20067856|P5|NOT COMPLETED|Period One||0
8141434|NCT02703324|20067857|P4|NOT COMPLETED|Period One||0
8141435|NCT02703324|20067858|P3|NOT COMPLETED|Period One||0
8141436|NCT02703324|20067859|P2|NOT COMPLETED|Period One||0
8141437|NCT02703324|20067860|P1|NOT COMPLETED|Period One||0
8141438|NCT02703324|20067855|P6|COMPLETED|Period One||5
8141439|NCT02703324|20067856|P5|COMPLETED|Period One||5
8141440|NCT02703324|20067857|P4|COMPLETED|Period One||5
8141441|NCT02703324|20067858|P3|COMPLETED|Period One||5
8141442|NCT02703324|20067859|P2|COMPLETED|Period One||5
8141443|NCT02703324|20067860|P1|COMPLETED|Period One||5
8141444|NCT02703324|20067855|P6|Received Study Drug|Period One||5
8141445|NCT02703324|20067856|P5|Received Study Drug|Period One||5
8141446|NCT02703324|20067857|P4|Received Study Drug|Period One||5
8141447|NCT02703324|20067858|P3|Received Study Drug|Period One||5
8141448|NCT02703324|20067859|P2|Received Study Drug|Period One||5
8141449|NCT02703324|20067860|P1|Received Study Drug|Period One||5
8141450|NCT02703324|20067855|P6|STARTED|Period One||5
8141451|NCT02703324|20067856|P5|STARTED|Period One||5
8141452|NCT02703324|20067857|P4|STARTED|Period One||5
8141453|NCT02703324|20067858|P3|STARTED|Period One||5
8141454|NCT02703324|20067859|P2|STARTED|Period One||5
8141455|NCT02703324|20067860|P1|STARTED|Period One||5
8141456|NCT02703311|20067869|P1|NOT COMPLETED|Overall Study||8
8141457|NCT02703311|20067869|P1|COMPLETED|Overall Study||3
8141458|NCT02703311|20067869|P1|30 Day Follow-Up Completed|Overall Study||9
8141459|NCT02703311|20067869|P1|Implanted|Overall Study||11
8141460|NCT02703311|20067869|P1|STARTED|Overall Study||11
8141461|NCT02703259|20067887|P2|NOT COMPLETED|2 Weeks Postoperative Assessment||10
8141462|NCT02703259|20067888|P1|NOT COMPLETED|2 Weeks Postoperative Assessment||10
8141463|NCT02703259|20067887|P2|COMPLETED|2 Weeks Postoperative Assessment||51
8141464|NCT02703259|20067888|P1|COMPLETED|2 Weeks Postoperative Assessment||58
8141465|NCT02703259|20067887|P2|STARTED|2 Weeks Postoperative Assessment||61
8141466|NCT02703259|20067888|P1|STARTED|2 Weeks Postoperative Assessment||68
8141467|NCT02703259|20067887|P2|NOT COMPLETED|24 Hours Postoperative Assessment||6
8141468|NCT02703259|20067888|P1|NOT COMPLETED|24 Hours Postoperative Assessment||2
8141469|NCT02703259|20067887|P2|COMPLETED|24 Hours Postoperative Assessment||61
8141470|NCT02703259|20067888|P1|COMPLETED|24 Hours Postoperative Assessment||68
8141471|NCT02703259|20067887|P2|STARTED|24 Hours Postoperative Assessment||67
8141472|NCT02703259|20067888|P1|STARTED|24 Hours Postoperative Assessment||70
8141473|NCT02702999|20067906|P2|NOT COMPLETED|Overall Study||0
8141474|NCT02702999|20067907|P1|NOT COMPLETED|Overall Study||0
8141475|NCT02702999|20067906|P2|COMPLETED|Overall Study||104
8141476|NCT02702999|20067907|P1|COMPLETED|Overall Study||102
8141477|NCT02702999|20067906|P2|STARTED|Overall Study||104
8141478|NCT02702999|20067907|P1|STARTED|Overall Study||102
8141479|NCT02702921|20067925|P2|NOT COMPLETED|Overall Study||8
8141480|NCT02702921|20067926|P1|NOT COMPLETED|Overall Study||14
8141481|NCT02702921|20067925|P2|COMPLETED|Overall Study||95
8141482|NCT02702921|20067926|P1|COMPLETED|Overall Study||84
8141483|NCT02702921|20067925|P2|STARTED|Overall Study||103
8141484|NCT02702921|20067926|P1|STARTED|Overall Study||98
8141485|NCT02702609|20067936|P2|NOT COMPLETED|Overall Study||4
8141486|NCT02702609|20067937|P1|NOT COMPLETED|Overall Study||9
8141487|NCT02702609|20067936|P2|COMPLETED|Overall Study||17
8141488|NCT02702609|20067937|P1|COMPLETED|Overall Study||15
8141489|NCT02702609|20067936|P2|Crown Delivery|Overall Study||18
8141490|NCT02702609|20067937|P1|Crown Delivery|Overall Study||16
8141491|NCT02702609|20067936|P2|Implant Placement|Overall Study||21
8141492|NCT02702609|20067937|P1|Implant Placement|Overall Study||23
8141493|NCT02702609|20067936|P2|STARTED|Overall Study||21
8141494|NCT02702609|20067937|P1|STARTED|Overall Study||24
8141503|NCT02702388|20067978|P2|NOT COMPLETED|Overall Study||77
8141504|NCT02702388|20067979|P1|NOT COMPLETED|Overall Study||75
8141505|NCT02702388|20067978|P2|COMPLETED|Overall Study||0
8141506|NCT02702388|20067979|P1|COMPLETED|Overall Study||0
8141507|NCT02702388|20067978|P2|STARTED|Overall Study||77
8141508|NCT02702388|20067979|P1|STARTED|Overall Study||75
8141509|NCT02702193|20068001|P2|NOT COMPLETED|12 Month Follow up||18
8141510|NCT02702193|20068002|P1|NOT COMPLETED|12 Month Follow up||17
8141511|NCT02702193|20068001|P2|COMPLETED|12 Month Follow up||69
8141512|NCT02702193|20068002|P1|COMPLETED|12 Month Follow up||69
8141513|NCT02702193|20068001|P2|STARTED|12 Month Follow up||87
8141514|NCT02702193|20068002|P1|STARTED|12 Month Follow up||86
8141515|NCT02702193|20068001|P2|NOT COMPLETED|8 Month Follow up||18
8141516|NCT02702193|20068002|P1|NOT COMPLETED|8 Month Follow up||15
8141517|NCT02702193|20068001|P2|COMPLETED|8 Month Follow up||69
8141518|NCT02702193|20068002|P1|COMPLETED|8 Month Follow up||71
8141519|NCT02702193|20068001|P2|STARTED|8 Month Follow up||87
8141520|NCT02702193|20068002|P1|STARTED|8 Month Follow up||86
8141521|NCT02702193|20068001|P2|NOT COMPLETED|4 Month Follow up||18
8141522|NCT02702193|20068002|P1|NOT COMPLETED|4 Month Follow up||18
8141523|NCT02702193|20068001|P2|COMPLETED|4 Month Follow up||69
8141524|NCT02702193|20068002|P1|COMPLETED|4 Month Follow up||68
8141525|NCT02702193|20068001|P2|STARTED|4 Month Follow up||87
8141526|NCT02702193|20068002|P1|STARTED|4 Month Follow up||86
8141527|NCT02702193|20068001|P2|NOT COMPLETED|Baseline Assessment/Randomization||0
8141528|NCT02702193|20068002|P1|NOT COMPLETED|Baseline Assessment/Randomization||1
8141529|NCT02702193|20068001|P2|COMPLETED|Baseline Assessment/Randomization||87
8141530|NCT02702193|20068002|P1|COMPLETED|Baseline Assessment/Randomization||85
8141531|NCT02702193|20068001|P2|STARTED|Baseline Assessment/Randomization||87
8141532|NCT02702193|20068002|P1|STARTED|Baseline Assessment/Randomization||86
8141533|NCT02702011|20068030|P4|NOT COMPLETED|Overall Study||0
8141534|NCT02702011|20068031|P3|NOT COMPLETED|Overall Study||0
8141535|NCT02702011|20068032|P2|NOT COMPLETED|Overall Study||1
8141536|NCT02702011|20068033|P1|NOT COMPLETED|Overall Study||0
8141537|NCT02702011|20068030|P4|COMPLETED|Overall Study||12
8141538|NCT02702011|20068031|P3|COMPLETED|Overall Study||12
8141539|NCT02702011|20068032|P2|COMPLETED|Overall Study||12
8141540|NCT02702011|20068033|P1|COMPLETED|Overall Study||11
8141541|NCT02702011|20068030|P4|STARTED|Overall Study|Started are the treated patients.|12
8141542|NCT02702011|20068031|P3|STARTED|Overall Study|Started are the treated patients.|12
8141543|NCT02702011|20068032|P2|STARTED|Overall Study|Started are the treated patients.|13
8141544|NCT02702011|20068033|P1|STARTED|Overall Study|Started are the treated patients.|11
8141545|NCT02701985|20068045|P2|NOT COMPLETED|Overall Study||6
8141546|NCT02701985|20068046|P1|NOT COMPLETED|Overall Study||3
8141547|NCT02701985|20068045|P2|COMPLETED|Overall Study||32
8141548|NCT02701985|20068046|P1|COMPLETED|Overall Study||34
8141549|NCT02701985|20068045|P2|STARTED|Overall Study||38
8141550|NCT02701985|20068046|P1|STARTED|Overall Study||37
8141551|NCT02701868|20068090|P3|NOT COMPLETED|Overall Study||0
8141552|NCT02701868|20068091|P2|NOT COMPLETED|Overall Study||0
8141553|NCT02701868|20068092|P1|NOT COMPLETED|Overall Study||0
8141554|NCT02701868|20068090|P3|COMPLETED|Overall Study||75
8141555|NCT02701868|20068091|P2|COMPLETED|Overall Study||75
8141556|NCT02701868|20068092|P1|COMPLETED|Overall Study||21
8141557|NCT02701868|20068090|P3|STARTED|Overall Study||75
8141558|NCT02701868|20068091|P2|STARTED|Overall Study||75
8141559|NCT02701868|20068092|P1|STARTED|Overall Study||21
8141560|NCT02701777|20068105|P3|NOT COMPLETED|Overall Study||4
8141561|NCT02701777|20068106|P2|NOT COMPLETED|Overall Study||3
8141562|NCT02701777|20068107|P1|NOT COMPLETED|Overall Study||4
8141563|NCT02701777|20068105|P3|COMPLETED|Overall Study||12
8141564|NCT02701777|20068106|P2|COMPLETED|Overall Study||13
8141565|NCT02701777|20068107|P1|COMPLETED|Overall Study||8
8141566|NCT02701777|20068105|P3|STARTED|Overall Study||16
8141567|NCT02701777|20068106|P2|STARTED|Overall Study||16
8141568|NCT02701777|20068107|P1|STARTED|Overall Study||12
8141569|NCT02701764|20068123|P2|NOT COMPLETED|Overall Study||1
8141570|NCT02701764|20068124|P1|NOT COMPLETED|Overall Study||0
8141571|NCT02701764|20068123|P2|COMPLETED|Overall Study||21
8141572|NCT02701764|20068124|P1|COMPLETED|Overall Study||21
8141573|NCT02701764|20068123|P2|STARTED|Overall Study||22
8141574|NCT02701764|20068124|P1|STARTED|Overall Study||21
8141575|NCT02701647|20068147|P3|NOT COMPLETED|Overall Study||1
8141576|NCT02701647|20068148|P2|NOT COMPLETED|Overall Study||0
8141577|NCT02701647|20068149|P1|NOT COMPLETED|Overall Study||0
8141578|NCT02701647|20068147|P3|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16
8141579|NCT02701647|20068148|P2|COMPLETED|Overall Study||17
8141580|NCT02701647|20068149|P1|COMPLETED|Overall Study||17
8141581|NCT02701647|20068147|P3|STARTED|Overall Study||17
8141582|NCT02701647|20068148|P2|STARTED|Overall Study||17
8141583|NCT02701647|20068149|P1|STARTED|Overall Study||17
8141584|NCT02701634|20068183|P2|NOT COMPLETED|Overall Study||31
8141585|NCT02701634|20068184|P1|NOT COMPLETED|Overall Study||32
8141586|NCT02701634|20068183|P2|COMPLETED|Overall Study||2
8141587|NCT02701634|20068184|P1|COMPLETED|Overall Study||1
8141588|NCT02701634|20068183|P2|STARTED|Overall Study||33
8141589|NCT02701634|20068184|P1|STARTED|Overall Study||33
8141590|NCT02701582|20068214|P2|NOT COMPLETED|Overall Study||0
8141591|NCT02701582|20068215|P1|NOT COMPLETED|Overall Study||2
8141592|NCT02701582|20068214|P2|COMPLETED|Overall Study||33
8141593|NCT02701582|20068215|P1|COMPLETED|Overall Study||33
8141594|NCT02701582|20068214|P2|STARTED|Overall Study||33
8141595|NCT02701582|20068215|P1|STARTED|Overall Study||35
8141596|NCT02701556|20068239|P2|NOT COMPLETED|Overall Study||20
8141597|NCT02701556|20068240|P1|NOT COMPLETED|Overall Study||23
8141598|NCT02701556|20068239|P2|COMPLETED|Overall Study||178
8141599|NCT02701556|20068240|P1|COMPLETED|Overall Study||175
8141600|NCT02701556|20068239|P2|STARTED|Overall Study||198
8141601|NCT02701556|20068240|P1|STARTED|Overall Study||198
8141602|NCT02701387|20068246|P1|NOT COMPLETED|Overall Study||0
8141603|NCT02701387|20068246|P1|COMPLETED|Overall Study||7
8141604|NCT02701387|20068246|P1|STARTED|Overall Study||7
8141605|NCT02701361|20068254|P3|NOT COMPLETED|Overall Study||2
8141606|NCT02701361|20068255|P2|NOT COMPLETED|Overall Study||3
8141607|NCT02701361|20068256|P1|NOT COMPLETED|Overall Study||9
8141608|NCT02701361|20068254|P3|COMPLETED|Overall Study||16
8141609|NCT02701361|20068255|P2|COMPLETED|Overall Study||28
8141610|NCT02701361|20068256|P1|COMPLETED|Overall Study||22
8141611|NCT02701361|20068254|P3|STARTED|Overall Study||18
8141612|NCT02701361|20068255|P2|STARTED|Overall Study||31
8141613|NCT02701361|20068256|P1|STARTED|Overall Study||31
8141614|NCT02701296|20068297|P2|NOT COMPLETED|Overall Study||2
8141615|NCT02701296|20068298|P1|NOT COMPLETED|Overall Study||0
8141616|NCT02701296|20068297|P2|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
8141617|NCT02701296|20068298|P1|COMPLETED|Overall Study||42
8141618|NCT02701296|20068297|P2|STARTED|Overall Study||38
8141619|NCT02701296|20068298|P1|STARTED|Overall Study||42
8141620|NCT02701270|20068314|P4|NOT COMPLETED|Fourth Intervention at Visit 4||0
8141621|NCT02701270|20068315|P3|NOT COMPLETED|Fourth Intervention at Visit 4||0
8141622|NCT02701270|20068316|P2|NOT COMPLETED|Fourth Intervention at Visit 4||0
8141623|NCT02701270|20068317|P1|NOT COMPLETED|Fourth Intervention at Visit 4||0
8141624|NCT02701270|20068314|P4|COMPLETED|Fourth Intervention at Visit 4||3
8141625|NCT02701270|20068315|P3|COMPLETED|Fourth Intervention at Visit 4||3
8141626|NCT02701270|20068316|P2|COMPLETED|Fourth Intervention at Visit 4||3
8141627|NCT02701270|20068317|P1|COMPLETED|Fourth Intervention at Visit 4||2
8141628|NCT02701270|20068314|P4|STARTED|Fourth Intervention at Visit 4||3
8141629|NCT02701270|20068315|P3|STARTED|Fourth Intervention at Visit 4||3
8141630|NCT02701270|20068316|P2|STARTED|Fourth Intervention at Visit 4||3
8141631|NCT02701270|20068317|P1|STARTED|Fourth Intervention at Visit 4||2
8141632|NCT02701270|20068314|P4|NOT COMPLETED|Third Intervention at Visit 3||0
8141633|NCT02701270|20068315|P3|NOT COMPLETED|Third Intervention at Visit 3||0
8141634|NCT02701270|20068316|P2|NOT COMPLETED|Third Intervention at Visit 3||0
8141635|NCT02701270|20068317|P1|NOT COMPLETED|Third Intervention at Visit 3||0
8141636|NCT02701270|20068314|P4|COMPLETED|Third Intervention at Visit 3||3
8141637|NCT02701270|20068315|P3|COMPLETED|Third Intervention at Visit 3||3
8141638|NCT02701270|20068316|P2|COMPLETED|Third Intervention at Visit 3||3
8141639|NCT02701270|20068317|P1|COMPLETED|Third Intervention at Visit 3||2
8141640|NCT02701270|20068314|P4|STARTED|Third Intervention at Visit 3||3
8141641|NCT02701270|20068315|P3|STARTED|Third Intervention at Visit 3||3
8141642|NCT02701270|20068316|P2|STARTED|Third Intervention at Visit 3||3
8141643|NCT02701270|20068317|P1|STARTED|Third Intervention at Visit 3||2
8141644|NCT02701270|20068314|P4|NOT COMPLETED|Second Intervention at Visit 2||0
8141645|NCT02701270|20068315|P3|NOT COMPLETED|Second Intervention at Visit 2||0
8141646|NCT02701270|20068316|P2|NOT COMPLETED|Second Intervention at Visit 2||0
8141647|NCT02701270|20068317|P1|NOT COMPLETED|Second Intervention at Visit 2||0
8141648|NCT02701270|20068314|P4|COMPLETED|Second Intervention at Visit 2||3
8141649|NCT02701270|20068315|P3|COMPLETED|Second Intervention at Visit 2||3
8141650|NCT02701270|20068316|P2|COMPLETED|Second Intervention at Visit 2||3
8141651|NCT02701270|20068317|P1|COMPLETED|Second Intervention at Visit 2||2
8141652|NCT02701270|20068314|P4|STARTED|Second Intervention at Visit 2||3
8141653|NCT02701270|20068315|P3|STARTED|Second Intervention at Visit 2||3
8141654|NCT02701270|20068316|P2|STARTED|Second Intervention at Visit 2||3
8141655|NCT02701270|20068317|P1|STARTED|Second Intervention at Visit 2||2
8141656|NCT02701270|20068314|P4|NOT COMPLETED|First Intervention at Visit 1||0
8141657|NCT02701270|20068315|P3|NOT COMPLETED|First Intervention at Visit 1||0
8141658|NCT02701270|20068316|P2|NOT COMPLETED|First Intervention at Visit 1||0
8141659|NCT02701270|20068317|P1|NOT COMPLETED|First Intervention at Visit 1||0
8141660|NCT02701270|20068314|P4|COMPLETED|First Intervention at Visit 1||3
8141661|NCT02701270|20068315|P3|COMPLETED|First Intervention at Visit 1||3
8141662|NCT02701270|20068316|P2|COMPLETED|First Intervention at Visit 1||3
8141663|NCT02701270|20068317|P1|COMPLETED|First Intervention at Visit 1||2
8141664|NCT02701270|20068314|P4|STARTED|First Intervention at Visit 1||3
8141665|NCT02701270|20068315|P3|STARTED|First Intervention at Visit 1||3
8141666|NCT02701270|20068316|P2|STARTED|First Intervention at Visit 1||3
8141667|NCT02701270|20068317|P1|STARTED|First Intervention at Visit 1||2
8141668|NCT02701257|20068336|P5|NOT COMPLETED|Overall Study||3
8141669|NCT02701257|20068337|P4|NOT COMPLETED|Overall Study||1
8141670|NCT02701257|20068338|P3|NOT COMPLETED|Overall Study||0
8141671|NCT02701257|20068339|P2|NOT COMPLETED|Overall Study||3
8141672|NCT02701257|20068340|P1|NOT COMPLETED|Overall Study||0
8141673|NCT02701257|20068336|P5|COMPLETED|Overall Study||1
8141674|NCT02701257|20068337|P4|COMPLETED|Overall Study||3
8141675|NCT02701257|20068338|P3|COMPLETED|Overall Study||0
8141676|NCT02701257|20068339|P2|COMPLETED|Overall Study||3
8141677|NCT02701257|20068340|P1|COMPLETED|Overall Study||6
8141678|NCT02701257|20068336|P5|STARTED|Overall Study||4
8141679|NCT02701257|20068337|P4|STARTED|Overall Study||4
8141680|NCT02701257|20068338|P3|STARTED|Overall Study||0
8141681|NCT02701257|20068339|P2|STARTED|Overall Study||6
8141682|NCT02701257|20068340|P1|STARTED|Overall Study||6
8141683|NCT02701101|20068527|P1|NOT COMPLETED|Overall Study||0
8141684|NCT02701101|20068527|P1|COMPLETED|Overall Study||189
8141685|NCT02701101|20068527|P1|STARTED|Overall Study||189
8141686|NCT02701049|20068536|P3|NOT COMPLETED|Overall Study||0
8141687|NCT02701049|20068537|P2|NOT COMPLETED|Overall Study||0
8141688|NCT02701049|20068538|P1|NOT COMPLETED|Overall Study||0
8141689|NCT02701049|20068536|P3|COMPLETED|Overall Study|Total patients included in analysis|198
8141690|NCT02701049|20068537|P2|COMPLETED|Overall Study|Total patients included in analysis|342
8141691|NCT02701049|20068538|P1|COMPLETED|Overall Study|Total patients included in analysis|209
8141692|NCT02701049|20068536|P3|STARTED|Overall Study|Patients who completed a follow-up survey|198
8141693|NCT02701049|20068537|P2|STARTED|Overall Study|Patients who completed a follow-up survey|342
8141694|NCT02701049|20068538|P1|STARTED|Overall Study|Patients who completed a follow-up survey|209
8141695|NCT02700997|20068550|P1|NOT COMPLETED|Overall Study||2
8141696|NCT02700997|20068550|P1|COMPLETED|Overall Study||15
8141697|NCT02700997|20068550|P1|STARTED|Overall Study||17
8141698|NCT02700984|20068556|P2|NOT COMPLETED|Overall Study||14
8141699|NCT02700984|20068557|P1|NOT COMPLETED|Overall Study||15
8141700|NCT02700984|20068556|P2|COMPLETED|Overall Study||53
8141701|NCT02700984|20068557|P1|COMPLETED|Overall Study||200
8141702|NCT02700984|20068556|P2|STARTED|Overall Study||67
8141703|NCT02700984|20068557|P1|STARTED|Overall Study||215
8141704|NCT02700919|20068609|P3|NOT COMPLETED|Overall Study||4
8141705|NCT02700919|20068610|P2|NOT COMPLETED|Overall Study||12
8141706|NCT02700919|20068611|P1|NOT COMPLETED|Overall Study||12
8141707|NCT02700919|20068609|P3|COMPLETED|Overall Study||87
8141708|NCT02700919|20068610|P2|COMPLETED|Overall Study||85
8141709|NCT02700919|20068611|P1|COMPLETED|Overall Study||82
8141710|NCT02700919|20068609|P3|STARTED|Overall Study||91
8141711|NCT02700919|20068610|P2|STARTED|Overall Study||97
8141712|NCT02700919|20068611|P1|STARTED|Overall Study||94
8141713|NCT02700815|20068673|P4|NOT COMPLETED|Overall Study||7
8141714|NCT02700815|20068674|P3|NOT COMPLETED|Overall Study||4
8141715|NCT02700815|20068675|P2|NOT COMPLETED|Overall Study||7
8141716|NCT02700815|20068676|P1|NOT COMPLETED|Overall Study||1
8141717|NCT02700815|20068673|P4|COMPLETED|Overall Study||218
8141718|NCT02700815|20068674|P3|COMPLETED|Overall Study||219
8141719|NCT02700815|20068675|P2|COMPLETED|Overall Study||216
8141720|NCT02700815|20068676|P1|COMPLETED|Overall Study||74
8141721|NCT02700815|20068673|P4|STARTED|Overall Study||225
8141722|NCT02700815|20068674|P3|STARTED|Overall Study||223
8141723|NCT02700815|20068675|P2|STARTED|Overall Study||223
8141724|NCT02700815|20068676|P1|STARTED|Overall Study||75
8141725|NCT02700412|20068714|P1|NOT COMPLETED|Overall Study||33
8141726|NCT02700412|20068714|P1|COMPLETED|Overall Study||47
8141727|NCT02700412|20068714|P1|STARTED|Overall Study||80
8141728|NCT02700334|20068724|P2|NOT COMPLETED|Overall Study||0
8141729|NCT02700334|20068725|P1|NOT COMPLETED|Overall Study||0
8141730|NCT02700334|20068724|P2|COMPLETED|Overall Study||12
8141731|NCT02700334|20068725|P1|COMPLETED|Overall Study||12
8141732|NCT02700334|20068724|P2|STARTED|Overall Study||12
8141733|NCT02700334|20068725|P1|STARTED|Overall Study||12
8141746|NCT02699970|20068845|P1|NOT COMPLETED|Overall Study||0
8141747|NCT02699970|20068845|P1|COMPLETED|Overall Study||399
8141748|NCT02699970|20068845|P1|Inter-system|Overall Study||399
8141749|NCT02699970|20068845|P1|Intra-system|Overall Study||399
8141750|NCT02699970|20068845|P1|STARTED|Overall Study||399
8141751|NCT02699892|20068850|P1|NOT COMPLETED|Overall Study||36
8141752|NCT02699892|20068850|P1|COMPLETED|Overall Study||94
8141753|NCT02699892|20068850|P1|STARTED|Overall Study||130
8141758|NCT02699684|20068863|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
8141759|NCT02699684|20068864|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
8141760|NCT02699684|20068863|P2|COMPLETED|Period 2, Second 30 Days of Wear||38
8141761|NCT02699684|20068864|P1|COMPLETED|Period 2, Second 30 Days of Wear||36
8141762|NCT02699684|20068863|P2|STARTED|Period 2, Second 30 Days of Wear||38
8141763|NCT02699684|20068864|P1|STARTED|Period 2, Second 30 Days of Wear||37
8141764|NCT02699684|20068863|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||0
8141765|NCT02699684|20068864|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
8141766|NCT02699684|20068863|P2|COMPLETED|Period 1, First 30 Days of Wear||38
8141767|NCT02699684|20068864|P1|COMPLETED|Period 1, First 30 Days of Wear||37
8141768|NCT02699684|20068863|P2|STARTED|Period 1, First 30 Days of Wear||38
8141769|NCT02699684|20068864|P1|STARTED|Period 1, First 30 Days of Wear||37
8141770|NCT02699632|20068874|P1|NOT COMPLETED|Overall Study||2
8141771|NCT02699632|20068874|P1|COMPLETED|Overall Study||358
8141772|NCT02699632|20068874|P1|STARTED|Overall Study||360
8141773|NCT02699593|20068881|P2|NOT COMPLETED|Period 2||2
8141774|NCT02699593|20068882|P1|NOT COMPLETED|Period 2||2
8141775|NCT02699593|20068881|P2|COMPLETED|Period 2||60
8141776|NCT02699593|20068882|P1|COMPLETED|Period 2||65
8141777|NCT02699593|20068881|P2|STARTED|Period 2||62
8141778|NCT02699593|20068882|P1|STARTED|Period 2||67
8141779|NCT02699593|20068881|P2|NOT COMPLETED|Period 1||7
8141780|NCT02699593|20068882|P1|NOT COMPLETED|Period 1||5
8141781|NCT02699593|20068881|P2|COMPLETED|Period 1||62
8141782|NCT02699593|20068882|P1|COMPLETED|Period 1||67
8141783|NCT02699593|20068881|P2|STARTED|Period 1||69
8141784|NCT02699593|20068882|P1|STARTED|Period 1||72
8141785|NCT02699463|20068892|P2|NOT COMPLETED|Overall Study||9
8141786|NCT02699463|20068893|P1|NOT COMPLETED|Overall Study||15
8141787|NCT02699463|20068892|P2|COMPLETED|Overall Study||109
8141788|NCT02699463|20068893|P1|COMPLETED|Overall Study||100
8141789|NCT02699463|20068892|P2|STARTED|Overall Study||118
8141790|NCT02699463|20068893|P1|STARTED|Overall Study||115
8141791|NCT02699450|20068902|P3|NOT COMPLETED|Overall Study||15
8141792|NCT02699450|20068903|P2|NOT COMPLETED|Overall Study||5
8141793|NCT02699450|20068904|P1|NOT COMPLETED|Overall Study||15
8141794|NCT02699450|20068902|P3|COMPLETED|Overall Study||67
8141795|NCT02699450|20068903|P2|COMPLETED|Overall Study||50
8141796|NCT02699450|20068904|P1|COMPLETED|Overall Study||75
8141797|NCT02699450|20068902|P3|Completed up to Week 24|Overall Study||73
8141798|NCT02699450|20068903|P2|Completed up to Week 24|Overall Study||53
8141799|NCT02699450|20068904|P1|Completed up to Week 24|Overall Study||81
8141800|NCT02699450|20068902|P3|Received at Least One Dose of Study Drug|Overall Study||80
8141801|NCT02699450|20068903|P2|Received at Least One Dose of Study Drug|Overall Study||55
8141802|NCT02699450|20068904|P1|Received at Least One Dose of Study Drug|Overall Study||89
8141803|NCT02699450|20068902|P3|STARTED|Overall Study||82
8141804|NCT02699450|20068903|P2|STARTED|Overall Study||55
8141805|NCT02699450|20068904|P1|STARTED|Overall Study||90
8141806|NCT02699125|20069039|P2|NOT COMPLETED|Second Intervention (6 Weeks).||2
8141807|NCT02699125|20069040|P1|NOT COMPLETED|Second Intervention (6 Weeks).||7
8141808|NCT02699125|20069039|P2|COMPLETED|Second Intervention (6 Weeks).||14
8141809|NCT02699125|20069040|P1|COMPLETED|Second Intervention (6 Weeks).||11
8141810|NCT02699125|20069039|P2|STARTED|Second Intervention (6 Weeks).||16
8141811|NCT02699125|20069040|P1|STARTED|Second Intervention (6 Weeks).||18
8141812|NCT02699125|20069039|P2|NOT COMPLETED|First Intervention (6 Weeks).||0
8141813|NCT02699125|20069040|P1|NOT COMPLETED|First Intervention (6 Weeks).||0
8141814|NCT02699125|20069039|P2|COMPLETED|First Intervention (6 Weeks).||16
8141815|NCT02699125|20069040|P1|COMPLETED|First Intervention (6 Weeks).||18
8141816|NCT02699125|20069039|P2|STARTED|First Intervention (6 Weeks).||16
8141817|NCT02699125|20069040|P1|STARTED|First Intervention (6 Weeks).||18
8141818|NCT02699125|20069039|P2|NOT COMPLETED|Placebo||4
8141819|NCT02699125|20069040|P1|NOT COMPLETED|Placebo||3
8141820|NCT02699125|20069039|P2|COMPLETED|Placebo||16
8141821|NCT02699125|20069040|P1|COMPLETED|Placebo||18
8141822|NCT02699125|20069039|P2|STARTED|Placebo||20
8141823|NCT02699125|20069040|P1|STARTED|Placebo||21
8141824|NCT02699099|20069054|P3|NOT COMPLETED|Overall Study||3
8141825|NCT02699099|20069055|P2|NOT COMPLETED|Overall Study||2
8141826|NCT02699099|20069056|P1|NOT COMPLETED|Overall Study||7
8141827|NCT02699099|20069054|P3|COMPLETED|Overall Study||229
8141828|NCT02699099|20069055|P2|COMPLETED|Overall Study||234
8141829|NCT02699099|20069056|P1|COMPLETED|Overall Study||224
8141830|NCT02699099|20069054|P3|STARTED|Overall Study||232
8141831|NCT02699099|20069055|P2|STARTED|Overall Study||236
8141832|NCT02699099|20069056|P1|STARTED|Overall Study||231
8141833|NCT02698865|20069132|P2|NOT COMPLETED|Overall Study||33
8141834|NCT02698865|20069133|P1|NOT COMPLETED|Overall Study||35
8141835|NCT02698865|20069132|P2|COMPLETED|Overall Study||47
8141836|NCT02698865|20069133|P1|COMPLETED|Overall Study||105
8141837|NCT02698865|20069132|P2|Treated|Overall Study||80
8141838|NCT02698865|20069133|P1|Treated|Overall Study||140
8141839|NCT02698865|20069132|P2|STARTED|Overall Study||80
8141840|NCT02698865|20069133|P1|STARTED|Overall Study||140
8141841|NCT02698800|20069141|P2|NOT COMPLETED|Overall Study||0
8141842|NCT02698800|20069142|P1|NOT COMPLETED|Overall Study||1
8141843|NCT02698800|20069141|P2|COMPLETED|Overall Study||8
8141844|NCT02698800|20069142|P1|COMPLETED|Overall Study||6
8141845|NCT02698800|20069141|P2|STARTED|Overall Study||8
8141846|NCT02698800|20069142|P1|STARTED|Overall Study||7
8141847|NCT02698735|20069150|P1|NOT COMPLETED|Overall Study||0
8141848|NCT02698735|20069150|P1|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5
8141849|NCT02698735|20069150|P1|STARTED|Overall Study||5
8141850|NCT02698566|20069164|P2|NOT COMPLETED|Overall Study||0
8141851|NCT02698566|20069165|P1|NOT COMPLETED|Overall Study||0
8141852|NCT02698566|20069164|P2|COMPLETED|Overall Study||3
8141853|NCT02698566|20069165|P1|COMPLETED|Overall Study||35
8141854|NCT02698566|20069164|P2|STARTED|Overall Study||3
8141855|NCT02698566|20069165|P1|STARTED|Overall Study||35
8141856|NCT02698475|20069171|P1|NOT COMPLETED|Overall Study||5
8141857|NCT02698475|20069171|P1|COMPLETED|Overall Study||39
8141858|NCT02698475|20069171|P1|Ongoing|Overall Study||28
8141859|NCT02698475|20069171|P1|STARTED|Overall Study||44
8141860|NCT02698436|20069188|P2|NOT COMPLETED|Overall Study||7
8141861|NCT02698436|20069189|P1|NOT COMPLETED|Overall Study||7
8141862|NCT02698436|20069188|P2|COMPLETED|Overall Study||51
8141863|NCT02698436|20069189|P1|COMPLETED|Overall Study||52
8141864|NCT02698436|20069188|P2|STARTED|Overall Study||58
8141865|NCT02698436|20069189|P1|STARTED|Overall Study||59
8141866|NCT02698423|20069229|P2|NOT COMPLETED|Overall Study||24
8141867|NCT02698423|20069230|P1|NOT COMPLETED|Overall Study||19
8141868|NCT02698423|20069229|P2|COMPLETED|Overall Study||307
8141869|NCT02698423|20069230|P1|COMPLETED|Overall Study||317
8141870|NCT02698423|20069229|P2|STARTED|Overall Study||331
8141871|NCT02698423|20069230|P1|STARTED|Overall Study||336
8141872|NCT02698410|20069238|P1|NOT COMPLETED|Overall Study||4
8141873|NCT02698410|20069238|P1|COMPLETED|Overall Study||36
8141874|NCT02698410|20069238|P1|STARTED|Overall Study||40
8141875|NCT02698371|20069257|P1|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2
8141876|NCT02698371|20069257|P1|COMPLETED|ADU-SE (G6) Arm/Group Flow||33
8141877|NCT02698371|20069257|P1|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35
8141878|NCT02698371|20069257|P1|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3
8141879|NCT02698371|20069257|P1|COMPLETED|ADU-ER (G5) Arm/Group Flow||32
8141880|NCT02698371|20069257|P1|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35
8141881|NCT02698371|20069257|P1|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3
8141882|NCT02698371|20069257|P1|COMPLETED|FBU-SE (G4) Arm/Group Flow||32
8141883|NCT02698371|20069257|P1|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35
8141884|NCT02698371|20069257|P1|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3
8141885|NCT02698371|20069257|P1|COMPLETED|FBU-ER (G3) Arm/Group Flow||32
8141886|NCT02698371|20069257|P1|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35
8141887|NCT02698371|20069257|P1|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3
8141888|NCT02698371|20069257|P1|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32
8141889|NCT02698371|20069257|P1|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35
8141890|NCT02698371|20069257|P1|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3
8141891|NCT02698371|20069257|P1|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32
8141892|NCT02698371|20069257|P1|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35
8141893|NCT02698371|20069257|P1|NOT COMPLETED|All Participants Flow||3
8141894|NCT02698371|20069257|P1|COMPLETED|All Participants Flow||35
8141895|NCT02698371|20069257|P1|STARTED|All Participants Flow||38
8141896|NCT02698241|20069379|P1|NOT COMPLETED|Overall Study||34
8141897|NCT02698241|20069379|P1|COMPLETED|Overall Study|Number of subjects completed the study (no early exit or death)|45
8141898|NCT02698241|20069379|P1|Baseline & Programming|Overall Study|Number of subjects that passed screening and completed baseline and programming visit|66
8141899|NCT02698241|20069379|P1|STARTED|Overall Study|Number of subjects enrolled the study|79
8141906|NCT02698176|20069417|P4|NOT COMPLETED|Overall Study||0
8141907|NCT02698176|20069418|P3|NOT COMPLETED|Overall Study||1
8141908|NCT02698176|20069419|P2|NOT COMPLETED|Overall Study||3
8141909|NCT02698176|20069420|P1|NOT COMPLETED|Overall Study||9
8141910|NCT02698176|20069417|P4|COMPLETED|Overall Study||0
8141911|NCT02698176|20069418|P3|COMPLETED|Overall Study||0
8141912|NCT02698176|20069419|P2|COMPLETED|Overall Study||0
8141913|NCT02698176|20069420|P1|COMPLETED|Overall Study||0
8141914|NCT02698176|20069417|P4|STARTED|Overall Study|No participants were enrolled in Part B.|0
8141915|NCT02698176|20069418|P3|STARTED|Overall Study||1
8141916|NCT02698176|20069419|P2|STARTED|Overall Study||3
8141917|NCT02698176|20069420|P1|STARTED|Overall Study||9
8141918|NCT02698033|20069455|P1|NOT COMPLETED|Overall Study||1
8141919|NCT02698033|20069455|P1|COMPLETED|Overall Study||6
8141920|NCT02698033|20069455|P1|STARTED|Overall Study||7
8141921|NCT02697890|20069461|P2|NOT COMPLETED|Overall Study||0
8141922|NCT02697890|20069462|P1|NOT COMPLETED|Overall Study||0
8141923|NCT02697890|20069461|P2|COMPLETED|Overall Study||14
8141924|NCT02697890|20069462|P1|COMPLETED|Overall Study||14
8141925|NCT02697890|20069461|P2|STARTED|Overall Study||14
8141926|NCT02697890|20069462|P1|STARTED|Overall Study||14
8141939|NCT02697617|20069658|P2|NOT COMPLETED|Overall Study||2
8141940|NCT02697617|20069659|P1|NOT COMPLETED|Overall Study||1
8141941|NCT02697617|20069658|P2|COMPLETED|Overall Study||7
8141942|NCT02697617|20069659|P1|COMPLETED|Overall Study|15 completed both arms|8
8141943|NCT02697617|20069658|P2|STARTED|Overall Study||9
8141944|NCT02697617|20069659|P1|STARTED|Overall Study||9
8141945|NCT02697435|20069679|P2|NOT COMPLETED|Overall Study||4
8141946|NCT02697435|20069680|P1|NOT COMPLETED|Overall Study||1
8141947|NCT02697435|20069679|P2|COMPLETED|Overall Study||26
8141948|NCT02697435|20069680|P1|COMPLETED|Overall Study||24
8141949|NCT02697435|20069679|P2|STARTED|Overall Study||30
8141950|NCT02697435|20069680|P1|STARTED|Overall Study||25
8141951|NCT02697292|20069690|P2|NOT COMPLETED|Overall Study||0
8141952|NCT02697292|20069691|P1|NOT COMPLETED|Overall Study||0
8141953|NCT02697292|20069690|P2|COMPLETED|Overall Study||8
8141954|NCT02697292|20069691|P1|COMPLETED|Overall Study||9
8141955|NCT02697292|20069690|P2|STARTED|Overall Study||8
8141956|NCT02697292|20069691|P1|STARTED|Overall Study||9
8141957|NCT02697240|20069699|P1|NOT COMPLETED|Overall Study||0
8141958|NCT02697240|20069699|P1|COMPLETED|Overall Study||4
8141959|NCT02697240|20069699|P1|STARTED|Overall Study||4
8141960|NCT02697214|20069708|P6|NOT COMPLETED|Overall Study||0
8141961|NCT02697214|20069709|P5|NOT COMPLETED|Overall Study||0
8141962|NCT02697214|20069710|P4|NOT COMPLETED|Overall Study||0
8141963|NCT02697214|20069711|P3|NOT COMPLETED|Overall Study||0
8141964|NCT02697214|20069712|P2|NOT COMPLETED|Overall Study||0
8141965|NCT02697214|20069713|P1|NOT COMPLETED|Overall Study||0
8141966|NCT02697214|20069708|P6|COMPLETED|Overall Study||50
8141967|NCT02697214|20069709|P5|COMPLETED|Overall Study||50
8141968|NCT02697214|20069710|P4|COMPLETED|Overall Study||24
8141969|NCT02697214|20069711|P3|COMPLETED|Overall Study||25
8141970|NCT02697214|20069712|P2|COMPLETED|Overall Study||25
8141971|NCT02697214|20069713|P1|COMPLETED|Overall Study||26
8141972|NCT02697214|20069708|P6|Heart Rate at 6mph|Overall Study||50
8141973|NCT02697214|20069709|P5|Heart Rate at 6mph|Overall Study||50
8141974|NCT02697214|20069710|P4|Heart Rate at 6mph|Overall Study||24
8141975|NCT02697214|20069711|P3|Heart Rate at 6mph|Overall Study||25
8141976|NCT02697214|20069712|P2|Heart Rate at 6mph|Overall Study||25
8141977|NCT02697214|20069713|P1|Heart Rate at 6mph|Overall Study||26
8141978|NCT02697214|20069708|P6|Heart Rate at 4mph|Overall Study||50
8141979|NCT02697214|20069709|P5|Heart Rate at 4mph|Overall Study||50
8141980|NCT02697214|20069710|P4|Heart Rate at 4mph|Overall Study||24
8141981|NCT02697214|20069711|P3|Heart Rate at 4mph|Overall Study||25
8141982|NCT02697214|20069712|P2|Heart Rate at 4mph|Overall Study||25
8141983|NCT02697214|20069713|P1|Heart Rate at 4mph|Overall Study||26
8141984|NCT02697214|20069708|P6|Heart Rate at 3mph|Overall Study||50
8141985|NCT02697214|20069709|P5|Heart Rate at 3mph|Overall Study||50
8141986|NCT02697214|20069710|P4|Heart Rate at 3mph|Overall Study||24
8141987|NCT02697214|20069711|P3|Heart Rate at 3mph|Overall Study||25
8141988|NCT02697214|20069712|P2|Heart Rate at 3mph|Overall Study||25
8141989|NCT02697214|20069713|P1|Heart Rate at 3mph|Overall Study||26
8141990|NCT02697214|20069708|P6|Heart Rate at 2mph|Overall Study||50
8141991|NCT02697214|20069709|P5|Heart Rate at 2mph|Overall Study||50
8141992|NCT02697214|20069710|P4|Heart Rate at 2mph|Overall Study||24
8141993|NCT02697214|20069711|P3|Heart Rate at 2mph|Overall Study||25
8141994|NCT02697214|20069712|P2|Heart Rate at 2mph|Overall Study||25
8141995|NCT02697214|20069713|P1|Heart Rate at 2mph|Overall Study||26
8141996|NCT02697214|20069708|P6|STARTED|Overall Study||50
8141997|NCT02697214|20069709|P5|STARTED|Overall Study||50
8141998|NCT02697214|20069710|P4|STARTED|Overall Study||24
8141999|NCT02697214|20069711|P3|STARTED|Overall Study||25
8142000|NCT02697214|20069712|P2|STARTED|Overall Study||25
8142001|NCT02697214|20069713|P1|STARTED|Overall Study||26
8142002|NCT02697188|20069723|P1|NOT COMPLETED|TE Period 5 - 800 mg BID||0
8142003|NCT02697188|20069723|P1|COMPLETED|TE Period 5 - 800 mg BID||12
8142004|NCT02697188|20069723|P1|STARTED|TE Period 5 - 800 mg BID||12
8142005|NCT02697188|20069723|P1|NOT COMPLETED|TU Period 4 - 400 BID||0
8142006|NCT02697188|20069723|P1|COMPLETED|TU Period 4 - 400 BID||12
8142007|NCT02697188|20069723|P1|STARTED|TU Period 4 - 400 BID||12
8142008|NCT02697188|20069723|P1|NOT COMPLETED|TU Period 3 - 200 mg BID||0
8142009|NCT02697188|20069723|P1|COMPLETED|TU Period 3 - 200 mg BID||12
8142010|NCT02697188|20069723|P1|STARTED|TU Period 3 - 200 mg BID||12
8142011|NCT02697188|20069723|P1|NOT COMPLETED|TU Period 2 - 200 mg QD||0
8142012|NCT02697188|20069723|P1|COMPLETED|TU Period 2 - 200 mg QD||12
8142013|NCT02697188|20069723|P1|STARTED|TU Period 2 - 200 mg QD||12
8142014|NCT02697188|20069723|P1|NOT COMPLETED|TE Period 1 - 400 mg QD||0
8142015|NCT02697188|20069723|P1|COMPLETED|TE Period 1 - 400 mg QD||12
8142016|NCT02697188|20069723|P1|STARTED|TE Period 1 - 400 mg QD||12
8142017|NCT02696967|20069736|P4|NOT COMPLETED|Overall Study||0
8142018|NCT02696967|20069737|P3|NOT COMPLETED|Overall Study||0
8142019|NCT02696967|20069738|P2|NOT COMPLETED|Overall Study||0
8142020|NCT02696967|20069739|P1|NOT COMPLETED|Overall Study||0
8142021|NCT02696967|20069736|P4|COMPLETED|Overall Study||10
8142022|NCT02696967|20069737|P3|COMPLETED|Overall Study||6
8142023|NCT02696967|20069738|P2|COMPLETED|Overall Study||6
8142024|NCT02696967|20069739|P1|COMPLETED|Overall Study||4
8142025|NCT02696967|20069736|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8142026|NCT02696967|20069737|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||4
8142027|NCT02696967|20069738|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||6
8142028|NCT02696967|20069739|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||4
8142029|NCT02696967|20069736|P4|STARTED|Overall Study||10
8142030|NCT02696967|20069737|P3|STARTED|Overall Study||6
8142031|NCT02696967|20069738|P2|STARTED|Overall Study||6
8142032|NCT02696967|20069739|P1|STARTED|Overall Study||4
8142045|NCT02696850|20069823|P2|NOT COMPLETED|Overall Study||8
8142046|NCT02696850|20069824|P1|NOT COMPLETED|Overall Study||11
8142047|NCT02696850|20069823|P2|COMPLETED|Overall Study||32
8142048|NCT02696850|20069824|P1|COMPLETED|Overall Study||29
8142049|NCT02696850|20069823|P2|STARTED|Overall Study||40
8142050|NCT02696850|20069824|P1|STARTED|Overall Study||40
8142051|NCT02696798|20069837|P3|NOT COMPLETED|Post-treatment Follow-up Period||19
8142052|NCT02696798|20069838|P2|NOT COMPLETED|Post-treatment Follow-up Period||26
8142053|NCT02696798|20069839|P1|NOT COMPLETED|Post-treatment Follow-up Period||5
8142054|NCT02696798|20069837|P3|COMPLETED|Post-treatment Follow-up Period||3
8142055|NCT02696798|20069838|P2|COMPLETED|Post-treatment Follow-up Period||8
8142056|NCT02696798|20069839|P1|COMPLETED|Post-treatment Follow-up Period||0
8142057|NCT02696798|20069837|P3|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22
8142058|NCT02696798|20069838|P2|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34
8142059|NCT02696798|20069839|P1|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5
8142060|NCT02696798|20069837|P3|NOT COMPLETED|Extended Treatment Period||10
8142061|NCT02696798|20069838|P2|NOT COMPLETED|Extended Treatment Period||9
8142062|NCT02696798|20069839|P1|NOT COMPLETED|Extended Treatment Period||12
8142063|NCT02696798|20069837|P3|COMPLETED|Extended Treatment Period||80
8142064|NCT02696798|20069838|P2|COMPLETED|Extended Treatment Period||89
8142065|NCT02696798|20069839|P1|COMPLETED|Extended Treatment Period||81
8142066|NCT02696798|20069837|P3|STARTED|Extended Treatment Period||90
8142067|NCT02696798|20069838|P2|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98
8142068|NCT02696798|20069839|P1|STARTED|Extended Treatment Period||93
8142069|NCT02696798|20069837|P3|NOT COMPLETED|Blinded Treatment Dosing Period||8
8142070|NCT02696798|20069838|P2|NOT COMPLETED|Blinded Treatment Dosing Period||15
8142071|NCT02696798|20069839|P1|NOT COMPLETED|Blinded Treatment Dosing Period||11
8142072|NCT02696798|20069837|P3|COMPLETED|Blinded Treatment Dosing Period||90
8142073|NCT02696798|20069838|P2|COMPLETED|Blinded Treatment Dosing Period||99
8142074|NCT02696798|20069839|P1|COMPLETED|Blinded Treatment Dosing Period||93
8142075|NCT02696798|20069837|P3|STARTED|Blinded Treatment Dosing Period||98
8142076|NCT02696798|20069838|P2|STARTED|Blinded Treatment Dosing Period||114
8142077|NCT02696798|20069839|P1|STARTED|Blinded Treatment Dosing Period||104
8142078|NCT02696785|20069936|P4|NOT COMPLETED|Follow-up Period||8
8142079|NCT02696785|20069937|P3|NOT COMPLETED|Follow-up Period||13
8142080|NCT02696785|20069938|P2|NOT COMPLETED|Follow-up Period||0
8142081|NCT02696785|20069939|P1|NOT COMPLETED|Follow-up Period||1
8142082|NCT02696785|20069936|P4|COMPLETED|Follow-up Period||8
8142083|NCT02696785|20069937|P3|COMPLETED|Follow-up Period||11
8142084|NCT02696785|20069938|P2|COMPLETED|Follow-up Period||0
8142085|NCT02696785|20069939|P1|COMPLETED|Follow-up Period||0
8142086|NCT02696785|20069936|P4|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16
8142087|NCT02696785|20069937|P3|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24
8142088|NCT02696785|20069938|P2|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0
8142089|NCT02696785|20069939|P1|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1
8142090|NCT02696785|20069936|P4|NOT COMPLETED|Extended Treatment Period||6
8142091|NCT02696785|20069937|P3|NOT COMPLETED|Extended Treatment Period||5
8142092|NCT02696785|20069938|P2|NOT COMPLETED|Extended Treatment Period||6
8142093|NCT02696785|20069939|P1|NOT COMPLETED|Extended Treatment Period||3
8142094|NCT02696785|20069936|P4|COMPLETED|Extended Treatment Period||72
8142095|NCT02696785|20069937|P3|COMPLETED|Extended Treatment Period||74
8142096|NCT02696785|20069938|P2|COMPLETED|Extended Treatment Period||80
8142097|NCT02696785|20069939|P1|COMPLETED|Extended Treatment Period||83
8142098|NCT02696785|20069936|P4|STARTED|Extended Treatment Period||78
8142099|NCT02696785|20069937|P3|STARTED|Extended Treatment Period||79
8142100|NCT02696785|20069938|P2|STARTED|Extended Treatment Period||86
8142101|NCT02696785|20069939|P1|STARTED|Extended Treatment Period||86
8142102|NCT02696785|20069936|P4|NOT COMPLETED|Washout Period||0
8142103|NCT02696785|20069937|P3|NOT COMPLETED|Washout Period||0
8142104|NCT02696785|20069938|P2|NOT COMPLETED|Washout Period||2
8142105|NCT02696785|20069939|P1|NOT COMPLETED|Washout Period||0
8142106|NCT02696785|20069936|P4|COMPLETED|Washout Period||0
8142107|NCT02696785|20069937|P3|COMPLETED|Washout Period||0
8142108|NCT02696785|20069938|P2|COMPLETED|Washout Period||86
8142109|NCT02696785|20069939|P1|COMPLETED|Washout Period||0
8142110|NCT02696785|20069936|P4|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
8142111|NCT02696785|20069937|P3|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
8142112|NCT02696785|20069938|P2|STARTED|Washout Period||88
8142113|NCT02696785|20069939|P1|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
8142114|NCT02696785|20069936|P4|NOT COMPLETED|Blinded Treatment Period||3
8142115|NCT02696785|20069937|P3|NOT COMPLETED|Blinded Treatment Period||4
8142116|NCT02696785|20069938|P2|NOT COMPLETED|Blinded Treatment Period||2
8142117|NCT02696785|20069939|P1|NOT COMPLETED|Blinded Treatment Period||1
8142118|NCT02696785|20069936|P4|COMPLETED|Blinded Treatment Period||78
8142119|NCT02696785|20069937|P3|COMPLETED|Blinded Treatment Period||79
8142120|NCT02696785|20069938|P2|COMPLETED|Blinded Treatment Period||88
8142121|NCT02696785|20069939|P1|COMPLETED|Blinded Treatment Period||86
8142122|NCT02696785|20069936|P4|Received at Least One Dose of Study Drug|Blinded Treatment Period||81
8142123|NCT02696785|20069937|P3|Received at Least One Dose of Study Drug|Blinded Treatment Period||83
8142124|NCT02696785|20069938|P2|Received at Least One Dose of Study Drug|Blinded Treatment Period||90
8142125|NCT02696785|20069939|P1|Received at Least One Dose of Study Drug|Blinded Treatment Period||86
8142126|NCT02696785|20069936|P4|STARTED|Blinded Treatment Period||81
8142127|NCT02696785|20069937|P3|STARTED|Blinded Treatment Period||83
8142128|NCT02696785|20069938|P2|STARTED|Blinded Treatment Period||90
8142129|NCT02696785|20069939|P1|STARTED|Blinded Treatment Period||87
8142130|NCT02696434|20070059|P2|NOT COMPLETED|Overall Study||18
8142131|NCT02696434|20070060|P1|NOT COMPLETED|Overall Study||22
8142132|NCT02696434|20070059|P2|COMPLETED|Overall Study||33
8142133|NCT02696434|20070060|P1|COMPLETED|Overall Study||28
8142134|NCT02696434|20070059|P2|STARTED|Overall Study||51
8142135|NCT02696434|20070060|P1|STARTED|Overall Study||50
8142136|NCT02696317|20070078|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
8142137|NCT02696317|20070079|P1|NOT COMPLETED|Period 2, 10 Days of Wear||1
8142138|NCT02696317|20070078|P2|COMPLETED|Period 2, 10 Days of Wear||36
8142139|NCT02696317|20070079|P1|COMPLETED|Period 2, 10 Days of Wear||39
8142140|NCT02696317|20070078|P2|STARTED|Period 2, 10 Days of Wear||36
8142141|NCT02696317|20070079|P1|STARTED|Period 2, 10 Days of Wear||40
8142142|NCT02696317|20070078|P2|NOT COMPLETED|Period 1, 10 Days of Wear||0
8142143|NCT02696317|20070079|P1|NOT COMPLETED|Period 1, 10 Days of Wear||0
8142144|NCT02696317|20070078|P2|COMPLETED|Period 1, 10 Days of Wear||36
8142145|NCT02696317|20070079|P1|COMPLETED|Period 1, 10 Days of Wear||40
8142146|NCT02696317|20070078|P2|STARTED|Period 1, 10 Days of Wear||36
8142147|NCT02696317|20070079|P1|STARTED|Period 1, 10 Days of Wear||40
8142148|NCT02696317|20070078|P2|NOT COMPLETED|Habitual, 10 Days of Wear||4
8142149|NCT02696317|20070079|P1|NOT COMPLETED|Habitual, 10 Days of Wear||2
8142150|NCT02696317|20070078|P2|COMPLETED|Habitual, 10 Days of Wear||36
8142151|NCT02696317|20070079|P1|COMPLETED|Habitual, 10 Days of Wear||40
8142152|NCT02696317|20070078|P2|STARTED|Habitual, 10 Days of Wear||40
8142153|NCT02696317|20070079|P1|STARTED|Habitual, 10 Days of Wear||42
8142154|NCT02696291|20070095|P2|NOT COMPLETED|Overall Study||0
8142155|NCT02696291|20070096|P1|NOT COMPLETED|Overall Study||0
8142156|NCT02696291|20070095|P2|COMPLETED|Overall Study||2
8142157|NCT02696291|20070096|P1|COMPLETED|Overall Study||5
8142158|NCT02696291|20070095|P2|STARTED|Overall Study||2
8142159|NCT02696291|20070096|P1|STARTED|Overall Study||5
8142160|NCT02696226|20070123|P4|NOT COMPLETED|Overall Study||0
8142161|NCT02696226|20070124|P3|NOT COMPLETED|Overall Study||2
8142162|NCT02696226|20070125|P2|NOT COMPLETED|Overall Study||0
8142163|NCT02696226|20070126|P1|NOT COMPLETED|Overall Study||1
8142164|NCT02696226|20070123|P4|COMPLETED|Overall Study||0
8142165|NCT02696226|20070124|P3|COMPLETED|Overall Study||0
8142166|NCT02696226|20070125|P2|COMPLETED|Overall Study||0
8142167|NCT02696226|20070126|P1|COMPLETED|Overall Study||0
8142168|NCT02696226|20070123|P4|STARTED|Overall Study||0
8142169|NCT02696226|20070124|P3|STARTED|Overall Study||2
8142170|NCT02696226|20070125|P2|STARTED|Overall Study||0
8142171|NCT02696226|20070126|P1|STARTED|Overall Study||1
8142172|NCT02696200|20070138|P2|NOT COMPLETED|Overall Study||0
8142173|NCT02696200|20070139|P1|NOT COMPLETED|Overall Study||0
8142174|NCT02696200|20070138|P2|COMPLETED|Overall Study||30
8142175|NCT02696200|20070139|P1|COMPLETED|Overall Study||32
8142176|NCT02696200|20070138|P2|STARTED|Overall Study||30
8142177|NCT02696200|20070139|P1|STARTED|Overall Study||32
8142178|NCT02696083|20070149|P1|NOT COMPLETED|Overall Study||6
8142179|NCT02696083|20070149|P1|COMPLETED|Overall Study||13
8142180|NCT02696083|20070149|P1|STARTED|Overall Study||19
8142181|NCT02696070|20070160|P2|NOT COMPLETED|Overall Study||2
8142182|NCT02696070|20070161|P1|NOT COMPLETED|Overall Study||1
8142183|NCT02696070|20070160|P2|COMPLETED|Overall Study||12
8142184|NCT02696070|20070161|P1|COMPLETED|Overall Study||7
8142185|NCT02696070|20070160|P2|STARTED|Overall Study||14
8142186|NCT02696070|20070161|P1|STARTED|Overall Study||8
8142205|NCT02695719|20070186|P2|NOT COMPLETED|Overall Study||10
8142206|NCT02695719|20070187|P1|NOT COMPLETED|Overall Study||3
8142207|NCT02695719|20070186|P2|COMPLETED|Overall Study||72
8142208|NCT02695719|20070187|P1|COMPLETED|Overall Study||71
8142209|NCT02695719|20070186|P2|STARTED|Overall Study||82
8142210|NCT02695719|20070187|P1|STARTED|Overall Study||74
8142211|NCT02695628|20070205|P1|NOT COMPLETED|Overall Study||1
8142212|NCT02695628|20070205|P1|COMPLETED|Overall Study||4
8142213|NCT02695628|20070205|P1|STARTED|Overall Study||5
8142214|NCT02695537|20070211|P1|NOT COMPLETED|Overall Study||38
8142215|NCT02695537|20070211|P1|COMPLETED|Overall Study||51
8142216|NCT02695537|20070211|P1|STARTED|Overall Study||89
8142217|NCT02695524|20070221|P2|NOT COMPLETED|Overall Study||3
8142218|NCT02695524|20070222|P1|NOT COMPLETED|Overall Study||3
8142219|NCT02695524|20070221|P2|COMPLETED|Overall Study||27
8142220|NCT02695524|20070222|P1|COMPLETED|Overall Study||27
8142221|NCT02695524|20070221|P2|STARTED|Overall Study||30
8142222|NCT02695524|20070222|P1|STARTED|Overall Study||30
8142223|NCT02695446|20070242|P1|NOT COMPLETED|Overall Study||0
8142224|NCT02695446|20070242|P1|COMPLETED|Overall Study||12
8142225|NCT02695446|20070242|P1|STARTED|Overall Study||12
8142238|NCT02695329|20070276|P2|NOT COMPLETED|Overall Study||5
8142239|NCT02695329|20070277|P1|NOT COMPLETED|Overall Study||5
8142240|NCT02695329|20070276|P2|COMPLETED|Overall Study||45
8142241|NCT02695329|20070277|P1|COMPLETED|Overall Study||45
8142242|NCT02695329|20070276|P2|STARTED|Overall Study||50
8142243|NCT02695329|20070277|P1|STARTED|Overall Study||50
8142244|NCT02695290|20070289|P1|NOT COMPLETED|Overall Study||0
8142245|NCT02695290|20070289|P1|COMPLETED|Overall Study||1
8142246|NCT02695290|20070289|P1|STARTED|Overall Study||1
8142247|NCT02694978|20070297|P2|NOT COMPLETED|Overall Study||60
8142248|NCT02694978|20070298|P1|NOT COMPLETED|Overall Study||71
8142249|NCT02694978|20070297|P2|COMPLETED|Overall Study||948
8142250|NCT02694978|20070298|P1|COMPLETED|Overall Study||935
8142251|NCT02694978|20070297|P2|Received at Least 1 Dose of Study Drug|Overall Study||1000
8142252|NCT02694978|20070298|P1|Received at Least 1 Dose of Study Drug|Overall Study||997
8142253|NCT02694978|20070297|P2|STARTED|Overall Study||1008
8142254|NCT02694978|20070298|P1|STARTED|Overall Study||1006
8142255|NCT02694835|20070312|P2|NOT COMPLETED|Overall Study||0
8142256|NCT02694835|20070313|P1|NOT COMPLETED|Overall Study||0
8142257|NCT02694835|20070312|P2|COMPLETED|Overall Study||39
8142258|NCT02694835|20070313|P1|COMPLETED|Overall Study||41
8142259|NCT02694835|20070312|P2|STARTED|Overall Study||39
8142260|NCT02694835|20070313|P1|STARTED|Overall Study||41
8142261|NCT02694757|20070319|P1|NOT COMPLETED|Overall Study||3
8142262|NCT02694757|20070319|P1|COMPLETED|Overall Study||0
8142263|NCT02694757|20070319|P1|STARTED|Overall Study||3
8142274|NCT02694718|20070334|P1|NOT COMPLETED|Overall Study||2
8142275|NCT02694718|20070334|P1|COMPLETED|Overall Study||58
8142276|NCT02694718|20070334|P1|STARTED|Overall Study||60
8142277|NCT02694601|20070344|P1|NOT COMPLETED|Overall Study||0
8142278|NCT02694601|20070344|P1|COMPLETED|Overall Study||10
8142279|NCT02694601|20070344|P1|STARTED|Overall Study||10
8142280|NCT02694562|20070352|P1|NOT COMPLETED|Overall Study||18
8142281|NCT02694562|20070352|P1|COMPLETED|Overall Study||2
8142282|NCT02694562|20070352|P1|STARTED|Overall Study||20
8142283|NCT02694549|20070361|P1|NOT COMPLETED|Overall Study||2
8142284|NCT02694549|20070361|P1|COMPLETED|Overall Study||10
8142285|NCT02694549|20070361|P1|STARTED|Overall Study||12
8142286|NCT02694536|20070367|P1|NOT COMPLETED|Overall Study||80
8142287|NCT02694536|20070367|P1|COMPLETED|Overall Study||0
8142288|NCT02694536|20070367|P1|STARTED|Overall Study||80
8142331|NCT02694445|20070408|P1|NOT COMPLETED|Overall Study||52
8142332|NCT02694445|20070408|P1|COMPLETED|Overall Study||3046
8142333|NCT02694445|20070408|P1|STARTED|Overall Study||3098
8142334|NCT02694328|20070414|P2|NOT COMPLETED|Overall Study||98
8142335|NCT02694328|20070415|P1|NOT COMPLETED|Overall Study||100
8142336|NCT02694328|20070414|P2|COMPLETED|Overall Study||176
8142337|NCT02694328|20070415|P1|COMPLETED|Overall Study||176
8142338|NCT02694328|20070414|P2|STARTED|Overall Study||274
8142339|NCT02694328|20070415|P1|STARTED|Overall Study||276
8142340|NCT02694315|20070427|P1|NOT COMPLETED|Overall Study||0
8142341|NCT02694315|20070427|P1|COMPLETED|Overall Study||200
8142342|NCT02694315|20070427|P1|STARTED|Overall Study||200
8142343|NCT02694198|20070432|P1|NOT COMPLETED|Overall Study||0
8142344|NCT02694198|20070432|P1|COMPLETED|Overall Study||135
8142345|NCT02694198|20070432|P1|STARTED|Overall Study||135
8142346|NCT02693834|20070437|P2|NOT COMPLETED|Week 2 Practice||1
8142347|NCT02693834|20070438|P1|NOT COMPLETED|Week 2 Practice||0
8142348|NCT02693834|20070437|P2|COMPLETED|Week 2 Practice||10
8142349|NCT02693834|20070438|P1|COMPLETED|Week 2 Practice||10
8142350|NCT02693834|20070437|P2|STARTED|Week 2 Practice||11
8142351|NCT02693834|20070438|P1|STARTED|Week 2 Practice||10
8142352|NCT02693834|20070437|P2|NOT COMPLETED|Week 1 Practice||0
8142353|NCT02693834|20070438|P1|NOT COMPLETED|Week 1 Practice||0
8142354|NCT02693834|20070437|P2|COMPLETED|Week 1 Practice||11
8142355|NCT02693834|20070438|P1|COMPLETED|Week 1 Practice||10
8142356|NCT02693834|20070437|P2|STARTED|Week 1 Practice|During the first week of practice, 11 participants were assigned to DAAFO group|11
8142357|NCT02693834|20070438|P1|STARTED|Week 1 Practice|During the first week of practice, 10 participants were assigned to PLS AFO group|10
8142358|NCT02693834|20070437|P2|NOT COMPLETED|Baseline Measurement||0
8142359|NCT02693834|20070438|P1|NOT COMPLETED|Baseline Measurement||2
8142360|NCT02693834|20070437|P2|COMPLETED|Baseline Measurement|10 particiapnts completed wearing DA AFO during the first week and 10 the second week (1 was lost)|11
8142361|NCT02693834|20070438|P1|COMPLETED|Baseline Measurement|10 particiapnts completed wearing PLS AFO during the first week and 10 during the second week|10
8142362|NCT02693834|20070437|P2|STARTED|Baseline Measurement|11 participants were assigned to DA AFO first group|11
8142363|NCT02693834|20070438|P1|STARTED|Baseline Measurement|10 were randomized to PLS AFO first week group (2 dropped out at baseline)|12
8142370|NCT02693704|20070459|P4|NOT COMPLETED|Overall Study||0
8142371|NCT02693704|20070460|P3|NOT COMPLETED|Overall Study||0
8142372|NCT02693704|20070461|P2|NOT COMPLETED|Overall Study||0
8142373|NCT02693704|20070462|P1|NOT COMPLETED|Overall Study||0
8142374|NCT02693704|20070459|P4|COMPLETED|Overall Study||10
8142375|NCT02693704|20070460|P3|COMPLETED|Overall Study||10
8142376|NCT02693704|20070461|P2|COMPLETED|Overall Study||10
8142377|NCT02693704|20070462|P1|COMPLETED|Overall Study||10
8142378|NCT02693704|20070459|P4|STARTED|Overall Study||10
8142379|NCT02693704|20070460|P3|STARTED|Overall Study||10
8142380|NCT02693704|20070461|P2|STARTED|Overall Study||10
8142381|NCT02693704|20070462|P1|STARTED|Overall Study||10
8142382|NCT02693691|20070480|P1|NOT COMPLETED|Extended Follow-Up (Until Last pt 12M)||24
8142383|NCT02693691|20070480|P1|COMPLETED|Extended Follow-Up (Until Last pt 12M)||160
8142384|NCT02693691|20070480|P1|STARTED|Extended Follow-Up (Until Last pt 12M)||184
8142385|NCT02693691|20070480|P1|NOT COMPLETED|Primary Endpoint Analysis (First 12M)||50
8142386|NCT02693691|20070480|P1|COMPLETED|Primary Endpoint Analysis (First 12M)||184
8142387|NCT02693691|20070480|P1|STARTED|Primary Endpoint Analysis (First 12M)||234
8142388|NCT02693418|20070492|P5|NOT COMPLETED|Overall Study||0
8142389|NCT02693418|20070493|P4|NOT COMPLETED|Overall Study||0
8142390|NCT02693418|20070494|P3|NOT COMPLETED|Overall Study||2
8142391|NCT02693418|20070495|P2|NOT COMPLETED|Overall Study||2
8142392|NCT02693418|20070496|P1|NOT COMPLETED|Overall Study||1
8142393|NCT02693418|20070492|P5|COMPLETED|Overall Study||21
8142394|NCT02693418|20070493|P4|COMPLETED|Overall Study||20
8142395|NCT02693418|20070494|P3|COMPLETED|Overall Study||19
8142396|NCT02693418|20070495|P2|COMPLETED|Overall Study||19
8142397|NCT02693418|20070496|P1|COMPLETED|Overall Study||21
8142398|NCT02693418|20070492|P5|STARTED|Overall Study||21
8142399|NCT02693418|20070493|P4|STARTED|Overall Study||20
8142400|NCT02693418|20070494|P3|STARTED|Overall Study||21
8142401|NCT02693418|20070495|P2|STARTED|Overall Study||21
8142402|NCT02693418|20070496|P1|STARTED|Overall Study||22
8142403|NCT02693171|20070513|P1|NOT COMPLETED|Overall Study||9
8142404|NCT02693171|20070513|P1|COMPLETED|Overall Study||3
8142405|NCT02693171|20070513|P1|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12
8142406|NCT02693132|20070523|P3|NOT COMPLETED|Overall Study||1
8142407|NCT02693132|20070524|P2|NOT COMPLETED|Overall Study||1
8142408|NCT02693132|20070525|P1|NOT COMPLETED|Overall Study||1
8142409|NCT02693132|20070523|P3|COMPLETED|Overall Study||17
8142410|NCT02693132|20070524|P2|COMPLETED|Overall Study||16
8142411|NCT02693132|20070525|P1|COMPLETED|Overall Study||16
8142412|NCT02693132|20070523|P3|STARTED|Overall Study||18
8142413|NCT02693132|20070524|P2|STARTED|Overall Study||17
8142414|NCT02693132|20070525|P1|STARTED|Overall Study||17
8142415|NCT02693106|20070545|P1|NOT COMPLETED|Overall Study||3
8142416|NCT02693106|20070545|P1|COMPLETED|Overall Study||10
8142417|NCT02693106|20070545|P1|STARTED|Overall Study||13
8142418|NCT02693002|20070557|P2|NOT COMPLETED|Overall Study||0
8142419|NCT02693002|20070558|P1|NOT COMPLETED|Overall Study||1
8142420|NCT02693002|20070557|P2|COMPLETED|Overall Study||2
8142421|NCT02693002|20070558|P1|COMPLETED|Overall Study||1
8142422|NCT02693002|20070557|P2|STARTED|Overall Study||2
8142423|NCT02693002|20070558|P1|STARTED|Overall Study||2
8142424|NCT02692859|20070572|P2|NOT COMPLETED|Overall Study||95
8142425|NCT02692859|20070573|P1|NOT COMPLETED|Overall Study||84
8142426|NCT02692859|20070572|P2|COMPLETED|Overall Study||901
8142427|NCT02692859|20070573|P1|COMPLETED|Overall Study||912
8142428|NCT02692859|20070572|P2|STARTED|Overall Study||996
8142429|NCT02692859|20070573|P1|STARTED|Overall Study||996
8142430|NCT02692716|20070581|P2|NOT COMPLETED|Overall Study||6
8142431|NCT02692716|20070582|P1|NOT COMPLETED|Overall Study||5
8142432|NCT02692716|20070581|P2|COMPLETED|Overall Study||1586
8142433|NCT02692716|20070582|P1|COMPLETED|Overall Study||1586
8142434|NCT02692716|20070581|P2|Exposed|Overall Study||1591
8142435|NCT02692716|20070582|P1|Exposed|Overall Study||1591
8142436|NCT02692716|20070581|P2|Full Analysis Set (FAS)|Overall Study||1592
8142437|NCT02692716|20070582|P1|Full Analysis Set (FAS)|Overall Study||1591
8142438|NCT02692716|20070581|P2|STARTED|Overall Study||1592
8142439|NCT02692716|20070582|P1|STARTED|Overall Study||1591
8142443|NCT02692560|20070630|P2|NOT COMPLETED|Overall Study||6
8142444|NCT02692560|20070631|P1|NOT COMPLETED|Overall Study||0
8142445|NCT02692560|20070630|P2|COMPLETED|Overall Study||25
8142446|NCT02692560|20070631|P1|COMPLETED|Overall Study||29
8142447|NCT02692560|20070630|P2|STARTED|Overall Study||31
8142448|NCT02692560|20070631|P1|STARTED|Overall Study||29
8142449|NCT02692495|20070653|P2|NOT COMPLETED|Overall Study||0
8142450|NCT02692495|20070654|P1|NOT COMPLETED|Overall Study||0
8142451|NCT02692495|20070653|P2|COMPLETED|Overall Study||4
8142452|NCT02692495|20070654|P1|COMPLETED|Overall Study||12
8142453|NCT02692495|20070653|P2|STARTED|Overall Study||4
8142454|NCT02692495|20070654|P1|STARTED|Overall Study||12
8142455|NCT02692482|20070671|P2|NOT COMPLETED|Overall Study||4
8142456|NCT02692482|20070672|P1|NOT COMPLETED|Overall Study||3
8142457|NCT02692482|20070671|P2|COMPLETED|Overall Study||178
8142458|NCT02692482|20070672|P1|COMPLETED|Overall Study||174
8142459|NCT02692482|20070671|P2|STARTED|Overall Study||182
8142460|NCT02692482|20070672|P1|STARTED|Overall Study||177
8142461|NCT02692417|20070686|P2|NOT COMPLETED|Overall Study||1
8142462|NCT02692417|20070687|P1|NOT COMPLETED|Overall Study||6
8142463|NCT02692417|20070686|P2|COMPLETED|Overall Study||6
8142464|NCT02692417|20070687|P1|COMPLETED|Overall Study||3
8142465|NCT02692417|20070686|P2|STARTED|Overall Study||7
8142466|NCT02692417|20070687|P1|STARTED|Overall Study||9
8142467|NCT02692235|20070699|P2|NOT COMPLETED|Overall Study||3
8142468|NCT02692235|20070700|P1|NOT COMPLETED|Overall Study||3
8142469|NCT02692235|20070699|P2|COMPLETED|Overall Study||11
8142470|NCT02692235|20070700|P1|COMPLETED|Overall Study||11
8142471|NCT02692235|20070699|P2|STARTED|Overall Study||14
8142472|NCT02692235|20070700|P1|STARTED|Overall Study||14
8142473|NCT02692209|20070708|P1|NOT COMPLETED|Overall Study||0
8142474|NCT02692209|20070708|P1|COMPLETED|Overall Study||298
8142475|NCT02692209|20070708|P1|STARTED|Overall Study||298
8142476|NCT02692040|20070731|P17|NOT COMPLETED|Overall Study||0
8142477|NCT02692040|20070732|P16|NOT COMPLETED|Overall Study||1
8142478|NCT02692040|20070733|P15|NOT COMPLETED|Overall Study||1
8142479|NCT02692040|20070734|P14|NOT COMPLETED|Overall Study||3
8142480|NCT02692040|20070735|P13|NOT COMPLETED|Overall Study||1
8142481|NCT02692040|20070736|P12|NOT COMPLETED|Overall Study||0
8142482|NCT02692040|20070737|P11|NOT COMPLETED|Overall Study||0
8142483|NCT02692040|20070738|P10|NOT COMPLETED|Overall Study||0
8142484|NCT02692040|20070739|P9|NOT COMPLETED|Overall Study||0
8142485|NCT02692040|20070740|P8|NOT COMPLETED|Overall Study||0
8142486|NCT02692040|20070741|P7|NOT COMPLETED|Overall Study||0
8142487|NCT02692040|20070742|P6|NOT COMPLETED|Overall Study||0
8142488|NCT02692040|20070743|P5|NOT COMPLETED|Overall Study||0
8142489|NCT02692040|20070744|P4|NOT COMPLETED|Overall Study||0
8142490|NCT02692040|20070745|P3|NOT COMPLETED|Overall Study||0
8142491|NCT02692040|20070746|P2|NOT COMPLETED|Overall Study||0
8142492|NCT02692040|20070747|P1|NOT COMPLETED|Overall Study||0
8142493|NCT02692040|20070731|P17|COMPLETED|Overall Study||4
8142494|NCT02692040|20070732|P16|COMPLETED|Overall Study||5
8142495|NCT02692040|20070733|P15|COMPLETED|Overall Study||5
8142496|NCT02692040|20070734|P14|COMPLETED|Overall Study||3
8142497|NCT02692040|20070735|P13|COMPLETED|Overall Study||5
8142498|NCT02692040|20070736|P12|COMPLETED|Overall Study||5
8142499|NCT02692040|20070737|P11|COMPLETED|Overall Study||5
8142500|NCT02692040|20070738|P10|COMPLETED|Overall Study||4
8142501|NCT02692040|20070739|P9|COMPLETED|Overall Study||5
8142502|NCT02692040|20070740|P8|COMPLETED|Overall Study||5
8142503|NCT02692040|20070741|P7|COMPLETED|Overall Study||5
8142504|NCT02692040|20070742|P6|COMPLETED|Overall Study||5
8142505|NCT02692040|20070743|P5|COMPLETED|Overall Study||4
8142506|NCT02692040|20070744|P4|COMPLETED|Overall Study||5
8142507|NCT02692040|20070745|P3|COMPLETED|Overall Study||5
8142508|NCT02692040|20070746|P2|COMPLETED|Overall Study||4
8142509|NCT02692040|20070747|P1|COMPLETED|Overall Study||10
8142510|NCT02692040|20070731|P17|STARTED|Overall Study||4
8142511|NCT02692040|20070732|P16|STARTED|Overall Study||6
8142512|NCT02692040|20070733|P15|STARTED|Overall Study||6
8142513|NCT02692040|20070734|P14|STARTED|Overall Study||6
8142514|NCT02692040|20070735|P13|STARTED|Overall Study||6
8142515|NCT02692040|20070736|P12|STARTED|Overall Study||5
8142516|NCT02692040|20070737|P11|STARTED|Overall Study||5
8142517|NCT02692040|20070738|P10|STARTED|Overall Study||4
8142518|NCT02692040|20070739|P9|STARTED|Overall Study||5
8142519|NCT02692040|20070740|P8|STARTED|Overall Study||5
8142520|NCT02692040|20070741|P7|STARTED|Overall Study||5
8142521|NCT02692040|20070742|P6|STARTED|Overall Study||5
8142522|NCT02692040|20070743|P5|STARTED|Overall Study||4
8142523|NCT02692040|20070744|P4|STARTED|Overall Study||5
8142524|NCT02692040|20070745|P3|STARTED|Overall Study||5
8142525|NCT02692040|20070746|P2|STARTED|Overall Study||4
8142526|NCT02692040|20070747|P1|STARTED|Overall Study||10
8142527|NCT02691936|20070839|P2|NOT COMPLETED|Overall Study||5
8142528|NCT02691936|20070840|P1|NOT COMPLETED|Overall Study||2
8142529|NCT02691936|20070839|P2|COMPLETED|Overall Study||29
8142530|NCT02691936|20070840|P1|COMPLETED|Overall Study||33
8142531|NCT02691936|20070839|P2|STARTED|Overall Study||34
8142532|NCT02691936|20070840|P1|STARTED|Overall Study||35
8142533|NCT02691741|20070862|P2|NOT COMPLETED|Overall Study||7
8142534|NCT02691741|20070863|P1|NOT COMPLETED|Overall Study||1
8142535|NCT02691741|20070862|P2|COMPLETED|Overall Study||87
8142536|NCT02691741|20070863|P1|COMPLETED|Overall Study||93
8142537|NCT02691741|20070862|P2|Safety Analysis Set|Overall Study||89
8142538|NCT02691741|20070863|P1|Safety Analysis Set|Overall Study||93
8142539|NCT02691741|20070862|P2|Best-Case Analysis Set|Overall Study||85
8142540|NCT02691741|20070863|P1|Best-Case Analysis Set|Overall Study||86
8142541|NCT02691741|20070862|P2|All-Implanted Analysis Set|Overall Study||89
8142542|NCT02691741|20070863|P1|All-Implanted Analysis Set|Overall Study||93
8142543|NCT02691741|20070862|P2|STARTED|Overall Study||94
8142544|NCT02691741|20070863|P1|STARTED|Overall Study||94
8142578|NCT02691572|20071199|P2|NOT COMPLETED|Overall Study||1
8142579|NCT02691572|20071200|P1|NOT COMPLETED|Overall Study||1
8142580|NCT02691572|20071199|P2|COMPLETED|Overall Study||39
8142581|NCT02691572|20071200|P1|COMPLETED|Overall Study||39
8142582|NCT02691572|20071199|P2|STARTED|Overall Study||40
8142583|NCT02691572|20071200|P1|STARTED|Overall Study||40
8142584|NCT02691507|20071208|P2|NOT COMPLETED|Overall Study||1
8142585|NCT02691507|20071209|P1|NOT COMPLETED|Overall Study||0
8142586|NCT02691507|20071208|P2|COMPLETED|Overall Study||12
8142587|NCT02691507|20071209|P1|COMPLETED|Overall Study||40
8142588|NCT02691507|20071208|P2|STARTED|Overall Study||13
8142589|NCT02691507|20071209|P1|STARTED|Overall Study||40
8142614|NCT02691416|20071383|P2|NOT COMPLETED|Overall Study||0
8142615|NCT02691416|20071384|P1|NOT COMPLETED|Overall Study||0
8142616|NCT02691416|20071383|P2|COMPLETED|Overall Study||30
8142617|NCT02691416|20071384|P1|COMPLETED|Overall Study||30
8142618|NCT02691416|20071383|P2|STARTED|Overall Study||30
8142619|NCT02691416|20071384|P1|STARTED|Overall Study||30
8142620|NCT02691260|20071408|P4|NOT COMPLETED|Overall Study||3
8142621|NCT02691260|20071409|P3|NOT COMPLETED|Overall Study||2
8142622|NCT02691260|20071410|P2|NOT COMPLETED|Overall Study||2
8142623|NCT02691260|20071411|P1|NOT COMPLETED|Overall Study||2
8142624|NCT02691260|20071408|P4|COMPLETED|Overall Study||23
8142625|NCT02691260|20071409|P3|COMPLETED|Overall Study||25
8142626|NCT02691260|20071410|P2|COMPLETED|Overall Study||24
8142627|NCT02691260|20071411|P1|COMPLETED|Overall Study||24
8142628|NCT02691260|20071408|P4|STARTED|Overall Study||26
8142629|NCT02691260|20071409|P3|STARTED|Overall Study||27
8142630|NCT02691260|20071410|P2|STARTED|Overall Study||26
8142631|NCT02691260|20071411|P1|STARTED|Overall Study||26
8142632|NCT02691247|20071424|P3|NOT COMPLETED|Overall Study||3
8142633|NCT02691247|20071425|P2|NOT COMPLETED|Overall Study||2
8142634|NCT02691247|20071426|P1|NOT COMPLETED|Overall Study||3
8142635|NCT02691247|20071424|P3|COMPLETED|Overall Study||43
8142636|NCT02691247|20071425|P2|COMPLETED|Overall Study||22
8142637|NCT02691247|20071426|P1|COMPLETED|Overall Study||37
8142638|NCT02691247|20071424|P3|STARTED|Overall Study||46
8142639|NCT02691247|20071425|P2|STARTED|Overall Study||24
8142640|NCT02691247|20071426|P1|STARTED|Overall Study||40
8142641|NCT02691143|20071445|P2|NOT COMPLETED|Overall Study||0
8142642|NCT02691143|20071446|P1|NOT COMPLETED|Overall Study||0
8142643|NCT02691143|20071445|P2|COMPLETED|Overall Study||23
8142644|NCT02691143|20071446|P1|COMPLETED|Overall Study||27
8142645|NCT02691143|20071445|P2|STARTED|Overall Study||23
8142646|NCT02691143|20071446|P1|STARTED|Overall Study||27
8142653|NCT02690974|20071471|P1|NOT COMPLETED|Overall Study||40
8142654|NCT02690974|20071471|P1|COMPLETED|Overall Study||262
8142655|NCT02690974|20071471|P1|STARTED|Overall Study||302
8142656|NCT02690948|20071484|P2|NOT COMPLETED|Overall Study||0
8142657|NCT02690948|20071485|P1|NOT COMPLETED|Overall Study||0
8142658|NCT02690948|20071484|P2|COMPLETED|Overall Study||7
8142659|NCT02690948|20071485|P1|COMPLETED|Overall Study||9
8142660|NCT02690948|20071484|P2|STARTED|Overall Study||7
8142661|NCT02690948|20071485|P1|STARTED|Overall Study||9
8142662|NCT02690935|20071503|P2|NOT COMPLETED|Overall Study||0
8142663|NCT02690935|20071504|P1|NOT COMPLETED|Overall Study||0
8142664|NCT02690935|20071503|P2|COMPLETED|Overall Study|Count of participants|51
8142665|NCT02690935|20071504|P1|COMPLETED|Overall Study|Count of participants|51
8142666|NCT02690935|20071503|P2|STARTED|Overall Study|Count of participants|51
8142667|NCT02690935|20071504|P1|STARTED|Overall Study|Count of participants|51
8142668|NCT02690727|20071512|P2|NOT COMPLETED|Overall Study||2
8142669|NCT02690727|20071513|P1|NOT COMPLETED|Overall Study||2
8142670|NCT02690727|20071512|P2|COMPLETED|Overall Study||7
8142671|NCT02690727|20071513|P1|COMPLETED|Overall Study||7
8142672|NCT02690727|20071512|P2|STARTED|Overall Study||9
8142673|NCT02690727|20071513|P1|STARTED|Overall Study||9
8142674|NCT02690701|20071525|P2|NOT COMPLETED|Treatment Period 2||5
8142675|NCT02690701|20071526|P1|NOT COMPLETED|Treatment Period 2||3
8142676|NCT02690701|20071525|P2|COMPLETED|Treatment Period 2||37
8142677|NCT02690701|20071526|P1|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41
8142678|NCT02690701|20071525|P2|STARTED|Treatment Period 2||42
8142679|NCT02690701|20071526|P1|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44
8142680|NCT02690701|20071525|P2|NOT COMPLETED|Treatment Period 1||3
8142681|NCT02690701|20071526|P1|NOT COMPLETED|Treatment Period 1||2
8142682|NCT02690701|20071525|P2|COMPLETED|Treatment Period 1||42
8142683|NCT02690701|20071526|P1|COMPLETED|Treatment Period 1||44
8142684|NCT02690701|20071525|P2|STARTED|Treatment Period 1||45
8142685|NCT02690701|20071526|P1|STARTED|Treatment Period 1||46
8142689|NCT02690194|20071601|P3|NOT COMPLETED|Overall Study||0
8142690|NCT02690194|20071602|P2|NOT COMPLETED|Overall Study||4
8142691|NCT02690194|20071603|P1|NOT COMPLETED|Overall Study||1
8142692|NCT02690194|20071601|P3|COMPLETED|Overall Study||19
8142693|NCT02690194|20071602|P2|COMPLETED|Overall Study||14
8142694|NCT02690194|20071603|P1|COMPLETED|Overall Study||16
8142695|NCT02690194|20071601|P3|STARTED|Overall Study||19
8142696|NCT02690194|20071602|P2|STARTED|Overall Study||18
8142697|NCT02690194|20071603|P1|STARTED|Overall Study||17
8142698|NCT02690181|20071652|P6|NOT COMPLETED|Overall Study||0
8142699|NCT02690181|20071653|P5|NOT COMPLETED|Overall Study||0
8142700|NCT02690181|20071654|P4|NOT COMPLETED|Overall Study||0
8142701|NCT02690181|20071655|P3|NOT COMPLETED|Overall Study||0
8142702|NCT02690181|20071656|P2|NOT COMPLETED|Overall Study||0
8142703|NCT02690181|20071657|P1|NOT COMPLETED|Overall Study||0
8142704|NCT02690181|20071652|P6|COMPLETED|Overall Study||21
8142705|NCT02690181|20071653|P5|COMPLETED|Overall Study||6
8142706|NCT02690181|20071654|P4|COMPLETED|Overall Study||10
8142707|NCT02690181|20071655|P3|COMPLETED|Overall Study||15
8142708|NCT02690181|20071656|P2|COMPLETED|Overall Study||14
8142709|NCT02690181|20071657|P1|COMPLETED|Overall Study||14
8142710|NCT02690181|20071652|P6|STARTED|Overall Study||21
8142711|NCT02690181|20071653|P5|STARTED|Overall Study||6
8142712|NCT02690181|20071654|P4|STARTED|Overall Study||10
8142713|NCT02690181|20071655|P3|STARTED|Overall Study||15
8142714|NCT02690181|20071656|P2|STARTED|Overall Study||14
8142715|NCT02690181|20071657|P1|STARTED|Overall Study||14
8142716|NCT02689973|20071783|P4|NOT COMPLETED|Overall Study||53
8142717|NCT02689973|20071784|P3|NOT COMPLETED|Overall Study||72
8142718|NCT02689973|20071785|P2|NOT COMPLETED|Overall Study||49
8142719|NCT02689973|20071786|P1|NOT COMPLETED|Overall Study||54
8142720|NCT02689973|20071783|P4|COMPLETED|Overall Study||232
8142721|NCT02689973|20071784|P3|COMPLETED|Overall Study||279
8142722|NCT02689973|20071785|P2|COMPLETED|Overall Study||221
8142723|NCT02689973|20071786|P1|COMPLETED|Overall Study||257
8142724|NCT02689973|20071783|P4|STARTED|Overall Study||285
8142725|NCT02689973|20071784|P3|STARTED|Overall Study||351
8142726|NCT02689973|20071785|P2|STARTED|Overall Study||270
8142727|NCT02689973|20071786|P1|STARTED|Overall Study||311
8142728|NCT02689804|20071810|P2|NOT COMPLETED|Overall Study||0
8142729|NCT02689804|20071811|P1|NOT COMPLETED|Overall Study||2
8142730|NCT02689804|20071810|P2|COMPLETED|Overall Study||16
8142731|NCT02689804|20071811|P1|COMPLETED|Overall Study||16
8142732|NCT02689804|20071810|P2|STARTED|Overall Study||16
8142733|NCT02689804|20071811|P1|STARTED|Overall Study||18
8142734|NCT02689492|20071837|P1|NOT COMPLETED|Overall Study||86
8142735|NCT02689492|20071837|P1|COMPLETED|Overall Study||315
8142736|NCT02689492|20071837|P1|STARTED|Overall Study||401
8142737|NCT02689219|20071853|P2|NOT COMPLETED|Overall Study||7
8142738|NCT02689219|20071854|P1|NOT COMPLETED|Overall Study||11
8142739|NCT02689219|20071853|P2|COMPLETED|Overall Study||0
8142740|NCT02689219|20071854|P1|COMPLETED|Overall Study||0
8142741|NCT02689219|20071853|P2|STARTED|Overall Study||7
8142742|NCT02689219|20071854|P1|STARTED|Overall Study||11
8142743|NCT02689206|20071871|P5|NOT COMPLETED|Overall Study||8
8142744|NCT02689206|20071872|P4|NOT COMPLETED|Overall Study||4
8142745|NCT02689206|20071873|P3|NOT COMPLETED|Overall Study||4
8142746|NCT02689206|20071874|P2|NOT COMPLETED|Overall Study||1
8142747|NCT02689206|20071875|P1|NOT COMPLETED|Overall Study||3
8142748|NCT02689206|20071871|P5|COMPLETED|Overall Study||14
8142749|NCT02689206|20071872|P4|COMPLETED|Overall Study||17
8142750|NCT02689206|20071873|P3|COMPLETED|Overall Study||16
8142751|NCT02689206|20071874|P2|COMPLETED|Overall Study||19
8142752|NCT02689206|20071875|P1|COMPLETED|Overall Study||17
8142753|NCT02689206|20071871|P5|STARTED|Overall Study||22
8142754|NCT02689206|20071872|P4|STARTED|Overall Study||21
8142755|NCT02689206|20071873|P3|STARTED|Overall Study||20
8142756|NCT02689206|20071874|P2|STARTED|Overall Study||20
8142757|NCT02689206|20071875|P1|STARTED|Overall Study||20
8142758|NCT02689154|20072079|P1|NOT COMPLETED|Overall Study||0
8142759|NCT02689154|20072079|P1|COMPLETED|Overall Study||18
8142760|NCT02689154|20072079|P1|STARTED|Overall Study||18
8142761|NCT02688933|20072088|P2|NOT COMPLETED|Overall Study||37
8142762|NCT02688933|20072089|P1|NOT COMPLETED|Overall Study||29
8142763|NCT02688933|20072088|P2|COMPLETED|Overall Study||281
8142764|NCT02688933|20072089|P1|COMPLETED|Overall Study||291
8142765|NCT02688933|20072088|P2|STARTED|Overall Study||318
8142766|NCT02688933|20072089|P1|STARTED|Overall Study||320
8142767|NCT02688868|20072109|P1|NOT COMPLETED|Overall Study||4
8142768|NCT02688868|20072109|P1|COMPLETED|Overall Study||34
8142769|NCT02688868|20072109|P1|STARTED|Overall Study||38
8142770|NCT02688842|20072121|P1|NOT COMPLETED|Overall Study||0
8142771|NCT02688842|20072121|P1|COMPLETED|Overall Study||38
8142772|NCT02688842|20072121|P1|STARTED|Overall Study||38
8142773|NCT02688829|20072137|P1|NOT COMPLETED|Overall Study||2
8142774|NCT02688829|20072137|P1|COMPLETED|Overall Study||19
8142775|NCT02688829|20072137|P1|STARTED|Overall Study||21
8142776|NCT02688764|20072149|P2|NOT COMPLETED|Overall Study||17
8142777|NCT02688764|20072150|P1|NOT COMPLETED|Overall Study||40
8142778|NCT02688764|20072149|P2|COMPLETED|Overall Study||2
8142779|NCT02688764|20072150|P1|COMPLETED|Overall Study||26
8142780|NCT02688764|20072149|P2|Treated in Stage 2|Overall Study||8
8142781|NCT02688764|20072150|P1|Treated in Stage 2|Overall Study||43
8142782|NCT02688764|20072149|P2|Treated in Stage 1|Overall Study||19
8142783|NCT02688764|20072150|P1|Treated in Stage 1|Overall Study||66
8142784|NCT02688764|20072149|P2|STARTED|Overall Study||19
8142785|NCT02688764|20072150|P1|STARTED|Overall Study||66
8142786|NCT02688556|20072200|P2|NOT COMPLETED|Overall Study||12
8142787|NCT02688556|20072201|P1|NOT COMPLETED|Overall Study||25
8142788|NCT02688556|20072200|P2|COMPLETED|Overall Study||361
8142789|NCT02688556|20072201|P1|COMPLETED|Overall Study||347
8142790|NCT02688556|20072200|P2|STARTED|Overall Study||373
8142791|NCT02688556|20072201|P1|STARTED|Overall Study||372
8142792|NCT02688387|20072217|P22|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142793|NCT02688387|20072218|P21|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142794|NCT02688387|20072219|P20|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142795|NCT02688387|20072220|P19|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142796|NCT02688387|20072221|P18|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142797|NCT02688387|20072222|P17|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142798|NCT02688387|20072223|P16|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142799|NCT02688387|20072224|P15|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142800|NCT02688387|20072225|P14|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142801|NCT02688387|20072226|P13|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142802|NCT02688387|20072227|P12|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142803|NCT02688387|20072228|P11|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142804|NCT02688387|20072229|P10|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142805|NCT02688387|20072230|P9|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142806|NCT02688387|20072231|P8|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142807|NCT02688387|20072232|P7|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142808|NCT02688387|20072233|P6|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142809|NCT02688387|20072234|P5|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142810|NCT02688387|20072235|P4|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142811|NCT02688387|20072236|P3|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142812|NCT02688387|20072237|P2|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142813|NCT02688387|20072238|P1|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142814|NCT02688387|20072217|P22|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8
8142815|NCT02688387|20072218|P21|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6
8142816|NCT02688387|20072219|P20|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
8142817|NCT02688387|20072220|P19|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
8142818|NCT02688387|20072221|P18|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142819|NCT02688387|20072222|P17|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142820|NCT02688387|20072223|P16|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142821|NCT02688387|20072224|P15|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142822|NCT02688387|20072225|P14|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142823|NCT02688387|20072226|P13|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142824|NCT02688387|20072227|P12|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142825|NCT02688387|20072228|P11|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142826|NCT02688387|20072229|P10|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142827|NCT02688387|20072230|P9|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142828|NCT02688387|20072231|P8|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142829|NCT02688387|20072232|P7|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142830|NCT02688387|20072233|P6|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142831|NCT02688387|20072234|P5|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142832|NCT02688387|20072235|P4|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142833|NCT02688387|20072236|P3|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142834|NCT02688387|20072237|P2|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142835|NCT02688387|20072238|P1|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
8142836|NCT02688387|20072217|P22|STARTED|Part 3B, Period 4 (up to 6 Days)||8
8142837|NCT02688387|20072218|P21|STARTED|Part 3B, Period 4 (up to 6 Days)||6
8142838|NCT02688387|20072219|P20|STARTED|Part 3B, Period 4 (up to 6 Days)||7
8142839|NCT02688387|20072220|P19|STARTED|Part 3B, Period 4 (up to 6 Days)||7
8142840|NCT02688387|20072221|P18|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142841|NCT02688387|20072222|P17|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142842|NCT02688387|20072223|P16|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142843|NCT02688387|20072224|P15|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142844|NCT02688387|20072225|P14|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142845|NCT02688387|20072226|P13|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142846|NCT02688387|20072227|P12|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142847|NCT02688387|20072228|P11|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142848|NCT02688387|20072229|P10|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142849|NCT02688387|20072230|P9|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142850|NCT02688387|20072231|P8|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142851|NCT02688387|20072232|P7|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142852|NCT02688387|20072233|P6|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142853|NCT02688387|20072234|P5|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142854|NCT02688387|20072235|P4|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142855|NCT02688387|20072236|P3|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142856|NCT02688387|20072237|P2|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142857|NCT02688387|20072238|P1|STARTED|Part 3B, Period 4 (up to 6 Days)||0
8142858|NCT02688387|20072217|P22|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142859|NCT02688387|20072218|P21|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
8142860|NCT02688387|20072219|P20|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
8142861|NCT02688387|20072220|P19|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
8142862|NCT02688387|20072221|P18|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142863|NCT02688387|20072222|P17|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142864|NCT02688387|20072223|P16|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142865|NCT02688387|20072224|P15|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142866|NCT02688387|20072225|P14|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142867|NCT02688387|20072226|P13|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142868|NCT02688387|20072227|P12|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142869|NCT02688387|20072228|P11|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142870|NCT02688387|20072229|P10|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142871|NCT02688387|20072230|P9|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142872|NCT02688387|20072231|P8|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142873|NCT02688387|20072232|P7|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142874|NCT02688387|20072233|P6|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142875|NCT02688387|20072234|P5|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142876|NCT02688387|20072235|P4|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142877|NCT02688387|20072236|P3|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142878|NCT02688387|20072237|P2|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142879|NCT02688387|20072238|P1|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142880|NCT02688387|20072217|P22|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8
8142881|NCT02688387|20072218|P21|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6
8142882|NCT02688387|20072219|P20|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
8142883|NCT02688387|20072220|P19|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
8142884|NCT02688387|20072221|P18|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142885|NCT02688387|20072222|P17|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142886|NCT02688387|20072223|P16|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142887|NCT02688387|20072224|P15|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142888|NCT02688387|20072225|P14|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142889|NCT02688387|20072226|P13|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142890|NCT02688387|20072227|P12|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142891|NCT02688387|20072228|P11|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142892|NCT02688387|20072229|P10|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142893|NCT02688387|20072230|P9|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142894|NCT02688387|20072231|P8|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142895|NCT02688387|20072232|P7|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142896|NCT02688387|20072233|P6|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142897|NCT02688387|20072234|P5|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142898|NCT02688387|20072235|P4|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142899|NCT02688387|20072236|P3|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142900|NCT02688387|20072237|P2|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142901|NCT02688387|20072238|P1|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
8142902|NCT02688387|20072217|P22|STARTED|Part 3B, Washout Period 3 (10 Days)||8
8142903|NCT02688387|20072218|P21|STARTED|Part 3B, Washout Period 3 (10 Days)||7
8142904|NCT02688387|20072219|P20|STARTED|Part 3B, Washout Period 3 (10 Days)||8
8142905|NCT02688387|20072220|P19|STARTED|Part 3B, Washout Period 3 (10 Days)||8
8142906|NCT02688387|20072221|P18|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142907|NCT02688387|20072222|P17|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142908|NCT02688387|20072223|P16|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142909|NCT02688387|20072224|P15|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142910|NCT02688387|20072225|P14|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142911|NCT02688387|20072226|P13|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142912|NCT02688387|20072227|P12|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142913|NCT02688387|20072228|P11|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142914|NCT02688387|20072229|P10|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142915|NCT02688387|20072230|P9|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142916|NCT02688387|20072231|P8|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142917|NCT02688387|20072232|P7|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142918|NCT02688387|20072233|P6|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142919|NCT02688387|20072234|P5|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142920|NCT02688387|20072235|P4|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142921|NCT02688387|20072236|P3|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142922|NCT02688387|20072237|P2|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142923|NCT02688387|20072238|P1|STARTED|Part 3B, Washout Period 3 (10 Days)||0
8142924|NCT02688387|20072217|P22|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142925|NCT02688387|20072218|P21|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1
8142926|NCT02688387|20072219|P20|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142927|NCT02688387|20072220|P19|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142928|NCT02688387|20072221|P18|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142929|NCT02688387|20072222|P17|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142930|NCT02688387|20072223|P16|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142931|NCT02688387|20072224|P15|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142932|NCT02688387|20072225|P14|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142933|NCT02688387|20072226|P13|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142934|NCT02688387|20072227|P12|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142935|NCT02688387|20072228|P11|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142936|NCT02688387|20072229|P10|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142937|NCT02688387|20072230|P9|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142938|NCT02688387|20072231|P8|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142939|NCT02688387|20072232|P7|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142940|NCT02688387|20072233|P6|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142941|NCT02688387|20072234|P5|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142942|NCT02688387|20072235|P4|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142943|NCT02688387|20072236|P3|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142944|NCT02688387|20072237|P2|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142945|NCT02688387|20072238|P1|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142946|NCT02688387|20072217|P22|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
8142947|NCT02688387|20072218|P21|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7
8142948|NCT02688387|20072219|P20|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
8142949|NCT02688387|20072220|P19|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
8142950|NCT02688387|20072221|P18|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142951|NCT02688387|20072222|P17|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142952|NCT02688387|20072223|P16|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142953|NCT02688387|20072224|P15|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142954|NCT02688387|20072225|P14|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142955|NCT02688387|20072226|P13|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142956|NCT02688387|20072227|P12|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142957|NCT02688387|20072228|P11|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142958|NCT02688387|20072229|P10|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142959|NCT02688387|20072230|P9|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142960|NCT02688387|20072231|P8|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142961|NCT02688387|20072232|P7|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142962|NCT02688387|20072233|P6|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142963|NCT02688387|20072234|P5|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142964|NCT02688387|20072235|P4|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142965|NCT02688387|20072236|P3|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142966|NCT02688387|20072237|P2|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142967|NCT02688387|20072238|P1|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
8142968|NCT02688387|20072217|P22|STARTED|Part 3B, Period 3 (up to 6 Days)||8
8142969|NCT02688387|20072218|P21|STARTED|Part 3B, Period 3 (up to 6 Days)||8
8142970|NCT02688387|20072219|P20|STARTED|Part 3B, Period 3 (up to 6 Days)||8
8142971|NCT02688387|20072220|P19|STARTED|Part 3B, Period 3 (up to 6 Days)||8
8142972|NCT02688387|20072221|P18|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142973|NCT02688387|20072222|P17|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142974|NCT02688387|20072223|P16|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142975|NCT02688387|20072224|P15|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142976|NCT02688387|20072225|P14|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142977|NCT02688387|20072226|P13|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142978|NCT02688387|20072227|P12|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142979|NCT02688387|20072228|P11|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142980|NCT02688387|20072229|P10|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142981|NCT02688387|20072230|P9|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142982|NCT02688387|20072231|P8|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142983|NCT02688387|20072232|P7|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142984|NCT02688387|20072233|P6|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142985|NCT02688387|20072234|P5|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142986|NCT02688387|20072235|P4|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142987|NCT02688387|20072236|P3|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142988|NCT02688387|20072237|P2|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142989|NCT02688387|20072238|P1|STARTED|Part 3B, Period 3 (up to 6 Days)||0
8142990|NCT02688387|20072217|P22|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142991|NCT02688387|20072218|P21|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142992|NCT02688387|20072219|P20|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142993|NCT02688387|20072220|P19|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142994|NCT02688387|20072221|P18|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142995|NCT02688387|20072222|P17|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142996|NCT02688387|20072223|P16|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142997|NCT02688387|20072224|P15|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142998|NCT02688387|20072225|P14|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8142999|NCT02688387|20072226|P13|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143000|NCT02688387|20072227|P12|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143001|NCT02688387|20072228|P11|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143002|NCT02688387|20072229|P10|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143003|NCT02688387|20072230|P9|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143004|NCT02688387|20072231|P8|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143005|NCT02688387|20072232|P7|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143006|NCT02688387|20072233|P6|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143007|NCT02688387|20072234|P5|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143008|NCT02688387|20072235|P4|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143009|NCT02688387|20072236|P3|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143010|NCT02688387|20072237|P2|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143011|NCT02688387|20072238|P1|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143012|NCT02688387|20072217|P22|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
8143013|NCT02688387|20072218|P21|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
8143014|NCT02688387|20072219|P20|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
8143015|NCT02688387|20072220|P19|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
8143016|NCT02688387|20072221|P18|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143017|NCT02688387|20072222|P17|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143018|NCT02688387|20072223|P16|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143019|NCT02688387|20072224|P15|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143020|NCT02688387|20072225|P14|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143021|NCT02688387|20072226|P13|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143022|NCT02688387|20072227|P12|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143023|NCT02688387|20072228|P11|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143024|NCT02688387|20072229|P10|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143025|NCT02688387|20072230|P9|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143026|NCT02688387|20072231|P8|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143027|NCT02688387|20072232|P7|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143028|NCT02688387|20072233|P6|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143029|NCT02688387|20072234|P5|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143030|NCT02688387|20072235|P4|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143031|NCT02688387|20072236|P3|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143032|NCT02688387|20072237|P2|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143033|NCT02688387|20072238|P1|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
8143034|NCT02688387|20072217|P22|STARTED|Part 3B, Washout Period 2 (10 Days)||8
8143035|NCT02688387|20072218|P21|STARTED|Part 3B, Washout Period 2 (10 Days)||8
8143036|NCT02688387|20072219|P20|STARTED|Part 3B, Washout Period 2 (10 Days)||8
8143037|NCT02688387|20072220|P19|STARTED|Part 3B, Washout Period 2 (10 Days)||8
8143038|NCT02688387|20072221|P18|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143039|NCT02688387|20072222|P17|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143040|NCT02688387|20072223|P16|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143041|NCT02688387|20072224|P15|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143042|NCT02688387|20072225|P14|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143043|NCT02688387|20072226|P13|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143044|NCT02688387|20072227|P12|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143045|NCT02688387|20072228|P11|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143046|NCT02688387|20072229|P10|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143047|NCT02688387|20072230|P9|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143048|NCT02688387|20072231|P8|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143049|NCT02688387|20072232|P7|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143050|NCT02688387|20072233|P6|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143051|NCT02688387|20072234|P5|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143052|NCT02688387|20072235|P4|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143053|NCT02688387|20072236|P3|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143054|NCT02688387|20072237|P2|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143055|NCT02688387|20072238|P1|STARTED|Part 3B, Washout Period 2 (10 Days)||0
8143056|NCT02688387|20072217|P22|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143057|NCT02688387|20072218|P21|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143058|NCT02688387|20072219|P20|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143059|NCT02688387|20072220|P19|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143060|NCT02688387|20072221|P18|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143061|NCT02688387|20072222|P17|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143062|NCT02688387|20072223|P16|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143063|NCT02688387|20072224|P15|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143064|NCT02688387|20072225|P14|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143065|NCT02688387|20072226|P13|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143066|NCT02688387|20072227|P12|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143067|NCT02688387|20072228|P11|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143068|NCT02688387|20072229|P10|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143069|NCT02688387|20072230|P9|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143070|NCT02688387|20072231|P8|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143071|NCT02688387|20072232|P7|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143072|NCT02688387|20072233|P6|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143073|NCT02688387|20072234|P5|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143074|NCT02688387|20072235|P4|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143075|NCT02688387|20072236|P3|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143076|NCT02688387|20072237|P2|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143077|NCT02688387|20072238|P1|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143078|NCT02688387|20072217|P22|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
8143079|NCT02688387|20072218|P21|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
8143080|NCT02688387|20072219|P20|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
8143081|NCT02688387|20072220|P19|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
8143082|NCT02688387|20072221|P18|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143083|NCT02688387|20072222|P17|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143084|NCT02688387|20072223|P16|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143085|NCT02688387|20072224|P15|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143086|NCT02688387|20072225|P14|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143087|NCT02688387|20072226|P13|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143088|NCT02688387|20072227|P12|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143089|NCT02688387|20072228|P11|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143090|NCT02688387|20072229|P10|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143091|NCT02688387|20072230|P9|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143092|NCT02688387|20072231|P8|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143093|NCT02688387|20072232|P7|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143094|NCT02688387|20072233|P6|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143095|NCT02688387|20072234|P5|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143096|NCT02688387|20072235|P4|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143097|NCT02688387|20072236|P3|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143098|NCT02688387|20072237|P2|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143099|NCT02688387|20072238|P1|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
8143100|NCT02688387|20072217|P22|STARTED|Part 3B, Period 2 (up to 6 Days)||8
8143101|NCT02688387|20072218|P21|STARTED|Part 3B, Period 2 (up to 6 Days)||8
8143102|NCT02688387|20072219|P20|STARTED|Part 3B, Period 2 (up to 6 Days)||8
8143103|NCT02688387|20072220|P19|STARTED|Part 3B, Period 2 (up to 6 Days)||8
8143104|NCT02688387|20072221|P18|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143105|NCT02688387|20072222|P17|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143106|NCT02688387|20072223|P16|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143107|NCT02688387|20072224|P15|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143108|NCT02688387|20072225|P14|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143109|NCT02688387|20072226|P13|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143110|NCT02688387|20072227|P12|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143111|NCT02688387|20072228|P11|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143112|NCT02688387|20072229|P10|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143113|NCT02688387|20072230|P9|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143114|NCT02688387|20072231|P8|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143115|NCT02688387|20072232|P7|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143116|NCT02688387|20072233|P6|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143117|NCT02688387|20072234|P5|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143118|NCT02688387|20072235|P4|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143119|NCT02688387|20072236|P3|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143120|NCT02688387|20072237|P2|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143121|NCT02688387|20072238|P1|STARTED|Part 3B, Period 2 (up to 6 Days)||0
8143122|NCT02688387|20072217|P22|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143123|NCT02688387|20072218|P21|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143124|NCT02688387|20072219|P20|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143125|NCT02688387|20072220|P19|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143126|NCT02688387|20072221|P18|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143127|NCT02688387|20072222|P17|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143128|NCT02688387|20072223|P16|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143129|NCT02688387|20072224|P15|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143130|NCT02688387|20072225|P14|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143131|NCT02688387|20072226|P13|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143132|NCT02688387|20072227|P12|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143133|NCT02688387|20072228|P11|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143134|NCT02688387|20072229|P10|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143135|NCT02688387|20072230|P9|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143136|NCT02688387|20072231|P8|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143137|NCT02688387|20072232|P7|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143138|NCT02688387|20072233|P6|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143139|NCT02688387|20072234|P5|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143140|NCT02688387|20072235|P4|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143141|NCT02688387|20072236|P3|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143142|NCT02688387|20072237|P2|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143143|NCT02688387|20072238|P1|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143144|NCT02688387|20072217|P22|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
8143145|NCT02688387|20072218|P21|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
8143146|NCT02688387|20072219|P20|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
8143147|NCT02688387|20072220|P19|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
8143148|NCT02688387|20072221|P18|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143149|NCT02688387|20072222|P17|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143150|NCT02688387|20072223|P16|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143151|NCT02688387|20072224|P15|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143152|NCT02688387|20072225|P14|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143153|NCT02688387|20072226|P13|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143154|NCT02688387|20072227|P12|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143155|NCT02688387|20072228|P11|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143156|NCT02688387|20072229|P10|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143157|NCT02688387|20072230|P9|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143158|NCT02688387|20072231|P8|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143159|NCT02688387|20072232|P7|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143160|NCT02688387|20072233|P6|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143161|NCT02688387|20072234|P5|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143162|NCT02688387|20072235|P4|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143163|NCT02688387|20072236|P3|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143164|NCT02688387|20072237|P2|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143165|NCT02688387|20072238|P1|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
8143166|NCT02688387|20072217|P22|STARTED|Part 3B, Washout Period 1 (10 Days)||8
8143167|NCT02688387|20072218|P21|STARTED|Part 3B, Washout Period 1 (10 Days)||8
8143168|NCT02688387|20072219|P20|STARTED|Part 3B, Washout Period 1 (10 Days)||8
8143169|NCT02688387|20072220|P19|STARTED|Part 3B, Washout Period 1 (10 Days)||8
8143170|NCT02688387|20072221|P18|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143171|NCT02688387|20072222|P17|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143172|NCT02688387|20072223|P16|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143173|NCT02688387|20072224|P15|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143174|NCT02688387|20072225|P14|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143175|NCT02688387|20072226|P13|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143176|NCT02688387|20072227|P12|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143177|NCT02688387|20072228|P11|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143178|NCT02688387|20072229|P10|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143179|NCT02688387|20072230|P9|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143180|NCT02688387|20072231|P8|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143181|NCT02688387|20072232|P7|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143182|NCT02688387|20072233|P6|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143183|NCT02688387|20072234|P5|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143184|NCT02688387|20072235|P4|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143185|NCT02688387|20072236|P3|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143186|NCT02688387|20072237|P2|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143187|NCT02688387|20072238|P1|STARTED|Part 3B, Washout Period 1 (10 Days)||0
8143188|NCT02688387|20072217|P22|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143189|NCT02688387|20072218|P21|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143190|NCT02688387|20072219|P20|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143191|NCT02688387|20072220|P19|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143192|NCT02688387|20072221|P18|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143193|NCT02688387|20072222|P17|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143194|NCT02688387|20072223|P16|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143195|NCT02688387|20072224|P15|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143196|NCT02688387|20072225|P14|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143197|NCT02688387|20072226|P13|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143198|NCT02688387|20072227|P12|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143199|NCT02688387|20072228|P11|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143200|NCT02688387|20072229|P10|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143201|NCT02688387|20072230|P9|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143202|NCT02688387|20072231|P8|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143203|NCT02688387|20072232|P7|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143204|NCT02688387|20072233|P6|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143205|NCT02688387|20072234|P5|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143206|NCT02688387|20072235|P4|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143207|NCT02688387|20072236|P3|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143208|NCT02688387|20072237|P2|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143209|NCT02688387|20072238|P1|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143210|NCT02688387|20072217|P22|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
8143211|NCT02688387|20072218|P21|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
8143212|NCT02688387|20072219|P20|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
8143213|NCT02688387|20072220|P19|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
8143214|NCT02688387|20072221|P18|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143215|NCT02688387|20072222|P17|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143216|NCT02688387|20072223|P16|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143217|NCT02688387|20072224|P15|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143218|NCT02688387|20072225|P14|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143219|NCT02688387|20072226|P13|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143220|NCT02688387|20072227|P12|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143221|NCT02688387|20072228|P11|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143222|NCT02688387|20072229|P10|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143223|NCT02688387|20072230|P9|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143224|NCT02688387|20072231|P8|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143225|NCT02688387|20072232|P7|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143226|NCT02688387|20072233|P6|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143227|NCT02688387|20072234|P5|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143228|NCT02688387|20072235|P4|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143229|NCT02688387|20072236|P3|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143230|NCT02688387|20072237|P2|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143231|NCT02688387|20072238|P1|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
8143232|NCT02688387|20072217|P22|STARTED|Part 3B, Period 1 (up to 6 Days)||8
8143233|NCT02688387|20072218|P21|STARTED|Part 3B, Period 1 (up to 6 Days)||8
8143234|NCT02688387|20072219|P20|STARTED|Part 3B, Period 1 (up to 6 Days)||8
8143235|NCT02688387|20072220|P19|STARTED|Part 3B, Period 1 (up to 6 Days)||8
8143236|NCT02688387|20072221|P18|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143237|NCT02688387|20072222|P17|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143238|NCT02688387|20072223|P16|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143239|NCT02688387|20072224|P15|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143240|NCT02688387|20072225|P14|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143241|NCT02688387|20072226|P13|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143242|NCT02688387|20072227|P12|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143243|NCT02688387|20072228|P11|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143244|NCT02688387|20072229|P10|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143245|NCT02688387|20072230|P9|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143246|NCT02688387|20072231|P8|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143247|NCT02688387|20072232|P7|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143248|NCT02688387|20072233|P6|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143249|NCT02688387|20072234|P5|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143250|NCT02688387|20072235|P4|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143251|NCT02688387|20072236|P3|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143252|NCT02688387|20072237|P2|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143253|NCT02688387|20072238|P1|STARTED|Part 3B, Period 1 (up to 6 Days)||0
8143254|NCT02688387|20072217|P22|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143255|NCT02688387|20072218|P21|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143256|NCT02688387|20072219|P20|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143257|NCT02688387|20072220|P19|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143258|NCT02688387|20072221|P18|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143259|NCT02688387|20072222|P17|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143260|NCT02688387|20072223|P16|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143261|NCT02688387|20072224|P15|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143262|NCT02688387|20072225|P14|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143263|NCT02688387|20072226|P13|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143264|NCT02688387|20072227|P12|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143265|NCT02688387|20072228|P11|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143266|NCT02688387|20072229|P10|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143267|NCT02688387|20072230|P9|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143268|NCT02688387|20072231|P8|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143269|NCT02688387|20072232|P7|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143270|NCT02688387|20072233|P6|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143271|NCT02688387|20072234|P5|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143272|NCT02688387|20072235|P4|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143273|NCT02688387|20072236|P3|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143274|NCT02688387|20072237|P2|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143275|NCT02688387|20072238|P1|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143276|NCT02688387|20072217|P22|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143277|NCT02688387|20072218|P21|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143278|NCT02688387|20072219|P20|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143279|NCT02688387|20072220|P19|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143280|NCT02688387|20072221|P18|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
8143281|NCT02688387|20072222|P17|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
8143282|NCT02688387|20072223|P16|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
8143283|NCT02688387|20072224|P15|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
8143284|NCT02688387|20072225|P14|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143285|NCT02688387|20072226|P13|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143286|NCT02688387|20072227|P12|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143287|NCT02688387|20072228|P11|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143288|NCT02688387|20072229|P10|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143289|NCT02688387|20072230|P9|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143290|NCT02688387|20072231|P8|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143291|NCT02688387|20072232|P7|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143292|NCT02688387|20072233|P6|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143293|NCT02688387|20072234|P5|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143294|NCT02688387|20072235|P4|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143295|NCT02688387|20072236|P3|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143296|NCT02688387|20072237|P2|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143297|NCT02688387|20072238|P1|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
8143298|NCT02688387|20072217|P22|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143299|NCT02688387|20072218|P21|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143300|NCT02688387|20072219|P20|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143301|NCT02688387|20072220|P19|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143302|NCT02688387|20072221|P18|STARTED|Part 3A, Period 4 (up to 6 Days)||8
8143303|NCT02688387|20072222|P17|STARTED|Part 3A, Period 4 (up to 6 Days)||8
8143304|NCT02688387|20072223|P16|STARTED|Part 3A, Period 4 (up to 6 Days)||8
8143305|NCT02688387|20072224|P15|STARTED|Part 3A, Period 4 (up to 6 Days)||8
8143306|NCT02688387|20072225|P14|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143307|NCT02688387|20072226|P13|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143308|NCT02688387|20072227|P12|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143309|NCT02688387|20072228|P11|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143310|NCT02688387|20072229|P10|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143311|NCT02688387|20072230|P9|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143312|NCT02688387|20072231|P8|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143313|NCT02688387|20072232|P7|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143314|NCT02688387|20072233|P6|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143315|NCT02688387|20072234|P5|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143316|NCT02688387|20072235|P4|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143317|NCT02688387|20072236|P3|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143318|NCT02688387|20072237|P2|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143319|NCT02688387|20072238|P1|STARTED|Part 3A, Period 4 (up to 6 Days)||0
8143320|NCT02688387|20072217|P22|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143321|NCT02688387|20072218|P21|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143322|NCT02688387|20072219|P20|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143323|NCT02688387|20072220|P19|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143324|NCT02688387|20072221|P18|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143325|NCT02688387|20072222|P17|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143326|NCT02688387|20072223|P16|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143327|NCT02688387|20072224|P15|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143328|NCT02688387|20072225|P14|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143329|NCT02688387|20072226|P13|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143330|NCT02688387|20072227|P12|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143331|NCT02688387|20072228|P11|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143332|NCT02688387|20072229|P10|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143333|NCT02688387|20072230|P9|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143334|NCT02688387|20072231|P8|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143335|NCT02688387|20072232|P7|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143336|NCT02688387|20072233|P6|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143337|NCT02688387|20072234|P5|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143338|NCT02688387|20072235|P4|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143339|NCT02688387|20072236|P3|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143340|NCT02688387|20072237|P2|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143341|NCT02688387|20072238|P1|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143342|NCT02688387|20072217|P22|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143343|NCT02688387|20072218|P21|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143344|NCT02688387|20072219|P20|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143345|NCT02688387|20072220|P19|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143346|NCT02688387|20072221|P18|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
8143347|NCT02688387|20072222|P17|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
8143348|NCT02688387|20072223|P16|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
8143349|NCT02688387|20072224|P15|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
8143350|NCT02688387|20072225|P14|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143351|NCT02688387|20072226|P13|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143352|NCT02688387|20072227|P12|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143353|NCT02688387|20072228|P11|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143354|NCT02688387|20072229|P10|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143355|NCT02688387|20072230|P9|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143356|NCT02688387|20072231|P8|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143357|NCT02688387|20072232|P7|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143358|NCT02688387|20072233|P6|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143359|NCT02688387|20072234|P5|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143360|NCT02688387|20072235|P4|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143361|NCT02688387|20072236|P3|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143362|NCT02688387|20072237|P2|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143363|NCT02688387|20072238|P1|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
8143364|NCT02688387|20072217|P22|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143365|NCT02688387|20072218|P21|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143366|NCT02688387|20072219|P20|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143367|NCT02688387|20072220|P19|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143368|NCT02688387|20072221|P18|STARTED|Part 3A, Washout Period 3 (10 Days)||8
8143369|NCT02688387|20072222|P17|STARTED|Part 3A, Washout Period 3 (10 Days)||8
8143370|NCT02688387|20072223|P16|STARTED|Part 3A, Washout Period 3 (10 Days)||8
8143371|NCT02688387|20072224|P15|STARTED|Part 3A, Washout Period 3 (10 Days)||8
8143372|NCT02688387|20072225|P14|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143373|NCT02688387|20072226|P13|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143374|NCT02688387|20072227|P12|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143375|NCT02688387|20072228|P11|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143376|NCT02688387|20072229|P10|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143377|NCT02688387|20072230|P9|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143378|NCT02688387|20072231|P8|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143379|NCT02688387|20072232|P7|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143380|NCT02688387|20072233|P6|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143381|NCT02688387|20072234|P5|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143382|NCT02688387|20072235|P4|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143383|NCT02688387|20072236|P3|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143384|NCT02688387|20072237|P2|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143385|NCT02688387|20072238|P1|STARTED|Part 3A, Washout Period 3 (10 Days)||0
8143386|NCT02688387|20072217|P22|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143387|NCT02688387|20072218|P21|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143388|NCT02688387|20072219|P20|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143389|NCT02688387|20072220|P19|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143390|NCT02688387|20072221|P18|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143391|NCT02688387|20072222|P17|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143392|NCT02688387|20072223|P16|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143393|NCT02688387|20072224|P15|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143394|NCT02688387|20072225|P14|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143395|NCT02688387|20072226|P13|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143396|NCT02688387|20072227|P12|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143397|NCT02688387|20072228|P11|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143398|NCT02688387|20072229|P10|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143399|NCT02688387|20072230|P9|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143400|NCT02688387|20072231|P8|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143401|NCT02688387|20072232|P7|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143402|NCT02688387|20072233|P6|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143403|NCT02688387|20072234|P5|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143404|NCT02688387|20072235|P4|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143405|NCT02688387|20072236|P3|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143406|NCT02688387|20072237|P2|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143407|NCT02688387|20072238|P1|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143408|NCT02688387|20072217|P22|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143409|NCT02688387|20072218|P21|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143410|NCT02688387|20072219|P20|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143411|NCT02688387|20072220|P19|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143412|NCT02688387|20072221|P18|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
8143413|NCT02688387|20072222|P17|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
8143414|NCT02688387|20072223|P16|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
8143415|NCT02688387|20072224|P15|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
8143416|NCT02688387|20072225|P14|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143417|NCT02688387|20072226|P13|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143418|NCT02688387|20072227|P12|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143419|NCT02688387|20072228|P11|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143420|NCT02688387|20072229|P10|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143421|NCT02688387|20072230|P9|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143422|NCT02688387|20072231|P8|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143423|NCT02688387|20072232|P7|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143424|NCT02688387|20072233|P6|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143425|NCT02688387|20072234|P5|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143426|NCT02688387|20072235|P4|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143427|NCT02688387|20072236|P3|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143428|NCT02688387|20072237|P2|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143429|NCT02688387|20072238|P1|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
8143430|NCT02688387|20072217|P22|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143431|NCT02688387|20072218|P21|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143432|NCT02688387|20072219|P20|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143433|NCT02688387|20072220|P19|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143434|NCT02688387|20072221|P18|STARTED|Part 3A, Period 3 (up to 6 Days)||8
8143435|NCT02688387|20072222|P17|STARTED|Part 3A, Period 3 (up to 6 Days)||8
8143436|NCT02688387|20072223|P16|STARTED|Part 3A, Period 3 (up to 6 Days)||8
8143437|NCT02688387|20072224|P15|STARTED|Part 3A, Period 3 (up to 6 Days)||8
8143438|NCT02688387|20072225|P14|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143439|NCT02688387|20072226|P13|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143440|NCT02688387|20072227|P12|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143441|NCT02688387|20072228|P11|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143442|NCT02688387|20072229|P10|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143443|NCT02688387|20072230|P9|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143444|NCT02688387|20072231|P8|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143445|NCT02688387|20072232|P7|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143446|NCT02688387|20072233|P6|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143447|NCT02688387|20072234|P5|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143448|NCT02688387|20072235|P4|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143449|NCT02688387|20072236|P3|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143450|NCT02688387|20072237|P2|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143451|NCT02688387|20072238|P1|STARTED|Part 3A, Period 3 (up to 6 Days)||0
8143452|NCT02688387|20072217|P22|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143453|NCT02688387|20072218|P21|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143454|NCT02688387|20072219|P20|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143455|NCT02688387|20072220|P19|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143456|NCT02688387|20072221|P18|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143457|NCT02688387|20072222|P17|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143458|NCT02688387|20072223|P16|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143459|NCT02688387|20072224|P15|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143460|NCT02688387|20072225|P14|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143461|NCT02688387|20072226|P13|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143462|NCT02688387|20072227|P12|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143463|NCT02688387|20072228|P11|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143464|NCT02688387|20072229|P10|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143465|NCT02688387|20072230|P9|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143466|NCT02688387|20072231|P8|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143467|NCT02688387|20072232|P7|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143468|NCT02688387|20072233|P6|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143469|NCT02688387|20072234|P5|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143470|NCT02688387|20072235|P4|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143471|NCT02688387|20072236|P3|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143472|NCT02688387|20072237|P2|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143473|NCT02688387|20072238|P1|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143474|NCT02688387|20072217|P22|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143475|NCT02688387|20072218|P21|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143476|NCT02688387|20072219|P20|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143477|NCT02688387|20072220|P19|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143478|NCT02688387|20072221|P18|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
8143479|NCT02688387|20072222|P17|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
8143480|NCT02688387|20072223|P16|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
8143481|NCT02688387|20072224|P15|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
8143482|NCT02688387|20072225|P14|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143483|NCT02688387|20072226|P13|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143484|NCT02688387|20072227|P12|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143485|NCT02688387|20072228|P11|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143486|NCT02688387|20072229|P10|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143487|NCT02688387|20072230|P9|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143488|NCT02688387|20072231|P8|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143489|NCT02688387|20072232|P7|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143490|NCT02688387|20072233|P6|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143491|NCT02688387|20072234|P5|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143492|NCT02688387|20072235|P4|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143493|NCT02688387|20072236|P3|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143494|NCT02688387|20072237|P2|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143495|NCT02688387|20072238|P1|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
8143496|NCT02688387|20072217|P22|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143497|NCT02688387|20072218|P21|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143498|NCT02688387|20072219|P20|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143499|NCT02688387|20072220|P19|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143500|NCT02688387|20072221|P18|STARTED|Part 3A, Washout Period 2 (10 Days)||8
8143501|NCT02688387|20072222|P17|STARTED|Part 3A, Washout Period 2 (10 Days)||8
8143502|NCT02688387|20072223|P16|STARTED|Part 3A, Washout Period 2 (10 Days)||8
8143503|NCT02688387|20072224|P15|STARTED|Part 3A, Washout Period 2 (10 Days)||8
8143504|NCT02688387|20072225|P14|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143505|NCT02688387|20072226|P13|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143506|NCT02688387|20072227|P12|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143507|NCT02688387|20072228|P11|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143508|NCT02688387|20072229|P10|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143509|NCT02688387|20072230|P9|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143510|NCT02688387|20072231|P8|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143511|NCT02688387|20072232|P7|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143512|NCT02688387|20072233|P6|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143513|NCT02688387|20072234|P5|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143514|NCT02688387|20072235|P4|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143515|NCT02688387|20072236|P3|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143516|NCT02688387|20072237|P2|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143517|NCT02688387|20072238|P1|STARTED|Part 3A, Washout Period 2 (10 Days)||0
8143518|NCT02688387|20072217|P22|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143519|NCT02688387|20072218|P21|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143520|NCT02688387|20072219|P20|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143521|NCT02688387|20072220|P19|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143522|NCT02688387|20072221|P18|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143523|NCT02688387|20072222|P17|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143524|NCT02688387|20072223|P16|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143525|NCT02688387|20072224|P15|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143526|NCT02688387|20072225|P14|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143527|NCT02688387|20072226|P13|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143528|NCT02688387|20072227|P12|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143529|NCT02688387|20072228|P11|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143530|NCT02688387|20072229|P10|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143531|NCT02688387|20072230|P9|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143532|NCT02688387|20072231|P8|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143533|NCT02688387|20072232|P7|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143534|NCT02688387|20072233|P6|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143535|NCT02688387|20072234|P5|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143536|NCT02688387|20072235|P4|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143537|NCT02688387|20072236|P3|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143538|NCT02688387|20072237|P2|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143539|NCT02688387|20072238|P1|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143540|NCT02688387|20072217|P22|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143541|NCT02688387|20072218|P21|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143542|NCT02688387|20072219|P20|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143543|NCT02688387|20072220|P19|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143544|NCT02688387|20072221|P18|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
8143545|NCT02688387|20072222|P17|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
8143546|NCT02688387|20072223|P16|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
8143547|NCT02688387|20072224|P15|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
8143548|NCT02688387|20072225|P14|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143549|NCT02688387|20072226|P13|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143550|NCT02688387|20072227|P12|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143551|NCT02688387|20072228|P11|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143552|NCT02688387|20072229|P10|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143553|NCT02688387|20072230|P9|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143554|NCT02688387|20072231|P8|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143555|NCT02688387|20072232|P7|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143556|NCT02688387|20072233|P6|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143557|NCT02688387|20072234|P5|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143558|NCT02688387|20072235|P4|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143559|NCT02688387|20072236|P3|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143560|NCT02688387|20072237|P2|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143561|NCT02688387|20072238|P1|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
8143562|NCT02688387|20072217|P22|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143563|NCT02688387|20072218|P21|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143564|NCT02688387|20072219|P20|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143565|NCT02688387|20072220|P19|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143566|NCT02688387|20072221|P18|STARTED|Part 3A, Period 2 (up to 6 Days)||8
8143567|NCT02688387|20072222|P17|STARTED|Part 3A, Period 2 (up to 6 Days)||8
8143568|NCT02688387|20072223|P16|STARTED|Part 3A, Period 2 (up to 6 Days)||8
8143569|NCT02688387|20072224|P15|STARTED|Part 3A, Period 2 (up to 6 Days)||8
8143570|NCT02688387|20072225|P14|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143571|NCT02688387|20072226|P13|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143572|NCT02688387|20072227|P12|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143573|NCT02688387|20072228|P11|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143574|NCT02688387|20072229|P10|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143575|NCT02688387|20072230|P9|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143576|NCT02688387|20072231|P8|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143577|NCT02688387|20072232|P7|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143578|NCT02688387|20072233|P6|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143579|NCT02688387|20072234|P5|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143580|NCT02688387|20072235|P4|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143581|NCT02688387|20072236|P3|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143582|NCT02688387|20072237|P2|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143583|NCT02688387|20072238|P1|STARTED|Part 3A, Period 2 (up to 6 Days)||0
8143584|NCT02688387|20072217|P22|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143585|NCT02688387|20072218|P21|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143586|NCT02688387|20072219|P20|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143587|NCT02688387|20072220|P19|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143588|NCT02688387|20072221|P18|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143589|NCT02688387|20072222|P17|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143590|NCT02688387|20072223|P16|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143591|NCT02688387|20072224|P15|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143592|NCT02688387|20072225|P14|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143593|NCT02688387|20072226|P13|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143594|NCT02688387|20072227|P12|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143595|NCT02688387|20072228|P11|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143596|NCT02688387|20072229|P10|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143597|NCT02688387|20072230|P9|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143598|NCT02688387|20072231|P8|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143599|NCT02688387|20072232|P7|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143600|NCT02688387|20072233|P6|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143601|NCT02688387|20072234|P5|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143602|NCT02688387|20072235|P4|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143603|NCT02688387|20072236|P3|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143604|NCT02688387|20072237|P2|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143605|NCT02688387|20072238|P1|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143606|NCT02688387|20072217|P22|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143607|NCT02688387|20072218|P21|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143608|NCT02688387|20072219|P20|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143609|NCT02688387|20072220|P19|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143610|NCT02688387|20072221|P18|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
8143611|NCT02688387|20072222|P17|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
8143612|NCT02688387|20072223|P16|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
8143613|NCT02688387|20072224|P15|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
8143614|NCT02688387|20072225|P14|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143615|NCT02688387|20072226|P13|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143616|NCT02688387|20072227|P12|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143617|NCT02688387|20072228|P11|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143618|NCT02688387|20072229|P10|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143619|NCT02688387|20072230|P9|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143620|NCT02688387|20072231|P8|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143621|NCT02688387|20072232|P7|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143622|NCT02688387|20072233|P6|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143623|NCT02688387|20072234|P5|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143624|NCT02688387|20072235|P4|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143625|NCT02688387|20072236|P3|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143626|NCT02688387|20072237|P2|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143627|NCT02688387|20072238|P1|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
8143628|NCT02688387|20072217|P22|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143629|NCT02688387|20072218|P21|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143630|NCT02688387|20072219|P20|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143631|NCT02688387|20072220|P19|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143632|NCT02688387|20072221|P18|STARTED|Part 3A, Washout Period 1 (10 Days)||8
8143633|NCT02688387|20072222|P17|STARTED|Part 3A, Washout Period 1 (10 Days)||8
8143634|NCT02688387|20072223|P16|STARTED|Part 3A, Washout Period 1 (10 Days)||8
8143635|NCT02688387|20072224|P15|STARTED|Part 3A, Washout Period 1 (10 Days)||8
8143636|NCT02688387|20072225|P14|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143637|NCT02688387|20072226|P13|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143638|NCT02688387|20072227|P12|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143639|NCT02688387|20072228|P11|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143640|NCT02688387|20072229|P10|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143641|NCT02688387|20072230|P9|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143642|NCT02688387|20072231|P8|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143643|NCT02688387|20072232|P7|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143644|NCT02688387|20072233|P6|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143645|NCT02688387|20072234|P5|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143646|NCT02688387|20072235|P4|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143647|NCT02688387|20072236|P3|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143648|NCT02688387|20072237|P2|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143649|NCT02688387|20072238|P1|STARTED|Part 3A, Washout Period 1 (10 Days)||0
8143650|NCT02688387|20072217|P22|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143651|NCT02688387|20072218|P21|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143652|NCT02688387|20072219|P20|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143653|NCT02688387|20072220|P19|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143654|NCT02688387|20072221|P18|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143655|NCT02688387|20072222|P17|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143656|NCT02688387|20072223|P16|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143657|NCT02688387|20072224|P15|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1
8143658|NCT02688387|20072225|P14|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143659|NCT02688387|20072226|P13|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143660|NCT02688387|20072227|P12|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143661|NCT02688387|20072228|P11|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143662|NCT02688387|20072229|P10|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143663|NCT02688387|20072230|P9|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143664|NCT02688387|20072231|P8|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143665|NCT02688387|20072232|P7|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143666|NCT02688387|20072233|P6|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143667|NCT02688387|20072234|P5|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143668|NCT02688387|20072235|P4|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143669|NCT02688387|20072236|P3|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143670|NCT02688387|20072237|P2|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143671|NCT02688387|20072238|P1|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143672|NCT02688387|20072217|P22|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143673|NCT02688387|20072218|P21|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143674|NCT02688387|20072219|P20|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143675|NCT02688387|20072220|P19|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143676|NCT02688387|20072221|P18|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
8143677|NCT02688387|20072222|P17|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
8143678|NCT02688387|20072223|P16|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
8143679|NCT02688387|20072224|P15|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
8143680|NCT02688387|20072225|P14|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143681|NCT02688387|20072226|P13|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143682|NCT02688387|20072227|P12|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143683|NCT02688387|20072228|P11|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143684|NCT02688387|20072229|P10|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143685|NCT02688387|20072230|P9|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143686|NCT02688387|20072231|P8|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143687|NCT02688387|20072232|P7|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143688|NCT02688387|20072233|P6|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143689|NCT02688387|20072234|P5|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143690|NCT02688387|20072235|P4|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143691|NCT02688387|20072236|P3|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143692|NCT02688387|20072237|P2|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143693|NCT02688387|20072238|P1|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
8143694|NCT02688387|20072217|P22|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143695|NCT02688387|20072218|P21|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143696|NCT02688387|20072219|P20|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143697|NCT02688387|20072220|P19|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143698|NCT02688387|20072221|P18|STARTED|Part 3A, Period 1 (up to 6 Days)||8
8143699|NCT02688387|20072222|P17|STARTED|Part 3A, Period 1 (up to 6 Days)||8
8143700|NCT02688387|20072223|P16|STARTED|Part 3A, Period 1 (up to 6 Days)||8
8143701|NCT02688387|20072224|P15|STARTED|Part 3A, Period 1 (up to 6 Days)||9
8143702|NCT02688387|20072225|P14|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143703|NCT02688387|20072226|P13|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143704|NCT02688387|20072227|P12|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143705|NCT02688387|20072228|P11|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143706|NCT02688387|20072229|P10|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143707|NCT02688387|20072230|P9|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143708|NCT02688387|20072231|P8|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143709|NCT02688387|20072232|P7|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143710|NCT02688387|20072233|P6|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143711|NCT02688387|20072234|P5|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143712|NCT02688387|20072235|P4|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143713|NCT02688387|20072236|P3|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143714|NCT02688387|20072237|P2|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143715|NCT02688387|20072238|P1|STARTED|Part 3A, Period 1 (up to 6 Days)||0
8143716|NCT02688387|20072217|P22|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143717|NCT02688387|20072218|P21|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143718|NCT02688387|20072219|P20|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143719|NCT02688387|20072220|P19|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143720|NCT02688387|20072221|P18|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143721|NCT02688387|20072222|P17|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143722|NCT02688387|20072223|P16|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143723|NCT02688387|20072224|P15|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143724|NCT02688387|20072225|P14|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143725|NCT02688387|20072226|P13|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143726|NCT02688387|20072227|P12|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143727|NCT02688387|20072228|P11|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143728|NCT02688387|20072229|P10|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143729|NCT02688387|20072230|P9|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143730|NCT02688387|20072231|P8|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143731|NCT02688387|20072232|P7|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143732|NCT02688387|20072233|P6|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143733|NCT02688387|20072234|P5|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143734|NCT02688387|20072235|P4|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143735|NCT02688387|20072236|P3|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143736|NCT02688387|20072237|P2|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143737|NCT02688387|20072238|P1|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143738|NCT02688387|20072217|P22|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143739|NCT02688387|20072218|P21|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143740|NCT02688387|20072219|P20|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143741|NCT02688387|20072220|P19|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143742|NCT02688387|20072221|P18|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143743|NCT02688387|20072222|P17|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143744|NCT02688387|20072223|P16|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143745|NCT02688387|20072224|P15|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143746|NCT02688387|20072225|P14|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
8143747|NCT02688387|20072226|P13|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
8143748|NCT02688387|20072227|P12|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
8143749|NCT02688387|20072228|P11|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
8143750|NCT02688387|20072229|P10|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143751|NCT02688387|20072230|P9|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143752|NCT02688387|20072231|P8|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143753|NCT02688387|20072232|P7|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143754|NCT02688387|20072233|P6|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143755|NCT02688387|20072234|P5|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143756|NCT02688387|20072235|P4|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143757|NCT02688387|20072236|P3|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143758|NCT02688387|20072237|P2|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143759|NCT02688387|20072238|P1|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
8143760|NCT02688387|20072217|P22|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143761|NCT02688387|20072218|P21|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143762|NCT02688387|20072219|P20|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143763|NCT02688387|20072220|P19|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143764|NCT02688387|20072221|P18|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143765|NCT02688387|20072222|P17|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143766|NCT02688387|20072223|P16|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143767|NCT02688387|20072224|P15|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143768|NCT02688387|20072225|P14|STARTED|Part 2, Period 4 (up to 6 Days)||5
8143769|NCT02688387|20072226|P13|STARTED|Part 2, Period 4 (up to 6 Days)||5
8143770|NCT02688387|20072227|P12|STARTED|Part 2, Period 4 (up to 6 Days)||5
8143771|NCT02688387|20072228|P11|STARTED|Part 2, Period 4 (up to 6 Days)||5
8143772|NCT02688387|20072229|P10|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143773|NCT02688387|20072230|P9|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143774|NCT02688387|20072231|P8|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143775|NCT02688387|20072232|P7|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143776|NCT02688387|20072233|P6|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143777|NCT02688387|20072234|P5|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143778|NCT02688387|20072235|P4|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143779|NCT02688387|20072236|P3|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143780|NCT02688387|20072237|P2|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143781|NCT02688387|20072238|P1|STARTED|Part 2, Period 4 (up to 6 Days)||0
8143782|NCT02688387|20072217|P22|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143783|NCT02688387|20072218|P21|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143784|NCT02688387|20072219|P20|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143785|NCT02688387|20072220|P19|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143786|NCT02688387|20072221|P18|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143787|NCT02688387|20072222|P17|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143788|NCT02688387|20072223|P16|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143789|NCT02688387|20072224|P15|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143790|NCT02688387|20072225|P14|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143791|NCT02688387|20072226|P13|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143792|NCT02688387|20072227|P12|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143793|NCT02688387|20072228|P11|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143794|NCT02688387|20072229|P10|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143795|NCT02688387|20072230|P9|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143796|NCT02688387|20072231|P8|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143797|NCT02688387|20072232|P7|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143798|NCT02688387|20072233|P6|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143799|NCT02688387|20072234|P5|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143800|NCT02688387|20072235|P4|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143801|NCT02688387|20072236|P3|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143802|NCT02688387|20072237|P2|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143803|NCT02688387|20072238|P1|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143804|NCT02688387|20072217|P22|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143805|NCT02688387|20072218|P21|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143806|NCT02688387|20072219|P20|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143807|NCT02688387|20072220|P19|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143808|NCT02688387|20072221|P18|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143809|NCT02688387|20072222|P17|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143810|NCT02688387|20072223|P16|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143811|NCT02688387|20072224|P15|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143812|NCT02688387|20072225|P14|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
8143813|NCT02688387|20072226|P13|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
8143814|NCT02688387|20072227|P12|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
8143815|NCT02688387|20072228|P11|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
8143816|NCT02688387|20072229|P10|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143817|NCT02688387|20072230|P9|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143818|NCT02688387|20072231|P8|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143819|NCT02688387|20072232|P7|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143820|NCT02688387|20072233|P6|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143821|NCT02688387|20072234|P5|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143822|NCT02688387|20072235|P4|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143823|NCT02688387|20072236|P3|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143824|NCT02688387|20072237|P2|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143825|NCT02688387|20072238|P1|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
8143826|NCT02688387|20072217|P22|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143827|NCT02688387|20072218|P21|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143828|NCT02688387|20072219|P20|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143829|NCT02688387|20072220|P19|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143830|NCT02688387|20072221|P18|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143831|NCT02688387|20072222|P17|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143832|NCT02688387|20072223|P16|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143833|NCT02688387|20072224|P15|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143834|NCT02688387|20072225|P14|STARTED|Part 2, Washout Period 3 (10 Days)||5
8143835|NCT02688387|20072226|P13|STARTED|Part 2, Washout Period 3 (10 Days)||5
8143836|NCT02688387|20072227|P12|STARTED|Part 2, Washout Period 3 (10 Days)||5
8143837|NCT02688387|20072228|P11|STARTED|Part 2, Washout Period 3 (10 Days)||5
8143838|NCT02688387|20072229|P10|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143839|NCT02688387|20072230|P9|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143840|NCT02688387|20072231|P8|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143841|NCT02688387|20072232|P7|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143842|NCT02688387|20072233|P6|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143843|NCT02688387|20072234|P5|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143844|NCT02688387|20072235|P4|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143845|NCT02688387|20072236|P3|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143846|NCT02688387|20072237|P2|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143847|NCT02688387|20072238|P1|STARTED|Part 2, Washout Period 3 (10 Days)||0
8143848|NCT02688387|20072217|P22|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143849|NCT02688387|20072218|P21|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143850|NCT02688387|20072219|P20|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143851|NCT02688387|20072220|P19|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143852|NCT02688387|20072221|P18|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143853|NCT02688387|20072222|P17|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143854|NCT02688387|20072223|P16|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143855|NCT02688387|20072224|P15|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143856|NCT02688387|20072225|P14|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143857|NCT02688387|20072226|P13|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143858|NCT02688387|20072227|P12|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143859|NCT02688387|20072228|P11|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143860|NCT02688387|20072229|P10|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143861|NCT02688387|20072230|P9|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143862|NCT02688387|20072231|P8|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143863|NCT02688387|20072232|P7|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143864|NCT02688387|20072233|P6|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143865|NCT02688387|20072234|P5|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143866|NCT02688387|20072235|P4|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143867|NCT02688387|20072236|P3|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143868|NCT02688387|20072237|P2|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143869|NCT02688387|20072238|P1|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143870|NCT02688387|20072217|P22|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143871|NCT02688387|20072218|P21|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143872|NCT02688387|20072219|P20|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143873|NCT02688387|20072220|P19|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143874|NCT02688387|20072221|P18|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143875|NCT02688387|20072222|P17|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143876|NCT02688387|20072223|P16|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143877|NCT02688387|20072224|P15|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143878|NCT02688387|20072225|P14|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
8143879|NCT02688387|20072226|P13|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
8143880|NCT02688387|20072227|P12|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
8143881|NCT02688387|20072228|P11|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
8143882|NCT02688387|20072229|P10|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143883|NCT02688387|20072230|P9|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143884|NCT02688387|20072231|P8|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143885|NCT02688387|20072232|P7|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143886|NCT02688387|20072233|P6|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143887|NCT02688387|20072234|P5|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143888|NCT02688387|20072235|P4|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143889|NCT02688387|20072236|P3|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143890|NCT02688387|20072237|P2|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143891|NCT02688387|20072238|P1|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
8143892|NCT02688387|20072217|P22|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143893|NCT02688387|20072218|P21|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143894|NCT02688387|20072219|P20|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143895|NCT02688387|20072220|P19|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143896|NCT02688387|20072221|P18|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143897|NCT02688387|20072222|P17|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143898|NCT02688387|20072223|P16|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143899|NCT02688387|20072224|P15|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143900|NCT02688387|20072225|P14|STARTED|Part 2, Period 3 (up to 6 Days)||5
8143901|NCT02688387|20072226|P13|STARTED|Part 2, Period 3 (up to 6 Days)||5
8143902|NCT02688387|20072227|P12|STARTED|Part 2, Period 3 (up to 6 Days)||5
8143903|NCT02688387|20072228|P11|STARTED|Part 2, Period 3 (up to 6 Days)||5
8143904|NCT02688387|20072229|P10|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143905|NCT02688387|20072230|P9|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143906|NCT02688387|20072231|P8|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143907|NCT02688387|20072232|P7|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143908|NCT02688387|20072233|P6|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143909|NCT02688387|20072234|P5|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143910|NCT02688387|20072235|P4|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143911|NCT02688387|20072236|P3|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143912|NCT02688387|20072237|P2|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143913|NCT02688387|20072238|P1|STARTED|Part 2, Period 3 (up to 6 Days)||0
8143914|NCT02688387|20072217|P22|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143915|NCT02688387|20072218|P21|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143916|NCT02688387|20072219|P20|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143917|NCT02688387|20072220|P19|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143918|NCT02688387|20072221|P18|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143919|NCT02688387|20072222|P17|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143920|NCT02688387|20072223|P16|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143921|NCT02688387|20072224|P15|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143922|NCT02688387|20072225|P14|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143923|NCT02688387|20072226|P13|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143924|NCT02688387|20072227|P12|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143925|NCT02688387|20072228|P11|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143926|NCT02688387|20072229|P10|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143927|NCT02688387|20072230|P9|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143928|NCT02688387|20072231|P8|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143929|NCT02688387|20072232|P7|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143930|NCT02688387|20072233|P6|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143931|NCT02688387|20072234|P5|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143932|NCT02688387|20072235|P4|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143933|NCT02688387|20072236|P3|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143934|NCT02688387|20072237|P2|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143935|NCT02688387|20072238|P1|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143936|NCT02688387|20072217|P22|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143937|NCT02688387|20072218|P21|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143938|NCT02688387|20072219|P20|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143939|NCT02688387|20072220|P19|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143940|NCT02688387|20072221|P18|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143941|NCT02688387|20072222|P17|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143942|NCT02688387|20072223|P16|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143943|NCT02688387|20072224|P15|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143944|NCT02688387|20072225|P14|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
8143945|NCT02688387|20072226|P13|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
8143946|NCT02688387|20072227|P12|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
8143947|NCT02688387|20072228|P11|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
8143948|NCT02688387|20072229|P10|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143949|NCT02688387|20072230|P9|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143950|NCT02688387|20072231|P8|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143951|NCT02688387|20072232|P7|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143952|NCT02688387|20072233|P6|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143953|NCT02688387|20072234|P5|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143954|NCT02688387|20072235|P4|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143955|NCT02688387|20072236|P3|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143956|NCT02688387|20072237|P2|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143957|NCT02688387|20072238|P1|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
8143958|NCT02688387|20072217|P22|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143959|NCT02688387|20072218|P21|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143960|NCT02688387|20072219|P20|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143961|NCT02688387|20072220|P19|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143962|NCT02688387|20072221|P18|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143963|NCT02688387|20072222|P17|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143964|NCT02688387|20072223|P16|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143965|NCT02688387|20072224|P15|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143966|NCT02688387|20072225|P14|STARTED|Part 2, Washout Period 2 (10 Days)||5
8143967|NCT02688387|20072226|P13|STARTED|Part 2, Washout Period 2 (10 Days)||5
8143968|NCT02688387|20072227|P12|STARTED|Part 2, Washout Period 2 (10 Days)||5
8143969|NCT02688387|20072228|P11|STARTED|Part 2, Washout Period 2 (10 Days)||5
8143970|NCT02688387|20072229|P10|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143971|NCT02688387|20072230|P9|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143972|NCT02688387|20072231|P8|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143973|NCT02688387|20072232|P7|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143974|NCT02688387|20072233|P6|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143975|NCT02688387|20072234|P5|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143976|NCT02688387|20072235|P4|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143977|NCT02688387|20072236|P3|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143978|NCT02688387|20072237|P2|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143979|NCT02688387|20072238|P1|STARTED|Part 2, Washout Period 2 (10 Days)||0
8143980|NCT02688387|20072217|P22|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143981|NCT02688387|20072218|P21|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143982|NCT02688387|20072219|P20|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143983|NCT02688387|20072220|P19|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143984|NCT02688387|20072221|P18|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143985|NCT02688387|20072222|P17|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143986|NCT02688387|20072223|P16|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143987|NCT02688387|20072224|P15|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143988|NCT02688387|20072225|P14|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143989|NCT02688387|20072226|P13|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143990|NCT02688387|20072227|P12|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143991|NCT02688387|20072228|P11|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143992|NCT02688387|20072229|P10|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143993|NCT02688387|20072230|P9|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143994|NCT02688387|20072231|P8|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143995|NCT02688387|20072232|P7|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143996|NCT02688387|20072233|P6|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143997|NCT02688387|20072234|P5|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143998|NCT02688387|20072235|P4|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8143999|NCT02688387|20072236|P3|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144000|NCT02688387|20072237|P2|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144001|NCT02688387|20072238|P1|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144002|NCT02688387|20072217|P22|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144003|NCT02688387|20072218|P21|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144004|NCT02688387|20072219|P20|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144005|NCT02688387|20072220|P19|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144006|NCT02688387|20072221|P18|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144007|NCT02688387|20072222|P17|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144008|NCT02688387|20072223|P16|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144009|NCT02688387|20072224|P15|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144010|NCT02688387|20072225|P14|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
8144011|NCT02688387|20072226|P13|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
8144012|NCT02688387|20072227|P12|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
8144013|NCT02688387|20072228|P11|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
8144014|NCT02688387|20072229|P10|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144015|NCT02688387|20072230|P9|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144016|NCT02688387|20072231|P8|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144017|NCT02688387|20072232|P7|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144018|NCT02688387|20072233|P6|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144019|NCT02688387|20072234|P5|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144020|NCT02688387|20072235|P4|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144021|NCT02688387|20072236|P3|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144022|NCT02688387|20072237|P2|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144023|NCT02688387|20072238|P1|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
8144024|NCT02688387|20072217|P22|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144025|NCT02688387|20072218|P21|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144026|NCT02688387|20072219|P20|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144027|NCT02688387|20072220|P19|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144028|NCT02688387|20072221|P18|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144029|NCT02688387|20072222|P17|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144030|NCT02688387|20072223|P16|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144031|NCT02688387|20072224|P15|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144032|NCT02688387|20072225|P14|STARTED|Part 2, Period 2 (up to 6 Days)||5
8144033|NCT02688387|20072226|P13|STARTED|Part 2, Period 2 (up to 6 Days)||5
8144034|NCT02688387|20072227|P12|STARTED|Part 2, Period 2 (up to 6 Days)||5
8144035|NCT02688387|20072228|P11|STARTED|Part 2, Period 2 (up to 6 Days)||5
8144036|NCT02688387|20072229|P10|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144037|NCT02688387|20072230|P9|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144038|NCT02688387|20072231|P8|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144039|NCT02688387|20072232|P7|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144040|NCT02688387|20072233|P6|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144041|NCT02688387|20072234|P5|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144042|NCT02688387|20072235|P4|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144043|NCT02688387|20072236|P3|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144044|NCT02688387|20072237|P2|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144045|NCT02688387|20072238|P1|STARTED|Part 2, Period 2 (up to 6 Days)||0
8144046|NCT02688387|20072217|P22|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144047|NCT02688387|20072218|P21|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144048|NCT02688387|20072219|P20|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144049|NCT02688387|20072220|P19|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144050|NCT02688387|20072221|P18|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144051|NCT02688387|20072222|P17|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144052|NCT02688387|20072223|P16|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144053|NCT02688387|20072224|P15|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144054|NCT02688387|20072225|P14|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144055|NCT02688387|20072226|P13|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144056|NCT02688387|20072227|P12|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144057|NCT02688387|20072228|P11|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144058|NCT02688387|20072229|P10|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144059|NCT02688387|20072230|P9|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144060|NCT02688387|20072231|P8|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144061|NCT02688387|20072232|P7|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144062|NCT02688387|20072233|P6|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144063|NCT02688387|20072234|P5|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144064|NCT02688387|20072235|P4|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144065|NCT02688387|20072236|P3|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144066|NCT02688387|20072237|P2|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144067|NCT02688387|20072238|P1|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144068|NCT02688387|20072217|P22|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144069|NCT02688387|20072218|P21|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144070|NCT02688387|20072219|P20|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144071|NCT02688387|20072220|P19|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144072|NCT02688387|20072221|P18|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144073|NCT02688387|20072222|P17|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144074|NCT02688387|20072223|P16|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144075|NCT02688387|20072224|P15|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144076|NCT02688387|20072225|P14|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
8144077|NCT02688387|20072226|P13|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
8144078|NCT02688387|20072227|P12|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
8144079|NCT02688387|20072228|P11|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
8144080|NCT02688387|20072229|P10|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144081|NCT02688387|20072230|P9|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144082|NCT02688387|20072231|P8|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144083|NCT02688387|20072232|P7|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144084|NCT02688387|20072233|P6|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144085|NCT02688387|20072234|P5|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144086|NCT02688387|20072235|P4|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144087|NCT02688387|20072236|P3|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144088|NCT02688387|20072237|P2|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144089|NCT02688387|20072238|P1|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
8144090|NCT02688387|20072217|P22|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144091|NCT02688387|20072218|P21|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144092|NCT02688387|20072219|P20|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144093|NCT02688387|20072220|P19|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144094|NCT02688387|20072221|P18|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144095|NCT02688387|20072222|P17|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144096|NCT02688387|20072223|P16|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144097|NCT02688387|20072224|P15|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144098|NCT02688387|20072225|P14|STARTED|Part 2, Washout Period 1 (10 Days)||5
8144099|NCT02688387|20072226|P13|STARTED|Part 2, Washout Period 1 (10 Days)||5
8144100|NCT02688387|20072227|P12|STARTED|Part 2, Washout Period 1 (10 Days)||5
8144101|NCT02688387|20072228|P11|STARTED|Part 2, Washout Period 1 (10 Days)||5
8144102|NCT02688387|20072229|P10|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144103|NCT02688387|20072230|P9|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144104|NCT02688387|20072231|P8|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144105|NCT02688387|20072232|P7|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144106|NCT02688387|20072233|P6|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144107|NCT02688387|20072234|P5|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144108|NCT02688387|20072235|P4|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144109|NCT02688387|20072236|P3|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144110|NCT02688387|20072237|P2|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144111|NCT02688387|20072238|P1|STARTED|Part 2, Washout Period 1 (10 Days)||0
8144112|NCT02688387|20072217|P22|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144113|NCT02688387|20072218|P21|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144349|NCT02688387|20072234|P5|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144114|NCT02688387|20072219|P20|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144115|NCT02688387|20072220|P19|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144116|NCT02688387|20072221|P18|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144117|NCT02688387|20072222|P17|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144118|NCT02688387|20072223|P16|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144119|NCT02688387|20072224|P15|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144120|NCT02688387|20072225|P14|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144121|NCT02688387|20072226|P13|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144122|NCT02688387|20072227|P12|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144123|NCT02688387|20072228|P11|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1
8144124|NCT02688387|20072229|P10|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144125|NCT02688387|20072230|P9|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144126|NCT02688387|20072231|P8|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144127|NCT02688387|20072232|P7|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144128|NCT02688387|20072233|P6|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144129|NCT02688387|20072234|P5|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144130|NCT02688387|20072235|P4|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144131|NCT02688387|20072236|P3|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144132|NCT02688387|20072237|P2|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144133|NCT02688387|20072238|P1|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144134|NCT02688387|20072217|P22|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144135|NCT02688387|20072218|P21|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144136|NCT02688387|20072219|P20|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144137|NCT02688387|20072220|P19|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144138|NCT02688387|20072221|P18|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144139|NCT02688387|20072222|P17|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144140|NCT02688387|20072223|P16|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144141|NCT02688387|20072224|P15|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144142|NCT02688387|20072225|P14|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
8144143|NCT02688387|20072226|P13|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
8144144|NCT02688387|20072227|P12|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
8144145|NCT02688387|20072228|P11|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
8144146|NCT02688387|20072229|P10|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144147|NCT02688387|20072230|P9|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144148|NCT02688387|20072231|P8|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144149|NCT02688387|20072232|P7|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144150|NCT02688387|20072233|P6|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144151|NCT02688387|20072234|P5|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144152|NCT02688387|20072235|P4|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144153|NCT02688387|20072236|P3|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144154|NCT02688387|20072237|P2|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144155|NCT02688387|20072238|P1|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
8144156|NCT02688387|20072217|P22|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144157|NCT02688387|20072218|P21|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144158|NCT02688387|20072219|P20|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144159|NCT02688387|20072220|P19|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144160|NCT02688387|20072221|P18|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144161|NCT02688387|20072222|P17|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144162|NCT02688387|20072223|P16|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144163|NCT02688387|20072224|P15|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144164|NCT02688387|20072225|P14|STARTED|Part 2, Period 1 (up to 6 Days)||5
8144165|NCT02688387|20072226|P13|STARTED|Part 2, Period 1 (up to 6 Days)||5
8144166|NCT02688387|20072227|P12|STARTED|Part 2, Period 1 (up to 6 Days)||5
8144167|NCT02688387|20072228|P11|STARTED|Part 2, Period 1 (up to 6 Days)||6
8144168|NCT02688387|20072229|P10|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144169|NCT02688387|20072230|P9|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144170|NCT02688387|20072231|P8|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144171|NCT02688387|20072232|P7|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144172|NCT02688387|20072233|P6|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144173|NCT02688387|20072234|P5|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144174|NCT02688387|20072235|P4|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144175|NCT02688387|20072236|P3|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144176|NCT02688387|20072237|P2|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144177|NCT02688387|20072238|P1|STARTED|Part 2, Period 1 (up to 6 Days)||0
8144178|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144179|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144180|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144181|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144182|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144183|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144184|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144185|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144186|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144187|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144188|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144189|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144190|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144191|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144192|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144193|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144194|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144195|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144196|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144197|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144198|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144199|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144200|NCT02688387|20072217|P22|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144201|NCT02688387|20072218|P21|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144202|NCT02688387|20072219|P20|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144203|NCT02688387|20072220|P19|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144204|NCT02688387|20072221|P18|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144205|NCT02688387|20072222|P17|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144206|NCT02688387|20072223|P16|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144207|NCT02688387|20072224|P15|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144208|NCT02688387|20072225|P14|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144209|NCT02688387|20072226|P13|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144210|NCT02688387|20072227|P12|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144211|NCT02688387|20072228|P11|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
8144212|NCT02688387|20072229|P10|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144213|NCT02688387|20072230|P9|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144214|NCT02688387|20072231|P8|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144215|NCT02688387|20072232|P7|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144216|NCT02688387|20072233|P6|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144217|NCT02688387|20072234|P5|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144218|NCT02688387|20072235|P4|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144219|NCT02688387|20072236|P3|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144220|NCT02688387|20072237|P2|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144221|NCT02688387|20072238|P1|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
8144222|NCT02688387|20072217|P22|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144223|NCT02688387|20072218|P21|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144224|NCT02688387|20072219|P20|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144225|NCT02688387|20072220|P19|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144226|NCT02688387|20072221|P18|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144227|NCT02688387|20072222|P17|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144228|NCT02688387|20072223|P16|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144229|NCT02688387|20072224|P15|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144230|NCT02688387|20072225|P14|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144231|NCT02688387|20072226|P13|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144232|NCT02688387|20072227|P12|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144233|NCT02688387|20072228|P11|STARTED|Part 1, Period 5 (up to 6 Days)||0
8144234|NCT02688387|20072229|P10|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144235|NCT02688387|20072230|P9|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144236|NCT02688387|20072231|P8|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144237|NCT02688387|20072232|P7|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144238|NCT02688387|20072233|P6|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144239|NCT02688387|20072234|P5|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144240|NCT02688387|20072235|P4|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144241|NCT02688387|20072236|P3|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144242|NCT02688387|20072237|P2|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144243|NCT02688387|20072238|P1|STARTED|Part 1, Period 5 (up to 6 Days)||2
8144244|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144245|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144246|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144247|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144248|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144249|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144250|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144251|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144252|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144253|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144254|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144255|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144256|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144257|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144258|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144259|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144260|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144261|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144262|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144263|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144264|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144265|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144266|NCT02688387|20072217|P22|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144267|NCT02688387|20072218|P21|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144268|NCT02688387|20072219|P20|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144269|NCT02688387|20072220|P19|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144270|NCT02688387|20072221|P18|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144271|NCT02688387|20072222|P17|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144272|NCT02688387|20072223|P16|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144273|NCT02688387|20072224|P15|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144274|NCT02688387|20072225|P14|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144275|NCT02688387|20072226|P13|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144276|NCT02688387|20072227|P12|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144277|NCT02688387|20072228|P11|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
8144278|NCT02688387|20072229|P10|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144279|NCT02688387|20072230|P9|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144280|NCT02688387|20072231|P8|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144281|NCT02688387|20072232|P7|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144282|NCT02688387|20072233|P6|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144283|NCT02688387|20072234|P5|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144284|NCT02688387|20072235|P4|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144285|NCT02688387|20072236|P3|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144286|NCT02688387|20072237|P2|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144287|NCT02688387|20072238|P1|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
8144288|NCT02688387|20072217|P22|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144289|NCT02688387|20072218|P21|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144290|NCT02688387|20072219|P20|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144291|NCT02688387|20072220|P19|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144292|NCT02688387|20072221|P18|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144293|NCT02688387|20072222|P17|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144294|NCT02688387|20072223|P16|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144295|NCT02688387|20072224|P15|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144296|NCT02688387|20072225|P14|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144297|NCT02688387|20072226|P13|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144298|NCT02688387|20072227|P12|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144299|NCT02688387|20072228|P11|STARTED|Part 1, Washout Period 4 (7 Days)||0
8144300|NCT02688387|20072229|P10|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144301|NCT02688387|20072230|P9|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144302|NCT02688387|20072231|P8|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144303|NCT02688387|20072232|P7|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144304|NCT02688387|20072233|P6|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144305|NCT02688387|20072234|P5|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144306|NCT02688387|20072235|P4|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144307|NCT02688387|20072236|P3|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144308|NCT02688387|20072237|P2|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144309|NCT02688387|20072238|P1|STARTED|Part 1, Washout Period 4 (7 Days)||2
8144310|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144311|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144312|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144313|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144314|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144315|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144316|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144317|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144318|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144319|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144320|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144321|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144322|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144323|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144324|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144325|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144326|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144327|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144328|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144329|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144330|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144331|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144332|NCT02688387|20072217|P22|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144333|NCT02688387|20072218|P21|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144334|NCT02688387|20072219|P20|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144335|NCT02688387|20072220|P19|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144336|NCT02688387|20072221|P18|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144337|NCT02688387|20072222|P17|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144338|NCT02688387|20072223|P16|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144339|NCT02688387|20072224|P15|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144340|NCT02688387|20072225|P14|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144341|NCT02688387|20072226|P13|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144342|NCT02688387|20072227|P12|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144343|NCT02688387|20072228|P11|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
8144344|NCT02688387|20072229|P10|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144345|NCT02688387|20072230|P9|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144346|NCT02688387|20072231|P8|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144347|NCT02688387|20072232|P7|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144348|NCT02688387|20072233|P6|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144350|NCT02688387|20072235|P4|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144351|NCT02688387|20072236|P3|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144352|NCT02688387|20072237|P2|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144353|NCT02688387|20072238|P1|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
8144354|NCT02688387|20072217|P22|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144355|NCT02688387|20072218|P21|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144356|NCT02688387|20072219|P20|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144357|NCT02688387|20072220|P19|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144358|NCT02688387|20072221|P18|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144359|NCT02688387|20072222|P17|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144360|NCT02688387|20072223|P16|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144361|NCT02688387|20072224|P15|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144362|NCT02688387|20072225|P14|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144363|NCT02688387|20072226|P13|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144364|NCT02688387|20072227|P12|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144365|NCT02688387|20072228|P11|STARTED|Part 1, Period 4 (up to 6 Days)||0
8144366|NCT02688387|20072229|P10|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144367|NCT02688387|20072230|P9|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144368|NCT02688387|20072231|P8|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144369|NCT02688387|20072232|P7|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144370|NCT02688387|20072233|P6|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144371|NCT02688387|20072234|P5|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144372|NCT02688387|20072235|P4|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144373|NCT02688387|20072236|P3|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144374|NCT02688387|20072237|P2|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144375|NCT02688387|20072238|P1|STARTED|Part 1, Period 4 (up to 6 Days)||2
8144376|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144377|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144378|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144379|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144380|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144381|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144382|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144383|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144384|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144385|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144386|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144387|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144388|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144389|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144390|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144391|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144392|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144393|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144394|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144395|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144396|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144397|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1
8144398|NCT02688387|20072217|P22|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144399|NCT02688387|20072218|P21|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144400|NCT02688387|20072219|P20|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144401|NCT02688387|20072220|P19|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144402|NCT02688387|20072221|P18|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144403|NCT02688387|20072222|P17|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144404|NCT02688387|20072223|P16|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144405|NCT02688387|20072224|P15|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144406|NCT02688387|20072225|P14|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144407|NCT02688387|20072226|P13|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144408|NCT02688387|20072227|P12|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144409|NCT02688387|20072228|P11|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
8144410|NCT02688387|20072229|P10|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144411|NCT02688387|20072230|P9|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144412|NCT02688387|20072231|P8|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144413|NCT02688387|20072232|P7|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144414|NCT02688387|20072233|P6|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144415|NCT02688387|20072234|P5|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144416|NCT02688387|20072235|P4|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144417|NCT02688387|20072236|P3|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144418|NCT02688387|20072237|P2|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144419|NCT02688387|20072238|P1|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
8144420|NCT02688387|20072217|P22|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144421|NCT02688387|20072218|P21|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144422|NCT02688387|20072219|P20|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144423|NCT02688387|20072220|P19|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144424|NCT02688387|20072221|P18|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144425|NCT02688387|20072222|P17|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144426|NCT02688387|20072223|P16|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144427|NCT02688387|20072224|P15|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144428|NCT02688387|20072225|P14|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144429|NCT02688387|20072226|P13|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144430|NCT02688387|20072227|P12|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144431|NCT02688387|20072228|P11|STARTED|Part 1, Washout Period 3 (7 Days)||0
8144432|NCT02688387|20072229|P10|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144433|NCT02688387|20072230|P9|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144434|NCT02688387|20072231|P8|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144435|NCT02688387|20072232|P7|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144436|NCT02688387|20072233|P6|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144437|NCT02688387|20072234|P5|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144438|NCT02688387|20072235|P4|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144439|NCT02688387|20072236|P3|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144440|NCT02688387|20072237|P2|STARTED|Part 1, Washout Period 3 (7 Days)||2
8144441|NCT02688387|20072238|P1|STARTED|Part 1, Washout Period 3 (7 Days)||3
8144442|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144443|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144444|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144445|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144446|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144447|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144448|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144449|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144450|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144451|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144452|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144453|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144454|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144455|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144456|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144457|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144458|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144459|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144460|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144461|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144462|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144463|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144464|NCT02688387|20072217|P22|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144465|NCT02688387|20072218|P21|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144466|NCT02688387|20072219|P20|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144467|NCT02688387|20072220|P19|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144468|NCT02688387|20072221|P18|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144469|NCT02688387|20072222|P17|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144470|NCT02688387|20072223|P16|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144471|NCT02688387|20072224|P15|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144472|NCT02688387|20072225|P14|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144473|NCT02688387|20072226|P13|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144474|NCT02688387|20072227|P12|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144475|NCT02688387|20072228|P11|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
8144476|NCT02688387|20072229|P10|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144477|NCT02688387|20072230|P9|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144478|NCT02688387|20072231|P8|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144479|NCT02688387|20072232|P7|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144480|NCT02688387|20072233|P6|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144481|NCT02688387|20072234|P5|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144482|NCT02688387|20072235|P4|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144483|NCT02688387|20072236|P3|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144484|NCT02688387|20072237|P2|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
8144485|NCT02688387|20072238|P1|COMPLETED|Part 1, Period 3 (up to 6 Days)||3
8144486|NCT02688387|20072217|P22|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144487|NCT02688387|20072218|P21|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144488|NCT02688387|20072219|P20|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144489|NCT02688387|20072220|P19|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144490|NCT02688387|20072221|P18|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144491|NCT02688387|20072222|P17|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144492|NCT02688387|20072223|P16|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144493|NCT02688387|20072224|P15|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144494|NCT02688387|20072225|P14|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144495|NCT02688387|20072226|P13|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144496|NCT02688387|20072227|P12|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144497|NCT02688387|20072228|P11|STARTED|Part 1, Period 3 (up to 6 Days)||0
8144498|NCT02688387|20072229|P10|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144499|NCT02688387|20072230|P9|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144500|NCT02688387|20072231|P8|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144501|NCT02688387|20072232|P7|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144502|NCT02688387|20072233|P6|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144503|NCT02688387|20072234|P5|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144504|NCT02688387|20072235|P4|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144505|NCT02688387|20072236|P3|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144506|NCT02688387|20072237|P2|STARTED|Part 1, Period 3 (up to 6 Days)||2
8144507|NCT02688387|20072238|P1|STARTED|Part 1, Period 3 (up to 6 Days)||3
8144508|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144509|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144510|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144511|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144512|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144513|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144514|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144515|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144516|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144517|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144518|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144519|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144520|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144521|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144522|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144523|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144524|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144525|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144526|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144527|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144528|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144529|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144530|NCT02688387|20072217|P22|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144531|NCT02688387|20072218|P21|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144532|NCT02688387|20072219|P20|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144533|NCT02688387|20072220|P19|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144534|NCT02688387|20072221|P18|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144535|NCT02688387|20072222|P17|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144536|NCT02688387|20072223|P16|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144537|NCT02688387|20072224|P15|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144538|NCT02688387|20072225|P14|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144539|NCT02688387|20072226|P13|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144540|NCT02688387|20072227|P12|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144541|NCT02688387|20072228|P11|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
8144542|NCT02688387|20072229|P10|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144543|NCT02688387|20072230|P9|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144544|NCT02688387|20072231|P8|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144545|NCT02688387|20072232|P7|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144546|NCT02688387|20072233|P6|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144547|NCT02688387|20072234|P5|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144548|NCT02688387|20072235|P4|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144549|NCT02688387|20072236|P3|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144550|NCT02688387|20072237|P2|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
8144551|NCT02688387|20072238|P1|COMPLETED|Part 1, Washout Period 2 (7 Days)||3
8144552|NCT02688387|20072217|P22|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144553|NCT02688387|20072218|P21|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144554|NCT02688387|20072219|P20|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144555|NCT02688387|20072220|P19|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144556|NCT02688387|20072221|P18|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144557|NCT02688387|20072222|P17|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144558|NCT02688387|20072223|P16|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144559|NCT02688387|20072224|P15|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144560|NCT02688387|20072225|P14|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144561|NCT02688387|20072226|P13|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144562|NCT02688387|20072227|P12|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144563|NCT02688387|20072228|P11|STARTED|Part 1, Washout Period 2 (7 Days)||0
8144564|NCT02688387|20072229|P10|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144565|NCT02688387|20072230|P9|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144566|NCT02688387|20072231|P8|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144567|NCT02688387|20072232|P7|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144568|NCT02688387|20072233|P6|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144569|NCT02688387|20072234|P5|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144570|NCT02688387|20072235|P4|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144571|NCT02688387|20072236|P3|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144572|NCT02688387|20072237|P2|STARTED|Part 1, Washout Period 2 (7 Days)||2
8144573|NCT02688387|20072238|P1|STARTED|Part 1, Washout Period 2 (7 Days)||3
8144574|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144575|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144576|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144577|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144578|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144579|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144580|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144581|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144582|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144583|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144584|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144585|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144586|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144587|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144588|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144589|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144590|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144591|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
8144592|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144593|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
8144594|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144595|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144596|NCT02688387|20072217|P22|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144597|NCT02688387|20072218|P21|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144598|NCT02688387|20072219|P20|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144599|NCT02688387|20072220|P19|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144600|NCT02688387|20072221|P18|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144601|NCT02688387|20072222|P17|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144602|NCT02688387|20072223|P16|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144603|NCT02688387|20072224|P15|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144604|NCT02688387|20072225|P14|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144605|NCT02688387|20072226|P13|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144606|NCT02688387|20072227|P12|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144607|NCT02688387|20072228|P11|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
8144608|NCT02688387|20072229|P10|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144609|NCT02688387|20072230|P9|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144610|NCT02688387|20072231|P8|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144611|NCT02688387|20072232|P7|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144612|NCT02688387|20072233|P6|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144613|NCT02688387|20072234|P5|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144614|NCT02688387|20072235|P4|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144615|NCT02688387|20072236|P3|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144616|NCT02688387|20072237|P2|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
8144617|NCT02688387|20072238|P1|COMPLETED|Part 1, Period 2 (up to 6 Days)||3
8144618|NCT02688387|20072217|P22|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144619|NCT02688387|20072218|P21|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144620|NCT02688387|20072219|P20|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144621|NCT02688387|20072220|P19|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144622|NCT02688387|20072221|P18|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144623|NCT02688387|20072222|P17|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144624|NCT02688387|20072223|P16|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144625|NCT02688387|20072224|P15|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144626|NCT02688387|20072225|P14|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144627|NCT02688387|20072226|P13|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144628|NCT02688387|20072227|P12|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144629|NCT02688387|20072228|P11|STARTED|Part 1, Period 2 (up to 6 Days)||0
8144630|NCT02688387|20072229|P10|STARTED|Part 1, Period 2 (up to 6 Days)||2
8144631|NCT02688387|20072230|P9|STARTED|Part 1, Period 2 (up to 6 Days)||2
8144632|NCT02688387|20072231|P8|STARTED|Part 1, Period 2 (up to 6 Days)||2
8144633|NCT02688387|20072232|P7|STARTED|Part 1, Period 2 (up to 6 Days)||2
8144634|NCT02688387|20072233|P6|STARTED|Part 1, Period 2 (up to 6 Days)||2
8144635|NCT02688387|20072234|P5|STARTED|Part 1, Period 2 (up to 6 Days)||3
8144636|NCT02688387|20072235|P4|STARTED|Part 1, Period 2 (up to 6 Days)||2
8144637|NCT02688387|20072236|P3|STARTED|Part 1, Period 2 (up to 6 Days)||3
8144638|NCT02688387|20072237|P2|STARTED|Part 1, Period 2 (up to 6 Days)||2
8144639|NCT02688387|20072238|P1|STARTED|Part 1, Period 2 (up to 6 Days)||3
8144640|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144641|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144642|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144643|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144644|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144645|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144646|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144647|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144648|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144649|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144650|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144651|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144652|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144653|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144654|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144655|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144656|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144657|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144658|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144659|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144660|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1
8144661|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144662|NCT02688387|20072217|P22|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144663|NCT02688387|20072218|P21|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144664|NCT02688387|20072219|P20|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144665|NCT02688387|20072220|P19|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144666|NCT02688387|20072221|P18|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144667|NCT02688387|20072222|P17|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144668|NCT02688387|20072223|P16|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144669|NCT02688387|20072224|P15|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144670|NCT02688387|20072225|P14|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144671|NCT02688387|20072226|P13|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144672|NCT02688387|20072227|P12|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144673|NCT02688387|20072228|P11|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
8144674|NCT02688387|20072229|P10|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8144675|NCT02688387|20072230|P9|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8144676|NCT02688387|20072231|P8|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8144677|NCT02688387|20072232|P7|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8144678|NCT02688387|20072233|P6|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8144679|NCT02688387|20072234|P5|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
8144680|NCT02688387|20072235|P4|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8144681|NCT02688387|20072236|P3|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
8144682|NCT02688387|20072237|P2|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
8144683|NCT02688387|20072238|P1|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
8144684|NCT02688387|20072217|P22|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144685|NCT02688387|20072218|P21|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144686|NCT02688387|20072219|P20|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144687|NCT02688387|20072220|P19|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144688|NCT02688387|20072221|P18|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144689|NCT02688387|20072222|P17|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144690|NCT02688387|20072223|P16|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144691|NCT02688387|20072224|P15|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144692|NCT02688387|20072225|P14|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144693|NCT02688387|20072226|P13|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144694|NCT02688387|20072227|P12|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144695|NCT02688387|20072228|P11|STARTED|Part 1, Washout Period 1 (7 Days)||0
8144696|NCT02688387|20072229|P10|STARTED|Part 1, Washout Period 1 (7 Days)||2
8144697|NCT02688387|20072230|P9|STARTED|Part 1, Washout Period 1 (7 Days)||2
8144698|NCT02688387|20072231|P8|STARTED|Part 1, Washout Period 1 (7 Days)||2
8144699|NCT02688387|20072232|P7|STARTED|Part 1, Washout Period 1 (7 Days)||2
8144700|NCT02688387|20072233|P6|STARTED|Part 1, Washout Period 1 (7 Days)||2
8144701|NCT02688387|20072234|P5|STARTED|Part 1, Washout Period 1 (7 Days)||3
8144702|NCT02688387|20072235|P4|STARTED|Part 1, Washout Period 1 (7 Days)||2
8144703|NCT02688387|20072236|P3|STARTED|Part 1, Washout Period 1 (7 Days)||3
8144704|NCT02688387|20072237|P2|STARTED|Part 1, Washout Period 1 (7 Days)||3
8144705|NCT02688387|20072238|P1|STARTED|Part 1, Washout Period 1 (7 Days)||3
8144706|NCT02688387|20072217|P22|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144707|NCT02688387|20072218|P21|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144708|NCT02688387|20072219|P20|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144709|NCT02688387|20072220|P19|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144710|NCT02688387|20072221|P18|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144711|NCT02688387|20072222|P17|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144712|NCT02688387|20072223|P16|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144713|NCT02688387|20072224|P15|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144714|NCT02688387|20072225|P14|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144715|NCT02688387|20072226|P13|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144716|NCT02688387|20072227|P12|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144717|NCT02688387|20072228|P11|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144718|NCT02688387|20072229|P10|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144719|NCT02688387|20072230|P9|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144720|NCT02688387|20072231|P8|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144721|NCT02688387|20072232|P7|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144722|NCT02688387|20072233|P6|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144723|NCT02688387|20072234|P5|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144724|NCT02688387|20072235|P4|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
8144725|NCT02688387|20072236|P3|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
8144726|NCT02688387|20072237|P2|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144727|NCT02688387|20072238|P1|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144728|NCT02688387|20072217|P22|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144729|NCT02688387|20072218|P21|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144730|NCT02688387|20072219|P20|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144731|NCT02688387|20072220|P19|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144732|NCT02688387|20072221|P18|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144733|NCT02688387|20072222|P17|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144734|NCT02688387|20072223|P16|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144735|NCT02688387|20072224|P15|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144736|NCT02688387|20072225|P14|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144737|NCT02688387|20072226|P13|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144738|NCT02688387|20072227|P12|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144739|NCT02688387|20072228|P11|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
8144740|NCT02688387|20072229|P10|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8144741|NCT02688387|20072230|P9|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8144742|NCT02688387|20072231|P8|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8144743|NCT02688387|20072232|P7|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8144744|NCT02688387|20072233|P6|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8144745|NCT02688387|20072234|P5|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
8144746|NCT02688387|20072235|P4|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
8144747|NCT02688387|20072236|P3|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
8144748|NCT02688387|20072237|P2|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
8144749|NCT02688387|20072238|P1|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
8144750|NCT02688387|20072217|P22|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144751|NCT02688387|20072218|P21|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144752|NCT02688387|20072219|P20|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144753|NCT02688387|20072220|P19|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144754|NCT02688387|20072221|P18|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144755|NCT02688387|20072222|P17|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144756|NCT02688387|20072223|P16|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144757|NCT02688387|20072224|P15|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144758|NCT02688387|20072225|P14|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144759|NCT02688387|20072226|P13|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144760|NCT02688387|20072227|P12|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144761|NCT02688387|20072228|P11|STARTED|Part 1, Period 1 (up to 6 Days)||0
8144762|NCT02688387|20072229|P10|STARTED|Part 1, Period 1 (up to 6 Days)||2
8144763|NCT02688387|20072230|P9|STARTED|Part 1, Period 1 (up to 6 Days)||2
8144764|NCT02688387|20072231|P8|STARTED|Part 1, Period 1 (up to 6 Days)||2
8144765|NCT02688387|20072232|P7|STARTED|Part 1, Period 1 (up to 6 Days)||2
8144766|NCT02688387|20072233|P6|STARTED|Part 1, Period 1 (up to 6 Days)||2
8144767|NCT02688387|20072234|P5|STARTED|Part 1, Period 1 (up to 6 Days)||3
8144768|NCT02688387|20072235|P4|STARTED|Part 1, Period 1 (up to 6 Days)||3
8144769|NCT02688387|20072236|P3|STARTED|Part 1, Period 1 (up to 6 Days)||4
8144770|NCT02688387|20072237|P2|STARTED|Part 1, Period 1 (up to 6 Days)||3
8144771|NCT02688387|20072238|P1|STARTED|Part 1, Period 1 (up to 6 Days)||3
8144772|NCT02688218|20072497|P2|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
8144773|NCT02688218|20072498|P1|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
8144774|NCT02688218|20072497|P2|COMPLETED|Second Exercise Intervention (2 Hours)||6
8144775|NCT02688218|20072498|P1|COMPLETED|Second Exercise Intervention (2 Hours)||24
8144776|NCT02688218|20072497|P2|STARTED|Second Exercise Intervention (2 Hours)||6
8144777|NCT02688218|20072498|P1|STARTED|Second Exercise Intervention (2 Hours)||24
8144778|NCT02688218|20072497|P2|NOT COMPLETED|Washout (30 Minutes)||0
8144779|NCT02688218|20072498|P1|NOT COMPLETED|Washout (30 Minutes)||0
8144780|NCT02688218|20072497|P2|COMPLETED|Washout (30 Minutes)||6
8144781|NCT02688218|20072498|P1|COMPLETED|Washout (30 Minutes)||24
8144782|NCT02688218|20072497|P2|STARTED|Washout (30 Minutes)||6
8144783|NCT02688218|20072498|P1|STARTED|Washout (30 Minutes)||24
8144784|NCT02688218|20072497|P2|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
8144785|NCT02688218|20072498|P1|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
8144786|NCT02688218|20072497|P2|COMPLETED|First Exercise Intervention (2 Hours)||6
8144787|NCT02688218|20072498|P1|COMPLETED|First Exercise Intervention (2 Hours)||24
8144788|NCT02688218|20072497|P2|STARTED|First Exercise Intervention (2 Hours)||6
8144789|NCT02688218|20072498|P1|STARTED|First Exercise Intervention (2 Hours)||24
8144796|NCT02688153|20072526|P2|NOT COMPLETED|Overall Study||7
8144797|NCT02688153|20072527|P1|NOT COMPLETED|Overall Study||15
8144798|NCT02688153|20072526|P2|COMPLETED|Overall Study||51
8144799|NCT02688153|20072527|P1|COMPLETED|Overall Study||47
8144800|NCT02688153|20072526|P2|Final Randomized Arm/Group|Overall Study||61
8144801|NCT02688153|20072527|P1|Final Randomized Arm/Group|Overall Study||59
8144802|NCT02688153|20072526|P2|STARTED|Overall Study||58
8144803|NCT02688153|20072527|P1|STARTED|Overall Study||62
8144804|NCT02687919|20072587|P2|NOT COMPLETED|Overall Study||6
8144805|NCT02687919|20072588|P1|NOT COMPLETED|Overall Study||8
8144806|NCT02687919|20072587|P2|COMPLETED|Overall Study||9
8144807|NCT02687919|20072588|P1|COMPLETED|Overall Study||8
8144808|NCT02687919|20072587|P2|STARTED|Overall Study||15
8144809|NCT02687919|20072588|P1|STARTED|Overall Study||16
8144816|NCT02687542|20072636|P5|NOT COMPLETED|Overall Study||20
8144817|NCT02687542|20072637|P4|NOT COMPLETED|Overall Study||10
8144818|NCT02687542|20072638|P3|NOT COMPLETED|Overall Study||14
8144819|NCT02687542|20072639|P2|NOT COMPLETED|Overall Study||12
8144820|NCT02687542|20072640|P1|NOT COMPLETED|Overall Study||8
8144821|NCT02687542|20072636|P5|COMPLETED|Overall Study||24
8144822|NCT02687542|20072637|P4|COMPLETED|Overall Study||3
8144823|NCT02687542|20072638|P3|COMPLETED|Overall Study||1
8144824|NCT02687542|20072639|P2|COMPLETED|Overall Study||1
8144825|NCT02687542|20072640|P1|COMPLETED|Overall Study||15
8144826|NCT02687542|20072636|P5|STARTED|Overall Study||44
8144827|NCT02687542|20072637|P4|STARTED|Overall Study||13
8144828|NCT02687542|20072638|P3|STARTED|Overall Study||15
8144829|NCT02687542|20072639|P2|STARTED|Overall Study||13
8144830|NCT02687542|20072640|P1|STARTED|Overall Study||23
8144831|NCT02687529|20072714|P2|NOT COMPLETED|Overall Study||0
8144832|NCT02687529|20072715|P1|NOT COMPLETED|Overall Study||0
8144833|NCT02687529|20072714|P2|COMPLETED|Overall Study||32
8144834|NCT02687529|20072715|P1|COMPLETED|Overall Study||34
8144835|NCT02687529|20072714|P2|STARTED|Overall Study||32
8144836|NCT02687529|20072715|P1|STARTED|Overall Study||34
8144837|NCT02687412|20072723|P2|NOT COMPLETED|Overall Study||0
8144838|NCT02687412|20072724|P1|NOT COMPLETED|Overall Study||0
8144839|NCT02687412|20072723|P2|COMPLETED|Overall Study||57
8144840|NCT02687412|20072724|P1|COMPLETED|Overall Study||50
8144841|NCT02687412|20072723|P2|STARTED|Overall Study||57
8144842|NCT02687412|20072724|P1|STARTED|Overall Study||50
8144843|NCT02687217|20072752|P2|NOT COMPLETED|Overall Study||0
8144844|NCT02687217|20072753|P1|NOT COMPLETED|Overall Study||0
8144845|NCT02687217|20072752|P2|COMPLETED|Overall Study||30
8144846|NCT02687217|20072753|P1|COMPLETED|Overall Study||30
8144847|NCT02687217|20072752|P2|STARTED|Overall Study||30
8144848|NCT02687217|20072753|P1|STARTED|Overall Study||30
8144849|NCT02687191|20072769|P6|NOT COMPLETED|Overall Study||1
8144850|NCT02687191|20072770|P5|NOT COMPLETED|Overall Study||1
8144851|NCT02687191|20072771|P4|NOT COMPLETED|Overall Study||1
8144852|NCT02687191|20072772|P3|NOT COMPLETED|Overall Study||1
8144853|NCT02687191|20072773|P2|NOT COMPLETED|Overall Study||1
8144854|NCT02687191|20072774|P1|NOT COMPLETED|Overall Study||0
8144855|NCT02687191|20072769|P6|COMPLETED|Overall Study||2
8144856|NCT02687191|20072770|P5|COMPLETED|Overall Study||2
8144857|NCT02687191|20072771|P4|COMPLETED|Overall Study||5
8144858|NCT02687191|20072772|P3|COMPLETED|Overall Study||2
8144859|NCT02687191|20072773|P2|COMPLETED|Overall Study||2
8144860|NCT02687191|20072774|P1|COMPLETED|Overall Study||3
8144861|NCT02687191|20072769|P6|STARTED|Overall Study||3
8144862|NCT02687191|20072770|P5|STARTED|Overall Study||3
8144863|NCT02687191|20072771|P4|STARTED|Overall Study||6
8144864|NCT02687191|20072772|P3|STARTED|Overall Study||3
8144865|NCT02687191|20072773|P2|STARTED|Overall Study||3
8144866|NCT02687191|20072774|P1|STARTED|Overall Study||3
8144867|NCT02687165|20072908|P2|NOT COMPLETED|Overall Study||0
8144868|NCT02687165|20072909|P1|NOT COMPLETED|Overall Study||0
8144869|NCT02687165|20072908|P2|COMPLETED|Overall Study||0
8144870|NCT02687165|20072909|P1|COMPLETED|Overall Study||0
8144871|NCT02687165|20072908|P2|STARTED|Overall Study||0
8144872|NCT02687165|20072909|P1|STARTED|Overall Study||0
8144873|NCT02687139|20072915|P1|NOT COMPLETED|Overall Study||0
8144874|NCT02687139|20072915|P1|COMPLETED|Overall Study||34
8144875|NCT02687139|20072915|P1|STARTED|Overall Study||34
8144876|NCT02687126|20072920|P1|NOT COMPLETED|Data Analysis||0
8144877|NCT02687126|20072920|P1|COMPLETED|Data Analysis||106
8144878|NCT02687126|20072920|P1|STARTED|Data Analysis||106
8144879|NCT02687126|20072920|P1|NOT COMPLETED|Data Collection||0
8144880|NCT02687126|20072920|P1|COMPLETED|Data Collection||106
8144881|NCT02687126|20072920|P1|STARTED|Data Collection||106
8144882|NCT02686437|20072929|P2|NOT COMPLETED|Overall Study||8
8144883|NCT02686437|20072930|P1|NOT COMPLETED|Overall Study||3
8144884|NCT02686437|20072929|P2|COMPLETED|Overall Study||12
8144885|NCT02686437|20072930|P1|COMPLETED|Overall Study||13
8144886|NCT02686437|20072929|P2|STARTED|Overall Study||20
8144887|NCT02686437|20072930|P1|STARTED|Overall Study||16
8144888|NCT02686164|20072938|P1|NOT COMPLETED|Overall Study||3
8144889|NCT02686164|20072938|P1|COMPLETED|Overall Study||27
8144890|NCT02686164|20072938|P1|STARTED|Overall Study||30
8144891|NCT02686138|20072950|P2|NOT COMPLETED|Overall Study||65
8144892|NCT02686138|20072951|P1|NOT COMPLETED|Overall Study||74
8144893|NCT02686138|20072950|P2|COMPLETED|Overall Study||235
8144894|NCT02686138|20072951|P1|COMPLETED|Overall Study||219
8144895|NCT02686138|20072950|P2|STARTED|Overall Study||300
8144896|NCT02686138|20072951|P1|STARTED|Overall Study||293
8144897|NCT02686034|20072975|P2|NOT COMPLETED|Open Label Period 3||1
8144898|NCT02686034|20072976|P1|NOT COMPLETED|Open Label Period 3||0
8144899|NCT02686034|20072975|P2|COMPLETED|Open Label Period 3||121
8144900|NCT02686034|20072976|P1|COMPLETED|Open Label Period 3||117
8144901|NCT02686034|20072975|P2|STARTED|Open Label Period 3||122
8144902|NCT02686034|20072976|P1|STARTED|Open Label Period 3||117
8144903|NCT02686034|20072975|P2|NOT COMPLETED|Randomized Controlled Period 2||4
8144904|NCT02686034|20072976|P1|NOT COMPLETED|Randomized Controlled Period 2||5
8144905|NCT02686034|20072975|P2|COMPLETED|Randomized Controlled Period 2||122
8144906|NCT02686034|20072976|P1|COMPLETED|Randomized Controlled Period 2||117
8144907|NCT02686034|20072975|P2|STARTED|Randomized Controlled Period 2||126
8144908|NCT02686034|20072976|P1|STARTED|Randomized Controlled Period 2||122
8144909|NCT02686034|20072975|P2|NOT COMPLETED|Run-In Period 1||17
8144910|NCT02686034|20072976|P1|NOT COMPLETED|Run-In Period 1||20
8144911|NCT02686034|20072975|P2|COMPLETED|Run-In Period 1||126
8144912|NCT02686034|20072976|P1|COMPLETED|Run-In Period 1||122
8144913|NCT02686034|20072975|P2|STARTED|Run-In Period 1||143
8144914|NCT02686034|20072976|P1|STARTED|Run-In Period 1||142
8144915|NCT02685956|20073014|P2|NOT COMPLETED|Overall Study||0
8144916|NCT02685956|20073015|P1|NOT COMPLETED|Overall Study||0
8144917|NCT02685956|20073014|P2|COMPLETED|Overall Study||1978
8144918|NCT02685956|20073015|P1|COMPLETED|Overall Study||317
8144919|NCT02685956|20073014|P2|STARTED|Overall Study||1978
8144920|NCT02685956|20073015|P1|STARTED|Overall Study||317
8144921|NCT02685826|20073026|P3|NOT COMPLETED|Overall Study||21
8144922|NCT02685826|20073027|P2|NOT COMPLETED|Overall Study||10
8144923|NCT02685826|20073028|P1|NOT COMPLETED|Overall Study||25
8144924|NCT02685826|20073026|P3|COMPLETED|Overall Study||0
8144925|NCT02685826|20073027|P2|COMPLETED|Overall Study||0
8144926|NCT02685826|20073028|P1|COMPLETED|Overall Study||0
8144927|NCT02685826|20073026|P3|STARTED|Overall Study||21
8144928|NCT02685826|20073027|P2|STARTED|Overall Study||10
8144929|NCT02685826|20073028|P1|STARTED|Overall Study||25
8144930|NCT02685566|20073111|P2|NOT COMPLETED|Second Reading Session||0
8144931|NCT02685566|20073112|P1|NOT COMPLETED|Second Reading Session||0
8144932|NCT02685566|20073111|P2|COMPLETED|Second Reading Session||50
8144933|NCT02685566|20073112|P1|COMPLETED|Second Reading Session||50
8144934|NCT02685566|20073111|P2|STARTED|Second Reading Session||50
8144935|NCT02685566|20073112|P1|STARTED|Second Reading Session||50
8144936|NCT02685566|20073111|P2|NOT COMPLETED|4 Week Memory Washout Period||0
8144937|NCT02685566|20073112|P1|NOT COMPLETED|4 Week Memory Washout Period||0
8144938|NCT02685566|20073111|P2|COMPLETED|4 Week Memory Washout Period||50
8144939|NCT02685566|20073112|P1|COMPLETED|4 Week Memory Washout Period||50
8144940|NCT02685566|20073111|P2|STARTED|4 Week Memory Washout Period||50
8144941|NCT02685566|20073112|P1|STARTED|4 Week Memory Washout Period||50
8144942|NCT02685566|20073111|P2|NOT COMPLETED|First Reading Session||0
8144943|NCT02685566|20073112|P1|NOT COMPLETED|First Reading Session||0
8144944|NCT02685566|20073111|P2|COMPLETED|First Reading Session||50
8144945|NCT02685566|20073112|P1|COMPLETED|First Reading Session||50
8144946|NCT02685566|20073111|P2|STARTED|First Reading Session||50
8144947|NCT02685566|20073112|P1|STARTED|First Reading Session||50
8144948|NCT02685488|20073122|P2|NOT COMPLETED|Overall Study||1
8144949|NCT02685488|20073123|P1|NOT COMPLETED|Overall Study||0
8144950|NCT02685488|20073122|P2|COMPLETED|Overall Study||13
8144951|NCT02685488|20073123|P1|COMPLETED|Overall Study||12
8144952|NCT02685488|20073122|P2|STARTED|Overall Study||14
8144953|NCT02685488|20073123|P1|STARTED|Overall Study||12
8144954|NCT02685436|20073137|P1|NOT COMPLETED|Overall Study||14
8144955|NCT02685436|20073137|P1|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38
8144956|NCT02685436|20073137|P1|STARTED|Overall Study|the overall studied group|52
8144957|NCT02685293|20073141|P2|NOT COMPLETED|Treatment Period 2||0
8144958|NCT02685293|20073142|P1|NOT COMPLETED|Treatment Period 2||0
8144959|NCT02685293|20073141|P2|COMPLETED|Treatment Period 2||3
8144960|NCT02685293|20073142|P1|COMPLETED|Treatment Period 2||1
8144961|NCT02685293|20073141|P2|STARTED|Treatment Period 2||3
8144962|NCT02685293|20073142|P1|STARTED|Treatment Period 2||1
8144963|NCT02685293|20073141|P2|NOT COMPLETED|Washout Period||0
8144964|NCT02685293|20073142|P1|NOT COMPLETED|Washout Period||0
8144965|NCT02685293|20073141|P2|COMPLETED|Washout Period||3
8144966|NCT02685293|20073142|P1|COMPLETED|Washout Period||1
8144967|NCT02685293|20073141|P2|STARTED|Washout Period||3
8144968|NCT02685293|20073142|P1|STARTED|Washout Period||1
8144969|NCT02685293|20073141|P2|NOT COMPLETED|Treatment Period 1||0
8144970|NCT02685293|20073142|P1|NOT COMPLETED|Treatment Period 1||0
8144971|NCT02685293|20073141|P2|COMPLETED|Treatment Period 1||3
8144972|NCT02685293|20073142|P1|COMPLETED|Treatment Period 1||1
8144973|NCT02685293|20073141|P2|STARTED|Treatment Period 1||3
8144974|NCT02685293|20073142|P1|STARTED|Treatment Period 1||1
8144975|NCT02685202|20073176|P1|NOT COMPLETED|Overall Study||9
8144976|NCT02685202|20073176|P1|COMPLETED|Overall Study||0
8144977|NCT02685202|20073176|P1|STARTED|Overall Study||9
8144978|NCT02685072|20073184|P2|NOT COMPLETED|3-Month Follow-Up||0
8144979|NCT02685072|20073185|P1|NOT COMPLETED|3-Month Follow-Up||0
8144980|NCT02685072|20073184|P2|COMPLETED|3-Month Follow-Up||22
8144981|NCT02685072|20073185|P1|COMPLETED|3-Month Follow-Up||19
8144982|NCT02685072|20073184|P2|STARTED|3-Month Follow-Up||22
8144983|NCT02685072|20073185|P1|STARTED|3-Month Follow-Up||19
8144984|NCT02685072|20073184|P2|NOT COMPLETED|1-Month Follow-Up||0
8144985|NCT02685072|20073185|P1|NOT COMPLETED|1-Month Follow-Up||1
8144986|NCT02685072|20073184|P2|COMPLETED|1-Month Follow-Up||22
8144987|NCT02685072|20073185|P1|COMPLETED|1-Month Follow-Up||19
8144988|NCT02685072|20073184|P2|STARTED|1-Month Follow-Up||22
8144989|NCT02685072|20073185|P1|STARTED|1-Month Follow-Up||20
8144990|NCT02685072|20073184|P2|NOT COMPLETED|Treatment Period||9
8144991|NCT02685072|20073185|P1|NOT COMPLETED|Treatment Period||13
8144992|NCT02685072|20073184|P2|COMPLETED|Treatment Period||22
8144993|NCT02685072|20073185|P1|COMPLETED|Treatment Period||20
8144994|NCT02685072|20073184|P2|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22
8144995|NCT02685072|20073185|P1|Completed Week 8 Visit|Treatment Period||20
8144996|NCT02685072|20073184|P2|Completed Week 7 Visit|Treatment Period||18
8144997|NCT02685072|20073185|P1|Completed Week 7 Visit|Treatment Period||17
8144998|NCT02685072|20073184|P2|Completed Week 6 Visit|Treatment Period||19
8144999|NCT02685072|20073185|P1|Completed Week 6 Visit|Treatment Period||18
8145000|NCT02685072|20073184|P2|Completed Week 5 Visit|Treatment Period||22
8145001|NCT02685072|20073185|P1|Completed Week 5 Visit|Treatment Period||19
8145002|NCT02685072|20073184|P2|Completed Week 4 Visit|Treatment Period||23
8145003|NCT02685072|20073185|P1|Completed Week 4 Visit|Treatment Period||19
8145004|NCT02685072|20073184|P2|Completed Week 3 Visit|Treatment Period||23
8145005|NCT02685072|20073185|P1|Completed Week 3 Visit|Treatment Period||20
8145006|NCT02685072|20073184|P2|Completed Week 2 Visit|Treatment Period||26
8145007|NCT02685072|20073185|P1|Completed Week 2 Visit|Treatment Period||23
8145008|NCT02685072|20073184|P2|STARTED|Treatment Period||31
8145009|NCT02685072|20073185|P1|STARTED|Treatment Period||33
8145010|NCT02685033|20073229|P2|NOT COMPLETED|Overall Study||2
8145011|NCT02685033|20073230|P1|NOT COMPLETED|Overall Study||3
8145012|NCT02685033|20073229|P2|COMPLETED|Overall Study||8
8145013|NCT02685033|20073230|P1|COMPLETED|Overall Study||67
8145014|NCT02685033|20073229|P2|STARTED|Overall Study||10
8145015|NCT02685033|20073230|P1|STARTED|Overall Study||70
8145016|NCT02685007|20073256|P1|NOT COMPLETED|Overall Study||0
8145017|NCT02685007|20073256|P1|COMPLETED|Overall Study||131
8145018|NCT02685007|20073256|P1|STARTED|Overall Study||131
8145019|NCT02684981|20073266|P3|NOT COMPLETED|Overall Study||127
8145020|NCT02684981|20073267|P2|NOT COMPLETED|Overall Study||210
8145021|NCT02684981|20073268|P1|NOT COMPLETED|Overall Study||240
8145022|NCT02684981|20073266|P3|COMPLETED|Overall Study||2059
8145023|NCT02684981|20073267|P2|COMPLETED|Overall Study||2969
8145024|NCT02684981|20073268|P1|COMPLETED|Overall Study||3860
8145025|NCT02684981|20073266|P3|STARTED|Overall Study||2186
8145026|NCT02684981|20073267|P2|STARTED|Overall Study||3179
8145027|NCT02684981|20073268|P1|STARTED|Overall Study||4100
8145028|NCT02684942|20073304|P6|NOT COMPLETED|Overall Study||0
8145029|NCT02684942|20073305|P5|NOT COMPLETED|Overall Study||0
8145030|NCT02684942|20073306|P4|NOT COMPLETED|Overall Study||0
8145031|NCT02684942|20073307|P3|NOT COMPLETED|Overall Study||0
8145032|NCT02684942|20073308|P2|NOT COMPLETED|Overall Study||0
8145033|NCT02684942|20073309|P1|NOT COMPLETED|Overall Study||0
8145034|NCT02684942|20073304|P6|COMPLETED|Overall Study||6
8145035|NCT02684942|20073305|P5|COMPLETED|Overall Study||6
8145036|NCT02684942|20073306|P4|COMPLETED|Overall Study||7
8145037|NCT02684942|20073307|P3|COMPLETED|Overall Study||7
8145038|NCT02684942|20073308|P2|COMPLETED|Overall Study||7
8145039|NCT02684942|20073309|P1|COMPLETED|Overall Study||7
8145040|NCT02684942|20073304|P6|STARTED|Overall Study||6
8145041|NCT02684942|20073305|P5|STARTED|Overall Study||6
8145042|NCT02684942|20073306|P4|STARTED|Overall Study||7
8145043|NCT02684942|20073307|P3|STARTED|Overall Study||7
8145044|NCT02684942|20073308|P2|STARTED|Overall Study||7
8145045|NCT02684942|20073309|P1|STARTED|Overall Study||7
8145046|NCT02684851|20073325|P2|NOT COMPLETED|Overall Study||0
8145047|NCT02684851|20073326|P1|NOT COMPLETED|Overall Study||0
8145048|NCT02684851|20073325|P2|COMPLETED|Overall Study||45
8145049|NCT02684851|20073326|P1|COMPLETED|Overall Study||42
8145050|NCT02684851|20073325|P2|STARTED|Overall Study||45
8145051|NCT02684851|20073326|P1|STARTED|Overall Study||42
8145052|NCT02684630|20073340|P2|NOT COMPLETED|Overall Study||3
8145053|NCT02684630|20073341|P1|NOT COMPLETED|Overall Study||5
8145054|NCT02684630|20073340|P2|COMPLETED|Overall Study||60
8145055|NCT02684630|20073341|P1|COMPLETED|Overall Study||60
8145056|NCT02684630|20073340|P2|STARTED|Overall Study||63
8145057|NCT02684630|20073341|P1|STARTED|Overall Study||65
8145058|NCT02684604|20073351|P2|NOT COMPLETED|Overall Study||0
8145059|NCT02684604|20073352|P1|NOT COMPLETED|Overall Study||0
8145060|NCT02684604|20073351|P2|COMPLETED|Overall Study||44
8145061|NCT02684604|20073352|P1|COMPLETED|Overall Study||44
8145062|NCT02684604|20073351|P2|STARTED|Overall Study||44
8145063|NCT02684604|20073352|P1|STARTED|Overall Study||44
8145064|NCT02684591|20073360|P2|NOT COMPLETED|Overall Study||3
8145065|NCT02684591|20073361|P1|NOT COMPLETED|Overall Study||1
8145066|NCT02684591|20073360|P2|COMPLETED|Overall Study||22
8145067|NCT02684591|20073361|P1|COMPLETED|Overall Study||24
8145068|NCT02684591|20073360|P2|STARTED|Overall Study||25
8145069|NCT02684591|20073361|P1|STARTED|Overall Study||25
8145070|NCT02684435|20073369|P1|NOT COMPLETED|Overall Study||0
8145071|NCT02684435|20073369|P1|COMPLETED|Overall Study||63
8145072|NCT02684435|20073369|P1|STARTED|Overall Study||63
8145073|NCT02684396|20073383|P6|NOT COMPLETED|Overall Study||0
8145074|NCT02684396|20073384|P5|NOT COMPLETED|Overall Study||0
8145075|NCT02684396|20073385|P4|NOT COMPLETED|Overall Study||0
8145076|NCT02684396|20073386|P3|NOT COMPLETED|Overall Study||0
8145077|NCT02684396|20073387|P2|NOT COMPLETED|Overall Study||0
8145078|NCT02684396|20073388|P1|NOT COMPLETED|Overall Study||0
8145079|NCT02684396|20073383|P6|COMPLETED|Overall Study||10
8145080|NCT02684396|20073384|P5|COMPLETED|Overall Study||5
8145081|NCT02684396|20073385|P4|COMPLETED|Overall Study||6
8145082|NCT02684396|20073386|P3|COMPLETED|Overall Study||6
8145083|NCT02684396|20073387|P2|COMPLETED|Overall Study||6
8145084|NCT02684396|20073388|P1|COMPLETED|Overall Study||6
8145085|NCT02684396|20073383|P6|STARTED|Overall Study||10
8145086|NCT02684396|20073384|P5|STARTED|Overall Study||5
8145087|NCT02684396|20073385|P4|STARTED|Overall Study||6
8145088|NCT02684396|20073386|P3|STARTED|Overall Study||6
8145089|NCT02684396|20073387|P2|STARTED|Overall Study||6
8145090|NCT02684396|20073388|P1|STARTED|Overall Study||6
8145163|NCT02684344|20073548|P2|NOT COMPLETED|Overall Study||1
8145164|NCT02684344|20073549|P1|NOT COMPLETED|Overall Study||0
8145165|NCT02684344|20073548|P2|COMPLETED|Overall Study||3
8145166|NCT02684344|20073549|P1|COMPLETED|Overall Study||1
8145167|NCT02684344|20073548|P2|STARTED|Overall Study||4
8145168|NCT02684344|20073549|P1|STARTED|Overall Study||1
8145169|NCT02684279|20073555|P1|NOT COMPLETED|Overall Study||279
8145170|NCT02684279|20073555|P1|COMPLETED|Overall Study||249
8145171|NCT02684279|20073555|P1|STARTED|Overall Study||528
8145172|NCT02684188|20073580|P2|NOT COMPLETED|Overall Study||3
8145173|NCT02684188|20073581|P1|NOT COMPLETED|Overall Study||2
8145174|NCT02684188|20073580|P2|COMPLETED|Overall Study||47
8145175|NCT02684188|20073581|P1|COMPLETED|Overall Study||75
8145176|NCT02684188|20073580|P2|STARTED|Overall Study||50
8145177|NCT02684188|20073581|P1|STARTED|Overall Study||77
8145178|NCT02684097|20073607|P2|NOT COMPLETED|Overall Study||6
8145179|NCT02684097|20073608|P1|NOT COMPLETED|Overall Study||13
8145180|NCT02684097|20073607|P2|COMPLETED|Overall Study||1
8145181|NCT02684097|20073608|P1|COMPLETED|Overall Study||2
8145182|NCT02684097|20073607|P2|STARTED|Overall Study||7
8145183|NCT02684097|20073608|P1|STARTED|Overall Study||15
8145184|NCT02683954|20073626|P2|NOT COMPLETED|Overall Study||0
8145185|NCT02683954|20073627|P1|NOT COMPLETED|Overall Study||0
8145186|NCT02683954|20073626|P2|COMPLETED|Overall Study||30
8145187|NCT02683954|20073627|P1|COMPLETED|Overall Study||30
8145188|NCT02683954|20073626|P2|STARTED|Overall Study||30
8145189|NCT02683954|20073627|P1|STARTED|Overall Study||30
8145190|NCT02683928|20073635|P2|NOT COMPLETED|Overall Study||8
8145191|NCT02683928|20073636|P1|NOT COMPLETED|Overall Study||22
8145192|NCT02683928|20073635|P2|COMPLETED|Overall Study||8
8145193|NCT02683928|20073636|P1|COMPLETED|Overall Study||26
8145194|NCT02683928|20073635|P2|STARTED|Overall Study||16
8145195|NCT02683928|20073636|P1|STARTED|Overall Study||48
8145196|NCT02683876|20073656|P2|NOT COMPLETED|Overall Study||0
8145197|NCT02683876|20073657|P1|NOT COMPLETED|Overall Study||2
8145198|NCT02683876|20073656|P2|COMPLETED|Overall Study||22
8145199|NCT02683876|20073657|P1|COMPLETED|Overall Study||15
8145200|NCT02683876|20073656|P2|STARTED|Overall Study||22
8145201|NCT02683876|20073657|P1|STARTED|Overall Study||17
8145202|NCT02683785|20073667|P2|NOT COMPLETED|Overall Study||4
8145203|NCT02683785|20073668|P1|NOT COMPLETED|Overall Study||1
8145204|NCT02683785|20073667|P2|COMPLETED|Overall Study||18
8145205|NCT02683785|20073668|P1|COMPLETED|Overall Study||21
8145206|NCT02683785|20073667|P2|STARTED|Overall Study||22
8145207|NCT02683785|20073668|P1|STARTED|Overall Study||22
8145208|NCT02683772|20073708|P2|NOT COMPLETED|Overall Study||0
8145209|NCT02683772|20073709|P1|NOT COMPLETED|Overall Study||0
8145210|NCT02683772|20073708|P2|COMPLETED|Overall Study||23
8145211|NCT02683772|20073709|P1|COMPLETED|Overall Study||15
8145212|NCT02683772|20073708|P2|STARTED|Overall Study||23
8145213|NCT02683772|20073709|P1|STARTED|Overall Study||15
8145214|NCT02683746|20073725|P2|NOT COMPLETED|Overall Study||14
8145215|NCT02683746|20073726|P1|NOT COMPLETED|Overall Study||16
8145216|NCT02683746|20073725|P2|COMPLETED|Overall Study||140
8145217|NCT02683746|20073726|P1|COMPLETED|Overall Study||138
8145218|NCT02683746|20073725|P2|STARTED|Overall Study||154
8145219|NCT02683746|20073726|P1|STARTED|Overall Study||154
8145220|NCT02683707|20073756|P2|NOT COMPLETED|Overall Study||0
8145221|NCT02683707|20073757|P1|NOT COMPLETED|Overall Study||0
8145222|NCT02683707|20073756|P2|COMPLETED|Overall Study||107
8145223|NCT02683707|20073757|P1|COMPLETED|Overall Study||105
8145224|NCT02683707|20073756|P2|STARTED|Overall Study||107
8145225|NCT02683707|20073757|P1|STARTED|Overall Study||105
8145226|NCT02683668|20073769|P3|NOT COMPLETED|Period 3||0
8145227|NCT02683668|20073770|P2|NOT COMPLETED|Period 3||0
8145228|NCT02683668|20073771|P1|NOT COMPLETED|Period 3||0
8145229|NCT02683668|20073769|P3|COMPLETED|Period 3||43
8145230|NCT02683668|20073770|P2|COMPLETED|Period 3||0
8145231|NCT02683668|20073771|P1|COMPLETED|Period 3||0
8145232|NCT02683668|20073769|P3|STARTED|Period 3||43
8145233|NCT02683668|20073770|P2|STARTED|Period 3||0
8145234|NCT02683668|20073771|P1|STARTED|Period 3||0
8145235|NCT02683668|20073769|P3|NOT COMPLETED|Period 2||0
8145236|NCT02683668|20073770|P2|NOT COMPLETED|Period 2||1
8145237|NCT02683668|20073771|P1|NOT COMPLETED|Period 2||0
8145238|NCT02683668|20073769|P3|COMPLETED|Period 2||0
8145239|NCT02683668|20073770|P2|COMPLETED|Period 2||43
8145240|NCT02683668|20073771|P1|COMPLETED|Period 2||0
8145241|NCT02683668|20073769|P3|STARTED|Period 2||0
8145242|NCT02683668|20073770|P2|STARTED|Period 2||44
8145243|NCT02683668|20073771|P1|STARTED|Period 2||0
8145244|NCT02683668|20073769|P3|NOT COMPLETED|Period 1||0
8145245|NCT02683668|20073770|P2|NOT COMPLETED|Period 1||0
8145246|NCT02683668|20073771|P1|NOT COMPLETED|Period 1||0
8145247|NCT02683668|20073769|P3|COMPLETED|Period 1||0
8145248|NCT02683668|20073770|P2|COMPLETED|Period 1||0
8145249|NCT02683668|20073771|P1|COMPLETED|Period 1||44
8145250|NCT02683668|20073769|P3|STARTED|Period 1||0
8145251|NCT02683668|20073770|P2|STARTED|Period 1||0
8145252|NCT02683668|20073771|P1|STARTED|Period 1||44
8145253|NCT02683577|20073789|P3|NOT COMPLETED|Overall Study||0
8145254|NCT02683577|20073790|P2|NOT COMPLETED|Overall Study||0
8145255|NCT02683577|20073791|P1|NOT COMPLETED|Overall Study||0
8145256|NCT02683577|20073789|P3|COMPLETED|Overall Study||8
8145257|NCT02683577|20073790|P2|COMPLETED|Overall Study||8
8145258|NCT02683577|20073791|P1|COMPLETED|Overall Study||8
8145259|NCT02683577|20073789|P3|STARTED|Overall Study||8
8145260|NCT02683577|20073790|P2|STARTED|Overall Study||8
8145261|NCT02683577|20073791|P1|STARTED|Overall Study||8
8145262|NCT02683525|20073837|P1|NOT COMPLETED|Overall Study||8
8145263|NCT02683525|20073837|P1|COMPLETED|Overall Study||29
8145264|NCT02683525|20073837|P1|STARTED|Overall Study||37
8145265|NCT02683421|20073855|P4|NOT COMPLETED|Overall Study||0
8145266|NCT02683421|20073856|P3|NOT COMPLETED|Overall Study||0
8145267|NCT02683421|20073857|P2|NOT COMPLETED|Overall Study||0
8145268|NCT02683421|20073858|P1|NOT COMPLETED|Overall Study||0
8145269|NCT02683421|20073855|P4|COMPLETED|Overall Study||5
8145270|NCT02683421|20073856|P3|COMPLETED|Overall Study||4
8145271|NCT02683421|20073857|P2|COMPLETED|Overall Study||4
8145272|NCT02683421|20073858|P1|COMPLETED|Overall Study||5
8145273|NCT02683421|20073855|P4|STARTED|Overall Study||5
8145274|NCT02683421|20073856|P3|STARTED|Overall Study||4
8145275|NCT02683421|20073857|P2|STARTED|Overall Study||4
8145276|NCT02683421|20073858|P1|STARTED|Overall Study||5
8145277|NCT02683174|20073876|P1|NOT COMPLETED|Overall Study||0
8145278|NCT02683174|20073876|P1|COMPLETED|Overall Study||86
8145279|NCT02683174|20073876|P1|STARTED|Overall Study||86
8145280|NCT02683161|20073886|P1|NOT COMPLETED|Overall Study||0
8145281|NCT02683161|20073886|P1|COMPLETED|Overall Study||5
8145282|NCT02683161|20073886|P1|STARTED|Overall Study||5
8145283|NCT02683109|20073892|P2|NOT COMPLETED|Overall Study||0
8145284|NCT02683109|20073893|P1|NOT COMPLETED|Overall Study||1
8145285|NCT02683109|20073892|P2|COMPLETED|Overall Study||111
8145286|NCT02683109|20073893|P1|COMPLETED|Overall Study||109
8145287|NCT02683109|20073892|P2|STARTED|Overall Study||111
8145288|NCT02683109|20073893|P1|STARTED|Overall Study||110
8145289|NCT02683083|20073904|P1|NOT COMPLETED|Overall Study||0
8145290|NCT02683083|20073904|P1|COMPLETED|Overall Study||9
8145291|NCT02683083|20073904|P1|STARTED|Overall Study||9
8145292|NCT02682823|20073914|P5|NOT COMPLETED|Overall Study||1
8145293|NCT02682823|20073915|P4|NOT COMPLETED|Overall Study||1
8145294|NCT02682823|20073916|P3|NOT COMPLETED|Overall Study||1
8145295|NCT02682823|20073917|P2|NOT COMPLETED|Overall Study||1
8145296|NCT02682823|20073918|P1|NOT COMPLETED|Overall Study||0
8145297|NCT02682823|20073914|P5|COMPLETED|Overall Study||18
8145298|NCT02682823|20073915|P4|COMPLETED|Overall Study||16
8145299|NCT02682823|20073916|P3|COMPLETED|Overall Study||18
8145300|NCT02682823|20073917|P2|COMPLETED|Overall Study||18
8145301|NCT02682823|20073918|P1|COMPLETED|Overall Study||17
8145302|NCT02682823|20073914|P5|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19
8145303|NCT02682823|20073915|P4|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17
8145304|NCT02682823|20073916|P3|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18
8145305|NCT02682823|20073917|P2|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19
8145306|NCT02682823|20073918|P1|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17
8145307|NCT02682823|20073914|P5|STARTED|Overall Study||19
8145308|NCT02682823|20073915|P4|STARTED|Overall Study||17
8145309|NCT02682823|20073916|P3|STARTED|Overall Study||19
8145310|NCT02682823|20073917|P2|STARTED|Overall Study||19
8145311|NCT02682823|20073918|P1|STARTED|Overall Study||17
8145312|NCT02682602|20073954|P2|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0
8145313|NCT02682602|20073955|P1|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3
8145314|NCT02682602|20073954|P2|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0
8145315|NCT02682602|20073955|P1|COMPLETED|Post-operative Fluoroscopy for Implanted||7
8145316|NCT02682602|20073954|P2|STARTED|Post-operative Fluoroscopy for Implanted||0
8145317|NCT02682602|20073955|P1|STARTED|Post-operative Fluoroscopy for Implanted||10
8145318|NCT02682602|20073954|P2|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0
8145319|NCT02682602|20073955|P1|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1
8145320|NCT02682602|20073954|P2|COMPLETED|Pre-operative Diseased & Normal Hips||10
8145321|NCT02682602|20073955|P1|COMPLETED|Pre-operative Diseased & Normal Hips||10
8145322|NCT02682602|20073954|P2|STARTED|Pre-operative Diseased & Normal Hips||10
8145323|NCT02682602|20073955|P1|STARTED|Pre-operative Diseased & Normal Hips||11
8145324|NCT02682563|20073974|P2|NOT COMPLETED|Overall Study||0
8145325|NCT02682563|20073975|P1|NOT COMPLETED|Overall Study||0
8145326|NCT02682563|20073974|P2|COMPLETED|Overall Study||20
8145327|NCT02682563|20073975|P1|COMPLETED|Overall Study||24
8145328|NCT02682563|20073974|P2|STARTED|Overall Study||20
8145329|NCT02682563|20073975|P1|STARTED|Overall Study||24
8145330|NCT02682498|20074001|P2|NOT COMPLETED|Overall Study||0
8145331|NCT02682498|20074002|P1|NOT COMPLETED|Overall Study||0
8145332|NCT02682498|20074001|P2|COMPLETED|Overall Study||20
8145333|NCT02682498|20074002|P1|COMPLETED|Overall Study||18
8145334|NCT02682498|20074001|P2|STARTED|Overall Study||20
8145335|NCT02682498|20074002|P1|STARTED|Overall Study||18
8145345|NCT02682264|20074088|P2|NOT COMPLETED|Overall Study||122
8145346|NCT02682264|20074089|P1|NOT COMPLETED|Overall Study||138
8145347|NCT02682264|20074088|P2|COMPLETED|Overall Study||168
8145348|NCT02682264|20074089|P1|COMPLETED|Overall Study||179
8145349|NCT02682264|20074088|P2|STARTED|Overall Study||290
8145350|NCT02682264|20074089|P1|STARTED|Overall Study||317
8145351|NCT02682069|20074095|P1|NOT COMPLETED|Overall Study||0
8145352|NCT02682069|20074095|P1|COMPLETED|Overall Study||30
8145353|NCT02682069|20074095|P1|STARTED|Overall Study||30
8145354|NCT02682056|20074099|P1|NOT COMPLETED|Overall Study||0
8145355|NCT02682056|20074099|P1|COMPLETED|Overall Study||15
8145356|NCT02682056|20074099|P1|STARTED|Overall Study||15
8145357|NCT02682030|20074115|P2|NOT COMPLETED|Overall Study||2
8145358|NCT02682030|20074116|P1|NOT COMPLETED|Overall Study||1
8145359|NCT02682030|20074115|P2|COMPLETED|Overall Study||2
8145360|NCT02682030|20074116|P1|COMPLETED|Overall Study||0
8145361|NCT02682030|20074115|P2|STARTED|Overall Study||4
8145362|NCT02682030|20074116|P1|STARTED|Overall Study||1
8145363|NCT02681809|20074135|P3|NOT COMPLETED|Overall Study||1
8145364|NCT02681809|20074136|P2|NOT COMPLETED|Overall Study||4
8145365|NCT02681809|20074137|P1|NOT COMPLETED|Overall Study||5
8145366|NCT02681809|20074135|P3|COMPLETED|Overall Study||8
8145367|NCT02681809|20074136|P2|COMPLETED|Overall Study||15
8145368|NCT02681809|20074137|P1|COMPLETED|Overall Study||15
8145369|NCT02681809|20074135|P3|STARTED|Overall Study||9
8145370|NCT02681809|20074136|P2|STARTED|Overall Study||19
8145371|NCT02681809|20074137|P1|STARTED|Overall Study||20
8145372|NCT02681757|20074150|P2|NOT COMPLETED|Overall Study||0
8145373|NCT02681757|20074151|P1|NOT COMPLETED|Overall Study||0
8145374|NCT02681757|20074150|P2|COMPLETED|Overall Study||49
8145375|NCT02681757|20074151|P1|COMPLETED|Overall Study||47
8145376|NCT02681757|20074150|P2|STARTED|Overall Study||49
8145377|NCT02681757|20074151|P1|STARTED|Overall Study||47
8145378|NCT02681614|20074161|P1|NOT COMPLETED|Overall Study||0
8145379|NCT02681614|20074161|P1|COMPLETED|Overall Study||5
8145380|NCT02681614|20074161|P1|STARTED|Overall Study||5
8145381|NCT02681510|20074175|P1|NOT COMPLETED|Overall Study||10
8145382|NCT02681510|20074175|P1|COMPLETED|Overall Study||26
8145383|NCT02681510|20074175|P1|STARTED|Overall Study||36
8145384|NCT02681458|20074184|P2|NOT COMPLETED|Overall Study||656
8145385|NCT02681458|20074185|P1|NOT COMPLETED|Overall Study||645
8145386|NCT02681458|20074184|P2|COMPLETED|Overall Study||62
8145387|NCT02681458|20074185|P1|COMPLETED|Overall Study||73
8145388|NCT02681458|20074184|P2|STARTED|Overall Study||718
8145389|NCT02681458|20074185|P1|STARTED|Overall Study||718
8145390|NCT02681172|20074191|P1|NOT COMPLETED|Overall Study||13
8145391|NCT02681172|20074191|P1|COMPLETED|Overall Study||205
8145392|NCT02681172|20074191|P1|Per Protocol Set|Overall Study||205
8145393|NCT02681172|20074191|P1|Full Analysis Set|Overall Study||205
8145394|NCT02681172|20074191|P1|Safety Analysis Set|Overall Study||205
8145395|NCT02681172|20074191|P1|STARTED|Overall Study||218
8145396|NCT02681094|20074205|P3|NOT COMPLETED|2 - Enrolled Participants Set||54
8145397|NCT02681094|20074206|P2|NOT COMPLETED|2 - Enrolled Participants Set||41
8145398|NCT02681094|20074207|P1|NOT COMPLETED|2 - Enrolled Participants Set||40
8145399|NCT02681094|20074205|P3|COMPLETED|2 - Enrolled Participants Set||248
8145400|NCT02681094|20074206|P2|COMPLETED|2 - Enrolled Participants Set||261
8145401|NCT02681094|20074207|P1|COMPLETED|2 - Enrolled Participants Set||261
8145402|NCT02681094|20074205|P3|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
8145403|NCT02681094|20074206|P2|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
8145404|NCT02681094|20074207|P1|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
8145405|NCT02681094|20074205|P3|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
8145406|NCT02681094|20074206|P2|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
8145407|NCT02681094|20074207|P1|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
8145408|NCT02681094|20074205|P3|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
8145409|NCT02681094|20074206|P2|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
8145410|NCT02681094|20074207|P1|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
8145411|NCT02681094|20074205|P3|COMPLETED|1 -Modified Enrolled Participants Set||243
8145412|NCT02681094|20074206|P2|COMPLETED|1 -Modified Enrolled Participants Set||255
8145413|NCT02681094|20074207|P1|COMPLETED|1 -Modified Enrolled Participants Set||256
8145414|NCT02681094|20074205|P3|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
8145415|NCT02681094|20074206|P2|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
8145416|NCT02681094|20074207|P1|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
8145417|NCT02681094|20074205|P3|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
8145418|NCT02681094|20074206|P2|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
8145419|NCT02681094|20074207|P1|STARTED|1 -Modified Enrolled Participants Set||293
8145420|NCT02680847|20074226|P3|NOT COMPLETED|Overall Study||3
8145421|NCT02680847|20074227|P2|NOT COMPLETED|Overall Study||3
8145422|NCT02680847|20074228|P1|NOT COMPLETED|Overall Study||5
8145423|NCT02680847|20074226|P3|COMPLETED|Overall Study||4
8145424|NCT02680847|20074227|P2|COMPLETED|Overall Study||6
8145425|NCT02680847|20074228|P1|COMPLETED|Overall Study||11
8145426|NCT02680847|20074226|P3|STARTED|Overall Study||7
8145427|NCT02680847|20074227|P2|STARTED|Overall Study||9
8145428|NCT02680847|20074228|P1|STARTED|Overall Study||16
8145429|NCT02680834|20074265|P2|NOT COMPLETED|Overall Study||3
8145430|NCT02680834|20074266|P1|NOT COMPLETED|Overall Study||11
8145431|NCT02680834|20074265|P2|COMPLETED|Overall Study||27
8145432|NCT02680834|20074266|P1|COMPLETED|Overall Study||15
8145433|NCT02680834|20074265|P2|STARTED|Overall Study||30
8145434|NCT02680834|20074266|P1|STARTED|Overall Study||26
8145435|NCT02680756|20074278|P2|NOT COMPLETED|Overall Study||19
8145436|NCT02680756|20074279|P1|NOT COMPLETED|Overall Study||32
8145437|NCT02680756|20074278|P2|COMPLETED|Overall Study||106
8145438|NCT02680756|20074279|P1|COMPLETED|Overall Study||93
8145439|NCT02680756|20074278|P2|Received Treatment|Overall Study||120
8145440|NCT02680756|20074279|P1|Received Treatment|Overall Study||127
8145441|NCT02680756|20074278|P2|STARTED|Overall Study||125
8145442|NCT02680756|20074279|P1|STARTED|Overall Study||125
8145443|NCT02680665|20074327|P1|NOT COMPLETED|Overall Study||5
8145444|NCT02680665|20074327|P1|COMPLETED|Overall Study||115
8145445|NCT02680665|20074327|P1|STARTED|Overall Study||120
8145446|NCT02680639|20074333|P3|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
8145447|NCT02680639|20074334|P2|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
8145448|NCT02680639|20074335|P1|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
8145449|NCT02680639|20074333|P3|COMPLETED|High Frequency Oscillation (HFO) Therapy||1
8145450|NCT02680639|20074334|P2|COMPLETED|High Frequency Oscillation (HFO) Therapy||2
8145451|NCT02680639|20074335|P1|COMPLETED|High Frequency Oscillation (HFO) Therapy||0
8145452|NCT02680639|20074333|P3|STARTED|High Frequency Oscillation (HFO) Therapy||1
8145453|NCT02680639|20074334|P2|STARTED|High Frequency Oscillation (HFO) Therapy||2
8145454|NCT02680639|20074335|P1|STARTED|High Frequency Oscillation (HFO) Therapy||0
8145455|NCT02680639|20074333|P3|NOT COMPLETED|Screening Period||0
8145456|NCT02680639|20074334|P2|NOT COMPLETED|Screening Period||0
8145457|NCT02680639|20074335|P1|NOT COMPLETED|Screening Period||7
8145458|NCT02680639|20074333|P3|COMPLETED|Screening Period||0
8145459|NCT02680639|20074334|P2|COMPLETED|Screening Period||0
8145460|NCT02680639|20074335|P1|COMPLETED|Screening Period||3
8145461|NCT02680639|20074333|P3|STARTED|Screening Period||0
8145462|NCT02680639|20074334|P2|STARTED|Screening Period||0
8145463|NCT02680639|20074335|P1|STARTED|Screening Period||10
8145464|NCT02680457|20074356|P2|NOT COMPLETED|Cross-over Intervention||0
8145465|NCT02680457|20074357|P1|NOT COMPLETED|Cross-over Intervention||0
8145466|NCT02680457|20074356|P2|COMPLETED|Cross-over Intervention||6
8145467|NCT02680457|20074357|P1|COMPLETED|Cross-over Intervention||6
8145468|NCT02680457|20074356|P2|STARTED|Cross-over Intervention||6
8145469|NCT02680457|20074357|P1|STARTED|Cross-over Intervention||6
8145470|NCT02680457|20074356|P2|NOT COMPLETED|Washout Period||0
8145471|NCT02680457|20074357|P1|NOT COMPLETED|Washout Period||0
8145472|NCT02680457|20074356|P2|COMPLETED|Washout Period||6
8145473|NCT02680457|20074357|P1|COMPLETED|Washout Period||6
8145474|NCT02680457|20074356|P2|STARTED|Washout Period||6
8145475|NCT02680457|20074357|P1|STARTED|Washout Period||6
8145476|NCT02680457|20074356|P2|NOT COMPLETED|Initial Intervention||0
8145477|NCT02680457|20074357|P1|NOT COMPLETED|Initial Intervention||0
8145478|NCT02680457|20074356|P2|COMPLETED|Initial Intervention||6
8145479|NCT02680457|20074357|P1|COMPLETED|Initial Intervention||6
8145480|NCT02680457|20074356|P2|STARTED|Initial Intervention||6
8145481|NCT02680457|20074357|P1|STARTED|Initial Intervention||6
8145482|NCT02680301|20074367|P2|NOT COMPLETED|Overall Study||1
8145483|NCT02680301|20074368|P1|NOT COMPLETED|Overall Study||0
8145484|NCT02680301|20074367|P2|COMPLETED|Overall Study||17
8145485|NCT02680301|20074368|P1|COMPLETED|Overall Study||22
8145486|NCT02680301|20074367|P2|STARTED|Overall Study||18
8145487|NCT02680301|20074368|P1|STARTED|Overall Study||22
8145488|NCT02680158|20074376|P6|NOT COMPLETED|Overall Study||0
8145489|NCT02680158|20074377|P5|NOT COMPLETED|Overall Study||0
8145490|NCT02680158|20074378|P4|NOT COMPLETED|Overall Study||0
8145491|NCT02680158|20074379|P3|NOT COMPLETED|Overall Study||0
8145492|NCT02680158|20074380|P2|NOT COMPLETED|Overall Study||0
8145493|NCT02680158|20074381|P1|NOT COMPLETED|Overall Study||0
8145494|NCT02680158|20074376|P6|COMPLETED|Overall Study||8
8145495|NCT02680158|20074377|P5|COMPLETED|Overall Study||8
8145496|NCT02680158|20074378|P4|COMPLETED|Overall Study||8
8145497|NCT02680158|20074379|P3|COMPLETED|Overall Study||8
8145498|NCT02680158|20074380|P2|COMPLETED|Overall Study||8
8145499|NCT02680158|20074381|P1|COMPLETED|Overall Study||8
8145500|NCT02680158|20074376|P6|STARTED|Overall Study||8
8145501|NCT02680158|20074377|P5|STARTED|Overall Study||8
8145502|NCT02680158|20074378|P4|STARTED|Overall Study||8
8145503|NCT02680158|20074379|P3|STARTED|Overall Study||8
8145504|NCT02680158|20074380|P2|STARTED|Overall Study||8
8145505|NCT02680158|20074381|P1|STARTED|Overall Study||8
8145506|NCT02680145|20074392|P1|NOT COMPLETED|Overall Study||11
8145507|NCT02680145|20074392|P1|COMPLETED|Overall Study||47
8145508|NCT02680145|20074392|P1|STARTED|Overall Study||58
8145509|NCT02680054|20074399|P1|NOT COMPLETED|Overall Study||11
8145510|NCT02680054|20074399|P1|COMPLETED|Overall Study||27
8145511|NCT02680054|20074399|P1|STARTED|Overall Study||38
8145512|NCT02680041|20074417|P1|NOT COMPLETED|Overall Study||10
8145513|NCT02680041|20074417|P1|COMPLETED|Overall Study||211
8145514|NCT02680041|20074417|P1|Received 18F-fluciclovine|Overall Study||213
8145515|NCT02680041|20074417|P1|STARTED|Overall Study||221
8145516|NCT02680002|20074432|P6|NOT COMPLETED|Overall Study||9
8145517|NCT02680002|20074433|P5|NOT COMPLETED|Overall Study||11
8145518|NCT02680002|20074434|P4|NOT COMPLETED|Overall Study||4
8145519|NCT02680002|20074435|P3|NOT COMPLETED|Overall Study||10
8145520|NCT02680002|20074436|P2|NOT COMPLETED|Overall Study||4
8145521|NCT02680002|20074437|P1|NOT COMPLETED|Overall Study||13
8145522|NCT02680002|20074432|P6|COMPLETED|Overall Study||61
8145523|NCT02680002|20074433|P5|COMPLETED|Overall Study||59
8145524|NCT02680002|20074434|P4|COMPLETED|Overall Study||67
8145525|NCT02680002|20074435|P3|COMPLETED|Overall Study||60
8145526|NCT02680002|20074436|P2|COMPLETED|Overall Study||66
8145527|NCT02680002|20074437|P1|COMPLETED|Overall Study||58
8145528|NCT02680002|20074432|P6|Day 201|Overall Study||61
8145529|NCT02680002|20074433|P5|Day 201|Overall Study||59
8145530|NCT02680002|20074434|P4|Day 201|Overall Study||67
8145531|NCT02680002|20074435|P3|Day 201|Overall Study||60
8145532|NCT02680002|20074436|P2|Day 201|Overall Study||66
8145533|NCT02680002|20074437|P1|Day 201|Overall Study||58
8145534|NCT02680002|20074432|P6|Day 21 (Dose 2)|Overall Study||63
8145535|NCT02680002|20074433|P5|Day 21 (Dose 2)|Overall Study||65
8145536|NCT02680002|20074434|P4|Day 21 (Dose 2)|Overall Study||69
8145537|NCT02680002|20074435|P3|Day 21 (Dose 2)|Overall Study||65
8145538|NCT02680002|20074436|P2|Day 21 (Dose 2)|Overall Study||68
8145539|NCT02680002|20074437|P1|Day 21 (Dose 2)|Overall Study||63
8145540|NCT02680002|20074432|P6|Day 0 (Dose 1)|Overall Study||68
8145541|NCT02680002|20074433|P5|Day 0 (Dose 1)|Overall Study||70
8145542|NCT02680002|20074434|P4|Day 0 (Dose 1)|Overall Study||71
8145543|NCT02680002|20074435|P3|Day 0 (Dose 1)|Overall Study||70
8145544|NCT02680002|20074436|P2|Day 0 (Dose 1)|Overall Study||70
8145545|NCT02680002|20074437|P1|Day 0 (Dose 1)|Overall Study||70
8145546|NCT02680002|20074432|P6|STARTED|Overall Study||70
8145547|NCT02680002|20074433|P5|STARTED|Overall Study||70
8145548|NCT02680002|20074434|P4|STARTED|Overall Study||71
8145549|NCT02680002|20074435|P3|STARTED|Overall Study||70
8145550|NCT02680002|20074436|P2|STARTED|Overall Study||70
8145551|NCT02680002|20074437|P1|STARTED|Overall Study||71
8145552|NCT02679976|20074553|P1|NOT COMPLETED|Overall Study||0
8145553|NCT02679976|20074553|P1|COMPLETED|Overall Study||30
8145554|NCT02679976|20074553|P1|Myopes|Overall Study||14
8145555|NCT02679976|20074553|P1|Hyperopes|Overall Study||16
8145556|NCT02679976|20074553|P1|STARTED|Overall Study||30
8145560|NCT02679807|20074571|P2|NOT COMPLETED|Overall Study||16
8145561|NCT02679807|20074572|P1|NOT COMPLETED|Overall Study||22
8145562|NCT02679807|20074571|P2|COMPLETED|Overall Study||153
8145563|NCT02679807|20074572|P1|COMPLETED|Overall Study||143
8145564|NCT02679807|20074571|P2|STARTED|Overall Study||169
8145565|NCT02679807|20074572|P1|STARTED|Overall Study||165
8145572|NCT02679729|20074623|P9|NOT COMPLETED|Overall Study||0
8145573|NCT02679729|20074624|P8|NOT COMPLETED|Overall Study||0
8145574|NCT02679729|20074625|P7|NOT COMPLETED|Overall Study||1
8145575|NCT02679729|20074626|P6|NOT COMPLETED|Overall Study||0
8145576|NCT02679729|20074627|P5|NOT COMPLETED|Overall Study||1
8145577|NCT02679729|20074628|P4|NOT COMPLETED|Overall Study||0
8145578|NCT02679729|20074629|P3|NOT COMPLETED|Overall Study||0
8145579|NCT02679729|20074630|P2|NOT COMPLETED|Overall Study||2
8145580|NCT02679729|20074631|P1|NOT COMPLETED|Overall Study||0
8145581|NCT02679729|20074623|P9|COMPLETED|Overall Study||6
8145582|NCT02679729|20074624|P8|COMPLETED|Overall Study||14
8145583|NCT02679729|20074625|P7|COMPLETED|Overall Study||5
8145584|NCT02679729|20074626|P6|COMPLETED|Overall Study||6
8145585|NCT02679729|20074627|P5|COMPLETED|Overall Study||5
8145586|NCT02679729|20074628|P4|COMPLETED|Overall Study||6
8145587|NCT02679729|20074629|P3|COMPLETED|Overall Study||6
8145588|NCT02679729|20074630|P2|COMPLETED|Overall Study||5
8145589|NCT02679729|20074631|P1|COMPLETED|Overall Study||6
8145590|NCT02679729|20074623|P9|STARTED|Overall Study||6
8145591|NCT02679729|20074624|P8|STARTED|Overall Study||14
8145592|NCT02679729|20074625|P7|STARTED|Overall Study||6
8145593|NCT02679729|20074626|P6|STARTED|Overall Study||6
8145594|NCT02679729|20074627|P5|STARTED|Overall Study||6
8145595|NCT02679729|20074628|P4|STARTED|Overall Study||6
8145596|NCT02679729|20074629|P3|STARTED|Overall Study||6
8145597|NCT02679729|20074630|P2|STARTED|Overall Study||7
8145598|NCT02679729|20074631|P1|STARTED|Overall Study||6
8145599|NCT02679690|20074735|P1|NOT COMPLETED|Overall Study||1
8145600|NCT02679690|20074735|P1|COMPLETED|Overall Study||9
8145601|NCT02679690|20074735|P1|STARTED|Overall Study||10
8145602|NCT02679573|20074743|P2|NOT COMPLETED|Overall Study||39
8145603|NCT02679573|20074744|P1|NOT COMPLETED|Overall Study||37
8145604|NCT02679573|20074743|P2|COMPLETED|Overall Study||389
8145605|NCT02679573|20074744|P1|COMPLETED|Overall Study||394
8145606|NCT02679573|20074743|P2|STARTED|Overall Study||428
8145607|NCT02679573|20074744|P1|STARTED|Overall Study||431
8145608|NCT02679469|20074760|P1|NOT COMPLETED|Overall Study||0
8145609|NCT02679469|20074760|P1|COMPLETED|Overall Study||7
8145610|NCT02679469|20074760|P1|STARTED|Overall Study||7
8145611|NCT02679287|20074768|P2|NOT COMPLETED|Phase 4||0
8145612|NCT02679287|20074769|P1|NOT COMPLETED|Phase 4||0
8145613|NCT02679287|20074768|P2|COMPLETED|Phase 4||39
8145614|NCT02679287|20074769|P1|COMPLETED|Phase 4||40
8145615|NCT02679287|20074768|P2|STARTED|Phase 4||39
8145616|NCT02679287|20074769|P1|STARTED|Phase 4||40
8145617|NCT02679287|20074768|P2|NOT COMPLETED|Period 3||1
8145618|NCT02679287|20074769|P1|NOT COMPLETED|Period 3||0
8145619|NCT02679287|20074768|P2|COMPLETED|Period 3||39
8145620|NCT02679287|20074769|P1|COMPLETED|Period 3||40
8145621|NCT02679287|20074768|P2|STARTED|Period 3||40
8145622|NCT02679287|20074769|P1|STARTED|Period 3||40
8145623|NCT02679287|20074768|P2|NOT COMPLETED|Period 2||0
8145624|NCT02679287|20074769|P1|NOT COMPLETED|Period 2||3
8145625|NCT02679287|20074768|P2|COMPLETED|Period 2||40
8145626|NCT02679287|20074769|P1|COMPLETED|Period 2||40
8145627|NCT02679287|20074768|P2|STARTED|Period 2||40
8145628|NCT02679287|20074769|P1|STARTED|Period 2||43
8145629|NCT02679287|20074768|P2|NOT COMPLETED|Period 1: Randomization-Study Session 1||6
8145630|NCT02679287|20074769|P1|NOT COMPLETED|Period 1: Randomization-Study Session 1||4
8145631|NCT02679287|20074768|P2|COMPLETED|Period 1: Randomization-Study Session 1||40
8145632|NCT02679287|20074769|P1|COMPLETED|Period 1: Randomization-Study Session 1||43
8145633|NCT02679287|20074768|P2|STARTED|Period 1: Randomization-Study Session 1||46
8145634|NCT02679287|20074769|P1|STARTED|Period 1: Randomization-Study Session 1||47
8145635|NCT02679274|20074799|P2|NOT COMPLETED|Overall Study||0
8145636|NCT02679274|20074800|P1|NOT COMPLETED|Overall Study||1
8145637|NCT02679274|20074799|P2|COMPLETED|Overall Study||1
8145638|NCT02679274|20074800|P1|COMPLETED|Overall Study||1
8145639|NCT02679274|20074799|P2|STARTED|Overall Study||1
8145640|NCT02679274|20074800|P1|STARTED|Overall Study||2
8145641|NCT02679235|20074830|P1|NOT COMPLETED|Overall Study||4
8145642|NCT02679235|20074830|P1|COMPLETED|Overall Study||11
8145643|NCT02679235|20074830|P1|STARTED|Overall Study||15
8145644|NCT02679222|20074837|P1|NOT COMPLETED|Overall Study||1
8145645|NCT02679222|20074837|P1|COMPLETED|Overall Study||9
8145646|NCT02679222|20074837|P1|STARTED|Overall Study||10
8145647|NCT02679079|20074857|P3|NOT COMPLETED|Overall Study||2
8145648|NCT02679079|20074858|P2|NOT COMPLETED|Overall Study||2
8145649|NCT02679079|20074859|P1|NOT COMPLETED|Overall Study||4
8145650|NCT02679079|20074857|P3|COMPLETED|Overall Study||31
8145651|NCT02679079|20074858|P2|COMPLETED|Overall Study||30
8145652|NCT02679079|20074859|P1|COMPLETED|Overall Study||29
8145653|NCT02679079|20074857|P3|ITT Analysis Set|Overall Study||32
8145654|NCT02679079|20074858|P2|ITT Analysis Set|Overall Study||32
8145655|NCT02679079|20074859|P1|ITT Analysis Set|Overall Study||31
8145656|NCT02679079|20074857|P3|STARTED|Overall Study||33
8145657|NCT02679079|20074858|P2|STARTED|Overall Study||32
8145658|NCT02679079|20074859|P1|STARTED|Overall Study||33
8145659|NCT02679066|20074893|P2|NOT COMPLETED|Overall Study||0
8145660|NCT02679066|20074894|P1|NOT COMPLETED|Overall Study||0
8145661|NCT02679066|20074893|P2|COMPLETED|Overall Study||100
8145662|NCT02679066|20074894|P1|COMPLETED|Overall Study||100
8145663|NCT02679066|20074893|P2|STARTED|Overall Study||100
8145664|NCT02679066|20074894|P1|STARTED|Overall Study||100
8145665|NCT02678923|20074904|P2|NOT COMPLETED|Overall Study||5
8145666|NCT02678923|20074905|P1|NOT COMPLETED|Overall Study||6
8145667|NCT02678923|20074904|P2|COMPLETED|Overall Study||62
8145668|NCT02678923|20074905|P1|COMPLETED|Overall Study||53
8145669|NCT02678923|20074904|P2|mITT Population|Overall Study||61
8145670|NCT02678923|20074905|P1|mITT Population|Overall Study||52
8145671|NCT02678923|20074904|P2|Received at Least 1 Dose of Study Drug|Overall Study||64
8145672|NCT02678923|20074905|P1|Received at Least 1 Dose of Study Drug|Overall Study||58
8145673|NCT02678923|20074904|P2|STARTED|Overall Study||67
8145674|NCT02678923|20074905|P1|STARTED|Overall Study||59
8145675|NCT02678676|20074921|P2|NOT COMPLETED|Overall Study||872
8145676|NCT02678676|20074922|P1|NOT COMPLETED|Overall Study||888
8145677|NCT02678676|20074921|P2|COMPLETED|Overall Study||907
8145678|NCT02678676|20074922|P1|COMPLETED|Overall Study||932
8145679|NCT02678676|20074921|P2|STARTED|Overall Study||1779
8145680|NCT02678676|20074922|P1|STARTED|Overall Study||1820
8145681|NCT02678442|20074932|P2|NOT COMPLETED|Second Intervention||2
8145682|NCT02678442|20074933|P1|NOT COMPLETED|Second Intervention||2
8145683|NCT02678442|20074932|P2|COMPLETED|Second Intervention||23
8145684|NCT02678442|20074933|P1|COMPLETED|Second Intervention||23
8145685|NCT02678442|20074932|P2|STARTED|Second Intervention||25
8145686|NCT02678442|20074933|P1|STARTED|Second Intervention||25
8145687|NCT02678442|20074932|P2|NOT COMPLETED|First Intervention||0
8145688|NCT02678442|20074933|P1|NOT COMPLETED|First Intervention||0
8145689|NCT02678442|20074932|P2|COMPLETED|First Intervention||25
8145690|NCT02678442|20074933|P1|COMPLETED|First Intervention||25
8145691|NCT02678442|20074932|P2|STARTED|First Intervention||25
8145692|NCT02678442|20074933|P1|STARTED|First Intervention||25
8145693|NCT02678416|20074953|P1|NOT COMPLETED|Part 2||3
8145694|NCT02678416|20074953|P1|COMPLETED|Part 2||64
8145695|NCT02678416|20074953|P1|Per Protocol Population|Part 2||64
8145696|NCT02678416|20074953|P1|Pharmacokinetic Population|Part 2||65
8145697|NCT02678416|20074953|P1|Modified Intent to Treat Population|Part 2||66
8145698|NCT02678416|20074953|P1|Treated (Safety Population)|Part 2||66
8145699|NCT02678416|20074953|P1|STARTED|Part 2|Part 2 enrolled all new participants|67
8145700|NCT02678416|20074953|P1|NOT COMPLETED|Part 1||1
8145701|NCT02678416|20074953|P1|COMPLETED|Part 1||11
8145702|NCT02678416|20074953|P1|Per Protocol Population|Part 1||8
8145703|NCT02678416|20074953|P1|Modified Intent to Treat (mITT)|Part 1||12
8145704|NCT02678416|20074953|P1|Safety Population|Part 1||12
8145705|NCT02678416|20074953|P1|STARTED|Part 1||12
8145706|NCT02678390|20074973|P2|NOT COMPLETED|MCT + AE (5 Days)||0
8145707|NCT02678390|20074974|P1|NOT COMPLETED|MCT + AE (5 Days)||0
8145708|NCT02678390|20074973|P2|COMPLETED|MCT + AE (5 Days)||9
8145709|NCT02678390|20074974|P1|COMPLETED|MCT + AE (5 Days)||10
8145710|NCT02678390|20074973|P2|STARTED|MCT + AE (5 Days)||9
8145711|NCT02678390|20074974|P1|STARTED|MCT + AE (5 Days)||10
8145712|NCT02678390|20074973|P2|NOT COMPLETED|AE (1 Day)||1
8145713|NCT02678390|20074974|P1|NOT COMPLETED|AE (1 Day)||0
8145714|NCT02678390|20074973|P2|COMPLETED|AE (1 Day)||9
8145715|NCT02678390|20074974|P1|COMPLETED|AE (1 Day)||10
8145716|NCT02678390|20074973|P2|STARTED|AE (1 Day)||10
8145717|NCT02678390|20074974|P1|STARTED|AE (1 Day)||10
8145718|NCT02678390|20074973|P2|NOT COMPLETED|MCT (5 Days)||0
8145719|NCT02678390|20074974|P1|NOT COMPLETED|MCT (5 Days)||0
8145720|NCT02678390|20074973|P2|COMPLETED|MCT (5 Days)||10
8145721|NCT02678390|20074974|P1|COMPLETED|MCT (5 Days)||10
8145722|NCT02678390|20074973|P2|STARTED|MCT (5 Days)||10
8145723|NCT02678390|20074974|P1|STARTED|MCT (5 Days)||10
8145724|NCT02678390|20074973|P2|NOT COMPLETED|Control (5 Days)||0
8145725|NCT02678390|20074974|P1|NOT COMPLETED|Control (5 Days)||0
8145726|NCT02678390|20074973|P2|COMPLETED|Control (5 Days)||10
8145727|NCT02678390|20074974|P1|COMPLETED|Control (5 Days)||10
8145728|NCT02678390|20074973|P2|STARTED|Control (5 Days)||10
8145729|NCT02678390|20074974|P1|STARTED|Control (5 Days)||10
8145730|NCT02678286|20074990|P2|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
8145731|NCT02678286|20074991|P1|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
8145732|NCT02678286|20074990|P2|COMPLETED|Study Overall (28 Day Follow-Up)||105
8145733|NCT02678286|20074991|P1|COMPLETED|Study Overall (28 Day Follow-Up)||104
8145734|NCT02678286|20074990|P2|STARTED|Study Overall (28 Day Follow-Up)||109
8145735|NCT02678286|20074991|P1|STARTED|Study Overall (28 Day Follow-Up)||110
8145736|NCT02678286|20074990|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
8145737|NCT02678286|20074991|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
8145738|NCT02678286|20074990|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
8145739|NCT02678286|20074991|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
8145740|NCT02678286|20074990|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
8145741|NCT02678286|20074991|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
8145742|NCT02678039|20075023|P2|NOT COMPLETED|Overall Study||0
8145743|NCT02678039|20075024|P1|NOT COMPLETED|Overall Study||0
8145744|NCT02678039|20075023|P2|COMPLETED|Overall Study||47
8145745|NCT02678039|20075024|P1|COMPLETED|Overall Study||53
8145746|NCT02678039|20075023|P2|STARTED|Overall Study||47
8145747|NCT02678039|20075024|P1|STARTED|Overall Study||53
8145748|NCT02678000|20075043|P5|NOT COMPLETED|PART 2||0
8145749|NCT02678000|20075044|P4|NOT COMPLETED|PART 2||1
8145750|NCT02678000|20075045|P3|NOT COMPLETED|PART 2||3
8145751|NCT02678000|20075046|P2|NOT COMPLETED|PART 2||0
8145752|NCT02678000|20075047|P1|NOT COMPLETED|PART 2||0
8145753|NCT02678000|20075043|P5|COMPLETED|PART 2||18
8145754|NCT02678000|20075044|P4|COMPLETED|PART 2||26
8145755|NCT02678000|20075045|P3|COMPLETED|PART 2||25
8145756|NCT02678000|20075046|P2|COMPLETED|PART 2||0
8145757|NCT02678000|20075047|P1|COMPLETED|PART 2||0
8145758|NCT02678000|20075043|P5|STARTED|PART 2||18
8145759|NCT02678000|20075044|P4|STARTED|PART 2||27
8145760|NCT02678000|20075045|P3|STARTED|PART 2||28
8145761|NCT02678000|20075046|P2|STARTED|PART 2||0
8145762|NCT02678000|20075047|P1|STARTED|PART 2||0
8145763|NCT02678000|20075043|P5|NOT COMPLETED|PART 1||0
8145764|NCT02678000|20075044|P4|NOT COMPLETED|PART 1||0
8145765|NCT02678000|20075045|P3|NOT COMPLETED|PART 1||0
8145766|NCT02678000|20075046|P2|NOT COMPLETED|PART 1||0
8145767|NCT02678000|20075047|P1|NOT COMPLETED|PART 1||0
8145768|NCT02678000|20075043|P5|COMPLETED|PART 1||0
8145769|NCT02678000|20075044|P4|COMPLETED|PART 1||0
8145770|NCT02678000|20075045|P3|COMPLETED|PART 1||0
8145771|NCT02678000|20075046|P2|COMPLETED|PART 1||4
8145772|NCT02678000|20075047|P1|COMPLETED|PART 1||7
8145773|NCT02678000|20075043|P5|STARTED|PART 1||0
8145774|NCT02678000|20075044|P4|STARTED|PART 1||0
8145775|NCT02678000|20075045|P3|STARTED|PART 1||0
8145776|NCT02678000|20075046|P2|STARTED|PART 1||4
8145777|NCT02678000|20075047|P1|STARTED|PART 1||7
8145786|NCT02677844|20075114|P7|NOT COMPLETED|Period 7||0
8145787|NCT02677844|20075115|P6|NOT COMPLETED|Period 7||0
8145788|NCT02677844|20075116|P5|NOT COMPLETED|Period 7||0
8145789|NCT02677844|20075117|P4|NOT COMPLETED|Period 7||0
8145790|NCT02677844|20075118|P3|NOT COMPLETED|Period 7||0
8145791|NCT02677844|20075119|P2|NOT COMPLETED|Period 7||0
8145792|NCT02677844|20075120|P1|NOT COMPLETED|Period 7||0
8145793|NCT02677844|20075114|P7|COMPLETED|Period 7||4
8145794|NCT02677844|20075115|P6|COMPLETED|Period 7||4
8145795|NCT02677844|20075116|P5|COMPLETED|Period 7||7
8145796|NCT02677844|20075117|P4|COMPLETED|Period 7||0
8145797|NCT02677844|20075118|P3|COMPLETED|Period 7||0
8145798|NCT02677844|20075119|P2|COMPLETED|Period 7||0
8145799|NCT02677844|20075120|P1|COMPLETED|Period 7||0
8145800|NCT02677844|20075114|P7|STARTED|Period 7||4
8145801|NCT02677844|20075115|P6|STARTED|Period 7||4
8145802|NCT02677844|20075116|P5|STARTED|Period 7||7
8145803|NCT02677844|20075117|P4|STARTED|Period 7||0
8145804|NCT02677844|20075118|P3|STARTED|Period 7||0
8145805|NCT02677844|20075119|P2|STARTED|Period 7||0
8145806|NCT02677844|20075120|P1|STARTED|Period 7||0
8145807|NCT02677844|20075114|P7|NOT COMPLETED|Period 6||0
8145808|NCT02677844|20075115|P6|NOT COMPLETED|Period 6||0
8145809|NCT02677844|20075116|P5|NOT COMPLETED|Period 6||0
8145810|NCT02677844|20075117|P4|NOT COMPLETED|Period 6||0
8145811|NCT02677844|20075118|P3|NOT COMPLETED|Period 6||0
8145812|NCT02677844|20075119|P2|NOT COMPLETED|Period 6||0
8145813|NCT02677844|20075120|P1|NOT COMPLETED|Period 6||0
8145814|NCT02677844|20075114|P7|COMPLETED|Period 6||4
8145815|NCT02677844|20075115|P6|COMPLETED|Period 6||4
8145816|NCT02677844|20075116|P5|COMPLETED|Period 6||7
8145817|NCT02677844|20075117|P4|COMPLETED|Period 6||0
8145818|NCT02677844|20075118|P3|COMPLETED|Period 6||0
8145819|NCT02677844|20075119|P2|COMPLETED|Period 6||0
8145820|NCT02677844|20075120|P1|COMPLETED|Period 6||0
8145821|NCT02677844|20075114|P7|STARTED|Period 6||4
8145822|NCT02677844|20075115|P6|STARTED|Period 6||4
8145823|NCT02677844|20075116|P5|STARTED|Period 6||7
8145824|NCT02677844|20075117|P4|STARTED|Period 6||0
8145825|NCT02677844|20075118|P3|STARTED|Period 6||0
8145826|NCT02677844|20075119|P2|STARTED|Period 6||0
8145827|NCT02677844|20075120|P1|STARTED|Period 6||0
8145828|NCT02677844|20075114|P7|NOT COMPLETED|Period 5||0
8145829|NCT02677844|20075115|P6|NOT COMPLETED|Period 5||0
8145830|NCT02677844|20075116|P5|NOT COMPLETED|Period 5||0
8145831|NCT02677844|20075117|P4|NOT COMPLETED|Period 5||0
8145832|NCT02677844|20075118|P3|NOT COMPLETED|Period 5||0
8145833|NCT02677844|20075119|P2|NOT COMPLETED|Period 5||0
8145834|NCT02677844|20075120|P1|NOT COMPLETED|Period 5||0
8145835|NCT02677844|20075114|P7|COMPLETED|Period 5||4
8145836|NCT02677844|20075115|P6|COMPLETED|Period 5||4
8145837|NCT02677844|20075116|P5|COMPLETED|Period 5||7
8145838|NCT02677844|20075117|P4|COMPLETED|Period 5||0
8145839|NCT02677844|20075118|P3|COMPLETED|Period 5||0
8145840|NCT02677844|20075119|P2|COMPLETED|Period 5||0
8145841|NCT02677844|20075120|P1|COMPLETED|Period 5||0
8145842|NCT02677844|20075114|P7|STARTED|Period 5||4
8145843|NCT02677844|20075115|P6|STARTED|Period 5||4
8145844|NCT02677844|20075116|P5|STARTED|Period 5||7
8145845|NCT02677844|20075117|P4|STARTED|Period 5||0
8145846|NCT02677844|20075118|P3|STARTED|Period 5||0
8145847|NCT02677844|20075119|P2|STARTED|Period 5||0
8145848|NCT02677844|20075120|P1|STARTED|Period 5||0
8145849|NCT02677844|20075114|P7|NOT COMPLETED|Period 4 (DDI)||0
8145850|NCT02677844|20075115|P6|NOT COMPLETED|Period 4 (DDI)||0
8145851|NCT02677844|20075116|P5|NOT COMPLETED|Period 4 (DDI)||0
8145852|NCT02677844|20075117|P4|NOT COMPLETED|Period 4 (DDI)||0
8145853|NCT02677844|20075118|P3|NOT COMPLETED|Period 4 (DDI)||0
8145854|NCT02677844|20075119|P2|NOT COMPLETED|Period 4 (DDI)||0
8145855|NCT02677844|20075120|P1|NOT COMPLETED|Period 4 (DDI)||0
8145856|NCT02677844|20075114|P7|COMPLETED|Period 4 (DDI)||4
8145857|NCT02677844|20075115|P6|COMPLETED|Period 4 (DDI)||4
8145858|NCT02677844|20075116|P5|COMPLETED|Period 4 (DDI)||7
8145859|NCT02677844|20075117|P4|COMPLETED|Period 4 (DDI)||0
8145860|NCT02677844|20075118|P3|COMPLETED|Period 4 (DDI)||0
8145861|NCT02677844|20075119|P2|COMPLETED|Period 4 (DDI)||0
8145862|NCT02677844|20075120|P1|COMPLETED|Period 4 (DDI)||0
8145863|NCT02677844|20075114|P7|STARTED|Period 4 (DDI)||4
8145864|NCT02677844|20075115|P6|STARTED|Period 4 (DDI)||4
8145865|NCT02677844|20075116|P5|STARTED|Period 4 (DDI)||7
8145866|NCT02677844|20075117|P4|STARTED|Period 4 (DDI)||0
8145867|NCT02677844|20075118|P3|STARTED|Period 4 (DDI)||0
8145868|NCT02677844|20075119|P2|STARTED|Period 4 (DDI)||0
8145869|NCT02677844|20075120|P1|STARTED|Period 4 (DDI)||0
8145870|NCT02677844|20075114|P7|NOT COMPLETED|Period 4||0
8145871|NCT02677844|20075115|P6|NOT COMPLETED|Period 4||0
8145872|NCT02677844|20075116|P5|NOT COMPLETED|Period 4||0
8145873|NCT02677844|20075117|P4|NOT COMPLETED|Period 4||0
8145874|NCT02677844|20075118|P3|NOT COMPLETED|Period 4||0
8145875|NCT02677844|20075119|P2|NOT COMPLETED|Period 4||0
8145876|NCT02677844|20075120|P1|NOT COMPLETED|Period 4||0
8145877|NCT02677844|20075114|P7|COMPLETED|Period 4||0
8145878|NCT02677844|20075115|P6|COMPLETED|Period 4||0
8145879|NCT02677844|20075116|P5|COMPLETED|Period 4||0
8145880|NCT02677844|20075117|P4|COMPLETED|Period 4||4
8145881|NCT02677844|20075118|P3|COMPLETED|Period 4||5
8145882|NCT02677844|20075119|P2|COMPLETED|Period 4||5
8145883|NCT02677844|20075120|P1|COMPLETED|Period 4||5
8145884|NCT02677844|20075114|P7|STARTED|Period 4||0
8145885|NCT02677844|20075115|P6|STARTED|Period 4||0
8145886|NCT02677844|20075116|P5|STARTED|Period 4||0
8145887|NCT02677844|20075117|P4|STARTED|Period 4||4
8145888|NCT02677844|20075118|P3|STARTED|Period 4||5
8145889|NCT02677844|20075119|P2|STARTED|Period 4||5
8145890|NCT02677844|20075120|P1|STARTED|Period 4||5
8145891|NCT02677844|20075114|P7|NOT COMPLETED|Period 3||0
8145892|NCT02677844|20075115|P6|NOT COMPLETED|Period 3||0
8145893|NCT02677844|20075116|P5|NOT COMPLETED|Period 3||0
8145894|NCT02677844|20075117|P4|NOT COMPLETED|Period 3||1
8145895|NCT02677844|20075118|P3|NOT COMPLETED|Period 3||0
8145896|NCT02677844|20075119|P2|NOT COMPLETED|Period 3||0
8145897|NCT02677844|20075120|P1|NOT COMPLETED|Period 3||0
8145898|NCT02677844|20075114|P7|COMPLETED|Period 3||0
8145899|NCT02677844|20075115|P6|COMPLETED|Period 3||0
8145900|NCT02677844|20075116|P5|COMPLETED|Period 3||0
8145901|NCT02677844|20075117|P4|COMPLETED|Period 3||4
8145902|NCT02677844|20075118|P3|COMPLETED|Period 3||5
8145903|NCT02677844|20075119|P2|COMPLETED|Period 3||5
8145904|NCT02677844|20075120|P1|COMPLETED|Period 3||5
8145905|NCT02677844|20075114|P7|STARTED|Period 3||0
8145906|NCT02677844|20075115|P6|STARTED|Period 3||0
8145907|NCT02677844|20075116|P5|STARTED|Period 3||0
8145908|NCT02677844|20075117|P4|STARTED|Period 3||5
8145909|NCT02677844|20075118|P3|STARTED|Period 3||5
8145910|NCT02677844|20075119|P2|STARTED|Period 3||5
8145911|NCT02677844|20075120|P1|STARTED|Period 3||5
8145912|NCT02677844|20075114|P7|NOT COMPLETED|Period 2||0
8145913|NCT02677844|20075115|P6|NOT COMPLETED|Period 2||0
8145914|NCT02677844|20075116|P5|NOT COMPLETED|Period 2||0
8145915|NCT02677844|20075117|P4|NOT COMPLETED|Period 2||0
8145916|NCT02677844|20075118|P3|NOT COMPLETED|Period 2||0
8145917|NCT02677844|20075119|P2|NOT COMPLETED|Period 2||0
8145918|NCT02677844|20075120|P1|NOT COMPLETED|Period 2||0
8145919|NCT02677844|20075114|P7|COMPLETED|Period 2||0
8145920|NCT02677844|20075115|P6|COMPLETED|Period 2||0
8145921|NCT02677844|20075116|P5|COMPLETED|Period 2||0
8145922|NCT02677844|20075117|P4|COMPLETED|Period 2||5
8145923|NCT02677844|20075118|P3|COMPLETED|Period 2||5
8145924|NCT02677844|20075119|P2|COMPLETED|Period 2||5
8145925|NCT02677844|20075120|P1|COMPLETED|Period 2||5
8145926|NCT02677844|20075114|P7|STARTED|Period 2||0
8145927|NCT02677844|20075115|P6|STARTED|Period 2||0
8145928|NCT02677844|20075116|P5|STARTED|Period 2||0
8145929|NCT02677844|20075117|P4|STARTED|Period 2||5
8145930|NCT02677844|20075118|P3|STARTED|Period 2||5
8145931|NCT02677844|20075119|P2|STARTED|Period 2||5
8145932|NCT02677844|20075120|P1|STARTED|Period 2||5
8145933|NCT02677844|20075114|P7|NOT COMPLETED|Period 1||0
8145934|NCT02677844|20075115|P6|NOT COMPLETED|Period 1||0
8145935|NCT02677844|20075116|P5|NOT COMPLETED|Period 1||0
8145936|NCT02677844|20075117|P4|NOT COMPLETED|Period 1||0
8145937|NCT02677844|20075118|P3|NOT COMPLETED|Period 1||0
8145938|NCT02677844|20075119|P2|NOT COMPLETED|Period 1||0
8145939|NCT02677844|20075120|P1|NOT COMPLETED|Period 1||0
8145940|NCT02677844|20075114|P7|COMPLETED|Period 1||0
8145941|NCT02677844|20075115|P6|COMPLETED|Period 1||0
8145942|NCT02677844|20075116|P5|COMPLETED|Period 1||0
8145943|NCT02677844|20075117|P4|COMPLETED|Period 1||5
8145944|NCT02677844|20075118|P3|COMPLETED|Period 1||5
8145945|NCT02677844|20075119|P2|COMPLETED|Period 1||5
8145946|NCT02677844|20075120|P1|COMPLETED|Period 1||5
8145947|NCT02677844|20075114|P7|STARTED|Period 1||0
8145948|NCT02677844|20075115|P6|STARTED|Period 1||0
8145949|NCT02677844|20075116|P5|STARTED|Period 1||0
8145950|NCT02677844|20075117|P4|STARTED|Period 1||5
8145951|NCT02677844|20075118|P3|STARTED|Period 1||5
8145952|NCT02677844|20075119|P2|STARTED|Period 1||5
8145953|NCT02677844|20075120|P1|STARTED|Period 1||5
8145954|NCT02677779|20075150|P2|NOT COMPLETED|Overall Study||0
8145955|NCT02677779|20075151|P1|NOT COMPLETED|Overall Study||0
8145956|NCT02677779|20075150|P2|COMPLETED|Overall Study||10
8145957|NCT02677779|20075151|P1|COMPLETED|Overall Study||10
8145958|NCT02677779|20075150|P2|STARTED|Overall Study||10
8145959|NCT02677779|20075151|P1|STARTED|Overall Study||10
8145960|NCT02677766|20075167|P2|NOT COMPLETED|Overall Study||3
8145961|NCT02677766|20075168|P1|NOT COMPLETED|Overall Study||5
8145962|NCT02677766|20075167|P2|COMPLETED|Overall Study||17
8145963|NCT02677766|20075168|P1|COMPLETED|Overall Study||15
8145964|NCT02677766|20075167|P2|STARTED|Overall Study||20
8145965|NCT02677766|20075168|P1|STARTED|Overall Study||20
8145966|NCT02677753|20075176|P2|NOT COMPLETED|Overall Study||0
8145967|NCT02677753|20075177|P1|NOT COMPLETED|Overall Study||1
8145968|NCT02677753|20075176|P2|COMPLETED|Overall Study||38
8145969|NCT02677753|20075177|P1|COMPLETED|Overall Study||36
8145970|NCT02677753|20075176|P2|STARTED|Overall Study||38
8145971|NCT02677753|20075177|P1|STARTED|Overall Study||37
8145972|NCT02677740|20075185|P2|NOT COMPLETED|Overall Study||0
8145973|NCT02677740|20075186|P1|NOT COMPLETED|Overall Study||0
8145974|NCT02677740|20075185|P2|COMPLETED|Overall Study||1
8145975|NCT02677740|20075186|P1|COMPLETED|Overall Study||7
8145976|NCT02677740|20075185|P2|STARTED|Overall Study||1
8145977|NCT02677740|20075186|P1|STARTED|Overall Study||7
8145978|NCT02677714|20075200|P2|NOT COMPLETED|Overall Study||0
8145979|NCT02677714|20075201|P1|NOT COMPLETED|Overall Study||2
8145980|NCT02677714|20075200|P2|COMPLETED|Overall Study||2
8145981|NCT02677714|20075201|P1|COMPLETED|Overall Study||10
8145982|NCT02677714|20075200|P2|STARTED|Overall Study||2
8145983|NCT02677714|20075201|P1|STARTED|Overall Study||12
8145984|NCT02677623|20075216|P4|NOT COMPLETED|Overall Study||0
8145985|NCT02677623|20075217|P3|NOT COMPLETED|Overall Study||0
8145986|NCT02677623|20075218|P2|NOT COMPLETED|Overall Study||0
8145987|NCT02677623|20075219|P1|NOT COMPLETED|Overall Study||0
8145988|NCT02677623|20075216|P4|COMPLETED|Overall Study||33
8145989|NCT02677623|20075217|P3|COMPLETED|Overall Study||32
8145990|NCT02677623|20075218|P2|COMPLETED|Overall Study||32
8145991|NCT02677623|20075219|P1|COMPLETED|Overall Study||33
8145992|NCT02677623|20075216|P4|STARTED|Overall Study||33
8145993|NCT02677623|20075217|P3|STARTED|Overall Study||32
8145994|NCT02677623|20075218|P2|STARTED|Overall Study||32
8145995|NCT02677623|20075219|P1|STARTED|Overall Study||33
8145996|NCT02677493|20075232|P3|NOT COMPLETED|Overall Study||3
8145997|NCT02677493|20075233|P2|NOT COMPLETED|Overall Study||2
8145998|NCT02677493|20075234|P1|NOT COMPLETED|Overall Study||11
8145999|NCT02677493|20075232|P3|COMPLETED|Overall Study||296
8146000|NCT02677493|20075233|P2|COMPLETED|Overall Study||296
8146001|NCT02677493|20075234|P1|COMPLETED|Overall Study||1186
8146002|NCT02677493|20075232|P3|STARTED|Overall Study||299
8146003|NCT02677493|20075233|P2|STARTED|Overall Study||298
8146004|NCT02677493|20075234|P1|STARTED|Overall Study||1197
8146005|NCT02677428|20075263|P2|NOT COMPLETED|Overall Study||0
8146006|NCT02677428|20075264|P1|NOT COMPLETED|Overall Study||0
8146007|NCT02677428|20075263|P2|COMPLETED|Overall Study||55
8146008|NCT02677428|20075264|P1|COMPLETED|Overall Study||63
8146009|NCT02677428|20075263|P2|STARTED|Overall Study||55
8146010|NCT02677428|20075264|P1|STARTED|Overall Study||63
8146011|NCT02677220|20075272|P1|NOT COMPLETED|Overall Study||1
8146012|NCT02677220|20075272|P1|COMPLETED|Overall Study||0
8146013|NCT02677220|20075272|P1|STARTED|Overall Study||1
8146014|NCT02677116|20075287|P9|NOT COMPLETED|Overall Study||2
8146015|NCT02677116|20075288|P8|NOT COMPLETED|Overall Study||2
8146016|NCT02677116|20075289|P7|NOT COMPLETED|Overall Study||4
8146017|NCT02677116|20075290|P6|NOT COMPLETED|Overall Study||4
8146018|NCT02677116|20075291|P5|NOT COMPLETED|Overall Study||1
8146019|NCT02677116|20075292|P4|NOT COMPLETED|Overall Study||3
8146020|NCT02677116|20075293|P3|NOT COMPLETED|Overall Study||3
8146021|NCT02677116|20075294|P2|NOT COMPLETED|Overall Study||4
8146022|NCT02677116|20075295|P1|NOT COMPLETED|Overall Study||3
8146023|NCT02677116|20075287|P9|COMPLETED|Overall Study||2
8146024|NCT02677116|20075288|P8|COMPLETED|Overall Study||2
8146025|NCT02677116|20075289|P7|COMPLETED|Overall Study||2
8146026|NCT02677116|20075290|P6|COMPLETED|Overall Study||9
8146027|NCT02677116|20075291|P5|COMPLETED|Overall Study||0
8146028|NCT02677116|20075292|P4|COMPLETED|Overall Study||7
8146029|NCT02677116|20075293|P3|COMPLETED|Overall Study||6
8146030|NCT02677116|20075294|P2|COMPLETED|Overall Study||7
8146031|NCT02677116|20075295|P1|COMPLETED|Overall Study||7
8146032|NCT02677116|20075287|P9|Progressive Disease|Overall Study||2
8146033|NCT02677116|20075288|P8|Progressive Disease|Overall Study||2
8146034|NCT02677116|20075289|P7|Progressive Disease|Overall Study||2
8146035|NCT02677116|20075290|P6|Progressive Disease|Overall Study||9
8146036|NCT02677116|20075291|P5|Progressive Disease|Overall Study||0
8146037|NCT02677116|20075292|P4|Progressive Disease|Overall Study||7
8146038|NCT02677116|20075293|P3|Progressive Disease|Overall Study||6
8146039|NCT02677116|20075294|P2|Progressive Disease|Overall Study||7
8146040|NCT02677116|20075295|P1|Progressive Disease|Overall Study||7
8146041|NCT02677116|20075287|P9|Cycle 1 Olaratumab Alone|Overall Study||4
8146042|NCT02677116|20075288|P8|Cycle 1 Olaratumab Alone|Overall Study||4
8146043|NCT02677116|20075289|P7|Cycle 1 Olaratumab Alone|Overall Study||6
8146044|NCT02677116|20075290|P6|Cycle 1 Olaratumab Alone|Overall Study||13
8146045|NCT02677116|20075291|P5|Cycle 1 Olaratumab Alone|Overall Study||1
8146046|NCT02677116|20075292|P4|Cycle 1 Olaratumab Alone|Overall Study||10
8146047|NCT02677116|20075293|P3|Cycle 1 Olaratumab Alone|Overall Study||9
8146048|NCT02677116|20075294|P2|Cycle 1 Olaratumab Alone|Overall Study||11
8146049|NCT02677116|20075295|P1|Cycle 1 Olaratumab Alone|Overall Study||10
8146050|NCT02677116|20075287|P9|STARTED|Overall Study||4
8146051|NCT02677116|20075288|P8|STARTED|Overall Study||4
8146052|NCT02677116|20075289|P7|STARTED|Overall Study||6
8146053|NCT02677116|20075290|P6|STARTED|Overall Study||13
8146054|NCT02677116|20075291|P5|STARTED|Overall Study||1
8146055|NCT02677116|20075292|P4|STARTED|Overall Study||10
8146056|NCT02677116|20075293|P3|STARTED|Overall Study||9
8146057|NCT02677116|20075294|P2|STARTED|Overall Study||11
8146058|NCT02677116|20075295|P1|STARTED|Overall Study||10
8146059|NCT02676895|20075368|P3|NOT COMPLETED|Overall Study||3
8146060|NCT02676895|20075369|P2|NOT COMPLETED|Overall Study||3
8146061|NCT02676895|20075370|P1|NOT COMPLETED|Overall Study||2
8146062|NCT02676895|20075368|P3|COMPLETED|Overall Study||21
8146063|NCT02676895|20075369|P2|COMPLETED|Overall Study||23
8146064|NCT02676895|20075370|P1|COMPLETED|Overall Study||20
8146065|NCT02676895|20075368|P3|STARTED|Overall Study||24
8146066|NCT02676895|20075369|P2|STARTED|Overall Study||26
8146067|NCT02676895|20075370|P1|STARTED|Overall Study||22
8146068|NCT02676882|20075413|P2|NOT COMPLETED|Overall Study||2
8146069|NCT02676882|20075414|P1|NOT COMPLETED|Overall Study||3
8146070|NCT02676882|20075413|P2|COMPLETED|Overall Study||5
8146071|NCT02676882|20075414|P1|COMPLETED|Overall Study||10
8146072|NCT02676882|20075413|P2|Evaluable|Overall Study||6
8146073|NCT02676882|20075414|P1|Evaluable|Overall Study||11
8146074|NCT02676882|20075413|P2|STARTED|Overall Study||7
8146075|NCT02676882|20075414|P1|STARTED|Overall Study||13
8146076|NCT02676843|20075420|P1|NOT COMPLETED|Overall Study||0
8146077|NCT02676843|20075420|P1|COMPLETED|Overall Study||7
8146078|NCT02676843|20075420|P1|STARTED|Overall Study||7
8146079|NCT02676466|20075433|P8|NOT COMPLETED|Overall Study||1
8146080|NCT02676466|20075434|P7|NOT COMPLETED|Overall Study||1
8146081|NCT02676466|20075435|P6|NOT COMPLETED|Overall Study||1
8146082|NCT02676466|20075436|P5|NOT COMPLETED|Overall Study||3
8146083|NCT02676466|20075437|P4|NOT COMPLETED|Overall Study||0
8146084|NCT02676466|20075438|P3|NOT COMPLETED|Overall Study||2
8146085|NCT02676466|20075439|P2|NOT COMPLETED|Overall Study||5
8146086|NCT02676466|20075440|P1|NOT COMPLETED|Overall Study||4
8146087|NCT02676466|20075433|P8|COMPLETED|Overall Study||13
8146088|NCT02676466|20075434|P7|COMPLETED|Overall Study||12
8146089|NCT02676466|20075435|P6|COMPLETED|Overall Study||12
8146090|NCT02676466|20075436|P5|COMPLETED|Overall Study||23
8146091|NCT02676466|20075437|P4|COMPLETED|Overall Study||17
8146092|NCT02676466|20075438|P3|COMPLETED|Overall Study||24
8146093|NCT02676466|20075439|P2|COMPLETED|Overall Study||66
8146094|NCT02676466|20075440|P1|COMPLETED|Overall Study||105
8146095|NCT02676466|20075433|P8|STARTED|Overall Study||14
8146096|NCT02676466|20075434|P7|STARTED|Overall Study||13
8146097|NCT02676466|20075435|P6|STARTED|Overall Study||13
8146098|NCT02676466|20075436|P5|STARTED|Overall Study||26
8146099|NCT02676466|20075437|P4|STARTED|Overall Study||17
8146100|NCT02676466|20075438|P3|STARTED|Overall Study||26
8146101|NCT02676466|20075439|P2|STARTED|Overall Study||71
8146102|NCT02676466|20075440|P1|STARTED|Overall Study||109
8146103|NCT02676375|20075509|P3|NOT COMPLETED|Overall Study||3
8146104|NCT02676375|20075510|P2|NOT COMPLETED|Overall Study||4
8146105|NCT02676375|20075511|P1|NOT COMPLETED|Overall Study||1
8146106|NCT02676375|20075509|P3|COMPLETED|Overall Study||11
8146107|NCT02676375|20075510|P2|COMPLETED|Overall Study||10
8146108|NCT02676375|20075511|P1|COMPLETED|Overall Study||13
8146109|NCT02676375|20075509|P3|STARTED|Overall Study||14
8146110|NCT02676375|20075510|P2|STARTED|Overall Study||14
8146111|NCT02676375|20075511|P1|STARTED|Overall Study||14
8146112|NCT02675998|20075523|P4|NOT COMPLETED|4-Week Randomized Withdrawal Period||8
8146113|NCT02675998|20075524|P3|NOT COMPLETED|4-Week Randomized Withdrawal Period||2
8146114|NCT02675998|20075525|P2|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
8146115|NCT02675998|20075526|P1|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
8146116|NCT02675998|20075523|P4|COMPLETED|4-Week Randomized Withdrawal Period||74
8146117|NCT02675998|20075524|P3|COMPLETED|4-Week Randomized Withdrawal Period||32
8146118|NCT02675998|20075525|P2|COMPLETED|4-Week Randomized Withdrawal Period||22
8146119|NCT02675998|20075526|P1|COMPLETED|4-Week Randomized Withdrawal Period||24
8146120|NCT02675998|20075523|P4|STARTED|4-Week Randomized Withdrawal Period||82
8146121|NCT02675998|20075524|P3|STARTED|4-Week Randomized Withdrawal Period||34
8146122|NCT02675998|20075525|P2|STARTED|4-Week Randomized Withdrawal Period||23
8146123|NCT02675998|20075526|P1|STARTED|4-Week Randomized Withdrawal Period||25
8146124|NCT02675998|20075523|P4|NOT COMPLETED|8-Week Treatment Period||0
8146125|NCT02675998|20075524|P3|NOT COMPLETED|8-Week Treatment Period||19
8146126|NCT02675998|20075525|P2|NOT COMPLETED|8-Week Treatment Period||19
8146127|NCT02675998|20075526|P1|NOT COMPLETED|8-Week Treatment Period||17
8146128|NCT02675998|20075523|P4|COMPLETED|8-Week Treatment Period||0
8146129|NCT02675998|20075524|P3|COMPLETED|8-Week Treatment Period||53
8146130|NCT02675998|20075525|P2|COMPLETED|8-Week Treatment Period||54
8146131|NCT02675998|20075526|P1|COMPLETED|8-Week Treatment Period||57
8146132|NCT02675998|20075523|P4|STARTED|8-Week Treatment Period||0
8146133|NCT02675998|20075524|P3|STARTED|8-Week Treatment Period||72
8146134|NCT02675998|20075525|P2|STARTED|8-Week Treatment Period||73
8146135|NCT02675998|20075526|P1|STARTED|8-Week Treatment Period||74
8146136|NCT02675907|20075542|P2|NOT COMPLETED|Study Overall||4
8146137|NCT02675907|20075543|P1|NOT COMPLETED|Study Overall||3
8146138|NCT02675907|20075542|P2|COMPLETED|Study Overall||97
8146139|NCT02675907|20075543|P1|COMPLETED|Study Overall||97
8146140|NCT02675907|20075542|P2|STARTED|Study Overall||101
8146141|NCT02675907|20075543|P1|STARTED|Study Overall||100
8146142|NCT02675907|20075542|P2|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
8146143|NCT02675907|20075543|P1|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
8146144|NCT02675907|20075542|P2|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
8146145|NCT02675907|20075543|P1|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
8146146|NCT02675907|20075542|P2|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
8146147|NCT02675907|20075543|P1|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
8146148|NCT02675764|20075575|P2|NOT COMPLETED|Overall Study||0
8146149|NCT02675764|20075576|P1|NOT COMPLETED|Overall Study||0
8146150|NCT02675764|20075575|P2|COMPLETED|Overall Study||6
8146151|NCT02675764|20075576|P1|COMPLETED|Overall Study||6
8146152|NCT02675764|20075575|P2|STARTED|Overall Study||6
8146153|NCT02675764|20075576|P1|STARTED|Overall Study||6
8146154|NCT02675751|20075588|P1|NOT COMPLETED|Overall Study||16
8146155|NCT02675751|20075588|P1|COMPLETED|Overall Study||151
8146156|NCT02675751|20075588|P1|STARTED|Overall Study||167
8146157|NCT02675634|20075592|P6|NOT COMPLETED|Test Period 3||0
8146158|NCT02675634|20075593|P5|NOT COMPLETED|Test Period 3||0
8146159|NCT02675634|20075594|P4|NOT COMPLETED|Test Period 3||0
8146160|NCT02675634|20075595|P3|NOT COMPLETED|Test Period 3||0
8146161|NCT02675634|20075596|P2|NOT COMPLETED|Test Period 3||0
8146162|NCT02675634|20075597|P1|NOT COMPLETED|Test Period 3||0
8146163|NCT02675634|20075592|P6|COMPLETED|Test Period 3||8
8146164|NCT02675634|20075593|P5|COMPLETED|Test Period 3||10
8146165|NCT02675634|20075594|P4|COMPLETED|Test Period 3||8
8146166|NCT02675634|20075595|P3|COMPLETED|Test Period 3||8
8146167|NCT02675634|20075596|P2|COMPLETED|Test Period 3||7
8146168|NCT02675634|20075597|P1|COMPLETED|Test Period 3||9
8146169|NCT02675634|20075592|P6|STARTED|Test Period 3||8
8146170|NCT02675634|20075593|P5|STARTED|Test Period 3||10
8146171|NCT02675634|20075594|P4|STARTED|Test Period 3||8
8146172|NCT02675634|20075595|P3|STARTED|Test Period 3||8
8146173|NCT02675634|20075596|P2|STARTED|Test Period 3||7
8146174|NCT02675634|20075597|P1|STARTED|Test Period 3||9
8146175|NCT02675634|20075592|P6|NOT COMPLETED|Test Period 2||1
8146176|NCT02675634|20075593|P5|NOT COMPLETED|Test Period 2||0
8146177|NCT02675634|20075594|P4|NOT COMPLETED|Test Period 2||0
8146178|NCT02675634|20075595|P3|NOT COMPLETED|Test Period 2||0
8146179|NCT02675634|20075596|P2|NOT COMPLETED|Test Period 2||0
8146180|NCT02675634|20075597|P1|NOT COMPLETED|Test Period 2||1
8146181|NCT02675634|20075592|P6|COMPLETED|Test Period 2||8
8146182|NCT02675634|20075593|P5|COMPLETED|Test Period 2||10
8146183|NCT02675634|20075594|P4|COMPLETED|Test Period 2||8
8146184|NCT02675634|20075595|P3|COMPLETED|Test Period 2||8
8146185|NCT02675634|20075596|P2|COMPLETED|Test Period 2||7
8146186|NCT02675634|20075597|P1|COMPLETED|Test Period 2||9
8146187|NCT02675634|20075592|P6|STARTED|Test Period 2||9
8146188|NCT02675634|20075593|P5|STARTED|Test Period 2||10
8146189|NCT02675634|20075594|P4|STARTED|Test Period 2||8
8146190|NCT02675634|20075595|P3|STARTED|Test Period 2||8
8146191|NCT02675634|20075596|P2|STARTED|Test Period 2||7
8146192|NCT02675634|20075597|P1|STARTED|Test Period 2||10
8146193|NCT02675634|20075592|P6|NOT COMPLETED|Test Period 1||0
8146194|NCT02675634|20075593|P5|NOT COMPLETED|Test Period 1||0
8146195|NCT02675634|20075594|P4|NOT COMPLETED|Test Period 1||1
8146196|NCT02675634|20075595|P3|NOT COMPLETED|Test Period 1||1
8146197|NCT02675634|20075596|P2|NOT COMPLETED|Test Period 1||1
8146198|NCT02675634|20075597|P1|NOT COMPLETED|Test Period 1||0
8146199|NCT02675634|20075592|P6|COMPLETED|Test Period 1||9
8146200|NCT02675634|20075593|P5|COMPLETED|Test Period 1||10
8146201|NCT02675634|20075594|P4|COMPLETED|Test Period 1||8
8146202|NCT02675634|20075595|P3|COMPLETED|Test Period 1||8
8146203|NCT02675634|20075596|P2|COMPLETED|Test Period 1||7
8146204|NCT02675634|20075597|P1|COMPLETED|Test Period 1||10
8146205|NCT02675634|20075592|P6|STARTED|Test Period 1||9
8146206|NCT02675634|20075593|P5|STARTED|Test Period 1||10
8146207|NCT02675634|20075594|P4|STARTED|Test Period 1||9
8146208|NCT02675634|20075595|P3|STARTED|Test Period 1||9
8146209|NCT02675634|20075596|P2|STARTED|Test Period 1||8
8146210|NCT02675634|20075597|P1|STARTED|Test Period 1||10
8146211|NCT02675543|20075607|P2|NOT COMPLETED|Overall Study||0
8146212|NCT02675543|20075608|P1|NOT COMPLETED|Overall Study||0
8146213|NCT02675543|20075607|P2|COMPLETED|Overall Study||20
8146214|NCT02675543|20075608|P1|COMPLETED|Overall Study||15
8146215|NCT02675543|20075607|P2|STARTED|Overall Study||20
8146216|NCT02675543|20075608|P1|STARTED|Overall Study||15
8146217|NCT02675517|20075614|P1|NOT COMPLETED|Overall Study||159
8146218|NCT02675517|20075614|P1|COMPLETED|Overall Study||1578
8146219|NCT02675517|20075614|P1|STARTED|Overall Study||1737
8146244|NCT02675075|20075710|P2|NOT COMPLETED|Overall Study||0
8146245|NCT02675075|20075711|P1|NOT COMPLETED|Overall Study||3
8146246|NCT02675075|20075710|P2|COMPLETED|Overall Study||19
8146247|NCT02675075|20075711|P1|COMPLETED|Overall Study||12
8146248|NCT02675075|20075710|P2|STARTED|Overall Study||19
8146249|NCT02675075|20075711|P1|STARTED|Overall Study||15
8146250|NCT02674854|20075723|P3|NOT COMPLETED|Overall Study||14
8146251|NCT02674854|20075724|P2|NOT COMPLETED|Overall Study||27
8146252|NCT02674854|20075725|P1|NOT COMPLETED|Overall Study||24
8146253|NCT02674854|20075723|P3|COMPLETED|Overall Study||236
8146254|NCT02674854|20075724|P2|COMPLETED|Overall Study||228
8146255|NCT02674854|20075725|P1|COMPLETED|Overall Study||221
8146256|NCT02674854|20075723|P3|STARTED|Overall Study||250
8146257|NCT02674854|20075724|P2|STARTED|Overall Study||255
8146258|NCT02674854|20075725|P1|STARTED|Overall Study||245
8146262|NCT02674659|20075749|P2|NOT COMPLETED|Overall Study||4
8146263|NCT02674659|20075750|P1|NOT COMPLETED|Overall Study||4
8146264|NCT02674659|20075749|P2|COMPLETED|Overall Study||40
8146265|NCT02674659|20075750|P1|COMPLETED|Overall Study||39
8146266|NCT02674659|20075749|P2|STARTED|Overall Study||44
8146267|NCT02674659|20075750|P1|STARTED|Overall Study||43
8146268|NCT02674633|20075774|P2|NOT COMPLETED|Overall Study||4
8146269|NCT02674633|20075775|P1|NOT COMPLETED|Overall Study||5
8146270|NCT02674633|20075774|P2|COMPLETED|Overall Study||164
8146271|NCT02674633|20075775|P1|COMPLETED|Overall Study||175
8146272|NCT02674633|20075774|P2|STARTED|Overall Study||168
8146273|NCT02674633|20075775|P1|STARTED|Overall Study||180
8146279|NCT02674477|20075820|P2|NOT COMPLETED|Overall Study||2
8146280|NCT02674477|20075821|P1|NOT COMPLETED|Overall Study||8
8146281|NCT02674477|20075820|P2|COMPLETED|Overall Study||45
8146282|NCT02674477|20075821|P1|COMPLETED|Overall Study||40
8146283|NCT02674477|20075820|P2|STARTED|Overall Study||47
8146284|NCT02674477|20075821|P1|STARTED|Overall Study||48
8146285|NCT02674412|20075831|P2|NOT COMPLETED|Overall Study||0
8146286|NCT02674412|20075832|P1|NOT COMPLETED|Overall Study||0
8146287|NCT02674412|20075831|P2|COMPLETED|Overall Study||5
8146288|NCT02674412|20075832|P1|COMPLETED|Overall Study||5
8146289|NCT02674412|20075831|P2|STARTED|Overall Study||5
8146290|NCT02674412|20075832|P1|STARTED|Overall Study||5
8146291|NCT02674386|20075845|P3|NOT COMPLETED|Overall Study||1
8146292|NCT02674386|20075846|P2|NOT COMPLETED|Overall Study||10
8146293|NCT02674386|20075847|P1|NOT COMPLETED|Overall Study||0
8146294|NCT02674386|20075845|P3|COMPLETED|Overall Study||16
8146295|NCT02674386|20075846|P2|COMPLETED|Overall Study||107
8146296|NCT02674386|20075847|P1|COMPLETED|Overall Study||20
8146297|NCT02674386|20075845|P3|Safety Analysis Set|Overall Study||17
8146298|NCT02674386|20075846|P2|Safety Analysis Set|Overall Study||113
8146299|NCT02674386|20075847|P1|Safety Analysis Set|Overall Study||20
8146300|NCT02674386|20075845|P3|STARTED|Overall Study||17
8146301|NCT02674386|20075846|P2|STARTED|Overall Study||117
8146302|NCT02674386|20075847|P1|STARTED|Overall Study||20
8146303|NCT02674334|20075902|P2|NOT COMPLETED|Overall Study||3
8146304|NCT02674334|20075903|P1|NOT COMPLETED|Overall Study||7
8146305|NCT02674334|20075902|P2|COMPLETED|Overall Study||40
8146306|NCT02674334|20075903|P1|COMPLETED|Overall Study||40
8146307|NCT02674334|20075902|P2|STARTED|Overall Study||43
8146308|NCT02674334|20075903|P1|STARTED|Overall Study||47
8146309|NCT02674204|20075913|P2|NOT COMPLETED|Overall Study||0
8146310|NCT02674204|20075914|P1|NOT COMPLETED|Overall Study||1
8146311|NCT02674204|20075913|P2|COMPLETED|Overall Study||1
8146312|NCT02674204|20075914|P1|COMPLETED|Overall Study||0
8146313|NCT02674204|20075913|P2|STARTED|Overall Study||1
8146314|NCT02674204|20075914|P1|STARTED|Overall Study||1
8146321|NCT02673944|20076139|P1|NOT COMPLETED|Overall Study||0
8146322|NCT02673944|20076139|P1|COMPLETED|Overall Study||10
8146323|NCT02673944|20076139|P1|STARTED|Overall Study||10
8146324|NCT02673918|20076146|P2|NOT COMPLETED|Overall Study||4
8146325|NCT02673918|20076147|P1|NOT COMPLETED|Overall Study||6
8146326|NCT02673918|20076146|P2|COMPLETED|Overall Study||20
8146327|NCT02673918|20076147|P1|COMPLETED|Overall Study||29
8146328|NCT02673918|20076146|P2|STARTED|Overall Study||24
8146329|NCT02673918|20076147|P1|STARTED|Overall Study||35
8146330|NCT02673684|20076175|P2|NOT COMPLETED|Overall Study||8
8146331|NCT02673684|20076176|P1|NOT COMPLETED|Overall Study||9
8146332|NCT02673684|20076175|P2|COMPLETED|Overall Study||0
8146333|NCT02673684|20076176|P1|COMPLETED|Overall Study||0
8146334|NCT02673684|20076175|P2|STARTED|Overall Study||8
8146335|NCT02673684|20076176|P1|STARTED|Overall Study||9
8146336|NCT02673619|20076192|P4|NOT COMPLETED|Overall Study||0
8146337|NCT02673619|20076193|P3|NOT COMPLETED|Overall Study||3
8146338|NCT02673619|20076194|P2|NOT COMPLETED|Overall Study||1
8146339|NCT02673619|20076195|P1|NOT COMPLETED|Overall Study||2
8146340|NCT02673619|20076192|P4|COMPLETED|Overall Study||7
8146341|NCT02673619|20076193|P3|COMPLETED|Overall Study||23
8146342|NCT02673619|20076194|P2|COMPLETED|Overall Study||4
8146343|NCT02673619|20076195|P1|COMPLETED|Overall Study||18
8146344|NCT02673619|20076192|P4|STARTED|Overall Study||7
8146345|NCT02673619|20076193|P3|STARTED|Overall Study||26
8146346|NCT02673619|20076194|P2|STARTED|Overall Study||5
8146347|NCT02673619|20076195|P1|STARTED|Overall Study||20
8146348|NCT02673541|20076287|P2|NOT COMPLETED|Overall Study||0
8146349|NCT02673541|20076288|P1|NOT COMPLETED|Overall Study||0
8146350|NCT02673541|20076287|P2|COMPLETED|Overall Study||2
8146351|NCT02673541|20076288|P1|COMPLETED|Overall Study||3
8146352|NCT02673541|20076287|P2|STARTED|Overall Study||2
8146353|NCT02673541|20076288|P1|STARTED|Overall Study||3
8146354|NCT02673515|20076306|P2|NOT COMPLETED|Overall Study||1
8146355|NCT02673515|20076307|P1|NOT COMPLETED|Overall Study||2
8146356|NCT02673515|20076306|P2|COMPLETED|Overall Study||29
8146357|NCT02673515|20076307|P1|COMPLETED|Overall Study||28
8146358|NCT02673515|20076306|P2|STARTED|Overall Study||30
8146359|NCT02673515|20076307|P1|STARTED|Overall Study||30
8146360|NCT02673489|20076323|P2|NOT COMPLETED|Follow Up Period||2
8146361|NCT02673489|20076324|P1|NOT COMPLETED|Follow Up Period||0
8146362|NCT02673489|20076323|P2|COMPLETED|Follow Up Period||21
8146363|NCT02673489|20076324|P1|COMPLETED|Follow Up Period||50
8146364|NCT02673489|20076323|P2|STARTED|Follow Up Period||23
8146365|NCT02673489|20076324|P1|STARTED|Follow Up Period||50
8146366|NCT02673489|20076323|P2|NOT COMPLETED|Treatment Period||3
8146367|NCT02673489|20076324|P1|NOT COMPLETED|Treatment Period||5
8146368|NCT02673489|20076323|P2|COMPLETED|Treatment Period||21
8146369|NCT02673489|20076324|P1|COMPLETED|Treatment Period||49
8146370|NCT02673489|20076323|P2|STARTED|Treatment Period||24
8146371|NCT02673489|20076324|P1|STARTED|Treatment Period||54
8146372|NCT02673372|20076339|P2|NOT COMPLETED|Overall Study||0
8146373|NCT02673372|20076340|P1|NOT COMPLETED|Overall Study||0
8146374|NCT02673372|20076339|P2|COMPLETED|Overall Study||30
8146375|NCT02673372|20076340|P1|COMPLETED|Overall Study||30
8146376|NCT02673372|20076339|P2|STARTED|Overall Study||30
8146377|NCT02673372|20076340|P1|STARTED|Overall Study||30
8146387|NCT02673138|20076375|P1|NOT COMPLETED|Overall Study||0
8146388|NCT02673138|20076375|P1|COMPLETED|Overall Study||10
8146389|NCT02673138|20076375|P1|STARTED|Overall Study||10
8146390|NCT02672852|20076389|P7|NOT COMPLETED|Part B||12
8146391|NCT02672852|20076390|P6|NOT COMPLETED|Part B||11
8146392|NCT02672852|20076391|P5|NOT COMPLETED|Part B||16
8146393|NCT02672852|20076392|P4|NOT COMPLETED|Part B||0
8146394|NCT02672852|20076393|P3|NOT COMPLETED|Part B||0
8146395|NCT02672852|20076394|P2|NOT COMPLETED|Part B||0
8146396|NCT02672852|20076395|P1|NOT COMPLETED|Part B||0
8146397|NCT02672852|20076389|P7|COMPLETED|Part B||51
8146398|NCT02672852|20076390|P6|COMPLETED|Part B||100
8146399|NCT02672852|20076391|P5|COMPLETED|Part B||209
8146400|NCT02672852|20076392|P4|COMPLETED|Part B||0
8146401|NCT02672852|20076393|P3|COMPLETED|Part B||0
8146402|NCT02672852|20076394|P2|COMPLETED|Part B||0
8146403|NCT02672852|20076395|P1|COMPLETED|Part B||0
8146404|NCT02672852|20076389|P7|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63
8146405|NCT02672852|20076390|P6|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111
8146406|NCT02672852|20076391|P5|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225
8146407|NCT02672852|20076392|P4|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
8146408|NCT02672852|20076393|P3|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
8146409|NCT02672852|20076394|P2|STARTED|Part B||0
8146410|NCT02672852|20076395|P1|STARTED|Part B||0
8146411|NCT02672852|20076389|P7|NOT COMPLETED|Part A2||0
8146412|NCT02672852|20076390|P6|NOT COMPLETED|Part A2||0
8146413|NCT02672852|20076391|P5|NOT COMPLETED|Part A2||0
8146414|NCT02672852|20076392|P4|NOT COMPLETED|Part A2||4
8146415|NCT02672852|20076393|P3|NOT COMPLETED|Part A2||10
8146416|NCT02672852|20076394|P2|NOT COMPLETED|Part A2||0
8146417|NCT02672852|20076395|P1|NOT COMPLETED|Part A2||0
8146418|NCT02672852|20076389|P7|COMPLETED|Part A2||0
8146419|NCT02672852|20076390|P6|COMPLETED|Part A2||0
8146420|NCT02672852|20076391|P5|COMPLETED|Part A2||0
8146421|NCT02672852|20076392|P4|COMPLETED|Part A2||399
8146422|NCT02672852|20076393|P3|COMPLETED|Part A2||83
8146423|NCT02672852|20076394|P2|COMPLETED|Part A2||0
8146424|NCT02672852|20076395|P1|COMPLETED|Part A2||0
8146425|NCT02672852|20076389|P7|STARTED|Part A2||0
8146426|NCT02672852|20076390|P6|STARTED|Part A2||0
8146427|NCT02672852|20076391|P5|STARTED|Part A2||0
8146428|NCT02672852|20076392|P4|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403
8146429|NCT02672852|20076393|P3|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93
8146430|NCT02672852|20076394|P2|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
8146431|NCT02672852|20076395|P1|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
8146432|NCT02672852|20076389|P7|NOT COMPLETED|Part A1||0
8146433|NCT02672852|20076390|P6|NOT COMPLETED|Part A1||0
8146434|NCT02672852|20076391|P5|NOT COMPLETED|Part A1||0
8146435|NCT02672852|20076392|P4|NOT COMPLETED|Part A1||0
8146436|NCT02672852|20076393|P3|NOT COMPLETED|Part A1||0
8146437|NCT02672852|20076394|P2|NOT COMPLETED|Part A1||4
8146438|NCT02672852|20076395|P1|NOT COMPLETED|Part A1||3
8146439|NCT02672852|20076389|P7|COMPLETED|Part A1||0
8146440|NCT02672852|20076390|P6|COMPLETED|Part A1||0
8146441|NCT02672852|20076391|P5|COMPLETED|Part A1||0
8146442|NCT02672852|20076392|P4|COMPLETED|Part A1||0
8146443|NCT02672852|20076393|P3|COMPLETED|Part A1||0
8146444|NCT02672852|20076394|P2|COMPLETED|Part A1||403
8146445|NCT02672852|20076395|P1|COMPLETED|Part A1||97
8146446|NCT02672852|20076389|P7|STARTED|Part A1||0
8146447|NCT02672852|20076390|P6|STARTED|Part A1||0
8146448|NCT02672852|20076391|P5|STARTED|Part A1||0
8146449|NCT02672852|20076392|P4|STARTED|Part A1||0
8146450|NCT02672852|20076393|P3|STARTED|Part A1||0
8146451|NCT02672852|20076394|P2|STARTED|Part A1||407
8146452|NCT02672852|20076395|P1|STARTED|Part A1||100
8146453|NCT02672553|20076426|P2|NOT COMPLETED|Overall Study||8
8146454|NCT02672553|20076427|P1|NOT COMPLETED|Overall Study||12
8146455|NCT02672553|20076426|P2|COMPLETED|Overall Study||41
8146456|NCT02672553|20076427|P1|COMPLETED|Overall Study||39
8146457|NCT02672553|20076426|P2|As Intended (AI) Randomized Arm/Group|Overall Study||48
8146458|NCT02672553|20076427|P1|As Intended (AI) Randomized Arm/Group|Overall Study||46
8146459|NCT02672553|20076426|P2|As Treated (AT) Randomized Arm/Group|Overall Study||51
8146460|NCT02672553|20076427|P1|As Treated (AT) Randomized Arm/Group|Overall Study||46
8146461|NCT02672553|20076426|P2|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48
8146462|NCT02672553|20076427|P1|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49
8146463|NCT02672553|20076426|P2|STARTED|Overall Study||49
8146464|NCT02672553|20076427|P1|STARTED|Overall Study||51
8146465|NCT02672514|20076489|P2|NOT COMPLETED|Overall Study||0
8146466|NCT02672514|20076490|P1|NOT COMPLETED|Overall Study||0
8146467|NCT02672514|20076489|P2|COMPLETED|Overall Study||51
8146468|NCT02672514|20076490|P1|COMPLETED|Overall Study||53
8146469|NCT02672514|20076489|P2|STARTED|Overall Study||51
8146470|NCT02672514|20076490|P1|STARTED|Overall Study||53
8146471|NCT02672423|20076499|P10|NOT COMPLETED|Period 3||0
8146472|NCT02672423|20076500|P9|NOT COMPLETED|Period 3||0
8146473|NCT02672423|20076501|P8|NOT COMPLETED|Period 3||1
8146474|NCT02672423|20076502|P7|NOT COMPLETED|Period 3||0
8146475|NCT02672423|20076503|P6|NOT COMPLETED|Period 3||1
8146476|NCT02672423|20076504|P5|NOT COMPLETED|Period 3||0
8146477|NCT02672423|20076505|P4|NOT COMPLETED|Period 3||0
8146478|NCT02672423|20076506|P3|NOT COMPLETED|Period 3||0
8146479|NCT02672423|20076507|P2|NOT COMPLETED|Period 3||0
8146480|NCT02672423|20076508|P1|NOT COMPLETED|Period 3||0
8146481|NCT02672423|20076499|P10|COMPLETED|Period 3||0
8146482|NCT02672423|20076500|P9|COMPLETED|Period 3||0
8146483|NCT02672423|20076501|P8|COMPLETED|Period 3||14
8146484|NCT02672423|20076502|P7|COMPLETED|Period 3||15
8146485|NCT02672423|20076503|P6|COMPLETED|Period 3||14
8146486|NCT02672423|20076504|P5|COMPLETED|Period 3||14
8146487|NCT02672423|20076505|P4|COMPLETED|Period 3||15
8146488|NCT02672423|20076506|P3|COMPLETED|Period 3||13
8146489|NCT02672423|20076507|P2|COMPLETED|Period 3||0
8146490|NCT02672423|20076508|P1|COMPLETED|Period 3||0
8146491|NCT02672423|20076499|P10|STARTED|Period 3|Part C was a 2-period study design.|0
8146492|NCT02672423|20076500|P9|STARTED|Period 3|Part C was a 2-period study design.|0
8146493|NCT02672423|20076501|P8|STARTED|Period 3||15
8146494|NCT02672423|20076502|P7|STARTED|Period 3||15
8146495|NCT02672423|20076503|P6|STARTED|Period 3||15
8146496|NCT02672423|20076504|P5|STARTED|Period 3||14
8146497|NCT02672423|20076505|P4|STARTED|Period 3||15
8146498|NCT02672423|20076506|P3|STARTED|Period 3||13
8146499|NCT02672423|20076507|P2|STARTED|Period 3|Part A was a 2-period study design.|0
8146500|NCT02672423|20076508|P1|STARTED|Period 3|Part A was a 2-period study design.|0
8146501|NCT02672423|20076499|P10|NOT COMPLETED|Washout 2||0
8146502|NCT02672423|20076500|P9|NOT COMPLETED|Washout 2||0
8146503|NCT02672423|20076501|P8|NOT COMPLETED|Washout 2||0
8146504|NCT02672423|20076502|P7|NOT COMPLETED|Washout 2||0
8146505|NCT02672423|20076503|P6|NOT COMPLETED|Washout 2||0
8146506|NCT02672423|20076504|P5|NOT COMPLETED|Washout 2||0
8146507|NCT02672423|20076505|P4|NOT COMPLETED|Washout 2||0
8146508|NCT02672423|20076506|P3|NOT COMPLETED|Washout 2||0
8146509|NCT02672423|20076507|P2|NOT COMPLETED|Washout 2||0
8146510|NCT02672423|20076508|P1|NOT COMPLETED|Washout 2||0
8146511|NCT02672423|20076499|P10|COMPLETED|Washout 2||12
8146512|NCT02672423|20076500|P9|COMPLETED|Washout 2||12
8146513|NCT02672423|20076501|P8|COMPLETED|Washout 2||15
8146514|NCT02672423|20076502|P7|COMPLETED|Washout 2||15
8146515|NCT02672423|20076503|P6|COMPLETED|Washout 2||15
8146516|NCT02672423|20076504|P5|COMPLETED|Washout 2||14
8146517|NCT02672423|20076505|P4|COMPLETED|Washout 2||15
8146518|NCT02672423|20076506|P3|COMPLETED|Washout 2||13
8146519|NCT02672423|20076507|P2|COMPLETED|Washout 2||7
8146520|NCT02672423|20076508|P1|COMPLETED|Washout 2||7
8146521|NCT02672423|20076499|P10|STARTED|Washout 2||12
8146522|NCT02672423|20076500|P9|STARTED|Washout 2||12
8146523|NCT02672423|20076501|P8|STARTED|Washout 2||15
8146524|NCT02672423|20076502|P7|STARTED|Washout 2||15
8146525|NCT02672423|20076503|P6|STARTED|Washout 2||15
8146526|NCT02672423|20076504|P5|STARTED|Washout 2||14
8146527|NCT02672423|20076505|P4|STARTED|Washout 2||15
8146528|NCT02672423|20076506|P3|STARTED|Washout 2||13
8146529|NCT02672423|20076507|P2|STARTED|Washout 2||7
8146530|NCT02672423|20076508|P1|STARTED|Washout 2||7
8146531|NCT02672423|20076499|P10|NOT COMPLETED|Period 2||0
8146532|NCT02672423|20076500|P9|NOT COMPLETED|Period 2||0
8146533|NCT02672423|20076501|P8|NOT COMPLETED|Period 2||0
8146534|NCT02672423|20076502|P7|NOT COMPLETED|Period 2||0
8146535|NCT02672423|20076503|P6|NOT COMPLETED|Period 2||0
8146536|NCT02672423|20076504|P5|NOT COMPLETED|Period 2||0
8146537|NCT02672423|20076505|P4|NOT COMPLETED|Period 2||0
8146538|NCT02672423|20076506|P3|NOT COMPLETED|Period 2||1
8146539|NCT02672423|20076507|P2|NOT COMPLETED|Period 2||0
8146540|NCT02672423|20076508|P1|NOT COMPLETED|Period 2||0
8146541|NCT02672423|20076499|P10|COMPLETED|Period 2||12
8146542|NCT02672423|20076500|P9|COMPLETED|Period 2||12
8146543|NCT02672423|20076501|P8|COMPLETED|Period 2||15
8146544|NCT02672423|20076502|P7|COMPLETED|Period 2||15
8146545|NCT02672423|20076503|P6|COMPLETED|Period 2||15
8146546|NCT02672423|20076504|P5|COMPLETED|Period 2||14
8146547|NCT02672423|20076505|P4|COMPLETED|Period 2||15
8146548|NCT02672423|20076506|P3|COMPLETED|Period 2||13
8146549|NCT02672423|20076507|P2|COMPLETED|Period 2||7
8146550|NCT02672423|20076508|P1|COMPLETED|Period 2||7
8146551|NCT02672423|20076499|P10|STARTED|Period 2||12
8146552|NCT02672423|20076500|P9|STARTED|Period 2||12
8146553|NCT02672423|20076501|P8|STARTED|Period 2||15
8146554|NCT02672423|20076502|P7|STARTED|Period 2||15
8146555|NCT02672423|20076503|P6|STARTED|Period 2||15
8146556|NCT02672423|20076504|P5|STARTED|Period 2||14
8146557|NCT02672423|20076505|P4|STARTED|Period 2||15
8146558|NCT02672423|20076506|P3|STARTED|Period 2||14
8146559|NCT02672423|20076507|P2|STARTED|Period 2||7
8146560|NCT02672423|20076508|P1|STARTED|Period 2||7
8146561|NCT02672423|20076499|P10|NOT COMPLETED|Washout 1||0
8146562|NCT02672423|20076500|P9|NOT COMPLETED|Washout 1||0
8146563|NCT02672423|20076501|P8|NOT COMPLETED|Washout 1||0
8146564|NCT02672423|20076502|P7|NOT COMPLETED|Washout 1||0
8146565|NCT02672423|20076503|P6|NOT COMPLETED|Washout 1||0
8146566|NCT02672423|20076504|P5|NOT COMPLETED|Washout 1||0
8146567|NCT02672423|20076505|P4|NOT COMPLETED|Washout 1||0
8146568|NCT02672423|20076506|P3|NOT COMPLETED|Washout 1||0
8146569|NCT02672423|20076507|P2|NOT COMPLETED|Washout 1||0
8146570|NCT02672423|20076508|P1|NOT COMPLETED|Washout 1||0
8146571|NCT02672423|20076499|P10|COMPLETED|Washout 1||12
8146572|NCT02672423|20076500|P9|COMPLETED|Washout 1||12
8146573|NCT02672423|20076501|P8|COMPLETED|Washout 1||15
8146574|NCT02672423|20076502|P7|COMPLETED|Washout 1||15
8146575|NCT02672423|20076503|P6|COMPLETED|Washout 1||15
8146576|NCT02672423|20076504|P5|COMPLETED|Washout 1||14
8146577|NCT02672423|20076505|P4|COMPLETED|Washout 1||15
8146578|NCT02672423|20076506|P3|COMPLETED|Washout 1||14
8146579|NCT02672423|20076507|P2|COMPLETED|Washout 1||7
8146580|NCT02672423|20076508|P1|COMPLETED|Washout 1||7
8146581|NCT02672423|20076499|P10|STARTED|Washout 1||12
8146582|NCT02672423|20076500|P9|STARTED|Washout 1||12
8146583|NCT02672423|20076501|P8|STARTED|Washout 1||15
8146584|NCT02672423|20076502|P7|STARTED|Washout 1||15
8146585|NCT02672423|20076503|P6|STARTED|Washout 1||15
8146586|NCT02672423|20076504|P5|STARTED|Washout 1||14
8146587|NCT02672423|20076505|P4|STARTED|Washout 1||15
8146588|NCT02672423|20076506|P3|STARTED|Washout 1||14
8146589|NCT02672423|20076507|P2|STARTED|Washout 1||7
8146590|NCT02672423|20076508|P1|STARTED|Washout 1||7
8146591|NCT02672423|20076499|P10|NOT COMPLETED|Period 1||0
8146592|NCT02672423|20076500|P9|NOT COMPLETED|Period 1||0
8146593|NCT02672423|20076501|P8|NOT COMPLETED|Period 1||0
8146594|NCT02672423|20076502|P7|NOT COMPLETED|Period 1||0
8146595|NCT02672423|20076503|P6|NOT COMPLETED|Period 1||0
8146596|NCT02672423|20076504|P5|NOT COMPLETED|Period 1||1
8146597|NCT02672423|20076505|P4|NOT COMPLETED|Period 1||0
8146598|NCT02672423|20076506|P3|NOT COMPLETED|Period 1||0
8146599|NCT02672423|20076507|P2|NOT COMPLETED|Period 1||0
8146600|NCT02672423|20076508|P1|NOT COMPLETED|Period 1||0
8146601|NCT02672423|20076499|P10|COMPLETED|Period 1||12
8146602|NCT02672423|20076500|P9|COMPLETED|Period 1||12
8146603|NCT02672423|20076501|P8|COMPLETED|Period 1||15
8146604|NCT02672423|20076502|P7|COMPLETED|Period 1||15
8146605|NCT02672423|20076503|P6|COMPLETED|Period 1||15
8146606|NCT02672423|20076504|P5|COMPLETED|Period 1||14
8146607|NCT02672423|20076505|P4|COMPLETED|Period 1||15
8146608|NCT02672423|20076506|P3|COMPLETED|Period 1||14
8146609|NCT02672423|20076507|P2|COMPLETED|Period 1||7
8146610|NCT02672423|20076508|P1|COMPLETED|Period 1||7
8146611|NCT02672423|20076499|P10|Received at Least One Dose of Study Drug|Period 1||12
8146612|NCT02672423|20076500|P9|Received at Least One Dose of Study Drug|Period 1||12
8146613|NCT02672423|20076501|P8|Received at Least One Dose of Study Drug|Period 1||15
8146614|NCT02672423|20076502|P7|Received at Least One Dose of Study Drug|Period 1||15
8146615|NCT02672423|20076503|P6|Received at Least One Dose of Study Drug|Period 1||15
8146616|NCT02672423|20076504|P5|Received at Least One Dose of Study Drug|Period 1||15
8146617|NCT02672423|20076505|P4|Received at Least One Dose of Study Drug|Period 1||15
8146618|NCT02672423|20076506|P3|Received at Least One Dose of Study Drug|Period 1||14
8146619|NCT02672423|20076507|P2|Received at Least One Dose of Study Drug|Period 1||7
8146620|NCT02672423|20076508|P1|Received at Least One Dose of Study Drug|Period 1||7
8146621|NCT02672423|20076499|P10|STARTED|Period 1||12
8146622|NCT02672423|20076500|P9|STARTED|Period 1||12
8146623|NCT02672423|20076501|P8|STARTED|Period 1||15
8146624|NCT02672423|20076502|P7|STARTED|Period 1||15
8146625|NCT02672423|20076503|P6|STARTED|Period 1||15
8146626|NCT02672423|20076504|P5|STARTED|Period 1||15
8146627|NCT02672423|20076505|P4|STARTED|Period 1||15
8146628|NCT02672423|20076506|P3|STARTED|Period 1||14
8146629|NCT02672423|20076507|P2|STARTED|Period 1||7
8146630|NCT02672423|20076508|P1|STARTED|Period 1||7
8146631|NCT02672176|20076533|P2|NOT COMPLETED|Overall Study||26
8146632|NCT02672176|20076534|P1|NOT COMPLETED|Overall Study||6
8146633|NCT02672176|20076533|P2|COMPLETED|Overall Study||132
8146634|NCT02672176|20076534|P1|COMPLETED|Overall Study||155
8146635|NCT02672176|20076533|P2|STARTED|Overall Study||158
8146636|NCT02672176|20076534|P1|STARTED|Overall Study||161
8146637|NCT02672111|20076570|P2|NOT COMPLETED|Overall Study||12
8146638|NCT02672111|20076571|P1|NOT COMPLETED|Overall Study||58
8146639|NCT02672111|20076570|P2|COMPLETED|Overall Study||25
8146640|NCT02672111|20076571|P1|COMPLETED|Overall Study||132
8146641|NCT02672111|20076570|P2|Completed Treatment|Overall Study||29
8146642|NCT02672111|20076571|P1|Completed Treatment|Overall Study||138
8146643|NCT02672111|20076570|P2|STARTED|Overall Study||37
8146644|NCT02672111|20076571|P1|STARTED|Overall Study||190
8146645|NCT02672033|20076593|P1|NOT COMPLETED|Overall Study||0
8146646|NCT02672033|20076593|P1|COMPLETED|Overall Study||2
8146647|NCT02672033|20076593|P1|STARTED|Overall Study||2
8146648|NCT02671760|20076603|P3|NOT COMPLETED|Overall Study||0
8146649|NCT02671760|20076604|P2|NOT COMPLETED|Overall Study||1
8146650|NCT02671760|20076605|P1|NOT COMPLETED|Overall Study||0
8146651|NCT02671760|20076603|P3|COMPLETED|Overall Study||13
8146652|NCT02671760|20076604|P2|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
8146653|NCT02671760|20076605|P1|COMPLETED|Overall Study||13
8146654|NCT02671760|20076603|P3|STARTED|Overall Study||13
8146655|NCT02671760|20076604|P2|STARTED|Overall Study||13
8146656|NCT02671760|20076605|P1|STARTED|Overall Study||13
8146657|NCT02671500|20076631|P1|NOT COMPLETED|Overall Study||14
8146658|NCT02671500|20076631|P1|COMPLETED|Overall Study||361
8146659|NCT02671500|20076631|P1|STARTED|Overall Study||375
8146660|NCT02671461|20076646|P3|NOT COMPLETED|Follow-up||1
8146661|NCT02671461|20076647|P2|NOT COMPLETED|Follow-up||1
8146662|NCT02671461|20076648|P1|NOT COMPLETED|Follow-up||1
8146663|NCT02671461|20076646|P3|COMPLETED|Follow-up||6
8146664|NCT02671461|20076647|P2|COMPLETED|Follow-up||4
8146665|NCT02671461|20076648|P1|COMPLETED|Follow-up||1
8146666|NCT02671461|20076646|P3|STARTED|Follow-up||7
8146667|NCT02671461|20076647|P2|STARTED|Follow-up||5
8146668|NCT02671461|20076648|P1|STARTED|Follow-up||2
8146669|NCT02671461|20076646|P3|NOT COMPLETED|Treatment||5
8146670|NCT02671461|20076647|P2|NOT COMPLETED|Treatment||3
8146671|NCT02671461|20076648|P1|NOT COMPLETED|Treatment||2
8146672|NCT02671461|20076646|P3|COMPLETED|Treatment||2
8146673|NCT02671461|20076647|P2|COMPLETED|Treatment||2
8146674|NCT02671461|20076648|P1|COMPLETED|Treatment||1
8146675|NCT02671461|20076646|P3|STARTED|Treatment||7
8146676|NCT02671461|20076647|P2|STARTED|Treatment||5
8146677|NCT02671461|20076648|P1|STARTED|Treatment||3
8146678|NCT02671422|20076671|P1|NOT COMPLETED|Overall Study||260
8146679|NCT02671422|20076671|P1|COMPLETED|Overall Study||0
8146680|NCT02671422|20076671|P1|Not Treated With Vargatef®|Overall Study||3
8146681|NCT02671422|20076671|P1|STARTED|Overall Study||260
8146682|NCT02671266|20076677|P2|NOT COMPLETED|Overall Study||1
8146683|NCT02671266|20076678|P1|NOT COMPLETED|Overall Study||1
8146684|NCT02671266|20076677|P2|COMPLETED|Overall Study||20
8146685|NCT02671266|20076678|P1|COMPLETED|Overall Study||19
8146686|NCT02671266|20076677|P2|Healthy Participants|Overall Study||8
8146687|NCT02671266|20076678|P1|Healthy Participants|Overall Study||8
8146688|NCT02671266|20076677|P2|OCD Participants|Overall Study||3
8146689|NCT02671266|20076678|P1|OCD Participants|Overall Study||2
8146690|NCT02671266|20076677|P2|BDD Participants|Overall Study||9
8146691|NCT02671266|20076678|P1|BDD Participants|Overall Study||9
8146692|NCT02671266|20076677|P2|STARTED|Overall Study||21
8146693|NCT02671266|20076678|P1|STARTED|Overall Study||20
8146694|NCT02671136|20076692|P2|NOT COMPLETED|Overall Study||0
8146695|NCT02671136|20076693|P1|NOT COMPLETED|Overall Study||0
8146696|NCT02671136|20076692|P2|COMPLETED|Overall Study||0
8146697|NCT02671136|20076693|P1|COMPLETED|Overall Study||3
8146698|NCT02671136|20076692|P2|STARTED|Overall Study||0
8146699|NCT02671136|20076693|P1|STARTED|Overall Study||3
8146703|NCT02670928|20076709|P2|NOT COMPLETED|Overall Study||1
8146704|NCT02670928|20076710|P1|NOT COMPLETED|Overall Study||10
8146705|NCT02670928|20076709|P2|COMPLETED|Overall Study||29
8146706|NCT02670928|20076710|P1|COMPLETED|Overall Study||90
8146707|NCT02670928|20076709|P2|STARTED|Overall Study||30
8146708|NCT02670928|20076710|P1|STARTED|Overall Study||100
8146709|NCT02670915|20076737|P3|NOT COMPLETED|Overall Study||5
8146710|NCT02670915|20076738|P2|NOT COMPLETED|Overall Study||8
8146711|NCT02670915|20076739|P1|NOT COMPLETED|Overall Study||4
8146712|NCT02670915|20076737|P3|COMPLETED|Overall Study||253
8146713|NCT02670915|20076738|P2|COMPLETED|Overall Study||251
8146714|NCT02670915|20076739|P1|COMPLETED|Overall Study||256
8146715|NCT02670915|20076737|P3|STARTED|Overall Study||258
8146716|NCT02670915|20076738|P2|STARTED|Overall Study||259
8146717|NCT02670915|20076739|P1|STARTED|Overall Study||260
8146718|NCT02670811|20076986|P2|NOT COMPLETED|Overall Study||0
8146719|NCT02670811|20076987|P1|NOT COMPLETED|Overall Study||1
8146720|NCT02670811|20076986|P2|COMPLETED|Overall Study||18
8146721|NCT02670811|20076987|P1|COMPLETED|Overall Study||17
8146722|NCT02670811|20076986|P2|STARTED|Overall Study||18
8146723|NCT02670811|20076987|P1|STARTED|Overall Study||18
8146724|NCT02670629|20077005|P2|NOT COMPLETED|Overall Study||0
8146725|NCT02670629|20077006|P1|NOT COMPLETED|Overall Study||0
8146726|NCT02670629|20077005|P2|COMPLETED|Overall Study||29
8146727|NCT02670629|20077006|P1|COMPLETED|Overall Study||29
8146728|NCT02670629|20077005|P2|STARTED|Overall Study||29
8146729|NCT02670629|20077006|P1|STARTED|Overall Study||29
8146730|NCT02670551|20077023|P3|NOT COMPLETED|Overall Study||31
8146731|NCT02670551|20077024|P2|NOT COMPLETED|Overall Study||26
8146732|NCT02670551|20077025|P1|NOT COMPLETED|Overall Study||28
8146733|NCT02670551|20077023|P3|COMPLETED|Overall Study||134
8146734|NCT02670551|20077024|P2|COMPLETED|Overall Study||134
8146735|NCT02670551|20077025|P1|COMPLETED|Overall Study||135
8146736|NCT02670551|20077023|P3|Received Treatment (Safety Population)|Overall Study||165
8146737|NCT02670551|20077024|P2|Received Treatment (Safety Population)|Overall Study||157
8146738|NCT02670551|20077025|P1|Received Treatment (Safety Population)|Overall Study||158
8146739|NCT02670551|20077023|P3|STARTED|Overall Study||165
8146740|NCT02670551|20077024|P2|STARTED|Overall Study||160
8146741|NCT02670551|20077025|P1|STARTED|Overall Study||163
8146742|NCT02670538|20077039|P3|NOT COMPLETED|Overall Study||30
8146743|NCT02670538|20077040|P2|NOT COMPLETED|Overall Study||32
8146744|NCT02670538|20077041|P1|NOT COMPLETED|Overall Study||32
8146745|NCT02670538|20077039|P3|COMPLETED|Overall Study||128
8146746|NCT02670538|20077040|P2|COMPLETED|Overall Study||136
8146747|NCT02670538|20077041|P1|COMPLETED|Overall Study||135
8146748|NCT02670538|20077039|P3|Intent-to-Treat Population|Overall Study||153
8146749|NCT02670538|20077040|P2|Intent-to-Treat Population|Overall Study||162
8146750|NCT02670538|20077041|P1|Intent-to-Treat Population|Overall Study||163
8146751|NCT02670538|20077039|P3|Safety Population : Received Study Drug|Overall Study||158
8146752|NCT02670538|20077040|P2|Safety Population : Received Study Drug|Overall Study||167
8146753|NCT02670538|20077041|P1|Safety Population : Received Study Drug|Overall Study||165
8146754|NCT02670538|20077039|P3|STARTED|Overall Study||158
8146755|NCT02670538|20077040|P2|STARTED|Overall Study||168
8146756|NCT02670538|20077041|P1|STARTED|Overall Study||167
8146757|NCT02670473|20077052|P1|NOT COMPLETED|Overall Study||1
8146758|NCT02670473|20077052|P1|COMPLETED|Overall Study||34
8146759|NCT02670473|20077052|P1|STARTED|Overall Study||35
8146760|NCT02670343|20077105|P1|NOT COMPLETED|Overall Study||0
8146761|NCT02670343|20077105|P1|COMPLETED|Overall Study||8
8146762|NCT02670343|20077105|P1|STARTED|Overall Study||8
8146763|NCT02670330|20077111|P2|NOT COMPLETED|Overall Study||77
8146764|NCT02670330|20077112|P1|NOT COMPLETED|Overall Study||75
8146765|NCT02670330|20077111|P2|COMPLETED|Overall Study||0
8146766|NCT02670330|20077112|P1|COMPLETED|Overall Study||0
8146767|NCT02670330|20077111|P2|Received At Least 1 Dose Of Study Drug|Overall Study||77
8146768|NCT02670330|20077112|P1|Received At Least 1 Dose Of Study Drug|Overall Study||75
8146769|NCT02670330|20077111|P2|STARTED|Overall Study||77
8146770|NCT02670330|20077112|P1|STARTED|Overall Study||75
8146771|NCT02670083|20077124|P2|NOT COMPLETED|Overall Study||319
8146772|NCT02670083|20077125|P1|NOT COMPLETED|Overall Study||321
8146773|NCT02670083|20077124|P2|COMPLETED|Overall Study||85
8146774|NCT02670083|20077125|P1|COMPLETED|Overall Study||88
8146775|NCT02670083|20077124|P2|STARTED|Overall Study||404
8146776|NCT02670083|20077125|P1|STARTED|Overall Study||409
8146777|NCT02669940|20077170|P2|NOT COMPLETED|Overall Study||3
8146778|NCT02669940|20077171|P1|NOT COMPLETED|Overall Study||1
8146779|NCT02669940|20077170|P2|COMPLETED|Overall Study||92
8146780|NCT02669940|20077171|P1|COMPLETED|Overall Study||62
8146781|NCT02669940|20077170|P2|STARTED|Overall Study||95
8146782|NCT02669940|20077171|P1|STARTED|Overall Study||63
8146783|NCT02669914|20077227|P3|NOT COMPLETED|Overall Study||0
8146784|NCT02669914|20077228|P2|NOT COMPLETED|Overall Study||0
8146785|NCT02669914|20077229|P1|NOT COMPLETED|Overall Study||0
8146786|NCT02669914|20077227|P3|COMPLETED|Overall Study||0
8146787|NCT02669914|20077228|P2|COMPLETED|Overall Study||0
8146788|NCT02669914|20077229|P1|COMPLETED|Overall Study||4
8146789|NCT02669914|20077227|P3|STARTED|Overall Study||0
8146790|NCT02669914|20077228|P2|STARTED|Overall Study||0
8146791|NCT02669914|20077229|P1|STARTED|Overall Study||4
8146792|NCT02669862|20077273|P3|NOT COMPLETED|Overall Study||5
8146793|NCT02669862|20077274|P2|NOT COMPLETED|Overall Study||5
8146794|NCT02669862|20077275|P1|NOT COMPLETED|Overall Study||2
8146795|NCT02669862|20077273|P3|COMPLETED|Overall Study||26
8146796|NCT02669862|20077274|P2|COMPLETED|Overall Study||29
8146797|NCT02669862|20077275|P1|COMPLETED|Overall Study||31
8146798|NCT02669862|20077273|P3|STARTED|Overall Study||31
8146799|NCT02669862|20077274|P2|STARTED|Overall Study||34
8146800|NCT02669862|20077275|P1|STARTED|Overall Study||33
8146801|NCT02669849|20077291|P3|NOT COMPLETED|Overall Study||24
8146802|NCT02669849|20077292|P2|NOT COMPLETED|Overall Study||2
8146803|NCT02669849|20077293|P1|NOT COMPLETED|Overall Study||18
8146804|NCT02669849|20077291|P3|COMPLETED|Overall Study||8
8146805|NCT02669849|20077292|P2|COMPLETED|Overall Study||4
8146806|NCT02669849|20077293|P1|COMPLETED|Overall Study||11
8146807|NCT02669849|20077291|P3|STARTED|Overall Study||32
8146808|NCT02669849|20077292|P2|STARTED|Overall Study||6
8146809|NCT02669849|20077293|P1|STARTED|Overall Study||29
8146810|NCT02669784|20077315|P2|NOT COMPLETED|Overall Study||0
8146811|NCT02669784|20077316|P1|NOT COMPLETED|Overall Study||0
8146812|NCT02669784|20077315|P2|COMPLETED|Overall Study||16
8146813|NCT02669784|20077316|P1|COMPLETED|Overall Study||18
8146814|NCT02669784|20077315|P2|STARTED|Overall Study||16
8146815|NCT02669784|20077316|P1|STARTED|Overall Study||18
8146816|NCT02669758|20077336|P1|NOT COMPLETED|Overall Study||94
8146817|NCT02669758|20077336|P1|COMPLETED|Overall Study||183
8146818|NCT02669758|20077336|P1|STARTED|Overall Study||277
8146819|NCT02669667|20077347|P7|NOT COMPLETED|Overall Study||0
8146820|NCT02669667|20077348|P6|NOT COMPLETED|Overall Study||1
8146821|NCT02669667|20077349|P5|NOT COMPLETED|Overall Study||0
8146822|NCT02669667|20077350|P4|NOT COMPLETED|Overall Study||0
8146823|NCT02669667|20077351|P3|NOT COMPLETED|Overall Study||0
8146824|NCT02669667|20077352|P2|NOT COMPLETED|Overall Study||0
8146825|NCT02669667|20077353|P1|NOT COMPLETED|Overall Study||0
8146826|NCT02669667|20077347|P7|COMPLETED|Overall Study||6
8146827|NCT02669667|20077348|P6|COMPLETED|Overall Study||5
8146828|NCT02669667|20077349|P5|COMPLETED|Overall Study||6
8146829|NCT02669667|20077350|P4|COMPLETED|Overall Study||6
8146830|NCT02669667|20077351|P3|COMPLETED|Overall Study||4
8146831|NCT02669667|20077352|P2|COMPLETED|Overall Study||4
8146832|NCT02669667|20077353|P1|COMPLETED|Overall Study||12
8146833|NCT02669667|20077347|P7|STARTED|Overall Study||6
8146834|NCT02669667|20077348|P6|STARTED|Overall Study||6
8146835|NCT02669667|20077349|P5|STARTED|Overall Study||6
8146836|NCT02669667|20077350|P4|STARTED|Overall Study||6
8146837|NCT02669667|20077351|P3|STARTED|Overall Study||4
8146838|NCT02669667|20077352|P2|STARTED|Overall Study||4
8146839|NCT02669667|20077353|P1|STARTED|Overall Study||12
8146840|NCT02669615|20077447|P1|NOT COMPLETED|Overall Study||0
8146841|NCT02669615|20077447|P1|COMPLETED|Overall Study||24
8146842|NCT02669615|20077447|P1|STARTED|Overall Study||24
8146843|NCT02669433|20077456|P3|NOT COMPLETED|Overall Study||15
8146844|NCT02669433|20077457|P2|NOT COMPLETED|Overall Study||14
8146845|NCT02669433|20077458|P1|NOT COMPLETED|Overall Study||15
8146846|NCT02669433|20077456|P3|COMPLETED|Overall Study||74
8146847|NCT02669433|20077457|P2|COMPLETED|Overall Study||75
8146848|NCT02669433|20077458|P1|COMPLETED|Overall Study||76
8146849|NCT02669433|20077456|P3|UPDRS Primary Population|Overall Study||84
8146850|NCT02669433|20077457|P2|UPDRS Primary Population|Overall Study||87
8146851|NCT02669433|20077458|P1|UPDRS Primary Population|Overall Study||87
8146852|NCT02669433|20077456|P3|Completers Population|Overall Study||69
8146853|NCT02669433|20077457|P2|Completers Population|Overall Study||72
8146854|NCT02669433|20077458|P1|Completers Population|Overall Study||73
8146855|NCT02669433|20077456|P3|Per-Protocol Population|Overall Study||82
8146856|NCT02669433|20077457|P2|Per-Protocol Population|Overall Study||79
8146857|NCT02669433|20077458|P1|Per-Protocol Population|Overall Study||78
8146858|NCT02669433|20077456|P3|Intent to Treat (ITT) Population|Overall Study||87
8146859|NCT02669433|20077457|P2|Intent to Treat (ITT) Population|Overall Study||89
8146860|NCT02669433|20077458|P1|Intent to Treat (ITT) Population|Overall Study||89
8146861|NCT02669433|20077456|P3|Safety Population|Overall Study||88
8146862|NCT02669433|20077457|P2|Safety Population|Overall Study||89
8146863|NCT02669433|20077458|P1|Safety Population|Overall Study||91
8146864|NCT02669433|20077456|P3|STARTED|Overall Study||89
8146865|NCT02669433|20077457|P2|STARTED|Overall Study||89
8146866|NCT02669433|20077458|P1|STARTED|Overall Study||91
8146867|NCT02669407|20077472|P1|NOT COMPLETED|Overall Study||3
8146868|NCT02669407|20077472|P1|COMPLETED|Overall Study||11
8146869|NCT02669407|20077472|P1|STARTED|Overall Study||14
8146870|NCT02669329|20077489|P1|NOT COMPLETED|Overall Study||0
8146871|NCT02669329|20077489|P1|COMPLETED|Overall Study||30
8146872|NCT02669329|20077489|P1|STARTED|Overall Study||30
8146894|NCT02669095|20077653|P2|NOT COMPLETED|Overall Study||3
8146895|NCT02669095|20077654|P1|NOT COMPLETED|Overall Study||1
8146896|NCT02669095|20077653|P2|COMPLETED|Overall Study||72
8146897|NCT02669095|20077654|P1|COMPLETED|Overall Study||74
8146898|NCT02669095|20077653|P2|STARTED|Overall Study||75
8146899|NCT02669095|20077654|P1|STARTED|Overall Study||75
8146900|NCT02669082|20077662|P1|NOT COMPLETED|Overall Study||1
8146901|NCT02669082|20077662|P1|COMPLETED|Overall Study||25
8146902|NCT02669082|20077662|P1|STARTED|Overall Study||26
8146903|NCT02669043|20077674|P1|NOT COMPLETED|Overall Study||4
8146904|NCT02669043|20077674|P1|COMPLETED|Overall Study||4
8146905|NCT02669043|20077674|P1|STARTED|Overall Study||8
8146933|NCT02668952|20077819|P2|NOT COMPLETED|Overall Study||0
8146934|NCT02668952|20077820|P1|NOT COMPLETED|Overall Study||0
8146935|NCT02668952|20077819|P2|COMPLETED|Overall Study||14
8146936|NCT02668952|20077820|P1|COMPLETED|Overall Study||16
8146937|NCT02668952|20077819|P2|STARTED|Overall Study||14
8146938|NCT02668952|20077820|P1|STARTED|Overall Study||16
8146939|NCT02668822|20077840|P2|NOT COMPLETED|Overall Study||9
8146940|NCT02668822|20077841|P1|NOT COMPLETED|Overall Study||9
8146941|NCT02668822|20077840|P2|COMPLETED|Overall Study||0
8146942|NCT02668822|20077841|P1|COMPLETED|Overall Study||0
8146943|NCT02668822|20077840|P2|STARTED|Overall Study||9
8146944|NCT02668822|20077841|P1|STARTED|Overall Study||9
8146945|NCT02668783|20077863|P2|NOT COMPLETED|Overall Study||12
8146946|NCT02668783|20077864|P1|NOT COMPLETED|Overall Study||13
8146947|NCT02668783|20077863|P2|COMPLETED|Overall Study||0
8146948|NCT02668783|20077864|P1|COMPLETED|Overall Study||0
8146949|NCT02668783|20077863|P2|Treated|Overall Study||11
8146950|NCT02668783|20077864|P1|Treated|Overall Study||13
8146951|NCT02668783|20077863|P2|STARTED|Overall Study||12
8146952|NCT02668783|20077864|P1|STARTED|Overall Study||13
8146953|NCT02668640|20077884|P1|NOT COMPLETED|Overall Study||14
8146954|NCT02668640|20077884|P1|COMPLETED|Overall Study||41
8146955|NCT02668640|20077884|P1|STARTED|Overall Study||55
8146956|NCT02668432|20077897|P2|NOT COMPLETED|Overall Study||0
8146957|NCT02668432|20077898|P1|NOT COMPLETED|Overall Study||0
8146958|NCT02668432|20077897|P2|COMPLETED|Overall Study||4
8146959|NCT02668432|20077898|P1|COMPLETED|Overall Study||5
8146960|NCT02668432|20077897|P2|STARTED|Overall Study||4
8146961|NCT02668432|20077898|P1|STARTED|Overall Study||5
8146962|NCT02668302|20077936|P2|NOT COMPLETED|Overall Study||0
8146963|NCT02668302|20077937|P1|NOT COMPLETED|Overall Study||1
8146964|NCT02668302|20077936|P2|COMPLETED|Overall Study||20
8146965|NCT02668302|20077937|P1|COMPLETED|Overall Study||19
8146966|NCT02668302|20077936|P2|STARTED|Overall Study||20
8146967|NCT02668302|20077937|P1|STARTED|Overall Study||20
8146968|NCT02668198|20077943|P1|NOT COMPLETED|Overall Study||0
8146969|NCT02668198|20077943|P1|COMPLETED|Overall Study||230
8146970|NCT02668198|20077943|P1|STARTED|Overall Study||230
8146971|NCT02667951|20077957|P2|NOT COMPLETED|Overall Study||23
8146972|NCT02667951|20077958|P1|NOT COMPLETED|Overall Study||21
8146973|NCT02667951|20077957|P2|COMPLETED|Overall Study||40
8146974|NCT02667951|20077958|P1|COMPLETED|Overall Study||45
8146975|NCT02667951|20077957|P2|STARTED|Overall Study||63
8146976|NCT02667951|20077958|P1|STARTED|Overall Study||66
8146977|NCT02667912|20077976|P2|NOT COMPLETED|Overall Study||3
8146978|NCT02667912|20077977|P1|NOT COMPLETED|Overall Study||5
8146979|NCT02667912|20077976|P2|COMPLETED|Overall Study||24
8146980|NCT02667912|20077977|P1|COMPLETED|Overall Study||23
8146981|NCT02667912|20077976|P2|Six Months|Overall Study||24
8146982|NCT02667912|20077977|P1|Six Months|Overall Study||27
8146983|NCT02667912|20077976|P2|STARTED|Overall Study||27
8146984|NCT02667912|20077977|P1|STARTED|Overall Study||28
8146985|NCT02667821|20078029|P1|NOT COMPLETED|Overall Study||0
8146986|NCT02667821|20078029|P1|COMPLETED|Overall Study||20
8146987|NCT02667821|20078029|P1|STARTED|Overall Study||20
8146988|NCT02667704|20078035|P1|NOT COMPLETED|Treatment Period 2||0
8146989|NCT02667704|20078035|P1|COMPLETED|Treatment Period 2||13
8146990|NCT02667704|20078035|P1|STARTED|Treatment Period 2||13
8146991|NCT02667704|20078035|P1|NOT COMPLETED|Treatment Period 1||0
8146992|NCT02667704|20078035|P1|COMPLETED|Treatment Period 1||13
8146993|NCT02667704|20078035|P1|STARTED|Treatment Period 1||13
8146994|NCT02667639|20078048|P2|NOT COMPLETED|Overall Study||0
8146995|NCT02667639|20078049|P1|NOT COMPLETED|Overall Study||0
8146996|NCT02667639|20078048|P2|COMPLETED|Overall Study||10
8146997|NCT02667639|20078049|P1|COMPLETED|Overall Study||25
8146998|NCT02667639|20078048|P2|STARTED|Overall Study||10
8146999|NCT02667639|20078049|P1|STARTED|Overall Study||25
8147000|NCT02667626|20078077|P2|NOT COMPLETED|Overall Study||1
8147001|NCT02667626|20078078|P1|NOT COMPLETED|Overall Study||0
8147002|NCT02667626|20078077|P2|COMPLETED|Overall Study||95
8147003|NCT02667626|20078078|P1|COMPLETED|Overall Study||86
8147004|NCT02667626|20078077|P2|STARTED|Overall Study||96
8147005|NCT02667626|20078078|P1|STARTED|Overall Study||86
8147006|NCT02667457|20078094|P2|NOT COMPLETED|Overall Study||2
8147007|NCT02667457|20078095|P1|NOT COMPLETED|Overall Study||1
8147008|NCT02667457|20078094|P2|COMPLETED|Overall Study||10
8147009|NCT02667457|20078095|P1|COMPLETED|Overall Study||26
8147010|NCT02667457|20078094|P2|Full Analysis Set Population (FAS)|Overall Study||10
8147011|NCT02667457|20078095|P1|Full Analysis Set Population (FAS)|Overall Study||25
8147012|NCT02667457|20078094|P2|Dosed Participants|Overall Study||10
8147013|NCT02667457|20078095|P1|Dosed Participants|Overall Study||26
8147014|NCT02667457|20078094|P2|STARTED|Overall Study||12
8147015|NCT02667457|20078095|P1|STARTED|Overall Study||27
8147016|NCT02667288|20078119|P1|NOT COMPLETED|Overall Study||13
8147017|NCT02667288|20078119|P1|COMPLETED|Overall Study||134
8147018|NCT02667288|20078119|P1|STARTED|Overall Study||147
8147019|NCT02667275|20078126|P2|NOT COMPLETED|Overall Study||15
8147020|NCT02667275|20078127|P1|NOT COMPLETED|Overall Study||11
8147021|NCT02667275|20078126|P2|COMPLETED|Overall Study||228
8147022|NCT02667275|20078127|P1|COMPLETED|Overall Study||233
8147023|NCT02667275|20078126|P2|STARTED|Overall Study||243
8147024|NCT02667275|20078127|P1|STARTED|Overall Study||244
8147025|NCT02667236|20078137|P2|NOT COMPLETED|Overall Study||1
8147026|NCT02667236|20078138|P1|NOT COMPLETED|Overall Study||3
8147027|NCT02667236|20078137|P2|COMPLETED|Overall Study||226
8147028|NCT02667236|20078138|P1|COMPLETED|Overall Study||220
8147029|NCT02667236|20078137|P2|STARTED|Overall Study||227
8147030|NCT02667236|20078138|P1|STARTED|Overall Study||223
8147031|NCT02666950|20078146|P1|NOT COMPLETED|Overall Study||0
8147032|NCT02666950|20078146|P1|COMPLETED|Overall Study||3
8147033|NCT02666950|20078146|P1|STARTED|Overall Study||3
8147034|NCT02666846|20078159|P3|NOT COMPLETED|Overall Study||0
8147035|NCT02666846|20078160|P2|NOT COMPLETED|Overall Study||0
8147036|NCT02666846|20078161|P1|NOT COMPLETED|Overall Study||0
8147037|NCT02666846|20078159|P3|COMPLETED|Overall Study||20
8147038|NCT02666846|20078160|P2|COMPLETED|Overall Study||20
8147039|NCT02666846|20078161|P1|COMPLETED|Overall Study||20
8147040|NCT02666846|20078159|P3|STARTED|Overall Study||20
8147041|NCT02666846|20078160|P2|STARTED|Overall Study||20
8147042|NCT02666846|20078161|P1|STARTED|Overall Study||20
8147043|NCT02666664|20078260|P2|NOT COMPLETED|Overall Study||84
8147044|NCT02666664|20078261|P1|NOT COMPLETED|Overall Study||36
8147045|NCT02666664|20078260|P2|COMPLETED|Overall Study||1404
8147046|NCT02666664|20078261|P1|COMPLETED|Overall Study||706
8147047|NCT02666664|20078260|P2|STARTED|Overall Study||1488
8147048|NCT02666664|20078261|P1|STARTED|Overall Study||742
8147049|NCT02666560|20078325|P2|NOT COMPLETED|Condition 2 (1 Day)||0
8147050|NCT02666560|20078326|P1|NOT COMPLETED|Condition 2 (1 Day)||0
8147051|NCT02666560|20078325|P2|COMPLETED|Condition 2 (1 Day)||11
8147052|NCT02666560|20078326|P1|COMPLETED|Condition 2 (1 Day)||8
8147053|NCT02666560|20078325|P2|STARTED|Condition 2 (1 Day)||11
8147054|NCT02666560|20078326|P1|STARTED|Condition 2 (1 Day)||8
8147055|NCT02666560|20078325|P2|NOT COMPLETED|Condition 1 (1 Day)||0
8147056|NCT02666560|20078326|P1|NOT COMPLETED|Condition 1 (1 Day)||0
8147057|NCT02666560|20078325|P2|COMPLETED|Condition 1 (1 Day)||11
8147058|NCT02666560|20078326|P1|COMPLETED|Condition 1 (1 Day)||8
8147059|NCT02666560|20078325|P2|STARTED|Condition 1 (1 Day)||11
8147060|NCT02666560|20078326|P1|STARTED|Condition 1 (1 Day)||8
8147061|NCT02666508|20078344|P2|NOT COMPLETED|Overall Study||0
8147062|NCT02666508|20078345|P1|NOT COMPLETED|Overall Study||0
8147063|NCT02666508|20078344|P2|COMPLETED|Overall Study||30
8147064|NCT02666508|20078345|P1|COMPLETED|Overall Study||31
8147065|NCT02666508|20078344|P2|STARTED|Overall Study||30
8147066|NCT02666508|20078345|P1|STARTED|Overall Study||31
8147067|NCT02666430|20078359|P2|NOT COMPLETED|Period 3||0
8147068|NCT02666430|20078360|P1|NOT COMPLETED|Period 3||1
8147069|NCT02666430|20078359|P2|COMPLETED|Period 3||58
8147070|NCT02666430|20078360|P1|COMPLETED|Period 3||61
8147071|NCT02666430|20078359|P2|STARTED|Period 3||58
8147072|NCT02666430|20078360|P1|STARTED|Period 3||62
8147073|NCT02666430|20078359|P2|NOT COMPLETED|Period 2||4
8147074|NCT02666430|20078360|P1|NOT COMPLETED|Period 2||1
8147075|NCT02666430|20078359|P2|COMPLETED|Period 2||58
8147076|NCT02666430|20078360|P1|COMPLETED|Period 2||62
8147077|NCT02666430|20078359|P2|STARTED|Period 2||62
8147078|NCT02666430|20078360|P1|STARTED|Period 2||63
8147079|NCT02666430|20078359|P2|NOT COMPLETED|Period 1||1
8147080|NCT02666430|20078360|P1|NOT COMPLETED|Period 1||1
8147081|NCT02666430|20078359|P2|COMPLETED|Period 1||62
8147082|NCT02666430|20078360|P1|COMPLETED|Period 1||63
8147083|NCT02666430|20078359|P2|STARTED|Period 1||63
8147084|NCT02666430|20078360|P1|STARTED|Period 1||64
8147085|NCT02666430|20078359|P2|NOT COMPLETED|Baseline||0
8147086|NCT02666430|20078360|P1|NOT COMPLETED|Baseline||0
8147087|NCT02666430|20078359|P2|COMPLETED|Baseline||63
8147088|NCT02666430|20078360|P1|COMPLETED|Baseline||64
8147089|NCT02666430|20078359|P2|STARTED|Baseline||63
8147090|NCT02666430|20078360|P1|STARTED|Baseline||64
8147091|NCT02666352|20078389|P3|NOT COMPLETED|Overall Study||0
8147092|NCT02666352|20078390|P2|NOT COMPLETED|Overall Study||0
8147093|NCT02666352|20078391|P1|NOT COMPLETED|Overall Study||0
8147094|NCT02666352|20078389|P3|COMPLETED|Overall Study||8
8147095|NCT02666352|20078390|P2|COMPLETED|Overall Study||8
8147096|NCT02666352|20078391|P1|COMPLETED|Overall Study||8
8147097|NCT02666352|20078389|P3|STARTED|Overall Study||8
8147098|NCT02666352|20078390|P2|STARTED|Overall Study||8
8147099|NCT02666352|20078391|P1|STARTED|Overall Study||8
8147100|NCT02666222|20078495|P1|NOT COMPLETED|Overall Study||2
8147101|NCT02666222|20078495|P1|COMPLETED|Overall Study||49
8147102|NCT02666222|20078495|P1|STARTED|Overall Study||51
8147103|NCT02665741|20078506|P3|NOT COMPLETED|Overall Study||0
8147104|NCT02665741|20078507|P2|NOT COMPLETED|Overall Study||0
8147105|NCT02665741|20078508|P1|NOT COMPLETED|Overall Study||0
8147106|NCT02665741|20078506|P3|COMPLETED|Overall Study||42
8147107|NCT02665741|20078507|P2|COMPLETED|Overall Study||42
8147108|NCT02665741|20078508|P1|COMPLETED|Overall Study||42
8147109|NCT02665741|20078506|P3|STARTED|Overall Study||42
8147110|NCT02665741|20078507|P2|STARTED|Overall Study||42
8147111|NCT02665741|20078508|P1|STARTED|Overall Study||42
8147112|NCT02665728|20078525|P1|NOT COMPLETED|Overall Study||0
8147113|NCT02665728|20078525|P1|COMPLETED|Overall Study||33
8147114|NCT02665728|20078525|P1|STARTED|Overall Study||33
8147115|NCT02665689|20078531|P2|NOT COMPLETED|Overall Study||2
8147116|NCT02665689|20078532|P1|NOT COMPLETED|Overall Study||2
8147117|NCT02665689|20078531|P2|COMPLETED|Overall Study||0
8147118|NCT02665689|20078532|P1|COMPLETED|Overall Study||0
8147119|NCT02665689|20078531|P2|STARTED|Overall Study||2
8147120|NCT02665689|20078532|P1|STARTED|Overall Study||2
8147121|NCT02665468|20078554|P2|NOT COMPLETED|Overall Study||0
8147122|NCT02665468|20078555|P1|NOT COMPLETED|Overall Study||0
8147123|NCT02665468|20078554|P2|COMPLETED|Overall Study||601
8147124|NCT02665468|20078555|P1|COMPLETED|Overall Study||595
8147125|NCT02665468|20078554|P2|STARTED|Overall Study||601
8147126|NCT02665468|20078555|P1|STARTED|Overall Study||595
8147127|NCT02665455|20078567|P1|NOT COMPLETED|Overall Study||9
8147128|NCT02665455|20078567|P1|COMPLETED|Overall Study||74
8147129|NCT02665455|20078567|P1|STARTED|Overall Study||83
8147130|NCT02665364|20078573|P2|NOT COMPLETED|Overall Study||9
8147131|NCT02665364|20078574|P1|NOT COMPLETED|Overall Study||6
8147132|NCT02665364|20078573|P2|COMPLETED|Overall Study||84
8147133|NCT02665364|20078574|P1|COMPLETED|Overall Study||85
8147134|NCT02665364|20078573|P2|STARTED|Overall Study||93
8147135|NCT02665364|20078574|P1|STARTED|Overall Study||91
8147136|NCT02665286|20078611|P3|NOT COMPLETED|Overall Study||1
8147137|NCT02665286|20078612|P2|NOT COMPLETED|Overall Study||2
8147138|NCT02665286|20078613|P1|NOT COMPLETED|Overall Study||3
8147139|NCT02665286|20078611|P3|COMPLETED|Overall Study||80
8147140|NCT02665286|20078612|P2|COMPLETED|Overall Study||78
8147141|NCT02665286|20078613|P1|COMPLETED|Overall Study||76
8147142|NCT02665286|20078611|P3|STARTED|Overall Study||81
8147143|NCT02665286|20078612|P2|STARTED|Overall Study||80
8147144|NCT02665286|20078613|P1|STARTED|Overall Study||79
8147145|NCT02665273|20078632|P2|NOT COMPLETED|Overall Study||0
8147146|NCT02665273|20078633|P1|NOT COMPLETED|Overall Study||0
8147147|NCT02665273|20078632|P2|COMPLETED|Overall Study||15
8147148|NCT02665273|20078633|P1|COMPLETED|Overall Study||13
8147149|NCT02665273|20078632|P2|STARTED|Overall Study||15
8147150|NCT02665273|20078633|P1|STARTED|Overall Study||13
8147151|NCT02665260|20078649|P4|NOT COMPLETED|Overall Study||1
8147152|NCT02665260|20078650|P3|NOT COMPLETED|Overall Study||4
8147153|NCT02665260|20078651|P2|NOT COMPLETED|Overall Study||1
8147154|NCT02665260|20078652|P1|NOT COMPLETED|Overall Study||2
8147155|NCT02665260|20078649|P4|COMPLETED|Overall Study||21
8147156|NCT02665260|20078650|P3|COMPLETED|Overall Study||21
8147157|NCT02665260|20078651|P2|COMPLETED|Overall Study||22
8147158|NCT02665260|20078652|P1|COMPLETED|Overall Study||22
8147159|NCT02665260|20078649|P4|STARTED|Overall Study||22
8147160|NCT02665260|20078650|P3|STARTED|Overall Study||25
8147161|NCT02665260|20078651|P2|STARTED|Overall Study||23
8147162|NCT02665260|20078652|P1|STARTED|Overall Study||24
8147163|NCT02665221|20078668|P2|NOT COMPLETED|Overall Study||15
8147164|NCT02665221|20078669|P1|NOT COMPLETED|Overall Study||15
8147165|NCT02665221|20078668|P2|COMPLETED|Overall Study||0
8147166|NCT02665221|20078669|P1|COMPLETED|Overall Study||0
8147167|NCT02665221|20078668|P2|STARTED|Overall Study||15
8147168|NCT02665221|20078669|P1|STARTED|Overall Study||15
8147169|NCT02664987|20078681|P1|NOT COMPLETED|Overall Study||0
8147170|NCT02664987|20078681|P1|COMPLETED|Overall Study||462
8147171|NCT02664987|20078681|P1|STARTED|Overall Study||462
8147172|NCT02664961|20078690|P1|NOT COMPLETED|Overall Study||0
8147173|NCT02664961|20078690|P1|COMPLETED|Overall Study||3
8147174|NCT02664961|20078690|P1|STARTED|Overall Study||3
8147175|NCT02664922|20078703|P4|NOT COMPLETED|Overall Study||0
8147176|NCT02664922|20078704|P3|NOT COMPLETED|Overall Study||0
8147177|NCT02664922|20078705|P2|NOT COMPLETED|Overall Study||0
8147178|NCT02664922|20078706|P1|NOT COMPLETED|Overall Study||1
8147179|NCT02664922|20078703|P4|COMPLETED|Overall Study||5
8147180|NCT02664922|20078704|P3|COMPLETED|Overall Study||7
8147181|NCT02664922|20078705|P2|COMPLETED|Overall Study||12
8147182|NCT02664922|20078706|P1|COMPLETED|Overall Study||10
8147183|NCT02664922|20078703|P4|STARTED|Overall Study||5
8147184|NCT02664922|20078704|P3|STARTED|Overall Study||7
8147185|NCT02664922|20078705|P2|STARTED|Overall Study||12
8147186|NCT02664922|20078706|P1|STARTED|Overall Study||11
8147187|NCT02664610|20078738|P2|NOT COMPLETED|Overall Study||7
8147188|NCT02664610|20078739|P1|NOT COMPLETED|Overall Study||14
8147189|NCT02664610|20078738|P2|COMPLETED|Overall Study||41
8147190|NCT02664610|20078739|P1|COMPLETED|Overall Study||32
8147191|NCT02664610|20078738|P2|STARTED|Overall Study||48
8147192|NCT02664610|20078739|P1|STARTED|Overall Study||46
8147193|NCT02664532|20078749|P2|NOT COMPLETED|Overall Study||0
8147194|NCT02664532|20078750|P1|NOT COMPLETED|Overall Study||0
8147195|NCT02664532|20078749|P2|COMPLETED|Overall Study||75
8147196|NCT02664532|20078750|P1|COMPLETED|Overall Study||75
8147197|NCT02664532|20078749|P2|STARTED|Overall Study||75
8147198|NCT02664532|20078750|P1|STARTED|Overall Study||75
8147205|NCT02664363|20078793|P1|NOT COMPLETED|Overall Study||0
8147206|NCT02664363|20078793|P1|COMPLETED|Overall Study||3
8147207|NCT02664363|20078793|P1|STARTED|Overall Study||3
8147208|NCT02664311|20078800|P2|NOT COMPLETED|Overall Study||0
8147209|NCT02664311|20078801|P1|NOT COMPLETED|Overall Study||0
8147210|NCT02664311|20078800|P2|COMPLETED|Overall Study||3
8147211|NCT02664311|20078801|P1|COMPLETED|Overall Study||6
8147212|NCT02664311|20078800|P2|STARTED|Overall Study||3
8147213|NCT02664311|20078801|P1|STARTED|Overall Study||6
8147214|NCT02664272|20078811|P1|NOT COMPLETED|Overall Study||2
8147215|NCT02664272|20078811|P1|COMPLETED|Overall Study||38
8147216|NCT02664272|20078811|P1|STARTED|Overall Study||40
8147217|NCT02664220|20078819|P2|NOT COMPLETED|Overall Study||0
8147218|NCT02664220|20078820|P1|NOT COMPLETED|Overall Study||0
8147219|NCT02664220|20078819|P2|COMPLETED|Overall Study||50
8147220|NCT02664220|20078820|P1|COMPLETED|Overall Study||50
8147221|NCT02664220|20078819|P2|STARTED|Overall Study||50
8147222|NCT02664220|20078820|P1|STARTED|Overall Study||50
8147223|NCT02664181|20078834|P2|NOT COMPLETED|Overall Study||0
8147224|NCT02664181|20078835|P1|NOT COMPLETED|Overall Study||0
8147225|NCT02664181|20078834|P2|COMPLETED|Overall Study||5
8147226|NCT02664181|20078835|P1|COMPLETED|Overall Study||8
8147227|NCT02664181|20078834|P2|STARTED|Overall Study||5
8147228|NCT02664181|20078835|P1|STARTED|Overall Study||8
8147229|NCT02663882|20078847|P2|NOT COMPLETED|Overall Study||2
8147230|NCT02663882|20078848|P1|NOT COMPLETED|Overall Study||4
8147231|NCT02663882|20078847|P2|COMPLETED|Overall Study||34
8147232|NCT02663882|20078848|P1|COMPLETED|Overall Study||35
8147233|NCT02663882|20078847|P2|STARTED|Overall Study||36
8147234|NCT02663882|20078848|P1|STARTED|Overall Study||39
8147235|NCT02663817|20078860|P1|NOT COMPLETED|Overall Study||2
8147236|NCT02663817|20078860|P1|COMPLETED|Overall Study||50
8147237|NCT02663817|20078860|P1|STARTED|Overall Study||52
8147238|NCT02663752|20078866|P1|NOT COMPLETED|Overall Study||0
8147239|NCT02663752|20078866|P1|COMPLETED|Overall Study||1
8147240|NCT02663752|20078866|P1|STARTED|Overall Study||1
8147266|NCT02663674|20078938|P2|NOT COMPLETED|Overall Study||10
8147267|NCT02663674|20078939|P1|NOT COMPLETED|Overall Study||7
8147268|NCT02663674|20078938|P2|COMPLETED|Overall Study||29
8147269|NCT02663674|20078939|P1|COMPLETED|Overall Study||26
8147270|NCT02663674|20078938|P2|STARTED|Overall Study||39
8147271|NCT02663674|20078939|P1|STARTED|Overall Study||33
8147272|NCT02663453|20079203|P2|NOT COMPLETED|Overall Study||4
8147273|NCT02663453|20079204|P1|NOT COMPLETED|Overall Study||5
8147274|NCT02663453|20079203|P2|COMPLETED|Overall Study||18
8147275|NCT02663453|20079204|P1|COMPLETED|Overall Study||17
8147276|NCT02663453|20079203|P2|STARTED|Overall Study||22
8147277|NCT02663453|20079204|P1|STARTED|Overall Study||22
8147278|NCT02663232|20079226|P1|NOT COMPLETED|Overall Study||0
8147279|NCT02663232|20079226|P1|COMPLETED|Overall Study||264
8147280|NCT02663232|20079226|P1|STARTED|Overall Study||264
8147281|NCT02663128|20079249|P6|NOT COMPLETED|Period 3||0
8147282|NCT02663128|20079250|P5|NOT COMPLETED|Period 3||0
8147283|NCT02663128|20079251|P4|NOT COMPLETED|Period 3||0
8147284|NCT02663128|20079252|P3|NOT COMPLETED|Period 3||0
8147285|NCT02663128|20079253|P2|NOT COMPLETED|Period 3||0
8147286|NCT02663128|20079254|P1|NOT COMPLETED|Period 3||0
8147287|NCT02663128|20079249|P6|COMPLETED|Period 3||3
8147288|NCT02663128|20079250|P5|COMPLETED|Period 3||2
8147289|NCT02663128|20079251|P4|COMPLETED|Period 3||3
8147290|NCT02663128|20079252|P3|COMPLETED|Period 3||3
8147291|NCT02663128|20079253|P2|COMPLETED|Period 3||3
8147292|NCT02663128|20079254|P1|COMPLETED|Period 3||3
8147293|NCT02663128|20079249|P6|STARTED|Period 3||3
8147294|NCT02663128|20079250|P5|STARTED|Period 3||2
8147295|NCT02663128|20079251|P4|STARTED|Period 3||3
8147296|NCT02663128|20079252|P3|STARTED|Period 3||3
8147297|NCT02663128|20079253|P2|STARTED|Period 3||3
8147298|NCT02663128|20079254|P1|STARTED|Period 3||3
8147299|NCT02663128|20079249|P6|NOT COMPLETED|Period 2||0
8147300|NCT02663128|20079250|P5|NOT COMPLETED|Period 2||1
8147301|NCT02663128|20079251|P4|NOT COMPLETED|Period 2||0
8147302|NCT02663128|20079252|P3|NOT COMPLETED|Period 2||0
8147303|NCT02663128|20079253|P2|NOT COMPLETED|Period 2||0
8147304|NCT02663128|20079254|P1|NOT COMPLETED|Period 2||0
8147305|NCT02663128|20079249|P6|COMPLETED|Period 2||3
8147306|NCT02663128|20079250|P5|COMPLETED|Period 2||2
8147307|NCT02663128|20079251|P4|COMPLETED|Period 2||3
8147308|NCT02663128|20079252|P3|COMPLETED|Period 2||3
8147309|NCT02663128|20079253|P2|COMPLETED|Period 2||3
8147310|NCT02663128|20079254|P1|COMPLETED|Period 2||3
8147311|NCT02663128|20079249|P6|STARTED|Period 2||3
8147312|NCT02663128|20079250|P5|STARTED|Period 2||3
8147313|NCT02663128|20079251|P4|STARTED|Period 2||3
8147314|NCT02663128|20079252|P3|STARTED|Period 2||3
8147315|NCT02663128|20079253|P2|STARTED|Period 2||3
8147316|NCT02663128|20079254|P1|STARTED|Period 2||3
8147317|NCT02663128|20079249|P6|NOT COMPLETED|Period 1||0
8147318|NCT02663128|20079250|P5|NOT COMPLETED|Period 1||0
8147319|NCT02663128|20079251|P4|NOT COMPLETED|Period 1||0
8147320|NCT02663128|20079252|P3|NOT COMPLETED|Period 1||0
8147321|NCT02663128|20079253|P2|NOT COMPLETED|Period 1||0
8147322|NCT02663128|20079254|P1|NOT COMPLETED|Period 1||0
8147323|NCT02663128|20079249|P6|COMPLETED|Period 1||3
8147324|NCT02663128|20079250|P5|COMPLETED|Period 1||3
8147325|NCT02663128|20079251|P4|COMPLETED|Period 1||3
8147326|NCT02663128|20079252|P3|COMPLETED|Period 1||3
8147327|NCT02663128|20079253|P2|COMPLETED|Period 1||3
8147328|NCT02663128|20079254|P1|COMPLETED|Period 1||3
8147329|NCT02663128|20079249|P6|Received at Least One Dose of Study Drug|Period 1||3
8147330|NCT02663128|20079250|P5|Received at Least One Dose of Study Drug|Period 1||3
8147331|NCT02663128|20079251|P4|Received at Least One Dose of Study Drug|Period 1||3
8147332|NCT02663128|20079252|P3|Received at Least One Dose of Study Drug|Period 1||3
8147333|NCT02663128|20079253|P2|Received at Least One Dose of Study Drug|Period 1||3
8147334|NCT02663128|20079254|P1|Received at Least One Dose of Study Drug|Period 1||3
8147335|NCT02663128|20079249|P6|STARTED|Period 1||3
8147336|NCT02663128|20079250|P5|STARTED|Period 1||3
8147337|NCT02663128|20079251|P4|STARTED|Period 1||3
8147338|NCT02663128|20079252|P3|STARTED|Period 1||3
8147339|NCT02663128|20079253|P2|STARTED|Period 1||3
8147340|NCT02663128|20079254|P1|STARTED|Period 1||3
8147341|NCT02662764|20079268|P1|NOT COMPLETED|Overall Study||30
8147342|NCT02662764|20079268|P1|COMPLETED|Overall Study|First 24-hours of study treatment|290
8147343|NCT02662764|20079268|P1|STARTED|Overall Study||320
8147344|NCT02662608|20079328|P1|NOT COMPLETED|Overall Study||0
8147345|NCT02662608|20079328|P1|COMPLETED|Overall Study||1
8147346|NCT02662608|20079328|P1|STARTED|Overall Study||1
8147347|NCT02662569|20079336|P4|NOT COMPLETED|Overall Study||4
8147348|NCT02662569|20079337|P3|NOT COMPLETED|Overall Study||6
8147349|NCT02662569|20079338|P2|NOT COMPLETED|Overall Study||1
8147350|NCT02662569|20079339|P1|NOT COMPLETED|Overall Study||7
8147351|NCT02662569|20079336|P4|COMPLETED|Overall Study||328
8147352|NCT02662569|20079337|P3|COMPLETED|Overall Study||321
8147353|NCT02662569|20079338|P2|COMPLETED|Overall Study||160
8147354|NCT02662569|20079339|P1|COMPLETED|Overall Study||159
8147355|NCT02662569|20079336|P4|Received Study Drug|Overall Study||332
8147356|NCT02662569|20079337|P3|Received Study Drug|Overall Study||325
8147357|NCT02662569|20079338|P2|Received Study Drug|Overall Study||160
8147358|NCT02662569|20079339|P1|Received Study Drug|Overall Study||164
8147359|NCT02662569|20079336|P4|STARTED|Overall Study||332
8147360|NCT02662569|20079337|P3|STARTED|Overall Study||327
8147361|NCT02662569|20079338|P2|STARTED|Overall Study||161
8147362|NCT02662569|20079339|P1|STARTED|Overall Study||166
8147363|NCT02662556|20079437|P1|NOT COMPLETED|Overall Study||8
8147364|NCT02662556|20079437|P1|COMPLETED|Overall Study||132
8147365|NCT02662556|20079437|P1|STARTED|Overall Study||140
8147366|NCT02662387|20079446|P2|NOT COMPLETED|Overall Study||0
8147367|NCT02662387|20079447|P1|NOT COMPLETED|Overall Study||0
8147368|NCT02662387|20079446|P2|COMPLETED|Overall Study||28
8147369|NCT02662387|20079447|P1|COMPLETED|Overall Study||27
8147370|NCT02662387|20079446|P2|STARTED|Overall Study||28
8147371|NCT02662387|20079447|P1|STARTED|Overall Study||27
8147372|NCT02662244|20079455|P1|NOT COMPLETED|Overall Study||2
8147373|NCT02662244|20079455|P1|COMPLETED|Overall Study||31
8147374|NCT02662244|20079455|P1|STARTED|Overall Study||33
8147375|NCT02662036|20079465|P2|NOT COMPLETED|Overall Study||13
8147376|NCT02662036|20079466|P1|NOT COMPLETED|Overall Study||13
8147377|NCT02662036|20079465|P2|COMPLETED|Overall Study||22
8147378|NCT02662036|20079466|P1|COMPLETED|Overall Study||22
8147379|NCT02662036|20079465|P2|STARTED|Overall Study||35
8147380|NCT02662036|20079466|P1|STARTED|Overall Study||35
8147381|NCT02661828|20079494|P2|NOT COMPLETED|Overall Study||0
8147382|NCT02661828|20079495|P1|NOT COMPLETED|Overall Study||0
8147383|NCT02661828|20079494|P2|COMPLETED|Overall Study||0
8147384|NCT02661828|20079495|P1|COMPLETED|Overall Study||1
8147385|NCT02661828|20079494|P2|STARTED|Overall Study||0
8147386|NCT02661828|20079495|P1|STARTED|Overall Study||1
8147387|NCT02661815|20079506|P4|NOT COMPLETED|Overall Study||0
8147388|NCT02661815|20079507|P3|NOT COMPLETED|Overall Study||0
8147389|NCT02661815|20079508|P2|NOT COMPLETED|Overall Study||0
8147390|NCT02661815|20079509|P1|NOT COMPLETED|Overall Study||1
8147391|NCT02661815|20079506|P4|COMPLETED|Overall Study||0
8147392|NCT02661815|20079507|P3|COMPLETED|Overall Study||0
8147393|NCT02661815|20079508|P2|COMPLETED|Overall Study||0
8147394|NCT02661815|20079509|P1|COMPLETED|Overall Study||5
8147395|NCT02661815|20079506|P4|STARTED|Overall Study||0
8147396|NCT02661815|20079507|P3|STARTED|Overall Study||0
8147397|NCT02661815|20079508|P2|STARTED|Overall Study||0
8147398|NCT02661815|20079509|P1|STARTED|Overall Study||6
8147399|NCT02661737|20079523|P1|NOT COMPLETED|Overall Study||34
8147400|NCT02661737|20079523|P1|COMPLETED|Overall Study||469
8147401|NCT02661737|20079523|P1|STARTED|Overall Study||503
8147402|NCT02661594|20079531|P4|NOT COMPLETED|Overall Study||0
8147403|NCT02661594|20079532|P3|NOT COMPLETED|Overall Study||1
8147404|NCT02661594|20079533|P2|NOT COMPLETED|Overall Study||0
8147405|NCT02661594|20079534|P1|NOT COMPLETED|Overall Study||1
8147406|NCT02661594|20079531|P4|COMPLETED|Overall Study||9
8147407|NCT02661594|20079532|P3|COMPLETED|Overall Study||9
8147408|NCT02661594|20079533|P2|COMPLETED|Overall Study||11
8147409|NCT02661594|20079534|P1|COMPLETED|Overall Study||9
8147410|NCT02661594|20079531|P4|STARTED|Overall Study||9
8147411|NCT02661594|20079532|P3|STARTED|Overall Study||10
8147412|NCT02661594|20079533|P2|STARTED|Overall Study||11
8147413|NCT02661594|20079534|P1|STARTED|Overall Study||10
8147414|NCT02661490|20079549|P5|NOT COMPLETED|Overall Study||3
8147415|NCT02661490|20079550|P4|NOT COMPLETED|Overall Study||1
8147416|NCT02661490|20079551|P3|NOT COMPLETED|Overall Study||2
8147417|NCT02661490|20079552|P2|NOT COMPLETED|Overall Study||2
8147418|NCT02661490|20079553|P1|NOT COMPLETED|Overall Study||3
8147419|NCT02661490|20079549|P5|COMPLETED|Overall Study||23
8147420|NCT02661490|20079550|P4|COMPLETED|Overall Study||71
8147421|NCT02661490|20079551|P3|COMPLETED|Overall Study||70
8147422|NCT02661490|20079552|P2|COMPLETED|Overall Study||72
8147423|NCT02661490|20079553|P1|COMPLETED|Overall Study||73
8147424|NCT02661490|20079549|P5|STARTED|Overall Study||26
8147425|NCT02661490|20079550|P4|STARTED|Overall Study||72
8147426|NCT02661490|20079551|P3|STARTED|Overall Study||72
8147427|NCT02661490|20079552|P2|STARTED|Overall Study||74
8147428|NCT02661490|20079553|P1|STARTED|Overall Study||76
8147429|NCT02661256|20079690|P1|NOT COMPLETED|Overall Study||0
8147430|NCT02661256|20079690|P1|COMPLETED|Overall Study||7
8147431|NCT02661256|20079690|P1|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7
8147432|NCT02661178|20079721|P15|NOT COMPLETED|Part 2||0
8147433|NCT02661178|20079722|P14|NOT COMPLETED|Part 2||0
8147434|NCT02661178|20079723|P13|NOT COMPLETED|Part 2||0
8147435|NCT02661178|20079724|P12|NOT COMPLETED|Part 2||0
8147436|NCT02661178|20079725|P11|NOT COMPLETED|Part 2||0
8147437|NCT02661178|20079726|P10|NOT COMPLETED|Part 2||0
8147438|NCT02661178|20079727|P9|NOT COMPLETED|Part 2||0
8147439|NCT02661178|20079728|P8|NOT COMPLETED|Part 2||0
8147440|NCT02661178|20079729|P7|NOT COMPLETED|Part 2||0
8147441|NCT02661178|20079730|P6|NOT COMPLETED|Part 2||0
8147442|NCT02661178|20079731|P5|NOT COMPLETED|Part 2||0
8147443|NCT02661178|20079732|P4|NOT COMPLETED|Part 2||0
8147444|NCT02661178|20079733|P3|NOT COMPLETED|Part 2||0
8147445|NCT02661178|20079734|P2|NOT COMPLETED|Part 2||0
8147446|NCT02661178|20079735|P1|NOT COMPLETED|Part 2||0
8147447|NCT02661178|20079721|P15|COMPLETED|Part 2||2
8147448|NCT02661178|20079722|P14|COMPLETED|Part 2||2
8147449|NCT02661178|20079723|P13|COMPLETED|Part 2||6
8147450|NCT02661178|20079724|P12|COMPLETED|Part 2||6
8147451|NCT02661178|20079725|P11|COMPLETED|Part 2||0
8147452|NCT02661178|20079726|P10|COMPLETED|Part 2||0
8147453|NCT02661178|20079727|P9|COMPLETED|Part 2||0
8147454|NCT02661178|20079728|P8|COMPLETED|Part 2||0
8147455|NCT02661178|20079729|P7|COMPLETED|Part 2||0
8147456|NCT02661178|20079730|P6|COMPLETED|Part 2||0
8147457|NCT02661178|20079731|P5|COMPLETED|Part 2||0
8147458|NCT02661178|20079732|P4|COMPLETED|Part 2||0
8147459|NCT02661178|20079733|P3|COMPLETED|Part 2||0
8147460|NCT02661178|20079734|P2|COMPLETED|Part 2||0
8147461|NCT02661178|20079735|P1|COMPLETED|Part 2||0
8147462|NCT02661178|20079721|P15|STARTED|Part 2||2
8147463|NCT02661178|20079722|P14|STARTED|Part 2||2
8147464|NCT02661178|20079723|P13|STARTED|Part 2||6
8147465|NCT02661178|20079724|P12|STARTED|Part 2||6
8147466|NCT02661178|20079725|P11|STARTED|Part 2||0
8147467|NCT02661178|20079726|P10|STARTED|Part 2||0
8147468|NCT02661178|20079727|P9|STARTED|Part 2||0
8147469|NCT02661178|20079728|P8|STARTED|Part 2||0
8147470|NCT02661178|20079729|P7|STARTED|Part 2||0
8147471|NCT02661178|20079730|P6|STARTED|Part 2||0
8147472|NCT02661178|20079731|P5|STARTED|Part 2||0
8147473|NCT02661178|20079732|P4|STARTED|Part 2||0
8147474|NCT02661178|20079733|P3|STARTED|Part 2||0
8147475|NCT02661178|20079734|P2|STARTED|Part 2||0
8147476|NCT02661178|20079735|P1|STARTED|Part 2||0
8147477|NCT02661178|20079721|P15|NOT COMPLETED|Part 1||0
8147478|NCT02661178|20079722|P14|NOT COMPLETED|Part 1||0
8147479|NCT02661178|20079723|P13|NOT COMPLETED|Part 1||0
8147480|NCT02661178|20079724|P12|NOT COMPLETED|Part 1||0
8147481|NCT02661178|20079725|P11|NOT COMPLETED|Part 1||0
8147482|NCT02661178|20079726|P10|NOT COMPLETED|Part 1||0
8147483|NCT02661178|20079727|P9|NOT COMPLETED|Part 1||0
8147484|NCT02661178|20079728|P8|NOT COMPLETED|Part 1||0
8147485|NCT02661178|20079729|P7|NOT COMPLETED|Part 1||0
8147486|NCT02661178|20079730|P6|NOT COMPLETED|Part 1||0
8147487|NCT02661178|20079731|P5|NOT COMPLETED|Part 1||0
8147488|NCT02661178|20079732|P4|NOT COMPLETED|Part 1||0
8147489|NCT02661178|20079733|P3|NOT COMPLETED|Part 1||0
8147490|NCT02661178|20079734|P2|NOT COMPLETED|Part 1||0
8147491|NCT02661178|20079735|P1|NOT COMPLETED|Part 1||1
8147492|NCT02661178|20079721|P15|COMPLETED|Part 1||0
8147493|NCT02661178|20079722|P14|COMPLETED|Part 1||0
8147494|NCT02661178|20079723|P13|COMPLETED|Part 1||0
8147495|NCT02661178|20079724|P12|COMPLETED|Part 1||0
8147496|NCT02661178|20079725|P11|COMPLETED|Part 1||4
8147497|NCT02661178|20079726|P10|COMPLETED|Part 1||12
8147498|NCT02661178|20079727|P9|COMPLETED|Part 1||6
8147499|NCT02661178|20079728|P8|COMPLETED|Part 1||6
8147500|NCT02661178|20079729|P7|COMPLETED|Part 1||6
8147501|NCT02661178|20079730|P6|COMPLETED|Part 1||6
8147502|NCT02661178|20079731|P5|COMPLETED|Part 1||5
8147503|NCT02661178|20079732|P4|COMPLETED|Part 1||6
8147504|NCT02661178|20079733|P3|COMPLETED|Part 1||6
8147505|NCT02661178|20079734|P2|COMPLETED|Part 1||5
8147506|NCT02661178|20079735|P1|COMPLETED|Part 1||0
8147507|NCT02661178|20079721|P15|STARTED|Part 1||0
8147508|NCT02661178|20079722|P14|STARTED|Part 1||0
8147509|NCT02661178|20079723|P13|STARTED|Part 1||0
8147510|NCT02661178|20079724|P12|STARTED|Part 1||0
8147511|NCT02661178|20079725|P11|STARTED|Part 1||4
8147512|NCT02661178|20079726|P10|STARTED|Part 1||12
8147513|NCT02661178|20079727|P9|STARTED|Part 1||6
8147514|NCT02661178|20079728|P8|STARTED|Part 1||6
8147515|NCT02661178|20079729|P7|STARTED|Part 1||6
8147516|NCT02661178|20079730|P6|STARTED|Part 1||6
8147517|NCT02661178|20079731|P5|STARTED|Part 1||5
8147518|NCT02661178|20079732|P4|STARTED|Part 1||6
8147519|NCT02661178|20079733|P3|STARTED|Part 1||6
8147520|NCT02661178|20079734|P2|STARTED|Part 1||5
8147521|NCT02661178|20079735|P1|STARTED|Part 1||1
8147522|NCT02661126|20080002|P2|NOT COMPLETED|Overall Study||0
8147523|NCT02661126|20080003|P1|NOT COMPLETED|Overall Study||0
8147524|NCT02661126|20080002|P2|COMPLETED|Overall Study||8
8147525|NCT02661126|20080003|P1|COMPLETED|Overall Study||8
8147526|NCT02661126|20080002|P2|STARTED|Overall Study||8
8147527|NCT02661126|20080003|P1|STARTED|Overall Study||8
8147528|NCT02661061|20080093|P2|NOT COMPLETED|Overall Study||2
8147529|NCT02661061|20080094|P1|NOT COMPLETED|Overall Study||2
8147530|NCT02661061|20080093|P2|COMPLETED|Overall Study||2
8147531|NCT02661061|20080094|P1|COMPLETED|Overall Study||3
8147532|NCT02661061|20080093|P2|STARTED|Overall Study||4
8147533|NCT02661061|20080094|P1|STARTED|Overall Study||5
8147534|NCT02660983|20080104|P2|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9
8147535|NCT02660983|20080105|P1|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3
8147536|NCT02660983|20080104|P2|COMPLETED|Open Label Extension Phase (24 Weeks)||66
8147537|NCT02660983|20080105|P1|COMPLETED|Open Label Extension Phase (24 Weeks)||83
8147538|NCT02660983|20080104|P2|Safety Set|Open Label Extension Phase (24 Weeks)||75
8147539|NCT02660983|20080105|P1|Safety Set|Open Label Extension Phase (24 Weeks)||86
8147540|NCT02660983|20080104|P2|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|75
8147541|NCT02660983|20080105|P1|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|86
8147542|NCT02660983|20080104|P2|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26
8147543|NCT02660983|20080105|P1|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24
8147544|NCT02660983|20080104|P2|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122
8147545|NCT02660983|20080105|P1|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130
8147546|NCT02660983|20080104|P2|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147
8147547|NCT02660983|20080105|P1|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153
8147548|NCT02660983|20080104|P2|STARTED|Double-blind (DB) Phase (24 Weeks)||148
8147549|NCT02660983|20080105|P1|STARTED|Double-blind (DB) Phase (24 Weeks)||154
8147550|NCT02660918|20080120|P2|NOT COMPLETED|Overall Study||1
8147551|NCT02660918|20080121|P1|NOT COMPLETED|Overall Study||1
8147552|NCT02660918|20080120|P2|COMPLETED|Overall Study|Age ineligible|41
8147553|NCT02660918|20080121|P1|COMPLETED|Overall Study|Age ineligible|41
8147554|NCT02660918|20080120|P2|STARTED|Overall Study||42
8147555|NCT02660918|20080121|P1|STARTED|Overall Study||42
8147556|NCT02660853|20080143|P1|NOT COMPLETED|Overall Study||0
8147557|NCT02660853|20080143|P1|COMPLETED|Overall Study||25
8147558|NCT02660853|20080143|P1|STARTED|Overall Study||25
8147559|NCT02660801|20080154|P2|NOT COMPLETED|Overall Study||0
8147560|NCT02660801|20080155|P1|NOT COMPLETED|Overall Study||0
8147561|NCT02660801|20080154|P2|COMPLETED|Overall Study||15
8147562|NCT02660801|20080155|P1|COMPLETED|Overall Study||11
8147563|NCT02660801|20080154|P2|STARTED|Overall Study||15
8147564|NCT02660801|20080155|P1|STARTED|Overall Study||11
8147565|NCT02660580|20080171|P5|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
8147566|NCT02660580|20080172|P4|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
8147567|NCT02660580|20080173|P3|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18
8147568|NCT02660580|20080174|P2|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
8147569|NCT02660580|20080175|P1|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
8147570|NCT02660580|20080171|P5|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
8147571|NCT02660580|20080172|P4|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
8147572|NCT02660580|20080173|P3|COMPLETED|Extended Treatment Period(Week 16 to 52)||195
8147573|NCT02660580|20080174|P2|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
8147574|NCT02660580|20080175|P1|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
8147575|NCT02660580|20080171|P5|STARTED|Extended Treatment Period(Week 16 to 52)||101
8147576|NCT02660580|20080172|P4|STARTED|Extended Treatment Period(Week 16 to 52)||101
8147577|NCT02660580|20080173|P3|STARTED|Extended Treatment Period(Week 16 to 52)||213
8147578|NCT02660580|20080174|P2|STARTED|Extended Treatment Period(Week 16 to 52)||0
8147579|NCT02660580|20080175|P1|STARTED|Extended Treatment Period(Week 16 to 52)||0
8147580|NCT02660580|20080171|P5|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
8147581|NCT02660580|20080172|P4|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
8147582|NCT02660580|20080173|P3|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
8147583|NCT02660580|20080174|P2|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19
8147584|NCT02660580|20080175|P1|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9
8147585|NCT02660580|20080171|P5|COMPLETED|Core Treatment Period (Week 1 to 16)||0
8147586|NCT02660580|20080172|P4|COMPLETED|Core Treatment Period (Week 1 to 16)||0
8147587|NCT02660580|20080173|P3|COMPLETED|Core Treatment Period (Week 1 to 16)||0
8147588|NCT02660580|20080174|P2|COMPLETED|Core Treatment Period (Week 1 to 16)||202
8147589|NCT02660580|20080175|P1|COMPLETED|Core Treatment Period (Week 1 to 16)||213
8147590|NCT02660580|20080171|P5|Treated|Core Treatment Period (Week 1 to 16)||0
8147591|NCT02660580|20080172|P4|Treated|Core Treatment Period (Week 1 to 16)||0
8147592|NCT02660580|20080173|P3|Treated|Core Treatment Period (Week 1 to 16)||0
8147593|NCT02660580|20080174|P2|Treated|Core Treatment Period (Week 1 to 16)||220
8147594|NCT02660580|20080175|P1|Treated|Core Treatment Period (Week 1 to 16)||221
8147595|NCT02660580|20080171|P5|STARTED|Core Treatment Period (Week 1 to 16)||0
8147596|NCT02660580|20080172|P4|STARTED|Core Treatment Period (Week 1 to 16)||0
8147597|NCT02660580|20080173|P3|STARTED|Core Treatment Period (Week 1 to 16)||0
8147598|NCT02660580|20080174|P2|STARTED|Core Treatment Period (Week 1 to 16)||221
8147599|NCT02660580|20080175|P1|STARTED|Core Treatment Period (Week 1 to 16)||222
8147600|NCT02660528|20080284|P1|NOT COMPLETED|Overall Study||0
8147601|NCT02660528|20080284|P1|COMPLETED|Overall Study||0
8147602|NCT02660528|20080284|P1|STARTED|Overall Study||0
8147603|NCT02660242|20080290|P1|NOT COMPLETED|Glucagon Injection||1
8147604|NCT02660242|20080290|P1|COMPLETED|Glucagon Injection||15
8147605|NCT02660242|20080290|P1|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
8147606|NCT02660242|20080290|P1|NOT COMPLETED|Glucose Tabs||1
8147607|NCT02660242|20080290|P1|COMPLETED|Glucose Tabs||15
8147608|NCT02660242|20080290|P1|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
8147609|NCT02660242|20080290|P1|NOT COMPLETED|Basal Insulin Reduction||0
8147610|NCT02660242|20080290|P1|COMPLETED|Basal Insulin Reduction||16
8147611|NCT02660242|20080290|P1|STARTED|Basal Insulin Reduction||16
8147612|NCT02660242|20080290|P1|NOT COMPLETED|Control||0
8147613|NCT02660242|20080290|P1|COMPLETED|Control||16
8147614|NCT02660242|20080290|P1|STARTED|Control||16
8147615|NCT02660229|20080346|P2|NOT COMPLETED|Overall Study||1
8147616|NCT02660229|20080347|P1|NOT COMPLETED|Overall Study||2
8147617|NCT02660229|20080346|P2|COMPLETED|Overall Study||31
8147618|NCT02660229|20080347|P1|COMPLETED|Overall Study||32
8147619|NCT02660229|20080346|P2|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
8147620|NCT02660229|20080347|P1|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
8147621|NCT02660229|20080346|P2|FAS Set|Overall Study||32
8147622|NCT02660229|20080347|P1|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
8147623|NCT02660229|20080346|P2|Safety Analysis Set|Overall Study||32
8147624|NCT02660229|20080347|P1|Safety Analysis Set|Overall Study||34
8147625|NCT02660229|20080346|P2|STARTED|Overall Study|Randomization|32
8147626|NCT02660229|20080347|P1|STARTED|Overall Study|Randomization|34
8147627|NCT02660112|20080359|P1|NOT COMPLETED|Overall Study||0
8147628|NCT02660112|20080359|P1|COMPLETED|Overall Study||10
8147629|NCT02660112|20080359|P1|STARTED|Overall Study||10
8147630|NCT02659787|20080364|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8147631|NCT02659787|20080365|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8147632|NCT02659787|20080364|P2|COMPLETED|Second Intervention (1 Day)||19
8147633|NCT02659787|20080365|P1|COMPLETED|Second Intervention (1 Day)||19
8147634|NCT02659787|20080364|P2|STARTED|Second Intervention (1 Day)||19
8147635|NCT02659787|20080365|P1|STARTED|Second Intervention (1 Day)||19
8147636|NCT02659787|20080364|P2|NOT COMPLETED|Washout (3 Days)||0
8147637|NCT02659787|20080365|P1|NOT COMPLETED|Washout (3 Days)||0
8147638|NCT02659787|20080364|P2|COMPLETED|Washout (3 Days)||19
8147639|NCT02659787|20080365|P1|COMPLETED|Washout (3 Days)||19
8147640|NCT02659787|20080364|P2|STARTED|Washout (3 Days)||19
8147641|NCT02659787|20080365|P1|STARTED|Washout (3 Days)||19
8147642|NCT02659787|20080364|P2|NOT COMPLETED|First Intervention (1 Day)||0
8147643|NCT02659787|20080365|P1|NOT COMPLETED|First Intervention (1 Day)||0
8147644|NCT02659787|20080364|P2|COMPLETED|First Intervention (1 Day)||19
8147645|NCT02659787|20080365|P1|COMPLETED|First Intervention (1 Day)||19
8147646|NCT02659787|20080364|P2|STARTED|First Intervention (1 Day)||19
8147647|NCT02659787|20080365|P1|STARTED|First Intervention (1 Day)||19
8147648|NCT02659709|20080371|P1|NOT COMPLETED|Overall Study||0
8147649|NCT02659709|20080371|P1|COMPLETED|Overall Study||50
8147650|NCT02659709|20080371|P1|STARTED|Overall Study||50
8147651|NCT02659631|20080388|P10|NOT COMPLETED|Overall Study||0
8147652|NCT02659631|20080389|P9|NOT COMPLETED|Overall Study||2
8147653|NCT02659631|20080390|P8|NOT COMPLETED|Overall Study||3
8147654|NCT02659631|20080391|P7|NOT COMPLETED|Overall Study||1
8147655|NCT02659631|20080392|P6|NOT COMPLETED|Overall Study||3
8147656|NCT02659631|20080393|P5|NOT COMPLETED|Overall Study||5
8147657|NCT02659631|20080394|P4|NOT COMPLETED|Overall Study||2
8147658|NCT02659631|20080395|P3|NOT COMPLETED|Overall Study||3
8147659|NCT02659631|20080396|P2|NOT COMPLETED|Overall Study||2
8147660|NCT02659631|20080397|P1|NOT COMPLETED|Overall Study||1
8147661|NCT02659631|20080388|P10|COMPLETED|Overall Study||1
8147662|NCT02659631|20080389|P9|COMPLETED|Overall Study||0
8147663|NCT02659631|20080390|P8|COMPLETED|Overall Study||0
8147664|NCT02659631|20080391|P7|COMPLETED|Overall Study||3
8147665|NCT02659631|20080392|P6|COMPLETED|Overall Study||2
8147666|NCT02659631|20080393|P5|COMPLETED|Overall Study||0
8147667|NCT02659631|20080394|P4|COMPLETED|Overall Study||0
8147668|NCT02659631|20080395|P3|COMPLETED|Overall Study||0
8147669|NCT02659631|20080396|P2|COMPLETED|Overall Study||0
8147670|NCT02659631|20080397|P1|COMPLETED|Overall Study||0
8147671|NCT02659631|20080388|P10|STARTED|Overall Study||1
8147672|NCT02659631|20080389|P9|STARTED|Overall Study||2
8147673|NCT02659631|20080390|P8|STARTED|Overall Study||3
8147674|NCT02659631|20080391|P7|STARTED|Overall Study||4
8147675|NCT02659631|20080392|P6|STARTED|Overall Study||5
8147676|NCT02659631|20080393|P5|STARTED|Overall Study||5
8147677|NCT02659631|20080394|P4|STARTED|Overall Study||2
8147678|NCT02659631|20080395|P3|STARTED|Overall Study||3
8147679|NCT02659631|20080396|P2|STARTED|Overall Study||2
8147680|NCT02659631|20080397|P1|STARTED|Overall Study||1
8147687|NCT02659501|20080548|P2|NOT COMPLETED|Overall Study||0
8147688|NCT02659501|20080549|P1|NOT COMPLETED|Overall Study||0
8147689|NCT02659501|20080548|P2|COMPLETED|Overall Study||12
8147690|NCT02659501|20080549|P1|COMPLETED|Overall Study||12
8147691|NCT02659501|20080548|P2|STARTED|Overall Study||12
8147692|NCT02659501|20080549|P1|STARTED|Overall Study||12
8147693|NCT02659098|20080563|P1|NOT COMPLETED|Overall Study||7
8147694|NCT02659098|20080563|P1|COMPLETED|Overall Study||14
8147695|NCT02659098|20080563|P1|STARTED|Overall Study||21
8147696|NCT02658877|20080594|P2|NOT COMPLETED|Overall Study||0
8147697|NCT02658877|20080595|P1|NOT COMPLETED|Overall Study||0
8147698|NCT02658877|20080594|P2|COMPLETED|Overall Study||0
8147699|NCT02658877|20080595|P1|COMPLETED|Overall Study||3
8147700|NCT02658877|20080594|P2|STARTED|Overall Study||0
8147701|NCT02658877|20080595|P1|STARTED|Overall Study||3
8147702|NCT02658851|20080621|P1|NOT COMPLETED|Overall Study||0
8147703|NCT02658851|20080621|P1|COMPLETED|Overall Study||100
8147704|NCT02658851|20080621|P1|STARTED|Overall Study||100
8147708|NCT02658461|20080638|P3|NOT COMPLETED|Overall Study||0
8147709|NCT02658461|20080639|P2|NOT COMPLETED|Overall Study||0
8147710|NCT02658461|20080640|P1|NOT COMPLETED|Overall Study||0
8147711|NCT02658461|20080638|P3|COMPLETED|Overall Study||12
8147712|NCT02658461|20080639|P2|COMPLETED|Overall Study||12
8147713|NCT02658461|20080640|P1|COMPLETED|Overall Study||12
8147714|NCT02658461|20080638|P3|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
8147715|NCT02658461|20080639|P2|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
8147716|NCT02658461|20080640|P1|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
8147717|NCT02658357|20080668|P2|NOT COMPLETED|Overall Study||0
8147718|NCT02658357|20080669|P1|NOT COMPLETED|Overall Study||0
8147719|NCT02658357|20080668|P2|COMPLETED|Overall Study||0
8147720|NCT02658357|20080669|P1|COMPLETED|Overall Study||0
8147721|NCT02658357|20080668|P2|STARTED|Overall Study||0
8147722|NCT02658357|20080669|P1|STARTED|Overall Study||0
8147723|NCT02658240|20080681|P2|NOT COMPLETED|Overall Study||0
8147724|NCT02658240|20080682|P1|NOT COMPLETED|Overall Study||0
8147725|NCT02658240|20080681|P2|COMPLETED|Overall Study||30
8147726|NCT02658240|20080682|P1|COMPLETED|Overall Study||30
8147727|NCT02658240|20080681|P2|STARTED|Overall Study||30
8147728|NCT02658240|20080682|P1|STARTED|Overall Study||30
8147729|NCT02658149|20080696|P2|NOT COMPLETED|Overall Study||0
8147730|NCT02658149|20080697|P1|NOT COMPLETED|Overall Study||1
8147731|NCT02658149|20080696|P2|COMPLETED|Overall Study||50
8147732|NCT02658149|20080697|P1|COMPLETED|Overall Study||49
8147733|NCT02658149|20080696|P2|STARTED|Overall Study||50
8147734|NCT02658149|20080697|P1|STARTED|Overall Study||50
8147735|NCT02658084|20080713|P2|NOT COMPLETED|Overall Study||0
8147736|NCT02658084|20080714|P1|NOT COMPLETED|Overall Study||2
8147737|NCT02658084|20080713|P2|COMPLETED|Overall Study||0
8147738|NCT02658084|20080714|P1|COMPLETED|Overall Study||0
8147739|NCT02658084|20080713|P2|STARTED|Overall Study||0
8147740|NCT02658084|20080714|P1|STARTED|Overall Study||2
8147741|NCT02658019|20080723|P1|NOT COMPLETED|Overall Study||1
8147742|NCT02658019|20080723|P1|COMPLETED|Overall Study||28
8147743|NCT02658019|20080723|P1|STARTED|Overall Study||29
8147744|NCT02657928|20080734|P2|NOT COMPLETED|Overall Study||0
8147745|NCT02657928|20080735|P1|NOT COMPLETED|Overall Study||0
8147746|NCT02657928|20080734|P2|COMPLETED|Overall Study||20
8147747|NCT02657928|20080735|P1|COMPLETED|Overall Study||20
8147748|NCT02657928|20080734|P2|STARTED|Overall Study||20
8147749|NCT02657928|20080735|P1|STARTED|Overall Study||20
8147750|NCT02657915|20080751|P2|NOT COMPLETED|Overall Study||0
8147751|NCT02657915|20080752|P1|NOT COMPLETED|Overall Study||0
8147752|NCT02657915|20080751|P2|COMPLETED|Overall Study||28
8147753|NCT02657915|20080752|P1|COMPLETED|Overall Study||24
8147754|NCT02657915|20080751|P2|Per-protocol Population|Overall Study||24
8147755|NCT02657915|20080752|P1|Per-protocol Population|Overall Study||23
8147756|NCT02657915|20080751|P2|Intent-to Treat (ITT) Population|Overall Study||28
8147757|NCT02657915|20080752|P1|Intent-to Treat (ITT) Population|Overall Study||24
8147758|NCT02657915|20080751|P2|STARTED|Overall Study||28
8147759|NCT02657915|20080752|P1|STARTED|Overall Study||24
8147772|NCT02657629|20080799|P2|NOT COMPLETED|Overall Study||0
8147773|NCT02657629|20080800|P1|NOT COMPLETED|Overall Study||2
8147774|NCT02657629|20080799|P2|COMPLETED|Overall Study||14
8147775|NCT02657629|20080800|P1|COMPLETED|Overall Study||12
8147776|NCT02657629|20080799|P2|STARTED|Overall Study||14
8147777|NCT02657629|20080800|P1|STARTED|Overall Study||14
8147778|NCT02657564|20080806|P1|NOT COMPLETED|Overall Study||74
8147779|NCT02657564|20080806|P1|COMPLETED|Overall Study||1163
8147780|NCT02657564|20080806|P1|STARTED|Overall Study||1237
8147781|NCT02657538|20080811|P1|NOT COMPLETED|Overall Study||4
8147782|NCT02657538|20080811|P1|COMPLETED|Overall Study||31
8147783|NCT02657538|20080811|P1|Received Visual Caries Detection + Bite|Overall Study||35
8147784|NCT02657538|20080811|P1|Received Near Infrared Transillumination|Overall Study||35
8147785|NCT02657538|20080811|P1|STARTED|Overall Study||35
8147792|NCT02657408|20080851|P2|NOT COMPLETED|Overall Study||7
8147793|NCT02657408|20080852|P1|NOT COMPLETED|Overall Study||3
8147794|NCT02657408|20080851|P2|COMPLETED|Overall Study||22
8147795|NCT02657408|20080852|P1|COMPLETED|Overall Study||25
8147796|NCT02657408|20080851|P2|STARTED|Overall Study||29
8147797|NCT02657408|20080852|P1|STARTED|Overall Study||28
8147798|NCT02657369|20080876|P1|NOT COMPLETED|Overall Study||34
8147799|NCT02657369|20080876|P1|COMPLETED|Overall Study||0
8147800|NCT02657369|20080876|P1|STARTED|Overall Study||34
8147801|NCT02657252|20080886|P2|NOT COMPLETED|Overall Study||7
8147802|NCT02657252|20080887|P1|NOT COMPLETED|Overall Study||10
8147803|NCT02657252|20080886|P2|COMPLETED|Overall Study||51
8147804|NCT02657252|20080887|P1|COMPLETED|Overall Study||47
8147805|NCT02657252|20080886|P2|STARTED|Overall Study||58
8147806|NCT02657252|20080887|P1|STARTED|Overall Study||57
8147807|NCT02657226|20080897|P1|NOT COMPLETED|Overall Study||0
8147808|NCT02657226|20080897|P1|COMPLETED|Overall Study||15724
8147809|NCT02657226|20080897|P1|STARTED|Overall Study||15724
8147810|NCT02657031|20080907|P2|NOT COMPLETED|Overall Study||2
8147811|NCT02657031|20080908|P1|NOT COMPLETED|Overall Study||1
8147812|NCT02657031|20080907|P2|COMPLETED|Overall Study||23
8147813|NCT02657031|20080908|P1|COMPLETED|Overall Study||28
8147814|NCT02657031|20080907|P2|STARTED|Overall Study||25
8147815|NCT02657031|20080908|P1|STARTED|Overall Study||29
8147816|NCT02656875|20080922|P1|NOT COMPLETED|Overall Study||70
8147817|NCT02656875|20080922|P1|COMPLETED|Overall Study||698
8147818|NCT02656875|20080922|P1|STARTED|Overall Study||768
8147819|NCT02656836|20080926|P1|NOT COMPLETED|Overall Study||3
8147820|NCT02656836|20080926|P1|COMPLETED|Overall Study||6
8147821|NCT02656836|20080926|P1|STARTED|Overall Study||9
8147822|NCT02656745|20080930|P1|NOT COMPLETED|Overall Study||0
8147823|NCT02656745|20080930|P1|COMPLETED|Overall Study||416
8147824|NCT02656745|20080930|P1|STARTED|Overall Study||416
8147825|NCT02656693|20080940|P3|NOT COMPLETED|Overall Study||3
8147826|NCT02656693|20080941|P2|NOT COMPLETED|Overall Study||2
8147827|NCT02656693|20080942|P1|NOT COMPLETED|Overall Study||1
8147828|NCT02656693|20080940|P3|COMPLETED|Overall Study||295
8147829|NCT02656693|20080941|P2|COMPLETED|Overall Study||214
8147830|NCT02656693|20080942|P1|COMPLETED|Overall Study||325
8147831|NCT02656693|20080940|P3|STARTED|Overall Study||298
8147832|NCT02656693|20080941|P2|STARTED|Overall Study||216
8147833|NCT02656693|20080942|P1|STARTED|Overall Study||326
8147834|NCT02656485|20081029|P4|NOT COMPLETED|Overall Study||2
8147835|NCT02656485|20081030|P3|NOT COMPLETED|Overall Study||2
8147836|NCT02656485|20081031|P2|NOT COMPLETED|Overall Study||3
8147837|NCT02656485|20081032|P1|NOT COMPLETED|Overall Study||2
8147838|NCT02656485|20081029|P4|COMPLETED|Overall Study||7
8147839|NCT02656485|20081030|P3|COMPLETED|Overall Study||7
8147840|NCT02656485|20081031|P2|COMPLETED|Overall Study||6
8147841|NCT02656485|20081032|P1|COMPLETED|Overall Study||7
8147842|NCT02656485|20081029|P4|STARTED|Overall Study||9
8147843|NCT02656485|20081030|P3|STARTED|Overall Study||9
8147844|NCT02656485|20081031|P2|STARTED|Overall Study||9
8147845|NCT02656485|20081032|P1|STARTED|Overall Study||9
8147846|NCT02656420|20081048|P4|NOT COMPLETED|Overall Study||0
8147847|NCT02656420|20081049|P3|NOT COMPLETED|Overall Study||0
8147848|NCT02656420|20081050|P2|NOT COMPLETED|Overall Study||1
8147849|NCT02656420|20081051|P1|NOT COMPLETED|Overall Study||0
8147850|NCT02656420|20081048|P4|COMPLETED|Overall Study||55
8147851|NCT02656420|20081049|P3|COMPLETED|Overall Study||35
8147852|NCT02656420|20081050|P2|COMPLETED|Overall Study||24
8147853|NCT02656420|20081051|P1|COMPLETED|Overall Study||55
8147854|NCT02656420|20081048|P4|STARTED|Overall Study||55
8147855|NCT02656420|20081049|P3|STARTED|Overall Study||35
8147856|NCT02656420|20081050|P2|STARTED|Overall Study||25
8147857|NCT02656420|20081051|P1|STARTED|Overall Study||55
8147858|NCT02656329|20081067|P2|NOT COMPLETED|Overall Study||157
8147859|NCT02656329|20081068|P1|NOT COMPLETED|Overall Study||164
8147860|NCT02656329|20081067|P2|COMPLETED|Overall Study||0
8147861|NCT02656329|20081068|P1|COMPLETED|Overall Study||0
8147862|NCT02656329|20081067|P2|STARTED|Overall Study||157
8147863|NCT02656329|20081068|P1|STARTED|Overall Study||164
8147870|NCT02656199|20081095|P1|NOT COMPLETED|Overall Study||0
8147871|NCT02656199|20081095|P1|COMPLETED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
8147872|NCT02656199|20081095|P1|STARTED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
8147873|NCT02656173|20081101|P2|NOT COMPLETED|Overall Study||11
8147874|NCT02656173|20081102|P1|NOT COMPLETED|Overall Study||13
8147875|NCT02656173|20081101|P2|COMPLETED|Overall Study||272
8147876|NCT02656173|20081102|P1|COMPLETED|Overall Study||272
8147877|NCT02656173|20081101|P2|Received Treatment|Overall Study||282
8147878|NCT02656173|20081102|P1|Received Treatment|Overall Study||284
8147879|NCT02656173|20081101|P2|STARTED|Overall Study||283
8147880|NCT02656173|20081102|P1|STARTED|Overall Study||285
8147881|NCT02656160|20081138|P2|NOT COMPLETED|Second Study Night||0
8147882|NCT02656160|20081139|P1|NOT COMPLETED|Second Study Night||0
8147883|NCT02656160|20081138|P2|COMPLETED|Second Study Night||6
8147884|NCT02656160|20081139|P1|COMPLETED|Second Study Night||4
8147885|NCT02656160|20081138|P2|STARTED|Second Study Night||6
8147886|NCT02656160|20081139|P1|STARTED|Second Study Night|3 subjects did not return for the second study night|4
8147887|NCT02656160|20081138|P2|NOT COMPLETED|First Study Night||0
8147888|NCT02656160|20081139|P1|NOT COMPLETED|First Study Night||0
8147889|NCT02656160|20081138|P2|COMPLETED|First Study Night||6
8147890|NCT02656160|20081139|P1|COMPLETED|First Study Night||7
8147891|NCT02656160|20081138|P2|STARTED|First Study Night||6
8147892|NCT02656160|20081139|P1|STARTED|First Study Night||7
8147893|NCT02656069|20081149|P2|NOT COMPLETED|Second Intervention||1
8147894|NCT02656069|20081150|P1|NOT COMPLETED|Second Intervention||1
8147895|NCT02656069|20081149|P2|COMPLETED|Second Intervention||35
8147896|NCT02656069|20081150|P1|COMPLETED|Second Intervention||43
8147897|NCT02656069|20081149|P2|STARTED|Second Intervention||36
8147898|NCT02656069|20081150|P1|STARTED|Second Intervention||44
8147899|NCT02656069|20081149|P2|NOT COMPLETED|First Intervention||0
8147900|NCT02656069|20081150|P1|NOT COMPLETED|First Intervention||0
8147901|NCT02656069|20081149|P2|COMPLETED|First Intervention||36
8147902|NCT02656069|20081150|P1|COMPLETED|First Intervention||44
8147903|NCT02656069|20081149|P2|STARTED|First Intervention||36
8147904|NCT02656069|20081150|P1|STARTED|First Intervention||44
8147908|NCT02655679|20081193|P5|NOT COMPLETED|Overall Study||1
8147909|NCT02655679|20081194|P4|NOT COMPLETED|Overall Study||4
8147910|NCT02655679|20081195|P3|NOT COMPLETED|Overall Study||1
8147911|NCT02655679|20081196|P2|NOT COMPLETED|Overall Study||3
8147912|NCT02655679|20081197|P1|NOT COMPLETED|Overall Study||3
8147913|NCT02655679|20081193|P5|COMPLETED|Overall Study||19
8147914|NCT02655679|20081194|P4|COMPLETED|Overall Study||20
8147915|NCT02655679|20081195|P3|COMPLETED|Overall Study||19
8147916|NCT02655679|20081196|P2|COMPLETED|Overall Study||16
8147917|NCT02655679|20081197|P1|COMPLETED|Overall Study||18
8147918|NCT02655679|20081193|P5|Received Study Drug (Safety Population)|Overall Study||20
8147919|NCT02655679|20081194|P4|Received Study Drug (Safety Population)|Overall Study||24
8147920|NCT02655679|20081195|P3|Received Study Drug (Safety Population)|Overall Study||20
8147921|NCT02655679|20081196|P2|Received Study Drug (Safety Population)|Overall Study||19
8147922|NCT02655679|20081197|P1|Received Study Drug (Safety Population)|Overall Study||20
8147923|NCT02655679|20081193|P5|STARTED|Overall Study||20
8147924|NCT02655679|20081194|P4|STARTED|Overall Study||24
8147925|NCT02655679|20081195|P3|STARTED|Overall Study||20
8147926|NCT02655679|20081196|P2|STARTED|Overall Study||19
8147927|NCT02655679|20081197|P1|STARTED|Overall Study||21
8147928|NCT02655666|20081269|P1|NOT COMPLETED|Overall Study||12
8147929|NCT02655666|20081269|P1|COMPLETED|Overall Study||4
8147930|NCT02655666|20081269|P1|STARTED|Overall Study||16
8147931|NCT02655653|20081285|P2|NOT COMPLETED|Overall Study||0
8147932|NCT02655653|20081286|P1|NOT COMPLETED|Overall Study||0
8147933|NCT02655653|20081285|P2|COMPLETED|Overall Study||58
8147934|NCT02655653|20081286|P1|COMPLETED|Overall Study||56
8147935|NCT02655653|20081285|P2|STARTED|Overall Study||58
8147936|NCT02655653|20081286|P1|STARTED|Overall Study||56
8147937|NCT02655510|20081311|P3|NOT COMPLETED|Overall Study||0
8147938|NCT02655510|20081312|P2|NOT COMPLETED|Overall Study||0
8147939|NCT02655510|20081313|P1|NOT COMPLETED|Overall Study||0
8147940|NCT02655510|20081311|P3|COMPLETED|Overall Study||6
8147941|NCT02655510|20081312|P2|COMPLETED|Overall Study||6
8147942|NCT02655510|20081313|P1|COMPLETED|Overall Study||6
8147943|NCT02655510|20081311|P3|STARTED|Overall Study||6
8147944|NCT02655510|20081312|P2|STARTED|Overall Study||6
8147945|NCT02655510|20081313|P1|STARTED|Overall Study||6
8147946|NCT02655419|20081323|P2|NOT COMPLETED|Overall Study||7
8147947|NCT02655419|20081324|P1|NOT COMPLETED|Overall Study||5
8147948|NCT02655419|20081323|P2|COMPLETED|Overall Study||16
8147949|NCT02655419|20081324|P1|COMPLETED|Overall Study||12
8147950|NCT02655419|20081323|P2|Treated|Overall Study||18
8147951|NCT02655419|20081324|P1|Treated|Overall Study||16
8147952|NCT02655419|20081323|P2|STARTED|Overall Study||23
8147953|NCT02655419|20081324|P1|STARTED|Overall Study||17
8147954|NCT02655237|20081444|P2|NOT COMPLETED|Overall Study||11
8147955|NCT02655237|20081445|P1|NOT COMPLETED|Overall Study||17
8147956|NCT02655237|20081444|P2|COMPLETED|Overall Study||131
8147957|NCT02655237|20081445|P1|COMPLETED|Overall Study||122
8147958|NCT02655237|20081444|P2|STARTED|Overall Study||142
8147959|NCT02655237|20081445|P1|STARTED|Overall Study||139
8147960|NCT02655224|20081485|P2|NOT COMPLETED|Overall Study||1
8147961|NCT02655224|20081486|P1|NOT COMPLETED|Overall Study||1
8147962|NCT02655224|20081485|P2|COMPLETED|Overall Study||31
8147963|NCT02655224|20081486|P1|COMPLETED|Overall Study||32
8147964|NCT02655224|20081485|P2|STARTED|Overall Study||32
8147965|NCT02655224|20081486|P1|STARTED|Overall Study||33
8147976|NCT02654977|20081551|P1|NOT COMPLETED|Overall Study||7
8147977|NCT02654977|20081551|P1|COMPLETED|Overall Study||4
8147978|NCT02654977|20081551|P1|STARTED|Overall Study||11
8147979|NCT02654782|20081558|P2|NOT COMPLETED|Overall Study||0
8147980|NCT02654782|20081559|P1|NOT COMPLETED|Overall Study||0
8147981|NCT02654782|20081558|P2|COMPLETED|Overall Study||5
8147982|NCT02654782|20081559|P1|COMPLETED|Overall Study||5
8147983|NCT02654782|20081558|P2|STARTED|Overall Study||5
8147984|NCT02654782|20081559|P1|STARTED|Overall Study||5
8147985|NCT02654769|20081570|P3|NOT COMPLETED|Overall Study||1
8147986|NCT02654769|20081571|P2|NOT COMPLETED|Overall Study||1
8147987|NCT02654769|20081572|P1|NOT COMPLETED|Overall Study||4
8147988|NCT02654769|20081570|P3|COMPLETED|Overall Study||142
8147989|NCT02654769|20081571|P2|COMPLETED|Overall Study||148
8147990|NCT02654769|20081572|P1|COMPLETED|Overall Study||145
8147991|NCT02654769|20081570|P3|STARTED|Overall Study||143
8147992|NCT02654769|20081571|P2|STARTED|Overall Study||149
8147993|NCT02654769|20081572|P1|STARTED|Overall Study||149
8147994|NCT02654717|20081585|P2|NOT COMPLETED|Overall Study||5
8147995|NCT02654717|20081586|P1|NOT COMPLETED|Overall Study||6
8147996|NCT02654717|20081585|P2|COMPLETED|Overall Study||50
8147997|NCT02654717|20081586|P1|COMPLETED|Overall Study||50
8147998|NCT02654717|20081585|P2|STARTED|Overall Study||55
8147999|NCT02654717|20081586|P1|STARTED|Overall Study||56
8148000|NCT02654652|20081594|P2|NOT COMPLETED|Overall Study||3
8148001|NCT02654652|20081595|P1|NOT COMPLETED|Overall Study||1
8148002|NCT02654652|20081594|P2|COMPLETED|Overall Study||18
8148003|NCT02654652|20081595|P1|COMPLETED|Overall Study||18
8148004|NCT02654652|20081594|P2|STARTED|Overall Study||21
8148005|NCT02654652|20081595|P1|STARTED|Overall Study||19
8148006|NCT02654639|20081603|P1|NOT COMPLETED|Overall Study||0
8148007|NCT02654639|20081603|P1|COMPLETED|Overall Study||4
8148008|NCT02654639|20081603|P1|STARTED|Overall Study||4
8148009|NCT02654483|20081609|P2|NOT COMPLETED|Open-label||0
8148010|NCT02654483|20081610|P1|NOT COMPLETED|Open-label||0
8148011|NCT02654483|20081609|P2|COMPLETED|Open-label||3
8148012|NCT02654483|20081610|P1|COMPLETED|Open-label||5
8148013|NCT02654483|20081609|P2|STARTED|Open-label|4 participants did not continue to open-label arm|3
8148014|NCT02654483|20081610|P1|STARTED|Open-label|2 participants did not proceed to open-label arm|5
8148015|NCT02654483|20081609|P2|NOT COMPLETED|Double-blind||0
8148016|NCT02654483|20081610|P1|NOT COMPLETED|Double-blind||0
8148017|NCT02654483|20081609|P2|COMPLETED|Double-blind||7
8148018|NCT02654483|20081610|P1|COMPLETED|Double-blind||7
8148019|NCT02654483|20081609|P2|STARTED|Double-blind||7
8148020|NCT02654483|20081610|P1|STARTED|Double-blind||7
8148021|NCT02654314|20081624|P2|NOT COMPLETED|Overall Study||0
8148022|NCT02654314|20081625|P1|NOT COMPLETED|Overall Study||0
8148023|NCT02654314|20081624|P2|COMPLETED|Overall Study||141
8148024|NCT02654314|20081625|P1|COMPLETED|Overall Study||136
8148025|NCT02654314|20081624|P2|STARTED|Overall Study||141
8148026|NCT02654314|20081625|P1|STARTED|Overall Study||136
8148027|NCT02654145|20081637|P1|NOT COMPLETED|Overall Study||7
8148028|NCT02654145|20081637|P1|COMPLETED|Overall Study||138
8148029|NCT02654145|20081637|P1|STARTED|Overall Study||145
8148030|NCT02654132|20081646|P2|NOT COMPLETED|Overall Study||46
8148031|NCT02654132|20081647|P1|NOT COMPLETED|Overall Study||36
8148032|NCT02654132|20081646|P2|COMPLETED|Overall Study||11
8148033|NCT02654132|20081647|P1|COMPLETED|Overall Study||24
8148034|NCT02654132|20081646|P2|STARTED|Overall Study||57
8148035|NCT02654132|20081647|P1|STARTED|Overall Study||60
8148036|NCT02654054|20081658|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||30
8148037|NCT02654054|20081659|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||8
8148038|NCT02654054|20081660|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||8
8148039|NCT02654054|20081658|P3|COMPLETED|Post-Treatment Follow-Up Period||29
8148040|NCT02654054|20081659|P2|COMPLETED|Post-Treatment Follow-Up Period||24
8148041|NCT02654054|20081660|P1|COMPLETED|Post-Treatment Follow-Up Period||17
8148042|NCT02654054|20081658|P3|STARTED|Post-Treatment Follow-Up Period||59
8148043|NCT02654054|20081659|P2|STARTED|Post-Treatment Follow-Up Period||32
8148044|NCT02654054|20081660|P1|STARTED|Post-Treatment Follow-Up Period||25
8148045|NCT02654054|20081658|P3|NOT COMPLETED|Treatment Period||43
8148046|NCT02654054|20081659|P2|NOT COMPLETED|Treatment Period||23
8148047|NCT02654054|20081660|P1|NOT COMPLETED|Treatment Period||19
8148048|NCT02654054|20081658|P3|COMPLETED|Treatment Period||164
8148049|NCT02654054|20081659|P2|COMPLETED|Treatment Period||81
8148050|NCT02654054|20081660|P1|COMPLETED|Treatment Period||83
8148051|NCT02654054|20081658|P3|Randomized and Treated|Treatment Period||206
8148052|NCT02654054|20081659|P2|Randomized and Treated|Treatment Period||104
8148053|NCT02654054|20081660|P1|Randomized and Treated|Treatment Period||102
8148054|NCT02654054|20081658|P3|STARTED|Treatment Period||207
8148055|NCT02654054|20081659|P2|STARTED|Treatment Period||104
8148056|NCT02654054|20081660|P1|STARTED|Treatment Period||102
8148057|NCT02654002|20081695|P9|NOT COMPLETED|Overall Study||0
8148058|NCT02654002|20081696|P8|NOT COMPLETED|Overall Study||1
8148059|NCT02654002|20081697|P7|NOT COMPLETED|Overall Study||1
8148060|NCT02654002|20081698|P6|NOT COMPLETED|Overall Study||1
8148061|NCT02654002|20081699|P5|NOT COMPLETED|Overall Study||0
8148062|NCT02654002|20081700|P4|NOT COMPLETED|Overall Study||0
8148063|NCT02654002|20081701|P3|NOT COMPLETED|Overall Study||0
8148064|NCT02654002|20081702|P2|NOT COMPLETED|Overall Study||0
8148065|NCT02654002|20081703|P1|NOT COMPLETED|Overall Study||0
8148066|NCT02654002|20081695|P9|COMPLETED|Overall Study||24
8148067|NCT02654002|20081696|P8|COMPLETED|Overall Study||11
8148068|NCT02654002|20081697|P7|COMPLETED|Overall Study||11
8148069|NCT02654002|20081698|P6|COMPLETED|Overall Study||11
8148070|NCT02654002|20081699|P5|COMPLETED|Overall Study||12
8148071|NCT02654002|20081700|P4|COMPLETED|Overall Study||12
8148072|NCT02654002|20081701|P3|COMPLETED|Overall Study||12
8148073|NCT02654002|20081702|P2|COMPLETED|Overall Study||12
8148074|NCT02654002|20081703|P1|COMPLETED|Overall Study||12
8148075|NCT02654002|20081695|P9|STARTED|Overall Study||24
8148076|NCT02654002|20081696|P8|STARTED|Overall Study||12
8148077|NCT02654002|20081697|P7|STARTED|Overall Study||12
8148078|NCT02654002|20081698|P6|STARTED|Overall Study||12
8148079|NCT02654002|20081699|P5|STARTED|Overall Study||12
8148080|NCT02654002|20081700|P4|STARTED|Overall Study||12
8148081|NCT02654002|20081701|P3|STARTED|Overall Study||12
8148082|NCT02654002|20081702|P2|STARTED|Overall Study||12
8148083|NCT02654002|20081703|P1|STARTED|Overall Study||12
8148084|NCT02653872|20081829|P1|NOT COMPLETED|Overall Study||0
8148085|NCT02653872|20081829|P1|COMPLETED|Overall Study||15
8148086|NCT02653872|20081829|P1|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
8148087|NCT02653872|20081829|P1|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
8148088|NCT02653872|20081829|P1|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
8148089|NCT02653872|20081829|P1|STARTED|Overall Study||15
8148090|NCT02653768|20081866|P2|NOT COMPLETED|9-Month Follow-Up (Primary)||16
8148091|NCT02653768|20081867|P1|NOT COMPLETED|9-Month Follow-Up (Primary)||33
8148092|NCT02653768|20081866|P2|COMPLETED|9-Month Follow-Up (Primary)||95
8148093|NCT02653768|20081867|P1|COMPLETED|9-Month Follow-Up (Primary)|13 withdrew/refused before 9 months; others missed prior assessments but remained in study|163
8148094|NCT02653768|20081866|P2|STARTED|9-Month Follow-Up (Primary)|4 withdrew/excluded before 9 months; others missed prior assessments but remained in study|111
8148095|NCT02653768|20081867|P1|STARTED|9-Month Follow-Up (Primary)|34 withdrew/excluded before 9 months; others missed prior assessments but remained in study|196
8148096|NCT02653768|20081866|P2|NOT COMPLETED|6-Month Follow-Up||13
8148097|NCT02653768|20081867|P1|NOT COMPLETED|6-Month Follow-Up||45
8148098|NCT02653768|20081866|P2|COMPLETED|6-Month Follow-Up||100
8148099|NCT02653768|20081867|P1|COMPLETED|6-Month Follow-Up||164
8148100|NCT02653768|20081866|P2|STARTED|6-Month Follow-Up|2 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|113
8148101|NCT02653768|20081867|P1|STARTED|6-Month Follow-Up|21 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|209
8148102|NCT02653768|20081866|P2|NOT COMPLETED|3-Month Follow-Up||15
8148103|NCT02653768|20081867|P1|NOT COMPLETED|3-Month Follow-Up||66
8148104|NCT02653768|20081866|P2|COMPLETED|3-Month Follow-Up||100
8148105|NCT02653768|20081867|P1|COMPLETED|3-Month Follow-Up||164
8148106|NCT02653768|20081866|P2|STARTED|3-Month Follow-Up||115
8148107|NCT02653768|20081867|P1|STARTED|3-Month Follow-Up||230
8148108|NCT02653625|20081877|P1|NOT COMPLETED|Overall Study||4
8148109|NCT02653625|20081877|P1|COMPLETED|Overall Study||20
8148110|NCT02653625|20081877|P1|STARTED|Overall Study||24
8148111|NCT02653560|20081886|P4|NOT COMPLETED|Placebo Phase||0
8148112|NCT02653560|20081887|P3|NOT COMPLETED|Placebo Phase||0
8148113|NCT02653560|20081888|P2|NOT COMPLETED|Placebo Phase||0
8148114|NCT02653560|20081889|P1|NOT COMPLETED|Placebo Phase||0
8148115|NCT02653560|20081886|P4|COMPLETED|Placebo Phase||30
8148116|NCT02653560|20081887|P3|COMPLETED|Placebo Phase||0
8148117|NCT02653560|20081888|P2|COMPLETED|Placebo Phase||0
8148118|NCT02653560|20081889|P1|COMPLETED|Placebo Phase||0
8148119|NCT02653560|20081886|P4|STARTED|Placebo Phase||30
8148120|NCT02653560|20081887|P3|STARTED|Placebo Phase||0
8148121|NCT02653560|20081888|P2|STARTED|Placebo Phase||0
8148122|NCT02653560|20081889|P1|STARTED|Placebo Phase||0
8148123|NCT02653560|20081886|P4|NOT COMPLETED|KCl Phase||0
8148124|NCT02653560|20081887|P3|NOT COMPLETED|KCl Phase||0
8148125|NCT02653560|20081888|P2|NOT COMPLETED|KCl Phase||0
8148126|NCT02653560|20081889|P1|NOT COMPLETED|KCl Phase||0
8148127|NCT02653560|20081886|P4|COMPLETED|KCl Phase||0
8148128|NCT02653560|20081887|P3|COMPLETED|KCl Phase||30
8148129|NCT02653560|20081888|P2|COMPLETED|KCl Phase||0
8148130|NCT02653560|20081889|P1|COMPLETED|KCl Phase||0
8148131|NCT02653560|20081886|P4|STARTED|KCl Phase||0
8148132|NCT02653560|20081887|P3|STARTED|KCl Phase||30
8148133|NCT02653560|20081888|P2|STARTED|KCl Phase||0
8148134|NCT02653560|20081889|P1|STARTED|KCl Phase||0
8148135|NCT02653560|20081886|P4|NOT COMPLETED|K Citrate Phase||0
8148136|NCT02653560|20081887|P3|NOT COMPLETED|K Citrate Phase||0
8148137|NCT02653560|20081888|P2|NOT COMPLETED|K Citrate Phase||0
8148138|NCT02653560|20081889|P1|NOT COMPLETED|K Citrate Phase||0
8148139|NCT02653560|20081886|P4|COMPLETED|K Citrate Phase||0
8148140|NCT02653560|20081887|P3|COMPLETED|K Citrate Phase||0
8148141|NCT02653560|20081888|P2|COMPLETED|K Citrate Phase||30
8148142|NCT02653560|20081889|P1|COMPLETED|K Citrate Phase||0
8148143|NCT02653560|20081886|P4|STARTED|K Citrate Phase||0
8148144|NCT02653560|20081887|P3|STARTED|K Citrate Phase||0
8148145|NCT02653560|20081888|P2|STARTED|K Citrate Phase||30
8148146|NCT02653560|20081889|P1|STARTED|K Citrate Phase||0
8148147|NCT02653560|20081886|P4|NOT COMPLETED|KMgCit Phase||0
8148148|NCT02653560|20081887|P3|NOT COMPLETED|KMgCit Phase||0
8148149|NCT02653560|20081888|P2|NOT COMPLETED|KMgCit Phase||0
8148150|NCT02653560|20081889|P1|NOT COMPLETED|KMgCit Phase||0
8148151|NCT02653560|20081886|P4|COMPLETED|KMgCit Phase||0
8148152|NCT02653560|20081887|P3|COMPLETED|KMgCit Phase||0
8148153|NCT02653560|20081888|P2|COMPLETED|KMgCit Phase||0
8148154|NCT02653560|20081889|P1|COMPLETED|KMgCit Phase||30
8148155|NCT02653560|20081886|P4|STARTED|KMgCit Phase||0
8148156|NCT02653560|20081887|P3|STARTED|KMgCit Phase||0
8148157|NCT02653560|20081888|P2|STARTED|KMgCit Phase||0
8148158|NCT02653560|20081889|P1|STARTED|KMgCit Phase||30
8148159|NCT02653495|20081901|P2|NOT COMPLETED|Overall Study||0
8148160|NCT02653495|20081902|P1|NOT COMPLETED|Overall Study||12
8148161|NCT02653495|20081901|P2|COMPLETED|Overall Study||2
8148162|NCT02653495|20081902|P1|COMPLETED|Overall Study||3
8148163|NCT02653495|20081901|P2|STARTED|Overall Study||2
8148164|NCT02653495|20081902|P1|STARTED|Overall Study||15
8148165|NCT02653456|20081916|P1|NOT COMPLETED|Overall Study||5
8148166|NCT02653456|20081916|P1|COMPLETED|Overall Study||59
8148167|NCT02653456|20081916|P1|STARTED|Overall Study||64
8148168|NCT02653417|20081927|P4|NOT COMPLETED|Overall Study||5
8148169|NCT02653417|20081928|P3|NOT COMPLETED|Overall Study||3
8148170|NCT02653417|20081929|P2|NOT COMPLETED|Overall Study||2
8148171|NCT02653417|20081930|P1|NOT COMPLETED|Overall Study||1
8148172|NCT02653417|20081927|P4|COMPLETED|Overall Study||33
8148173|NCT02653417|20081928|P3|COMPLETED|Overall Study||26
8148174|NCT02653417|20081929|P2|COMPLETED|Overall Study||32
8148175|NCT02653417|20081930|P1|COMPLETED|Overall Study||37
8148176|NCT02653417|20081927|P4|STARTED|Overall Study||38
8148177|NCT02653417|20081928|P3|STARTED|Overall Study||29
8148178|NCT02653417|20081929|P2|STARTED|Overall Study||34
8148179|NCT02653417|20081930|P1|STARTED|Overall Study||38
8148180|NCT02653326|20081954|P2|NOT COMPLETED|Overall Study||7
8148181|NCT02653326|20081955|P1|NOT COMPLETED|Overall Study||10
8148182|NCT02653326|20081954|P2|COMPLETED|Overall Study||27
8148183|NCT02653326|20081955|P1|COMPLETED|Overall Study||22
8148184|NCT02653326|20081954|P2|STARTED|Overall Study||34
8148185|NCT02653326|20081955|P1|STARTED|Overall Study||32
8148186|NCT02653183|20081969|P2|NOT COMPLETED|Overall Study||4
8148187|NCT02653183|20081970|P1|NOT COMPLETED|Overall Study||4
8148188|NCT02653183|20081969|P2|COMPLETED|Overall Study||46
8148189|NCT02653183|20081970|P1|COMPLETED|Overall Study||49
8148190|NCT02653183|20081969|P2|STARTED|Overall Study||50
8148191|NCT02653183|20081970|P1|STARTED|Overall Study||53
8148192|NCT02653170|20081993|P3|NOT COMPLETED|Overall Study||18
8148193|NCT02653170|20081994|P2|NOT COMPLETED|Overall Study||16
8148194|NCT02653170|20081995|P1|NOT COMPLETED|Overall Study||17
8148195|NCT02653170|20081993|P3|COMPLETED|Overall Study||72
8148196|NCT02653170|20081994|P2|COMPLETED|Overall Study||72
8148197|NCT02653170|20081995|P1|COMPLETED|Overall Study||70
8148198|NCT02653170|20081993|P3|STARTED|Overall Study||90
8148199|NCT02653170|20081994|P2|STARTED|Overall Study||88
8148200|NCT02653170|20081995|P1|STARTED|Overall Study||87
8148201|NCT02653144|20082018|P3|NOT COMPLETED|Overall Study||0
8148202|NCT02653144|20082019|P2|NOT COMPLETED|Overall Study||0
8148203|NCT02653144|20082020|P1|NOT COMPLETED|Overall Study||0
8148204|NCT02653144|20082018|P3|COMPLETED|Overall Study||31
8148205|NCT02653144|20082019|P2|COMPLETED|Overall Study||28
8148206|NCT02653144|20082020|P1|COMPLETED|Overall Study||30
8148207|NCT02653144|20082018|P3|STARTED|Overall Study||31
8148208|NCT02653144|20082019|P2|STARTED|Overall Study||28
8148209|NCT02653144|20082020|P1|STARTED|Overall Study||30
8148222|NCT02652780|20082046|P1|NOT COMPLETED|Overall Study||0
8148223|NCT02652780|20082046|P1|COMPLETED|Overall Study||37
8148224|NCT02652780|20082046|P1|STARTED|Overall Study||37
8148225|NCT02652767|20082072|P1|NOT COMPLETED|Overall Study||4
8148226|NCT02652767|20082072|P1|COMPLETED|Overall Study||35
8148227|NCT02652767|20082072|P1|Completed Week 48|Overall Study||38
8148228|NCT02652767|20082072|P1|STARTED|Overall Study||39
8148229|NCT02652624|20082100|P2|NOT COMPLETED|Extension Phase||4
8148230|NCT02652624|20082101|P1|NOT COMPLETED|Extension Phase||4
8148231|NCT02652624|20082100|P2|COMPLETED|Extension Phase||224
8148232|NCT02652624|20082101|P1|COMPLETED|Extension Phase||227
8148233|NCT02652624|20082100|P2|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228
8148234|NCT02652624|20082101|P1|STARTED|Extension Phase||231
8148235|NCT02652624|20082100|P2|NOT COMPLETED|Randomized Phase||5
8148236|NCT02652624|20082101|P1|NOT COMPLETED|Randomized Phase||3
8148237|NCT02652624|20082100|P2|COMPLETED|Randomized Phase||231
8148238|NCT02652624|20082101|P1|COMPLETED|Randomized Phase||231
8148239|NCT02652624|20082100|P2|STARTED|Randomized Phase||236
8148240|NCT02652624|20082101|P1|STARTED|Randomized Phase||234
8148241|NCT02652481|20082113|P1|NOT COMPLETED|Phase 2||18
8148242|NCT02652481|20082113|P1|COMPLETED|Phase 2||243
8148243|NCT02652481|20082113|P1|STARTED|Phase 2||261
8148244|NCT02652481|20082113|P1|NOT COMPLETED|Phase 1||98
8148245|NCT02652481|20082113|P1|COMPLETED|Phase 1||141
8148246|NCT02652481|20082113|P1|STARTED|Phase 1||239
8148247|NCT02652468|20082121|P1|NOT COMPLETED|Overall Study||0
8148248|NCT02652468|20082121|P1|COMPLETED|Overall Study||11
8148249|NCT02652468|20082121|P1|STARTED|Overall Study||11
8148250|NCT02652416|20082129|P4|NOT COMPLETED|Overall Study||0
8148251|NCT02652416|20082130|P3|NOT COMPLETED|Overall Study||0
8148252|NCT02652416|20082131|P2|NOT COMPLETED|Overall Study||0
8148253|NCT02652416|20082132|P1|NOT COMPLETED|Overall Study||0
8148254|NCT02652416|20082129|P4|COMPLETED|Overall Study||18
8148255|NCT02652416|20082130|P3|COMPLETED|Overall Study||18
8148256|NCT02652416|20082131|P2|COMPLETED|Overall Study||18
8148257|NCT02652416|20082132|P1|COMPLETED|Overall Study||18
8148258|NCT02652416|20082129|P4|Subjects Who Participated in MD Part|Overall Study||18
8148259|NCT02652416|20082130|P3|Subjects Who Participated in MD Part|Overall Study||0
8148260|NCT02652416|20082131|P2|Subjects Who Participated in MD Part|Overall Study||0
8148261|NCT02652416|20082132|P1|Subjects Who Participated in MD Part|Overall Study||6
8148262|NCT02652416|20082129|P4|STARTED|Overall Study||18
8148263|NCT02652416|20082130|P3|STARTED|Overall Study||18
8148264|NCT02652416|20082131|P2|STARTED|Overall Study||18
8148265|NCT02652416|20082132|P1|STARTED|Overall Study||18
8148266|NCT02652390|20082163|P3|NOT COMPLETED|Overall Study||0
8148267|NCT02652390|20082164|P2|NOT COMPLETED|Overall Study||0
8148268|NCT02652390|20082165|P1|NOT COMPLETED|Overall Study||0
8148269|NCT02652390|20082163|P3|COMPLETED|Overall Study||37
8148270|NCT02652390|20082164|P2|COMPLETED|Overall Study||37
8148271|NCT02652390|20082165|P1|COMPLETED|Overall Study||37
8148272|NCT02652390|20082163|P3|STARTED|Overall Study||37
8148273|NCT02652390|20082164|P2|STARTED|Overall Study||37
8148274|NCT02652390|20082165|P1|STARTED|Overall Study||37
8148275|NCT02652260|20082189|P2|NOT COMPLETED|Overall Study||2
8148276|NCT02652260|20082190|P1|NOT COMPLETED|Overall Study||0
8148277|NCT02652260|20082189|P2|COMPLETED|Overall Study||41
8148278|NCT02652260|20082190|P1|COMPLETED|Overall Study||43
8148279|NCT02652260|20082189|P2|STARTED|Overall Study||43
8148280|NCT02652260|20082190|P1|STARTED|Overall Study||43
8148281|NCT02652221|20082226|P1|NOT COMPLETED|Overall Study||0
8148282|NCT02652221|20082226|P1|COMPLETED|Overall Study||55
8148283|NCT02652221|20082226|P1|STARTED|Overall Study||55
8148284|NCT02652208|20082235|P2|NOT COMPLETED|Overall Study||2
8148285|NCT02652208|20082236|P1|NOT COMPLETED|Overall Study||4
8148286|NCT02652208|20082235|P2|COMPLETED|Overall Study||15
8148287|NCT02652208|20082236|P1|COMPLETED|Overall Study||13
8148288|NCT02652208|20082235|P2|STARTED|Overall Study||17
8148289|NCT02652208|20082236|P1|STARTED|Overall Study||17
8148290|NCT02652156|20082249|P3|NOT COMPLETED|Overall Study||0
8148291|NCT02652156|20082250|P2|NOT COMPLETED|Overall Study||0
8148292|NCT02652156|20082251|P1|NOT COMPLETED|Overall Study||1
8148293|NCT02652156|20082249|P3|COMPLETED|Overall Study||4
8148294|NCT02652156|20082250|P2|COMPLETED|Overall Study||6
8148295|NCT02652156|20082251|P1|COMPLETED|Overall Study||3
8148296|NCT02652156|20082249|P3|STARTED|Overall Study||4
8148297|NCT02652156|20082250|P2|STARTED|Overall Study||6
8148298|NCT02652156|20082251|P1|STARTED|Overall Study||4
8148299|NCT02651987|20082279|P2|NOT COMPLETED|Overall Study||5
8148300|NCT02651987|20082280|P1|NOT COMPLETED|Overall Study||5
8148301|NCT02651987|20082279|P2|COMPLETED|Overall Study||46
8148302|NCT02651987|20082280|P1|COMPLETED|Overall Study||43
8148303|NCT02651987|20082279|P2|STARTED|Overall Study||51
8148304|NCT02651987|20082280|P1|STARTED|Overall Study||48
8148305|NCT02651922|20082321|P1|NOT COMPLETED|Overall Study||2
8148306|NCT02651922|20082321|P1|COMPLETED|Overall Study||154
8148307|NCT02651922|20082321|P1|STARTED|Overall Study||156
8148308|NCT02651688|20082341|P3|NOT COMPLETED|Overall Study||3
8148309|NCT02651688|20082342|P2|NOT COMPLETED|Overall Study||5
8148310|NCT02651688|20082343|P1|NOT COMPLETED|Overall Study||2
8148311|NCT02651688|20082341|P3|COMPLETED|Overall Study||12
8148312|NCT02651688|20082342|P2|COMPLETED|Overall Study||12
8148313|NCT02651688|20082343|P1|COMPLETED|Overall Study||16
8148314|NCT02651688|20082341|P3|STARTED|Overall Study||15
8148315|NCT02651688|20082342|P2|STARTED|Overall Study||17
8148316|NCT02651688|20082343|P1|STARTED|Overall Study||18
8148317|NCT02651584|20082410|P2|NOT COMPLETED|Overall Study||92
8148318|NCT02651584|20082411|P1|NOT COMPLETED|Overall Study||89
8148319|NCT02651584|20082410|P2|COMPLETED|Overall Study||121
8148320|NCT02651584|20082411|P1|COMPLETED|Overall Study||126
8148321|NCT02651584|20082410|P2|STARTED|Overall Study||213
8148322|NCT02651584|20082411|P1|STARTED|Overall Study||215
8148323|NCT02651467|20082426|P3|NOT COMPLETED|Overall Study||4
8148324|NCT02651467|20082427|P2|NOT COMPLETED|Overall Study||0
8148325|NCT02651467|20082428|P1|NOT COMPLETED|Overall Study||1
8148326|NCT02651467|20082426|P3|COMPLETED|Overall Study||69
8148327|NCT02651467|20082427|P2|COMPLETED|Overall Study||74
8148328|NCT02651467|20082428|P1|COMPLETED|Overall Study||73
8148329|NCT02651467|20082426|P3|STARTED|Overall Study||73
8148330|NCT02651467|20082427|P2|STARTED|Overall Study||74
8148331|NCT02651467|20082428|P1|STARTED|Overall Study||74
8148332|NCT02651415|20082447|P1|NOT COMPLETED|Overall Study||2
8148333|NCT02651415|20082447|P1|COMPLETED|Overall Study|10 patients were evaluable.|10
8148334|NCT02651415|20082447|P1|STARTED|Overall Study|12 patients were enrolled.|12
8148335|NCT02651337|20082456|P1|NOT COMPLETED|Overall Study||1
8148336|NCT02651337|20082456|P1|COMPLETED|Overall Study||4
8148337|NCT02651337|20082456|P1|STARTED|Overall Study||5
8148338|NCT02651272|20082460|P1|NOT COMPLETED|Overall Study||3
8148339|NCT02651272|20082460|P1|COMPLETED|Overall Study||1
8148340|NCT02651272|20082460|P1|STARTED|Overall Study||4
8148341|NCT02651259|20082477|P2|NOT COMPLETED|Overall Study||0
8148342|NCT02651259|20082478|P1|NOT COMPLETED|Overall Study||0
8148343|NCT02651259|20082477|P2|COMPLETED|Overall Study||25
8148344|NCT02651259|20082478|P1|COMPLETED|Overall Study||25
8148345|NCT02651259|20082477|P2|STARTED|Overall Study||25
8148346|NCT02651259|20082478|P1|STARTED|Overall Study||25
8148347|NCT02651220|20082522|P3|NOT COMPLETED|Overall Study||29
8148348|NCT02651220|20082523|P2|NOT COMPLETED|Overall Study||27
8148349|NCT02651220|20082524|P1|NOT COMPLETED|Overall Study||23
8148350|NCT02651220|20082522|P3|COMPLETED|Overall Study||300
8148351|NCT02651220|20082523|P2|COMPLETED|Overall Study||308
8148352|NCT02651220|20082524|P1|COMPLETED|Overall Study||314
8148353|NCT02651220|20082522|P3|STARTED|Overall Study||329
8148354|NCT02651220|20082523|P2|STARTED|Overall Study||335
8148355|NCT02651220|20082524|P1|STARTED|Overall Study||337
8148356|NCT02651194|20082538|P1|NOT COMPLETED|Overall Study||5
8148357|NCT02651194|20082538|P1|COMPLETED|Overall Study||99
8148358|NCT02651194|20082538|P1|STARTED|Overall Study||104
8148359|NCT02651155|20082546|P2|NOT COMPLETED|Overall Study||2
8148360|NCT02651155|20082547|P1|NOT COMPLETED|Overall Study||6
8148361|NCT02651155|20082546|P2|COMPLETED|Overall Study||103
8148362|NCT02651155|20082547|P1|COMPLETED|Overall Study||93
8148363|NCT02651155|20082546|P2|STARTED|Overall Study||105
8148364|NCT02651155|20082547|P1|STARTED|Overall Study||99
8148365|NCT02651103|20082563|P1|NOT COMPLETED|Overall Study||0
8148366|NCT02651103|20082563|P1|COMPLETED|Overall Study||30
8148367|NCT02651103|20082563|P1|STARTED|Overall Study||30
8148371|NCT02650921|20082572|P1|NOT COMPLETED|Overall Study||8
8148372|NCT02650921|20082572|P1|COMPLETED|Overall Study||84
8148373|NCT02650921|20082572|P1|STARTED|Overall Study||92
8148406|NCT02650466|20082678|P1|NOT COMPLETED|Overall Study||7
8148407|NCT02650466|20082678|P1|COMPLETED|Overall Study||17
8148408|NCT02650466|20082678|P1|STARTED|Overall Study||24
8148409|NCT02650440|20082686|P2|NOT COMPLETED|Overall Study||2
8148410|NCT02650440|20082687|P1|NOT COMPLETED|Overall Study||0
8148411|NCT02650440|20082686|P2|COMPLETED|Overall Study||8
8148412|NCT02650440|20082687|P1|COMPLETED|Overall Study||10
8148413|NCT02650440|20082686|P2|STARTED|Overall Study||10
8148414|NCT02650440|20082687|P1|STARTED|Overall Study||10
8148415|NCT02650219|20082705|P2|NOT COMPLETED|Overall Study||0
8148416|NCT02650219|20082706|P1|NOT COMPLETED|Overall Study||0
8148417|NCT02650219|20082705|P2|COMPLETED|Overall Study||20
8148418|NCT02650219|20082706|P1|COMPLETED|Overall Study||40
8148419|NCT02650219|20082705|P2|STARTED|Overall Study||20
8148420|NCT02650219|20082706|P1|STARTED|Overall Study||40
8148421|NCT02650193|20082719|P3|NOT COMPLETED|Overall Study||0
8148422|NCT02650193|20082720|P2|NOT COMPLETED|Overall Study||0
8148423|NCT02650193|20082721|P1|NOT COMPLETED|Overall Study||0
8148424|NCT02650193|20082719|P3|COMPLETED|Overall Study||13
8148425|NCT02650193|20082720|P2|COMPLETED|Overall Study||6
8148426|NCT02650193|20082721|P1|COMPLETED|Overall Study||6
8148427|NCT02650193|20082719|P3|STARTED|Overall Study||13
8148428|NCT02650193|20082720|P2|STARTED|Overall Study||6
8148429|NCT02650193|20082721|P1|STARTED|Overall Study||6
8148430|NCT02650128|20082808|P1|NOT COMPLETED|Overall Study||2
8148431|NCT02650128|20082808|P1|COMPLETED|Overall Study||58
8148432|NCT02650128|20082808|P1|30 Day Primary and Safety Endpoint|Overall Study||60
8148433|NCT02650128|20082808|P1|STARTED|Overall Study||60
8148440|NCT02649894|20082847|P2|NOT COMPLETED|Overall Study||11
8148441|NCT02649894|20082848|P1|NOT COMPLETED|Overall Study||44
8148442|NCT02649894|20082847|P2|COMPLETED|Overall Study||27
8148443|NCT02649894|20082848|P1|COMPLETED|Overall Study||37
8148444|NCT02649894|20082847|P2|Completed Day 30|Overall Study||35
8148445|NCT02649894|20082848|P1|Completed Day 30|Overall Study||56
8148446|NCT02649894|20082847|P2|Device Inserted|Overall Study||37
8148447|NCT02649894|20082848|P1|Device Inserted|Overall Study||77
8148448|NCT02649894|20082847|P2|STARTED|Overall Study||38
8148449|NCT02649894|20082848|P1|STARTED|Overall Study||81
8148450|NCT02649842|20082868|P1|NOT COMPLETED|Overall Study||0
8148451|NCT02649842|20082868|P1|COMPLETED|Overall Study||101
8148452|NCT02649842|20082868|P1|STARTED|Overall Study||101
8148453|NCT02649634|20082876|P2|NOT COMPLETED|Overall Study||6
8148454|NCT02649634|20082877|P1|NOT COMPLETED|Overall Study||3
8148455|NCT02649634|20082876|P2|COMPLETED|Overall Study||60
8148456|NCT02649634|20082877|P1|COMPLETED|Overall Study||66
8148457|NCT02649634|20082876|P2|STARTED|Overall Study||66
8148458|NCT02649634|20082877|P1|STARTED|Overall Study||69
8148480|NCT02649556|20082985|P4|NOT COMPLETED|Overall Study||23
8148481|NCT02649556|20082986|P3|NOT COMPLETED|Overall Study||50
8148482|NCT02649556|20082987|P2|NOT COMPLETED|Overall Study||112
8148483|NCT02649556|20082988|P1|NOT COMPLETED|Overall Study||63
8148484|NCT02649556|20082985|P4|COMPLETED|Overall Study||28
8148485|NCT02649556|20082986|P3|COMPLETED|Overall Study||102
8148486|NCT02649556|20082987|P2|COMPLETED|Overall Study||312
8148487|NCT02649556|20082988|P1|COMPLETED|Overall Study||167
8148488|NCT02649556|20082985|P4|STARTED|Overall Study||51
8148489|NCT02649556|20082986|P3|STARTED|Overall Study||152
8148490|NCT02649556|20082987|P2|STARTED|Overall Study||424
8148491|NCT02649556|20082988|P1|STARTED|Overall Study||230
8148492|NCT02649322|20083028|P2|NOT COMPLETED|Overall Study||0
8148493|NCT02649322|20083029|P1|NOT COMPLETED|Overall Study||0
8148494|NCT02649322|20083028|P2|COMPLETED|Overall Study||57
8148495|NCT02649322|20083029|P1|COMPLETED|Overall Study||58
8148496|NCT02649322|20083028|P2|STARTED|Overall Study||57
8148497|NCT02649322|20083029|P1|STARTED|Overall Study||58
8148501|NCT02649192|20083051|P6|NOT COMPLETED|Overall Study||0
8148502|NCT02649192|20083052|P5|NOT COMPLETED|Overall Study||1
8148503|NCT02649192|20083053|P4|NOT COMPLETED|Overall Study||2
8148504|NCT02649192|20083054|P3|NOT COMPLETED|Overall Study||1
8148505|NCT02649192|20083055|P2|NOT COMPLETED|Overall Study||0
8148506|NCT02649192|20083056|P1|NOT COMPLETED|Overall Study||0
8148507|NCT02649192|20083051|P6|COMPLETED|Overall Study||14
8148508|NCT02649192|20083052|P5|COMPLETED|Overall Study||11
8148509|NCT02649192|20083053|P4|COMPLETED|Overall Study||20
8148510|NCT02649192|20083054|P3|COMPLETED|Overall Study||21
8148511|NCT02649192|20083055|P2|COMPLETED|Overall Study||4
8148512|NCT02649192|20083056|P1|COMPLETED|Overall Study||5
8148513|NCT02649192|20083051|P6|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6
8148514|NCT02649192|20083052|P5|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5
8148515|NCT02649192|20083053|P4|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10
8148516|NCT02649192|20083054|P3|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11
8148517|NCT02649192|20083055|P2|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2
8148518|NCT02649192|20083056|P1|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3
8148519|NCT02649192|20083051|P6|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8
8148520|NCT02649192|20083052|P5|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7
8148521|NCT02649192|20083053|P4|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12
8148522|NCT02649192|20083054|P3|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11
8148523|NCT02649192|20083055|P2|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
8148524|NCT02649192|20083056|P1|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
8148525|NCT02649192|20083051|P6|STARTED|Overall Study||14
8148526|NCT02649192|20083052|P5|STARTED|Overall Study||12
8148527|NCT02649192|20083053|P4|STARTED|Overall Study||22
8148528|NCT02649192|20083054|P3|STARTED|Overall Study||22
8148529|NCT02649192|20083055|P2|STARTED|Overall Study||4
8148530|NCT02649192|20083056|P1|STARTED|Overall Study||5
8148531|NCT02648971|20083114|P2|NOT COMPLETED|Overall Study||0
8148532|NCT02648971|20083115|P1|NOT COMPLETED|Overall Study||0
8148533|NCT02648971|20083114|P2|COMPLETED|Overall Study||18
8148534|NCT02648971|20083115|P1|COMPLETED|Overall Study||18
8148535|NCT02648971|20083114|P2|STARTED|Overall Study||18
8148536|NCT02648971|20083115|P1|STARTED|Overall Study||18
8148537|NCT02648698|20083137|P2|NOT COMPLETED|Overall Study||5
8148538|NCT02648698|20083138|P1|NOT COMPLETED|Overall Study||1
8148539|NCT02648698|20083137|P2|COMPLETED|Overall Study||55
8148540|NCT02648698|20083138|P1|COMPLETED|Overall Study||59
8148541|NCT02648698|20083137|P2|STARTED|Overall Study||60
8148542|NCT02648698|20083138|P1|STARTED|Overall Study||60
8148543|NCT02648646|20083144|P1|NOT COMPLETED|Overall Study||2
8148544|NCT02648646|20083144|P1|COMPLETED|Overall Study||8
8148545|NCT02648646|20083144|P1|STARTED|Overall Study||10
8148546|NCT02648438|20083195|P3|NOT COMPLETED|Overall Study||0
8148547|NCT02648438|20083196|P2|NOT COMPLETED|Overall Study||3
8148548|NCT02648438|20083197|P1|NOT COMPLETED|Overall Study||3
8148549|NCT02648438|20083195|P3|COMPLETED|Overall Study||6
8148550|NCT02648438|20083196|P2|COMPLETED|Overall Study||9
8148551|NCT02648438|20083197|P1|COMPLETED|Overall Study||9
8148552|NCT02648438|20083195|P3|STARTED|Overall Study||6
8148553|NCT02648438|20083196|P2|STARTED|Overall Study||12
8148554|NCT02648438|20083197|P1|STARTED|Overall Study||12
8148555|NCT02648230|20083237|P1|NOT COMPLETED|Overall Study||0
8148556|NCT02648230|20083237|P1|COMPLETED|Overall Study||74
8148557|NCT02648230|20083237|P1|STARTED|Overall Study||74
8148558|NCT02648217|20083243|P2|NOT COMPLETED|Overall Study||5
8148559|NCT02648217|20083244|P1|NOT COMPLETED|Overall Study||10
8148560|NCT02648217|20083243|P2|COMPLETED|Overall Study||127
8148561|NCT02648217|20083244|P1|COMPLETED|Overall Study||121
8148562|NCT02648217|20083243|P2|Exposed|Overall Study||132
8148563|NCT02648217|20083244|P1|Exposed|Overall Study||130
8148564|NCT02648217|20083243|P2|STARTED|Overall Study||132
8148565|NCT02648217|20083244|P1|STARTED|Overall Study||131
8148566|NCT02648204|20083266|P4|NOT COMPLETED|Overall Study||16
8148567|NCT02648204|20083267|P3|NOT COMPLETED|Overall Study||13
8148568|NCT02648204|20083268|P2|NOT COMPLETED|Overall Study||21
8148569|NCT02648204|20083269|P1|NOT COMPLETED|Overall Study||22
8148570|NCT02648204|20083266|P4|COMPLETED|Overall Study||284
8148571|NCT02648204|20083267|P3|COMPLETED|Overall Study||287
8148572|NCT02648204|20083268|P2|COMPLETED|Overall Study||279
8148573|NCT02648204|20083269|P1|COMPLETED|Overall Study||279
8148574|NCT02648204|20083266|P4|Exposed|Overall Study||299
8148575|NCT02648204|20083267|P3|Exposed|Overall Study||299
8148576|NCT02648204|20083268|P2|Exposed|Overall Study||300
8148577|NCT02648204|20083269|P1|Exposed|Overall Study||301
8148578|NCT02648204|20083266|P4|STARTED|Overall Study||300
8148579|NCT02648204|20083267|P3|STARTED|Overall Study||300
8148580|NCT02648204|20083268|P2|STARTED|Overall Study||300
8148581|NCT02648204|20083269|P1|STARTED|Overall Study||301
8148582|NCT02648178|20083387|P1|NOT COMPLETED|Overall Study||9
8148583|NCT02648178|20083387|P1|COMPLETED|Overall Study||10
8148584|NCT02648178|20083387|P1|STARTED|Overall Study||19
8148585|NCT02648022|20083394|P2|NOT COMPLETED|Overall Study||0
8148586|NCT02648022|20083395|P1|NOT COMPLETED|Overall Study||0
8148587|NCT02648022|20083394|P2|COMPLETED|Overall Study||39
8148588|NCT02648022|20083395|P1|COMPLETED|Overall Study||40
8148589|NCT02648022|20083394|P2|STARTED|Overall Study||39
8148590|NCT02648022|20083395|P1|STARTED|Overall Study||40
8148591|NCT02647944|20083407|P2|NOT COMPLETED|Overall Study||3
8148592|NCT02647944|20083408|P1|NOT COMPLETED|Overall Study||2
8148593|NCT02647944|20083407|P2|COMPLETED|Overall Study||18
8148594|NCT02647944|20083408|P1|COMPLETED|Overall Study||17
8148595|NCT02647944|20083407|P2|STARTED|Overall Study||21
8148596|NCT02647944|20083408|P1|STARTED|Overall Study||19
8148597|NCT02647905|20083432|P1|NOT COMPLETED|Overall Study||3
8148598|NCT02647905|20083432|P1|COMPLETED|Overall Study||87
8148599|NCT02647905|20083432|P1|STARTED|Overall Study||90
8148600|NCT02647866|20083442|P5|NOT COMPLETED|Overall Study||8
8148601|NCT02647866|20083443|P4|NOT COMPLETED|Overall Study||6
8148602|NCT02647866|20083444|P3|NOT COMPLETED|Overall Study||5
8148603|NCT02647866|20083445|P2|NOT COMPLETED|Overall Study||4
8148604|NCT02647866|20083446|P1|NOT COMPLETED|Overall Study||5
8148605|NCT02647866|20083442|P5|COMPLETED|Overall Study||9
8148606|NCT02647866|20083443|P4|COMPLETED|Overall Study||15
8148607|NCT02647866|20083444|P3|COMPLETED|Overall Study||4
8148608|NCT02647866|20083445|P2|COMPLETED|Overall Study||6
8148609|NCT02647866|20083446|P1|COMPLETED|Overall Study||4
8148610|NCT02647866|20083442|P5|Discontinued the Study|Overall Study||8
8148611|NCT02647866|20083443|P4|Discontinued the Study|Overall Study||6
8148612|NCT02647866|20083444|P3|Discontinued the Study|Overall Study||5
8148613|NCT02647866|20083445|P2|Discontinued the Study|Overall Study||4
8148614|NCT02647866|20083446|P1|Discontinued the Study|Overall Study||5
8148615|NCT02647866|20083442|P5|Discontinued the Treatment|Overall Study||8
8148616|NCT02647866|20083443|P4|Discontinued the Treatment|Overall Study||5
8148617|NCT02647866|20083444|P3|Discontinued the Treatment|Overall Study||5
8148618|NCT02647866|20083445|P2|Discontinued the Treatment|Overall Study||5
8148619|NCT02647866|20083446|P1|Discontinued the Treatment|Overall Study||4
8148620|NCT02647866|20083442|P5|Moved From LTE to OLE Therapy|Overall Study||2
8148621|NCT02647866|20083443|P4|Moved From LTE to OLE Therapy|Overall Study||0
8148622|NCT02647866|20083444|P3|Moved From LTE to OLE Therapy|Overall Study||0
8148623|NCT02647866|20083445|P2|Moved From LTE to OLE Therapy|Overall Study||5
8148624|NCT02647866|20083446|P1|Moved From LTE to OLE Therapy|Overall Study||0
8148625|NCT02647866|20083442|P5|Completed OLE Follow-up|Overall Study||10
8148626|NCT02647866|20083443|P4|Completed OLE Follow-up|Overall Study||14
8148627|NCT02647866|20083444|P3|Completed OLE Follow-up|Overall Study||4
8148628|NCT02647866|20083445|P2|Completed OLE Follow-up|Overall Study||6
8148629|NCT02647866|20083446|P1|Completed OLE Follow-up|Overall Study||0
8148630|NCT02647866|20083442|P5|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|13
8148631|NCT02647866|20083443|P4|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|17
8148632|NCT02647866|20083444|P3|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|4
8148633|NCT02647866|20083445|P2|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy.|7
8148634|NCT02647866|20083446|P1|Completed Open-Label Extension Therapy|Overall Study||0
8148635|NCT02647866|20083442|P5|Completed LTE Follow-up|Overall Study||0
8148636|NCT02647866|20083443|P4|Completed LTE Follow-up|Overall Study||0
8148637|NCT02647866|20083444|P3|Completed LTE Follow-up|Overall Study||0
8148638|NCT02647866|20083445|P2|Completed LTE Follow-up|Overall Study||0
8148639|NCT02647866|20083446|P1|Completed LTE Follow-up|Overall Study||2
8148640|NCT02647866|20083442|P5|Completed Long-Term Extension Therapy|Overall Study||0
8148641|NCT02647866|20083443|P4|Completed Long-Term Extension Therapy|Overall Study||0
8148642|NCT02647866|20083444|P3|Completed Long-Term Extension Therapy|Overall Study||0
8148643|NCT02647866|20083445|P2|Completed Long-Term Extension Therapy|Overall Study||0
8148644|NCT02647866|20083446|P1|Completed Long-Term Extension Therapy|Overall Study|10 add'l treatments of KHK4083 (same dose as Induction Therapy) as maintenance therapy.|3
8148645|NCT02647866|20083442|P5|Completed Induction Therapy Follow-Up|Overall Study||2
8148646|NCT02647866|20083443|P4|Completed Induction Therapy Follow-Up|Overall Study||0
8148647|NCT02647866|20083444|P3|Completed Induction Therapy Follow-Up|Overall Study||2
8148648|NCT02647866|20083445|P2|Completed Induction Therapy Follow-Up|Overall Study||1
8148649|NCT02647866|20083446|P1|Completed Induction Therapy Follow-Up|Overall Study||5
8148650|NCT02647866|20083442|P5|Completed Induction Therapy|Overall Study|Subjects received Placebo for 12 weeks|17
8148651|NCT02647866|20083443|P4|Completed Induction Therapy|Overall Study|Subjects received the maximum tolerated dose of KHK4083 10.0 mg/kg for 12 weeks|19
8148652|NCT02647866|20083444|P3|Completed Induction Therapy|Overall Study|Subjects received KHK4083 10.0 mg/kg for 12 weeks|8
8148823|NCT02646826|20084027|P4|COMPLETED|Overall Study||21
8148653|NCT02647866|20083445|P2|Completed Induction Therapy|Overall Study|Subjects received KHK4083 3.0 mg/kg for 12 weeks|9
8148654|NCT02647866|20083446|P1|Completed Induction Therapy|Overall Study|Subjects received KHK4083 1.0 mg/kg for 12 weeks|8
8148655|NCT02647866|20083442|P5|STARTED|Overall Study||17
8148656|NCT02647866|20083443|P4|STARTED|Overall Study||21
8148657|NCT02647866|20083444|P3|STARTED|Overall Study||9
8148658|NCT02647866|20083445|P2|STARTED|Overall Study||10
8148659|NCT02647866|20083446|P1|STARTED|Overall Study||9
8148660|NCT02647788|20083523|P2|NOT COMPLETED|Overall Study||13
8148661|NCT02647788|20083524|P1|NOT COMPLETED|Overall Study||16
8148662|NCT02647788|20083523|P2|COMPLETED|Overall Study||57
8148663|NCT02647788|20083524|P1|COMPLETED|Overall Study||54
8148664|NCT02647788|20083523|P2|STARTED|Overall Study||70
8148665|NCT02647788|20083524|P1|STARTED|Overall Study||70
8148666|NCT02647658|20083536|P2|NOT COMPLETED|Overall Study||24
8148667|NCT02647658|20083537|P1|NOT COMPLETED|Overall Study||15
8148668|NCT02647658|20083536|P2|COMPLETED|Overall Study||1069
8148669|NCT02647658|20083537|P1|COMPLETED|Overall Study||1192
8148670|NCT02647658|20083536|P2|6 Month Assessment|Overall Study||635
8148671|NCT02647658|20083537|P1|6 Month Assessment|Overall Study||658
8148672|NCT02647658|20083536|P2|STARTED|Overall Study||1093
8148673|NCT02647658|20083537|P1|STARTED|Overall Study||1207
8148680|NCT02647346|20083576|P1|NOT COMPLETED|Overall Study||3
8148681|NCT02647346|20083576|P1|COMPLETED|Overall Study||129
8148682|NCT02647346|20083576|P1|STARTED|Overall Study||132
8148683|NCT02647320|20083588|P5|NOT COMPLETED|Overall Study||17
8148684|NCT02647320|20083589|P4|NOT COMPLETED|Overall Study||10
8148685|NCT02647320|20083590|P3|NOT COMPLETED|Overall Study||15
8148686|NCT02647320|20083591|P2|NOT COMPLETED|Overall Study||11
8148687|NCT02647320|20083592|P1|NOT COMPLETED|Overall Study||12
8148688|NCT02647320|20083588|P5|COMPLETED|Overall Study||52
8148689|NCT02647320|20083589|P4|COMPLETED|Overall Study||58
8148690|NCT02647320|20083590|P3|COMPLETED|Overall Study||54
8148691|NCT02647320|20083591|P2|COMPLETED|Overall Study||35
8148692|NCT02647320|20083592|P1|COMPLETED|Overall Study||34
8148693|NCT02647320|20083588|P5|Modified Intent-to-Treat Set (mITT)|Overall Study||62
8148694|NCT02647320|20083589|P4|Modified Intent-to-Treat Set (mITT)|Overall Study||62
8148695|NCT02647320|20083590|P3|Modified Intent-to-Treat Set (mITT)|Overall Study||61
8148696|NCT02647320|20083591|P2|Modified Intent-to-Treat Set (mITT)|Overall Study||38
8148697|NCT02647320|20083592|P1|Modified Intent-to-Treat Set (mITT)|Overall Study||40
8148698|NCT02647320|20083588|P5|Safety Set|Overall Study||69
8148699|NCT02647320|20083589|P4|Safety Set|Overall Study||68
8148700|NCT02647320|20083590|P3|Safety Set|Overall Study||68
8148701|NCT02647320|20083591|P2|Safety Set|Overall Study||44
8148702|NCT02647320|20083592|P1|Safety Set|Overall Study||43
8148703|NCT02647320|20083588|P5|Inadvertently Randomized|Overall Study||0
8148704|NCT02647320|20083589|P4|Inadvertently Randomized|Overall Study||1
8148705|NCT02647320|20083590|P3|Inadvertently Randomized|Overall Study||0
8148706|NCT02647320|20083591|P2|Inadvertently Randomized|Overall Study||0
8148707|NCT02647320|20083592|P1|Inadvertently Randomized|Overall Study||0
8148708|NCT02647320|20083588|P5|STARTED|Overall Study||69
8148709|NCT02647320|20083589|P4|STARTED|Overall Study||68
8148710|NCT02647320|20083590|P3|STARTED|Overall Study||69
8148711|NCT02647320|20083591|P2|STARTED|Overall Study||46
8148712|NCT02647320|20083592|P1|STARTED|Overall Study||46
8148713|NCT02647281|20083683|P9|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
8148714|NCT02647281|20083684|P8|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148715|NCT02647281|20083685|P7|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148716|NCT02647281|20083686|P6|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148717|NCT02647281|20083687|P5|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148718|NCT02647281|20083688|P4|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148719|NCT02647281|20083689|P3|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148720|NCT02647281|20083690|P2|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148721|NCT02647281|20083691|P1|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148722|NCT02647281|20083683|P9|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
8148723|NCT02647281|20083684|P8|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
8148724|NCT02647281|20083685|P7|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
8148725|NCT02647281|20083686|P6|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
8148726|NCT02647281|20083687|P5|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148727|NCT02647281|20083688|P4|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148728|NCT02647281|20083689|P3|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148729|NCT02647281|20083690|P2|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148730|NCT02647281|20083691|P1|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148731|NCT02647281|20083683|P9|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
8148732|NCT02647281|20083684|P8|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
8148733|NCT02647281|20083685|P7|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
8148734|NCT02647281|20083686|P6|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
8148735|NCT02647281|20083687|P5|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148736|NCT02647281|20083688|P4|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148737|NCT02647281|20083689|P3|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148738|NCT02647281|20083690|P2|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148739|NCT02647281|20083691|P1|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
8148740|NCT02647281|20083683|P9|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148741|NCT02647281|20083684|P8|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148742|NCT02647281|20083685|P7|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148743|NCT02647281|20083686|P6|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148744|NCT02647281|20083687|P5|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148745|NCT02647281|20083688|P4|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148746|NCT02647281|20083689|P3|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148747|NCT02647281|20083690|P2|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148748|NCT02647281|20083691|P1|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148749|NCT02647281|20083683|P9|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148750|NCT02647281|20083684|P8|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148751|NCT02647281|20083685|P7|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148752|NCT02647281|20083686|P6|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
8148753|NCT02647281|20083687|P5|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
8148754|NCT02647281|20083688|P4|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
8148755|NCT02647281|20083689|P3|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
8148756|NCT02647281|20083690|P2|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
8148757|NCT02647281|20083691|P1|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
8148758|NCT02647281|20083683|P9|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
8148759|NCT02647281|20083684|P8|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
8148760|NCT02647281|20083685|P7|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
8148761|NCT02647281|20083686|P6|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
8148762|NCT02647281|20083687|P5|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
8148763|NCT02647281|20083688|P4|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
8148764|NCT02647281|20083689|P3|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
8148765|NCT02647281|20083690|P2|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
8148766|NCT02647281|20083691|P1|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
8148767|NCT02647203|20083871|P2|NOT COMPLETED|24 Month Follow-up||11
8148768|NCT02647203|20083872|P1|NOT COMPLETED|24 Month Follow-up||6
8148769|NCT02647203|20083871|P2|COMPLETED|24 Month Follow-up||138
8148770|NCT02647203|20083872|P1|COMPLETED|24 Month Follow-up||142
8148771|NCT02647203|20083871|P2|STARTED|24 Month Follow-up||149
8148772|NCT02647203|20083872|P1|STARTED|24 Month Follow-up||148
8148773|NCT02647203|20083871|P2|NOT COMPLETED|12 Month Follow-up||23
8148774|NCT02647203|20083872|P1|NOT COMPLETED|12 Month Follow-up||25
8148775|NCT02647203|20083871|P2|COMPLETED|12 Month Follow-up||149
8148776|NCT02647203|20083872|P1|COMPLETED|12 Month Follow-up||148
8148777|NCT02647203|20083871|P2|STARTED|12 Month Follow-up||172
8148778|NCT02647203|20083872|P1|STARTED|12 Month Follow-up||173
8148779|NCT02646891|20083890|P10|NOT COMPLETED|Overall Study||5
8148780|NCT02646891|20083891|P9|NOT COMPLETED|Overall Study||10
8148781|NCT02646891|20083892|P8|NOT COMPLETED|Overall Study||13
8148782|NCT02646891|20083893|P7|NOT COMPLETED|Overall Study||9
8148783|NCT02646891|20083894|P6|NOT COMPLETED|Overall Study||0
8148784|NCT02646891|20083895|P5|NOT COMPLETED|Overall Study||0
8148785|NCT02646891|20083896|P4|NOT COMPLETED|Overall Study||0
8148786|NCT02646891|20083897|P3|NOT COMPLETED|Overall Study||1
8148787|NCT02646891|20083898|P2|NOT COMPLETED|Overall Study||1
8148788|NCT02646891|20083899|P1|NOT COMPLETED|Overall Study||2
8148789|NCT02646891|20083890|P10|COMPLETED|Overall Study||134
8148790|NCT02646891|20083891|P9|COMPLETED|Overall Study||130
8148791|NCT02646891|20083892|P8|COMPLETED|Overall Study||127
8148792|NCT02646891|20083893|P7|COMPLETED|Overall Study||130
8148793|NCT02646891|20083894|P6|COMPLETED|Overall Study||12
8148794|NCT02646891|20083895|P5|COMPLETED|Overall Study||12
8148795|NCT02646891|20083896|P4|COMPLETED|Overall Study||6
8148796|NCT02646891|20083897|P3|COMPLETED|Overall Study||11
8148797|NCT02646891|20083898|P2|COMPLETED|Overall Study||11
8148798|NCT02646891|20083899|P1|COMPLETED|Overall Study||4
8148799|NCT02646891|20083890|P10|Received at Least 1 Dose|Overall Study||139
8148800|NCT02646891|20083891|P9|Received at Least 1 Dose|Overall Study||140
8148801|NCT02646891|20083892|P8|Received at Least 1 Dose|Overall Study|One participant was randomized but determined to be ineligible pre-vaccination.|139
8148802|NCT02646891|20083893|P7|Received at Least 1 Dose|Overall Study||139
8148803|NCT02646891|20083894|P6|Received at Least 1 Dose|Overall Study||12
8148804|NCT02646891|20083895|P5|Received at Least 1 Dose|Overall Study||12
8148805|NCT02646891|20083896|P4|Received at Least 1 Dose|Overall Study||6
8148806|NCT02646891|20083897|P3|Received at Least 1 Dose|Overall Study||12
8148807|NCT02646891|20083898|P2|Received at Least 1 Dose|Overall Study||12
8148808|NCT02646891|20083899|P1|Received at Least 1 Dose|Overall Study||6
8148809|NCT02646891|20083890|P10|STARTED|Overall Study||139
8148810|NCT02646891|20083891|P9|STARTED|Overall Study||140
8148811|NCT02646891|20083892|P8|STARTED|Overall Study||140
8148812|NCT02646891|20083893|P7|STARTED|Overall Study||139
8148813|NCT02646891|20083894|P6|STARTED|Overall Study||12
8148814|NCT02646891|20083895|P5|STARTED|Overall Study||12
8148815|NCT02646891|20083896|P4|STARTED|Overall Study||6
8148816|NCT02646891|20083897|P3|STARTED|Overall Study||12
8148817|NCT02646891|20083898|P2|STARTED|Overall Study||12
8148818|NCT02646891|20083899|P1|STARTED|Overall Study||6
8148819|NCT02646826|20084027|P4|NOT COMPLETED|Overall Study||1
8148820|NCT02646826|20084028|P3|NOT COMPLETED|Overall Study||1
8148821|NCT02646826|20084029|P2|NOT COMPLETED|Overall Study||0
8148822|NCT02646826|20084030|P1|NOT COMPLETED|Overall Study||2
8148824|NCT02646826|20084028|P3|COMPLETED|Overall Study||20
8148825|NCT02646826|20084029|P2|COMPLETED|Overall Study||22
8148826|NCT02646826|20084030|P1|COMPLETED|Overall Study||19
8148827|NCT02646826|20084027|P4|STARTED|Overall Study||22
8148828|NCT02646826|20084028|P3|STARTED|Overall Study||21
8148829|NCT02646826|20084029|P2|STARTED|Overall Study||22
8148830|NCT02646826|20084030|P1|STARTED|Overall Study||21
8148831|NCT02646761|20084054|P2|NOT COMPLETED|Overall Study||10
8148832|NCT02646761|20084055|P1|NOT COMPLETED|Overall Study||8
8148833|NCT02646761|20084054|P2|COMPLETED|Overall Study||10
8148834|NCT02646761|20084055|P1|COMPLETED|Overall Study||10
8148835|NCT02646761|20084054|P2|5-week Assessment|Overall Study||10
8148836|NCT02646761|20084055|P1|5-week Assessment|Overall Study||12
8148837|NCT02646761|20084054|P2|Baseline Assessment|Overall Study||12
8148838|NCT02646761|20084055|P1|Baseline Assessment|Overall Study||13
8148839|NCT02646761|20084054|P2|Subject Withdrew Before Baseline|Overall Study||8
8148840|NCT02646761|20084055|P1|Subject Withdrew Before Baseline|Overall Study||5
8148841|NCT02646761|20084054|P2|STARTED|Overall Study||20
8148842|NCT02646761|20084055|P1|STARTED|Overall Study||18
8148843|NCT02646566|20084073|P3|NOT COMPLETED|Overall Study||5
8148844|NCT02646566|20084074|P2|NOT COMPLETED|Overall Study||4
8148845|NCT02646566|20084075|P1|NOT COMPLETED|Overall Study||6
8148846|NCT02646566|20084073|P3|COMPLETED|Overall Study||230
8148847|NCT02646566|20084074|P2|COMPLETED|Overall Study||226
8148848|NCT02646566|20084075|P1|COMPLETED|Overall Study||231
8148849|NCT02646566|20084073|P3|STARTED|Overall Study||235
8148850|NCT02646566|20084074|P2|STARTED|Overall Study||230
8148851|NCT02646566|20084075|P1|STARTED|Overall Study||237
8148852|NCT02646449|20084115|P2|NOT COMPLETED|Overall Study||0
8148853|NCT02646449|20084116|P1|NOT COMPLETED|Overall Study||0
8148854|NCT02646449|20084115|P2|COMPLETED|Overall Study||3
8148855|NCT02646449|20084116|P1|COMPLETED|Overall Study||4
8148856|NCT02646449|20084115|P2|STARTED|Overall Study||3
8148857|NCT02646449|20084116|P1|STARTED|Overall Study||4
8148858|NCT02646371|20084126|P2|NOT COMPLETED|Overall Study||0
8148859|NCT02646371|20084127|P1|NOT COMPLETED|Overall Study||0
8148860|NCT02646371|20084126|P2|COMPLETED|Overall Study||33
8148861|NCT02646371|20084127|P1|COMPLETED|Overall Study||34
8148862|NCT02646371|20084126|P2|STARTED|Overall Study||33
8148863|NCT02646371|20084127|P1|STARTED|Overall Study||34
8148864|NCT02646332|20084135|P2|NOT COMPLETED|Overall Study||3
8148865|NCT02646332|20084136|P1|NOT COMPLETED|Overall Study||0
8148866|NCT02646332|20084135|P2|COMPLETED|Overall Study||121
8148867|NCT02646332|20084136|P1|COMPLETED|Overall Study||124
8148868|NCT02646332|20084135|P2|STARTED|Overall Study||124
8148869|NCT02646332|20084136|P1|STARTED|Overall Study||124
8148870|NCT02646124|20084144|P2|NOT COMPLETED|Overall Study||2
8148871|NCT02646124|20084145|P1|NOT COMPLETED|Overall Study||0
8148872|NCT02646124|20084144|P2|COMPLETED|Overall Study||55
8148873|NCT02646124|20084145|P1|COMPLETED|Overall Study||57
8148874|NCT02646124|20084144|P2|STARTED|Overall Study||57
8148875|NCT02646124|20084145|P1|STARTED|Overall Study||57
8148876|NCT02645760|20084161|P2|NOT COMPLETED|Overall Study||0
8148877|NCT02645760|20084162|P1|NOT COMPLETED|Overall Study||0
8148878|NCT02645760|20084161|P2|COMPLETED|Overall Study||19
8148879|NCT02645760|20084162|P1|COMPLETED|Overall Study||19
8148880|NCT02645760|20084161|P2|STARTED|Overall Study||19
8148881|NCT02645760|20084162|P1|STARTED|Overall Study||19
8148882|NCT02645617|20084174|P1|NOT COMPLETED|Overall Study||0
8148883|NCT02645617|20084174|P1|COMPLETED|Overall Study||12
8148884|NCT02645617|20084174|P1|STARTED|Overall Study||12
8148885|NCT02645409|20084181|P2|NOT COMPLETED|Overall Study||0
8148886|NCT02645409|20084182|P1|NOT COMPLETED|Overall Study||4
8148887|NCT02645409|20084181|P2|COMPLETED|Overall Study||0
8148888|NCT02645409|20084182|P1|COMPLETED|Overall Study||10
8148889|NCT02645409|20084181|P2|STARTED|Overall Study|It was decided to not continue with the Radical Nephrectomy arm of the study.|0
8148890|NCT02645409|20084182|P1|STARTED|Overall Study||14
8148891|NCT02645253|20084191|P4|NOT COMPLETED|Overall Study||0
8148892|NCT02645253|20084192|P3|NOT COMPLETED|Overall Study||0
8148893|NCT02645253|20084193|P2|NOT COMPLETED|Overall Study||0
8148894|NCT02645253|20084194|P1|NOT COMPLETED|Overall Study||0
8148895|NCT02645253|20084191|P4|COMPLETED|Overall Study||6
8148896|NCT02645253|20084192|P3|COMPLETED|Overall Study||7
8148897|NCT02645253|20084193|P2|COMPLETED|Overall Study||7
8148898|NCT02645253|20084194|P1|COMPLETED|Overall Study||7
8148899|NCT02645253|20084191|P4|STARTED|Overall Study||6
8148900|NCT02645253|20084192|P3|STARTED|Overall Study||7
8148901|NCT02645253|20084193|P2|STARTED|Overall Study||7
8148902|NCT02645253|20084194|P1|STARTED|Overall Study||7
8148903|NCT02645123|20084316|P3|NOT COMPLETED|Overall Study||0
8148904|NCT02645123|20084317|P2|NOT COMPLETED|Overall Study||0
8148905|NCT02645123|20084318|P1|NOT COMPLETED|Overall Study||0
8148906|NCT02645123|20084316|P3|COMPLETED|Overall Study||25
8148907|NCT02645123|20084317|P2|COMPLETED|Overall Study||25
8148908|NCT02645123|20084318|P1|COMPLETED|Overall Study||25
8148909|NCT02645123|20084316|P3|STARTED|Overall Study||25
8148910|NCT02645123|20084317|P2|STARTED|Overall Study||25
8148911|NCT02645123|20084318|P1|STARTED|Overall Study||25
8148912|NCT02645019|20084340|P5|NOT COMPLETED|Overall Study||0
8148913|NCT02645019|20084341|P4|NOT COMPLETED|Overall Study||0
8148914|NCT02645019|20084342|P3|NOT COMPLETED|Overall Study||0
8148915|NCT02645019|20084343|P2|NOT COMPLETED|Overall Study||0
8148916|NCT02645019|20084344|P1|NOT COMPLETED|Overall Study||0
8148917|NCT02645019|20084340|P5|COMPLETED|Overall Study||24
8148918|NCT02645019|20084341|P4|COMPLETED|Overall Study||33
8148919|NCT02645019|20084342|P3|COMPLETED|Overall Study||15
8148920|NCT02645019|20084343|P2|COMPLETED|Overall Study||15
8148921|NCT02645019|20084344|P1|COMPLETED|Overall Study||13
8148922|NCT02645019|20084340|P5|STARTED|Overall Study||24
8148923|NCT02645019|20084341|P4|STARTED|Overall Study||33
8148924|NCT02645019|20084342|P3|STARTED|Overall Study||15
8148925|NCT02645019|20084343|P2|STARTED|Overall Study||15
8148926|NCT02645019|20084344|P1|STARTED|Overall Study||13
8148927|NCT02644668|20084369|P3|NOT COMPLETED|Overall Study||3
8148928|NCT02644668|20084370|P2|NOT COMPLETED|Overall Study||0
8148929|NCT02644668|20084371|P1|NOT COMPLETED|Overall Study||2
8148930|NCT02644668|20084369|P3|COMPLETED|Overall Study||17
8148931|NCT02644668|20084370|P2|COMPLETED|Overall Study||24
8148932|NCT02644668|20084371|P1|COMPLETED|Overall Study||24
8148933|NCT02644668|20084369|P3|STARTED|Overall Study||20
8148934|NCT02644668|20084370|P2|STARTED|Overall Study||24
8148935|NCT02644668|20084371|P1|STARTED|Overall Study||26
8148936|NCT02644356|20084410|P1|NOT COMPLETED|Overall Study||2
8148937|NCT02644356|20084410|P1|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
8148938|NCT02644356|20084410|P1|STARTED|Overall Study||51
8148939|NCT02644343|20084420|P1|NOT COMPLETED|Overall Study||1
8148940|NCT02644343|20084420|P1|COMPLETED|Overall Study||39
8148941|NCT02644343|20084420|P1|STARTED|Overall Study||40
8148942|NCT02644278|20084428|P4|NOT COMPLETED|Overall Study||0
8148943|NCT02644278|20084429|P3|NOT COMPLETED|Overall Study||0
8148944|NCT02644278|20084430|P2|NOT COMPLETED|Overall Study||0
8148945|NCT02644278|20084431|P1|NOT COMPLETED|Overall Study||0
8148946|NCT02644278|20084428|P4|COMPLETED|Overall Study||3
8148947|NCT02644278|20084429|P3|COMPLETED|Overall Study||6
8148948|NCT02644278|20084430|P2|COMPLETED|Overall Study||3
8148949|NCT02644278|20084431|P1|COMPLETED|Overall Study||3
8148950|NCT02644278|20084428|P4|STARTED|Overall Study||3
8148951|NCT02644278|20084429|P3|STARTED|Overall Study||6
8148952|NCT02644278|20084430|P2|STARTED|Overall Study||3
8148953|NCT02644278|20084431|P1|STARTED|Overall Study||3
8148954|NCT02644122|20084497|P1|NOT COMPLETED|Overall Study||1
8148955|NCT02644122|20084497|P1|COMPLETED|Overall Study||0
8148956|NCT02644122|20084497|P1|STARTED|Overall Study||1
8148957|NCT02644109|20084507|P2|NOT COMPLETED|Overall Study||4
8148958|NCT02644109|20084508|P1|NOT COMPLETED|Overall Study||0
8148959|NCT02644109|20084507|P2|COMPLETED|Overall Study||24
8148960|NCT02644109|20084508|P1|COMPLETED|Overall Study||24
8148961|NCT02644109|20084507|P2|STARTED|Overall Study||28
8148962|NCT02644109|20084508|P1|STARTED|Overall Study||24
8148963|NCT02644096|20084516|P2|NOT COMPLETED|Overall Study||25
8148964|NCT02644096|20084517|P1|NOT COMPLETED|Overall Study||28
8148965|NCT02644096|20084516|P2|COMPLETED|Overall Study||57
8148966|NCT02644096|20084517|P1|COMPLETED|Overall Study||65
8148967|NCT02644096|20084516|P2|9 Month SF-36 Questionnaire|Overall Study||57
8148968|NCT02644096|20084517|P1|9 Month SF-36 Questionnaire|Overall Study||65
8148969|NCT02644096|20084516|P2|12 Week SF-36 Questionnaire|Overall Study||59
8148970|NCT02644096|20084517|P1|12 Week SF-36 Questionnaire|Overall Study||68
8148971|NCT02644096|20084516|P2|10 Week Interview|Overall Study||59
8148972|NCT02644096|20084517|P1|10 Week Interview|Overall Study|Not done in control group|0
8148973|NCT02644096|20084516|P2|2 Week Interview|Overall Study||68
8148974|NCT02644096|20084517|P1|2 Week Interview|Overall Study|Not done in control group|0
8148975|NCT02644096|20084516|P2|STARTED|Overall Study||82
8148976|NCT02644096|20084517|P1|STARTED|Overall Study||93
8148977|NCT02643979|20084525|P2|NOT COMPLETED|Overall Study||0
8148978|NCT02643979|20084526|P1|NOT COMPLETED|Overall Study||0
8148979|NCT02643979|20084525|P2|COMPLETED|Overall Study||11
8148980|NCT02643979|20084526|P1|COMPLETED|Overall Study||11
8148981|NCT02643979|20084525|P2|STARTED|Overall Study||11
8148982|NCT02643979|20084526|P1|STARTED|Overall Study||11
8148983|NCT02643875|20084544|P1|NOT COMPLETED|Overall Study||8
8148984|NCT02643875|20084544|P1|COMPLETED|Overall Study||28
8148985|NCT02643875|20084544|P1|Received 1.75 D|Overall Study||36
8148986|NCT02643875|20084544|P1|Received 0.75|Overall Study||36
8148987|NCT02643875|20084544|P1|STARTED|Overall Study||36
8148988|NCT02643862|20084553|P2|NOT COMPLETED|Overall Study||0
8148989|NCT02643862|20084554|P1|NOT COMPLETED|Overall Study||0
8148990|NCT02643862|20084553|P2|COMPLETED|Overall Study||12
8148991|NCT02643862|20084554|P1|COMPLETED|Overall Study||36
8148992|NCT02643862|20084553|P2|STARTED|Overall Study||12
8148993|NCT02643862|20084554|P1|STARTED|Overall Study||36
8148994|NCT02643849|20084562|P1|NOT COMPLETED|Overall Study||25
8148995|NCT02643849|20084562|P1|COMPLETED|Overall Study||82
8148996|NCT02643849|20084562|P1|STARTED|Overall Study||107
8148997|NCT02643693|20084569|P6|NOT COMPLETED|Overall Study||1
8148998|NCT02643693|20084570|P5|NOT COMPLETED|Overall Study||0
8148999|NCT02643693|20084571|P4|NOT COMPLETED|Overall Study||0
8149000|NCT02643693|20084572|P3|NOT COMPLETED|Overall Study||1
8149001|NCT02643693|20084573|P2|NOT COMPLETED|Overall Study||2
8149002|NCT02643693|20084574|P1|NOT COMPLETED|Overall Study||2
8149003|NCT02643693|20084569|P6|COMPLETED|Overall Study||3
8149004|NCT02643693|20084570|P5|COMPLETED|Overall Study||4
8149005|NCT02643693|20084571|P4|COMPLETED|Overall Study||4
8149006|NCT02643693|20084572|P3|COMPLETED|Overall Study||3
8149007|NCT02643693|20084573|P2|COMPLETED|Overall Study||2
8149008|NCT02643693|20084574|P1|COMPLETED|Overall Study||2
8149009|NCT02643693|20084569|P6|STARTED|Overall Study||4
8149010|NCT02643693|20084570|P5|STARTED|Overall Study||4
8149011|NCT02643693|20084571|P4|STARTED|Overall Study||4
8149012|NCT02643693|20084572|P3|STARTED|Overall Study||4
8149013|NCT02643693|20084573|P2|STARTED|Overall Study||4
8149014|NCT02643693|20084574|P1|STARTED|Overall Study||4
8149015|NCT02643628|20084587|P2|NOT COMPLETED|Overall Study||6
8149016|NCT02643628|20084588|P1|NOT COMPLETED|Overall Study||1
8149017|NCT02643628|20084587|P2|COMPLETED|Overall Study||17
8149018|NCT02643628|20084588|P1|COMPLETED|Overall Study||20
8149019|NCT02643628|20084587|P2|STARTED|Overall Study||23
8149020|NCT02643628|20084588|P1|STARTED|Overall Study||21
8149021|NCT02643615|20084604|P2|NOT COMPLETED|Overall Study||0
8149022|NCT02643615|20084605|P1|NOT COMPLETED|Overall Study||0
8149023|NCT02643615|20084604|P2|COMPLETED|Overall Study||11
8149024|NCT02643615|20084605|P1|COMPLETED|Overall Study||9
8149025|NCT02643615|20084604|P2|STARTED|Overall Study||11
8149026|NCT02643615|20084605|P1|STARTED|Overall Study||9
8149027|NCT02643472|20084619|P2|NOT COMPLETED|Overall Study||34
8149028|NCT02643472|20084620|P1|NOT COMPLETED|Overall Study||27
8149029|NCT02643472|20084619|P2|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116
8149030|NCT02643472|20084620|P1|COMPLETED|Overall Study||123
8149031|NCT02643472|20084619|P2|STARTED|Overall Study||150
8149032|NCT02643472|20084620|P1|STARTED|Overall Study||150
8149033|NCT02643394|20084646|P2|NOT COMPLETED|Overall Study||5
8149034|NCT02643394|20084647|P1|NOT COMPLETED|Overall Study||4
8149035|NCT02643394|20084646|P2|COMPLETED|Overall Study||50
8149036|NCT02643394|20084647|P1|COMPLETED|Overall Study||51
8149037|NCT02643394|20084646|P2|STARTED|Overall Study||55
8149038|NCT02643394|20084647|P1|STARTED|Overall Study||55
8149039|NCT02643355|20084657|P2|NOT COMPLETED|Overall Study||5
8149040|NCT02643355|20084658|P1|NOT COMPLETED|Overall Study||1
8149041|NCT02643355|20084657|P2|COMPLETED|Overall Study||30
8149042|NCT02643355|20084658|P1|COMPLETED|Overall Study||33
8149043|NCT02643355|20084657|P2|STARTED|Overall Study||35
8149044|NCT02643355|20084658|P1|STARTED|Overall Study||34
8149045|NCT02643251|20084672|P2|NOT COMPLETED|Overall Study||2
8149046|NCT02643251|20084673|P1|NOT COMPLETED|Overall Study||11
8149047|NCT02643251|20084672|P2|COMPLETED|Overall Study||67
8149048|NCT02643251|20084673|P1|COMPLETED|Overall Study||58
8149049|NCT02643251|20084672|P2|STARTED|Overall Study||69
8149050|NCT02643251|20084673|P1|STARTED|Overall Study||69
8149051|NCT02643225|20084683|P2|NOT COMPLETED|Overall Study||0
8149052|NCT02643225|20084684|P1|NOT COMPLETED|Overall Study||0
8149053|NCT02643225|20084683|P2|COMPLETED|Overall Study||40
8149054|NCT02643225|20084684|P1|COMPLETED|Overall Study||40
8149055|NCT02643225|20084683|P2|STARTED|Overall Study||40
8149056|NCT02643225|20084684|P1|STARTED|Overall Study||40
8149057|NCT02643199|20084696|P1|NOT COMPLETED|Overall Study||0
8149058|NCT02643199|20084696|P1|COMPLETED|Overall Study||90
8149059|NCT02643199|20084696|P1|STARTED|Overall Study||90
8149060|NCT02643095|20084701|P1|NOT COMPLETED|Overall Study||1
8149061|NCT02643095|20084701|P1|COMPLETED|Overall Study||21
8149062|NCT02643095|20084701|P1|STARTED|Overall Study||22
8149063|NCT02643082|20084705|P2|NOT COMPLETED|Period 2||0
8149064|NCT02643082|20084706|P1|NOT COMPLETED|Period 2||0
8149065|NCT02643082|20084705|P2|COMPLETED|Period 2||10
8149066|NCT02643082|20084706|P1|COMPLETED|Period 2||9
8149067|NCT02643082|20084705|P2|STARTED|Period 2||10
8149068|NCT02643082|20084706|P1|STARTED|Period 2||9
8149069|NCT02643082|20084705|P2|NOT COMPLETED|Washout||0
8149070|NCT02643082|20084706|P1|NOT COMPLETED|Washout||0
8149071|NCT02643082|20084705|P2|COMPLETED|Washout||10
8149072|NCT02643082|20084706|P1|COMPLETED|Washout||9
8149073|NCT02643082|20084705|P2|STARTED|Washout||10
8149074|NCT02643082|20084706|P1|STARTED|Washout||9
8149075|NCT02643082|20084705|P2|NOT COMPLETED|Period 1||0
8149076|NCT02643082|20084706|P1|NOT COMPLETED|Period 1||1
8149077|NCT02643082|20084705|P2|COMPLETED|Period 1||10
8149078|NCT02643082|20084706|P1|COMPLETED|Period 1||9
8149079|NCT02643082|20084705|P2|STARTED|Period 1||10
8149080|NCT02643082|20084706|P1|STARTED|Period 1||10
8149081|NCT02643004|20084723|P2|NOT COMPLETED|Second Intervention (One Week)||0
8149082|NCT02643004|20084724|P1|NOT COMPLETED|Second Intervention (One Week)||0
8149083|NCT02643004|20084723|P2|COMPLETED|Second Intervention (One Week)||35
8149084|NCT02643004|20084724|P1|COMPLETED|Second Intervention (One Week)||35
8149085|NCT02643004|20084723|P2|STARTED|Second Intervention (One Week)||35
8149086|NCT02643004|20084724|P1|STARTED|Second Intervention (One Week)||35
8149087|NCT02643004|20084723|P2|NOT COMPLETED|First Intervention (One Week)||0
8149088|NCT02643004|20084724|P1|NOT COMPLETED|First Intervention (One Week)||0
8149089|NCT02643004|20084723|P2|COMPLETED|First Intervention (One Week)||35
8149090|NCT02643004|20084724|P1|COMPLETED|First Intervention (One Week)||35
8149091|NCT02643004|20084723|P2|STARTED|First Intervention (One Week)||35
8149092|NCT02643004|20084724|P1|STARTED|First Intervention (One Week)||35
8149093|NCT02642991|20084764|P2|NOT COMPLETED|Second Intervention||0
8149094|NCT02642991|20084765|P1|NOT COMPLETED|Second Intervention||0
8149095|NCT02642991|20084764|P2|COMPLETED|Second Intervention||22
8149096|NCT02642991|20084765|P1|COMPLETED|Second Intervention||22
8149097|NCT02642991|20084764|P2|STARTED|Second Intervention||22
8149098|NCT02642991|20084765|P1|STARTED|Second Intervention||22
8149099|NCT02642991|20084764|P2|NOT COMPLETED|First Intervention||0
8149100|NCT02642991|20084765|P1|NOT COMPLETED|First Intervention||0
8149101|NCT02642991|20084764|P2|COMPLETED|First Intervention||22
8149102|NCT02642991|20084765|P1|COMPLETED|First Intervention||22
8149103|NCT02642991|20084764|P2|STARTED|First Intervention||22
8149104|NCT02642991|20084765|P1|STARTED|First Intervention||22
8149105|NCT02642965|20084846|P1|NOT COMPLETED|Overall Study||13
8149106|NCT02642965|20084846|P1|COMPLETED|Overall Study||25
8149107|NCT02642965|20084846|P1|STARTED|Overall Study||38
8149108|NCT02642952|20084862|P2|NOT COMPLETED|Overall Study||5
8149109|NCT02642952|20084863|P1|NOT COMPLETED|Overall Study||2
8149110|NCT02642952|20084862|P2|COMPLETED|Overall Study||25
8149111|NCT02642952|20084863|P1|COMPLETED|Overall Study||19
8149112|NCT02642952|20084862|P2|STARTED|Overall Study||30
8149113|NCT02642952|20084863|P1|STARTED|Overall Study||21
8149114|NCT02642835|20084877|P1|NOT COMPLETED|Overall Study||0
8149115|NCT02642835|20084877|P1|COMPLETED|Overall Study||48
8149116|NCT02642835|20084877|P1|STARTED|Overall Study||48
8149117|NCT02642679|20084890|P1|NOT COMPLETED|Overall Study||3
8149118|NCT02642679|20084890|P1|COMPLETED|Overall Study||16
8149119|NCT02642679|20084890|P1|STARTED|Overall Study||19
8149120|NCT02642653|20084898|P2|NOT COMPLETED|Overall Study||0
8149121|NCT02642653|20084899|P1|NOT COMPLETED|Overall Study||2
8149122|NCT02642653|20084898|P2|COMPLETED|Overall Study||16
8149123|NCT02642653|20084899|P1|COMPLETED|Overall Study||12
8149124|NCT02642653|20084898|P2|STARTED|Overall Study||16
8149125|NCT02642653|20084899|P1|STARTED|Overall Study||14
8149126|NCT02642627|20084931|P1|NOT COMPLETED|Overall Study||3
8149127|NCT02642627|20084931|P1|COMPLETED|Overall Study||39
8149128|NCT02642627|20084931|P1|STARTED|Overall Study||42
8149129|NCT02642614|20084940|P4|NOT COMPLETED|Overall Study||2
8149130|NCT02642614|20084941|P3|NOT COMPLETED|Overall Study||2
8149131|NCT02642614|20084942|P2|NOT COMPLETED|Overall Study||2
8149132|NCT02642614|20084943|P1|NOT COMPLETED|Overall Study||3
8149133|NCT02642614|20084940|P4|COMPLETED|Overall Study||28
8149134|NCT02642614|20084941|P3|COMPLETED|Overall Study||28
8149135|NCT02642614|20084942|P2|COMPLETED|Overall Study||28
8149136|NCT02642614|20084943|P1|COMPLETED|Overall Study||27
8149137|NCT02642614|20084940|P4|STARTED|Overall Study||30
8149138|NCT02642614|20084941|P3|STARTED|Overall Study||30
8149139|NCT02642614|20084942|P2|STARTED|Overall Study||30
8149140|NCT02642614|20084943|P1|STARTED|Overall Study||30
8149141|NCT02642575|20084975|P1|NOT COMPLETED|Overall Study||0
8149142|NCT02642575|20084975|P1|COMPLETED|Overall Study||67
8149143|NCT02642575|20084975|P1|STARTED|Overall Study||67
8149144|NCT02642536|20084983|P2|NOT COMPLETED|Overall Study||5
8149145|NCT02642536|20084984|P1|NOT COMPLETED|Overall Study||2
8149146|NCT02642536|20084983|P2|COMPLETED|Overall Study||18
8149147|NCT02642536|20084984|P1|COMPLETED|Overall Study||19
8149148|NCT02642536|20084983|P2|STARTED|Overall Study||23
8149149|NCT02642536|20084984|P1|STARTED|Overall Study||21
8149153|NCT02642393|20085018|P2|NOT COMPLETED|Overall Study||92
8149154|NCT02642393|20085019|P1|NOT COMPLETED|Overall Study||99
8149155|NCT02642393|20085018|P2|COMPLETED|Overall Study|"Participants who completed the study:
~On-drug: 40; In-person off-drug: 16; By telephone off-drug: 1"|57
8149156|NCT02642393|20085019|P1|COMPLETED|Overall Study|"Participants who completed the study:
~On-drug: 31; In-person off-drug:13; By telephone off-drug: 6"|50
8149157|NCT02642393|20085018|P2|STARTED|Overall Study||149
8149158|NCT02642393|20085019|P1|STARTED|Overall Study||149
8149159|NCT02642237|20085047|P2|NOT COMPLETED|Overall Study||0
8149160|NCT02642237|20085048|P1|NOT COMPLETED|Overall Study||0
8149161|NCT02642237|20085047|P2|COMPLETED|Overall Study||15
8149162|NCT02642237|20085048|P1|COMPLETED|Overall Study||15
8149163|NCT02642237|20085047|P2|STARTED|Overall Study||15
8149164|NCT02642237|20085048|P1|STARTED|Overall Study||15
8149165|NCT02642159|20085056|P2|NOT COMPLETED|Overall Study||8
8149166|NCT02642159|20085057|P1|NOT COMPLETED|Overall Study||31
8149167|NCT02642159|20085056|P2|COMPLETED|Overall Study||129
8149168|NCT02642159|20085057|P1|COMPLETED|Overall Study||245
8149169|NCT02642159|20085056|P2|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
8149170|NCT02642159|20085057|P1|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only 'intended to prescribe' in the Alirocumab arm but not actually administered.|47
8149171|NCT02642159|20085056|P2|ITT Population|Overall Study||136
8149172|NCT02642159|20085057|P1|ITT Population|Overall Study||273
8149173|NCT02642159|20085056|P2|Treated (Safety Population)|Overall Study||137
8149174|NCT02642159|20085057|P1|Treated (Safety Population)|Overall Study||275
8149175|NCT02642159|20085056|P2|STARTED|Overall Study|Randomized|137
8149176|NCT02642159|20085057|P1|STARTED|Overall Study|Randomized|276
8149177|NCT02641912|20085109|P2|NOT COMPLETED|Overall Study||0
8149178|NCT02641912|20085110|P1|NOT COMPLETED|Overall Study||0
8149179|NCT02641912|20085109|P2|COMPLETED|Overall Study||47
8149180|NCT02641912|20085110|P1|COMPLETED|Overall Study||53
8149181|NCT02641912|20085109|P2|STARTED|Overall Study||47
8149182|NCT02641912|20085110|P1|STARTED|Overall Study||53
8149183|NCT02641730|20085181|P5|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1
8149184|NCT02641730|20085182|P4|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
8149185|NCT02641730|20085183|P3|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
8149186|NCT02641730|20085184|P2|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
8149187|NCT02641730|20085185|P1|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
8149188|NCT02641730|20085181|P5|COMPLETED|Observational Period (Week 60 - Week 84)||43
8149189|NCT02641730|20085182|P4|COMPLETED|Observational Period (Week 60 - Week 84)||45
8149190|NCT02641730|20085183|P3|COMPLETED|Observational Period (Week 60 - Week 84)||24
8149191|NCT02641730|20085184|P2|COMPLETED|Observational Period (Week 60 - Week 84)||21
8149192|NCT02641730|20085185|P1|COMPLETED|Observational Period (Week 60 - Week 84)||0
8149193|NCT02641730|20085181|P5|STARTED|Observational Period (Week 60 - Week 84)||44
8149194|NCT02641730|20085182|P4|STARTED|Observational Period (Week 60 - Week 84)||45
8149195|NCT02641730|20085183|P3|STARTED|Observational Period (Week 60 - Week 84)||24
8149196|NCT02641730|20085184|P2|STARTED|Observational Period (Week 60 - Week 84)||21
8149197|NCT02641730|20085185|P1|STARTED|Observational Period (Week 60 - Week 84)||0
8149198|NCT02641730|20085181|P5|NOT COMPLETED|After Controlled Period (Week 16 - 52)||6
8149199|NCT02641730|20085182|P4|NOT COMPLETED|After Controlled Period (Week 16 - 52)||8
8149200|NCT02641730|20085183|P3|NOT COMPLETED|After Controlled Period (Week 16 - 52)||2
8149201|NCT02641730|20085184|P2|NOT COMPLETED|After Controlled Period (Week 16 - 52)||4
8149202|NCT02641730|20085185|P1|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
8149203|NCT02641730|20085181|P5|COMPLETED|After Controlled Period (Week 16 - 52)||44
8149204|NCT02641730|20085182|P4|COMPLETED|After Controlled Period (Week 16 - 52)||45
8149205|NCT02641730|20085183|P3|COMPLETED|After Controlled Period (Week 16 - 52)||24
8149206|NCT02641730|20085184|P2|COMPLETED|After Controlled Period (Week 16 - 52)||21
8149207|NCT02641730|20085185|P1|COMPLETED|After Controlled Period (Week 16 - 52)||0
8149208|NCT02641730|20085181|P5|STARTED|After Controlled Period (Week 16 - 52)||50
8149209|NCT02641730|20085182|P4|STARTED|After Controlled Period (Week 16 - 52)||53
8149210|NCT02641730|20085183|P3|STARTED|After Controlled Period (Week 16 - 52)||26
8149211|NCT02641730|20085184|P2|STARTED|After Controlled Period (Week 16 - 52)||25
8149212|NCT02641730|20085185|P1|STARTED|After Controlled Period (Week 16 - 52)||0
8149213|NCT02641730|20085181|P5|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
8149214|NCT02641730|20085182|P4|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1
8149215|NCT02641730|20085183|P3|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8149216|NCT02641730|20085184|P2|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8149217|NCT02641730|20085185|P1|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
8149218|NCT02641730|20085181|P5|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50
8149219|NCT02641730|20085182|P4|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53
8149220|NCT02641730|20085183|P3|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8149221|NCT02641730|20085184|P2|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8149222|NCT02641730|20085185|P1|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51
8149223|NCT02641730|20085181|P5|STARTED|Placebo Controlled Period (Week 0 - 16)||52
8149224|NCT02641730|20085182|P4|STARTED|Placebo Controlled Period (Week 0 - 16)||54
8149225|NCT02641730|20085183|P3|STARTED|Placebo Controlled Period (Week 0 - 16)||0
8149226|NCT02641730|20085184|P2|STARTED|Placebo Controlled Period (Week 0 - 16)||0
8149227|NCT02641730|20085185|P1|STARTED|Placebo Controlled Period (Week 0 - 16)||53
8149228|NCT02641587|20085289|P2|NOT COMPLETED|Ambulatory Period||0
8149229|NCT02641587|20085290|P1|NOT COMPLETED|Ambulatory Period||1
8149230|NCT02641587|20085289|P2|COMPLETED|Ambulatory Period||39
8149231|NCT02641587|20085290|P1|COMPLETED|Ambulatory Period||76
8149232|NCT02641587|20085289|P2|STARTED|Ambulatory Period||39
8149233|NCT02641587|20085290|P1|STARTED|Ambulatory Period||77
8149234|NCT02641587|20085289|P2|NOT COMPLETED|Confinement Period||1
8149235|NCT02641587|20085290|P1|NOT COMPLETED|Confinement Period||3
8149236|NCT02641587|20085289|P2|COMPLETED|Confinement Period||39
8149237|NCT02641587|20085290|P1|COMPLETED|Confinement Period||77
8149238|NCT02641587|20085289|P2|STARTED|Confinement Period||40
8149239|NCT02641587|20085290|P1|STARTED|Confinement Period||80
8149240|NCT02641561|20085315|P4|NOT COMPLETED|Overall Study||0
8149241|NCT02641561|20085316|P3|NOT COMPLETED|Overall Study||0
8149242|NCT02641561|20085317|P2|NOT COMPLETED|Overall Study||0
8149243|NCT02641561|20085318|P1|NOT COMPLETED|Overall Study||0
8149244|NCT02641561|20085315|P4|COMPLETED|Overall Study||48
8149245|NCT02641561|20085316|P3|COMPLETED|Overall Study||48
8149246|NCT02641561|20085317|P2|COMPLETED|Overall Study||48
8149247|NCT02641561|20085318|P1|COMPLETED|Overall Study||48
8149248|NCT02641561|20085315|P4|STARTED|Overall Study||48
8149249|NCT02641561|20085316|P3|STARTED|Overall Study||48
8149250|NCT02641561|20085317|P2|STARTED|Overall Study||48
8149251|NCT02641561|20085318|P1|STARTED|Overall Study||48
8149252|NCT02641522|20085404|P1|NOT COMPLETED|Overall Study||0
8149253|NCT02641522|20085404|P1|COMPLETED|Overall Study||10
8149254|NCT02641522|20085404|P1|STARTED|Overall Study||10
8149255|NCT02641392|20085411|P3|NOT COMPLETED|Overall Study||293
8149256|NCT02641392|20085412|P2|NOT COMPLETED|Overall Study||13
8149257|NCT02641392|20085413|P1|NOT COMPLETED|Overall Study||4
8149258|NCT02641392|20085411|P3|COMPLETED|Overall Study||0
8149259|NCT02641392|20085412|P2|COMPLETED|Overall Study||0
8149260|NCT02641392|20085413|P1|COMPLETED|Overall Study||0
8149261|NCT02641392|20085411|P3|STARTED|Overall Study||293
8149262|NCT02641392|20085412|P2|STARTED|Overall Study||13
8149263|NCT02641392|20085413|P1|STARTED|Overall Study||4
8149264|NCT02641379|20085432|P11|NOT COMPLETED|Overall Study||8
8149265|NCT02641379|20085433|P10|NOT COMPLETED|Overall Study||9
8149266|NCT02641379|20085434|P9|NOT COMPLETED|Overall Study||6
8149267|NCT02641379|20085435|P8|NOT COMPLETED|Overall Study||19
8149268|NCT02641379|20085436|P7|NOT COMPLETED|Overall Study||13
8149269|NCT02641379|20085437|P6|NOT COMPLETED|Overall Study||16
8149270|NCT02641379|20085438|P5|NOT COMPLETED|Overall Study||17
8149271|NCT02641379|20085439|P4|NOT COMPLETED|Overall Study||17
8149272|NCT02641379|20085440|P3|NOT COMPLETED|Overall Study||71
8149273|NCT02641379|20085441|P2|NOT COMPLETED|Overall Study||51
8149274|NCT02641379|20085442|P1|NOT COMPLETED|Overall Study||35
8149275|NCT02641379|20085432|P11|COMPLETED|Overall Study||0
8149276|NCT02641379|20085433|P10|COMPLETED|Overall Study||36
8149277|NCT02641379|20085434|P9|COMPLETED|Overall Study||36
8149278|NCT02641379|20085435|P8|COMPLETED|Overall Study||1
8149279|NCT02641379|20085436|P7|COMPLETED|Overall Study||12
8149280|NCT02641379|20085437|P6|COMPLETED|Overall Study||20
8149281|NCT02641379|20085438|P5|COMPLETED|Overall Study||0
8149282|NCT02641379|20085439|P4|COMPLETED|Overall Study||139
8149283|NCT02641379|20085440|P3|COMPLETED|Overall Study||7
8149284|NCT02641379|20085441|P2|COMPLETED|Overall Study||101
8149285|NCT02641379|20085442|P1|COMPLETED|Overall Study||107
8149286|NCT02641379|20085432|P11|STARTED|Overall Study||8
8149287|NCT02641379|20085433|P10|STARTED|Overall Study||45
8149288|NCT02641379|20085434|P9|STARTED|Overall Study||42
8149289|NCT02641379|20085435|P8|STARTED|Overall Study||20
8149290|NCT02641379|20085436|P7|STARTED|Overall Study||25
8149291|NCT02641379|20085437|P6|STARTED|Overall Study||36
8149292|NCT02641379|20085438|P5|STARTED|Overall Study||17
8149293|NCT02641379|20085439|P4|STARTED|Overall Study||156
8149294|NCT02641379|20085440|P3|STARTED|Overall Study||78
8149295|NCT02641379|20085441|P2|STARTED|Overall Study||152
8149296|NCT02641379|20085442|P1|STARTED|Overall Study||142
8149297|NCT02641249|20085507|P1|NOT COMPLETED|Overall Study||4
8149298|NCT02641249|20085507|P1|COMPLETED|Overall Study||15
8149299|NCT02641249|20085507|P1|STARTED|Overall Study||19
8149300|NCT02641080|20085518|P2|NOT COMPLETED|Overall Study||7
8149301|NCT02641080|20085519|P1|NOT COMPLETED|Overall Study||2
8149302|NCT02641080|20085518|P2|COMPLETED|Overall Study||33
8149303|NCT02641080|20085519|P1|COMPLETED|Overall Study||38
8149304|NCT02641080|20085518|P2|STARTED|Overall Study||40
8149305|NCT02641080|20085519|P1|STARTED|Overall Study||40
8149306|NCT02641067|20085533|P2|NOT COMPLETED|Overall Study||0
8149307|NCT02641067|20085534|P1|NOT COMPLETED|Overall Study||0
8149308|NCT02641067|20085533|P2|COMPLETED|Overall Study||8
8149309|NCT02641067|20085534|P1|COMPLETED|Overall Study||8
8149310|NCT02641067|20085533|P2|STARTED|Overall Study||8
8149311|NCT02641067|20085534|P1|STARTED|Overall Study||8
8149312|NCT02640807|20085557|P3|NOT COMPLETED|Overall Study||0
8149313|NCT02640807|20085558|P2|NOT COMPLETED|Overall Study||0
8149314|NCT02640807|20085559|P1|NOT COMPLETED|Overall Study||0
8149315|NCT02640807|20085557|P3|COMPLETED|Overall Study||10
8149316|NCT02640807|20085558|P2|COMPLETED|Overall Study||8
8149317|NCT02640807|20085559|P1|COMPLETED|Overall Study||9
8149318|NCT02640807|20085557|P3|STARTED|Overall Study||10
8149319|NCT02640807|20085558|P2|STARTED|Overall Study||8
8149320|NCT02640807|20085559|P1|STARTED|Overall Study||9
8149321|NCT02640755|20085575|P2|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
8149322|NCT02640755|20085576|P1|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2
8149323|NCT02640755|20085575|P2|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0
8149324|NCT02640755|20085576|P1|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
8149325|NCT02640755|20085575|P2|STARTED|Multiple Dose Period (Day 8 - EoS)||1
8149326|NCT02640755|20085576|P1|STARTED|Multiple Dose Period (Day 8 - EoS)||3
8149327|NCT02640755|20085575|P2|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
8149328|NCT02640755|20085576|P1|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
8149329|NCT02640755|20085575|P2|COMPLETED|Single Dose Period (Day 1 - 8)||1
8149330|NCT02640755|20085576|P1|COMPLETED|Single Dose Period (Day 1 - 8)||3
8149331|NCT02640755|20085575|P2|STARTED|Single Dose Period (Day 1 - 8)||1
8149332|NCT02640755|20085576|P1|STARTED|Single Dose Period (Day 1 - 8)||3
8149333|NCT02640716|20085613|P2|NOT COMPLETED|Overall Study||9
8149334|NCT02640716|20085614|P1|NOT COMPLETED|Overall Study||7
8149335|NCT02640716|20085613|P2|COMPLETED|Overall Study||21
8149336|NCT02640716|20085614|P1|COMPLETED|Overall Study||23
8149337|NCT02640716|20085613|P2|Training Completion|Overall Study||27
8149338|NCT02640716|20085614|P1|Training Completion|Overall Study||27
8149339|NCT02640716|20085613|P2|STARTED|Overall Study||30
8149340|NCT02640716|20085614|P1|STARTED|Overall Study||30
8149341|NCT02640677|20085630|P1|NOT COMPLETED|Overall Study||2
8149342|NCT02640677|20085630|P1|COMPLETED|Overall Study||0
8149343|NCT02640677|20085630|P1|STARTED|Overall Study||2
8149347|NCT02640612|20085646|P3|NOT COMPLETED|Overall Study||6
8149348|NCT02640612|20085647|P2|NOT COMPLETED|Overall Study||14
8149349|NCT02640612|20085648|P1|NOT COMPLETED|Overall Study||22
8149350|NCT02640612|20085646|P3|COMPLETED|Overall Study||96
8149351|NCT02640612|20085647|P2|COMPLETED|Overall Study||89
8149352|NCT02640612|20085648|P1|COMPLETED|Overall Study||203
8149353|NCT02640612|20085646|P3|STARTED|Overall Study||102
8149354|NCT02640612|20085647|P2|STARTED|Overall Study||103
8149355|NCT02640612|20085648|P1|STARTED|Overall Study||225
8149356|NCT02640573|20085668|P1|NOT COMPLETED|Overall Study||1
8149357|NCT02640573|20085668|P1|COMPLETED|Overall Study||0
8149358|NCT02640573|20085668|P1|STARTED|Overall Study||1
8149359|NCT02640547|20085672|P1|NOT COMPLETED|Overall Study||11
8149360|NCT02640547|20085672|P1|COMPLETED|Overall Study||383
8149361|NCT02640547|20085672|P1|STARTED|Overall Study||394
8149368|NCT02640404|20085762|P2|NOT COMPLETED|Overall Study||0
8149369|NCT02640404|20085763|P1|NOT COMPLETED|Overall Study||2
8149370|NCT02640404|20085762|P2|COMPLETED|Overall Study||112
8149371|NCT02640404|20085763|P1|COMPLETED|Overall Study||110
8149372|NCT02640404|20085762|P2|STARTED|Overall Study||112
8149373|NCT02640404|20085763|P1|STARTED|Overall Study||112
8149374|NCT02640235|20085773|P2|NOT COMPLETED|Overall Study||14
8149375|NCT02640235|20085774|P1|NOT COMPLETED|Overall Study||14
8149376|NCT02640235|20085773|P2|COMPLETED|Overall Study||115
8149377|NCT02640235|20085774|P1|COMPLETED|Overall Study||117
8149378|NCT02640235|20085773|P2|STARTED|Overall Study||129
8149379|NCT02640235|20085774|P1|STARTED|Overall Study||131
8149398|NCT02640053|20085818|P2|NOT COMPLETED|Overall Study||4
8149399|NCT02640053|20085819|P1|NOT COMPLETED|Overall Study||4
8149400|NCT02640053|20085818|P2|COMPLETED|Overall Study||17
8149401|NCT02640053|20085819|P1|COMPLETED|Overall Study||17
8149402|NCT02640053|20085818|P2|STARTED|Overall Study||21
8149403|NCT02640053|20085819|P1|STARTED|Overall Study||21
8149404|NCT02639910|20085841|P2|NOT COMPLETED|Overall Study||8
8149405|NCT02639910|20085842|P1|NOT COMPLETED|Overall Study||4
8149406|NCT02639910|20085841|P2|COMPLETED|Overall Study||5
8149407|NCT02639910|20085842|P1|COMPLETED|Overall Study||7
8149408|NCT02639910|20085841|P2|STARTED|Overall Study||13
8149409|NCT02639910|20085842|P1|STARTED|Overall Study||11
8149410|NCT02639637|20085859|P4|NOT COMPLETED|Overall Study||0
8149411|NCT02639637|20085860|P3|NOT COMPLETED|Overall Study||0
8149412|NCT02639637|20085861|P2|NOT COMPLETED|Overall Study||0
8149413|NCT02639637|20085862|P1|NOT COMPLETED|Overall Study||0
8149414|NCT02639637|20085859|P4|COMPLETED|Overall Study||3
8149415|NCT02639637|20085860|P3|COMPLETED|Overall Study||2
8149416|NCT02639637|20085861|P2|COMPLETED|Overall Study||6
8149417|NCT02639637|20085862|P1|COMPLETED|Overall Study||7
8149418|NCT02639637|20085859|P4|STARTED|Overall Study||3
8149419|NCT02639637|20085860|P3|STARTED|Overall Study||2
8149420|NCT02639637|20085861|P2|STARTED|Overall Study||6
8149421|NCT02639637|20085862|P1|STARTED|Overall Study||7
8149428|NCT02639494|20085953|P1|NOT COMPLETED|Overall Study||0
8149429|NCT02639494|20085953|P1|COMPLETED|Overall Study||20
8149430|NCT02639494|20085953|P1|STARTED|Overall Study||20
8149431|NCT02639429|20085970|P2|NOT COMPLETED|Overall Study||0
8149432|NCT02639429|20085971|P1|NOT COMPLETED|Overall Study||0
8149433|NCT02639429|20085970|P2|COMPLETED|Overall Study||123
8149434|NCT02639429|20085971|P1|COMPLETED|Overall Study||113
8149435|NCT02639429|20085970|P2|STARTED|Overall Study||123
8149436|NCT02639429|20085971|P1|STARTED|Overall Study||113
8149437|NCT02639390|20086007|P2|NOT COMPLETED|Overall Study||2
8149438|NCT02639390|20086008|P1|NOT COMPLETED|Overall Study||0
8149439|NCT02639390|20086007|P2|COMPLETED|Overall Study||3
8149440|NCT02639390|20086008|P1|COMPLETED|Overall Study||0
8149441|NCT02639390|20086007|P2|STARTED|Overall Study||5
8149442|NCT02639390|20086008|P1|STARTED|Overall Study||0
8149443|NCT02639351|20086029|P5|NOT COMPLETED|Overall Study||0
8149444|NCT02639351|20086030|P4|NOT COMPLETED|Overall Study||0
8149445|NCT02639351|20086031|P3|NOT COMPLETED|Overall Study||0
8149446|NCT02639351|20086032|P2|NOT COMPLETED|Overall Study||0
8149447|NCT02639351|20086033|P1|NOT COMPLETED|Overall Study||0
8149448|NCT02639351|20086029|P5|COMPLETED|Overall Study||16
8149449|NCT02639351|20086030|P4|COMPLETED|Overall Study||16
8149450|NCT02639351|20086031|P3|COMPLETED|Overall Study||16
8149451|NCT02639351|20086032|P2|COMPLETED|Overall Study||16
8149452|NCT02639351|20086033|P1|COMPLETED|Overall Study||16
8149453|NCT02639351|20086029|P5|STARTED|Overall Study||16
8149454|NCT02639351|20086030|P4|STARTED|Overall Study||16
8149455|NCT02639351|20086031|P3|STARTED|Overall Study||16
8149456|NCT02639351|20086032|P2|STARTED|Overall Study||16
8149457|NCT02639351|20086033|P1|STARTED|Overall Study||16
8149458|NCT02639338|20086382|P2|NOT COMPLETED|Overall Study||5
8149459|NCT02639338|20086383|P1|NOT COMPLETED|Overall Study||4
8149460|NCT02639338|20086382|P2|COMPLETED|Overall Study||105
8149461|NCT02639338|20086383|P1|COMPLETED|Overall Study||106
8149462|NCT02639338|20086382|P2|STARTED|Overall Study||110
8149463|NCT02639338|20086383|P1|STARTED|Overall Study||110
8149464|NCT02639286|20086401|P2|NOT COMPLETED|Overall Study||0
8149465|NCT02639286|20086402|P1|NOT COMPLETED|Overall Study||0
8149466|NCT02639286|20086401|P2|COMPLETED|Overall Study||2
8149467|NCT02639286|20086402|P1|COMPLETED|Overall Study||3
8149468|NCT02639286|20086401|P2|STARTED|Overall Study||2
8149469|NCT02639286|20086402|P1|STARTED|Overall Study||3
8149470|NCT02639247|20086428|P2|NOT COMPLETED|Overall Study||2
8149471|NCT02639247|20086429|P1|NOT COMPLETED|Overall Study||5
8149472|NCT02639247|20086428|P2|COMPLETED|Overall Study||149
8149473|NCT02639247|20086429|P1|COMPLETED|Overall Study||177
8149474|NCT02639247|20086428|P2|STARTED|Overall Study||151
8149475|NCT02639247|20086429|P1|STARTED|Overall Study||182
8149482|NCT02639052|20086481|P1|NOT COMPLETED|Overall Study||1
8149483|NCT02639052|20086481|P1|COMPLETED|Overall Study||34
8149484|NCT02639052|20086481|P1|Visit 4 (3-month Follow-up)|Overall Study||34
8149485|NCT02639052|20086481|P1|Visit 3 (1-month Follow-up)|Overall Study||35
8149486|NCT02639052|20086481|P1|Visit 2 (1-week Follow-up)|Overall Study||35
8149487|NCT02639052|20086481|P1|Visit 1 (Baseline)|Overall Study||35
8149488|NCT02639052|20086481|P1|STARTED|Overall Study||35
8149489|NCT02638974|20086497|P2|NOT COMPLETED|Overall Study||3
8149490|NCT02638974|20086498|P1|NOT COMPLETED|Overall Study||3
8149491|NCT02638974|20086497|P2|COMPLETED|Overall Study||22
8149492|NCT02638974|20086498|P1|COMPLETED|Overall Study||23
8149493|NCT02638974|20086497|P2|STARTED|Overall Study||25
8149494|NCT02638974|20086498|P1|STARTED|Overall Study||26
8149495|NCT02638948|20086518|P4|NOT COMPLETED|Overall Study||8
8149496|NCT02638948|20086519|P3|NOT COMPLETED|Overall Study||7
8149497|NCT02638948|20086520|P2|NOT COMPLETED|Overall Study||11
8149498|NCT02638948|20086521|P1|NOT COMPLETED|Overall Study||9
8149499|NCT02638948|20086518|P4|COMPLETED|Overall Study||18
8149500|NCT02638948|20086519|P3|COMPLETED|Overall Study||66
8149501|NCT02638948|20086520|P2|COMPLETED|Overall Study||62
8149502|NCT02638948|20086521|P1|COMPLETED|Overall Study||66
8149503|NCT02638948|20086518|P4|STARTED|Overall Study||26
8149504|NCT02638948|20086519|P3|STARTED|Overall Study||73
8149505|NCT02638948|20086520|P2|STARTED|Overall Study||73
8149506|NCT02638948|20086521|P1|STARTED|Overall Study||75
8149507|NCT02638623|20086608|P2|NOT COMPLETED|Overall Study||6
8149508|NCT02638623|20086609|P1|NOT COMPLETED|Overall Study||7
8149509|NCT02638623|20086608|P2|COMPLETED|Overall Study||19
8149510|NCT02638623|20086609|P1|COMPLETED|Overall Study||20
8149511|NCT02638623|20086608|P2|STARTED|Overall Study||25
8149512|NCT02638623|20086609|P1|STARTED|Overall Study||27
8149513|NCT02638597|20086627|P2|NOT COMPLETED|Overall Study||5
8149514|NCT02638597|20086628|P1|NOT COMPLETED|Overall Study||4
8149515|NCT02638597|20086627|P2|COMPLETED|Overall Study||3
8149516|NCT02638597|20086628|P1|COMPLETED|Overall Study||4
8149517|NCT02638597|20086627|P2|STARTED|Overall Study||8
8149518|NCT02638597|20086628|P1|STARTED|Overall Study||8
8149519|NCT02638493|20086639|P3|NOT COMPLETED|Overall Study||0
8149520|NCT02638493|20086640|P2|NOT COMPLETED|Overall Study||0
8149521|NCT02638493|20086641|P1|NOT COMPLETED|Overall Study||2
8149522|NCT02638493|20086639|P3|COMPLETED|Overall Study||8
8149523|NCT02638493|20086640|P2|COMPLETED|Overall Study||8
8149524|NCT02638493|20086641|P1|COMPLETED|Overall Study||8
8149525|NCT02638493|20086639|P3|STARTED|Overall Study||8
8149526|NCT02638493|20086640|P2|STARTED|Overall Study||8
8149527|NCT02638493|20086641|P1|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
8149528|NCT02638337|20086672|P2|NOT COMPLETED|Overall Study||36
8149529|NCT02638337|20086673|P1|NOT COMPLETED|Overall Study||33
8149530|NCT02638337|20086672|P2|COMPLETED|Overall Study||279
8149531|NCT02638337|20086673|P1|COMPLETED|Overall Study||283
8149532|NCT02638337|20086672|P2|Received Treatment|Overall Study||315
8149533|NCT02638337|20086673|P1|Received Treatment|Overall Study||313
8149534|NCT02638337|20086672|P2|STARTED|Overall Study||315
8149535|NCT02638337|20086673|P1|STARTED|Overall Study||316
8149536|NCT02638259|20086757|P2|NOT COMPLETED|Treatment Period 2||11
8149537|NCT02638259|20086758|P1|NOT COMPLETED|Treatment Period 2||6
8149538|NCT02638259|20086757|P2|COMPLETED|Treatment Period 2||155
8149539|NCT02638259|20086758|P1|COMPLETED|Treatment Period 2||169
8149540|NCT02638259|20086757|P2|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
8149541|NCT02638259|20086758|P1|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
8149542|NCT02638259|20086757|P2|NOT COMPLETED|Treatment Period 1||18
8149543|NCT02638259|20086758|P1|NOT COMPLETED|Treatment Period 1||5
8149544|NCT02638259|20086757|P2|COMPLETED|Treatment Period 1||172
8149545|NCT02638259|20086758|P1|COMPLETED|Treatment Period 1||181
8149546|NCT02638259|20086757|P2|STARTED|Treatment Period 1||190
8149547|NCT02638259|20086758|P1|STARTED|Treatment Period 1||186
8149548|NCT02638168|20086832|P2|NOT COMPLETED|Overall Study||0
8149549|NCT02638168|20086833|P1|NOT COMPLETED|Overall Study||0
8149550|NCT02638168|20086832|P2|COMPLETED|Overall Study||0
8149551|NCT02638168|20086833|P1|COMPLETED|Overall Study||3
8149552|NCT02638168|20086832|P2|STARTED|Overall Study||0
8149553|NCT02638168|20086833|P1|STARTED|Overall Study||3
8149554|NCT02638129|20086850|P2|NOT COMPLETED|Overall Study||30
8149555|NCT02638129|20086851|P1|NOT COMPLETED|Overall Study||28
8149556|NCT02638129|20086850|P2|COMPLETED|Overall Study||0
8149557|NCT02638129|20086851|P1|COMPLETED|Overall Study||0
8149558|NCT02638129|20086850|P2|STARTED|Overall Study||30
8149559|NCT02638129|20086851|P1|STARTED|Overall Study||28
8149560|NCT02638103|20086867|P4|NOT COMPLETED|Overall Study||142
8149561|NCT02638103|20086868|P3|NOT COMPLETED|Overall Study||85
8149562|NCT02638103|20086869|P2|NOT COMPLETED|Overall Study||118
8149563|NCT02638103|20086870|P1|NOT COMPLETED|Overall Study||106
8149564|NCT02638103|20086867|P4|COMPLETED|Overall Study||383
8149565|NCT02638103|20086868|P3|COMPLETED|Overall Study||335
8149566|NCT02638103|20086869|P2|COMPLETED|Overall Study||408
8149567|NCT02638103|20086870|P1|COMPLETED|Overall Study||313
8149568|NCT02638103|20086867|P4|Full Analysis Set (FAS)|Overall Study||523
8149569|NCT02638103|20086868|P3|Full Analysis Set (FAS)|Overall Study||419
8149570|NCT02638103|20086869|P2|Full Analysis Set (FAS)|Overall Study||520
8149571|NCT02638103|20086870|P1|Full Analysis Set (FAS)|Overall Study||416
8149572|NCT02638103|20086867|P4|Safety Analysis Set|Overall Study||525
8149573|NCT02638103|20086868|P3|Safety Analysis Set|Overall Study||419
8149574|NCT02638103|20086869|P2|Safety Analysis Set|Overall Study||526
8149575|NCT02638103|20086870|P1|Safety Analysis Set|Overall Study||418
8149576|NCT02638103|20086867|P4|STARTED|Overall Study||525
8149577|NCT02638103|20086868|P3|STARTED|Overall Study||420
8149578|NCT02638103|20086869|P2|STARTED|Overall Study||526
8149579|NCT02638103|20086870|P1|STARTED|Overall Study||419
8149580|NCT02638051|20086946|P2|NOT COMPLETED|Overall Study||0
8149581|NCT02638051|20086947|P1|NOT COMPLETED|Overall Study||0
8149582|NCT02638051|20086946|P2|COMPLETED|Overall Study||130
8149583|NCT02638051|20086947|P1|COMPLETED|Overall Study||130
8149584|NCT02638051|20086946|P2|STARTED|Overall Study||130
8149585|NCT02638051|20086947|P1|STARTED|Overall Study||130
8149586|NCT02638012|20086957|P1|NOT COMPLETED|Overall Study||1
8149587|NCT02638012|20086957|P1|COMPLETED|Overall Study||7
8149588|NCT02638012|20086957|P1|STARTED|Overall Study||8
8149589|NCT02637999|20086968|P3|NOT COMPLETED|Overall Study||2
8149590|NCT02637999|20086969|P2|NOT COMPLETED|Overall Study||2
8149591|NCT02637999|20086970|P1|NOT COMPLETED|Overall Study||1
8149592|NCT02637999|20086968|P3|COMPLETED|Overall Study||6
8149593|NCT02637999|20086969|P2|COMPLETED|Overall Study||6
8149594|NCT02637999|20086970|P1|COMPLETED|Overall Study||7
8149595|NCT02637999|20086968|P3|STARTED|Overall Study||8
8149596|NCT02637999|20086969|P2|STARTED|Overall Study||8
8149597|NCT02637999|20086970|P1|STARTED|Overall Study||8
8149598|NCT02637856|20087002|P2|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||4
8149599|NCT02637856|20087003|P1|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||0
8149600|NCT02637856|20087002|P2|COMPLETED|Sub-Study (Week 72 to Week 100)||125
8149601|NCT02637856|20087003|P1|COMPLETED|Sub-Study (Week 72 to Week 100)||0
8149602|NCT02637856|20087002|P2|STARTED|Sub-Study (Week 72 to Week 100)||129
8149603|NCT02637856|20087003|P1|STARTED|Sub-Study (Week 72 to Week 100)||0
8149604|NCT02637856|20087002|P2|NOT COMPLETED|Main Study (Baseline to Week 100)||0
8149605|NCT02637856|20087003|P1|NOT COMPLETED|Main Study (Baseline to Week 100)||219
8149606|NCT02637856|20087002|P2|COMPLETED|Main Study (Baseline to Week 100)||0
8149607|NCT02637856|20087003|P1|COMPLETED|Main Study (Baseline to Week 100)||389
8149608|NCT02637856|20087002|P2|STARTED|Main Study (Baseline to Week 100)||0
8149609|NCT02637856|20087003|P1|STARTED|Main Study (Baseline to Week 100)||608
8149610|NCT02637804|20087022|P4|NOT COMPLETED|Second Intervention (1 Week)||0
8149611|NCT02637804|20087023|P3|NOT COMPLETED|Second Intervention (1 Week)||0
8149612|NCT02637804|20087024|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8149613|NCT02637804|20087025|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8149614|NCT02637804|20087022|P4|COMPLETED|Second Intervention (1 Week)||26
8149615|NCT02637804|20087023|P3|COMPLETED|Second Intervention (1 Week)||25
8149616|NCT02637804|20087024|P2|COMPLETED|Second Intervention (1 Week)||28
8149617|NCT02637804|20087025|P1|COMPLETED|Second Intervention (1 Week)||27
8149618|NCT02637804|20087022|P4|STARTED|Second Intervention (1 Week)||26
8149619|NCT02637804|20087023|P3|STARTED|Second Intervention (1 Week)||25
8149620|NCT02637804|20087024|P2|STARTED|Second Intervention (1 Week)||28
8149621|NCT02637804|20087025|P1|STARTED|Second Intervention (1 Week)||27
8149622|NCT02637804|20087022|P4|NOT COMPLETED|First Intervention (1 Week)||0
8149623|NCT02637804|20087023|P3|NOT COMPLETED|First Intervention (1 Week)||0
8149624|NCT02637804|20087024|P2|NOT COMPLETED|First Intervention (1 Week)||0
8149625|NCT02637804|20087025|P1|NOT COMPLETED|First Intervention (1 Week)||0
8149626|NCT02637804|20087022|P4|COMPLETED|First Intervention (1 Week)||26
8149627|NCT02637804|20087023|P3|COMPLETED|First Intervention (1 Week)||25
8149628|NCT02637804|20087024|P2|COMPLETED|First Intervention (1 Week)||28
8149629|NCT02637804|20087025|P1|COMPLETED|First Intervention (1 Week)||27
8149630|NCT02637804|20087022|P4|STARTED|First Intervention (1 Week)||26
8149631|NCT02637804|20087023|P3|STARTED|First Intervention (1 Week)||25
8149632|NCT02637804|20087024|P2|STARTED|First Intervention (1 Week)||28
8149633|NCT02637804|20087025|P1|STARTED|First Intervention (1 Week)||27
8149634|NCT02637557|20087133|P4|NOT COMPLETED|Overall Study||7
8149635|NCT02637557|20087134|P3|NOT COMPLETED|Overall Study||9
8149636|NCT02637557|20087135|P2|NOT COMPLETED|Overall Study||5
8149637|NCT02637557|20087136|P1|NOT COMPLETED|Overall Study||8
8149638|NCT02637557|20087133|P4|COMPLETED|Overall Study||62
8149639|NCT02637557|20087134|P3|COMPLETED|Overall Study||62
8149640|NCT02637557|20087135|P2|COMPLETED|Overall Study||66
8149641|NCT02637557|20087136|P1|COMPLETED|Overall Study||63
8149642|NCT02637557|20087133|P4|STARTED|Overall Study||69
8149643|NCT02637557|20087134|P3|STARTED|Overall Study||71
8149644|NCT02637557|20087135|P2|STARTED|Overall Study||71
8149645|NCT02637557|20087136|P1|STARTED|Overall Study||71
8149646|NCT02637323|20087228|P2|NOT COMPLETED|Overall Study||1
8149647|NCT02637323|20087229|P1|NOT COMPLETED|Overall Study||2
8149648|NCT02637323|20087228|P2|COMPLETED|Overall Study||17
8149649|NCT02637323|20087229|P1|COMPLETED|Overall Study||61
8149650|NCT02637323|20087228|P2|STARTED|Overall Study||18
8149651|NCT02637323|20087229|P1|STARTED|Overall Study||63
8149652|NCT02637141|20087240|P3|NOT COMPLETED|Overall Study||1
8149653|NCT02637141|20087241|P2|NOT COMPLETED|Overall Study||2
8149654|NCT02637141|20087242|P1|NOT COMPLETED|Overall Study||2
8149655|NCT02637141|20087240|P3|COMPLETED|Overall Study||19
8149656|NCT02637141|20087241|P2|COMPLETED|Overall Study||20
8149657|NCT02637141|20087242|P1|COMPLETED|Overall Study||20
8149658|NCT02637141|20087240|P3|Received Study Drug|Overall Study||19
8149659|NCT02637141|20087241|P2|Received Study Drug|Overall Study||21
8149660|NCT02637141|20087242|P1|Received Study Drug|Overall Study||22
8149661|NCT02637141|20087240|P3|STARTED|Overall Study||20
8149662|NCT02637141|20087241|P2|STARTED|Overall Study||22
8149663|NCT02637141|20087242|P1|STARTED|Overall Study||22
8149664|NCT02637063|20087277|P3|NOT COMPLETED|Overall Study||6
8149665|NCT02637063|20087278|P2|NOT COMPLETED|Overall Study||4
8149666|NCT02637063|20087279|P1|NOT COMPLETED|Overall Study||5
8149667|NCT02637063|20087277|P3|COMPLETED|Overall Study||62
8149668|NCT02637063|20087278|P2|COMPLETED|Overall Study||64
8149669|NCT02637063|20087279|P1|COMPLETED|Overall Study||62
8149670|NCT02637063|20087277|P3|STARTED|Overall Study||68
8149671|NCT02637063|20087278|P2|STARTED|Overall Study||68
8149672|NCT02637063|20087279|P1|STARTED|Overall Study||67
8149673|NCT02637037|20087307|P2|NOT COMPLETED|Overall Study||1
8149674|NCT02637037|20087308|P1|NOT COMPLETED|Overall Study||4
8149675|NCT02637037|20087307|P2|COMPLETED|Overall Study||39
8149676|NCT02637037|20087308|P1|COMPLETED|Overall Study||36
8149677|NCT02637037|20087307|P2|STARTED|Overall Study||40
8149678|NCT02637037|20087308|P1|STARTED|Overall Study||40
8149679|NCT02636907|20087374|P1|NOT COMPLETED|Extension Phase||10
8149680|NCT02636907|20087374|P1|COMPLETED|Extension Phase||62
8149681|NCT02636907|20087374|P1|STARTED|Extension Phase||72
8149682|NCT02636907|20087374|P1|NOT COMPLETED|Autoinjector Assessment Period||4
8149683|NCT02636907|20087374|P1|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
8149684|NCT02636907|20087374|P1|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
8149685|NCT02636712|20087383|P1|NOT COMPLETED|Overall Study||0
8149686|NCT02636712|20087383|P1|COMPLETED|Overall Study||10
8149687|NCT02636712|20087383|P1|STARTED|Overall Study||10
8149688|NCT02636608|20087391|P1|NOT COMPLETED|Overall Study||11
8149689|NCT02636608|20087391|P1|COMPLETED|Overall Study||233
8149690|NCT02636608|20087391|P1|Received Treatment|Overall Study||243
8149691|NCT02636608|20087391|P1|STARTED|Overall Study||244
8149695|NCT02636361|20087425|P5|NOT COMPLETED|Period 5||0
8149696|NCT02636361|20087426|P4|NOT COMPLETED|Period 5||0
8149697|NCT02636361|20087427|P3|NOT COMPLETED|Period 5||0
8149698|NCT02636361|20087428|P2|NOT COMPLETED|Period 5||0
8149699|NCT02636361|20087429|P1|NOT COMPLETED|Period 5||0
8149700|NCT02636361|20087425|P5|COMPLETED|Period 5||4
8149701|NCT02636361|20087426|P4|COMPLETED|Period 5||4
8149702|NCT02636361|20087427|P3|COMPLETED|Period 5||5
8149703|NCT02636361|20087428|P2|COMPLETED|Period 5||5
8149704|NCT02636361|20087429|P1|COMPLETED|Period 5||5
8149705|NCT02636361|20087425|P5|STARTED|Period 5||4
8149706|NCT02636361|20087426|P4|STARTED|Period 5||4
8149707|NCT02636361|20087427|P3|STARTED|Period 5||5
8149708|NCT02636361|20087428|P2|STARTED|Period 5||5
8149709|NCT02636361|20087429|P1|STARTED|Period 5||5
8149710|NCT02636361|20087425|P5|NOT COMPLETED|Period 4||0
8149711|NCT02636361|20087426|P4|NOT COMPLETED|Period 4||1
8149712|NCT02636361|20087427|P3|NOT COMPLETED|Period 4||0
8149713|NCT02636361|20087428|P2|NOT COMPLETED|Period 4||0
8149714|NCT02636361|20087429|P1|NOT COMPLETED|Period 4||0
8149715|NCT02636361|20087425|P5|COMPLETED|Period 4||4
8149716|NCT02636361|20087426|P4|COMPLETED|Period 4||4
8149717|NCT02636361|20087427|P3|COMPLETED|Period 4||5
8149718|NCT02636361|20087428|P2|COMPLETED|Period 4||5
8149719|NCT02636361|20087429|P1|COMPLETED|Period 4||5
8149720|NCT02636361|20087425|P5|STARTED|Period 4||4
8149721|NCT02636361|20087426|P4|STARTED|Period 4||5
8149722|NCT02636361|20087427|P3|STARTED|Period 4||5
8149723|NCT02636361|20087428|P2|STARTED|Period 4||5
8149724|NCT02636361|20087429|P1|STARTED|Period 4||5
8149725|NCT02636361|20087425|P5|NOT COMPLETED|Period 3||0
8149726|NCT02636361|20087426|P4|NOT COMPLETED|Period 3||0
8149727|NCT02636361|20087427|P3|NOT COMPLETED|Period 3||0
8149728|NCT02636361|20087428|P2|NOT COMPLETED|Period 3||0
8149729|NCT02636361|20087429|P1|NOT COMPLETED|Period 3||0
8149730|NCT02636361|20087425|P5|COMPLETED|Period 3||4
8149731|NCT02636361|20087426|P4|COMPLETED|Period 3||5
8149732|NCT02636361|20087427|P3|COMPLETED|Period 3||5
8149733|NCT02636361|20087428|P2|COMPLETED|Period 3||5
8149734|NCT02636361|20087429|P1|COMPLETED|Period 3||5
8149735|NCT02636361|20087425|P5|STARTED|Period 3||4
8149736|NCT02636361|20087426|P4|STARTED|Period 3||5
8149737|NCT02636361|20087427|P3|STARTED|Period 3||5
8149738|NCT02636361|20087428|P2|STARTED|Period 3||5
8149739|NCT02636361|20087429|P1|STARTED|Period 3||5
8149740|NCT02636361|20087425|P5|NOT COMPLETED|Period 2||0
8149741|NCT02636361|20087426|P4|NOT COMPLETED|Period 2||0
8149742|NCT02636361|20087427|P3|NOT COMPLETED|Period 2||0
8149743|NCT02636361|20087428|P2|NOT COMPLETED|Period 2||0
8149744|NCT02636361|20087429|P1|NOT COMPLETED|Period 2||0
8149745|NCT02636361|20087425|P5|COMPLETED|Period 2||4
8149746|NCT02636361|20087426|P4|COMPLETED|Period 2||5
8149747|NCT02636361|20087427|P3|COMPLETED|Period 2||5
8149748|NCT02636361|20087428|P2|COMPLETED|Period 2||5
8149749|NCT02636361|20087429|P1|COMPLETED|Period 2||5
8149750|NCT02636361|20087425|P5|STARTED|Period 2||4
8149751|NCT02636361|20087426|P4|STARTED|Period 2||5
8149752|NCT02636361|20087427|P3|STARTED|Period 2||5
8149753|NCT02636361|20087428|P2|STARTED|Period 2||5
8149754|NCT02636361|20087429|P1|STARTED|Period 2||5
8149755|NCT02636361|20087425|P5|NOT COMPLETED|Period 1||1
8149756|NCT02636361|20087426|P4|NOT COMPLETED|Period 1||0
8149757|NCT02636361|20087427|P3|NOT COMPLETED|Period 1||0
8149758|NCT02636361|20087428|P2|NOT COMPLETED|Period 1||1
8149759|NCT02636361|20087429|P1|NOT COMPLETED|Period 1||0
8149760|NCT02636361|20087425|P5|COMPLETED|Period 1||4
8149761|NCT02636361|20087426|P4|COMPLETED|Period 1||5
8149762|NCT02636361|20087427|P3|COMPLETED|Period 1||5
8149763|NCT02636361|20087428|P2|COMPLETED|Period 1||5
8149764|NCT02636361|20087429|P1|COMPLETED|Period 1||5
8149765|NCT02636361|20087425|P5|Received at Least One Dose of Study Drug|Period 1||4
8149766|NCT02636361|20087426|P4|Received at Least One Dose of Study Drug|Period 1||5
8149767|NCT02636361|20087427|P3|Received at Least One Dose of Study Drug|Period 1||5
8149768|NCT02636361|20087428|P2|Received at Least One Dose of Study Drug|Period 1||5
8149769|NCT02636361|20087429|P1|Received at Least One Dose of Study Drug|Period 1||5
8149770|NCT02636361|20087425|P5|STARTED|Period 1||5
8149771|NCT02636361|20087426|P4|STARTED|Period 1||5
8149772|NCT02636361|20087427|P3|STARTED|Period 1||5
8149773|NCT02636361|20087428|P2|STARTED|Period 1||6
8149774|NCT02636361|20087429|P1|STARTED|Period 1||5
8149775|NCT02636283|20087448|P2|NOT COMPLETED|Overall Study||3
8149776|NCT02636283|20087449|P1|NOT COMPLETED|Overall Study||2
8149777|NCT02636283|20087448|P2|COMPLETED|Overall Study||0
8149778|NCT02636283|20087449|P1|COMPLETED|Overall Study||1
8149779|NCT02636283|20087448|P2|STARTED|Overall Study||3
8149780|NCT02636283|20087449|P1|STARTED|Overall Study||3
8149781|NCT02636049|20087463|P1|NOT COMPLETED|Overall Study||0
8149782|NCT02636049|20087463|P1|COMPLETED|Overall Study||12
8149783|NCT02636049|20087463|P1|Triferic 35 Micrograms/kg IV Push|Overall Study||12
8149784|NCT02636049|20087463|P1|Triferic 6 mg IV Over 3 Hours|Overall Study||12
8149785|NCT02636049|20087463|P1|STARTED|Overall Study||12
8149786|NCT02635984|20087477|P2|NOT COMPLETED|Overall Study||4
8149787|NCT02635984|20087478|P1|NOT COMPLETED|Overall Study||3
8149788|NCT02635984|20087477|P2|COMPLETED|Overall Study||51
8149789|NCT02635984|20087478|P1|COMPLETED|Overall Study||50
8149790|NCT02635984|20087477|P2|STARTED|Overall Study||55
8149791|NCT02635984|20087478|P1|STARTED|Overall Study||53
8149792|NCT02635880|20087498|P1|NOT COMPLETED|Overall Study||0
8149793|NCT02635880|20087498|P1|COMPLETED|Overall Study||32
8149794|NCT02635880|20087498|P1|STARTED|Overall Study||32
8149795|NCT02635828|20087503|P1|NOT COMPLETED|Overall Study||14
8149796|NCT02635828|20087503|P1|COMPLETED|Overall Study||40
8149797|NCT02635828|20087503|P1|STARTED|Overall Study||54
8149798|NCT02635737|20087508|P1|NOT COMPLETED|Overall Study||1
8149799|NCT02635737|20087508|P1|COMPLETED|Overall Study||28
8149800|NCT02635737|20087508|P1|STARTED|Overall Study||29
8149801|NCT02635646|20087521|P2|NOT COMPLETED|Overall Study||26
8149802|NCT02635646|20087522|P1|NOT COMPLETED|Overall Study||25
8149803|NCT02635646|20087521|P2|COMPLETED|Overall Study||39
8149804|NCT02635646|20087522|P1|COMPLETED|Overall Study||32
8149805|NCT02635646|20087521|P2|STARTED|Overall Study||65
8149806|NCT02635646|20087522|P1|STARTED|Overall Study||57
8149807|NCT02635542|20087538|P2|NOT COMPLETED|Overall Study||0
8149808|NCT02635542|20087539|P1|NOT COMPLETED|Overall Study||0
8149809|NCT02635542|20087538|P2|COMPLETED|Overall Study||50
8149810|NCT02635542|20087539|P1|COMPLETED|Overall Study||50
8149811|NCT02635542|20087538|P2|STARTED|Overall Study||50
8149812|NCT02635542|20087539|P1|STARTED|Overall Study||50
8149813|NCT02635425|20087549|P2|NOT COMPLETED|Overall Study||0
8149814|NCT02635425|20087550|P1|NOT COMPLETED|Overall Study||0
8149815|NCT02635425|20087549|P2|COMPLETED|Overall Study||15
8149816|NCT02635425|20087550|P1|COMPLETED|Overall Study||15
8149817|NCT02635425|20087549|P2|STARTED|Overall Study||15
8149818|NCT02635425|20087550|P1|STARTED|Overall Study||15
8149819|NCT02635347|20087558|P2|NOT COMPLETED|Overall Study||7
8149820|NCT02635347|20087559|P1|NOT COMPLETED|Overall Study||20
8149821|NCT02635347|20087558|P2|COMPLETED|Overall Study||63
8149822|NCT02635347|20087559|P1|COMPLETED|Overall Study||31
8149823|NCT02635347|20087558|P2|Analyses|Overall Study||63
8149824|NCT02635347|20087559|P1|Analyses|Overall Study||30
8149825|NCT02635347|20087558|P2|Follow up|Overall Study||63
8149826|NCT02635347|20087559|P1|Follow up|Overall Study||31
8149827|NCT02635347|20087558|P2|Protocol Completion|Overall Study||63
8149828|NCT02635347|20087559|P1|Protocol Completion|Overall Study||22
8149829|NCT02635347|20087558|P2|Enrollment|Overall Study||63
8149830|NCT02635347|20087559|P1|Enrollment|Overall Study||31
8149831|NCT02635347|20087558|P2|Screening|Overall Study||70
8149832|NCT02635347|20087559|P1|Screening|Overall Study||51
8149833|NCT02635347|20087558|P2|STARTED|Overall Study||70
8149834|NCT02635347|20087559|P1|STARTED|Overall Study||51
8149835|NCT02635204|20087590|P2|NOT COMPLETED|Overall Study||1
8149836|NCT02635204|20087591|P1|NOT COMPLETED|Overall Study||2
8149837|NCT02635204|20087590|P2|COMPLETED|Overall Study||88
8149838|NCT02635204|20087591|P1|COMPLETED|Overall Study||176
8149839|NCT02635204|20087590|P2|STARTED|Overall Study||89
8149840|NCT02635204|20087591|P1|STARTED|Overall Study||178
8149841|NCT02634983|20087601|P2|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0
8149842|NCT02634983|20087602|P1|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2
8149843|NCT02634983|20087601|P2|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15
8149844|NCT02634983|20087602|P1|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14
8149845|NCT02634983|20087601|P2|STARTED|Period 2 (Second Treatment, 8-10 Days)||15
8149846|NCT02634983|20087602|P1|STARTED|Period 2 (Second Treatment, 8-10 Days)||16
8149847|NCT02634983|20087601|P2|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
8149848|NCT02634983|20087602|P1|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
8149849|NCT02634983|20087601|P2|COMPLETED|Washout (Approximately 7-14 Days)||15
8149850|NCT02634983|20087602|P1|COMPLETED|Washout (Approximately 7-14 Days)||16
8149851|NCT02634983|20087601|P2|STARTED|Washout (Approximately 7-14 Days)||15
8149852|NCT02634983|20087602|P1|STARTED|Washout (Approximately 7-14 Days)||16
8149853|NCT02634983|20087601|P2|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
8149854|NCT02634983|20087602|P1|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
8149855|NCT02634983|20087601|P2|COMPLETED|Period One (First Treatment, 8-10 Days)||15
8149856|NCT02634983|20087602|P1|COMPLETED|Period One (First Treatment, 8-10 Days)||16
8149857|NCT02634983|20087601|P2|STARTED|Period One (First Treatment, 8-10 Days)||15
8149858|NCT02634983|20087602|P1|STARTED|Period One (First Treatment, 8-10 Days)||16
8149859|NCT02634827|20087622|P1|NOT COMPLETED|Overall Study||0
8149860|NCT02634827|20087622|P1|COMPLETED|Overall Study||1
8149861|NCT02634827|20087622|P1|STARTED|Overall Study||1
8149862|NCT02634814|20087636|P3|NOT COMPLETED|Overall Study||0
8149863|NCT02634814|20087637|P2|NOT COMPLETED|Overall Study||6
8149864|NCT02634814|20087638|P1|NOT COMPLETED|Overall Study||2
8149865|NCT02634814|20087636|P3|COMPLETED|Overall Study||29
8149866|NCT02634814|20087637|P2|COMPLETED|Overall Study||23
8149867|NCT02634814|20087638|P1|COMPLETED|Overall Study||30
8149868|NCT02634814|20087636|P3|STARTED|Overall Study||29
8149869|NCT02634814|20087637|P2|STARTED|Overall Study||29
8149870|NCT02634814|20087638|P1|STARTED|Overall Study||32
8149871|NCT02634801|20087661|P3|NOT COMPLETED|Follow-up Period||8
8149872|NCT02634801|20087662|P2|NOT COMPLETED|Follow-up Period||8
8149873|NCT02634801|20087663|P1|NOT COMPLETED|Follow-up Period||5
8149874|NCT02634801|20087661|P3|COMPLETED|Follow-up Period||38
8149875|NCT02634801|20087662|P2|COMPLETED|Follow-up Period||18
8149876|NCT02634801|20087663|P1|COMPLETED|Follow-up Period||36
8149877|NCT02634801|20087661|P3|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
8149878|NCT02634801|20087662|P2|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
8149879|NCT02634801|20087663|P1|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
8149880|NCT02634801|20087661|P3|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
8149881|NCT02634801|20087662|P2|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
8149882|NCT02634801|20087663|P1|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
8149883|NCT02634801|20087661|P3|COMPLETED|Extension Period (Weeks 24 to 36)||29
8149884|NCT02634801|20087662|P2|COMPLETED|Extension Period (Weeks 24 to 36)||18
8149885|NCT02634801|20087663|P1|COMPLETED|Extension Period (Weeks 24 to 36)||45
8149886|NCT02634801|20087661|P3|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
8149887|NCT02634801|20087662|P2|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
8149888|NCT02634801|20087663|P1|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
8149889|NCT02634801|20087661|P3|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
8149890|NCT02634801|20087662|P2|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
8149891|NCT02634801|20087663|P1|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
8149892|NCT02634801|20087661|P3|COMPLETED|Treatment Period (Weeks 0 to 24)||49
8149893|NCT02634801|20087662|P2|COMPLETED|Treatment Period (Weeks 0 to 24)||23
8149894|NCT02634801|20087663|P1|COMPLETED|Treatment Period (Weeks 0 to 24)||50
8149895|NCT02634801|20087661|P3|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
8149896|NCT02634801|20087662|P2|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
8149897|NCT02634801|20087663|P1|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
8149898|NCT02634801|20087661|P3|STARTED|Treatment Period (Weeks 0 to 24)||54
8149899|NCT02634801|20087662|P2|STARTED|Treatment Period (Weeks 0 to 24)||54
8149900|NCT02634801|20087663|P1|STARTED|Treatment Period (Weeks 0 to 24)||54
8149901|NCT02634788|20087763|P4|NOT COMPLETED|Overall Study||5
8149902|NCT02634788|20087764|P3|NOT COMPLETED|Overall Study||5
8149903|NCT02634788|20087765|P2|NOT COMPLETED|Overall Study||10
8149904|NCT02634788|20087766|P1|NOT COMPLETED|Overall Study||4
8149905|NCT02634788|20087763|P4|COMPLETED|Overall Study||77
8149906|NCT02634788|20087764|P3|COMPLETED|Overall Study||75
8149907|NCT02634788|20087765|P2|COMPLETED|Overall Study||71
8149908|NCT02634788|20087766|P1|COMPLETED|Overall Study||75
8149909|NCT02634788|20087763|P4|STARTED|Overall Study||82
8149910|NCT02634788|20087764|P3|STARTED|Overall Study||80
8149911|NCT02634788|20087765|P2|STARTED|Overall Study||81
8149912|NCT02634788|20087766|P1|STARTED|Overall Study||79
8149913|NCT02634606|20087832|P1|NOT COMPLETED|Overall Study||13
8149914|NCT02634606|20087832|P1|COMPLETED|Overall Study||0
8149915|NCT02634606|20087832|P1|STARTED|Overall Study||13
8149916|NCT02634580|20087844|P4|NOT COMPLETED|Open-label Extension Period||1
8149917|NCT02634580|20087845|P3|NOT COMPLETED|Open-label Extension Period||0
8149918|NCT02634580|20087846|P2|NOT COMPLETED|Open-label Extension Period||1
8149919|NCT02634580|20087847|P1|NOT COMPLETED|Open-label Extension Period||0
8149920|NCT02634580|20087844|P4|COMPLETED|Open-label Extension Period||20
8149921|NCT02634580|20087845|P3|COMPLETED|Open-label Extension Period||18
8149922|NCT02634580|20087846|P2|COMPLETED|Open-label Extension Period||10
8149923|NCT02634580|20087847|P1|COMPLETED|Open-label Extension Period||9
8149924|NCT02634580|20087844|P4|Received Open-label Treatment|Open-label Extension Period||20
8149925|NCT02634580|20087845|P3|Received Open-label Treatment|Open-label Extension Period||18
8149926|NCT02634580|20087846|P2|Received Open-label Treatment|Open-label Extension Period||11
8149927|NCT02634580|20087847|P1|Received Open-label Treatment|Open-label Extension Period||9
8149928|NCT02634580|20087844|P4|STARTED|Open-label Extension Period|Includes 1 participant who did not complete the double-blind period but had study visits during OLE|21
8149929|NCT02634580|20087845|P3|STARTED|Open-label Extension Period||18
8149930|NCT02634580|20087846|P2|STARTED|Open-label Extension Period||11
8149931|NCT02634580|20087847|P1|STARTED|Open-label Extension Period||9
8149932|NCT02634580|20087844|P4|NOT COMPLETED|Double-blind Treatment Period||1
8149933|NCT02634580|20087845|P3|NOT COMPLETED|Double-blind Treatment Period||1
8149934|NCT02634580|20087846|P2|NOT COMPLETED|Double-blind Treatment Period||0
8149935|NCT02634580|20087847|P1|NOT COMPLETED|Double-blind Treatment Period||1
8149936|NCT02634580|20087844|P4|COMPLETED|Double-blind Treatment Period||20
8149937|NCT02634580|20087845|P3|COMPLETED|Double-blind Treatment Period||18
8149938|NCT02634580|20087846|P2|COMPLETED|Double-blind Treatment Period||11
8149939|NCT02634580|20087847|P1|COMPLETED|Double-blind Treatment Period||9
8149940|NCT02634580|20087844|P4|STARTED|Double-blind Treatment Period||21
8149941|NCT02634580|20087845|P3|STARTED|Double-blind Treatment Period||19
8149942|NCT02634580|20087846|P2|STARTED|Double-blind Treatment Period||11
8149943|NCT02634580|20087847|P1|STARTED|Double-blind Treatment Period||10
8149944|NCT02634346|20087905|P3|NOT COMPLETED|Overall Study||23
8149945|NCT02634346|20087906|P2|NOT COMPLETED|Overall Study||14
8149946|NCT02634346|20087907|P1|NOT COMPLETED|Overall Study||12
8149947|NCT02634346|20087905|P3|COMPLETED|Overall Study||111
8149948|NCT02634346|20087906|P2|COMPLETED|Overall Study||119
8149949|NCT02634346|20087907|P1|COMPLETED|Overall Study||122
8149950|NCT02634346|20087905|P3|STARTED|Overall Study||134
8149951|NCT02634346|20087906|P2|STARTED|Overall Study||133
8149952|NCT02634346|20087907|P1|STARTED|Overall Study||134
8149953|NCT02634320|20087921|P1|NOT COMPLETED|Overall Study||16
8149954|NCT02634320|20087921|P1|COMPLETED|Overall Study||35
8149955|NCT02634320|20087921|P1|STARTED|Overall Study||51
8149956|NCT02634177|20087932|P2|NOT COMPLETED|Overall Study||12
8149957|NCT02634177|20087933|P1|NOT COMPLETED|Overall Study||11
8149958|NCT02634177|20087932|P2|COMPLETED|Overall Study||141
8149959|NCT02634177|20087933|P1|COMPLETED|Overall Study||140
8149960|NCT02634177|20087932|P2|STARTED|Overall Study||153
8149961|NCT02634177|20087933|P1|STARTED|Overall Study||151
8149962|NCT02634151|20087957|P2|NOT COMPLETED|Overall Study||2
8149963|NCT02634151|20087958|P1|NOT COMPLETED|Overall Study||1
8149964|NCT02634151|20087957|P2|COMPLETED|Overall Study||50
8149965|NCT02634151|20087958|P1|COMPLETED|Overall Study||52
8149966|NCT02634151|20087957|P2|Safety Set|Overall Study||51
8149967|NCT02634151|20087958|P1|Safety Set|Overall Study||54
8149968|NCT02634151|20087957|P2|Full Analysis Set|Overall Study||52
8149969|NCT02634151|20087958|P1|Full Analysis Set|Overall Study||53
8149970|NCT02634151|20087957|P2|STARTED|Overall Study||52
8149971|NCT02634151|20087958|P1|STARTED|Overall Study||53
8149972|NCT02634073|20088044|P4|NOT COMPLETED|Overall Study||0
8149973|NCT02634073|20088045|P3|NOT COMPLETED|Overall Study||0
8149974|NCT02634073|20088046|P2|NOT COMPLETED|Overall Study||0
8149975|NCT02634073|20088047|P1|NOT COMPLETED|Overall Study||0
8149976|NCT02634073|20088044|P4|COMPLETED|Overall Study||4
8149977|NCT02634073|20088045|P3|COMPLETED|Overall Study||4
8149978|NCT02634073|20088046|P2|COMPLETED|Overall Study||4
8149979|NCT02634073|20088047|P1|COMPLETED|Overall Study||4
8149980|NCT02634073|20088044|P4|STARTED|Overall Study||4
8149981|NCT02634073|20088045|P3|STARTED|Overall Study||4
8149982|NCT02634073|20088046|P2|STARTED|Overall Study||4
8149983|NCT02634073|20088047|P1|STARTED|Overall Study||4
8149984|NCT02633956|20088137|P4|NOT COMPLETED|Overall Study||0
8149985|NCT02633956|20088138|P3|NOT COMPLETED|Overall Study||2
8149986|NCT02633956|20088139|P2|NOT COMPLETED|Overall Study||2
8149987|NCT02633956|20088140|P1|NOT COMPLETED|Overall Study||1
8149988|NCT02633956|20088137|P4|COMPLETED|Overall Study||21
8149989|NCT02633956|20088138|P3|COMPLETED|Overall Study||20
8149990|NCT02633956|20088139|P2|COMPLETED|Overall Study||19
8149991|NCT02633956|20088140|P1|COMPLETED|Overall Study||19
8149992|NCT02633956|20088137|P4|STARTED|Overall Study||21
8149993|NCT02633956|20088138|P3|STARTED|Overall Study||22
8149994|NCT02633956|20088139|P2|STARTED|Overall Study||21
8149995|NCT02633956|20088140|P1|STARTED|Overall Study||20
8149996|NCT02633800|20088160|P2|NOT COMPLETED|Overall Study||43
8149997|NCT02633800|20088161|P1|NOT COMPLETED|Overall Study||44
8149998|NCT02633800|20088160|P2|COMPLETED|Overall Study||0
8149999|NCT02633800|20088161|P1|COMPLETED|Overall Study||0
8150000|NCT02633800|20088160|P2|STARTED|Overall Study||43
8150001|NCT02633800|20088161|P1|STARTED|Overall Study||44
8150002|NCT02633787|20088171|P1|NOT COMPLETED|Overall Study||1
8150003|NCT02633787|20088171|P1|COMPLETED|Overall Study||109
8150004|NCT02633787|20088171|P1|STARTED|Overall Study||110
8150005|NCT02633735|20088179|P2|NOT COMPLETED|Implementation Phase||0
8150006|NCT02633735|20088180|P1|NOT COMPLETED|Implementation Phase||0
8150007|NCT02633735|20088179|P2|COMPLETED|Implementation Phase||2150
8150008|NCT02633735|20088180|P1|COMPLETED|Implementation Phase||1991
8150009|NCT02633735|20088179|P2|STARTED|Implementation Phase||2150
8150010|NCT02633735|20088180|P1|STARTED|Implementation Phase||1991
8150011|NCT02633735|20088179|P2|NOT COMPLETED|Pre-implementation Phase||0
8150012|NCT02633735|20088180|P1|NOT COMPLETED|Pre-implementation Phase||0
8150013|NCT02633735|20088179|P2|COMPLETED|Pre-implementation Phase||1011
8150014|NCT02633735|20088180|P1|COMPLETED|Pre-implementation Phase||788
8150015|NCT02633735|20088179|P2|STARTED|Pre-implementation Phase||1011
8150016|NCT02633735|20088180|P1|STARTED|Pre-implementation Phase||788
8150035|NCT02633488|20088218|P2|NOT COMPLETED|Overall Study||0
8150036|NCT02633488|20088219|P1|NOT COMPLETED|Overall Study||0
8150037|NCT02633488|20088218|P2|COMPLETED|Overall Study||5
8150038|NCT02633488|20088219|P1|COMPLETED|Overall Study||6
8150039|NCT02633488|20088218|P2|STARTED|Overall Study||5
8150040|NCT02633488|20088219|P1|STARTED|Overall Study||6
8150041|NCT02633371|20088225|P1|NOT COMPLETED|Overall Study||3
8150042|NCT02633371|20088225|P1|COMPLETED|Overall Study||7
8150043|NCT02633371|20088225|P1|STARTED|Overall Study||10
8150044|NCT02633358|20088231|P2|NOT COMPLETED|Overall Study||0
8150045|NCT02633358|20088232|P1|NOT COMPLETED|Overall Study||0
8150046|NCT02633358|20088231|P2|COMPLETED|Overall Study||54
8150047|NCT02633358|20088232|P1|COMPLETED|Overall Study||87
8150048|NCT02633358|20088231|P2|STARTED|Overall Study||54
8150049|NCT02633358|20088232|P1|STARTED|Overall Study||87
8150050|NCT02633241|20088246|P1|NOT COMPLETED|Overall Study||3
8150051|NCT02633241|20088246|P1|COMPLETED|Overall Study||27
8150052|NCT02633241|20088246|P1|STARTED|Overall Study||30
8150053|NCT02633215|20088259|P2|NOT COMPLETED|Overall Study||3
8150054|NCT02633215|20088260|P1|NOT COMPLETED|Overall Study||2
8150055|NCT02633215|20088259|P2|COMPLETED|Overall Study||15
8150056|NCT02633215|20088260|P1|COMPLETED|Overall Study||16
8150057|NCT02633215|20088259|P2|STARTED|Overall Study||18
8150058|NCT02633215|20088260|P1|STARTED|Overall Study||18
8150059|NCT02633020|20088272|P2|NOT COMPLETED|Overall Study||0
8150060|NCT02633020|20088273|P1|NOT COMPLETED|Overall Study||1
8150061|NCT02633020|20088272|P2|COMPLETED|Overall Study||9
8150062|NCT02633020|20088273|P1|COMPLETED|Overall Study||18
8150063|NCT02633020|20088272|P2|STARTED|Overall Study||9
8150064|NCT02633020|20088273|P1|STARTED|Overall Study||19
8150065|NCT02632838|20088297|P2|NOT COMPLETED|Overall Study||2
8150066|NCT02632838|20088298|P1|NOT COMPLETED|Overall Study||3
8150067|NCT02632838|20088297|P2|COMPLETED|Overall Study||13
8150068|NCT02632838|20088298|P1|COMPLETED|Overall Study||12
8150069|NCT02632838|20088297|P2|STARTED|Overall Study||15
8150070|NCT02632838|20088298|P1|STARTED|Overall Study||15
8150071|NCT02632812|20088314|P2|NOT COMPLETED|Overall Study||0
8150072|NCT02632812|20088315|P1|NOT COMPLETED|Overall Study||0
8150073|NCT02632812|20088314|P2|COMPLETED|Overall Study||12
8150074|NCT02632812|20088315|P1|COMPLETED|Overall Study||12
8150075|NCT02632812|20088314|P2|STARTED|Overall Study||12
8150076|NCT02632812|20088315|P1|STARTED|Overall Study||12
8150077|NCT02632786|20088335|P2|NOT COMPLETED|Overall Study||7
8150078|NCT02632786|20088336|P1|NOT COMPLETED|Overall Study||11
8150079|NCT02632786|20088335|P2|COMPLETED|Overall Study||56
8150080|NCT02632786|20088336|P1|COMPLETED|Overall Study||55
8150081|NCT02632786|20088335|P2|Randomized and Dosed|Overall Study||63
8150082|NCT02632786|20088336|P1|Randomized and Dosed|Overall Study||66
8150083|NCT02632786|20088335|P2|Informed Consent Obtained|Overall Study||63
8150084|NCT02632786|20088336|P1|Informed Consent Obtained|Overall Study||66
8150085|NCT02632786|20088335|P2|STARTED|Overall Study||63
8150086|NCT02632786|20088336|P1|STARTED|Overall Study||66
8150087|NCT02632747|20088356|P2|NOT COMPLETED|Treatment Period 2||0
8150088|NCT02632747|20088357|P1|NOT COMPLETED|Treatment Period 2||0
8150089|NCT02632747|20088356|P2|COMPLETED|Treatment Period 2||15
8150090|NCT02632747|20088357|P1|COMPLETED|Treatment Period 2||15
8150091|NCT02632747|20088356|P2|STARTED|Treatment Period 2||15
8150092|NCT02632747|20088357|P1|STARTED|Treatment Period 2||15
8150093|NCT02632747|20088356|P2|NOT COMPLETED|Wash-out Period||0
8150094|NCT02632747|20088357|P1|NOT COMPLETED|Wash-out Period||1
8150095|NCT02632747|20088356|P2|COMPLETED|Wash-out Period||15
8150096|NCT02632747|20088357|P1|COMPLETED|Wash-out Period||15
8150097|NCT02632747|20088356|P2|STARTED|Wash-out Period||15
8150098|NCT02632747|20088357|P1|STARTED|Wash-out Period||16
8150099|NCT02632747|20088356|P2|NOT COMPLETED|Treatment Period 1||0
8150100|NCT02632747|20088357|P1|NOT COMPLETED|Treatment Period 1||0
8150101|NCT02632747|20088356|P2|COMPLETED|Treatment Period 1||15
8150102|NCT02632747|20088357|P1|COMPLETED|Treatment Period 1||16
8150103|NCT02632747|20088356|P2|STARTED|Treatment Period 1||15
8150104|NCT02632747|20088357|P1|STARTED|Treatment Period 1||16
8150105|NCT02632526|20088371|P6|NOT COMPLETED|Overall Study||0
8150106|NCT02632526|20088372|P5|NOT COMPLETED|Overall Study||0
8150107|NCT02632526|20088373|P4|NOT COMPLETED|Overall Study||0
8150108|NCT02632526|20088374|P3|NOT COMPLETED|Overall Study||0
8150109|NCT02632526|20088375|P2|NOT COMPLETED|Overall Study||0
8150110|NCT02632526|20088376|P1|NOT COMPLETED|Overall Study||0
8150111|NCT02632526|20088371|P6|COMPLETED|Overall Study||8
8150112|NCT02632526|20088372|P5|COMPLETED|Overall Study||4
8150113|NCT02632526|20088373|P4|COMPLETED|Overall Study||12
8150114|NCT02632526|20088374|P3|COMPLETED|Overall Study||24
8150115|NCT02632526|20088375|P2|COMPLETED|Overall Study||12
8150116|NCT02632526|20088376|P1|COMPLETED|Overall Study||36
8150117|NCT02632526|20088371|P6|STARTED|Overall Study||8
8150118|NCT02632526|20088372|P5|STARTED|Overall Study||4
8150119|NCT02632526|20088373|P4|STARTED|Overall Study||12
8150120|NCT02632526|20088374|P3|STARTED|Overall Study||24
8150121|NCT02632526|20088375|P2|STARTED|Overall Study||12
8150122|NCT02632526|20088376|P1|STARTED|Overall Study||36
8150123|NCT02632110|20088557|P10|NOT COMPLETED|Overall Study||1
8150124|NCT02632110|20088558|P9|NOT COMPLETED|Overall Study||1
8150125|NCT02632110|20088559|P8|NOT COMPLETED|Overall Study||3
8150126|NCT02632110|20088560|P7|NOT COMPLETED|Overall Study||3
8150127|NCT02632110|20088561|P6|NOT COMPLETED|Overall Study||1
8150128|NCT02632110|20088562|P5|NOT COMPLETED|Overall Study||1
8150129|NCT02632110|20088563|P4|NOT COMPLETED|Overall Study||0
8150130|NCT02632110|20088564|P3|NOT COMPLETED|Overall Study||0
8150131|NCT02632110|20088565|P2|NOT COMPLETED|Overall Study||1
8150132|NCT02632110|20088566|P1|NOT COMPLETED|Overall Study||1
8150133|NCT02632110|20088557|P10|COMPLETED|Overall Study||29
8150134|NCT02632110|20088558|P9|COMPLETED|Overall Study||29
8150135|NCT02632110|20088559|P8|COMPLETED|Overall Study||23
8150136|NCT02632110|20088560|P7|COMPLETED|Overall Study||23
8150137|NCT02632110|20088561|P6|COMPLETED|Overall Study||28
8150138|NCT02632110|20088562|P5|COMPLETED|Overall Study||28
8150139|NCT02632110|20088563|P4|COMPLETED|Overall Study||27
8150140|NCT02632110|20088564|P3|COMPLETED|Overall Study||27
8150141|NCT02632110|20088565|P2|COMPLETED|Overall Study||24
8150142|NCT02632110|20088566|P1|COMPLETED|Overall Study||24
8150143|NCT02632110|20088557|P10|STARTED|Overall Study||30
8150144|NCT02632110|20088558|P9|STARTED|Overall Study||30
8150145|NCT02632110|20088559|P8|STARTED|Overall Study||26
8150146|NCT02632110|20088560|P7|STARTED|Overall Study||26
8150147|NCT02632110|20088561|P6|STARTED|Overall Study||29
8150148|NCT02632110|20088562|P5|STARTED|Overall Study||29
8150149|NCT02632110|20088563|P4|STARTED|Overall Study||27
8150150|NCT02632110|20088564|P3|STARTED|Overall Study||27
8150151|NCT02632110|20088565|P2|STARTED|Overall Study||25
8150152|NCT02632110|20088566|P1|STARTED|Overall Study||25
8150153|NCT02631954|20089035|P2|NOT COMPLETED|Overall Study||0
8150154|NCT02631954|20089036|P1|NOT COMPLETED|Overall Study||0
8150155|NCT02631954|20089035|P2|COMPLETED|Overall Study||12
8150156|NCT02631954|20089036|P1|COMPLETED|Overall Study||12
8150157|NCT02631954|20089035|P2|STARTED|Overall Study||12
8150158|NCT02631954|20089036|P1|STARTED|Overall Study||12
8150159|NCT02631876|20089056|P2|NOT COMPLETED|Overall Study||63
8150160|NCT02631876|20089057|P1|NOT COMPLETED|Overall Study||119
8150161|NCT02631876|20089056|P2|COMPLETED|Overall Study||55
8150162|NCT02631876|20089057|P1|COMPLETED|Overall Study||129
8150163|NCT02631876|20089056|P2|Safety Population|Overall Study||109
8150164|NCT02631876|20089057|P1|Safety Population|Overall Study||243
8150165|NCT02631876|20089056|P2|STARTED|Overall Study||118
8150166|NCT02631876|20089057|P1|STARTED|Overall Study||248
8150167|NCT02631837|20089083|P2|NOT COMPLETED|Overall Study||0
8150168|NCT02631837|20089084|P1|NOT COMPLETED|Overall Study||0
8150169|NCT02631837|20089083|P2|COMPLETED|Overall Study||35
8150170|NCT02631837|20089084|P1|COMPLETED|Overall Study||35
8150171|NCT02631837|20089083|P2|STARTED|Overall Study||35
8150172|NCT02631837|20089084|P1|STARTED|Overall Study||35
8150173|NCT02631772|20089122|P2|NOT COMPLETED|Overall Study||0
8150174|NCT02631772|20089123|P1|NOT COMPLETED|Overall Study||0
8150175|NCT02631772|20089122|P2|COMPLETED|Overall Study||16
8150176|NCT02631772|20089123|P1|COMPLETED|Overall Study||16
8150177|NCT02631772|20089122|P2|STARTED|Overall Study||16
8150178|NCT02631772|20089123|P1|STARTED|Overall Study||16
8150179|NCT02631746|20089133|P1|NOT COMPLETED|Overall Study||3
8150180|NCT02631746|20089133|P1|COMPLETED|Overall Study||0
8150181|NCT02631746|20089133|P1|STARTED|Overall Study||3
8150185|NCT02631551|20089154|P4|NOT COMPLETED|Overall Study||11
8150186|NCT02631551|20089155|P3|NOT COMPLETED|Overall Study||11
8150187|NCT02631551|20089156|P2|NOT COMPLETED|Overall Study||19
8150188|NCT02631551|20089157|P1|NOT COMPLETED|Overall Study||13
8150189|NCT02631551|20089154|P4|COMPLETED|Overall Study||276
8150190|NCT02631551|20089155|P3|COMPLETED|Overall Study||283
8150191|NCT02631551|20089156|P2|COMPLETED|Overall Study||278
8150192|NCT02631551|20089157|P1|COMPLETED|Overall Study||289
8150193|NCT02631551|20089154|P4|STARTED|Overall Study||287
8150194|NCT02631551|20089155|P3|STARTED|Overall Study||294
8150195|NCT02631551|20089156|P2|STARTED|Overall Study||297
8150196|NCT02631551|20089157|P1|STARTED|Overall Study||302
8150197|NCT02631525|20089169|P2|NOT COMPLETED|Overall Study||0
8150198|NCT02631525|20089170|P1|NOT COMPLETED|Overall Study||0
8150199|NCT02631525|20089169|P2|COMPLETED|Overall Study||20
8150200|NCT02631525|20089170|P1|COMPLETED|Overall Study||20
8150201|NCT02631525|20089169|P2|STARTED|Overall Study||20
8150202|NCT02631525|20089170|P1|STARTED|Overall Study||20
8150213|NCT02631057|20089247|P2|NOT COMPLETED|Overall Study||0
8150214|NCT02631057|20089248|P1|NOT COMPLETED|Overall Study||0
8150215|NCT02631057|20089247|P2|COMPLETED|Overall Study||3414
8150216|NCT02631057|20089248|P1|COMPLETED|Overall Study||899
8150217|NCT02631057|20089247|P2|STARTED|Overall Study||3414
8150218|NCT02631057|20089248|P1|STARTED|Overall Study||899
8150219|NCT02630992|20089254|P1|NOT COMPLETED|Overall Study||13
8150220|NCT02630992|20089254|P1|COMPLETED|Overall Study||99
8150221|NCT02630992|20089254|P1|STARTED|Overall Study||112
8150222|NCT02630966|20089273|P2|NOT COMPLETED|Overall Study||8
8150223|NCT02630966|20089274|P1|NOT COMPLETED|Overall Study||2
8150224|NCT02630966|20089273|P2|COMPLETED|Overall Study||10
8150225|NCT02630966|20089274|P1|COMPLETED|Overall Study||14
8150226|NCT02630966|20089273|P2|STARTED|Overall Study||18
8150227|NCT02630966|20089274|P1|STARTED|Overall Study||16
8150228|NCT02630719|20089292|P2|NOT COMPLETED|Overall Study||0
8150229|NCT02630719|20089293|P1|NOT COMPLETED|Overall Study||0
8150230|NCT02630719|20089292|P2|COMPLETED|Overall Study||6
8150231|NCT02630719|20089293|P1|COMPLETED|Overall Study||4
8150232|NCT02630719|20089292|P2|STARTED|Overall Study||6
8150233|NCT02630719|20089293|P1|STARTED|Overall Study||4
8150234|NCT02630706|20089302|P3|NOT COMPLETED|Overall Study||10
8150235|NCT02630706|20089303|P2|NOT COMPLETED|Overall Study||9
8150236|NCT02630706|20089304|P1|NOT COMPLETED|Overall Study||7
8150237|NCT02630706|20089302|P3|COMPLETED|Overall Study||157
8150238|NCT02630706|20089303|P2|COMPLETED|Overall Study||160
8150239|NCT02630706|20089304|P1|COMPLETED|Overall Study||163
8150240|NCT02630706|20089302|P3|Treated|Overall Study||167
8150241|NCT02630706|20089303|P2|Treated|Overall Study||169
8150242|NCT02630706|20089304|P1|Treated|Overall Study||170
8150243|NCT02630706|20089302|P3|STARTED|Overall Study||167
8150244|NCT02630706|20089303|P2|STARTED|Overall Study||169
8150245|NCT02630706|20089304|P1|STARTED|Overall Study||170
8150246|NCT02630693|20089413|P2|NOT COMPLETED|Overall Study||1
8150247|NCT02630693|20089414|P1|NOT COMPLETED|Overall Study||0
8150248|NCT02630693|20089413|P2|COMPLETED|Overall Study||89
8150249|NCT02630693|20089414|P1|COMPLETED|Overall Study||90
8150250|NCT02630693|20089413|P2|STARTED|Overall Study||90
8150251|NCT02630693|20089414|P1|STARTED|Overall Study||90
8150252|NCT02630563|20089426|P1|NOT COMPLETED|Overall Study||1
8150253|NCT02630563|20089426|P1|COMPLETED|Overall Study||8
8150254|NCT02630563|20089426|P1|STARTED|Overall Study||9
8150255|NCT02630472|20089437|P2|NOT COMPLETED|Overall Study||0
8150256|NCT02630472|20089438|P1|NOT COMPLETED|Overall Study||10
8150257|NCT02630472|20089437|P2|COMPLETED|Overall Study||0
8150258|NCT02630472|20089438|P1|COMPLETED|Overall Study||0
8150259|NCT02630472|20089437|P2|STARTED|Overall Study||0
8150260|NCT02630472|20089438|P1|STARTED|Overall Study||10
8150261|NCT02630459|20089456|P8|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150262|NCT02630459|20089457|P7|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150263|NCT02630459|20089458|P6|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150264|NCT02630459|20089459|P5|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150265|NCT02630459|20089460|P4|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150266|NCT02630459|20089461|P3|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150267|NCT02630459|20089462|P2|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150268|NCT02630459|20089463|P1|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150269|NCT02630459|20089456|P8|COMPLETED|Optional CHU Sub-Study (During OLTP)||25
8150270|NCT02630459|20089457|P7|COMPLETED|Optional CHU Sub-Study (During OLTP)||24
8150271|NCT02630459|20089458|P6|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150272|NCT02630459|20089459|P5|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150273|NCT02630459|20089460|P4|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150274|NCT02630459|20089461|P3|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150275|NCT02630459|20089462|P2|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150276|NCT02630459|20089463|P1|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
8150277|NCT02630459|20089456|P8|STARTED|Optional CHU Sub-Study (During OLTP)||25
8150278|NCT02630459|20089457|P7|STARTED|Optional CHU Sub-Study (During OLTP)||24
8150279|NCT02630459|20089458|P6|STARTED|Optional CHU Sub-Study (During OLTP)||0
8150280|NCT02630459|20089459|P5|STARTED|Optional CHU Sub-Study (During OLTP)||0
8150281|NCT02630459|20089460|P4|STARTED|Optional CHU Sub-Study (During OLTP)||0
8150282|NCT02630459|20089461|P3|STARTED|Optional CHU Sub-Study (During OLTP)||0
8150283|NCT02630459|20089462|P2|STARTED|Optional CHU Sub-Study (During OLTP)||0
8150284|NCT02630459|20089463|P1|STARTED|Optional CHU Sub-Study (During OLTP)||0
8150285|NCT02630459|20089456|P8|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150286|NCT02630459|20089457|P7|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150287|NCT02630459|20089458|P6|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||4
8150288|NCT02630459|20089459|P5|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||29
8150289|NCT02630459|20089460|P4|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150290|NCT02630459|20089461|P3|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150291|NCT02630459|20089462|P2|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150292|NCT02630459|20089463|P1|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150293|NCT02630459|20089456|P8|COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150294|NCT02630459|20089457|P7|COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150295|NCT02630459|20089458|P6|COMPLETED|Open-Label Treatment Phase (OLTP)||69
8150296|NCT02630459|20089459|P5|COMPLETED|Open-Label Treatment Phase (OLTP)||357
8150297|NCT02630459|20089460|P4|COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150298|NCT02630459|20089461|P3|COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150299|NCT02630459|20089462|P2|COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150300|NCT02630459|20089463|P1|COMPLETED|Open-Label Treatment Phase (OLTP)||0
8150301|NCT02630459|20089456|P8|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150302|NCT02630459|20089457|P7|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150303|NCT02630459|20089458|P6|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150304|NCT02630459|20089459|P5|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||116
8150305|NCT02630459|20089460|P4|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150306|NCT02630459|20089461|P3|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150307|NCT02630459|20089462|P2|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150308|NCT02630459|20089463|P1|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150309|NCT02630459|20089456|P8|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150310|NCT02630459|20089457|P7|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150311|NCT02630459|20089458|P6|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||73
8150312|NCT02630459|20089459|P5|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150313|NCT02630459|20089460|P4|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150314|NCT02630459|20089461|P3|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150315|NCT02630459|20089462|P2|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150316|NCT02630459|20089463|P1|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150317|NCT02630459|20089456|P8|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150318|NCT02630459|20089457|P7|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150319|NCT02630459|20089458|P6|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150320|NCT02630459|20089459|P5|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||270
8150321|NCT02630459|20089460|P4|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150322|NCT02630459|20089461|P3|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150323|NCT02630459|20089462|P2|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150324|NCT02630459|20089463|P1|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
8150325|NCT02630459|20089456|P8|STARTED|Open-Label Treatment Phase (OLTP)||0
8150326|NCT02630459|20089457|P7|STARTED|Open-Label Treatment Phase (OLTP)||0
8150327|NCT02630459|20089458|P6|STARTED|Open-Label Treatment Phase (OLTP)||73
8150328|NCT02630459|20089459|P5|STARTED|Open-Label Treatment Phase (OLTP)||386
8150329|NCT02630459|20089460|P4|STARTED|Open-Label Treatment Phase (OLTP)||0
8150330|NCT02630459|20089461|P3|STARTED|Open-Label Treatment Phase (OLTP)||0
8150331|NCT02630459|20089462|P2|STARTED|Open-Label Treatment Phase (OLTP)||0
8150332|NCT02630459|20089463|P1|STARTED|Open-Label Treatment Phase (OLTP)||0
8150333|NCT02630459|20089456|P8|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150334|NCT02630459|20089457|P7|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150335|NCT02630459|20089458|P6|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150336|NCT02630459|20089459|P5|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150337|NCT02630459|20089460|P4|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
8150338|NCT02630459|20089461|P3|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||5
8150339|NCT02630459|20089462|P2|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||2
8150340|NCT02630459|20089463|P1|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
8150341|NCT02630459|20089456|P8|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150342|NCT02630459|20089457|P7|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150343|NCT02630459|20089458|P6|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150344|NCT02630459|20089459|P5|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
8150345|NCT02630459|20089460|P4|COMPLETED|Double-Blind Treatment Phase (DBTP)||134
8150346|NCT02630459|20089461|P3|COMPLETED|Double-Blind Treatment Phase (DBTP)||130
8150347|NCT02630459|20089462|P2|COMPLETED|Double-Blind Treatment Phase (DBTP)||65
8150348|NCT02630459|20089463|P1|COMPLETED|Double-Blind Treatment Phase (DBTP)||133
8150349|NCT02630459|20089456|P8|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
8150350|NCT02630459|20089457|P7|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
8150351|NCT02630459|20089458|P6|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
8150352|NCT02630459|20089459|P5|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
8150353|NCT02630459|20089460|P4|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||137
8150354|NCT02630459|20089461|P3|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||135
8150355|NCT02630459|20089462|P2|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||66
8150356|NCT02630459|20089463|P1|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||136
8150357|NCT02630459|20089456|P8|STARTED|Double-Blind Treatment Phase (DBTP)||0
8150358|NCT02630459|20089457|P7|STARTED|Double-Blind Treatment Phase (DBTP)||0
8150359|NCT02630459|20089458|P6|STARTED|Double-Blind Treatment Phase (DBTP)||0
8150360|NCT02630459|20089459|P5|STARTED|Double-Blind Treatment Phase (DBTP)||0
8150361|NCT02630459|20089460|P4|STARTED|Double-Blind Treatment Phase (DBTP)||137
8150362|NCT02630459|20089461|P3|STARTED|Double-Blind Treatment Phase (DBTP)||135
8150363|NCT02630459|20089462|P2|STARTED|Double-Blind Treatment Phase (DBTP)||67
8150364|NCT02630459|20089463|P1|STARTED|Double-Blind Treatment Phase (DBTP)||136
8150365|NCT02630251|20089522|P4|NOT COMPLETED|Overall Study||0
8150366|NCT02630251|20089523|P3|NOT COMPLETED|Overall Study||1
8150367|NCT02630251|20089524|P2|NOT COMPLETED|Overall Study||0
8150368|NCT02630251|20089525|P1|NOT COMPLETED|Overall Study||0
8150369|NCT02630251|20089522|P4|COMPLETED|Overall Study||1
8150370|NCT02630251|20089523|P3|COMPLETED|Overall Study||0
8150371|NCT02630251|20089524|P2|COMPLETED|Overall Study||1
8150372|NCT02630251|20089525|P1|COMPLETED|Overall Study||2
8150373|NCT02630251|20089522|P4|STARTED|Overall Study||1
8150374|NCT02630251|20089523|P3|STARTED|Overall Study||1
8150375|NCT02630251|20089524|P2|STARTED|Overall Study||1
8150376|NCT02630251|20089525|P1|STARTED|Overall Study||2
8150377|NCT02630186|20089639|P1|NOT COMPLETED|Overall Study||1
8150378|NCT02630186|20089639|P1|COMPLETED|Overall Study||2
8150379|NCT02630186|20089639|P1|STARTED|Overall Study||3
8150380|NCT02629965|20089655|P2|NOT COMPLETED|Period 2||0
8150381|NCT02629965|20089656|P1|NOT COMPLETED|Period 2||1
8150382|NCT02629965|20089655|P2|COMPLETED|Period 2||90
8150383|NCT02629965|20089656|P1|COMPLETED|Period 2||87
8150384|NCT02629965|20089655|P2|STARTED|Period 2||90
8150385|NCT02629965|20089656|P1|STARTED|Period 2||88
8150386|NCT02629965|20089655|P2|NOT COMPLETED|Period 1||2
8150387|NCT02629965|20089656|P1|NOT COMPLETED|Period 1||4
8150388|NCT02629965|20089655|P2|COMPLETED|Period 1||90
8150389|NCT02629965|20089656|P1|COMPLETED|Period 1||88
8150390|NCT02629965|20089655|P2|STARTED|Period 1||92
8150391|NCT02629965|20089656|P1|STARTED|Period 1||92
8150392|NCT02629861|20089695|P3|NOT COMPLETED|Overall Study||28
8150393|NCT02629861|20089696|P2|NOT COMPLETED|Overall Study||27
8150394|NCT02629861|20089697|P1|NOT COMPLETED|Overall Study||29
8150395|NCT02629861|20089695|P3|COMPLETED|Overall Study||262
8150396|NCT02629861|20089696|P2|COMPLETED|Overall Study||264
8150397|NCT02629861|20089697|P1|COMPLETED|Overall Study||265
8150398|NCT02629861|20089695|P3|Full Analysis Set|Overall Study||287
8150399|NCT02629861|20089696|P2|Full Analysis Set|Overall Study||288
8150400|NCT02629861|20089697|P1|Full Analysis Set|Overall Study||290
8150401|NCT02629861|20089695|P3|Safety Population|Overall Study||289
8150402|NCT02629861|20089696|P2|Safety Population|Overall Study||291
8150403|NCT02629861|20089697|P1|Safety Population|Overall Study||294
8150404|NCT02629861|20089695|P3|Intent to Treat (ITT)|Overall Study||290
8150405|NCT02629861|20089696|P2|Intent to Treat (ITT)|Overall Study||291
8150406|NCT02629861|20089697|P1|Intent to Treat (ITT)|Overall Study||294
8150407|NCT02629861|20089695|P3|STARTED|Overall Study||290
8150408|NCT02629861|20089696|P2|STARTED|Overall Study||291
8150409|NCT02629861|20089697|P1|STARTED|Overall Study||294
8150410|NCT02629822|20089744|P1|NOT COMPLETED|Extension Study||6
8150411|NCT02629822|20089744|P1|COMPLETED|Extension Study||0
8150412|NCT02629822|20089744|P1|STARTED|Extension Study|Enrollment in Extension Study was voluntary.|6
8150413|NCT02629822|20089744|P1|NOT COMPLETED|Base Study||3
8150414|NCT02629822|20089744|P1|COMPLETED|Base Study||7
8150415|NCT02629822|20089744|P1|STARTED|Base Study||10
8150416|NCT02629354|20089760|P2|NOT COMPLETED|Follow-up||0
8150417|NCT02629354|20089761|P1|NOT COMPLETED|Follow-up||0
8150418|NCT02629354|20089760|P2|COMPLETED|Follow-up||18
8150419|NCT02629354|20089761|P1|COMPLETED|Follow-up||18
8150420|NCT02629354|20089760|P2|STARTED|Follow-up||18
8150421|NCT02629354|20089761|P1|STARTED|Follow-up||18
8150422|NCT02629354|20089760|P2|NOT COMPLETED|Period 2||0
8150423|NCT02629354|20089761|P1|NOT COMPLETED|Period 2||0
8150424|NCT02629354|20089760|P2|COMPLETED|Period 2||18
8150425|NCT02629354|20089761|P1|COMPLETED|Period 2||18
8150426|NCT02629354|20089760|P2|STARTED|Period 2||18
8150427|NCT02629354|20089761|P1|STARTED|Period 2||18
8150428|NCT02629354|20089760|P2|NOT COMPLETED|Washout Period||0
8150429|NCT02629354|20089761|P1|NOT COMPLETED|Washout Period||0
8150430|NCT02629354|20089760|P2|COMPLETED|Washout Period||18
8150431|NCT02629354|20089761|P1|COMPLETED|Washout Period||18
8150432|NCT02629354|20089760|P2|STARTED|Washout Period||18
8150433|NCT02629354|20089761|P1|STARTED|Washout Period||18
8150434|NCT02629354|20089760|P2|NOT COMPLETED|Period 1||0
8150435|NCT02629354|20089761|P1|NOT COMPLETED|Period 1||0
8150436|NCT02629354|20089760|P2|COMPLETED|Period 1||18
8150437|NCT02629354|20089761|P1|COMPLETED|Period 1||18
8150438|NCT02629354|20089760|P2|STARTED|Period 1||18
8150439|NCT02629354|20089761|P1|STARTED|Period 1||18
8150440|NCT02629159|20089786|P3|NOT COMPLETED|Overall Study||51
8150441|NCT02629159|20089787|P2|NOT COMPLETED|Overall Study||39
8150442|NCT02629159|20089788|P1|NOT COMPLETED|Overall Study||56
8150443|NCT02629159|20089786|P3|COMPLETED|Overall Study||600
8150444|NCT02629159|20089787|P2|COMPLETED|Overall Study||288
8150445|NCT02629159|20089788|P1|COMPLETED|Overall Study||595
8150446|NCT02629159|20089786|P3|Rescued at Week 22|Overall Study||18
8150447|NCT02629159|20089787|P2|Rescued at Week 22|Overall Study||7
8150448|NCT02629159|20089788|P1|Rescued at Week 22|Overall Study||26
8150449|NCT02629159|20089786|P3|Rescued at Week 18|Overall Study||29
8150450|NCT02629159|20089787|P2|Rescued at Week 18|Overall Study||14
8150451|NCT02629159|20089788|P1|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48
8150452|NCT02629159|20089786|P3|Rescued at Week 14|Overall Study||78
8150453|NCT02629159|20089787|P2|Rescued at Week 14|Overall Study||56
8150454|NCT02629159|20089788|P1|Rescued at Week 14|Overall Study||231
8150455|NCT02629159|20089786|P3|Completed Week 14 on Study Drug|Overall Study||620
8150456|NCT02629159|20089787|P2|Completed Week 14 on Study Drug|Overall Study||300
8150457|NCT02629159|20089788|P1|Completed Week 14 on Study Drug|Overall Study||620
8150458|NCT02629159|20089786|P3|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650
8150459|NCT02629159|20089787|P2|Received Assigned Study Drug|Overall Study||327
8150460|NCT02629159|20089788|P1|Received Assigned Study Drug|Overall Study||651
8150461|NCT02629159|20089786|P3|STARTED|Overall Study||651
8150462|NCT02629159|20089787|P2|STARTED|Overall Study||327
8150463|NCT02629159|20089788|P1|STARTED|Overall Study||651
8150464|NCT02629133|20089840|P2|NOT COMPLETED|Overall Study||2
8150465|NCT02629133|20089841|P1|NOT COMPLETED|Overall Study||4
8150466|NCT02629133|20089840|P2|COMPLETED|Overall Study||23
8150467|NCT02629133|20089841|P1|COMPLETED|Overall Study||21
8150468|NCT02629133|20089840|P2|STARTED|Overall Study||25
8150469|NCT02629133|20089841|P1|STARTED|Overall Study||25
8150470|NCT02629094|20089855|P1|NOT COMPLETED|Overall Study||0
8150471|NCT02629094|20089855|P1|COMPLETED|Overall Study||5
8150472|NCT02629094|20089855|P1|STARTED|Overall Study||5
8150473|NCT02628964|20089862|P2|NOT COMPLETED|Overall Study||1
8150474|NCT02628964|20089863|P1|NOT COMPLETED|Overall Study||0
8150475|NCT02628964|20089862|P2|COMPLETED|Overall Study||49
8150476|NCT02628964|20089863|P1|COMPLETED|Overall Study||50
8150477|NCT02628964|20089862|P2|STARTED|Overall Study||50
8150478|NCT02628964|20089863|P1|STARTED|Overall Study||50
8150479|NCT02628938|20089884|P3|NOT COMPLETED|Overall Study||4
8150480|NCT02628938|20089885|P2|NOT COMPLETED|Overall Study||2
8150481|NCT02628938|20089886|P1|NOT COMPLETED|Overall Study||5
8150482|NCT02628938|20089884|P3|COMPLETED|Overall Study||11
8150483|NCT02628938|20089885|P2|COMPLETED|Overall Study||13
8150484|NCT02628938|20089886|P1|COMPLETED|Overall Study||10
8150485|NCT02628938|20089884|P3|STARTED|Overall Study||15
8150486|NCT02628938|20089885|P2|STARTED|Overall Study||15
8150487|NCT02628938|20089886|P1|STARTED|Overall Study||15
8150488|NCT02628873|20089902|P2|NOT COMPLETED|Second Test (1 Hour)||0
8150489|NCT02628873|20089903|P1|NOT COMPLETED|Second Test (1 Hour)||1
8150490|NCT02628873|20089902|P2|COMPLETED|Second Test (1 Hour)||6
8150491|NCT02628873|20089903|P1|COMPLETED|Second Test (1 Hour)||13
8150492|NCT02628873|20089902|P2|STARTED|Second Test (1 Hour)||6
8150493|NCT02628873|20089903|P1|STARTED|Second Test (1 Hour)||14
8150494|NCT02628873|20089902|P2|NOT COMPLETED|Break (1 Hour)||1
8150495|NCT02628873|20089903|P1|NOT COMPLETED|Break (1 Hour)||0
8150496|NCT02628873|20089902|P2|COMPLETED|Break (1 Hour)||6
8150497|NCT02628873|20089903|P1|COMPLETED|Break (1 Hour)||14
8150498|NCT02628873|20089902|P2|STARTED|Break (1 Hour)||7
8150499|NCT02628873|20089903|P1|STARTED|Break (1 Hour)||14
8150500|NCT02628873|20089902|P2|NOT COMPLETED|First Test (1 Hour)||0
8150501|NCT02628873|20089903|P1|NOT COMPLETED|First Test (1 Hour)||0
8150502|NCT02628873|20089902|P2|COMPLETED|First Test (1 Hour)||7
8150503|NCT02628873|20089903|P1|COMPLETED|First Test (1 Hour)||14
8150504|NCT02628873|20089902|P2|STARTED|First Test (1 Hour)||7
8150505|NCT02628873|20089903|P1|STARTED|First Test (1 Hour)||14
8150506|NCT02628769|20089913|P2|NOT COMPLETED|Second Intervention||1
8150507|NCT02628769|20089914|P1|NOT COMPLETED|Second Intervention||2
8150508|NCT02628769|20089913|P2|COMPLETED|Second Intervention||1
8150509|NCT02628769|20089914|P1|COMPLETED|Second Intervention||0
8150510|NCT02628769|20089913|P2|STARTED|Second Intervention||2
8150511|NCT02628769|20089914|P1|STARTED|Second Intervention||2
8150512|NCT02628769|20089913|P2|NOT COMPLETED|Wash Out (28 Days)||0
8150513|NCT02628769|20089914|P1|NOT COMPLETED|Wash Out (28 Days)||0
8150514|NCT02628769|20089913|P2|COMPLETED|Wash Out (28 Days)||2
8150515|NCT02628769|20089914|P1|COMPLETED|Wash Out (28 Days)||2
8150516|NCT02628769|20089913|P2|STARTED|Wash Out (28 Days)||2
8150517|NCT02628769|20089914|P1|STARTED|Wash Out (28 Days)||2
8150518|NCT02628769|20089913|P2|NOT COMPLETED|First Intervention||1
8150519|NCT02628769|20089914|P1|NOT COMPLETED|First Intervention||1
8150520|NCT02628769|20089913|P2|COMPLETED|First Intervention||2
8150521|NCT02628769|20089914|P1|COMPLETED|First Intervention||2
8150522|NCT02628769|20089913|P2|STARTED|First Intervention||3
8150523|NCT02628769|20089914|P1|STARTED|First Intervention||3
8150524|NCT02628743|20089952|P1|NOT COMPLETED|Overall Study||131
8150525|NCT02628743|20089952|P1|COMPLETED|Overall Study||0
8150526|NCT02628743|20089952|P1|STARTED|Overall Study||131
8150527|NCT02628600|20089978|P2|NOT COMPLETED|Overall Study||32
8150528|NCT02628600|20089979|P1|NOT COMPLETED|Overall Study||24
8150529|NCT02628600|20089978|P2|COMPLETED|Overall Study||58
8150530|NCT02628600|20089979|P1|COMPLETED|Overall Study||49
8150531|NCT02628600|20089978|P2|Participant Discontinued the Study|Overall Study||32
8150532|NCT02628600|20089979|P1|Participant Discontinued the Study|Overall Study||24
8150533|NCT02628600|20089978|P2|STARTED|Overall Study||90
8150534|NCT02628600|20089979|P1|STARTED|Overall Study||73
8150535|NCT02628418|20089993|P2|NOT COMPLETED|Overall Study||2
8150536|NCT02628418|20089994|P1|NOT COMPLETED|Overall Study||1
8150537|NCT02628418|20089993|P2|COMPLETED|Overall Study||13
8150538|NCT02628418|20089994|P1|COMPLETED|Overall Study||14
8150539|NCT02628418|20089993|P2|STARTED|Overall Study||15
8150540|NCT02628418|20089994|P1|STARTED|Overall Study||15
8150541|NCT02628236|20090015|P1|NOT COMPLETED|Overall Study||0
8150542|NCT02628236|20090015|P1|COMPLETED|Overall Study||14
8150543|NCT02628236|20090015|P1|STARTED|Overall Study||14
8150544|NCT02628223|20090054|P2|NOT COMPLETED|Overall Study||2
8150545|NCT02628223|20090055|P1|NOT COMPLETED|Overall Study||0
8150546|NCT02628223|20090054|P2|COMPLETED|Overall Study||36
8150547|NCT02628223|20090055|P1|COMPLETED|Overall Study||38
8150548|NCT02628223|20090054|P2|STARTED|Overall Study||38
8150549|NCT02628223|20090055|P1|STARTED|Overall Study||38
8150550|NCT02628106|20090071|P1|NOT COMPLETED|Overall Study||0
8150551|NCT02628106|20090071|P1|COMPLETED|Overall Study||21
8150552|NCT02628106|20090071|P1|STARTED|Overall Study||21
8150553|NCT02628093|20090077|P2|NOT COMPLETED|Overall Study||0
8150554|NCT02628093|20090078|P1|NOT COMPLETED|Overall Study||0
8150555|NCT02628093|20090077|P2|COMPLETED|Overall Study||29
8150556|NCT02628093|20090078|P1|COMPLETED|Overall Study||31
8150557|NCT02628093|20090077|P2|STARTED|Overall Study||29
8150558|NCT02628093|20090078|P1|STARTED|Overall Study||31
8150559|NCT02628028|20090104|P8|NOT COMPLETED|Long-term Extension (LTE) Period||61
8150560|NCT02628028|20090105|P7|NOT COMPLETED|Long-term Extension (LTE) Period||58
8150561|NCT02628028|20090106|P6|NOT COMPLETED|Long-term Extension (LTE) Period||60
8150562|NCT02628028|20090107|P5|NOT COMPLETED|Long-term Extension (LTE) Period||0
8150563|NCT02628028|20090108|P4|NOT COMPLETED|Long-term Extension (LTE) Period||0
8150564|NCT02628028|20090109|P3|NOT COMPLETED|Long-term Extension (LTE) Period||0
8150565|NCT02628028|20090110|P2|NOT COMPLETED|Long-term Extension (LTE) Period||0
8150566|NCT02628028|20090111|P1|NOT COMPLETED|Long-term Extension (LTE) Period||0
8150567|NCT02628028|20090104|P8|COMPLETED|Long-term Extension (LTE) Period||0
8150568|NCT02628028|20090105|P7|COMPLETED|Long-term Extension (LTE) Period||0
8150569|NCT02628028|20090106|P6|COMPLETED|Long-term Extension (LTE) Period||1
8150570|NCT02628028|20090107|P5|COMPLETED|Long-term Extension (LTE) Period||0
8150571|NCT02628028|20090108|P4|COMPLETED|Long-term Extension (LTE) Period||0
8150572|NCT02628028|20090109|P3|COMPLETED|Long-term Extension (LTE) Period||0
8150573|NCT02628028|20090110|P2|COMPLETED|Long-term Extension (LTE) Period||0
8150574|NCT02628028|20090111|P1|COMPLETED|Long-term Extension (LTE) Period||0
8150575|NCT02628028|20090104|P8|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
8150576|NCT02628028|20090105|P7|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
8150577|NCT02628028|20090106|P6|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
8150578|NCT02628028|20090107|P5|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8150579|NCT02628028|20090108|P4|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8150580|NCT02628028|20090109|P3|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8150581|NCT02628028|20090110|P2|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8150582|NCT02628028|20090111|P1|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
8150583|NCT02628028|20090104|P8|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
8150584|NCT02628028|20090105|P7|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58
8150585|NCT02628028|20090106|P6|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
8150586|NCT02628028|20090107|P5|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0
8150587|NCT02628028|20090108|P4|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
8150588|NCT02628028|20090109|P3|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
8150589|NCT02628028|20090110|P2|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
8150590|NCT02628028|20090111|P1|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
8150591|NCT02628028|20090104|P8|NOT COMPLETED|Dosing Period||15
8150592|NCT02628028|20090105|P7|NOT COMPLETED|Dosing Period||16
8150593|NCT02628028|20090106|P6|NOT COMPLETED|Dosing Period||14
8150594|NCT02628028|20090107|P5|NOT COMPLETED|Dosing Period||16
8150595|NCT02628028|20090108|P4|NOT COMPLETED|Dosing Period||0
8150596|NCT02628028|20090109|P3|NOT COMPLETED|Dosing Period||1
8150597|NCT02628028|20090110|P2|NOT COMPLETED|Dosing Period||0
8150598|NCT02628028|20090111|P1|NOT COMPLETED|Dosing Period||0
8150599|NCT02628028|20090104|P8|COMPLETED|Dosing Period||48
8150600|NCT02628028|20090105|P7|COMPLETED|Dosing Period||46
8150601|NCT02628028|20090106|P6|COMPLETED|Dosing Period||49
8150602|NCT02628028|20090107|P5|COMPLETED|Dosing Period||46
8150603|NCT02628028|20090108|P4|COMPLETED|Dosing Period||8
8150604|NCT02628028|20090109|P3|COMPLETED|Dosing Period||9
8150605|NCT02628028|20090110|P2|COMPLETED|Dosing Period||9
8150606|NCT02628028|20090111|P1|COMPLETED|Dosing Period||9
8150607|NCT02628028|20090104|P8|Received at Least 1dose of Study Drug|Dosing Period||63
8150608|NCT02628028|20090105|P7|Received at Least 1dose of Study Drug|Dosing Period||62
8150609|NCT02628028|20090106|P6|Received at Least 1dose of Study Drug|Dosing Period||63
8150610|NCT02628028|20090107|P5|Received at Least 1dose of Study Drug|Dosing Period||62
8150611|NCT02628028|20090108|P4|Received at Least 1dose of Study Drug|Dosing Period||8
8150612|NCT02628028|20090109|P3|Received at Least 1dose of Study Drug|Dosing Period||10
8150613|NCT02628028|20090110|P2|Received at Least 1dose of Study Drug|Dosing Period||9
8150614|NCT02628028|20090111|P1|Received at Least 1dose of Study Drug|Dosing Period||9
8150615|NCT02628028|20090104|P8|STARTED|Dosing Period||63
8150616|NCT02628028|20090105|P7|STARTED|Dosing Period||62
8150617|NCT02628028|20090106|P6|STARTED|Dosing Period||63
8150618|NCT02628028|20090107|P5|STARTED|Dosing Period||62
8150619|NCT02628028|20090108|P4|STARTED|Dosing Period||8
8150620|NCT02628028|20090109|P3|STARTED|Dosing Period||10
8150621|NCT02628028|20090110|P2|STARTED|Dosing Period||9
8150622|NCT02628028|20090111|P1|STARTED|Dosing Period||9
8150629|NCT02627924|20090166|P1|NOT COMPLETED|Overall Study||12
8150630|NCT02627924|20090166|P1|COMPLETED|Overall Study||79
8150631|NCT02627924|20090166|P1|STARTED|Overall Study||91
8150632|NCT02627794|20090183|P1|NOT COMPLETED|Overall Study||0
8150633|NCT02627794|20090183|P1|COMPLETED|Overall Study||3
8150634|NCT02627794|20090183|P1|STARTED|Overall Study||3
8150635|NCT02627144|20090196|P1|NOT COMPLETED|Overall Study||365
8150636|NCT02627144|20090196|P1|COMPLETED|Overall Study||0
8150637|NCT02627144|20090196|P1|Treated|Overall Study||359
8150638|NCT02627144|20090196|P1|STARTED|Overall Study||365
8150639|NCT02627118|20090204|P1|NOT COMPLETED|Overall Study||0
8150640|NCT02627118|20090204|P1|COMPLETED|Overall Study||10
8150641|NCT02627118|20090204|P1|STARTED|Overall Study||10
8150642|NCT02627001|20090211|P2|NOT COMPLETED|Overall Study||0
8150643|NCT02627001|20090212|P1|NOT COMPLETED|Overall Study||0
8150644|NCT02627001|20090211|P2|COMPLETED|Overall Study||14
8150645|NCT02627001|20090212|P1|COMPLETED|Overall Study||13
8150646|NCT02627001|20090211|P2|STARTED|Overall Study||14
8150647|NCT02627001|20090212|P1|STARTED|Overall Study||13
8150648|NCT02626910|20090222|P4|NOT COMPLETED|Overall Study||0
8150649|NCT02626910|20090223|P3|NOT COMPLETED|Overall Study||0
8150650|NCT02626910|20090224|P2|NOT COMPLETED|Overall Study||0
8150651|NCT02626910|20090225|P1|NOT COMPLETED|Overall Study||0
8150652|NCT02626910|20090222|P4|COMPLETED|Overall Study||10
8150653|NCT02626910|20090223|P3|COMPLETED|Overall Study||6
8150654|NCT02626910|20090224|P2|COMPLETED|Overall Study||10
8150655|NCT02626910|20090225|P1|COMPLETED|Overall Study||23
8150656|NCT02626910|20090222|P4|STARTED|Overall Study||10
8150657|NCT02626910|20090223|P3|STARTED|Overall Study||6
8150658|NCT02626910|20090224|P2|STARTED|Overall Study||10
8150659|NCT02626910|20090225|P1|STARTED|Overall Study||23
8150660|NCT02626819|20090237|P2|NOT COMPLETED|Overall Study||3
8150661|NCT02626819|20090238|P1|NOT COMPLETED|Overall Study||4
8150662|NCT02626819|20090237|P2|COMPLETED|Overall Study||20
8150663|NCT02626819|20090238|P1|COMPLETED|Overall Study||18
8150664|NCT02626819|20090237|P2|STARTED|Overall Study||23
8150665|NCT02626819|20090238|P1|STARTED|Overall Study||22
8150666|NCT02626780|20090258|P1|NOT COMPLETED|Overall Study||3
8150667|NCT02626780|20090258|P1|COMPLETED|Overall Study||4
8150668|NCT02626780|20090258|P1|Withdrew From Study|Overall Study||3
8150669|NCT02626780|20090258|P1|STARTED|Overall Study||7
8150670|NCT02626611|20090266|P3|NOT COMPLETED|Overall Study||3
8150671|NCT02626611|20090267|P2|NOT COMPLETED|Overall Study||1
8150672|NCT02626611|20090268|P1|NOT COMPLETED|Overall Study||4
8150673|NCT02626611|20090266|P3|COMPLETED|Overall Study||16
8150674|NCT02626611|20090267|P2|COMPLETED|Overall Study||20
8150675|NCT02626611|20090268|P1|COMPLETED|Overall Study||16
8150676|NCT02626611|20090266|P3|STARTED|Overall Study||19
8150677|NCT02626611|20090267|P2|STARTED|Overall Study||21
8150678|NCT02626611|20090268|P1|STARTED|Overall Study||20
8150679|NCT02626520|20090291|P2|NOT COMPLETED|Overall Study||10
8150680|NCT02626520|20090292|P1|NOT COMPLETED|Overall Study||1
8150681|NCT02626520|20090291|P2|COMPLETED|Overall Study||0
8150682|NCT02626520|20090292|P1|COMPLETED|Overall Study||0
8150683|NCT02626520|20090291|P2|STARTED|Overall Study||10
8150684|NCT02626520|20090292|P1|STARTED|Overall Study||1
8150685|NCT02626182|20090304|P2|NOT COMPLETED|Overall Study||0
8150686|NCT02626182|20090305|P1|NOT COMPLETED|Overall Study||2
8150687|NCT02626182|20090304|P2|COMPLETED|Overall Study||3
8150688|NCT02626182|20090305|P1|COMPLETED|Overall Study||9
8150689|NCT02626182|20090304|P2|STARTED|Overall Study||3
8150690|NCT02626182|20090305|P1|STARTED|Overall Study||11
8150691|NCT02626026|20090321|P6|NOT COMPLETED|Overall Study||0
8150692|NCT02626026|20090322|P5|NOT COMPLETED|Overall Study||1
8150693|NCT02626026|20090323|P4|NOT COMPLETED|Overall Study||0
8150694|NCT02626026|20090324|P3|NOT COMPLETED|Overall Study||0
8150695|NCT02626026|20090325|P2|NOT COMPLETED|Overall Study||0
8150696|NCT02626026|20090326|P1|NOT COMPLETED|Overall Study||0
8150697|NCT02626026|20090321|P6|COMPLETED|Overall Study||5
8150698|NCT02626026|20090322|P5|COMPLETED|Overall Study||16
8150699|NCT02626026|20090323|P4|COMPLETED|Overall Study||2
8150700|NCT02626026|20090324|P3|COMPLETED|Overall Study||8
8150701|NCT02626026|20090325|P2|COMPLETED|Overall Study||2
8150702|NCT02626026|20090326|P1|COMPLETED|Overall Study||8
8150703|NCT02626026|20090321|P6|STARTED|Overall Study||5
8150704|NCT02626026|20090322|P5|STARTED|Overall Study||17
8150705|NCT02626026|20090323|P4|STARTED|Overall Study||2
8150706|NCT02626026|20090324|P3|STARTED|Overall Study||8
8150707|NCT02626026|20090325|P2|STARTED|Overall Study||2
8150708|NCT02626026|20090326|P1|STARTED|Overall Study||8
8150709|NCT02626000|20090404|P1|NOT COMPLETED|Overall Study||36
8150710|NCT02626000|20090404|P1|COMPLETED|Overall Study||0
8150711|NCT02626000|20090404|P1|STARTED|Overall Study||36
8150720|NCT02625922|20090529|P2|NOT COMPLETED|Overall Study||2
8150721|NCT02625922|20090530|P1|NOT COMPLETED|Overall Study||2
8150722|NCT02625922|20090529|P2|COMPLETED|Overall Study||10
8150723|NCT02625922|20090530|P1|COMPLETED|Overall Study||12
8150724|NCT02625922|20090529|P2|Completed Treatment Period 2|Overall Study||8
8150725|NCT02625922|20090530|P1|Completed Treatment Period 2|Overall Study||11
8150726|NCT02625922|20090529|P2|Completed Treatment Period 1|Overall Study||10
8150727|NCT02625922|20090530|P1|Completed Treatment Period 1|Overall Study||12
8150728|NCT02625922|20090529|P2|STARTED|Overall Study||12
8150729|NCT02625922|20090530|P1|STARTED|Overall Study||14
8150730|NCT02625844|20090543|P1|NOT COMPLETED|Overall Study||0
8150731|NCT02625844|20090543|P1|COMPLETED|Overall Study||110
8150732|NCT02625844|20090543|P1|STARTED|Overall Study||110
8150733|NCT02625623|20090549|P2|NOT COMPLETED|Overall Study||1
8150734|NCT02625623|20090550|P1|NOT COMPLETED|Overall Study||9
8150735|NCT02625623|20090549|P2|COMPLETED|Overall Study||184
8150736|NCT02625623|20090550|P1|COMPLETED|Overall Study||177
8150737|NCT02625623|20090549|P2|Treated|Overall Study||184
8150738|NCT02625623|20090550|P1|Treated|Overall Study||177
8150739|NCT02625623|20090549|P2|STARTED|Overall Study||185
8150740|NCT02625623|20090550|P1|STARTED|Overall Study||186
8150741|NCT02625571|20090570|P1|NOT COMPLETED|Overall Study||3
8150742|NCT02625571|20090570|P1|COMPLETED|Overall Study||10
8150743|NCT02625571|20090570|P1|STARTED|Overall Study||13
8150744|NCT02625545|20090575|P1|NOT COMPLETED|Overall Study||0
8150745|NCT02625545|20090575|P1|COMPLETED|Overall Study||45
8150746|NCT02625545|20090575|P1|12 Month|Overall Study||45
8150747|NCT02625545|20090575|P1|6 Month|Overall Study||45
8150748|NCT02625545|20090575|P1|3 Month|Overall Study||45
8150749|NCT02625545|20090575|P1|STARTED|Overall Study||45
8150750|NCT02625428|20090591|P2|NOT COMPLETED|Overall Study||0
8150751|NCT02625428|20090592|P1|NOT COMPLETED|Overall Study||0
8150752|NCT02625428|20090591|P2|COMPLETED|Overall Study||20
8150753|NCT02625428|20090592|P1|COMPLETED|Overall Study||20
8150754|NCT02625428|20090591|P2|STARTED|Overall Study||20
8150755|NCT02625428|20090592|P1|STARTED|Overall Study||20
8150756|NCT02625402|20090602|P2|NOT COMPLETED|Overall Study||12
8150757|NCT02625402|20090603|P1|NOT COMPLETED|Overall Study||9
8150758|NCT02625402|20090602|P2|COMPLETED|Overall Study||25
8150759|NCT02625402|20090603|P1|COMPLETED|Overall Study||33
8150760|NCT02625402|20090602|P2|STARTED|Overall Study||37
8150761|NCT02625402|20090603|P1|STARTED|Overall Study||42
8150774|NCT02625298|20090624|P2|NOT COMPLETED|Overall Study||0
8150775|NCT02625298|20090625|P1|NOT COMPLETED|Overall Study||1
8150776|NCT02625298|20090624|P2|COMPLETED|Overall Study||13
8150777|NCT02625298|20090625|P1|COMPLETED|Overall Study||10
8150778|NCT02625298|20090624|P2|STARTED|Overall Study||13
8150779|NCT02625298|20090625|P1|STARTED|Overall Study||11
8150780|NCT02625259|20090638|P5|NOT COMPLETED|Second Intervention (Day 15)||0
8150781|NCT02625259|20090639|P4|NOT COMPLETED|Second Intervention (Day 15)||0
8150782|NCT02625259|20090640|P3|NOT COMPLETED|Second Intervention (Day 15)||0
8150783|NCT02625259|20090641|P2|NOT COMPLETED|Second Intervention (Day 15)||0
8150784|NCT02625259|20090642|P1|NOT COMPLETED|Second Intervention (Day 15)||0
8150785|NCT02625259|20090638|P5|COMPLETED|Second Intervention (Day 15)||0
8150786|NCT02625259|20090639|P4|COMPLETED|Second Intervention (Day 15)||9
8150787|NCT02625259|20090640|P3|COMPLETED|Second Intervention (Day 15)||7
8150788|NCT02625259|20090641|P2|COMPLETED|Second Intervention (Day 15)||8
8150789|NCT02625259|20090642|P1|COMPLETED|Second Intervention (Day 15)||9
8150790|NCT02625259|20090638|P5|STARTED|Second Intervention (Day 15)||0
8150791|NCT02625259|20090639|P4|STARTED|Second Intervention (Day 15)||9
8150792|NCT02625259|20090640|P3|STARTED|Second Intervention (Day 15)||7
8150793|NCT02625259|20090641|P2|STARTED|Second Intervention (Day 15)||8
8150794|NCT02625259|20090642|P1|STARTED|Second Intervention (Day 15)||9
8150795|NCT02625259|20090638|P5|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8150796|NCT02625259|20090639|P4|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8150797|NCT02625259|20090640|P3|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8150798|NCT02625259|20090641|P2|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8150799|NCT02625259|20090642|P1|NOT COMPLETED|Washout (Day 2 to Day 14)||0
8150800|NCT02625259|20090638|P5|COMPLETED|Washout (Day 2 to Day 14)||0
8150801|NCT02625259|20090639|P4|COMPLETED|Washout (Day 2 to Day 14)||9
8150802|NCT02625259|20090640|P3|COMPLETED|Washout (Day 2 to Day 14)||7
8150803|NCT02625259|20090641|P2|COMPLETED|Washout (Day 2 to Day 14)||8
8150804|NCT02625259|20090642|P1|COMPLETED|Washout (Day 2 to Day 14)||9
8150805|NCT02625259|20090638|P5|STARTED|Washout (Day 2 to Day 14)||0
8150806|NCT02625259|20090639|P4|STARTED|Washout (Day 2 to Day 14)||9
8150807|NCT02625259|20090640|P3|STARTED|Washout (Day 2 to Day 14)||7
8150808|NCT02625259|20090641|P2|STARTED|Washout (Day 2 to Day 14)||8
8150809|NCT02625259|20090642|P1|STARTED|Washout (Day 2 to Day 14)||9
8150810|NCT02625259|20090638|P5|NOT COMPLETED|First Intervention (Day 1)||0
8150811|NCT02625259|20090639|P4|NOT COMPLETED|First Intervention (Day 1)||1
8150812|NCT02625259|20090640|P3|NOT COMPLETED|First Intervention (Day 1)||1
8150813|NCT02625259|20090641|P2|NOT COMPLETED|First Intervention (Day 1)||1
8150814|NCT02625259|20090642|P1|NOT COMPLETED|First Intervention (Day 1)||2
8150815|NCT02625259|20090638|P5|COMPLETED|First Intervention (Day 1)||16
8150816|NCT02625259|20090639|P4|COMPLETED|First Intervention (Day 1)||9
8150817|NCT02625259|20090640|P3|COMPLETED|First Intervention (Day 1)||7
8150818|NCT02625259|20090641|P2|COMPLETED|First Intervention (Day 1)||8
8150819|NCT02625259|20090642|P1|COMPLETED|First Intervention (Day 1)||9
8150820|NCT02625259|20090638|P5|STARTED|First Intervention (Day 1)||16
8150821|NCT02625259|20090639|P4|STARTED|First Intervention (Day 1)||10
8150822|NCT02625259|20090640|P3|STARTED|First Intervention (Day 1)||8
8150823|NCT02625259|20090641|P2|STARTED|First Intervention (Day 1)||9
8150824|NCT02625259|20090642|P1|STARTED|First Intervention (Day 1)||11
8150825|NCT02625233|20090679|P2|NOT COMPLETED|Overall Study||0
8150826|NCT02625233|20090680|P1|NOT COMPLETED|Overall Study||2
8150827|NCT02625233|20090679|P2|COMPLETED|Overall Study||56
8150828|NCT02625233|20090680|P1|COMPLETED|Overall Study||47
8150829|NCT02625233|20090679|P2|STARTED|Overall Study||56
8150830|NCT02625233|20090680|P1|STARTED|Overall Study||49
8150831|NCT02625220|20090688|P1|NOT COMPLETED|Overall Study||7
8150832|NCT02625220|20090688|P1|COMPLETED|Overall Study||163
8150833|NCT02625220|20090688|P1|STARTED|Overall Study||170
8150834|NCT02625207|20090699|P4|NOT COMPLETED|Part 2 (11 Days)||0
8150835|NCT02625207|20090700|P3|NOT COMPLETED|Part 2 (11 Days)||0
8150836|NCT02625207|20090701|P2|NOT COMPLETED|Part 2 (11 Days)||0
8150837|NCT02625207|20090702|P1|NOT COMPLETED|Part 2 (11 Days)||0
8150838|NCT02625207|20090699|P4|COMPLETED|Part 2 (11 Days)||0
8150839|NCT02625207|20090700|P3|COMPLETED|Part 2 (11 Days)||12
8150840|NCT02625207|20090701|P2|COMPLETED|Part 2 (11 Days)||0
8150841|NCT02625207|20090702|P1|COMPLETED|Part 2 (11 Days)||11
8150842|NCT02625207|20090699|P4|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
8150843|NCT02625207|20090700|P3|STARTED|Part 2 (11 Days)||12
8150844|NCT02625207|20090701|P2|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
8150845|NCT02625207|20090702|P1|STARTED|Part 2 (11 Days)||11
8150846|NCT02625207|20090699|P4|NOT COMPLETED|Part 1 (6 Days)||0
8150847|NCT02625207|20090700|P3|NOT COMPLETED|Part 1 (6 Days)||0
8150848|NCT02625207|20090701|P2|NOT COMPLETED|Part 1 (6 Days)||0
8150849|NCT02625207|20090702|P1|NOT COMPLETED|Part 1 (6 Days)||0
8150850|NCT02625207|20090699|P4|COMPLETED|Part 1 (6 Days)||12
8150851|NCT02625207|20090700|P3|COMPLETED|Part 1 (6 Days)||12
8150852|NCT02625207|20090701|P2|COMPLETED|Part 1 (6 Days)||12
8150853|NCT02625207|20090702|P1|COMPLETED|Part 1 (6 Days)||11
8150854|NCT02625207|20090699|P4|STARTED|Part 1 (6 Days)||12
8150855|NCT02625207|20090700|P3|STARTED|Part 1 (6 Days)||12
8150856|NCT02625207|20090701|P2|STARTED|Part 1 (6 Days)||12
8150857|NCT02625207|20090702|P1|STARTED|Part 1 (6 Days)||11
8150858|NCT02625181|20090791|P3|NOT COMPLETED|Overall Study||0
8150859|NCT02625181|20090792|P2|NOT COMPLETED|Overall Study||0
8150860|NCT02625181|20090793|P1|NOT COMPLETED|Overall Study||0
8150861|NCT02625181|20090791|P3|COMPLETED|Overall Study||12707
8150862|NCT02625181|20090792|P2|COMPLETED|Overall Study||12809
8150863|NCT02625181|20090793|P1|COMPLETED|Overall Study||1518
8150864|NCT02625181|20090791|P3|STARTED|Overall Study||12707
8150865|NCT02625181|20090792|P2|STARTED|Overall Study||12809
8150866|NCT02625181|20090793|P1|STARTED|Overall Study||1518
8150867|NCT02624986|20090816|P8|NOT COMPLETED|Overall Study||5
8150868|NCT02624986|20090817|P7|NOT COMPLETED|Overall Study||4
8150869|NCT02624986|20090818|P6|NOT COMPLETED|Overall Study||2
8150870|NCT02624986|20090819|P5|NOT COMPLETED|Overall Study||4
8150871|NCT02624986|20090820|P4|NOT COMPLETED|Overall Study||3
8150872|NCT02624986|20090821|P3|NOT COMPLETED|Overall Study||2
8150873|NCT02624986|20090822|P2|NOT COMPLETED|Overall Study||3
8150874|NCT02624986|20090823|P1|NOT COMPLETED|Overall Study||2
8150875|NCT02624986|20090816|P8|COMPLETED|Overall Study||0
8150876|NCT02624986|20090817|P7|COMPLETED|Overall Study||0
8150877|NCT02624986|20090818|P6|COMPLETED|Overall Study||0
8150878|NCT02624986|20090819|P5|COMPLETED|Overall Study||0
8150879|NCT02624986|20090820|P4|COMPLETED|Overall Study||0
8150880|NCT02624986|20090821|P3|COMPLETED|Overall Study||0
8150881|NCT02624986|20090822|P2|COMPLETED|Overall Study||0
8150882|NCT02624986|20090823|P1|COMPLETED|Overall Study||0
8150883|NCT02624986|20090816|P8|Received Any Study Treatment|Overall Study||5
8150884|NCT02624986|20090817|P7|Received Any Study Treatment|Overall Study||4
8150885|NCT02624986|20090818|P6|Received Any Study Treatment|Overall Study||2
8150886|NCT02624986|20090819|P5|Received Any Study Treatment|Overall Study||4
8150887|NCT02624986|20090820|P4|Received Any Study Treatment|Overall Study||3
8150888|NCT02624986|20090821|P3|Received Any Study Treatment|Overall Study||2
8150889|NCT02624986|20090822|P2|Received Any Study Treatment|Overall Study||3
8150890|NCT02624986|20090823|P1|Received Any Study Treatment|Overall Study||1
8150891|NCT02624986|20090816|P8|STARTED|Overall Study||5
8150892|NCT02624986|20090817|P7|STARTED|Overall Study||4
8150893|NCT02624986|20090818|P6|STARTED|Overall Study||2
8150894|NCT02624986|20090819|P5|STARTED|Overall Study||4
8150895|NCT02624986|20090820|P4|STARTED|Overall Study||3
8150896|NCT02624986|20090821|P3|STARTED|Overall Study||2
8150897|NCT02624986|20090822|P2|STARTED|Overall Study||3
8150898|NCT02624986|20090823|P1|STARTED|Overall Study||2
8150899|NCT02624843|20091003|P3|NOT COMPLETED|Overall Study||8
8150900|NCT02624843|20091004|P2|NOT COMPLETED|Overall Study||36
8150901|NCT02624843|20091005|P1|NOT COMPLETED|Overall Study||37
8150902|NCT02624843|20091003|P3|COMPLETED|Overall Study||16
8150903|NCT02624843|20091004|P2|COMPLETED|Overall Study||72
8150904|NCT02624843|20091005|P1|COMPLETED|Overall Study||70
8150905|NCT02624843|20091003|P3|STARTED|Overall Study||24
8150906|NCT02624843|20091004|P2|STARTED|Overall Study||108
8150907|NCT02624843|20091005|P1|STARTED|Overall Study||107
8150908|NCT02624791|20091013|P6|NOT COMPLETED|Overall Study||0
8150909|NCT02624791|20091014|P5|NOT COMPLETED|Overall Study||0
8150910|NCT02624791|20091015|P4|NOT COMPLETED|Overall Study||0
8150911|NCT02624791|20091016|P3|NOT COMPLETED|Overall Study||0
8150912|NCT02624791|20091017|P2|NOT COMPLETED|Overall Study||0
8150913|NCT02624791|20091018|P1|NOT COMPLETED|Overall Study||2
8150914|NCT02624791|20091013|P6|COMPLETED|Overall Study||2
8150915|NCT02624791|20091014|P5|COMPLETED|Overall Study||2
8150916|NCT02624791|20091015|P4|COMPLETED|Overall Study||2
8150917|NCT02624791|20091016|P3|COMPLETED|Overall Study||2
8150918|NCT02624791|20091017|P2|COMPLETED|Overall Study||1
8150919|NCT02624791|20091018|P1|COMPLETED|Overall Study||0
8150920|NCT02624791|20091013|P6|STARTED|Overall Study||2
8150921|NCT02624791|20091014|P5|STARTED|Overall Study||2
8150922|NCT02624791|20091015|P4|STARTED|Overall Study||2
8150923|NCT02624791|20091016|P3|STARTED|Overall Study||2
8150924|NCT02624791|20091017|P2|STARTED|Overall Study||1
8150925|NCT02624791|20091018|P1|STARTED|Overall Study||2
8150926|NCT02624713|20091025|P2|NOT COMPLETED|Overall Study||0
8150927|NCT02624713|20091026|P1|NOT COMPLETED|Overall Study||14
8150928|NCT02624713|20091025|P2|COMPLETED|Overall Study||81
8150929|NCT02624713|20091026|P1|COMPLETED|Overall Study||64
8150930|NCT02624713|20091025|P2|STARTED|Overall Study||81
8150931|NCT02624713|20091026|P1|STARTED|Overall Study||78
8150932|NCT02624700|20091035|P2|NOT COMPLETED|Overall Study||0
8150933|NCT02624700|20091036|P1|NOT COMPLETED|Overall Study||0
8150934|NCT02624700|20091035|P2|COMPLETED|Overall Study||4
8150935|NCT02624700|20091036|P1|COMPLETED|Overall Study||9
8150936|NCT02624700|20091035|P2|STARTED|Overall Study||4
8150937|NCT02624700|20091036|P1|STARTED|Overall Study||9
8150938|NCT02624687|20091050|P2|NOT COMPLETED|Overall Study||2
8150939|NCT02624687|20091051|P1|NOT COMPLETED|Overall Study||1
8150940|NCT02624687|20091050|P2|COMPLETED|Overall Study||12
8150941|NCT02624687|20091051|P1|COMPLETED|Overall Study||12
8150942|NCT02624687|20091050|P2|STARTED|Overall Study||14
8150943|NCT02624687|20091051|P1|STARTED|Overall Study||13
8150944|NCT02624492|20091082|P3|NOT COMPLETED|Overall Study||5
8150945|NCT02624492|20091083|P2|NOT COMPLETED|Overall Study||4
8150946|NCT02624492|20091084|P1|NOT COMPLETED|Overall Study||2
8150947|NCT02624492|20091082|P3|COMPLETED|Overall Study||3
8150948|NCT02624492|20091083|P2|COMPLETED|Overall Study||4
8150949|NCT02624492|20091084|P1|COMPLETED|Overall Study||3
8150950|NCT02624492|20091082|P3|STARTED|Overall Study||8
8150951|NCT02624492|20091083|P2|STARTED|Overall Study||8
8150952|NCT02624492|20091084|P1|STARTED|Overall Study||5
8150953|NCT02624375|20091110|P1|NOT COMPLETED|Overall Study||0
8150954|NCT02624375|20091110|P1|COMPLETED|Overall Study||10
8150955|NCT02624375|20091110|P1|STARTED|Overall Study||10
8150956|NCT02624284|20091119|P3|NOT COMPLETED|Overall Study||11
8150957|NCT02624284|20091120|P2|NOT COMPLETED|Overall Study||18
8150958|NCT02624284|20091121|P1|NOT COMPLETED|Overall Study||14
8150959|NCT02624284|20091119|P3|COMPLETED|Overall Study||36
8150960|NCT02624284|20091120|P2|COMPLETED|Overall Study||35
8150961|NCT02624284|20091121|P1|COMPLETED|Overall Study||35
8150962|NCT02624284|20091119|P3|STARTED|Overall Study||47
8150963|NCT02624284|20091120|P2|STARTED|Overall Study||53
8150964|NCT02624284|20091121|P1|STARTED|Overall Study||49
8150965|NCT02624050|20091140|P2|NOT COMPLETED|Overall Study||0
8150966|NCT02624050|20091141|P1|NOT COMPLETED|Overall Study||6
8150967|NCT02624050|20091140|P2|COMPLETED|Overall Study||25
8150968|NCT02624050|20091141|P1|COMPLETED|Overall Study||20
8150969|NCT02624050|20091140|P2|STARTED|Overall Study||25
8150970|NCT02624050|20091141|P1|STARTED|Overall Study||26
8150971|NCT02623959|20091169|P2|NOT COMPLETED|Overall Study||1
8150972|NCT02623959|20091170|P1|NOT COMPLETED|Overall Study||0
8150973|NCT02623959|20091169|P2|COMPLETED|Overall Study|due to progression|0
8150974|NCT02623959|20091170|P1|COMPLETED|Overall Study||0
8150975|NCT02623959|20091169|P2|STARTED|Overall Study||1
8150976|NCT02623959|20091170|P1|STARTED|Overall Study||0
8150977|NCT02623855|20091180|P2|NOT COMPLETED|Overall Study||16
8150978|NCT02623855|20091181|P1|NOT COMPLETED|Overall Study||10
8150979|NCT02623855|20091180|P2|COMPLETED|Overall Study||84
8150980|NCT02623855|20091181|P1|COMPLETED|Overall Study||46
8150981|NCT02623855|20091180|P2|STARTED|Overall Study||100
8150982|NCT02623855|20091181|P1|STARTED|Overall Study||56
8150983|NCT02623829|20091203|P2|NOT COMPLETED|Overall Study||1
8150984|NCT02623829|20091204|P1|NOT COMPLETED|Overall Study||1
8150985|NCT02623829|20091203|P2|COMPLETED|Overall Study||20
8150986|NCT02623829|20091204|P1|COMPLETED|Overall Study||20
8150987|NCT02623829|20091203|P2|STARTED|Overall Study||21
8150988|NCT02623829|20091204|P1|STARTED|Overall Study||21
8150989|NCT02623803|20091216|P2|NOT COMPLETED|Overall Study||0
8150990|NCT02623803|20091217|P1|NOT COMPLETED|Overall Study||0
8150991|NCT02623803|20091216|P2|COMPLETED|Overall Study||23
8150992|NCT02623803|20091217|P1|COMPLETED|Overall Study||25
8150993|NCT02623803|20091216|P2|STARTED|Overall Study||23
8150994|NCT02623803|20091217|P1|STARTED|Overall Study||25
8150995|NCT02623725|20091263|P2|NOT COMPLETED|Overall Study||6
8150996|NCT02623725|20091264|P1|NOT COMPLETED|Overall Study||16
8150997|NCT02623725|20091263|P2|COMPLETED|Overall Study||58
8150998|NCT02623725|20091264|P1|COMPLETED|Overall Study||171
8150999|NCT02623725|20091263|P2|STARTED|Overall Study||64
8151000|NCT02623725|20091264|P1|STARTED|Overall Study||187
8151001|NCT02623361|20091298|P2|NOT COMPLETED|Overall Study||2
8151002|NCT02623361|20091299|P1|NOT COMPLETED|Overall Study||0
8151003|NCT02623361|20091298|P2|COMPLETED|Overall Study||38
8151004|NCT02623361|20091299|P1|COMPLETED|Overall Study||40
8151005|NCT02623361|20091298|P2|STARTED|Overall Study||40
8151006|NCT02623361|20091299|P1|STARTED|Overall Study||40
8151007|NCT02623348|20091311|P2|NOT COMPLETED|Overall Study||2
8151008|NCT02623348|20091312|P1|NOT COMPLETED|Overall Study||3
8151009|NCT02623348|20091311|P2|COMPLETED|Overall Study||28
8151010|NCT02623348|20091312|P1|COMPLETED|Overall Study||27
8151011|NCT02623348|20091311|P2|3-month Assessment|Overall Study||26
8151012|NCT02623348|20091312|P1|3-month Assessment|Overall Study||27
8151013|NCT02623348|20091311|P2|STARTED|Overall Study||30
8151014|NCT02623348|20091312|P1|STARTED|Overall Study||30
8151015|NCT02623335|20091338|P2|NOT COMPLETED|Overall Study||36
8151016|NCT02623335|20091339|P1|NOT COMPLETED|Overall Study||27
8151017|NCT02623335|20091338|P2|COMPLETED|Overall Study||187
8151018|NCT02623335|20091339|P1|COMPLETED|Overall Study||196
8151019|NCT02623335|20091338|P2|T3 Survey (12-14 Weeks)|Overall Study||187
8151020|NCT02623335|20091339|P1|T3 Survey (12-14 Weeks)|Overall Study||196
8151021|NCT02623335|20091338|P2|T2 Survey (6-8 Weeks)|Overall Study||192
8151022|NCT02623335|20091339|P1|T2 Survey (6-8 Weeks)|Overall Study||199
8151023|NCT02623335|20091338|P2|T1 Survey (24-48 Hours)|Overall Study||214
8151024|NCT02623335|20091339|P1|T1 Survey (24-48 Hours)|Overall Study||216
8151025|NCT02623335|20091338|P2|T0 Audio Recording (Day of Consultation)|Overall Study||222
8151026|NCT02623335|20091339|P1|T0 Audio Recording (Day of Consultation)|Overall Study||223
8151027|NCT02623335|20091338|P2|STARTED|Overall Study||223
8151028|NCT02623335|20091339|P1|STARTED|Overall Study||223
8151029|NCT02623322|20091366|P3|NOT COMPLETED|Overall Study||0
8151030|NCT02623322|20091367|P2|NOT COMPLETED|Overall Study||1
8151031|NCT02623322|20091368|P1|NOT COMPLETED|Overall Study||2
8151032|NCT02623322|20091366|P3|COMPLETED|Overall Study||40
8151033|NCT02623322|20091367|P2|COMPLETED|Overall Study||40
8151034|NCT02623322|20091368|P1|COMPLETED|Overall Study||41
8151035|NCT02623322|20091366|P3|STARTED|Overall Study||40
8151036|NCT02623322|20091367|P2|STARTED|Overall Study||41
8151037|NCT02623322|20091368|P1|STARTED|Overall Study||43
8151038|NCT02623218|20091406|P5|NOT COMPLETED|Overall Study||0
8151039|NCT02623218|20091407|P4|NOT COMPLETED|Overall Study||0
8151040|NCT02623218|20091408|P3|NOT COMPLETED|Overall Study||0
8151041|NCT02623218|20091409|P2|NOT COMPLETED|Overall Study||1
8151042|NCT02623218|20091410|P1|NOT COMPLETED|Overall Study||0
8151043|NCT02623218|20091406|P5|COMPLETED|Overall Study||4
8151044|NCT02623218|20091407|P4|COMPLETED|Overall Study||4
8151045|NCT02623218|20091408|P3|COMPLETED|Overall Study||4
8151046|NCT02623218|20091409|P2|COMPLETED|Overall Study||3
8151047|NCT02623218|20091410|P1|COMPLETED|Overall Study||5
8151048|NCT02623218|20091406|P5|STARTED|Overall Study||4
8151049|NCT02623218|20091407|P4|STARTED|Overall Study||4
8151050|NCT02623218|20091408|P3|STARTED|Overall Study||4
8151051|NCT02623218|20091409|P2|STARTED|Overall Study||4
8151052|NCT02623218|20091410|P1|STARTED|Overall Study||5
8151053|NCT02622828|20091432|P1|NOT COMPLETED|Overall Study||3
8151054|NCT02622828|20091432|P1|COMPLETED|Overall Study||1
8151055|NCT02622828|20091432|P1|STARTED|Overall Study||4
8151056|NCT02622724|20091439|P2|NOT COMPLETED|Overall Study||103
8151057|NCT02622724|20091440|P1|NOT COMPLETED|Overall Study||93
8151058|NCT02622724|20091439|P2|COMPLETED|Overall Study||49
8151059|NCT02622724|20091440|P1|COMPLETED|Overall Study||51
8151060|NCT02622724|20091439|P2|Long-Term Follow-Up (Day 180)|Overall Study||74
8151061|NCT02622724|20091440|P1|Long-Term Follow-Up (Day 180)|Overall Study||73
8151062|NCT02622724|20091439|P2|Long-Term Follow-Up (Day 90)|Overall Study||101
8151063|NCT02622724|20091440|P1|Long-Term Follow-Up (Day 90)|Overall Study||96
8151064|NCT02622724|20091439|P2|Short-Term Follow-Up (Day 28)|Overall Study||115
8151065|NCT02622724|20091440|P1|Short-Term Follow-Up (Day 28)|Overall Study||105
8151066|NCT02622724|20091439|P2|Subjects Randomised|Overall Study||155
8151067|NCT02622724|20091440|P1|Subjects Randomised|Overall Study||146
8151068|NCT02622724|20091439|P2|STARTED|Overall Study||152
8151069|NCT02622724|20091440|P1|STARTED|Overall Study||144
8151070|NCT02622568|20091518|P2|NOT COMPLETED|Overall Study||5
8151071|NCT02622568|20091519|P1|NOT COMPLETED|Overall Study||5
8151072|NCT02622568|20091518|P2|COMPLETED|Overall Study||9
8151073|NCT02622568|20091519|P1|COMPLETED|Overall Study||9
8151074|NCT02622568|20091518|P2|STARTED|Overall Study||14
8151075|NCT02622568|20091519|P1|STARTED|Overall Study||14
8151092|NCT02622191|20091577|P2|NOT COMPLETED|Overall Study||0
8151093|NCT02622191|20091578|P1|NOT COMPLETED|Overall Study||0
8151094|NCT02622191|20091577|P2|COMPLETED|Overall Study||14
8151095|NCT02622191|20091578|P1|COMPLETED|Overall Study||19
8151096|NCT02622191|20091577|P2|STARTED|Overall Study||14
8151097|NCT02622191|20091578|P1|STARTED|Overall Study||19
8151098|NCT02622178|20091588|P3|NOT COMPLETED|Overall Study||0
8151099|NCT02622178|20091589|P2|NOT COMPLETED|Overall Study||0
8151100|NCT02622178|20091590|P1|NOT COMPLETED|Overall Study||0
8151101|NCT02622178|20091588|P3|COMPLETED|Overall Study||49
8151102|NCT02622178|20091589|P2|COMPLETED|Overall Study||45
8151103|NCT02622178|20091590|P1|COMPLETED|Overall Study||42
8151104|NCT02622178|20091588|P3|STARTED|Overall Study||49
8151105|NCT02622178|20091589|P2|STARTED|Overall Study||45
8151106|NCT02622178|20091590|P1|STARTED|Overall Study||42
8151107|NCT02622113|20091603|P2|NOT COMPLETED|Overall Study||10
8151108|NCT02622113|20091604|P1|NOT COMPLETED|Overall Study||5
8151109|NCT02622113|20091603|P2|COMPLETED|Overall Study||66
8151110|NCT02622113|20091604|P1|COMPLETED|Overall Study||62
8151111|NCT02622113|20091603|P2|STARTED|Overall Study||76
8151112|NCT02622113|20091604|P1|STARTED|Overall Study||67
8151113|NCT02622074|20091622|P6|NOT COMPLETED|Overall Study||0
8151114|NCT02622074|20091623|P5|NOT COMPLETED|Overall Study||1
8151115|NCT02622074|20091624|P4|NOT COMPLETED|Overall Study||1
8151116|NCT02622074|20091625|P3|NOT COMPLETED|Overall Study||0
8151117|NCT02622074|20091626|P2|NOT COMPLETED|Overall Study||1
8151118|NCT02622074|20091627|P1|NOT COMPLETED|Overall Study||4
8151119|NCT02622074|20091622|P6|COMPLETED|Overall Study||10
8151120|NCT02622074|20091623|P5|COMPLETED|Overall Study||9
8151121|NCT02622074|20091624|P4|COMPLETED|Overall Study||9
8151122|NCT02622074|20091625|P3|COMPLETED|Overall Study||10
8151123|NCT02622074|20091626|P2|COMPLETED|Overall Study||9
8151124|NCT02622074|20091627|P1|COMPLETED|Overall Study||6
8151125|NCT02622074|20091622|P6|STARTED|Overall Study||10
8151126|NCT02622074|20091623|P5|STARTED|Overall Study||10
8151127|NCT02622074|20091624|P4|STARTED|Overall Study||10
8151128|NCT02622074|20091625|P3|STARTED|Overall Study||10
8151129|NCT02622074|20091626|P2|STARTED|Overall Study||10
8151130|NCT02622074|20091627|P1|STARTED|Overall Study||10
8151131|NCT02621983|20091715|P2|NOT COMPLETED|Overall Study||11
8151132|NCT02621983|20091716|P1|NOT COMPLETED|Overall Study||12
8151133|NCT02621983|20091715|P2|COMPLETED|Overall Study||6
8151134|NCT02621983|20091716|P1|COMPLETED|Overall Study||9
8151135|NCT02621983|20091715|P2|STARTED|Overall Study||17
8151136|NCT02621983|20091716|P1|STARTED|Overall Study||21
8151137|NCT02621931|20091731|P3|NOT COMPLETED|Overall Study||36
8151138|NCT02621931|20091732|P2|NOT COMPLETED|Overall Study||27
8151139|NCT02621931|20091733|P1|NOT COMPLETED|Overall Study||33
8151140|NCT02621931|20091731|P3|COMPLETED|Overall Study||343
8151141|NCT02621931|20091732|P2|COMPLETED|Overall Study||349
8151142|NCT02621931|20091733|P1|COMPLETED|Overall Study||342
8151143|NCT02621931|20091731|P3|Full Analysis Set|Overall Study||375
8151144|NCT02621931|20091732|P2|Full Analysis Set|Overall Study||375
8151145|NCT02621931|20091733|P1|Full Analysis Set|Overall Study||371
8151146|NCT02621931|20091731|P3|Safety and ITT Populations|Overall Study||379
8151147|NCT02621931|20091732|P2|Safety and ITT Populations|Overall Study||376
8151148|NCT02621931|20091733|P1|Safety and ITT Populations|Overall Study||375
8151149|NCT02621931|20091731|P3|STARTED|Overall Study||379
8151150|NCT02621931|20091732|P2|STARTED|Overall Study||376
8151151|NCT02621931|20091733|P1|STARTED|Overall Study||375
8151152|NCT02621892|20091784|P2|NOT COMPLETED|Randomized Withdrawal Period||12
8151153|NCT02621892|20091785|P1|NOT COMPLETED|Randomized Withdrawal Period||11
8151154|NCT02621892|20091784|P2|COMPLETED|Randomized Withdrawal Period||260
8151155|NCT02621892|20091785|P1|COMPLETED|Randomized Withdrawal Period||250
8151156|NCT02621892|20091784|P2|STARTED|Randomized Withdrawal Period||272
8151157|NCT02621892|20091785|P1|STARTED|Randomized Withdrawal Period||261
8151158|NCT02621892|20091784|P2|NOT COMPLETED|Treatment Period||27
8151159|NCT02621892|20091785|P1|NOT COMPLETED|Treatment Period||46
8151160|NCT02621892|20091784|P2|COMPLETED|Treatment Period||272
8151161|NCT02621892|20091785|P1|COMPLETED|Treatment Period||261
8151162|NCT02621892|20091784|P2|STARTED|Treatment Period||299
8151163|NCT02621892|20091785|P1|STARTED|Treatment Period||307
8151164|NCT02621619|20091803|P2|NOT COMPLETED|Overall Study||0
8151165|NCT02621619|20091804|P1|NOT COMPLETED|Overall Study||0
8151166|NCT02621619|20091803|P2|COMPLETED|Overall Study||79
8151167|NCT02621619|20091804|P1|COMPLETED|Overall Study||80
8151168|NCT02621619|20091803|P2|STARTED|Overall Study||79
8151169|NCT02621619|20091804|P1|STARTED|Overall Study||80
8151170|NCT02621606|20091815|P3|NOT COMPLETED|Overall Study||0
8151171|NCT02621606|20091816|P2|NOT COMPLETED|Overall Study||1
8151172|NCT02621606|20091817|P1|NOT COMPLETED|Overall Study||0
8151173|NCT02621606|20091815|P3|COMPLETED|Overall Study||10
8151174|NCT02621606|20091816|P2|COMPLETED|Overall Study||6
8151175|NCT02621606|20091817|P1|COMPLETED|Overall Study||3
8151176|NCT02621606|20091815|P3|Treated|Overall Study||10
8151177|NCT02621606|20091816|P2|Treated|Overall Study||7
8151178|NCT02621606|20091817|P1|Treated|Overall Study||3
8151179|NCT02621606|20091815|P3|STARTED|Overall Study||10
8151180|NCT02621606|20091816|P2|STARTED|Overall Study||7
8151181|NCT02621606|20091817|P1|STARTED|Overall Study||3
8151188|NCT02621073|20091854|P2|NOT COMPLETED|Overall Study||3
8151189|NCT02621073|20091855|P1|NOT COMPLETED|Overall Study||3
8151190|NCT02621073|20091854|P2|COMPLETED|Overall Study||0
8151191|NCT02621073|20091855|P1|COMPLETED|Overall Study||1
8151192|NCT02621073|20091854|P2|STARTED|Overall Study||3
8151193|NCT02621073|20091855|P1|STARTED|Overall Study||4
8151194|NCT02621060|20091865|P2|NOT COMPLETED|Overall Study||1
8151195|NCT02621060|20091866|P1|NOT COMPLETED|Overall Study||3
8151196|NCT02621060|20091865|P2|COMPLETED|Overall Study||14
8151197|NCT02621060|20091866|P1|COMPLETED|Overall Study||12
8151198|NCT02621060|20091865|P2|STARTED|Overall Study||15
8151199|NCT02621060|20091866|P1|STARTED|Overall Study||15
8151200|NCT02621047|20091917|P3|NOT COMPLETED|Overall Study||1
8151201|NCT02621047|20091918|P2|NOT COMPLETED|Overall Study||0
8151202|NCT02621047|20091919|P1|NOT COMPLETED|Overall Study||0
8151203|NCT02621047|20091917|P3|COMPLETED|Overall Study||11
8151204|NCT02621047|20091918|P2|COMPLETED|Overall Study||8
8151205|NCT02621047|20091919|P1|COMPLETED|Overall Study||8
8151206|NCT02621047|20091917|P3|STARTED|Overall Study||12
8151207|NCT02621047|20091918|P2|STARTED|Overall Study||8
8151208|NCT02621047|20091919|P1|STARTED|Overall Study||8
8151209|NCT02621034|20092035|P3|NOT COMPLETED|Overall Study||5
8151210|NCT02621034|20092036|P2|NOT COMPLETED|Overall Study||2
8151211|NCT02621034|20092037|P1|NOT COMPLETED|Overall Study||3
8151212|NCT02621034|20092035|P3|COMPLETED|Overall Study||50
8151213|NCT02621034|20092036|P2|COMPLETED|Overall Study||50
8151214|NCT02621034|20092037|P1|COMPLETED|Overall Study||50
8151215|NCT02621034|20092035|P3|STARTED|Overall Study||55
8151216|NCT02621034|20092036|P2|STARTED|Overall Study||52
8151217|NCT02621034|20092037|P1|STARTED|Overall Study||53
8151218|NCT02620917|20092050|P1|NOT COMPLETED|Overall Study||0
8151219|NCT02620917|20092050|P1|COMPLETED|Overall Study||6623
8151220|NCT02620917|20092050|P1|STARTED|Overall Study||6623
8151221|NCT02620878|20092059|P2|NOT COMPLETED|Overall Study||0
8151222|NCT02620878|20092060|P1|NOT COMPLETED|Overall Study||0
8151223|NCT02620878|20092059|P2|COMPLETED|Overall Study||16
8151224|NCT02620878|20092060|P1|COMPLETED|Overall Study||16
8151225|NCT02620878|20092059|P2|STARTED|Overall Study||16
8151226|NCT02620878|20092060|P1|STARTED|Overall Study||16
8151227|NCT02620787|20092071|P2|NOT COMPLETED|Overall Study||0
8151228|NCT02620787|20092072|P1|NOT COMPLETED|Overall Study||2
8151229|NCT02620787|20092071|P2|COMPLETED|Overall Study||6
8151230|NCT02620787|20092072|P1|COMPLETED|Overall Study||10
8151231|NCT02620787|20092071|P2|STARTED|Overall Study||6
8151232|NCT02620787|20092072|P1|STARTED|Overall Study||12
8151233|NCT02620774|20092084|P2|NOT COMPLETED|Overall Study||0
8151234|NCT02620774|20092085|P1|NOT COMPLETED|Overall Study||0
8151235|NCT02620774|20092084|P2|COMPLETED|Overall Study||6
8151236|NCT02620774|20092085|P1|COMPLETED|Overall Study||10
8151237|NCT02620774|20092084|P2|STARTED|Overall Study||6
8151238|NCT02620774|20092085|P1|STARTED|Overall Study||10
8151239|NCT02620683|20092103|P2|NOT COMPLETED|Second Intervention (Visit 2)||0
8151240|NCT02620683|20092104|P1|NOT COMPLETED|Second Intervention (Visit 2)||0
8151241|NCT02620683|20092103|P2|COMPLETED|Second Intervention (Visit 2)||11
8151242|NCT02620683|20092104|P1|COMPLETED|Second Intervention (Visit 2)||12
8151243|NCT02620683|20092103|P2|STARTED|Second Intervention (Visit 2)||11
8151244|NCT02620683|20092104|P1|STARTED|Second Intervention (Visit 2)||12
8151245|NCT02620683|20092103|P2|NOT COMPLETED|Washout (2 Weeks)||0
8151246|NCT02620683|20092104|P1|NOT COMPLETED|Washout (2 Weeks)||0
8151247|NCT02620683|20092103|P2|COMPLETED|Washout (2 Weeks)||11
8151248|NCT02620683|20092104|P1|COMPLETED|Washout (2 Weeks)||12
8151249|NCT02620683|20092103|P2|STARTED|Washout (2 Weeks)||11
8151250|NCT02620683|20092104|P1|STARTED|Washout (2 Weeks)||12
8151251|NCT02620683|20092103|P2|NOT COMPLETED|First Intervention (Visit 1)||0
8151252|NCT02620683|20092104|P1|NOT COMPLETED|First Intervention (Visit 1)||0
8151253|NCT02620683|20092103|P2|COMPLETED|First Intervention (Visit 1)||11
8151254|NCT02620683|20092104|P1|COMPLETED|First Intervention (Visit 1)||12
8151255|NCT02620683|20092103|P2|STARTED|First Intervention (Visit 1)||11
8151256|NCT02620683|20092104|P1|STARTED|First Intervention (Visit 1)||12
8151257|NCT02620384|20092114|P2|NOT COMPLETED|Overall Study||7
8151258|NCT02620384|20092115|P1|NOT COMPLETED|Overall Study||4
8151259|NCT02620384|20092114|P2|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
8151260|NCT02620384|20092115|P1|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
8151261|NCT02620384|20092114|P2|STARTED|Overall Study||73
8151262|NCT02620384|20092115|P1|STARTED|Overall Study||70
8151263|NCT02620020|20092147|P4|NOT COMPLETED|Overall Study||26
8151264|NCT02620020|20092148|P3|NOT COMPLETED|Overall Study||25
8151265|NCT02620020|20092149|P2|NOT COMPLETED|Overall Study||35
8151266|NCT02620020|20092150|P1|NOT COMPLETED|Overall Study||44
8151267|NCT02620020|20092147|P4|COMPLETED|Overall Study||115
8151268|NCT02620020|20092148|P3|COMPLETED|Overall Study||115
8151269|NCT02620020|20092149|P2|COMPLETED|Overall Study||106
8151270|NCT02620020|20092150|P1|COMPLETED|Overall Study||97
8151271|NCT02620020|20092147|P4|Modified Intent to Treat Set (mITT)|Overall Study||140
8151272|NCT02620020|20092148|P3|Modified Intent to Treat Set (mITT)|Overall Study||139
8151273|NCT02620020|20092149|P2|Modified Intent to Treat Set (mITT)|Overall Study||139
8151274|NCT02620020|20092150|P1|Modified Intent to Treat Set (mITT)|Overall Study||140
8151275|NCT02620020|20092147|P4|STARTED|Overall Study||141
8151276|NCT02620020|20092148|P3|STARTED|Overall Study||140
8151277|NCT02620020|20092149|P2|STARTED|Overall Study||141
8151278|NCT02620020|20092150|P1|STARTED|Overall Study||141
8151279|NCT02619812|20092176|P4|NOT COMPLETED|Overall Study||2
8151280|NCT02619812|20092177|P3|NOT COMPLETED|Overall Study||1
8151281|NCT02619812|20092178|P2|NOT COMPLETED|Overall Study||0
8151282|NCT02619812|20092179|P1|NOT COMPLETED|Overall Study||0
8151283|NCT02619812|20092176|P4|COMPLETED|Overall Study||0
8151284|NCT02619812|20092177|P3|COMPLETED|Overall Study||0
8151285|NCT02619812|20092178|P2|COMPLETED|Overall Study||0
8151286|NCT02619812|20092179|P1|COMPLETED|Overall Study||0
8151287|NCT02619812|20092176|P4|STARTED|Overall Study||2
8151288|NCT02619812|20092177|P3|STARTED|Overall Study||1
8151289|NCT02619812|20092178|P2|STARTED|Overall Study||0
8151290|NCT02619812|20092179|P1|STARTED|Overall Study||0
8151291|NCT02619799|20092195|P2|NOT COMPLETED|Overall Study||0
8151292|NCT02619799|20092196|P1|NOT COMPLETED|Overall Study||0
8151293|NCT02619799|20092195|P2|COMPLETED|Overall Study||25
8151294|NCT02619799|20092196|P1|COMPLETED|Overall Study||25
8151295|NCT02619799|20092195|P2|STARTED|Overall Study||25
8151296|NCT02619799|20092196|P1|STARTED|Overall Study||25
8151297|NCT02619617|20092212|P2|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4
8151298|NCT02619617|20092213|P1|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0
8151299|NCT02619617|20092212|P2|COMPLETED|Period 2 SOM230 - 2nd Attack||24
8151300|NCT02619617|20092213|P1|COMPLETED|Period 2 SOM230 - 2nd Attack||0
8151301|NCT02619617|20092212|P2|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28
8151302|NCT02619617|20092213|P1|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0
8151303|NCT02619617|20092212|P2|STARTED|Period 2 SOM230 - 2nd Attack||28
8151304|NCT02619617|20092213|P1|STARTED|Period 2 SOM230 - 2nd Attack||0
8151305|NCT02619617|20092212|P2|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
8151306|NCT02619617|20092213|P1|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
8151307|NCT02619617|20092212|P2|COMPLETED|Period 1 Placebo - 1st AttacK||0
8151308|NCT02619617|20092213|P1|COMPLETED|Period 1 Placebo - 1st AttacK||28
8151309|NCT02619617|20092212|P2|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0
8151310|NCT02619617|20092213|P1|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28
8151311|NCT02619617|20092212|P2|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0
8151312|NCT02619617|20092213|P1|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20
8151313|NCT02619617|20092212|P2|STARTED|Period 1 Placebo - 1st AttacK||0
8151314|NCT02619617|20092213|P1|STARTED|Period 1 Placebo - 1st AttacK||28
8151315|NCT02619591|20092225|P2|NOT COMPLETED|Overall Study||121
8151316|NCT02619591|20092226|P1|NOT COMPLETED|Overall Study||139
8151317|NCT02619591|20092225|P2|COMPLETED|Overall Study||0
8151318|NCT02619591|20092226|P1|COMPLETED|Overall Study||0
8151319|NCT02619591|20092225|P2|STARTED|Overall Study||121
8151320|NCT02619591|20092226|P1|STARTED|Overall Study||139
8151321|NCT02619409|20092237|P5|NOT COMPLETED|Overall Study||0
8151322|NCT02619409|20092238|P4|NOT COMPLETED|Overall Study||0
8151323|NCT02619409|20092239|P3|NOT COMPLETED|Overall Study||0
8151324|NCT02619409|20092240|P2|NOT COMPLETED|Overall Study||0
8151325|NCT02619409|20092241|P1|NOT COMPLETED|Overall Study||0
8151326|NCT02619409|20092237|P5|COMPLETED|Overall Study||6
8151327|NCT02619409|20092238|P4|COMPLETED|Overall Study||6
8151328|NCT02619409|20092239|P3|COMPLETED|Overall Study||6
8151329|NCT02619409|20092240|P2|COMPLETED|Overall Study||6
8151330|NCT02619409|20092241|P1|COMPLETED|Overall Study||6
8151331|NCT02619409|20092237|P5|STARTED|Overall Study||6
8151332|NCT02619409|20092238|P4|STARTED|Overall Study||6
8151333|NCT02619409|20092239|P3|STARTED|Overall Study||6
8151334|NCT02619409|20092240|P2|STARTED|Overall Study||6
8151335|NCT02619409|20092241|P1|STARTED|Overall Study||6
8151336|NCT02619396|20092262|P4|NOT COMPLETED|Overall Study||0
8151337|NCT02619396|20092263|P3|NOT COMPLETED|Overall Study||0
8151338|NCT02619396|20092264|P2|NOT COMPLETED|Overall Study||0
8151339|NCT02619396|20092265|P1|NOT COMPLETED|Overall Study||0
8151340|NCT02619396|20092262|P4|COMPLETED|Overall Study||20
8151341|NCT02619396|20092263|P3|COMPLETED|Overall Study||20
8151342|NCT02619396|20092264|P2|COMPLETED|Overall Study||20
8151343|NCT02619396|20092265|P1|COMPLETED|Overall Study||20
8151344|NCT02619396|20092262|P4|STARTED|Overall Study||20
8151345|NCT02619396|20092263|P3|STARTED|Overall Study||20
8151346|NCT02619396|20092264|P2|STARTED|Overall Study||20
8151347|NCT02619396|20092265|P1|STARTED|Overall Study||20
8151348|NCT02619175|20092309|P2|NOT COMPLETED|Overall Study||0
8151349|NCT02619175|20092310|P1|NOT COMPLETED|Overall Study||2
8151350|NCT02619175|20092309|P2|COMPLETED|Overall Study||16
8151351|NCT02619175|20092310|P1|COMPLETED|Overall Study||16
8151352|NCT02619175|20092309|P2|STARTED|Overall Study||16
8151353|NCT02619175|20092310|P1|STARTED|Overall Study||18
8151354|NCT02618928|20092324|P1|NOT COMPLETED|Overall Study||58
8151355|NCT02618928|20092324|P1|COMPLETED|Overall Study||677
8151356|NCT02618928|20092324|P1|Received Treatment|Overall Study||728
8151357|NCT02618928|20092324|P1|STARTED|Overall Study||735
8151358|NCT02618915|20092357|P2|NOT COMPLETED|Overall Study||0
8151359|NCT02618915|20092358|P1|NOT COMPLETED|Overall Study||0
8151360|NCT02618915|20092357|P2|COMPLETED|Overall Study||3
8151361|NCT02618915|20092358|P1|COMPLETED|Overall Study||3
8151362|NCT02618915|20092357|P2|STARTED|Overall Study||3
8151363|NCT02618915|20092358|P1|STARTED|Overall Study||3
8151364|NCT02618772|20092384|P2|NOT COMPLETED|Overall Study||0
8151365|NCT02618772|20092385|P1|NOT COMPLETED|Overall Study||1
8151366|NCT02618772|20092384|P2|COMPLETED|Overall Study||40
8151367|NCT02618772|20092385|P1|COMPLETED|Overall Study||38
8151368|NCT02618772|20092384|P2|Withdrawal by Subject|Overall Study||0
8151369|NCT02618772|20092385|P1|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
8151370|NCT02618772|20092384|P2|STARTED|Overall Study||40
8151371|NCT02618772|20092385|P1|STARTED|Overall Study||39
8151372|NCT02618759|20092419|P2|NOT COMPLETED|Overall Study||5
8151373|NCT02618759|20092420|P1|NOT COMPLETED|Overall Study||2
8151374|NCT02618759|20092419|P2|COMPLETED|Overall Study||54
8151375|NCT02618759|20092420|P1|COMPLETED|Overall Study||58
8151376|NCT02618759|20092419|P2|STARTED|Overall Study||59
8151377|NCT02618759|20092420|P1|STARTED|Overall Study||60
8151378|NCT02618642|20092440|P4|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
8151379|NCT02618642|20092441|P3|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
8151380|NCT02618642|20092442|P2|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
8151381|NCT02618642|20092443|P1|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
8151382|NCT02618642|20092440|P4|COMPLETED|After 10 PILER Irradiation Treatments||15
8151383|NCT02618642|20092441|P3|COMPLETED|After 10 PILER Irradiation Treatments||15
8151384|NCT02618642|20092442|P2|COMPLETED|After 10 PILER Irradiation Treatments||15
8151385|NCT02618642|20092443|P1|COMPLETED|After 10 PILER Irradiation Treatments||15
8151386|NCT02618642|20092440|P4|STARTED|After 10 PILER Irradiation Treatments||15
8151387|NCT02618642|20092441|P3|STARTED|After 10 PILER Irradiation Treatments||15
8151388|NCT02618642|20092442|P2|STARTED|After 10 PILER Irradiation Treatments||15
8151389|NCT02618642|20092443|P1|STARTED|After 10 PILER Irradiation Treatments||15
8151390|NCT02618642|20092440|P4|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
8151391|NCT02618642|20092441|P3|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
8151392|NCT02618642|20092442|P2|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
8151393|NCT02618642|20092443|P1|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
8151394|NCT02618642|20092440|P4|COMPLETED|Before 10 PILER Irradiation Treatments||15
8151395|NCT02618642|20092441|P3|COMPLETED|Before 10 PILER Irradiation Treatments||15
8151396|NCT02618642|20092442|P2|COMPLETED|Before 10 PILER Irradiation Treatments||15
8151397|NCT02618642|20092443|P1|COMPLETED|Before 10 PILER Irradiation Treatments||15
8151398|NCT02618642|20092440|P4|STARTED|Before 10 PILER Irradiation Treatments||15
8151399|NCT02618642|20092441|P3|STARTED|Before 10 PILER Irradiation Treatments||15
8151400|NCT02618642|20092442|P2|STARTED|Before 10 PILER Irradiation Treatments||15
8151401|NCT02618642|20092443|P1|STARTED|Before 10 PILER Irradiation Treatments||15
8151402|NCT02618512|20092469|P1|NOT COMPLETED|Overall Study||0
8151403|NCT02618512|20092469|P1|COMPLETED|Overall Study||3
8151404|NCT02618512|20092469|P1|STARTED|Overall Study||3
8151405|NCT02618187|20092477|P4|NOT COMPLETED|Overall Study||5
8151406|NCT02618187|20092478|P3|NOT COMPLETED|Overall Study||4
8151407|NCT02618187|20092479|P2|NOT COMPLETED|Overall Study||2
8151408|NCT02618187|20092480|P1|NOT COMPLETED|Overall Study||2
8151409|NCT02618187|20092477|P4|COMPLETED|Overall Study||12
8151410|NCT02618187|20092478|P3|COMPLETED|Overall Study||11
8151411|NCT02618187|20092479|P2|COMPLETED|Overall Study||9
8151412|NCT02618187|20092480|P1|COMPLETED|Overall Study||13
8151413|NCT02618187|20092477|P4|Completed|Overall Study||13
8151414|NCT02618187|20092478|P3|Completed|Overall Study||13
8151415|NCT02618187|20092479|P2|Completed|Overall Study||10
8151416|NCT02618187|20092480|P1|Completed|Overall Study||13
8151417|NCT02618187|20092477|P4|STARTED|Overall Study||17
8151418|NCT02618187|20092478|P3|STARTED|Overall Study||15
8151419|NCT02618187|20092479|P2|STARTED|Overall Study||11
8151420|NCT02618187|20092480|P1|STARTED|Overall Study||15
8151421|NCT02618031|20092508|P2|NOT COMPLETED|Overall Study||0
8151422|NCT02618031|20092509|P1|NOT COMPLETED|Overall Study||1
8151423|NCT02618031|20092508|P2|COMPLETED|Overall Study||11
8151424|NCT02618031|20092509|P1|COMPLETED|Overall Study||45
8151425|NCT02618031|20092508|P2|STARTED|Overall Study||11
8151426|NCT02618031|20092509|P1|STARTED|Overall Study||46
8151427|NCT02617901|20092521|P1|NOT COMPLETED|Overall Study||0
8151428|NCT02617901|20092521|P1|COMPLETED|Overall Study||20
8151429|NCT02617901|20092521|P1|STARTED|Overall Study||20
8151430|NCT02617888|20092528|P3|NOT COMPLETED|Overall Study||0
8151431|NCT02617888|20092529|P2|NOT COMPLETED|Overall Study||7
8151432|NCT02617888|20092530|P1|NOT COMPLETED|Overall Study||1
8151433|NCT02617888|20092528|P3|COMPLETED|Overall Study||127
8151434|NCT02617888|20092529|P2|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
8151435|NCT02617888|20092530|P1|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
8151436|NCT02617888|20092528|P3|STARTED|Overall Study||127
8151437|NCT02617888|20092529|P2|STARTED|Overall Study||51
8151438|NCT02617888|20092530|P1|STARTED|Overall Study||50
8151439|NCT02617784|20092539|P2|NOT COMPLETED|Overall Study||0
8151440|NCT02617784|20092540|P1|NOT COMPLETED|Overall Study||0
8151441|NCT02617784|20092539|P2|COMPLETED|Overall Study||12
8151442|NCT02617784|20092540|P1|COMPLETED|Overall Study||12
8151443|NCT02617784|20092539|P2|Second Dose Assessment Period|Overall Study||12
8151444|NCT02617784|20092540|P1|Second Dose Assessment Period|Overall Study||11
8151445|NCT02617784|20092539|P2|First Dose Assessment Period|Overall Study||12
8151446|NCT02617784|20092540|P1|First Dose Assessment Period|Overall Study||12
8151447|NCT02617784|20092539|P2|STARTED|Overall Study||12
8151448|NCT02617784|20092540|P1|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
8151449|NCT02617667|20092591|P4|NOT COMPLETED|Overall Study||1
8151450|NCT02617667|20092592|P3|NOT COMPLETED|Overall Study||4
8151451|NCT02617667|20092593|P2|NOT COMPLETED|Overall Study||1
8151452|NCT02617667|20092594|P1|NOT COMPLETED|Overall Study||1
8151453|NCT02617667|20092591|P4|COMPLETED|Overall Study||52
8151454|NCT02617667|20092592|P3|COMPLETED|Overall Study||48
8151455|NCT02617667|20092593|P2|COMPLETED|Overall Study||50
8151456|NCT02617667|20092594|P1|COMPLETED|Overall Study||50
8151457|NCT02617667|20092591|P4|STARTED|Overall Study||53
8151458|NCT02617667|20092592|P3|STARTED|Overall Study||52
8151459|NCT02617667|20092593|P2|STARTED|Overall Study||51
8151460|NCT02617667|20092594|P1|STARTED|Overall Study||51
8151461|NCT02616900|20092606|P1|NOT COMPLETED|Overall Study||23
8151462|NCT02616900|20092606|P1|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51
8151463|NCT02616900|20092606|P1|Completed 3mo Trial|Overall Study||57
8151464|NCT02616900|20092606|P1|STARTED|Overall Study||74
8151465|NCT02616783|20092614|P2|NOT COMPLETED|Overall Study||2
8151466|NCT02616783|20092615|P1|NOT COMPLETED|Overall Study||6
8151467|NCT02616783|20092614|P2|COMPLETED|Overall Study||54
8151468|NCT02616783|20092615|P1|COMPLETED|Overall Study||105
8151469|NCT02616783|20092614|P2|STARTED|Overall Study||56
8151470|NCT02616783|20092615|P1|STARTED|Overall Study||111
8151471|NCT02616614|20092638|P3|NOT COMPLETED|Overall Study||29
8151472|NCT02616614|20092639|P2|NOT COMPLETED|Overall Study||60
8151473|NCT02616614|20092640|P1|NOT COMPLETED|Overall Study||65
8151474|NCT02616614|20092638|P3|COMPLETED|Overall Study||141
8151475|NCT02616614|20092639|P2|COMPLETED|Overall Study||285
8151476|NCT02616614|20092640|P1|COMPLETED|Overall Study||282
8151477|NCT02616614|20092638|P3|PP Population|Overall Study||122
8151478|NCT02616614|20092639|P2|PP Population|Overall Study||255
8151479|NCT02616614|20092640|P1|PP Population|Overall Study||253
8151480|NCT02616614|20092638|P3|mITT Population|Overall Study||160
8151481|NCT02616614|20092639|P2|mITT Population|Overall Study||325
8151482|NCT02616614|20092640|P1|mITT Population|Overall Study||325
8151483|NCT02616614|20092638|P3|Safety Population|Overall Study||161
8151484|NCT02616614|20092639|P2|Safety Population|Overall Study||328
8151485|NCT02616614|20092640|P1|Safety Population|Overall Study||329
8151486|NCT02616614|20092638|P3|STARTED|Overall Study||170
8151487|NCT02616614|20092639|P2|STARTED|Overall Study||345
8151488|NCT02616614|20092640|P1|STARTED|Overall Study||347
8151489|NCT02616601|20092657|P3|NOT COMPLETED|Overall Study||7
8151490|NCT02616601|20092658|P2|NOT COMPLETED|Overall Study||4
8151491|NCT02616601|20092659|P1|NOT COMPLETED|Overall Study||9
8151492|NCT02616601|20092657|P3|COMPLETED|Overall Study||135
8151493|NCT02616601|20092658|P2|COMPLETED|Overall Study||136
8151494|NCT02616601|20092659|P1|COMPLETED|Overall Study||131
8151495|NCT02616601|20092657|P3|PP Population|Overall Study||123
8151496|NCT02616601|20092658|P2|PP Population|Overall Study||121
8151497|NCT02616601|20092659|P1|PP Population|Overall Study||112
8151498|NCT02616601|20092657|P3|mITT Population|Overall Study||138
8151499|NCT02616601|20092658|P2|mITT Population|Overall Study||136
8151500|NCT02616601|20092659|P1|mITT Population|Overall Study||137
8151501|NCT02616601|20092657|P3|Safety Population|Overall Study||142
8151502|NCT02616601|20092658|P2|Safety Population|Overall Study||140
8151503|NCT02616601|20092659|P1|Safety Population|Overall Study||140
8151504|NCT02616601|20092657|P3|STARTED|Overall Study||142
8151505|NCT02616601|20092658|P2|STARTED|Overall Study||140
8151506|NCT02616601|20092659|P1|STARTED|Overall Study||140
8151507|NCT02616523|20092670|P3|NOT COMPLETED|Overall Study||0
8151508|NCT02616523|20092671|P2|NOT COMPLETED|Overall Study||0
8151509|NCT02616523|20092672|P1|NOT COMPLETED|Overall Study||1
8151510|NCT02616523|20092670|P3|COMPLETED|Overall Study|April 2015|20
8151511|NCT02616523|20092671|P2|COMPLETED|Overall Study|April 2015|20
8151512|NCT02616523|20092672|P1|COMPLETED|Overall Study|April 2015|19
8151513|NCT02616523|20092670|P3|STARTED|Overall Study|June 2014|20
8151514|NCT02616523|20092671|P2|STARTED|Overall Study|June 2014|20
8151515|NCT02616523|20092672|P1|STARTED|Overall Study|June 2014|20
8151516|NCT02616380|20092686|P1|NOT COMPLETED|Overall Study||3
8151517|NCT02616380|20092686|P1|COMPLETED|Overall Study||97
8151518|NCT02616380|20092686|P1|STARTED|Overall Study||100
8151531|NCT02616029|20092727|P2|NOT COMPLETED|Overall Study||2
8151532|NCT02616029|20092728|P1|NOT COMPLETED|Overall Study||4
8151533|NCT02616029|20092727|P2|COMPLETED|Overall Study||26
8151534|NCT02616029|20092728|P1|COMPLETED|Overall Study||34
8151535|NCT02616029|20092727|P2|STARTED|Overall Study||28
8151536|NCT02616029|20092728|P1|STARTED|Overall Study||38
8151537|NCT02615990|20092799|P2|NOT COMPLETED|Overall Study||1
8151538|NCT02615990|20092800|P1|NOT COMPLETED|Overall Study||1
8151539|NCT02615990|20092799|P2|COMPLETED|Overall Study||0
8151540|NCT02615990|20092800|P1|COMPLETED|Overall Study||0
8151541|NCT02615990|20092799|P2|STARTED|Overall Study||1
8151542|NCT02615990|20092800|P1|STARTED|Overall Study||1
8151543|NCT02615743|20092846|P2|NOT COMPLETED|Overall Study||3
8151544|NCT02615743|20092847|P1|NOT COMPLETED|Overall Study||6
8151545|NCT02615743|20092846|P2|COMPLETED|Overall Study||17
8151546|NCT02615743|20092847|P1|COMPLETED|Overall Study||15
8151547|NCT02615743|20092846|P2|STARTED|Overall Study||20
8151548|NCT02615743|20092847|P1|STARTED|Overall Study||21
8151549|NCT02615717|20092861|P2|NOT COMPLETED|Overall Study||0
8151550|NCT02615717|20092862|P1|NOT COMPLETED|Overall Study||0
8151551|NCT02615717|20092861|P2|COMPLETED|Overall Study||3
8151552|NCT02615717|20092862|P1|COMPLETED|Overall Study||3
8151553|NCT02615717|20092861|P2|STARTED|Overall Study||3
8151554|NCT02615717|20092862|P1|STARTED|Overall Study||3
8151555|NCT02615535|20092876|P2|NOT COMPLETED|Overall Study||1
8151556|NCT02615535|20092877|P1|NOT COMPLETED|Overall Study||4
8151557|NCT02615535|20092876|P2|COMPLETED|Overall Study||10
8151558|NCT02615535|20092877|P1|COMPLETED|Overall Study||10
8151559|NCT02615535|20092876|P2|STARTED|Overall Study||11
8151560|NCT02615535|20092877|P1|STARTED|Overall Study||14
8151561|NCT02615509|20092897|P1|NOT COMPLETED|Overall Study||146
8151562|NCT02615509|20092897|P1|COMPLETED|Overall Study||201
8151563|NCT02615509|20092897|P1|STARTED|Overall Study||347
8151564|NCT02615470|20092907|P2|NOT COMPLETED|Overall Study||32
8151565|NCT02615470|20092908|P1|NOT COMPLETED|Overall Study||21
8151566|NCT02615470|20092907|P2|COMPLETED|Overall Study||30
8151567|NCT02615470|20092908|P1|COMPLETED|Overall Study||37
8151568|NCT02615470|20092907|P2|Completed the Baseline Surveys|Overall Study||47
8151569|NCT02615470|20092908|P1|Completed the Baseline Surveys|Overall Study||46
8151570|NCT02615470|20092907|P2|STARTED|Overall Study||62
8151571|NCT02615470|20092908|P1|STARTED|Overall Study||58
8151572|NCT02615249|20092918|P1|NOT COMPLETED|Overall Study||1
8151573|NCT02615249|20092918|P1|COMPLETED|Overall Study||121
8151574|NCT02615249|20092918|P1|STARTED|Overall Study||122
8151575|NCT02615158|20092928|P3|NOT COMPLETED|Overall Study||16
8151576|NCT02615158|20092929|P2|NOT COMPLETED|Overall Study||16
8151577|NCT02615158|20092930|P1|NOT COMPLETED|Overall Study||21
8151578|NCT02615158|20092928|P3|COMPLETED|Overall Study||75
8151579|NCT02615158|20092929|P2|COMPLETED|Overall Study||76
8151580|NCT02615158|20092930|P1|COMPLETED|Overall Study||73
8151581|NCT02615158|20092928|P3|STARTED|Overall Study||91
8151582|NCT02615158|20092929|P2|STARTED|Overall Study||92
8151583|NCT02615158|20092930|P1|STARTED|Overall Study||94
8151584|NCT02615145|20092959|P4|NOT COMPLETED|Overall Study||1
8151585|NCT02615145|20092960|P3|NOT COMPLETED|Overall Study||8
8151586|NCT02615145|20092961|P2|NOT COMPLETED|Overall Study||15
8151587|NCT02615145|20092962|P1|NOT COMPLETED|Overall Study||27
8151588|NCT02615145|20092959|P4|COMPLETED|Overall Study||0
8151589|NCT02615145|20092960|P3|COMPLETED|Overall Study||40
8151590|NCT02615145|20092961|P2|COMPLETED|Overall Study||263
8151591|NCT02615145|20092962|P1|COMPLETED|Overall Study||118
8151592|NCT02615145|20092959|P4|3DAA + RBV|Overall Study||0
8151593|NCT02615145|20092960|P3|3DAA + RBV|Overall Study||2
8151594|NCT02615145|20092961|P2|3DAA + RBV|Overall Study||17
8151595|NCT02615145|20092962|P1|3DAA + RBV|Overall Study||140
8151596|NCT02615145|20092959|P4|3DAA|Overall Study||0
8151597|NCT02615145|20092960|P3|3DAA|Overall Study||0
8151598|NCT02615145|20092961|P2|3DAA|Overall Study||261
8151599|NCT02615145|20092962|P1|3DAA|Overall Study||5
8151600|NCT02615145|20092959|P4|2 DAA + Ribavirin (RBV)|Overall Study||0
8151601|NCT02615145|20092960|P3|2 DAA + Ribavirin (RBV)|Overall Study||45
8151602|NCT02615145|20092961|P2|2 DAA + Ribavirin (RBV)|Overall Study||0
8151603|NCT02615145|20092962|P1|2 DAA + Ribavirin (RBV)|Overall Study||0
8151604|NCT02615145|20092959|P4|STARTED|Overall Study||1
8151605|NCT02615145|20092960|P3|STARTED|Overall Study||48
8151606|NCT02615145|20092961|P2|STARTED|Overall Study||278
8151607|NCT02615145|20092962|P1|STARTED|Overall Study||145
8151608|NCT02614924|20093038|P2|NOT COMPLETED|Overall Study||0
8151609|NCT02614924|20093039|P1|NOT COMPLETED|Overall Study||0
8151610|NCT02614924|20093038|P2|COMPLETED|Overall Study||20
8151611|NCT02614924|20093039|P1|COMPLETED|Overall Study||20
8151612|NCT02614924|20093038|P2|STARTED|Overall Study||20
8151613|NCT02614924|20093039|P1|STARTED|Overall Study||20
8151614|NCT02614898|20093049|P2|NOT COMPLETED|Overall Study||51
8151615|NCT02614898|20093050|P1|NOT COMPLETED|Overall Study||15
8151616|NCT02614898|20093049|P2|COMPLETED|Overall Study||1
8151617|NCT02614898|20093050|P1|COMPLETED|Overall Study||0
8151618|NCT02614898|20093049|P2|Safety Population|Overall Study||52
8151619|NCT02614898|20093050|P1|Safety Population|Overall Study||15
8151620|NCT02614898|20093049|P2|STARTED|Overall Study||52
8151621|NCT02614898|20093050|P1|STARTED|Overall Study||15
8151622|NCT02614794|20093062|P2|NOT COMPLETED|Overall Study||202
8151623|NCT02614794|20093063|P1|NOT COMPLETED|Overall Study||410
8151624|NCT02614794|20093062|P2|COMPLETED|Overall Study||0
8151625|NCT02614794|20093063|P1|COMPLETED|Overall Study||0
8151626|NCT02614794|20093062|P2|STARTED|Overall Study||202
8151627|NCT02614794|20093063|P1|STARTED|Overall Study||410
8151628|NCT02614729|20093097|P2|NOT COMPLETED|Overall Study||0
8151629|NCT02614729|20093098|P1|NOT COMPLETED|Overall Study||1
8151630|NCT02614729|20093097|P2|COMPLETED|Overall Study||17
8151631|NCT02614729|20093098|P1|COMPLETED|Overall Study||17
8151632|NCT02614729|20093097|P2|STARTED|Overall Study||17
8151633|NCT02614729|20093098|P1|STARTED|Overall Study||18
8151640|NCT02614690|20093128|P3|NOT COMPLETED|Overall Study||0
8151641|NCT02614690|20093129|P2|NOT COMPLETED|Overall Study||0
8151642|NCT02614690|20093130|P1|NOT COMPLETED|Overall Study||0
8151643|NCT02614690|20093128|P3|COMPLETED|Overall Study||20
8151644|NCT02614690|20093129|P2|COMPLETED|Overall Study||20
8151645|NCT02614690|20093130|P1|COMPLETED|Overall Study||20
8151646|NCT02614690|20093128|P3|STARTED|Overall Study||20
8151647|NCT02614690|20093129|P2|STARTED|Overall Study||20
8151648|NCT02614690|20093130|P1|STARTED|Overall Study||20
8151649|NCT02614586|20093156|P1|NOT COMPLETED|Overall Study||0
8151650|NCT02614586|20093156|P1|COMPLETED|Overall Study||11
8151651|NCT02614586|20093156|P1|STARTED|Overall Study||11
8151652|NCT02614560|20093163|P2|NOT COMPLETED|Overall Study||2
8151653|NCT02614560|20093164|P1|NOT COMPLETED|Overall Study||6
8151654|NCT02614560|20093163|P2|COMPLETED|Overall Study||6
8151655|NCT02614560|20093164|P1|COMPLETED|Overall Study||0
8151656|NCT02614560|20093163|P2|STARTED|Overall Study||8
8151657|NCT02614560|20093164|P1|STARTED|Overall Study||6
8151658|NCT02614469|20093181|P2|NOT COMPLETED|Period 2||0
8151659|NCT02614469|20093182|P1|NOT COMPLETED|Period 2||0
8151660|NCT02614469|20093181|P2|COMPLETED|Period 2||9
8151661|NCT02614469|20093182|P1|COMPLETED|Period 2||9
8151662|NCT02614469|20093181|P2|STARTED|Period 2||9
8151663|NCT02614469|20093182|P1|STARTED|Period 2||9
8151664|NCT02614469|20093181|P2|NOT COMPLETED|Period 1||0
8151665|NCT02614469|20093182|P1|NOT COMPLETED|Period 1||0
8151666|NCT02614469|20093181|P2|COMPLETED|Period 1||9
8151667|NCT02614469|20093182|P1|COMPLETED|Period 1||9
8151668|NCT02614469|20093181|P2|STARTED|Period 1||9
8151669|NCT02614469|20093182|P1|STARTED|Period 1||9
8151670|NCT02614287|20093212|P2|NOT COMPLETED|Post Treatment Follow-up Phase||5
8151671|NCT02614287|20093213|P1|NOT COMPLETED|Post Treatment Follow-up Phase||9
8151672|NCT02614287|20093212|P2|COMPLETED|Post Treatment Follow-up Phase||119
8151673|NCT02614287|20093213|P1|COMPLETED|Post Treatment Follow-up Phase||103
8151674|NCT02614287|20093212|P2|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124
8151675|NCT02614287|20093213|P1|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112
8151676|NCT02614287|20093212|P2|NOT COMPLETED|Open Label (OL) Treatment Phase||22
8151677|NCT02614287|20093213|P1|NOT COMPLETED|Open Label (OL) Treatment Phase||38
8151678|NCT02614287|20093212|P2|COMPLETED|Open Label (OL) Treatment Phase||113
8151679|NCT02614287|20093213|P1|COMPLETED|Open Label (OL) Treatment Phase||97
8151680|NCT02614287|20093212|P2|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
8151681|NCT02614287|20093213|P1|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
8151682|NCT02614287|20093212|P2|STARTED|Open Label (OL) Treatment Phase||135
8151683|NCT02614287|20093213|P1|STARTED|Open Label (OL) Treatment Phase||135
8151684|NCT02614274|20093247|P1|NOT COMPLETED|Overall Study||4
8151685|NCT02614274|20093247|P1|COMPLETED|Overall Study||5
8151686|NCT02614274|20093247|P1|STARTED|Overall Study||9
8151699|NCT02614222|20093300|P2|NOT COMPLETED|Overall Study||0
8151700|NCT02614222|20093301|P1|NOT COMPLETED|Overall Study||0
8151701|NCT02614222|20093300|P2|COMPLETED|Overall Study||14
8151702|NCT02614222|20093301|P1|COMPLETED|Overall Study||13
8151703|NCT02614222|20093300|P2|STARTED|Overall Study||14
8151704|NCT02614222|20093301|P1|STARTED|Overall Study||13
8151705|NCT02614196|20093327|P6|NOT COMPLETED|Post Treatment Follow-up Phase||0
8151706|NCT02614196|20093328|P5|NOT COMPLETED|Post Treatment Follow-up Phase||2
8151707|NCT02614196|20093329|P4|NOT COMPLETED|Post Treatment Follow-up Phase||1
8151708|NCT02614196|20093330|P3|NOT COMPLETED|Post Treatment Follow-up Phase||8
8151709|NCT02614196|20093331|P2|NOT COMPLETED|Post Treatment Follow-up Phase||5
8151710|NCT02614196|20093332|P1|NOT COMPLETED|Post Treatment Follow-up Phase||20
8151711|NCT02614196|20093327|P6|COMPLETED|Post Treatment Follow-up Phase||19
8151712|NCT02614196|20093328|P5|COMPLETED|Post Treatment Follow-up Phase||13
8151713|NCT02614196|20093329|P4|COMPLETED|Post Treatment Follow-up Phase||24
8151714|NCT02614196|20093330|P3|COMPLETED|Post Treatment Follow-up Phase||199
8151715|NCT02614196|20093331|P2|COMPLETED|Post Treatment Follow-up Phase||208
8151716|NCT02614196|20093332|P1|COMPLETED|Post Treatment Follow-up Phase||390
8151717|NCT02614196|20093327|P6|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19
8151718|NCT02614196|20093328|P5|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15
8151719|NCT02614196|20093329|P4|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25
8151720|NCT02614196|20093330|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207
8151721|NCT02614196|20093331|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213
8151722|NCT02614196|20093332|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410
8151723|NCT02614196|20093327|P6|NOT COMPLETED|Double Blind Treatment Phase||0
8151724|NCT02614196|20093328|P5|NOT COMPLETED|Double Blind Treatment Phase||1
8151725|NCT02614196|20093329|P4|NOT COMPLETED|Double Blind Treatment Phase||4
8151726|NCT02614196|20093330|P3|NOT COMPLETED|Double Blind Treatment Phase||31
8151727|NCT02614196|20093331|P2|NOT COMPLETED|Double Blind Treatment Phase||30
8151728|NCT02614196|20093332|P1|NOT COMPLETED|Double Blind Treatment Phase||76
8151729|NCT02614196|20093327|P6|COMPLETED|Double Blind Treatment Phase||19
8151730|NCT02614196|20093328|P5|COMPLETED|Double Blind Treatment Phase||14
8151731|NCT02614196|20093329|P4|COMPLETED|Double Blind Treatment Phase||26
8151732|NCT02614196|20093330|P3|COMPLETED|Double Blind Treatment Phase||195
8151733|NCT02614196|20093331|P2|COMPLETED|Double Blind Treatment Phase||203
8151734|NCT02614196|20093332|P1|COMPLETED|Double Blind Treatment Phase||387
8151735|NCT02614196|20093327|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19
8151736|NCT02614196|20093328|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14
8151737|NCT02614196|20093329|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30
8151738|NCT02614196|20093330|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223
8151739|NCT02614196|20093331|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231
8151740|NCT02614196|20093332|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461
8151741|NCT02614196|20093327|P6|STARTED|Double Blind Treatment Phase||19
8151742|NCT02614196|20093328|P5|STARTED|Double Blind Treatment Phase||15
8151743|NCT02614196|20093329|P4|STARTED|Double Blind Treatment Phase||30
8151744|NCT02614196|20093330|P3|STARTED|Double Blind Treatment Phase||226
8151745|NCT02614196|20093331|P2|STARTED|Double Blind Treatment Phase||233
8151746|NCT02614196|20093332|P1|STARTED|Double Blind Treatment Phase||463
8151747|NCT02614183|20093378|P3|NOT COMPLETED|Post Treatment Follow-up Phase||12
8151748|NCT02614183|20093379|P2|NOT COMPLETED|Post Treatment Follow-up Phase||6
8151749|NCT02614183|20093380|P1|NOT COMPLETED|Post Treatment Follow-up Phase||18
8151750|NCT02614183|20093378|P3|COMPLETED|Post Treatment Follow-up Phase||171
8151751|NCT02614183|20093379|P2|COMPLETED|Post Treatment Follow-up Phase||179
8151752|NCT02614183|20093380|P1|COMPLETED|Post Treatment Follow-up Phase||354
8151753|NCT02614183|20093378|P3|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
8151754|NCT02614183|20093379|P2|Safety Population|Post Treatment Follow-up Phase||183
8151755|NCT02614183|20093380|P1|Safety Population|Post Treatment Follow-up Phase||372
8151756|NCT02614183|20093378|P3|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
8151757|NCT02614183|20093379|P2|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
8151758|NCT02614183|20093380|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
8151759|NCT02614183|20093378|P3|NOT COMPLETED|Double Blind Treatment Phase||39
8151760|NCT02614183|20093379|P2|NOT COMPLETED|Double Blind Treatment Phase||37
8151761|NCT02614183|20093380|P1|NOT COMPLETED|Double Blind Treatment Phase||83
8151762|NCT02614183|20093378|P3|COMPLETED|Double Blind Treatment Phase||175
8151763|NCT02614183|20093379|P2|COMPLETED|Double Blind Treatment Phase||177
8151764|NCT02614183|20093380|P1|COMPLETED|Double Blind Treatment Phase||351
8151765|NCT02614183|20093378|P3|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
8151766|NCT02614183|20093379|P2|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
8151767|NCT02614183|20093380|P1|Safety Population|Double Blind Treatment Phase||432
8151768|NCT02614183|20093378|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
8151769|NCT02614183|20093379|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
8151770|NCT02614183|20093380|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
8151771|NCT02614183|20093378|P3|STARTED|Double Blind Treatment Phase||214
8151772|NCT02614183|20093379|P2|STARTED|Double Blind Treatment Phase||214
8151773|NCT02614183|20093380|P1|STARTED|Double Blind Treatment Phase||434
8151774|NCT02614131|20093424|P7|NOT COMPLETED|Overall Study||1
8151775|NCT02614131|20093425|P6|NOT COMPLETED|Overall Study||0
8151776|NCT02614131|20093426|P5|NOT COMPLETED|Overall Study||0
8151777|NCT02614131|20093427|P4|NOT COMPLETED|Overall Study||0
8151778|NCT02614131|20093428|P3|NOT COMPLETED|Overall Study||0
8151779|NCT02614131|20093429|P2|NOT COMPLETED|Overall Study||0
8151780|NCT02614131|20093430|P1|NOT COMPLETED|Overall Study||1
8151781|NCT02614131|20093424|P7|COMPLETED|Overall Study||4
8151782|NCT02614131|20093425|P6|COMPLETED|Overall Study||2
8151783|NCT02614131|20093426|P5|COMPLETED|Overall Study||8
8151784|NCT02614131|20093427|P4|COMPLETED|Overall Study||8
8151785|NCT02614131|20093428|P3|COMPLETED|Overall Study||8
8151786|NCT02614131|20093429|P2|COMPLETED|Overall Study||8
8151787|NCT02614131|20093430|P1|COMPLETED|Overall Study||10
8151788|NCT02614131|20093424|P7|Received at Least One Dose of Drug|Overall Study||5
8151789|NCT02614131|20093425|P6|Received at Least One Dose of Drug|Overall Study||2
8151790|NCT02614131|20093426|P5|Received at Least One Dose of Drug|Overall Study||8
8151791|NCT02614131|20093427|P4|Received at Least One Dose of Drug|Overall Study||8
8151792|NCT02614131|20093428|P3|Received at Least One Dose of Drug|Overall Study||8
8151793|NCT02614131|20093429|P2|Received at Least One Dose of Drug|Overall Study||8
8151794|NCT02614131|20093430|P1|Received at Least One Dose of Drug|Overall Study||11
8151795|NCT02614131|20093424|P7|STARTED|Overall Study||5
8151796|NCT02614131|20093425|P6|STARTED|Overall Study||2
8151797|NCT02614131|20093426|P5|STARTED|Overall Study||8
8151798|NCT02614131|20093427|P4|STARTED|Overall Study||8
8151799|NCT02614131|20093428|P3|STARTED|Overall Study||8
8151800|NCT02614131|20093429|P2|STARTED|Overall Study||8
8151801|NCT02614131|20093430|P1|STARTED|Overall Study||11
8151802|NCT02614079|20093461|P1|NOT COMPLETED|Overall Study||1
8151803|NCT02614079|20093461|P1|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
8151804|NCT02614079|20093461|P1|STARTED|Overall Study||6
8151805|NCT02613910|20093465|P1|NOT COMPLETED|Overall Study||1
8151806|NCT02613910|20093465|P1|COMPLETED|Overall Study||0
8151807|NCT02613910|20093465|P1|STARTED|Overall Study||1
8151808|NCT02613897|20093517|P3|NOT COMPLETED|Overall Study||0
8151809|NCT02613897|20093518|P2|NOT COMPLETED|Overall Study||0
8151810|NCT02613897|20093519|P1|NOT COMPLETED|Overall Study||0
8151811|NCT02613897|20093517|P3|COMPLETED|Overall Study||12
8151812|NCT02613897|20093518|P2|COMPLETED|Overall Study||22
8151813|NCT02613897|20093519|P1|COMPLETED|Overall Study||22
8151814|NCT02613897|20093517|P3|STARTED|Overall Study||12
8151815|NCT02613897|20093518|P2|STARTED|Overall Study||22
8151816|NCT02613897|20093519|P1|STARTED|Overall Study||22
8151817|NCT02613871|20093551|P1|NOT COMPLETED|Overall Study||3
8151818|NCT02613871|20093551|P1|COMPLETED|Overall Study||108
8151819|NCT02613871|20093551|P1|STARTED|Overall Study||111
8151820|NCT02613572|20093573|P3|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
8151821|NCT02613572|20093574|P2|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||1
8151822|NCT02613572|20093575|P1|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
8151823|NCT02613572|20093573|P3|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
8151824|NCT02613572|20093574|P2|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
8151825|NCT02613572|20093575|P1|COMPLETED|Phase II: Double-Blind Rand Plac Control||0
8151826|NCT02613572|20093573|P3|STARTED|Phase II: Double-Blind Rand Plac Control||26
8151827|NCT02613572|20093574|P2|STARTED|Phase II: Double-Blind Rand Plac Control||27
8151828|NCT02613572|20093575|P1|STARTED|Phase II: Double-Blind Rand Plac Control||0
8151829|NCT02613572|20093573|P3|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
8151830|NCT02613572|20093574|P2|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
8151831|NCT02613572|20093575|P1|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||1
8151832|NCT02613572|20093573|P3|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
8151833|NCT02613572|20093574|P2|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
8151834|NCT02613572|20093575|P1|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||14
8151835|NCT02613572|20093573|P3|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8151836|NCT02613572|20093574|P2|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8151837|NCT02613572|20093575|P1|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||14
8151838|NCT02613572|20093573|P3|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8151839|NCT02613572|20093574|P2|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8151840|NCT02613572|20093575|P1|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
8151841|NCT02613572|20093573|P3|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8151842|NCT02613572|20093574|P2|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
8151843|NCT02613572|20093575|P1|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
8151844|NCT02613572|20093573|P3|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
8151845|NCT02613572|20093574|P2|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
8151846|NCT02613572|20093575|P1|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||15
8151847|NCT02613507|20093597|P2|NOT COMPLETED|Overall Study||164
8151848|NCT02613507|20093598|P1|NOT COMPLETED|Overall Study||288
8151849|NCT02613507|20093597|P2|COMPLETED|Overall Study||2
8151850|NCT02613507|20093598|P1|COMPLETED|Overall Study||50
8151851|NCT02613507|20093597|P2|STARTED|Overall Study||166
8151852|NCT02613507|20093598|P1|STARTED|Overall Study||338
8151853|NCT02613481|20093614|P1|NOT COMPLETED|Overall Study||9
8151854|NCT02613481|20093614|P1|COMPLETED|Overall Study||41
8151855|NCT02613481|20093614|P1|STARTED|Overall Study||50
8151856|NCT02613403|20093625|P5|NOT COMPLETED|Overall Study||0
8151857|NCT02613403|20093626|P4|NOT COMPLETED|Overall Study||0
8151858|NCT02613403|20093627|P3|NOT COMPLETED|Overall Study||0
8151859|NCT02613403|20093628|P2|NOT COMPLETED|Overall Study||1
8151860|NCT02613403|20093629|P1|NOT COMPLETED|Overall Study||2
8151861|NCT02613403|20093625|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
8151862|NCT02613403|20093626|P4|COMPLETED|Overall Study||13
8151863|NCT02613403|20093627|P3|COMPLETED|Overall Study||9
8151864|NCT02613403|20093628|P2|COMPLETED|Overall Study||35
8151865|NCT02613403|20093629|P1|COMPLETED|Overall Study||34
8151866|NCT02613403|20093625|P5|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
8151867|NCT02613403|20093626|P4|Treated|Overall Study||13
8151868|NCT02613403|20093627|P3|Treated|Overall Study||9
8151869|NCT02613403|20093628|P2|Treated|Overall Study||36
8151870|NCT02613403|20093629|P1|Treated|Overall Study||35
8151871|NCT02613403|20093625|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
8151872|NCT02613403|20093626|P4|STARTED|Overall Study||13
8151873|NCT02613403|20093627|P3|STARTED|Overall Study||9
8151874|NCT02613403|20093628|P2|STARTED|Overall Study||36
8151875|NCT02613403|20093629|P1|STARTED|Overall Study||36
8151876|NCT02613338|20093671|P1|NOT COMPLETED|Overall Study||0
8151877|NCT02613338|20093671|P1|COMPLETED|Overall Study||30
8151878|NCT02613338|20093671|P1|STARTED|Overall Study||30
8151879|NCT02613221|20093681|P1|NOT COMPLETED|Overall Study||55
8151880|NCT02613221|20093681|P1|COMPLETED|Overall Study||1
8151881|NCT02613221|20093681|P1|Safety Population: Received Study Drug|Overall Study||55
8151882|NCT02613221|20093681|P1|STARTED|Overall Study||56
8151883|NCT02613208|20093693|P1|NOT COMPLETED|Overall Study||47
8151884|NCT02613208|20093693|P1|COMPLETED|Overall Study||64
8151885|NCT02613208|20093693|P1|STARTED|Overall Study||111
8151886|NCT02613182|20093707|P1|NOT COMPLETED|Overall Study||34
8151887|NCT02613182|20093707|P1|COMPLETED|Overall Study||0
8151888|NCT02613182|20093707|P1|Number of Patients Dosed|Overall Study||34
8151889|NCT02613182|20093707|P1|STARTED|Overall Study||34
8151890|NCT02613117|20093713|P2|NOT COMPLETED|Overall Study||0
8151891|NCT02613117|20093714|P1|NOT COMPLETED|Overall Study||0
8151892|NCT02613117|20093713|P2|COMPLETED|Overall Study||47
8151893|NCT02613117|20093714|P1|COMPLETED|Overall Study||57
8151894|NCT02613117|20093713|P2|STARTED|Overall Study||47
8151895|NCT02613117|20093714|P1|STARTED|Overall Study||57
8151896|NCT02612909|20093729|P5|NOT COMPLETED|Phase 3||0
8151897|NCT02612909|20093730|P4|NOT COMPLETED|Phase 3||1
8151898|NCT02612909|20093731|P3|NOT COMPLETED|Phase 3||0
8151899|NCT02612909|20093732|P2|NOT COMPLETED|Phase 3||0
8151900|NCT02612909|20093733|P1|NOT COMPLETED|Phase 3||0
8151901|NCT02612909|20093729|P5|COMPLETED|Phase 3||525
8151902|NCT02612909|20093730|P4|COMPLETED|Phase 3||104
8151903|NCT02612909|20093731|P3|COMPLETED|Phase 3||0
8151904|NCT02612909|20093732|P2|COMPLETED|Phase 3||0
8151905|NCT02612909|20093733|P1|COMPLETED|Phase 3||0
8151906|NCT02612909|20093729|P5|Completed Day 43 Clinic Visit|Phase 3||524
8151907|NCT02612909|20093730|P4|Completed Day 43 Clinic Visit|Phase 3||104
8151908|NCT02612909|20093731|P3|Completed Day 43 Clinic Visit|Phase 3||0
8151909|NCT02612909|20093732|P2|Completed Day 43 Clinic Visit|Phase 3||0
8151910|NCT02612909|20093733|P1|Completed Day 43 Clinic Visit|Phase 3||0
8151911|NCT02612909|20093729|P5|Completed Day 29 Clinic Visit|Phase 3||525
8151912|NCT02612909|20093730|P4|Completed Day 29 Clinic Visit|Phase 3||104
8151913|NCT02612909|20093731|P3|Completed Day 29 Clinic Visit|Phase 3||0
8151914|NCT02612909|20093732|P2|Completed Day 29 Clinic Visit|Phase 3||0
8151915|NCT02612909|20093733|P1|Completed Day 29 Clinic Visit|Phase 3||0
8151916|NCT02612909|20093729|P5|Received Injection 2|Phase 3||520
8151917|NCT02612909|20093730|P4|Received Injection 2|Phase 3||103
8151918|NCT02612909|20093731|P3|Received Injection 2|Phase 3||0
8151919|NCT02612909|20093732|P2|Received Injection 2|Phase 3||0
8151920|NCT02612909|20093733|P1|Received Injection 2|Phase 3||0
8151921|NCT02612909|20093729|P5|Received Injection 1|Phase 3||525
8151922|NCT02612909|20093730|P4|Received Injection 1|Phase 3||105
8151923|NCT02612909|20093731|P3|Received Injection 1|Phase 3||0
8151924|NCT02612909|20093732|P2|Received Injection 1|Phase 3||0
8151925|NCT02612909|20093733|P1|Received Injection 1|Phase 3||0
8151926|NCT02612909|20093729|P5|STARTED|Phase 3||525
8151927|NCT02612909|20093730|P4|STARTED|Phase 3||105
8151928|NCT02612909|20093731|P3|STARTED|Phase 3||0
8151929|NCT02612909|20093732|P2|STARTED|Phase 3||0
8151930|NCT02612909|20093733|P1|STARTED|Phase 3||0
8151931|NCT02612909|20093729|P5|NOT COMPLETED|Phase 2||0
8151932|NCT02612909|20093730|P4|NOT COMPLETED|Phase 2||0
8151933|NCT02612909|20093731|P3|NOT COMPLETED|Phase 2||1
8151934|NCT02612909|20093732|P2|NOT COMPLETED|Phase 2||5
8151935|NCT02612909|20093733|P1|NOT COMPLETED|Phase 2||2
8151936|NCT02612909|20093729|P5|COMPLETED|Phase 2||0
8151937|NCT02612909|20093730|P4|COMPLETED|Phase 2||0
8151938|NCT02612909|20093731|P3|COMPLETED|Phase 2||99
8151939|NCT02612909|20093732|P2|COMPLETED|Phase 2||95
8151940|NCT02612909|20093733|P1|COMPLETED|Phase 2||98
8151941|NCT02612909|20093729|P5|Completed Day 43 Clinic Visit|Phase 2||0
8151942|NCT02612909|20093730|P4|Completed Day 43 Clinic Visit|Phase 2||0
8151943|NCT02612909|20093731|P3|Completed Day 43 Clinic Visit|Phase 2||99
8151944|NCT02612909|20093732|P2|Completed Day 43 Clinic Visit|Phase 2||94
8151945|NCT02612909|20093733|P1|Completed Day 43 Clinic Visit|Phase 2||97
8151946|NCT02612909|20093729|P5|Completed Day 29 Clinic Visit|Phase 2||0
8151947|NCT02612909|20093730|P4|Completed Day 29 Clinic Visit|Phase 2||0
8151948|NCT02612909|20093731|P3|Completed Day 29 Clinic Visit|Phase 2||99
8151949|NCT02612909|20093732|P2|Completed Day 29 Clinic Visit|Phase 2||95
8151950|NCT02612909|20093733|P1|Completed Day 29 Clinic Visit|Phase 2||98
8151951|NCT02612909|20093729|P5|Received Injection 2|Phase 2||0
8151952|NCT02612909|20093730|P4|Received Injection 2|Phase 2||0
8151953|NCT02612909|20093731|P3|Received Injection 2|Phase 2||99
8151954|NCT02612909|20093732|P2|Received Injection 2|Phase 2||95
8151955|NCT02612909|20093733|P1|Received Injection 2|Phase 2||98
8151956|NCT02612909|20093729|P5|Received Injection 1|Phase 2||0
8151957|NCT02612909|20093730|P4|Received Injection 1|Phase 2||0
8151958|NCT02612909|20093731|P3|Received Injection 1|Phase 2||100
8151959|NCT02612909|20093732|P2|Received Injection 1|Phase 2||100
8151960|NCT02612909|20093733|P1|Received Injection 1|Phase 2||100
8151961|NCT02612909|20093729|P5|STARTED|Phase 2||0
8151962|NCT02612909|20093730|P4|STARTED|Phase 2||0
8151963|NCT02612909|20093731|P3|STARTED|Phase 2||100
8151964|NCT02612909|20093732|P2|STARTED|Phase 2||100
8151965|NCT02612909|20093733|P1|STARTED|Phase 2||100
8151966|NCT02612857|20093801|P3|NOT COMPLETED|Overall Study||4
8151967|NCT02612857|20093802|P2|NOT COMPLETED|Overall Study||4
8151968|NCT02612857|20093803|P1|NOT COMPLETED|Overall Study||3
8151969|NCT02612857|20093801|P3|COMPLETED|Overall Study||6
8151970|NCT02612857|20093802|P2|COMPLETED|Overall Study||5
8151971|NCT02612857|20093803|P1|COMPLETED|Overall Study||8
8151972|NCT02612857|20093801|P3|STARTED|Overall Study||10
8151973|NCT02612857|20093802|P2|STARTED|Overall Study||9
8151974|NCT02612857|20093803|P1|STARTED|Overall Study||11
8151981|NCT02612727|20093829|P2|NOT COMPLETED|Overall Study||4
8151982|NCT02612727|20093830|P1|NOT COMPLETED|Overall Study||5
8151983|NCT02612727|20093829|P2|COMPLETED|Overall Study||83
8151984|NCT02612727|20093830|P1|COMPLETED|Overall Study||82
8151985|NCT02612727|20093829|P2|STARTED|Overall Study||87
8151986|NCT02612727|20093830|P1|STARTED|Overall Study||87
8151987|NCT02612688|20093840|P2|NOT COMPLETED|Overall Study||0
8151988|NCT02612688|20093841|P1|NOT COMPLETED|Overall Study||0
8151989|NCT02612688|20093840|P2|COMPLETED|Overall Study||70013
8151990|NCT02612688|20093841|P1|COMPLETED|Overall Study||33035
8151991|NCT02612688|20093840|P2|STARTED|Overall Study||70013
8151992|NCT02612688|20093841|P1|STARTED|Overall Study||33035
8151993|NCT02612623|20093889|P4|NOT COMPLETED|Overall Study||0
8151994|NCT02612623|20093890|P3|NOT COMPLETED|Overall Study||1
8151995|NCT02612623|20093891|P2|NOT COMPLETED|Overall Study||1
8151996|NCT02612623|20093892|P1|NOT COMPLETED|Overall Study||1
8151997|NCT02612623|20093889|P4|COMPLETED|Overall Study||4
8151998|NCT02612623|20093890|P3|COMPLETED|Overall Study||5
8151999|NCT02612623|20093891|P2|COMPLETED|Overall Study||5
8152000|NCT02612623|20093892|P1|COMPLETED|Overall Study||7
8152001|NCT02612623|20093889|P4|Treated|Overall Study||4
8152002|NCT02612623|20093890|P3|Treated|Overall Study||6
8152003|NCT02612623|20093891|P2|Treated|Overall Study||5
8152004|NCT02612623|20093892|P1|Treated|Overall Study||8
8152005|NCT02612623|20093889|P4|STARTED|Overall Study||4
8152006|NCT02612623|20093890|P3|STARTED|Overall Study||6
8152007|NCT02612623|20093891|P2|STARTED|Overall Study||6
8152008|NCT02612623|20093892|P1|STARTED|Overall Study||8
8152009|NCT02612610|20093906|P4|NOT COMPLETED|Overall Study||13
8152010|NCT02612610|20093907|P3|NOT COMPLETED|Overall Study||5
8152011|NCT02612610|20093908|P2|NOT COMPLETED|Overall Study||8
8152012|NCT02612610|20093909|P1|NOT COMPLETED|Overall Study||5
8152013|NCT02612610|20093906|P4|COMPLETED|Overall Study||50
8152014|NCT02612610|20093907|P3|COMPLETED|Overall Study||58
8152015|NCT02612610|20093908|P2|COMPLETED|Overall Study||56
8152016|NCT02612610|20093909|P1|COMPLETED|Overall Study||58
8152017|NCT02612610|20093906|P4|Treated|Overall Study||63
8152018|NCT02612610|20093907|P3|Treated|Overall Study||63
8152019|NCT02612610|20093908|P2|Treated|Overall Study||63
8152020|NCT02612610|20093909|P1|Treated|Overall Study||63
8152021|NCT02612610|20093906|P4|STARTED|Overall Study||63
8152022|NCT02612610|20093907|P3|STARTED|Overall Study||63
8152023|NCT02612610|20093908|P2|STARTED|Overall Study||64
8152024|NCT02612610|20093909|P1|STARTED|Overall Study||63
8152025|NCT02612428|20094153|P2|NOT COMPLETED|VTL-308E||7
8152026|NCT02612428|20094154|P1|NOT COMPLETED|VTL-308E||11
8152027|NCT02612428|20094153|P2|COMPLETED|VTL-308E||49
8152028|NCT02612428|20094154|P1|COMPLETED|VTL-308E||53
8152029|NCT02612428|20094153|P2|STARTED|VTL-308E||56
8152030|NCT02612428|20094154|P1|STARTED|VTL-308E||64
8152031|NCT02612428|20094153|P2|NOT COMPLETED|VTL-308||17
8152032|NCT02612428|20094154|P1|NOT COMPLETED|VTL-308||14
8152033|NCT02612428|20094153|P2|COMPLETED|VTL-308||56
8152034|NCT02612428|20094154|P1|COMPLETED|VTL-308||64
8152035|NCT02612428|20094153|P2|STARTED|VTL-308||73
8152036|NCT02612428|20094154|P1|STARTED|VTL-308||78
8152037|NCT02612285|20094164|P1|NOT COMPLETED|Overall Study||1
8152038|NCT02612285|20094164|P1|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
8152039|NCT02612285|20094164|P1|STARTED|Overall Study||1
8152040|NCT02612155|20094170|P2|NOT COMPLETED|Overall Study||3
8152041|NCT02612155|20094171|P1|NOT COMPLETED|Overall Study||3
8152042|NCT02612155|20094170|P2|COMPLETED|Overall Study||15
8152043|NCT02612155|20094171|P1|COMPLETED|Overall Study||14
8152044|NCT02612155|20094170|P2|STARTED|Overall Study||18
8152045|NCT02612155|20094171|P1|STARTED|Overall Study||17
8152046|NCT02612077|20094191|P1|NOT COMPLETED|Overall Study||466
8152047|NCT02612077|20094191|P1|COMPLETED|Overall Study||299
8152048|NCT02612077|20094191|P1|Efficacy Analysis Set|Overall Study||737
8152049|NCT02612077|20094191|P1|Safety Analysis Set|Overall Study||760
8152050|NCT02612077|20094191|P1|Did Not Receive Study Product|Overall Study||5
8152051|NCT02612077|20094191|P1|STARTED|Overall Study||765
8152052|NCT02612064|20094203|P2|NOT COMPLETED|Overall Study||3
8152053|NCT02612064|20094204|P1|NOT COMPLETED|Overall Study||1
8152054|NCT02612064|20094203|P2|COMPLETED|Overall Study||112
8152055|NCT02612064|20094204|P1|COMPLETED|Overall Study||114
8152056|NCT02612064|20094203|P2|STARTED|Overall Study||115
8152057|NCT02612064|20094204|P1|STARTED|Overall Study||115
8152058|NCT02611882|20094217|P3|NOT COMPLETED|Overall Study||0
8152059|NCT02611882|20094218|P2|NOT COMPLETED|Overall Study||0
8152060|NCT02611882|20094219|P1|NOT COMPLETED|Overall Study||33
8152061|NCT02611882|20094217|P3|COMPLETED|Overall Study||0
8152062|NCT02611882|20094218|P2|COMPLETED|Overall Study||150
8152063|NCT02611882|20094219|P1|COMPLETED|Overall Study||42
8152064|NCT02611882|20094217|P3|Completed Surgery Per Protocol|Overall Study||0
8152065|NCT02611882|20094218|P2|Completed Surgery Per Protocol|Overall Study||0
8152066|NCT02611882|20094219|P1|Completed Surgery Per Protocol|Overall Study||42
8152067|NCT02611882|20094217|P3|STARTED|Overall Study||0
8152068|NCT02611882|20094218|P2|STARTED|Overall Study||150
8152069|NCT02611882|20094219|P1|STARTED|Overall Study||75
8152070|NCT02611830|20094237|P4|NOT COMPLETED|Maintenance Phase||15
8152071|NCT02611830|20094238|P3|NOT COMPLETED|Maintenance Phase||31
8152072|NCT02611830|20094239|P2|NOT COMPLETED|Maintenance Phase||36
8152073|NCT02611830|20094240|P1|NOT COMPLETED|Maintenance Phase||0
8152074|NCT02611830|20094237|P4|COMPLETED|Maintenance Phase||39
8152075|NCT02611830|20094238|P3|COMPLETED|Maintenance Phase||75
8152076|NCT02611830|20094239|P2|COMPLETED|Maintenance Phase||20
8152077|NCT02611830|20094240|P1|COMPLETED|Maintenance Phase||0
8152078|NCT02611830|20094237|P4|STARTED|Maintenance Phase||54
8152079|NCT02611830|20094238|P3|STARTED|Maintenance Phase||106
8152080|NCT02611830|20094239|P2|STARTED|Maintenance Phase||56
8152081|NCT02611830|20094240|P1|STARTED|Maintenance Phase||0
8152082|NCT02611830|20094237|P4|NOT COMPLETED|OL Induction Phase||0
8152083|NCT02611830|20094238|P3|NOT COMPLETED|OL Induction Phase||0
8152084|NCT02611830|20094239|P2|NOT COMPLETED|OL Induction Phase||0
8152085|NCT02611830|20094240|P1|NOT COMPLETED|OL Induction Phase||30
8152086|NCT02611830|20094237|P4|COMPLETED|OL Induction Phase||0
8152087|NCT02611830|20094238|P3|COMPLETED|OL Induction Phase||0
8152088|NCT02611830|20094239|P2|COMPLETED|OL Induction Phase||0
8152089|NCT02611830|20094240|P1|COMPLETED|OL Induction Phase||353
8152090|NCT02611830|20094237|P4|STARTED|OL Induction Phase||0
8152091|NCT02611830|20094238|P3|STARTED|OL Induction Phase||0
8152092|NCT02611830|20094239|P2|STARTED|OL Induction Phase||0
8152093|NCT02611830|20094240|P1|STARTED|OL Induction Phase||383
8152094|NCT02611817|20094264|P3|NOT COMPLETED|Double-blind Maintenance Phase||107
8152095|NCT02611817|20094265|P2|NOT COMPLETED|Double-blind Maintenance Phase||62
8152096|NCT02611817|20094266|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
8152097|NCT02611817|20094264|P3|COMPLETED|Double-blind Maintenance Phase||168
8152098|NCT02611817|20094265|P2|COMPLETED|Double-blind Maintenance Phase||73
8152099|NCT02611817|20094266|P1|COMPLETED|Double-blind Maintenance Phase||0
8152100|NCT02611817|20094264|P3|STARTED|Double-blind Maintenance Phase||275
8152101|NCT02611817|20094265|P2|STARTED|Double-blind Maintenance Phase||135
8152102|NCT02611817|20094266|P1|STARTED|Double-blind Maintenance Phase||0
8152103|NCT02611817|20094264|P3|NOT COMPLETED|Open-label Induction Phase||0
8152104|NCT02611817|20094265|P2|NOT COMPLETED|Open-label Induction Phase||0
8152105|NCT02611817|20094266|P1|NOT COMPLETED|Open-label Induction Phase||50
8152106|NCT02611817|20094264|P3|COMPLETED|Open-label Induction Phase||0
8152107|NCT02611817|20094265|P2|COMPLETED|Open-label Induction Phase||0
8152108|NCT02611817|20094266|P1|COMPLETED|Open-label Induction Phase||594
8152109|NCT02611817|20094264|P3|STARTED|Open-label Induction Phase||0
8152110|NCT02611817|20094265|P2|STARTED|Open-label Induction Phase||0
8152111|NCT02611817|20094266|P1|STARTED|Open-label Induction Phase||644
8152112|NCT02611765|20094281|P2|NOT COMPLETED|Overall Study||6
8152113|NCT02611765|20094282|P1|NOT COMPLETED|Overall Study||2
8152114|NCT02611765|20094281|P2|COMPLETED|Overall Study||29
8152115|NCT02611765|20094282|P1|COMPLETED|Overall Study||27
8152116|NCT02611765|20094281|P2|STARTED|Overall Study||35
8152117|NCT02611765|20094282|P1|STARTED|Overall Study||29
8152118|NCT02611752|20094290|P2|NOT COMPLETED|Overall Study||1
8152119|NCT02611752|20094291|P1|NOT COMPLETED|Overall Study||0
8152120|NCT02611752|20094290|P2|COMPLETED|Overall Study||24
8152121|NCT02611752|20094291|P1|COMPLETED|Overall Study||22
8152122|NCT02611752|20094290|P2|Day11-13 Hydromorphone Challenge Injs|Overall Study||24
8152123|NCT02611752|20094291|P1|Day11-13 Hydromorphone Challenge Injs|Overall Study||22
8152124|NCT02611752|20094290|P2|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24
8152125|NCT02611752|20094291|P1|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22
8152126|NCT02611752|20094290|P2|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24
8152127|NCT02611752|20094291|P1|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22
8152128|NCT02611752|20094290|P2|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25
8152129|NCT02611752|20094291|P1|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22
8152130|NCT02611752|20094290|P2|STARTED|Overall Study||25
8152131|NCT02611752|20094291|P1|STARTED|Overall Study||22
8152132|NCT02611479|20094323|P1|NOT COMPLETED|Data Cleaning||2
8152133|NCT02611479|20094323|P1|COMPLETED|Data Cleaning||149
8152134|NCT02611479|20094323|P1|STARTED|Data Cleaning||151
8152135|NCT02611479|20094323|P1|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18
8152136|NCT02611479|20094323|P1|COMPLETED|Post-Surgery Follow-up at 1-Year||151
8152137|NCT02611479|20094323|P1|STARTED|Post-Surgery Follow-up at 1-Year||169
8152138|NCT02611479|20094323|P1|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2
8152139|NCT02611479|20094323|P1|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169
8152140|NCT02611479|20094323|P1|STARTED|Post-Surgery Follow-up at 30-90 Days||171
8152141|NCT02611479|20094323|P1|NOT COMPLETED|Baseline Enrollment||13
8152142|NCT02611479|20094323|P1|COMPLETED|Baseline Enrollment||171
8152143|NCT02611479|20094323|P1|STARTED|Baseline Enrollment||184
8152144|NCT02611362|20094329|P2|NOT COMPLETED|Overall Study||6
8152145|NCT02611362|20094330|P1|NOT COMPLETED|Overall Study||9
8152146|NCT02611362|20094329|P2|COMPLETED|Overall Study||35
8152147|NCT02611362|20094330|P1|COMPLETED|Overall Study||32
8152148|NCT02611362|20094329|P2|6-month Follow-up|Overall Study||35
8152149|NCT02611362|20094330|P1|6-month Follow-up|Overall Study||32
8152150|NCT02611362|20094329|P2|Immediate Posttest (3 Months)|Overall Study||34
8152151|NCT02611362|20094330|P1|Immediate Posttest (3 Months)|Overall Study||33
8152152|NCT02611362|20094329|P2|STARTED|Overall Study||41
8152153|NCT02611362|20094330|P1|STARTED|Overall Study||41
8152154|NCT02611154|20094346|P1|NOT COMPLETED|Overall Study||0
8152155|NCT02611154|20094346|P1|COMPLETED|Overall Study||5
8152156|NCT02611154|20094346|P1|STARTED|Overall Study||5
8152157|NCT02610972|20094367|P2|NOT COMPLETED|Overall Study||0
8152158|NCT02610972|20094368|P1|NOT COMPLETED|Overall Study||0
8152159|NCT02610972|20094367|P2|COMPLETED|Overall Study||50
8152160|NCT02610972|20094368|P1|COMPLETED|Overall Study||100
8152161|NCT02610972|20094367|P2|STARTED|Overall Study||50
8152162|NCT02610972|20094368|P1|STARTED|Overall Study||100
8152175|NCT02610842|20094474|P1|NOT COMPLETED|Overall Study||5
8152176|NCT02610842|20094474|P1|COMPLETED|Overall Study||22
8152177|NCT02610842|20094474|P1|STARTED|Overall Study||27
8152178|NCT02610816|20094483|P4|NOT COMPLETED|Phase 2||6
8152179|NCT02610816|20094484|P3|NOT COMPLETED|Phase 2||11
8152180|NCT02610816|20094485|P2|NOT COMPLETED|Phase 2||0
8152181|NCT02610816|20094486|P1|NOT COMPLETED|Phase 2||0
8152182|NCT02610816|20094483|P4|COMPLETED|Phase 2||4
8152183|NCT02610816|20094484|P3|COMPLETED|Phase 2||8
8152184|NCT02610816|20094485|P2|COMPLETED|Phase 2||0
8152185|NCT02610816|20094486|P1|COMPLETED|Phase 2||0
8152186|NCT02610816|20094483|P4|STARTED|Phase 2||10
8152187|NCT02610816|20094484|P3|STARTED|Phase 2||19
8152188|NCT02610816|20094485|P2|STARTED|Phase 2||0
8152189|NCT02610816|20094486|P1|STARTED|Phase 2||0
8152190|NCT02610816|20094483|P4|NOT COMPLETED|Phase 1||0
8152191|NCT02610816|20094484|P3|NOT COMPLETED|Phase 1||0
8152192|NCT02610816|20094485|P2|NOT COMPLETED|Phase 1||8
8152193|NCT02610816|20094486|P1|NOT COMPLETED|Phase 1||4
8152194|NCT02610816|20094483|P4|COMPLETED|Phase 1||0
8152195|NCT02610816|20094484|P3|COMPLETED|Phase 1||0
8152196|NCT02610816|20094485|P2|COMPLETED|Phase 1||17
8152197|NCT02610816|20094486|P1|COMPLETED|Phase 1||34
8152198|NCT02610816|20094483|P4|STARTED|Phase 1||0
8152199|NCT02610816|20094484|P3|STARTED|Phase 1||0
8152200|NCT02610816|20094485|P2|STARTED|Phase 1||25
8152201|NCT02610816|20094486|P1|STARTED|Phase 1||38
8152208|NCT02610725|20094516|P1|NOT COMPLETED|Overall Study||206
8152209|NCT02610725|20094516|P1|COMPLETED|Overall Study||75
8152210|NCT02610725|20094516|P1|STARTED|Overall Study||281
8152211|NCT02610634|20094524|P2|NOT COMPLETED|Overall Study||0
8152212|NCT02610634|20094525|P1|NOT COMPLETED|Overall Study||0
8152213|NCT02610634|20094524|P2|COMPLETED|Overall Study||40
8152214|NCT02610634|20094525|P1|COMPLETED|Overall Study||60
8152215|NCT02610634|20094524|P2|STARTED|Overall Study||40
8152216|NCT02610634|20094525|P1|STARTED|Overall Study||60
8152217|NCT02610231|20094531|P1|NOT COMPLETED|Overall Study||60
8152218|NCT02610231|20094531|P1|COMPLETED|Overall Study||179
8152219|NCT02610231|20094531|P1|STARTED|Overall Study||239
8152220|NCT02610192|20094538|P1|NOT COMPLETED|Overall Study||9
8152221|NCT02610192|20094538|P1|COMPLETED|Overall Study||41
8152222|NCT02610192|20094538|P1|STARTED|Overall Study|52 subjects had signed consent form, but 50 subjects have been treated. 2 subjects became SF.|50
8152223|NCT02610140|20094553|P2|NOT COMPLETED|Long-term Follow-up||66
8152224|NCT02610140|20094554|P1|NOT COMPLETED|Long-term Follow-up||123
8152225|NCT02610140|20094553|P2|COMPLETED|Long-term Follow-up||0
8152226|NCT02610140|20094554|P1|COMPLETED|Long-term Follow-up||0
8152227|NCT02610140|20094553|P2|STARTED|Long-term Follow-up||66
8152228|NCT02610140|20094554|P1|STARTED|Long-term Follow-up||123
8152229|NCT02610140|20094553|P2|NOT COMPLETED|Active Follow-up||26
8152230|NCT02610140|20094554|P1|NOT COMPLETED|Active Follow-up||48
8152231|NCT02610140|20094553|P2|COMPLETED|Active Follow-up||0
8152232|NCT02610140|20094554|P1|COMPLETED|Active Follow-up||0
8152233|NCT02610140|20094553|P2|STARTED|Active Follow-up||26
8152234|NCT02610140|20094554|P1|STARTED|Active Follow-up||48
8152235|NCT02610140|20094553|P2|NOT COMPLETED|Safety Follow-up||24
8152236|NCT02610140|20094554|P1|NOT COMPLETED|Safety Follow-up||45
8152237|NCT02610140|20094553|P2|COMPLETED|Safety Follow-up||21
8152238|NCT02610140|20094554|P1|COMPLETED|Safety Follow-up||57
8152239|NCT02610140|20094553|P2|STARTED|Safety Follow-up||45
8152240|NCT02610140|20094554|P1|STARTED|Safety Follow-up||102
8152241|NCT02610140|20094553|P2|NOT COMPLETED|Randomization and Treatment Period||82
8152242|NCT02610140|20094554|P1|NOT COMPLETED|Randomization and Treatment Period||166
8152243|NCT02610140|20094553|P2|COMPLETED|Randomization and Treatment Period||0
8152244|NCT02610140|20094554|P1|COMPLETED|Randomization and Treatment Period||0
8152245|NCT02610140|20094553|P2|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|72
8152246|NCT02610140|20094554|P1|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|163
8152247|NCT02610140|20094553|P2|STARTED|Randomization and Treatment Period||82
8152248|NCT02610140|20094554|P1|STARTED|Randomization and Treatment Period||166
8152249|NCT02609984|20094586|P2|NOT COMPLETED|Overall Study||39
8152250|NCT02609984|20094587|P1|NOT COMPLETED|Overall Study||44
8152251|NCT02609984|20094586|P2|COMPLETED|Overall Study||5
8152252|NCT02609984|20094587|P1|COMPLETED|Overall Study||1
8152253|NCT02609984|20094586|P2|Treated|Overall Study||43
8152254|NCT02609984|20094587|P1|Treated|Overall Study||45
8152255|NCT02609984|20094586|P2|STARTED|Overall Study||44
8152256|NCT02609984|20094587|P1|STARTED|Overall Study||45
8152257|NCT02609841|20094621|P1|NOT COMPLETED|Overall Study||28
8152258|NCT02609841|20094621|P1|COMPLETED|Overall Study||212
8152259|NCT02609841|20094621|P1|STARTED|Overall Study||240
8152260|NCT02609672|20094629|P2|NOT COMPLETED|Overall Study||1
8152261|NCT02609672|20094630|P1|NOT COMPLETED|Overall Study||3
8152262|NCT02609672|20094629|P2|COMPLETED|Overall Study||11
8152263|NCT02609672|20094630|P1|COMPLETED|Overall Study||9
8152264|NCT02609672|20094629|P2|STARTED|Overall Study||12
8152265|NCT02609672|20094630|P1|STARTED|Overall Study||12
8152266|NCT02609659|20094664|P1|NOT COMPLETED|Overall Study||8
8152267|NCT02609659|20094664|P1|COMPLETED|Overall Study||97
8152268|NCT02609659|20094664|P1|STARTED|Overall Study||105
8152269|NCT02609633|20094674|P2|NOT COMPLETED|Overall Study||2
8152270|NCT02609633|20094675|P1|NOT COMPLETED|Overall Study||5
8152271|NCT02609633|20094674|P2|COMPLETED|Overall Study||54
8152272|NCT02609633|20094675|P1|COMPLETED|Overall Study||37
8152273|NCT02609633|20094674|P2|Full Analysis Set (FAS)|Overall Study||46
8152274|NCT02609633|20094675|P1|Full Analysis Set (FAS)|Overall Study||32
8152275|NCT02609633|20094674|P2|STARTED|Overall Study||56
8152276|NCT02609633|20094675|P1|STARTED|Overall Study||42
8152277|NCT02609607|20094702|P2|NOT COMPLETED|Overall Study||1
8152278|NCT02609607|20094703|P1|NOT COMPLETED|Overall Study||0
8152279|NCT02609607|20094702|P2|COMPLETED|Overall Study||4
8152280|NCT02609607|20094703|P1|COMPLETED|Overall Study||6
8152281|NCT02609607|20094702|P2|STARTED|Overall Study||5
8152282|NCT02609607|20094703|P1|STARTED|Overall Study||6
8152283|NCT02609399|20094727|P2|NOT COMPLETED|Influenza Season 2016-2017||5
8152284|NCT02609399|20094728|P1|NOT COMPLETED|Influenza Season 2016-2017||9
8152285|NCT02609399|20094727|P2|COMPLETED|Influenza Season 2016-2017||59
8152286|NCT02609399|20094728|P1|COMPLETED|Influenza Season 2016-2017||49
8152287|NCT02609399|20094727|P2|STARTED|Influenza Season 2016-2017||64
8152288|NCT02609399|20094728|P1|STARTED|Influenza Season 2016-2017||58
8152289|NCT02609399|20094727|P2|NOT COMPLETED|Influenza Season 2015-2016||2
8152290|NCT02609399|20094728|P1|NOT COMPLETED|Influenza Season 2015-2016||3
8152291|NCT02609399|20094727|P2|COMPLETED|Influenza Season 2015-2016||29
8152292|NCT02609399|20094728|P1|COMPLETED|Influenza Season 2015-2016||24
8152293|NCT02609399|20094727|P2|STARTED|Influenza Season 2015-2016||31
8152294|NCT02609399|20094728|P1|STARTED|Influenza Season 2015-2016||27
8152295|NCT02609308|20094742|P2|NOT COMPLETED|Overall Study||0
8152296|NCT02609308|20094743|P1|NOT COMPLETED|Overall Study||0
8152297|NCT02609308|20094742|P2|COMPLETED|Overall Study||11
8152298|NCT02609308|20094743|P1|COMPLETED|Overall Study||10
8152299|NCT02609308|20094742|P2|STARTED|Overall Study||11
8152300|NCT02609308|20094743|P1|STARTED|Overall Study||10
8152301|NCT02609204|20094753|P1|NOT COMPLETED|Overall Study||0
8152302|NCT02609204|20094753|P1|COMPLETED|Overall Study||51
8152303|NCT02609204|20094753|P1|STARTED|Overall Study||51
8152304|NCT02609178|20094758|P6|NOT COMPLETED|Third Crown||0
8152305|NCT02609178|20094759|P5|NOT COMPLETED|Third Crown||0
8152306|NCT02609178|20094760|P4|NOT COMPLETED|Third Crown||0
8152307|NCT02609178|20094761|P3|NOT COMPLETED|Third Crown||0
8152308|NCT02609178|20094762|P2|NOT COMPLETED|Third Crown||0
8152309|NCT02609178|20094763|P1|NOT COMPLETED|Third Crown||0
8152310|NCT02609178|20094758|P6|COMPLETED|Third Crown||2
8152311|NCT02609178|20094759|P5|COMPLETED|Third Crown||0
8152312|NCT02609178|20094760|P4|COMPLETED|Third Crown||2
8152313|NCT02609178|20094761|P3|COMPLETED|Third Crown||5
8152314|NCT02609178|20094762|P2|COMPLETED|Third Crown||1
8152315|NCT02609178|20094763|P1|COMPLETED|Third Crown||0
8152316|NCT02609178|20094758|P6|STARTED|Third Crown||2
8152317|NCT02609178|20094759|P5|STARTED|Third Crown||0
8152318|NCT02609178|20094760|P4|STARTED|Third Crown||2
8152319|NCT02609178|20094761|P3|STARTED|Third Crown||5
8152320|NCT02609178|20094762|P2|STARTED|Third Crown||1
8152321|NCT02609178|20094763|P1|STARTED|Third Crown||0
8152322|NCT02609178|20094758|P6|NOT COMPLETED|5-minute Washout Time||0
8152323|NCT02609178|20094759|P5|NOT COMPLETED|5-minute Washout Time||0
8152324|NCT02609178|20094760|P4|NOT COMPLETED|5-minute Washout Time||0
8152325|NCT02609178|20094761|P3|NOT COMPLETED|5-minute Washout Time||0
8152326|NCT02609178|20094762|P2|NOT COMPLETED|5-minute Washout Time||0
8152327|NCT02609178|20094763|P1|NOT COMPLETED|5-minute Washout Time||0
8152328|NCT02609178|20094758|P6|COMPLETED|5-minute Washout Time||2
8152329|NCT02609178|20094759|P5|COMPLETED|5-minute Washout Time||0
8152330|NCT02609178|20094760|P4|COMPLETED|5-minute Washout Time||2
8152331|NCT02609178|20094761|P3|COMPLETED|5-minute Washout Time||5
8152332|NCT02609178|20094762|P2|COMPLETED|5-minute Washout Time||1
8152333|NCT02609178|20094763|P1|COMPLETED|5-minute Washout Time||0
8152334|NCT02609178|20094758|P6|STARTED|5-minute Washout Time||2
8152335|NCT02609178|20094759|P5|STARTED|5-minute Washout Time||0
8152336|NCT02609178|20094760|P4|STARTED|5-minute Washout Time||2
8152337|NCT02609178|20094761|P3|STARTED|5-minute Washout Time||5
8152338|NCT02609178|20094762|P2|STARTED|5-minute Washout Time||1
8152339|NCT02609178|20094763|P1|STARTED|5-minute Washout Time||0
8152340|NCT02609178|20094758|P6|NOT COMPLETED|Second Crown||0
8152341|NCT02609178|20094759|P5|NOT COMPLETED|Second Crown||0
8152342|NCT02609178|20094760|P4|NOT COMPLETED|Second Crown||0
8152343|NCT02609178|20094761|P3|NOT COMPLETED|Second Crown||0
8152344|NCT02609178|20094762|P2|NOT COMPLETED|Second Crown||0
8152345|NCT02609178|20094763|P1|NOT COMPLETED|Second Crown||0
8152346|NCT02609178|20094758|P6|COMPLETED|Second Crown||2
8152347|NCT02609178|20094759|P5|COMPLETED|Second Crown||0
8152348|NCT02609178|20094760|P4|COMPLETED|Second Crown||2
8152349|NCT02609178|20094761|P3|COMPLETED|Second Crown||5
8152350|NCT02609178|20094762|P2|COMPLETED|Second Crown||1
8152351|NCT02609178|20094763|P1|COMPLETED|Second Crown||0
8152352|NCT02609178|20094758|P6|STARTED|Second Crown||2
8152353|NCT02609178|20094759|P5|STARTED|Second Crown||0
8152354|NCT02609178|20094760|P4|STARTED|Second Crown||2
8152355|NCT02609178|20094761|P3|STARTED|Second Crown||5
8152356|NCT02609178|20094762|P2|STARTED|Second Crown||1
8152357|NCT02609178|20094763|P1|STARTED|Second Crown||0
8152358|NCT02609178|20094758|P6|NOT COMPLETED|5-minute Washout Time||0
8152359|NCT02609178|20094759|P5|NOT COMPLETED|5-minute Washout Time||0
8152360|NCT02609178|20094760|P4|NOT COMPLETED|5-minute Washout Time||0
8152361|NCT02609178|20094761|P3|NOT COMPLETED|5-minute Washout Time||0
8152362|NCT02609178|20094762|P2|NOT COMPLETED|5-minute Washout Time||0
8152363|NCT02609178|20094763|P1|NOT COMPLETED|5-minute Washout Time||0
8152364|NCT02609178|20094758|P6|COMPLETED|5-minute Washout Time||2
8152365|NCT02609178|20094759|P5|COMPLETED|5-minute Washout Time||0
8152366|NCT02609178|20094760|P4|COMPLETED|5-minute Washout Time||2
8152367|NCT02609178|20094761|P3|COMPLETED|5-minute Washout Time||5
8152368|NCT02609178|20094762|P2|COMPLETED|5-minute Washout Time||1
8152369|NCT02609178|20094763|P1|COMPLETED|5-minute Washout Time||0
8152370|NCT02609178|20094758|P6|STARTED|5-minute Washout Time||2
8152371|NCT02609178|20094759|P5|STARTED|5-minute Washout Time||0
8152372|NCT02609178|20094760|P4|STARTED|5-minute Washout Time||2
8152373|NCT02609178|20094761|P3|STARTED|5-minute Washout Time||5
8152374|NCT02609178|20094762|P2|STARTED|5-minute Washout Time||1
8152375|NCT02609178|20094763|P1|STARTED|5-minute Washout Time||0
8152376|NCT02609178|20094758|P6|NOT COMPLETED|First Crown||0
8152377|NCT02609178|20094759|P5|NOT COMPLETED|First Crown||0
8152378|NCT02609178|20094760|P4|NOT COMPLETED|First Crown||1
8152379|NCT02609178|20094761|P3|NOT COMPLETED|First Crown||1
8152380|NCT02609178|20094762|P2|NOT COMPLETED|First Crown||0
8152381|NCT02609178|20094763|P1|NOT COMPLETED|First Crown||0
8152382|NCT02609178|20094758|P6|COMPLETED|First Crown||2
8152383|NCT02609178|20094759|P5|COMPLETED|First Crown||0
8152384|NCT02609178|20094760|P4|COMPLETED|First Crown||2
8152385|NCT02609178|20094761|P3|COMPLETED|First Crown||5
8152386|NCT02609178|20094762|P2|COMPLETED|First Crown||1
8152387|NCT02609178|20094763|P1|COMPLETED|First Crown||0
8152388|NCT02609178|20094758|P6|STARTED|First Crown||2
8152389|NCT02609178|20094759|P5|STARTED|First Crown||0
8152390|NCT02609178|20094760|P4|STARTED|First Crown||3
8152391|NCT02609178|20094761|P3|STARTED|First Crown||6
8152392|NCT02609178|20094762|P2|STARTED|First Crown||1
8152393|NCT02609178|20094763|P1|STARTED|First Crown||0
8152394|NCT02609113|20094780|P2|NOT COMPLETED|Overall Study||2
8152395|NCT02609113|20094781|P1|NOT COMPLETED|Overall Study||2
8152396|NCT02609113|20094780|P2|COMPLETED|Overall Study||9
8152397|NCT02609113|20094781|P1|COMPLETED|Overall Study||9
8152398|NCT02609113|20094780|P2|STARTED|Overall Study||11
8152399|NCT02609113|20094781|P1|STARTED|Overall Study||11
8152400|NCT02609100|20094795|P2|NOT COMPLETED|Overall Study||0
8152401|NCT02609100|20094796|P1|NOT COMPLETED|Overall Study||0
8152402|NCT02609100|20094795|P2|COMPLETED|Overall Study||2
8152403|NCT02609100|20094796|P1|COMPLETED|Overall Study||2
8152404|NCT02609100|20094795|P2|STARTED|Overall Study||2
8152405|NCT02609100|20094796|P1|STARTED|Overall Study||2
8152406|NCT02608905|20094814|P2|NOT COMPLETED|Overall Study||0
8152407|NCT02608905|20094815|P1|NOT COMPLETED|Overall Study||2
8152408|NCT02608905|20094814|P2|COMPLETED|Overall Study||10
8152409|NCT02608905|20094815|P1|COMPLETED|Overall Study||5
8152410|NCT02608905|20094814|P2|STARTED|Overall Study||10
8152411|NCT02608905|20094815|P1|STARTED|Overall Study||7
8152412|NCT02608892|20094825|P2|NOT COMPLETED|Overall Study||0
8152413|NCT02608892|20094826|P1|NOT COMPLETED|Overall Study||1
8152414|NCT02608892|20094825|P2|COMPLETED|Overall Study||49
8152415|NCT02608892|20094826|P1|COMPLETED|Overall Study||50
8152416|NCT02608892|20094825|P2|STARTED|Overall Study||49
8152417|NCT02608892|20094826|P1|STARTED|Overall Study||51
8152418|NCT02608879|20094838|P3|NOT COMPLETED|Overall Study||3
8152419|NCT02608879|20094839|P2|NOT COMPLETED|Overall Study||0
8152420|NCT02608879|20094840|P1|NOT COMPLETED|Overall Study||1
8152421|NCT02608879|20094838|P3|COMPLETED|Overall Study||0
8152422|NCT02608879|20094839|P2|COMPLETED|Overall Study||6
8152423|NCT02608879|20094840|P1|COMPLETED|Overall Study||9
8152424|NCT02608879|20094838|P3|STARTED|Overall Study||3
8152425|NCT02608879|20094839|P2|STARTED|Overall Study||6
8152426|NCT02608879|20094840|P1|STARTED|Overall Study||10
8152430|NCT02608489|20094871|P2|NOT COMPLETED|Overall Study||10
8152431|NCT02608489|20094872|P1|NOT COMPLETED|Overall Study||13
8152432|NCT02608489|20094871|P2|COMPLETED|Overall Study||33
8152433|NCT02608489|20094872|P1|COMPLETED|Overall Study||30
8152434|NCT02608489|20094871|P2|STARTED|Overall Study||43
8152435|NCT02608489|20094872|P1|STARTED|Overall Study||43
8152436|NCT02608476|20094894|P2|NOT COMPLETED|Overall Study||81
8152437|NCT02608476|20094895|P1|NOT COMPLETED|Overall Study||67
8152438|NCT02608476|20094894|P2|COMPLETED|Overall Study||282
8152439|NCT02608476|20094895|P1|COMPLETED|Overall Study||302
8152440|NCT02608476|20094894|P2|STARTED|Overall Study||363
8152441|NCT02608476|20094895|P1|STARTED|Overall Study||369
8152451|NCT02608450|20094925|P2|NOT COMPLETED|Overall Study||65
8152452|NCT02608450|20094926|P1|NOT COMPLETED|Overall Study||66
8152453|NCT02608450|20094925|P2|COMPLETED|Overall Study||290
8152454|NCT02608450|20094926|P1|COMPLETED|Overall Study||287
8152455|NCT02608450|20094925|P2|STARTED|Overall Study||355
8152456|NCT02608450|20094926|P1|STARTED|Overall Study||353
8152467|NCT02608177|20094965|P2|NOT COMPLETED|Overall Study||0
8152468|NCT02608177|20094966|P1|NOT COMPLETED|Overall Study||0
8152469|NCT02608177|20094965|P2|COMPLETED|Overall Study||1
8152470|NCT02608177|20094966|P1|COMPLETED|Overall Study||2
8152471|NCT02608177|20094965|P2|STARTED|Overall Study||1
8152472|NCT02608177|20094966|P1|STARTED|Overall Study||2
8152473|NCT02608099|20094988|P2|NOT COMPLETED|Overall Study||2
8152474|NCT02608099|20094989|P1|NOT COMPLETED|Overall Study||3
8152475|NCT02608099|20094988|P2|COMPLETED|Overall Study||150
8152476|NCT02608099|20094989|P1|COMPLETED|Overall Study||145
8152477|NCT02608099|20094988|P2|Safety|Overall Study||151
8152478|NCT02608099|20094989|P1|Safety|Overall Study||149
8152479|NCT02608099|20094988|P2|STARTED|Overall Study||152
8152480|NCT02608099|20094989|P1|STARTED|Overall Study||148
8152493|NCT02607865|20095103|P4|NOT COMPLETED|Overall Study||16
8152494|NCT02607865|20095104|P3|NOT COMPLETED|Overall Study||27
8152495|NCT02607865|20095105|P2|NOT COMPLETED|Overall Study||30
8152496|NCT02607865|20095106|P1|NOT COMPLETED|Overall Study||33
8152497|NCT02607865|20095103|P4|COMPLETED|Overall Study||451
8152498|NCT02607865|20095104|P3|COMPLETED|Overall Study||438
8152499|NCT02607865|20095105|P2|COMPLETED|Overall Study||436
8152500|NCT02607865|20095106|P1|COMPLETED|Overall Study||433
8152501|NCT02607865|20095103|P4|Safety Analysis Set (SAS)|Overall Study||466
8152502|NCT02607865|20095104|P3|Safety Analysis Set (SAS)|Overall Study||465
8152503|NCT02607865|20095105|P2|Safety Analysis Set (SAS)|Overall Study||464
8152504|NCT02607865|20095106|P1|Safety Analysis Set (SAS)|Overall Study||466
8152505|NCT02607865|20095103|P4|Full Analysis Set (FAS)|Overall Study||467
8152506|NCT02607865|20095104|P3|Full Analysis Set (FAS)|Overall Study||465
8152507|NCT02607865|20095105|P2|Full Analysis Set (FAS)|Overall Study||465
8152508|NCT02607865|20095106|P1|Full Analysis Set (FAS)|Overall Study||466
8152509|NCT02607865|20095103|P4|STARTED|Overall Study||467
8152510|NCT02607865|20095104|P3|STARTED|Overall Study||465
8152511|NCT02607865|20095105|P2|STARTED|Overall Study||466
8152512|NCT02607865|20095106|P1|STARTED|Overall Study||466
8152513|NCT02607800|20095280|P2|NOT COMPLETED|Overall Study||11
8152514|NCT02607800|20095281|P1|NOT COMPLETED|Overall Study||10
8152515|NCT02607800|20095280|P2|COMPLETED|Overall Study||430
8152516|NCT02607800|20095281|P1|COMPLETED|Overall Study||492
8152517|NCT02607800|20095280|P2|STARTED|Overall Study||441
8152518|NCT02607800|20095281|P1|STARTED|Overall Study||502
8152519|NCT02607735|20095299|P3|NOT COMPLETED|Deferred Treatment Substudy||5
8152520|NCT02607735|20095300|P2|NOT COMPLETED|Deferred Treatment Substudy||0
8152521|NCT02607735|20095301|P1|NOT COMPLETED|Deferred Treatment Substudy||0
8152522|NCT02607735|20095299|P3|COMPLETED|Deferred Treatment Substudy||142
8152523|NCT02607735|20095300|P2|COMPLETED|Deferred Treatment Substudy||0
8152524|NCT02607735|20095301|P1|COMPLETED|Deferred Treatment Substudy||0
8152525|NCT02607735|20095299|P3|STARTED|Deferred Treatment Substudy||147
8152526|NCT02607735|20095300|P2|STARTED|Deferred Treatment Substudy||0
8152527|NCT02607735|20095301|P1|STARTED|Deferred Treatment Substudy||0
8152528|NCT02607735|20095299|P3|NOT COMPLETED|Primary Study||0
8152529|NCT02607735|20095300|P2|NOT COMPLETED|Primary Study||0
8152530|NCT02607735|20095301|P1|NOT COMPLETED|Primary Study||7
8152531|NCT02607735|20095299|P3|COMPLETED|Primary Study||0
8152532|NCT02607735|20095300|P2|COMPLETED|Primary Study||152
8152533|NCT02607735|20095301|P1|COMPLETED|Primary Study||257
8152534|NCT02607735|20095299|P3|STARTED|Primary Study||0
8152535|NCT02607735|20095300|P2|STARTED|Primary Study||152
8152536|NCT02607735|20095301|P1|STARTED|Primary Study||264
8152537|NCT02607618|20095323|P2|NOT COMPLETED|Overall Study||2
8152538|NCT02607618|20095324|P1|NOT COMPLETED|Overall Study||11
8152539|NCT02607618|20095323|P2|COMPLETED|Overall Study||305
8152540|NCT02607618|20095324|P1|COMPLETED|Overall Study||295
8152541|NCT02607618|20095323|P2|STARTED|Overall Study||307
8152542|NCT02607618|20095324|P1|STARTED|Overall Study||306
8152560|NCT02607254|20095469|P3|NOT COMPLETED|Overall Study||0
8152561|NCT02607254|20095470|P2|NOT COMPLETED|Overall Study||0
8152562|NCT02607254|20095471|P1|NOT COMPLETED|Overall Study||0
8152563|NCT02607254|20095469|P3|COMPLETED|Overall Study||5
8152564|NCT02607254|20095470|P2|COMPLETED|Overall Study||3
8152565|NCT02607254|20095471|P1|COMPLETED|Overall Study||3
8152566|NCT02607254|20095469|P3|STARTED|Overall Study||5
8152567|NCT02607254|20095470|P2|STARTED|Overall Study||3
8152568|NCT02607254|20095471|P1|STARTED|Overall Study||3
8152569|NCT02607228|20095495|P7|NOT COMPLETED|Overall Study||2
8152570|NCT02607228|20095496|P6|NOT COMPLETED|Overall Study||6
8152571|NCT02607228|20095497|P5|NOT COMPLETED|Overall Study||5
8152572|NCT02607228|20095498|P4|NOT COMPLETED|Overall Study||6
8152573|NCT02607228|20095499|P3|NOT COMPLETED|Overall Study||3
8152574|NCT02607228|20095500|P2|NOT COMPLETED|Overall Study||4
8152575|NCT02607228|20095501|P1|NOT COMPLETED|Overall Study||5
8152576|NCT02607228|20095495|P7|COMPLETED|Overall Study||0
8152577|NCT02607228|20095496|P6|COMPLETED|Overall Study||0
8152578|NCT02607228|20095497|P5|COMPLETED|Overall Study||0
8152579|NCT02607228|20095498|P4|COMPLETED|Overall Study||0
8152580|NCT02607228|20095499|P3|COMPLETED|Overall Study||0
8152581|NCT02607228|20095500|P2|COMPLETED|Overall Study||0
8152582|NCT02607228|20095501|P1|COMPLETED|Overall Study||0
8152583|NCT02607228|20095495|P7|STARTED|Overall Study||2
8152584|NCT02607228|20095496|P6|STARTED|Overall Study||6
8152585|NCT02607228|20095497|P5|STARTED|Overall Study||5
8152586|NCT02607228|20095498|P4|STARTED|Overall Study||6
8152587|NCT02607228|20095499|P3|STARTED|Overall Study||3
8152588|NCT02607228|20095500|P2|STARTED|Overall Study||4
8152589|NCT02607228|20095501|P1|STARTED|Overall Study||5
8152590|NCT02607124|20095580|P1|NOT COMPLETED|Overall Study||0
8152591|NCT02607124|20095580|P1|COMPLETED|Overall Study||10
8152592|NCT02607124|20095580|P1|STARTED|Overall Study|11 participants were enrolled however 1 participant withdrew before starting study treatment.|10
8152593|NCT02606903|20095589|P2|NOT COMPLETED|Overall Study||0
8152594|NCT02606903|20095590|P1|NOT COMPLETED|Overall Study||0
8152595|NCT02606903|20095589|P2|COMPLETED|Overall Study||36
8152596|NCT02606903|20095590|P1|COMPLETED|Overall Study||35
8152597|NCT02606903|20095589|P2|STARTED|Overall Study||36
8152598|NCT02606903|20095590|P1|STARTED|Overall Study||35
8152599|NCT02606877|20095604|P2|NOT COMPLETED|Overall Study||1
8152600|NCT02606877|20095605|P1|NOT COMPLETED|Overall Study||4
8152601|NCT02606877|20095604|P2|COMPLETED|Overall Study||16
8152602|NCT02606877|20095605|P1|COMPLETED|Overall Study||16
8152603|NCT02606877|20095604|P2|STARTED|Overall Study||17
8152604|NCT02606877|20095605|P1|STARTED|Overall Study||20
8152605|NCT02606838|20095619|P1|NOT COMPLETED|Overall Study||0
8152606|NCT02606838|20095619|P1|COMPLETED|Overall Study||119
8152607|NCT02606838|20095619|P1|STARTED|Overall Study||119
8152608|NCT02606734|20095627|P1|NOT COMPLETED|Overall Study||0
8152609|NCT02606734|20095627|P1|COMPLETED|Overall Study||44
8152610|NCT02606734|20095627|P1|STARTED|Overall Study||44
8152611|NCT02606708|20095631|P1|NOT COMPLETED|Overall Study||0
8152612|NCT02606708|20095631|P1|COMPLETED|Overall Study||314
8152613|NCT02606708|20095631|P1|STARTED|Overall Study||314
8152614|NCT02606643|20095644|P2|NOT COMPLETED|Overall Study||3
8152615|NCT02606643|20095645|P1|NOT COMPLETED|Overall Study||1
8152616|NCT02606643|20095644|P2|COMPLETED|Overall Study||73
8152617|NCT02606643|20095645|P1|COMPLETED|Overall Study||67
8152618|NCT02606643|20095644|P2|STARTED|Overall Study||76
8152619|NCT02606643|20095645|P1|STARTED|Overall Study||68
8152620|NCT02606604|20095657|P2|NOT COMPLETED|Overall Study||0
8152621|NCT02606604|20095658|P1|NOT COMPLETED|Overall Study||1
8152622|NCT02606604|20095657|P2|COMPLETED|Overall Study||7
8152623|NCT02606604|20095658|P1|COMPLETED|Overall Study||7
8152624|NCT02606604|20095657|P2|STARTED|Overall Study||7
8152625|NCT02606604|20095658|P1|STARTED|Overall Study||8
8152626|NCT02606500|20095684|P2|NOT COMPLETED|Overall Study||0
8152627|NCT02606500|20095685|P1|NOT COMPLETED|Overall Study||0
8152628|NCT02606500|20095684|P2|COMPLETED|Overall Study||35
8152629|NCT02606500|20095685|P1|COMPLETED|Overall Study||35
8152630|NCT02606500|20095684|P2|STARTED|Overall Study||35
8152631|NCT02606500|20095685|P1|STARTED|Overall Study||35
8152632|NCT02606279|20095703|P2|NOT COMPLETED|Overall Study||1
8152633|NCT02606279|20095704|P1|NOT COMPLETED|Overall Study||0
8152634|NCT02606279|20095703|P2|COMPLETED|Overall Study||0
8152635|NCT02606279|20095704|P1|COMPLETED|Overall Study||0
8152636|NCT02606279|20095703|P2|STARTED|Overall Study||1
8152637|NCT02606279|20095704|P1|STARTED|Overall Study||0
8152638|NCT02606253|20095719|P3|NOT COMPLETED|Overall Study||0
8152639|NCT02606253|20095720|P2|NOT COMPLETED|Overall Study||2
8152640|NCT02606253|20095721|P1|NOT COMPLETED|Overall Study||5
8152641|NCT02606253|20095719|P3|COMPLETED|Overall Study||20
8152642|NCT02606253|20095720|P2|COMPLETED|Overall Study||18
8152643|NCT02606253|20095721|P1|COMPLETED|Overall Study||15
8152644|NCT02606253|20095719|P3|STARTED|Overall Study||20
8152645|NCT02606253|20095720|P2|STARTED|Overall Study||20
8152646|NCT02606253|20095721|P1|STARTED|Overall Study||20
8152647|NCT02605993|20095784|P4|NOT COMPLETED|Extension Period||7
8152648|NCT02605993|20095785|P3|NOT COMPLETED|Extension Period||7
8152649|NCT02605993|20095786|P2|NOT COMPLETED|Extension Period||6
8152650|NCT02605993|20095787|P1|NOT COMPLETED|Extension Period||6
8152651|NCT02605993|20095784|P4|COMPLETED|Extension Period||0
8152652|NCT02605993|20095785|P3|COMPLETED|Extension Period||0
8152653|NCT02605993|20095786|P2|COMPLETED|Extension Period||0
8152654|NCT02605993|20095787|P1|COMPLETED|Extension Period||0
8152655|NCT02605993|20095784|P4|STARTED|Extension Period||7
8152656|NCT02605993|20095785|P3|STARTED|Extension Period||7
8152657|NCT02605993|20095786|P2|STARTED|Extension Period||6
8152658|NCT02605993|20095787|P1|STARTED|Extension Period||6
8152659|NCT02605993|20095784|P4|NOT COMPLETED|Treatment Period||0
8152660|NCT02605993|20095785|P3|NOT COMPLETED|Treatment Period||0
8152661|NCT02605993|20095786|P2|NOT COMPLETED|Treatment Period||0
8152662|NCT02605993|20095787|P1|NOT COMPLETED|Treatment Period||0
8152663|NCT02605993|20095784|P4|COMPLETED|Treatment Period||7
8152664|NCT02605993|20095785|P3|COMPLETED|Treatment Period||7
8152665|NCT02605993|20095786|P2|COMPLETED|Treatment Period||6
8152666|NCT02605993|20095787|P1|COMPLETED|Treatment Period||6
8152667|NCT02605993|20095784|P4|Received at Least 1 Dose of Study Drug|Treatment Period||7
8152668|NCT02605993|20095785|P3|Received at Least 1 Dose of Study Drug|Treatment Period||7
8152669|NCT02605993|20095786|P2|Received at Least 1 Dose of Study Drug|Treatment Period||6
8152670|NCT02605993|20095787|P1|Received at Least 1 Dose of Study Drug|Treatment Period||6
8152671|NCT02605993|20095784|P4|STARTED|Treatment Period||7
8152672|NCT02605993|20095785|P3|STARTED|Treatment Period||7
8152673|NCT02605993|20095786|P2|STARTED|Treatment Period||6
8152674|NCT02605993|20095787|P1|STARTED|Treatment Period||6
8152675|NCT02605954|20095823|P2|NOT COMPLETED|Overall Study||4
8152676|NCT02605954|20095824|P1|NOT COMPLETED|Overall Study||12
8152677|NCT02605954|20095823|P2|COMPLETED|Overall Study||88
8152678|NCT02605954|20095824|P1|COMPLETED|Overall Study||171
8152679|NCT02605954|20095823|P2|STARTED|Overall Study||92
8152680|NCT02605954|20095824|P1|STARTED|Overall Study||183
8152681|NCT02605928|20095841|P1|NOT COMPLETED|Overall Study||33
8152682|NCT02605928|20095841|P1|COMPLETED|Overall Study||46
8152683|NCT02605928|20095841|P1|Pivotal Phase, Statistical Phase|Overall Study||51
8152684|NCT02605928|20095841|P1|STARTED|Overall Study||79
8152685|NCT02605876|20095848|P3|NOT COMPLETED|Overall Study||0
8152686|NCT02605876|20095849|P2|NOT COMPLETED|Overall Study||0
8152687|NCT02605876|20095850|P1|NOT COMPLETED|Overall Study||0
8152688|NCT02605876|20095848|P3|COMPLETED|Overall Study||25
8152689|NCT02605876|20095849|P2|COMPLETED|Overall Study||25
8152690|NCT02605876|20095850|P1|COMPLETED|Overall Study||25
8152691|NCT02605876|20095848|P3|STARTED|Overall Study||25
8152692|NCT02605876|20095849|P2|STARTED|Overall Study||25
8152693|NCT02605876|20095850|P1|STARTED|Overall Study||25
8152694|NCT02605863|20095875|P2|NOT COMPLETED|Overall Study||0
8152695|NCT02605863|20095876|P1|NOT COMPLETED|Overall Study||0
8152696|NCT02605863|20095875|P2|COMPLETED|Overall Study||0
8152697|NCT02605863|20095876|P1|COMPLETED|Overall Study||1
8152698|NCT02605863|20095875|P2|STARTED|Overall Study||0
8152699|NCT02605863|20095876|P1|STARTED|Overall Study||1
8152706|NCT02605824|20095924|P2|NOT COMPLETED|Overall Study||0
8152707|NCT02605824|20095925|P1|NOT COMPLETED|Overall Study||1
8152708|NCT02605824|20095924|P2|COMPLETED|Overall Study||0
8152709|NCT02605824|20095925|P1|COMPLETED|Overall Study||0
8152710|NCT02605824|20095924|P2|STARTED|Overall Study||0
8152711|NCT02605824|20095925|P1|STARTED|Overall Study||1
8152712|NCT02605642|20095935|P2|NOT COMPLETED|Overall Study||21
8152713|NCT02605642|20095936|P1|NOT COMPLETED|Overall Study||96
8152714|NCT02605642|20095935|P2|COMPLETED|Overall Study||86
8152715|NCT02605642|20095936|P1|COMPLETED|Overall Study||131
8152716|NCT02605642|20095935|P2|Safety Set|Overall Study||107
8152717|NCT02605642|20095936|P1|Safety Set|Overall Study||221
8152718|NCT02605642|20095935|P2|STARTED|Overall Study||107
8152719|NCT02605642|20095936|P1|STARTED|Overall Study||227
8152720|NCT02605447|20095978|P1|NOT COMPLETED|Overall Study||102
8152721|NCT02605447|20095978|P1|COMPLETED|Overall Study||1385
8152722|NCT02605447|20095978|P1|STARTED|Overall Study||1487
8152723|NCT02605395|20095984|P2|NOT COMPLETED|Period 2, Day 8||0
8152724|NCT02605395|20095985|P1|NOT COMPLETED|Period 2, Day 8||0
8152725|NCT02605395|20095984|P2|COMPLETED|Period 2, Day 8||35
8152726|NCT02605395|20095985|P1|COMPLETED|Period 2, Day 8||35
8152727|NCT02605395|20095984|P2|STARTED|Period 2, Day 8||35
8152728|NCT02605395|20095985|P1|STARTED|Period 2, Day 8||35
8152729|NCT02605395|20095984|P2|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
8152730|NCT02605395|20095985|P1|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
8152731|NCT02605395|20095984|P2|COMPLETED|Washout Period, Day 2 to Day 7||35
8152732|NCT02605395|20095985|P1|COMPLETED|Washout Period, Day 2 to Day 7||35
8152733|NCT02605395|20095984|P2|STARTED|Washout Period, Day 2 to Day 7||35
8152734|NCT02605395|20095985|P1|STARTED|Washout Period, Day 2 to Day 7||35
8152735|NCT02605395|20095984|P2|NOT COMPLETED|Period 1, Day 1||0
8152736|NCT02605395|20095985|P1|NOT COMPLETED|Period 1, Day 1||0
8152737|NCT02605395|20095984|P2|COMPLETED|Period 1, Day 1||35
8152738|NCT02605395|20095985|P1|COMPLETED|Period 1, Day 1||35
8152739|NCT02605395|20095984|P2|STARTED|Period 1, Day 1||35
8152740|NCT02605395|20095985|P1|STARTED|Period 1, Day 1||35
8152741|NCT02605304|20096003|P2|NOT COMPLETED|Overall Study||0
8152742|NCT02605304|20096004|P1|NOT COMPLETED|Overall Study||0
8152743|NCT02605304|20096003|P2|COMPLETED|Overall Study||3
8152744|NCT02605304|20096004|P1|COMPLETED|Overall Study||4
8152745|NCT02605304|20096003|P2|STARTED|Overall Study||3
8152746|NCT02605304|20096004|P1|STARTED|Overall Study||4
8152747|NCT02605187|20096028|P4|NOT COMPLETED|Overall Study||1
8152748|NCT02605187|20096029|P3|NOT COMPLETED|Overall Study||11
8152749|NCT02605187|20096030|P2|NOT COMPLETED|Overall Study||2
8152750|NCT02605187|20096031|P1|NOT COMPLETED|Overall Study||8
8152751|NCT02605187|20096028|P4|COMPLETED|Overall Study||15
8152752|NCT02605187|20096029|P3|COMPLETED|Overall Study||72
8152753|NCT02605187|20096030|P2|COMPLETED|Overall Study||19
8152754|NCT02605187|20096031|P1|COMPLETED|Overall Study||32
8152755|NCT02605187|20096028|P4|STARTED|Overall Study||16
8152756|NCT02605187|20096029|P3|STARTED|Overall Study||83
8152757|NCT02605187|20096030|P2|STARTED|Overall Study||21
8152758|NCT02605187|20096031|P1|STARTED|Overall Study||40
8152759|NCT02605174|20096089|P7|NOT COMPLETED|Overall Study||89
8152760|NCT02605174|20096090|P6|NOT COMPLETED|Overall Study||32
8152761|NCT02605174|20096091|P5|NOT COMPLETED|Overall Study||53
8152762|NCT02605174|20096092|P4|NOT COMPLETED|Overall Study||36
8152763|NCT02605174|20096093|P3|NOT COMPLETED|Overall Study||76
8152764|NCT02605174|20096094|P2|NOT COMPLETED|Overall Study||23
8152765|NCT02605174|20096095|P1|NOT COMPLETED|Overall Study||64
8152766|NCT02605174|20096089|P7|COMPLETED|Overall Study||662
8152767|NCT02605174|20096090|P6|COMPLETED|Overall Study||217
8152768|NCT02605174|20096091|P5|COMPLETED|Overall Study||448
8152769|NCT02605174|20096092|P4|COMPLETED|Overall Study||216
8152770|NCT02605174|20096093|P3|COMPLETED|Overall Study||426
8152771|NCT02605174|20096094|P2|COMPLETED|Overall Study||226
8152772|NCT02605174|20096095|P1|COMPLETED|Overall Study||437
8152773|NCT02605174|20096089|P7|Received Optional 2nd Dose|Overall Study||361
8152774|NCT02605174|20096090|P6|Received Optional 2nd Dose|Overall Study||74
8152775|NCT02605174|20096091|P5|Received Optional 2nd Dose|Overall Study||144
8152776|NCT02605174|20096092|P4|Received Optional 2nd Dose|Overall Study||83
8152777|NCT02605174|20096093|P3|Received Optional 2nd Dose|Overall Study||177
8152778|NCT02605174|20096094|P2|Received Optional 2nd Dose|Overall Study||96
8152779|NCT02605174|20096095|P1|Received Optional 2nd Dose|Overall Study||206
8152780|NCT02605174|20096089|P7|Received at Least 1 Dose of Study Drug|Overall Study||645
8152781|NCT02605174|20096090|P6|Received at Least 1 Dose of Study Drug|Overall Study||215
8152782|NCT02605174|20096091|P5|Received at Least 1 Dose of Study Drug|Overall Study||434
8152783|NCT02605174|20096092|P4|Received at Least 1 Dose of Study Drug|Overall Study||212
8152784|NCT02605174|20096093|P3|Received at Least 1 Dose of Study Drug|Overall Study||423
8152785|NCT02605174|20096094|P2|Received at Least 1 Dose of Study Drug|Overall Study||225
8152786|NCT02605174|20096095|P1|Received at Least 1 Dose of Study Drug|Overall Study||429
8152787|NCT02605174|20096089|P7|STARTED|Overall Study||751
8152788|NCT02605174|20096090|P6|STARTED|Overall Study||249
8152789|NCT02605174|20096091|P5|STARTED|Overall Study||501
8152790|NCT02605174|20096092|P4|STARTED|Overall Study||252
8152791|NCT02605174|20096093|P3|STARTED|Overall Study||502
8152792|NCT02605174|20096094|P2|STARTED|Overall Study||249
8152793|NCT02605174|20096095|P1|STARTED|Overall Study||501
8152794|NCT02605122|20096157|P2|NOT COMPLETED|Overall Study||2
8152795|NCT02605122|20096158|P1|NOT COMPLETED|Overall Study||5
8152796|NCT02605122|20096157|P2|COMPLETED|Overall Study||22
8152797|NCT02605122|20096158|P1|COMPLETED|Overall Study||68
8152798|NCT02605122|20096157|P2|Received Study Drug|Overall Study||24
8152799|NCT02605122|20096158|P1|Received Study Drug|Overall Study||70
8152800|NCT02605122|20096157|P2|STARTED|Overall Study||24
8152801|NCT02605122|20096158|P1|STARTED|Overall Study||73
8152802|NCT02604810|20096170|P1|NOT COMPLETED|IGSC 20%, 24 Weeks||7
8152803|NCT02604810|20096170|P1|COMPLETED|IGSC 20%, 24 Weeks||42
8152804|NCT02604810|20096170|P1|STARTED|IGSC 20%, 24 Weeks||49
8152805|NCT02604810|20096170|P1|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3
8152806|NCT02604810|20096170|P1|COMPLETED|IGIV-C 10%, 4-5 Weeks||49
8152807|NCT02604810|20096170|P1|STARTED|IGIV-C 10%, 4-5 Weeks||52
8152808|NCT02604589|20096181|P3|NOT COMPLETED|Overall Study||1
8152809|NCT02604589|20096182|P2|NOT COMPLETED|Overall Study||0
8152810|NCT02604589|20096183|P1|NOT COMPLETED|Overall Study||0
8152811|NCT02604589|20096181|P3|COMPLETED|Overall Study||1
8152812|NCT02604589|20096182|P2|COMPLETED|Overall Study||5
8152813|NCT02604589|20096183|P1|COMPLETED|Overall Study||3
8152814|NCT02604589|20096181|P3|STARTED|Overall Study||2
8152815|NCT02604589|20096182|P2|STARTED|Overall Study||5
8152816|NCT02604589|20096183|P1|STARTED|Overall Study||3
8152817|NCT02604550|20096211|P2|NOT COMPLETED|Overall Study||26
8152818|NCT02604550|20096212|P1|NOT COMPLETED|Overall Study||25
8152819|NCT02604550|20096211|P2|COMPLETED|Overall Study||33
8152820|NCT02604550|20096212|P1|COMPLETED|Overall Study||31
8152821|NCT02604550|20096211|P2|STARTED|Overall Study||59
8152822|NCT02604550|20096212|P1|STARTED|Overall Study||56
8152823|NCT02604433|20096238|P2|NOT COMPLETED|Post Treatment Follow-up Period||24
8152824|NCT02604433|20096239|P1|NOT COMPLETED|Post Treatment Follow-up Period||42
8152825|NCT02604433|20096238|P2|COMPLETED|Post Treatment Follow-up Period||0
8152826|NCT02604433|20096239|P1|COMPLETED|Post Treatment Follow-up Period||0
8152827|NCT02604433|20096238|P2|STARTED|Post Treatment Follow-up Period||24
8152828|NCT02604433|20096239|P1|STARTED|Post Treatment Follow-up Period||42
8152829|NCT02604433|20096238|P2|NOT COMPLETED|Open-Label Treatment Period||0
8152830|NCT02604433|20096239|P1|NOT COMPLETED|Open-Label Treatment Period||0
8152831|NCT02604433|20096238|P2|COMPLETED|Open-Label Treatment Period||0
8152832|NCT02604433|20096239|P1|COMPLETED|Open-Label Treatment Period||0
8152833|NCT02604433|20096238|P2|STARTED|Open-Label Treatment Period||0
8152834|NCT02604433|20096239|P1|STARTED|Open-Label Treatment Period||0
8152835|NCT02604433|20096238|P2|NOT COMPLETED|Double-blind Treatment Period||106
8152836|NCT02604433|20096239|P1|NOT COMPLETED|Double-blind Treatment Period||218
8152837|NCT02604433|20096238|P2|COMPLETED|Double-blind Treatment Period|Completed study per original protocol|6
8152838|NCT02604433|20096239|P1|COMPLETED|Double-blind Treatment Period|Completed study per original protocol|6
8152839|NCT02604433|20096238|P2|Completed 48 Weeks of Treatment|Double-blind Treatment Period||96
8152840|NCT02604433|20096239|P1|Completed 48 Weeks of Treatment|Double-blind Treatment Period||200
8152841|NCT02604433|20096238|P2|Completed 24 Weeks of Treatment|Double-blind Treatment Period||102
8152842|NCT02604433|20096239|P1|Completed 24 Weeks of Treatment|Double-blind Treatment Period||210
8152843|NCT02604433|20096238|P2|Health-Related Quality of Life Populatio|Double-blind Treatment Period||103
8152844|NCT02604433|20096239|P1|Health-Related Quality of Life Populatio|Double-blind Treatment Period||211
8152845|NCT02604433|20096238|P2|Pharmacokinetic Population|Double-blind Treatment Period|Participants did not take luspatercept.|0
8152846|NCT02604433|20096239|P1|Pharmacokinetic Population|Double-blind Treatment Period||221
8152847|NCT02604433|20096238|P2|Safety Population|Double-blind Treatment Period||109
8152848|NCT02604433|20096239|P1|Safety Population|Double-blind Treatment Period||223
8152849|NCT02604433|20096238|P2|Intent to Treat Population|Double-blind Treatment Period||112
8152850|NCT02604433|20096239|P1|Intent to Treat Population|Double-blind Treatment Period||224
8152851|NCT02604433|20096238|P2|STARTED|Double-blind Treatment Period||112
8152852|NCT02604433|20096239|P1|STARTED|Double-blind Treatment Period||224
8152865|NCT02604342|20096323|P2|NOT COMPLETED|Overall Study||23
8152866|NCT02604342|20096324|P1|NOT COMPLETED|Overall Study||43
8152867|NCT02604342|20096323|P2|COMPLETED|Overall Study||17
8152868|NCT02604342|20096324|P1|COMPLETED|Overall Study||36
8152869|NCT02604342|20096323|P2|STARTED|Overall Study||40
8152870|NCT02604342|20096324|P1|STARTED|Overall Study||79
8152871|NCT02604264|20096376|P2|NOT COMPLETED|Intervention||242
8152872|NCT02604264|20096377|P1|NOT COMPLETED|Intervention||200
8152873|NCT02604264|20096376|P2|COMPLETED|Intervention||1225
8152874|NCT02604264|20096377|P1|COMPLETED|Intervention||1245
8152875|NCT02604264|20096376|P2|STARTED|Intervention||1467
8152876|NCT02604264|20096377|P1|STARTED|Intervention||1445
8152877|NCT02604264|20096376|P2|NOT COMPLETED|Run-In||0
8152878|NCT02604264|20096377|P1|NOT COMPLETED|Run-In||0
8152879|NCT02604264|20096376|P2|COMPLETED|Run-In||611
8152880|NCT02604264|20096377|P1|COMPLETED|Run-In||618
8152881|NCT02604264|20096376|P2|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
8152882|NCT02604264|20096377|P1|STARTED|Run-In||618
8152883|NCT02604212|20096387|P4|NOT COMPLETED|Overall Study||3
8152884|NCT02604212|20096388|P3|NOT COMPLETED|Overall Study||4
8152885|NCT02604212|20096389|P2|NOT COMPLETED|Overall Study||1
8152886|NCT02604212|20096390|P1|NOT COMPLETED|Overall Study||2
8152887|NCT02604212|20096387|P4|COMPLETED|Overall Study||8
8152888|NCT02604212|20096388|P3|COMPLETED|Overall Study||6
8152889|NCT02604212|20096389|P2|COMPLETED|Overall Study||4
8152890|NCT02604212|20096390|P1|COMPLETED|Overall Study||4
8152891|NCT02604212|20096387|P4|STARTED|Overall Study||11
8152892|NCT02604212|20096388|P3|STARTED|Overall Study||10
8152893|NCT02604212|20096389|P2|STARTED|Overall Study||5
8152894|NCT02604212|20096390|P1|STARTED|Overall Study||6
8152895|NCT02604199|20096458|P4|NOT COMPLETED|Overall Study||3
8152896|NCT02604199|20096459|P3|NOT COMPLETED|Overall Study||0
8152897|NCT02604199|20096460|P2|NOT COMPLETED|Overall Study||3
8152898|NCT02604199|20096461|P1|NOT COMPLETED|Overall Study||0
8152899|NCT02604199|20096458|P4|COMPLETED|Overall Study||18
8152900|NCT02604199|20096459|P3|COMPLETED|Overall Study||17
8152901|NCT02604199|20096460|P2|COMPLETED|Overall Study||8
8152902|NCT02604199|20096461|P1|COMPLETED|Overall Study||9
8152903|NCT02604199|20096458|P4|STARTED|Overall Study||21
8152904|NCT02604199|20096459|P3|STARTED|Overall Study||17
8152905|NCT02604199|20096460|P2|STARTED|Overall Study||11
8152906|NCT02604199|20096461|P1|STARTED|Overall Study||9
8152907|NCT02604173|20096512|P3|NOT COMPLETED|Overall Study||0
8152908|NCT02604173|20096513|P2|NOT COMPLETED|Overall Study||0
8152909|NCT02604173|20096514|P1|NOT COMPLETED|Overall Study||0
8152910|NCT02604173|20096512|P3|COMPLETED|Overall Study||35
8152911|NCT02604173|20096513|P2|COMPLETED|Overall Study||35
8152912|NCT02604173|20096514|P1|COMPLETED|Overall Study||33
8152913|NCT02604173|20096512|P3|STARTED|Overall Study||35
8152914|NCT02604173|20096513|P2|STARTED|Overall Study||35
8152915|NCT02604173|20096514|P1|STARTED|Overall Study||33
8152916|NCT02604160|20096530|P2|NOT COMPLETED|Overall Study||2
8152917|NCT02604160|20096531|P1|NOT COMPLETED|Overall Study||0
8152918|NCT02604160|20096530|P2|COMPLETED|Overall Study||3
8152919|NCT02604160|20096531|P1|COMPLETED|Overall Study||2
8152920|NCT02604160|20096530|P2|Received at Least One Dose of Study Drug|Overall Study||5
8152921|NCT02604160|20096531|P1|Received at Least One Dose of Study Drug|Overall Study||2
8152922|NCT02604160|20096530|P2|STARTED|Overall Study||5
8152923|NCT02604160|20096531|P1|STARTED|Overall Study||2
8152930|NCT02603952|20096575|P4|NOT COMPLETED|Overall Study||1
8152931|NCT02603952|20096576|P3|NOT COMPLETED|Overall Study||0
8152932|NCT02603952|20096577|P2|NOT COMPLETED|Overall Study||0
8152933|NCT02603952|20096578|P1|NOT COMPLETED|Overall Study||1
8152934|NCT02603952|20096575|P4|COMPLETED|Overall Study||31
8152935|NCT02603952|20096576|P3|COMPLETED|Overall Study||31
8152936|NCT02603952|20096577|P2|COMPLETED|Overall Study||31
8152937|NCT02603952|20096578|P1|COMPLETED|Overall Study||31
8152938|NCT02603952|20096575|P4|Treated|Overall Study||31
8152939|NCT02603952|20096576|P3|Treated|Overall Study||31
8152940|NCT02603952|20096577|P2|Treated|Overall Study||31
8152941|NCT02603952|20096578|P1|Treated|Overall Study||32
8152942|NCT02603952|20096575|P4|STARTED|Overall Study||32
8152943|NCT02603952|20096576|P3|STARTED|Overall Study||31
8152944|NCT02603952|20096577|P2|STARTED|Overall Study||31
8152945|NCT02603952|20096578|P1|STARTED|Overall Study||32
8152946|NCT02603926|20096619|P1|NOT COMPLETED|Overall Study||0
8152947|NCT02603926|20096619|P1|COMPLETED|Overall Study||6
8152948|NCT02603926|20096619|P1|STARTED|Overall Study||6
8152949|NCT02603887|20096626|P1|NOT COMPLETED|Overall Study||6
8152950|NCT02603887|20096626|P1|COMPLETED|Overall Study||7
8152951|NCT02603887|20096626|P1|Cycle 8|Overall Study||7
8152952|NCT02603887|20096626|P1|Cycle 1|Overall Study||13
8152953|NCT02603887|20096626|P1|STARTED|Overall Study||13
8152954|NCT02603809|20096639|P6|NOT COMPLETED|Overall Study||10
8152955|NCT02603809|20096640|P5|NOT COMPLETED|Overall Study||11
8152956|NCT02603809|20096641|P4|NOT COMPLETED|Overall Study||12
8152957|NCT02603809|20096642|P3|NOT COMPLETED|Overall Study||7
8152958|NCT02603809|20096643|P2|NOT COMPLETED|Overall Study||8
8152959|NCT02603809|20096644|P1|NOT COMPLETED|Overall Study||12
8152960|NCT02603809|20096639|P6|COMPLETED|Overall Study||71
8152961|NCT02603809|20096640|P5|COMPLETED|Overall Study||70
8152962|NCT02603809|20096641|P4|COMPLETED|Overall Study||70
8152963|NCT02603809|20096642|P3|COMPLETED|Overall Study||75
8152964|NCT02603809|20096643|P2|COMPLETED|Overall Study||74
8152965|NCT02603809|20096644|P1|COMPLETED|Overall Study||70
8152966|NCT02603809|20096639|P6|Completed Study|Overall Study||75
8152967|NCT02603809|20096640|P5|Completed Study|Overall Study||78
8152968|NCT02603809|20096641|P4|Completed Study|Overall Study||76
8152969|NCT02603809|20096642|P3|Completed Study|Overall Study||79
8152970|NCT02603809|20096643|P2|Completed Study|Overall Study||79
8152971|NCT02603809|20096644|P1|Completed Study|Overall Study||75
8152972|NCT02603809|20096639|P6|Modified Per-Protocol Set|Overall Study||69
8152973|NCT02603809|20096640|P5|Modified Per-Protocol Set|Overall Study||68
8152974|NCT02603809|20096641|P4|Modified Per-Protocol Set|Overall Study||67
8152975|NCT02603809|20096642|P3|Modified Per-Protocol Set|Overall Study||71
8152976|NCT02603809|20096643|P2|Modified Per-Protocol Set|Overall Study||68
8152977|NCT02603809|20096644|P1|Modified Per-Protocol Set|Overall Study|One participant had out of analysis window blood pressure measurements.|66
8152978|NCT02603809|20096639|P6|Per-protocol Set|Overall Study||69
8152979|NCT02603809|20096640|P5|Per-protocol Set|Overall Study||68
8152980|NCT02603809|20096641|P4|Per-protocol Set|Overall Study||67
8152981|NCT02603809|20096642|P3|Per-protocol Set|Overall Study||71
8152982|NCT02603809|20096643|P2|Per-protocol Set|Overall Study||68
8152983|NCT02603809|20096644|P1|Per-protocol Set|Overall Study||67
8152984|NCT02603809|20096639|P6|STARTED|Overall Study||81
8152985|NCT02603809|20096640|P5|STARTED|Overall Study||81
8152986|NCT02603809|20096641|P4|STARTED|Overall Study||82
8152987|NCT02603809|20096642|P3|STARTED|Overall Study||82
8152988|NCT02603809|20096643|P2|STARTED|Overall Study||82
8152989|NCT02603809|20096644|P1|STARTED|Overall Study||82
8152990|NCT02603666|20096700|P1|NOT COMPLETED|Overall Study||0
8152991|NCT02603666|20096700|P1|COMPLETED|Overall Study||130
8152992|NCT02603666|20096700|P1|STARTED|Overall Study||130
8152999|NCT02603419|20096761|P6|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||3
8153000|NCT02603419|20096762|P5|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153001|NCT02603419|20096763|P4|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153002|NCT02603419|20096764|P3|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153003|NCT02603419|20096765|P2|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153004|NCT02603419|20096766|P1|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153005|NCT02603419|20096761|P6|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153006|NCT02603419|20096762|P5|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153007|NCT02603419|20096763|P4|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153008|NCT02603419|20096764|P3|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153009|NCT02603419|20096765|P2|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153010|NCT02603419|20096766|P1|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
8153011|NCT02603419|20096761|P6|STARTED|Expansion Phase:Maximum Exposure:48Weeks|Participants started expansion phase while other few participants were completing lead-in phase.|3
8153012|NCT02603419|20096762|P5|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8153013|NCT02603419|20096763|P4|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8153014|NCT02603419|20096764|P3|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8153015|NCT02603419|20096765|P2|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8153016|NCT02603419|20096766|P1|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
8153017|NCT02603419|20096761|P6|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153018|NCT02603419|20096762|P5|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153019|NCT02603419|20096763|P4|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153020|NCT02603419|20096764|P3|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153021|NCT02603419|20096765|P2|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||7
8153022|NCT02603419|20096766|P1|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153023|NCT02603419|20096761|P6|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153024|NCT02603419|20096762|P5|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153025|NCT02603419|20096763|P4|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153026|NCT02603419|20096764|P3|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153027|NCT02603419|20096765|P2|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153028|NCT02603419|20096766|P1|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153029|NCT02603419|20096761|P6|Treated|Lead-in Phase:Maximum Exposure:123Weeks||0
8153030|NCT02603419|20096762|P5|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8153031|NCT02603419|20096763|P4|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8153032|NCT02603419|20096764|P3|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8153033|NCT02603419|20096765|P2|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8153034|NCT02603419|20096766|P1|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
8153035|NCT02603419|20096761|P6|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||0
8153036|NCT02603419|20096762|P5|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153037|NCT02603419|20096763|P4|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153038|NCT02603419|20096764|P3|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153039|NCT02603419|20096765|P2|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||7
8153040|NCT02603419|20096766|P1|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
8153041|NCT02603393|20096953|P2|NOT COMPLETED|Overall Study||54
8153042|NCT02603393|20096954|P1|NOT COMPLETED|Overall Study||71
8153043|NCT02603393|20096953|P2|COMPLETED|Overall Study||472
8153044|NCT02603393|20096954|P1|COMPLETED|Overall Study||456
8153045|NCT02603393|20096953|P2|STARTED|Overall Study||526
8153046|NCT02603393|20096954|P1|STARTED|Overall Study||527
8153047|NCT02603211|20096980|P1|NOT COMPLETED|Overall Study||0
8153048|NCT02603211|20096980|P1|COMPLETED|Overall Study||20
8153049|NCT02603211|20096980|P1|STARTED|Overall Study||20
8153050|NCT02603172|20096993|P8|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153051|NCT02603172|20096994|P7|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153052|NCT02603172|20096995|P6|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153053|NCT02603172|20096996|P5|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153054|NCT02603172|20096997|P4|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153055|NCT02603172|20096998|P3|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153056|NCT02603172|20096999|P2|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153057|NCT02603172|20097000|P1|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
8153058|NCT02603172|20096993|P8|COMPLETED|Part C (Approximately 13 Weeks)||0
8153059|NCT02603172|20096994|P7|COMPLETED|Part C (Approximately 13 Weeks)||0
8153060|NCT02603172|20096995|P6|COMPLETED|Part C (Approximately 13 Weeks)||0
8153061|NCT02603172|20096996|P5|COMPLETED|Part C (Approximately 13 Weeks)||0
8153062|NCT02603172|20096997|P4|COMPLETED|Part C (Approximately 13 Weeks)||0
8153063|NCT02603172|20096998|P3|COMPLETED|Part C (Approximately 13 Weeks)||0
8153064|NCT02603172|20096999|P2|COMPLETED|Part C (Approximately 13 Weeks)||0
8153065|NCT02603172|20097000|P1|COMPLETED|Part C (Approximately 13 Weeks)||0
8153066|NCT02603172|20096993|P8|STARTED|Part C (Approximately 13 Weeks)||0
8153067|NCT02603172|20096994|P7|STARTED|Part C (Approximately 13 Weeks)||0
8153068|NCT02603172|20096995|P6|STARTED|Part C (Approximately 13 Weeks)||0
8153069|NCT02603172|20096996|P5|STARTED|Part C (Approximately 13 Weeks)||0
8153070|NCT02603172|20096997|P4|STARTED|Part C (Approximately 13 Weeks)||0
8153071|NCT02603172|20096998|P3|STARTED|Part C (Approximately 13 Weeks)||0
8153072|NCT02603172|20096999|P2|STARTED|Part C (Approximately 13 Weeks)||0
8153073|NCT02603172|20097000|P1|STARTED|Part C (Approximately 13 Weeks)||0
8153074|NCT02603172|20096993|P8|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153075|NCT02603172|20096994|P7|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153076|NCT02603172|20096995|P6|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153077|NCT02603172|20096996|P5|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153078|NCT02603172|20096997|P4|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153079|NCT02603172|20096998|P3|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153080|NCT02603172|20096999|P2|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153081|NCT02603172|20097000|P1|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
8153082|NCT02603172|20096993|P8|COMPLETED|Part B (Approximately 7 Weeks)||0
8153083|NCT02603172|20096994|P7|COMPLETED|Part B (Approximately 7 Weeks)||0
8153084|NCT02603172|20096995|P6|COMPLETED|Part B (Approximately 7 Weeks)||0
8153085|NCT02603172|20096996|P5|COMPLETED|Part B (Approximately 7 Weeks)||6
8153086|NCT02603172|20096997|P4|COMPLETED|Part B (Approximately 7 Weeks)||1
8153087|NCT02603172|20096998|P3|COMPLETED|Part B (Approximately 7 Weeks)||0
8153088|NCT02603172|20096999|P2|COMPLETED|Part B (Approximately 7 Weeks)||1
8153089|NCT02603172|20097000|P1|COMPLETED|Part B (Approximately 7 Weeks)||0
8153090|NCT02603172|20096993|P8|STARTED|Part B (Approximately 7 Weeks)||0
8153091|NCT02603172|20096994|P7|STARTED|Part B (Approximately 7 Weeks)||0
8153092|NCT02603172|20096995|P6|STARTED|Part B (Approximately 7 Weeks)||0
8153093|NCT02603172|20096996|P5|STARTED|Part B (Approximately 7 Weeks)||6
8153094|NCT02603172|20096997|P4|STARTED|Part B (Approximately 7 Weeks)||1
8153095|NCT02603172|20096998|P3|STARTED|Part B (Approximately 7 Weeks)||0
8153096|NCT02603172|20096999|P2|STARTED|Part B (Approximately 7 Weeks)||1
8153097|NCT02603172|20097000|P1|STARTED|Part B (Approximately 7 Weeks)||0
8153098|NCT02603172|20096993|P8|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8153099|NCT02603172|20096994|P7|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8153100|NCT02603172|20096995|P6|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8153101|NCT02603172|20096996|P5|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8153102|NCT02603172|20096997|P4|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8153103|NCT02603172|20096998|P3|NOT COMPLETED|Part A (Approximately 16 Weeks)||1
8153104|NCT02603172|20096999|P2|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8153105|NCT02603172|20097000|P1|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
8153106|NCT02603172|20096993|P8|COMPLETED|Part A (Approximately 16 Weeks)||0
8153107|NCT02603172|20096994|P7|COMPLETED|Part A (Approximately 16 Weeks)||0
8153108|NCT02603172|20096995|P6|COMPLETED|Part A (Approximately 16 Weeks)||0
8153109|NCT02603172|20096996|P5|COMPLETED|Part A (Approximately 16 Weeks)||0
8153110|NCT02603172|20096997|P4|COMPLETED|Part A (Approximately 16 Weeks)||1
8153111|NCT02603172|20096998|P3|COMPLETED|Part A (Approximately 16 Weeks)||7
8153112|NCT02603172|20096999|P2|COMPLETED|Part A (Approximately 16 Weeks)||1
8153113|NCT02603172|20097000|P1|COMPLETED|Part A (Approximately 16 Weeks)||7
8153114|NCT02603172|20096993|P8|STARTED|Part A (Approximately 16 Weeks)||0
8153115|NCT02603172|20096994|P7|STARTED|Part A (Approximately 16 Weeks)||0
8153116|NCT02603172|20096995|P6|STARTED|Part A (Approximately 16 Weeks)||0
8153117|NCT02603172|20096996|P5|STARTED|Part A (Approximately 16 Weeks)||0
8153118|NCT02603172|20096997|P4|STARTED|Part A (Approximately 16 Weeks)||1
8153119|NCT02603172|20096998|P3|STARTED|Part A (Approximately 16 Weeks)||8
8153120|NCT02603172|20096999|P2|STARTED|Part A (Approximately 16 Weeks)||1
8153121|NCT02603172|20097000|P1|STARTED|Part A (Approximately 16 Weeks)||7
8153122|NCT02603120|20097128|P2|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||11
8153123|NCT02603120|20097129|P1|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||5
8153124|NCT02603120|20097128|P2|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
8153125|NCT02603120|20097129|P1|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
8153126|NCT02603120|20097128|P2|STARTED|OL Extension B/F/TAF Treatment Phase||265
8153127|NCT02603120|20097129|P1|STARTED|OL Extension B/F/TAF Treatment Phase||259
8153128|NCT02603120|20097128|P2|NOT COMPLETED|Double-Blind Treatment Phase||16
8153129|NCT02603120|20097129|P1|NOT COMPLETED|Double-Blind Treatment Phase||19
8153130|NCT02603120|20097128|P2|COMPLETED|Double-Blind Treatment Phase||267
8153131|NCT02603120|20097129|P1|COMPLETED|Double-Blind Treatment Phase||265
8153132|NCT02603120|20097128|P2|STARTED|Double-Blind Treatment Phase||283
8153133|NCT02603120|20097129|P1|STARTED|Double-Blind Treatment Phase||284
8153134|NCT02603107|20097151|P2|NOT COMPLETED|Optional Extension Phase||13
8153135|NCT02603107|20097152|P1|NOT COMPLETED|Optional Extension Phase||9
8153136|NCT02603107|20097151|P2|COMPLETED|Optional Extension Phase||232
8153137|NCT02603107|20097152|P1|COMPLETED|Optional Extension Phase||263
8153138|NCT02603107|20097151|P2|STARTED|Optional Extension Phase|21 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|245
8153139|NCT02603107|20097152|P1|STARTED|Optional Extension Phase|3 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|272
8153140|NCT02603107|20097151|P2|NOT COMPLETED|Randomized Phase||21
8153141|NCT02603107|20097152|P1|NOT COMPLETED|Randomized Phase||15
8153142|NCT02603107|20097151|P2|COMPLETED|Randomized Phase||266
8153143|NCT02603107|20097152|P1|COMPLETED|Randomized Phase||275
8153144|NCT02603107|20097151|P2|STARTED|Randomized Phase||287
8153145|NCT02603107|20097152|P1|STARTED|Randomized Phase||290
8153146|NCT02602496|20097167|P3|NOT COMPLETED|Overall Study||0
8153147|NCT02602496|20097168|P2|NOT COMPLETED|Overall Study||2
8153148|NCT02602496|20097169|P1|NOT COMPLETED|Overall Study||1
8153149|NCT02602496|20097167|P3|COMPLETED|Overall Study||17
8153150|NCT02602496|20097168|P2|COMPLETED|Overall Study||18
8153151|NCT02602496|20097169|P1|COMPLETED|Overall Study||14
8153152|NCT02602496|20097167|P3|STARTED|Overall Study||17
8153153|NCT02602496|20097168|P2|STARTED|Overall Study||20
8153154|NCT02602496|20097169|P1|STARTED|Overall Study||15
8153155|NCT02602223|20097198|P1|NOT COMPLETED|Overall Study||0
8153156|NCT02602223|20097198|P1|COMPLETED|Overall Study||9
8153157|NCT02602223|20097198|P1|STARTED|Overall Study||9
8153158|NCT02602080|20097217|P3|NOT COMPLETED|Overall Study||3
8153159|NCT02602080|20097218|P2|NOT COMPLETED|Overall Study||1
8153160|NCT02602080|20097219|P1|NOT COMPLETED|Overall Study||6
8153161|NCT02602080|20097217|P3|COMPLETED|Overall Study||15
8153162|NCT02602080|20097218|P2|COMPLETED|Overall Study||15
8153163|NCT02602080|20097219|P1|COMPLETED|Overall Study||15
8153164|NCT02602080|20097217|P3|STARTED|Overall Study||18
8153165|NCT02602080|20097218|P2|STARTED|Overall Study||16
8153166|NCT02602080|20097219|P1|STARTED|Overall Study||21
8153167|NCT02601976|20097254|P1|NOT COMPLETED|Overall Study||0
8153168|NCT02601976|20097254|P1|COMPLETED|Overall Study||64
8153169|NCT02601976|20097254|P1|STARTED|Overall Study||64
8153170|NCT02601820|20097262|P1|NOT COMPLETED|1-Yr Post-Treatment (T5)||88
8153171|NCT02601820|20097262|P1|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440
8153172|NCT02601820|20097262|P1|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528
8153173|NCT02601820|20097262|P1|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3
8153174|NCT02601820|20097262|P1|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561
8153175|NCT02601820|20097262|P1|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564
8153176|NCT02601820|20097262|P1|NOT COMPLETED|Late On-Treatment (T3)||49
8153177|NCT02601820|20097262|P1|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524
8153178|NCT02601820|20097262|P1|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573
8153179|NCT02601820|20097262|P1|NOT COMPLETED|Early On-Treatment (T2)||51
8153180|NCT02601820|20097262|P1|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533
8153181|NCT02601820|20097262|P1|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584
8153182|NCT02601820|20097262|P1|NOT COMPLETED|Pre-Treatment (T1)||0
8153183|NCT02601820|20097262|P1|COMPLETED|Pre-Treatment (T1)||1601
8153184|NCT02601820|20097262|P1|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601
8153185|NCT02601625|20097291|P4|NOT COMPLETED|Overall Study||1
8153186|NCT02601625|20097292|P3|NOT COMPLETED|Overall Study||1
8153187|NCT02601625|20097293|P2|NOT COMPLETED|Overall Study||0
8153188|NCT02601625|20097294|P1|NOT COMPLETED|Overall Study||0
8153189|NCT02601625|20097291|P4|COMPLETED|Overall Study||11
8153190|NCT02601625|20097292|P3|COMPLETED|Overall Study||5
8153191|NCT02601625|20097293|P2|COMPLETED|Overall Study||6
8153192|NCT02601625|20097294|P1|COMPLETED|Overall Study||6
8153193|NCT02601625|20097291|P4|STARTED|Overall Study||12
8153194|NCT02601625|20097292|P3|STARTED|Overall Study||6
8153195|NCT02601625|20097293|P2|STARTED|Overall Study||6
8153196|NCT02601625|20097294|P1|STARTED|Overall Study||6
8153197|NCT02601573|20097347|P5|NOT COMPLETED|Overall Study||2
8153198|NCT02601573|20097348|P4|NOT COMPLETED|Overall Study||1
8153199|NCT02601573|20097349|P3|NOT COMPLETED|Overall Study||1
8153200|NCT02601573|20097350|P2|NOT COMPLETED|Overall Study||4
8153201|NCT02601573|20097351|P1|NOT COMPLETED|Overall Study||0
8153202|NCT02601573|20097347|P5|COMPLETED|Overall Study||16
8153203|NCT02601573|20097348|P4|COMPLETED|Overall Study||17
8153204|NCT02601573|20097349|P3|COMPLETED|Overall Study||16
8153205|NCT02601573|20097350|P2|COMPLETED|Overall Study||20
8153206|NCT02601573|20097351|P1|COMPLETED|Overall Study||23
8153207|NCT02601573|20097347|P5|STARTED|Overall Study|Number randomized and treated.|18
8153208|NCT02601573|20097348|P4|STARTED|Overall Study|Number randomized and treated.|18
8153209|NCT02601573|20097349|P3|STARTED|Overall Study|Number randomized and treated.|17
8153210|NCT02601573|20097350|P2|STARTED|Overall Study|Number randomized and treated.|24
8153211|NCT02601573|20097351|P1|STARTED|Overall Study|Number randomized and treated.|23
8153212|NCT02601560|20097386|P8|NOT COMPLETED|Overall Study||0
8153213|NCT02601560|20097387|P7|NOT COMPLETED|Overall Study||1
8153214|NCT02601560|20097388|P6|NOT COMPLETED|Overall Study||0
8153215|NCT02601560|20097389|P5|NOT COMPLETED|Overall Study||0
8153216|NCT02601560|20097390|P4|NOT COMPLETED|Overall Study||0
8153217|NCT02601560|20097391|P3|NOT COMPLETED|Overall Study||0
8153218|NCT02601560|20097392|P2|NOT COMPLETED|Overall Study||0
8153219|NCT02601560|20097393|P1|NOT COMPLETED|Overall Study||0
8153220|NCT02601560|20097386|P8|COMPLETED|Overall Study||6
8153221|NCT02601560|20097387|P7|COMPLETED|Overall Study||5
8153222|NCT02601560|20097388|P6|COMPLETED|Overall Study||4
8153223|NCT02601560|20097389|P5|COMPLETED|Overall Study||6
8153224|NCT02601560|20097390|P4|COMPLETED|Overall Study||6
8153225|NCT02601560|20097391|P3|COMPLETED|Overall Study||6
8153226|NCT02601560|20097392|P2|COMPLETED|Overall Study||6
8153227|NCT02601560|20097393|P1|COMPLETED|Overall Study||8
8153228|NCT02601560|20097386|P8|STARTED|Overall Study||6
8153229|NCT02601560|20097387|P7|STARTED|Overall Study||6
8153230|NCT02601560|20097388|P6|STARTED|Overall Study||4
8153231|NCT02601560|20097389|P5|STARTED|Overall Study||6
8153232|NCT02601560|20097390|P4|STARTED|Overall Study||6
8153233|NCT02601560|20097391|P3|STARTED|Overall Study||6
8153234|NCT02601560|20097392|P2|STARTED|Overall Study||6
8153235|NCT02601560|20097393|P1|STARTED|Overall Study||8
8153236|NCT02601469|20097577|P2|NOT COMPLETED|Overall Study||0
8153237|NCT02601469|20097578|P1|NOT COMPLETED|Overall Study||1
8153238|NCT02601469|20097577|P2|COMPLETED|Overall Study||1
8153239|NCT02601469|20097578|P1|COMPLETED|Overall Study||24
8153240|NCT02601469|20097577|P2|STARTED|Overall Study||1
8153241|NCT02601469|20097578|P1|STARTED|Overall Study||25
8153251|NCT02601300|20097608|P1|NOT COMPLETED|Extension Phase||17
8153252|NCT02601300|20097608|P1|COMPLETED|Extension Phase||18
8153253|NCT02601300|20097608|P1|Treated With IP|Extension Phase||34
8153254|NCT02601300|20097608|P1|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
8153255|NCT02601300|20097608|P1|NOT COMPLETED|Induction Phase||3
8153256|NCT02601300|20097608|P1|COMPLETED|Induction Phase||38
8153257|NCT02601300|20097608|P1|STARTED|Induction Phase||41
8153386|NCT02600351|20097841|P4|COMPLETED|Overall Study||22
8153312|NCT02601170|20097664|P2|NOT COMPLETED|Overall Study||0
8153313|NCT02601170|20097665|P1|NOT COMPLETED|Overall Study||0
8153314|NCT02601170|20097664|P2|COMPLETED|Overall Study||11
8153315|NCT02601170|20097665|P1|COMPLETED|Overall Study||11
8153316|NCT02601170|20097664|P2|STARTED|Overall Study||11
8153317|NCT02601170|20097665|P1|STARTED|Overall Study||11
8153322|NCT02600871|20097693|P2|NOT COMPLETED|Overall Study||10
8153323|NCT02600871|20097694|P1|NOT COMPLETED|Overall Study||13
8153324|NCT02600871|20097693|P2|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
8153325|NCT02600871|20097694|P1|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
8153326|NCT02600871|20097693|P2|STARTED|Overall Study||49
8153327|NCT02600871|20097694|P1|STARTED|Overall Study||52
8153328|NCT02600845|20097704|P1|NOT COMPLETED|Overall Study||18
8153329|NCT02600845|20097704|P1|COMPLETED|Overall Study||104
8153330|NCT02600845|20097704|P1|STARTED|Overall Study||122
8153331|NCT02600819|20097719|P2|NOT COMPLETED|BVY OL Extension Phase||0
8153332|NCT02600819|20097720|P1|NOT COMPLETED|BVY OL Extension Phase||0
8153333|NCT02600819|20097719|P2|COMPLETED|BVY OL Extension Phase||10
8153334|NCT02600819|20097720|P1|COMPLETED|BVY OL Extension Phase||0
8153335|NCT02600819|20097719|P2|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|10
8153336|NCT02600819|20097720|P1|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0
8153337|NCT02600819|20097719|P2|NOT COMPLETED|GEN Phase||0
8153338|NCT02600819|20097720|P1|NOT COMPLETED|GEN Phase||16
8153339|NCT02600819|20097719|P2|COMPLETED|GEN Phase||0
8153340|NCT02600819|20097720|P1|COMPLETED|GEN Phase||39
8153341|NCT02600819|20097719|P2|STARTED|GEN Phase||0
8153342|NCT02600819|20097720|P1|STARTED|GEN Phase||55
8153343|NCT02600767|20097740|P1|NOT COMPLETED|Overall Study||5
8153344|NCT02600767|20097740|P1|COMPLETED|Overall Study||74
8153345|NCT02600767|20097740|P1|STARTED|Overall Study||79
8153346|NCT02600715|20097746|P2|NOT COMPLETED|Overall Study||0
8153347|NCT02600715|20097747|P1|NOT COMPLETED|Overall Study||0
8153348|NCT02600715|20097746|P2|COMPLETED|Overall Study||13
8153349|NCT02600715|20097747|P1|COMPLETED|Overall Study||13
8153350|NCT02600715|20097746|P2|Completed 2-week Follow-up Appointment|Overall Study||12
8153351|NCT02600715|20097747|P1|Completed 2-week Follow-up Appointment|Overall Study||13
8153352|NCT02600715|20097746|P2|Received Treatment and Suppository|Overall Study||13
8153353|NCT02600715|20097747|P1|Received Treatment and Suppository|Overall Study||13
8153354|NCT02600715|20097746|P2|Allocated to Randomization|Overall Study||13
8153355|NCT02600715|20097747|P1|Allocated to Randomization|Overall Study||13
8153356|NCT02600715|20097746|P2|STARTED|Overall Study||13
8153357|NCT02600715|20097747|P1|STARTED|Overall Study||13
8153358|NCT02600637|20097778|P2|NOT COMPLETED|Overall Study||5
8153359|NCT02600637|20097779|P1|NOT COMPLETED|Overall Study||5
8153360|NCT02600637|20097778|P2|COMPLETED|Overall Study||13
8153361|NCT02600637|20097779|P1|COMPLETED|Overall Study||14
8153362|NCT02600637|20097778|P2|STARTED|Overall Study||18
8153363|NCT02600637|20097779|P1|STARTED|Overall Study||19
8153364|NCT02600611|20097791|P2|NOT COMPLETED|Overall Study||0
8153365|NCT02600611|20097792|P1|NOT COMPLETED|Overall Study||2
8153366|NCT02600611|20097791|P2|COMPLETED|Overall Study||300
8153367|NCT02600611|20097792|P1|COMPLETED|Overall Study||298
8153368|NCT02600611|20097791|P2|STARTED|Overall Study||300
8153369|NCT02600611|20097792|P1|STARTED|Overall Study||300
8153370|NCT02600559|20097800|P1|NOT COMPLETED|Overall Study||23
8153371|NCT02600559|20097800|P1|COMPLETED|Overall Study||478
8153372|NCT02600559|20097800|P1|STARTED|Overall Study||501
8153373|NCT02600403|20097812|P3|NOT COMPLETED|Overall Study||0
8153374|NCT02600403|20097813|P2|NOT COMPLETED|Overall Study||0
8153375|NCT02600403|20097814|P1|NOT COMPLETED|Overall Study||0
8153376|NCT02600403|20097812|P3|COMPLETED|Overall Study||11
8153377|NCT02600403|20097813|P2|COMPLETED|Overall Study||6
8153378|NCT02600403|20097814|P1|COMPLETED|Overall Study||44
8153379|NCT02600403|20097812|P3|STARTED|Overall Study||11
8153380|NCT02600403|20097813|P2|STARTED|Overall Study||6
8153381|NCT02600403|20097814|P1|STARTED|Overall Study||44
8153382|NCT02600351|20097841|P4|NOT COMPLETED|Overall Study||5
8153383|NCT02600351|20097842|P3|NOT COMPLETED|Overall Study||6
8153384|NCT02600351|20097843|P2|NOT COMPLETED|Overall Study||0
8153385|NCT02600351|20097844|P1|NOT COMPLETED|Overall Study||5
8153387|NCT02600351|20097842|P3|COMPLETED|Overall Study||20
8153388|NCT02600351|20097843|P2|COMPLETED|Overall Study||17
8153389|NCT02600351|20097844|P1|COMPLETED|Overall Study||12
8153390|NCT02600351|20097841|P4|STARTED|Overall Study||27
8153391|NCT02600351|20097842|P3|STARTED|Overall Study||26
8153392|NCT02600351|20097843|P2|STARTED|Overall Study||17
8153393|NCT02600351|20097844|P1|STARTED|Overall Study||17
8153394|NCT02600325|20097874|P1|NOT COMPLETED|Overall Study||0
8153395|NCT02600325|20097874|P1|COMPLETED|Overall Study||80
8153396|NCT02600325|20097874|P1|STARTED|Overall Study||80
8153397|NCT02599961|20097879|P1|NOT COMPLETED|Overall Study||15
8153398|NCT02599961|20097879|P1|COMPLETED|Overall Study||0
8153399|NCT02599961|20097879|P1|STARTED|Overall Study||15
8153400|NCT02599766|20097889|P1|NOT COMPLETED|Overall Study||3
8153401|NCT02599766|20097889|P1|COMPLETED|Overall Study||19
8153402|NCT02599766|20097889|P1|STARTED|Overall Study||22
8153403|NCT02599688|20097921|P1|NOT COMPLETED|Overall Study||4
8153404|NCT02599688|20097921|P1|COMPLETED|Overall Study||14
8153405|NCT02599688|20097921|P1|STARTED|Overall Study||18
8153406|NCT02599649|20097929|P4|NOT COMPLETED|Overall Study||0
8153407|NCT02599649|20097930|P3|NOT COMPLETED|Overall Study||0
8153408|NCT02599649|20097931|P2|NOT COMPLETED|Overall Study||0
8153409|NCT02599649|20097932|P1|NOT COMPLETED|Overall Study||0
8153410|NCT02599649|20097929|P4|COMPLETED|Overall Study||0
8153411|NCT02599649|20097930|P3|COMPLETED|Overall Study||8
8153412|NCT02599649|20097931|P2|COMPLETED|Overall Study||0
8153413|NCT02599649|20097932|P1|COMPLETED|Overall Study||2
8153414|NCT02599649|20097929|P4|STARTED|Overall Study||0
8153415|NCT02599649|20097930|P3|STARTED|Overall Study||8
8153416|NCT02599649|20097931|P2|STARTED|Overall Study||0
8153417|NCT02599649|20097932|P1|STARTED|Overall Study||2
8153418|NCT02599441|20097942|P1|NOT COMPLETED|Overall Study||0
8153419|NCT02599441|20097942|P1|COMPLETED|Overall Study||9
8153420|NCT02599441|20097942|P1|STARTED|Overall Study||9
8153421|NCT02599194|20097948|P1|NOT COMPLETED|Overall Study||0
8153422|NCT02599194|20097948|P1|COMPLETED|Overall Study||7
8153423|NCT02599194|20097948|P1|STARTED|Overall Study||7
8153430|NCT02598934|20097974|P2|NOT COMPLETED|Overall Study||22
8153431|NCT02598934|20097975|P1|NOT COMPLETED|Overall Study||19
8153432|NCT02598934|20097974|P2|COMPLETED|Overall Study||132
8153433|NCT02598934|20097975|P1|COMPLETED|Overall Study||135
8153434|NCT02598934|20097974|P2|STARTED|Overall Study||154
8153435|NCT02598934|20097975|P1|STARTED|Overall Study||154
8153436|NCT02598622|20097987|P2|NOT COMPLETED|Overall Study||0
8153437|NCT02598622|20097988|P1|NOT COMPLETED|Overall Study||6
8153438|NCT02598622|20097987|P2|COMPLETED|Overall Study||0
8153439|NCT02598622|20097988|P1|COMPLETED|Overall Study||2
8153440|NCT02598622|20097987|P2|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
8153441|NCT02598622|20097988|P1|STARTED|Overall Study||8
8153442|NCT02598583|20097996|P2|NOT COMPLETED|Overall Study||0
8153443|NCT02598583|20097997|P1|NOT COMPLETED|Overall Study||0
8153444|NCT02598583|20097996|P2|COMPLETED|Overall Study||7
8153445|NCT02598583|20097997|P1|COMPLETED|Overall Study||6
8153446|NCT02598583|20097996|P2|STARTED|Overall Study||7
8153447|NCT02598583|20097997|P1|STARTED|Overall Study||6
8153448|NCT02598297|20098017|P2|NOT COMPLETED|Overall Study||24
8153449|NCT02598297|20098018|P1|NOT COMPLETED|Overall Study||25
8153450|NCT02598297|20098017|P2|COMPLETED|Overall Study||0
8153451|NCT02598297|20098018|P1|COMPLETED|Overall Study||0
8153452|NCT02598297|20098017|P2|Subjects Followed for Survival|Overall Study||0
8153453|NCT02598297|20098018|P1|Subjects Followed for Survival|Overall Study||1
8153454|NCT02598297|20098017|P2|Not Treted Wit Study Drug|Overall Study||0
8153455|NCT02598297|20098018|P1|Not Treted Wit Study Drug|Overall Study||1
8153456|NCT02598297|20098017|P2|STARTED|Overall Study||24
8153457|NCT02598297|20098018|P1|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25
8153458|NCT02598193|20098044|P1|NOT COMPLETED|Overall Study||16
8153459|NCT02598193|20098044|P1|COMPLETED|Overall Study||73
8153460|NCT02598193|20098044|P1|STARTED|Overall Study||89
8153461|NCT02598128|20098052|P4|NOT COMPLETED|Period C: Days 12 to 20||0
8153462|NCT02598128|20098053|P3|NOT COMPLETED|Period C: Days 12 to 20||0
8153463|NCT02598128|20098054|P2|NOT COMPLETED|Period C: Days 12 to 20||0
8153464|NCT02598128|20098055|P1|NOT COMPLETED|Period C: Days 12 to 20||0
8153465|NCT02598128|20098052|P4|COMPLETED|Period C: Days 12 to 20||33
8153466|NCT02598128|20098053|P3|COMPLETED|Period C: Days 12 to 20||0
8153467|NCT02598128|20098054|P2|COMPLETED|Period C: Days 12 to 20||0
8153468|NCT02598128|20098055|P1|COMPLETED|Period C: Days 12 to 20||0
8153469|NCT02598128|20098052|P4|STARTED|Period C: Days 12 to 20||33
8153470|NCT02598128|20098053|P3|STARTED|Period C: Days 12 to 20||0
8153471|NCT02598128|20098054|P2|STARTED|Period C: Days 12 to 20||0
8153472|NCT02598128|20098055|P1|STARTED|Period C: Days 12 to 20||0
8153473|NCT02598128|20098052|P4|NOT COMPLETED|Period B: Days 1 to 11||0
8153474|NCT02598128|20098053|P3|NOT COMPLETED|Period B: Days 1 to 11||0
8153475|NCT02598128|20098054|P2|NOT COMPLETED|Period B: Days 1 to 11||0
8153476|NCT02598128|20098055|P1|NOT COMPLETED|Period B: Days 1 to 11||0
8153477|NCT02598128|20098052|P4|COMPLETED|Period B: Days 1 to 11||0
8153478|NCT02598128|20098053|P3|COMPLETED|Period B: Days 1 to 11||16
8153479|NCT02598128|20098054|P2|COMPLETED|Period B: Days 1 to 11||17
8153480|NCT02598128|20098055|P1|COMPLETED|Period B: Days 1 to 11||0
8153481|NCT02598128|20098052|P4|STARTED|Period B: Days 1 to 11||0
8153482|NCT02598128|20098053|P3|STARTED|Period B: Days 1 to 11||16
8153483|NCT02598128|20098054|P2|STARTED|Period B: Days 1 to 11||17
8153484|NCT02598128|20098055|P1|STARTED|Period B: Days 1 to 11||0
8153485|NCT02598128|20098052|P4|NOT COMPLETED|Period A: Days -7 to -1||0
8153486|NCT02598128|20098053|P3|NOT COMPLETED|Period A: Days -7 to -1||0
8153487|NCT02598128|20098054|P2|NOT COMPLETED|Period A: Days -7 to -1||0
8153488|NCT02598128|20098055|P1|NOT COMPLETED|Period A: Days -7 to -1||1
8153489|NCT02598128|20098052|P4|COMPLETED|Period A: Days -7 to -1||0
8153490|NCT02598128|20098053|P3|COMPLETED|Period A: Days -7 to -1||0
8153491|NCT02598128|20098054|P2|COMPLETED|Period A: Days -7 to -1||0
8153492|NCT02598128|20098055|P1|COMPLETED|Period A: Days -7 to -1||33
8153493|NCT02598128|20098052|P4|STARTED|Period A: Days -7 to -1||0
8153494|NCT02598128|20098053|P3|STARTED|Period A: Days -7 to -1||0
8153495|NCT02598128|20098054|P2|STARTED|Period A: Days -7 to -1||0
8153496|NCT02598128|20098055|P1|STARTED|Period A: Days -7 to -1||34
8153497|NCT02598089|20098069|P2|NOT COMPLETED|Overall Study||0
8153498|NCT02598089|20098070|P1|NOT COMPLETED|Overall Study||0
8153499|NCT02598089|20098069|P2|COMPLETED|Overall Study||30
8153500|NCT02598089|20098070|P1|COMPLETED|Overall Study||30
8153501|NCT02598089|20098069|P2|STARTED|Overall Study||30
8153502|NCT02598089|20098070|P1|STARTED|Overall Study||30
8153503|NCT02598076|20098098|P2|NOT COMPLETED|Overall Study||3
8153504|NCT02598076|20098099|P1|NOT COMPLETED|Overall Study||2
8153505|NCT02598076|20098098|P2|COMPLETED|Overall Study||26
8153506|NCT02598076|20098099|P1|COMPLETED|Overall Study||29
8153507|NCT02598076|20098098|P2|STARTED|Overall Study||29
8153508|NCT02598076|20098099|P1|STARTED|Overall Study||31
8153509|NCT02597946|20098113|P1|NOT COMPLETED|Overall Study||18
8153510|NCT02597946|20098113|P1|COMPLETED|Overall Study||0
8153511|NCT02597946|20098113|P1|STARTED|Overall Study||18
8153512|NCT02597933|20098124|P2|NOT COMPLETED|Overall Study||51
8153513|NCT02597933|20098125|P1|NOT COMPLETED|Overall Study||38
8153514|NCT02597933|20098124|P2|COMPLETED|Overall Study||239
8153515|NCT02597933|20098125|P1|COMPLETED|Overall Study||252
8153516|NCT02597933|20098124|P2|Treated Patients|Overall Study||288
8153517|NCT02597933|20098125|P1|Treated Patients|Overall Study||288
8153518|NCT02597933|20098124|P2|STARTED|Overall Study|Started are randomised|290
8153519|NCT02597933|20098125|P1|STARTED|Overall Study|Started are randomised|290
8153520|NCT02597920|20098156|P3|NOT COMPLETED|Overall Study||6
8153521|NCT02597920|20098157|P2|NOT COMPLETED|Overall Study||84
8153522|NCT02597920|20098158|P1|NOT COMPLETED|Overall Study||41
8153523|NCT02597920|20098156|P3|COMPLETED|Overall Study||72
8153524|NCT02597920|20098157|P2|COMPLETED|Overall Study||1075
8153525|NCT02597920|20098158|P1|COMPLETED|Overall Study||544
8153526|NCT02597920|20098156|P3|STARTED|Overall Study||78
8153527|NCT02597920|20098157|P2|STARTED|Overall Study||1159
8153528|NCT02597920|20098158|P1|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585
8153529|NCT02597907|20098183|P2|NOT COMPLETED|Overall Study||0
8153530|NCT02597907|20098184|P1|NOT COMPLETED|Overall Study||0
8153531|NCT02597907|20098183|P2|COMPLETED|Overall Study||44
8153532|NCT02597907|20098184|P1|COMPLETED|Overall Study||44
8153533|NCT02597907|20098183|P2|STARTED|Overall Study||44
8153534|NCT02597907|20098184|P1|STARTED|Overall Study||44
8153535|NCT02597855|20098192|P2|NOT COMPLETED|Overall Study||1
8153536|NCT02597855|20098193|P1|NOT COMPLETED|Overall Study||2
8153537|NCT02597855|20098192|P2|COMPLETED|Overall Study||13
8153538|NCT02597855|20098193|P1|COMPLETED|Overall Study||16
8153539|NCT02597855|20098192|P2|STARTED|Overall Study||14
8153540|NCT02597855|20098193|P1|STARTED|Overall Study||18
8153541|NCT02597673|20098205|P4|NOT COMPLETED|Overall Study||5
8153542|NCT02597673|20098206|P3|NOT COMPLETED|Overall Study||5
8153543|NCT02597673|20098207|P2|NOT COMPLETED|Overall Study||6
8153544|NCT02597673|20098208|P1|NOT COMPLETED|Overall Study||3
8153545|NCT02597673|20098205|P4|COMPLETED|Overall Study||25
8153546|NCT02597673|20098206|P3|COMPLETED|Overall Study||28
8153547|NCT02597673|20098207|P2|COMPLETED|Overall Study||27
8153548|NCT02597673|20098208|P1|COMPLETED|Overall Study||31
8153549|NCT02597673|20098205|P4|STARTED|Overall Study||30
8153550|NCT02597673|20098206|P3|STARTED|Overall Study||33
8153551|NCT02597673|20098207|P2|STARTED|Overall Study||33
8153552|NCT02597673|20098208|P1|STARTED|Overall Study||34
8153553|NCT02597582|20098260|P2|NOT COMPLETED|Overall Study||0
8153554|NCT02597582|20098261|P1|NOT COMPLETED|Overall Study||0
8153555|NCT02597582|20098260|P2|COMPLETED|Overall Study||20
8153556|NCT02597582|20098261|P1|COMPLETED|Overall Study||21
8153557|NCT02597582|20098260|P2|STARTED|Overall Study||20
8153558|NCT02597582|20098261|P1|STARTED|Overall Study||21
8153559|NCT02597543|20098279|P2|NOT COMPLETED|Overall Study||0
8153560|NCT02597543|20098280|P1|NOT COMPLETED|Overall Study||0
8153561|NCT02597543|20098279|P2|COMPLETED|Overall Study||8
8153562|NCT02597543|20098280|P1|COMPLETED|Overall Study||6
8153563|NCT02597543|20098279|P2|STARTED|Overall Study||8
8153564|NCT02597543|20098280|P1|STARTED|Overall Study||6
8153571|NCT02597452|20098313|P1|NOT COMPLETED|Overall Study||30
8153572|NCT02597452|20098313|P1|COMPLETED|Overall Study||486
8153573|NCT02597452|20098313|P1|STARTED|Overall Study||516
8153574|NCT02597127|20098331|P8|NOT COMPLETED|Overall Study||2
8153575|NCT02597127|20098332|P7|NOT COMPLETED|Overall Study||4
8153576|NCT02597127|20098333|P6|NOT COMPLETED|Overall Study||4
8153577|NCT02597127|20098334|P5|NOT COMPLETED|Overall Study||5
8153578|NCT02597127|20098335|P4|NOT COMPLETED|Overall Study||5
8153579|NCT02597127|20098336|P3|NOT COMPLETED|Overall Study||8
8153580|NCT02597127|20098337|P2|NOT COMPLETED|Overall Study||3
8153581|NCT02597127|20098338|P1|NOT COMPLETED|Overall Study||1
8153582|NCT02597127|20098331|P8|COMPLETED|Overall Study||60
8153583|NCT02597127|20098332|P7|COMPLETED|Overall Study||57
8153584|NCT02597127|20098333|P6|COMPLETED|Overall Study||59
8153585|NCT02597127|20098334|P5|COMPLETED|Overall Study||57
8153586|NCT02597127|20098335|P4|COMPLETED|Overall Study||60
8153587|NCT02597127|20098336|P3|COMPLETED|Overall Study||58
8153588|NCT02597127|20098337|P2|COMPLETED|Overall Study||59
8153589|NCT02597127|20098338|P1|COMPLETED|Overall Study||59
8153590|NCT02597127|20098331|P8|Treated|Overall Study||62
8153591|NCT02597127|20098332|P7|Treated|Overall Study||61
8153592|NCT02597127|20098333|P6|Treated|Overall Study||62
8153593|NCT02597127|20098334|P5|Treated|Overall Study||61
8153594|NCT02597127|20098335|P4|Treated|Overall Study||65
8153595|NCT02597127|20098336|P3|Treated|Overall Study||65
8153596|NCT02597127|20098337|P2|Treated|Overall Study||61
8153597|NCT02597127|20098338|P1|Treated|Overall Study||60
8153598|NCT02597127|20098331|P8|STARTED|Overall Study||62
8153599|NCT02597127|20098332|P7|STARTED|Overall Study||61
8153600|NCT02597127|20098333|P6|STARTED|Overall Study||63
8153601|NCT02597127|20098334|P5|STARTED|Overall Study||62
8153602|NCT02597127|20098335|P4|STARTED|Overall Study||65
8153603|NCT02597127|20098336|P3|STARTED|Overall Study||66
8153604|NCT02597127|20098337|P2|STARTED|Overall Study||62
8153605|NCT02597127|20098338|P1|STARTED|Overall Study||60
8153609|NCT02597049|20098434|P3|NOT COMPLETED|Overall Study||3
8153610|NCT02597049|20098435|P2|NOT COMPLETED|Overall Study||5
8153611|NCT02597049|20098436|P1|NOT COMPLETED|Overall Study||7
8153612|NCT02597049|20098434|P3|COMPLETED|Overall Study||137
8153613|NCT02597049|20098435|P2|COMPLETED|Overall Study||137
8153614|NCT02597049|20098436|P1|COMPLETED|Overall Study||135
8153615|NCT02597049|20098434|P3|Received at Least One Dose of Study Drug|Overall Study||140
8153616|NCT02597049|20098435|P2|Received at Least One Dose of Study Drug|Overall Study||141
8153617|NCT02597049|20098436|P1|Received at Least One Dose of Study Drug|Overall Study||142
8153618|NCT02597049|20098434|P3|STARTED|Overall Study||140
8153619|NCT02597049|20098435|P2|STARTED|Overall Study||142
8153620|NCT02597049|20098436|P1|STARTED|Overall Study||142
8153630|NCT02596958|20098508|P1|NOT COMPLETED|Overall Study||996
8153631|NCT02596958|20098508|P1|COMPLETED|Overall Study||0
8153632|NCT02596958|20098508|P1|STARTED|Overall Study||996
8153633|NCT02596945|20098520|P1|NOT COMPLETED|Overall Study||56
8153634|NCT02596945|20098520|P1|COMPLETED|Overall Study||167
8153635|NCT02596945|20098520|P1|Treated|Overall Study||220
8153636|NCT02596945|20098520|P1|STARTED|Overall Study||223
8153637|NCT02596906|20098528|P2|NOT COMPLETED|Overall Study||3
8153638|NCT02596906|20098529|P1|NOT COMPLETED|Overall Study||4
8153639|NCT02596906|20098528|P2|COMPLETED|Overall Study||7
8153640|NCT02596906|20098529|P1|COMPLETED|Overall Study||8
8153641|NCT02596906|20098528|P2|STARTED|Overall Study||10
8153642|NCT02596906|20098529|P1|STARTED|Overall Study||12
8153643|NCT02596893|20098541|P4|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
8153644|NCT02596893|20098542|P3|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
8153645|NCT02596893|20098543|P2|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
8153646|NCT02596893|20098544|P1|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
8153647|NCT02596893|20098541|P4|COMPLETED|Follow-Up Period Weeks 0 to 52||47
8153648|NCT02596893|20098542|P3|COMPLETED|Follow-Up Period Weeks 0 to 52||56
8153649|NCT02596893|20098543|P2|COMPLETED|Follow-Up Period Weeks 0 to 52||51
8153650|NCT02596893|20098544|P1|COMPLETED|Follow-Up Period Weeks 0 to 52||57
8153651|NCT02596893|20098541|P4|STARTED|Follow-Up Period Weeks 0 to 52||47
8153652|NCT02596893|20098542|P3|STARTED|Follow-Up Period Weeks 0 to 52||56
8153653|NCT02596893|20098543|P2|STARTED|Follow-Up Period Weeks 0 to 52||51
8153654|NCT02596893|20098544|P1|STARTED|Follow-Up Period Weeks 0 to 52||57
8153655|NCT02596893|20098541|P4|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166
8153656|NCT02596893|20098542|P3|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162
8153657|NCT02596893|20098543|P2|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168
8153658|NCT02596893|20098544|P1|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164
8153659|NCT02596893|20098541|P4|COMPLETED|Overall Double-Blind Period Weeks 0-52||9
8153660|NCT02596893|20098542|P3|COMPLETED|Overall Double-Blind Period Weeks 0-52||14
8153661|NCT02596893|20098543|P2|COMPLETED|Overall Double-Blind Period Weeks 0-52||8
8153662|NCT02596893|20098544|P1|COMPLETED|Overall Double-Blind Period Weeks 0-52||10
8153663|NCT02596893|20098541|P4|STARTED|Overall Double-Blind Period Weeks 0-52||175
8153664|NCT02596893|20098542|P3|STARTED|Overall Double-Blind Period Weeks 0-52||176
8153665|NCT02596893|20098543|P2|STARTED|Overall Double-Blind Period Weeks 0-52||176
8153666|NCT02596893|20098544|P1|STARTED|Overall Double-Blind Period Weeks 0-52||174
8153667|NCT02596867|20098598|P1|NOT COMPLETED|Overall Study||0
8153668|NCT02596867|20098598|P1|COMPLETED|Overall Study||2
8153669|NCT02596867|20098598|P1|2 Patients Prospectively Recruited|Overall Study||2
8153670|NCT02596867|20098598|P1|STARTED|Overall Study||2
8153671|NCT02596854|20098603|P1|NOT COMPLETED|Overall Study||8
8153672|NCT02596854|20098603|P1|COMPLETED|Overall Study||109
8153673|NCT02596854|20098603|P1|STARTED|Overall Study||117
8153674|NCT02596750|20098609|P2|NOT COMPLETED|30 Minutes||0
8153675|NCT02596750|20098610|P1|NOT COMPLETED|30 Minutes||0
8153676|NCT02596750|20098609|P2|COMPLETED|30 Minutes||21
8153677|NCT02596750|20098610|P1|COMPLETED|30 Minutes||21
8153678|NCT02596750|20098609|P2|STARTED|30 Minutes||21
8153679|NCT02596750|20098610|P1|STARTED|30 Minutes||21
8153680|NCT02596750|20098609|P2|NOT COMPLETED|10 Minutes||0
8153681|NCT02596750|20098610|P1|NOT COMPLETED|10 Minutes||0
8153682|NCT02596750|20098609|P2|COMPLETED|10 Minutes||21
8153683|NCT02596750|20098610|P1|COMPLETED|10 Minutes||21
8153684|NCT02596750|20098609|P2|STARTED|10 Minutes||21
8153685|NCT02596750|20098610|P1|STARTED|10 Minutes||21
8153686|NCT02596750|20098609|P2|NOT COMPLETED|5 Minutes||0
8153687|NCT02596750|20098610|P1|NOT COMPLETED|5 Minutes||0
8153688|NCT02596750|20098609|P2|COMPLETED|5 Minutes||21
8153689|NCT02596750|20098610|P1|COMPLETED|5 Minutes||21
8153690|NCT02596750|20098609|P2|STARTED|5 Minutes||21
8153691|NCT02596750|20098610|P1|STARTED|5 Minutes||21
8153692|NCT02596750|20098609|P2|NOT COMPLETED|2 Minutes||0
8153693|NCT02596750|20098610|P1|NOT COMPLETED|2 Minutes||0
8153694|NCT02596750|20098609|P2|COMPLETED|2 Minutes||21
8153695|NCT02596750|20098610|P1|COMPLETED|2 Minutes||21
8153696|NCT02596750|20098609|P2|STARTED|2 Minutes||21
8153697|NCT02596750|20098610|P1|STARTED|2 Minutes||21
8153698|NCT02596750|20098609|P2|NOT COMPLETED|Baseline||0
8153699|NCT02596750|20098610|P1|NOT COMPLETED|Baseline||0
8153700|NCT02596750|20098609|P2|COMPLETED|Baseline||21
8153701|NCT02596750|20098610|P1|COMPLETED|Baseline||21
8153702|NCT02596750|20098609|P2|STARTED|Baseline||21
8153703|NCT02596750|20098610|P1|STARTED|Baseline||21
8153704|NCT02596711|20098625|P3|NOT COMPLETED|Overall Study||3
8153705|NCT02596711|20098626|P2|NOT COMPLETED|Overall Study||2
8153706|NCT02596711|20098627|P1|NOT COMPLETED|Overall Study||1
8153707|NCT02596711|20098625|P3|COMPLETED|Overall Study||5
8153708|NCT02596711|20098626|P2|COMPLETED|Overall Study||6
8153709|NCT02596711|20098627|P1|COMPLETED|Overall Study||8
8153710|NCT02596711|20098625|P3|6 Month Follow-up|Overall Study||5
8153711|NCT02596711|20098626|P2|6 Month Follow-up|Overall Study||6
8153712|NCT02596711|20098627|P1|6 Month Follow-up|Overall Study||8
8153713|NCT02596711|20098625|P3|3 Month Follow-up|Overall Study||6
8153714|NCT02596711|20098626|P2|3 Month Follow-up|Overall Study||6
8153715|NCT02596711|20098627|P1|3 Month Follow-up|Overall Study||8
8153716|NCT02596711|20098625|P3|Visit 3|Overall Study||6
8153717|NCT02596711|20098626|P2|Visit 3|Overall Study||8
8153718|NCT02596711|20098627|P1|Visit 3|Overall Study||7
8153719|NCT02596711|20098625|P3|Visit 2|Overall Study||6
8153720|NCT02596711|20098626|P2|Visit 2|Overall Study||7
8153721|NCT02596711|20098627|P1|Visit 2|Overall Study||9
8153722|NCT02596711|20098625|P3|STARTED|Overall Study||8
8153723|NCT02596711|20098626|P2|STARTED|Overall Study||8
8153724|NCT02596711|20098627|P1|STARTED|Overall Study||9
8153725|NCT02596620|20098643|P2|NOT COMPLETED|Overall Study||1
8153726|NCT02596620|20098644|P1|NOT COMPLETED|Overall Study||1
8153727|NCT02596620|20098643|P2|COMPLETED|Overall Study|Completed on 30th September 2015|81
8153728|NCT02596620|20098644|P1|COMPLETED|Overall Study|Completed on 30th September 2015|81
8153729|NCT02596620|20098643|P2|STARTED|Overall Study|Started from 1st October 2013|82
8153730|NCT02596620|20098644|P1|STARTED|Overall Study|Started from 1st October 2013|82
8153731|NCT02596451|20098653|P3|NOT COMPLETED|Overall Study||14
8153732|NCT02596451|20098654|P2|NOT COMPLETED|Overall Study||18
8153733|NCT02596451|20098655|P1|NOT COMPLETED|Overall Study||4
8153734|NCT02596451|20098653|P3|COMPLETED|Overall Study||373
8153735|NCT02596451|20098654|P2|COMPLETED|Overall Study||374
8153736|NCT02596451|20098655|P1|COMPLETED|Overall Study||381
8153737|NCT02596451|20098653|P3|STARTED|Overall Study||387
8153738|NCT02596451|20098654|P2|STARTED|Overall Study||392
8153739|NCT02596451|20098655|P1|STARTED|Overall Study||385
8153740|NCT02596321|20098664|P2|NOT COMPLETED|Overall Study||0
8153741|NCT02596321|20098665|P1|NOT COMPLETED|Overall Study||3
8153742|NCT02596321|20098664|P2|COMPLETED|Overall Study||56
8153743|NCT02596321|20098665|P1|COMPLETED|Overall Study||53
8153744|NCT02596321|20098664|P2|STARTED|Overall Study||56
8153745|NCT02596321|20098665|P1|STARTED|Overall Study||56
8153746|NCT02596230|20098682|P5|NOT COMPLETED|Objective 2, One Year||78
8153747|NCT02596230|20098683|P4|NOT COMPLETED|Objective 2, One Year||58
8153748|NCT02596230|20098684|P3|NOT COMPLETED|Objective 2, One Year||98
8153749|NCT02596230|20098685|P2|NOT COMPLETED|Objective 2, One Year||68
8153750|NCT02596230|20098686|P1|NOT COMPLETED|Objective 2, One Year||0
8153751|NCT02596230|20098682|P5|COMPLETED|Objective 2, One Year||714
8153752|NCT02596230|20098683|P4|COMPLETED|Objective 2, One Year||471
8153753|NCT02596230|20098684|P3|COMPLETED|Objective 2, One Year||812
8153754|NCT02596230|20098685|P2|COMPLETED|Objective 2, One Year||710
8153755|NCT02596230|20098686|P1|COMPLETED|Objective 2, One Year||0
8153756|NCT02596230|20098682|P5|STARTED|Objective 2, One Year||792
8153757|NCT02596230|20098683|P4|STARTED|Objective 2, One Year||529
8153758|NCT02596230|20098684|P3|STARTED|Objective 2, One Year||910
8153759|NCT02596230|20098685|P2|STARTED|Objective 2, One Year||778
8153760|NCT02596230|20098686|P1|STARTED|Objective 2, One Year||0
8153761|NCT02596230|20098682|P5|NOT COMPLETED|Screening Period for Objective 2||0
8153762|NCT02596230|20098683|P4|NOT COMPLETED|Screening Period for Objective 2||846
8153763|NCT02596230|20098684|P3|NOT COMPLETED|Screening Period for Objective 2||0
8153764|NCT02596230|20098685|P2|NOT COMPLETED|Screening Period for Objective 2||228
8153765|NCT02596230|20098686|P1|NOT COMPLETED|Screening Period for Objective 2||3714
8153766|NCT02596230|20098682|P5|COMPLETED|Screening Period for Objective 2||792
8153767|NCT02596230|20098683|P4|COMPLETED|Screening Period for Objective 2||529
8153768|NCT02596230|20098684|P3|COMPLETED|Screening Period for Objective 2||910
8153769|NCT02596230|20098685|P2|COMPLETED|Screening Period for Objective 2||778
8153770|NCT02596230|20098686|P1|COMPLETED|Screening Period for Objective 2||0
8153771|NCT02596230|20098682|P5|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|792
8153772|NCT02596230|20098683|P4|STARTED|Screening Period for Objective 2||1375
8153773|NCT02596230|20098684|P3|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|910
8153774|NCT02596230|20098685|P2|STARTED|Screening Period for Objective 2||1006
8153775|NCT02596230|20098686|P1|STARTED|Screening Period for Objective 2||3714
8153776|NCT02596230|20098682|P5|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8153777|NCT02596230|20098683|P4|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8153778|NCT02596230|20098684|P3|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8153779|NCT02596230|20098685|P2|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8153780|NCT02596230|20098686|P1|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
8153781|NCT02596230|20098682|P5|COMPLETED|Objective 1, One Visit During 14 Days||0
8153782|NCT02596230|20098683|P4|COMPLETED|Objective 1, One Visit During 14 Days||1375
8153783|NCT02596230|20098684|P3|COMPLETED|Objective 1, One Visit During 14 Days||0
8153784|NCT02596230|20098685|P2|COMPLETED|Objective 1, One Visit During 14 Days||1006
8153785|NCT02596230|20098686|P1|COMPLETED|Objective 1, One Visit During 14 Days||3714
8153786|NCT02596230|20098682|P5|STARTED|Objective 1, One Visit During 14 Days||0
8153787|NCT02596230|20098683|P4|STARTED|Objective 1, One Visit During 14 Days||1375
8153788|NCT02596230|20098684|P3|STARTED|Objective 1, One Visit During 14 Days||0
8153789|NCT02596230|20098685|P2|STARTED|Objective 1, One Visit During 14 Days||1006
8153790|NCT02596230|20098686|P1|STARTED|Objective 1, One Visit During 14 Days||3714
8153791|NCT02596035|20098710|P3|NOT COMPLETED|Overall Study||1
8153792|NCT02596035|20098711|P2|NOT COMPLETED|Overall Study||44
8153793|NCT02596035|20098712|P1|NOT COMPLETED|Overall Study||86
8153794|NCT02596035|20098710|P3|COMPLETED|Overall Study||0
8153795|NCT02596035|20098711|P2|COMPLETED|Overall Study||0
8153796|NCT02596035|20098712|P1|COMPLETED|Overall Study||11
8153797|NCT02596035|20098710|P3|STARTED|Overall Study||1
8153798|NCT02596035|20098711|P2|STARTED|Overall Study||44
8153799|NCT02596035|20098712|P1|STARTED|Overall Study||97
8153800|NCT02596022|20098741|P2|NOT COMPLETED|Overall Study||0
8153801|NCT02596022|20098742|P1|NOT COMPLETED|Overall Study||0
8153802|NCT02596022|20098741|P2|COMPLETED|Overall Study||8
8153803|NCT02596022|20098742|P1|COMPLETED|Overall Study||10
8153804|NCT02596022|20098741|P2|STARTED|Overall Study||8
8153805|NCT02596022|20098742|P1|STARTED|Overall Study||10
8153806|NCT02596009|20098748|P6|NOT COMPLETED|Overall Study||0
8153807|NCT02596009|20098749|P5|NOT COMPLETED|Overall Study||0
8153808|NCT02596009|20098750|P4|NOT COMPLETED|Overall Study||0
8153809|NCT02596009|20098751|P3|NOT COMPLETED|Overall Study||0
8153810|NCT02596009|20098752|P2|NOT COMPLETED|Overall Study||1
8153811|NCT02596009|20098753|P1|NOT COMPLETED|Overall Study||0
8153812|NCT02596009|20098748|P6|COMPLETED|Overall Study||17
8153813|NCT02596009|20098749|P5|COMPLETED|Overall Study||18
8153814|NCT02596009|20098750|P4|COMPLETED|Overall Study||16
8153815|NCT02596009|20098751|P3|COMPLETED|Overall Study||16
8153816|NCT02596009|20098752|P2|COMPLETED|Overall Study||15
8153817|NCT02596009|20098753|P1|COMPLETED|Overall Study||14
8153818|NCT02596009|20098748|P6|STARTED|Overall Study||17
8153819|NCT02596009|20098749|P5|STARTED|Overall Study||18
8153820|NCT02596009|20098750|P4|STARTED|Overall Study||16
8153821|NCT02596009|20098751|P3|STARTED|Overall Study||16
8153822|NCT02596009|20098752|P2|STARTED|Overall Study||16
8153823|NCT02596009|20098753|P1|STARTED|Overall Study||14
8153824|NCT02595983|20098762|P1|NOT COMPLETED|Overall Study||4
8153825|NCT02595983|20098762|P1|COMPLETED|Overall Study||8
8153826|NCT02595983|20098762|P1|STARTED|Overall Study||12
8153827|NCT02595970|20098770|P1|NOT COMPLETED|Overall Study||20
8153828|NCT02595970|20098770|P1|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100
8153829|NCT02595970|20098770|P1|STARTED|Overall Study||120
8153830|NCT02595723|20098787|P3|NOT COMPLETED|Third Intervention (4 Days)||0
8153831|NCT02595723|20098788|P2|NOT COMPLETED|Third Intervention (4 Days)||0
8153832|NCT02595723|20098789|P1|NOT COMPLETED|Third Intervention (4 Days)||0
8153833|NCT02595723|20098787|P3|COMPLETED|Third Intervention (4 Days)||7
8153834|NCT02595723|20098788|P2|COMPLETED|Third Intervention (4 Days)||5
8153835|NCT02595723|20098789|P1|COMPLETED|Third Intervention (4 Days)||6
8153836|NCT02595723|20098787|P3|STARTED|Third Intervention (4 Days)||7
8153837|NCT02595723|20098788|P2|STARTED|Third Intervention (4 Days)||5
8153838|NCT02595723|20098789|P1|STARTED|Third Intervention (4 Days)||6
8153839|NCT02595723|20098787|P3|NOT COMPLETED|Second Washout (21 Days)||0
8153840|NCT02595723|20098788|P2|NOT COMPLETED|Second Washout (21 Days)||1
8153841|NCT02595723|20098789|P1|NOT COMPLETED|Second Washout (21 Days)||0
8153842|NCT02595723|20098787|P3|COMPLETED|Second Washout (21 Days)||7
8153843|NCT02595723|20098788|P2|COMPLETED|Second Washout (21 Days)||5
8153844|NCT02595723|20098789|P1|COMPLETED|Second Washout (21 Days)||6
8153845|NCT02595723|20098787|P3|STARTED|Second Washout (21 Days)||7
8153846|NCT02595723|20098788|P2|STARTED|Second Washout (21 Days)||6
8153847|NCT02595723|20098789|P1|STARTED|Second Washout (21 Days)||6
8153848|NCT02595723|20098787|P3|NOT COMPLETED|Second Intervention (4 Days)||0
8153849|NCT02595723|20098788|P2|NOT COMPLETED|Second Intervention (4 Days)||0
8153850|NCT02595723|20098789|P1|NOT COMPLETED|Second Intervention (4 Days)||0
8153851|NCT02595723|20098787|P3|COMPLETED|Second Intervention (4 Days)||7
8153852|NCT02595723|20098788|P2|COMPLETED|Second Intervention (4 Days)||6
8153853|NCT02595723|20098789|P1|COMPLETED|Second Intervention (4 Days)||6
8153854|NCT02595723|20098787|P3|STARTED|Second Intervention (4 Days)||7
8153855|NCT02595723|20098788|P2|STARTED|Second Intervention (4 Days)||6
8153856|NCT02595723|20098789|P1|STARTED|Second Intervention (4 Days)||6
8153857|NCT02595723|20098787|P3|NOT COMPLETED|First Washout (21 Days)||0
8153858|NCT02595723|20098788|P2|NOT COMPLETED|First Washout (21 Days)||0
8153859|NCT02595723|20098789|P1|NOT COMPLETED|First Washout (21 Days)||2
8153860|NCT02595723|20098787|P3|COMPLETED|First Washout (21 Days)||7
8153861|NCT02595723|20098788|P2|COMPLETED|First Washout (21 Days)||6
8153862|NCT02595723|20098789|P1|COMPLETED|First Washout (21 Days)||6
8153863|NCT02595723|20098787|P3|STARTED|First Washout (21 Days)||7
8153864|NCT02595723|20098788|P2|STARTED|First Washout (21 Days)||6
8153865|NCT02595723|20098789|P1|STARTED|First Washout (21 Days)||8
8153866|NCT02595723|20098787|P3|NOT COMPLETED|First Intervention (4 Days)||0
8153867|NCT02595723|20098788|P2|NOT COMPLETED|First Intervention (4 Days)||0
8153868|NCT02595723|20098789|P1|NOT COMPLETED|First Intervention (4 Days)||0
8153869|NCT02595723|20098787|P3|COMPLETED|First Intervention (4 Days)||7
8153870|NCT02595723|20098788|P2|COMPLETED|First Intervention (4 Days)||6
8153871|NCT02595723|20098789|P1|COMPLETED|First Intervention (4 Days)||8
8153872|NCT02595723|20098787|P3|STARTED|First Intervention (4 Days)||7
8153873|NCT02595723|20098788|P2|STARTED|First Intervention (4 Days)||6
8153874|NCT02595723|20098789|P1|STARTED|First Intervention (4 Days)||8
8153875|NCT02595684|20098799|P2|NOT COMPLETED|Overall Study||0
8153876|NCT02595684|20098800|P1|NOT COMPLETED|Overall Study||0
8153877|NCT02595684|20098799|P2|COMPLETED|Overall Study||9
8153878|NCT02595684|20098800|P1|COMPLETED|Overall Study||9
8153879|NCT02595684|20098799|P2|STARTED|Overall Study||9
8153880|NCT02595684|20098800|P1|STARTED|Overall Study||9
8153881|NCT02595567|20098838|P1|NOT COMPLETED|Overall Study||0
8153882|NCT02595567|20098838|P1|COMPLETED|Overall Study||25
8153883|NCT02595567|20098838|P1|STARTED|Overall Study||25
8153884|NCT02595528|20098846|P4|NOT COMPLETED|Overall Study||4
8153885|NCT02595528|20098847|P3|NOT COMPLETED|Overall Study||1
8153886|NCT02595528|20098848|P2|NOT COMPLETED|Overall Study||3
8153887|NCT02595528|20098849|P1|NOT COMPLETED|Overall Study||2
8153888|NCT02595528|20098846|P4|COMPLETED|Overall Study||36
8153889|NCT02595528|20098847|P3|COMPLETED|Overall Study||41
8153890|NCT02595528|20098848|P2|COMPLETED|Overall Study||37
8153891|NCT02595528|20098849|P1|COMPLETED|Overall Study||39
8153892|NCT02595528|20098846|P4|STARTED|Overall Study||40
8153893|NCT02595528|20098847|P3|STARTED|Overall Study||42
8153894|NCT02595528|20098848|P2|STARTED|Overall Study||40
8153895|NCT02595528|20098849|P1|STARTED|Overall Study||41
8153896|NCT02595502|20098859|P2|NOT COMPLETED|Period 3||2
8153897|NCT02595502|20098860|P1|NOT COMPLETED|Period 3||1
8153898|NCT02595502|20098859|P2|COMPLETED|Period 3||136
8153899|NCT02595502|20098860|P1|COMPLETED|Period 3||140
8153900|NCT02595502|20098859|P2|STARTED|Period 3||138
8153901|NCT02595502|20098860|P1|STARTED|Period 3||141
8153902|NCT02595502|20098859|P2|NOT COMPLETED|Period 2||2
8153903|NCT02595502|20098860|P1|NOT COMPLETED|Period 2||1
8153904|NCT02595502|20098859|P2|COMPLETED|Period 2||138
8153905|NCT02595502|20098860|P1|COMPLETED|Period 2||141
8153906|NCT02595502|20098859|P2|STARTED|Period 2||140
8153907|NCT02595502|20098860|P1|STARTED|Period 2||142
8153908|NCT02595502|20098859|P2|NOT COMPLETED|Period 1||2
8153909|NCT02595502|20098860|P1|NOT COMPLETED|Period 1||1
8153910|NCT02595502|20098859|P2|COMPLETED|Period 1||140
8153911|NCT02595502|20098860|P1|COMPLETED|Period 1||142
8153912|NCT02595502|20098859|P2|STARTED|Period 1||142
8153913|NCT02595502|20098860|P1|STARTED|Period 1||143
8153914|NCT02595450|20098866|P1|NOT COMPLETED|Overall Study||81
8153915|NCT02595450|20098866|P1|COMPLETED|Overall Study||218
8153916|NCT02595450|20098866|P1|Treated|Overall Study||291
8153917|NCT02595450|20098866|P1|STARTED|Overall Study||299
8153918|NCT02595437|20098872|P1|NOT COMPLETED|Triferic Via Hemodialysate||0
8153919|NCT02595437|20098872|P1|COMPLETED|Triferic Via Hemodialysate||21
8153920|NCT02595437|20098872|P1|STARTED|Triferic Via Hemodialysate||21
8153921|NCT02595437|20098872|P1|NOT COMPLETED|Triferic Via IV||1
8153922|NCT02595437|20098872|P1|COMPLETED|Triferic Via IV||21
8153923|NCT02595437|20098872|P1|STARTED|Triferic Via IV||22
8153927|NCT02595073|20098901|P2|NOT COMPLETED|Overall Study||1
8153928|NCT02595073|20098902|P1|NOT COMPLETED|Overall Study||2
8153929|NCT02595073|20098901|P2|COMPLETED|Overall Study||62
8153930|NCT02595073|20098902|P1|COMPLETED|Overall Study||59
8153931|NCT02595073|20098901|P2|STARTED|Overall Study||63
8153932|NCT02595073|20098902|P1|STARTED|Overall Study||61
8153933|NCT02595008|20098912|P2|NOT COMPLETED|Overall Study||0
8153934|NCT02595008|20098913|P1|NOT COMPLETED|Overall Study||1
8153935|NCT02595008|20098912|P2|COMPLETED|Overall Study||4
8153936|NCT02595008|20098913|P1|COMPLETED|Overall Study||19
8153937|NCT02595008|20098912|P2|STARTED|Overall Study||4
8153938|NCT02595008|20098913|P1|STARTED|Overall Study||20
8153939|NCT02594826|20098921|P2|NOT COMPLETED|Overall Study||60
8153940|NCT02594826|20098922|P1|NOT COMPLETED|Overall Study||57
8153941|NCT02594826|20098921|P2|COMPLETED|Overall Study||298
8153942|NCT02594826|20098922|P1|COMPLETED|Overall Study||290
8153943|NCT02594826|20098921|P2|STARTED|Overall Study||358
8153944|NCT02594826|20098922|P1|STARTED|Overall Study||347
8153945|NCT02594644|20098932|P2|NOT COMPLETED|Overall Study||1
8153946|NCT02594644|20098933|P1|NOT COMPLETED|Overall Study||0
8153947|NCT02594644|20098932|P2|COMPLETED|Overall Study||15
8153948|NCT02594644|20098933|P1|COMPLETED|Overall Study||16
8153949|NCT02594644|20098932|P2|STARTED|Overall Study||16
8153950|NCT02594644|20098933|P1|STARTED|Overall Study||16
8153951|NCT02594163|20098951|P2|NOT COMPLETED|Follow-up Period||12
8153952|NCT02594163|20098952|P1|NOT COMPLETED|Follow-up Period||11
8153953|NCT02594163|20098951|P2|COMPLETED|Follow-up Period||1
8153954|NCT02594163|20098952|P1|COMPLETED|Follow-up Period||1
8153955|NCT02594163|20098951|P2|STARTED|Follow-up Period|All participants were to be followed after treatment|13
8153956|NCT02594163|20098952|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|12
8153957|NCT02594163|20098951|P2|NOT COMPLETED|Treatment Period||12
8153958|NCT02594163|20098952|P1|NOT COMPLETED|Treatment Period||7
8153959|NCT02594163|20098951|P2|COMPLETED|Treatment Period||1
8153960|NCT02594163|20098952|P1|COMPLETED|Treatment Period||5
8153961|NCT02594163|20098951|P2|STARTED|Treatment Period||13
8153962|NCT02594163|20098952|P1|STARTED|Treatment Period||12
8153969|NCT02594098|20098983|P2|NOT COMPLETED|Overall Study||13
8153970|NCT02594098|20098984|P1|NOT COMPLETED|Overall Study||26
8153971|NCT02594098|20098983|P2|COMPLETED|Overall Study||1
8153972|NCT02594098|20098984|P1|COMPLETED|Overall Study||1
8153973|NCT02594098|20098983|P2|STARTED|Overall Study||14
8153974|NCT02594098|20098984|P1|STARTED|Overall Study||27
8153975|NCT02593903|20099046|P2|NOT COMPLETED|Overall Study||1
8153976|NCT02593903|20099047|P1|NOT COMPLETED|Overall Study||0
8153977|NCT02593903|20099046|P2|COMPLETED|Overall Study||31
8153978|NCT02593903|20099047|P1|COMPLETED|Overall Study||35
8153979|NCT02593903|20099046|P2|STARTED|Overall Study||32
8153980|NCT02593903|20099047|P1|STARTED|Overall Study||35
8153981|NCT02593864|20099053|P1|NOT COMPLETED|Overall Study||6
8153982|NCT02593864|20099053|P1|COMPLETED|Overall Study||19
8153983|NCT02593864|20099053|P1|STARTED|Overall Study||25
8153996|NCT02593773|20099073|P1|NOT COMPLETED|Overall Study||35
8153997|NCT02593773|20099073|P1|COMPLETED|Overall Study||51
8153998|NCT02593773|20099073|P1|STARTED|Overall Study||86
8153999|NCT02593630|20099083|P1|NOT COMPLETED|Overall Study||1
8154000|NCT02593630|20099083|P1|COMPLETED|Overall Study||53
8154001|NCT02593630|20099083|P1|STARTED|Overall Study||54
8154002|NCT02593396|20099091|P2|NOT COMPLETED|Overall Study||14
8154003|NCT02593396|20099092|P1|NOT COMPLETED|Overall Study||15
8154004|NCT02593396|20099091|P2|COMPLETED|Overall Study||26
8154005|NCT02593396|20099092|P1|COMPLETED|Overall Study||25
8154006|NCT02593396|20099091|P2|At Least Done One Efficacy Assessment|Overall Study||36
8154007|NCT02593396|20099092|P1|At Least Done One Efficacy Assessment|Overall Study||36
8154008|NCT02593396|20099091|P2|STARTED|Overall Study||40
8154009|NCT02593396|20099092|P1|STARTED|Overall Study||40
8154010|NCT02593305|20099105|P3|NOT COMPLETED|Post 2||0
8154011|NCT02593305|20099106|P2|NOT COMPLETED|Post 2||0
8154012|NCT02593305|20099107|P1|NOT COMPLETED|Post 2||0
8154013|NCT02593305|20099105|P3|COMPLETED|Post 2||0
8154014|NCT02593305|20099106|P2|COMPLETED|Post 2||6
8154015|NCT02593305|20099107|P1|COMPLETED|Post 2||7
8154016|NCT02593305|20099105|P3|STARTED|Post 2||0
8154017|NCT02593305|20099106|P2|STARTED|Post 2||6
8154018|NCT02593305|20099107|P1|STARTED|Post 2||7
8154019|NCT02593305|20099105|P3|NOT COMPLETED|Baseline 2||0
8154020|NCT02593305|20099106|P2|NOT COMPLETED|Baseline 2||0
8154021|NCT02593305|20099107|P1|NOT COMPLETED|Baseline 2||0
8154022|NCT02593305|20099105|P3|COMPLETED|Baseline 2||0
8154023|NCT02593305|20099106|P2|COMPLETED|Baseline 2||6
8154024|NCT02593305|20099107|P1|COMPLETED|Baseline 2||7
8154025|NCT02593305|20099105|P3|STARTED|Baseline 2||0
8154026|NCT02593305|20099106|P2|STARTED|Baseline 2||6
8154027|NCT02593305|20099107|P1|STARTED|Baseline 2||7
8154028|NCT02593305|20099105|P3|NOT COMPLETED|Post 1||10
8154029|NCT02593305|20099106|P2|NOT COMPLETED|Post 1||0
8154030|NCT02593305|20099107|P1|NOT COMPLETED|Post 1||0
8154031|NCT02593305|20099105|P3|COMPLETED|Post 1||0
8154032|NCT02593305|20099106|P2|COMPLETED|Post 1||6
8154033|NCT02593305|20099107|P1|COMPLETED|Post 1||7
8154034|NCT02593305|20099105|P3|STARTED|Post 1||10
8154035|NCT02593305|20099106|P2|STARTED|Post 1||6
8154036|NCT02593305|20099107|P1|STARTED|Post 1||7
8154037|NCT02593305|20099105|P3|NOT COMPLETED|Baseline 1||0
8154038|NCT02593305|20099106|P2|NOT COMPLETED|Baseline 1||0
8154039|NCT02593305|20099107|P1|NOT COMPLETED|Baseline 1||0
8154040|NCT02593305|20099105|P3|COMPLETED|Baseline 1||10
8154041|NCT02593305|20099106|P2|COMPLETED|Baseline 1||6
8154042|NCT02593305|20099107|P1|COMPLETED|Baseline 1||7
8154043|NCT02593305|20099105|P3|STARTED|Baseline 1||10
8154044|NCT02593305|20099106|P2|STARTED|Baseline 1||6
8154045|NCT02593305|20099107|P1|STARTED|Baseline 1||7
8154046|NCT02593149|20099122|P2|NOT COMPLETED|Intervention||115
8154047|NCT02593149|20099123|P1|NOT COMPLETED|Intervention||116
8154048|NCT02593149|20099122|P2|COMPLETED|Intervention||845
8154049|NCT02593149|20099123|P1|COMPLETED|Intervention||826
8154050|NCT02593149|20099122|P2|STARTED|Intervention||960
8154051|NCT02593149|20099123|P1|STARTED|Intervention||942
8154052|NCT02593149|20099122|P2|NOT COMPLETED|Run-In||38
8154053|NCT02593149|20099123|P1|NOT COMPLETED|Run-In||36
8154054|NCT02593149|20099122|P2|COMPLETED|Run-In||323
8154055|NCT02593149|20099123|P1|COMPLETED|Run-In||304
8154056|NCT02593149|20099122|P2|STARTED|Run-In||361
8154057|NCT02593149|20099123|P1|STARTED|Run-In||340
8154058|NCT02593097|20099131|P2|NOT COMPLETED|Second Intervention (12 Weeks)||1
8154059|NCT02593097|20099132|P1|NOT COMPLETED|Second Intervention (12 Weeks)||3
8154060|NCT02593097|20099131|P2|COMPLETED|Second Intervention (12 Weeks)||15
8154061|NCT02593097|20099132|P1|COMPLETED|Second Intervention (12 Weeks)||9
8154062|NCT02593097|20099131|P2|STARTED|Second Intervention (12 Weeks)||16
8154063|NCT02593097|20099132|P1|STARTED|Second Intervention (12 Weeks)||12
8154064|NCT02593097|20099131|P2|NOT COMPLETED|Washout (4 Weeks)||0
8154065|NCT02593097|20099132|P1|NOT COMPLETED|Washout (4 Weeks)||0
8154066|NCT02593097|20099131|P2|COMPLETED|Washout (4 Weeks)||16
8154067|NCT02593097|20099132|P1|COMPLETED|Washout (4 Weeks)||12
8154068|NCT02593097|20099131|P2|STARTED|Washout (4 Weeks)||16
8154069|NCT02593097|20099132|P1|STARTED|Washout (4 Weeks)||12
8154070|NCT02593097|20099131|P2|NOT COMPLETED|First Intervention (12 Weeks)||4
8154071|NCT02593097|20099132|P1|NOT COMPLETED|First Intervention (12 Weeks)||2
8154072|NCT02593097|20099131|P2|COMPLETED|First Intervention (12 Weeks)||16
8154073|NCT02593097|20099132|P1|COMPLETED|First Intervention (12 Weeks)||12
8154074|NCT02593097|20099131|P2|Received Intervention|First Intervention (12 Weeks)||20
8154075|NCT02593097|20099132|P1|Received Intervention|First Intervention (12 Weeks)||14
8154076|NCT02593097|20099131|P2|STARTED|First Intervention (12 Weeks)||20
8154077|NCT02593097|20099132|P1|STARTED|First Intervention (12 Weeks)||14
8154078|NCT02593032|20099144|P2|NOT COMPLETED|Overall Study||0
8154079|NCT02593032|20099145|P1|NOT COMPLETED|Overall Study||0
8154080|NCT02593032|20099144|P2|COMPLETED|Overall Study||33
8154081|NCT02593032|20099145|P1|COMPLETED|Overall Study||17
8154082|NCT02593032|20099144|P2|STARTED|Overall Study||33
8154083|NCT02593032|20099145|P1|STARTED|Overall Study||17
8154084|NCT02592876|20099153|P2|NOT COMPLETED|Overall Study||40
8154085|NCT02592876|20099154|P1|NOT COMPLETED|Overall Study||41
8154086|NCT02592876|20099153|P2|COMPLETED|Overall Study||0
8154087|NCT02592876|20099154|P1|COMPLETED|Overall Study||0
8154088|NCT02592876|20099153|P2|Completed Treatment|Overall Study||32
8154089|NCT02592876|20099154|P1|Completed Treatment|Overall Study||34
8154090|NCT02592876|20099153|P2|Received Study Drug|Overall Study||40
8154091|NCT02592876|20099154|P1|Received Study Drug|Overall Study||40
8154092|NCT02592876|20099153|P2|STARTED|Overall Study||40
8154093|NCT02592876|20099154|P1|STARTED|Overall Study||41
8154094|NCT02592655|20099180|P1|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
8154095|NCT02592655|20099180|P1|COMPLETED|Fourth Tourniquet Right Thigh.||4
8154096|NCT02592655|20099180|P1|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
8154097|NCT02592655|20099180|P1|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
8154098|NCT02592655|20099180|P1|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
8154099|NCT02592655|20099180|P1|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
8154100|NCT02592655|20099180|P1|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
8154101|NCT02592655|20099180|P1|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
8154102|NCT02592655|20099180|P1|COMPLETED|Third Tourniquet, Left Thigh.||19
8154103|NCT02592655|20099180|P1|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
8154104|NCT02592655|20099180|P1|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
8154105|NCT02592655|20099180|P1|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
8154106|NCT02592655|20099180|P1|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
8154107|NCT02592655|20099180|P1|STARTED|Third Tourniquet, Left Thigh.||19
8154108|NCT02592655|20099180|P1|NOT COMPLETED|Second Tourniquet Right Thigh.||0
8154109|NCT02592655|20099180|P1|COMPLETED|Second Tourniquet Right Thigh.||19
8154110|NCT02592655|20099180|P1|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
8154111|NCT02592655|20099180|P1|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
8154112|NCT02592655|20099180|P1|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
8154113|NCT02592655|20099180|P1|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
8154114|NCT02592655|20099180|P1|STARTED|Second Tourniquet Right Thigh.||19
8154115|NCT02592655|20099180|P1|NOT COMPLETED|First Tourniquet, Left Thigh.||0
8154116|NCT02592655|20099180|P1|COMPLETED|First Tourniquet, Left Thigh.||19
8154117|NCT02592655|20099180|P1|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
8154118|NCT02592655|20099180|P1|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
8154119|NCT02592655|20099180|P1|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
8154120|NCT02592655|20099180|P1|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
8154121|NCT02592655|20099180|P1|STARTED|First Tourniquet, Left Thigh.||19
8154122|NCT02592629|20099198|P3|NOT COMPLETED|Overall Study||0
8154123|NCT02592629|20099199|P2|NOT COMPLETED|Overall Study||0
8154124|NCT02592629|20099200|P1|NOT COMPLETED|Overall Study||0
8154125|NCT02592629|20099198|P3|COMPLETED|Overall Study||5
8154126|NCT02592629|20099199|P2|COMPLETED|Overall Study||9
8154127|NCT02592629|20099200|P1|COMPLETED|Overall Study||5
8154128|NCT02592629|20099198|P3|STARTED|Overall Study||5
8154129|NCT02592629|20099199|P2|STARTED|Overall Study||9
8154130|NCT02592629|20099200|P1|STARTED|Overall Study||5
8154131|NCT02592486|20099210|P2|NOT COMPLETED|Overall Study||5
8154132|NCT02592486|20099211|P1|NOT COMPLETED|Overall Study||0
8154133|NCT02592486|20099210|P2|COMPLETED|Overall Study||76
8154134|NCT02592486|20099211|P1|COMPLETED|Overall Study||81
8154135|NCT02592486|20099210|P2|STARTED|Overall Study||81
8154136|NCT02592486|20099211|P1|STARTED|Overall Study||81
8154143|NCT02592434|20099234|P3|NOT COMPLETED|Double Blind Phase (26 Weeks)||47
8154144|NCT02592434|20099235|P2|NOT COMPLETED|Double Blind Phase (26 Weeks)||27
8154145|NCT02592434|20099236|P1|NOT COMPLETED|Double Blind Phase (26 Weeks)||0
8154146|NCT02592434|20099234|P3|COMPLETED|Double Blind Phase (26 Weeks)||38
8154147|NCT02592434|20099235|P2|COMPLETED|Double Blind Phase (26 Weeks)||61
8154148|NCT02592434|20099236|P1|COMPLETED|Double Blind Phase (26 Weeks)||0
8154149|NCT02592434|20099234|P3|Treated|Double Blind Phase (26 Weeks)||85
8154150|NCT02592434|20099235|P2|Treated|Double Blind Phase (26 Weeks)||88
8154151|NCT02592434|20099236|P1|Treated|Double Blind Phase (26 Weeks)||0
8154152|NCT02592434|20099234|P3|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase,achieved at least a JIA ACR 30 response in OL phase.|85
8154153|NCT02592434|20099235|P2|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase, achieved at least a JIA ACR 30 response in OL phase.|88
8154154|NCT02592434|20099236|P1|STARTED|Double Blind Phase (26 Weeks)||0
8154155|NCT02592434|20099234|P3|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
8154156|NCT02592434|20099235|P2|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
8154157|NCT02592434|20099236|P1|NOT COMPLETED|Open-Label Phase (18 Weeks)||40
8154158|NCT02592434|20099234|P3|COMPLETED|Open-Label Phase (18 Weeks)||0
8154159|NCT02592434|20099235|P2|COMPLETED|Open-Label Phase (18 Weeks)||0
8154160|NCT02592434|20099236|P1|COMPLETED|Open-Label Phase (18 Weeks)||185
8154161|NCT02592434|20099234|P3|Treated|Open-Label Phase (18 Weeks)||0
8154162|NCT02592434|20099235|P2|Treated|Open-Label Phase (18 Weeks)||0
8154163|NCT02592434|20099236|P1|Treated|Open-Label Phase (18 Weeks)||225
8154164|NCT02592434|20099234|P3|STARTED|Open-Label Phase (18 Weeks)||0
8154165|NCT02592434|20099235|P2|STARTED|Open-Label Phase (18 Weeks)||0
8154166|NCT02592434|20099236|P1|STARTED|Open-Label Phase (18 Weeks)||225
8154167|NCT02592421|20099354|P2|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
8154168|NCT02592421|20099355|P1|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
8154169|NCT02592421|20099354|P2|COMPLETED|Study 3: Pancreatic Clamp Conditions||10
8154170|NCT02592421|20099355|P1|COMPLETED|Study 3: Pancreatic Clamp Conditions||20
8154171|NCT02592421|20099354|P2|STARTED|Study 3: Pancreatic Clamp Conditions||10
8154172|NCT02592421|20099355|P1|STARTED|Study 3: Pancreatic Clamp Conditions||20
8154173|NCT02592421|20099354|P2|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
8154174|NCT02592421|20099355|P1|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
8154175|NCT02592421|20099354|P2|COMPLETED|Study 2: Glucose Clamp Conditions||10
8154176|NCT02592421|20099355|P1|COMPLETED|Study 2: Glucose Clamp Conditions||20
8154177|NCT02592421|20099354|P2|STARTED|Study 2: Glucose Clamp Conditions||10
8154178|NCT02592421|20099355|P1|STARTED|Study 2: Glucose Clamp Conditions||20
8154179|NCT02592421|20099354|P2|NOT COMPLETED|Study 1||0
8154180|NCT02592421|20099355|P1|NOT COMPLETED|Study 1||0
8154181|NCT02592421|20099354|P2|COMPLETED|Study 1||10
8154182|NCT02592421|20099355|P1|COMPLETED|Study 1||20
8154183|NCT02592421|20099354|P2|STARTED|Study 1||10
8154184|NCT02592421|20099355|P1|STARTED|Study 1||20
8154185|NCT02592018|20099367|P1|NOT COMPLETED|Overall Study||2
8154186|NCT02592018|20099367|P1|COMPLETED|Overall Study||13
8154187|NCT02592018|20099367|P1|STARTED|Overall Study||15
8154188|NCT02591537|20099384|P2|NOT COMPLETED|Overall Study||0
8154189|NCT02591537|20099385|P1|NOT COMPLETED|Overall Study||0
8154190|NCT02591537|20099384|P2|COMPLETED|Overall Study||8
8154191|NCT02591537|20099385|P1|COMPLETED|Overall Study||8
8154192|NCT02591537|20099384|P2|STARTED|Overall Study||8
8154193|NCT02591537|20099385|P1|STARTED|Overall Study||8
8154194|NCT02591511|20099407|P2|NOT COMPLETED|Overall Study||0
8154195|NCT02591511|20099408|P1|NOT COMPLETED|Overall Study||0
8154196|NCT02591511|20099407|P2|COMPLETED|Overall Study||33
8154197|NCT02591511|20099408|P1|COMPLETED|Overall Study||30
8154198|NCT02591511|20099407|P2|STARTED|Overall Study||33
8154199|NCT02591511|20099408|P1|STARTED|Overall Study||30
8154200|NCT02591290|20099414|P1|NOT COMPLETED|Overall Study||2
8154201|NCT02591290|20099414|P1|COMPLETED|Overall Study||58
8154202|NCT02591290|20099414|P1|Vaccinated Dose 2|Overall Study||58
8154203|NCT02591290|20099414|P1|Vaccinated Dose 1|Overall Study||60
8154204|NCT02591290|20099414|P1|STARTED|Overall Study||60
8154205|NCT02591238|20099424|P4|NOT COMPLETED|Overall Study||3
8154206|NCT02591238|20099425|P3|NOT COMPLETED|Overall Study||0
8154207|NCT02591238|20099426|P2|NOT COMPLETED|Overall Study||1
8154208|NCT02591238|20099427|P1|NOT COMPLETED|Overall Study||1
8154209|NCT02591238|20099424|P4|COMPLETED|Overall Study||15
8154210|NCT02591238|20099425|P3|COMPLETED|Overall Study||17
8154211|NCT02591238|20099426|P2|COMPLETED|Overall Study||16
8154212|NCT02591238|20099427|P1|COMPLETED|Overall Study||15
8154213|NCT02591238|20099424|P4|STARTED|Overall Study||18
8154214|NCT02591238|20099425|P3|STARTED|Overall Study||17
8154215|NCT02591238|20099426|P2|STARTED|Overall Study||17
8154216|NCT02591238|20099427|P1|STARTED|Overall Study||16
8154217|NCT02591056|20099457|P1|NOT COMPLETED|Overall Study||0
8154218|NCT02591056|20099457|P1|COMPLETED|Overall Study||27
8154219|NCT02591056|20099457|P1|STARTED|Overall Study||27
8154220|NCT02590939|20099463|P2|NOT COMPLETED|Overall Study||2
8154221|NCT02590939|20099464|P1|NOT COMPLETED|Overall Study||5
8154222|NCT02590939|20099463|P2|COMPLETED|Overall Study||52
8154223|NCT02590939|20099464|P1|COMPLETED|Overall Study||47
8154224|NCT02590939|20099463|P2|STARTED|Overall Study||54
8154225|NCT02590939|20099464|P1|STARTED|Overall Study||52
8154226|NCT02590588|20099484|P1|NOT COMPLETED|Overall Study||1
8154227|NCT02590588|20099484|P1|COMPLETED|Overall Study||0
8154228|NCT02590588|20099484|P1|STARTED|Overall Study||1
8154229|NCT02590562|20099492|P1|NOT COMPLETED|Overall Study||6
8154230|NCT02590562|20099492|P1|COMPLETED|Overall Study||802
8154231|NCT02590562|20099492|P1|STARTED|Overall Study||808
8154232|NCT02590432|20099551|P9|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
8154233|NCT02590432|20099552|P8|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
8154234|NCT02590432|20099553|P7|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8154235|NCT02590432|20099554|P6|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8154236|NCT02590432|20099555|P5|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8154237|NCT02590432|20099556|P4|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8154238|NCT02590432|20099557|P3|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8154239|NCT02590432|20099558|P2|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8154240|NCT02590432|20099559|P1|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
8154241|NCT02590432|20099551|P9|COMPLETED|Dose-reduced Open Label Treatment Period||8
8154242|NCT02590432|20099552|P8|COMPLETED|Dose-reduced Open Label Treatment Period||13
8154243|NCT02590432|20099553|P7|COMPLETED|Dose-reduced Open Label Treatment Period||0
8154244|NCT02590432|20099554|P6|COMPLETED|Dose-reduced Open Label Treatment Period||0
8154245|NCT02590432|20099555|P5|COMPLETED|Dose-reduced Open Label Treatment Period||0
8154246|NCT02590432|20099556|P4|COMPLETED|Dose-reduced Open Label Treatment Period||0
8154247|NCT02590432|20099557|P3|COMPLETED|Dose-reduced Open Label Treatment Period||0
8154248|NCT02590432|20099558|P2|COMPLETED|Dose-reduced Open Label Treatment Period||0
8154249|NCT02590432|20099559|P1|COMPLETED|Dose-reduced Open Label Treatment Period||0
8154250|NCT02590432|20099551|P9|STARTED|Dose-reduced Open Label Treatment Period||26
8154251|NCT02590432|20099552|P8|STARTED|Dose-reduced Open Label Treatment Period||31
8154252|NCT02590432|20099553|P7|STARTED|Dose-reduced Open Label Treatment Period||0
8154253|NCT02590432|20099554|P6|STARTED|Dose-reduced Open Label Treatment Period||0
8154254|NCT02590432|20099555|P5|STARTED|Dose-reduced Open Label Treatment Period||0
8154255|NCT02590432|20099556|P4|STARTED|Dose-reduced Open Label Treatment Period||0
8154256|NCT02590432|20099557|P3|STARTED|Dose-reduced Open Label Treatment Period||0
8154257|NCT02590432|20099558|P2|STARTED|Dose-reduced Open Label Treatment Period||0
8154258|NCT02590432|20099559|P1|STARTED|Dose-reduced Open Label Treatment Period||0
8154259|NCT02590432|20099551|P9|NOT COMPLETED|Double-blind Treatment Period||0
8154260|NCT02590432|20099552|P8|NOT COMPLETED|Double-blind Treatment Period||0
8154261|NCT02590432|20099553|P7|NOT COMPLETED|Double-blind Treatment Period||21
8154262|NCT02590432|20099554|P6|NOT COMPLETED|Double-blind Treatment Period||26
8154263|NCT02590432|20099555|P5|NOT COMPLETED|Double-blind Treatment Period||9
8154264|NCT02590432|20099556|P4|NOT COMPLETED|Double-blind Treatment Period||15
8154265|NCT02590432|20099557|P3|NOT COMPLETED|Double-blind Treatment Period||17
8154266|NCT02590432|20099558|P2|NOT COMPLETED|Double-blind Treatment Period||0
8154267|NCT02590432|20099559|P1|NOT COMPLETED|Double-blind Treatment Period||0
8154268|NCT02590432|20099551|P9|COMPLETED|Double-blind Treatment Period||0
8154269|NCT02590432|20099552|P8|COMPLETED|Double-blind Treatment Period||0
8154270|NCT02590432|20099553|P7|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9
8154271|NCT02590432|20099554|P6|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6
8154272|NCT02590432|20099555|P5|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7
8154273|NCT02590432|20099556|P4|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3
8154274|NCT02590432|20099557|P3|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1
8154275|NCT02590432|20099558|P2|COMPLETED|Double-blind Treatment Period||0
8154276|NCT02590432|20099559|P1|COMPLETED|Double-blind Treatment Period||0
8154277|NCT02590432|20099551|P9|STARTED|Double-blind Treatment Period||0
8154278|NCT02590432|20099552|P8|STARTED|Double-blind Treatment Period||0
8154279|NCT02590432|20099553|P7|STARTED|Double-blind Treatment Period||30
8154280|NCT02590432|20099554|P6|STARTED|Double-blind Treatment Period||32
8154281|NCT02590432|20099555|P5|STARTED|Double-blind Treatment Period||16
8154282|NCT02590432|20099556|P4|STARTED|Double-blind Treatment Period||18
8154283|NCT02590432|20099557|P3|STARTED|Double-blind Treatment Period||18
8154284|NCT02590432|20099558|P2|STARTED|Double-blind Treatment Period||0
8154285|NCT02590432|20099559|P1|STARTED|Double-blind Treatment Period||0
8154286|NCT02590432|20099551|P9|NOT COMPLETED|Open-label Treatment Period||0
8154287|NCT02590432|20099552|P8|NOT COMPLETED|Open-label Treatment Period||0
8154288|NCT02590432|20099553|P7|NOT COMPLETED|Open-label Treatment Period||0
8154289|NCT02590432|20099554|P6|NOT COMPLETED|Open-label Treatment Period||0
8154290|NCT02590432|20099555|P5|NOT COMPLETED|Open-label Treatment Period||0
8154291|NCT02590432|20099556|P4|NOT COMPLETED|Open-label Treatment Period||0
8154292|NCT02590432|20099557|P3|NOT COMPLETED|Open-label Treatment Period||0
8154293|NCT02590432|20099558|P2|NOT COMPLETED|Open-label Treatment Period||152
8154294|NCT02590432|20099559|P1|NOT COMPLETED|Open-label Treatment Period||232
8154295|NCT02590432|20099551|P9|COMPLETED|Open-label Treatment Period||0
8154296|NCT02590432|20099552|P8|COMPLETED|Open-label Treatment Period||0
8154297|NCT02590432|20099553|P7|COMPLETED|Open-label Treatment Period||0
8154298|NCT02590432|20099554|P6|COMPLETED|Open-label Treatment Period||0
8154299|NCT02590432|20099555|P5|COMPLETED|Open-label Treatment Period||0
8154300|NCT02590432|20099556|P4|COMPLETED|Open-label Treatment Period||0
8154301|NCT02590432|20099557|P3|COMPLETED|Open-label Treatment Period||0
8154302|NCT02590432|20099558|P2|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166
8154303|NCT02590432|20099559|P1|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276
8154304|NCT02590432|20099551|P9|STARTED|Open-label Treatment Period||0
8154305|NCT02590432|20099552|P8|STARTED|Open-label Treatment Period||0
8154306|NCT02590432|20099553|P7|STARTED|Open-label Treatment Period||0
8154307|NCT02590432|20099554|P6|STARTED|Open-label Treatment Period||0
8154308|NCT02590432|20099555|P5|STARTED|Open-label Treatment Period||0
8154309|NCT02590432|20099556|P4|STARTED|Open-label Treatment Period||0
8154310|NCT02590432|20099557|P3|STARTED|Open-label Treatment Period||0
8154311|NCT02590432|20099558|P2|STARTED|Open-label Treatment Period||318
8154312|NCT02590432|20099559|P1|STARTED|Open-label Treatment Period||508
8154313|NCT02590406|20099595|P2|NOT COMPLETED|Overall Study||1
8154314|NCT02590406|20099596|P1|NOT COMPLETED|Overall Study||1
8154315|NCT02590406|20099595|P2|COMPLETED|Overall Study||24
8154316|NCT02590406|20099596|P1|COMPLETED|Overall Study||24
8154317|NCT02590406|20099595|P2|STARTED|Overall Study||25
8154318|NCT02590406|20099596|P1|STARTED|Overall Study||25
8154319|NCT02590354|20099610|P1|NOT COMPLETED|Phase 2 - Treatment Interruption||2
8154320|NCT02590354|20099610|P1|COMPLETED|Phase 2 - Treatment Interruption||14
8154321|NCT02590354|20099610|P1|STARTED|Phase 2 - Treatment Interruption||16
8154322|NCT02590354|20099610|P1|NOT COMPLETED|Phase 1||98
8154323|NCT02590354|20099610|P1|COMPLETED|Phase 1||16
8154324|NCT02590354|20099610|P1|STARTED|Phase 1||114
8154325|NCT02590068|20099620|P2|NOT COMPLETED|Overall Study||0
8154326|NCT02590068|20099621|P1|NOT COMPLETED|Overall Study||0
8154327|NCT02590068|20099620|P2|COMPLETED|Overall Study||14
8154328|NCT02590068|20099621|P1|COMPLETED|Overall Study||0
8154329|NCT02590068|20099620|P2|STARTED|Overall Study||14
8154330|NCT02590068|20099621|P1|STARTED|Overall Study||0
8154331|NCT02590003|20099637|P2|NOT COMPLETED|Overall Study||2
8154332|NCT02590003|20099638|P1|NOT COMPLETED|Overall Study||1
8154333|NCT02590003|20099637|P2|COMPLETED|Overall Study||0
8154334|NCT02590003|20099638|P1|COMPLETED|Overall Study||0
8154335|NCT02590003|20099637|P2|STARTED|Overall Study||2
8154336|NCT02590003|20099638|P1|STARTED|Overall Study||1
8154343|NCT02589808|20099667|P1|NOT COMPLETED|Overall Study||0
8154344|NCT02589808|20099667|P1|COMPLETED|Overall Study||76
8154345|NCT02589808|20099667|P1|STARTED|Overall Study||76
8154346|NCT02589665|20099675|P10|NOT COMPLETED|Maintenance Extension Period||68
8154347|NCT02589665|20099676|P9|NOT COMPLETED|Maintenance Extension Period||0
8154348|NCT02589665|20099677|P8|NOT COMPLETED|Maintenance Extension Period||0
8154349|NCT02589665|20099678|P7|NOT COMPLETED|Maintenance Extension Period||0
8154350|NCT02589665|20099679|P6|NOT COMPLETED|Maintenance Extension Period||0
8154351|NCT02589665|20099680|P5|NOT COMPLETED|Maintenance Extension Period||0
8154352|NCT02589665|20099681|P4|NOT COMPLETED|Maintenance Extension Period||0
8154353|NCT02589665|20099682|P3|NOT COMPLETED|Maintenance Extension Period||0
8154354|NCT02589665|20099683|P2|NOT COMPLETED|Maintenance Extension Period||0
8154355|NCT02589665|20099684|P1|NOT COMPLETED|Maintenance Extension Period||0
8154356|NCT02589665|20099675|P10|COMPLETED|Maintenance Extension Period||0
8154357|NCT02589665|20099676|P9|COMPLETED|Maintenance Extension Period||0
8154358|NCT02589665|20099677|P8|COMPLETED|Maintenance Extension Period||0
8154359|NCT02589665|20099678|P7|COMPLETED|Maintenance Extension Period||0
8154360|NCT02589665|20099679|P6|COMPLETED|Maintenance Extension Period||0
8154361|NCT02589665|20099680|P5|COMPLETED|Maintenance Extension Period||0
8154362|NCT02589665|20099681|P4|COMPLETED|Maintenance Extension Period||0
8154363|NCT02589665|20099682|P3|COMPLETED|Maintenance Extension Period||0
8154364|NCT02589665|20099683|P2|COMPLETED|Maintenance Extension Period||0
8154365|NCT02589665|20099684|P1|COMPLETED|Maintenance Extension Period||0
8154366|NCT02589665|20099675|P10|STARTED|Maintenance Extension Period||68
8154367|NCT02589665|20099676|P9|STARTED|Maintenance Extension Period||0
8154368|NCT02589665|20099677|P8|STARTED|Maintenance Extension Period||0
8154369|NCT02589665|20099678|P7|STARTED|Maintenance Extension Period||0
8154370|NCT02589665|20099679|P6|STARTED|Maintenance Extension Period||0
8154371|NCT02589665|20099680|P5|STARTED|Maintenance Extension Period||0
8154372|NCT02589665|20099681|P4|STARTED|Maintenance Extension Period||0
8154373|NCT02589665|20099682|P3|STARTED|Maintenance Extension Period||0
8154374|NCT02589665|20099683|P2|STARTED|Maintenance Extension Period||0
8154375|NCT02589665|20099684|P1|STARTED|Maintenance Extension Period||0
8154376|NCT02589665|20099675|P10|NOT COMPLETED|Induction Extension Period||0
8154377|NCT02589665|20099676|P9|NOT COMPLETED|Induction Extension Period||12
8154378|NCT02589665|20099677|P8|NOT COMPLETED|Induction Extension Period||2
8154379|NCT02589665|20099678|P7|NOT COMPLETED|Induction Extension Period||0
8154380|NCT02589665|20099679|P6|NOT COMPLETED|Induction Extension Period||0
8154381|NCT02589665|20099680|P5|NOT COMPLETED|Induction Extension Period||0
8154382|NCT02589665|20099681|P4|NOT COMPLETED|Induction Extension Period||0
8154383|NCT02589665|20099682|P3|NOT COMPLETED|Induction Extension Period||0
8154384|NCT02589665|20099683|P2|NOT COMPLETED|Induction Extension Period||0
8154385|NCT02589665|20099684|P1|NOT COMPLETED|Induction Extension Period||0
8154386|NCT02589665|20099675|P10|COMPLETED|Induction Extension Period||0
8154387|NCT02589665|20099676|P9|COMPLETED|Induction Extension Period||84
8154388|NCT02589665|20099677|P8|COMPLETED|Induction Extension Period||30
8154389|NCT02589665|20099678|P7|COMPLETED|Induction Extension Period||0
8154390|NCT02589665|20099679|P6|COMPLETED|Induction Extension Period||0
8154391|NCT02589665|20099680|P5|COMPLETED|Induction Extension Period||0
8154392|NCT02589665|20099681|P4|COMPLETED|Induction Extension Period||0
8154393|NCT02589665|20099682|P3|COMPLETED|Induction Extension Period||0
8154394|NCT02589665|20099683|P2|COMPLETED|Induction Extension Period||0
8154395|NCT02589665|20099684|P1|COMPLETED|Induction Extension Period||0
8154396|NCT02589665|20099675|P10|STARTED|Induction Extension Period||0
8154397|NCT02589665|20099676|P9|STARTED|Induction Extension Period||96
8154398|NCT02589665|20099677|P8|STARTED|Induction Extension Period||32
8154399|NCT02589665|20099678|P7|STARTED|Induction Extension Period||0
8154400|NCT02589665|20099679|P6|STARTED|Induction Extension Period||0
8154401|NCT02589665|20099680|P5|STARTED|Induction Extension Period||0
8154402|NCT02589665|20099681|P4|STARTED|Induction Extension Period||0
8154403|NCT02589665|20099682|P3|STARTED|Induction Extension Period||0
8154404|NCT02589665|20099683|P2|STARTED|Induction Extension Period||0
8154405|NCT02589665|20099684|P1|STARTED|Induction Extension Period||0
8154406|NCT02589665|20099675|P10|NOT COMPLETED|Maintenance Period||0
8154407|NCT02589665|20099676|P9|NOT COMPLETED|Maintenance Period||0
8154408|NCT02589665|20099677|P8|NOT COMPLETED|Maintenance Period||0
8154409|NCT02589665|20099678|P7|NOT COMPLETED|Maintenance Period||46
8154410|NCT02589665|20099679|P6|NOT COMPLETED|Maintenance Period||47
8154411|NCT02589665|20099680|P5|NOT COMPLETED|Maintenance Period||13
8154412|NCT02589665|20099681|P4|NOT COMPLETED|Maintenance Period||0
8154413|NCT02589665|20099682|P3|NOT COMPLETED|Maintenance Period||0
8154414|NCT02589665|20099683|P2|NOT COMPLETED|Maintenance Period||0
8154415|NCT02589665|20099684|P1|NOT COMPLETED|Maintenance Period||0
8154416|NCT02589665|20099675|P10|COMPLETED|Maintenance Period||0
8154417|NCT02589665|20099676|P9|COMPLETED|Maintenance Period||0
8154418|NCT02589665|20099677|P8|COMPLETED|Maintenance Period||0
8154419|NCT02589665|20099678|P7|COMPLETED|Maintenance Period||0
8154420|NCT02589665|20099679|P6|COMPLETED|Maintenance Period||0
8154421|NCT02589665|20099680|P5|COMPLETED|Maintenance Period||0
8154422|NCT02589665|20099681|P4|COMPLETED|Maintenance Period||0
8154423|NCT02589665|20099682|P3|COMPLETED|Maintenance Period||0
8154424|NCT02589665|20099683|P2|COMPLETED|Maintenance Period||0
8154425|NCT02589665|20099684|P1|COMPLETED|Maintenance Period||0
8154426|NCT02589665|20099675|P10|STARTED|Maintenance Period||0
8154427|NCT02589665|20099676|P9|STARTED|Maintenance Period||0
8154428|NCT02589665|20099677|P8|STARTED|Maintenance Period||0
8154429|NCT02589665|20099678|P7|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|46
8154430|NCT02589665|20099679|P6|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|47
8154431|NCT02589665|20099680|P5|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|13
8154432|NCT02589665|20099681|P4|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
8154433|NCT02589665|20099682|P3|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
8154434|NCT02589665|20099683|P2|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
8154435|NCT02589665|20099684|P1|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
8154436|NCT02589665|20099675|P10|NOT COMPLETED|Induction Period||0
8154437|NCT02589665|20099676|P9|NOT COMPLETED|Induction Period||0
8154438|NCT02589665|20099677|P8|NOT COMPLETED|Induction Period||0
8154439|NCT02589665|20099678|P7|NOT COMPLETED|Induction Period||0
8154440|NCT02589665|20099679|P6|NOT COMPLETED|Induction Period||0
8154441|NCT02589665|20099680|P5|NOT COMPLETED|Induction Period||0
8154442|NCT02589665|20099681|P4|NOT COMPLETED|Induction Period||4
8154443|NCT02589665|20099682|P3|NOT COMPLETED|Induction Period||2
8154444|NCT02589665|20099683|P2|NOT COMPLETED|Induction Period||2
8154445|NCT02589665|20099684|P1|NOT COMPLETED|Induction Period||3
8154446|NCT02589665|20099675|P10|COMPLETED|Induction Period||0
8154447|NCT02589665|20099676|P9|COMPLETED|Induction Period||0
8154448|NCT02589665|20099677|P8|COMPLETED|Induction Period||0
8154449|NCT02589665|20099678|P7|COMPLETED|Induction Period||0
8154450|NCT02589665|20099679|P6|COMPLETED|Induction Period||0
8154451|NCT02589665|20099680|P5|COMPLETED|Induction Period||0
8154452|NCT02589665|20099681|P4|COMPLETED|Induction Period||57
8154453|NCT02589665|20099682|P3|COMPLETED|Induction Period||60
8154454|NCT02589665|20099683|P2|COMPLETED|Induction Period||61
8154455|NCT02589665|20099684|P1|COMPLETED|Induction Period||60
8154456|NCT02589665|20099675|P10|Received at Least One Dose of Study Drug|Induction Period||0
8154457|NCT02589665|20099676|P9|Received at Least One Dose of Study Drug|Induction Period||0
8154458|NCT02589665|20099677|P8|Received at Least One Dose of Study Drug|Induction Period||0
8154459|NCT02589665|20099678|P7|Received at Least One Dose of Study Drug|Induction Period||0
8154460|NCT02589665|20099679|P6|Received at Least One Dose of Study Drug|Induction Period||0
8154461|NCT02589665|20099680|P5|Received at Least One Dose of Study Drug|Induction Period||0
8154462|NCT02589665|20099681|P4|Received at Least One Dose of Study Drug|Induction Period||60
8154463|NCT02589665|20099682|P3|Received at Least One Dose of Study Drug|Induction Period||62
8154464|NCT02589665|20099683|P2|Received at Least One Dose of Study Drug|Induction Period||63
8154465|NCT02589665|20099684|P1|Received at Least One Dose of Study Drug|Induction Period||63
8154466|NCT02589665|20099675|P10|STARTED|Induction Period||0
8154467|NCT02589665|20099676|P9|STARTED|Induction Period||0
8154468|NCT02589665|20099677|P8|STARTED|Induction Period||0
8154469|NCT02589665|20099678|P7|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
8154470|NCT02589665|20099679|P6|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
8154471|NCT02589665|20099680|P5|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
8154472|NCT02589665|20099681|P4|STARTED|Induction Period||61
8154473|NCT02589665|20099682|P3|STARTED|Induction Period||62
8154474|NCT02589665|20099683|P2|STARTED|Induction Period||63
8154475|NCT02589665|20099684|P1|STARTED|Induction Period||63
8154476|NCT02589639|20099749|P3|NOT COMPLETED|Overall Study||4
8154477|NCT02589639|20099750|P2|NOT COMPLETED|Overall Study||10
8154478|NCT02589639|20099751|P1|NOT COMPLETED|Overall Study||10
8154479|NCT02589639|20099749|P3|COMPLETED|Overall Study||86
8154480|NCT02589639|20099750|P2|COMPLETED|Overall Study||79
8154481|NCT02589639|20099751|P1|COMPLETED|Overall Study||80
8154482|NCT02589639|20099749|P3|Treated|Overall Study||90
8154483|NCT02589639|20099750|P2|Treated|Overall Study||86
8154484|NCT02589639|20099751|P1|Treated|Overall Study||90
8154485|NCT02589639|20099749|P3|STARTED|Overall Study||90
8154486|NCT02589639|20099750|P2|STARTED|Overall Study||89
8154487|NCT02589639|20099751|P1|STARTED|Overall Study||90
8154488|NCT02589626|20099764|P2|NOT COMPLETED|Overall Study||2
8154489|NCT02589626|20099765|P1|NOT COMPLETED|Overall Study||3
8154490|NCT02589626|20099764|P2|COMPLETED|Overall Study||31
8154491|NCT02589626|20099765|P1|COMPLETED|Overall Study||29
8154492|NCT02589626|20099764|P2|STARTED|Overall Study|Entered are treated patients|33
8154493|NCT02589626|20099765|P1|STARTED|Overall Study|Entered are treated patients|32
8154497|NCT02589171|20099779|P2|NOT COMPLETED|Overall Study||5
8154498|NCT02589171|20099780|P1|NOT COMPLETED|Overall Study||7
8154499|NCT02589171|20099779|P2|COMPLETED|Overall Study||30
8154500|NCT02589171|20099780|P1|COMPLETED|Overall Study||28
8154501|NCT02589171|20099779|P2|Week 6 Follow up|Overall Study||30
8154502|NCT02589171|20099780|P1|Week 6 Follow up|Overall Study||28
8154503|NCT02589171|20099779|P2|Week 1 Follow up|Overall Study||34
8154504|NCT02589171|20099780|P1|Week 1 Follow up|Overall Study||35
8154505|NCT02589171|20099779|P2|Day 1 Follow up|Overall Study||35
8154506|NCT02589171|20099780|P1|Day 1 Follow up|Overall Study||35
8154507|NCT02589171|20099779|P2|STARTED|Overall Study||35
8154508|NCT02589171|20099780|P1|STARTED|Overall Study||35
8154509|NCT02589145|20099823|P3|NOT COMPLETED|Overall Study||0
8154510|NCT02589145|20099824|P2|NOT COMPLETED|Overall Study||0
8154511|NCT02589145|20099825|P1|NOT COMPLETED|Overall Study||0
8154512|NCT02589145|20099823|P3|COMPLETED|Overall Study||2
8154513|NCT02589145|20099824|P2|COMPLETED|Overall Study||2
8154514|NCT02589145|20099825|P1|COMPLETED|Overall Study||4
8154515|NCT02589145|20099823|P3|STARTED|Overall Study||2
8154516|NCT02589145|20099824|P2|STARTED|Overall Study||2
8154517|NCT02589145|20099825|P1|STARTED|Overall Study||4
8154518|NCT02589067|20099853|P2|NOT COMPLETED|Overall Study||6
8154519|NCT02589067|20099854|P1|NOT COMPLETED|Overall Study||5
8154520|NCT02589067|20099853|P2|COMPLETED|Overall Study||28
8154521|NCT02589067|20099854|P1|COMPLETED|Overall Study||28
8154522|NCT02589067|20099853|P2|STARTED|Overall Study||34
8154523|NCT02589067|20099854|P1|STARTED|Overall Study||33
8154524|NCT02588976|20099866|P1|NOT COMPLETED|Overall Study||0
8154525|NCT02588976|20099866|P1|COMPLETED|Overall Study||30
8154526|NCT02588976|20099866|P1|STARTED|Overall Study||30
8154527|NCT02588872|20099873|P2|NOT COMPLETED|Overall Study||0
8154528|NCT02588872|20099874|P1|NOT COMPLETED|Overall Study||0
8154529|NCT02588872|20099873|P2|COMPLETED|Overall Study||52
8154530|NCT02588872|20099874|P1|COMPLETED|Overall Study||59
8154531|NCT02588872|20099873|P2|STARTED|Overall Study||52
8154532|NCT02588872|20099874|P1|STARTED|Overall Study||59
8154533|NCT02588833|20099890|P2|NOT COMPLETED|Part 3 (Safety Follow-up)||2
8154534|NCT02588833|20099891|P1|NOT COMPLETED|Part 3 (Safety Follow-up)||0
8154535|NCT02588833|20099890|P2|COMPLETED|Part 3 (Safety Follow-up)||2
8154536|NCT02588833|20099891|P1|COMPLETED|Part 3 (Safety Follow-up)||3
8154629|NCT02587962|20100207|P3|STARTED|Overall Study||6
8154537|NCT02588833|20099890|P2|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|4
8154538|NCT02588833|20099891|P1|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|3
8154539|NCT02588833|20099890|P2|NOT COMPLETED|Part 2C||2
8154540|NCT02588833|20099891|P1|NOT COMPLETED|Part 2C||0
8154541|NCT02588833|20099890|P2|COMPLETED|Part 2C||12
8154542|NCT02588833|20099891|P1|COMPLETED|Part 2C||0
8154543|NCT02588833|20099890|P2|STARTED|Part 2C|17 subjects completed Part 2B and 3 entered extension study without participating in Part 2C.|14
8154544|NCT02588833|20099891|P1|STARTED|Part 2C||0
8154545|NCT02588833|20099890|P2|NOT COMPLETED|Part 2B||1
8154546|NCT02588833|20099891|P1|NOT COMPLETED|Part 2B||0
8154547|NCT02588833|20099890|P2|COMPLETED|Part 2B||17
8154548|NCT02588833|20099891|P1|COMPLETED|Part 2B||0
8154549|NCT02588833|20099890|P2|STARTED|Part 2B||18
8154550|NCT02588833|20099891|P1|STARTED|Part 2B||0
8154551|NCT02588833|20099890|P2|NOT COMPLETED|Part 2A||2
8154552|NCT02588833|20099891|P1|NOT COMPLETED|Part 2A||0
8154553|NCT02588833|20099890|P2|COMPLETED|Part 2A||18
8154554|NCT02588833|20099891|P1|COMPLETED|Part 2A||0
8154555|NCT02588833|20099890|P2|STARTED|Part 2A||20
8154556|NCT02588833|20099891|P1|STARTED|Part 2A|Part 2A is not applicable since Cohort 1 subjects proceeded immediately to Part 3.|0
8154557|NCT02588833|20099890|P2|NOT COMPLETED|Part 1||0
8154558|NCT02588833|20099891|P1|NOT COMPLETED|Part 1||1
8154559|NCT02588833|20099890|P2|COMPLETED|Part 1||20
8154560|NCT02588833|20099891|P1|COMPLETED|Part 1||2
8154561|NCT02588833|20099890|P2|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|20
8154562|NCT02588833|20099891|P1|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|3
8154563|NCT02588599|20099910|P1|NOT COMPLETED|Overall Study||0
8154564|NCT02588599|20099910|P1|COMPLETED|Overall Study||54
8154565|NCT02588599|20099910|P1|STARTED|Overall Study||54
8154566|NCT02588573|20099917|P2|NOT COMPLETED|Overall Study||0
8154567|NCT02588573|20099918|P1|NOT COMPLETED|Overall Study||0
8154568|NCT02588573|20099917|P2|COMPLETED|Overall Study||45
8154569|NCT02588573|20099918|P1|COMPLETED|Overall Study||45
8154570|NCT02588573|20099917|P2|Randomized Eye Somofilcon A|Overall Study||45
8154571|NCT02588573|20099918|P1|Randomized Eye Somofilcon A|Overall Study||45
8154572|NCT02588573|20099917|P2|Randomized Eye Etafilcon A|Overall Study||45
8154573|NCT02588573|20099918|P1|Randomized Eye Etafilcon A|Overall Study||45
8154574|NCT02588573|20099917|P2|STARTED|Overall Study||45
8154575|NCT02588573|20099918|P1|STARTED|Overall Study||45
8154579|NCT02588261|20099960|P2|NOT COMPLETED|Overall Study||263
8154580|NCT02588261|20099961|P1|NOT COMPLETED|Overall Study||267
8154581|NCT02588261|20099960|P2|COMPLETED|Overall Study||0
8154582|NCT02588261|20099961|P1|COMPLETED|Overall Study||0
8154583|NCT02588261|20099960|P2|Treated|Overall Study||262
8154584|NCT02588261|20099961|P1|Treated|Overall Study||265
8154585|NCT02588261|20099960|P2|STARTED|Overall Study||263
8154586|NCT02588261|20099961|P1|STARTED|Overall Study||267
8154587|NCT02588092|20099997|P10|NOT COMPLETED|Overall Study||3
8154588|NCT02588092|20099998|P9|NOT COMPLETED|Overall Study||6
8154589|NCT02588092|20099999|P8|NOT COMPLETED|Overall Study||4
8154590|NCT02588092|20100000|P7|NOT COMPLETED|Overall Study||3
8154591|NCT02588092|20100001|P6|NOT COMPLETED|Overall Study||3
8154592|NCT02588092|20100002|P5|NOT COMPLETED|Overall Study||3
8154593|NCT02588092|20100003|P4|NOT COMPLETED|Overall Study||3
8154594|NCT02588092|20100004|P3|NOT COMPLETED|Overall Study||3
8154595|NCT02588092|20100005|P2|NOT COMPLETED|Overall Study||3
8154596|NCT02588092|20100006|P1|NOT COMPLETED|Overall Study||4
8154597|NCT02588092|20099997|P10|COMPLETED|Overall Study||0
8154598|NCT02588092|20099998|P9|COMPLETED|Overall Study||0
8154599|NCT02588092|20099999|P8|COMPLETED|Overall Study||0
8154600|NCT02588092|20100000|P7|COMPLETED|Overall Study||0
8154601|NCT02588092|20100001|P6|COMPLETED|Overall Study||0
8154602|NCT02588092|20100002|P5|COMPLETED|Overall Study||0
8154603|NCT02588092|20100003|P4|COMPLETED|Overall Study||0
8154604|NCT02588092|20100004|P3|COMPLETED|Overall Study||0
8154605|NCT02588092|20100005|P2|COMPLETED|Overall Study||0
8154606|NCT02588092|20100006|P1|COMPLETED|Overall Study||0
8154607|NCT02588092|20099997|P10|STARTED|Overall Study||3
8154608|NCT02588092|20099998|P9|STARTED|Overall Study||6
8154609|NCT02588092|20099999|P8|STARTED|Overall Study||4
8154610|NCT02588092|20100000|P7|STARTED|Overall Study||3
8154611|NCT02588092|20100001|P6|STARTED|Overall Study||3
8154612|NCT02588092|20100002|P5|STARTED|Overall Study||3
8154613|NCT02588092|20100003|P4|STARTED|Overall Study||3
8154614|NCT02588092|20100004|P3|STARTED|Overall Study||3
8154615|NCT02588092|20100005|P2|STARTED|Overall Study||3
8154616|NCT02588092|20100006|P1|STARTED|Overall Study||4
8154617|NCT02587962|20100205|P5|NOT COMPLETED|Overall Study||15
8154618|NCT02587962|20100206|P4|NOT COMPLETED|Overall Study||6
8154619|NCT02587962|20100207|P3|NOT COMPLETED|Overall Study||6
8154620|NCT02587962|20100208|P2|NOT COMPLETED|Overall Study||3
8154621|NCT02587962|20100209|P1|NOT COMPLETED|Overall Study||2
8154622|NCT02587962|20100205|P5|COMPLETED|Overall Study||0
8154623|NCT02587962|20100206|P4|COMPLETED|Overall Study||1
8154624|NCT02587962|20100207|P3|COMPLETED|Overall Study||0
8154625|NCT02587962|20100208|P2|COMPLETED|Overall Study||0
8154626|NCT02587962|20100209|P1|COMPLETED|Overall Study||1
8154627|NCT02587962|20100205|P5|STARTED|Overall Study||15
8154628|NCT02587962|20100206|P4|STARTED|Overall Study||7
8154630|NCT02587962|20100208|P2|STARTED|Overall Study||3
8154631|NCT02587962|20100209|P1|STARTED|Overall Study||3
8154632|NCT02587819|20100281|P1|NOT COMPLETED|Overall Study||2
8154633|NCT02587819|20100281|P1|COMPLETED|Overall Study||19
8154634|NCT02587819|20100281|P1|Exposed|Overall Study||21
8154635|NCT02587819|20100281|P1|STARTED|Overall Study||21
8154636|NCT02587650|20100288|P4|NOT COMPLETED|Overall Study||0
8154637|NCT02587650|20100289|P3|NOT COMPLETED|Overall Study||0
8154638|NCT02587650|20100290|P2|NOT COMPLETED|Overall Study||0
8154639|NCT02587650|20100291|P1|NOT COMPLETED|Overall Study||0
8154640|NCT02587650|20100288|P4|COMPLETED|Overall Study||0
8154641|NCT02587650|20100289|P3|COMPLETED|Overall Study||1
8154642|NCT02587650|20100290|P2|COMPLETED|Overall Study||0
8154643|NCT02587650|20100291|P1|COMPLETED|Overall Study||0
8154644|NCT02587650|20100288|P4|STARTED|Overall Study||0
8154645|NCT02587650|20100289|P3|STARTED|Overall Study||1
8154646|NCT02587650|20100290|P2|STARTED|Overall Study||0
8154647|NCT02587650|20100291|P1|STARTED|Overall Study||0
8154648|NCT02587520|20100317|P18|NOT COMPLETED|Overall Study||0
8154649|NCT02587520|20100318|P17|NOT COMPLETED|Overall Study||0
8154650|NCT02587520|20100319|P16|NOT COMPLETED|Overall Study||0
8154651|NCT02587520|20100320|P15|NOT COMPLETED|Overall Study||0
8154652|NCT02587520|20100321|P14|NOT COMPLETED|Overall Study||1
8154653|NCT02587520|20100322|P13|NOT COMPLETED|Overall Study||0
8154654|NCT02587520|20100323|P12|NOT COMPLETED|Overall Study||4
8154655|NCT02587520|20100324|P11|NOT COMPLETED|Overall Study||3
8154656|NCT02587520|20100325|P10|NOT COMPLETED|Overall Study||5
8154657|NCT02587520|20100326|P9|NOT COMPLETED|Overall Study||3
8154658|NCT02587520|20100327|P8|NOT COMPLETED|Overall Study||2
8154659|NCT02587520|20100328|P7|NOT COMPLETED|Overall Study||3
8154660|NCT02587520|20100329|P6|NOT COMPLETED|Overall Study||3
8154661|NCT02587520|20100330|P5|NOT COMPLETED|Overall Study||0
8154662|NCT02587520|20100331|P4|NOT COMPLETED|Overall Study||5
8154663|NCT02587520|20100332|P3|NOT COMPLETED|Overall Study||1
8154664|NCT02587520|20100333|P2|NOT COMPLETED|Overall Study||2
8154665|NCT02587520|20100334|P1|NOT COMPLETED|Overall Study||2
8154666|NCT02587520|20100317|P18|COMPLETED|Overall Study||78
8154667|NCT02587520|20100318|P17|COMPLETED|Overall Study||76
8154668|NCT02587520|20100319|P16|COMPLETED|Overall Study||72
8154669|NCT02587520|20100320|P15|COMPLETED|Overall Study||78
8154670|NCT02587520|20100321|P14|COMPLETED|Overall Study||73
8154671|NCT02587520|20100322|P13|COMPLETED|Overall Study||77
8154672|NCT02587520|20100323|P12|COMPLETED|Overall Study||69
8154673|NCT02587520|20100324|P11|COMPLETED|Overall Study||73
8154674|NCT02587520|20100325|P10|COMPLETED|Overall Study||71
8154675|NCT02587520|20100326|P9|COMPLETED|Overall Study||73
8154676|NCT02587520|20100327|P8|COMPLETED|Overall Study||71
8154677|NCT02587520|20100328|P7|COMPLETED|Overall Study||73
8154678|NCT02587520|20100329|P6|COMPLETED|Overall Study||72
8154679|NCT02587520|20100330|P5|COMPLETED|Overall Study||75
8154680|NCT02587520|20100331|P4|COMPLETED|Overall Study||74
8154681|NCT02587520|20100332|P3|COMPLETED|Overall Study||77
8154682|NCT02587520|20100333|P2|COMPLETED|Overall Study||69
8154683|NCT02587520|20100334|P1|COMPLETED|Overall Study||78
8154684|NCT02587520|20100317|P18|Safety Analysis Set (SafAS)|Overall Study||78
8154685|NCT02587520|20100318|P17|Safety Analysis Set (SafAS)|Overall Study||76
8154686|NCT02587520|20100319|P16|Safety Analysis Set (SafAS)|Overall Study||72
8154687|NCT02587520|20100320|P15|Safety Analysis Set (SafAS)|Overall Study||78
8154688|NCT02587520|20100321|P14|Safety Analysis Set (SafAS)|Overall Study||73
8154689|NCT02587520|20100322|P13|Safety Analysis Set (SafAS)|Overall Study||77
8154690|NCT02587520|20100323|P12|Safety Analysis Set (SafAS)|Overall Study||72
8154691|NCT02587520|20100324|P11|Safety Analysis Set (SafAS)|Overall Study||76
8154692|NCT02587520|20100325|P10|Safety Analysis Set (SafAS)|Overall Study||76
8154693|NCT02587520|20100326|P9|Safety Analysis Set (SafAS)|Overall Study||76
8154694|NCT02587520|20100327|P8|Safety Analysis Set (SafAS)|Overall Study||73
8154695|NCT02587520|20100328|P7|Safety Analysis Set (SafAS)|Overall Study||76
8154696|NCT02587520|20100329|P6|Safety Analysis Set (SafAS)|Overall Study||75
8154697|NCT02587520|20100330|P5|Safety Analysis Set (SafAS)|Overall Study||75
8154698|NCT02587520|20100331|P4|Safety Analysis Set (SafAS)|Overall Study||77
8154699|NCT02587520|20100332|P3|Safety Analysis Set (SafAS)|Overall Study||77
8154700|NCT02587520|20100333|P2|Safety Analysis Set (SafAS)|Overall Study||71
8154701|NCT02587520|20100334|P1|Safety Analysis Set (SafAS)|Overall Study||79
8154702|NCT02587520|20100317|P18|STARTED|Overall Study||78
8154703|NCT02587520|20100318|P17|STARTED|Overall Study||76
8154704|NCT02587520|20100319|P16|STARTED|Overall Study||72
8154705|NCT02587520|20100320|P15|STARTED|Overall Study||78
8154706|NCT02587520|20100321|P14|STARTED|Overall Study||74
8154707|NCT02587520|20100322|P13|STARTED|Overall Study||77
8154708|NCT02587520|20100323|P12|STARTED|Overall Study||73
8154709|NCT02587520|20100324|P11|STARTED|Overall Study||76
8154710|NCT02587520|20100325|P10|STARTED|Overall Study||76
8154711|NCT02587520|20100326|P9|STARTED|Overall Study||76
8154712|NCT02587520|20100327|P8|STARTED|Overall Study||73
8154713|NCT02587520|20100328|P7|STARTED|Overall Study||76
8154714|NCT02587520|20100329|P6|STARTED|Overall Study||75
8154715|NCT02587520|20100330|P5|STARTED|Overall Study||75
8154716|NCT02587520|20100331|P4|STARTED|Overall Study||79
8154717|NCT02587520|20100332|P3|STARTED|Overall Study||78
8154718|NCT02587520|20100333|P2|STARTED|Overall Study||71
8154719|NCT02587520|20100334|P1|STARTED|Overall Study||80
8154720|NCT02587351|20100374|P2|NOT COMPLETED|Overall Study||0
8154721|NCT02587351|20100375|P1|NOT COMPLETED|Overall Study||0
8154722|NCT02587351|20100374|P2|COMPLETED|Overall Study||264
8154723|NCT02587351|20100375|P1|COMPLETED|Overall Study||268
8154724|NCT02587351|20100374|P2|STARTED|Overall Study||264
8154725|NCT02587351|20100375|P1|STARTED|Overall Study||268
8154726|NCT02587234|20100429|P2|NOT COMPLETED|Overall Study||3
8154727|NCT02587234|20100430|P1|NOT COMPLETED|Overall Study||1
8154728|NCT02587234|20100429|P2|COMPLETED|Overall Study||7
8154729|NCT02587234|20100430|P1|COMPLETED|Overall Study||10
8154730|NCT02587234|20100429|P2|STARTED|Overall Study||10
8154731|NCT02587234|20100430|P1|STARTED|Overall Study||11
8154732|NCT02587221|20100442|P2|NOT COMPLETED|Overall Study||123
8154733|NCT02587221|20100443|P1|NOT COMPLETED|Overall Study||131
8154734|NCT02587221|20100442|P2|COMPLETED|Overall Study||3273
8154735|NCT02587221|20100443|P1|COMPLETED|Overall Study||3263
8154736|NCT02587221|20100442|P2|Treated|Overall Study||3382
8154737|NCT02587221|20100443|P1|Treated|Overall Study||3379
8154738|NCT02587221|20100442|P2|STARTED|Overall Study||3396
8154739|NCT02587221|20100443|P1|STARTED|Overall Study||3394
8154740|NCT02587143|20100489|P2|NOT COMPLETED|Overall Study||0
8154741|NCT02587143|20100490|P1|NOT COMPLETED|Overall Study||1
8154742|NCT02587143|20100489|P2|COMPLETED|Overall Study||60
8154743|NCT02587143|20100490|P1|COMPLETED|Overall Study||65
8154744|NCT02587143|20100489|P2|STARTED|Overall Study||60
8154745|NCT02587143|20100490|P1|STARTED|Overall Study||66
8154746|NCT02587117|20100498|P2|NOT COMPLETED|Overall Study||0
8154747|NCT02587117|20100499|P1|NOT COMPLETED|Overall Study||0
8154748|NCT02587117|20100498|P2|COMPLETED|Overall Study||15
8154749|NCT02587117|20100499|P1|COMPLETED|Overall Study||13
8154750|NCT02587117|20100498|P2|STARTED|Overall Study||15
8154751|NCT02587117|20100499|P1|STARTED|Overall Study||13
8154752|NCT02587065|20100507|P1|NOT COMPLETED|Overall Study||27
8154753|NCT02587065|20100507|P1|COMPLETED|Overall Study||166
8154754|NCT02587065|20100507|P1|STARTED|Overall Study||193
8154755|NCT02586974|20100523|P2|NOT COMPLETED|Overall Study||0
8154756|NCT02586974|20100524|P1|NOT COMPLETED|Overall Study||0
8154757|NCT02586974|20100523|P2|COMPLETED|Overall Study||32
8154758|NCT02586974|20100524|P1|COMPLETED|Overall Study||32
8154759|NCT02586974|20100523|P2|STARTED|Overall Study||32
8154760|NCT02586974|20100524|P1|STARTED|Overall Study||32
8154761|NCT02586909|20100536|P1|NOT COMPLETED|Overall Study||948
8154762|NCT02586909|20100536|P1|COMPLETED|Overall Study||151
8154763|NCT02586909|20100536|P1|STARTED|Overall Study||1099
8154764|NCT02586896|20100542|P2|NOT COMPLETED|Overall Study||17
8154765|NCT02586896|20100543|P1|NOT COMPLETED|Overall Study||19
8154766|NCT02586896|20100542|P2|COMPLETED|Overall Study||133
8154767|NCT02586896|20100543|P1|COMPLETED|Overall Study||131
8154768|NCT02586896|20100542|P2|3-Month Follow-up|Overall Study||123
8154769|NCT02586896|20100543|P1|3-Month Follow-up|Overall Study||126
8154770|NCT02586896|20100542|P2|STARTED|Overall Study||150
8154771|NCT02586896|20100543|P1|STARTED|Overall Study||150
8154799|NCT02586506|20100603|P1|NOT COMPLETED|Overall Study||9
8154800|NCT02586506|20100603|P1|COMPLETED|Overall Study||250
8154801|NCT02586506|20100603|P1|STARTED|Overall Study||259
8154802|NCT02586493|20100609|P1|NOT COMPLETED|Overall Study||12
8154803|NCT02586493|20100609|P1|COMPLETED|Overall Study||266
8154804|NCT02586493|20100609|P1|STARTED|Overall Study||278
8154805|NCT02586415|20100617|P2|NOT COMPLETED|Overall Study||25
8154806|NCT02586415|20100618|P1|NOT COMPLETED|Overall Study||14
8154807|NCT02586415|20100617|P2|COMPLETED|Overall Study||65
8154808|NCT02586415|20100618|P1|COMPLETED|Overall Study||78
8154809|NCT02586415|20100617|P2|Day 90 Assessment|Overall Study||65
8154810|NCT02586415|20100618|P1|Day 90 Assessment|Overall Study||78
8154811|NCT02586415|20100617|P2|Day 30 Assessment|Overall Study||70
8154812|NCT02586415|20100618|P1|Day 30 Assessment|Overall Study||81
8154813|NCT02586415|20100617|P2|24 Hour Assessment|Overall Study||90
8154814|NCT02586415|20100618|P1|24 Hour Assessment|Overall Study||91
8154815|NCT02586415|20100617|P2|STARTED|Overall Study||90
8154816|NCT02586415|20100618|P1|STARTED|Overall Study||92
8154817|NCT02586233|20100635|P7|NOT COMPLETED|Overall Study||2
8154818|NCT02586233|20100636|P6|NOT COMPLETED|Overall Study||2
8154819|NCT02586233|20100637|P5|NOT COMPLETED|Overall Study||2
8154820|NCT02586233|20100638|P4|NOT COMPLETED|Overall Study||0
8154821|NCT02586233|20100639|P3|NOT COMPLETED|Overall Study||0
8154822|NCT02586233|20100640|P2|NOT COMPLETED|Overall Study||2
8154823|NCT02586233|20100641|P1|NOT COMPLETED|Overall Study||0
8154824|NCT02586233|20100635|P7|COMPLETED|Overall Study||24
8154825|NCT02586233|20100636|P6|COMPLETED|Overall Study||16
8154826|NCT02586233|20100637|P5|COMPLETED|Overall Study||16
8154827|NCT02586233|20100638|P4|COMPLETED|Overall Study||17
8154828|NCT02586233|20100639|P3|COMPLETED|Overall Study||13
8154829|NCT02586233|20100640|P2|COMPLETED|Overall Study||5
8154830|NCT02586233|20100641|P1|COMPLETED|Overall Study||7
8154831|NCT02586233|20100635|P7|STARTED|Overall Study||26
8154832|NCT02586233|20100636|P6|STARTED|Overall Study||18
8154833|NCT02586233|20100637|P5|STARTED|Overall Study||18
8154834|NCT02586233|20100638|P4|STARTED|Overall Study||17
8154835|NCT02586233|20100639|P3|STARTED|Overall Study||13
8154836|NCT02586233|20100640|P2|STARTED|Overall Study||7
8154837|NCT02586233|20100641|P1|STARTED|Overall Study||7
8154841|NCT02586077|20100705|P1|NOT COMPLETED|Overall Study||8
8154842|NCT02586077|20100705|P1|COMPLETED|Overall Study||28
8154843|NCT02586077|20100705|P1|STARTED|Overall Study||36
8154872|NCT02586012|20100752|P6|NOT COMPLETED|Overall Study||3
8154873|NCT02586012|20100753|P5|NOT COMPLETED|Overall Study||1
8154874|NCT02586012|20100754|P4|NOT COMPLETED|Overall Study||2
8154875|NCT02586012|20100755|P3|NOT COMPLETED|Overall Study||1
8154876|NCT02586012|20100756|P2|NOT COMPLETED|Overall Study||3
8154877|NCT02586012|20100757|P1|NOT COMPLETED|Overall Study||1
8154878|NCT02586012|20100752|P6|COMPLETED|Overall Study||2
8154879|NCT02586012|20100753|P5|COMPLETED|Overall Study||4
8154880|NCT02586012|20100754|P4|COMPLETED|Overall Study||3
8154881|NCT02586012|20100755|P3|COMPLETED|Overall Study||4
8154882|NCT02586012|20100756|P2|COMPLETED|Overall Study||2
8154883|NCT02586012|20100757|P1|COMPLETED|Overall Study||4
8154884|NCT02586012|20100752|P6|STARTED|Overall Study||5
8154885|NCT02586012|20100753|P5|STARTED|Overall Study||5
8154886|NCT02586012|20100754|P4|STARTED|Overall Study||5
8154887|NCT02586012|20100755|P3|STARTED|Overall Study||5
8154888|NCT02586012|20100756|P2|STARTED|Overall Study||5
8154889|NCT02586012|20100757|P1|STARTED|Overall Study||5
8154890|NCT02585999|20100768|P1|NOT COMPLETED|Overall Study||2
8154891|NCT02585999|20100768|P1|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
8154892|NCT02585999|20100768|P1|STARTED|Overall Study||28
8154917|NCT02585934|20100848|P2|NOT COMPLETED|Overall Study||73
8154918|NCT02585934|20100849|P1|NOT COMPLETED|Overall Study||69
8154919|NCT02585934|20100848|P2|COMPLETED|Overall Study||581
8154920|NCT02585934|20100849|P1|COMPLETED|Overall Study||592
8154921|NCT02585934|20100848|P2|Per Protocol (PP)|Overall Study||582
8154922|NCT02585934|20100849|P1|Per Protocol (PP)|Overall Study||603
8154923|NCT02585934|20100848|P2|Intent to Treat (ITT)|Overall Study||633
8154924|NCT02585934|20100849|P1|Intent to Treat (ITT)|Overall Study||643
8154925|NCT02585934|20100848|P2|Safety Population|Overall Study||651
8154926|NCT02585934|20100849|P1|Safety Population|Overall Study||656
8154927|NCT02585934|20100848|P2|STARTED|Overall Study||654
8154928|NCT02585934|20100849|P1|STARTED|Overall Study||661
8154929|NCT02585895|20100872|P2|NOT COMPLETED|Post-primary Period||0
8154930|NCT02585895|20100873|P1|NOT COMPLETED|Post-primary Period||0
8154931|NCT02585895|20100872|P2|COMPLETED|Post-primary Period||19
8154932|NCT02585895|20100873|P1|COMPLETED|Post-primary Period||20
8154933|NCT02585895|20100872|P2|STARTED|Post-primary Period||19
8154934|NCT02585895|20100873|P1|STARTED|Post-primary Period||20
8154935|NCT02585895|20100872|P2|NOT COMPLETED|Primary Period||0
8154936|NCT02585895|20100873|P1|NOT COMPLETED|Primary Period||0
8154937|NCT02585895|20100872|P2|COMPLETED|Primary Period||19
8154938|NCT02585895|20100873|P1|COMPLETED|Primary Period||20
8154939|NCT02585895|20100872|P2|STARTED|Primary Period||19
8154940|NCT02585895|20100873|P1|STARTED|Primary Period||20
8154941|NCT02585843|20100890|P2|NOT COMPLETED|Overall Study||0
8154942|NCT02585843|20100891|P1|NOT COMPLETED|Overall Study||1
8154943|NCT02585843|20100890|P2|COMPLETED|Overall Study||10
8154944|NCT02585843|20100891|P1|COMPLETED|Overall Study||9
8154945|NCT02585843|20100890|P2|STARTED|Overall Study||10
8154946|NCT02585843|20100891|P1|STARTED|Overall Study||10
8154947|NCT02585830|20100905|P1|NOT COMPLETED|Overall Study||3
8154948|NCT02585830|20100905|P1|COMPLETED|Overall Study||22
8154949|NCT02585830|20100905|P1|STARTED|Overall Study||25
8154950|NCT02585778|20100914|P2|NOT COMPLETED|Overall Study||15
8154951|NCT02585778|20100915|P1|NOT COMPLETED|Overall Study||33
8154952|NCT02585778|20100914|P2|COMPLETED|Overall Study||157
8154953|NCT02585778|20100915|P1|COMPLETED|Overall Study||312
8154954|NCT02585778|20100914|P2|T2DM Participants|Overall Study||147
8154955|NCT02585778|20100915|P1|T2DM Participants|Overall Study||294
8154956|NCT02585778|20100914|P2|T1DM Participants|Overall Study||25
8154957|NCT02585778|20100915|P1|T1DM Participants|Overall Study||51
8154958|NCT02585778|20100914|P2|mITT Population|Overall Study||164
8154959|NCT02585778|20100915|P1|mITT Population|Overall Study||333
8154960|NCT02585778|20100914|P2|ITT Population|Overall Study||167
8154961|NCT02585778|20100915|P1|ITT Population|Overall Study||336
8154962|NCT02585778|20100914|P2|Treated (Safety Population)|Overall Study||170
8154963|NCT02585778|20100915|P1|Treated (Safety Population)|Overall Study||344
8154964|NCT02585778|20100914|P2|STARTED|Overall Study|Randomized|172
8154965|NCT02585778|20100915|P1|STARTED|Overall Study|Randomized|345
8154966|NCT02585713|20101031|P2|NOT COMPLETED|Overall Study||8
8154967|NCT02585713|20101032|P1|NOT COMPLETED|Overall Study||5
8154968|NCT02585713|20101031|P2|COMPLETED|Overall Study||142
8154969|NCT02585713|20101032|P1|COMPLETED|Overall Study||145
8154970|NCT02585713|20101031|P2|STARTED|Overall Study||150
8154971|NCT02585713|20101032|P1|STARTED|Overall Study||150
8154972|NCT02585700|20101044|P2|NOT COMPLETED|Overall Study||0
8154973|NCT02585700|20101045|P1|NOT COMPLETED|Overall Study||0
8154974|NCT02585700|20101044|P2|COMPLETED|Overall Study||30
8154975|NCT02585700|20101045|P1|COMPLETED|Overall Study||30
8154976|NCT02585700|20101044|P2|STARTED|Overall Study||30
8154977|NCT02585700|20101045|P1|STARTED|Overall Study||30
8154978|NCT02585245|20101071|P1|NOT COMPLETED|Overall Study||13
8154979|NCT02585245|20101071|P1|COMPLETED|Overall Study||594
8154980|NCT02585245|20101071|P1|STARTED|Overall Study||607
8154981|NCT02584998|20101079|P3|NOT COMPLETED|Overall Study||0
8154982|NCT02584998|20101080|P2|NOT COMPLETED|Overall Study||0
8154983|NCT02584998|20101081|P1|NOT COMPLETED|Overall Study||0
8154984|NCT02584998|20101079|P3|COMPLETED|Overall Study||261
8154985|NCT02584998|20101080|P2|COMPLETED|Overall Study||261
8154986|NCT02584998|20101081|P1|COMPLETED|Overall Study||260
8154987|NCT02584998|20101079|P3|STARTED|Overall Study||261
8154988|NCT02584998|20101080|P2|STARTED|Overall Study||261
8154989|NCT02584998|20101081|P1|STARTED|Overall Study||260
8155008|NCT02584868|20101154|P2|NOT COMPLETED|Overall Study||0
8155009|NCT02584868|20101155|P1|NOT COMPLETED|Overall Study||0
8155010|NCT02584868|20101154|P2|COMPLETED|Overall Study||44
8155011|NCT02584868|20101155|P1|COMPLETED|Overall Study||44
8155012|NCT02584868|20101154|P2|STARTED|Overall Study||44
8155013|NCT02584868|20101155|P1|STARTED|Overall Study||44
8155014|NCT02584855|20101225|P6|NOT COMPLETED|Post Treatment Follow-up Period||0
8155015|NCT02584855|20101226|P5|NOT COMPLETED|Post Treatment Follow-up Period||8
8155016|NCT02584855|20101227|P4|NOT COMPLETED|Post Treatment Follow-up Period||0
8155017|NCT02584855|20101228|P3|NOT COMPLETED|Post Treatment Follow-up Period||0
8155018|NCT02584855|20101229|P2|NOT COMPLETED|Post Treatment Follow-up Period||0
8155019|NCT02584855|20101230|P1|NOT COMPLETED|Post Treatment Follow-up Period||0
8155020|NCT02584855|20101225|P6|COMPLETED|Post Treatment Follow-up Period||12
8155021|NCT02584855|20101226|P5|COMPLETED|Post Treatment Follow-up Period||347
8155022|NCT02584855|20101227|P4|COMPLETED|Post Treatment Follow-up Period||0
8155023|NCT02584855|20101228|P3|COMPLETED|Post Treatment Follow-up Period||0
8155024|NCT02584855|20101229|P2|COMPLETED|Post Treatment Follow-up Period||0
8155025|NCT02584855|20101230|P1|COMPLETED|Post Treatment Follow-up Period||0
8155026|NCT02584855|20101225|P6|STARTED|Post Treatment Follow-up Period||12
8155027|NCT02584855|20101226|P5|STARTED|Post Treatment Follow-up Period||355
8155028|NCT02584855|20101227|P4|STARTED|Post Treatment Follow-up Period||0
8155029|NCT02584855|20101228|P3|STARTED|Post Treatment Follow-up Period||0
8155030|NCT02584855|20101229|P2|STARTED|Post Treatment Follow-up Period||0
8155031|NCT02584855|20101230|P1|STARTED|Post Treatment Follow-up Period||0
8155032|NCT02584855|20101225|P6|NOT COMPLETED|Double-Blind Withdrawal Period||0
8155033|NCT02584855|20101226|P5|NOT COMPLETED|Double-Blind Withdrawal Period||0
8155034|NCT02584855|20101227|P4|NOT COMPLETED|Double-Blind Withdrawal Period||1
8155035|NCT02584855|20101228|P3|NOT COMPLETED|Double-Blind Withdrawal Period||2
8155036|NCT02584855|20101229|P2|NOT COMPLETED|Double-Blind Withdrawal Period||15
8155037|NCT02584855|20101230|P1|NOT COMPLETED|Double-Blind Withdrawal Period||0
8155038|NCT02584855|20101225|P6|COMPLETED|Double-Blind Withdrawal Period||0
8155039|NCT02584855|20101226|P5|COMPLETED|Double-Blind Withdrawal Period||0
8155040|NCT02584855|20101227|P4|COMPLETED|Double-Blind Withdrawal Period||78
8155041|NCT02584855|20101228|P3|COMPLETED|Double-Blind Withdrawal Period||77
8155042|NCT02584855|20101229|P2|COMPLETED|Double-Blind Withdrawal Period||118
8155043|NCT02584855|20101230|P1|COMPLETED|Double-Blind Withdrawal Period||0
8155044|NCT02584855|20101225|P6|Relapsed|Double-Blind Withdrawal Period||0
8155045|NCT02584855|20101226|P5|Relapsed|Double-Blind Withdrawal Period||0
8155046|NCT02584855|20101227|P4|Relapsed|Double-Blind Withdrawal Period||30
8155047|NCT02584855|20101228|P3|Relapsed|Double-Blind Withdrawal Period||67
8155048|NCT02584855|20101229|P2|Relapsed|Double-Blind Withdrawal Period||0
8155049|NCT02584855|20101230|P1|Relapsed|Double-Blind Withdrawal Period||0
8155050|NCT02584855|20101225|P6|STARTED|Double-Blind Withdrawal Period||0
8155051|NCT02584855|20101226|P5|STARTED|Double-Blind Withdrawal Period||0
8155052|NCT02584855|20101227|P4|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
8155053|NCT02584855|20101228|P3|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
8155054|NCT02584855|20101229|P2|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133
8155055|NCT02584855|20101230|P1|STARTED|Double-Blind Withdrawal Period||0
8155056|NCT02584855|20101225|P6|NOT COMPLETED|Open-Label Treatment Period||0
8155057|NCT02584855|20101226|P5|NOT COMPLETED|Open-Label Treatment Period||0
8155058|NCT02584855|20101227|P4|NOT COMPLETED|Open-Label Treatment Period||0
8155059|NCT02584855|20101228|P3|NOT COMPLETED|Open-Label Treatment Period||0
8155060|NCT02584855|20101229|P2|NOT COMPLETED|Open-Label Treatment Period||0
8155061|NCT02584855|20101230|P1|NOT COMPLETED|Open-Label Treatment Period||103
8155062|NCT02584855|20101225|P6|COMPLETED|Open-Label Treatment Period||0
8155063|NCT02584855|20101226|P5|COMPLETED|Open-Label Treatment Period||0
8155064|NCT02584855|20101227|P4|COMPLETED|Open-Label Treatment Period||0
8155065|NCT02584855|20101228|P3|COMPLETED|Open-Label Treatment Period||0
8155066|NCT02584855|20101229|P2|COMPLETED|Open-Label Treatment Period||0
8155067|NCT02584855|20101230|P1|COMPLETED|Open-Label Treatment Period||291
8155068|NCT02584855|20101225|P6|Non-randomized|Open-Label Treatment Period||0
8155069|NCT02584855|20101226|P5|Non-randomized|Open-Label Treatment Period||0
8155070|NCT02584855|20101227|P4|Non-randomized|Open-Label Treatment Period||0
8155071|NCT02584855|20101228|P3|Non-randomized|Open-Label Treatment Period||0
8155072|NCT02584855|20101229|P2|Non-randomized|Open-Label Treatment Period||0
8155073|NCT02584855|20101230|P1|Non-randomized|Open-Label Treatment Period||133
8155074|NCT02584855|20101225|P6|Met Randomization Criteria|Open-Label Treatment Period||0
8155075|NCT02584855|20101226|P5|Met Randomization Criteria|Open-Label Treatment Period||0
8155076|NCT02584855|20101227|P4|Met Randomization Criteria|Open-Label Treatment Period||0
8155077|NCT02584855|20101228|P3|Met Randomization Criteria|Open-Label Treatment Period||0
8155078|NCT02584855|20101229|P2|Met Randomization Criteria|Open-Label Treatment Period||0
8155079|NCT02584855|20101230|P1|Met Randomization Criteria|Open-Label Treatment Period||158
8155080|NCT02584855|20101225|P6|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8155081|NCT02584855|20101226|P5|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8155082|NCT02584855|20101227|P4|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8155083|NCT02584855|20101228|P3|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8155084|NCT02584855|20101229|P2|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
8155085|NCT02584855|20101230|P1|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394
8155086|NCT02584855|20101225|P6|STARTED|Open-Label Treatment Period||0
8155087|NCT02584855|20101226|P5|STARTED|Open-Label Treatment Period||0
8155088|NCT02584855|20101227|P4|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
8155089|NCT02584855|20101228|P3|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
8155090|NCT02584855|20101229|P2|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0
8155091|NCT02584855|20101230|P1|STARTED|Open-Label Treatment Period||394
8155092|NCT02584790|20101264|P1|NOT COMPLETED|Overall Study||15
8155093|NCT02584790|20101264|P1|COMPLETED|Overall Study||40
8155094|NCT02584790|20101264|P1|STARTED|Overall Study||55
8155095|NCT02584725|20101273|P3|NOT COMPLETED|Overall Study||0
8155096|NCT02584725|20101274|P2|NOT COMPLETED|Overall Study||0
8155097|NCT02584725|20101275|P1|NOT COMPLETED|Overall Study||0
8155098|NCT02584725|20101273|P3|COMPLETED|Overall Study||28
8155099|NCT02584725|20101274|P2|COMPLETED|Overall Study||28
8155100|NCT02584725|20101275|P1|COMPLETED|Overall Study||28
8155101|NCT02584725|20101273|P3|STARTED|Overall Study||28
8155102|NCT02584725|20101274|P2|STARTED|Overall Study||28
8155103|NCT02584725|20101275|P1|STARTED|Overall Study||28
8155104|NCT02584686|20101318|P2|NOT COMPLETED|Overall Study||0
8155105|NCT02584686|20101319|P1|NOT COMPLETED|Overall Study||0
8155106|NCT02584686|20101318|P2|COMPLETED|Overall Study||12
8155107|NCT02584686|20101319|P1|COMPLETED|Overall Study||12
8155108|NCT02584686|20101318|P2|STARTED|Overall Study||12
8155109|NCT02584686|20101319|P1|STARTED|Overall Study||12
8155110|NCT02584673|20101347|P2|NOT COMPLETED|Overall Study||0
8155111|NCT02584673|20101348|P1|NOT COMPLETED|Overall Study||0
8155112|NCT02584673|20101347|P2|COMPLETED|Overall Study||15
8155113|NCT02584673|20101348|P1|COMPLETED|Overall Study||15
8155114|NCT02584673|20101347|P2|STARTED|Overall Study||15
8155115|NCT02584673|20101348|P1|STARTED|Overall Study||15
8155116|NCT02584660|20101362|P2|NOT COMPLETED|Overall Study||8
8155117|NCT02584660|20101363|P1|NOT COMPLETED|Overall Study||7
8155118|NCT02584660|20101362|P2|COMPLETED|Overall Study||55
8155119|NCT02584660|20101363|P1|COMPLETED|Overall Study||44
8155120|NCT02584660|20101362|P2|Treated|Overall Study||63
8155121|NCT02584660|20101363|P1|Treated|Overall Study||49
8155122|NCT02584660|20101362|P2|STARTED|Overall Study||63
8155123|NCT02584660|20101363|P1|STARTED|Overall Study||51
8155124|NCT02584608|20101379|P1|NOT COMPLETED|Overall Study||0
8155125|NCT02584608|20101379|P1|COMPLETED|Overall Study||12
8155126|NCT02584608|20101379|P1|STARTED|Overall Study||12
8155127|NCT02584504|20101387|P3|NOT COMPLETED|Open-label Treatment||8
8155128|NCT02584504|20101388|P2|NOT COMPLETED|Open-label Treatment||4
8155129|NCT02584504|20101389|P1|NOT COMPLETED|Open-label Treatment||2
8155130|NCT02584504|20101387|P3|COMPLETED|Open-label Treatment||47
8155131|NCT02584504|20101388|P2|COMPLETED|Open-label Treatment||47
8155132|NCT02584504|20101389|P1|COMPLETED|Open-label Treatment||52
8155133|NCT02584504|20101387|P3|Treated|Open-label Treatment||54
8155134|NCT02584504|20101388|P2|Treated|Open-label Treatment||50
8155135|NCT02584504|20101389|P1|Treated|Open-label Treatment||54
8155136|NCT02584504|20101387|P3|STARTED|Open-label Treatment||55
8155137|NCT02584504|20101388|P2|STARTED|Open-label Treatment||51
8155138|NCT02584504|20101389|P1|STARTED|Open-label Treatment||54
8155139|NCT02584504|20101387|P3|NOT COMPLETED|Double-blind Treatment||1
8155140|NCT02584504|20101388|P2|NOT COMPLETED|Double-blind Treatment||2
8155141|NCT02584504|20101389|P1|NOT COMPLETED|Double-blind Treatment||0
8155142|NCT02584504|20101387|P3|COMPLETED|Double-blind Treatment||55
8155143|NCT02584504|20101388|P2|COMPLETED|Double-blind Treatment||51
8155144|NCT02584504|20101389|P1|COMPLETED|Double-blind Treatment||54
8155145|NCT02584504|20101387|P3|Safety Population|Double-blind Treatment||56
8155146|NCT02584504|20101388|P2|Safety Population|Double-blind Treatment||53
8155147|NCT02584504|20101389|P1|Safety Population|Double-blind Treatment||54
8155148|NCT02584504|20101387|P3|mITT Population|Double-blind Treatment||56
8155149|NCT02584504|20101388|P2|mITT Population|Double-blind Treatment||53
8155150|NCT02584504|20101389|P1|mITT Population|Double-blind Treatment||54
8155151|NCT02584504|20101387|P3|ITT Population|Double-blind Treatment||56
8155152|NCT02584504|20101388|P2|ITT Population|Double-blind Treatment||53
8155153|NCT02584504|20101389|P1|ITT Population|Double-blind Treatment||54
8155154|NCT02584504|20101387|P3|STARTED|Double-blind Treatment|Randomized|56
8155155|NCT02584504|20101388|P2|STARTED|Double-blind Treatment|Randomized|53
8155156|NCT02584504|20101389|P1|STARTED|Double-blind Treatment|Randomized|54
8155157|NCT02584452|20101445|P2|NOT COMPLETED|Overall Study||2
8155158|NCT02584452|20101446|P1|NOT COMPLETED|Overall Study||2
8155159|NCT02584452|20101445|P2|COMPLETED|Overall Study||21
8155160|NCT02584452|20101446|P1|COMPLETED|Overall Study||32
8155161|NCT02584452|20101445|P2|STARTED|Overall Study||23
8155162|NCT02584452|20101446|P1|STARTED|Overall Study||34
8155163|NCT02584257|20101474|P9|NOT COMPLETED|Period 5||0
8155164|NCT02584257|20101475|P8|NOT COMPLETED|Period 5||0
8155165|NCT02584257|20101476|P7|NOT COMPLETED|Period 5||0
8155166|NCT02584257|20101477|P6|NOT COMPLETED|Period 5||0
8155167|NCT02584257|20101478|P5|NOT COMPLETED|Period 5||0
8155168|NCT02584257|20101479|P4|NOT COMPLETED|Period 5||0
8155169|NCT02584257|20101480|P3|NOT COMPLETED|Period 5||0
8155170|NCT02584257|20101481|P2|NOT COMPLETED|Period 5||0
8155171|NCT02584257|20101482|P1|NOT COMPLETED|Period 5||0
8155172|NCT02584257|20101474|P9|COMPLETED|Period 5||9
8155173|NCT02584257|20101475|P8|COMPLETED|Period 5||9
8155174|NCT02584257|20101476|P7|COMPLETED|Period 5||17
8155175|NCT02584257|20101477|P6|COMPLETED|Period 5||10
8155176|NCT02584257|20101478|P5|COMPLETED|Period 5||10
8155177|NCT02584257|20101479|P4|COMPLETED|Period 5||8
8155178|NCT02584257|20101480|P3|COMPLETED|Period 5||9
8155179|NCT02584257|20101481|P2|COMPLETED|Period 5||8
8155180|NCT02584257|20101482|P1|COMPLETED|Period 5||8
8155181|NCT02584257|20101474|P9|STARTED|Period 5||9
8155182|NCT02584257|20101475|P8|STARTED|Period 5||9
8155183|NCT02584257|20101476|P7|STARTED|Period 5||17
8155184|NCT02584257|20101477|P6|STARTED|Period 5||10
8155185|NCT02584257|20101478|P5|STARTED|Period 5||10
8155186|NCT02584257|20101479|P4|STARTED|Period 5||8
8155187|NCT02584257|20101480|P3|STARTED|Period 5||9
8155188|NCT02584257|20101481|P2|STARTED|Period 5||8
8155189|NCT02584257|20101482|P1|STARTED|Period 5||8
8155190|NCT02584257|20101474|P9|NOT COMPLETED|Period 4||0
8155191|NCT02584257|20101475|P8|NOT COMPLETED|Period 4||0
8155192|NCT02584257|20101476|P7|NOT COMPLETED|Period 4||0
8155193|NCT02584257|20101477|P6|NOT COMPLETED|Period 4||0
8155194|NCT02584257|20101478|P5|NOT COMPLETED|Period 4||0
8155195|NCT02584257|20101479|P4|NOT COMPLETED|Period 4||0
8155196|NCT02584257|20101480|P3|NOT COMPLETED|Period 4||0
8155197|NCT02584257|20101481|P2|NOT COMPLETED|Period 4||0
8155198|NCT02584257|20101482|P1|NOT COMPLETED|Period 4||0
8155199|NCT02584257|20101474|P9|COMPLETED|Period 4||9
8155200|NCT02584257|20101475|P8|COMPLETED|Period 4||9
8155201|NCT02584257|20101476|P7|COMPLETED|Period 4||17
8155202|NCT02584257|20101477|P6|COMPLETED|Period 4||10
8155203|NCT02584257|20101478|P5|COMPLETED|Period 4||10
8155204|NCT02584257|20101479|P4|COMPLETED|Period 4||8
8155205|NCT02584257|20101480|P3|COMPLETED|Period 4||9
8155206|NCT02584257|20101481|P2|COMPLETED|Period 4||8
8155207|NCT02584257|20101482|P1|COMPLETED|Period 4||8
8155208|NCT02584257|20101474|P9|STARTED|Period 4||9
8155209|NCT02584257|20101475|P8|STARTED|Period 4||9
8155210|NCT02584257|20101476|P7|STARTED|Period 4||17
8155211|NCT02584257|20101477|P6|STARTED|Period 4||10
8155212|NCT02584257|20101478|P5|STARTED|Period 4||10
8155213|NCT02584257|20101479|P4|STARTED|Period 4||8
8155214|NCT02584257|20101480|P3|STARTED|Period 4||9
8155215|NCT02584257|20101481|P2|STARTED|Period 4||8
8155216|NCT02584257|20101482|P1|STARTED|Period 4||8
8155217|NCT02584257|20101474|P9|NOT COMPLETED|Period 3||0
8155218|NCT02584257|20101475|P8|NOT COMPLETED|Period 3||0
8155219|NCT02584257|20101476|P7|NOT COMPLETED|Period 3||0
8155220|NCT02584257|20101477|P6|NOT COMPLETED|Period 3||0
8155221|NCT02584257|20101478|P5|NOT COMPLETED|Period 3||0
8155222|NCT02584257|20101479|P4|NOT COMPLETED|Period 3||0
8155223|NCT02584257|20101480|P3|NOT COMPLETED|Period 3||0
8155224|NCT02584257|20101481|P2|NOT COMPLETED|Period 3||0
8155225|NCT02584257|20101482|P1|NOT COMPLETED|Period 3||0
8155226|NCT02584257|20101474|P9|COMPLETED|Period 3||9
8155227|NCT02584257|20101475|P8|COMPLETED|Period 3||9
8155228|NCT02584257|20101476|P7|COMPLETED|Period 3||17
8155229|NCT02584257|20101477|P6|COMPLETED|Period 3||10
8155230|NCT02584257|20101478|P5|COMPLETED|Period 3||10
8155231|NCT02584257|20101479|P4|COMPLETED|Period 3||8
8155232|NCT02584257|20101480|P3|COMPLETED|Period 3||9
8155233|NCT02584257|20101481|P2|COMPLETED|Period 3||8
8155234|NCT02584257|20101482|P1|COMPLETED|Period 3||8
8155235|NCT02584257|20101474|P9|STARTED|Period 3||9
8155236|NCT02584257|20101475|P8|STARTED|Period 3||9
8155237|NCT02584257|20101476|P7|STARTED|Period 3||17
8155238|NCT02584257|20101477|P6|STARTED|Period 3||10
8155239|NCT02584257|20101478|P5|STARTED|Period 3||10
8155240|NCT02584257|20101479|P4|STARTED|Period 3||8
8155241|NCT02584257|20101480|P3|STARTED|Period 3||9
8155242|NCT02584257|20101481|P2|STARTED|Period 3||8
8155243|NCT02584257|20101482|P1|STARTED|Period 3||8
8155244|NCT02584257|20101474|P9|NOT COMPLETED|Period 2||0
8155245|NCT02584257|20101475|P8|NOT COMPLETED|Period 2||0
8155246|NCT02584257|20101476|P7|NOT COMPLETED|Period 2||0
8155247|NCT02584257|20101477|P6|NOT COMPLETED|Period 2||0
8155248|NCT02584257|20101478|P5|NOT COMPLETED|Period 2||0
8155249|NCT02584257|20101479|P4|NOT COMPLETED|Period 2||0
8155250|NCT02584257|20101480|P3|NOT COMPLETED|Period 2||0
8155251|NCT02584257|20101481|P2|NOT COMPLETED|Period 2||1
8155252|NCT02584257|20101482|P1|NOT COMPLETED|Period 2||1
8155253|NCT02584257|20101474|P9|COMPLETED|Period 2||9
8155254|NCT02584257|20101475|P8|COMPLETED|Period 2||9
8155255|NCT02584257|20101476|P7|COMPLETED|Period 2||17
8155256|NCT02584257|20101477|P6|COMPLETED|Period 2||10
8155257|NCT02584257|20101478|P5|COMPLETED|Period 2||10
8155258|NCT02584257|20101479|P4|COMPLETED|Period 2||8
8155259|NCT02584257|20101480|P3|COMPLETED|Period 2||9
8155260|NCT02584257|20101481|P2|COMPLETED|Period 2||8
8155261|NCT02584257|20101482|P1|COMPLETED|Period 2||8
8155262|NCT02584257|20101474|P9|STARTED|Period 2||9
8155263|NCT02584257|20101475|P8|STARTED|Period 2||9
8155264|NCT02584257|20101476|P7|STARTED|Period 2||17
8155265|NCT02584257|20101477|P6|STARTED|Period 2||10
8155266|NCT02584257|20101478|P5|STARTED|Period 2||10
8155267|NCT02584257|20101479|P4|STARTED|Period 2||8
8155268|NCT02584257|20101480|P3|STARTED|Period 2||9
8155269|NCT02584257|20101481|P2|STARTED|Period 2||9
8155270|NCT02584257|20101482|P1|STARTED|Period 2||9
8155271|NCT02584257|20101474|P9|NOT COMPLETED|Period 1||0
8155272|NCT02584257|20101475|P8|NOT COMPLETED|Period 1||0
8155273|NCT02584257|20101476|P7|NOT COMPLETED|Period 1||1
8155274|NCT02584257|20101477|P6|NOT COMPLETED|Period 1||0
8155275|NCT02584257|20101478|P5|NOT COMPLETED|Period 1||0
8155276|NCT02584257|20101479|P4|NOT COMPLETED|Period 1||0
8155277|NCT02584257|20101480|P3|NOT COMPLETED|Period 1||0
8155278|NCT02584257|20101481|P2|NOT COMPLETED|Period 1||0
8155279|NCT02584257|20101482|P1|NOT COMPLETED|Period 1||0
8155280|NCT02584257|20101474|P9|COMPLETED|Period 1||9
8155281|NCT02584257|20101475|P8|COMPLETED|Period 1||9
8155282|NCT02584257|20101476|P7|COMPLETED|Period 1||17
8155283|NCT02584257|20101477|P6|COMPLETED|Period 1||10
8155284|NCT02584257|20101478|P5|COMPLETED|Period 1||10
8155285|NCT02584257|20101479|P4|COMPLETED|Period 1||8
8155286|NCT02584257|20101480|P3|COMPLETED|Period 1||9
8155287|NCT02584257|20101481|P2|COMPLETED|Period 1||9
8155288|NCT02584257|20101482|P1|COMPLETED|Period 1||9
8155289|NCT02584257|20101474|P9|STARTED|Period 1||9
8155290|NCT02584257|20101475|P8|STARTED|Period 1||9
8155291|NCT02584257|20101476|P7|STARTED|Period 1||18
8155292|NCT02584257|20101477|P6|STARTED|Period 1||10
8155293|NCT02584257|20101478|P5|STARTED|Period 1||10
8155294|NCT02584257|20101479|P4|STARTED|Period 1||8
8155295|NCT02584257|20101480|P3|STARTED|Period 1||9
8155296|NCT02584257|20101481|P2|STARTED|Period 1||9
8155297|NCT02584257|20101482|P1|STARTED|Period 1||9
8155301|NCT02583477|20101503|P2|NOT COMPLETED|Overall Study||20
8155302|NCT02583477|20101504|P1|NOT COMPLETED|Overall Study||3
8155303|NCT02583477|20101503|P2|COMPLETED|Overall Study||0
8155304|NCT02583477|20101504|P1|COMPLETED|Overall Study||0
8155305|NCT02583477|20101503|P2|Completed Treatment|Overall Study||0
8155306|NCT02583477|20101504|P1|Completed Treatment|Overall Study||0
8155307|NCT02583477|20101503|P2|Received Treatment|Overall Study||20
8155308|NCT02583477|20101504|P1|Received Treatment|Overall Study||3
8155309|NCT02583477|20101503|P2|STARTED|Overall Study||20
8155310|NCT02583477|20101504|P1|STARTED|Overall Study||3
8155311|NCT02583425|20101524|P1|NOT COMPLETED|Treatment Period||1
8155312|NCT02583425|20101524|P1|COMPLETED|Treatment Period||9
8155313|NCT02583425|20101524|P1|STARTED|Treatment Period||10
8155314|NCT02583425|20101524|P1|NOT COMPLETED|Baseline||5
8155315|NCT02583425|20101524|P1|COMPLETED|Baseline||10
8155316|NCT02583425|20101524|P1|STARTED|Baseline||15
8155317|NCT02583425|20101524|P1|NOT COMPLETED|Screening||12
8155318|NCT02583425|20101524|P1|COMPLETED|Screening||15
8155319|NCT02583425|20101524|P1|STARTED|Screening||27
8155320|NCT02583399|20101529|P1|NOT COMPLETED|Overall Study||6
8155321|NCT02583399|20101529|P1|COMPLETED|Overall Study||24
8155322|NCT02583399|20101529|P1|STARTED|Overall Study||30
8155344|NCT02583256|20101587|P4|NOT COMPLETED|Overall Study||3
8155345|NCT02583256|20101588|P3|NOT COMPLETED|Overall Study||2
8155346|NCT02583256|20101589|P2|NOT COMPLETED|Overall Study||2
8155347|NCT02583256|20101590|P1|NOT COMPLETED|Overall Study||3
8155348|NCT02583256|20101587|P4|COMPLETED|Overall Study||390
8155349|NCT02583256|20101588|P3|COMPLETED|Overall Study||400
8155350|NCT02583256|20101589|P2|COMPLETED|Overall Study||401
8155351|NCT02583256|20101590|P1|COMPLETED|Overall Study||400
8155352|NCT02583256|20101587|P4|Exposed|Overall Study||393
8155353|NCT02583256|20101588|P3|Exposed|Overall Study||402
8155354|NCT02583256|20101589|P2|Exposed|Overall Study||403
8155355|NCT02583256|20101590|P1|Exposed|Overall Study||403
8155356|NCT02583256|20101587|P4|STARTED|Overall Study||393
8155357|NCT02583256|20101588|P3|STARTED|Overall Study||402
8155358|NCT02583256|20101589|P2|STARTED|Overall Study||403
8155359|NCT02583256|20101590|P1|STARTED|Overall Study||403
8155360|NCT02583230|20101678|P1|NOT COMPLETED|Overall Study||0
8155361|NCT02583230|20101678|P1|COMPLETED|Overall Study||11
8155362|NCT02583230|20101678|P1|STARTED|Overall Study||11
8155372|NCT02582983|20101748|P1|NOT COMPLETED|Overall Study||6
8155373|NCT02582983|20101748|P1|COMPLETED|Overall Study||17
8155374|NCT02582983|20101748|P1|STARTED|Overall Study||23
8155375|NCT02582970|20101753|P1|NOT COMPLETED|Overall Study||0
8155376|NCT02582970|20101753|P1|COMPLETED|Overall Study||40
8155377|NCT02582970|20101753|P1|STARTED|Overall Study||40
8155381|NCT02582840|20101772|P3|NOT COMPLETED|Overall Study||0
8155382|NCT02582840|20101773|P2|NOT COMPLETED|Overall Study||0
8155383|NCT02582840|20101774|P1|NOT COMPLETED|Overall Study||0
8155384|NCT02582840|20101772|P3|COMPLETED|Overall Study||14
8155385|NCT02582840|20101773|P2|COMPLETED|Overall Study||14
8155386|NCT02582840|20101774|P1|COMPLETED|Overall Study||14
8155387|NCT02582840|20101772|P3|STARTED|Overall Study||14
8155388|NCT02582840|20101773|P2|STARTED|Overall Study||14
8155389|NCT02582840|20101774|P1|STARTED|Overall Study||14
8155390|NCT02582814|20101817|P2|NOT COMPLETED|Overall Study||7
8155391|NCT02582814|20101818|P1|NOT COMPLETED|Overall Study||9
8155392|NCT02582814|20101817|P2|COMPLETED|Overall Study||68
8155393|NCT02582814|20101818|P1|COMPLETED|Overall Study||67
8155394|NCT02582814|20101817|P2|STARTED|Overall Study||75
8155395|NCT02582814|20101818|P1|STARTED|Overall Study||76
8155396|NCT02582749|20101858|P2|NOT COMPLETED|Overall Study||11
8155397|NCT02582749|20101859|P1|NOT COMPLETED|Overall Study||5
8155398|NCT02582749|20101858|P2|COMPLETED|Overall Study||0
8155399|NCT02582749|20101859|P1|COMPLETED|Overall Study||0
8155400|NCT02582749|20101858|P2|STARTED|Overall Study||11
8155401|NCT02582749|20101859|P1|STARTED|Overall Study||5
8155402|NCT02582684|20101889|P1|NOT COMPLETED|Overall Study||17
8155403|NCT02582684|20101889|P1|COMPLETED|Overall Study||105
8155404|NCT02582684|20101889|P1|STARTED|Overall Study||122
8155405|NCT02582671|20101908|P1|NOT COMPLETED|Overall Study||2
8155406|NCT02582671|20101908|P1|COMPLETED|Overall Study||99
8155407|NCT02582671|20101908|P1|STARTED|Overall Study||101
8155408|NCT02582658|20101920|P1|NOT COMPLETED|Overall Study||25
8155409|NCT02582658|20101920|P1|COMPLETED|Overall Study||146
8155410|NCT02582658|20101920|P1|STARTED|Overall Study||171
8155414|NCT02582515|20101953|P2|NOT COMPLETED|Overall Study||1
8155415|NCT02582515|20101954|P1|NOT COMPLETED|Overall Study||0
8155416|NCT02582515|20101953|P2|COMPLETED|Overall Study||10
8155417|NCT02582515|20101954|P1|COMPLETED|Overall Study||9
8155418|NCT02582515|20101953|P2|Received Study Intervention|Overall Study||10
8155419|NCT02582515|20101954|P1|Received Study Intervention|Overall Study||9
8155420|NCT02582515|20101953|P2|STARTED|Overall Study||11
8155421|NCT02582515|20101954|P1|STARTED|Overall Study||9
8155422|NCT02582255|20101962|P2|NOT COMPLETED|Overall Study||3
8155423|NCT02582255|20101963|P1|NOT COMPLETED|Overall Study||0
8155424|NCT02582255|20101962|P2|COMPLETED|Overall Study||47
8155425|NCT02582255|20101963|P1|COMPLETED|Overall Study||50
8155426|NCT02582255|20101962|P2|STARTED|Overall Study||50
8155427|NCT02582255|20101963|P1|STARTED|Overall Study||50
8155428|NCT02582242|20101976|P2|NOT COMPLETED|Overall Study||17
8155429|NCT02582242|20101977|P1|NOT COMPLETED|Overall Study||20
8155430|NCT02582242|20101976|P2|COMPLETED|Overall Study||200
8155431|NCT02582242|20101977|P1|COMPLETED|Overall Study||200
8155432|NCT02582242|20101976|P2|STARTED|Overall Study||217
8155433|NCT02582242|20101977|P1|STARTED|Overall Study||220
8155434|NCT02582216|20102017|P1|NOT COMPLETED|Overall Study||0
8155435|NCT02582216|20102017|P1|COMPLETED|Overall Study||22
8155436|NCT02582216|20102017|P1|STARTED|Overall Study||22
8155437|NCT02582151|20102024|P2|NOT COMPLETED|Overall Study||0
8155438|NCT02582151|20102025|P1|NOT COMPLETED|Overall Study||2
8155439|NCT02582151|20102024|P2|COMPLETED|Overall Study||16
8155440|NCT02582151|20102025|P1|COMPLETED|Overall Study||12
8155441|NCT02582151|20102024|P2|STARTED|Overall Study||16
8155442|NCT02582151|20102025|P1|STARTED|Overall Study||14
8155443|NCT02581995|20102041|P1|NOT COMPLETED|Overall Study||31
8155444|NCT02581995|20102041|P1|COMPLETED|Overall Study||529
8155445|NCT02581995|20102041|P1|Treated|Overall Study||560
8155446|NCT02581995|20102041|P1|STARTED|Overall Study||560
8155450|NCT02581891|20102063|P2|NOT COMPLETED|Overall Study||19
8155451|NCT02581891|20102064|P1|NOT COMPLETED|Overall Study||16
8155452|NCT02581891|20102063|P2|COMPLETED|Overall Study||117
8155453|NCT02581891|20102064|P1|COMPLETED|Overall Study||119
8155454|NCT02581891|20102063|P2|Completed Treatment|Overall Study||117
8155455|NCT02581891|20102064|P1|Completed Treatment|Overall Study||120
8155456|NCT02581891|20102063|P2|STARTED|Overall Study||136
8155457|NCT02581891|20102064|P1|STARTED|Overall Study||135
8155458|NCT02581865|20102090|P3|NOT COMPLETED|Overall Study||16
8155459|NCT02581865|20102091|P2|NOT COMPLETED|Overall Study||7
8155460|NCT02581865|20102092|P1|NOT COMPLETED|Overall Study||4
8155461|NCT02581865|20102090|P3|COMPLETED|Overall Study||26
8155462|NCT02581865|20102091|P2|COMPLETED|Overall Study||35
8155463|NCT02581865|20102092|P1|COMPLETED|Overall Study||36
8155464|NCT02581865|20102090|P3|STARTED|Overall Study||42
8155465|NCT02581865|20102091|P2|STARTED|Overall Study||42
8155466|NCT02581865|20102092|P1|STARTED|Overall Study||40
8155467|NCT02581839|20102115|P1|NOT COMPLETED|Overall Study||0
8155468|NCT02581839|20102115|P1|COMPLETED|Overall Study||9
8155469|NCT02581839|20102115|P1|STARTED|Overall Study||9
8155470|NCT02581488|20102127|P2|NOT COMPLETED|Overall Study||11
8155471|NCT02581488|20102128|P1|NOT COMPLETED|Overall Study||9
8155472|NCT02581488|20102127|P2|COMPLETED|Overall Study||40
8155473|NCT02581488|20102128|P1|COMPLETED|Overall Study||42
8155474|NCT02581488|20102127|P2|STARTED|Overall Study||51
8155475|NCT02581488|20102128|P1|STARTED|Overall Study||51
8155476|NCT02581475|20102144|P2|NOT COMPLETED|Overall Study||15
8155477|NCT02581475|20102145|P1|NOT COMPLETED|Overall Study||11
8155478|NCT02581475|20102144|P2|COMPLETED|Overall Study||178
8155479|NCT02581475|20102145|P1|COMPLETED|Overall Study||182
8155480|NCT02581475|20102144|P2|STARTED|Overall Study||193
8155481|NCT02581475|20102145|P1|STARTED|Overall Study||193
8155482|NCT02581410|20102159|P2|NOT COMPLETED|End of Study Phase||11
8155483|NCT02581410|20102160|P1|NOT COMPLETED|End of Study Phase||5
8155484|NCT02581410|20102159|P2|COMPLETED|End of Study Phase||204
8155485|NCT02581410|20102160|P1|COMPLETED|End of Study Phase||210
8155486|NCT02581410|20102159|P2|STARTED|End of Study Phase||215
8155487|NCT02581410|20102160|P1|STARTED|End of Study Phase||215
8155488|NCT02581410|20102159|P2|NOT COMPLETED|Vaccination Phase||3
8155489|NCT02581410|20102160|P1|NOT COMPLETED|Vaccination Phase||2
8155490|NCT02581410|20102159|P2|COMPLETED|Vaccination Phase||212
8155491|NCT02581410|20102160|P1|COMPLETED|Vaccination Phase||213
8155492|NCT02581410|20102159|P2|STARTED|Vaccination Phase||215
8155493|NCT02581410|20102160|P1|STARTED|Vaccination Phase||215
8155494|NCT02581345|20102190|P4|NOT COMPLETED|Part 2: Week 17 to Week 47||12
8155495|NCT02581345|20102191|P3|NOT COMPLETED|Part 2: Week 17 to Week 47||15
8155496|NCT02581345|20102192|P2|NOT COMPLETED|Part 2: Week 17 to Week 47||0
8155497|NCT02581345|20102193|P1|NOT COMPLETED|Part 2: Week 17 to Week 47||29
8155498|NCT02581345|20102190|P4|COMPLETED|Part 2: Week 17 to Week 47||119
8155499|NCT02581345|20102191|P3|COMPLETED|Part 2: Week 17 to Week 47||117
8155500|NCT02581345|20102192|P2|COMPLETED|Part 2: Week 17 to Week 47||0
8155501|NCT02581345|20102193|P1|COMPLETED|Part 2: Week 17 to Week 47||242
8155502|NCT02581345|20102190|P4|STARTED|Part 2: Week 17 to Week 47||131
8155503|NCT02581345|20102191|P3|STARTED|Part 2: Week 17 to Week 47||132
8155504|NCT02581345|20102192|P2|STARTED|Part 2: Week 17 to Week 47||0
8155505|NCT02581345|20102193|P1|STARTED|Part 2: Week 17 to Week 47||271
8155506|NCT02581345|20102190|P4|NOT COMPLETED|Part 1: up to Week 16||0
8155507|NCT02581345|20102191|P3|NOT COMPLETED|Part 1: up to Week 16||0
8155508|NCT02581345|20102192|P2|NOT COMPLETED|Part 1: up to Week 16||23
8155509|NCT02581345|20102193|P1|NOT COMPLETED|Part 1: up to Week 16||15
8155510|NCT02581345|20102190|P4|COMPLETED|Part 1: up to Week 16||0
8155511|NCT02581345|20102191|P3|COMPLETED|Part 1: up to Week 16||0
8155512|NCT02581345|20102192|P2|COMPLETED|Part 1: up to Week 16||263
8155513|NCT02581345|20102193|P1|COMPLETED|Part 1: up to Week 16||271
8155514|NCT02581345|20102190|P4|STARTED|Part 1: up to Week 16||0
8155515|NCT02581345|20102191|P3|STARTED|Part 1: up to Week 16||0
8155516|NCT02581345|20102192|P2|STARTED|Part 1: up to Week 16||286
8155517|NCT02581345|20102193|P1|STARTED|Part 1: up to Week 16||286
8155518|NCT02581202|20102295|P1|NOT COMPLETED|Overall Study||14
8155519|NCT02581202|20102295|P1|COMPLETED|Overall Study||202
8155520|NCT02581202|20102295|P1|STARTED|Overall Study||216
8155521|NCT02581189|20102334|P1|NOT COMPLETED|Overall Study||53
8155522|NCT02581189|20102334|P1|COMPLETED|Overall Study||481
8155523|NCT02581189|20102334|P1|STARTED|Overall Study||534
8155524|NCT02581163|20102348|P1|NOT COMPLETED|Overall Study||29
8155525|NCT02581163|20102348|P1|COMPLETED|Overall Study||282
8155526|NCT02581163|20102348|P1|STARTED|Overall Study||311
8155530|NCT02581111|20102369|P2|NOT COMPLETED|Overall Study||7
8155531|NCT02581111|20102370|P1|NOT COMPLETED|Overall Study||2
8155532|NCT02581111|20102369|P2|COMPLETED|Overall Study||94
8155533|NCT02581111|20102370|P1|COMPLETED|Overall Study||96
8155534|NCT02581111|20102369|P2|STARTED|Overall Study||101
8155535|NCT02581111|20102370|P1|STARTED|Overall Study||98
8155536|NCT02580877|20102382|P2|NOT COMPLETED|Overall Study||4
8155537|NCT02580877|20102383|P1|NOT COMPLETED|Overall Study||1
8155538|NCT02580877|20102382|P2|COMPLETED|Overall Study||43
8155539|NCT02580877|20102383|P1|COMPLETED|Overall Study||44
8155540|NCT02580877|20102382|P2|STARTED|Overall Study||47
8155541|NCT02580877|20102383|P1|STARTED|Overall Study||45
8155542|NCT02580799|20102391|P1|NOT COMPLETED|Overall Study||0
8155543|NCT02580799|20102391|P1|COMPLETED|Overall Study||30
8155544|NCT02580799|20102391|P1|STARTED|Overall Study||30
8155545|NCT02580591|20102417|P4|NOT COMPLETED|Overall Study||12
8155546|NCT02580591|20102418|P3|NOT COMPLETED|Overall Study||13
8155547|NCT02580591|20102419|P2|NOT COMPLETED|Overall Study||10
8155548|NCT02580591|20102420|P1|NOT COMPLETED|Overall Study||18
8155549|NCT02580591|20102417|P4|COMPLETED|Overall Study||233
8155550|NCT02580591|20102418|P3|COMPLETED|Overall Study||235
8155551|NCT02580591|20102419|P2|COMPLETED|Overall Study||232
8155552|NCT02580591|20102420|P1|COMPLETED|Overall Study||224
8155553|NCT02580591|20102417|P4|Treated|Overall Study||245
8155554|NCT02580591|20102418|P3|Treated|Overall Study||248
8155555|NCT02580591|20102419|P2|Treated|Overall Study||241
8155556|NCT02580591|20102420|P1|Treated|Overall Study||241
8155557|NCT02580591|20102417|P4|STARTED|Overall Study||245
8155558|NCT02580591|20102418|P3|STARTED|Overall Study||248
8155559|NCT02580591|20102419|P2|STARTED|Overall Study||242
8155560|NCT02580591|20102420|P1|STARTED|Overall Study||242
8155561|NCT02580357|20102453|P3|NOT COMPLETED|Overall Study||0
8155562|NCT02580357|20102454|P2|NOT COMPLETED|Overall Study||0
8155563|NCT02580357|20102455|P1|NOT COMPLETED|Overall Study||3
8155564|NCT02580357|20102453|P3|COMPLETED|Overall Study||18
8155565|NCT02580357|20102454|P2|COMPLETED|Overall Study||18
8155566|NCT02580357|20102455|P1|COMPLETED|Overall Study||15
8155567|NCT02580357|20102453|P3|STARTED|Overall Study||18
8155568|NCT02580357|20102454|P2|STARTED|Overall Study||18
8155569|NCT02580357|20102455|P1|STARTED|Overall Study||18
8155570|NCT02580318|20102466|P1|NOT COMPLETED|Overall Study||0
8155571|NCT02580318|20102466|P1|COMPLETED|Overall Study||54
8155572|NCT02580318|20102466|P1|Drinking Water (5 Minutes)|Overall Study||54
8155573|NCT02580318|20102466|P1|Drinking Water (Immediate)|Overall Study||51
8155574|NCT02580318|20102466|P1|Hyperventilation (10 Minutes)|Overall Study||54
8155575|NCT02580318|20102466|P1|Hyperventilation (5 Minutes)|Overall Study||54
8155576|NCT02580318|20102466|P1|Hyperventilation (Immediate)|Overall Study||54
8155577|NCT02580318|20102466|P1|Poor Effort|Overall Study||53
8155578|NCT02580318|20102466|P1|STARTED|Overall Study||54
8155579|NCT02580240|20102472|P2|NOT COMPLETED|Overall Study||0
8155580|NCT02580240|20102473|P1|NOT COMPLETED|Overall Study||2
8155581|NCT02580240|20102472|P2|COMPLETED|Overall Study||58
8155582|NCT02580240|20102473|P1|COMPLETED|Overall Study||60
8155583|NCT02580240|20102472|P2|STARTED|Overall Study||58
8155584|NCT02580240|20102473|P1|STARTED|Overall Study||62
8155585|NCT02580201|20102483|P2|NOT COMPLETED|Overall Study||0
8155586|NCT02580201|20102484|P1|NOT COMPLETED|Overall Study||0
8155587|NCT02580201|20102483|P2|COMPLETED|Overall Study||104
8155588|NCT02580201|20102484|P1|COMPLETED|Overall Study||50
8155589|NCT02580201|20102483|P2|STARTED|Overall Study||104
8155590|NCT02580201|20102484|P1|STARTED|Overall Study||50
8155591|NCT02580188|20102497|P2|NOT COMPLETED|Overall Study||3
8155592|NCT02580188|20102498|P1|NOT COMPLETED|Overall Study||3
8155593|NCT02580188|20102497|P2|COMPLETED|Overall Study||32
8155594|NCT02580188|20102498|P1|COMPLETED|Overall Study||32
8155595|NCT02580188|20102497|P2|STARTED|Overall Study||35
8155596|NCT02580188|20102498|P1|STARTED|Overall Study||35
8155609|NCT02579928|20102580|P2|NOT COMPLETED|Overall Study||0
8155610|NCT02579928|20102581|P1|NOT COMPLETED|Overall Study||1
8155611|NCT02579928|20102580|P2|COMPLETED|Overall Study||11
8155612|NCT02579928|20102581|P1|COMPLETED|Overall Study||5
8155613|NCT02579928|20102580|P2|STARTED|Overall Study||11
8155614|NCT02579928|20102581|P1|STARTED|Overall Study||6
8155615|NCT02579915|20102589|P2|NOT COMPLETED|Overall Study||5
8155616|NCT02579915|20102590|P1|NOT COMPLETED|Overall Study||10
8155617|NCT02579915|20102589|P2|COMPLETED|Overall Study||16
8155618|NCT02579915|20102590|P1|COMPLETED|Overall Study||9
8155619|NCT02579915|20102589|P2|STARTED|Overall Study||21
8155620|NCT02579915|20102590|P1|STARTED|Overall Study||19
8155621|NCT02579876|20102598|P2|NOT COMPLETED|Overall Study||0
8155622|NCT02579876|20102599|P1|NOT COMPLETED|Overall Study||1
8155623|NCT02579876|20102598|P2|COMPLETED|Overall Study||5
8155624|NCT02579876|20102599|P1|COMPLETED|Overall Study||14
8155625|NCT02579876|20102598|P2|STARTED|Overall Study||5
8155626|NCT02579876|20102599|P1|STARTED|Overall Study||15
8155635|NCT02579811|20102642|P1|NOT COMPLETED|Overall Study||0
8155636|NCT02579811|20102642|P1|COMPLETED|Overall Study||40
8155637|NCT02579811|20102642|P1|STARTED|Overall Study||40
8155638|NCT02579772|20102649|P2|NOT COMPLETED|Overall Study||2
8155639|NCT02579772|20102650|P1|NOT COMPLETED|Overall Study||2
8155640|NCT02579772|20102649|P2|COMPLETED|Overall Study||3
8155641|NCT02579772|20102650|P1|COMPLETED|Overall Study||6
8155642|NCT02579772|20102649|P2|STARTED|Overall Study||5
8155643|NCT02579772|20102650|P1|STARTED|Overall Study||8
8155644|NCT02579759|20102671|P3|NOT COMPLETED|Overall Study||21
8155645|NCT02579759|20102672|P2|NOT COMPLETED|Overall Study||64
8155646|NCT02579759|20102673|P1|NOT COMPLETED|Overall Study||24
8155647|NCT02579759|20102671|P3|COMPLETED|Overall Study||80
8155648|NCT02579759|20102672|P2|COMPLETED|Overall Study||49
8155649|NCT02579759|20102673|P1|COMPLETED|Overall Study||85
8155650|NCT02579759|20102671|P3|STARTED|Overall Study||101
8155651|NCT02579759|20102672|P2|STARTED|Overall Study||113
8155652|NCT02579759|20102673|P1|STARTED|Overall Study||109
8155653|NCT02579629|20102720|P3|NOT COMPLETED|Overall Study||2
8155654|NCT02579629|20102721|P2|NOT COMPLETED|Overall Study||1
8155655|NCT02579629|20102722|P1|NOT COMPLETED|Overall Study||2
8155656|NCT02579629|20102720|P3|COMPLETED|Overall Study||20
8155657|NCT02579629|20102721|P2|COMPLETED|Overall Study||19
8155658|NCT02579629|20102722|P1|COMPLETED|Overall Study||20
8155659|NCT02579629|20102720|P3|STARTED|Overall Study||22
8155660|NCT02579629|20102721|P2|STARTED|Overall Study||20
8155661|NCT02579629|20102722|P1|STARTED|Overall Study||22
8155662|NCT02579616|20102769|P1|NOT COMPLETED|Overall Study||3
8155663|NCT02579616|20102769|P1|COMPLETED|Overall Study||26
8155664|NCT02579616|20102769|P1|Treated|Overall Study||26
8155665|NCT02579616|20102769|P1|STARTED|Overall Study||29
8155666|NCT02579603|20102782|P2|NOT COMPLETED|Overall Study||2
8155667|NCT02579603|20102783|P1|NOT COMPLETED|Overall Study||4
8155668|NCT02579603|20102782|P2|COMPLETED|Overall Study||51
8155669|NCT02579603|20102783|P1|COMPLETED|Overall Study||48
8155670|NCT02579603|20102782|P2|Number of Patients Treated|Overall Study||53
8155671|NCT02579603|20102783|P1|Number of Patients Treated|Overall Study||51
8155672|NCT02579603|20102782|P2|STARTED|Overall Study|Started are the randomised patients|53
8155673|NCT02579603|20102783|P1|STARTED|Overall Study|Started are the randomised patients|52
8155674|NCT02579421|20102796|P4|NOT COMPLETED|Overall Study||3
8155675|NCT02579421|20102797|P3|NOT COMPLETED|Overall Study||1
8155676|NCT02579421|20102798|P2|NOT COMPLETED|Overall Study||5
8155677|NCT02579421|20102799|P1|NOT COMPLETED|Overall Study||6
8155678|NCT02579421|20102796|P4|COMPLETED|Overall Study||3
8155679|NCT02579421|20102797|P3|COMPLETED|Overall Study||5
8155680|NCT02579421|20102798|P2|COMPLETED|Overall Study||18
8155681|NCT02579421|20102799|P1|COMPLETED|Overall Study||17
8155682|NCT02579421|20102796|P4|STARTED|Overall Study||6
8155683|NCT02579421|20102797|P3|STARTED|Overall Study||6
8155684|NCT02579421|20102798|P2|STARTED|Overall Study||23
8155685|NCT02579421|20102799|P1|STARTED|Overall Study||23
8155686|NCT02579382|20102813|P4|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||5
8155687|NCT02579382|20102814|P3|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||4
8155688|NCT02579382|20102815|P2|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||7
8155689|NCT02579382|20102816|P1|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||1
8155690|NCT02579382|20102813|P4|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
8155691|NCT02579382|20102814|P3|COMPLETED|Optional Treatment Extension Phase(OTEP)||50
8155692|NCT02579382|20102815|P2|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
8155693|NCT02579382|20102816|P1|COMPLETED|Optional Treatment Extension Phase(OTEP)||26
8155694|NCT02579382|20102813|P4|STARTED|Optional Treatment Extension Phase(OTEP)|3 participants who completed the Main Study Phase did not enter the OTEP.|49
8155695|NCT02579382|20102814|P3|STARTED|Optional Treatment Extension Phase(OTEP)||54
8155696|NCT02579382|20102815|P2|STARTED|Optional Treatment Extension Phase(OTEP)|2 participants who completed the Main Study Phase did not enter the OTEP.|51
8155697|NCT02579382|20102816|P1|STARTED|Optional Treatment Extension Phase(OTEP)|1 participant who completed the Main Study Phase did not enter the OTEP.|27
8155698|NCT02579382|20102813|P4|NOT COMPLETED|Main Study Phase||3
8155699|NCT02579382|20102814|P3|NOT COMPLETED|Main Study Phase||2
8155700|NCT02579382|20102815|P2|NOT COMPLETED|Main Study Phase||0
8155701|NCT02579382|20102816|P1|NOT COMPLETED|Main Study Phase||0
8155702|NCT02579382|20102813|P4|COMPLETED|Main Study Phase||52
8155703|NCT02579382|20102814|P3|COMPLETED|Main Study Phase||54
8155704|NCT02579382|20102815|P2|COMPLETED|Main Study Phase||53
8155705|NCT02579382|20102816|P1|COMPLETED|Main Study Phase||28
8155706|NCT02579382|20102813|P4|STARTED|Main Study Phase||55
8155707|NCT02579382|20102814|P3|STARTED|Main Study Phase||56
8155708|NCT02579382|20102815|P2|STARTED|Main Study Phase||53
8155709|NCT02579382|20102816|P1|STARTED|Main Study Phase||28
8155710|NCT02579135|20102911|P2|NOT COMPLETED|Overall Study||9
8155711|NCT02579135|20102912|P1|NOT COMPLETED|Overall Study||2
8155712|NCT02579135|20102911|P2|COMPLETED|Overall Study||106
8155713|NCT02579135|20102912|P1|COMPLETED|Overall Study||105
8155714|NCT02579135|20102911|P2|STARTED|Overall Study||115
8155715|NCT02579135|20102912|P1|STARTED|Overall Study||107
8155716|NCT02579057|20102923|P2|NOT COMPLETED|Overall Study||0
8155717|NCT02579057|20102924|P1|NOT COMPLETED|Overall Study||0
8155718|NCT02579057|20102923|P2|COMPLETED|Overall Study||21
8155719|NCT02579057|20102924|P1|COMPLETED|Overall Study||19
8155720|NCT02579057|20102923|P2|STARTED|Overall Study||21
8155721|NCT02579057|20102924|P1|STARTED|Overall Study||19
8155722|NCT02578992|20102938|P2|NOT COMPLETED|Overall Study||3
8155723|NCT02578992|20102939|P1|NOT COMPLETED|Overall Study||3
8155724|NCT02578992|20102938|P2|COMPLETED|Overall Study|October 2015|62
8155725|NCT02578992|20102939|P1|COMPLETED|Overall Study|October 2015|62
8155726|NCT02578992|20102938|P2|STARTED|Overall Study|November 2014|65
8155727|NCT02578992|20102939|P1|STARTED|Overall Study|November 2014|65
8155728|NCT02578940|20102951|P1|NOT COMPLETED|Overall Study||6
8155729|NCT02578940|20102951|P1|COMPLETED|Overall Study||103
8155730|NCT02578940|20102951|P1|Received 18F-fluciclovine|Overall Study||104
8155731|NCT02578940|20102951|P1|STARTED|Overall Study||109
8155732|NCT02578862|20102960|P2|NOT COMPLETED|Overall Study||2
8155733|NCT02578862|20102961|P1|NOT COMPLETED|Overall Study||0
8155734|NCT02578862|20102960|P2|COMPLETED|Overall Study||33
8155735|NCT02578862|20102961|P1|COMPLETED|Overall Study||37
8155736|NCT02578862|20102960|P2|STARTED|Overall Study||35
8155737|NCT02578862|20102961|P1|STARTED|Overall Study||37
8155738|NCT02578745|20102979|P2|NOT COMPLETED|Overall Study||0
8155739|NCT02578745|20102980|P1|NOT COMPLETED|Overall Study||0
8155740|NCT02578745|20102979|P2|COMPLETED|Overall Study||60
8155741|NCT02578745|20102980|P1|COMPLETED|Overall Study||60
8155742|NCT02578745|20102979|P2|STARTED|Overall Study||60
8155743|NCT02578745|20102980|P1|STARTED|Overall Study||60
8155744|NCT02578706|20102999|P3|NOT COMPLETED|Overall Study||0
8155745|NCT02578706|20103000|P2|NOT COMPLETED|Overall Study||5
8155746|NCT02578706|20103001|P1|NOT COMPLETED|Overall Study||1
8155747|NCT02578706|20102999|P3|COMPLETED|Overall Study||8
8155748|NCT02578706|20103000|P2|COMPLETED|Overall Study||5
8155749|NCT02578706|20103001|P1|COMPLETED|Overall Study||8
8155750|NCT02578706|20102999|P3|STARTED|Overall Study||8
8155751|NCT02578706|20103000|P2|STARTED|Overall Study||10
8155752|NCT02578706|20103001|P1|STARTED|Overall Study||9
8155753|NCT02578680|20103080|P2|NOT COMPLETED|Overall Study||206
8155754|NCT02578680|20103081|P1|NOT COMPLETED|Overall Study||410
8155755|NCT02578680|20103080|P2|COMPLETED|Overall Study||0
8155756|NCT02578680|20103081|P1|COMPLETED|Overall Study||0
8155757|NCT02578680|20103080|P2|Switched to Pembrolizumab|Overall Study||67
8155758|NCT02578680|20103081|P1|Switched to Pembrolizumab|Overall Study||0
8155759|NCT02578680|20103080|P2|Treated|Overall Study||202
8155760|NCT02578680|20103081|P1|Treated|Overall Study||405
8155761|NCT02578680|20103080|P2|STARTED|Overall Study||206
8155762|NCT02578680|20103081|P1|STARTED|Overall Study||410
8155763|NCT02578316|20103097|P1|NOT COMPLETED|Extension Phase||6
8155764|NCT02578316|20103097|P1|COMPLETED|Extension Phase||0
8155765|NCT02578316|20103097|P1|STARTED|Extension Phase||6
8155766|NCT02578316|20103097|P1|NOT COMPLETED|Study Phase||0
8155767|NCT02578316|20103097|P1|COMPLETED|Study Phase||6
8155768|NCT02578316|20103097|P1|STARTED|Study Phase||6
8155769|NCT02578238|20103121|P1|NOT COMPLETED|Overall Study||0
8155770|NCT02578238|20103121|P1|COMPLETED|Overall Study||143
8155771|NCT02578238|20103121|P1|STARTED|Overall Study||143
8155772|NCT02578199|20103125|P1|NOT COMPLETED|Overall Study||4
8155773|NCT02578199|20103125|P1|COMPLETED|Overall Study||27
8155774|NCT02578199|20103125|P1|STARTED|Overall Study||31
8155775|NCT02578186|20103130|P2|NOT COMPLETED|Period 2 (Second of Crossover)||0
8155776|NCT02578186|20103131|P1|NOT COMPLETED|Period 2 (Second of Crossover)||0
8155777|NCT02578186|20103130|P2|COMPLETED|Period 2 (Second of Crossover)||13
8155778|NCT02578186|20103131|P1|COMPLETED|Period 2 (Second of Crossover)||12
8155779|NCT02578186|20103130|P2|STARTED|Period 2 (Second of Crossover)||13
8155780|NCT02578186|20103131|P1|STARTED|Period 2 (Second of Crossover)||12
8155781|NCT02578186|20103130|P2|NOT COMPLETED|Period 1 (First of Crossover)||5
8155782|NCT02578186|20103131|P1|NOT COMPLETED|Period 1 (First of Crossover)||5
8155783|NCT02578186|20103130|P2|COMPLETED|Period 1 (First of Crossover)||13
8155784|NCT02578186|20103131|P1|COMPLETED|Period 1 (First of Crossover)||12
8155785|NCT02578186|20103130|P2|STARTED|Period 1 (First of Crossover)||18
8155786|NCT02578186|20103131|P1|STARTED|Period 1 (First of Crossover)||17
8155787|NCT02577991|20103140|P3|NOT COMPLETED|Overall Study||0
8155788|NCT02577991|20103141|P2|NOT COMPLETED|Overall Study||2
8155789|NCT02577991|20103142|P1|NOT COMPLETED|Overall Study||3
8155790|NCT02577991|20103140|P3|COMPLETED|Overall Study||29
8155791|NCT02577991|20103141|P2|COMPLETED|Overall Study||25
8155792|NCT02577991|20103142|P1|COMPLETED|Overall Study||21
8155793|NCT02577991|20103140|P3|STARTED|Overall Study||29
8155794|NCT02577991|20103141|P2|STARTED|Overall Study||27
8155795|NCT02577991|20103142|P1|STARTED|Overall Study||24
8155796|NCT02577978|20103164|P2|NOT COMPLETED|Overall Study||4
8155797|NCT02577978|20103165|P1|NOT COMPLETED|Overall Study||7
8155798|NCT02577978|20103164|P2|COMPLETED|Overall Study||25
8155799|NCT02577978|20103165|P1|COMPLETED|Overall Study||25
8155800|NCT02577978|20103164|P2|STARTED|Overall Study||29
8155801|NCT02577978|20103165|P1|STARTED|Overall Study||32
8155802|NCT02577900|20103198|P3|NOT COMPLETED|Overall Study||0
8155803|NCT02577900|20103199|P2|NOT COMPLETED|Overall Study||0
8155804|NCT02577900|20103200|P1|NOT COMPLETED|Overall Study||0
8155805|NCT02577900|20103198|P3|COMPLETED|Overall Study||10
8155806|NCT02577900|20103199|P2|COMPLETED|Overall Study||10
8155807|NCT02577900|20103200|P1|COMPLETED|Overall Study||11
8155808|NCT02577900|20103198|P3|STARTED|Overall Study||10
8155809|NCT02577900|20103199|P2|STARTED|Overall Study||10
8155810|NCT02577900|20103200|P1|STARTED|Overall Study||11
8155811|NCT02577887|20103220|P1|NOT COMPLETED|Overall Study||298
8155812|NCT02577887|20103220|P1|COMPLETED|Overall Study||1803
8155813|NCT02577887|20103220|P1|6 Month Follow-up|Overall Study||1938
8155814|NCT02577887|20103220|P1|STARTED|Overall Study||2101
8155815|NCT02577822|20103229|P2|NOT COMPLETED|Overall Study||13
8155816|NCT02577822|20103230|P1|NOT COMPLETED|Overall Study||6
8155817|NCT02577822|20103229|P2|COMPLETED|Overall Study||20
8155818|NCT02577822|20103230|P1|COMPLETED|Overall Study||21
8155819|NCT02577822|20103229|P2|STARTED|Overall Study||33
8155820|NCT02577822|20103230|P1|STARTED|Overall Study||27
8155821|NCT02577718|20103246|P1|NOT COMPLETED|Overall Study||8
8155822|NCT02577718|20103246|P1|COMPLETED|Overall Study||52
8155823|NCT02577718|20103246|P1|STARTED|Overall Study||60
8155824|NCT02577601|20103252|P1|NOT COMPLETED|UPA+COC (1 Month)||0
8155825|NCT02577601|20103252|P1|COMPLETED|UPA+COC (1 Month)||33
8155826|NCT02577601|20103252|P1|STARTED|UPA+COC (1 Month)||33
8155827|NCT02577601|20103252|P1|NOT COMPLETED|Washout (1 Month)||0
8155828|NCT02577601|20103252|P1|COMPLETED|Washout (1 Month)||33
8155829|NCT02577601|20103252|P1|STARTED|Washout (1 Month)||33
8155830|NCT02577601|20103252|P1|NOT COMPLETED|UPA Only (1 Month)||0
8155831|NCT02577601|20103252|P1|COMPLETED|UPA Only (1 Month)||36
8155832|NCT02577601|20103252|P1|STARTED|UPA Only (1 Month)||36
8155833|NCT02577510|20103259|P2|NOT COMPLETED|Overall Study||0
8155834|NCT02577510|20103260|P1|NOT COMPLETED|Overall Study||0
8155835|NCT02577510|20103259|P2|COMPLETED|Overall Study||21
8155836|NCT02577510|20103260|P1|COMPLETED|Overall Study||21
8155837|NCT02577510|20103259|P2|STARTED|Overall Study||21
8155838|NCT02577510|20103260|P1|STARTED|Overall Study||21
8155839|NCT02577445|20103274|P2|NOT COMPLETED|Overall Study||17
8155840|NCT02577445|20103275|P1|NOT COMPLETED|Overall Study||14
8155841|NCT02577445|20103274|P2|COMPLETED|Overall Study|study terminated prematurely|0
8155842|NCT02577445|20103275|P1|COMPLETED|Overall Study|study terminated prematurely|0
8155843|NCT02577445|20103274|P2|STARTED|Overall Study||17
8155844|NCT02577445|20103275|P1|STARTED|Overall Study||14
8155845|NCT02577354|20103288|P2|NOT COMPLETED|Overall Study||13
8155846|NCT02577354|20103289|P1|NOT COMPLETED|Overall Study||15
8155847|NCT02577354|20103288|P2|COMPLETED|Overall Study||89
8155848|NCT02577354|20103289|P1|COMPLETED|Overall Study||87
8155849|NCT02577354|20103288|P2|120 Day Primary Endpoint|Overall Study||101
8155850|NCT02577354|20103289|P1|120 Day Primary Endpoint|Overall Study||100
8155851|NCT02577354|20103288|P2|STARTED|Overall Study||102
8155852|NCT02577354|20103289|P1|STARTED|Overall Study||102
8155853|NCT02577315|20103349|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8155854|NCT02577315|20103350|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8155855|NCT02577315|20103349|P2|COMPLETED|Treatment Period 2 (4 Days)||12
8155856|NCT02577315|20103350|P1|COMPLETED|Treatment Period 2 (4 Days)||12
8155857|NCT02577315|20103349|P2|STARTED|Treatment Period 2 (4 Days)||12
8155858|NCT02577315|20103350|P1|STARTED|Treatment Period 2 (4 Days)||12
8155859|NCT02577315|20103349|P2|NOT COMPLETED|Washout Period (5 Days)||0
8155860|NCT02577315|20103350|P1|NOT COMPLETED|Washout Period (5 Days)||0
8155861|NCT02577315|20103349|P2|COMPLETED|Washout Period (5 Days)||12
8155862|NCT02577315|20103350|P1|COMPLETED|Washout Period (5 Days)||12
8155863|NCT02577315|20103349|P2|STARTED|Washout Period (5 Days)||12
8155864|NCT02577315|20103350|P1|STARTED|Washout Period (5 Days)||12
8155865|NCT02577315|20103349|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
8155866|NCT02577315|20103350|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8155867|NCT02577315|20103349|P2|COMPLETED|Treatment Period 1 (4 Days)||12
8155868|NCT02577315|20103350|P1|COMPLETED|Treatment Period 1 (4 Days)||12
8155869|NCT02577315|20103349|P2|STARTED|Treatment Period 1 (4 Days)||13
8155870|NCT02577315|20103350|P1|STARTED|Treatment Period 1 (4 Days)||12
8155871|NCT02577146|20103366|P1|NOT COMPLETED|Overall Study||28
8155872|NCT02577146|20103366|P1|COMPLETED|Overall Study||46
8155873|NCT02577146|20103366|P1|STARTED|Overall Study||74
8155874|NCT02577107|20103373|P2|NOT COMPLETED|Overall Study||1
8155875|NCT02577107|20103374|P1|NOT COMPLETED|Overall Study||0
8155876|NCT02577107|20103373|P2|COMPLETED|Overall Study||5
8155877|NCT02577107|20103374|P1|COMPLETED|Overall Study||6
8155878|NCT02577107|20103373|P2|STARTED|Overall Study||6
8155879|NCT02577107|20103374|P1|STARTED|Overall Study||6
8155880|NCT02577042|20103388|P2|NOT COMPLETED|Overall Study||3
8155881|NCT02577042|20103389|P1|NOT COMPLETED|Overall Study||5
8155882|NCT02577042|20103388|P2|COMPLETED|Overall Study||19
8155883|NCT02577042|20103389|P1|COMPLETED|Overall Study||15
8155884|NCT02577042|20103388|P2|STARTED|Overall Study||22
8155885|NCT02577042|20103389|P1|STARTED|Overall Study||20
8155886|NCT02577029|20103441|P8|NOT COMPLETED|Overall Study||12
8155887|NCT02577029|20103442|P7|NOT COMPLETED|Overall Study||12
8155888|NCT02577029|20103443|P6|NOT COMPLETED|Overall Study||13
8155889|NCT02577029|20103444|P5|NOT COMPLETED|Overall Study||11
8155890|NCT02577029|20103445|P4|NOT COMPLETED|Overall Study||12
8155891|NCT02577029|20103446|P3|NOT COMPLETED|Overall Study||7
8155892|NCT02577029|20103447|P2|NOT COMPLETED|Overall Study||2
8155893|NCT02577029|20103448|P1|NOT COMPLETED|Overall Study||10
8155894|NCT02577029|20103441|P8|COMPLETED|Overall Study||0
8155895|NCT02577029|20103442|P7|COMPLETED|Overall Study||0
8155896|NCT02577029|20103443|P6|COMPLETED|Overall Study||0
8155897|NCT02577029|20103444|P5|COMPLETED|Overall Study||0
8155898|NCT02577029|20103445|P4|COMPLETED|Overall Study||0
8155899|NCT02577029|20103446|P3|COMPLETED|Overall Study||0
8155900|NCT02577029|20103447|P2|COMPLETED|Overall Study||0
8155901|NCT02577029|20103448|P1|COMPLETED|Overall Study||0
8155902|NCT02577029|20103441|P8|STARTED|Overall Study||12
8155903|NCT02577029|20103442|P7|STARTED|Overall Study||12
8155904|NCT02577029|20103443|P6|STARTED|Overall Study||13
8155905|NCT02577029|20103444|P5|STARTED|Overall Study||11
8155906|NCT02577029|20103445|P4|STARTED|Overall Study||12
8155907|NCT02577029|20103446|P3|STARTED|Overall Study||7
8155908|NCT02577029|20103447|P2|STARTED|Overall Study||2
8155909|NCT02577029|20103448|P1|STARTED|Overall Study||10
8155910|NCT02577016|20103556|P2|NOT COMPLETED|Overall Study||2
8155911|NCT02577016|20103557|P1|NOT COMPLETED|Overall Study||2
8155912|NCT02577016|20103556|P2|COMPLETED|Overall Study||69
8155913|NCT02577016|20103557|P1|COMPLETED|Overall Study||68
8155914|NCT02577016|20103556|P2|STARTED|Overall Study||71
8155915|NCT02577016|20103557|P1|STARTED|Overall Study||70
8155916|NCT02577003|20103575|P2|NOT COMPLETED|Overall Study||5
8155917|NCT02577003|20103576|P1|NOT COMPLETED|Overall Study||2
8155918|NCT02577003|20103575|P2|COMPLETED|Overall Study||65
8155919|NCT02577003|20103576|P1|COMPLETED|Overall Study||71
8155920|NCT02577003|20103575|P2|STARTED|Overall Study||70
8155921|NCT02577003|20103576|P1|STARTED|Overall Study||73
8155922|NCT02576990|20103596|P2|NOT COMPLETED|Overall Study||24
8155923|NCT02576990|20103597|P1|NOT COMPLETED|Overall Study||43
8155924|NCT02576990|20103596|P2|COMPLETED|Overall Study||0
8155925|NCT02576990|20103597|P1|COMPLETED|Overall Study||13
8155926|NCT02576990|20103596|P2|Treated|Overall Study||23
8155927|NCT02576990|20103597|P1|Treated|Overall Study||53
8155928|NCT02576990|20103596|P2|STARTED|Overall Study||24
8155929|NCT02576990|20103597|P1|STARTED|Overall Study||56
8155938|NCT02576951|20103648|P4|NOT COMPLETED|Overall Study||5
8155939|NCT02576951|20103649|P3|NOT COMPLETED|Overall Study||2
8155940|NCT02576951|20103650|P2|NOT COMPLETED|Overall Study||0
8155941|NCT02576951|20103651|P1|NOT COMPLETED|Overall Study||1
8155942|NCT02576951|20103648|P4|COMPLETED|Overall Study||75
8155943|NCT02576951|20103649|P3|COMPLETED|Overall Study||78
8155944|NCT02576951|20103650|P2|COMPLETED|Overall Study||3
8155945|NCT02576951|20103651|P1|COMPLETED|Overall Study||14
8155946|NCT02576951|20103648|P4|Received at Least One Dose of Study Drug|Overall Study||80
8155947|NCT02576951|20103649|P3|Received at Least One Dose of Study Drug|Overall Study||80
8155948|NCT02576951|20103650|P2|Received at Least One Dose of Study Drug|Overall Study||3
8155949|NCT02576951|20103651|P1|Received at Least One Dose of Study Drug|Overall Study||15
8155950|NCT02576951|20103648|P4|STARTED|Overall Study||80
8155951|NCT02576951|20103649|P3|STARTED|Overall Study||80
8155952|NCT02576951|20103650|P2|STARTED|Overall Study||3
8155953|NCT02576951|20103651|P1|STARTED|Overall Study||15
8155954|NCT02576938|20103675|P3|NOT COMPLETED|Overall Study||12
8155955|NCT02576938|20103676|P2|NOT COMPLETED|Overall Study||12
8155956|NCT02576938|20103677|P1|NOT COMPLETED|Overall Study||20
8155957|NCT02576938|20103675|P3|COMPLETED|Overall Study||26
8155958|NCT02576938|20103676|P2|COMPLETED|Overall Study||25
8155959|NCT02576938|20103677|P1|COMPLETED|Overall Study||29
8155960|NCT02576938|20103675|P3|Received at Least One Dose of Study Drug|Overall Study||38
8155961|NCT02576938|20103676|P2|Received at Least One Dose of Study Drug|Overall Study||37
8155962|NCT02576938|20103677|P1|Received at Least One Dose of Study Drug|Overall Study||49
8155963|NCT02576938|20103675|P3|STARTED|Overall Study||38
8155964|NCT02576938|20103676|P2|STARTED|Overall Study||37
8155965|NCT02576938|20103677|P1|STARTED|Overall Study||49
8155966|NCT02576899|20103707|P2|NOT COMPLETED|Overall Study||13
8155967|NCT02576899|20103708|P1|NOT COMPLETED|Overall Study||11
8155968|NCT02576899|20103707|P2|COMPLETED|Overall Study||7
8155969|NCT02576899|20103708|P1|COMPLETED|Overall Study||5
8155970|NCT02576899|20103707|P2|STARTED|Overall Study||20
8155971|NCT02576899|20103708|P1|STARTED|Overall Study||16
8155972|NCT02576678|20103723|P3|NOT COMPLETED|Overall Study||5
8155973|NCT02576678|20103724|P2|NOT COMPLETED|Overall Study||1
8155974|NCT02576678|20103725|P1|NOT COMPLETED|Overall Study||5
8155975|NCT02576678|20103723|P3|COMPLETED|Overall Study||16
8155976|NCT02576678|20103724|P2|COMPLETED|Overall Study||7
8155977|NCT02576678|20103725|P1|COMPLETED|Overall Study||8
8155978|NCT02576678|20103723|P3|Pharmacokinetic (PK) Population|Overall Study||18
8155979|NCT02576678|20103724|P2|Pharmacokinetic (PK) Population|Overall Study||8
8155980|NCT02576678|20103725|P1|Pharmacokinetic (PK) Population|Overall Study||12
8155981|NCT02576678|20103723|P3|STARTED|Overall Study||21
8155982|NCT02576678|20103724|P2|STARTED|Overall Study||8
8155983|NCT02576678|20103725|P1|STARTED|Overall Study||13
8155984|NCT02576652|20103757|P1|NOT COMPLETED|Overall Study||2
8155985|NCT02576652|20103757|P1|COMPLETED|Overall Study||4
8155986|NCT02576652|20103757|P1|STARTED|Overall Study||6
8155987|NCT02576639|20103769|P5|NOT COMPLETED|Overall Study||4
8155988|NCT02576639|20103770|P4|NOT COMPLETED|Overall Study||1
8155989|NCT02576639|20103771|P3|NOT COMPLETED|Overall Study||2
8155990|NCT02576639|20103772|P2|NOT COMPLETED|Overall Study||2
8155991|NCT02576639|20103773|P1|NOT COMPLETED|Overall Study||2
8155992|NCT02576639|20103769|P5|COMPLETED|Overall Study||20
8155993|NCT02576639|20103770|P4|COMPLETED|Overall Study||25
8155994|NCT02576639|20103771|P3|COMPLETED|Overall Study||23
8155995|NCT02576639|20103772|P2|COMPLETED|Overall Study||23
8155996|NCT02576639|20103773|P1|COMPLETED|Overall Study||22
8155997|NCT02576639|20103769|P5|Safety Analysis Set|Overall Study||24
8155998|NCT02576639|20103770|P4|Safety Analysis Set|Overall Study||26
8155999|NCT02576639|20103771|P3|Safety Analysis Set|Overall Study||25
8156000|NCT02576639|20103772|P2|Safety Analysis Set|Overall Study||25
8156001|NCT02576639|20103773|P1|Safety Analysis Set|Overall Study||24
8156002|NCT02576639|20103769|P5|Pharmacokinetic Analysis Set|Overall Study||24
8156003|NCT02576639|20103770|P4|Pharmacokinetic Analysis Set|Overall Study||26
8156004|NCT02576639|20103771|P3|Pharmacokinetic Analysis Set|Overall Study||25
8156005|NCT02576639|20103772|P2|Pharmacokinetic Analysis Set|Overall Study||25
8156006|NCT02576639|20103773|P1|Pharmacokinetic Analysis Set|Overall Study||0
8156007|NCT02576639|20103769|P5|Pharmacodynamic Analysis Set|Overall Study||25
8156008|NCT02576639|20103770|P4|Pharmacodynamic Analysis Set|Overall Study||25
8156009|NCT02576639|20103771|P3|Pharmacodynamic Analysis Set|Overall Study||25
8156010|NCT02576639|20103772|P2|Pharmacodynamic Analysis Set|Overall Study||24
8156011|NCT02576639|20103773|P1|Pharmacodynamic Analysis Set|Overall Study||24
8156012|NCT02576639|20103769|P5|STARTED|Overall Study||24
8156013|NCT02576639|20103770|P4|STARTED|Overall Study||26
8156014|NCT02576639|20103771|P3|STARTED|Overall Study||25
8156015|NCT02576639|20103772|P2|STARTED|Overall Study||25
8156016|NCT02576639|20103773|P1|STARTED|Overall Study||24
8156017|NCT02576587|20103832|P2|NOT COMPLETED|Follow up Period (Case Only)||155
8156018|NCT02576587|20103833|P1|NOT COMPLETED|Follow up Period (Case Only)||117
8156019|NCT02576587|20103832|P2|COMPLETED|Follow up Period (Case Only)||0
8156020|NCT02576587|20103833|P1|COMPLETED|Follow up Period (Case Only)||44
8156021|NCT02576587|20103832|P2|Selected for Follow up|Follow up Period (Case Only)||0
8156022|NCT02576587|20103833|P1|Selected for Follow up|Follow up Period (Case Only)||61
8156023|NCT02576587|20103832|P2|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
8156024|NCT02576587|20103833|P1|STARTED|Follow up Period (Case Only)|Completed baseline.|161
8156025|NCT02576587|20103832|P2|NOT COMPLETED|Baseline||1
8156026|NCT02576587|20103833|P1|NOT COMPLETED|Baseline||0
8156027|NCT02576587|20103832|P2|COMPLETED|Baseline|Baseline visit completed|155
8156028|NCT02576587|20103833|P1|COMPLETED|Baseline|Baseline visit completed|161
8156029|NCT02576587|20103832|P2|STARTED|Baseline|Total controls baseline visit|156
8156030|NCT02576587|20103833|P1|STARTED|Baseline|Total cases baseline visit|161
8156031|NCT02576535|20103851|P1|NOT COMPLETED|Overall Study||2
8156032|NCT02576535|20103851|P1|COMPLETED|Overall Study||16
8156033|NCT02576535|20103851|P1|STARTED|Overall Study||18
8156052|NCT02576249|20103879|P2|NOT COMPLETED|Overall Study||0
8156053|NCT02576249|20103880|P1|NOT COMPLETED|Overall Study||0
8156054|NCT02576249|20103879|P2|COMPLETED|Overall Study||14
8156055|NCT02576249|20103880|P1|COMPLETED|Overall Study||15
8156056|NCT02576249|20103879|P2|STARTED|Overall Study||14
8156057|NCT02576249|20103880|P1|STARTED|Overall Study||15
8156058|NCT02576145|20103892|P2|NOT COMPLETED|Overall Study||1
8156059|NCT02576145|20103893|P1|NOT COMPLETED|Overall Study||3
8156060|NCT02576145|20103892|P2|COMPLETED|Overall Study||4
8156061|NCT02576145|20103893|P1|COMPLETED|Overall Study||3
8156062|NCT02576145|20103892|P2|STARTED|Overall Study||5
8156063|NCT02576145|20103893|P1|STARTED|Overall Study||6
8156064|NCT02576067|20103931|P2|NOT COMPLETED|Overall Study||36
8156065|NCT02576067|20103932|P1|NOT COMPLETED|Overall Study||34
8156066|NCT02576067|20103931|P2|COMPLETED|Overall Study||27
8156067|NCT02576067|20103932|P1|COMPLETED|Overall Study||26
8156068|NCT02576067|20103931|P2|STARTED|Overall Study||63
8156069|NCT02576067|20103932|P1|STARTED|Overall Study||60
8156070|NCT02576054|20103942|P1|NOT COMPLETED|Overall Study||1
8156071|NCT02576054|20103942|P1|COMPLETED|Overall Study||100
8156072|NCT02576054|20103942|P1|Vaccination 3|Overall Study||100
8156073|NCT02576054|20103942|P1|Vaccination 2|Overall Study||100
8156074|NCT02576054|20103942|P1|Vaccination 1|Overall Study||100
8156075|NCT02576054|20103942|P1|STARTED|Overall Study||101
8156076|NCT02576041|20103957|P1|NOT COMPLETED|Bilastine (Active Treatement)||0
8156077|NCT02576041|20103957|P1|COMPLETED|Bilastine (Active Treatement)||18
8156078|NCT02576041|20103957|P1|STARTED|Bilastine (Active Treatement)||18
8156079|NCT02576041|20103957|P1|NOT COMPLETED|Placebo (run-in)||0
8156080|NCT02576041|20103957|P1|COMPLETED|Placebo (run-in)||18
8156081|NCT02576041|20103957|P1|STARTED|Placebo (run-in)||18
8156082|NCT02575950|20103963|P4|NOT COMPLETED|Overall Study||5
8156083|NCT02575950|20103964|P3|NOT COMPLETED|Overall Study||0
8156084|NCT02575950|20103965|P2|NOT COMPLETED|Overall Study||1
8156085|NCT02575950|20103966|P1|NOT COMPLETED|Overall Study||0
8156086|NCT02575950|20103963|P4|COMPLETED|Overall Study||20
8156087|NCT02575950|20103964|P3|COMPLETED|Overall Study||6
8156088|NCT02575950|20103965|P2|COMPLETED|Overall Study||5
8156089|NCT02575950|20103966|P1|COMPLETED|Overall Study||3
8156090|NCT02575950|20103963|P4|STARTED|Overall Study||25
8156091|NCT02575950|20103964|P3|STARTED|Overall Study||6
8156092|NCT02575950|20103965|P2|STARTED|Overall Study||6
8156093|NCT02575950|20103966|P1|STARTED|Overall Study||3
8156094|NCT02575911|20103995|P1|NOT COMPLETED|Overall Study||1
8156095|NCT02575911|20103995|P1|COMPLETED|Overall Study||29
8156096|NCT02575911|20103995|P1|STARTED|Overall Study||30
8156097|NCT02575833|20104015|P2|NOT COMPLETED|Overall Study||1
8156098|NCT02575833|20104016|P1|NOT COMPLETED|Overall Study||1
8156099|NCT02575833|20104015|P2|COMPLETED|Overall Study||44
8156100|NCT02575833|20104016|P1|COMPLETED|Overall Study||43
8156101|NCT02575833|20104015|P2|Received Study Drug|Overall Study||44
8156102|NCT02575833|20104016|P1|Received Study Drug|Overall Study||44
8156103|NCT02575833|20104015|P2|STARTED|Overall Study||45
8156104|NCT02575833|20104016|P1|STARTED|Overall Study||44
8156105|NCT02575807|20104031|P5|NOT COMPLETED|Overall Study||4
8156106|NCT02575807|20104032|P4|NOT COMPLETED|Overall Study||2
8156107|NCT02575807|20104033|P3|NOT COMPLETED|Overall Study||16
8156108|NCT02575807|20104034|P2|NOT COMPLETED|Overall Study||4
8156109|NCT02575807|20104035|P1|NOT COMPLETED|Overall Study||9
8156110|NCT02575807|20104031|P5|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8156111|NCT02575807|20104032|P4|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8156112|NCT02575807|20104033|P3|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8156113|NCT02575807|20104034|P2|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8156114|NCT02575807|20104035|P1|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
8156115|NCT02575807|20104031|P5|Treated|Overall Study||3
8156116|NCT02575807|20104032|P4|Treated|Overall Study||1
8156117|NCT02575807|20104033|P3|Treated|Overall Study||16
8156118|NCT02575807|20104034|P2|Treated|Overall Study||4
8156119|NCT02575807|20104035|P1|Treated|Overall Study||8
8156120|NCT02575807|20104031|P5|STARTED|Overall Study||4
8156121|NCT02575807|20104032|P4|STARTED|Overall Study||2
8156122|NCT02575807|20104033|P3|STARTED|Overall Study||16
8156123|NCT02575807|20104034|P2|STARTED|Overall Study||4
8156124|NCT02575807|20104035|P1|STARTED|Overall Study||9
8156125|NCT02575365|20104075|P1|NOT COMPLETED|Overall Study||4
8156126|NCT02575365|20104075|P1|COMPLETED|Overall Study||0
8156127|NCT02575365|20104075|P1|STARTED|Overall Study||4
8156128|NCT02575300|20104085|P1|NOT COMPLETED|Overall Study||0
8156129|NCT02575300|20104085|P1|COMPLETED|Overall Study||20
8156130|NCT02575300|20104085|P1|STARTED|Overall Study||20
8156131|NCT02575079|20104095|P2|NOT COMPLETED|Overall Study||0
8156132|NCT02575079|20104096|P1|NOT COMPLETED|Overall Study||6
8156133|NCT02575079|20104095|P2|COMPLETED|Overall Study||71
8156134|NCT02575079|20104096|P1|COMPLETED|Overall Study||42
8156135|NCT02575079|20104095|P2|STARTED|Overall Study||71
8156136|NCT02575079|20104096|P1|STARTED|Overall Study||48
8156137|NCT02574858|20104110|P1|NOT COMPLETED|Overall Study||0
8156138|NCT02574858|20104110|P1|COMPLETED|Overall Study||25
8156139|NCT02574858|20104110|P1|STARTED|Overall Study||25
8156140|NCT02574845|20104121|P6|NOT COMPLETED|Overall Study||1
8156141|NCT02574845|20104122|P5|NOT COMPLETED|Overall Study||1
8156142|NCT02574845|20104123|P4|NOT COMPLETED|Overall Study||0
8156143|NCT02574845|20104124|P3|NOT COMPLETED|Overall Study||0
8156144|NCT02574845|20104125|P2|NOT COMPLETED|Overall Study||1
8156145|NCT02574845|20104126|P1|NOT COMPLETED|Overall Study||0
8156146|NCT02574845|20104121|P6|COMPLETED|Overall Study||2
8156147|NCT02574845|20104122|P5|COMPLETED|Overall Study||2
8156148|NCT02574845|20104123|P4|COMPLETED|Overall Study||3
8156149|NCT02574845|20104124|P3|COMPLETED|Overall Study||3
8156150|NCT02574845|20104125|P2|COMPLETED|Overall Study||2
8156151|NCT02574845|20104126|P1|COMPLETED|Overall Study||3
8156152|NCT02574845|20104121|P6|Received R|Overall Study||3
8156153|NCT02574845|20104122|P5|Received R|Overall Study||2
8156154|NCT02574845|20104123|P4|Received R|Overall Study||3
8156155|NCT02574845|20104124|P3|Received R|Overall Study||3
8156156|NCT02574845|20104125|P2|Received R|Overall Study||2
8156157|NCT02574845|20104126|P1|Received R|Overall Study||3
8156158|NCT02574845|20104121|P6|Received T5|Overall Study||2
8156159|NCT02574845|20104122|P5|Received T5|Overall Study||3
8156160|NCT02574845|20104123|P4|Received T5|Overall Study||3
8156161|NCT02574845|20104124|P3|Received T5|Overall Study||3
8156162|NCT02574845|20104125|P2|Received T5|Overall Study||2
8156163|NCT02574845|20104126|P1|Received T5|Overall Study||3
8156164|NCT02574845|20104121|P6|Received T4|Overall Study||2
8156165|NCT02574845|20104122|P5|Received T4|Overall Study||2
8156166|NCT02574845|20104123|P4|Received T4|Overall Study||3
8156167|NCT02574845|20104124|P3|Received T4|Overall Study||3
8156168|NCT02574845|20104125|P2|Received T4|Overall Study||2
8156169|NCT02574845|20104126|P1|Received T4|Overall Study||3
8156170|NCT02574845|20104121|P6|Received T3|Overall Study||3
8156171|NCT02574845|20104122|P5|Received T3|Overall Study||2
8156172|NCT02574845|20104123|P4|Received T3|Overall Study||3
8156173|NCT02574845|20104124|P3|Received T3|Overall Study||3
8156174|NCT02574845|20104125|P2|Received T3|Overall Study||2
8156175|NCT02574845|20104126|P1|Received T3|Overall Study|one subject missed treatment period 2|2
8156176|NCT02574845|20104121|P6|Received T2|Overall Study||3
8156177|NCT02574845|20104122|P5|Received T2|Overall Study||2
8156178|NCT02574845|20104123|P4|Received T2|Overall Study||3
8156179|NCT02574845|20104124|P3|Received T2|Overall Study||3
8156180|NCT02574845|20104125|P2|Received T2|Overall Study||3
8156181|NCT02574845|20104126|P1|Received T2|Overall Study||3
8156182|NCT02574845|20104121|P6|Received T1|Overall Study|one subject missed treatment period 2|2
8156183|NCT02574845|20104122|P5|Received T1|Overall Study||2
8156184|NCT02574845|20104123|P4|Received T1|Overall Study||3
8156185|NCT02574845|20104124|P3|Received T1|Overall Study||3
8156186|NCT02574845|20104125|P2|Received T1|Overall Study||2
8156187|NCT02574845|20104126|P1|Received T1|Overall Study||3
8156188|NCT02574845|20104121|P6|STARTED|Overall Study||3
8156189|NCT02574845|20104122|P5|STARTED|Overall Study||3
8156190|NCT02574845|20104123|P4|STARTED|Overall Study||3
8156191|NCT02574845|20104124|P3|STARTED|Overall Study||3
8156192|NCT02574845|20104125|P2|STARTED|Overall Study||3
8156193|NCT02574845|20104126|P1|STARTED|Overall Study||3
8156194|NCT02574832|20104152|P1|NOT COMPLETED|Overall Study||0
8156195|NCT02574832|20104152|P1|COMPLETED|Overall Study||2
8156196|NCT02574832|20104152|P1|STARTED|Overall Study||2
8156257|NCT02574598|20104268|P2|NOT COMPLETED|Overall Study||0
8156258|NCT02574598|20104269|P1|NOT COMPLETED|Overall Study||0
8156259|NCT02574598|20104268|P2|COMPLETED|Overall Study||38
8156260|NCT02574598|20104269|P1|COMPLETED|Overall Study||40
8156261|NCT02574598|20104268|P2|STARTED|Overall Study||38
8156262|NCT02574598|20104269|P1|STARTED|Overall Study||40
8156275|NCT02574312|20104322|P2|NOT COMPLETED|3 Months Follow-up||0
8156276|NCT02574312|20104323|P1|NOT COMPLETED|3 Months Follow-up||1
8156277|NCT02574312|20104322|P2|COMPLETED|3 Months Follow-up||44
8156278|NCT02574312|20104323|P1|COMPLETED|3 Months Follow-up|One subject withdrew consent|43
8156279|NCT02574312|20104322|P2|STARTED|3 Months Follow-up||44
8156280|NCT02574312|20104323|P1|STARTED|3 Months Follow-up||44
8156281|NCT02574312|20104322|P2|NOT COMPLETED|Pre-Operative||0
8156282|NCT02574312|20104323|P1|NOT COMPLETED|Pre-Operative||0
8156283|NCT02574312|20104322|P2|COMPLETED|Pre-Operative||44
8156284|NCT02574312|20104323|P1|COMPLETED|Pre-Operative||44
8156285|NCT02574312|20104322|P2|STARTED|Pre-Operative||44
8156286|NCT02574312|20104323|P1|STARTED|Pre-Operative||44
8156287|NCT02574260|20104339|P1|NOT COMPLETED|Overall Study||1
8156288|NCT02574260|20104339|P1|COMPLETED|Overall Study||2
8156289|NCT02574260|20104339|P1|STARTED|Overall Study||3
8156290|NCT02574247|20104348|P3|NOT COMPLETED|Overall Study||5
8156291|NCT02574247|20104349|P2|NOT COMPLETED|Overall Study||3
8156292|NCT02574247|20104350|P1|NOT COMPLETED|Overall Study||5
8156293|NCT02574247|20104348|P3|COMPLETED|Overall Study||5
8156294|NCT02574247|20104349|P2|COMPLETED|Overall Study||5
8156295|NCT02574247|20104350|P1|COMPLETED|Overall Study||5
8156296|NCT02574247|20104348|P3|STARTED|Overall Study||10
8156297|NCT02574247|20104349|P2|STARTED|Overall Study||8
8156298|NCT02574247|20104350|P1|STARTED|Overall Study||10
8156299|NCT02573948|20104362|P1|NOT COMPLETED|Longitudinal Cohort||56
8156300|NCT02573948|20104362|P1|COMPLETED|Longitudinal Cohort||194
8156301|NCT02573948|20104362|P1|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
8156302|NCT02573948|20104362|P1|NOT COMPLETED|RDS||0
8156303|NCT02573948|20104362|P1|COMPLETED|RDS||603
8156304|NCT02573948|20104362|P1|STARTED|RDS||603
8156305|NCT02573870|20104372|P2|NOT COMPLETED|Overall Study||7
8156306|NCT02573870|20104373|P1|NOT COMPLETED|Overall Study||0
8156307|NCT02573870|20104372|P2|COMPLETED|Overall Study||35
8156308|NCT02573870|20104373|P1|COMPLETED|Overall Study||20
8156309|NCT02573870|20104372|P2|STARTED|Overall Study||42
8156310|NCT02573870|20104373|P1|STARTED|Overall Study||20
8156311|NCT02573857|20104381|P2|NOT COMPLETED|Overall Study||0
8156312|NCT02573857|20104382|P1|NOT COMPLETED|Overall Study||0
8156313|NCT02573857|20104381|P2|COMPLETED|Overall Study||8
8156314|NCT02573857|20104382|P1|COMPLETED|Overall Study||8
8156315|NCT02573857|20104381|P2|STARTED|Overall Study||8
8156316|NCT02573857|20104382|P1|STARTED|Overall Study||8
8156323|NCT02573467|20104421|P4|NOT COMPLETED|Post-treatment Follow up Epoch||3
8156324|NCT02573467|20104422|P3|NOT COMPLETED|Post-treatment Follow up Epoch||10
8156325|NCT02573467|20104423|P2|NOT COMPLETED|Post-treatment Follow up Epoch||5
8156326|NCT02573467|20104424|P1|NOT COMPLETED|Post-treatment Follow up Epoch||6
8156327|NCT02573467|20104421|P4|COMPLETED|Post-treatment Follow up Epoch||44
8156328|NCT02573467|20104422|P3|COMPLETED|Post-treatment Follow up Epoch||34
8156329|NCT02573467|20104423|P2|COMPLETED|Post-treatment Follow up Epoch||41
8156330|NCT02573467|20104424|P1|COMPLETED|Post-treatment Follow up Epoch||35
8156331|NCT02573467|20104421|P4|STARTED|Post-treatment Follow up Epoch||47
8156332|NCT02573467|20104422|P3|STARTED|Post-treatment Follow up Epoch||44
8156333|NCT02573467|20104423|P2|STARTED|Post-treatment Follow up Epoch||46
8156334|NCT02573467|20104424|P1|STARTED|Post-treatment Follow up Epoch||41
8156335|NCT02573467|20104421|P4|NOT COMPLETED|Double-blind Treatment Epoch||55
8156336|NCT02573467|20104422|P3|NOT COMPLETED|Double-blind Treatment Epoch||51
8156337|NCT02573467|20104423|P2|NOT COMPLETED|Double-blind Treatment Epoch||52
8156338|NCT02573467|20104424|P1|NOT COMPLETED|Double-blind Treatment Epoch||53
8156339|NCT02573467|20104421|P4|COMPLETED|Double-blind Treatment Epoch||0
8156340|NCT02573467|20104422|P3|COMPLETED|Double-blind Treatment Epoch||0
8156341|NCT02573467|20104423|P2|COMPLETED|Double-blind Treatment Epoch||0
8156342|NCT02573467|20104424|P1|COMPLETED|Double-blind Treatment Epoch||0
8156343|NCT02573467|20104421|P4|Full Analysis Set|Double-blind Treatment Epoch||55
8156344|NCT02573467|20104422|P3|Full Analysis Set|Double-blind Treatment Epoch||51
8156345|NCT02573467|20104423|P2|Full Analysis Set|Double-blind Treatment Epoch||52
8156346|NCT02573467|20104424|P1|Full Analysis Set|Double-blind Treatment Epoch||53
8156347|NCT02573467|20104421|P4|STARTED|Double-blind Treatment Epoch||55
8156348|NCT02573467|20104422|P3|STARTED|Double-blind Treatment Epoch||51
8156349|NCT02573467|20104423|P2|STARTED|Double-blind Treatment Epoch||52
8156350|NCT02573467|20104424|P1|STARTED|Double-blind Treatment Epoch||53
8156351|NCT02573402|20104465|P2|NOT COMPLETED|Overall Study||0
8156352|NCT02573402|20104466|P1|NOT COMPLETED|Overall Study||0
8156353|NCT02573402|20104465|P2|COMPLETED|Overall Study||7
8156354|NCT02573402|20104466|P1|COMPLETED|Overall Study||12
8156355|NCT02573402|20104465|P2|STARTED|Overall Study||7
8156356|NCT02573402|20104466|P1|STARTED|Overall Study||12
8156357|NCT02573311|20104488|P2|NOT COMPLETED|Disposition for Part 2||26
8156358|NCT02573311|20104489|P1|NOT COMPLETED|Disposition for Part 2||210
8156359|NCT02573311|20104488|P2|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|127
8156360|NCT02573311|20104489|P1|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|754
8156361|NCT02573311|20104488|P2|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|153
8156362|NCT02573311|20104489|P1|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|964
8156363|NCT02573311|20104488|P2|NOT COMPLETED|Disposition for Part 1||3
8156364|NCT02573311|20104489|P1|NOT COMPLETED|Disposition for Part 1||7
8156365|NCT02573311|20104488|P2|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|361
8156366|NCT02573311|20104489|P1|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|1730
8156367|NCT02573311|20104488|P2|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|364
8156368|NCT02573311|20104489|P1|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|1737
8156369|NCT02573233|20104505|P2|NOT COMPLETED|Overall Study||0
8156370|NCT02573233|20104506|P1|NOT COMPLETED|Overall Study||0
8156371|NCT02573233|20104505|P2|COMPLETED|Overall Study||20
8156372|NCT02573233|20104506|P1|COMPLETED|Overall Study||22
8156373|NCT02573233|20104505|P2|STARTED|Overall Study||20
8156374|NCT02573233|20104506|P1|STARTED|Overall Study||22
8156375|NCT02573181|20104533|P2|NOT COMPLETED|Overall Study||0
8156376|NCT02573181|20104534|P1|NOT COMPLETED|Overall Study||0
8156377|NCT02573181|20104533|P2|COMPLETED|Overall Study||126
8156378|NCT02573181|20104534|P1|COMPLETED|Overall Study||127
8156379|NCT02573181|20104533|P2|Vaccinated|Overall Study||126
8156380|NCT02573181|20104534|P1|Vaccinated|Overall Study||127
8156381|NCT02573181|20104533|P2|STARTED|Overall Study||126
8156382|NCT02573181|20104534|P1|STARTED|Overall Study||127
8156383|NCT02573155|20104558|P2|NOT COMPLETED|Period 5||0
8156384|NCT02573155|20104559|P1|NOT COMPLETED|Period 5||0
8156385|NCT02573155|20104558|P2|COMPLETED|Period 5||28
8156386|NCT02573155|20104559|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8156387|NCT02573155|20104558|P2|STARTED|Period 5||28
8156388|NCT02573155|20104559|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8156389|NCT02573155|20104558|P2|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
8156390|NCT02573155|20104559|P1|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
8156391|NCT02573155|20104558|P2|COMPLETED|Washout Between Treatment Period 4 and 5||28
8156392|NCT02573155|20104559|P1|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
8156393|NCT02573155|20104558|P2|STARTED|Washout Between Treatment Period 4 and 5||29
8156394|NCT02573155|20104559|P1|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
8156395|NCT02573155|20104558|P2|NOT COMPLETED|Period 4||0
8156396|NCT02573155|20104559|P1|NOT COMPLETED|Period 4||0
8156397|NCT02573155|20104558|P2|COMPLETED|Period 4||29
8156398|NCT02573155|20104559|P1|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
8156399|NCT02573155|20104558|P2|STARTED|Period 4||29
8156400|NCT02573155|20104559|P1|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
8156401|NCT02573155|20104558|P2|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
8156402|NCT02573155|20104559|P1|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
8156403|NCT02573155|20104558|P2|COMPLETED|Washout Between Treatment Period 3 and 4||29
8156404|NCT02573155|20104559|P1|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
8156405|NCT02573155|20104558|P2|STARTED|Washout Between Treatment Period 3 and 4||31
8156406|NCT02573155|20104559|P1|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
8156407|NCT02573155|20104558|P2|NOT COMPLETED|Period 3||0
8156408|NCT02573155|20104559|P1|NOT COMPLETED|Period 3||0
8156409|NCT02573155|20104558|P2|COMPLETED|Period 3||31
8156410|NCT02573155|20104559|P1|COMPLETED|Period 3||15
8156411|NCT02573155|20104558|P2|STARTED|Period 3||31
8156412|NCT02573155|20104559|P1|STARTED|Period 3||15
8156413|NCT02573155|20104558|P2|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
8156414|NCT02573155|20104559|P1|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
8156415|NCT02573155|20104558|P2|COMPLETED|Washout Between Treatment Period 2 and 3||31
8156416|NCT02573155|20104559|P1|COMPLETED|Washout Between Treatment Period 2 and 3||15
8156417|NCT02573155|20104558|P2|STARTED|Washout Between Treatment Period 2 and 3||33
8156418|NCT02573155|20104559|P1|STARTED|Washout Between Treatment Period 2 and 3||16
8156419|NCT02573155|20104558|P2|NOT COMPLETED|Period 2||0
8156420|NCT02573155|20104559|P1|NOT COMPLETED|Period 2||0
8156421|NCT02573155|20104558|P2|COMPLETED|Period 2||33
8156422|NCT02573155|20104559|P1|COMPLETED|Period 2||16
8156423|NCT02573155|20104558|P2|STARTED|Period 2||33
8156424|NCT02573155|20104559|P1|STARTED|Period 2||16
8156425|NCT02573155|20104558|P2|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
8156426|NCT02573155|20104559|P1|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
8156427|NCT02573155|20104558|P2|COMPLETED|Washout Between Treatment Period 1 and 2||33
8156428|NCT02573155|20104559|P1|COMPLETED|Washout Between Treatment Period 1 and 2||16
8156429|NCT02573155|20104558|P2|STARTED|Washout Between Treatment Period 1 and 2||38
8156430|NCT02573155|20104559|P1|STARTED|Washout Between Treatment Period 1 and 2||16
8156431|NCT02573155|20104558|P2|NOT COMPLETED|Treatment Period 1||0
8156432|NCT02573155|20104559|P1|NOT COMPLETED|Treatment Period 1||0
8156433|NCT02573155|20104558|P2|COMPLETED|Treatment Period 1||38
8156434|NCT02573155|20104559|P1|COMPLETED|Treatment Period 1||16
8156435|NCT02573155|20104558|P2|STARTED|Treatment Period 1||38
8156436|NCT02573155|20104559|P1|STARTED|Treatment Period 1||16
8156437|NCT02573012|20104707|P2|NOT COMPLETED|Overall Study||15
8156438|NCT02573012|20104708|P1|NOT COMPLETED|Overall Study||15
8156439|NCT02573012|20104707|P2|COMPLETED|Overall Study||113
8156440|NCT02573012|20104708|P1|COMPLETED|Overall Study||116
8156441|NCT02573012|20104707|P2|STARTED|Overall Study||128
8156442|NCT02573012|20104708|P1|STARTED|Overall Study||131
8156443|NCT02572817|20104760|P2|NOT COMPLETED|Overall Study||6
8156444|NCT02572817|20104761|P1|NOT COMPLETED|Overall Study||9
8156445|NCT02572817|20104760|P2|COMPLETED|Overall Study||41
8156446|NCT02572817|20104761|P1|COMPLETED|Overall Study||82
8156447|NCT02572817|20104760|P2|STARTED|Overall Study||47
8156448|NCT02572817|20104761|P1|STARTED|Overall Study||91
8156449|NCT02572752|20104828|P3|NOT COMPLETED|Period 3 Including Washout||0
8156450|NCT02572752|20104829|P2|NOT COMPLETED|Period 3 Including Washout||0
8156451|NCT02572752|20104830|P1|NOT COMPLETED|Period 3 Including Washout||0
8156452|NCT02572752|20104828|P3|COMPLETED|Period 3 Including Washout||24
8156453|NCT02572752|20104829|P2|COMPLETED|Period 3 Including Washout||23
8156454|NCT02572752|20104830|P1|COMPLETED|Period 3 Including Washout||23
8156455|NCT02572752|20104828|P3|STARTED|Period 3 Including Washout||24
8156456|NCT02572752|20104829|P2|STARTED|Period 3 Including Washout||23
8156457|NCT02572752|20104830|P1|STARTED|Period 3 Including Washout||23
8156458|NCT02572752|20104828|P3|NOT COMPLETED|Period 2 Including Washout||0
8156459|NCT02572752|20104829|P2|NOT COMPLETED|Period 2 Including Washout||0
8156460|NCT02572752|20104830|P1|NOT COMPLETED|Period 2 Including Washout||0
8156461|NCT02572752|20104828|P3|COMPLETED|Period 2 Including Washout||24
8156462|NCT02572752|20104829|P2|COMPLETED|Period 2 Including Washout||23
8156463|NCT02572752|20104830|P1|COMPLETED|Period 2 Including Washout||23
8156464|NCT02572752|20104828|P3|STARTED|Period 2 Including Washout||24
8156465|NCT02572752|20104829|P2|STARTED|Period 2 Including Washout||23
8156466|NCT02572752|20104830|P1|STARTED|Period 2 Including Washout||23
8156467|NCT02572752|20104828|P3|NOT COMPLETED|Period 1 Including Washout||0
8156468|NCT02572752|20104829|P2|NOT COMPLETED|Period 1 Including Washout||0
8156469|NCT02572752|20104830|P1|NOT COMPLETED|Period 1 Including Washout||0
8156470|NCT02572752|20104828|P3|COMPLETED|Period 1 Including Washout||24
8156471|NCT02572752|20104829|P2|COMPLETED|Period 1 Including Washout||23
8156472|NCT02572752|20104830|P1|COMPLETED|Period 1 Including Washout||23
8156473|NCT02572752|20104828|P3|STARTED|Period 1 Including Washout||24
8156474|NCT02572752|20104829|P2|STARTED|Period 1 Including Washout||23
8156475|NCT02572752|20104830|P1|STARTED|Period 1 Including Washout||23
8156476|NCT02572609|20104845|P2|NOT COMPLETED|Period 2: Treatment Period 2||0
8156477|NCT02572609|20104846|P1|NOT COMPLETED|Period 2: Treatment Period 2||0
8156478|NCT02572609|20104845|P2|COMPLETED|Period 2: Treatment Period 2||18
8156479|NCT02572609|20104846|P1|COMPLETED|Period 2: Treatment Period 2||18
8156480|NCT02572609|20104845|P2|STARTED|Period 2: Treatment Period 2||18
8156481|NCT02572609|20104846|P1|STARTED|Period 2: Treatment Period 2||18
8156482|NCT02572609|20104845|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
8156483|NCT02572609|20104846|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
8156484|NCT02572609|20104845|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||18
8156485|NCT02572609|20104846|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||18
8156486|NCT02572609|20104845|P2|STARTED|Period 1: Treatment Period 1 + Washout||18
8156487|NCT02572609|20104846|P1|STARTED|Period 1: Treatment Period 1 + Washout||18
8156488|NCT02572570|20104854|P1|NOT COMPLETED|Overall Study||27
8156489|NCT02572570|20104854|P1|COMPLETED|Overall Study||0
8156490|NCT02572570|20104854|P1|5 Year Follow-Up|Overall Study||0
8156491|NCT02572570|20104854|P1|3 Year Follow-Up|Overall Study||5
8156492|NCT02572570|20104854|P1|2 Year Follow-Up|Overall Study||13
8156493|NCT02572570|20104854|P1|1 Year Follow-Up|Overall Study||20
8156494|NCT02572570|20104854|P1|Filtek Supreme Ultra|Overall Study||27
8156495|NCT02572570|20104854|P1|Filtek Bulk Fill Posterior|Overall Study||27
8156496|NCT02572570|20104854|P1|STARTED|Overall Study||27
8156497|NCT02572427|20104871|P2|NOT COMPLETED|Overall Study||9
8156498|NCT02572427|20104872|P1|NOT COMPLETED|Overall Study||6
8156499|NCT02572427|20104871|P2|COMPLETED|Overall Study||36
8156500|NCT02572427|20104872|P1|COMPLETED|Overall Study||31
8156501|NCT02572427|20104871|P2|STARTED|Overall Study||45
8156502|NCT02572427|20104872|P1|STARTED|Overall Study||37
8156503|NCT02572401|20104884|P4|NOT COMPLETED|Overall Study||10
8156504|NCT02572401|20104885|P3|NOT COMPLETED|Overall Study||9
8156505|NCT02572401|20104886|P2|NOT COMPLETED|Overall Study||8
8156506|NCT02572401|20104887|P1|NOT COMPLETED|Overall Study||5
8156507|NCT02572401|20104884|P4|COMPLETED|Overall Study||88
8156508|NCT02572401|20104885|P3|COMPLETED|Overall Study||89
8156509|NCT02572401|20104886|P2|COMPLETED|Overall Study||90
8156510|NCT02572401|20104887|P1|COMPLETED|Overall Study||92
8156511|NCT02572401|20104884|P4|STARTED|Overall Study||98
8156512|NCT02572401|20104885|P3|STARTED|Overall Study||98
8156513|NCT02572401|20104886|P2|STARTED|Overall Study||98
8156514|NCT02572401|20104887|P1|STARTED|Overall Study||97
8156515|NCT02572388|20104917|P4|NOT COMPLETED|Overall Study||2
8156516|NCT02572388|20104918|P3|NOT COMPLETED|Overall Study||2
8156517|NCT02572388|20104919|P2|NOT COMPLETED|Overall Study||1
8156518|NCT02572388|20104920|P1|NOT COMPLETED|Overall Study||1
8156519|NCT02572388|20104917|P4|COMPLETED|Overall Study||4
8156520|NCT02572388|20104918|P3|COMPLETED|Overall Study||8
8156521|NCT02572388|20104919|P2|COMPLETED|Overall Study||3
8156522|NCT02572388|20104920|P1|COMPLETED|Overall Study||10
8156523|NCT02572388|20104917|P4|STARTED|Overall Study||6
8156524|NCT02572388|20104918|P3|STARTED|Overall Study||10
8156525|NCT02572388|20104919|P2|STARTED|Overall Study||4
8156526|NCT02572388|20104920|P1|STARTED|Overall Study||11
8156536|NCT02572076|20104961|P1|NOT COMPLETED|Overall Study||1
8156537|NCT02572076|20104961|P1|COMPLETED|Overall Study||9
8156538|NCT02572076|20104961|P1|STARTED|Overall Study||10
8156539|NCT02571972|20104965|P1|NOT COMPLETED|Overall Study||4
8156540|NCT02571972|20104965|P1|COMPLETED|Overall Study||10
8156541|NCT02571972|20104965|P1|STARTED|Overall Study|2 patients signed consent but withdrew from the study prior to using dorzolamide-timolol drops.|14
8156542|NCT02571777|20104977|P5|NOT COMPLETED|Overall Study||36
8156543|NCT02571777|20104978|P4|NOT COMPLETED|Overall Study||37
8156544|NCT02571777|20104979|P3|NOT COMPLETED|Overall Study||41
8156545|NCT02571777|20104980|P2|NOT COMPLETED|Overall Study||38
8156546|NCT02571777|20104981|P1|NOT COMPLETED|Overall Study||39
8156547|NCT02571777|20104977|P5|COMPLETED|Overall Study||582
8156548|NCT02571777|20104978|P4|COMPLETED|Overall Study||580
8156549|NCT02571777|20104979|P3|COMPLETED|Overall Study||577
8156550|NCT02571777|20104980|P2|COMPLETED|Overall Study||582
8156551|NCT02571777|20104981|P1|COMPLETED|Overall Study||580
8156552|NCT02571777|20104977|P5|Safety Set (SAF)|Overall Study||618
8156553|NCT02571777|20104978|P4|Safety Set (SAF)|Overall Study||608
8156554|NCT02571777|20104979|P3|Safety Set (SAF)|Overall Study||613
8156555|NCT02571777|20104980|P2|Safety Set (SAF)|Overall Study||617
8156556|NCT02571777|20104981|P1|Safety Set (SAF)|Overall Study||616
8156557|NCT02571777|20104977|P5|Full Analysis Set (FAS)|Overall Study||612
8156558|NCT02571777|20104978|P4|Full Analysis Set (FAS)|Overall Study||607
8156559|NCT02571777|20104979|P3|Full Analysis Set (FAS)|Overall Study||611
8156560|NCT02571777|20104980|P2|Full Analysis Set (FAS)|Overall Study||616
8156561|NCT02571777|20104981|P1|Full Analysis Set (FAS)|Overall Study||615
8156562|NCT02571777|20104977|P5|STARTED|Overall Study||618
8156563|NCT02571777|20104978|P4|STARTED|Overall Study||617
8156564|NCT02571777|20104979|P3|STARTED|Overall Study||618
8156565|NCT02571777|20104980|P2|STARTED|Overall Study||620
8156566|NCT02571777|20104981|P1|STARTED|Overall Study||619
8156567|NCT02571634|20105108|P1|NOT COMPLETED|Overall Study||0
8156568|NCT02571634|20105108|P1|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
8156569|NCT02571634|20105108|P1|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
8156570|NCT02571452|20105118|P2|NOT COMPLETED|Overall Study 6-Month Follow-up||0
8156571|NCT02571452|20105119|P1|NOT COMPLETED|Overall Study 6-Month Follow-up||5
8156572|NCT02571452|20105118|P2|COMPLETED|Overall Study 6-Month Follow-up||0
8156573|NCT02571452|20105119|P1|COMPLETED|Overall Study 6-Month Follow-up||42
8156574|NCT02571452|20105118|P2|STARTED|Overall Study 6-Month Follow-up|Participants in the PMRT arm were not invited to complete 6-Month Follow-up.|0
8156575|NCT02571452|20105119|P1|STARTED|Overall Study 6-Month Follow-up||47
8156576|NCT02571452|20105118|P2|NOT COMPLETED|Overall Study Treatment||1
8156577|NCT02571452|20105119|P1|NOT COMPLETED|Overall Study Treatment||0
8156578|NCT02571452|20105118|P2|COMPLETED|Overall Study Treatment||45
8156579|NCT02571452|20105119|P1|COMPLETED|Overall Study Treatment||47
8156580|NCT02571452|20105118|P2|STARTED|Overall Study Treatment||46
8156581|NCT02571452|20105119|P1|STARTED|Overall Study Treatment||47
8156582|NCT02571439|20105133|P2|NOT COMPLETED|Overall Study||0
8156583|NCT02571439|20105134|P1|NOT COMPLETED|Overall Study||0
8156584|NCT02571439|20105133|P2|COMPLETED|Overall Study||21
8156585|NCT02571439|20105134|P1|COMPLETED|Overall Study||20
8156586|NCT02571439|20105133|P2|STARTED|Overall Study||21
8156587|NCT02571439|20105134|P1|STARTED|Overall Study||20
8156588|NCT02571244|20105160|P2|NOT COMPLETED|Overall Study||1
8156589|NCT02571244|20105161|P1|NOT COMPLETED|Overall Study||3
8156590|NCT02571244|20105160|P2|COMPLETED|Overall Study||21
8156591|NCT02571244|20105161|P1|COMPLETED|Overall Study||41
8156592|NCT02571244|20105160|P2|STARTED|Overall Study||22
8156593|NCT02571244|20105161|P1|STARTED|Overall Study||44
8156594|NCT02571218|20105177|P2|NOT COMPLETED|Overall Study||0
8156595|NCT02571218|20105178|P1|NOT COMPLETED|Overall Study||0
8156596|NCT02571218|20105177|P2|COMPLETED|Overall Study||41
8156597|NCT02571218|20105178|P1|COMPLETED|Overall Study||40
8156598|NCT02571218|20105177|P2|STARTED|Overall Study||41
8156599|NCT02571218|20105178|P1|STARTED|Overall Study||40
8156600|NCT02571153|20105189|P3|NOT COMPLETED|Overall Study||2
8156601|NCT02571153|20105190|P2|NOT COMPLETED|Overall Study||8
8156602|NCT02571153|20105191|P1|NOT COMPLETED|Overall Study||6
8156603|NCT02571153|20105189|P3|COMPLETED|Overall Study||43
8156604|NCT02571153|20105190|P2|COMPLETED|Overall Study||37
8156605|NCT02571153|20105191|P1|COMPLETED|Overall Study||39
8156606|NCT02571153|20105189|P3|STARTED|Overall Study||45
8156607|NCT02571153|20105190|P2|STARTED|Overall Study||45
8156608|NCT02571153|20105191|P1|STARTED|Overall Study||45
8156609|NCT02571075|20105219|P2|NOT COMPLETED|Overall Study||24
8156610|NCT02571075|20105220|P1|NOT COMPLETED|Overall Study||20
8156611|NCT02571075|20105219|P2|COMPLETED|Overall Study||26
8156612|NCT02571075|20105220|P1|COMPLETED|Overall Study||25
8156613|NCT02571075|20105219|P2|STARTED|Overall Study||50
8156614|NCT02571075|20105220|P1|STARTED|Overall Study||45
8156615|NCT02571049|20105234|P2|NOT COMPLETED|Randomization||2
8156616|NCT02571049|20105235|P1|NOT COMPLETED|Randomization||0
8156617|NCT02571049|20105234|P2|COMPLETED|Randomization||10
8156618|NCT02571049|20105235|P1|COMPLETED|Randomization||8
8156619|NCT02571049|20105234|P2|STARTED|Randomization||12
8156620|NCT02571049|20105235|P1|STARTED|Randomization||8
8156621|NCT02571049|20105234|P2|NOT COMPLETED|Screening||2
8156622|NCT02571049|20105235|P1|NOT COMPLETED|Screening||2
8156623|NCT02571049|20105234|P2|COMPLETED|Screening||12
8156624|NCT02571049|20105235|P1|COMPLETED|Screening||8
8156625|NCT02571049|20105234|P2|STARTED|Screening||14
8156626|NCT02571049|20105235|P1|STARTED|Screening||10
8156627|NCT02570750|20105243|P2|NOT COMPLETED|Overall Study||5
8156628|NCT02570750|20105244|P1|NOT COMPLETED|Overall Study||14
8156629|NCT02570750|20105243|P2|COMPLETED|Overall Study||68
8156630|NCT02570750|20105244|P1|COMPLETED|Overall Study||96
8156631|NCT02570750|20105243|P2|STARTED|Overall Study||73
8156632|NCT02570750|20105244|P1|STARTED|Overall Study||110
8156633|NCT02570711|20105262|P2|NOT COMPLETED|Overall Study||2
8156634|NCT02570711|20105263|P1|NOT COMPLETED|Overall Study||1
8156635|NCT02570711|20105262|P2|COMPLETED|Overall Study||0
8156636|NCT02570711|20105263|P1|COMPLETED|Overall Study||0
8156637|NCT02570711|20105262|P2|STARTED|Overall Study||2
8156638|NCT02570711|20105263|P1|STARTED|Overall Study||1
8156639|NCT02570425|20105271|P2|NOT COMPLETED|Visit 3||0
8156640|NCT02570425|20105272|P1|NOT COMPLETED|Visit 3||0
8156641|NCT02570425|20105271|P2|COMPLETED|Visit 3||231
8156642|NCT02570425|20105272|P1|COMPLETED|Visit 3||229
8156643|NCT02570425|20105271|P2|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
8156644|NCT02570425|20105272|P1|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
8156645|NCT02570425|20105271|P2|NOT COMPLETED|Visit 2||0
8156646|NCT02570425|20105272|P1|NOT COMPLETED|Visit 2||0
8156647|NCT02570425|20105271|P2|COMPLETED|Visit 2||247
8156648|NCT02570425|20105272|P1|COMPLETED|Visit 2||251
8156649|NCT02570425|20105271|P2|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
8156650|NCT02570425|20105272|P1|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
8156651|NCT02570425|20105271|P2|NOT COMPLETED|Visit 1||0
8156652|NCT02570425|20105272|P1|NOT COMPLETED|Visit 1||0
8156653|NCT02570425|20105271|P2|COMPLETED|Visit 1||242
8156654|NCT02570425|20105272|P1|COMPLETED|Visit 1||274
8156655|NCT02570425|20105271|P2|STARTED|Visit 1||242
8156656|NCT02570425|20105272|P1|STARTED|Visit 1||274
8156657|NCT02570295|20105321|P2|NOT COMPLETED|Overall Study||58
8156658|NCT02570295|20105322|P1|NOT COMPLETED|Overall Study||11
8156659|NCT02570295|20105321|P2|COMPLETED|Overall Study||289
8156660|NCT02570295|20105322|P1|COMPLETED|Overall Study||364
8156661|NCT02570295|20105321|P2|STARTED|Overall Study||347
8156662|NCT02570295|20105322|P1|STARTED|Overall Study||375
8156663|NCT02570165|20105351|P7|NOT COMPLETED|Overall Study||0
8156664|NCT02570165|20105352|P6|NOT COMPLETED|Overall Study||2
8156665|NCT02570165|20105353|P5|NOT COMPLETED|Overall Study||6
8156666|NCT02570165|20105354|P4|NOT COMPLETED|Overall Study||5
8156667|NCT02570165|20105355|P3|NOT COMPLETED|Overall Study||5
8156668|NCT02570165|20105356|P2|NOT COMPLETED|Overall Study||3
8156669|NCT02570165|20105357|P1|NOT COMPLETED|Overall Study||2
8156670|NCT02570165|20105351|P7|COMPLETED|Overall Study||47
8156671|NCT02570165|20105352|P6|COMPLETED|Overall Study||44
8156672|NCT02570165|20105353|P5|COMPLETED|Overall Study||41
8156673|NCT02570165|20105354|P4|COMPLETED|Overall Study||40
8156674|NCT02570165|20105355|P3|COMPLETED|Overall Study||41
8156675|NCT02570165|20105356|P2|COMPLETED|Overall Study||43
8156676|NCT02570165|20105357|P1|COMPLETED|Overall Study||44
8156677|NCT02570165|20105351|P7|STARTED|Overall Study||47
8156678|NCT02570165|20105352|P6|STARTED|Overall Study||46
8156679|NCT02570165|20105353|P5|STARTED|Overall Study||47
8156680|NCT02570165|20105354|P4|STARTED|Overall Study||45
8156681|NCT02570165|20105355|P3|STARTED|Overall Study||46
8156682|NCT02570165|20105356|P2|STARTED|Overall Study||46
8156683|NCT02570165|20105357|P1|STARTED|Overall Study||46
8156684|NCT02570152|20105380|P1|NOT COMPLETED|Overall Study||15
8156685|NCT02570152|20105380|P1|COMPLETED|Overall Study||1989
8156686|NCT02570152|20105380|P1|STARTED|Overall Study||2004
8156687|NCT02570139|20105396|P2|NOT COMPLETED|Overall Study||0
8156688|NCT02570139|20105397|P1|NOT COMPLETED|Overall Study||0
8156689|NCT02570139|20105396|P2|COMPLETED|Overall Study||21
8156690|NCT02570139|20105397|P1|COMPLETED|Overall Study||24
8156691|NCT02570139|20105396|P2|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
8156692|NCT02570139|20105397|P1|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
8156693|NCT02570126|20105411|P2|NOT COMPLETED|Overall Study||9
8156694|NCT02570126|20105412|P1|NOT COMPLETED|Overall Study||6
8156695|NCT02570126|20105411|P2|COMPLETED|Overall Study||607
8156696|NCT02570126|20105412|P1|COMPLETED|Overall Study||609
8156697|NCT02570126|20105411|P2|STARTED|Overall Study||616
8156698|NCT02570126|20105412|P1|STARTED|Overall Study||615
8156699|NCT02570074|20105438|P2|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0
8156700|NCT02570074|20105439|P1|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1
8156701|NCT02570074|20105438|P2|COMPLETED|Period 2 (Second Dosing Regimen)||10
8156702|NCT02570074|20105439|P1|COMPLETED|Period 2 (Second Dosing Regimen)||8
8156703|NCT02570074|20105438|P2|STARTED|Period 2 (Second Dosing Regimen)||10
8156704|NCT02570074|20105439|P1|STARTED|Period 2 (Second Dosing Regimen)||9
8156705|NCT02570074|20105438|P2|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
8156706|NCT02570074|20105439|P1|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
8156707|NCT02570074|20105438|P2|COMPLETED|Period 1 (First Dosing Regimen)||10
8156708|NCT02570074|20105439|P1|COMPLETED|Period 1 (First Dosing Regimen)||9
8156709|NCT02570074|20105438|P2|STARTED|Period 1 (First Dosing Regimen)||10
8156710|NCT02570074|20105439|P1|STARTED|Period 1 (First Dosing Regimen)||9
8156711|NCT02570022|20105499|P2|NOT COMPLETED|Overall Study||0
8156712|NCT02570022|20105500|P1|NOT COMPLETED|Overall Study||0
8156713|NCT02570022|20105499|P2|COMPLETED|Overall Study||31
8156714|NCT02570022|20105500|P1|COMPLETED|Overall Study||26
8156715|NCT02570022|20105499|P2|STARTED|Overall Study||31
8156716|NCT02570022|20105500|P1|STARTED|Overall Study||26
8156717|NCT02569996|20105508|P1|NOT COMPLETED|Overall Study||55
8156718|NCT02569996|20105508|P1|COMPLETED|Overall Study||69
8156719|NCT02569996|20105508|P1|STARTED|Overall Study||124
8156720|NCT02569957|20105520|P2|NOT COMPLETED|Overall Study||1
8156721|NCT02569957|20105521|P1|NOT COMPLETED|Overall Study||0
8156722|NCT02569957|20105520|P2|COMPLETED|Overall Study||0
8156723|NCT02569957|20105521|P1|COMPLETED|Overall Study||0
8156724|NCT02569957|20105520|P2|STARTED|Overall Study||1
8156725|NCT02569957|20105521|P1|STARTED|Overall Study||0
8156726|NCT02569853|20105553|P2|NOT COMPLETED|Overall Study||14
8156727|NCT02569853|20105554|P1|NOT COMPLETED|Overall Study||20
8156728|NCT02569853|20105553|P2|COMPLETED|Overall Study||123
8156729|NCT02569853|20105554|P1|COMPLETED|Overall Study||111
8156730|NCT02569853|20105553|P2|STARTED|Overall Study||137
8156731|NCT02569853|20105554|P1|STARTED|Overall Study||131
8156732|NCT02569710|20105572|P10|NOT COMPLETED|Overall Study||0
8156733|NCT02569710|20105573|P9|NOT COMPLETED|Overall Study||1
8156734|NCT02569710|20105574|P8|NOT COMPLETED|Overall Study||0
8156735|NCT02569710|20105575|P7|NOT COMPLETED|Overall Study||2
8156736|NCT02569710|20105576|P6|NOT COMPLETED|Overall Study||1
8156737|NCT02569710|20105577|P5|NOT COMPLETED|Overall Study||1
8156738|NCT02569710|20105578|P4|NOT COMPLETED|Overall Study||0
8156739|NCT02569710|20105579|P3|NOT COMPLETED|Overall Study||0
8156740|NCT02569710|20105580|P2|NOT COMPLETED|Overall Study||0
8156741|NCT02569710|20105581|P1|NOT COMPLETED|Overall Study||1
8156742|NCT02569710|20105572|P10|COMPLETED|Overall Study||4
8156743|NCT02569710|20105573|P9|COMPLETED|Overall Study||14
8156744|NCT02569710|20105574|P8|COMPLETED|Overall Study||30
8156745|NCT02569710|20105575|P7|COMPLETED|Overall Study||12
8156746|NCT02569710|20105576|P6|COMPLETED|Overall Study||4
8156747|NCT02569710|20105577|P5|COMPLETED|Overall Study||7
8156748|NCT02569710|20105578|P4|COMPLETED|Overall Study||20
8156749|NCT02569710|20105579|P3|COMPLETED|Overall Study||20
8156750|NCT02569710|20105580|P2|COMPLETED|Overall Study||25
8156751|NCT02569710|20105581|P1|COMPLETED|Overall Study||19
8156752|NCT02569710|20105572|P10|STARTED|Overall Study||4
8156753|NCT02569710|20105573|P9|STARTED|Overall Study||15
8156754|NCT02569710|20105574|P8|STARTED|Overall Study||30
8156755|NCT02569710|20105575|P7|STARTED|Overall Study||14
8156756|NCT02569710|20105576|P6|STARTED|Overall Study||5
8156757|NCT02569710|20105577|P5|STARTED|Overall Study||8
8156758|NCT02569710|20105578|P4|STARTED|Overall Study||20
8156759|NCT02569710|20105579|P3|STARTED|Overall Study||20
8156760|NCT02569710|20105580|P2|STARTED|Overall Study||25
8156761|NCT02569710|20105581|P1|STARTED|Overall Study||20
8156762|NCT02569658|20105891|P2|NOT COMPLETED|Overall Study||1
8156763|NCT02569658|20105892|P1|NOT COMPLETED|Overall Study||1
8156764|NCT02569658|20105891|P2|COMPLETED|Overall Study||56
8156765|NCT02569658|20105892|P1|COMPLETED|Overall Study||52
8156766|NCT02569658|20105891|P2|STARTED|Overall Study||57
8156767|NCT02569658|20105892|P1|STARTED|Overall Study||53
8156768|NCT02569541|20105908|P1|NOT COMPLETED|Overall Study||21
8156769|NCT02569541|20105908|P1|COMPLETED|Overall Study||9
8156770|NCT02569541|20105908|P1|STARTED|Overall Study||30
8156771|NCT02569437|20105921|P2|NOT COMPLETED|Overall Study||14
8156772|NCT02569437|20105922|P1|NOT COMPLETED|Overall Study||12
8156773|NCT02569437|20105921|P2|COMPLETED|Overall Study||11
8156774|NCT02569437|20105922|P1|COMPLETED|Overall Study||12
8156775|NCT02569437|20105921|P2|STARTED|Overall Study||25
8156776|NCT02569437|20105922|P1|STARTED|Overall Study||24
8156777|NCT02569411|20105938|P2|NOT COMPLETED|Overall Study||64
8156778|NCT02569411|20105939|P1|NOT COMPLETED|Overall Study||65
8156779|NCT02569411|20105938|P2|COMPLETED|Overall Study||0
8156780|NCT02569411|20105939|P1|COMPLETED|Overall Study||0
8156781|NCT02569411|20105938|P2|STARTED|Overall Study||64
8156782|NCT02569411|20105939|P1|STARTED|Overall Study||65
8156783|NCT02569398|20105952|P3|NOT COMPLETED|Overall Study||183
8156784|NCT02569398|20105953|P2|NOT COMPLETED|Overall Study||189
8156785|NCT02569398|20105954|P1|NOT COMPLETED|Overall Study||185
8156786|NCT02569398|20105952|P3|COMPLETED|Overall Study||0
8156787|NCT02569398|20105953|P2|COMPLETED|Overall Study||0
8156788|NCT02569398|20105954|P1|COMPLETED|Overall Study||0
8156789|NCT02569398|20105952|P3|STARTED|Overall Study||183
8156790|NCT02569398|20105953|P2|STARTED|Overall Study||189
8156791|NCT02569398|20105954|P1|STARTED|Overall Study||185
8156792|NCT02569112|20105977|P2|NOT COMPLETED|Overall Study||0
8156793|NCT02569112|20105978|P1|NOT COMPLETED|Overall Study||0
8156794|NCT02569112|20105977|P2|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
8156795|NCT02569112|20105978|P1|COMPLETED|Overall Study||10
8156796|NCT02569112|20105977|P2|STARTED|Overall Study||10
8156797|NCT02569112|20105978|P1|STARTED|Overall Study||10
8156798|NCT02569086|20105983|P1|NOT COMPLETED|Overall Study||0
8156799|NCT02569086|20105983|P1|COMPLETED|Overall Study||22
8156800|NCT02569086|20105983|P1|STARTED|Overall Study||22
8156801|NCT02568852|20105990|P2|NOT COMPLETED|Overall Study||0
8156802|NCT02568852|20105991|P1|NOT COMPLETED|Overall Study||0
8156803|NCT02568852|20105990|P2|COMPLETED|Overall Study||25
8156804|NCT02568852|20105991|P1|COMPLETED|Overall Study||25
8156805|NCT02568852|20105990|P2|STARTED|Overall Study||25
8156806|NCT02568852|20105991|P1|STARTED|Overall Study||25
8156807|NCT02568683|20106029|P2|NOT COMPLETED|Overall Study||4
8156808|NCT02568683|20106030|P1|NOT COMPLETED|Overall Study||6
8156809|NCT02568683|20106029|P2|COMPLETED|Overall Study||0
8156810|NCT02568683|20106030|P1|COMPLETED|Overall Study||0
8156811|NCT02568683|20106029|P2|STARTED|Overall Study||4
8156812|NCT02568683|20106030|P1|STARTED|Overall Study||6
8156813|NCT02568644|20106044|P2|NOT COMPLETED|Overall Study||0
8156814|NCT02568644|20106045|P1|NOT COMPLETED|Overall Study||0
8156815|NCT02568644|20106044|P2|COMPLETED|Overall Study||30
8156816|NCT02568644|20106045|P1|COMPLETED|Overall Study||30
8156817|NCT02568644|20106044|P2|STARTED|Overall Study||30
8156818|NCT02568644|20106045|P1|STARTED|Overall Study||30
8156819|NCT02568475|20106059|P2|NOT COMPLETED|Overall Study||43
8156820|NCT02568475|20106060|P1|NOT COMPLETED|Overall Study||51
8156821|NCT02568475|20106059|P2|COMPLETED|Overall Study||52
8156822|NCT02568475|20106060|P1|COMPLETED|Overall Study||46
8156823|NCT02568475|20106059|P2|Post-test|Overall Study||82
8156824|NCT02568475|20106060|P1|Post-test|Overall Study||85
8156825|NCT02568475|20106059|P2|STARTED|Overall Study||95
8156826|NCT02568475|20106060|P1|STARTED|Overall Study||97
8156827|NCT02568397|20106074|P2|NOT COMPLETED|Period 2||2
8156828|NCT02568397|20106075|P1|NOT COMPLETED|Period 2||0
8156829|NCT02568397|20106074|P2|COMPLETED|Period 2||58
8156830|NCT02568397|20106075|P1|COMPLETED|Period 2||0
8156831|NCT02568397|20106074|P2|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60
8156832|NCT02568397|20106075|P1|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0
8156833|NCT02568397|20106074|P2|NOT COMPLETED|Period 1||0
8156834|NCT02568397|20106075|P1|NOT COMPLETED|Period 1||0
8156835|NCT02568397|20106074|P2|COMPLETED|Period 1||0
8156836|NCT02568397|20106075|P1|COMPLETED|Period 1||60
8156837|NCT02568397|20106074|P2|Received at Least 1 Dose of Study Drug|Period 1||0
8156838|NCT02568397|20106075|P1|Received at Least 1 Dose of Study Drug|Period 1||60
8156839|NCT02568397|20106074|P2|STARTED|Period 1||0
8156840|NCT02568397|20106075|P1|STARTED|Period 1||60
8156841|NCT02568384|20106099|P1|NOT COMPLETED|Overall Study||2
8156842|NCT02568384|20106099|P1|COMPLETED|Overall Study||43
8156843|NCT02568384|20106099|P1|STARTED|Overall Study||45
8156844|NCT02568345|20106109|P1|NOT COMPLETED|Overall Study||0
8156845|NCT02568345|20106109|P1|COMPLETED|Overall Study||31
8156846|NCT02568345|20106109|P1|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
8156847|NCT02568345|20106109|P1|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
8156848|NCT02568345|20106109|P1|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
8156849|NCT02568345|20106109|P1|STARTED|Overall Study||31
8156850|NCT02568254|20106113|P6|NOT COMPLETED|Period 3||0
8156851|NCT02568254|20106114|P5|NOT COMPLETED|Period 3||1
8156852|NCT02568254|20106115|P4|NOT COMPLETED|Period 3||0
8156853|NCT02568254|20106116|P3|NOT COMPLETED|Period 3||0
8156854|NCT02568254|20106117|P2|NOT COMPLETED|Period 3||0
8156855|NCT02568254|20106118|P1|NOT COMPLETED|Period 3||0
8156856|NCT02568254|20106113|P6|COMPLETED|Period 3||12
8156857|NCT02568254|20106114|P5|COMPLETED|Period 3||11
8156858|NCT02568254|20106115|P4|COMPLETED|Period 3||12
8156859|NCT02568254|20106116|P3|COMPLETED|Period 3||12
8156860|NCT02568254|20106117|P2|COMPLETED|Period 3||12
8156861|NCT02568254|20106118|P1|COMPLETED|Period 3||13
8156862|NCT02568254|20106113|P6|STARTED|Period 3||12
8156863|NCT02568254|20106114|P5|STARTED|Period 3||12
8156864|NCT02568254|20106115|P4|STARTED|Period 3||12
8156865|NCT02568254|20106116|P3|STARTED|Period 3||12
8156866|NCT02568254|20106117|P2|STARTED|Period 3||12
8156867|NCT02568254|20106118|P1|STARTED|Period 3||13
8156868|NCT02568254|20106113|P6|NOT COMPLETED|Period 2||0
8156869|NCT02568254|20106114|P5|NOT COMPLETED|Period 2||0
8156870|NCT02568254|20106115|P4|NOT COMPLETED|Period 2||0
8156871|NCT02568254|20106116|P3|NOT COMPLETED|Period 2||1
8156872|NCT02568254|20106117|P2|NOT COMPLETED|Period 2||0
8156873|NCT02568254|20106118|P1|NOT COMPLETED|Period 2||0
8156874|NCT02568254|20106113|P6|COMPLETED|Period 2||12
8156875|NCT02568254|20106114|P5|COMPLETED|Period 2||12
8156876|NCT02568254|20106115|P4|COMPLETED|Period 2||12
8156877|NCT02568254|20106116|P3|COMPLETED|Period 2||12
8156878|NCT02568254|20106117|P2|COMPLETED|Period 2||12
8156879|NCT02568254|20106118|P1|COMPLETED|Period 2||13
8156880|NCT02568254|20106113|P6|STARTED|Period 2||12
8156881|NCT02568254|20106114|P5|STARTED|Period 2||12
8156882|NCT02568254|20106115|P4|STARTED|Period 2||12
8156883|NCT02568254|20106116|P3|STARTED|Period 2||13
8156884|NCT02568254|20106117|P2|STARTED|Period 2||12
8156885|NCT02568254|20106118|P1|STARTED|Period 2||13
8156886|NCT02568254|20106113|P6|NOT COMPLETED|Period 1||0
8156887|NCT02568254|20106114|P5|NOT COMPLETED|Period 1||0
8156888|NCT02568254|20106115|P4|NOT COMPLETED|Period 1||0
8156889|NCT02568254|20106116|P3|NOT COMPLETED|Period 1||0
8156890|NCT02568254|20106117|P2|NOT COMPLETED|Period 1||0
8156891|NCT02568254|20106118|P1|NOT COMPLETED|Period 1||0
8156892|NCT02568254|20106113|P6|COMPLETED|Period 1||12
8156893|NCT02568254|20106114|P5|COMPLETED|Period 1||12
8156894|NCT02568254|20106115|P4|COMPLETED|Period 1||12
8156895|NCT02568254|20106116|P3|COMPLETED|Period 1||13
8156896|NCT02568254|20106117|P2|COMPLETED|Period 1||12
8156897|NCT02568254|20106118|P1|COMPLETED|Period 1||13
8156898|NCT02568254|20106113|P6|STARTED|Period 1||12
8156899|NCT02568254|20106114|P5|STARTED|Period 1||12
8156900|NCT02568254|20106115|P4|STARTED|Period 1||12
8156901|NCT02568254|20106116|P3|STARTED|Period 1||13
8156902|NCT02568254|20106117|P2|STARTED|Period 1||12
8156903|NCT02568254|20106118|P1|STARTED|Period 1||13
8156904|NCT02568046|20106128|P2|NOT COMPLETED|Overall Study||3
8156905|NCT02568046|20106129|P1|NOT COMPLETED|Overall Study||5
8156906|NCT02568046|20106128|P2|COMPLETED|Overall Study||2
8156907|NCT02568046|20106129|P1|COMPLETED|Overall Study||0
8156908|NCT02568046|20106128|P2|STARTED|Overall Study||5
8156909|NCT02568046|20106129|P1|STARTED|Overall Study||5
8156910|NCT02568007|20106138|P3|NOT COMPLETED|Overall Study||0
8156911|NCT02568007|20106139|P2|NOT COMPLETED|Overall Study||0
8156912|NCT02568007|20106140|P1|NOT COMPLETED|Overall Study||0
8156913|NCT02568007|20106138|P3|COMPLETED|Overall Study||0
8156914|NCT02568007|20106139|P2|COMPLETED|Overall Study||2
8156915|NCT02568007|20106140|P1|COMPLETED|Overall Study||2
8156916|NCT02568007|20106138|P3|STARTED|Overall Study||0
8156917|NCT02568007|20106139|P2|STARTED|Overall Study||2
8156918|NCT02568007|20106140|P1|STARTED|Overall Study||2
8156919|NCT02567968|20106169|P2|NOT COMPLETED|Second Intervention||0
8156920|NCT02567968|20106170|P1|NOT COMPLETED|Second Intervention||0
8156921|NCT02567968|20106169|P2|COMPLETED|Second Intervention||4
8156922|NCT02567968|20106170|P1|COMPLETED|Second Intervention||4
8156923|NCT02567968|20106169|P2|STARTED|Second Intervention||4
8156924|NCT02567968|20106170|P1|STARTED|Second Intervention||4
8156925|NCT02567968|20106169|P2|NOT COMPLETED|Washout (2 Weeks)||0
8156926|NCT02567968|20106170|P1|NOT COMPLETED|Washout (2 Weeks)||0
8156927|NCT02567968|20106169|P2|COMPLETED|Washout (2 Weeks)||4
8156928|NCT02567968|20106170|P1|COMPLETED|Washout (2 Weeks)||4
8156929|NCT02567968|20106169|P2|STARTED|Washout (2 Weeks)||4
8156930|NCT02567968|20106170|P1|STARTED|Washout (2 Weeks)||4
8156931|NCT02567968|20106169|P2|NOT COMPLETED|First Intervention||0
8156932|NCT02567968|20106170|P1|NOT COMPLETED|First Intervention||0
8156933|NCT02567968|20106169|P2|COMPLETED|First Intervention||4
8156934|NCT02567968|20106170|P1|COMPLETED|First Intervention||4
8156935|NCT02567968|20106169|P2|STARTED|First Intervention||4
8156936|NCT02567968|20106170|P1|STARTED|First Intervention||4
8156937|NCT02567708|20106192|P2|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
8156938|NCT02567708|20106193|P1|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
8156939|NCT02567708|20106192|P2|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
8156940|NCT02567708|20106193|P1|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
8156941|NCT02567708|20106192|P2|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
8156942|NCT02567708|20106193|P1|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
8156943|NCT02567708|20106192|P2|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
8156944|NCT02567708|20106193|P1|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
8156945|NCT02567708|20106192|P2|COMPLETED|Washout Period (Up to 4 Weeks)||23
8156946|NCT02567708|20106193|P1|COMPLETED|Washout Period (Up to 4 Weeks)||22
8156947|NCT02567708|20106192|P2|STARTED|Washout Period (Up to 4 Weeks)||23
8156948|NCT02567708|20106193|P1|STARTED|Washout Period (Up to 4 Weeks)||22
8156949|NCT02567708|20106192|P2|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
8156950|NCT02567708|20106193|P1|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
8156951|NCT02567708|20106192|P2|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
8156952|NCT02567708|20106193|P1|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
8156953|NCT02567708|20106192|P2|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
8156954|NCT02567708|20106193|P1|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
8156955|NCT02567656|20106238|P6|NOT COMPLETED|Overall Study||0
8156956|NCT02567656|20106239|P5|NOT COMPLETED|Overall Study||0
8156957|NCT02567656|20106240|P4|NOT COMPLETED|Overall Study||0
8156958|NCT02567656|20106241|P3|NOT COMPLETED|Overall Study||2
8156959|NCT02567656|20106242|P2|NOT COMPLETED|Overall Study||1
8156960|NCT02567656|20106243|P1|NOT COMPLETED|Overall Study||1
8156961|NCT02567656|20106238|P6|COMPLETED|Overall Study||20
8156962|NCT02567656|20106239|P5|COMPLETED|Overall Study||19
8156963|NCT02567656|20106240|P4|COMPLETED|Overall Study||6
8156964|NCT02567656|20106241|P3|COMPLETED|Overall Study||3
8156965|NCT02567656|20106242|P2|COMPLETED|Overall Study||3
8156966|NCT02567656|20106243|P1|COMPLETED|Overall Study||3
8156967|NCT02567656|20106238|P6|STARTED|Overall Study||20
8156968|NCT02567656|20106239|P5|STARTED|Overall Study||19
8156969|NCT02567656|20106240|P4|STARTED|Overall Study||6
8156970|NCT02567656|20106241|P3|STARTED|Overall Study||5
8156971|NCT02567656|20106242|P2|STARTED|Overall Study||4
8156972|NCT02567656|20106243|P1|STARTED|Overall Study||4
8156973|NCT02567552|20106275|P2|NOT COMPLETED|Overall Study||1
8156974|NCT02567552|20106276|P1|NOT COMPLETED|Overall Study||0
8156975|NCT02567552|20106275|P2|COMPLETED|Overall Study|dropout by pain in the puncture site|11
8156976|NCT02567552|20106276|P1|COMPLETED|Overall Study||12
8156977|NCT02567552|20106275|P2|STARTED|Overall Study||12
8156978|NCT02567552|20106276|P1|STARTED|Overall Study||12
8156979|NCT02567188|20106306|P1|NOT COMPLETED|Overall Study||35
8156980|NCT02567188|20106306|P1|COMPLETED|Overall Study||109
8156981|NCT02567188|20106306|P1|STARTED|Overall Study||144
8156982|NCT02566889|20106337|P2|NOT COMPLETED|Overall Study||5
8156983|NCT02566889|20106338|P1|NOT COMPLETED|Overall Study||13
8156984|NCT02566889|20106337|P2|COMPLETED|Overall Study||3
8156985|NCT02566889|20106338|P1|COMPLETED|Overall Study||32
8156986|NCT02566889|20106337|P2|Cross-over to Dose Escalation Group|Overall Study||0
8156987|NCT02566889|20106338|P1|Cross-over to Dose Escalation Group|Overall Study||1
8156988|NCT02566889|20106337|P2|STARTED|Overall Study||8
8156989|NCT02566889|20106338|P1|STARTED|Overall Study||45
8156990|NCT02566785|20106356|P2|NOT COMPLETED|Overall Study||3
8156991|NCT02566785|20106357|P1|NOT COMPLETED|Overall Study||1
8156992|NCT02566785|20106356|P2|COMPLETED|Overall Study||15
8156993|NCT02566785|20106357|P1|COMPLETED|Overall Study||14
8156994|NCT02566785|20106356|P2|STARTED|Overall Study||18
8156995|NCT02566785|20106357|P1|STARTED|Overall Study||15
8157318|NCT02566031|20106708|P1|STARTED|Overall Study||189
8157251|NCT02566590|20106553|P2|NOT COMPLETED|Overall Study||0
8157252|NCT02566590|20106554|P1|NOT COMPLETED|Overall Study||0
8157253|NCT02566590|20106553|P2|COMPLETED|Overall Study||10
8157254|NCT02566590|20106554|P1|COMPLETED|Overall Study||10
8157255|NCT02566590|20106553|P2|STARTED|Overall Study||10
8157256|NCT02566590|20106554|P1|STARTED|Overall Study||10
8157257|NCT02566577|20106562|P2|NOT COMPLETED|Overall Study||2
8157258|NCT02566577|20106563|P1|NOT COMPLETED|Overall Study||3
8157259|NCT02566577|20106562|P2|COMPLETED|Overall Study||4
8157260|NCT02566577|20106563|P1|COMPLETED|Overall Study||6
8157261|NCT02566577|20106562|P2|STARTED|Overall Study||6
8157262|NCT02566577|20106563|P1|STARTED|Overall Study||9
8157263|NCT02566369|20106591|P2|NOT COMPLETED|Overall Study||61
8157264|NCT02566369|20106592|P1|NOT COMPLETED|Overall Study||72
8157265|NCT02566369|20106591|P2|COMPLETED|Overall Study||535
8157266|NCT02566369|20106592|P1|COMPLETED|Overall Study||540
8157267|NCT02566369|20106591|P2|STARTED|Overall Study||596
8157268|NCT02566369|20106592|P1|STARTED|Overall Study||612
8157269|NCT02566317|20106600|P2|NOT COMPLETED|Overall Study||62
8157270|NCT02566317|20106601|P1|NOT COMPLETED|Overall Study||29
8157271|NCT02566317|20106600|P2|COMPLETED|Overall Study||292
8157272|NCT02566317|20106601|P1|COMPLETED|Overall Study||247
8157273|NCT02566317|20106600|P2|STARTED|Overall Study||354
8157274|NCT02566317|20106601|P1|STARTED|Overall Study||276
8157275|NCT02566265|20106613|P2|NOT COMPLETED|Overall Study||6
8157276|NCT02566265|20106614|P1|NOT COMPLETED|Overall Study||9
8157277|NCT02566265|20106613|P2|COMPLETED|Overall Study||35
8157278|NCT02566265|20106614|P1|COMPLETED|Overall Study||72
8157279|NCT02566265|20106613|P2|End of Study Visit (Optional)|Overall Study||18
8157280|NCT02566265|20106614|P1|End of Study Visit (Optional)|Overall Study||38
8157281|NCT02566265|20106613|P2|30 Days Following 2nd Vaccine|Overall Study||35
8157282|NCT02566265|20106614|P1|30 Days Following 2nd Vaccine|Overall Study||72
8157283|NCT02566265|20106613|P2|Day of Second Vaccine|Overall Study||41
8157284|NCT02566265|20106614|P1|Day of Second Vaccine|Overall Study||74
8157285|NCT02566265|20106613|P2|Day 7 (+/- 2 Days) (Optional)|Overall Study||12
8157286|NCT02566265|20106614|P1|Day 7 (+/- 2 Days) (Optional)|Overall Study||19
8157287|NCT02566265|20106613|P2|STARTED|Overall Study||41
8157288|NCT02566265|20106614|P1|STARTED|Overall Study||81
8157289|NCT02566135|20106622|P2|NOT COMPLETED|Overall Study||0
8157290|NCT02566135|20106623|P1|NOT COMPLETED|Overall Study||0
8157291|NCT02566135|20106622|P2|COMPLETED|Overall Study||29
8157292|NCT02566135|20106623|P1|COMPLETED|Overall Study||29
8157293|NCT02566135|20106622|P2|STARTED|Overall Study||29
8157294|NCT02566135|20106623|P1|STARTED|Overall Study||29
8157295|NCT02566109|20106643|P1|NOT COMPLETED|Overall Study||1
8157296|NCT02566109|20106643|P1|COMPLETED|Overall Study||5
8157297|NCT02566109|20106643|P1|STARTED|Overall Study||6
8157298|NCT02566083|20106655|P2|NOT COMPLETED|Overall Study||10
8157299|NCT02566083|20106656|P1|NOT COMPLETED|Overall Study||16
8157300|NCT02566083|20106655|P2|COMPLETED|Overall Study||141
8157301|NCT02566083|20106656|P1|COMPLETED|Overall Study||198
8157302|NCT02566083|20106655|P2|STARTED|Overall Study||151
8157303|NCT02566083|20106656|P1|STARTED|Overall Study||214
8157304|NCT02566044|20106665|P3|NOT COMPLETED|Overall Study||0
8157305|NCT02566044|20106666|P2|NOT COMPLETED|Overall Study||0
8157306|NCT02566044|20106667|P1|NOT COMPLETED|Overall Study||0
8157307|NCT02566044|20106665|P3|COMPLETED|Overall Study||4
8157308|NCT02566044|20106666|P2|COMPLETED|Overall Study||6
8157309|NCT02566044|20106667|P1|COMPLETED|Overall Study||6
8157310|NCT02566044|20106665|P3|STARTED|Overall Study||4
8157311|NCT02566044|20106666|P2|STARTED|Overall Study||6
8157312|NCT02566044|20106667|P1|STARTED|Overall Study||6
8157313|NCT02566031|20106707|P2|NOT COMPLETED|Overall Study||12
8157314|NCT02566031|20106708|P1|NOT COMPLETED|Overall Study||20
8157315|NCT02566031|20106707|P2|COMPLETED|Overall Study||178
8157316|NCT02566031|20106708|P1|COMPLETED|Overall Study||169
8157317|NCT02566031|20106707|P2|STARTED|Overall Study||190
8157319|NCT02566005|20106725|P2|NOT COMPLETED|Overall Study||6
8157320|NCT02566005|20106726|P1|NOT COMPLETED|Overall Study||8
8157321|NCT02566005|20106725|P2|COMPLETED|Overall Study||94
8157322|NCT02566005|20106726|P1|COMPLETED|Overall Study||92
8157323|NCT02566005|20106725|P2|STARTED|Overall Study||100
8157324|NCT02566005|20106726|P1|STARTED|Overall Study||100
8157329|NCT02565810|20106788|P1|NOT COMPLETED|Overall Study||1
8157330|NCT02565810|20106788|P1|COMPLETED|Overall Study||48
8157331|NCT02565810|20106788|P1|STARTED|Overall Study||49
8157332|NCT02565784|20106797|P1|NOT COMPLETED|Second Treatment||2
8157333|NCT02565784|20106797|P1|COMPLETED|Second Treatment||96
8157334|NCT02565784|20106797|P1|12 Months Follow-up|Second Treatment||96
8157335|NCT02565784|20106797|P1|6 Months Follow-up|Second Treatment||97
8157336|NCT02565784|20106797|P1|STARTED|Second Treatment||98
8157337|NCT02565784|20106797|P1|NOT COMPLETED|First Treatment||2
8157338|NCT02565784|20106797|P1|COMPLETED|First Treatment||98
8157339|NCT02565784|20106797|P1|12 Months Follow-up|First Treatment||98
8157340|NCT02565784|20106797|P1|6 Months Follow-up|First Treatment||99
8157341|NCT02565784|20106797|P1|STARTED|First Treatment||100
8157342|NCT02565706|20106809|P4|NOT COMPLETED|Overall Study||85
8157343|NCT02565706|20106810|P3|NOT COMPLETED|Overall Study||89
8157344|NCT02565706|20106811|P2|NOT COMPLETED|Overall Study||82
8157345|NCT02565706|20106812|P1|NOT COMPLETED|Overall Study||77
8157346|NCT02565706|20106809|P4|COMPLETED|Overall Study||116
8157347|NCT02565706|20106810|P3|COMPLETED|Overall Study||104
8157348|NCT02565706|20106811|P2|COMPLETED|Overall Study||90
8157349|NCT02565706|20106812|P1|COMPLETED|Overall Study||101
8157350|NCT02565706|20106809|P4|STARTED|Overall Study||201
8157351|NCT02565706|20106810|P3|STARTED|Overall Study||193
8157352|NCT02565706|20106811|P2|STARTED|Overall Study||172
8157353|NCT02565706|20106812|P1|STARTED|Overall Study||178
8157354|NCT02565628|20106884|P2|NOT COMPLETED|Overall Study||0
8157355|NCT02565628|20106885|P1|NOT COMPLETED|Overall Study||0
8157356|NCT02565628|20106884|P2|COMPLETED|Overall Study||9
8157357|NCT02565628|20106885|P1|COMPLETED|Overall Study||10
8157358|NCT02565628|20106884|P2|Received Treatment|Overall Study||9
8157359|NCT02565628|20106885|P1|Received Treatment|Overall Study||10
8157360|NCT02565628|20106884|P2|STARTED|Overall Study||9
8157361|NCT02565628|20106885|P1|STARTED|Overall Study||10
8157382|NCT02565576|20107036|P2|NOT COMPLETED|Overall Study||5
8157383|NCT02565576|20107037|P1|NOT COMPLETED|Overall Study||5
8157384|NCT02565576|20107036|P2|COMPLETED|Overall Study||17
8157385|NCT02565576|20107037|P1|COMPLETED|Overall Study||17
8157386|NCT02565576|20107036|P2|STARTED|Overall Study||22
8157387|NCT02565576|20107037|P1|STARTED|Overall Study||22
8157388|NCT02565485|20107064|P2|NOT COMPLETED|Overall Study||0
8157389|NCT02565485|20107065|P1|NOT COMPLETED|Overall Study||0
8157390|NCT02565485|20107064|P2|COMPLETED|Overall Study||137
8157391|NCT02565485|20107065|P1|COMPLETED|Overall Study||139
8157392|NCT02565485|20107064|P2|STARTED|Overall Study||137
8157393|NCT02565485|20107065|P1|STARTED|Overall Study||139
8157394|NCT02565381|20107080|P3|NOT COMPLETED|Overall Study||1
8157395|NCT02565381|20107081|P2|NOT COMPLETED|Overall Study||0
8157396|NCT02565381|20107082|P1|NOT COMPLETED|Overall Study||1
8157397|NCT02565381|20107080|P3|COMPLETED|Overall Study||24
8157398|NCT02565381|20107081|P2|COMPLETED|Overall Study||25
8157399|NCT02565381|20107082|P1|COMPLETED|Overall Study||24
8157400|NCT02565381|20107080|P3|STARTED|Overall Study||25
8157401|NCT02565381|20107081|P2|STARTED|Overall Study||25
8157402|NCT02565381|20107082|P1|STARTED|Overall Study||25
8157403|NCT02565186|20107122|P2|NOT COMPLETED|Overall Study||621
8157404|NCT02565186|20107123|P1|NOT COMPLETED|Overall Study||580
8157405|NCT02565186|20107122|P2|COMPLETED|Overall Study||504
8157406|NCT02565186|20107123|P1|COMPLETED|Overall Study||466
8157407|NCT02565186|20107122|P2|Received at Least One Dose of Study Drug|Overall Study||1039
8157408|NCT02565186|20107123|P1|Received at Least One Dose of Study Drug|Overall Study||991
8157409|NCT02565186|20107122|P2|STARTED|Overall Study||1125
8157410|NCT02565186|20107123|P1|STARTED|Overall Study||1046
8157411|NCT02565147|20107137|P2|NOT COMPLETED|Overall Study||3
8157412|NCT02565147|20107138|P1|NOT COMPLETED|Overall Study||6
8157413|NCT02565147|20107137|P2|COMPLETED|Overall Study||37
8157414|NCT02565147|20107138|P1|COMPLETED|Overall Study||32
8157415|NCT02565147|20107137|P2|Per-Protocol Population|Overall Study||36
8157416|NCT02565147|20107138|P1|Per-Protocol Population|Overall Study||28
8157417|NCT02565147|20107137|P2|Received Study Drug|Overall Study||40
8157418|NCT02565147|20107138|P1|Received Study Drug|Overall Study||38
8157419|NCT02565147|20107137|P2|STARTED|Overall Study||40
8157420|NCT02565147|20107138|P1|STARTED|Overall Study||38
8157421|NCT02565108|20107162|P2|NOT COMPLETED|Overall Study||0
8157422|NCT02565108|20107163|P1|NOT COMPLETED|Overall Study||2
8157423|NCT02565108|20107162|P2|COMPLETED|Overall Study||4
8157424|NCT02565108|20107163|P1|COMPLETED|Overall Study||14
8157425|NCT02565108|20107162|P2|Pharmacokinetic (PK) Set|Overall Study||3
8157426|NCT02565108|20107163|P1|Pharmacokinetic (PK) Set|Overall Study||10
8157427|NCT02565108|20107162|P2|Safety Set|Overall Study||4
8157428|NCT02565108|20107163|P1|Safety Set|Overall Study||16
8157429|NCT02565108|20107162|P2|STARTED|Overall Study||4
8157430|NCT02565108|20107163|P1|STARTED|Overall Study||16
8157431|NCT02564952|20107179|P1|NOT COMPLETED|Overall Study||11
8157432|NCT02564952|20107179|P1|COMPLETED|Overall Study||7
8157433|NCT02564952|20107179|P1|Completed OLE Titration Period|Overall Study||16
8157434|NCT02564952|20107179|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
8157435|NCT02564952|20107179|P1|STARTED|Overall Study||18
8157436|NCT02564926|20107185|P2|NOT COMPLETED|Overall Study||7
8157437|NCT02564926|20107186|P1|NOT COMPLETED|Overall Study||8
8157438|NCT02564926|20107185|P2|COMPLETED|Overall Study||54
8157439|NCT02564926|20107186|P1|COMPLETED|Overall Study||52
8157440|NCT02564926|20107185|P2|STARTED|Overall Study||61
8157441|NCT02564926|20107186|P1|STARTED|Overall Study||60
8157442|NCT02564887|20107224|P2|NOT COMPLETED|Overall Study||0
8157443|NCT02564887|20107225|P1|NOT COMPLETED|Overall Study||6
8157444|NCT02564887|20107224|P2|COMPLETED|Overall Study||10
8157445|NCT02564887|20107225|P1|COMPLETED|Overall Study||10
8157446|NCT02564887|20107224|P2|STARTED|Overall Study||10
8157447|NCT02564887|20107225|P1|STARTED|Overall Study||16
8157448|NCT02564718|20107243|P2|NOT COMPLETED|Overall Study||1
8157449|NCT02564718|20107244|P1|NOT COMPLETED|Overall Study||0
8157450|NCT02564718|20107243|P2|COMPLETED|Overall Study||4
8157451|NCT02564718|20107244|P1|COMPLETED|Overall Study||5
8157452|NCT02564718|20107243|P2|STARTED|Overall Study||5
8157453|NCT02564718|20107244|P1|STARTED|Overall Study||5
8157454|NCT02564497|20107274|P2|NOT COMPLETED|Overall Study||0
8157455|NCT02564497|20107275|P1|NOT COMPLETED|Overall Study||0
8157456|NCT02564497|20107274|P2|COMPLETED|Overall Study||72
8157457|NCT02564497|20107275|P1|COMPLETED|Overall Study||74
8157458|NCT02564497|20107274|P2|STARTED|Overall Study||72
8157459|NCT02564497|20107275|P1|STARTED|Overall Study||74
8157460|NCT02564432|20107293|P1|NOT COMPLETED|Overall Study||2
8157461|NCT02564432|20107293|P1|COMPLETED|Overall Study|1 patient suffered periprosthetic fracture at 8 months; 1 failed to osseointegrate|8
8157462|NCT02564432|20107293|P1|STARTED|Overall Study||10
8157463|NCT02564354|20107301|P2|NOT COMPLETED|Overall Study||0
8157464|NCT02564354|20107302|P1|NOT COMPLETED|Overall Study||0
8157465|NCT02564354|20107301|P2|COMPLETED|Overall Study||8
8157466|NCT02564354|20107302|P1|COMPLETED|Overall Study||10
8157467|NCT02564354|20107301|P2|STARTED|Overall Study||8
8157468|NCT02564354|20107302|P1|STARTED|Overall Study||10
8157469|NCT02564263|20107332|P2|NOT COMPLETED|Overall Study||314
8157470|NCT02564263|20107333|P1|NOT COMPLETED|Overall Study||314
8157471|NCT02564263|20107332|P2|COMPLETED|Overall Study||0
8157472|NCT02564263|20107333|P1|COMPLETED|Overall Study||0
8157473|NCT02564263|20107332|P2|Treated|Overall Study||296
8157474|NCT02564263|20107333|P1|Treated|Overall Study||314
8157475|NCT02564263|20107332|P2|STARTED|Overall Study||314
8157476|NCT02564263|20107333|P1|STARTED|Overall Study||314
8157477|NCT02564211|20107355|P1|NOT COMPLETED|Overall Study||4
8157478|NCT02564211|20107355|P1|COMPLETED|Overall Study||73
8157479|NCT02564211|20107355|P1|STARTED|Overall Study||77
8157480|NCT02564120|20107366|P1|NOT COMPLETED|Overall Study||446
8157481|NCT02564120|20107366|P1|COMPLETED|Overall Study||1110
8157482|NCT02564120|20107366|P1|STARTED|Overall Study||1556
8157483|NCT02564055|20107414|P6|NOT COMPLETED|Overall Study||12
8157484|NCT02564055|20107415|P5|NOT COMPLETED|Overall Study||15
8157485|NCT02564055|20107416|P4|NOT COMPLETED|Overall Study||6
8157486|NCT02564055|20107417|P3|NOT COMPLETED|Overall Study||12
8157487|NCT02564055|20107418|P2|NOT COMPLETED|Overall Study||5
8157488|NCT02564055|20107419|P1|NOT COMPLETED|Overall Study||6
8157489|NCT02564055|20107414|P6|COMPLETED|Overall Study||28
8157490|NCT02564055|20107415|P5|COMPLETED|Overall Study||27
8157491|NCT02564055|20107416|P4|COMPLETED|Overall Study||35
8157492|NCT02564055|20107417|P3|COMPLETED|Overall Study||31
8157493|NCT02564055|20107418|P2|COMPLETED|Overall Study||36
8157494|NCT02564055|20107419|P1|COMPLETED|Overall Study||34
8157495|NCT02564055|20107414|P6|STARTED|Overall Study||40
8157496|NCT02564055|20107415|P5|STARTED|Overall Study||42
8157497|NCT02564055|20107416|P4|STARTED|Overall Study||41
8157498|NCT02564055|20107417|P3|STARTED|Overall Study||43
8157499|NCT02564055|20107418|P2|STARTED|Overall Study||41
8157500|NCT02564055|20107419|P1|STARTED|Overall Study||40
8157501|NCT02564042|20107673|P6|NOT COMPLETED|Overall Study||14
8157502|NCT02564042|20107674|P5|NOT COMPLETED|Overall Study||11
8157503|NCT02564042|20107675|P4|NOT COMPLETED|Overall Study||3
8157504|NCT02564042|20107676|P3|NOT COMPLETED|Overall Study||6
8157505|NCT02564042|20107677|P2|NOT COMPLETED|Overall Study||8
8157506|NCT02564042|20107678|P1|NOT COMPLETED|Overall Study||11
8157507|NCT02564042|20107673|P6|COMPLETED|Overall Study||24
8157508|NCT02564042|20107674|P5|COMPLETED|Overall Study||26
8157509|NCT02564042|20107675|P4|COMPLETED|Overall Study||35
8157510|NCT02564042|20107676|P3|COMPLETED|Overall Study||32
8157511|NCT02564042|20107677|P2|COMPLETED|Overall Study||30
8157512|NCT02564042|20107678|P1|COMPLETED|Overall Study||27
8157513|NCT02564042|20107673|P6|STARTED|Overall Study||38
8157514|NCT02564042|20107674|P5|STARTED|Overall Study||37
8157515|NCT02564042|20107675|P4|STARTED|Overall Study||38
8157516|NCT02564042|20107676|P3|STARTED|Overall Study||38
8157517|NCT02564042|20107677|P2|STARTED|Overall Study||38
8157518|NCT02564042|20107678|P1|STARTED|Overall Study||38
8157519|NCT02564029|20107890|P1|NOT COMPLETED|Overall Study||0
8157520|NCT02564029|20107890|P1|COMPLETED|Overall Study||7
8157521|NCT02564029|20107890|P1|STARTED|Overall Study||7
8157522|NCT02564016|20107933|P2|NOT COMPLETED|Overall Study||10
8157523|NCT02564016|20107934|P1|NOT COMPLETED|Overall Study||18
8157524|NCT02564016|20107933|P2|COMPLETED|Overall Study||4
8157525|NCT02564016|20107934|P1|COMPLETED|Overall Study||4
8157526|NCT02564016|20107933|P2|STARTED|Overall Study||14
8157527|NCT02564016|20107934|P1|STARTED|Overall Study||22
8157528|NCT02563990|20107946|P2|NOT COMPLETED|Overall Study||0
8157529|NCT02563990|20107947|P1|NOT COMPLETED|Overall Study||0
8157530|NCT02563990|20107946|P2|COMPLETED|Overall Study||14
8157531|NCT02563990|20107947|P1|COMPLETED|Overall Study||12
8157532|NCT02563990|20107946|P2|STARTED|Overall Study||14
8157533|NCT02563990|20107947|P1|STARTED|Overall Study||12
8157534|NCT02563899|20107973|P4|NOT COMPLETED|Overall Study||0
8157535|NCT02563899|20107974|P3|NOT COMPLETED|Overall Study||1
8157536|NCT02563899|20107975|P2|NOT COMPLETED|Overall Study||0
8157537|NCT02563899|20107976|P1|NOT COMPLETED|Overall Study||1
8157538|NCT02563899|20107973|P4|COMPLETED|Overall Study||6
8157539|NCT02563899|20107974|P3|COMPLETED|Overall Study||9
8157540|NCT02563899|20107975|P2|COMPLETED|Overall Study||5
8157541|NCT02563899|20107976|P1|COMPLETED|Overall Study||17
8157542|NCT02563899|20107973|P4|STARTED|Overall Study||6
8157543|NCT02563899|20107974|P3|STARTED|Overall Study||10
8157544|NCT02563899|20107975|P2|STARTED|Overall Study||5
8157545|NCT02563899|20107976|P1|STARTED|Overall Study||18
8157546|NCT02563860|20108017|P1|NOT COMPLETED|Overall Study||1
8157547|NCT02563860|20108017|P1|COMPLETED|Overall Study||19
8157548|NCT02563860|20108017|P1|STARTED|Overall Study||20
8157549|NCT02563834|20108024|P2|NOT COMPLETED|Insulin Infusion (*Day 2)||0
8157550|NCT02563834|20108025|P1|NOT COMPLETED|Insulin Infusion (*Day 2)||0
8157551|NCT02563834|20108024|P2|COMPLETED|Insulin Infusion (*Day 2)||8
8157552|NCT02563834|20108025|P1|COMPLETED|Insulin Infusion (*Day 2)||10
8157553|NCT02563834|20108024|P2|STARTED|Insulin Infusion (*Day 2)||8
8157554|NCT02563834|20108025|P1|STARTED|Insulin Infusion (*Day 2)||10
8157555|NCT02563834|20108024|P2|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
8157556|NCT02563834|20108025|P1|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
8157557|NCT02563834|20108024|P2|COMPLETED|Control (Saline) Infusion (*Day 1)||8
8157558|NCT02563834|20108025|P1|COMPLETED|Control (Saline) Infusion (*Day 1)||10
8157559|NCT02563834|20108024|P2|STARTED|Control (Saline) Infusion (*Day 1)||8
8157560|NCT02563834|20108025|P1|STARTED|Control (Saline) Infusion (*Day 1)||10
8157561|NCT02563808|20108043|P2|NOT COMPLETED|Overall Study||0
8157562|NCT02563808|20108044|P1|NOT COMPLETED|Overall Study||0
8157563|NCT02563808|20108043|P2|COMPLETED|Overall Study||88
8157564|NCT02563808|20108044|P1|COMPLETED|Overall Study||96
8157565|NCT02563808|20108043|P2|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88
8157566|NCT02563808|20108044|P1|STARTED|Overall Study||96
8157567|NCT02563548|20108052|P6|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17
8157568|NCT02563548|20108053|P5|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25
8157569|NCT02563548|20108054|P4|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157570|NCT02563548|20108055|P3|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157571|NCT02563548|20108056|P2|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157572|NCT02563548|20108057|P1|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157573|NCT02563548|20108052|P6|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157574|NCT02563548|20108053|P5|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157575|NCT02563548|20108054|P4|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157576|NCT02563548|20108055|P3|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157577|NCT02563548|20108056|P2|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157578|NCT02563548|20108057|P1|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
8157579|NCT02563548|20108052|P6|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17
8157580|NCT02563548|20108053|P5|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24
8157581|NCT02563548|20108054|P4|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
8157582|NCT02563548|20108055|P3|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
8157583|NCT02563548|20108056|P2|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
8157584|NCT02563548|20108057|P1|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
8157585|NCT02563548|20108052|P6|STARTED|Dose Expansion (Up to 60 Weeks)||17
8157586|NCT02563548|20108053|P5|STARTED|Dose Expansion (Up to 60 Weeks)||25
8157587|NCT02563548|20108054|P4|STARTED|Dose Expansion (Up to 60 Weeks)||0
8157588|NCT02563548|20108055|P3|STARTED|Dose Expansion (Up to 60 Weeks)||0
8157589|NCT02563548|20108056|P2|STARTED|Dose Expansion (Up to 60 Weeks)||0
8157590|NCT02563548|20108057|P1|STARTED|Dose Expansion (Up to 60 Weeks)||0
8157591|NCT02563548|20108052|P6|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157592|NCT02563548|20108053|P5|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157593|NCT02563548|20108054|P4|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
8157594|NCT02563548|20108055|P3|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7
8157595|NCT02563548|20108056|P2|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
8157596|NCT02563548|20108057|P1|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3
8157597|NCT02563548|20108052|P6|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157598|NCT02563548|20108053|P5|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157599|NCT02563548|20108054|P4|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157600|NCT02563548|20108055|P3|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157601|NCT02563548|20108056|P2|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157602|NCT02563548|20108057|P1|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
8157603|NCT02563548|20108052|P6|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
8157604|NCT02563548|20108053|P5|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
8157605|NCT02563548|20108054|P4|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
8157606|NCT02563548|20108055|P3|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7
8157607|NCT02563548|20108056|P2|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
8157608|NCT02563548|20108057|P1|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3
8157609|NCT02563548|20108052|P6|STARTED|Dose Escalation (Up to 46 Weeks)||0
8157610|NCT02563548|20108053|P5|STARTED|Dose Escalation (Up to 46 Weeks)||0
8157611|NCT02563548|20108054|P4|STARTED|Dose Escalation (Up to 46 Weeks)||2
8157612|NCT02563548|20108055|P3|STARTED|Dose Escalation (Up to 46 Weeks)||7
8157613|NCT02563548|20108056|P2|STARTED|Dose Escalation (Up to 46 Weeks)||2
8157614|NCT02563548|20108057|P1|STARTED|Dose Escalation (Up to 46 Weeks)||3
8157615|NCT02563496|20108124|P5|NOT COMPLETED|Overall Study||0
8157616|NCT02563496|20108125|P4|NOT COMPLETED|Overall Study||0
8157617|NCT02563496|20108126|P3|NOT COMPLETED|Overall Study||0
8157618|NCT02563496|20108127|P2|NOT COMPLETED|Overall Study||0
8157619|NCT02563496|20108128|P1|NOT COMPLETED|Overall Study||0
8157620|NCT02563496|20108124|P5|COMPLETED|Overall Study||19
8157621|NCT02563496|20108125|P4|COMPLETED|Overall Study||22
8157622|NCT02563496|20108126|P3|COMPLETED|Overall Study||5
8157623|NCT02563496|20108127|P2|COMPLETED|Overall Study||14
8157624|NCT02563496|20108128|P1|COMPLETED|Overall Study||0
8157625|NCT02563496|20108124|P5|STARTED|Overall Study||19
8157626|NCT02563496|20108125|P4|STARTED|Overall Study||22
8157627|NCT02563496|20108126|P3|STARTED|Overall Study||5
8157628|NCT02563496|20108127|P2|STARTED|Overall Study||14
8157629|NCT02563496|20108128|P1|STARTED|Overall Study|No participants were enrolled since they didn't meet inclusion/exclusion criteria.|0
8157630|NCT02563106|20108166|P2|NOT COMPLETED|Overall Study||29
8157631|NCT02563106|20108167|P1|NOT COMPLETED|Overall Study||34
8157632|NCT02563106|20108166|P2|COMPLETED|Overall Study||178
8157633|NCT02563106|20108167|P1|COMPLETED|Overall Study||172
8157634|NCT02563106|20108166|P2|STARTED|Overall Study||207
8157635|NCT02563106|20108167|P1|STARTED|Overall Study||206
8157636|NCT02563093|20108177|P4|NOT COMPLETED|Overall Study||0
8157637|NCT02563093|20108178|P3|NOT COMPLETED|Overall Study||0
8157638|NCT02563093|20108179|P2|NOT COMPLETED|Overall Study||0
8157639|NCT02563093|20108180|P1|NOT COMPLETED|Overall Study||0
8157640|NCT02563093|20108177|P4|COMPLETED|Overall Study||51
8157641|NCT02563093|20108178|P3|COMPLETED|Overall Study||53
8157642|NCT02563093|20108179|P2|COMPLETED|Overall Study||52
8157643|NCT02563093|20108180|P1|COMPLETED|Overall Study||52
8157644|NCT02563093|20108177|P4|STARTED|Overall Study||51
8157645|NCT02563093|20108178|P3|STARTED|Overall Study||53
8157646|NCT02563093|20108179|P2|STARTED|Overall Study||52
8157647|NCT02563093|20108180|P1|STARTED|Overall Study||52
8157648|NCT02563028|20108206|P1|NOT COMPLETED|Overall Study||2
8157649|NCT02563028|20108206|P1|COMPLETED|Overall Study||18
8157650|NCT02563028|20108206|P1|STARTED|Overall Study||20
8157651|NCT02562989|20108216|P3|NOT COMPLETED|Overall Study||0
8157652|NCT02562989|20108217|P2|NOT COMPLETED|Overall Study||0
8157653|NCT02562989|20108218|P1|NOT COMPLETED|Overall Study||0
8157654|NCT02562989|20108216|P3|COMPLETED|Overall Study||6
8157655|NCT02562989|20108217|P2|COMPLETED|Overall Study||4
8157656|NCT02562989|20108218|P1|COMPLETED|Overall Study||3
8157657|NCT02562989|20108216|P3|STARTED|Overall Study||6
8157658|NCT02562989|20108217|P2|STARTED|Overall Study||4
8157659|NCT02562989|20108218|P1|STARTED|Overall Study||3
8157660|NCT02562924|20108244|P3|NOT COMPLETED|Overall Study||4
8157661|NCT02562924|20108245|P2|NOT COMPLETED|Overall Study||11
8157662|NCT02562924|20108246|P1|NOT COMPLETED|Overall Study||1
8157663|NCT02562924|20108244|P3|COMPLETED|Overall Study||8
8157664|NCT02562924|20108245|P2|COMPLETED|Overall Study||1
8157665|NCT02562924|20108246|P1|COMPLETED|Overall Study||12
8157666|NCT02562924|20108244|P3|STARTED|Overall Study||12
8157667|NCT02562924|20108245|P2|STARTED|Overall Study||12
8157668|NCT02562924|20108246|P1|STARTED|Overall Study||13
8157675|NCT02562755|20108278|P2|NOT COMPLETED|Overall Study||72
8157676|NCT02562755|20108279|P1|NOT COMPLETED|Overall Study||73
8157677|NCT02562755|20108278|P2|COMPLETED|Overall Study||153
8157678|NCT02562755|20108279|P1|COMPLETED|Overall Study||161
8157679|NCT02562755|20108278|P2|Safety Population|Overall Study||217
8157680|NCT02562755|20108279|P1|Safety Population|Overall Study||218
8157681|NCT02562755|20108278|P2|STARTED|Overall Study||225
8157682|NCT02562755|20108279|P1|STARTED|Overall Study||234
8157683|NCT02562521|20108287|P2|NOT COMPLETED|Overall Study||0
8157684|NCT02562521|20108288|P1|NOT COMPLETED|Overall Study||0
8157685|NCT02562521|20108287|P2|COMPLETED|Overall Study||7
8157686|NCT02562521|20108288|P1|COMPLETED|Overall Study||18
8157687|NCT02562521|20108287|P2|STARTED|Overall Study||7
8157688|NCT02562521|20108288|P1|STARTED|Overall Study||18
8157689|NCT02562482|20108304|P2|NOT COMPLETED|Overall Study||16
8157690|NCT02562482|20108305|P1|NOT COMPLETED|Overall Study||21
8157691|NCT02562482|20108304|P2|COMPLETED|Overall Study||183
8157692|NCT02562482|20108305|P1|COMPLETED|Overall Study||180
8157693|NCT02562482|20108304|P2|Received 2nd Injection|Overall Study||192
8157694|NCT02562482|20108305|P1|Received 2nd Injection|Overall Study||192
8157695|NCT02562482|20108304|P2|Received 1st Injection|Overall Study||199
8157696|NCT02562482|20108305|P1|Received 1st Injection|Overall Study||197
8157697|NCT02562482|20108304|P2|STARTED|Overall Study||199
8157698|NCT02562482|20108305|P1|STARTED|Overall Study||201
8157699|NCT02561897|20108329|P2|NOT COMPLETED|Overall Study||0
8157700|NCT02561897|20108330|P1|NOT COMPLETED|Overall Study||0
8157701|NCT02561897|20108329|P2|COMPLETED|Overall Study||3
8157702|NCT02561897|20108330|P1|COMPLETED|Overall Study||2
8157703|NCT02561897|20108329|P2|STARTED|Overall Study||3
8157704|NCT02561897|20108330|P1|STARTED|Overall Study||2
8157705|NCT02561832|20108340|P2|NOT COMPLETED|Overall Study||4
8157706|NCT02561832|20108341|P1|NOT COMPLETED|Overall Study||7
8157707|NCT02561832|20108340|P2|COMPLETED|Overall Study||3
8157708|NCT02561832|20108341|P1|COMPLETED|Overall Study||1
8157709|NCT02561832|20108340|P2|INFORMED CONSENT OBTAINED|Overall Study||7
8157710|NCT02561832|20108341|P1|INFORMED CONSENT OBTAINED|Overall Study||8
8157711|NCT02561832|20108340|P2|STARTED|Overall Study||7
8157712|NCT02561832|20108341|P1|STARTED|Overall Study||8
8157713|NCT02561806|20108349|P2|NOT COMPLETED|Post-Treatment Follow-up||1
8157714|NCT02561806|20108350|P1|NOT COMPLETED|Post-Treatment Follow-up||2
8157715|NCT02561806|20108349|P2|COMPLETED|Post-Treatment Follow-up||59
8157716|NCT02561806|20108350|P1|COMPLETED|Post-Treatment Follow-up||155
8157717|NCT02561806|20108349|P2|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
8157718|NCT02561806|20108350|P1|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
8157719|NCT02561806|20108349|P2|NOT COMPLETED|Maintenance Period||8
8157720|NCT02561806|20108350|P1|NOT COMPLETED|Maintenance Period||13
8157721|NCT02561806|20108349|P2|COMPLETED|Maintenance Period||123
8157722|NCT02561806|20108350|P1|COMPLETED|Maintenance Period||151
8157723|NCT02561806|20108349|P2|STARTED|Maintenance Period||131
8157724|NCT02561806|20108350|P1|STARTED|Maintenance Period||164
8157725|NCT02561806|20108349|P2|NOT COMPLETED|Induction Period||5
8157726|NCT02561806|20108350|P1|NOT COMPLETED|Induction Period||2
8157727|NCT02561806|20108349|P2|COMPLETED|Induction Period||131
8157728|NCT02561806|20108350|P1|COMPLETED|Induction Period||164
8157729|NCT02561806|20108349|P2|Received At Least One Dose of Study Drug|Induction Period||135
8157730|NCT02561806|20108350|P1|Received At Least One Dose of Study Drug|Induction Period||166
8157731|NCT02561806|20108349|P2|STARTED|Induction Period||136
8157732|NCT02561806|20108350|P1|STARTED|Induction Period||166
8157733|NCT02561702|20108406|P2|NOT COMPLETED|Second Intervention||0
8157734|NCT02561702|20108407|P1|NOT COMPLETED|Second Intervention||0
8157735|NCT02561702|20108406|P2|COMPLETED|Second Intervention||2
8157736|NCT02561702|20108407|P1|COMPLETED|Second Intervention||2
8157737|NCT02561702|20108406|P2|STARTED|Second Intervention||2
8157738|NCT02561702|20108407|P1|STARTED|Second Intervention||2
8157739|NCT02561702|20108406|P2|NOT COMPLETED|Washout||0
8157740|NCT02561702|20108407|P1|NOT COMPLETED|Washout||0
8157741|NCT02561702|20108406|P2|COMPLETED|Washout||2
8157742|NCT02561702|20108407|P1|COMPLETED|Washout||2
8157743|NCT02561702|20108406|P2|STARTED|Washout||2
8157744|NCT02561702|20108407|P1|STARTED|Washout||2
8157745|NCT02561702|20108406|P2|NOT COMPLETED|First Intervention||0
8157746|NCT02561702|20108407|P1|NOT COMPLETED|First Intervention||0
8157747|NCT02561702|20108406|P2|COMPLETED|First Intervention||2
8157748|NCT02561702|20108407|P1|COMPLETED|First Intervention||2
8157749|NCT02561702|20108406|P2|STARTED|First Intervention||2
8157750|NCT02561702|20108407|P1|STARTED|First Intervention||2
8157751|NCT02561585|20108417|P2|NOT COMPLETED|Overall Study||5
8157752|NCT02561585|20108418|P1|NOT COMPLETED|Overall Study||3
8157753|NCT02561585|20108417|P2|COMPLETED|Overall Study||6
8157754|NCT02561585|20108418|P1|COMPLETED|Overall Study||17
8157755|NCT02561585|20108417|P2|STARTED|Overall Study||11
8157756|NCT02561585|20108418|P1|STARTED|Overall Study||20
8157757|NCT02561572|20108454|P2|NOT COMPLETED|Overall Study||2
8157758|NCT02561572|20108455|P1|NOT COMPLETED|Overall Study||2
8157759|NCT02561572|20108454|P2|COMPLETED|Overall Study||62
8157760|NCT02561572|20108455|P1|COMPLETED|Overall Study||62
8157761|NCT02561572|20108454|P2|STARTED|Overall Study||64
8157762|NCT02561572|20108455|P1|STARTED|Overall Study||64
8157763|NCT02561481|20108473|P2|NOT COMPLETED|Main Trial - Open Label Phase||0
8157764|NCT02561481|20108474|P1|NOT COMPLETED|Main Trial - Open Label Phase||13
8157765|NCT02561481|20108473|P2|COMPLETED|Main Trial - Open Label Phase||0
8157766|NCT02561481|20108474|P1|COMPLETED|Main Trial - Open Label Phase||32
8157767|NCT02561481|20108473|P2|STARTED|Main Trial - Open Label Phase||0
8157768|NCT02561481|20108474|P1|STARTED|Main Trial - Open Label Phase||45
8157769|NCT02561481|20108473|P2|NOT COMPLETED|Main Trial - Double Blind Phase||2
8157770|NCT02561481|20108474|P1|NOT COMPLETED|Main Trial - Double Blind Phase||3
8157771|NCT02561481|20108473|P2|COMPLETED|Main Trial - Double Blind Phase||23
8157772|NCT02561481|20108474|P1|COMPLETED|Main Trial - Double Blind Phase||22
8157773|NCT02561481|20108473|P2|STARTED|Main Trial - Double Blind Phase||25
8157774|NCT02561481|20108474|P1|STARTED|Main Trial - Double Blind Phase||25
8157775|NCT02561481|20108473|P2|NOT COMPLETED|Pilot Trial||0
8157776|NCT02561481|20108474|P1|NOT COMPLETED|Pilot Trial||0
8157777|NCT02561481|20108473|P2|COMPLETED|Pilot Trial||0
8157778|NCT02561481|20108474|P1|COMPLETED|Pilot Trial||10
8157779|NCT02561481|20108473|P2|STARTED|Pilot Trial||0
8157780|NCT02561481|20108474|P1|STARTED|Pilot Trial||10
8157781|NCT02561338|20108517|P5|NOT COMPLETED|Overall Study||2
8157782|NCT02561338|20108518|P4|NOT COMPLETED|Overall Study||5
8157783|NCT02561338|20108519|P3|NOT COMPLETED|Overall Study||9
8157784|NCT02561338|20108520|P2|NOT COMPLETED|Overall Study||6
8157785|NCT02561338|20108521|P1|NOT COMPLETED|Overall Study||8
8157786|NCT02561338|20108517|P5|COMPLETED|Overall Study||51
8157787|NCT02561338|20108518|P4|COMPLETED|Overall Study||46
8157788|NCT02561338|20108519|P3|COMPLETED|Overall Study||42
8157789|NCT02561338|20108520|P2|COMPLETED|Overall Study||44
8157790|NCT02561338|20108521|P1|COMPLETED|Overall Study||45
8157791|NCT02561338|20108517|P5|STARTED|Overall Study||53
8157792|NCT02561338|20108518|P4|STARTED|Overall Study||51
8157793|NCT02561338|20108519|P3|STARTED|Overall Study||51
8157794|NCT02561338|20108520|P2|STARTED|Overall Study||50
8157795|NCT02561338|20108521|P1|STARTED|Overall Study||53
8157910|NCT02561130|20108959|P2|NOT COMPLETED|Overall Study||1
8157911|NCT02561130|20108960|P1|NOT COMPLETED|Overall Study||1
8157912|NCT02561130|20108959|P2|COMPLETED|Overall Study||76
8157913|NCT02561130|20108960|P1|COMPLETED|Overall Study||76
8157914|NCT02561130|20108959|P2|STARTED|Overall Study||77
8157915|NCT02561130|20108960|P1|STARTED|Overall Study||77
8157916|NCT02561078|20108984|P2|NOT COMPLETED|Overall Study||25
8157917|NCT02561078|20108985|P1|NOT COMPLETED|Overall Study||30
8157918|NCT02561078|20108984|P2|COMPLETED|Overall Study||186
8157919|NCT02561078|20108985|P1|COMPLETED|Overall Study||179
8157920|NCT02561078|20108984|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
8157921|NCT02561078|20108985|P1|Received at Least 1 Dose of Study Drug|Overall Study||208
8157922|NCT02561078|20108984|P2|STARTED|Overall Study||211
8157923|NCT02561078|20108985|P1|STARTED|Overall Study||209
8157924|NCT02560922|20109009|P2|NOT COMPLETED|Overall Study||12
8157925|NCT02560922|20109010|P1|NOT COMPLETED|Overall Study||26
8157926|NCT02560922|20109009|P2|COMPLETED|Overall Study||112
8157927|NCT02560922|20109010|P1|COMPLETED|Overall Study||98
8157928|NCT02560922|20109009|P2|STARTED|Overall Study||124
8157929|NCT02560922|20109010|P1|STARTED|Overall Study||124
8157930|NCT02560779|20109036|P2|NOT COMPLETED|Overall Study||0
8157931|NCT02560779|20109037|P1|NOT COMPLETED|Overall Study||0
8157932|NCT02560779|20109036|P2|COMPLETED|Overall Study||13
8157933|NCT02560779|20109037|P1|COMPLETED|Overall Study||14
8157934|NCT02560779|20109036|P2|STARTED|Overall Study||13
8157935|NCT02560779|20109037|P1|STARTED|Overall Study||14
8157936|NCT02560753|20109053|P4|NOT COMPLETED|Overall Study||0
8157937|NCT02560753|20109054|P3|NOT COMPLETED|Overall Study||1
8157938|NCT02560753|20109055|P2|NOT COMPLETED|Overall Study||0
8157939|NCT02560753|20109056|P1|NOT COMPLETED|Overall Study||1
8157940|NCT02560753|20109053|P4|COMPLETED|Overall Study||8
8157941|NCT02560753|20109054|P3|COMPLETED|Overall Study||9
8157942|NCT02560753|20109055|P2|COMPLETED|Overall Study||9
8157943|NCT02560753|20109056|P1|COMPLETED|Overall Study||8
8157944|NCT02560753|20109053|P4|STARTED|Overall Study||8
8157945|NCT02560753|20109054|P3|STARTED|Overall Study||10
8157946|NCT02560753|20109055|P2|STARTED|Overall Study||9
8157947|NCT02560753|20109056|P1|STARTED|Overall Study||9
8157948|NCT02560701|20109084|P2|NOT COMPLETED|Overall Study||51466
8157949|NCT02560701|20109085|P1|NOT COMPLETED|Overall Study||4543
8157950|NCT02560701|20109084|P2|COMPLETED|Overall Study||37776
8157951|NCT02560701|20109085|P1|COMPLETED|Overall Study||3517
8157952|NCT02560701|20109084|P2|Matched Cohort|Overall Study||37776
8157953|NCT02560701|20109085|P1|Matched Cohort|Overall Study||3517
8157954|NCT02560701|20109084|P2|Bipolar Diagnosis Time Constraints|Overall Study||39427
8157955|NCT02560701|20109085|P1|Bipolar Diagnosis Time Constraints|Overall Study||3533
8157956|NCT02560701|20109084|P2|Restrict to Patients Between 12 and 64|Overall Study||82367
8157957|NCT02560701|20109085|P1|Restrict to Patients Between 12 and 64|Overall Study||7598
8157958|NCT02560701|20109084|P2|Carve Out|Overall Study||88729
8157959|NCT02560701|20109085|P1|Carve Out|Overall Study||8060
8157960|NCT02560701|20109084|P2|STARTED|Overall Study||89242
8157961|NCT02560701|20109085|P1|STARTED|Overall Study||8060
8157962|NCT02560584|20109101|P1|NOT COMPLETED|Overall Study||0
8157963|NCT02560584|20109101|P1|COMPLETED|Overall Study||304
8157964|NCT02560584|20109101|P1|STARTED|Overall Study||304
8157965|NCT02560558|20109110|P2|NOT COMPLETED|Overall Study||6
8157966|NCT02560558|20109111|P1|NOT COMPLETED|Overall Study||7
8157967|NCT02560558|20109110|P2|COMPLETED|Overall Study||76
8157968|NCT02560558|20109111|P1|COMPLETED|Overall Study||77
8157969|NCT02560558|20109110|P2|STARTED|Overall Study||82
8157970|NCT02560558|20109111|P1|STARTED|Overall Study||84
8157971|NCT02560493|20109139|P2|NOT COMPLETED|Overall Study||0
8157972|NCT02560493|20109140|P1|NOT COMPLETED|Overall Study||1
8157973|NCT02560493|20109139|P2|COMPLETED|Overall Study||23
8157974|NCT02560493|20109140|P1|COMPLETED|Overall Study||22
8157975|NCT02560493|20109139|P2|STARTED|Overall Study||23
8157976|NCT02560493|20109140|P1|STARTED|Overall Study||23
8157977|NCT02560389|20109163|P3|NOT COMPLETED|Overall Study||2
8157978|NCT02560389|20109164|P2|NOT COMPLETED|Overall Study||3
8157979|NCT02560389|20109165|P1|NOT COMPLETED|Overall Study||1
8157980|NCT02560389|20109163|P3|COMPLETED|Overall Study||27
8157981|NCT02560389|20109164|P2|COMPLETED|Overall Study||25
8157982|NCT02560389|20109165|P1|COMPLETED|Overall Study||33
8157983|NCT02560389|20109163|P3|STARTED|Overall Study||29
8157984|NCT02560389|20109164|P2|STARTED|Overall Study||28
8157985|NCT02560389|20109165|P1|STARTED|Overall Study||34
8157986|NCT02560324|20109181|P2|NOT COMPLETED|Period 2 (2 Weeks)||2
8157987|NCT02560324|20109182|P1|NOT COMPLETED|Period 2 (2 Weeks)||1
8157988|NCT02560324|20109181|P2|COMPLETED|Period 2 (2 Weeks)||21
8157989|NCT02560324|20109182|P1|COMPLETED|Period 2 (2 Weeks)||22
8157990|NCT02560324|20109181|P2|STARTED|Period 2 (2 Weeks)||23
8157991|NCT02560324|20109182|P1|STARTED|Period 2 (2 Weeks)||23
8157992|NCT02560324|20109181|P2|NOT COMPLETED|Washout (2 Weeks)||2
8157993|NCT02560324|20109182|P1|NOT COMPLETED|Washout (2 Weeks)||0
8157994|NCT02560324|20109181|P2|COMPLETED|Washout (2 Weeks)||23
8157995|NCT02560324|20109182|P1|COMPLETED|Washout (2 Weeks)||23
8157996|NCT02560324|20109181|P2|STARTED|Washout (2 Weeks)||25
8157997|NCT02560324|20109182|P1|STARTED|Washout (2 Weeks)||23
8157998|NCT02560324|20109181|P2|NOT COMPLETED|Period 1 (2 Weeks)||9
8157999|NCT02560324|20109182|P1|NOT COMPLETED|Period 1 (2 Weeks)||12
8158000|NCT02560324|20109181|P2|COMPLETED|Period 1 (2 Weeks)||25
8158001|NCT02560324|20109182|P1|COMPLETED|Period 1 (2 Weeks)||23
8158002|NCT02560324|20109181|P2|STARTED|Period 1 (2 Weeks)||34
8158003|NCT02560324|20109182|P1|STARTED|Period 1 (2 Weeks)||35
8158004|NCT02560051|20109199|P3|NOT COMPLETED|Overall Study||1
8158005|NCT02560051|20109200|P2|NOT COMPLETED|Overall Study||4
8158006|NCT02560051|20109201|P1|NOT COMPLETED|Overall Study||3
8158007|NCT02560051|20109199|P3|COMPLETED|Overall Study||4
8158008|NCT02560051|20109200|P2|COMPLETED|Overall Study||4
8158009|NCT02560051|20109201|P1|COMPLETED|Overall Study||3
8158010|NCT02560051|20109199|P3|STARTED|Overall Study||5
8158011|NCT02560051|20109200|P2|STARTED|Overall Study||8
8158012|NCT02560051|20109201|P1|STARTED|Overall Study||6
8158013|NCT02560038|20109257|P1|NOT COMPLETED|Overall Study||2
8158014|NCT02560038|20109257|P1|COMPLETED|Overall Study||1
8158015|NCT02560038|20109257|P1|STARTED|Overall Study||3
8158016|NCT02560025|20109263|P1|NOT COMPLETED|Overall Study||3
8158017|NCT02560025|20109263|P1|COMPLETED|Overall Study||39
8158018|NCT02560025|20109263|P1|STARTED|Overall Study||42
8158019|NCT02560012|20109272|P1|NOT COMPLETED|Overall Study||2
8158020|NCT02560012|20109272|P1|COMPLETED|Overall Study||1
8158021|NCT02560012|20109272|P1|STARTED|Overall Study||3
8158022|NCT02559895|20109280|P4|NOT COMPLETED|Overall Study||60
8158023|NCT02559895|20109281|P3|NOT COMPLETED|Overall Study||54
8158024|NCT02559895|20109282|P2|NOT COMPLETED|Overall Study||53
8158025|NCT02559895|20109283|P1|NOT COMPLETED|Overall Study||55
8158026|NCT02559895|20109280|P4|COMPLETED|Overall Study||165
8158027|NCT02559895|20109281|P3|COMPLETED|Overall Study||170
8158028|NCT02559895|20109282|P2|COMPLETED|Overall Study||172
8158029|NCT02559895|20109283|P1|COMPLETED|Overall Study||169
8158030|NCT02559895|20109280|P4|Participants Treated|Overall Study||222
8158031|NCT02559895|20109281|P3|Participants Treated|Overall Study||223
8158032|NCT02559895|20109282|P2|Participants Treated|Overall Study||221
8158033|NCT02559895|20109283|P1|Participants Treated|Overall Study||222
8158034|NCT02559895|20109280|P4|STARTED|Overall Study||225
8158035|NCT02559895|20109281|P3|STARTED|Overall Study||224
8158036|NCT02559895|20109282|P2|STARTED|Overall Study||225
8158037|NCT02559895|20109283|P1|STARTED|Overall Study||224
8158038|NCT02559817|20109378|P5|NOT COMPLETED|Post-treatment Period||0
8158039|NCT02559817|20109379|P4|NOT COMPLETED|Post-treatment Period||0
8158040|NCT02559817|20109380|P3|NOT COMPLETED|Post-treatment Period||0
8158041|NCT02559817|20109381|P2|NOT COMPLETED|Post-treatment Period||0
8158042|NCT02559817|20109382|P1|NOT COMPLETED|Post-treatment Period||0
8158043|NCT02559817|20109378|P5|COMPLETED|Post-treatment Period||8
8158044|NCT02559817|20109379|P4|COMPLETED|Post-treatment Period||22
8158045|NCT02559817|20109380|P3|COMPLETED|Post-treatment Period||20
8158046|NCT02559817|20109381|P2|COMPLETED|Post-treatment Period||27
8158047|NCT02559817|20109382|P1|COMPLETED|Post-treatment Period||18
8158048|NCT02559817|20109378|P5|STARTED|Post-treatment Period||8
8158049|NCT02559817|20109379|P4|STARTED|Post-treatment Period||22
8158050|NCT02559817|20109380|P3|STARTED|Post-treatment Period|1 participant who did not complete the first period, entered and completed the Post-treatment Period|20
8158051|NCT02559817|20109381|P2|STARTED|Post-treatment Period||27
8158052|NCT02559817|20109382|P1|STARTED|Post-treatment Period||18
8158053|NCT02559817|20109378|P5|NOT COMPLETED|Treatment Period||0
8158054|NCT02559817|20109379|P4|NOT COMPLETED|Treatment Period||2
8158055|NCT02559817|20109380|P3|NOT COMPLETED|Treatment Period||2
8158056|NCT02559817|20109381|P2|NOT COMPLETED|Treatment Period||2
8158057|NCT02559817|20109382|P1|NOT COMPLETED|Treatment Period||1
8158058|NCT02559817|20109378|P5|COMPLETED|Treatment Period||8
8158059|NCT02559817|20109379|P4|COMPLETED|Treatment Period||22
8158060|NCT02559817|20109380|P3|COMPLETED|Treatment Period||19
8158061|NCT02559817|20109381|P2|COMPLETED|Treatment Period||27
8158062|NCT02559817|20109382|P1|COMPLETED|Treatment Period||18
8158063|NCT02559817|20109378|P5|STARTED|Treatment Period||8
8158064|NCT02559817|20109379|P4|STARTED|Treatment Period||24
8158065|NCT02559817|20109380|P3|STARTED|Treatment Period||21
8158066|NCT02559817|20109381|P2|STARTED|Treatment Period||29
8158067|NCT02559817|20109382|P1|STARTED|Treatment Period||19
8158068|NCT02559713|20109419|P1|NOT COMPLETED|Overall Study||1
8158069|NCT02559713|20109419|P1|COMPLETED|Overall Study||10
8158070|NCT02559713|20109419|P1|Pharmacokinetic Set|Overall Study||11
8158071|NCT02559713|20109419|P1|Safety Set|Overall Study||11
8158072|NCT02559713|20109419|P1|STARTED|Overall Study||11
8158076|NCT02559622|20109442|P4|NOT COMPLETED|Overall Study||3
8158077|NCT02559622|20109443|P3|NOT COMPLETED|Overall Study||2
8158078|NCT02559622|20109444|P2|NOT COMPLETED|Overall Study||5
8158079|NCT02559622|20109445|P1|NOT COMPLETED|Overall Study||1
8158080|NCT02559622|20109442|P4|COMPLETED|Overall Study||20
8158081|NCT02559622|20109443|P3|COMPLETED|Overall Study||24
8158082|NCT02559622|20109444|P2|COMPLETED|Overall Study||49
8158083|NCT02559622|20109445|P1|COMPLETED|Overall Study||47
8158084|NCT02559622|20109442|P4|STARTED|Overall Study||23
8158085|NCT02559622|20109443|P3|STARTED|Overall Study||26
8158086|NCT02559622|20109444|P2|STARTED|Overall Study||54
8158087|NCT02559622|20109445|P1|STARTED|Overall Study||48
8158088|NCT02559570|20109529|P5|NOT COMPLETED|Overall Study||2
8158089|NCT02559570|20109530|P4|NOT COMPLETED|Overall Study||3
8158090|NCT02559570|20109531|P3|NOT COMPLETED|Overall Study||2
8158091|NCT02559570|20109532|P2|NOT COMPLETED|Overall Study||2
8158092|NCT02559570|20109533|P1|NOT COMPLETED|Overall Study||2
8158093|NCT02559570|20109529|P5|COMPLETED|Overall Study||14
8158094|NCT02559570|20109530|P4|COMPLETED|Overall Study||36
8158095|NCT02559570|20109531|P3|COMPLETED|Overall Study||39
8158096|NCT02559570|20109532|P2|COMPLETED|Overall Study||34
8158097|NCT02559570|20109533|P1|COMPLETED|Overall Study||39
8158098|NCT02559570|20109529|P5|STARTED|Overall Study||16
8158099|NCT02559570|20109530|P4|STARTED|Overall Study||39
8158100|NCT02559570|20109531|P3|STARTED|Overall Study||41
8158101|NCT02559570|20109532|P2|STARTED|Overall Study||36
8158102|NCT02559570|20109533|P1|STARTED|Overall Study||41
8158103|NCT02559414|20109571|P3|NOT COMPLETED|Overall Study||2
8158104|NCT02559414|20109572|P2|NOT COMPLETED|Overall Study||2
8158105|NCT02559414|20109573|P1|NOT COMPLETED|Overall Study||1
8158106|NCT02559414|20109571|P3|COMPLETED|Overall Study||20
8158107|NCT02559414|20109572|P2|COMPLETED|Overall Study||20
8158108|NCT02559414|20109573|P1|COMPLETED|Overall Study||10
8158109|NCT02559414|20109571|P3|STARTED|Overall Study||22
8158110|NCT02559414|20109572|P2|STARTED|Overall Study||22
8158111|NCT02559414|20109573|P1|STARTED|Overall Study||11
8158112|NCT02559310|20109613|P2|NOT COMPLETED|Overall Study||19
8158113|NCT02559310|20109614|P1|NOT COMPLETED|Overall Study||27
8158114|NCT02559310|20109613|P2|COMPLETED|Overall Study||256
8158115|NCT02559310|20109614|P1|COMPLETED|Overall Study||249
8158116|NCT02559310|20109613|P2|STARTED|Overall Study||275
8158117|NCT02559310|20109614|P1|STARTED|Overall Study||276
8158118|NCT02559206|20109632|P8|NOT COMPLETED|Overall Study||9
8158119|NCT02559206|20109633|P7|NOT COMPLETED|Overall Study||6
8158120|NCT02559206|20109634|P6|NOT COMPLETED|Overall Study||14
8158121|NCT02559206|20109635|P5|NOT COMPLETED|Overall Study||12
8158122|NCT02559206|20109636|P4|NOT COMPLETED|Overall Study||14
8158123|NCT02559206|20109637|P3|NOT COMPLETED|Overall Study||9
8158124|NCT02559206|20109638|P2|NOT COMPLETED|Overall Study||12
8158125|NCT02559206|20109639|P1|NOT COMPLETED|Overall Study||8
8158126|NCT02559206|20109632|P8|COMPLETED|Overall Study||57
8158127|NCT02559206|20109633|P7|COMPLETED|Overall Study||60
8158128|NCT02559206|20109634|P6|COMPLETED|Overall Study||53
8158129|NCT02559206|20109635|P5|COMPLETED|Overall Study||55
8158130|NCT02559206|20109636|P4|COMPLETED|Overall Study||53
8158131|NCT02559206|20109637|P3|COMPLETED|Overall Study||58
8158132|NCT02559206|20109638|P2|COMPLETED|Overall Study||54
8158133|NCT02559206|20109639|P1|COMPLETED|Overall Study||58
8158134|NCT02559206|20109632|P8|STARTED|Overall Study||66
8158135|NCT02559206|20109633|P7|STARTED|Overall Study||66
8158136|NCT02559206|20109634|P6|STARTED|Overall Study||67
8158137|NCT02559206|20109635|P5|STARTED|Overall Study||67
8158138|NCT02559206|20109636|P4|STARTED|Overall Study||67
8158139|NCT02559206|20109637|P3|STARTED|Overall Study||67
8158140|NCT02559206|20109638|P2|STARTED|Overall Study||66
8158141|NCT02559206|20109639|P1|STARTED|Overall Study||66
8158142|NCT02558894|20109681|P2|NOT COMPLETED|Overall Study||33
8158143|NCT02558894|20109682|P1|NOT COMPLETED|Overall Study||32
8158144|NCT02558894|20109681|P2|COMPLETED|Overall Study||0
8158145|NCT02558894|20109682|P1|COMPLETED|Overall Study||0
8158146|NCT02558894|20109681|P2|Patients Who Received IP|Overall Study||32
8158147|NCT02558894|20109682|P1|Patients Who Received IP|Overall Study||32
8158148|NCT02558894|20109681|P2|STARTED|Overall Study||33
8158149|NCT02558894|20109682|P1|STARTED|Overall Study||32
8158150|NCT02558829|20109710|P8|NOT COMPLETED|Overall Study||3
8158151|NCT02558829|20109711|P7|NOT COMPLETED|Overall Study||1
8158152|NCT02558829|20109712|P6|NOT COMPLETED|Overall Study||2
8158153|NCT02558829|20109713|P5|NOT COMPLETED|Overall Study||2
8158154|NCT02558829|20109714|P4|NOT COMPLETED|Overall Study||2
8158155|NCT02558829|20109715|P3|NOT COMPLETED|Overall Study||3
8158156|NCT02558829|20109716|P2|NOT COMPLETED|Overall Study||3
8158157|NCT02558829|20109717|P1|NOT COMPLETED|Overall Study||1
8158158|NCT02558829|20109710|P8|COMPLETED|Overall Study||8
8158159|NCT02558829|20109711|P7|COMPLETED|Overall Study||17
8158160|NCT02558829|20109712|P6|COMPLETED|Overall Study||24
8158161|NCT02558829|20109713|P5|COMPLETED|Overall Study||16
8158162|NCT02558829|20109714|P4|COMPLETED|Overall Study||16
8158163|NCT02558829|20109715|P3|COMPLETED|Overall Study||21
8158164|NCT02558829|20109716|P2|COMPLETED|Overall Study||18
8158165|NCT02558829|20109717|P1|COMPLETED|Overall Study||20
8158166|NCT02558829|20109710|P8|STARTED|Overall Study||11
8158167|NCT02558829|20109711|P7|STARTED|Overall Study||18
8158168|NCT02558829|20109712|P6|STARTED|Overall Study||26
8158169|NCT02558829|20109713|P5|STARTED|Overall Study||18
8158170|NCT02558829|20109714|P4|STARTED|Overall Study||18
8158171|NCT02558829|20109715|P3|STARTED|Overall Study||24
8158172|NCT02558829|20109716|P2|STARTED|Overall Study||21
8158173|NCT02558829|20109717|P1|STARTED|Overall Study||21
8158174|NCT02558790|20109743|P1|NOT COMPLETED|Overall Study||7
8158175|NCT02558790|20109743|P1|COMPLETED|Overall Study||13
8158176|NCT02558790|20109743|P1|Treated|Overall Study||15
8158177|NCT02558790|20109743|P1|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
8158178|NCT02558400|20109750|P3|NOT COMPLETED|Overall Study||33
8158179|NCT02558400|20109751|P2|NOT COMPLETED|Overall Study||96
8158180|NCT02558400|20109752|P1|NOT COMPLETED|Overall Study||79
8158181|NCT02558400|20109750|P3|COMPLETED|Overall Study||203
8158182|NCT02558400|20109751|P2|COMPLETED|Overall Study||148
8158183|NCT02558400|20109752|P1|COMPLETED|Overall Study||159
8158184|NCT02558400|20109750|P3|STARTED|Overall Study||236
8158185|NCT02558400|20109751|P2|STARTED|Overall Study||244
8158186|NCT02558400|20109752|P1|STARTED|Overall Study||238
8158187|NCT02558374|20109765|P2|NOT COMPLETED|Overall Study||43
8158188|NCT02558374|20109766|P1|NOT COMPLETED|Overall Study||108
8158189|NCT02558374|20109765|P2|COMPLETED|Overall Study||314
8158190|NCT02558374|20109766|P1|COMPLETED|Overall Study||243
8158191|NCT02558374|20109765|P2|STARTED|Overall Study||357
8158192|NCT02558374|20109766|P1|STARTED|Overall Study||351
8158201|NCT02557698|20109803|P2|NOT COMPLETED|Overall Study||0
8158202|NCT02557698|20109804|P1|NOT COMPLETED|Overall Study||0
8158203|NCT02557698|20109803|P2|COMPLETED|Overall Study||30
8158204|NCT02557698|20109804|P1|COMPLETED|Overall Study||30
8158205|NCT02557698|20109803|P2|STARTED|Overall Study||30
8158206|NCT02557698|20109804|P1|STARTED|Overall Study||30
8158207|NCT02557646|20109868|P1|NOT COMPLETED|Overall Study||276
8158208|NCT02557646|20109868|P1|COMPLETED|Overall Study||417
8158209|NCT02557646|20109868|P1|STARTED|Overall Study||693
8158210|NCT02557555|20109886|P1|NOT COMPLETED|Overall Study||0
8158211|NCT02557555|20109886|P1|COMPLETED|Overall Study||100
8158212|NCT02557555|20109886|P1|STARTED|Overall Study||100
8158213|NCT02557516|20109895|P4|NOT COMPLETED|Overall Study||9
8158214|NCT02557516|20109896|P3|NOT COMPLETED|Overall Study||4
8158215|NCT02557516|20109897|P2|NOT COMPLETED|Overall Study||5
8158216|NCT02557516|20109898|P1|NOT COMPLETED|Overall Study||1
8158217|NCT02557516|20109895|P4|COMPLETED|Overall Study||0
8158218|NCT02557516|20109896|P3|COMPLETED|Overall Study||0
8158219|NCT02557516|20109897|P2|COMPLETED|Overall Study||1
8158220|NCT02557516|20109898|P1|COMPLETED|Overall Study||2
8158221|NCT02557516|20109895|P4|STARTED|Overall Study||9
8158222|NCT02557516|20109896|P3|STARTED|Overall Study||4
8158223|NCT02557516|20109897|P2|STARTED|Overall Study||6
8158224|NCT02557516|20109898|P1|STARTED|Overall Study||3
8158225|NCT02557399|20109919|P2|NOT COMPLETED|Overall Study||8
8158226|NCT02557399|20109920|P1|NOT COMPLETED|Overall Study||7
8158227|NCT02557399|20109919|P2|COMPLETED|Overall Study||169
8158228|NCT02557399|20109920|P1|COMPLETED|Overall Study||165
8158229|NCT02557399|20109919|P2|STARTED|Overall Study||177
8158230|NCT02557399|20109920|P1|STARTED|Overall Study||172
8158231|NCT02557100|20109955|P3|NOT COMPLETED|Cumulative Abatacept Period||4
8158232|NCT02557100|20109956|P2|NOT COMPLETED|Cumulative Abatacept Period||0
8158233|NCT02557100|20109957|P1|NOT COMPLETED|Cumulative Abatacept Period||0
8158234|NCT02557100|20109955|P3|COMPLETED|Cumulative Abatacept Period||72
8158235|NCT02557100|20109956|P2|COMPLETED|Cumulative Abatacept Period||0
8158236|NCT02557100|20109957|P1|COMPLETED|Cumulative Abatacept Period||0
8158237|NCT02557100|20109955|P3|STARTED|Cumulative Abatacept Period||76
8158238|NCT02557100|20109956|P2|STARTED|Cumulative Abatacept Period||0
8158239|NCT02557100|20109957|P1|STARTED|Cumulative Abatacept Period||0
8158240|NCT02557100|20109955|P3|NOT COMPLETED|Transition to Open Label||0
8158241|NCT02557100|20109956|P2|NOT COMPLETED|Transition to Open Label||36
8158242|NCT02557100|20109957|P1|NOT COMPLETED|Transition to Open Label||40
8158243|NCT02557100|20109955|P3|COMPLETED|Transition to Open Label||0
8158244|NCT02557100|20109956|P2|COMPLETED|Transition to Open Label||0
8158245|NCT02557100|20109957|P1|COMPLETED|Transition to Open Label||0
8158246|NCT02557100|20109955|P3|STARTED|Transition to Open Label||0
8158247|NCT02557100|20109956|P2|STARTED|Transition to Open Label||36
8158248|NCT02557100|20109957|P1|STARTED|Transition to Open Label||40
8158249|NCT02557100|20109955|P3|NOT COMPLETED|Single Blind Treatment Period||0
8158250|NCT02557100|20109956|P2|NOT COMPLETED|Single Blind Treatment Period||4
8158251|NCT02557100|20109957|P1|NOT COMPLETED|Single Blind Treatment Period||0
8158252|NCT02557100|20109955|P3|COMPLETED|Single Blind Treatment Period||0
8158253|NCT02557100|20109956|P2|COMPLETED|Single Blind Treatment Period||36
8158254|NCT02557100|20109957|P1|COMPLETED|Single Blind Treatment Period||40
8158255|NCT02557100|20109955|P3|STARTED|Single Blind Treatment Period||0
8158256|NCT02557100|20109956|P2|STARTED|Single Blind Treatment Period||40
8158257|NCT02557100|20109957|P1|STARTED|Single Blind Treatment Period||40
8158258|NCT02557035|20109985|P2|NOT COMPLETED|Overall Study||9
8158259|NCT02557035|20109986|P1|NOT COMPLETED|Overall Study||7
8158260|NCT02557035|20109985|P2|COMPLETED|Overall Study||206
8158261|NCT02557035|20109986|P1|COMPLETED|Overall Study||218
8158262|NCT02557035|20109985|P2|STARTED|Overall Study||215
8158263|NCT02557035|20109986|P1|STARTED|Overall Study||225
8158264|NCT02556918|20110010|P2|NOT COMPLETED|Overall Study||10
8158265|NCT02556918|20110011|P1|NOT COMPLETED|Overall Study||9
8158266|NCT02556918|20110010|P2|COMPLETED|Overall Study||91
8158267|NCT02556918|20110011|P1|COMPLETED|Overall Study||91
8158268|NCT02556918|20110010|P2|STARTED|Overall Study||101
8158269|NCT02556918|20110011|P1|STARTED|Overall Study||100
8158270|NCT02556801|20110071|P4|NOT COMPLETED|Overall Study||5
8158271|NCT02556801|20110072|P3|NOT COMPLETED|Overall Study||4
8158272|NCT02556801|20110073|P2|NOT COMPLETED|Overall Study||7
8158273|NCT02556801|20110074|P1|NOT COMPLETED|Overall Study||2
8158274|NCT02556801|20110071|P4|COMPLETED|Overall Study||37
8158275|NCT02556801|20110072|P3|COMPLETED|Overall Study||38
8158276|NCT02556801|20110073|P2|COMPLETED|Overall Study||35
8158277|NCT02556801|20110074|P1|COMPLETED|Overall Study||40
8158278|NCT02556801|20110071|P4|STARTED|Overall Study||42
8158279|NCT02556801|20110072|P3|STARTED|Overall Study||42
8158280|NCT02556801|20110073|P2|STARTED|Overall Study||42
8158281|NCT02556801|20110074|P1|STARTED|Overall Study||42
8158282|NCT02556788|20110126|P2|NOT COMPLETED|Overall Study||37
8158283|NCT02556788|20110127|P1|NOT COMPLETED|Overall Study||44
8158284|NCT02556788|20110126|P2|COMPLETED|Overall Study||573
8158285|NCT02556788|20110127|P1|COMPLETED|Overall Study||558
8158286|NCT02556788|20110126|P2|STARTED|Overall Study||610
8158287|NCT02556788|20110127|P1|STARTED|Overall Study||602
8158288|NCT02556632|20110136|P3|NOT COMPLETED|Overall Study||9
8158289|NCT02556632|20110137|P2|NOT COMPLETED|Overall Study||6
8158290|NCT02556632|20110138|P1|NOT COMPLETED|Overall Study||5
8158291|NCT02556632|20110136|P3|COMPLETED|Overall Study||53
8158292|NCT02556632|20110137|P2|COMPLETED|Overall Study||59
8158293|NCT02556632|20110138|P1|COMPLETED|Overall Study||59
8158294|NCT02556632|20110136|P3|STARTED|Overall Study||62
8158295|NCT02556632|20110137|P2|STARTED|Overall Study||65
8158296|NCT02556632|20110138|P1|STARTED|Overall Study||64
8158297|NCT02556554|20110155|P5|NOT COMPLETED|Overall Study||0
8158298|NCT02556554|20110156|P4|NOT COMPLETED|Overall Study||0
8158299|NCT02556554|20110157|P3|NOT COMPLETED|Overall Study||4
8158300|NCT02556554|20110158|P2|NOT COMPLETED|Overall Study||1
8158301|NCT02556554|20110159|P1|NOT COMPLETED|Overall Study||0
8158302|NCT02556554|20110155|P5|COMPLETED|Overall Study||14
8158303|NCT02556554|20110156|P4|COMPLETED|Overall Study||12
8158304|NCT02556554|20110157|P3|COMPLETED|Overall Study||15
8158305|NCT02556554|20110158|P2|COMPLETED|Overall Study||13
8158306|NCT02556554|20110159|P1|COMPLETED|Overall Study||8
8158307|NCT02556554|20110155|P5|STARTED|Overall Study||14
8158308|NCT02556554|20110156|P4|STARTED|Overall Study||12
8158309|NCT02556554|20110157|P3|STARTED|Overall Study||19
8158310|NCT02556554|20110158|P2|STARTED|Overall Study||14
8158311|NCT02556554|20110159|P1|STARTED|Overall Study||8
8158312|NCT02556333|20110174|P1|NOT COMPLETED|Overall Study||0
8158313|NCT02556333|20110174|P1|COMPLETED|Overall Study||1
8158314|NCT02556333|20110174|P1|STARTED|Overall Study||1
8158315|NCT02556307|20110178|P1|NOT COMPLETED|Overall Study||53
8158316|NCT02556307|20110178|P1|COMPLETED|Overall Study||217
8158317|NCT02556307|20110178|P1|Treated|Overall Study||268
8158318|NCT02556307|20110178|P1|STARTED|Overall Study||270
8158322|NCT02556203|20110203|P2|NOT COMPLETED|Overall Study||26
8158323|NCT02556203|20110204|P1|NOT COMPLETED|Overall Study||27
8158324|NCT02556203|20110203|P2|COMPLETED|Overall Study||792
8158325|NCT02556203|20110204|P1|COMPLETED|Overall Study||799
8158326|NCT02556203|20110203|P2|Received Treatment|Overall Study||807
8158327|NCT02556203|20110204|P1|Received Treatment|Overall Study||801
8158328|NCT02556203|20110203|P2|STARTED|Overall Study||818
8158329|NCT02556203|20110204|P1|STARTED|Overall Study||826
8158330|NCT02556177|20110226|P2|NOT COMPLETED|Overall Study||61
8158331|NCT02556177|20110227|P1|NOT COMPLETED|Overall Study||283
8158332|NCT02556177|20110226|P2|COMPLETED|Overall Study||91
8158333|NCT02556177|20110227|P1|COMPLETED|Overall Study||42
8158334|NCT02556177|20110226|P2|STARTED|Overall Study||152
8158335|NCT02556177|20110227|P1|STARTED|Overall Study||325
8158336|NCT02556138|20110235|P1|NOT COMPLETED|Overall Study||1
8158337|NCT02556138|20110235|P1|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
8158338|NCT02556138|20110235|P1|STARTED|Overall Study||8
8158339|NCT02556112|20110244|P3|NOT COMPLETED|Overall Study||12
8158340|NCT02556112|20110245|P2|NOT COMPLETED|Overall Study||17
8158341|NCT02556112|20110246|P1|NOT COMPLETED|Overall Study||10
8158342|NCT02556112|20110244|P3|COMPLETED|Overall Study||30
8158343|NCT02556112|20110245|P2|COMPLETED|Overall Study||23
8158344|NCT02556112|20110246|P1|COMPLETED|Overall Study||30
8158345|NCT02556112|20110244|P3|STARTED|Overall Study||42
8158346|NCT02556112|20110245|P2|STARTED|Overall Study||40
8158347|NCT02556112|20110246|P1|STARTED|Overall Study||40
8158348|NCT02555878|20110271|P2|NOT COMPLETED|Overall Study||150
8158349|NCT02555878|20110272|P1|NOT COMPLETED|Overall Study||166
8158350|NCT02555878|20110271|P2|COMPLETED|Overall Study||270
8158351|NCT02555878|20110272|P1|COMPLETED|Overall Study||255
8158352|NCT02555878|20110271|P2|Treated|Overall Study||405
8158353|NCT02555878|20110272|P1|Treated|Overall Study||404
8158354|NCT02555878|20110271|P2|STARTED|Overall Study||420
8158355|NCT02555878|20110272|P1|STARTED|Overall Study||421
8158356|NCT02555722|20110304|P2|NOT COMPLETED|Month 3||0
8158357|NCT02555722|20110305|P1|NOT COMPLETED|Month 3||0
8158358|NCT02555722|20110304|P2|COMPLETED|Month 3||29
8158359|NCT02555722|20110305|P1|COMPLETED|Month 3||54
8158360|NCT02555722|20110304|P2|STARTED|Month 3||29
8158361|NCT02555722|20110305|P1|STARTED|Month 3||54
8158362|NCT02555722|20110304|P2|NOT COMPLETED|Month 2||0
8158363|NCT02555722|20110305|P1|NOT COMPLETED|Month 2||4
8158364|NCT02555722|20110304|P2|COMPLETED|Month 2||29
8158365|NCT02555722|20110305|P1|COMPLETED|Month 2||54
8158366|NCT02555722|20110304|P2|STARTED|Month 2||29
8158367|NCT02555722|20110305|P1|STARTED|Month 2||58
8158368|NCT02555722|20110304|P2|NOT COMPLETED|Month 1||0
8158369|NCT02555722|20110305|P1|NOT COMPLETED|Month 1||1
8158370|NCT02555722|20110304|P2|COMPLETED|Month 1||29
8158371|NCT02555722|20110305|P1|COMPLETED|Month 1||58
8158372|NCT02555722|20110304|P2|STARTED|Month 1||29
8158373|NCT02555722|20110305|P1|STARTED|Month 1||59
8158374|NCT02555722|20110304|P2|NOT COMPLETED|Week 2||1
8158375|NCT02555722|20110305|P1|NOT COMPLETED|Week 2||1
8158376|NCT02555722|20110304|P2|COMPLETED|Week 2||29
8158377|NCT02555722|20110305|P1|COMPLETED|Week 2||59
8158378|NCT02555722|20110304|P2|STARTED|Week 2||30
8158379|NCT02555722|20110305|P1|STARTED|Week 2||60
8158380|NCT02555722|20110304|P2|NOT COMPLETED|Week 1||0
8158381|NCT02555722|20110305|P1|NOT COMPLETED|Week 1||0
8158382|NCT02555722|20110304|P2|COMPLETED|Week 1||30
8158383|NCT02555722|20110305|P1|COMPLETED|Week 1||60
8158384|NCT02555722|20110304|P2|STARTED|Week 1||30
8158385|NCT02555722|20110305|P1|STARTED|Week 1||60
8158386|NCT02555722|20110304|P2|NOT COMPLETED|Lens Dispensed||0
8158387|NCT02555722|20110305|P1|NOT COMPLETED|Lens Dispensed||0
8158388|NCT02555722|20110304|P2|COMPLETED|Lens Dispensed||30
8158389|NCT02555722|20110305|P1|COMPLETED|Lens Dispensed||60
8158390|NCT02555722|20110304|P2|STARTED|Lens Dispensed||30
8158391|NCT02555722|20110305|P1|STARTED|Lens Dispensed||60
8158392|NCT02555683|20110490|P3|NOT COMPLETED|Overall Study||29
8158393|NCT02555683|20110491|P2|NOT COMPLETED|Overall Study||17
8158394|NCT02555683|20110492|P1|NOT COMPLETED|Overall Study||19
8158395|NCT02555683|20110490|P3|COMPLETED|Overall Study||269
8158396|NCT02555683|20110491|P2|COMPLETED|Overall Study||278
8158397|NCT02555683|20110492|P1|COMPLETED|Overall Study||282
8158398|NCT02555683|20110490|P3|FAS/SAF: Overall Population|Overall Study||298
8158399|NCT02555683|20110491|P2|FAS/SAF: Overall Population|Overall Study||293
8158400|NCT02555683|20110492|P1|FAS/SAF: Overall Population|Overall Study||299
8158401|NCT02555683|20110490|P3|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
8158402|NCT02555683|20110491|P2|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
8158403|NCT02555683|20110492|P1|FAS/SAF: High Eosinophil Subpopulation|Overall Study||200
8158404|NCT02555683|20110490|P3|STARTED|Overall Study||298
8158405|NCT02555683|20110491|P2|STARTED|Overall Study||295
8158406|NCT02555683|20110492|P1|STARTED|Overall Study||301
8158407|NCT02555657|20110523|P2|NOT COMPLETED|Overall Study||310
8158408|NCT02555657|20110524|P1|NOT COMPLETED|Overall Study||312
8158409|NCT02555657|20110523|P2|COMPLETED|Overall Study||0
8158410|NCT02555657|20110524|P1|COMPLETED|Overall Study||0
8158411|NCT02555657|20110523|P2|Treated|Overall Study||292
8158412|NCT02555657|20110524|P1|Treated|Overall Study||309
8158413|NCT02555657|20110523|P2|STARTED|Overall Study||310
8158414|NCT02555657|20110524|P1|STARTED|Overall Study||312
8158415|NCT02555631|20110562|P1|NOT COMPLETED|Overall Study||4
8158416|NCT02555631|20110562|P1|COMPLETED|Overall Study||25
8158417|NCT02555631|20110562|P1|STARTED|Overall Study||29
8158418|NCT02555618|20110571|P2|NOT COMPLETED|Overall Study||0
8158419|NCT02555618|20110572|P1|NOT COMPLETED|Overall Study||1
8158420|NCT02555618|20110571|P2|COMPLETED|Overall Study||200
8158421|NCT02555618|20110572|P1|COMPLETED|Overall Study||199
8158422|NCT02555618|20110571|P2|STARTED|Overall Study||200
8158423|NCT02555618|20110572|P1|STARTED|Overall Study||200
8158424|NCT02555371|20110614|P5|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3
8158425|NCT02555371|20110615|P4|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4
8158426|NCT02555371|20110616|P3|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8158427|NCT02555371|20110617|P2|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8158428|NCT02555371|20110618|P1|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8158429|NCT02555371|20110614|P5|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42
8158430|NCT02555371|20110615|P4|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80
8158431|NCT02555371|20110616|P3|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8158432|NCT02555371|20110617|P2|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8158433|NCT02555371|20110618|P1|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
8158434|NCT02555371|20110614|P5|STARTED|PartD(OL: 52W Post-randomization PartC)||45
8158435|NCT02555371|20110615|P4|STARTED|PartD(OL: 52W Post-randomization PartC)||84
8158436|NCT02555371|20110616|P3|STARTED|PartD(OL: 52W Post-randomization PartC)||0
8158437|NCT02555371|20110617|P2|STARTED|PartD(OL: 52W Post-randomization PartC)||0
8158438|NCT02555371|20110618|P1|STARTED|PartD(OL: 52W Post-randomization PartC)||0
8158439|NCT02555371|20110614|P5|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
8158440|NCT02555371|20110615|P4|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
8158441|NCT02555371|20110616|P3|NOT COMPLETED|Part C (DB Period: Up to 52W)||48
8158442|NCT02555371|20110617|P2|NOT COMPLETED|Part C (DB Period: Up to 52W)||89
8158443|NCT02555371|20110618|P1|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
8158444|NCT02555371|20110614|P5|COMPLETED|Part C (DB Period: Up to 52W)||0
8158445|NCT02555371|20110615|P4|COMPLETED|Part C (DB Period: Up to 52W)||0
8158446|NCT02555371|20110616|P3|COMPLETED|Part C (DB Period: Up to 52W)||96
8158447|NCT02555371|20110617|P2|COMPLETED|Part C (DB Period: Up to 52W)||62
8158448|NCT02555371|20110618|P1|COMPLETED|Part C (DB Period: Up to 52W)||0
8158449|NCT02555371|20110614|P5|STARTED|Part C (DB Period: Up to 52W)||0
8158450|NCT02555371|20110615|P4|STARTED|Part C (DB Period: Up to 52W)||0
8158451|NCT02555371|20110616|P3|STARTED|Part C (DB Period: Up to 52W)||144
8158452|NCT02555371|20110617|P2|STARTED|Part C (DB Period: Up to 52W)||151
8158453|NCT02555371|20110618|P1|STARTED|Part C (DB Period: Up to 52W)||0
8158454|NCT02555371|20110614|P5|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158455|NCT02555371|20110615|P4|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158456|NCT02555371|20110616|P3|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158457|NCT02555371|20110617|P2|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158458|NCT02555371|20110618|P1|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11
8158459|NCT02555371|20110614|P5|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158460|NCT02555371|20110615|P4|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158461|NCT02555371|20110616|P3|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158462|NCT02555371|20110617|P2|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158463|NCT02555371|20110618|P1|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295
8158464|NCT02555371|20110614|P5|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158465|NCT02555371|20110615|P4|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158466|NCT02555371|20110616|P3|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158467|NCT02555371|20110617|P2|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
8158468|NCT02555371|20110618|P1|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306
8158469|NCT02555306|20110637|P4|NOT COMPLETED|Overall Study||0
8158470|NCT02555306|20110638|P3|NOT COMPLETED|Overall Study||0
8158471|NCT02555306|20110639|P2|NOT COMPLETED|Overall Study||0
8158472|NCT02555306|20110640|P1|NOT COMPLETED|Overall Study||0
8158473|NCT02555306|20110637|P4|COMPLETED|Overall Study||3
8158474|NCT02555306|20110638|P3|COMPLETED|Overall Study||3
8158475|NCT02555306|20110639|P2|COMPLETED|Overall Study||3
8158476|NCT02555306|20110640|P1|COMPLETED|Overall Study||3
8158477|NCT02555306|20110637|P4|STARTED|Overall Study||3
8158478|NCT02555306|20110638|P3|STARTED|Overall Study||3
8158479|NCT02555306|20110639|P2|STARTED|Overall Study||3
8158480|NCT02555306|20110640|P1|STARTED|Overall Study||3
8158481|NCT02555228|20110656|P2|NOT COMPLETED|Overall Study||0
8158482|NCT02555228|20110657|P1|NOT COMPLETED|Overall Study||0
8158483|NCT02555228|20110656|P2|COMPLETED|Overall Study|29th October 2015|27
8158484|NCT02555228|20110657|P1|COMPLETED|Overall Study|19th November 2015|27
8158485|NCT02555228|20110656|P2|STARTED|Overall Study|14th August 2015|27
8158486|NCT02555228|20110657|P1|STARTED|Overall Study|20th August 2015|27
8158487|NCT02555215|20110669|P1|NOT COMPLETED|Overall Study||3
8158488|NCT02555215|20110669|P1|COMPLETED|Overall Study||17
8158489|NCT02555215|20110669|P1|STARTED|Overall Study||20
8158490|NCT02555098|20110680|P2|NOT COMPLETED|Second Intervention||0
8158491|NCT02555098|20110681|P1|NOT COMPLETED|Second Intervention||0
8158492|NCT02555098|20110680|P2|COMPLETED|Second Intervention||11
8158493|NCT02555098|20110681|P1|COMPLETED|Second Intervention||12
8158494|NCT02555098|20110680|P2|STARTED|Second Intervention||11
8158495|NCT02555098|20110681|P1|STARTED|Second Intervention||12
8158496|NCT02555098|20110680|P2|NOT COMPLETED|First Intervention||0
8158497|NCT02555098|20110681|P1|NOT COMPLETED|First Intervention||0
8158498|NCT02555098|20110680|P2|COMPLETED|First Intervention||11
8158499|NCT02555098|20110681|P1|COMPLETED|First Intervention||12
8158500|NCT02555098|20110680|P2|STARTED|First Intervention||11
8158501|NCT02555098|20110681|P1|STARTED|First Intervention||12
8158502|NCT02554981|20110701|P1|NOT COMPLETED|Overall Study||5
8158503|NCT02554981|20110701|P1|COMPLETED|Overall Study||46
8158504|NCT02554981|20110701|P1|STARTED|Overall Study||51
8158505|NCT02554929|20110727|P2|NOT COMPLETED|Overall Study||12
8158506|NCT02554929|20110728|P1|NOT COMPLETED|Overall Study||6
8158507|NCT02554929|20110727|P2|COMPLETED|Overall Study||32
8158508|NCT02554929|20110728|P1|COMPLETED|Overall Study||40
8158509|NCT02554929|20110727|P2|Per Protocol 6 Month Follow-up|Overall Study||32
8158510|NCT02554929|20110728|P1|Per Protocol 6 Month Follow-up|Overall Study||40
8158511|NCT02554929|20110727|P2|Per Protocol Post-Intervention|Overall Study||36
8158512|NCT02554929|20110728|P1|Per Protocol Post-Intervention|Overall Study||42
8158513|NCT02554929|20110727|P2|Per Protocol Received Intervention|Overall Study||36
8158514|NCT02554929|20110728|P1|Per Protocol Received Intervention|Overall Study||44
8158515|NCT02554929|20110727|P2|STARTED|Overall Study||44
8158516|NCT02554929|20110728|P1|STARTED|Overall Study||46
8158517|NCT02554890|20110746|P2|NOT COMPLETED|Open-label||52
8158518|NCT02554890|20110747|P1|NOT COMPLETED|Open-label||0
8158519|NCT02554890|20110746|P2|COMPLETED|Open-label||835
8158520|NCT02554890|20110747|P1|COMPLETED|Open-label||0
8158521|NCT02554890|20110746|P2|STARTED|Open-label||887
8158522|NCT02554890|20110747|P1|STARTED|Open-label||0
8158523|NCT02554890|20110746|P2|NOT COMPLETED|Double-blind||91
8158524|NCT02554890|20110747|P1|NOT COMPLETED|Double-blind||96
8158525|NCT02554890|20110746|P2|COMPLETED|Double-blind||352
8158526|NCT02554890|20110747|P1|COMPLETED|Double-blind||348
8158527|NCT02554890|20110746|P2|Treated Patients|Double-blind||439
8158528|NCT02554890|20110747|P1|Treated Patients|Double-blind||436
8158529|NCT02554890|20110746|P2|STARTED|Double-blind||443
8158530|NCT02554890|20110747|P1|STARTED|Double-blind||444
8158531|NCT02554877|20110775|P4|NOT COMPLETED|Overall Study||7
8158532|NCT02554877|20110776|P3|NOT COMPLETED|Overall Study||6
8158533|NCT02554877|20110777|P2|NOT COMPLETED|Overall Study||7
8158534|NCT02554877|20110778|P1|NOT COMPLETED|Overall Study||12
8158535|NCT02554877|20110775|P4|COMPLETED|Overall Study||45
8158536|NCT02554877|20110776|P3|COMPLETED|Overall Study||46
8158537|NCT02554877|20110777|P2|COMPLETED|Overall Study||44
8158538|NCT02554877|20110778|P1|COMPLETED|Overall Study||39
8158539|NCT02554877|20110775|P4|STARTED|Overall Study||52
8158540|NCT02554877|20110776|P3|STARTED|Overall Study||52
8158541|NCT02554877|20110777|P2|STARTED|Overall Study||51
8158542|NCT02554877|20110778|P1|STARTED|Overall Study||51
8158543|NCT02554799|20110842|P2|NOT COMPLETED|Overall Study||0
8158544|NCT02554799|20110843|P1|NOT COMPLETED|Overall Study||0
8158545|NCT02554799|20110842|P2|COMPLETED|Overall Study||9
8158546|NCT02554799|20110843|P1|COMPLETED|Overall Study||9
8158547|NCT02554799|20110842|P2|STARTED|Overall Study||9
8158548|NCT02554799|20110843|P1|STARTED|Overall Study||9
8158549|NCT02554786|20110866|P5|NOT COMPLETED|Overall Study||30
8158550|NCT02554786|20110867|P4|NOT COMPLETED|Overall Study||41
8158551|NCT02554786|20110868|P3|NOT COMPLETED|Overall Study||30
8158552|NCT02554786|20110869|P2|NOT COMPLETED|Overall Study||26
8158553|NCT02554786|20110870|P1|NOT COMPLETED|Overall Study||35
8158554|NCT02554786|20110866|P5|COMPLETED|Overall Study||416
8158555|NCT02554786|20110867|P4|COMPLETED|Overall Study||403
8158556|NCT02554786|20110868|P3|COMPLETED|Overall Study||412
8158557|NCT02554786|20110869|P2|COMPLETED|Overall Study||413
8158558|NCT02554786|20110870|P1|COMPLETED|Overall Study||410
8158559|NCT02554786|20110866|P5|STARTED|Overall Study||446
8158560|NCT02554786|20110867|P4|STARTED|Overall Study||444
8158561|NCT02554786|20110868|P3|STARTED|Overall Study||442
8158562|NCT02554786|20110869|P2|STARTED|Overall Study||439
8158563|NCT02554786|20110870|P1|STARTED|Overall Study||445
8158564|NCT02554760|20111012|P2|NOT COMPLETED|Overall Study||0
8158565|NCT02554760|20111013|P1|NOT COMPLETED|Overall Study||0
8158566|NCT02554760|20111012|P2|COMPLETED|Overall Study||10
8158567|NCT02554760|20111013|P1|COMPLETED|Overall Study||9
8158568|NCT02554760|20111012|P2|STARTED|Overall Study||10
8158569|NCT02554760|20111013|P1|STARTED|Overall Study||9
8158570|NCT02554682|20111032|P10|NOT COMPLETED|Overall Study||2
8158571|NCT02554682|20111033|P9|NOT COMPLETED|Overall Study||2
8158572|NCT02554682|20111034|P8|NOT COMPLETED|Overall Study||6
8158573|NCT02554682|20111035|P7|NOT COMPLETED|Overall Study||6
8158574|NCT02554682|20111036|P6|NOT COMPLETED|Overall Study||1
8158575|NCT02554682|20111037|P5|NOT COMPLETED|Overall Study||2
8158576|NCT02554682|20111038|P4|NOT COMPLETED|Overall Study||3
8158577|NCT02554682|20111039|P3|NOT COMPLETED|Overall Study||4
8158578|NCT02554682|20111040|P2|NOT COMPLETED|Overall Study||12
8158579|NCT02554682|20111041|P1|NOT COMPLETED|Overall Study||15
8158580|NCT02554682|20111032|P10|COMPLETED|Overall Study||24
8158581|NCT02554682|20111033|P9|COMPLETED|Overall Study||24
8158582|NCT02554682|20111034|P8|COMPLETED|Overall Study||22
8158583|NCT02554682|20111035|P7|COMPLETED|Overall Study||22
8158584|NCT02554682|20111036|P6|COMPLETED|Overall Study||39
8158585|NCT02554682|20111037|P5|COMPLETED|Overall Study||38
8158586|NCT02554682|20111038|P4|COMPLETED|Overall Study||37
8158587|NCT02554682|20111039|P3|COMPLETED|Overall Study||36
8158588|NCT02554682|20111040|P2|COMPLETED|Overall Study||28
8158589|NCT02554682|20111041|P1|COMPLETED|Overall Study||25
8158590|NCT02554682|20111032|P10|STARTED|Overall Study||26
8158591|NCT02554682|20111033|P9|STARTED|Overall Study||26
8158592|NCT02554682|20111034|P8|STARTED|Overall Study||28
8158593|NCT02554682|20111035|P7|STARTED|Overall Study||28
8158594|NCT02554682|20111036|P6|STARTED|Overall Study||40
8158595|NCT02554682|20111037|P5|STARTED|Overall Study||40
8158596|NCT02554682|20111038|P4|STARTED|Overall Study||40
8158597|NCT02554682|20111039|P3|STARTED|Overall Study||40
8158598|NCT02554682|20111040|P2|STARTED|Overall Study||40
8158599|NCT02554682|20111041|P1|STARTED|Overall Study||40
8158603|NCT02554435|20111100|P2|NOT COMPLETED|Overall Study||1
8158604|NCT02554435|20111101|P1|NOT COMPLETED|Overall Study||6
8158605|NCT02554435|20111100|P2|COMPLETED|Overall Study||19
8158606|NCT02554435|20111101|P1|COMPLETED|Overall Study||14
8158607|NCT02554435|20111100|P2|STARTED|Overall Study||20
8158608|NCT02554435|20111101|P1|STARTED|Overall Study||20
8158609|NCT02554279|20111135|P2|NOT COMPLETED|Overall Study||18
8158610|NCT02554279|20111136|P1|NOT COMPLETED|Overall Study||32
8158611|NCT02554279|20111135|P2|COMPLETED|Overall Study||291
8158612|NCT02554279|20111136|P1|COMPLETED|Overall Study||279
8158613|NCT02554279|20111135|P2|Completed Fresh Blastocyst Transfer|Overall Study||191
8158614|NCT02554279|20111136|P1|Completed Fresh Blastocyst Transfer|Overall Study||201
8158615|NCT02554279|20111135|P2|Completed Oocyte Retrieval|Overall Study||306
8158616|NCT02554279|20111136|P1|Completed Oocyte Retrieval|Overall Study||292
8158617|NCT02554279|20111135|P2|Received Trigger|Overall Study||307
8158618|NCT02554279|20111136|P1|Received Trigger|Overall Study||293
8158619|NCT02554279|20111135|P2|Completed Day 6 of Stimulation|Overall Study||309
8158620|NCT02554279|20111136|P1|Completed Day 6 of Stimulation|Overall Study||308
8158621|NCT02554279|20111135|P2|Treated|Overall Study||309
8158622|NCT02554279|20111136|P1|Treated|Overall Study||310
8158623|NCT02554279|20111135|P2|STARTED|Overall Study||309
8158624|NCT02554279|20111136|P1|STARTED|Overall Study||311
8158625|NCT02554019|20111171|P3|NOT COMPLETED|Overall Study||2
8158626|NCT02554019|20111172|P2|NOT COMPLETED|Overall Study||0
8158627|NCT02554019|20111173|P1|NOT COMPLETED|Overall Study||2
8158628|NCT02554019|20111171|P3|COMPLETED|Overall Study||10
8158629|NCT02554019|20111172|P2|COMPLETED|Overall Study||12
8158630|NCT02554019|20111173|P1|COMPLETED|Overall Study||10
8158631|NCT02554019|20111171|P3|STARTED|Overall Study||12
8158632|NCT02554019|20111172|P2|STARTED|Overall Study||12
8158633|NCT02554019|20111173|P1|STARTED|Overall Study||12
8158634|NCT02553928|20111195|P2|NOT COMPLETED|Overall Study||3
8158635|NCT02553928|20111196|P1|NOT COMPLETED|Overall Study||2
8158636|NCT02553928|20111195|P2|COMPLETED|Overall Study||29
8158637|NCT02553928|20111196|P1|COMPLETED|Overall Study||28
8158638|NCT02553928|20111195|P2|STARTED|Overall Study||32
8158639|NCT02553928|20111196|P1|STARTED|Overall Study||30
8158655|NCT02553772|20111250|P2|NOT COMPLETED|Overall Study||6
8158656|NCT02553772|20111251|P1|NOT COMPLETED|Overall Study||6
8158657|NCT02553772|20111250|P2|COMPLETED|Overall Study||116
8158658|NCT02553772|20111251|P1|COMPLETED|Overall Study||114
8158659|NCT02553772|20111250|P2|STARTED|Overall Study||122
8158660|NCT02553772|20111251|P1|STARTED|Overall Study||120
8158661|NCT02553746|20111267|P2|NOT COMPLETED|Overall Study||2
8158662|NCT02553746|20111268|P1|NOT COMPLETED|Overall Study||3
8158663|NCT02553746|20111267|P2|COMPLETED|Overall Study||64
8158664|NCT02553746|20111268|P1|COMPLETED|Overall Study||77
8158665|NCT02553746|20111267|P2|STARTED|Overall Study||66
8158666|NCT02553746|20111268|P1|STARTED|Overall Study||80
8158667|NCT02553629|20111296|P2|NOT COMPLETED|Overall Study||6
8158668|NCT02553629|20111297|P1|NOT COMPLETED|Overall Study||3
8158669|NCT02553629|20111296|P2|COMPLETED|Overall Study||50
8158670|NCT02553629|20111297|P1|COMPLETED|Overall Study||50
8158671|NCT02553629|20111296|P2|STARTED|Overall Study||56
8158672|NCT02553629|20111297|P1|STARTED|Overall Study||53
8158673|NCT02553538|20111313|P2|NOT COMPLETED|Overall Study||56
8158674|NCT02553538|20111314|P1|NOT COMPLETED|Overall Study||187
8158675|NCT02553538|20111313|P2|COMPLETED|Overall Study||764
8158676|NCT02553538|20111314|P1|COMPLETED|Overall Study||605
8158677|NCT02553538|20111313|P2|STARTED|Overall Study||820
8158678|NCT02553538|20111314|P1|STARTED|Overall Study||792
8158679|NCT02553512|20111326|P1|NOT COMPLETED|Overall Study||23
8158680|NCT02553512|20111326|P1|COMPLETED|Overall Study||144
8158681|NCT02553512|20111326|P1|STARTED|Overall Study||167
8158682|NCT02553499|20111348|P14|NOT COMPLETED|Overall Study||2
8158683|NCT02553499|20111349|P13|NOT COMPLETED|Overall Study||3
8158684|NCT02553499|20111350|P12|NOT COMPLETED|Overall Study||3
8158685|NCT02553499|20111351|P11|NOT COMPLETED|Overall Study||3
8158686|NCT02553499|20111352|P10|NOT COMPLETED|Overall Study||3
8158687|NCT02553499|20111353|P9|NOT COMPLETED|Overall Study||3
8158688|NCT02553499|20111354|P8|NOT COMPLETED|Overall Study||3
8158689|NCT02553499|20111355|P7|NOT COMPLETED|Overall Study||3
8158690|NCT02553499|20111356|P6|NOT COMPLETED|Overall Study||3
8158691|NCT02553499|20111357|P5|NOT COMPLETED|Overall Study||3
8158692|NCT02553499|20111358|P4|NOT COMPLETED|Overall Study||2
8158693|NCT02553499|20111359|P3|NOT COMPLETED|Overall Study||2
8158694|NCT02553499|20111360|P2|NOT COMPLETED|Overall Study||2
8158695|NCT02553499|20111361|P1|NOT COMPLETED|Overall Study||2
8158696|NCT02553499|20111348|P14|COMPLETED|Overall Study||0
8158697|NCT02553499|20111349|P13|COMPLETED|Overall Study||0
8158698|NCT02553499|20111350|P12|COMPLETED|Overall Study||0
8158699|NCT02553499|20111351|P11|COMPLETED|Overall Study||0
8158700|NCT02553499|20111352|P10|COMPLETED|Overall Study||0
8158701|NCT02553499|20111353|P9|COMPLETED|Overall Study||0
8158702|NCT02553499|20111354|P8|COMPLETED|Overall Study||0
8158703|NCT02553499|20111355|P7|COMPLETED|Overall Study||0
8158704|NCT02553499|20111356|P6|COMPLETED|Overall Study||0
8158705|NCT02553499|20111357|P5|COMPLETED|Overall Study||0
8158706|NCT02553499|20111358|P4|COMPLETED|Overall Study||0
8158707|NCT02553499|20111359|P3|COMPLETED|Overall Study||0
8158708|NCT02553499|20111360|P2|COMPLETED|Overall Study||0
8158709|NCT02553499|20111361|P1|COMPLETED|Overall Study||0
8158710|NCT02553499|20111348|P14|STARTED|Overall Study||2
8158711|NCT02553499|20111349|P13|STARTED|Overall Study||3
8158712|NCT02553499|20111350|P12|STARTED|Overall Study||3
8158713|NCT02553499|20111351|P11|STARTED|Overall Study||3
8158714|NCT02553499|20111352|P10|STARTED|Overall Study||3
8158715|NCT02553499|20111353|P9|STARTED|Overall Study||3
8158716|NCT02553499|20111354|P8|STARTED|Overall Study||3
8158717|NCT02553499|20111355|P7|STARTED|Overall Study||3
8158718|NCT02553499|20111356|P6|STARTED|Overall Study||3
8158719|NCT02553499|20111357|P5|STARTED|Overall Study||3
8158720|NCT02553499|20111358|P4|STARTED|Overall Study||2
8158721|NCT02553499|20111359|P3|STARTED|Overall Study||2
8158722|NCT02553499|20111360|P2|STARTED|Overall Study||2
8158723|NCT02553499|20111361|P1|STARTED|Overall Study||2
8158724|NCT02553421|20111463|P2|NOT COMPLETED|Overall Study||1
8158725|NCT02553421|20111464|P1|NOT COMPLETED|Overall Study||29
8158726|NCT02553421|20111463|P2|COMPLETED|Overall Study||57
8158727|NCT02553421|20111464|P1|COMPLETED|Overall Study||156
8158728|NCT02553421|20111463|P2|STARTED|Overall Study||58
8158729|NCT02553421|20111464|P1|STARTED|Overall Study||185
8158730|NCT02553395|20111472|P2|NOT COMPLETED|Second Intervention||0
8158731|NCT02553395|20111473|P1|NOT COMPLETED|Second Intervention||0
8158732|NCT02553395|20111472|P2|COMPLETED|Second Intervention||18
8158733|NCT02553395|20111473|P1|COMPLETED|Second Intervention||12
8158734|NCT02553395|20111472|P2|STARTED|Second Intervention||18
8158735|NCT02553395|20111473|P1|STARTED|Second Intervention||12
8158736|NCT02553395|20111472|P2|NOT COMPLETED|First Intervention||0
8158737|NCT02553395|20111473|P1|NOT COMPLETED|First Intervention||0
8158738|NCT02553395|20111472|P2|COMPLETED|First Intervention||18
8158739|NCT02553395|20111473|P1|COMPLETED|First Intervention||12
8158740|NCT02553395|20111472|P2|STARTED|First Intervention||18
8158741|NCT02553395|20111473|P1|STARTED|First Intervention||12
8158742|NCT02553330|20111519|P3|NOT COMPLETED|Overall Study||37
8158743|NCT02553330|20111520|P2|NOT COMPLETED|Overall Study||39
8158744|NCT02553330|20111521|P1|NOT COMPLETED|Overall Study||5
8158745|NCT02553330|20111519|P3|COMPLETED|Overall Study||2
8158746|NCT02553330|20111520|P2|COMPLETED|Overall Study||0
8158747|NCT02553330|20111521|P1|COMPLETED|Overall Study||7
8158748|NCT02553330|20111519|P3|STARTED|Overall Study||39
8158749|NCT02553330|20111520|P2|STARTED|Overall Study||39
8158750|NCT02553330|20111521|P1|STARTED|Overall Study||12
8158751|NCT02553317|20111545|P2|NOT COMPLETED|Open-label (OL) Treatment Period||4
8158752|NCT02553317|20111546|P1|NOT COMPLETED|Open-label (OL) Treatment Period||0
8158753|NCT02553317|20111545|P2|COMPLETED|Open-label (OL) Treatment Period||22
8158754|NCT02553317|20111546|P1|COMPLETED|Open-label (OL) Treatment Period||2
8158755|NCT02553317|20111545|P2|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26
8158756|NCT02553317|20111546|P1|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2
8158757|NCT02553317|20111545|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||8
8158758|NCT02553317|20111546|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||3
8158759|NCT02553317|20111545|P2|COMPLETED|Double-blind (DB) Treatment Period||65
8158760|NCT02553317|20111546|P1|COMPLETED|Double-blind (DB) Treatment Period||68
8158761|NCT02553317|20111545|P2|STARTED|Double-blind (DB) Treatment Period||73
8158762|NCT02553317|20111546|P1|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71
8158763|NCT02553317|20111545|P2|NOT COMPLETED|Overall Treatment Period + Follow-up||23
8158764|NCT02553317|20111546|P1|NOT COMPLETED|Overall Treatment Period + Follow-up||14
8158765|NCT02553317|20111545|P2|COMPLETED|Overall Treatment Period + Follow-up||50
8158766|NCT02553317|20111546|P1|COMPLETED|Overall Treatment Period + Follow-up||58
8158767|NCT02553317|20111545|P2|Received Study Drug|Overall Treatment Period + Follow-up||73
8158768|NCT02553317|20111546|P1|Received Study Drug|Overall Treatment Period + Follow-up||71
8158769|NCT02553317|20111545|P2|STARTED|Overall Treatment Period + Follow-up||73
8158770|NCT02553317|20111546|P1|STARTED|Overall Treatment Period + Follow-up||72
8158771|NCT02553135|20111569|P1|NOT COMPLETED|Overall Study||0
8158772|NCT02553135|20111569|P1|COMPLETED|Overall Study||6
8158773|NCT02553135|20111569|P1|STARTED|Overall Study||6
8158774|NCT02552966|20111576|P1|NOT COMPLETED|Overall Study||5
8158775|NCT02552966|20111576|P1|COMPLETED|Overall Study||15
8158776|NCT02552966|20111576|P1|STARTED|Overall Study||20
8158777|NCT02552810|20111585|P2|NOT COMPLETED|Overall Study||0
8158778|NCT02552810|20111586|P1|NOT COMPLETED|Overall Study||0
8158779|NCT02552810|20111585|P2|COMPLETED|Overall Study||15
8158780|NCT02552810|20111586|P1|COMPLETED|Overall Study||15
8158781|NCT02552810|20111585|P2|STARTED|Overall Study||15
8158782|NCT02552810|20111586|P1|STARTED|Overall Study||15
8158783|NCT02552732|20111602|P1|NOT COMPLETED|Overall Study||10
8158784|NCT02552732|20111602|P1|COMPLETED|Overall Study||19
8158785|NCT02552732|20111602|P1|Completed Day 1 and Day 31 Spirometry|Overall Study||12
8158786|NCT02552732|20111602|P1|Completed Week 4|Overall Study||19
8158787|NCT02552732|20111602|P1|Completed Week 3|Overall Study||19
8158788|NCT02552732|20111602|P1|Completed Week 2|Overall Study||20
8158789|NCT02552732|20111602|P1|Completed Week 1|Overall Study||21
8158790|NCT02552732|20111602|P1|Used Device|Overall Study||23
8158791|NCT02552732|20111602|P1|STARTED|Overall Study||29
8158792|NCT02552368|20111629|P1|NOT COMPLETED|Overall Study||13
8158793|NCT02552368|20111629|P1|COMPLETED|Overall Study||10
8158794|NCT02552368|20111629|P1|STARTED|Overall Study||23
8158795|NCT02552355|20111638|P4|NOT COMPLETED|Overall Study||1
8158796|NCT02552355|20111639|P3|NOT COMPLETED|Overall Study||2
8158797|NCT02552355|20111640|P2|NOT COMPLETED|Overall Study||2
8158798|NCT02552355|20111641|P1|NOT COMPLETED|Overall Study||0
8158799|NCT02552355|20111638|P4|COMPLETED|Overall Study||14
8158800|NCT02552355|20111639|P3|COMPLETED|Overall Study||12
8158801|NCT02552355|20111640|P2|COMPLETED|Overall Study||11
8158802|NCT02552355|20111641|P1|COMPLETED|Overall Study||14
8158803|NCT02552355|20111638|P4|STARTED|Overall Study||15
8158804|NCT02552355|20111639|P3|STARTED|Overall Study||14
8158805|NCT02552355|20111640|P2|STARTED|Overall Study||13
8158806|NCT02552355|20111641|P1|STARTED|Overall Study||14
8158807|NCT02552316|20111683|P1|NOT COMPLETED|Overall Study||2
8158808|NCT02552316|20111683|P1|COMPLETED|Overall Study||32
8158809|NCT02552316|20111683|P1|STARTED|Overall Study||34
8158810|NCT02552303|20111735|P4|NOT COMPLETED|Follow-Up||0
8158811|NCT02552303|20111736|P3|NOT COMPLETED|Follow-Up||1
8158812|NCT02552303|20111737|P2|NOT COMPLETED|Follow-Up||2
8158813|NCT02552303|20111738|P1|NOT COMPLETED|Follow-Up||0
8158814|NCT02552303|20111735|P4|COMPLETED|Follow-Up||10
8158815|NCT02552303|20111736|P3|COMPLETED|Follow-Up||6
8158816|NCT02552303|20111737|P2|COMPLETED|Follow-Up||6
8158817|NCT02552303|20111738|P1|COMPLETED|Follow-Up||7
8158818|NCT02552303|20111735|P4|STARTED|Follow-Up||10
8158819|NCT02552303|20111736|P3|STARTED|Follow-Up||7
8158820|NCT02552303|20111737|P2|STARTED|Follow-Up||8
8158821|NCT02552303|20111738|P1|STARTED|Follow-Up||7
8158822|NCT02552303|20111735|P4|NOT COMPLETED|Allocation||1
8158823|NCT02552303|20111736|P3|NOT COMPLETED|Allocation||1
8158824|NCT02552303|20111737|P2|NOT COMPLETED|Allocation||2
8158825|NCT02552303|20111738|P1|NOT COMPLETED|Allocation||3
8158826|NCT02552303|20111735|P4|COMPLETED|Allocation||10
8158827|NCT02552303|20111736|P3|COMPLETED|Allocation||7
8158828|NCT02552303|20111737|P2|COMPLETED|Allocation||8
8158829|NCT02552303|20111738|P1|COMPLETED|Allocation||7
8158830|NCT02552303|20111735|P4|STARTED|Allocation||11
8158831|NCT02552303|20111736|P3|STARTED|Allocation||8
8158832|NCT02552303|20111737|P2|STARTED|Allocation||10
8158833|NCT02552303|20111738|P1|STARTED|Allocation||10
8158845|NCT02552147|20111840|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8158846|NCT02552147|20111841|P1|NOT COMPLETED|Second Intervention (7 Days)||2
8158847|NCT02552147|20111840|P2|COMPLETED|Second Intervention (7 Days)||4
8158848|NCT02552147|20111841|P1|COMPLETED|Second Intervention (7 Days)||1
8158849|NCT02552147|20111840|P2|STARTED|Second Intervention (7 Days)||4
8158850|NCT02552147|20111841|P1|STARTED|Second Intervention (7 Days)||3
8158851|NCT02552147|20111840|P2|NOT COMPLETED|Washout (7 Days)||0
8158852|NCT02552147|20111841|P1|NOT COMPLETED|Washout (7 Days)||0
8158853|NCT02552147|20111840|P2|COMPLETED|Washout (7 Days)||4
8158854|NCT02552147|20111841|P1|COMPLETED|Washout (7 Days)||3
8158855|NCT02552147|20111840|P2|STARTED|Washout (7 Days)||4
8158856|NCT02552147|20111841|P1|STARTED|Washout (7 Days)||3
8158857|NCT02552147|20111840|P2|NOT COMPLETED|First Intervention (7 Days)||0
8158858|NCT02552147|20111841|P1|NOT COMPLETED|First Intervention (7 Days)||1
8158859|NCT02552147|20111840|P2|COMPLETED|First Intervention (7 Days)||4
8158860|NCT02552147|20111841|P1|COMPLETED|First Intervention (7 Days)||3
8158861|NCT02552147|20111840|P2|STARTED|First Intervention (7 Days)||4
8158862|NCT02552147|20111841|P1|STARTED|First Intervention (7 Days)||4
8158935|NCT02551887|20112128|P3|NOT COMPLETED|Overall Study||0
8158936|NCT02551887|20112129|P2|NOT COMPLETED|Overall Study||0
8158937|NCT02551887|20112130|P1|NOT COMPLETED|Overall Study||0
8158938|NCT02551887|20112128|P3|COMPLETED|Overall Study||222
8158939|NCT02551887|20112129|P2|COMPLETED|Overall Study||124
8158940|NCT02551887|20112130|P1|COMPLETED|Overall Study||301
8158941|NCT02551887|20112128|P3|STARTED|Overall Study||222
8158942|NCT02551887|20112129|P2|STARTED|Overall Study||124
8158943|NCT02551887|20112130|P1|STARTED|Overall Study||301
8158944|NCT02551874|20112143|P2|NOT COMPLETED|Overall Study||39
8158945|NCT02551874|20112144|P1|NOT COMPLETED|Overall Study||28
8158946|NCT02551874|20112143|P2|COMPLETED|Overall Study||287
8158947|NCT02551874|20112144|P1|COMPLETED|Overall Study||296
8158948|NCT02551874|20112143|P2|Received Treatment in Long-term Study|Overall Study||284
8158949|NCT02551874|20112144|P1|Received Treatment in Long-term Study|Overall Study||295
8158950|NCT02551874|20112143|P2|Entered Long-term Study|Overall Study||294
8158951|NCT02551874|20112144|P1|Entered Long-term Study|Overall Study||306
8158952|NCT02551874|20112143|P2|Received Treatment in Short-term Study|Overall Study||319
8158953|NCT02551874|20112144|P1|Received Treatment in Short-term Study|Overall Study||324
8158954|NCT02551874|20112143|P2|STARTED|Overall Study||326
8158955|NCT02551874|20112144|P1|STARTED|Overall Study||324
8158956|NCT02551822|20112162|P2|NOT COMPLETED|Overall Study||2
8158957|NCT02551822|20112163|P1|NOT COMPLETED|Overall Study||2
8158958|NCT02551822|20112162|P2|COMPLETED|Overall Study||10
8158959|NCT02551822|20112163|P1|COMPLETED|Overall Study||9
8158960|NCT02551822|20112162|P2|STARTED|Overall Study||12
8158961|NCT02551822|20112163|P1|STARTED|Overall Study||11
8158962|NCT02551809|20112176|P3|NOT COMPLETED|Overall Study||1
8158963|NCT02551809|20112177|P2|NOT COMPLETED|Overall Study||1
8158964|NCT02551809|20112178|P1|NOT COMPLETED|Overall Study||0
8158965|NCT02551809|20112176|P3|COMPLETED|Overall Study||13
8158966|NCT02551809|20112177|P2|COMPLETED|Overall Study||14
8158967|NCT02551809|20112178|P1|COMPLETED|Overall Study||14
8158968|NCT02551809|20112176|P3|STARTED|Overall Study||14
8158969|NCT02551809|20112177|P2|STARTED|Overall Study||15
8158970|NCT02551809|20112178|P1|STARTED|Overall Study||14
8158971|NCT02551770|20112186|P2|NOT COMPLETED|Overall Study||3
8158972|NCT02551770|20112187|P1|NOT COMPLETED|Overall Study||3
8158973|NCT02551770|20112186|P2|COMPLETED|Overall Study||48
8158974|NCT02551770|20112187|P1|COMPLETED|Overall Study||48
8158975|NCT02551770|20112186|P2|STARTED|Overall Study||51
8158976|NCT02551770|20112187|P1|STARTED|Overall Study||51
8158977|NCT02551757|20112206|P2|NOT COMPLETED|Overall Study||3
8158978|NCT02551757|20112207|P1|NOT COMPLETED|Overall Study||7
8158979|NCT02551757|20112206|P2|COMPLETED|Overall Study||17
8158980|NCT02551757|20112207|P1|COMPLETED|Overall Study||13
8158981|NCT02551757|20112206|P2|STARTED|Overall Study||20
8158982|NCT02551757|20112207|P1|STARTED|Overall Study||20
8158983|NCT02551744|20112219|P2|NOT COMPLETED|Overall Study||0
8158984|NCT02551744|20112220|P1|NOT COMPLETED|Overall Study||0
8158985|NCT02551744|20112219|P2|COMPLETED|Overall Study||51
8158986|NCT02551744|20112220|P1|COMPLETED|Overall Study||50
8158987|NCT02551744|20112219|P2|STARTED|Overall Study||51
8158988|NCT02551744|20112220|P1|STARTED|Overall Study||50
8158989|NCT02551731|20112226|P1|NOT COMPLETED|Overall Study||2
8158990|NCT02551731|20112226|P1|COMPLETED|Overall Study||7
8158991|NCT02551731|20112226|P1|STARTED|Overall Study||9
8158992|NCT02551692|20112246|P3|NOT COMPLETED|Overall Study||5
8158993|NCT02551692|20112247|P2|NOT COMPLETED|Overall Study||1
8158994|NCT02551692|20112248|P1|NOT COMPLETED|Overall Study||1
8158995|NCT02551692|20112246|P3|COMPLETED|Overall Study||25
8158996|NCT02551692|20112247|P2|COMPLETED|Overall Study||26
8158997|NCT02551692|20112248|P1|COMPLETED|Overall Study||30
8158998|NCT02551692|20112246|P3|STARTED|Overall Study||30
8158999|NCT02551692|20112247|P2|STARTED|Overall Study||27
8159000|NCT02551692|20112248|P1|STARTED|Overall Study||31
8159001|NCT02551666|20112264|P2|NOT COMPLETED|Overall Study||3
8159002|NCT02551666|20112265|P1|NOT COMPLETED|Overall Study||1
8159003|NCT02551666|20112264|P2|COMPLETED|Overall Study||16
8159004|NCT02551666|20112265|P1|COMPLETED|Overall Study||15
8159005|NCT02551666|20112264|P2|STARTED|Overall Study||19
8159006|NCT02551666|20112265|P1|STARTED|Overall Study||16
8159007|NCT02551653|20112293|P2|NOT COMPLETED|Overall Study||0
8159008|NCT02551653|20112294|P1|NOT COMPLETED|Overall Study||0
8159009|NCT02551653|20112293|P2|COMPLETED|Overall Study||5
8159010|NCT02551653|20112294|P1|COMPLETED|Overall Study||5
8159011|NCT02551653|20112293|P2|STARTED|Overall Study||5
8159012|NCT02551653|20112294|P1|STARTED|Overall Study||5
8159013|NCT02551432|20112302|P1|NOT COMPLETED|Overall Study||0
8159014|NCT02551432|20112302|P1|COMPLETED|Overall Study||26
8159015|NCT02551432|20112302|P1|STARTED|Overall Study||26
8159016|NCT02551224|20112308|P2|NOT COMPLETED|Second Intervention (5 Min After First )||0
8159017|NCT02551224|20112309|P1|NOT COMPLETED|Second Intervention (5 Min After First )||0
8159018|NCT02551224|20112308|P2|COMPLETED|Second Intervention (5 Min After First )||50
8159019|NCT02551224|20112309|P1|COMPLETED|Second Intervention (5 Min After First )||50
8159020|NCT02551224|20112308|P2|STARTED|Second Intervention (5 Min After First )||50
8159021|NCT02551224|20112309|P1|STARTED|Second Intervention (5 Min After First )||50
8159022|NCT02551224|20112308|P2|NOT COMPLETED|First Intervention||0
8159023|NCT02551224|20112309|P1|NOT COMPLETED|First Intervention||0
8159024|NCT02551224|20112308|P2|COMPLETED|First Intervention||50
8159025|NCT02551224|20112309|P1|COMPLETED|First Intervention||50
8159026|NCT02551224|20112308|P2|STARTED|First Intervention||50
8159027|NCT02551224|20112309|P1|STARTED|First Intervention||50
8159028|NCT02551094|20112319|P2|NOT COMPLETED|Overall Study||147
8159029|NCT02551094|20112320|P1|NOT COMPLETED|Overall Study||140
8159030|NCT02551094|20112319|P2|COMPLETED|Overall Study||2232
8159031|NCT02551094|20112320|P1|COMPLETED|Overall Study||2226
8159032|NCT02551094|20112319|P2|STARTED|Overall Study||2379
8159033|NCT02551094|20112320|P1|STARTED|Overall Study||2366
8159034|NCT02551055|20112355|P8|NOT COMPLETED|Overall Study||0
8159035|NCT02551055|20112356|P7|NOT COMPLETED|Overall Study||3
8159036|NCT02551055|20112357|P6|NOT COMPLETED|Overall Study||1
8159037|NCT02551055|20112358|P5|NOT COMPLETED|Overall Study||7
8159038|NCT02551055|20112359|P4|NOT COMPLETED|Overall Study||5
8159039|NCT02551055|20112360|P3|NOT COMPLETED|Overall Study||2
8159040|NCT02551055|20112361|P2|NOT COMPLETED|Overall Study||6
8159041|NCT02551055|20112362|P1|NOT COMPLETED|Overall Study||4
8159042|NCT02551055|20112355|P8|COMPLETED|Overall Study||0
8159043|NCT02551055|20112356|P7|COMPLETED|Overall Study||1
8159044|NCT02551055|20112357|P6|COMPLETED|Overall Study||1
8159045|NCT02551055|20112358|P5|COMPLETED|Overall Study||0
8159046|NCT02551055|20112359|P4|COMPLETED|Overall Study||1
8159047|NCT02551055|20112360|P3|COMPLETED|Overall Study||1
8159048|NCT02551055|20112361|P2|COMPLETED|Overall Study||0
8159049|NCT02551055|20112362|P1|COMPLETED|Overall Study||0
8159050|NCT02551055|20112355|P8|STARTED|Overall Study||0
8159051|NCT02551055|20112356|P7|STARTED|Overall Study||4
8159052|NCT02551055|20112357|P6|STARTED|Overall Study||2
8159053|NCT02551055|20112358|P5|STARTED|Overall Study||7
8159054|NCT02551055|20112359|P4|STARTED|Overall Study||6
8159055|NCT02551055|20112360|P3|STARTED|Overall Study||3
8159056|NCT02551055|20112361|P2|STARTED|Overall Study||6
8159057|NCT02551055|20112362|P1|STARTED|Overall Study||4
8159082|NCT02550795|20112520|P3|NOT COMPLETED|Overall Study||0
8159083|NCT02550795|20112521|P2|NOT COMPLETED|Overall Study||1
8159084|NCT02550795|20112522|P1|NOT COMPLETED|Overall Study||0
8159085|NCT02550795|20112520|P3|COMPLETED|Overall Study||50
8159086|NCT02550795|20112521|P2|COMPLETED|Overall Study||49
8159087|NCT02550795|20112522|P1|COMPLETED|Overall Study||50
8159088|NCT02550795|20112520|P3|STARTED|Overall Study||50
8159089|NCT02550795|20112521|P2|STARTED|Overall Study||50
8159090|NCT02550795|20112522|P1|STARTED|Overall Study||50
8159097|NCT02550288|20112586|P5|NOT COMPLETED|Overall Study||3
8159098|NCT02550288|20112587|P4|NOT COMPLETED|Overall Study||3
8159099|NCT02550288|20112588|P3|NOT COMPLETED|Overall Study||1
8159100|NCT02550288|20112589|P2|NOT COMPLETED|Overall Study||3
8159101|NCT02550288|20112590|P1|NOT COMPLETED|Overall Study||2
8159102|NCT02550288|20112586|P5|COMPLETED|Overall Study||66
8159103|NCT02550288|20112587|P4|COMPLETED|Overall Study||65
8159104|NCT02550288|20112588|P3|COMPLETED|Overall Study||68
8159105|NCT02550288|20112589|P2|COMPLETED|Overall Study||65
8159106|NCT02550288|20112590|P1|COMPLETED|Overall Study||33
8159107|NCT02550288|20112586|P5|STARTED|Overall Study||69
8159108|NCT02550288|20112587|P4|STARTED|Overall Study||68
8159109|NCT02550288|20112588|P3|STARTED|Overall Study||69
8159110|NCT02550288|20112589|P2|STARTED|Overall Study||68
8159111|NCT02550288|20112590|P1|STARTED|Overall Study||35
8159112|NCT02550210|20112687|P1|NOT COMPLETED|Overall Study||4
8159113|NCT02550210|20112687|P1|COMPLETED|Overall Study||19
8159114|NCT02550210|20112687|P1|STARTED|Overall Study||23
8159115|NCT02550197|20112696|P2|NOT COMPLETED|Overall Study||0
8159116|NCT02550197|20112697|P1|NOT COMPLETED|Overall Study||0
8159117|NCT02550197|20112696|P2|COMPLETED|Overall Study||100
8159118|NCT02550197|20112697|P1|COMPLETED|Overall Study||200
8159119|NCT02550197|20112696|P2|STARTED|Overall Study||100
8159120|NCT02550197|20112697|P1|STARTED|Overall Study||200
8159121|NCT02550132|20112715|P1|NOT COMPLETED|Overall Study||0
8159122|NCT02550132|20112715|P1|COMPLETED|Overall Study||25
8159123|NCT02550132|20112715|P1|STARTED|Overall Study||25
8159124|NCT02550106|20112746|P1|NOT COMPLETED|Overall Study||12
8159125|NCT02550106|20112746|P1|COMPLETED|Overall Study||124
8159126|NCT02550106|20112746|P1|STARTED|Overall Study||136
8159127|NCT02549859|20112770|P1|NOT COMPLETED|Visit 2||0
8159128|NCT02549859|20112770|P1|COMPLETED|Visit 2||10
8159129|NCT02549859|20112770|P1|STARTED|Visit 2||10
8159130|NCT02549859|20112770|P1|NOT COMPLETED|Long-term 60 Hz DBS||1
8159131|NCT02549859|20112770|P1|COMPLETED|Long-term 60 Hz DBS||10
8159132|NCT02549859|20112770|P1|STARTED|Long-term 60 Hz DBS||11
8159133|NCT02549859|20112770|P1|NOT COMPLETED|Visit 1||0
8159134|NCT02549859|20112770|P1|COMPLETED|Visit 1||11
8159135|NCT02549859|20112770|P1|STARTED|Visit 1||11
8159136|NCT02549755|20112835|P1|NOT COMPLETED|Overall Study||1
8159137|NCT02549755|20112835|P1|COMPLETED|Overall Study||0
8159138|NCT02549755|20112835|P1|STARTED|Overall Study||1
8159139|NCT02549716|20112841|P2|NOT COMPLETED|Overall Study||0
8159140|NCT02549716|20112842|P1|NOT COMPLETED|Overall Study||0
8159141|NCT02549716|20112841|P2|COMPLETED|Overall Study||2
8159142|NCT02549716|20112842|P1|COMPLETED|Overall Study||1
8159143|NCT02549716|20112841|P2|STARTED|Overall Study||2
8159144|NCT02549716|20112842|P1|STARTED|Overall Study||1
8159145|NCT02549573|20112856|P2|NOT COMPLETED|Overall Study||3
8159146|NCT02549573|20112857|P1|NOT COMPLETED|Overall Study||0
8159147|NCT02549573|20112856|P2|COMPLETED|Overall Study||4
8159148|NCT02549573|20112857|P1|COMPLETED|Overall Study||6
8159149|NCT02549573|20112856|P2|STARTED|Overall Study||7
8159150|NCT02549573|20112857|P1|STARTED|Overall Study||6
8159151|NCT02549508|20112901|P2|NOT COMPLETED|Overall Study||17
8159152|NCT02549508|20112902|P1|NOT COMPLETED|Overall Study||14
8159153|NCT02549508|20112901|P2|COMPLETED|Overall Study||21
8159154|NCT02549508|20112902|P1|COMPLETED|Overall Study||33
8159155|NCT02549508|20112901|P2|STARTED|Overall Study||38
8159156|NCT02549508|20112902|P1|STARTED|Overall Study||47
8159157|NCT02549365|20112914|P2|NOT COMPLETED|Overall Study||0
8159158|NCT02549365|20112915|P1|NOT COMPLETED|Overall Study||0
8159159|NCT02549365|20112914|P2|COMPLETED|Overall Study||112
8159160|NCT02549365|20112915|P1|COMPLETED|Overall Study||164
8159161|NCT02549365|20112914|P2|STARTED|Overall Study||112
8159162|NCT02549365|20112915|P1|STARTED|Overall Study||164
8159163|NCT02549352|20112924|P2|NOT COMPLETED|12-month Follow-up||12
8159164|NCT02549352|20112925|P1|NOT COMPLETED|12-month Follow-up||8
8159165|NCT02549352|20112924|P2|COMPLETED|12-month Follow-up||81
8159166|NCT02549352|20112925|P1|COMPLETED|12-month Follow-up||199
8159167|NCT02549352|20112924|P2|STARTED|12-month Follow-up||93
8159168|NCT02549352|20112925|P1|STARTED|12-month Follow-up||207
8159169|NCT02549352|20112924|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
8159170|NCT02549352|20112925|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
8159171|NCT02549352|20112924|P2|COMPLETED|3-day Treatment and 8-week Follow-up||96
8159172|NCT02549352|20112925|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
8159173|NCT02549352|20112924|P2|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
8159174|NCT02549352|20112925|P1|Treated|3-day Treatment and 8-week Follow-up||209
8159175|NCT02549352|20112924|P2|STARTED|3-day Treatment and 8-week Follow-up||102
8159176|NCT02549352|20112925|P1|STARTED|3-day Treatment and 8-week Follow-up||209
8159177|NCT02549339|20112941|P2|NOT COMPLETED|12-month Follow-up||11
8159178|NCT02549339|20112942|P1|NOT COMPLETED|12-month Follow-up||9
8159179|NCT02549339|20112941|P2|COMPLETED|12-month Follow-up||87
8159180|NCT02549339|20112942|P1|COMPLETED|12-month Follow-up||192
8159181|NCT02549339|20112941|P2|STARTED|12-month Follow-up||98
8159182|NCT02549339|20112942|P1|STARTED|12-month Follow-up||201
8159183|NCT02549339|20112941|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
8159184|NCT02549339|20112942|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
8159185|NCT02549339|20112941|P2|COMPLETED|3-day Treatment and 8-week Follow-up||99
8159186|NCT02549339|20112942|P1|COMPLETED|3-day Treatment and 8-week Follow-up||201
8159187|NCT02549339|20112941|P2|Treated|3-day Treatment and 8-week Follow-up||104
8159188|NCT02549339|20112942|P1|Treated|3-day Treatment and 8-week Follow-up||202
8159189|NCT02549339|20112941|P2|STARTED|3-day Treatment and 8-week Follow-up||104
8159190|NCT02549339|20112942|P1|STARTED|3-day Treatment and 8-week Follow-up||205
8159191|NCT02549287|20112958|P2|NOT COMPLETED|Overall Study||32
8159192|NCT02549287|20112959|P1|NOT COMPLETED|Overall Study||80
8159193|NCT02549287|20112958|P2|COMPLETED|Overall Study||64
8159194|NCT02549287|20112959|P1|COMPLETED|Overall Study||113
8159195|NCT02549287|20112958|P2|STARTED|Overall Study||96
8159196|NCT02549287|20112959|P1|STARTED|Overall Study||193
8159197|NCT02549196|20112993|P4|NOT COMPLETED|Overall Study||1
8159198|NCT02549196|20112994|P3|NOT COMPLETED|Overall Study||1
8159199|NCT02549196|20112995|P2|NOT COMPLETED|Overall Study||0
8159200|NCT02549196|20112996|P1|NOT COMPLETED|Overall Study||1
8159201|NCT02549196|20112993|P4|COMPLETED|Overall Study||12
8159202|NCT02549196|20112994|P3|COMPLETED|Overall Study||5
8159203|NCT02549196|20112995|P2|COMPLETED|Overall Study||1
8159204|NCT02549196|20112996|P1|COMPLETED|Overall Study||7
8159205|NCT02549196|20112993|P4|STARTED|Overall Study||13
8159206|NCT02549196|20112994|P3|STARTED|Overall Study||6
8159207|NCT02549196|20112995|P2|STARTED|Overall Study||1
8159208|NCT02549196|20112996|P1|STARTED|Overall Study||8
8159209|NCT02549040|20113010|P1|NOT COMPLETED|Period 5||0
8159210|NCT02549040|20113010|P1|COMPLETED|Period 5||16
8159211|NCT02549040|20113010|P1|STARTED|Period 5||16
8159212|NCT02549040|20113010|P1|NOT COMPLETED|Period 4||0
8159213|NCT02549040|20113010|P1|COMPLETED|Period 4||16
8159214|NCT02549040|20113010|P1|STARTED|Period 4||16
8159215|NCT02549040|20113010|P1|NOT COMPLETED|Period 3||0
8159216|NCT02549040|20113010|P1|COMPLETED|Period 3||16
8159217|NCT02549040|20113010|P1|STARTED|Period 3||16
8159218|NCT02549040|20113010|P1|NOT COMPLETED|Period 2||0
8159219|NCT02549040|20113010|P1|COMPLETED|Period 2||16
8159220|NCT02549040|20113010|P1|STARTED|Period 2||16
8159221|NCT02549040|20113010|P1|NOT COMPLETED|Period 1||0
8159222|NCT02549040|20113010|P1|COMPLETED|Period 1||16
8159223|NCT02549040|20113010|P1|STARTED|Period 1||16
8159224|NCT02549027|20113052|P6|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8159225|NCT02549027|20113053|P5|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
8159226|NCT02549027|20113054|P4|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8159227|NCT02549027|20113055|P3|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8159228|NCT02549027|20113056|P2|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8159229|NCT02549027|20113057|P1|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
8159230|NCT02549027|20113052|P6|COMPLETED|Period 5 - MK-6096 or Placebo||1
8159231|NCT02549027|20113053|P5|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
8159232|NCT02549027|20113054|P4|COMPLETED|Period 5 - MK-6096 or Placebo||0
8159233|NCT02549027|20113055|P3|COMPLETED|Period 5 - MK-6096 or Placebo||0
8159234|NCT02549027|20113056|P2|COMPLETED|Period 5 - MK-6096 or Placebo||0
8159235|NCT02549027|20113057|P1|COMPLETED|Period 5 - MK-6096 or Placebo||0
8159236|NCT02549027|20113052|P6|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
8159237|NCT02549027|20113053|P5|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
8159238|NCT02549027|20113054|P4|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
8159239|NCT02549027|20113055|P3|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
8159240|NCT02549027|20113056|P2|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
8159241|NCT02549027|20113057|P1|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
8159242|NCT02549027|20113052|P6|NOT COMPLETED|Washout After Period 4||0
8159243|NCT02549027|20113053|P5|NOT COMPLETED|Washout After Period 4||0
8159244|NCT02549027|20113054|P4|NOT COMPLETED|Washout After Period 4||1
8159245|NCT02549027|20113055|P3|NOT COMPLETED|Washout After Period 4||1
8159246|NCT02549027|20113056|P2|NOT COMPLETED|Washout After Period 4||1
8159247|NCT02549027|20113057|P1|NOT COMPLETED|Washout After Period 4||0
8159248|NCT02549027|20113052|P6|COMPLETED|Washout After Period 4||0
8159249|NCT02549027|20113053|P5|COMPLETED|Washout After Period 4||0
8159250|NCT02549027|20113054|P4|COMPLETED|Washout After Period 4||4
8159251|NCT02549027|20113055|P3|COMPLETED|Washout After Period 4||4
8159252|NCT02549027|20113056|P2|COMPLETED|Washout After Period 4||4
8159253|NCT02549027|20113057|P1|COMPLETED|Washout After Period 4||5
8159254|NCT02549027|20113052|P6|STARTED|Washout After Period 4||0
8159255|NCT02549027|20113053|P5|STARTED|Washout After Period 4||0
8159256|NCT02549027|20113054|P4|STARTED|Washout After Period 4||5
8159257|NCT02549027|20113055|P3|STARTED|Washout After Period 4||5
8159258|NCT02549027|20113056|P2|STARTED|Washout After Period 4||5
8159259|NCT02549027|20113057|P1|STARTED|Washout After Period 4||5
8159260|NCT02549027|20113052|P6|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8159261|NCT02549027|20113053|P5|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8159262|NCT02549027|20113054|P4|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8159263|NCT02549027|20113055|P3|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8159264|NCT02549027|20113056|P2|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8159265|NCT02549027|20113057|P1|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
8159266|NCT02549027|20113052|P6|COMPLETED|Period 4 - MK-1064 or Placebo||0
8159267|NCT02549027|20113053|P5|COMPLETED|Period 4 - MK-1064 or Placebo||0
8159268|NCT02549027|20113054|P4|COMPLETED|Period 4 - MK-1064 or Placebo||5
8159269|NCT02549027|20113055|P3|COMPLETED|Period 4 - MK-1064 or Placebo||5
8159270|NCT02549027|20113056|P2|COMPLETED|Period 4 - MK-1064 or Placebo||5
8159271|NCT02549027|20113057|P1|COMPLETED|Period 4 - MK-1064 or Placebo||5
8159272|NCT02549027|20113052|P6|STARTED|Period 4 - MK-1064 or Placebo||0
8159273|NCT02549027|20113053|P5|STARTED|Period 4 - MK-1064 or Placebo||0
8159274|NCT02549027|20113054|P4|STARTED|Period 4 - MK-1064 or Placebo||5
8159275|NCT02549027|20113055|P3|STARTED|Period 4 - MK-1064 or Placebo||5
8159276|NCT02549027|20113056|P2|STARTED|Period 4 - MK-1064 or Placebo||5
8159277|NCT02549027|20113057|P1|STARTED|Period 4 - MK-1064 or Placebo||5
8159278|NCT02549027|20113052|P6|NOT COMPLETED|Washout After Period 3||0
8159279|NCT02549027|20113053|P5|NOT COMPLETED|Washout After Period 3||0
8159280|NCT02549027|20113054|P4|NOT COMPLETED|Washout After Period 3||0
8159281|NCT02549027|20113055|P3|NOT COMPLETED|Washout After Period 3||0
8159282|NCT02549027|20113056|P2|NOT COMPLETED|Washout After Period 3||0
8159283|NCT02549027|20113057|P1|NOT COMPLETED|Washout After Period 3||0
8159284|NCT02549027|20113052|P6|COMPLETED|Washout After Period 3||0
8159285|NCT02549027|20113053|P5|COMPLETED|Washout After Period 3||0
8159286|NCT02549027|20113054|P4|COMPLETED|Washout After Period 3||5
8159287|NCT02549027|20113055|P3|COMPLETED|Washout After Period 3||5
8159288|NCT02549027|20113056|P2|COMPLETED|Washout After Period 3||5
8159289|NCT02549027|20113057|P1|COMPLETED|Washout After Period 3||5
8159290|NCT02549027|20113052|P6|STARTED|Washout After Period 3||0
8159291|NCT02549027|20113053|P5|STARTED|Washout After Period 3||0
8159292|NCT02549027|20113054|P4|STARTED|Washout After Period 3||5
8159293|NCT02549027|20113055|P3|STARTED|Washout After Period 3||5
8159294|NCT02549027|20113056|P2|STARTED|Washout After Period 3||5
8159295|NCT02549027|20113057|P1|STARTED|Washout After Period 3||5
8159296|NCT02549027|20113052|P6|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8159297|NCT02549027|20113053|P5|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8159298|NCT02549027|20113054|P4|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8159299|NCT02549027|20113055|P3|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8159300|NCT02549027|20113056|P2|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8159301|NCT02549027|20113057|P1|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
8159302|NCT02549027|20113052|P6|COMPLETED|Period 3 - MK-1064 or Placebo||0
8159303|NCT02549027|20113053|P5|COMPLETED|Period 3 - MK-1064 or Placebo||0
8159304|NCT02549027|20113054|P4|COMPLETED|Period 3 - MK-1064 or Placebo||5
8159305|NCT02549027|20113055|P3|COMPLETED|Period 3 - MK-1064 or Placebo||5
8159306|NCT02549027|20113056|P2|COMPLETED|Period 3 - MK-1064 or Placebo||5
8159307|NCT02549027|20113057|P1|COMPLETED|Period 3 - MK-1064 or Placebo||5
8159308|NCT02549027|20113052|P6|STARTED|Period 3 - MK-1064 or Placebo||0
8159309|NCT02549027|20113053|P5|STARTED|Period 3 - MK-1064 or Placebo||0
8159310|NCT02549027|20113054|P4|STARTED|Period 3 - MK-1064 or Placebo||5
8159311|NCT02549027|20113055|P3|STARTED|Period 3 - MK-1064 or Placebo||5
8159312|NCT02549027|20113056|P2|STARTED|Period 3 - MK-1064 or Placebo||5
8159313|NCT02549027|20113057|P1|STARTED|Period 3 - MK-1064 or Placebo||5
8159314|NCT02549027|20113052|P6|NOT COMPLETED|Washout After Period 2||0
8159315|NCT02549027|20113053|P5|NOT COMPLETED|Washout After Period 2||0
8159316|NCT02549027|20113054|P4|NOT COMPLETED|Washout After Period 2||0
8159317|NCT02549027|20113055|P3|NOT COMPLETED|Washout After Period 2||0
8159318|NCT02549027|20113056|P2|NOT COMPLETED|Washout After Period 2||0
8159319|NCT02549027|20113057|P1|NOT COMPLETED|Washout After Period 2||0
8159320|NCT02549027|20113052|P6|COMPLETED|Washout After Period 2||0
8159321|NCT02549027|20113053|P5|COMPLETED|Washout After Period 2||0
8159322|NCT02549027|20113054|P4|COMPLETED|Washout After Period 2||5
8159323|NCT02549027|20113055|P3|COMPLETED|Washout After Period 2||5
8159324|NCT02549027|20113056|P2|COMPLETED|Washout After Period 2||5
8159325|NCT02549027|20113057|P1|COMPLETED|Washout After Period 2||5
8159326|NCT02549027|20113052|P6|STARTED|Washout After Period 2||0
8159327|NCT02549027|20113053|P5|STARTED|Washout After Period 2||0
8159328|NCT02549027|20113054|P4|STARTED|Washout After Period 2||5
8159329|NCT02549027|20113055|P3|STARTED|Washout After Period 2||5
8159330|NCT02549027|20113056|P2|STARTED|Washout After Period 2||5
8159331|NCT02549027|20113057|P1|STARTED|Washout After Period 2||5
8159332|NCT02549027|20113052|P6|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8159333|NCT02549027|20113053|P5|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8159334|NCT02549027|20113054|P4|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8159335|NCT02549027|20113055|P3|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8159336|NCT02549027|20113056|P2|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8159337|NCT02549027|20113057|P1|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
8159338|NCT02549027|20113052|P6|COMPLETED|Period 2 - MK-1064 or Placebo||0
8159339|NCT02549027|20113053|P5|COMPLETED|Period 2 - MK-1064 or Placebo||0
8159340|NCT02549027|20113054|P4|COMPLETED|Period 2 - MK-1064 or Placebo||5
8159341|NCT02549027|20113055|P3|COMPLETED|Period 2 - MK-1064 or Placebo||5
8159342|NCT02549027|20113056|P2|COMPLETED|Period 2 - MK-1064 or Placebo||5
8159343|NCT02549027|20113057|P1|COMPLETED|Period 2 - MK-1064 or Placebo||5
8159344|NCT02549027|20113052|P6|STARTED|Period 2 - MK-1064 or Placebo||0
8159345|NCT02549027|20113053|P5|STARTED|Period 2 - MK-1064 or Placebo||0
8159346|NCT02549027|20113054|P4|STARTED|Period 2 - MK-1064 or Placebo||5
8159347|NCT02549027|20113055|P3|STARTED|Period 2 - MK-1064 or Placebo||5
8159348|NCT02549027|20113056|P2|STARTED|Period 2 - MK-1064 or Placebo||5
8159349|NCT02549027|20113057|P1|STARTED|Period 2 - MK-1064 or Placebo||5
8159350|NCT02549027|20113052|P6|NOT COMPLETED|Washout After Period 1||0
8159351|NCT02549027|20113053|P5|NOT COMPLETED|Washout After Period 1||0
8159352|NCT02549027|20113054|P4|NOT COMPLETED|Washout After Period 1||0
8159353|NCT02549027|20113055|P3|NOT COMPLETED|Washout After Period 1||0
8159354|NCT02549027|20113056|P2|NOT COMPLETED|Washout After Period 1||0
8159355|NCT02549027|20113057|P1|NOT COMPLETED|Washout After Period 1||0
8159356|NCT02549027|20113052|P6|COMPLETED|Washout After Period 1||0
8159357|NCT02549027|20113053|P5|COMPLETED|Washout After Period 1||0
8159358|NCT02549027|20113054|P4|COMPLETED|Washout After Period 1||5
8159359|NCT02549027|20113055|P3|COMPLETED|Washout After Period 1||5
8159360|NCT02549027|20113056|P2|COMPLETED|Washout After Period 1||5
8159361|NCT02549027|20113057|P1|COMPLETED|Washout After Period 1||5
8159362|NCT02549027|20113052|P6|STARTED|Washout After Period 1||0
8159363|NCT02549027|20113053|P5|STARTED|Washout After Period 1||0
8159364|NCT02549027|20113054|P4|STARTED|Washout After Period 1||5
8159365|NCT02549027|20113055|P3|STARTED|Washout After Period 1||5
8159366|NCT02549027|20113056|P2|STARTED|Washout After Period 1||5
8159367|NCT02549027|20113057|P1|STARTED|Washout After Period 1||5
8159368|NCT02549027|20113052|P6|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8159369|NCT02549027|20113053|P5|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8159370|NCT02549027|20113054|P4|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8159371|NCT02549027|20113055|P3|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8159372|NCT02549027|20113056|P2|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8159373|NCT02549027|20113057|P1|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
8159374|NCT02549027|20113052|P6|COMPLETED|Period 1 - MK-1064 or Placebo||0
8159375|NCT02549027|20113053|P5|COMPLETED|Period 1 - MK-1064 or Placebo||0
8159376|NCT02549027|20113054|P4|COMPLETED|Period 1 - MK-1064 or Placebo||5
8159377|NCT02549027|20113055|P3|COMPLETED|Period 1 - MK-1064 or Placebo||5
8159378|NCT02549027|20113056|P2|COMPLETED|Period 1 - MK-1064 or Placebo||5
8159379|NCT02549027|20113057|P1|COMPLETED|Period 1 - MK-1064 or Placebo||5
8159380|NCT02549027|20113052|P6|STARTED|Period 1 - MK-1064 or Placebo||0
8159381|NCT02549027|20113053|P5|STARTED|Period 1 - MK-1064 or Placebo||0
8159382|NCT02549027|20113054|P4|STARTED|Period 1 - MK-1064 or Placebo||5
8159383|NCT02549027|20113055|P3|STARTED|Period 1 - MK-1064 or Placebo||5
8159384|NCT02549027|20113056|P2|STARTED|Period 1 - MK-1064 or Placebo||5
8159385|NCT02549027|20113057|P1|STARTED|Period 1 - MK-1064 or Placebo||5
8159386|NCT02549014|20113094|P2|NOT COMPLETED|Overall Study||0
8159387|NCT02549014|20113095|P1|NOT COMPLETED|Overall Study||0
8159388|NCT02549014|20113094|P2|COMPLETED|Overall Study||8
8159389|NCT02549014|20113095|P1|COMPLETED|Overall Study||8
8159390|NCT02549014|20113094|P2|STARTED|Overall Study||8
8159391|NCT02549014|20113095|P1|STARTED|Overall Study||8
8159392|NCT02548962|20113187|P2|NOT COMPLETED|Overall Study||0
8159393|NCT02548962|20113188|P1|NOT COMPLETED|Overall Study||1
8159394|NCT02548962|20113187|P2|COMPLETED|Overall Study||3
8159395|NCT02548962|20113188|P1|COMPLETED|Overall Study||7
8159396|NCT02548962|20113187|P2|STARTED|Overall Study||3
8159397|NCT02548962|20113188|P1|STARTED|Overall Study||8
8159398|NCT02548845|20113198|P1|NOT COMPLETED|Overall Study||0
8159399|NCT02548845|20113198|P1|COMPLETED|Overall Study||70
8159400|NCT02548845|20113198|P1|STARTED|Overall Study||70
8159401|NCT02548754|20113212|P2|NOT COMPLETED|Overall Study||4
8159402|NCT02548754|20113213|P1|NOT COMPLETED|Overall Study||2
8159403|NCT02548754|20113212|P2|COMPLETED|Overall Study||23
8159404|NCT02548754|20113213|P1|COMPLETED|Overall Study||24
8159405|NCT02548754|20113212|P2|STARTED|Overall Study||27
8159406|NCT02548754|20113213|P1|STARTED|Overall Study||26
8159407|NCT02548728|20113225|P2|NOT COMPLETED|Overall Study||0
8159408|NCT02548728|20113226|P1|NOT COMPLETED|Overall Study||0
8159409|NCT02548728|20113225|P2|COMPLETED|Overall Study||6
8159410|NCT02548728|20113226|P1|COMPLETED|Overall Study||6
8159411|NCT02548728|20113225|P2|STARTED|Overall Study||6
8159412|NCT02548728|20113226|P1|STARTED|Overall Study||6
8159413|NCT02548650|20113240|P2|NOT COMPLETED|Double Therapy||2
8159414|NCT02548650|20113241|P1|NOT COMPLETED|Double Therapy||1
8159415|NCT02548650|20113240|P2|COMPLETED|Double Therapy||30
8159416|NCT02548650|20113241|P1|COMPLETED|Double Therapy||28
8159417|NCT02548650|20113240|P2|STARTED|Double Therapy||32
8159418|NCT02548650|20113241|P1|STARTED|Double Therapy||29
8159419|NCT02548650|20113240|P2|NOT COMPLETED|Triple Therapy||4
8159420|NCT02548650|20113241|P1|NOT COMPLETED|Triple Therapy||1
8159421|NCT02548650|20113240|P2|COMPLETED|Triple Therapy||32
8159422|NCT02548650|20113241|P1|COMPLETED|Triple Therapy||29
8159423|NCT02548650|20113240|P2|STARTED|Triple Therapy||36
8159424|NCT02548650|20113241|P1|STARTED|Triple Therapy||30
8159425|NCT02548585|20113256|P7|NOT COMPLETED|Overall Study||1
8159426|NCT02548585|20113257|P6|NOT COMPLETED|Overall Study||2
8159427|NCT02548585|20113258|P5|NOT COMPLETED|Overall Study||3
8159428|NCT02548585|20113259|P4|NOT COMPLETED|Overall Study||2
8159429|NCT02548585|20113260|P3|NOT COMPLETED|Overall Study||0
8159430|NCT02548585|20113261|P2|NOT COMPLETED|Overall Study||0
8159431|NCT02548585|20113262|P1|NOT COMPLETED|Overall Study||2
8159432|NCT02548585|20113256|P7|COMPLETED|Overall Study||11
8159433|NCT02548585|20113257|P6|COMPLETED|Overall Study||10
8159434|NCT02548585|20113258|P5|COMPLETED|Overall Study||22
8159435|NCT02548585|20113259|P4|COMPLETED|Overall Study||5
8159436|NCT02548585|20113260|P3|COMPLETED|Overall Study||6
8159437|NCT02548585|20113261|P2|COMPLETED|Overall Study||6
8159438|NCT02548585|20113262|P1|COMPLETED|Overall Study||43
8159439|NCT02548585|20113256|P7|Treated|Overall Study||12
8159440|NCT02548585|20113257|P6|Treated|Overall Study||11
8159441|NCT02548585|20113258|P5|Treated|Overall Study||25
8159442|NCT02548585|20113259|P4|Treated|Overall Study||7
8159443|NCT02548585|20113260|P3|Treated|Overall Study||6
8159444|NCT02548585|20113261|P2|Treated|Overall Study||6
8159445|NCT02548585|20113262|P1|Treated|Overall Study||45
8159446|NCT02548585|20113256|P7|STARTED|Overall Study||12
8159447|NCT02548585|20113257|P6|STARTED|Overall Study||12
8159448|NCT02548585|20113258|P5|STARTED|Overall Study||25
8159449|NCT02548585|20113259|P4|STARTED|Overall Study||7
8159450|NCT02548585|20113260|P3|STARTED|Overall Study||6
8159451|NCT02548585|20113261|P2|STARTED|Overall Study||6
8159452|NCT02548585|20113262|P1|STARTED|Overall Study||45
8159453|NCT02548455|20113480|P1|NOT COMPLETED|Overall Study||240
8159454|NCT02548455|20113480|P1|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
8159455|NCT02548455|20113480|P1|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
8159456|NCT02548455|20113480|P1|Completed 6-Month Follow-up|Overall Study||259
8159457|NCT02548455|20113480|P1|Completed Pre-Discharge|Overall Study||484
8159458|NCT02548455|20113480|P1|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
8159459|NCT02548312|20113492|P8|NOT COMPLETED|Overall Study||42
8159460|NCT02548312|20113493|P7|NOT COMPLETED|Overall Study||40
8159461|NCT02548312|20113494|P6|NOT COMPLETED|Overall Study||40
8159462|NCT02548312|20113495|P5|NOT COMPLETED|Overall Study||34
8159463|NCT02548312|20113496|P4|NOT COMPLETED|Overall Study||46
8159464|NCT02548312|20113497|P3|NOT COMPLETED|Overall Study||38
8159465|NCT02548312|20113498|P2|NOT COMPLETED|Overall Study||43
8159466|NCT02548312|20113499|P1|NOT COMPLETED|Overall Study||33
8159467|NCT02548312|20113492|P8|COMPLETED|Overall Study||91
8159468|NCT02548312|20113493|P7|COMPLETED|Overall Study||93
8159469|NCT02548312|20113494|P6|COMPLETED|Overall Study||93
8159470|NCT02548312|20113495|P5|COMPLETED|Overall Study||99
8159471|NCT02548312|20113496|P4|COMPLETED|Overall Study||87
8159472|NCT02548312|20113497|P3|COMPLETED|Overall Study||96
8159473|NCT02548312|20113498|P2|COMPLETED|Overall Study||90
8159474|NCT02548312|20113499|P1|COMPLETED|Overall Study||100
8159475|NCT02548312|20113492|P8|STARTED|Overall Study||133
8159476|NCT02548312|20113493|P7|STARTED|Overall Study||133
8159477|NCT02548312|20113494|P6|STARTED|Overall Study||133
8159478|NCT02548312|20113495|P5|STARTED|Overall Study||133
8159479|NCT02548312|20113496|P4|STARTED|Overall Study||133
8159480|NCT02548312|20113497|P3|STARTED|Overall Study||134
8159481|NCT02548312|20113498|P2|STARTED|Overall Study||133
8159482|NCT02548312|20113499|P1|STARTED|Overall Study||133
8159483|NCT02548156|20113541|P6|NOT COMPLETED|Period 3||0
8159484|NCT02548156|20113542|P5|NOT COMPLETED|Period 3||0
8159485|NCT02548156|20113543|P4|NOT COMPLETED|Period 3||0
8159486|NCT02548156|20113544|P3|NOT COMPLETED|Period 3||0
8159487|NCT02548156|20113545|P2|NOT COMPLETED|Period 3||0
8159488|NCT02548156|20113546|P1|NOT COMPLETED|Period 3||0
8159489|NCT02548156|20113541|P6|COMPLETED|Period 3||5
8159490|NCT02548156|20113542|P5|COMPLETED|Period 3||4
8159491|NCT02548156|20113543|P4|COMPLETED|Period 3||5
8159492|NCT02548156|20113544|P3|COMPLETED|Period 3||4
8159493|NCT02548156|20113545|P2|COMPLETED|Period 3||5
8159494|NCT02548156|20113546|P1|COMPLETED|Period 3||5
8159495|NCT02548156|20113541|P6|STARTED|Period 3||5
8159496|NCT02548156|20113542|P5|STARTED|Period 3||4
8159497|NCT02548156|20113543|P4|STARTED|Period 3||5
8159498|NCT02548156|20113544|P3|STARTED|Period 3||4
8159499|NCT02548156|20113545|P2|STARTED|Period 3||5
8159500|NCT02548156|20113546|P1|STARTED|Period 3||5
8159501|NCT02548156|20113541|P6|NOT COMPLETED|Washout Period 2||0
8159502|NCT02548156|20113542|P5|NOT COMPLETED|Washout Period 2||0
8159503|NCT02548156|20113543|P4|NOT COMPLETED|Washout Period 2||0
8159504|NCT02548156|20113544|P3|NOT COMPLETED|Washout Period 2||0
8159505|NCT02548156|20113545|P2|NOT COMPLETED|Washout Period 2||0
8159506|NCT02548156|20113546|P1|NOT COMPLETED|Washout Period 2||0
8159507|NCT02548156|20113541|P6|COMPLETED|Washout Period 2||5
8159508|NCT02548156|20113542|P5|COMPLETED|Washout Period 2||4
8159509|NCT02548156|20113543|P4|COMPLETED|Washout Period 2||5
8159510|NCT02548156|20113544|P3|COMPLETED|Washout Period 2||4
8159511|NCT02548156|20113545|P2|COMPLETED|Washout Period 2||5
8159512|NCT02548156|20113546|P1|COMPLETED|Washout Period 2||5
8159513|NCT02548156|20113541|P6|STARTED|Washout Period 2||5
8159514|NCT02548156|20113542|P5|STARTED|Washout Period 2||4
8159515|NCT02548156|20113543|P4|STARTED|Washout Period 2||5
8159516|NCT02548156|20113544|P3|STARTED|Washout Period 2||4
8159517|NCT02548156|20113545|P2|STARTED|Washout Period 2||5
8159518|NCT02548156|20113546|P1|STARTED|Washout Period 2||5
8159519|NCT02548156|20113541|P6|NOT COMPLETED|Period 2||0
8159520|NCT02548156|20113542|P5|NOT COMPLETED|Period 2||0
8159521|NCT02548156|20113543|P4|NOT COMPLETED|Period 2||0
8159522|NCT02548156|20113544|P3|NOT COMPLETED|Period 2||0
8159523|NCT02548156|20113545|P2|NOT COMPLETED|Period 2||0
8159524|NCT02548156|20113546|P1|NOT COMPLETED|Period 2||0
8159525|NCT02548156|20113541|P6|COMPLETED|Period 2||5
8159526|NCT02548156|20113542|P5|COMPLETED|Period 2||4
8159527|NCT02548156|20113543|P4|COMPLETED|Period 2||5
8159528|NCT02548156|20113544|P3|COMPLETED|Period 2||4
8159529|NCT02548156|20113545|P2|COMPLETED|Period 2||5
8159530|NCT02548156|20113546|P1|COMPLETED|Period 2||5
8159531|NCT02548156|20113541|P6|STARTED|Period 2||5
8159532|NCT02548156|20113542|P5|STARTED|Period 2||4
8159533|NCT02548156|20113543|P4|STARTED|Period 2||5
8159534|NCT02548156|20113544|P3|STARTED|Period 2||4
8159535|NCT02548156|20113545|P2|STARTED|Period 2||5
8159536|NCT02548156|20113546|P1|STARTED|Period 2||5
8159537|NCT02548156|20113541|P6|NOT COMPLETED|Washout Period 1||0
8159538|NCT02548156|20113542|P5|NOT COMPLETED|Washout Period 1||1
8159539|NCT02548156|20113543|P4|NOT COMPLETED|Washout Period 1||0
8159540|NCT02548156|20113544|P3|NOT COMPLETED|Washout Period 1||0
8159541|NCT02548156|20113545|P2|NOT COMPLETED|Washout Period 1||0
8159542|NCT02548156|20113546|P1|NOT COMPLETED|Washout Period 1||0
8159543|NCT02548156|20113541|P6|COMPLETED|Washout Period 1||5
8159544|NCT02548156|20113542|P5|COMPLETED|Washout Period 1||4
8159545|NCT02548156|20113543|P4|COMPLETED|Washout Period 1||5
8159546|NCT02548156|20113544|P3|COMPLETED|Washout Period 1||4
8159547|NCT02548156|20113545|P2|COMPLETED|Washout Period 1||5
8159548|NCT02548156|20113546|P1|COMPLETED|Washout Period 1||5
8159549|NCT02548156|20113541|P6|STARTED|Washout Period 1||5
8159550|NCT02548156|20113542|P5|STARTED|Washout Period 1||5
8159551|NCT02548156|20113543|P4|STARTED|Washout Period 1||5
8159552|NCT02548156|20113544|P3|STARTED|Washout Period 1||4
8159553|NCT02548156|20113545|P2|STARTED|Washout Period 1||5
8159554|NCT02548156|20113546|P1|STARTED|Washout Period 1||5
8159555|NCT02548156|20113541|P6|NOT COMPLETED|Period 1||0
8159556|NCT02548156|20113542|P5|NOT COMPLETED|Period 1||0
8159557|NCT02548156|20113543|P4|NOT COMPLETED|Period 1||0
8159558|NCT02548156|20113544|P3|NOT COMPLETED|Period 1||0
8159559|NCT02548156|20113545|P2|NOT COMPLETED|Period 1||0
8159560|NCT02548156|20113546|P1|NOT COMPLETED|Period 1||0
8159561|NCT02548156|20113541|P6|COMPLETED|Period 1||5
8159562|NCT02548156|20113542|P5|COMPLETED|Period 1||5
8159563|NCT02548156|20113543|P4|COMPLETED|Period 1||5
8159564|NCT02548156|20113544|P3|COMPLETED|Period 1||4
8159565|NCT02548156|20113545|P2|COMPLETED|Period 1||5
8159566|NCT02548156|20113546|P1|COMPLETED|Period 1||5
8159567|NCT02548156|20113541|P6|STARTED|Period 1||5
8159568|NCT02548156|20113542|P5|STARTED|Period 1||5
8159569|NCT02548156|20113543|P4|STARTED|Period 1||5
8159570|NCT02548156|20113544|P3|STARTED|Period 1||4
8159571|NCT02548156|20113545|P2|STARTED|Period 1||5
8159572|NCT02548156|20113546|P1|STARTED|Period 1||5
8159573|NCT02548143|20113565|P2|NOT COMPLETED|Overall Study||1
8159574|NCT02548143|20113566|P1|NOT COMPLETED|Overall Study||1
8159575|NCT02548143|20113565|P2|COMPLETED|Overall Study||5
8159576|NCT02548143|20113566|P1|COMPLETED|Overall Study||5
8159577|NCT02548143|20113565|P2|STARTED|Overall Study||6
8159578|NCT02548143|20113566|P1|STARTED|Overall Study||6
8159579|NCT02548078|20113578|P2|NOT COMPLETED|Overall Study||6
8159580|NCT02548078|20113579|P1|NOT COMPLETED|Overall Study||5
8159581|NCT02548078|20113578|P2|COMPLETED|Overall Study||294
8159582|NCT02548078|20113579|P1|COMPLETED|Overall Study||295
8159583|NCT02548078|20113578|P2|STARTED|Overall Study||300
8159584|NCT02548078|20113579|P1|STARTED|Overall Study||300
8159588|NCT02547974|20113775|P4|NOT COMPLETED|Overall Study||0
8159589|NCT02547974|20113776|P3|NOT COMPLETED|Overall Study||0
8159590|NCT02547974|20113777|P2|NOT COMPLETED|Overall Study||0
8159591|NCT02547974|20113778|P1|NOT COMPLETED|Overall Study||1
8159592|NCT02547974|20113775|P4|COMPLETED|Overall Study||44
8159593|NCT02547974|20113776|P3|COMPLETED|Overall Study||30
8159594|NCT02547974|20113777|P2|COMPLETED|Overall Study||31
8159595|NCT02547974|20113778|P1|COMPLETED|Overall Study||14
8159596|NCT02547974|20113775|P4|STARTED|Overall Study||44
8159597|NCT02547974|20113776|P3|STARTED|Overall Study||30
8159598|NCT02547974|20113777|P2|STARTED|Overall Study||31
8159599|NCT02547974|20113778|P1|STARTED|Overall Study||15
8159600|NCT02547935|20113865|P3|NOT COMPLETED|Overall Study||5
8159601|NCT02547935|20113866|P2|NOT COMPLETED|Overall Study||8
8159602|NCT02547935|20113867|P1|NOT COMPLETED|Overall Study||5
8159603|NCT02547935|20113865|P3|COMPLETED|Overall Study||143
8159604|NCT02547935|20113866|P2|COMPLETED|Overall Study||137
8159605|NCT02547935|20113867|P1|COMPLETED|Overall Study||150
8159606|NCT02547935|20113865|P3|Safety Analysis Set|Overall Study||148
8159607|NCT02547935|20113866|P2|Safety Analysis Set|Overall Study||145
8159608|NCT02547935|20113867|P1|Safety Analysis Set|Overall Study||152
8159609|NCT02547935|20113865|P3|Full Analysis Set|Overall Study||148
8159610|NCT02547935|20113866|P2|Full Analysis Set|Overall Study||144
8159611|NCT02547935|20113867|P1|Full Analysis Set|Overall Study||152
8159612|NCT02547935|20113865|P3|Received Treatment|Overall Study||148
8159613|NCT02547935|20113866|P2|Received Treatment|Overall Study||145
8159614|NCT02547935|20113867|P1|Received Treatment|Overall Study||152
8159615|NCT02547935|20113865|P3|STARTED|Overall Study||148
8159616|NCT02547935|20113866|P2|STARTED|Overall Study||145
8159617|NCT02547935|20113867|P1|STARTED|Overall Study||155
8159618|NCT02547779|20113896|P2|NOT COMPLETED|Overall Study||0
8159619|NCT02547779|20113897|P1|NOT COMPLETED|Overall Study||0
8159620|NCT02547779|20113896|P2|COMPLETED|Overall Study||5207
8159621|NCT02547779|20113897|P1|COMPLETED|Overall Study||5214
8159622|NCT02547779|20113896|P2|STARTED|Overall Study||5207
8159623|NCT02547779|20113897|P1|STARTED|Overall Study||5214
8159624|NCT02547766|20113905|P1|NOT COMPLETED|Overall Study||1
8159625|NCT02547766|20113905|P1|COMPLETED|Overall Study||9
8159626|NCT02547766|20113905|P1|STARTED|Overall Study||10
8159627|NCT02547714|20113912|P1|NOT COMPLETED|Overall Study||0
8159628|NCT02547714|20113912|P1|COMPLETED|Overall Study||34
8159629|NCT02547714|20113912|P1|STARTED|Overall Study||34
8159630|NCT02547649|20113925|P3|NOT COMPLETED|Overall Study||4
8159631|NCT02547649|20113926|P2|NOT COMPLETED|Overall Study||5
8159632|NCT02547649|20113927|P1|NOT COMPLETED|Overall Study||3
8159633|NCT02547649|20113925|P3|COMPLETED|Overall Study||224
8159634|NCT02547649|20113926|P2|COMPLETED|Overall Study||226
8159635|NCT02547649|20113927|P1|COMPLETED|Overall Study||228
8159636|NCT02547649|20113925|P3|Vaccinated|Overall Study||227
8159637|NCT02547649|20113926|P2|Vaccinated|Overall Study||231
8159638|NCT02547649|20113927|P1|Vaccinated|Overall Study||231
8159639|NCT02547649|20113925|P3|STARTED|Overall Study||228
8159640|NCT02547649|20113926|P2|STARTED|Overall Study||231
8159641|NCT02547649|20113927|P1|STARTED|Overall Study||231
8159642|NCT02547623|20113961|P2|NOT COMPLETED|Overall Study||3
8159643|NCT02547623|20113962|P1|NOT COMPLETED|Overall Study||4
8159644|NCT02547623|20113961|P2|COMPLETED|Overall Study||52
8159645|NCT02547623|20113962|P1|COMPLETED|Overall Study||122
8159646|NCT02547623|20113961|P2|STARTED|Overall Study||55
8159647|NCT02547623|20113962|P1|STARTED|Overall Study||126
8159648|NCT02547454|20113992|P1|NOT COMPLETED|Overall Study||172
8159649|NCT02547454|20113992|P1|COMPLETED|Overall Study||221
8159650|NCT02547454|20113992|P1|STARTED|Overall Study||393
8159651|NCT02547363|20114022|P2|NOT COMPLETED|12-month Follow-up||5
8159652|NCT02547363|20114023|P1|NOT COMPLETED|12-month Follow-up||10
8159653|NCT02547363|20114022|P2|COMPLETED|12-month Follow-up||81
8159654|NCT02547363|20114023|P1|COMPLETED|12-month Follow-up||194
8159655|NCT02547363|20114022|P2|STARTED|12-month Follow-up||86
8159656|NCT02547363|20114023|P1|STARTED|12-month Follow-up||204
8159657|NCT02547363|20114022|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
8159658|NCT02547363|20114023|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
8159659|NCT02547363|20114022|P2|COMPLETED|3-day Treatment and 8-week Follow-up||94
8159660|NCT02547363|20114023|P1|COMPLETED|3-day Treatment and 8-week Follow-up||207
8159661|NCT02547363|20114022|P2|Treated|3-day Treatment and 8-week Follow-up||104
8159662|NCT02547363|20114023|P1|Treated|3-day Treatment and 8-week Follow-up||209
8159663|NCT02547363|20114022|P2|STARTED|3-day Treatment and 8-week Follow-up||105
8159664|NCT02547363|20114023|P1|STARTED|3-day Treatment and 8-week Follow-up||211
8159665|NCT02547233|20114039|P2|NOT COMPLETED|12-month Follow-up||17
8159666|NCT02547233|20114040|P1|NOT COMPLETED|12-month Follow-up||14
8159667|NCT02547233|20114039|P2|COMPLETED|12-month Follow-up||67
8159668|NCT02547233|20114040|P1|COMPLETED|12-month Follow-up||185
8159669|NCT02547233|20114039|P2|STARTED|12-month Follow-up||84
8159670|NCT02547233|20114040|P1|STARTED|12-month Follow-up||199
8159671|NCT02547233|20114039|P2|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
8159672|NCT02547233|20114040|P1|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
8159673|NCT02547233|20114039|P2|COMPLETED|3-day Treatment and 8-week Follow-up||92
8159674|NCT02547233|20114040|P1|COMPLETED|3-day Treatment and 8-week Follow-up||203
8159675|NCT02547233|20114039|P2|Treated|3-day Treatment and 8-week Follow-up||100
8159676|NCT02547233|20114040|P1|Treated|3-day Treatment and 8-week Follow-up||205
8159677|NCT02547233|20114039|P2|STARTED|3-day Treatment and 8-week Follow-up||102
8159678|NCT02547233|20114040|P1|STARTED|3-day Treatment and 8-week Follow-up||205
8159679|NCT02547220|20114056|P2|NOT COMPLETED|Overall Study||20
8159680|NCT02547220|20114057|P1|NOT COMPLETED|Overall Study||19
8159681|NCT02547220|20114056|P2|COMPLETED|Overall Study||0
8159682|NCT02547220|20114057|P1|COMPLETED|Overall Study||0
8159683|NCT02547220|20114056|P2|STARTED|Overall Study||20
8159684|NCT02547220|20114057|P1|STARTED|Overall Study||19
8159685|NCT02547129|20114093|P2|NOT COMPLETED|Overall Study||0
8159686|NCT02547129|20114094|P1|NOT COMPLETED|Overall Study||1
8159687|NCT02547129|20114093|P2|COMPLETED|Overall Study||2
8159688|NCT02547129|20114094|P1|COMPLETED|Overall Study||1
8159689|NCT02547129|20114093|P2|STARTED|Overall Study||2
8159690|NCT02547129|20114094|P1|STARTED|Overall Study||2
8159691|NCT02547064|20114108|P2|NOT COMPLETED|Overall Study||2
8159692|NCT02547064|20114109|P1|NOT COMPLETED|Overall Study||3
8159693|NCT02547064|20114108|P2|COMPLETED|Overall Study||79
8159694|NCT02547064|20114109|P1|COMPLETED|Overall Study||78
8159695|NCT02547064|20114108|P2|STARTED|Overall Study||81
8159696|NCT02547064|20114109|P1|STARTED|Overall Study||81
8159697|NCT02547038|20114137|P2|NOT COMPLETED|Overall Study||2
8159698|NCT02547038|20114138|P1|NOT COMPLETED|Overall Study||3
8159699|NCT02547038|20114137|P2|COMPLETED|Overall Study||174
8159700|NCT02547038|20114138|P1|COMPLETED|Overall Study||173
8159701|NCT02547038|20114137|P2|STARTED|Overall Study||176
8159702|NCT02547038|20114138|P1|STARTED|Overall Study||176
8159703|NCT02547012|20114146|P2|NOT COMPLETED|Overall Study||0
8159704|NCT02547012|20114147|P1|NOT COMPLETED|Overall Study||0
8159705|NCT02547012|20114146|P2|COMPLETED|Overall Study||27
8159706|NCT02547012|20114147|P1|COMPLETED|Overall Study||24
8159707|NCT02547012|20114146|P2|STARTED|Overall Study||27
8159708|NCT02547012|20114147|P1|STARTED|Overall Study||24
8159721|NCT02546856|20114181|P2|NOT COMPLETED|6 Months Evaluation||7
8159722|NCT02546856|20114182|P1|NOT COMPLETED|6 Months Evaluation||8
8159723|NCT02546856|20114181|P2|COMPLETED|6 Months Evaluation||138
8159724|NCT02546856|20114182|P1|COMPLETED|6 Months Evaluation||136
8159725|NCT02546856|20114181|P2|STARTED|6 Months Evaluation||145
8159726|NCT02546856|20114182|P1|STARTED|6 Months Evaluation||144
8159727|NCT02546856|20114181|P2|NOT COMPLETED|4 Months Evaluation||11
8159728|NCT02546856|20114182|P1|NOT COMPLETED|4 Months Evaluation||20
8159729|NCT02546856|20114181|P2|COMPLETED|4 Months Evaluation||145
8159730|NCT02546856|20114182|P1|COMPLETED|4 Months Evaluation||144
8159731|NCT02546856|20114181|P2|STARTED|4 Months Evaluation||156
8159732|NCT02546856|20114182|P1|STARTED|4 Months Evaluation||164
8159733|NCT02546765|20114232|P4|NOT COMPLETED|Overall Study||0
8159734|NCT02546765|20114233|P3|NOT COMPLETED|Overall Study||0
8159735|NCT02546765|20114234|P2|NOT COMPLETED|Overall Study||1
8159736|NCT02546765|20114235|P1|NOT COMPLETED|Overall Study||0
8159737|NCT02546765|20114232|P4|COMPLETED|Overall Study||30
8159738|NCT02546765|20114233|P3|COMPLETED|Overall Study||30
8159739|NCT02546765|20114234|P2|COMPLETED|Overall Study|29 Received study drug; 1 withdrew before surgery and after randomization|29
8159740|NCT02546765|20114235|P1|COMPLETED|Overall Study||31
8159741|NCT02546765|20114232|P4|STARTED|Overall Study||30
8159742|NCT02546765|20114233|P3|STARTED|Overall Study||30
8159743|NCT02546765|20114234|P2|STARTED|Overall Study||30
8159744|NCT02546765|20114235|P1|STARTED|Overall Study||31
8159745|NCT02546609|20114276|P3|NOT COMPLETED|Overall Study||7
8159746|NCT02546609|20114277|P2|NOT COMPLETED|Overall Study||11
8159747|NCT02546609|20114278|P1|NOT COMPLETED|Overall Study||2
8159748|NCT02546609|20114276|P3|COMPLETED|Overall Study||25
8159749|NCT02546609|20114277|P2|COMPLETED|Overall Study||24
8159750|NCT02546609|20114278|P1|COMPLETED|Overall Study||22
8159751|NCT02546609|20114276|P3|STARTED|Overall Study||32
8159752|NCT02546609|20114277|P2|STARTED|Overall Study||35
8159753|NCT02546609|20114278|P1|STARTED|Overall Study||24
8159754|NCT02546570|20114321|P2|NOT COMPLETED|Overall Study||0
8159755|NCT02546570|20114322|P1|NOT COMPLETED|Overall Study||0
8159756|NCT02546570|20114321|P2|COMPLETED|Overall Study||2
8159757|NCT02546570|20114322|P1|COMPLETED|Overall Study||9
8159758|NCT02546570|20114321|P2|Crossover Order: Placebo, Oxytocin|Overall Study||0
8159759|NCT02546570|20114322|P1|Crossover Order: Placebo, Oxytocin|Overall Study||3
8159760|NCT02546570|20114321|P2|Crossover Order: Oxytocin, Placebo|Overall Study||2
8159761|NCT02546570|20114322|P1|Crossover Order: Oxytocin, Placebo|Overall Study||6
8159762|NCT02546570|20114321|P2|STARTED|Overall Study||2
8159763|NCT02546570|20114322|P1|STARTED|Overall Study||9
8159764|NCT02546544|20114358|P1|NOT COMPLETED|Overall Study||16
8159765|NCT02546544|20114358|P1|COMPLETED|Overall Study||0
8159766|NCT02546544|20114358|P1|Received Allocated Intervention|Overall Study||16
8159767|NCT02546544|20114358|P1|STARTED|Overall Study||16
8159768|NCT02546388|20114369|P2|NOT COMPLETED|Overall Study||0
8159769|NCT02546388|20114370|P1|NOT COMPLETED|Overall Study||0
8159770|NCT02546388|20114369|P2|COMPLETED|Overall Study||13
8159771|NCT02546388|20114370|P1|COMPLETED|Overall Study||4
8159772|NCT02546388|20114369|P2|STARTED|Overall Study||13
8159773|NCT02546388|20114370|P1|STARTED|Overall Study||4
8159774|NCT02546375|20114377|P1|NOT COMPLETED|Overall Study||0
8159775|NCT02546375|20114377|P1|COMPLETED|Overall Study||87
8159776|NCT02546375|20114377|P1|STARTED|Overall Study||87
8159777|NCT02546362|20114399|P1|NOT COMPLETED|12-week Treatment Period||9
8159778|NCT02546362|20114399|P1|COMPLETED|12-week Treatment Period||38
8159779|NCT02546362|20114399|P1|STARTED|12-week Treatment Period||47
8159780|NCT02546362|20114399|P1|NOT COMPLETED|4-week Treatment Period||3
8159781|NCT02546362|20114399|P1|COMPLETED|4-week Treatment Period||47
8159782|NCT02546362|20114399|P1|STARTED|4-week Treatment Period||50
8159783|NCT02546323|20114420|P2|NOT COMPLETED|Overall Study||66
8159784|NCT02546323|20114421|P1|NOT COMPLETED|Overall Study||60
8159785|NCT02546323|20114420|P2|COMPLETED|Overall Study||205
8159786|NCT02546323|20114421|P1|COMPLETED|Overall Study||212
8159787|NCT02546323|20114420|P2|Received Treatment|Overall Study||268
8159788|NCT02546323|20114421|P1|Received Treatment|Overall Study||272
8159789|NCT02546323|20114420|P2|STARTED|Overall Study||271
8159790|NCT02546323|20114421|P1|STARTED|Overall Study||272
8159791|NCT02546193|20114441|P4|NOT COMPLETED|Overall Study||0
8159792|NCT02546193|20114442|P3|NOT COMPLETED|Overall Study||2
8159793|NCT02546193|20114443|P2|NOT COMPLETED|Overall Study||6
8159794|NCT02546193|20114444|P1|NOT COMPLETED|Overall Study||6
8159795|NCT02546193|20114441|P4|COMPLETED|Overall Study||0
8159796|NCT02546193|20114442|P3|COMPLETED|Overall Study||0
8159797|NCT02546193|20114443|P2|COMPLETED|Overall Study||4
8159798|NCT02546193|20114444|P1|COMPLETED|Overall Study||4
8159799|NCT02546193|20114441|P4|STARTED|Overall Study||0
8159800|NCT02546193|20114442|P3|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2
8159801|NCT02546193|20114443|P2|STARTED|Overall Study||10
8159802|NCT02546193|20114444|P1|STARTED|Overall Study||10
8159803|NCT02545933|20114481|P3|NOT COMPLETED|Overall Study||4
8159804|NCT02545933|20114482|P2|NOT COMPLETED|Overall Study||3
8159805|NCT02545933|20114483|P1|NOT COMPLETED|Overall Study||6
8159806|NCT02545933|20114481|P3|COMPLETED|Overall Study||39
8159807|NCT02545933|20114482|P2|COMPLETED|Overall Study||40
8159808|NCT02545933|20114483|P1|COMPLETED|Overall Study||38
8159809|NCT02545933|20114481|P3|STARTED|Overall Study||43
8159810|NCT02545933|20114482|P2|STARTED|Overall Study||43
8159811|NCT02545933|20114483|P1|STARTED|Overall Study||44
8159830|NCT02545608|20114569|P2|NOT COMPLETED|Overall Study||7
8159831|NCT02545608|20114570|P1|NOT COMPLETED|Overall Study||0
8159832|NCT02545608|20114569|P2|COMPLETED|Overall Study||93
8159833|NCT02545608|20114570|P1|COMPLETED|Overall Study||9
8159834|NCT02545608|20114569|P2|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100
8159835|NCT02545608|20114570|P1|STARTED|Overall Study||9
8159836|NCT02545543|20114579|P2|NOT COMPLETED|Overall Study||34
8159837|NCT02545543|20114580|P1|NOT COMPLETED|Overall Study||81
8159838|NCT02545543|20114579|P2|COMPLETED|Overall Study||535
8159839|NCT02545543|20114580|P1|COMPLETED|Overall Study||1628
8159840|NCT02545543|20114579|P2|STARTED|Overall Study||569
8159841|NCT02545543|20114580|P1|STARTED|Overall Study||1709
8159842|NCT02545504|20114606|P2|NOT COMPLETED|Overall Study||214
8159843|NCT02545504|20114607|P1|NOT COMPLETED|Overall Study||218
8159844|NCT02545504|20114606|P2|COMPLETED|Overall Study||0
8159845|NCT02545504|20114607|P1|COMPLETED|Overall Study||0
8159846|NCT02545504|20114606|P2|STARTED|Overall Study||214
8159847|NCT02545504|20114607|P1|STARTED|Overall Study||218
8159848|NCT02545322|20114621|P1|NOT COMPLETED|Overall Study||3
8159849|NCT02545322|20114621|P1|COMPLETED|Overall Study||15
8159850|NCT02545322|20114621|P1|STARTED|Overall Study||18
8159851|NCT02545270|20114629|P3|NOT COMPLETED|Overall Study||2
8159852|NCT02545270|20114630|P2|NOT COMPLETED|Overall Study||1
8159853|NCT02545270|20114631|P1|NOT COMPLETED|Overall Study||0
8159854|NCT02545270|20114629|P3|COMPLETED|Overall Study||3
8159855|NCT02545270|20114630|P2|COMPLETED|Overall Study||4
8159856|NCT02545270|20114631|P1|COMPLETED|Overall Study||6
8159857|NCT02545270|20114629|P3|STARTED|Overall Study||5
8159858|NCT02545270|20114630|P2|STARTED|Overall Study||5
8159859|NCT02545270|20114631|P1|STARTED|Overall Study||6
8159860|NCT02545101|20114641|P1|NOT COMPLETED|Overall Study||0
8159861|NCT02545101|20114641|P1|COMPLETED|Overall Study||100
8159862|NCT02545101|20114641|P1|STARTED|Overall Study||100
8159863|NCT02545075|20114660|P2|NOT COMPLETED|Treatment||53
8159864|NCT02545075|20114661|P1|NOT COMPLETED|Treatment||122
8159865|NCT02545075|20114660|P2|COMPLETED|Treatment||0
8159866|NCT02545075|20114661|P1|COMPLETED|Treatment||0
8159867|NCT02545075|20114660|P2|STARTED|Treatment||53
8159868|NCT02545075|20114661|P1|STARTED|Treatment||122
8159869|NCT02545075|20114660|P2|NOT COMPLETED|Randomization||7
8159870|NCT02545075|20114661|P1|NOT COMPLETED|Randomization||0
8159871|NCT02545075|20114660|P2|COMPLETED|Randomization||53
8159872|NCT02545075|20114661|P1|COMPLETED|Randomization||122
8159873|NCT02545075|20114660|P2|STARTED|Randomization||60
8159874|NCT02545075|20114661|P1|STARTED|Randomization||122
8159875|NCT02544984|20114683|P2|NOT COMPLETED|Overall Study||2
8159876|NCT02544984|20114684|P1|NOT COMPLETED|Overall Study||2
8159877|NCT02544984|20114683|P2|COMPLETED|Overall Study||28
8159878|NCT02544984|20114684|P1|COMPLETED|Overall Study||28
8159879|NCT02544984|20114683|P2|STARTED|Overall Study||30
8159880|NCT02544984|20114684|P1|STARTED|Overall Study||30
8159881|NCT02544763|20114697|P3|NOT COMPLETED|Overall Study||1
8159882|NCT02544763|20114698|P2|NOT COMPLETED|Overall Study||12
8159883|NCT02544763|20114699|P1|NOT COMPLETED|Overall Study||10
8159884|NCT02544763|20114697|P3|COMPLETED|Overall Study||75
8159885|NCT02544763|20114698|P2|COMPLETED|Overall Study||61
8159886|NCT02544763|20114699|P1|COMPLETED|Overall Study||65
8159887|NCT02544763|20114697|P3|STARTED|Overall Study||76
8159888|NCT02544763|20114698|P2|STARTED|Overall Study||73
8159889|NCT02544763|20114699|P1|STARTED|Overall Study||75
8159890|NCT02544633|20114723|P4|NOT COMPLETED|Survival Follow-up Period||12
8159891|NCT02544633|20114724|P3|NOT COMPLETED|Survival Follow-up Period||7
8159892|NCT02544633|20114725|P2|NOT COMPLETED|Survival Follow-up Period||19
8159893|NCT02544633|20114726|P1|NOT COMPLETED|Survival Follow-up Period||28
8159894|NCT02544633|20114723|P4|COMPLETED|Survival Follow-up Period||0
8159895|NCT02544633|20114724|P3|COMPLETED|Survival Follow-up Period||0
8159896|NCT02544633|20114725|P2|COMPLETED|Survival Follow-up Period||0
8159897|NCT02544633|20114726|P1|COMPLETED|Survival Follow-up Period||0
8159898|NCT02544633|20114723|P4|STARTED|Survival Follow-up Period||12
8159899|NCT02544633|20114724|P3|STARTED|Survival Follow-up Period||7
8159900|NCT02544633|20114725|P2|STARTED|Survival Follow-up Period||19
8159901|NCT02544633|20114726|P1|STARTED|Survival Follow-up Period||28
8159902|NCT02544633|20114723|P4|NOT COMPLETED|Treatment Period||12
8159903|NCT02544633|20114724|P3|NOT COMPLETED|Treatment Period||8
8159904|NCT02544633|20114725|P2|NOT COMPLETED|Treatment Period||20
8159905|NCT02544633|20114726|P1|NOT COMPLETED|Treatment Period||28
8159906|NCT02544633|20114723|P4|COMPLETED|Treatment Period||0
8159907|NCT02544633|20114724|P3|COMPLETED|Treatment Period||0
8159908|NCT02544633|20114725|P2|COMPLETED|Treatment Period||0
8159909|NCT02544633|20114726|P1|COMPLETED|Treatment Period||0
8159910|NCT02544633|20114723|P4|STARTED|Treatment Period||12
8159911|NCT02544633|20114724|P3|STARTED|Treatment Period||8
8159912|NCT02544633|20114725|P2|STARTED|Treatment Period||20
8159913|NCT02544633|20114726|P1|STARTED|Treatment Period||28
8159914|NCT02544607|20114799|P1|NOT COMPLETED|Overall Study||0
8159915|NCT02544607|20114799|P1|COMPLETED|Overall Study||16
8159916|NCT02544607|20114799|P1|STARTED|Overall Study||16
8159926|NCT02544217|20114861|P6|NOT COMPLETED|Overall Study||0
8159927|NCT02544217|20114862|P5|NOT COMPLETED|Overall Study||0
8159928|NCT02544217|20114863|P4|NOT COMPLETED|Overall Study||0
8159929|NCT02544217|20114864|P3|NOT COMPLETED|Overall Study||0
8159930|NCT02544217|20114865|P2|NOT COMPLETED|Overall Study||1
8159931|NCT02544217|20114866|P1|NOT COMPLETED|Overall Study||1
8159932|NCT02544217|20114861|P6|COMPLETED|Overall Study||6
8159933|NCT02544217|20114862|P5|COMPLETED|Overall Study||4
8159934|NCT02544217|20114863|P4|COMPLETED|Overall Study||4
8159935|NCT02544217|20114864|P3|COMPLETED|Overall Study||4
8159936|NCT02544217|20114865|P2|COMPLETED|Overall Study|Two subjects prematurely withdrew from the study for non-medical reasons and were replaced.|6
8159937|NCT02544217|20114866|P1|COMPLETED|Overall Study||6
8159938|NCT02544217|20114861|P6|STARTED|Overall Study||6
8159939|NCT02544217|20114862|P5|STARTED|Overall Study||4
8159940|NCT02544217|20114863|P4|STARTED|Overall Study||4
8159941|NCT02544217|20114864|P3|STARTED|Overall Study||4
8159942|NCT02544217|20114865|P2|STARTED|Overall Study||7
8159943|NCT02544217|20114866|P1|STARTED|Overall Study||7
8159944|NCT02544152|20115661|P2|NOT COMPLETED|Overall Study||7
8159945|NCT02544152|20115662|P1|NOT COMPLETED|Overall Study||1
8159946|NCT02544152|20115661|P2|COMPLETED|Overall Study||30
8159947|NCT02544152|20115662|P1|COMPLETED|Overall Study||33
8159948|NCT02544152|20115661|P2|Safety Analysis Set (SAS)|Overall Study||37
8159949|NCT02544152|20115662|P1|Safety Analysis Set (SAS)|Overall Study||34
8159950|NCT02544152|20115661|P2|Modified Intent to Treat (mITT)|Overall Study||37
8159951|NCT02544152|20115662|P1|Modified Intent to Treat (mITT)|Overall Study||34
8159952|NCT02544152|20115661|P2|STARTED|Overall Study||37
8159953|NCT02544152|20115662|P1|STARTED|Overall Study||34
8159954|NCT02544074|20115705|P21|NOT COMPLETED|Overall Study||0
8159955|NCT02544074|20115706|P20|NOT COMPLETED|Overall Study||0
8159956|NCT02544074|20115707|P19|NOT COMPLETED|Overall Study||0
8159957|NCT02544074|20115708|P18|NOT COMPLETED|Overall Study||0
8159958|NCT02544074|20115709|P17|NOT COMPLETED|Overall Study||0
8159959|NCT02544074|20115710|P16|NOT COMPLETED|Overall Study||0
8159960|NCT02544074|20115711|P15|NOT COMPLETED|Overall Study||0
8159961|NCT02544074|20115712|P14|NOT COMPLETED|Overall Study||0
8159962|NCT02544074|20115713|P13|NOT COMPLETED|Overall Study||0
8159963|NCT02544074|20115714|P12|NOT COMPLETED|Overall Study||0
8159964|NCT02544074|20115715|P11|NOT COMPLETED|Overall Study||0
8159965|NCT02544074|20115716|P10|NOT COMPLETED|Overall Study||1
8159966|NCT02544074|20115717|P9|NOT COMPLETED|Overall Study||0
8159967|NCT02544074|20115718|P8|NOT COMPLETED|Overall Study||0
8159968|NCT02544074|20115719|P7|NOT COMPLETED|Overall Study||0
8159969|NCT02544074|20115720|P6|NOT COMPLETED|Overall Study||1
8159970|NCT02544074|20115721|P5|NOT COMPLETED|Overall Study||0
8159971|NCT02544074|20115722|P4|NOT COMPLETED|Overall Study||0
8159972|NCT02544074|20115723|P3|NOT COMPLETED|Overall Study||0
8159973|NCT02544074|20115724|P2|NOT COMPLETED|Overall Study||1
8159974|NCT02544074|20115725|P1|NOT COMPLETED|Overall Study||0
8159975|NCT02544074|20115705|P21|COMPLETED|Overall Study||3
8159976|NCT02544074|20115706|P20|COMPLETED|Overall Study||3
8159977|NCT02544074|20115707|P19|COMPLETED|Overall Study||4
8159978|NCT02544074|20115708|P18|COMPLETED|Overall Study||3
8159979|NCT02544074|20115709|P17|COMPLETED|Overall Study||6
8159980|NCT02544074|20115710|P16|COMPLETED|Overall Study||8
8159981|NCT02544074|20115711|P15|COMPLETED|Overall Study||5
8159982|NCT02544074|20115712|P14|COMPLETED|Overall Study||5
8159983|NCT02544074|20115713|P13|COMPLETED|Overall Study||4
8159984|NCT02544074|20115714|P12|COMPLETED|Overall Study||3
8159985|NCT02544074|20115715|P11|COMPLETED|Overall Study||2
8159986|NCT02544074|20115716|P10|COMPLETED|Overall Study||1
8159987|NCT02544074|20115717|P9|COMPLETED|Overall Study||6
8159988|NCT02544074|20115718|P8|COMPLETED|Overall Study||4
8159989|NCT02544074|20115719|P7|COMPLETED|Overall Study||2
8159990|NCT02544074|20115720|P6|COMPLETED|Overall Study||0
8159991|NCT02544074|20115721|P5|COMPLETED|Overall Study||4
8159992|NCT02544074|20115722|P4|COMPLETED|Overall Study||1
8159993|NCT02544074|20115723|P3|COMPLETED|Overall Study||1
8159994|NCT02544074|20115724|P2|COMPLETED|Overall Study||0
8159995|NCT02544074|20115725|P1|COMPLETED|Overall Study||1
8159996|NCT02544074|20115705|P21|STARTED|Overall Study||3
8159997|NCT02544074|20115706|P20|STARTED|Overall Study||3
8159998|NCT02544074|20115707|P19|STARTED|Overall Study||4
8159999|NCT02544074|20115708|P18|STARTED|Overall Study||3
8160000|NCT02544074|20115709|P17|STARTED|Overall Study||6
8160001|NCT02544074|20115710|P16|STARTED|Overall Study||8
8160002|NCT02544074|20115711|P15|STARTED|Overall Study||5
8160003|NCT02544074|20115712|P14|STARTED|Overall Study||5
8160004|NCT02544074|20115713|P13|STARTED|Overall Study||4
8160005|NCT02544074|20115714|P12|STARTED|Overall Study||3
8160006|NCT02544074|20115715|P11|STARTED|Overall Study||2
8160007|NCT02544074|20115716|P10|STARTED|Overall Study||2
8160008|NCT02544074|20115717|P9|STARTED|Overall Study||6
8160009|NCT02544074|20115718|P8|STARTED|Overall Study||4
8160010|NCT02544074|20115719|P7|STARTED|Overall Study||2
8160011|NCT02544074|20115720|P6|STARTED|Overall Study||1
8160012|NCT02544074|20115721|P5|STARTED|Overall Study||4
8160013|NCT02544074|20115722|P4|STARTED|Overall Study||1
8160014|NCT02544074|20115723|P3|STARTED|Overall Study||1
8160015|NCT02544074|20115724|P2|STARTED|Overall Study||1
8160016|NCT02544074|20115725|P1|STARTED|Overall Study||1
8160017|NCT02543918|20115761|P2|NOT COMPLETED|Overall Study||4
8160018|NCT02543918|20115762|P1|NOT COMPLETED|Overall Study||3
8160019|NCT02543918|20115761|P2|COMPLETED|Overall Study||39
8160020|NCT02543918|20115762|P1|COMPLETED|Overall Study||38
8160021|NCT02543918|20115761|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
8160022|NCT02543918|20115762|P1|Received at Least 1 Dose of Study Drug|Overall Study||41
8160023|NCT02543918|20115761|P2|STARTED|Overall Study||43
8160024|NCT02543918|20115762|P1|STARTED|Overall Study||41
8160025|NCT02543892|20115776|P8|NOT COMPLETED|Had Immunology Data||0
8160026|NCT02543892|20115777|P7|NOT COMPLETED|Had Immunology Data||1
8160027|NCT02543892|20115778|P6|NOT COMPLETED|Had Immunology Data||0
8160028|NCT02543892|20115779|P5|NOT COMPLETED|Had Immunology Data||0
8160029|NCT02543892|20115780|P4|NOT COMPLETED|Had Immunology Data||0
8160030|NCT02543892|20115781|P3|NOT COMPLETED|Had Immunology Data||0
8160031|NCT02543892|20115782|P2|NOT COMPLETED|Had Immunology Data||0
8160032|NCT02543892|20115783|P1|NOT COMPLETED|Had Immunology Data||0
8160033|NCT02543892|20115776|P8|COMPLETED|Had Immunology Data||49
8160034|NCT02543892|20115777|P7|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
8160035|NCT02543892|20115778|P6|COMPLETED|Had Immunology Data||49
8160036|NCT02543892|20115779|P5|COMPLETED|Had Immunology Data||50
8160037|NCT02543892|20115780|P4|COMPLETED|Had Immunology Data||12
8160038|NCT02543892|20115781|P3|COMPLETED|Had Immunology Data||12
8160039|NCT02543892|20115782|P2|COMPLETED|Had Immunology Data||11
8160040|NCT02543892|20115783|P1|COMPLETED|Had Immunology Data||11
8160041|NCT02543892|20115776|P8|STARTED|Had Immunology Data||49
8160042|NCT02543892|20115777|P7|STARTED|Had Immunology Data||50
8160043|NCT02543892|20115778|P6|STARTED|Had Immunology Data||49
8160044|NCT02543892|20115779|P5|STARTED|Had Immunology Data||50
8160045|NCT02543892|20115780|P4|STARTED|Had Immunology Data||12
8160046|NCT02543892|20115781|P3|STARTED|Had Immunology Data||12
8160047|NCT02543892|20115782|P2|STARTED|Had Immunology Data||11
8160048|NCT02543892|20115783|P1|STARTED|Had Immunology Data||11
8160049|NCT02543892|20115776|P8|NOT COMPLETED|Received Vaccination 2||1
8160050|NCT02543892|20115777|P7|NOT COMPLETED|Received Vaccination 2||0
8160051|NCT02543892|20115778|P6|NOT COMPLETED|Received Vaccination 2||1
8160052|NCT02543892|20115779|P5|NOT COMPLETED|Received Vaccination 2||0
8160053|NCT02543892|20115780|P4|NOT COMPLETED|Received Vaccination 2||0
8160054|NCT02543892|20115781|P3|NOT COMPLETED|Received Vaccination 2||0
8160055|NCT02543892|20115782|P2|NOT COMPLETED|Received Vaccination 2||1
8160056|NCT02543892|20115783|P1|NOT COMPLETED|Received Vaccination 2||1
8160057|NCT02543892|20115776|P8|COMPLETED|Received Vaccination 2||49
8160058|NCT02543892|20115777|P7|COMPLETED|Received Vaccination 2||50
8160059|NCT02543892|20115778|P6|COMPLETED|Received Vaccination 2||49
8160060|NCT02543892|20115779|P5|COMPLETED|Received Vaccination 2||50
8160061|NCT02543892|20115780|P4|COMPLETED|Received Vaccination 2||12
8160062|NCT02543892|20115781|P3|COMPLETED|Received Vaccination 2||12
8160063|NCT02543892|20115782|P2|COMPLETED|Received Vaccination 2||11
8160064|NCT02543892|20115783|P1|COMPLETED|Received Vaccination 2||11
8160065|NCT02543892|20115776|P8|STARTED|Received Vaccination 2||50
8160066|NCT02543892|20115777|P7|STARTED|Received Vaccination 2||50
8160067|NCT02543892|20115778|P6|STARTED|Received Vaccination 2||50
8160068|NCT02543892|20115779|P5|STARTED|Received Vaccination 2||50
8160069|NCT02543892|20115780|P4|STARTED|Received Vaccination 2||12
8160070|NCT02543892|20115781|P3|STARTED|Received Vaccination 2||12
8160071|NCT02543892|20115782|P2|STARTED|Received Vaccination 2||12
8160072|NCT02543892|20115783|P1|STARTED|Received Vaccination 2||12
8160073|NCT02543892|20115776|P8|NOT COMPLETED|Received Vaccination 1||0
8160074|NCT02543892|20115777|P7|NOT COMPLETED|Received Vaccination 1||0
8160075|NCT02543892|20115778|P6|NOT COMPLETED|Received Vaccination 1||0
8160076|NCT02543892|20115779|P5|NOT COMPLETED|Received Vaccination 1||0
8160077|NCT02543892|20115780|P4|NOT COMPLETED|Received Vaccination 1||0
8160078|NCT02543892|20115781|P3|NOT COMPLETED|Received Vaccination 1||0
8160079|NCT02543892|20115782|P2|NOT COMPLETED|Received Vaccination 1||0
8160080|NCT02543892|20115783|P1|NOT COMPLETED|Received Vaccination 1||0
8160081|NCT02543892|20115776|P8|COMPLETED|Received Vaccination 1||50
8160082|NCT02543892|20115777|P7|COMPLETED|Received Vaccination 1||50
8160083|NCT02543892|20115778|P6|COMPLETED|Received Vaccination 1||50
8160084|NCT02543892|20115779|P5|COMPLETED|Received Vaccination 1||50
8160085|NCT02543892|20115780|P4|COMPLETED|Received Vaccination 1||12
8160086|NCT02543892|20115781|P3|COMPLETED|Received Vaccination 1||12
8160087|NCT02543892|20115782|P2|COMPLETED|Received Vaccination 1||12
8160088|NCT02543892|20115783|P1|COMPLETED|Received Vaccination 1||12
8160089|NCT02543892|20115776|P8|STARTED|Received Vaccination 1||50
8160090|NCT02543892|20115777|P7|STARTED|Received Vaccination 1||50
8160091|NCT02543892|20115778|P6|STARTED|Received Vaccination 1||50
8160092|NCT02543892|20115779|P5|STARTED|Received Vaccination 1||50
8160093|NCT02543892|20115780|P4|STARTED|Received Vaccination 1||12
8160094|NCT02543892|20115781|P3|STARTED|Received Vaccination 1||12
8160095|NCT02543892|20115782|P2|STARTED|Received Vaccination 1||12
8160096|NCT02543892|20115783|P1|STARTED|Received Vaccination 1||12
8160097|NCT02543840|20115831|P2|NOT COMPLETED|Overall Study||0
8160098|NCT02543840|20115832|P1|NOT COMPLETED|Overall Study||0
8160099|NCT02543840|20115831|P2|COMPLETED|Overall Study||62
8160100|NCT02543840|20115832|P1|COMPLETED|Overall Study||1050
8160101|NCT02543840|20115831|P2|12 Month Timepoint (t12)|Overall Study|22 new providers completed at 12 months; 21 completed at both 0 and 12 months. 19 completed only T0.|22
8160102|NCT02543840|20115832|P1|12 Month Timepoint (t12)|Overall Study|91 continued from 0 months (t0), 16 from 6 months (t6), 91 from t0 & t6; 391 added at 12 months.|391
8160103|NCT02543840|20115831|P2|6 Month Timepoint (t6)|Overall Study||0
8160104|NCT02543840|20115832|P1|6 Month Timepoint (t6)|Overall Study|593 participants started at 0 months; 188 repeated and 66 participants added at 6 months timepoint.|66
8160105|NCT02543840|20115831|P2|0 Month Timepoint (t0)|Overall Study||40
8160106|NCT02543840|20115832|P1|0 Month Timepoint (t0)|Overall Study||593
8160107|NCT02543840|20115831|P2|STARTED|Overall Study||62
8160108|NCT02543840|20115832|P1|STARTED|Overall Study|This is a quasi-experimental design, not a RCT. 1050 veterans did 1436 interviews at 3 time points.|1050
8160109|NCT02543801|20115850|P4|NOT COMPLETED|Overall Study||0
8160110|NCT02543801|20115851|P3|NOT COMPLETED|Overall Study||0
8160111|NCT02543801|20115852|P2|NOT COMPLETED|Overall Study||2
8160112|NCT02543801|20115853|P1|NOT COMPLETED|Overall Study||1
8160113|NCT02543801|20115850|P4|COMPLETED|Overall Study||59
8160114|NCT02543801|20115851|P3|COMPLETED|Overall Study||59
8160115|NCT02543801|20115852|P2|COMPLETED|Overall Study||58
8160116|NCT02543801|20115853|P1|COMPLETED|Overall Study||60
8160117|NCT02543801|20115850|P4|STARTED|Overall Study||59
8160118|NCT02543801|20115851|P3|STARTED|Overall Study||59
8160119|NCT02543801|20115852|P2|STARTED|Overall Study||60
8160120|NCT02543801|20115853|P1|STARTED|Overall Study||61
8160121|NCT02543658|20115873|P2|NOT COMPLETED|Overall Study||4
8160122|NCT02543658|20115874|P1|NOT COMPLETED|Overall Study||0
8160123|NCT02543658|20115873|P2|COMPLETED|Overall Study||36
8160124|NCT02543658|20115874|P1|COMPLETED|Overall Study||40
8160125|NCT02543658|20115873|P2|STARTED|Overall Study||40
8160126|NCT02543658|20115874|P1|STARTED|Overall Study||40
8160127|NCT02543554|20115902|P2|NOT COMPLETED|Overall Study||0
8160128|NCT02543554|20115903|P1|NOT COMPLETED|Overall Study||0
8160129|NCT02543554|20115902|P2|COMPLETED|Overall Study||513
8160130|NCT02543554|20115903|P1|COMPLETED|Overall Study||1192
8160131|NCT02543554|20115902|P2|STARTED|Overall Study||513
8160132|NCT02543554|20115903|P1|STARTED|Overall Study||1192
8160133|NCT02543528|20115911|P5|NOT COMPLETED|Extended Wear Period||0
8160134|NCT02543528|20115912|P4|NOT COMPLETED|Extended Wear Period||12
8160135|NCT02543528|20115913|P3|NOT COMPLETED|Extended Wear Period||23
8160136|NCT02543528|20115914|P2|NOT COMPLETED|Extended Wear Period||21
8160137|NCT02543528|20115915|P1|NOT COMPLETED|Extended Wear Period||28
8160138|NCT02543528|20115911|P5|COMPLETED|Extended Wear Period||0
8160139|NCT02543528|20115912|P4|COMPLETED|Extended Wear Period||23
8160140|NCT02543528|20115913|P3|COMPLETED|Extended Wear Period||13
8160141|NCT02543528|20115914|P2|COMPLETED|Extended Wear Period||14
8160142|NCT02543528|20115915|P1|COMPLETED|Extended Wear Period||8
8160143|NCT02543528|20115911|P5|STARTED|Extended Wear Period||0
8160144|NCT02543528|20115912|P4|STARTED|Extended Wear Period||35
8160145|NCT02543528|20115913|P3|STARTED|Extended Wear Period||36
8160146|NCT02543528|20115914|P2|STARTED|Extended Wear Period||35
8160147|NCT02543528|20115915|P1|STARTED|Extended Wear Period||36
8160148|NCT02543528|20115911|P5|NOT COMPLETED|Adaptation Period||26
8160149|NCT02543528|20115912|P4|NOT COMPLETED|Adaptation Period||0
8160150|NCT02543528|20115913|P3|NOT COMPLETED|Adaptation Period||0
8160151|NCT02543528|20115914|P2|NOT COMPLETED|Adaptation Period||0
8160152|NCT02543528|20115915|P1|NOT COMPLETED|Adaptation Period||0
8160153|NCT02543528|20115911|P5|COMPLETED|Adaptation Period||142
8160154|NCT02543528|20115912|P4|COMPLETED|Adaptation Period||0
8160155|NCT02543528|20115913|P3|COMPLETED|Adaptation Period||0
8160156|NCT02543528|20115914|P2|COMPLETED|Adaptation Period||0
8160157|NCT02543528|20115915|P1|COMPLETED|Adaptation Period||0
8160158|NCT02543528|20115911|P5|STARTED|Adaptation Period||168
8160159|NCT02543528|20115912|P4|STARTED|Adaptation Period||0
8160160|NCT02543528|20115913|P3|STARTED|Adaptation Period||0
8160161|NCT02543528|20115914|P2|STARTED|Adaptation Period||0
8160162|NCT02543528|20115915|P1|STARTED|Adaptation Period||0
8160163|NCT02543437|20115934|P1|NOT COMPLETED|Overall Study||0
8160164|NCT02543437|20115934|P1|COMPLETED|Overall Study||117
8160165|NCT02543437|20115934|P1|STARTED|Overall Study||117
8160166|NCT02543398|20115941|P2|NOT COMPLETED|Overall Study||0
8160167|NCT02543398|20115942|P1|NOT COMPLETED|Overall Study||0
8160168|NCT02543398|20115941|P2|COMPLETED|Overall Study||20
8160169|NCT02543398|20115942|P1|COMPLETED|Overall Study||20
8160170|NCT02543398|20115941|P2|STARTED|Overall Study||20
8160171|NCT02543398|20115942|P1|STARTED|Overall Study||20
8160172|NCT02543346|20115948|P4|NOT COMPLETED|Second Treatment Visit||0
8160173|NCT02543346|20115949|P3|NOT COMPLETED|Second Treatment Visit||0
8160174|NCT02543346|20115950|P2|NOT COMPLETED|Second Treatment Visit||0
8160175|NCT02543346|20115951|P1|NOT COMPLETED|Second Treatment Visit||0
8160176|NCT02543346|20115948|P4|COMPLETED|Second Treatment Visit||21
8160177|NCT02543346|20115949|P3|COMPLETED|Second Treatment Visit||22
8160178|NCT02543346|20115950|P2|COMPLETED|Second Treatment Visit||23
8160179|NCT02543346|20115951|P1|COMPLETED|Second Treatment Visit||25
8160180|NCT02543346|20115948|P4|STARTED|Second Treatment Visit||21
8160181|NCT02543346|20115949|P3|STARTED|Second Treatment Visit||22
8160182|NCT02543346|20115950|P2|STARTED|Second Treatment Visit||23
8160183|NCT02543346|20115951|P1|STARTED|Second Treatment Visit||25
8160184|NCT02543346|20115948|P4|NOT COMPLETED|Second Priming Visit||2
8160185|NCT02543346|20115949|P3|NOT COMPLETED|Second Priming Visit||2
8160186|NCT02543346|20115950|P2|NOT COMPLETED|Second Priming Visit||2
8160187|NCT02543346|20115951|P1|NOT COMPLETED|Second Priming Visit||1
8160188|NCT02543346|20115948|P4|COMPLETED|Second Priming Visit||21
8160189|NCT02543346|20115949|P3|COMPLETED|Second Priming Visit||22
8160190|NCT02543346|20115950|P2|COMPLETED|Second Priming Visit||23
8160191|NCT02543346|20115951|P1|COMPLETED|Second Priming Visit||25
8160192|NCT02543346|20115948|P4|STARTED|Second Priming Visit||23
8160193|NCT02543346|20115949|P3|STARTED|Second Priming Visit||24
8160194|NCT02543346|20115950|P2|STARTED|Second Priming Visit||25
8160195|NCT02543346|20115951|P1|STARTED|Second Priming Visit||26
8160196|NCT02543346|20115948|P4|NOT COMPLETED|Washout (at Least 14 Days)||0
8160197|NCT02543346|20115949|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
8160198|NCT02543346|20115950|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
8160199|NCT02543346|20115951|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
8160200|NCT02543346|20115948|P4|COMPLETED|Washout (at Least 14 Days)||23
8160201|NCT02543346|20115949|P3|COMPLETED|Washout (at Least 14 Days)||24
8160202|NCT02543346|20115950|P2|COMPLETED|Washout (at Least 14 Days)||25
8160203|NCT02543346|20115951|P1|COMPLETED|Washout (at Least 14 Days)||26
8160204|NCT02543346|20115948|P4|STARTED|Washout (at Least 14 Days)||23
8160205|NCT02543346|20115949|P3|STARTED|Washout (at Least 14 Days)||24
8160206|NCT02543346|20115950|P2|STARTED|Washout (at Least 14 Days)||25
8160207|NCT02543346|20115951|P1|STARTED|Washout (at Least 14 Days)||26
8160208|NCT02543346|20115948|P4|NOT COMPLETED|First Treatment Visit||0
8160209|NCT02543346|20115949|P3|NOT COMPLETED|First Treatment Visit||0
8160210|NCT02543346|20115950|P2|NOT COMPLETED|First Treatment Visit||0
8160211|NCT02543346|20115951|P1|NOT COMPLETED|First Treatment Visit||0
8160212|NCT02543346|20115948|P4|COMPLETED|First Treatment Visit||23
8160213|NCT02543346|20115949|P3|COMPLETED|First Treatment Visit||24
8160214|NCT02543346|20115950|P2|COMPLETED|First Treatment Visit||25
8160215|NCT02543346|20115951|P1|COMPLETED|First Treatment Visit||26
8160216|NCT02543346|20115948|P4|STARTED|First Treatment Visit||23
8160217|NCT02543346|20115949|P3|STARTED|First Treatment Visit||24
8160218|NCT02543346|20115950|P2|STARTED|First Treatment Visit||25
8160219|NCT02543346|20115951|P1|STARTED|First Treatment Visit||26
8160220|NCT02543346|20115948|P4|NOT COMPLETED|First Priming Visit||0
8160221|NCT02543346|20115949|P3|NOT COMPLETED|First Priming Visit||0
8160222|NCT02543346|20115950|P2|NOT COMPLETED|First Priming Visit||0
8160223|NCT02543346|20115951|P1|NOT COMPLETED|First Priming Visit||0
8160224|NCT02543346|20115948|P4|COMPLETED|First Priming Visit||23
8160225|NCT02543346|20115949|P3|COMPLETED|First Priming Visit||24
8160226|NCT02543346|20115950|P2|COMPLETED|First Priming Visit||25
8160227|NCT02543346|20115951|P1|COMPLETED|First Priming Visit||26
8160228|NCT02543346|20115948|P4|STARTED|First Priming Visit||23
8160229|NCT02543346|20115949|P3|STARTED|First Priming Visit||24
8160230|NCT02543346|20115950|P2|STARTED|First Priming Visit||25
8160231|NCT02543346|20115951|P1|STARTED|First Priming Visit||26
8160232|NCT02543294|20115977|P1|NOT COMPLETED|Overall Study||12
8160233|NCT02543294|20115977|P1|COMPLETED|Overall Study||8
8160234|NCT02543294|20115977|P1|STARTED|Overall Study||20
8160235|NCT02542943|20115985|P3|NOT COMPLETED|Overall Study||0
8160236|NCT02542943|20115986|P2|NOT COMPLETED|Overall Study||1
8160237|NCT02542943|20115987|P1|NOT COMPLETED|Overall Study||1
8160238|NCT02542943|20115985|P3|COMPLETED|Overall Study||81
8160239|NCT02542943|20115986|P2|COMPLETED|Overall Study||79
8160240|NCT02542943|20115987|P1|COMPLETED|Overall Study||78
8160241|NCT02542943|20115985|P3|STARTED|Overall Study||81
8160242|NCT02542943|20115986|P2|STARTED|Overall Study||80
8160243|NCT02542943|20115987|P1|STARTED|Overall Study||79
8160244|NCT02542865|20116014|P2|NOT COMPLETED|Overall Study||0
8160245|NCT02542865|20116015|P1|NOT COMPLETED|Overall Study||17
8160246|NCT02542865|20116014|P2|COMPLETED|Overall Study||462
8160247|NCT02542865|20116015|P1|COMPLETED|Overall Study||445
8160248|NCT02542865|20116014|P2|Treated|Overall Study||462
8160249|NCT02542865|20116015|P1|Treated|Overall Study||460
8160250|NCT02542865|20116014|P2|STARTED|Overall Study||462
8160251|NCT02542865|20116015|P1|STARTED|Overall Study||462
8160252|NCT02542761|20116059|P2|NOT COMPLETED|Second Intervention||0
8160253|NCT02542761|20116060|P1|NOT COMPLETED|Second Intervention||0
8160254|NCT02542761|20116059|P2|COMPLETED|Second Intervention||5
8160255|NCT02542761|20116060|P1|COMPLETED|Second Intervention||5
8160256|NCT02542761|20116059|P2|STARTED|Second Intervention||5
8160257|NCT02542761|20116060|P1|STARTED|Second Intervention||5
8160258|NCT02542761|20116059|P2|NOT COMPLETED|Acclimation Period 2||0
8160259|NCT02542761|20116060|P1|NOT COMPLETED|Acclimation Period 2||0
8160260|NCT02542761|20116059|P2|COMPLETED|Acclimation Period 2||5
8160261|NCT02542761|20116060|P1|COMPLETED|Acclimation Period 2||5
8160262|NCT02542761|20116059|P2|STARTED|Acclimation Period 2||5
8160263|NCT02542761|20116060|P1|STARTED|Acclimation Period 2||5
8160264|NCT02542761|20116059|P2|NOT COMPLETED|First Intervention||0
8160265|NCT02542761|20116060|P1|NOT COMPLETED|First Intervention||0
8160266|NCT02542761|20116059|P2|COMPLETED|First Intervention||5
8160267|NCT02542761|20116060|P1|COMPLETED|First Intervention||5
8160268|NCT02542761|20116059|P2|STARTED|First Intervention||5
8160269|NCT02542761|20116060|P1|STARTED|First Intervention||5
8160270|NCT02542761|20116059|P2|NOT COMPLETED|Acclimation Period 1||0
8160271|NCT02542761|20116060|P1|NOT COMPLETED|Acclimation Period 1||0
8160272|NCT02542761|20116059|P2|COMPLETED|Acclimation Period 1||5
8160273|NCT02542761|20116060|P1|COMPLETED|Acclimation Period 1||5
8160274|NCT02542761|20116059|P2|STARTED|Acclimation Period 1||5
8160275|NCT02542761|20116060|P1|STARTED|Acclimation Period 1||5
8160276|NCT02542631|20116078|P2|NOT COMPLETED|Overall Study||31
8160277|NCT02542631|20116079|P1|NOT COMPLETED|Overall Study||31
8160278|NCT02542631|20116078|P2|COMPLETED|Overall Study||108
8160279|NCT02542631|20116079|P1|COMPLETED|Overall Study||108
8160280|NCT02542631|20116078|P2|STARTED|Overall Study||139
8160281|NCT02542631|20116079|P1|STARTED|Overall Study||139
8160282|NCT02542605|20116101|P3|NOT COMPLETED|Part B: Randomization Phase||1
8160283|NCT02542605|20116102|P2|NOT COMPLETED|Part B: Randomization Phase||0
8160284|NCT02542605|20116103|P1|NOT COMPLETED|Part B: Randomization Phase||0
8160285|NCT02542605|20116101|P3|COMPLETED|Part B: Randomization Phase||7
8160286|NCT02542605|20116102|P2|COMPLETED|Part B: Randomization Phase||9
8160287|NCT02542605|20116103|P1|COMPLETED|Part B: Randomization Phase||0
8160288|NCT02542605|20116101|P3|Received Placebo/Erenumab|Part B: Randomization Phase||7
8160289|NCT02542605|20116102|P2|Received Placebo/Erenumab|Part B: Randomization Phase||9
8160290|NCT02542605|20116103|P1|Received Placebo/Erenumab|Part B: Randomization Phase||0
8160291|NCT02542605|20116101|P3|PACAP-38 naïve Participants|Part B: Randomization Phase||8
8160292|NCT02542605|20116102|P2|PACAP-38 naïve Participants|Part B: Randomization Phase||7
8160293|NCT02542605|20116103|P1|PACAP-38 naïve Participants|Part B: Randomization Phase||0
8160294|NCT02542605|20116101|P3|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
8160295|NCT02542605|20116102|P2|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2
8160296|NCT02542605|20116103|P1|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
8160297|NCT02542605|20116101|P3|STARTED|Part B: Randomization Phase||8
8160298|NCT02542605|20116102|P2|STARTED|Part B: Randomization Phase||9
8160299|NCT02542605|20116103|P1|STARTED|Part B: Randomization Phase||0
8160300|NCT02542605|20116101|P3|NOT COMPLETED|Part B: Challenge Phase||0
8160301|NCT02542605|20116102|P2|NOT COMPLETED|Part B: Challenge Phase||0
8160302|NCT02542605|20116103|P1|NOT COMPLETED|Part B: Challenge Phase||1
8160303|NCT02542605|20116101|P3|COMPLETED|Part B: Challenge Phase||0
8160304|NCT02542605|20116102|P2|COMPLETED|Part B: Challenge Phase||0
8160305|NCT02542605|20116103|P1|COMPLETED|Part B: Challenge Phase||22
8160306|NCT02542605|20116101|P3|Proceeded to Randomization Phase|Part B: Challenge Phase||0
8160307|NCT02542605|20116102|P2|Proceeded to Randomization Phase|Part B: Challenge Phase||0
8160308|NCT02542605|20116103|P1|Proceeded to Randomization Phase|Part B: Challenge Phase||15
8160309|NCT02542605|20116101|P3|Received PACAP-38|Part B: Challenge Phase||0
8160310|NCT02542605|20116102|P2|Received PACAP-38|Part B: Challenge Phase||0
8160311|NCT02542605|20116103|P1|Received PACAP-38|Part B: Challenge Phase||23
8160312|NCT02542605|20116101|P3|STARTED|Part B: Challenge Phase||0
8160313|NCT02542605|20116102|P2|STARTED|Part B: Challenge Phase||0
8160314|NCT02542605|20116103|P1|STARTED|Part B: Challenge Phase||23
8160315|NCT02542605|20116101|P3|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8160316|NCT02542605|20116102|P2|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8160317|NCT02542605|20116103|P1|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8160318|NCT02542605|20116101|P3|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8160319|NCT02542605|20116102|P2|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
8160320|NCT02542605|20116103|P1|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12
8160321|NCT02542605|20116101|P3|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
8160322|NCT02542605|20116102|P2|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
8160411|NCT02541669|20116355|P5|NOT COMPLETED|Open Label Treatment Period||0
8160323|NCT02542605|20116103|P1|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2
8160324|NCT02542605|20116101|P3|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
8160325|NCT02542605|20116102|P2|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
8160326|NCT02542605|20116103|P1|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12
8160327|NCT02542605|20116101|P3|STARTED|Part A: PACAP-38 Dose Selection Phase||0
8160328|NCT02542605|20116102|P2|STARTED|Part A: PACAP-38 Dose Selection Phase||0
8160329|NCT02542605|20116103|P1|STARTED|Part A: PACAP-38 Dose Selection Phase||12
8160330|NCT02542462|20116154|P4|NOT COMPLETED|Overall Study||1
8160331|NCT02542462|20116155|P3|NOT COMPLETED|Overall Study||0
8160332|NCT02542462|20116156|P2|NOT COMPLETED|Overall Study||0
8160333|NCT02542462|20116157|P1|NOT COMPLETED|Overall Study||0
8160334|NCT02542462|20116154|P4|COMPLETED|Overall Study||25
8160335|NCT02542462|20116155|P3|COMPLETED|Overall Study||25
8160336|NCT02542462|20116156|P2|COMPLETED|Overall Study||25
8160337|NCT02542462|20116157|P1|COMPLETED|Overall Study||25
8160338|NCT02542462|20116154|P4|STARTED|Overall Study||26
8160339|NCT02542462|20116155|P3|STARTED|Overall Study||25
8160340|NCT02542462|20116156|P2|STARTED|Overall Study||25
8160341|NCT02542462|20116157|P1|STARTED|Overall Study||25
8160342|NCT02542410|20116171|P2|NOT COMPLETED|Overall Study||1
8160343|NCT02542410|20116172|P1|NOT COMPLETED|Overall Study||2
8160344|NCT02542410|20116171|P2|COMPLETED|Overall Study||4
8160345|NCT02542410|20116172|P1|COMPLETED|Overall Study||3
8160346|NCT02542410|20116171|P2|STARTED|Overall Study||5
8160347|NCT02542410|20116172|P1|STARTED|Overall Study||5
8160348|NCT02542280|20116182|P2|NOT COMPLETED|Overall Study||8
8160349|NCT02542280|20116183|P1|NOT COMPLETED|Overall Study||12
8160350|NCT02542280|20116182|P2|COMPLETED|Overall Study||167
8160351|NCT02542280|20116183|P1|COMPLETED|Overall Study||162
8160352|NCT02542280|20116182|P2|STARTED|Overall Study||175
8160353|NCT02542280|20116183|P1|STARTED|Overall Study||174
8160357|NCT02542072|20116199|P2|NOT COMPLETED|Second Intervention (1 Month)||0
8160358|NCT02542072|20116200|P1|NOT COMPLETED|Second Intervention (1 Month)||2
8160359|NCT02542072|20116199|P2|COMPLETED|Second Intervention (1 Month)||43
8160360|NCT02542072|20116200|P1|COMPLETED|Second Intervention (1 Month)||37
8160361|NCT02542072|20116199|P2|STARTED|Second Intervention (1 Month)||43
8160362|NCT02542072|20116200|P1|STARTED|Second Intervention (1 Month)||39
8160363|NCT02542072|20116199|P2|NOT COMPLETED|First Intervention (1 Month)||3
8160364|NCT02542072|20116200|P1|NOT COMPLETED|First Intervention (1 Month)||5
8160365|NCT02542072|20116199|P2|COMPLETED|First Intervention (1 Month)||43
8160366|NCT02542072|20116200|P1|COMPLETED|First Intervention (1 Month)||39
8160367|NCT02542072|20116199|P2|STARTED|First Intervention (1 Month)||46
8160368|NCT02542072|20116200|P1|STARTED|First Intervention (1 Month)||44
8160369|NCT02542046|20116303|P3|NOT COMPLETED|Overall Study||0
8160370|NCT02542046|20116304|P2|NOT COMPLETED|Overall Study||0
8160371|NCT02542046|20116305|P1|NOT COMPLETED|Overall Study||0
8160372|NCT02542046|20116303|P3|COMPLETED|Overall Study||300
8160373|NCT02542046|20116304|P2|COMPLETED|Overall Study||300
8160374|NCT02542046|20116305|P1|COMPLETED|Overall Study||300
8160375|NCT02542046|20116303|P3|STARTED|Overall Study||300
8160376|NCT02542046|20116304|P2|STARTED|Overall Study||300
8160377|NCT02542046|20116305|P1|STARTED|Overall Study||300
8160378|NCT02541942|20116319|P1|NOT COMPLETED|Overall Study||0
8160379|NCT02541942|20116319|P1|COMPLETED|Overall Study||19
8160380|NCT02541942|20116319|P1|STARTED|Overall Study||19
8160381|NCT02541903|20116324|P1|NOT COMPLETED|Overall Study||1
8160382|NCT02541903|20116324|P1|COMPLETED|Overall Study||7
8160383|NCT02541903|20116324|P1|STARTED|Overall Study||8
8160384|NCT02541864|20116333|P2|NOT COMPLETED|Overall Study||0
8160385|NCT02541864|20116334|P1|NOT COMPLETED|Overall Study||0
8160386|NCT02541864|20116333|P2|COMPLETED|Overall Study||166
8160387|NCT02541864|20116334|P1|COMPLETED|Overall Study||164
8160388|NCT02541864|20116333|P2|STARTED|Overall Study||166
8160389|NCT02541864|20116334|P1|STARTED|Overall Study||164
8160390|NCT02541812|20116342|P2|NOT COMPLETED|Overall Study||0
8160391|NCT02541812|20116343|P1|NOT COMPLETED|Overall Study||0
8160392|NCT02541812|20116342|P2|COMPLETED|Overall Study||10
8160393|NCT02541812|20116343|P1|COMPLETED|Overall Study||10
8160394|NCT02541812|20116342|P2|STARTED|Overall Study||10
8160395|NCT02541812|20116343|P1|STARTED|Overall Study||10
8160396|NCT02541669|20116355|P5|NOT COMPLETED|Double-Blinded Treatment Period||1
8160397|NCT02541669|20116356|P4|NOT COMPLETED|Double-Blinded Treatment Period||0
8160398|NCT02541669|20116357|P3|NOT COMPLETED|Double-Blinded Treatment Period||1
8160399|NCT02541669|20116358|P2|NOT COMPLETED|Double-Blinded Treatment Period||0
8160400|NCT02541669|20116359|P1|NOT COMPLETED|Double-Blinded Treatment Period||0
8160401|NCT02541669|20116355|P5|COMPLETED|Double-Blinded Treatment Period||15
8160402|NCT02541669|20116356|P4|COMPLETED|Double-Blinded Treatment Period||16
8160403|NCT02541669|20116357|P3|COMPLETED|Double-Blinded Treatment Period||15
8160404|NCT02541669|20116358|P2|COMPLETED|Double-Blinded Treatment Period||0
8160405|NCT02541669|20116359|P1|COMPLETED|Double-Blinded Treatment Period||0
8160406|NCT02541669|20116355|P5|STARTED|Double-Blinded Treatment Period||16
8160407|NCT02541669|20116356|P4|STARTED|Double-Blinded Treatment Period||16
8160408|NCT02541669|20116357|P3|STARTED|Double-Blinded Treatment Period||16
8160409|NCT02541669|20116358|P2|STARTED|Double-Blinded Treatment Period||0
8160410|NCT02541669|20116359|P1|STARTED|Double-Blinded Treatment Period||0
8160412|NCT02541669|20116356|P4|NOT COMPLETED|Open Label Treatment Period||0
8160413|NCT02541669|20116357|P3|NOT COMPLETED|Open Label Treatment Period||0
8160414|NCT02541669|20116358|P2|NOT COMPLETED|Open Label Treatment Period||0
8160415|NCT02541669|20116359|P1|NOT COMPLETED|Open Label Treatment Period||0
8160416|NCT02541669|20116355|P5|COMPLETED|Open Label Treatment Period||0
8160417|NCT02541669|20116356|P4|COMPLETED|Open Label Treatment Period||0
8160418|NCT02541669|20116357|P3|COMPLETED|Open Label Treatment Period||0
8160419|NCT02541669|20116358|P2|COMPLETED|Open Label Treatment Period||8
8160420|NCT02541669|20116359|P1|COMPLETED|Open Label Treatment Period||8
8160421|NCT02541669|20116355|P5|STARTED|Open Label Treatment Period||0
8160422|NCT02541669|20116356|P4|STARTED|Open Label Treatment Period||0
8160423|NCT02541669|20116357|P3|STARTED|Open Label Treatment Period||0
8160424|NCT02541669|20116358|P2|STARTED|Open Label Treatment Period||8
8160425|NCT02541669|20116359|P1|STARTED|Open Label Treatment Period||8
8160426|NCT02541604|20116406|P12|NOT COMPLETED|Overall Study||3
8160427|NCT02541604|20116407|P11|NOT COMPLETED|Overall Study||2
8160428|NCT02541604|20116408|P10|NOT COMPLETED|Overall Study||4
8160429|NCT02541604|20116409|P9|NOT COMPLETED|Overall Study||4
8160430|NCT02541604|20116410|P8|NOT COMPLETED|Overall Study||10
8160431|NCT02541604|20116411|P7|NOT COMPLETED|Overall Study||10
8160432|NCT02541604|20116412|P6|NOT COMPLETED|Overall Study||10
8160433|NCT02541604|20116413|P5|NOT COMPLETED|Overall Study||10
8160434|NCT02541604|20116414|P4|NOT COMPLETED|Overall Study||3
8160435|NCT02541604|20116415|P3|NOT COMPLETED|Overall Study||11
8160436|NCT02541604|20116416|P2|NOT COMPLETED|Overall Study||9
8160437|NCT02541604|20116417|P1|NOT COMPLETED|Overall Study||11
8160438|NCT02541604|20116406|P12|COMPLETED|Overall Study||0
8160439|NCT02541604|20116407|P11|COMPLETED|Overall Study||0
8160440|NCT02541604|20116408|P10|COMPLETED|Overall Study||0
8160441|NCT02541604|20116409|P9|COMPLETED|Overall Study||0
8160442|NCT02541604|20116410|P8|COMPLETED|Overall Study||0
8160443|NCT02541604|20116411|P7|COMPLETED|Overall Study||0
8160444|NCT02541604|20116412|P6|COMPLETED|Overall Study||0
8160445|NCT02541604|20116413|P5|COMPLETED|Overall Study||0
8160446|NCT02541604|20116414|P4|COMPLETED|Overall Study||0
8160447|NCT02541604|20116415|P3|COMPLETED|Overall Study||0
8160448|NCT02541604|20116416|P2|COMPLETED|Overall Study||0
8160449|NCT02541604|20116417|P1|COMPLETED|Overall Study||0
8160450|NCT02541604|20116406|P12|STARTED|Overall Study||3
8160451|NCT02541604|20116407|P11|STARTED|Overall Study||2
8160452|NCT02541604|20116408|P10|STARTED|Overall Study||4
8160453|NCT02541604|20116409|P9|STARTED|Overall Study||4
8160454|NCT02541604|20116410|P8|STARTED|Overall Study||10
8160455|NCT02541604|20116411|P7|STARTED|Overall Study||10
8160456|NCT02541604|20116412|P6|STARTED|Overall Study||10
8160457|NCT02541604|20116413|P5|STARTED|Overall Study||10
8160458|NCT02541604|20116414|P4|STARTED|Overall Study||3
8160459|NCT02541604|20116415|P3|STARTED|Overall Study||11
8160460|NCT02541604|20116416|P2|STARTED|Overall Study||9
8160461|NCT02541604|20116417|P1|STARTED|Overall Study||11
8160462|NCT02541565|20116522|P1|NOT COMPLETED|Overall Study||3
8160463|NCT02541565|20116522|P1|COMPLETED|Overall Study||27
8160464|NCT02541565|20116522|P1|STARTED|Overall Study||30
8160465|NCT02541422|20116526|P2|NOT COMPLETED|Second Intervention||0
8160466|NCT02541422|20116527|P1|NOT COMPLETED|Second Intervention||0
8160467|NCT02541422|20116526|P2|COMPLETED|Second Intervention||26
8160468|NCT02541422|20116527|P1|COMPLETED|Second Intervention||23
8160469|NCT02541422|20116526|P2|STARTED|Second Intervention||26
8160470|NCT02541422|20116527|P1|STARTED|Second Intervention||23
8160471|NCT02541422|20116526|P2|NOT COMPLETED|First Intervention||0
8160472|NCT02541422|20116527|P1|NOT COMPLETED|First Intervention||0
8160473|NCT02541422|20116526|P2|COMPLETED|First Intervention||26
8160474|NCT02541422|20116527|P1|COMPLETED|First Intervention||23
8160475|NCT02541422|20116526|P2|STARTED|First Intervention||26
8160476|NCT02541422|20116527|P1|STARTED|First Intervention||23
8160477|NCT02540850|20116536|P3|NOT COMPLETED|Overall Study||34
8160478|NCT02540850|20116537|P2|NOT COMPLETED|Overall Study||66
8160479|NCT02540850|20116538|P1|NOT COMPLETED|Overall Study||69
8160480|NCT02540850|20116536|P3|COMPLETED|Overall Study||410
8160481|NCT02540850|20116537|P2|COMPLETED|Overall Study||330
8160482|NCT02540850|20116538|P1|COMPLETED|Overall Study||291
8160483|NCT02540850|20116536|P3|STARTED|Overall Study||444
8160484|NCT02540850|20116537|P2|STARTED|Overall Study||396
8160485|NCT02540850|20116538|P1|STARTED|Overall Study||360
8160486|NCT02540772|20116566|P2|NOT COMPLETED|Overall Study||0
8160487|NCT02540772|20116567|P1|NOT COMPLETED|Overall Study||0
8160488|NCT02540772|20116566|P2|COMPLETED|Overall Study||10
8160489|NCT02540772|20116567|P1|COMPLETED|Overall Study||10
8160490|NCT02540772|20116566|P2|STARTED|Overall Study||10
8160491|NCT02540772|20116567|P1|STARTED|Overall Study||10
8160492|NCT02540668|20116579|P2|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1
8160493|NCT02540668|20116580|P1|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0
8160494|NCT02540668|20116579|P2|COMPLETED|Period 2 - LY3314814 and Warfarin||14
8160495|NCT02540668|20116580|P1|COMPLETED|Period 2 - LY3314814 and Warfarin||0
8160496|NCT02540668|20116579|P2|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15
8160497|NCT02540668|20116580|P1|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0
8160498|NCT02540668|20116579|P2|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
8160499|NCT02540668|20116580|P1|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
8160500|NCT02540668|20116579|P2|COMPLETED|Period 1 - Warfarin Single Dose||0
8160501|NCT02540668|20116580|P1|COMPLETED|Period 1 - Warfarin Single Dose||15
8160502|NCT02540668|20116579|P2|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0
8160503|NCT02540668|20116580|P1|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15
8160504|NCT02540668|20116579|P2|STARTED|Period 1 - Warfarin Single Dose||0
8160505|NCT02540668|20116580|P1|STARTED|Period 1 - Warfarin Single Dose||15
8160506|NCT02540629|20116599|P2|NOT COMPLETED|Overall Study||0
8160507|NCT02540629|20116600|P1|NOT COMPLETED|Overall Study||0
8160508|NCT02540629|20116599|P2|COMPLETED|Overall Study||6469
8160509|NCT02540629|20116600|P1|COMPLETED|Overall Study||6201
8160510|NCT02540629|20116599|P2|STARTED|Overall Study||6469
8160511|NCT02540629|20116600|P1|STARTED|Overall Study||6201
8160512|NCT02540538|20116611|P3|NOT COMPLETED|Overall Study||0
8160513|NCT02540538|20116612|P2|NOT COMPLETED|Overall Study||1
8160514|NCT02540538|20116613|P1|NOT COMPLETED|Overall Study||0
8160515|NCT02540538|20116611|P3|COMPLETED|Overall Study||10
8160516|NCT02540538|20116612|P2|COMPLETED|Overall Study||11
8160517|NCT02540538|20116613|P1|COMPLETED|Overall Study||12
8160518|NCT02540538|20116611|P3|STARTED|Overall Study||10
8160519|NCT02540538|20116612|P2|STARTED|Overall Study||12
8160520|NCT02540538|20116613|P1|STARTED|Overall Study||12
8160521|NCT02540447|20116629|P2|NOT COMPLETED|Overall Study||0
8160522|NCT02540447|20116630|P1|NOT COMPLETED|Overall Study||0
8160523|NCT02540447|20116629|P2|COMPLETED|Overall Study||40
8160524|NCT02540447|20116630|P1|COMPLETED|Overall Study||40
8160525|NCT02540447|20116629|P2|STARTED|Overall Study||40
8160526|NCT02540447|20116630|P1|STARTED|Overall Study||40
8160527|NCT02540434|20116646|P2|NOT COMPLETED|Overall Study||0
8160528|NCT02540434|20116647|P1|NOT COMPLETED|Overall Study||0
8160529|NCT02540434|20116646|P2|COMPLETED|Overall Study||1
8160530|NCT02540434|20116647|P1|COMPLETED|Overall Study||1
8160531|NCT02540434|20116646|P2|STARTED|Overall Study||1
8160532|NCT02540434|20116647|P1|STARTED|Overall Study||1
8160533|NCT02540356|20116681|P2|NOT COMPLETED|Overall Study||0
8160534|NCT02540356|20116682|P1|NOT COMPLETED|Overall Study||1
8160535|NCT02540356|20116681|P2|COMPLETED|Overall Study||0
8160536|NCT02540356|20116682|P1|COMPLETED|Overall Study||0
8160537|NCT02540356|20116681|P2|STARTED|Overall Study||0
8160538|NCT02540356|20116682|P1|STARTED|Overall Study||1
8160539|NCT02540291|20116717|P4|NOT COMPLETED|Overall Study||7
8160540|NCT02540291|20116718|P3|NOT COMPLETED|Overall Study||7
8160541|NCT02540291|20116719|P2|NOT COMPLETED|Overall Study||8
8160542|NCT02540291|20116720|P1|NOT COMPLETED|Overall Study||8
8160543|NCT02540291|20116717|P4|COMPLETED|Overall Study||0
8160544|NCT02540291|20116718|P3|COMPLETED|Overall Study||0
8160545|NCT02540291|20116719|P2|COMPLETED|Overall Study||0
8160546|NCT02540291|20116720|P1|COMPLETED|Overall Study||0
8160547|NCT02540291|20116717|P4|STARTED|Overall Study||7
8160548|NCT02540291|20116718|P3|STARTED|Overall Study||7
8160549|NCT02540291|20116719|P2|STARTED|Overall Study||8
8160550|NCT02540291|20116720|P1|STARTED|Overall Study||8
8160551|NCT02540265|20116755|P3|NOT COMPLETED|Overall Study||1
8160552|NCT02540265|20116756|P2|NOT COMPLETED|Overall Study||0
8160553|NCT02540265|20116757|P1|NOT COMPLETED|Overall Study||0
8160554|NCT02540265|20116755|P3|COMPLETED|Overall Study||18
8160555|NCT02540265|20116756|P2|COMPLETED|Overall Study||20
8160556|NCT02540265|20116757|P1|COMPLETED|Overall Study||20
8160557|NCT02540265|20116755|P3|Treatment Completion|Overall Study||18
8160558|NCT02540265|20116756|P2|Treatment Completion|Overall Study||19
8160559|NCT02540265|20116757|P1|Treatment Completion|Overall Study||20
8160560|NCT02540265|20116755|P3|STARTED|Overall Study||19
8160561|NCT02540265|20116756|P2|STARTED|Overall Study||20
8160562|NCT02540265|20116757|P1|STARTED|Overall Study||20
8160563|NCT02540226|20116779|P2|NOT COMPLETED|Overall Study||1
8160564|NCT02540226|20116780|P1|NOT COMPLETED|Overall Study||2
8160565|NCT02540226|20116779|P2|COMPLETED|Overall Study||32
8160566|NCT02540226|20116780|P1|COMPLETED|Overall Study||31
8160567|NCT02540226|20116779|P2|STARTED|Overall Study||33
8160568|NCT02540226|20116780|P1|STARTED|Overall Study||33
8160569|NCT02540213|20116812|P1|NOT COMPLETED|Overall Study||39
8160570|NCT02540213|20116812|P1|COMPLETED|Overall Study||201
8160571|NCT02540213|20116812|P1|STARTED|Overall Study||240
8160572|NCT02540161|20116837|P4|NOT COMPLETED|Overall Study||0
8160573|NCT02540161|20116838|P3|NOT COMPLETED|Overall Study||0
8160574|NCT02540161|20116839|P2|NOT COMPLETED|Overall Study||0
8160575|NCT02540161|20116840|P1|NOT COMPLETED|Overall Study||0
8160576|NCT02540161|20116837|P4|COMPLETED|Overall Study||7
8160577|NCT02540161|20116838|P3|COMPLETED|Overall Study||5
8160578|NCT02540161|20116839|P2|COMPLETED|Overall Study||7
8160579|NCT02540161|20116840|P1|COMPLETED|Overall Study||20
8160580|NCT02540161|20116837|P4|STARTED|Overall Study||7
8160581|NCT02540161|20116838|P3|STARTED|Overall Study||5
8160582|NCT02540161|20116839|P2|STARTED|Overall Study||7
8160583|NCT02540161|20116840|P1|STARTED|Overall Study||20
8160584|NCT02540083|20116866|P1|NOT COMPLETED|Overall Study||16
8160585|NCT02540083|20116866|P1|COMPLETED|Overall Study||78
8160586|NCT02540083|20116866|P1|STARTED|Overall Study||94
8160587|NCT02539992|20116879|P3|NOT COMPLETED|Overall Study||4
8160588|NCT02539992|20116880|P2|NOT COMPLETED|Overall Study||4
8160589|NCT02539992|20116881|P1|NOT COMPLETED|Overall Study||0
8160590|NCT02539992|20116879|P3|COMPLETED|Overall Study||14
8160591|NCT02539992|20116880|P2|COMPLETED|Overall Study||7
8160592|NCT02539992|20116881|P1|COMPLETED|Overall Study||15
8160593|NCT02539992|20116879|P3|STARTED|Overall Study||18
8160594|NCT02539992|20116880|P2|STARTED|Overall Study||11
8160595|NCT02539992|20116881|P1|STARTED|Overall Study||15
8160596|NCT02539797|20116907|P3|NOT COMPLETED|Overall Study||0
8160597|NCT02539797|20116908|P2|NOT COMPLETED|Overall Study||1
8160598|NCT02539797|20116909|P1|NOT COMPLETED|Overall Study||0
8160599|NCT02539797|20116907|P3|COMPLETED|Overall Study||13
8160600|NCT02539797|20116908|P2|COMPLETED|Overall Study||12
8160601|NCT02539797|20116909|P1|COMPLETED|Overall Study||12
8160602|NCT02539797|20116907|P3|STARTED|Overall Study||13
8160603|NCT02539797|20116908|P2|STARTED|Overall Study||13
8160604|NCT02539797|20116909|P1|STARTED|Overall Study||12
8160605|NCT02539654|20116920|P1|NOT COMPLETED|Overall Study||0
8160606|NCT02539654|20116920|P1|COMPLETED|Overall Study||14
8160607|NCT02539654|20116920|P1|STARTED|Overall Study||14
8160608|NCT02539563|20116932|P2|NOT COMPLETED|Overall Study||14
8160609|NCT02539563|20116933|P1|NOT COMPLETED|Overall Study||6
8160610|NCT02539563|20116932|P2|COMPLETED|Overall Study||42
8160611|NCT02539563|20116933|P1|COMPLETED|Overall Study||39
8160612|NCT02539563|20116932|P2|STARTED|Overall Study||56
8160613|NCT02539563|20116933|P1|STARTED|Overall Study||45
8160614|NCT02539511|20116949|P2|NOT COMPLETED|Overall Study||0
8160615|NCT02539511|20116950|P1|NOT COMPLETED|Overall Study||6
8160616|NCT02539511|20116949|P2|COMPLETED|Overall Study||17
8160617|NCT02539511|20116950|P1|COMPLETED|Overall Study||17
8160618|NCT02539511|20116949|P2|STARTED|Overall Study||17
8160619|NCT02539511|20116950|P1|STARTED|Overall Study||23
8160620|NCT02539368|20116961|P5|NOT COMPLETED|Overall Study||14
8160621|NCT02539368|20116962|P4|NOT COMPLETED|Overall Study||7
8160622|NCT02539368|20116963|P3|NOT COMPLETED|Overall Study||67
8160623|NCT02539368|20116964|P2|NOT COMPLETED|Overall Study||101
8160624|NCT02539368|20116965|P1|NOT COMPLETED|Overall Study||405
8160625|NCT02539368|20116961|P5|COMPLETED|Overall Study||88
8160626|NCT02539368|20116962|P4|COMPLETED|Overall Study||60
8160627|NCT02539368|20116963|P3|COMPLETED|Overall Study||291
8160628|NCT02539368|20116964|P2|COMPLETED|Overall Study||393
8160629|NCT02539368|20116965|P1|COMPLETED|Overall Study||1117
8160630|NCT02539368|20116961|P5|STARTED|Overall Study||102
8160631|NCT02539368|20116962|P4|STARTED|Overall Study||67
8160632|NCT02539368|20116963|P3|STARTED|Overall Study||358
8160633|NCT02539368|20116964|P2|STARTED|Overall Study||494
8160634|NCT02539368|20116965|P1|STARTED|Overall Study||1522
8160635|NCT02539342|20117087|P2|NOT COMPLETED|Overall Study||0
8160636|NCT02539342|20117088|P1|NOT COMPLETED|Overall Study||0
8160637|NCT02539342|20117087|P2|COMPLETED|Overall Study||0
8160638|NCT02539342|20117088|P1|COMPLETED|Overall Study||1
8160639|NCT02539342|20117087|P2|STARTED|Overall Study||0
8160640|NCT02539342|20117088|P1|STARTED|Overall Study||1
8160661|NCT02539134|20117126|P6|NOT COMPLETED|Overall Study||0
8160662|NCT02539134|20117127|P5|NOT COMPLETED|Overall Study||0
8160663|NCT02539134|20117128|P4|NOT COMPLETED|Overall Study||0
8160664|NCT02539134|20117129|P3|NOT COMPLETED|Overall Study||0
8160665|NCT02539134|20117130|P2|NOT COMPLETED|Overall Study||0
8160666|NCT02539134|20117131|P1|NOT COMPLETED|Overall Study||1
8160667|NCT02539134|20117126|P6|COMPLETED|Overall Study||6
8160668|NCT02539134|20117127|P5|COMPLETED|Overall Study||6
8160669|NCT02539134|20117128|P4|COMPLETED|Overall Study||6
8160670|NCT02539134|20117129|P3|COMPLETED|Overall Study||6
8160671|NCT02539134|20117130|P2|COMPLETED|Overall Study||6
8160672|NCT02539134|20117131|P1|COMPLETED|Overall Study||9
8160673|NCT02539134|20117126|P6|STARTED|Overall Study||6
8160674|NCT02539134|20117127|P5|STARTED|Overall Study||6
8160675|NCT02539134|20117128|P4|STARTED|Overall Study||6
8160676|NCT02539134|20117129|P3|STARTED|Overall Study||6
8160677|NCT02539134|20117130|P2|STARTED|Overall Study||6
8160678|NCT02539134|20117131|P1|STARTED|Overall Study||10
8160679|NCT02539108|20117185|P2|NOT COMPLETED|Overall Study||0
8160680|NCT02539108|20117186|P1|NOT COMPLETED|Overall Study||0
8160681|NCT02539108|20117185|P2|COMPLETED|Overall Study||30
8160682|NCT02539108|20117186|P1|COMPLETED|Overall Study||30
8160683|NCT02539108|20117185|P2|STARTED|Overall Study||30
8160684|NCT02539108|20117186|P1|STARTED|Overall Study||30
8160685|NCT02538965|20117200|P1|NOT COMPLETED|Follow-Up Period||17
8160686|NCT02538965|20117200|P1|COMPLETED|Follow-Up Period||0
8160687|NCT02538965|20117200|P1|STARTED|Follow-Up Period||17
8160688|NCT02538965|20117200|P1|NOT COMPLETED|Treatment Period||17
8160689|NCT02538965|20117200|P1|COMPLETED|Treatment Period||0
8160690|NCT02538965|20117200|P1|STARTED|Treatment Period||17
8160691|NCT02538783|20117221|P2|NOT COMPLETED|Overall Study||1
8160692|NCT02538783|20117222|P1|NOT COMPLETED|Overall Study||0
8160693|NCT02538783|20117221|P2|COMPLETED|Overall Study||128
8160694|NCT02538783|20117222|P1|COMPLETED|Overall Study||130
8160695|NCT02538783|20117221|P2|STARTED|Overall Study||129
8160696|NCT02538783|20117222|P1|STARTED|Overall Study||130
8160697|NCT02538679|20117233|P3|NOT COMPLETED|Overall Study||8
8160698|NCT02538679|20117234|P2|NOT COMPLETED|Overall Study||9
8160699|NCT02538679|20117235|P1|NOT COMPLETED|Overall Study||3
8160700|NCT02538679|20117233|P3|COMPLETED|Overall Study||41
8160701|NCT02538679|20117234|P2|COMPLETED|Overall Study||45
8160702|NCT02538679|20117235|P1|COMPLETED|Overall Study||21
8160703|NCT02538679|20117233|P3|STARTED|Overall Study||49
8160704|NCT02538679|20117234|P2|STARTED|Overall Study||54
8160705|NCT02538679|20117235|P1|STARTED|Overall Study||24
8160706|NCT02538666|20117246|P3|NOT COMPLETED|Overall Study||1
8160707|NCT02538666|20117247|P2|NOT COMPLETED|Overall Study||1
8160708|NCT02538666|20117248|P1|NOT COMPLETED|Overall Study||2
8160709|NCT02538666|20117246|P3|COMPLETED|Overall Study||278
8160710|NCT02538666|20117247|P2|COMPLETED|Overall Study||279
8160711|NCT02538666|20117248|P1|COMPLETED|Overall Study||273
8160712|NCT02538666|20117246|P3|STARTED|Overall Study||279
8160713|NCT02538666|20117247|P2|STARTED|Overall Study||280
8160714|NCT02538666|20117248|P1|STARTED|Overall Study||275
8160715|NCT02538614|20117267|P1|NOT COMPLETED|Overall Study||2
8160716|NCT02538614|20117267|P1|COMPLETED|Overall Study||0
8160717|NCT02538614|20117267|P1|STARTED|Overall Study||2
8160730|NCT02538471|20117307|P1|NOT COMPLETED|Overall Study||2
8160731|NCT02538471|20117307|P1|COMPLETED|Overall Study||1
8160732|NCT02538471|20117307|P1|STARTED|Overall Study||3
8160733|NCT02538419|20117317|P2|NOT COMPLETED|Overall Study||0
8160734|NCT02538419|20117318|P1|NOT COMPLETED|Overall Study||0
8160735|NCT02538419|20117317|P2|COMPLETED|Overall Study||20
8160736|NCT02538419|20117318|P1|COMPLETED|Overall Study||20
8160737|NCT02538419|20117317|P2|STARTED|Overall Study||20
8160738|NCT02538419|20117318|P1|STARTED|Overall Study||20
8160739|NCT02538354|20117336|P2|NOT COMPLETED|Overall Study||0
8160740|NCT02538354|20117337|P1|NOT COMPLETED|Overall Study||0
8160741|NCT02538354|20117336|P2|COMPLETED|Overall Study||30
8160742|NCT02538354|20117337|P1|COMPLETED|Overall Study||40
8160743|NCT02538354|20117336|P2|STARTED|Overall Study||30
8160744|NCT02538354|20117337|P1|STARTED|Overall Study||40
8160745|NCT02538107|20117343|P1|NOT COMPLETED|Overall Study||110
8160746|NCT02538107|20117343|P1|COMPLETED|Overall Study||180
8160747|NCT02538107|20117343|P1|STARTED|Overall Study||290
8160748|NCT02538094|20117363|P2|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
8160749|NCT02538094|20117364|P1|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
8160750|NCT02538094|20117363|P2|COMPLETED|Intervention 2 (5 Days Per Participant)||3
8160751|NCT02538094|20117364|P1|COMPLETED|Intervention 2 (5 Days Per Participant)||2
8160752|NCT02538094|20117363|P2|STARTED|Intervention 2 (5 Days Per Participant)||3
8160753|NCT02538094|20117364|P1|STARTED|Intervention 2 (5 Days Per Participant)||2
8160754|NCT02538094|20117363|P2|NOT COMPLETED|Washout (4 Weeks)||1
8160755|NCT02538094|20117364|P1|NOT COMPLETED|Washout (4 Weeks)||0
8160756|NCT02538094|20117363|P2|COMPLETED|Washout (4 Weeks)||3
8160757|NCT02538094|20117364|P1|COMPLETED|Washout (4 Weeks)||2
8160758|NCT02538094|20117363|P2|STARTED|Washout (4 Weeks)||4
8160759|NCT02538094|20117364|P1|STARTED|Washout (4 Weeks)||2
8160760|NCT02538094|20117363|P2|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||1
8160761|NCT02538094|20117364|P1|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||0
8160762|NCT02538094|20117363|P2|COMPLETED|Intervention 1 (5 Days Per Participant)||4
8160763|NCT02538094|20117364|P1|COMPLETED|Intervention 1 (5 Days Per Participant)||2
8160764|NCT02538094|20117363|P2|STARTED|Intervention 1 (5 Days Per Participant)||5
8160765|NCT02538094|20117364|P1|STARTED|Intervention 1 (5 Days Per Participant)||2
8160766|NCT02538042|20117374|P2|NOT COMPLETED|Overall Study||11
8160767|NCT02538042|20117375|P1|NOT COMPLETED|Overall Study||11
8160768|NCT02538042|20117374|P2|COMPLETED|Overall Study||6
8160769|NCT02538042|20117375|P1|COMPLETED|Overall Study||6
8160770|NCT02538042|20117374|P2|Completed All Post-Quit Visits|Overall Study||12
8160771|NCT02538042|20117375|P1|Completed All Post-Quit Visits|Overall Study||12
8160772|NCT02538042|20117374|P2|Attended Post-Quit Visit|Overall Study||14
8160773|NCT02538042|20117375|P1|Attended Post-Quit Visit|Overall Study||15
8160774|NCT02538042|20117374|P2|Completed All MCE Sessions|Overall Study||15
8160775|NCT02538042|20117375|P1|Completed All MCE Sessions|Overall Study||15
8160776|NCT02538042|20117374|P2|STARTED|Overall Study||17
8160777|NCT02538042|20117375|P1|STARTED|Overall Study||17
8160778|NCT02538029|20117394|P3|NOT COMPLETED|Overall Study||1
8160779|NCT02538029|20117395|P2|NOT COMPLETED|Overall Study||0
8160780|NCT02538029|20117396|P1|NOT COMPLETED|Overall Study||1
8160781|NCT02538029|20117394|P3|COMPLETED|Overall Study||10
8160782|NCT02538029|20117395|P2|COMPLETED|Overall Study||10
8160783|NCT02538029|20117396|P1|COMPLETED|Overall Study||23
8160784|NCT02538029|20117394|P3|STARTED|Overall Study||11
8160785|NCT02538029|20117395|P2|STARTED|Overall Study||10
8160786|NCT02538029|20117396|P1|STARTED|Overall Study||24
8160787|NCT02538016|20117418|P1|NOT COMPLETED|Overall Study||0
8160788|NCT02538016|20117418|P1|COMPLETED|Overall Study||4
8160789|NCT02538016|20117418|P1|STARTED|Overall Study||4
8160790|NCT02537951|20117423|P1|NOT COMPLETED|Overall Study||0
8160791|NCT02537951|20117423|P1|COMPLETED|Overall Study||10
8160792|NCT02537951|20117423|P1|STARTED|Overall Study||10
8160793|NCT02537873|20117433|P2|NOT COMPLETED|Overall Study||4
8160794|NCT02537873|20117434|P1|NOT COMPLETED|Overall Study||8
8160795|NCT02537873|20117433|P2|COMPLETED|Overall Study||4
8160796|NCT02537873|20117434|P1|COMPLETED|Overall Study||9
8160797|NCT02537873|20117433|P2|STARTED|Overall Study||8
8160798|NCT02537873|20117434|P1|STARTED|Overall Study||17
8160799|NCT02537730|20117452|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8160800|NCT02537730|20117453|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8160801|NCT02537730|20117452|P2|COMPLETED|Second Intervention (7 Days)||16
8160802|NCT02537730|20117453|P1|COMPLETED|Second Intervention (7 Days)||17
8160803|NCT02537730|20117452|P2|STARTED|Second Intervention (7 Days)||16
8160804|NCT02537730|20117453|P1|STARTED|Second Intervention (7 Days)||17
8160805|NCT02537730|20117452|P2|NOT COMPLETED|First Intervention (7 Days)||0
8160806|NCT02537730|20117453|P1|NOT COMPLETED|First Intervention (7 Days)||0
8160807|NCT02537730|20117452|P2|COMPLETED|First Intervention (7 Days)||16
8160808|NCT02537730|20117453|P1|COMPLETED|First Intervention (7 Days)||17
8160809|NCT02537730|20117452|P2|STARTED|First Intervention (7 Days)||16
8160810|NCT02537730|20117453|P1|STARTED|First Intervention (7 Days)||17
8160811|NCT02537717|20117465|P1|NOT COMPLETED|Overall Study||0
8160812|NCT02537717|20117465|P1|COMPLETED|Overall Study||17
8160813|NCT02537717|20117465|P1|STARTED|Overall Study||17
8160814|NCT02537574|20117487|P3|NOT COMPLETED|Overall Study||108
8160815|NCT02537574|20117488|P2|NOT COMPLETED|Overall Study||103
8160816|NCT02537574|20117489|P1|NOT COMPLETED|Overall Study||99
8160817|NCT02537574|20117487|P3|COMPLETED|Overall Study||18
8160818|NCT02537574|20117488|P2|COMPLETED|Overall Study||23
8160819|NCT02537574|20117489|P1|COMPLETED|Overall Study||27
8160820|NCT02537574|20117487|P3|STARTED|Overall Study||126
8160821|NCT02537574|20117488|P2|STARTED|Overall Study||126
8160822|NCT02537574|20117489|P1|STARTED|Overall Study||126
8160823|NCT02537522|20117515|P4|NOT COMPLETED|Phase II - Period 2 Bilateral||0
8160824|NCT02537522|20117516|P3|NOT COMPLETED|Phase II - Period 2 Bilateral||0
8160825|NCT02537522|20117517|P2|NOT COMPLETED|Phase II - Period 2 Bilateral||0
8160826|NCT02537522|20117518|P1|NOT COMPLETED|Phase II - Period 2 Bilateral||0
8160827|NCT02537522|20117515|P4|COMPLETED|Phase II - Period 2 Bilateral||22
8160828|NCT02537522|20117516|P3|COMPLETED|Phase II - Period 2 Bilateral||23
8160829|NCT02537522|20117517|P2|COMPLETED|Phase II - Period 2 Bilateral||0
8160830|NCT02537522|20117518|P1|COMPLETED|Phase II - Period 2 Bilateral||0
8160831|NCT02537522|20117515|P4|STARTED|Phase II - Period 2 Bilateral||22
8160832|NCT02537522|20117516|P3|STARTED|Phase II - Period 2 Bilateral||23
8160833|NCT02537522|20117517|P2|STARTED|Phase II - Period 2 Bilateral||0
8160834|NCT02537522|20117518|P1|STARTED|Phase II - Period 2 Bilateral||0
8160835|NCT02537522|20117515|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||1
8160836|NCT02537522|20117516|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
8160837|NCT02537522|20117517|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
8160838|NCT02537522|20117518|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
8160839|NCT02537522|20117515|P4|COMPLETED|Phase II - Period 1 Bilateral||22
8160840|NCT02537522|20117516|P3|COMPLETED|Phase II - Period 1 Bilateral||23
8160841|NCT02537522|20117517|P2|COMPLETED|Phase II - Period 1 Bilateral||0
8160842|NCT02537522|20117518|P1|COMPLETED|Phase II - Period 1 Bilateral||0
8160843|NCT02537522|20117515|P4|STARTED|Phase II - Period 1 Bilateral||23
8160844|NCT02537522|20117516|P3|STARTED|Phase II - Period 1 Bilateral||23
8160845|NCT02537522|20117517|P2|STARTED|Phase II - Period 1 Bilateral||0
8160846|NCT02537522|20117518|P1|STARTED|Phase II - Period 1 Bilateral||0
8160847|NCT02537522|20117515|P4|NOT COMPLETED|Phase I - Contralateral||0
8160848|NCT02537522|20117516|P3|NOT COMPLETED|Phase I - Contralateral||0
8160849|NCT02537522|20117517|P2|NOT COMPLETED|Phase I - Contralateral||10
8160850|NCT02537522|20117518|P1|NOT COMPLETED|Phase I - Contralateral||15
8160851|NCT02537522|20117515|P4|COMPLETED|Phase I - Contralateral||0
8160852|NCT02537522|20117516|P3|COMPLETED|Phase I - Contralateral||0
8160853|NCT02537522|20117517|P2|COMPLETED|Phase I - Contralateral||27
8160854|NCT02537522|20117518|P1|COMPLETED|Phase I - Contralateral||19
8160855|NCT02537522|20117515|P4|STARTED|Phase I - Contralateral||0
8160856|NCT02537522|20117516|P3|STARTED|Phase I - Contralateral||0
8160857|NCT02537522|20117517|P2|STARTED|Phase I - Contralateral||37
8160858|NCT02537522|20117518|P1|STARTED|Phase I - Contralateral||34
8160859|NCT02537444|20117528|P2|NOT COMPLETED|Overall Study||39
8160860|NCT02537444|20117529|P1|NOT COMPLETED|Overall Study||39
8160861|NCT02537444|20117528|P2|COMPLETED|Overall Study||0
8160862|NCT02537444|20117529|P1|COMPLETED|Overall Study||0
8160863|NCT02537444|20117528|P2|Discontinued Study|Overall Study||39
8160864|NCT02537444|20117529|P1|Discontinued Study|Overall Study||39
8160865|NCT02537444|20117528|P2|Received Study Medication|Overall Study||39
8160866|NCT02537444|20117529|P1|Received Study Medication|Overall Study||38
8160867|NCT02537444|20117528|P2|Enrolled|Overall Study||39
8160868|NCT02537444|20117529|P1|Enrolled|Overall Study||39
8160869|NCT02537444|20117528|P2|STARTED|Overall Study||39
8160870|NCT02537444|20117529|P1|STARTED|Overall Study||39
8160871|NCT02537431|20117535|P1|NOT COMPLETED|Treatment Extension Period II||0
8160872|NCT02537431|20117535|P1|COMPLETED|Treatment Extension Period II||8
8160873|NCT02537431|20117535|P1|STARTED|Treatment Extension Period II|5 participants completing Treatment Extension Period I did not enter Treatment Extension Period II|8
8160874|NCT02537431|20117535|P1|NOT COMPLETED|Treatment Extension Period I||0
8160875|NCT02537431|20117535|P1|COMPLETED|Treatment Extension Period I||13
8160876|NCT02537431|20117535|P1|STARTED|Treatment Extension Period I||13
8160877|NCT02537431|20117535|P1|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1
8160878|NCT02537431|20117535|P1|COMPLETED|Open-Label Period (Week 0 to Week 48)|Completed Open-Label Period (Week 0 - Week 48)|13
8160879|NCT02537431|20117535|P1|STARTED|Open-Label Period (Week 0 to Week 48)|Screened and received at least 1 dose of study drug.|14
8160880|NCT02537015|20117564|P1|NOT COMPLETED|Overall Study||6
8160881|NCT02537015|20117564|P1|COMPLETED|Overall Study||75
8160882|NCT02537015|20117564|P1|STARTED|Overall Study||81
8160883|NCT02536976|20117570|P2|NOT COMPLETED|Overall Study||1
8160884|NCT02536976|20117571|P1|NOT COMPLETED|Overall Study||0
8160885|NCT02536976|20117570|P2|COMPLETED|Overall Study||1
8160886|NCT02536976|20117571|P1|COMPLETED|Overall Study||3
8160887|NCT02536976|20117570|P2|Washout|Overall Study||1
8160888|NCT02536976|20117571|P1|Washout|Overall Study||3
8160889|NCT02536976|20117570|P2|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1
8160890|NCT02536976|20117571|P1|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3
8160891|NCT02536976|20117570|P2|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1
8160892|NCT02536976|20117571|P1|Randomization|Overall Study|2 weeks double blind mirabegron|3
8160893|NCT02536976|20117570|P2|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2
8160894|NCT02536976|20117571|P1|STARTED|Overall Study|2 weeks single blind placebo run-in|3
8160895|NCT02536963|20117581|P1|NOT COMPLETED|Overall Study||18
8160896|NCT02536963|20117581|P1|COMPLETED|Overall Study||300
8160897|NCT02536963|20117581|P1|STARTED|Overall Study||318
8160910|NCT02536781|20117653|P2|NOT COMPLETED|Overall Study||0
8160911|NCT02536781|20117654|P1|NOT COMPLETED|Overall Study||2
8160912|NCT02536781|20117653|P2|COMPLETED|Overall Study||34
8160913|NCT02536781|20117654|P1|COMPLETED|Overall Study||34
8160914|NCT02536781|20117653|P2|STARTED|Overall Study||34
8160915|NCT02536781|20117654|P1|STARTED|Overall Study||36
8160916|NCT02536664|20117664|P2|NOT COMPLETED|Overall Study||80
8160917|NCT02536664|20117665|P1|NOT COMPLETED|Overall Study||107
8160918|NCT02536664|20117664|P2|COMPLETED|Overall Study||97
8160919|NCT02536664|20117665|P1|COMPLETED|Overall Study||205
8160920|NCT02536664|20117664|P2|STARTED|Overall Study||177
8160921|NCT02536664|20117665|P1|STARTED|Overall Study||312
8160922|NCT02536378|20117685|P2|NOT COMPLETED|Overall Study||7
8160923|NCT02536378|20117686|P1|NOT COMPLETED|Overall Study||7
8160924|NCT02536378|20117685|P2|COMPLETED|Overall Study||53
8160925|NCT02536378|20117686|P1|COMPLETED|Overall Study||625
8160926|NCT02536378|20117685|P2|STARTED|Overall Study||60
8160927|NCT02536378|20117686|P1|STARTED|Overall Study||632
8160932|NCT02536313|20117726|P2|NOT COMPLETED|Overall Study||1
8160933|NCT02536313|20117727|P1|NOT COMPLETED|Overall Study||0
8160934|NCT02536313|20117726|P2|COMPLETED|Overall Study||24
8160935|NCT02536313|20117727|P1|COMPLETED|Overall Study||24
8160936|NCT02536313|20117726|P2|STARTED|Overall Study||25
8160937|NCT02536313|20117727|P1|STARTED|Overall Study||24
8160938|NCT02536248|20117745|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8160939|NCT02536248|20117746|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8160940|NCT02536248|20117745|P2|COMPLETED|Second Intervention (6 Weeks)||10
8160941|NCT02536248|20117746|P1|COMPLETED|Second Intervention (6 Weeks)||10
8160942|NCT02536248|20117745|P2|STARTED|Second Intervention (6 Weeks)||10
8160943|NCT02536248|20117746|P1|STARTED|Second Intervention (6 Weeks)||10
8160944|NCT02536248|20117745|P2|NOT COMPLETED|Wash-out (14 Days)||0
8160945|NCT02536248|20117746|P1|NOT COMPLETED|Wash-out (14 Days)||0
8160946|NCT02536248|20117745|P2|COMPLETED|Wash-out (14 Days)||10
8160947|NCT02536248|20117746|P1|COMPLETED|Wash-out (14 Days)||10
8160948|NCT02536248|20117745|P2|STARTED|Wash-out (14 Days)||10
8160949|NCT02536248|20117746|P1|STARTED|Wash-out (14 Days)||10
8160950|NCT02536248|20117745|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
8160951|NCT02536248|20117746|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
8160952|NCT02536248|20117745|P2|COMPLETED|First Intervention (6 Weeks)||10
8160953|NCT02536248|20117746|P1|COMPLETED|First Intervention (6 Weeks)||10
8160954|NCT02536248|20117745|P2|STARTED|First Intervention (6 Weeks)||10
8160955|NCT02536248|20117746|P1|STARTED|First Intervention (6 Weeks)||10
8160956|NCT02536105|20117758|P1|NOT COMPLETED|Methylphenidate HCl ER Suspension||2
8160957|NCT02536105|20117758|P1|COMPLETED|Methylphenidate HCl ER Suspension||72
8160958|NCT02536105|20117758|P1|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74
8160959|NCT02536105|20117758|P1|STARTED|Methylphenidate HCl ER Suspension||74
8160960|NCT02536105|20117758|P1|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1
8160961|NCT02536105|20117758|P1|COMPLETED|Methylphenidate HCl ER Tablet 2||72
8160962|NCT02536105|20117758|P1|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73
8160963|NCT02536105|20117758|P1|STARTED|Methylphenidate HCl ER Tablet 2||73
8160964|NCT02536105|20117758|P1|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0
8160965|NCT02536105|20117758|P1|COMPLETED|Methylphenidate HCl ER Tablet 1||72
8160966|NCT02536105|20117758|P1|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72
8160967|NCT02536105|20117758|P1|STARTED|Methylphenidate HCl ER Tablet 1||72
8160968|NCT02536105|20117758|P1|NOT COMPLETED|Placebo||2
8160969|NCT02536105|20117758|P1|COMPLETED|Placebo||72
8160970|NCT02536105|20117758|P1|Completion of Placebo Day|Placebo||74
8160971|NCT02536105|20117758|P1|STARTED|Placebo||74
8160972|NCT02536105|20117758|P1|NOT COMPLETED|Concerta Open Label||8
8160973|NCT02536105|20117758|P1|COMPLETED|Concerta Open Label||72
8160974|NCT02536105|20117758|P1|Completion of Phase|Concerta Open Label||76
8160975|NCT02536105|20117758|P1|STARTED|Concerta Open Label||80
8160976|NCT02536040|20117782|P2|NOT COMPLETED|Overall Study||1
8160977|NCT02536040|20117783|P1|NOT COMPLETED|Overall Study||1
8160978|NCT02536040|20117782|P2|COMPLETED|Overall Study||35
8160979|NCT02536040|20117783|P1|COMPLETED|Overall Study||29
8160980|NCT02536040|20117782|P2|STARTED|Overall Study||36
8160981|NCT02536040|20117783|P1|STARTED|Overall Study||30
8160982|NCT02535806|20117789|P1|NOT COMPLETED|Overall Study||0
8160983|NCT02535806|20117789|P1|COMPLETED|Overall Study||2
8160984|NCT02535806|20117789|P1|STARTED|Overall Study||2
8160985|NCT02535741|20117796|P1|NOT COMPLETED|Overall Study||32
8160986|NCT02535741|20117796|P1|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
8160987|NCT02535741|20117796|P1|STARTED|Overall Study||168
8160988|NCT02535715|20117804|P3|NOT COMPLETED|Overall Study||1
8160989|NCT02535715|20117805|P2|NOT COMPLETED|Overall Study||0
8160990|NCT02535715|20117806|P1|NOT COMPLETED|Overall Study||0
8160991|NCT02535715|20117804|P3|COMPLETED|Overall Study||2
8160992|NCT02535715|20117805|P2|COMPLETED|Overall Study||4
8160993|NCT02535715|20117806|P1|COMPLETED|Overall Study||4
8160994|NCT02535715|20117804|P3|STARTED|Overall Study||3
8160995|NCT02535715|20117805|P2|STARTED|Overall Study||4
8160996|NCT02535715|20117806|P1|STARTED|Overall Study||4
8160997|NCT02535611|20117828|P2|NOT COMPLETED|Overall Study||0
8160998|NCT02535611|20117829|P1|NOT COMPLETED|Overall Study||0
8160999|NCT02535611|20117828|P2|COMPLETED|Overall Study||20
8161000|NCT02535611|20117829|P1|COMPLETED|Overall Study||27
8161001|NCT02535611|20117828|P2|STARTED|Overall Study||20
8161002|NCT02535611|20117829|P1|STARTED|Overall Study||27
8161003|NCT02535481|20117843|P2|NOT COMPLETED|Overall Study||0
8161004|NCT02535481|20117844|P1|NOT COMPLETED|Overall Study||0
8161005|NCT02535481|20117843|P2|COMPLETED|Overall Study||22
8161006|NCT02535481|20117844|P1|COMPLETED|Overall Study||22
8161007|NCT02535481|20117843|P2|STARTED|Overall Study||22
8161008|NCT02535481|20117844|P1|STARTED|Overall Study||22
8161009|NCT02535416|20117869|P9|NOT COMPLETED|Overall Study||0
8161010|NCT02535416|20117870|P8|NOT COMPLETED|Overall Study||0
8161011|NCT02535416|20117871|P7|NOT COMPLETED|Overall Study||0
8161012|NCT02535416|20117872|P6|NOT COMPLETED|Overall Study||0
8161013|NCT02535416|20117873|P5|NOT COMPLETED|Overall Study||0
8161014|NCT02535416|20117874|P4|NOT COMPLETED|Overall Study||0
8161015|NCT02535416|20117875|P3|NOT COMPLETED|Overall Study||0
8161016|NCT02535416|20117876|P2|NOT COMPLETED|Overall Study||0
8161017|NCT02535416|20117877|P1|NOT COMPLETED|Overall Study||1
8161018|NCT02535416|20117869|P9|COMPLETED|Overall Study||6
8161019|NCT02535416|20117870|P8|COMPLETED|Overall Study||6
8161020|NCT02535416|20117871|P7|COMPLETED|Overall Study||6
8161021|NCT02535416|20117872|P6|COMPLETED|Overall Study||4
8161022|NCT02535416|20117873|P5|COMPLETED|Overall Study||4
8161023|NCT02535416|20117874|P4|COMPLETED|Overall Study||4
8161024|NCT02535416|20117875|P3|COMPLETED|Overall Study||4
8161025|NCT02535416|20117876|P2|COMPLETED|Overall Study||2
8161026|NCT02535416|20117877|P1|COMPLETED|Overall Study||3
8161027|NCT02535416|20117869|P9|STARTED|Overall Study||6
8161028|NCT02535416|20117870|P8|STARTED|Overall Study||6
8161029|NCT02535416|20117871|P7|STARTED|Overall Study||6
8161030|NCT02535416|20117872|P6|STARTED|Overall Study||4
8161031|NCT02535416|20117873|P5|STARTED|Overall Study||4
8161032|NCT02535416|20117874|P4|STARTED|Overall Study||4
8161033|NCT02535416|20117875|P3|STARTED|Overall Study||4
8161034|NCT02535416|20117876|P2|STARTED|Overall Study||2
8161035|NCT02535416|20117877|P1|STARTED|Overall Study||4
8161036|NCT02535364|20117929|P1|NOT COMPLETED|12-Month Follow-up Period||35
8161037|NCT02535364|20117929|P1|COMPLETED|12-Month Follow-up Period||3
8161038|NCT02535364|20117929|P1|STARTED|12-Month Follow-up Period||38
8161039|NCT02535364|20117929|P1|NOT COMPLETED|Study Treatment||2
8161040|NCT02535364|20117929|P1|COMPLETED|Study Treatment||38
8161041|NCT02535364|20117929|P1|STARTED|Study Treatment||40
8161042|NCT02535364|20117929|P1|NOT COMPLETED|Part B Screening||17
8161043|NCT02535364|20117929|P1|COMPLETED|Part B Screening||40
8161044|NCT02535364|20117929|P1|STARTED|Part B Screening||57
8161045|NCT02535364|20117929|P1|NOT COMPLETED|Part A Screening Through Leukapheresis||25
8161046|NCT02535364|20117929|P1|COMPLETED|Part A Screening Through Leukapheresis||57
8161047|NCT02535364|20117929|P1|STARTED|Part A Screening Through Leukapheresis||82
8161053|NCT02535026|20117959|P1|NOT COMPLETED|Overall Study||0
8161054|NCT02535026|20117959|P1|COMPLETED|Overall Study||580
8161055|NCT02535026|20117959|P1|STARTED|Overall Study||580
8161056|NCT02535000|20118013|P2|NOT COMPLETED|Overall Study||2
8161057|NCT02535000|20118014|P1|NOT COMPLETED|Overall Study||1
8161058|NCT02535000|20118013|P2|COMPLETED|Overall Study||28
8161059|NCT02535000|20118014|P1|COMPLETED|Overall Study||29
8161060|NCT02535000|20118013|P2|STARTED|Overall Study||30
8161061|NCT02535000|20118014|P1|STARTED|Overall Study||30
8161071|NCT02534896|20118188|P3|NOT COMPLETED|Overall Study||1
8161072|NCT02534896|20118189|P2|NOT COMPLETED|Overall Study||1
8161073|NCT02534896|20118190|P1|NOT COMPLETED|Overall Study||4
8161074|NCT02534896|20118188|P3|COMPLETED|Overall Study||48
8161075|NCT02534896|20118189|P2|COMPLETED|Overall Study||51
8161076|NCT02534896|20118190|P1|COMPLETED|Overall Study||45
8161077|NCT02534896|20118188|P3|STARTED|Overall Study||49
8161078|NCT02534896|20118189|P2|STARTED|Overall Study||52
8161079|NCT02534896|20118190|P1|STARTED|Overall Study||49
8161080|NCT02534883|20118209|P2|NOT COMPLETED|Overall Study||3
8161081|NCT02534883|20118210|P1|NOT COMPLETED|Overall Study||8
8161082|NCT02534883|20118209|P2|COMPLETED|Overall Study||0
8161083|NCT02534883|20118210|P1|COMPLETED|Overall Study||0
8161084|NCT02534883|20118209|P2|STARTED|Overall Study||3
8161085|NCT02534883|20118210|P1|STARTED|Overall Study||8
8161086|NCT02534493|20118226|P1|NOT COMPLETED|Overall Study||2
8161087|NCT02534493|20118226|P1|COMPLETED|Overall Study||11
8161088|NCT02534493|20118226|P1|STARTED|Overall Study||13
8161089|NCT02534350|20118237|P2|NOT COMPLETED|Overall Study||0
8161090|NCT02534350|20118238|P1|NOT COMPLETED|Overall Study||4
8161091|NCT02534350|20118237|P2|COMPLETED|Overall Study||20
8161092|NCT02534350|20118238|P1|COMPLETED|Overall Study||37
8161093|NCT02534350|20118237|P2|STARTED|Overall Study||20
8161094|NCT02534350|20118238|P1|STARTED|Overall Study||41
8161095|NCT02534324|20118252|P2|NOT COMPLETED|Overall Study||8
8161096|NCT02534324|20118253|P1|NOT COMPLETED|Overall Study||25
8161097|NCT02534324|20118252|P2|COMPLETED|Overall Study||40
8161098|NCT02534324|20118253|P1|COMPLETED|Overall Study||73
8161099|NCT02534324|20118252|P2|STARTED|Overall Study||48
8161100|NCT02534324|20118253|P1|STARTED|Overall Study||98
8161101|NCT02534285|20118265|P2|NOT COMPLETED|Overall Study||0
8161102|NCT02534285|20118266|P1|NOT COMPLETED|Overall Study||0
8161103|NCT02534285|20118265|P2|COMPLETED|Overall Study||50
8161104|NCT02534285|20118266|P1|COMPLETED|Overall Study||50
8161105|NCT02534285|20118265|P2|STARTED|Overall Study||50
8161106|NCT02534285|20118266|P1|STARTED|Overall Study||50
8161107|NCT02534129|20118272|P2|NOT COMPLETED|Overall Study||0
8161108|NCT02534129|20118273|P1|NOT COMPLETED|Overall Study||0
8161109|NCT02534129|20118272|P2|COMPLETED|Overall Study||13
8161110|NCT02534129|20118273|P1|COMPLETED|Overall Study||13
8161111|NCT02534129|20118272|P2|STARTED|Overall Study||13
8161112|NCT02534129|20118273|P1|STARTED|Overall Study||13
8161113|NCT02534038|20118281|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
8161114|NCT02534038|20118282|P1|NOT COMPLETED|Period 2 (6 Weeks)||0
8161115|NCT02534038|20118281|P2|COMPLETED|Period 2 (6 Weeks)||0
8161116|NCT02534038|20118282|P1|COMPLETED|Period 2 (6 Weeks)||1
8161117|NCT02534038|20118281|P2|STARTED|Period 2 (6 Weeks)||0
8161118|NCT02534038|20118282|P1|STARTED|Period 2 (6 Weeks)||1
8161119|NCT02534038|20118281|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
8161120|NCT02534038|20118282|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
8161121|NCT02534038|20118281|P2|COMPLETED|Period 1 (6 Weeks)||0
8161122|NCT02534038|20118282|P1|COMPLETED|Period 1 (6 Weeks)||1
8161123|NCT02534038|20118281|P2|STARTED|Period 1 (6 Weeks)||0
8161124|NCT02534038|20118282|P1|STARTED|Period 1 (6 Weeks)||1
8161125|NCT02533999|20118318|P2|NOT COMPLETED|Overall Study||7
8161126|NCT02533999|20118319|P1|NOT COMPLETED|Overall Study||6
8161127|NCT02533999|20118318|P2|COMPLETED|Overall Study||30
8161128|NCT02533999|20118319|P1|COMPLETED|Overall Study||32
8161129|NCT02533999|20118318|P2|STARTED|Overall Study||37
8161130|NCT02533999|20118319|P1|STARTED|Overall Study||38
8161131|NCT02533921|20118339|P2|NOT COMPLETED|Overall Study||11
8161132|NCT02533921|20118340|P1|NOT COMPLETED|Overall Study||16
8161133|NCT02533921|20118339|P2|COMPLETED|Overall Study||95
8161134|NCT02533921|20118340|P1|COMPLETED|Overall Study||88
8161135|NCT02533921|20118339|P2|STARTED|Overall Study||106
8161136|NCT02533921|20118340|P1|STARTED|Overall Study||104
8161137|NCT02533726|20118358|P2|NOT COMPLETED|Treatment||0
8161138|NCT02533726|20118359|P1|NOT COMPLETED|Treatment||0
8161139|NCT02533726|20118358|P2|COMPLETED|Treatment||603
8161140|NCT02533726|20118359|P1|COMPLETED|Treatment||709
8161141|NCT02533726|20118358|P2|Per Protocol Population|Treatment||555
8161142|NCT02533726|20118359|P1|Per Protocol Population|Treatment||671
8161143|NCT02533726|20118358|P2|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
8161144|NCT02533726|20118359|P1|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
8161145|NCT02533726|20118358|P2|NOT COMPLETED|Initial Allocation||0
8161146|NCT02533726|20118359|P1|NOT COMPLETED|Initial Allocation||0
8161147|NCT02533726|20118358|P2|COMPLETED|Initial Allocation||653
8161148|NCT02533726|20118359|P1|COMPLETED|Initial Allocation||659
8161149|NCT02533726|20118358|P2|STARTED|Initial Allocation||653
8161150|NCT02533726|20118359|P1|STARTED|Initial Allocation||659
8161151|NCT02533570|20118370|P3|NOT COMPLETED|Overall Study||1
8161152|NCT02533570|20118371|P2|NOT COMPLETED|Overall Study||1
8161153|NCT02533570|20118372|P1|NOT COMPLETED|Overall Study||0
8161154|NCT02533570|20118370|P3|COMPLETED|Overall Study||7
8161155|NCT02533570|20118371|P2|COMPLETED|Overall Study||7
8161156|NCT02533570|20118372|P1|COMPLETED|Overall Study||4
8161157|NCT02533570|20118370|P3|STARTED|Overall Study||8
8161158|NCT02533570|20118371|P2|STARTED|Overall Study||8
8161159|NCT02533570|20118372|P1|STARTED|Overall Study||4
8161160|NCT02533531|20118383|P1|NOT COMPLETED|Overall Study||1
8161161|NCT02533531|20118383|P1|COMPLETED|Overall Study||0
8161162|NCT02533531|20118383|P1|STARTED|Overall Study||1
8161163|NCT02533505|20118388|P2|NOT COMPLETED|Overall Study||1
8161164|NCT02533505|20118389|P1|NOT COMPLETED|Overall Study||3
8161165|NCT02533505|20118388|P2|COMPLETED|Overall Study||24
8161166|NCT02533505|20118389|P1|COMPLETED|Overall Study||23
8161167|NCT02533505|20118388|P2|STARTED|Overall Study||25
8161168|NCT02533505|20118389|P1|STARTED|Overall Study||26
8161169|NCT02533466|20118421|P2|NOT COMPLETED|Overall Study||0
8161170|NCT02533466|20118422|P1|NOT COMPLETED|Overall Study||0
8161171|NCT02533466|20118421|P2|COMPLETED|Overall Study||14
8161172|NCT02533466|20118422|P1|COMPLETED|Overall Study||16
8161173|NCT02533466|20118421|P2|STARTED|Overall Study||14
8161174|NCT02533466|20118422|P1|STARTED|Overall Study||16
8161175|NCT02533453|20118446|P1|NOT COMPLETED|Overall Study||9
8161176|NCT02533453|20118446|P1|COMPLETED|Overall Study||101
8161177|NCT02533453|20118446|P1|STARTED|Overall Study||110
8161178|NCT02533427|20118455|P1|NOT COMPLETED|Overall Study||0
8161179|NCT02533427|20118455|P1|COMPLETED|Overall Study||15
8161180|NCT02533427|20118455|P1|STARTED|Overall Study||15
8161181|NCT02533401|20118505|P1|NOT COMPLETED|Overall Study||11
8161182|NCT02533401|20118505|P1|COMPLETED|Overall Study||23
8161183|NCT02533401|20118505|P1|STARTED|Overall Study||34
8161184|NCT02533375|20118513|P1|NOT COMPLETED|Overall Study||5
8161185|NCT02533375|20118513|P1|COMPLETED|Overall Study||5
8161186|NCT02533375|20118513|P1|STARTED|Overall Study||10
8161187|NCT02533258|20118545|P1|NOT COMPLETED|Overall Study||8
8161188|NCT02533258|20118545|P1|COMPLETED|Overall Study||5
8161189|NCT02533258|20118545|P1|STARTED|Overall Study||13
8161190|NCT02533167|20118557|P1|NOT COMPLETED|Overall Study||15
8161191|NCT02533167|20118557|P1|COMPLETED|Overall Study||55
8161192|NCT02533167|20118557|P1|STARTED|Overall Study||70
8161193|NCT02533089|20118568|P2|NOT COMPLETED|Overall Study||114
8161194|NCT02533089|20118569|P1|NOT COMPLETED|Overall Study||241
8161195|NCT02533089|20118568|P2|COMPLETED|Overall Study|6 HC accrued no eligible patients 8 HC no patients with outcome data 114 cases missing outcome|434
8161196|NCT02533089|20118569|P1|COMPLETED|Overall Study|4 HC accrued no eligable patients 11 HC no patients with outcome data 241 cases missing outcome|364
8161197|NCT02533089|20118568|P2|STARTED|Overall Study||548
8161198|NCT02533089|20118569|P1|STARTED|Overall Study||605
8161199|NCT02533063|20118581|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||0
8161200|NCT02533063|20118582|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||0
8161201|NCT02533063|20118581|P2|COMPLETED|Intervention 2 (8 Weeks)||11
8161202|NCT02533063|20118582|P1|COMPLETED|Intervention 2 (8 Weeks)||14
8161203|NCT02533063|20118581|P2|STARTED|Intervention 2 (8 Weeks)||11
8161204|NCT02533063|20118582|P1|STARTED|Intervention 2 (8 Weeks)||14
8161205|NCT02533063|20118581|P2|NOT COMPLETED|Washout (4 Weeks)||0
8161206|NCT02533063|20118582|P1|NOT COMPLETED|Washout (4 Weeks)||0
8161207|NCT02533063|20118581|P2|COMPLETED|Washout (4 Weeks)||11
8161208|NCT02533063|20118582|P1|COMPLETED|Washout (4 Weeks)||14
8161209|NCT02533063|20118581|P2|STARTED|Washout (4 Weeks)||11
8161210|NCT02533063|20118582|P1|STARTED|Washout (4 Weeks)||14
8161211|NCT02533063|20118581|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||5
8161212|NCT02533063|20118582|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||2
8161213|NCT02533063|20118581|P2|COMPLETED|Intervention 1 (8 Weeks)||11
8161214|NCT02533063|20118582|P1|COMPLETED|Intervention 1 (8 Weeks)||14
8161215|NCT02533063|20118581|P2|STARTED|Intervention 1 (8 Weeks)||16
8161216|NCT02533063|20118582|P1|STARTED|Intervention 1 (8 Weeks)||16
8161217|NCT02532998|20118604|P1|NOT COMPLETED|Overall Study||0
8161218|NCT02532998|20118604|P1|COMPLETED|Overall Study||23
8161219|NCT02532998|20118604|P1|STARTED|Overall Study||23
8161220|NCT02532972|20118686|P1|NOT COMPLETED|Overall Study||1
8161221|NCT02532972|20118686|P1|COMPLETED|Overall Study||10
8161222|NCT02532972|20118686|P1|STARTED|Overall Study||11
8161223|NCT02532933|20118694|P2|NOT COMPLETED|Overall Study||6
8161224|NCT02532933|20118695|P1|NOT COMPLETED|Overall Study||6
8161225|NCT02532933|20118694|P2|COMPLETED|Overall Study||16
8161226|NCT02532933|20118695|P1|COMPLETED|Overall Study||16
8161227|NCT02532933|20118694|P2|STARTED|Overall Study||22
8161228|NCT02532933|20118695|P1|STARTED|Overall Study||22
8161229|NCT02532855|20118703|P2|NOT COMPLETED|Overall Study||11
8161230|NCT02532855|20118704|P1|NOT COMPLETED|Overall Study||8
8161231|NCT02532855|20118703|P2|COMPLETED|Overall Study||296
8161232|NCT02532855|20118704|P1|COMPLETED|Overall Study||299
8161233|NCT02532855|20118703|P2|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
8161234|NCT02532855|20118704|P1|Treated|Overall Study||307
8161235|NCT02532855|20118703|P2|STARTED|Overall Study||307
8161236|NCT02532855|20118704|P1|STARTED|Overall Study||307
8161237|NCT02532764|20118738|P10|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
8161238|NCT02532764|20118739|P9|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
8161239|NCT02532764|20118740|P8|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
8161240|NCT02532764|20118741|P7|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161241|NCT02532764|20118742|P6|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161242|NCT02532764|20118743|P5|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161243|NCT02532764|20118744|P4|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161244|NCT02532764|20118745|P3|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161245|NCT02532764|20118746|P2|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161246|NCT02532764|20118747|P1|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161247|NCT02532764|20118738|P10|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8
8161248|NCT02532764|20118739|P9|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5
8161249|NCT02532764|20118740|P8|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
8161250|NCT02532764|20118741|P7|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
8161251|NCT02532764|20118742|P6|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
8161252|NCT02532764|20118743|P5|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161253|NCT02532764|20118744|P4|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161254|NCT02532764|20118745|P3|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161255|NCT02532764|20118746|P2|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161256|NCT02532764|20118747|P1|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
8161257|NCT02532764|20118738|P10|STARTED|Multiple Ascending Dose (MAD) Cohorst||9
8161258|NCT02532764|20118739|P9|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
8161259|NCT02532764|20118740|P8|STARTED|Multiple Ascending Dose (MAD) Cohorst||7
8161260|NCT02532764|20118741|P7|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
8161261|NCT02532764|20118742|P6|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
8161262|NCT02532764|20118743|P5|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8161263|NCT02532764|20118744|P4|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8161264|NCT02532764|20118745|P3|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8161265|NCT02532764|20118746|P2|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8161266|NCT02532764|20118747|P1|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
8161267|NCT02532764|20118738|P10|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161268|NCT02532764|20118739|P9|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161269|NCT02532764|20118740|P8|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161270|NCT02532764|20118741|P7|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161271|NCT02532764|20118742|P6|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161272|NCT02532764|20118743|P5|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161273|NCT02532764|20118744|P4|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161274|NCT02532764|20118745|P3|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161275|NCT02532764|20118746|P2|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161276|NCT02532764|20118747|P1|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161277|NCT02532764|20118738|P10|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161278|NCT02532764|20118739|P9|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161279|NCT02532764|20118740|P8|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161280|NCT02532764|20118741|P7|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161281|NCT02532764|20118742|P6|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
8161282|NCT02532764|20118743|P5|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
8161283|NCT02532764|20118744|P4|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
8161284|NCT02532764|20118745|P3|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
8161285|NCT02532764|20118746|P2|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
8161286|NCT02532764|20118747|P1|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
8161287|NCT02532764|20118738|P10|STARTED|Single Ascending Dose (SAD) Cohorts||0
8161288|NCT02532764|20118739|P9|STARTED|Single Ascending Dose (SAD) Cohorts||0
8161289|NCT02532764|20118740|P8|STARTED|Single Ascending Dose (SAD) Cohorts||0
8161290|NCT02532764|20118741|P7|STARTED|Single Ascending Dose (SAD) Cohorts||0
8161291|NCT02532764|20118742|P6|STARTED|Single Ascending Dose (SAD) Cohorts||0
8161292|NCT02532764|20118743|P5|STARTED|Single Ascending Dose (SAD) Cohorts||9
8161293|NCT02532764|20118744|P4|STARTED|Single Ascending Dose (SAD) Cohorts||6
8161294|NCT02532764|20118745|P3|STARTED|Single Ascending Dose (SAD) Cohorts||9
8161295|NCT02532764|20118746|P2|STARTED|Single Ascending Dose (SAD) Cohorts||6
8161296|NCT02532764|20118747|P1|STARTED|Single Ascending Dose (SAD) Cohorts||6
8161297|NCT02532647|20118898|P3|NOT COMPLETED|Overall Study||1
8161298|NCT02532647|20118899|P2|NOT COMPLETED|Overall Study||0
8161299|NCT02532647|20118900|P1|NOT COMPLETED|Overall Study||1
8161300|NCT02532647|20118898|P3|COMPLETED|Overall Study||30
8161301|NCT02532647|20118899|P2|COMPLETED|Overall Study||16
8161302|NCT02532647|20118900|P1|COMPLETED|Overall Study||31
8161303|NCT02532647|20118898|P3|Safety Population|Overall Study||30
8161304|NCT02532647|20118899|P2|Safety Population|Overall Study||16
8161305|NCT02532647|20118900|P1|Safety Population|Overall Study||31
8161306|NCT02532647|20118898|P3|STARTED|Overall Study||31
8161307|NCT02532647|20118899|P2|STARTED|Overall Study||16
8161308|NCT02532647|20118900|P1|STARTED|Overall Study||32
8161309|NCT02532556|20118914|P1|NOT COMPLETED|Overall Study||0
8161310|NCT02532556|20118914|P1|COMPLETED|Overall Study||12
8161311|NCT02532556|20118914|P1|STARTED|Overall Study||12
8161312|NCT02532543|20118942|P4|NOT COMPLETED|Overall Study||0
8161313|NCT02532543|20118943|P3|NOT COMPLETED|Overall Study||1
8161314|NCT02532543|20118944|P2|NOT COMPLETED|Overall Study||0
8161315|NCT02532543|20118945|P1|NOT COMPLETED|Overall Study||0
8161316|NCT02532543|20118942|P4|COMPLETED|Overall Study||4
8161317|NCT02532543|20118943|P3|COMPLETED|Overall Study||4
8161318|NCT02532543|20118944|P2|COMPLETED|Overall Study||4
8161319|NCT02532543|20118945|P1|COMPLETED|Overall Study||3
8161320|NCT02532543|20118942|P4|STARTED|Overall Study||4
8161321|NCT02532543|20118943|P3|STARTED|Overall Study||5
8161322|NCT02532543|20118944|P2|STARTED|Overall Study||4
8161323|NCT02532543|20118945|P1|STARTED|Overall Study||3
8161324|NCT02532517|20118979|P1|NOT COMPLETED|Overall Study||17
8161325|NCT02532517|20118979|P1|COMPLETED|Overall Study||28
8161326|NCT02532517|20118979|P1|mITT Analysis Set|Overall Study||44
8161327|NCT02532517|20118979|P1|STARTED|Overall Study||45
8161328|NCT02532465|20118999|P2|NOT COMPLETED|Overall Study||1
8161329|NCT02532465|20119000|P1|NOT COMPLETED|Overall Study||1
8161330|NCT02532465|20118999|P2|COMPLETED|Overall Study||24
8161331|NCT02532465|20119000|P1|COMPLETED|Overall Study||24
8161332|NCT02532465|20118999|P2|STARTED|Overall Study||25
8161333|NCT02532465|20119000|P1|STARTED|Overall Study||25
8161334|NCT02532374|20119010|P1|NOT COMPLETED|Overall Study||2
8161335|NCT02532374|20119010|P1|COMPLETED|Overall Study||14
8161336|NCT02532374|20119010|P1|P3L150 μg/Puff (Visit 6)|Overall Study||14
8161337|NCT02532374|20119010|P1|P3L 80 μg/Puff (Visit 5)|Overall Study||14
8161338|NCT02532374|20119010|P1|P3L 50 μg/Puff (Visit 4)|Overall Study||15
8161339|NCT02532374|20119010|P1|Nicorette Inhalator (Visit 3)|Overall Study||15
8161340|NCT02532374|20119010|P1|STARTED|Overall Study||16
8161341|NCT02532283|20119036|P2|NOT COMPLETED|Overall Study||5
8161342|NCT02532283|20119037|P1|NOT COMPLETED|Overall Study||9
8161343|NCT02532283|20119036|P2|COMPLETED|Overall Study||30
8161344|NCT02532283|20119037|P1|COMPLETED|Overall Study||55
8161345|NCT02532283|20119036|P2|Full Analysis Set|Overall Study||32
8161346|NCT02532283|20119037|P1|Full Analysis Set|Overall Study||63
8161347|NCT02532283|20119036|P2|STARTED|Overall Study||35
8161348|NCT02532283|20119037|P1|STARTED|Overall Study||64
8161349|NCT02532179|20119079|P1|NOT COMPLETED|Overall Study||3
8161350|NCT02532179|20119079|P1|COMPLETED|Overall Study||9
8161351|NCT02532179|20119079|P1|STARTED|Overall Study||12
8161352|NCT02532036|20119088|P2|NOT COMPLETED|Overall Study||0
8161353|NCT02532036|20119089|P1|NOT COMPLETED|Overall Study||0
8161354|NCT02532036|20119088|P2|COMPLETED|Overall Study||0
8161355|NCT02532036|20119089|P1|COMPLETED|Overall Study||2
8161356|NCT02532036|20119088|P2|STARTED|Overall Study||0
8161357|NCT02532036|20119089|P1|STARTED|Overall Study||2
8161358|NCT02532010|20119095|P2|NOT COMPLETED|Overall Study||4
8161359|NCT02532010|20119096|P1|NOT COMPLETED|Overall Study||9
8161360|NCT02532010|20119095|P2|COMPLETED|Overall Study||0
8161361|NCT02532010|20119096|P1|COMPLETED|Overall Study||0
8161362|NCT02532010|20119095|P2|STARTED|Overall Study||4
8161363|NCT02532010|20119096|P1|STARTED|Overall Study||9
8161364|NCT02531971|20119116|P2|NOT COMPLETED|Overall Study||0
8161365|NCT02531971|20119117|P1|NOT COMPLETED|Overall Study||0
8161366|NCT02531971|20119116|P2|COMPLETED|Overall Study||13
8161367|NCT02531971|20119117|P1|COMPLETED|Overall Study||11
8161368|NCT02531971|20119116|P2|STARTED|Overall Study||13
8161369|NCT02531971|20119117|P1|STARTED|Overall Study||11
8161370|NCT02531867|20119124|P1|NOT COMPLETED|Overall Study||0
8161371|NCT02531867|20119124|P1|COMPLETED|Overall Study||13
8161372|NCT02531867|20119124|P1|STARTED|Overall Study||13
8161373|NCT02531802|20119149|P21|NOT COMPLETED|Received Vaccination 2||1
8161374|NCT02531802|20119150|P20|NOT COMPLETED|Received Vaccination 2||1
8161375|NCT02531802|20119151|P19|NOT COMPLETED|Received Vaccination 2||3
8161376|NCT02531802|20119152|P18|NOT COMPLETED|Received Vaccination 2||4
8161377|NCT02531802|20119153|P17|NOT COMPLETED|Received Vaccination 2||0
8161378|NCT02531802|20119154|P16|NOT COMPLETED|Received Vaccination 2||0
8161379|NCT02531802|20119155|P15|NOT COMPLETED|Received Vaccination 2||1
8161380|NCT02531802|20119156|P14|NOT COMPLETED|Received Vaccination 2||2
8161381|NCT02531802|20119157|P13|NOT COMPLETED|Received Vaccination 2||2
8161382|NCT02531802|20119158|P12|NOT COMPLETED|Received Vaccination 2||0
8161383|NCT02531802|20119159|P11|NOT COMPLETED|Received Vaccination 2||2
8161384|NCT02531802|20119160|P10|NOT COMPLETED|Received Vaccination 2||3
8161385|NCT02531802|20119161|P9|NOT COMPLETED|Received Vaccination 2||0
8161386|NCT02531802|20119162|P8|NOT COMPLETED|Received Vaccination 2||0
8161387|NCT02531802|20119163|P7|NOT COMPLETED|Received Vaccination 2||0
8161388|NCT02531802|20119164|P6|NOT COMPLETED|Received Vaccination 2||3
8161389|NCT02531802|20119165|P5|NOT COMPLETED|Received Vaccination 2||0
8161390|NCT02531802|20119166|P4|NOT COMPLETED|Received Vaccination 2||0
8161391|NCT02531802|20119167|P3|NOT COMPLETED|Received Vaccination 2||1
8161392|NCT02531802|20119168|P2|NOT COMPLETED|Received Vaccination 2||0
8161393|NCT02531802|20119169|P1|NOT COMPLETED|Received Vaccination 2||0
8161394|NCT02531802|20119149|P21|COMPLETED|Received Vaccination 2||49
8161395|NCT02531802|20119150|P20|COMPLETED|Received Vaccination 2||29
8161396|NCT02531802|20119151|P19|COMPLETED|Received Vaccination 2||27
8161397|NCT02531802|20119152|P18|COMPLETED|Received Vaccination 2||26
8161398|NCT02531802|20119153|P17|COMPLETED|Received Vaccination 2||30
8161399|NCT02531802|20119154|P16|COMPLETED|Received Vaccination 2||30
8161400|NCT02531802|20119155|P15|COMPLETED|Received Vaccination 2||39
8161401|NCT02531802|20119156|P14|COMPLETED|Received Vaccination 2||13
8161402|NCT02531802|20119157|P13|COMPLETED|Received Vaccination 2||13
8161403|NCT02531802|20119158|P12|COMPLETED|Received Vaccination 2||15
8161404|NCT02531802|20119159|P11|COMPLETED|Received Vaccination 2||13
8161405|NCT02531802|20119160|P10|COMPLETED|Received Vaccination 2||49
8161406|NCT02531802|20119161|P9|COMPLETED|Received Vaccination 2||15
8161407|NCT02531802|20119162|P8|COMPLETED|Received Vaccination 2||15
8161408|NCT02531802|20119163|P7|COMPLETED|Received Vaccination 2||15
8161409|NCT02531802|20119164|P6|COMPLETED|Received Vaccination 2||0
8161410|NCT02531802|20119165|P5|COMPLETED|Received Vaccination 2||15
8161411|NCT02531802|20119166|P4|COMPLETED|Received Vaccination 2||15
8161412|NCT02531802|20119167|P3|COMPLETED|Received Vaccination 2||14
8161413|NCT02531802|20119168|P2|COMPLETED|Received Vaccination 2||15
8161414|NCT02531802|20119169|P1|COMPLETED|Received Vaccination 2||15
8161415|NCT02531802|20119149|P21|STARTED|Received Vaccination 2||50
8161416|NCT02531802|20119150|P20|STARTED|Received Vaccination 2||30
8161417|NCT02531802|20119151|P19|STARTED|Received Vaccination 2||30
8161418|NCT02531802|20119152|P18|STARTED|Received Vaccination 2||30
8161419|NCT02531802|20119153|P17|STARTED|Received Vaccination 2||30
8161420|NCT02531802|20119154|P16|STARTED|Received Vaccination 2||30
8161421|NCT02531802|20119155|P15|STARTED|Received Vaccination 2||40
8161422|NCT02531802|20119156|P14|STARTED|Received Vaccination 2||15
8161423|NCT02531802|20119157|P13|STARTED|Received Vaccination 2||15
8161424|NCT02531802|20119158|P12|STARTED|Received Vaccination 2||15
8161425|NCT02531802|20119159|P11|STARTED|Received Vaccination 2||15
8161426|NCT02531802|20119160|P10|STARTED|Received Vaccination 2||52
8161427|NCT02531802|20119161|P9|STARTED|Received Vaccination 2||15
8161428|NCT02531802|20119162|P8|STARTED|Received Vaccination 2||15
8161429|NCT02531802|20119163|P7|STARTED|Received Vaccination 2||15
8161430|NCT02531802|20119164|P6|STARTED|Received Vaccination 2||3
8161431|NCT02531802|20119165|P5|STARTED|Received Vaccination 2||15
8161432|NCT02531802|20119166|P4|STARTED|Received Vaccination 2||15
8161433|NCT02531802|20119167|P3|STARTED|Received Vaccination 2||15
8161434|NCT02531802|20119168|P2|STARTED|Received Vaccination 2||15
8161435|NCT02531802|20119169|P1|STARTED|Received Vaccination 2||15
8161436|NCT02531802|20119149|P21|NOT COMPLETED|Received Vaccination 1||0
8161437|NCT02531802|20119150|P20|NOT COMPLETED|Received Vaccination 1||0
8161438|NCT02531802|20119151|P19|NOT COMPLETED|Received Vaccination 1||0
8161439|NCT02531802|20119152|P18|NOT COMPLETED|Received Vaccination 1||0
8161440|NCT02531802|20119153|P17|NOT COMPLETED|Received Vaccination 1||0
8161441|NCT02531802|20119154|P16|NOT COMPLETED|Received Vaccination 1||0
8161442|NCT02531802|20119155|P15|NOT COMPLETED|Received Vaccination 1||0
8161443|NCT02531802|20119156|P14|NOT COMPLETED|Received Vaccination 1||0
8161444|NCT02531802|20119157|P13|NOT COMPLETED|Received Vaccination 1||0
8161445|NCT02531802|20119158|P12|NOT COMPLETED|Received Vaccination 1||0
8161446|NCT02531802|20119159|P11|NOT COMPLETED|Received Vaccination 1||0
8161447|NCT02531802|20119160|P10|NOT COMPLETED|Received Vaccination 1||0
8161448|NCT02531802|20119161|P9|NOT COMPLETED|Received Vaccination 1||0
8161449|NCT02531802|20119162|P8|NOT COMPLETED|Received Vaccination 1||0
8161450|NCT02531802|20119163|P7|NOT COMPLETED|Received Vaccination 1||0
8161451|NCT02531802|20119164|P6|NOT COMPLETED|Received Vaccination 1||0
8161452|NCT02531802|20119165|P5|NOT COMPLETED|Received Vaccination 1||0
8161453|NCT02531802|20119166|P4|NOT COMPLETED|Received Vaccination 1||0
8161454|NCT02531802|20119167|P3|NOT COMPLETED|Received Vaccination 1||0
8161455|NCT02531802|20119168|P2|NOT COMPLETED|Received Vaccination 1||0
8161456|NCT02531802|20119169|P1|NOT COMPLETED|Received Vaccination 1||0
8161457|NCT02531802|20119149|P21|COMPLETED|Received Vaccination 1||50
8161458|NCT02531802|20119150|P20|COMPLETED|Received Vaccination 1||30
8161459|NCT02531802|20119151|P19|COMPLETED|Received Vaccination 1||30
8161460|NCT02531802|20119152|P18|COMPLETED|Received Vaccination 1||30
8161461|NCT02531802|20119153|P17|COMPLETED|Received Vaccination 1||30
8161462|NCT02531802|20119154|P16|COMPLETED|Received Vaccination 1||30
8161463|NCT02531802|20119155|P15|COMPLETED|Received Vaccination 1||40
8161464|NCT02531802|20119156|P14|COMPLETED|Received Vaccination 1||15
8161465|NCT02531802|20119157|P13|COMPLETED|Received Vaccination 1||15
8161466|NCT02531802|20119158|P12|COMPLETED|Received Vaccination 1||15
8161467|NCT02531802|20119159|P11|COMPLETED|Received Vaccination 1||15
8161468|NCT02531802|20119160|P10|COMPLETED|Received Vaccination 1||52
8161469|NCT02531802|20119161|P9|COMPLETED|Received Vaccination 1||15
8161470|NCT02531802|20119162|P8|COMPLETED|Received Vaccination 1||15
8161471|NCT02531802|20119163|P7|COMPLETED|Received Vaccination 1||15
8161472|NCT02531802|20119164|P6|COMPLETED|Received Vaccination 1||3
8161473|NCT02531802|20119165|P5|COMPLETED|Received Vaccination 1||15
8161474|NCT02531802|20119166|P4|COMPLETED|Received Vaccination 1||15
8161475|NCT02531802|20119167|P3|COMPLETED|Received Vaccination 1||15
8161476|NCT02531802|20119168|P2|COMPLETED|Received Vaccination 1||15
8161477|NCT02531802|20119169|P1|COMPLETED|Received Vaccination 1||15
8161478|NCT02531802|20119149|P21|STARTED|Received Vaccination 1||50
8161479|NCT02531802|20119150|P20|STARTED|Received Vaccination 1||30
8161480|NCT02531802|20119151|P19|STARTED|Received Vaccination 1||30
8161481|NCT02531802|20119152|P18|STARTED|Received Vaccination 1||30
8161482|NCT02531802|20119153|P17|STARTED|Received Vaccination 1||30
8161483|NCT02531802|20119154|P16|STARTED|Received Vaccination 1||30
8161484|NCT02531802|20119155|P15|STARTED|Received Vaccination 1||40
8161485|NCT02531802|20119156|P14|STARTED|Received Vaccination 1||15
8161486|NCT02531802|20119157|P13|STARTED|Received Vaccination 1||15
8161487|NCT02531802|20119158|P12|STARTED|Received Vaccination 1||15
8161488|NCT02531802|20119159|P11|STARTED|Received Vaccination 1||15
8161489|NCT02531802|20119160|P10|STARTED|Received Vaccination 1||52
8161490|NCT02531802|20119161|P9|STARTED|Received Vaccination 1||15
8161491|NCT02531802|20119162|P8|STARTED|Received Vaccination 1||15
8161492|NCT02531802|20119163|P7|STARTED|Received Vaccination 1||15
8161493|NCT02531802|20119164|P6|STARTED|Received Vaccination 1||3
8161494|NCT02531802|20119165|P5|STARTED|Received Vaccination 1||15
8161495|NCT02531802|20119166|P4|STARTED|Received Vaccination 1||15
8161496|NCT02531802|20119167|P3|STARTED|Received Vaccination 1||15
8161497|NCT02531802|20119168|P2|STARTED|Received Vaccination 1||15
8161498|NCT02531802|20119169|P1|STARTED|Received Vaccination 1||15
8161499|NCT02531698|20119601|P2|NOT COMPLETED|Overall Study||2
8161500|NCT02531698|20119602|P1|NOT COMPLETED|Overall Study||11
8161501|NCT02531698|20119601|P2|COMPLETED|Overall Study||104
8161502|NCT02531698|20119602|P1|COMPLETED|Overall Study||283
8161503|NCT02531698|20119601|P2|STARTED|Overall Study||106
8161504|NCT02531698|20119602|P1|STARTED|Overall Study||294
8161505|NCT02531646|20119849|P3|NOT COMPLETED|Overall Study||0
8161506|NCT02531646|20119850|P2|NOT COMPLETED|Overall Study||1
8161507|NCT02531646|20119851|P1|NOT COMPLETED|Overall Study||5
8161508|NCT02531646|20119849|P3|COMPLETED|Overall Study||11
8161509|NCT02531646|20119850|P2|COMPLETED|Overall Study||17
8161510|NCT02531646|20119851|P1|COMPLETED|Overall Study||32
8161511|NCT02531646|20119849|P3|STARTED|Overall Study||11
8161512|NCT02531646|20119850|P2|STARTED|Overall Study||18
8161513|NCT02531646|20119851|P1|STARTED|Overall Study||37
8161514|NCT02531633|20119870|P10|NOT COMPLETED|Part B (104 Weeks)||4
8161515|NCT02531633|20119871|P9|NOT COMPLETED|Part B (104 Weeks)||5
8161516|NCT02531633|20119872|P8|NOT COMPLETED|Part B (104 Weeks)||4
8161517|NCT02531633|20119873|P7|NOT COMPLETED|Part B (104 Weeks)||5
8161518|NCT02531633|20119874|P6|NOT COMPLETED|Part B (104 Weeks)||8
8161519|NCT02531633|20119875|P5|NOT COMPLETED|Part B (104 Weeks)||0
8161520|NCT02531633|20119876|P4|NOT COMPLETED|Part B (104 Weeks)||0
8161521|NCT02531633|20119877|P3|NOT COMPLETED|Part B (104 Weeks)||0
8161522|NCT02531633|20119878|P2|NOT COMPLETED|Part B (104 Weeks)||0
8161523|NCT02531633|20119879|P1|NOT COMPLETED|Part B (104 Weeks)||0
8161524|NCT02531633|20119870|P10|COMPLETED|Part B (104 Weeks)||0
8161525|NCT02531633|20119871|P9|COMPLETED|Part B (104 Weeks)||0
8161526|NCT02531633|20119872|P8|COMPLETED|Part B (104 Weeks)||0
8161527|NCT02531633|20119873|P7|COMPLETED|Part B (104 Weeks)||0
8161528|NCT02531633|20119874|P6|COMPLETED|Part B (104 Weeks)||0
8161529|NCT02531633|20119875|P5|COMPLETED|Part B (104 Weeks)||0
8161530|NCT02531633|20119876|P4|COMPLETED|Part B (104 Weeks)||0
8161531|NCT02531633|20119877|P3|COMPLETED|Part B (104 Weeks)||0
8161532|NCT02531633|20119878|P2|COMPLETED|Part B (104 Weeks)||0
8161533|NCT02531633|20119879|P1|COMPLETED|Part B (104 Weeks)||0
8161534|NCT02531633|20119870|P10|STARTED|Part B (104 Weeks)||4
8161535|NCT02531633|20119871|P9|STARTED|Part B (104 Weeks)||5
8161536|NCT02531633|20119872|P8|STARTED|Part B (104 Weeks)||4
8161537|NCT02531633|20119873|P7|STARTED|Part B (104 Weeks)||5
8161538|NCT02531633|20119874|P6|STARTED|Part B (104 Weeks)||8
8161539|NCT02531633|20119875|P5|STARTED|Part B (104 Weeks)||0
8161540|NCT02531633|20119876|P4|STARTED|Part B (104 Weeks)||0
8161541|NCT02531633|20119877|P3|STARTED|Part B (104 Weeks)||0
8161542|NCT02531633|20119878|P2|STARTED|Part B (104 Weeks)||0
8161543|NCT02531633|20119879|P1|STARTED|Part B (104 Weeks)||0
8161544|NCT02531633|20119870|P10|NOT COMPLETED|Part A (52 Weeks)||0
8161545|NCT02531633|20119871|P9|NOT COMPLETED|Part A (52 Weeks)||0
8161546|NCT02531633|20119872|P8|NOT COMPLETED|Part A (52 Weeks)||0
8161547|NCT02531633|20119873|P7|NOT COMPLETED|Part A (52 Weeks)||0
8161548|NCT02531633|20119874|P6|NOT COMPLETED|Part A (52 Weeks)||0
8161549|NCT02531633|20119875|P5|NOT COMPLETED|Part A (52 Weeks)||23
8161550|NCT02531633|20119876|P4|NOT COMPLETED|Part A (52 Weeks)||22
8161551|NCT02531633|20119877|P3|NOT COMPLETED|Part A (52 Weeks)||22
8161552|NCT02531633|20119878|P2|NOT COMPLETED|Part A (52 Weeks)||34
8161553|NCT02531633|20119879|P1|NOT COMPLETED|Part A (52 Weeks)||34
8161554|NCT02531633|20119870|P10|COMPLETED|Part A (52 Weeks)||0
8161555|NCT02531633|20119871|P9|COMPLETED|Part A (52 Weeks)||0
8161556|NCT02531633|20119872|P8|COMPLETED|Part A (52 Weeks)||0
8161557|NCT02531633|20119873|P7|COMPLETED|Part A (52 Weeks)||0
8161558|NCT02531633|20119874|P6|COMPLETED|Part A (52 Weeks)||0
8161559|NCT02531633|20119875|P5|COMPLETED|Part A (52 Weeks)||4
8161560|NCT02531633|20119876|P4|COMPLETED|Part A (52 Weeks)||5
8161561|NCT02531633|20119877|P3|COMPLETED|Part A (52 Weeks)||4
8161562|NCT02531633|20119878|P2|COMPLETED|Part A (52 Weeks)||5
8161563|NCT02531633|20119879|P1|COMPLETED|Part A (52 Weeks)||8
8161564|NCT02531633|20119870|P10|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161565|NCT02531633|20119871|P9|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161566|NCT02531633|20119872|P8|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161567|NCT02531633|20119873|P7|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161568|NCT02531633|20119874|P6|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161569|NCT02531633|20119875|P5|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161570|NCT02531633|20119876|P4|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161571|NCT02531633|20119877|P3|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
8161572|NCT02531633|20119878|P2|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
8161573|NCT02531633|20119879|P1|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
8161574|NCT02531633|20119870|P10|STARTED|Part A (52 Weeks)||0
8161575|NCT02531633|20119871|P9|STARTED|Part A (52 Weeks)||0
8161576|NCT02531633|20119872|P8|STARTED|Part A (52 Weeks)||0
8161577|NCT02531633|20119873|P7|STARTED|Part A (52 Weeks)||0
8161578|NCT02531633|20119874|P6|STARTED|Part A (52 Weeks)||0
8161579|NCT02531633|20119875|P5|STARTED|Part A (52 Weeks)||27
8161580|NCT02531633|20119876|P4|STARTED|Part A (52 Weeks)||27
8161581|NCT02531633|20119877|P3|STARTED|Part A (52 Weeks)||26
8161582|NCT02531633|20119878|P2|STARTED|Part A (52 Weeks)||39
8161583|NCT02531633|20119879|P1|STARTED|Part A (52 Weeks)||42
8161584|NCT02531438|20120358|P2|NOT COMPLETED|Overall Study||26
8161585|NCT02531438|20120359|P1|NOT COMPLETED|Overall Study||30
8161586|NCT02531438|20120358|P2|COMPLETED|Overall Study||362
8161587|NCT02531438|20120359|P1|COMPLETED|Overall Study||356
8161588|NCT02531438|20120358|P2|STARTED|Overall Study||388
8161589|NCT02531438|20120359|P1|STARTED|Overall Study||386
8161590|NCT02531373|20120378|P9|NOT COMPLETED|Overall Study||9
8161591|NCT02531373|20120379|P8|NOT COMPLETED|Overall Study||9
8161592|NCT02531373|20120380|P7|NOT COMPLETED|Overall Study||11
8161593|NCT02531373|20120381|P6|NOT COMPLETED|Overall Study||9
8161594|NCT02531373|20120382|P5|NOT COMPLETED|Overall Study||8
8161595|NCT02531373|20120383|P4|NOT COMPLETED|Overall Study||0
8161596|NCT02531373|20120384|P3|NOT COMPLETED|Overall Study||0
8161597|NCT02531373|20120385|P2|NOT COMPLETED|Overall Study||0
8161598|NCT02531373|20120386|P1|NOT COMPLETED|Overall Study||0
8161599|NCT02531373|20120378|P9|COMPLETED|Overall Study||43
8161600|NCT02531373|20120379|P8|COMPLETED|Overall Study||43
8161601|NCT02531373|20120380|P7|COMPLETED|Overall Study||41
8161602|NCT02531373|20120381|P6|COMPLETED|Overall Study||42
8161603|NCT02531373|20120382|P5|COMPLETED|Overall Study||43
8161604|NCT02531373|20120383|P4|COMPLETED|Overall Study||20
8161605|NCT02531373|20120384|P3|COMPLETED|Overall Study||20
8161606|NCT02531373|20120385|P2|COMPLETED|Overall Study||20
8161607|NCT02531373|20120386|P1|COMPLETED|Overall Study||20
8161608|NCT02531373|20120378|P9|Vaccination 4|Overall Study||43
8161609|NCT02531373|20120379|P8|Vaccination 4|Overall Study||43
8161610|NCT02531373|20120380|P7|Vaccination 4|Overall Study||43
8161611|NCT02531373|20120381|P6|Vaccination 4|Overall Study||43
8161612|NCT02531373|20120382|P5|Vaccination 4|Overall Study||44
8161613|NCT02531373|20120383|P4|Vaccination 4|Overall Study||0
8161614|NCT02531373|20120384|P3|Vaccination 4|Overall Study||0
8161615|NCT02531373|20120385|P2|Vaccination 4|Overall Study||0
8161616|NCT02531373|20120386|P1|Vaccination 4|Overall Study||0
8161617|NCT02531373|20120378|P9|Vaccination 3|Overall Study||49
8161618|NCT02531373|20120379|P8|Vaccination 3|Overall Study||51
8161619|NCT02531373|20120380|P7|Vaccination 3|Overall Study||49
8161620|NCT02531373|20120381|P6|Vaccination 3|Overall Study||47
8161621|NCT02531373|20120382|P5|Vaccination 3|Overall Study||48
8161622|NCT02531373|20120383|P4|Vaccination 3|Overall Study||0
8161623|NCT02531373|20120384|P3|Vaccination 3|Overall Study||0
8161624|NCT02531373|20120385|P2|Vaccination 3|Overall Study||0
8161625|NCT02531373|20120386|P1|Vaccination 3|Overall Study||0
8161626|NCT02531373|20120378|P9|Vaccination 2|Overall Study||51
8161627|NCT02531373|20120379|P8|Vaccination 2|Overall Study||51
8161628|NCT02531373|20120380|P7|Vaccination 2|Overall Study||50
8161629|NCT02531373|20120381|P6|Vaccination 2|Overall Study||48
8161630|NCT02531373|20120382|P5|Vaccination 2|Overall Study||49
8161631|NCT02531373|20120383|P4|Vaccination 2|Overall Study||0
8161632|NCT02531373|20120384|P3|Vaccination 2|Overall Study||0
8161633|NCT02531373|20120385|P2|Vaccination 2|Overall Study||0
8161634|NCT02531373|20120386|P1|Vaccination 2|Overall Study||0
8161635|NCT02531373|20120378|P9|Vaccination 1|Overall Study||52
8161636|NCT02531373|20120379|P8|Vaccination 1|Overall Study||52
8161637|NCT02531373|20120380|P7|Vaccination 1|Overall Study||52
8161638|NCT02531373|20120381|P6|Vaccination 1|Overall Study||50
8161639|NCT02531373|20120382|P5|Vaccination 1|Overall Study||50
8161640|NCT02531373|20120383|P4|Vaccination 1|Overall Study||20
8161641|NCT02531373|20120384|P3|Vaccination 1|Overall Study||20
8161642|NCT02531373|20120385|P2|Vaccination 1|Overall Study||20
8161643|NCT02531373|20120386|P1|Vaccination 1|Overall Study||20
8161644|NCT02531373|20120378|P9|STARTED|Overall Study||52
8161645|NCT02531373|20120379|P8|STARTED|Overall Study||52
8161646|NCT02531373|20120380|P7|STARTED|Overall Study||52
8161647|NCT02531373|20120381|P6|STARTED|Overall Study||51
8161648|NCT02531373|20120382|P5|STARTED|Overall Study||51
8161649|NCT02531373|20120383|P4|STARTED|Overall Study||20
8161650|NCT02531373|20120384|P3|STARTED|Overall Study||20
8161651|NCT02531373|20120385|P2|STARTED|Overall Study||20
8161652|NCT02531373|20120386|P1|STARTED|Overall Study||20
8161653|NCT02531321|20120445|P2|NOT COMPLETED|Overall Study||0
8161654|NCT02531321|20120446|P1|NOT COMPLETED|Overall Study||2
8161655|NCT02531321|20120445|P2|COMPLETED|Overall Study||10
8161656|NCT02531321|20120446|P1|COMPLETED|Overall Study||5
8161657|NCT02531321|20120445|P2|STARTED|Overall Study||10
8161658|NCT02531321|20120446|P1|STARTED|Overall Study||7
8161659|NCT02531308|20120454|P1|NOT COMPLETED|Overall Study||3
8161660|NCT02531308|20120454|P1|COMPLETED|Overall Study||2
8161661|NCT02531308|20120454|P1|STARTED|Overall Study||5
8161662|NCT02531113|20120458|P1|NOT COMPLETED|Extension Period: Week 12 up to Week 160||38
8161663|NCT02531113|20120458|P1|COMPLETED|Extension Period: Week 12 up to Week 160||14
8161664|NCT02531113|20120458|P1|STARTED|Extension Period: Week 12 up to Week 160|6 participants completed induction; did not advance to extension due to lack efficacy.|52
8161665|NCT02531113|20120458|P1|NOT COMPLETED|Induction Period: Week 0 to 12||11
8161666|NCT02531113|20120458|P1|COMPLETED|Induction Period: Week 0 to 12||58
8161667|NCT02531113|20120458|P1|STARTED|Induction Period: Week 0 to 12||69
8161668|NCT02531035|20120494|P2|NOT COMPLETED|Overall Study||95
8161669|NCT02531035|20120495|P1|NOT COMPLETED|Overall Study||81
8161670|NCT02531035|20120494|P2|COMPLETED|Overall Study||605
8161671|NCT02531035|20120495|P1|COMPLETED|Overall Study||624
8161672|NCT02531035|20120494|P2|Treated|Overall Study||699
8161673|NCT02531035|20120495|P1|Treated|Overall Study||703
8161674|NCT02531035|20120494|P2|STARTED|Overall Study||700
8161675|NCT02531035|20120495|P1|STARTED|Overall Study||705
8161676|NCT02531022|20120511|P2|NOT COMPLETED|Overall Study||2
8161677|NCT02531022|20120512|P1|NOT COMPLETED|Overall Study||0
8161678|NCT02531022|20120511|P2|COMPLETED|Overall Study||48
8161679|NCT02531022|20120512|P1|COMPLETED|Overall Study||55
8161680|NCT02531022|20120511|P2|STARTED|Overall Study||50
8161681|NCT02531022|20120512|P1|STARTED|Overall Study||55
8161682|NCT02530970|20120520|P1|NOT COMPLETED|Overall Study||134
8161683|NCT02530970|20120520|P1|COMPLETED|Overall Study||891
8161684|NCT02530970|20120520|P1|STARTED|Overall Study||1025
8161685|NCT02530671|20120527|P2|NOT COMPLETED|Overall Study||0
8161686|NCT02530671|20120528|P1|NOT COMPLETED|Overall Study||3
8161687|NCT02530671|20120527|P2|COMPLETED|Overall Study||55
8161688|NCT02530671|20120528|P1|COMPLETED|Overall Study||52
8161689|NCT02530671|20120527|P2|STARTED|Overall Study||55
8161690|NCT02530671|20120528|P1|STARTED|Overall Study||55
8161708|NCT02530554|20120548|P4|NOT COMPLETED|Overall Study||0
8161709|NCT02530554|20120549|P3|NOT COMPLETED|Overall Study||0
8161710|NCT02530554|20120550|P2|NOT COMPLETED|Overall Study||0
8161711|NCT02530554|20120551|P1|NOT COMPLETED|Overall Study||0
8161712|NCT02530554|20120548|P4|COMPLETED|Overall Study||14
8161713|NCT02530554|20120549|P3|COMPLETED|Overall Study||12
8161714|NCT02530554|20120550|P2|COMPLETED|Overall Study||14
8161715|NCT02530554|20120551|P1|COMPLETED|Overall Study||12
8161716|NCT02530554|20120548|P4|STARTED|Overall Study||14
8161717|NCT02530554|20120549|P3|STARTED|Overall Study||12
8161718|NCT02530554|20120550|P2|STARTED|Overall Study||14
8161719|NCT02530554|20120551|P1|STARTED|Overall Study||12
8161720|NCT02530515|20120561|P3|NOT COMPLETED|Overall Study||0
8161721|NCT02530515|20120562|P2|NOT COMPLETED|Overall Study||0
8161722|NCT02530515|20120563|P1|NOT COMPLETED|Overall Study||0
8161723|NCT02530515|20120561|P3|COMPLETED|Overall Study||8
8161724|NCT02530515|20120562|P2|COMPLETED|Overall Study||0
8161725|NCT02530515|20120563|P1|COMPLETED|Overall Study||0
8161726|NCT02530515|20120561|P3|STARTED|Overall Study||8
8161727|NCT02530515|20120562|P2|STARTED|Overall Study||0
8161728|NCT02530515|20120563|P1|STARTED|Overall Study||0
8161729|NCT02530476|20120584|P4|NOT COMPLETED|Overall Study||0
8161730|NCT02530476|20120585|P3|NOT COMPLETED|Overall Study||0
8161731|NCT02530476|20120586|P2|NOT COMPLETED|Overall Study||0
8161732|NCT02530476|20120587|P1|NOT COMPLETED|Overall Study||0
8161733|NCT02530476|20120584|P4|COMPLETED|Overall Study||3
8161734|NCT02530476|20120585|P3|COMPLETED|Overall Study||7
8161735|NCT02530476|20120586|P2|COMPLETED|Overall Study||3
8161736|NCT02530476|20120587|P1|COMPLETED|Overall Study||4
8161737|NCT02530476|20120584|P4|STARTED|Overall Study||3
8161738|NCT02530476|20120585|P3|STARTED|Overall Study||7
8161739|NCT02530476|20120586|P2|STARTED|Overall Study||3
8161740|NCT02530476|20120587|P1|STARTED|Overall Study||4
8161741|NCT02530450|20120611|P2|NOT COMPLETED|Overall Study||5
8161742|NCT02530450|20120612|P1|NOT COMPLETED|Overall Study||6
8161743|NCT02530450|20120611|P2|COMPLETED|Overall Study||9
8161744|NCT02530450|20120612|P1|COMPLETED|Overall Study||10
8161745|NCT02530450|20120611|P2|STARTED|Overall Study||14
8161746|NCT02530450|20120612|P1|STARTED|Overall Study||16
8161747|NCT02530385|20120620|P2|NOT COMPLETED|Overall Study||1
8161748|NCT02530385|20120621|P1|NOT COMPLETED|Overall Study||0
8161749|NCT02530385|20120620|P2|COMPLETED|Overall Study||11
8161750|NCT02530385|20120621|P1|COMPLETED|Overall Study||12
8161751|NCT02530385|20120620|P2|STARTED|Overall Study||12
8161752|NCT02530385|20120621|P1|STARTED|Overall Study||12
8161771|NCT02530151|20120682|P2|NOT COMPLETED|Overall Study||16
8161772|NCT02530151|20120683|P1|NOT COMPLETED|Overall Study||21
8161773|NCT02530151|20120682|P2|COMPLETED|Overall Study||17
8161774|NCT02530151|20120683|P1|COMPLETED|Overall Study||16
8161775|NCT02530151|20120682|P2|STARTED|Overall Study||33
8161776|NCT02530151|20120683|P1|STARTED|Overall Study||37
8161777|NCT02530125|20120693|P1|NOT COMPLETED|Followed for Survival for 2 Years||3
8161778|NCT02530125|20120693|P1|COMPLETED|Followed for Survival for 2 Years||0
8161779|NCT02530125|20120693|P1|STARTED|Followed for Survival for 2 Years||3
8161780|NCT02530125|20120693|P1|NOT COMPLETED|Completed Treatment||1
8161781|NCT02530125|20120693|P1|COMPLETED|Completed Treatment||3
8161782|NCT02530125|20120693|P1|STARTED|Completed Treatment||4
8161783|NCT02529995|20120707|P2|NOT COMPLETED|Part B||12
8161784|NCT02529995|20120708|P1|NOT COMPLETED|Part B||6
8161785|NCT02529995|20120707|P2|COMPLETED|Part B||4
8161786|NCT02529995|20120708|P1|COMPLETED|Part B||9
8161787|NCT02529995|20120707|P2|STARTED|Part B||16
8161788|NCT02529995|20120708|P1|STARTED|Part B||15
8161789|NCT02529995|20120707|P2|NOT COMPLETED|Part A||16
8161790|NCT02529995|20120708|P1|NOT COMPLETED|Part A||15
8161791|NCT02529995|20120707|P2|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
8161792|NCT02529995|20120708|P1|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
8161793|NCT02529995|20120707|P2|STARTED|Part A||16
8161794|NCT02529995|20120708|P1|STARTED|Part A||15
8161795|NCT02529553|20120751|P9|NOT COMPLETED|Overall Study||3
8161796|NCT02529553|20120752|P8|NOT COMPLETED|Overall Study||6
8161797|NCT02529553|20120753|P7|NOT COMPLETED|Overall Study||3
8161798|NCT02529553|20120754|P6|NOT COMPLETED|Overall Study||4
8161799|NCT02529553|20120755|P5|NOT COMPLETED|Overall Study||3
8161800|NCT02529553|20120756|P4|NOT COMPLETED|Overall Study||3
8161801|NCT02529553|20120757|P3|NOT COMPLETED|Overall Study||1
8161802|NCT02529553|20120758|P2|NOT COMPLETED|Overall Study||1
8161803|NCT02529553|20120759|P1|NOT COMPLETED|Overall Study||1
8161804|NCT02529553|20120751|P9|COMPLETED|Overall Study||0
8161805|NCT02529553|20120752|P8|COMPLETED|Overall Study||0
8161806|NCT02529553|20120753|P7|COMPLETED|Overall Study||0
8161807|NCT02529553|20120754|P6|COMPLETED|Overall Study||0
8161808|NCT02529553|20120755|P5|COMPLETED|Overall Study||0
8161809|NCT02529553|20120756|P4|COMPLETED|Overall Study||0
8161810|NCT02529553|20120757|P3|COMPLETED|Overall Study||0
8161811|NCT02529553|20120758|P2|COMPLETED|Overall Study||0
8161812|NCT02529553|20120759|P1|COMPLETED|Overall Study||0
8161813|NCT02529553|20120751|P9|STARTED|Overall Study||3
8161814|NCT02529553|20120752|P8|STARTED|Overall Study||6
8161815|NCT02529553|20120753|P7|STARTED|Overall Study||3
8161816|NCT02529553|20120754|P6|STARTED|Overall Study||4
8161817|NCT02529553|20120755|P5|STARTED|Overall Study||3
8161818|NCT02529553|20120756|P4|STARTED|Overall Study||3
8161819|NCT02529553|20120757|P3|STARTED|Overall Study||1
8161820|NCT02529553|20120758|P2|STARTED|Overall Study||1
8161821|NCT02529553|20120759|P1|STARTED|Overall Study||1
8161822|NCT02529488|20120798|P1|NOT COMPLETED|Overall Study||4
8161823|NCT02529488|20120798|P1|COMPLETED|Overall Study||145
8161824|NCT02529488|20120798|P1|STARTED|Overall Study||149
8161828|NCT02529072|20120813|P2|NOT COMPLETED|Overall Study||0
8161829|NCT02529072|20120814|P1|NOT COMPLETED|Overall Study||0
8161830|NCT02529072|20120813|P2|COMPLETED|Overall Study||3
8161831|NCT02529072|20120814|P1|COMPLETED|Overall Study||3
8161832|NCT02529072|20120813|P2|STARTED|Overall Study||3
8161833|NCT02529072|20120814|P1|STARTED|Overall Study||3
8161834|NCT02528786|20120824|P1|NOT COMPLETED|Overall Study||0
8161835|NCT02528786|20120824|P1|COMPLETED|Overall Study||8
8161836|NCT02528786|20120824|P1|STARTED|Overall Study||8
8161837|NCT02528721|20120830|P2|NOT COMPLETED|Overall Study||3
8161838|NCT02528721|20120831|P1|NOT COMPLETED|Overall Study||7
8161839|NCT02528721|20120830|P2|COMPLETED|Overall Study||76
8161840|NCT02528721|20120831|P1|COMPLETED|Overall Study||196
8161841|NCT02528721|20120830|P2|STARTED|Overall Study||79
8161842|NCT02528721|20120831|P1|STARTED|Overall Study||203
8161854|NCT02528409|20120863|P2|NOT COMPLETED|Overall Study||16
8161855|NCT02528409|20120864|P1|NOT COMPLETED|Overall Study||22
8161856|NCT02528409|20120863|P2|COMPLETED|Overall Study||24
8161857|NCT02528409|20120864|P1|COMPLETED|Overall Study||18
8161858|NCT02528409|20120863|P2|STARTED|Overall Study||40
8161859|NCT02528409|20120864|P1|STARTED|Overall Study||40
8161860|NCT02528331|20120886|P1|NOT COMPLETED|Overall Study||2
8161861|NCT02528331|20120886|P1|COMPLETED|Overall Study||0
8161862|NCT02528331|20120886|P1|STARTED|Overall Study||2
8161863|NCT02528318|20120898|P5|NOT COMPLETED|Overall Study||0
8161864|NCT02528318|20120899|P4|NOT COMPLETED|Overall Study||0
8161865|NCT02528318|20120900|P3|NOT COMPLETED|Overall Study||0
8161866|NCT02528318|20120901|P2|NOT COMPLETED|Overall Study||0
8161867|NCT02528318|20120902|P1|NOT COMPLETED|Overall Study||0
8161868|NCT02528318|20120898|P5|COMPLETED|Overall Study||24
8161869|NCT02528318|20120899|P4|COMPLETED|Overall Study||0
8161870|NCT02528318|20120900|P3|COMPLETED|Overall Study||8
8161871|NCT02528318|20120901|P2|COMPLETED|Overall Study||8
8161872|NCT02528318|20120902|P1|COMPLETED|Overall Study||8
8161873|NCT02528318|20120898|P5|STARTED|Overall Study||24
8161874|NCT02528318|20120899|P4|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0
8161875|NCT02528318|20120900|P3|STARTED|Overall Study||8
8161876|NCT02528318|20120901|P2|STARTED|Overall Study||8
8161877|NCT02528318|20120902|P1|STARTED|Overall Study||8
8161878|NCT02528305|20120954|P1|NOT COMPLETED|Overall Study||3
8161879|NCT02528305|20120954|P1|COMPLETED|Overall Study||9
8161880|NCT02528305|20120954|P1|End of Intervention Period Assessment|Overall Study||9
8161881|NCT02528305|20120954|P1|End of Control Period Assessment|Overall Study||11
8161882|NCT02528305|20120954|P1|STARTED|Overall Study||12
8161883|NCT02528253|20121001|P5|NOT COMPLETED|Overall Study||223
8161884|NCT02528253|20121002|P4|NOT COMPLETED|Overall Study||136
8161885|NCT02528253|20121003|P3|NOT COMPLETED|Overall Study||140
8161886|NCT02528253|20121004|P2|NOT COMPLETED|Overall Study||70
8161887|NCT02528253|20121005|P1|NOT COMPLETED|Overall Study||75
8161888|NCT02528253|20121001|P5|COMPLETED|Overall Study||379
8161889|NCT02528253|20121002|P4|COMPLETED|Overall Study||271
8161890|NCT02528253|20121003|P3|COMPLETED|Overall Study||267
8161891|NCT02528253|20121004|P2|COMPLETED|Overall Study||134
8161892|NCT02528253|20121005|P1|COMPLETED|Overall Study||130
8161893|NCT02528253|20121001|P5|Treated at Week 16|Overall Study||307
8161894|NCT02528253|20121002|P4|Treated at Week 16|Overall Study||242
8161895|NCT02528253|20121003|P3|Treated at Week 16|Overall Study||236
8161896|NCT02528253|20121004|P2|Treated at Week 16|Overall Study||95
8161897|NCT02528253|20121005|P1|Treated at Week 16|Overall Study||99
8161898|NCT02528253|20121001|P5|Intent to Treat Population|Overall Study|3 participants randomized to placebo arm received tramadol during the course of study|605
8161899|NCT02528253|20121002|P4|Intent to Treat Population|Overall Study||407
8161900|NCT02528253|20121003|P3|Intent to Treat Population|Overall Study||407
8161901|NCT02528253|20121004|P2|Intent to Treat Population|Overall Study||204
8161902|NCT02528253|20121005|P1|Intent to Treat Population|Overall Study||202
8161903|NCT02528253|20121001|P5|STARTED|Overall Study||602
8161904|NCT02528253|20121002|P4|STARTED|Overall Study||407
8161905|NCT02528253|20121003|P3|STARTED|Overall Study||407
8161906|NCT02528253|20121004|P2|STARTED|Overall Study||204
8161907|NCT02528253|20121005|P1|STARTED|Overall Study||205
8161908|NCT02528214|20121298|P2|NOT COMPLETED|Overall Study||3
8161909|NCT02528214|20121299|P1|NOT COMPLETED|Overall Study||0
8161910|NCT02528214|20121298|P2|COMPLETED|Overall Study||100
8161911|NCT02528214|20121299|P1|COMPLETED|Overall Study||107
8161912|NCT02528214|20121298|P2|Treated|Overall Study||103
8161913|NCT02528214|20121299|P1|Treated|Overall Study||107
8161914|NCT02528214|20121298|P2|STARTED|Overall Study||103
8161915|NCT02528214|20121299|P1|STARTED|Overall Study||107
8161916|NCT02528188|20121334|P3|NOT COMPLETED|Overall Study||251
8161917|NCT02528188|20121335|P2|NOT COMPLETED|Overall Study||276
8161918|NCT02528188|20121336|P1|NOT COMPLETED|Overall Study||267
8161919|NCT02528188|20121334|P3|COMPLETED|Overall Study||757
8161920|NCT02528188|20121335|P2|COMPLETED|Overall Study||729
8161921|NCT02528188|20121336|P1|COMPLETED|Overall Study||741
8161922|NCT02528188|20121334|P3|Treated|Overall Study||996
8161923|NCT02528188|20121335|P2|Treated|Overall Study||998
8161924|NCT02528188|20121336|P1|Treated|Overall Study||1002
8161925|NCT02528188|20121334|P3|STARTED|Overall Study||1008
8161926|NCT02528188|20121335|P2|STARTED|Overall Study||1005
8161927|NCT02528188|20121336|P1|STARTED|Overall Study||1008
8161928|NCT02528097|20121588|P2|NOT COMPLETED|Overall Study||0
8161929|NCT02528097|20121589|P1|NOT COMPLETED|Overall Study||0
8161930|NCT02528097|20121588|P2|COMPLETED|Overall Study||1
8161931|NCT02528097|20121589|P1|COMPLETED|Overall Study||1
8161932|NCT02528097|20121588|P2|STARTED|Overall Study||1
8161933|NCT02528097|20121589|P1|STARTED|Overall Study||1
8161934|NCT02527694|20121599|P2|NOT COMPLETED|Overall Study||8
8161935|NCT02527694|20121600|P1|NOT COMPLETED|Overall Study||10
8161936|NCT02527694|20121599|P2|COMPLETED|Overall Study||21
8161937|NCT02527694|20121600|P1|COMPLETED|Overall Study||10
8161938|NCT02527694|20121599|P2|STARTED|Overall Study||29
8161939|NCT02527694|20121600|P1|STARTED|Overall Study||20
8161940|NCT02527681|20121608|P1|NOT COMPLETED|Overall Study||0
8161941|NCT02527681|20121608|P1|COMPLETED|Overall Study||15
8161942|NCT02527681|20121608|P1|STARTED|Overall Study||15
8161958|NCT02527161|20121678|P1|NOT COMPLETED|Overall Study||132
8161959|NCT02527161|20121678|P1|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 5 year outcome interval.|73
8161960|NCT02527161|20121678|P1|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|205
8161961|NCT02527148|20121697|P2|NOT COMPLETED|Overall Study||0
8161962|NCT02527148|20121698|P1|NOT COMPLETED|Overall Study||1
8161963|NCT02527148|20121697|P2|COMPLETED|Overall Study||50
8161964|NCT02527148|20121698|P1|COMPLETED|Overall Study||49
8161965|NCT02527148|20121697|P2|STARTED|Overall Study||50
8161966|NCT02527148|20121698|P1|STARTED|Overall Study||50
8161967|NCT02526693|20121728|P2|NOT COMPLETED|Overall Study||1
8161968|NCT02526693|20121729|P1|NOT COMPLETED|Overall Study||3
8161969|NCT02526693|20121728|P2|COMPLETED|Overall Study||50
8161970|NCT02526693|20121729|P1|COMPLETED|Overall Study||50
8161971|NCT02526693|20121728|P2|STARTED|Overall Study||51
8161972|NCT02526693|20121729|P1|STARTED|Overall Study||53
8161973|NCT02526680|20121739|P1|NOT COMPLETED|Overall Study||0
8161974|NCT02526680|20121739|P1|COMPLETED|Overall Study||27
8161975|NCT02526680|20121739|P1|STARTED|Overall Study||27
8161976|NCT02526667|20121746|P3|NOT COMPLETED|Groin||0
8161977|NCT02526667|20121747|P2|NOT COMPLETED|Groin||0
8161978|NCT02526667|20121748|P1|NOT COMPLETED|Groin||0
8161979|NCT02526667|20121746|P3|COMPLETED|Groin||294
8161980|NCT02526667|20121747|P2|COMPLETED|Groin||56
8161981|NCT02526667|20121748|P1|COMPLETED|Groin||290
8161982|NCT02526667|20121746|P3|STARTED|Groin||294
8161983|NCT02526667|20121747|P2|STARTED|Groin||56
8161984|NCT02526667|20121748|P1|STARTED|Groin||290
8161985|NCT02526667|20121746|P3|NOT COMPLETED|Abdomen||0
8161986|NCT02526667|20121747|P2|NOT COMPLETED|Abdomen||0
8161987|NCT02526667|20121748|P1|NOT COMPLETED|Abdomen||0
8161988|NCT02526667|20121746|P3|COMPLETED|Abdomen||281
8161989|NCT02526667|20121747|P2|COMPLETED|Abdomen||56
8161990|NCT02526667|20121748|P1|COMPLETED|Abdomen||284
8161991|NCT02526667|20121746|P3|STARTED|Abdomen||281
8161992|NCT02526667|20121747|P2|STARTED|Abdomen||56
8161993|NCT02526667|20121748|P1|STARTED|Abdomen||284
8161994|NCT02526654|20121764|P2|NOT COMPLETED|Overall Study||0
8161995|NCT02526654|20121765|P1|NOT COMPLETED|Overall Study||0
8161996|NCT02526654|20121764|P2|COMPLETED|Overall Study||36
8161997|NCT02526654|20121765|P1|COMPLETED|Overall Study||79
8161998|NCT02526654|20121764|P2|STARTED|Overall Study||36
8161999|NCT02526654|20121765|P1|STARTED|Overall Study||79
8162000|NCT02526550|20121774|P1|NOT COMPLETED|Overall Study||1
8162001|NCT02526550|20121774|P1|COMPLETED|Overall Study||49
8162002|NCT02526550|20121774|P1|STARTED|Overall Study||50
8162003|NCT02526524|20121786|P6|NOT COMPLETED|Overall Study||21
8162004|NCT02526524|20121787|P5|NOT COMPLETED|Overall Study||24
8162005|NCT02526524|20121788|P4|NOT COMPLETED|Overall Study||7
8162006|NCT02526524|20121789|P3|NOT COMPLETED|Overall Study||26
8162007|NCT02526524|20121790|P2|NOT COMPLETED|Overall Study||9
8162008|NCT02526524|20121791|P1|NOT COMPLETED|Overall Study||12
8162009|NCT02526524|20121786|P6|COMPLETED|Overall Study||73
8162010|NCT02526524|20121787|P5|COMPLETED|Overall Study||72
8162011|NCT02526524|20121788|P4|COMPLETED|Overall Study||89
8162012|NCT02526524|20121789|P3|COMPLETED|Overall Study||70
8162013|NCT02526524|20121790|P2|COMPLETED|Overall Study||86
8162014|NCT02526524|20121791|P1|COMPLETED|Overall Study||82
8162015|NCT02526524|20121786|P6|STARTED|Overall Study||94
8162016|NCT02526524|20121787|P5|STARTED|Overall Study||96
8162017|NCT02526524|20121788|P4|STARTED|Overall Study||96
8162018|NCT02526524|20121789|P3|STARTED|Overall Study||96
8162019|NCT02526524|20121790|P2|STARTED|Overall Study||95
8162020|NCT02526524|20121791|P1|STARTED|Overall Study||94
8162021|NCT02526290|20121805|P1|NOT COMPLETED|Overall Study||8
8162022|NCT02526290|20121805|P1|COMPLETED|Overall Study||89
8162023|NCT02526290|20121805|P1|STARTED|Overall Study||97
8162024|NCT02526212|20121814|P2|NOT COMPLETED|Overall Study||1
8162025|NCT02526212|20121815|P1|NOT COMPLETED|Overall Study||2
8162026|NCT02526212|20121814|P2|COMPLETED|Overall Study||7
8162027|NCT02526212|20121815|P1|COMPLETED|Overall Study||8
8162028|NCT02526212|20121814|P2|STARTED|Overall Study||8
8162029|NCT02526212|20121815|P1|STARTED|Overall Study||10
8162030|NCT02525874|20121829|P1|NOT COMPLETED|Overall Study||60
8162031|NCT02525874|20121829|P1|COMPLETED|Overall Study||158
8162032|NCT02525874|20121829|P1|STARTED|Overall Study||218
8162033|NCT02525744|20121842|P4|NOT COMPLETED|Period 5||0
8162034|NCT02525744|20121843|P3|NOT COMPLETED|Period 5||0
8162035|NCT02525744|20121844|P2|NOT COMPLETED|Period 5||0
8162036|NCT02525744|20121845|P1|NOT COMPLETED|Period 5||1
8162037|NCT02525744|20121842|P4|COMPLETED|Period 5||6
8162038|NCT02525744|20121843|P3|COMPLETED|Period 5||5
8162039|NCT02525744|20121844|P2|COMPLETED|Period 5||5
8162040|NCT02525744|20121845|P1|COMPLETED|Period 5||4
8162041|NCT02525744|20121842|P4|Received at Least 1 Dose of Study Drug|Period 5||6
8162042|NCT02525744|20121843|P3|Received at Least 1 Dose of Study Drug|Period 5||5
8162043|NCT02525744|20121844|P2|Received at Least 1 Dose of Study Drug|Period 5||5
8162044|NCT02525744|20121845|P1|Received at Least 1 Dose of Study Drug|Period 5||4
8162045|NCT02525744|20121842|P4|STARTED|Period 5||6
8162046|NCT02525744|20121843|P3|STARTED|Period 5||5
8162047|NCT02525744|20121844|P2|STARTED|Period 5||5
8162048|NCT02525744|20121845|P1|STARTED|Period 5||5
8162049|NCT02525744|20121842|P4|NOT COMPLETED|Period 4||0
8162050|NCT02525744|20121843|P3|NOT COMPLETED|Period 4||0
8162051|NCT02525744|20121844|P2|NOT COMPLETED|Period 4||0
8162052|NCT02525744|20121845|P1|NOT COMPLETED|Period 4||1
8162053|NCT02525744|20121842|P4|COMPLETED|Period 4||6
8162054|NCT02525744|20121843|P3|COMPLETED|Period 4||5
8162055|NCT02525744|20121844|P2|COMPLETED|Period 4||5
8162056|NCT02525744|20121845|P1|COMPLETED|Period 4||5
8162057|NCT02525744|20121842|P4|Received at Least 1 Dose of Study Drug|Period 4||6
8162058|NCT02525744|20121843|P3|Received at Least 1 Dose of Study Drug|Period 4||5
8162059|NCT02525744|20121844|P2|Received at Least 1 Dose of Study Drug|Period 4||5
8162060|NCT02525744|20121845|P1|Received at Least 1 Dose of Study Drug|Period 4||6
8162061|NCT02525744|20121842|P4|STARTED|Period 4||6
8162062|NCT02525744|20121843|P3|STARTED|Period 4||5
8162063|NCT02525744|20121844|P2|STARTED|Period 4||5
8162064|NCT02525744|20121845|P1|STARTED|Period 4||6
8162065|NCT02525744|20121842|P4|NOT COMPLETED|Period 3||0
8162066|NCT02525744|20121843|P3|NOT COMPLETED|Period 3||0
8162067|NCT02525744|20121844|P2|NOT COMPLETED|Period 3||1
8162068|NCT02525744|20121845|P1|NOT COMPLETED|Period 3||0
8162069|NCT02525744|20121842|P4|COMPLETED|Period 3||6
8162070|NCT02525744|20121843|P3|COMPLETED|Period 3||5
8162071|NCT02525744|20121844|P2|COMPLETED|Period 3||5
8162072|NCT02525744|20121845|P1|COMPLETED|Period 3||6
8162073|NCT02525744|20121842|P4|Received at Least 1 Dose of Study Drug|Period 3||6
8162074|NCT02525744|20121843|P3|Received at Least 1 Dose of Study Drug|Period 3||5
8162075|NCT02525744|20121844|P2|Received at Least 1 Dose of Study Drug|Period 3||6
8162076|NCT02525744|20121845|P1|Received at Least 1 Dose of Study Drug|Period 3||6
8162077|NCT02525744|20121842|P4|STARTED|Period 3||6
8162078|NCT02525744|20121843|P3|STARTED|Period 3||5
8162079|NCT02525744|20121844|P2|STARTED|Period 3||6
8162080|NCT02525744|20121845|P1|STARTED|Period 3||6
8162081|NCT02525744|20121842|P4|NOT COMPLETED|Period 2||0
8162082|NCT02525744|20121843|P3|NOT COMPLETED|Period 2||0
8162083|NCT02525744|20121844|P2|NOT COMPLETED|Period 2||0
8162084|NCT02525744|20121845|P1|NOT COMPLETED|Period 2||0
8162085|NCT02525744|20121842|P4|COMPLETED|Period 2||6
8162086|NCT02525744|20121843|P3|COMPLETED|Period 2||5
8162087|NCT02525744|20121844|P2|COMPLETED|Period 2||6
8162088|NCT02525744|20121845|P1|COMPLETED|Period 2||6
8162089|NCT02525744|20121842|P4|Received at Least 1 Dose of Study Drug|Period 2||6
8162090|NCT02525744|20121843|P3|Received at Least 1 Dose of Study Drug|Period 2||5
8162091|NCT02525744|20121844|P2|Received at Least 1 Dose of Study Drug|Period 2||6
8162092|NCT02525744|20121845|P1|Received at Least 1 Dose of Study Drug|Period 2||6
8162093|NCT02525744|20121842|P4|STARTED|Period 2||6
8162094|NCT02525744|20121843|P3|STARTED|Period 2||5
8162095|NCT02525744|20121844|P2|STARTED|Period 2||6
8162096|NCT02525744|20121845|P1|STARTED|Period 2||6
8162097|NCT02525744|20121842|P4|NOT COMPLETED|Period 1||0
8162098|NCT02525744|20121843|P3|NOT COMPLETED|Period 1||1
8162099|NCT02525744|20121844|P2|NOT COMPLETED|Period 1||0
8162100|NCT02525744|20121845|P1|NOT COMPLETED|Period 1||0
8162101|NCT02525744|20121842|P4|COMPLETED|Period 1||6
8162102|NCT02525744|20121843|P3|COMPLETED|Period 1||5
8162103|NCT02525744|20121844|P2|COMPLETED|Period 1||6
8162104|NCT02525744|20121845|P1|COMPLETED|Period 1||6
8162105|NCT02525744|20121842|P4|Received at Least 1 Dose of Study Drug|Period 1||6
8162106|NCT02525744|20121843|P3|Received at Least 1 Dose of Study Drug|Period 1||5
8162107|NCT02525744|20121844|P2|Received at Least 1 Dose of Study Drug|Period 1||6
8162108|NCT02525744|20121845|P1|Received at Least 1 Dose of Study Drug|Period 1||6
8162109|NCT02525744|20121842|P4|STARTED|Period 1||6
8162110|NCT02525744|20121843|P3|STARTED|Period 1||6
8162111|NCT02525744|20121844|P2|STARTED|Period 1||6
8162112|NCT02525744|20121845|P1|STARTED|Period 1||6
8162113|NCT02525718|20121861|P2|NOT COMPLETED|Overall Study||1
8162114|NCT02525718|20121862|P1|NOT COMPLETED|Overall Study||1
8162115|NCT02525718|20121861|P2|COMPLETED|Overall Study||23
8162116|NCT02525718|20121862|P1|COMPLETED|Overall Study||22
8162117|NCT02525718|20121861|P2|STARTED|Overall Study||24
8162118|NCT02525718|20121862|P1|STARTED|Overall Study||23
8162119|NCT02525653|20121874|P1|NOT COMPLETED|Overall Study||0
8162120|NCT02525653|20121874|P1|COMPLETED|Overall Study||40
8162121|NCT02525653|20121874|P1|STARTED|Overall Study||40
8162122|NCT02525627|20121881|P2|NOT COMPLETED|Overall Study||13
8162123|NCT02525627|20121882|P1|NOT COMPLETED|Overall Study||14
8162124|NCT02525627|20121881|P2|COMPLETED|Overall Study||5
8162125|NCT02525627|20121882|P1|COMPLETED|Overall Study||2
8162126|NCT02525627|20121881|P2|STARTED|Overall Study||18
8162127|NCT02525627|20121882|P1|STARTED|Overall Study||16
8162128|NCT02525588|20121894|P2|NOT COMPLETED|Overall Study||3
8162129|NCT02525588|20121895|P1|NOT COMPLETED|Overall Study||6
8162130|NCT02525588|20121894|P2|COMPLETED|Overall Study||45
8162131|NCT02525588|20121895|P1|COMPLETED|Overall Study||42
8162132|NCT02525588|20121894|P2|STARTED|Overall Study||48
8162133|NCT02525588|20121895|P1|STARTED|Overall Study||48
8162134|NCT02525575|20121911|P1|NOT COMPLETED|Overall Study||15
8162135|NCT02525575|20121911|P1|COMPLETED|Overall Study||22
8162136|NCT02525575|20121911|P1|STARTED|Overall Study||37
8162137|NCT02525549|20121921|P3|NOT COMPLETED|Overall Study||19
8162138|NCT02525549|20121922|P2|NOT COMPLETED|Overall Study||53
8162139|NCT02525549|20121923|P1|NOT COMPLETED|Overall Study||35
8162140|NCT02525549|20121921|P3|COMPLETED|Overall Study||159
8162141|NCT02525549|20121922|P2|COMPLETED|Overall Study||307
8162142|NCT02525549|20121923|P1|COMPLETED|Overall Study||330
8162143|NCT02525549|20121921|P3|STARTED|Overall Study||178
8162144|NCT02525549|20121922|P2|STARTED|Overall Study||360
8162145|NCT02525549|20121923|P1|STARTED|Overall Study||365
8162146|NCT02525536|20121937|P3|NOT COMPLETED|Overall Study||0
8162147|NCT02525536|20121938|P2|NOT COMPLETED|Overall Study||0
8162148|NCT02525536|20121939|P1|NOT COMPLETED|Overall Study||0
8162149|NCT02525536|20121937|P3|COMPLETED|Overall Study||6
8162150|NCT02525536|20121938|P2|COMPLETED|Overall Study||6
8162151|NCT02525536|20121939|P1|COMPLETED|Overall Study||6
8162152|NCT02525536|20121937|P3|STARTED|Overall Study||6
8162153|NCT02525536|20121938|P2|STARTED|Overall Study||6
8162154|NCT02525536|20121939|P1|STARTED|Overall Study||6
8162155|NCT02525523|20122012|P2|NOT COMPLETED|Overall Study||25
8162156|NCT02525523|20122013|P1|NOT COMPLETED|Overall Study||23
8162157|NCT02525523|20122012|P2|COMPLETED|Overall Study||44
8162158|NCT02525523|20122013|P1|COMPLETED|Overall Study||46
8162159|NCT02525523|20122012|P2|STARTED|Overall Study||69
8162160|NCT02525523|20122013|P1|STARTED|Overall Study||69
8162161|NCT02525133|20122023|P2|NOT COMPLETED|Overall Study||3
8162162|NCT02525133|20122024|P1|NOT COMPLETED|Overall Study||10
8162163|NCT02525133|20122023|P2|COMPLETED|Overall Study||103
8162164|NCT02525133|20122024|P1|COMPLETED|Overall Study||203
8162165|NCT02525133|20122023|P2|Randomized But Not Treated|Overall Study||0
8162166|NCT02525133|20122024|P1|Randomized But Not Treated|Overall Study||4
8162167|NCT02525133|20122023|P2|STARTED|Overall Study||106
8162168|NCT02525133|20122024|P1|STARTED|Overall Study||213
8162169|NCT02525094|20122042|P2|NOT COMPLETED|Overall Study||8
8162170|NCT02525094|20122043|P1|NOT COMPLETED|Overall Study||8
8162171|NCT02525094|20122042|P2|COMPLETED|Overall Study||48
8162172|NCT02525094|20122043|P1|COMPLETED|Overall Study||49
8162173|NCT02525094|20122042|P2|Treated|Overall Study||55
8162174|NCT02525094|20122043|P1|Treated|Overall Study||56
8162175|NCT02525094|20122042|P2|STARTED|Overall Study||56
8162176|NCT02525094|20122043|P1|STARTED|Overall Study||57
8162177|NCT02525055|20122076|P6|NOT COMPLETED|Overall Study||0
8162178|NCT02525055|20122077|P5|NOT COMPLETED|Overall Study||0
8162179|NCT02525055|20122078|P4|NOT COMPLETED|Overall Study||0
8162180|NCT02525055|20122079|P3|NOT COMPLETED|Overall Study||0
8162181|NCT02525055|20122080|P2|NOT COMPLETED|Overall Study||0
8162182|NCT02525055|20122081|P1|NOT COMPLETED|Overall Study||0
8162183|NCT02525055|20122076|P6|COMPLETED|Overall Study||16
8162184|NCT02525055|20122077|P5|COMPLETED|Overall Study||6
8162185|NCT02525055|20122078|P4|COMPLETED|Overall Study||6
8162186|NCT02525055|20122079|P3|COMPLETED|Overall Study||6
8162187|NCT02525055|20122080|P2|COMPLETED|Overall Study||6
8162188|NCT02525055|20122081|P1|COMPLETED|Overall Study||6
8162189|NCT02525055|20122076|P6|STARTED|Overall Study||16
8162190|NCT02525055|20122077|P5|STARTED|Overall Study||6
8162191|NCT02525055|20122078|P4|STARTED|Overall Study||6
8162192|NCT02525055|20122079|P3|STARTED|Overall Study||6
8162193|NCT02525055|20122080|P2|STARTED|Overall Study||6
8162194|NCT02525055|20122081|P1|STARTED|Overall Study||6
8162195|NCT02524977|20122097|P2|NOT COMPLETED|Overall Study||45
8162196|NCT02524977|20122098|P1|NOT COMPLETED|Overall Study||46
8162197|NCT02524977|20122097|P2|COMPLETED|Overall Study||801
8162198|NCT02524977|20122098|P1|COMPLETED|Overall Study||692
8162199|NCT02524977|20122097|P2|STARTED|Overall Study||846
8162200|NCT02524977|20122098|P1|STARTED|Overall Study||738
8162201|NCT02524847|20122106|P1|NOT COMPLETED|Overall Study||14
8162202|NCT02524847|20122106|P1|COMPLETED|Overall Study||15
8162203|NCT02524847|20122106|P1|Started Second Line Treatment|Overall Study||5
8162204|NCT02524847|20122106|P1|Completed Treatment Up to Week 12|Overall Study||14
8162205|NCT02524847|20122106|P1|STARTED|Overall Study||29
8162206|NCT02524665|20122118|P1|NOT COMPLETED|Overall Study||1
8162207|NCT02524665|20122118|P1|COMPLETED|Overall Study||19
8162208|NCT02524665|20122118|P1|STARTED|Overall Study||20
8162209|NCT02524561|20122136|P3|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
8162210|NCT02524561|20122137|P2|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
8162211|NCT02524561|20122138|P1|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
8162212|NCT02524561|20122136|P3|COMPLETED|Final: Year 3 or 4 Post-randomization||187
8162213|NCT02524561|20122137|P2|COMPLETED|Final: Year 3 or 4 Post-randomization||162
8162214|NCT02524561|20122138|P1|COMPLETED|Final: Year 3 or 4 Post-randomization||168
8162215|NCT02524561|20122136|P3|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
8162216|NCT02524561|20122137|P2|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
8162217|NCT02524561|20122138|P1|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
8162218|NCT02524561|20122136|P3|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
8162219|NCT02524561|20122137|P2|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
8162220|NCT02524561|20122138|P1|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
8162221|NCT02524561|20122136|P3|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
8162222|NCT02524561|20122137|P2|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
8162223|NCT02524561|20122138|P1|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
8162224|NCT02524561|20122136|P3|COMPLETED|Year 1: Post Randomization Mammograms||187
8162225|NCT02524561|20122137|P2|COMPLETED|Year 1: Post Randomization Mammograms||162
8162226|NCT02524561|20122138|P1|COMPLETED|Year 1: Post Randomization Mammograms||168
8162227|NCT02524561|20122136|P3|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
8162228|NCT02524561|20122137|P2|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
8162229|NCT02524561|20122138|P1|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
8162230|NCT02524561|20122136|P3|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
8162231|NCT02524561|20122137|P2|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
8162232|NCT02524561|20122138|P1|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
8162233|NCT02524561|20122136|P3|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
8162234|NCT02524561|20122137|P2|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
8162235|NCT02524561|20122138|P1|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
8162236|NCT02524561|20122136|P3|COMPLETED|Baseline: Pre-randomization Mammogram||187
8162237|NCT02524561|20122137|P2|COMPLETED|Baseline: Pre-randomization Mammogram||162
8162238|NCT02524561|20122138|P1|COMPLETED|Baseline: Pre-randomization Mammogram||168
8162239|NCT02524561|20122136|P3|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
8162240|NCT02524561|20122137|P2|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
8162241|NCT02524561|20122138|P1|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
8162242|NCT02524561|20122136|P3|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
8162243|NCT02524561|20122137|P2|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
8162244|NCT02524561|20122138|P1|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
8162245|NCT02524418|20122155|P1|NOT COMPLETED|Overall Study||13
8162246|NCT02524418|20122155|P1|COMPLETED|Overall Study||75
8162247|NCT02524418|20122155|P1|STARTED|Overall Study||88
8162252|NCT02524158|20122179|P2|NOT COMPLETED|6-month Assessment||21
8162253|NCT02524158|20122180|P1|NOT COMPLETED|6-month Assessment||22
8162254|NCT02524158|20122179|P2|COMPLETED|6-month Assessment||55
8162255|NCT02524158|20122180|P1|COMPLETED|6-month Assessment||54
8162256|NCT02524158|20122179|P2|STARTED|6-month Assessment||76
8162257|NCT02524158|20122180|P1|STARTED|6-month Assessment||76
8162258|NCT02524158|20122179|P2|NOT COMPLETED|12-weeks Assessment||13
8162259|NCT02524158|20122180|P1|NOT COMPLETED|12-weeks Assessment||19
8162260|NCT02524158|20122179|P2|COMPLETED|12-weeks Assessment||63
8162261|NCT02524158|20122180|P1|COMPLETED|12-weeks Assessment||57
8162262|NCT02524158|20122179|P2|STARTED|12-weeks Assessment||76
8162263|NCT02524158|20122180|P1|STARTED|12-weeks Assessment||76
8162264|NCT02524145|20122222|P3|NOT COMPLETED|Overall Study||3
8162265|NCT02524145|20122223|P2|NOT COMPLETED|Overall Study||2
8162266|NCT02524145|20122224|P1|NOT COMPLETED|Overall Study||2
8162267|NCT02524145|20122222|P3|COMPLETED|Overall Study||7
8162268|NCT02524145|20122223|P2|COMPLETED|Overall Study||13
8162269|NCT02524145|20122224|P1|COMPLETED|Overall Study||13
8162270|NCT02524145|20122222|P3|STARTED|Overall Study||10
8162271|NCT02524145|20122223|P2|STARTED|Overall Study||15
8162272|NCT02524145|20122224|P1|STARTED|Overall Study||15
8162273|NCT02524106|20122236|P2|NOT COMPLETED|Overall Study||0
8162274|NCT02524106|20122237|P1|NOT COMPLETED|Overall Study||0
8162275|NCT02524106|20122236|P2|COMPLETED|Overall Study||5
8162276|NCT02524106|20122237|P1|COMPLETED|Overall Study||6
8162277|NCT02524106|20122236|P2|STARTED|Overall Study||5
8162278|NCT02524106|20122237|P1|STARTED|Overall Study||6
8162279|NCT02524054|20122247|P3|NOT COMPLETED|Overall Study||0
8162280|NCT02524054|20122248|P2|NOT COMPLETED|Overall Study||0
8162281|NCT02524054|20122249|P1|NOT COMPLETED|Overall Study||0
8162282|NCT02524054|20122247|P3|COMPLETED|Overall Study||8
8162283|NCT02524054|20122248|P2|COMPLETED|Overall Study||9
8162284|NCT02524054|20122249|P1|COMPLETED|Overall Study||7
8162285|NCT02524054|20122247|P3|STARTED|Overall Study||8
8162286|NCT02524054|20122248|P2|STARTED|Overall Study||9
8162287|NCT02524054|20122249|P1|STARTED|Overall Study||7
8162288|NCT02523924|20122260|P1|NOT COMPLETED|Overall Study||0
8162289|NCT02523924|20122260|P1|COMPLETED|Overall Study||31
8162290|NCT02523924|20122260|P1|STARTED|Overall Study||31
8162291|NCT02523690|20122270|P2|NOT COMPLETED|Overall Study||0
8162292|NCT02523690|20122271|P1|NOT COMPLETED|Overall Study||0
8162293|NCT02523690|20122270|P2|COMPLETED|Overall Study||2
8162294|NCT02523690|20122271|P1|COMPLETED|Overall Study||3
8162295|NCT02523690|20122270|P2|STARTED|Overall Study||2
8162296|NCT02523690|20122271|P1|STARTED|Overall Study||3
8162297|NCT02523599|20122289|P2|NOT COMPLETED|Overall Study||1
8162298|NCT02523599|20122290|P1|NOT COMPLETED|Overall Study||8
8162299|NCT02523599|20122289|P2|COMPLETED|Overall Study||100
8162300|NCT02523599|20122290|P1|COMPLETED|Overall Study||196
8162301|NCT02523599|20122289|P2|Randomized But Not Treated|Overall Study||0
8162302|NCT02523599|20122290|P1|Randomized But Not Treated|Overall Study||1
8162303|NCT02523599|20122289|P2|STARTED|Overall Study||101
8162304|NCT02523599|20122290|P1|STARTED|Overall Study||204
8162305|NCT02523586|20122306|P1|NOT COMPLETED|Overall Study||4
8162306|NCT02523586|20122306|P1|COMPLETED|Overall Study||10
8162307|NCT02523586|20122306|P1|STARTED|Overall Study||14
8162308|NCT02523235|20122319|P2|NOT COMPLETED|Overall Study||0
8162309|NCT02523235|20122320|P1|NOT COMPLETED|Overall Study||0
8162310|NCT02523235|20122319|P2|COMPLETED|Overall Study||58
8162311|NCT02523235|20122320|P1|COMPLETED|Overall Study||56
8162312|NCT02523235|20122319|P2|STARTED|Overall Study||58
8162313|NCT02523235|20122320|P1|STARTED|Overall Study||56
8162317|NCT02522845|20122347|P2|NOT COMPLETED|Overall Study||35
8162318|NCT02522845|20122348|P1|NOT COMPLETED|Overall Study||37
8162319|NCT02522845|20122347|P2|COMPLETED|Overall Study||69
8162320|NCT02522845|20122348|P1|COMPLETED|Overall Study||63
8162321|NCT02522845|20122347|P2|STARTED|Overall Study||104
8162322|NCT02522845|20122348|P1|STARTED|Overall Study||100
8162323|NCT02522728|20122372|P2|NOT COMPLETED|Overall Study||11
8162324|NCT02522728|20122373|P1|NOT COMPLETED|Overall Study||12
8162325|NCT02522728|20122372|P2|COMPLETED|Overall Study||19
8162326|NCT02522728|20122373|P1|COMPLETED|Overall Study||16
8162327|NCT02522728|20122372|P2|STARTED|Overall Study||30
8162328|NCT02522728|20122373|P1|STARTED|Overall Study||28
8162335|NCT02522624|20122400|P2|NOT COMPLETED|Overall Study||0
8162336|NCT02522624|20122401|P1|NOT COMPLETED|Overall Study||1
8162337|NCT02522624|20122400|P2|COMPLETED|Overall Study||163
8162338|NCT02522624|20122401|P1|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
8162339|NCT02522624|20122400|P2|STARTED|Overall Study||163
8162340|NCT02522624|20122401|P1|STARTED|Overall Study||165
8162344|NCT02522442|20122430|P2|NOT COMPLETED|Overall Study||0
8162345|NCT02522442|20122431|P1|NOT COMPLETED|Overall Study||0
8162346|NCT02522442|20122430|P2|COMPLETED|Overall Study||22
8162347|NCT02522442|20122431|P1|COMPLETED|Overall Study||26
8162348|NCT02522442|20122430|P2|STARTED|Overall Study||22
8162349|NCT02522442|20122431|P1|STARTED|Overall Study||26
8162350|NCT02522403|20122447|P2|NOT COMPLETED|Overall Study||6
8162351|NCT02522403|20122448|P1|NOT COMPLETED|Overall Study||4
8162352|NCT02522403|20122447|P2|COMPLETED|Overall Study||13
8162353|NCT02522403|20122448|P1|COMPLETED|Overall Study||13
8162354|NCT02522403|20122447|P2|STARTED|Overall Study||19
8162355|NCT02522403|20122448|P1|STARTED|Overall Study||17
8162356|NCT02522377|20122460|P2|NOT COMPLETED|Overall Study||0
8162357|NCT02522377|20122461|P1|NOT COMPLETED|Overall Study||4
8162358|NCT02522377|20122460|P2|COMPLETED|Overall Study||5
8162359|NCT02522377|20122461|P1|COMPLETED|Overall Study||3
8162360|NCT02522377|20122460|P2|STARTED|Overall Study||5
8162361|NCT02522377|20122461|P1|STARTED|Overall Study||7
8162362|NCT02522325|20122477|P2|NOT COMPLETED|Overall Study||1
8162363|NCT02522325|20122478|P1|NOT COMPLETED|Overall Study||0
8162364|NCT02522325|20122477|P2|COMPLETED|Overall Study||14
8162365|NCT02522325|20122478|P1|COMPLETED|Overall Study||15
8162366|NCT02522325|20122477|P2|STARTED|Overall Study||15
8162367|NCT02522325|20122478|P1|STARTED|Overall Study||15
8162368|NCT02522299|20122486|P2|NOT COMPLETED|Overall Study||1
8162369|NCT02522299|20122487|P1|NOT COMPLETED|Overall Study||4
8162370|NCT02522299|20122486|P2|COMPLETED|Overall Study||21
8162371|NCT02522299|20122487|P1|COMPLETED|Overall Study||18
8162372|NCT02522299|20122486|P2|STARTED|Overall Study||22
8162373|NCT02522299|20122487|P1|STARTED|Overall Study||22
8162374|NCT02522286|20122570|P4|NOT COMPLETED|Overall Study||3
8162375|NCT02522286|20122571|P3|NOT COMPLETED|Overall Study||0
8162376|NCT02522286|20122572|P2|NOT COMPLETED|Overall Study||0
8162377|NCT02522286|20122573|P1|NOT COMPLETED|Overall Study||3
8162378|NCT02522286|20122570|P4|COMPLETED|Overall Study||75
8162379|NCT02522286|20122571|P3|COMPLETED|Overall Study||75
8162380|NCT02522286|20122572|P2|COMPLETED|Overall Study||75
8162381|NCT02522286|20122573|P1|COMPLETED|Overall Study||75
8162382|NCT02522286|20122570|P4|STARTED|Overall Study||78
8162383|NCT02522286|20122571|P3|STARTED|Overall Study||75
8162384|NCT02522286|20122572|P2|STARTED|Overall Study||75
8162385|NCT02522286|20122573|P1|STARTED|Overall Study||78
8162386|NCT02521974|20122601|P2|NOT COMPLETED|Overall Study||4
8162387|NCT02521974|20122602|P1|NOT COMPLETED|Overall Study||3
8162388|NCT02521974|20122601|P2|COMPLETED|Overall Study||110
8162389|NCT02521974|20122602|P1|COMPLETED|Overall Study||47
8162390|NCT02521974|20122601|P2|STARTED|Overall Study||114
8162391|NCT02521974|20122602|P1|STARTED|Overall Study||50
8162392|NCT02521948|20122609|P1|NOT COMPLETED|Overall Study||13
8162393|NCT02521948|20122609|P1|COMPLETED|Overall Study||37
8162394|NCT02521948|20122609|P1|STARTED|Overall Study||50
8162395|NCT02521792|20122618|P1|NOT COMPLETED|Overall Study||6
8162396|NCT02521792|20122618|P1|COMPLETED|Overall Study||0
8162397|NCT02521792|20122618|P1|Received Treatment|Overall Study||4
8162398|NCT02521792|20122618|P1|STARTED|Overall Study||6
8162399|NCT02521766|20122633|P2|NOT COMPLETED|Overall Study||3
8162400|NCT02521766|20122634|P1|NOT COMPLETED|Overall Study||5
8162401|NCT02521766|20122633|P2|COMPLETED|Overall Study||62
8162402|NCT02521766|20122634|P1|COMPLETED|Overall Study||44
8162403|NCT02521766|20122633|P2|Per Protocol|Overall Study||65
8162404|NCT02521766|20122634|P1|Per Protocol|Overall Study||47
8162405|NCT02521766|20122633|P2|STARTED|Overall Study||65
8162406|NCT02521766|20122634|P1|STARTED|Overall Study||49
8162407|NCT02521376|20122668|P4|NOT COMPLETED|Overall Study||0
8162408|NCT02521376|20122669|P3|NOT COMPLETED|Overall Study||0
8162409|NCT02521376|20122670|P2|NOT COMPLETED|Overall Study||0
8162410|NCT02521376|20122671|P1|NOT COMPLETED|Overall Study||1
8162411|NCT02521376|20122668|P4|COMPLETED|Overall Study||20
8162412|NCT02521376|20122669|P3|COMPLETED|Overall Study||10
8162413|NCT02521376|20122670|P2|COMPLETED|Overall Study||18
8162414|NCT02521376|20122671|P1|COMPLETED|Overall Study||7
8162415|NCT02521376|20122668|P4|STARTED|Overall Study||20
8162416|NCT02521376|20122669|P3|STARTED|Overall Study||10
8162417|NCT02521376|20122670|P2|STARTED|Overall Study||18
8162418|NCT02521376|20122671|P1|STARTED|Overall Study||8
8162419|NCT02521259|20122703|P2|NOT COMPLETED|Overall Study||5
8162420|NCT02521259|20122704|P1|NOT COMPLETED|Overall Study||1
8162421|NCT02521259|20122703|P2|COMPLETED|Overall Study||28
8162422|NCT02521259|20122704|P1|COMPLETED|Overall Study||34
8162423|NCT02521259|20122703|P2|STARTED|Overall Study||33
8162424|NCT02521259|20122704|P1|STARTED|Overall Study||35
8162425|NCT02521181|20122713|P3|NOT COMPLETED|Overall Study||0
8162426|NCT02521181|20122714|P2|NOT COMPLETED|Overall Study||0
8162427|NCT02521181|20122715|P1|NOT COMPLETED|Overall Study||0
8162428|NCT02521181|20122713|P3|COMPLETED|Overall Study|All patients included in primary analysis|52
8162429|NCT02521181|20122714|P2|COMPLETED|Overall Study|All patients included in primary analysis|90
8162430|NCT02521181|20122715|P1|COMPLETED|Overall Study|All patients included in primary analysis|52
8162431|NCT02521181|20122713|P3|STARTED|Overall Study||52
8162432|NCT02521181|20122714|P2|STARTED|Overall Study||90
8162433|NCT02521181|20122715|P1|STARTED|Overall Study||52
8162434|NCT02520726|20122725|P2|NOT COMPLETED|Overall Study||2
8162435|NCT02520726|20122726|P1|NOT COMPLETED|Overall Study||3
8162436|NCT02520726|20122725|P2|COMPLETED|Overall Study||0
8162437|NCT02520726|20122726|P1|COMPLETED|Overall Study||0
8162438|NCT02520726|20122725|P2|STARTED|Overall Study||2
8162439|NCT02520726|20122726|P1|STARTED|Overall Study||3
8162440|NCT02520531|20122736|P2|NOT COMPLETED|Overall Study||6
8162441|NCT02520531|20122737|P1|NOT COMPLETED|Overall Study||6
8162442|NCT02520531|20122736|P2|COMPLETED|Overall Study||36
8162443|NCT02520531|20122737|P1|COMPLETED|Overall Study||36
8162444|NCT02520531|20122736|P2|STARTED|Overall Study||42
8162445|NCT02520531|20122737|P1|STARTED|Overall Study||42
8162446|NCT02520518|20122755|P4|NOT COMPLETED|Overall Study||1
8162447|NCT02520518|20122756|P3|NOT COMPLETED|Overall Study||2
8162448|NCT02520518|20122757|P2|NOT COMPLETED|Overall Study||0
8162449|NCT02520518|20122758|P1|NOT COMPLETED|Overall Study||0
8162450|NCT02520518|20122755|P4|COMPLETED|Overall Study||1
8162451|NCT02520518|20122756|P3|COMPLETED|Overall Study||1
8162452|NCT02520518|20122757|P2|COMPLETED|Overall Study||1
8162453|NCT02520518|20122758|P1|COMPLETED|Overall Study||3
8162454|NCT02520518|20122755|P4|STARTED|Overall Study||2
8162455|NCT02520518|20122756|P3|STARTED|Overall Study||3
8162456|NCT02520518|20122757|P2|STARTED|Overall Study||1
8162457|NCT02520518|20122758|P1|STARTED|Overall Study||3
8162484|NCT02520297|20123002|P1|NOT COMPLETED|Overall Study||0
8162485|NCT02520297|20123002|P1|COMPLETED|Overall Study||1
8162486|NCT02520297|20123002|P1|STARTED|Overall Study||1
8162487|NCT02520284|20123012|P3|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34
8162488|NCT02520284|20123013|P2|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35
8162489|NCT02520284|20123014|P1|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32
8162490|NCT02520284|20123012|P3|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
8162491|NCT02520284|20123013|P2|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
8162492|NCT02520284|20123014|P1|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
8162493|NCT02520284|20123012|P3|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34
8162494|NCT02520284|20123013|P2|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35
8162495|NCT02520284|20123014|P1|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32
8162496|NCT02520284|20123012|P3|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18
8162497|NCT02520284|20123013|P2|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16
8162498|NCT02520284|20123014|P1|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20
8162499|NCT02520284|20123012|P3|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
8162500|NCT02520284|20123013|P2|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
8162501|NCT02520284|20123014|P1|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
8162502|NCT02520284|20123012|P3|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18
8162503|NCT02520284|20123013|P2|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16
8162504|NCT02520284|20123014|P1|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20
8162505|NCT02520284|20123012|P3|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
8162506|NCT02520284|20123013|P2|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4
8162507|NCT02520284|20123014|P1|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
8162508|NCT02520284|20123012|P3|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53
8162509|NCT02520284|20123013|P2|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52
8162510|NCT02520284|20123014|P1|COMPLETED|Blinded Induction Phase: Up to Week 8||52
8162511|NCT02520284|20123012|P3|STARTED|Blinded Induction Phase: Up to Week 8||55
8162512|NCT02520284|20123013|P2|STARTED|Blinded Induction Phase: Up to Week 8||56
8162513|NCT02520284|20123014|P1|STARTED|Blinded Induction Phase: Up to Week 8||54
8162514|NCT02520089|20123048|P2|NOT COMPLETED|Overall Study||4
8162515|NCT02520089|20123049|P1|NOT COMPLETED|Overall Study||3
8162516|NCT02520089|20123048|P2|COMPLETED|Overall Study||7
8162517|NCT02520089|20123049|P1|COMPLETED|Overall Study||9
8162518|NCT02520089|20123048|P2|STARTED|Overall Study||11
8162519|NCT02520089|20123049|P1|STARTED|Overall Study||12
8162520|NCT02519855|20123059|P2|NOT COMPLETED|Overall Study||4
8162521|NCT02519855|20123060|P1|NOT COMPLETED|Overall Study||3
8162522|NCT02519855|20123059|P2|COMPLETED|Overall Study||437
8162523|NCT02519855|20123060|P1|COMPLETED|Overall Study||438
8162524|NCT02519855|20123059|P2|Vaccinated at Week 4|Overall Study||424
8162525|NCT02519855|20123060|P1|Vaccinated at Week 4|Overall Study||432
8162526|NCT02519855|20123059|P2|Vaccinated on Day 1|Overall Study||441
8162527|NCT02519855|20123060|P1|Vaccinated on Day 1|Overall Study||440
8162528|NCT02519855|20123059|P2|STARTED|Overall Study|Participants are included as treated|441
8162529|NCT02519855|20123060|P1|STARTED|Overall Study|Participants are included as treated|441
8162530|NCT02519842|20123078|P3|NOT COMPLETED|Optional Extension: Cycles 2-6||29
8162531|NCT02519842|20123079|P2|NOT COMPLETED|Optional Extension: Cycles 2-6||0
8162532|NCT02519842|20123080|P1|NOT COMPLETED|Optional Extension: Cycles 2-6||0
8162533|NCT02519842|20123078|P3|COMPLETED|Optional Extension: Cycles 2-6||26
8162534|NCT02519842|20123079|P2|COMPLETED|Optional Extension: Cycles 2-6||0
8162535|NCT02519842|20123080|P1|COMPLETED|Optional Extension: Cycles 2-6||0
8162536|NCT02519842|20123078|P3|Treated|Optional Extension: Cycles 2-6||55
8162537|NCT02519842|20123079|P2|Treated|Optional Extension: Cycles 2-6||0
8162538|NCT02519842|20123080|P1|Treated|Optional Extension: Cycles 2-6||0
8162539|NCT02519842|20123078|P3|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
8162540|NCT02519842|20123079|P2|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
8162541|NCT02519842|20123080|P1|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
8162542|NCT02519842|20123078|P3|NOT COMPLETED|Base Study: Cycle 1||0
8162543|NCT02519842|20123079|P2|NOT COMPLETED|Base Study: Cycle 1||3
8162544|NCT02519842|20123080|P1|NOT COMPLETED|Base Study: Cycle 1||2
8162545|NCT02519842|20123078|P3|COMPLETED|Base Study: Cycle 1||0
8162546|NCT02519842|20123079|P2|COMPLETED|Base Study: Cycle 1||34
8162547|NCT02519842|20123080|P1|COMPLETED|Base Study: Cycle 1||36
8162548|NCT02519842|20123078|P3|Treated|Base Study: Cycle 1||0
8162549|NCT02519842|20123079|P2|Treated|Base Study: Cycle 1||34
8162550|NCT02519842|20123080|P1|Treated|Base Study: Cycle 1||37
8162551|NCT02519842|20123078|P3|STARTED|Base Study: Cycle 1||0
8162552|NCT02519842|20123079|P2|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
8162553|NCT02519842|20123080|P1|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
8162554|NCT02519712|20123099|P1|NOT COMPLETED|Overall Study||4
8162555|NCT02519712|20123099|P1|COMPLETED|Overall Study||0
8162556|NCT02519712|20123099|P1|STARTED|Overall Study||4
8162557|NCT02519621|20123106|P3|NOT COMPLETED|Overall Study||0
8162558|NCT02519621|20123107|P2|NOT COMPLETED|Overall Study||0
8162559|NCT02519621|20123108|P1|NOT COMPLETED|Overall Study||0
8162560|NCT02519621|20123106|P3|COMPLETED|Overall Study||30
8162561|NCT02519621|20123107|P2|COMPLETED|Overall Study||30
8162562|NCT02519621|20123108|P1|COMPLETED|Overall Study||30
8162563|NCT02519621|20123106|P3|STARTED|Overall Study||30
8162564|NCT02519621|20123107|P2|STARTED|Overall Study||30
8162565|NCT02519621|20123108|P1|STARTED|Overall Study||30
8162566|NCT02519595|20123128|P3|NOT COMPLETED|Overall Study||16
8162567|NCT02519595|20123129|P2|NOT COMPLETED|Overall Study||22
8162568|NCT02519595|20123130|P1|NOT COMPLETED|Overall Study||8
8162569|NCT02519595|20123128|P3|COMPLETED|Overall Study||40
8162570|NCT02519595|20123129|P2|COMPLETED|Overall Study||35
8162571|NCT02519595|20123130|P1|COMPLETED|Overall Study||50
8162572|NCT02519595|20123128|P3|STARTED|Overall Study||56
8162573|NCT02519595|20123129|P2|STARTED|Overall Study||57
8162574|NCT02519595|20123130|P1|STARTED|Overall Study||58
8162575|NCT02519504|20123155|P2|NOT COMPLETED|Overall Study||103
8162576|NCT02519504|20123156|P1|NOT COMPLETED|Overall Study||113
8162577|NCT02519504|20123155|P2|COMPLETED|Overall Study||144
8162578|NCT02519504|20123156|P1|COMPLETED|Overall Study||206
8162579|NCT02519504|20123155|P2|Attended Direct Testing|Overall Study||149
8162580|NCT02519504|20123156|P1|Attended Direct Testing|Overall Study||212
8162581|NCT02519504|20123155|P2|STARTED|Overall Study||247
8162582|NCT02519504|20123156|P1|STARTED|Overall Study||319
8162583|NCT02519387|20123216|P1|NOT COMPLETED|Overall Study||22
8162584|NCT02519387|20123216|P1|COMPLETED|Overall Study||56
8162585|NCT02519387|20123216|P1|STARTED|Overall Study||78
8162586|NCT02519244|20123224|P1|NOT COMPLETED|Overall Study||0
8162587|NCT02519244|20123224|P1|COMPLETED|Overall Study||10
8162588|NCT02519244|20123224|P1|STARTED|Overall Study||10
8162589|NCT02519231|20123255|P2|NOT COMPLETED|Overall Study||6
8162590|NCT02519231|20123256|P1|NOT COMPLETED|Overall Study||2
8162591|NCT02519231|20123255|P2|COMPLETED|Overall Study|Six participants never turned in their bleeding diaries.|8
8162592|NCT02519231|20123256|P1|COMPLETED|Overall Study|One was lost to follow up and never took the treatment. another never turned in bleeding diary.|12
8162593|NCT02519231|20123255|P2|STARTED|Overall Study||14
8162594|NCT02519231|20123256|P1|STARTED|Overall Study||14
8162595|NCT02519036|20123270|P6|NOT COMPLETED|Overall Study||0
8162596|NCT02519036|20123271|P5|NOT COMPLETED|Overall Study||0
8162597|NCT02519036|20123272|P4|NOT COMPLETED|Overall Study||0
8162598|NCT02519036|20123273|P3|NOT COMPLETED|Overall Study||0
8162599|NCT02519036|20123274|P2|NOT COMPLETED|Overall Study||0
8162600|NCT02519036|20123275|P1|NOT COMPLETED|Overall Study||0
8162601|NCT02519036|20123270|P6|COMPLETED|Overall Study||10
8162602|NCT02519036|20123271|P5|COMPLETED|Overall Study||9
8162603|NCT02519036|20123272|P4|COMPLETED|Overall Study||6
8162604|NCT02519036|20123273|P3|COMPLETED|Overall Study||6
8162605|NCT02519036|20123274|P2|COMPLETED|Overall Study||3
8162606|NCT02519036|20123275|P1|COMPLETED|Overall Study||12
8162607|NCT02519036|20123270|P6|STARTED|Overall Study||10
8162608|NCT02519036|20123271|P5|STARTED|Overall Study||9
8162609|NCT02519036|20123272|P4|STARTED|Overall Study||6
8162610|NCT02519036|20123273|P3|STARTED|Overall Study||6
8162611|NCT02519036|20123274|P2|STARTED|Overall Study||3
8162612|NCT02519036|20123275|P1|STARTED|Overall Study||12
8162613|NCT02519023|20123330|P2|NOT COMPLETED|Overall Study||7
8162614|NCT02519023|20123331|P1|NOT COMPLETED|Overall Study||18
8162615|NCT02519023|20123330|P2|COMPLETED|Overall Study||31
8162616|NCT02519023|20123331|P1|COMPLETED|Overall Study||31
8162617|NCT02519023|20123330|P2|STARTED|Overall Study||38
8162618|NCT02519023|20123331|P1|STARTED|Overall Study||49
8162619|NCT02518997|20123363|P1|NOT COMPLETED|Overall Study||0
8162620|NCT02518997|20123363|P1|COMPLETED|Overall Study||18
8162621|NCT02518997|20123363|P1|STARTED|Overall Study||18
8162622|NCT02518971|20123372|P2|NOT COMPLETED|Overall Study||20
8162623|NCT02518971|20123373|P1|NOT COMPLETED|Overall Study||23
8162624|NCT02518971|20123372|P2|COMPLETED|Overall Study||67
8162625|NCT02518971|20123373|P1|COMPLETED|Overall Study||64
8162626|NCT02518971|20123372|P2|STARTED|Overall Study||87
8162627|NCT02518971|20123373|P1|STARTED|Overall Study||87
8162628|NCT02518919|20123393|P3|NOT COMPLETED|Overall Study||2
8162629|NCT02518919|20123394|P2|NOT COMPLETED|Overall Study||1
8162630|NCT02518919|20123395|P1|NOT COMPLETED|Overall Study||1
8162631|NCT02518919|20123393|P3|COMPLETED|Overall Study||19
8162632|NCT02518919|20123394|P2|COMPLETED|Overall Study||20
8162633|NCT02518919|20123395|P1|COMPLETED|Overall Study||20
8162634|NCT02518919|20123393|P3|STARTED|Overall Study||21
8162635|NCT02518919|20123394|P2|STARTED|Overall Study||21
8162636|NCT02518919|20123395|P1|STARTED|Overall Study||21
8162637|NCT02518750|20123415|P1|NOT COMPLETED|Overall Study||2
8162638|NCT02518750|20123415|P1|COMPLETED|Overall Study||1
8162639|NCT02518750|20123415|P1|STARTED|Overall Study||3
8162640|NCT02518685|20123425|P2|NOT COMPLETED|Overall Study||10
8162641|NCT02518685|20123426|P1|NOT COMPLETED|Overall Study||49
8162642|NCT02518685|20123425|P2|COMPLETED|Overall Study||79
8162643|NCT02518685|20123426|P1|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164
8162644|NCT02518685|20123425|P2|Per Protocol Analysis|Overall Study||89
8162645|NCT02518685|20123426|P1|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168
8162646|NCT02518685|20123425|P2|Enrolled|Overall Study||89
8162647|NCT02518685|20123426|P1|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213
8162648|NCT02518685|20123425|P2|Randomized Cohort|Overall Study||89
8162649|NCT02518685|20123426|P1|Randomized Cohort|Overall Study||181
8162650|NCT02518685|20123425|P2|Safety Cohort|Overall Study||89
8162651|NCT02518685|20123426|P1|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203
8162652|NCT02518685|20123425|P2|STARTED|Overall Study||89
8162653|NCT02518685|20123426|P1|STARTED|Overall Study||213
8162654|NCT02518620|20123435|P2|NOT COMPLETED|Overall Study||26
8162655|NCT02518620|20123436|P1|NOT COMPLETED|Overall Study||52
8162656|NCT02518620|20123435|P2|COMPLETED|Overall Study||123
8162657|NCT02518620|20123436|P1|COMPLETED|Overall Study||205
8162658|NCT02518620|20123435|P2|STARTED|Overall Study||149
8162659|NCT02518620|20123436|P1|STARTED|Overall Study||257
8162660|NCT02518490|20123459|P2|NOT COMPLETED|Overall Study||1
8162661|NCT02518490|20123460|P1|NOT COMPLETED|Overall Study||1
8162662|NCT02518490|20123459|P2|COMPLETED|Overall Study||17
8162663|NCT02518490|20123460|P1|COMPLETED|Overall Study||17
8162664|NCT02518490|20123459|P2|STARTED|Overall Study||18
8162665|NCT02518490|20123460|P1|STARTED|Overall Study||18
8162666|NCT02518464|20123478|P1|NOT COMPLETED|Overall Study||2
8162667|NCT02518464|20123478|P1|COMPLETED|Overall Study||38
8162668|NCT02518464|20123478|P1|STARTED|Overall Study||40
8162678|NCT02518113|20123499|P4|NOT COMPLETED|Overall Study||0
8162679|NCT02518113|20123500|P3|NOT COMPLETED|Overall Study||4
8162680|NCT02518113|20123501|P2|NOT COMPLETED|Overall Study||5
8162681|NCT02518113|20123502|P1|NOT COMPLETED|Overall Study||3
8162682|NCT02518113|20123499|P4|COMPLETED|Overall Study||3
8162683|NCT02518113|20123500|P3|COMPLETED|Overall Study||11
8162684|NCT02518113|20123501|P2|COMPLETED|Overall Study||7
8162685|NCT02518113|20123502|P1|COMPLETED|Overall Study||3
8162686|NCT02518113|20123499|P4|STARTED|Overall Study||3
8162687|NCT02518113|20123500|P3|STARTED|Overall Study||15
8162688|NCT02518113|20123501|P2|STARTED|Overall Study||12
8162689|NCT02518113|20123502|P1|STARTED|Overall Study||6
8162690|NCT02518048|20123543|P1|NOT COMPLETED|Overall Study||1
8162691|NCT02518048|20123543|P1|COMPLETED|Overall Study||34
8162692|NCT02518048|20123543|P1|STARTED|Overall Study||35
8162693|NCT02517996|20123556|P2|NOT COMPLETED|Overall Study||0
8162694|NCT02517996|20123557|P1|NOT COMPLETED|Overall Study||0
8162695|NCT02517996|20123556|P2|COMPLETED|Overall Study||9
8162696|NCT02517996|20123557|P1|COMPLETED|Overall Study||8
8162697|NCT02517996|20123556|P2|STARTED|Overall Study||9
8162698|NCT02517996|20123557|P1|STARTED|Overall Study||8
8162699|NCT02517905|20123571|P2|NOT COMPLETED|Overall Study||2
8162700|NCT02517905|20123572|P1|NOT COMPLETED|Overall Study||10
8162701|NCT02517905|20123571|P2|COMPLETED|Overall Study||57
8162702|NCT02517905|20123572|P1|COMPLETED|Overall Study||97
8162703|NCT02517905|20123571|P2|STARTED|Overall Study||59
8162704|NCT02517905|20123572|P1|STARTED|Overall Study||107
8162705|NCT02517866|20123588|P3|NOT COMPLETED|Overall Study||0
8162706|NCT02517866|20123589|P2|NOT COMPLETED|Overall Study||6
8162707|NCT02517866|20123590|P1|NOT COMPLETED|Overall Study||20
8162708|NCT02517866|20123588|P3|COMPLETED|Overall Study||1
8162709|NCT02517866|20123589|P2|COMPLETED|Overall Study||84
8162710|NCT02517866|20123590|P1|COMPLETED|Overall Study||269
8162711|NCT02517866|20123588|P3|STARTED|Overall Study||1
8162712|NCT02517866|20123589|P2|STARTED|Overall Study||90
8162713|NCT02517866|20123590|P1|STARTED|Overall Study||289
8162714|NCT02517658|20123635|P3|NOT COMPLETED|Overall Study||0
8162715|NCT02517658|20123636|P2|NOT COMPLETED|Overall Study||0
8162716|NCT02517658|20123637|P1|NOT COMPLETED|Overall Study||0
8162717|NCT02517658|20123635|P3|COMPLETED|Overall Study||33
8162718|NCT02517658|20123636|P2|COMPLETED|Overall Study||33
8162719|NCT02517658|20123637|P1|COMPLETED|Overall Study||33
8162720|NCT02517658|20123635|P3|STARTED|Overall Study||33
8162721|NCT02517658|20123636|P2|STARTED|Overall Study||33
8162722|NCT02517658|20123637|P1|STARTED|Overall Study||33
8162723|NCT02517580|20123645|P1|NOT COMPLETED|Overall Study||4
8162724|NCT02517580|20123645|P1|COMPLETED|Overall Study||56
8162725|NCT02517580|20123645|P1|STARTED|Overall Study||60
8162726|NCT02517567|20123649|P4|NOT COMPLETED|Fourth Exposure (8 Hours)||0
8162727|NCT02517567|20123650|P3|NOT COMPLETED|Fourth Exposure (8 Hours)||0
8162728|NCT02517567|20123651|P2|NOT COMPLETED|Fourth Exposure (8 Hours)||0
8162729|NCT02517567|20123652|P1|NOT COMPLETED|Fourth Exposure (8 Hours)||0
8162730|NCT02517567|20123649|P4|COMPLETED|Fourth Exposure (8 Hours)||8
8162731|NCT02517567|20123650|P3|COMPLETED|Fourth Exposure (8 Hours)||6
8162732|NCT02517567|20123651|P2|COMPLETED|Fourth Exposure (8 Hours)||8
8162733|NCT02517567|20123652|P1|COMPLETED|Fourth Exposure (8 Hours)||6
8162734|NCT02517567|20123649|P4|STARTED|Fourth Exposure (8 Hours)||8
8162735|NCT02517567|20123650|P3|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
8162736|NCT02517567|20123651|P2|STARTED|Fourth Exposure (8 Hours)||8
8162737|NCT02517567|20123652|P1|STARTED|Fourth Exposure (8 Hours)||6
8162738|NCT02517567|20123649|P4|NOT COMPLETED|Third Exposure (8 Hours)||0
8162739|NCT02517567|20123650|P3|NOT COMPLETED|Third Exposure (8 Hours)||0
8162740|NCT02517567|20123651|P2|NOT COMPLETED|Third Exposure (8 Hours)||0
8162741|NCT02517567|20123652|P1|NOT COMPLETED|Third Exposure (8 Hours)||0
8162742|NCT02517567|20123649|P4|COMPLETED|Third Exposure (8 Hours)||8
8162743|NCT02517567|20123650|P3|COMPLETED|Third Exposure (8 Hours)||7
8162744|NCT02517567|20123651|P2|COMPLETED|Third Exposure (8 Hours)||8
8162745|NCT02517567|20123652|P1|COMPLETED|Third Exposure (8 Hours)||6
8162746|NCT02517567|20123649|P4|STARTED|Third Exposure (8 Hours)||8
8162747|NCT02517567|20123650|P3|STARTED|Third Exposure (8 Hours)||7
8162748|NCT02517567|20123651|P2|STARTED|Third Exposure (8 Hours)||8
8162749|NCT02517567|20123652|P1|STARTED|Third Exposure (8 Hours)||6
8162750|NCT02517567|20123649|P4|NOT COMPLETED|Second Exposure (8 Hours)||0
8162751|NCT02517567|20123650|P3|NOT COMPLETED|Second Exposure (8 Hours)||0
8162752|NCT02517567|20123651|P2|NOT COMPLETED|Second Exposure (8 Hours)||0
8162753|NCT02517567|20123652|P1|NOT COMPLETED|Second Exposure (8 Hours)||0
8162754|NCT02517567|20123649|P4|COMPLETED|Second Exposure (8 Hours)||8
8162755|NCT02517567|20123650|P3|COMPLETED|Second Exposure (8 Hours)||7
8162756|NCT02517567|20123651|P2|COMPLETED|Second Exposure (8 Hours)||8
8162757|NCT02517567|20123652|P1|COMPLETED|Second Exposure (8 Hours)||6
8162758|NCT02517567|20123649|P4|STARTED|Second Exposure (8 Hours)||8
8162759|NCT02517567|20123650|P3|STARTED|Second Exposure (8 Hours)||7
8162760|NCT02517567|20123651|P2|STARTED|Second Exposure (8 Hours)||8
8162761|NCT02517567|20123652|P1|STARTED|Second Exposure (8 Hours)||6
8162762|NCT02517567|20123649|P4|NOT COMPLETED|First Exposure (8 Hours)||0
8162763|NCT02517567|20123650|P3|NOT COMPLETED|First Exposure (8 Hours)||0
8162764|NCT02517567|20123651|P2|NOT COMPLETED|First Exposure (8 Hours)||0
8162765|NCT02517567|20123652|P1|NOT COMPLETED|First Exposure (8 Hours)||0
8162766|NCT02517567|20123649|P4|COMPLETED|First Exposure (8 Hours)||8
8162767|NCT02517567|20123650|P3|COMPLETED|First Exposure (8 Hours)||7
8162768|NCT02517567|20123651|P2|COMPLETED|First Exposure (8 Hours)||8
8162769|NCT02517567|20123652|P1|COMPLETED|First Exposure (8 Hours)||6
8162770|NCT02517567|20123649|P4|STARTED|First Exposure (8 Hours)||8
8162771|NCT02517567|20123650|P3|STARTED|First Exposure (8 Hours)||7
8162772|NCT02517567|20123651|P2|STARTED|First Exposure (8 Hours)||8
8162773|NCT02517567|20123652|P1|STARTED|First Exposure (8 Hours)||6
8162774|NCT02517541|20123661|P1|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
8162775|NCT02517541|20123661|P1|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
8162776|NCT02517541|20123661|P1|STARTED|Test Period (SenSura Mio Convex Soft)||73
8162777|NCT02517541|20123661|P1|NOT COMPLETED|Baseline Period (Own Product)||1
8162778|NCT02517541|20123661|P1|COMPLETED|Baseline Period (Own Product)||73
8162779|NCT02517541|20123661|P1|STARTED|Baseline Period (Own Product)||74
8162780|NCT02517528|20123667|P1|NOT COMPLETED|Overall Study||1
8162781|NCT02517528|20123667|P1|COMPLETED|Overall Study||103
8162782|NCT02517528|20123667|P1|STARTED|Overall Study||104
8162783|NCT02517515|20123677|P2|NOT COMPLETED|Overall Study||2
8162784|NCT02517515|20123678|P1|NOT COMPLETED|Overall Study||2
8162785|NCT02517515|20123677|P2|COMPLETED|Overall Study||323
8162786|NCT02517515|20123678|P1|COMPLETED|Overall Study||323
8162787|NCT02517515|20123677|P2|STARTED|Overall Study||325
8162788|NCT02517515|20123678|P1|STARTED|Overall Study||325
8162789|NCT02517463|20123695|P2|NOT COMPLETED|Overall Study||2
8162790|NCT02517463|20123696|P1|NOT COMPLETED|Overall Study||5
8162791|NCT02517463|20123695|P2|COMPLETED|Overall Study||329
8162792|NCT02517463|20123696|P1|COMPLETED|Overall Study||364
8162793|NCT02517463|20123695|P2|STARTED|Overall Study||331
8162794|NCT02517463|20123696|P1|STARTED|Overall Study||369
8162795|NCT02517268|20123708|P2|NOT COMPLETED|Overall Study||0
8162796|NCT02517268|20123709|P1|NOT COMPLETED|Overall Study||1
8162797|NCT02517268|20123708|P2|COMPLETED|Overall Study||37
8162798|NCT02517268|20123709|P1|COMPLETED|Overall Study||39
8162799|NCT02517268|20123708|P2|STARTED|Overall Study||37
8162800|NCT02517268|20123709|P1|STARTED|Overall Study||40
8162801|NCT02517047|20123723|P1|NOT COMPLETED|Overall Study||2
8162802|NCT02517047|20123723|P1|COMPLETED|Overall Study||24
8162803|NCT02517047|20123723|P1|STARTED|Overall Study||26
8162804|NCT02517021|20123732|P2|NOT COMPLETED|Overall Study||85
8162805|NCT02517021|20123733|P1|NOT COMPLETED|Overall Study||83
8162806|NCT02517021|20123732|P2|COMPLETED|Overall Study||117
8162807|NCT02517021|20123733|P1|COMPLETED|Overall Study||120
8162808|NCT02517021|20123732|P2|STARTED|Overall Study||202
8162809|NCT02517021|20123733|P1|STARTED|Overall Study||203
8162810|NCT02516982|20123761|P4|NOT COMPLETED|Overall Study||50
8162811|NCT02516982|20123762|P3|NOT COMPLETED|Overall Study||48
8162812|NCT02516982|20123763|P2|NOT COMPLETED|Overall Study||35
8162813|NCT02516982|20123764|P1|NOT COMPLETED|Overall Study||32
8162814|NCT02516982|20123761|P4|COMPLETED|Overall Study||125
8162815|NCT02516982|20123762|P3|COMPLETED|Overall Study||126
8162816|NCT02516982|20123763|P2|COMPLETED|Overall Study||257
8162817|NCT02516982|20123764|P1|COMPLETED|Overall Study||273
8162818|NCT02516982|20123761|P4|STARTED|Overall Study||175
8162819|NCT02516982|20123762|P3|STARTED|Overall Study||174
8162820|NCT02516982|20123763|P2|STARTED|Overall Study||292
8162821|NCT02516982|20123764|P1|STARTED|Overall Study||305
8162822|NCT02516605|20123791|P5|NOT COMPLETED|Overall Study||1
8162823|NCT02516605|20123792|P4|NOT COMPLETED|Overall Study||1
8162824|NCT02516605|20123793|P3|NOT COMPLETED|Overall Study||0
8162825|NCT02516605|20123794|P2|NOT COMPLETED|Overall Study||0
8162826|NCT02516605|20123795|P1|NOT COMPLETED|Overall Study||0
8162827|NCT02516605|20123791|P5|COMPLETED|Overall Study||20
8162828|NCT02516605|20123792|P4|COMPLETED|Overall Study||7
8162829|NCT02516605|20123793|P3|COMPLETED|Overall Study||12
8162830|NCT02516605|20123794|P2|COMPLETED|Overall Study||9
8162831|NCT02516605|20123795|P1|COMPLETED|Overall Study||11
8162832|NCT02516605|20123791|P5|STARTED|Overall Study||21
8162833|NCT02516605|20123792|P4|STARTED|Overall Study||8
8162834|NCT02516605|20123793|P3|STARTED|Overall Study||12
8162835|NCT02516605|20123794|P2|STARTED|Overall Study||9
8162836|NCT02516605|20123795|P1|STARTED|Overall Study||11
8162837|NCT02516592|20123866|P2|NOT COMPLETED|Overall Study||13
8162838|NCT02516592|20123867|P1|NOT COMPLETED|Overall Study||16
8162839|NCT02516592|20123866|P2|COMPLETED|Overall Study||238
8162840|NCT02516592|20123867|P1|COMPLETED|Overall Study||235
8162841|NCT02516592|20123866|P2|Full Analysis Set|Overall Study||250
8162842|NCT02516592|20123867|P1|Full Analysis Set|Overall Study||248
8162843|NCT02516592|20123866|P2|STARTED|Overall Study||251
8162844|NCT02516592|20123867|P1|STARTED|Overall Study||251
8162845|NCT02516579|20123881|P1|NOT COMPLETED|Overall Study||0
8162846|NCT02516579|20123881|P1|COMPLETED|Overall Study||1906
8162847|NCT02516579|20123881|P1|STARTED|Overall Study||1906
8162848|NCT02516410|20123889|P2|NOT COMPLETED|Overall Study||2
8162849|NCT02516410|20123890|P1|NOT COMPLETED|Overall Study||0
8162850|NCT02516410|20123889|P2|COMPLETED|Overall Study||81
8162851|NCT02516410|20123890|P1|COMPLETED|Overall Study||85
8162852|NCT02516410|20123889|P2|STARTED|Overall Study||83
8162853|NCT02516410|20123890|P1|STARTED|Overall Study||85
8162854|NCT02516306|20123919|P2|NOT COMPLETED|Period 2: Day 8 - 91||2
8162855|NCT02516306|20123920|P1|NOT COMPLETED|Period 2: Day 8 - 91||1
8162856|NCT02516306|20123919|P2|COMPLETED|Period 2: Day 8 - 91||23
8162857|NCT02516306|20123920|P1|COMPLETED|Period 2: Day 8 - 91||49
8162858|NCT02516306|20123919|P2|STARTED|Period 2: Day 8 - 91||25
8162859|NCT02516306|20123920|P1|STARTED|Period 2: Day 8 - 91||50
8162860|NCT02516306|20123919|P2|NOT COMPLETED|Period 1: Day 1 - 7||0
8162861|NCT02516306|20123920|P1|NOT COMPLETED|Period 1: Day 1 - 7||0
8162862|NCT02516306|20123919|P2|COMPLETED|Period 1: Day 1 - 7||25
8162863|NCT02516306|20123920|P1|COMPLETED|Period 1: Day 1 - 7||50
8162864|NCT02516306|20123919|P2|STARTED|Period 1: Day 1 - 7||25
8162865|NCT02516306|20123920|P1|STARTED|Period 1: Day 1 - 7||50
8162866|NCT02516228|20123926|P1|NOT COMPLETED|Overall Study||3
8162867|NCT02516228|20123926|P1|COMPLETED|Overall Study||3
8162868|NCT02516228|20123926|P1|STARTED|Overall Study||6
8162869|NCT02516202|20123937|P3|NOT COMPLETED|Overall Study||3
8162870|NCT02516202|20123938|P2|NOT COMPLETED|Overall Study||1
8162871|NCT02516202|20123939|P1|NOT COMPLETED|Overall Study||2
8162872|NCT02516202|20123937|P3|COMPLETED|Overall Study||97
8162873|NCT02516202|20123938|P2|COMPLETED|Overall Study||99
8162874|NCT02516202|20123939|P1|COMPLETED|Overall Study||100
8162875|NCT02516202|20123937|P3|STARTED|Overall Study||100
8162876|NCT02516202|20123938|P2|STARTED|Overall Study||100
8162877|NCT02516202|20123939|P1|STARTED|Overall Study||102
8162878|NCT02516163|20123965|P1|NOT COMPLETED|Overall Study||28
8162879|NCT02516163|20123965|P1|COMPLETED|Overall Study||24
8162880|NCT02516163|20123965|P1|STARTED|Overall Study||52
8162881|NCT02516150|20123969|P1|NOT COMPLETED|Overall Study||0
8162882|NCT02516150|20123969|P1|COMPLETED|Overall Study||15
8162883|NCT02516150|20123969|P1|STARTED|Overall Study||15
8162884|NCT02516098|20123979|P2|NOT COMPLETED|Washout After Period 2||0
8162885|NCT02516098|20123980|P1|NOT COMPLETED|Washout After Period 2||0
8162886|NCT02516098|20123979|P2|COMPLETED|Washout After Period 2||26
8162887|NCT02516098|20123980|P1|COMPLETED|Washout After Period 2||27
8162888|NCT02516098|20123979|P2|STARTED|Washout After Period 2||26
8162889|NCT02516098|20123980|P1|STARTED|Washout After Period 2||27
8162890|NCT02516098|20123979|P2|NOT COMPLETED|Period 2||1
8162891|NCT02516098|20123980|P1|NOT COMPLETED|Period 2||0
8162892|NCT02516098|20123979|P2|COMPLETED|Period 2||26
8162893|NCT02516098|20123980|P1|COMPLETED|Period 2||27
8162894|NCT02516098|20123979|P2|STARTED|Period 2||27
8162895|NCT02516098|20123980|P1|STARTED|Period 2||27
8162896|NCT02516098|20123979|P2|NOT COMPLETED|Washout After Period 1||1
8162897|NCT02516098|20123980|P1|NOT COMPLETED|Washout After Period 1||0
8162898|NCT02516098|20123979|P2|COMPLETED|Washout After Period 1||27
8162899|NCT02516098|20123980|P1|COMPLETED|Washout After Period 1||27
8162900|NCT02516098|20123979|P2|STARTED|Washout After Period 1||28
8162901|NCT02516098|20123980|P1|STARTED|Washout After Period 1||27
8162902|NCT02516098|20123979|P2|NOT COMPLETED|Period 1||0
8162903|NCT02516098|20123980|P1|NOT COMPLETED|Period 1||1
8162904|NCT02516098|20123979|P2|COMPLETED|Period 1||28
8162905|NCT02516098|20123980|P1|COMPLETED|Period 1||27
8162906|NCT02516098|20123979|P2|STARTED|Period 1||28
8162907|NCT02516098|20123980|P1|STARTED|Period 1||28
8162908|NCT02516046|20123992|P1|NOT COMPLETED|Overall Study||92
8162909|NCT02516046|20123992|P1|COMPLETED|Overall Study|Completed = included in autopsy cohort|64
8162910|NCT02516046|20123992|P1|Valid Autopsy Results and PET Scan|Overall Study|includes 3 front-runners|67
8162911|NCT02516046|20123992|P1|Died While on Study|Overall Study||73
8162912|NCT02516046|20123992|P1|STARTED|Overall Study|Total number of subjects scanned|156
8162913|NCT02515994|20124008|P2|NOT COMPLETED|Overall Study||7
8162914|NCT02515994|20124009|P1|NOT COMPLETED|Overall Study||10
8162915|NCT02515994|20124008|P2|COMPLETED|Overall Study||105
8162916|NCT02515994|20124009|P1|COMPLETED|Overall Study||99
8162917|NCT02515994|20124008|P2|STARTED|Overall Study||112
8162918|NCT02515994|20124009|P1|STARTED|Overall Study||109
8162919|NCT02515942|20124024|P3|NOT COMPLETED|Overall Study||4
8162920|NCT02515942|20124025|P2|NOT COMPLETED|Overall Study||3
8162921|NCT02515942|20124026|P1|NOT COMPLETED|Overall Study||7
8162922|NCT02515942|20124024|P3|COMPLETED|Overall Study||35
8162923|NCT02515942|20124025|P2|COMPLETED|Overall Study||36
8162924|NCT02515942|20124026|P1|COMPLETED|Overall Study||29
8162925|NCT02515942|20124024|P3|Completed Day 337|Overall Study||35
8162926|NCT02515942|20124025|P2|Completed Day 337|Overall Study||36
8162927|NCT02515942|20124026|P1|Completed Day 337|Overall Study||30
8162928|NCT02515942|20124024|P3|Completed Day 253|Overall Study||36
8162929|NCT02515942|20124025|P2|Completed Day 253|Overall Study||37
8162930|NCT02515942|20124026|P1|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
8162931|NCT02515942|20124024|P3|Completed Day 169|Overall Study||37
8162932|NCT02515942|20124025|P2|Completed Day 169|Overall Study||37
8162933|NCT02515942|20124026|P1|Completed Day 169|Overall Study||32
8162934|NCT02515942|20124024|P3|Completed Day 85|Overall Study||37
8162935|NCT02515942|20124025|P2|Completed Day 85|Overall Study||38
8162936|NCT02515942|20124026|P1|Completed Day 85|Overall Study||35
8162937|NCT02515942|20124024|P3|Pharmacokinetics (PK) Analysis Set|Overall Study||0
8162938|NCT02515942|20124025|P2|Pharmacokinetics (PK) Analysis Set|Overall Study||39
8162939|NCT02515942|20124026|P1|Pharmacokinetics (PK) Analysis Set|Overall Study||36
8162940|NCT02515942|20124024|P3|Per Protocol Analysis Set (PPS)|Overall Study||34
8162941|NCT02515942|20124025|P2|Per Protocol Analysis Set (PPS)|Overall Study||35
8162942|NCT02515942|20124026|P1|Per Protocol Analysis Set (PPS)|Overall Study||30
8162943|NCT02515942|20124024|P3|Full Analysis Set (FAS)|Overall Study||38
8162944|NCT02515942|20124025|P2|Full Analysis Set (FAS)|Overall Study||37
8162945|NCT02515942|20124026|P1|Full Analysis Set (FAS)|Overall Study||35
8162946|NCT02515942|20124024|P3|Safety Analysis Set|Overall Study||39
8162947|NCT02515942|20124025|P2|Safety Analysis Set|Overall Study||39
8162948|NCT02515942|20124026|P1|Safety Analysis Set|Overall Study||36
8162949|NCT02515942|20124024|P3|STARTED|Overall Study||39
8162950|NCT02515942|20124025|P2|STARTED|Overall Study||39
8162951|NCT02515942|20124026|P1|STARTED|Overall Study||36
8162952|NCT02515890|20124078|P5|NOT COMPLETED|Overall Study||0
8162953|NCT02515890|20124079|P4|NOT COMPLETED|Overall Study||0
8162954|NCT02515890|20124080|P3|NOT COMPLETED|Overall Study||0
8162955|NCT02515890|20124081|P2|NOT COMPLETED|Overall Study||0
8162956|NCT02515890|20124082|P1|NOT COMPLETED|Overall Study||0
8162957|NCT02515890|20124078|P5|COMPLETED|Overall Study||8
8162958|NCT02515890|20124079|P4|COMPLETED|Overall Study||8
8162959|NCT02515890|20124080|P3|COMPLETED|Overall Study||5
8162960|NCT02515890|20124081|P2|COMPLETED|Overall Study||4
8162961|NCT02515890|20124082|P1|COMPLETED|Overall Study||7
8162962|NCT02515890|20124078|P5|STARTED|Overall Study||8
8162963|NCT02515890|20124079|P4|STARTED|Overall Study||8
8162964|NCT02515890|20124080|P3|STARTED|Overall Study||5
8162965|NCT02515890|20124081|P2|STARTED|Overall Study||4
8162966|NCT02515890|20124082|P1|STARTED|Overall Study||7
8162967|NCT02515851|20124095|P2|NOT COMPLETED|Overall Study||0
8162968|NCT02515851|20124096|P1|NOT COMPLETED|Overall Study||0
8162969|NCT02515851|20124095|P2|COMPLETED|Overall Study||15
8162970|NCT02515851|20124096|P1|COMPLETED|Overall Study||15
8162971|NCT02515851|20124095|P2|STARTED|Overall Study||15
8162972|NCT02515851|20124096|P1|STARTED|Overall Study||15
8162973|NCT02515669|20124112|P4|NOT COMPLETED|228 Week Open-Label Phase||26
8162974|NCT02515669|20124113|P3|NOT COMPLETED|228 Week Open-Label Phase||8
8162975|NCT02515669|20124114|P2|NOT COMPLETED|228 Week Open-Label Phase||9
8162976|NCT02515669|20124115|P1|NOT COMPLETED|228 Week Open-Label Phase||0
8162977|NCT02515669|20124112|P4|COMPLETED|228 Week Open-Label Phase||0
8162978|NCT02515669|20124113|P3|COMPLETED|228 Week Open-Label Phase||0
8162979|NCT02515669|20124114|P2|COMPLETED|228 Week Open-Label Phase||0
8162980|NCT02515669|20124115|P1|COMPLETED|228 Week Open-Label Phase||0
8162981|NCT02515669|20124112|P4|STARTED|228 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26
8162982|NCT02515669|20124113|P3|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8
8162983|NCT02515669|20124114|P2|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9
8162984|NCT02515669|20124115|P1|STARTED|228 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
8162985|NCT02515669|20124112|P4|NOT COMPLETED|24 Week Double-Blind Phase||0
8162986|NCT02515669|20124113|P3|NOT COMPLETED|24 Week Double-Blind Phase||0
8162987|NCT02515669|20124114|P2|NOT COMPLETED|24 Week Double-Blind Phase||0
8162988|NCT02515669|20124115|P1|NOT COMPLETED|24 Week Double-Blind Phase||0
8162989|NCT02515669|20124112|P4|COMPLETED|24 Week Double-Blind Phase||19
8162990|NCT02515669|20124113|P3|COMPLETED|24 Week Double-Blind Phase||6
8162991|NCT02515669|20124114|P2|COMPLETED|24 Week Double-Blind Phase||7
8162992|NCT02515669|20124115|P1|COMPLETED|24 Week Double-Blind Phase||11
8162993|NCT02515669|20124112|P4|STARTED|24 Week Double-Blind Phase||19
8162994|NCT02515669|20124113|P3|STARTED|24 Week Double-Blind Phase||6
8162995|NCT02515669|20124114|P2|STARTED|24 Week Double-Blind Phase||7
8162996|NCT02515669|20124115|P1|STARTED|24 Week Double-Blind Phase||11
8162997|NCT02515656|20124193|P2|NOT COMPLETED|Overall Study||71
8162998|NCT02515656|20124194|P1|NOT COMPLETED|Overall Study||56
8162999|NCT02515656|20124193|P2|COMPLETED|Overall Study||261
8163000|NCT02515656|20124194|P1|COMPLETED|Overall Study||270
8163001|NCT02515656|20124193|P2|Safety Population|Overall Study||328
8163002|NCT02515656|20124194|P1|Safety Population|Overall Study||325
8163003|NCT02515656|20124193|P2|Per Protocol Set (PPS)|Overall Study||275
8163004|NCT02515656|20124194|P1|Per Protocol Set (PPS)|Overall Study||277
8163005|NCT02515656|20124193|P2|Full Analysis Set (FAS)|Overall Study||309
8163006|NCT02515656|20124194|P1|Full Analysis Set (FAS)|Overall Study||302
8163007|NCT02515656|20124193|P2|STARTED|Overall Study||332
8163008|NCT02515656|20124194|P1|STARTED|Overall Study||326
8163009|NCT02515630|20124212|P1|NOT COMPLETED|Overall Study||16
8163010|NCT02515630|20124212|P1|COMPLETED|Overall Study||25
8163011|NCT02515630|20124212|P1|STARTED|Overall Study||41
8163012|NCT02515331|20124285|P3|NOT COMPLETED|Overall Study||4
8163013|NCT02515331|20124286|P2|NOT COMPLETED|Overall Study||0
8163014|NCT02515331|20124287|P1|NOT COMPLETED|Overall Study||2
8163015|NCT02515331|20124285|P3|COMPLETED|Overall Study||28
8163016|NCT02515331|20124286|P2|COMPLETED|Overall Study||15
8163017|NCT02515331|20124287|P1|COMPLETED|Overall Study||15
8163018|NCT02515331|20124285|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8163019|NCT02515331|20124286|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||15
8163020|NCT02515331|20124287|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||17
8163021|NCT02515331|20124285|P3|Primary Pharmacodynamic Analysis Set|Overall Study||29
8163022|NCT02515331|20124286|P2|Primary Pharmacodynamic Analysis Set|Overall Study||14
8163023|NCT02515331|20124287|P1|Primary Pharmacodynamic Analysis Set|Overall Study||15
8163024|NCT02515331|20124285|P3|STARTED|Overall Study||32
8163025|NCT02515331|20124286|P2|STARTED|Overall Study||15
8163026|NCT02515331|20124287|P1|STARTED|Overall Study||17
8163027|NCT02515305|20124311|P3|NOT COMPLETED|Overall Study||14
8163028|NCT02515305|20124312|P2|NOT COMPLETED|Overall Study||35
8163029|NCT02515305|20124313|P1|NOT COMPLETED|Overall Study||29
8163030|NCT02515305|20124311|P3|COMPLETED|Overall Study||113
8163031|NCT02515305|20124312|P2|COMPLETED|Overall Study||343
8163032|NCT02515305|20124313|P1|COMPLETED|Overall Study||356
8163033|NCT02515305|20124311|P3|STARTED|Overall Study||127
8163034|NCT02515305|20124312|P2|STARTED|Overall Study||378
8163035|NCT02515305|20124313|P1|STARTED|Overall Study||385
8163036|NCT02515279|20124324|P1|NOT COMPLETED|Overall Study||104
8163037|NCT02515279|20124324|P1|COMPLETED|Overall Study||359
8163038|NCT02515279|20124324|P1|STARTED|Overall Study||463
8163039|NCT02515253|20124332|P2|NOT COMPLETED|Overall Study||8
8163040|NCT02515253|20124333|P1|NOT COMPLETED|Overall Study||7
8163041|NCT02515253|20124332|P2|COMPLETED|Overall Study||8
8163042|NCT02515253|20124333|P1|COMPLETED|Overall Study||10
8163043|NCT02515253|20124332|P2|STARTED|Overall Study||16
8163044|NCT02515253|20124333|P1|STARTED|Overall Study||17
8163045|NCT02515097|20124343|P2|NOT COMPLETED|Overall Study||6
8163046|NCT02515097|20124344|P1|NOT COMPLETED|Overall Study||7
8163047|NCT02515097|20124343|P2|COMPLETED|Overall Study||65
8163048|NCT02515097|20124344|P1|COMPLETED|Overall Study||135
8163049|NCT02515097|20124343|P2|Safety Population|Overall Study||70
8163050|NCT02515097|20124344|P1|Safety Population|Overall Study||142
8163051|NCT02515097|20124343|P2|Intent-to-Treat (ITT) Population|Overall Study||71
8163052|NCT02515097|20124344|P1|Intent-to-Treat (ITT) Population|Overall Study||142
8163053|NCT02515097|20124343|P2|STARTED|Overall Study||71
8163054|NCT02515097|20124344|P1|STARTED|Overall Study||142
8163055|NCT02515058|20124354|P2|NOT COMPLETED|Overall Study||2
8163056|NCT02515058|20124355|P1|NOT COMPLETED|Overall Study||3
8163057|NCT02515058|20124354|P2|COMPLETED|Overall Study||20
8163058|NCT02515058|20124355|P1|COMPLETED|Overall Study||18
8163059|NCT02515058|20124354|P2|STARTED|Overall Study||22
8163060|NCT02515058|20124355|P1|STARTED|Overall Study||21
8163061|NCT02515045|20124365|P3|NOT COMPLETED|Overall Study||4
8163062|NCT02515045|20124366|P2|NOT COMPLETED|Overall Study||4
8163063|NCT02515045|20124367|P1|NOT COMPLETED|Overall Study||0
8163064|NCT02515045|20124365|P3|COMPLETED|Overall Study||55
8163065|NCT02515045|20124366|P2|COMPLETED|Overall Study||26
8163066|NCT02515045|20124367|P1|COMPLETED|Overall Study||29
8163067|NCT02515045|20124365|P3|STARTED|Overall Study||59
8163068|NCT02515045|20124366|P2|STARTED|Overall Study||30
8163069|NCT02515045|20124367|P1|STARTED|Overall Study||29
8163070|NCT02514889|20124383|P2|NOT COMPLETED|Follow-up Assessment Participation||12
8163071|NCT02514889|20124384|P1|NOT COMPLETED|Follow-up Assessment Participation||10
8163072|NCT02514889|20124383|P2|COMPLETED|Follow-up Assessment Participation||86
8163073|NCT02514889|20124384|P1|COMPLETED|Follow-up Assessment Participation||92
8163074|NCT02514889|20124383|P2|STARTED|Follow-up Assessment Participation||98
8163075|NCT02514889|20124384|P1|STARTED|Follow-up Assessment Participation||102
8163076|NCT02514889|20124383|P2|NOT COMPLETED|Intervention Participation||8
8163077|NCT02514889|20124384|P1|NOT COMPLETED|Intervention Participation||9
8163078|NCT02514889|20124383|P2|COMPLETED|Intervention Participation||98
8163079|NCT02514889|20124384|P1|COMPLETED|Intervention Participation||102
8163080|NCT02514889|20124383|P2|STARTED|Intervention Participation||106
8163081|NCT02514889|20124384|P1|STARTED|Intervention Participation||111
8163082|NCT02514889|20124383|P2|NOT COMPLETED|Randomization/Allocation to Condition||24
8163083|NCT02514889|20124384|P1|NOT COMPLETED|Randomization/Allocation to Condition||20
8163084|NCT02514889|20124383|P2|COMPLETED|Randomization/Allocation to Condition||106
8163085|NCT02514889|20124384|P1|COMPLETED|Randomization/Allocation to Condition||111
8163086|NCT02514889|20124383|P2|STARTED|Randomization/Allocation to Condition||130
8163087|NCT02514889|20124384|P1|STARTED|Randomization/Allocation to Condition||131
8163088|NCT02514824|20124404|P4|NOT COMPLETED|Overall Study||0
8163089|NCT02514824|20124405|P3|NOT COMPLETED|Overall Study||0
8163090|NCT02514824|20124406|P2|NOT COMPLETED|Overall Study||1
8163091|NCT02514824|20124407|P1|NOT COMPLETED|Overall Study||1
8163092|NCT02514824|20124404|P4|COMPLETED|Overall Study||0
8163093|NCT02514824|20124405|P3|COMPLETED|Overall Study||0
8163094|NCT02514824|20124406|P2|COMPLETED|Overall Study||4
8163095|NCT02514824|20124407|P1|COMPLETED|Overall Study||3
8163096|NCT02514824|20124404|P4|Evaluable for Dose-limiting Toxicity|Overall Study||0
8163097|NCT02514824|20124405|P3|Evaluable for Dose-limiting Toxicity|Overall Study||0
8163098|NCT02514824|20124406|P2|Evaluable for Dose-limiting Toxicity|Overall Study||5
8163099|NCT02514824|20124407|P1|Evaluable for Dose-limiting Toxicity|Overall Study||3
8163100|NCT02514824|20124404|P4|STARTED|Overall Study||0
8163101|NCT02514824|20124405|P3|STARTED|Overall Study||0
8163102|NCT02514824|20124406|P2|STARTED|Overall Study||5
8163103|NCT02514824|20124407|P1|STARTED|Overall Study||4
8163104|NCT02514772|20124418|P2|NOT COMPLETED|Overall Study||2
8163105|NCT02514772|20124419|P1|NOT COMPLETED|Overall Study||3
8163106|NCT02514772|20124418|P2|COMPLETED|Overall Study||52
8163107|NCT02514772|20124419|P1|COMPLETED|Overall Study||50
8163108|NCT02514772|20124418|P2|STARTED|Overall Study||54
8163109|NCT02514772|20124419|P1|STARTED|Overall Study||53
8163110|NCT02514746|20124433|P2|NOT COMPLETED|Overall Study||15
8163111|NCT02514746|20124434|P1|NOT COMPLETED|Overall Study||22
8163112|NCT02514746|20124433|P2|COMPLETED|Overall Study||109
8163113|NCT02514746|20124434|P1|COMPLETED|Overall Study||415
8163114|NCT02514746|20124433|P2|Received CD-JEV Booster Vaccine|Overall Study||109
8163115|NCT02514746|20124434|P1|Received CD-JEV Booster Vaccine|Overall Study||424
8163116|NCT02514746|20124433|P2|Valid Serology 4 Years Post Primary Dose|Overall Study||109
8163117|NCT02514746|20124434|P1|Valid Serology 4 Years Post Primary Dose|Overall Study||424
8163118|NCT02514746|20124433|P2|Valid Serology 3 Years Post Primary Dose|Overall Study||123
8163119|NCT02514746|20124434|P1|Valid Serology 3 Years Post Primary Dose|Overall Study||437
8163120|NCT02514746|20124433|P2|STARTED|Overall Study||124
8163121|NCT02514746|20124434|P1|STARTED|Overall Study||437
8163122|NCT02514577|20124471|P2|NOT COMPLETED|Overall Study||13
8163123|NCT02514577|20124472|P1|NOT COMPLETED|Overall Study||14
8163124|NCT02514577|20124471|P2|COMPLETED|Overall Study||61
8163125|NCT02514577|20124472|P1|COMPLETED|Overall Study||129
8163126|NCT02514577|20124471|P2|Safety Population|Overall Study||72
8163127|NCT02514577|20124472|P1|Safety Population|Overall Study||142
8163128|NCT02514577|20124471|P2|Intent-to-Treat (ITT) Population|Overall Study||74
8163129|NCT02514577|20124472|P1|Intent-to-Treat (ITT) Population|Overall Study||143
8163130|NCT02514577|20124471|P2|STARTED|Overall Study||74
8163131|NCT02514577|20124472|P1|STARTED|Overall Study||143
8163132|NCT02514551|20124482|P2|NOT COMPLETED|Overall Study||3
8163133|NCT02514551|20124483|P1|NOT COMPLETED|Overall Study||0
8163134|NCT02514551|20124482|P2|COMPLETED|Overall Study||119
8163135|NCT02514551|20124483|P1|COMPLETED|Overall Study||123
8163136|NCT02514551|20124482|P2|Received at Least One Dose of Study Drug|Overall Study||120
8163137|NCT02514551|20124483|P1|Received at Least One Dose of Study Drug|Overall Study||123
8163138|NCT02514551|20124482|P2|STARTED|Overall Study||122
8163139|NCT02514551|20124483|P1|STARTED|Overall Study||123
8163140|NCT02514473|20124500|P2|NOT COMPLETED|Overall Study||5
8163141|NCT02514473|20124501|P1|NOT COMPLETED|Overall Study||3
8163142|NCT02514473|20124500|P2|COMPLETED|Overall Study||98
8163143|NCT02514473|20124501|P1|COMPLETED|Overall Study||98
8163144|NCT02514473|20124500|P2|STARTED|Overall Study||103
8163145|NCT02514473|20124501|P1|STARTED|Overall Study||101
8163146|NCT02514174|20124542|P1|NOT COMPLETED|Overall Study||25
8163147|NCT02514174|20124542|P1|COMPLETED|Overall Study||0
8163148|NCT02514174|20124542|P1|STARTED|Overall Study||25
8163149|NCT02514122|20124553|P2|NOT COMPLETED|Overall Study||0
8163150|NCT02514122|20124554|P1|NOT COMPLETED|Overall Study||2
8163151|NCT02514122|20124553|P2|COMPLETED|Overall Study||29
8163152|NCT02514122|20124554|P1|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
8163153|NCT02514122|20124553|P2|STARTED|Overall Study||29
8163154|NCT02514122|20124554|P1|STARTED|Overall Study||32
8163155|NCT02514083|20124562|P1|NOT COMPLETED|Overall Study||1
8163156|NCT02514083|20124562|P1|COMPLETED|Overall Study||28
8163157|NCT02514083|20124562|P1|STARTED|Overall Study||29
8163176|NCT02514044|20124581|P1|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
8163177|NCT02514044|20124581|P1|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
8163178|NCT02514044|20124581|P1|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
8163179|NCT02514044|20124581|P1|NOT COMPLETED|Washout (1 Week)||0
8163180|NCT02514044|20124581|P1|COMPLETED|Washout (1 Week)||10
8163181|NCT02514044|20124581|P1|STARTED|Washout (1 Week)||10
8163182|NCT02514044|20124581|P1|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
8163183|NCT02514044|20124581|P1|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
8163184|NCT02514044|20124581|P1|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
8163185|NCT02513940|20124595|P6|NOT COMPLETED|Overall Study||0
8163186|NCT02513940|20124596|P5|NOT COMPLETED|Overall Study||0
8163187|NCT02513940|20124597|P4|NOT COMPLETED|Overall Study||0
8163188|NCT02513940|20124598|P3|NOT COMPLETED|Overall Study||0
8163189|NCT02513940|20124599|P2|NOT COMPLETED|Overall Study||0
8163190|NCT02513940|20124600|P1|NOT COMPLETED|Overall Study||0
8163191|NCT02513940|20124595|P6|COMPLETED|Overall Study||3
8163192|NCT02513940|20124596|P5|COMPLETED|Overall Study||2
8163193|NCT02513940|20124597|P4|COMPLETED|Overall Study||2
8163194|NCT02513940|20124598|P3|COMPLETED|Overall Study||2
8163195|NCT02513940|20124599|P2|COMPLETED|Overall Study||3
8163196|NCT02513940|20124600|P1|COMPLETED|Overall Study||2
8163197|NCT02513940|20124595|P6|STARTED|Overall Study||3
8163198|NCT02513940|20124596|P5|STARTED|Overall Study||2
8163199|NCT02513940|20124597|P4|STARTED|Overall Study||2
8163200|NCT02513940|20124598|P3|STARTED|Overall Study||2
8163201|NCT02513940|20124599|P2|STARTED|Overall Study||3
8163202|NCT02513940|20124600|P1|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2
8163203|NCT02513823|20124620|P1|NOT COMPLETED|Overall Study||5
8163204|NCT02513823|20124620|P1|COMPLETED|Overall Study||22
8163205|NCT02513823|20124620|P1|STARTED|Overall Study||27
8163206|NCT02513771|20124627|P2|NOT COMPLETED|Overall Study||1
8163207|NCT02513771|20124628|P1|NOT COMPLETED|Overall Study||2
8163208|NCT02513771|20124627|P2|COMPLETED|Overall Study||44
8163209|NCT02513771|20124628|P1|COMPLETED|Overall Study||43
8163210|NCT02513771|20124627|P2|STARTED|Overall Study||45
8163211|NCT02513771|20124628|P1|STARTED|Overall Study||45
8163212|NCT02513745|20124666|P2|NOT COMPLETED|Overall Study||3
8163213|NCT02513745|20124667|P1|NOT COMPLETED|Overall Study||3
8163214|NCT02513745|20124666|P2|COMPLETED|Overall Study||39
8163215|NCT02513745|20124667|P1|COMPLETED|Overall Study||39
8163216|NCT02513745|20124666|P2|STARTED|Overall Study||42
8163217|NCT02513745|20124667|P1|STARTED|Overall Study||42
8163239|NCT02513641|20124907|P1|NOT COMPLETED|Overall Study||0
8163240|NCT02513641|20124907|P1|COMPLETED|Overall Study||8
8163241|NCT02513641|20124907|P1|STARTED|Overall Study||8
8163242|NCT02513550|20124921|P6|NOT COMPLETED|Post-Treatment Follow-up Period||0
8163243|NCT02513550|20124922|P5|NOT COMPLETED|Post-Treatment Follow-up Period||0
8163244|NCT02513550|20124923|P4|NOT COMPLETED|Post-Treatment Follow-up Period||0
8163245|NCT02513550|20124924|P3|NOT COMPLETED|Post-Treatment Follow-up Period||63
8163246|NCT02513550|20124925|P2|NOT COMPLETED|Post-Treatment Follow-up Period||39
8163247|NCT02513550|20124926|P1|NOT COMPLETED|Post-Treatment Follow-up Period||31
8163248|NCT02513550|20124921|P6|COMPLETED|Post-Treatment Follow-up Period||15
8163249|NCT02513550|20124922|P5|COMPLETED|Post-Treatment Follow-up Period||4
8163250|NCT02513550|20124923|P4|COMPLETED|Post-Treatment Follow-up Period||9
8163251|NCT02513550|20124924|P3|COMPLETED|Post-Treatment Follow-up Period||496
8163252|NCT02513550|20124925|P2|COMPLETED|Post-Treatment Follow-up Period||244
8163253|NCT02513550|20124926|P1|COMPLETED|Post-Treatment Follow-up Period||254
8163254|NCT02513550|20124921|P6|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
8163255|NCT02513550|20124922|P5|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
8163256|NCT02513550|20124923|P4|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
8163257|NCT02513550|20124924|P3|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
8163258|NCT02513550|20124925|P2|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
8163259|NCT02513550|20124926|P1|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
8163260|NCT02513550|20124921|P6|NOT COMPLETED|Double Blind Treatment Period||1
8163261|NCT02513550|20124922|P5|NOT COMPLETED|Double Blind Treatment Period||1
8163262|NCT02513550|20124923|P4|NOT COMPLETED|Double Blind Treatment Period||0
8163263|NCT02513550|20124924|P3|NOT COMPLETED|Double Blind Treatment Period||74
8163264|NCT02513550|20124925|P2|NOT COMPLETED|Double Blind Treatment Period||38
8163265|NCT02513550|20124926|P1|NOT COMPLETED|Double Blind Treatment Period||36
8163266|NCT02513550|20124921|P6|COMPLETED|Double Blind Treatment Period||15
8163267|NCT02513550|20124922|P5|COMPLETED|Double Blind Treatment Period||4
8163268|NCT02513550|20124923|P4|COMPLETED|Double Blind Treatment Period||9
8163269|NCT02513550|20124924|P3|COMPLETED|Double Blind Treatment Period||537
8163270|NCT02513550|20124925|P2|COMPLETED|Double Blind Treatment Period||268
8163271|NCT02513550|20124926|P1|COMPLETED|Double Blind Treatment Period||274
8163272|NCT02513550|20124921|P6|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
8163273|NCT02513550|20124922|P5|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
8163274|NCT02513550|20124923|P4|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
8163275|NCT02513550|20124924|P3|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
8163276|NCT02513550|20124925|P2|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
8163277|NCT02513550|20124926|P1|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
8163278|NCT02513550|20124921|P6|STARTED|Double Blind Treatment Period||16
8163279|NCT02513550|20124922|P5|STARTED|Double Blind Treatment Period||5
8163280|NCT02513550|20124923|P4|STARTED|Double Blind Treatment Period||9
8163281|NCT02513550|20124924|P3|STARTED|Double Blind Treatment Period||611
8163282|NCT02513550|20124925|P2|STARTED|Double Blind Treatment Period||306
8163283|NCT02513550|20124926|P1|STARTED|Double Blind Treatment Period||310
8163284|NCT02513498|20124998|P1|NOT COMPLETED|Overall Study||24
8163285|NCT02513498|20124998|P1|COMPLETED|Overall Study||26
8163286|NCT02513498|20124998|P1|STARTED|Overall Study||50
8163297|NCT02513459|20125056|P1|NOT COMPLETED|Overall Study||21
8163298|NCT02513459|20125056|P1|COMPLETED|Overall Study||44
8163299|NCT02513459|20125056|P1|STARTED|Overall Study||65
8163300|NCT02513446|20125097|P2|NOT COMPLETED|Period 2||0
8163301|NCT02513446|20125098|P1|NOT COMPLETED|Period 2||0
8163302|NCT02513446|20125097|P2|COMPLETED|Period 2||8
8163303|NCT02513446|20125098|P1|COMPLETED|Period 2||8
8163304|NCT02513446|20125097|P2|STARTED|Period 2||8
8163305|NCT02513446|20125098|P1|STARTED|Period 2||8
8163306|NCT02513446|20125097|P2|NOT COMPLETED|Washout Period of 10 Days||0
8163307|NCT02513446|20125098|P1|NOT COMPLETED|Washout Period of 10 Days||0
8163308|NCT02513446|20125097|P2|COMPLETED|Washout Period of 10 Days||8
8163309|NCT02513446|20125098|P1|COMPLETED|Washout Period of 10 Days||8
8163310|NCT02513446|20125097|P2|STARTED|Washout Period of 10 Days||8
8163311|NCT02513446|20125098|P1|STARTED|Washout Period of 10 Days||8
8163312|NCT02513446|20125097|P2|NOT COMPLETED|Period 1||0
8163313|NCT02513446|20125098|P1|NOT COMPLETED|Period 1||0
8163314|NCT02513446|20125097|P2|COMPLETED|Period 1||8
8163315|NCT02513446|20125098|P1|COMPLETED|Period 1||8
8163316|NCT02513446|20125097|P2|STARTED|Period 1||8
8163317|NCT02513446|20125098|P1|STARTED|Period 1||8
8163318|NCT02513212|20125111|P2|NOT COMPLETED|Overall Study||0
8163319|NCT02513212|20125112|P1|NOT COMPLETED|Overall Study||1
8163320|NCT02513212|20125111|P2|COMPLETED|Overall Study||12
8163321|NCT02513212|20125112|P1|COMPLETED|Overall Study||11
8163322|NCT02513212|20125111|P2|STARTED|Overall Study||12
8163323|NCT02513212|20125112|P1|STARTED|Overall Study||12
8163324|NCT02513160|20125124|P4|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
8163325|NCT02513160|20125125|P3|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
8163326|NCT02513160|20125126|P2|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
8163327|NCT02513160|20125127|P1|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
8163328|NCT02513160|20125124|P4|COMPLETED|Treatment Period (Day 0 to Week 6)||103
8163329|NCT02513160|20125125|P3|COMPLETED|Treatment Period (Day 0 to Week 6)||104
8163330|NCT02513160|20125126|P2|COMPLETED|Treatment Period (Day 0 to Week 6)||104
8163331|NCT02513160|20125127|P1|COMPLETED|Treatment Period (Day 0 to Week 6)||101
8163332|NCT02513160|20125124|P4|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
8163333|NCT02513160|20125125|P3|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
8163334|NCT02513160|20125126|P2|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
8163335|NCT02513160|20125127|P1|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
8163336|NCT02513160|20125124|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8163337|NCT02513160|20125125|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8163338|NCT02513160|20125126|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8163339|NCT02513160|20125127|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
8163340|NCT02513160|20125124|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8163341|NCT02513160|20125125|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8163342|NCT02513160|20125126|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8163343|NCT02513160|20125127|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||425
8163344|NCT02513160|20125124|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
8163345|NCT02513160|20125125|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
8163346|NCT02513160|20125126|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
8163347|NCT02513160|20125127|P1|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
8163348|NCT02513121|20125164|P2|NOT COMPLETED|Overall Study||0
8163349|NCT02513121|20125165|P1|NOT COMPLETED|Overall Study||0
8163350|NCT02513121|20125164|P2|COMPLETED|Overall Study||20
8163351|NCT02513121|20125165|P1|COMPLETED|Overall Study||20
8163352|NCT02513121|20125164|P2|STARTED|Overall Study||20
8163353|NCT02513121|20125165|P1|STARTED|Overall Study||20
8163360|NCT02512900|20125194|P2|NOT COMPLETED|Overall Study||0
8163361|NCT02512900|20125195|P1|NOT COMPLETED|Overall Study||0
8163362|NCT02512900|20125194|P2|COMPLETED|Overall Study||10
8163363|NCT02512900|20125195|P1|COMPLETED|Overall Study||11
8163364|NCT02512900|20125194|P2|STARTED|Overall Study||10
8163365|NCT02512900|20125195|P1|STARTED|Overall Study||11
8163366|NCT02512874|20125226|P1|NOT COMPLETED|Overall Study||2
8163367|NCT02512874|20125226|P1|COMPLETED|Overall Study||63
8163368|NCT02512874|20125226|P1|STARTED|Overall Study||65
8163369|NCT02512861|20125237|P2|NOT COMPLETED|Overall Study||9
8163370|NCT02512861|20125238|P1|NOT COMPLETED|Overall Study||6
8163371|NCT02512861|20125237|P2|COMPLETED|Overall Study||40
8163372|NCT02512861|20125238|P1|COMPLETED|Overall Study||38
8163373|NCT02512861|20125237|P2|STARTED|Overall Study||49
8163374|NCT02512861|20125238|P1|STARTED|Overall Study||44
8163375|NCT02512809|20125259|P1|NOT COMPLETED|Overall Study||0
8163376|NCT02512809|20125259|P1|COMPLETED|Overall Study||25
8163377|NCT02512809|20125259|P1|STARTED|Overall Study||25
8163378|NCT02512783|20125265|P2|NOT COMPLETED|Overall Study||0
8163379|NCT02512783|20125266|P1|NOT COMPLETED|Overall Study||0
8163380|NCT02512783|20125265|P2|COMPLETED|Overall Study||75
8163381|NCT02512783|20125266|P1|COMPLETED|Overall Study||96
8163382|NCT02512783|20125265|P2|STARTED|Overall Study||75
8163383|NCT02512783|20125266|P1|STARTED|Overall Study||96
8163384|NCT02512679|20125274|P2|NOT COMPLETED|Overall Study||0
8163385|NCT02512679|20125275|P1|NOT COMPLETED|Overall Study||0
8163386|NCT02512679|20125274|P2|COMPLETED|Overall Study||0
8163387|NCT02512679|20125275|P1|COMPLETED|Overall Study||20
8163388|NCT02512679|20125274|P2|STARTED|Overall Study||0
8163389|NCT02512679|20125275|P1|STARTED|Overall Study||20
8163390|NCT02512575|20125293|P10|NOT COMPLETED|Overall Study||0
8163391|NCT02512575|20125294|P9|NOT COMPLETED|Overall Study||0
8163392|NCT02512575|20125295|P8|NOT COMPLETED|Overall Study||0
8163393|NCT02512575|20125296|P7|NOT COMPLETED|Overall Study||0
8163394|NCT02512575|20125297|P6|NOT COMPLETED|Overall Study||0
8163395|NCT02512575|20125298|P5|NOT COMPLETED|Overall Study||0
8163396|NCT02512575|20125299|P4|NOT COMPLETED|Overall Study||0
8163397|NCT02512575|20125300|P3|NOT COMPLETED|Overall Study||0
8163398|NCT02512575|20125301|P2|NOT COMPLETED|Overall Study||0
8163399|NCT02512575|20125302|P1|NOT COMPLETED|Overall Study||0
8163400|NCT02512575|20125293|P10|COMPLETED|Overall Study||18
8163401|NCT02512575|20125294|P9|COMPLETED|Overall Study||6
8163402|NCT02512575|20125295|P8|COMPLETED|Overall Study||6
8163403|NCT02512575|20125296|P7|COMPLETED|Overall Study||6
8163404|NCT02512575|20125297|P6|COMPLETED|Overall Study||6
8163405|NCT02512575|20125298|P5|COMPLETED|Overall Study||6
8163406|NCT02512575|20125299|P4|COMPLETED|Overall Study||6
8163407|NCT02512575|20125300|P3|COMPLETED|Overall Study||6
8163408|NCT02512575|20125301|P2|COMPLETED|Overall Study||6
8163409|NCT02512575|20125302|P1|COMPLETED|Overall Study||6
8163410|NCT02512575|20125293|P10|STARTED|Overall Study||18
8163411|NCT02512575|20125294|P9|STARTED|Overall Study||6
8163412|NCT02512575|20125295|P8|STARTED|Overall Study||6
8163413|NCT02512575|20125296|P7|STARTED|Overall Study||6
8163414|NCT02512575|20125297|P6|STARTED|Overall Study||6
8163415|NCT02512575|20125298|P5|STARTED|Overall Study||6
8163416|NCT02512575|20125299|P4|STARTED|Overall Study||6
8163417|NCT02512575|20125300|P3|STARTED|Overall Study||6
8163418|NCT02512575|20125301|P2|STARTED|Overall Study||6
8163419|NCT02512575|20125302|P1|STARTED|Overall Study||6
8163429|NCT02512419|20125424|P2|NOT COMPLETED|Overall Study||0
8163430|NCT02512419|20125425|P1|NOT COMPLETED|Overall Study||2
8163431|NCT02512419|20125424|P2|COMPLETED|Overall Study||24
8163432|NCT02512419|20125425|P1|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22
8163433|NCT02512419|20125424|P2|STARTED|Overall Study||24
8163434|NCT02512419|20125425|P1|STARTED|Overall Study||24
8163435|NCT02512393|20125435|P2|NOT COMPLETED|Overall Study||0
8163436|NCT02512393|20125436|P1|NOT COMPLETED|Overall Study||1
8163437|NCT02512393|20125435|P2|COMPLETED|Overall Study||20
8163438|NCT02512393|20125436|P1|COMPLETED|Overall Study||20
8163439|NCT02512393|20125435|P2|STARTED|Overall Study||20
8163440|NCT02512393|20125436|P1|STARTED|Overall Study||21
8163441|NCT02512302|20125516|P10|NOT COMPLETED|Period 5||0
8163442|NCT02512302|20125517|P9|NOT COMPLETED|Period 5||0
8163443|NCT02512302|20125518|P8|NOT COMPLETED|Period 5||0
8163444|NCT02512302|20125519|P7|NOT COMPLETED|Period 5||0
8163445|NCT02512302|20125520|P6|NOT COMPLETED|Period 5||0
8163446|NCT02512302|20125521|P5|NOT COMPLETED|Period 5||0
8163447|NCT02512302|20125522|P4|NOT COMPLETED|Period 5||0
8163448|NCT02512302|20125523|P3|NOT COMPLETED|Period 5||0
8163449|NCT02512302|20125524|P2|NOT COMPLETED|Period 5||0
8163450|NCT02512302|20125525|P1|NOT COMPLETED|Period 5||0
8163451|NCT02512302|20125516|P10|COMPLETED|Period 5||2
8163452|NCT02512302|20125517|P9|COMPLETED|Period 5||3
8163453|NCT02512302|20125518|P8|COMPLETED|Period 5||3
8163454|NCT02512302|20125519|P7|COMPLETED|Period 5||1
8163455|NCT02512302|20125520|P6|COMPLETED|Period 5||3
8163456|NCT02512302|20125521|P5|COMPLETED|Period 5||3
8163457|NCT02512302|20125522|P4|COMPLETED|Period 5||3
8163458|NCT02512302|20125523|P3|COMPLETED|Period 5||3
8163459|NCT02512302|20125524|P2|COMPLETED|Period 5||2
8163460|NCT02512302|20125525|P1|COMPLETED|Period 5||3
8163461|NCT02512302|20125516|P10|STARTED|Period 5||2
8163462|NCT02512302|20125517|P9|STARTED|Period 5||3
8163463|NCT02512302|20125518|P8|STARTED|Period 5||3
8163464|NCT02512302|20125519|P7|STARTED|Period 5||1
8163465|NCT02512302|20125520|P6|STARTED|Period 5||3
8163466|NCT02512302|20125521|P5|STARTED|Period 5||3
8163467|NCT02512302|20125522|P4|STARTED|Period 5||3
8163468|NCT02512302|20125523|P3|STARTED|Period 5||3
8163469|NCT02512302|20125524|P2|STARTED|Period 5||2
8163470|NCT02512302|20125525|P1|STARTED|Period 5||3
8163471|NCT02512302|20125516|P10|NOT COMPLETED|Period 4||0
8163472|NCT02512302|20125517|P9|NOT COMPLETED|Period 4||0
8163473|NCT02512302|20125518|P8|NOT COMPLETED|Period 4||0
8163474|NCT02512302|20125519|P7|NOT COMPLETED|Period 4||1
8163475|NCT02512302|20125520|P6|NOT COMPLETED|Period 4||0
8163476|NCT02512302|20125521|P5|NOT COMPLETED|Period 4||0
8163477|NCT02512302|20125522|P4|NOT COMPLETED|Period 4||0
8163478|NCT02512302|20125523|P3|NOT COMPLETED|Period 4||0
8163479|NCT02512302|20125524|P2|NOT COMPLETED|Period 4||0
8163480|NCT02512302|20125525|P1|NOT COMPLETED|Period 4||0
8163481|NCT02512302|20125516|P10|COMPLETED|Period 4||2
8163482|NCT02512302|20125517|P9|COMPLETED|Period 4||3
8163483|NCT02512302|20125518|P8|COMPLETED|Period 4||3
8163484|NCT02512302|20125519|P7|COMPLETED|Period 4||1
8163485|NCT02512302|20125520|P6|COMPLETED|Period 4||3
8163486|NCT02512302|20125521|P5|COMPLETED|Period 4||3
8163487|NCT02512302|20125522|P4|COMPLETED|Period 4||3
8163488|NCT02512302|20125523|P3|COMPLETED|Period 4||3
8163489|NCT02512302|20125524|P2|COMPLETED|Period 4||2
8163490|NCT02512302|20125525|P1|COMPLETED|Period 4||3
8163491|NCT02512302|20125516|P10|STARTED|Period 4||2
8163492|NCT02512302|20125517|P9|STARTED|Period 4||3
8163493|NCT02512302|20125518|P8|STARTED|Period 4||3
8163494|NCT02512302|20125519|P7|STARTED|Period 4||2
8163495|NCT02512302|20125520|P6|STARTED|Period 4||3
8163496|NCT02512302|20125521|P5|STARTED|Period 4||3
8163497|NCT02512302|20125522|P4|STARTED|Period 4||3
8163498|NCT02512302|20125523|P3|STARTED|Period 4||3
8163499|NCT02512302|20125524|P2|STARTED|Period 4||2
8163500|NCT02512302|20125525|P1|STARTED|Period 4||3
8163501|NCT02512302|20125516|P10|NOT COMPLETED|Period 3||0
8163502|NCT02512302|20125517|P9|NOT COMPLETED|Period 3||0
8163503|NCT02512302|20125518|P8|NOT COMPLETED|Period 3||0
8163504|NCT02512302|20125519|P7|NOT COMPLETED|Period 3||0
8163505|NCT02512302|20125520|P6|NOT COMPLETED|Period 3||0
8163506|NCT02512302|20125521|P5|NOT COMPLETED|Period 3||0
8163507|NCT02512302|20125522|P4|NOT COMPLETED|Period 3||0
8163508|NCT02512302|20125523|P3|NOT COMPLETED|Period 3||1
8163509|NCT02512302|20125524|P2|NOT COMPLETED|Period 3||0
8163510|NCT02512302|20125525|P1|NOT COMPLETED|Period 3||0
8163511|NCT02512302|20125516|P10|COMPLETED|Period 3||2
8163512|NCT02512302|20125517|P9|COMPLETED|Period 3||3
8163513|NCT02512302|20125518|P8|COMPLETED|Period 3||3
8163514|NCT02512302|20125519|P7|COMPLETED|Period 3||2
8163515|NCT02512302|20125520|P6|COMPLETED|Period 3||3
8163516|NCT02512302|20125521|P5|COMPLETED|Period 3||3
8163517|NCT02512302|20125522|P4|COMPLETED|Period 3||3
8163518|NCT02512302|20125523|P3|COMPLETED|Period 3||3
8163519|NCT02512302|20125524|P2|COMPLETED|Period 3||2
8163520|NCT02512302|20125525|P1|COMPLETED|Period 3||3
8163521|NCT02512302|20125516|P10|STARTED|Period 3||2
8163522|NCT02512302|20125517|P9|STARTED|Period 3||3
8163523|NCT02512302|20125518|P8|STARTED|Period 3||3
8163524|NCT02512302|20125519|P7|STARTED|Period 3||2
8163525|NCT02512302|20125520|P6|STARTED|Period 3||3
8163526|NCT02512302|20125521|P5|STARTED|Period 3||3
8163527|NCT02512302|20125522|P4|STARTED|Period 3||3
8163528|NCT02512302|20125523|P3|STARTED|Period 3||4
8163529|NCT02512302|20125524|P2|STARTED|Period 3||2
8163530|NCT02512302|20125525|P1|STARTED|Period 3||3
8163531|NCT02512302|20125516|P10|NOT COMPLETED|Period 2||1
8163532|NCT02512302|20125517|P9|NOT COMPLETED|Period 2||0
8163533|NCT02512302|20125518|P8|NOT COMPLETED|Period 2||0
8163534|NCT02512302|20125519|P7|NOT COMPLETED|Period 2||0
8163535|NCT02512302|20125520|P6|NOT COMPLETED|Period 2||0
8163536|NCT02512302|20125521|P5|NOT COMPLETED|Period 2||0
8163537|NCT02512302|20125522|P4|NOT COMPLETED|Period 2||0
8163538|NCT02512302|20125523|P3|NOT COMPLETED|Period 2||0
8163539|NCT02512302|20125524|P2|NOT COMPLETED|Period 2||0
8163540|NCT02512302|20125525|P1|NOT COMPLETED|Period 2||0
8163541|NCT02512302|20125516|P10|COMPLETED|Period 2||2
8163542|NCT02512302|20125517|P9|COMPLETED|Period 2||3
8163543|NCT02512302|20125518|P8|COMPLETED|Period 2||3
8163544|NCT02512302|20125519|P7|COMPLETED|Period 2||2
8163545|NCT02512302|20125520|P6|COMPLETED|Period 2||3
8163546|NCT02512302|20125521|P5|COMPLETED|Period 2||3
8163547|NCT02512302|20125522|P4|COMPLETED|Period 2||3
8163548|NCT02512302|20125523|P3|COMPLETED|Period 2||4
8163549|NCT02512302|20125524|P2|COMPLETED|Period 2||2
8163550|NCT02512302|20125525|P1|COMPLETED|Period 2||3
8163551|NCT02512302|20125516|P10|STARTED|Period 2||3
8163552|NCT02512302|20125517|P9|STARTED|Period 2||3
8163553|NCT02512302|20125518|P8|STARTED|Period 2||3
8163554|NCT02512302|20125519|P7|STARTED|Period 2||2
8163555|NCT02512302|20125520|P6|STARTED|Period 2||3
8163556|NCT02512302|20125521|P5|STARTED|Period 2||3
8163557|NCT02512302|20125522|P4|STARTED|Period 2||3
8163558|NCT02512302|20125523|P3|STARTED|Period 2||4
8163559|NCT02512302|20125524|P2|STARTED|Period 2||2
8163560|NCT02512302|20125525|P1|STARTED|Period 2||3
8163561|NCT02512302|20125516|P10|NOT COMPLETED|Period 1||0
8163562|NCT02512302|20125517|P9|NOT COMPLETED|Period 1||0
8163563|NCT02512302|20125518|P8|NOT COMPLETED|Period 1||0
8163564|NCT02512302|20125519|P7|NOT COMPLETED|Period 1||0
8163565|NCT02512302|20125520|P6|NOT COMPLETED|Period 1||0
8163566|NCT02512302|20125521|P5|NOT COMPLETED|Period 1||0
8163567|NCT02512302|20125522|P4|NOT COMPLETED|Period 1||0
8163568|NCT02512302|20125523|P3|NOT COMPLETED|Period 1||0
8163569|NCT02512302|20125524|P2|NOT COMPLETED|Period 1||1
8163570|NCT02512302|20125525|P1|NOT COMPLETED|Period 1||0
8163571|NCT02512302|20125516|P10|COMPLETED|Period 1||3
8163572|NCT02512302|20125517|P9|COMPLETED|Period 1||3
8163573|NCT02512302|20125518|P8|COMPLETED|Period 1||3
8163574|NCT02512302|20125519|P7|COMPLETED|Period 1||2
8163575|NCT02512302|20125520|P6|COMPLETED|Period 1||3
8163576|NCT02512302|20125521|P5|COMPLETED|Period 1||3
8163577|NCT02512302|20125522|P4|COMPLETED|Period 1||3
8163578|NCT02512302|20125523|P3|COMPLETED|Period 1||4
8163579|NCT02512302|20125524|P2|COMPLETED|Period 1||2
8163580|NCT02512302|20125525|P1|COMPLETED|Period 1||3
8163581|NCT02512302|20125516|P10|STARTED|Period 1||3
8163582|NCT02512302|20125517|P9|STARTED|Period 1||3
8163583|NCT02512302|20125518|P8|STARTED|Period 1||3
8163584|NCT02512302|20125519|P7|STARTED|Period 1||2
8163585|NCT02512302|20125520|P6|STARTED|Period 1||3
8163586|NCT02512302|20125521|P5|STARTED|Period 1||3
8163587|NCT02512302|20125522|P4|STARTED|Period 1||3
8163588|NCT02512302|20125523|P3|STARTED|Period 1||4
8163589|NCT02512302|20125524|P2|STARTED|Period 1||3
8163590|NCT02512302|20125525|P1|STARTED|Period 1||3
8163591|NCT02512276|20125599|P2|NOT COMPLETED|Overall Study||11
8163592|NCT02512276|20125600|P1|NOT COMPLETED|Overall Study||8
8163593|NCT02512276|20125599|P2|COMPLETED|Overall Study||2029
8163594|NCT02512276|20125600|P1|COMPLETED|Overall Study||2030
8163595|NCT02512276|20125599|P2|STARTED|Overall Study||2040
8163596|NCT02512276|20125600|P1|STARTED|Overall Study||2038
8163597|NCT02512224|20125618|P2|NOT COMPLETED|Overall Study||0
8163598|NCT02512224|20125619|P1|NOT COMPLETED|Overall Study||0
8163599|NCT02512224|20125618|P2|COMPLETED|Overall Study||2912
8163600|NCT02512224|20125619|P1|COMPLETED|Overall Study||2912
8163601|NCT02512224|20125618|P2|STARTED|Overall Study||2912
8163602|NCT02512224|20125619|P1|STARTED|Overall Study||2912
8163603|NCT02512094|20125635|P1|NOT COMPLETED|Overall Study||0
8163604|NCT02512094|20125635|P1|COMPLETED|Overall Study||53
8163605|NCT02512094|20125635|P1|STARTED|Overall Study||53
8163606|NCT02512068|20125641|P2|NOT COMPLETED|Overall Study||13
8163607|NCT02512068|20125642|P1|NOT COMPLETED|Overall Study||12
8163608|NCT02512068|20125641|P2|COMPLETED|Overall Study||39
8163609|NCT02512068|20125642|P1|COMPLETED|Overall Study||43
8163610|NCT02512068|20125641|P2|STARTED|Overall Study||52
8163611|NCT02512068|20125642|P1|STARTED|Overall Study||55
8163612|NCT02512042|20125668|P2|NOT COMPLETED|Overall Study||25
8163613|NCT02512042|20125669|P1|NOT COMPLETED|Overall Study||23
8163614|NCT02512042|20125668|P2|COMPLETED|Overall Study||453
8163615|NCT02512042|20125669|P1|COMPLETED|Overall Study||472
8163616|NCT02512042|20125668|P2|STARTED|Overall Study||478
8163617|NCT02512042|20125669|P1|STARTED|Overall Study||495
8163618|NCT02511782|20125678|P3|NOT COMPLETED|Overall Study||0
8163619|NCT02511782|20125679|P2|NOT COMPLETED|Overall Study||0
8163620|NCT02511782|20125680|P1|NOT COMPLETED|Overall Study||1
8163621|NCT02511782|20125678|P3|COMPLETED|Overall Study||10
8163622|NCT02511782|20125679|P2|COMPLETED|Overall Study||2
8163623|NCT02511782|20125680|P1|COMPLETED|Overall Study||50
8163624|NCT02511782|20125678|P3|STARTED|Overall Study||10
8163625|NCT02511782|20125679|P2|STARTED|Overall Study||2
8163626|NCT02511782|20125680|P1|STARTED|Overall Study||51
8163627|NCT02511730|20125690|P2|NOT COMPLETED|Session Reading Session||0
8163628|NCT02511730|20125691|P1|NOT COMPLETED|Session Reading Session||0
8163629|NCT02511730|20125690|P2|COMPLETED|Session Reading Session||50
8163630|NCT02511730|20125691|P1|COMPLETED|Session Reading Session||50
8163631|NCT02511730|20125690|P2|STARTED|Session Reading Session||50
8163632|NCT02511730|20125691|P1|STARTED|Session Reading Session||50
8163633|NCT02511730|20125690|P2|NOT COMPLETED|4 Week Memory Washout Period||0
8163634|NCT02511730|20125691|P1|NOT COMPLETED|4 Week Memory Washout Period||0
8163635|NCT02511730|20125690|P2|COMPLETED|4 Week Memory Washout Period||50
8163636|NCT02511730|20125691|P1|COMPLETED|4 Week Memory Washout Period||50
8163637|NCT02511730|20125690|P2|STARTED|4 Week Memory Washout Period||50
8163638|NCT02511730|20125691|P1|STARTED|4 Week Memory Washout Period||50
8163639|NCT02511730|20125690|P2|NOT COMPLETED|First Reading Session||0
8163640|NCT02511730|20125691|P1|NOT COMPLETED|First Reading Session||0
8163641|NCT02511730|20125690|P2|COMPLETED|First Reading Session||50
8163642|NCT02511730|20125691|P1|COMPLETED|First Reading Session||50
8163643|NCT02511730|20125690|P2|STARTED|First Reading Session||50
8163644|NCT02511730|20125691|P1|STARTED|First Reading Session||50
8163645|NCT02511717|20125699|P2|NOT COMPLETED|Overall Study||0
8163646|NCT02511717|20125700|P1|NOT COMPLETED|Overall Study||2
8163647|NCT02511717|20125699|P2|COMPLETED|Overall Study||10
8163648|NCT02511717|20125700|P1|COMPLETED|Overall Study||8
8163649|NCT02511717|20125699|P2|STARTED|Overall Study||10
8163650|NCT02511717|20125700|P1|STARTED|Overall Study||10
8163657|NCT02511587|20125721|P2|NOT COMPLETED|Overall Study||0
8163658|NCT02511587|20125722|P1|NOT COMPLETED|Overall Study||0
8163659|NCT02511587|20125721|P2|COMPLETED|Overall Study||58
8163660|NCT02511587|20125722|P1|COMPLETED|Overall Study||58
8163661|NCT02511587|20125721|P2|STARTED|Overall Study||58
8163662|NCT02511587|20125722|P1|STARTED|Overall Study||58
8163663|NCT02511561|20125735|P3|NOT COMPLETED|Overall Study||0
8163664|NCT02511561|20125736|P2|NOT COMPLETED|Overall Study||0
8163665|NCT02511561|20125737|P1|NOT COMPLETED|Overall Study||0
8163666|NCT02511561|20125735|P3|COMPLETED|Overall Study||25
8163667|NCT02511561|20125736|P2|COMPLETED|Overall Study||25
8163668|NCT02511561|20125737|P1|COMPLETED|Overall Study||25
8163669|NCT02511561|20125735|P3|STARTED|Overall Study||25
8163670|NCT02511561|20125736|P2|STARTED|Overall Study||25
8163671|NCT02511561|20125737|P1|STARTED|Overall Study||25
8163672|NCT02511535|20125763|P3|NOT COMPLETED|Overall Study||0
8163673|NCT02511535|20125764|P2|NOT COMPLETED|Overall Study||0
8163674|NCT02511535|20125765|P1|NOT COMPLETED|Overall Study||0
8163675|NCT02511535|20125763|P3|COMPLETED|Overall Study||49
8163676|NCT02511535|20125764|P2|COMPLETED|Overall Study||21
8163677|NCT02511535|20125765|P1|COMPLETED|Overall Study||49
8163678|NCT02511535|20125763|P3|STARTED|Overall Study||49
8163679|NCT02511535|20125764|P2|STARTED|Overall Study||21
8163680|NCT02511535|20125765|P1|STARTED|Overall Study||49
8163681|NCT02511431|20125788|P6|NOT COMPLETED|Post-treatment Follow-up||0
8163682|NCT02511431|20125789|P5|NOT COMPLETED|Post-treatment Follow-up||0
8163683|NCT02511431|20125790|P4|NOT COMPLETED|Post-treatment Follow-up||0
8163684|NCT02511431|20125791|P3|NOT COMPLETED|Post-treatment Follow-up||0
8163685|NCT02511431|20125792|P2|NOT COMPLETED|Post-treatment Follow-up||0
8163686|NCT02511431|20125793|P1|NOT COMPLETED|Post-treatment Follow-up||0
8163687|NCT02511431|20125788|P6|COMPLETED|Post-treatment Follow-up||2
8163688|NCT02511431|20125789|P5|COMPLETED|Post-treatment Follow-up||3
8163689|NCT02511431|20125790|P4|COMPLETED|Post-treatment Follow-up||3
8163690|NCT02511431|20125791|P3|COMPLETED|Post-treatment Follow-up||3
8163691|NCT02511431|20125792|P2|COMPLETED|Post-treatment Follow-up||4
8163692|NCT02511431|20125793|P1|COMPLETED|Post-treatment Follow-up||4
8163693|NCT02511431|20125788|P6|STARTED|Post-treatment Follow-up||2
8163694|NCT02511431|20125789|P5|STARTED|Post-treatment Follow-up||3
8163695|NCT02511431|20125790|P4|STARTED|Post-treatment Follow-up||3
8163696|NCT02511431|20125791|P3|STARTED|Post-treatment Follow-up||3
8163697|NCT02511431|20125792|P2|STARTED|Post-treatment Follow-up||4
8163698|NCT02511431|20125793|P1|STARTED|Post-treatment Follow-up||4
8163699|NCT02511431|20125788|P6|NOT COMPLETED|Treatment||1
8163700|NCT02511431|20125789|P5|NOT COMPLETED|Treatment||0
8163701|NCT02511431|20125790|P4|NOT COMPLETED|Treatment||0
8163702|NCT02511431|20125791|P3|NOT COMPLETED|Treatment||1
8163703|NCT02511431|20125792|P2|NOT COMPLETED|Treatment||0
8163704|NCT02511431|20125793|P1|NOT COMPLETED|Treatment||0
8163705|NCT02511431|20125788|P6|COMPLETED|Treatment||2
8163706|NCT02511431|20125789|P5|COMPLETED|Treatment||3
8163707|NCT02511431|20125790|P4|COMPLETED|Treatment||3
8163708|NCT02511431|20125791|P3|COMPLETED|Treatment||3
8163709|NCT02511431|20125792|P2|COMPLETED|Treatment||4
8163710|NCT02511431|20125793|P1|COMPLETED|Treatment||4
8163711|NCT02511431|20125788|P6|STARTED|Treatment||3
8163712|NCT02511431|20125789|P5|STARTED|Treatment||3
8163713|NCT02511431|20125790|P4|STARTED|Treatment||3
8163714|NCT02511431|20125791|P3|STARTED|Treatment||4
8163715|NCT02511431|20125792|P2|STARTED|Treatment||4
8163716|NCT02511431|20125793|P1|STARTED|Treatment||4
8163717|NCT02511379|20125814|P1|NOT COMPLETED|Overall Study||0
8163718|NCT02511379|20125814|P1|COMPLETED|Overall Study||14
8163719|NCT02511379|20125814|P1|STARTED|Overall Study||14
8163720|NCT02511184|20125820|P2|NOT COMPLETED|Overall Study||7
8163721|NCT02511184|20125821|P1|NOT COMPLETED|Overall Study||2
8163722|NCT02511184|20125820|P2|COMPLETED|Overall Study||0
8163723|NCT02511184|20125821|P1|COMPLETED|Overall Study||0
8163724|NCT02511184|20125820|P2|STARTED|Overall Study||7
8163725|NCT02511184|20125821|P1|STARTED|Overall Study||2
8163726|NCT02510820|20125871|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
8163727|NCT02510820|20125872|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
8163728|NCT02510820|20125871|P2|COMPLETED|Second Intervention (4 Weeks)||26
8163729|NCT02510820|20125872|P1|COMPLETED|Second Intervention (4 Weeks)||20
8163730|NCT02510820|20125871|P2|STARTED|Second Intervention (4 Weeks)||26
8163731|NCT02510820|20125872|P1|STARTED|Second Intervention (4 Weeks)||21
8163732|NCT02510820|20125871|P2|NOT COMPLETED|Washout (1 Week)||0
8163733|NCT02510820|20125872|P1|NOT COMPLETED|Washout (1 Week)||0
8163734|NCT02510820|20125871|P2|COMPLETED|Washout (1 Week)||26
8163735|NCT02510820|20125872|P1|COMPLETED|Washout (1 Week)||21
8163736|NCT02510820|20125871|P2|STARTED|Washout (1 Week)||26
8163737|NCT02510820|20125872|P1|STARTED|Washout (1 Week)||21
8163738|NCT02510820|20125871|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
8163739|NCT02510820|20125872|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8163740|NCT02510820|20125871|P2|COMPLETED|First Intervention (4 Weeks)||26
8163741|NCT02510820|20125872|P1|COMPLETED|First Intervention (4 Weeks)||21
8163742|NCT02510820|20125871|P2|STARTED|First Intervention (4 Weeks)||27
8163743|NCT02510820|20125872|P1|STARTED|First Intervention (4 Weeks)||21
8163744|NCT02510664|20125913|P3|NOT COMPLETED|Overall Study||0
8163745|NCT02510664|20125914|P2|NOT COMPLETED|Overall Study||20
8163746|NCT02510664|20125915|P1|NOT COMPLETED|Overall Study||20
8163747|NCT02510664|20125913|P3|COMPLETED|Overall Study||4
8163748|NCT02510664|20125914|P2|COMPLETED|Overall Study||64
8163749|NCT02510664|20125915|P1|COMPLETED|Overall Study||64
8163750|NCT02510664|20125913|P3|STARTED|Overall Study||4
8163751|NCT02510664|20125914|P2|STARTED|Overall Study||84
8163752|NCT02510664|20125915|P1|STARTED|Overall Study||84
8163753|NCT02510144|20125946|P2|NOT COMPLETED|Overall Study||0
8163754|NCT02510144|20125947|P1|NOT COMPLETED|Overall Study||0
8163755|NCT02510144|20125946|P2|COMPLETED|Overall Study||41
8163756|NCT02510144|20125947|P1|COMPLETED|Overall Study||39
8163757|NCT02510144|20125946|P2|STARTED|Overall Study||41
8163758|NCT02510144|20125947|P1|STARTED|Overall Study||39
8163759|NCT02510014|20125957|P2|NOT COMPLETED|Treatment Period||57
8163760|NCT02510014|20125958|P1|NOT COMPLETED|Treatment Period||206
8163761|NCT02510014|20125957|P2|COMPLETED|Treatment Period||200
8163762|NCT02510014|20125958|P1|COMPLETED|Treatment Period||206
8163763|NCT02510014|20125957|P2|STARTED|Treatment Period||257
8163764|NCT02510014|20125958|P1|STARTED|Treatment Period||412
8163765|NCT02510014|20125957|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
8163766|NCT02510014|20125958|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
8163767|NCT02510014|20125957|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||257
8163768|NCT02510014|20125958|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||412
8163769|NCT02510014|20125957|P2|STARTED|Run-In Period (Days -14 to Day -1)||267
8163770|NCT02510014|20125958|P1|STARTED|Run-In Period (Days -14 to Day -1)||508
8163771|NCT02509936|20125980|P2|NOT COMPLETED|Overall Study||16
8163772|NCT02509936|20125981|P1|NOT COMPLETED|Overall Study||12
8163773|NCT02509936|20125980|P2|COMPLETED|Overall Study||145
8163774|NCT02509936|20125981|P1|COMPLETED|Overall Study||151
8163775|NCT02509936|20125980|P2|STARTED|Overall Study||161
8163776|NCT02509936|20125981|P1|STARTED|Overall Study||163
8163777|NCT02509767|20126007|P2|NOT COMPLETED|Overall Study||41
8163778|NCT02509767|20126008|P1|NOT COMPLETED|Overall Study||44
8163779|NCT02509767|20126007|P2|COMPLETED|Overall Study||159
8163780|NCT02509767|20126008|P1|COMPLETED|Overall Study||157
8163781|NCT02509767|20126007|P2|STARTED|Overall Study||200
8163782|NCT02509767|20126008|P1|STARTED|Overall Study||201
8163783|NCT02509624|20126023|P4|NOT COMPLETED|Overall Study||0
8163784|NCT02509624|20126024|P3|NOT COMPLETED|Overall Study||0
8163785|NCT02509624|20126025|P2|NOT COMPLETED|Overall Study||0
8163786|NCT02509624|20126026|P1|NOT COMPLETED|Overall Study||0
8163787|NCT02509624|20126023|P4|COMPLETED|Overall Study||22
8163788|NCT02509624|20126024|P3|COMPLETED|Overall Study||10
8163789|NCT02509624|20126025|P2|COMPLETED|Overall Study||10
8163790|NCT02509624|20126026|P1|COMPLETED|Overall Study||10
8163791|NCT02509624|20126023|P4|STARTED|Overall Study||22
8163792|NCT02509624|20126024|P3|STARTED|Overall Study||10
8163793|NCT02509624|20126025|P2|STARTED|Overall Study||10
8163794|NCT02509624|20126026|P1|STARTED|Overall Study||10
8163795|NCT02509585|20126058|P1|NOT COMPLETED|Overall Study||0
8163796|NCT02509585|20126058|P1|COMPLETED|Overall Study||18
8163797|NCT02509585|20126058|P1|STARTED|Overall Study||18
8163798|NCT02509481|20126073|P2|NOT COMPLETED|Overall Study||0
8163799|NCT02509481|20126074|P1|NOT COMPLETED|Overall Study||0
8163800|NCT02509481|20126073|P2|COMPLETED|Overall Study||1447
8163801|NCT02509481|20126074|P1|COMPLETED|Overall Study||1265
8163802|NCT02509481|20126073|P2|STARTED|Overall Study||1447
8163803|NCT02509481|20126074|P1|STARTED|Overall Study||1265
8163804|NCT02509156|20126092|P2|NOT COMPLETED|Randomized Phase||1
8163805|NCT02509156|20126093|P1|NOT COMPLETED|Randomized Phase||2
8163806|NCT02509156|20126092|P2|COMPLETED|Randomized Phase||16
8163807|NCT02509156|20126093|P1|COMPLETED|Randomized Phase||12
8163808|NCT02509156|20126092|P2|STARTED|Randomized Phase||17
8163809|NCT02509156|20126093|P1|STARTED|Randomized Phase|Includes randomized participants only|14
8163810|NCT02509156|20126092|P2|NOT COMPLETED|Open-Label Lead-In Phase||0
8163811|NCT02509156|20126093|P1|NOT COMPLETED|Open-Label Lead-In Phase||0
8163812|NCT02509156|20126092|P2|COMPLETED|Open-Label Lead-In Phase||0
8163813|NCT02509156|20126093|P1|COMPLETED|Open-Label Lead-In Phase||6
8163814|NCT02509156|20126092|P2|STARTED|Open-Label Lead-In Phase||0
8163815|NCT02509156|20126093|P1|STARTED|Open-Label Lead-In Phase||6
8163816|NCT02509117|20126163|P10|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163817|NCT02509117|20126164|P9|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163818|NCT02509117|20126165|P8|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163819|NCT02509117|20126166|P7|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163820|NCT02509117|20126167|P6|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163821|NCT02509117|20126168|P5|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163822|NCT02509117|20126169|P4|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163823|NCT02509117|20126170|P3|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163824|NCT02509117|20126171|P2|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163825|NCT02509117|20126172|P1|NOT COMPLETED|Period 4 -Part A: 4 Days||0
8163826|NCT02509117|20126163|P10|COMPLETED|Period 4 -Part A: 4 Days||0
8163827|NCT02509117|20126164|P9|COMPLETED|Period 4 -Part A: 4 Days||0
8163828|NCT02509117|20126165|P8|COMPLETED|Period 4 -Part A: 4 Days||0
8163829|NCT02509117|20126166|P7|COMPLETED|Period 4 -Part A: 4 Days||0
8163830|NCT02509117|20126167|P6|COMPLETED|Period 4 -Part A: 4 Days||0
8163831|NCT02509117|20126168|P5|COMPLETED|Period 4 -Part A: 4 Days||0
8163832|NCT02509117|20126169|P4|COMPLETED|Period 4 -Part A: 4 Days||2
8163833|NCT02509117|20126170|P3|COMPLETED|Period 4 -Part A: 4 Days||2
8163834|NCT02509117|20126171|P2|COMPLETED|Period 4 -Part A: 4 Days||2
8163835|NCT02509117|20126172|P1|COMPLETED|Period 4 -Part A: 4 Days||2
8163836|NCT02509117|20126163|P10|STARTED|Period 4 -Part A: 4 Days||0
8163837|NCT02509117|20126164|P9|STARTED|Period 4 -Part A: 4 Days||0
8163838|NCT02509117|20126165|P8|STARTED|Period 4 -Part A: 4 Days||0
8163839|NCT02509117|20126166|P7|STARTED|Period 4 -Part A: 4 Days||0
8163840|NCT02509117|20126167|P6|STARTED|Period 4 -Part A: 4 Days||0
8163841|NCT02509117|20126168|P5|STARTED|Period 4 -Part A: 4 Days||0
8163842|NCT02509117|20126169|P4|STARTED|Period 4 -Part A: 4 Days||2
8163843|NCT02509117|20126170|P3|STARTED|Period 4 -Part A: 4 Days||2
8163844|NCT02509117|20126171|P2|STARTED|Period 4 -Part A: 4 Days||2
8163845|NCT02509117|20126172|P1|STARTED|Period 4 -Part A: 4 Days||2
8163846|NCT02509117|20126163|P10|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163847|NCT02509117|20126164|P9|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163848|NCT02509117|20126165|P8|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163849|NCT02509117|20126166|P7|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163850|NCT02509117|20126167|P6|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163851|NCT02509117|20126168|P5|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163852|NCT02509117|20126169|P4|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163853|NCT02509117|20126170|P3|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163854|NCT02509117|20126171|P2|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163855|NCT02509117|20126172|P1|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163856|NCT02509117|20126163|P10|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163857|NCT02509117|20126164|P9|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163858|NCT02509117|20126165|P8|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163859|NCT02509117|20126166|P7|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163860|NCT02509117|20126167|P6|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163861|NCT02509117|20126168|P5|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
8163862|NCT02509117|20126169|P4|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
8163863|NCT02509117|20126170|P3|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
8163864|NCT02509117|20126171|P2|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
8163865|NCT02509117|20126172|P1|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
8163866|NCT02509117|20126163|P10|STARTED|Washout Period 3 (Part A: 7 Days)||0
8163867|NCT02509117|20126164|P9|STARTED|Washout Period 3 (Part A: 7 Days)||0
8163868|NCT02509117|20126165|P8|STARTED|Washout Period 3 (Part A: 7 Days)||0
8163869|NCT02509117|20126166|P7|STARTED|Washout Period 3 (Part A: 7 Days)||0
8163870|NCT02509117|20126167|P6|STARTED|Washout Period 3 (Part A: 7 Days)||0
8163871|NCT02509117|20126168|P5|STARTED|Washout Period 3 (Part A: 7 Days)||0
8163872|NCT02509117|20126169|P4|STARTED|Washout Period 3 (Part A: 7 Days)||2
8163873|NCT02509117|20126170|P3|STARTED|Washout Period 3 (Part A: 7 Days)||2
8163874|NCT02509117|20126171|P2|STARTED|Washout Period 3 (Part A: 7 Days)||2
8163875|NCT02509117|20126172|P1|STARTED|Washout Period 3 (Part A: 7 Days)||2
8163876|NCT02509117|20126163|P10|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163877|NCT02509117|20126164|P9|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163878|NCT02509117|20126165|P8|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163879|NCT02509117|20126166|P7|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163880|NCT02509117|20126167|P6|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163881|NCT02509117|20126168|P5|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163882|NCT02509117|20126169|P4|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163883|NCT02509117|20126170|P3|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163884|NCT02509117|20126171|P2|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163885|NCT02509117|20126172|P1|NOT COMPLETED|Period 3 -Part A: 4 Days||0
8163886|NCT02509117|20126163|P10|COMPLETED|Period 3 -Part A: 4 Days||0
8163887|NCT02509117|20126164|P9|COMPLETED|Period 3 -Part A: 4 Days||0
8163888|NCT02509117|20126165|P8|COMPLETED|Period 3 -Part A: 4 Days||0
8163889|NCT02509117|20126166|P7|COMPLETED|Period 3 -Part A: 4 Days||0
8163890|NCT02509117|20126167|P6|COMPLETED|Period 3 -Part A: 4 Days||0
8163891|NCT02509117|20126168|P5|COMPLETED|Period 3 -Part A: 4 Days||0
8163892|NCT02509117|20126169|P4|COMPLETED|Period 3 -Part A: 4 Days||2
8163893|NCT02509117|20126170|P3|COMPLETED|Period 3 -Part A: 4 Days||2
8163894|NCT02509117|20126171|P2|COMPLETED|Period 3 -Part A: 4 Days||2
8163895|NCT02509117|20126172|P1|COMPLETED|Period 3 -Part A: 4 Days||2
8163896|NCT02509117|20126163|P10|STARTED|Period 3 -Part A: 4 Days||0
8163897|NCT02509117|20126164|P9|STARTED|Period 3 -Part A: 4 Days||0
8163898|NCT02509117|20126165|P8|STARTED|Period 3 -Part A: 4 Days||0
8163899|NCT02509117|20126166|P7|STARTED|Period 3 -Part A: 4 Days||0
8163900|NCT02509117|20126167|P6|STARTED|Period 3 -Part A: 4 Days||0
8163901|NCT02509117|20126168|P5|STARTED|Period 3 -Part A: 4 Days||0
8163902|NCT02509117|20126169|P4|STARTED|Period 3 -Part A: 4 Days||2
8163903|NCT02509117|20126170|P3|STARTED|Period 3 -Part A: 4 Days||2
8163904|NCT02509117|20126171|P2|STARTED|Period 3 -Part A: 4 Days||2
8163905|NCT02509117|20126172|P1|STARTED|Period 3 -Part A: 4 Days||2
8163906|NCT02509117|20126163|P10|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163907|NCT02509117|20126164|P9|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163908|NCT02509117|20126165|P8|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163909|NCT02509117|20126166|P7|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163910|NCT02509117|20126167|P6|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163911|NCT02509117|20126168|P5|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163912|NCT02509117|20126169|P4|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163913|NCT02509117|20126170|P3|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163914|NCT02509117|20126171|P2|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163915|NCT02509117|20126172|P1|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163916|NCT02509117|20126163|P10|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163917|NCT02509117|20126164|P9|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163918|NCT02509117|20126165|P8|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163919|NCT02509117|20126166|P7|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163920|NCT02509117|20126167|P6|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163921|NCT02509117|20126168|P5|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
8163922|NCT02509117|20126169|P4|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
8163923|NCT02509117|20126170|P3|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
8163924|NCT02509117|20126171|P2|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
8163925|NCT02509117|20126172|P1|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
8163926|NCT02509117|20126163|P10|STARTED|Washout Period 2 (Part A: 7 Days)||0
8163927|NCT02509117|20126164|P9|STARTED|Washout Period 2 (Part A: 7 Days)||0
8163928|NCT02509117|20126165|P8|STARTED|Washout Period 2 (Part A: 7 Days)||0
8163929|NCT02509117|20126166|P7|STARTED|Washout Period 2 (Part A: 7 Days)||0
8163930|NCT02509117|20126167|P6|STARTED|Washout Period 2 (Part A: 7 Days)||0
8163931|NCT02509117|20126168|P5|STARTED|Washout Period 2 (Part A: 7 Days)||0
8163932|NCT02509117|20126169|P4|STARTED|Washout Period 2 (Part A: 7 Days)||2
8163933|NCT02509117|20126170|P3|STARTED|Washout Period 2 (Part A: 7 Days)||2
8163934|NCT02509117|20126171|P2|STARTED|Washout Period 2 (Part A: 7 Days)||2
8163935|NCT02509117|20126172|P1|STARTED|Washout Period 2 (Part A: 7 Days)||2
8163936|NCT02509117|20126163|P10|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163937|NCT02509117|20126164|P9|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163938|NCT02509117|20126165|P8|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163939|NCT02509117|20126166|P7|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163940|NCT02509117|20126167|P6|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163941|NCT02509117|20126168|P5|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163942|NCT02509117|20126169|P4|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163943|NCT02509117|20126170|P3|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163944|NCT02509117|20126171|P2|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163945|NCT02509117|20126172|P1|NOT COMPLETED|Period 2 -Part A: 4 Days||0
8163946|NCT02509117|20126163|P10|COMPLETED|Period 2 -Part A: 4 Days||0
8163947|NCT02509117|20126164|P9|COMPLETED|Period 2 -Part A: 4 Days||0
8163948|NCT02509117|20126165|P8|COMPLETED|Period 2 -Part A: 4 Days||0
8163949|NCT02509117|20126166|P7|COMPLETED|Period 2 -Part A: 4 Days||0
8163950|NCT02509117|20126167|P6|COMPLETED|Period 2 -Part A: 4 Days||0
8163951|NCT02509117|20126168|P5|COMPLETED|Period 2 -Part A: 4 Days||0
8163952|NCT02509117|20126169|P4|COMPLETED|Period 2 -Part A: 4 Days||2
8163953|NCT02509117|20126170|P3|COMPLETED|Period 2 -Part A: 4 Days||2
8163954|NCT02509117|20126171|P2|COMPLETED|Period 2 -Part A: 4 Days||2
8163955|NCT02509117|20126172|P1|COMPLETED|Period 2 -Part A: 4 Days||2
8163956|NCT02509117|20126163|P10|Treated|Period 2 -Part A: 4 Days||0
8163957|NCT02509117|20126164|P9|Treated|Period 2 -Part A: 4 Days||0
8163958|NCT02509117|20126165|P8|Treated|Period 2 -Part A: 4 Days||0
8163959|NCT02509117|20126166|P7|Treated|Period 2 -Part A: 4 Days||0
8163960|NCT02509117|20126167|P6|Treated|Period 2 -Part A: 4 Days||0
8163961|NCT02509117|20126168|P5|Treated|Period 2 -Part A: 4 Days||0
8163962|NCT02509117|20126169|P4|Treated|Period 2 -Part A: 4 Days||2
8163963|NCT02509117|20126170|P3|Treated|Period 2 -Part A: 4 Days||2
8163964|NCT02509117|20126171|P2|Treated|Period 2 -Part A: 4 Days||2
8163965|NCT02509117|20126172|P1|Treated|Period 2 -Part A: 4 Days||2
8163966|NCT02509117|20126163|P10|STARTED|Period 2 -Part A: 4 Days||0
8163967|NCT02509117|20126164|P9|STARTED|Period 2 -Part A: 4 Days||0
8163968|NCT02509117|20126165|P8|STARTED|Period 2 -Part A: 4 Days||0
8163969|NCT02509117|20126166|P7|STARTED|Period 2 -Part A: 4 Days||0
8163970|NCT02509117|20126167|P6|STARTED|Period 2 -Part A: 4 Days||0
8163971|NCT02509117|20126168|P5|STARTED|Period 2 -Part A: 4 Days||0
8163972|NCT02509117|20126169|P4|STARTED|Period 2 -Part A: 4 Days||2
8163973|NCT02509117|20126170|P3|STARTED|Period 2 -Part A: 4 Days||2
8163974|NCT02509117|20126171|P2|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
8163975|NCT02509117|20126172|P1|STARTED|Period 2 -Part A: 4 Days||2
8163976|NCT02509117|20126163|P10|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163977|NCT02509117|20126164|P9|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163978|NCT02509117|20126165|P8|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163979|NCT02509117|20126166|P7|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163980|NCT02509117|20126167|P6|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163981|NCT02509117|20126168|P5|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163982|NCT02509117|20126169|P4|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163983|NCT02509117|20126170|P3|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163984|NCT02509117|20126171|P2|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163985|NCT02509117|20126172|P1|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163986|NCT02509117|20126163|P10|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163987|NCT02509117|20126164|P9|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163988|NCT02509117|20126165|P8|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163989|NCT02509117|20126166|P7|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163990|NCT02509117|20126167|P6|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163991|NCT02509117|20126168|P5|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
8163992|NCT02509117|20126169|P4|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
8163993|NCT02509117|20126170|P3|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
8163994|NCT02509117|20126171|P2|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
8163995|NCT02509117|20126172|P1|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
8163996|NCT02509117|20126163|P10|STARTED|Washout Period 1 (Part A: 7 Days)||0
8163997|NCT02509117|20126164|P9|STARTED|Washout Period 1 (Part A: 7 Days)||0
8163998|NCT02509117|20126165|P8|STARTED|Washout Period 1 (Part A: 7 Days)||0
8163999|NCT02509117|20126166|P7|STARTED|Washout Period 1 (Part A: 7 Days)||0
8164000|NCT02509117|20126167|P6|STARTED|Washout Period 1 (Part A: 7 Days)||0
8164001|NCT02509117|20126168|P5|STARTED|Washout Period 1 (Part A: 7 Days)||0
8164002|NCT02509117|20126169|P4|STARTED|Washout Period 1 (Part A: 7 Days)||2
8164003|NCT02509117|20126170|P3|STARTED|Washout Period 1 (Part A: 7 Days)||2
8164004|NCT02509117|20126171|P2|STARTED|Washout Period 1 (Part A: 7 Days)||1
8164005|NCT02509117|20126172|P1|STARTED|Washout Period 1 (Part A: 7 Days)||2
8164006|NCT02509117|20126163|P10|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164007|NCT02509117|20126164|P9|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164008|NCT02509117|20126165|P8|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164009|NCT02509117|20126166|P7|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164010|NCT02509117|20126167|P6|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164011|NCT02509117|20126168|P5|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164012|NCT02509117|20126169|P4|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164013|NCT02509117|20126170|P3|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164014|NCT02509117|20126171|P2|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
8164015|NCT02509117|20126172|P1|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
8164016|NCT02509117|20126163|P10|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164017|NCT02509117|20126164|P9|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
8164018|NCT02509117|20126165|P8|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164019|NCT02509117|20126166|P7|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164020|NCT02509117|20126167|P6|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164021|NCT02509117|20126168|P5|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164022|NCT02509117|20126169|P4|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164023|NCT02509117|20126170|P3|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164024|NCT02509117|20126171|P2|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
8164025|NCT02509117|20126172|P1|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164026|NCT02509117|20126163|P10|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
8164027|NCT02509117|20126164|P9|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
8164028|NCT02509117|20126165|P8|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164029|NCT02509117|20126166|P7|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164030|NCT02509117|20126167|P6|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164031|NCT02509117|20126168|P5|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164032|NCT02509117|20126169|P4|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164033|NCT02509117|20126170|P3|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164034|NCT02509117|20126171|P2|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
8164035|NCT02509117|20126172|P1|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164036|NCT02509117|20126163|P10|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
8164037|NCT02509117|20126164|P9|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
8164038|NCT02509117|20126165|P8|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164039|NCT02509117|20126166|P7|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164040|NCT02509117|20126167|P6|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164041|NCT02509117|20126168|P5|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
8164042|NCT02509117|20126169|P4|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164043|NCT02509117|20126170|P3|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164044|NCT02509117|20126171|P2|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164045|NCT02509117|20126172|P1|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
8164046|NCT02509078|20126383|P2|NOT COMPLETED|Overall Study||1
8164047|NCT02509078|20126384|P1|NOT COMPLETED|Overall Study||1
8164048|NCT02509078|20126383|P2|COMPLETED|Overall Study||505
8164049|NCT02509078|20126384|P1|COMPLETED|Overall Study||501
8164050|NCT02509078|20126383|P2|STARTED|Overall Study||506
8164051|NCT02509078|20126384|P1|STARTED|Overall Study||502
8164052|NCT02509065|20126420|P23|NOT COMPLETED|Overall Study||0
8164053|NCT02509065|20126421|P22|NOT COMPLETED|Overall Study||0
8164054|NCT02509065|20126422|P21|NOT COMPLETED|Overall Study||0
8164055|NCT02509065|20126423|P20|NOT COMPLETED|Overall Study||0
8164056|NCT02509065|20126424|P19|NOT COMPLETED|Overall Study||0
8164057|NCT02509065|20126425|P18|NOT COMPLETED|Overall Study||0
8164058|NCT02509065|20126426|P17|NOT COMPLETED|Overall Study||0
8164059|NCT02509065|20126427|P16|NOT COMPLETED|Overall Study||0
8164060|NCT02509065|20126428|P15|NOT COMPLETED|Overall Study||0
8164061|NCT02509065|20126429|P14|NOT COMPLETED|Overall Study||0
8164062|NCT02509065|20126430|P13|NOT COMPLETED|Overall Study||0
8164063|NCT02509065|20126431|P12|NOT COMPLETED|Overall Study||0
8164064|NCT02509065|20126432|P11|NOT COMPLETED|Overall Study||0
8164065|NCT02509065|20126433|P10|NOT COMPLETED|Overall Study||0
8164066|NCT02509065|20126434|P9|NOT COMPLETED|Overall Study||0
8164067|NCT02509065|20126435|P8|NOT COMPLETED|Overall Study||0
8164068|NCT02509065|20126436|P7|NOT COMPLETED|Overall Study||0
8164069|NCT02509065|20126437|P6|NOT COMPLETED|Overall Study||0
8164070|NCT02509065|20126438|P5|NOT COMPLETED|Overall Study||0
8164071|NCT02509065|20126439|P4|NOT COMPLETED|Overall Study||0
8164072|NCT02509065|20126440|P3|NOT COMPLETED|Overall Study||0
8164073|NCT02509065|20126441|P2|NOT COMPLETED|Overall Study||0
8164074|NCT02509065|20126442|P1|NOT COMPLETED|Overall Study||0
8164075|NCT02509065|20126420|P23|COMPLETED|Overall Study||1
8164076|NCT02509065|20126421|P22|COMPLETED|Overall Study||1
8164077|NCT02509065|20126422|P21|COMPLETED|Overall Study||1
8164078|NCT02509065|20126423|P20|COMPLETED|Overall Study||1
8164079|NCT02509065|20126424|P19|COMPLETED|Overall Study||1
8164080|NCT02509065|20126425|P18|COMPLETED|Overall Study||1
8164081|NCT02509065|20126426|P17|COMPLETED|Overall Study||1
8164082|NCT02509065|20126427|P16|COMPLETED|Overall Study||1
8164083|NCT02509065|20126428|P15|COMPLETED|Overall Study||1
8164084|NCT02509065|20126429|P14|COMPLETED|Overall Study||1
8164085|NCT02509065|20126430|P13|COMPLETED|Overall Study||1
8164086|NCT02509065|20126431|P12|COMPLETED|Overall Study||1
8164087|NCT02509065|20126432|P11|COMPLETED|Overall Study||1
8164088|NCT02509065|20126433|P10|COMPLETED|Overall Study||1
8164089|NCT02509065|20126434|P9|COMPLETED|Overall Study||1
8164090|NCT02509065|20126435|P8|COMPLETED|Overall Study||1
8164091|NCT02509065|20126436|P7|COMPLETED|Overall Study||1
8164092|NCT02509065|20126437|P6|COMPLETED|Overall Study||1
8164093|NCT02509065|20126438|P5|COMPLETED|Overall Study||1
8164094|NCT02509065|20126439|P4|COMPLETED|Overall Study||1
8164095|NCT02509065|20126440|P3|COMPLETED|Overall Study||2
8164096|NCT02509065|20126441|P2|COMPLETED|Overall Study||1
8164097|NCT02509065|20126442|P1|COMPLETED|Overall Study||1
8164098|NCT02509065|20126420|P23|STARTED|Overall Study||1
8164099|NCT02509065|20126421|P22|STARTED|Overall Study||1
8164100|NCT02509065|20126422|P21|STARTED|Overall Study||1
8164101|NCT02509065|20126423|P20|STARTED|Overall Study||1
8164102|NCT02509065|20126424|P19|STARTED|Overall Study||1
8164103|NCT02509065|20126425|P18|STARTED|Overall Study||1
8164104|NCT02509065|20126426|P17|STARTED|Overall Study||1
8164105|NCT02509065|20126427|P16|STARTED|Overall Study||1
8164106|NCT02509065|20126428|P15|STARTED|Overall Study||1
8164107|NCT02509065|20126429|P14|STARTED|Overall Study||1
8164108|NCT02509065|20126430|P13|STARTED|Overall Study||1
8164109|NCT02509065|20126431|P12|STARTED|Overall Study||1
8164110|NCT02509065|20126432|P11|STARTED|Overall Study||1
8164111|NCT02509065|20126433|P10|STARTED|Overall Study||1
8164112|NCT02509065|20126434|P9|STARTED|Overall Study||1
8164113|NCT02509065|20126435|P8|STARTED|Overall Study||1
8164114|NCT02509065|20126436|P7|STARTED|Overall Study||1
8164115|NCT02509065|20126437|P6|STARTED|Overall Study||1
8164116|NCT02509065|20126438|P5|STARTED|Overall Study||1
8164117|NCT02509065|20126439|P4|STARTED|Overall Study||1
8164118|NCT02509065|20126440|P3|STARTED|Overall Study||2
8164119|NCT02509065|20126441|P2|STARTED|Overall Study||1
8164120|NCT02509065|20126442|P1|STARTED|Overall Study||1
8164121|NCT02509026|20126527|P1|NOT COMPLETED|Retreatment Period (12 Weeks)||4
8164122|NCT02509026|20126527|P1|COMPLETED|Retreatment Period (12 Weeks)||84
8164123|NCT02509026|20126527|P1|Treated|Retreatment Period (12 Weeks)||87
8164124|NCT02509026|20126527|P1|STARTED|Retreatment Period (12 Weeks)|Participants who completed Period 2 and achieved ASDAS-ESR>=2.1 were eligible to enter into Period 3|88
8164125|NCT02509026|20126527|P1|NOT COMPLETED|Withdrawal Period (40 Weeks)||7
8164126|NCT02509026|20126527|P1|COMPLETED|Withdrawal Period (40 Weeks)||112
8164127|NCT02509026|20126527|P1|STARTED|Withdrawal Period (40 Weeks)|Participants who completed Period 1 and achieved ASDAS-CRP<1.3 were eligible to enter into Period 2|119
8164128|NCT02509026|20126527|P1|NOT COMPLETED|Induction Period (24 Weeks)||22
8164129|NCT02509026|20126527|P1|COMPLETED|Induction Period (24 Weeks)||188
8164130|NCT02509026|20126527|P1|Treated|Induction Period (24 Weeks)||209
8164131|NCT02509026|20126527|P1|STARTED|Induction Period (24 Weeks)||210
8164132|NCT02508935|20126724|P1|NOT COMPLETED|Overall Study||23
8164133|NCT02508935|20126724|P1|COMPLETED|Overall Study||0
8164134|NCT02508935|20126724|P1|STARTED|Overall Study||23
8164135|NCT02508701|20126740|P4|NOT COMPLETED|Overall Study||3
8164136|NCT02508701|20126741|P3|NOT COMPLETED|Overall Study||5
8164137|NCT02508701|20126742|P2|NOT COMPLETED|Overall Study||5
8164138|NCT02508701|20126743|P1|NOT COMPLETED|Overall Study||9
8164139|NCT02508701|20126740|P4|COMPLETED|Overall Study||1
8164140|NCT02508701|20126741|P3|COMPLETED|Overall Study||0
8164141|NCT02508701|20126742|P2|COMPLETED|Overall Study||1
8164142|NCT02508701|20126743|P1|COMPLETED|Overall Study||0
8164143|NCT02508701|20126740|P4|STARTED|Overall Study||4
8164144|NCT02508701|20126741|P3|STARTED|Overall Study||5
8164145|NCT02508701|20126742|P2|STARTED|Overall Study||6
8164146|NCT02508701|20126743|P1|STARTED|Overall Study||9
8164147|NCT02508480|20126767|P2|NOT COMPLETED|Overall Study||4
8164148|NCT02508480|20126768|P1|NOT COMPLETED|Overall Study||5
8164149|NCT02508480|20126767|P2|COMPLETED|Overall Study||93
8164150|NCT02508480|20126768|P1|COMPLETED|Overall Study||90
8164151|NCT02508480|20126767|P2|Six-Month Follow-Up|Overall Study||86
8164152|NCT02508480|20126768|P1|Six-Month Follow-Up|Overall Study||84
8164153|NCT02508480|20126767|P2|Three Month Follow-up|Overall Study||86
8164154|NCT02508480|20126768|P1|Three Month Follow-up|Overall Study||84
8164155|NCT02508480|20126767|P2|Post-Treatment Assessment|Overall Study||89
8164156|NCT02508480|20126768|P1|Post-Treatment Assessment|Overall Study||87
8164157|NCT02508480|20126767|P2|STARTED|Overall Study||97
8164158|NCT02508480|20126768|P1|STARTED|Overall Study||95
8164159|NCT02508428|20126792|P2|NOT COMPLETED|Overall Study||67
8164160|NCT02508428|20126793|P1|NOT COMPLETED|Overall Study||52
8164161|NCT02508428|20126792|P2|COMPLETED|Overall Study||44
8164162|NCT02508428|20126793|P1|COMPLETED|Overall Study||62
8164163|NCT02508428|20126792|P2|STARTED|Overall Study||111
8164164|NCT02508428|20126793|P1|STARTED|Overall Study||114
8164165|NCT02508259|20126809|P2|NOT COMPLETED|Overall Study||0
8164166|NCT02508259|20126810|P1|NOT COMPLETED|Overall Study||0
8164167|NCT02508259|20126809|P2|COMPLETED|Overall Study||5
8164168|NCT02508259|20126810|P1|COMPLETED|Overall Study||5
8164169|NCT02508259|20126809|P2|STARTED|Overall Study||5
8164170|NCT02508259|20126810|P1|STARTED|Overall Study||5
8164177|NCT02508194|20126845|P2|NOT COMPLETED|Overall Study||44
8164178|NCT02508194|20126846|P1|NOT COMPLETED|Overall Study||52
8164179|NCT02508194|20126845|P2|COMPLETED|Overall Study||907
8164180|NCT02508194|20126846|P1|COMPLETED|Overall Study||897
8164181|NCT02508194|20126845|P2|STARTED|Overall Study||951
8164182|NCT02508194|20126846|P1|STARTED|Overall Study||949
8164183|NCT02508116|20126886|P2|NOT COMPLETED|Overall Study||7
8164184|NCT02508116|20126887|P1|NOT COMPLETED|Overall Study||8
8164185|NCT02508116|20126886|P2|COMPLETED|Overall Study||250
8164186|NCT02508116|20126887|P1|COMPLETED|Overall Study||244
8164187|NCT02508116|20126886|P2|Received Intervention as Randomized|Overall Study||255
8164188|NCT02508116|20126887|P1|Received Intervention as Randomized|Overall Study||249
8164189|NCT02508116|20126886|P2|STARTED|Overall Study||257
8164190|NCT02508116|20126887|P1|STARTED|Overall Study||252
8164191|NCT02508103|20126901|P2|NOT COMPLETED|Overall Study||0
8164192|NCT02508103|20126902|P1|NOT COMPLETED|Overall Study||0
8164193|NCT02508103|20126901|P2|COMPLETED|Overall Study||5
8164194|NCT02508103|20126902|P1|COMPLETED|Overall Study||5
8164195|NCT02508103|20126901|P2|STARTED|Overall Study||5
8164196|NCT02508103|20126902|P1|STARTED|Overall Study||5
8164197|NCT02508077|20126910|P1|NOT COMPLETED|Overall Study||0
8164198|NCT02508077|20126910|P1|COMPLETED|Overall Study||1
8164199|NCT02508077|20126910|P1|STARTED|Overall Study||1
8164200|NCT02507973|20126914|P1|NOT COMPLETED|Overall Study||1
8164201|NCT02507973|20126914|P1|COMPLETED|Overall Study||7
8164202|NCT02507973|20126914|P1|STARTED|Overall Study||8
8164203|NCT02507752|20126920|P1|NOT COMPLETED|Overall Study||17
8164204|NCT02507752|20126920|P1|COMPLETED|Overall Study||55
8164205|NCT02507752|20126920|P1|STARTED|Overall Study||72
8164206|NCT02507388|20126940|P2|NOT COMPLETED|Overall Study||0
8164207|NCT02507388|20126941|P1|NOT COMPLETED|Overall Study||0
8164208|NCT02507388|20126940|P2|COMPLETED|Overall Study||25
8164209|NCT02507388|20126941|P1|COMPLETED|Overall Study||25
8164210|NCT02507388|20126940|P2|STARTED|Overall Study||25
8164211|NCT02507388|20126941|P1|STARTED|Overall Study||25
8164212|NCT02507375|20126964|P2|NOT COMPLETED|Overall Study||8
8164213|NCT02507375|20126965|P1|NOT COMPLETED|Overall Study||4
8164214|NCT02507375|20126964|P2|COMPLETED|Overall Study||1
8164215|NCT02507375|20126965|P1|COMPLETED|Overall Study||2
8164216|NCT02507375|20126964|P2|Extension Period|Overall Study||1
8164217|NCT02507375|20126965|P1|Extension Period|Overall Study||2
8164218|NCT02507375|20126964|P2|Cycle 6|Overall Study||1
8164219|NCT02507375|20126965|P1|Cycle 6|Overall Study||3
8164220|NCT02507375|20126964|P2|Cycle 5|Overall Study||1
8164221|NCT02507375|20126965|P1|Cycle 5|Overall Study||3
8164222|NCT02507375|20126964|P2|Cycle 4|Overall Study||2
8164223|NCT02507375|20126965|P1|Cycle 4|Overall Study||4
8164224|NCT02507375|20126964|P2|Cycle 3|Overall Study||5
8164225|NCT02507375|20126965|P1|Cycle 3|Overall Study||4
8164226|NCT02507375|20126964|P2|Cycle 2|Overall Study||5
8164227|NCT02507375|20126965|P1|Cycle 2|Overall Study||5
8164228|NCT02507375|20126964|P2|Received Pertuzumab|Overall Study||6
8164229|NCT02507375|20126965|P1|Received Pertuzumab|Overall Study||6
8164230|NCT02507375|20126964|P2|Cycle 1|Overall Study||9
8164231|NCT02507375|20126965|P1|Cycle 1|Overall Study||6
8164232|NCT02507375|20126964|P2|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
8164233|NCT02507375|20126965|P1|STARTED|Overall Study||6
8164234|NCT02507349|20126984|P2|NOT COMPLETED|Overall Study||161
8164235|NCT02507349|20126985|P1|NOT COMPLETED|Overall Study||187
8164236|NCT02507349|20126984|P2|COMPLETED|Overall Study||1050
8164237|NCT02507349|20126985|P1|COMPLETED|Overall Study||1045
8164238|NCT02507349|20126984|P2|STARTED|Overall Study||1211
8164239|NCT02507349|20126985|P1|STARTED|Overall Study||1232
8164240|NCT02507219|20127009|P6|NOT COMPLETED|Overall Study||0
8164241|NCT02507219|20127010|P5|NOT COMPLETED|Overall Study||1
8164242|NCT02507219|20127011|P4|NOT COMPLETED|Overall Study||0
8164243|NCT02507219|20127012|P3|NOT COMPLETED|Overall Study||0
8164244|NCT02507219|20127013|P2|NOT COMPLETED|Overall Study||0
8164245|NCT02507219|20127014|P1|NOT COMPLETED|Overall Study||1
8164246|NCT02507219|20127009|P6|COMPLETED|Overall Study||3
8164247|NCT02507219|20127010|P5|COMPLETED|Overall Study||3
8164248|NCT02507219|20127011|P4|COMPLETED|Overall Study||3
8164249|NCT02507219|20127012|P3|COMPLETED|Overall Study||3
8164250|NCT02507219|20127013|P2|COMPLETED|Overall Study||4
8164251|NCT02507219|20127014|P1|COMPLETED|Overall Study||4
8164252|NCT02507219|20127009|P6|STARTED|Overall Study||3
8164253|NCT02507219|20127010|P5|STARTED|Overall Study||4
8164254|NCT02507219|20127011|P4|STARTED|Overall Study||3
8164255|NCT02507219|20127012|P3|STARTED|Overall Study||3
8164256|NCT02507219|20127013|P2|STARTED|Overall Study||4
8164257|NCT02507219|20127014|P1|STARTED|Overall Study||5
8164258|NCT02507011|20127022|P2|NOT COMPLETED|Second Intervention||0
8164259|NCT02507011|20127023|P1|NOT COMPLETED|Second Intervention||0
8164260|NCT02507011|20127022|P2|COMPLETED|Second Intervention||1
8164261|NCT02507011|20127023|P1|COMPLETED|Second Intervention||1
8164262|NCT02507011|20127022|P2|STARTED|Second Intervention||1
8164263|NCT02507011|20127023|P1|STARTED|Second Intervention||1
8164264|NCT02507011|20127022|P2|NOT COMPLETED|First Intervention||0
8164265|NCT02507011|20127023|P1|NOT COMPLETED|First Intervention||0
8164266|NCT02507011|20127022|P2|COMPLETED|First Intervention||1
8164267|NCT02507011|20127023|P1|COMPLETED|First Intervention||1
8164268|NCT02507011|20127022|P2|STARTED|First Intervention||1
8164269|NCT02507011|20127023|P1|STARTED|First Intervention||1
8164270|NCT02506985|20127031|P2|NOT COMPLETED|Overall Study||0
8164271|NCT02506985|20127032|P1|NOT COMPLETED|Overall Study||0
8164272|NCT02506985|20127031|P2|COMPLETED|Overall Study||6
8164273|NCT02506985|20127032|P1|COMPLETED|Overall Study||4
8164274|NCT02506985|20127031|P2|STARTED|Overall Study||6
8164275|NCT02506985|20127032|P1|STARTED|Overall Study||4
8164276|NCT02506881|20127050|P4|NOT COMPLETED|Second Intervention (Day 1)||0
8164277|NCT02506881|20127051|P3|NOT COMPLETED|Second Intervention (Day 1)||0
8164278|NCT02506881|20127052|P2|NOT COMPLETED|Second Intervention (Day 1)||0
8164279|NCT02506881|20127053|P1|NOT COMPLETED|Second Intervention (Day 1)||0
8164280|NCT02506881|20127050|P4|COMPLETED|Second Intervention (Day 1)||12
8164281|NCT02506881|20127051|P3|COMPLETED|Second Intervention (Day 1)||12
8164282|NCT02506881|20127052|P2|COMPLETED|Second Intervention (Day 1)||12
8164283|NCT02506881|20127053|P1|COMPLETED|Second Intervention (Day 1)||12
8164284|NCT02506881|20127050|P4|STARTED|Second Intervention (Day 1)||12
8164285|NCT02506881|20127051|P3|STARTED|Second Intervention (Day 1)||12
8164286|NCT02506881|20127052|P2|STARTED|Second Intervention (Day 1)||12
8164287|NCT02506881|20127053|P1|STARTED|Second Intervention (Day 1)||12
8164288|NCT02506881|20127050|P4|NOT COMPLETED|Washout (at Least 25 Days)||0
8164289|NCT02506881|20127051|P3|NOT COMPLETED|Washout (at Least 25 Days)||0
8164290|NCT02506881|20127052|P2|NOT COMPLETED|Washout (at Least 25 Days)||0
8164291|NCT02506881|20127053|P1|NOT COMPLETED|Washout (at Least 25 Days)||0
8164292|NCT02506881|20127050|P4|COMPLETED|Washout (at Least 25 Days)||12
8164293|NCT02506881|20127051|P3|COMPLETED|Washout (at Least 25 Days)||12
8164294|NCT02506881|20127052|P2|COMPLETED|Washout (at Least 25 Days)||12
8164295|NCT02506881|20127053|P1|COMPLETED|Washout (at Least 25 Days)||12
8164296|NCT02506881|20127050|P4|STARTED|Washout (at Least 25 Days)||12
8164297|NCT02506881|20127051|P3|STARTED|Washout (at Least 25 Days)||12
8164298|NCT02506881|20127052|P2|STARTED|Washout (at Least 25 Days)||12
8164299|NCT02506881|20127053|P1|STARTED|Washout (at Least 25 Days)||12
8164300|NCT02506881|20127050|P4|NOT COMPLETED|First Intervention (Day 1)||12
8164301|NCT02506881|20127051|P3|NOT COMPLETED|First Intervention (Day 1)||13
8164302|NCT02506881|20127052|P2|NOT COMPLETED|First Intervention (Day 1)||0
8164303|NCT02506881|20127053|P1|NOT COMPLETED|First Intervention (Day 1)||1
8164304|NCT02506881|20127050|P4|COMPLETED|First Intervention (Day 1)||12
8164305|NCT02506881|20127051|P3|COMPLETED|First Intervention (Day 1)||12
8164306|NCT02506881|20127052|P2|COMPLETED|First Intervention (Day 1)||12
8164307|NCT02506881|20127053|P1|COMPLETED|First Intervention (Day 1)||12
8164308|NCT02506881|20127050|P4|STARTED|First Intervention (Day 1)||24
8164309|NCT02506881|20127051|P3|STARTED|First Intervention (Day 1)||25
8164310|NCT02506881|20127052|P2|STARTED|First Intervention (Day 1)||12
8164311|NCT02506881|20127053|P1|STARTED|First Intervention (Day 1)||13
8164312|NCT02506868|20127089|P2|NOT COMPLETED|Additional Period of Study (Until 52W)||5
8164313|NCT02506868|20127090|P1|NOT COMPLETED|Additional Period of Study (Until 52W)||3
8164314|NCT02506868|20127089|P2|COMPLETED|Additional Period of Study (Until 52W)||85
8164315|NCT02506868|20127090|P1|COMPLETED|Additional Period of Study (Until 52W)||83
8164316|NCT02506868|20127089|P2|STARTED|Additional Period of Study (Until 52W)||90
8164317|NCT02506868|20127090|P1|STARTED|Additional Period of Study (Until 52W)||86
8164318|NCT02506868|20127089|P2|NOT COMPLETED|Main Period of Study (24 Weeks)||8
8164319|NCT02506868|20127090|P1|NOT COMPLETED|Main Period of Study (24 Weeks)||12
8164320|NCT02506868|20127089|P2|COMPLETED|Main Period of Study (24 Weeks)||90
8164321|NCT02506868|20127090|P1|COMPLETED|Main Period of Study (24 Weeks)||86
8164322|NCT02506868|20127089|P2|Per Protocol Population|Main Period of Study (24 Weeks)||90
8164323|NCT02506868|20127090|P1|Per Protocol Population|Main Period of Study (24 Weeks)||86
8164324|NCT02506868|20127089|P2|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97
8164325|NCT02506868|20127090|P1|mITT Population|Main Period of Study (24 Weeks)||98
8164326|NCT02506868|20127089|P2|STARTED|Main Period of Study (24 Weeks)||98
8164327|NCT02506868|20127090|P1|STARTED|Main Period of Study (24 Weeks)||98
8164328|NCT02506816|20127126|P1|NOT COMPLETED|Overall Study||3
8164329|NCT02506816|20127126|P1|COMPLETED|Overall Study||33
8164330|NCT02506816|20127126|P1|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31
8164331|NCT02506816|20127126|P1|STARTED|Overall Study||36
8164332|NCT02506673|20127135|P2|NOT COMPLETED|Overall Study||0
8164333|NCT02506673|20127136|P1|NOT COMPLETED|Overall Study||0
8164334|NCT02506673|20127135|P2|COMPLETED|Overall Study||13
8164335|NCT02506673|20127136|P1|COMPLETED|Overall Study||13
8164336|NCT02506673|20127135|P2|STARTED|Overall Study||13
8164337|NCT02506673|20127136|P1|STARTED|Overall Study||13
8164338|NCT02506660|20127168|P2|NOT COMPLETED|Overall Study||1
8164339|NCT02506660|20127169|P1|NOT COMPLETED|Overall Study||2
8164340|NCT02506660|20127168|P2|COMPLETED|Overall Study||63
8164341|NCT02506660|20127169|P1|COMPLETED|Overall Study||62
8164342|NCT02506660|20127168|P2|STARTED|Overall Study||64
8164343|NCT02506660|20127169|P1|STARTED|Overall Study||64
8164344|NCT02506634|20127195|P1|NOT COMPLETED|Overall Study||17
8164345|NCT02506634|20127195|P1|COMPLETED|Overall Study||357
8164346|NCT02506634|20127195|P1|Participants Who Finished GERDQ|Overall Study||342
8164347|NCT02506634|20127195|P1|Participants Who Received PPI Treatment|Overall Study||357
8164348|NCT02506634|20127195|P1|Participants Who Were Diagnosed as GERD|Overall Study||154
8164349|NCT02506634|20127195|P1|STARTED|Overall Study||374
8164350|NCT02506309|20127235|P2|NOT COMPLETED|Overall Study||20
8164351|NCT02506309|20127236|P1|NOT COMPLETED|Overall Study||18
8164352|NCT02506309|20127235|P2|COMPLETED|Overall Study||64
8164353|NCT02506309|20127236|P1|COMPLETED|Overall Study||66
8164354|NCT02506309|20127235|P2|STARTED|Overall Study||84
8164355|NCT02506309|20127236|P1|STARTED|Overall Study||84
8164356|NCT02506257|20127252|P4|NOT COMPLETED|Overall Study||0
8164357|NCT02506257|20127253|P3|NOT COMPLETED|Overall Study||4
8164358|NCT02506257|20127254|P2|NOT COMPLETED|Overall Study||2
8164359|NCT02506257|20127255|P1|NOT COMPLETED|Overall Study||0
8164360|NCT02506257|20127252|P4|COMPLETED|Overall Study||9
8164361|NCT02506257|20127253|P3|COMPLETED|Overall Study||23
8164362|NCT02506257|20127254|P2|COMPLETED|Overall Study||26
8164363|NCT02506257|20127255|P1|COMPLETED|Overall Study||26
8164364|NCT02506257|20127252|P4|STARTED|Overall Study||9
8164365|NCT02506257|20127253|P3|STARTED|Overall Study||27
8164366|NCT02506257|20127254|P2|STARTED|Overall Study||28
8164367|NCT02506257|20127255|P1|STARTED|Overall Study||26
8164368|NCT02506101|20127287|P2|NOT COMPLETED|Overall Study||0
8164369|NCT02506101|20127288|P1|NOT COMPLETED|Overall Study||2
8164370|NCT02506101|20127287|P2|COMPLETED|Overall Study||0
8164371|NCT02506101|20127288|P1|COMPLETED|Overall Study||0
8164372|NCT02506101|20127287|P2|STARTED|Overall Study||0
8164373|NCT02506101|20127288|P1|STARTED|Overall Study||2
8164374|NCT02506036|20127304|P2|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
8164375|NCT02506036|20127305|P1|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
8164376|NCT02506036|20127304|P2|COMPLETED|Second Intervention (4-6 Weeks)||1
8164377|NCT02506036|20127305|P1|COMPLETED|Second Intervention (4-6 Weeks)||2
8164378|NCT02506036|20127304|P2|STARTED|Second Intervention (4-6 Weeks)||1
8164379|NCT02506036|20127305|P1|STARTED|Second Intervention (4-6 Weeks)||2
8164380|NCT02506036|20127304|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
8164381|NCT02506036|20127305|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
8164382|NCT02506036|20127304|P2|COMPLETED|Washout (1-2 Weeks)||1
8164383|NCT02506036|20127305|P1|COMPLETED|Washout (1-2 Weeks)||2
8164384|NCT02506036|20127304|P2|STARTED|Washout (1-2 Weeks)||1
8164385|NCT02506036|20127305|P1|STARTED|Washout (1-2 Weeks)||2
8164386|NCT02506036|20127304|P2|NOT COMPLETED|First Intervention (4-6 Weeks)||2
8164387|NCT02506036|20127305|P1|NOT COMPLETED|First Intervention (4-6 Weeks)||1
8164388|NCT02506036|20127304|P2|COMPLETED|First Intervention (4-6 Weeks)||1
8164389|NCT02506036|20127305|P1|COMPLETED|First Intervention (4-6 Weeks)||2
8164390|NCT02506036|20127304|P2|STARTED|First Intervention (4-6 Weeks)||3
8164391|NCT02506036|20127305|P1|STARTED|First Intervention (4-6 Weeks)||3
8164392|NCT02505945|20127313|P2|NOT COMPLETED|Overall Study||4
8164393|NCT02505945|20127314|P1|NOT COMPLETED|Overall Study||22
8164394|NCT02505945|20127313|P2|COMPLETED|Overall Study||46
8164395|NCT02505945|20127314|P1|COMPLETED|Overall Study||80
8164396|NCT02505945|20127313|P2|STARTED|Overall Study||50
8164397|NCT02505945|20127314|P1|STARTED|Overall Study||102
8164398|NCT02505919|20127324|P2|NOT COMPLETED|36 Months Follow-Up||5
8164399|NCT02505919|20127325|P1|NOT COMPLETED|36 Months Follow-Up||15
8164400|NCT02505919|20127324|P2|COMPLETED|36 Months Follow-Up||55
8164401|NCT02505919|20127325|P1|COMPLETED|36 Months Follow-Up||97
8164402|NCT02505919|20127324|P2|STARTED|36 Months Follow-Up||60
8164403|NCT02505919|20127325|P1|STARTED|36 Months Follow-Up||112
8164404|NCT02505919|20127324|P2|NOT COMPLETED|24 Months Follow-Up||1
8164405|NCT02505919|20127325|P1|NOT COMPLETED|24 Months Follow-Up||3
8164406|NCT02505919|20127324|P2|COMPLETED|24 Months Follow-Up||60
8164407|NCT02505919|20127325|P1|COMPLETED|24 Months Follow-Up||112
8164408|NCT02505919|20127324|P2|STARTED|24 Months Follow-Up||61
8164409|NCT02505919|20127325|P1|STARTED|24 Months Follow-Up||115
8164410|NCT02505919|20127324|P2|NOT COMPLETED|12 Months Follow-Up||2
8164411|NCT02505919|20127325|P1|NOT COMPLETED|12 Months Follow-Up||1
8164412|NCT02505919|20127324|P2|COMPLETED|12 Months Follow-Up||61
8164413|NCT02505919|20127325|P1|COMPLETED|12 Months Follow-Up||115
8164414|NCT02505919|20127324|P2|STARTED|12 Months Follow-Up||63
8164415|NCT02505919|20127325|P1|STARTED|12 Months Follow-Up||116
8164416|NCT02505919|20127324|P2|NOT COMPLETED|6 Months Follow-Up||2
8164417|NCT02505919|20127325|P1|NOT COMPLETED|6 Months Follow-Up||0
8164418|NCT02505919|20127324|P2|COMPLETED|6 Months Follow-Up||63
8164419|NCT02505919|20127325|P1|COMPLETED|6 Months Follow-Up||116
8164420|NCT02505919|20127324|P2|STARTED|6 Months Follow-Up||65
8164421|NCT02505919|20127325|P1|STARTED|6 Months Follow-Up||116
8164422|NCT02505919|20127324|P2|NOT COMPLETED|3 Months Follow-Up||0
8164423|NCT02505919|20127325|P1|NOT COMPLETED|3 Months Follow-Up||0
8164424|NCT02505919|20127324|P2|COMPLETED|3 Months Follow-Up||65
8164425|NCT02505919|20127325|P1|COMPLETED|3 Months Follow-Up||116
8164426|NCT02505919|20127324|P2|STARTED|3 Months Follow-Up||65
8164427|NCT02505919|20127325|P1|STARTED|3 Months Follow-Up||116
8164428|NCT02505919|20127324|P2|NOT COMPLETED|1 Month Follow-Up||0
8164429|NCT02505919|20127325|P1|NOT COMPLETED|1 Month Follow-Up||0
8164430|NCT02505919|20127324|P2|COMPLETED|1 Month Follow-Up||65
8164431|NCT02505919|20127325|P1|COMPLETED|1 Month Follow-Up||116
8164432|NCT02505919|20127324|P2|STARTED|1 Month Follow-Up||65
8164433|NCT02505919|20127325|P1|STARTED|1 Month Follow-Up||116
8164434|NCT02505919|20127324|P2|NOT COMPLETED|1 Week Follow-Up||0
8164435|NCT02505919|20127325|P1|NOT COMPLETED|1 Week Follow-Up||0
8164436|NCT02505919|20127324|P2|COMPLETED|1 Week Follow-Up||65
8164437|NCT02505919|20127325|P1|COMPLETED|1 Week Follow-Up||116
8164438|NCT02505919|20127324|P2|STARTED|1 Week Follow-Up||65
8164439|NCT02505919|20127325|P1|STARTED|1 Week Follow-Up||116
8164440|NCT02505919|20127324|P2|NOT COMPLETED|Treatment||2
8164441|NCT02505919|20127325|P1|NOT COMPLETED|Treatment||1
8164442|NCT02505919|20127324|P2|COMPLETED|Treatment||65
8164443|NCT02505919|20127325|P1|COMPLETED|Treatment||116
8164444|NCT02505919|20127324|P2|STARTED|Treatment||67
8164445|NCT02505919|20127325|P1|STARTED|Treatment||117
8164446|NCT02505867|20127335|P2|NOT COMPLETED|Overall Study||6
8164447|NCT02505867|20127336|P1|NOT COMPLETED|Overall Study||6
8164448|NCT02505867|20127335|P2|COMPLETED|Overall Study||0
8164449|NCT02505867|20127336|P1|COMPLETED|Overall Study||0
8164450|NCT02505867|20127335|P2|STARTED|Overall Study||6
8164451|NCT02505867|20127336|P1|STARTED|Overall Study||6
8164452|NCT02505542|20127342|P4|NOT COMPLETED|Part B: Double-Blind Period||7
8164453|NCT02505542|20127343|P3|NOT COMPLETED|Part B: Double-Blind Period||9
8164454|NCT02505542|20127344|P2|NOT COMPLETED|Part B: Double-Blind Period||12
8164455|NCT02505542|20127345|P1|NOT COMPLETED|Part B: Double-Blind Period||0
8164456|NCT02505542|20127342|P4|COMPLETED|Part B: Double-Blind Period||98
8164457|NCT02505542|20127343|P3|COMPLETED|Part B: Double-Blind Period||95
8164458|NCT02505542|20127344|P2|COMPLETED|Part B: Double-Blind Period||92
8164459|NCT02505542|20127345|P1|COMPLETED|Part B: Double-Blind Period||0
8164460|NCT02505542|20127342|P4|Started Escape Period|Part B: Double-Blind Period||15
8164461|NCT02505542|20127343|P3|Started Escape Period|Part B: Double-Blind Period||7
8164462|NCT02505542|20127344|P2|Started Escape Period|Part B: Double-Blind Period||73
8164463|NCT02505542|20127345|P1|Started Escape Period|Part B: Double-Blind Period||0
8164464|NCT02505542|20127342|P4|STARTED|Part B: Double-Blind Period||105
8164465|NCT02505542|20127343|P3|STARTED|Part B: Double-Blind Period||104
8164466|NCT02505542|20127344|P2|STARTED|Part B: Double-Blind Period||104
8164467|NCT02505542|20127345|P1|STARTED|Part B: Double-Blind Period||0
8164468|NCT02505542|20127342|P4|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
8164469|NCT02505542|20127343|P3|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
8164470|NCT02505542|20127344|P2|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
8164471|NCT02505542|20127345|P1|NOT COMPLETED|Completed Part A, Did Not Enter Part B||346
8164472|NCT02505542|20127342|P4|COMPLETED|Completed Part A, Did Not Enter Part B||0
8164473|NCT02505542|20127343|P3|COMPLETED|Completed Part A, Did Not Enter Part B||0
8164474|NCT02505542|20127344|P2|COMPLETED|Completed Part A, Did Not Enter Part B||0
8164475|NCT02505542|20127345|P1|COMPLETED|Completed Part A, Did Not Enter Part B||313
8164476|NCT02505542|20127342|P4|STARTED|Completed Part A, Did Not Enter Part B||0
8164477|NCT02505542|20127343|P3|STARTED|Completed Part A, Did Not Enter Part B||0
8164478|NCT02505542|20127344|P2|STARTED|Completed Part A, Did Not Enter Part B||0
8164479|NCT02505542|20127345|P1|STARTED|Completed Part A, Did Not Enter Part B||659
8164480|NCT02505542|20127342|P4|NOT COMPLETED|Part A: Open-Label Period||0
8164481|NCT02505542|20127343|P3|NOT COMPLETED|Part A: Open-Label Period||0
8164482|NCT02505542|20127344|P2|NOT COMPLETED|Part A: Open-Label Period||0
8164483|NCT02505542|20127345|P1|NOT COMPLETED|Part A: Open-Label Period||77
8164484|NCT02505542|20127342|P4|COMPLETED|Part A: Open-Label Period||0
8164485|NCT02505542|20127343|P3|COMPLETED|Part A: Open-Label Period||0
8164486|NCT02505542|20127344|P2|COMPLETED|Part A: Open-Label Period||0
8164487|NCT02505542|20127345|P1|COMPLETED|Part A: Open-Label Period||659
8164488|NCT02505542|20127342|P4|STARTED|Part A: Open-Label Period||0
8164489|NCT02505542|20127343|P3|STARTED|Part A: Open-Label Period||0
8164490|NCT02505542|20127344|P2|STARTED|Part A: Open-Label Period||0
8164491|NCT02505542|20127345|P1|STARTED|Part A: Open-Label Period||736
8164492|NCT02505334|20127453|P2|NOT COMPLETED|Extension Treatment Period||0
8164493|NCT02505334|20127454|P1|NOT COMPLETED|Extension Treatment Period||18
8164494|NCT02505334|20127453|P2|COMPLETED|Extension Treatment Period||0
8164495|NCT02505334|20127454|P1|COMPLETED|Extension Treatment Period||194
8164496|NCT02505334|20127453|P2|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
8164497|NCT02505334|20127454|P1|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
8164498|NCT02505334|20127453|P2|NOT COMPLETED|Main Treatment Period||39
8164499|NCT02505334|20127454|P1|NOT COMPLETED|Main Treatment Period||15
8164500|NCT02505334|20127453|P2|COMPLETED|Main Treatment Period||194
8164501|NCT02505334|20127454|P1|COMPLETED|Main Treatment Period||218
8164502|NCT02505334|20127453|P2|STARTED|Main Treatment Period||233
8164503|NCT02505334|20127454|P1|STARTED|Main Treatment Period||233
8164504|NCT02505269|20127579|P1|NOT COMPLETED|Overall Study||0
8164505|NCT02505269|20127579|P1|COMPLETED|Overall Study||34
8164506|NCT02505269|20127579|P1|STARTED|Overall Study||34
8164507|NCT02505217|20127587|P2|NOT COMPLETED|Overall Study||2
8164508|NCT02505217|20127588|P1|NOT COMPLETED|Overall Study||1
8164509|NCT02505217|20127587|P2|COMPLETED|Overall Study||93
8164510|NCT02505217|20127588|P1|COMPLETED|Overall Study||104
8164511|NCT02505217|20127587|P2|STARTED|Overall Study||95
8164512|NCT02505217|20127588|P1|STARTED|Overall Study||105
8164513|NCT02504931|20127598|P2|NOT COMPLETED|Overall Study||10
8164514|NCT02504931|20127599|P1|NOT COMPLETED|Overall Study||12
8164515|NCT02504931|20127598|P2|COMPLETED|Overall Study||13
8164516|NCT02504931|20127599|P1|COMPLETED|Overall Study||14
8164517|NCT02504931|20127598|P2|STARTED|Overall Study||23
8164518|NCT02504931|20127599|P1|STARTED|Overall Study||26
8164519|NCT02504892|20127607|P1|NOT COMPLETED|Overall Study||2
8164520|NCT02504892|20127607|P1|COMPLETED|Overall Study||1
8164521|NCT02504892|20127607|P1|STARTED|Overall Study||3
8164522|NCT02504827|20127614|P1|NOT COMPLETED|Overall Study||1
8164523|NCT02504827|20127614|P1|COMPLETED|Overall Study||11
8164524|NCT02504827|20127614|P1|STARTED|Overall Study||12
8164525|NCT02504775|20127619|P2|NOT COMPLETED|Period 2||0
8164526|NCT02504775|20127620|P1|NOT COMPLETED|Period 2||0
8164527|NCT02504775|20127619|P2|COMPLETED|Period 2||14
8164528|NCT02504775|20127620|P1|COMPLETED|Period 2||14
8164529|NCT02504775|20127619|P2|STARTED|Period 2||14
8164530|NCT02504775|20127620|P1|STARTED|Period 2||14
8164531|NCT02504775|20127619|P2|NOT COMPLETED|Washout||0
8164532|NCT02504775|20127620|P1|NOT COMPLETED|Washout||0
8164533|NCT02504775|20127619|P2|COMPLETED|Washout||14
8164534|NCT02504775|20127620|P1|COMPLETED|Washout||14
8164535|NCT02504775|20127619|P2|STARTED|Washout||14
8164536|NCT02504775|20127620|P1|STARTED|Washout||14
8164537|NCT02504775|20127619|P2|NOT COMPLETED|Period 1||0
8164538|NCT02504775|20127620|P1|NOT COMPLETED|Period 1||0
8164539|NCT02504775|20127619|P2|COMPLETED|Period 1||14
8164540|NCT02504775|20127620|P1|COMPLETED|Period 1||14
8164541|NCT02504775|20127619|P2|STARTED|Period 1||14
8164542|NCT02504775|20127620|P1|STARTED|Period 1||14
8164543|NCT02504723|20127634|P2|NOT COMPLETED|Overall Study||0
8164544|NCT02504723|20127635|P1|NOT COMPLETED|Overall Study||0
8164545|NCT02504723|20127634|P2|COMPLETED|Overall Study||61
8164546|NCT02504723|20127635|P1|COMPLETED|Overall Study||60
8164547|NCT02504723|20127634|P2|STARTED|Overall Study||61
8164548|NCT02504723|20127635|P1|STARTED|Overall Study||60
8164549|NCT02504671|20127653|P6|NOT COMPLETED|Overall Study||14
8164550|NCT02504671|20127654|P5|NOT COMPLETED|Overall Study||12
8164551|NCT02504671|20127655|P4|NOT COMPLETED|Overall Study||10
8164552|NCT02504671|20127656|P3|NOT COMPLETED|Overall Study||10
8164553|NCT02504671|20127657|P2|NOT COMPLETED|Overall Study||14
8164554|NCT02504671|20127658|P1|NOT COMPLETED|Overall Study||12
8164555|NCT02504671|20127653|P6|COMPLETED|Overall Study||23
8164556|NCT02504671|20127654|P5|COMPLETED|Overall Study||25
8164557|NCT02504671|20127655|P4|COMPLETED|Overall Study||27
8164558|NCT02504671|20127656|P3|COMPLETED|Overall Study||27
8164559|NCT02504671|20127657|P2|COMPLETED|Overall Study||23
8164560|NCT02504671|20127658|P1|COMPLETED|Overall Study||25
8164561|NCT02504671|20127653|P6|STARTED|Overall Study||37
8164562|NCT02504671|20127654|P5|STARTED|Overall Study||37
8164563|NCT02504671|20127655|P4|STARTED|Overall Study||37
8164564|NCT02504671|20127656|P3|STARTED|Overall Study||37
8164565|NCT02504671|20127657|P2|STARTED|Overall Study||37
8164566|NCT02504671|20127658|P1|STARTED|Overall Study||37
8164567|NCT02504645|20127800|P2|NOT COMPLETED|Overall Study||25
8164568|NCT02504645|20127801|P1|NOT COMPLETED|Overall Study||24
8164569|NCT02504645|20127800|P2|COMPLETED|Overall Study||76
8164570|NCT02504645|20127801|P1|COMPLETED|Overall Study||77
8164571|NCT02504645|20127800|P2|STARTED|Overall Study||101
8164572|NCT02504645|20127801|P1|STARTED|Overall Study||101
8164573|NCT02504619|20127809|P1|NOT COMPLETED|Overall Study||0
8164574|NCT02504619|20127809|P1|COMPLETED|Overall Study||1
8164575|NCT02504619|20127809|P1|STARTED|Overall Study||1
8164576|NCT02504554|20127817|P2|NOT COMPLETED|Overall Study||0
8164577|NCT02504554|20127818|P1|NOT COMPLETED|Overall Study||0
8164578|NCT02504554|20127817|P2|COMPLETED|Overall Study||6
8164579|NCT02504554|20127818|P1|COMPLETED|Overall Study||12
8164580|NCT02504554|20127817|P2|STARTED|Overall Study||6
8164581|NCT02504554|20127818|P1|STARTED|Overall Study|1 participant was switched from the oral group to the rectal group due to nausea/vomiting.|12
8164582|NCT02504541|20127830|P1|NOT COMPLETED|Overall Study||20
8164583|NCT02504541|20127830|P1|COMPLETED|Overall Study||113
8164584|NCT02504541|20127830|P1|STARTED|Overall Study||133
8164585|NCT02504502|20127836|P2|NOT COMPLETED|Crossover to Enhanced Report||0
8164586|NCT02504502|20127837|P1|NOT COMPLETED|Crossover to Enhanced Report||5
8164587|NCT02504502|20127836|P2|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
8164588|NCT02504502|20127837|P1|COMPLETED|Crossover to Enhanced Report||15
8164589|NCT02504502|20127836|P2|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
8164590|NCT02504502|20127837|P1|STARTED|Crossover to Enhanced Report||20
8164591|NCT02504502|20127836|P2|NOT COMPLETED|Routine Care vs. Enhanced Report||7
8164592|NCT02504502|20127837|P1|NOT COMPLETED|Routine Care vs. Enhanced Report||4
8164593|NCT02504502|20127836|P2|COMPLETED|Routine Care vs. Enhanced Report||21
8164594|NCT02504502|20127837|P1|COMPLETED|Routine Care vs. Enhanced Report||20
8164595|NCT02504502|20127836|P2|STARTED|Routine Care vs. Enhanced Report||28
8164596|NCT02504502|20127837|P1|STARTED|Routine Care vs. Enhanced Report||24
8164597|NCT02504424|20127843|P1|NOT COMPLETED|Overall Study||2
8164598|NCT02504424|20127843|P1|COMPLETED|Overall Study||48
8164599|NCT02504424|20127843|P1|STARTED|Overall Study||50
8164600|NCT02504320|20127852|P4|NOT COMPLETED|Treatment Period 4||0
8164601|NCT02504320|20127853|P3|NOT COMPLETED|Treatment Period 4||0
8164602|NCT02504320|20127854|P2|NOT COMPLETED|Treatment Period 4||0
8164603|NCT02504320|20127855|P1|NOT COMPLETED|Treatment Period 4||0
8164604|NCT02504320|20127852|P4|COMPLETED|Treatment Period 4||19
8164605|NCT02504320|20127853|P3|COMPLETED|Treatment Period 4||18
8164606|NCT02504320|20127854|P2|COMPLETED|Treatment Period 4||18
8164607|NCT02504320|20127855|P1|COMPLETED|Treatment Period 4||19
8164608|NCT02504320|20127852|P4|STARTED|Treatment Period 4||19
8164609|NCT02504320|20127853|P3|STARTED|Treatment Period 4||18
8164610|NCT02504320|20127854|P2|STARTED|Treatment Period 4||18
8164611|NCT02504320|20127855|P1|STARTED|Treatment Period 4||19
8164612|NCT02504320|20127852|P4|NOT COMPLETED|Treatment Period 3||1
8164613|NCT02504320|20127853|P3|NOT COMPLETED|Treatment Period 3||1
8164614|NCT02504320|20127854|P2|NOT COMPLETED|Treatment Period 3||0
8164615|NCT02504320|20127855|P1|NOT COMPLETED|Treatment Period 3||0
8164616|NCT02504320|20127852|P4|COMPLETED|Treatment Period 3||19
8164617|NCT02504320|20127853|P3|COMPLETED|Treatment Period 3||18
8164618|NCT02504320|20127854|P2|COMPLETED|Treatment Period 3||18
8164619|NCT02504320|20127855|P1|COMPLETED|Treatment Period 3||19
8164620|NCT02504320|20127852|P4|STARTED|Treatment Period 3||20
8164621|NCT02504320|20127853|P3|STARTED|Treatment Period 3||19
8164622|NCT02504320|20127854|P2|STARTED|Treatment Period 3||18
8164623|NCT02504320|20127855|P1|STARTED|Treatment Period 3||19
8164624|NCT02504320|20127852|P4|NOT COMPLETED|Treatment Period 2||0
8164625|NCT02504320|20127853|P3|NOT COMPLETED|Treatment Period 2||0
8164626|NCT02504320|20127854|P2|NOT COMPLETED|Treatment Period 2||1
8164627|NCT02504320|20127855|P1|NOT COMPLETED|Treatment Period 2||0
8164628|NCT02504320|20127852|P4|COMPLETED|Treatment Period 2||20
8164629|NCT02504320|20127853|P3|COMPLETED|Treatment Period 2||19
8164630|NCT02504320|20127854|P2|COMPLETED|Treatment Period 2||18
8164631|NCT02504320|20127855|P1|COMPLETED|Treatment Period 2||19
8164632|NCT02504320|20127852|P4|STARTED|Treatment Period 2||20
8164633|NCT02504320|20127853|P3|STARTED|Treatment Period 2||19
8164634|NCT02504320|20127854|P2|STARTED|Treatment Period 2||19
8164635|NCT02504320|20127855|P1|STARTED|Treatment Period 2||19
8164636|NCT02504320|20127852|P4|NOT COMPLETED|Treatment Period 1||0
8164637|NCT02504320|20127853|P3|NOT COMPLETED|Treatment Period 1||1
8164638|NCT02504320|20127854|P2|NOT COMPLETED|Treatment Period 1||0
8164639|NCT02504320|20127855|P1|NOT COMPLETED|Treatment Period 1||0
8164640|NCT02504320|20127852|P4|COMPLETED|Treatment Period 1||20
8164641|NCT02504320|20127853|P3|COMPLETED|Treatment Period 1||19
8164642|NCT02504320|20127854|P2|COMPLETED|Treatment Period 1||19
8164643|NCT02504320|20127855|P1|COMPLETED|Treatment Period 1||19
8164644|NCT02504320|20127852|P4|STARTED|Treatment Period 1||20
8164645|NCT02504320|20127853|P3|STARTED|Treatment Period 1||20
8164646|NCT02504320|20127854|P2|STARTED|Treatment Period 1||19
8164647|NCT02504320|20127855|P1|STARTED|Treatment Period 1||19
8164648|NCT02504294|20127875|P2|NOT COMPLETED|Overall Study||48
8164649|NCT02504294|20127876|P1|NOT COMPLETED|Overall Study||56
8164650|NCT02504294|20127875|P2|COMPLETED|Overall Study||158
8164651|NCT02504294|20127876|P1|COMPLETED|Overall Study||156
8164652|NCT02504294|20127875|P2|STARTED|Overall Study||206
8164653|NCT02504294|20127876|P1|STARTED|Overall Study||212
8164660|NCT02504216|20127903|P2|NOT COMPLETED|Overall Study||15
8164661|NCT02504216|20127904|P1|NOT COMPLETED|Overall Study||11
8164662|NCT02504216|20127903|P2|COMPLETED|Overall Study||3263
8164663|NCT02504216|20127904|P1|COMPLETED|Overall Study||3275
8164664|NCT02504216|20127903|P2|Received Treatment|Overall Study||3248
8164665|NCT02504216|20127904|P1|Received Treatment|Overall Study||3256
8164666|NCT02504216|20127903|P2|STARTED|Overall Study||3278
8164667|NCT02504216|20127904|P1|STARTED|Overall Study||3286
8164668|NCT02504099|20127930|P1|NOT COMPLETED|Overall Study||0
8164669|NCT02504099|20127930|P1|COMPLETED|Overall Study||3
8164670|NCT02504099|20127930|P1|STARTED|Overall Study||3
8164671|NCT02504073|20127938|P1|NOT COMPLETED|Overall Study||0
8164672|NCT02504073|20127938|P1|COMPLETED|Overall Study||54
8164673|NCT02504073|20127938|P1|STARTED|Overall Study||54
8164674|NCT02503982|20127944|P1|NOT COMPLETED|Overall Study||0
8164675|NCT02503982|20127944|P1|COMPLETED|Overall Study||13
8164676|NCT02503982|20127944|P1|STARTED|Overall Study||13
8164677|NCT02503865|20127951|P3|NOT COMPLETED|Overall Study||2
8164678|NCT02503865|20127952|P2|NOT COMPLETED|Overall Study||47
8164679|NCT02503865|20127953|P1|NOT COMPLETED|Overall Study||5
8164680|NCT02503865|20127951|P3|COMPLETED|Overall Study||64
8164681|NCT02503865|20127952|P2|COMPLETED|Overall Study||222
8164682|NCT02503865|20127953|P1|COMPLETED|Overall Study||65
8164683|NCT02503865|20127951|P3|STARTED|Overall Study||66
8164684|NCT02503865|20127952|P2|STARTED|Overall Study||269
8164685|NCT02503865|20127953|P1|STARTED|Overall Study||70
8164686|NCT02503852|20127977|P4|NOT COMPLETED|Overall Study||1
8164687|NCT02503852|20127978|P3|NOT COMPLETED|Overall Study||3
8164688|NCT02503852|20127979|P2|NOT COMPLETED|Overall Study||3
8164689|NCT02503852|20127980|P1|NOT COMPLETED|Overall Study||4
8164690|NCT02503852|20127977|P4|COMPLETED|Overall Study||8
8164691|NCT02503852|20127978|P3|COMPLETED|Overall Study||21
8164692|NCT02503852|20127979|P2|COMPLETED|Overall Study||19
8164693|NCT02503852|20127980|P1|COMPLETED|Overall Study||12
8164694|NCT02503852|20127977|P4|STARTED|Overall Study||9
8164695|NCT02503852|20127978|P3|STARTED|Overall Study||24
8164696|NCT02503852|20127979|P2|STARTED|Overall Study||22
8164697|NCT02503852|20127980|P1|STARTED|Overall Study||16
8164698|NCT02503787|20127998|P1|NOT COMPLETED|Implant to 3 Month Endpoint||3
8164699|NCT02503787|20127998|P1|COMPLETED|Implant to 3 Month Endpoint||29
8164700|NCT02503787|20127998|P1|STARTED|Implant to 3 Month Endpoint||32
8164701|NCT02503787|20127998|P1|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
8164702|NCT02503787|20127998|P1|COMPLETED|Successful Trial (≥50% Pain Relief)||32
8164703|NCT02503787|20127998|P1|STARTED|Successful Trial (≥50% Pain Relief)||37
8164704|NCT02503787|20127998|P1|NOT COMPLETED|Device Trial (HD Programming Trial)||7
8164705|NCT02503787|20127998|P1|COMPLETED|Device Trial (HD Programming Trial)||37
8164706|NCT02503787|20127998|P1|STARTED|Device Trial (HD Programming Trial)||44
8164707|NCT02503787|20127998|P1|NOT COMPLETED|Enrollment||20
8164708|NCT02503787|20127998|P1|COMPLETED|Enrollment||44
8164709|NCT02503787|20127998|P1|STARTED|Enrollment||64
8164710|NCT02503735|20128005|P1|NOT COMPLETED|Overall Study||0
8164711|NCT02503735|20128005|P1|COMPLETED|Overall Study||10
8164712|NCT02503735|20128005|P1|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8
8164713|NCT02503735|20128005|P1|STARTED|Overall Study||10
8164717|NCT02503501|20128036|P2|NOT COMPLETED|Overall Study||3
8164718|NCT02503501|20128037|P1|NOT COMPLETED|Overall Study||1
8164719|NCT02503501|20128036|P2|COMPLETED|Overall Study||13
8164720|NCT02503501|20128037|P1|COMPLETED|Overall Study||18
8164721|NCT02503501|20128036|P2|STARTED|Overall Study||16
8164722|NCT02503501|20128037|P1|STARTED|Overall Study||19
8164723|NCT02503410|20128049|P2|NOT COMPLETED|Overall Study||0
8164724|NCT02503410|20128050|P1|NOT COMPLETED|Overall Study||0
8164725|NCT02503410|20128049|P2|COMPLETED|Overall Study||3
8164726|NCT02503410|20128050|P1|COMPLETED|Overall Study||4
8164727|NCT02503410|20128049|P2|STARTED|Overall Study||3
8164728|NCT02503410|20128050|P1|STARTED|Overall Study||4
8164729|NCT02503332|20128073|P4|NOT COMPLETED|Overall Study||4
8164730|NCT02503332|20128074|P3|NOT COMPLETED|Overall Study||8
8164731|NCT02503332|20128075|P2|NOT COMPLETED|Overall Study||19
8164732|NCT02503332|20128076|P1|NOT COMPLETED|Overall Study||34
8164733|NCT02503332|20128073|P4|COMPLETED|Overall Study||36
8164734|NCT02503332|20128074|P3|COMPLETED|Overall Study||33
8164735|NCT02503332|20128075|P2|COMPLETED|Overall Study||60
8164736|NCT02503332|20128076|P1|COMPLETED|Overall Study||52
8164737|NCT02503332|20128073|P4|STARTED|Overall Study||40
8164738|NCT02503332|20128074|P3|STARTED|Overall Study||41
8164739|NCT02503332|20128075|P2|STARTED|Overall Study||79
8164740|NCT02503332|20128076|P1|STARTED|Overall Study||86
8164741|NCT02503254|20128113|P2|NOT COMPLETED|Overall Study||0
8164742|NCT02503254|20128114|P1|NOT COMPLETED|Overall Study||0
8164743|NCT02503254|20128113|P2|COMPLETED|Overall Study||39
8164744|NCT02503254|20128114|P1|COMPLETED|Overall Study||41
8164745|NCT02503254|20128113|P2|STARTED|Overall Study||39
8164746|NCT02503254|20128114|P1|STARTED|Overall Study||41
8164747|NCT02503215|20128127|P1|NOT COMPLETED|Overall Study||3
8164748|NCT02503215|20128127|P1|COMPLETED|Overall Study||14
8164749|NCT02503215|20128127|P1|STARTED|Overall Study||17
8164750|NCT02503202|20128138|P5|NOT COMPLETED|Extension: Month 6 to 24||1
8164751|NCT02503202|20128139|P4|NOT COMPLETED|Extension: Month 6 to 24||18
8164752|NCT02503202|20128140|P3|NOT COMPLETED|Extension: Month 6 to 24||9
8164753|NCT02503202|20128141|P2|NOT COMPLETED|Extension: Month 6 to 24||16
8164754|NCT02503202|20128142|P1|NOT COMPLETED|Extension: Month 6 to 24||11
8164755|NCT02503202|20128138|P5|COMPLETED|Extension: Month 6 to 24||67
8164756|NCT02503202|20128139|P4|COMPLETED|Extension: Month 6 to 24||119
8164757|NCT02503202|20128140|P3|COMPLETED|Extension: Month 6 to 24||103
8164758|NCT02503202|20128141|P2|COMPLETED|Extension: Month 6 to 24||114
8164759|NCT02503202|20128142|P1|COMPLETED|Extension: Month 6 to 24||108
8164760|NCT02503202|20128138|P5|STARTED|Extension: Month 6 to 24||68
8164761|NCT02503202|20128139|P4|STARTED|Extension: Month 6 to 24||137
8164762|NCT02503202|20128140|P3|STARTED|Extension: Month 6 to 24||112
8164763|NCT02503202|20128141|P2|STARTED|Extension: Month 6 to 24||130
8164764|NCT02503202|20128142|P1|STARTED|Extension: Month 6 to 24||119
8164765|NCT02503202|20128138|P5|NOT COMPLETED|Base Study: Up to Month 6||3
8164766|NCT02503202|20128139|P4|NOT COMPLETED|Base Study: Up to Month 6||11
8164767|NCT02503202|20128140|P3|NOT COMPLETED|Base Study: Up to Month 6||15
8164768|NCT02503202|20128141|P2|NOT COMPLETED|Base Study: Up to Month 6||12
8164769|NCT02503202|20128142|P1|NOT COMPLETED|Base Study: Up to Month 6||18
8164770|NCT02503202|20128138|P5|COMPLETED|Base Study: Up to Month 6||130
8164771|NCT02503202|20128139|P4|COMPLETED|Base Study: Up to Month 6||255
8164772|NCT02503202|20128140|P3|COMPLETED|Base Study: Up to Month 6||252
8164773|NCT02503202|20128141|P2|COMPLETED|Base Study: Up to Month 6||253
8164774|NCT02503202|20128142|P1|COMPLETED|Base Study: Up to Month 6||248
8164775|NCT02503202|20128138|P5|Vaccinated|Base Study: Up to Month 6||133
8164776|NCT02503202|20128139|P4|Vaccinated|Base Study: Up to Month 6||264
8164777|NCT02503202|20128140|P3|Vaccinated|Base Study: Up to Month 6||266
8164778|NCT02503202|20128141|P2|Vaccinated|Base Study: Up to Month 6||265
8164779|NCT02503202|20128142|P1|Vaccinated|Base Study: Up to Month 6||266
8164780|NCT02503202|20128138|P5|STARTED|Base Study: Up to Month 6||133
8164781|NCT02503202|20128139|P4|STARTED|Base Study: Up to Month 6||266
8164782|NCT02503202|20128140|P3|STARTED|Base Study: Up to Month 6||267
8164783|NCT02503202|20128141|P2|STARTED|Base Study: Up to Month 6||265
8164784|NCT02503202|20128142|P1|STARTED|Base Study: Up to Month 6||266
8164785|NCT02503085|20128184|P4|NOT COMPLETED|Period 4||0
8164786|NCT02503085|20128185|P3|NOT COMPLETED|Period 4||0
8164787|NCT02503085|20128186|P2|NOT COMPLETED|Period 4||0
8164788|NCT02503085|20128187|P1|NOT COMPLETED|Period 4||0
8164789|NCT02503085|20128184|P4|COMPLETED|Period 4||7
8164790|NCT02503085|20128185|P3|COMPLETED|Period 4||6
8164791|NCT02503085|20128186|P2|COMPLETED|Period 4||7
8164792|NCT02503085|20128187|P1|COMPLETED|Period 4||6
8164793|NCT02503085|20128184|P4|STARTED|Period 4||7
8164794|NCT02503085|20128185|P3|STARTED|Period 4||6
8164795|NCT02503085|20128186|P2|STARTED|Period 4||7
8164796|NCT02503085|20128187|P1|STARTED|Period 4||6
8164797|NCT02503085|20128184|P4|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8164798|NCT02503085|20128185|P3|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8164799|NCT02503085|20128186|P2|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8164800|NCT02503085|20128187|P1|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
8164801|NCT02503085|20128184|P4|COMPLETED|Period 3: Washout (3 to 7 Days)||7
8164802|NCT02503085|20128185|P3|COMPLETED|Period 3: Washout (3 to 7 Days)||6
8164803|NCT02503085|20128186|P2|COMPLETED|Period 3: Washout (3 to 7 Days)||7
8164804|NCT02503085|20128187|P1|COMPLETED|Period 3: Washout (3 to 7 Days)||6
8164805|NCT02503085|20128184|P4|STARTED|Period 3: Washout (3 to 7 Days)||7
8164806|NCT02503085|20128185|P3|STARTED|Period 3: Washout (3 to 7 Days)||6
8164807|NCT02503085|20128186|P2|STARTED|Period 3: Washout (3 to 7 Days)||7
8164808|NCT02503085|20128187|P1|STARTED|Period 3: Washout (3 to 7 Days)||6
8164809|NCT02503085|20128184|P4|NOT COMPLETED|Period 3||0
8164810|NCT02503085|20128185|P3|NOT COMPLETED|Period 3||0
8164811|NCT02503085|20128186|P2|NOT COMPLETED|Period 3||0
8164812|NCT02503085|20128187|P1|NOT COMPLETED|Period 3||0
8164813|NCT02503085|20128184|P4|COMPLETED|Period 3||7
8164814|NCT02503085|20128185|P3|COMPLETED|Period 3||6
8164815|NCT02503085|20128186|P2|COMPLETED|Period 3||7
8164816|NCT02503085|20128187|P1|COMPLETED|Period 3||6
8164817|NCT02503085|20128184|P4|STARTED|Period 3||7
8164818|NCT02503085|20128185|P3|STARTED|Period 3||6
8164819|NCT02503085|20128186|P2|STARTED|Period 3||7
8164820|NCT02503085|20128187|P1|STARTED|Period 3||6
8164821|NCT02503085|20128184|P4|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
8164822|NCT02503085|20128185|P3|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
8164823|NCT02503085|20128186|P2|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
8164824|NCT02503085|20128187|P1|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
8164825|NCT02503085|20128184|P4|COMPLETED|Period 2: Washout (3 to 7 Days)||7
8164826|NCT02503085|20128185|P3|COMPLETED|Period 2: Washout (3 to 7 Days)||6
8164827|NCT02503085|20128186|P2|COMPLETED|Period 2: Washout (3 to 7 Days)||7
8164828|NCT02503085|20128187|P1|COMPLETED|Period 2: Washout (3 to 7 Days)||6
8164829|NCT02503085|20128184|P4|STARTED|Period 2: Washout (3 to 7 Days)||7
8164830|NCT02503085|20128185|P3|STARTED|Period 2: Washout (3 to 7 Days)||7
8164831|NCT02503085|20128186|P2|STARTED|Period 2: Washout (3 to 7 Days)||7
8164832|NCT02503085|20128187|P1|STARTED|Period 2: Washout (3 to 7 Days)||7
8164833|NCT02503085|20128184|P4|NOT COMPLETED|Period 2||0
8164834|NCT02503085|20128185|P3|NOT COMPLETED|Period 2||0
8164835|NCT02503085|20128186|P2|NOT COMPLETED|Period 2||0
8164836|NCT02503085|20128187|P1|NOT COMPLETED|Period 2||0
8164837|NCT02503085|20128184|P4|COMPLETED|Period 2||7
8164838|NCT02503085|20128185|P3|COMPLETED|Period 2||7
8164839|NCT02503085|20128186|P2|COMPLETED|Period 2||7
8164840|NCT02503085|20128187|P1|COMPLETED|Period 2||7
8164841|NCT02503085|20128184|P4|STARTED|Period 2||7
8164842|NCT02503085|20128185|P3|STARTED|Period 2||7
8164843|NCT02503085|20128186|P2|STARTED|Period 2||7
8164844|NCT02503085|20128187|P1|STARTED|Period 2||7
8164845|NCT02503085|20128184|P4|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8164846|NCT02503085|20128185|P3|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8164847|NCT02503085|20128186|P2|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8164848|NCT02503085|20128187|P1|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
8164849|NCT02503085|20128184|P4|COMPLETED|Period 1: Washout (3 to 7 Days)||7
8164850|NCT02503085|20128185|P3|COMPLETED|Period 1: Washout (3 to 7 Days)||7
8164851|NCT02503085|20128186|P2|COMPLETED|Period 1: Washout (3 to 7 Days)||7
8164852|NCT02503085|20128187|P1|COMPLETED|Period 1: Washout (3 to 7 Days)||7
8164853|NCT02503085|20128184|P4|STARTED|Period 1: Washout (3 to 7 Days)||7
8164854|NCT02503085|20128185|P3|STARTED|Period 1: Washout (3 to 7 Days)||7
8164855|NCT02503085|20128186|P2|STARTED|Period 1: Washout (3 to 7 Days)||7
8164856|NCT02503085|20128187|P1|STARTED|Period 1: Washout (3 to 7 Days)||7
8164857|NCT02503085|20128184|P4|NOT COMPLETED|Period 1||0
8164858|NCT02503085|20128185|P3|NOT COMPLETED|Period 1||0
8164859|NCT02503085|20128186|P2|NOT COMPLETED|Period 1||0
8164860|NCT02503085|20128187|P1|NOT COMPLETED|Period 1||0
8164861|NCT02503085|20128184|P4|COMPLETED|Period 1||7
8164862|NCT02503085|20128185|P3|COMPLETED|Period 1||7
8164863|NCT02503085|20128186|P2|COMPLETED|Period 1||7
8164864|NCT02503085|20128187|P1|COMPLETED|Period 1||7
8164865|NCT02503085|20128184|P4|STARTED|Period 1||7
8164866|NCT02503085|20128185|P3|STARTED|Period 1||7
8164867|NCT02503085|20128186|P2|STARTED|Period 1||7
8164868|NCT02503085|20128187|P1|STARTED|Period 1||7
8164869|NCT02502864|20128226|P1|NOT COMPLETED|Overall Study||1
8164870|NCT02502864|20128226|P1|COMPLETED|Overall Study||8
8164871|NCT02502864|20128226|P1|STARTED|Overall Study||9
8164872|NCT02502734|20128235|P2|NOT COMPLETED|Double-blind Treatment Period 2||0
8164873|NCT02502734|20128236|P1|NOT COMPLETED|Double-blind Treatment Period 2||0
8164874|NCT02502734|20128235|P2|COMPLETED|Double-blind Treatment Period 2||30
8164875|NCT02502734|20128236|P1|COMPLETED|Double-blind Treatment Period 2||28
8164876|NCT02502734|20128235|P2|STARTED|Double-blind Treatment Period 2||30
8164877|NCT02502734|20128236|P1|STARTED|Double-blind Treatment Period 2||28
8164878|NCT02502734|20128235|P2|NOT COMPLETED|Washout Period||0
8164879|NCT02502734|20128236|P1|NOT COMPLETED|Washout Period||1
8164880|NCT02502734|20128235|P2|COMPLETED|Washout Period||30
8164881|NCT02502734|20128236|P1|COMPLETED|Washout Period||28
8164882|NCT02502734|20128235|P2|STARTED|Washout Period||30
8164883|NCT02502734|20128236|P1|STARTED|Washout Period||29
8164884|NCT02502734|20128235|P2|NOT COMPLETED|Double-blind Treatment Period 1||0
8164885|NCT02502734|20128236|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
8164886|NCT02502734|20128235|P2|COMPLETED|Double-blind Treatment Period 1||30
8164887|NCT02502734|20128236|P1|COMPLETED|Double-blind Treatment Period 1||29
8164888|NCT02502734|20128235|P2|STARTED|Double-blind Treatment Period 1||30
8164889|NCT02502734|20128236|P1|STARTED|Double-blind Treatment Period 1||30
8164890|NCT02502526|20128247|P3|NOT COMPLETED|Overall Study||6
8164891|NCT02502526|20128248|P2|NOT COMPLETED|Overall Study||4
8164892|NCT02502526|20128249|P1|NOT COMPLETED|Overall Study||6
8164893|NCT02502526|20128247|P3|COMPLETED|Overall Study||55
8164894|NCT02502526|20128248|P2|COMPLETED|Overall Study||55
8164895|NCT02502526|20128249|P1|COMPLETED|Overall Study||56
8164896|NCT02502526|20128247|P3|Intent-to-Treat (ITT)|Overall Study||59
8164897|NCT02502526|20128248|P2|Intent-to-Treat (ITT)|Overall Study||57
8164898|NCT02502526|20128249|P1|Intent-to-Treat (ITT)|Overall Study||57
8164899|NCT02502526|20128247|P3|STARTED|Overall Study||61
8164900|NCT02502526|20128248|P2|STARTED|Overall Study||59
8164901|NCT02502526|20128249|P1|STARTED|Overall Study||62
8164902|NCT02502487|20128265|P3|NOT COMPLETED|Overall Study||0
8164903|NCT02502487|20128266|P2|NOT COMPLETED|Overall Study||0
8164904|NCT02502487|20128267|P1|NOT COMPLETED|Overall Study||0
8164905|NCT02502487|20128265|P3|COMPLETED|Overall Study||86
8164906|NCT02502487|20128266|P2|COMPLETED|Overall Study||86
8164907|NCT02502487|20128267|P1|COMPLETED|Overall Study||86
8164908|NCT02502487|20128265|P3|STARTED|Overall Study||86
8164909|NCT02502487|20128266|P2|STARTED|Overall Study||86
8164910|NCT02502487|20128267|P1|STARTED|Overall Study||86
8164911|NCT02502461|20128337|P2|NOT COMPLETED|Overall Study||0
8164912|NCT02502461|20128338|P1|NOT COMPLETED|Overall Study||0
8164913|NCT02502461|20128337|P2|COMPLETED|Overall Study||44
8164914|NCT02502461|20128338|P1|COMPLETED|Overall Study||46
8164915|NCT02502461|20128337|P2|STARTED|Overall Study||44
8164916|NCT02502461|20128338|P1|STARTED|Overall Study||46
8164917|NCT02502149|20128346|P5|NOT COMPLETED|Treatment Period||0
8164918|NCT02502149|20128347|P4|NOT COMPLETED|Treatment Period||0
8164919|NCT02502149|20128348|P3|NOT COMPLETED|Treatment Period||0
8164920|NCT02502149|20128349|P2|NOT COMPLETED|Treatment Period||0
8164921|NCT02502149|20128350|P1|NOT COMPLETED|Treatment Period||0
8164922|NCT02502149|20128346|P5|COMPLETED|Treatment Period||12
8164923|NCT02502149|20128347|P4|COMPLETED|Treatment Period||11
8164924|NCT02502149|20128348|P3|COMPLETED|Treatment Period||0
8164925|NCT02502149|20128349|P2|COMPLETED|Treatment Period||0
8164926|NCT02502149|20128350|P1|COMPLETED|Treatment Period||0
8164927|NCT02502149|20128346|P5|STARTED|Treatment Period||12
8164928|NCT02502149|20128347|P4|STARTED|Treatment Period||11
8164929|NCT02502149|20128348|P3|STARTED|Treatment Period||0
8164930|NCT02502149|20128349|P2|STARTED|Treatment Period||0
8164931|NCT02502149|20128350|P1|STARTED|Treatment Period||0
8164932|NCT02502149|20128346|P5|NOT COMPLETED|PK2 Assessment Period||0
8164933|NCT02502149|20128347|P4|NOT COMPLETED|PK2 Assessment Period||0
8164934|NCT02502149|20128348|P3|NOT COMPLETED|PK2 Assessment Period||0
8164935|NCT02502149|20128349|P2|NOT COMPLETED|PK2 Assessment Period||0
8164936|NCT02502149|20128350|P1|NOT COMPLETED|PK2 Assessment Period||0
8164937|NCT02502149|20128346|P5|COMPLETED|PK2 Assessment Period||0
8164938|NCT02502149|20128347|P4|COMPLETED|PK2 Assessment Period||0
8164939|NCT02502149|20128348|P3|COMPLETED|PK2 Assessment Period||12
8164940|NCT02502149|20128349|P2|COMPLETED|PK2 Assessment Period||11
8164941|NCT02502149|20128350|P1|COMPLETED|PK2 Assessment Period||0
8164942|NCT02502149|20128346|P5|STARTED|PK2 Assessment Period||0
8164943|NCT02502149|20128347|P4|STARTED|PK2 Assessment Period||0
8164944|NCT02502149|20128348|P3|STARTED|PK2 Assessment Period||12
8164945|NCT02502149|20128349|P2|STARTED|PK2 Assessment Period||11
8164946|NCT02502149|20128350|P1|STARTED|PK2 Assessment Period||0
8164947|NCT02502149|20128346|P5|NOT COMPLETED|Intermediate||0
8164948|NCT02502149|20128347|P4|NOT COMPLETED|Intermediate||0
8164949|NCT02502149|20128348|P3|NOT COMPLETED|Intermediate||0
8164950|NCT02502149|20128349|P2|NOT COMPLETED|Intermediate||0
8164951|NCT02502149|20128350|P1|NOT COMPLETED|Intermediate||1
8164952|NCT02502149|20128346|P5|COMPLETED|Intermediate||0
8164953|NCT02502149|20128347|P4|COMPLETED|Intermediate||0
8164954|NCT02502149|20128348|P3|COMPLETED|Intermediate||0
8164955|NCT02502149|20128349|P2|COMPLETED|Intermediate||0
8164956|NCT02502149|20128350|P1|COMPLETED|Intermediate||23
8164957|NCT02502149|20128346|P5|STARTED|Intermediate||0
8164958|NCT02502149|20128347|P4|STARTED|Intermediate||0
8164959|NCT02502149|20128348|P3|STARTED|Intermediate||0
8164960|NCT02502149|20128349|P2|STARTED|Intermediate||0
8164961|NCT02502149|20128350|P1|STARTED|Intermediate||24
8164962|NCT02502149|20128346|P5|NOT COMPLETED|PK1 Assessment Period||0
8164963|NCT02502149|20128347|P4|NOT COMPLETED|PK1 Assessment Period||0
8164964|NCT02502149|20128348|P3|NOT COMPLETED|PK1 Assessment Period||0
8164965|NCT02502149|20128349|P2|NOT COMPLETED|PK1 Assessment Period||0
8164966|NCT02502149|20128350|P1|NOT COMPLETED|PK1 Assessment Period||0
8164967|NCT02502149|20128346|P5|COMPLETED|PK1 Assessment Period||0
8164968|NCT02502149|20128347|P4|COMPLETED|PK1 Assessment Period||0
8164969|NCT02502149|20128348|P3|COMPLETED|PK1 Assessment Period||0
8164970|NCT02502149|20128349|P2|COMPLETED|PK1 Assessment Period||0
8164971|NCT02502149|20128350|P1|COMPLETED|PK1 Assessment Period||24
8164972|NCT02502149|20128346|P5|STARTED|PK1 Assessment Period||0
8164973|NCT02502149|20128347|P4|STARTED|PK1 Assessment Period||0
8164974|NCT02502149|20128348|P3|STARTED|PK1 Assessment Period||0
8164975|NCT02502149|20128349|P2|STARTED|PK1 Assessment Period||0
8164976|NCT02502149|20128350|P1|STARTED|PK1 Assessment Period||24
8164977|NCT02502071|20128469|P1|NOT COMPLETED|Overall Study||0
8164978|NCT02502071|20128469|P1|COMPLETED|Overall Study||45
8164979|NCT02502071|20128469|P1|STARTED|Overall Study||45
8164980|NCT02502019|20128474|P1|NOT COMPLETED|Overall Study||0
8164981|NCT02502019|20128474|P1|COMPLETED|Overall Study||27
8164982|NCT02502019|20128474|P1|STARTED|Overall Study||27
8164983|NCT02501928|20128485|P6|NOT COMPLETED|Overall Study||0
8164984|NCT02501928|20128486|P5|NOT COMPLETED|Overall Study||1
8164985|NCT02501928|20128487|P4|NOT COMPLETED|Overall Study||0
8164986|NCT02501928|20128488|P3|NOT COMPLETED|Overall Study||0
8164987|NCT02501928|20128489|P2|NOT COMPLETED|Overall Study||0
8164988|NCT02501928|20128490|P1|NOT COMPLETED|Overall Study||0
8164989|NCT02501928|20128485|P6|COMPLETED|Overall Study||3
8164990|NCT02501928|20128486|P5|COMPLETED|Overall Study||6
8164991|NCT02501928|20128487|P4|COMPLETED|Overall Study||0
8164992|NCT02501928|20128488|P3|COMPLETED|Overall Study||0
8164993|NCT02501928|20128489|P2|COMPLETED|Overall Study||2
8164994|NCT02501928|20128490|P1|COMPLETED|Overall Study||0
8164995|NCT02501928|20128485|P6|STARTED|Overall Study||3
8164996|NCT02501928|20128486|P5|STARTED|Overall Study||7
8164997|NCT02501928|20128487|P4|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
8164998|NCT02501928|20128488|P3|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
8164999|NCT02501928|20128489|P2|STARTED|Overall Study||2
8165000|NCT02501928|20128490|P1|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
8165001|NCT02501759|20128708|P1|NOT COMPLETED|Overall Study||1
8165002|NCT02501759|20128708|P1|COMPLETED|Overall Study||1
8165003|NCT02501759|20128708|P1|STARTED|Overall Study||2
8165004|NCT02501629|20128716|P2|NOT COMPLETED|Overall Study||7
8165005|NCT02501629|20128717|P1|NOT COMPLETED|Overall Study||5
8165006|NCT02501629|20128716|P2|COMPLETED|Overall Study||81
8165007|NCT02501629|20128717|P1|COMPLETED|Overall Study||84
8165008|NCT02501629|20128716|P2|STARTED|Overall Study||88
8165009|NCT02501629|20128717|P1|STARTED|Overall Study||89
8165010|NCT02501590|20128741|P2|NOT COMPLETED|Overall Study||0
8165011|NCT02501590|20128742|P1|NOT COMPLETED|Overall Study||0
8165012|NCT02501590|20128741|P2|COMPLETED|Overall Study||35
8165013|NCT02501590|20128742|P1|COMPLETED|Overall Study||13
8165014|NCT02501590|20128741|P2|STARTED|Overall Study||35
8165015|NCT02501590|20128742|P1|STARTED|Overall Study||13
8165016|NCT02501538|20128748|P1|NOT COMPLETED|Overall Study||3
8165017|NCT02501538|20128748|P1|COMPLETED|Overall Study||20
8165018|NCT02501538|20128748|P1|STARTED|Overall Study||23
8165019|NCT02501473|20128763|P8|NOT COMPLETED|Overall Study||0
8165020|NCT02501473|20128764|P7|NOT COMPLETED|Overall Study||1
8165021|NCT02501473|20128765|P6|NOT COMPLETED|Overall Study||14
8165022|NCT02501473|20128766|P5|NOT COMPLETED|Overall Study||4
8165023|NCT02501473|20128767|P4|NOT COMPLETED|Overall Study||14
8165024|NCT02501473|20128768|P3|NOT COMPLETED|Overall Study||13
8165025|NCT02501473|20128769|P2|NOT COMPLETED|Overall Study||3
8165026|NCT02501473|20128770|P1|NOT COMPLETED|Overall Study||3
8165027|NCT02501473|20128763|P8|COMPLETED|Overall Study||0
8165028|NCT02501473|20128764|P7|COMPLETED|Overall Study||0
8165029|NCT02501473|20128765|P6|COMPLETED|Overall Study||0
8165030|NCT02501473|20128766|P5|COMPLETED|Overall Study||0
8165031|NCT02501473|20128767|P4|COMPLETED|Overall Study||0
8165032|NCT02501473|20128768|P3|COMPLETED|Overall Study||0
8165033|NCT02501473|20128769|P2|COMPLETED|Overall Study||0
8165034|NCT02501473|20128770|P1|COMPLETED|Overall Study||0
8165035|NCT02501473|20128763|P8|Treated|Overall Study||0
8165036|NCT02501473|20128764|P7|Treated|Overall Study||1
8165037|NCT02501473|20128765|P6|Treated|Overall Study||14
8165038|NCT02501473|20128766|P5|Treated|Overall Study||4
8165039|NCT02501473|20128767|P4|Treated|Overall Study||13
8165040|NCT02501473|20128768|P3|Treated|Overall Study||13
8165041|NCT02501473|20128769|P2|Treated|Overall Study||3
8165042|NCT02501473|20128770|P1|Treated|Overall Study||3
8165043|NCT02501473|20128763|P8|STARTED|Overall Study||0
8165044|NCT02501473|20128764|P7|STARTED|Overall Study||1
8165045|NCT02501473|20128765|P6|STARTED|Overall Study||14
8165046|NCT02501473|20128766|P5|STARTED|Overall Study||4
8165047|NCT02501473|20128767|P4|STARTED|Overall Study||14
8165048|NCT02501473|20128768|P3|STARTED|Overall Study||13
8165049|NCT02501473|20128769|P2|STARTED|Overall Study||3
8165050|NCT02501473|20128770|P1|STARTED|Overall Study||3
8165051|NCT02501161|20128865|P2|NOT COMPLETED|Overall Study||25
8165052|NCT02501161|20128866|P1|NOT COMPLETED|Overall Study||22
8165053|NCT02501161|20128865|P2|COMPLETED|Overall Study||481
8165054|NCT02501161|20128866|P1|COMPLETED|Overall Study||484
8165055|NCT02501161|20128865|P2|Exposed|Overall Study||504
8165056|NCT02501161|20128866|P1|Exposed|Overall Study||506
8165057|NCT02501161|20128865|P2|STARTED|Overall Study||506
8165058|NCT02501161|20128866|P1|STARTED|Overall Study||506
8165059|NCT02501135|20128978|P1|NOT COMPLETED|Overall Study||0
8165060|NCT02501135|20128978|P1|COMPLETED|Overall Study||281
8165061|NCT02501135|20128978|P1|STARTED|Overall Study||281
8165062|NCT02500979|20128990|P2|NOT COMPLETED|Period 2||0
8165063|NCT02500979|20128991|P1|NOT COMPLETED|Period 2||1
8165064|NCT02500979|20128990|P2|COMPLETED|Period 2||16
8165065|NCT02500979|20128991|P1|COMPLETED|Period 2||11
8165066|NCT02500979|20128990|P2|STARTED|Period 2||16
8165067|NCT02500979|20128991|P1|STARTED|Period 2||12
8165068|NCT02500979|20128990|P2|NOT COMPLETED|Period 1||1
8165069|NCT02500979|20128991|P1|NOT COMPLETED|Period 1||4
8165070|NCT02500979|20128990|P2|COMPLETED|Period 1||16
8165071|NCT02500979|20128991|P1|COMPLETED|Period 1||12
8165072|NCT02500979|20128990|P2|STARTED|Period 1||17
8165073|NCT02500979|20128991|P1|STARTED|Period 1||16
8165074|NCT02500901|20129025|P1|NOT COMPLETED|Overall Study||2
8165075|NCT02500901|20129025|P1|COMPLETED|Overall Study||0
8165076|NCT02500901|20129025|P1|STARTED|Overall Study||2
8165077|NCT02500836|20129034|P3|NOT COMPLETED|Overall Study||1
8165078|NCT02500836|20129035|P2|NOT COMPLETED|Overall Study||5
8165079|NCT02500836|20129036|P1|NOT COMPLETED|Overall Study||3
8165080|NCT02500836|20129034|P3|COMPLETED|Overall Study||127
8165081|NCT02500836|20129035|P2|COMPLETED|Overall Study||254
8165082|NCT02500836|20129036|P1|COMPLETED|Overall Study||256
8165083|NCT02500836|20129034|P3|STARTED|Overall Study||128
8165084|NCT02500836|20129035|P2|STARTED|Overall Study||259
8165085|NCT02500836|20129036|P1|STARTED|Overall Study||259
8165118|NCT02500758|20129120|P2|NOT COMPLETED|Second Intervention (2 Minutes)||2
8165119|NCT02500758|20129121|P1|NOT COMPLETED|Second Intervention (2 Minutes)||3
8165120|NCT02500758|20129120|P2|COMPLETED|Second Intervention (2 Minutes)||10
8165121|NCT02500758|20129121|P1|COMPLETED|Second Intervention (2 Minutes)||10
8165122|NCT02500758|20129120|P2|STARTED|Second Intervention (2 Minutes)||12
8165123|NCT02500758|20129121|P1|STARTED|Second Intervention (2 Minutes)||13
8165124|NCT02500758|20129120|P2|NOT COMPLETED|Washout (1 Week)||2
8165125|NCT02500758|20129121|P1|NOT COMPLETED|Washout (1 Week)||2
8165126|NCT02500758|20129120|P2|COMPLETED|Washout (1 Week)||12
8165127|NCT02500758|20129121|P1|COMPLETED|Washout (1 Week)||13
8165128|NCT02500758|20129120|P2|STARTED|Washout (1 Week)||14
8165129|NCT02500758|20129121|P1|STARTED|Washout (1 Week)||15
8165130|NCT02500758|20129120|P2|NOT COMPLETED|First Intervention (2 Minutes)||1
8165131|NCT02500758|20129121|P1|NOT COMPLETED|First Intervention (2 Minutes)||0
8165132|NCT02500758|20129120|P2|COMPLETED|First Intervention (2 Minutes)||14
8165133|NCT02500758|20129121|P1|COMPLETED|First Intervention (2 Minutes)||15
8165134|NCT02500758|20129120|P2|STARTED|First Intervention (2 Minutes)||15
8165135|NCT02500758|20129121|P1|STARTED|First Intervention (2 Minutes)||15
8165136|NCT02500732|20129131|P2|NOT COMPLETED|Overall Study||1
8165137|NCT02500732|20129132|P1|NOT COMPLETED|Overall Study||0
8165138|NCT02500732|20129131|P2|COMPLETED|Overall Study|Not true event in 1 participant (pseudosyncope)|29
8165139|NCT02500732|20129132|P1|COMPLETED|Overall Study||27
8165140|NCT02500732|20129131|P2|STARTED|Overall Study||30
8165141|NCT02500732|20129132|P1|STARTED|Overall Study||27
8165142|NCT02500706|20129149|P3|NOT COMPLETED|Overall Study||7
8165143|NCT02500706|20129150|P2|NOT COMPLETED|Overall Study||7
8165144|NCT02500706|20129151|P1|NOT COMPLETED|Overall Study||4
8165145|NCT02500706|20129149|P3|COMPLETED|Overall Study||335
8165146|NCT02500706|20129150|P2|COMPLETED|Overall Study||334
8165147|NCT02500706|20129151|P1|COMPLETED|Overall Study||338
8165148|NCT02500706|20129149|P3|Exposed|Overall Study||342
8165149|NCT02500706|20129150|P2|Exposed|Overall Study||341
8165150|NCT02500706|20129151|P1|Exposed|Overall Study||342
8165151|NCT02500706|20129149|P3|STARTED|Overall Study||342
8165152|NCT02500706|20129150|P2|STARTED|Overall Study||341
8165153|NCT02500706|20129151|P1|STARTED|Overall Study||342
8165154|NCT02500641|20129305|P2|NOT COMPLETED|Overall Study||12
8165155|NCT02500641|20129306|P1|NOT COMPLETED|Overall Study||10
8165156|NCT02500641|20129305|P2|COMPLETED|Overall Study||86
8165157|NCT02500641|20129306|P1|COMPLETED|Overall Study||88
8165158|NCT02500641|20129305|P2|STARTED|Overall Study||98
8165159|NCT02500641|20129306|P1|STARTED|Overall Study||98
8165160|NCT02500628|20129314|P2|NOT COMPLETED|Overall Study||0
8165161|NCT02500628|20129315|P1|NOT COMPLETED|Overall Study||0
8165162|NCT02500628|20129314|P2|COMPLETED|Overall Study||23
8165163|NCT02500628|20129315|P1|COMPLETED|Overall Study||38
8165164|NCT02500628|20129314|P2|STARTED|Overall Study||23
8165165|NCT02500628|20129315|P1|STARTED|Overall Study||38
8165169|NCT02500537|20129331|P2|NOT COMPLETED|Overall Study||1
8165170|NCT02500537|20129332|P1|NOT COMPLETED|Overall Study||3
8165171|NCT02500537|20129331|P2|COMPLETED|Overall Study||39
8165172|NCT02500537|20129332|P1|COMPLETED|Overall Study||57
8165173|NCT02500537|20129331|P2|STARTED|Overall Study||40
8165174|NCT02500537|20129332|P1|STARTED|Overall Study||60
8165175|NCT02500368|20129350|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8165176|NCT02500368|20129351|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8165177|NCT02500368|20129350|P2|COMPLETED|Second Intervention (1 Week)||20
8165178|NCT02500368|20129351|P1|COMPLETED|Second Intervention (1 Week)||20
8165179|NCT02500368|20129350|P2|STARTED|Second Intervention (1 Week)||20
8165180|NCT02500368|20129351|P1|STARTED|Second Intervention (1 Week)||20
8165181|NCT02500368|20129350|P2|NOT COMPLETED|First Intervention (1 Week)||0
8165182|NCT02500368|20129351|P1|NOT COMPLETED|First Intervention (1 Week)||0
8165183|NCT02500368|20129350|P2|COMPLETED|First Intervention (1 Week)||20
8165184|NCT02500368|20129351|P1|COMPLETED|First Intervention (1 Week)||20
8165185|NCT02500368|20129350|P2|STARTED|First Intervention (1 Week)||20
8165186|NCT02500368|20129351|P1|STARTED|First Intervention (1 Week)||20
8165187|NCT02500056|20129401|P2|NOT COMPLETED|Overall Study||8
8165188|NCT02500056|20129402|P1|NOT COMPLETED|Overall Study||7
8165189|NCT02500056|20129401|P2|COMPLETED|Overall Study||65
8165190|NCT02500056|20129402|P1|COMPLETED|Overall Study||63
8165191|NCT02500056|20129401|P2|STARTED|Overall Study||73
8165192|NCT02500056|20129402|P1|STARTED|Overall Study||70
8165193|NCT02499952|20129412|P1|NOT COMPLETED|Overall Study||10
8165194|NCT02499952|20129412|P1|COMPLETED|Overall Study||2
8165195|NCT02499952|20129412|P1|STARTED|Overall Study||12
8165196|NCT02499900|20129421|P2|NOT COMPLETED|Extension Study Period||20
8165197|NCT02499900|20129422|P1|NOT COMPLETED|Extension Study Period||12
8165198|NCT02499900|20129421|P2|COMPLETED|Extension Study Period||377
8165199|NCT02499900|20129422|P1|COMPLETED|Extension Study Period||380
8165200|NCT02499900|20129421|P2|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
8165201|NCT02499900|20129422|P1|Safety Analysis Set|Extension Study Period||392
8165202|NCT02499900|20129421|P2|STARTED|Extension Study Period||397
8165203|NCT02499900|20129422|P1|STARTED|Extension Study Period||392
8165204|NCT02499900|20129421|P2|NOT COMPLETED|Completed Core, Continued Into Extension||2
8165205|NCT02499900|20129422|P1|NOT COMPLETED|Completed Core, Continued Into Extension||3
8165206|NCT02499900|20129421|P2|COMPLETED|Completed Core, Continued Into Extension||397
8165207|NCT02499900|20129422|P1|COMPLETED|Completed Core, Continued Into Extension||392
8165208|NCT02499900|20129421|P2|STARTED|Completed Core, Continued Into Extension||399
8165209|NCT02499900|20129422|P1|STARTED|Completed Core, Continued Into Extension||395
8165210|NCT02499900|20129421|P2|NOT COMPLETED|Core Study Period||32
8165211|NCT02499900|20129422|P1|NOT COMPLETED|Core Study Period||35
8165212|NCT02499900|20129421|P2|COMPLETED|Core Study Period||399
8165213|NCT02499900|20129422|P1|COMPLETED|Core Study Period||395
8165214|NCT02499900|20129421|P2|Safety Analysis Set|Core Study Period||430
8165215|NCT02499900|20129422|P1|Safety Analysis Set|Core Study Period||427
8165216|NCT02499900|20129421|P2|STARTED|Core Study Period||431
8165217|NCT02499900|20129422|P1|STARTED|Core Study Period||430
8165218|NCT02499887|20129444|P2|NOT COMPLETED|Overall Study||0
8165219|NCT02499887|20129445|P1|NOT COMPLETED|Overall Study||0
8165220|NCT02499887|20129444|P2|COMPLETED|Overall Study||3
8165221|NCT02499887|20129445|P1|COMPLETED|Overall Study||3
8165222|NCT02499887|20129444|P2|STARTED|Overall Study||3
8165223|NCT02499887|20129445|P1|STARTED|Overall Study||3
8165224|NCT02499783|20129453|P3|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29
8165225|NCT02499783|20129454|P2|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
8165226|NCT02499783|20129455|P1|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
8165227|NCT02499783|20129453|P3|COMPLETED|Open Label Period: Weeks 8 to 26||159
8165228|NCT02499783|20129454|P2|COMPLETED|Open Label Period: Weeks 8 to 26||0
8165229|NCT02499783|20129455|P1|COMPLETED|Open Label Period: Weeks 8 to 26||0
8165230|NCT02499783|20129453|P3|STARTED|Open Label Period: Weeks 8 to 26||188
8165231|NCT02499783|20129454|P2|STARTED|Open Label Period: Weeks 8 to 26||0
8165232|NCT02499783|20129455|P1|STARTED|Open Label Period: Weeks 8 to 26||0
8165233|NCT02499783|20129453|P3|NOT COMPLETED|DB Period: Weeks 0-8||0
8165234|NCT02499783|20129454|P2|NOT COMPLETED|DB Period: Weeks 0-8||7
8165235|NCT02499783|20129455|P1|NOT COMPLETED|DB Period: Weeks 0-8||10
8165236|NCT02499783|20129453|P3|COMPLETED|DB Period: Weeks 0-8||0
8165237|NCT02499783|20129454|P2|COMPLETED|DB Period: Weeks 0-8||96
8165238|NCT02499783|20129455|P1|COMPLETED|DB Period: Weeks 0-8||92
8165239|NCT02499783|20129453|P3|STARTED|DB Period: Weeks 0-8||0
8165240|NCT02499783|20129454|P2|STARTED|DB Period: Weeks 0-8||103
8165241|NCT02499783|20129455|P1|STARTED|DB Period: Weeks 0-8||102
8165242|NCT02499783|20129453|P3|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
8165243|NCT02499783|20129454|P2|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5
8165244|NCT02499783|20129455|P1|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4
8165245|NCT02499783|20129453|P3|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
8165246|NCT02499783|20129454|P2|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
8165247|NCT02499783|20129455|P1|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
8165248|NCT02499783|20129453|P3|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0
8165249|NCT02499783|20129454|P2|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103
8165250|NCT02499783|20129455|P1|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102
8165251|NCT02499770|20129504|P2|NOT COMPLETED|Overall Study||77
8165252|NCT02499770|20129505|P1|NOT COMPLETED|Overall Study||19
8165253|NCT02499770|20129504|P2|COMPLETED|Overall Study||0
8165254|NCT02499770|20129505|P1|COMPLETED|Overall Study||0
8165255|NCT02499770|20129504|P2|STARTED|Overall Study||77
8165256|NCT02499770|20129505|P1|STARTED|Overall Study||19
8165257|NCT02499692|20129614|P1|NOT COMPLETED|Overall Study||0
8165258|NCT02499692|20129614|P1|COMPLETED|Overall Study||103
8165259|NCT02499692|20129614|P1|STARTED|Overall Study||103
8165260|NCT02499575|20129625|P2|NOT COMPLETED|Overall Study||1
8165261|NCT02499575|20129626|P1|NOT COMPLETED|Overall Study||0
8165262|NCT02499575|20129625|P2|COMPLETED|Overall Study||0
8165263|NCT02499575|20129626|P1|COMPLETED|Overall Study||1
8165264|NCT02499575|20129625|P2|STARTED|Overall Study||1
8165265|NCT02499575|20129626|P1|STARTED|Overall Study||1
8165266|NCT02499406|20129636|P1|NOT COMPLETED|Overall Study||4
8165267|NCT02499406|20129636|P1|COMPLETED|Overall Study||13
8165268|NCT02499406|20129636|P1|STARTED|Overall Study||17
8165272|NCT02499263|20129657|P1|NOT COMPLETED|Overall Study||62
8165273|NCT02499263|20129657|P1|COMPLETED|Overall Study||84
8165274|NCT02499263|20129657|P1|STARTED|Overall Study||146
8165275|NCT02499172|20129694|P4|NOT COMPLETED|Overall Study||436
8165276|NCT02499172|20129695|P3|NOT COMPLETED|Overall Study||523
8165277|NCT02499172|20129696|P2|NOT COMPLETED|Overall Study||64
8165278|NCT02499172|20129697|P1|NOT COMPLETED|Overall Study||65
8165279|NCT02499172|20129694|P4|COMPLETED|Overall Study||0
8165280|NCT02499172|20129695|P3|COMPLETED|Overall Study||0
8165281|NCT02499172|20129696|P2|COMPLETED|Overall Study||835
8165282|NCT02499172|20129697|P1|COMPLETED|Overall Study||835
8165283|NCT02499172|20129694|P4|STARTED|Overall Study||436
8165284|NCT02499172|20129695|P3|STARTED|Overall Study||523
8165285|NCT02499172|20129696|P2|STARTED|Overall Study||899
8165286|NCT02499172|20129697|P1|STARTED|Overall Study||900
8165299|NCT02499146|20129734|P1|NOT COMPLETED|Overall Study||26
8165300|NCT02499146|20129734|P1|COMPLETED|Overall Study||0
8165301|NCT02499146|20129734|P1|STARTED|Overall Study||26
8165302|NCT02499120|20129774|P2|NOT COMPLETED|Overall Study||60
8165303|NCT02499120|20129775|P1|NOT COMPLETED|Overall Study||65
8165304|NCT02499120|20129774|P2|COMPLETED|Overall Study||0
8165305|NCT02499120|20129775|P1|COMPLETED|Overall Study||0
8165306|NCT02499120|20129774|P2|Received Treatment|Overall Study||60
8165307|NCT02499120|20129775|P1|Received Treatment|Overall Study||64
8165308|NCT02499120|20129774|P2|STARTED|Overall Study||60
8165309|NCT02499120|20129775|P1|STARTED|Overall Study||65
8165310|NCT02499029|20129806|P2|NOT COMPLETED|Overall Study||3
8165311|NCT02499029|20129807|P1|NOT COMPLETED|Overall Study||5
8165312|NCT02499029|20129806|P2|COMPLETED|Overall Study||14
8165313|NCT02499029|20129807|P1|COMPLETED|Overall Study||13
8165314|NCT02499029|20129806|P2|STARTED|Overall Study||17
8165315|NCT02499029|20129807|P1|STARTED|Overall Study||18
8165316|NCT02498834|20129821|P2|NOT COMPLETED|Overall Study||10
8165317|NCT02498834|20129822|P1|NOT COMPLETED|Overall Study||10
8165318|NCT02498834|20129821|P2|COMPLETED|Overall Study||164
8165319|NCT02498834|20129822|P1|COMPLETED|Overall Study||175
8165320|NCT02498834|20129821|P2|STARTED|Overall Study||174
8165321|NCT02498834|20129822|P1|STARTED|Overall Study||185
8165322|NCT02498821|20129834|P2|NOT COMPLETED|Overall Study||5
8165323|NCT02498821|20129835|P1|NOT COMPLETED|Overall Study||3
8165324|NCT02498821|20129834|P2|COMPLETED|Overall Study||60
8165325|NCT02498821|20129835|P1|COMPLETED|Overall Study||60
8165326|NCT02498821|20129834|P2|STARTED|Overall Study||65
8165327|NCT02498821|20129835|P1|STARTED|Overall Study||63
8165328|NCT02498769|20129864|P2|NOT COMPLETED|Overall Study||0
8165329|NCT02498769|20129865|P1|NOT COMPLETED|Overall Study||0
8165330|NCT02498769|20129864|P2|COMPLETED|Overall Study||67
8165331|NCT02498769|20129865|P1|COMPLETED|Overall Study||63
8165332|NCT02498769|20129864|P2|STARTED|Overall Study||67
8165333|NCT02498769|20129865|P1|STARTED|Overall Study||63
8165334|NCT02498678|20129879|P2|NOT COMPLETED|Overall Study||2
8165335|NCT02498678|20129880|P1|NOT COMPLETED|Overall Study||0
8165336|NCT02498678|20129879|P2|COMPLETED|Overall Study||23
8165337|NCT02498678|20129880|P1|COMPLETED|Overall Study||25
8165338|NCT02498678|20129879|P2|STARTED|Overall Study||25
8165339|NCT02498678|20129880|P1|STARTED|Overall Study||25
8165340|NCT02498652|20129896|P2|NOT COMPLETED|Overall Study||1
8165341|NCT02498652|20129897|P1|NOT COMPLETED|Overall Study||0
8165342|NCT02498652|20129896|P2|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
8165343|NCT02498652|20129897|P1|COMPLETED|Overall Study||20
8165344|NCT02498652|20129896|P2|STARTED|Overall Study||21
8165345|NCT02498652|20129897|P1|STARTED|Overall Study||20
8165352|NCT02498522|20130013|P2|NOT COMPLETED|Overall Study||2
8165353|NCT02498522|20130014|P1|NOT COMPLETED|Overall Study||2
8165354|NCT02498522|20130013|P2|COMPLETED|Overall Study||83
8165355|NCT02498522|20130014|P1|COMPLETED|Overall Study||83
8165356|NCT02498522|20130013|P2|STARTED|Overall Study||85
8165357|NCT02498522|20130014|P1|STARTED|Overall Study||85
8165358|NCT02498483|20130022|P2|NOT COMPLETED|Overall Study||0
8165359|NCT02498483|20130023|P1|NOT COMPLETED|Overall Study||0
8165360|NCT02498483|20130022|P2|COMPLETED|Overall Study||5
8165361|NCT02498483|20130023|P1|COMPLETED|Overall Study||6
8165362|NCT02498483|20130022|P2|STARTED|Overall Study||5
8165363|NCT02498483|20130023|P1|STARTED|Overall Study||6
8165364|NCT02498418|20130040|P3|NOT COMPLETED|Overall Study||6
8165365|NCT02498418|20130041|P2|NOT COMPLETED|Overall Study||2
8165366|NCT02498418|20130042|P1|NOT COMPLETED|Overall Study||2
8165367|NCT02498418|20130040|P3|COMPLETED|Overall Study||238
8165368|NCT02498418|20130041|P2|COMPLETED|Overall Study||246
8165369|NCT02498418|20130042|P1|COMPLETED|Overall Study||245
8165370|NCT02498418|20130040|P3|Per-protocol Analysis Set|Overall Study||176
8165371|NCT02498418|20130041|P2|Per-protocol Analysis Set|Overall Study||181
8165372|NCT02498418|20130042|P1|Per-protocol Analysis Set|Overall Study||182
8165373|NCT02498418|20130040|P3|Modified Intent-to-treat Population|Overall Study||180
8165374|NCT02498418|20130041|P2|Modified Intent-to-treat Population|Overall Study||186
8165375|NCT02498418|20130042|P1|Modified Intent-to-treat Population|Overall Study||183
8165376|NCT02498418|20130040|P3|Safety Population|Overall Study||244
8165377|NCT02498418|20130041|P2|Safety Population|Overall Study||247
8165378|NCT02498418|20130042|P1|Safety Population|Overall Study||246
8165379|NCT02498418|20130040|P3|STARTED|Overall Study||244
8165380|NCT02498418|20130041|P2|STARTED|Overall Study||248
8165381|NCT02498418|20130042|P1|STARTED|Overall Study||247
8165382|NCT02498236|20130066|P8|NOT COMPLETED|Overall Study||1
8165383|NCT02498236|20130067|P7|NOT COMPLETED|Overall Study||1
8165384|NCT02498236|20130068|P6|NOT COMPLETED|Overall Study||0
8165385|NCT02498236|20130069|P5|NOT COMPLETED|Overall Study||1
8165386|NCT02498236|20130070|P4|NOT COMPLETED|Overall Study||0
8165387|NCT02498236|20130071|P3|NOT COMPLETED|Overall Study||0
8165388|NCT02498236|20130072|P2|NOT COMPLETED|Overall Study||0
8165389|NCT02498236|20130073|P1|NOT COMPLETED|Overall Study||1
8165390|NCT02498236|20130066|P8|COMPLETED|Overall Study||6
8165391|NCT02498236|20130067|P7|COMPLETED|Overall Study||6
8165392|NCT02498236|20130068|P6|COMPLETED|Overall Study||6
8165393|NCT02498236|20130069|P5|COMPLETED|Overall Study||6
8165394|NCT02498236|20130070|P4|COMPLETED|Overall Study||6
8165395|NCT02498236|20130071|P3|COMPLETED|Overall Study||6
8165396|NCT02498236|20130072|P2|COMPLETED|Overall Study||6
8165397|NCT02498236|20130073|P1|COMPLETED|Overall Study||5
8165398|NCT02498236|20130066|P8|Randomized|Overall Study||7
8165399|NCT02498236|20130067|P7|Randomized|Overall Study||7
8165400|NCT02498236|20130068|P6|Randomized|Overall Study||6
8165401|NCT02498236|20130069|P5|Randomized|Overall Study||7
8165402|NCT02498236|20130070|P4|Randomized|Overall Study||6
8165403|NCT02498236|20130071|P3|Randomized|Overall Study||6
8165404|NCT02498236|20130072|P2|Randomized|Overall Study||6
8165405|NCT02498236|20130073|P1|Randomized|Overall Study||6
8165406|NCT02498236|20130066|P8|STARTED|Overall Study||7
8165407|NCT02498236|20130067|P7|STARTED|Overall Study||7
8165408|NCT02498236|20130068|P6|STARTED|Overall Study||6
8165409|NCT02498236|20130069|P5|STARTED|Overall Study||7
8165410|NCT02498236|20130070|P4|STARTED|Overall Study||6
8165411|NCT02498236|20130071|P3|STARTED|Overall Study||6
8165412|NCT02498236|20130072|P2|STARTED|Overall Study||6
8165413|NCT02498236|20130073|P1|STARTED|Overall Study||6
8165414|NCT02498067|20130102|P1|NOT COMPLETED|Overall Study||33
8165415|NCT02498067|20130102|P1|COMPLETED|Overall Study||71
8165416|NCT02498067|20130102|P1|STARTED|Overall Study||104
8165417|NCT02497976|20130123|P2|NOT COMPLETED|Overall Study||1
8165418|NCT02497976|20130124|P1|NOT COMPLETED|Overall Study||2
8165419|NCT02497976|20130123|P2|COMPLETED|Overall Study||13
8165420|NCT02497976|20130124|P1|COMPLETED|Overall Study||26
8165421|NCT02497976|20130123|P2|STARTED|Overall Study||14
8165422|NCT02497976|20130124|P1|STARTED|Overall Study||28
8165423|NCT02497937|20130140|P2|NOT COMPLETED|Period 2 (Up to 7 Days)||0
8165424|NCT02497937|20130141|P1|NOT COMPLETED|Period 2 (Up to 7 Days)||0
8165425|NCT02497937|20130140|P2|COMPLETED|Period 2 (Up to 7 Days)||5
8165426|NCT02497937|20130141|P1|COMPLETED|Period 2 (Up to 7 Days)||6
8165427|NCT02497937|20130140|P2|STARTED|Period 2 (Up to 7 Days)||5
8165428|NCT02497937|20130141|P1|STARTED|Period 2 (Up to 7 Days)||6
8165429|NCT02497937|20130140|P2|NOT COMPLETED|Washout Period (Up to 14 Days)||0
8165430|NCT02497937|20130141|P1|NOT COMPLETED|Washout Period (Up to 14 Days)||0
8165431|NCT02497937|20130140|P2|COMPLETED|Washout Period (Up to 14 Days)||5
8165432|NCT02497937|20130141|P1|COMPLETED|Washout Period (Up to 14 Days)||6
8165433|NCT02497937|20130140|P2|STARTED|Washout Period (Up to 14 Days)||5
8165434|NCT02497937|20130141|P1|STARTED|Washout Period (Up to 14 Days)||6
8165435|NCT02497937|20130140|P2|NOT COMPLETED|Period 1 (Up to 7 Days)||0
8165436|NCT02497937|20130141|P1|NOT COMPLETED|Period 1 (Up to 7 Days)||0
8165437|NCT02497937|20130140|P2|COMPLETED|Period 1 (Up to 7 Days)||5
8165438|NCT02497937|20130141|P1|COMPLETED|Period 1 (Up to 7 Days)||6
8165439|NCT02497937|20130140|P2|STARTED|Period 1 (Up to 7 Days)||5
8165440|NCT02497937|20130141|P1|STARTED|Period 1 (Up to 7 Days)||6
8165441|NCT02497781|20130219|P2|NOT COMPLETED|Overall Study||3
8165442|NCT02497781|20130220|P1|NOT COMPLETED|Overall Study||4
8165443|NCT02497781|20130219|P2|COMPLETED|Overall Study||26
8165444|NCT02497781|20130220|P1|COMPLETED|Overall Study||64
8165445|NCT02497781|20130219|P2|Treated|Overall Study||28
8165446|NCT02497781|20130220|P1|Treated|Overall Study||67
8165447|NCT02497781|20130219|P2|STARTED|Overall Study||29
8165448|NCT02497781|20130220|P1|STARTED|Overall Study||68
8165449|NCT02497755|20130283|P2|NOT COMPLETED|Overall Study||0
8165450|NCT02497755|20130284|P1|NOT COMPLETED|Overall Study||1
8165451|NCT02497755|20130283|P2|COMPLETED|Overall Study||1
8165452|NCT02497755|20130284|P1|COMPLETED|Overall Study||17
8165453|NCT02497755|20130283|P2|STARTED|Overall Study||1
8165454|NCT02497755|20130284|P1|STARTED|Overall Study||18
8165455|NCT02497612|20130301|P4|NOT COMPLETED|Overall Study||47
8165456|NCT02497612|20130302|P3|NOT COMPLETED|Overall Study||49
8165457|NCT02497612|20130303|P2|NOT COMPLETED|Overall Study||57
8165458|NCT02497612|20130304|P1|NOT COMPLETED|Overall Study||66
8165459|NCT02497612|20130301|P4|COMPLETED|Overall Study||46
8165460|NCT02497612|20130302|P3|COMPLETED|Overall Study||48
8165461|NCT02497612|20130303|P2|COMPLETED|Overall Study||37
8165462|NCT02497612|20130304|P1|COMPLETED|Overall Study||27
8165463|NCT02497612|20130301|P4|Cohort 4: >6 Months to <=2 Years|Overall Study||7
8165464|NCT02497612|20130302|P3|Cohort 4: >6 Months to <=2 Years|Overall Study||6
8165465|NCT02497612|20130303|P2|Cohort 4: >6 Months to <=2 Years|Overall Study||8
8165466|NCT02497612|20130304|P1|Cohort 4: >6 Months to <=2 Years|Overall Study||7
8165467|NCT02497612|20130301|P4|Cohort 3: >2 Years to <=5 Years|Overall Study||65
8165468|NCT02497612|20130302|P3|Cohort 3: >2 Years to <=5 Years|Overall Study||67
8165469|NCT02497612|20130303|P2|Cohort 3: >2 Years to <=5 Years|Overall Study||66
8165470|NCT02497612|20130304|P1|Cohort 3: >2 Years to <=5 Years|Overall Study||66
8165471|NCT02497612|20130301|P4|Cohort 2: >5 Years to <=14 Years|Overall Study||5
8165472|NCT02497612|20130302|P3|Cohort 2: >5 Years to <=14 Years|Overall Study||6
8165473|NCT02497612|20130303|P2|Cohort 2: >5 Years to <=14 Years|Overall Study||5
8165474|NCT02497612|20130304|P1|Cohort 2: >5 Years to <=14 Years|Overall Study||6
8165475|NCT02497612|20130301|P4|Cohort 1: >14 Years to <70 Years|Overall Study||16
8165476|NCT02497612|20130302|P3|Cohort 1: >14 Years to <70 Years|Overall Study||18
8165477|NCT02497612|20130303|P2|Cohort 1: >14 Years to <70 Years|Overall Study||15
8165478|NCT02497612|20130304|P1|Cohort 1: >14 Years to <70 Years|Overall Study||14
8165479|NCT02497612|20130301|P4|Treated|Overall Study||91
8165480|NCT02497612|20130302|P3|Treated|Overall Study||96
8165481|NCT02497612|20130303|P2|Treated|Overall Study||94
8165482|NCT02497612|20130304|P1|Treated|Overall Study||92
8165483|NCT02497612|20130301|P4|STARTED|Overall Study||93
8165484|NCT02497612|20130302|P3|STARTED|Overall Study||97
8165485|NCT02497612|20130303|P2|STARTED|Overall Study||94
8165486|NCT02497612|20130304|P1|STARTED|Overall Study||93
8165487|NCT02497469|20130432|P2|NOT COMPLETED|Overall Study||115
8165488|NCT02497469|20130433|P1|NOT COMPLETED|Overall Study||169
8165489|NCT02497469|20130432|P2|COMPLETED|Overall Study||270
8165490|NCT02497469|20130433|P1|COMPLETED|Overall Study||217
8165491|NCT02497469|20130432|P2|Safety Analysis Set|Overall Study||383
8165492|NCT02497469|20130433|P1|Safety Analysis Set|Overall Study||386
8165493|NCT02497469|20130432|P2|STARTED|Overall Study||385
8165494|NCT02497469|20130433|P1|STARTED|Overall Study||386
8165495|NCT02497391|20130443|P6|NOT COMPLETED|Period 3 (14 Days)||0
8165496|NCT02497391|20130444|P5|NOT COMPLETED|Period 3 (14 Days)||1
8165497|NCT02497391|20130445|P4|NOT COMPLETED|Period 3 (14 Days)||0
8165498|NCT02497391|20130446|P3|NOT COMPLETED|Period 3 (14 Days)||1
8165499|NCT02497391|20130447|P2|NOT COMPLETED|Period 3 (14 Days)||1
8165500|NCT02497391|20130448|P1|NOT COMPLETED|Period 3 (14 Days)||0
8165501|NCT02497391|20130443|P6|COMPLETED|Period 3 (14 Days)||13
8165502|NCT02497391|20130444|P5|COMPLETED|Period 3 (14 Days)||13
8165503|NCT02497391|20130445|P4|COMPLETED|Period 3 (14 Days)||13
8165504|NCT02497391|20130446|P3|COMPLETED|Period 3 (14 Days)||12
8165505|NCT02497391|20130447|P2|COMPLETED|Period 3 (14 Days)||13
8165506|NCT02497391|20130448|P1|COMPLETED|Period 3 (14 Days)||12
8165507|NCT02497391|20130443|P6|STARTED|Period 3 (14 Days)||13
8165508|NCT02497391|20130444|P5|STARTED|Period 3 (14 Days)||14
8165509|NCT02497391|20130445|P4|STARTED|Period 3 (14 Days)||13
8165510|NCT02497391|20130446|P3|STARTED|Period 3 (14 Days)||13
8165511|NCT02497391|20130447|P2|STARTED|Period 3 (14 Days)||14
8165512|NCT02497391|20130448|P1|STARTED|Period 3 (14 Days)||12
8165513|NCT02497391|20130443|P6|NOT COMPLETED|Period 2 (14 Days)||3
8165514|NCT02497391|20130444|P5|NOT COMPLETED|Period 2 (14 Days)||2
8165515|NCT02497391|20130445|P4|NOT COMPLETED|Period 2 (14 Days)||3
8165516|NCT02497391|20130446|P3|NOT COMPLETED|Period 2 (14 Days)||3
8165517|NCT02497391|20130447|P2|NOT COMPLETED|Period 2 (14 Days)||1
8165518|NCT02497391|20130448|P1|NOT COMPLETED|Period 2 (14 Days)||4
8165519|NCT02497391|20130443|P6|COMPLETED|Period 2 (14 Days)||13
8165520|NCT02497391|20130444|P5|COMPLETED|Period 2 (14 Days)||14
8165521|NCT02497391|20130445|P4|COMPLETED|Period 2 (14 Days)||13
8165522|NCT02497391|20130446|P3|COMPLETED|Period 2 (14 Days)||13
8165523|NCT02497391|20130447|P2|COMPLETED|Period 2 (14 Days)||14
8165524|NCT02497391|20130448|P1|COMPLETED|Period 2 (14 Days)||12
8165525|NCT02497391|20130443|P6|STARTED|Period 2 (14 Days)||16
8165526|NCT02497391|20130444|P5|STARTED|Period 2 (14 Days)||16
8165527|NCT02497391|20130445|P4|STARTED|Period 2 (14 Days)||16
8165528|NCT02497391|20130446|P3|STARTED|Period 2 (14 Days)||16
8165529|NCT02497391|20130447|P2|STARTED|Period 2 (14 Days)||15
8165530|NCT02497391|20130448|P1|STARTED|Period 2 (14 Days)||16
8165531|NCT02497391|20130443|P6|NOT COMPLETED|Period 1 (14 Days)||0
8165532|NCT02497391|20130444|P5|NOT COMPLETED|Period 1 (14 Days)||0
8165533|NCT02497391|20130445|P4|NOT COMPLETED|Period 1 (14 Days)||0
8165534|NCT02497391|20130446|P3|NOT COMPLETED|Period 1 (14 Days)||0
8165535|NCT02497391|20130447|P2|NOT COMPLETED|Period 1 (14 Days)||0
8165536|NCT02497391|20130448|P1|NOT COMPLETED|Period 1 (14 Days)||0
8165537|NCT02497391|20130443|P6|COMPLETED|Period 1 (14 Days)||16
8165538|NCT02497391|20130444|P5|COMPLETED|Period 1 (14 Days)||16
8165539|NCT02497391|20130445|P4|COMPLETED|Period 1 (14 Days)||16
8165540|NCT02497391|20130446|P3|COMPLETED|Period 1 (14 Days)||16
8165541|NCT02497391|20130447|P2|COMPLETED|Period 1 (14 Days)||15
8165542|NCT02497391|20130448|P1|COMPLETED|Period 1 (14 Days)||16
8165543|NCT02497391|20130443|P6|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8165544|NCT02497391|20130444|P5|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8165545|NCT02497391|20130445|P4|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8165546|NCT02497391|20130446|P3|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8165547|NCT02497391|20130447|P2|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
8165548|NCT02497391|20130448|P1|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
8165549|NCT02497391|20130443|P6|STARTED|Period 1 (14 Days)||16
8165550|NCT02497391|20130444|P5|STARTED|Period 1 (14 Days)||16
8165551|NCT02497391|20130445|P4|STARTED|Period 1 (14 Days)||16
8165552|NCT02497391|20130446|P3|STARTED|Period 1 (14 Days)||16
8165553|NCT02497391|20130447|P2|STARTED|Period 1 (14 Days)||15
8165554|NCT02497391|20130448|P1|STARTED|Period 1 (14 Days)||16
8165555|NCT02497287|20130459|P1|NOT COMPLETED|Follow-up Phase (4 Week)||31
8165556|NCT02497287|20130459|P1|COMPLETED|Follow-up Phase (4 Week)||326
8165557|NCT02497287|20130459|P1|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357
8165558|NCT02497287|20130459|P1|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453
8165559|NCT02497287|20130459|P1|COMPLETED|Optimization/Maintenance (48 Weeks)||150
8165560|NCT02497287|20130459|P1|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603
8165561|NCT02497287|20130459|P1|NOT COMPLETED|Induction Phase (4 Weeks)||199
8165562|NCT02497287|20130459|P1|COMPLETED|Induction Phase (4 Weeks)||580
8165563|NCT02497287|20130459|P1|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779
8165564|NCT02497235|20130503|P5|NOT COMPLETED|Overall Study||0
8165565|NCT02497235|20130504|P4|NOT COMPLETED|Overall Study||0
8165566|NCT02497235|20130505|P3|NOT COMPLETED|Overall Study||0
8165567|NCT02497235|20130506|P2|NOT COMPLETED|Overall Study||0
8165568|NCT02497235|20130507|P1|NOT COMPLETED|Overall Study||0
8165569|NCT02497235|20130503|P5|COMPLETED|Overall Study||3
8165570|NCT02497235|20130504|P4|COMPLETED|Overall Study||2
8165571|NCT02497235|20130505|P3|COMPLETED|Overall Study||2
8165572|NCT02497235|20130506|P2|COMPLETED|Overall Study||2
8165573|NCT02497235|20130507|P1|COMPLETED|Overall Study||2
8165574|NCT02497235|20130503|P5|STARTED|Overall Study||3
8165575|NCT02497235|20130504|P4|STARTED|Overall Study||2
8165576|NCT02497235|20130505|P3|STARTED|Overall Study||2
8165577|NCT02497235|20130506|P2|STARTED|Overall Study||2
8165578|NCT02497235|20130507|P1|STARTED|Overall Study||2
8165579|NCT02497040|20130540|P3|NOT COMPLETED|Overall Study||0
8165580|NCT02497040|20130541|P2|NOT COMPLETED|Overall Study||0
8165581|NCT02497040|20130542|P1|NOT COMPLETED|Overall Study||0
8165582|NCT02497040|20130540|P3|COMPLETED|Overall Study||30
8165583|NCT02497040|20130541|P2|COMPLETED|Overall Study||30
8165584|NCT02497040|20130542|P1|COMPLETED|Overall Study||30
8165585|NCT02497040|20130540|P3|STARTED|Overall Study||30
8165586|NCT02497040|20130541|P2|STARTED|Overall Study||30
8165587|NCT02497040|20130542|P1|STARTED|Overall Study||30
8165588|NCT02497001|20130554|P4|NOT COMPLETED|Overall Study||41
8165589|NCT02497001|20130555|P3|NOT COMPLETED|Overall Study||50
8165590|NCT02497001|20130556|P2|NOT COMPLETED|Overall Study||103
8165591|NCT02497001|20130557|P1|NOT COMPLETED|Overall Study||74
8165592|NCT02497001|20130554|P4|COMPLETED|Overall Study||278
8165593|NCT02497001|20130555|P3|COMPLETED|Overall Study||266
8165594|NCT02497001|20130556|P2|COMPLETED|Overall Study||524
8165595|NCT02497001|20130557|P1|COMPLETED|Overall Study||566
8165596|NCT02497001|20130554|P4|STARTED|Overall Study||319
8165597|NCT02497001|20130555|P3|STARTED|Overall Study||316
8165598|NCT02497001|20130556|P2|STARTED|Overall Study||627
8165599|NCT02497001|20130557|P1|STARTED|Overall Study||640
8165600|NCT02496884|20130618|P4|NOT COMPLETED|Overall Study||0
8165601|NCT02496884|20130619|P3|NOT COMPLETED|Overall Study||0
8165602|NCT02496884|20130620|P2|NOT COMPLETED|Overall Study||3
8165603|NCT02496884|20130621|P1|NOT COMPLETED|Overall Study||2
8165604|NCT02496884|20130618|P4|COMPLETED|Overall Study||4
8165605|NCT02496884|20130619|P3|COMPLETED|Overall Study||1
8165606|NCT02496884|20130620|P2|COMPLETED|Overall Study||31
8165607|NCT02496884|20130621|P1|COMPLETED|Overall Study||15
8165608|NCT02496884|20130618|P4|Completed Treatment Per Protocol|Overall Study||3
8165609|NCT02496884|20130619|P3|Completed Treatment Per Protocol|Overall Study||1
8165610|NCT02496884|20130620|P2|Completed Treatment Per Protocol|Overall Study||27
8165611|NCT02496884|20130621|P1|Completed Treatment Per Protocol|Overall Study||16
8165612|NCT02496884|20130618|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||4
8165613|NCT02496884|20130619|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8165614|NCT02496884|20130620|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||33
8165615|NCT02496884|20130621|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8165616|NCT02496884|20130618|P4|Modified Intent to Treat Set (mITT)|Overall Study||4
8165617|NCT02496884|20130619|P3|Modified Intent to Treat Set (mITT)|Overall Study||1
8165618|NCT02496884|20130620|P2|Modified Intent to Treat Set (mITT)|Overall Study||34
8165619|NCT02496884|20130621|P1|Modified Intent to Treat Set (mITT)|Overall Study||17
8165620|NCT02496884|20130618|P4|Safety Analysis Set|Overall Study||4
8165621|NCT02496884|20130619|P3|Safety Analysis Set|Overall Study||1
8165622|NCT02496884|20130620|P2|Safety Analysis Set|Overall Study||34
8165623|NCT02496884|20130621|P1|Safety Analysis Set|Overall Study||17
8165624|NCT02496884|20130618|P4|STARTED|Overall Study||4
8165625|NCT02496884|20130619|P3|STARTED|Overall Study||1
8165626|NCT02496884|20130620|P2|STARTED|Overall Study||34
8165627|NCT02496884|20130621|P1|STARTED|Overall Study||17
8165628|NCT02496767|20130647|P8|NOT COMPLETED|Double-blind, Withdrawal Phase||5
8165629|NCT02496767|20130648|P7|NOT COMPLETED|Double-blind, Withdrawal Phase||4
8165630|NCT02496767|20130649|P6|NOT COMPLETED|Double-blind, Withdrawal Phase||6
8165631|NCT02496767|20130650|P5|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8165632|NCT02496767|20130651|P4|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8165633|NCT02496767|20130652|P3|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8165634|NCT02496767|20130653|P2|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8165635|NCT02496767|20130654|P1|NOT COMPLETED|Double-blind, Withdrawal Phase||0
8165636|NCT02496767|20130647|P8|COMPLETED|Double-blind, Withdrawal Phase||96
8165637|NCT02496767|20130648|P7|COMPLETED|Double-blind, Withdrawal Phase||99
8165638|NCT02496767|20130649|P6|COMPLETED|Double-blind, Withdrawal Phase||126
8165639|NCT02496767|20130650|P5|COMPLETED|Double-blind, Withdrawal Phase||0
8165640|NCT02496767|20130651|P4|COMPLETED|Double-blind, Withdrawal Phase||0
8165641|NCT02496767|20130652|P3|COMPLETED|Double-blind, Withdrawal Phase||0
8165642|NCT02496767|20130653|P2|COMPLETED|Double-blind, Withdrawal Phase||0
8165643|NCT02496767|20130654|P1|COMPLETED|Double-blind, Withdrawal Phase||0
8165644|NCT02496767|20130647|P8|STARTED|Double-blind, Withdrawal Phase||101
8165645|NCT02496767|20130648|P7|STARTED|Double-blind, Withdrawal Phase||103
8165646|NCT02496767|20130649|P6|STARTED|Double-blind, Withdrawal Phase||132
8165647|NCT02496767|20130650|P5|STARTED|Double-blind, Withdrawal Phase||0
8165648|NCT02496767|20130651|P4|STARTED|Double-blind, Withdrawal Phase||0
8165649|NCT02496767|20130652|P3|STARTED|Double-blind, Withdrawal Phase||0
8165650|NCT02496767|20130653|P2|STARTED|Double-blind, Withdrawal Phase||0
8165651|NCT02496767|20130654|P1|STARTED|Double-blind, Withdrawal Phase||0
8165652|NCT02496767|20130647|P8|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8165653|NCT02496767|20130648|P7|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8165654|NCT02496767|20130649|P6|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8165655|NCT02496767|20130650|P5|NOT COMPLETED|Double-blind, Placebo-controlled Phase||66
8165656|NCT02496767|20130651|P4|NOT COMPLETED|Double-blind, Placebo-controlled Phase||61
8165657|NCT02496767|20130652|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||46
8165658|NCT02496767|20130653|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||56
8165659|NCT02496767|20130654|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8165660|NCT02496767|20130647|P8|COMPLETED|Double-blind, Placebo-controlled Phase||0
8165661|NCT02496767|20130648|P7|COMPLETED|Double-blind, Placebo-controlled Phase||0
8165662|NCT02496767|20130649|P6|COMPLETED|Double-blind, Placebo-controlled Phase||0
8165663|NCT02496767|20130650|P5|COMPLETED|Double-blind, Placebo-controlled Phase||59
8165664|NCT02496767|20130651|P4|COMPLETED|Double-blind, Placebo-controlled Phase||65
8165665|NCT02496767|20130652|P3|COMPLETED|Double-blind, Placebo-controlled Phase||80
8165666|NCT02496767|20130653|P2|COMPLETED|Double-blind, Placebo-controlled Phase||132
8165667|NCT02496767|20130654|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
8165668|NCT02496767|20130647|P8|STARTED|Double-blind, Placebo-controlled Phase||0
8165669|NCT02496767|20130648|P7|STARTED|Double-blind, Placebo-controlled Phase||0
8165670|NCT02496767|20130649|P6|STARTED|Double-blind, Placebo-controlled Phase||0
8165671|NCT02496767|20130650|P5|STARTED|Double-blind, Placebo-controlled Phase||125
8165672|NCT02496767|20130651|P4|STARTED|Double-blind, Placebo-controlled Phase||126
8165673|NCT02496767|20130652|P3|STARTED|Double-blind, Placebo-controlled Phase||126
8165674|NCT02496767|20130653|P2|STARTED|Double-blind, Placebo-controlled Phase||188
8165675|NCT02496767|20130654|P1|STARTED|Double-blind, Placebo-controlled Phase||0
8165676|NCT02496767|20130647|P8|NOT COMPLETED|Open-label Lead-in Phase||0
8165677|NCT02496767|20130648|P7|NOT COMPLETED|Open-label Lead-in Phase||0
8165678|NCT02496767|20130649|P6|NOT COMPLETED|Open-label Lead-in Phase||0
8165679|NCT02496767|20130650|P5|NOT COMPLETED|Open-label Lead-in Phase||0
8165680|NCT02496767|20130651|P4|NOT COMPLETED|Open-label Lead-in Phase||0
8165681|NCT02496767|20130652|P3|NOT COMPLETED|Open-label Lead-in Phase||0
8165682|NCT02496767|20130653|P2|NOT COMPLETED|Open-label Lead-in Phase||0
8165683|NCT02496767|20130654|P1|NOT COMPLETED|Open-label Lead-in Phase||179
8165684|NCT02496767|20130647|P8|COMPLETED|Open-label Lead-in Phase||0
8165685|NCT02496767|20130648|P7|COMPLETED|Open-label Lead-in Phase||0
8165686|NCT02496767|20130649|P6|COMPLETED|Open-label Lead-in Phase||0
8165687|NCT02496767|20130650|P5|COMPLETED|Open-label Lead-in Phase||0
8165688|NCT02496767|20130651|P4|COMPLETED|Open-label Lead-in Phase||0
8165689|NCT02496767|20130652|P3|COMPLETED|Open-label Lead-in Phase||0
8165690|NCT02496767|20130653|P2|COMPLETED|Open-label Lead-in Phase||0
8165691|NCT02496767|20130654|P1|COMPLETED|Open-label Lead-in Phase||565
8165692|NCT02496767|20130647|P8|STARTED|Open-label Lead-in Phase||0
8165693|NCT02496767|20130648|P7|STARTED|Open-label Lead-in Phase||0
8165694|NCT02496767|20130649|P6|STARTED|Open-label Lead-in Phase||0
8165695|NCT02496767|20130650|P5|STARTED|Open-label Lead-in Phase||0
8165696|NCT02496767|20130651|P4|STARTED|Open-label Lead-in Phase||0
8165697|NCT02496767|20130652|P3|STARTED|Open-label Lead-in Phase||0
8165698|NCT02496767|20130653|P2|STARTED|Open-label Lead-in Phase||0
8165699|NCT02496767|20130654|P1|STARTED|Open-label Lead-in Phase||744
8165700|NCT02496702|20130694|P2|NOT COMPLETED|Overall Study||8
8165701|NCT02496702|20130695|P1|NOT COMPLETED|Overall Study||8
8165702|NCT02496702|20130694|P2|COMPLETED|Overall Study||22
8165703|NCT02496702|20130695|P1|COMPLETED|Overall Study||22
8165704|NCT02496702|20130694|P2|Did Not Receive Allocated Intervention|Overall Study||0
8165705|NCT02496702|20130695|P1|Did Not Receive Allocated Intervention|Overall Study||9
8165706|NCT02496702|20130694|P2|Received Allocated Intervention|Overall Study||0
8165707|NCT02496702|20130695|P1|Received Allocated Intervention|Overall Study||21
8165708|NCT02496702|20130694|P2|STARTED|Overall Study||30
8165709|NCT02496702|20130695|P1|STARTED|Overall Study||30
8165710|NCT02496533|20130717|P2|NOT COMPLETED|Overall Study||6
8165711|NCT02496533|20130718|P1|NOT COMPLETED|Overall Study||3
8165712|NCT02496533|20130717|P2|COMPLETED|Overall Study||106
8165713|NCT02496533|20130718|P1|COMPLETED|Overall Study||102
8165714|NCT02496533|20130717|P2|STARTED|Overall Study||112
8165715|NCT02496533|20130718|P1|STARTED|Overall Study||105
8165716|NCT02496221|20130730|P2|NOT COMPLETED|Treatment Period 2 - 4 Days||1
8165717|NCT02496221|20130731|P1|NOT COMPLETED|Treatment Period 2 - 4 Days||2
8165718|NCT02496221|20130730|P2|COMPLETED|Treatment Period 2 - 4 Days||9
8165719|NCT02496221|20130731|P1|COMPLETED|Treatment Period 2 - 4 Days||8
8165720|NCT02496221|20130730|P2|STARTED|Treatment Period 2 - 4 Days||10
8165721|NCT02496221|20130731|P1|STARTED|Treatment Period 2 - 4 Days||10
8165722|NCT02496221|20130730|P2|NOT COMPLETED|Treatment Period 1 - 4 Days||0
8165723|NCT02496221|20130731|P1|NOT COMPLETED|Treatment Period 1 - 4 Days||0
8165724|NCT02496221|20130730|P2|COMPLETED|Treatment Period 1 - 4 Days||10
8165725|NCT02496221|20130731|P1|COMPLETED|Treatment Period 1 - 4 Days||10
8165726|NCT02496221|20130730|P2|STARTED|Treatment Period 1 - 4 Days||10
8165727|NCT02496221|20130731|P1|STARTED|Treatment Period 1 - 4 Days||10
8165728|NCT02496091|20130765|P1|NOT COMPLETED|Overall Study||2
8165729|NCT02496091|20130765|P1|COMPLETED|Overall Study||142
8165730|NCT02496091|20130765|P1|STARTED|Overall Study||144
8165731|NCT02496039|20130774|P1|NOT COMPLETED|Overall Study||4
8165732|NCT02496039|20130774|P1|COMPLETED|Overall Study||1
8165733|NCT02496039|20130774|P1|STARTED|Overall Study||5
8165734|NCT02496000|20130789|P3|NOT COMPLETED|Overall Study||2
8165735|NCT02496000|20130790|P2|NOT COMPLETED|Overall Study||5
8165736|NCT02496000|20130791|P1|NOT COMPLETED|Overall Study||2
8165737|NCT02496000|20130789|P3|COMPLETED|Overall Study||61
8165738|NCT02496000|20130790|P2|COMPLETED|Overall Study||56
8165739|NCT02496000|20130791|P1|COMPLETED|Overall Study||62
8165740|NCT02496000|20130789|P3|STARTED|Overall Study||63
8165741|NCT02496000|20130790|P2|STARTED|Overall Study||61
8165742|NCT02496000|20130791|P1|STARTED|Overall Study||64
8165743|NCT02495948|20130812|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
8165744|NCT02495948|20130813|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
8165745|NCT02495948|20130812|P2|COMPLETED|Period 2, Second 30 Days of Wear||82
8165746|NCT02495948|20130813|P1|COMPLETED|Period 2, Second 30 Days of Wear||82
8165747|NCT02495948|20130812|P2|STARTED|Period 2, Second 30 Days of Wear||83
8165748|NCT02495948|20130813|P1|STARTED|Period 2, Second 30 Days of Wear||83
8165749|NCT02495948|20130812|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
8165750|NCT02495948|20130813|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
8165751|NCT02495948|20130812|P2|COMPLETED|Period 1, First 30 Days of Wear||83
8165752|NCT02495948|20130813|P1|COMPLETED|Period 1, First 30 Days of Wear||83
8165753|NCT02495948|20130812|P2|STARTED|Period 1, First 30 Days of Wear||84
8165754|NCT02495948|20130813|P1|STARTED|Period 1, First 30 Days of Wear||83
8165755|NCT02495883|20130822|P2|NOT COMPLETED|Overall Study||0
8165756|NCT02495883|20130823|P1|NOT COMPLETED|Overall Study||1
8165757|NCT02495883|20130822|P2|COMPLETED|Overall Study||24
8165758|NCT02495883|20130823|P1|COMPLETED|Overall Study||31
8165759|NCT02495883|20130822|P2|STARTED|Overall Study||24
8165760|NCT02495883|20130823|P1|STARTED|Overall Study||32
8165761|NCT02495857|20130831|P3|NOT COMPLETED|Overall Study||18
8165762|NCT02495857|20130832|P2|NOT COMPLETED|Overall Study||16
8165763|NCT02495857|20130833|P1|NOT COMPLETED|Overall Study||22
8165764|NCT02495857|20130831|P3|COMPLETED|Overall Study||181
8165765|NCT02495857|20130832|P2|COMPLETED|Overall Study||184
8165766|NCT02495857|20130833|P1|COMPLETED|Overall Study||178
8165767|NCT02495857|20130831|P3|STARTED|Overall Study||199
8165768|NCT02495857|20130832|P2|STARTED|Overall Study||200
8165769|NCT02495857|20130833|P1|STARTED|Overall Study||200
8165770|NCT02495844|20130849|P2|NOT COMPLETED|Overall Study||4
8165771|NCT02495844|20130850|P1|NOT COMPLETED|Overall Study||1
8165772|NCT02495844|20130849|P2|COMPLETED|Overall Study||24
8165773|NCT02495844|20130850|P1|COMPLETED|Overall Study||26
8165774|NCT02495844|20130849|P2|STARTED|Overall Study||28
8165775|NCT02495844|20130850|P1|STARTED|Overall Study||27
8165776|NCT02495831|20130880|P2|NOT COMPLETED|Second Intervention||0
8165777|NCT02495831|20130881|P1|NOT COMPLETED|Second Intervention||0
8165778|NCT02495831|20130880|P2|COMPLETED|Second Intervention||10
8165779|NCT02495831|20130881|P1|COMPLETED|Second Intervention||12
8165780|NCT02495831|20130880|P2|STARTED|Second Intervention||10
8165781|NCT02495831|20130881|P1|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
8165782|NCT02495831|20130880|P2|NOT COMPLETED|First Intervention||0
8165783|NCT02495831|20130881|P1|NOT COMPLETED|First Intervention||0
8165784|NCT02495831|20130880|P2|COMPLETED|First Intervention||10
8165785|NCT02495831|20130881|P1|COMPLETED|First Intervention||13
8165786|NCT02495831|20130880|P2|STARTED|First Intervention||10
8165787|NCT02495831|20130881|P1|STARTED|First Intervention||13
8165788|NCT02495779|20130895|P1|NOT COMPLETED|Overall Study||6
8165789|NCT02495779|20130895|P1|COMPLETED|Overall Study||48
8165790|NCT02495779|20130895|P1|STARTED|Overall Study||54
8165791|NCT02495623|20130902|P3|NOT COMPLETED|Overall Study||8
8165792|NCT02495623|20130903|P2|NOT COMPLETED|Overall Study||9
8165793|NCT02495623|20130904|P1|NOT COMPLETED|Overall Study||5
8165794|NCT02495623|20130902|P3|COMPLETED|Overall Study||20
8165795|NCT02495623|20130903|P2|COMPLETED|Overall Study||17
8165796|NCT02495623|20130904|P1|COMPLETED|Overall Study||20
8165797|NCT02495623|20130902|P3|Dosed|Overall Study||22
8165798|NCT02495623|20130903|P2|Dosed|Overall Study||19
8165799|NCT02495623|20130904|P1|Dosed|Overall Study||22
8165800|NCT02495623|20130902|P3|STARTED|Overall Study||28
8165801|NCT02495623|20130903|P2|STARTED|Overall Study||26
8165802|NCT02495623|20130904|P1|STARTED|Overall Study||25
8165803|NCT02495467|20130914|P2|NOT COMPLETED|Second Intervention (4 Weeks)||3
8165804|NCT02495467|20130915|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8165805|NCT02495467|20130914|P2|COMPLETED|Second Intervention (4 Weeks)||113
8165806|NCT02495467|20130915|P1|COMPLETED|Second Intervention (4 Weeks)||112
8165807|NCT02495467|20130914|P2|STARTED|Second Intervention (4 Weeks)||116
8165808|NCT02495467|20130915|P1|STARTED|Second Intervention (4 Weeks)||112
8165809|NCT02495467|20130914|P2|NOT COMPLETED|Washout (1 Week)||2
8165810|NCT02495467|20130915|P1|NOT COMPLETED|Washout (1 Week)||2
8165811|NCT02495467|20130914|P2|COMPLETED|Washout (1 Week)||116
8165812|NCT02495467|20130915|P1|COMPLETED|Washout (1 Week)||112
8165813|NCT02495467|20130914|P2|STARTED|Washout (1 Week)||118
8165814|NCT02495467|20130915|P1|STARTED|Washout (1 Week)||114
8165815|NCT02495467|20130914|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8165816|NCT02495467|20130915|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8165817|NCT02495467|20130914|P2|COMPLETED|First Intervention (4 Weeks)|One subject completed visits in treatment Period 1 but never used treatment|118
8165818|NCT02495467|20130915|P1|COMPLETED|First Intervention (4 Weeks)||114
8165819|NCT02495467|20130914|P2|STARTED|First Intervention (4 Weeks)||118
8165820|NCT02495467|20130915|P1|STARTED|First Intervention (4 Weeks)||114
8165821|NCT02495454|20130943|P1|NOT COMPLETED|Overall Study||1
8165822|NCT02495454|20130943|P1|COMPLETED|Overall Study|One case excluded for violation of inclusion criteria (transformed lymphoma)|33
8165823|NCT02495454|20130943|P1|STARTED|Overall Study||34
8165824|NCT02495389|20130952|P1|NOT COMPLETED|Overall Study||40
8165825|NCT02495389|20130952|P1|COMPLETED|Overall Study||44
8165826|NCT02495389|20130952|P1|STARTED|Overall Study||84
8165827|NCT02495259|20130963|P3|NOT COMPLETED|Overall Study||0
8165828|NCT02495259|20130964|P2|NOT COMPLETED|Overall Study||1
8165829|NCT02495259|20130965|P1|NOT COMPLETED|Overall Study||0
8165830|NCT02495259|20130963|P3|COMPLETED|Overall Study||8
8165831|NCT02495259|20130964|P2|COMPLETED|Overall Study||3
8165832|NCT02495259|20130965|P1|COMPLETED|Overall Study||7
8165833|NCT02495259|20130963|P3|STARTED|Overall Study||8
8165834|NCT02495259|20130964|P2|STARTED|Overall Study||4
8165835|NCT02495259|20130965|P1|STARTED|Overall Study||7
8165836|NCT02495233|20130990|P2|NOT COMPLETED|Overall Study||1
8165837|NCT02495233|20130991|P1|NOT COMPLETED|Overall Study||0
8165838|NCT02495233|20130990|P2|COMPLETED|Overall Study||6
8165839|NCT02495233|20130991|P1|COMPLETED|Overall Study||3
8165840|NCT02495233|20130990|P2|STARTED|Overall Study||7
8165841|NCT02495233|20130991|P1|STARTED|Overall Study||3
8165842|NCT02495168|20131020|P3|NOT COMPLETED|Overall Study||17
8165843|NCT02495168|20131021|P2|NOT COMPLETED|Overall Study||54
8165844|NCT02495168|20131022|P1|NOT COMPLETED|Overall Study||38
8165845|NCT02495168|20131020|P3|COMPLETED|Overall Study||110
8165846|NCT02495168|20131021|P2|COMPLETED|Overall Study||462
8165847|NCT02495168|20131022|P1|COMPLETED|Overall Study||466
8165848|NCT02495168|20131020|P3|Day 42 (D42PPS) Population|Overall Study||88
8165849|NCT02495168|20131021|P2|Day 42 (D42PPS) Population|Overall Study||383
8165850|NCT02495168|20131022|P1|Day 42 (D42PPS) Population|Overall Study||382
8165851|NCT02495168|20131020|P3|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99
8165852|NCT02495168|20131021|P2|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
8165853|NCT02495168|20131022|P1|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
8165854|NCT02495168|20131020|P3|Modified Intent-to-Treat Population|Overall Study||111
8165855|NCT02495168|20131021|P2|Modified Intent-to-Treat Population|Overall Study||478
8165856|NCT02495168|20131022|P1|Modified Intent-to-Treat Population|Overall Study||468
8165857|NCT02495168|20131020|P3|Safety Population|Overall Study||126
8165858|NCT02495168|20131021|P2|Safety Population|Overall Study||514
8165859|NCT02495168|20131022|P1|Safety Population|Overall Study||501
8165860|NCT02495168|20131020|P3|STARTED|Overall Study||127
8165861|NCT02495168|20131021|P2|STARTED|Overall Study||516
8165862|NCT02495168|20131022|P1|STARTED|Overall Study||504
8165863|NCT02495103|20131041|P2|NOT COMPLETED|Overall Study||0
8165864|NCT02495103|20131042|P1|NOT COMPLETED|Overall Study||0
8165865|NCT02495103|20131041|P2|COMPLETED|Overall Study||4
8165866|NCT02495103|20131042|P1|COMPLETED|Overall Study||3
8165867|NCT02495103|20131041|P2|STARTED|Overall Study||4
8165868|NCT02495103|20131042|P1|STARTED|Overall Study||3
8165869|NCT02495038|20131057|P3|NOT COMPLETED|Overall Study||0
8165870|NCT02495038|20131058|P2|NOT COMPLETED|Overall Study||0
8165871|NCT02495038|20131059|P1|NOT COMPLETED|Overall Study||0
8165872|NCT02495038|20131057|P3|COMPLETED|Overall Study||27
8165873|NCT02495038|20131058|P2|COMPLETED|Overall Study||27
8165874|NCT02495038|20131059|P1|COMPLETED|Overall Study||27
8165875|NCT02495038|20131057|P3|STARTED|Overall Study||27
8165876|NCT02495038|20131058|P2|STARTED|Overall Study||27
8165877|NCT02495038|20131059|P1|STARTED|Overall Study||27
8165878|NCT02495025|20131096|P2|NOT COMPLETED|Overall Study||14
8165879|NCT02495025|20131097|P1|NOT COMPLETED|Overall Study||26
8165880|NCT02495025|20131096|P2|COMPLETED|Overall Study||61
8165881|NCT02495025|20131097|P1|COMPLETED|Overall Study||51
8165882|NCT02495025|20131096|P2|STARTED|Overall Study||75
8165883|NCT02495025|20131097|P1|STARTED|Overall Study||77
8165884|NCT02494817|20131111|P2|NOT COMPLETED|Overall Study||49
8165885|NCT02494817|20131112|P1|NOT COMPLETED|Overall Study||55
8165886|NCT02494817|20131111|P2|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87
8165887|NCT02494817|20131112|P1|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107
8165888|NCT02494817|20131111|P2|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98
8165889|NCT02494817|20131112|P1|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115
8165890|NCT02494817|20131111|P2|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92
8165891|NCT02494817|20131112|P1|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125
8165892|NCT02494817|20131111|P2|STARTED|Overall Study|representing 68 couples|136
8165893|NCT02494817|20131112|P1|STARTED|Overall Study|representing 81 couples|162
8165894|NCT02494713|20131132|P1|NOT COMPLETED|Overall Study||0
8165895|NCT02494713|20131132|P1|COMPLETED|Overall Study||4
8165896|NCT02494713|20131132|P1|STARTED|Overall Study||4
8165897|NCT02494596|20131149|P3|NOT COMPLETED|Overall Study||1
8165898|NCT02494596|20131150|P2|NOT COMPLETED|Overall Study||5
8165899|NCT02494596|20131151|P1|NOT COMPLETED|Overall Study||3
8165900|NCT02494596|20131149|P3|COMPLETED|Overall Study||6
8165901|NCT02494596|20131150|P2|COMPLETED|Overall Study||2
8165902|NCT02494596|20131151|P1|COMPLETED|Overall Study||2
8165903|NCT02494596|20131149|P3|STARTED|Overall Study||7
8165904|NCT02494596|20131150|P2|STARTED|Overall Study||7
8165905|NCT02494596|20131151|P1|STARTED|Overall Study||5
8165918|NCT02494518|20131237|P3|NOT COMPLETED|Overall Study||3
8165919|NCT02494518|20131238|P2|NOT COMPLETED|Overall Study||2
8165920|NCT02494518|20131239|P1|NOT COMPLETED|Overall Study||1
8165921|NCT02494518|20131237|P3|COMPLETED|Overall Study||8
8165922|NCT02494518|20131238|P2|COMPLETED|Overall Study||10
8165923|NCT02494518|20131239|P1|COMPLETED|Overall Study||10
8165924|NCT02494518|20131237|P3|STARTED|Overall Study||11
8165925|NCT02494518|20131238|P2|STARTED|Overall Study||12
8165926|NCT02494518|20131239|P1|STARTED|Overall Study||11
8165927|NCT02494440|20131271|P1|NOT COMPLETED|Overall Study||0
8165928|NCT02494440|20131271|P1|COMPLETED|Overall Study||90
8165929|NCT02494440|20131271|P1|STARTED|Overall Study||90
8165930|NCT02494401|20131279|P2|NOT COMPLETED|Overall Study||27
8165931|NCT02494401|20131280|P1|NOT COMPLETED|Overall Study||25
8165932|NCT02494401|20131279|P2|COMPLETED|Overall Study||106
8165933|NCT02494401|20131280|P1|COMPLETED|Overall Study||109
8165934|NCT02494401|20131279|P2|6 Month Follow up|Overall Study||106
8165935|NCT02494401|20131280|P1|6 Month Follow up|Overall Study||109
8165936|NCT02494401|20131279|P2|Week 16|Overall Study||124
8165937|NCT02494401|20131280|P1|Week 16|Overall Study||123
8165938|NCT02494401|20131279|P2|STARTED|Overall Study||133
8165939|NCT02494401|20131280|P1|STARTED|Overall Study||134
8165940|NCT02494336|20131320|P2|NOT COMPLETED|Overall Study||0
8165941|NCT02494336|20131321|P1|NOT COMPLETED|Overall Study||0
8165942|NCT02494336|20131320|P2|COMPLETED|Overall Study||24
8165943|NCT02494336|20131321|P1|COMPLETED|Overall Study||24
8165944|NCT02494336|20131320|P2|STARTED|Overall Study||24
8165945|NCT02494336|20131321|P1|STARTED|Overall Study||24
8165946|NCT02494323|20131339|P1|NOT COMPLETED|Overall Study||0
8165947|NCT02494323|20131339|P1|COMPLETED|Overall Study||70
8165948|NCT02494323|20131339|P1|STARTED|Overall Study||70
8165949|NCT02494206|20131344|P1|NOT COMPLETED|Overall Study||2
8165950|NCT02494206|20131344|P1|COMPLETED|Overall Study||7
8165951|NCT02494206|20131344|P1|STARTED|Overall Study||9
8165952|NCT02494180|20131350|P2|NOT COMPLETED|Overall Study||0
8165953|NCT02494180|20131351|P1|NOT COMPLETED|Overall Study||0
8165954|NCT02494180|20131350|P2|COMPLETED|Overall Study||85
8165955|NCT02494180|20131351|P1|COMPLETED|Overall Study||85
8165956|NCT02494180|20131350|P2|STARTED|Overall Study||85
8165957|NCT02494180|20131351|P1|STARTED|Overall Study||85
8165958|NCT02494102|20131373|P2|NOT COMPLETED|Overall Study||0
8165959|NCT02494102|20131374|P1|NOT COMPLETED|Overall Study||0
8165960|NCT02494102|20131373|P2|COMPLETED|Overall Study||47
8165961|NCT02494102|20131374|P1|COMPLETED|Overall Study||42
8165962|NCT02494102|20131373|P2|STARTED|Overall Study||47
8165963|NCT02494102|20131374|P1|STARTED|Overall Study||42
8165964|NCT02494076|20131384|P2|NOT COMPLETED|Overall Study||0
8165965|NCT02494076|20131385|P1|NOT COMPLETED|Overall Study||0
8165966|NCT02494076|20131384|P2|COMPLETED|Overall Study||26
8165967|NCT02494076|20131385|P1|COMPLETED|Overall Study||26
8165968|NCT02494076|20131384|P2|STARTED|Overall Study||26
8165969|NCT02494076|20131385|P1|STARTED|Overall Study||26
8165970|NCT02493946|20131398|P3|NOT COMPLETED|Open Label Period||86
8165971|NCT02493946|20131399|P2|NOT COMPLETED|Open Label Period||0
8165972|NCT02493946|20131400|P1|NOT COMPLETED|Open Label Period||0
8165973|NCT02493946|20131398|P3|COMPLETED|Open Label Period||509
8165974|NCT02493946|20131399|P2|COMPLETED|Open Label Period||0
8165975|NCT02493946|20131400|P1|COMPLETED|Open Label Period||0
8165976|NCT02493946|20131398|P3|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595
8165977|NCT02493946|20131399|P2|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
8165978|NCT02493946|20131400|P1|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
8165979|NCT02493946|20131398|P3|NOT COMPLETED|DB Period||0
8165980|NCT02493946|20131399|P2|NOT COMPLETED|DB Period||5
8165981|NCT02493946|20131400|P1|NOT COMPLETED|DB Period||8
8165982|NCT02493946|20131398|P3|COMPLETED|DB Period||0
8165983|NCT02493946|20131399|P2|COMPLETED|DB Period||59
8165984|NCT02493946|20131400|P1|COMPLETED|DB Period||118
8165985|NCT02493946|20131398|P3|STARTED|DB Period||0
8165986|NCT02493946|20131399|P2|STARTED|DB Period||64
8165987|NCT02493946|20131400|P1|STARTED|DB Period||126
8165988|NCT02493868|20131433|P2|NOT COMPLETED|Follow-up Phase||2
8165989|NCT02493868|20131434|P1|NOT COMPLETED|Follow-up Phase||11
8165990|NCT02493868|20131433|P2|COMPLETED|Follow-up Phase||62
8165991|NCT02493868|20131434|P1|COMPLETED|Follow-up Phase||470
8165992|NCT02493868|20131433|P2|STARTED|Follow-up Phase||64
8165993|NCT02493868|20131434|P1|STARTED|Follow-up Phase||481
8165994|NCT02493868|20131433|P2|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22
8165995|NCT02493868|20131434|P1|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13
8165996|NCT02493868|20131433|P2|COMPLETED|Maintenance Phase: DE+TE Participants||177
8165997|NCT02493868|20131434|P1|COMPLETED|Maintenance Phase: DE+TE Participants||139
8165998|NCT02493868|20131433|P2|Stable Responders|Maintenance Phase: DE+TE Participants||59
8165999|NCT02493868|20131434|P1|Stable Responders|Maintenance Phase: DE+TE Participants||62
8166000|NCT02493868|20131433|P2|Stable Remitters|Maintenance Phase: DE+TE Participants||86
8166001|NCT02493868|20131434|P1|Stable Remitters|Maintenance Phase: DE+TE Participants||90
8166002|NCT02493868|20131433|P2|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199
8166003|NCT02493868|20131434|P1|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152
8166004|NCT02493868|20131433|P2|NOT COMPLETED|Optimization Phase: DE+TE Participants||32
8166005|NCT02493868|20131434|P1|NOT COMPLETED|Optimization Phase: DE+TE Participants||158
8166006|NCT02493868|20131433|P2|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54
8166007|NCT02493868|20131434|P1|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297
8166008|NCT02493868|20131433|P2|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86
8166009|NCT02493868|20131434|P1|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455
8166010|NCT02493868|20131433|P2|NOT COMPLETED|Induction Phase: DE Participants||0
8166011|NCT02493868|20131434|P1|NOT COMPLETED|Induction Phase: DE Participants||164
8166012|NCT02493868|20131433|P2|COMPLETED|Induction Phase: DE Participants||0
8166013|NCT02493868|20131434|P1|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273
8166014|NCT02493868|20131433|P2|STARTED|Induction Phase: DE Participants||0
8166015|NCT02493868|20131434|P1|STARTED|Induction Phase: DE Participants||437
8166016|NCT02493855|20131483|P3|NOT COMPLETED|Overall Study||0
8166017|NCT02493855|20131484|P2|NOT COMPLETED|Overall Study||1
8166018|NCT02493855|20131485|P1|NOT COMPLETED|Overall Study||2
8166019|NCT02493855|20131483|P3|COMPLETED|Overall Study||6
8166020|NCT02493855|20131484|P2|COMPLETED|Overall Study||18
8166021|NCT02493855|20131485|P1|COMPLETED|Overall Study||19
8166022|NCT02493855|20131483|P3|STARTED|Overall Study||6
8166023|NCT02493855|20131484|P2|STARTED|Overall Study||19
8166024|NCT02493855|20131485|P1|STARTED|Overall Study||21
8166031|NCT02493764|20131506|P2|NOT COMPLETED|Overall Study||82
8166032|NCT02493764|20131507|P1|NOT COMPLETED|Overall Study||83
8166033|NCT02493764|20131506|P2|COMPLETED|Overall Study||187
8166034|NCT02493764|20131507|P1|COMPLETED|Overall Study||185
8166035|NCT02493764|20131506|P2|STARTED|Overall Study||269
8166036|NCT02493764|20131507|P1|STARTED|Overall Study||268
8166043|NCT02493712|20131566|P3|NOT COMPLETED|Overall Study||6
8166044|NCT02493712|20131567|P2|NOT COMPLETED|Overall Study||6
8166045|NCT02493712|20131568|P1|NOT COMPLETED|Overall Study||2
8166046|NCT02493712|20131566|P3|COMPLETED|Overall Study||11
8166047|NCT02493712|20131567|P2|COMPLETED|Overall Study||12
8166048|NCT02493712|20131568|P1|COMPLETED|Overall Study||14
8166049|NCT02493712|20131566|P3|STARTED|Overall Study||17
8166050|NCT02493712|20131567|P2|STARTED|Overall Study||18
8166051|NCT02493712|20131568|P1|STARTED|Overall Study||16
8166052|NCT02493621|20131581|P2|NOT COMPLETED|Overall Study||0
8166053|NCT02493621|20131582|P1|NOT COMPLETED|Overall Study||0
8166054|NCT02493621|20131581|P2|COMPLETED|Overall Study||58
8166055|NCT02493621|20131582|P1|COMPLETED|Overall Study||58
8166056|NCT02493621|20131581|P2|STARTED|Overall Study||58
8166057|NCT02493621|20131582|P1|STARTED|Overall Study||58
8166058|NCT02493608|20131592|P2|NOT COMPLETED|Overall Study||0
8166059|NCT02493608|20131593|P1|NOT COMPLETED|Overall Study||0
8166060|NCT02493608|20131592|P2|COMPLETED|Overall Study||48
8166061|NCT02493608|20131593|P1|COMPLETED|Overall Study||48
8166062|NCT02493608|20131592|P2|STARTED|Overall Study||48
8166063|NCT02493608|20131593|P1|STARTED|Overall Study||48
8166064|NCT02493517|20131605|P2|NOT COMPLETED|Overall Study||7
8166065|NCT02493517|20131606|P1|NOT COMPLETED|Overall Study||2
8166066|NCT02493517|20131605|P2|COMPLETED|Overall Study||57
8166067|NCT02493517|20131606|P1|COMPLETED|Overall Study||62
8166068|NCT02493517|20131605|P2|STARTED|Overall Study||64
8166069|NCT02493517|20131606|P1|STARTED|Overall Study||64
8166070|NCT02493452|20131631|P3|NOT COMPLETED|Overall Study||54
8166071|NCT02493452|20131632|P2|NOT COMPLETED|Overall Study||49
8166072|NCT02493452|20131633|P1|NOT COMPLETED|Overall Study||50
8166073|NCT02493452|20131631|P3|COMPLETED|Overall Study||325
8166074|NCT02493452|20131632|P2|COMPLETED|Overall Study||328
8166075|NCT02493452|20131633|P1|COMPLETED|Overall Study||329
8166076|NCT02493452|20131631|P3|STARTED|Overall Study||379
8166077|NCT02493452|20131632|P2|STARTED|Overall Study||377
8166078|NCT02493452|20131633|P1|STARTED|Overall Study||379
8166079|NCT02493361|20131665|P1|NOT COMPLETED|Overall Study||3
8166080|NCT02493361|20131665|P1|COMPLETED|Overall Study||21
8166081|NCT02493361|20131665|P1|Week 24 Assessment|Overall Study||21
8166082|NCT02493361|20131665|P1|STARTED|Overall Study||24
8166083|NCT02493257|20131677|P2|NOT COMPLETED|Overall Study||1
8166084|NCT02493257|20131678|P1|NOT COMPLETED|Overall Study||1
8166085|NCT02493257|20131677|P2|COMPLETED|Overall Study||10
8166086|NCT02493257|20131678|P1|COMPLETED|Overall Study||10
8166087|NCT02493257|20131677|P2|12 Week Follow up|Overall Study||10
8166088|NCT02493257|20131678|P1|12 Week Follow up|Overall Study||10
8166089|NCT02493257|20131677|P2|4 Week Follow up|Overall Study||11
8166090|NCT02493257|20131678|P1|4 Week Follow up|Overall Study||11
8166091|NCT02493257|20131677|P2|STARTED|Overall Study||11
8166092|NCT02493257|20131678|P1|STARTED|Overall Study||11
8166093|NCT02493127|20131692|P2|NOT COMPLETED|Overall Study||1
8166094|NCT02493127|20131693|P1|NOT COMPLETED|Overall Study||1
8166095|NCT02493127|20131692|P2|COMPLETED|Overall Study||60
8166096|NCT02493127|20131693|P1|COMPLETED|Overall Study||60
8166097|NCT02493127|20131692|P2|STARTED|Overall Study||61
8166098|NCT02493127|20131693|P1|STARTED|Overall Study||61
8166099|NCT02493088|20131705|P1|NOT COMPLETED|Overall Study||0
8166100|NCT02493088|20131705|P1|COMPLETED|Overall Study||11
8166101|NCT02493088|20131705|P1|STARTED|Overall Study||11
8166102|NCT02493062|20131711|P1|NOT COMPLETED|Overall Study||12
8166103|NCT02493062|20131711|P1|COMPLETED|Overall Study||23
8166104|NCT02493062|20131711|P1|STARTED|Overall Study||35
8166105|NCT02493036|20131722|P3|NOT COMPLETED|Overall Study||2
8166106|NCT02493036|20131723|P2|NOT COMPLETED|Overall Study||2
8166107|NCT02493036|20131724|P1|NOT COMPLETED|Overall Study||1
8166108|NCT02493036|20131722|P3|COMPLETED|Overall Study||15
8166109|NCT02493036|20131723|P2|COMPLETED|Overall Study||18
8166110|NCT02493036|20131724|P1|COMPLETED|Overall Study||16
8166111|NCT02493036|20131722|P3|STARTED|Overall Study||17
8166112|NCT02493036|20131723|P2|STARTED|Overall Study||20
8166113|NCT02493036|20131724|P1|STARTED|Overall Study||17
8166114|NCT02492997|20131734|P2|NOT COMPLETED|Overall Study||1
8166115|NCT02492997|20131735|P1|NOT COMPLETED|Overall Study||2
8166116|NCT02492997|20131734|P2|COMPLETED|Overall Study||20
8166117|NCT02492997|20131735|P1|COMPLETED|Overall Study||19
8166118|NCT02492997|20131734|P2|STARTED|Overall Study||21
8166119|NCT02492997|20131735|P1|STARTED|Overall Study||21
8166120|NCT02492984|20131745|P2|NOT COMPLETED|Overall Study||0
8166121|NCT02492984|20131746|P1|NOT COMPLETED|Overall Study||3
8166122|NCT02492984|20131745|P2|COMPLETED|Overall Study||14
8166123|NCT02492984|20131746|P1|COMPLETED|Overall Study||70
8166124|NCT02492984|20131745|P2|STARTED|Overall Study||14
8166125|NCT02492984|20131746|P1|STARTED|Overall Study||73
8166126|NCT02492958|20131770|P4|NOT COMPLETED|Overall Study||0
8166127|NCT02492958|20131771|P3|NOT COMPLETED|Overall Study||2
8166128|NCT02492958|20131772|P2|NOT COMPLETED|Overall Study||0
8166129|NCT02492958|20131773|P1|NOT COMPLETED|Overall Study||1
8166130|NCT02492958|20131770|P4|COMPLETED|Overall Study||34
8166131|NCT02492958|20131771|P3|COMPLETED|Overall Study||32
8166132|NCT02492958|20131772|P2|COMPLETED|Overall Study||34
8166133|NCT02492958|20131773|P1|COMPLETED|Overall Study||33
8166134|NCT02492958|20131770|P4|STARTED|Overall Study||34
8166135|NCT02492958|20131771|P3|STARTED|Overall Study||34
8166136|NCT02492958|20131772|P2|STARTED|Overall Study||34
8166137|NCT02492958|20131773|P1|STARTED|Overall Study||34
8166138|NCT02492880|20131859|P1|NOT COMPLETED|Overall Study||2
8166139|NCT02492880|20131859|P1|COMPLETED|Overall Study||13
8166140|NCT02492880|20131859|P1|STARTED|Overall Study||15
8166141|NCT02492841|20131866|P3|NOT COMPLETED|Overall Study||35
8166142|NCT02492841|20131867|P2|NOT COMPLETED|Overall Study||31
8166143|NCT02492841|20131868|P1|NOT COMPLETED|Overall Study||34
8166144|NCT02492841|20131866|P3|COMPLETED|Overall Study||25
8166145|NCT02492841|20131867|P2|COMPLETED|Overall Study||22
8166146|NCT02492841|20131868|P1|COMPLETED|Overall Study||22
8166147|NCT02492841|20131866|P3|STARTED|Overall Study||60
8166148|NCT02492841|20131867|P2|STARTED|Overall Study||53
8166149|NCT02492841|20131868|P1|STARTED|Overall Study||56
8166150|NCT02492802|20131879|P1|NOT COMPLETED|Overall Study||0
8166151|NCT02492802|20131879|P1|COMPLETED|Overall Study||64
8166152|NCT02492802|20131879|P1|STARTED|Overall Study||64
8166153|NCT02492763|20131887|P4|NOT COMPLETED|Overall Study||13
8166154|NCT02492763|20131888|P3|NOT COMPLETED|Overall Study||10
8166155|NCT02492763|20131889|P2|NOT COMPLETED|Overall Study||15
8166156|NCT02492763|20131890|P1|NOT COMPLETED|Overall Study||16
8166157|NCT02492763|20131887|P4|COMPLETED|Overall Study||30
8166158|NCT02492763|20131888|P3|COMPLETED|Overall Study||33
8166159|NCT02492763|20131889|P2|COMPLETED|Overall Study||29
8166160|NCT02492763|20131890|P1|COMPLETED|Overall Study||30
8166161|NCT02492763|20131887|P4|Treated|Overall Study||42
8166162|NCT02492763|20131888|P3|Treated|Overall Study||43
8166163|NCT02492763|20131889|P2|Treated|Overall Study||44
8166164|NCT02492763|20131890|P1|Treated|Overall Study||46
8166165|NCT02492763|20131887|P4|STARTED|Overall Study||43
8166166|NCT02492763|20131888|P3|STARTED|Overall Study||43
8166167|NCT02492763|20131889|P2|STARTED|Overall Study||44
8166168|NCT02492763|20131890|P1|STARTED|Overall Study||46
8166169|NCT02492750|20131947|P3|NOT COMPLETED|Overall Study||0
8166170|NCT02492750|20131948|P2|NOT COMPLETED|Overall Study||0
8166171|NCT02492750|20131949|P1|NOT COMPLETED|Overall Study||0
8166172|NCT02492750|20131947|P3|COMPLETED|Overall Study||6
8166173|NCT02492750|20131948|P2|COMPLETED|Overall Study||4
8166174|NCT02492750|20131949|P1|COMPLETED|Overall Study||4
8166175|NCT02492750|20131947|P3|STARTED|Overall Study||6
8166176|NCT02492750|20131948|P2|STARTED|Overall Study||4
8166177|NCT02492750|20131949|P1|STARTED|Overall Study||4
8166178|NCT02492451|20131966|P3|NOT COMPLETED|Overall Study||0
8166179|NCT02492451|20131967|P2|NOT COMPLETED|Overall Study||0
8166180|NCT02492451|20131968|P1|NOT COMPLETED|Overall Study||0
8166181|NCT02492451|20131966|P3|COMPLETED|Overall Study||39
8166182|NCT02492451|20131967|P2|COMPLETED|Overall Study||39
8166183|NCT02492451|20131968|P1|COMPLETED|Overall Study||40
8166184|NCT02492451|20131966|P3|STARTED|Overall Study||39
8166185|NCT02492451|20131967|P2|STARTED|Overall Study||39
8166186|NCT02492451|20131968|P1|STARTED|Overall Study||40
8166187|NCT02492295|20131976|P1|NOT COMPLETED|Overall Study||0
8166188|NCT02492295|20131976|P1|COMPLETED|Overall Study||0
8166189|NCT02492295|20131976|P1|STARTED|Overall Study||0
8166190|NCT02492165|20131995|P4|NOT COMPLETED|Overall Study||0
8166191|NCT02492165|20131996|P3|NOT COMPLETED|Overall Study||0
8166192|NCT02492165|20131997|P2|NOT COMPLETED|Overall Study||1
8166193|NCT02492165|20131998|P1|NOT COMPLETED|Overall Study||0
8166194|NCT02492165|20131995|P4|COMPLETED|Overall Study||30
8166195|NCT02492165|20131996|P3|COMPLETED|Overall Study||60
8166196|NCT02492165|20131997|P2|COMPLETED|Overall Study||59
8166197|NCT02492165|20131998|P1|COMPLETED|Overall Study||100
8166198|NCT02492165|20131995|P4|STARTED|Overall Study||30
8166199|NCT02492165|20131996|P3|STARTED|Overall Study||60
8166200|NCT02492165|20131997|P2|STARTED|Overall Study||60
8166201|NCT02492165|20131998|P1|STARTED|Overall Study||100
8166202|NCT02492100|20132020|P1|NOT COMPLETED|Overall Study||1
8166203|NCT02492100|20132020|P1|COMPLETED|Overall Study||46
8166204|NCT02492100|20132020|P1|STARTED|Overall Study||47
8166205|NCT02491944|20132027|P1|NOT COMPLETED|Overall Study||0
8166206|NCT02491944|20132027|P1|COMPLETED|Overall Study||10
8166207|NCT02491944|20132027|P1|STARTED|Overall Study||10
8166208|NCT02491892|20132049|P2|NOT COMPLETED|Overall Study||38
8166209|NCT02491892|20132050|P1|NOT COMPLETED|Overall Study||41
8166210|NCT02491892|20132049|P2|COMPLETED|Overall Study||0
8166211|NCT02491892|20132050|P1|COMPLETED|Overall Study||0
8166212|NCT02491892|20132049|P2|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
8166213|NCT02491892|20132050|P1|Treated|Overall Study||41
8166214|NCT02491892|20132049|P2|STARTED|Overall Study||38
8166215|NCT02491892|20132050|P1|STARTED|Overall Study||41
8166216|NCT02491788|20132096|P2|NOT COMPLETED|Overall Study||0
8166217|NCT02491788|20132097|P1|NOT COMPLETED|Overall Study||0
8166218|NCT02491788|20132096|P2|COMPLETED|Overall Study||11
8166219|NCT02491788|20132097|P1|COMPLETED|Overall Study||8
8166220|NCT02491788|20132096|P2|STARTED|Overall Study||11
8166221|NCT02491788|20132097|P1|STARTED|Overall Study||8
8166222|NCT02491684|20132105|P2|NOT COMPLETED|Treatment Phase||3
8166223|NCT02491684|20132106|P1|NOT COMPLETED|Treatment Phase||3
8166224|NCT02491684|20132105|P2|COMPLETED|Treatment Phase||57
8166225|NCT02491684|20132106|P1|COMPLETED|Treatment Phase||58
8166226|NCT02491684|20132105|P2|STARTED|Treatment Phase||60
8166227|NCT02491684|20132106|P1|STARTED|Treatment Phase||61
8166228|NCT02491684|20132105|P2|NOT COMPLETED|Pre-treatment Phase||0
8166229|NCT02491684|20132106|P1|NOT COMPLETED|Pre-treatment Phase||0
8166230|NCT02491684|20132105|P2|COMPLETED|Pre-treatment Phase||60
8166231|NCT02491684|20132106|P1|COMPLETED|Pre-treatment Phase||61
8166232|NCT02491684|20132105|P2|STARTED|Pre-treatment Phase||60
8166233|NCT02491684|20132106|P1|STARTED|Pre-treatment Phase||61
8166234|NCT02491463|20132144|P4|NOT COMPLETED|Overall Study||1
8166235|NCT02491463|20132145|P3|NOT COMPLETED|Overall Study||4
8166236|NCT02491463|20132146|P2|NOT COMPLETED|Overall Study||10
8166237|NCT02491463|20132147|P1|NOT COMPLETED|Overall Study||2
8166238|NCT02491463|20132144|P4|COMPLETED|Overall Study||14
8166239|NCT02491463|20132145|P3|COMPLETED|Overall Study||15
8166240|NCT02491463|20132146|P2|COMPLETED|Overall Study||21
8166241|NCT02491463|20132147|P1|COMPLETED|Overall Study||5
8166242|NCT02491463|20132144|P4|STARTED|Overall Study||15
8166243|NCT02491463|20132145|P3|STARTED|Overall Study||19
8166244|NCT02491463|20132146|P2|STARTED|Overall Study||31
8166245|NCT02491463|20132147|P1|STARTED|Overall Study||7
8166246|NCT02491437|20132235|P2|NOT COMPLETED|Overall Study||357
8166247|NCT02491437|20132236|P1|NOT COMPLETED|Overall Study||352
8166248|NCT02491437|20132235|P2|COMPLETED|Overall Study||157
8166249|NCT02491437|20132236|P1|COMPLETED|Overall Study||168
8166250|NCT02491437|20132235|P2|Full Analysis Sample|Overall Study||489
8166251|NCT02491437|20132236|P1|Full Analysis Sample|Overall Study||494
8166252|NCT02491437|20132235|P2|Safety Sample|Overall Study||512
8166253|NCT02491437|20132236|P1|Safety Sample|Overall Study||518
8166254|NCT02491437|20132235|P2|STARTED|Overall Study||514
8166255|NCT02491437|20132236|P1|STARTED|Overall Study||520
8166256|NCT02491411|20132250|P1|NOT COMPLETED|Overall Study||4
8166257|NCT02491411|20132250|P1|COMPLETED|Overall Study||0
8166258|NCT02491411|20132250|P1|STARTED|Overall Study||4
8166259|NCT02491359|20132260|P1|NOT COMPLETED|Overall Study||16
8166260|NCT02491359|20132260|P1|COMPLETED|Overall Study||4
8166261|NCT02491359|20132260|P1|STARTED|Overall Study||20
8166262|NCT02491073|20132281|P2|NOT COMPLETED|Overall Study||0
8166263|NCT02491073|20132282|P1|NOT COMPLETED|Overall Study||1
8166264|NCT02491073|20132281|P2|COMPLETED|Overall Study||34
8166265|NCT02491073|20132282|P1|COMPLETED|Overall Study||36
8166266|NCT02491073|20132281|P2|STARTED|Overall Study||34
8166267|NCT02491073|20132282|P1|STARTED|Overall Study||37
8166268|NCT02490670|20132310|P2|NOT COMPLETED|Period 2 (19 Days)||0
8166269|NCT02490670|20132311|P1|NOT COMPLETED|Period 2 (19 Days)||0
8166270|NCT02490670|20132310|P2|COMPLETED|Period 2 (19 Days)||14
8166271|NCT02490670|20132311|P1|COMPLETED|Period 2 (19 Days)||14
8166272|NCT02490670|20132310|P2|STARTED|Period 2 (19 Days)||14
8166273|NCT02490670|20132311|P1|STARTED|Period 2 (19 Days)||14
8166274|NCT02490670|20132310|P2|NOT COMPLETED|Washout Period (7 Days)||0
8166275|NCT02490670|20132311|P1|NOT COMPLETED|Washout Period (7 Days)||0
8166276|NCT02490670|20132310|P2|COMPLETED|Washout Period (7 Days)||14
8166277|NCT02490670|20132311|P1|COMPLETED|Washout Period (7 Days)||14
8166278|NCT02490670|20132310|P2|STARTED|Washout Period (7 Days)||14
8166279|NCT02490670|20132311|P1|STARTED|Washout Period (7 Days)||14
8166280|NCT02490670|20132310|P2|NOT COMPLETED|Period 1 (19 Days)||0
8166281|NCT02490670|20132311|P1|NOT COMPLETED|Period 1 (19 Days)||0
8166282|NCT02490670|20132310|P2|COMPLETED|Period 1 (19 Days)||14
8166283|NCT02490670|20132311|P1|COMPLETED|Period 1 (19 Days)||14
8166284|NCT02490670|20132310|P2|STARTED|Period 1 (19 Days)||14
8166285|NCT02490670|20132311|P1|STARTED|Period 1 (19 Days)||14
8166286|NCT02490631|20132321|P2|NOT COMPLETED|Overall Study||3
8166287|NCT02490631|20132322|P1|NOT COMPLETED|Overall Study||3
8166288|NCT02490631|20132321|P2|COMPLETED|Overall Study||75
8166289|NCT02490631|20132322|P1|COMPLETED|Overall Study||76
8166290|NCT02490631|20132321|P2|STARTED|Overall Study||78
8166291|NCT02490631|20132322|P1|STARTED|Overall Study||79
8166292|NCT02490475|20132334|P4|NOT COMPLETED|Period 2: Extension Phase||1
8166293|NCT02490475|20132335|P3|NOT COMPLETED|Period 2: Extension Phase||3
8166294|NCT02490475|20132336|P2|NOT COMPLETED|Period 2: Extension Phase||0
8166295|NCT02490475|20132337|P1|NOT COMPLETED|Period 2: Extension Phase||1
8166296|NCT02490475|20132334|P4|COMPLETED|Period 2: Extension Phase||0
8166297|NCT02490475|20132335|P3|COMPLETED|Period 2: Extension Phase||0
8166298|NCT02490475|20132336|P2|COMPLETED|Period 2: Extension Phase||0
8166299|NCT02490475|20132337|P1|COMPLETED|Period 2: Extension Phase||0
8166300|NCT02490475|20132334|P4|STARTED|Period 2: Extension Phase||1
8166301|NCT02490475|20132335|P3|STARTED|Period 2: Extension Phase||3
8166302|NCT02490475|20132336|P2|STARTED|Period 2: Extension Phase||0
8166303|NCT02490475|20132337|P1|STARTED|Period 2: Extension Phase||1
8166304|NCT02490475|20132334|P4|NOT COMPLETED|Period 1: First 6 Cycles||5
8166305|NCT02490475|20132335|P3|NOT COMPLETED|Period 1: First 6 Cycles||6
8166306|NCT02490475|20132336|P2|NOT COMPLETED|Period 1: First 6 Cycles||2
8166307|NCT02490475|20132337|P1|NOT COMPLETED|Period 1: First 6 Cycles||6
8166308|NCT02490475|20132334|P4|COMPLETED|Period 1: First 6 Cycles||0
8166309|NCT02490475|20132335|P3|COMPLETED|Period 1: First 6 Cycles||0
8166310|NCT02490475|20132336|P2|COMPLETED|Period 1: First 6 Cycles||0
8166311|NCT02490475|20132337|P1|COMPLETED|Period 1: First 6 Cycles||0
8166312|NCT02490475|20132334|P4|STARTED|Period 1: First 6 Cycles||5
8166313|NCT02490475|20132335|P3|STARTED|Period 1: First 6 Cycles||6
8166314|NCT02490475|20132336|P2|STARTED|Period 1: First 6 Cycles||2
8166315|NCT02490475|20132337|P1|STARTED|Period 1: First 6 Cycles||6
8166316|NCT02490371|20132415|P2|NOT COMPLETED|Overall Study||1
8166317|NCT02490371|20132416|P1|NOT COMPLETED|Overall Study||1
8166318|NCT02490371|20132415|P2|COMPLETED|Overall Study||11
8166319|NCT02490371|20132416|P1|COMPLETED|Overall Study||11
8166320|NCT02490371|20132415|P2|STARTED|Overall Study||12
8166321|NCT02490371|20132416|P1|STARTED|Overall Study||12
8166322|NCT02490293|20132434|P2|NOT COMPLETED|Overall Study||3
8166323|NCT02490293|20132435|P1|NOT COMPLETED|Overall Study||2
8166324|NCT02490293|20132434|P2|COMPLETED|Overall Study||99
8166325|NCT02490293|20132435|P1|COMPLETED|Overall Study||94
8166326|NCT02490293|20132434|P2|STARTED|Overall Study||102
8166327|NCT02490293|20132435|P1|STARTED|Overall Study||96
8166328|NCT02489981|20132443|P1|NOT COMPLETED|Overall Study||127
8166329|NCT02489981|20132443|P1|COMPLETED|Overall Study||213
8166330|NCT02489981|20132443|P1|STARTED|Overall Study||340
8166331|NCT02489968|20132450|P6|NOT COMPLETED|Double-blind Treatment Period||8
8166332|NCT02489968|20132451|P5|NOT COMPLETED|Double-blind Treatment Period||6
8166333|NCT02489968|20132452|P4|NOT COMPLETED|Double-blind Treatment Period||8
8166334|NCT02489968|20132453|P3|NOT COMPLETED|Double-blind Treatment Period||2
8166335|NCT02489968|20132454|P2|NOT COMPLETED|Double-blind Treatment Period||0
8166336|NCT02489968|20132455|P1|NOT COMPLETED|Double-blind Treatment Period||0
8166337|NCT02489968|20132450|P6|COMPLETED|Double-blind Treatment Period||108
8166338|NCT02489968|20132451|P5|COMPLETED|Double-blind Treatment Period||110
8166339|NCT02489968|20132452|P4|COMPLETED|Double-blind Treatment Period||100
8166340|NCT02489968|20132453|P3|COMPLETED|Double-blind Treatment Period||105
8166341|NCT02489968|20132454|P2|COMPLETED|Double-blind Treatment Period||0
8166342|NCT02489968|20132455|P1|COMPLETED|Double-blind Treatment Period||0
8166343|NCT02489968|20132450|P6|STARTED|Double-blind Treatment Period||116
8166344|NCT02489968|20132451|P5|STARTED|Double-blind Treatment Period||116
8166345|NCT02489968|20132452|P4|STARTED|Double-blind Treatment Period||108
8166346|NCT02489968|20132453|P3|STARTED|Double-blind Treatment Period||107
8166347|NCT02489968|20132454|P2|STARTED|Double-blind Treatment Period||0
8166348|NCT02489968|20132455|P1|STARTED|Double-blind Treatment Period||0
8166349|NCT02489968|20132450|P6|NOT COMPLETED|Open-label Treatment Period||0
8166350|NCT02489968|20132451|P5|NOT COMPLETED|Open-label Treatment Period||0
8166351|NCT02489968|20132452|P4|NOT COMPLETED|Open-label Treatment Period||0
8166352|NCT02489968|20132453|P3|NOT COMPLETED|Open-label Treatment Period||0
8166353|NCT02489968|20132454|P2|NOT COMPLETED|Open-label Treatment Period||208
8166354|NCT02489968|20132455|P1|NOT COMPLETED|Open-label Treatment Period||224
8166355|NCT02489968|20132450|P6|COMPLETED|Open-label Treatment Period||0
8166356|NCT02489968|20132451|P5|COMPLETED|Open-label Treatment Period||0
8166357|NCT02489968|20132452|P4|COMPLETED|Open-label Treatment Period||0
8166358|NCT02489968|20132453|P3|COMPLETED|Open-label Treatment Period||0
8166359|NCT02489968|20132454|P2|COMPLETED|Open-label Treatment Period||232
8166360|NCT02489968|20132455|P1|COMPLETED|Open-label Treatment Period||215
8166361|NCT02489968|20132450|P6|STARTED|Open-label Treatment Period||0
8166362|NCT02489968|20132451|P5|STARTED|Open-label Treatment Period||0
8166363|NCT02489968|20132452|P4|STARTED|Open-label Treatment Period||0
8166364|NCT02489968|20132453|P3|STARTED|Open-label Treatment Period||0
8166365|NCT02489968|20132454|P2|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
8166366|NCT02489968|20132455|P1|STARTED|Open-label Treatment Period||439
8166367|NCT02489799|20132469|P2|NOT COMPLETED|Overall Study||9
8166368|NCT02489799|20132470|P1|NOT COMPLETED|Overall Study||9
8166369|NCT02489799|20132469|P2|COMPLETED|Overall Study||38
8166370|NCT02489799|20132470|P1|COMPLETED|Overall Study||36
8166371|NCT02489799|20132469|P2|Postsurgical One Week Visit (V3)|Overall Study||39
8166372|NCT02489799|20132470|P1|Postsurgical One Week Visit (V3)|Overall Study||40
8166373|NCT02489799|20132469|P2|Presurgical Consent Visit (V2)|Overall Study||39
8166374|NCT02489799|20132470|P1|Presurgical Consent Visit (V2)|Overall Study||40
8166375|NCT02489799|20132469|P2|STARTED|Overall Study||47
8166376|NCT02489799|20132470|P1|STARTED|Overall Study||45
8166377|NCT02489773|20132496|P2|NOT COMPLETED|Overall Study||2
8166378|NCT02489773|20132497|P1|NOT COMPLETED|Overall Study||7
8166379|NCT02489773|20132496|P2|COMPLETED|Overall Study||50
8166380|NCT02489773|20132497|P1|COMPLETED|Overall Study||91
8166381|NCT02489773|20132496|P2|STARTED|Overall Study||52
8166382|NCT02489773|20132497|P1|STARTED|Overall Study||98
8166383|NCT02489500|20132507|P2|NOT COMPLETED|Overall Study||1
8166384|NCT02489500|20132508|P1|NOT COMPLETED|Overall Study||1
8166385|NCT02489500|20132507|P2|COMPLETED|Overall Study||0
8166386|NCT02489500|20132508|P1|COMPLETED|Overall Study||1
8166387|NCT02489500|20132507|P2|STARTED|Overall Study||1
8166388|NCT02489500|20132508|P1|STARTED|Overall Study||2
8166389|NCT02489357|20132520|P1|NOT COMPLETED|Overall Study||0
8166390|NCT02489357|20132520|P1|COMPLETED|Overall Study||12
8166391|NCT02489357|20132520|P1|STARTED|Overall Study||12
8166398|NCT02489279|20132568|P2|NOT COMPLETED|Overall Study||10
8166399|NCT02489279|20132569|P1|NOT COMPLETED|Overall Study||12
8166400|NCT02489279|20132568|P2|COMPLETED|Overall Study||31
8166401|NCT02489279|20132569|P1|COMPLETED|Overall Study||32
8166402|NCT02489279|20132568|P2|STARTED|Overall Study||41
8166403|NCT02489279|20132569|P1|STARTED|Overall Study||44
8166404|NCT02489227|20132584|P3|NOT COMPLETED|Overall Study||19
8166405|NCT02489227|20132585|P2|NOT COMPLETED|Overall Study||34
8166406|NCT02489227|20132586|P1|NOT COMPLETED|Overall Study||54
8166407|NCT02489227|20132584|P3|COMPLETED|Overall Study||117
8166408|NCT02489227|20132585|P2|COMPLETED|Overall Study||101
8166409|NCT02489227|20132586|P1|COMPLETED|Overall Study||220
8166410|NCT02489227|20132584|P3|STARTED|Overall Study||136
8166411|NCT02489227|20132585|P2|STARTED|Overall Study||135
8166412|NCT02489227|20132586|P1|STARTED|Overall Study||274
8166413|NCT02489110|20132598|P2|NOT COMPLETED|Overall Study||25
8166414|NCT02489110|20132599|P1|NOT COMPLETED|Overall Study||27
8166415|NCT02489110|20132598|P2|COMPLETED|Overall Study||50
8166416|NCT02489110|20132599|P1|COMPLETED|Overall Study||48
8166417|NCT02489110|20132598|P2|STARTED|Overall Study||75
8166418|NCT02489110|20132599|P1|STARTED|Overall Study||75
8166419|NCT02488980|20132610|P3|NOT COMPLETED|Overall Study||2
8166420|NCT02488980|20132611|P2|NOT COMPLETED|Overall Study||2
8166421|NCT02488980|20132612|P1|NOT COMPLETED|Overall Study||2
8166422|NCT02488980|20132610|P3|COMPLETED|Overall Study||99
8166423|NCT02488980|20132611|P2|COMPLETED|Overall Study||99
8166424|NCT02488980|20132612|P1|COMPLETED|Overall Study||102
8166425|NCT02488980|20132610|P3|STARTED|Overall Study||101
8166426|NCT02488980|20132611|P2|STARTED|Overall Study||101
8166427|NCT02488980|20132612|P1|STARTED|Overall Study||104
8166428|NCT02488915|20132629|P1|NOT COMPLETED|Overall Study||26
8166429|NCT02488915|20132629|P1|COMPLETED|Overall Study||202
8166430|NCT02488915|20132629|P1|STARTED|Overall Study||228
8166431|NCT02488824|20132647|P2|NOT COMPLETED|Overall Study||1
8166432|NCT02488824|20132648|P1|NOT COMPLETED|Overall Study||1
8166433|NCT02488824|20132647|P2|COMPLETED|Overall Study||19
8166434|NCT02488824|20132648|P1|COMPLETED|Overall Study||20
8166435|NCT02488824|20132647|P2|STARTED|Overall Study||20
8166436|NCT02488824|20132648|P1|STARTED|Overall Study||21
8166437|NCT02488681|20132662|P1|NOT COMPLETED|Overall Study||7
8166438|NCT02488681|20132662|P1|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
8166439|NCT02488681|20132662|P1|STARTED|Overall Study|Patients with Micra implant attempt|276
8166440|NCT02488330|20132666|P1|NOT COMPLETED|Overall Study||12
8166441|NCT02488330|20132666|P1|COMPLETED|Overall Study||0
8166442|NCT02488330|20132666|P1|STARTED|Overall Study||12
8166443|NCT02488317|20132672|P2|NOT COMPLETED|Overall Study||47
8166444|NCT02488317|20132673|P1|NOT COMPLETED|Overall Study||54
8166445|NCT02488317|20132672|P2|COMPLETED|Overall Study||70
8166446|NCT02488317|20132673|P1|COMPLETED|Overall Study||63
8166447|NCT02488317|20132672|P2|STARTED|Overall Study||117
8166448|NCT02488317|20132673|P1|STARTED|Overall Study||117
8166449|NCT02488239|20132687|P1|NOT COMPLETED|Overall Study||10
8166450|NCT02488239|20132687|P1|COMPLETED|Overall Study||54
8166451|NCT02488239|20132687|P1|STARTED|Overall Study||64
8166452|NCT02488070|20132692|P1|NOT COMPLETED|Overall Study||0
8166453|NCT02488070|20132692|P1|COMPLETED|Overall Study||10
8166454|NCT02488070|20132692|P1|STARTED|Overall Study||10
8166455|NCT02488018|20132700|P1|NOT COMPLETED|Overall Study||0
8166456|NCT02488018|20132700|P1|COMPLETED|Overall Study||10
8166457|NCT02488018|20132700|P1|STARTED|Overall Study||10
8166458|NCT02488005|20132704|P1|NOT COMPLETED|Overall Study||2
8166459|NCT02488005|20132704|P1|COMPLETED|Overall Study||13
8166460|NCT02488005|20132704|P1|STARTED|Overall Study||15
8166464|NCT02487810|20132726|P2|NOT COMPLETED|Overall Study||0
8166465|NCT02487810|20132727|P1|NOT COMPLETED|Overall Study||1
8166466|NCT02487810|20132726|P2|COMPLETED|Overall Study||102
8166467|NCT02487810|20132727|P1|COMPLETED|Overall Study||97
8166468|NCT02487810|20132726|P2|STARTED|Overall Study||102
8166469|NCT02487810|20132727|P1|STARTED|Overall Study||98
8166470|NCT02487771|20132759|P2|NOT COMPLETED|Overall Study||14
8166471|NCT02487771|20132760|P1|NOT COMPLETED|Overall Study||10
8166472|NCT02487771|20132759|P2|COMPLETED|Overall Study||85
8166473|NCT02487771|20132760|P1|COMPLETED|Overall Study||81
8166474|NCT02487771|20132759|P2|STARTED|Overall Study||99
8166475|NCT02487771|20132760|P1|STARTED|Overall Study||91
8166476|NCT02487563|20132913|P3|NOT COMPLETED|Overall Study||1
8166477|NCT02487563|20132914|P2|NOT COMPLETED|Overall Study||3
8166478|NCT02487563|20132915|P1|NOT COMPLETED|Overall Study||2
8166479|NCT02487563|20132913|P3|COMPLETED|Overall Study||31
8166480|NCT02487563|20132914|P2|COMPLETED|Overall Study||30
8166481|NCT02487563|20132915|P1|COMPLETED|Overall Study||30
8166482|NCT02487563|20132913|P3|STARTED|Overall Study||32
8166483|NCT02487563|20132914|P2|STARTED|Overall Study||33
8166484|NCT02487563|20132915|P1|STARTED|Overall Study||32
8166485|NCT02487498|20132926|P2|NOT COMPLETED|Period: Period 2||5
8166486|NCT02487498|20132927|P1|NOT COMPLETED|Period: Period 2||6
8166487|NCT02487498|20132926|P2|COMPLETED|Period: Period 2||154
8166488|NCT02487498|20132927|P1|COMPLETED|Period: Period 2||164
8166489|NCT02487498|20132926|P2|STARTED|Period: Period 2||159
8166490|NCT02487498|20132927|P1|STARTED|Period: Period 2||170
8166491|NCT02487498|20132926|P2|NOT COMPLETED|Period: Washout||7
8166492|NCT02487498|20132927|P1|NOT COMPLETED|Period: Washout||2
8166493|NCT02487498|20132926|P2|COMPLETED|Period: Washout||159
8166494|NCT02487498|20132927|P1|COMPLETED|Period: Washout||170
8166495|NCT02487498|20132926|P2|STARTED|Period: Washout||166
8166496|NCT02487498|20132927|P1|STARTED|Period: Washout||172
8166497|NCT02487498|20132926|P2|NOT COMPLETED|Period: Period 1||11
8166498|NCT02487498|20132927|P1|NOT COMPLETED|Period: Period 1||6
8166499|NCT02487498|20132926|P2|COMPLETED|Period: Period 1||166
8166500|NCT02487498|20132927|P1|COMPLETED|Period: Period 1||172
8166501|NCT02487498|20132926|P2|STARTED|Period: Period 1||177
8166502|NCT02487498|20132927|P1|STARTED|Period: Period 1||178
8166503|NCT02487485|20132952|P2|NOT COMPLETED|Overall Study||3
8166504|NCT02487485|20132953|P1|NOT COMPLETED|Overall Study||3
8166505|NCT02487485|20132952|P2|COMPLETED|Overall Study||8
8166506|NCT02487485|20132953|P1|COMPLETED|Overall Study||9
8166507|NCT02487485|20132952|P2|STARTED|Overall Study||11
8166508|NCT02487485|20132953|P1|STARTED|Overall Study||12
8166509|NCT02487472|20132971|P1|NOT COMPLETED|Overall Study||11
8166510|NCT02487472|20132971|P1|COMPLETED|Overall Study||90
8166511|NCT02487472|20132971|P1|STARTED|Overall Study||101
8166512|NCT02487446|20132987|P2|NOT COMPLETED|Period 2||5
8166513|NCT02487446|20132988|P1|NOT COMPLETED|Period 2||8
8166514|NCT02487446|20132987|P2|COMPLETED|Period 2||158
8166515|NCT02487446|20132988|P1|COMPLETED|Period 2||154
8166516|NCT02487446|20132987|P2|STARTED|Period 2||163
8166517|NCT02487446|20132988|P1|STARTED|Period 2||162
8166518|NCT02487446|20132987|P2|NOT COMPLETED|Washout||8
8166519|NCT02487446|20132988|P1|NOT COMPLETED|Washout||3
8166520|NCT02487446|20132987|P2|COMPLETED|Washout||163
8166521|NCT02487446|20132988|P1|COMPLETED|Washout||162
8166522|NCT02487446|20132987|P2|STARTED|Washout||171
8166523|NCT02487446|20132988|P1|STARTED|Washout||165
8166524|NCT02487446|20132987|P2|NOT COMPLETED|Period 1||8
8166525|NCT02487446|20132988|P1|NOT COMPLETED|Period 1||13
8166526|NCT02487446|20132987|P2|COMPLETED|Period 1||171
8166527|NCT02487446|20132988|P1|COMPLETED|Period 1||165
8166528|NCT02487446|20132987|P2|STARTED|Period 1||179
8166529|NCT02487446|20132988|P1|STARTED|Period 1||178
8166530|NCT02487303|20133014|P3|NOT COMPLETED|Overall Study||1
8166531|NCT02487303|20133015|P2|NOT COMPLETED|Overall Study||4
8166532|NCT02487303|20133016|P1|NOT COMPLETED|Overall Study||2
8166533|NCT02487303|20133014|P3|COMPLETED|Overall Study||47
8166534|NCT02487303|20133015|P2|COMPLETED|Overall Study||47
8166535|NCT02487303|20133016|P1|COMPLETED|Overall Study||47
8166536|NCT02487303|20133014|P3|STARTED|Overall Study||48
8166537|NCT02487303|20133015|P2|STARTED|Overall Study||51
8166538|NCT02487303|20133016|P1|STARTED|Overall Study||49
8166539|NCT02487277|20133035|P2|NOT COMPLETED|Overall Study||0
8166540|NCT02487277|20133036|P1|NOT COMPLETED|Overall Study||0
8166541|NCT02487277|20133035|P2|COMPLETED|Overall Study||0
8166542|NCT02487277|20133036|P1|COMPLETED|Overall Study||3
8166543|NCT02487277|20133035|P2|STARTED|Overall Study||0
8166544|NCT02487277|20133036|P1|STARTED|Overall Study||3
8166545|NCT02487225|20133053|P2|NOT COMPLETED|Overall Study||30
8166546|NCT02487225|20133054|P1|NOT COMPLETED|Overall Study||27
8166547|NCT02487225|20133053|P2|COMPLETED|Overall Study||8
8166548|NCT02487225|20133054|P1|COMPLETED|Overall Study||18
8166549|NCT02487225|20133053|P2|STARTED|Overall Study||38
8166550|NCT02487225|20133054|P1|STARTED|Overall Study||45
8166551|NCT02487199|20133068|P2|NOT COMPLETED|Overall Study||1
8166552|NCT02487199|20133069|P1|NOT COMPLETED|Overall Study||0
8166553|NCT02487199|20133068|P2|COMPLETED|Overall Study||4
8166554|NCT02487199|20133069|P1|COMPLETED|Overall Study||13
8166555|NCT02487199|20133068|P2|STARTED|Overall Study||5
8166556|NCT02487199|20133069|P1|STARTED|Overall Study||13
8166557|NCT02487056|20133081|P1|NOT COMPLETED|Overall Study||16
8166558|NCT02487056|20133081|P1|COMPLETED|Overall Study||1606
8166559|NCT02487056|20133081|P1|STARTED|Overall Study||1622
8166560|NCT02487030|20133094|P7|NOT COMPLETED|Overall Study||0
8166561|NCT02487030|20133095|P6|NOT COMPLETED|Overall Study||1
8166562|NCT02487030|20133096|P5|NOT COMPLETED|Overall Study||2
8166563|NCT02487030|20133097|P4|NOT COMPLETED|Overall Study||2
8166564|NCT02487030|20133098|P3|NOT COMPLETED|Overall Study||2
8166565|NCT02487030|20133099|P2|NOT COMPLETED|Overall Study||4
8166566|NCT02487030|20133100|P1|NOT COMPLETED|Overall Study||2
8166567|NCT02487030|20133094|P7|COMPLETED|Overall Study||11
8166568|NCT02487030|20133095|P6|COMPLETED|Overall Study||37
8166569|NCT02487030|20133096|P5|COMPLETED|Overall Study||34
8166570|NCT02487030|20133097|P4|COMPLETED|Overall Study||40
8166571|NCT02487030|20133098|P3|COMPLETED|Overall Study||41
8166572|NCT02487030|20133099|P2|COMPLETED|Overall Study||38
8166573|NCT02487030|20133100|P1|COMPLETED|Overall Study||41
8166574|NCT02487030|20133094|P7|STARTED|Overall Study||11
8166575|NCT02487030|20133095|P6|STARTED|Overall Study||38
8166576|NCT02487030|20133096|P5|STARTED|Overall Study||36
8166577|NCT02487030|20133097|P4|STARTED|Overall Study||42
8166578|NCT02487030|20133098|P3|STARTED|Overall Study||43
8166579|NCT02487030|20133099|P2|STARTED|Overall Study||42
8166580|NCT02487030|20133100|P1|STARTED|Overall Study||43
8166581|NCT02486952|20133131|P1|NOT COMPLETED|Overall Study||50
8166582|NCT02486952|20133131|P1|COMPLETED|Overall Study||104
8166583|NCT02486952|20133131|P1|Started Induction Therapy|Overall Study||151
8166584|NCT02486952|20133131|P1|STARTED|Overall Study||154
8166585|NCT02486939|20133138|P2|NOT COMPLETED|Overall Study||2
8166586|NCT02486939|20133139|P1|NOT COMPLETED|Overall Study||1
8166587|NCT02486939|20133138|P2|COMPLETED|Overall Study||132
8166588|NCT02486939|20133139|P1|COMPLETED|Overall Study||224
8166589|NCT02486939|20133138|P2|STARTED|Overall Study||134
8166590|NCT02486939|20133139|P1|STARTED|Overall Study||225
8166591|NCT02486796|20133149|P2|NOT COMPLETED|Overall Study||1
8166592|NCT02486796|20133150|P1|NOT COMPLETED|Overall Study||2
8166593|NCT02486796|20133149|P2|COMPLETED|Overall Study||1
8166594|NCT02486796|20133150|P1|COMPLETED|Overall Study||1
8166595|NCT02486796|20133149|P2|STARTED|Overall Study||2
8166596|NCT02486796|20133150|P1|STARTED|Overall Study||3
8166597|NCT02486757|20133162|P1|NOT COMPLETED|Overall Study||1
8166598|NCT02486757|20133162|P1|COMPLETED|Overall Study||5
8166599|NCT02486757|20133162|P1|STARTED|Overall Study||6
8166600|NCT02486692|20133168|P2|NOT COMPLETED|Overall Study||7
8166601|NCT02486692|20133169|P1|NOT COMPLETED|Overall Study||4
8166602|NCT02486692|20133168|P2|COMPLETED|Overall Study||23
8166603|NCT02486692|20133169|P1|COMPLETED|Overall Study||26
8166604|NCT02486692|20133168|P2|STARTED|Overall Study||30
8166605|NCT02486692|20133169|P1|STARTED|Overall Study||30
8166606|NCT02486653|20133181|P2|NOT COMPLETED|Overall Study||4
8166607|NCT02486653|20133182|P1|NOT COMPLETED|Overall Study||6
8166608|NCT02486653|20133181|P2|COMPLETED|Overall Study||71
8166609|NCT02486653|20133182|P1|COMPLETED|Overall Study||70
8166610|NCT02486653|20133181|P2|STARTED|Overall Study||75
8166611|NCT02486653|20133182|P1|STARTED|Overall Study||76
8166612|NCT02486627|20133206|P2|NOT COMPLETED|Overall Study||9
8166613|NCT02486627|20133207|P1|NOT COMPLETED|Overall Study||7
8166614|NCT02486627|20133206|P2|COMPLETED|Overall Study||294
8166615|NCT02486627|20133207|P1|COMPLETED|Overall Study||299
8166616|NCT02486627|20133206|P2|STARTED|Overall Study||303
8166617|NCT02486627|20133207|P1|STARTED|Overall Study||306
8166618|NCT02486588|20133230|P6|NOT COMPLETED|Overall Study||746
8166619|NCT02486588|20133231|P5|NOT COMPLETED|Overall Study||746
8166620|NCT02486588|20133232|P4|NOT COMPLETED|Overall Study||738
8166621|NCT02486588|20133233|P3|NOT COMPLETED|Overall Study||755
8166622|NCT02486588|20133234|P2|NOT COMPLETED|Overall Study||750
8166623|NCT02486588|20133235|P1|NOT COMPLETED|Overall Study||738
8166624|NCT02486588|20133230|P6|COMPLETED|Overall Study||459
8166625|NCT02486588|20133231|P5|COMPLETED|Overall Study||497
8166626|NCT02486588|20133232|P4|COMPLETED|Overall Study||468
8166627|NCT02486588|20133233|P3|COMPLETED|Overall Study||465
8166628|NCT02486588|20133234|P2|COMPLETED|Overall Study||502
8166629|NCT02486588|20133235|P1|COMPLETED|Overall Study||450
8166630|NCT02486588|20133230|P6|STARTED|Overall Study||1205
8166631|NCT02486588|20133231|P5|STARTED|Overall Study||1243
8166632|NCT02486588|20133232|P4|STARTED|Overall Study||1206
8166633|NCT02486588|20133233|P3|STARTED|Overall Study||1220
8166634|NCT02486588|20133234|P2|STARTED|Overall Study||1252
8166635|NCT02486588|20133235|P1|STARTED|Overall Study||1188
8166636|NCT02486328|20133293|P2|NOT COMPLETED|Overall Study||1
8166637|NCT02486328|20133294|P1|NOT COMPLETED|Overall Study||2
8166638|NCT02486328|20133293|P2|COMPLETED|Overall Study||50
8166639|NCT02486328|20133294|P1|COMPLETED|Overall Study||50
8166640|NCT02486328|20133293|P2|STARTED|Overall Study||51
8166641|NCT02486328|20133294|P1|STARTED|Overall Study||52
8166642|NCT02486302|20133310|P1|NOT COMPLETED|Overall Study||676
8166643|NCT02486302|20133310|P1|COMPLETED|Overall Study||858
8166644|NCT02486302|20133310|P1|Treated|Overall Study||1523
8166645|NCT02486302|20133310|P1|STARTED|Overall Study||1534
8166646|NCT02486263|20133367|P2|NOT COMPLETED|Overall Study||1
8166647|NCT02486263|20133368|P1|NOT COMPLETED|Overall Study||3
8166648|NCT02486263|20133367|P2|COMPLETED|Overall Study||35
8166649|NCT02486263|20133368|P1|COMPLETED|Overall Study||37
8166650|NCT02486263|20133367|P2|STARTED|Overall Study||36
8166651|NCT02486263|20133368|P1|STARTED|Overall Study||40
8166652|NCT02486211|20133384|P2|NOT COMPLETED|Overall Study||0
8166653|NCT02486211|20133385|P1|NOT COMPLETED|Overall Study||1
8166654|NCT02486211|20133384|P2|COMPLETED|Overall Study||7
8166655|NCT02486211|20133385|P1|COMPLETED|Overall Study||6
8166656|NCT02486211|20133384|P2|STARTED|Overall Study||7
8166657|NCT02486211|20133385|P1|STARTED|Overall Study||7
8166658|NCT02486016|20133399|P1|NOT COMPLETED|Overall Study||0
8166659|NCT02486016|20133399|P1|COMPLETED|Overall Study||10
8166660|NCT02486016|20133399|P1|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10
8166661|NCT02485925|20133407|P1|NOT COMPLETED|Overall Study||15
8166662|NCT02485925|20133407|P1|COMPLETED|Overall Study||185
8166663|NCT02485925|20133407|P1|Per-Protocol Population|Overall Study||166
8166664|NCT02485925|20133407|P1|Intent to Treat (ITT) Population|Overall Study||193
8166665|NCT02485925|20133407|P1|Safety Population|Overall Study||200
8166666|NCT02485925|20133407|P1|STARTED|Overall Study||200
8166667|NCT02485912|20133417|P2|NOT COMPLETED|Overall Study||0
8166668|NCT02485912|20133418|P1|NOT COMPLETED|Overall Study||0
8166669|NCT02485912|20133417|P2|COMPLETED|Overall Study||20
8166670|NCT02485912|20133418|P1|COMPLETED|Overall Study||20
8166671|NCT02485912|20133417|P2|STARTED|Overall Study||20
8166672|NCT02485912|20133418|P1|STARTED|Overall Study||20
8166673|NCT02485834|20133426|P2|NOT COMPLETED|Overall Study||0
8166674|NCT02485834|20133427|P1|NOT COMPLETED|Overall Study||0
8166675|NCT02485834|20133426|P2|COMPLETED|Overall Study||2
8166676|NCT02485834|20133427|P1|COMPLETED|Overall Study||3
8166677|NCT02485834|20133426|P2|STARTED|Overall Study||2
8166678|NCT02485834|20133427|P1|STARTED|Overall Study||3
8166694|NCT02485561|20133466|P3|NOT COMPLETED|Overall Study||23
8166695|NCT02485561|20133467|P2|NOT COMPLETED|Overall Study||39
8166696|NCT02485561|20133468|P1|NOT COMPLETED|Overall Study||28
8166697|NCT02485561|20133466|P3|COMPLETED|Overall Study||136
8166698|NCT02485561|20133467|P2|COMPLETED|Overall Study||118
8166699|NCT02485561|20133468|P1|COMPLETED|Overall Study||133
8166700|NCT02485561|20133466|P3|Completed 1 mo Survey|Overall Study||144
8166701|NCT02485561|20133467|P2|Completed 1 mo Survey|Overall Study||138
8166702|NCT02485561|20133468|P1|Completed 1 mo Survey|Overall Study||145
8166703|NCT02485561|20133466|P3|STARTED|Overall Study||159
8166704|NCT02485561|20133467|P2|STARTED|Overall Study||157
8166705|NCT02485561|20133468|P1|STARTED|Overall Study||161
8166706|NCT02485483|20133505|P2|NOT COMPLETED|Overall Study||0
8166707|NCT02485483|20133506|P1|NOT COMPLETED|Overall Study||54
8166708|NCT02485483|20133505|P2|COMPLETED|Overall Study||1015
8166709|NCT02485483|20133506|P1|COMPLETED|Overall Study||223
8166710|NCT02485483|20133505|P2|STARTED|Overall Study||1015
8166711|NCT02485483|20133506|P1|STARTED|Overall Study||277
8166712|NCT02485353|20133521|P1|NOT COMPLETED|Overall Study||2
8166713|NCT02485353|20133521|P1|COMPLETED|Overall Study||0
8166714|NCT02485353|20133521|P1|STARTED|Overall Study||2
8166715|NCT02485301|20133528|P2|NOT COMPLETED|Overall Study||49
8166716|NCT02485301|20133529|P1|NOT COMPLETED|Overall Study||38
8166717|NCT02485301|20133528|P2|COMPLETED|Overall Study||1455
8166718|NCT02485301|20133529|P1|COMPLETED|Overall Study||1471
8166719|NCT02485301|20133528|P2|STARTED|Overall Study||1504
8166720|NCT02485301|20133529|P1|STARTED|Overall Study||1509
8166721|NCT02485158|20133579|P1|NOT COMPLETED|Overall Study||4
8166722|NCT02485158|20133579|P1|COMPLETED|Overall Study||24
8166723|NCT02485158|20133579|P1|STARTED|Overall Study||28
8166724|NCT02484911|20133668|P2|NOT COMPLETED|Overall Study||2
8166725|NCT02484911|20133669|P1|NOT COMPLETED|Overall Study||4
8166726|NCT02484911|20133668|P2|COMPLETED|Overall Study||58
8166727|NCT02484911|20133669|P1|COMPLETED|Overall Study||56
8166728|NCT02484911|20133668|P2|STARTED|Overall Study||60
8166729|NCT02484911|20133669|P1|STARTED|Overall Study||60
8166730|NCT02484898|20133697|P1|NOT COMPLETED|Overall Study||18
8166731|NCT02484898|20133697|P1|COMPLETED|Overall Study||182
8166732|NCT02484898|20133697|P1|STARTED|Overall Study||200
8166733|NCT02484859|20133703|P2|NOT COMPLETED|Overall Study||0
8166734|NCT02484859|20133704|P1|NOT COMPLETED|Overall Study||0
8166735|NCT02484859|20133703|P2|COMPLETED|Overall Study||44
8166736|NCT02484859|20133704|P1|COMPLETED|Overall Study||44
8166737|NCT02484859|20133703|P2|STARTED|Overall Study||44
8166738|NCT02484859|20133704|P1|STARTED|Overall Study||44
8166739|NCT02484807|20133724|P6|NOT COMPLETED|Overall Study||0
8166740|NCT02484807|20133725|P5|NOT COMPLETED|Overall Study||0
8166741|NCT02484807|20133726|P4|NOT COMPLETED|Overall Study||0
8166742|NCT02484807|20133727|P3|NOT COMPLETED|Overall Study||0
8166743|NCT02484807|20133728|P2|NOT COMPLETED|Overall Study||0
8166744|NCT02484807|20133729|P1|NOT COMPLETED|Overall Study||0
8166745|NCT02484807|20133724|P6|COMPLETED|Overall Study||6
8166746|NCT02484807|20133725|P5|COMPLETED|Overall Study||33
8166747|NCT02484807|20133726|P4|COMPLETED|Overall Study||21
8166748|NCT02484807|20133727|P3|COMPLETED|Overall Study||19
8166749|NCT02484807|20133728|P2|COMPLETED|Overall Study||7
8166750|NCT02484807|20133729|P1|COMPLETED|Overall Study||39
8166751|NCT02484807|20133724|P6|STARTED|Overall Study||6
8166752|NCT02484807|20133725|P5|STARTED|Overall Study||33
8166753|NCT02484807|20133726|P4|STARTED|Overall Study||21
8166754|NCT02484807|20133727|P3|STARTED|Overall Study||19
8166755|NCT02484807|20133728|P2|STARTED|Overall Study||7
8166756|NCT02484807|20133729|P1|STARTED|Overall Study||39
8166757|NCT02484729|20133759|P10|NOT COMPLETED|Overall Study||1
8166758|NCT02484729|20133760|P9|NOT COMPLETED|Overall Study||0
8166759|NCT02484729|20133761|P8|NOT COMPLETED|Overall Study||0
8166760|NCT02484729|20133762|P7|NOT COMPLETED|Overall Study||0
8166761|NCT02484729|20133763|P6|NOT COMPLETED|Overall Study||0
8166762|NCT02484729|20133764|P5|NOT COMPLETED|Overall Study||0
8166763|NCT02484729|20133765|P4|NOT COMPLETED|Overall Study||0
8166764|NCT02484729|20133766|P3|NOT COMPLETED|Overall Study||0
8166765|NCT02484729|20133767|P2|NOT COMPLETED|Overall Study||0
8166766|NCT02484729|20133768|P1|NOT COMPLETED|Overall Study||0
8166767|NCT02484729|20133759|P10|COMPLETED|Overall Study||7
8166768|NCT02484729|20133760|P9|COMPLETED|Overall Study||6
8166769|NCT02484729|20133761|P8|COMPLETED|Overall Study||6
8166770|NCT02484729|20133762|P7|COMPLETED|Overall Study||5
8166771|NCT02484729|20133763|P6|COMPLETED|Overall Study||6
8166772|NCT02484729|20133764|P5|COMPLETED|Overall Study||5
8166773|NCT02484729|20133765|P4|COMPLETED|Overall Study||6
8166774|NCT02484729|20133766|P3|COMPLETED|Overall Study||6
8166775|NCT02484729|20133767|P2|COMPLETED|Overall Study||6
8166776|NCT02484729|20133768|P1|COMPLETED|Overall Study||16
8166777|NCT02484729|20133759|P10|STARTED|Overall Study||8
8166778|NCT02484729|20133760|P9|STARTED|Overall Study||6
8166779|NCT02484729|20133761|P8|STARTED|Overall Study||6
8166780|NCT02484729|20133762|P7|STARTED|Overall Study||5
8166781|NCT02484729|20133763|P6|STARTED|Overall Study||6
8166782|NCT02484729|20133764|P5|STARTED|Overall Study||5
8166783|NCT02484729|20133765|P4|STARTED|Overall Study||6
8166784|NCT02484729|20133766|P3|STARTED|Overall Study||6
8166785|NCT02484729|20133767|P2|STARTED|Overall Study||6
8166786|NCT02484729|20133768|P1|STARTED|Overall Study||16
8166787|NCT02484690|20133969|P5|NOT COMPLETED|Overall Study||6
8166788|NCT02484690|20133970|P4|NOT COMPLETED|Overall Study||2
8166789|NCT02484690|20133971|P3|NOT COMPLETED|Overall Study||3
8166790|NCT02484690|20133972|P2|NOT COMPLETED|Overall Study||6
8166791|NCT02484690|20133973|P1|NOT COMPLETED|Overall Study||4
8166792|NCT02484690|20133969|P5|COMPLETED|Overall Study||58
8166793|NCT02484690|20133970|P4|COMPLETED|Overall Study||44
8166794|NCT02484690|20133971|P3|COMPLETED|Overall Study||36
8166795|NCT02484690|20133972|P2|COMPLETED|Overall Study||40
8166796|NCT02484690|20133973|P1|COMPLETED|Overall Study||64
8166797|NCT02484690|20133969|P5|Received at Least One Dose of Study Drug|Overall Study||64
8166798|NCT02484690|20133970|P4|Received at Least One Dose of Study Drug|Overall Study||46
8166799|NCT02484690|20133971|P3|Received at Least One Dose of Study Drug|Overall Study||39
8166800|NCT02484690|20133972|P2|Received at Least One Dose of Study Drug|Overall Study||46
8166801|NCT02484690|20133973|P1|Received at Least One Dose of Study Drug|Overall Study||67
8166802|NCT02484690|20133969|P5|STARTED|Overall Study||64
8166803|NCT02484690|20133970|P4|STARTED|Overall Study||46
8166804|NCT02484690|20133971|P3|STARTED|Overall Study||39
8166805|NCT02484690|20133972|P2|STARTED|Overall Study||46
8166806|NCT02484690|20133973|P1|STARTED|Overall Study||68
8166807|NCT02484651|20134117|P2|NOT COMPLETED|Overall Study||4
8166808|NCT02484651|20134118|P1|NOT COMPLETED|Overall Study||3
8166809|NCT02484651|20134117|P2|COMPLETED|Overall Study||31
8166810|NCT02484651|20134118|P1|COMPLETED|Overall Study||32
8166811|NCT02484651|20134117|P2|Data Analysis|Overall Study||31
8166812|NCT02484651|20134118|P1|Data Analysis|Overall Study||32
8166813|NCT02484651|20134117|P2|End of Clinical Study|Overall Study||35
8166814|NCT02484651|20134118|P1|End of Clinical Study|Overall Study||35
8166815|NCT02484651|20134117|P2|STARTED|Overall Study|35 patients were randomized|35
8166816|NCT02484651|20134118|P1|STARTED|Overall Study|35 patients were randomized|35
8166817|NCT02484222|20134130|P1|NOT COMPLETED|Overall Study||3
8166818|NCT02484222|20134130|P1|COMPLETED|Overall Study||77
8166819|NCT02484222|20134130|P1|STARTED|Overall Study||80
8166820|NCT02484092|20134137|P1|NOT COMPLETED|Overall Study||0
8166821|NCT02484092|20134137|P1|COMPLETED|Overall Study||15
8166822|NCT02484092|20134137|P1|STARTED|Overall Study||15
8166823|NCT02483975|20134152|P2|NOT COMPLETED|Overall Study||2
8166824|NCT02483975|20134153|P1|NOT COMPLETED|Overall Study||2
8166825|NCT02483975|20134152|P2|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
8166826|NCT02483975|20134153|P1|COMPLETED|Overall Study||54
8166827|NCT02483975|20134152|P2|STARTED|Overall Study||55
8166828|NCT02483975|20134153|P1|STARTED|Overall Study||56
8166829|NCT02483676|20134169|P2|NOT COMPLETED|Overall Study||5
8166830|NCT02483676|20134170|P1|NOT COMPLETED|Overall Study||6
8166831|NCT02483676|20134169|P2|COMPLETED|Overall Study||17
8166832|NCT02483676|20134170|P1|COMPLETED|Overall Study||17
8166833|NCT02483676|20134169|P2|STARTED|Overall Study||22
8166834|NCT02483676|20134170|P1|STARTED|Overall Study||23
8166835|NCT02483611|20134191|P3|NOT COMPLETED|Overall Study||1
8166836|NCT02483611|20134192|P2|NOT COMPLETED|Overall Study||0
8166837|NCT02483611|20134193|P1|NOT COMPLETED|Overall Study||0
8166838|NCT02483611|20134191|P3|COMPLETED|Overall Study|One patient required decurarization|15
8166839|NCT02483611|20134192|P2|COMPLETED|Overall Study||16
8166840|NCT02483611|20134193|P1|COMPLETED|Overall Study||16
8166841|NCT02483611|20134191|P3|STARTED|Overall Study||16
8166842|NCT02483611|20134192|P2|STARTED|Overall Study||16
8166843|NCT02483611|20134193|P1|STARTED|Overall Study||16
8166844|NCT02483585|20134290|P2|NOT COMPLETED|Open-label Treatment Phase||25
8166845|NCT02483585|20134291|P1|NOT COMPLETED|Open-label Treatment Phase||27
8166846|NCT02483585|20134290|P2|COMPLETED|Open-label Treatment Phase||243
8166847|NCT02483585|20134291|P1|COMPLETED|Open-label Treatment Phase||243
8166848|NCT02483585|20134290|P2|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
8166849|NCT02483585|20134291|P1|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
8166850|NCT02483585|20134290|P2|NOT COMPLETED|Double-blind Treatment Phase||15
8166851|NCT02483585|20134291|P1|NOT COMPLETED|Double-blind Treatment Phase||16
8166852|NCT02483585|20134290|P2|COMPLETED|Double-blind Treatment Phase||271
8166853|NCT02483585|20134291|P1|COMPLETED|Double-blind Treatment Phase||275
8166854|NCT02483585|20134290|P2|Received Treatment|Double-blind Treatment Phase||283
8166855|NCT02483585|20134291|P1|Received Treatment|Double-blind Treatment Phase||289
8166856|NCT02483585|20134290|P2|STARTED|Double-blind Treatment Phase||286
8166857|NCT02483585|20134291|P1|STARTED|Double-blind Treatment Phase||291
8166858|NCT02483572|20134313|P2|NOT COMPLETED|Overall Study||1
8166859|NCT02483572|20134314|P1|NOT COMPLETED|Overall Study||2
8166860|NCT02483572|20134313|P2|COMPLETED|Overall Study||1
8166861|NCT02483572|20134314|P1|COMPLETED|Overall Study||0
8166862|NCT02483572|20134313|P2|STARTED|Overall Study||2
8166863|NCT02483572|20134314|P1|STARTED|Overall Study||2
8166864|NCT02483533|20134328|P2|NOT COMPLETED|Overall Study||50
8166865|NCT02483533|20134329|P1|NOT COMPLETED|Overall Study||50
8166866|NCT02483533|20134328|P2|COMPLETED|Overall Study||0
8166867|NCT02483533|20134329|P1|COMPLETED|Overall Study||0
8166868|NCT02483533|20134328|P2|STARTED|Overall Study||50
8166869|NCT02483533|20134329|P1|STARTED|Overall Study||50
8166870|NCT02483520|20134339|P2|NOT COMPLETED|Overall Study||24
8166871|NCT02483520|20134340|P1|NOT COMPLETED|Overall Study||11
8166872|NCT02483520|20134339|P2|COMPLETED|Overall Study||73
8166873|NCT02483520|20134340|P1|COMPLETED|Overall Study||81
8166874|NCT02483520|20134339|P2|Persons With Dementia|Overall Study||41
8166875|NCT02483520|20134340|P1|Persons With Dementia|Overall Study||42
8166876|NCT02483520|20134339|P2|Caregivers|Overall Study||56
8166877|NCT02483520|20134340|P1|Caregivers|Overall Study||50
8166878|NCT02483520|20134339|P2|STARTED|Overall Study||97
8166879|NCT02483520|20134340|P1|STARTED|Overall Study||92
8166880|NCT02483416|20134380|P2|NOT COMPLETED|Overall Study||1
8166881|NCT02483416|20134381|P1|NOT COMPLETED|Overall Study||3
8166882|NCT02483416|20134380|P2|COMPLETED|Overall Study||6
8166883|NCT02483416|20134381|P1|COMPLETED|Overall Study||18
8166884|NCT02483416|20134380|P2|STARTED|Overall Study||7
8166885|NCT02483416|20134381|P1|STARTED|Overall Study||21
8166886|NCT02483000|20134436|P1|NOT COMPLETED|Overall Study||0
8166887|NCT02483000|20134436|P1|COMPLETED|Overall Study||3
8166888|NCT02483000|20134436|P1|STARTED|Overall Study||3
8166889|NCT02482935|20134445|P2|NOT COMPLETED|Period 2||0
8166890|NCT02482935|20134446|P1|NOT COMPLETED|Period 2||0
8166891|NCT02482935|20134445|P2|COMPLETED|Period 2||15
8166892|NCT02482935|20134446|P1|COMPLETED|Period 2||14
8166893|NCT02482935|20134445|P2|Follow-up|Period 2||15
8166894|NCT02482935|20134446|P1|Follow-up|Period 2||14
8166895|NCT02482935|20134445|P2|Received Abemaciclib|Period 2||15
8166896|NCT02482935|20134446|P1|Received Abemaciclib|Period 2||14
8166897|NCT02482935|20134445|P2|STARTED|Period 2||15
8166898|NCT02482935|20134446|P1|STARTED|Period 2||14
8166899|NCT02482935|20134445|P2|NOT COMPLETED|Period 1||0
8166900|NCT02482935|20134446|P1|NOT COMPLETED|Period 1||1
8166901|NCT02482935|20134445|P2|COMPLETED|Period 1||15
8166902|NCT02482935|20134446|P1|COMPLETED|Period 1||14
8166903|NCT02482935|20134445|P2|Washout|Period 1||15
8166904|NCT02482935|20134446|P1|Washout|Period 1||15
8166905|NCT02482935|20134445|P2|Received Abemaciclib|Period 1||15
8166906|NCT02482935|20134446|P1|Received Abemaciclib|Period 1||15
8166907|NCT02482935|20134445|P2|STARTED|Period 1||15
8166908|NCT02482935|20134446|P1|STARTED|Period 1||15
8166909|NCT02482870|20134456|P2|NOT COMPLETED|Period 2 - Rest of the Study||0
8166910|NCT02482870|20134457|P1|NOT COMPLETED|Period 2 - Rest of the Study||0
8166911|NCT02482870|20134456|P2|COMPLETED|Period 2 - Rest of the Study||202
8166912|NCT02482870|20134457|P1|COMPLETED|Period 2 - Rest of the Study||186
8166913|NCT02482870|20134456|P2|STARTED|Period 2 - Rest of the Study||202
8166914|NCT02482870|20134457|P1|STARTED|Period 2 - Rest of the Study||186
8166915|NCT02482870|20134456|P2|NOT COMPLETED|Period 1 - First 60 Patients||0
8166916|NCT02482870|20134457|P1|NOT COMPLETED|Period 1 - First 60 Patients||0
8166917|NCT02482870|20134456|P2|COMPLETED|Period 1 - First 60 Patients||30
8166918|NCT02482870|20134457|P1|COMPLETED|Period 1 - First 60 Patients||30
8166919|NCT02482870|20134456|P2|STARTED|Period 1 - First 60 Patients||30
8166920|NCT02482870|20134457|P1|STARTED|Period 1 - First 60 Patients||30
8166921|NCT02482805|20134474|P3|NOT COMPLETED|Overall Study||0
8166922|NCT02482805|20134475|P2|NOT COMPLETED|Overall Study||4
8166923|NCT02482805|20134476|P1|NOT COMPLETED|Overall Study||4
8166924|NCT02482805|20134474|P3|COMPLETED|Overall Study||20
8166925|NCT02482805|20134475|P2|COMPLETED|Overall Study||23
8166926|NCT02482805|20134476|P1|COMPLETED|Overall Study||22
8166927|NCT02482805|20134474|P3|STARTED|Overall Study||20
8166928|NCT02482805|20134475|P2|STARTED|Overall Study||27
8166929|NCT02482805|20134476|P1|STARTED|Overall Study||26
8166930|NCT02482675|20134490|P23|NOT COMPLETED|Overall Study||0
8166931|NCT02482675|20134491|P22|NOT COMPLETED|Overall Study||0
8166932|NCT02482675|20134492|P21|NOT COMPLETED|Overall Study||0
8166933|NCT02482675|20134493|P20|NOT COMPLETED|Overall Study||0
8166934|NCT02482675|20134494|P19|NOT COMPLETED|Overall Study||0
8166935|NCT02482675|20134495|P18|NOT COMPLETED|Overall Study||0
8166936|NCT02482675|20134496|P17|NOT COMPLETED|Overall Study||0
8166937|NCT02482675|20134497|P16|NOT COMPLETED|Overall Study||0
8166938|NCT02482675|20134498|P15|NOT COMPLETED|Overall Study||0
8166939|NCT02482675|20134499|P14|NOT COMPLETED|Overall Study||0
8166940|NCT02482675|20134500|P13|NOT COMPLETED|Overall Study||0
8166941|NCT02482675|20134501|P12|NOT COMPLETED|Overall Study||0
8166942|NCT02482675|20134502|P11|NOT COMPLETED|Overall Study||0
8166943|NCT02482675|20134503|P10|NOT COMPLETED|Overall Study||0
8166944|NCT02482675|20134504|P9|NOT COMPLETED|Overall Study||0
8166945|NCT02482675|20134505|P8|NOT COMPLETED|Overall Study||0
8166946|NCT02482675|20134506|P7|NOT COMPLETED|Overall Study||0
8166947|NCT02482675|20134507|P6|NOT COMPLETED|Overall Study||0
8166948|NCT02482675|20134508|P5|NOT COMPLETED|Overall Study||0
8166949|NCT02482675|20134509|P4|NOT COMPLETED|Overall Study||0
8166950|NCT02482675|20134510|P3|NOT COMPLETED|Overall Study||0
8166951|NCT02482675|20134511|P2|NOT COMPLETED|Overall Study||0
8166952|NCT02482675|20134512|P1|NOT COMPLETED|Overall Study||0
8166953|NCT02482675|20134490|P23|COMPLETED|Overall Study||1
8166954|NCT02482675|20134491|P22|COMPLETED|Overall Study||1
8166955|NCT02482675|20134492|P21|COMPLETED|Overall Study||1
8166956|NCT02482675|20134493|P20|COMPLETED|Overall Study||1
8166957|NCT02482675|20134494|P19|COMPLETED|Overall Study||1
8166958|NCT02482675|20134495|P18|COMPLETED|Overall Study||1
8166959|NCT02482675|20134496|P17|COMPLETED|Overall Study||1
8166960|NCT02482675|20134497|P16|COMPLETED|Overall Study||1
8166961|NCT02482675|20134498|P15|COMPLETED|Overall Study||1
8166962|NCT02482675|20134499|P14|COMPLETED|Overall Study||1
8166963|NCT02482675|20134500|P13|COMPLETED|Overall Study||1
8166964|NCT02482675|20134501|P12|COMPLETED|Overall Study||1
8166965|NCT02482675|20134502|P11|COMPLETED|Overall Study||1
8166966|NCT02482675|20134503|P10|COMPLETED|Overall Study||1
8166967|NCT02482675|20134504|P9|COMPLETED|Overall Study||1
8166968|NCT02482675|20134505|P8|COMPLETED|Overall Study||1
8166969|NCT02482675|20134506|P7|COMPLETED|Overall Study||1
8166970|NCT02482675|20134507|P6|COMPLETED|Overall Study||1
8166971|NCT02482675|20134508|P5|COMPLETED|Overall Study||1
8166972|NCT02482675|20134509|P4|COMPLETED|Overall Study||1
8166973|NCT02482675|20134510|P3|COMPLETED|Overall Study||1
8166974|NCT02482675|20134511|P2|COMPLETED|Overall Study||1
8166975|NCT02482675|20134512|P1|COMPLETED|Overall Study||1
8166976|NCT02482675|20134490|P23|STARTED|Overall Study||1
8166977|NCT02482675|20134491|P22|STARTED|Overall Study||1
8166978|NCT02482675|20134492|P21|STARTED|Overall Study||1
8166979|NCT02482675|20134493|P20|STARTED|Overall Study||1
8166980|NCT02482675|20134494|P19|STARTED|Overall Study||1
8166981|NCT02482675|20134495|P18|STARTED|Overall Study||1
8166982|NCT02482675|20134496|P17|STARTED|Overall Study||1
8166983|NCT02482675|20134497|P16|STARTED|Overall Study||1
8166984|NCT02482675|20134498|P15|STARTED|Overall Study||1
8166985|NCT02482675|20134499|P14|STARTED|Overall Study||1
8166986|NCT02482675|20134500|P13|STARTED|Overall Study||1
8166987|NCT02482675|20134501|P12|STARTED|Overall Study||1
8166988|NCT02482675|20134502|P11|STARTED|Overall Study||1
8166989|NCT02482675|20134503|P10|STARTED|Overall Study||1
8166990|NCT02482675|20134504|P9|STARTED|Overall Study||1
8166991|NCT02482675|20134505|P8|STARTED|Overall Study||1
8166992|NCT02482675|20134506|P7|STARTED|Overall Study||1
8166993|NCT02482675|20134507|P6|STARTED|Overall Study||1
8166994|NCT02482675|20134508|P5|STARTED|Overall Study||1
8166995|NCT02482675|20134509|P4|STARTED|Overall Study||1
8166996|NCT02482675|20134510|P3|STARTED|Overall Study||1
8166997|NCT02482675|20134511|P2|STARTED|Overall Study||1
8166998|NCT02482675|20134512|P1|STARTED|Overall Study||1
8166999|NCT02482610|20134570|P6|NOT COMPLETED|Overall Study||0
8167000|NCT02482610|20134571|P5|NOT COMPLETED|Overall Study||0
8167001|NCT02482610|20134572|P4|NOT COMPLETED|Overall Study||0
8167002|NCT02482610|20134573|P3|NOT COMPLETED|Overall Study||0
8167003|NCT02482610|20134574|P2|NOT COMPLETED|Overall Study||0
8167004|NCT02482610|20134575|P1|NOT COMPLETED|Overall Study||0
8167005|NCT02482610|20134570|P6|COMPLETED|Overall Study||5
8167006|NCT02482610|20134571|P5|COMPLETED|Overall Study||3
8167007|NCT02482610|20134572|P4|COMPLETED|Overall Study||3
8167008|NCT02482610|20134573|P3|COMPLETED|Overall Study||2
8167009|NCT02482610|20134574|P2|COMPLETED|Overall Study||5
8167010|NCT02482610|20134575|P1|COMPLETED|Overall Study||4
8167011|NCT02482610|20134570|P6|STARTED|Overall Study||5
8167012|NCT02482610|20134571|P5|STARTED|Overall Study||3
8167013|NCT02482610|20134572|P4|STARTED|Overall Study||3
8167014|NCT02482610|20134573|P3|STARTED|Overall Study||2
8167015|NCT02482610|20134574|P2|STARTED|Overall Study||5
8167016|NCT02482610|20134575|P1|STARTED|Overall Study||4
8167017|NCT02482571|20134595|P1|NOT COMPLETED|Overall Study||8
8167018|NCT02482571|20134595|P1|COMPLETED|Overall Study||17
8167019|NCT02482571|20134595|P1|STARTED|Overall Study||25
8167020|NCT02482428|20134607|P5|NOT COMPLETED|Overall Study||7
8167021|NCT02482428|20134608|P4|NOT COMPLETED|Overall Study||2
8167022|NCT02482428|20134609|P3|NOT COMPLETED|Overall Study||1
8167023|NCT02482428|20134610|P2|NOT COMPLETED|Overall Study||12
8167024|NCT02482428|20134611|P1|NOT COMPLETED|Overall Study||9
8167025|NCT02482428|20134607|P5|COMPLETED|Overall Study||15
8167026|NCT02482428|20134608|P4|COMPLETED|Overall Study||8
8167027|NCT02482428|20134609|P3|COMPLETED|Overall Study||9
8167028|NCT02482428|20134610|P2|COMPLETED|Overall Study||10
8167029|NCT02482428|20134611|P1|COMPLETED|Overall Study||15
8167030|NCT02482428|20134607|P5|STARTED|Overall Study||22
8167031|NCT02482428|20134608|P4|STARTED|Overall Study||10
8167032|NCT02482428|20134609|P3|STARTED|Overall Study||10
8167033|NCT02482428|20134610|P2|STARTED|Overall Study||22
8167034|NCT02482428|20134611|P1|STARTED|Overall Study||24
8167035|NCT02482298|20134634|P3|NOT COMPLETED|Overall Study||3
8167036|NCT02482298|20134635|P2|NOT COMPLETED|Overall Study||3
8167037|NCT02482298|20134636|P1|NOT COMPLETED|Overall Study||2
8167038|NCT02482298|20134634|P3|COMPLETED|Overall Study||27
8167039|NCT02482298|20134635|P2|COMPLETED|Overall Study||24
8167040|NCT02482298|20134636|P1|COMPLETED|Overall Study||28
8167041|NCT02482298|20134634|P3|STARTED|Overall Study||30
8167042|NCT02482298|20134635|P2|STARTED|Overall Study||27
8167043|NCT02482298|20134636|P1|STARTED|Overall Study||30
8167044|NCT02482233|20134658|P2|NOT COMPLETED|Overall Study||1
8167045|NCT02482233|20134659|P1|NOT COMPLETED|Overall Study||1
8167046|NCT02482233|20134658|P2|COMPLETED|Overall Study||19
8167047|NCT02482233|20134659|P1|COMPLETED|Overall Study||9
8167048|NCT02482233|20134658|P2|STARTED|Overall Study||20
8167049|NCT02482233|20134659|P1|STARTED|Overall Study||10
8167050|NCT02482129|20134695|P2|NOT COMPLETED|Overall Study||2
8167051|NCT02482129|20134696|P1|NOT COMPLETED|Overall Study||6
8167052|NCT02482129|20134695|P2|COMPLETED|Overall Study||9
8167053|NCT02482129|20134696|P1|COMPLETED|Overall Study||26
8167054|NCT02482129|20134695|P2|Treated, as Randomized|Overall Study||9
8167055|NCT02482129|20134696|P1|Treated, as Randomized|Overall Study||30
8167056|NCT02482129|20134695|P2|STARTED|Overall Study||11
8167057|NCT02482129|20134696|P1|STARTED|Overall Study||32
8167058|NCT02482025|20134725|P2|NOT COMPLETED|Overall Study||0
8167059|NCT02482025|20134726|P1|NOT COMPLETED|Overall Study||0
8167060|NCT02482025|20134725|P2|COMPLETED|Overall Study||118
8167061|NCT02482025|20134726|P1|COMPLETED|Overall Study||122
8167062|NCT02482025|20134725|P2|STARTED|Overall Study||118
8167063|NCT02482025|20134726|P1|STARTED|Overall Study||122
8167064|NCT02481947|20134736|P2|NOT COMPLETED|Overall Study||36
8167065|NCT02481947|20134737|P1|NOT COMPLETED|Overall Study||46
8167066|NCT02481947|20134736|P2|COMPLETED|Overall Study||193
8167067|NCT02481947|20134737|P1|COMPLETED|Overall Study||184
8167068|NCT02481947|20134736|P2|STARTED|Overall Study||229
8167069|NCT02481947|20134737|P1|STARTED|Overall Study||230
8167073|NCT02481830|20134750|P2|NOT COMPLETED|Overall Study||20
8167074|NCT02481830|20134751|P1|NOT COMPLETED|Overall Study||2
8167075|NCT02481830|20134750|P2|COMPLETED|Overall Study||265
8167076|NCT02481830|20134751|P1|COMPLETED|Overall Study||282
8167077|NCT02481830|20134750|P2|STARTED|Overall Study||285
8167078|NCT02481830|20134751|P1|STARTED|Overall Study||284
8167079|NCT02481596|20134764|P3|NOT COMPLETED|Overall Study||8
8167080|NCT02481596|20134765|P2|NOT COMPLETED|Overall Study||1
8167081|NCT02481596|20134766|P1|NOT COMPLETED|Overall Study||3
8167082|NCT02481596|20134764|P3|COMPLETED|Overall Study||245
8167083|NCT02481596|20134765|P2|COMPLETED|Overall Study||126
8167084|NCT02481596|20134766|P1|COMPLETED|Overall Study||123
8167085|NCT02481596|20134764|P3|STARTED|Overall Study||253
8167086|NCT02481596|20134765|P2|STARTED|Overall Study||127
8167087|NCT02481596|20134766|P1|STARTED|Overall Study||126
8167088|NCT02481557|20134791|P2|NOT COMPLETED|Overall Study||0
8167089|NCT02481557|20134792|P1|NOT COMPLETED|Overall Study||0
8167090|NCT02481557|20134791|P2|COMPLETED|Overall Study||19
8167091|NCT02481557|20134792|P1|COMPLETED|Overall Study||17
8167092|NCT02481557|20134791|P2|STARTED|Overall Study||19
8167093|NCT02481557|20134792|P1|STARTED|Overall Study||17
8167094|NCT02481440|20134800|P1|NOT COMPLETED|Overall Study||61
8167095|NCT02481440|20134800|P1|COMPLETED|Overall Study||41
8167096|NCT02481440|20134800|P1|STARTED|Overall Study||102
8167097|NCT02481375|20134817|P4|NOT COMPLETED|Overall Study||14
8167098|NCT02481375|20134818|P3|NOT COMPLETED|Overall Study||10
8167099|NCT02481375|20134819|P2|NOT COMPLETED|Overall Study||11
8167100|NCT02481375|20134820|P1|NOT COMPLETED|Overall Study||14
8167101|NCT02481375|20134817|P4|COMPLETED|Overall Study||186
8167102|NCT02481375|20134818|P3|COMPLETED|Overall Study||191
8167103|NCT02481375|20134819|P2|COMPLETED|Overall Study||191
8167104|NCT02481375|20134820|P1|COMPLETED|Overall Study||192
8167105|NCT02481375|20134817|P4|STARTED|Overall Study||200
8167106|NCT02481375|20134818|P3|STARTED|Overall Study||201
8167107|NCT02481375|20134819|P2|STARTED|Overall Study||202
8167108|NCT02481375|20134820|P1|STARTED|Overall Study||206
8167109|NCT02481297|20134832|P2|NOT COMPLETED|Overall Study||0
8167110|NCT02481297|20134833|P1|NOT COMPLETED|Overall Study||0
8167111|NCT02481297|20134832|P2|COMPLETED|Overall Study||6
8167112|NCT02481297|20134833|P1|COMPLETED|Overall Study||1
8167113|NCT02481297|20134832|P2|STARTED|Overall Study||6
8167114|NCT02481297|20134833|P1|STARTED|Overall Study||1
8167115|NCT02481258|20134845|P2|NOT COMPLETED|Overall Study||0
8167116|NCT02481258|20134846|P1|NOT COMPLETED|Overall Study||0
8167117|NCT02481258|20134845|P2|COMPLETED|Overall Study||11
8167118|NCT02481258|20134846|P1|COMPLETED|Overall Study||12
8167119|NCT02481258|20134845|P2|STARTED|Overall Study||11
8167120|NCT02481258|20134846|P1|STARTED|Overall Study||12
8167121|NCT02481219|20134864|P2|NOT COMPLETED|Overall Study||1
8167122|NCT02481219|20134865|P1|NOT COMPLETED|Overall Study||2
8167123|NCT02481219|20134864|P2|COMPLETED|Overall Study||61
8167124|NCT02481219|20134865|P1|COMPLETED|Overall Study||58
8167125|NCT02481219|20134864|P2|STARTED|Overall Study||62
8167126|NCT02481219|20134865|P1|STARTED|Overall Study||60
8167127|NCT02481206|20134883|P2|NOT COMPLETED|Overall Study||1
8167128|NCT02481206|20134884|P1|NOT COMPLETED|Overall Study||5
8167129|NCT02481206|20134883|P2|COMPLETED|Overall Study||31
8167130|NCT02481206|20134884|P1|COMPLETED|Overall Study||29
8167131|NCT02481206|20134883|P2|STARTED|Overall Study||32
8167132|NCT02481206|20134884|P1|STARTED|Overall Study||34
8167133|NCT02481141|20134905|P2|NOT COMPLETED|Overall Study||5
8167134|NCT02481141|20134906|P1|NOT COMPLETED|Overall Study||9
8167135|NCT02481141|20134905|P2|COMPLETED|Overall Study||13
8167136|NCT02481141|20134906|P1|COMPLETED|Overall Study||26
8167137|NCT02481141|20134905|P2|STARTED|Overall Study||18
8167138|NCT02481141|20134906|P1|STARTED|Overall Study||35
8167139|NCT02481050|20134958|P1|NOT COMPLETED|Overall Study||58
8167140|NCT02481050|20134958|P1|COMPLETED|Overall Study||0
8167141|NCT02481050|20134958|P1|STARTED|Overall Study||58
8167142|NCT02480998|20134969|P2|NOT COMPLETED|Overall Study||0
8167143|NCT02480998|20134970|P1|NOT COMPLETED|Overall Study||0
8167144|NCT02480998|20134969|P2|COMPLETED|Overall Study||28
8167145|NCT02480998|20134970|P1|COMPLETED|Overall Study||56
8167146|NCT02480998|20134969|P2|STARTED|Overall Study||28
8167147|NCT02480998|20134970|P1|STARTED|Overall Study||56
8167148|NCT02480920|20134982|P1|NOT COMPLETED|Overall Study||0
8167149|NCT02480920|20134982|P1|COMPLETED|Overall Study||2738
8167150|NCT02480920|20134982|P1|STARTED|Overall Study||2738
8167151|NCT02480764|20134989|P3|NOT COMPLETED|Overall Study||21
8167152|NCT02480764|20134990|P2|NOT COMPLETED|Overall Study||20
8167153|NCT02480764|20134991|P1|NOT COMPLETED|Overall Study||10
8167154|NCT02480764|20134989|P3|COMPLETED|Overall Study||183
8167155|NCT02480764|20134990|P2|COMPLETED|Overall Study||189
8167156|NCT02480764|20134991|P1|COMPLETED|Overall Study||189
8167157|NCT02480764|20134989|P3|STARTED|Overall Study||204
8167158|NCT02480764|20134990|P2|STARTED|Overall Study||209
8167159|NCT02480764|20134991|P1|STARTED|Overall Study||199
8167160|NCT02480712|20135017|P1|NOT COMPLETED|Overall Study||11
8167161|NCT02480712|20135017|P1|COMPLETED|Overall Study||96
8167162|NCT02480712|20135017|P1|STARTED|Overall Study||107
8167163|NCT02480621|20135036|P2|NOT COMPLETED|Follow Up||2
8167164|NCT02480621|20135037|P1|NOT COMPLETED|Follow Up||4
8167165|NCT02480621|20135036|P2|COMPLETED|Follow Up||37
8167166|NCT02480621|20135037|P1|COMPLETED|Follow Up||39
8167167|NCT02480621|20135036|P2|STARTED|Follow Up||39
8167168|NCT02480621|20135037|P1|STARTED|Follow Up||43
8167169|NCT02480621|20135036|P2|NOT COMPLETED|Randomization||1
8167170|NCT02480621|20135037|P1|NOT COMPLETED|Randomization||1
8167171|NCT02480621|20135036|P2|COMPLETED|Randomization||39
8167172|NCT02480621|20135037|P1|COMPLETED|Randomization||43
8167173|NCT02480621|20135036|P2|STARTED|Randomization||40
8167174|NCT02480621|20135037|P1|STARTED|Randomization||44
8167175|NCT02480582|20135043|P6|NOT COMPLETED|Overall Study||0
8167176|NCT02480582|20135044|P5|NOT COMPLETED|Overall Study||0
8167177|NCT02480582|20135045|P4|NOT COMPLETED|Overall Study||0
8167178|NCT02480582|20135046|P3|NOT COMPLETED|Overall Study||0
8167179|NCT02480582|20135047|P2|NOT COMPLETED|Overall Study||0
8167180|NCT02480582|20135048|P1|NOT COMPLETED|Overall Study||0
8167181|NCT02480582|20135043|P6|COMPLETED|Overall Study||7
8167182|NCT02480582|20135044|P5|COMPLETED|Overall Study||7
8167183|NCT02480582|20135045|P4|COMPLETED|Overall Study||7
8167184|NCT02480582|20135046|P3|COMPLETED|Overall Study||7
8167185|NCT02480582|20135047|P2|COMPLETED|Overall Study||7
8167186|NCT02480582|20135048|P1|COMPLETED|Overall Study||7
8167187|NCT02480582|20135043|P6|STARTED|Overall Study||7
8167188|NCT02480582|20135044|P5|STARTED|Overall Study||7
8167189|NCT02480582|20135045|P4|STARTED|Overall Study||7
8167190|NCT02480582|20135046|P3|STARTED|Overall Study||7
8167191|NCT02480582|20135047|P2|STARTED|Overall Study||7
8167192|NCT02480582|20135048|P1|STARTED|Overall Study||7
8167193|NCT02480439|20135071|P3|NOT COMPLETED|Treatment Period 3||0
8167194|NCT02480439|20135072|P2|NOT COMPLETED|Treatment Period 3||0
8167195|NCT02480439|20135073|P1|NOT COMPLETED|Treatment Period 3||0
8167196|NCT02480439|20135071|P3|COMPLETED|Treatment Period 3||7
8167197|NCT02480439|20135072|P2|COMPLETED|Treatment Period 3||7
8167198|NCT02480439|20135073|P1|COMPLETED|Treatment Period 3||8
8167199|NCT02480439|20135071|P3|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
8167200|NCT02480439|20135072|P2|STARTED|Treatment Period 3||7
8167201|NCT02480439|20135073|P1|STARTED|Treatment Period 3||8
8167202|NCT02480439|20135071|P3|NOT COMPLETED|Treatment Period 2||0
8167203|NCT02480439|20135072|P2|NOT COMPLETED|Treatment Period 2||0
8167204|NCT02480439|20135073|P1|NOT COMPLETED|Treatment Period 2||0
8167205|NCT02480439|20135071|P3|COMPLETED|Treatment Period 2||8
8167206|NCT02480439|20135072|P2|COMPLETED|Treatment Period 2||7
8167207|NCT02480439|20135073|P1|COMPLETED|Treatment Period 2||8
8167208|NCT02480439|20135071|P3|STARTED|Treatment Period 2||8
8167209|NCT02480439|20135072|P2|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
8167210|NCT02480439|20135073|P1|STARTED|Treatment Period 2||8
8167211|NCT02480439|20135071|P3|NOT COMPLETED|Treatment Period 1||0
8167212|NCT02480439|20135072|P2|NOT COMPLETED|Treatment Period 1||0
8167213|NCT02480439|20135073|P1|NOT COMPLETED|Treatment Period 1||0
8167214|NCT02480439|20135071|P3|COMPLETED|Treatment Period 1||8
8167215|NCT02480439|20135072|P2|COMPLETED|Treatment Period 1||8
8167216|NCT02480439|20135073|P1|COMPLETED|Treatment Period 1||8
8167217|NCT02480439|20135071|P3|STARTED|Treatment Period 1||8
8167218|NCT02480439|20135072|P2|STARTED|Treatment Period 1||8
8167219|NCT02480439|20135073|P1|STARTED|Treatment Period 1||8
8167220|NCT02480166|20135099|P3|NOT COMPLETED|Overall Study||0
8167221|NCT02480166|20135100|P2|NOT COMPLETED|Overall Study||0
8167222|NCT02480166|20135101|P1|NOT COMPLETED|Overall Study||0
8167223|NCT02480166|20135099|P3|COMPLETED|Overall Study||4
8167224|NCT02480166|20135100|P2|COMPLETED|Overall Study||36
8167225|NCT02480166|20135101|P1|COMPLETED|Overall Study||20
8167226|NCT02480166|20135099|P3|STARTED|Overall Study||4
8167227|NCT02480166|20135100|P2|STARTED|Overall Study||36
8167228|NCT02480166|20135101|P1|STARTED|Overall Study||20
8167229|NCT02480153|20135114|P3|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4
8167230|NCT02480153|20135115|P2|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3
8167231|NCT02480153|20135116|P1|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7
8167232|NCT02480153|20135114|P3|COMPLETED|Period 3: Week 52 Dosing to Week 78||123
8167233|NCT02480153|20135115|P2|COMPLETED|Period 3: Week 52 Dosing to Week 78||118
8167234|NCT02480153|20135116|P1|COMPLETED|Period 3: Week 52 Dosing to Week 78||252
8167235|NCT02480153|20135114|P3|Received Treatment|Period 3: Week 52 Dosing to Week 78||127
8167236|NCT02480153|20135115|P2|Received Treatment|Period 3: Week 52 Dosing to Week 78||120
8167237|NCT02480153|20135116|P1|Received Treatment|Period 3: Week 52 Dosing to Week 78||258
8167238|NCT02480153|20135114|P3|STARTED|Period 3: Week 52 Dosing to Week 78||127
8167239|NCT02480153|20135115|P2|STARTED|Period 3: Week 52 Dosing to Week 78||121
8167240|NCT02480153|20135116|P1|STARTED|Period 3: Week 52 Dosing to Week 78||259
8167241|NCT02480153|20135114|P3|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7
8167242|NCT02480153|20135115|P2|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13
8167243|NCT02480153|20135116|P1|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20
8167244|NCT02480153|20135114|P3|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127
8167245|NCT02480153|20135115|P2|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122
8167246|NCT02480153|20135116|P1|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263
8167247|NCT02480153|20135114|P3|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133
8167248|NCT02480153|20135115|P2|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135
8167249|NCT02480153|20135116|P1|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283
8167250|NCT02480153|20135114|P3|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134
8167251|NCT02480153|20135115|P2|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135
8167252|NCT02480153|20135116|P1|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283
8167253|NCT02480153|20135114|P3|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
8167254|NCT02480153|20135115|P2|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16
8167255|NCT02480153|20135116|P1|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4
8167256|NCT02480153|20135114|P3|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
8167257|NCT02480153|20135115|P2|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284
8167258|NCT02480153|20135116|P1|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293
8167259|NCT02480153|20135114|P3|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0
8167260|NCT02480153|20135115|P2|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299
8167261|NCT02480153|20135116|P1|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297
8167262|NCT02480153|20135114|P3|STARTED|Period 1: First Dose to Week 26 Pre-dose||0
8167263|NCT02480153|20135115|P2|STARTED|Period 1: First Dose to Week 26 Pre-dose||300
8167264|NCT02480153|20135116|P1|STARTED|Period 1: First Dose to Week 26 Pre-dose||297
8167271|NCT02480010|20135306|P2|NOT COMPLETED|Overall Study||33
8167272|NCT02480010|20135307|P1|NOT COMPLETED|Overall Study||35
8167273|NCT02480010|20135306|P2|COMPLETED|Overall Study||0
8167274|NCT02480010|20135307|P1|COMPLETED|Overall Study||0
8167275|NCT02480010|20135306|P2|STARTED|Overall Study||33
8167276|NCT02480010|20135307|P1|STARTED|Overall Study||35
8167277|NCT02479880|20135353|P2|NOT COMPLETED|Overall Study||13
8167278|NCT02479880|20135354|P1|NOT COMPLETED|Overall Study||13
8167279|NCT02479880|20135353|P2|COMPLETED|Overall Study||2
8167280|NCT02479880|20135354|P1|COMPLETED|Overall Study||2
8167281|NCT02479880|20135353|P2|STARTED|Overall Study||15
8167282|NCT02479880|20135354|P1|STARTED|Overall Study||15
8167283|NCT02479802|20135360|P1|NOT COMPLETED|Overall Study||2
8167284|NCT02479802|20135360|P1|COMPLETED|Overall Study||11
8167285|NCT02479802|20135360|P1|STARTED|Overall Study||13
8167286|NCT02479763|20135371|P2|NOT COMPLETED|Overall Study||3
8167287|NCT02479763|20135372|P1|NOT COMPLETED|Overall Study||3
8167288|NCT02479763|20135371|P2|COMPLETED|Overall Study||50
8167289|NCT02479763|20135372|P1|COMPLETED|Overall Study||50
8167290|NCT02479763|20135371|P2|STARTED|Overall Study||53
8167291|NCT02479763|20135372|P1|STARTED|Overall Study||53
8167292|NCT02479412|20135387|P9|NOT COMPLETED|Overall Study||1
8167293|NCT02479412|20135388|P8|NOT COMPLETED|Overall Study||1
8167294|NCT02479412|20135389|P7|NOT COMPLETED|Overall Study||0
8167295|NCT02479412|20135390|P6|NOT COMPLETED|Overall Study||0
8167296|NCT02479412|20135391|P5|NOT COMPLETED|Overall Study||1
8167297|NCT02479412|20135392|P4|NOT COMPLETED|Overall Study||1
8167298|NCT02479412|20135393|P3|NOT COMPLETED|Overall Study||2
8167299|NCT02479412|20135394|P2|NOT COMPLETED|Overall Study||0
8167300|NCT02479412|20135395|P1|NOT COMPLETED|Overall Study||0
8167301|NCT02479412|20135387|P9|COMPLETED|Overall Study||6
8167302|NCT02479412|20135388|P8|COMPLETED|Overall Study||4
8167303|NCT02479412|20135389|P7|COMPLETED|Overall Study||6
8167304|NCT02479412|20135390|P6|COMPLETED|Overall Study||5
8167305|NCT02479412|20135391|P5|COMPLETED|Overall Study||5
8167306|NCT02479412|20135392|P4|COMPLETED|Overall Study||6
8167307|NCT02479412|20135393|P3|COMPLETED|Overall Study||4
8167308|NCT02479412|20135394|P2|COMPLETED|Overall Study||6
8167309|NCT02479412|20135395|P1|COMPLETED|Overall Study||6
8167310|NCT02479412|20135387|P9|STARTED|Overall Study||7
8167311|NCT02479412|20135388|P8|STARTED|Overall Study||5
8167312|NCT02479412|20135389|P7|STARTED|Overall Study||6
8167313|NCT02479412|20135390|P6|STARTED|Overall Study||5
8167314|NCT02479412|20135391|P5|STARTED|Overall Study||6
8167315|NCT02479412|20135392|P4|STARTED|Overall Study||7
8167316|NCT02479412|20135393|P3|STARTED|Overall Study||6
8167317|NCT02479412|20135394|P2|STARTED|Overall Study||6
8167318|NCT02479412|20135395|P1|STARTED|Overall Study||6
8167319|NCT02479139|20135472|P6|NOT COMPLETED|Overall Study||6
8167320|NCT02479139|20135473|P5|NOT COMPLETED|Overall Study||5
8167321|NCT02479139|20135474|P4|NOT COMPLETED|Overall Study||7
8167322|NCT02479139|20135475|P3|NOT COMPLETED|Overall Study||7
8167323|NCT02479139|20135476|P2|NOT COMPLETED|Overall Study||10
8167324|NCT02479139|20135477|P1|NOT COMPLETED|Overall Study||8
8167325|NCT02479139|20135472|P6|COMPLETED|Overall Study||19
8167326|NCT02479139|20135473|P5|COMPLETED|Overall Study||17
8167327|NCT02479139|20135474|P4|COMPLETED|Overall Study||14
8167328|NCT02479139|20135475|P3|COMPLETED|Overall Study||21
8167329|NCT02479139|20135476|P2|COMPLETED|Overall Study||12
8167330|NCT02479139|20135477|P1|COMPLETED|Overall Study||19
8167331|NCT02479139|20135472|P6|STARTED|Overall Study||25
8167332|NCT02479139|20135473|P5|STARTED|Overall Study||22
8167333|NCT02479139|20135474|P4|STARTED|Overall Study||21
8167334|NCT02479139|20135475|P3|STARTED|Overall Study||28
8167335|NCT02479139|20135476|P2|STARTED|Overall Study||22
8167336|NCT02479139|20135477|P1|STARTED|Overall Study||27
8167337|NCT02478671|20135503|P1|NOT COMPLETED|Overall Study||0
8167338|NCT02478671|20135503|P1|COMPLETED|Overall Study||4
8167339|NCT02478671|20135503|P1|STARTED|Overall Study||4
8167340|NCT02478632|20135510|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4
8167341|NCT02478632|20135511|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7
8167342|NCT02478632|20135510|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40
8167343|NCT02478632|20135511|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42
8167344|NCT02478632|20135510|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||44
8167345|NCT02478632|20135511|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||49
8167346|NCT02478632|20135510|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5
8167347|NCT02478632|20135511|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4
8167348|NCT02478632|20135510|P2|COMPLETED|Early Switch Phase (Up to Week 52)||44
8167349|NCT02478632|20135511|P1|COMPLETED|Early Switch Phase (Up to Week 52)||49
8167350|NCT02478632|20135510|P2|STARTED|Early Switch Phase (Up to Week 52)||49
8167351|NCT02478632|20135511|P1|STARTED|Early Switch Phase (Up to Week 52)||53
8167352|NCT02478580|20135537|P2|NOT COMPLETED|Overall Study||0
8167353|NCT02478580|20135538|P1|NOT COMPLETED|Overall Study||0
8167354|NCT02478580|20135537|P2|COMPLETED|Overall Study||33
8167355|NCT02478580|20135538|P1|COMPLETED|Overall Study||34
8167356|NCT02478580|20135537|P2|STARTED|Overall Study||33
8167357|NCT02478580|20135538|P1|STARTED|Overall Study||34
8167358|NCT02478463|20135546|P1|NOT COMPLETED|Treatment Period 2 (Up to 52 Weeks)||1
8167359|NCT02478463|20135546|P1|COMPLETED|Treatment Period 2 (Up to 52 Weeks)||16
8167360|NCT02478463|20135546|P1|STARTED|Treatment Period 2 (Up to 52 Weeks)||17
8167361|NCT02478463|20135546|P1|NOT COMPLETED|Washout Period (Up to 42 Days)||1
8167362|NCT02478463|20135546|P1|COMPLETED|Washout Period (Up to 42 Days)||17
8167363|NCT02478463|20135546|P1|STARTED|Washout Period (Up to 42 Days)||18
8167364|NCT02478463|20135546|P1|NOT COMPLETED|Treatment Period 1 (Up to Day 29)||1
8167365|NCT02478463|20135546|P1|COMPLETED|Treatment Period 1 (Up to Day 29)||18
8167366|NCT02478463|20135546|P1|STARTED|Treatment Period 1 (Up to Day 29)||19
8167367|NCT02478398|20135663|P2|NOT COMPLETED|Overall Study||21
8167368|NCT02478398|20135664|P1|NOT COMPLETED|Overall Study||52
8167369|NCT02478398|20135663|P2|COMPLETED|Overall Study||491
8167370|NCT02478398|20135664|P1|COMPLETED|Overall Study||461
8167371|NCT02478398|20135663|P2|Treated|Overall Study||510
8167372|NCT02478398|20135664|P1|Treated|Overall Study||512
8167373|NCT02478398|20135663|P2|STARTED|Overall Study||512
8167374|NCT02478398|20135664|P1|STARTED|Overall Study||513
8167375|NCT02478372|20135684|P2|NOT COMPLETED|Overall Study||14
8167376|NCT02478372|20135685|P1|NOT COMPLETED|Overall Study||13
8167377|NCT02478372|20135684|P2|COMPLETED|Overall Study||107
8167378|NCT02478372|20135685|P1|COMPLETED|Overall Study||108
8167379|NCT02478372|20135684|P2|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
8167380|NCT02478372|20135685|P1|Reviewed at One Year|Overall Study|Routine follow up at one year|108
8167381|NCT02478372|20135684|P2|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
8167382|NCT02478372|20135685|P1|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
8167383|NCT02478372|20135684|P2|Recieved Allocation Intervention|Overall Study||113
8167384|NCT02478372|20135685|P1|Recieved Allocation Intervention|Overall Study||109
8167385|NCT02478372|20135684|P2|STARTED|Overall Study||121
8167386|NCT02478372|20135685|P1|STARTED|Overall Study||121
8167387|NCT02478359|20135709|P2|NOT COMPLETED|Overall Study||65
8167388|NCT02478359|20135710|P1|NOT COMPLETED|Overall Study||106
8167389|NCT02478359|20135709|P2|COMPLETED|Overall Study||1293
8167390|NCT02478359|20135710|P1|COMPLETED|Overall Study||1243
8167391|NCT02478359|20135709|P2|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 65|1293
8167392|NCT02478359|20135710|P1|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 106|1243
8167393|NCT02478359|20135709|P2|STARTED|Overall Study||1358
8167394|NCT02478359|20135710|P1|STARTED|Overall Study||1349
8167395|NCT02478164|20135782|P1|NOT COMPLETED|Overall Study||15
8167396|NCT02478164|20135782|P1|COMPLETED|Overall Study||0
8167397|NCT02478164|20135782|P1|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
8167398|NCT02477709|20135789|P1|NOT COMPLETED|Overall Study||0
8167399|NCT02477709|20135789|P1|COMPLETED|Overall Study||6
8167400|NCT02477709|20135789|P1|STARTED|Overall Study||6
8167401|NCT02477670|20135795|P7|NOT COMPLETED|Stage 2||0
8167402|NCT02477670|20135796|P6|NOT COMPLETED|Stage 2||0
8167403|NCT02477670|20135797|P5|NOT COMPLETED|Stage 2||0
8167404|NCT02477670|20135798|P4|NOT COMPLETED|Stage 2||1
8167405|NCT02477670|20135799|P3|NOT COMPLETED|Stage 2||2
8167406|NCT02477670|20135800|P2|NOT COMPLETED|Stage 2||0
8167407|NCT02477670|20135801|P1|NOT COMPLETED|Stage 2||0
8167408|NCT02477670|20135795|P7|COMPLETED|Stage 2||42
8167409|NCT02477670|20135796|P6|COMPLETED|Stage 2||1
8167410|NCT02477670|20135797|P5|COMPLETED|Stage 2||2
8167411|NCT02477670|20135798|P4|COMPLETED|Stage 2||32
8167412|NCT02477670|20135799|P3|COMPLETED|Stage 2||28
8167413|NCT02477670|20135800|P2|COMPLETED|Stage 2||0
8167414|NCT02477670|20135801|P1|COMPLETED|Stage 2||0
8167415|NCT02477670|20135795|P7|STARTED|Stage 2||42
8167416|NCT02477670|20135796|P6|STARTED|Stage 2||1
8167417|NCT02477670|20135797|P5|STARTED|Stage 2||2
8167418|NCT02477670|20135798|P4|STARTED|Stage 2||33
8167419|NCT02477670|20135799|P3|STARTED|Stage 2||30
8167420|NCT02477670|20135800|P2|STARTED|Stage 2||0
8167421|NCT02477670|20135801|P1|STARTED|Stage 2||0
8167422|NCT02477670|20135795|P7|NOT COMPLETED|Stage 1||0
8167423|NCT02477670|20135796|P6|NOT COMPLETED|Stage 1||0
8167424|NCT02477670|20135797|P5|NOT COMPLETED|Stage 1||0
8167425|NCT02477670|20135798|P4|NOT COMPLETED|Stage 1||0
8167426|NCT02477670|20135799|P3|NOT COMPLETED|Stage 1||0
8167427|NCT02477670|20135800|P2|NOT COMPLETED|Stage 1||13
8167428|NCT02477670|20135801|P1|NOT COMPLETED|Stage 1||4
8167429|NCT02477670|20135795|P7|COMPLETED|Stage 1||0
8167430|NCT02477670|20135796|P6|COMPLETED|Stage 1||0
8167431|NCT02477670|20135797|P5|COMPLETED|Stage 1||0
8167432|NCT02477670|20135798|P4|COMPLETED|Stage 1||0
8167433|NCT02477670|20135799|P3|COMPLETED|Stage 1||0
8167434|NCT02477670|20135800|P2|COMPLETED|Stage 1||67
8167435|NCT02477670|20135801|P1|COMPLETED|Stage 1||43
8167436|NCT02477670|20135795|P7|STARTED|Stage 1||0
8167437|NCT02477670|20135796|P6|STARTED|Stage 1||0
8167438|NCT02477670|20135797|P5|STARTED|Stage 1||0
8167439|NCT02477670|20135798|P4|STARTED|Stage 1||0
8167440|NCT02477670|20135799|P3|STARTED|Stage 1||0
8167441|NCT02477670|20135800|P2|STARTED|Stage 1||80
8167442|NCT02477670|20135801|P1|STARTED|Stage 1||47
8167443|NCT02477618|20136017|P2|NOT COMPLETED|Overall Study||14
8167444|NCT02477618|20136018|P1|NOT COMPLETED|Overall Study||15
8167445|NCT02477618|20136017|P2|COMPLETED|Overall Study||53
8167446|NCT02477618|20136018|P1|COMPLETED|Overall Study||50
8167447|NCT02477618|20136017|P2|Intent-to-Treat Analysis Set|Overall Study||66
8167448|NCT02477618|20136018|P1|Intent-to-Treat Analysis Set|Overall Study||66
8167449|NCT02477618|20136017|P2|STARTED|Overall Study||67
8167450|NCT02477618|20136018|P1|STARTED|Overall Study||65
8167451|NCT02477605|20136042|P2|NOT COMPLETED|Overall Study||4
8167452|NCT02477605|20136043|P1|NOT COMPLETED|Overall Study||1
8167453|NCT02477605|20136042|P2|COMPLETED|Overall Study||64
8167454|NCT02477605|20136043|P1|COMPLETED|Overall Study||67
8167455|NCT02477605|20136042|P2|Randomized and Treated|Overall Study||68
8167456|NCT02477605|20136043|P1|Randomized and Treated|Overall Study||67
8167457|NCT02477605|20136042|P2|STARTED|Overall Study||68
8167458|NCT02477605|20136043|P1|STARTED|Overall Study||68
8167459|NCT02477553|20136059|P2|NOT COMPLETED|Overall Study||20
8167460|NCT02477553|20136060|P1|NOT COMPLETED|Overall Study||20
8167461|NCT02477553|20136059|P2|COMPLETED|Overall Study||344
8167462|NCT02477553|20136060|P1|COMPLETED|Overall Study||344
8167463|NCT02477553|20136059|P2|STARTED|Overall Study||364
8167464|NCT02477553|20136060|P1|STARTED|Overall Study||364
8167465|NCT02477527|20136080|P1|NOT COMPLETED|Overall Study||6
8167466|NCT02477527|20136080|P1|COMPLETED|Overall Study||21
8167467|NCT02477527|20136080|P1|STARTED|Overall Study||27
8167468|NCT02477423|20136090|P2|NOT COMPLETED|Overall Study||4
8167469|NCT02477423|20136091|P1|NOT COMPLETED|Overall Study||1
8167470|NCT02477423|20136090|P2|COMPLETED|Overall Study||11
8167471|NCT02477423|20136091|P1|COMPLETED|Overall Study||11
8167472|NCT02477423|20136090|P2|STARTED|Overall Study||15
8167473|NCT02477423|20136091|P1|STARTED|Overall Study||12
8167474|NCT02477332|20136115|P6|NOT COMPLETED|Overall Study||5
8167475|NCT02477332|20136116|P5|NOT COMPLETED|Overall Study||4
8167476|NCT02477332|20136117|P4|NOT COMPLETED|Overall Study||13
8167477|NCT02477332|20136118|P3|NOT COMPLETED|Overall Study||12
8167478|NCT02477332|20136119|P2|NOT COMPLETED|Overall Study||7
8167479|NCT02477332|20136120|P1|NOT COMPLETED|Overall Study||3
8167480|NCT02477332|20136115|P6|COMPLETED|Overall Study||37
8167481|NCT02477332|20136116|P5|COMPLETED|Overall Study||39
8167482|NCT02477332|20136117|P4|COMPLETED|Overall Study||72
8167483|NCT02477332|20136118|P3|COMPLETED|Overall Study||73
8167484|NCT02477332|20136119|P2|COMPLETED|Overall Study||77
8167485|NCT02477332|20136120|P1|COMPLETED|Overall Study||40
8167486|NCT02477332|20136115|P6|STARTED|Overall Study||42
8167487|NCT02477332|20136116|P5|STARTED|Overall Study||43
8167488|NCT02477332|20136117|P4|STARTED|Overall Study||85
8167489|NCT02477332|20136118|P3|STARTED|Overall Study||85
8167490|NCT02477332|20136119|P2|STARTED|Overall Study||84
8167491|NCT02477332|20136120|P1|STARTED|Overall Study||43
8167492|NCT02477319|20136198|P4|NOT COMPLETED|Overall Study||22
8167493|NCT02477319|20136199|P3|NOT COMPLETED|Overall Study||15
8167494|NCT02477319|20136200|P2|NOT COMPLETED|Overall Study||3
8167495|NCT02477319|20136201|P1|NOT COMPLETED|Overall Study||0
8167496|NCT02477319|20136198|P4|COMPLETED|Overall Study||171
8167497|NCT02477319|20136199|P3|COMPLETED|Overall Study||149
8167498|NCT02477319|20136200|P2|COMPLETED|Overall Study||37
8167499|NCT02477319|20136201|P1|COMPLETED|Overall Study||55
8167500|NCT02477319|20136198|P4|STARTED|Overall Study||193
8167501|NCT02477319|20136199|P3|STARTED|Overall Study||164
8167502|NCT02477319|20136200|P2|STARTED|Overall Study||40
8167503|NCT02477319|20136201|P1|STARTED|Overall Study||55
8167504|NCT02477215|20136212|P3|NOT COMPLETED|Fixed Dose Phase||0
8167505|NCT02477215|20136213|P2|NOT COMPLETED|Fixed Dose Phase||7
8167506|NCT02477215|20136214|P1|NOT COMPLETED|Fixed Dose Phase||0
8167507|NCT02477215|20136212|P3|COMPLETED|Fixed Dose Phase||0
8167508|NCT02477215|20136213|P2|COMPLETED|Fixed Dose Phase||13
8167509|NCT02477215|20136214|P1|COMPLETED|Fixed Dose Phase||0
8167510|NCT02477215|20136212|P3|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
8167511|NCT02477215|20136213|P2|STARTED|Fixed Dose Phase|Subjects in Period 1 did not continue into Period 2. This is a new subject population.|20
8167512|NCT02477215|20136214|P1|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
8167513|NCT02477215|20136212|P3|NOT COMPLETED|Dose Escalation Phase||0
8167514|NCT02477215|20136213|P2|NOT COMPLETED|Dose Escalation Phase||2
8167515|NCT02477215|20136214|P1|NOT COMPLETED|Dose Escalation Phase||1
8167516|NCT02477215|20136212|P3|COMPLETED|Dose Escalation Phase||6
8167517|NCT02477215|20136213|P2|COMPLETED|Dose Escalation Phase||6
8167518|NCT02477215|20136214|P1|COMPLETED|Dose Escalation Phase||3
8167519|NCT02477215|20136212|P3|STARTED|Dose Escalation Phase||6
8167520|NCT02477215|20136213|P2|STARTED|Dose Escalation Phase||8
8167521|NCT02477215|20136214|P1|STARTED|Dose Escalation Phase||4
8167522|NCT02477020|20136230|P2|NOT COMPLETED|Overall Study||28
8167523|NCT02477020|20136231|P1|NOT COMPLETED|Overall Study||30
8167524|NCT02477020|20136230|P2|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
8167525|NCT02477020|20136231|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
8167526|NCT02477020|20136230|P2|STARTED|Overall Study||83
8167527|NCT02477020|20136231|P1|STARTED|Overall Study||81
8167534|NCT02476890|20136292|P4|NOT COMPLETED|Overall Study||0
8167535|NCT02476890|20136293|P3|NOT COMPLETED|Overall Study||0
8167536|NCT02476890|20136294|P2|NOT COMPLETED|Overall Study||0
8167537|NCT02476890|20136295|P1|NOT COMPLETED|Overall Study||0
8167538|NCT02476890|20136292|P4|COMPLETED|Overall Study||12
8167539|NCT02476890|20136293|P3|COMPLETED|Overall Study||12
8167540|NCT02476890|20136294|P2|COMPLETED|Overall Study||6
8167541|NCT02476890|20136295|P1|COMPLETED|Overall Study||6
8167542|NCT02476890|20136292|P4|Washout|Overall Study||12
8167543|NCT02476890|20136293|P3|Washout|Overall Study||12
8167544|NCT02476890|20136294|P2|Washout|Overall Study||6
8167545|NCT02476890|20136295|P1|Washout|Overall Study||6
8167546|NCT02476890|20136292|P4|STARTED|Overall Study|Crossover study|12
8167547|NCT02476890|20136293|P3|STARTED|Overall Study|Crossover study|12
8167548|NCT02476890|20136294|P2|STARTED|Overall Study|Crossover study|6
8167549|NCT02476890|20136295|P1|STARTED|Overall Study|Crossover study|6
8167550|NCT02476617|20136331|P1|NOT COMPLETED|Overall Study||2
8167551|NCT02476617|20136331|P1|COMPLETED|Overall Study||23
8167552|NCT02476617|20136331|P1|STARTED|Overall Study||25
8167553|NCT02476578|20136337|P2|NOT COMPLETED|Overall Study||56
8167554|NCT02476578|20136338|P1|NOT COMPLETED|Overall Study||41
8167555|NCT02476578|20136337|P2|COMPLETED|Overall Study||4218
8167556|NCT02476578|20136338|P1|COMPLETED|Overall Study||4269
8167557|NCT02476578|20136337|P2|Left Before End of Trial|Overall Study||13
8167558|NCT02476578|20136338|P1|Left Before End of Trial|Overall Study||6
8167559|NCT02476578|20136337|P2|Died Before Email Was Sent|Overall Study||43
8167560|NCT02476578|20136338|P1|Died Before Email Was Sent|Overall Study||35
8167561|NCT02476578|20136337|P2|STARTED|Overall Study||4274
8167562|NCT02476578|20136338|P1|STARTED|Overall Study||4310
8167563|NCT02476565|20136352|P2|NOT COMPLETED|Overall Study||0
8167564|NCT02476565|20136353|P1|NOT COMPLETED|Overall Study||0
8167565|NCT02476565|20136352|P2|COMPLETED|Overall Study||19
8167566|NCT02476565|20136353|P1|COMPLETED|Overall Study||20
8167567|NCT02476565|20136352|P2|STARTED|Overall Study||19
8167568|NCT02476565|20136353|P1|STARTED|Overall Study||20
8167569|NCT02476448|20136377|P4|NOT COMPLETED|Overall Study||0
8167570|NCT02476448|20136378|P3|NOT COMPLETED|Overall Study||0
8167571|NCT02476448|20136379|P2|NOT COMPLETED|Overall Study||0
8167572|NCT02476448|20136380|P1|NOT COMPLETED|Overall Study||0
8167573|NCT02476448|20136377|P4|COMPLETED|Overall Study||44
8167574|NCT02476448|20136378|P3|COMPLETED|Overall Study||44
8167575|NCT02476448|20136379|P2|COMPLETED|Overall Study||44
8167576|NCT02476448|20136380|P1|COMPLETED|Overall Study||44
8167577|NCT02476448|20136377|P4|STARTED|Overall Study||44
8167578|NCT02476448|20136378|P3|STARTED|Overall Study||44
8167579|NCT02476448|20136379|P2|STARTED|Overall Study||44
8167580|NCT02476448|20136380|P1|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44
8167581|NCT02476422|20136400|P2|NOT COMPLETED|Overall Study||1
8167582|NCT02476422|20136401|P1|NOT COMPLETED|Overall Study||0
8167583|NCT02476422|20136400|P2|COMPLETED|Overall Study||161
8167584|NCT02476422|20136401|P1|COMPLETED|Overall Study||166
8167585|NCT02476422|20136400|P2|STARTED|Overall Study||162
8167586|NCT02476422|20136401|P1|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
8167587|NCT02476357|20136433|P2|NOT COMPLETED|Overall Study||0
8167588|NCT02476357|20136434|P1|NOT COMPLETED|Overall Study||0
8167589|NCT02476357|20136433|P2|COMPLETED|Overall Study||40
8167590|NCT02476357|20136434|P1|COMPLETED|Overall Study||40
8167591|NCT02476357|20136433|P2|STARTED|Overall Study||40
8167592|NCT02476357|20136434|P1|STARTED|Overall Study||40
8167593|NCT02476201|20136442|P1|NOT COMPLETED|Overall Study||26
8167594|NCT02476201|20136442|P1|COMPLETED|Overall Study||79
8167595|NCT02476201|20136442|P1|6 Months Visit|Overall Study||82
8167596|NCT02476201|20136442|P1|Sucessful Implants|Overall Study||102
8167597|NCT02476201|20136442|P1|Implant Attempts|Overall Study||103
8167598|NCT02476201|20136442|P1|STARTED|Overall Study||105
8167599|NCT02476175|20136450|P1|NOT COMPLETED|Overall Study||2
8167600|NCT02476175|20136450|P1|COMPLETED|Overall Study||33
8167601|NCT02476175|20136450|P1|STARTED|Overall Study||35
8167602|NCT02476032|20136461|P3|NOT COMPLETED|Overall Study||1
8167603|NCT02476032|20136462|P2|NOT COMPLETED|Overall Study||1
8167604|NCT02476032|20136463|P1|NOT COMPLETED|Overall Study||0
8167605|NCT02476032|20136461|P3|COMPLETED|Overall Study||19
8167606|NCT02476032|20136462|P2|COMPLETED|Overall Study||19
8167607|NCT02476032|20136463|P1|COMPLETED|Overall Study||20
8167608|NCT02476032|20136461|P3|STARTED|Overall Study||20
8167609|NCT02476032|20136462|P2|STARTED|Overall Study||20
8167610|NCT02476032|20136463|P1|STARTED|Overall Study||20
8167611|NCT02476006|20136474|P1|NOT COMPLETED|Overall Study||120
8167612|NCT02476006|20136474|P1|COMPLETED|Overall Study||878
8167613|NCT02476006|20136474|P1|Treated|Overall Study||994
8167614|NCT02476006|20136474|P1|STARTED|Overall Study||998
8167615|NCT02475980|20136488|P1|NOT COMPLETED|Overall Study||5
8167616|NCT02475980|20136488|P1|COMPLETED|Overall Study||8
8167617|NCT02475980|20136488|P1|STARTED|Overall Study||13
8167618|NCT02475837|20136499|P2|NOT COMPLETED|Overall Study||0
8167619|NCT02475837|20136500|P1|NOT COMPLETED|Overall Study||0
8167620|NCT02475837|20136499|P2|COMPLETED|Overall Study||7
8167621|NCT02475837|20136500|P1|COMPLETED|Overall Study||6
8167622|NCT02475837|20136499|P2|STARTED|Overall Study||7
8167623|NCT02475837|20136500|P1|STARTED|Overall Study||6
8167624|NCT02475733|20136514|P2|NOT COMPLETED|Overall Study||0
8167625|NCT02475733|20136515|P1|NOT COMPLETED|Overall Study||2
8167626|NCT02475733|20136514|P2|COMPLETED|Overall Study||22
8167627|NCT02475733|20136515|P1|COMPLETED|Overall Study||59
8167628|NCT02475733|20136514|P2|STARTED|Overall Study||22
8167629|NCT02475733|20136515|P1|STARTED|Overall Study||61
8167630|NCT02475655|20136572|P2|NOT COMPLETED|Overall Study||1
8167631|NCT02475655|20136573|P1|NOT COMPLETED|Overall Study||0
8167632|NCT02475655|20136572|P2|COMPLETED|Overall Study||19
8167633|NCT02475655|20136573|P1|COMPLETED|Overall Study||40
8167634|NCT02475655|20136572|P2|STARTED|Overall Study||20
8167635|NCT02475655|20136573|P1|STARTED|Overall Study||40
8167636|NCT02475629|20136725|P1|NOT COMPLETED|Overall Study||9
8167637|NCT02475629|20136725|P1|COMPLETED|Overall Study||31
8167638|NCT02475629|20136725|P1|STARTED|Overall Study||40
8167639|NCT02475564|20136748|P2|NOT COMPLETED|Overall Study||1
8167640|NCT02475564|20136749|P1|NOT COMPLETED|Overall Study||4
8167641|NCT02475564|20136748|P2|COMPLETED|Overall Study||21
8167642|NCT02475564|20136749|P1|COMPLETED|Overall Study||18
8167643|NCT02475564|20136748|P2|STARTED|Overall Study||22
8167644|NCT02475564|20136749|P1|STARTED|Overall Study||22
8167645|NCT02475395|20136761|P2|NOT COMPLETED|Overall Study||3
8167646|NCT02475395|20136762|P1|NOT COMPLETED|Overall Study||30
8167647|NCT02475395|20136761|P2|COMPLETED|Overall Study||11
8167648|NCT02475395|20136762|P1|COMPLETED|Overall Study||228
8167649|NCT02475395|20136761|P2|STARTED|Overall Study||14
8167650|NCT02475395|20136762|P1|STARTED|Overall Study||258
8167651|NCT02475278|20136772|P1|NOT COMPLETED|Overall Study||2
8167652|NCT02475278|20136772|P1|COMPLETED|Overall Study||48
8167653|NCT02475278|20136772|P1|STARTED|Overall Study||50
8167654|NCT02475265|20136783|P1|NOT COMPLETED|Overall Study||3
8167655|NCT02475265|20136783|P1|COMPLETED|Overall Study||8
8167656|NCT02475265|20136783|P1|STARTED|Overall Study||11
8167657|NCT02475070|20136789|P2|NOT COMPLETED|Overall Study||0
8167658|NCT02475070|20136790|P1|NOT COMPLETED|Overall Study||0
8167659|NCT02475070|20136789|P2|COMPLETED|Overall Study||11
8167660|NCT02475070|20136790|P1|COMPLETED|Overall Study||17
8167661|NCT02475070|20136789|P2|STARTED|Overall Study||11
8167662|NCT02475070|20136790|P1|STARTED|Overall Study||17
8167663|NCT02475031|20136800|P2|NOT COMPLETED|Overall Study||0
8167664|NCT02475031|20136801|P1|NOT COMPLETED|Overall Study||0
8167665|NCT02475031|20136800|P2|COMPLETED|Overall Study||35
8167666|NCT02475031|20136801|P1|COMPLETED|Overall Study||35
8167667|NCT02475031|20136800|P2|STARTED|Overall Study||35
8167668|NCT02475031|20136801|P1|STARTED|Overall Study||35
8167669|NCT02474901|20136817|P2|NOT COMPLETED|Overall Study||0
8167670|NCT02474901|20136818|P1|NOT COMPLETED|Overall Study||1
8167671|NCT02474901|20136817|P2|COMPLETED|Overall Study||56
8167672|NCT02474901|20136818|P1|COMPLETED|Overall Study||44
8167673|NCT02474901|20136817|P2|STARTED|Overall Study||56
8167674|NCT02474901|20136818|P1|STARTED|Overall Study||45
8167675|NCT02474589|20136834|P2|NOT COMPLETED|Overall Study||5
8167676|NCT02474589|20136835|P1|NOT COMPLETED|Overall Study||25
8167677|NCT02474589|20136834|P2|COMPLETED|Overall Study||85
8167678|NCT02474589|20136835|P1|COMPLETED|Overall Study||334
8167679|NCT02474589|20136834|P2|STARTED|Overall Study||90
8167680|NCT02474589|20136835|P1|STARTED|Overall Study||359
8167681|NCT02474498|20136844|P3|NOT COMPLETED|Overall Study||0
8167682|NCT02474498|20136845|P2|NOT COMPLETED|Overall Study||0
8167683|NCT02474498|20136846|P1|NOT COMPLETED|Overall Study||0
8167684|NCT02474498|20136844|P3|COMPLETED|Overall Study||14
8167685|NCT02474498|20136845|P2|COMPLETED|Overall Study||14
8167686|NCT02474498|20136846|P1|COMPLETED|Overall Study||13
8167687|NCT02474498|20136844|P3|STARTED|Overall Study||14
8167688|NCT02474498|20136845|P2|STARTED|Overall Study||14
8167689|NCT02474498|20136846|P1|STARTED|Overall Study||13
8167690|NCT02474407|20136863|P2|NOT COMPLETED|Second Intervention (14 Days)||0
8167691|NCT02474407|20136864|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8167692|NCT02474407|20136863|P2|COMPLETED|Second Intervention (14 Days)||39
8167693|NCT02474407|20136864|P1|COMPLETED|Second Intervention (14 Days)||39
8167694|NCT02474407|20136863|P2|STARTED|Second Intervention (14 Days)||39
8167695|NCT02474407|20136864|P1|STARTED|Second Intervention (14 Days)||39
8167696|NCT02474407|20136863|P2|NOT COMPLETED|Washout (14 Days)||0
8167697|NCT02474407|20136864|P1|NOT COMPLETED|Washout (14 Days)||0
8167698|NCT02474407|20136863|P2|COMPLETED|Washout (14 Days)||39
8167699|NCT02474407|20136864|P1|COMPLETED|Washout (14 Days)||39
8167700|NCT02474407|20136863|P2|STARTED|Washout (14 Days)||39
8167701|NCT02474407|20136864|P1|STARTED|Washout (14 Days)||39
8167702|NCT02474407|20136863|P2|NOT COMPLETED|First Intervention (14 Days)||0
8167703|NCT02474407|20136864|P1|NOT COMPLETED|First Intervention (14 Days)||0
8167704|NCT02474407|20136863|P2|COMPLETED|First Intervention (14 Days)||39
8167705|NCT02474407|20136864|P1|COMPLETED|First Intervention (14 Days)||39
8167706|NCT02474407|20136863|P2|STARTED|First Intervention (14 Days)||39
8167707|NCT02474407|20136864|P1|STARTED|First Intervention (14 Days)||39
8167708|NCT02474082|20136894|P2|NOT COMPLETED|Overall Study||54
8167709|NCT02474082|20136895|P1|NOT COMPLETED|Overall Study||6
8167710|NCT02474082|20136894|P2|COMPLETED|Overall Study||43
8167711|NCT02474082|20136895|P1|COMPLETED|Overall Study||99
8167712|NCT02474082|20136894|P2|Full Analysis Set (FAS)|Overall Study||95
8167713|NCT02474082|20136895|P1|Full Analysis Set (FAS)|Overall Study||105
8167714|NCT02474082|20136894|P2|STARTED|Overall Study||97
8167715|NCT02474082|20136895|P1|STARTED|Overall Study||105
8167716|NCT02474069|20136929|P3|NOT COMPLETED|Comparative Dosing Phase (CDP)||6
8167717|NCT02474069|20136930|P2|NOT COMPLETED|Comparative Dosing Phase (CDP)||9
8167718|NCT02474069|20136931|P1|NOT COMPLETED|Comparative Dosing Phase (CDP)||0
8167719|NCT02474069|20136929|P3|COMPLETED|Comparative Dosing Phase (CDP)||157
8167720|NCT02474069|20136930|P2|COMPLETED|Comparative Dosing Phase (CDP)||153
8167721|NCT02474069|20136931|P1|COMPLETED|Comparative Dosing Phase (CDP)||0
8167722|NCT02474069|20136929|P3|STARTED|Comparative Dosing Phase (CDP)||163
8167723|NCT02474069|20136930|P2|STARTED|Comparative Dosing Phase (CDP)||162
8167724|NCT02474069|20136931|P1|STARTED|Comparative Dosing Phase (CDP)||0
8167725|NCT02474069|20136929|P3|NOT COMPLETED|Selection Phase (SP)||0
8167726|NCT02474069|20136930|P2|NOT COMPLETED|Selection Phase (SP)||0
8167727|NCT02474069|20136931|P1|NOT COMPLETED|Selection Phase (SP)||23
8167728|NCT02474069|20136929|P3|COMPLETED|Selection Phase (SP)||0
8167729|NCT02474069|20136930|P2|COMPLETED|Selection Phase (SP)||0
8167730|NCT02474069|20136931|P1|COMPLETED|Selection Phase (SP)||749
8167731|NCT02474069|20136929|P3|STARTED|Selection Phase (SP)||0
8167732|NCT02474069|20136930|P2|STARTED|Selection Phase (SP)||0
8167733|NCT02474069|20136931|P1|STARTED|Selection Phase (SP)||772
8167734|NCT02473991|20136956|P1|NOT COMPLETED|Overall Study||0
8167735|NCT02473991|20136956|P1|COMPLETED|Overall Study||395
8167736|NCT02473991|20136956|P1|STARTED|Overall Study||395
8167737|NCT02473965|20136964|P2|NOT COMPLETED|Overall Study||10
8167738|NCT02473965|20136965|P1|NOT COMPLETED|Overall Study||12
8167739|NCT02473965|20136964|P2|COMPLETED|Overall Study||20
8167740|NCT02473965|20136965|P1|COMPLETED|Overall Study||18
8167741|NCT02473965|20136964|P2|STARTED|Overall Study||30
8167742|NCT02473965|20136965|P1|STARTED|Overall Study||30
8167743|NCT02473952|20136977|P2|NOT COMPLETED|Overall Study||8
8167744|NCT02473952|20136978|P1|NOT COMPLETED|Overall Study||2
8167745|NCT02473952|20136977|P2|COMPLETED|Overall Study||24
8167746|NCT02473952|20136978|P1|COMPLETED|Overall Study||28
8167747|NCT02473952|20136977|P2|STARTED|Overall Study||32
8167748|NCT02473952|20136978|P1|STARTED|Overall Study||30
8167749|NCT02473913|20136986|P2|NOT COMPLETED|Overall Study||3
8167750|NCT02473913|20136987|P1|NOT COMPLETED|Overall Study||3
8167751|NCT02473913|20136986|P2|COMPLETED|Overall Study||8
8167752|NCT02473913|20136987|P1|COMPLETED|Overall Study||8
8167753|NCT02473913|20136986|P2|STARTED|Overall Study||11
8167754|NCT02473913|20136987|P1|STARTED|Overall Study||11
8167755|NCT02473783|20137007|P2|NOT COMPLETED|Overall Study||0
8167756|NCT02473783|20137008|P1|NOT COMPLETED|Overall Study||0
8167757|NCT02473783|20137007|P2|COMPLETED|Overall Study||17
8167758|NCT02473783|20137008|P1|COMPLETED|Overall Study||20
8167759|NCT02473783|20137007|P2|STARTED|Overall Study||17
8167760|NCT02473783|20137008|P1|STARTED|Overall Study||20
8167761|NCT02473718|20137018|P2|NOT COMPLETED|Overall Study||0
8167762|NCT02473718|20137019|P1|NOT COMPLETED|Overall Study||0
8167763|NCT02473718|20137018|P2|COMPLETED|Overall Study||41
8167764|NCT02473718|20137019|P1|COMPLETED|Overall Study||41
8167765|NCT02473718|20137018|P2|STARTED|Overall Study||41
8167766|NCT02473718|20137019|P1|STARTED|Overall Study||41
8167767|NCT02473640|20137039|P1|NOT COMPLETED|Treatment Period 2||0
8167768|NCT02473640|20137039|P1|COMPLETED|Treatment Period 2||14
8167769|NCT02473640|20137039|P1|STARTED|Treatment Period 2||14
8167770|NCT02473640|20137039|P1|NOT COMPLETED|Run-in Phase||0
8167771|NCT02473640|20137039|P1|COMPLETED|Run-in Phase||14
8167772|NCT02473640|20137039|P1|STARTED|Run-in Phase||14
8167773|NCT02473640|20137039|P1|NOT COMPLETED|Treatment Period 1||1
8167774|NCT02473640|20137039|P1|COMPLETED|Treatment Period 1||14
8167775|NCT02473640|20137039|P1|STARTED|Treatment Period 1||15
8167776|NCT02473523|20137048|P1|NOT COMPLETED|Overall Study||2
8167777|NCT02473523|20137048|P1|COMPLETED|Overall Study||0
8167778|NCT02473523|20137048|P1|STARTED|Overall Study||2
8167779|NCT02473510|20137069|P2|NOT COMPLETED|Overall Study||2
8167780|NCT02473510|20137070|P1|NOT COMPLETED|Overall Study||1
8167781|NCT02473510|20137069|P2|COMPLETED|Overall Study||238
8167782|NCT02473510|20137070|P1|COMPLETED|Overall Study||59
8167783|NCT02473510|20137069|P2|STARTED|Overall Study||240
8167784|NCT02473510|20137070|P1|STARTED|Overall Study||60
8167785|NCT02473471|20137084|P1|NOT COMPLETED|Overall Study||3
8167786|NCT02473471|20137084|P1|COMPLETED|Overall Study||32
8167787|NCT02473471|20137084|P1|Randomized Not Treated|Overall Study||2
8167788|NCT02473471|20137084|P1|Received Allocated Intervention|Overall Study||33
8167789|NCT02473471|20137084|P1|STARTED|Overall Study||35
8167790|NCT02473445|20137115|P1|NOT COMPLETED|Overall Study||22
8167791|NCT02473445|20137115|P1|COMPLETED|Overall Study||0
8167792|NCT02473445|20137115|P1|STARTED|Overall Study||22
8167793|NCT02473367|20137121|P1|NOT COMPLETED|Period 4||1
8167794|NCT02473367|20137121|P1|COMPLETED|Period 4||18
8167795|NCT02473367|20137121|P1|STARTED|Period 4||19
8167796|NCT02473367|20137121|P1|NOT COMPLETED|Wait 3||0
8167797|NCT02473367|20137121|P1|COMPLETED|Wait 3||19
8167798|NCT02473367|20137121|P1|STARTED|Wait 3||19
8167799|NCT02473367|20137121|P1|NOT COMPLETED|Period 3||0
8167800|NCT02473367|20137121|P1|COMPLETED|Period 3||19
8167801|NCT02473367|20137121|P1|STARTED|Period 3||19
8167802|NCT02473367|20137121|P1|NOT COMPLETED|Wait 2||0
8167803|NCT02473367|20137121|P1|COMPLETED|Wait 2||19
8167804|NCT02473367|20137121|P1|STARTED|Wait 2||19
8167805|NCT02473367|20137121|P1|NOT COMPLETED|Period 2||0
8167806|NCT02473367|20137121|P1|COMPLETED|Period 2||19
8167807|NCT02473367|20137121|P1|STARTED|Period 2||19
8167808|NCT02473367|20137121|P1|NOT COMPLETED|Wait 1||1
8167809|NCT02473367|20137121|P1|COMPLETED|Wait 1||19
8167810|NCT02473367|20137121|P1|STARTED|Wait 1||20
8167811|NCT02473367|20137121|P1|NOT COMPLETED|Period 1||0
8167812|NCT02473367|20137121|P1|COMPLETED|Period 1||20
8167813|NCT02473367|20137121|P1|STARTED|Period 1||20
8167814|NCT02473289|20137141|P2|NOT COMPLETED|Overall Study||13
8167815|NCT02473289|20137142|P1|NOT COMPLETED|Overall Study||11
8167816|NCT02473289|20137141|P2|COMPLETED|Overall Study||81
8167817|NCT02473289|20137142|P1|COMPLETED|Overall Study||88
8167818|NCT02473289|20137141|P2|STARTED|Overall Study||94
8167819|NCT02473289|20137142|P1|STARTED|Overall Study||99
8167820|NCT02472977|20137167|P3|NOT COMPLETED|Overall Study||8
8167821|NCT02472977|20137168|P2|NOT COMPLETED|Overall Study||27
8167822|NCT02472977|20137169|P1|NOT COMPLETED|Overall Study||6
8167823|NCT02472977|20137167|P3|COMPLETED|Overall Study||0
8167824|NCT02472977|20137168|P2|COMPLETED|Overall Study||0
8167825|NCT02472977|20137169|P1|COMPLETED|Overall Study||0
8167826|NCT02472977|20137167|P3|STARTED|Overall Study||8
8167827|NCT02472977|20137168|P2|STARTED|Overall Study||27
8167828|NCT02472977|20137169|P1|STARTED|Overall Study||6
8167829|NCT02472964|20137194|P2|NOT COMPLETED|Part 2 (Week 24-week 48)||63
8167830|NCT02472964|20137195|P1|NOT COMPLETED|Part 2 (Week 24-week 48)||65
8167831|NCT02472964|20137194|P2|COMPLETED|Part 2 (Week 24-week 48)||116
8167832|NCT02472964|20137195|P1|COMPLETED|Part 2 (Week 24-week 48)||98
8167833|NCT02472964|20137194|P2|STARTED|Part 2 (Week 24-week 48)||179
8167834|NCT02472964|20137195|P1|STARTED|Part 2 (Week 24-week 48)||163
8167835|NCT02472964|20137194|P2|NOT COMPLETED|Part 1 (up to Week 24)||62
8167836|NCT02472964|20137195|P1|NOT COMPLETED|Part 1 (up to Week 24)||75
8167837|NCT02472964|20137194|P2|COMPLETED|Part 1 (up to Week 24)||185
8167838|NCT02472964|20137195|P1|COMPLETED|Part 1 (up to Week 24)||171
8167839|NCT02472964|20137194|P2|STARTED|Part 1 (up to Week 24)||247
8167840|NCT02472964|20137195|P1|STARTED|Part 1 (up to Week 24)||246
8167841|NCT02472886|20137204|P3|NOT COMPLETED|Overall Study||1
8167842|NCT02472886|20137205|P2|NOT COMPLETED|Overall Study||2
8167843|NCT02472886|20137206|P1|NOT COMPLETED|Overall Study||0
8167844|NCT02472886|20137204|P3|COMPLETED|Overall Study||26
8167845|NCT02472886|20137205|P2|COMPLETED|Overall Study||57
8167846|NCT02472886|20137206|P1|COMPLETED|Overall Study||67
8167847|NCT02472886|20137204|P3|STARTED|Overall Study||27
8167848|NCT02472886|20137205|P2|STARTED|Overall Study||59
8167849|NCT02472886|20137206|P1|STARTED|Overall Study||67
8167850|NCT02472847|20137234|P2|NOT COMPLETED|Overall Study||5
8167851|NCT02472847|20137235|P1|NOT COMPLETED|Overall Study||1
8167852|NCT02472847|20137234|P2|COMPLETED|Overall Study||21
8167853|NCT02472847|20137235|P1|COMPLETED|Overall Study||23
8167854|NCT02472847|20137234|P2|STARTED|Overall Study||26
8167855|NCT02472847|20137235|P1|STARTED|Overall Study||24
8167856|NCT02472795|20137246|P5|NOT COMPLETED|Overall Study||3
8167857|NCT02472795|20137247|P4|NOT COMPLETED|Overall Study||0
8167858|NCT02472795|20137248|P3|NOT COMPLETED|Overall Study||0
8167859|NCT02472795|20137249|P2|NOT COMPLETED|Overall Study||1
8167860|NCT02472795|20137250|P1|NOT COMPLETED|Overall Study||0
8167861|NCT02472795|20137246|P5|COMPLETED|Overall Study||14
8167862|NCT02472795|20137247|P4|COMPLETED|Overall Study||13
8167863|NCT02472795|20137248|P3|COMPLETED|Overall Study||13
8167864|NCT02472795|20137249|P2|COMPLETED|Overall Study||11
8167865|NCT02472795|20137250|P1|COMPLETED|Overall Study||12
8167866|NCT02472795|20137246|P5|Modified Pharmacodynamic Analysis Set|Overall Study||16
8167867|NCT02472795|20137247|P4|Modified Pharmacodynamic Analysis Set|Overall Study||9
8167868|NCT02472795|20137248|P3|Modified Pharmacodynamic Analysis Set|Overall Study||13
8167869|NCT02472795|20137249|P2|Modified Pharmacodynamic Analysis Set|Overall Study||10
8167870|NCT02472795|20137250|P1|Modified Pharmacodynamic Analysis Set|Overall Study||12
8167871|NCT02472795|20137246|P5|Pharmacodynamic Set|Overall Study||16
8167872|NCT02472795|20137247|P4|Pharmacodynamic Set|Overall Study||13
8167873|NCT02472795|20137248|P3|Pharmacodynamic Set|Overall Study||13
8167874|NCT02472795|20137249|P2|Pharmacodynamic Set|Overall Study||10
8167875|NCT02472795|20137250|P1|Pharmacodynamic Set|Overall Study||12
8167876|NCT02472795|20137246|P5|STARTED|Overall Study||17
8167877|NCT02472795|20137247|P4|STARTED|Overall Study||13
8167878|NCT02472795|20137248|P3|STARTED|Overall Study||13
8167879|NCT02472795|20137249|P2|STARTED|Overall Study||12
8167880|NCT02472795|20137250|P1|STARTED|Overall Study||12
8167881|NCT02472756|20137282|P1|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
8167882|NCT02472756|20137282|P1|COMPLETED|Maintenance (Approximately 2 Years)||10
8167883|NCT02472756|20137282|P1|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
8167884|NCT02472756|20137282|P1|NOT COMPLETED|Induction (Approximately 6 Months)||2
8167885|NCT02472756|20137282|P1|COMPLETED|Induction (Approximately 6 Months)||39
8167886|NCT02472756|20137282|P1|Treated|Induction (Approximately 6 Months)||40
8167887|NCT02472756|20137282|P1|STARTED|Induction (Approximately 6 Months)||41
8167888|NCT02472730|20137290|P2|NOT COMPLETED|Overall Study||7
8167889|NCT02472730|20137291|P1|NOT COMPLETED|Overall Study||9
8167890|NCT02472730|20137290|P2|COMPLETED|Overall Study||102
8167891|NCT02472730|20137291|P1|COMPLETED|Overall Study||101
8167892|NCT02472730|20137290|P2|STARTED|Overall Study||109
8167893|NCT02472730|20137291|P1|STARTED|Overall Study||110
8167894|NCT02472652|20137303|P1|NOT COMPLETED|Overall Study||1
8167895|NCT02472652|20137303|P1|COMPLETED|Overall Study||1
8167896|NCT02472652|20137303|P1|STARTED|Overall Study||2
8167897|NCT02472639|20137310|P2|NOT COMPLETED|Overall Study||3
8167898|NCT02472639|20137311|P1|NOT COMPLETED|Overall Study||4
8167899|NCT02472639|20137310|P2|COMPLETED|Overall Study||0
8167900|NCT02472639|20137311|P1|COMPLETED|Overall Study||0
8167901|NCT02472639|20137310|P2|STARTED|Overall Study||3
8167902|NCT02472639|20137311|P1|STARTED|Overall Study||4
8167903|NCT02472522|20137327|P2|NOT COMPLETED|Overall Study||0
8167904|NCT02472522|20137328|P1|NOT COMPLETED|Overall Study||0
8167905|NCT02472522|20137327|P2|COMPLETED|Overall Study||50
8167906|NCT02472522|20137328|P1|COMPLETED|Overall Study||50
8167907|NCT02472522|20137327|P2|STARTED|Overall Study||50
8167908|NCT02472522|20137328|P1|STARTED|Overall Study||50
8167909|NCT02472457|20137360|P2|NOT COMPLETED|Overall Study||1
8167910|NCT02472457|20137361|P1|NOT COMPLETED|Overall Study||0
8167911|NCT02472457|20137360|P2|COMPLETED|Overall Study||10
8167912|NCT02472457|20137361|P1|COMPLETED|Overall Study||8
8167913|NCT02472457|20137360|P2|STARTED|Overall Study||11
8167914|NCT02472457|20137361|P1|STARTED|Overall Study|1 subject followed the Specific Carbohydrate Diet|8
8167915|NCT02472405|20137367|P1|NOT COMPLETED|Overall Study||10
8167916|NCT02472405|20137367|P1|COMPLETED|Overall Study||8
8167917|NCT02472405|20137367|P1|STARTED|Overall Study||18
8167918|NCT02472366|20137375|P2|NOT COMPLETED|Overall Study||0
8167919|NCT02472366|20137376|P1|NOT COMPLETED|Overall Study||1
8167920|NCT02472366|20137375|P2|COMPLETED|Overall Study||10
8167921|NCT02472366|20137376|P1|COMPLETED|Overall Study||5
8167922|NCT02472366|20137375|P2|STARTED|Overall Study||10
8167923|NCT02472366|20137376|P1|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
8167924|NCT02472353|20137392|P2|NOT COMPLETED|Overall Study||6
8167925|NCT02472353|20137393|P1|NOT COMPLETED|Overall Study||4
8167926|NCT02472353|20137392|P2|COMPLETED|Overall Study||10
8167927|NCT02472353|20137393|P1|COMPLETED|Overall Study||10
8167928|NCT02472353|20137392|P2|STARTED|Overall Study||16
8167929|NCT02472353|20137393|P1|STARTED|Overall Study||14
8167930|NCT02472314|20137401|P2|NOT COMPLETED|Overall Study||0
8167931|NCT02472314|20137402|P1|NOT COMPLETED|Overall Study||0
8167932|NCT02472314|20137401|P2|COMPLETED|Overall Study||36
8167933|NCT02472314|20137402|P1|COMPLETED|Overall Study||34
8167934|NCT02472314|20137401|P2|STARTED|Overall Study||36
8167935|NCT02472314|20137402|P1|STARTED|Overall Study||34
8167936|NCT02472262|20137417|P3|NOT COMPLETED|Overall Study||25
8167937|NCT02472262|20137418|P2|NOT COMPLETED|Overall Study||21
8167938|NCT02472262|20137419|P1|NOT COMPLETED|Overall Study||18
8167939|NCT02472262|20137417|P3|COMPLETED|Overall Study||93
8167940|NCT02472262|20137418|P2|COMPLETED|Overall Study||99
8167941|NCT02472262|20137419|P1|COMPLETED|Overall Study||99
8167942|NCT02472262|20137417|P3|STARTED|Overall Study||118
8167943|NCT02472262|20137418|P2|STARTED|Overall Study||120
8167944|NCT02472262|20137419|P1|STARTED|Overall Study||117
8167945|NCT02472223|20137429|P2|NOT COMPLETED|Overall Study||5
8167946|NCT02472223|20137430|P1|NOT COMPLETED|Overall Study||6
8167947|NCT02472223|20137429|P2|COMPLETED|Overall Study||7
8167948|NCT02472223|20137430|P1|COMPLETED|Overall Study||10
8167949|NCT02472223|20137429|P2|STARTED|Overall Study||12
8167950|NCT02472223|20137430|P1|STARTED|Overall Study||16
8167951|NCT02472145|20137441|P3|NOT COMPLETED|Overall Study||157
8167952|NCT02472145|20137442|P2|NOT COMPLETED|Overall Study||159
8167953|NCT02472145|20137443|P1|NOT COMPLETED|Overall Study||10
8167954|NCT02472145|20137441|P3|COMPLETED|Overall Study||0
8167955|NCT02472145|20137442|P2|COMPLETED|Overall Study||0
8167956|NCT02472145|20137443|P1|COMPLETED|Overall Study||0
8167957|NCT02472145|20137441|P3|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147
8167958|NCT02472145|20137442|P2|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165
8167959|NCT02472145|20137443|P1|Safety|Overall Study||10
8167960|NCT02472145|20137441|P3|Treated|Overall Study||156
8167961|NCT02472145|20137442|P2|Treated|Overall Study||156
8167962|NCT02472145|20137443|P1|Treated|Overall Study||10
8167963|NCT02472145|20137441|P3|STARTED|Overall Study||157
8167964|NCT02472145|20137442|P2|STARTED|Overall Study||159
8167965|NCT02472145|20137443|P1|STARTED|Overall Study||10
8167966|NCT02471755|20137464|P2|NOT COMPLETED|Overall Study||1
8167967|NCT02471755|20137465|P1|NOT COMPLETED|Overall Study||1
8167968|NCT02471755|20137464|P2|COMPLETED|Overall Study||44
8167969|NCT02471755|20137465|P1|COMPLETED|Overall Study||44
8167970|NCT02471755|20137464|P2|STARTED|Overall Study||45
8167971|NCT02471755|20137465|P1|STARTED|Overall Study||45
8167972|NCT02471651|20137483|P2|NOT COMPLETED|Overall Study||5
8167973|NCT02471651|20137484|P1|NOT COMPLETED|Overall Study||5
8167974|NCT02471651|20137483|P2|COMPLETED|Overall Study||15
8167975|NCT02471651|20137484|P1|COMPLETED|Overall Study||15
8167976|NCT02471651|20137483|P2|STARTED|Overall Study||20
8167977|NCT02471651|20137484|P1|STARTED|Overall Study||20
8167978|NCT02471612|20137494|P1|NOT COMPLETED|Overall Study||2
8167979|NCT02471612|20137494|P1|COMPLETED|Overall Study||157
8167980|NCT02471612|20137494|P1|STARTED|Overall Study||159
8167981|NCT02471521|20137513|P2|NOT COMPLETED|Overall Study||8
8167982|NCT02471521|20137514|P1|NOT COMPLETED|Overall Study||0
8167983|NCT02471521|20137513|P2|COMPLETED|Overall Study||52
8167984|NCT02471521|20137514|P1|COMPLETED|Overall Study||60
8167985|NCT02471521|20137513|P2|STARTED|Overall Study||60
8167986|NCT02471521|20137514|P1|STARTED|Overall Study||60
8167987|NCT02471404|20137525|P3|NOT COMPLETED|Overall Study||25
8167988|NCT02471404|20137526|P2|NOT COMPLETED|Overall Study||14
8167989|NCT02471404|20137527|P1|NOT COMPLETED|Overall Study||33
8167990|NCT02471404|20137525|P3|COMPLETED|Overall Study||288
8167991|NCT02471404|20137526|P2|COMPLETED|Overall Study||298
8167992|NCT02471404|20137527|P1|COMPLETED|Overall Study||281
8167993|NCT02471404|20137525|P3|STARTED|Overall Study||313
8167994|NCT02471404|20137526|P2|STARTED|Overall Study||312
8167995|NCT02471404|20137527|P1|STARTED|Overall Study||314
8167996|NCT02471326|20137550|P1|NOT COMPLETED|Overall Study||1
8167997|NCT02471326|20137550|P1|COMPLETED|Overall Study||9
8167998|NCT02471326|20137550|P1|STARTED|Overall Study||10
8167999|NCT02471313|20137555|P1|NOT COMPLETED|Overall Study||0
8168000|NCT02471313|20137555|P1|COMPLETED|Overall Study||3
8168001|NCT02471313|20137555|P1|STARTED|Overall Study||3
8168002|NCT02471183|20137559|P1|NOT COMPLETED|Extended Treatment Period||1
8168003|NCT02471183|20137559|P1|COMPLETED|Extended Treatment Period||31
8168004|NCT02471183|20137559|P1|STARTED|Extended Treatment Period||32
8168005|NCT02471183|20137559|P1|NOT COMPLETED|Main Treatment Period||2
8168006|NCT02471183|20137559|P1|COMPLETED|Main Treatment Period||32
8168007|NCT02471183|20137559|P1|STARTED|Main Treatment Period||34
8168008|NCT02471014|20137576|P2|NOT COMPLETED|Overall Study||2
8168009|NCT02471014|20137577|P1|NOT COMPLETED|Overall Study||2
8168010|NCT02471014|20137576|P2|COMPLETED|Overall Study||23
8168011|NCT02471014|20137577|P1|COMPLETED|Overall Study||23
8168012|NCT02471014|20137576|P2|STARTED|Overall Study||25
8168013|NCT02471014|20137577|P1|STARTED|Overall Study||25
8168014|NCT02470949|20137583|P2|NOT COMPLETED|Second Intervention||0
8168015|NCT02470949|20137584|P1|NOT COMPLETED|Second Intervention||0
8168016|NCT02470949|20137583|P2|COMPLETED|Second Intervention||2
8168017|NCT02470949|20137584|P1|COMPLETED|Second Intervention||4
8168018|NCT02470949|20137583|P2|STARTED|Second Intervention||2
8168019|NCT02470949|20137584|P1|STARTED|Second Intervention||4
8168020|NCT02470949|20137583|P2|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
8168021|NCT02470949|20137584|P1|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
8168022|NCT02470949|20137583|P2|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
8168023|NCT02470949|20137584|P1|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
8168024|NCT02470949|20137583|P2|STARTED|Washout Period for a Minimum of 4 Weeks||5
8168025|NCT02470949|20137584|P1|STARTED|Washout Period for a Minimum of 4 Weeks||4
8168026|NCT02470949|20137583|P2|NOT COMPLETED|First Intervention||0
8168027|NCT02470949|20137584|P1|NOT COMPLETED|First Intervention||0
8168028|NCT02470949|20137583|P2|COMPLETED|First Intervention||5
8168029|NCT02470949|20137584|P1|COMPLETED|First Intervention||4
8168030|NCT02470949|20137583|P2|STARTED|First Intervention||5
8168031|NCT02470949|20137584|P1|STARTED|First Intervention||4
8168032|NCT02470910|20137594|P1|NOT COMPLETED|Overall Study||0
8168033|NCT02470910|20137594|P1|COMPLETED|Overall Study||15
8168034|NCT02470910|20137594|P1|STARTED|Overall Study||15
8168035|NCT02470806|20137603|P2|NOT COMPLETED|Overall Study||42
8168036|NCT02470806|20137604|P1|NOT COMPLETED|Overall Study||18
8168037|NCT02470806|20137603|P2|COMPLETED|Overall Study||42
8168038|NCT02470806|20137604|P1|COMPLETED|Overall Study||62
8168039|NCT02470806|20137603|P2|STARTED|Overall Study|The Safety analysis included 164, ITT was 161, and Per Protocol was 115 subjects (total both arms).|84
8168040|NCT02470806|20137604|P1|STARTED|Overall Study||80
8168041|NCT02470754|20137618|P2|NOT COMPLETED|Overall Study||0
8168042|NCT02470754|20137619|P1|NOT COMPLETED|Overall Study||2
8168043|NCT02470754|20137618|P2|COMPLETED|Overall Study||19
8168044|NCT02470754|20137619|P1|COMPLETED|Overall Study||17
8168045|NCT02470754|20137618|P2|STARTED|Overall Study||19
8168046|NCT02470754|20137619|P1|STARTED|Overall Study||19
8168047|NCT02470741|20137647|P2|NOT COMPLETED|Overall Study||2
8168048|NCT02470741|20137648|P1|NOT COMPLETED|Overall Study||3
8168049|NCT02470741|20137647|P2|COMPLETED|Overall Study||4
8168050|NCT02470741|20137648|P1|COMPLETED|Overall Study||3
8168051|NCT02470741|20137647|P2|STARTED|Overall Study||6
8168052|NCT02470741|20137648|P1|STARTED|Overall Study||6
8168065|NCT02470494|20137682|P1|NOT COMPLETED|Overall Study||5
8168066|NCT02470494|20137682|P1|COMPLETED|Overall Study||41
8168067|NCT02470494|20137682|P1|STARTED|Overall Study||46
8168068|NCT02470429|20137692|P2|NOT COMPLETED|Overall Study||0
8168069|NCT02470429|20137693|P1|NOT COMPLETED|Overall Study||2
8168070|NCT02470429|20137692|P2|COMPLETED|Overall Study||49
8168071|NCT02470429|20137693|P1|COMPLETED|Overall Study||48
8168072|NCT02470429|20137692|P2|STARTED|Overall Study||49
8168073|NCT02470429|20137693|P1|STARTED|Overall Study||50
8168074|NCT02470403|20137711|P5|NOT COMPLETED|Overall Study||0
8168075|NCT02470403|20137712|P4|NOT COMPLETED|Overall Study||4
8168076|NCT02470403|20137713|P3|NOT COMPLETED|Overall Study||0
8168077|NCT02470403|20137714|P2|NOT COMPLETED|Overall Study||1
8168078|NCT02470403|20137715|P1|NOT COMPLETED|Overall Study||2
8168079|NCT02470403|20137711|P5|COMPLETED|Overall Study||10
8168080|NCT02470403|20137712|P4|COMPLETED|Overall Study||39
8168081|NCT02470403|20137713|P3|COMPLETED|Overall Study||40
8168082|NCT02470403|20137714|P2|COMPLETED|Overall Study||43
8168083|NCT02470403|20137715|P1|COMPLETED|Overall Study||42
8168084|NCT02470403|20137711|P5|Normoglycemic|Overall Study||5
8168085|NCT02470403|20137712|P4|Normoglycemic|Overall Study||23
8168086|NCT02470403|20137713|P3|Normoglycemic|Overall Study||20
8168087|NCT02470403|20137714|P2|Normoglycemic|Overall Study||20
8168088|NCT02470403|20137715|P1|Normoglycemic|Overall Study||20
8168089|NCT02470403|20137711|P5|Dysglycemic|Overall Study||5
8168090|NCT02470403|20137712|P4|Dysglycemic|Overall Study||20
8168091|NCT02470403|20137713|P3|Dysglycemic|Overall Study||20
8168092|NCT02470403|20137714|P2|Dysglycemic|Overall Study||24
8168093|NCT02470403|20137715|P1|Dysglycemic|Overall Study||24
8168094|NCT02470403|20137711|P5|STARTED|Overall Study||10
8168095|NCT02470403|20137712|P4|STARTED|Overall Study||43
8168096|NCT02470403|20137713|P3|STARTED|Overall Study||40
8168097|NCT02470403|20137714|P2|STARTED|Overall Study||44
8168098|NCT02470403|20137715|P1|STARTED|Overall Study||44
8168099|NCT02470390|20137755|P2|NOT COMPLETED|Overall Study||1
8168100|NCT02470390|20137756|P1|NOT COMPLETED|Overall Study||0
8168101|NCT02470390|20137755|P2|COMPLETED|Overall Study||6
8168102|NCT02470390|20137756|P1|COMPLETED|Overall Study||6
8168103|NCT02470390|20137755|P2|STARTED|Overall Study||7
8168104|NCT02470390|20137756|P1|STARTED|Overall Study||6
8168105|NCT02470312|20137784|P2|NOT COMPLETED|Overall Study||12
8168106|NCT02470312|20137785|P1|NOT COMPLETED|Overall Study||5
8168107|NCT02470312|20137784|P2|COMPLETED|Overall Study||419
8168108|NCT02470312|20137785|P1|COMPLETED|Overall Study||142
8168109|NCT02470312|20137784|P2|STARTED|Overall Study||431
8168110|NCT02470312|20137785|P1|STARTED|Overall Study||147
8168111|NCT02469961|20137795|P2|NOT COMPLETED|Overall Study||1
8168112|NCT02469961|20137796|P1|NOT COMPLETED|Overall Study||4
8168113|NCT02469961|20137795|P2|COMPLETED|Overall Study||24
8168114|NCT02469961|20137796|P1|COMPLETED|Overall Study||21
8168115|NCT02469961|20137795|P2|STARTED|Overall Study||25
8168116|NCT02469961|20137796|P1|STARTED|Overall Study||25
8168117|NCT02469896|20137810|P2|NOT COMPLETED|Overall Study||0
8168118|NCT02469896|20137811|P1|NOT COMPLETED|Overall Study||2
8168119|NCT02469896|20137810|P2|COMPLETED|Overall Study||14
8168120|NCT02469896|20137811|P1|COMPLETED|Overall Study||6
8168121|NCT02469896|20137810|P2|STARTED|Overall Study||14
8168122|NCT02469896|20137811|P1|STARTED|Overall Study||8
8168123|NCT02469870|20137837|P2|NOT COMPLETED|Overall Study||7
8168124|NCT02469870|20137838|P1|NOT COMPLETED|Overall Study||4
8168125|NCT02469870|20137837|P2|COMPLETED|Overall Study||72
8168126|NCT02469870|20137838|P1|COMPLETED|Overall Study||73
8168127|NCT02469870|20137837|P2|STARTED|Overall Study||79
8168128|NCT02469870|20137838|P1|STARTED|Overall Study||77
8168129|NCT02469714|20137856|P2|NOT COMPLETED|Overall Study||5
8168130|NCT02469714|20137857|P1|NOT COMPLETED|Overall Study||8
8168131|NCT02469714|20137856|P2|COMPLETED|Overall Study||50
8168132|NCT02469714|20137857|P1|COMPLETED|Overall Study||47
8168133|NCT02469714|20137856|P2|8 Month Follow-Up|Overall Study||50
8168134|NCT02469714|20137857|P1|8 Month Follow-Up|Overall Study||49
8168135|NCT02469714|20137856|P2|4 Month Follow-Up|Overall Study||51
8168136|NCT02469714|20137857|P1|4 Month Follow-Up|Overall Study||50
8168137|NCT02469714|20137856|P2|STARTED|Overall Study||55
8168138|NCT02469714|20137857|P1|STARTED|Overall Study||55
8168139|NCT02469701|20137877|P1|NOT COMPLETED|Overall Study||0
8168140|NCT02469701|20137877|P1|COMPLETED|Overall Study||10
8168141|NCT02469701|20137877|P1|STARTED|Overall Study||10
8168142|NCT02469623|20137881|P1|NOT COMPLETED|Overall Study||13
8168143|NCT02469623|20137881|P1|COMPLETED|Overall Study||72
8168144|NCT02469623|20137881|P1|STARTED|Overall Study||85
8168145|NCT02469610|20137888|P2|NOT COMPLETED|Overall Study||1
8168146|NCT02469610|20137889|P1|NOT COMPLETED|Overall Study||4
8168147|NCT02469610|20137888|P2|COMPLETED|Overall Study||30
8168148|NCT02469610|20137889|P1|COMPLETED|Overall Study||30
8168149|NCT02469610|20137888|P2|STARTED|Overall Study||31
8168150|NCT02469610|20137889|P1|STARTED|Overall Study||34
8168151|NCT02469597|20137899|P2|NOT COMPLETED|Overall Study||0
8168152|NCT02469597|20137900|P1|NOT COMPLETED|Overall Study||0
8168153|NCT02469597|20137899|P2|COMPLETED|Overall Study||24
8168154|NCT02469597|20137900|P1|COMPLETED|Overall Study||22
8168155|NCT02469597|20137899|P2|STARTED|Overall Study||24
8168156|NCT02469597|20137900|P1|STARTED|Overall Study||22
8168157|NCT02469415|20137916|P1|NOT COMPLETED|Overall Study||3
8168158|NCT02469415|20137916|P1|COMPLETED|Overall Study||0
8168159|NCT02469415|20137916|P1|STARTED|Overall Study||3
8168160|NCT02469298|20137924|P4|NOT COMPLETED|Overall Study||2
8168161|NCT02469298|20137925|P3|NOT COMPLETED|Overall Study||2
8168162|NCT02469298|20137926|P2|NOT COMPLETED|Overall Study||1
8168163|NCT02469298|20137927|P1|NOT COMPLETED|Overall Study||1
8168164|NCT02469298|20137924|P4|COMPLETED|Overall Study||5
8168165|NCT02469298|20137925|P3|COMPLETED|Overall Study||14
8168166|NCT02469298|20137926|P2|COMPLETED|Overall Study||6
8168167|NCT02469298|20137927|P1|COMPLETED|Overall Study||14
8168168|NCT02469298|20137924|P4|STARTED|Overall Study||7
8168169|NCT02469298|20137925|P3|STARTED|Overall Study||16
8168170|NCT02469298|20137926|P2|STARTED|Overall Study||7
8168171|NCT02469298|20137927|P1|STARTED|Overall Study||15
8168172|NCT02469246|20138067|P2|NOT COMPLETED|Open-Label Extension (OLE)||0
8168173|NCT02469246|20138068|P1|NOT COMPLETED|Open-Label Extension (OLE)||0
8168174|NCT02469246|20138067|P2|COMPLETED|Open-Label Extension (OLE)||5
8168175|NCT02469246|20138068|P1|COMPLETED|Open-Label Extension (OLE)||6
8168176|NCT02469246|20138067|P2|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5
8168177|NCT02469246|20138068|P1|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6
8168178|NCT02469246|20138067|P2|NOT COMPLETED|Double-Blind Phase||56
8168179|NCT02469246|20138068|P1|NOT COMPLETED|Double-Blind Phase||67
8168180|NCT02469246|20138067|P2|COMPLETED|Double-Blind Phase||226
8168181|NCT02469246|20138068|P1|COMPLETED|Double-Blind Phase||218
8168182|NCT02469246|20138067|P2|STARTED|Double-Blind Phase||282
8168183|NCT02469246|20138068|P1|STARTED|Double-Blind Phase||285
8168184|NCT02469168|20138100|P2|NOT COMPLETED|Overall Study||0
8168185|NCT02469168|20138101|P1|NOT COMPLETED|Overall Study||1
8168186|NCT02469168|20138100|P2|COMPLETED|Overall Study||0
8168187|NCT02469168|20138101|P1|COMPLETED|Overall Study||0
8168188|NCT02469168|20138100|P2|STARTED|Overall Study||0
8168189|NCT02469168|20138101|P1|STARTED|Overall Study||1
8168190|NCT02469116|20138109|P1|NOT COMPLETED|Overall Study||0
8168191|NCT02469116|20138109|P1|COMPLETED|Overall Study||18
8168192|NCT02469116|20138109|P1|STARTED|Overall Study||18
8168193|NCT02469090|20138121|P3|NOT COMPLETED|Period 2: Maintenance Treatment Phase||20
8168194|NCT02469090|20138122|P2|NOT COMPLETED|Period 2: Maintenance Treatment Phase||9
8168195|NCT02469090|20138123|P1|NOT COMPLETED|Period 2: Maintenance Treatment Phase||0
8168196|NCT02469090|20138121|P3|COMPLETED|Period 2: Maintenance Treatment Phase||34
8168197|NCT02469090|20138122|P2|COMPLETED|Period 2: Maintenance Treatment Phase||46
8168198|NCT02469090|20138123|P1|COMPLETED|Period 2: Maintenance Treatment Phase||0
8168199|NCT02469090|20138121|P3|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to APL-130277 Maintenance Phase|54
8168200|NCT02469090|20138122|P2|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to Placebo in the Maintenance Phase|55
8168201|NCT02469090|20138123|P1|STARTED|Period 2: Maintenance Treatment Phase|Subjects who completed the Titration Phase were eligible to proceed to Maintenance Treatment Phase|0
8168202|NCT02469090|20138121|P3|NOT COMPLETED|Period 1: Dose Titration Phase||0
8168203|NCT02469090|20138122|P2|NOT COMPLETED|Period 1: Dose Titration Phase||0
8168204|NCT02469090|20138123|P1|NOT COMPLETED|Period 1: Dose Titration Phase||32
8168205|NCT02469090|20138121|P3|COMPLETED|Period 1: Dose Titration Phase||0
8168206|NCT02469090|20138122|P2|COMPLETED|Period 1: Dose Titration Phase||0
8168207|NCT02469090|20138123|P1|COMPLETED|Period 1: Dose Titration Phase||109
8168208|NCT02469090|20138121|P3|STARTED|Period 1: Dose Titration Phase||0
8168209|NCT02469090|20138122|P2|STARTED|Period 1: Dose Titration Phase||0
8168210|NCT02469090|20138123|P1|STARTED|Period 1: Dose Titration Phase||141
8168211|NCT02469077|20138150|P2|NOT COMPLETED|Post Intervention /Followup||1
8168212|NCT02469077|20138151|P1|NOT COMPLETED|Post Intervention /Followup||2
8168213|NCT02469077|20138150|P2|COMPLETED|Post Intervention /Followup||44
8168214|NCT02469077|20138151|P1|COMPLETED|Post Intervention /Followup||38
8168215|NCT02469077|20138150|P2|Post Intervention Naloxone|Post Intervention /Followup||44
8168216|NCT02469077|20138151|P1|Post Intervention Naloxone|Post Intervention /Followup||39
8168217|NCT02469077|20138150|P2|Post Intervention Morphine|Post Intervention /Followup||45
8168218|NCT02469077|20138151|P1|Post Intervention Morphine|Post Intervention /Followup||40
8168219|NCT02469077|20138150|P2|Post Intervention Placebo|Post Intervention /Followup||45
8168220|NCT02469077|20138151|P1|Post Intervention Placebo|Post Intervention /Followup||39
8168221|NCT02469077|20138150|P2|STARTED|Post Intervention /Followup||45
8168222|NCT02469077|20138151|P1|STARTED|Post Intervention /Followup||40
8168223|NCT02469077|20138150|P2|NOT COMPLETED|Post Randomization/Intervention Period||4
8168224|NCT02469077|20138151|P1|NOT COMPLETED|Post Randomization/Intervention Period||4
8168225|NCT02469077|20138150|P2|COMPLETED|Post Randomization/Intervention Period||45
8168226|NCT02469077|20138151|P1|COMPLETED|Post Randomization/Intervention Period||40
8168227|NCT02469077|20138150|P2|STARTED|Post Randomization/Intervention Period||49
8168228|NCT02469077|20138151|P1|STARTED|Post Randomization/Intervention Period||44
8168229|NCT02469077|20138150|P2|NOT COMPLETED|Pre Randomization - Pre Intervention||0
8168230|NCT02469077|20138151|P1|NOT COMPLETED|Pre Randomization - Pre Intervention||0
8168231|NCT02469077|20138150|P2|COMPLETED|Pre Randomization - Pre Intervention||49
8168232|NCT02469077|20138151|P1|COMPLETED|Pre Randomization - Pre Intervention||44
8168233|NCT02469077|20138150|P2|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||49
8168234|NCT02469077|20138151|P1|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||44
8168235|NCT02469077|20138150|P2|Pre Intervention Morpine|Pre Randomization - Pre Intervention||49
8168236|NCT02469077|20138151|P1|Pre Intervention Morpine|Pre Randomization - Pre Intervention||44
8168237|NCT02469077|20138150|P2|Pre Intervention Placebo|Pre Randomization - Pre Intervention||49
8168238|NCT02469077|20138151|P1|Pre Intervention Placebo|Pre Randomization - Pre Intervention||44
8168239|NCT02469077|20138150|P2|STARTED|Pre Randomization - Pre Intervention||49
8168240|NCT02469077|20138151|P1|STARTED|Pre Randomization - Pre Intervention||44
8168241|NCT02469064|20138183|P2|NOT COMPLETED|Overall Study||3
8168242|NCT02469064|20138184|P1|NOT COMPLETED|Overall Study||1
8168243|NCT02469064|20138183|P2|COMPLETED|Overall Study||59
8168244|NCT02469064|20138184|P1|COMPLETED|Overall Study||63
8168245|NCT02469064|20138183|P2|STARTED|Overall Study||62
8168246|NCT02469064|20138184|P1|STARTED|Overall Study||64
8168247|NCT02469038|20138194|P2|NOT COMPLETED|Overall Study||5
8168248|NCT02469038|20138195|P1|NOT COMPLETED|Overall Study||4
8168249|NCT02469038|20138194|P2|COMPLETED|Overall Study||19
8168250|NCT02469038|20138195|P1|COMPLETED|Overall Study||22
8168251|NCT02469038|20138194|P2|STARTED|Overall Study||24
8168252|NCT02469038|20138195|P1|STARTED|Overall Study||26
8168253|NCT02468934|20138213|P1|NOT COMPLETED|Overall Study||7
8168254|NCT02468934|20138213|P1|COMPLETED|Overall Study||20
8168255|NCT02468934|20138213|P1|Underwent Total Knee Arthroplasty|Overall Study||20
8168256|NCT02468934|20138213|P1|Enrolled/Received Leads|Overall Study||24
8168257|NCT02468934|20138213|P1|STARTED|Overall Study||27
8168258|NCT02468830|20138232|P1|NOT COMPLETED|Overall Study||3
8168259|NCT02468830|20138232|P1|COMPLETED|Overall Study||55
8168260|NCT02468830|20138232|P1|STARTED|Overall Study||58
8168261|NCT02468700|20138242|P2|NOT COMPLETED|Overall Study||2
8168262|NCT02468700|20138243|P1|NOT COMPLETED|Overall Study||2
8168263|NCT02468700|20138242|P2|COMPLETED|Overall Study||19
8168264|NCT02468700|20138243|P1|COMPLETED|Overall Study||20
8168265|NCT02468700|20138242|P2|STARTED|Overall Study||21
8168266|NCT02468700|20138243|P1|STARTED|Overall Study||22
8168267|NCT02468674|20138264|P9|NOT COMPLETED|Overall Study||3
8168268|NCT02468674|20138265|P8|NOT COMPLETED|Overall Study||4
8168269|NCT02468674|20138266|P7|NOT COMPLETED|Overall Study||1
8168270|NCT02468674|20138267|P6|NOT COMPLETED|Overall Study||1
8168271|NCT02468674|20138268|P5|NOT COMPLETED|Overall Study||1
8168272|NCT02468674|20138269|P4|NOT COMPLETED|Overall Study||1
8168273|NCT02468674|20138270|P3|NOT COMPLETED|Overall Study||0
8168274|NCT02468674|20138271|P2|NOT COMPLETED|Overall Study||0
8168275|NCT02468674|20138272|P1|NOT COMPLETED|Overall Study||1
8168276|NCT02468674|20138264|P9|COMPLETED|Overall Study||40
8168277|NCT02468674|20138265|P8|COMPLETED|Overall Study||65
8168278|NCT02468674|20138266|P7|COMPLETED|Overall Study||14
8168279|NCT02468674|20138267|P6|COMPLETED|Overall Study||6
8168280|NCT02468674|20138268|P5|COMPLETED|Overall Study||6
8168281|NCT02468674|20138269|P4|COMPLETED|Overall Study||3
8168282|NCT02468674|20138270|P3|COMPLETED|Overall Study||5
8168283|NCT02468674|20138271|P2|COMPLETED|Overall Study||5
8168284|NCT02468674|20138272|P1|COMPLETED|Overall Study||4
8168285|NCT02468674|20138264|P9|STARTED|Overall Study||43
8168286|NCT02468674|20138265|P8|STARTED|Overall Study||69
8168287|NCT02468674|20138266|P7|STARTED|Overall Study||15
8168288|NCT02468674|20138267|P6|STARTED|Overall Study||7
8168289|NCT02468674|20138268|P5|STARTED|Overall Study||7
8168290|NCT02468674|20138269|P4|STARTED|Overall Study||4
8168291|NCT02468674|20138270|P3|STARTED|Overall Study||5
8168292|NCT02468674|20138271|P2|STARTED|Overall Study||5
8168293|NCT02468674|20138272|P1|STARTED|Overall Study||5
8168294|NCT02468648|20138328|P1|NOT COMPLETED|Overall Study||1
8168295|NCT02468648|20138328|P1|COMPLETED|Overall Study||71
8168296|NCT02468648|20138328|P1|STARTED|Overall Study||72
8168297|NCT02468583|20138337|P2|NOT COMPLETED|Overall Study||0
8168298|NCT02468583|20138338|P1|NOT COMPLETED|Overall Study||0
8168299|NCT02468583|20138337|P2|COMPLETED|Overall Study||3
8168300|NCT02468583|20138338|P1|COMPLETED|Overall Study||3
8168301|NCT02468583|20138337|P2|STARTED|Overall Study||3
8168302|NCT02468583|20138338|P1|STARTED|Overall Study||3
8168303|NCT02468570|20138376|P2|NOT COMPLETED|Overall Study||0
8168304|NCT02468570|20138377|P1|NOT COMPLETED|Overall Study||0
8168305|NCT02468570|20138376|P2|COMPLETED|Overall Study||3
8168306|NCT02468570|20138377|P1|COMPLETED|Overall Study||6
8168307|NCT02468570|20138376|P2|STARTED|Overall Study||3
8168308|NCT02468570|20138377|P1|STARTED|Overall Study||6
8168309|NCT02468414|20138395|P2|NOT COMPLETED|Overall Study||0
8168310|NCT02468414|20138396|P1|NOT COMPLETED|Overall Study||3
8168311|NCT02468414|20138395|P2|COMPLETED|Overall Study||0
8168312|NCT02468414|20138396|P1|COMPLETED|Overall Study||0
8168313|NCT02468414|20138395|P2|Safety Follow-up|Overall Study||0
8168314|NCT02468414|20138396|P1|Safety Follow-up|Overall Study||0
8168315|NCT02468414|20138395|P2|Implantation|Overall Study||0
8168316|NCT02468414|20138396|P1|Implantation|Overall Study||1
8168317|NCT02468414|20138395|P2|Harvesting|Overall Study||0
8168318|NCT02468414|20138396|P1|Harvesting|Overall Study||1
8168319|NCT02468414|20138395|P2|Successfully Screened|Overall Study||0
8168320|NCT02468414|20138396|P1|Successfully Screened|Overall Study||2
8168321|NCT02468414|20138395|P2|STARTED|Overall Study||0
8168322|NCT02468414|20138396|P1|STARTED|Overall Study||3
8168323|NCT02468193|20138402|P1|NOT COMPLETED|Overall Study||6
8168324|NCT02468193|20138402|P1|COMPLETED|Overall Study||3
8168325|NCT02468193|20138402|P1|Discontinued Study in Optional Ext. Per.|Overall Study||2
8168326|NCT02468193|20138402|P1|Completed Optional Extension Period|Overall Study||0
8168327|NCT02468193|20138402|P1|Compl. Wk-48, Entered Opt. Ext. Period|Overall Study||2
8168328|NCT02468193|20138402|P1|Compl. Wk-48, Didn't Enter Opt. Ext. Per|Overall Study||0
8168329|NCT02468193|20138402|P1|Discontinued at or Prior to Week48|Overall Study||2
8168330|NCT02468193|20138402|P1|Completed Week-48 (Study Period II)|Overall Study||2
8168331|NCT02468193|20138402|P1|Completed Week-12, Entered Study Per. II|Overall Study||4
8168332|NCT02468193|20138402|P1|Completed Week-12, Did Not Enter Per. II|Overall Study||3
8168333|NCT02468193|20138402|P1|Discontinued at or Prior to Week-12|Overall Study||2
8168334|NCT02468193|20138402|P1|Completed Week-12 (Study Period I)|Overall Study||7
8168335|NCT02468193|20138402|P1|STARTED|Overall Study||9
8168336|NCT02468154|20138496|P2|NOT COMPLETED|Overall Study||0
8168337|NCT02468154|20138497|P1|NOT COMPLETED|Overall Study||0
8168338|NCT02468154|20138496|P2|COMPLETED|Overall Study||28
8168339|NCT02468154|20138497|P1|COMPLETED|Overall Study||29
8168340|NCT02468154|20138496|P2|STARTED|Overall Study||28
8168341|NCT02468154|20138497|P1|STARTED|Overall Study||29
8168342|NCT02467842|20138512|P3|NOT COMPLETED|Overall Study||0
8168343|NCT02467842|20138513|P2|NOT COMPLETED|Overall Study||0
8168344|NCT02467842|20138514|P1|NOT COMPLETED|Overall Study||0
8168345|NCT02467842|20138512|P3|COMPLETED|Overall Study||378
8168346|NCT02467842|20138513|P2|COMPLETED|Overall Study||373
8168347|NCT02467842|20138514|P1|COMPLETED|Overall Study||752
8168348|NCT02467842|20138512|P3|STARTED|Overall Study||378
8168349|NCT02467842|20138513|P2|STARTED|Overall Study||373
8168350|NCT02467842|20138514|P1|STARTED|Overall Study||752
8168351|NCT02467777|20138539|P2|NOT COMPLETED|Overall Study||0
8168352|NCT02467777|20138540|P1|NOT COMPLETED|Overall Study||0
8168353|NCT02467777|20138539|P2|COMPLETED|Overall Study||27
8168354|NCT02467777|20138540|P1|COMPLETED|Overall Study||23
8168355|NCT02467777|20138539|P2|STARTED|Overall Study||27
8168356|NCT02467777|20138540|P1|STARTED|Overall Study||23
8168357|NCT02467621|20138548|P2|NOT COMPLETED|Overall Study||6
8168358|NCT02467621|20138549|P1|NOT COMPLETED|Overall Study||1
8168359|NCT02467621|20138548|P2|COMPLETED|Overall Study||1647
8168360|NCT02467621|20138549|P1|COMPLETED|Overall Study||1644
8168361|NCT02467621|20138548|P2|STARTED|Overall Study||1653
8168362|NCT02467621|20138549|P1|STARTED|Overall Study||1645
8168363|NCT02467504|20138569|P2|NOT COMPLETED|Overall Study||1
8168364|NCT02467504|20138570|P1|NOT COMPLETED|Overall Study||6
8168365|NCT02467504|20138569|P2|COMPLETED|Overall Study||23
8168366|NCT02467504|20138570|P1|COMPLETED|Overall Study||17
8168367|NCT02467504|20138569|P2|STARTED|Overall Study||24
8168368|NCT02467504|20138570|P1|STARTED|Overall Study||23
8168369|NCT02467491|20138614|P1|NOT COMPLETED|Overall Study||0
8168370|NCT02467491|20138614|P1|COMPLETED|Overall Study||12
8168371|NCT02467491|20138614|P1|STARTED|Overall Study||12
8168372|NCT02467465|20138625|P2|NOT COMPLETED|Overall Study||0
8168373|NCT02467465|20138626|P1|NOT COMPLETED|Overall Study||0
8168374|NCT02467465|20138625|P2|COMPLETED|Overall Study||15
8168375|NCT02467465|20138626|P1|COMPLETED|Overall Study||15
8168376|NCT02467465|20138625|P2|STARTED|Overall Study||15
8168377|NCT02467465|20138626|P1|STARTED|Overall Study||15
8168378|NCT02467387|20138670|P2|NOT COMPLETED|Second Intervention||0
8168379|NCT02467387|20138671|P1|NOT COMPLETED|Second Intervention||3
8168380|NCT02467387|20138670|P2|COMPLETED|Second Intervention||12
8168381|NCT02467387|20138671|P1|COMPLETED|Second Intervention||7
8168382|NCT02467387|20138670|P2|STARTED|Second Intervention||12
8168383|NCT02467387|20138671|P1|STARTED|Second Intervention||10
8168384|NCT02467387|20138670|P2|NOT COMPLETED|First Intervention||0
8168385|NCT02467387|20138671|P1|NOT COMPLETED|First Intervention||1
8168386|NCT02467387|20138670|P2|COMPLETED|First Intervention||12
8168387|NCT02467387|20138671|P1|COMPLETED|First Intervention||10
8168388|NCT02467387|20138670|P2|Received Treatment as Randomized|First Intervention||12
8168389|NCT02467387|20138671|P1|Received Treatment as Randomized|First Intervention||10
8168390|NCT02467387|20138670|P2|STARTED|First Intervention||12
8168391|NCT02467387|20138671|P1|STARTED|First Intervention||11
8168392|NCT02467179|20138681|P2|NOT COMPLETED|Overall Study||0
8168393|NCT02467179|20138682|P1|NOT COMPLETED|Overall Study||0
8168394|NCT02467179|20138681|P2|COMPLETED|Overall Study||25
8168395|NCT02467179|20138682|P1|COMPLETED|Overall Study||25
8168396|NCT02467179|20138681|P2|STARTED|Overall Study||25
8168397|NCT02467179|20138682|P1|STARTED|Overall Study||25
8168398|NCT02467075|20138692|P2|NOT COMPLETED|30 Day Follow-up||0
8168399|NCT02467075|20138693|P1|NOT COMPLETED|30 Day Follow-up||0
8168400|NCT02467075|20138692|P2|COMPLETED|30 Day Follow-up||1
8168401|NCT02467075|20138693|P1|COMPLETED|30 Day Follow-up||0
8168402|NCT02467075|20138692|P2|STARTED|30 Day Follow-up||1
8168403|NCT02467075|20138693|P1|STARTED|30 Day Follow-up||0
8168404|NCT02467075|20138692|P2|NOT COMPLETED|72 Hour Follow-up||0
8168405|NCT02467075|20138693|P1|NOT COMPLETED|72 Hour Follow-up||0
8168406|NCT02467075|20138692|P2|COMPLETED|72 Hour Follow-up||1
8168407|NCT02467075|20138693|P1|COMPLETED|72 Hour Follow-up||0
8168408|NCT02467075|20138692|P2|STARTED|72 Hour Follow-up||1
8168409|NCT02467075|20138693|P1|STARTED|72 Hour Follow-up||0
8168410|NCT02467075|20138692|P2|NOT COMPLETED|48 Hour Follow-up||0
8168411|NCT02467075|20138693|P1|NOT COMPLETED|48 Hour Follow-up||0
8168412|NCT02467075|20138692|P2|COMPLETED|48 Hour Follow-up||1
8168413|NCT02467075|20138693|P1|COMPLETED|48 Hour Follow-up||0
8168414|NCT02467075|20138692|P2|STARTED|48 Hour Follow-up||1
8168415|NCT02467075|20138693|P1|STARTED|48 Hour Follow-up||0
8168416|NCT02467075|20138692|P2|NOT COMPLETED|Initial CT Scan||0
8168417|NCT02467075|20138693|P1|NOT COMPLETED|Initial CT Scan||0
8168418|NCT02467075|20138692|P2|COMPLETED|Initial CT Scan||1
8168419|NCT02467075|20138693|P1|COMPLETED|Initial CT Scan||0
8168420|NCT02467075|20138692|P2|STARTED|Initial CT Scan||1
8168421|NCT02467075|20138693|P1|STARTED|Initial CT Scan||0
8168422|NCT02466958|20138711|P2|NOT COMPLETED|Overall Study||3
8168423|NCT02466958|20138712|P1|NOT COMPLETED|Overall Study||10
8168424|NCT02466958|20138711|P2|COMPLETED|Overall Study||9
8168425|NCT02466958|20138712|P1|COMPLETED|Overall Study||7
8168426|NCT02466958|20138711|P2|STARTED|Overall Study||12
8168427|NCT02466958|20138712|P1|STARTED|Overall Study||17
8168428|NCT02466659|20138724|P2|NOT COMPLETED|Overall Study||2
8168429|NCT02466659|20138725|P1|NOT COMPLETED|Overall Study||5
8168430|NCT02466659|20138724|P2|COMPLETED|Overall Study||1
8168431|NCT02466659|20138725|P1|COMPLETED|Overall Study||0
8168432|NCT02466659|20138724|P2|STARTED|Overall Study||3
8168433|NCT02466659|20138725|P1|STARTED|Overall Study||5
8168434|NCT02466646|20138736|P3|NOT COMPLETED|Overall Study||0
8168435|NCT02466646|20138737|P2|NOT COMPLETED|Overall Study||0
8168436|NCT02466646|20138738|P1|NOT COMPLETED|Overall Study||0
8168437|NCT02466646|20138736|P3|COMPLETED|Overall Study||14
8168438|NCT02466646|20138737|P2|COMPLETED|Overall Study||14
8168439|NCT02466646|20138738|P1|COMPLETED|Overall Study||14
8168440|NCT02466646|20138736|P3|STARTED|Overall Study||14
8168441|NCT02466646|20138737|P2|STARTED|Overall Study||14
8168442|NCT02466646|20138738|P1|STARTED|Overall Study||14
8168443|NCT02466555|20138779|P1|NOT COMPLETED|Overall Study||2
8168444|NCT02466555|20138779|P1|COMPLETED|Overall Study||28
8168445|NCT02466555|20138779|P1|STARTED|Overall Study||30
8168446|NCT02466516|20138791|P5|NOT COMPLETED|Overall Study||0
8168447|NCT02466516|20138792|P4|NOT COMPLETED|Overall Study||0
8168448|NCT02466516|20138793|P3|NOT COMPLETED|Overall Study||1
8168449|NCT02466516|20138794|P2|NOT COMPLETED|Overall Study||1
8168450|NCT02466516|20138795|P1|NOT COMPLETED|Overall Study||4
8168451|NCT02466516|20138791|P5|COMPLETED|Overall Study||10
8168452|NCT02466516|20138792|P4|COMPLETED|Overall Study||10
8168453|NCT02466516|20138793|P3|COMPLETED|Overall Study||9
8168454|NCT02466516|20138794|P2|COMPLETED|Overall Study||21
8168455|NCT02466516|20138795|P1|COMPLETED|Overall Study||16
8168456|NCT02466516|20138791|P5|STARTED|Overall Study||10
8168457|NCT02466516|20138792|P4|STARTED|Overall Study||10
8168458|NCT02466516|20138793|P3|STARTED|Overall Study||10
8168459|NCT02466516|20138794|P2|STARTED|Overall Study||22
8168460|NCT02466516|20138795|P1|STARTED|Overall Study||20
8168469|NCT02466412|20138825|P2|NOT COMPLETED|Second Intervention (Day 3)||0
8168470|NCT02466412|20138826|P1|NOT COMPLETED|Second Intervention (Day 3)||0
8168471|NCT02466412|20138825|P2|COMPLETED|Second Intervention (Day 3)||24
8168472|NCT02466412|20138826|P1|COMPLETED|Second Intervention (Day 3)||24
8168473|NCT02466412|20138825|P2|STARTED|Second Intervention (Day 3)||24
8168474|NCT02466412|20138826|P1|STARTED|Second Intervention (Day 3)||24
8168475|NCT02466412|20138825|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8168476|NCT02466412|20138826|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8168477|NCT02466412|20138825|P2|COMPLETED|Washout Period of 1 Day (Day 2)||24
8168478|NCT02466412|20138826|P1|COMPLETED|Washout Period of 1 Day (Day 2)||24
8168479|NCT02466412|20138825|P2|STARTED|Washout Period of 1 Day (Day 2)||24
8168480|NCT02466412|20138826|P1|STARTED|Washout Period of 1 Day (Day 2)||24
8168481|NCT02466412|20138825|P2|NOT COMPLETED|First Intervention (Day 1)||0
8168482|NCT02466412|20138826|P1|NOT COMPLETED|First Intervention (Day 1)||0
8168483|NCT02466412|20138825|P2|COMPLETED|First Intervention (Day 1)||24
8168484|NCT02466412|20138826|P1|COMPLETED|First Intervention (Day 1)||24
8168485|NCT02466412|20138825|P2|STARTED|First Intervention (Day 1)||24
8168486|NCT02466412|20138826|P1|STARTED|First Intervention (Day 1)||24
8168487|NCT02466412|20138825|P2|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
8168488|NCT02466412|20138826|P1|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
8168489|NCT02466412|20138825|P2|COMPLETED|Washout Period of 1 Day (Day -1)||24
8168490|NCT02466412|20138826|P1|COMPLETED|Washout Period of 1 Day (Day -1)||24
8168491|NCT02466412|20138825|P2|STARTED|Washout Period of 1 Day (Day -1)||24
8168492|NCT02466412|20138826|P1|STARTED|Washout Period of 1 Day (Day -1)||24
8168493|NCT02466399|20138837|P2|NOT COMPLETED|Overall Study||0
8168494|NCT02466399|20138838|P1|NOT COMPLETED|Overall Study||2
8168495|NCT02466399|20138837|P2|COMPLETED|Overall Study||27
8168496|NCT02466399|20138838|P1|COMPLETED|Overall Study||51
8168497|NCT02466399|20138837|P2|STARTED|Overall Study||27
8168498|NCT02466399|20138838|P1|STARTED|Overall Study||53
8168499|NCT02466230|20138844|P1|NOT COMPLETED|Overall Study||0
8168500|NCT02466230|20138844|P1|COMPLETED|Overall Study||28
8168501|NCT02466230|20138844|P1|STARTED|Overall Study||28
8168502|NCT02466087|20138849|P2|NOT COMPLETED|Second Intervention: Weeks 7-12||0
8168503|NCT02466087|20138850|P1|NOT COMPLETED|Second Intervention: Weeks 7-12||0
8168504|NCT02466087|20138849|P2|COMPLETED|Second Intervention: Weeks 7-12||57
8168505|NCT02466087|20138850|P1|COMPLETED|Second Intervention: Weeks 7-12||55
8168506|NCT02466087|20138849|P2|STARTED|Second Intervention: Weeks 7-12||57
8168507|NCT02466087|20138850|P1|STARTED|Second Intervention: Weeks 7-12||55
8168508|NCT02466087|20138849|P2|NOT COMPLETED|First Intervention: Weeks 1-6||7
8168509|NCT02466087|20138850|P1|NOT COMPLETED|First Intervention: Weeks 1-6||7
8168510|NCT02466087|20138849|P2|COMPLETED|First Intervention: Weeks 1-6||57
8168511|NCT02466087|20138850|P1|COMPLETED|First Intervention: Weeks 1-6||55
8168512|NCT02466087|20138849|P2|STARTED|First Intervention: Weeks 1-6||64
8168513|NCT02466087|20138850|P1|STARTED|First Intervention: Weeks 1-6||62
8168514|NCT02465931|20138862|P2|NOT COMPLETED|Overall Study||11
8168515|NCT02465931|20138863|P1|NOT COMPLETED|Overall Study||11
8168516|NCT02465931|20138862|P2|COMPLETED|Overall Study||45
8168517|NCT02465931|20138863|P1|COMPLETED|Overall Study||44
8168518|NCT02465931|20138862|P2|STARTED|Overall Study||56
8168519|NCT02465931|20138863|P1|STARTED|Overall Study||55
8168520|NCT02465866|20138869|P4|NOT COMPLETED|Period 4: Washout (14 Days)||0
8168521|NCT02465866|20138870|P3|NOT COMPLETED|Period 4: Washout (14 Days)||0
8168522|NCT02465866|20138871|P2|NOT COMPLETED|Period 4: Washout (14 Days)||0
8168523|NCT02465866|20138872|P1|NOT COMPLETED|Period 4: Washout (14 Days)||0
8168524|NCT02465866|20138869|P4|COMPLETED|Period 4: Washout (14 Days)||5
8168525|NCT02465866|20138870|P3|COMPLETED|Period 4: Washout (14 Days)||5
8168526|NCT02465866|20138871|P2|COMPLETED|Period 4: Washout (14 Days)||4
8168527|NCT02465866|20138872|P1|COMPLETED|Period 4: Washout (14 Days)||5
8168528|NCT02465866|20138869|P4|STARTED|Period 4: Washout (14 Days)||5
8168529|NCT02465866|20138870|P3|STARTED|Period 4: Washout (14 Days)||5
8168530|NCT02465866|20138871|P2|STARTED|Period 4: Washout (14 Days)||4
8168531|NCT02465866|20138872|P1|STARTED|Period 4: Washout (14 Days)||5
8168532|NCT02465866|20138869|P4|NOT COMPLETED|Period 4||0
8168533|NCT02465866|20138870|P3|NOT COMPLETED|Period 4||0
8168534|NCT02465866|20138871|P2|NOT COMPLETED|Period 4||0
8168535|NCT02465866|20138872|P1|NOT COMPLETED|Period 4||0
8168536|NCT02465866|20138869|P4|COMPLETED|Period 4||5
8168537|NCT02465866|20138870|P3|COMPLETED|Period 4||5
8168538|NCT02465866|20138871|P2|COMPLETED|Period 4||4
8168539|NCT02465866|20138872|P1|COMPLETED|Period 4||5
8168540|NCT02465866|20138869|P4|STARTED|Period 4||5
8168541|NCT02465866|20138870|P3|STARTED|Period 4||5
8168542|NCT02465866|20138871|P2|STARTED|Period 4||4
8168543|NCT02465866|20138872|P1|STARTED|Period 4||5
8168544|NCT02465866|20138869|P4|NOT COMPLETED|Period 3: Washout (14 Days)||0
8168545|NCT02465866|20138870|P3|NOT COMPLETED|Period 3: Washout (14 Days)||0
8168546|NCT02465866|20138871|P2|NOT COMPLETED|Period 3: Washout (14 Days)||0
8168547|NCT02465866|20138872|P1|NOT COMPLETED|Period 3: Washout (14 Days)||0
8168548|NCT02465866|20138869|P4|COMPLETED|Period 3: Washout (14 Days)||5
8168549|NCT02465866|20138870|P3|COMPLETED|Period 3: Washout (14 Days)||5
8168550|NCT02465866|20138871|P2|COMPLETED|Period 3: Washout (14 Days)||4
8168551|NCT02465866|20138872|P1|COMPLETED|Period 3: Washout (14 Days)||5
8168552|NCT02465866|20138869|P4|STARTED|Period 3: Washout (14 Days)||5
8168553|NCT02465866|20138870|P3|STARTED|Period 3: Washout (14 Days)||5
8168554|NCT02465866|20138871|P2|STARTED|Period 3: Washout (14 Days)||4
8168555|NCT02465866|20138872|P1|STARTED|Period 3: Washout (14 Days)||5
8168556|NCT02465866|20138869|P4|NOT COMPLETED|Period 3||0
8168557|NCT02465866|20138870|P3|NOT COMPLETED|Period 3||0
8168558|NCT02465866|20138871|P2|NOT COMPLETED|Period 3||1
8168559|NCT02465866|20138872|P1|NOT COMPLETED|Period 3||0
8168560|NCT02465866|20138869|P4|COMPLETED|Period 3||5
8168561|NCT02465866|20138870|P3|COMPLETED|Period 3||5
8168562|NCT02465866|20138871|P2|COMPLETED|Period 3||4
8168563|NCT02465866|20138872|P1|COMPLETED|Period 3||5
8168564|NCT02465866|20138869|P4|STARTED|Period 3||5
8168565|NCT02465866|20138870|P3|STARTED|Period 3||5
8168566|NCT02465866|20138871|P2|STARTED|Period 3||5
8168567|NCT02465866|20138872|P1|STARTED|Period 3||5
8168568|NCT02465866|20138869|P4|NOT COMPLETED|Period 2: Washout (14 Days)||0
8168569|NCT02465866|20138870|P3|NOT COMPLETED|Period 2: Washout (14 Days)||0
8168570|NCT02465866|20138871|P2|NOT COMPLETED|Period 2: Washout (14 Days)||0
8168571|NCT02465866|20138872|P1|NOT COMPLETED|Period 2: Washout (14 Days)||0
8168572|NCT02465866|20138869|P4|COMPLETED|Period 2: Washout (14 Days)||5
8168573|NCT02465866|20138870|P3|COMPLETED|Period 2: Washout (14 Days)||5
8168574|NCT02465866|20138871|P2|COMPLETED|Period 2: Washout (14 Days)||5
8168575|NCT02465866|20138872|P1|COMPLETED|Period 2: Washout (14 Days)||5
8168576|NCT02465866|20138869|P4|STARTED|Period 2: Washout (14 Days)||5
8168577|NCT02465866|20138870|P3|STARTED|Period 2: Washout (14 Days)||5
8168578|NCT02465866|20138871|P2|STARTED|Period 2: Washout (14 Days)||5
8168579|NCT02465866|20138872|P1|STARTED|Period 2: Washout (14 Days)||5
8168580|NCT02465866|20138869|P4|NOT COMPLETED|Period 2||0
8168581|NCT02465866|20138870|P3|NOT COMPLETED|Period 2||0
8168582|NCT02465866|20138871|P2|NOT COMPLETED|Period 2||0
8168583|NCT02465866|20138872|P1|NOT COMPLETED|Period 2||0
8168584|NCT02465866|20138869|P4|COMPLETED|Period 2||5
8168585|NCT02465866|20138870|P3|COMPLETED|Period 2||5
8168586|NCT02465866|20138871|P2|COMPLETED|Period 2||5
8168587|NCT02465866|20138872|P1|COMPLETED|Period 2||5
8168588|NCT02465866|20138869|P4|STARTED|Period 2||5
8168589|NCT02465866|20138870|P3|STARTED|Period 2||5
8168590|NCT02465866|20138871|P2|STARTED|Period 2||5
8168591|NCT02465866|20138872|P1|STARTED|Period 2||5
8168592|NCT02465866|20138869|P4|NOT COMPLETED|Period 1: Washout (14 Days)||0
8168593|NCT02465866|20138870|P3|NOT COMPLETED|Period 1: Washout (14 Days)||0
8168594|NCT02465866|20138871|P2|NOT COMPLETED|Period 1: Washout (14 Days)||0
8168595|NCT02465866|20138872|P1|NOT COMPLETED|Period 1: Washout (14 Days)||0
8168596|NCT02465866|20138869|P4|COMPLETED|Period 1: Washout (14 Days)||5
8168597|NCT02465866|20138870|P3|COMPLETED|Period 1: Washout (14 Days)||5
8168598|NCT02465866|20138871|P2|COMPLETED|Period 1: Washout (14 Days)||5
8168599|NCT02465866|20138872|P1|COMPLETED|Period 1: Washout (14 Days)||5
8168600|NCT02465866|20138869|P4|STARTED|Period 1: Washout (14 Days)||5
8168601|NCT02465866|20138870|P3|STARTED|Period 1: Washout (14 Days)||5
8168602|NCT02465866|20138871|P2|STARTED|Period 1: Washout (14 Days)||5
8168603|NCT02465866|20138872|P1|STARTED|Period 1: Washout (14 Days)||5
8168604|NCT02465866|20138869|P4|NOT COMPLETED|Period 1||0
8168605|NCT02465866|20138870|P3|NOT COMPLETED|Period 1||0
8168606|NCT02465866|20138871|P2|NOT COMPLETED|Period 1||0
8168607|NCT02465866|20138872|P1|NOT COMPLETED|Period 1||0
8168608|NCT02465866|20138869|P4|COMPLETED|Period 1||5
8168609|NCT02465866|20138870|P3|COMPLETED|Period 1||5
8168610|NCT02465866|20138871|P2|COMPLETED|Period 1||5
8168611|NCT02465866|20138872|P1|COMPLETED|Period 1||5
8168612|NCT02465866|20138869|P4|STARTED|Period 1||5
8168613|NCT02465866|20138870|P3|STARTED|Period 1||5
8168614|NCT02465866|20138871|P2|STARTED|Period 1||5
8168615|NCT02465866|20138872|P1|STARTED|Period 1||5
8168616|NCT02465632|20138945|P3|NOT COMPLETED|Overall Study||17
8168617|NCT02465632|20138946|P2|NOT COMPLETED|Overall Study||23
8168618|NCT02465632|20138947|P1|NOT COMPLETED|Overall Study||31
8168619|NCT02465632|20138945|P3|COMPLETED|Overall Study||203
8168620|NCT02465632|20138946|P2|COMPLETED|Overall Study||417
8168621|NCT02465632|20138947|P1|COMPLETED|Overall Study||409
8168622|NCT02465632|20138945|P3|STARTED|Overall Study||220
8168623|NCT02465632|20138946|P2|STARTED|Overall Study||440
8168624|NCT02465632|20138947|P1|STARTED|Overall Study||440
8168625|NCT02465528|20138962|P4|NOT COMPLETED|Overall Study||5
8168626|NCT02465528|20138963|P3|NOT COMPLETED|Overall Study||12
8168627|NCT02465528|20138964|P2|NOT COMPLETED|Overall Study||4
8168628|NCT02465528|20138965|P1|NOT COMPLETED|Overall Study||1
8168629|NCT02465528|20138962|P4|COMPLETED|Overall Study||0
8168630|NCT02465528|20138963|P3|COMPLETED|Overall Study||0
8168631|NCT02465528|20138964|P2|COMPLETED|Overall Study||0
8168632|NCT02465528|20138965|P1|COMPLETED|Overall Study||0
8168633|NCT02465528|20138962|P4|STARTED|Overall Study||5
8168634|NCT02465528|20138963|P3|STARTED|Overall Study||12
8168635|NCT02465528|20138964|P2|STARTED|Overall Study||4
8168636|NCT02465528|20138965|P1|STARTED|Overall Study||1
8168637|NCT02465515|20138998|P2|NOT COMPLETED|Overall Study||111
8168638|NCT02465515|20138999|P1|NOT COMPLETED|Overall Study||154
8168639|NCT02465515|20138998|P2|COMPLETED|Overall Study||4620
8168640|NCT02465515|20138999|P1|COMPLETED|Overall Study||4578
8168641|NCT02465515|20138998|P2|STARTED|Overall Study||4731
8168642|NCT02465515|20138999|P1|STARTED|Overall Study||4732
8168643|NCT02465489|20139045|P1|NOT COMPLETED|Overall Study||5
8168644|NCT02465489|20139045|P1|COMPLETED|Overall Study||15
8168645|NCT02465489|20139045|P1|STARTED|Overall Study||20
8168646|NCT02465463|20139074|P2|NOT COMPLETED|Overall Study||1
8168647|NCT02465463|20139075|P1|NOT COMPLETED|Overall Study||4
8168648|NCT02465463|20139074|P2|COMPLETED|Overall Study||4
8168649|NCT02465463|20139075|P1|COMPLETED|Overall Study||4
8168650|NCT02465463|20139074|P2|STARTED|Overall Study||5
8168651|NCT02465463|20139075|P1|STARTED|Overall Study||8
8168652|NCT02465450|20139094|P6|NOT COMPLETED|Treatment Period 2||0
8168653|NCT02465450|20139095|P5|NOT COMPLETED|Treatment Period 2||4
8168654|NCT02465450|20139096|P4|NOT COMPLETED|Treatment Period 2||3
8168655|NCT02465450|20139097|P3|NOT COMPLETED|Treatment Period 2||0
8168656|NCT02465450|20139098|P2|NOT COMPLETED|Treatment Period 2||0
8168657|NCT02465450|20139099|P1|NOT COMPLETED|Treatment Period 2||0
8168658|NCT02465450|20139094|P6|COMPLETED|Treatment Period 2||23
8168659|NCT02465450|20139095|P5|COMPLETED|Treatment Period 2||24
8168660|NCT02465450|20139096|P4|COMPLETED|Treatment Period 2||27
8168661|NCT02465450|20139097|P3|COMPLETED|Treatment Period 2||0
8168662|NCT02465450|20139098|P2|COMPLETED|Treatment Period 2||0
8168663|NCT02465450|20139099|P1|COMPLETED|Treatment Period 2||0
8168664|NCT02465450|20139094|P6|STARTED|Treatment Period 2||23
8168665|NCT02465450|20139095|P5|STARTED|Treatment Period 2||28
8168666|NCT02465450|20139096|P4|STARTED|Treatment Period 2||30
8168667|NCT02465450|20139097|P3|STARTED|Treatment Period 2||0
8168668|NCT02465450|20139098|P2|STARTED|Treatment Period 2||0
8168669|NCT02465450|20139099|P1|STARTED|Treatment Period 2||0
8168670|NCT02465450|20139094|P6|NOT COMPLETED|Treatment Period 1||0
8168671|NCT02465450|20139095|P5|NOT COMPLETED|Treatment Period 1||0
8168672|NCT02465450|20139096|P4|NOT COMPLETED|Treatment Period 1||0
8168673|NCT02465450|20139097|P3|NOT COMPLETED|Treatment Period 1||1
8168674|NCT02465450|20139098|P2|NOT COMPLETED|Treatment Period 1||1
8168675|NCT02465450|20139099|P1|NOT COMPLETED|Treatment Period 1||2
8168676|NCT02465450|20139094|P6|COMPLETED|Treatment Period 1||0
8168677|NCT02465450|20139095|P5|COMPLETED|Treatment Period 1||0
8168678|NCT02465450|20139096|P4|COMPLETED|Treatment Period 1||0
8168679|NCT02465450|20139097|P3|COMPLETED|Treatment Period 1||34
8168680|NCT02465450|20139098|P2|COMPLETED|Treatment Period 1||23
8168681|NCT02465450|20139099|P1|COMPLETED|Treatment Period 1||24
8168682|NCT02465450|20139094|P6|STARTED|Treatment Period 1||0
8168683|NCT02465450|20139095|P5|STARTED|Treatment Period 1||0
8168684|NCT02465450|20139096|P4|STARTED|Treatment Period 1||0
8168685|NCT02465450|20139097|P3|STARTED|Treatment Period 1||35
8168686|NCT02465450|20139098|P2|STARTED|Treatment Period 1||24
8168687|NCT02465450|20139099|P1|STARTED|Treatment Period 1||26
8168700|NCT02465372|20139146|P2|NOT COMPLETED|Overall Study||97
8168701|NCT02465372|20139147|P1|NOT COMPLETED|Overall Study||122
8168702|NCT02465372|20139146|P2|COMPLETED|Overall Study||153
8168703|NCT02465372|20139147|P1|COMPLETED|Overall Study||227
8168704|NCT02465372|20139146|P2|STARTED|Overall Study||250
8168705|NCT02465372|20139147|P1|STARTED|Overall Study||349
8168706|NCT02465216|20139162|P5|NOT COMPLETED|Overall Study||3
8168707|NCT02465216|20139163|P4|NOT COMPLETED|Overall Study||2
8168708|NCT02465216|20139164|P3|NOT COMPLETED|Overall Study||1
8168709|NCT02465216|20139165|P2|NOT COMPLETED|Overall Study||0
8168710|NCT02465216|20139166|P1|NOT COMPLETED|Overall Study||3
8168711|NCT02465216|20139162|P5|COMPLETED|Overall Study||9
8168712|NCT02465216|20139163|P4|COMPLETED|Overall Study||12
8168713|NCT02465216|20139164|P3|COMPLETED|Overall Study||13
8168714|NCT02465216|20139165|P2|COMPLETED|Overall Study||5
8168715|NCT02465216|20139166|P1|COMPLETED|Overall Study||12
8168716|NCT02465216|20139162|P5|STARTED|Overall Study||12
8168717|NCT02465216|20139163|P4|STARTED|Overall Study||14
8168718|NCT02465216|20139164|P3|STARTED|Overall Study||14
8168719|NCT02465216|20139165|P2|STARTED|Overall Study||5
8168720|NCT02465216|20139166|P1|STARTED|Overall Study||15
8168721|NCT02465203|20139186|P3|NOT COMPLETED|Overall Study||13
8168722|NCT02465203|20139187|P2|NOT COMPLETED|Overall Study||36
8168723|NCT02465203|20139188|P1|NOT COMPLETED|Overall Study||56
8168724|NCT02465203|20139186|P3|COMPLETED|Overall Study||0
8168725|NCT02465203|20139187|P2|COMPLETED|Overall Study||0
8168726|NCT02465203|20139188|P1|COMPLETED|Overall Study||0
8168727|NCT02465203|20139186|P3|STARTED|Overall Study||13
8168728|NCT02465203|20139187|P2|STARTED|Overall Study||36
8168729|NCT02465203|20139188|P1|STARTED|Overall Study||56
8168730|NCT02465099|20139201|P2|NOT COMPLETED|Overall Study||0
8168731|NCT02465099|20139202|P1|NOT COMPLETED|Overall Study||0
8168732|NCT02465099|20139201|P2|COMPLETED|Overall Study||19
8168733|NCT02465099|20139202|P1|COMPLETED|Overall Study||45
8168734|NCT02465099|20139201|P2|STARTED|Overall Study||19
8168735|NCT02465099|20139202|P1|STARTED|Overall Study||45
8168736|NCT02465073|20139211|P3|NOT COMPLETED|Overall Study||1
8168737|NCT02465073|20139212|P2|NOT COMPLETED|Overall Study||1
8168738|NCT02465073|20139213|P1|NOT COMPLETED|Overall Study||2
8168739|NCT02465073|20139211|P3|COMPLETED|Overall Study||15
8168740|NCT02465073|20139212|P2|COMPLETED|Overall Study||15
8168741|NCT02465073|20139213|P1|COMPLETED|Overall Study||15
8168742|NCT02465073|20139211|P3|STARTED|Overall Study||16
8168743|NCT02465073|20139212|P2|STARTED|Overall Study||16
8168744|NCT02465073|20139213|P1|STARTED|Overall Study||17
8168745|NCT02464917|20139223|P2|NOT COMPLETED|Overall Study||0
8168746|NCT02464917|20139224|P1|NOT COMPLETED|Overall Study||0
8168747|NCT02464917|20139223|P2|COMPLETED|Overall Study||35
8168748|NCT02464917|20139224|P1|COMPLETED|Overall Study||35
8168749|NCT02464917|20139223|P2|STARTED|Overall Study||35
8168750|NCT02464917|20139224|P1|STARTED|Overall Study||35
8168751|NCT02464540|20139250|P2|NOT COMPLETED|Overall Study||0
8168752|NCT02464540|20139251|P1|NOT COMPLETED|Overall Study||0
8168753|NCT02464540|20139250|P2|COMPLETED|Overall Study||11
8168754|NCT02464540|20139251|P1|COMPLETED|Overall Study||11
8168755|NCT02464540|20139250|P2|STARTED|Overall Study||11
8168756|NCT02464540|20139251|P1|STARTED|Overall Study||11
8168757|NCT02464176|20139260|P3|NOT COMPLETED|Overall Study||0
8168758|NCT02464176|20139261|P2|NOT COMPLETED|Overall Study||0
8168759|NCT02464176|20139262|P1|NOT COMPLETED|Overall Study||0
8168760|NCT02464176|20139260|P3|COMPLETED|Overall Study||15
8168761|NCT02464176|20139261|P2|COMPLETED|Overall Study||50
8168762|NCT02464176|20139262|P1|COMPLETED|Overall Study||50
8168763|NCT02464176|20139260|P3|STARTED|Overall Study||15
8168764|NCT02464176|20139261|P2|STARTED|Overall Study||50
8168765|NCT02464176|20139262|P1|STARTED|Overall Study||50
8168766|NCT02464163|20139283|P4|NOT COMPLETED|Overall Study||5
8168767|NCT02464163|20139284|P3|NOT COMPLETED|Overall Study||5
8168768|NCT02464163|20139285|P2|NOT COMPLETED|Overall Study||8
8168769|NCT02464163|20139286|P1|NOT COMPLETED|Overall Study||3
8168770|NCT02464163|20139283|P4|COMPLETED|Overall Study||96
8168771|NCT02464163|20139284|P3|COMPLETED|Overall Study||97
8168772|NCT02464163|20139285|P2|COMPLETED|Overall Study||94
8168773|NCT02464163|20139286|P1|COMPLETED|Overall Study||99
8168774|NCT02464163|20139283|P4|STARTED|Overall Study||101
8168775|NCT02464163|20139284|P3|STARTED|Overall Study||102
8168776|NCT02464163|20139285|P2|STARTED|Overall Study||102
8168777|NCT02464163|20139286|P1|STARTED|Overall Study||102
8168778|NCT02464059|20139308|P1|NOT COMPLETED|Overall Study||6
8168779|NCT02464059|20139308|P1|COMPLETED|Overall Study||17
8168780|NCT02464059|20139308|P1|STARTED|Overall Study||23
8168784|NCT02463981|20139345|P2|NOT COMPLETED|Overall Study||2
8168785|NCT02463981|20139346|P1|NOT COMPLETED|Overall Study||3
8168786|NCT02463981|20139345|P2|COMPLETED|Overall Study||14
8168787|NCT02463981|20139346|P1|COMPLETED|Overall Study||18
8168788|NCT02463981|20139345|P2|STARTED|Overall Study||16
8168789|NCT02463981|20139346|P1|STARTED|Overall Study||21
8168790|NCT02463487|20139356|P2|NOT COMPLETED|Overall Study||10
8168791|NCT02463487|20139357|P1|NOT COMPLETED|Overall Study||10
8168792|NCT02463487|20139356|P2|COMPLETED|Overall Study||65
8168793|NCT02463487|20139357|P1|COMPLETED|Overall Study||65
8168794|NCT02463487|20139356|P2|STARTED|Overall Study||75
8168795|NCT02463487|20139357|P1|STARTED|Overall Study||75
8168796|NCT02463409|20139367|P1|NOT COMPLETED|Overall Study||2
8168797|NCT02463409|20139367|P1|COMPLETED|Overall Study||4
8168798|NCT02463409|20139367|P1|STARTED|Overall Study||6
8168799|NCT02463331|20139375|P2|NOT COMPLETED|Overall Study||6
8168800|NCT02463331|20139376|P1|NOT COMPLETED|Overall Study||16
8168801|NCT02463331|20139375|P2|COMPLETED|Overall Study||25
8168802|NCT02463331|20139376|P1|COMPLETED|Overall Study||10
8168803|NCT02463331|20139375|P2|STARTED|Overall Study||31
8168804|NCT02463331|20139376|P1|STARTED|Overall Study||26
8168805|NCT02463227|20139384|P1|NOT COMPLETED|Overall Study||0
8168806|NCT02463227|20139384|P1|COMPLETED|Overall Study||14
8168807|NCT02463227|20139384|P1|STARTED|Overall Study||14
8168808|NCT02463097|20139392|P1|NOT COMPLETED|Overall Study||1
8168809|NCT02463097|20139392|P1|COMPLETED|Overall Study||123
8168810|NCT02463097|20139392|P1|STARTED|Overall Study||124
8168811|NCT02463071|20139401|P3|NOT COMPLETED|Overall Study||6
8168812|NCT02463071|20139402|P2|NOT COMPLETED|Overall Study||16
8168813|NCT02463071|20139403|P1|NOT COMPLETED|Overall Study||12
8168814|NCT02463071|20139401|P3|COMPLETED|Overall Study||71
8168815|NCT02463071|20139402|P2|COMPLETED|Overall Study||138
8168816|NCT02463071|20139403|P1|COMPLETED|Overall Study||140
8168817|NCT02463071|20139401|P3|STARTED|Overall Study||77
8168818|NCT02463071|20139402|P2|STARTED|Overall Study||154
8168819|NCT02463071|20139403|P1|STARTED|Overall Study||152
8168820|NCT02463032|20139431|P2|NOT COMPLETED|Overall Study||64
8168821|NCT02463032|20139432|P1|NOT COMPLETED|Overall Study||71
8168822|NCT02463032|20139431|P2|COMPLETED|Overall Study||0
8168823|NCT02463032|20139432|P1|COMPLETED|Overall Study||1
8168824|NCT02463032|20139431|P2|STARTED|Overall Study||64
8168825|NCT02463032|20139432|P1|STARTED|Overall Study||72
8168826|NCT02462967|20139453|P3|NOT COMPLETED|Overall Study||3
8168827|NCT02462967|20139454|P2|NOT COMPLETED|Overall Study||6
8168828|NCT02462967|20139455|P1|NOT COMPLETED|Overall Study||2
8168829|NCT02462967|20139453|P3|COMPLETED|Overall Study||51
8168830|NCT02462967|20139454|P2|COMPLETED|Overall Study||48
8168831|NCT02462967|20139455|P1|COMPLETED|Overall Study||52
8168832|NCT02462967|20139453|P3|STARTED|Overall Study||54
8168833|NCT02462967|20139454|P2|STARTED|Overall Study||54
8168834|NCT02462967|20139455|P1|STARTED|Overall Study||54
8168835|NCT02462928|20139484|P3|NOT COMPLETED|Overall Study||57
8168836|NCT02462928|20139485|P2|NOT COMPLETED|Overall Study||92
8168837|NCT02462928|20139486|P1|NOT COMPLETED|Overall Study||90
8168838|NCT02462928|20139484|P3|COMPLETED|Overall Study||255
8168839|NCT02462928|20139485|P2|COMPLETED|Overall Study||221
8168840|NCT02462928|20139486|P1|COMPLETED|Overall Study||224
8168841|NCT02462928|20139484|P3|STARTED|Overall Study||312
8168842|NCT02462928|20139485|P2|STARTED|Overall Study||313
8168843|NCT02462928|20139486|P1|STARTED|Overall Study||314
8168877|NCT02462486|20139580|P3|NOT COMPLETED|Overall Study||52
8168878|NCT02462486|20139581|P2|NOT COMPLETED|Overall Study||92
8168879|NCT02462486|20139582|P1|NOT COMPLETED|Overall Study||94
8168880|NCT02462486|20139580|P3|COMPLETED|Overall Study||266
8168881|NCT02462486|20139581|P2|COMPLETED|Overall Study||223
8168882|NCT02462486|20139582|P1|COMPLETED|Overall Study||222
8168883|NCT02462486|20139580|P3|STARTED|Overall Study||318
8168884|NCT02462486|20139581|P2|STARTED|Overall Study||315
8168885|NCT02462486|20139582|P1|STARTED|Overall Study||316
8168886|NCT02462473|20139602|P1|NOT COMPLETED|Overall Study||4
8168887|NCT02462473|20139602|P1|COMPLETED|Overall Study||5
8168888|NCT02462473|20139602|P1|STARTED|Overall Study||9
8168889|NCT02462382|20139615|P2|NOT COMPLETED|Overall Study||0
8168890|NCT02462382|20139616|P1|NOT COMPLETED|Overall Study||0
8168891|NCT02462382|20139615|P2|COMPLETED|Overall Study||27
8168892|NCT02462382|20139616|P1|COMPLETED|Overall Study||24
8168893|NCT02462382|20139615|P2|STARTED|Overall Study||27
8168894|NCT02462382|20139616|P1|STARTED|Overall Study||24
8168895|NCT02462291|20139630|P2|NOT COMPLETED|Overall Study||6
8168896|NCT02462291|20139631|P1|NOT COMPLETED|Overall Study||5
8168897|NCT02462291|20139630|P2|COMPLETED|Overall Study||75
8168898|NCT02462291|20139631|P1|COMPLETED|Overall Study||77
8168899|NCT02462291|20139630|P2|STARTED|Overall Study||81
8168900|NCT02462291|20139631|P1|STARTED|Overall Study||82
8168901|NCT02462148|20139672|P3|NOT COMPLETED|Overall Study||0
8168902|NCT02462148|20139673|P2|NOT COMPLETED|Overall Study||0
8168903|NCT02462148|20139674|P1|NOT COMPLETED|Overall Study||1
8168904|NCT02462148|20139672|P3|COMPLETED|Overall Study||12
8168905|NCT02462148|20139673|P2|COMPLETED|Overall Study||36
8168906|NCT02462148|20139674|P1|COMPLETED|Overall Study||36
8168907|NCT02462148|20139672|P3|STARTED|Overall Study||12
8168908|NCT02462148|20139673|P2|STARTED|Overall Study||36
8168909|NCT02462148|20139674|P1|STARTED|Overall Study||37
8168910|NCT02462122|20139699|P2|NOT COMPLETED|Overall Study||13
8168911|NCT02462122|20139700|P1|NOT COMPLETED|Overall Study||21
8168912|NCT02462122|20139699|P2|COMPLETED|Overall Study||61
8168913|NCT02462122|20139700|P1|COMPLETED|Overall Study||120
8168914|NCT02462122|20139699|P2|STARTED|Overall Study||74
8168915|NCT02462122|20139700|P1|STARTED|Overall Study||141
8168916|NCT02462083|20139708|P1|NOT COMPLETED|Overall Study||419
8168917|NCT02462083|20139708|P1|COMPLETED|Overall Study||136
8168918|NCT02462083|20139708|P1|Safety Population|Overall Study||550
8168919|NCT02462083|20139708|P1|STARTED|Overall Study||555
8168920|NCT02462070|20139714|P2|NOT COMPLETED|Overall Study||11
8168921|NCT02462070|20139715|P1|NOT COMPLETED|Overall Study||23
8168922|NCT02462070|20139714|P2|COMPLETED|Overall Study||57
8168923|NCT02462070|20139715|P1|COMPLETED|Overall Study||112
8168924|NCT02462070|20139714|P2|STARTED|Overall Study||68
8168925|NCT02462070|20139715|P1|STARTED|Overall Study||135
8168926|NCT02462057|20139728|P5|NOT COMPLETED|Overall Study||50
8168927|NCT02462057|20139729|P4|NOT COMPLETED|Overall Study||51
8168928|NCT02462057|20139730|P3|NOT COMPLETED|Overall Study||46
8168929|NCT02462057|20139731|P2|NOT COMPLETED|Overall Study||40
8168930|NCT02462057|20139732|P1|NOT COMPLETED|Overall Study||54
8168931|NCT02462057|20139728|P5|COMPLETED|Overall Study||708
8168932|NCT02462057|20139729|P4|COMPLETED|Overall Study||701
8168933|NCT02462057|20139730|P3|COMPLETED|Overall Study||766
8168934|NCT02462057|20139731|P2|COMPLETED|Overall Study||753
8168935|NCT02462057|20139732|P1|COMPLETED|Overall Study||737
8168936|NCT02462057|20139728|P5|STARTED|Overall Study||758
8168937|NCT02462057|20139729|P4|STARTED|Overall Study||752
8168938|NCT02462057|20139730|P3|STARTED|Overall Study||812
8168939|NCT02462057|20139731|P2|STARTED|Overall Study||793
8168940|NCT02462057|20139732|P1|STARTED|Overall Study||791
8168941|NCT02461992|20139744|P1|NOT COMPLETED|Overall Study||0
8168942|NCT02461992|20139744|P1|COMPLETED|Overall Study||13
8168943|NCT02461992|20139744|P1|STARTED|Overall Study||13
8168944|NCT02461966|20139764|P3|NOT COMPLETED|Overall Study||0
8168945|NCT02461966|20139765|P2|NOT COMPLETED|Overall Study||0
8168946|NCT02461966|20139766|P1|NOT COMPLETED|Overall Study||0
8168947|NCT02461966|20139764|P3|COMPLETED|Overall Study||60
8168948|NCT02461966|20139765|P2|COMPLETED|Overall Study||80
8168949|NCT02461966|20139766|P1|COMPLETED|Overall Study||160
8168950|NCT02461966|20139764|P3|STARTED|Overall Study||60
8168951|NCT02461966|20139765|P2|STARTED|Overall Study||80
8168952|NCT02461966|20139766|P1|STARTED|Overall Study||160
8168953|NCT02461771|20139777|P3|NOT COMPLETED|Overall Study||0
8168954|NCT02461771|20139778|P2|NOT COMPLETED|Overall Study||0
8168955|NCT02461771|20139779|P1|NOT COMPLETED|Overall Study||0
8168956|NCT02461771|20139777|P3|COMPLETED|Overall Study||7
8168957|NCT02461771|20139778|P2|COMPLETED|Overall Study||3
8168958|NCT02461771|20139779|P1|COMPLETED|Overall Study||3
8168959|NCT02461771|20139777|P3|STARTED|Overall Study||7
8168960|NCT02461771|20139778|P2|STARTED|Overall Study||3
8168961|NCT02461771|20139779|P1|STARTED|Overall Study||3
8168962|NCT02461758|20139818|P4|NOT COMPLETED|Overall Study||0
8168963|NCT02461758|20139819|P3|NOT COMPLETED|Overall Study||1
8168964|NCT02461758|20139820|P2|NOT COMPLETED|Overall Study||1
8168965|NCT02461758|20139821|P1|NOT COMPLETED|Overall Study||0
8168966|NCT02461758|20139818|P4|COMPLETED|Overall Study||15
8168967|NCT02461758|20139819|P3|COMPLETED|Overall Study||25
8168968|NCT02461758|20139820|P2|COMPLETED|Overall Study||19
8168969|NCT02461758|20139821|P1|COMPLETED|Overall Study||20
8168970|NCT02461758|20139818|P4|STARTED|Overall Study||15
8168971|NCT02461758|20139819|P3|STARTED|Overall Study||26
8168972|NCT02461758|20139820|P2|STARTED|Overall Study||20
8168973|NCT02461758|20139821|P1|STARTED|Overall Study||20
8168974|NCT02461745|20139847|P2|NOT COMPLETED|Overall Study||4
8168975|NCT02461745|20139848|P1|NOT COMPLETED|Overall Study||14
8168976|NCT02461745|20139847|P2|COMPLETED|Overall Study||66
8168977|NCT02461745|20139848|P1|COMPLETED|Overall Study||116
8168978|NCT02461745|20139847|P2|STARTED|Overall Study||70
8168979|NCT02461745|20139848|P1|STARTED|Overall Study||130
8168980|NCT02461693|20139858|P2|NOT COMPLETED|Overall Study||0
8168981|NCT02461693|20139859|P1|NOT COMPLETED|Overall Study||0
8168982|NCT02461693|20139858|P2|COMPLETED|Overall Study||102
8168983|NCT02461693|20139859|P1|COMPLETED|Overall Study||103
8168984|NCT02461693|20139858|P2|STARTED|Overall Study||102
8168985|NCT02461693|20139859|P1|STARTED|Overall Study||103
8168986|NCT02461628|20139873|P2|NOT COMPLETED|Overall Study||7
8168987|NCT02461628|20139874|P1|NOT COMPLETED|Overall Study||4
8168988|NCT02461628|20139873|P2|COMPLETED|Overall Study||3625
8168989|NCT02461628|20139874|P1|COMPLETED|Overall Study||3729
8168990|NCT02461628|20139873|P2|18 Month Survey|Overall Study||905
8168991|NCT02461628|20139874|P1|18 Month Survey|Overall Study||995
8168992|NCT02461628|20139873|P2|12 Month Survey|Overall Study||914
8168993|NCT02461628|20139874|P1|12 Month Survey|Overall Study||882
8168994|NCT02461628|20139873|P2|6 Month Survey|Overall Study||832
8168995|NCT02461628|20139874|P1|6 Month Survey|Overall Study||814
8168996|NCT02461628|20139873|P2|Baseline Survey|Overall Study||974
8168997|NCT02461628|20139874|P1|Baseline Survey|Overall Study||1038
8168998|NCT02461628|20139873|P2|STARTED|Overall Study||3632
8168999|NCT02461628|20139874|P1|STARTED|Overall Study||3733
8169000|NCT02461589|20139898|P10|NOT COMPLETED|Overall Study||5
8169001|NCT02461589|20139899|P9|NOT COMPLETED|Overall Study||6
8169002|NCT02461589|20139900|P8|NOT COMPLETED|Overall Study||5
8169003|NCT02461589|20139901|P7|NOT COMPLETED|Overall Study||6
8169004|NCT02461589|20139902|P6|NOT COMPLETED|Overall Study||3
8169005|NCT02461589|20139903|P5|NOT COMPLETED|Overall Study||2
8169006|NCT02461589|20139904|P4|NOT COMPLETED|Overall Study||5
8169007|NCT02461589|20139905|P3|NOT COMPLETED|Overall Study||5
8169008|NCT02461589|20139906|P2|NOT COMPLETED|Overall Study||2
8169009|NCT02461589|20139907|P1|NOT COMPLETED|Overall Study||6
8169010|NCT02461589|20139898|P10|COMPLETED|Overall Study||60
8169011|NCT02461589|20139899|P9|COMPLETED|Overall Study||123
8169012|NCT02461589|20139900|P8|COMPLETED|Overall Study||60
8169013|NCT02461589|20139901|P7|COMPLETED|Overall Study||58
8169014|NCT02461589|20139902|P6|COMPLETED|Overall Study||61
8169015|NCT02461589|20139903|P5|COMPLETED|Overall Study||62
8169016|NCT02461589|20139904|P4|COMPLETED|Overall Study||58
8169017|NCT02461589|20139905|P3|COMPLETED|Overall Study||60
8169018|NCT02461589|20139906|P2|COMPLETED|Overall Study||61
8169019|NCT02461589|20139907|P1|COMPLETED|Overall Study||58
8169020|NCT02461589|20139898|P10|Exposed|Overall Study||64
8169021|NCT02461589|20139899|P9|Exposed|Overall Study||129
8169022|NCT02461589|20139900|P8|Exposed|Overall Study||65
8169023|NCT02461589|20139901|P7|Exposed|Overall Study||64
8169024|NCT02461589|20139902|P6|Exposed|Overall Study||64
8169025|NCT02461589|20139903|P5|Exposed|Overall Study||64
8169026|NCT02461589|20139904|P4|Exposed|Overall Study||63
8169027|NCT02461589|20139905|P3|Exposed|Overall Study||65
8169028|NCT02461589|20139906|P2|Exposed|Overall Study||63
8169029|NCT02461589|20139907|P1|Exposed|Overall Study||64
8169030|NCT02461589|20139898|P10|STARTED|Overall Study||65
8169031|NCT02461589|20139899|P9|STARTED|Overall Study||129
8169032|NCT02461589|20139900|P8|STARTED|Overall Study||65
8169033|NCT02461589|20139901|P7|STARTED|Overall Study||64
8169034|NCT02461589|20139902|P6|STARTED|Overall Study||64
8169035|NCT02461589|20139903|P5|STARTED|Overall Study||64
8169036|NCT02461589|20139904|P4|STARTED|Overall Study||63
8169037|NCT02461589|20139905|P3|STARTED|Overall Study||65
8169038|NCT02461589|20139906|P2|STARTED|Overall Study||63
8169039|NCT02461589|20139907|P1|STARTED|Overall Study||64
8169040|NCT02461563|20139963|P4|NOT COMPLETED|Overall Study||0
8169041|NCT02461563|20139964|P3|NOT COMPLETED|Overall Study||0
8169042|NCT02461563|20139965|P2|NOT COMPLETED|Overall Study||0
8169043|NCT02461563|20139966|P1|NOT COMPLETED|Overall Study||0
8169044|NCT02461563|20139963|P4|COMPLETED|Overall Study||3
8169045|NCT02461563|20139964|P3|COMPLETED|Overall Study||3
8169046|NCT02461563|20139965|P2|COMPLETED|Overall Study||3
8169047|NCT02461563|20139966|P1|COMPLETED|Overall Study||3
8169048|NCT02461563|20139963|P4|STARTED|Overall Study||3
8169049|NCT02461563|20139964|P3|STARTED|Overall Study||3
8169050|NCT02461563|20139965|P2|STARTED|Overall Study||3
8169051|NCT02461563|20139966|P1|STARTED|Overall Study||3
8169052|NCT02461550|20140000|P1|NOT COMPLETED|Overall Study||0
8169053|NCT02461550|20140000|P1|COMPLETED|Overall Study||2
8169054|NCT02461550|20140000|P1|STARTED|Overall Study||2
8169055|NCT02461433|20140006|P2|NOT COMPLETED|Overall Study||0
8169056|NCT02461433|20140007|P1|NOT COMPLETED|Overall Study||0
8169057|NCT02461433|20140006|P2|COMPLETED|Overall Study||1
8169058|NCT02461433|20140007|P1|COMPLETED|Overall Study||1
8169059|NCT02461433|20140006|P2|STARTED|Overall Study||1
8169060|NCT02461433|20140007|P1|STARTED|Overall Study||1
8169061|NCT02461355|20140033|P1|NOT COMPLETED|Overall Study||0
8169062|NCT02461355|20140033|P1|COMPLETED|Overall Study||2
8169063|NCT02461355|20140033|P1|STARTED|Overall Study||2
8169064|NCT02461290|20140040|P1|NOT COMPLETED|Overall Study||10
8169065|NCT02461290|20140040|P1|COMPLETED|Overall Study||89
8169066|NCT02461290|20140040|P1|STARTED|Overall Study||99
8169067|NCT02461160|20140060|P13|NOT COMPLETED|Overall Study||0
8169068|NCT02461160|20140061|P12|NOT COMPLETED|Overall Study||0
8169069|NCT02461160|20140062|P11|NOT COMPLETED|Overall Study||0
8169070|NCT02461160|20140063|P10|NOT COMPLETED|Overall Study||0
8169071|NCT02461160|20140064|P9|NOT COMPLETED|Overall Study||0
8169072|NCT02461160|20140065|P8|NOT COMPLETED|Overall Study||1
8169073|NCT02461160|20140066|P7|NOT COMPLETED|Overall Study||0
8169074|NCT02461160|20140067|P6|NOT COMPLETED|Overall Study||0
8169075|NCT02461160|20140068|P5|NOT COMPLETED|Overall Study||0
8169076|NCT02461160|20140069|P4|NOT COMPLETED|Overall Study||0
8169077|NCT02461160|20140070|P3|NOT COMPLETED|Overall Study||0
8169078|NCT02461160|20140071|P2|NOT COMPLETED|Overall Study||0
8169079|NCT02461160|20140072|P1|NOT COMPLETED|Overall Study||0
8169080|NCT02461160|20140060|P13|COMPLETED|Overall Study||8
8169081|NCT02461160|20140061|P12|COMPLETED|Overall Study||4
8169082|NCT02461160|20140062|P11|COMPLETED|Overall Study||4
8169083|NCT02461160|20140063|P10|COMPLETED|Overall Study||4
8169084|NCT02461160|20140064|P9|COMPLETED|Overall Study||12
8169085|NCT02461160|20140065|P8|COMPLETED|Overall Study||5
8169086|NCT02461160|20140066|P7|COMPLETED|Overall Study||6
8169087|NCT02461160|20140067|P6|COMPLETED|Overall Study||6
8169088|NCT02461160|20140068|P5|COMPLETED|Overall Study||6
8169089|NCT02461160|20140069|P4|COMPLETED|Overall Study||12
8169090|NCT02461160|20140070|P3|COMPLETED|Overall Study||6
8169091|NCT02461160|20140071|P2|COMPLETED|Overall Study||6
8169092|NCT02461160|20140072|P1|COMPLETED|Overall Study||8
8169093|NCT02461160|20140060|P13|STARTED|Overall Study||8
8169094|NCT02461160|20140061|P12|STARTED|Overall Study||4
8169095|NCT02461160|20140062|P11|STARTED|Overall Study||4
8169096|NCT02461160|20140063|P10|STARTED|Overall Study||4
8169097|NCT02461160|20140064|P9|STARTED|Overall Study||12
8169098|NCT02461160|20140065|P8|STARTED|Overall Study||6
8169099|NCT02461160|20140066|P7|STARTED|Overall Study||6
8169100|NCT02461160|20140067|P6|STARTED|Overall Study||6
8169101|NCT02461160|20140068|P5|STARTED|Overall Study||6
8169102|NCT02461160|20140069|P4|STARTED|Overall Study||12
8169103|NCT02461160|20140070|P3|STARTED|Overall Study||6
8169104|NCT02461160|20140071|P2|STARTED|Overall Study||6
8169105|NCT02461160|20140072|P1|STARTED|Overall Study||8
8169106|NCT02461134|20140283|P1|NOT COMPLETED|Overall Study||1
8169107|NCT02461134|20140283|P1|COMPLETED|Overall Study||0
8169108|NCT02461134|20140283|P1|STARTED|Overall Study||1
8169115|NCT02460978|20140309|P3|NOT COMPLETED|Overall Study||33
8169116|NCT02460978|20140310|P2|NOT COMPLETED|Overall Study||25
8169117|NCT02460978|20140311|P1|NOT COMPLETED|Overall Study||27
8169118|NCT02460978|20140309|P3|COMPLETED|Overall Study||239
8169119|NCT02460978|20140310|P2|COMPLETED|Overall Study||245
8169120|NCT02460978|20140311|P1|COMPLETED|Overall Study||244
8169121|NCT02460978|20140309|P3|STARTED|Overall Study||272
8169122|NCT02460978|20140310|P2|STARTED|Overall Study||270
8169123|NCT02460978|20140311|P1|STARTED|Overall Study||271
8169124|NCT02460822|20140337|P1|NOT COMPLETED|Overall Study||1
8169125|NCT02460822|20140337|P1|COMPLETED|Overall Study||15
8169126|NCT02460822|20140337|P1|STARTED|Overall Study||16
8169127|NCT02460679|20140346|P1|NOT COMPLETED|Overall Study||5
8169128|NCT02460679|20140346|P1|COMPLETED|Overall Study||14
8169129|NCT02460679|20140346|P1|Received at Least 1 Dose of Study Drug|Overall Study||19
8169130|NCT02460679|20140346|P1|STARTED|Overall Study||19
8169131|NCT02460575|20140371|P2|NOT COMPLETED|Overall Study||0
8169132|NCT02460575|20140372|P1|NOT COMPLETED|Overall Study||1
8169133|NCT02460575|20140371|P2|COMPLETED|Overall Study||20
8169134|NCT02460575|20140372|P1|COMPLETED|Overall Study||39
8169135|NCT02460575|20140371|P2|STARTED|Overall Study||20
8169136|NCT02460575|20140372|P1|STARTED|Overall Study||40
8169137|NCT02460562|20140382|P2|NOT COMPLETED|Overall Study||16
8169138|NCT02460562|20140383|P1|NOT COMPLETED|Overall Study||15
8169139|NCT02460562|20140382|P2|COMPLETED|Overall Study||60
8169140|NCT02460562|20140383|P1|COMPLETED|Overall Study||59
8169141|NCT02460562|20140382|P2|STARTED|Overall Study||76
8169142|NCT02460562|20140383|P1|STARTED|Overall Study||74
8169143|NCT02460458|20140391|P1|NOT COMPLETED|Second Prospective Phase||152
8169144|NCT02460458|20140391|P1|COMPLETED|Second Prospective Phase|Information not available yet, anticipated date is december 2022|0
8169145|NCT02460458|20140391|P1|STARTED|Second Prospective Phase||152
8169146|NCT02460458|20140391|P1|NOT COMPLETED|Confirmation of Clinical Phase Data||9
8169147|NCT02460458|20140391|P1|COMPLETED|Confirmation of Clinical Phase Data||152
8169148|NCT02460458|20140391|P1|STARTED|Confirmation of Clinical Phase Data||161
8169149|NCT02460458|20140391|P1|NOT COMPLETED|First Prospective Phase||16
8169150|NCT02460458|20140391|P1|COMPLETED|First Prospective Phase||161
8169151|NCT02460458|20140391|P1|STARTED|First Prospective Phase||177
8169152|NCT02460458|20140391|P1|NOT COMPLETED|Confirmatory Phase||88
8169153|NCT02460458|20140391|P1|COMPLETED|Confirmatory Phase||177
8169154|NCT02460458|20140391|P1|STARTED|Confirmatory Phase||265
8169155|NCT02460458|20140391|P1|NOT COMPLETED|Retrospective Phase||0
8169156|NCT02460458|20140391|P1|COMPLETED|Retrospective Phase||265
8169157|NCT02460458|20140391|P1|STARTED|Retrospective Phase||265
8169158|NCT02460380|20140407|P2|NOT COMPLETED|Overall Study||5
8169159|NCT02460380|20140408|P1|NOT COMPLETED|Overall Study||10
8169160|NCT02460380|20140407|P2|COMPLETED|Overall Study||18
8169161|NCT02460380|20140408|P1|COMPLETED|Overall Study||35
8169162|NCT02460380|20140407|P2|STARTED|Overall Study||23
8169163|NCT02460380|20140408|P1|STARTED|Overall Study||45
8169164|NCT02460263|20140428|P1|NOT COMPLETED|In-Home Period||0
8169165|NCT02460263|20140428|P1|COMPLETED|In-Home Period||28
8169166|NCT02460263|20140428|P1|STARTED|In-Home Period||28
8169167|NCT02460263|20140428|P1|NOT COMPLETED|Transition Period||2
8169168|NCT02460263|20140428|P1|COMPLETED|Transition Period||28
8169169|NCT02460263|20140428|P1|STARTED|Transition Period||30
8169170|NCT02460263|20140428|P1|NOT COMPLETED|In-Center Period||0
8169171|NCT02460263|20140428|P1|COMPLETED|In-Center Period||30
8169172|NCT02460263|20140428|P1|STARTED|In-Center Period||30
8169179|NCT02460172|20140460|P1|NOT COMPLETED|Overall Study||0
8169180|NCT02460172|20140460|P1|COMPLETED|Overall Study||25
8169181|NCT02460172|20140460|P1|STARTED|Overall Study||25
8169182|NCT02460159|20140476|P2|NOT COMPLETED|Overall Study||1
8169183|NCT02460159|20140477|P1|NOT COMPLETED|Overall Study||6
8169184|NCT02460159|20140476|P2|COMPLETED|Overall Study||17
8169185|NCT02460159|20140477|P1|COMPLETED|Overall Study||111
8169186|NCT02460159|20140476|P2|STARTED|Overall Study||18
8169187|NCT02460159|20140477|P1|STARTED|Overall Study||117
8169188|NCT02459951|20140505|P1|NOT COMPLETED|Overall Study||1
8169189|NCT02459951|20140505|P1|COMPLETED|Overall Study||9
8169190|NCT02459951|20140505|P1|STARTED|Overall Study||10
8169191|NCT02459899|20140516|P4|NOT COMPLETED|Overall Study||2
8169192|NCT02459899|20140517|P3|NOT COMPLETED|Overall Study||0
8169193|NCT02459899|20140518|P2|NOT COMPLETED|Overall Study||6
8169194|NCT02459899|20140519|P1|NOT COMPLETED|Overall Study||3
8169195|NCT02459899|20140516|P4|COMPLETED|Overall Study||33
8169196|NCT02459899|20140517|P3|COMPLETED|Overall Study||35
8169197|NCT02459899|20140518|P2|COMPLETED|Overall Study||29
8169198|NCT02459899|20140519|P1|COMPLETED|Overall Study||33
8169199|NCT02459899|20140516|P4|STARTED|Overall Study||35
8169200|NCT02459899|20140517|P3|STARTED|Overall Study||35
8169201|NCT02459899|20140518|P2|STARTED|Overall Study||35
8169202|NCT02459899|20140519|P1|STARTED|Overall Study||36
8169203|NCT02459795|20140552|P3|NOT COMPLETED|Overall Study||1
8169204|NCT02459795|20140553|P2|NOT COMPLETED|Overall Study||3
8169205|NCT02459795|20140554|P1|NOT COMPLETED|Overall Study||6
8169206|NCT02459795|20140552|P3|COMPLETED|Overall Study||92
8169207|NCT02459795|20140553|P2|COMPLETED|Overall Study||186
8169208|NCT02459795|20140554|P1|COMPLETED|Overall Study||181
8169209|NCT02459795|20140552|P3|STARTED|Overall Study||93
8169210|NCT02459795|20140553|P2|STARTED|Overall Study||189
8169211|NCT02459795|20140554|P1|STARTED|Overall Study||187
8169212|NCT02459665|20140566|P4|NOT COMPLETED|Overall Study||2
8169213|NCT02459665|20140567|P3|NOT COMPLETED|Overall Study||1
8169214|NCT02459665|20140568|P2|NOT COMPLETED|Overall Study||1
8169215|NCT02459665|20140569|P1|NOT COMPLETED|Overall Study||0
8169216|NCT02459665|20140566|P4|COMPLETED|Overall Study||15
8169217|NCT02459665|20140567|P3|COMPLETED|Overall Study||16
8169218|NCT02459665|20140568|P2|COMPLETED|Overall Study||16
8169219|NCT02459665|20140569|P1|COMPLETED|Overall Study||17
8169220|NCT02459665|20140566|P4|Month 6 Visit|Overall Study||15
8169221|NCT02459665|20140567|P3|Month 6 Visit|Overall Study||16
8169222|NCT02459665|20140568|P2|Month 6 Visit|Overall Study||16
8169223|NCT02459665|20140569|P1|Month 6 Visit|Overall Study||17
8169224|NCT02459665|20140566|P4|Month 2 Visit|Overall Study||16
8169225|NCT02459665|20140567|P3|Month 2 Visit|Overall Study||17
8169226|NCT02459665|20140568|P2|Month 2 Visit|Overall Study||16
8169227|NCT02459665|20140569|P1|Month 2 Visit|Overall Study||17
8169228|NCT02459665|20140566|P4|Month 1 Visit|Overall Study||16
8169229|NCT02459665|20140567|P3|Month 1 Visit|Overall Study||17
8169230|NCT02459665|20140568|P2|Month 1 Visit|Overall Study||17
8169231|NCT02459665|20140569|P1|Month 1 Visit|Overall Study||17
8169232|NCT02459665|20140566|P4|Day 7 Visit|Overall Study||16
8169233|NCT02459665|20140567|P3|Day 7 Visit|Overall Study||17
8169234|NCT02459665|20140568|P2|Day 7 Visit|Overall Study||17
8169235|NCT02459665|20140569|P1|Day 7 Visit|Overall Study||17
8169236|NCT02459665|20140566|P4|STARTED|Overall Study||17
8169237|NCT02459665|20140567|P3|STARTED|Overall Study||17
8169238|NCT02459665|20140568|P2|STARTED|Overall Study||17
8169239|NCT02459665|20140569|P1|STARTED|Overall Study||17
8169240|NCT02459418|20140600|P2|NOT COMPLETED|Overall Study||6
8169241|NCT02459418|20140601|P1|NOT COMPLETED|Overall Study||8
8169242|NCT02459418|20140600|P2|COMPLETED|Overall Study||15
8169243|NCT02459418|20140601|P1|COMPLETED|Overall Study||13
8169244|NCT02459418|20140600|P2|Received Second Treatment|Overall Study||15
8169245|NCT02459418|20140601|P1|Received Second Treatment|Overall Study||13
8169246|NCT02459418|20140600|P2|Received First Treatment|Overall Study||21
8169247|NCT02459418|20140601|P1|Received First Treatment|Overall Study||21
8169248|NCT02459418|20140600|P2|STARTED|Overall Study||21
8169249|NCT02459418|20140601|P1|STARTED|Overall Study||21
8169250|NCT02459275|20140623|P2|NOT COMPLETED|Overall Study||0
8169251|NCT02459275|20140624|P1|NOT COMPLETED|Overall Study||0
8169252|NCT02459275|20140623|P2|COMPLETED|Overall Study||17
8169253|NCT02459275|20140624|P1|COMPLETED|Overall Study||19
8169254|NCT02459275|20140623|P2|STARTED|Overall Study||17
8169255|NCT02459275|20140624|P1|STARTED|Overall Study||19
8169256|NCT02459262|20140651|P11|NOT COMPLETED|Overall Study||0
8169257|NCT02459262|20140652|P10|NOT COMPLETED|Overall Study||1
8169258|NCT02459262|20140653|P9|NOT COMPLETED|Overall Study||0
8169259|NCT02459262|20140654|P8|NOT COMPLETED|Overall Study||0
8169260|NCT02459262|20140655|P7|NOT COMPLETED|Overall Study||0
8169261|NCT02459262|20140656|P6|NOT COMPLETED|Overall Study||0
8169262|NCT02459262|20140657|P5|NOT COMPLETED|Overall Study||0
8169263|NCT02459262|20140658|P4|NOT COMPLETED|Overall Study||0
8169264|NCT02459262|20140659|P3|NOT COMPLETED|Overall Study||0
8169265|NCT02459262|20140660|P2|NOT COMPLETED|Overall Study||0
8169266|NCT02459262|20140661|P1|NOT COMPLETED|Overall Study||0
8169267|NCT02459262|20140651|P11|COMPLETED|Overall Study||45
8169268|NCT02459262|20140652|P10|COMPLETED|Overall Study||44
8169269|NCT02459262|20140653|P9|COMPLETED|Overall Study||45
8169270|NCT02459262|20140654|P8|COMPLETED|Overall Study||45
8169271|NCT02459262|20140655|P7|COMPLETED|Overall Study||12
8169272|NCT02459262|20140656|P6|COMPLETED|Overall Study||8
8169273|NCT02459262|20140657|P5|COMPLETED|Overall Study||8
8169274|NCT02459262|20140658|P4|COMPLETED|Overall Study||8
8169275|NCT02459262|20140659|P3|COMPLETED|Overall Study||8
8169276|NCT02459262|20140660|P2|COMPLETED|Overall Study||8
8169277|NCT02459262|20140661|P1|COMPLETED|Overall Study||8
8169278|NCT02459262|20140651|P11|STARTED|Overall Study||45
8169279|NCT02459262|20140652|P10|STARTED|Overall Study||45
8169280|NCT02459262|20140653|P9|STARTED|Overall Study||45
8169281|NCT02459262|20140654|P8|STARTED|Overall Study||45
8169282|NCT02459262|20140655|P7|STARTED|Overall Study||12
8169283|NCT02459262|20140656|P6|STARTED|Overall Study||8
8169284|NCT02459262|20140657|P5|STARTED|Overall Study||8
8169285|NCT02459262|20140658|P4|STARTED|Overall Study||8
8169286|NCT02459262|20140659|P3|STARTED|Overall Study||8
8169287|NCT02459262|20140660|P2|STARTED|Overall Study||8
8169288|NCT02459262|20140661|P1|STARTED|Overall Study||8
8169289|NCT02459197|20140706|P2|NOT COMPLETED|Overall Study||1
8169290|NCT02459197|20140707|P1|NOT COMPLETED|Overall Study||0
8169291|NCT02459197|20140706|P2|COMPLETED|Overall Study||55
8169292|NCT02459197|20140707|P1|COMPLETED|Overall Study||58
8169293|NCT02459197|20140706|P2|STARTED|Overall Study||56
8169294|NCT02459197|20140707|P1|STARTED|Overall Study||58
8169295|NCT02459119|20140721|P1|NOT COMPLETED|Overall Study||0
8169296|NCT02459119|20140721|P1|COMPLETED|Overall Study||17
8169297|NCT02459119|20140721|P1|STARTED|Overall Study||17
8169298|NCT02459093|20140731|P2|NOT COMPLETED|Overall Study||18
8169299|NCT02459093|20140732|P1|NOT COMPLETED|Overall Study||12
8169300|NCT02459093|20140731|P2|COMPLETED|Overall Study||257
8169301|NCT02459093|20140732|P1|COMPLETED|Overall Study||263
8169302|NCT02459093|20140731|P2|STARTED|Overall Study||275
8169303|NCT02459093|20140732|P1|STARTED|Overall Study||275
8169313|NCT02458768|20140770|P2|NOT COMPLETED|Overall Study||5
8169314|NCT02458768|20140771|P1|NOT COMPLETED|Overall Study||7
8169315|NCT02458768|20140770|P2|COMPLETED|Overall Study||50
8169316|NCT02458768|20140771|P1|COMPLETED|Overall Study||50
8169317|NCT02458768|20140770|P2|STARTED|Overall Study||55
8169318|NCT02458768|20140771|P1|STARTED|Overall Study||57
8169319|NCT02458690|20140779|P2|NOT COMPLETED|Overall Study||9
8169320|NCT02458690|20140780|P1|NOT COMPLETED|Overall Study||8
8169321|NCT02458690|20140779|P2|COMPLETED|Overall Study||100
8169322|NCT02458690|20140780|P1|COMPLETED|Overall Study||99
8169323|NCT02458690|20140779|P2|STARTED|Overall Study||109
8169324|NCT02458690|20140780|P1|STARTED|Overall Study||107
8169415|NCT02458365|20140804|P2|NOT COMPLETED|Overall Study||294
8169416|NCT02458365|20140805|P1|NOT COMPLETED|Overall Study||277
8169417|NCT02458365|20140804|P2|COMPLETED|Overall Study||1607
8169418|NCT02458365|20140805|P1|COMPLETED|Overall Study||1723
8169419|NCT02458365|20140804|P2|STARTED|Overall Study||1901
8169420|NCT02458365|20140805|P1|STARTED|Overall Study||2000
8169421|NCT02458352|20140825|P1|NOT COMPLETED|Overall Study||0
8169422|NCT02458352|20140825|P1|COMPLETED|Overall Study||105
8169423|NCT02458352|20140825|P1|STARTED|Overall Study||105
8169424|NCT02458287|20140837|P4|NOT COMPLETED|Overall Study||3
8169425|NCT02458287|20140838|P3|NOT COMPLETED|Overall Study||3
8169426|NCT02458287|20140839|P2|NOT COMPLETED|Overall Study||4
8169427|NCT02458287|20140840|P1|NOT COMPLETED|Overall Study||0
8169428|NCT02458287|20140837|P4|COMPLETED|Overall Study||97
8169429|NCT02458287|20140838|P3|COMPLETED|Overall Study||46
8169430|NCT02458287|20140839|P2|COMPLETED|Overall Study||96
8169431|NCT02458287|20140840|P1|COMPLETED|Overall Study||50
8169432|NCT02458287|20140837|P4|STARTED|Overall Study||100
8169433|NCT02458287|20140838|P3|STARTED|Overall Study||49
8169434|NCT02458287|20140839|P2|STARTED|Overall Study||100
8169435|NCT02458287|20140840|P1|STARTED|Overall Study||50
8169436|NCT02458235|20140885|P1|NOT COMPLETED|Overall Study||0
8169437|NCT02458235|20140885|P1|COMPLETED|Overall Study||17
8169438|NCT02458235|20140885|P1|STARTED|Overall Study||17
8169463|NCT02457897|20140939|P1|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0
8169464|NCT02457897|20140939|P1|COMPLETED|Part 2 Long-term (6 Month) Study||5
8169465|NCT02457897|20140939|P1|STARTED|Part 2 Long-term (6 Month) Study|Two patients were not eligible for Part 2 study because their HbA1c was less than 7.|5
8169466|NCT02457897|20140939|P1|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0
8169467|NCT02457897|20140939|P1|COMPLETED|Part 1 Short-term (2 Weeks) Study||7
8169468|NCT02457897|20140939|P1|STARTED|Part 1 Short-term (2 Weeks) Study||7
8169469|NCT02457819|20140946|P1|NOT COMPLETED|Overall Study||99
8169470|NCT02457819|20140946|P1|COMPLETED|Overall Study||138
8169471|NCT02457819|20140946|P1|Safety Population|Overall Study||236
8169472|NCT02457819|20140946|P1|STARTED|Overall Study||237
8169473|NCT02457793|20140958|P6|NOT COMPLETED|Overall Study||6
8169474|NCT02457793|20140959|P5|NOT COMPLETED|Overall Study||4
8169475|NCT02457793|20140960|P4|NOT COMPLETED|Overall Study||5
8169476|NCT02457793|20140961|P3|NOT COMPLETED|Overall Study||3
8169477|NCT02457793|20140962|P2|NOT COMPLETED|Overall Study||4
8169478|NCT02457793|20140963|P1|NOT COMPLETED|Overall Study||1
8169479|NCT02457793|20140958|P6|COMPLETED|Overall Study||0
8169480|NCT02457793|20140959|P5|COMPLETED|Overall Study||0
8169481|NCT02457793|20140960|P4|COMPLETED|Overall Study||0
8169482|NCT02457793|20140961|P3|COMPLETED|Overall Study||0
8169483|NCT02457793|20140962|P2|COMPLETED|Overall Study||1
8169484|NCT02457793|20140963|P1|COMPLETED|Overall Study||0
8169485|NCT02457793|20140958|P6|STARTED|Overall Study||6
8169486|NCT02457793|20140959|P5|STARTED|Overall Study||4
8169487|NCT02457793|20140960|P4|STARTED|Overall Study||5
8169488|NCT02457793|20140961|P3|STARTED|Overall Study||3
8169489|NCT02457793|20140962|P2|STARTED|Overall Study||5
8169490|NCT02457793|20140963|P1|STARTED|Overall Study||1
8169491|NCT02457728|20141103|P1|NOT COMPLETED|Overall Study||0
8169492|NCT02457728|20141103|P1|COMPLETED|Overall Study||34
8169493|NCT02457728|20141103|P1|STARTED|Overall Study||34
8169494|NCT02457637|20141107|P1|NOT COMPLETED|Clinic or Telephone Follow-up||71
8169495|NCT02457637|20141107|P1|COMPLETED|Clinic or Telephone Follow-up||2529
8169496|NCT02457637|20141107|P1|One-year Death|Clinic or Telephone Follow-up||475
8169497|NCT02457637|20141107|P1|One-year Liver Transplantation|Clinic or Telephone Follow-up||182
8169498|NCT02457637|20141107|P1|STARTED|Clinic or Telephone Follow-up||2600
8169499|NCT02457637|20141107|P1|NOT COMPLETED|28-Days Hospitalization and Observation||0
8169500|NCT02457637|20141107|P1|COMPLETED|28-Days Hospitalization and Observation|Death and receiving Liver transplantation are two end points of our observation.|2600
8169501|NCT02457637|20141107|P1|Death|28-Days Hospitalization and Observation||74
8169502|NCT02457637|20141107|P1|Liver Transplantation|28-Days Hospitalization and Observation||124
8169503|NCT02457637|20141107|P1|STARTED|28-Days Hospitalization and Observation||2600
8169504|NCT02457637|20141107|P1|NOT COMPLETED|Recruitment||0
8169505|NCT02457637|20141107|P1|COMPLETED|Recruitment|2361 patients were excluded according to our exclusion criteria,2600 patients remained.|2600
8169506|NCT02457637|20141107|P1|STARTED|Recruitment|2600 is the number of inpatients who met our eligibility.|2600
8169507|NCT02457611|20141115|P1|NOT COMPLETED|Overall Study||3
8169508|NCT02457611|20141115|P1|COMPLETED|Overall Study||23
8169509|NCT02457611|20141115|P1|STARTED|Overall Study||26
8169510|NCT02457546|20141129|P2|NOT COMPLETED|Overall Study||4
8169511|NCT02457546|20141130|P1|NOT COMPLETED|Overall Study||9
8169512|NCT02457546|20141129|P2|COMPLETED|Overall Study||116
8169513|NCT02457546|20141130|P1|COMPLETED|Overall Study||105
8169514|NCT02457546|20141129|P2|STARTED|Overall Study||120
8169515|NCT02457546|20141130|P1|STARTED|Overall Study||114
8169516|NCT02457403|20141140|P2|NOT COMPLETED|Overall Study||0
8169517|NCT02457403|20141141|P1|NOT COMPLETED|Overall Study||0
8169518|NCT02457403|20141140|P2|COMPLETED|Overall Study||34
8169519|NCT02457403|20141141|P1|COMPLETED|Overall Study||34
8169520|NCT02457403|20141140|P2|STARTED|Overall Study|34 historic controls|34
8169521|NCT02457403|20141141|P1|STARTED|Overall Study|34 participants|34
8169522|NCT02457325|20141151|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8169523|NCT02457325|20141152|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8169524|NCT02457325|20141151|P2|COMPLETED|Second Intervention (1 Day)||23
8169525|NCT02457325|20141152|P1|COMPLETED|Second Intervention (1 Day)||23
8169526|NCT02457325|20141151|P2|STARTED|Second Intervention (1 Day)||23
8169527|NCT02457325|20141152|P1|STARTED|Second Intervention (1 Day)||23
8169528|NCT02457325|20141151|P2|NOT COMPLETED|Washout (1-2 Months)||0
8169529|NCT02457325|20141152|P1|NOT COMPLETED|Washout (1-2 Months)||0
8169530|NCT02457325|20141151|P2|COMPLETED|Washout (1-2 Months)||23
8169531|NCT02457325|20141152|P1|COMPLETED|Washout (1-2 Months)||23
8169532|NCT02457325|20141151|P2|STARTED|Washout (1-2 Months)||23
8169533|NCT02457325|20141152|P1|STARTED|Washout (1-2 Months)||23
8169534|NCT02457325|20141151|P2|NOT COMPLETED|First Intervention (1 Day)||2
8169535|NCT02457325|20141152|P1|NOT COMPLETED|First Intervention (1 Day)||2
8169536|NCT02457325|20141151|P2|COMPLETED|First Intervention (1 Day)||23
8169537|NCT02457325|20141152|P1|COMPLETED|First Intervention (1 Day)||23
8169538|NCT02457325|20141151|P2|STARTED|First Intervention (1 Day)||25
8169539|NCT02457325|20141152|P1|STARTED|First Intervention (1 Day)||25
8169540|NCT02457260|20141181|P3|NOT COMPLETED|Overall Study||1
8169541|NCT02457260|20141182|P2|NOT COMPLETED|Overall Study||3
8169542|NCT02457260|20141183|P1|NOT COMPLETED|Overall Study||2
8169543|NCT02457260|20141181|P3|COMPLETED|Overall Study||1
8169544|NCT02457260|20141182|P2|COMPLETED|Overall Study||4
8169545|NCT02457260|20141183|P1|COMPLETED|Overall Study||10
8169546|NCT02457260|20141181|P3|STARTED|Overall Study||2
8169547|NCT02457260|20141182|P2|STARTED|Overall Study||7
8169548|NCT02457260|20141183|P1|STARTED|Overall Study||12
8169549|NCT02457247|20141225|P4|NOT COMPLETED|Period 2||0
8169550|NCT02457247|20141226|P3|NOT COMPLETED|Period 2||0
8169551|NCT02457247|20141227|P2|NOT COMPLETED|Period 2||3
8169552|NCT02457247|20141228|P1|NOT COMPLETED|Period 2||2
8169553|NCT02457247|20141225|P4|COMPLETED|Period 2||70
8169554|NCT02457247|20141226|P3|COMPLETED|Period 2||68
8169555|NCT02457247|20141227|P2|COMPLETED|Period 2||65
8169556|NCT02457247|20141228|P1|COMPLETED|Period 2||64
8169557|NCT02457247|20141225|P4|STARTED|Period 2||70
8169558|NCT02457247|20141226|P3|STARTED|Period 2||68
8169559|NCT02457247|20141227|P2|STARTED|Period 2||68
8169560|NCT02457247|20141228|P1|STARTED|Period 2||66
8169561|NCT02457247|20141225|P4|NOT COMPLETED|Period 1||0
8169562|NCT02457247|20141226|P3|NOT COMPLETED|Period 1||0
8169563|NCT02457247|20141227|P2|NOT COMPLETED|Period 1||2
8169564|NCT02457247|20141228|P1|NOT COMPLETED|Period 1||2
8169565|NCT02457247|20141225|P4|COMPLETED|Period 1||70
8169566|NCT02457247|20141226|P3|COMPLETED|Period 1||68
8169567|NCT02457247|20141227|P2|COMPLETED|Period 1||68
8169568|NCT02457247|20141228|P1|COMPLETED|Period 1||66
8169569|NCT02457247|20141225|P4|STARTED|Period 1||70
8169570|NCT02457247|20141226|P3|STARTED|Period 1||68
8169571|NCT02457247|20141227|P2|STARTED|Period 1||70
8169572|NCT02457247|20141228|P1|STARTED|Period 1||68
8169573|NCT02457195|20141248|P1|NOT COMPLETED|Overall Study||9
8169574|NCT02457195|20141248|P1|COMPLETED|Overall Study||41
8169575|NCT02457195|20141248|P1|STARTED|Overall Study||50
8169576|NCT02457182|20141254|P2|NOT COMPLETED|Overall Study||0
8169577|NCT02457182|20141255|P1|NOT COMPLETED|Overall Study||1
8169578|NCT02457182|20141254|P2|COMPLETED|Overall Study||11
8169579|NCT02457182|20141255|P1|COMPLETED|Overall Study||8
8169580|NCT02457182|20141254|P2|STARTED|Overall Study||11
8169581|NCT02457182|20141255|P1|STARTED|Overall Study||9
8169582|NCT02457065|20141273|P2|NOT COMPLETED|Overall Study||11
8169583|NCT02457065|20141274|P1|NOT COMPLETED|Overall Study||9
8169584|NCT02457065|20141273|P2|COMPLETED|Overall Study||16
8169585|NCT02457065|20141274|P1|COMPLETED|Overall Study||18
8169586|NCT02457065|20141273|P2|STARTED|Overall Study||27
8169587|NCT02457065|20141274|P1|STARTED|Overall Study||27
8169588|NCT02456896|20141284|P2|NOT COMPLETED|Overall Study||4
8169589|NCT02456896|20141285|P1|NOT COMPLETED|Overall Study||6
8169590|NCT02456896|20141284|P2|COMPLETED|Overall Study||21
8169591|NCT02456896|20141285|P1|COMPLETED|Overall Study||19
8169592|NCT02456896|20141284|P2|STARTED|Overall Study||25
8169593|NCT02456896|20141285|P1|STARTED|Overall Study||25
8169594|NCT02456740|20141296|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
8169595|NCT02456740|20141297|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
8169596|NCT02456740|20141298|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
8169597|NCT02456740|20141299|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
8169598|NCT02456740|20141300|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
8169599|NCT02456740|20141301|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
8169600|NCT02456740|20141302|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8169601|NCT02456740|20141303|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8169602|NCT02456740|20141304|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8169603|NCT02456740|20141296|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
8169604|NCT02456740|20141297|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
8169605|NCT02456740|20141298|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
8169606|NCT02456740|20141299|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
8169607|NCT02456740|20141300|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
8169608|NCT02456740|20141301|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
8169609|NCT02456740|20141302|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8169610|NCT02456740|20141303|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8169611|NCT02456740|20141304|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8169612|NCT02456740|20141296|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
8169613|NCT02456740|20141297|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
8169614|NCT02456740|20141298|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
8169615|NCT02456740|20141299|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
8169616|NCT02456740|20141300|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
8169617|NCT02456740|20141301|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
8169618|NCT02456740|20141302|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8169619|NCT02456740|20141303|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8169620|NCT02456740|20141304|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8169621|NCT02456740|20141296|P9|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169622|NCT02456740|20141297|P8|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169623|NCT02456740|20141298|P7|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169624|NCT02456740|20141299|P6|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169625|NCT02456740|20141300|P5|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169626|NCT02456740|20141301|P4|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169627|NCT02456740|20141302|P3|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
8169628|NCT02456740|20141303|P2|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
8169629|NCT02456740|20141304|P1|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
8169630|NCT02456740|20141296|P9|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169631|NCT02456740|20141297|P8|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169632|NCT02456740|20141298|P7|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169633|NCT02456740|20141299|P6|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169634|NCT02456740|20141300|P5|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169635|NCT02456740|20141301|P4|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
8169636|NCT02456740|20141302|P3|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
8169637|NCT02456740|20141303|P2|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
8169638|NCT02456740|20141304|P1|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
8169639|NCT02456740|20141296|P9|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8169640|NCT02456740|20141297|P8|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8169641|NCT02456740|20141298|P7|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8169642|NCT02456740|20141299|P6|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8169643|NCT02456740|20141300|P5|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8169644|NCT02456740|20141301|P4|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
8169645|NCT02456740|20141302|P3|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
8169646|NCT02456740|20141303|P2|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
8169647|NCT02456740|20141304|P1|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
8169648|NCT02456740|20141296|P9|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8169649|NCT02456740|20141297|P8|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8169650|NCT02456740|20141298|P7|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8169651|NCT02456740|20141299|P6|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8169652|NCT02456740|20141300|P5|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8169653|NCT02456740|20141301|P4|STARTED|Double-blind Treatment Phase (24 Weeks)||0
8169654|NCT02456740|20141302|P3|STARTED|Double-blind Treatment Phase (24 Weeks)||319
8169655|NCT02456740|20141303|P2|STARTED|Double-blind Treatment Phase (24 Weeks)||317
8169656|NCT02456740|20141304|P1|STARTED|Double-blind Treatment Phase (24 Weeks)||319
8169657|NCT02456727|20141328|P2|NOT COMPLETED|Overall Study||106
8169658|NCT02456727|20141329|P1|NOT COMPLETED|Overall Study||109
8169659|NCT02456727|20141328|P2|COMPLETED|Overall Study||284
8169660|NCT02456727|20141329|P1|COMPLETED|Overall Study||280
8169661|NCT02456727|20141328|P2|24 Week|Overall Study||284
8169662|NCT02456727|20141329|P1|24 Week|Overall Study||280
8169663|NCT02456727|20141328|P2|12 Week|Overall Study||310
8169664|NCT02456727|20141329|P1|12 Week|Overall Study||295
8169665|NCT02456727|20141328|P2|6 Week|Overall Study||320
8169666|NCT02456727|20141329|P1|6 Week|Overall Study||298
8169667|NCT02456727|20141328|P2|Initiated Treatment|Overall Study||360
8169668|NCT02456727|20141329|P1|Initiated Treatment|Overall Study||346
8169669|NCT02456727|20141328|P2|STARTED|Overall Study||390
8169670|NCT02456727|20141329|P1|STARTED|Overall Study||389
8169671|NCT02456662|20141411|P2|NOT COMPLETED|Overall Study||1
8169672|NCT02456662|20141412|P1|NOT COMPLETED|Overall Study||2
8169673|NCT02456662|20141411|P2|COMPLETED|Overall Study||159
8169674|NCT02456662|20141412|P1|COMPLETED|Overall Study||157
8169675|NCT02456662|20141411|P2|STARTED|Overall Study||160
8169676|NCT02456662|20141412|P1|STARTED|Overall Study||159
8169677|NCT02456636|20141421|P3|NOT COMPLETED|Overall Study||75
8169678|NCT02456636|20141422|P2|NOT COMPLETED|Overall Study||69
8169679|NCT02456636|20141423|P1|NOT COMPLETED|Overall Study||68
8169680|NCT02456636|20141421|P3|COMPLETED|Overall Study||400
8169681|NCT02456636|20141422|P2|COMPLETED|Overall Study||410
8169682|NCT02456636|20141423|P1|COMPLETED|Overall Study||410
8169683|NCT02456636|20141421|P3|18 Month|Overall Study||461
8169684|NCT02456636|20141422|P2|18 Month|Overall Study||463
8169685|NCT02456636|20141423|P1|18 Month|Overall Study||467
8169686|NCT02456636|20141421|P3|6 Month|Overall Study||468
8169687|NCT02456636|20141422|P2|6 Month|Overall Study||474
8169688|NCT02456636|20141423|P1|6 Month|Overall Study||474
8169689|NCT02456636|20141421|P3|STARTED|Overall Study||475
8169690|NCT02456636|20141422|P2|STARTED|Overall Study||479
8169691|NCT02456636|20141423|P1|STARTED|Overall Study||478
8169692|NCT02456103|20141473|P1|NOT COMPLETED|Overall Study||246
8169693|NCT02456103|20141473|P1|COMPLETED|Overall Study||0
8169694|NCT02456103|20141473|P1|Intent-to-treat (ITT) Population|Overall Study||244
8169695|NCT02456103|20141473|P1|As-Treated Population|Overall Study||245
8169696|NCT02456103|20141473|P1|STARTED|Overall Study||246
8169697|NCT02455518|20141486|P4|NOT COMPLETED|Overall Study||3
8169698|NCT02455518|20141487|P3|NOT COMPLETED|Overall Study||1
8169699|NCT02455518|20141488|P2|NOT COMPLETED|Overall Study||1
8169700|NCT02455518|20141489|P1|NOT COMPLETED|Overall Study||0
8169701|NCT02455518|20141486|P4|COMPLETED|Overall Study||101
8169702|NCT02455518|20141487|P3|COMPLETED|Overall Study||103
8169703|NCT02455518|20141488|P2|COMPLETED|Overall Study||103
8169704|NCT02455518|20141489|P1|COMPLETED|Overall Study||104
8169705|NCT02455518|20141486|P4|STARTED|Overall Study||104
8169706|NCT02455518|20141487|P3|STARTED|Overall Study||104
8169707|NCT02455518|20141488|P2|STARTED|Overall Study||104
8169708|NCT02455518|20141489|P1|STARTED|Overall Study||104
8169709|NCT02455453|20141503|P1|NOT COMPLETED|Overall Study||0
8169710|NCT02455453|20141503|P1|COMPLETED|Overall Study||47
8169711|NCT02455453|20141503|P1|STARTED|Overall Study||47
8169712|NCT02455388|20141511|P3|NOT COMPLETED|Overall Study||11
8169713|NCT02455388|20141512|P2|NOT COMPLETED|Overall Study||0
8169714|NCT02455388|20141513|P1|NOT COMPLETED|Overall Study||1
8169715|NCT02455388|20141511|P3|COMPLETED|Overall Study||326
8169716|NCT02455388|20141512|P2|COMPLETED|Overall Study||15
8169717|NCT02455388|20141513|P1|COMPLETED|Overall Study||17
8169718|NCT02455388|20141511|P3|STARTED|Overall Study||337
8169719|NCT02455388|20141512|P2|STARTED|Overall Study||15
8169720|NCT02455388|20141513|P1|STARTED|Overall Study||18
8169721|NCT02455336|20141524|P2|NOT COMPLETED|Overall Study||2
8169722|NCT02455336|20141525|P1|NOT COMPLETED|Overall Study||5
8169723|NCT02455336|20141524|P2|COMPLETED|Overall Study||6
8169724|NCT02455336|20141525|P1|COMPLETED|Overall Study||10
8169725|NCT02455336|20141524|P2|STARTED|Overall Study||8
8169726|NCT02455336|20141525|P1|STARTED|Overall Study||15
8169727|NCT02455076|20141540|P5|NOT COMPLETED|Outpatient||12
8169728|NCT02455076|20141541|P4|NOT COMPLETED|Outpatient||6
8169729|NCT02455076|20141542|P3|NOT COMPLETED|Outpatient||0
8169730|NCT02455076|20141543|P2|NOT COMPLETED|Outpatient||0
8169731|NCT02455076|20141544|P1|NOT COMPLETED|Outpatient||0
8169732|NCT02455076|20141540|P5|COMPLETED|Outpatient||43
8169733|NCT02455076|20141541|P4|COMPLETED|Outpatient||42
8169734|NCT02455076|20141542|P3|COMPLETED|Outpatient||0
8169735|NCT02455076|20141543|P2|COMPLETED|Outpatient||0
8169736|NCT02455076|20141544|P1|COMPLETED|Outpatient||0
8169737|NCT02455076|20141540|P5|STARTED|Outpatient||55
8169738|NCT02455076|20141541|P4|STARTED|Outpatient||48
8169739|NCT02455076|20141542|P3|STARTED|Outpatient||0
8169740|NCT02455076|20141543|P2|STARTED|Outpatient||0
8169741|NCT02455076|20141544|P1|STARTED|Outpatient||0
8169742|NCT02455076|20141540|P5|NOT COMPLETED|Inpatient||0
8169743|NCT02455076|20141541|P4|NOT COMPLETED|Inpatient||0
8169744|NCT02455076|20141542|P3|NOT COMPLETED|Inpatient||0
8169745|NCT02455076|20141543|P2|NOT COMPLETED|Inpatient||1
8169746|NCT02455076|20141544|P1|NOT COMPLETED|Inpatient||4
8169747|NCT02455076|20141540|P5|COMPLETED|Inpatient||0
8169748|NCT02455076|20141541|P4|COMPLETED|Inpatient||0
8169749|NCT02455076|20141542|P3|COMPLETED|Inpatient||52
8169750|NCT02455076|20141543|P2|COMPLETED|Inpatient||50
8169751|NCT02455076|20141544|P1|COMPLETED|Inpatient||43
8169752|NCT02455076|20141540|P5|STARTED|Inpatient||0
8169753|NCT02455076|20141541|P4|STARTED|Inpatient||0
8169754|NCT02455076|20141542|P3|STARTED|Inpatient||52
8169755|NCT02455076|20141543|P2|STARTED|Inpatient||51
8169756|NCT02455076|20141544|P1|STARTED|Inpatient||47
8169757|NCT02455050|20141630|P4|NOT COMPLETED|Treatment Period 2||1
8169758|NCT02455050|20141631|P3|NOT COMPLETED|Treatment Period 2||2
8169759|NCT02455050|20141632|P2|NOT COMPLETED|Treatment Period 2||0
8169760|NCT02455050|20141633|P1|NOT COMPLETED|Treatment Period 2||1
8169761|NCT02455050|20141630|P4|COMPLETED|Treatment Period 2||17
8169762|NCT02455050|20141631|P3|COMPLETED|Treatment Period 2||17
8169763|NCT02455050|20141632|P2|COMPLETED|Treatment Period 2||18
8169764|NCT02455050|20141633|P1|COMPLETED|Treatment Period 2||18
8169765|NCT02455050|20141630|P4|STARTED|Treatment Period 2||18
8169766|NCT02455050|20141631|P3|STARTED|Treatment Period 2||19
8169767|NCT02455050|20141632|P2|STARTED|Treatment Period 2||18
8169768|NCT02455050|20141633|P1|STARTED|Treatment Period 2||19
8169769|NCT02455050|20141630|P4|NOT COMPLETED|Treatment Period 1||2
8169770|NCT02455050|20141631|P3|NOT COMPLETED|Treatment Period 1||1
8169771|NCT02455050|20141632|P2|NOT COMPLETED|Treatment Period 1||1
8169772|NCT02455050|20141633|P1|NOT COMPLETED|Treatment Period 1||1
8169773|NCT02455050|20141630|P4|COMPLETED|Treatment Period 1||18
8169774|NCT02455050|20141631|P3|COMPLETED|Treatment Period 1||19
8169775|NCT02455050|20141632|P2|COMPLETED|Treatment Period 1||18
8169776|NCT02455050|20141633|P1|COMPLETED|Treatment Period 1||19
8169777|NCT02455050|20141630|P4|STARTED|Treatment Period 1||20
8169778|NCT02455050|20141631|P3|STARTED|Treatment Period 1||20
8169779|NCT02455050|20141632|P2|STARTED|Treatment Period 1||19
8169780|NCT02455050|20141633|P1|STARTED|Treatment Period 1||20
8169781|NCT02454959|20141697|P1|NOT COMPLETED|Overall Study||9
8169782|NCT02454959|20141697|P1|COMPLETED|Overall Study||70
8169783|NCT02454959|20141697|P1|GFF MDI (PT003) Without Aerochamber|Overall Study||77
8169784|NCT02454959|20141697|P1|GFF MDI (PT003) With Aerochamber|Overall Study||73
8169785|NCT02454959|20141697|P1|STARTED|Overall Study||79
8169794|NCT02454608|20141726|P3|NOT COMPLETED|Open Label Period||19
8169795|NCT02454608|20141727|P2|NOT COMPLETED|Open Label Period||0
8169796|NCT02454608|20141728|P1|NOT COMPLETED|Open Label Period||0
8169797|NCT02454608|20141726|P3|COMPLETED|Open Label Period||10
8169798|NCT02454608|20141727|P2|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
8169799|NCT02454608|20141728|P1|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
8169800|NCT02454608|20141726|P3|STARTED|Open Label Period||29
8169801|NCT02454608|20141727|P2|STARTED|Open Label Period|This arm is not part of this period of the study|0
8169802|NCT02454608|20141728|P1|STARTED|Open Label Period|This arm is not part of this period of the study|0
8169803|NCT02454608|20141726|P3|NOT COMPLETED|Double-Blind Period||0
8169804|NCT02454608|20141727|P2|NOT COMPLETED|Double-Blind Period||2
8169805|NCT02454608|20141728|P1|NOT COMPLETED|Double-Blind Period||0
8169806|NCT02454608|20141726|P3|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
8169807|NCT02454608|20141727|P2|COMPLETED|Double-Blind Period||12
8169808|NCT02454608|20141728|P1|COMPLETED|Double-Blind Period||15
8169809|NCT02454608|20141726|P3|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
8169810|NCT02454608|20141727|P2|STARTED|Double-Blind Period||14
8169811|NCT02454608|20141728|P1|STARTED|Double-Blind Period||15
8169812|NCT02454530|20141751|P2|NOT COMPLETED|Overall Study||127
8169813|NCT02454530|20141752|P1|NOT COMPLETED|Overall Study||70
8169814|NCT02454530|20141751|P2|COMPLETED|Overall Study||481
8169815|NCT02454530|20141752|P1|COMPLETED|Overall Study||482
8169816|NCT02454530|20141751|P2|STARTED|Overall Study||608
8169817|NCT02454530|20141752|P1|STARTED|Overall Study||552
8169818|NCT02454478|20141789|P1|NOT COMPLETED|Overall Study||1
8169819|NCT02454478|20141789|P1|COMPLETED|Overall Study||6
8169820|NCT02454478|20141789|P1|STARTED|Overall Study||7
8169821|NCT02454296|20141805|P2|NOT COMPLETED|Overall Study||0
8169822|NCT02454296|20141806|P1|NOT COMPLETED|Overall Study||0
8169823|NCT02454296|20141805|P2|COMPLETED|Overall Study||21
8169824|NCT02454296|20141806|P1|COMPLETED|Overall Study||20
8169825|NCT02454296|20141805|P2|STARTED|Overall Study||21
8169826|NCT02454296|20141806|P1|STARTED|Overall Study||20
8169827|NCT02454283|20141818|P2|NOT COMPLETED|Overall Study||0
8169828|NCT02454283|20141819|P1|NOT COMPLETED|Overall Study||0
8169829|NCT02454283|20141818|P2|COMPLETED|Overall Study||15
8169830|NCT02454283|20141819|P1|COMPLETED|Overall Study||26
8169831|NCT02454283|20141818|P2|STARTED|Overall Study||15
8169832|NCT02454283|20141819|P1|STARTED|Overall Study||26
8169833|NCT02454179|20141829|P2|NOT COMPLETED|Overall Study||39
8169834|NCT02454179|20141830|P1|NOT COMPLETED|Overall Study||39
8169835|NCT02454179|20141829|P2|COMPLETED|Overall Study||0
8169836|NCT02454179|20141830|P1|COMPLETED|Overall Study||0
8169837|NCT02454179|20141829|P2|Discontinue Study|Overall Study||39
8169838|NCT02454179|20141830|P1|Discontinue Study|Overall Study||39
8169839|NCT02454179|20141829|P2|Received Study Medication|Overall Study||37
8169840|NCT02454179|20141830|P1|Received Study Medication|Overall Study||39
8169841|NCT02454179|20141829|P2|Enrolled|Overall Study||39
8169842|NCT02454179|20141830|P1|Enrolled|Overall Study||39
8169843|NCT02454179|20141829|P2|STARTED|Overall Study||39
8169844|NCT02454179|20141830|P1|STARTED|Overall Study||39
8169845|NCT02454127|20141840|P4|NOT COMPLETED|Overall Study||20
8169846|NCT02454127|20141841|P3|NOT COMPLETED|Overall Study||14
8169847|NCT02454127|20141842|P2|NOT COMPLETED|Overall Study||14
8169848|NCT02454127|20141843|P1|NOT COMPLETED|Overall Study||19
8169849|NCT02454127|20141840|P4|COMPLETED|Overall Study||20
8169850|NCT02454127|20141841|P3|COMPLETED|Overall Study||26
8169851|NCT02454127|20141842|P2|COMPLETED|Overall Study||26
8169852|NCT02454127|20141843|P1|COMPLETED|Overall Study||21
8169853|NCT02454127|20141840|P4|STARTED|Overall Study||40
8169854|NCT02454127|20141841|P3|STARTED|Overall Study||40
8169855|NCT02454127|20141842|P2|STARTED|Overall Study||40
8169856|NCT02454127|20141843|P1|STARTED|Overall Study||40
8169857|NCT02454101|20141883|P2|NOT COMPLETED|Overall Study||7
8169858|NCT02454101|20141884|P1|NOT COMPLETED|Overall Study||5
8169859|NCT02454101|20141883|P2|COMPLETED|Overall Study||143
8169860|NCT02454101|20141884|P1|COMPLETED|Overall Study||145
8169861|NCT02454101|20141883|P2|STARTED|Overall Study||150
8169862|NCT02454101|20141884|P1|STARTED|Overall Study||150
8169863|NCT02453841|20141906|P1|NOT COMPLETED|Overall Study||3
8169864|NCT02453841|20141906|P1|COMPLETED|Overall Study||27
8169865|NCT02453841|20141906|P1|STARTED|Overall Study||30
8169866|NCT02453750|20141913|P1|NOT COMPLETED|Overall Study||0
8169867|NCT02453750|20141913|P1|COMPLETED|Overall Study||21
8169868|NCT02453750|20141913|P1|STARTED|Overall Study||21
8169869|NCT02453711|20141929|P9|NOT COMPLETED|Overall Study||13
8169870|NCT02453711|20141930|P8|NOT COMPLETED|Overall Study||7
8169871|NCT02453711|20141931|P7|NOT COMPLETED|Overall Study||3
8169872|NCT02453711|20141932|P6|NOT COMPLETED|Overall Study||6
8169873|NCT02453711|20141933|P5|NOT COMPLETED|Overall Study||2
8169874|NCT02453711|20141934|P4|NOT COMPLETED|Overall Study||7
8169875|NCT02453711|20141935|P3|NOT COMPLETED|Overall Study||9
8169876|NCT02453711|20141936|P2|NOT COMPLETED|Overall Study||7
8169877|NCT02453711|20141937|P1|NOT COMPLETED|Overall Study||11
8169878|NCT02453711|20141929|P9|COMPLETED|Overall Study||123
8169879|NCT02453711|20141930|P8|COMPLETED|Overall Study||96
8169880|NCT02453711|20141931|P7|COMPLETED|Overall Study||100
8169881|NCT02453711|20141932|P6|COMPLETED|Overall Study||96
8169882|NCT02453711|20141933|P5|COMPLETED|Overall Study||100
8169883|NCT02453711|20141934|P4|COMPLETED|Overall Study||96
8169884|NCT02453711|20141935|P3|COMPLETED|Overall Study||94
8169885|NCT02453711|20141936|P2|COMPLETED|Overall Study||95
8169886|NCT02453711|20141937|P1|COMPLETED|Overall Study||92
8169887|NCT02453711|20141929|P9|Safety Analysis Set|Overall Study||136
8169888|NCT02453711|20141930|P8|Safety Analysis Set|Overall Study||103
8169889|NCT02453711|20141931|P7|Safety Analysis Set|Overall Study||103
8169890|NCT02453711|20141932|P6|Safety Analysis Set|Overall Study||102
8169891|NCT02453711|20141933|P5|Safety Analysis Set|Overall Study||102
8169892|NCT02453711|20141934|P4|Safety Analysis Set|Overall Study||103
8169893|NCT02453711|20141935|P3|Safety Analysis Set|Overall Study||103
8169894|NCT02453711|20141936|P2|Safety Analysis Set|Overall Study||102
8169895|NCT02453711|20141937|P1|Safety Analysis Set|Overall Study||103
8169896|NCT02453711|20141929|P9|Full Analysis Set|Overall Study||136
8169897|NCT02453711|20141930|P8|Full Analysis Set|Overall Study||103
8169898|NCT02453711|20141931|P7|Full Analysis Set|Overall Study||103
8169899|NCT02453711|20141932|P6|Full Analysis Set|Overall Study||102
8169900|NCT02453711|20141933|P5|Full Analysis Set|Overall Study||102
8169901|NCT02453711|20141934|P4|Full Analysis Set|Overall Study||103
8169902|NCT02453711|20141935|P3|Full Analysis Set|Overall Study||103
8169903|NCT02453711|20141936|P2|Full Analysis Set|Overall Study||102
8169904|NCT02453711|20141937|P1|Full Analysis Set|Overall Study||103
8169905|NCT02453711|20141929|P9|STARTED|Overall Study||136
8169906|NCT02453711|20141930|P8|STARTED|Overall Study||103
8169907|NCT02453711|20141931|P7|STARTED|Overall Study||103
8169908|NCT02453711|20141932|P6|STARTED|Overall Study||102
8169909|NCT02453711|20141933|P5|STARTED|Overall Study||102
8169910|NCT02453711|20141934|P4|STARTED|Overall Study||103
8169911|NCT02453711|20141935|P3|STARTED|Overall Study||103
8169912|NCT02453711|20141936|P2|STARTED|Overall Study||102
8169913|NCT02453711|20141937|P1|STARTED|Overall Study||103
8169914|NCT02453685|20142281|P2|NOT COMPLETED|Overall Study||12
8169915|NCT02453685|20142282|P1|NOT COMPLETED|Overall Study||19
8169916|NCT02453685|20142281|P2|COMPLETED|Overall Study||155
8169917|NCT02453685|20142282|P1|COMPLETED|Overall Study||149
8169918|NCT02453685|20142281|P2|Exposed|Overall Study||166
8169919|NCT02453685|20142282|P1|Exposed|Overall Study||166
8169920|NCT02453685|20142281|P2|STARTED|Overall Study||167
8169921|NCT02453685|20142282|P1|STARTED|Overall Study||168
8169922|NCT02453672|20142297|P3|NOT COMPLETED|Overall Study||1
8169923|NCT02453672|20142298|P2|NOT COMPLETED|Overall Study||2
8169924|NCT02453672|20142299|P1|NOT COMPLETED|Overall Study||3
8169925|NCT02453672|20142297|P3|COMPLETED|Overall Study||38
8169926|NCT02453672|20142298|P2|COMPLETED|Overall Study||38
8169927|NCT02453672|20142299|P1|COMPLETED|Overall Study||37
8169928|NCT02453672|20142297|P3|STARTED|Overall Study||39
8169929|NCT02453672|20142298|P2|STARTED|Overall Study||40
8169930|NCT02453672|20142299|P1|STARTED|Overall Study||40
8169931|NCT02453581|20142316|P3|NOT COMPLETED|Overall Study||0
8169932|NCT02453581|20142317|P2|NOT COMPLETED|Overall Study||0
8169933|NCT02453581|20142318|P1|NOT COMPLETED|Overall Study||0
8169934|NCT02453581|20142316|P3|COMPLETED|Overall Study||8
8169935|NCT02453581|20142317|P2|COMPLETED|Overall Study||8
8169936|NCT02453581|20142318|P1|COMPLETED|Overall Study||8
8169937|NCT02453581|20142316|P3|STARTED|Overall Study||8
8169938|NCT02453581|20142317|P2|STARTED|Overall Study||8
8169939|NCT02453581|20142318|P1|STARTED|Overall Study||8
8169940|NCT02453555|20142340|P6|NOT COMPLETED|Extension Period||1
8169941|NCT02453555|20142341|P5|NOT COMPLETED|Extension Period||1
8169942|NCT02453555|20142342|P4|NOT COMPLETED|Extension Period||2
8169943|NCT02453555|20142343|P3|NOT COMPLETED|Extension Period||3
8169944|NCT02453555|20142344|P2|NOT COMPLETED|Extension Period||0
8169945|NCT02453555|20142345|P1|NOT COMPLETED|Extension Period||0
8169946|NCT02453555|20142340|P6|COMPLETED|Extension Period||5
8169947|NCT02453555|20142341|P5|COMPLETED|Extension Period||79
8169948|NCT02453555|20142342|P4|COMPLETED|Extension Period||49
8169949|NCT02453555|20142343|P3|COMPLETED|Extension Period||123
8169950|NCT02453555|20142344|P2|COMPLETED|Extension Period||0
8169951|NCT02453555|20142345|P1|COMPLETED|Extension Period||0
8169952|NCT02453555|20142340|P6|STARTED|Extension Period||6
8169953|NCT02453555|20142341|P5|STARTED|Extension Period||80
8169954|NCT02453555|20142342|P4|STARTED|Extension Period||51
8169955|NCT02453555|20142343|P3|STARTED|Extension Period||126
8169956|NCT02453555|20142344|P2|STARTED|Extension Period|This reporting group is not applicable in this period.|0
8169957|NCT02453555|20142345|P1|STARTED|Extension Period|This reporting group is not applicable in this period.|0
8169958|NCT02453555|20142340|P6|NOT COMPLETED|24-week Double-blind Treatment Period||0
8169959|NCT02453555|20142341|P5|NOT COMPLETED|24-week Double-blind Treatment Period||0
8169960|NCT02453555|20142342|P4|NOT COMPLETED|24-week Double-blind Treatment Period||0
8169961|NCT02453555|20142343|P3|NOT COMPLETED|24-week Double-blind Treatment Period||0
8169962|NCT02453555|20142344|P2|NOT COMPLETED|24-week Double-blind Treatment Period||7
8169963|NCT02453555|20142345|P1|NOT COMPLETED|24-week Double-blind Treatment Period||5
8169964|NCT02453555|20142340|P6|COMPLETED|24-week Double-blind Treatment Period||0
8169965|NCT02453555|20142341|P5|COMPLETED|24-week Double-blind Treatment Period||0
8169966|NCT02453555|20142342|P4|COMPLETED|24-week Double-blind Treatment Period||0
8169967|NCT02453555|20142343|P3|COMPLETED|24-week Double-blind Treatment Period||0
8169968|NCT02453555|20142344|P2|COMPLETED|24-week Double-blind Treatment Period||86
8169969|NCT02453555|20142345|P1|COMPLETED|24-week Double-blind Treatment Period||177
8169970|NCT02453555|20142340|P6|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
8169971|NCT02453555|20142341|P5|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
8169972|NCT02453555|20142342|P4|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
8169973|NCT02453555|20142343|P3|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
8169974|NCT02453555|20142344|P2|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93
8169975|NCT02453555|20142345|P1|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182
8169976|NCT02453386|20142361|P3|NOT COMPLETED|Overall Study||41
8169977|NCT02453386|20142362|P2|NOT COMPLETED|Overall Study||49
8169978|NCT02453386|20142363|P1|NOT COMPLETED|Overall Study||49
8169979|NCT02453386|20142361|P3|COMPLETED|Overall Study||108
8169980|NCT02453386|20142362|P2|COMPLETED|Overall Study||100
8169981|NCT02453386|20142363|P1|COMPLETED|Overall Study||102
8169982|NCT02453386|20142361|P3|STARTED|Overall Study||149
8169983|NCT02453386|20142362|P2|STARTED|Overall Study||149
8169984|NCT02453386|20142363|P1|STARTED|Overall Study||151
8169985|NCT02453360|20142389|P3|NOT COMPLETED|Overall Study||0
8169986|NCT02453360|20142390|P2|NOT COMPLETED|Overall Study||0
8169987|NCT02453360|20142391|P1|NOT COMPLETED|Overall Study||0
8169988|NCT02453360|20142389|P3|COMPLETED|Overall Study||20
8169989|NCT02453360|20142390|P2|COMPLETED|Overall Study||20
8169990|NCT02453360|20142391|P1|COMPLETED|Overall Study||20
8169991|NCT02453360|20142389|P3|STARTED|Overall Study||20
8169992|NCT02453360|20142390|P2|STARTED|Overall Study||20
8169993|NCT02453360|20142391|P1|STARTED|Overall Study||20
8169994|NCT02453347|20142411|P1|NOT COMPLETED|Overall Study||0
8169995|NCT02453347|20142411|P1|COMPLETED|Overall Study||6
8169996|NCT02453347|20142411|P1|STARTED|Overall Study||6
8169997|NCT02453321|20142427|P3|NOT COMPLETED|Overall Study||2
8169998|NCT02453321|20142428|P2|NOT COMPLETED|Overall Study||2
8169999|NCT02453321|20142429|P1|NOT COMPLETED|Overall Study||1
8170000|NCT02453321|20142427|P3|COMPLETED|Overall Study||19
8170001|NCT02453321|20142428|P2|COMPLETED|Overall Study||19
8170002|NCT02453321|20142429|P1|COMPLETED|Overall Study||19
8170003|NCT02453321|20142427|P3|STARTED|Overall Study||21
8170004|NCT02453321|20142428|P2|STARTED|Overall Study||21
8170005|NCT02453321|20142429|P1|STARTED|Overall Study||20
8170018|NCT02453256|20142532|P2|NOT COMPLETED|Open Label Period||7
8170019|NCT02453256|20142533|P1|NOT COMPLETED|Open Label Period||7
8170020|NCT02453256|20142532|P2|COMPLETED|Open Label Period||85
8170021|NCT02453256|20142533|P1|COMPLETED|Open Label Period||82
8170022|NCT02453256|20142532|P2|STARTED|Open Label Period||92
8170023|NCT02453256|20142533|P1|STARTED|Open Label Period||89
8170024|NCT02453256|20142532|P2|NOT COMPLETED|Double Blind Period||9
8170025|NCT02453256|20142533|P1|NOT COMPLETED|Double Blind Period||13
8170026|NCT02453256|20142532|P2|COMPLETED|Double Blind Period||95
8170027|NCT02453256|20142533|P1|COMPLETED|Double Blind Period||93
8170028|NCT02453256|20142532|P2|STARTED|Double Blind Period||104
8170029|NCT02453256|20142533|P1|STARTED|Double Blind Period||106
8170033|NCT02453113|20142661|P1|NOT COMPLETED|Overall Study||0
8170034|NCT02453113|20142661|P1|COMPLETED|Overall Study||10
8170035|NCT02453113|20142661|P1|STARTED|Overall Study||10
8170036|NCT02453048|20142670|P5|NOT COMPLETED|Overall Study||6
8170037|NCT02453048|20142671|P4|NOT COMPLETED|Overall Study||0
8170038|NCT02453048|20142672|P3|NOT COMPLETED|Overall Study||2
8170039|NCT02453048|20142673|P2|NOT COMPLETED|Overall Study||1
8170040|NCT02453048|20142674|P1|NOT COMPLETED|Overall Study||0
8170041|NCT02453048|20142670|P5|COMPLETED|Overall Study||0
8170042|NCT02453048|20142671|P4|COMPLETED|Overall Study||12
8170043|NCT02453048|20142672|P3|COMPLETED|Overall Study||10
8170044|NCT02453048|20142673|P2|COMPLETED|Overall Study||11
8170045|NCT02453048|20142674|P1|COMPLETED|Overall Study||12
8170046|NCT02453048|20142670|P5|6-month Follow-up|Overall Study||6
8170047|NCT02453048|20142671|P4|6-month Follow-up|Overall Study||12
8170048|NCT02453048|20142672|P3|6-month Follow-up|Overall Study||12
8170049|NCT02453048|20142673|P2|6-month Follow-up|Overall Study||12
8170050|NCT02453048|20142674|P1|6-month Follow-up|Overall Study||12
8170051|NCT02453048|20142670|P5|STARTED|Overall Study||6
8170052|NCT02453048|20142671|P4|STARTED|Overall Study||12
8170053|NCT02453048|20142672|P3|STARTED|Overall Study||12
8170054|NCT02453048|20142673|P2|STARTED|Overall Study||12
8170055|NCT02453048|20142674|P1|STARTED|Overall Study||12
8170056|NCT02452944|20142698|P2|NOT COMPLETED|Overall Study||0
8170057|NCT02452944|20142699|P1|NOT COMPLETED|Overall Study||0
8170058|NCT02452944|20142698|P2|COMPLETED|Overall Study||31
8170059|NCT02452944|20142699|P1|COMPLETED|Overall Study||31
8170060|NCT02452944|20142698|P2|STARTED|Overall Study||31
8170061|NCT02452944|20142699|P1|STARTED|Overall Study||31
8170062|NCT02452931|20142707|P1|NOT COMPLETED|Overall Study||4
8170063|NCT02452931|20142707|P1|COMPLETED|Overall Study||60
8170064|NCT02452931|20142707|P1|STARTED|Overall Study||64
8170065|NCT02452892|20142734|P4|NOT COMPLETED|Follow-up||1
8170066|NCT02452892|20142735|P3|NOT COMPLETED|Follow-up||0
8170067|NCT02452892|20142736|P2|NOT COMPLETED|Follow-up||0
8170068|NCT02452892|20142737|P1|NOT COMPLETED|Follow-up||1
8170069|NCT02452892|20142734|P4|COMPLETED|Follow-up||38
8170070|NCT02452892|20142735|P3|COMPLETED|Follow-up||7
8170071|NCT02452892|20142736|P2|COMPLETED|Follow-up||7
8170072|NCT02452892|20142737|P1|COMPLETED|Follow-up||62
8170073|NCT02452892|20142734|P4|STARTED|Follow-up||39
8170074|NCT02452892|20142735|P3|STARTED|Follow-up||7
8170075|NCT02452892|20142736|P2|STARTED|Follow-up||7
8170076|NCT02452892|20142737|P1|STARTED|Follow-up||63
8170077|NCT02452892|20142734|P4|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
8170078|NCT02452892|20142735|P3|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
8170079|NCT02452892|20142736|P2|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
8170080|NCT02452892|20142737|P1|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
8170081|NCT02452892|20142734|P4|COMPLETED|Week 2 Stratification & Re-Randomization||39
8170082|NCT02452892|20142735|P3|COMPLETED|Week 2 Stratification & Re-Randomization||7
8170083|NCT02452892|20142736|P2|COMPLETED|Week 2 Stratification & Re-Randomization||7
8170084|NCT02452892|20142737|P1|COMPLETED|Week 2 Stratification & Re-Randomization||63
8170085|NCT02452892|20142734|P4|Responders|Week 2 Stratification & Re-Randomization||0
8170086|NCT02452892|20142735|P3|Responders|Week 2 Stratification & Re-Randomization||7
8170087|NCT02452892|20142736|P2|Responders|Week 2 Stratification & Re-Randomization||7
8170088|NCT02452892|20142737|P1|Responders|Week 2 Stratification & Re-Randomization||27
8170089|NCT02452892|20142734|P4|Non-reponders|Week 2 Stratification & Re-Randomization||41
8170090|NCT02452892|20142735|P3|Non-reponders|Week 2 Stratification & Re-Randomization||0
8170091|NCT02452892|20142736|P2|Non-reponders|Week 2 Stratification & Re-Randomization||0
8170092|NCT02452892|20142737|P1|Non-reponders|Week 2 Stratification & Re-Randomization||38
8170093|NCT02452892|20142734|P4|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
8170094|NCT02452892|20142735|P3|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
8170095|NCT02452892|20142736|P2|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
8170096|NCT02452892|20142737|P1|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
8170097|NCT02452892|20142734|P4|NOT COMPLETED|Week 1 Initial Randommization||0
8170098|NCT02452892|20142735|P3|NOT COMPLETED|Week 1 Initial Randommization||1
8170099|NCT02452892|20142736|P2|NOT COMPLETED|Week 1 Initial Randommization||0
8170100|NCT02452892|20142737|P1|NOT COMPLETED|Week 1 Initial Randommization||1
8170101|NCT02452892|20142734|P4|COMPLETED|Week 1 Initial Randommization||0
8170102|NCT02452892|20142735|P3|COMPLETED|Week 1 Initial Randommization||40
8170103|NCT02452892|20142736|P2|COMPLETED|Week 1 Initial Randommization||40
8170104|NCT02452892|20142737|P1|COMPLETED|Week 1 Initial Randommization||40
8170105|NCT02452892|20142734|P4|STARTED|Week 1 Initial Randommization||0
8170106|NCT02452892|20142735|P3|STARTED|Week 1 Initial Randommization||41
8170107|NCT02452892|20142736|P2|STARTED|Week 1 Initial Randommization||40
8170108|NCT02452892|20142737|P1|STARTED|Week 1 Initial Randommization||41
8170109|NCT02452554|20142772|P6|NOT COMPLETED|Overall Study||9
8170110|NCT02452554|20142773|P5|NOT COMPLETED|Overall Study||5
8170111|NCT02452554|20142774|P4|NOT COMPLETED|Overall Study||1
8170112|NCT02452554|20142775|P3|NOT COMPLETED|Overall Study||11
8170113|NCT02452554|20142776|P2|NOT COMPLETED|Overall Study||17
8170114|NCT02452554|20142777|P1|NOT COMPLETED|Overall Study||17
8170115|NCT02452554|20142772|P6|COMPLETED|Overall Study||1
8170116|NCT02452554|20142773|P5|COMPLETED|Overall Study||0
8170117|NCT02452554|20142774|P4|COMPLETED|Overall Study||0
8170118|NCT02452554|20142775|P3|COMPLETED|Overall Study||1
8170119|NCT02452554|20142776|P2|COMPLETED|Overall Study||0
8170120|NCT02452554|20142777|P1|COMPLETED|Overall Study||0
8170121|NCT02452554|20142772|P6|STARTED|Overall Study||10
8170122|NCT02452554|20142773|P5|STARTED|Overall Study||5
8170123|NCT02452554|20142774|P4|STARTED|Overall Study||1
8170124|NCT02452554|20142775|P3|STARTED|Overall Study||12
8170125|NCT02452554|20142776|P2|STARTED|Overall Study||17
8170126|NCT02452554|20142777|P1|STARTED|Overall Study||17
8170127|NCT02452528|20142794|P2|NOT COMPLETED|Overall Study||1
8170128|NCT02452528|20142795|P1|NOT COMPLETED|Overall Study||1
8170129|NCT02452528|20142794|P2|COMPLETED|Overall Study||1
8170130|NCT02452528|20142795|P1|COMPLETED|Overall Study||1
8170131|NCT02452528|20142794|P2|STARTED|Overall Study||2
8170132|NCT02452528|20142795|P1|STARTED|Overall Study||2
8170133|NCT02452463|20142830|P3|NOT COMPLETED|Overall Study||0
8170134|NCT02452463|20142831|P2|NOT COMPLETED|Overall Study||2
8170135|NCT02452463|20142832|P1|NOT COMPLETED|Overall Study||2
8170136|NCT02452463|20142830|P3|COMPLETED|Overall Study||0
8170137|NCT02452463|20142831|P2|COMPLETED|Overall Study||1
8170138|NCT02452463|20142832|P1|COMPLETED|Overall Study||3
8170139|NCT02452463|20142830|P3|STARTED|Overall Study|"No participants were enrolled in the Arm III (Nintedanib, Durvalumab) Arm."|0
8170140|NCT02452463|20142831|P2|STARTED|Overall Study||3
8170141|NCT02452463|20142832|P1|STARTED|Overall Study||5
8170142|NCT02452424|20142875|P11|NOT COMPLETED|Overall Study||2
8170143|NCT02452424|20142876|P10|NOT COMPLETED|Overall Study||2
8170144|NCT02452424|20142877|P9|NOT COMPLETED|Overall Study||6
8170145|NCT02452424|20142878|P8|NOT COMPLETED|Overall Study||4
8170146|NCT02452424|20142879|P7|NOT COMPLETED|Overall Study||10
8170147|NCT02452424|20142880|P6|NOT COMPLETED|Overall Study||1
8170148|NCT02452424|20142881|P5|NOT COMPLETED|Overall Study||2
8170149|NCT02452424|20142882|P4|NOT COMPLETED|Overall Study||8
8170150|NCT02452424|20142883|P3|NOT COMPLETED|Overall Study||7
8170151|NCT02452424|20142884|P2|NOT COMPLETED|Overall Study||3
8170152|NCT02452424|20142885|P1|NOT COMPLETED|Overall Study||2
8170153|NCT02452424|20142875|P11|COMPLETED|Overall Study||4
8170154|NCT02452424|20142876|P10|COMPLETED|Overall Study||1
8170155|NCT02452424|20142877|P9|COMPLETED|Overall Study||9
8170156|NCT02452424|20142878|P8|COMPLETED|Overall Study||4
8170157|NCT02452424|20142879|P7|COMPLETED|Overall Study||3
8170158|NCT02452424|20142880|P6|COMPLETED|Overall Study||5
8170159|NCT02452424|20142881|P5|COMPLETED|Overall Study||2
8170160|NCT02452424|20142882|P4|COMPLETED|Overall Study||1
8170161|NCT02452424|20142883|P3|COMPLETED|Overall Study||0
8170162|NCT02452424|20142884|P2|COMPLETED|Overall Study||0
8170163|NCT02452424|20142885|P1|COMPLETED|Overall Study||2
8170164|NCT02452424|20142875|P11|STARTED|Overall Study||6
8170165|NCT02452424|20142876|P10|STARTED|Overall Study||3
8170166|NCT02452424|20142877|P9|STARTED|Overall Study||15
8170167|NCT02452424|20142878|P8|STARTED|Overall Study||8
8170168|NCT02452424|20142879|P7|STARTED|Overall Study||13
8170169|NCT02452424|20142880|P6|STARTED|Overall Study||6
8170170|NCT02452424|20142881|P5|STARTED|Overall Study||4
8170171|NCT02452424|20142882|P4|STARTED|Overall Study||9
8170172|NCT02452424|20142883|P3|STARTED|Overall Study||7
8170173|NCT02452424|20142884|P2|STARTED|Overall Study||3
8170174|NCT02452424|20142885|P1|STARTED|Overall Study||4
8170175|NCT02452398|20142920|P1|NOT COMPLETED|Overall Study||41
8170176|NCT02452398|20142920|P1|COMPLETED|Overall Study|Study was halted prematurely. No results analysis completed.|38
8170177|NCT02452398|20142920|P1|STARTED|Overall Study|Study was halted prematurely. No results analysis completed.|79
8170178|NCT02452359|20142924|P1|NOT COMPLETED|Overall Study||21
8170179|NCT02452359|20142924|P1|COMPLETED|Overall Study||33
8170180|NCT02452359|20142924|P1|STARTED|Overall Study||54
8170181|NCT02452346|20142928|P1|NOT COMPLETED|Overall Study||9
8170182|NCT02452346|20142928|P1|COMPLETED|Overall Study||3
8170183|NCT02452346|20142928|P1|STARTED|Overall Study||12
8170184|NCT02452320|20142936|P2|NOT COMPLETED|Overall Study||1
8170185|NCT02452320|20142937|P1|NOT COMPLETED|Overall Study||0
8170186|NCT02452320|20142936|P2|COMPLETED|Overall Study||63
8170187|NCT02452320|20142937|P1|COMPLETED|Overall Study||64
8170188|NCT02452320|20142936|P2|STARTED|Overall Study||64
8170189|NCT02452320|20142937|P1|STARTED|Overall Study||64
8170190|NCT02452190|20142949|P2|NOT COMPLETED|Overall Study||24
8170191|NCT02452190|20142950|P1|NOT COMPLETED|Overall Study||35
8170192|NCT02452190|20142949|P2|COMPLETED|Overall Study||212
8170193|NCT02452190|20142950|P1|COMPLETED|Overall Study||197
8170194|NCT02452190|20142949|P2|Safety Population|Overall Study||237
8170195|NCT02452190|20142950|P1|Safety Population|Overall Study||231
8170196|NCT02452190|20142949|P2|Intent to Treat (ITT) Population|Overall Study||234
8170197|NCT02452190|20142950|P1|Intent to Treat (ITT) Population|Overall Study||230
8170198|NCT02452190|20142949|P2|STARTED|Overall Study||236
8170199|NCT02452190|20142950|P1|STARTED|Overall Study||232
8170200|NCT02452060|20142976|P2|NOT COMPLETED|Overall Study||0
8170201|NCT02452060|20142977|P1|NOT COMPLETED|Overall Study||0
8170202|NCT02452060|20142976|P2|COMPLETED|Overall Study||44
8170203|NCT02452060|20142977|P1|COMPLETED|Overall Study||46
8170204|NCT02452060|20142976|P2|STARTED|Overall Study||44
8170205|NCT02452060|20142977|P1|STARTED|Overall Study||46
8170206|NCT02452047|20142988|P3|NOT COMPLETED|Overall Study||2
8170207|NCT02452047|20142989|P2|NOT COMPLETED|Overall Study||5
8170208|NCT02452047|20142990|P1|NOT COMPLETED|Overall Study||4
8170209|NCT02452047|20142988|P3|COMPLETED|Overall Study||1
8170210|NCT02452047|20142989|P2|COMPLETED|Overall Study||11
8170211|NCT02452047|20142990|P1|COMPLETED|Overall Study||27
8170212|NCT02452047|20142988|P3|STARTED|Overall Study||3
8170213|NCT02452047|20142989|P2|STARTED|Overall Study||16
8170214|NCT02452047|20142990|P1|STARTED|Overall Study||31
8170215|NCT02452034|20143055|P6|NOT COMPLETED|Overall Study||3
8170216|NCT02452034|20143056|P5|NOT COMPLETED|Overall Study||1
8170217|NCT02452034|20143057|P4|NOT COMPLETED|Overall Study||1
8170218|NCT02452034|20143058|P3|NOT COMPLETED|Overall Study||1
8170219|NCT02452034|20143059|P2|NOT COMPLETED|Overall Study||1
8170220|NCT02452034|20143060|P1|NOT COMPLETED|Overall Study||2
8170221|NCT02452034|20143055|P6|COMPLETED|Overall Study||26
8170222|NCT02452034|20143056|P5|COMPLETED|Overall Study||19
8170223|NCT02452034|20143057|P4|COMPLETED|Overall Study||16
8170224|NCT02452034|20143058|P3|COMPLETED|Overall Study||14
8170225|NCT02452034|20143059|P2|COMPLETED|Overall Study||20
8170226|NCT02452034|20143060|P1|COMPLETED|Overall Study||14
8170227|NCT02452034|20143055|P6|Treated|Overall Study||29
8170228|NCT02452034|20143056|P5|Treated|Overall Study||20
8170229|NCT02452034|20143057|P4|Treated|Overall Study||16
8170230|NCT02452034|20143058|P3|Treated|Overall Study||15
8170231|NCT02452034|20143059|P2|Treated|Overall Study||21
8170232|NCT02452034|20143060|P1|Treated|Overall Study||14
8170233|NCT02452034|20143055|P6|STARTED|Overall Study||29
8170234|NCT02452034|20143056|P5|STARTED|Overall Study||20
8170235|NCT02452034|20143057|P4|STARTED|Overall Study||17
8170236|NCT02452034|20143058|P3|STARTED|Overall Study||15
8170237|NCT02452034|20143059|P2|STARTED|Overall Study||21
8170238|NCT02452034|20143060|P1|STARTED|Overall Study||16
8170239|NCT02451995|20143124|P2|NOT COMPLETED|Overall Study||0
8170240|NCT02451995|20143125|P1|NOT COMPLETED|Overall Study||0
8170241|NCT02451995|20143124|P2|COMPLETED|Overall Study||41
8170242|NCT02451995|20143125|P1|COMPLETED|Overall Study||42
8170243|NCT02451995|20143124|P2|STARTED|Overall Study||41
8170244|NCT02451995|20143125|P1|STARTED|Overall Study||42
8170255|NCT02451930|20143163|P2|NOT COMPLETED|Overall Study||30
8170256|NCT02451930|20143164|P1|NOT COMPLETED|Overall Study||2
8170257|NCT02451930|20143163|P2|COMPLETED|Overall Study||38
8170258|NCT02451930|20143164|P1|COMPLETED|Overall Study||1
8170259|NCT02451930|20143163|P2|Part C Participants|Overall Study||7
8170260|NCT02451930|20143164|P1|Part C Participants|Overall Study||0
8170261|NCT02451930|20143163|P2|Part B Participants|Overall Study||55
8170262|NCT02451930|20143164|P1|Part B Participants|Overall Study||0
8170263|NCT02451930|20143163|P2|Part A Cohort 2 Participants|Overall Study||6
8170264|NCT02451930|20143164|P1|Part A Cohort 2 Participants|Overall Study||0
8170265|NCT02451930|20143163|P2|Received at Least One Dose of Study Drug|Overall Study||68
8170266|NCT02451930|20143164|P1|Received at Least One Dose of Study Drug|Overall Study||3
8170267|NCT02451930|20143163|P2|STARTED|Overall Study||68
8170268|NCT02451930|20143164|P1|STARTED|Overall Study||3
8170269|NCT02451917|20143187|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
8170270|NCT02451917|20143188|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
8170271|NCT02451917|20143187|P2|COMPLETED|Second Intervention (24 Weeks)||15
8170272|NCT02451917|20143188|P1|COMPLETED|Second Intervention (24 Weeks)||14
8170273|NCT02451917|20143187|P2|STARTED|Second Intervention (24 Weeks)||15
8170274|NCT02451917|20143188|P1|STARTED|Second Intervention (24 Weeks)||14
8170275|NCT02451917|20143187|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
8170276|NCT02451917|20143188|P1|NOT COMPLETED|First Intervention (24 Weeks)||2
8170277|NCT02451917|20143187|P2|COMPLETED|First Intervention (24 Weeks)||15
8170278|NCT02451917|20143188|P1|COMPLETED|First Intervention (24 Weeks)||14
8170279|NCT02451917|20143187|P2|STARTED|First Intervention (24 Weeks)||18
8170280|NCT02451917|20143188|P1|STARTED|First Intervention (24 Weeks)||16
8170281|NCT02451839|20143206|P3|NOT COMPLETED|Overall Study||7
8170282|NCT02451839|20143207|P2|NOT COMPLETED|Overall Study||19
8170283|NCT02451839|20143208|P1|NOT COMPLETED|Overall Study||28
8170284|NCT02451839|20143206|P3|COMPLETED|Overall Study||30
8170285|NCT02451839|20143207|P2|COMPLETED|Overall Study||40
8170286|NCT02451839|20143208|P1|COMPLETED|Overall Study||44
8170287|NCT02451839|20143206|P3|Baseline WHODAS Data Recorded|Overall Study||37
8170288|NCT02451839|20143207|P2|Baseline WHODAS Data Recorded|Overall Study||57
8170289|NCT02451839|20143208|P1|Baseline WHODAS Data Recorded|Overall Study||70
8170290|NCT02451839|20143206|P3|STARTED|Overall Study||37
8170291|NCT02451839|20143207|P2|STARTED|Overall Study||59
8170292|NCT02451839|20143208|P1|STARTED|Overall Study||72
8170293|NCT02451670|20143230|P2|NOT COMPLETED|Overall Study||696
8170294|NCT02451670|20143231|P1|NOT COMPLETED|Overall Study||714
8170295|NCT02451670|20143230|P2|COMPLETED|Overall Study||4387
8170296|NCT02451670|20143231|P1|COMPLETED|Overall Study||4550
8170297|NCT02451670|20143230|P2|STARTED|Overall Study||5083
8170298|NCT02451670|20143231|P1|STARTED|Overall Study||5264
8170299|NCT02451514|20143240|P3|NOT COMPLETED|Overall Study||0
8170300|NCT02451514|20143241|P2|NOT COMPLETED|Overall Study||0
8170301|NCT02451514|20143242|P1|NOT COMPLETED|Overall Study||0
8170302|NCT02451514|20143240|P3|COMPLETED|Overall Study||50
8170303|NCT02451514|20143241|P2|COMPLETED|Overall Study||46
8170304|NCT02451514|20143242|P1|COMPLETED|Overall Study||33
8170305|NCT02451514|20143240|P3|STARTED|Overall Study||50
8170306|NCT02451514|20143241|P2|STARTED|Overall Study||46
8170307|NCT02451514|20143242|P1|STARTED|Overall Study||33
8170308|NCT02451488|20143330|P2|NOT COMPLETED|Overall Study||0
8170309|NCT02451488|20143331|P1|NOT COMPLETED|Overall Study||0
8170310|NCT02451488|20143330|P2|COMPLETED|Overall Study||4
8170311|NCT02451488|20143331|P1|COMPLETED|Overall Study||4
8170312|NCT02451488|20143330|P2|STARTED|Overall Study||4
8170313|NCT02451488|20143331|P1|STARTED|Overall Study||4
8170314|NCT02451358|20143341|P4|NOT COMPLETED|Overall Study||0
8170315|NCT02451358|20143342|P3|NOT COMPLETED|Overall Study||1
8170316|NCT02451358|20143343|P2|NOT COMPLETED|Overall Study||2
8170317|NCT02451358|20143344|P1|NOT COMPLETED|Overall Study||1
8170318|NCT02451358|20143341|P4|COMPLETED|Overall Study||100
8170319|NCT02451358|20143342|P3|COMPLETED|Overall Study||99
8170320|NCT02451358|20143343|P2|COMPLETED|Overall Study||98
8170321|NCT02451358|20143344|P1|COMPLETED|Overall Study||99
8170322|NCT02451358|20143341|P4|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
8170323|NCT02451358|20143342|P3|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
8170324|NCT02451358|20143343|P2|Vaccinated at Day 28|Overall Study||98
8170325|NCT02451358|20143344|P1|Vaccinated at Day 28|Overall Study||99
8170326|NCT02451358|20143341|P4|Vaccinated at Day 0|Overall Study||100
8170327|NCT02451358|20143342|P3|Vaccinated at Day 0|Overall Study||100
8170328|NCT02451358|20143343|P2|Vaccinated at Day 0|Overall Study||100
8170329|NCT02451358|20143344|P1|Vaccinated at Day 0|Overall Study||100
8170330|NCT02451358|20143341|P4|STARTED|Overall Study||100
8170331|NCT02451358|20143342|P3|STARTED|Overall Study||100
8170332|NCT02451358|20143343|P2|STARTED|Overall Study||100
8170333|NCT02451358|20143344|P1|STARTED|Overall Study||100
8170334|NCT02451202|20143368|P2|NOT COMPLETED|Overall Study||3
8170335|NCT02451202|20143369|P1|NOT COMPLETED|Overall Study||2
8170336|NCT02451202|20143368|P2|COMPLETED|Overall Study||48
8170337|NCT02451202|20143369|P1|COMPLETED|Overall Study||49
8170338|NCT02451202|20143368|P2|STARTED|Overall Study||51
8170339|NCT02451202|20143369|P1|STARTED|Overall Study||51
8170340|NCT02451150|20143379|P2|NOT COMPLETED|Overall Study||0
8170341|NCT02451150|20143380|P1|NOT COMPLETED|Overall Study||0
8170342|NCT02451150|20143379|P2|COMPLETED|Overall Study||3
8170343|NCT02451150|20143380|P1|COMPLETED|Overall Study||3
8170344|NCT02451150|20143379|P2|STARTED|Overall Study||3
8170345|NCT02451150|20143380|P1|STARTED|Overall Study||3
8170346|NCT02451137|20143432|P2|NOT COMPLETED|Overall Study||298
8170347|NCT02451137|20143433|P1|NOT COMPLETED|Overall Study||246
8170348|NCT02451137|20143432|P2|COMPLETED|Overall Study||1355
8170349|NCT02451137|20143433|P1|COMPLETED|Overall Study||1405
8170350|NCT02451137|20143432|P2|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621
8170351|NCT02451137|20143433|P1|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637
8170352|NCT02451137|20143432|P2|Treated|Overall Study||1626
8170353|NCT02451137|20143433|P1|Treated|Overall Study||1632
8170354|NCT02451137|20143432|P2|STARTED|Overall Study||1653
8170355|NCT02451137|20143433|P1|STARTED|Overall Study||1651
8170356|NCT02451124|20143463|P1|NOT COMPLETED|Overall Study||1
8170357|NCT02451124|20143463|P1|COMPLETED|Overall Study||155
8170358|NCT02451124|20143463|P1|STARTED|Overall Study||156
8170359|NCT02451007|20143474|P1|NOT COMPLETED|Overall Study||7
8170360|NCT02451007|20143474|P1|COMPLETED|Overall Study||32
8170361|NCT02451007|20143474|P1|STARTED|Overall Study||39
8170367|NCT02450799|20143495|P3|NOT COMPLETED|Overall Study||0
8170368|NCT02450799|20143496|P2|NOT COMPLETED|Overall Study||0
8170369|NCT02450799|20143497|P1|NOT COMPLETED|Overall Study||0
8170370|NCT02450799|20143495|P3|COMPLETED|Overall Study||30
8170371|NCT02450799|20143496|P2|COMPLETED|Overall Study||37
8170372|NCT02450799|20143497|P1|COMPLETED|Overall Study||31
8170373|NCT02450799|20143495|P3|STARTED|Overall Study||30
8170374|NCT02450799|20143496|P2|STARTED|Overall Study||37
8170375|NCT02450799|20143497|P1|STARTED|Overall Study||31
8170376|NCT02450747|20143508|P1|NOT COMPLETED|Overall Study||0
8170377|NCT02450747|20143508|P1|COMPLETED|Overall Study||39
8170378|NCT02450747|20143508|P1|STARTED|Overall Study||39
8170379|NCT02450591|20143517|P1|NOT COMPLETED|Overall Study||0
8170380|NCT02450591|20143517|P1|COMPLETED|Overall Study||4
8170381|NCT02450591|20143517|P1|STARTED|Overall Study||4
8170382|NCT02450578|20143525|P4|NOT COMPLETED|Overall Study||0
8170383|NCT02450578|20143526|P3|NOT COMPLETED|Overall Study||0
8170384|NCT02450578|20143527|P2|NOT COMPLETED|Overall Study||0
8170385|NCT02450578|20143528|P1|NOT COMPLETED|Overall Study||1
8170386|NCT02450578|20143525|P4|COMPLETED|Overall Study||4
8170387|NCT02450578|20143526|P3|COMPLETED|Overall Study||6
8170388|NCT02450578|20143527|P2|COMPLETED|Overall Study||6
8170389|NCT02450578|20143528|P1|COMPLETED|Overall Study||5
8170390|NCT02450578|20143525|P4|STARTED|Overall Study||4
8170391|NCT02450578|20143526|P3|STARTED|Overall Study||6
8170392|NCT02450578|20143527|P2|STARTED|Overall Study||6
8170393|NCT02450578|20143528|P1|STARTED|Overall Study||6
8170394|NCT02450552|20143574|P3|NOT COMPLETED|Overall Study||5
8170395|NCT02450552|20143575|P2|NOT COMPLETED|Overall Study||0
8170396|NCT02450552|20143576|P1|NOT COMPLETED|Overall Study||5
8170397|NCT02450552|20143574|P3|COMPLETED|Overall Study||18
8170398|NCT02450552|20143575|P2|COMPLETED|Overall Study||23
8170399|NCT02450552|20143576|P1|COMPLETED|Overall Study||14
8170400|NCT02450552|20143574|P3|STARTED|Overall Study||23
8170401|NCT02450552|20143575|P2|STARTED|Overall Study||23
8170402|NCT02450552|20143576|P1|STARTED|Overall Study||19
8170413|NCT02450526|20143644|P5|NOT COMPLETED|OL Period (Cycles 2-5)||41
8170414|NCT02450526|20143645|P4|NOT COMPLETED|OL Period (Cycles 2-5)||0
8170415|NCT02450526|20143646|P3|NOT COMPLETED|OL Period (Cycles 2-5)||0
8170416|NCT02450526|20143647|P2|NOT COMPLETED|OL Period (Cycles 2-5)||0
8170417|NCT02450526|20143648|P1|NOT COMPLETED|OL Period (Cycles 2-5)||0
8170418|NCT02450526|20143644|P5|COMPLETED|OL Period (Cycles 2-5)||424
8170419|NCT02450526|20143645|P4|COMPLETED|OL Period (Cycles 2-5)||0
8170420|NCT02450526|20143646|P3|COMPLETED|OL Period (Cycles 2-5)||0
8170421|NCT02450526|20143647|P2|COMPLETED|OL Period (Cycles 2-5)||0
8170422|NCT02450526|20143648|P1|COMPLETED|OL Period (Cycles 2-5)||0
8170423|NCT02450526|20143644|P5|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8170424|NCT02450526|20143645|P4|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8170425|NCT02450526|20143646|P3|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8170426|NCT02450526|20143647|P2|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8170427|NCT02450526|20143648|P1|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
8170428|NCT02450526|20143644|P5|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2
8170429|NCT02450526|20143645|P4|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
8170430|NCT02450526|20143646|P3|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
8170431|NCT02450526|20143647|P2|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
8170432|NCT02450526|20143648|P1|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
8170433|NCT02450526|20143644|P5|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11
8170434|NCT02450526|20143645|P4|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
8170435|NCT02450526|20143646|P3|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
8170436|NCT02450526|20143647|P2|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
8170437|NCT02450526|20143648|P1|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
8170438|NCT02450526|20143644|P5|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28
8170439|NCT02450526|20143645|P4|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
8170440|NCT02450526|20143646|P3|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
8170441|NCT02450526|20143647|P2|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
8170442|NCT02450526|20143648|P1|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
8170443|NCT02450526|20143644|P5|Safety Population|OL Period (Cycles 2-5)||465
8170444|NCT02450526|20143645|P4|Safety Population|OL Period (Cycles 2-5)||0
8170445|NCT02450526|20143646|P3|Safety Population|OL Period (Cycles 2-5)||0
8170446|NCT02450526|20143647|P2|Safety Population|OL Period (Cycles 2-5)||0
8170447|NCT02450526|20143648|P1|Safety Population|OL Period (Cycles 2-5)||0
8170448|NCT02450526|20143644|P5|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465
8170449|NCT02450526|20143645|P4|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
8170450|NCT02450526|20143646|P3|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
8170451|NCT02450526|20143647|P2|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
8170452|NCT02450526|20143648|P1|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
8170453|NCT02450526|20143644|P5|NOT COMPLETED|DB Period (Cycle 1)||0
8170454|NCT02450526|20143645|P4|NOT COMPLETED|DB Period (Cycle 1)||2
8170455|NCT02450526|20143646|P3|NOT COMPLETED|DB Period (Cycle 1)||10
8170456|NCT02450526|20143647|P2|NOT COMPLETED|DB Period (Cycle 1)||3
8170457|NCT02450526|20143648|P1|NOT COMPLETED|DB Period (Cycle 1)||31
8170458|NCT02450526|20143644|P5|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
8170459|NCT02450526|20143645|P4|COMPLETED|DB Period (Cycle 1)||20
8170460|NCT02450526|20143646|P3|COMPLETED|DB Period (Cycle 1)||97
8170461|NCT02450526|20143647|P2|COMPLETED|DB Period (Cycle 1)||63
8170462|NCT02450526|20143648|P1|COMPLETED|DB Period (Cycle 1)||294
8170463|NCT02450526|20143644|P5|Safety Population|DB Period (Cycle 1)||0
8170464|NCT02450526|20143645|P4|Safety Population|DB Period (Cycle 1)||21
8170465|NCT02450526|20143646|P3|Safety Population|DB Period (Cycle 1)||107
8170466|NCT02450526|20143647|P2|Safety Population|DB Period (Cycle 1)||66
8170467|NCT02450526|20143648|P1|Safety Population|DB Period (Cycle 1)||326
8170468|NCT02450526|20143644|P5|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
8170469|NCT02450526|20143645|P4|STARTED|DB Period (Cycle 1)||22
8170470|NCT02450526|20143646|P3|STARTED|DB Period (Cycle 1)||107
8170471|NCT02450526|20143647|P2|STARTED|DB Period (Cycle 1)||66
8170472|NCT02450526|20143648|P1|STARTED|DB Period (Cycle 1)||325
8170473|NCT02450487|20143733|P1|NOT COMPLETED|Overall Study||3
8170474|NCT02450487|20143733|P1|COMPLETED|Overall Study||102
8170475|NCT02450487|20143733|P1|STARTED|Overall Study||105
8170476|NCT02450383|20143740|P2|NOT COMPLETED|Overall Study||0
8170477|NCT02450383|20143741|P1|NOT COMPLETED|Overall Study||0
8170478|NCT02450383|20143740|P2|COMPLETED|Overall Study||10
8170479|NCT02450383|20143741|P1|COMPLETED|Overall Study||10
8170480|NCT02450383|20143740|P2|STARTED|Overall Study||10
8170481|NCT02450383|20143741|P1|STARTED|Overall Study||10
8170488|NCT02449915|20143779|P2|NOT COMPLETED|Overall Study||4
8170489|NCT02449915|20143780|P1|NOT COMPLETED|Overall Study||2
8170490|NCT02449915|20143779|P2|COMPLETED|Overall Study||31
8170491|NCT02449915|20143780|P1|COMPLETED|Overall Study||33
8170492|NCT02449915|20143779|P2|STARTED|Overall Study||35
8170493|NCT02449915|20143780|P1|STARTED|Overall Study||35
8170494|NCT02449902|20143788|P2|NOT COMPLETED|Overall Study||2
8170495|NCT02449902|20143789|P1|NOT COMPLETED|Overall Study||0
8170496|NCT02449902|20143788|P2|COMPLETED|Overall Study||24
8170497|NCT02449902|20143789|P1|COMPLETED|Overall Study||24
8170498|NCT02449902|20143788|P2|STARTED|Overall Study||26
8170499|NCT02449902|20143789|P1|STARTED|Overall Study||24
8170500|NCT02449889|20143816|P3|NOT COMPLETED|Overall Study||1
8170501|NCT02449889|20143817|P2|NOT COMPLETED|Overall Study||6
8170502|NCT02449889|20143818|P1|NOT COMPLETED|Overall Study||1
8170503|NCT02449889|20143816|P3|COMPLETED|Overall Study||59
8170504|NCT02449889|20143817|P2|COMPLETED|Overall Study||52
8170505|NCT02449889|20143818|P1|COMPLETED|Overall Study||57
8170506|NCT02449889|20143816|P3|STARTED|Overall Study||60
8170507|NCT02449889|20143817|P2|STARTED|Overall Study||58
8170508|NCT02449889|20143818|P1|STARTED|Overall Study||58
8170509|NCT02449798|20143844|P1|NOT COMPLETED|Overall Study||0
8170510|NCT02449798|20143844|P1|COMPLETED|Overall Study||120
8170511|NCT02449798|20143844|P1|STARTED|Overall Study||120
8170512|NCT02449473|20143858|P2|NOT COMPLETED|Overall Study||0
8170513|NCT02449473|20143859|P1|NOT COMPLETED|Overall Study||0
8170514|NCT02449473|20143858|P2|COMPLETED|Overall Study||40
8170515|NCT02449473|20143859|P1|COMPLETED|Overall Study||39
8170516|NCT02449473|20143858|P2|STARTED|Overall Study||40
8170517|NCT02449473|20143859|P1|STARTED|Overall Study||39
8170518|NCT02449434|20143875|P2|NOT COMPLETED|Overall Study||0
8170519|NCT02449434|20143876|P1|NOT COMPLETED|Overall Study||0
8170520|NCT02449434|20143875|P2|COMPLETED|Overall Study||300
8170521|NCT02449434|20143876|P1|COMPLETED|Overall Study||300
8170522|NCT02449434|20143875|P2|STARTED|Overall Study||300
8170523|NCT02449434|20143876|P1|STARTED|Overall Study||300
8170524|NCT02449356|20143884|P2|NOT COMPLETED|Overall Study||0
8170525|NCT02449356|20143885|P1|NOT COMPLETED|Overall Study||0
8170526|NCT02449356|20143884|P2|COMPLETED|Overall Study||30
8170527|NCT02449356|20143885|P1|COMPLETED|Overall Study||30
8170528|NCT02449356|20143884|P2|STARTED|Overall Study||30
8170529|NCT02449356|20143885|P1|STARTED|Overall Study||30
8170530|NCT02449291|20143904|P3|NOT COMPLETED|Overall Study||1
8170531|NCT02449291|20143905|P2|NOT COMPLETED|Overall Study||2
8170532|NCT02449291|20143906|P1|NOT COMPLETED|Overall Study||5
8170533|NCT02449291|20143904|P3|COMPLETED|Overall Study||180
8170534|NCT02449291|20143905|P2|COMPLETED|Overall Study||186
8170535|NCT02449291|20143906|P1|COMPLETED|Overall Study||186
8170536|NCT02449291|20143904|P3|STARTED|Overall Study||181
8170537|NCT02449291|20143905|P2|STARTED|Overall Study||188
8170538|NCT02449291|20143906|P1|STARTED|Overall Study||191
8170539|NCT02449174|20143943|P2|NOT COMPLETED|Overall Study||0
8170540|NCT02449174|20143944|P1|NOT COMPLETED|Overall Study||0
8170541|NCT02449174|20143943|P2|COMPLETED|Overall Study||32
8170542|NCT02449174|20143944|P1|COMPLETED|Overall Study||36
8170543|NCT02449174|20143943|P2|STARTED|Overall Study||32
8170544|NCT02449174|20143944|P1|STARTED|Overall Study||36
8170545|NCT02449044|20143952|P1|NOT COMPLETED|Overall Study||64
8170546|NCT02449044|20143952|P1|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
8170547|NCT02449044|20143952|P1|STARTED|Overall Study||111
8170548|NCT02449018|20143973|P2|NOT COMPLETED|Overall Study||2
8170549|NCT02449018|20143974|P1|NOT COMPLETED|Overall Study||12
8170550|NCT02449018|20143973|P2|COMPLETED|Overall Study||26
8170551|NCT02449018|20143974|P1|COMPLETED|Overall Study||52
8170552|NCT02449018|20143973|P2|STARTED|Overall Study||28
8170553|NCT02449018|20143974|P1|STARTED|Overall Study||64
8170554|NCT02448914|20144001|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8170555|NCT02448914|20144002|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8170556|NCT02448914|20144001|P2|COMPLETED|Second Intervention (1 Day)||5
8170557|NCT02448914|20144002|P1|COMPLETED|Second Intervention (1 Day)||6
8170558|NCT02448914|20144001|P2|STARTED|Second Intervention (1 Day)||5
8170559|NCT02448914|20144002|P1|STARTED|Second Intervention (1 Day)||6
8170560|NCT02448914|20144001|P2|NOT COMPLETED|First Intervention (1 Day)||0
8170561|NCT02448914|20144002|P1|NOT COMPLETED|First Intervention (1 Day)||0
8170562|NCT02448914|20144001|P2|COMPLETED|First Intervention (1 Day)||5
8170563|NCT02448914|20144002|P1|COMPLETED|First Intervention (1 Day)||6
8170564|NCT02448914|20144001|P2|STARTED|First Intervention (1 Day)||5
8170565|NCT02448914|20144002|P1|STARTED|First Intervention (1 Day)||6
8170566|NCT02448875|20144021|P3|NOT COMPLETED|Overall Study||1
8170567|NCT02448875|20144022|P2|NOT COMPLETED|Overall Study||1
8170568|NCT02448875|20144023|P1|NOT COMPLETED|Overall Study||7
8170569|NCT02448875|20144021|P3|COMPLETED|Overall Study||60
8170570|NCT02448875|20144022|P2|COMPLETED|Overall Study||20
8170571|NCT02448875|20144023|P1|COMPLETED|Overall Study||53
8170572|NCT02448875|20144021|P3|Safety Analysis Set|Overall Study||61
8170573|NCT02448875|20144022|P2|Safety Analysis Set|Overall Study||21
8170574|NCT02448875|20144023|P1|Safety Analysis Set|Overall Study||60
8170575|NCT02448875|20144021|P3|Full Analysis Set|Overall Study||61
8170576|NCT02448875|20144022|P2|Full Analysis Set|Overall Study||21
8170577|NCT02448875|20144023|P1|Full Analysis Set|Overall Study||60
8170578|NCT02448875|20144021|P3|Completed Dose Selection Phase|Overall Study||20
8170579|NCT02448875|20144022|P2|Completed Dose Selection Phase|Overall Study||21
8170580|NCT02448875|20144023|P1|Completed Dose Selection Phase|Overall Study||20
8170581|NCT02448875|20144021|P3|STARTED|Overall Study||61
8170582|NCT02448875|20144022|P2|STARTED|Overall Study||21
8170583|NCT02448875|20144023|P1|STARTED|Overall Study||60
8170584|NCT02448862|20144048|P2|NOT COMPLETED|Overall Study||0
8170585|NCT02448862|20144049|P1|NOT COMPLETED|Overall Study||0
8170586|NCT02448862|20144048|P2|COMPLETED|Overall Study||6050
8170587|NCT02448862|20144049|P1|COMPLETED|Overall Study||4525
8170588|NCT02448862|20144048|P2|STARTED|Overall Study||6050
8170589|NCT02448862|20144049|P1|STARTED|Overall Study||4525
8170622|NCT02448719|20144155|P11|NOT COMPLETED|Overall Study||0
8170623|NCT02448719|20144156|P10|NOT COMPLETED|Overall Study||0
8170624|NCT02448719|20144157|P9|NOT COMPLETED|Overall Study||0
8170625|NCT02448719|20144158|P8|NOT COMPLETED|Overall Study||0
8170626|NCT02448719|20144159|P7|NOT COMPLETED|Overall Study||0
8170627|NCT02448719|20144160|P6|NOT COMPLETED|Overall Study||0
8170628|NCT02448719|20144161|P5|NOT COMPLETED|Overall Study||1
8170629|NCT02448719|20144162|P4|NOT COMPLETED|Overall Study||0
8170630|NCT02448719|20144163|P3|NOT COMPLETED|Overall Study||0
8170631|NCT02448719|20144164|P2|NOT COMPLETED|Overall Study||0
8170632|NCT02448719|20144165|P1|NOT COMPLETED|Overall Study||0
8170633|NCT02448719|20144155|P11|COMPLETED|Overall Study||6
8170634|NCT02448719|20144156|P10|COMPLETED|Overall Study||6
8170635|NCT02448719|20144157|P9|COMPLETED|Overall Study||6
8170636|NCT02448719|20144158|P8|COMPLETED|Overall Study||6
8170637|NCT02448719|20144159|P7|COMPLETED|Overall Study||6
8170638|NCT02448719|20144160|P6|COMPLETED|Overall Study||6
8170639|NCT02448719|20144161|P5|COMPLETED|Overall Study||5
8170640|NCT02448719|20144162|P4|COMPLETED|Overall Study||6
8170641|NCT02448719|20144163|P3|COMPLETED|Overall Study||6
8170642|NCT02448719|20144164|P2|COMPLETED|Overall Study||6
8170643|NCT02448719|20144165|P1|COMPLETED|Overall Study||12
8170644|NCT02448719|20144155|P11|STARTED|Overall Study||6
8170645|NCT02448719|20144156|P10|STARTED|Overall Study||6
8170646|NCT02448719|20144157|P9|STARTED|Overall Study||6
8170647|NCT02448719|20144158|P8|STARTED|Overall Study||6
8170648|NCT02448719|20144159|P7|STARTED|Overall Study||6
8170649|NCT02448719|20144160|P6|STARTED|Overall Study||6
8170650|NCT02448719|20144161|P5|STARTED|Overall Study||6
8170651|NCT02448719|20144162|P4|STARTED|Overall Study||6
8170652|NCT02448719|20144163|P3|STARTED|Overall Study||6
8170653|NCT02448719|20144164|P2|STARTED|Overall Study||6
8170654|NCT02448719|20144165|P1|STARTED|Overall Study||12
8170655|NCT02448706|20144389|P2|NOT COMPLETED|Overall Study||4
8170656|NCT02448706|20144390|P1|NOT COMPLETED|Overall Study||5
8170657|NCT02448706|20144389|P2|COMPLETED|Overall Study||20
8170658|NCT02448706|20144390|P1|COMPLETED|Overall Study||20
8170659|NCT02448706|20144389|P2|Completed Baseline Testing|Overall Study||23
8170660|NCT02448706|20144390|P1|Completed Baseline Testing|Overall Study||24
8170661|NCT02448706|20144389|P2|Withdrew for Personal Reasons|Overall Study||1
8170662|NCT02448706|20144390|P1|Withdrew for Personal Reasons|Overall Study||1
8170663|NCT02448706|20144389|P2|STARTED|Overall Study||24
8170664|NCT02448706|20144390|P1|STARTED|Overall Study||25
8170665|NCT02448680|20144404|P2|NOT COMPLETED|Overall Study||3
8170666|NCT02448680|20144405|P1|NOT COMPLETED|Overall Study||1
8170667|NCT02448680|20144404|P2|COMPLETED|Overall Study||10
8170668|NCT02448680|20144405|P1|COMPLETED|Overall Study||11
8170669|NCT02448680|20144404|P2|STARTED|Overall Study||13
8170670|NCT02448680|20144405|P1|STARTED|Overall Study||12
8170671|NCT02448654|20144425|P2|NOT COMPLETED|Overall Study||4
8170672|NCT02448654|20144426|P1|NOT COMPLETED|Overall Study||3
8170673|NCT02448654|20144425|P2|COMPLETED|Overall Study||13
8170674|NCT02448654|20144426|P1|COMPLETED|Overall Study||16
8170675|NCT02448654|20144425|P2|Started Pills (Tolcapone or Placebo)|Overall Study||15
8170676|NCT02448654|20144426|P1|Started Pills (Tolcapone or Placebo)|Overall Study||17
8170677|NCT02448654|20144425|P2|STARTED|Overall Study||17
8170678|NCT02448654|20144426|P1|STARTED|Overall Study||19
8170679|NCT02448641|20144439|P3|NOT COMPLETED|Overall Study||4
8170680|NCT02448641|20144440|P2|NOT COMPLETED|Overall Study||5
8170681|NCT02448641|20144441|P1|NOT COMPLETED|Overall Study||1
8170682|NCT02448641|20144439|P3|COMPLETED|Overall Study||48
8170683|NCT02448641|20144440|P2|COMPLETED|Overall Study||51
8170684|NCT02448641|20144441|P1|COMPLETED|Overall Study||54
8170685|NCT02448641|20144439|P3|STARTED|Overall Study||52
8170686|NCT02448641|20144440|P2|STARTED|Overall Study||56
8170687|NCT02448641|20144441|P1|STARTED|Overall Study||55
8170688|NCT02448563|20144474|P2|NOT COMPLETED|Overall Study||11
8170689|NCT02448563|20144475|P1|NOT COMPLETED|Overall Study||16
8170690|NCT02448563|20144474|P2|COMPLETED|Overall Study||19
8170691|NCT02448563|20144475|P1|COMPLETED|Overall Study||16
8170692|NCT02448563|20144474|P2|STARTED|Overall Study|Randomized after completing Visit 2|30
8170693|NCT02448563|20144475|P1|STARTED|Overall Study|Randomized after completing Visit 2|32
8170703|NCT02448368|20144515|P13|NOT COMPLETED|Overall Study||0
8170704|NCT02448368|20144516|P12|NOT COMPLETED|Overall Study||0
8170705|NCT02448368|20144517|P11|NOT COMPLETED|Overall Study||0
8170706|NCT02448368|20144518|P10|NOT COMPLETED|Overall Study||0
8170707|NCT02448368|20144519|P9|NOT COMPLETED|Overall Study||0
8170708|NCT02448368|20144520|P8|NOT COMPLETED|Overall Study||0
8170709|NCT02448368|20144521|P7|NOT COMPLETED|Overall Study||0
8170710|NCT02448368|20144522|P6|NOT COMPLETED|Overall Study||0
8170711|NCT02448368|20144523|P5|NOT COMPLETED|Overall Study||0
8170712|NCT02448368|20144524|P4|NOT COMPLETED|Overall Study||0
8170713|NCT02448368|20144525|P3|NOT COMPLETED|Overall Study||0
8170714|NCT02448368|20144526|P2|NOT COMPLETED|Overall Study||0
8170715|NCT02448368|20144527|P1|NOT COMPLETED|Overall Study||0
8170716|NCT02448368|20144515|P13|COMPLETED|Overall Study||5
8170717|NCT02448368|20144516|P12|COMPLETED|Overall Study||5
8170718|NCT02448368|20144517|P11|COMPLETED|Overall Study||5
8170719|NCT02448368|20144518|P10|COMPLETED|Overall Study||2
8170720|NCT02448368|20144519|P9|COMPLETED|Overall Study||2
8170721|NCT02448368|20144520|P8|COMPLETED|Overall Study||2
8170722|NCT02448368|20144521|P7|COMPLETED|Overall Study||2
8170723|NCT02448368|20144522|P6|COMPLETED|Overall Study||2
8170724|NCT02448368|20144523|P5|COMPLETED|Overall Study||2
8170725|NCT02448368|20144524|P4|COMPLETED|Overall Study||2
8170726|NCT02448368|20144525|P3|COMPLETED|Overall Study||2
8170727|NCT02448368|20144526|P2|COMPLETED|Overall Study||2
8170728|NCT02448368|20144527|P1|COMPLETED|Overall Study||2
8170729|NCT02448368|20144515|P13|STARTED|Overall Study||5
8170730|NCT02448368|20144516|P12|STARTED|Overall Study||5
8170731|NCT02448368|20144517|P11|STARTED|Overall Study||5
8170732|NCT02448368|20144518|P10|STARTED|Overall Study||2
8170733|NCT02448368|20144519|P9|STARTED|Overall Study||2
8170734|NCT02448368|20144520|P8|STARTED|Overall Study||2
8170735|NCT02448368|20144521|P7|STARTED|Overall Study||2
8170736|NCT02448368|20144522|P6|STARTED|Overall Study||2
8170737|NCT02448368|20144523|P5|STARTED|Overall Study||2
8170738|NCT02448368|20144524|P4|STARTED|Overall Study||2
8170739|NCT02448368|20144525|P3|STARTED|Overall Study||2
8170740|NCT02448368|20144526|P2|STARTED|Overall Study||2
8170741|NCT02448368|20144527|P1|STARTED|Overall Study||2
8170742|NCT02448303|20144604|P2|NOT COMPLETED|Overall Study||36
8170743|NCT02448303|20144605|P1|NOT COMPLETED|Overall Study||38
8170744|NCT02448303|20144604|P2|COMPLETED|Overall Study||0
8170745|NCT02448303|20144605|P1|COMPLETED|Overall Study||0
8170746|NCT02448303|20144604|P2|Discontinued Study|Overall Study||36
8170747|NCT02448303|20144605|P1|Discontinued Study|Overall Study||38
8170748|NCT02448303|20144604|P2|Received Study Medication|Overall Study||35
8170749|NCT02448303|20144605|P1|Received Study Medication|Overall Study||33
8170750|NCT02448303|20144604|P2|Enrolled|Overall Study||36
8170751|NCT02448303|20144605|P1|Enrolled|Overall Study||38
8170752|NCT02448303|20144604|P2|STARTED|Overall Study||36
8170753|NCT02448303|20144605|P1|STARTED|Overall Study||38
8170754|NCT02448043|20144613|P2|NOT COMPLETED|Overall Study||4
8170755|NCT02448043|20144614|P1|NOT COMPLETED|Overall Study||3
8170756|NCT02448043|20144613|P2|COMPLETED|Overall Study||18
8170757|NCT02448043|20144614|P1|COMPLETED|Overall Study||20
8170758|NCT02448043|20144613|P2|STARTED|Overall Study||22
8170759|NCT02448043|20144614|P1|STARTED|Overall Study||23
8170760|NCT02447952|20144632|P1|NOT COMPLETED|Overall Study||7
8170761|NCT02447952|20144632|P1|COMPLETED|Overall Study||18
8170762|NCT02447952|20144632|P1|STARTED|Overall Study||25
8170763|NCT02447926|20144684|P1|NOT COMPLETED|Overall Study||0
8170764|NCT02447926|20144684|P1|COMPLETED|Overall Study||1
8170765|NCT02447926|20144684|P1|STARTED|Overall Study||1
8170766|NCT02447887|20144689|P1|NOT COMPLETED|Overall Study||3
8170767|NCT02447887|20144689|P1|COMPLETED|Overall Study||0
8170768|NCT02447887|20144689|P1|STARTED|Overall Study||3
8170769|NCT02447848|20144702|P1|NOT COMPLETED|Overall Study||11
8170770|NCT02447848|20144702|P1|COMPLETED|Overall Study||65
8170771|NCT02447848|20144702|P1|STARTED|Overall Study||76
8170772|NCT02447575|20144708|P1|NOT COMPLETED|Overall Study||0
8170773|NCT02447575|20144708|P1|COMPLETED|Overall Study||23
8170774|NCT02447575|20144708|P1|STARTED|Overall Study|23 subjects were enrolled in the study: http://dx.doi.org/10.1016/j.chest.2016.08.017|23
8170787|NCT02447458|20144743|P6|NOT COMPLETED|Overall Study||0
8170788|NCT02447458|20144744|P5|NOT COMPLETED|Overall Study||0
8170789|NCT02447458|20144745|P4|NOT COMPLETED|Overall Study||0
8170790|NCT02447458|20144746|P3|NOT COMPLETED|Overall Study||1
8170791|NCT02447458|20144747|P2|NOT COMPLETED|Overall Study||0
8170792|NCT02447458|20144748|P1|NOT COMPLETED|Overall Study||0
8170793|NCT02447458|20144743|P6|COMPLETED|Overall Study||10
8170794|NCT02447458|20144744|P5|COMPLETED|Overall Study||6
8170795|NCT02447458|20144745|P4|COMPLETED|Overall Study||6
8170796|NCT02447458|20144746|P3|COMPLETED|Overall Study||5
8170797|NCT02447458|20144747|P2|COMPLETED|Overall Study||6
8170798|NCT02447458|20144748|P1|COMPLETED|Overall Study||5
8170799|NCT02447458|20144743|P6|STARTED|Overall Study||10
8170800|NCT02447458|20144744|P5|STARTED|Overall Study||6
8170801|NCT02447458|20144745|P4|STARTED|Overall Study||6
8170802|NCT02447458|20144746|P3|STARTED|Overall Study||6
8170803|NCT02447458|20144747|P2|STARTED|Overall Study||6
8170804|NCT02447458|20144748|P1|STARTED|Overall Study||5
8170805|NCT02447432|20144846|P2|NOT COMPLETED|Epoch 002||0
8170806|NCT02447432|20144847|P1|NOT COMPLETED|Epoch 002||0
8170807|NCT02447432|20144846|P2|COMPLETED|Epoch 002||145
8170808|NCT02447432|20144847|P1|COMPLETED|Epoch 002||152
8170809|NCT02447432|20144846|P2|STARTED|Epoch 002||145
8170810|NCT02447432|20144847|P1|STARTED|Epoch 002||152
8170811|NCT02447432|20144846|P2|NOT COMPLETED|Epoch 001||13
8170812|NCT02447432|20144847|P1|NOT COMPLETED|Epoch 001||5
8170813|NCT02447432|20144846|P2|COMPLETED|Epoch 001||147
8170814|NCT02447432|20144847|P1|COMPLETED|Epoch 001||155
8170815|NCT02447432|20144846|P2|STARTED|Epoch 001||160
8170816|NCT02447432|20144847|P1|STARTED|Epoch 001||160
8170817|NCT02447328|20144879|P1|NOT COMPLETED|Overall Study||1
8170818|NCT02447328|20144879|P1|COMPLETED|Overall Study||82
8170819|NCT02447328|20144879|P1|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
8170820|NCT02447250|20144883|P1|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5
8170821|NCT02447250|20144883|P1|COMPLETED|Third Dose (360 mcg Albuterol)||8
8170822|NCT02447250|20144883|P1|STARTED|Third Dose (360 mcg Albuterol)||13
8170823|NCT02447250|20144883|P1|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1
8170824|NCT02447250|20144883|P1|COMPLETED|Second Dose (270 mcg Albuterol)||13
8170825|NCT02447250|20144883|P1|STARTED|Second Dose (270 mcg Albuterol)||14
8170826|NCT02447250|20144883|P1|NOT COMPLETED|First Dose (180 mcg Albuterol)||0
8170827|NCT02447250|20144883|P1|COMPLETED|First Dose (180 mcg Albuterol)||14
8170828|NCT02447250|20144883|P1|STARTED|First Dose (180 mcg Albuterol)||14
8170829|NCT02447133|20144894|P1|NOT COMPLETED|Overall Study||0
8170830|NCT02447133|20144894|P1|COMPLETED|Overall Study||12
8170831|NCT02447133|20144894|P1|STARTED|Overall Study||12
8170832|NCT02447081|20144900|P1|NOT COMPLETED|Overall Study||224
8170833|NCT02447081|20144900|P1|COMPLETED|Overall Study||864
8170834|NCT02447081|20144900|P1|STARTED|Overall Study||1088
8170835|NCT02447029|20144916|P2|NOT COMPLETED|Overall Study||2
8170836|NCT02447029|20144917|P1|NOT COMPLETED|Overall Study||3
8170837|NCT02447029|20144916|P2|COMPLETED|Overall Study||68
8170838|NCT02447029|20144917|P1|COMPLETED|Overall Study||69
8170839|NCT02447029|20144916|P2|Treated|Overall Study||68
8170840|NCT02447029|20144917|P1|Treated|Overall Study||69
8170841|NCT02447029|20144916|P2|STARTED|Overall Study||70
8170842|NCT02447029|20144917|P1|STARTED|Overall Study||72
8170843|NCT02447003|20144937|P2|NOT COMPLETED|Overall Study||84
8170844|NCT02447003|20144938|P1|NOT COMPLETED|Overall Study||170
8170845|NCT02447003|20144937|P2|COMPLETED|Overall Study||0
8170846|NCT02447003|20144938|P1|COMPLETED|Overall Study||0
8170847|NCT02447003|20144937|P2|STARTED|Overall Study||84
8170848|NCT02447003|20144938|P1|STARTED|Overall Study||170
8170849|NCT02446990|20144974|P2|NOT COMPLETED|Overall Study||658
8170850|NCT02446990|20144975|P1|NOT COMPLETED|Overall Study||720
8170851|NCT02446990|20144974|P2|COMPLETED|Overall Study||8894
8170852|NCT02446990|20144975|P1|COMPLETED|Overall Study||8830
8170853|NCT02446990|20144974|P2|STARTED|Overall Study||9552
8170854|NCT02446990|20144975|P1|STARTED|Overall Study||9550
8170855|NCT02446912|20145010|P3|NOT COMPLETED|Overall Study||35
8170856|NCT02446912|20145011|P2|NOT COMPLETED|Overall Study||35
8170857|NCT02446912|20145012|P1|NOT COMPLETED|Overall Study||18
8170858|NCT02446912|20145010|P3|COMPLETED|Overall Study||149
8170859|NCT02446912|20145011|P2|COMPLETED|Overall Study||145
8170860|NCT02446912|20145012|P1|COMPLETED|Overall Study||75
8170861|NCT02446912|20145010|P3|Participants Who Completed Week 52|Overall Study||157
8170862|NCT02446912|20145011|P2|Participants Who Completed Week 52|Overall Study||153
8170863|NCT02446912|20145012|P1|Participants Who Completed Week 52|Overall Study||80
8170864|NCT02446912|20145010|P3|STARTED|Overall Study||184
8170865|NCT02446912|20145011|P2|STARTED|Overall Study||180
8170866|NCT02446912|20145012|P1|STARTED|Overall Study||93
8170867|NCT02446899|20145085|P2|NOT COMPLETED|Overall Study||48
8170868|NCT02446899|20145086|P1|NOT COMPLETED|Overall Study||25
8170869|NCT02446899|20145085|P2|COMPLETED|Overall Study||136
8170870|NCT02446899|20145086|P1|COMPLETED|Overall Study||156
8170871|NCT02446899|20145085|P2|Received Study Drug|Overall Study||182
8170872|NCT02446899|20145086|P1|Received Study Drug|Overall Study||180
8170873|NCT02446899|20145085|P2|STARTED|Overall Study||184
8170874|NCT02446899|20145086|P1|STARTED|Overall Study||181
8170875|NCT02446886|20145112|P2|NOT COMPLETED|Overall Study||4
8170876|NCT02446886|20145113|P1|NOT COMPLETED|Overall Study||2
8170877|NCT02446886|20145112|P2|COMPLETED|Overall Study||3
8170878|NCT02446886|20145113|P1|COMPLETED|Overall Study||6
8170879|NCT02446886|20145112|P2|STARTED|Overall Study||7
8170880|NCT02446886|20145113|P1|STARTED|Overall Study||8
8170881|NCT02446847|20145131|P2|NOT COMPLETED|Overall Study||2
8170882|NCT02446847|20145132|P1|NOT COMPLETED|Overall Study||0
8170883|NCT02446847|20145131|P2|COMPLETED|Overall Study||6
8170884|NCT02446847|20145132|P1|COMPLETED|Overall Study||8
8170885|NCT02446847|20145131|P2|STARTED|Overall Study||8
8170886|NCT02446847|20145132|P1|STARTED|Overall Study||8
8170887|NCT02446769|20145142|P3|NOT COMPLETED|Study Period||0
8170888|NCT02446769|20145143|P2|NOT COMPLETED|Study Period||2
8170889|NCT02446769|20145144|P1|NOT COMPLETED|Study Period||0
8170890|NCT02446769|20145142|P3|COMPLETED|Study Period||3
8170891|NCT02446769|20145143|P2|COMPLETED|Study Period||2
8170892|NCT02446769|20145144|P1|COMPLETED|Study Period||0
8170893|NCT02446769|20145142|P3|STARTED|Study Period||3
8170894|NCT02446769|20145143|P2|STARTED|Study Period||4
8170895|NCT02446769|20145144|P1|STARTED|Study Period||0
8170896|NCT02446769|20145142|P3|NOT COMPLETED|Screening Period||0
8170897|NCT02446769|20145143|P2|NOT COMPLETED|Screening Period||0
8170898|NCT02446769|20145144|P1|NOT COMPLETED|Screening Period||11
8170899|NCT02446769|20145142|P3|COMPLETED|Screening Period||0
8170900|NCT02446769|20145143|P2|COMPLETED|Screening Period||0
8170901|NCT02446769|20145144|P1|COMPLETED|Screening Period||7
8170902|NCT02446769|20145142|P3|STARTED|Screening Period||0
8170903|NCT02446769|20145143|P2|STARTED|Screening Period||0
8170904|NCT02446769|20145144|P1|STARTED|Screening Period||18
8170905|NCT02446743|20145167|P2|NOT COMPLETED|Overall Study||5
8170906|NCT02446743|20145168|P1|NOT COMPLETED|Overall Study||5
8170907|NCT02446743|20145167|P2|COMPLETED|Overall Study||250
8170908|NCT02446743|20145168|P1|COMPLETED|Overall Study||271
8170909|NCT02446743|20145167|P2|STARTED|Overall Study||255
8170910|NCT02446743|20145168|P1|STARTED|Overall Study||276
8170911|NCT02446717|20145323|P5|NOT COMPLETED|Overall Study||1
8170912|NCT02446717|20145324|P4|NOT COMPLETED|Overall Study||1
8170913|NCT02446717|20145325|P3|NOT COMPLETED|Overall Study||2
8170914|NCT02446717|20145326|P2|NOT COMPLETED|Overall Study||1
8170915|NCT02446717|20145327|P1|NOT COMPLETED|Overall Study||0
8170916|NCT02446717|20145323|P5|COMPLETED|Overall Study||46
8170917|NCT02446717|20145324|P4|COMPLETED|Overall Study||43
8170918|NCT02446717|20145325|P3|COMPLETED|Overall Study||20
8170919|NCT02446717|20145326|P2|COMPLETED|Overall Study||21
8170920|NCT02446717|20145327|P1|COMPLETED|Overall Study||6
8170921|NCT02446717|20145323|P5|STARTED|Overall Study||47
8170922|NCT02446717|20145324|P4|STARTED|Overall Study||44
8170923|NCT02446717|20145325|P3|STARTED|Overall Study||22
8170924|NCT02446717|20145326|P2|STARTED|Overall Study||22
8170925|NCT02446717|20145327|P1|STARTED|Overall Study||6
8170926|NCT02446691|20145354|P1|NOT COMPLETED|Overall Study||11
8170927|NCT02446691|20145354|P1|COMPLETED|Overall Study||117
8170928|NCT02446691|20145354|P1|STARTED|Overall Study||128
8170929|NCT02446613|20145374|P2|NOT COMPLETED|Overall Study||0
8170930|NCT02446613|20145375|P1|NOT COMPLETED|Overall Study||0
8170931|NCT02446613|20145374|P2|COMPLETED|Overall Study||10
8170932|NCT02446613|20145375|P1|COMPLETED|Overall Study||6
8170933|NCT02446613|20145374|P2|STARTED|Overall Study||10
8170934|NCT02446613|20145375|P1|STARTED|Overall Study||6
8170935|NCT02446496|20145397|P1|NOT COMPLETED|Overall Study||0
8170936|NCT02446496|20145397|P1|COMPLETED|Overall Study||24
8170937|NCT02446496|20145397|P1|STARTED|Overall Study||24
8170938|NCT02446483|20145409|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
8170939|NCT02446483|20145410|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
8170940|NCT02446483|20145409|P2|COMPLETED|Period 3: Intervention Period 2||30
8170941|NCT02446483|20145410|P1|COMPLETED|Period 3: Intervention Period 2||30
8170942|NCT02446483|20145409|P2|STARTED|Period 3: Intervention Period 2||30
8170943|NCT02446483|20145410|P1|STARTED|Period 3: Intervention Period 2||30
8170944|NCT02446483|20145409|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8170945|NCT02446483|20145410|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8170946|NCT02446483|20145409|P2|COMPLETED|Period 2: Washout Period (7 Days)||30
8170947|NCT02446483|20145410|P1|COMPLETED|Period 2: Washout Period (7 Days)||30
8170948|NCT02446483|20145409|P2|STARTED|Period 2: Washout Period (7 Days)||30
8170949|NCT02446483|20145410|P1|STARTED|Period 2: Washout Period (7 Days)||30
8170950|NCT02446483|20145409|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
8170951|NCT02446483|20145410|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
8170952|NCT02446483|20145409|P2|COMPLETED|Period 1: Intervention Period 1||30
8170953|NCT02446483|20145410|P1|COMPLETED|Period 1: Intervention Period 1||30
8170954|NCT02446483|20145409|P2|STARTED|Period 1: Intervention Period 1||30
8170955|NCT02446483|20145410|P1|STARTED|Period 1: Intervention Period 1||30
8170956|NCT02446418|20145424|P2|NOT COMPLETED|Overall Study||16
8170957|NCT02446418|20145425|P1|NOT COMPLETED|Overall Study||18
8170958|NCT02446418|20145424|P2|COMPLETED|Overall Study||194
8170959|NCT02446418|20145425|P1|COMPLETED|Overall Study||192
8170960|NCT02446418|20145424|P2|STARTED|Overall Study||210
8170961|NCT02446418|20145425|P1|STARTED|Overall Study||210
8170962|NCT02446314|20145439|P4|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
8170963|NCT02446314|20145440|P3|NOT COMPLETED|Thirteen to Twenty Four Weeks||2
8170964|NCT02446314|20145441|P2|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
8170965|NCT02446314|20145442|P1|NOT COMPLETED|Thirteen to Twenty Four Weeks||0
8170966|NCT02446314|20145439|P4|COMPLETED|Thirteen to Twenty Four Weeks||28
8170967|NCT02446314|20145440|P3|COMPLETED|Thirteen to Twenty Four Weeks||29
8170968|NCT02446314|20145441|P2|COMPLETED|Thirteen to Twenty Four Weeks||28
8170969|NCT02446314|20145442|P1|COMPLETED|Thirteen to Twenty Four Weeks||27
8170970|NCT02446314|20145439|P4|STARTED|Thirteen to Twenty Four Weeks||29
8170971|NCT02446314|20145440|P3|STARTED|Thirteen to Twenty Four Weeks||31
8170972|NCT02446314|20145441|P2|STARTED|Thirteen to Twenty Four Weeks||29
8170973|NCT02446314|20145442|P1|STARTED|Thirteen to Twenty Four Weeks||27
8170974|NCT02446314|20145439|P4|NOT COMPLETED|Zero to Twelve Weeks.||2
8170975|NCT02446314|20145440|P3|NOT COMPLETED|Zero to Twelve Weeks.||0
8170976|NCT02446314|20145441|P2|NOT COMPLETED|Zero to Twelve Weeks.||1
8170977|NCT02446314|20145442|P1|NOT COMPLETED|Zero to Twelve Weeks.||3
8170978|NCT02446314|20145439|P4|COMPLETED|Zero to Twelve Weeks.||29
8170979|NCT02446314|20145440|P3|COMPLETED|Zero to Twelve Weeks.||31
8170980|NCT02446314|20145441|P2|COMPLETED|Zero to Twelve Weeks.||29
8170981|NCT02446314|20145442|P1|COMPLETED|Zero to Twelve Weeks.||27
8170982|NCT02446314|20145439|P4|STARTED|Zero to Twelve Weeks.||31
8170983|NCT02446314|20145440|P3|STARTED|Zero to Twelve Weeks.||31
8170984|NCT02446314|20145441|P2|STARTED|Zero to Twelve Weeks.||30
8170985|NCT02446314|20145442|P1|STARTED|Zero to Twelve Weeks.||30
8170986|NCT02446223|20145488|P1|NOT COMPLETED|Overall Study||1
8170987|NCT02446223|20145488|P1|COMPLETED|Overall Study||20
8170988|NCT02446223|20145488|P1|STARTED|Overall Study||21
8170989|NCT02446171|20145496|P4|NOT COMPLETED|Overall Study||0
8170990|NCT02446171|20145497|P3|NOT COMPLETED|Overall Study||2
8170991|NCT02446171|20145498|P2|NOT COMPLETED|Overall Study||0
8170992|NCT02446171|20145499|P1|NOT COMPLETED|Overall Study||0
8170993|NCT02446171|20145496|P4|COMPLETED|Overall Study||11
8170994|NCT02446171|20145497|P3|COMPLETED|Overall Study||9
8170995|NCT02446171|20145498|P2|COMPLETED|Overall Study||11
8170996|NCT02446171|20145499|P1|COMPLETED|Overall Study||11
8170997|NCT02446171|20145496|P4|STARTED|Overall Study||11
8170998|NCT02446171|20145497|P3|STARTED|Overall Study||11
8170999|NCT02446171|20145498|P2|STARTED|Overall Study||11
8171000|NCT02446171|20145499|P1|STARTED|Overall Study||11
8171001|NCT02446015|20145570|P2|NOT COMPLETED|Overall Study||1
8171002|NCT02446015|20145571|P1|NOT COMPLETED|Overall Study||1
8171003|NCT02446015|20145570|P2|COMPLETED|Overall Study||62
8171004|NCT02446015|20145571|P1|COMPLETED|Overall Study||33
8171005|NCT02446015|20145570|P2|STARTED|Overall Study||63
8171006|NCT02446015|20145571|P1|STARTED|Overall Study||34
8171019|NCT02445911|20145615|P4|NOT COMPLETED|Overall Study||0
8171020|NCT02445911|20145616|P3|NOT COMPLETED|Overall Study||0
8171021|NCT02445911|20145617|P2|NOT COMPLETED|Overall Study||0
8171022|NCT02445911|20145618|P1|NOT COMPLETED|Overall Study||0
8171023|NCT02445911|20145615|P4|COMPLETED|Overall Study||20
8171024|NCT02445911|20145616|P3|COMPLETED|Overall Study||21
8171025|NCT02445911|20145617|P2|COMPLETED|Overall Study||20
8171026|NCT02445911|20145618|P1|COMPLETED|Overall Study||20
8171027|NCT02445911|20145615|P4|STARTED|Overall Study||20
8171028|NCT02445911|20145616|P3|STARTED|Overall Study||21
8171029|NCT02445911|20145617|P2|STARTED|Overall Study||20
8171030|NCT02445911|20145618|P1|STARTED|Overall Study||20
8171031|NCT02445859|20145690|P2|NOT COMPLETED|Overall Study||3
8171032|NCT02445859|20145691|P1|NOT COMPLETED|Overall Study||2
8171033|NCT02445859|20145690|P2|COMPLETED|Overall Study||42
8171034|NCT02445859|20145691|P1|COMPLETED|Overall Study||43
8171035|NCT02445859|20145690|P2|STARTED|Overall Study||45
8171036|NCT02445859|20145691|P1|STARTED|Overall Study||45
8171037|NCT02445807|20145699|P2|NOT COMPLETED|Overall Study||0
8171038|NCT02445807|20145700|P1|NOT COMPLETED|Overall Study||0
8171039|NCT02445807|20145699|P2|COMPLETED|Overall Study||89
8171040|NCT02445807|20145700|P1|COMPLETED|Overall Study||176
8171041|NCT02445807|20145699|P2|STARTED|Overall Study||89
8171042|NCT02445807|20145700|P1|STARTED|Overall Study||176
8171043|NCT02445794|20145714|P4|NOT COMPLETED|Overall Study||0
8171044|NCT02445794|20145715|P3|NOT COMPLETED|Overall Study||2
8171045|NCT02445794|20145716|P2|NOT COMPLETED|Overall Study||0
8171046|NCT02445794|20145717|P1|NOT COMPLETED|Overall Study||0
8171047|NCT02445794|20145714|P4|COMPLETED|Overall Study||3
8171048|NCT02445794|20145715|P3|COMPLETED|Overall Study||5
8171049|NCT02445794|20145716|P2|COMPLETED|Overall Study||3
8171050|NCT02445794|20145717|P1|COMPLETED|Overall Study||6
8171051|NCT02445794|20145714|P4|STARTED|Overall Study||3
8171052|NCT02445794|20145715|P3|STARTED|Overall Study||7
8171053|NCT02445794|20145716|P2|STARTED|Overall Study||3
8171054|NCT02445794|20145717|P1|STARTED|Overall Study||6
8171055|NCT02445755|20145747|P1|NOT COMPLETED|Overall Study||13
8171056|NCT02445755|20145747|P1|COMPLETED|Overall Study||100
8171057|NCT02445755|20145747|P1|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
8171058|NCT02445625|20145754|P1|NOT COMPLETED|Overall Study||0
8171059|NCT02445625|20145754|P1|COMPLETED|Overall Study||15
8171060|NCT02445625|20145754|P1|STARTED|Overall Study||15
8171061|NCT02445586|20145761|P1|NOT COMPLETED|Overall Study||39
8171062|NCT02445586|20145761|P1|COMPLETED|Overall Study||13
8171063|NCT02445586|20145761|P1|Received at Least One Dose of Study Drug|Overall Study||52
8171064|NCT02445586|20145761|P1|STARTED|Overall Study||52
8171065|NCT02445573|20145801|P2|NOT COMPLETED|Overall Study||2
8171066|NCT02445573|20145802|P1|NOT COMPLETED|Overall Study||1
8171067|NCT02445573|20145801|P2|COMPLETED|Overall Study||38
8171068|NCT02445573|20145802|P1|COMPLETED|Overall Study||39
8171069|NCT02445573|20145801|P2|STARTED|Overall Study||40
8171070|NCT02445573|20145802|P1|STARTED|Overall Study||40
8171071|NCT02445326|20145818|P2|NOT COMPLETED|Overall Study||1
8171072|NCT02445326|20145819|P1|NOT COMPLETED|Overall Study||2
8171073|NCT02445326|20145818|P2|COMPLETED|Overall Study||37
8171074|NCT02445326|20145819|P1|COMPLETED|Overall Study||33
8171075|NCT02445326|20145818|P2|STARTED|Overall Study||38
8171076|NCT02445326|20145819|P1|STARTED|Overall Study||35
8171077|NCT02445287|20145837|P2|NOT COMPLETED|Overall Study||0
8171078|NCT02445287|20145838|P1|NOT COMPLETED|Overall Study||0
8171079|NCT02445287|20145837|P2|COMPLETED|Overall Study||13
8171080|NCT02445287|20145838|P1|COMPLETED|Overall Study||35
8171081|NCT02445287|20145837|P2|STARTED|Overall Study||13
8171082|NCT02445287|20145838|P1|STARTED|Overall Study||35
8171083|NCT02445196|20145853|P2|NOT COMPLETED|Overall Study||6
8171084|NCT02445196|20145854|P1|NOT COMPLETED|Overall Study||11
8171085|NCT02445196|20145853|P2|COMPLETED|Overall Study||52
8171086|NCT02445196|20145854|P1|COMPLETED|Overall Study||51
8171087|NCT02445196|20145853|P2|STARTED|Overall Study||58
8171088|NCT02445196|20145854|P1|STARTED|Overall Study||62
8171089|NCT02445027|20145867|P1|NOT COMPLETED|Overall Study||15
8171090|NCT02445027|20145867|P1|COMPLETED|Overall Study||45
8171091|NCT02445027|20145867|P1|STARTED|Overall Study||60
8171092|NCT02445014|20145871|P1|NOT COMPLETED|Overall Study||0
8171093|NCT02445014|20145871|P1|COMPLETED|Overall Study||3
8171094|NCT02445014|20145871|P1|STARTED|Overall Study||3
8171095|NCT02444988|20145877|P2|NOT COMPLETED|Overall Study||0
8171096|NCT02444988|20145878|P1|NOT COMPLETED|Overall Study||0
8171097|NCT02444988|20145877|P2|COMPLETED|Overall Study||2735
8171098|NCT02444988|20145878|P1|COMPLETED|Overall Study||2646
8171099|NCT02444988|20145877|P2|STARTED|Overall Study||2735
8171100|NCT02444988|20145878|P1|STARTED|Overall Study||2646
8171101|NCT02444936|20145888|P2|NOT COMPLETED|Overall Study||0
8171102|NCT02444936|20145889|P1|NOT COMPLETED|Overall Study||0
8171103|NCT02444936|20145888|P2|COMPLETED|Overall Study||12
8171104|NCT02444936|20145889|P1|COMPLETED|Overall Study||10
8171105|NCT02444936|20145888|P2|STARTED|Overall Study||12
8171106|NCT02444936|20145889|P1|STARTED|Overall Study||10
8171107|NCT02444793|20145899|P4|NOT COMPLETED|Overall Study||3
8171108|NCT02444793|20145900|P3|NOT COMPLETED|Overall Study||4
8171109|NCT02444793|20145901|P2|NOT COMPLETED|Overall Study||6
8171110|NCT02444793|20145902|P1|NOT COMPLETED|Overall Study||11
8171111|NCT02444793|20145899|P4|COMPLETED|Overall Study||0
8171112|NCT02444793|20145900|P3|COMPLETED|Overall Study||0
8171113|NCT02444793|20145901|P2|COMPLETED|Overall Study||0
8171114|NCT02444793|20145902|P1|COMPLETED|Overall Study||0
8171115|NCT02444793|20145899|P4|STARTED|Overall Study||3
8171116|NCT02444793|20145900|P3|STARTED|Overall Study||4
8171117|NCT02444793|20145901|P2|STARTED|Overall Study||6
8171118|NCT02444793|20145902|P1|STARTED|Overall Study||11
8171119|NCT02444715|20146029|P2|NOT COMPLETED|Overall Study||16
8171120|NCT02444715|20146030|P1|NOT COMPLETED|Overall Study||10
8171121|NCT02444715|20146029|P2|COMPLETED|Overall Study||32
8171122|NCT02444715|20146030|P1|COMPLETED|Overall Study||36
8171123|NCT02444715|20146029|P2|STARTED|Overall Study||48
8171124|NCT02444715|20146030|P1|STARTED|Overall Study||46
8171125|NCT02444533|20146061|P2|NOT COMPLETED|Overall Study||4
8171126|NCT02444533|20146062|P1|NOT COMPLETED|Overall Study||2
8171127|NCT02444533|20146061|P2|COMPLETED|Overall Study||18
8171128|NCT02444533|20146062|P1|COMPLETED|Overall Study||15
8171129|NCT02444533|20146061|P2|STARTED|Overall Study||22
8171130|NCT02444533|20146062|P1|STARTED|Overall Study||17
8171131|NCT02444234|20146076|P2|NOT COMPLETED|Second Intervention (3 Days)||0
8171132|NCT02444234|20146077|P1|NOT COMPLETED|Second Intervention (3 Days)||0
8171133|NCT02444234|20146076|P2|COMPLETED|Second Intervention (3 Days)||5
8171134|NCT02444234|20146077|P1|COMPLETED|Second Intervention (3 Days)||6
8171135|NCT02444234|20146076|P2|STARTED|Second Intervention (3 Days)||5
8171136|NCT02444234|20146077|P1|STARTED|Second Intervention (3 Days)||6
8171137|NCT02444234|20146076|P2|NOT COMPLETED|Washout (2 Day Minimum)||0
8171138|NCT02444234|20146077|P1|NOT COMPLETED|Washout (2 Day Minimum)||0
8171139|NCT02444234|20146076|P2|COMPLETED|Washout (2 Day Minimum)||5
8171140|NCT02444234|20146077|P1|COMPLETED|Washout (2 Day Minimum)||6
8171141|NCT02444234|20146076|P2|STARTED|Washout (2 Day Minimum)||5
8171142|NCT02444234|20146077|P1|STARTED|Washout (2 Day Minimum)||6
8171143|NCT02444234|20146076|P2|NOT COMPLETED|First Intervention (3 Days)||0
8171144|NCT02444234|20146077|P1|NOT COMPLETED|First Intervention (3 Days)||0
8171145|NCT02444234|20146076|P2|COMPLETED|First Intervention (3 Days)||5
8171146|NCT02444234|20146077|P1|COMPLETED|First Intervention (3 Days)||6
8171147|NCT02444234|20146076|P2|STARTED|First Intervention (3 Days)||5
8171148|NCT02444234|20146077|P1|STARTED|First Intervention (3 Days)||6
8171149|NCT02444182|20146095|P2|NOT COMPLETED|Overall Study||5
8171150|NCT02444182|20146096|P1|NOT COMPLETED|Overall Study||2
8171151|NCT02444182|20146095|P2|COMPLETED|Overall Study||49
8171152|NCT02444182|20146096|P1|COMPLETED|Overall Study||52
8171153|NCT02444182|20146095|P2|STARTED|Overall Study||54
8171154|NCT02444182|20146096|P1|STARTED|Overall Study||54
8171155|NCT02444143|20146106|P2|NOT COMPLETED|Overall Study||1
8171156|NCT02444143|20146107|P1|NOT COMPLETED|Overall Study||0
8171157|NCT02444143|20146106|P2|COMPLETED|Overall Study|1 patient withdrawal|9
8171158|NCT02444143|20146107|P1|COMPLETED|Overall Study||10
8171159|NCT02444143|20146106|P2|STARTED|Overall Study||10
8171160|NCT02444143|20146107|P1|STARTED|Overall Study||10
8171161|NCT02443883|20146119|P4|NOT COMPLETED|Overall Study||5
8171162|NCT02443883|20146120|P3|NOT COMPLETED|Overall Study||1
8171163|NCT02443883|20146121|P2|NOT COMPLETED|Overall Study||4
8171164|NCT02443883|20146122|P1|NOT COMPLETED|Overall Study||6
8171165|NCT02443883|20146119|P4|COMPLETED|Overall Study||36
8171166|NCT02443883|20146120|P3|COMPLETED|Overall Study||40
8171167|NCT02443883|20146121|P2|COMPLETED|Overall Study||38
8171168|NCT02443883|20146122|P1|COMPLETED|Overall Study||34
8171169|NCT02443883|20146119|P4|Received at Least One Dose of Study Drug|Overall Study||40
8171170|NCT02443883|20146120|P3|Received at Least One Dose of Study Drug|Overall Study||41
8171171|NCT02443883|20146121|P2|Received at Least One Dose of Study Drug|Overall Study||42
8171172|NCT02443883|20146122|P1|Received at Least One Dose of Study Drug|Overall Study||38
8171173|NCT02443883|20146119|P4|STARTED|Overall Study||41
8171174|NCT02443883|20146120|P3|STARTED|Overall Study||41
8171175|NCT02443883|20146121|P2|STARTED|Overall Study||42
8171176|NCT02443883|20146122|P1|STARTED|Overall Study||40
8171177|NCT02443805|20146142|P2|NOT COMPLETED|Overall Study||127
8171178|NCT02443805|20146143|P1|NOT COMPLETED|Overall Study||213
8171179|NCT02443805|20146142|P2|COMPLETED|Overall Study||678
8171180|NCT02443805|20146143|P1|COMPLETED|Overall Study||589
8171181|NCT02443805|20146142|P2|STARTED|Overall Study||805
8171182|NCT02443805|20146143|P1|STARTED|Overall Study||802
8171183|NCT02443792|20146155|P2|NOT COMPLETED|Overall Study||2
8171184|NCT02443792|20146156|P1|NOT COMPLETED|Overall Study||7
8171185|NCT02443792|20146155|P2|COMPLETED|Overall Study||23
8171186|NCT02443792|20146156|P1|COMPLETED|Overall Study||43
8171187|NCT02443792|20146155|P2|STARTED|Overall Study||25
8171188|NCT02443792|20146156|P1|STARTED|Overall Study||50
8171420|NCT02443688|20146366|P3|NOT COMPLETED|Overall Study||12
8171421|NCT02443688|20146367|P2|NOT COMPLETED|Overall Study||9
8171422|NCT02443688|20146368|P1|NOT COMPLETED|Overall Study||12
8171423|NCT02443688|20146366|P3|COMPLETED|Overall Study||55
8171424|NCT02443688|20146367|P2|COMPLETED|Overall Study||58
8171425|NCT02443688|20146368|P1|COMPLETED|Overall Study||54
8171426|NCT02443688|20146366|P3|STARTED|Overall Study||67
8171427|NCT02443688|20146367|P2|STARTED|Overall Study||67
8171428|NCT02443688|20146368|P1|STARTED|Overall Study||66
8171429|NCT02443571|20146433|P3|NOT COMPLETED|Overall Study||0
8171430|NCT02443571|20146434|P2|NOT COMPLETED|Overall Study||0
8171431|NCT02443571|20146435|P1|NOT COMPLETED|Overall Study||0
8171432|NCT02443571|20146433|P3|COMPLETED|Overall Study||23
8171433|NCT02443571|20146434|P2|COMPLETED|Overall Study||95
8171434|NCT02443571|20146435|P1|COMPLETED|Overall Study||596
8171435|NCT02443571|20146433|P3|STARTED|Overall Study||23
8171436|NCT02443571|20146434|P2|STARTED|Overall Study||95
8171437|NCT02443571|20146435|P1|STARTED|Overall Study||596
8171438|NCT02443519|20146447|P2|NOT COMPLETED|Overall Study||3
8171439|NCT02443519|20146448|P1|NOT COMPLETED|Overall Study||2
8171440|NCT02443519|20146447|P2|COMPLETED|Overall Study||26
8171441|NCT02443519|20146448|P1|COMPLETED|Overall Study||29
8171442|NCT02443519|20146447|P2|STARTED|Overall Study||29
8171443|NCT02443519|20146448|P1|STARTED|Overall Study||31
8171444|NCT02443402|20146478|P2|NOT COMPLETED|Overall Study||3
8171445|NCT02443402|20146479|P1|NOT COMPLETED|Overall Study||4
8171446|NCT02443402|20146478|P2|COMPLETED|Overall Study||28
8171447|NCT02443402|20146479|P1|COMPLETED|Overall Study||32
8171448|NCT02443402|20146478|P2|STARTED|Overall Study||31
8171449|NCT02443402|20146479|P1|STARTED|Overall Study||36
8171450|NCT02443337|20146541|P2|NOT COMPLETED|Overall Study||2
8171451|NCT02443337|20146542|P1|NOT COMPLETED|Overall Study||5
8171452|NCT02443337|20146541|P2|COMPLETED|Overall Study||14
8171453|NCT02443337|20146542|P1|COMPLETED|Overall Study||10
8171454|NCT02443337|20146541|P2|Received at Least One Dose of Study Drug|Overall Study||16
8171455|NCT02443337|20146542|P1|Received at Least One Dose of Study Drug|Overall Study||15
8171456|NCT02443337|20146541|P2|STARTED|Overall Study||16
8171457|NCT02443337|20146542|P1|STARTED|Overall Study||15
8171458|NCT02443298|20146560|P2|NOT COMPLETED|Overall Study||5
8171459|NCT02443298|20146561|P1|NOT COMPLETED|Overall Study||4
8171460|NCT02443298|20146560|P2|COMPLETED|Overall Study||104
8171461|NCT02443298|20146561|P1|COMPLETED|Overall Study||101
8171462|NCT02443298|20146560|P2|STARTED|Overall Study||109
8171463|NCT02443298|20146561|P1|STARTED|Overall Study||105
8171488|NCT02443103|20147032|P1|NOT COMPLETED|Overall Study||3
8171489|NCT02443103|20147032|P1|COMPLETED|Overall Study||1
8171490|NCT02443103|20147032|P1|STARTED|Overall Study||4
8171491|NCT02442856|20147037|P1|NOT COMPLETED|Overall Study||0
8171492|NCT02442856|20147037|P1|COMPLETED|Overall Study||21
8171493|NCT02442856|20147037|P1|STARTED|Overall Study||21
8171494|NCT02442830|20147045|P2|NOT COMPLETED|Overall Study||1
8171495|NCT02442830|20147046|P1|NOT COMPLETED|Overall Study||0
8171496|NCT02442830|20147045|P2|COMPLETED|Overall Study||44
8171497|NCT02442830|20147046|P1|COMPLETED|Overall Study||42
8171498|NCT02442830|20147045|P2|STARTED|Overall Study||45
8171499|NCT02442830|20147046|P1|STARTED|Overall Study||42
8171500|NCT02442804|20147056|P2|NOT COMPLETED|Overall Study||1
8171501|NCT02442804|20147057|P1|NOT COMPLETED|Overall Study||1
8171502|NCT02442804|20147056|P2|COMPLETED|Overall Study||7
8171503|NCT02442804|20147057|P1|COMPLETED|Overall Study||7
8171504|NCT02442804|20147056|P2|STARTED|Overall Study||8
8171505|NCT02442804|20147057|P1|STARTED|Overall Study||8
8171506|NCT02442700|20147087|P2|NOT COMPLETED|Later 12 Weeks||0
8171507|NCT02442700|20147088|P1|NOT COMPLETED|Later 12 Weeks||0
8171508|NCT02442700|20147087|P2|COMPLETED|Later 12 Weeks||12
8171509|NCT02442700|20147088|P1|COMPLETED|Later 12 Weeks||12
8171510|NCT02442700|20147087|P2|STARTED|Later 12 Weeks||12
8171511|NCT02442700|20147088|P1|STARTED|Later 12 Weeks||12
8171512|NCT02442700|20147087|P2|NOT COMPLETED|First 12 Weeks||0
8171513|NCT02442700|20147088|P1|NOT COMPLETED|First 12 Weeks||0
8171514|NCT02442700|20147087|P2|COMPLETED|First 12 Weeks||12
8171515|NCT02442700|20147088|P1|COMPLETED|First 12 Weeks||12
8171516|NCT02442700|20147087|P2|STARTED|First 12 Weeks||12
8171517|NCT02442700|20147088|P1|STARTED|First 12 Weeks||12
8171518|NCT02442687|20147099|P3|NOT COMPLETED|Overall Study||3
8171519|NCT02442687|20147100|P2|NOT COMPLETED|Overall Study||11
8171520|NCT02442687|20147101|P1|NOT COMPLETED|Overall Study||8
8171521|NCT02442687|20147099|P3|COMPLETED|Overall Study||19
8171522|NCT02442687|20147100|P2|COMPLETED|Overall Study||11
8171523|NCT02442687|20147101|P1|COMPLETED|Overall Study||13
8171524|NCT02442687|20147099|P3|STARTED|Overall Study||22
8171525|NCT02442687|20147100|P2|STARTED|Overall Study||22
8171526|NCT02442687|20147101|P1|STARTED|Overall Study||21
8171527|NCT02442622|20147164|P2|NOT COMPLETED|Overall Study||1
8171528|NCT02442622|20147165|P1|NOT COMPLETED|Overall Study||3
8171529|NCT02442622|20147164|P2|COMPLETED|Overall Study||16
8171530|NCT02442622|20147165|P1|COMPLETED|Overall Study||12
8171531|NCT02442622|20147164|P2|STARTED|Overall Study||17
8171532|NCT02442622|20147165|P1|STARTED|Overall Study||15
8171542|NCT02442310|20147184|P1|NOT COMPLETED|Overall Study||3
8171543|NCT02442310|20147184|P1|COMPLETED|Overall Study||17
8171544|NCT02442310|20147184|P1|STARTED|Overall Study||20
8171545|NCT02442284|20147206|P1|NOT COMPLETED|Overall Study||7
8171546|NCT02442284|20147206|P1|COMPLETED|Overall Study||92
8171547|NCT02442284|20147206|P1|STARTED|Overall Study||99
8171548|NCT02442271|20147213|P1|NOT COMPLETED|Overall Study||4
8171549|NCT02442271|20147213|P1|COMPLETED|Overall Study||218
8171550|NCT02442271|20147213|P1|STARTED|Overall Study||222
8171551|NCT02442206|20147239|P2|NOT COMPLETED|Period 2||0
8171552|NCT02442206|20147240|P1|NOT COMPLETED|Period 2||1
8171553|NCT02442206|20147239|P2|COMPLETED|Period 2||29
8171554|NCT02442206|20147240|P1|COMPLETED|Period 2||28
8171555|NCT02442206|20147239|P2|STARTED|Period 2||29
8171556|NCT02442206|20147240|P1|STARTED|Period 2||29
8171557|NCT02442206|20147239|P2|NOT COMPLETED|Period 1||3
8171558|NCT02442206|20147240|P1|NOT COMPLETED|Period 1||1
8171559|NCT02442206|20147239|P2|COMPLETED|Period 1||29
8171560|NCT02442206|20147240|P1|COMPLETED|Period 1||29
8171561|NCT02442206|20147239|P2|STARTED|Period 1||32
8171562|NCT02442206|20147240|P1|STARTED|Period 1||30
8171563|NCT02441946|20147272|P3|NOT COMPLETED|Extension Period (8 Weeks)||0
8171564|NCT02441946|20147273|P2|NOT COMPLETED|Extension Period (8 Weeks)||0
8171565|NCT02441946|20147274|P1|NOT COMPLETED|Extension Period (8 Weeks)||2
8171566|NCT02441946|20147272|P3|COMPLETED|Extension Period (8 Weeks)||0
8171567|NCT02441946|20147273|P2|COMPLETED|Extension Period (8 Weeks)||0
8171568|NCT02441946|20147274|P1|COMPLETED|Extension Period (8 Weeks)||40
8171569|NCT02441946|20147272|P3|STARTED|Extension Period (8 Weeks)||0
8171570|NCT02441946|20147273|P2|STARTED|Extension Period (8 Weeks)||0
8171571|NCT02441946|20147274|P1|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42
8171572|NCT02441946|20147272|P3|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
8171573|NCT02441946|20147273|P2|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
8171574|NCT02441946|20147274|P1|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
8171575|NCT02441946|20147272|P3|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
8171576|NCT02441946|20147273|P2|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
8171577|NCT02441946|20147274|P1|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
8171578|NCT02441946|20147272|P3|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
8171579|NCT02441946|20147273|P2|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
8171580|NCT02441946|20147274|P1|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5
8171581|NCT02441946|20147272|P3|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
8171582|NCT02441946|20147273|P2|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
8171583|NCT02441946|20147274|P1|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217
8171584|NCT02441946|20147272|P3|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
8171585|NCT02441946|20147273|P2|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
8171586|NCT02441946|20147274|P1|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
8171587|NCT02441946|20147272|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8171588|NCT02441946|20147273|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
8171589|NCT02441946|20147274|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
8171590|NCT02441946|20147272|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
8171591|NCT02441946|20147273|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
8171592|NCT02441946|20147274|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
8171593|NCT02441946|20147272|P3|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
8171594|NCT02441946|20147273|P2|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
8171595|NCT02441946|20147274|P1|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
8171596|NCT02441946|20147272|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||74
8171597|NCT02441946|20147273|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||76
8171598|NCT02441946|20147274|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||74
8171599|NCT02441517|20147295|P1|NOT COMPLETED|Overall Study||4
8171600|NCT02441517|20147295|P1|COMPLETED|Overall Study||0
8171601|NCT02441517|20147295|P1|Received Treatment|Overall Study||4
8171602|NCT02441517|20147295|P1|STARTED|Overall Study||4
8171603|NCT02441309|20147308|P3|NOT COMPLETED|Overall Study||3
8171604|NCT02441309|20147309|P2|NOT COMPLETED|Overall Study||2
8171605|NCT02441309|20147310|P1|NOT COMPLETED|Overall Study||3
8171606|NCT02441309|20147308|P3|COMPLETED|Overall Study||0
8171607|NCT02441309|20147309|P2|COMPLETED|Overall Study||0
8171608|NCT02441309|20147310|P1|COMPLETED|Overall Study||0
8171609|NCT02441309|20147308|P3|Received Allocated Intervention|Overall Study||3
8171610|NCT02441309|20147309|P2|Received Allocated Intervention|Overall Study||2
8171611|NCT02441309|20147310|P1|Received Allocated Intervention|Overall Study||1
8171612|NCT02441309|20147308|P3|STARTED|Overall Study||3
8171613|NCT02441309|20147309|P2|STARTED|Overall Study||2
8171614|NCT02441309|20147310|P1|STARTED|Overall Study||3
8171615|NCT02441283|20147339|P1|NOT COMPLETED|Overall Study||90
8171616|NCT02441283|20147339|P1|COMPLETED|Overall Study||287
8171617|NCT02441283|20147339|P1|STARTED|Overall Study||377
8171618|NCT02441218|20147352|P2|NOT COMPLETED|Overall Study||612
8171619|NCT02441218|20147353|P1|NOT COMPLETED|Overall Study||578
8171620|NCT02441218|20147352|P2|COMPLETED|Overall Study||2652
8171621|NCT02441218|20147353|P1|COMPLETED|Overall Study||2663
8171622|NCT02441218|20147352|P2|STARTED|Overall Study||3264
8171623|NCT02441218|20147353|P1|STARTED|Overall Study||3241
8171624|NCT02441179|20147379|P2|NOT COMPLETED|Overall Study||1
8171625|NCT02441179|20147380|P1|NOT COMPLETED|Overall Study||1
8171626|NCT02441179|20147379|P2|COMPLETED|Overall Study||16
8171627|NCT02441179|20147380|P1|COMPLETED|Overall Study||17
8171628|NCT02441179|20147379|P2|STARTED|Overall Study||17
8171629|NCT02441179|20147380|P1|STARTED|Overall Study||18
8171630|NCT02441114|20147398|P1|NOT COMPLETED|Period3||0
8171631|NCT02441114|20147398|P1|COMPLETED|Period3||6
8171632|NCT02441114|20147398|P1|STARTED|Period3||6
8171633|NCT02441114|20147398|P1|NOT COMPLETED|Washout2||4
8171634|NCT02441114|20147398|P1|COMPLETED|Washout2||6
8171635|NCT02441114|20147398|P1|STARTED|Washout2||10
8171636|NCT02441114|20147398|P1|NOT COMPLETED|Period2||0
8171637|NCT02441114|20147398|P1|COMPLETED|Period2||10
8171638|NCT02441114|20147398|P1|STARTED|Period2||10
8171639|NCT02441114|20147398|P1|NOT COMPLETED|Washout1||0
8171640|NCT02441114|20147398|P1|COMPLETED|Washout1||10
8171641|NCT02441114|20147398|P1|STARTED|Washout1||10
8171642|NCT02441114|20147398|P1|NOT COMPLETED|Period1||0
8171643|NCT02441114|20147398|P1|COMPLETED|Period1||10
8171644|NCT02441114|20147398|P1|STARTED|Period1||10
8171645|NCT02441062|20147404|P1|NOT COMPLETED|Overall Study||0
8171646|NCT02441062|20147404|P1|COMPLETED|Overall Study||122
8171647|NCT02441062|20147404|P1|STARTED|Overall Study||122
8171648|NCT02441036|20147413|P5|NOT COMPLETED|Overall Study||0
8171649|NCT02441036|20147414|P4|NOT COMPLETED|Overall Study||1
8171650|NCT02441036|20147415|P3|NOT COMPLETED|Overall Study||0
8171651|NCT02441036|20147416|P2|NOT COMPLETED|Overall Study||1
8171652|NCT02441036|20147417|P1|NOT COMPLETED|Overall Study||0
8171653|NCT02441036|20147413|P5|COMPLETED|Overall Study||1
8171654|NCT02441036|20147414|P4|COMPLETED|Overall Study||3
8171655|NCT02441036|20147415|P3|COMPLETED|Overall Study||3
8171656|NCT02441036|20147416|P2|COMPLETED|Overall Study||4
8171657|NCT02441036|20147417|P1|COMPLETED|Overall Study||3
8171658|NCT02441036|20147413|P5|Tissue Resected|Overall Study||1
8171659|NCT02441036|20147414|P4|Tissue Resected|Overall Study||3
8171660|NCT02441036|20147415|P3|Tissue Resected|Overall Study||3
8171661|NCT02441036|20147416|P2|Tissue Resected|Overall Study||4
8171662|NCT02441036|20147417|P1|Tissue Resected|Overall Study||3
8171663|NCT02441036|20147413|P5|Treated|Overall Study||1
8171664|NCT02441036|20147414|P4|Treated|Overall Study||4
8171665|NCT02441036|20147415|P3|Treated|Overall Study||3
8171666|NCT02441036|20147416|P2|Treated|Overall Study||5
8171667|NCT02441036|20147417|P1|Treated|Overall Study||3
8171668|NCT02441036|20147413|P5|STARTED|Overall Study||1
8171669|NCT02441036|20147414|P4|STARTED|Overall Study||4
8171670|NCT02441036|20147415|P3|STARTED|Overall Study||3
8171671|NCT02441036|20147416|P2|STARTED|Overall Study||5
8171672|NCT02441036|20147417|P1|STARTED|Overall Study||3
8171678|NCT02440659|20147495|P2|NOT COMPLETED|Overall Study||335
8171679|NCT02440659|20147496|P1|NOT COMPLETED|Overall Study||651
8171680|NCT02440659|20147495|P2|COMPLETED|Overall Study||614
8171681|NCT02440659|20147496|P1|COMPLETED|Overall Study||1346
8171682|NCT02440659|20147495|P2|STARTED|Overall Study||949
8171683|NCT02440659|20147496|P1|STARTED|Overall Study||1997
8171684|NCT02440633|20147502|P1|NOT COMPLETED|Overall Study||0
8171685|NCT02440633|20147502|P1|COMPLETED|Overall Study||8
8171686|NCT02440633|20147502|P1|STARTED|Overall Study||8
8171687|NCT02440594|20147519|P8|NOT COMPLETED|Overall Study||56
8171688|NCT02440594|20147520|P7|NOT COMPLETED|Overall Study||37
8171689|NCT02440594|20147521|P6|NOT COMPLETED|Overall Study||7
8171690|NCT02440594|20147522|P5|NOT COMPLETED|Overall Study||9
8171691|NCT02440594|20147523|P4|NOT COMPLETED|Overall Study||89
8171692|NCT02440594|20147524|P3|NOT COMPLETED|Overall Study||117
8171693|NCT02440594|20147525|P2|NOT COMPLETED|Overall Study||108
8171694|NCT02440594|20147526|P1|NOT COMPLETED|Overall Study||132
8171695|NCT02440594|20147519|P8|COMPLETED|Overall Study||234
8171696|NCT02440594|20147520|P7|COMPLETED|Overall Study||113
8171697|NCT02440594|20147521|P6|COMPLETED|Overall Study||47
8171698|NCT02440594|20147522|P5|COMPLETED|Overall Study||46
8171699|NCT02440594|20147523|P4|COMPLETED|Overall Study||340
8171700|NCT02440594|20147524|P3|COMPLETED|Overall Study||319
8171701|NCT02440594|20147525|P2|COMPLETED|Overall Study||401
8171702|NCT02440594|20147526|P1|COMPLETED|Overall Study||377
8171703|NCT02440594|20147519|P8|STARTED|Overall Study||290
8171704|NCT02440594|20147520|P7|STARTED|Overall Study||150
8171705|NCT02440594|20147521|P6|STARTED|Overall Study||54
8171706|NCT02440594|20147522|P5|STARTED|Overall Study||55
8171707|NCT02440594|20147523|P4|STARTED|Overall Study||429
8171708|NCT02440594|20147524|P3|STARTED|Overall Study||436
8171709|NCT02440594|20147525|P2|STARTED|Overall Study||509
8171710|NCT02440594|20147526|P1|STARTED|Overall Study||509
8171711|NCT02440451|20147558|P1|NOT COMPLETED|Overall Study||0
8171712|NCT02440451|20147558|P1|COMPLETED|Overall Study||15
8171713|NCT02440451|20147558|P1|STARTED|Overall Study||15
8171714|NCT02440334|20147564|P1|NOT COMPLETED|Overall Study||0
8171715|NCT02440334|20147564|P1|COMPLETED|Overall Study||53
8171716|NCT02440334|20147564|P1|STARTED|Overall Study||53
8171717|NCT02440308|20147568|P1|NOT COMPLETED|Overall Study||0
8171718|NCT02440308|20147568|P1|COMPLETED|Overall Study||10
8171719|NCT02440308|20147568|P1|STARTED|Overall Study||10
8171720|NCT02440204|20147576|P3|NOT COMPLETED|Overall Study||0
8171721|NCT02440204|20147577|P2|NOT COMPLETED|Overall Study||0
8171722|NCT02440204|20147578|P1|NOT COMPLETED|Overall Study||0
8171723|NCT02440204|20147576|P3|COMPLETED|Overall Study||22
8171724|NCT02440204|20147577|P2|COMPLETED|Overall Study||24
8171725|NCT02440204|20147578|P1|COMPLETED|Overall Study||22
8171726|NCT02440204|20147576|P3|STARTED|Overall Study||22
8171727|NCT02440204|20147577|P2|STARTED|Overall Study||24
8171728|NCT02440204|20147578|P1|STARTED|Overall Study||22
8171729|NCT02440022|20147591|P2|NOT COMPLETED|Overall Study||13
8171730|NCT02440022|20147592|P1|NOT COMPLETED|Overall Study||27
8171731|NCT02440022|20147591|P2|COMPLETED|Overall Study||131
8171732|NCT02440022|20147592|P1|COMPLETED|Overall Study||114
8171733|NCT02440022|20147591|P2|STARTED|Overall Study||144
8171734|NCT02440022|20147592|P1|STARTED|Overall Study||141
8171735|NCT02439879|20147618|P2|NOT COMPLETED|Overall Study||0
8171736|NCT02439879|20147619|P1|NOT COMPLETED|Overall Study||0
8171737|NCT02439879|20147618|P2|COMPLETED|Overall Study||17
8171738|NCT02439879|20147619|P1|COMPLETED|Overall Study||16
8171739|NCT02439879|20147618|P2|STARTED|Overall Study||17
8171740|NCT02439879|20147619|P1|STARTED|Overall Study||16
8171741|NCT02439814|20147627|P2|NOT COMPLETED|Overall Study||0
8171742|NCT02439814|20147628|P1|NOT COMPLETED|Overall Study||0
8171743|NCT02439814|20147627|P2|COMPLETED|Overall Study||10
8171744|NCT02439814|20147628|P1|COMPLETED|Overall Study||11
8171745|NCT02439814|20147627|P2|STARTED|Overall Study||10
8171746|NCT02439814|20147628|P1|STARTED|Overall Study||11
8171747|NCT02439710|20147634|P1|NOT COMPLETED|Overall Study||0
8171748|NCT02439710|20147634|P1|COMPLETED|Overall Study||656
8171749|NCT02439710|20147634|P1|STARTED|Overall Study||656
8171750|NCT02439320|20147643|P3|NOT COMPLETED|Overall Study||99
8171751|NCT02439320|20147644|P2|NOT COMPLETED|Overall Study||114
8171752|NCT02439320|20147645|P1|NOT COMPLETED|Overall Study||96
8171753|NCT02439320|20147643|P3|COMPLETED|Overall Study||643
8171754|NCT02439320|20147644|P2|COMPLETED|Overall Study||631
8171755|NCT02439320|20147645|P1|COMPLETED|Overall Study||648
8171756|NCT02439320|20147643|P3|2nd Dose (After 2 Hour Assessment)|Overall Study||401
8171757|NCT02439320|20147644|P2|2nd Dose (After 2 Hour Assessment)|Overall Study||238
8171758|NCT02439320|20147645|P1|2nd Dose (After 2 Hour Assessment)|Overall Study||289
8171759|NCT02439320|20147643|P3|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617
8171760|NCT02439320|20147644|P2|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609
8171761|NCT02439320|20147645|P1|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630
8171762|NCT02439320|20147643|P3|Confirmed Eligibility|Overall Study||705
8171763|NCT02439320|20147644|P2|Confirmed Eligibility|Overall Study||695
8171764|NCT02439320|20147645|P1|Confirmed Eligibility|Overall Study||710
8171765|NCT02439320|20147643|P3|STARTED|Overall Study||742
8171766|NCT02439320|20147644|P2|STARTED|Overall Study||745
8171767|NCT02439320|20147645|P1|STARTED|Overall Study||744
8171768|NCT02439281|20147690|P2|NOT COMPLETED|Overall Study||0
8171769|NCT02439281|20147691|P1|NOT COMPLETED|Overall Study||0
8171770|NCT02439281|20147690|P2|COMPLETED|Overall Study||26
8171771|NCT02439281|20147691|P1|COMPLETED|Overall Study||24
8171772|NCT02439281|20147690|P2|STARTED|Overall Study||26
8171773|NCT02439281|20147691|P1|STARTED|Overall Study||24
8171774|NCT02439164|20147711|P2|NOT COMPLETED|Overall Study||0
8171775|NCT02439164|20147712|P1|NOT COMPLETED|Overall Study||0
8171776|NCT02439164|20147711|P2|COMPLETED|Overall Study||18
8171777|NCT02439164|20147712|P1|COMPLETED|Overall Study||18
8171778|NCT02439164|20147711|P2|STARTED|Overall Study||18
8171779|NCT02439164|20147712|P1|STARTED|Overall Study||18
8171780|NCT02439138|20147725|P1|NOT COMPLETED|Overall Study||3
8171781|NCT02439138|20147725|P1|COMPLETED|Overall Study||2
8171782|NCT02439138|20147725|P1|STARTED|Overall Study||5
8171783|NCT02438826|20147738|P4|NOT COMPLETED|Post-Treatment Phase||0
8171784|NCT02438826|20147739|P3|NOT COMPLETED|Post-Treatment Phase||0
8171785|NCT02438826|20147740|P2|NOT COMPLETED|Post-Treatment Phase||1
8171786|NCT02438826|20147741|P1|NOT COMPLETED|Post-Treatment Phase||9
8171787|NCT02438826|20147738|P4|COMPLETED|Post-Treatment Phase||4
8171788|NCT02438826|20147739|P3|COMPLETED|Post-Treatment Phase||2
8171789|NCT02438826|20147740|P2|COMPLETED|Post-Treatment Phase||92
8171790|NCT02438826|20147741|P1|COMPLETED|Post-Treatment Phase||84
8171791|NCT02438826|20147738|P4|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|4
8171792|NCT02438826|20147739|P3|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|2
8171793|NCT02438826|20147740|P2|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
8171794|NCT02438826|20147741|P1|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
8171795|NCT02438826|20147738|P4|NOT COMPLETED|Open-Label Treatment Phase||0
8171796|NCT02438826|20147739|P3|NOT COMPLETED|Open-Label Treatment Phase||0
8171797|NCT02438826|20147740|P2|NOT COMPLETED|Open-Label Treatment Phase||33
8171798|NCT02438826|20147741|P1|NOT COMPLETED|Open-Label Treatment Phase||44
8171799|NCT02438826|20147738|P4|COMPLETED|Open-Label Treatment Phase||0
8171800|NCT02438826|20147739|P3|COMPLETED|Open-Label Treatment Phase||0
8171801|NCT02438826|20147740|P2|COMPLETED|Open-Label Treatment Phase||80
8171802|NCT02438826|20147741|P1|COMPLETED|Open-Label Treatment Phase||72
8171803|NCT02438826|20147738|P4|STARTED|Open-Label Treatment Phase||0
8171804|NCT02438826|20147739|P3|STARTED|Open-Label Treatment Phase||0
8171805|NCT02438826|20147740|P2|STARTED|Open-Label Treatment Phase||113
8171806|NCT02438826|20147741|P1|STARTED|Open-Label Treatment Phase|This period is optional phase, one participant chose not to enter the open-label phase.|116
8171807|NCT02438826|20147738|P4|NOT COMPLETED|Double-Blind Treatment Phase||0
8171808|NCT02438826|20147739|P3|NOT COMPLETED|Double-Blind Treatment Phase||0
8171809|NCT02438826|20147740|P2|NOT COMPLETED|Double-Blind Treatment Phase||4
8171810|NCT02438826|20147741|P1|NOT COMPLETED|Double-Blind Treatment Phase||6
8171811|NCT02438826|20147738|P4|COMPLETED|Double-Blind Treatment Phase||0
8171812|NCT02438826|20147739|P3|COMPLETED|Double-Blind Treatment Phase||0
8171813|NCT02438826|20147740|P2|COMPLETED|Double-Blind Treatment Phase||113
8171814|NCT02438826|20147741|P1|COMPLETED|Double-Blind Treatment Phase||117
8171815|NCT02438826|20147738|P4|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
8171816|NCT02438826|20147739|P3|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
8171817|NCT02438826|20147740|P2|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||117
8171818|NCT02438826|20147741|P1|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||120
8171819|NCT02438826|20147738|P4|STARTED|Double-Blind Treatment Phase||0
8171820|NCT02438826|20147739|P3|STARTED|Double-Blind Treatment Phase||0
8171821|NCT02438826|20147740|P2|STARTED|Double-Blind Treatment Phase||117
8171822|NCT02438826|20147741|P1|STARTED|Double-Blind Treatment Phase||123
8171823|NCT02438813|20147775|P1|NOT COMPLETED|Overall Study||525
8171824|NCT02438813|20147775|P1|COMPLETED|Overall Study||504
8171825|NCT02438813|20147775|P1|Did Not ReceiveTreatment for SMF|Overall Study||353
8171826|NCT02438813|20147775|P1|Received Treatment for SMF|Overall Study||676
8171827|NCT02438813|20147775|P1|STARTED|Overall Study||1029
8171828|NCT02438787|20147827|P3|NOT COMPLETED|Overall Study||83
8171829|NCT02438787|20147828|P2|NOT COMPLETED|Overall Study||83
8171830|NCT02438787|20147829|P1|NOT COMPLETED|Overall Study||81
8171831|NCT02438787|20147827|P3|COMPLETED|Overall Study||22
8171832|NCT02438787|20147828|P2|COMPLETED|Overall Study||23
8171833|NCT02438787|20147829|P1|COMPLETED|Overall Study||23
8171834|NCT02438787|20147827|P3|Cross Over at Week 24|Overall Study||0
8171835|NCT02438787|20147828|P2|Cross Over at Week 24|Overall Study||0
8171836|NCT02438787|20147829|P1|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
8171837|NCT02438787|20147827|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
8171838|NCT02438787|20147828|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
8171839|NCT02438787|20147829|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
8171840|NCT02438787|20147827|P3|STARTED|Overall Study||105
8171841|NCT02438787|20147828|P2|STARTED|Overall Study||106
8171842|NCT02438787|20147829|P1|STARTED|Overall Study||104
8171843|NCT02438540|20147874|P2|NOT COMPLETED|Overall Study||0
8171844|NCT02438540|20147875|P1|NOT COMPLETED|Overall Study||0
8171845|NCT02438540|20147874|P2|COMPLETED|Overall Study||20
8171846|NCT02438540|20147875|P1|COMPLETED|Overall Study||19
8171847|NCT02438540|20147874|P2|STARTED|Overall Study||20
8171848|NCT02438540|20147875|P1|STARTED|Overall Study||19
8171849|NCT02438475|20147917|P2|NOT COMPLETED|Overall Study||0
8171850|NCT02438475|20147918|P1|NOT COMPLETED|Overall Study||2
8171851|NCT02438475|20147917|P2|COMPLETED|Overall Study||104
8171852|NCT02438475|20147918|P1|COMPLETED|Overall Study||102
8171853|NCT02438475|20147917|P2|STARTED|Overall Study||104
8171854|NCT02438475|20147918|P1|STARTED|Overall Study||104
8171855|NCT02438423|20147932|P4|NOT COMPLETED|Overall Study||0
8171856|NCT02438423|20147933|P3|NOT COMPLETED|Overall Study||0
8171857|NCT02438423|20147934|P2|NOT COMPLETED|Overall Study||0
8171858|NCT02438423|20147935|P1|NOT COMPLETED|Overall Study||0
8171859|NCT02438423|20147932|P4|COMPLETED|Overall Study||25
8171860|NCT02438423|20147933|P3|COMPLETED|Overall Study||25
8171861|NCT02438423|20147934|P2|COMPLETED|Overall Study||25
8171862|NCT02438423|20147935|P1|COMPLETED|Overall Study||25
8171863|NCT02438423|20147932|P4|STARTED|Overall Study||25
8171864|NCT02438423|20147933|P3|STARTED|Overall Study||25
8171865|NCT02438423|20147934|P2|STARTED|Overall Study||25
8171866|NCT02438423|20147935|P1|STARTED|Overall Study||25
8171867|NCT02438384|20147962|P3|NOT COMPLETED|Overall Study||4
8171868|NCT02438384|20147963|P2|NOT COMPLETED|Overall Study||6
8171869|NCT02438384|20147964|P1|NOT COMPLETED|Overall Study||8
8171870|NCT02438384|20147962|P3|COMPLETED|Overall Study||21
8171871|NCT02438384|20147963|P2|COMPLETED|Overall Study||19
8171872|NCT02438384|20147964|P1|COMPLETED|Overall Study||17
8171873|NCT02438384|20147962|P3|STARTED|Overall Study||25
8171874|NCT02438384|20147963|P2|STARTED|Overall Study||25
8171875|NCT02438384|20147964|P1|STARTED|Overall Study||25
8171876|NCT02438280|20147983|P2|NOT COMPLETED|Overall Study||0
8171877|NCT02438280|20147984|P1|NOT COMPLETED|Overall Study||1
8171878|NCT02438280|20147983|P2|COMPLETED|Overall Study||13
8171879|NCT02438280|20147984|P1|COMPLETED|Overall Study||13
8171880|NCT02438280|20147983|P2|STARTED|Overall Study||13
8171881|NCT02438280|20147984|P1|STARTED|Overall Study||14
8171882|NCT02438137|20147994|P2|NOT COMPLETED|Overall Study||6
8171883|NCT02438137|20147995|P1|NOT COMPLETED|Overall Study||8
8171884|NCT02438137|20147994|P2|COMPLETED|Overall Study||15
8171885|NCT02438137|20147995|P1|COMPLETED|Overall Study||36
8171886|NCT02438137|20147994|P2|STARTED|Overall Study||21
8171887|NCT02438137|20147995|P1|STARTED|Overall Study||44
8171888|NCT02437903|20148003|P1|NOT COMPLETED|Overall Study||5
8171889|NCT02437903|20148003|P1|COMPLETED|Overall Study||25
8171890|NCT02437903|20148003|P1|STARTED|Overall Study||30
8171891|NCT02437890|20148016|P5|NOT COMPLETED|Overall Study||16
8171892|NCT02437890|20148017|P4|NOT COMPLETED|Overall Study||22
8171893|NCT02437890|20148018|P3|NOT COMPLETED|Overall Study||15
8171894|NCT02437890|20148019|P2|NOT COMPLETED|Overall Study||16
8171895|NCT02437890|20148020|P1|NOT COMPLETED|Overall Study||8
8171896|NCT02437890|20148016|P5|COMPLETED|Overall Study||46
8171897|NCT02437890|20148017|P4|COMPLETED|Overall Study||40
8171898|NCT02437890|20148018|P3|COMPLETED|Overall Study||47
8171899|NCT02437890|20148019|P2|COMPLETED|Overall Study||48
8171900|NCT02437890|20148020|P1|COMPLETED|Overall Study||54
8171901|NCT02437890|20148016|P5|STARTED|Overall Study||62
8171902|NCT02437890|20148017|P4|STARTED|Overall Study||62
8171903|NCT02437890|20148018|P3|STARTED|Overall Study||62
8171904|NCT02437890|20148019|P2|STARTED|Overall Study||64
8171905|NCT02437890|20148020|P1|STARTED|Overall Study||62
8171906|NCT02437864|20148233|P2|NOT COMPLETED|Overall Study||0
8171907|NCT02437864|20148234|P1|NOT COMPLETED|Overall Study||4
8171908|NCT02437864|20148233|P2|COMPLETED|Overall Study||160
8171909|NCT02437864|20148234|P1|COMPLETED|Overall Study||196
8171910|NCT02437864|20148233|P2|STARTED|Overall Study||160
8171911|NCT02437864|20148234|P1|STARTED|Overall Study||200
8171912|NCT02437669|20148248|P1|NOT COMPLETED|Overall Study||0
8171913|NCT02437669|20148248|P1|COMPLETED|Overall Study||35
8171914|NCT02437669|20148248|P1|STARTED|Overall Study||35
8171915|NCT02437513|20148255|P1|NOT COMPLETED|Overall Study||2
8171916|NCT02437513|20148255|P1|COMPLETED|Overall Study||0
8171917|NCT02437513|20148255|P1|STARTED|Overall Study||2
8171918|NCT02437487|20148265|P2|NOT COMPLETED|Overall Study||14
8171919|NCT02437487|20148266|P1|NOT COMPLETED|Overall Study||27
8171920|NCT02437487|20148265|P2|COMPLETED|Overall Study||16
8171921|NCT02437487|20148266|P1|COMPLETED|Overall Study||32
8171922|NCT02437487|20148265|P2|Intention-to-Treat Population|Overall Study||30
8171923|NCT02437487|20148266|P1|Intention-to-Treat Population|Overall Study||59
8171924|NCT02437487|20148265|P2|Actual Treatment Received|Overall Study||29
8171925|NCT02437487|20148266|P1|Actual Treatment Received|Overall Study||60
8171926|NCT02437487|20148265|P2|STARTED|Overall Study||30
8171927|NCT02437487|20148266|P1|STARTED|Overall Study||59
8171928|NCT02437409|20148280|P1|NOT COMPLETED|Overall Study||15
8171929|NCT02437409|20148280|P1|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
8171930|NCT02437409|20148280|P1|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
8171931|NCT02437383|20148291|P2|NOT COMPLETED|Overall Study||13
8171932|NCT02437383|20148292|P1|NOT COMPLETED|Overall Study||13
8171933|NCT02437383|20148291|P2|COMPLETED|Overall Study||87
8171934|NCT02437383|20148292|P1|COMPLETED|Overall Study||87
8171935|NCT02437383|20148291|P2|STARTED|Overall Study||100
8171936|NCT02437383|20148292|P1|STARTED|Overall Study||100
8171937|NCT02437344|20148366|P1|NOT COMPLETED|Overall Study||1
8171938|NCT02437344|20148366|P1|COMPLETED|Overall Study||15
8171939|NCT02437344|20148366|P1|STARTED|Overall Study||16
8171950|NCT02437305|20148382|P2|NOT COMPLETED|Overall Study||12
8171951|NCT02437305|20148383|P1|NOT COMPLETED|Overall Study||18
8171952|NCT02437305|20148382|P2|COMPLETED|Overall Study||38
8171953|NCT02437305|20148383|P1|COMPLETED|Overall Study||32
8171954|NCT02437305|20148382|P2|STARTED|Overall Study||50
8171955|NCT02437305|20148383|P1|STARTED|Overall Study||50
8171956|NCT02437253|20148393|P2|NOT COMPLETED|Overall Study||0
8171957|NCT02437253|20148394|P1|NOT COMPLETED|Overall Study||0
8171958|NCT02437253|20148393|P2|COMPLETED|Overall Study||1
8171959|NCT02437253|20148394|P1|COMPLETED|Overall Study||1
8171960|NCT02437253|20148393|P2|STARTED|Overall Study||1
8171961|NCT02437253|20148394|P1|STARTED|Overall Study||1
8171962|NCT02437188|20148410|P2|NOT COMPLETED|Overall Study||9
8171963|NCT02437188|20148411|P1|NOT COMPLETED|Overall Study||4
8171964|NCT02437188|20148410|P2|COMPLETED|Overall Study||35
8171965|NCT02437188|20148411|P1|COMPLETED|Overall Study||40
8171966|NCT02437188|20148410|P2|STARTED|Overall Study||44
8171967|NCT02437188|20148411|P1|STARTED|Overall Study||44
8171968|NCT02437162|20148428|P3|NOT COMPLETED|Overall Study||109
8171969|NCT02437162|20148429|P2|NOT COMPLETED|Overall Study||108
8171970|NCT02437162|20148430|P1|NOT COMPLETED|Overall Study||107
8171971|NCT02437162|20148428|P3|COMPLETED|Overall Study||6
8171972|NCT02437162|20148429|P2|COMPLETED|Overall Study||8
8171973|NCT02437162|20148430|P1|COMPLETED|Overall Study||9
8171974|NCT02437162|20148428|P3|Cross Over at Week 24|Overall Study||0
8171975|NCT02437162|20148429|P2|Cross Over at Week 24|Overall Study||0
8171976|NCT02437162|20148430|P1|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
8171977|NCT02437162|20148428|P3|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
8171978|NCT02437162|20148429|P2|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
8171979|NCT02437162|20148430|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
8171980|NCT02437162|20148428|P3|Treated|Overall Study||114
8171981|NCT02437162|20148429|P2|Treated|Overall Study||116
8171982|NCT02437162|20148430|P1|Treated|Overall Study||116
8171983|NCT02437162|20148428|P3|STARTED|Overall Study||115
8171984|NCT02437162|20148429|P2|STARTED|Overall Study||116
8171985|NCT02437162|20148430|P1|STARTED|Overall Study||116
8171986|NCT02436915|20148550|P2|NOT COMPLETED|Overall Study||1
8171987|NCT02436915|20148551|P1|NOT COMPLETED|Overall Study||0
8171988|NCT02436915|20148550|P2|COMPLETED|Overall Study||9
8171989|NCT02436915|20148551|P1|COMPLETED|Overall Study||9
8171990|NCT02436915|20148550|P2|STARTED|Overall Study||10
8171991|NCT02436915|20148551|P1|STARTED|Overall Study||9
8171992|NCT02436889|20148573|P2|NOT COMPLETED|Overall Study||1
8171993|NCT02436889|20148574|P1|NOT COMPLETED|Overall Study||1
8171994|NCT02436889|20148573|P2|COMPLETED|Overall Study||10
8171995|NCT02436889|20148574|P1|COMPLETED|Overall Study||11
8171996|NCT02436889|20148573|P2|STARTED|Overall Study||11
8171997|NCT02436889|20148574|P1|STARTED|Overall Study||12
8171998|NCT02436811|20148593|P3|NOT COMPLETED|Overall Study||7
8171999|NCT02436811|20148594|P2|NOT COMPLETED|Overall Study||9
8172000|NCT02436811|20148595|P1|NOT COMPLETED|Overall Study||2
8172001|NCT02436811|20148593|P3|COMPLETED|Overall Study||53
8172002|NCT02436811|20148594|P2|COMPLETED|Overall Study||51
8172003|NCT02436811|20148595|P1|COMPLETED|Overall Study||58
8172004|NCT02436811|20148593|P3|STARTED|Overall Study||60
8172005|NCT02436811|20148594|P2|STARTED|Overall Study||60
8172006|NCT02436811|20148595|P1|STARTED|Overall Study||60
8172007|NCT02436759|20148605|P2|NOT COMPLETED|Overall Study||1
8172008|NCT02436759|20148606|P1|NOT COMPLETED|Overall Study||4
8172009|NCT02436759|20148605|P2|COMPLETED|Overall Study||45
8172010|NCT02436759|20148606|P1|COMPLETED|Overall Study||90
8172011|NCT02436759|20148605|P2|Subjects Treated|Overall Study||46
8172012|NCT02436759|20148606|P1|Subjects Treated|Overall Study||94
8172013|NCT02436759|20148605|P2|Subjects Randomized|Overall Study||46
8172014|NCT02436759|20148606|P1|Subjects Randomized|Overall Study||94
8172015|NCT02436759|20148605|P2|STARTED|Overall Study||46
8172016|NCT02436759|20148606|P1|STARTED|Overall Study||94
8172017|NCT02436681|20148614|P1|NOT COMPLETED|Overall Study||14
8172018|NCT02436681|20148614|P1|COMPLETED|Overall Study||27
8172019|NCT02436681|20148614|P1|STARTED|Overall Study||41
8172020|NCT02436668|20148627|P2|NOT COMPLETED|Overall Study||4
8172021|NCT02436668|20148628|P1|NOT COMPLETED|Overall Study||1
8172022|NCT02436668|20148627|P2|COMPLETED|Overall Study||207
8172023|NCT02436668|20148628|P1|COMPLETED|Overall Study||212
8172024|NCT02436668|20148627|P2|STARTED|Overall Study||211
8172025|NCT02436668|20148628|P1|STARTED|Overall Study||213
8172026|NCT02436577|20148654|P6|NOT COMPLETED|Overall Study||0
8172027|NCT02436577|20148655|P5|NOT COMPLETED|Overall Study||0
8172028|NCT02436577|20148656|P4|NOT COMPLETED|Overall Study||0
8172029|NCT02436577|20148657|P3|NOT COMPLETED|Overall Study||0
8172030|NCT02436577|20148658|P2|NOT COMPLETED|Overall Study||1
8172031|NCT02436577|20148659|P1|NOT COMPLETED|Overall Study||0
8172032|NCT02436577|20148654|P6|COMPLETED|Overall Study||7
8172033|NCT02436577|20148655|P5|COMPLETED|Overall Study||7
8172034|NCT02436577|20148656|P4|COMPLETED|Overall Study||7
8172035|NCT02436577|20148657|P3|COMPLETED|Overall Study||7
8172036|NCT02436577|20148658|P2|COMPLETED|Overall Study||6
8172037|NCT02436577|20148659|P1|COMPLETED|Overall Study||7
8172038|NCT02436577|20148654|P6|STARTED|Overall Study||7
8172039|NCT02436577|20148655|P5|STARTED|Overall Study||7
8172040|NCT02436577|20148656|P4|STARTED|Overall Study||7
8172041|NCT02436577|20148657|P3|STARTED|Overall Study||7
8172042|NCT02436577|20148658|P2|STARTED|Overall Study||7
8172043|NCT02436577|20148659|P1|STARTED|Overall Study||7
8172044|NCT02436356|20148715|P3|NOT COMPLETED|Overall Study||2
8172045|NCT02436356|20148716|P2|NOT COMPLETED|Overall Study||1
8172046|NCT02436356|20148717|P1|NOT COMPLETED|Overall Study||5
8172047|NCT02436356|20148715|P3|COMPLETED|Overall Study||2
8172048|NCT02436356|20148716|P2|COMPLETED|Overall Study||10
8172049|NCT02436356|20148717|P1|COMPLETED|Overall Study||28
8172050|NCT02436356|20148715|P3|Low Energy Fracture|Overall Study||0
8172051|NCT02436356|20148716|P2|Low Energy Fracture|Overall Study||0
8172052|NCT02436356|20148717|P1|Low Energy Fracture|Overall Study||19
8172053|NCT02436356|20148715|P3|High Energy Fracture|Overall Study||4
8172054|NCT02436356|20148716|P2|High Energy Fracture|Overall Study||0
8172055|NCT02436356|20148717|P1|High Energy Fracture|Overall Study||14
8172056|NCT02436356|20148715|P3|STARTED|Overall Study||4
8172057|NCT02436356|20148716|P2|STARTED|Overall Study||11
8172058|NCT02436356|20148717|P1|STARTED|Overall Study||33
8172059|NCT02436330|20148748|P2|NOT COMPLETED|Cohort 6||1
8172060|NCT02436330|20148749|P1|NOT COMPLETED|Cohort 6||3
8172061|NCT02436330|20148748|P2|COMPLETED|Cohort 6||4
8172062|NCT02436330|20148749|P1|COMPLETED|Cohort 6||1
8172063|NCT02436330|20148748|P2|STARTED|Cohort 6||5
8172064|NCT02436330|20148749|P1|STARTED|Cohort 6||4
8172065|NCT02436330|20148748|P2|NOT COMPLETED|Cohort 5||4
8172066|NCT02436330|20148749|P1|NOT COMPLETED|Cohort 5||6
8172067|NCT02436330|20148748|P2|COMPLETED|Cohort 5||1
8172068|NCT02436330|20148749|P1|COMPLETED|Cohort 5||4
8172069|NCT02436330|20148748|P2|STARTED|Cohort 5||5
8172070|NCT02436330|20148749|P1|STARTED|Cohort 5||10
8172071|NCT02436330|20148748|P2|NOT COMPLETED|Cohort 4||0
8172072|NCT02436330|20148749|P1|NOT COMPLETED|Cohort 4||2
8172073|NCT02436330|20148748|P2|COMPLETED|Cohort 4||0
8172074|NCT02436330|20148749|P1|COMPLETED|Cohort 4||4
8172075|NCT02436330|20148748|P2|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
8172076|NCT02436330|20148749|P1|STARTED|Cohort 4||6
8172077|NCT02436330|20148748|P2|NOT COMPLETED|Cohort 3||0
8172078|NCT02436330|20148749|P1|NOT COMPLETED|Cohort 3||5
8172079|NCT02436330|20148748|P2|COMPLETED|Cohort 3||0
8172080|NCT02436330|20148749|P1|COMPLETED|Cohort 3||7
8172081|NCT02436330|20148748|P2|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
8172082|NCT02436330|20148749|P1|STARTED|Cohort 3||12
8172083|NCT02436330|20148748|P2|NOT COMPLETED|Cohort 2||3
8172084|NCT02436330|20148749|P1|NOT COMPLETED|Cohort 2||4
8172085|NCT02436330|20148748|P2|COMPLETED|Cohort 2||7
8172086|NCT02436330|20148749|P1|COMPLETED|Cohort 2||10
8172087|NCT02436330|20148748|P2|STARTED|Cohort 2||10
8172088|NCT02436330|20148749|P1|STARTED|Cohort 2||14
8172089|NCT02436330|20148748|P2|NOT COMPLETED|Cohort 1||3
8172090|NCT02436330|20148749|P1|NOT COMPLETED|Cohort 1||5
8172091|NCT02436330|20148748|P2|COMPLETED|Cohort 1||1
8172092|NCT02436330|20148749|P1|COMPLETED|Cohort 1||9
8172093|NCT02436330|20148748|P2|STARTED|Cohort 1||4
8172094|NCT02436330|20148749|P1|STARTED|Cohort 1||14
8172095|NCT02436304|20148794|P3|NOT COMPLETED|Overall Study||1
8172096|NCT02436304|20148795|P2|NOT COMPLETED|Overall Study||2
8172097|NCT02436304|20148796|P1|NOT COMPLETED|Overall Study||0
8172098|NCT02436304|20148794|P3|COMPLETED|Overall Study||100
8172099|NCT02436304|20148795|P2|COMPLETED|Overall Study||100
8172100|NCT02436304|20148796|P1|COMPLETED|Overall Study||153
8172101|NCT02436304|20148794|P3|STARTED|Overall Study||101
8172102|NCT02436304|20148795|P2|STARTED|Overall Study||102
8172103|NCT02436304|20148796|P1|STARTED|Overall Study||153
8172104|NCT02436239|20148815|P4|NOT COMPLETED|Down-Taper Period||2
8172105|NCT02436239|20148816|P3|NOT COMPLETED|Down-Taper Period||1
8172106|NCT02436239|20148817|P2|NOT COMPLETED|Down-Taper Period||4
8172107|NCT02436239|20148818|P1|NOT COMPLETED|Down-Taper Period||4
8172108|NCT02436239|20148815|P4|COMPLETED|Down-Taper Period||4
8172109|NCT02436239|20148816|P3|COMPLETED|Down-Taper Period||43
8172110|NCT02436239|20148817|P2|COMPLETED|Down-Taper Period||99
8172111|NCT02436239|20148818|P1|COMPLETED|Down-Taper Period||86
8172112|NCT02436239|20148815|P4|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6
8172113|NCT02436239|20148816|P3|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44
8172114|NCT02436239|20148817|P2|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103
8172115|NCT02436239|20148818|P1|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90
8172116|NCT02436239|20148815|P4|NOT COMPLETED|Open-Lable Treatment Period||5
8172117|NCT02436239|20148816|P3|NOT COMPLETED|Open-Lable Treatment Period||27
8172118|NCT02436239|20148817|P2|NOT COMPLETED|Open-Lable Treatment Period||34
8172119|NCT02436239|20148818|P1|NOT COMPLETED|Open-Lable Treatment Period||33
8172120|NCT02436239|20148815|P4|COMPLETED|Open-Lable Treatment Period||7
8172121|NCT02436239|20148816|P3|COMPLETED|Open-Lable Treatment Period||38
8172122|NCT02436239|20148817|P2|COMPLETED|Open-Lable Treatment Period||97
8172123|NCT02436239|20148818|P1|COMPLETED|Open-Lable Treatment Period||89
8172124|NCT02436239|20148815|P4|STARTED|Open-Lable Treatment Period||12
8172125|NCT02436239|20148816|P3|STARTED|Open-Lable Treatment Period||65
8172126|NCT02436239|20148817|P2|STARTED|Open-Lable Treatment Period||131
8172127|NCT02436239|20148818|P1|STARTED|Open-Lable Treatment Period||122
8172128|NCT02436200|20148840|P1|NOT COMPLETED|Overall Study||1
8172129|NCT02436200|20148840|P1|COMPLETED|Overall Study||20
8172130|NCT02436200|20148840|P1|STARTED|Overall Study||21
8172131|NCT02436135|20148847|P2|NOT COMPLETED|Overall Study||4
8172132|NCT02436135|20148848|P1|NOT COMPLETED|Overall Study||6
8172133|NCT02436135|20148847|P2|COMPLETED|Overall Study||0
8172134|NCT02436135|20148848|P1|COMPLETED|Overall Study||0
8172135|NCT02436135|20148847|P2|STARTED|Overall Study||4
8172136|NCT02436135|20148848|P1|STARTED|Overall Study||6
8172137|NCT02436031|20148872|P2|NOT COMPLETED|Second Study Night||0
8172138|NCT02436031|20148873|P1|NOT COMPLETED|Second Study Night||0
8172139|NCT02436031|20148872|P2|COMPLETED|Second Study Night||8
8172140|NCT02436031|20148873|P1|COMPLETED|Second Study Night||7
8172141|NCT02436031|20148872|P2|STARTED|Second Study Night||8
8172142|NCT02436031|20148873|P1|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
8172143|NCT02436031|20148872|P2|NOT COMPLETED|First Study Night||0
8172144|NCT02436031|20148873|P1|NOT COMPLETED|First Study Night||0
8172145|NCT02436031|20148872|P2|COMPLETED|First Study Night||8
8172146|NCT02436031|20148873|P1|COMPLETED|First Study Night||8
8172147|NCT02436031|20148872|P2|STARTED|First Study Night||8
8172148|NCT02436031|20148873|P1|STARTED|First Study Night||8
8172149|NCT02436005|20148883|P2|NOT COMPLETED|Second Intervention||1
8172150|NCT02436005|20148884|P1|NOT COMPLETED|Second Intervention||0
8172151|NCT02436005|20148883|P2|COMPLETED|Second Intervention||12
8172152|NCT02436005|20148884|P1|COMPLETED|Second Intervention||12
8172153|NCT02436005|20148883|P2|STARTED|Second Intervention||13
8172154|NCT02436005|20148884|P1|STARTED|Second Intervention||12
8172155|NCT02436005|20148883|P2|NOT COMPLETED|First Intervention||0
8172156|NCT02436005|20148884|P1|NOT COMPLETED|First Intervention||0
8172157|NCT02436005|20148883|P2|COMPLETED|First Intervention||13
8172158|NCT02436005|20148884|P1|COMPLETED|First Intervention||12
8172159|NCT02436005|20148883|P2|STARTED|First Intervention||13
8172160|NCT02436005|20148884|P1|STARTED|First Intervention||12
8172161|NCT02435966|20148949|P3|NOT COMPLETED|Overall Study||0
8172162|NCT02435966|20148950|P2|NOT COMPLETED|Overall Study||1
8172163|NCT02435966|20148951|P1|NOT COMPLETED|Overall Study||0
8172164|NCT02435966|20148949|P3|COMPLETED|Overall Study||30
8172165|NCT02435966|20148950|P2|COMPLETED|Overall Study||53
8172166|NCT02435966|20148951|P1|COMPLETED|Overall Study||47
8172167|NCT02435966|20148949|P3|Follow-up|Overall Study||30
8172168|NCT02435966|20148950|P2|Follow-up|Overall Study||53
8172169|NCT02435966|20148951|P1|Follow-up|Overall Study||47
8172170|NCT02435966|20148949|P3|Second Intervention|Overall Study||30
8172171|NCT02435966|20148950|P2|Second Intervention|Overall Study||53
8172172|NCT02435966|20148951|P1|Second Intervention|Overall Study||47
8172173|NCT02435966|20148949|P3|First Intervention|Overall Study||30
8172174|NCT02435966|20148950|P2|First Intervention|Overall Study||54
8172175|NCT02435966|20148951|P1|First Intervention|Overall Study||47
8172176|NCT02435966|20148949|P3|STARTED|Overall Study||30
8172177|NCT02435966|20148950|P2|STARTED|Overall Study||54
8172178|NCT02435966|20148951|P1|STARTED|Overall Study||47
8172179|NCT02435914|20148963|P4|NOT COMPLETED|Overall Study||0
8172180|NCT02435914|20148964|P3|NOT COMPLETED|Overall Study||1
8172181|NCT02435914|20148965|P2|NOT COMPLETED|Overall Study||1
8172182|NCT02435914|20148966|P1|NOT COMPLETED|Overall Study||1
8172183|NCT02435914|20148963|P4|COMPLETED|Overall Study||59
8172184|NCT02435914|20148964|P3|COMPLETED|Overall Study||59
8172185|NCT02435914|20148965|P2|COMPLETED|Overall Study||58
8172186|NCT02435914|20148966|P1|COMPLETED|Overall Study||57
8172187|NCT02435914|20148963|P4|STARTED|Overall Study||59
8172188|NCT02435914|20148964|P3|STARTED|Overall Study||60
8172189|NCT02435914|20148965|P2|STARTED|Overall Study||59
8172190|NCT02435914|20148966|P1|STARTED|Overall Study||58
8172194|NCT02435836|20148994|P1|NOT COMPLETED|Overall Study||631
8172195|NCT02435836|20148994|P1|COMPLETED|Overall Study||0
8172196|NCT02435836|20148994|P1|STARTED|Overall Study||631
8172197|NCT02435706|20149012|P2|NOT COMPLETED|Overall Study||1
8172198|NCT02435706|20149013|P1|NOT COMPLETED|Overall Study||2
8172199|NCT02435706|20149012|P2|COMPLETED|Overall Study||20
8172200|NCT02435706|20149013|P1|COMPLETED|Overall Study||16
8172201|NCT02435706|20149012|P2|STARTED|Overall Study||21
8172202|NCT02435706|20149013|P1|STARTED|Overall Study||18
8172203|NCT02435524|20149027|P2|NOT COMPLETED|Endline Survey||0
8172204|NCT02435524|20149028|P1|NOT COMPLETED|Endline Survey||0
8172205|NCT02435524|20149027|P2|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
8172206|NCT02435524|20149028|P1|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
8172207|NCT02435524|20149027|P2|STARTED|Endline Survey||1161
8172208|NCT02435524|20149028|P1|STARTED|Endline Survey||1092
8172209|NCT02435524|20149027|P2|NOT COMPLETED|Baseline Survey||0
8172210|NCT02435524|20149028|P1|NOT COMPLETED|Baseline Survey||0
8172211|NCT02435524|20149027|P2|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
8172212|NCT02435524|20149028|P1|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
8172213|NCT02435524|20149027|P2|STARTED|Baseline Survey||1177
8172214|NCT02435524|20149028|P1|STARTED|Baseline Survey||1111
8172215|NCT02435511|20149036|P2|NOT COMPLETED|Overall Study||35
8172216|NCT02435511|20149037|P1|NOT COMPLETED|Overall Study||44
8172217|NCT02435511|20149036|P2|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174
8172218|NCT02435511|20149037|P1|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158
8172219|NCT02435511|20149036|P2|STARTED|Overall Study|Defined as enrolled and completed baseline|209
8172220|NCT02435511|20149037|P1|STARTED|Overall Study|Defined as enrolled and completed baseline|202
8172241|NCT02435277|20149083|P4|NOT COMPLETED|Overall Study||0
8172242|NCT02435277|20149084|P3|NOT COMPLETED|Overall Study||0
8172243|NCT02435277|20149085|P2|NOT COMPLETED|Overall Study||1
8172244|NCT02435277|20149086|P1|NOT COMPLETED|Overall Study||2
8172245|NCT02435277|20149083|P4|COMPLETED|Overall Study||11
8172246|NCT02435277|20149084|P3|COMPLETED|Overall Study||11
8172247|NCT02435277|20149085|P2|COMPLETED|Overall Study||15
8172248|NCT02435277|20149086|P1|COMPLETED|Overall Study||10
8172249|NCT02435277|20149083|P4|STARTED|Overall Study||11
8172250|NCT02435277|20149084|P3|STARTED|Overall Study||11
8172251|NCT02435277|20149085|P2|STARTED|Overall Study||16
8172252|NCT02435277|20149086|P1|STARTED|Overall Study||12
8172253|NCT02435147|20149100|P1|NOT COMPLETED|Overall Study||11
8172254|NCT02435147|20149100|P1|COMPLETED|Overall Study||75
8172255|NCT02435147|20149100|P1|STARTED|Overall Study||86
8172256|NCT02435069|20149105|P5|NOT COMPLETED|Effectiveness - Second Intervention||1
8172257|NCT02435069|20149106|P4|NOT COMPLETED|Effectiveness - Second Intervention||0
8172258|NCT02435069|20149107|P3|NOT COMPLETED|Effectiveness - Second Intervention||0
8172259|NCT02435069|20149108|P2|NOT COMPLETED|Effectiveness - Second Intervention||0
8172260|NCT02435069|20149109|P1|NOT COMPLETED|Effectiveness - Second Intervention||0
8172261|NCT02435069|20149105|P5|COMPLETED|Effectiveness - Second Intervention||0
8172262|NCT02435069|20149106|P4|COMPLETED|Effectiveness - Second Intervention||1
8172263|NCT02435069|20149107|P3|COMPLETED|Effectiveness - Second Intervention||0
8172264|NCT02435069|20149108|P2|COMPLETED|Effectiveness - Second Intervention||0
8172265|NCT02435069|20149109|P1|COMPLETED|Effectiveness - Second Intervention||0
8172266|NCT02435069|20149105|P5|STARTED|Effectiveness - Second Intervention||1
8172267|NCT02435069|20149106|P4|STARTED|Effectiveness - Second Intervention||1
8172268|NCT02435069|20149107|P3|STARTED|Effectiveness - Second Intervention||0
8172269|NCT02435069|20149108|P2|STARTED|Effectiveness - Second Intervention||0
8172270|NCT02435069|20149109|P1|STARTED|Effectiveness - Second Intervention||0
8172271|NCT02435069|20149105|P5|NOT COMPLETED|Dose Response - First Intervention||0
8172272|NCT02435069|20149106|P4|NOT COMPLETED|Dose Response - First Intervention||0
8172273|NCT02435069|20149107|P3|NOT COMPLETED|Dose Response - First Intervention||1
8172274|NCT02435069|20149108|P2|NOT COMPLETED|Dose Response - First Intervention||1
8172275|NCT02435069|20149109|P1|NOT COMPLETED|Dose Response - First Intervention||0
8172276|NCT02435069|20149105|P5|COMPLETED|Dose Response - First Intervention||0
8172277|NCT02435069|20149106|P4|COMPLETED|Dose Response - First Intervention||0
8172278|NCT02435069|20149107|P3|COMPLETED|Dose Response - First Intervention||1
8172279|NCT02435069|20149108|P2|COMPLETED|Dose Response - First Intervention||2
8172280|NCT02435069|20149109|P1|COMPLETED|Dose Response - First Intervention||0
8172281|NCT02435069|20149105|P5|STARTED|Dose Response - First Intervention||0
8172282|NCT02435069|20149106|P4|STARTED|Dose Response - First Intervention||0
8172283|NCT02435069|20149107|P3|STARTED|Dose Response - First Intervention||2
8172284|NCT02435069|20149108|P2|STARTED|Dose Response - First Intervention||3
8172285|NCT02435069|20149109|P1|STARTED|Dose Response - First Intervention||0
8172286|NCT02435069|20149105|P5|NOT COMPLETED|Preoperative Baseline Phase||0
8172287|NCT02435069|20149106|P4|NOT COMPLETED|Preoperative Baseline Phase||0
8172288|NCT02435069|20149107|P3|NOT COMPLETED|Preoperative Baseline Phase||0
8172289|NCT02435069|20149108|P2|NOT COMPLETED|Preoperative Baseline Phase||0
8172290|NCT02435069|20149109|P1|NOT COMPLETED|Preoperative Baseline Phase||0
8172291|NCT02435069|20149105|P5|COMPLETED|Preoperative Baseline Phase||0
8172292|NCT02435069|20149106|P4|COMPLETED|Preoperative Baseline Phase||0
8172293|NCT02435069|20149107|P3|COMPLETED|Preoperative Baseline Phase||0
8172294|NCT02435069|20149108|P2|COMPLETED|Preoperative Baseline Phase||0
8172295|NCT02435069|20149109|P1|COMPLETED|Preoperative Baseline Phase||5
8172296|NCT02435069|20149105|P5|STARTED|Preoperative Baseline Phase||0
8172297|NCT02435069|20149106|P4|STARTED|Preoperative Baseline Phase||0
8172298|NCT02435069|20149107|P3|STARTED|Preoperative Baseline Phase||0
8172299|NCT02435069|20149108|P2|STARTED|Preoperative Baseline Phase||0
8172300|NCT02435069|20149109|P1|STARTED|Preoperative Baseline Phase||5
8172301|NCT02434939|20149131|P2|NOT COMPLETED|Overall Study||49
8172302|NCT02434939|20149132|P1|NOT COMPLETED|Overall Study||37
8172303|NCT02434939|20149131|P2|COMPLETED|Overall Study||71
8172304|NCT02434939|20149132|P1|COMPLETED|Overall Study||83
8172305|NCT02434939|20149131|P2|STARTED|Overall Study||120
8172306|NCT02434939|20149132|P1|STARTED|Overall Study||120
8172307|NCT02434770|20149147|P3|NOT COMPLETED|Week 18 to Week||6
8172308|NCT02434770|20149148|P2|NOT COMPLETED|Week 18 to Week||8
8172309|NCT02434770|20149149|P1|NOT COMPLETED|Week 18 to Week||8
8172310|NCT02434770|20149147|P3|COMPLETED|Week 18 to Week||227
8172311|NCT02434770|20149148|P2|COMPLETED|Week 18 to Week||220
8172312|NCT02434770|20149149|P1|COMPLETED|Week 18 to Week||227
8172313|NCT02434770|20149147|P3|STARTED|Week 18 to Week||233
8172314|NCT02434770|20149148|P2|STARTED|Week 18 to Week||228
8172315|NCT02434770|20149149|P1|STARTED|Week 18 to Week||235
8172316|NCT02434770|20149147|P3|NOT COMPLETED|Week 1 to Week 18||17
8172317|NCT02434770|20149148|P2|NOT COMPLETED|Week 1 to Week 18||22
8172318|NCT02434770|20149149|P1|NOT COMPLETED|Week 1 to Week 18||15
8172319|NCT02434770|20149147|P3|COMPLETED|Week 1 to Week 18||233
8172320|NCT02434770|20149148|P2|COMPLETED|Week 1 to Week 18||228
8172321|NCT02434770|20149149|P1|COMPLETED|Week 1 to Week 18||235
8172322|NCT02434770|20149147|P3|Received at Least One Vaccination|Week 1 to Week 18||250
8172323|NCT02434770|20149148|P2|Received at Least One Vaccination|Week 1 to Week 18||250
8172324|NCT02434770|20149149|P1|Received at Least One Vaccination|Week 1 to Week 18||249
8172325|NCT02434770|20149147|P3|STARTED|Week 1 to Week 18||250
8172326|NCT02434770|20149148|P2|STARTED|Week 1 to Week 18||250
8172327|NCT02434770|20149149|P1|STARTED|Week 1 to Week 18||250
8172328|NCT02434523|20149186|P2|NOT COMPLETED|Overall Study||6
8172329|NCT02434523|20149187|P1|NOT COMPLETED|Overall Study||5
8172330|NCT02434523|20149186|P2|COMPLETED|Overall Study||9
8172331|NCT02434523|20149187|P1|COMPLETED|Overall Study||10
8172332|NCT02434523|20149186|P2|STARTED|Overall Study||15
8172333|NCT02434523|20149187|P1|STARTED|Overall Study||15
8172334|NCT02434497|20149199|P1|NOT COMPLETED|Overall Study||5
8172335|NCT02434497|20149199|P1|COMPLETED|Overall Study||4
8172336|NCT02434497|20149199|P1|STARTED|Overall Study||9
8172337|NCT02434471|20149299|P1|NOT COMPLETED|Overall Study||9
8172338|NCT02434471|20149299|P1|COMPLETED|Overall Study||25
8172339|NCT02434471|20149299|P1|STARTED|Overall Study||34
8172340|NCT02434354|20149306|P1|NOT COMPLETED|Overall Study||3
8172341|NCT02434354|20149306|P1|COMPLETED|Overall Study||30
8172342|NCT02434354|20149306|P1|Post Consent Screening|Overall Study||30
8172343|NCT02434354|20149306|P1|STARTED|Overall Study|Consented|33
8172344|NCT02434328|20149312|P2|NOT COMPLETED|Overall Study||42
8172345|NCT02434328|20149313|P1|NOT COMPLETED|Overall Study||30
8172346|NCT02434328|20149312|P2|COMPLETED|Overall Study||329
8172347|NCT02434328|20149313|P1|COMPLETED|Overall Study||342
8172348|NCT02434328|20149312|P2|Randomized and Treated|Overall Study||369
8172349|NCT02434328|20149313|P1|Randomized and Treated|Overall Study||370
8172350|NCT02434328|20149312|P2|STARTED|Overall Study||371
8172351|NCT02434328|20149313|P1|STARTED|Overall Study||372
8172352|NCT02434146|20149376|P1|NOT COMPLETED|Overall Study||0
8172353|NCT02434146|20149376|P1|COMPLETED|Overall Study||3
8172354|NCT02434146|20149376|P1|STARTED|Overall Study||3
8172355|NCT02433834|20149388|P1|NOT COMPLETED|Overall Study||37
8172356|NCT02433834|20149388|P1|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
8172357|NCT02433834|20149388|P1|SAL 50 µg|Overall Study||167
8172358|NCT02433834|20149388|P1|Placebo MDI|Overall Study||174
8172359|NCT02433834|20149388|P1|GP MDI 1.9 µg|Overall Study||107
8172360|NCT02433834|20149388|P1|GP MDI 3.6 µg|Overall Study||118
8172361|NCT02433834|20149388|P1|GP MDI 7.2 µg|Overall Study||228
8172362|NCT02433834|20149388|P1|GP MDI 14.4 µg|Overall Study||230
8172363|NCT02433834|20149388|P1|GP MDI 28.8 µg|Overall Study||112
8172364|NCT02433834|20149388|P1|STARTED|Overall Study||248
8172365|NCT02433678|20149448|P2|NOT COMPLETED|Overall Study||2
8172366|NCT02433678|20149449|P1|NOT COMPLETED|Overall Study||1
8172367|NCT02433678|20149448|P2|COMPLETED|Overall Study||24
8172368|NCT02433678|20149449|P1|COMPLETED|Overall Study||25
8172369|NCT02433678|20149448|P2|STARTED|Overall Study||26
8172370|NCT02433678|20149449|P1|STARTED|Overall Study||26
8172371|NCT02433665|20149483|P2|NOT COMPLETED|Overall Study||0
8172372|NCT02433665|20149484|P1|NOT COMPLETED|Overall Study||0
8172373|NCT02433665|20149483|P2|COMPLETED|Overall Study||79
8172374|NCT02433665|20149484|P1|COMPLETED|Overall Study||77
8172375|NCT02433665|20149483|P2|STARTED|Overall Study||79
8172376|NCT02433665|20149484|P1|STARTED|Overall Study||77
8172377|NCT02433613|20149490|P1|NOT COMPLETED|Overall Study||17
8172378|NCT02433613|20149490|P1|COMPLETED|Overall Study||1054
8172379|NCT02433613|20149490|P1|STARTED|Overall Study||1071
8172380|NCT02433496|20149510|P3|NOT COMPLETED|Overall Study||0
8172381|NCT02433496|20149511|P2|NOT COMPLETED|Overall Study||0
8172382|NCT02433496|20149512|P1|NOT COMPLETED|Overall Study||0
8172383|NCT02433496|20149510|P3|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
8172384|NCT02433496|20149511|P2|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
8172385|NCT02433496|20149512|P1|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
8172386|NCT02433496|20149510|P3|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
8172387|NCT02433496|20149511|P2|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
8172388|NCT02433496|20149512|P1|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
8172389|NCT02433483|20149542|P1|NOT COMPLETED|Overall Study||2
8172390|NCT02433483|20149542|P1|COMPLETED|Overall Study||0
8172391|NCT02433483|20149542|P1|STARTED|Overall Study||2
8172395|NCT02433366|20149564|P2|NOT COMPLETED|Overall Study||0
8172396|NCT02433366|20149565|P1|NOT COMPLETED|Overall Study||0
8172397|NCT02433366|20149564|P2|COMPLETED|Overall Study||802
8172398|NCT02433366|20149565|P1|COMPLETED|Overall Study||411
8172399|NCT02433366|20149564|P2|STARTED|Overall Study||802
8172400|NCT02433366|20149565|P1|STARTED|Overall Study||411
8172401|NCT02433340|20149577|P4|NOT COMPLETED|Overall Study||2
8172402|NCT02433340|20149578|P3|NOT COMPLETED|Overall Study||2
8172403|NCT02433340|20149579|P2|NOT COMPLETED|Overall Study||2
8172404|NCT02433340|20149580|P1|NOT COMPLETED|Overall Study||2
8172405|NCT02433340|20149577|P4|COMPLETED|Overall Study||38
8172406|NCT02433340|20149578|P3|COMPLETED|Overall Study||37
8172407|NCT02433340|20149579|P2|COMPLETED|Overall Study||35
8172408|NCT02433340|20149580|P1|COMPLETED|Overall Study||40
8172409|NCT02433340|20149577|P4|STARTED|Overall Study||40
8172410|NCT02433340|20149578|P3|STARTED|Overall Study||39
8172411|NCT02433340|20149579|P2|STARTED|Overall Study||37
8172412|NCT02433340|20149580|P1|STARTED|Overall Study||42
8172413|NCT02433288|20150474|P2|NOT COMPLETED|Overall Study||126
8172414|NCT02433288|20150475|P1|NOT COMPLETED|Overall Study||123
8172415|NCT02433288|20150474|P2|COMPLETED|Overall Study||316
8172416|NCT02433288|20150475|P1|COMPLETED|Overall Study||320
8172417|NCT02433288|20150474|P2|STARTED|Overall Study||442
8172418|NCT02433288|20150475|P1|STARTED|Overall Study||443
8172419|NCT02433080|20150491|P2|NOT COMPLETED|Overall Study||4
8172420|NCT02433080|20150492|P1|NOT COMPLETED|Overall Study||1
8172421|NCT02433080|20150491|P2|COMPLETED|Overall Study||24
8172422|NCT02433080|20150492|P1|COMPLETED|Overall Study||25
8172423|NCT02433080|20150491|P2|8 Weeks|Overall Study||24
8172424|NCT02433080|20150492|P1|8 Weeks|Overall Study||25
8172425|NCT02433080|20150491|P2|STARTED|Overall Study||28
8172426|NCT02433080|20150492|P1|STARTED|Overall Study||26
8172430|NCT02432729|20150523|P1|NOT COMPLETED|Month 12 Visit||196
8172431|NCT02432729|20150523|P1|COMPLETED|Month 12 Visit||436
8172432|NCT02432729|20150523|P1|STARTED|Month 12 Visit||632
8172433|NCT02432729|20150523|P1|NOT COMPLETED|Month 6 Visit||86
8172434|NCT02432729|20150523|P1|COMPLETED|Month 6 Visit||632
8172435|NCT02432729|20150523|P1|STARTED|Month 6 Visit||718
8172436|NCT02432729|20150523|P1|NOT COMPLETED|Month 3 Visit||2
8172437|NCT02432729|20150523|P1|COMPLETED|Month 3 Visit||718
8172438|NCT02432729|20150523|P1|STARTED|Month 3 Visit||720
8172439|NCT02432716|20150551|P2|NOT COMPLETED|Overall Study||0
8172440|NCT02432716|20150552|P1|NOT COMPLETED|Overall Study||0
8172441|NCT02432716|20150551|P2|COMPLETED|Overall Study||6
8172442|NCT02432716|20150552|P1|COMPLETED|Overall Study||6
8172443|NCT02432716|20150551|P2|STARTED|Overall Study||6
8172444|NCT02432716|20150552|P1|STARTED|Overall Study||6
8172445|NCT02432456|20150568|P2|NOT COMPLETED|Overall Study||0
8172446|NCT02432456|20150569|P1|NOT COMPLETED|Overall Study||0
8172447|NCT02432456|20150568|P2|COMPLETED|Overall Study||75
8172448|NCT02432456|20150569|P1|COMPLETED|Overall Study||75
8172449|NCT02432456|20150568|P2|STARTED|Overall Study||75
8172450|NCT02432456|20150569|P1|STARTED|Overall Study||75
8172451|NCT02432300|20150591|P1|NOT COMPLETED|Overall Study||4
8172452|NCT02432300|20150591|P1|COMPLETED|Overall Study||13
8172453|NCT02432300|20150591|P1|STARTED|Overall Study||17
8172512|NCT02432196|20150737|P1|NOT COMPLETED|Overall Study||26
8172513|NCT02432196|20150737|P1|COMPLETED|Overall Study||0
8172514|NCT02432196|20150737|P1|Implanted With Device|Overall Study||25
8172515|NCT02432196|20150737|P1|STARTED|Overall Study||26
8172516|NCT02432144|20150745|P1|NOT COMPLETED|Overall Study||1
8172517|NCT02432144|20150745|P1|COMPLETED|Overall Study||11
8172518|NCT02432144|20150745|P1|STARTED|Overall Study||12
8172519|NCT02432105|20150753|P3|NOT COMPLETED|Overall Study||3
8172520|NCT02432105|20150754|P2|NOT COMPLETED|Overall Study||2
8172521|NCT02432105|20150755|P1|NOT COMPLETED|Overall Study||2
8172522|NCT02432105|20150753|P3|COMPLETED|Overall Study||108
8172523|NCT02432105|20150754|P2|COMPLETED|Overall Study||108
8172524|NCT02432105|20150755|P1|COMPLETED|Overall Study||162
8172525|NCT02432105|20150753|P3|STARTED|Overall Study||111
8172526|NCT02432105|20150754|P2|STARTED|Overall Study||110
8172527|NCT02432105|20150755|P1|STARTED|Overall Study||164
8172528|NCT02432040|20150772|P2|NOT COMPLETED|Overall Study||6
8172529|NCT02432040|20150773|P1|NOT COMPLETED|Overall Study||8
8172530|NCT02432040|20150772|P2|COMPLETED|Overall Study||8
8172531|NCT02432040|20150773|P1|COMPLETED|Overall Study||6
8172532|NCT02432040|20150772|P2|STARTED|Overall Study||14
8172533|NCT02432040|20150773|P1|STARTED|Overall Study||14
8172534|NCT02431806|20150797|P4|NOT COMPLETED|Double-blind Down-taper Period||0
8172535|NCT02431806|20150798|P3|NOT COMPLETED|Double-blind Down-taper Period||0
8172536|NCT02431806|20150799|P2|NOT COMPLETED|Double-blind Down-taper Period||0
8172537|NCT02431806|20150800|P1|NOT COMPLETED|Double-blind Down-taper Period||0
8172538|NCT02431806|20150797|P4|COMPLETED|Double-blind Down-taper Period||107
8172539|NCT02431806|20150798|P3|COMPLETED|Double-blind Down-taper Period||104
8172540|NCT02431806|20150799|P2|COMPLETED|Double-blind Down-taper Period||109
8172541|NCT02431806|20150800|P1|COMPLETED|Double-blind Down-taper Period||111
8172542|NCT02431806|20150797|P4|STARTED|Double-blind Down-taper Period||107
8172543|NCT02431806|20150798|P3|STARTED|Double-blind Down-taper Period||104
8172544|NCT02431806|20150799|P2|STARTED|Double-blind Down-taper Period||109
8172545|NCT02431806|20150800|P1|STARTED|Double-blind Down-taper Period||111
8172546|NCT02431806|20150797|P4|NOT COMPLETED|Double-blind Treatment Period||26
8172547|NCT02431806|20150798|P3|NOT COMPLETED|Double-blind Treatment Period||32
8172548|NCT02431806|20150799|P2|NOT COMPLETED|Double-blind Treatment Period||21
8172549|NCT02431806|20150800|P1|NOT COMPLETED|Double-blind Treatment Period||25
8172550|NCT02431806|20150797|P4|COMPLETED|Double-blind Treatment Period||109
8172551|NCT02431806|20150798|P3|COMPLETED|Double-blind Treatment Period||107
8172552|NCT02431806|20150799|P2|COMPLETED|Double-blind Treatment Period||115
8172553|NCT02431806|20150800|P1|COMPLETED|Double-blind Treatment Period||117
8172554|NCT02431806|20150797|P4|Safety Population|Double-blind Treatment Period||134
8172555|NCT02431806|20150798|P3|Safety Population|Double-blind Treatment Period||138
8172556|NCT02431806|20150799|P2|Safety Population|Double-blind Treatment Period||134
8172557|NCT02431806|20150800|P1|Safety Population|Double-blind Treatment Period||141
8172558|NCT02431806|20150797|P4|STARTED|Double-blind Treatment Period||135
8172559|NCT02431806|20150798|P3|STARTED|Double-blind Treatment Period||139
8172560|NCT02431806|20150799|P2|STARTED|Double-blind Treatment Period||136
8172561|NCT02431806|20150800|P1|STARTED|Double-blind Treatment Period||142
8172562|NCT02431793|20150817|P3|NOT COMPLETED|Overall Study||117
8172563|NCT02431793|20150818|P2|NOT COMPLETED|Overall Study||134
8172564|NCT02431793|20150819|P1|NOT COMPLETED|Overall Study||119
8172565|NCT02431793|20150817|P3|COMPLETED|Overall Study||90
8172566|NCT02431793|20150818|P2|COMPLETED|Overall Study||109
8172567|NCT02431793|20150819|P1|COMPLETED|Overall Study||83
8172568|NCT02431793|20150817|P3|Completed T3 (30 Days Post Enrollment)|Overall Study||93
8172569|NCT02431793|20150818|P2|Completed T3 (30 Days Post Enrollment)|Overall Study||113
8172570|NCT02431793|20150819|P1|Completed T3 (30 Days Post Enrollment)|Overall Study||85
8172571|NCT02431793|20150817|P3|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107
8172572|NCT02431793|20150818|P2|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141
8172573|NCT02431793|20150819|P1|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95
8172574|NCT02431793|20150817|P3|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143
8172575|NCT02431793|20150818|P2|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180
8172576|NCT02431793|20150819|P1|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136
8172577|NCT02431793|20150817|P3|STARTED|Overall Study||207
8172578|NCT02431793|20150818|P2|STARTED|Overall Study||243
8172579|NCT02431793|20150819|P1|STARTED|Overall Study||202
8172580|NCT02431754|20150841|P2|NOT COMPLETED|Period 2 (8 Weeks)||4
8172581|NCT02431754|20150842|P1|NOT COMPLETED|Period 2 (8 Weeks)||1
8172582|NCT02431754|20150841|P2|COMPLETED|Period 2 (8 Weeks)||78
8172583|NCT02431754|20150842|P1|COMPLETED|Period 2 (8 Weeks)||74
8172584|NCT02431754|20150841|P2|STARTED|Period 2 (8 Weeks)||82
8172585|NCT02431754|20150842|P1|STARTED|Period 2 (8 Weeks)||75
8172586|NCT02431754|20150841|P2|NOT COMPLETED|Wash-out Period (4 Weeks)||0
8172587|NCT02431754|20150842|P1|NOT COMPLETED|Wash-out Period (4 Weeks)||4
8172588|NCT02431754|20150841|P2|COMPLETED|Wash-out Period (4 Weeks)||82
8172589|NCT02431754|20150842|P1|COMPLETED|Wash-out Period (4 Weeks)||75
8172590|NCT02431754|20150841|P2|STARTED|Wash-out Period (4 Weeks)||82
8172591|NCT02431754|20150842|P1|STARTED|Wash-out Period (4 Weeks)||79
8172592|NCT02431754|20150841|P2|NOT COMPLETED|Period 1 (8 Weeks)||4
8172593|NCT02431754|20150842|P1|NOT COMPLETED|Period 1 (8 Weeks)||6
8172594|NCT02431754|20150841|P2|COMPLETED|Period 1 (8 Weeks)||82
8172595|NCT02431754|20150842|P1|COMPLETED|Period 1 (8 Weeks)||79
8172596|NCT02431754|20150841|P2|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
8172597|NCT02431754|20150842|P1|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
8172598|NCT02431754|20150841|P2|STARTED|Period 1 (8 Weeks)||86
8172599|NCT02431754|20150842|P1|STARTED|Period 1 (8 Weeks)||85
8172600|NCT02431741|20150860|P1|NOT COMPLETED|Overall Study||0
8172601|NCT02431741|20150860|P1|COMPLETED|Overall Study||14
8172602|NCT02431741|20150860|P1|STARTED|Overall Study||14
8172603|NCT02431702|20150864|P7|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172604|NCT02431702|20150865|P6|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||17
8172605|NCT02431702|20150866|P5|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||10
8172606|NCT02431702|20150867|P4|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||9
8172607|NCT02431702|20150868|P3|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172608|NCT02431702|20150869|P2|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172609|NCT02431702|20150870|P1|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172610|NCT02431702|20150864|P7|COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172611|NCT02431702|20150865|P6|COMPLETED|Part 3: 9 Month of Additional Treatment||46
8172612|NCT02431702|20150866|P5|COMPLETED|Part 3: 9 Month of Additional Treatment||47
8172613|NCT02431702|20150867|P4|COMPLETED|Part 3: 9 Month of Additional Treatment||40
8172614|NCT02431702|20150868|P3|COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172615|NCT02431702|20150869|P2|COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172616|NCT02431702|20150870|P1|COMPLETED|Part 3: 9 Month of Additional Treatment||0
8172617|NCT02431702|20150864|P7|STARTED|Part 3: 9 Month of Additional Treatment||0
8172618|NCT02431702|20150865|P6|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|63
8172619|NCT02431702|20150866|P5|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|57
8172620|NCT02431702|20150867|P4|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to continue treatment in this group.|49
8172621|NCT02431702|20150868|P3|STARTED|Part 3: 9 Month of Additional Treatment||0
8172622|NCT02431702|20150869|P2|STARTED|Part 3: 9 Month of Additional Treatment||0
8172623|NCT02431702|20150870|P1|STARTED|Part 3: 9 Month of Additional Treatment||0
8172624|NCT02431702|20150864|P7|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172625|NCT02431702|20150865|P6|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172626|NCT02431702|20150866|P5|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172627|NCT02431702|20150867|P4|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172628|NCT02431702|20150868|P3|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||29
8172629|NCT02431702|20150869|P2|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||26
8172630|NCT02431702|20150870|P1|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172631|NCT02431702|20150864|P7|COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172632|NCT02431702|20150865|P6|COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172633|NCT02431702|20150866|P5|COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172634|NCT02431702|20150867|P4|COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172635|NCT02431702|20150868|P3|COMPLETED|Part 2: 9Month Disease Progression Phase||128
8172636|NCT02431702|20150869|P2|COMPLETED|Part 2: 9Month Disease Progression Phase||52
8172637|NCT02431702|20150870|P1|COMPLETED|Part 2: 9Month Disease Progression Phase||0
8172638|NCT02431702|20150864|P7|STARTED|Part 2: 9Month Disease Progression Phase||0
8172639|NCT02431702|20150865|P6|STARTED|Part 2: 9Month Disease Progression Phase||0
8172640|NCT02431702|20150866|P5|STARTED|Part 2: 9Month Disease Progression Phase||0
8172641|NCT02431702|20150867|P4|STARTED|Part 2: 9Month Disease Progression Phase||0
8172642|NCT02431702|20150868|P3|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|157
8172643|NCT02431702|20150869|P2|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|78
8172644|NCT02431702|20150870|P1|STARTED|Part 2: 9Month Disease Progression Phase||0
8172645|NCT02431702|20150864|P7|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
8172646|NCT02431702|20150865|P6|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172647|NCT02431702|20150866|P5|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172648|NCT02431702|20150867|P4|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172649|NCT02431702|20150868|P3|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172650|NCT02431702|20150869|P2|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172651|NCT02431702|20150870|P1|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||34
8172652|NCT02431702|20150864|P7|COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
8172653|NCT02431702|20150865|P6|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172654|NCT02431702|20150866|P5|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172655|NCT02431702|20150867|P4|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172656|NCT02431702|20150868|P3|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172657|NCT02431702|20150869|P2|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
8172658|NCT02431702|20150870|P1|COMPLETED|Part 1: 2-Month Oral Run-in Phase||239
8172659|NCT02431702|20150864|P7|STARTED|Part 1: 2-Month Oral Run-in Phase||64
8172660|NCT02431702|20150865|P6|STARTED|Part 1: 2-Month Oral Run-in Phase||0
8172661|NCT02431702|20150866|P5|STARTED|Part 1: 2-Month Oral Run-in Phase||0
8172662|NCT02431702|20150867|P4|STARTED|Part 1: 2-Month Oral Run-in Phase||0
8172663|NCT02431702|20150868|P3|STARTED|Part 1: 2-Month Oral Run-in Phase||0
8172664|NCT02431702|20150869|P2|STARTED|Part 1: 2-Month Oral Run-in Phase||0
8172665|NCT02431702|20150870|P1|STARTED|Part 1: 2-Month Oral Run-in Phase||273
8172666|NCT02431676|20150946|P3|NOT COMPLETED|Overall Study||2
8172667|NCT02431676|20150947|P2|NOT COMPLETED|Overall Study||1
8172668|NCT02431676|20150948|P1|NOT COMPLETED|Overall Study||0
8172669|NCT02431676|20150946|P3|COMPLETED|Overall Study||40
8172670|NCT02431676|20150947|P2|COMPLETED|Overall Study||38
8172671|NCT02431676|20150948|P1|COMPLETED|Overall Study||40
8172672|NCT02431676|20150946|P3|STARTED|Overall Study||42
8172673|NCT02431676|20150947|P2|STARTED|Overall Study||39
8172674|NCT02431676|20150948|P1|STARTED|Overall Study||40
8172675|NCT02431650|20150964|P2|NOT COMPLETED|Overall Study||0
8172676|NCT02431650|20150965|P1|NOT COMPLETED|Overall Study||0
8172677|NCT02431650|20150964|P2|COMPLETED|Overall Study||6
8172678|NCT02431650|20150965|P1|COMPLETED|Overall Study||5
8172679|NCT02431650|20150964|P2|STARTED|Overall Study||6
8172680|NCT02431650|20150965|P1|STARTED|Overall Study||5
8172681|NCT02431637|20150973|P1|NOT COMPLETED|Overall Study||0
8172682|NCT02431637|20150973|P1|COMPLETED|Overall Study||6
8172683|NCT02431637|20150973|P1|STARTED|Overall Study||6
8172684|NCT02431598|20150978|P6|NOT COMPLETED|Overall Study||0
8172685|NCT02431598|20150979|P5|NOT COMPLETED|Overall Study||0
8172686|NCT02431598|20150980|P4|NOT COMPLETED|Overall Study||0
8172687|NCT02431598|20150981|P3|NOT COMPLETED|Overall Study||0
8172688|NCT02431598|20150982|P2|NOT COMPLETED|Overall Study||0
8172689|NCT02431598|20150983|P1|NOT COMPLETED|Overall Study||0
8172690|NCT02431598|20150978|P6|COMPLETED|Overall Study||6
8172691|NCT02431598|20150979|P5|COMPLETED|Overall Study||7
8172692|NCT02431598|20150980|P4|COMPLETED|Overall Study||7
8172693|NCT02431598|20150981|P3|COMPLETED|Overall Study||9
8172694|NCT02431598|20150982|P2|COMPLETED|Overall Study||9
8172695|NCT02431598|20150983|P1|COMPLETED|Overall Study||6
8172696|NCT02431598|20150978|P6|STARTED|Overall Study||6
8172697|NCT02431598|20150979|P5|STARTED|Overall Study||7
8172698|NCT02431598|20150980|P4|STARTED|Overall Study||7
8172699|NCT02431598|20150981|P3|STARTED|Overall Study||9
8172700|NCT02431598|20150982|P2|STARTED|Overall Study||9
8172701|NCT02431598|20150983|P1|STARTED|Overall Study||6
8172702|NCT02431572|20151010|P3|NOT COMPLETED|Overall Study||0
8172703|NCT02431572|20151011|P2|NOT COMPLETED|Overall Study||0
8172704|NCT02431572|20151012|P1|NOT COMPLETED|Overall Study||1
8172705|NCT02431572|20151010|P3|COMPLETED|Overall Study||9
8172706|NCT02431572|20151011|P2|COMPLETED|Overall Study||1
8172707|NCT02431572|20151012|P1|COMPLETED|Overall Study||0
8172708|NCT02431572|20151010|P3|STARTED|Overall Study||9
8172709|NCT02431572|20151011|P2|STARTED|Overall Study||1
8172710|NCT02431572|20151012|P1|STARTED|Overall Study||1
8172723|NCT02431533|20151051|P2|NOT COMPLETED|Overall Study||3
8172724|NCT02431533|20151052|P1|NOT COMPLETED|Overall Study||2
8172725|NCT02431533|20151051|P2|COMPLETED|Overall Study||22
8172726|NCT02431533|20151052|P1|COMPLETED|Overall Study||23
8172727|NCT02431533|20151051|P2|STARTED|Overall Study||25
8172728|NCT02431533|20151052|P1|STARTED|Overall Study||25
8172729|NCT02431494|20151087|P3|NOT COMPLETED|Overall Study||0
8172730|NCT02431494|20151088|P2|NOT COMPLETED|Overall Study||0
8172731|NCT02431494|20151089|P1|NOT COMPLETED|Overall Study||0
8172732|NCT02431494|20151087|P3|COMPLETED|Overall Study||0
8172733|NCT02431494|20151088|P2|COMPLETED|Overall Study||0
8172734|NCT02431494|20151089|P1|COMPLETED|Overall Study||0
8172735|NCT02431494|20151087|P3|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
8172736|NCT02431494|20151088|P2|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
8172737|NCT02431494|20151089|P1|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
8172738|NCT02431468|20151118|P3|NOT COMPLETED|Overall Study||9
8172739|NCT02431468|20151119|P2|NOT COMPLETED|Overall Study||18
8172740|NCT02431468|20151120|P1|NOT COMPLETED|Overall Study||8
8172741|NCT02431468|20151118|P3|COMPLETED|Overall Study||39
8172742|NCT02431468|20151119|P2|COMPLETED|Overall Study||29
8172743|NCT02431468|20151120|P1|COMPLETED|Overall Study||38
8172744|NCT02431468|20151118|P3|STARTED|Overall Study||48
8172745|NCT02431468|20151119|P2|STARTED|Overall Study||47
8172746|NCT02431468|20151120|P1|STARTED|Overall Study||46
8172747|NCT02431455|20151142|P2|NOT COMPLETED|Overall Study||0
8172748|NCT02431455|20151143|P1|NOT COMPLETED|Overall Study||0
8172749|NCT02431455|20151142|P2|COMPLETED|Overall Study||112
8172750|NCT02431455|20151143|P1|COMPLETED|Overall Study||112
8172751|NCT02431455|20151142|P2|STARTED|Overall Study||112
8172752|NCT02431455|20151143|P1|STARTED|Overall Study||112
8172753|NCT02431299|20151157|P2|NOT COMPLETED|Overall Study||1
8172754|NCT02431299|20151158|P1|NOT COMPLETED|Overall Study||53
8172755|NCT02431299|20151157|P2|COMPLETED|Overall Study||62
8172756|NCT02431299|20151158|P1|COMPLETED|Overall Study||183
8172757|NCT02431299|20151157|P2|STARTED|Overall Study||63
8172758|NCT02431299|20151158|P1|STARTED|Overall Study||236
8172759|NCT02431273|20151171|P1|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0
8172760|NCT02431273|20151171|P1|COMPLETED|TDF-FTC-MVC (Triple IVR)||6
8172761|NCT02431273|20151171|P1|STARTED|TDF-FTC-MVC (Triple IVR)||6
8172762|NCT02431273|20151171|P1|NOT COMPLETED|TDF-FTC (Dual IVR)||0
8172763|NCT02431273|20151171|P1|COMPLETED|TDF-FTC (Dual IVR)||6
8172764|NCT02431273|20151171|P1|STARTED|TDF-FTC (Dual IVR)||6
8172765|NCT02431273|20151171|P1|NOT COMPLETED|TDF (Single IVR)||0
8172766|NCT02431273|20151171|P1|COMPLETED|TDF (Single IVR)||6
8172767|NCT02431273|20151171|P1|STARTED|TDF (Single IVR)||6
8172768|NCT02431260|20151211|P14|NOT COMPLETED|Overall Study||1
8172769|NCT02431260|20151212|P13|NOT COMPLETED|Overall Study||10
8172770|NCT02431260|20151213|P12|NOT COMPLETED|Overall Study||4
8172771|NCT02431260|20151214|P11|NOT COMPLETED|Overall Study||4
8172772|NCT02431260|20151215|P10|NOT COMPLETED|Overall Study||8
8172773|NCT02431260|20151216|P9|NOT COMPLETED|Overall Study||8
8172774|NCT02431260|20151217|P8|NOT COMPLETED|Overall Study||3
8172775|NCT02431260|20151218|P7|NOT COMPLETED|Overall Study||4
8172776|NCT02431260|20151219|P6|NOT COMPLETED|Overall Study||4
8172777|NCT02431260|20151220|P5|NOT COMPLETED|Overall Study||3
8172778|NCT02431260|20151221|P4|NOT COMPLETED|Overall Study||5
8172779|NCT02431260|20151222|P3|NOT COMPLETED|Overall Study||6
8172780|NCT02431260|20151223|P2|NOT COMPLETED|Overall Study||5
8172781|NCT02431260|20151224|P1|NOT COMPLETED|Overall Study||4
8172782|NCT02431260|20151211|P14|COMPLETED|Overall Study||0
8172783|NCT02431260|20151212|P13|COMPLETED|Overall Study||0
8172784|NCT02431260|20151213|P12|COMPLETED|Overall Study||0
8172785|NCT02431260|20151214|P11|COMPLETED|Overall Study||0
8172786|NCT02431260|20151215|P10|COMPLETED|Overall Study||0
8172787|NCT02431260|20151216|P9|COMPLETED|Overall Study||0
8172788|NCT02431260|20151217|P8|COMPLETED|Overall Study||0
8172789|NCT02431260|20151218|P7|COMPLETED|Overall Study||0
8172790|NCT02431260|20151219|P6|COMPLETED|Overall Study||0
8172791|NCT02431260|20151220|P5|COMPLETED|Overall Study||0
8172792|NCT02431260|20151221|P4|COMPLETED|Overall Study||0
8172793|NCT02431260|20151222|P3|COMPLETED|Overall Study||0
8172794|NCT02431260|20151223|P2|COMPLETED|Overall Study||0
8172795|NCT02431260|20151224|P1|COMPLETED|Overall Study||0
8172796|NCT02431260|20151211|P14|STARTED|Overall Study||1
8172797|NCT02431260|20151212|P13|STARTED|Overall Study||10
8172798|NCT02431260|20151213|P12|STARTED|Overall Study||4
8172799|NCT02431260|20151214|P11|STARTED|Overall Study||4
8172800|NCT02431260|20151215|P10|STARTED|Overall Study||8
8172801|NCT02431260|20151216|P9|STARTED|Overall Study||8
8172802|NCT02431260|20151217|P8|STARTED|Overall Study||3
8172803|NCT02431260|20151218|P7|STARTED|Overall Study||4
8172804|NCT02431260|20151219|P6|STARTED|Overall Study||4
8172805|NCT02431260|20151220|P5|STARTED|Overall Study||3
8172806|NCT02431260|20151221|P4|STARTED|Overall Study||5
8172807|NCT02431260|20151222|P3|STARTED|Overall Study||6
8172808|NCT02431260|20151223|P2|STARTED|Overall Study||5
8172809|NCT02431260|20151224|P1|STARTED|Overall Study||4
8172810|NCT02431247|20151317|P2|NOT COMPLETED|Overall Study||363
8172811|NCT02431247|20151318|P1|NOT COMPLETED|Overall Study||362
8172812|NCT02431247|20151317|P2|COMPLETED|Overall Study||0
8172813|NCT02431247|20151318|P1|COMPLETED|Overall Study||0
8172814|NCT02431247|20151317|P2|STARTED|Overall Study||363
8172815|NCT02431247|20151318|P1|STARTED|Overall Study||362
8172831|NCT02430870|20151411|P8|NOT COMPLETED|Part 2||1
8172832|NCT02430870|20151412|P7|NOT COMPLETED|Part 2||1
8172833|NCT02430870|20151413|P6|NOT COMPLETED|Part 2||0
8172834|NCT02430870|20151414|P5|NOT COMPLETED|Part 2||0
8172835|NCT02430870|20151415|P4|NOT COMPLETED|Part 2||0
8172836|NCT02430870|20151416|P3|NOT COMPLETED|Part 2||0
8172837|NCT02430870|20151417|P2|NOT COMPLETED|Part 2||0
8172838|NCT02430870|20151418|P1|NOT COMPLETED|Part 2||0
8172839|NCT02430870|20151411|P8|COMPLETED|Part 2||7
8172840|NCT02430870|20151412|P7|COMPLETED|Part 2||5
8172841|NCT02430870|20151413|P6|COMPLETED|Part 2||6
8172842|NCT02430870|20151414|P5|COMPLETED|Part 2||6
8172843|NCT02430870|20151415|P4|COMPLETED|Part 2||6
8172844|NCT02430870|20151416|P3|COMPLETED|Part 2||0
8172845|NCT02430870|20151417|P2|COMPLETED|Part 2||0
8172846|NCT02430870|20151418|P1|COMPLETED|Part 2||0
8172847|NCT02430870|20151411|P8|STARTED|Part 2||8
8172848|NCT02430870|20151412|P7|STARTED|Part 2||6
8172849|NCT02430870|20151413|P6|STARTED|Part 2||6
8172850|NCT02430870|20151414|P5|STARTED|Part 2||6
8172851|NCT02430870|20151415|P4|STARTED|Part 2||6
8172852|NCT02430870|20151416|P3|STARTED|Part 2||0
8172853|NCT02430870|20151417|P2|STARTED|Part 2||0
8172854|NCT02430870|20151418|P1|STARTED|Part 2||0
8172855|NCT02430870|20151411|P8|NOT COMPLETED|Part 1||0
8172856|NCT02430870|20151412|P7|NOT COMPLETED|Part 1||0
8172857|NCT02430870|20151413|P6|NOT COMPLETED|Part 1||0
8172858|NCT02430870|20151414|P5|NOT COMPLETED|Part 1||0
8172859|NCT02430870|20151415|P4|NOT COMPLETED|Part 1||0
8172860|NCT02430870|20151416|P3|NOT COMPLETED|Part 1||0
8172861|NCT02430870|20151417|P2|NOT COMPLETED|Part 1||0
8172862|NCT02430870|20151418|P1|NOT COMPLETED|Part 1||0
8172863|NCT02430870|20151411|P8|COMPLETED|Part 1||0
8172864|NCT02430870|20151412|P7|COMPLETED|Part 1||0
8172865|NCT02430870|20151413|P6|COMPLETED|Part 1||0
8172866|NCT02430870|20151414|P5|COMPLETED|Part 1||0
8172867|NCT02430870|20151415|P4|COMPLETED|Part 1||0
8172868|NCT02430870|20151416|P3|COMPLETED|Part 1||4
8172869|NCT02430870|20151417|P2|COMPLETED|Part 1||6
8172870|NCT02430870|20151418|P1|COMPLETED|Part 1||6
8172871|NCT02430870|20151411|P8|STARTED|Part 1||0
8172872|NCT02430870|20151412|P7|STARTED|Part 1||0
8172873|NCT02430870|20151413|P6|STARTED|Part 1||0
8172874|NCT02430870|20151414|P5|STARTED|Part 1||0
8172875|NCT02430870|20151415|P4|STARTED|Part 1||0
8172876|NCT02430870|20151416|P3|STARTED|Part 1||4
8172877|NCT02430870|20151417|P2|STARTED|Part 1||6
8172878|NCT02430870|20151418|P1|STARTED|Part 1||6
8172879|NCT02430818|20151492|P2|NOT COMPLETED|Overall Study||0
8172880|NCT02430818|20151493|P1|NOT COMPLETED|Overall Study||0
8172881|NCT02430818|20151492|P2|COMPLETED|Overall Study||6
8172882|NCT02430818|20151493|P1|COMPLETED|Overall Study||7
8172883|NCT02430818|20151492|P2|STARTED|Overall Study||6
8172884|NCT02430818|20151493|P1|STARTED|Overall Study||7
8172885|NCT02430532|20151505|P2|NOT COMPLETED|Overall Study||28
8172886|NCT02430532|20151506|P1|NOT COMPLETED|Overall Study||30
8172887|NCT02430532|20151505|P2|COMPLETED|Overall Study||0
8172888|NCT02430532|20151506|P1|COMPLETED|Overall Study||0
8172889|NCT02430532|20151505|P2|STARTED|Overall Study||28
8172890|NCT02430532|20151506|P1|STARTED|Overall Study||30
8172894|NCT02430389|20151538|P2|NOT COMPLETED|Overall Study||0
8172895|NCT02430389|20151539|P1|NOT COMPLETED|Overall Study||0
8172896|NCT02430389|20151538|P2|COMPLETED|Overall Study||10
8172897|NCT02430389|20151539|P1|COMPLETED|Overall Study||10
8172898|NCT02430389|20151538|P2|STARTED|Overall Study||10
8172899|NCT02430389|20151539|P1|STARTED|Overall Study||10
8172900|NCT02430337|20151549|P2|NOT COMPLETED|Overall Study||0
8172901|NCT02430337|20151550|P1|NOT COMPLETED|Overall Study||0
8172902|NCT02430337|20151549|P2|COMPLETED|Overall Study||20
8172903|NCT02430337|20151550|P1|COMPLETED|Overall Study||11
8172904|NCT02430337|20151549|P2|STARTED|Overall Study||20
8172905|NCT02430337|20151550|P1|STARTED|Overall Study||11
8172906|NCT02430311|20151563|P2|NOT COMPLETED|Part B||8
8172907|NCT02430311|20151564|P1|NOT COMPLETED|Part B||10
8172908|NCT02430311|20151563|P2|COMPLETED|Part B||7
8172909|NCT02430311|20151564|P1|COMPLETED|Part B||9
8172910|NCT02430311|20151563|P2|Received Paclitaxel|Part B||14
8172911|NCT02430311|20151564|P1|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
8172912|NCT02430311|20151563|P2|Received Olaparib|Part B||15
8172913|NCT02430311|20151564|P1|Received Olaparib|Part B||19
8172914|NCT02430311|20151563|P2|STARTED|Part B||15
8172915|NCT02430311|20151564|P1|STARTED|Part B||19
8172916|NCT02430311|20151563|P2|NOT COMPLETED|Part A||1
8172917|NCT02430311|20151564|P1|NOT COMPLETED|Part A||1
8172918|NCT02430311|20151563|P2|COMPLETED|Part A||15
8172919|NCT02430311|20151564|P1|COMPLETED|Part A||19
8172920|NCT02430311|20151563|P2|Received Paclitaxel|Part A||16
8172921|NCT02430311|20151564|P1|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
8172922|NCT02430311|20151563|P2|Received Olaparib|Part A||16
8172923|NCT02430311|20151564|P1|Received Olaparib|Part A||20
8172924|NCT02430311|20151563|P2|STARTED|Part A||16
8172925|NCT02430311|20151564|P1|STARTED|Part A||20
8172926|NCT02430090|20151600|P3|NOT COMPLETED|Overall Study||0
8172927|NCT02430090|20151601|P2|NOT COMPLETED|Overall Study||0
8172928|NCT02430090|20151602|P1|NOT COMPLETED|Overall Study||0
8172929|NCT02430090|20151600|P3|COMPLETED|Overall Study||15
8172930|NCT02430090|20151601|P2|COMPLETED|Overall Study||15
8172931|NCT02430090|20151602|P1|COMPLETED|Overall Study||15
8172932|NCT02430090|20151600|P3|STARTED|Overall Study||15
8172933|NCT02430090|20151601|P2|STARTED|Overall Study||15
8172934|NCT02430090|20151602|P1|STARTED|Overall Study||15
8172935|NCT02429869|20151610|P1|NOT COMPLETED|Overall Study||0
8172936|NCT02429869|20151610|P1|COMPLETED|Overall Study||10
8172937|NCT02429869|20151610|P1|STARTED|Overall Study||10
8172944|NCT02429791|20151637|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28
8172945|NCT02429791|20151638|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25
8172946|NCT02429791|20151637|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210
8172947|NCT02429791|20151638|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214
8172948|NCT02429791|20151637|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||238
8172949|NCT02429791|20151638|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||239
8172950|NCT02429791|20151637|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18
8172951|NCT02429791|20151638|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13
8172952|NCT02429791|20151637|P2|COMPLETED|Early Switch Phase (Up to Week 52)||238
8172953|NCT02429791|20151638|P1|COMPLETED|Early Switch Phase (Up to Week 52)||239
8172954|NCT02429791|20151637|P2|STARTED|Early Switch Phase (Up to Week 52)||256
8172955|NCT02429791|20151638|P1|STARTED|Early Switch Phase (Up to Week 52)||252
8172956|NCT02429778|20151726|P2|NOT COMPLETED|Overall Study||0
8172957|NCT02429778|20151727|P1|NOT COMPLETED|Overall Study||7
8172958|NCT02429778|20151726|P2|COMPLETED|Overall Study||20
8172959|NCT02429778|20151727|P1|COMPLETED|Overall Study||13
8172960|NCT02429778|20151726|P2|STARTED|Overall Study||20
8172961|NCT02429778|20151727|P1|STARTED|Overall Study||20
8172962|NCT02429583|20151741|P2|NOT COMPLETED|Overall Study||20
8172963|NCT02429583|20151742|P1|NOT COMPLETED|Overall Study||0
8172964|NCT02429583|20151741|P2|COMPLETED|Overall Study||3
8172965|NCT02429583|20151742|P1|COMPLETED|Overall Study||1
8172966|NCT02429583|20151741|P2|STARTED|Overall Study||23
8172967|NCT02429583|20151742|P1|STARTED|Overall Study||1
8172968|NCT02429427|20151758|P2|NOT COMPLETED|Overall Study||179
8172969|NCT02429427|20151759|P1|NOT COMPLETED|Overall Study||371
8172970|NCT02429427|20151758|P2|COMPLETED|Overall Study||697
8172971|NCT02429427|20151759|P1|COMPLETED|Overall Study||1392
8172972|NCT02429427|20151758|P2|STARTED|Overall Study||876
8172973|NCT02429427|20151759|P1|STARTED|Overall Study||1763
8172974|NCT02429310|20151773|P2|NOT COMPLETED|Overall Study||3
8172975|NCT02429310|20151774|P1|NOT COMPLETED|Overall Study||2
8172976|NCT02429310|20151773|P2|COMPLETED|Overall Study||17
8172977|NCT02429310|20151774|P1|COMPLETED|Overall Study||20
8172978|NCT02429310|20151773|P2|STARTED|Overall Study||20
8172979|NCT02429310|20151774|P1|STARTED|Overall Study||22
8172980|NCT02429258|20151784|P2|NOT COMPLETED|Overall Study||1
8172981|NCT02429258|20151785|P1|NOT COMPLETED|Overall Study||2
8172982|NCT02429258|20151784|P2|COMPLETED|Overall Study||49
8172983|NCT02429258|20151785|P1|COMPLETED|Overall Study||48
8172984|NCT02429258|20151784|P2|STARTED|Overall Study||50
8172985|NCT02429258|20151785|P1|STARTED|Overall Study||50
8172986|NCT02429115|20151817|P6|NOT COMPLETED|Overall Study||1
8172987|NCT02429115|20151818|P5|NOT COMPLETED|Overall Study||7
8172988|NCT02429115|20151819|P4|NOT COMPLETED|Overall Study||8
8172989|NCT02429115|20151820|P3|NOT COMPLETED|Overall Study||16
8172990|NCT02429115|20151821|P2|NOT COMPLETED|Overall Study||10
8172991|NCT02429115|20151822|P1|NOT COMPLETED|Overall Study||12
8172992|NCT02429115|20151817|P6|COMPLETED|Overall Study||27
8172993|NCT02429115|20151818|P5|COMPLETED|Overall Study||22
8172994|NCT02429115|20151819|P4|COMPLETED|Overall Study||21
8172995|NCT02429115|20151820|P3|COMPLETED|Overall Study||35
8172996|NCT02429115|20151821|P2|COMPLETED|Overall Study||42
8172997|NCT02429115|20151822|P1|COMPLETED|Overall Study||40
8172998|NCT02429115|20151817|P6|STARTED|Overall Study||28
8172999|NCT02429115|20151818|P5|STARTED|Overall Study||29
8173000|NCT02429115|20151819|P4|STARTED|Overall Study||29
8173001|NCT02429115|20151820|P3|STARTED|Overall Study||51
8173002|NCT02429115|20151821|P2|STARTED|Overall Study||52
8173003|NCT02429115|20151822|P1|STARTED|Overall Study||52
8173004|NCT02428855|20151839|P1|NOT COMPLETED|Overall Study||2
8173005|NCT02428855|20151839|P1|COMPLETED|Overall Study||6
8173006|NCT02428855|20151839|P1|STARTED|Overall Study||8
8173007|NCT02428699|20151846|P2|NOT COMPLETED|Period 2||0
8173008|NCT02428699|20151847|P1|NOT COMPLETED|Period 2||0
8173009|NCT02428699|20151846|P2|COMPLETED|Period 2||23
8173010|NCT02428699|20151847|P1|COMPLETED|Period 2||24
8173011|NCT02428699|20151846|P2|STARTED|Period 2||23
8173012|NCT02428699|20151847|P1|STARTED|Period 2||24
8173013|NCT02428699|20151846|P2|NOT COMPLETED|Washout Period 1||2
8173014|NCT02428699|20151847|P1|NOT COMPLETED|Washout Period 1||1
8173015|NCT02428699|20151846|P2|COMPLETED|Washout Period 1||23
8173016|NCT02428699|20151847|P1|COMPLETED|Washout Period 1||24
8173017|NCT02428699|20151846|P2|STARTED|Washout Period 1||25
8173018|NCT02428699|20151847|P1|STARTED|Washout Period 1||25
8173019|NCT02428699|20151846|P2|NOT COMPLETED|Period 1||0
8173020|NCT02428699|20151847|P1|NOT COMPLETED|Period 1||0
8173021|NCT02428699|20151846|P2|COMPLETED|Period 1||25
8173022|NCT02428699|20151847|P1|COMPLETED|Period 1||25
8173023|NCT02428699|20151846|P2|STARTED|Period 1||25
8173024|NCT02428699|20151847|P1|STARTED|Period 1||25
8173025|NCT02428608|20151875|P1|NOT COMPLETED|Overall Study||83
8173026|NCT02428608|20151875|P1|COMPLETED|Overall Study||487
8173027|NCT02428608|20151875|P1|STARTED|Overall Study||570
8173028|NCT02428595|20151880|P1|NOT COMPLETED|Treatment||19
8173029|NCT02428595|20151880|P1|COMPLETED|Treatment||54
8173030|NCT02428595|20151880|P1|STARTED|Treatment||73
8173031|NCT02428595|20151880|P1|NOT COMPLETED|Fitting||64
8173032|NCT02428595|20151880|P1|COMPLETED|Fitting||73
8173033|NCT02428595|20151880|P1|STARTED|Fitting||137
8173034|NCT02428478|20151896|P2|NOT COMPLETED|Second Study Night||0
8173035|NCT02428478|20151897|P1|NOT COMPLETED|Second Study Night||0
8173036|NCT02428478|20151896|P2|COMPLETED|Second Study Night||6
8173037|NCT02428478|20151897|P1|COMPLETED|Second Study Night||8
8173038|NCT02428478|20151896|P2|STARTED|Second Study Night|2 participants did not return for the second study night|6
8173039|NCT02428478|20151897|P1|STARTED|Second Study Night|1 participant did not return for the second study night|8
8173040|NCT02428478|20151896|P2|NOT COMPLETED|First Study Night||0
8173041|NCT02428478|20151897|P1|NOT COMPLETED|First Study Night||0
8173042|NCT02428478|20151896|P2|COMPLETED|First Study Night||8
8173043|NCT02428478|20151897|P1|COMPLETED|First Study Night||9
8173044|NCT02428478|20151896|P2|STARTED|First Study Night||8
8173045|NCT02428478|20151897|P1|STARTED|First Study Night||9
8173046|NCT02428413|20151907|P2|NOT COMPLETED|Overall Study||9
8173047|NCT02428413|20151908|P1|NOT COMPLETED|Overall Study||8
8173048|NCT02428413|20151907|P2|COMPLETED|Overall Study||52
8173049|NCT02428413|20151908|P1|COMPLETED|Overall Study||56
8173050|NCT02428413|20151907|P2|STARTED|Overall Study||61
8173051|NCT02428413|20151908|P1|STARTED|Overall Study||64
8173052|NCT02428309|20151920|P1|NOT COMPLETED|Overall Study||0
8173053|NCT02428309|20151920|P1|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1
8173054|NCT02428309|20151920|P1|STARTED|Overall Study||1
8173055|NCT02428296|20151943|P1|NOT COMPLETED|Overall Study||9
8173056|NCT02428296|20151943|P1|COMPLETED|Overall Study|Number of participants who completed the full course of treatment.|30
8173057|NCT02428296|20151943|P1|Treated|Overall Study||39
8173058|NCT02428296|20151943|P1|STARTED|Overall Study||39
8173059|NCT02428231|20151955|P2|NOT COMPLETED|Overall Study||17
8173060|NCT02428231|20151956|P1|NOT COMPLETED|Overall Study||13
8173061|NCT02428231|20151955|P2|COMPLETED|Overall Study||15
8173062|NCT02428231|20151956|P1|COMPLETED|Overall Study||17
8173063|NCT02428231|20151955|P2|STARTED|Overall Study||32
8173064|NCT02428231|20151956|P1|STARTED|Overall Study||30
8173071|NCT02427984|20151988|P3|NOT COMPLETED|Overall Study||18
8173072|NCT02427984|20151989|P2|NOT COMPLETED|Overall Study||5
8173073|NCT02427984|20151990|P1|NOT COMPLETED|Overall Study||13
8173074|NCT02427984|20151988|P3|COMPLETED|Overall Study||32
8173075|NCT02427984|20151989|P2|COMPLETED|Overall Study||40
8173076|NCT02427984|20151990|P1|COMPLETED|Overall Study||40
8173077|NCT02427984|20151988|P3|STARTED|Overall Study||50
8173078|NCT02427984|20151989|P2|STARTED|Overall Study||45
8173079|NCT02427984|20151990|P1|STARTED|Overall Study||53
8173080|NCT02427958|20152004|P1|NOT COMPLETED|Overall Study||24
8173081|NCT02427958|20152004|P1|COMPLETED|Overall Study||283
8173082|NCT02427958|20152004|P1|STARTED|Overall Study||307
8173083|NCT02427841|20152009|P1|NOT COMPLETED|Overall Study||8
8173084|NCT02427841|20152009|P1|COMPLETED|Overall Study||11
8173085|NCT02427841|20152009|P1|STARTED|Overall Study||19
8173086|NCT02427750|20152015|P2|NOT COMPLETED|Overall Study||0
8173087|NCT02427750|20152016|P1|NOT COMPLETED|Overall Study||0
8173088|NCT02427750|20152015|P2|COMPLETED|Overall Study||63
8173089|NCT02427750|20152016|P1|COMPLETED|Overall Study||63
8173090|NCT02427750|20152015|P2|STARTED|Overall Study||63
8173091|NCT02427750|20152016|P1|STARTED|Overall Study||63
8173092|NCT02427737|20152041|P2|NOT COMPLETED|Duke Pre- and Post-Training Groups||395
8173093|NCT02427737|20152042|P1|NOT COMPLETED|Duke Pre- and Post-Training Groups||779
8173094|NCT02427737|20152041|P2|COMPLETED|Duke Pre- and Post-Training Groups||4051
8173095|NCT02427737|20152042|P1|COMPLETED|Duke Pre- and Post-Training Groups||8879
8173096|NCT02427737|20152041|P2|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446
8173097|NCT02427737|20152042|P1|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658
8173098|NCT02427737|20152041|P2|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215
8173099|NCT02427737|20152042|P1|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220
8173100|NCT02427737|20152041|P2|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716
8173101|NCT02427737|20152042|P1|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928
8173102|NCT02427737|20152041|P2|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931
8173103|NCT02427737|20152042|P1|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148
8173104|NCT02427737|20152041|P2|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213
8173105|NCT02427737|20152042|P1|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214
8173106|NCT02427737|20152041|P2|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857
8173107|NCT02427737|20152042|P1|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907
8173108|NCT02427737|20152041|P2|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070
8173109|NCT02427737|20152042|P1|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121
8173110|NCT02427737|20152041|P2|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214
8173111|NCT02427737|20152042|P1|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215
8173112|NCT02427737|20152041|P2|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032
8173113|NCT02427737|20152042|P1|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815
8173114|NCT02427737|20152041|P2|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246
8173115|NCT02427737|20152042|P1|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030
8173116|NCT02427737|20152041|P2|NOT COMPLETED|OSU Baseline Q4FY15||216
8173117|NCT02427737|20152042|P1|NOT COMPLETED|OSU Baseline Q4FY15||218
8173118|NCT02427737|20152041|P2|COMPLETED|OSU Baseline Q4FY15||3230
8173119|NCT02427737|20152042|P1|COMPLETED|OSU Baseline Q4FY15||3940
8173120|NCT02427737|20152041|P2|STARTED|OSU Baseline Q4FY15||3446
8173121|NCT02427737|20152042|P1|STARTED|OSU Baseline Q4FY15||4158
8173122|NCT02427672|20152090|P2|NOT COMPLETED|Overall Study||2
8173123|NCT02427672|20152091|P1|NOT COMPLETED|Overall Study||1
8173124|NCT02427672|20152090|P2|COMPLETED|Overall Study||42
8173125|NCT02427672|20152091|P1|COMPLETED|Overall Study||39
8173126|NCT02427672|20152090|P2|STARTED|Overall Study||44
8173127|NCT02427672|20152091|P1|STARTED|Overall Study||40
8173128|NCT02427646|20152101|P2|NOT COMPLETED|Overall Study||14
8173129|NCT02427646|20152102|P1|NOT COMPLETED|Overall Study||8
8173130|NCT02427646|20152101|P2|COMPLETED|Overall Study||14
8173131|NCT02427646|20152102|P1|COMPLETED|Overall Study||16
8173132|NCT02427646|20152101|P2|STARTED|Overall Study||28
8173133|NCT02427646|20152102|P1|STARTED|Overall Study||24
8173134|NCT02427607|20152110|P1|NOT COMPLETED|Overall Study||1
8173135|NCT02427607|20152110|P1|COMPLETED|Overall Study||6
8173136|NCT02427607|20152110|P1|STARTED|Overall Study||7
8173137|NCT02427477|20152116|P2|NOT COMPLETED|Period 3||0
8173138|NCT02427477|20152117|P1|NOT COMPLETED|Period 3||0
8173139|NCT02427477|20152116|P2|COMPLETED|Period 3||60
8173140|NCT02427477|20152117|P1|COMPLETED|Period 3||59
8173141|NCT02427477|20152116|P2|STARTED|Period 3||60
8173142|NCT02427477|20152117|P1|STARTED|Period 3||59
8173143|NCT02427477|20152116|P2|NOT COMPLETED|Period 2||0
8173144|NCT02427477|20152117|P1|NOT COMPLETED|Period 2||0
8173145|NCT02427477|20152116|P2|COMPLETED|Period 2||60
8173146|NCT02427477|20152117|P1|COMPLETED|Period 2||59
8173147|NCT02427477|20152116|P2|STARTED|Period 2||60
8173148|NCT02427477|20152117|P1|STARTED|Period 2||59
8173149|NCT02427477|20152116|P2|NOT COMPLETED|Period 1||0
8173150|NCT02427477|20152117|P1|NOT COMPLETED|Period 1||1
8173151|NCT02427477|20152116|P2|COMPLETED|Period 1||60
8173152|NCT02427477|20152117|P1|COMPLETED|Period 1||59
8173153|NCT02427477|20152116|P2|STARTED|Period 1||60
8173154|NCT02427477|20152117|P1|STARTED|Period 1||60
8173155|NCT02427399|20152130|P5|NOT COMPLETED|Overall Study||15
8173156|NCT02427399|20152131|P4|NOT COMPLETED|Overall Study||18
8173157|NCT02427399|20152132|P3|NOT COMPLETED|Overall Study||12
8173158|NCT02427399|20152133|P2|NOT COMPLETED|Overall Study||16
8173159|NCT02427399|20152134|P1|NOT COMPLETED|Overall Study||14
8173160|NCT02427399|20152130|P5|COMPLETED|Overall Study||205
8173161|NCT02427399|20152131|P4|COMPLETED|Overall Study||202
8173162|NCT02427399|20152132|P3|COMPLETED|Overall Study||208
8173163|NCT02427399|20152133|P2|COMPLETED|Overall Study||204
8173164|NCT02427399|20152134|P1|COMPLETED|Overall Study||206
8173165|NCT02427399|20152130|P5|STARTED|Overall Study||220
8173166|NCT02427399|20152131|P4|STARTED|Overall Study||220
8173167|NCT02427399|20152132|P3|STARTED|Overall Study||220
8173168|NCT02427399|20152133|P2|STARTED|Overall Study||220
8173169|NCT02427399|20152134|P1|STARTED|Overall Study||220
8173170|NCT02427100|20152158|P2|NOT COMPLETED|Overall Study||2
8173171|NCT02427100|20152159|P1|NOT COMPLETED|Overall Study||0
8173172|NCT02427100|20152158|P2|COMPLETED|Overall Study||15
8173173|NCT02427100|20152159|P1|COMPLETED|Overall Study||15
8173174|NCT02427100|20152158|P2|STARTED|Overall Study||17
8173175|NCT02427100|20152159|P1|STARTED|Overall Study||15
8173176|NCT02426918|20152170|P3|NOT COMPLETED|Overall Study||14
8173177|NCT02426918|20152171|P2|NOT COMPLETED|Overall Study||19
8173178|NCT02426918|20152172|P1|NOT COMPLETED|Overall Study||17
8173179|NCT02426918|20152170|P3|COMPLETED|Overall Study||97
8173180|NCT02426918|20152171|P2|COMPLETED|Overall Study||90
8173181|NCT02426918|20152172|P1|COMPLETED|Overall Study||93
8173182|NCT02426918|20152170|P3|Safety Population|Overall Study||107
8173183|NCT02426918|20152171|P2|Safety Population|Overall Study||107
8173184|NCT02426918|20152172|P1|Safety Population|Overall Study||110
8173185|NCT02426918|20152170|P3|STARTED|Overall Study||111
8173186|NCT02426918|20152171|P2|STARTED|Overall Study||109
8173187|NCT02426918|20152172|P1|STARTED|Overall Study||110
8173188|NCT02426749|20152194|P2|NOT COMPLETED|Overall Study||1
8173189|NCT02426749|20152195|P1|NOT COMPLETED|Overall Study||3
8173190|NCT02426749|20152194|P2|COMPLETED|Overall Study||9
8173191|NCT02426749|20152195|P1|COMPLETED|Overall Study||9
8173192|NCT02426749|20152194|P2|STARTED|Overall Study||10
8173193|NCT02426749|20152195|P1|STARTED|Overall Study||12
8173197|NCT02426580|20152214|P2|NOT COMPLETED|Overall Study||16
8173198|NCT02426580|20152215|P1|NOT COMPLETED|Overall Study||11
8173199|NCT02426580|20152214|P2|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54
8173200|NCT02426580|20152215|P1|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59
8173201|NCT02426580|20152214|P2|STARTED|Overall Study|January 2014|70
8173202|NCT02426580|20152215|P1|STARTED|Overall Study|April 2015|70
8173203|NCT02426541|20152223|P2|NOT COMPLETED|Overall Study||0
8173204|NCT02426541|20152224|P1|NOT COMPLETED|Overall Study||1
8173205|NCT02426541|20152223|P2|COMPLETED|Overall Study||16
8173206|NCT02426541|20152224|P1|COMPLETED|Overall Study||15
8173207|NCT02426541|20152223|P2|STARTED|Overall Study||16
8173208|NCT02426541|20152224|P1|STARTED|Overall Study||16
8173209|NCT02426138|20152236|P2|NOT COMPLETED|Intent to Treat Population Milestone||0
8173210|NCT02426138|20152237|P1|NOT COMPLETED|Intent to Treat Population Milestone||0
8173211|NCT02426138|20152236|P2|COMPLETED|Intent to Treat Population Milestone||22
8173212|NCT02426138|20152237|P1|COMPLETED|Intent to Treat Population Milestone||20
8173213|NCT02426138|20152236|P2|STARTED|Intent to Treat Population Milestone||22
8173214|NCT02426138|20152237|P1|STARTED|Intent to Treat Population Milestone||20
8173215|NCT02426138|20152236|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
8173216|NCT02426138|20152237|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
8173217|NCT02426138|20152236|P2|COMPLETED|Second Intervention (12 Weeks)||22
8173218|NCT02426138|20152237|P1|COMPLETED|Second Intervention (12 Weeks)||20
8173219|NCT02426138|20152236|P2|STARTED|Second Intervention (12 Weeks)||22
8173220|NCT02426138|20152237|P1|STARTED|Second Intervention (12 Weeks)||20
8173221|NCT02426138|20152236|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
8173222|NCT02426138|20152237|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
8173223|NCT02426138|20152236|P2|COMPLETED|First Intervention (12 Weeks)||22
8173224|NCT02426138|20152237|P1|COMPLETED|First Intervention (12 Weeks)||20
8173225|NCT02426138|20152236|P2|STARTED|First Intervention (12 Weeks)||23
8173226|NCT02426138|20152237|P1|STARTED|First Intervention (12 Weeks)||21
8173237|NCT02425956|20152302|P1|NOT COMPLETED|Overall Study||0
8173238|NCT02425956|20152302|P1|COMPLETED|Overall Study||21
8173239|NCT02425956|20152302|P1|STARTED|Overall Study||21
8173240|NCT02425826|20152309|P3|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
8173241|NCT02425826|20152310|P2|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
8173242|NCT02425826|20152311|P1|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
8173243|NCT02425826|20152309|P3|COMPLETED|Post-Treatment Observational Follow-Up||49
8173244|NCT02425826|20152310|P2|COMPLETED|Post-Treatment Observational Follow-Up||0
8173245|NCT02425826|20152311|P1|COMPLETED|Post-Treatment Observational Follow-Up||80
8173246|NCT02425826|20152309|P3|STARTED|Post-Treatment Observational Follow-Up||49
8173247|NCT02425826|20152310|P2|STARTED|Post-Treatment Observational Follow-Up||0
8173248|NCT02425826|20152311|P1|STARTED|Post-Treatment Observational Follow-Up||81
8173249|NCT02425826|20152309|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
8173250|NCT02425826|20152310|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
8173251|NCT02425826|20152311|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
8173252|NCT02425826|20152309|P3|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
8173253|NCT02425826|20152310|P2|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
8173254|NCT02425826|20152311|P1|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
8173255|NCT02425826|20152309|P3|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
8173256|NCT02425826|20152310|P2|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
8173257|NCT02425826|20152311|P1|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
8173258|NCT02425826|20152309|P3|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
8173259|NCT02425826|20152310|P2|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
8173260|NCT02425826|20152311|P1|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
8173261|NCT02425826|20152309|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
8173262|NCT02425826|20152310|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
8173263|NCT02425826|20152311|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
8173264|NCT02425826|20152309|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
8173265|NCT02425826|20152310|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
8173266|NCT02425826|20152311|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
8173267|NCT02425826|20152309|P3|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
8173268|NCT02425826|20152310|P2|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
8173269|NCT02425826|20152311|P1|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
8173270|NCT02425826|20152309|P3|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
8173271|NCT02425826|20152310|P2|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
8173272|NCT02425826|20152311|P1|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
8173273|NCT02425449|20152349|P5|NOT COMPLETED|Overall Study||0
8173274|NCT02425449|20152350|P4|NOT COMPLETED|Overall Study||0
8173275|NCT02425449|20152351|P3|NOT COMPLETED|Overall Study||0
8173276|NCT02425449|20152352|P2|NOT COMPLETED|Overall Study||0
8173277|NCT02425449|20152353|P1|NOT COMPLETED|Overall Study||0
8173278|NCT02425449|20152349|P5|COMPLETED|Overall Study||5
8173279|NCT02425449|20152350|P4|COMPLETED|Overall Study||5
8173280|NCT02425449|20152351|P3|COMPLETED|Overall Study||5
8173281|NCT02425449|20152352|P2|COMPLETED|Overall Study||4
8173282|NCT02425449|20152353|P1|COMPLETED|Overall Study||0
8173283|NCT02425449|20152349|P5|STARTED|Overall Study||5
8173284|NCT02425449|20152350|P4|STARTED|Overall Study||5
8173285|NCT02425449|20152351|P3|STARTED|Overall Study||5
8173286|NCT02425449|20152352|P2|STARTED|Overall Study||4
8173287|NCT02425449|20152353|P1|STARTED|Overall Study||0
8173288|NCT02425111|20152365|P1|NOT COMPLETED|Part B: Treatment Extension Period||10
8173289|NCT02425111|20152365|P1|COMPLETED|Part B: Treatment Extension Period||46
8173290|NCT02425111|20152365|P1|STARTED|Part B: Treatment Extension Period||56
8173291|NCT02425111|20152365|P1|NOT COMPLETED|Part A: Treatment Period||23
8173292|NCT02425111|20152365|P1|COMPLETED|Part A: Treatment Period||78
8173293|NCT02425111|20152365|P1|STARTED|Part A: Treatment Period||101
8173294|NCT02425098|20152386|P2|NOT COMPLETED|Overall Study||16
8173295|NCT02425098|20152387|P1|NOT COMPLETED|Overall Study||13
8173296|NCT02425098|20152386|P2|COMPLETED|Overall Study||159
8173297|NCT02425098|20152387|P1|COMPLETED|Overall Study||163
8173298|NCT02425098|20152386|P2|STARTED|Overall Study||175
8173299|NCT02425098|20152387|P1|STARTED|Overall Study||176
8173300|NCT02424799|20152435|P6|NOT COMPLETED|Part C (Up to Day 23)||0
8173301|NCT02424799|20152436|P5|NOT COMPLETED|Part C (Up to Day 23)||0
8173302|NCT02424799|20152437|P4|NOT COMPLETED|Part C (Up to Day 23)||0
8173303|NCT02424799|20152438|P3|NOT COMPLETED|Part C (Up to Day 23)||0
8173304|NCT02424799|20152439|P2|NOT COMPLETED|Part C (Up to Day 23)||0
8173305|NCT02424799|20152440|P1|NOT COMPLETED|Part C (Up to Day 23)||0
8173306|NCT02424799|20152435|P6|COMPLETED|Part C (Up to Day 23)||4
8173307|NCT02424799|20152436|P5|COMPLETED|Part C (Up to Day 23)||1
8173308|NCT02424799|20152437|P4|COMPLETED|Part C (Up to Day 23)||0
8173309|NCT02424799|20152438|P3|COMPLETED|Part C (Up to Day 23)||0
8173310|NCT02424799|20152439|P2|COMPLETED|Part C (Up to Day 23)||0
8173311|NCT02424799|20152440|P1|COMPLETED|Part C (Up to Day 23)||0
8173312|NCT02424799|20152435|P6|STARTED|Part C (Up to Day 23)||4
8173313|NCT02424799|20152436|P5|STARTED|Part C (Up to Day 23)||1
8173314|NCT02424799|20152437|P4|STARTED|Part C (Up to Day 23)||0
8173315|NCT02424799|20152438|P3|STARTED|Part C (Up to Day 23)||0
8173316|NCT02424799|20152439|P2|STARTED|Part C (Up to Day 23)||0
8173317|NCT02424799|20152440|P1|STARTED|Part C (Up to Day 23)||0
8173318|NCT02424799|20152435|P6|NOT COMPLETED|Part B (Up to Day 19)||0
8173319|NCT02424799|20152436|P5|NOT COMPLETED|Part B (Up to Day 19)||0
8173320|NCT02424799|20152437|P4|NOT COMPLETED|Part B (Up to Day 19)||0
8173321|NCT02424799|20152438|P3|NOT COMPLETED|Part B (Up to Day 19)||0
8173322|NCT02424799|20152439|P2|NOT COMPLETED|Part B (Up to Day 19)||0
8173323|NCT02424799|20152440|P1|NOT COMPLETED|Part B (Up to Day 19)||0
8173324|NCT02424799|20152435|P6|COMPLETED|Part B (Up to Day 19)||0
8173325|NCT02424799|20152436|P5|COMPLETED|Part B (Up to Day 19)||0
8173326|NCT02424799|20152437|P4|COMPLETED|Part B (Up to Day 19)||9
8173327|NCT02424799|20152438|P3|COMPLETED|Part B (Up to Day 19)||3
8173328|NCT02424799|20152439|P2|COMPLETED|Part B (Up to Day 19)||0
8173329|NCT02424799|20152440|P1|COMPLETED|Part B (Up to Day 19)||0
8173330|NCT02424799|20152435|P6|STARTED|Part B (Up to Day 19)||0
8173331|NCT02424799|20152436|P5|STARTED|Part B (Up to Day 19)||0
8173332|NCT02424799|20152437|P4|STARTED|Part B (Up to Day 19)||9
8173333|NCT02424799|20152438|P3|STARTED|Part B (Up to Day 19)||3
8173334|NCT02424799|20152439|P2|STARTED|Part B (Up to Day 19)||0
8173335|NCT02424799|20152440|P1|STARTED|Part B (Up to Day 19)||0
8173336|NCT02424799|20152435|P6|NOT COMPLETED|Part A (Up to Day 11)||0
8173337|NCT02424799|20152436|P5|NOT COMPLETED|Part A (Up to Day 11)||0
8173338|NCT02424799|20152437|P4|NOT COMPLETED|Part A (Up to Day 11)||0
8173339|NCT02424799|20152438|P3|NOT COMPLETED|Part A (Up to Day 11)||0
8173340|NCT02424799|20152439|P2|NOT COMPLETED|Part A (Up to Day 11)||0
8173341|NCT02424799|20152440|P1|NOT COMPLETED|Part A (Up to Day 11)||0
8173342|NCT02424799|20152435|P6|COMPLETED|Part A (Up to Day 11)||0
8173343|NCT02424799|20152436|P5|COMPLETED|Part A (Up to Day 11)||0
8173344|NCT02424799|20152437|P4|COMPLETED|Part A (Up to Day 11)||0
8173345|NCT02424799|20152438|P3|COMPLETED|Part A (Up to Day 11)||0
8173346|NCT02424799|20152439|P2|COMPLETED|Part A (Up to Day 11)||8
8173347|NCT02424799|20152440|P1|COMPLETED|Part A (Up to Day 11)||9
8173348|NCT02424799|20152435|P6|STARTED|Part A (Up to Day 11)||0
8173349|NCT02424799|20152436|P5|STARTED|Part A (Up to Day 11)||0
8173350|NCT02424799|20152437|P4|STARTED|Part A (Up to Day 11)||0
8173351|NCT02424799|20152438|P3|STARTED|Part A (Up to Day 11)||0
8173352|NCT02424799|20152439|P2|STARTED|Part A (Up to Day 11)||8
8173353|NCT02424799|20152440|P1|STARTED|Part A (Up to Day 11)||9
8173354|NCT02424734|20152539|P3|NOT COMPLETED|Overall Study||0
8173355|NCT02424734|20152540|P2|NOT COMPLETED|Overall Study||2
8173356|NCT02424734|20152541|P1|NOT COMPLETED|Overall Study||2
8173357|NCT02424734|20152539|P3|COMPLETED|Overall Study||2
8173358|NCT02424734|20152540|P2|COMPLETED|Overall Study||3
8173359|NCT02424734|20152541|P1|COMPLETED|Overall Study||2
8173360|NCT02424734|20152539|P3|Treated|Overall Study||2
8173361|NCT02424734|20152540|P2|Treated|Overall Study||5
8173362|NCT02424734|20152541|P1|Treated|Overall Study||4
8173363|NCT02424734|20152539|P3|STARTED|Overall Study||2
8173364|NCT02424734|20152540|P2|STARTED|Overall Study||5
8173365|NCT02424734|20152541|P1|STARTED|Overall Study||4
8173366|NCT02424630|20152560|P2|NOT COMPLETED|Overall Study||3
8173367|NCT02424630|20152561|P1|NOT COMPLETED|Overall Study||1
8173368|NCT02424630|20152560|P2|COMPLETED|Overall Study||24
8173369|NCT02424630|20152561|P1|COMPLETED|Overall Study||24
8173370|NCT02424630|20152560|P2|STARTED|Overall Study||27
8173371|NCT02424630|20152561|P1|STARTED|Overall Study||25
8173372|NCT02424591|20152571|P2|NOT COMPLETED|Overall Study||3
8173373|NCT02424591|20152572|P1|NOT COMPLETED|Overall Study||2
8173374|NCT02424591|20152571|P2|COMPLETED|Overall Study||20
8173375|NCT02424591|20152572|P1|COMPLETED|Overall Study||20
8173376|NCT02424591|20152571|P2|STARTED|Overall Study||23
8173377|NCT02424591|20152572|P1|STARTED|Overall Study||22
8173378|NCT02424578|20152584|P2|NOT COMPLETED|Overall Study||1
8173379|NCT02424578|20152585|P1|NOT COMPLETED|Overall Study||0
8173380|NCT02424578|20152584|P2|COMPLETED|Overall Study||14
8173381|NCT02424578|20152585|P1|COMPLETED|Overall Study||15
8173382|NCT02424578|20152584|P2|STARTED|Overall Study||15
8173383|NCT02424578|20152585|P1|STARTED|Overall Study||15
8173384|NCT02424565|20152591|P2|NOT COMPLETED|Period 2 (D3)||0
8173385|NCT02424565|20152592|P1|NOT COMPLETED|Period 2 (D3)||0
8173386|NCT02424565|20152591|P2|COMPLETED|Period 2 (D3)||6
8173387|NCT02424565|20152592|P1|COMPLETED|Period 2 (D3)||8
8173388|NCT02424565|20152591|P2|STARTED|Period 2 (D3)||6
8173389|NCT02424565|20152592|P1|STARTED|Period 2 (D3)||8
8173390|NCT02424565|20152591|P2|NOT COMPLETED|Washout Period||0
8173391|NCT02424565|20152592|P1|NOT COMPLETED|Washout Period||0
8173392|NCT02424565|20152591|P2|COMPLETED|Washout Period||6
8173393|NCT02424565|20152592|P1|COMPLETED|Washout Period||8
8173394|NCT02424565|20152591|P2|STARTED|Washout Period||6
8173395|NCT02424565|20152592|P1|STARTED|Washout Period||8
8173396|NCT02424565|20152591|P2|NOT COMPLETED|Period 1 (D0)||1
8173397|NCT02424565|20152592|P1|NOT COMPLETED|Period 1 (D0)||0
8173398|NCT02424565|20152591|P2|COMPLETED|Period 1 (D0)||6
8173399|NCT02424565|20152592|P1|COMPLETED|Period 1 (D0)||8
8173400|NCT02424565|20152591|P2|STARTED|Period 1 (D0)||7
8173401|NCT02424565|20152592|P1|STARTED|Period 1 (D0)||8
8173402|NCT02424539|20152601|P3|NOT COMPLETED|Overall Study||8
8173403|NCT02424539|20152602|P2|NOT COMPLETED|Overall Study||8
8173404|NCT02424539|20152603|P1|NOT COMPLETED|Overall Study||14
8173405|NCT02424539|20152601|P3|COMPLETED|Overall Study||111
8173406|NCT02424539|20152602|P2|COMPLETED|Overall Study||111
8173407|NCT02424539|20152603|P1|COMPLETED|Overall Study||106
8173408|NCT02424539|20152601|P3|STARTED|Overall Study||119
8173409|NCT02424539|20152602|P2|STARTED|Overall Study||119
8173410|NCT02424539|20152603|P1|STARTED|Overall Study||120
8173411|NCT02424526|20152667|P2|NOT COMPLETED|Overall Study||0
8173412|NCT02424526|20152668|P1|NOT COMPLETED|Overall Study||0
8173413|NCT02424526|20152667|P2|COMPLETED|Overall Study||10
8173414|NCT02424526|20152668|P1|COMPLETED|Overall Study||9
8173415|NCT02424526|20152667|P2|STARTED|Overall Study||10
8173416|NCT02424526|20152668|P1|STARTED|Overall Study||9
8173417|NCT02424383|20152686|P1|NOT COMPLETED|Overall Study||376
8173418|NCT02424383|20152686|P1|COMPLETED|Overall Study||629
8173419|NCT02424383|20152686|P1|Per-Protocol Population|Overall Study||966
8173420|NCT02424383|20152686|P1|STARTED|Overall Study||1005
8173421|NCT02424357|20152699|P2|NOT COMPLETED|Overall Study||0
8173422|NCT02424357|20152700|P1|NOT COMPLETED|Overall Study||0
8173423|NCT02424357|20152699|P2|COMPLETED|Overall Study||30
8173424|NCT02424357|20152700|P1|COMPLETED|Overall Study||35
8173425|NCT02424357|20152699|P2|STARTED|Overall Study||30
8173426|NCT02424357|20152700|P1|STARTED|Overall Study||35
8173427|NCT02424344|20152710|P2|NOT COMPLETED|Overall Study||10
8173428|NCT02424344|20152711|P1|NOT COMPLETED|Overall Study||7
8173429|NCT02424344|20152710|P2|COMPLETED|Overall Study||123
8173430|NCT02424344|20152711|P1|COMPLETED|Overall Study||127
8173431|NCT02424344|20152710|P2|STARTED|Overall Study||133
8173432|NCT02424344|20152711|P1|STARTED|Overall Study||134
8173433|NCT02424175|20152721|P1|NOT COMPLETED|Overall Study||0
8173434|NCT02424175|20152721|P1|COMPLETED|Overall Study||10
8173435|NCT02424175|20152721|P1|STARTED|Overall Study||10
8173436|NCT02424149|20152729|P2|NOT COMPLETED|Overall Study||1
8173437|NCT02424149|20152730|P1|NOT COMPLETED|Overall Study||2
8173438|NCT02424149|20152729|P2|COMPLETED|Overall Study||52
8173439|NCT02424149|20152730|P1|COMPLETED|Overall Study||52
8173440|NCT02424149|20152729|P2|STARTED|Overall Study||53
8173441|NCT02424149|20152730|P1|STARTED|Overall Study||54
8173442|NCT02424097|20152746|P2|NOT COMPLETED|Overall Study||2
8173443|NCT02424097|20152747|P1|NOT COMPLETED|Overall Study||1
8173444|NCT02424097|20152746|P2|COMPLETED|Overall Study||18
8173445|NCT02424097|20152747|P1|COMPLETED|Overall Study||19
8173446|NCT02424097|20152746|P2|STARTED|Overall Study||20
8173447|NCT02424097|20152747|P1|STARTED|Overall Study||20
8173448|NCT02423993|20152759|P4|NOT COMPLETED|Overall Study||0
8173449|NCT02423993|20152760|P3|NOT COMPLETED|Overall Study||0
8173450|NCT02423993|20152761|P2|NOT COMPLETED|Overall Study||0
8173451|NCT02423993|20152762|P1|NOT COMPLETED|Overall Study||0
8173452|NCT02423993|20152759|P4|COMPLETED|Overall Study||19
8173453|NCT02423993|20152760|P3|COMPLETED|Overall Study||23
8173454|NCT02423993|20152761|P2|COMPLETED|Overall Study||16
8173455|NCT02423993|20152762|P1|COMPLETED|Overall Study||19
8173456|NCT02423993|20152759|P4|STARTED|Overall Study||19
8173457|NCT02423993|20152760|P3|STARTED|Overall Study||23
8173458|NCT02423993|20152761|P2|STARTED|Overall Study||16
8173459|NCT02423993|20152762|P1|STARTED|Overall Study||19
8173460|NCT02423980|20152792|P1|NOT COMPLETED|Overall Study||0
8173461|NCT02423980|20152792|P1|COMPLETED|Overall Study||7
8173462|NCT02423980|20152792|P1|STARTED|Overall Study||7
8173463|NCT02423798|20152802|P1|NOT COMPLETED|Overall Study||3
8173464|NCT02423798|20152802|P1|COMPLETED|Overall Study||21
8173465|NCT02423798|20152802|P1|STARTED|Overall Study||24
8173466|NCT02423577|20152810|P2|NOT COMPLETED|Overall Study||0
8173467|NCT02423577|20152811|P1|NOT COMPLETED|Overall Study||0
8173468|NCT02423577|20152810|P2|COMPLETED|Overall Study||26
8173469|NCT02423577|20152811|P1|COMPLETED|Overall Study||53
8173470|NCT02423577|20152810|P2|STARTED|Overall Study||26
8173471|NCT02423577|20152811|P1|STARTED|Overall Study||53
8173472|NCT02423447|20152817|P2|NOT COMPLETED|Overall Study||0
8173473|NCT02423447|20152818|P1|NOT COMPLETED|Overall Study||0
8173474|NCT02423447|20152817|P2|COMPLETED|Overall Study||12
8173475|NCT02423447|20152818|P1|COMPLETED|Overall Study||13
8173476|NCT02423447|20152817|P2|STARTED|Overall Study||12
8173477|NCT02423447|20152818|P1|STARTED|Overall Study||13
8173478|NCT02423408|20152834|P2|NOT COMPLETED|Overall Study||2
8173479|NCT02423408|20152835|P1|NOT COMPLETED|Overall Study||1
8173480|NCT02423408|20152834|P2|COMPLETED|Overall Study||80
8173481|NCT02423408|20152835|P1|COMPLETED|Overall Study||82
8173482|NCT02423408|20152834|P2|STARTED|Overall Study||82
8173483|NCT02423408|20152835|P1|STARTED|Overall Study||83
8173484|NCT02423317|20152849|P2|NOT COMPLETED|Overall Study||0
8173485|NCT02423317|20152850|P1|NOT COMPLETED|Overall Study||0
8173486|NCT02423317|20152849|P2|COMPLETED|Overall Study||30
8173487|NCT02423317|20152850|P1|COMPLETED|Overall Study||30
8173488|NCT02423317|20152849|P2|STARTED|Overall Study||30
8173489|NCT02423317|20152850|P1|STARTED|Overall Study||30
8173490|NCT02423291|20152868|P1|NOT COMPLETED|Overall Study||15
8173491|NCT02423291|20152868|P1|COMPLETED|Overall Study|Patients that have completed therapy|0
8173492|NCT02423291|20152868|P1|STARTED|Overall Study|Patients enrolled|15
8173493|NCT02423200|20152874|P2|NOT COMPLETED|Overall Study||0
8173494|NCT02423200|20152875|P1|NOT COMPLETED|Overall Study||1
8173495|NCT02423200|20152874|P2|COMPLETED|Overall Study||1
8173496|NCT02423200|20152875|P1|COMPLETED|Overall Study||7
8173497|NCT02423200|20152874|P2|STARTED|Overall Study||1
8173498|NCT02423200|20152875|P1|STARTED|Overall Study||8
8173499|NCT02423122|20152885|P2|NOT COMPLETED|Overall Study||0
8173500|NCT02423122|20152886|P1|NOT COMPLETED|Overall Study||0
8173501|NCT02423122|20152885|P2|COMPLETED|Overall Study||7
8173502|NCT02423122|20152886|P1|COMPLETED|Overall Study||9
8173503|NCT02423122|20152885|P2|STARTED|Overall Study||7
8173504|NCT02423122|20152886|P1|STARTED|Overall Study||9
8173505|NCT02423109|20152898|P2|NOT COMPLETED|Lens 2||0
8173506|NCT02423109|20152899|P1|NOT COMPLETED|Lens 2||0
8173507|NCT02423109|20152898|P2|COMPLETED|Lens 2||14
8173508|NCT02423109|20152899|P1|COMPLETED|Lens 2||18
8173509|NCT02423109|20152898|P2|STARTED|Lens 2||14
8173510|NCT02423109|20152899|P1|STARTED|Lens 2||18
8173511|NCT02423109|20152898|P2|NOT COMPLETED|Lens 1||0
8173512|NCT02423109|20152899|P1|NOT COMPLETED|Lens 1||1
8173513|NCT02423109|20152898|P2|COMPLETED|Lens 1||14
8173514|NCT02423109|20152899|P1|COMPLETED|Lens 1||18
8173515|NCT02423109|20152898|P2|STARTED|Lens 1||14
8173516|NCT02423109|20152899|P1|STARTED|Lens 1||19
8173517|NCT02422940|20152909|P2|NOT COMPLETED|Overall Study||121
8173518|NCT02422940|20152910|P1|NOT COMPLETED|Overall Study||121
8173519|NCT02422940|20152909|P2|COMPLETED|Overall Study||21
8173520|NCT02422940|20152910|P1|COMPLETED|Overall Study||31
8173521|NCT02422940|20152909|P2|STARTED|Overall Study||142
8173522|NCT02422940|20152910|P1|STARTED|Overall Study||152
8173523|NCT02422797|20152932|P2|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18
8173524|NCT02422797|20152933|P1|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23
8173525|NCT02422797|20152932|P2|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221
8173526|NCT02422797|20152933|P1|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222
8173527|NCT02422797|20152932|P2|STARTED|Late Switch Phase (Week 52 to Week 148)||239
8173528|NCT02422797|20152933|P1|STARTED|Late Switch Phase (Week 52 to Week 148)||245
8173529|NCT02422797|20152932|P2|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
8173530|NCT02422797|20152933|P1|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
8173531|NCT02422797|20152932|P2|COMPLETED|Early Switch Phase (Up to Week 52)||239
8173532|NCT02422797|20152933|P1|COMPLETED|Early Switch Phase (Up to Week 52)||245
8173533|NCT02422797|20152932|P2|STARTED|Early Switch Phase (Up to Week 52)||255
8173534|NCT02422797|20152933|P1|STARTED|Early Switch Phase (Up to Week 52)||261
8173543|NCT02422446|20153030|P2|NOT COMPLETED|Overall Study||0
8173544|NCT02422446|20153031|P1|NOT COMPLETED|Overall Study||0
8173545|NCT02422446|20153030|P2|COMPLETED|Overall Study||1
8173546|NCT02422446|20153031|P1|COMPLETED|Overall Study||1
8173547|NCT02422446|20153030|P2|STARTED|Overall Study||1
8173548|NCT02422446|20153031|P1|STARTED|Overall Study||1
8173549|NCT02422303|20153039|P2|NOT COMPLETED|Overall Study||1
8173550|NCT02422303|20153040|P1|NOT COMPLETED|Overall Study||1
8173551|NCT02422303|20153039|P2|COMPLETED|Overall Study||5
8173552|NCT02422303|20153040|P1|COMPLETED|Overall Study||5
8173553|NCT02422303|20153039|P2|STARTED|Overall Study||6
8173554|NCT02422303|20153040|P1|STARTED|Overall Study||6
8173555|NCT02422290|20153046|P1|NOT COMPLETED|Overall Study||0
8173556|NCT02422290|20153046|P1|COMPLETED|Overall Study||5
8173557|NCT02422290|20153046|P1|STARTED|Overall Study||5
8173558|NCT02422264|20153055|P2|NOT COMPLETED|Overall Study||4
8173559|NCT02422264|20153056|P1|NOT COMPLETED|Overall Study||5
8173560|NCT02422264|20153055|P2|COMPLETED|Overall Study||301
8173561|NCT02422264|20153056|P1|COMPLETED|Overall Study||291
8173562|NCT02422264|20153055|P2|STARTED|Overall Study||305
8173563|NCT02422264|20153056|P1|STARTED|Overall Study||296
8173564|NCT02422186|20153102|P2|NOT COMPLETED|Follow-up Phase (2 Weeks)||0
8173565|NCT02422186|20153103|P1|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
8173566|NCT02422186|20153102|P2|COMPLETED|Follow-up Phase (2 Weeks)||3
8173567|NCT02422186|20153103|P1|COMPLETED|Follow-up Phase (2 Weeks)||8
8173568|NCT02422186|20153102|P2|STARTED|Follow-up Phase (2 Weeks)||3
8173569|NCT02422186|20153103|P1|STARTED|Follow-up Phase (2 Weeks)||12
8173570|NCT02422186|20153102|P2|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
8173571|NCT02422186|20153103|P1|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10
8173572|NCT02422186|20153102|P2|COMPLETED|Double-blind Induction Phase (4 Weeks)||60
8173573|NCT02422186|20153103|P1|COMPLETED|Double-blind Induction Phase (4 Weeks)||62
8173574|NCT02422186|20153102|P2|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65
8173575|NCT02422186|20153103|P1|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72
8173576|NCT02422186|20153102|P2|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65
8173577|NCT02422186|20153103|P1|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72
8173578|NCT02422186|20153102|P2|STARTED|Double-blind Induction Phase (4 Weeks)||66
8173579|NCT02422186|20153103|P1|STARTED|Double-blind Induction Phase (4 Weeks)||72
8173580|NCT02421952|20153125|P1|NOT COMPLETED|Overall Study||109
8173581|NCT02421952|20153125|P1|COMPLETED|Overall Study||99
8173582|NCT02421952|20153125|P1|Included in PACU Analysis|Overall Study||192
8173583|NCT02421952|20153125|P1|Excluded From PACU and Post-Analysis|Overall Study||16
8173584|NCT02421952|20153125|P1|STARTED|Overall Study||208
8173593|NCT02421887|20153163|P2|NOT COMPLETED|Overall Study||9
8173594|NCT02421887|20153164|P1|NOT COMPLETED|Overall Study||17
8173595|NCT02421887|20153163|P2|COMPLETED|Overall Study||77
8173596|NCT02421887|20153164|P1|COMPLETED|Overall Study||68
8173597|NCT02421887|20153163|P2|STARTED|Overall Study||86
8173598|NCT02421887|20153164|P1|STARTED|Overall Study||85
8173599|NCT02421666|20153190|P2|NOT COMPLETED|12-month Follow-up||16
8173600|NCT02421666|20153191|P1|NOT COMPLETED|12-month Follow-up||11
8173601|NCT02421666|20153190|P2|COMPLETED|12-month Follow-up||231
8173602|NCT02421666|20153191|P1|COMPLETED|12-month Follow-up||248
8173603|NCT02421666|20153190|P2|STARTED|12-month Follow-up||247
8173604|NCT02421666|20153191|P1|STARTED|12-month Follow-up||259
8173605|NCT02421666|20153190|P2|NOT COMPLETED|6-month Follow-up||13
8173606|NCT02421666|20153191|P1|NOT COMPLETED|6-month Follow-up||13
8173607|NCT02421666|20153190|P2|COMPLETED|6-month Follow-up||247
8173608|NCT02421666|20153191|P1|COMPLETED|6-month Follow-up||259
8173609|NCT02421666|20153190|P2|STARTED|6-month Follow-up||260
8173610|NCT02421666|20153191|P1|STARTED|6-month Follow-up||272
8173611|NCT02421666|20153190|P2|NOT COMPLETED|Overall Study Baseline||0
8173612|NCT02421666|20153191|P1|NOT COMPLETED|Overall Study Baseline||0
8173613|NCT02421666|20153190|P2|COMPLETED|Overall Study Baseline||260
8173614|NCT02421666|20153191|P1|COMPLETED|Overall Study Baseline||272
8173615|NCT02421666|20153190|P2|STARTED|Overall Study Baseline||260
8173616|NCT02421666|20153191|P1|STARTED|Overall Study Baseline||272
8173617|NCT02421588|20153199|P2|NOT COMPLETED|Overall Study||221
8173618|NCT02421588|20153200|P1|NOT COMPLETED|Overall Study||221
8173619|NCT02421588|20153199|P2|COMPLETED|Overall Study||0
8173620|NCT02421588|20153200|P1|COMPLETED|Overall Study||0
8173621|NCT02421588|20153199|P2|STARTED|Overall Study||221
8173622|NCT02421588|20153200|P1|STARTED|Overall Study||221
8173623|NCT02421510|20153223|P3|NOT COMPLETED|Overall Study||36
8173624|NCT02421510|20153224|P2|NOT COMPLETED|Overall Study||35
8173625|NCT02421510|20153225|P1|NOT COMPLETED|Overall Study||33
8173626|NCT02421510|20153223|P3|COMPLETED|Overall Study||227
8173627|NCT02421510|20153224|P2|COMPLETED|Overall Study||226
8173628|NCT02421510|20153225|P1|COMPLETED|Overall Study||225
8173629|NCT02421510|20153223|P3|Completed the 24 Week Treatment Period|Overall Study||240
8173630|NCT02421510|20153224|P2|Completed the 24 Week Treatment Period|Overall Study||239
8173631|NCT02421510|20153225|P1|Completed the 24 Week Treatment Period|Overall Study||236
8173632|NCT02421510|20153223|P3|STARTED|Overall Study||263
8173633|NCT02421510|20153224|P2|STARTED|Overall Study||261
8173634|NCT02421510|20153225|P1|STARTED|Overall Study||258
8173635|NCT02421419|20153257|P3|NOT COMPLETED|Overall Study||1
8173636|NCT02421419|20153258|P2|NOT COMPLETED|Overall Study||0
8173637|NCT02421419|20153259|P1|NOT COMPLETED|Overall Study||0
8173638|NCT02421419|20153257|P3|COMPLETED|Overall Study||8
8173639|NCT02421419|20153258|P2|COMPLETED|Overall Study||11
8173640|NCT02421419|20153259|P1|COMPLETED|Overall Study||6
8173641|NCT02421419|20153257|P3|STARTED|Overall Study||9
8173642|NCT02421419|20153258|P2|STARTED|Overall Study||11
8173643|NCT02421419|20153259|P1|STARTED|Overall Study||6
8173644|NCT02421354|20153276|P1|NOT COMPLETED|Overall Study||0
8173645|NCT02421354|20153276|P1|COMPLETED|Overall Study||8
8173646|NCT02421354|20153276|P1|STARTED|Overall Study||8
8173647|NCT02421224|20153289|P9|NOT COMPLETED|Overall Study||1
8173648|NCT02421224|20153290|P8|NOT COMPLETED|Overall Study||2
8173649|NCT02421224|20153291|P7|NOT COMPLETED|Overall Study||0
8173650|NCT02421224|20153292|P6|NOT COMPLETED|Overall Study||2
8173651|NCT02421224|20153293|P5|NOT COMPLETED|Overall Study||4
8173652|NCT02421224|20153294|P4|NOT COMPLETED|Overall Study||3
8173653|NCT02421224|20153295|P3|NOT COMPLETED|Overall Study||1
8173654|NCT02421224|20153296|P2|NOT COMPLETED|Overall Study||3
8173655|NCT02421224|20153297|P1|NOT COMPLETED|Overall Study||2
8173656|NCT02421224|20153289|P9|COMPLETED|Overall Study||495
8173657|NCT02421224|20153290|P8|COMPLETED|Overall Study||362
8173658|NCT02421224|20153291|P7|COMPLETED|Overall Study||489
8173659|NCT02421224|20153292|P6|COMPLETED|Overall Study||513
8173660|NCT02421224|20153293|P5|COMPLETED|Overall Study||491
8173661|NCT02421224|20153294|P4|COMPLETED|Overall Study||479
8173662|NCT02421224|20153295|P3|COMPLETED|Overall Study||507
8173663|NCT02421224|20153296|P2|COMPLETED|Overall Study||394
8173664|NCT02421224|20153297|P1|COMPLETED|Overall Study||442
8173665|NCT02421224|20153289|P9|STARTED|Overall Study||496
8173666|NCT02421224|20153290|P8|STARTED|Overall Study||364
8173667|NCT02421224|20153291|P7|STARTED|Overall Study||489
8173668|NCT02421224|20153292|P6|STARTED|Overall Study||515
8173669|NCT02421224|20153293|P5|STARTED|Overall Study||495
8173670|NCT02421224|20153294|P4|STARTED|Overall Study||482
8173671|NCT02421224|20153295|P3|STARTED|Overall Study||508
8173672|NCT02421224|20153296|P2|STARTED|Overall Study||397
8173673|NCT02421224|20153297|P1|STARTED|Overall Study||444
8173674|NCT02421211|20153346|P2|NOT COMPLETED|Overall Study||0
8173675|NCT02421211|20153347|P1|NOT COMPLETED|Overall Study||0
8173676|NCT02421211|20153346|P2|COMPLETED|Overall Study||20
8173677|NCT02421211|20153347|P1|COMPLETED|Overall Study||20
8173678|NCT02421211|20153346|P2|STARTED|Overall Study||20
8173679|NCT02421211|20153347|P1|STARTED|Overall Study||20
8173680|NCT02421172|20153393|P5|NOT COMPLETED|Period 2||1
8173681|NCT02421172|20153394|P4|NOT COMPLETED|Period 2||3
8173682|NCT02421172|20153395|P3|NOT COMPLETED|Period 2||7
8173683|NCT02421172|20153396|P2|NOT COMPLETED|Period 2||0
8173684|NCT02421172|20153397|P1|NOT COMPLETED|Period 2||0
8173685|NCT02421172|20153393|P5|COMPLETED|Period 2||14
8173686|NCT02421172|20153394|P4|COMPLETED|Period 2||13
8173687|NCT02421172|20153395|P3|COMPLETED|Period 2||22
8173688|NCT02421172|20153396|P2|COMPLETED|Period 2||0
8173689|NCT02421172|20153397|P1|COMPLETED|Period 2||0
8173690|NCT02421172|20153393|P5|STARTED|Period 2||15
8173691|NCT02421172|20153394|P4|STARTED|Period 2||16
8173692|NCT02421172|20153395|P3|STARTED|Period 2||29
8173693|NCT02421172|20153396|P2|STARTED|Period 2||0
8173694|NCT02421172|20153397|P1|STARTED|Period 2||0
8173695|NCT02421172|20153393|P5|NOT COMPLETED|Period 1||0
8173696|NCT02421172|20153394|P4|NOT COMPLETED|Period 1||0
8173697|NCT02421172|20153395|P3|NOT COMPLETED|Period 1||0
8173698|NCT02421172|20153396|P2|NOT COMPLETED|Period 1||2
8173699|NCT02421172|20153397|P1|NOT COMPLETED|Period 1||4
8173700|NCT02421172|20153393|P5|COMPLETED|Period 1||0
8173701|NCT02421172|20153394|P4|COMPLETED|Period 1||0
8173702|NCT02421172|20153395|P3|COMPLETED|Period 1||0
8173703|NCT02421172|20153396|P2|COMPLETED|Period 1||31
8173704|NCT02421172|20153397|P1|COMPLETED|Period 1||29
8173705|NCT02421172|20153393|P5|PK Analysis Set Period 1|Period 1||0
8173706|NCT02421172|20153394|P4|PK Analysis Set Period 1|Period 1||0
8173707|NCT02421172|20153395|P3|PK Analysis Set Period 1|Period 1||0
8173708|NCT02421172|20153396|P2|PK Analysis Set Period 1|Period 1||0
8173709|NCT02421172|20153397|P1|PK Analysis Set Period 1|Period 1||33
8173710|NCT02421172|20153393|P5|PD Analysis Set Period 1|Period 1||0
8173711|NCT02421172|20153394|P4|PD Analysis Set Period 1|Period 1||0
8173712|NCT02421172|20153395|P3|PD Analysis Set Period 1|Period 1||0
8173713|NCT02421172|20153396|P2|PD Analysis Set Period 1|Period 1||33
8173714|NCT02421172|20153397|P1|PD Analysis Set Period 1|Period 1||31
8173715|NCT02421172|20153393|P5|STARTED|Period 1||0
8173716|NCT02421172|20153394|P4|STARTED|Period 1||0
8173717|NCT02421172|20153395|P3|STARTED|Period 1||0
8173718|NCT02421172|20153396|P2|STARTED|Period 1||33
8173719|NCT02421172|20153397|P1|STARTED|Period 1||33
8173720|NCT02421146|20153424|P4|NOT COMPLETED|Overall Study||0
8173721|NCT02421146|20153425|P3|NOT COMPLETED|Overall Study||0
8173722|NCT02421146|20153426|P2|NOT COMPLETED|Overall Study||0
8173723|NCT02421146|20153427|P1|NOT COMPLETED|Overall Study||0
8173724|NCT02421146|20153424|P4|COMPLETED|Overall Study||3
8173725|NCT02421146|20153425|P3|COMPLETED|Overall Study||3
8173726|NCT02421146|20153426|P2|COMPLETED|Overall Study||4
8173727|NCT02421146|20153427|P1|COMPLETED|Overall Study||2
8173728|NCT02421146|20153424|P4|STARTED|Overall Study||3
8173729|NCT02421146|20153425|P3|STARTED|Overall Study||3
8173730|NCT02421146|20153426|P2|STARTED|Overall Study||4
8173731|NCT02421146|20153427|P1|STARTED|Overall Study||2
8173732|NCT02421120|20153441|P1|NOT COMPLETED|Overall Study||1
8173733|NCT02421120|20153441|P1|COMPLETED|Overall Study||20
8173734|NCT02421120|20153441|P1|STARTED|Overall Study||21
8173735|NCT02421094|20153451|P2|NOT COMPLETED|Overall Study||0
8173736|NCT02421094|20153452|P1|NOT COMPLETED|Overall Study||0
8173737|NCT02421094|20153451|P2|COMPLETED|Overall Study||15
8173738|NCT02421094|20153452|P1|COMPLETED|Overall Study||15
8173739|NCT02421094|20153451|P2|STARTED|Overall Study||15
8173740|NCT02421094|20153452|P1|STARTED|Overall Study||15
8173741|NCT02421055|20153464|P3|NOT COMPLETED|Overall Study||0
8173742|NCT02421055|20153465|P2|NOT COMPLETED|Overall Study||0
8173743|NCT02421055|20153466|P1|NOT COMPLETED|Overall Study||34
8173744|NCT02421055|20153464|P3|COMPLETED|Overall Study||74
8173745|NCT02421055|20153465|P2|COMPLETED|Overall Study||50
8173746|NCT02421055|20153466|P1|COMPLETED|Overall Study||0
8173747|NCT02421055|20153464|P3|Post-operative Complete Sample Set|Overall Study||14
8173748|NCT02421055|20153465|P2|Post-operative Complete Sample Set|Overall Study||13
8173749|NCT02421055|20153466|P1|Post-operative Complete Sample Set|Overall Study||0
8173750|NCT02421055|20153464|P3|Post-operative Serum Sample (Minimum)|Overall Study||26
8173751|NCT02421055|20153465|P2|Post-operative Serum Sample (Minimum)|Overall Study||23
8173752|NCT02421055|20153466|P1|Post-operative Serum Sample (Minimum)|Overall Study||0
8173753|NCT02421055|20153464|P3|Pre-operative Complete Sample Set|Overall Study||36
8173754|NCT02421055|20153465|P2|Pre-operative Complete Sample Set|Overall Study||22
8173755|NCT02421055|20153466|P1|Pre-operative Complete Sample Set|Overall Study||23
8173756|NCT02421055|20153464|P3|Pre-operative Serum Sample (Minimum)|Overall Study||74
8173757|NCT02421055|20153465|P2|Pre-operative Serum Sample (Minimum)|Overall Study||50
8173758|NCT02421055|20153466|P1|Pre-operative Serum Sample (Minimum)|Overall Study||34
8173759|NCT02421055|20153464|P3|STARTED|Overall Study||74
8173760|NCT02421055|20153465|P2|STARTED|Overall Study||50
8173761|NCT02421055|20153466|P1|STARTED|Overall Study||34
8173762|NCT02420951|20153493|P2|NOT COMPLETED|Overall Study||0
8173763|NCT02420951|20153494|P1|NOT COMPLETED|Overall Study||0
8173764|NCT02420951|20153493|P2|COMPLETED|Overall Study||25
8173765|NCT02420951|20153494|P1|COMPLETED|Overall Study||25
8173766|NCT02420951|20153493|P2|STARTED|Overall Study||25
8173767|NCT02420951|20153494|P1|STARTED|Overall Study||25
8173768|NCT02420873|20153513|P3|NOT COMPLETED|Overall Study||0
8173769|NCT02420873|20153514|P2|NOT COMPLETED|Overall Study||0
8173770|NCT02420873|20153515|P1|NOT COMPLETED|Overall Study||0
8173771|NCT02420873|20153513|P3|COMPLETED|Overall Study||0
8173772|NCT02420873|20153514|P2|COMPLETED|Overall Study||0
8173773|NCT02420873|20153515|P1|COMPLETED|Overall Study||9
8173774|NCT02420873|20153513|P3|STARTED|Overall Study||0
8173775|NCT02420873|20153514|P2|STARTED|Overall Study||0
8173776|NCT02420873|20153515|P1|STARTED|Overall Study||9
8173783|NCT02420691|20153594|P1|NOT COMPLETED|Overall Study||6
8173784|NCT02420691|20153594|P1|COMPLETED|Overall Study||14
8173785|NCT02420691|20153594|P1|STARTED|Overall Study||20
8173786|NCT02420379|20153604|P2|NOT COMPLETED|Overall Study||4
8173787|NCT02420379|20153605|P1|NOT COMPLETED|Overall Study||1
8173788|NCT02420379|20153604|P2|COMPLETED|Overall Study||3
8173789|NCT02420379|20153605|P1|COMPLETED|Overall Study||25
8173790|NCT02420379|20153604|P2|STARTED|Overall Study||7
8173791|NCT02420379|20153605|P1|STARTED|Overall Study||26
8173792|NCT02420353|20153625|P2|NOT COMPLETED|Overall Study||1
8173793|NCT02420353|20153626|P1|NOT COMPLETED|Overall Study||0
8173794|NCT02420353|20153625|P2|COMPLETED|Overall Study||9
8173795|NCT02420353|20153626|P1|COMPLETED|Overall Study||10
8173796|NCT02420353|20153625|P2|Allocation to Intervention|Overall Study||10
8173797|NCT02420353|20153626|P1|Allocation to Intervention|Overall Study||10
8173798|NCT02420353|20153625|P2|STARTED|Overall Study||10
8173799|NCT02420353|20153626|P1|STARTED|Overall Study||10
8173800|NCT02420327|20153718|P1|NOT COMPLETED|Overall Study||16
8173801|NCT02420327|20153718|P1|COMPLETED|Overall Study||27
8173802|NCT02420327|20153718|P1|STARTED|Overall Study||43
8173803|NCT02420262|20153754|P2|NOT COMPLETED|Overall Study||5
8173804|NCT02420262|20153755|P1|NOT COMPLETED|Overall Study||2
8173805|NCT02420262|20153754|P2|COMPLETED|Overall Study||249
8173806|NCT02420262|20153755|P1|COMPLETED|Overall Study||250
8173807|NCT02420262|20153754|P2|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
8173808|NCT02420262|20153755|P1|Exposed|Overall Study||252
8173809|NCT02420262|20153754|P2|STARTED|Overall Study||254
8173810|NCT02420262|20153755|P1|STARTED|Overall Study||252
8173811|NCT02420210|20153769|P1|NOT COMPLETED|Overall Study||0
8173812|NCT02420210|20153769|P1|COMPLETED|Overall Study||2
8173813|NCT02420210|20153769|P1|STARTED|Overall Study||2
8173814|NCT02420093|20153781|P2|NOT COMPLETED|Overall Study||1
8173815|NCT02420093|20153782|P1|NOT COMPLETED|Overall Study||1
8173816|NCT02420093|20153781|P2|COMPLETED|Overall Study||7
8173817|NCT02420093|20153782|P1|COMPLETED|Overall Study||8
8173818|NCT02420093|20153781|P2|STARTED|Overall Study||8
8173819|NCT02420093|20153782|P1|STARTED|Overall Study||9
8173820|NCT02420041|20153798|P2|NOT COMPLETED|Overall Study||0
8173821|NCT02420041|20153799|P1|NOT COMPLETED|Overall Study||0
8173822|NCT02420041|20153798|P2|COMPLETED|Overall Study||14
8173823|NCT02420041|20153799|P1|COMPLETED|Overall Study||14
8173824|NCT02420041|20153798|P2|STARTED|Overall Study||14
8173825|NCT02420041|20153799|P1|STARTED|Overall Study||14
8173826|NCT02420015|20153825|P2|NOT COMPLETED|Overall Study||0
8173827|NCT02420015|20153826|P1|NOT COMPLETED|Overall Study||0
8173828|NCT02420015|20153825|P2|COMPLETED|Overall Study||13
8173829|NCT02420015|20153826|P1|COMPLETED|Overall Study||21
8173830|NCT02420015|20153825|P2|STARTED|Overall Study||13
8173831|NCT02420015|20153826|P1|STARTED|Overall Study||21
8173832|NCT02419937|20153844|P2|NOT COMPLETED|Overall Study||0
8173833|NCT02419937|20153845|P1|NOT COMPLETED|Overall Study||1
8173834|NCT02419937|20153844|P2|COMPLETED|Overall Study||16
8173835|NCT02419937|20153845|P1|COMPLETED|Overall Study||11
8173836|NCT02419937|20153844|P2|STARTED|Overall Study||16
8173837|NCT02419937|20153845|P1|STARTED|Overall Study||12
8173838|NCT02419924|20153851|P1|NOT COMPLETED|Overall Study||0
8173839|NCT02419924|20153851|P1|COMPLETED|Overall Study||12
8173840|NCT02419924|20153851|P1|STARTED|Overall Study||12
8173841|NCT02419807|20153858|P1|NOT COMPLETED|Overall Study||10
8173842|NCT02419807|20153858|P1|COMPLETED|Overall Study||92
8173843|NCT02419807|20153858|P1|STARTED|Overall Study||102
8173844|NCT02419755|20153864|P2|NOT COMPLETED|Overall Study||4
8173845|NCT02419755|20153865|P1|NOT COMPLETED|Overall Study||3
8173846|NCT02419755|20153864|P2|COMPLETED|Overall Study||2
8173847|NCT02419755|20153865|P1|COMPLETED|Overall Study||3
8173848|NCT02419755|20153864|P2|STARTED|Overall Study||6
8173849|NCT02419755|20153865|P1|STARTED|Overall Study||6
8173850|NCT02419690|20153891|P2|NOT COMPLETED|Overall Study||0
8173851|NCT02419690|20153892|P1|NOT COMPLETED|Overall Study||0
8173852|NCT02419690|20153891|P2|COMPLETED|Overall Study||122
8173853|NCT02419690|20153892|P1|COMPLETED|Overall Study||122
8173854|NCT02419690|20153891|P2|STARTED|Overall Study||122
8173855|NCT02419690|20153892|P1|STARTED|Overall Study||122
8173856|NCT02419612|20153906|P2|NOT COMPLETED|Long-term Treatment Period||22
8173857|NCT02419612|20153907|P1|NOT COMPLETED|Long-term Treatment Period||22
8173858|NCT02419612|20153906|P2|COMPLETED|Long-term Treatment Period||164
8173859|NCT02419612|20153907|P1|COMPLETED|Long-term Treatment Period||174
8173860|NCT02419612|20153906|P2|Received Treatment|Long-term Treatment Period||183
8173861|NCT02419612|20153907|P1|Received Treatment|Long-term Treatment Period||196
8173862|NCT02419612|20153906|P2|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|186
8173863|NCT02419612|20153907|P1|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|196
8173864|NCT02419612|20153906|P2|NOT COMPLETED|Short-term Treatment Period||23
8173865|NCT02419612|20153907|P1|NOT COMPLETED|Short-term Treatment Period||17
8173866|NCT02419612|20153906|P2|COMPLETED|Short-term Treatment Period||194
8173867|NCT02419612|20153907|P1|COMPLETED|Short-term Treatment Period||210
8173868|NCT02419612|20153906|P2|Recevied Treatment|Short-term Treatment Period||216
8173869|NCT02419612|20153907|P1|Recevied Treatment|Short-term Treatment Period||227
8173870|NCT02419612|20153906|P2|STARTED|Short-term Treatment Period||217
8173871|NCT02419612|20153907|P1|STARTED|Short-term Treatment Period||227
8173872|NCT02419573|20153929|P2|NOT COMPLETED|Overall Study||0
8173873|NCT02419573|20153930|P1|NOT COMPLETED|Overall Study||4
8173874|NCT02419573|20153929|P2|COMPLETED|Overall Study||1505
8173875|NCT02419573|20153930|P1|COMPLETED|Overall Study||1495
8173876|NCT02419573|20153929|P2|STARTED|Overall Study||1505
8173877|NCT02419573|20153930|P1|STARTED|Overall Study||1499
8173878|NCT02419547|20153942|P1|NOT COMPLETED|Overall Study||0
8173879|NCT02419547|20153942|P1|COMPLETED|Overall Study||11
8173880|NCT02419547|20153942|P1|STARTED|Overall Study||11
8173881|NCT02419521|20153946|P1|NOT COMPLETED|Overall Study||1
8173882|NCT02419521|20153946|P1|COMPLETED|Overall Study||74
8173883|NCT02419521|20153946|P1|STARTED|Overall Study||75
8173884|NCT02419508|20153960|P2|NOT COMPLETED|Overall Study||4
8173885|NCT02419508|20153961|P1|NOT COMPLETED|Overall Study||10
8173886|NCT02419508|20153960|P2|COMPLETED|Overall Study||88
8173887|NCT02419508|20153961|P1|COMPLETED|Overall Study||86
8173888|NCT02419508|20153960|P2|Safety Analysis Set|Overall Study||92
8173889|NCT02419508|20153961|P1|Safety Analysis Set|Overall Study||95
8173890|NCT02419508|20153960|P2|Full Analysis Set|Overall Study||92
8173891|NCT02419508|20153961|P1|Full Analysis Set|Overall Study||95
8173892|NCT02419508|20153960|P2|STARTED|Overall Study||92
8173893|NCT02419508|20153961|P1|STARTED|Overall Study||96
8173894|NCT02419469|20153979|P1|NOT COMPLETED|Overall Study||1
8173895|NCT02419469|20153979|P1|COMPLETED|Overall Study||0
8173896|NCT02419469|20153979|P1|STARTED|Overall Study||1
8173897|NCT02419313|20153983|P2|NOT COMPLETED|Second Intervention||0
8173898|NCT02419313|20153984|P1|NOT COMPLETED|Second Intervention||1
8173899|NCT02419313|20153983|P2|COMPLETED|Second Intervention||15
8173900|NCT02419313|20153984|P1|COMPLETED|Second Intervention||15
8173901|NCT02419313|20153983|P2|STARTED|Second Intervention||15
8173902|NCT02419313|20153984|P1|STARTED|Second Intervention||16
8173903|NCT02419313|20153983|P2|NOT COMPLETED|First Intervention||0
8173904|NCT02419313|20153984|P1|NOT COMPLETED|First Intervention||2
8173905|NCT02419313|20153983|P2|COMPLETED|First Intervention||15
8173906|NCT02419313|20153984|P1|COMPLETED|First Intervention||16
8173907|NCT02419313|20153983|P2|STARTED|First Intervention||15
8173908|NCT02419313|20153984|P1|STARTED|First Intervention||18
8173909|NCT02419001|20153996|P2|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
8173910|NCT02419001|20153997|P1|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
8173911|NCT02419001|20153996|P2|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
8173912|NCT02419001|20153997|P1|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
8173913|NCT02419001|20153996|P2|STARTED|Period 2- Ceftriaxone With SYN-004||5
8173914|NCT02419001|20153997|P1|STARTED|Period 2- Ceftriaxone With SYN-004||5
8173915|NCT02419001|20153996|P2|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
8173916|NCT02419001|20153997|P1|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
8173917|NCT02419001|20153996|P2|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
8173918|NCT02419001|20153997|P1|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
8173919|NCT02419001|20153996|P2|STARTED|Period 1- Ceftriaxone Without SYN-004||5
8173920|NCT02419001|20153997|P1|STARTED|Period 1- Ceftriaxone Without SYN-004||6
8173921|NCT02418910|20154007|P1|NOT COMPLETED|Overall Study||7
8173922|NCT02418910|20154007|P1|COMPLETED|Overall Study||43
8173923|NCT02418910|20154007|P1|STARTED|Overall Study||50
8173924|NCT02418819|20154015|P4|NOT COMPLETED|Overall Study||1
8173925|NCT02418819|20154016|P3|NOT COMPLETED|Overall Study||4
8173926|NCT02418819|20154017|P2|NOT COMPLETED|Overall Study||0
8173927|NCT02418819|20154018|P1|NOT COMPLETED|Overall Study||1
8173928|NCT02418819|20154015|P4|COMPLETED|Overall Study||28
8173929|NCT02418819|20154016|P3|COMPLETED|Overall Study||29
8173930|NCT02418819|20154017|P2|COMPLETED|Overall Study||16
8173931|NCT02418819|20154018|P1|COMPLETED|Overall Study||21
8173932|NCT02418819|20154015|P4|STARTED|Overall Study||29
8173933|NCT02418819|20154016|P3|STARTED|Overall Study||33
8173934|NCT02418819|20154017|P2|STARTED|Overall Study||16
8173935|NCT02418819|20154018|P1|STARTED|Overall Study||22
8173936|NCT02418754|20154061|P5|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
8173937|NCT02418754|20154062|P4|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
8173938|NCT02418754|20154063|P3|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||37
8173939|NCT02418754|20154064|P2|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||42
8173940|NCT02418754|20154065|P1|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||33
8173941|NCT02418754|20154061|P5|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
8173942|NCT02418754|20154062|P4|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
8173943|NCT02418754|20154063|P3|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||71
8173944|NCT02418754|20154064|P2|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||64
8173945|NCT02418754|20154065|P1|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||70
8173946|NCT02418754|20154061|P5|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
8173947|NCT02418754|20154062|P4|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
8173948|NCT02418754|20154063|P3|STARTED|Period 2 (Day 1 to Week 52/End of Study)||108
8173949|NCT02418754|20154064|P2|STARTED|Period 2 (Day 1 to Week 52/End of Study)||106
8173950|NCT02418754|20154065|P1|STARTED|Period 2 (Day 1 to Week 52/End of Study)||103
8173951|NCT02418754|20154061|P5|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
8173952|NCT02418754|20154062|P4|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
8173953|NCT02418754|20154063|P3|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
8173954|NCT02418754|20154064|P2|NOT COMPLETED|Period 1 (Day 1 to Week 12)||4
8173955|NCT02418754|20154065|P1|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
8173956|NCT02418754|20154061|P5|COMPLETED|Period 1 (Day 1 to Week 12)||0
8173957|NCT02418754|20154062|P4|COMPLETED|Period 1 (Day 1 to Week 12)||0
8173958|NCT02418754|20154063|P3|COMPLETED|Period 1 (Day 1 to Week 12)||200
8173959|NCT02418754|20154064|P2|COMPLETED|Period 1 (Day 1 to Week 12)||196
8173960|NCT02418754|20154065|P1|COMPLETED|Period 1 (Day 1 to Week 12)||101
8173961|NCT02418754|20154061|P5|STARTED|Period 1 (Day 1 to Week 12)||0
8173962|NCT02418754|20154062|P4|STARTED|Period 1 (Day 1 to Week 12)||0
8173963|NCT02418754|20154063|P3|STARTED|Period 1 (Day 1 to Week 12)||202
8173964|NCT02418754|20154064|P2|STARTED|Period 1 (Day 1 to Week 12)||200
8173965|NCT02418754|20154065|P1|STARTED|Period 1 (Day 1 to Week 12)||103
8173966|NCT02418676|20154099|P3|NOT COMPLETED|Overall Study||0
8173967|NCT02418676|20154100|P2|NOT COMPLETED|Overall Study||0
8173968|NCT02418676|20154101|P1|NOT COMPLETED|Overall Study||0
8173969|NCT02418676|20154099|P3|COMPLETED|Overall Study||5
8173970|NCT02418676|20154100|P2|COMPLETED|Overall Study||5
8173971|NCT02418676|20154101|P1|COMPLETED|Overall Study||5
8173972|NCT02418676|20154099|P3|STARTED|Overall Study||5
8173973|NCT02418676|20154100|P2|STARTED|Overall Study||5
8173974|NCT02418676|20154101|P1|STARTED|Overall Study||5
8173975|NCT02418585|20154114|P2|NOT COMPLETED|Follow-up Phase (24 Weeks)||25
8173976|NCT02418585|20154115|P1|NOT COMPLETED|Follow-up Phase (24 Weeks)||18
8173977|NCT02418585|20154114|P2|COMPLETED|Follow-up Phase (24 Weeks)||27
8173978|NCT02418585|20154115|P1|COMPLETED|Follow-up Phase (24 Weeks)||16
8173979|NCT02418585|20154114|P2|STARTED|Follow-up Phase (24 Weeks)||52
8173980|NCT02418585|20154115|P1|STARTED|Follow-up Phase (24 Weeks)||34
8173981|NCT02418585|20154114|P2|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12
8173982|NCT02418585|20154115|P1|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18
8173983|NCT02418585|20154114|P2|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99
8173984|NCT02418585|20154115|P1|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98
8173985|NCT02418585|20154114|P2|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
8173986|NCT02418585|20154115|P1|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114
8173987|NCT02418585|20154114|P2|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
8173988|NCT02418585|20154115|P1|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115
8173989|NCT02418585|20154114|P2|STARTED|Double Blind (DB) Phase (4 Weeks)||111
8173990|NCT02418585|20154115|P1|STARTED|Double Blind (DB) Phase (4 Weeks)||116
8173991|NCT02418546|20154156|P3|NOT COMPLETED|Overall Study||3
8173992|NCT02418546|20154157|P2|NOT COMPLETED|Overall Study||6
8173993|NCT02418546|20154158|P1|NOT COMPLETED|Overall Study||7
8173994|NCT02418546|20154156|P3|COMPLETED|Overall Study||23
8173995|NCT02418546|20154157|P2|COMPLETED|Overall Study||20
8173996|NCT02418546|20154158|P1|COMPLETED|Overall Study||19
8173997|NCT02418546|20154156|P3|STARTED|Overall Study||26
8173998|NCT02418546|20154157|P2|STARTED|Overall Study||26
8173999|NCT02418546|20154158|P1|STARTED|Overall Study||26
8174000|NCT02418468|20154171|P2|NOT COMPLETED|Overall Study||1
8174001|NCT02418468|20154172|P1|NOT COMPLETED|Overall Study||2
8174002|NCT02418468|20154171|P2|COMPLETED|Overall Study||10
8174003|NCT02418468|20154172|P1|COMPLETED|Overall Study||11
8174004|NCT02418468|20154171|P2|STARTED|Overall Study||11
8174005|NCT02418468|20154172|P1|STARTED|Overall Study||13
8174006|NCT02418455|20154178|P1|NOT COMPLETED|Continuation Period||7
8174007|NCT02418455|20154178|P1|COMPLETED|Continuation Period||0
8174008|NCT02418455|20154178|P1|STARTED|Continuation Period||7
8174009|NCT02418455|20154178|P1|NOT COMPLETED|48-Week Treatment Period||1
8174010|NCT02418455|20154178|P1|COMPLETED|48-Week Treatment Period||7
8174011|NCT02418455|20154178|P1|Emergency IND (eIND)|48-Week Treatment Period||1
8174012|NCT02418455|20154178|P1|STARTED|48-Week Treatment Period||8
8174013|NCT02418312|20154201|P2|NOT COMPLETED|Overall Study||0
8174014|NCT02418312|20154202|P1|NOT COMPLETED|Overall Study||0
8174015|NCT02418312|20154201|P2|COMPLETED|Overall Study||114
8174016|NCT02418312|20154202|P1|COMPLETED|Overall Study||114
8174017|NCT02418312|20154201|P2|STARTED|Overall Study||114
8174018|NCT02418312|20154202|P1|STARTED|Overall Study||114
8174019|NCT02418234|20154208|P1|NOT COMPLETED|Overall Study||0
8174020|NCT02418234|20154208|P1|COMPLETED|Overall Study||314
8174021|NCT02418234|20154208|P1|STARTED|Overall Study||314
8174022|NCT02418182|20154221|P2|NOT COMPLETED|Overall Study||17
8174023|NCT02418182|20154222|P1|NOT COMPLETED|Overall Study||18
8174024|NCT02418182|20154221|P2|COMPLETED|Overall Study||33
8174025|NCT02418182|20154222|P1|COMPLETED|Overall Study||31
8174026|NCT02418182|20154221|P2|STARTED|Overall Study||50
8174027|NCT02418182|20154222|P1|STARTED|Overall Study||49
8174028|NCT02418156|20154234|P1|NOT COMPLETED|Overall Study||17
8174029|NCT02418156|20154234|P1|COMPLETED|Overall Study||21
8174030|NCT02418156|20154234|P1|STARTED|Overall Study||38
8174031|NCT02418026|20154240|P2|NOT COMPLETED|Overall Study||0
8174032|NCT02418026|20154241|P1|NOT COMPLETED|Overall Study||0
8174033|NCT02418026|20154240|P2|COMPLETED|Overall Study||35
8174034|NCT02418026|20154241|P1|COMPLETED|Overall Study||44
8174035|NCT02418026|20154240|P2|STARTED|Overall Study||35
8174036|NCT02418026|20154241|P1|STARTED|Overall Study||44
8174037|NCT02418000|20154276|P5|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4
8174038|NCT02418000|20154277|P4|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174039|NCT02418000|20154278|P3|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174040|NCT02418000|20154279|P2|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174041|NCT02418000|20154280|P1|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174042|NCT02418000|20154276|P5|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174043|NCT02418000|20154277|P4|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174044|NCT02418000|20154278|P3|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174045|NCT02418000|20154279|P2|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174046|NCT02418000|20154280|P1|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174047|NCT02418000|20154276|P5|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4
8174048|NCT02418000|20154277|P4|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174049|NCT02418000|20154278|P3|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174050|NCT02418000|20154279|P2|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174051|NCT02418000|20154280|P1|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
8174052|NCT02418000|20154276|P5|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174053|NCT02418000|20154277|P4|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3
8174054|NCT02418000|20154278|P3|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174055|NCT02418000|20154279|P2|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174056|NCT02418000|20154280|P1|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174057|NCT02418000|20154276|P5|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174058|NCT02418000|20154277|P4|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174059|NCT02418000|20154278|P3|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174060|NCT02418000|20154279|P2|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174061|NCT02418000|20154280|P1|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174062|NCT02418000|20154276|P5|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174063|NCT02418000|20154277|P4|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3
8174064|NCT02418000|20154278|P3|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174065|NCT02418000|20154279|P2|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174066|NCT02418000|20154280|P1|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
8174067|NCT02418000|20154276|P5|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174068|NCT02418000|20154277|P4|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174069|NCT02418000|20154278|P3|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3
8174070|NCT02418000|20154279|P2|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174071|NCT02418000|20154280|P1|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174072|NCT02418000|20154276|P5|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174073|NCT02418000|20154277|P4|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174074|NCT02418000|20154278|P3|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174075|NCT02418000|20154279|P2|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174076|NCT02418000|20154280|P1|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174077|NCT02418000|20154276|P5|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174078|NCT02418000|20154277|P4|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174079|NCT02418000|20154278|P3|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3
8174080|NCT02418000|20154279|P2|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174081|NCT02418000|20154280|P1|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
8174082|NCT02418000|20154276|P5|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174083|NCT02418000|20154277|P4|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174084|NCT02418000|20154278|P3|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174085|NCT02418000|20154279|P2|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10
8174086|NCT02418000|20154280|P1|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174087|NCT02418000|20154276|P5|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174088|NCT02418000|20154277|P4|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174089|NCT02418000|20154278|P3|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174090|NCT02418000|20154279|P2|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174091|NCT02418000|20154280|P1|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174092|NCT02418000|20154276|P5|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174093|NCT02418000|20154277|P4|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174094|NCT02418000|20154278|P3|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174095|NCT02418000|20154279|P2|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10
8174096|NCT02418000|20154280|P1|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
8174097|NCT02418000|20154276|P5|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174098|NCT02418000|20154277|P4|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174099|NCT02418000|20154278|P3|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174100|NCT02418000|20154279|P2|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174101|NCT02418000|20154280|P1|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7
8174102|NCT02418000|20154276|P5|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174103|NCT02418000|20154277|P4|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174104|NCT02418000|20154278|P3|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174105|NCT02418000|20154279|P2|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174106|NCT02418000|20154280|P1|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174107|NCT02418000|20154276|P5|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174108|NCT02418000|20154277|P4|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174109|NCT02418000|20154278|P3|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174110|NCT02418000|20154279|P2|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
8174111|NCT02418000|20154280|P1|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7
8174112|NCT02417961|20154398|P1|NOT COMPLETED|Overall Study||4
8174113|NCT02417961|20154398|P1|COMPLETED|Overall Study||112
8174114|NCT02417961|20154398|P1|STARTED|Overall Study||116
8174115|NCT02417935|20154410|P2|NOT COMPLETED|Tapering Period||0
8174116|NCT02417935|20154411|P1|NOT COMPLETED|Tapering Period||0
8174117|NCT02417935|20154410|P2|COMPLETED|Tapering Period||142
8174118|NCT02417935|20154411|P1|COMPLETED|Tapering Period||134
8174119|NCT02417935|20154410|P2|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
8174120|NCT02417935|20154411|P1|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
8174121|NCT02417935|20154410|P2|NOT COMPLETED|Treatment Period||16
8174122|NCT02417935|20154411|P1|NOT COMPLETED|Treatment Period||21
8174123|NCT02417935|20154410|P2|COMPLETED|Treatment Period||137
8174124|NCT02417935|20154411|P1|COMPLETED|Treatment Period||130
8174125|NCT02417935|20154410|P2|Received at Least One Dose of Study Drug|Treatment Period||152
8174126|NCT02417935|20154411|P1|Received at Least One Dose of Study Drug|Treatment Period||151
8174127|NCT02417935|20154410|P2|STARTED|Treatment Period||153
8174128|NCT02417935|20154411|P1|STARTED|Treatment Period||151
8174129|NCT02417844|20154435|P2|NOT COMPLETED|Overall Study||0
8174130|NCT02417844|20154436|P1|NOT COMPLETED|Overall Study||0
8174131|NCT02417844|20154435|P2|COMPLETED|Overall Study||17
8174132|NCT02417844|20154436|P1|COMPLETED|Overall Study||17
8174133|NCT02417844|20154435|P2|STARTED|Overall Study||17
8174134|NCT02417844|20154436|P1|STARTED|Overall Study||17
8174135|NCT02417831|20154452|P2|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
8174136|NCT02417831|20154453|P1|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
8174137|NCT02417831|20154452|P2|COMPLETED|Period 2: Treatment Period 2 + Washout||17
8174138|NCT02417831|20154453|P1|COMPLETED|Period 2: Treatment Period 2 + Washout||17
8174139|NCT02417831|20154452|P2|STARTED|Period 2: Treatment Period 2 + Washout||17
8174140|NCT02417831|20154453|P1|STARTED|Period 2: Treatment Period 2 + Washout||17
8174141|NCT02417831|20154452|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
8174142|NCT02417831|20154453|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
8174143|NCT02417831|20154452|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||17
8174144|NCT02417831|20154453|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||17
8174145|NCT02417831|20154452|P2|STARTED|Period 1: Treatment Period 1 + Washout||17
8174146|NCT02417831|20154453|P1|STARTED|Period 1: Treatment Period 1 + Washout||17
8174147|NCT02417753|20154469|P1|NOT COMPLETED|Overall Study||1
8174148|NCT02417753|20154469|P1|COMPLETED|Overall Study||0
8174149|NCT02417753|20154469|P1|STARTED|Overall Study||1
8174150|NCT02417532|20154479|P1|NOT COMPLETED|Overall Study||0
8174151|NCT02417532|20154479|P1|COMPLETED|Overall Study||56
8174152|NCT02417532|20154479|P1|STARTED|Overall Study||56
8174153|NCT02417441|20154489|P2|NOT COMPLETED|Overall Study||19
8174154|NCT02417441|20154490|P1|NOT COMPLETED|Overall Study||52
8174155|NCT02417441|20154489|P2|COMPLETED|Overall Study||306
8174156|NCT02417441|20154490|P1|COMPLETED|Overall Study||593
8174157|NCT02417441|20154489|P2|STARTED|Overall Study||325
8174158|NCT02417441|20154490|P1|STARTED|Overall Study||645
8174159|NCT02417376|20154511|P2|NOT COMPLETED|Overall Study||10
8174160|NCT02417376|20154512|P1|NOT COMPLETED|Overall Study||5
8174161|NCT02417376|20154511|P2|COMPLETED|Overall Study||25
8174162|NCT02417376|20154512|P1|COMPLETED|Overall Study||30
8174163|NCT02417376|20154511|P2|STARTED|Overall Study||35
8174164|NCT02417376|20154512|P1|STARTED|Overall Study||35
8174165|NCT02417246|20154558|P2|NOT COMPLETED|Phase 4 2nd Generic Administered||0
8174166|NCT02417246|20154559|P1|NOT COMPLETED|Phase 4 2nd Generic Administered||0
8174167|NCT02417246|20154558|P2|COMPLETED|Phase 4 2nd Generic Administered||20
8174168|NCT02417246|20154559|P1|COMPLETED|Phase 4 2nd Generic Administered||18
8174169|NCT02417246|20154558|P2|STARTED|Phase 4 2nd Generic Administered||20
8174170|NCT02417246|20154559|P1|STARTED|Phase 4 2nd Generic Administered||18
8174171|NCT02417246|20154558|P2|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0
8174172|NCT02417246|20154559|P1|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1
8174173|NCT02417246|20154558|P2|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20
8174174|NCT02417246|20154559|P1|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18
8174175|NCT02417246|20154558|P2|STARTED|Phase 3 Brand Name Metoprolol ER #2||20
8174176|NCT02417246|20154559|P1|STARTED|Phase 3 Brand Name Metoprolol ER #2||19
8174177|NCT02417246|20154558|P2|NOT COMPLETED|Phase 2 1st Generic Administered||0
8174178|NCT02417246|20154559|P1|NOT COMPLETED|Phase 2 1st Generic Administered||1
8174179|NCT02417246|20154558|P2|COMPLETED|Phase 2 1st Generic Administered||20
8174180|NCT02417246|20154559|P1|COMPLETED|Phase 2 1st Generic Administered||19
8174181|NCT02417246|20154558|P2|STARTED|Phase 2 1st Generic Administered||20
8174182|NCT02417246|20154559|P1|STARTED|Phase 2 1st Generic Administered||20
8174183|NCT02417246|20154558|P2|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
8174184|NCT02417246|20154559|P1|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
8174185|NCT02417246|20154558|P2|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
8174186|NCT02417246|20154559|P1|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
8174187|NCT02417246|20154558|P2|STARTED|Phase 1 Brand Name Metoprolol ER||24
8174188|NCT02417246|20154559|P1|STARTED|Phase 1 Brand Name Metoprolol ER||24
8174189|NCT02417233|20154582|P3|NOT COMPLETED|Overall Study||59
8174190|NCT02417233|20154583|P2|NOT COMPLETED|Overall Study||51
8174191|NCT02417233|20154584|P1|NOT COMPLETED|Overall Study||36
8174192|NCT02417233|20154582|P3|COMPLETED|Overall Study||239
8174193|NCT02417233|20154583|P2|COMPLETED|Overall Study||238
8174194|NCT02417233|20154584|P1|COMPLETED|Overall Study||133
8174195|NCT02417233|20154582|P3|STARTED|Overall Study||298
8174196|NCT02417233|20154583|P2|STARTED|Overall Study||289
8174197|NCT02417233|20154584|P1|STARTED|Overall Study||169
8174198|NCT02417129|20154607|P2|NOT COMPLETED|Overall Study||0
8174199|NCT02417129|20154608|P1|NOT COMPLETED|Overall Study||0
8174200|NCT02417129|20154607|P2|COMPLETED|Overall Study||0
8174201|NCT02417129|20154608|P1|COMPLETED|Overall Study||2
8174202|NCT02417129|20154607|P2|STARTED|Overall Study||0
8174203|NCT02417129|20154608|P1|STARTED|Overall Study||2
8174204|NCT02417064|20154621|P3|NOT COMPLETED|Follow-up Phase (24 Weeks)||51
8174205|NCT02417064|20154622|P2|NOT COMPLETED|Follow-up Phase (24 Weeks)||42
8174206|NCT02417064|20154623|P1|NOT COMPLETED|Follow-up Phase (24 Weeks)||39
8174207|NCT02417064|20154621|P3|COMPLETED|Follow-up Phase (24 Weeks)||18
8174208|NCT02417064|20154622|P2|COMPLETED|Follow-up Phase (24 Weeks)||10
8174209|NCT02417064|20154623|P1|COMPLETED|Follow-up Phase (24 Weeks)||8
8174210|NCT02417064|20154621|P3|STARTED|Follow-up Phase (24 Weeks)||69
8174211|NCT02417064|20154622|P2|STARTED|Follow-up Phase (24 Weeks)||52
8174212|NCT02417064|20154623|P1|STARTED|Follow-up Phase (24 Weeks)||47
8174213|NCT02417064|20154621|P3|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
8174214|NCT02417064|20154622|P2|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19
8174215|NCT02417064|20154623|P1|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
8174216|NCT02417064|20154621|P3|COMPLETED|Double-blind Induction Phase (4 Weeks)||107
8174217|NCT02417064|20154622|P2|COMPLETED|Double-blind Induction Phase (4 Weeks)||97
8174218|NCT02417064|20154623|P1|COMPLETED|Double-blind Induction Phase (4 Weeks)||111
8174219|NCT02417064|20154621|P3|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113
8174220|NCT02417064|20154622|P2|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116
8174221|NCT02417064|20154623|P1|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115
8174222|NCT02417064|20154621|P3|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113
8174223|NCT02417064|20154622|P2|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114
8174224|NCT02417064|20154623|P1|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115
8174225|NCT02417064|20154621|P3|STARTED|Double-blind Induction Phase (4 Weeks)||113
8174226|NCT02417064|20154622|P2|STARTED|Double-blind Induction Phase (4 Weeks)||116
8174227|NCT02417064|20154623|P1|STARTED|Double-blind Induction Phase (4 Weeks)||117
8174228|NCT02416973|20154682|P3|NOT COMPLETED|Overall Study||1
8174229|NCT02416973|20154683|P2|NOT COMPLETED|Overall Study||3
8174230|NCT02416973|20154684|P1|NOT COMPLETED|Overall Study||1
8174231|NCT02416973|20154682|P3|COMPLETED|Overall Study||13
8174232|NCT02416973|20154683|P2|COMPLETED|Overall Study||10
8174233|NCT02416973|20154684|P1|COMPLETED|Overall Study||13
8174234|NCT02416973|20154682|P3|STARTED|Overall Study||14
8174235|NCT02416973|20154683|P2|STARTED|Overall Study||13
8174236|NCT02416973|20154684|P1|STARTED|Overall Study||14
8174237|NCT02416934|20154694|P2|NOT COMPLETED|Overall Study||7
8174238|NCT02416934|20154695|P1|NOT COMPLETED|Overall Study||3
8174239|NCT02416934|20154694|P2|COMPLETED|Overall Study||31
8174240|NCT02416934|20154695|P1|COMPLETED|Overall Study||33
8174241|NCT02416934|20154694|P2|Last Participant Completed 1 yr|Overall Study||31
8174242|NCT02416934|20154695|P1|Last Participant Completed 1 yr|Overall Study||33
8174243|NCT02416934|20154694|P2|Double Blind (0-52 Weeks)|Overall Study||38
8174244|NCT02416934|20154695|P1|Double Blind (0-52 Weeks)|Overall Study||36
8174245|NCT02416934|20154694|P2|STARTED|Overall Study||38
8174246|NCT02416934|20154695|P1|STARTED|Overall Study||36
8174247|NCT02416908|20154710|P4|NOT COMPLETED|Maintenance Phase||0
8174248|NCT02416908|20154711|P3|NOT COMPLETED|Maintenance Phase||0
8174249|NCT02416908|20154712|P2|NOT COMPLETED|Maintenance Phase||0
8174250|NCT02416908|20154713|P1|NOT COMPLETED|Maintenance Phase||0
8174251|NCT02416908|20154710|P4|COMPLETED|Maintenance Phase||2
8174252|NCT02416908|20154711|P3|COMPLETED|Maintenance Phase||0
8174253|NCT02416908|20154712|P2|COMPLETED|Maintenance Phase||0
8174254|NCT02416908|20154713|P1|COMPLETED|Maintenance Phase||0
8174255|NCT02416908|20154710|P4|STARTED|Maintenance Phase||2
8174256|NCT02416908|20154711|P3|STARTED|Maintenance Phase||0
8174257|NCT02416908|20154712|P2|STARTED|Maintenance Phase||0
8174258|NCT02416908|20154713|P1|STARTED|Maintenance Phase||0
8174259|NCT02416908|20154710|P4|NOT COMPLETED|Dose Escalation Phase||0
8174260|NCT02416908|20154711|P3|NOT COMPLETED|Dose Escalation Phase||4
8174261|NCT02416908|20154712|P2|NOT COMPLETED|Dose Escalation Phase||0
8174262|NCT02416908|20154713|P1|NOT COMPLETED|Dose Escalation Phase||0
8174263|NCT02416908|20154710|P4|COMPLETED|Dose Escalation Phase||0
8174264|NCT02416908|20154711|P3|COMPLETED|Dose Escalation Phase||30
8174265|NCT02416908|20154712|P2|COMPLETED|Dose Escalation Phase||0
8174266|NCT02416908|20154713|P1|COMPLETED|Dose Escalation Phase||6
8174267|NCT02416908|20154710|P4|STARTED|Dose Escalation Phase||0
8174268|NCT02416908|20154711|P3|STARTED|Dose Escalation Phase||34
8174269|NCT02416908|20154712|P2|STARTED|Dose Escalation Phase||0
8174270|NCT02416908|20154713|P1|STARTED|Dose Escalation Phase||6
8174271|NCT02416791|20154731|P3|NOT COMPLETED|6 Months||1
8174272|NCT02416791|20154732|P2|NOT COMPLETED|6 Months||0
8174273|NCT02416791|20154733|P1|NOT COMPLETED|6 Months||0
8174274|NCT02416791|20154731|P3|COMPLETED|6 Months||2
8174275|NCT02416791|20154732|P2|COMPLETED|6 Months||3
8174276|NCT02416791|20154733|P1|COMPLETED|6 Months||3
8174277|NCT02416791|20154731|P3|STARTED|6 Months||3
8174278|NCT02416791|20154732|P2|STARTED|6 Months||3
8174279|NCT02416791|20154733|P1|STARTED|6 Months||3
8174280|NCT02416791|20154731|P3|NOT COMPLETED|6 Weeks||0
8174281|NCT02416791|20154732|P2|NOT COMPLETED|6 Weeks||0
8174282|NCT02416791|20154733|P1|NOT COMPLETED|6 Weeks||0
8174283|NCT02416791|20154731|P3|COMPLETED|6 Weeks||3
8174284|NCT02416791|20154732|P2|COMPLETED|6 Weeks||3
8174285|NCT02416791|20154733|P1|COMPLETED|6 Weeks||3
8174286|NCT02416791|20154731|P3|STARTED|6 Weeks||3
8174287|NCT02416791|20154732|P2|STARTED|6 Weeks||3
8174288|NCT02416791|20154733|P1|STARTED|6 Weeks||3
8174289|NCT02416713|20154775|P4|NOT COMPLETED|Overall Study||0
8174290|NCT02416713|20154776|P3|NOT COMPLETED|Overall Study||0
8174291|NCT02416713|20154777|P2|NOT COMPLETED|Overall Study||0
8174292|NCT02416713|20154778|P1|NOT COMPLETED|Overall Study||0
8174293|NCT02416713|20154775|P4|COMPLETED|Overall Study||10
8174294|NCT02416713|20154776|P3|COMPLETED|Overall Study||8
8174295|NCT02416713|20154777|P2|COMPLETED|Overall Study||9
8174296|NCT02416713|20154778|P1|COMPLETED|Overall Study||8
8174297|NCT02416713|20154775|P4|STARTED|Overall Study||10
8174298|NCT02416713|20154776|P3|STARTED|Overall Study||8
8174299|NCT02416713|20154777|P2|STARTED|Overall Study||9
8174300|NCT02416713|20154778|P1|STARTED|Overall Study||8
8174301|NCT02416622|20154791|P3|NOT COMPLETED|Overall Study||13
8174302|NCT02416622|20154792|P2|NOT COMPLETED|Overall Study||8
8174303|NCT02416622|20154793|P1|NOT COMPLETED|Overall Study||6
8174304|NCT02416622|20154791|P3|COMPLETED|Overall Study||0
8174305|NCT02416622|20154792|P2|COMPLETED|Overall Study||0
8174306|NCT02416622|20154793|P1|COMPLETED|Overall Study||0
8174307|NCT02416622|20154791|P3|Started Long-Term Follow-Up|Overall Study||13
8174308|NCT02416622|20154792|P2|Started Long-Term Follow-Up|Overall Study||8
8174309|NCT02416622|20154793|P1|Started Long-Term Follow-Up|Overall Study||6
8174310|NCT02416622|20154791|P3|Completed Month 12|Overall Study||13
8174311|NCT02416622|20154792|P2|Completed Month 12|Overall Study||8
8174312|NCT02416622|20154793|P1|Completed Month 12|Overall Study||6
8174313|NCT02416622|20154791|P3|STARTED|Overall Study||13
8174314|NCT02416622|20154792|P2|STARTED|Overall Study||8
8174315|NCT02416622|20154793|P1|STARTED|Overall Study||6
8174316|NCT02416193|20154812|P2|NOT COMPLETED|Overall Study||0
8174317|NCT02416193|20154813|P1|NOT COMPLETED|Overall Study||0
8174318|NCT02416193|20154812|P2|COMPLETED|Overall Study||15
8174319|NCT02416193|20154813|P1|COMPLETED|Overall Study||15
8174320|NCT02416193|20154812|P2|STARTED|Overall Study||15
8174321|NCT02416193|20154813|P1|STARTED|Overall Study||15
8174322|NCT02416180|20154831|P1|NOT COMPLETED|Overall Study||1
8174323|NCT02416180|20154831|P1|COMPLETED|Overall Study||110
8174324|NCT02416180|20154831|P1|STARTED|Overall Study||111
8174325|NCT02416102|20154841|P3|NOT COMPLETED|Overall Study||0
8174326|NCT02416102|20154842|P2|NOT COMPLETED|Overall Study||8
8174327|NCT02416102|20154843|P1|NOT COMPLETED|Overall Study||9
8174328|NCT02416102|20154841|P3|COMPLETED|Overall Study||0
8174329|NCT02416102|20154842|P2|COMPLETED|Overall Study||7
8174330|NCT02416102|20154843|P1|COMPLETED|Overall Study||7
8174331|NCT02416102|20154841|P3|STARTED|Overall Study||0
8174332|NCT02416102|20154842|P2|STARTED|Overall Study||15
8174333|NCT02416102|20154843|P1|STARTED|Overall Study||16
8174343|NCT02415998|20154883|P1|NOT COMPLETED|Overall Study||5
8174344|NCT02415998|20154883|P1|COMPLETED|Overall Study||20
8174345|NCT02415998|20154883|P1|STARTED|Overall Study||25
8174346|NCT02415959|20154892|P5|NOT COMPLETED|Overall Study||0
8174347|NCT02415959|20154893|P4|NOT COMPLETED|Overall Study||1
8174348|NCT02415959|20154894|P3|NOT COMPLETED|Overall Study||0
8174349|NCT02415959|20154895|P2|NOT COMPLETED|Overall Study||1
8174350|NCT02415959|20154896|P1|NOT COMPLETED|Overall Study||0
8174351|NCT02415959|20154892|P5|COMPLETED|Overall Study||14
8174352|NCT02415959|20154893|P4|COMPLETED|Overall Study||13
8174353|NCT02415959|20154894|P3|COMPLETED|Overall Study||14
8174354|NCT02415959|20154895|P2|COMPLETED|Overall Study||13
8174355|NCT02415959|20154896|P1|COMPLETED|Overall Study||14
8174356|NCT02415959|20154892|P5|STARTED|Overall Study||14
8174357|NCT02415959|20154893|P4|STARTED|Overall Study||14
8174358|NCT02415959|20154894|P3|STARTED|Overall Study||14
8174359|NCT02415959|20154895|P2|STARTED|Overall Study||14
8174360|NCT02415959|20154896|P1|STARTED|Overall Study||14
8174361|NCT02415855|20154930|P2|NOT COMPLETED|Overall Study||2
8174362|NCT02415855|20154931|P1|NOT COMPLETED|Overall Study||3
8174363|NCT02415855|20154930|P2|COMPLETED|Overall Study||62
8174364|NCT02415855|20154931|P1|COMPLETED|Overall Study||34
8174365|NCT02415855|20154930|P2|STARTED|Overall Study||64
8174366|NCT02415855|20154931|P1|STARTED|Overall Study||37
8174367|NCT02415842|20154958|P13|NOT COMPLETED|Overall Study||0
8174368|NCT02415842|20154959|P12|NOT COMPLETED|Overall Study||0
8174369|NCT02415842|20154960|P11|NOT COMPLETED|Overall Study||0
8174370|NCT02415842|20154961|P10|NOT COMPLETED|Overall Study||0
8174371|NCT02415842|20154962|P9|NOT COMPLETED|Overall Study||0
8174372|NCT02415842|20154963|P8|NOT COMPLETED|Overall Study||0
8174373|NCT02415842|20154964|P7|NOT COMPLETED|Overall Study||0
8174374|NCT02415842|20154965|P6|NOT COMPLETED|Overall Study||0
8174375|NCT02415842|20154966|P5|NOT COMPLETED|Overall Study||0
8174376|NCT02415842|20154967|P4|NOT COMPLETED|Overall Study||0
8174377|NCT02415842|20154968|P3|NOT COMPLETED|Overall Study||0
8174378|NCT02415842|20154969|P2|NOT COMPLETED|Overall Study||0
8174379|NCT02415842|20154970|P1|NOT COMPLETED|Overall Study||0
8174380|NCT02415842|20154958|P13|COMPLETED|Overall Study||20
8174381|NCT02415842|20154959|P12|COMPLETED|Overall Study||33
8174382|NCT02415842|20154960|P11|COMPLETED|Overall Study||49
8174383|NCT02415842|20154961|P10|COMPLETED|Overall Study||53
8174384|NCT02415842|20154962|P9|COMPLETED|Overall Study||29
8174385|NCT02415842|20154963|P8|COMPLETED|Overall Study||26
8174386|NCT02415842|20154964|P7|COMPLETED|Overall Study||30
8174387|NCT02415842|20154965|P6|COMPLETED|Overall Study||30
8174388|NCT02415842|20154966|P5|COMPLETED|Overall Study||30
8174389|NCT02415842|20154967|P4|COMPLETED|Overall Study||27
8174390|NCT02415842|20154968|P3|COMPLETED|Overall Study||29
8174391|NCT02415842|20154969|P2|COMPLETED|Overall Study||29
8174392|NCT02415842|20154970|P1|COMPLETED|Overall Study||29
8174393|NCT02415842|20154958|P13|STARTED|Overall Study||20
8174394|NCT02415842|20154959|P12|STARTED|Overall Study||33
8174395|NCT02415842|20154960|P11|STARTED|Overall Study||49
8174396|NCT02415842|20154961|P10|STARTED|Overall Study||53
8174397|NCT02415842|20154962|P9|STARTED|Overall Study||29
8174398|NCT02415842|20154963|P8|STARTED|Overall Study||26
8174399|NCT02415842|20154964|P7|STARTED|Overall Study||30
8174400|NCT02415842|20154965|P6|STARTED|Overall Study||30
8174401|NCT02415842|20154966|P5|STARTED|Overall Study||30
8174402|NCT02415842|20154967|P4|STARTED|Overall Study||27
8174403|NCT02415842|20154968|P3|STARTED|Overall Study||29
8174404|NCT02415842|20154969|P2|STARTED|Overall Study||29
8174405|NCT02415842|20154970|P1|STARTED|Overall Study||29
8174406|NCT02415608|20155311|P2|NOT COMPLETED|Overall Study||0
8174407|NCT02415608|20155312|P1|NOT COMPLETED|Overall Study||0
8174408|NCT02415608|20155311|P2|COMPLETED|Overall Study||1
8174409|NCT02415608|20155312|P1|COMPLETED|Overall Study||3
8174410|NCT02415608|20155311|P2|STARTED|Overall Study||1
8174411|NCT02415608|20155312|P1|STARTED|Overall Study||3
8174412|NCT02415595|20155342|P4|NOT COMPLETED|Overall Study||53
8174413|NCT02415595|20155343|P3|NOT COMPLETED|Overall Study||51
8174414|NCT02415595|20155344|P2|NOT COMPLETED|Overall Study||52
8174415|NCT02415595|20155345|P1|NOT COMPLETED|Overall Study||50
8174416|NCT02415595|20155342|P4|COMPLETED|Overall Study||0
8174417|NCT02415595|20155343|P3|COMPLETED|Overall Study||0
8174418|NCT02415595|20155344|P2|COMPLETED|Overall Study||0
8174419|NCT02415595|20155345|P1|COMPLETED|Overall Study||0
8174420|NCT02415595|20155342|P4|STARTED|Overall Study||53
8174421|NCT02415595|20155343|P3|STARTED|Overall Study||51
8174422|NCT02415595|20155344|P2|STARTED|Overall Study||52
8174423|NCT02415595|20155345|P1|STARTED|Overall Study||50
8174424|NCT02415439|20155417|P13|NOT COMPLETED|Overall Study||0
8174425|NCT02415439|20155418|P12|NOT COMPLETED|Overall Study||0
8174426|NCT02415439|20155419|P11|NOT COMPLETED|Overall Study||0
8174427|NCT02415439|20155420|P10|NOT COMPLETED|Overall Study||0
8174428|NCT02415439|20155421|P9|NOT COMPLETED|Overall Study||1
8174429|NCT02415439|20155422|P8|NOT COMPLETED|Overall Study||0
8174430|NCT02415439|20155423|P7|NOT COMPLETED|Overall Study||0
8174431|NCT02415439|20155424|P6|NOT COMPLETED|Overall Study||0
8174432|NCT02415439|20155425|P5|NOT COMPLETED|Overall Study||0
8174433|NCT02415439|20155426|P4|NOT COMPLETED|Overall Study||0
8174434|NCT02415439|20155427|P3|NOT COMPLETED|Overall Study||0
8174435|NCT02415439|20155428|P2|NOT COMPLETED|Overall Study||0
8174436|NCT02415439|20155429|P1|NOT COMPLETED|Overall Study||0
8174437|NCT02415439|20155417|P13|COMPLETED|Overall Study||8
8174438|NCT02415439|20155418|P12|COMPLETED|Overall Study||6
8174439|NCT02415439|20155419|P11|COMPLETED|Overall Study||6
8174440|NCT02415439|20155420|P10|COMPLETED|Overall Study||6
8174441|NCT02415439|20155421|P9|COMPLETED|Overall Study||5
8174442|NCT02415439|20155422|P8|COMPLETED|Overall Study||12
8174443|NCT02415439|20155423|P7|COMPLETED|Overall Study||6
8174444|NCT02415439|20155424|P6|COMPLETED|Overall Study||6
8174445|NCT02415439|20155425|P5|COMPLETED|Overall Study||6
8174446|NCT02415439|20155426|P4|COMPLETED|Overall Study||6
8174447|NCT02415439|20155427|P3|COMPLETED|Overall Study||6
8174448|NCT02415439|20155428|P2|COMPLETED|Overall Study||6
8174449|NCT02415439|20155429|P1|COMPLETED|Overall Study||6
8174450|NCT02415439|20155417|P13|STARTED|Overall Study||8
8174451|NCT02415439|20155418|P12|STARTED|Overall Study||6
8174452|NCT02415439|20155419|P11|STARTED|Overall Study||6
8174453|NCT02415439|20155420|P10|STARTED|Overall Study||6
8174454|NCT02415439|20155421|P9|STARTED|Overall Study||6
8174455|NCT02415439|20155422|P8|STARTED|Overall Study||12
8174456|NCT02415439|20155423|P7|STARTED|Overall Study||6
8174457|NCT02415439|20155424|P6|STARTED|Overall Study||6
8174458|NCT02415439|20155425|P5|STARTED|Overall Study||6
8174459|NCT02415439|20155426|P4|STARTED|Overall Study||6
8174460|NCT02415439|20155427|P3|STARTED|Overall Study||6
8174461|NCT02415439|20155428|P2|STARTED|Overall Study||6
8174462|NCT02415439|20155429|P1|STARTED|Overall Study||6
8174463|NCT02415400|20155487|P4|NOT COMPLETED|Overall Study||83
8174464|NCT02415400|20155488|P3|NOT COMPLETED|Overall Study||85
8174465|NCT02415400|20155489|P2|NOT COMPLETED|Overall Study||62
8174466|NCT02415400|20155490|P1|NOT COMPLETED|Overall Study||66
8174467|NCT02415400|20155487|P4|COMPLETED|Overall Study||1071
8174468|NCT02415400|20155488|P3|COMPLETED|Overall Study||1069
8174469|NCT02415400|20155489|P2|COMPLETED|Overall Study||1091
8174470|NCT02415400|20155490|P1|COMPLETED|Overall Study||1087
8174471|NCT02415400|20155487|P4|STARTED|Overall Study||1154
8174472|NCT02415400|20155488|P3|STARTED|Overall Study||1154
8174473|NCT02415400|20155489|P2|STARTED|Overall Study||1153
8174474|NCT02415400|20155490|P1|STARTED|Overall Study||1153
8174475|NCT02415244|20155516|P2|NOT COMPLETED|Overall Study||0
8174476|NCT02415244|20155517|P1|NOT COMPLETED|Overall Study||0
8174477|NCT02415244|20155516|P2|COMPLETED|Overall Study||25
8174478|NCT02415244|20155517|P1|COMPLETED|Overall Study||50
8174479|NCT02415244|20155516|P2|STARTED|Overall Study||25
8174480|NCT02415244|20155517|P1|STARTED|Overall Study||50
8174481|NCT02415166|20155527|P4|NOT COMPLETED|Overall Study||0
8174482|NCT02415166|20155528|P3|NOT COMPLETED|Overall Study||0
8174483|NCT02415166|20155529|P2|NOT COMPLETED|Overall Study||0
8174484|NCT02415166|20155530|P1|NOT COMPLETED|Overall Study||0
8174485|NCT02415166|20155527|P4|COMPLETED|Overall Study||0
8174486|NCT02415166|20155528|P3|COMPLETED|Overall Study||0
8174487|NCT02415166|20155529|P2|COMPLETED|Overall Study||0
8174488|NCT02415166|20155530|P1|COMPLETED|Overall Study||6
8174489|NCT02415166|20155527|P4|STARTED|Overall Study||0
8174490|NCT02415166|20155528|P3|STARTED|Overall Study||0
8174491|NCT02415166|20155529|P2|STARTED|Overall Study||0
8174492|NCT02415166|20155530|P1|STARTED|Overall Study||6
8174493|NCT02415127|20155558|P2|NOT COMPLETED|Overall Study||0
8174494|NCT02415127|20155559|P1|NOT COMPLETED|Overall Study||1
8174495|NCT02415127|20155558|P2|COMPLETED|Overall Study||45
8174496|NCT02415127|20155559|P1|COMPLETED|Overall Study||46
8174497|NCT02415127|20155558|P2|STARTED|Overall Study||45
8174498|NCT02415127|20155559|P1|STARTED|Overall Study||47
8174499|NCT02414958|20155576|P3|NOT COMPLETED|Overall Study||14
8174500|NCT02414958|20155577|P2|NOT COMPLETED|Overall Study||20
8174501|NCT02414958|20155578|P1|NOT COMPLETED|Overall Study||32
8174502|NCT02414958|20155576|P3|COMPLETED|Overall Study||230
8174503|NCT02414958|20155577|P2|COMPLETED|Overall Study||223
8174504|NCT02414958|20155578|P1|COMPLETED|Overall Study||211
8174505|NCT02414958|20155576|P3|STARTED|Overall Study||244
8174506|NCT02414958|20155577|P2|STARTED|Overall Study||243
8174507|NCT02414958|20155578|P1|STARTED|Overall Study||243
8174508|NCT02414854|20155611|P4|NOT COMPLETED|Overall Study||51
8174509|NCT02414854|20155612|P3|NOT COMPLETED|Overall Study||20
8174510|NCT02414854|20155613|P2|NOT COMPLETED|Overall Study||45
8174511|NCT02414854|20155614|P1|NOT COMPLETED|Overall Study||22
8174512|NCT02414854|20155611|P4|COMPLETED|Overall Study||582
8174513|NCT02414854|20155612|P3|COMPLETED|Overall Study||301
8174514|NCT02414854|20155613|P2|COMPLETED|Overall Study||586
8174515|NCT02414854|20155614|P1|COMPLETED|Overall Study||295
8174516|NCT02414854|20155611|P4|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
8174517|NCT02414854|20155612|P3|Treated|Overall Study||321
8174518|NCT02414854|20155613|P2|Treated|Overall Study||629
8174519|NCT02414854|20155614|P1|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
8174520|NCT02414854|20155611|P4|STARTED|Overall Study||633
8174521|NCT02414854|20155612|P3|STARTED|Overall Study||321
8174522|NCT02414854|20155613|P2|STARTED|Overall Study||631
8174523|NCT02414854|20155614|P1|STARTED|Overall Study||317
8174524|NCT02414841|20155778|P2|NOT COMPLETED|Overall Study||33
8174525|NCT02414841|20155779|P1|NOT COMPLETED|Overall Study||56
8174526|NCT02414841|20155778|P2|COMPLETED|Overall Study||175
8174527|NCT02414841|20155779|P1|COMPLETED|Overall Study||349
8174528|NCT02414841|20155778|P2|STARTED|Overall Study||208
8174529|NCT02414841|20155779|P1|STARTED|Overall Study||405
8174530|NCT02414828|20155791|P4|NOT COMPLETED|Overall Study||2
8174531|NCT02414828|20155792|P3|NOT COMPLETED|Overall Study||1
8174532|NCT02414828|20155793|P2|NOT COMPLETED|Overall Study||1
8174533|NCT02414828|20155794|P1|NOT COMPLETED|Overall Study||0
8174534|NCT02414828|20155791|P4|COMPLETED|Overall Study||29
8174535|NCT02414828|20155792|P3|COMPLETED|Overall Study||19
8174536|NCT02414828|20155793|P2|COMPLETED|Overall Study||9
8174537|NCT02414828|20155794|P1|COMPLETED|Overall Study||11
8174538|NCT02414828|20155791|P4|STARTED|Overall Study||31
8174539|NCT02414828|20155792|P3|STARTED|Overall Study||20
8174540|NCT02414828|20155793|P2|STARTED|Overall Study||10
8174541|NCT02414828|20155794|P1|STARTED|Overall Study||11
8174542|NCT02414698|20155834|P2|NOT COMPLETED|Overall Study||0
8174543|NCT02414698|20155835|P1|NOT COMPLETED|Overall Study||0
8174544|NCT02414698|20155834|P2|COMPLETED|Overall Study||1
8174545|NCT02414698|20155835|P1|COMPLETED|Overall Study||3
8174546|NCT02414698|20155834|P2|STARTED|Overall Study||1
8174547|NCT02414698|20155835|P1|STARTED|Overall Study||3
8174548|NCT02414633|20155845|P1|NOT COMPLETED|Overall Study||0
8174549|NCT02414633|20155845|P1|COMPLETED|Overall Study||148
8174550|NCT02414633|20155845|P1|STARTED|Overall Study||148
8174551|NCT02414243|20155868|P2|NOT COMPLETED|Overall Study||4
8174552|NCT02414243|20155869|P1|NOT COMPLETED|Overall Study||6
8174553|NCT02414243|20155868|P2|COMPLETED|Overall Study||17
8174554|NCT02414243|20155869|P1|COMPLETED|Overall Study||13
8174555|NCT02414243|20155868|P2|Entered Open Challenge at Home|Overall Study||20
8174556|NCT02414243|20155869|P1|Entered Open Challenge at Home|Overall Study||17
8174557|NCT02414243|20155868|P2|Moved to the Other Group|Overall Study||20
8174558|NCT02414243|20155869|P1|Moved to the Other Group|Overall Study||17
8174559|NCT02414243|20155868|P2|STARTED|Overall Study||21
8174560|NCT02414243|20155869|P1|STARTED|Overall Study||19
8174561|NCT02414204|20155878|P2|NOT COMPLETED|Overall Study||0
8174562|NCT02414204|20155879|P1|NOT COMPLETED|Overall Study||0
8174563|NCT02414204|20155878|P2|COMPLETED|Overall Study||2
8174564|NCT02414204|20155879|P1|COMPLETED|Overall Study||2
8174565|NCT02414204|20155878|P2|STARTED|Overall Study||2
8174566|NCT02414204|20155879|P1|STARTED|Overall Study||2
8174567|NCT02414152|20155887|P1|NOT COMPLETED|Overall Study||2
8174568|NCT02414152|20155887|P1|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
8174569|NCT02414152|20155887|P1|STARTED|Overall Study||2
8174570|NCT02413996|20155893|P2|NOT COMPLETED|Overall Study||2
8174571|NCT02413996|20155894|P1|NOT COMPLETED|Overall Study||9
8174572|NCT02413996|20155893|P2|COMPLETED|Overall Study||39
8174573|NCT02413996|20155894|P1|COMPLETED|Overall Study||35
8174574|NCT02413996|20155893|P2|STARTED|Overall Study||41
8174575|NCT02413996|20155894|P1|STARTED|Overall Study||44
8174576|NCT02413918|20155916|P1|NOT COMPLETED|Overall Study||25
8174577|NCT02413918|20155916|P1|COMPLETED|Overall Study||16
8174578|NCT02413918|20155916|P1|STARTED|Overall Study||41
8174579|NCT02413879|20155923|P1|NOT COMPLETED|Overall Study||0
8174580|NCT02413879|20155923|P1|COMPLETED|Overall Study||86
8174581|NCT02413879|20155923|P1|STARTED|Overall Study||86
8174582|NCT02413684|20155929|P1|NOT COMPLETED|Overall Study||13
8174583|NCT02413684|20155929|P1|COMPLETED|Overall Study||40
8174584|NCT02413684|20155929|P1|STARTED|Overall Study||53
8174585|NCT02413593|20155939|P1|NOT COMPLETED|Overall Study||4
8174586|NCT02413593|20155939|P1|COMPLETED|Overall Study||107
8174587|NCT02413593|20155939|P1|STARTED|Overall Study||111
8174588|NCT02413580|20155948|P1|NOT COMPLETED|Overall Study||3
8174589|NCT02413580|20155948|P1|COMPLETED|Overall Study||46
8174590|NCT02413580|20155948|P1|STARTED|Overall Study||49
8174591|NCT02413489|20155958|P3|NOT COMPLETED|Overall Study||5
8174592|NCT02413489|20155959|P2|NOT COMPLETED|Overall Study||16
8174593|NCT02413489|20155960|P1|NOT COMPLETED|Overall Study||15
8174594|NCT02413489|20155958|P3|COMPLETED|Overall Study||0
8174595|NCT02413489|20155959|P2|COMPLETED|Overall Study||0
8174596|NCT02413489|20155960|P1|COMPLETED|Overall Study||0
8174597|NCT02413489|20155958|P3|STARTED|Overall Study||5
8174598|NCT02413489|20155959|P2|STARTED|Overall Study||16
8174599|NCT02413489|20155960|P1|STARTED|Overall Study||15
8174600|NCT02413463|20155982|P2|NOT COMPLETED|Overall Study||2
8174601|NCT02413463|20155983|P1|NOT COMPLETED|Overall Study||5
8174602|NCT02413463|20155982|P2|COMPLETED|Overall Study||28
8174603|NCT02413463|20155983|P1|COMPLETED|Overall Study||25
8174604|NCT02413463|20155982|P2|STARTED|Overall Study||30
8174605|NCT02413463|20155983|P1|STARTED|Overall Study||30
8174606|NCT02413398|20156001|P2|NOT COMPLETED|Overall Study||7
8174607|NCT02413398|20156002|P1|NOT COMPLETED|Overall Study||4
8174608|NCT02413398|20156001|P2|COMPLETED|Overall Study||154
8174609|NCT02413398|20156002|P1|COMPLETED|Overall Study||156
8174610|NCT02413398|20156001|P2|STARTED|Overall Study||161
8174611|NCT02413398|20156002|P1|STARTED|Overall Study||160
8174630|NCT02413346|20156068|P2|NOT COMPLETED|Overall Study||70
8174631|NCT02413346|20156069|P1|NOT COMPLETED|Overall Study||59
8174632|NCT02413346|20156068|P2|COMPLETED|Overall Study||177
8174633|NCT02413346|20156069|P1|COMPLETED|Overall Study||177
8174634|NCT02413346|20156068|P2|STARTED|Overall Study||247
8174635|NCT02413346|20156069|P1|STARTED|Overall Study||236
8174636|NCT02413333|20156079|P2|NOT COMPLETED|Period 2||0
8174637|NCT02413333|20156080|P1|NOT COMPLETED|Period 2||1
8174638|NCT02413333|20156079|P2|COMPLETED|Period 2||65
8174639|NCT02413333|20156080|P1|COMPLETED|Period 2||64
8174640|NCT02413333|20156079|P2|STARTED|Period 2||65
8174641|NCT02413333|20156080|P1|STARTED|Period 2||65
8174642|NCT02413333|20156079|P2|NOT COMPLETED|Period 1||1
8174643|NCT02413333|20156080|P1|NOT COMPLETED|Period 1||1
8174644|NCT02413333|20156079|P2|COMPLETED|Period 1||65
8174645|NCT02413333|20156080|P1|COMPLETED|Period 1||65
8174646|NCT02413333|20156079|P2|Randomized and Treated|Period 1||66
8174647|NCT02413333|20156080|P1|Randomized and Treated|Period 1||66
8174648|NCT02413333|20156079|P2|STARTED|Period 1||66
8174649|NCT02413333|20156080|P1|STARTED|Period 1||66
8174650|NCT02413294|20156088|P1|NOT COMPLETED|Overall Study||1
8174651|NCT02413294|20156088|P1|COMPLETED|Overall Study||11
8174652|NCT02413294|20156088|P1|STARTED|Overall Study||12
8174653|NCT02413255|20156123|P17|NOT COMPLETED|Overall Study||0
8174654|NCT02413255|20156124|P16|NOT COMPLETED|Overall Study||0
8174655|NCT02413255|20156125|P15|NOT COMPLETED|Overall Study||1
8174656|NCT02413255|20156126|P14|NOT COMPLETED|Overall Study||0
8174657|NCT02413255|20156127|P13|NOT COMPLETED|Overall Study||0
8174658|NCT02413255|20156128|P12|NOT COMPLETED|Overall Study||0
8174659|NCT02413255|20156129|P11|NOT COMPLETED|Overall Study||0
8174660|NCT02413255|20156130|P10|NOT COMPLETED|Overall Study||0
8174661|NCT02413255|20156131|P9|NOT COMPLETED|Overall Study||0
8174662|NCT02413255|20156132|P8|NOT COMPLETED|Overall Study||0
8174663|NCT02413255|20156133|P7|NOT COMPLETED|Overall Study||0
8174664|NCT02413255|20156134|P6|NOT COMPLETED|Overall Study||0
8174665|NCT02413255|20156135|P5|NOT COMPLETED|Overall Study||0
8174666|NCT02413255|20156136|P4|NOT COMPLETED|Overall Study||0
8174667|NCT02413255|20156137|P3|NOT COMPLETED|Overall Study||0
8174668|NCT02413255|20156138|P2|NOT COMPLETED|Overall Study||0
8174669|NCT02413255|20156139|P1|NOT COMPLETED|Overall Study||0
8174670|NCT02413255|20156123|P17|COMPLETED|Overall Study||6
8174671|NCT02413255|20156124|P16|COMPLETED|Overall Study||6
8174672|NCT02413255|20156125|P15|COMPLETED|Overall Study||5
8174673|NCT02413255|20156126|P14|COMPLETED|Overall Study||6
8174674|NCT02413255|20156127|P13|COMPLETED|Overall Study||6
8174675|NCT02413255|20156128|P12|COMPLETED|Overall Study||6
8174676|NCT02413255|20156129|P11|COMPLETED|Overall Study||12
8174677|NCT02413255|20156130|P10|COMPLETED|Overall Study||6
8174678|NCT02413255|20156131|P9|COMPLETED|Overall Study||6
8174679|NCT02413255|20156132|P8|COMPLETED|Overall Study||6
8174680|NCT02413255|20156133|P7|COMPLETED|Overall Study||6
8174681|NCT02413255|20156134|P6|COMPLETED|Overall Study||6
8174682|NCT02413255|20156135|P5|COMPLETED|Overall Study||6
8174683|NCT02413255|20156136|P4|COMPLETED|Overall Study||6
8174684|NCT02413255|20156137|P3|COMPLETED|Overall Study||6
8174685|NCT02413255|20156138|P2|COMPLETED|Overall Study||6
8174686|NCT02413255|20156139|P1|COMPLETED|Overall Study||18
8174687|NCT02413255|20156123|P17|STARTED|Overall Study||6
8174688|NCT02413255|20156124|P16|STARTED|Overall Study||6
8174689|NCT02413255|20156125|P15|STARTED|Overall Study||6
8174690|NCT02413255|20156126|P14|STARTED|Overall Study||6
8174691|NCT02413255|20156127|P13|STARTED|Overall Study||6
8174692|NCT02413255|20156128|P12|STARTED|Overall Study||6
8174693|NCT02413255|20156129|P11|STARTED|Overall Study||12
8174694|NCT02413255|20156130|P10|STARTED|Overall Study||6
8174695|NCT02413255|20156131|P9|STARTED|Overall Study||6
8174696|NCT02413255|20156132|P8|STARTED|Overall Study||6
8174697|NCT02413255|20156133|P7|STARTED|Overall Study||6
8174698|NCT02413255|20156134|P6|STARTED|Overall Study||6
8174699|NCT02413255|20156135|P5|STARTED|Overall Study||6
8174700|NCT02413255|20156136|P4|STARTED|Overall Study||6
8174701|NCT02413255|20156137|P3|STARTED|Overall Study||6
8174702|NCT02413255|20156138|P2|STARTED|Overall Study||6
8174703|NCT02413255|20156139|P1|STARTED|Overall Study||18
8174704|NCT02413229|20156495|P8|NOT COMPLETED|Overall Study||4
8174705|NCT02413229|20156496|P7|NOT COMPLETED|Overall Study||0
8174706|NCT02413229|20156497|P6|NOT COMPLETED|Overall Study||0
8174707|NCT02413229|20156498|P5|NOT COMPLETED|Overall Study||3
8174708|NCT02413229|20156499|P4|NOT COMPLETED|Overall Study||1
8174709|NCT02413229|20156500|P3|NOT COMPLETED|Overall Study||1
8174710|NCT02413229|20156501|P2|NOT COMPLETED|Overall Study||1
8174711|NCT02413229|20156502|P1|NOT COMPLETED|Overall Study||1
8174712|NCT02413229|20156495|P8|COMPLETED|Overall Study||11
8174713|NCT02413229|20156496|P7|COMPLETED|Overall Study||25
8174714|NCT02413229|20156497|P6|COMPLETED|Overall Study||12
8174715|NCT02413229|20156498|P5|COMPLETED|Overall Study||21
8174716|NCT02413229|20156499|P4|COMPLETED|Overall Study||11
8174717|NCT02413229|20156500|P3|COMPLETED|Overall Study||25
8174718|NCT02413229|20156501|P2|COMPLETED|Overall Study||11
8174719|NCT02413229|20156502|P1|COMPLETED|Overall Study||24
8174720|NCT02413229|20156495|P8|STARTED|Overall Study||15
8174721|NCT02413229|20156496|P7|STARTED|Overall Study||25
8174722|NCT02413229|20156497|P6|STARTED|Overall Study||12
8174723|NCT02413229|20156498|P5|STARTED|Overall Study||24
8174724|NCT02413229|20156499|P4|STARTED|Overall Study||12
8174725|NCT02413229|20156500|P3|STARTED|Overall Study||26
8174726|NCT02413229|20156501|P2|STARTED|Overall Study||12
8174727|NCT02413229|20156502|P1|STARTED|Overall Study||25
8174728|NCT02413203|20156522|P2|NOT COMPLETED|Overall Study||0
8174729|NCT02413203|20156523|P1|NOT COMPLETED|Overall Study||0
8174730|NCT02413203|20156522|P2|COMPLETED|Overall Study||10
8174731|NCT02413203|20156523|P1|COMPLETED|Overall Study||10
8174732|NCT02413203|20156522|P2|STARTED|Overall Study||10
8174733|NCT02413203|20156523|P1|STARTED|Overall Study||10
8174734|NCT02413190|20156543|P1|NOT COMPLETED|Overall Study||0
8174735|NCT02413190|20156543|P1|COMPLETED|Overall Study||94
8174736|NCT02413190|20156543|P1|STARTED|Overall Study||94
8174737|NCT02413151|20156549|P2|NOT COMPLETED|Overall Study||2
8174738|NCT02413151|20156550|P1|NOT COMPLETED|Overall Study||10
8174739|NCT02413151|20156549|P2|COMPLETED|Overall Study||28
8174740|NCT02413151|20156550|P1|COMPLETED|Overall Study||22
8174741|NCT02413151|20156549|P2|STARTED|Overall Study||30
8174742|NCT02413151|20156550|P1|STARTED|Overall Study||32
8174743|NCT02413047|20156578|P1|NOT COMPLETED|Overall Study||0
8174744|NCT02413047|20156578|P1|COMPLETED|Overall Study||3
8174745|NCT02413047|20156578|P1|Participants on Adalimumab|Overall Study||1
8174746|NCT02413047|20156578|P1|Participants on Infliximab|Overall Study||2
8174747|NCT02413047|20156578|P1|STARTED|Overall Study||3
8174748|NCT02413034|20156591|P2|NOT COMPLETED|Overall Study||0
8174749|NCT02413034|20156592|P1|NOT COMPLETED|Overall Study||0
8174750|NCT02413034|20156591|P2|COMPLETED|Overall Study||14
8174751|NCT02413034|20156592|P1|COMPLETED|Overall Study||14
8174752|NCT02413034|20156591|P2|STARTED|Overall Study||14
8174753|NCT02413034|20156592|P1|STARTED|Overall Study||14
8174754|NCT02413008|20156602|P2|NOT COMPLETED|Overall Study||2
8174755|NCT02413008|20156603|P1|NOT COMPLETED|Overall Study||7
8174756|NCT02413008|20156602|P2|COMPLETED|Overall Study||9
8174757|NCT02413008|20156603|P1|COMPLETED|Overall Study||43
8174758|NCT02413008|20156602|P2|STARTED|Overall Study||11
8174759|NCT02413008|20156603|P1|STARTED|Overall Study||50
8174760|NCT02412878|20156641|P2|NOT COMPLETED|Overall Study||13
8174761|NCT02412878|20156642|P1|NOT COMPLETED|Overall Study||21
8174762|NCT02412878|20156641|P2|COMPLETED|Overall Study||227
8174763|NCT02412878|20156642|P1|COMPLETED|Overall Study||217
8174764|NCT02412878|20156641|P2|Received Carfilzomib|Overall Study||238
8174765|NCT02412878|20156642|P1|Received Carfilzomib|Overall Study||235
8174766|NCT02412878|20156641|P2|STARTED|Overall Study||240
8174767|NCT02412878|20156642|P1|STARTED|Overall Study||238
8174768|NCT02412852|20156660|P4|NOT COMPLETED|Overall Study||1
8174769|NCT02412852|20156661|P3|NOT COMPLETED|Overall Study||0
8174770|NCT02412852|20156662|P2|NOT COMPLETED|Overall Study||1
8174771|NCT02412852|20156663|P1|NOT COMPLETED|Overall Study||0
8174772|NCT02412852|20156660|P4|COMPLETED|Overall Study||8
8174773|NCT02412852|20156661|P3|COMPLETED|Overall Study||5
8174774|NCT02412852|20156662|P2|COMPLETED|Overall Study||7
8174775|NCT02412852|20156663|P1|COMPLETED|Overall Study||4
8174776|NCT02412852|20156660|P4|STARTED|Overall Study||9
8174777|NCT02412852|20156661|P3|STARTED|Overall Study||5
8174778|NCT02412852|20156662|P2|STARTED|Overall Study||8
8174779|NCT02412852|20156663|P1|STARTED|Overall Study||4
8174780|NCT02412761|20156689|P6|NOT COMPLETED|Third Intervention (2 Weeks)||0
8174781|NCT02412761|20156690|P5|NOT COMPLETED|Third Intervention (2 Weeks)||0
8174782|NCT02412761|20156691|P4|NOT COMPLETED|Third Intervention (2 Weeks)||0
8174783|NCT02412761|20156692|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
8174784|NCT02412761|20156693|P2|NOT COMPLETED|Third Intervention (2 Weeks)||0
8174785|NCT02412761|20156694|P1|NOT COMPLETED|Third Intervention (2 Weeks)||0
8174786|NCT02412761|20156689|P6|COMPLETED|Third Intervention (2 Weeks)||6
8174787|NCT02412761|20156690|P5|COMPLETED|Third Intervention (2 Weeks)||4
8174788|NCT02412761|20156691|P4|COMPLETED|Third Intervention (2 Weeks)||8
8174789|NCT02412761|20156692|P3|COMPLETED|Third Intervention (2 Weeks)||4
8174790|NCT02412761|20156693|P2|COMPLETED|Third Intervention (2 Weeks)||5
8174791|NCT02412761|20156694|P1|COMPLETED|Third Intervention (2 Weeks)||5
8174792|NCT02412761|20156689|P6|STARTED|Third Intervention (2 Weeks)||6
8174793|NCT02412761|20156690|P5|STARTED|Third Intervention (2 Weeks)||4
8174794|NCT02412761|20156691|P4|STARTED|Third Intervention (2 Weeks)||8
8174795|NCT02412761|20156692|P3|STARTED|Third Intervention (2 Weeks)||4
8174796|NCT02412761|20156693|P2|STARTED|Third Intervention (2 Weeks)||5
8174797|NCT02412761|20156694|P1|STARTED|Third Intervention (2 Weeks)||5
8174798|NCT02412761|20156689|P6|NOT COMPLETED|Second Intervention (2 Weeks)||0
8174799|NCT02412761|20156690|P5|NOT COMPLETED|Second Intervention (2 Weeks)||0
8174800|NCT02412761|20156691|P4|NOT COMPLETED|Second Intervention (2 Weeks)||0
8174801|NCT02412761|20156692|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
8174802|NCT02412761|20156693|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8174803|NCT02412761|20156694|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8174804|NCT02412761|20156689|P6|COMPLETED|Second Intervention (2 Weeks)||6
8174805|NCT02412761|20156690|P5|COMPLETED|Second Intervention (2 Weeks)||4
8174806|NCT02412761|20156691|P4|COMPLETED|Second Intervention (2 Weeks)||8
8174807|NCT02412761|20156692|P3|COMPLETED|Second Intervention (2 Weeks)||4
8174808|NCT02412761|20156693|P2|COMPLETED|Second Intervention (2 Weeks)||5
8174809|NCT02412761|20156694|P1|COMPLETED|Second Intervention (2 Weeks)||5
8174810|NCT02412761|20156689|P6|STARTED|Second Intervention (2 Weeks)||6
8174811|NCT02412761|20156690|P5|STARTED|Second Intervention (2 Weeks)||4
8174812|NCT02412761|20156691|P4|STARTED|Second Intervention (2 Weeks)||8
8174813|NCT02412761|20156692|P3|STARTED|Second Intervention (2 Weeks)||4
8174814|NCT02412761|20156693|P2|STARTED|Second Intervention (2 Weeks)||5
8174815|NCT02412761|20156694|P1|STARTED|Second Intervention (2 Weeks)||5
8174816|NCT02412761|20156689|P6|NOT COMPLETED|First Intervention (2 Weeks)||1
8174817|NCT02412761|20156690|P5|NOT COMPLETED|First Intervention (2 Weeks)||0
8174818|NCT02412761|20156691|P4|NOT COMPLETED|First Intervention (2 Weeks)||0
8174819|NCT02412761|20156692|P3|NOT COMPLETED|First Intervention (2 Weeks)||1
8174820|NCT02412761|20156693|P2|NOT COMPLETED|First Intervention (2 Weeks)||1
8174821|NCT02412761|20156694|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8174822|NCT02412761|20156689|P6|COMPLETED|First Intervention (2 Weeks)||6
8174823|NCT02412761|20156690|P5|COMPLETED|First Intervention (2 Weeks)||4
8174824|NCT02412761|20156691|P4|COMPLETED|First Intervention (2 Weeks)||8
8174825|NCT02412761|20156692|P3|COMPLETED|First Intervention (2 Weeks)||4
8174826|NCT02412761|20156693|P2|COMPLETED|First Intervention (2 Weeks)||5
8174827|NCT02412761|20156694|P1|COMPLETED|First Intervention (2 Weeks)||5
8174828|NCT02412761|20156689|P6|STARTED|First Intervention (2 Weeks)||7
8174829|NCT02412761|20156690|P5|STARTED|First Intervention (2 Weeks)||4
8174830|NCT02412761|20156691|P4|STARTED|First Intervention (2 Weeks)||8
8174831|NCT02412761|20156692|P3|STARTED|First Intervention (2 Weeks)||5
8174832|NCT02412761|20156693|P2|STARTED|First Intervention (2 Weeks)||6
8174833|NCT02412761|20156694|P1|STARTED|First Intervention (2 Weeks)||5
8174834|NCT02412722|20156708|P6|NOT COMPLETED|Overall Study||13
8174835|NCT02412722|20156709|P5|NOT COMPLETED|Overall Study||7
8174836|NCT02412722|20156710|P4|NOT COMPLETED|Overall Study||15
8174837|NCT02412722|20156711|P3|NOT COMPLETED|Overall Study||7
8174838|NCT02412722|20156712|P2|NOT COMPLETED|Overall Study||8
8174839|NCT02412722|20156713|P1|NOT COMPLETED|Overall Study||11
8174840|NCT02412722|20156708|P6|COMPLETED|Overall Study||0
8174841|NCT02412722|20156709|P5|COMPLETED|Overall Study||0
8174842|NCT02412722|20156710|P4|COMPLETED|Overall Study||0
8174843|NCT02412722|20156711|P3|COMPLETED|Overall Study||0
8174844|NCT02412722|20156712|P2|COMPLETED|Overall Study||0
8174845|NCT02412722|20156713|P1|COMPLETED|Overall Study||0
8174846|NCT02412722|20156708|P6|Safety Population|Overall Study||13
8174847|NCT02412722|20156709|P5|Safety Population|Overall Study||7
8174848|NCT02412722|20156710|P4|Safety Population|Overall Study||15
8174849|NCT02412722|20156711|P3|Safety Population|Overall Study||7
8174850|NCT02412722|20156712|P2|Safety Population|Overall Study||6
8174851|NCT02412722|20156713|P1|Safety Population|Overall Study||11
8174852|NCT02412722|20156708|P6|STARTED|Overall Study||13
8174853|NCT02412722|20156709|P5|STARTED|Overall Study||7
8174854|NCT02412722|20156710|P4|STARTED|Overall Study||15
8174855|NCT02412722|20156711|P3|STARTED|Overall Study||7
8174856|NCT02412722|20156712|P2|STARTED|Overall Study||8
8174857|NCT02412722|20156713|P1|STARTED|Overall Study||11
8174858|NCT02412670|20156783|P2|NOT COMPLETED|Overall Study||1
8174859|NCT02412670|20156784|P1|NOT COMPLETED|Overall Study||7
8174860|NCT02412670|20156783|P2|COMPLETED|Overall Study||5
8174861|NCT02412670|20156784|P1|COMPLETED|Overall Study||23
8174862|NCT02412670|20156783|P2|Eligible and Treated|Overall Study||6
8174863|NCT02412670|20156784|P1|Eligible and Treated|Overall Study||29
8174864|NCT02412670|20156783|P2|STARTED|Overall Study||6
8174865|NCT02412670|20156784|P1|STARTED|Overall Study||30
8174866|NCT02412657|20156805|P3|NOT COMPLETED|Overall Study||3
8174867|NCT02412657|20156806|P2|NOT COMPLETED|Overall Study||2
8174868|NCT02412657|20156807|P1|NOT COMPLETED|Overall Study||1
8174869|NCT02412657|20156805|P3|COMPLETED|Overall Study||22
8174870|NCT02412657|20156806|P2|COMPLETED|Overall Study||23
8174871|NCT02412657|20156807|P1|COMPLETED|Overall Study||24
8174872|NCT02412657|20156805|P3|STARTED|Overall Study||25
8174873|NCT02412657|20156806|P2|STARTED|Overall Study||25
8174874|NCT02412657|20156807|P1|STARTED|Overall Study||25
8174875|NCT02412644|20156817|P2|NOT COMPLETED|Overall Study||4
8174876|NCT02412644|20156818|P1|NOT COMPLETED|Overall Study||15
8174877|NCT02412644|20156817|P2|COMPLETED|Overall Study||4
8174878|NCT02412644|20156818|P1|COMPLETED|Overall Study||6
8174879|NCT02412644|20156817|P2|STARTED|Overall Study||8
8174880|NCT02412644|20156818|P1|STARTED|Overall Study||21
8174881|NCT02412501|20156830|P1|NOT COMPLETED|Overall Study||0
8174882|NCT02412501|20156830|P1|COMPLETED|Overall Study||101
8174883|NCT02412501|20156830|P1|STARTED|Overall Study||101
8174884|NCT02412488|20156851|P1|NOT COMPLETED|Overall Study||18
8174885|NCT02412488|20156851|P1|COMPLETED|Overall Study||174
8174886|NCT02412488|20156851|P1|Reveal LINQ Implanted|Overall Study||191
8174887|NCT02412488|20156851|P1|STARTED|Overall Study||192
8174888|NCT02412436|20156855|P1|NOT COMPLETED|Overall Study||18
8174889|NCT02412436|20156855|P1|COMPLETED|Overall Study||44
8174890|NCT02412436|20156855|P1|STARTED|Overall Study||62
8174891|NCT02412371|20156875|P6|NOT COMPLETED|Overall Study||5
8174892|NCT02412371|20156876|P5|NOT COMPLETED|Overall Study||12
8174893|NCT02412371|20156877|P4|NOT COMPLETED|Overall Study||8
8174894|NCT02412371|20156878|P3|NOT COMPLETED|Overall Study||7
8174895|NCT02412371|20156879|P2|NOT COMPLETED|Overall Study||9
8174896|NCT02412371|20156880|P1|NOT COMPLETED|Overall Study||7
8174897|NCT02412371|20156875|P6|COMPLETED|Overall Study||0
8174898|NCT02412371|20156876|P5|COMPLETED|Overall Study||0
8174899|NCT02412371|20156877|P4|COMPLETED|Overall Study||0
8174900|NCT02412371|20156878|P3|COMPLETED|Overall Study||0
8174901|NCT02412371|20156879|P2|COMPLETED|Overall Study||0
8174902|NCT02412371|20156880|P1|COMPLETED|Overall Study||0
8174903|NCT02412371|20156875|P6|STARTED|Overall Study||5
8174904|NCT02412371|20156876|P5|STARTED|Overall Study||12
8174905|NCT02412371|20156877|P4|STARTED|Overall Study||8
8174906|NCT02412371|20156878|P3|STARTED|Overall Study||7
8174907|NCT02412371|20156879|P2|STARTED|Overall Study||9
8174908|NCT02412371|20156880|P1|STARTED|Overall Study||7
8174909|NCT02412306|20156908|P5|NOT COMPLETED|Overall Study||2
8174910|NCT02412306|20156909|P4|NOT COMPLETED|Overall Study||0
8174911|NCT02412306|20156910|P3|NOT COMPLETED|Overall Study||16
8174912|NCT02412306|20156911|P2|NOT COMPLETED|Overall Study||8
8174913|NCT02412306|20156912|P1|NOT COMPLETED|Overall Study||5
8174914|NCT02412306|20156908|P5|COMPLETED|Overall Study||15
8174915|NCT02412306|20156909|P4|COMPLETED|Overall Study||14
8174916|NCT02412306|20156910|P3|COMPLETED|Overall Study||5
8174917|NCT02412306|20156911|P2|COMPLETED|Overall Study||1
8174918|NCT02412306|20156912|P1|COMPLETED|Overall Study||0
8174919|NCT02412306|20156908|P5|STARTED|Overall Study||17
8174920|NCT02412306|20156909|P4|STARTED|Overall Study||14
8174921|NCT02412306|20156910|P3|STARTED|Overall Study||21
8174922|NCT02412306|20156911|P2|STARTED|Overall Study||9
8174923|NCT02412306|20156912|P1|STARTED|Overall Study||5
8174924|NCT02412111|20156974|P3|NOT COMPLETED|Active Comparator Period (8 Weeks)||6
8174925|NCT02412111|20156975|P2|NOT COMPLETED|Active Comparator Period (8 Weeks)||1
8174926|NCT02412111|20156976|P1|NOT COMPLETED|Active Comparator Period (8 Weeks)||0
8174927|NCT02412111|20156974|P3|COMPLETED|Active Comparator Period (8 Weeks)||69
8174928|NCT02412111|20156975|P2|COMPLETED|Active Comparator Period (8 Weeks)||75
8174929|NCT02412111|20156976|P1|COMPLETED|Active Comparator Period (8 Weeks)||0
8174930|NCT02412111|20156974|P3|Full Analysis Set|Active Comparator Period (8 Weeks)||74
8174931|NCT02412111|20156975|P2|Full Analysis Set|Active Comparator Period (8 Weeks)||76
8174932|NCT02412111|20156976|P1|Full Analysis Set|Active Comparator Period (8 Weeks)||0
8174933|NCT02412111|20156974|P3|STARTED|Active Comparator Period (8 Weeks)||75
8174934|NCT02412111|20156975|P2|STARTED|Active Comparator Period (8 Weeks)||76
8174935|NCT02412111|20156976|P1|STARTED|Active Comparator Period (8 Weeks)||0
8174936|NCT02412111|20156974|P3|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
8174937|NCT02412111|20156975|P2|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
8174938|NCT02412111|20156976|P1|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3
8174939|NCT02412111|20156974|P3|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
8174940|NCT02412111|20156975|P2|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
8174941|NCT02412111|20156976|P1|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153
8174942|NCT02412111|20156974|P3|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
8174943|NCT02412111|20156975|P2|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
8174944|NCT02412111|20156976|P1|STARTED|Ivacaftor Run-in Period (4 Weeks)||156
8174945|NCT02412098|20156998|P3|NOT COMPLETED|Overall Study||0
8174946|NCT02412098|20156999|P2|NOT COMPLETED|Overall Study||0
8174947|NCT02412098|20157000|P1|NOT COMPLETED|Overall Study||0
8174948|NCT02412098|20156998|P3|COMPLETED|Overall Study||21
8174949|NCT02412098|20156999|P2|COMPLETED|Overall Study||14
8174950|NCT02412098|20157000|P1|COMPLETED|Overall Study||14
8174951|NCT02412098|20156998|P3|STARTED|Overall Study||21
8174952|NCT02412098|20156999|P2|STARTED|Overall Study||14
8174953|NCT02412098|20157000|P1|STARTED|Overall Study||14
8174954|NCT02411929|20157027|P1|NOT COMPLETED|Period 2||0
8174955|NCT02411929|20157027|P1|COMPLETED|Period 2||8
8174956|NCT02411929|20157027|P1|STARTED|Period 2||8
8174957|NCT02411929|20157027|P1|NOT COMPLETED|Washout Period||0
8174958|NCT02411929|20157027|P1|COMPLETED|Washout Period||8
8174959|NCT02411929|20157027|P1|STARTED|Washout Period||8
8174960|NCT02411929|20157027|P1|NOT COMPLETED|Period 1||0
8174961|NCT02411929|20157027|P1|COMPLETED|Period 1||8
8174962|NCT02411929|20157027|P1|STARTED|Period 1||8
8174963|NCT02411747|20157059|P2|NOT COMPLETED|Overall Study||4
8174964|NCT02411747|20157060|P1|NOT COMPLETED|Overall Study||3
8174965|NCT02411747|20157059|P2|COMPLETED|Overall Study||12
8174966|NCT02411747|20157060|P1|COMPLETED|Overall Study||13
8174967|NCT02411747|20157059|P2|Simulation Training Completed|Overall Study||16
8174968|NCT02411747|20157060|P1|Simulation Training Completed|Overall Study||16
8174969|NCT02411747|20157059|P2|STARTED|Overall Study||16
8174970|NCT02411747|20157060|P1|STARTED|Overall Study||16
8174971|NCT02411643|20157066|P1|NOT COMPLETED|Overall Study||0
8174972|NCT02411643|20157066|P1|COMPLETED|Overall Study||2
8174973|NCT02411643|20157066|P1|STARTED|Overall Study||2
8174974|NCT02411591|20157076|P3|NOT COMPLETED|Overall Study||3
8174975|NCT02411591|20157077|P2|NOT COMPLETED|Overall Study||10
8174976|NCT02411591|20157078|P1|NOT COMPLETED|Overall Study||0
8174977|NCT02411591|20157076|P3|COMPLETED|Overall Study||3
8174978|NCT02411591|20157077|P2|COMPLETED|Overall Study||47
8174979|NCT02411591|20157078|P1|COMPLETED|Overall Study||3
8174980|NCT02411591|20157076|P3|Death|Overall Study||0
8174981|NCT02411591|20157077|P2|Death|Overall Study||2
8174982|NCT02411591|20157078|P1|Death|Overall Study||0
8174983|NCT02411591|20157076|P3|Progressive Disease|Overall Study||3
8174984|NCT02411591|20157077|P2|Progressive Disease|Overall Study||42
8174985|NCT02411591|20157078|P1|Progressive Disease|Overall Study||3
8174986|NCT02411591|20157076|P3|Expansion Cohort Part B|Overall Study||0
8174987|NCT02411591|20157077|P2|Expansion Cohort Part B|Overall Study||51
8174988|NCT02411591|20157078|P1|Expansion Cohort Part B|Overall Study||0
8174989|NCT02411591|20157076|P3|Part A|Overall Study||6
8174990|NCT02411591|20157077|P2|Part A|Overall Study||6
8174991|NCT02411591|20157078|P1|Part A|Overall Study||3
8174992|NCT02411591|20157076|P3|STARTED|Overall Study||6
8174993|NCT02411591|20157077|P2|STARTED|Overall Study||57
8174994|NCT02411591|20157078|P1|STARTED|Overall Study||3
8174995|NCT02411578|20157110|P2|NOT COMPLETED|Extension Phase||0
8174996|NCT02411578|20157111|P1|NOT COMPLETED|Extension Phase||0
8174997|NCT02411578|20157110|P2|COMPLETED|Extension Phase||9
8174998|NCT02411578|20157111|P1|COMPLETED|Extension Phase||8
8174999|NCT02411578|20157110|P2|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
8175000|NCT02411578|20157111|P1|STARTED|Extension Phase||8
8175001|NCT02411578|20157110|P2|NOT COMPLETED|Crossover Trial Phase||1
8175002|NCT02411578|20157111|P1|NOT COMPLETED|Crossover Trial Phase||0
8175003|NCT02411578|20157110|P2|COMPLETED|Crossover Trial Phase||11
8175004|NCT02411578|20157111|P1|COMPLETED|Crossover Trial Phase||8
8175005|NCT02411578|20157110|P2|STARTED|Crossover Trial Phase||12
8175006|NCT02411578|20157111|P1|STARTED|Crossover Trial Phase||8
8175007|NCT02411565|20157153|P2|NOT COMPLETED|Overall Study||0
8175008|NCT02411565|20157154|P1|NOT COMPLETED|Overall Study||0
8175009|NCT02411565|20157153|P2|COMPLETED|Overall Study||2
8175010|NCT02411565|20157154|P1|COMPLETED|Overall Study||1
8175011|NCT02411565|20157153|P2|STARTED|Overall Study||2
8175012|NCT02411565|20157154|P1|STARTED|Overall Study||1
8175013|NCT02411539|20157168|P2|NOT COMPLETED|Overall Study||1
8175014|NCT02411539|20157169|P1|NOT COMPLETED|Overall Study||2
8175015|NCT02411539|20157168|P2|COMPLETED|Overall Study||19
8175016|NCT02411539|20157169|P1|COMPLETED|Overall Study||18
8175017|NCT02411539|20157168|P2|STARTED|Overall Study||20
8175018|NCT02411539|20157169|P1|STARTED|Overall Study||20
8175019|NCT02411461|20157247|P3|NOT COMPLETED|Overall Study||0
8175020|NCT02411461|20157248|P2|NOT COMPLETED|Overall Study||0
8175021|NCT02411461|20157249|P1|NOT COMPLETED|Overall Study||0
8175022|NCT02411461|20157247|P3|COMPLETED|Overall Study||15
8175023|NCT02411461|20157248|P2|COMPLETED|Overall Study||8
8175024|NCT02411461|20157249|P1|COMPLETED|Overall Study||16
8175025|NCT02411461|20157247|P3|STARTED|Overall Study||15
8175026|NCT02411461|20157248|P2|STARTED|Overall Study||8
8175027|NCT02411461|20157249|P1|STARTED|Overall Study||16
8175040|NCT02411396|20157291|P1|NOT COMPLETED|Overall Study||41
8175041|NCT02411396|20157291|P1|COMPLETED|Overall Study||442
8175042|NCT02411396|20157291|P1|STARTED|Overall Study||483
8175043|NCT02411292|20157304|P1|NOT COMPLETED|Overall Study||21
8175044|NCT02411292|20157304|P1|COMPLETED|Overall Study||89
8175045|NCT02411292|20157304|P1|STARTED|Overall Study||110
8175046|NCT02411201|20157310|P1|NOT COMPLETED|Overall Study||6
8175047|NCT02411201|20157310|P1|COMPLETED|Overall Study||45
8175048|NCT02411201|20157310|P1|STARTED|Overall Study||51
8175049|NCT02411110|20157323|P2|NOT COMPLETED|Treatment Period 2||4
8175050|NCT02411110|20157324|P1|NOT COMPLETED|Treatment Period 2||1
8175051|NCT02411110|20157323|P2|COMPLETED|Treatment Period 2||44
8175052|NCT02411110|20157324|P1|COMPLETED|Treatment Period 2||49
8175053|NCT02411110|20157323|P2|STARTED|Treatment Period 2|Period 2 was optional.|48
8175054|NCT02411110|20157324|P1|STARTED|Treatment Period 2|Period 2 was optional.|50
8175055|NCT02411110|20157323|P2|NOT COMPLETED|Treatment Period 1||7
8175056|NCT02411110|20157324|P1|NOT COMPLETED|Treatment Period 1||9
8175057|NCT02411110|20157323|P2|COMPLETED|Treatment Period 1||59
8175058|NCT02411110|20157324|P1|COMPLETED|Treatment Period 1||56
8175059|NCT02411110|20157323|P2|STARTED|Treatment Period 1||66
8175060|NCT02411110|20157324|P1|STARTED|Treatment Period 1||65
8175061|NCT02411084|20157334|P2|NOT COMPLETED|Overall Study||13
8175062|NCT02411084|20157335|P1|NOT COMPLETED|Overall Study||13
8175063|NCT02411084|20157334|P2|COMPLETED|Overall Study||5
8175064|NCT02411084|20157335|P1|COMPLETED|Overall Study||5
8175065|NCT02411084|20157334|P2|STARTED|Overall Study||18
8175066|NCT02411084|20157335|P1|STARTED|Overall Study||18
8175067|NCT02410967|20157350|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
8175068|NCT02410967|20157351|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
8175069|NCT02410967|20157350|P2|COMPLETED|Follow-up Phase (8 Weeks)||16
8175070|NCT02410967|20157351|P1|COMPLETED|Follow-up Phase (8 Weeks)||22
8175071|NCT02410967|20157350|P2|STARTED|Follow-up Phase (8 Weeks)||22
8175072|NCT02410967|20157351|P1|STARTED|Follow-up Phase (8 Weeks)||26
8175073|NCT02410967|20157350|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||4
8175074|NCT02410967|20157351|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||1
8175075|NCT02410967|20157350|P2|COMPLETED|Treatment Phase (4 Weeks)||22
8175076|NCT02410967|20157351|P1|COMPLETED|Treatment Phase (4 Weeks)||26
8175077|NCT02410967|20157350|P2|STARTED|Treatment Phase (4 Weeks)||26
8175078|NCT02410967|20157351|P1|STARTED|Treatment Phase (4 Weeks)||27
8175079|NCT02410824|20157367|P2|NOT COMPLETED|Second Intervention (One Week)||0
8175080|NCT02410824|20157368|P1|NOT COMPLETED|Second Intervention (One Week)||0
8175081|NCT02410824|20157367|P2|COMPLETED|Second Intervention (One Week)||22
8175082|NCT02410824|20157368|P1|COMPLETED|Second Intervention (One Week)||22
8175083|NCT02410824|20157367|P2|STARTED|Second Intervention (One Week)||22
8175084|NCT02410824|20157368|P1|STARTED|Second Intervention (One Week)||22
8175085|NCT02410824|20157367|P2|NOT COMPLETED|First Intervention (One Week)||1
8175086|NCT02410824|20157368|P1|NOT COMPLETED|First Intervention (One Week)||0
8175087|NCT02410824|20157367|P2|COMPLETED|First Intervention (One Week)||22
8175088|NCT02410824|20157368|P1|COMPLETED|First Intervention (One Week)||22
8175089|NCT02410824|20157367|P2|STARTED|First Intervention (One Week)||23
8175090|NCT02410824|20157368|P1|STARTED|First Intervention (One Week)||22
8175091|NCT02410811|20157404|P4|NOT COMPLETED|Overall Study||0
8175092|NCT02410811|20157405|P3|NOT COMPLETED|Overall Study||1
8175093|NCT02410811|20157406|P2|NOT COMPLETED|Overall Study||0
8175094|NCT02410811|20157407|P1|NOT COMPLETED|Overall Study||0
8175095|NCT02410811|20157404|P4|COMPLETED|Overall Study||7
8175096|NCT02410811|20157405|P3|COMPLETED|Overall Study||10
8175097|NCT02410811|20157406|P2|COMPLETED|Overall Study||10
8175098|NCT02410811|20157407|P1|COMPLETED|Overall Study||5
8175099|NCT02410811|20157404|P4|STARTED|Overall Study||7
8175100|NCT02410811|20157405|P3|STARTED|Overall Study||11
8175101|NCT02410811|20157406|P2|STARTED|Overall Study||10
8175102|NCT02410811|20157407|P1|STARTED|Overall Study||5
8175103|NCT02410707|20157421|P1|NOT COMPLETED|Overall Study||0
8175104|NCT02410707|20157421|P1|COMPLETED|Overall Study||43
8175105|NCT02410707|20157421|P1|STARTED|Overall Study||43
8175112|NCT02410577|20157447|P1|NOT COMPLETED|Overall Study||0
8175113|NCT02410577|20157447|P1|COMPLETED|Overall Study||2
8175114|NCT02410577|20157447|P1|STARTED|Overall Study||2
8175115|NCT02410551|20157451|P1|NOT COMPLETED|Overall Study||4
8175116|NCT02410551|20157451|P1|COMPLETED|Overall Study||0
8175117|NCT02410551|20157451|P1|STARTED|Overall Study||4
8175118|NCT02410382|20157458|P2|NOT COMPLETED|Overall Study||0
8175119|NCT02410382|20157459|P1|NOT COMPLETED|Overall Study||0
8175120|NCT02410382|20157458|P2|COMPLETED|Overall Study||0
8175121|NCT02410382|20157459|P1|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0
8175122|NCT02410382|20157458|P2|STARTED|Overall Study||0
8175123|NCT02410382|20157459|P1|STARTED|Overall Study||0
8175124|NCT02410343|20157469|P2|NOT COMPLETED|Extension Period (12 Months)||1
8175125|NCT02410343|20157470|P1|NOT COMPLETED|Extension Period (12 Months)||1
8175126|NCT02410343|20157469|P2|COMPLETED|Extension Period (12 Months)||0
8175127|NCT02410343|20157470|P1|COMPLETED|Extension Period (12 Months)||0
8175128|NCT02410343|20157469|P2|STARTED|Extension Period (12 Months)||1
8175129|NCT02410343|20157470|P1|STARTED|Extension Period (12 Months)||1
8175130|NCT02410343|20157469|P2|NOT COMPLETED|Core Period (24 Weeks)||7
8175131|NCT02410343|20157470|P1|NOT COMPLETED|Core Period (24 Weeks)||5
8175132|NCT02410343|20157469|P2|COMPLETED|Core Period (24 Weeks)||1
8175133|NCT02410343|20157470|P1|COMPLETED|Core Period (24 Weeks)||1
8175134|NCT02410343|20157469|P2|STARTED|Core Period (24 Weeks)||8
8175135|NCT02410343|20157470|P1|STARTED|Core Period (24 Weeks)||6
8175136|NCT02410291|20157507|P2|NOT COMPLETED|Overall Study||0
8175137|NCT02410291|20157508|P1|NOT COMPLETED|Overall Study||0
8175138|NCT02410291|20157507|P2|COMPLETED|Overall Study||29
8175139|NCT02410291|20157508|P1|COMPLETED|Overall Study||29
8175140|NCT02410291|20157507|P2|STARTED|Overall Study||29
8175141|NCT02410291|20157508|P1|STARTED|Overall Study||29
8175142|NCT02410278|20157516|P3|NOT COMPLETED|Study Treatment Period||4
8175143|NCT02410278|20157517|P2|NOT COMPLETED|Study Treatment Period||11
8175144|NCT02410278|20157518|P1|NOT COMPLETED|Study Treatment Period||0
8175145|NCT02410278|20157516|P3|COMPLETED|Study Treatment Period||29
8175146|NCT02410278|20157517|P2|COMPLETED|Study Treatment Period||20
8175147|NCT02410278|20157518|P1|COMPLETED|Study Treatment Period||0
8175148|NCT02410278|20157516|P3|Completed Randomized Study Treatment|Study Treatment Period||29
8175149|NCT02410278|20157517|P2|Completed Randomized Study Treatment|Study Treatment Period||20
8175150|NCT02410278|20157518|P1|Completed Randomized Study Treatment|Study Treatment Period||0
8175151|NCT02410278|20157516|P3|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
8175152|NCT02410278|20157517|P2|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
8175153|NCT02410278|20157518|P1|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
8175154|NCT02410278|20157516|P3|STARTED|Study Treatment Period||33
8175155|NCT02410278|20157517|P2|STARTED|Study Treatment Period||31
8175156|NCT02410278|20157518|P1|STARTED|Study Treatment Period||0
8175157|NCT02410278|20157516|P3|NOT COMPLETED|Run-in Period||0
8175158|NCT02410278|20157517|P2|NOT COMPLETED|Run-in Period||0
8175159|NCT02410278|20157518|P1|NOT COMPLETED|Run-in Period||38
8175160|NCT02410278|20157516|P3|COMPLETED|Run-in Period||0
8175161|NCT02410278|20157517|P2|COMPLETED|Run-in Period||0
8175162|NCT02410278|20157518|P1|COMPLETED|Run-in Period||64
8175163|NCT02410278|20157516|P3|Received at Least 1 Dose of DMF|Run-in Period||0
8175164|NCT02410278|20157517|P2|Received at Least 1 Dose of DMF|Run-in Period||0
8175165|NCT02410278|20157518|P1|Received at Least 1 Dose of DMF|Run-in Period||98
8175166|NCT02410278|20157516|P3|STARTED|Run-in Period||0
8175167|NCT02410278|20157517|P2|STARTED|Run-in Period||0
8175168|NCT02410278|20157518|P1|STARTED|Run-in Period||102
8175169|NCT02410252|20157543|P1|NOT COMPLETED|Overall Study||6
8175170|NCT02410252|20157543|P1|COMPLETED|Overall Study||19
8175171|NCT02410252|20157543|P1|STARTED|Overall Study||25
8175172|NCT02410213|20157549|P2|NOT COMPLETED|Overall Study||0
8175173|NCT02410213|20157550|P1|NOT COMPLETED|Overall Study||0
8175174|NCT02410213|20157549|P2|COMPLETED|Overall Study||19
8175175|NCT02410213|20157550|P1|COMPLETED|Overall Study||16
8175176|NCT02410213|20157549|P2|STARTED|Overall Study||19
8175177|NCT02410213|20157550|P1|STARTED|Overall Study||16
8175178|NCT02410200|20157556|P1|NOT COMPLETED|Overall Study||2
8175179|NCT02410200|20157556|P1|COMPLETED|Overall Study||20
8175180|NCT02410200|20157556|P1|STARTED|Overall Study||22
8175181|NCT02410161|20157569|P2|NOT COMPLETED|Overall Study||0
8175182|NCT02410161|20157570|P1|NOT COMPLETED|Overall Study||0
8175183|NCT02410161|20157569|P2|COMPLETED|Overall Study||10
8175184|NCT02410161|20157570|P1|COMPLETED|Overall Study||10
8175185|NCT02410161|20157569|P2|STARTED|Overall Study||10
8175186|NCT02410161|20157570|P1|STARTED|Overall Study||10
8175187|NCT02410018|20157586|P2|NOT COMPLETED|Overall Study||0
8175188|NCT02410018|20157587|P1|NOT COMPLETED|Overall Study||0
8175189|NCT02410018|20157586|P2|COMPLETED|Overall Study||1
8175190|NCT02410018|20157587|P1|COMPLETED|Overall Study||2
8175191|NCT02410018|20157586|P2|STARTED|Overall Study||1
8175192|NCT02410018|20157587|P1|STARTED|Overall Study||2
8175193|NCT02409927|20157607|P1|NOT COMPLETED|Overall Study||0
8175194|NCT02409927|20157607|P1|COMPLETED|Overall Study||10
8175195|NCT02409927|20157607|P1|STARTED|Overall Study||10
8175196|NCT02409914|20157615|P1|NOT COMPLETED|Overall Study||0
8175197|NCT02409914|20157615|P1|COMPLETED|Overall Study||7
8175198|NCT02409914|20157615|P1|STARTED|Overall Study||7
8175199|NCT02409784|20157621|P1|NOT COMPLETED|Overall Study||0
8175200|NCT02409784|20157621|P1|COMPLETED|Overall Study||10
8175201|NCT02409784|20157621|P1|STARTED|Overall Study||10
8175202|NCT02409732|20157626|P1|NOT COMPLETED|Overall Study||6
8175203|NCT02409732|20157626|P1|COMPLETED|Overall Study||14
8175204|NCT02409732|20157626|P1|STARTED|Overall Study|First patient consented on 4/23/15|20
8175205|NCT02409719|20157636|P2|NOT COMPLETED|Overall Study||3
8175206|NCT02409719|20157637|P1|NOT COMPLETED|Overall Study||3
8175207|NCT02409719|20157636|P2|COMPLETED|Overall Study||42
8175208|NCT02409719|20157637|P1|COMPLETED|Overall Study||28
8175209|NCT02409719|20157636|P2|12 Months|Overall Study||42
8175210|NCT02409719|20157637|P1|12 Months|Overall Study||28
8175211|NCT02409719|20157636|P2|6 Months|Overall Study||42
8175212|NCT02409719|20157637|P1|6 Months|Overall Study||28
8175213|NCT02409719|20157636|P2|3 Months|Overall Study||42
8175214|NCT02409719|20157637|P1|3 Months|Overall Study||28
8175215|NCT02409719|20157636|P2|6 Weeks|Overall Study||42
8175216|NCT02409719|20157637|P1|6 Weeks|Overall Study||28
8175217|NCT02409719|20157636|P2|4 Weeks|Overall Study||42
8175218|NCT02409719|20157637|P1|4 Weeks|Overall Study||28
8175219|NCT02409719|20157636|P2|2 Weeks|Overall Study||42
8175220|NCT02409719|20157637|P1|2 Weeks|Overall Study||28
8175221|NCT02409719|20157636|P2|STARTED|Overall Study||45
8175222|NCT02409719|20157637|P1|STARTED|Overall Study||31
8175223|NCT02409667|20157647|P5|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3
8175224|NCT02409667|20157648|P4|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8
8175225|NCT02409667|20157649|P3|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21
8175226|NCT02409667|20157650|P2|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23
8175227|NCT02409667|20157651|P1|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
8175228|NCT02409667|20157647|P5|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90
8175229|NCT02409667|20157648|P4|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106
8175230|NCT02409667|20157649|P3|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641
8175231|NCT02409667|20157650|P2|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621
8175232|NCT02409667|20157651|P1|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
8175233|NCT02409667|20157647|P5|STARTED|Treatment Period 2, Week 24 to Week 52)||93
8175234|NCT02409667|20157648|P4|STARTED|Treatment Period 2, Week 24 to Week 52)||114
8175235|NCT02409667|20157649|P3|STARTED|Treatment Period 2, Week 24 to Week 52)||662
8175236|NCT02409667|20157650|P2|STARTED|Treatment Period 2, Week 24 to Week 52)||644
8175237|NCT02409667|20157651|P1|STARTED|Treatment Period 2, Week 24 to Week 52)||0
8175238|NCT02409667|20157647|P5|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175239|NCT02409667|20157648|P4|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175240|NCT02409667|20157649|P3|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175241|NCT02409667|20157650|P2|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175242|NCT02409667|20157651|P1|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121
8175243|NCT02409667|20157647|P5|COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175244|NCT02409667|20157648|P4|COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175245|NCT02409667|20157649|P3|COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175246|NCT02409667|20157650|P2|COMPLETED|Treatment Period 1, Baseline to Week 24||0
8175247|NCT02409667|20157651|P1|COMPLETED|Treatment Period 1, Baseline to Week 24||1526
8175248|NCT02409667|20157647|P5|STARTED|Treatment Period 1, Baseline to Week 24||0
8175249|NCT02409667|20157648|P4|STARTED|Treatment Period 1, Baseline to Week 24||0
8175250|NCT02409667|20157649|P3|STARTED|Treatment Period 1, Baseline to Week 24||0
8175251|NCT02409667|20157650|P2|STARTED|Treatment Period 1, Baseline to Week 24||0
8175252|NCT02409667|20157651|P1|STARTED|Treatment Period 1, Baseline to Week 24||1647
8175253|NCT02409459|20157692|P2|NOT COMPLETED|Overall Study||1
8175254|NCT02409459|20157693|P1|NOT COMPLETED|Overall Study||1
8175255|NCT02409459|20157692|P2|COMPLETED|Overall Study||39
8175256|NCT02409459|20157693|P1|COMPLETED|Overall Study||40
8175257|NCT02409459|20157692|P2|STARTED|Overall Study||40
8175258|NCT02409459|20157693|P1|STARTED|Overall Study||41
8175259|NCT02409355|20157713|P2|NOT COMPLETED|Overall Study||4
8175260|NCT02409355|20157714|P1|NOT COMPLETED|Overall Study||4
8175261|NCT02409355|20157713|P2|COMPLETED|Overall Study||0
8175262|NCT02409355|20157714|P1|COMPLETED|Overall Study||0
8175263|NCT02409355|20157713|P2|STARTED|Overall Study||4
8175264|NCT02409355|20157714|P1|STARTED|Overall Study||4
8175265|NCT02409329|20157723|P3|NOT COMPLETED|Overall Study||9
8175266|NCT02409329|20157724|P2|NOT COMPLETED|Overall Study||6
8175267|NCT02409329|20157725|P1|NOT COMPLETED|Overall Study||5
8175268|NCT02409329|20157723|P3|COMPLETED|Overall Study||244
8175269|NCT02409329|20157724|P2|COMPLETED|Overall Study||120
8175270|NCT02409329|20157725|P1|COMPLETED|Overall Study||122
8175271|NCT02409329|20157723|P3|STARTED|Overall Study||253
8175272|NCT02409329|20157724|P2|STARTED|Overall Study||126
8175273|NCT02409329|20157725|P1|STARTED|Overall Study||127
8175274|NCT02409277|20157748|P3|NOT COMPLETED|Overall Study||0
8175275|NCT02409277|20157749|P2|NOT COMPLETED|Overall Study||17
8175276|NCT02409277|20157750|P1|NOT COMPLETED|Overall Study||100
8175277|NCT02409277|20157748|P3|COMPLETED|Overall Study||599
8175278|NCT02409277|20157749|P2|COMPLETED|Overall Study||43
8175279|NCT02409277|20157750|P1|COMPLETED|Overall Study||167
8175280|NCT02409277|20157748|P3|12 Months Follow-up|Overall Study||599
8175281|NCT02409277|20157749|P2|12 Months Follow-up|Overall Study||43
8175282|NCT02409277|20157750|P1|12 Months Follow-up|Overall Study||167
8175283|NCT02409277|20157748|P3|6 Months Follow-up|Overall Study||599
8175284|NCT02409277|20157749|P2|6 Months Follow-up|Overall Study||42
8175285|NCT02409277|20157750|P1|6 Months Follow-up|Overall Study||182
8175286|NCT02409277|20157748|P3|3 Months Follow-up|Overall Study||599
8175287|NCT02409277|20157749|P2|3 Months Follow-up|Overall Study||40
8175288|NCT02409277|20157750|P1|3 Months Follow-up|Overall Study||178
8175289|NCT02409277|20157748|P3|STARTED|Overall Study||599
8175290|NCT02409277|20157749|P2|STARTED|Overall Study||60
8175291|NCT02409277|20157750|P1|STARTED|Overall Study||267
8175292|NCT02408965|20157790|P2|NOT COMPLETED|Overall Study||0
8175293|NCT02408965|20157791|P1|NOT COMPLETED|Overall Study||0
8175294|NCT02408965|20157790|P2|COMPLETED|Overall Study||144
8175295|NCT02408965|20157791|P1|COMPLETED|Overall Study||140
8175296|NCT02408965|20157790|P2|STARTED|Overall Study||144
8175297|NCT02408965|20157791|P1|STARTED|Overall Study||140
8175298|NCT02408796|20157813|P1|NOT COMPLETED|Overall Study||0
8175299|NCT02408796|20157813|P1|COMPLETED|Overall Study||39
8175300|NCT02408796|20157813|P1|STARTED|Overall Study||39
8175301|NCT02408692|20157822|P3|NOT COMPLETED|Overall Study||0
8175302|NCT02408692|20157823|P2|NOT COMPLETED|Overall Study||0
8175303|NCT02408692|20157824|P1|NOT COMPLETED|Overall Study||0
8175304|NCT02408692|20157822|P3|COMPLETED|Overall Study||5
8175305|NCT02408692|20157823|P2|COMPLETED|Overall Study||5
8175306|NCT02408692|20157824|P1|COMPLETED|Overall Study||5
8175307|NCT02408692|20157822|P3|STARTED|Overall Study||5
8175308|NCT02408692|20157823|P2|STARTED|Overall Study||5
8175309|NCT02408692|20157824|P1|STARTED|Overall Study||5
8175310|NCT02408523|20157837|P2|NOT COMPLETED|Overall Study||18
8175311|NCT02408523|20157838|P1|NOT COMPLETED|Overall Study||11
8175312|NCT02408523|20157837|P2|COMPLETED|Overall Study||103
8175313|NCT02408523|20157838|P1|COMPLETED|Overall Study||110
8175314|NCT02408523|20157837|P2|Enrolled Safety Folllow-up Period|Overall Study||11
8175315|NCT02408523|20157838|P1|Enrolled Safety Folllow-up Period|Overall Study||10
8175316|NCT02408523|20157837|P2|Enrolled Taper Period|Overall Study||9
8175317|NCT02408523|20157838|P1|Enrolled Taper Period|Overall Study||7
8175318|NCT02408523|20157837|P2|Enrolled Transition Period|Overall Study||101
8175319|NCT02408523|20157838|P1|Enrolled Transition Period|Overall Study||108
8175320|NCT02408523|20157837|P2|Completed Treatment Period|Overall Study||103
8175321|NCT02408523|20157838|P1|Completed Treatment Period|Overall Study||110
8175322|NCT02408523|20157837|P2|STARTED|Overall Study||121
8175323|NCT02408523|20157838|P1|STARTED|Overall Study||121
8175324|NCT02408484|20157858|P1|NOT COMPLETED|Overall Study||4
8175325|NCT02408484|20157858|P1|COMPLETED|Overall Study||11
8175326|NCT02408484|20157858|P1|SURG Population|Overall Study||3
8175327|NCT02408484|20157858|P1|BLEED Population|Overall Study||8
8175328|NCT02408484|20157858|P1|firstBLEED Population|Overall Study||8
8175329|NCT02408484|20157858|P1|PK Population|Overall Study||13
8175330|NCT02408484|20157858|P1|FAS Population|Overall Study||14
8175331|NCT02408484|20157858|P1|SAF Population|Overall Study||14
8175332|NCT02408484|20157858|P1|STARTED|Overall Study||15
8175333|NCT02408445|20157892|P2|NOT COMPLETED|Overall Study||0
8175334|NCT02408445|20157893|P1|NOT COMPLETED|Overall Study||0
8175335|NCT02408445|20157892|P2|COMPLETED|Overall Study||10
8175336|NCT02408445|20157893|P1|COMPLETED|Overall Study||10
8175337|NCT02408445|20157892|P2|STARTED|Overall Study||10
8175338|NCT02408445|20157893|P1|STARTED|Overall Study||10
8175345|NCT02408263|20157945|P2|NOT COMPLETED|Overall Study||0
8175346|NCT02408263|20157946|P1|NOT COMPLETED|Overall Study||0
8175347|NCT02408263|20157945|P2|COMPLETED|Overall Study||25
8175348|NCT02408263|20157946|P1|COMPLETED|Overall Study||25
8175349|NCT02408263|20157945|P2|STARTED|Overall Study||25
8175350|NCT02408263|20157946|P1|STARTED|Overall Study||25
8175351|NCT02408198|20157954|P2|NOT COMPLETED|Overall Study||0
8175352|NCT02408198|20157955|P1|NOT COMPLETED|Overall Study||3
8175353|NCT02408198|20157954|P2|COMPLETED|Overall Study||5
8175354|NCT02408198|20157955|P1|COMPLETED|Overall Study||10
8175355|NCT02408198|20157954|P2|STARTED|Overall Study||5
8175356|NCT02408198|20157955|P1|STARTED|Overall Study||13
8175357|NCT02408120|20157963|P2|NOT COMPLETED|Overall Study||5
8175358|NCT02408120|20157964|P1|NOT COMPLETED|Overall Study||4
8175359|NCT02408120|20157963|P2|COMPLETED|Overall Study||107
8175360|NCT02408120|20157964|P1|COMPLETED|Overall Study||108
8175361|NCT02408120|20157963|P2|STARTED|Overall Study||112
8175362|NCT02408120|20157964|P1|STARTED|Overall Study||112
8175363|NCT02408068|20157990|P6|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8175364|NCT02408068|20157991|P5|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8175365|NCT02408068|20157992|P4|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8175366|NCT02408068|20157993|P3|NOT COMPLETED|Treatment 3 (1.5 Days)||1
8175367|NCT02408068|20157994|P2|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8175368|NCT02408068|20157995|P1|NOT COMPLETED|Treatment 3 (1.5 Days)||0
8175369|NCT02408068|20157990|P6|COMPLETED|Treatment 3 (1.5 Days)||3
8175370|NCT02408068|20157991|P5|COMPLETED|Treatment 3 (1.5 Days)||3
8175371|NCT02408068|20157992|P4|COMPLETED|Treatment 3 (1.5 Days)||3
8175372|NCT02408068|20157993|P3|COMPLETED|Treatment 3 (1.5 Days)||2
8175373|NCT02408068|20157994|P2|COMPLETED|Treatment 3 (1.5 Days)||3
8175374|NCT02408068|20157995|P1|COMPLETED|Treatment 3 (1.5 Days)||3
8175375|NCT02408068|20157990|P6|STARTED|Treatment 3 (1.5 Days)||3
8175376|NCT02408068|20157991|P5|STARTED|Treatment 3 (1.5 Days)||3
8175377|NCT02408068|20157992|P4|STARTED|Treatment 3 (1.5 Days)||3
8175378|NCT02408068|20157993|P3|STARTED|Treatment 3 (1.5 Days)||3
8175379|NCT02408068|20157994|P2|STARTED|Treatment 3 (1.5 Days)||3
8175380|NCT02408068|20157995|P1|STARTED|Treatment 3 (1.5 Days)||3
8175381|NCT02408068|20157990|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8175382|NCT02408068|20157991|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8175383|NCT02408068|20157992|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8175384|NCT02408068|20157993|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8175385|NCT02408068|20157994|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8175386|NCT02408068|20157995|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8175387|NCT02408068|20157990|P6|COMPLETED|Washout Period 2 (7 Days)||3
8175388|NCT02408068|20157991|P5|COMPLETED|Washout Period 2 (7 Days)||3
8175389|NCT02408068|20157992|P4|COMPLETED|Washout Period 2 (7 Days)||3
8175390|NCT02408068|20157993|P3|COMPLETED|Washout Period 2 (7 Days)||3
8175391|NCT02408068|20157994|P2|COMPLETED|Washout Period 2 (7 Days)||3
8175392|NCT02408068|20157995|P1|COMPLETED|Washout Period 2 (7 Days)||3
8175393|NCT02408068|20157990|P6|STARTED|Washout Period 2 (7 Days)||3
8175394|NCT02408068|20157991|P5|STARTED|Washout Period 2 (7 Days)||3
8175395|NCT02408068|20157992|P4|STARTED|Washout Period 2 (7 Days)||3
8175396|NCT02408068|20157993|P3|STARTED|Washout Period 2 (7 Days)||3
8175397|NCT02408068|20157994|P2|STARTED|Washout Period 2 (7 Days)||3
8175398|NCT02408068|20157995|P1|STARTED|Washout Period 2 (7 Days)||3
8175399|NCT02408068|20157990|P6|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8175400|NCT02408068|20157991|P5|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8175401|NCT02408068|20157992|P4|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8175402|NCT02408068|20157993|P3|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8175403|NCT02408068|20157994|P2|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8175404|NCT02408068|20157995|P1|NOT COMPLETED|Treatment 2 (1.5 Days)||0
8175405|NCT02408068|20157990|P6|COMPLETED|Treatment 2 (1.5 Days)||3
8175406|NCT02408068|20157991|P5|COMPLETED|Treatment 2 (1.5 Days)||3
8175407|NCT02408068|20157992|P4|COMPLETED|Treatment 2 (1.5 Days)||3
8175408|NCT02408068|20157993|P3|COMPLETED|Treatment 2 (1.5 Days)||3
8175409|NCT02408068|20157994|P2|COMPLETED|Treatment 2 (1.5 Days)||3
8175410|NCT02408068|20157995|P1|COMPLETED|Treatment 2 (1.5 Days)||3
8175411|NCT02408068|20157990|P6|STARTED|Treatment 2 (1.5 Days)||3
8175412|NCT02408068|20157991|P5|STARTED|Treatment 2 (1.5 Days)||3
8175413|NCT02408068|20157992|P4|STARTED|Treatment 2 (1.5 Days)||3
8175414|NCT02408068|20157993|P3|STARTED|Treatment 2 (1.5 Days)||3
8175415|NCT02408068|20157994|P2|STARTED|Treatment 2 (1.5 Days)||3
8175416|NCT02408068|20157995|P1|STARTED|Treatment 2 (1.5 Days)||3
8175417|NCT02408068|20157990|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
8175418|NCT02408068|20157991|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8175419|NCT02408068|20157992|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8175420|NCT02408068|20157993|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8175421|NCT02408068|20157994|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8175422|NCT02408068|20157995|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8175423|NCT02408068|20157990|P6|COMPLETED|Washout Period 1 (7 Days)||3
8175424|NCT02408068|20157991|P5|COMPLETED|Washout Period 1 (7 Days)||3
8175425|NCT02408068|20157992|P4|COMPLETED|Washout Period 1 (7 Days)||3
8175426|NCT02408068|20157993|P3|COMPLETED|Washout Period 1 (7 Days)||3
8175427|NCT02408068|20157994|P2|COMPLETED|Washout Period 1 (7 Days)||3
8175428|NCT02408068|20157995|P1|COMPLETED|Washout Period 1 (7 Days)||3
8175429|NCT02408068|20157990|P6|STARTED|Washout Period 1 (7 Days)||3
8175430|NCT02408068|20157991|P5|STARTED|Washout Period 1 (7 Days)||3
8175431|NCT02408068|20157992|P4|STARTED|Washout Period 1 (7 Days)||3
8175432|NCT02408068|20157993|P3|STARTED|Washout Period 1 (7 Days)||3
8175433|NCT02408068|20157994|P2|STARTED|Washout Period 1 (7 Days)||3
8175434|NCT02408068|20157995|P1|STARTED|Washout Period 1 (7 Days)||3
8175435|NCT02408068|20157990|P6|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8175436|NCT02408068|20157991|P5|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8175437|NCT02408068|20157992|P4|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8175438|NCT02408068|20157993|P3|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8175439|NCT02408068|20157994|P2|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8175440|NCT02408068|20157995|P1|NOT COMPLETED|Treatment 1 (1.5 Days)||0
8175441|NCT02408068|20157990|P6|COMPLETED|Treatment 1 (1.5 Days)||3
8175442|NCT02408068|20157991|P5|COMPLETED|Treatment 1 (1.5 Days)||3
8175443|NCT02408068|20157992|P4|COMPLETED|Treatment 1 (1.5 Days)||3
8175444|NCT02408068|20157993|P3|COMPLETED|Treatment 1 (1.5 Days)||3
8175445|NCT02408068|20157994|P2|COMPLETED|Treatment 1 (1.5 Days)||3
8175446|NCT02408068|20157995|P1|COMPLETED|Treatment 1 (1.5 Days)||3
8175447|NCT02408068|20157990|P6|STARTED|Treatment 1 (1.5 Days)||3
8175448|NCT02408068|20157991|P5|STARTED|Treatment 1 (1.5 Days)||3
8175449|NCT02408068|20157992|P4|STARTED|Treatment 1 (1.5 Days)||3
8175450|NCT02408068|20157993|P3|STARTED|Treatment 1 (1.5 Days)||3
8175451|NCT02408068|20157994|P2|STARTED|Treatment 1 (1.5 Days)||3
8175452|NCT02408068|20157995|P1|STARTED|Treatment 1 (1.5 Days)||3
8175453|NCT02407756|20158022|P4|NOT COMPLETED|Overall Study||0
8175454|NCT02407756|20158023|P3|NOT COMPLETED|Overall Study||0
8175455|NCT02407756|20158024|P2|NOT COMPLETED|Overall Study||0
8175456|NCT02407756|20158025|P1|NOT COMPLETED|Overall Study||0
8175457|NCT02407756|20158022|P4|COMPLETED|Overall Study||19
8175458|NCT02407756|20158023|P3|COMPLETED|Overall Study||20
8175459|NCT02407756|20158024|P2|COMPLETED|Overall Study||18
8175460|NCT02407756|20158025|P1|COMPLETED|Overall Study||20
8175461|NCT02407756|20158022|P4|Treated|Overall Study||19
8175462|NCT02407756|20158023|P3|Treated|Overall Study||20
8175463|NCT02407756|20158024|P2|Treated|Overall Study||18
8175464|NCT02407756|20158025|P1|Treated|Overall Study||20
8175465|NCT02407756|20158022|P4|STARTED|Overall Study||19
8175466|NCT02407756|20158023|P3|STARTED|Overall Study||20
8175467|NCT02407756|20158024|P2|STARTED|Overall Study||18
8175468|NCT02407756|20158025|P1|STARTED|Overall Study||20
8175469|NCT02407704|20158067|P4|NOT COMPLETED|Overall Study||3
8175470|NCT02407704|20158068|P3|NOT COMPLETED|Overall Study||1
8175471|NCT02407704|20158069|P2|NOT COMPLETED|Overall Study||0
8175472|NCT02407704|20158070|P1|NOT COMPLETED|Overall Study||0
8175473|NCT02407704|20158067|P4|COMPLETED|Overall Study||2
8175474|NCT02407704|20158068|P3|COMPLETED|Overall Study||4
8175475|NCT02407704|20158069|P2|COMPLETED|Overall Study||3
8175476|NCT02407704|20158070|P1|COMPLETED|Overall Study||2
8175477|NCT02407704|20158067|P4|STARTED|Overall Study||5
8175478|NCT02407704|20158068|P3|STARTED|Overall Study||5
8175479|NCT02407704|20158069|P2|STARTED|Overall Study||3
8175480|NCT02407704|20158070|P1|STARTED|Overall Study||2
8175511|NCT02407249|20158113|P1|NOT COMPLETED|Overall Study||26
8175512|NCT02407249|20158113|P1|COMPLETED|Overall Study||47
8175513|NCT02407249|20158113|P1|Treated|Overall Study||60
8175514|NCT02407249|20158113|P1|STARTED|Overall Study||73
8175603|NCT02407223|20158376|P3|NOT COMPLETED|Overall Study||122
8175604|NCT02407223|20158377|P2|NOT COMPLETED|Overall Study||118
8175605|NCT02407223|20158378|P1|NOT COMPLETED|Overall Study||116
8175606|NCT02407223|20158376|P3|COMPLETED|Overall Study||0
8175607|NCT02407223|20158377|P2|COMPLETED|Overall Study||0
8175608|NCT02407223|20158378|P1|COMPLETED|Overall Study||0
8175609|NCT02407223|20158376|P3|Qualified Re-randomization at Week 52|Overall Study||2
8175610|NCT02407223|20158377|P2|Qualified Re-randomization at Week 52|Overall Study||3
8175611|NCT02407223|20158378|P1|Qualified Re-randomization at Week 52|Overall Study||0
8175612|NCT02407223|20158376|P3|Cross Over at Week 24|Overall Study||0
8175613|NCT02407223|20158377|P2|Cross Over at Week 24|Overall Study||0
8175614|NCT02407223|20158378|P1|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60
8175615|NCT02407223|20158376|P3|Early Escape at Week 16|Overall Study||0
8175616|NCT02407223|20158377|P2|Early Escape at Week 16|Overall Study||0
8175617|NCT02407223|20158378|P1|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22
8175618|NCT02407223|20158376|P3|STARTED|Overall Study||122
8175619|NCT02407223|20158377|P2|STARTED|Overall Study||118
8175620|NCT02407223|20158378|P1|STARTED|Overall Study||116
8175621|NCT02407132|20158423|P2|NOT COMPLETED|12 Months Post-intervention||2
8175622|NCT02407132|20158424|P1|NOT COMPLETED|12 Months Post-intervention||13
8175623|NCT02407132|20158423|P2|COMPLETED|12 Months Post-intervention||90
8175624|NCT02407132|20158424|P1|COMPLETED|12 Months Post-intervention||83
8175625|NCT02407132|20158423|P2|STARTED|12 Months Post-intervention||92
8175626|NCT02407132|20158424|P1|STARTED|12 Months Post-intervention||96
8175627|NCT02407132|20158423|P2|NOT COMPLETED|6 Months Post-intervention||9
8175628|NCT02407132|20158424|P1|NOT COMPLETED|6 Months Post-intervention||11
8175629|NCT02407132|20158423|P2|COMPLETED|6 Months Post-intervention||92
8175630|NCT02407132|20158424|P1|COMPLETED|6 Months Post-intervention||96
8175631|NCT02407132|20158423|P2|STARTED|6 Months Post-intervention||101
8175632|NCT02407132|20158424|P1|STARTED|6 Months Post-intervention||107
8175633|NCT02407132|20158423|P2|NOT COMPLETED|Immediate Post-intervention||10
8175634|NCT02407132|20158424|P1|NOT COMPLETED|Immediate Post-intervention||3
8175635|NCT02407132|20158423|P2|COMPLETED|Immediate Post-intervention||101
8175636|NCT02407132|20158424|P1|COMPLETED|Immediate Post-intervention||107
8175637|NCT02407132|20158423|P2|STARTED|Immediate Post-intervention||111
8175638|NCT02407132|20158424|P1|STARTED|Immediate Post-intervention||110
8175639|NCT02407041|20158448|P1|NOT COMPLETED|Overall Study||0
8175640|NCT02407041|20158448|P1|COMPLETED|Overall Study||5
8175641|NCT02407041|20158448|P1|STARTED|Overall Study||5
8175642|NCT02406937|20158455|P3|NOT COMPLETED|Overall Study||2
8175643|NCT02406937|20158456|P2|NOT COMPLETED|Overall Study||1
8175644|NCT02406937|20158457|P1|NOT COMPLETED|Overall Study||1
8175645|NCT02406937|20158455|P3|COMPLETED|Overall Study||58
8175646|NCT02406937|20158456|P2|COMPLETED|Overall Study||59
8175647|NCT02406937|20158457|P1|COMPLETED|Overall Study||59
8175648|NCT02406937|20158455|P3|STARTED|Overall Study||60
8175649|NCT02406937|20158456|P2|STARTED|Overall Study||60
8175650|NCT02406937|20158457|P1|STARTED|Overall Study||60
8175651|NCT02406885|20158515|P2|NOT COMPLETED|Overall Study||2
8175652|NCT02406885|20158516|P1|NOT COMPLETED|Overall Study||3
8175653|NCT02406885|20158515|P2|COMPLETED|Overall Study||14
8175654|NCT02406885|20158516|P1|COMPLETED|Overall Study||14
8175655|NCT02406885|20158515|P2|STARTED|Overall Study||16
8175656|NCT02406885|20158516|P1|STARTED|Overall Study||17
8175657|NCT02406677|20158530|P2|NOT COMPLETED|Overall Study||598
8175658|NCT02406677|20158531|P1|NOT COMPLETED|Overall Study||301
8175659|NCT02406677|20158530|P2|COMPLETED|Overall Study||3967
8175660|NCT02406677|20158531|P1|COMPLETED|Overall Study||6135
8175661|NCT02406677|20158530|P2|STARTED|Overall Study||4565
8175662|NCT02406677|20158531|P1|STARTED|Overall Study||6436
8175663|NCT02406612|20158545|P2|NOT COMPLETED|Overall Study||4
8175664|NCT02406612|20158546|P1|NOT COMPLETED|Overall Study||4
8175665|NCT02406612|20158545|P2|COMPLETED|Overall Study||17
8175666|NCT02406612|20158546|P1|COMPLETED|Overall Study||22
8175667|NCT02406612|20158545|P2|STARTED|Overall Study||21
8175668|NCT02406612|20158546|P1|STARTED|Overall Study||26
8175669|NCT02406586|20158561|P3|NOT COMPLETED|Overall Study||2
8175670|NCT02406586|20158562|P2|NOT COMPLETED|Overall Study||4
8175671|NCT02406586|20158563|P1|NOT COMPLETED|Overall Study||1
8175672|NCT02406586|20158561|P3|COMPLETED|Overall Study||10
8175673|NCT02406586|20158562|P2|COMPLETED|Overall Study||8
8175674|NCT02406586|20158563|P1|COMPLETED|Overall Study||11
8175675|NCT02406586|20158561|P3|STARTED|Overall Study||12
8175676|NCT02406586|20158562|P2|STARTED|Overall Study||12
8175677|NCT02406586|20158563|P1|STARTED|Overall Study||12
8175678|NCT02406573|20158637|P1|NOT COMPLETED|Overall Study||0
8175679|NCT02406573|20158637|P1|COMPLETED|Overall Study||30
8175680|NCT02406573|20158637|P1|STARTED|Overall Study||30
8175681|NCT02406495|20158643|P1|NOT COMPLETED|Overall Study||0
8175682|NCT02406495|20158643|P1|COMPLETED|Overall Study||40
8175683|NCT02406495|20158643|P1|STARTED|Overall Study||40
8175684|NCT02406443|20158684|P2|NOT COMPLETED|Overall Study||2
8175685|NCT02406443|20158685|P1|NOT COMPLETED|Overall Study||2
8175686|NCT02406443|20158684|P2|COMPLETED|Overall Study||16
8175687|NCT02406443|20158685|P1|COMPLETED|Overall Study||16
8175688|NCT02406443|20158684|P2|STARTED|Overall Study||18
8175689|NCT02406443|20158685|P1|STARTED|Overall Study||18
8175690|NCT02406261|20158705|P2|NOT COMPLETED|Period 2||3
8175691|NCT02406261|20158706|P1|NOT COMPLETED|Period 2||0
8175692|NCT02406261|20158705|P2|COMPLETED|Period 2||29
8175693|NCT02406261|20158706|P1|COMPLETED|Period 2||0
8175694|NCT02406261|20158705|P2|STARTED|Period 2||32
8175695|NCT02406261|20158706|P1|STARTED|Period 2|Cohort A participated in Period 1 only|0
8175696|NCT02406261|20158705|P2|NOT COMPLETED|Period 1||0
8175697|NCT02406261|20158706|P1|NOT COMPLETED|Period 1||3
8175698|NCT02406261|20158705|P2|COMPLETED|Period 1||32
8175699|NCT02406261|20158706|P1|COMPLETED|Period 1||47
8175700|NCT02406261|20158705|P2|Received at Least One Dose of Study Drug|Period 1||32
8175701|NCT02406261|20158706|P1|Received at Least One Dose of Study Drug|Period 1||50
8175702|NCT02406261|20158705|P2|STARTED|Period 1||32
8175703|NCT02406261|20158706|P1|STARTED|Period 1||50
8175704|NCT02406248|20158718|P1|NOT COMPLETED|Overall Study||9
8175705|NCT02406248|20158718|P1|COMPLETED|Overall Study||99
8175706|NCT02406248|20158718|P1|STARTED|Overall Study||108
8175707|NCT02406027|20158729|P7|NOT COMPLETED|Open-label Phase (Period 2)||22
8175708|NCT02406027|20158730|P6|NOT COMPLETED|Open-label Phase (Period 2)||26
8175709|NCT02406027|20158731|P5|NOT COMPLETED|Open-label Phase (Period 2)||14
8175710|NCT02406027|20158732|P4|NOT COMPLETED|Open-label Phase (Period 2)||15
8175711|NCT02406027|20158733|P3|NOT COMPLETED|Open-label Phase (Period 2)||0
8175712|NCT02406027|20158734|P2|NOT COMPLETED|Open-label Phase (Period 2)||0
8175713|NCT02406027|20158735|P1|NOT COMPLETED|Open-label Phase (Period 2)||0
8175714|NCT02406027|20158729|P7|COMPLETED|Open-label Phase (Period 2)||0
8175715|NCT02406027|20158730|P6|COMPLETED|Open-label Phase (Period 2)||0
8175716|NCT02406027|20158731|P5|COMPLETED|Open-label Phase (Period 2)||0
8175717|NCT02406027|20158732|P4|COMPLETED|Open-label Phase (Period 2)||0
8175718|NCT02406027|20158733|P3|COMPLETED|Open-label Phase (Period 2)||0
8175719|NCT02406027|20158734|P2|COMPLETED|Open-label Phase (Period 2)||0
8175720|NCT02406027|20158735|P1|COMPLETED|Open-label Phase (Period 2)||0
8175721|NCT02406027|20158729|P7|STARTED|Open-label Phase (Period 2)||22
8175722|NCT02406027|20158730|P6|STARTED|Open-label Phase (Period 2)||26
8175723|NCT02406027|20158731|P5|STARTED|Open-label Phase (Period 2)||14
8175724|NCT02406027|20158732|P4|STARTED|Open-label Phase (Period 2)||15
8175725|NCT02406027|20158733|P3|STARTED|Open-label Phase (Period 2)||0
8175726|NCT02406027|20158734|P2|STARTED|Open-label Phase (Period 2)||0
8175727|NCT02406027|20158735|P1|STARTED|Open-label Phase (Period 2)||0
8175728|NCT02406027|20158729|P7|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175729|NCT02406027|20158730|P6|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175730|NCT02406027|20158731|P5|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175731|NCT02406027|20158732|P4|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175732|NCT02406027|20158733|P3|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4
8175733|NCT02406027|20158734|P2|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3
8175734|NCT02406027|20158735|P1|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6
8175735|NCT02406027|20158729|P7|COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175736|NCT02406027|20158730|P6|COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175737|NCT02406027|20158731|P5|COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175738|NCT02406027|20158732|P4|COMPLETED|Double-blind Treatment Phase (Period 1)||0
8175739|NCT02406027|20158733|P3|COMPLETED|Double-blind Treatment Phase (Period 1)||22
8175740|NCT02406027|20158734|P2|COMPLETED|Double-blind Treatment Phase (Period 1)||26
8175741|NCT02406027|20158735|P1|COMPLETED|Double-blind Treatment Phase (Period 1)||29
8175742|NCT02406027|20158729|P7|Prodromal|Double-blind Treatment Phase (Period 1)||0
8175743|NCT02406027|20158730|P6|Prodromal|Double-blind Treatment Phase (Period 1)||0
8175744|NCT02406027|20158731|P5|Prodromal|Double-blind Treatment Phase (Period 1)||0
8175745|NCT02406027|20158732|P4|Prodromal|Double-blind Treatment Phase (Period 1)||0
8175746|NCT02406027|20158733|P3|Prodromal|Double-blind Treatment Phase (Period 1)||20
8175747|NCT02406027|20158734|P2|Prodromal|Double-blind Treatment Phase (Period 1)||21
8175748|NCT02406027|20158735|P1|Prodromal|Double-blind Treatment Phase (Period 1)||29
8175749|NCT02406027|20158729|P7|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
8175750|NCT02406027|20158730|P6|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
8175751|NCT02406027|20158731|P5|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
8175752|NCT02406027|20158732|P4|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
8175753|NCT02406027|20158733|P3|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
8175754|NCT02406027|20158734|P2|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8
8175755|NCT02406027|20158735|P1|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
8175756|NCT02406027|20158729|P7|STARTED|Double-blind Treatment Phase (Period 1)||0
8175757|NCT02406027|20158730|P6|STARTED|Double-blind Treatment Phase (Period 1)||0
8175758|NCT02406027|20158731|P5|STARTED|Double-blind Treatment Phase (Period 1)||0
8175759|NCT02406027|20158732|P4|STARTED|Double-blind Treatment Phase (Period 1)||0
8175760|NCT02406027|20158733|P3|STARTED|Double-blind Treatment Phase (Period 1)||26
8175761|NCT02406027|20158734|P2|STARTED|Double-blind Treatment Phase (Period 1)||29
8175762|NCT02406027|20158735|P1|STARTED|Double-blind Treatment Phase (Period 1)||35
8175763|NCT02405962|20158765|P2|NOT COMPLETED|Overall Study||5
8175764|NCT02405962|20158766|P1|NOT COMPLETED|Overall Study||1
8175765|NCT02405962|20158765|P2|COMPLETED|Overall Study||79
8175766|NCT02405962|20158766|P1|COMPLETED|Overall Study||83
8175767|NCT02405962|20158765|P2|3 Months After the Intervention|Overall Study||79
8175768|NCT02405962|20158766|P1|3 Months After the Intervention|Overall Study||80
8175769|NCT02405962|20158765|P2|Post-intervention|Overall Study||81
8175770|NCT02405962|20158766|P1|Post-intervention|Overall Study||80
8175771|NCT02405962|20158765|P2|STARTED|Overall Study||84
8175772|NCT02405962|20158766|P1|STARTED|Overall Study||84
8175773|NCT02405780|20158804|P4|NOT COMPLETED|Period II||18
8175774|NCT02405780|20158805|P3|NOT COMPLETED|Period II||12
8175775|NCT02405780|20158806|P2|NOT COMPLETED|Period II||12
8175776|NCT02405780|20158807|P1|NOT COMPLETED|Period II||15
8175777|NCT02405780|20158804|P4|COMPLETED|Period II||172
8175778|NCT02405780|20158805|P3|COMPLETED|Period II||81
8175779|NCT02405780|20158806|P2|COMPLETED|Period II||88
8175780|NCT02405780|20158807|P1|COMPLETED|Period II||174
8175781|NCT02405780|20158804|P4|STARTED|Period II||190
8175782|NCT02405780|20158805|P3|STARTED|Period II||93
8175783|NCT02405780|20158806|P2|STARTED|Period II||100
8175784|NCT02405780|20158807|P1|STARTED|Period II||189
8175785|NCT02405780|20158804|P4|NOT COMPLETED|Period I||23
8175786|NCT02405780|20158805|P3|NOT COMPLETED|Period I||15
8175787|NCT02405780|20158806|P2|NOT COMPLETED|Period I||8
8175788|NCT02405780|20158807|P1|NOT COMPLETED|Period I||27
8175789|NCT02405780|20158804|P4|COMPLETED|Period I||190
8175790|NCT02405780|20158805|P3|COMPLETED|Period I||93
8175791|NCT02405780|20158806|P2|COMPLETED|Period I||100
8175792|NCT02405780|20158807|P1|COMPLETED|Period I||189
8175793|NCT02405780|20158804|P4|STARTED|Period I||213
8175794|NCT02405780|20158805|P3|STARTED|Period I||108
8175795|NCT02405780|20158806|P2|STARTED|Period I||108
8175796|NCT02405780|20158807|P1|STARTED|Period I||216
8175797|NCT02405442|20158870|P4|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
8175798|NCT02405442|20158871|P3|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
8175799|NCT02405442|20158872|P2|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
8175800|NCT02405442|20158873|P1|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3
8175801|NCT02405442|20158870|P4|COMPLETED|Extended Treatment Phase(up to Week 208)||0
8175802|NCT02405442|20158871|P3|COMPLETED|Extended Treatment Phase(up to Week 208)||0
8175803|NCT02405442|20158872|P2|COMPLETED|Extended Treatment Phase(up to Week 208)||0
8175804|NCT02405442|20158873|P1|COMPLETED|Extended Treatment Phase(up to Week 208)||0
8175805|NCT02405442|20158870|P4|STARTED|Extended Treatment Phase(up to Week 208)||2
8175806|NCT02405442|20158871|P3|STARTED|Extended Treatment Phase(up to Week 208)||2
8175807|NCT02405442|20158872|P2|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2
8175808|NCT02405442|20158873|P1|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3
8175809|NCT02405442|20158870|P4|NOT COMPLETED|Open-Label Phase (up to Week 52)||24
8175810|NCT02405442|20158871|P3|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
8175811|NCT02405442|20158872|P2|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
8175812|NCT02405442|20158873|P1|NOT COMPLETED|Open-Label Phase (up to Week 52)||48
8175813|NCT02405442|20158870|P4|COMPLETED|Open-Label Phase (up to Week 52)||2
8175814|NCT02405442|20158871|P3|COMPLETED|Open-Label Phase (up to Week 52)||2
8175815|NCT02405442|20158872|P2|COMPLETED|Open-Label Phase (up to Week 52)||3
8175816|NCT02405442|20158873|P1|COMPLETED|Open-Label Phase (up to Week 52)||4
8175817|NCT02405442|20158870|P4|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26
8175818|NCT02405442|20158871|P3|STARTED|Open-Label Phase (up to Week 52)||47
8175819|NCT02405442|20158872|P2|STARTED|Open-Label Phase (up to Week 52)||48
8175820|NCT02405442|20158873|P1|STARTED|Open-Label Phase (up to Week 52)||52
8175821|NCT02405442|20158870|P4|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
8175822|NCT02405442|20158871|P3|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6
8175823|NCT02405442|20158872|P2|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5
8175824|NCT02405442|20158873|P1|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
8175825|NCT02405442|20158870|P4|COMPLETED|Double-Blind Phase (up to Week 8)||27
8175826|NCT02405442|20158871|P3|COMPLETED|Double-Blind Phase (up to Week 8)||47
8175827|NCT02405442|20158872|P2|COMPLETED|Double-Blind Phase (up to Week 8)||48
8175828|NCT02405442|20158873|P1|COMPLETED|Double-Blind Phase (up to Week 8)||52
8175829|NCT02405442|20158870|P4|STARTED|Double-Blind Phase (up to Week 8)||28
8175830|NCT02405442|20158871|P3|STARTED|Double-Blind Phase (up to Week 8)||53
8175831|NCT02405442|20158872|P2|STARTED|Double-Blind Phase (up to Week 8)||53
8175832|NCT02405442|20158873|P1|STARTED|Double-Blind Phase (up to Week 8)||53
8175833|NCT02405429|20158899|P1|NOT COMPLETED|Overall Study||0
8175834|NCT02405429|20158899|P1|COMPLETED|Overall Study||49
8175835|NCT02405429|20158899|P1|STARTED|Overall Study||49
8175836|NCT02405390|20158909|P2|NOT COMPLETED|Overall Study||0
8175837|NCT02405390|20158910|P1|NOT COMPLETED|Overall Study||0
8175838|NCT02405390|20158909|P2|COMPLETED|Overall Study||46
8175839|NCT02405390|20158910|P1|COMPLETED|Overall Study||46
8175840|NCT02405390|20158909|P2|STARTED|Overall Study||46
8175841|NCT02405390|20158910|P1|STARTED|Overall Study||46
8175842|NCT02405195|20158918|P1|NOT COMPLETED|Overall Study||0
8175843|NCT02405195|20158918|P1|COMPLETED|Overall Study||18
8175844|NCT02405195|20158918|P1|STARTED|Overall Study||18
8175845|NCT02405091|20158927|P3|NOT COMPLETED|Overall Study||2
8175846|NCT02405091|20158928|P2|NOT COMPLETED|Overall Study||33
8175847|NCT02405091|20158929|P1|NOT COMPLETED|Overall Study||29
8175848|NCT02405091|20158927|P3|COMPLETED|Overall Study||9
8175849|NCT02405091|20158928|P2|COMPLETED|Overall Study||74
8175850|NCT02405091|20158929|P1|COMPLETED|Overall Study||20
8175851|NCT02405091|20158927|P3|STARTED|Overall Study||11
8175852|NCT02405091|20158928|P2|STARTED|Overall Study||107
8175853|NCT02405091|20158929|P1|STARTED|Overall Study||49
8175854|NCT02404792|20158952|P2|NOT COMPLETED|Overall Study||8
8175855|NCT02404792|20158953|P1|NOT COMPLETED|Overall Study||5
8175856|NCT02404792|20158952|P2|COMPLETED|Overall Study||29
8175857|NCT02404792|20158953|P1|COMPLETED|Overall Study||27
8175858|NCT02404792|20158952|P2|STARTED|Overall Study||37
8175859|NCT02404792|20158953|P1|STARTED|Overall Study||32
8175860|NCT02404649|20158965|P2|NOT COMPLETED|Overall Study||2
8175861|NCT02404649|20158966|P1|NOT COMPLETED|Overall Study||1
8175862|NCT02404649|20158965|P2|COMPLETED|Overall Study||14
8175863|NCT02404649|20158966|P1|COMPLETED|Overall Study||16
8175864|NCT02404649|20158965|P2|STARTED|Overall Study||16
8175865|NCT02404649|20158966|P1|STARTED|Overall Study||17
8175866|NCT02404610|20158976|P2|NOT COMPLETED|Overall Study||0
8175867|NCT02404610|20158977|P1|NOT COMPLETED|Overall Study||0
8175868|NCT02404610|20158976|P2|COMPLETED|Overall Study||53
8175869|NCT02404610|20158977|P1|COMPLETED|Overall Study||54
8175870|NCT02404610|20158976|P2|STARTED|Overall Study||53
8175871|NCT02404610|20158977|P1|STARTED|Overall Study||54
8175872|NCT02404545|20158985|P2|NOT COMPLETED|Overall Study||6
8175873|NCT02404545|20158986|P1|NOT COMPLETED|Overall Study||6
8175874|NCT02404545|20158985|P2|COMPLETED|Overall Study||0
8175875|NCT02404545|20158986|P1|COMPLETED|Overall Study||0
8175876|NCT02404545|20158985|P2|STARTED|Overall Study||6
8175877|NCT02404545|20158986|P1|STARTED|Overall Study||6
8175878|NCT02404532|20158993|P1|NOT COMPLETED|Overall Study||0
8175879|NCT02404532|20158993|P1|COMPLETED|Overall Study||29
8175880|NCT02404532|20158993|P1|STARTED|Overall Study||29
8175881|NCT02404493|20159005|P2|NOT COMPLETED|Overall Study||1
8175882|NCT02404493|20159006|P1|NOT COMPLETED|Overall Study||1
8175883|NCT02404493|20159005|P2|COMPLETED|Overall Study||5
8175884|NCT02404493|20159006|P1|COMPLETED|Overall Study||16
8175885|NCT02404493|20159005|P2|STARTED|Overall Study||6
8175886|NCT02404493|20159006|P1|STARTED|Overall Study||17
8175887|NCT02404389|20159251|P5|NOT COMPLETED|Overall Study||3
8175888|NCT02404389|20159252|P4|NOT COMPLETED|Overall Study||1
8175889|NCT02404389|20159253|P3|NOT COMPLETED|Overall Study||1
8175890|NCT02404389|20159254|P2|NOT COMPLETED|Overall Study||0
8175891|NCT02404389|20159255|P1|NOT COMPLETED|Overall Study||2
8175892|NCT02404389|20159251|P5|COMPLETED|Overall Study||18
8175893|NCT02404389|20159252|P4|COMPLETED|Overall Study||9
8175894|NCT02404389|20159253|P3|COMPLETED|Overall Study||10
8175895|NCT02404389|20159254|P2|COMPLETED|Overall Study||20
8175896|NCT02404389|20159255|P1|COMPLETED|Overall Study||18
8175897|NCT02404389|20159251|P5|STARTED|Overall Study||21
8175898|NCT02404389|20159252|P4|STARTED|Overall Study||10
8175899|NCT02404389|20159253|P3|STARTED|Overall Study||11
8175900|NCT02404389|20159254|P2|STARTED|Overall Study||20
8175901|NCT02404389|20159255|P1|STARTED|Overall Study||20
8175902|NCT02404350|20159295|P4|NOT COMPLETED|Overall Study||37
8175903|NCT02404350|20159296|P3|NOT COMPLETED|Overall Study||6
8175904|NCT02404350|20159297|P2|NOT COMPLETED|Overall Study||6
8175905|NCT02404350|20159298|P1|NOT COMPLETED|Overall Study||15
8175906|NCT02404350|20159295|P4|COMPLETED|Overall Study||295
8175907|NCT02404350|20159296|P3|COMPLETED|Overall Study||216
8175908|NCT02404350|20159297|P2|COMPLETED|Overall Study||214
8175909|NCT02404350|20159298|P1|COMPLETED|Overall Study||207
8175910|NCT02404350|20159295|P4|STARTED|Overall Study||332
8175911|NCT02404350|20159296|P3|STARTED|Overall Study||222
8175912|NCT02404350|20159297|P2|STARTED|Overall Study||220
8175913|NCT02404350|20159298|P1|STARTED|Overall Study||222
8175914|NCT02404311|20159346|P5|NOT COMPLETED|Part B: Month 30-36||0
8175915|NCT02404311|20159347|P4|NOT COMPLETED|Part B: Month 30-36||0
8175916|NCT02404311|20159348|P3|NOT COMPLETED|Part B: Month 30-36||0
8175917|NCT02404311|20159349|P2|NOT COMPLETED|Part B: Month 30-36||0
8175918|NCT02404311|20159350|P1|NOT COMPLETED|Part B: Month 30-36||0
8175919|NCT02404311|20159346|P5|COMPLETED|Part B: Month 30-36||7
8175920|NCT02404311|20159347|P4|COMPLETED|Part B: Month 30-36||31
8175921|NCT02404311|20159348|P3|COMPLETED|Part B: Month 30-36||32
8175922|NCT02404311|20159349|P2|COMPLETED|Part B: Month 30-36||0
8175923|NCT02404311|20159350|P1|COMPLETED|Part B: Month 30-36||0
8175924|NCT02404311|20159346|P5|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||6
8175925|NCT02404311|20159347|P4|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||30
8176110|NCT02402933|20159839|P1|COMPLETED|Overall Study||12
8175926|NCT02404311|20159348|P3|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||28
8175927|NCT02404311|20159349|P2|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
8175928|NCT02404311|20159350|P1|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
8175929|NCT02404311|20159346|P5|STARTED|Part B: Month 30-36||7
8175930|NCT02404311|20159347|P4|STARTED|Part B: Month 30-36||31
8175931|NCT02404311|20159348|P3|STARTED|Part B: Month 30-36||32
8175932|NCT02404311|20159349|P2|STARTED|Part B: Month 30-36||0
8175933|NCT02404311|20159350|P1|STARTED|Part B: Month 30-36||0
8175934|NCT02404311|20159346|P5|NOT COMPLETED|Part A: Month 0-18||0
8175935|NCT02404311|20159347|P4|NOT COMPLETED|Part A: Month 0-18||0
8175936|NCT02404311|20159348|P3|NOT COMPLETED|Part A: Month 0-18||0
8175937|NCT02404311|20159349|P2|NOT COMPLETED|Part A: Month 0-18||6
8175938|NCT02404311|20159350|P1|NOT COMPLETED|Part A: Month 0-18||26
8175939|NCT02404311|20159346|P5|COMPLETED|Part A: Month 0-18||0
8175940|NCT02404311|20159347|P4|COMPLETED|Part A: Month 0-18||0
8175941|NCT02404311|20159348|P3|COMPLETED|Part A: Month 0-18||0
8175942|NCT02404311|20159349|P2|COMPLETED|Part A: Month 0-18||36
8175943|NCT02404311|20159350|P1|COMPLETED|Part A: Month 0-18||184
8175944|NCT02404311|20159346|P5|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8175945|NCT02404311|20159347|P4|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8175946|NCT02404311|20159348|P3|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8175947|NCT02404311|20159349|P2|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||33
8175948|NCT02404311|20159350|P1|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||186
8175949|NCT02404311|20159346|P5|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8175950|NCT02404311|20159347|P4|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8175951|NCT02404311|20159348|P3|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
8175952|NCT02404311|20159349|P2|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||37
8175953|NCT02404311|20159350|P1|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||194
8175954|NCT02404311|20159346|P5|Per Protocol|Part A: Month 0-18||0
8175955|NCT02404311|20159347|P4|Per Protocol|Part A: Month 0-18||0
8175956|NCT02404311|20159348|P3|Per Protocol|Part A: Month 0-18||0
8175957|NCT02404311|20159349|P2|Per Protocol|Part A: Month 0-18||37
8175958|NCT02404311|20159350|P1|Per Protocol|Part A: Month 0-18||185
8175959|NCT02404311|20159346|P5|STARTED|Part A: Month 0-18||0
8175960|NCT02404311|20159347|P4|STARTED|Part A: Month 0-18||0
8175961|NCT02404311|20159348|P3|STARTED|Part A: Month 0-18||0
8175962|NCT02404311|20159349|P2|STARTED|Part A: Month 0-18||42
8175963|NCT02404311|20159350|P1|STARTED|Part A: Month 0-18||210
8175964|NCT02404285|20159454|P2|NOT COMPLETED|Overall Study||2
8175965|NCT02404285|20159455|P1|NOT COMPLETED|Overall Study||2
8175966|NCT02404285|20159454|P2|COMPLETED|Overall Study||33
8175967|NCT02404285|20159455|P1|COMPLETED|Overall Study||31
8175968|NCT02404285|20159454|P2|STARTED|Overall Study||35
8175969|NCT02404285|20159455|P1|STARTED|Overall Study||33
8175970|NCT02404220|20159491|P4|NOT COMPLETED|Overall Study||10
8175971|NCT02404220|20159492|P3|NOT COMPLETED|Overall Study||7
8175972|NCT02404220|20159493|P2|NOT COMPLETED|Overall Study||8
8175973|NCT02404220|20159494|P1|NOT COMPLETED|Overall Study||5
8175974|NCT02404220|20159491|P4|COMPLETED|Overall Study||0
8175975|NCT02404220|20159492|P3|COMPLETED|Overall Study||0
8175976|NCT02404220|20159493|P2|COMPLETED|Overall Study||0
8175977|NCT02404220|20159494|P1|COMPLETED|Overall Study||0
8175978|NCT02404220|20159491|P4|STARTED|Overall Study||10
8175979|NCT02404220|20159492|P3|STARTED|Overall Study||7
8175980|NCT02404220|20159493|P2|STARTED|Overall Study||8
8175981|NCT02404220|20159494|P1|STARTED|Overall Study||5
8175982|NCT02404168|20159520|P1|NOT COMPLETED|Overall Study||0
8175983|NCT02404168|20159520|P1|COMPLETED|Overall Study||4
8175984|NCT02404168|20159520|P1|STARTED|Overall Study||4
8175985|NCT02404103|20159530|P2|NOT COMPLETED|Overall Study||3
8175986|NCT02404103|20159531|P1|NOT COMPLETED|Overall Study||4
8175987|NCT02404103|20159530|P2|COMPLETED|Overall Study||9
8175988|NCT02404103|20159531|P1|COMPLETED|Overall Study||10
8175989|NCT02404103|20159530|P2|STARTED|Overall Study||12
8175990|NCT02404103|20159531|P1|STARTED|Overall Study||14
8175991|NCT02404025|20159551|P1|NOT COMPLETED|Overall Study||4
8175992|NCT02404025|20159551|P1|COMPLETED|Overall Study||6
8175993|NCT02404025|20159551|P1|STARTED|Overall Study||10
8175994|NCT02403999|20159583|P3|NOT COMPLETED|Overall Study||0
8175995|NCT02403999|20159584|P2|NOT COMPLETED|Overall Study||0
8175996|NCT02403999|20159585|P1|NOT COMPLETED|Overall Study||0
8175997|NCT02403999|20159583|P3|COMPLETED|Overall Study||11
8175998|NCT02403999|20159584|P2|COMPLETED|Overall Study||10
8175999|NCT02403999|20159585|P1|COMPLETED|Overall Study||10
8176000|NCT02403999|20159583|P3|STARTED|Overall Study||11
8176001|NCT02403999|20159584|P2|STARTED|Overall Study||10
8176002|NCT02403999|20159585|P1|STARTED|Overall Study||10
8176003|NCT02403986|20159598|P2|NOT COMPLETED|Overall Study||4
8176004|NCT02403986|20159599|P1|NOT COMPLETED|Overall Study||5
8176005|NCT02403986|20159598|P2|COMPLETED|Overall Study||23
8176006|NCT02403986|20159599|P1|COMPLETED|Overall Study||21
8176007|NCT02403986|20159598|P2|STARTED|Overall Study||27
8176008|NCT02403986|20159599|P1|STARTED|Overall Study||26
8176009|NCT02403895|20159607|P1|NOT COMPLETED|Overall Study||0
8176010|NCT02403895|20159607|P1|COMPLETED|Overall Study||11
8176011|NCT02403895|20159607|P1|STARTED|Overall Study||11
8176012|NCT02403830|20159620|P2|NOT COMPLETED|Visit 2||0
8176013|NCT02403830|20159621|P1|NOT COMPLETED|Visit 2||0
8176014|NCT02403830|20159620|P2|COMPLETED|Visit 2||15
8176015|NCT02403830|20159621|P1|COMPLETED|Visit 2||14
8176016|NCT02403830|20159620|P2|STARTED|Visit 2||15
8176017|NCT02403830|20159621|P1|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
8176018|NCT02403830|20159620|P2|NOT COMPLETED|Visit 1||0
8176019|NCT02403830|20159621|P1|NOT COMPLETED|Visit 1||0
8176020|NCT02403830|20159620|P2|COMPLETED|Visit 1||15
8176021|NCT02403830|20159621|P1|COMPLETED|Visit 1||15
8176022|NCT02403830|20159620|P2|STARTED|Visit 1||15
8176023|NCT02403830|20159621|P1|STARTED|Visit 1||15
8176024|NCT02403817|20159633|P2|NOT COMPLETED|Overall Study||0
8176025|NCT02403817|20159634|P1|NOT COMPLETED|Overall Study||5
8176026|NCT02403817|20159633|P2|COMPLETED|Overall Study||2
8176027|NCT02403817|20159634|P1|COMPLETED|Overall Study||23
8176028|NCT02403817|20159633|P2|STARTED|Overall Study||2
8176029|NCT02403817|20159634|P1|STARTED|Overall Study||28
8176030|NCT02403778|20159648|P2|NOT COMPLETED|Overall Study||0
8176031|NCT02403778|20159649|P1|NOT COMPLETED|Overall Study||0
8176032|NCT02403778|20159648|P2|COMPLETED|Overall Study||4
8176033|NCT02403778|20159649|P1|COMPLETED|Overall Study||6
8176034|NCT02403778|20159648|P2|STARTED|Overall Study||4
8176035|NCT02403778|20159649|P1|STARTED|Overall Study||6
8176036|NCT02403674|20159665|P2|NOT COMPLETED|Overall Study||63
8176037|NCT02403674|20159666|P1|NOT COMPLETED|Overall Study||55
8176038|NCT02403674|20159665|P2|COMPLETED|Overall Study||303
8176039|NCT02403674|20159666|P1|COMPLETED|Overall Study||313
8176040|NCT02403674|20159665|P2|Treated|Overall Study||364
8176041|NCT02403674|20159666|P1|Treated|Overall Study||364
8176042|NCT02403674|20159665|P2|STARTED|Overall Study||366
8176043|NCT02403674|20159666|P1|STARTED|Overall Study||368
8176044|NCT02403635|20159705|P1|NOT COMPLETED|Overall Study||9
8176045|NCT02403635|20159705|P1|COMPLETED|Overall Study||18
8176046|NCT02403635|20159705|P1|Received the First Dose|Overall Study||18
8176047|NCT02403635|20159705|P1|Screening (28 Days)|Overall Study||27
8176048|NCT02403635|20159705|P1|STARTED|Overall Study||27
8176049|NCT02403479|20159773|P2|NOT COMPLETED|Overall Study||0
8176050|NCT02403479|20159774|P1|NOT COMPLETED|Overall Study||2
8176051|NCT02403479|20159773|P2|COMPLETED|Overall Study||12
8176052|NCT02403479|20159774|P1|COMPLETED|Overall Study||8
8176053|NCT02403479|20159773|P2|STARTED|Overall Study||12
8176054|NCT02403479|20159774|P1|STARTED|Overall Study||10
8176055|NCT02403271|20159782|P2|NOT COMPLETED|Period 2||124
8176056|NCT02403271|20159783|P1|NOT COMPLETED|Period 2||0
8176057|NCT02403271|20159782|P2|COMPLETED|Period 2||0
8176058|NCT02403271|20159783|P1|COMPLETED|Period 2||0
8176059|NCT02403271|20159782|P2|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124
8176060|NCT02403271|20159783|P1|STARTED|Period 2||0
8176061|NCT02403271|20159782|P2|NOT COMPLETED|Period 1||0
8176062|NCT02403271|20159783|P1|NOT COMPLETED|Period 1||1
8176063|NCT02403271|20159782|P2|COMPLETED|Period 1||0
8176064|NCT02403271|20159783|P1|COMPLETED|Period 1||6
8176065|NCT02403271|20159782|P2|STARTED|Period 1||0
8176066|NCT02403271|20159783|P1|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7
8176067|NCT02403206|20159797|P2|NOT COMPLETED|Overall Study||10
8176068|NCT02403206|20159798|P1|NOT COMPLETED|Overall Study||11
8176069|NCT02403206|20159797|P2|COMPLETED|Overall Study||186
8176070|NCT02403206|20159798|P1|COMPLETED|Overall Study||183
8176071|NCT02403206|20159797|P2|Randomized and Treated|Overall Study||190
8176072|NCT02403206|20159798|P1|Randomized and Treated|Overall Study||188
8176073|NCT02403206|20159797|P2|Treated Prior to Randomization|Overall Study||1
8176074|NCT02403206|20159798|P1|Treated Prior to Randomization|Overall Study||0
8176075|NCT02403206|20159797|P2|STARTED|Overall Study||196
8176076|NCT02403206|20159798|P1|STARTED|Overall Study||194
8176077|NCT02403180|20159809|P2|NOT COMPLETED|Period 2 (5 Days)||1
8176078|NCT02403180|20159810|P1|NOT COMPLETED|Period 2 (5 Days)||0
8176079|NCT02403180|20159809|P2|COMPLETED|Period 2 (5 Days)||32
8176080|NCT02403180|20159810|P1|COMPLETED|Period 2 (5 Days)||36
8176081|NCT02403180|20159809|P2|STARTED|Period 2 (5 Days)||33
8176082|NCT02403180|20159810|P1|STARTED|Period 2 (5 Days)||36
8176083|NCT02403180|20159809|P2|NOT COMPLETED|Period 1 (5 Days)||0
8176084|NCT02403180|20159810|P1|NOT COMPLETED|Period 1 (5 Days)||0
8176085|NCT02403180|20159809|P2|COMPLETED|Period 1 (5 Days)||33
8176086|NCT02403180|20159810|P1|COMPLETED|Period 1 (5 Days)||36
8176087|NCT02403180|20159809|P2|Randomized|Period 1 (5 Days)||33
8176088|NCT02403180|20159810|P1|Randomized|Period 1 (5 Days)||36
8176089|NCT02403180|20159809|P2|STARTED|Period 1 (5 Days)||33
8176090|NCT02403180|20159810|P1|STARTED|Period 1 (5 Days)||36
8176091|NCT02403180|20159809|P2|NOT COMPLETED|Pre-Treatment Period||1
8176092|NCT02403180|20159810|P1|NOT COMPLETED|Pre-Treatment Period||0
8176093|NCT02403180|20159809|P2|COMPLETED|Pre-Treatment Period||33
8176094|NCT02403180|20159810|P1|COMPLETED|Pre-Treatment Period||36
8176095|NCT02403180|20159809|P2|STARTED|Pre-Treatment Period||34
8176096|NCT02403180|20159810|P1|STARTED|Pre-Treatment Period||36
8176097|NCT02403154|20159822|P4|NOT COMPLETED|Overall Study||1
8176098|NCT02403154|20159823|P3|NOT COMPLETED|Overall Study||1
8176099|NCT02403154|20159824|P2|NOT COMPLETED|Overall Study||0
8176100|NCT02403154|20159825|P1|NOT COMPLETED|Overall Study||2
8176101|NCT02403154|20159822|P4|COMPLETED|Overall Study||0
8176102|NCT02403154|20159823|P3|COMPLETED|Overall Study||0
8176103|NCT02403154|20159824|P2|COMPLETED|Overall Study||0
8176104|NCT02403154|20159825|P1|COMPLETED|Overall Study||0
8176105|NCT02403154|20159822|P4|STARTED|Overall Study||1
8176106|NCT02403154|20159823|P3|STARTED|Overall Study||1
8176107|NCT02403154|20159824|P2|STARTED|Overall Study||0
8176108|NCT02403154|20159825|P1|STARTED|Overall Study||2
8176109|NCT02402933|20159839|P1|NOT COMPLETED|Overall Study||14
8176111|NCT02402933|20159839|P1|Received at Least One Dose of Study Drug|Overall Study||22
8176112|NCT02402933|20159839|P1|STARTED|Overall Study||26
8176113|NCT02402907|20159848|P2|NOT COMPLETED|Overall Study||27
8176114|NCT02402907|20159849|P1|NOT COMPLETED|Overall Study||20
8176115|NCT02402907|20159848|P2|COMPLETED|Overall Study||647
8176116|NCT02402907|20159849|P1|COMPLETED|Overall Study||662
8176117|NCT02402907|20159848|P2|STARTED|Overall Study||674
8176118|NCT02402907|20159849|P1|STARTED|Overall Study||682
8176119|NCT02402881|20159869|P2|NOT COMPLETED|Post-Intervention Study Period||0
8176120|NCT02402881|20159870|P1|NOT COMPLETED|Post-Intervention Study Period||0
8176121|NCT02402881|20159869|P2|COMPLETED|Post-Intervention Study Period||8662
8176122|NCT02402881|20159870|P1|COMPLETED|Post-Intervention Study Period||3111
8176123|NCT02402881|20159869|P2|STARTED|Post-Intervention Study Period||8662
8176124|NCT02402881|20159870|P1|STARTED|Post-Intervention Study Period||3111
8176125|NCT02402881|20159869|P2|NOT COMPLETED|Pre-Intervention Study Period||0
8176126|NCT02402881|20159870|P1|NOT COMPLETED|Pre-Intervention Study Period||0
8176127|NCT02402881|20159869|P2|COMPLETED|Pre-Intervention Study Period||5657
8176128|NCT02402881|20159870|P1|COMPLETED|Pre-Intervention Study Period||2222
8176129|NCT02402881|20159869|P2|STARTED|Pre-Intervention Study Period||5657
8176130|NCT02402881|20159870|P1|STARTED|Pre-Intervention Study Period||2222
8176131|NCT02402764|20159878|P1|NOT COMPLETED|Overall Study||0
8176132|NCT02402764|20159878|P1|COMPLETED|Overall Study||10
8176133|NCT02402764|20159878|P1|STARTED|Overall Study||10
8176134|NCT02402452|20159888|P2|NOT COMPLETED|Overall Study||0
8176135|NCT02402452|20159889|P1|NOT COMPLETED|Overall Study||0
8176136|NCT02402452|20159888|P2|COMPLETED|Overall Study||10
8176137|NCT02402452|20159889|P1|COMPLETED|Overall Study||10
8176138|NCT02402452|20159888|P2|STARTED|Overall Study||10
8176139|NCT02402452|20159889|P1|STARTED|Overall Study||10
8176140|NCT02402322|20159904|P3|NOT COMPLETED|Follow-up||24
8176141|NCT02402322|20159905|P2|NOT COMPLETED|Follow-up||3
8176142|NCT02402322|20159906|P1|NOT COMPLETED|Follow-up||6
8176143|NCT02402322|20159904|P3|COMPLETED|Follow-up||0
8176144|NCT02402322|20159905|P2|COMPLETED|Follow-up||21
8176145|NCT02402322|20159906|P1|COMPLETED|Follow-up||18
8176146|NCT02402322|20159904|P3|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
8176147|NCT02402322|20159905|P2|STARTED|Follow-up||24
8176148|NCT02402322|20159906|P1|STARTED|Follow-up||24
8176149|NCT02402322|20159904|P3|NOT COMPLETED|Pretreatment||1
8176150|NCT02402322|20159905|P2|NOT COMPLETED|Pretreatment||1
8176151|NCT02402322|20159906|P1|NOT COMPLETED|Pretreatment||3
8176152|NCT02402322|20159904|P3|COMPLETED|Pretreatment||24
8176153|NCT02402322|20159905|P2|COMPLETED|Pretreatment||24
8176154|NCT02402322|20159906|P1|COMPLETED|Pretreatment||24
8176155|NCT02402322|20159904|P3|Posttreatment Measures|Pretreatment||24
8176156|NCT02402322|20159905|P2|Posttreatment Measures|Pretreatment||24
8176157|NCT02402322|20159906|P1|Posttreatment Measures|Pretreatment||24
8176158|NCT02402322|20159904|P3|STARTED|Pretreatment||25
8176159|NCT02402322|20159905|P2|STARTED|Pretreatment||25
8176160|NCT02402322|20159906|P1|STARTED|Pretreatment||27
8176161|NCT02402296|20159940|P2|NOT COMPLETED|Overall Study||0
8176162|NCT02402296|20159941|P1|NOT COMPLETED|Overall Study||0
8176163|NCT02402296|20159940|P2|COMPLETED|Overall Study||15
8176164|NCT02402296|20159941|P1|COMPLETED|Overall Study||15
8176165|NCT02402296|20159940|P2|STARTED|Overall Study||15
8176166|NCT02402296|20159941|P1|STARTED|Overall Study||15
8176167|NCT02402218|20159956|P3|NOT COMPLETED|Overall Study||17
8176168|NCT02402218|20159957|P2|NOT COMPLETED|Overall Study||13
8176169|NCT02402218|20159958|P1|NOT COMPLETED|Overall Study||14
8176170|NCT02402218|20159956|P3|COMPLETED|Overall Study||37
8176171|NCT02402218|20159957|P2|COMPLETED|Overall Study||41
8176172|NCT02402218|20159958|P1|COMPLETED|Overall Study||22
8176173|NCT02402218|20159956|P3|Achieved Sustained Virologic Response|Overall Study||37
8176174|NCT02402218|20159957|P2|Achieved Sustained Virologic Response|Overall Study||41
8176175|NCT02402218|20159958|P1|Achieved Sustained Virologic Response|Overall Study||22
8176176|NCT02402218|20159956|P3|Completed Treatment With LDV/SOF|Overall Study||39
8176177|NCT02402218|20159957|P2|Completed Treatment With LDV/SOF|Overall Study||42
8176178|NCT02402218|20159958|P1|Completed Treatment With LDV/SOF|Overall Study||23
8176179|NCT02402218|20159956|P3|Initiated Treatment With LDV/SOF|Overall Study||41
8176180|NCT02402218|20159957|P2|Initiated Treatment With LDV/SOF|Overall Study||45
8176181|NCT02402218|20159958|P1|Initiated Treatment With LDV/SOF|Overall Study||24
8176182|NCT02402218|20159956|P3|STARTED|Overall Study||54
8176183|NCT02402218|20159957|P2|STARTED|Overall Study||54
8176184|NCT02402218|20159958|P1|STARTED|Overall Study||36
8176188|NCT02402153|20160002|P1|NOT COMPLETED|Overall Study||0
8176189|NCT02402153|20160002|P1|COMPLETED|Overall Study||18
8176190|NCT02402153|20160002|P1|STARTED|Overall Study||18
8176191|NCT02402127|20160018|P6|NOT COMPLETED|Third Wear Period (1 Day)||0
8176192|NCT02402127|20160019|P5|NOT COMPLETED|Third Wear Period (1 Day)||0
8176193|NCT02402127|20160020|P4|NOT COMPLETED|Third Wear Period (1 Day)||0
8176194|NCT02402127|20160021|P3|NOT COMPLETED|Third Wear Period (1 Day)||0
8176195|NCT02402127|20160022|P2|NOT COMPLETED|Third Wear Period (1 Day)||0
8176196|NCT02402127|20160023|P1|NOT COMPLETED|Third Wear Period (1 Day)||0
8176197|NCT02402127|20160018|P6|COMPLETED|Third Wear Period (1 Day)||4
8176198|NCT02402127|20160019|P5|COMPLETED|Third Wear Period (1 Day)||4
8176199|NCT02402127|20160020|P4|COMPLETED|Third Wear Period (1 Day)||4
8176200|NCT02402127|20160021|P3|COMPLETED|Third Wear Period (1 Day)||4
8176201|NCT02402127|20160022|P2|COMPLETED|Third Wear Period (1 Day)||4
8176202|NCT02402127|20160023|P1|COMPLETED|Third Wear Period (1 Day)||4
8176203|NCT02402127|20160018|P6|STARTED|Third Wear Period (1 Day)||4
8176204|NCT02402127|20160019|P5|STARTED|Third Wear Period (1 Day)||4
8176205|NCT02402127|20160020|P4|STARTED|Third Wear Period (1 Day)||4
8176206|NCT02402127|20160021|P3|STARTED|Third Wear Period (1 Day)||4
8176207|NCT02402127|20160022|P2|STARTED|Third Wear Period (1 Day)||4
8176208|NCT02402127|20160023|P1|STARTED|Third Wear Period (1 Day)||4
8176209|NCT02402127|20160018|P6|NOT COMPLETED|Second Wear Period (1 Day)||0
8176210|NCT02402127|20160019|P5|NOT COMPLETED|Second Wear Period (1 Day)||0
8176211|NCT02402127|20160020|P4|NOT COMPLETED|Second Wear Period (1 Day)||0
8176212|NCT02402127|20160021|P3|NOT COMPLETED|Second Wear Period (1 Day)||0
8176213|NCT02402127|20160022|P2|NOT COMPLETED|Second Wear Period (1 Day)||0
8176214|NCT02402127|20160023|P1|NOT COMPLETED|Second Wear Period (1 Day)||0
8176215|NCT02402127|20160018|P6|COMPLETED|Second Wear Period (1 Day)||4
8176216|NCT02402127|20160019|P5|COMPLETED|Second Wear Period (1 Day)||4
8176217|NCT02402127|20160020|P4|COMPLETED|Second Wear Period (1 Day)||4
8176218|NCT02402127|20160021|P3|COMPLETED|Second Wear Period (1 Day)||4
8176219|NCT02402127|20160022|P2|COMPLETED|Second Wear Period (1 Day)||4
8176220|NCT02402127|20160023|P1|COMPLETED|Second Wear Period (1 Day)||4
8176221|NCT02402127|20160018|P6|STARTED|Second Wear Period (1 Day)||4
8176222|NCT02402127|20160019|P5|STARTED|Second Wear Period (1 Day)||4
8176223|NCT02402127|20160020|P4|STARTED|Second Wear Period (1 Day)||4
8176224|NCT02402127|20160021|P3|STARTED|Second Wear Period (1 Day)||4
8176225|NCT02402127|20160022|P2|STARTED|Second Wear Period (1 Day)||4
8176226|NCT02402127|20160023|P1|STARTED|Second Wear Period (1 Day)||4
8176227|NCT02402127|20160018|P6|NOT COMPLETED|First Wear Period (1 Day)||0
8176228|NCT02402127|20160019|P5|NOT COMPLETED|First Wear Period (1 Day)||0
8176229|NCT02402127|20160020|P4|NOT COMPLETED|First Wear Period (1 Day)||0
8176230|NCT02402127|20160021|P3|NOT COMPLETED|First Wear Period (1 Day)||0
8176231|NCT02402127|20160022|P2|NOT COMPLETED|First Wear Period (1 Day)||0
8176232|NCT02402127|20160023|P1|NOT COMPLETED|First Wear Period (1 Day)||0
8176233|NCT02402127|20160018|P6|COMPLETED|First Wear Period (1 Day)||4
8176234|NCT02402127|20160019|P5|COMPLETED|First Wear Period (1 Day)||4
8176235|NCT02402127|20160020|P4|COMPLETED|First Wear Period (1 Day)||4
8176236|NCT02402127|20160021|P3|COMPLETED|First Wear Period (1 Day)||4
8176237|NCT02402127|20160022|P2|COMPLETED|First Wear Period (1 Day)||4
8176238|NCT02402127|20160023|P1|COMPLETED|First Wear Period (1 Day)||4
8176239|NCT02402127|20160018|P6|Randomized and Treated|First Wear Period (1 Day)||4
8176240|NCT02402127|20160019|P5|Randomized and Treated|First Wear Period (1 Day)||4
8176241|NCT02402127|20160020|P4|Randomized and Treated|First Wear Period (1 Day)||4
8176242|NCT02402127|20160021|P3|Randomized and Treated|First Wear Period (1 Day)||4
8176243|NCT02402127|20160022|P2|Randomized and Treated|First Wear Period (1 Day)||4
8176244|NCT02402127|20160023|P1|Randomized and Treated|First Wear Period (1 Day)||4
8176245|NCT02402127|20160018|P6|STARTED|First Wear Period (1 Day)||4
8176246|NCT02402127|20160019|P5|STARTED|First Wear Period (1 Day)||4
8176247|NCT02402127|20160020|P4|STARTED|First Wear Period (1 Day)||4
8176248|NCT02402127|20160021|P3|STARTED|First Wear Period (1 Day)||4
8176249|NCT02402127|20160022|P2|STARTED|First Wear Period (1 Day)||4
8176250|NCT02402127|20160023|P1|STARTED|First Wear Period (1 Day)||4
8176251|NCT02402062|20160034|P1|NOT COMPLETED|Overall Study||0
8176252|NCT02402062|20160034|P1|COMPLETED|Overall Study||17
8176253|NCT02402062|20160034|P1|STARTED|Overall Study||17
8176254|NCT02402036|20160044|P1|NOT COMPLETED|Overall Study||0
8176255|NCT02402036|20160044|P1|COMPLETED|Overall Study||10
8176256|NCT02402036|20160044|P1|STARTED|Overall Study||10
8176257|NCT02401867|20160048|P1|NOT COMPLETED|Analysis||9
8176258|NCT02401867|20160048|P1|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
8176259|NCT02401867|20160048|P1|STARTED|Analysis||140
8176260|NCT02401867|20160048|P1|NOT COMPLETED|Specimen Collection||10
8176261|NCT02401867|20160048|P1|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
8176262|NCT02401867|20160048|P1|STARTED|Specimen Collection||150
8176263|NCT02401867|20160048|P1|NOT COMPLETED|Enrolled||0
8176264|NCT02401867|20160048|P1|COMPLETED|Enrolled||150
8176265|NCT02401867|20160048|P1|STARTED|Enrolled||150
8176266|NCT02401672|20160055|P2|NOT COMPLETED|Overall Study||3
8176267|NCT02401672|20160056|P1|NOT COMPLETED|Overall Study||1
8176268|NCT02401672|20160055|P2|COMPLETED|Overall Study||17
8176269|NCT02401672|20160056|P1|COMPLETED|Overall Study||21
8176270|NCT02401672|20160055|P2|STARTED|Overall Study||20
8176271|NCT02401672|20160056|P1|STARTED|Overall Study||22
8176272|NCT02401555|20160071|P3|NOT COMPLETED|Overall Study||0
8176273|NCT02401555|20160072|P2|NOT COMPLETED|Overall Study||0
8176274|NCT02401555|20160073|P1|NOT COMPLETED|Overall Study||0
8176275|NCT02401555|20160071|P3|COMPLETED|Overall Study||120
8176276|NCT02401555|20160072|P2|COMPLETED|Overall Study||212
8176277|NCT02401555|20160073|P1|COMPLETED|Overall Study||87
8176278|NCT02401555|20160071|P3|STARTED|Overall Study||120
8176279|NCT02401555|20160072|P2|STARTED|Overall Study||212
8176280|NCT02401555|20160073|P1|STARTED|Overall Study||87
8176281|NCT02401542|20160084|P3|NOT COMPLETED|Overall Study||0
8176282|NCT02401542|20160085|P2|NOT COMPLETED|Overall Study||0
8176283|NCT02401542|20160086|P1|NOT COMPLETED|Overall Study||1
8176284|NCT02401542|20160084|P3|COMPLETED|Overall Study||0
8176285|NCT02401542|20160085|P2|COMPLETED|Overall Study||30
8176286|NCT02401542|20160086|P1|COMPLETED|Overall Study||40
8176287|NCT02401542|20160084|P3|STARTED|Overall Study||0
8176288|NCT02401542|20160085|P2|STARTED|Overall Study||30
8176289|NCT02401542|20160086|P1|STARTED|Overall Study||41
8176290|NCT02401529|20160098|P2|NOT COMPLETED|Overall Study||7
8176291|NCT02401529|20160099|P1|NOT COMPLETED|Overall Study||9
8176292|NCT02401529|20160098|P2|COMPLETED|Overall Study||50
8176293|NCT02401529|20160099|P1|COMPLETED|Overall Study||50
8176294|NCT02401529|20160098|P2|STARTED|Overall Study||57
8176295|NCT02401529|20160099|P1|STARTED|Overall Study||59
8176296|NCT02401464|20160127|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8176297|NCT02401464|20160128|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8176298|NCT02401464|20160129|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8176299|NCT02401464|20160130|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
8176300|NCT02401464|20160127|P4|COMPLETED|Intervention Period 2 (6 Days)||13
8176301|NCT02401464|20160128|P3|COMPLETED|Intervention Period 2 (6 Days)||13
8176302|NCT02401464|20160129|P2|COMPLETED|Intervention Period 2 (6 Days)||13
8176303|NCT02401464|20160130|P1|COMPLETED|Intervention Period 2 (6 Days)||13
8176304|NCT02401464|20160127|P4|STARTED|Intervention Period 2 (6 Days)||13
8176305|NCT02401464|20160128|P3|STARTED|Intervention Period 2 (6 Days)||13
8176306|NCT02401464|20160129|P2|STARTED|Intervention Period 2 (6 Days)||13
8176307|NCT02401464|20160130|P1|STARTED|Intervention Period 2 (6 Days)||13
8176308|NCT02401464|20160127|P4|NOT COMPLETED|Washout Period (At Least 6 Days)||0
8176309|NCT02401464|20160128|P3|NOT COMPLETED|Washout Period (At Least 6 Days)||0
8176310|NCT02401464|20160129|P2|NOT COMPLETED|Washout Period (At Least 6 Days)||0
8176311|NCT02401464|20160130|P1|NOT COMPLETED|Washout Period (At Least 6 Days)||0
8176312|NCT02401464|20160127|P4|COMPLETED|Washout Period (At Least 6 Days)||13
8176313|NCT02401464|20160128|P3|COMPLETED|Washout Period (At Least 6 Days)||13
8176314|NCT02401464|20160129|P2|COMPLETED|Washout Period (At Least 6 Days)||13
8176315|NCT02401464|20160130|P1|COMPLETED|Washout Period (At Least 6 Days)||13
8176316|NCT02401464|20160127|P4|STARTED|Washout Period (At Least 6 Days)||13
8176317|NCT02401464|20160128|P3|STARTED|Washout Period (At Least 6 Days)||13
8176318|NCT02401464|20160129|P2|STARTED|Washout Period (At Least 6 Days)||13
8176319|NCT02401464|20160130|P1|STARTED|Washout Period (At Least 6 Days)||13
8176320|NCT02401464|20160127|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8176321|NCT02401464|20160128|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8176322|NCT02401464|20160129|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8176323|NCT02401464|20160130|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
8176324|NCT02401464|20160127|P4|COMPLETED|Intervention Period 1 (6 Days)||13
8176325|NCT02401464|20160128|P3|COMPLETED|Intervention Period 1 (6 Days)||13
8176326|NCT02401464|20160129|P2|COMPLETED|Intervention Period 1 (6 Days)||13
8176327|NCT02401464|20160130|P1|COMPLETED|Intervention Period 1 (6 Days)||13
8176328|NCT02401464|20160127|P4|STARTED|Intervention Period 1 (6 Days)||13
8176329|NCT02401464|20160128|P3|STARTED|Intervention Period 1 (6 Days)||13
8176330|NCT02401464|20160129|P2|STARTED|Intervention Period 1 (6 Days)||13
8176331|NCT02401464|20160130|P1|STARTED|Intervention Period 1 (6 Days)||13
8176332|NCT02401412|20160166|P2|NOT COMPLETED|Overall Study||32
8176333|NCT02401412|20160167|P1|NOT COMPLETED|Overall Study||30
8176334|NCT02401412|20160166|P2|COMPLETED|Overall Study||49
8176335|NCT02401412|20160167|P1|COMPLETED|Overall Study||59
8176336|NCT02401412|20160166|P2|Received Study Device|Overall Study||80
8176337|NCT02401412|20160167|P1|Received Study Device|Overall Study||89
8176338|NCT02401412|20160166|P2|STARTED|Overall Study||81
8176339|NCT02401412|20160167|P1|STARTED|Overall Study||89
8176340|NCT02401256|20160175|P1|NOT COMPLETED|Overall Study||17
8176341|NCT02401256|20160175|P1|COMPLETED|Overall Study||53
8176342|NCT02401256|20160175|P1|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
8176343|NCT02401256|20160175|P1|Finished Phase 3|Overall Study||53
8176344|NCT02401256|20160175|P1|Finished Phase 2|Overall Study||58
8176345|NCT02401256|20160175|P1|Finished Phase 1|Overall Study||64
8176346|NCT02401256|20160175|P1|STARTED|Overall Study||70
8176347|NCT02401230|20160184|P3|NOT COMPLETED|Overall Study||4
8176348|NCT02401230|20160185|P2|NOT COMPLETED|Overall Study||6
8176349|NCT02401230|20160186|P1|NOT COMPLETED|Overall Study||6
8176350|NCT02401230|20160184|P3|COMPLETED|Overall Study||21
8176351|NCT02401230|20160185|P2|COMPLETED|Overall Study||19
8176352|NCT02401230|20160186|P1|COMPLETED|Overall Study||20
8176353|NCT02401230|20160184|P3|STARTED|Overall Study||25
8176354|NCT02401230|20160185|P2|STARTED|Overall Study||25
8176355|NCT02401230|20160186|P1|STARTED|Overall Study||26
8176356|NCT02401048|20160221|P2|NOT COMPLETED|Overall Study||30
8176357|NCT02401048|20160222|P1|NOT COMPLETED|Overall Study||22
8176358|NCT02401048|20160221|P2|COMPLETED|Overall Study||4
8176359|NCT02401048|20160222|P1|COMPLETED|Overall Study||5
8176360|NCT02401048|20160221|P2|STARTED|Overall Study||34
8176361|NCT02401048|20160222|P1|STARTED|Overall Study||27
8176362|NCT02401022|20160254|P2|NOT COMPLETED|Overall Study||20
8176363|NCT02401022|20160255|P1|NOT COMPLETED|Overall Study||15
8176364|NCT02401022|20160254|P2|COMPLETED|Overall Study||90
8176365|NCT02401022|20160255|P1|COMPLETED|Overall Study||89
8176366|NCT02401022|20160254|P2|STARTED|Overall Study||110
8176367|NCT02401022|20160255|P1|STARTED|Overall Study||104
8176368|NCT02400996|20160261|P1|NOT COMPLETED|Overall Study||0
8176369|NCT02400996|20160261|P1|COMPLETED|Overall Study||40
8176370|NCT02400996|20160261|P1|STARTED|Overall Study||40
8176375|NCT02400749|20160275|P2|NOT COMPLETED|Week 17 - 32||3
8176376|NCT02400749|20160276|P1|NOT COMPLETED|Week 17 - 32||5
8176377|NCT02400749|20160275|P2|COMPLETED|Week 17 - 32||41
8176378|NCT02400749|20160276|P1|COMPLETED|Week 17 - 32||34
8176379|NCT02400749|20160275|P2|STARTED|Week 17 - 32||44
8176380|NCT02400749|20160276|P1|STARTED|Week 17 - 32||39
8176381|NCT02400749|20160275|P2|NOT COMPLETED|Week 0 -16||6
8176382|NCT02400749|20160276|P1|NOT COMPLETED|Week 0 -16||11
8176383|NCT02400749|20160275|P2|COMPLETED|Week 0 -16||44
8176384|NCT02400749|20160276|P1|COMPLETED|Week 0 -16||39
8176385|NCT02400749|20160275|P2|STARTED|Week 0 -16||50
8176386|NCT02400749|20160276|P1|STARTED|Week 0 -16||50
8176387|NCT02400710|20160292|P2|NOT COMPLETED|Overall Study||0
8176388|NCT02400710|20160293|P1|NOT COMPLETED|Overall Study||0
8176389|NCT02400710|20160292|P2|COMPLETED|Overall Study||10
8176390|NCT02400710|20160293|P1|COMPLETED|Overall Study||10
8176391|NCT02400710|20160292|P2|STARTED|Overall Study||10
8176392|NCT02400710|20160293|P1|STARTED|Overall Study||10
8176393|NCT02400580|20160303|P2|NOT COMPLETED|Overall Study||1
8176394|NCT02400580|20160304|P1|NOT COMPLETED|Overall Study||2
8176395|NCT02400580|20160303|P2|COMPLETED|Overall Study||91
8176396|NCT02400580|20160304|P1|COMPLETED|Overall Study||89
8176397|NCT02400580|20160303|P2|STARTED|Overall Study||92
8176398|NCT02400580|20160304|P1|STARTED|Overall Study||91
8176399|NCT02400463|20160320|P1|NOT COMPLETED|Overall Study||0
8176400|NCT02400463|20160320|P1|COMPLETED|Overall Study||6
8176401|NCT02400463|20160320|P1|STARTED|Overall Study||6
8176402|NCT02400437|20160328|P1|NOT COMPLETED|Overall Study||0
8176403|NCT02400437|20160328|P1|COMPLETED|Overall Study||26
8176404|NCT02400437|20160328|P1|STARTED|Overall Study||26
8176405|NCT02400346|20160339|P1|NOT COMPLETED|Overall Study||44
8176406|NCT02400346|20160339|P1|COMPLETED|Overall Study||88
8176407|NCT02400346|20160339|P1|STARTED|Overall Study||132
8176408|NCT02400333|20160347|P4|NOT COMPLETED|Overall Study||2
8176409|NCT02400333|20160348|P3|NOT COMPLETED|Overall Study||2
8176410|NCT02400333|20160349|P2|NOT COMPLETED|Overall Study||1
8176411|NCT02400333|20160350|P1|NOT COMPLETED|Overall Study||1
8176412|NCT02400333|20160347|P4|COMPLETED|Overall Study||7
8176413|NCT02400333|20160348|P3|COMPLETED|Overall Study||7
8176414|NCT02400333|20160349|P2|COMPLETED|Overall Study||8
8176415|NCT02400333|20160350|P1|COMPLETED|Overall Study||8
8176416|NCT02400333|20160347|P4|STARTED|Overall Study||9
8176417|NCT02400333|20160348|P3|STARTED|Overall Study||9
8176418|NCT02400333|20160349|P2|STARTED|Overall Study||9
8176419|NCT02400333|20160350|P1|STARTED|Overall Study||9
8176420|NCT02400307|20160410|P2|NOT COMPLETED|Overall Study||0
8176421|NCT02400307|20160411|P1|NOT COMPLETED|Overall Study||1
8176422|NCT02400307|20160410|P2|COMPLETED|Overall Study||8
8176423|NCT02400307|20160411|P1|COMPLETED|Overall Study||10
8176424|NCT02400307|20160410|P2|STARTED|Overall Study||8
8176425|NCT02400307|20160411|P1|STARTED|Overall Study||11
8176426|NCT02400073|20160431|P1|NOT COMPLETED|Overall Study||11
8176427|NCT02400073|20160431|P1|COMPLETED|Overall Study||111
8176428|NCT02400073|20160431|P1|STARTED|Overall Study||122
8176429|NCT02399917|20160439|P3|NOT COMPLETED|Overall Study||0
8176430|NCT02399917|20160440|P2|NOT COMPLETED|Overall Study||0
8176431|NCT02399917|20160441|P1|NOT COMPLETED|Overall Study||0
8176432|NCT02399917|20160439|P3|COMPLETED|Overall Study||24
8176433|NCT02399917|20160440|P2|COMPLETED|Overall Study||6
8176434|NCT02399917|20160441|P1|COMPLETED|Overall Study||6
8176435|NCT02399917|20160439|P3|STARTED|Overall Study||24
8176436|NCT02399917|20160440|P2|STARTED|Overall Study||6
8176437|NCT02399917|20160441|P1|STARTED|Overall Study||6
8176438|NCT02399345|20160459|P1|NOT COMPLETED|Overall Study||0
8176439|NCT02399345|20160459|P1|COMPLETED|Overall Study||10
8176440|NCT02399345|20160459|P1|STARTED|Overall Study||10
8176441|NCT02399254|20160465|P1|NOT COMPLETED|Overall Study||2
8176442|NCT02399254|20160465|P1|COMPLETED|Overall Study||19
8176443|NCT02399254|20160465|P1|STARTED|Overall Study||21
8176444|NCT02399163|20160472|P1|NOT COMPLETED|Overall Study||9
8176445|NCT02399163|20160472|P1|COMPLETED|Overall Study||53
8176446|NCT02399163|20160472|P1|STARTED|Overall Study||62
8176447|NCT02399111|20160500|P4|NOT COMPLETED|Overall Study||0
8176448|NCT02399111|20160501|P3|NOT COMPLETED|Overall Study||0
8176449|NCT02399111|20160502|P2|NOT COMPLETED|Overall Study||0
8176450|NCT02399111|20160503|P1|NOT COMPLETED|Overall Study||0
8176451|NCT02399111|20160500|P4|COMPLETED|Overall Study||0
8176452|NCT02399111|20160501|P3|COMPLETED|Overall Study||4
8176453|NCT02399111|20160502|P2|COMPLETED|Overall Study||1
8176454|NCT02399111|20160503|P1|COMPLETED|Overall Study||4
8176455|NCT02399111|20160500|P4|STARTED|Overall Study||0
8176456|NCT02399111|20160501|P3|STARTED|Overall Study||4
8176457|NCT02399111|20160502|P2|STARTED|Overall Study||1
8176458|NCT02399111|20160503|P1|STARTED|Overall Study||4
8176459|NCT02399085|20160517|P1|NOT COMPLETED|Overall Study||51
8176460|NCT02399085|20160517|P1|COMPLETED|Overall Study|30 patients completed the combination treatment on both study drugs (12 cycles).|30
8176461|NCT02399085|20160517|P1|STARTED|Overall Study||81
8176462|NCT02398409|20160527|P2|NOT COMPLETED|Overall Study||5
8176463|NCT02398409|20160528|P1|NOT COMPLETED|Overall Study||2
8176464|NCT02398409|20160527|P2|COMPLETED|Overall Study||63
8176465|NCT02398409|20160528|P1|COMPLETED|Overall Study||67
8176466|NCT02398409|20160527|P2|STARTED|Overall Study||68
8176467|NCT02398409|20160528|P1|STARTED|Overall Study||69
8176468|NCT02398227|20160542|P2|NOT COMPLETED|Overall Study||18
8176469|NCT02398227|20160543|P1|NOT COMPLETED|Overall Study||27
8176470|NCT02398227|20160542|P2|COMPLETED|Overall Study||71
8176471|NCT02398227|20160543|P1|COMPLETED|Overall Study||56
8176472|NCT02398227|20160542|P2|STARTED|Overall Study||89
8176473|NCT02398227|20160543|P1|STARTED|Overall Study||83
8176474|NCT02398188|20160553|P2|NOT COMPLETED|Overall Study||34
8176475|NCT02398188|20160554|P1|NOT COMPLETED|Overall Study||27
8176476|NCT02398188|20160553|P2|COMPLETED|Overall Study||361
8176477|NCT02398188|20160554|P1|COMPLETED|Overall Study||371
8176478|NCT02398188|20160553|P2|STARTED|Overall Study||395
8176479|NCT02398188|20160554|P1|STARTED|Overall Study||398
8176480|NCT02397954|20160564|P1|NOT COMPLETED|Overall Study||0
8176481|NCT02397954|20160564|P1|COMPLETED|Overall Study||4
8176482|NCT02397954|20160564|P1|STARTED|Overall Study||4
8176483|NCT02397915|20160572|P4|NOT COMPLETED|Period 2||0
8176484|NCT02397915|20160573|P3|NOT COMPLETED|Period 2||0
8176485|NCT02397915|20160574|P2|NOT COMPLETED|Period 2||0
8176486|NCT02397915|20160575|P1|NOT COMPLETED|Period 2||0
8176487|NCT02397915|20160572|P4|COMPLETED|Period 2||149
8176488|NCT02397915|20160573|P3|COMPLETED|Period 2||149
8176489|NCT02397915|20160574|P2|COMPLETED|Period 2||0
8176490|NCT02397915|20160575|P1|COMPLETED|Period 2||0
8176491|NCT02397915|20160572|P4|STARTED|Period 2||149
8176492|NCT02397915|20160573|P3|STARTED|Period 2||149
8176493|NCT02397915|20160574|P2|STARTED|Period 2||0
8176494|NCT02397915|20160575|P1|STARTED|Period 2||0
8176495|NCT02397915|20160572|P4|NOT COMPLETED|Period 1||0
8176496|NCT02397915|20160573|P3|NOT COMPLETED|Period 1||0
8176497|NCT02397915|20160574|P2|NOT COMPLETED|Period 1||1
8176498|NCT02397915|20160575|P1|NOT COMPLETED|Period 1||1
8176499|NCT02397915|20160572|P4|COMPLETED|Period 1||0
8176500|NCT02397915|20160573|P3|COMPLETED|Period 1||0
8176501|NCT02397915|20160574|P2|COMPLETED|Period 1||149
8176502|NCT02397915|20160575|P1|COMPLETED|Period 1||149
8176503|NCT02397915|20160572|P4|STARTED|Period 1||0
8176504|NCT02397915|20160573|P3|STARTED|Period 1||0
8176505|NCT02397915|20160574|P2|STARTED|Period 1||150
8176506|NCT02397915|20160575|P1|STARTED|Period 1||150
8176507|NCT02397837|20160627|P2|NOT COMPLETED|Overall Study||6
8176508|NCT02397837|20160628|P1|NOT COMPLETED|Overall Study||7
8176509|NCT02397837|20160627|P2|COMPLETED|Overall Study||24
8176510|NCT02397837|20160628|P1|COMPLETED|Overall Study||26
8176511|NCT02397837|20160627|P2|STARTED|Overall Study||30
8176512|NCT02397837|20160628|P1|STARTED|Overall Study||33
8176513|NCT02397785|20160654|P2|NOT COMPLETED|Overall Study||9
8176514|NCT02397785|20160655|P1|NOT COMPLETED|Overall Study||2
8176515|NCT02397785|20160654|P2|COMPLETED|Overall Study||25
8176516|NCT02397785|20160655|P1|COMPLETED|Overall Study||22
8176517|NCT02397785|20160654|P2|STARTED|Overall Study||34
8176518|NCT02397785|20160655|P1|STARTED|Overall Study||24
8176519|NCT02397707|20160702|P3|NOT COMPLETED|Overall Study||0
8176520|NCT02397707|20160703|P2|NOT COMPLETED|Overall Study||0
8176521|NCT02397707|20160704|P1|NOT COMPLETED|Overall Study||0
8176522|NCT02397707|20160702|P3|COMPLETED|Overall Study||9
8176523|NCT02397707|20160703|P2|COMPLETED|Overall Study||10
8176524|NCT02397707|20160704|P1|COMPLETED|Overall Study||14
8176525|NCT02397707|20160702|P3|STARTED|Overall Study||9
8176526|NCT02397707|20160703|P2|STARTED|Overall Study||10
8176527|NCT02397707|20160704|P1|STARTED|Overall Study||14
8176528|NCT02397694|20160723|P2|NOT COMPLETED|Open Label Extension Phase||1
8176529|NCT02397694|20160724|P1|NOT COMPLETED|Open Label Extension Phase||8
8176530|NCT02397694|20160723|P2|COMPLETED|Open Label Extension Phase||29
8176531|NCT02397694|20160724|P1|COMPLETED|Open Label Extension Phase||54
8176532|NCT02397694|20160723|P2|STARTED|Open Label Extension Phase||30
8176533|NCT02397694|20160724|P1|STARTED|Open Label Extension Phase||62
8176534|NCT02397694|20160723|P2|NOT COMPLETED|Double-Blinded Phase||3
8176535|NCT02397694|20160724|P1|NOT COMPLETED|Double-Blinded Phase||3
8176536|NCT02397694|20160723|P2|COMPLETED|Double-Blinded Phase||30
8176537|NCT02397694|20160724|P1|COMPLETED|Double-Blinded Phase||62
8176538|NCT02397694|20160723|P2|STARTED|Double-Blinded Phase||33
8176539|NCT02397694|20160724|P1|STARTED|Double-Blinded Phase||65
8176540|NCT02397655|20160762|P1|NOT COMPLETED|Overall Study||1301
8176541|NCT02397655|20160762|P1|COMPLETED|Overall Study||10711
8176542|NCT02397655|20160762|P1|STARTED|Overall Study||12012
8176543|NCT02397564|20160766|P1|NOT COMPLETED|Overall Study||4
8176544|NCT02397564|20160766|P1|COMPLETED|Overall Study||16
8176545|NCT02397564|20160766|P1|STARTED|Overall Study||20
8176546|NCT02397473|20160773|P2|NOT COMPLETED|Post Treatment Follow-up Phase||2
8176547|NCT02397473|20160774|P1|NOT COMPLETED|Post Treatment Follow-up Phase||3
8176548|NCT02397473|20160773|P2|COMPLETED|Post Treatment Follow-up Phase||45
8176549|NCT02397473|20160774|P1|COMPLETED|Post Treatment Follow-up Phase||47
8176550|NCT02397473|20160773|P2|STARTED|Post Treatment Follow-up Phase||47
8176551|NCT02397473|20160774|P1|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50
8176552|NCT02397473|20160773|P2|NOT COMPLETED|Treatment Phase||7
8176553|NCT02397473|20160774|P1|NOT COMPLETED|Treatment Phase||12
8176554|NCT02397473|20160773|P2|COMPLETED|Treatment Phase||45
8176555|NCT02397473|20160774|P1|COMPLETED|Treatment Phase||45
8176556|NCT02397473|20160773|P2|Received at Least One Dose of Study Drug|Treatment Phase||49
8176557|NCT02397473|20160774|P1|Received at Least One Dose of Study Drug|Treatment Phase||57
8176558|NCT02397473|20160773|P2|STARTED|Treatment Phase||52
8176559|NCT02397473|20160774|P1|STARTED|Treatment Phase||57
8176560|NCT02397447|20160804|P2|NOT COMPLETED|Overall Study||2
8176561|NCT02397447|20160805|P1|NOT COMPLETED|Overall Study||2
8176562|NCT02397447|20160804|P2|COMPLETED|Overall Study||10
8176563|NCT02397447|20160805|P1|COMPLETED|Overall Study||10
8176564|NCT02397447|20160804|P2|STARTED|Overall Study||12
8176565|NCT02397447|20160805|P1|STARTED|Overall Study||12
8176566|NCT02397408|20160851|P1|NOT COMPLETED|Overall Study||6
8176567|NCT02397408|20160851|P1|COMPLETED|Overall Study||12
8176568|NCT02397408|20160851|P1|Completed Surgery Per Protocol|Overall Study||16
8176569|NCT02397408|20160851|P1|STARTED|Overall Study||18
8176570|NCT02397265|20160869|P3|NOT COMPLETED|Third Intervention of Three||0
8176571|NCT02397265|20160870|P2|NOT COMPLETED|Third Intervention of Three||0
8176572|NCT02397265|20160871|P1|NOT COMPLETED|Third Intervention of Three||0
8176573|NCT02397265|20160869|P3|COMPLETED|Third Intervention of Three||2
8176574|NCT02397265|20160870|P2|COMPLETED|Third Intervention of Three||2
8176575|NCT02397265|20160871|P1|COMPLETED|Third Intervention of Three||2
8176576|NCT02397265|20160869|P3|STARTED|Third Intervention of Three||2
8176577|NCT02397265|20160870|P2|STARTED|Third Intervention of Three||2
8176578|NCT02397265|20160871|P1|STARTED|Third Intervention of Three||2
8176579|NCT02397265|20160869|P3|NOT COMPLETED|Second Intervention of Three||0
8176580|NCT02397265|20160870|P2|NOT COMPLETED|Second Intervention of Three||0
8176581|NCT02397265|20160871|P1|NOT COMPLETED|Second Intervention of Three||0
8176582|NCT02397265|20160869|P3|COMPLETED|Second Intervention of Three||2
8176583|NCT02397265|20160870|P2|COMPLETED|Second Intervention of Three||2
8176584|NCT02397265|20160871|P1|COMPLETED|Second Intervention of Three||2
8176585|NCT02397265|20160869|P3|STARTED|Second Intervention of Three||2
8176586|NCT02397265|20160870|P2|STARTED|Second Intervention of Three||2
8176587|NCT02397265|20160871|P1|STARTED|Second Intervention of Three||2
8176588|NCT02397265|20160869|P3|NOT COMPLETED|First Intervention of Three||0
8176589|NCT02397265|20160870|P2|NOT COMPLETED|First Intervention of Three||0
8176590|NCT02397265|20160871|P1|NOT COMPLETED|First Intervention of Three||0
8176591|NCT02397265|20160869|P3|COMPLETED|First Intervention of Three||2
8176592|NCT02397265|20160870|P2|COMPLETED|First Intervention of Three||2
8176593|NCT02397265|20160871|P1|COMPLETED|First Intervention of Three||2
8176594|NCT02397265|20160869|P3|STARTED|First Intervention of Three||2
8176595|NCT02397265|20160870|P2|STARTED|First Intervention of Three||2
8176596|NCT02397265|20160871|P1|STARTED|First Intervention of Three||2
8176597|NCT02397122|20160881|P2|NOT COMPLETED|Overall Study||0
8176598|NCT02397122|20160882|P1|NOT COMPLETED|Overall Study||0
8176599|NCT02397122|20160881|P2|COMPLETED|Overall Study||20
8176600|NCT02397122|20160882|P1|COMPLETED|Overall Study||20
8176601|NCT02397122|20160881|P2|STARTED|Overall Study||20
8176602|NCT02397122|20160882|P1|STARTED|Overall Study||20
8176621|NCT02396953|20160934|P3|NOT COMPLETED|Overall Study||3
8176622|NCT02396953|20160935|P2|NOT COMPLETED|Overall Study||3
8176623|NCT02396953|20160936|P1|NOT COMPLETED|Overall Study||4
8176624|NCT02396953|20160934|P3|COMPLETED|Overall Study||7
8176625|NCT02396953|20160935|P2|COMPLETED|Overall Study||6
8176626|NCT02396953|20160936|P1|COMPLETED|Overall Study||5
8176627|NCT02396953|20160934|P3|STARTED|Overall Study||10
8176628|NCT02396953|20160935|P2|STARTED|Overall Study||9
8176629|NCT02396953|20160936|P1|STARTED|Overall Study||9
8176630|NCT02396745|20160986|P1|NOT COMPLETED|Overall Study||0
8176631|NCT02396745|20160986|P1|COMPLETED|Overall Study||1
8176632|NCT02396745|20160986|P1|STARTED|Overall Study||1
8176633|NCT02396732|20160998|P2|NOT COMPLETED|Overall Study||0
8176634|NCT02396732|20160999|P1|NOT COMPLETED|Overall Study||0
8176635|NCT02396732|20160998|P2|COMPLETED|Overall Study||17
8176636|NCT02396732|20160999|P1|COMPLETED|Overall Study||14
8176637|NCT02396732|20160998|P2|STARTED|Overall Study||17
8176638|NCT02396732|20160999|P1|STARTED|Overall Study||14
8176639|NCT02396537|20161011|P2|NOT COMPLETED|Overall Study||1
8176640|NCT02396537|20161012|P1|NOT COMPLETED|Overall Study||0
8176641|NCT02396537|20161011|P2|COMPLETED|Overall Study||36
8176642|NCT02396537|20161012|P1|COMPLETED|Overall Study||40
8176643|NCT02396537|20161011|P2|STARTED|Overall Study||37
8176644|NCT02396537|20161012|P1|STARTED|Overall Study||40
8176645|NCT02396511|20161018|P1|NOT COMPLETED|Overall Study||0
8176646|NCT02396511|20161018|P1|COMPLETED|Overall Study||2
8176647|NCT02396511|20161018|P1|STARTED|Overall Study||2
8176648|NCT02396420|20161024|P1|NOT COMPLETED|Overall Study||1
8176649|NCT02396420|20161024|P1|COMPLETED|Overall Study||1
8176650|NCT02396420|20161024|P1|6 Months Post PAE|Overall Study||2
8176651|NCT02396420|20161024|P1|3 Months Post PAE|Overall Study||2
8176652|NCT02396420|20161024|P1|1 Month Post PAE|Overall Study||2
8176653|NCT02396420|20161024|P1|STARTED|Overall Study||2
8176654|NCT02396381|20161048|P2|NOT COMPLETED|Overall Study||74
8176655|NCT02396381|20161049|P1|NOT COMPLETED|Overall Study||107
8176656|NCT02396381|20161048|P2|COMPLETED|Overall Study||422
8176657|NCT02396381|20161049|P1|COMPLETED|Overall Study||381
8176658|NCT02396381|20161048|P2|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443
8176659|NCT02396381|20161049|P1|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414
8176660|NCT02396381|20161048|P2|STARTED|Overall Study||496
8176661|NCT02396381|20161049|P1|STARTED|Overall Study||488
8176662|NCT02396316|20161088|P2|NOT COMPLETED|Overall Study||5
8176663|NCT02396316|20161089|P1|NOT COMPLETED|Overall Study||7
8176664|NCT02396316|20161088|P2|COMPLETED|Overall Study||22
8176665|NCT02396316|20161089|P1|COMPLETED|Overall Study||20
8176666|NCT02396316|20161088|P2|Received Active Injection at Week 9|Overall Study||1
8176667|NCT02396316|20161089|P1|Received Active Injection at Week 9|Overall Study||2
8176668|NCT02396316|20161088|P2|Received Active Injection at Week 5|Overall Study||4
8176669|NCT02396316|20161089|P1|Received Active Injection at Week 5|Overall Study||4
8176670|NCT02396316|20161088|P2|Received AFL Injection at Week 1|Overall Study||22
8176671|NCT02396316|20161089|P1|Received AFL Injection at Week 1|Overall Study||0
8176672|NCT02396316|20161088|P2|Received Sham Injection at Week 1|Overall Study||0
8176673|NCT02396316|20161089|P1|Received Sham Injection at Week 1|Overall Study||10
8176674|NCT02396316|20161088|P2|Treated|Overall Study||27
8176675|NCT02396316|20161089|P1|Treated|Overall Study||27
8176676|NCT02396316|20161088|P2|STARTED|Overall Study||27
8176677|NCT02396316|20161089|P1|STARTED|Overall Study||27
8176678|NCT02396251|20161101|P2|NOT COMPLETED|Overall Study||5
8176679|NCT02396251|20161102|P1|NOT COMPLETED|Overall Study||13
8176680|NCT02396251|20161101|P2|COMPLETED|Overall Study||7
8176681|NCT02396251|20161102|P1|COMPLETED|Overall Study||23
8176682|NCT02396251|20161101|P2|STARTED|Overall Study||12
8176683|NCT02396251|20161102|P1|STARTED|Overall Study||36
8176684|NCT02396212|20161108|P1|NOT COMPLETED|Overall Study||3
8176685|NCT02396212|20161108|P1|COMPLETED|Overall Study||16
8176686|NCT02396212|20161108|P1|STARTED|Overall Study||19
8176687|NCT02396160|20161129|P2|NOT COMPLETED|Overall Study||2
8176688|NCT02396160|20161130|P1|NOT COMPLETED|Overall Study||6
8176689|NCT02396160|20161129|P2|COMPLETED|Overall Study||73
8176690|NCT02396160|20161130|P1|COMPLETED|Overall Study||69
8176691|NCT02396160|20161129|P2|STARTED|Overall Study||75
8176692|NCT02396160|20161130|P1|STARTED|Overall Study||75
8176693|NCT02396147|20161146|P2|NOT COMPLETED|Period 3||0
8176694|NCT02396147|20161147|P1|NOT COMPLETED|Period 3||0
8176695|NCT02396147|20161146|P2|COMPLETED|Period 3||27
8176696|NCT02396147|20161147|P1|COMPLETED|Period 3||27
8176697|NCT02396147|20161146|P2|STARTED|Period 3||27
8176698|NCT02396147|20161147|P1|STARTED|Period 3||27
8176699|NCT02396147|20161146|P2|NOT COMPLETED|Period 2||0
8176700|NCT02396147|20161147|P1|NOT COMPLETED|Period 2||0
8176701|NCT02396147|20161146|P2|COMPLETED|Period 2||27
8176702|NCT02396147|20161147|P1|COMPLETED|Period 2||27
8176703|NCT02396147|20161146|P2|STARTED|Period 2||27
8176704|NCT02396147|20161147|P1|STARTED|Period 2||27
8176705|NCT02396147|20161146|P2|NOT COMPLETED|Period 1||0
8176706|NCT02396147|20161147|P1|NOT COMPLETED|Period 1||0
8176707|NCT02396147|20161146|P2|COMPLETED|Period 1||27
8176708|NCT02396147|20161147|P1|COMPLETED|Period 1||27
8176709|NCT02396147|20161146|P2|STARTED|Period 1||27
8176710|NCT02396147|20161147|P1|STARTED|Period 1||27
8176726|NCT02395822|20161261|P1|NOT COMPLETED|Overall Study||2
8176727|NCT02395822|20161261|P1|COMPLETED|Overall Study||15
8176728|NCT02395822|20161261|P1|STARTED|Overall Study||17
8176729|NCT02395692|20161269|P2|NOT COMPLETED|Overall Study||0
8176730|NCT02395692|20161270|P1|NOT COMPLETED|Overall Study||0
8176731|NCT02395692|20161269|P2|COMPLETED|Overall Study||0
8176732|NCT02395692|20161270|P1|COMPLETED|Overall Study||19
8176733|NCT02395692|20161269|P2|STARTED|Overall Study||0
8176734|NCT02395692|20161270|P1|STARTED|Overall Study||19
8176735|NCT02395666|20161282|P2|NOT COMPLETED|Overall Study||1
8176736|NCT02395666|20161283|P1|NOT COMPLETED|Overall Study||6
8176737|NCT02395666|20161282|P2|COMPLETED|Overall Study||38
8176738|NCT02395666|20161283|P1|COMPLETED|Overall Study||95
8176739|NCT02395666|20161282|P2|STARTED|Overall Study||39
8176740|NCT02395666|20161283|P1|STARTED|Overall Study||101
8176741|NCT02395653|20161297|P1|NOT COMPLETED|Overall Study||12
8176742|NCT02395653|20161297|P1|COMPLETED|Overall Study||59
8176743|NCT02395653|20161297|P1|Received at Least 1 Dose of Study Drug|Overall Study||61
8176744|NCT02395653|20161297|P1|STARTED|Overall Study||71
8176745|NCT02395627|20161307|P3|NOT COMPLETED|Overall Study||0
8176746|NCT02395627|20161308|P2|NOT COMPLETED|Overall Study||3
8176747|NCT02395627|20161309|P1|NOT COMPLETED|Overall Study||3
8176748|NCT02395627|20161307|P3|COMPLETED|Overall Study||4
8176749|NCT02395627|20161308|P2|COMPLETED|Overall Study||13
8176750|NCT02395627|20161309|P1|COMPLETED|Overall Study||15
8176751|NCT02395627|20161307|P3|STARTED|Overall Study||4
8176752|NCT02395627|20161308|P2|STARTED|Overall Study||16
8176753|NCT02395627|20161309|P1|STARTED|Overall Study||18
8176754|NCT02395536|20161337|P2|NOT COMPLETED|Overall Study||30
8176755|NCT02395536|20161338|P1|NOT COMPLETED|Overall Study||20
8176756|NCT02395536|20161337|P2|COMPLETED|Overall Study||227
8176757|NCT02395536|20161338|P1|COMPLETED|Overall Study||244
8176758|NCT02395536|20161337|P2|REVEAL LINQ Insertion|Overall Study||231
8176759|NCT02395536|20161338|P1|REVEAL LINQ Insertion|Overall Study||251
8176760|NCT02395536|20161337|P2|STARTED|Overall Study||257
8176761|NCT02395536|20161338|P1|STARTED|Overall Study||264
8176762|NCT02395471|20161346|P2|NOT COMPLETED|Overall Study||3
8176763|NCT02395471|20161347|P1|NOT COMPLETED|Overall Study||7
8176764|NCT02395471|20161346|P2|COMPLETED|Overall Study||59
8176765|NCT02395471|20161347|P1|COMPLETED|Overall Study||122
8176766|NCT02395471|20161346|P2|STARTED|Overall Study||62
8176767|NCT02395471|20161347|P1|STARTED|Overall Study||129
8176768|NCT02395302|20161362|P1|NOT COMPLETED|Overall Study||14
8176769|NCT02395302|20161362|P1|COMPLETED|Overall Study||14
8176770|NCT02395302|20161362|P1|STARTED|Overall Study||28
8176771|NCT02395185|20161366|P1|NOT COMPLETED|Overall Study||0
8176772|NCT02395185|20161366|P1|COMPLETED|Overall Study||33
8176773|NCT02395185|20161366|P1|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
8176774|NCT02395185|20161366|P1|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
8176775|NCT02395185|20161366|P1|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
8176776|NCT02395185|20161366|P1|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
8176777|NCT02395185|20161366|P1|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
8176778|NCT02395185|20161366|P1|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
8176779|NCT02395185|20161366|P1|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
8176780|NCT02395185|20161366|P1|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
8176781|NCT02395185|20161366|P1|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
8176782|NCT02395185|20161366|P1|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
8176783|NCT02395185|20161366|P1|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
8176784|NCT02395185|20161366|P1|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
8176785|NCT02395185|20161366|P1|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
8176786|NCT02395185|20161366|P1|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
8176787|NCT02395185|20161366|P1|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
8176788|NCT02395185|20161366|P1|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
8176789|NCT02395185|20161366|P1|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
8176790|NCT02395185|20161366|P1|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
8176791|NCT02395185|20161366|P1|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
8176792|NCT02395172|20161382|P2|NOT COMPLETED|Overall Study||31
8176793|NCT02395172|20161383|P1|NOT COMPLETED|Overall Study||3
8176794|NCT02395172|20161382|P2|COMPLETED|Overall Study||365
8176795|NCT02395172|20161383|P1|COMPLETED|Overall Study||393
8176796|NCT02395172|20161382|P2|Treated|Overall Study||365
8176797|NCT02395172|20161383|P1|Treated|Overall Study||393
8176798|NCT02395172|20161382|P2|STARTED|Overall Study||396
8176799|NCT02395172|20161383|P1|STARTED|Overall Study||396
8176800|NCT02395133|20161422|P4|NOT COMPLETED|Overall Study||14
8176801|NCT02395133|20161423|P3|NOT COMPLETED|Overall Study||10
8176802|NCT02395133|20161424|P2|NOT COMPLETED|Overall Study||9
8176803|NCT02395133|20161425|P1|NOT COMPLETED|Overall Study||14
8176804|NCT02395133|20161422|P4|COMPLETED|Overall Study||155
8176805|NCT02395133|20161423|P3|COMPLETED|Overall Study||76
8176806|NCT02395133|20161424|P2|COMPLETED|Overall Study||75
8176807|NCT02395133|20161425|P1|COMPLETED|Overall Study||69
8176808|NCT02395133|20161422|P4|STARTED|Overall Study||169
8176809|NCT02395133|20161423|P3|STARTED|Overall Study||86
8176810|NCT02395133|20161424|P2|STARTED|Overall Study||84
8176811|NCT02395133|20161425|P1|STARTED|Overall Study||83
8176812|NCT02395055|20161513|P2|NOT COMPLETED|Overall Study||3
8176813|NCT02395055|20161514|P1|NOT COMPLETED|Overall Study||7
8176814|NCT02395055|20161513|P2|COMPLETED|Overall Study||44
8176815|NCT02395055|20161514|P1|COMPLETED|Overall Study||40
8176816|NCT02395055|20161513|P2|STARTED|Overall Study||47
8176817|NCT02395055|20161514|P1|STARTED|Overall Study||47
8176818|NCT02395042|20161527|P3|NOT COMPLETED|Treatment 2 Period||0
8176819|NCT02395042|20161528|P2|NOT COMPLETED|Treatment 2 Period||1
8176820|NCT02395042|20161529|P1|NOT COMPLETED|Treatment 2 Period||1
8176821|NCT02395042|20161527|P3|COMPLETED|Treatment 2 Period||13
8176822|NCT02395042|20161528|P2|COMPLETED|Treatment 2 Period||23
8176823|NCT02395042|20161529|P1|COMPLETED|Treatment 2 Period||9
8176824|NCT02395042|20161527|P3|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
8176825|NCT02395042|20161528|P2|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
8176826|NCT02395042|20161529|P1|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
8176827|NCT02395042|20161527|P3|NOT COMPLETED|Treatment 1 Period||2
8176828|NCT02395042|20161528|P2|NOT COMPLETED|Treatment 1 Period||6
8176829|NCT02395042|20161529|P1|NOT COMPLETED|Treatment 1 Period||3
8176830|NCT02395042|20161527|P3|COMPLETED|Treatment 1 Period||14
8176831|NCT02395042|20161528|P2|COMPLETED|Treatment 1 Period||25
8176832|NCT02395042|20161529|P1|COMPLETED|Treatment 1 Period||9
8176833|NCT02395042|20161527|P3|STARTED|Treatment 1 Period||16
8176834|NCT02395042|20161528|P2|STARTED|Treatment 1 Period||31
8176835|NCT02395042|20161529|P1|STARTED|Treatment 1 Period||12
8176836|NCT02394951|20161548|P2|NOT COMPLETED|Period II||4
8176837|NCT02394951|20161549|P1|NOT COMPLETED|Period II||0
8176838|NCT02394951|20161548|P2|COMPLETED|Period II||9
8176839|NCT02394951|20161549|P1|COMPLETED|Period II||11
8176840|NCT02394951|20161548|P2|STARTED|Period II||13
8176841|NCT02394951|20161549|P1|STARTED|Period II||11
8176842|NCT02394951|20161548|P2|NOT COMPLETED|Period I||1
8176843|NCT02394951|20161549|P1|NOT COMPLETED|Period I||1
8176844|NCT02394951|20161548|P2|COMPLETED|Period I||13
8176845|NCT02394951|20161549|P1|COMPLETED|Period I||11
8176846|NCT02394951|20161548|P2|STARTED|Period I||14
8176847|NCT02394951|20161549|P1|STARTED|Period I||12
8176848|NCT02394925|20161567|P1|NOT COMPLETED|Overall Study||29
8176849|NCT02394925|20161567|P1|COMPLETED|Overall Study||79
8176850|NCT02394925|20161567|P1|STARTED|Overall Study||108
8176851|NCT02394912|20161571|P1|NOT COMPLETED|Overall Study||0
8176852|NCT02394912|20161571|P1|COMPLETED|Overall Study||21
8176853|NCT02394912|20161571|P1|STARTED|Overall Study||21
8176854|NCT02394808|20161577|P2|NOT COMPLETED|Period 2||0
8176855|NCT02394808|20161578|P1|NOT COMPLETED|Period 2||1
8176856|NCT02394808|20161577|P2|COMPLETED|Period 2||28
8176857|NCT02394808|20161578|P1|COMPLETED|Period 2||24
8176858|NCT02394808|20161577|P2|STARTED|Period 2||28
8176859|NCT02394808|20161578|P1|STARTED|Period 2||25
8176860|NCT02394808|20161577|P2|NOT COMPLETED|Period 1||1
8176861|NCT02394808|20161578|P1|NOT COMPLETED|Period 1||0
8176862|NCT02394808|20161577|P2|COMPLETED|Period 1||28
8176863|NCT02394808|20161578|P1|COMPLETED|Period 1||25
8176864|NCT02394808|20161577|P2|STARTED|Period 1||29
8176865|NCT02394808|20161578|P1|STARTED|Period 1||25
8176866|NCT02394756|20161586|P6|NOT COMPLETED|Period 3||0
8176867|NCT02394756|20161587|P5|NOT COMPLETED|Period 3||0
8176868|NCT02394756|20161588|P4|NOT COMPLETED|Period 3||0
8176869|NCT02394756|20161589|P3|NOT COMPLETED|Period 3||0
8176870|NCT02394756|20161590|P2|NOT COMPLETED|Period 3||0
8176871|NCT02394756|20161591|P1|NOT COMPLETED|Period 3||0
8176872|NCT02394756|20161586|P6|COMPLETED|Period 3||6
8176873|NCT02394756|20161587|P5|COMPLETED|Period 3||6
8176874|NCT02394756|20161588|P4|COMPLETED|Period 3||6
8176875|NCT02394756|20161589|P3|COMPLETED|Period 3||6
8176876|NCT02394756|20161590|P2|COMPLETED|Period 3||6
8176877|NCT02394756|20161591|P1|COMPLETED|Period 3||7
8176878|NCT02394756|20161586|P6|STARTED|Period 3||6
8176879|NCT02394756|20161587|P5|STARTED|Period 3||6
8176880|NCT02394756|20161588|P4|STARTED|Period 3||6
8176881|NCT02394756|20161589|P3|STARTED|Period 3||6
8176882|NCT02394756|20161590|P2|STARTED|Period 3||6
8176883|NCT02394756|20161591|P1|STARTED|Period 3||7
8176884|NCT02394756|20161586|P6|NOT COMPLETED|Period 2||0
8176885|NCT02394756|20161587|P5|NOT COMPLETED|Period 2||1
8176886|NCT02394756|20161588|P4|NOT COMPLETED|Period 2||0
8176887|NCT02394756|20161589|P3|NOT COMPLETED|Period 2||0
8176888|NCT02394756|20161590|P2|NOT COMPLETED|Period 2||0
8176889|NCT02394756|20161591|P1|NOT COMPLETED|Period 2||0
8176890|NCT02394756|20161586|P6|COMPLETED|Period 2||6
8176891|NCT02394756|20161587|P5|COMPLETED|Period 2||6
8176892|NCT02394756|20161588|P4|COMPLETED|Period 2||6
8176893|NCT02394756|20161589|P3|COMPLETED|Period 2||6
8176894|NCT02394756|20161590|P2|COMPLETED|Period 2||6
8176895|NCT02394756|20161591|P1|COMPLETED|Period 2||7
8176896|NCT02394756|20161586|P6|STARTED|Period 2||6
8176897|NCT02394756|20161587|P5|STARTED|Period 2||7
8176898|NCT02394756|20161588|P4|STARTED|Period 2||6
8176899|NCT02394756|20161589|P3|STARTED|Period 2||6
8176900|NCT02394756|20161590|P2|STARTED|Period 2||6
8176901|NCT02394756|20161591|P1|STARTED|Period 2||7
8176902|NCT02394756|20161586|P6|NOT COMPLETED|Period 1||1
8176903|NCT02394756|20161587|P5|NOT COMPLETED|Period 1||0
8176904|NCT02394756|20161588|P4|NOT COMPLETED|Period 1||1
8176905|NCT02394756|20161589|P3|NOT COMPLETED|Period 1||1
8176906|NCT02394756|20161590|P2|NOT COMPLETED|Period 1||1
8176907|NCT02394756|20161591|P1|NOT COMPLETED|Period 1||0
8176908|NCT02394756|20161586|P6|COMPLETED|Period 1||6
8176909|NCT02394756|20161587|P5|COMPLETED|Period 1||7
8176910|NCT02394756|20161588|P4|COMPLETED|Period 1||6
8176911|NCT02394756|20161589|P3|COMPLETED|Period 1||6
8176912|NCT02394756|20161590|P2|COMPLETED|Period 1||6
8176913|NCT02394756|20161591|P1|COMPLETED|Period 1||7
8176914|NCT02394756|20161586|P6|STARTED|Period 1||7
8176915|NCT02394756|20161587|P5|STARTED|Period 1||7
8176916|NCT02394756|20161588|P4|STARTED|Period 1||7
8176917|NCT02394756|20161589|P3|STARTED|Period 1||7
8176918|NCT02394756|20161590|P2|STARTED|Period 1||7
8176919|NCT02394756|20161591|P1|STARTED|Period 1||7
8176920|NCT02394730|20161604|P2|NOT COMPLETED|Overall Study||1
8176921|NCT02394730|20161605|P1|NOT COMPLETED|Overall Study||1
8176922|NCT02394730|20161604|P2|COMPLETED|Overall Study||30
8176923|NCT02394730|20161605|P1|COMPLETED|Overall Study||33
8176924|NCT02394730|20161604|P2|STARTED|Overall Study||31
8176925|NCT02394730|20161605|P1|STARTED|Overall Study||34
8176926|NCT02394665|20161642|P3|NOT COMPLETED|Overall Study||0
8176927|NCT02394665|20161643|P2|NOT COMPLETED|Overall Study||0
8176928|NCT02394665|20161644|P1|NOT COMPLETED|Overall Study||1
8176929|NCT02394665|20161642|P3|COMPLETED|Overall Study||0
8176930|NCT02394665|20161643|P2|COMPLETED|Overall Study||0
8176931|NCT02394665|20161644|P1|COMPLETED|Overall Study||0
8176932|NCT02394665|20161642|P3|STARTED|Overall Study||0
8176933|NCT02394665|20161643|P2|STARTED|Overall Study||0
8176934|NCT02394665|20161644|P1|STARTED|Overall Study||1
8176935|NCT02394600|20161666|P2|NOT COMPLETED|Overall Study||2
8176936|NCT02394600|20161667|P1|NOT COMPLETED|Overall Study||4
8176937|NCT02394600|20161666|P2|COMPLETED|Overall Study||44
8176938|NCT02394600|20161667|P1|COMPLETED|Overall Study||43
8176939|NCT02394600|20161666|P2|STARTED|Overall Study||46
8176940|NCT02394600|20161667|P1|STARTED|Overall Study||47
8176941|NCT02394561|20161677|P2|NOT COMPLETED|Extension Phase||12
8176942|NCT02394561|20161678|P1|NOT COMPLETED|Extension Phase||11
8176943|NCT02394561|20161677|P2|COMPLETED|Extension Phase||207
8176944|NCT02394561|20161678|P1|COMPLETED|Extension Phase||151
8176945|NCT02394561|20161677|P2|STARTED|Extension Phase||219
8176946|NCT02394561|20161678|P1|STARTED|Extension Phase||162
8176947|NCT02394561|20161677|P2|NOT COMPLETED|CORE Phase||19
8176948|NCT02394561|20161678|P1|NOT COMPLETED|CORE Phase||13
8176949|NCT02394561|20161677|P2|COMPLETED|CORE Phase||227
8176950|NCT02394561|20161678|P1|COMPLETED|CORE Phase||172
8176951|NCT02394561|20161677|P2|ITT Set|CORE Phase||246
8176952|NCT02394561|20161678|P1|ITT Set|CORE Phase||184
8176953|NCT02394561|20161677|P2|Safety Set|CORE Phase||246
8176954|NCT02394561|20161678|P1|Safety Set|CORE Phase||185
8176955|NCT02394561|20161677|P2|Full Analysis Set|CORE Phase||246
8176956|NCT02394561|20161678|P1|Full Analysis Set|CORE Phase||185
8176957|NCT02394561|20161677|P2|STARTED|CORE Phase||246
8176958|NCT02394561|20161678|P1|STARTED|CORE Phase||185
8176962|NCT02394457|20161708|P2|NOT COMPLETED|Overall Study||0
8176963|NCT02394457|20161709|P1|NOT COMPLETED|Overall Study||0
8176964|NCT02394457|20161708|P2|COMPLETED|Overall Study||13
8176965|NCT02394457|20161709|P1|COMPLETED|Overall Study||15
8176966|NCT02394457|20161708|P2|STARTED|Overall Study||13
8176967|NCT02394457|20161709|P1|STARTED|Overall Study||15
8176968|NCT02394340|20161725|P1|NOT COMPLETED|Overall Study||2
8176969|NCT02394340|20161725|P1|COMPLETED|Overall Study||18
8176970|NCT02394340|20161725|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
8176971|NCT02394340|20161725|P1|STARTED|Overall Study||20
8176972|NCT02393950|20161732|P2|NOT COMPLETED|Overall Study||1
8176973|NCT02393950|20161733|P1|NOT COMPLETED|Overall Study||1
8176974|NCT02393950|20161732|P2|COMPLETED|Overall Study||8
8176975|NCT02393950|20161733|P1|COMPLETED|Overall Study||8
8176976|NCT02393950|20161732|P2|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
8176977|NCT02393950|20161733|P1|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
8176978|NCT02393950|20161732|P2|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
8176979|NCT02393950|20161733|P1|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
8176980|NCT02393950|20161732|P2|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
8176981|NCT02393950|20161733|P1|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
8176982|NCT02393950|20161732|P2|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
8176983|NCT02393950|20161733|P1|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
8176984|NCT02393950|20161732|P2|STARTED|Overall Study||9
8176985|NCT02393950|20161733|P1|STARTED|Overall Study||9
8176986|NCT02393859|20161800|P2|NOT COMPLETED|Overall Study||54
8176987|NCT02393859|20161801|P1|NOT COMPLETED|Overall Study||54
8176988|NCT02393859|20161800|P2|COMPLETED|Overall Study||0
8176989|NCT02393859|20161801|P1|COMPLETED|Overall Study||0
8176990|NCT02393859|20161800|P2|STARTED|Overall Study||54
8176991|NCT02393859|20161801|P1|STARTED|Overall Study||54
8176998|NCT02393677|20161839|P2|NOT COMPLETED|Overall Study||0
8176999|NCT02393677|20161840|P1|NOT COMPLETED|Overall Study||0
8177000|NCT02393677|20161839|P2|COMPLETED|Overall Study||40
8177001|NCT02393677|20161840|P1|COMPLETED|Overall Study||40
8177002|NCT02393677|20161839|P2|STARTED|Overall Study||40
8177003|NCT02393677|20161840|P1|STARTED|Overall Study||40
8177004|NCT02393547|20161846|P1|NOT COMPLETED|Overall Study||6
8177005|NCT02393547|20161846|P1|COMPLETED|Overall Study||14
8177006|NCT02393547|20161846|P1|STARTED|Overall Study||20
8177007|NCT02393417|20161857|P4|NOT COMPLETED|Overall Study||12
8177008|NCT02393417|20161858|P3|NOT COMPLETED|Overall Study||10
8177009|NCT02393417|20161859|P2|NOT COMPLETED|Overall Study||13
8177010|NCT02393417|20161860|P1|NOT COMPLETED|Overall Study||15
8177011|NCT02393417|20161857|P4|COMPLETED|Overall Study||29
8177012|NCT02393417|20161858|P3|COMPLETED|Overall Study||30
8177013|NCT02393417|20161859|P2|COMPLETED|Overall Study||32
8177014|NCT02393417|20161860|P1|COMPLETED|Overall Study||28
8177015|NCT02393417|20161857|P4|Completed Treatment|Overall Study||30
8177016|NCT02393417|20161858|P3|Completed Treatment|Overall Study||32
8177017|NCT02393417|20161859|P2|Completed Treatment|Overall Study||34
8177018|NCT02393417|20161860|P1|Completed Treatment|Overall Study||30
8177019|NCT02393417|20161857|P4|STARTED|Overall Study||41
8177020|NCT02393417|20161858|P3|STARTED|Overall Study||40
8177021|NCT02393417|20161859|P2|STARTED|Overall Study||45
8177022|NCT02393417|20161860|P1|STARTED|Overall Study||43
8177023|NCT02393378|20161918|P2|NOT COMPLETED|Overall Study||0
8177024|NCT02393378|20161919|P1|NOT COMPLETED|Overall Study||0
8177025|NCT02393378|20161918|P2|COMPLETED|Overall Study||4
8177026|NCT02393378|20161919|P1|COMPLETED|Overall Study||3
8177027|NCT02393378|20161918|P2|STARTED|Overall Study||4
8177028|NCT02393378|20161919|P1|STARTED|Overall Study||3
8177029|NCT02393209|20161937|P4|NOT COMPLETED|Overall Study||0
8177030|NCT02393209|20161938|P3|NOT COMPLETED|Overall Study||0
8177031|NCT02393209|20161939|P2|NOT COMPLETED|Overall Study||8
8177032|NCT02393209|20161940|P1|NOT COMPLETED|Overall Study||6
8177033|NCT02393209|20161937|P4|COMPLETED|Overall Study||0
8177034|NCT02393209|20161938|P3|COMPLETED|Overall Study||0
8177035|NCT02393209|20161939|P2|COMPLETED|Overall Study||0
8177036|NCT02393209|20161940|P1|COMPLETED|Overall Study||0
8177037|NCT02393209|20161937|P4|STARTED|Overall Study||0
8177038|NCT02393209|20161938|P3|STARTED|Overall Study||0
8177039|NCT02393209|20161939|P2|STARTED|Overall Study||8
8177040|NCT02393209|20161940|P1|STARTED|Overall Study||6
8177041|NCT02392806|20161998|P2|NOT COMPLETED|Overall Study||0
8177042|NCT02392806|20161999|P1|NOT COMPLETED|Overall Study||0
8177043|NCT02392806|20161998|P2|COMPLETED|Overall Study||21
8177044|NCT02392806|20161999|P1|COMPLETED|Overall Study||22
8177045|NCT02392806|20161998|P2|STARTED|Overall Study||21
8177046|NCT02392806|20161999|P1|STARTED|Overall Study||22
8177047|NCT02392767|20162009|P2|NOT COMPLETED|Overall Study||0
8177048|NCT02392767|20162010|P1|NOT COMPLETED|Overall Study||0
8177049|NCT02392767|20162009|P2|COMPLETED|Overall Study||13
8177050|NCT02392767|20162010|P1|COMPLETED|Overall Study||12
8177051|NCT02392767|20162009|P2|STARTED|Overall Study||13
8177052|NCT02392767|20162010|P1|STARTED|Overall Study||12
8177053|NCT02392624|20162029|P3|NOT COMPLETED|Overall Study||13
8177054|NCT02392624|20162030|P2|NOT COMPLETED|Overall Study||15
8177055|NCT02392624|20162031|P1|NOT COMPLETED|Overall Study||71
8177056|NCT02392624|20162029|P3|COMPLETED|Overall Study||40
8177057|NCT02392624|20162030|P2|COMPLETED|Overall Study||66
8177058|NCT02392624|20162031|P1|COMPLETED|Overall Study||0
8177059|NCT02392624|20162029|P3|STARTED|Overall Study||53
8177060|NCT02392624|20162030|P2|STARTED|Overall Study||81
8177061|NCT02392624|20162031|P1|STARTED|Overall Study||71
8177062|NCT02392611|20162053|P9|NOT COMPLETED|Overall Study||0
8177063|NCT02392611|20162054|P8|NOT COMPLETED|Overall Study||0
8177064|NCT02392611|20162055|P7|NOT COMPLETED|Overall Study||1
8177065|NCT02392611|20162056|P6|NOT COMPLETED|Overall Study||1
8177066|NCT02392611|20162057|P5|NOT COMPLETED|Overall Study||1
8177067|NCT02392611|20162058|P4|NOT COMPLETED|Overall Study||6
8177068|NCT02392611|20162059|P3|NOT COMPLETED|Overall Study||0
8177069|NCT02392611|20162060|P2|NOT COMPLETED|Overall Study||0
8177070|NCT02392611|20162061|P1|NOT COMPLETED|Overall Study||1
8177071|NCT02392611|20162053|P9|COMPLETED|Overall Study||3
8177072|NCT02392611|20162054|P8|COMPLETED|Overall Study||3
8177073|NCT02392611|20162055|P7|COMPLETED|Overall Study||3
8177074|NCT02392611|20162056|P6|COMPLETED|Overall Study||3
8177075|NCT02392611|20162057|P5|COMPLETED|Overall Study||5
8177076|NCT02392611|20162058|P4|COMPLETED|Overall Study||3
8177077|NCT02392611|20162059|P3|COMPLETED|Overall Study||1
8177078|NCT02392611|20162060|P2|COMPLETED|Overall Study||1
8177079|NCT02392611|20162061|P1|COMPLETED|Overall Study||1
8177080|NCT02392611|20162053|P9|STARTED|Overall Study||3
8177081|NCT02392611|20162054|P8|STARTED|Overall Study||3
8177082|NCT02392611|20162055|P7|STARTED|Overall Study||4
8177083|NCT02392611|20162056|P6|STARTED|Overall Study||4
8177084|NCT02392611|20162057|P5|STARTED|Overall Study||6
8177085|NCT02392611|20162058|P4|STARTED|Overall Study||9
8177086|NCT02392611|20162059|P3|STARTED|Overall Study||1
8177087|NCT02392611|20162060|P2|STARTED|Overall Study||1
8177088|NCT02392611|20162061|P1|STARTED|Overall Study||2
8177089|NCT02392559|20162137|P2|NOT COMPLETED|Overall Study||1
8177090|NCT02392559|20162138|P1|NOT COMPLETED|Overall Study||0
8177091|NCT02392559|20162137|P2|COMPLETED|Overall Study||104
8177092|NCT02392559|20162138|P1|COMPLETED|Overall Study||53
8177093|NCT02392559|20162137|P2|Randomized and Dosed|Overall Study||104
8177094|NCT02392559|20162138|P1|Randomized and Dosed|Overall Study||53
8177095|NCT02392559|20162137|P2|STARTED|Overall Study||105
8177096|NCT02392559|20162138|P1|STARTED|Overall Study||53
8177097|NCT02392507|20162169|P1|NOT COMPLETED|Maintenance Regimen||2
8177098|NCT02392507|20162169|P1|COMPLETED|Maintenance Regimen||32
8177099|NCT02392507|20162169|P1|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34
8177100|NCT02392507|20162169|P1|NOT COMPLETED|Induction Regimen||7
8177101|NCT02392507|20162169|P1|COMPLETED|Induction Regimen||47
8177102|NCT02392507|20162169|P1|Received at Least 1 Dose of Study Drug|Induction Regimen||54
8177103|NCT02392507|20162169|P1|STARTED|Induction Regimen||54
8177104|NCT02392494|20162187|P4|NOT COMPLETED|Overall Study||0
8177105|NCT02392494|20162188|P3|NOT COMPLETED|Overall Study||0
8177106|NCT02392494|20162189|P2|NOT COMPLETED|Overall Study||0
8177107|NCT02392494|20162190|P1|NOT COMPLETED|Overall Study||0
8177108|NCT02392494|20162187|P4|COMPLETED|Overall Study||0
8177109|NCT02392494|20162188|P3|COMPLETED|Overall Study||3
8177110|NCT02392494|20162189|P2|COMPLETED|Overall Study||3
8177111|NCT02392494|20162190|P1|COMPLETED|Overall Study||3
8177112|NCT02392494|20162187|P4|STARTED|Overall Study||0
8177113|NCT02392494|20162188|P3|STARTED|Overall Study||3
8177114|NCT02392494|20162189|P2|STARTED|Overall Study||3
8177115|NCT02392494|20162190|P1|STARTED|Overall Study||3
8177116|NCT02392481|20162208|P4|NOT COMPLETED|Overall Study||2
8177117|NCT02392481|20162209|P3|NOT COMPLETED|Overall Study||2
8177118|NCT02392481|20162210|P2|NOT COMPLETED|Overall Study||0
8177119|NCT02392481|20162211|P1|NOT COMPLETED|Overall Study||0
8177120|NCT02392481|20162208|P4|COMPLETED|Overall Study||25
8177121|NCT02392481|20162209|P3|COMPLETED|Overall Study||18
8177122|NCT02392481|20162210|P2|COMPLETED|Overall Study||12
8177123|NCT02392481|20162211|P1|COMPLETED|Overall Study||10
8177124|NCT02392481|20162208|P4|STARTED|Overall Study||27
8177125|NCT02392481|20162209|P3|STARTED|Overall Study||20
8177126|NCT02392481|20162210|P2|STARTED|Overall Study||12
8177127|NCT02392481|20162211|P1|STARTED|Overall Study||10
8177128|NCT02392403|20162233|P1|NOT COMPLETED|Overall Study||3
8177129|NCT02392403|20162233|P1|COMPLETED|Overall Study||42
8177130|NCT02392403|20162233|P1|STARTED|Overall Study||45
8177131|NCT02392377|20162247|P2|NOT COMPLETED|Overall Study||1
8177132|NCT02392377|20162248|P1|NOT COMPLETED|Overall Study||0
8177133|NCT02392377|20162247|P2|COMPLETED|Overall Study||0
8177134|NCT02392377|20162248|P1|COMPLETED|Overall Study||0
8177135|NCT02392377|20162247|P2|STARTED|Overall Study||1
8177136|NCT02392377|20162248|P1|STARTED|Overall Study||0
8177149|NCT02392247|20162340|P1|NOT COMPLETED|Overall Study||2
8177150|NCT02392247|20162340|P1|COMPLETED|Overall Study||50
8177151|NCT02392247|20162340|P1|STARTED|Overall Study||52
8177152|NCT02392234|20162351|P6|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8177153|NCT02392234|20162352|P5|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8177154|NCT02392234|20162353|P4|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8177155|NCT02392234|20162354|P3|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8177156|NCT02392234|20162355|P2|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
8177157|NCT02392234|20162356|P1|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
8177158|NCT02392234|20162351|P6|COMPLETED|Treatment Period 2 (8 Weeks)||38
8177159|NCT02392234|20162352|P5|COMPLETED|Treatment Period 2 (8 Weeks)||37
8177160|NCT02392234|20162353|P4|COMPLETED|Treatment Period 2 (8 Weeks)||41
8177161|NCT02392234|20162354|P3|COMPLETED|Treatment Period 2 (8 Weeks)||38
8177162|NCT02392234|20162355|P2|COMPLETED|Treatment Period 2 (8 Weeks)||43
8177163|NCT02392234|20162356|P1|COMPLETED|Treatment Period 2 (8 Weeks)||37
8177164|NCT02392234|20162351|P6|STARTED|Treatment Period 2 (8 Weeks)||38
8177165|NCT02392234|20162352|P5|STARTED|Treatment Period 2 (8 Weeks)||37
8177166|NCT02392234|20162353|P4|STARTED|Treatment Period 2 (8 Weeks)||41
8177167|NCT02392234|20162354|P3|STARTED|Treatment Period 2 (8 Weeks)||38
8177168|NCT02392234|20162355|P2|STARTED|Treatment Period 2 (8 Weeks)||43
8177169|NCT02392234|20162356|P1|STARTED|Treatment Period 2 (8 Weeks)||38
8177170|NCT02392234|20162351|P6|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
8177171|NCT02392234|20162352|P5|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
8177172|NCT02392234|20162353|P4|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
8177173|NCT02392234|20162354|P3|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
8177174|NCT02392234|20162355|P2|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
8177175|NCT02392234|20162356|P1|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
8177176|NCT02392234|20162351|P6|COMPLETED|Treatment Period 1 (8 Weeks)||38
8177177|NCT02392234|20162352|P5|COMPLETED|Treatment Period 1 (8 Weeks)||37
8177178|NCT02392234|20162353|P4|COMPLETED|Treatment Period 1 (8 Weeks)||41
8177179|NCT02392234|20162354|P3|COMPLETED|Treatment Period 1 (8 Weeks)||38
8177180|NCT02392234|20162355|P2|COMPLETED|Treatment Period 1 (8 Weeks)||43
8177181|NCT02392234|20162356|P1|COMPLETED|Treatment Period 1 (8 Weeks)||38
8177182|NCT02392234|20162351|P6|Treated|Treatment Period 1 (8 Weeks)||41
8177183|NCT02392234|20162352|P5|Treated|Treatment Period 1 (8 Weeks)||40
8177184|NCT02392234|20162353|P4|Treated|Treatment Period 1 (8 Weeks)||42
8177185|NCT02392234|20162354|P3|Treated|Treatment Period 1 (8 Weeks)||39
8177186|NCT02392234|20162355|P2|Treated|Treatment Period 1 (8 Weeks)||43
8177187|NCT02392234|20162356|P1|Treated|Treatment Period 1 (8 Weeks)||41
8177188|NCT02392234|20162351|P6|STARTED|Treatment Period 1 (8 Weeks)||41
8177189|NCT02392234|20162352|P5|STARTED|Treatment Period 1 (8 Weeks)||41
8177190|NCT02392234|20162353|P4|STARTED|Treatment Period 1 (8 Weeks)||42
8177191|NCT02392234|20162354|P3|STARTED|Treatment Period 1 (8 Weeks)||40
8177192|NCT02392234|20162355|P2|STARTED|Treatment Period 1 (8 Weeks)||43
8177193|NCT02392234|20162356|P1|STARTED|Treatment Period 1 (8 Weeks)||41
8177194|NCT02392208|20162378|P1|NOT COMPLETED|Telavancin After Hemodialysis||0
8177195|NCT02392208|20162378|P1|COMPLETED|Telavancin After Hemodialysis||8
8177196|NCT02392208|20162378|P1|STARTED|Telavancin After Hemodialysis||8
8177197|NCT02392208|20162378|P1|NOT COMPLETED|Telavancin Before Hemodialysis||0
8177198|NCT02392208|20162378|P1|COMPLETED|Telavancin Before Hemodialysis||8
8177199|NCT02392208|20162378|P1|STARTED|Telavancin Before Hemodialysis||8
8177200|NCT02392195|20162388|P1|NOT COMPLETED|Overall Study||8
8177201|NCT02392195|20162388|P1|COMPLETED|Overall Study||2
8177202|NCT02392195|20162388|P1|STARTED|Overall Study||10
8177203|NCT02392104|20162394|P1|NOT COMPLETED|Overall Study||11
8177204|NCT02392104|20162394|P1|COMPLETED|Overall Study||39
8177205|NCT02392104|20162394|P1|STARTED|Overall Study|one participant enrolled but was removed prior to starting study protocol|50
8177206|NCT02392000|20162405|P1|NOT COMPLETED|Overall Study||27
8177207|NCT02392000|20162405|P1|COMPLETED|Overall Study||11
8177208|NCT02392000|20162405|P1|STARTED|Overall Study||38
8177209|NCT02391987|20162415|P2|NOT COMPLETED|Overall Study||0
8177210|NCT02391987|20162416|P1|NOT COMPLETED|Overall Study||0
8177211|NCT02391987|20162415|P2|COMPLETED|Overall Study||58
8177212|NCT02391987|20162416|P1|COMPLETED|Overall Study||54
8177213|NCT02391987|20162415|P2|STARTED|Overall Study||58
8177214|NCT02391987|20162416|P1|STARTED|Overall Study||54
8177215|NCT02391961|20162428|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
8177216|NCT02391961|20162429|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
8177217|NCT02391961|20162428|P2|COMPLETED|Second Intervention (4 Weeks)||7
8177218|NCT02391961|20162429|P1|COMPLETED|Second Intervention (4 Weeks)||6
8177219|NCT02391961|20162428|P2|STARTED|Second Intervention (4 Weeks)||8
8177220|NCT02391961|20162429|P1|STARTED|Second Intervention (4 Weeks)||7
8177221|NCT02391961|20162428|P2|NOT COMPLETED|Washout (2 Weeks)||1
8177222|NCT02391961|20162429|P1|NOT COMPLETED|Washout (2 Weeks)||1
8177223|NCT02391961|20162428|P2|COMPLETED|Washout (2 Weeks)||8
8177224|NCT02391961|20162429|P1|COMPLETED|Washout (2 Weeks)||7
8177225|NCT02391961|20162428|P2|STARTED|Washout (2 Weeks)||9
8177226|NCT02391961|20162429|P1|STARTED|Washout (2 Weeks)||8
8177227|NCT02391961|20162428|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8177228|NCT02391961|20162429|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
8177229|NCT02391961|20162428|P2|COMPLETED|First Intervention (4 Weeks)||9
8177230|NCT02391961|20162429|P1|COMPLETED|First Intervention (4 Weeks)||8
8177231|NCT02391961|20162428|P2|STARTED|First Intervention (4 Weeks)||9
8177232|NCT02391961|20162429|P1|STARTED|First Intervention (4 Weeks)||10
8177233|NCT02391948|20162452|P5|NOT COMPLETED|24-month Assessment||10
8177234|NCT02391948|20162453|P4|NOT COMPLETED|24-month Assessment||9
8177235|NCT02391948|20162454|P3|NOT COMPLETED|24-month Assessment||3
8177236|NCT02391948|20162455|P2|NOT COMPLETED|24-month Assessment||10
8177237|NCT02391948|20162456|P1|NOT COMPLETED|24-month Assessment||14
8177238|NCT02391948|20162452|P5|COMPLETED|24-month Assessment||69
8177239|NCT02391948|20162453|P4|COMPLETED|24-month Assessment||75
8177240|NCT02391948|20162454|P3|COMPLETED|24-month Assessment||48
8177241|NCT02391948|20162455|P2|COMPLETED|24-month Assessment||97
8177242|NCT02391948|20162456|P1|COMPLETED|24-month Assessment||135
8177243|NCT02391948|20162452|P5|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79
8177244|NCT02391948|20162453|P4|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84
8177245|NCT02391948|20162454|P3|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51
8177246|NCT02391948|20162455|P2|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107
8177247|NCT02391948|20162456|P1|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149
8177248|NCT02391948|20162452|P5|NOT COMPLETED|18-month Assessment||30
8177249|NCT02391948|20162453|P4|NOT COMPLETED|18-month Assessment||36
8177250|NCT02391948|20162454|P3|NOT COMPLETED|18-month Assessment||26
8177251|NCT02391948|20162455|P2|NOT COMPLETED|18-month Assessment||50
8177252|NCT02391948|20162456|P1|NOT COMPLETED|18-month Assessment||72
8177253|NCT02391948|20162452|P5|COMPLETED|18-month Assessment||75
8177254|NCT02391948|20162453|P4|COMPLETED|18-month Assessment||83
8177255|NCT02391948|20162454|P3|COMPLETED|18-month Assessment||48
8177256|NCT02391948|20162455|P2|COMPLETED|18-month Assessment||101
8177257|NCT02391948|20162456|P1|COMPLETED|18-month Assessment||147
8177258|NCT02391948|20162452|P5|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105
8177259|NCT02391948|20162453|P4|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119
8177260|NCT02391948|20162454|P3|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74
8177261|NCT02391948|20162455|P2|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151
8177262|NCT02391948|20162456|P1|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219
8177263|NCT02391948|20162452|P5|NOT COMPLETED|12-month Assessment||6
8177264|NCT02391948|20162453|P4|NOT COMPLETED|12-month Assessment||9
8177265|NCT02391948|20162454|P3|NOT COMPLETED|12-month Assessment||4
8177266|NCT02391948|20162455|P2|NOT COMPLETED|12-month Assessment||9
8177267|NCT02391948|20162456|P1|NOT COMPLETED|12-month Assessment||8
8177268|NCT02391948|20162452|P5|COMPLETED|12-month Assessment||103
8177269|NCT02391948|20162453|P4|COMPLETED|12-month Assessment||116
8177270|NCT02391948|20162454|P3|COMPLETED|12-month Assessment||73
8177271|NCT02391948|20162455|P2|COMPLETED|12-month Assessment||147
8177272|NCT02391948|20162456|P1|COMPLETED|12-month Assessment||217
8177273|NCT02391948|20162452|P5|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109
8177274|NCT02391948|20162453|P4|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125
8177275|NCT02391948|20162454|P3|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77
8177276|NCT02391948|20162455|P2|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156
8177277|NCT02391948|20162456|P1|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225
8177278|NCT02391948|20162452|P5|NOT COMPLETED|6-month Assessment||26
8177279|NCT02391948|20162453|P4|NOT COMPLETED|6-month Assessment||45
8177280|NCT02391948|20162454|P3|NOT COMPLETED|6-month Assessment||31
8177281|NCT02391948|20162455|P2|NOT COMPLETED|6-month Assessment||56
8177282|NCT02391948|20162456|P1|NOT COMPLETED|6-month Assessment||79
8177283|NCT02391948|20162452|P5|COMPLETED|6-month Assessment||85
8177284|NCT02391948|20162453|P4|COMPLETED|6-month Assessment||84
8177285|NCT02391948|20162454|P3|COMPLETED|6-month Assessment||49
8177286|NCT02391948|20162455|P2|COMPLETED|6-month Assessment||105
8177287|NCT02391948|20162456|P1|COMPLETED|6-month Assessment||148
8177288|NCT02391948|20162452|P5|STARTED|6-month Assessment||111
8177289|NCT02391948|20162453|P4|STARTED|6-month Assessment||129
8177290|NCT02391948|20162454|P3|STARTED|6-month Assessment||80
8177291|NCT02391948|20162455|P2|STARTED|6-month Assessment||161
8177292|NCT02391948|20162456|P1|STARTED|6-month Assessment||227
8177293|NCT02391948|20162452|P5|NOT COMPLETED|Baseline||0
8177294|NCT02391948|20162453|P4|NOT COMPLETED|Baseline||0
8177295|NCT02391948|20162454|P3|NOT COMPLETED|Baseline||0
8177296|NCT02391948|20162455|P2|NOT COMPLETED|Baseline||0
8177297|NCT02391948|20162456|P1|NOT COMPLETED|Baseline||0
8177298|NCT02391948|20162452|P5|COMPLETED|Baseline||111
8177299|NCT02391948|20162453|P4|COMPLETED|Baseline||129
8177300|NCT02391948|20162454|P3|COMPLETED|Baseline||80
8177301|NCT02391948|20162455|P2|COMPLETED|Baseline||161
8177302|NCT02391948|20162456|P1|COMPLETED|Baseline||227
8177303|NCT02391948|20162452|P5|STARTED|Baseline||111
8177304|NCT02391948|20162453|P4|STARTED|Baseline||129
8177305|NCT02391948|20162454|P3|STARTED|Baseline||80
8177306|NCT02391948|20162455|P2|STARTED|Baseline||161
8177307|NCT02391948|20162456|P1|STARTED|Baseline||227
8177308|NCT02391714|20162550|P2|NOT COMPLETED|Overall Study||0
8177309|NCT02391714|20162551|P1|NOT COMPLETED|Overall Study||0
8177310|NCT02391714|20162550|P2|COMPLETED|Overall Study||40
8177311|NCT02391714|20162551|P1|COMPLETED|Overall Study||40
8177312|NCT02391714|20162550|P2|STARTED|Overall Study||40
8177313|NCT02391714|20162551|P1|STARTED|Overall Study||40
8177314|NCT02391701|20162563|P2|NOT COMPLETED|Overall Study||38
8177315|NCT02391701|20162564|P1|NOT COMPLETED|Overall Study||21
8177316|NCT02391701|20162563|P2|COMPLETED|Overall Study||315
8177317|NCT02391701|20162564|P1|COMPLETED|Overall Study||346
8177318|NCT02391701|20162563|P2|STARTED|Overall Study||353
8177319|NCT02391701|20162564|P1|STARTED|Overall Study||367
8177320|NCT02391584|20162580|P2|NOT COMPLETED|12 Month (End of Study)||0
8177321|NCT02391584|20162581|P1|NOT COMPLETED|12 Month (End of Study)||2
8177322|NCT02391584|20162580|P2|COMPLETED|12 Month (End of Study)||0
8177323|NCT02391584|20162581|P1|COMPLETED|12 Month (End of Study)||49
8177324|NCT02391584|20162580|P2|STARTED|12 Month (End of Study)||0
8177325|NCT02391584|20162581|P1|STARTED|12 Month (End of Study)||51
8177326|NCT02391584|20162580|P2|NOT COMPLETED|6 Month||0
8177327|NCT02391584|20162581|P1|NOT COMPLETED|6 Month||1
8177328|NCT02391584|20162580|P2|COMPLETED|6 Month||0
8177329|NCT02391584|20162581|P1|COMPLETED|6 Month||51
8177330|NCT02391584|20162580|P2|STARTED|6 Month||0
8177331|NCT02391584|20162581|P1|STARTED|6 Month||52
8177332|NCT02391584|20162580|P2|NOT COMPLETED|3 Month||0
8177333|NCT02391584|20162581|P1|NOT COMPLETED|3 Month||1
8177334|NCT02391584|20162580|P2|COMPLETED|3 Month||0
8177335|NCT02391584|20162581|P1|COMPLETED|3 Month||52
8177336|NCT02391584|20162580|P2|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
8177337|NCT02391584|20162581|P1|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
8177338|NCT02391584|20162580|P2|NOT COMPLETED|Primary Endpoint (6-weeks)||2
8177339|NCT02391584|20162581|P1|NOT COMPLETED|Primary Endpoint (6-weeks)||2
8177340|NCT02391584|20162580|P2|COMPLETED|Primary Endpoint (6-weeks)||27
8177341|NCT02391584|20162581|P1|COMPLETED|Primary Endpoint (6-weeks)||29
8177342|NCT02391584|20162580|P2|STARTED|Primary Endpoint (6-weeks)||29
8177343|NCT02391584|20162581|P1|STARTED|Primary Endpoint (6-weeks)||31
8177350|NCT02391363|20162619|P2|NOT COMPLETED|Overall Study||8
8177351|NCT02391363|20162620|P1|NOT COMPLETED|Overall Study||11
8177352|NCT02391363|20162619|P2|COMPLETED|Overall Study||56
8177353|NCT02391363|20162620|P1|COMPLETED|Overall Study||59
8177354|NCT02391363|20162619|P2|STARTED|Overall Study||64
8177355|NCT02391363|20162620|P1|STARTED|Overall Study||70
8177356|NCT02391350|20162686|P2|NOT COMPLETED|Overall Study||17
8177357|NCT02391350|20162687|P1|NOT COMPLETED|Overall Study||12
8177358|NCT02391350|20162686|P2|COMPLETED|Overall Study||93
8177359|NCT02391350|20162687|P1|COMPLETED|Overall Study||98
8177360|NCT02391350|20162686|P2|6-month Follow-up|Overall Study||96
8177361|NCT02391350|20162687|P1|6-month Follow-up|Overall Study||100
8177362|NCT02391350|20162686|P2|4-week Follow-up|Overall Study||105
8177363|NCT02391350|20162687|P1|4-week Follow-up|Overall Study||106
8177364|NCT02391350|20162686|P2|STARTED|Overall Study||110
8177365|NCT02391350|20162687|P1|STARTED|Overall Study||110
8177366|NCT02391311|20162705|P2|NOT COMPLETED|Overall Study||2
8177367|NCT02391311|20162706|P1|NOT COMPLETED|Overall Study||3
8177368|NCT02391311|20162705|P2|COMPLETED|Overall Study||19
8177369|NCT02391311|20162706|P1|COMPLETED|Overall Study||18
8177370|NCT02391311|20162705|P2|STARTED|Overall Study||21
8177371|NCT02391311|20162706|P1|STARTED|Overall Study||21
8177372|NCT02391116|20162714|P1|NOT COMPLETED|Survival Follow-up||4
8177373|NCT02391116|20162714|P1|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42
8177374|NCT02391116|20162714|P1|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46
8177375|NCT02391116|20162714|P1|NOT COMPLETED|Active Follow-up||3
8177376|NCT02391116|20162714|P1|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6
8177377|NCT02391116|20162714|P1|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9
8177378|NCT02391116|20162714|P1|NOT COMPLETED|Safety Follow-up||13
8177379|NCT02391116|20162714|P1|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43
8177380|NCT02391116|20162714|P1|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56
8177381|NCT02391116|20162714|P1|NOT COMPLETED|Treatment||14
8177382|NCT02391116|20162714|P1|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53
8177383|NCT02391116|20162714|P1|Included in Per Protocol Set|Treatment||40
8177384|NCT02391116|20162714|P1|STARTED|Treatment||67
8177385|NCT02391038|20162768|P3|NOT COMPLETED|Overall Study||6
8177386|NCT02391038|20162769|P2|NOT COMPLETED|Overall Study||3
8177387|NCT02391038|20162770|P1|NOT COMPLETED|Overall Study||3
8177388|NCT02391038|20162768|P3|COMPLETED|Overall Study||0
8177389|NCT02391038|20162769|P2|COMPLETED|Overall Study||0
8177390|NCT02391038|20162770|P1|COMPLETED|Overall Study||0
8177391|NCT02391038|20162768|P3|STARTED|Overall Study||6
8177392|NCT02391038|20162769|P2|STARTED|Overall Study||3
8177393|NCT02391038|20162770|P1|STARTED|Overall Study||3
8177394|NCT02390791|20162886|P2|NOT COMPLETED|Overall Study||0
8177395|NCT02390791|20162887|P1|NOT COMPLETED|Overall Study||0
8177396|NCT02390791|20162886|P2|COMPLETED|Overall Study||45
8177397|NCT02390791|20162887|P1|COMPLETED|Overall Study||40
8177398|NCT02390791|20162886|P2|STARTED|Overall Study||45
8177399|NCT02390791|20162887|P1|STARTED|Overall Study||40
8177400|NCT02390557|20162914|P3|NOT COMPLETED|Wave 2||23
8177401|NCT02390557|20162915|P2|NOT COMPLETED|Wave 2||41
8177402|NCT02390557|20162916|P1|NOT COMPLETED|Wave 2||72
8177403|NCT02390557|20162914|P3|COMPLETED|Wave 2||112
8177404|NCT02390557|20162915|P2|COMPLETED|Wave 2||115
8177405|NCT02390557|20162916|P1|COMPLETED|Wave 2||88
8177406|NCT02390557|20162914|P3|STARTED|Wave 2||135
8177407|NCT02390557|20162915|P2|STARTED|Wave 2||156
8177408|NCT02390557|20162916|P1|STARTED|Wave 2||160
8177409|NCT02390557|20162914|P3|NOT COMPLETED|Wave 1||0
8177410|NCT02390557|20162915|P2|NOT COMPLETED|Wave 1||0
8177411|NCT02390557|20162916|P1|NOT COMPLETED|Wave 1||0
8177412|NCT02390557|20162914|P3|COMPLETED|Wave 1||135
8177413|NCT02390557|20162915|P2|COMPLETED|Wave 1||156
8177414|NCT02390557|20162916|P1|COMPLETED|Wave 1||160
8177415|NCT02390557|20162914|P3|STARTED|Wave 1||135
8177416|NCT02390557|20162915|P2|STARTED|Wave 1||156
8177417|NCT02390557|20162916|P1|STARTED|Wave 1||160
8177418|NCT02390362|20162926|P2|NOT COMPLETED|Overall Study||1
8177419|NCT02390362|20162927|P1|NOT COMPLETED|Overall Study||0
8177420|NCT02390362|20162926|P2|COMPLETED|Overall Study||1
8177421|NCT02390362|20162927|P1|COMPLETED|Overall Study||1
8177422|NCT02390362|20162926|P2|STARTED|Overall Study||2
8177423|NCT02390362|20162927|P1|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1
8177424|NCT02390219|20162935|P1|NOT COMPLETED|Overall Study||13
8177425|NCT02390219|20162935|P1|COMPLETED|Overall Study||33
8177426|NCT02390219|20162935|P1|STARTED|Overall Study||46
8177427|NCT02390167|20162945|P1|NOT COMPLETED|Overall Study||1
8177428|NCT02390167|20162945|P1|COMPLETED|Overall Study||375
8177429|NCT02390167|20162945|P1|Without Diabetes|Overall Study||43
8177430|NCT02390167|20162945|P1|With Diabetes|Overall Study||333
8177431|NCT02390167|20162945|P1|STARTED|Overall Study||376
8177432|NCT02390076|20162967|P3|NOT COMPLETED|Overall Study||4
8177433|NCT02390076|20162968|P2|NOT COMPLETED|Overall Study||1
8177434|NCT02390076|20162969|P1|NOT COMPLETED|Overall Study||2
8177435|NCT02390076|20162967|P3|COMPLETED|Overall Study||11
8177436|NCT02390076|20162968|P2|COMPLETED|Overall Study||17
8177437|NCT02390076|20162969|P1|COMPLETED|Overall Study||16
8177438|NCT02390076|20162967|P3|STARTED|Overall Study||15
8177439|NCT02390076|20162968|P2|STARTED|Overall Study||18
8177440|NCT02390076|20162969|P1|STARTED|Overall Study||18
8177447|NCT02389894|20162998|P3|NOT COMPLETED|Overall Study||9
8177448|NCT02389894|20162999|P2|NOT COMPLETED|Overall Study||10
8177449|NCT02389894|20163000|P1|NOT COMPLETED|Overall Study||8
8177450|NCT02389894|20162998|P3|COMPLETED|Overall Study||123
8177451|NCT02389894|20162999|P2|COMPLETED|Overall Study||108
8177452|NCT02389894|20163000|P1|COMPLETED|Overall Study||125
8177453|NCT02389894|20162998|P3|STARTED|Overall Study||132
8177454|NCT02389894|20162999|P2|STARTED|Overall Study||118
8177455|NCT02389894|20163000|P1|STARTED|Overall Study||133
8177456|NCT02389881|20163075|P7|NOT COMPLETED|Overall Study||0
8177457|NCT02389881|20163076|P6|NOT COMPLETED|Overall Study||0
8177458|NCT02389881|20163077|P5|NOT COMPLETED|Overall Study||0
8177459|NCT02389881|20163078|P4|NOT COMPLETED|Overall Study||0
8177460|NCT02389881|20163079|P3|NOT COMPLETED|Overall Study||0
8177461|NCT02389881|20163080|P2|NOT COMPLETED|Overall Study||0
8177462|NCT02389881|20163081|P1|NOT COMPLETED|Overall Study||0
8177463|NCT02389881|20163075|P7|COMPLETED|Overall Study||2
8177464|NCT02389881|20163076|P6|COMPLETED|Overall Study||8
8177465|NCT02389881|20163077|P5|COMPLETED|Overall Study||6
8177466|NCT02389881|20163078|P4|COMPLETED|Overall Study||6
8177467|NCT02389881|20163079|P3|COMPLETED|Overall Study||6
8177468|NCT02389881|20163080|P2|COMPLETED|Overall Study||6
8177469|NCT02389881|20163081|P1|COMPLETED|Overall Study||6
8177470|NCT02389881|20163075|P7|STARTED|Overall Study||2
8177471|NCT02389881|20163076|P6|STARTED|Overall Study||8
8177472|NCT02389881|20163077|P5|STARTED|Overall Study||6
8177473|NCT02389881|20163078|P4|STARTED|Overall Study||6
8177474|NCT02389881|20163079|P3|STARTED|Overall Study||6
8177475|NCT02389881|20163080|P2|STARTED|Overall Study||6
8177476|NCT02389881|20163081|P1|STARTED|Overall Study||6
8177477|NCT02389829|20163132|P2|NOT COMPLETED|Overall Study||1
8177478|NCT02389829|20163133|P1|NOT COMPLETED|Overall Study||0
8177479|NCT02389829|20163132|P2|COMPLETED|Overall Study||62
8177480|NCT02389829|20163133|P1|COMPLETED|Overall Study||64
8177481|NCT02389829|20163132|P2|STARTED|Overall Study||63
8177482|NCT02389829|20163133|P1|STARTED|Overall Study||64
8177492|NCT02389764|20163182|P1|NOT COMPLETED|Overall Study||9
8177493|NCT02389764|20163182|P1|COMPLETED|Overall Study||0
8177494|NCT02389764|20163182|P1|STARTED|Overall Study||9
8177495|NCT02389738|20163187|P1|NOT COMPLETED|Overall Study||1
8177496|NCT02389738|20163187|P1|COMPLETED|Overall Study||5
8177497|NCT02389738|20163187|P1|STARTED|Overall Study||6
8177498|NCT02389725|20163193|P2|NOT COMPLETED|Overall Study||0
8177499|NCT02389725|20163194|P1|NOT COMPLETED|Overall Study||0
8177500|NCT02389725|20163193|P2|COMPLETED|Overall Study||60
8177501|NCT02389725|20163194|P1|COMPLETED|Overall Study||59
8177502|NCT02389725|20163193|P2|STARTED|Overall Study||60
8177503|NCT02389725|20163194|P1|STARTED|Overall Study||59
8177504|NCT02389712|20163208|P2|NOT COMPLETED|Overall Study||0
8177505|NCT02389712|20163209|P1|NOT COMPLETED|Overall Study||0
8177506|NCT02389712|20163208|P2|COMPLETED|Overall Study||1
8177507|NCT02389712|20163209|P1|COMPLETED|Overall Study||1
8177508|NCT02389712|20163208|P2|STARTED|Overall Study||1
8177509|NCT02389712|20163209|P1|STARTED|Overall Study||1
8177510|NCT02389621|20163217|P2|NOT COMPLETED|Posttreatment Period||4
8177511|NCT02389621|20163218|P1|NOT COMPLETED|Posttreatment Period||9
8177512|NCT02389621|20163217|P2|COMPLETED|Posttreatment Period||102
8177513|NCT02389621|20163218|P1|COMPLETED|Posttreatment Period||98
8177514|NCT02389621|20163217|P2|STARTED|Posttreatment Period||106
8177515|NCT02389621|20163218|P1|STARTED|Posttreatment Period||107
8177516|NCT02389621|20163217|P2|NOT COMPLETED|Treatment Period||1
8177517|NCT02389621|20163218|P1|NOT COMPLETED|Treatment Period||1
8177518|NCT02389621|20163217|P2|COMPLETED|Treatment Period||106
8177519|NCT02389621|20163218|P1|COMPLETED|Treatment Period||107
8177520|NCT02389621|20163217|P2|Received Study Drug|Treatment Period||107
8177521|NCT02389621|20163218|P1|Received Study Drug|Treatment Period||107
8177522|NCT02389621|20163217|P2|STARTED|Treatment Period||107
8177523|NCT02389621|20163218|P1|STARTED|Treatment Period||108
8177524|NCT02389452|20163248|P1|NOT COMPLETED|Overall Study||25
8177525|NCT02389452|20163248|P1|COMPLETED|Overall Study||369
8177526|NCT02389452|20163248|P1|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
8177527|NCT02389452|20163248|P1|STARTED|Overall Study||394
8177528|NCT02389374|20163269|P3|NOT COMPLETED|Overall Study||1
8177529|NCT02389374|20163270|P2|NOT COMPLETED|Overall Study||28
8177530|NCT02389374|20163271|P1|NOT COMPLETED|Overall Study||9
8177531|NCT02389374|20163269|P3|COMPLETED|Overall Study||10
8177532|NCT02389374|20163270|P2|COMPLETED|Overall Study||87
8177533|NCT02389374|20163271|P1|COMPLETED|Overall Study||46
8177534|NCT02389374|20163269|P3|STARTED|Overall Study||11
8177535|NCT02389374|20163270|P2|STARTED|Overall Study||115
8177536|NCT02389374|20163271|P1|STARTED|Overall Study||55
8177537|NCT02389361|20163303|P2|NOT COMPLETED|Overall Study||0
8177538|NCT02389361|20163304|P1|NOT COMPLETED|Overall Study||0
8177539|NCT02389361|20163303|P2|COMPLETED|Overall Study||27
8177540|NCT02389361|20163304|P1|COMPLETED|Overall Study||24
8177541|NCT02389361|20163303|P2|STARTED|Overall Study||27
8177542|NCT02389361|20163304|P1|STARTED|Overall Study||24
8177543|NCT02389101|20163310|P1|NOT COMPLETED|Overall Study||0
8177544|NCT02389101|20163310|P1|COMPLETED|Overall Study||21
8177545|NCT02389101|20163310|P1|STARTED|Overall Study||21
8177546|NCT02389088|20163314|P1|NOT COMPLETED|Phase II - All Study Participants||0
8177547|NCT02389088|20163314|P1|COMPLETED|Phase II - All Study Participants||9
8177548|NCT02389088|20163314|P1|STARTED|Phase II - All Study Participants||9
8177549|NCT02389088|20163314|P1|NOT COMPLETED|Overall Study - Phase I||0
8177550|NCT02389088|20163314|P1|COMPLETED|Overall Study - Phase I||9
8177551|NCT02389088|20163314|P1|STARTED|Overall Study - Phase I||9
8177552|NCT02388997|20163360|P2|NOT COMPLETED|Overall Study||6
8177553|NCT02388997|20163361|P1|NOT COMPLETED|Overall Study||3
8177554|NCT02388997|20163360|P2|COMPLETED|Overall Study||10
8177555|NCT02388997|20163361|P1|COMPLETED|Overall Study||12
8177556|NCT02388997|20163360|P2|STARTED|Overall Study||16
8177557|NCT02388997|20163361|P1|STARTED|Overall Study||15
8177558|NCT02388932|20163379|P1|NOT COMPLETED|Overall Study||1
8177559|NCT02388932|20163379|P1|COMPLETED|Overall Study||2
8177560|NCT02388932|20163379|P1|STARTED|Overall Study||3
8177561|NCT02388880|20163389|P1|NOT COMPLETED|Overall Study||0
8177562|NCT02388880|20163389|P1|COMPLETED|Overall Study||3
8177563|NCT02388880|20163389|P1|STARTED|Overall Study||3
8177564|NCT02388815|20163396|P1|NOT COMPLETED|Overall Study||4
8177565|NCT02388815|20163396|P1|COMPLETED|Overall Study||85
8177566|NCT02388815|20163396|P1|STARTED|Overall Study||89
8177567|NCT02388776|20163400|P1|NOT COMPLETED|Overall Study||2
8177568|NCT02388776|20163400|P1|COMPLETED|Overall Study||0
8177569|NCT02388776|20163400|P1|STARTED|Overall Study||2
8177570|NCT02388763|20163405|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
8177571|NCT02388763|20163406|P1|NOT COMPLETED|Period 2, 10 Days of Wear||0
8177572|NCT02388763|20163405|P2|COMPLETED|Period 2, 10 Days of Wear||30
8177573|NCT02388763|20163406|P1|COMPLETED|Period 2, 10 Days of Wear||30
8177574|NCT02388763|20163405|P2|STARTED|Period 2, 10 Days of Wear||30
8177575|NCT02388763|20163406|P1|STARTED|Period 2, 10 Days of Wear||30
8177576|NCT02388763|20163405|P2|NOT COMPLETED|Period 1, 10 Days of Wear||1
8177577|NCT02388763|20163406|P1|NOT COMPLETED|Period 1, 10 Days of Wear||1
8177578|NCT02388763|20163405|P2|COMPLETED|Period 1, 10 Days of Wear||30
8177579|NCT02388763|20163406|P1|COMPLETED|Period 1, 10 Days of Wear||30
8177580|NCT02388763|20163405|P2|STARTED|Period 1, 10 Days of Wear||31
8177581|NCT02388763|20163406|P1|STARTED|Period 1, 10 Days of Wear||31
8177582|NCT02388763|20163405|P2|NOT COMPLETED|Habitual, 10 Days of Wear||1
8177583|NCT02388763|20163406|P1|NOT COMPLETED|Habitual, 10 Days of Wear||1
8177584|NCT02388763|20163405|P2|COMPLETED|Habitual, 10 Days of Wear||31
8177585|NCT02388763|20163406|P1|COMPLETED|Habitual, 10 Days of Wear||31
8177586|NCT02388763|20163405|P2|STARTED|Habitual, 10 Days of Wear||32
8177587|NCT02388763|20163406|P1|STARTED|Habitual, 10 Days of Wear||32
8177588|NCT02388737|20163420|P3|NOT COMPLETED|Overall Study||62
8177589|NCT02388737|20163421|P2|NOT COMPLETED|Overall Study||60
8177590|NCT02388737|20163422|P1|NOT COMPLETED|Overall Study||54
8177591|NCT02388737|20163420|P3|COMPLETED|Overall Study||180
8177592|NCT02388737|20163421|P2|COMPLETED|Overall Study||166
8177593|NCT02388737|20163422|P1|COMPLETED|Overall Study||181
8177594|NCT02388737|20163420|P3|STARTED|Overall Study||242
8177595|NCT02388737|20163421|P2|STARTED|Overall Study||226
8177596|NCT02388737|20163422|P1|STARTED|Overall Study||235
8177597|NCT02388724|20163456|P2|NOT COMPLETED|Overall Study||13
8177598|NCT02388724|20163457|P1|NOT COMPLETED|Overall Study||12
8177599|NCT02388724|20163456|P2|COMPLETED|Overall Study||224
8177600|NCT02388724|20163457|P1|COMPLETED|Overall Study||232
8177601|NCT02388724|20163456|P2|Safety Set: Randomized But Not Treated|Overall Study||2
8177602|NCT02388724|20163457|P1|Safety Set: Randomized But Not Treated|Overall Study||0
8177603|NCT02388724|20163456|P2|STARTED|Overall Study||237
8177604|NCT02388724|20163457|P1|STARTED|Overall Study||244
8177605|NCT02388568|20163481|P2|NOT COMPLETED|Overall Study||15
8177606|NCT02388568|20163482|P1|NOT COMPLETED|Overall Study||10
8177607|NCT02388568|20163481|P2|COMPLETED|Overall Study||53
8177608|NCT02388568|20163482|P1|COMPLETED|Overall Study||59
8177609|NCT02388568|20163481|P2|STARTED|Overall Study||68
8177610|NCT02388568|20163482|P1|STARTED|Overall Study||69
8177611|NCT02388386|20163498|P1|NOT COMPLETED|Overall Study||0
8177612|NCT02388386|20163498|P1|COMPLETED|Overall Study||10
8177613|NCT02388386|20163498|P1|STARTED|Overall Study||10
8177614|NCT02388347|20163511|P5|NOT COMPLETED|Overall Study||0
8177615|NCT02388347|20163512|P4|NOT COMPLETED|Overall Study||0
8177616|NCT02388347|20163513|P3|NOT COMPLETED|Overall Study||1
8177617|NCT02388347|20163514|P2|NOT COMPLETED|Overall Study||0
8177618|NCT02388347|20163515|P1|NOT COMPLETED|Overall Study||0
8177619|NCT02388347|20163511|P5|COMPLETED|Overall Study||6
8177620|NCT02388347|20163512|P4|COMPLETED|Overall Study||6
8177621|NCT02388347|20163513|P3|COMPLETED|Overall Study||5
8177622|NCT02388347|20163514|P2|COMPLETED|Overall Study||6
8177623|NCT02388347|20163515|P1|COMPLETED|Overall Study||8
8177624|NCT02388347|20163511|P5|STARTED|Overall Study||6
8177625|NCT02388347|20163512|P4|STARTED|Overall Study||6
8177626|NCT02388347|20163513|P3|STARTED|Overall Study||6
8177627|NCT02388347|20163514|P2|STARTED|Overall Study||6
8177628|NCT02388347|20163515|P1|STARTED|Overall Study||8
8177629|NCT02388321|20163582|P2|NOT COMPLETED|Overall Study||0
8177630|NCT02388321|20163583|P1|NOT COMPLETED|Overall Study||0
8177631|NCT02388321|20163582|P2|COMPLETED|Overall Study||11
8177632|NCT02388321|20163583|P1|COMPLETED|Overall Study||11
8177633|NCT02388321|20163582|P2|STARTED|Overall Study||11
8177634|NCT02388321|20163583|P1|STARTED|Overall Study||11
8177635|NCT02388295|20163594|P3|NOT COMPLETED|Treatment Weeks 3 to 12||0
8177636|NCT02388295|20163595|P2|NOT COMPLETED|Treatment Weeks 3 to 12||1
8177637|NCT02388295|20163596|P1|NOT COMPLETED|Treatment Weeks 3 to 12||1
8177638|NCT02388295|20163594|P3|COMPLETED|Treatment Weeks 3 to 12||17
8177639|NCT02388295|20163595|P2|COMPLETED|Treatment Weeks 3 to 12||13
8177640|NCT02388295|20163596|P1|COMPLETED|Treatment Weeks 3 to 12||15
8177641|NCT02388295|20163594|P3|STARTED|Treatment Weeks 3 to 12||17
8177642|NCT02388295|20163595|P2|STARTED|Treatment Weeks 3 to 12||14
8177643|NCT02388295|20163596|P1|STARTED|Treatment Weeks 3 to 12||16
8177644|NCT02388295|20163594|P3|NOT COMPLETED|Dose Escalation Week 2||1
8177645|NCT02388295|20163595|P2|NOT COMPLETED|Dose Escalation Week 2||2
8177646|NCT02388295|20163596|P1|NOT COMPLETED|Dose Escalation Week 2||1
8177647|NCT02388295|20163594|P3|COMPLETED|Dose Escalation Week 2||17
8177648|NCT02388295|20163595|P2|COMPLETED|Dose Escalation Week 2||14
8177649|NCT02388295|20163596|P1|COMPLETED|Dose Escalation Week 2||16
8177650|NCT02388295|20163594|P3|STARTED|Dose Escalation Week 2||18
8177651|NCT02388295|20163595|P2|STARTED|Dose Escalation Week 2||16
8177652|NCT02388295|20163596|P1|STARTED|Dose Escalation Week 2||17
8177653|NCT02388295|20163594|P3|NOT COMPLETED|Dose Escalation Week 1||2
8177654|NCT02388295|20163595|P2|NOT COMPLETED|Dose Escalation Week 1||3
8177655|NCT02388295|20163596|P1|NOT COMPLETED|Dose Escalation Week 1||2
8177656|NCT02388295|20163594|P3|COMPLETED|Dose Escalation Week 1||18
8177657|NCT02388295|20163595|P2|COMPLETED|Dose Escalation Week 1||16
8177658|NCT02388295|20163596|P1|COMPLETED|Dose Escalation Week 1||17
8177659|NCT02388295|20163594|P3|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
8177660|NCT02388295|20163595|P2|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
8177661|NCT02388295|20163596|P1|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
8177662|NCT02388269|20163614|P3|NOT COMPLETED|Overall Study||10
8177663|NCT02388269|20163615|P2|NOT COMPLETED|Overall Study||2
8177664|NCT02388269|20163616|P1|NOT COMPLETED|Overall Study||9
8177665|NCT02388269|20163614|P3|COMPLETED|Overall Study||0
8177666|NCT02388269|20163615|P2|COMPLETED|Overall Study||38
8177667|NCT02388269|20163616|P1|COMPLETED|Overall Study||32
8177668|NCT02388269|20163614|P3|Open Label|Overall Study||0
8177669|NCT02388269|20163615|P2|Open Label|Overall Study||38
8177670|NCT02388269|20163616|P1|Open Label|Overall Study||37
8177671|NCT02388269|20163614|P3|Randomised Period|Overall Study||0
8177672|NCT02388269|20163615|P2|Randomised Period|Overall Study||40
8177673|NCT02388269|20163616|P1|Randomised Period|Overall Study||41
8177674|NCT02388269|20163614|P3|STARTED|Overall Study||10
8177675|NCT02388269|20163615|P2|STARTED|Overall Study||40
8177676|NCT02388269|20163616|P1|STARTED|Overall Study||41
8177677|NCT02388191|20163648|P2|NOT COMPLETED|Overall Study||0
8177678|NCT02388191|20163649|P1|NOT COMPLETED|Overall Study||1
8177679|NCT02388191|20163648|P2|COMPLETED|Overall Study||60
8177680|NCT02388191|20163649|P1|COMPLETED|Overall Study||58
8177681|NCT02388191|20163648|P2|STARTED|Overall Study||60
8177682|NCT02388191|20163649|P1|STARTED|Overall Study||59
8177683|NCT02388165|20163665|P2|NOT COMPLETED|Overall Study||130
8177684|NCT02388165|20163666|P1|NOT COMPLETED|Overall Study||127
8177685|NCT02388165|20163665|P2|COMPLETED|Overall Study||1594
8177686|NCT02388165|20163666|P1|COMPLETED|Overall Study||1599
8177687|NCT02388165|20163665|P2|Vaccinated (Safety Population)|Overall Study||1709
8177688|NCT02388165|20163666|P1|Vaccinated (Safety Population)|Overall Study||1708
8177689|NCT02388165|20163665|P2|STARTED|Overall Study||1724
8177690|NCT02388165|20163666|P1|STARTED|Overall Study||1726
8177691|NCT02388074|20163696|P1|NOT COMPLETED|Overall Study||3
8177692|NCT02388074|20163696|P1|COMPLETED|Overall Study||22
8177693|NCT02388074|20163696|P1|STARTED|Overall Study||25
8177694|NCT02387996|20163700|P1|NOT COMPLETED|Overall Study||204
8177695|NCT02387996|20163700|P1|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
8177696|NCT02387996|20163700|P1|STARTED|Overall Study||270
8177697|NCT02387983|20163711|P1|NOT COMPLETED|Overall Study||7
8177698|NCT02387983|20163711|P1|COMPLETED|Overall Study||58
8177699|NCT02387983|20163711|P1|STARTED|Overall Study||65
8177700|NCT02387970|20163725|P2|NOT COMPLETED|Overall Study||2
8177701|NCT02387970|20163726|P1|NOT COMPLETED|Overall Study||1
8177702|NCT02387970|20163725|P2|COMPLETED|Overall Study||23
8177703|NCT02387970|20163726|P1|COMPLETED|Overall Study||26
8177704|NCT02387970|20163725|P2|STARTED|Overall Study||25
8177705|NCT02387970|20163726|P1|STARTED|Overall Study||27
8177706|NCT02387957|20163747|P3|NOT COMPLETED|Overall Study||20
8177707|NCT02387957|20163748|P2|NOT COMPLETED|Overall Study||21
8177708|NCT02387957|20163749|P1|NOT COMPLETED|Overall Study||21
8177709|NCT02387957|20163747|P3|COMPLETED|Overall Study|The study was discontinued|1
8177710|NCT02387957|20163748|P2|COMPLETED|Overall Study|The study was discontinued|0
8177711|NCT02387957|20163749|P1|COMPLETED|Overall Study|The study was discontinued|0
8177712|NCT02387957|20163747|P3|STARTED|Overall Study||21
8177713|NCT02387957|20163748|P2|STARTED|Overall Study||21
8177714|NCT02387957|20163749|P1|STARTED|Overall Study||21
8177715|NCT02387853|20163760|P1|NOT COMPLETED|Overall Study||3
8177716|NCT02387853|20163760|P1|COMPLETED|Overall Study||103
8177717|NCT02387853|20163760|P1|STARTED|Overall Study||106
8177718|NCT02387840|20163782|P6|NOT COMPLETED|Overall Study||1
8177719|NCT02387840|20163783|P5|NOT COMPLETED|Overall Study||0
8177720|NCT02387840|20163784|P4|NOT COMPLETED|Overall Study||0
8177721|NCT02387840|20163785|P3|NOT COMPLETED|Overall Study||0
8177722|NCT02387840|20163786|P2|NOT COMPLETED|Overall Study||0
8177723|NCT02387840|20163787|P1|NOT COMPLETED|Overall Study||0
8177724|NCT02387840|20163782|P6|COMPLETED|Overall Study||5
8177725|NCT02387840|20163783|P5|COMPLETED|Overall Study||4
8177726|NCT02387840|20163784|P4|COMPLETED|Overall Study||8
8177727|NCT02387840|20163785|P3|COMPLETED|Overall Study||6
8177728|NCT02387840|20163786|P2|COMPLETED|Overall Study||6
8177729|NCT02387840|20163787|P1|COMPLETED|Overall Study||4
8177730|NCT02387840|20163782|P6|STARTED|Overall Study||6
8177731|NCT02387840|20163783|P5|STARTED|Overall Study||4
8177732|NCT02387840|20163784|P4|STARTED|Overall Study||8
8177733|NCT02387840|20163785|P3|STARTED|Overall Study||6
8177734|NCT02387840|20163786|P2|STARTED|Overall Study||6
8177735|NCT02387840|20163787|P1|STARTED|Overall Study||4
8177736|NCT02387814|20163817|P4|NOT COMPLETED|Overall Study||0
8177737|NCT02387814|20163818|P3|NOT COMPLETED|Overall Study||0
8177738|NCT02387814|20163819|P2|NOT COMPLETED|Overall Study||0
8177739|NCT02387814|20163820|P1|NOT COMPLETED|Overall Study||0
8177740|NCT02387814|20163817|P4|COMPLETED|Overall Study||6
8177741|NCT02387814|20163818|P3|COMPLETED|Overall Study||10
8177742|NCT02387814|20163819|P2|COMPLETED|Overall Study||9
8177743|NCT02387814|20163820|P1|COMPLETED|Overall Study||10
8177744|NCT02387814|20163817|P4|Received Abemaciclib|Overall Study||6
8177745|NCT02387814|20163818|P3|Received Abemaciclib|Overall Study||10
8177746|NCT02387814|20163819|P2|Received Abemaciclib|Overall Study||9
8177747|NCT02387814|20163820|P1|Received Abemaciclib|Overall Study||10
8177748|NCT02387814|20163817|P4|STARTED|Overall Study||6
8177749|NCT02387814|20163818|P3|STARTED|Overall Study||10
8177750|NCT02387814|20163819|P2|STARTED|Overall Study||9
8177751|NCT02387814|20163820|P1|STARTED|Overall Study||10
8177752|NCT02387801|20163836|P2|NOT COMPLETED|Post-Treatment Follow-up||0
8177753|NCT02387801|20163837|P1|NOT COMPLETED|Post-Treatment Follow-up||0
8177754|NCT02387801|20163836|P2|COMPLETED|Post-Treatment Follow-up||12
8177755|NCT02387801|20163837|P1|COMPLETED|Post-Treatment Follow-up||0
8177756|NCT02387801|20163836|P2|STARTED|Post-Treatment Follow-up||12
8177757|NCT02387801|20163837|P1|STARTED|Post-Treatment Follow-up||0
8177758|NCT02387801|20163836|P2|NOT COMPLETED|Maintenance Dosing Period||0
8177759|NCT02387801|20163837|P1|NOT COMPLETED|Maintenance Dosing Period||0
8177760|NCT02387801|20163836|P2|COMPLETED|Maintenance Dosing Period||12
8177761|NCT02387801|20163837|P1|COMPLETED|Maintenance Dosing Period||0
8177762|NCT02387801|20163836|P2|STARTED|Maintenance Dosing Period||12
8177763|NCT02387801|20163837|P1|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
8177764|NCT02387801|20163836|P2|NOT COMPLETED|Induction Dosing Period||0
8177765|NCT02387801|20163837|P1|NOT COMPLETED|Induction Dosing Period||0
8177766|NCT02387801|20163836|P2|COMPLETED|Induction Dosing Period||6
8177767|NCT02387801|20163837|P1|COMPLETED|Induction Dosing Period||6
8177768|NCT02387801|20163836|P2|STARTED|Induction Dosing Period||6
8177769|NCT02387801|20163837|P1|STARTED|Induction Dosing Period||6
8177770|NCT02387762|20163857|P2|NOT COMPLETED|Overall Study||0
8177771|NCT02387762|20163858|P1|NOT COMPLETED|Overall Study||1
8177772|NCT02387762|20163857|P2|COMPLETED|Overall Study||15
8177773|NCT02387762|20163858|P1|COMPLETED|Overall Study||15
8177774|NCT02387762|20163857|P2|STARTED|Overall Study||15
8177775|NCT02387762|20163858|P1|STARTED|Overall Study||16
8177776|NCT02387749|20163864|P1|NOT COMPLETED|Overall Study||0
8177777|NCT02387749|20163864|P1|COMPLETED|Overall Study||10
8177778|NCT02387749|20163864|P1|STARTED|Overall Study||10
8177779|NCT02387710|20163873|P2|NOT COMPLETED|Second Study Night||0
8177780|NCT02387710|20163874|P1|NOT COMPLETED|Second Study Night||0
8177781|NCT02387710|20163873|P2|COMPLETED|Second Study Night||7
8177782|NCT02387710|20163874|P1|COMPLETED|Second Study Night||9
8177783|NCT02387710|20163873|P2|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
8177784|NCT02387710|20163874|P1|STARTED|Second Study Night||9
8177785|NCT02387710|20163873|P2|NOT COMPLETED|First Study Night||0
8177786|NCT02387710|20163874|P1|NOT COMPLETED|First Study Night||0
8177787|NCT02387710|20163873|P2|COMPLETED|First Study Night||9
8177788|NCT02387710|20163874|P1|COMPLETED|First Study Night||9
8177789|NCT02387710|20163873|P2|STARTED|First Study Night||9
8177790|NCT02387710|20163874|P1|STARTED|First Study Night||9
8177791|NCT02387580|20163890|P6|NOT COMPLETED|Overall Study||0
8177792|NCT02387580|20163891|P5|NOT COMPLETED|Overall Study||0
8177793|NCT02387580|20163892|P4|NOT COMPLETED|Overall Study||1
8177794|NCT02387580|20163893|P3|NOT COMPLETED|Overall Study||0
8177795|NCT02387580|20163894|P2|NOT COMPLETED|Overall Study||0
8177796|NCT02387580|20163895|P1|NOT COMPLETED|Overall Study||0
8177797|NCT02387580|20163890|P6|COMPLETED|Overall Study||8
8177798|NCT02387580|20163891|P5|COMPLETED|Overall Study||8
8177799|NCT02387580|20163892|P4|COMPLETED|Overall Study||7
8177800|NCT02387580|20163893|P3|COMPLETED|Overall Study||8
8177801|NCT02387580|20163894|P2|COMPLETED|Overall Study||8
8177802|NCT02387580|20163895|P1|COMPLETED|Overall Study||8
8177803|NCT02387580|20163890|P6|STARTED|Overall Study||8
8177804|NCT02387580|20163891|P5|STARTED|Overall Study||8
8177805|NCT02387580|20163892|P4|STARTED|Overall Study||8
8177806|NCT02387580|20163893|P3|STARTED|Overall Study||8
8177807|NCT02387580|20163894|P2|STARTED|Overall Study||8
8177808|NCT02387580|20163895|P1|STARTED|Overall Study||8
8177809|NCT02387554|20163931|P4|NOT COMPLETED|Overall Study||2
8177810|NCT02387554|20163932|P3|NOT COMPLETED|Overall Study||2
8177811|NCT02387554|20163933|P2|NOT COMPLETED|Overall Study||0
8177812|NCT02387554|20163934|P1|NOT COMPLETED|Overall Study||3
8177813|NCT02387554|20163931|P4|COMPLETED|Overall Study||6
8177814|NCT02387554|20163932|P3|COMPLETED|Overall Study||6
8177815|NCT02387554|20163933|P2|COMPLETED|Overall Study||7
8177816|NCT02387554|20163934|P1|COMPLETED|Overall Study||7
8177817|NCT02387554|20163931|P4|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
8177818|NCT02387554|20163932|P3|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
8177819|NCT02387554|20163933|P2|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
8177820|NCT02387554|20163934|P1|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
8177821|NCT02387502|20163947|P3|NOT COMPLETED|Overall Study||0
8177822|NCT02387502|20163948|P2|NOT COMPLETED|Overall Study||0
8177823|NCT02387502|20163949|P1|NOT COMPLETED|Overall Study||0
8177824|NCT02387502|20163947|P3|COMPLETED|Overall Study||40
8177825|NCT02387502|20163948|P2|COMPLETED|Overall Study||40
8177826|NCT02387502|20163949|P1|COMPLETED|Overall Study||40
8177827|NCT02387502|20163947|P3|STARTED|Overall Study||40
8177828|NCT02387502|20163948|P2|STARTED|Overall Study||40
8177829|NCT02387502|20163949|P1|STARTED|Overall Study||40
8177830|NCT02387476|20163959|P2|NOT COMPLETED|Overall Study||5
8177831|NCT02387476|20163960|P1|NOT COMPLETED|Overall Study||6
8177832|NCT02387476|20163959|P2|COMPLETED|Overall Study||17
8177833|NCT02387476|20163960|P1|COMPLETED|Overall Study||19
8177834|NCT02387476|20163959|P2|STARTED|Overall Study||22
8177835|NCT02387476|20163960|P1|STARTED|Overall Study||25
8177836|NCT02387372|20163988|P2|NOT COMPLETED|Overall Study||0
8177837|NCT02387372|20163989|P1|NOT COMPLETED|Overall Study||1
8177838|NCT02387372|20163988|P2|COMPLETED|Overall Study||10
8177839|NCT02387372|20163989|P1|COMPLETED|Overall Study||26
8177840|NCT02387372|20163988|P2|Treated|Overall Study||10
8177841|NCT02387372|20163989|P1|Treated|Overall Study||26
8177842|NCT02387372|20163988|P2|STARTED|Overall Study||10
8177843|NCT02387372|20163989|P1|STARTED|Overall Study||27
8177844|NCT02387359|20164038|P3|NOT COMPLETED|Overall Study||56
8177845|NCT02387359|20164039|P2|NOT COMPLETED|Overall Study||42
8177846|NCT02387359|20164040|P1|NOT COMPLETED|Overall Study||59
8177847|NCT02387359|20164038|P3|COMPLETED|Overall Study||293
8177848|NCT02387359|20164039|P2|COMPLETED|Overall Study||309
8177849|NCT02387359|20164040|P1|COMPLETED|Overall Study||295
8177850|NCT02387359|20164038|P3|STARTED|Overall Study||349
8177851|NCT02387359|20164039|P2|STARTED|Overall Study||351
8177852|NCT02387359|20164040|P1|STARTED|Overall Study||354
8177853|NCT02387268|20164072|P1|NOT COMPLETED|Overall Study||1
8177854|NCT02387268|20164072|P1|COMPLETED|Overall Study||9
8177855|NCT02387268|20164072|P1|STARTED|Overall Study||10
8177856|NCT02387164|20164079|P2|NOT COMPLETED|Overall Study||2
8177857|NCT02387164|20164080|P1|NOT COMPLETED|Overall Study||3
8177858|NCT02387164|20164079|P2|COMPLETED|Overall Study||11
8177859|NCT02387164|20164080|P1|COMPLETED|Overall Study||10
8177860|NCT02387164|20164079|P2|STARTED|Overall Study||13
8177861|NCT02387164|20164080|P1|STARTED|Overall Study||13
8177862|NCT02387008|20164105|P3|NOT COMPLETED|Overall Study||0
8177863|NCT02387008|20164106|P2|NOT COMPLETED|Overall Study||0
8177864|NCT02387008|20164107|P1|NOT COMPLETED|Overall Study||0
8177865|NCT02387008|20164105|P3|COMPLETED|Overall Study||4
8177866|NCT02387008|20164106|P2|COMPLETED|Overall Study||0
8177867|NCT02387008|20164107|P1|COMPLETED|Overall Study||2
8177868|NCT02387008|20164105|P3|STARTED|Overall Study||4
8177869|NCT02387008|20164106|P2|STARTED|Overall Study||0
8177870|NCT02387008|20164107|P1|STARTED|Overall Study||2
8177871|NCT02386995|20164124|P1|NOT COMPLETED|Overall Study||0
8177872|NCT02386995|20164124|P1|COMPLETED|Overall Study||30
8177873|NCT02386995|20164124|P1|STARTED|Overall Study||30
8177874|NCT02386345|20164129|P1|NOT COMPLETED|Overall Study||102
8177875|NCT02386345|20164129|P1|COMPLETED|Overall Study||197
8177876|NCT02386345|20164129|P1|STARTED|Overall Study||299
8177877|NCT02386189|20164139|P2|NOT COMPLETED|Overall Study||3
8177878|NCT02386189|20164140|P1|NOT COMPLETED|Overall Study||4
8177879|NCT02386189|20164139|P2|COMPLETED|Overall Study||30
8177880|NCT02386189|20164140|P1|COMPLETED|Overall Study||26
8177881|NCT02386189|20164139|P2|STARTED|Overall Study||33
8177882|NCT02386189|20164140|P1|STARTED|Overall Study||30
8177883|NCT02386098|20164163|P5|NOT COMPLETED|Stage 2 (96 Weeks)||0
8177884|NCT02386098|20164164|P4|NOT COMPLETED|Stage 2 (96 Weeks)||0
8177885|NCT02386098|20164165|P3|NOT COMPLETED|Stage 2 (96 Weeks)||0
8177886|NCT02386098|20164166|P2|NOT COMPLETED|Stage 2 (96 Weeks)||0
8177887|NCT02386098|20164167|P1|NOT COMPLETED|Stage 2 (96 Weeks)||0
8177888|NCT02386098|20164163|P5|COMPLETED|Stage 2 (96 Weeks)||0
8177889|NCT02386098|20164164|P4|COMPLETED|Stage 2 (96 Weeks)||0
8177890|NCT02386098|20164165|P3|COMPLETED|Stage 2 (96 Weeks)||0
8177891|NCT02386098|20164166|P2|COMPLETED|Stage 2 (96 Weeks)||0
8177892|NCT02386098|20164167|P1|COMPLETED|Stage 2 (96 Weeks)||0
8177893|NCT02386098|20164163|P5|STARTED|Stage 2 (96 Weeks)||0
8177894|NCT02386098|20164164|P4|STARTED|Stage 2 (96 Weeks)||0
8177895|NCT02386098|20164165|P3|STARTED|Stage 2 (96 Weeks)||0
8177896|NCT02386098|20164166|P2|STARTED|Stage 2 (96 Weeks)||0
8177897|NCT02386098|20164167|P1|STARTED|Stage 2 (96 Weeks)||0
8177898|NCT02386098|20164163|P5|NOT COMPLETED|Stage 1 (96 Weeks)||0
8177899|NCT02386098|20164164|P4|NOT COMPLETED|Stage 1 (96 Weeks)||0
8177900|NCT02386098|20164165|P3|NOT COMPLETED|Stage 1 (96 Weeks)||0
8177901|NCT02386098|20164166|P2|NOT COMPLETED|Stage 1 (96 Weeks)||43
8177902|NCT02386098|20164167|P1|NOT COMPLETED|Stage 1 (96 Weeks)||43
8177903|NCT02386098|20164163|P5|COMPLETED|Stage 1 (96 Weeks)||0
8177904|NCT02386098|20164164|P4|COMPLETED|Stage 1 (96 Weeks)||0
8177905|NCT02386098|20164165|P3|COMPLETED|Stage 1 (96 Weeks)||0
8177906|NCT02386098|20164166|P2|COMPLETED|Stage 1 (96 Weeks)||0
8177907|NCT02386098|20164167|P1|COMPLETED|Stage 1 (96 Weeks)||0
8177908|NCT02386098|20164163|P5|STARTED|Stage 1 (96 Weeks)||0
8177909|NCT02386098|20164164|P4|STARTED|Stage 1 (96 Weeks)||0
8177910|NCT02386098|20164165|P3|STARTED|Stage 1 (96 Weeks)||0
8177911|NCT02386098|20164166|P2|STARTED|Stage 1 (96 Weeks)||43
8177912|NCT02386098|20164167|P1|STARTED|Stage 1 (96 Weeks)||43
8177913|NCT02385799|20164246|P2|NOT COMPLETED|Overall Study||8
8177914|NCT02385799|20164247|P1|NOT COMPLETED|Overall Study||5
8177915|NCT02385799|20164246|P2|COMPLETED|Overall Study||24
8177916|NCT02385799|20164247|P1|COMPLETED|Overall Study||21
8177917|NCT02385799|20164246|P2|Completed End-of-Treatment Visit|Overall Study||26
8177918|NCT02385799|20164247|P1|Completed End-of-Treatment Visit|Overall Study||21
8177919|NCT02385799|20164246|P2|STARTED|Overall Study||32
8177920|NCT02385799|20164247|P1|STARTED|Overall Study||26
8177921|NCT02385721|20164281|P1|NOT COMPLETED|Overall Study||230
8177922|NCT02385721|20164281|P1|COMPLETED|Overall Study||371
8177923|NCT02385721|20164281|P1|STARTED|Overall Study||601
8177924|NCT02385708|20164288|P2|NOT COMPLETED|Overall Study||15
8177925|NCT02385708|20164289|P1|NOT COMPLETED|Overall Study||8
8177926|NCT02385708|20164288|P2|COMPLETED|Overall Study||67
8177927|NCT02385708|20164289|P1|COMPLETED|Overall Study||73
8177928|NCT02385708|20164288|P2|Intervention Started|Overall Study||82
8177929|NCT02385708|20164289|P1|Intervention Started|Overall Study||81
8177930|NCT02385708|20164288|P2|STARTED|Overall Study||82
8177931|NCT02385708|20164289|P1|STARTED|Overall Study||81
8177932|NCT02385669|20164295|P1|NOT COMPLETED|Overall Study||2
8177933|NCT02385669|20164295|P1|COMPLETED|Overall Study||1
8177934|NCT02385669|20164295|P1|STARTED|Overall Study||3
8177935|NCT02385526|20164303|P3|NOT COMPLETED|Overall Study||0
8177936|NCT02385526|20164304|P2|NOT COMPLETED|Overall Study||3
8177937|NCT02385526|20164305|P1|NOT COMPLETED|Overall Study||2
8177938|NCT02385526|20164303|P3|COMPLETED|Overall Study||20
8177939|NCT02385526|20164304|P2|COMPLETED|Overall Study||17
8177940|NCT02385526|20164305|P1|COMPLETED|Overall Study||20
8177941|NCT02385526|20164303|P3|STARTED|Overall Study||20
8177942|NCT02385526|20164304|P2|STARTED|Overall Study||20
8177943|NCT02385526|20164305|P1|STARTED|Overall Study||22
8177953|NCT02385240|20164329|P3|NOT COMPLETED|Overall Study||1
8177954|NCT02385240|20164330|P2|NOT COMPLETED|Overall Study||6
8177955|NCT02385240|20164331|P1|NOT COMPLETED|Overall Study||1
8177956|NCT02385240|20164329|P3|COMPLETED|Overall Study||184
8177957|NCT02385240|20164330|P2|COMPLETED|Overall Study||178
8177958|NCT02385240|20164331|P1|COMPLETED|Overall Study||182
8177959|NCT02385240|20164329|P3|STARTED|Overall Study||185
8177960|NCT02385240|20164330|P2|STARTED|Overall Study||184
8177961|NCT02385240|20164331|P1|STARTED|Overall Study||183
8177962|NCT02385084|20164345|P6|NOT COMPLETED|Period 3||0
8177963|NCT02385084|20164346|P5|NOT COMPLETED|Period 3||0
8177964|NCT02385084|20164347|P4|NOT COMPLETED|Period 3||0
8177965|NCT02385084|20164348|P3|NOT COMPLETED|Period 3||0
8177966|NCT02385084|20164349|P2|NOT COMPLETED|Period 3||0
8177967|NCT02385084|20164350|P1|NOT COMPLETED|Period 3||0
8177968|NCT02385084|20164345|P6|COMPLETED|Period 3||3
8177969|NCT02385084|20164346|P5|COMPLETED|Period 3||2
8177970|NCT02385084|20164347|P4|COMPLETED|Period 3||3
8177971|NCT02385084|20164348|P3|COMPLETED|Period 3||1
8177972|NCT02385084|20164349|P2|COMPLETED|Period 3||3
8177973|NCT02385084|20164350|P1|COMPLETED|Period 3||2
8177974|NCT02385084|20164345|P6|Washout|Period 3||3
8177975|NCT02385084|20164346|P5|Washout|Period 3||2
8177976|NCT02385084|20164347|P4|Washout|Period 3||3
8177977|NCT02385084|20164348|P3|Washout|Period 3||1
8177978|NCT02385084|20164349|P2|Washout|Period 3||3
8177979|NCT02385084|20164350|P1|Washout|Period 3||2
8177980|NCT02385084|20164345|P6|Received LY2409021|Period 3||3
8177981|NCT02385084|20164346|P5|Received LY2409021|Period 3||2
8177982|NCT02385084|20164347|P4|Received LY2409021|Period 3||3
8177983|NCT02385084|20164348|P3|Received LY2409021|Period 3||1
8177984|NCT02385084|20164349|P2|Received LY2409021|Period 3||3
8177985|NCT02385084|20164350|P1|Received LY2409021|Period 3||2
8177986|NCT02385084|20164345|P6|STARTED|Period 3||3
8177987|NCT02385084|20164346|P5|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
8177988|NCT02385084|20164347|P4|STARTED|Period 3||3
8177989|NCT02385084|20164348|P3|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
8177990|NCT02385084|20164349|P2|STARTED|Period 3||3
8177991|NCT02385084|20164350|P1|STARTED|Period 3||2
8177992|NCT02385084|20164345|P6|NOT COMPLETED|Period 2||0
8177993|NCT02385084|20164346|P5|NOT COMPLETED|Period 2||0
8177994|NCT02385084|20164347|P4|NOT COMPLETED|Period 2||0
8177995|NCT02385084|20164348|P3|NOT COMPLETED|Period 2||1
8177996|NCT02385084|20164349|P2|NOT COMPLETED|Period 2||0
8177997|NCT02385084|20164350|P1|NOT COMPLETED|Period 2||0
8177998|NCT02385084|20164345|P6|COMPLETED|Period 2||3
8177999|NCT02385084|20164346|P5|COMPLETED|Period 2||3
8178000|NCT02385084|20164347|P4|COMPLETED|Period 2||3
8178001|NCT02385084|20164348|P3|COMPLETED|Period 2||2
8178002|NCT02385084|20164349|P2|COMPLETED|Period 2||3
8178003|NCT02385084|20164350|P1|COMPLETED|Period 2||2
8178004|NCT02385084|20164345|P6|Washout|Period 2||3
8178005|NCT02385084|20164346|P5|Washout|Period 2||3
8178006|NCT02385084|20164347|P4|Washout|Period 2||3
8178007|NCT02385084|20164348|P3|Washout|Period 2||3
8178008|NCT02385084|20164349|P2|Washout|Period 2||3
8178009|NCT02385084|20164350|P1|Washout|Period 2||2
8178010|NCT02385084|20164345|P6|Received LY2409021|Period 2||3
8178011|NCT02385084|20164346|P5|Received LY2409021|Period 2||3
8178012|NCT02385084|20164347|P4|Received LY2409021|Period 2||3
8178013|NCT02385084|20164348|P3|Received LY2409021|Period 2||3
8178014|NCT02385084|20164349|P2|Received LY2409021|Period 2||3
8178015|NCT02385084|20164350|P1|Received LY2409021|Period 2||2
8178016|NCT02385084|20164345|P6|STARTED|Period 2||3
8178017|NCT02385084|20164346|P5|STARTED|Period 2||3
8178018|NCT02385084|20164347|P4|STARTED|Period 2||3
8178019|NCT02385084|20164348|P3|STARTED|Period 2||3
8178020|NCT02385084|20164349|P2|STARTED|Period 2||3
8178021|NCT02385084|20164350|P1|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
8178022|NCT02385084|20164345|P6|NOT COMPLETED|Period 1||0
8178023|NCT02385084|20164346|P5|NOT COMPLETED|Period 1||0
8178024|NCT02385084|20164347|P4|NOT COMPLETED|Period 1||0
8178025|NCT02385084|20164348|P3|NOT COMPLETED|Period 1||0
8178026|NCT02385084|20164349|P2|NOT COMPLETED|Period 1||0
8178027|NCT02385084|20164350|P1|NOT COMPLETED|Period 1||0
8178028|NCT02385084|20164345|P6|COMPLETED|Period 1||3
8178029|NCT02385084|20164346|P5|COMPLETED|Period 1||3
8178030|NCT02385084|20164347|P4|COMPLETED|Period 1||3
8178031|NCT02385084|20164348|P3|COMPLETED|Period 1||3
8178032|NCT02385084|20164349|P2|COMPLETED|Period 1||3
8178033|NCT02385084|20164350|P1|COMPLETED|Period 1||3
8178034|NCT02385084|20164345|P6|Washout|Period 1||3
8178035|NCT02385084|20164346|P5|Washout|Period 1||3
8178036|NCT02385084|20164347|P4|Washout|Period 1||3
8178037|NCT02385084|20164348|P3|Washout|Period 1||3
8178038|NCT02385084|20164349|P2|Washout|Period 1||3
8178039|NCT02385084|20164350|P1|Washout|Period 1||3
8178040|NCT02385084|20164345|P6|Received LY2409021|Period 1||3
8178041|NCT02385084|20164346|P5|Received LY2409021|Period 1||3
8178042|NCT02385084|20164347|P4|Received LY2409021|Period 1||3
8178043|NCT02385084|20164348|P3|Received LY2409021|Period 1||3
8178044|NCT02385084|20164349|P2|Received LY2409021|Period 1||3
8178045|NCT02385084|20164350|P1|Received LY2409021|Period 1||3
8178046|NCT02385084|20164345|P6|STARTED|Period 1||3
8178047|NCT02385084|20164346|P5|STARTED|Period 1||3
8178048|NCT02385084|20164347|P4|STARTED|Period 1||3
8178049|NCT02385084|20164348|P3|STARTED|Period 1||3
8178050|NCT02385084|20164349|P2|STARTED|Period 1||3
8178051|NCT02385084|20164350|P1|STARTED|Period 1||3
8178058|NCT02384941|20164390|P3|NOT COMPLETED|Overall Study||41
8178059|NCT02384941|20164391|P2|NOT COMPLETED|Overall Study||35
8178060|NCT02384941|20164392|P1|NOT COMPLETED|Overall Study||50
8178061|NCT02384941|20164390|P3|COMPLETED|Overall Study||221
8178062|NCT02384941|20164391|P2|COMPLETED|Overall Study||228
8178063|NCT02384941|20164392|P1|COMPLETED|Overall Study||218
8178064|NCT02384941|20164390|P3|STARTED|Overall Study||262
8178065|NCT02384941|20164391|P2|STARTED|Overall Study||263
8178066|NCT02384941|20164392|P1|STARTED|Overall Study||268
8178067|NCT02384538|20164423|P2|NOT COMPLETED|Overall Study||15
8178068|NCT02384538|20164424|P1|NOT COMPLETED|Overall Study||6
8178069|NCT02384538|20164423|P2|COMPLETED|Overall Study||49
8178070|NCT02384538|20164424|P1|COMPLETED|Overall Study||61
8178071|NCT02384538|20164423|P2|STARTED|Overall Study||64
8178072|NCT02384538|20164424|P1|STARTED|Overall Study||67
8178073|NCT02384460|20164444|P2|NOT COMPLETED|Overall Study||7
8178074|NCT02384460|20164445|P1|NOT COMPLETED|Overall Study||7
8178075|NCT02384460|20164444|P2|COMPLETED|Overall Study||80
8178076|NCT02384460|20164445|P1|COMPLETED|Overall Study||75
8178077|NCT02384460|20164444|P2|Received at Least 1 Dose of Study Drug|Overall Study||87
8178078|NCT02384460|20164445|P1|Received at Least 1 Dose of Study Drug|Overall Study||82
8178079|NCT02384460|20164444|P2|STARTED|Overall Study||87
8178080|NCT02384460|20164445|P1|STARTED|Overall Study||82
8178081|NCT02384382|20164463|P1|NOT COMPLETED|Overall Study||23
8178082|NCT02384382|20164463|P1|COMPLETED|Overall Study||0
8178083|NCT02384382|20164463|P1|STARTED|Overall Study||23
8178084|NCT02384200|20164470|P2|NOT COMPLETED|Overall Study||0
8178085|NCT02384200|20164471|P1|NOT COMPLETED|Overall Study||0
8178086|NCT02384200|20164470|P2|COMPLETED|Overall Study||43
8178087|NCT02384200|20164471|P1|COMPLETED|Overall Study||43
8178088|NCT02384200|20164470|P2|STARTED|Overall Study||43
8178089|NCT02384200|20164471|P1|STARTED|Overall Study||43
8178090|NCT02384096|20164497|P2|NOT COMPLETED|Second Intervention (7 Days)||1
8178091|NCT02384096|20164498|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8178092|NCT02384096|20164497|P2|COMPLETED|Second Intervention (7 Days)||6
8178093|NCT02384096|20164498|P1|COMPLETED|Second Intervention (7 Days)||4
8178094|NCT02384096|20164497|P2|STARTED|Second Intervention (7 Days)||7
8178095|NCT02384096|20164498|P1|STARTED|Second Intervention (7 Days)||4
8178096|NCT02384096|20164497|P2|NOT COMPLETED|First Intervention (7 Days)||0
8178097|NCT02384096|20164498|P1|NOT COMPLETED|First Intervention (7 Days)||1
8178098|NCT02384096|20164497|P2|COMPLETED|First Intervention (7 Days)||7
8178099|NCT02384096|20164498|P1|COMPLETED|First Intervention (7 Days)||4
8178100|NCT02384096|20164497|P2|STARTED|First Intervention (7 Days)||7
8178101|NCT02384096|20164498|P1|STARTED|First Intervention (7 Days)||5
8178102|NCT02384070|20164506|P3|NOT COMPLETED|Overall Study||0
8178103|NCT02384070|20164507|P2|NOT COMPLETED|Overall Study||0
8178104|NCT02384070|20164508|P1|NOT COMPLETED|Overall Study||0
8178105|NCT02384070|20164506|P3|COMPLETED|Overall Study||100
8178106|NCT02384070|20164507|P2|COMPLETED|Overall Study||100
8178107|NCT02384070|20164508|P1|COMPLETED|Overall Study||100
8178108|NCT02384070|20164506|P3|STARTED|Overall Study||100
8178109|NCT02384070|20164507|P2|STARTED|Overall Study||100
8178110|NCT02384070|20164508|P1|STARTED|Overall Study||100
8178111|NCT02384044|20164524|P2|NOT COMPLETED|Overall Study||0
8178112|NCT02384044|20164525|P1|NOT COMPLETED|Overall Study||0
8178113|NCT02384044|20164524|P2|COMPLETED|Overall Study||15
8178114|NCT02384044|20164525|P1|COMPLETED|Overall Study||15
8178115|NCT02384044|20164524|P2|STARTED|Overall Study||15
8178116|NCT02384044|20164525|P1|STARTED|Overall Study||15
8178123|NCT02383940|20164556|P2|NOT COMPLETED|Overall Study||3
8178124|NCT02383940|20164557|P1|NOT COMPLETED|Overall Study||9
8178125|NCT02383940|20164556|P2|COMPLETED|Overall Study||40
8178126|NCT02383940|20164557|P1|COMPLETED|Overall Study||35
8178127|NCT02383940|20164556|P2|Treated|Overall Study||43
8178128|NCT02383940|20164557|P1|Treated|Overall Study||42
8178129|NCT02383940|20164556|P2|STARTED|Overall Study||43
8178130|NCT02383940|20164557|P1|STARTED|Overall Study||44
8178131|NCT02383862|20164573|P2|NOT COMPLETED|3 Month Follow up||21
8178132|NCT02383862|20164574|P1|NOT COMPLETED|3 Month Follow up||23
8178133|NCT02383862|20164573|P2|COMPLETED|3 Month Follow up||128
8178134|NCT02383862|20164574|P1|COMPLETED|3 Month Follow up||128
8178135|NCT02383862|20164573|P2|STARTED|3 Month Follow up||149
8178136|NCT02383862|20164574|P1|STARTED|3 Month Follow up||151
8178137|NCT02383862|20164573|P2|NOT COMPLETED|Baseline||0
8178138|NCT02383862|20164574|P1|NOT COMPLETED|Baseline||0
8178139|NCT02383862|20164573|P2|COMPLETED|Baseline||149
8178140|NCT02383862|20164574|P1|COMPLETED|Baseline||151
8178141|NCT02383862|20164573|P2|STARTED|Baseline||149
8178142|NCT02383862|20164574|P1|STARTED|Baseline||151
8178143|NCT02383758|20164607|P2|NOT COMPLETED|Overall Study||2
8178144|NCT02383758|20164608|P1|NOT COMPLETED|Overall Study||0
8178145|NCT02383758|20164607|P2|COMPLETED|Overall Study||8
8178146|NCT02383758|20164608|P1|COMPLETED|Overall Study||10
8178147|NCT02383758|20164607|P2|STARTED|Overall Study||10
8178148|NCT02383758|20164608|P1|STARTED|Overall Study||10
8178149|NCT02383719|20164620|P1|NOT COMPLETED|Overall Study||0
8178150|NCT02383719|20164620|P1|COMPLETED|Overall Study||18
8178151|NCT02383719|20164620|P1|STARTED|Overall Study||18
8178152|NCT02383706|20164624|P1|NOT COMPLETED|Overall Study||28
8178153|NCT02383706|20164624|P1|COMPLETED|Overall Study||80
8178154|NCT02383706|20164624|P1|STARTED|Overall Study||108
8178155|NCT02383667|20164630|P1|NOT COMPLETED|Overall Study||0
8178156|NCT02383667|20164630|P1|COMPLETED|Overall Study||20
8178157|NCT02383667|20164630|P1|STARTED|Overall Study||20
8178158|NCT02383589|20164636|P2|NOT COMPLETED|Safety Follow-up (SFU)||5
8178159|NCT02383589|20164637|P1|NOT COMPLETED|Safety Follow-up (SFU)||7
8178160|NCT02383589|20164636|P2|COMPLETED|Safety Follow-up (SFU)||53
8178161|NCT02383589|20164637|P1|COMPLETED|Safety Follow-up (SFU)||59
8178162|NCT02383589|20164636|P2|STARTED|Safety Follow-up (SFU)||58
8178163|NCT02383589|20164637|P1|STARTED|Safety Follow-up (SFU)||66
8178164|NCT02383589|20164636|P2|NOT COMPLETED|Treatment Period||10
8178165|NCT02383589|20164637|P1|NOT COMPLETED|Treatment Period||1
8178166|NCT02383589|20164636|P2|COMPLETED|Treatment Period||58
8178167|NCT02383589|20164637|P1|COMPLETED|Treatment Period||66
8178168|NCT02383589|20164636|P2|STARTED|Treatment Period||68
8178169|NCT02383589|20164637|P1|STARTED|Treatment Period||67
8178170|NCT02383576|20164662|P2|NOT COMPLETED|Overall Study||45
8178171|NCT02383576|20164663|P1|NOT COMPLETED|Overall Study||63
8178172|NCT02383576|20164662|P2|COMPLETED|Overall Study||46
8178173|NCT02383576|20164663|P1|COMPLETED|Overall Study||31
8178174|NCT02383576|20164662|P2|STARTED|Overall Study||91
8178175|NCT02383576|20164663|P1|STARTED|Overall Study||94
8178176|NCT02383472|20164679|P2|NOT COMPLETED|Overall Study||1
8178177|NCT02383472|20164680|P1|NOT COMPLETED|Overall Study||1
8178178|NCT02383472|20164679|P2|COMPLETED|Overall Study||29
8178179|NCT02383472|20164680|P1|COMPLETED|Overall Study||22
8178180|NCT02383472|20164679|P2|STARTED|Overall Study||30
8178181|NCT02383472|20164680|P1|STARTED|Overall Study||23
8178182|NCT02383433|20164694|P1|NOT COMPLETED|Overall Study||2
8178183|NCT02383433|20164694|P1|COMPLETED|Overall Study||0
8178184|NCT02383433|20164694|P1|STARTED|Overall Study||2
8178185|NCT02383420|20164701|P3|NOT COMPLETED|Overall Study||0
8178186|NCT02383420|20164702|P2|NOT COMPLETED|Overall Study||0
8178187|NCT02383420|20164703|P1|NOT COMPLETED|Overall Study||2
8178188|NCT02383420|20164701|P3|COMPLETED|Overall Study||3
8178189|NCT02383420|20164702|P2|COMPLETED|Overall Study||10
8178190|NCT02383420|20164703|P1|COMPLETED|Overall Study||8
8178191|NCT02383420|20164701|P3|STARTED|Overall Study||3
8178192|NCT02383420|20164702|P2|STARTED|Overall Study||10
8178193|NCT02383420|20164703|P1|STARTED|Overall Study||10
8178194|NCT02383355|20164713|P2|NOT COMPLETED|Overall Study||0
8178195|NCT02383355|20164714|P1|NOT COMPLETED|Overall Study||2
8178196|NCT02383355|20164713|P2|COMPLETED|Overall Study||21
8178197|NCT02383355|20164714|P1|COMPLETED|Overall Study||17
8178198|NCT02383355|20164713|P2|STARTED|Overall Study||21
8178199|NCT02383355|20164714|P1|STARTED|Overall Study||19
8178200|NCT02383173|20164730|P2|NOT COMPLETED|Overall Study||2
8178201|NCT02383173|20164731|P1|NOT COMPLETED|Overall Study||0
8178202|NCT02383173|20164730|P2|COMPLETED|Overall Study||44
8178203|NCT02383173|20164731|P1|COMPLETED|Overall Study||88
8178204|NCT02383173|20164730|P2|STARTED|Overall Study||46
8178205|NCT02383173|20164731|P1|STARTED|Overall Study||88
8178206|NCT02383056|20164755|P2|NOT COMPLETED|Overall Study||2
8178207|NCT02383056|20164756|P1|NOT COMPLETED|Overall Study||1
8178208|NCT02383056|20164755|P2|COMPLETED|Overall Study||5
8178209|NCT02383056|20164756|P1|COMPLETED|Overall Study||6
8178210|NCT02383056|20164755|P2|STARTED|Overall Study||7
8178211|NCT02383056|20164756|P1|STARTED|Overall Study||7
8178212|NCT02383043|20164769|P3|NOT COMPLETED|Overall Study||0
8178213|NCT02383043|20164770|P2|NOT COMPLETED|Overall Study||0
8178214|NCT02383043|20164771|P1|NOT COMPLETED|Overall Study||2
8178215|NCT02383043|20164769|P3|COMPLETED|Overall Study||4
8178216|NCT02383043|20164770|P2|COMPLETED|Overall Study||5
8178217|NCT02383043|20164771|P1|COMPLETED|Overall Study||7
8178218|NCT02383043|20164769|P3|STARTED|Overall Study||4
8178219|NCT02383043|20164770|P2|STARTED|Overall Study||5
8178220|NCT02383043|20164771|P1|STARTED|Overall Study||9
8178221|NCT02383017|20164782|P2|NOT COMPLETED|Overall Study||2
8178222|NCT02383017|20164783|P1|NOT COMPLETED|Overall Study||5
8178223|NCT02383017|20164782|P2|COMPLETED|Overall Study||11
8178224|NCT02383017|20164783|P1|COMPLETED|Overall Study||10
8178225|NCT02383017|20164782|P2|STARTED|Overall Study||13
8178226|NCT02383017|20164783|P1|STARTED|Overall Study||15
8178227|NCT02382991|20164807|P2|NOT COMPLETED|Overall Study||3
8178228|NCT02382991|20164808|P1|NOT COMPLETED|Overall Study||2
8178229|NCT02382991|20164807|P2|COMPLETED|Overall Study||15
8178230|NCT02382991|20164808|P1|COMPLETED|Overall Study||15
8178231|NCT02382991|20164807|P2|STARTED|Overall Study||18
8178232|NCT02382991|20164808|P1|STARTED|Overall Study||17
8178233|NCT02382939|20164820|P2|NOT COMPLETED|Overall Study||3
8178234|NCT02382939|20164821|P1|NOT COMPLETED|Overall Study||3
8178235|NCT02382939|20164820|P2|COMPLETED|Overall Study||58
8178236|NCT02382939|20164821|P1|COMPLETED|Overall Study||28
8178237|NCT02382939|20164820|P2|Exposed|Overall Study||61
8178238|NCT02382939|20164821|P1|Exposed|Overall Study||31
8178239|NCT02382939|20164820|P2|STARTED|Overall Study||61
8178240|NCT02382939|20164821|P1|STARTED|Overall Study||31
8178241|NCT02382913|20164842|P10|NOT COMPLETED|Overall Study||0
8178242|NCT02382913|20164843|P9|NOT COMPLETED|Overall Study||0
8178243|NCT02382913|20164844|P8|NOT COMPLETED|Overall Study||0
8178244|NCT02382913|20164845|P7|NOT COMPLETED|Overall Study||0
8178245|NCT02382913|20164846|P6|NOT COMPLETED|Overall Study||0
8178246|NCT02382913|20164847|P5|NOT COMPLETED|Overall Study||0
8178247|NCT02382913|20164848|P4|NOT COMPLETED|Overall Study||0
8178248|NCT02382913|20164849|P3|NOT COMPLETED|Overall Study||0
8178249|NCT02382913|20164850|P2|NOT COMPLETED|Overall Study||0
8178250|NCT02382913|20164851|P1|NOT COMPLETED|Overall Study||0
8178251|NCT02382913|20164842|P10|COMPLETED|Overall Study||33
8178252|NCT02382913|20164843|P9|COMPLETED|Overall Study||30
8178253|NCT02382913|20164844|P8|COMPLETED|Overall Study||30
8178254|NCT02382913|20164845|P7|COMPLETED|Overall Study||37
8178255|NCT02382913|20164846|P6|COMPLETED|Overall Study||30
8178256|NCT02382913|20164847|P5|COMPLETED|Overall Study||33
8178257|NCT02382913|20164848|P4|COMPLETED|Overall Study||27
8178258|NCT02382913|20164849|P3|COMPLETED|Overall Study||32
8178259|NCT02382913|20164850|P2|COMPLETED|Overall Study||36
8178260|NCT02382913|20164851|P1|COMPLETED|Overall Study||27
8178261|NCT02382913|20164842|P10|STARTED|Overall Study||33
8178262|NCT02382913|20164843|P9|STARTED|Overall Study||30
8178263|NCT02382913|20164844|P8|STARTED|Overall Study||30
8178264|NCT02382913|20164845|P7|STARTED|Overall Study||37
8178265|NCT02382913|20164846|P6|STARTED|Overall Study||30
8178266|NCT02382913|20164847|P5|STARTED|Overall Study||33
8178267|NCT02382913|20164848|P4|STARTED|Overall Study||27
8178268|NCT02382913|20164849|P3|STARTED|Overall Study||32
8178269|NCT02382913|20164850|P2|STARTED|Overall Study||36
8178270|NCT02382913|20164851|P1|STARTED|Overall Study||27
8178271|NCT02382848|20164887|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8178272|NCT02382848|20164888|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8178273|NCT02382848|20164887|P2|COMPLETED|Second Intervention (3 Weeks)||5
8178274|NCT02382848|20164888|P1|COMPLETED|Second Intervention (3 Weeks)||3
8178275|NCT02382848|20164887|P2|STARTED|Second Intervention (3 Weeks)||5
8178276|NCT02382848|20164888|P1|STARTED|Second Intervention (3 Weeks)||3
8178277|NCT02382848|20164887|P2|NOT COMPLETED|Washout (1 Week)||0
8178278|NCT02382848|20164888|P1|NOT COMPLETED|Washout (1 Week)||0
8178279|NCT02382848|20164887|P2|COMPLETED|Washout (1 Week)||5
8178280|NCT02382848|20164888|P1|COMPLETED|Washout (1 Week)||3
8178281|NCT02382848|20164887|P2|STARTED|Washout (1 Week)||5
8178282|NCT02382848|20164888|P1|STARTED|Washout (1 Week)||3
8178283|NCT02382848|20164887|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
8178284|NCT02382848|20164888|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
8178285|NCT02382848|20164887|P2|COMPLETED|First Intervention (3 Weeks)||5
8178286|NCT02382848|20164888|P1|COMPLETED|First Intervention (3 Weeks)||3
8178287|NCT02382848|20164887|P2|STARTED|First Intervention (3 Weeks)||5
8178288|NCT02382848|20164888|P1|STARTED|First Intervention (3 Weeks)||3
8178289|NCT02382796|20164904|P1|NOT COMPLETED|Overall Study||7
8178290|NCT02382796|20164904|P1|COMPLETED|Overall Study||0
8178291|NCT02382796|20164904|P1|STARTED|Overall Study||7
8178292|NCT02382744|20164911|P2|NOT COMPLETED|Overall Study||0
8178293|NCT02382744|20164912|P1|NOT COMPLETED|Overall Study||0
8178294|NCT02382744|20164911|P2|COMPLETED|Overall Study||40
8178295|NCT02382744|20164912|P1|COMPLETED|Overall Study||40
8178296|NCT02382744|20164911|P2|Analyzed|Overall Study||40
8178297|NCT02382744|20164912|P1|Analyzed|Overall Study||40
8178298|NCT02382744|20164911|P2|Allocated|Overall Study||40
8178299|NCT02382744|20164912|P1|Allocated|Overall Study||40
8178300|NCT02382744|20164911|P2|STARTED|Overall Study||40
8178301|NCT02382744|20164912|P1|STARTED|Overall Study||40
8178302|NCT02382705|20164943|P1|NOT COMPLETED|Overall Study||24
8178303|NCT02382705|20164943|P1|COMPLETED|Overall Study||33
8178304|NCT02382705|20164943|P1|STARTED|Overall Study||57
8178305|NCT02382640|20164954|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8178306|NCT02382640|20164955|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8178307|NCT02382640|20164956|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8178308|NCT02382640|20164957|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||1
8178309|NCT02382640|20164954|P4|COMPLETED|Intervention Period 4 (3 Days)||9
8178310|NCT02382640|20164955|P3|COMPLETED|Intervention Period 4 (3 Days)||9
8178311|NCT02382640|20164956|P2|COMPLETED|Intervention Period 4 (3 Days)||9
8178312|NCT02382640|20164957|P1|COMPLETED|Intervention Period 4 (3 Days)||8
8178313|NCT02382640|20164954|P4|STARTED|Intervention Period 4 (3 Days)||9
8178314|NCT02382640|20164955|P3|STARTED|Intervention Period 4 (3 Days)||9
8178315|NCT02382640|20164956|P2|STARTED|Intervention Period 4 (3 Days)||9
8178316|NCT02382640|20164957|P1|STARTED|Intervention Period 4 (3 Days)||9
8178317|NCT02382640|20164954|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8178318|NCT02382640|20164955|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8178319|NCT02382640|20164956|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8178320|NCT02382640|20164957|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8178321|NCT02382640|20164954|P4|COMPLETED|Washout Period 3 (7 Days)||9
8178322|NCT02382640|20164955|P3|COMPLETED|Washout Period 3 (7 Days)||9
8178323|NCT02382640|20164956|P2|COMPLETED|Washout Period 3 (7 Days)||9
8178324|NCT02382640|20164957|P1|COMPLETED|Washout Period 3 (7 Days)||9
8178325|NCT02382640|20164954|P4|STARTED|Washout Period 3 (7 Days)||9
8178326|NCT02382640|20164955|P3|STARTED|Washout Period 3 (7 Days)||9
8178327|NCT02382640|20164956|P2|STARTED|Washout Period 3 (7 Days)||9
8178328|NCT02382640|20164957|P1|STARTED|Washout Period 3 (7 Days)||9
8178329|NCT02382640|20164954|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8178330|NCT02382640|20164955|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8178331|NCT02382640|20164956|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8178332|NCT02382640|20164957|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8178333|NCT02382640|20164954|P4|COMPLETED|Intervention Period 3 (3 Days)||9
8178334|NCT02382640|20164955|P3|COMPLETED|Intervention Period 3 (3 Days)||9
8178335|NCT02382640|20164956|P2|COMPLETED|Intervention Period 3 (3 Days)||9
8178336|NCT02382640|20164957|P1|COMPLETED|Intervention Period 3 (3 Days)||9
8178337|NCT02382640|20164954|P4|STARTED|Intervention Period 3 (3 Days)||9
8178338|NCT02382640|20164955|P3|STARTED|Intervention Period 3 (3 Days)||9
8178339|NCT02382640|20164956|P2|STARTED|Intervention Period 3 (3 Days)||9
8178340|NCT02382640|20164957|P1|STARTED|Intervention Period 3 (3 Days)||9
8178341|NCT02382640|20164954|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8178342|NCT02382640|20164955|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8178343|NCT02382640|20164956|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8178344|NCT02382640|20164957|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8178345|NCT02382640|20164954|P4|COMPLETED|Washout Period 2 (7 Days)||9
8178346|NCT02382640|20164955|P3|COMPLETED|Washout Period 2 (7 Days)||9
8178347|NCT02382640|20164956|P2|COMPLETED|Washout Period 2 (7 Days)||9
8178348|NCT02382640|20164957|P1|COMPLETED|Washout Period 2 (7 Days)||9
8178349|NCT02382640|20164954|P4|STARTED|Washout Period 2 (7 Days)||9
8178350|NCT02382640|20164955|P3|STARTED|Washout Period 2 (7 Days)||9
8178351|NCT02382640|20164956|P2|STARTED|Washout Period 2 (7 Days)||9
8178352|NCT02382640|20164957|P1|STARTED|Washout Period 2 (7 Days)||9
8178353|NCT02382640|20164954|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8178354|NCT02382640|20164955|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8178355|NCT02382640|20164956|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8178356|NCT02382640|20164957|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8178357|NCT02382640|20164954|P4|COMPLETED|Intervention Period 2 (3 Days)||9
8178358|NCT02382640|20164955|P3|COMPLETED|Intervention Period 2 (3 Days)||9
8178359|NCT02382640|20164956|P2|COMPLETED|Intervention Period 2 (3 Days)||9
8178360|NCT02382640|20164957|P1|COMPLETED|Intervention Period 2 (3 Days)||9
8178361|NCT02382640|20164954|P4|STARTED|Intervention Period 2 (3 Days)||9
8178362|NCT02382640|20164955|P3|STARTED|Intervention Period 2 (3 Days)||9
8178363|NCT02382640|20164956|P2|STARTED|Intervention Period 2 (3 Days)||9
8178364|NCT02382640|20164957|P1|STARTED|Intervention Period 2 (3 Days)||9
8178365|NCT02382640|20164954|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8178366|NCT02382640|20164955|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8178367|NCT02382640|20164956|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8178368|NCT02382640|20164957|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8178369|NCT02382640|20164954|P4|COMPLETED|Washout Period 1 (7 Days)||9
8178370|NCT02382640|20164955|P3|COMPLETED|Washout Period 1 (7 Days)||9
8178371|NCT02382640|20164956|P2|COMPLETED|Washout Period 1 (7 Days)||9
8178372|NCT02382640|20164957|P1|COMPLETED|Washout Period 1 (7 Days)||9
8178373|NCT02382640|20164954|P4|STARTED|Washout Period 1 (7 Days)||9
8178374|NCT02382640|20164955|P3|STARTED|Washout Period 1 (7 Days)||9
8178375|NCT02382640|20164956|P2|STARTED|Washout Period 1 (7 Days)||9
8178376|NCT02382640|20164957|P1|STARTED|Washout Period 1 (7 Days)||9
8178377|NCT02382640|20164954|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8178378|NCT02382640|20164955|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8178379|NCT02382640|20164956|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8178380|NCT02382640|20164957|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8178381|NCT02382640|20164954|P4|COMPLETED|Intervention Period 1 (3 Days)||9
8178382|NCT02382640|20164955|P3|COMPLETED|Intervention Period 1 (3 Days)||9
8178383|NCT02382640|20164956|P2|COMPLETED|Intervention Period 1 (3 Days)||9
8178384|NCT02382640|20164957|P1|COMPLETED|Intervention Period 1 (3 Days)||9
8178385|NCT02382640|20164954|P4|STARTED|Intervention Period 1 (3 Days)||9
8178386|NCT02382640|20164955|P3|STARTED|Intervention Period 1 (3 Days)||9
8178387|NCT02382640|20164956|P2|STARTED|Intervention Period 1 (3 Days)||9
8178388|NCT02382640|20164957|P1|STARTED|Intervention Period 1 (3 Days)||9
8178389|NCT02382276|20164998|P3|NOT COMPLETED|Overall Study||39
8178390|NCT02382276|20164999|P2|NOT COMPLETED|Overall Study||10
8178391|NCT02382276|20165000|P1|NOT COMPLETED|Overall Study||11
8178392|NCT02382276|20164998|P3|COMPLETED|Overall Study||133
8178393|NCT02382276|20164999|P2|COMPLETED|Overall Study||84
8178394|NCT02382276|20165000|P1|COMPLETED|Overall Study||126
8178395|NCT02382276|20164998|P3|STARTED|Overall Study||172
8178396|NCT02382276|20164999|P2|STARTED|Overall Study||94
8178397|NCT02382276|20165000|P1|STARTED|Overall Study||137
8178398|NCT02382133|20165012|P1|NOT COMPLETED|Overall Study||33
8178399|NCT02382133|20165012|P1|COMPLETED|Overall Study||10
8178400|NCT02382133|20165012|P1|STARTED|Overall Study||43
8178401|NCT02382016|20165019|P2|NOT COMPLETED|OL Extension Period||0
8178402|NCT02382016|20165020|P1|NOT COMPLETED|OL Extension Period||6
8178403|NCT02382016|20165019|P2|COMPLETED|OL Extension Period||0
8178404|NCT02382016|20165020|P1|COMPLETED|OL Extension Period||27
8178405|NCT02382016|20165019|P2|STARTED|OL Extension Period||0
8178406|NCT02382016|20165020|P1|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33
8178407|NCT02382016|20165019|P2|NOT COMPLETED|Open-label (OL) Treatment Period||0
8178408|NCT02382016|20165020|P1|NOT COMPLETED|Open-label (OL) Treatment Period||9
8178409|NCT02382016|20165019|P2|COMPLETED|Open-label (OL) Treatment Period||0
8178410|NCT02382016|20165020|P1|COMPLETED|Open-label (OL) Treatment Period||71
8178411|NCT02382016|20165019|P2|STARTED|Open-label (OL) Treatment Period||0
8178412|NCT02382016|20165020|P1|STARTED|Open-label (OL) Treatment Period||80
8178413|NCT02382016|20165019|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||1
8178414|NCT02382016|20165020|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||4
8178415|NCT02382016|20165019|P2|COMPLETED|Double-blind (DB) Treatment Period||41
8178416|NCT02382016|20165020|P1|COMPLETED|Double-blind (DB) Treatment Period||39
8178417|NCT02382016|20165019|P2|STARTED|Double-blind (DB) Treatment Period||42
8178418|NCT02382016|20165020|P1|STARTED|Double-blind (DB) Treatment Period||43
8178419|NCT02381795|20165044|P1|NOT COMPLETED|Overall Study||3
8178420|NCT02381795|20165044|P1|COMPLETED|Overall Study||7
8178421|NCT02381795|20165044|P1|STARTED|Overall Study||10
8178422|NCT02381678|20165048|P3|NOT COMPLETED|Overall Study||0
8178423|NCT02381678|20165049|P2|NOT COMPLETED|Overall Study||0
8178424|NCT02381678|20165050|P1|NOT COMPLETED|Overall Study||0
8178425|NCT02381678|20165048|P3|COMPLETED|Overall Study||32
8178426|NCT02381678|20165049|P2|COMPLETED|Overall Study||139
8178427|NCT02381678|20165050|P1|COMPLETED|Overall Study||54
8178428|NCT02381678|20165048|P3|STARTED|Overall Study||32
8178429|NCT02381678|20165049|P2|STARTED|Overall Study||139
8178430|NCT02381678|20165050|P1|STARTED|Overall Study||54
8178431|NCT02381652|20165059|P3|NOT COMPLETED|Overall Study||1
8178432|NCT02381652|20165060|P2|NOT COMPLETED|Overall Study||0
8178433|NCT02381652|20165061|P1|NOT COMPLETED|Overall Study||0
8178434|NCT02381652|20165059|P3|COMPLETED|Overall Study||49
8178435|NCT02381652|20165060|P2|COMPLETED|Overall Study||98
8178436|NCT02381652|20165061|P1|COMPLETED|Overall Study||94
8178437|NCT02381652|20165059|P3|STARTED|Overall Study|Saline injection in 13-01 study; receiving a Cingal injection in 13-02|50
8178438|NCT02381652|20165060|P2|STARTED|Overall Study|Monovisc injection in 13-01 study; receiving a Cingal injection in 13-02|98
8178439|NCT02381652|20165061|P1|STARTED|Overall Study|Cingal injection in 13-01 study; receiving a 2nd Cingal injection in 13-02|94
8178440|NCT02381418|20165068|P1|NOT COMPLETED|Overall Study||0
8178441|NCT02381418|20165068|P1|COMPLETED|Overall Study||120
8178442|NCT02381418|20165068|P1|STARTED|Overall Study||120
8178443|NCT02381392|20165076|P2|NOT COMPLETED|Overall Study||0
8178444|NCT02381392|20165077|P1|NOT COMPLETED|Overall Study||0
8178445|NCT02381392|20165076|P2|COMPLETED|Overall Study||12
8178446|NCT02381392|20165077|P1|COMPLETED|Overall Study||11
8178447|NCT02381392|20165076|P2|STARTED|Overall Study||12
8178448|NCT02381392|20165077|P1|STARTED|Overall Study||11
8178449|NCT02381288|20165095|P4|NOT COMPLETED|Overall Study||0
8178450|NCT02381288|20165096|P3|NOT COMPLETED|Overall Study||0
8178451|NCT02381288|20165097|P2|NOT COMPLETED|Overall Study||0
8178452|NCT02381288|20165098|P1|NOT COMPLETED|Overall Study||0
8178453|NCT02381288|20165095|P4|COMPLETED|Overall Study||5
8178454|NCT02381288|20165096|P3|COMPLETED|Overall Study||5
8178455|NCT02381288|20165097|P2|COMPLETED|Overall Study||2
8178456|NCT02381288|20165098|P1|COMPLETED|Overall Study||5
8178457|NCT02381288|20165095|P4|STARTED|Overall Study||5
8178458|NCT02381288|20165096|P3|STARTED|Overall Study||5
8178459|NCT02381288|20165097|P2|STARTED|Overall Study||2
8178460|NCT02381288|20165098|P1|STARTED|Overall Study||5
8178461|NCT02381015|20165129|P4|NOT COMPLETED|Year 3 Chart Review||51
8178462|NCT02381015|20165130|P3|NOT COMPLETED|Year 3 Chart Review||58
8178463|NCT02381015|20165131|P2|NOT COMPLETED|Year 3 Chart Review||34
8178464|NCT02381015|20165132|P1|NOT COMPLETED|Year 3 Chart Review||47
8178465|NCT02381015|20165129|P4|COMPLETED|Year 3 Chart Review||118
8178466|NCT02381015|20165130|P3|COMPLETED|Year 3 Chart Review||115
8178467|NCT02381015|20165131|P2|COMPLETED|Year 3 Chart Review||134
8178468|NCT02381015|20165132|P1|COMPLETED|Year 3 Chart Review||125
8178469|NCT02381015|20165129|P4|STARTED|Year 3 Chart Review||169
8178470|NCT02381015|20165130|P3|STARTED|Year 3 Chart Review||173
8178471|NCT02381015|20165131|P2|STARTED|Year 3 Chart Review||168
8178472|NCT02381015|20165132|P1|STARTED|Year 3 Chart Review||172
8178473|NCT02381015|20165129|P4|NOT COMPLETED|Visit 3 - 3 Months Followup||0
8178474|NCT02381015|20165130|P3|NOT COMPLETED|Visit 3 - 3 Months Followup||0
8178475|NCT02381015|20165131|P2|NOT COMPLETED|Visit 3 - 3 Months Followup||0
8178476|NCT02381015|20165132|P1|NOT COMPLETED|Visit 3 - 3 Months Followup||0
8178477|NCT02381015|20165129|P4|COMPLETED|Visit 3 - 3 Months Followup||169
8178478|NCT02381015|20165130|P3|COMPLETED|Visit 3 - 3 Months Followup||173
8178479|NCT02381015|20165131|P2|COMPLETED|Visit 3 - 3 Months Followup||168
8178480|NCT02381015|20165132|P1|COMPLETED|Visit 3 - 3 Months Followup||172
8178481|NCT02381015|20165129|P4|STARTED|Visit 3 - 3 Months Followup||169
8178482|NCT02381015|20165130|P3|STARTED|Visit 3 - 3 Months Followup||173
8178483|NCT02381015|20165131|P2|STARTED|Visit 3 - 3 Months Followup||168
8178484|NCT02381015|20165132|P1|STARTED|Visit 3 - 3 Months Followup||172
8178485|NCT02381015|20165129|P4|NOT COMPLETED|Visit 2 - Results DIsclosure||3
8178486|NCT02381015|20165130|P3|NOT COMPLETED|Visit 2 - Results DIsclosure||2
8178487|NCT02381015|20165131|P2|NOT COMPLETED|Visit 2 - Results DIsclosure||5
8178488|NCT02381015|20165132|P1|NOT COMPLETED|Visit 2 - Results DIsclosure||3
8178489|NCT02381015|20165129|P4|COMPLETED|Visit 2 - Results DIsclosure||169
8178490|NCT02381015|20165130|P3|COMPLETED|Visit 2 - Results DIsclosure||173
8178491|NCT02381015|20165131|P2|COMPLETED|Visit 2 - Results DIsclosure||168
8178492|NCT02381015|20165132|P1|COMPLETED|Visit 2 - Results DIsclosure||172
8178493|NCT02381015|20165129|P4|STARTED|Visit 2 - Results DIsclosure||172
8178494|NCT02381015|20165130|P3|STARTED|Visit 2 - Results DIsclosure||175
8178495|NCT02381015|20165131|P2|STARTED|Visit 2 - Results DIsclosure||173
8178496|NCT02381015|20165132|P1|STARTED|Visit 2 - Results DIsclosure||175
8178497|NCT02381015|20165129|P4|NOT COMPLETED|Visit 1 - Enrollment||3
8178498|NCT02381015|20165130|P3|NOT COMPLETED|Visit 1 - Enrollment||0
8178499|NCT02381015|20165131|P2|NOT COMPLETED|Visit 1 - Enrollment||2
8178500|NCT02381015|20165132|P1|NOT COMPLETED|Visit 1 - Enrollment||0
8178501|NCT02381015|20165129|P4|COMPLETED|Visit 1 - Enrollment||172
8178502|NCT02381015|20165130|P3|COMPLETED|Visit 1 - Enrollment||175
8178503|NCT02381015|20165131|P2|COMPLETED|Visit 1 - Enrollment||173
8178504|NCT02381015|20165132|P1|COMPLETED|Visit 1 - Enrollment||175
8178505|NCT02381015|20165129|P4|STARTED|Visit 1 - Enrollment||175
8178506|NCT02381015|20165130|P3|STARTED|Visit 1 - Enrollment||175
8178507|NCT02381015|20165131|P2|STARTED|Visit 1 - Enrollment||175
8178508|NCT02381015|20165132|P1|STARTED|Visit 1 - Enrollment||175
8178509|NCT02380859|20165164|P2|NOT COMPLETED|Overall Study||0
8178510|NCT02380859|20165165|P1|NOT COMPLETED|Overall Study||2
8178511|NCT02380859|20165164|P2|COMPLETED|Overall Study||13
8178512|NCT02380859|20165165|P1|COMPLETED|Overall Study||17
8178513|NCT02380859|20165164|P2|STARTED|Overall Study||13
8178514|NCT02380859|20165165|P1|STARTED|Overall Study||19
8178515|NCT02380742|20165201|P2|NOT COMPLETED|Overall Study||0
8178516|NCT02380742|20165202|P1|NOT COMPLETED|Overall Study||1
8178517|NCT02380742|20165201|P2|COMPLETED|Overall Study||26
8178518|NCT02380742|20165202|P1|COMPLETED|Overall Study||27
8178519|NCT02380742|20165201|P2|STARTED|Overall Study||26
8178520|NCT02380742|20165202|P1|STARTED|Overall Study||28
8178521|NCT02380703|20165216|P2|NOT COMPLETED|Overall Study||36
8178522|NCT02380703|20165217|P1|NOT COMPLETED|Overall Study||36
8178523|NCT02380703|20165216|P2|COMPLETED|Overall Study||78
8178524|NCT02380703|20165217|P1|COMPLETED|Overall Study||78
8178525|NCT02380703|20165216|P2|Month 12|Overall Study||100
8178526|NCT02380703|20165217|P1|Month 12|Overall Study||99
8178527|NCT02380703|20165216|P2|Month 6|Overall Study||107
8178528|NCT02380703|20165217|P1|Month 6|Overall Study||102
8178529|NCT02380703|20165216|P2|Month 3|Overall Study||109
8178530|NCT02380703|20165217|P1|Month 3|Overall Study||104
8178531|NCT02380703|20165216|P2|STARTED|Overall Study||114
8178532|NCT02380703|20165217|P1|STARTED|Overall Study||114
8178533|NCT02380690|20165239|P2|NOT COMPLETED|Overall Study||12
8178534|NCT02380690|20165240|P1|NOT COMPLETED|Overall Study||34
8178535|NCT02380690|20165239|P2|COMPLETED|Overall Study||82
8178536|NCT02380690|20165240|P1|COMPLETED|Overall Study||85
8178537|NCT02380690|20165239|P2|STARTED|Overall Study||94
8178538|NCT02380690|20165240|P1|STARTED|Overall Study||119
8178539|NCT02380677|20165288|P12|NOT COMPLETED|Overall Study||5
8178540|NCT02380677|20165289|P11|NOT COMPLETED|Overall Study||4
8178541|NCT02380677|20165290|P10|NOT COMPLETED|Overall Study||2
8178542|NCT02380677|20165291|P9|NOT COMPLETED|Overall Study||4
8178543|NCT02380677|20165292|P8|NOT COMPLETED|Overall Study||4
8178544|NCT02380677|20165293|P7|NOT COMPLETED|Overall Study||3
8178545|NCT02380677|20165294|P6|NOT COMPLETED|Overall Study||6
8178546|NCT02380677|20165295|P5|NOT COMPLETED|Overall Study||6
8178547|NCT02380677|20165296|P4|NOT COMPLETED|Overall Study||3
8178548|NCT02380677|20165297|P3|NOT COMPLETED|Overall Study||3
8178549|NCT02380677|20165298|P2|NOT COMPLETED|Overall Study||1
8178550|NCT02380677|20165299|P1|NOT COMPLETED|Overall Study||1
8178551|NCT02380677|20165288|P12|COMPLETED|Overall Study||0
8178552|NCT02380677|20165289|P11|COMPLETED|Overall Study||0
8178553|NCT02380677|20165290|P10|COMPLETED|Overall Study||0
8178554|NCT02380677|20165291|P9|COMPLETED|Overall Study||0
8178555|NCT02380677|20165292|P8|COMPLETED|Overall Study||0
8178556|NCT02380677|20165293|P7|COMPLETED|Overall Study||0
8178557|NCT02380677|20165294|P6|COMPLETED|Overall Study||0
8178558|NCT02380677|20165295|P5|COMPLETED|Overall Study||0
8178559|NCT02380677|20165296|P4|COMPLETED|Overall Study||0
8178560|NCT02380677|20165297|P3|COMPLETED|Overall Study||0
8178561|NCT02380677|20165298|P2|COMPLETED|Overall Study||0
8178562|NCT02380677|20165299|P1|COMPLETED|Overall Study||0
8178563|NCT02380677|20165288|P12|STARTED|Overall Study||5
8178564|NCT02380677|20165289|P11|STARTED|Overall Study||4
8178565|NCT02380677|20165290|P10|STARTED|Overall Study||2
8178566|NCT02380677|20165291|P9|STARTED|Overall Study||4
8178567|NCT02380677|20165292|P8|STARTED|Overall Study||4
8178568|NCT02380677|20165293|P7|STARTED|Overall Study||3
8178569|NCT02380677|20165294|P6|STARTED|Overall Study||6
8178570|NCT02380677|20165295|P5|STARTED|Overall Study||6
8178571|NCT02380677|20165296|P4|STARTED|Overall Study||3
8178572|NCT02380677|20165297|P3|STARTED|Overall Study||3
8178573|NCT02380677|20165298|P2|STARTED|Overall Study||1
8178574|NCT02380677|20165299|P1|STARTED|Overall Study||1
8178599|NCT02380261|20165373|P1|NOT COMPLETED|Overall Study||0
8178600|NCT02380261|20165373|P1|COMPLETED|Overall Study||35
8178601|NCT02380261|20165373|P1|STARTED|Overall Study||35
8178602|NCT02380248|20165378|P1|NOT COMPLETED|Overall Study||14
8178603|NCT02380248|20165378|P1|COMPLETED|Overall Study||186
8178604|NCT02380248|20165378|P1|STARTED|Overall Study||200
8178605|NCT02380183|20165385|P2|NOT COMPLETED|Overall Study||0
8178606|NCT02380183|20165386|P1|NOT COMPLETED|Overall Study||0
8178607|NCT02380183|20165385|P2|COMPLETED|Overall Study||34
8178608|NCT02380183|20165386|P1|COMPLETED|Overall Study||36
8178609|NCT02380183|20165385|P2|STARTED|Overall Study||34
8178610|NCT02380183|20165386|P1|STARTED|Overall Study||36
8178611|NCT02379923|20165394|P1|NOT COMPLETED|Overall Study||5
8178612|NCT02379923|20165394|P1|COMPLETED|Overall Study||158
8178613|NCT02379923|20165394|P1|STARTED|Overall Study||163
8178614|NCT02379858|20165410|P2|NOT COMPLETED|Overall Study||0
8178615|NCT02379858|20165411|P1|NOT COMPLETED|Overall Study||0
8178616|NCT02379858|20165410|P2|COMPLETED|Overall Study||4
8178617|NCT02379858|20165411|P1|COMPLETED|Overall Study||6
8178618|NCT02379858|20165410|P2|STARTED|Overall Study||4
8178619|NCT02379858|20165411|P1|STARTED|Overall Study||6
8178620|NCT02379728|20165423|P4|NOT COMPLETED|Overall Study||3
8178621|NCT02379728|20165424|P3|NOT COMPLETED|Overall Study||10
8178622|NCT02379728|20165425|P2|NOT COMPLETED|Overall Study||0
8178623|NCT02379728|20165426|P1|NOT COMPLETED|Overall Study||6
8178624|NCT02379728|20165423|P4|COMPLETED|Overall Study||13
8178625|NCT02379728|20165424|P3|COMPLETED|Overall Study||74
8178626|NCT02379728|20165425|P2|COMPLETED|Overall Study||16
8178627|NCT02379728|20165426|P1|COMPLETED|Overall Study||78
8178628|NCT02379728|20165423|P4|STARTED|Overall Study||16
8178629|NCT02379728|20165424|P3|STARTED|Overall Study||84
8178630|NCT02379728|20165425|P2|STARTED|Overall Study||16
8178631|NCT02379728|20165426|P1|STARTED|Overall Study||84
8178632|NCT02379637|20165482|P2|NOT COMPLETED|Overall Study||1
8178633|NCT02379637|20165483|P1|NOT COMPLETED|Overall Study||2
8178634|NCT02379637|20165482|P2|COMPLETED|Overall Study||34
8178635|NCT02379637|20165483|P1|COMPLETED|Overall Study||33
8178636|NCT02379637|20165482|P2|STARTED|Overall Study||35
8178637|NCT02379637|20165483|P1|STARTED|Overall Study||35
8178638|NCT02379585|20165493|P2|NOT COMPLETED|Overall Study||5
8178639|NCT02379585|20165494|P1|NOT COMPLETED|Overall Study||3
8178640|NCT02379585|20165493|P2|COMPLETED|Overall Study||0
8178641|NCT02379585|20165494|P1|COMPLETED|Overall Study||0
8178642|NCT02379585|20165493|P2|STARTED|Overall Study||5
8178643|NCT02379585|20165494|P1|STARTED|Overall Study||3
8178644|NCT02379442|20165516|P1|NOT COMPLETED|Overall Study||0
8178645|NCT02379442|20165516|P1|COMPLETED|Overall Study||1
8178646|NCT02379442|20165516|P1|STARTED|Overall Study||1
8178647|NCT02379390|20165522|P2|NOT COMPLETED|Overall Study||2
8178648|NCT02379390|20165523|P1|NOT COMPLETED|Overall Study||2
8178649|NCT02379390|20165522|P2|COMPLETED|Overall Study||2
8178650|NCT02379390|20165523|P1|COMPLETED|Overall Study||2
8178651|NCT02379390|20165522|P2|STARTED|Overall Study||4
8178652|NCT02379390|20165523|P1|STARTED|Overall Study||4
8178653|NCT02379221|20165551|P1|NOT COMPLETED|Overall Study||1
8178654|NCT02379221|20165551|P1|COMPLETED|Overall Study||48
8178655|NCT02379221|20165551|P1|STARTED|Overall Study||49
8178656|NCT02379195|20165566|P1|NOT COMPLETED|Overall Study||0
8178657|NCT02379195|20165566|P1|COMPLETED|Overall Study||12
8178658|NCT02379195|20165566|P1|STARTED|Overall Study||12
8178659|NCT02379117|20165576|P2|NOT COMPLETED|Overall Study||0
8178660|NCT02379117|20165577|P1|NOT COMPLETED|Overall Study||0
8178661|NCT02379117|20165576|P2|COMPLETED|Overall Study||31
8178662|NCT02379117|20165577|P1|COMPLETED|Overall Study||30
8178663|NCT02379117|20165576|P2|STARTED|Overall Study||31
8178664|NCT02379117|20165577|P1|STARTED|Overall Study||30
8178665|NCT02379091|20165587|P4|NOT COMPLETED|Overall Study||14
8178666|NCT02379091|20165588|P3|NOT COMPLETED|Overall Study||7
8178667|NCT02379091|20165589|P2|NOT COMPLETED|Overall Study||10
8178668|NCT02379091|20165590|P1|NOT COMPLETED|Overall Study||12
8178669|NCT02379091|20165587|P4|COMPLETED|Overall Study||14
8178670|NCT02379091|20165588|P3|COMPLETED|Overall Study||18
8178671|NCT02379091|20165589|P2|COMPLETED|Overall Study||18
8178672|NCT02379091|20165590|P1|COMPLETED|Overall Study||15
8178673|NCT02379091|20165587|P4|Full Analysis Set|Overall Study||28
8178674|NCT02379091|20165588|P3|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
8178675|NCT02379091|20165589|P2|Full Analysis Set|Overall Study||28
8178676|NCT02379091|20165590|P1|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
8178677|NCT02379091|20165587|P4|STARTED|Overall Study||28
8178678|NCT02379091|20165588|P3|STARTED|Overall Study||25
8178679|NCT02379091|20165589|P2|STARTED|Overall Study||28
8178680|NCT02379091|20165590|P1|STARTED|Overall Study||27
8178681|NCT02379078|20165628|P2|NOT COMPLETED|Overall Study||35
8178682|NCT02379078|20165629|P1|NOT COMPLETED|Overall Study||39
8178683|NCT02379078|20165628|P2|COMPLETED|Overall Study||79
8178684|NCT02379078|20165629|P1|COMPLETED|Overall Study||72
8178685|NCT02379078|20165628|P2|STARTED|Overall Study||114
8178686|NCT02379078|20165629|P1|STARTED|Overall Study||111
8178687|NCT02379052|20165645|P2|NOT COMPLETED|Overall Study||5
8178688|NCT02379052|20165646|P1|NOT COMPLETED|Overall Study||6
8178689|NCT02379052|20165645|P2|COMPLETED|Overall Study||18
8178690|NCT02379052|20165646|P1|COMPLETED|Overall Study||18
8178691|NCT02379052|20165645|P2|STARTED|Overall Study||23
8178692|NCT02379052|20165646|P1|STARTED|Overall Study||24
8178693|NCT02378961|20165688|P4|NOT COMPLETED|Overall Study||1
8178694|NCT02378961|20165689|P3|NOT COMPLETED|Overall Study||1
8178695|NCT02378961|20165690|P2|NOT COMPLETED|Overall Study||2
8178696|NCT02378961|20165691|P1|NOT COMPLETED|Overall Study||4
8178697|NCT02378961|20165688|P4|COMPLETED|Overall Study||28
8178698|NCT02378961|20165689|P3|COMPLETED|Overall Study||35
8178699|NCT02378961|20165690|P2|COMPLETED|Overall Study||28
8178700|NCT02378961|20165691|P1|COMPLETED|Overall Study||29
8178701|NCT02378961|20165688|P4|STARTED|Overall Study||29
8178702|NCT02378961|20165689|P3|STARTED|Overall Study||36
8178703|NCT02378961|20165690|P2|STARTED|Overall Study||30
8178704|NCT02378961|20165691|P1|STARTED|Overall Study||33
8178705|NCT02378935|20165728|P7|NOT COMPLETED|Overall Study||0
8178706|NCT02378935|20165729|P6|NOT COMPLETED|Overall Study||0
8178707|NCT02378935|20165730|P5|NOT COMPLETED|Overall Study||0
8178708|NCT02378935|20165731|P4|NOT COMPLETED|Overall Study||6
8178709|NCT02378935|20165732|P3|NOT COMPLETED|Overall Study||3
8178710|NCT02378935|20165733|P2|NOT COMPLETED|Overall Study||0
8178711|NCT02378935|20165734|P1|NOT COMPLETED|Overall Study||10
8178712|NCT02378935|20165728|P7|COMPLETED|Overall Study||8
8178713|NCT02378935|20165729|P6|COMPLETED|Overall Study||32
8178714|NCT02378935|20165730|P5|COMPLETED|Overall Study||31
8178715|NCT02378935|20165731|P4|COMPLETED|Overall Study||25
8178716|NCT02378935|20165732|P3|COMPLETED|Overall Study||30
8178717|NCT02378935|20165733|P2|COMPLETED|Overall Study||36
8178718|NCT02378935|20165734|P1|COMPLETED|Overall Study||24
8178719|NCT02378935|20165728|P7|STARTED|Overall Study||8
8178720|NCT02378935|20165729|P6|STARTED|Overall Study||32
8178721|NCT02378935|20165730|P5|STARTED|Overall Study||31
8178722|NCT02378935|20165731|P4|STARTED|Overall Study||31
8178723|NCT02378935|20165732|P3|STARTED|Overall Study||33
8178724|NCT02378935|20165733|P2|STARTED|Overall Study||36
8178725|NCT02378935|20165734|P1|STARTED|Overall Study||34
8178726|NCT02378883|20165785|P1|NOT COMPLETED|12 Months Follow-Up||5
8178727|NCT02378883|20165785|P1|COMPLETED|12 Months Follow-Up||41
8178728|NCT02378883|20165785|P1|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46
8178729|NCT02378883|20165785|P1|NOT COMPLETED|30 Day Follow-Up||6
8178730|NCT02378883|20165785|P1|COMPLETED|30 Day Follow-Up||106
8178731|NCT02378883|20165785|P1|STARTED|30 Day Follow-Up||112
8178732|NCT02378883|20165785|P1|NOT COMPLETED|Discharge||0
8178733|NCT02378883|20165785|P1|COMPLETED|Discharge||112
8178734|NCT02378883|20165785|P1|STARTED|Discharge||112
8178735|NCT02378883|20165785|P1|NOT COMPLETED|Enrollment||9
8178736|NCT02378883|20165785|P1|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112
8178737|NCT02378883|20165785|P1|STARTED|Enrollment|Participants consented and assessed for eligibility|121
8178738|NCT02378844|20165798|P3|NOT COMPLETED|Open Label Period||0
8178739|NCT02378844|20165799|P2|NOT COMPLETED|Open Label Period||48
8178740|NCT02378844|20165800|P1|NOT COMPLETED|Open Label Period||43
8178741|NCT02378844|20165798|P3|COMPLETED|Open Label Period||0
8178742|NCT02378844|20165799|P2|COMPLETED|Open Label Period||87
8178743|NCT02378844|20165800|P1|COMPLETED|Open Label Period||99
8178744|NCT02378844|20165798|P3|STARTED|Open Label Period||0
8178745|NCT02378844|20165799|P2|STARTED|Open Label Period||135
8178746|NCT02378844|20165800|P1|STARTED|Open Label Period||142
8178747|NCT02378844|20165798|P3|NOT COMPLETED|Randomized Period (Double Blind)||0
8178748|NCT02378844|20165799|P2|NOT COMPLETED|Randomized Period (Double Blind)||32
8178749|NCT02378844|20165800|P1|NOT COMPLETED|Randomized Period (Double Blind)||23
8178750|NCT02378844|20165798|P3|COMPLETED|Randomized Period (Double Blind)||0
8178751|NCT02378844|20165799|P2|COMPLETED|Randomized Period (Double Blind)||135
8178752|NCT02378844|20165800|P1|COMPLETED|Randomized Period (Double Blind)||142
8178753|NCT02378844|20165798|P3|STARTED|Randomized Period (Double Blind)||0
8178754|NCT02378844|20165799|P2|STARTED|Randomized Period (Double Blind)||167
8178755|NCT02378844|20165800|P1|STARTED|Randomized Period (Double Blind)||165
8178756|NCT02378844|20165798|P3|NOT COMPLETED|Run-in Period||136
8178757|NCT02378844|20165799|P2|NOT COMPLETED|Run-in Period||5
8178758|NCT02378844|20165800|P1|NOT COMPLETED|Run-in Period||4
8178759|NCT02378844|20165798|P3|COMPLETED|Run-in Period||0
8178760|NCT02378844|20165799|P2|COMPLETED|Run-in Period||167
8178761|NCT02378844|20165800|P1|COMPLETED|Run-in Period||165
8178762|NCT02378844|20165798|P3|STARTED|Run-in Period||136
8178763|NCT02378844|20165799|P2|STARTED|Run-in Period||172
8178764|NCT02378844|20165800|P1|STARTED|Run-in Period||169
8178765|NCT02378753|20165830|P2|NOT COMPLETED|Overall Study||695
8178766|NCT02378753|20165831|P1|NOT COMPLETED|Overall Study||218
8178767|NCT02378753|20165830|P2|COMPLETED|Overall Study||3637
8178768|NCT02378753|20165831|P1|COMPLETED|Overall Study||4101
8178769|NCT02378753|20165830|P2|STARTED|Overall Study||4332
8178770|NCT02378753|20165831|P1|STARTED|Overall Study||4319
8178771|NCT02378662|20165851|P2|NOT COMPLETED|Overall Study||0
8178772|NCT02378662|20165852|P1|NOT COMPLETED|Overall Study||2
8178773|NCT02378662|20165851|P2|COMPLETED|Overall Study||0
8178774|NCT02378662|20165852|P1|COMPLETED|Overall Study||0
8178775|NCT02378662|20165851|P2|Implantation|Overall Study||0
8178776|NCT02378662|20165852|P1|Implantation|Overall Study||2
8178777|NCT02378662|20165851|P2|Harvesting|Overall Study||0
8178778|NCT02378662|20165852|P1|Harvesting|Overall Study||2
8178779|NCT02378662|20165851|P2|STARTED|Overall Study||0
8178780|NCT02378662|20165852|P1|STARTED|Overall Study||2
8178781|NCT02378506|20165858|P1|NOT COMPLETED|Overall Study||25
8178782|NCT02378506|20165858|P1|COMPLETED|Overall Study||163
8178783|NCT02378506|20165858|P1|Treated|Overall Study||187
8178784|NCT02378506|20165858|P1|STARTED|Overall Study||188
8178785|NCT02378480|20165877|P2|NOT COMPLETED|Overall Study||32
8178786|NCT02378480|20165878|P1|NOT COMPLETED|Overall Study||28
8178787|NCT02378480|20165877|P2|COMPLETED|Overall Study||294
8178788|NCT02378480|20165878|P1|COMPLETED|Overall Study||301
8178789|NCT02378480|20165877|P2|STARTED|Overall Study||326
8178790|NCT02378480|20165878|P1|STARTED|Overall Study||329
8178791|NCT02378402|20165893|P3|NOT COMPLETED|Overall Study||0
8178792|NCT02378402|20165894|P2|NOT COMPLETED|Overall Study||2
8178793|NCT02378402|20165895|P1|NOT COMPLETED|Overall Study||0
8178794|NCT02378402|20165893|P3|COMPLETED|Overall Study||21
8178795|NCT02378402|20165894|P2|COMPLETED|Overall Study||23
8178796|NCT02378402|20165895|P1|COMPLETED|Overall Study||25
8178797|NCT02378402|20165893|P3|STARTED|Overall Study||21
8178798|NCT02378402|20165894|P2|STARTED|Overall Study||25
8178799|NCT02378402|20165895|P1|STARTED|Overall Study||25
8178800|NCT02378220|20165905|P2|NOT COMPLETED|Overall Study||1
8178801|NCT02378220|20165906|P1|NOT COMPLETED|Overall Study||6
8178802|NCT02378220|20165905|P2|COMPLETED|Overall Study||56
8178803|NCT02378220|20165906|P1|COMPLETED|Overall Study||47
8178804|NCT02378220|20165905|P2|STARTED|Overall Study||57
8178805|NCT02378220|20165906|P1|STARTED|Overall Study||53
8178806|NCT02378207|20165940|P4|NOT COMPLETED|Overall Study||1
8178807|NCT02378207|20165941|P3|NOT COMPLETED|Overall Study||2
8178808|NCT02378207|20165942|P2|NOT COMPLETED|Overall Study||3
8178809|NCT02378207|20165943|P1|NOT COMPLETED|Overall Study||0
8178810|NCT02378207|20165940|P4|COMPLETED|Overall Study||11
8178811|NCT02378207|20165941|P3|COMPLETED|Overall Study||22
8178812|NCT02378207|20165942|P2|COMPLETED|Overall Study||21
8178813|NCT02378207|20165943|P1|COMPLETED|Overall Study||24
8178814|NCT02378207|20165940|P4|STARTED|Overall Study||12
8178815|NCT02378207|20165941|P3|STARTED|Overall Study||24
8178816|NCT02378207|20165942|P2|STARTED|Overall Study||24
8178817|NCT02378207|20165943|P1|STARTED|Overall Study||24
8178818|NCT02378038|20165957|P1|NOT COMPLETED|Overall Study||5
8178819|NCT02378038|20165957|P1|COMPLETED|Overall Study||0
8178820|NCT02378038|20165957|P1|STARTED|Overall Study||5
8178821|NCT02378025|20165969|P2|NOT COMPLETED|Overall Study||21
8178822|NCT02378025|20165970|P1|NOT COMPLETED|Overall Study||13
8178823|NCT02378025|20165969|P2|COMPLETED|Overall Study||15
8178824|NCT02378025|20165970|P1|COMPLETED|Overall Study||26
8178825|NCT02378025|20165969|P2|STARTED|Overall Study||36
8178826|NCT02378025|20165970|P1|STARTED|Overall Study||39
8178827|NCT02377986|20165986|P1|NOT COMPLETED|Overall Study||0
8178828|NCT02377986|20165986|P1|COMPLETED|Overall Study||5
8178829|NCT02377986|20165986|P1|STARTED|Overall Study||5
8178830|NCT02377947|20165991|P1|NOT COMPLETED|Overall Study||0
8178831|NCT02377947|20165991|P1|COMPLETED|Overall Study||50
8178832|NCT02377947|20165991|P1|STARTED|Overall Study||50
8178833|NCT02377921|20166004|P2|NOT COMPLETED|Overall Study||1
8178834|NCT02377921|20166005|P1|NOT COMPLETED|Overall Study||1
8178835|NCT02377921|20166004|P2|COMPLETED|Overall Study||43
8178836|NCT02377921|20166005|P1|COMPLETED|Overall Study||44
8178837|NCT02377921|20166004|P2|STARTED|Overall Study||44
8178838|NCT02377921|20166005|P1|STARTED|Overall Study||45
8178839|NCT02377817|20166029|P2|NOT COMPLETED|Overall Study||0
8178840|NCT02377817|20166030|P1|NOT COMPLETED|Overall Study||3
8178841|NCT02377817|20166029|P2|COMPLETED|Overall Study||10
8178842|NCT02377817|20166030|P1|COMPLETED|Overall Study||10
8178843|NCT02377817|20166029|P2|STARTED|Overall Study||10
8178844|NCT02377817|20166030|P1|STARTED|Overall Study||13
8178845|NCT02377700|20166092|P1|NOT COMPLETED|Overall Study||0
8178846|NCT02377700|20166092|P1|COMPLETED|Overall Study||5
8178847|NCT02377700|20166092|P1|STARTED|Overall Study||5
8178848|NCT02377674|20166098|P1|NOT COMPLETED|Overall Study||0
8178849|NCT02377674|20166098|P1|COMPLETED|Overall Study||5
8178850|NCT02377674|20166098|P1|STARTED|Overall Study||5
8178851|NCT02377466|20166105|P2|NOT COMPLETED|Overall Study||2
8178852|NCT02377466|20166106|P1|NOT COMPLETED|Overall Study||0
8178853|NCT02377466|20166105|P2|COMPLETED|Overall Study||10
8178854|NCT02377466|20166106|P1|COMPLETED|Overall Study||13
8178855|NCT02377466|20166105|P2|Treated|Overall Study||10
8178856|NCT02377466|20166106|P1|Treated|Overall Study||13
8178857|NCT02377466|20166105|P2|STARTED|Overall Study||12
8178858|NCT02377466|20166106|P1|STARTED|Overall Study||13
8178859|NCT02377427|20166224|P5|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
8178860|NCT02377427|20166225|P4|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
8178861|NCT02377427|20166226|P3|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
8178862|NCT02377427|20166227|P2|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
8178863|NCT02377427|20166228|P1|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
8178864|NCT02377427|20166224|P5|COMPLETED|Part B (From Week 20 and up to Week 80)||4
8178865|NCT02377427|20166225|P4|COMPLETED|Part B (From Week 20 and up to Week 80)||10
8178866|NCT02377427|20166226|P3|COMPLETED|Part B (From Week 20 and up to Week 80)||15
8178867|NCT02377427|20166227|P2|COMPLETED|Part B (From Week 20 and up to Week 80)||0
8178868|NCT02377427|20166228|P1|COMPLETED|Part B (From Week 20 and up to Week 80)||0
8178869|NCT02377427|20166224|P5|STARTED|Part B (From Week 20 and up to Week 80)||4
8178870|NCT02377427|20166225|P4|STARTED|Part B (From Week 20 and up to Week 80)||10
8178871|NCT02377427|20166226|P3|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
8178872|NCT02377427|20166227|P2|STARTED|Part B (From Week 20 and up to Week 80)||0
8178873|NCT02377427|20166228|P1|STARTED|Part B (From Week 20 and up to Week 80)||0
8178874|NCT02377427|20166224|P5|NOT COMPLETED|Part A (Up to Week 20)||0
8178875|NCT02377427|20166225|P4|NOT COMPLETED|Part A (Up to Week 20)||0
8178876|NCT02377427|20166226|P3|NOT COMPLETED|Part A (Up to Week 20)||0
8178877|NCT02377427|20166227|P2|NOT COMPLETED|Part A (Up to Week 20)||0
8178878|NCT02377427|20166228|P1|NOT COMPLETED|Part A (Up to Week 20)||4
8178879|NCT02377427|20166224|P5|COMPLETED|Part A (Up to Week 20)||0
8178880|NCT02377427|20166225|P4|COMPLETED|Part A (Up to Week 20)||0
8178881|NCT02377427|20166226|P3|COMPLETED|Part A (Up to Week 20)||0
8178882|NCT02377427|20166227|P2|COMPLETED|Part A (Up to Week 20)||10
8178883|NCT02377427|20166228|P1|COMPLETED|Part A (Up to Week 20)||22
8178884|NCT02377427|20166224|P5|STARTED|Part A (Up to Week 20)||0
8178885|NCT02377427|20166225|P4|STARTED|Part A (Up to Week 20)||0
8178886|NCT02377427|20166226|P3|STARTED|Part A (Up to Week 20)||0
8178887|NCT02377427|20166227|P2|STARTED|Part A (Up to Week 20)||10
8178888|NCT02377427|20166228|P1|STARTED|Part A (Up to Week 20)||26
8178889|NCT02377362|20166301|P13|NOT COMPLETED|Part B Overall||0
8178890|NCT02377362|20166302|P12|NOT COMPLETED|Part B Overall||1
8178891|NCT02377362|20166303|P11|NOT COMPLETED|Part B Overall||0
8178892|NCT02377362|20166304|P10|NOT COMPLETED|Part B Overall||1
8178893|NCT02377362|20166305|P9|NOT COMPLETED|Part B Overall||0
8178894|NCT02377362|20166306|P8|NOT COMPLETED|Part B Overall||1
8178895|NCT02377362|20166307|P7|NOT COMPLETED|Part B Overall||2
8178896|NCT02377362|20166308|P6|NOT COMPLETED|Part B Overall||0
8178897|NCT02377362|20166309|P5|NOT COMPLETED|Part B Overall||0
8178898|NCT02377362|20166310|P4|NOT COMPLETED|Part B Overall||0
8178899|NCT02377362|20166311|P3|NOT COMPLETED|Part B Overall||0
8178900|NCT02377362|20166312|P2|NOT COMPLETED|Part B Overall||0
8178901|NCT02377362|20166313|P1|NOT COMPLETED|Part B Overall||0
8178902|NCT02377362|20166301|P13|COMPLETED|Part B Overall||12
8178903|NCT02377362|20166302|P12|COMPLETED|Part B Overall||6
8178904|NCT02377362|20166303|P11|COMPLETED|Part B Overall||6
8178905|NCT02377362|20166304|P10|COMPLETED|Part B Overall||6
8178906|NCT02377362|20166305|P9|COMPLETED|Part B Overall||6
8178907|NCT02377362|20166306|P8|COMPLETED|Part B Overall||5
8178908|NCT02377362|20166307|P7|COMPLETED|Part B Overall||4
8178909|NCT02377362|20166308|P6|COMPLETED|Part B Overall||0
8178910|NCT02377362|20166309|P5|COMPLETED|Part B Overall||0
8178911|NCT02377362|20166310|P4|COMPLETED|Part B Overall||0
8178912|NCT02377362|20166311|P3|COMPLETED|Part B Overall||0
8178913|NCT02377362|20166312|P2|COMPLETED|Part B Overall||0
8178914|NCT02377362|20166313|P1|COMPLETED|Part B Overall||0
8178915|NCT02377362|20166301|P13|STARTED|Part B Overall||12
8178916|NCT02377362|20166302|P12|STARTED|Part B Overall||7
8178917|NCT02377362|20166303|P11|STARTED|Part B Overall||6
8178918|NCT02377362|20166304|P10|STARTED|Part B Overall||7
8178919|NCT02377362|20166305|P9|STARTED|Part B Overall||6
8178920|NCT02377362|20166306|P8|STARTED|Part B Overall||6
8178921|NCT02377362|20166307|P7|STARTED|Part B Overall||6
8178922|NCT02377362|20166308|P6|STARTED|Part B Overall||0
8178923|NCT02377362|20166309|P5|STARTED|Part B Overall||0
8178924|NCT02377362|20166310|P4|STARTED|Part B Overall||0
8178925|NCT02377362|20166311|P3|STARTED|Part B Overall||0
8178926|NCT02377362|20166312|P2|STARTED|Part B Overall||0
8178927|NCT02377362|20166313|P1|STARTED|Part B Overall||0
8178928|NCT02377362|20166301|P13|NOT COMPLETED|Part A Third Treatment||0
8178929|NCT02377362|20166302|P12|NOT COMPLETED|Part A Third Treatment||0
8178930|NCT02377362|20166303|P11|NOT COMPLETED|Part A Third Treatment||0
8178931|NCT02377362|20166304|P10|NOT COMPLETED|Part A Third Treatment||0
8178932|NCT02377362|20166305|P9|NOT COMPLETED|Part A Third Treatment||0
8178933|NCT02377362|20166306|P8|NOT COMPLETED|Part A Third Treatment||0
8178934|NCT02377362|20166307|P7|NOT COMPLETED|Part A Third Treatment||0
8178935|NCT02377362|20166308|P6|NOT COMPLETED|Part A Third Treatment||4
8178936|NCT02377362|20166309|P5|NOT COMPLETED|Part A Third Treatment||3
8178937|NCT02377362|20166310|P4|NOT COMPLETED|Part A Third Treatment||4
8178938|NCT02377362|20166311|P3|NOT COMPLETED|Part A Third Treatment||0
8178939|NCT02377362|20166312|P2|NOT COMPLETED|Part A Third Treatment||0
8178940|NCT02377362|20166313|P1|NOT COMPLETED|Part A Third Treatment||0
8178941|NCT02377362|20166301|P13|COMPLETED|Part A Third Treatment||0
8178942|NCT02377362|20166302|P12|COMPLETED|Part A Third Treatment||0
8178943|NCT02377362|20166303|P11|COMPLETED|Part A Third Treatment||0
8178944|NCT02377362|20166304|P10|COMPLETED|Part A Third Treatment||0
8178945|NCT02377362|20166305|P9|COMPLETED|Part A Third Treatment||0
8178946|NCT02377362|20166306|P8|COMPLETED|Part A Third Treatment||0
8178947|NCT02377362|20166307|P7|COMPLETED|Part A Third Treatment||0
8178948|NCT02377362|20166308|P6|COMPLETED|Part A Third Treatment||0
8178949|NCT02377362|20166309|P5|COMPLETED|Part A Third Treatment||0
8178950|NCT02377362|20166310|P4|COMPLETED|Part A Third Treatment||0
8178951|NCT02377362|20166311|P3|COMPLETED|Part A Third Treatment||4
8178952|NCT02377362|20166312|P2|COMPLETED|Part A Third Treatment||4
8178953|NCT02377362|20166313|P1|COMPLETED|Part A Third Treatment||4
8178954|NCT02377362|20166301|P13|STARTED|Part A Third Treatment||0
8178955|NCT02377362|20166302|P12|STARTED|Part A Third Treatment||0
8178956|NCT02377362|20166303|P11|STARTED|Part A Third Treatment||0
8178957|NCT02377362|20166304|P10|STARTED|Part A Third Treatment||0
8178958|NCT02377362|20166305|P9|STARTED|Part A Third Treatment||0
8178959|NCT02377362|20166306|P8|STARTED|Part A Third Treatment||0
8178960|NCT02377362|20166307|P7|STARTED|Part A Third Treatment||0
8178961|NCT02377362|20166308|P6|STARTED|Part A Third Treatment||4
8178962|NCT02377362|20166309|P5|STARTED|Part A Third Treatment||3
8178963|NCT02377362|20166310|P4|STARTED|Part A Third Treatment||4
8178964|NCT02377362|20166311|P3|STARTED|Part A Third Treatment||4
8178965|NCT02377362|20166312|P2|STARTED|Part A Third Treatment||4
8178966|NCT02377362|20166313|P1|STARTED|Part A Third Treatment||4
8178967|NCT02377362|20166301|P13|NOT COMPLETED|Part A Second Treatment||0
8178968|NCT02377362|20166302|P12|NOT COMPLETED|Part A Second Treatment||0
8178969|NCT02377362|20166303|P11|NOT COMPLETED|Part A Second Treatment||0
8178970|NCT02377362|20166304|P10|NOT COMPLETED|Part A Second Treatment||0
8178971|NCT02377362|20166305|P9|NOT COMPLETED|Part A Second Treatment||0
8178972|NCT02377362|20166306|P8|NOT COMPLETED|Part A Second Treatment||0
8178973|NCT02377362|20166307|P7|NOT COMPLETED|Part A Second Treatment||0
8178974|NCT02377362|20166308|P6|NOT COMPLETED|Part A Second Treatment||0
8178975|NCT02377362|20166309|P5|NOT COMPLETED|Part A Second Treatment||1
8178976|NCT02377362|20166310|P4|NOT COMPLETED|Part A Second Treatment||0
8178977|NCT02377362|20166311|P3|NOT COMPLETED|Part A Second Treatment||0
8178978|NCT02377362|20166312|P2|NOT COMPLETED|Part A Second Treatment||0
8178979|NCT02377362|20166313|P1|NOT COMPLETED|Part A Second Treatment||0
8178980|NCT02377362|20166301|P13|COMPLETED|Part A Second Treatment||0
8178981|NCT02377362|20166302|P12|COMPLETED|Part A Second Treatment||0
8178982|NCT02377362|20166303|P11|COMPLETED|Part A Second Treatment||0
8178983|NCT02377362|20166304|P10|COMPLETED|Part A Second Treatment||0
8178984|NCT02377362|20166305|P9|COMPLETED|Part A Second Treatment||0
8178985|NCT02377362|20166306|P8|COMPLETED|Part A Second Treatment||0
8178986|NCT02377362|20166307|P7|COMPLETED|Part A Second Treatment||0
8178987|NCT02377362|20166308|P6|COMPLETED|Part A Second Treatment||4
8178988|NCT02377362|20166309|P5|COMPLETED|Part A Second Treatment||3
8178989|NCT02377362|20166310|P4|COMPLETED|Part A Second Treatment||4
8178990|NCT02377362|20166311|P3|COMPLETED|Part A Second Treatment||4
8178991|NCT02377362|20166312|P2|COMPLETED|Part A Second Treatment||4
8178992|NCT02377362|20166313|P1|COMPLETED|Part A Second Treatment||4
8178993|NCT02377362|20166301|P13|STARTED|Part A Second Treatment||0
8178994|NCT02377362|20166302|P12|STARTED|Part A Second Treatment||0
8178995|NCT02377362|20166303|P11|STARTED|Part A Second Treatment||0
8178996|NCT02377362|20166304|P10|STARTED|Part A Second Treatment||0
8178997|NCT02377362|20166305|P9|STARTED|Part A Second Treatment||0
8178998|NCT02377362|20166306|P8|STARTED|Part A Second Treatment||0
8178999|NCT02377362|20166307|P7|STARTED|Part A Second Treatment||0
8179000|NCT02377362|20166308|P6|STARTED|Part A Second Treatment||4
8179001|NCT02377362|20166309|P5|STARTED|Part A Second Treatment||4
8179002|NCT02377362|20166310|P4|STARTED|Part A Second Treatment||4
8179003|NCT02377362|20166311|P3|STARTED|Part A Second Treatment||4
8179004|NCT02377362|20166312|P2|STARTED|Part A Second Treatment||4
8179005|NCT02377362|20166313|P1|STARTED|Part A Second Treatment||4
8179006|NCT02377362|20166301|P13|NOT COMPLETED|Part A First Treatment||0
8179007|NCT02377362|20166302|P12|NOT COMPLETED|Part A First Treatment||0
8179008|NCT02377362|20166303|P11|NOT COMPLETED|Part A First Treatment||0
8179009|NCT02377362|20166304|P10|NOT COMPLETED|Part A First Treatment||0
8179010|NCT02377362|20166305|P9|NOT COMPLETED|Part A First Treatment||0
8179011|NCT02377362|20166306|P8|NOT COMPLETED|Part A First Treatment||0
8179012|NCT02377362|20166307|P7|NOT COMPLETED|Part A First Treatment||0
8179013|NCT02377362|20166308|P6|NOT COMPLETED|Part A First Treatment||0
8179014|NCT02377362|20166309|P5|NOT COMPLETED|Part A First Treatment||0
8179015|NCT02377362|20166310|P4|NOT COMPLETED|Part A First Treatment||0
8179016|NCT02377362|20166311|P3|NOT COMPLETED|Part A First Treatment||0
8179017|NCT02377362|20166312|P2|NOT COMPLETED|Part A First Treatment||0
8179018|NCT02377362|20166313|P1|NOT COMPLETED|Part A First Treatment||0
8179019|NCT02377362|20166301|P13|COMPLETED|Part A First Treatment||0
8179020|NCT02377362|20166302|P12|COMPLETED|Part A First Treatment||0
8179021|NCT02377362|20166303|P11|COMPLETED|Part A First Treatment||0
8179022|NCT02377362|20166304|P10|COMPLETED|Part A First Treatment||0
8179023|NCT02377362|20166305|P9|COMPLETED|Part A First Treatment||0
8179024|NCT02377362|20166306|P8|COMPLETED|Part A First Treatment||0
8179025|NCT02377362|20166307|P7|COMPLETED|Part A First Treatment||0
8179026|NCT02377362|20166308|P6|COMPLETED|Part A First Treatment||4
8179027|NCT02377362|20166309|P5|COMPLETED|Part A First Treatment||4
8179028|NCT02377362|20166310|P4|COMPLETED|Part A First Treatment||4
8179029|NCT02377362|20166311|P3|COMPLETED|Part A First Treatment||4
8179030|NCT02377362|20166312|P2|COMPLETED|Part A First Treatment||4
8179031|NCT02377362|20166313|P1|COMPLETED|Part A First Treatment||4
8179032|NCT02377362|20166301|P13|STARTED|Part A First Treatment||0
8179033|NCT02377362|20166302|P12|STARTED|Part A First Treatment||0
8179034|NCT02377362|20166303|P11|STARTED|Part A First Treatment||0
8179035|NCT02377362|20166304|P10|STARTED|Part A First Treatment||0
8179036|NCT02377362|20166305|P9|STARTED|Part A First Treatment||0
8179037|NCT02377362|20166306|P8|STARTED|Part A First Treatment||0
8179038|NCT02377362|20166307|P7|STARTED|Part A First Treatment||0
8179039|NCT02377362|20166308|P6|STARTED|Part A First Treatment||4
8179040|NCT02377362|20166309|P5|STARTED|Part A First Treatment||4
8179041|NCT02377362|20166310|P4|STARTED|Part A First Treatment||4
8179042|NCT02377362|20166311|P3|STARTED|Part A First Treatment||4
8179043|NCT02377362|20166312|P2|STARTED|Part A First Treatment||4
8179044|NCT02377362|20166313|P1|STARTED|Part A First Treatment||4
8179045|NCT02377349|20166522|P2|NOT COMPLETED|Overall Study||11
8179046|NCT02377349|20166523|P1|NOT COMPLETED|Overall Study||16
8179047|NCT02377349|20166522|P2|COMPLETED|Overall Study||335
8179048|NCT02377349|20166523|P1|COMPLETED|Overall Study||325
8179049|NCT02377349|20166522|P2|STARTED|Overall Study||346
8179050|NCT02377349|20166523|P1|STARTED|Overall Study||341
8179051|NCT02377063|20166561|P1|NOT COMPLETED|Overall Study||5
8179052|NCT02377063|20166561|P1|COMPLETED|Overall Study||20
8179053|NCT02377063|20166561|P1|STARTED|Overall Study||25
8179054|NCT02376998|20166565|P1|NOT COMPLETED|Overall Study||9
8179055|NCT02376998|20166565|P1|COMPLETED|Overall Study||11
8179056|NCT02376998|20166565|P1|STARTED|Overall Study||20
8179057|NCT02376933|20166569|P1|NOT COMPLETED|Overall Study||2
8179058|NCT02376933|20166569|P1|COMPLETED|Overall Study||8
8179059|NCT02376933|20166569|P1|STARTED|Overall Study||10
8179072|NCT02376530|20166701|P4|NOT COMPLETED|Overall Study||0
8179073|NCT02376530|20166702|P3|NOT COMPLETED|Overall Study||0
8179074|NCT02376530|20166703|P2|NOT COMPLETED|Overall Study||0
8179075|NCT02376530|20166704|P1|NOT COMPLETED|Overall Study||0
8179076|NCT02376530|20166701|P4|COMPLETED|Overall Study||197
8179077|NCT02376530|20166702|P3|COMPLETED|Overall Study||197
8179078|NCT02376530|20166703|P2|COMPLETED|Overall Study||198
8179079|NCT02376530|20166704|P1|COMPLETED|Overall Study||196
8179080|NCT02376530|20166701|P4|STARTED|Overall Study||197
8179081|NCT02376530|20166702|P3|STARTED|Overall Study||197
8179082|NCT02376530|20166703|P2|STARTED|Overall Study||198
8179083|NCT02376530|20166704|P1|STARTED|Overall Study||196
8179084|NCT02376283|20166717|P3|NOT COMPLETED|Overall Study||0
8179085|NCT02376283|20166718|P2|NOT COMPLETED|Overall Study||0
8179086|NCT02376283|20166719|P1|NOT COMPLETED|Overall Study||0
8179087|NCT02376283|20166717|P3|COMPLETED|Overall Study||30
8179088|NCT02376283|20166718|P2|COMPLETED|Overall Study||30
8179089|NCT02376283|20166719|P1|COMPLETED|Overall Study||27
8179090|NCT02376283|20166717|P3|STARTED|Overall Study||30
8179091|NCT02376283|20166718|P2|STARTED|Overall Study||30
8179092|NCT02376283|20166719|P1|STARTED|Overall Study||27
8179093|NCT02376257|20166737|P3|NOT COMPLETED|Overall Study||0
8179094|NCT02376257|20166738|P2|NOT COMPLETED|Overall Study||0
8179095|NCT02376257|20166739|P1|NOT COMPLETED|Overall Study||0
8179096|NCT02376257|20166737|P3|COMPLETED|Overall Study||11
8179097|NCT02376257|20166738|P2|COMPLETED|Overall Study||12
8179098|NCT02376257|20166739|P1|COMPLETED|Overall Study||13
8179099|NCT02376257|20166737|P3|STARTED|Overall Study||11
8179100|NCT02376257|20166738|P2|STARTED|Overall Study||12
8179101|NCT02376257|20166739|P1|STARTED|Overall Study||13
8179102|NCT02376179|20166768|P1|NOT COMPLETED|Overall Study||0
8179103|NCT02376179|20166768|P1|COMPLETED|Overall Study||84
8179104|NCT02376179|20166768|P1|STARTED|Overall Study||84
8179105|NCT02376166|20166772|P1|NOT COMPLETED|Overall Study||3
8179106|NCT02376166|20166772|P1|COMPLETED|Overall Study||12
8179107|NCT02376166|20166772|P1|STARTED|Overall Study||15
8179108|NCT02375971|20166800|P3|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
8179109|NCT02375971|20166801|P2|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
8179110|NCT02375971|20166802|P1|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
8179111|NCT02375971|20166800|P3|COMPLETED|Follow-Up Phase (up to Day 169)||64
8179112|NCT02375971|20166801|P2|COMPLETED|Follow-Up Phase (up to Day 169)||71
8179113|NCT02375971|20166802|P1|COMPLETED|Follow-Up Phase (up to Day 169)||66
8179114|NCT02375971|20166800|P3|STARTED|Follow-Up Phase (up to Day 169)||69
8179115|NCT02375971|20166801|P2|STARTED|Follow-Up Phase (up to Day 169)||76
8179116|NCT02375971|20166802|P1|STARTED|Follow-Up Phase (up to Day 169)||73
8179117|NCT02375971|20166800|P3|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
8179118|NCT02375971|20166801|P2|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
8179119|NCT02375971|20166802|P1|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
8179120|NCT02375971|20166800|P3|COMPLETED|Treatment (Day 1 - Baseline)||69
8179121|NCT02375971|20166801|P2|COMPLETED|Treatment (Day 1 - Baseline)||76
8179122|NCT02375971|20166802|P1|COMPLETED|Treatment (Day 1 - Baseline)||73
8179123|NCT02375971|20166800|P3|PK Set|Treatment (Day 1 - Baseline)||0
8179124|NCT02375971|20166801|P2|PK Set|Treatment (Day 1 - Baseline)||46
8179125|NCT02375971|20166802|P1|PK Set|Treatment (Day 1 - Baseline)||49
8179126|NCT02375971|20166800|P3|VEGF Set|Treatment (Day 1 - Baseline)||51
8179127|NCT02375971|20166801|P2|VEGF Set|Treatment (Day 1 - Baseline)||26
8179128|NCT02375971|20166802|P1|VEGF Set|Treatment (Day 1 - Baseline)||19
8179129|NCT02375971|20166800|P3|Safety Set|Treatment (Day 1 - Baseline)||69
8179130|NCT02375971|20166801|P2|Safety Set|Treatment (Day 1 - Baseline)||76
8179131|NCT02375971|20166802|P1|Safety Set|Treatment (Day 1 - Baseline)||73
8179132|NCT02375971|20166800|P3|STARTED|Treatment (Day 1 - Baseline)||74
8179133|NCT02375971|20166801|P2|STARTED|Treatment (Day 1 - Baseline)||77
8179134|NCT02375971|20166802|P1|STARTED|Treatment (Day 1 - Baseline)||74
8179135|NCT02375724|20166844|P2|NOT COMPLETED|Overall Study||6
8179136|NCT02375724|20166845|P1|NOT COMPLETED|Overall Study||6
8179137|NCT02375724|20166844|P2|COMPLETED|Overall Study||128
8179138|NCT02375724|20166845|P1|COMPLETED|Overall Study||129
8179139|NCT02375724|20166844|P2|STARTED|Overall Study||134
8179140|NCT02375724|20166845|P1|STARTED|Overall Study||135
8179141|NCT02375698|20166857|P2|NOT COMPLETED|Overall Study||2
8179142|NCT02375698|20166858|P1|NOT COMPLETED|Overall Study||2
8179143|NCT02375698|20166857|P2|COMPLETED|Overall Study||4
8179144|NCT02375698|20166858|P1|COMPLETED|Overall Study||14
8179145|NCT02375698|20166857|P2|STARTED|Overall Study||6
8179146|NCT02375698|20166858|P1|STARTED|Overall Study||16
8179147|NCT02375373|20166866|P1|NOT COMPLETED|Overall Study||11
8179148|NCT02375373|20166866|P1|COMPLETED|Overall Study||1
8179149|NCT02375373|20166866|P1|STARTED|Overall Study||12
8179150|NCT02375347|20166870|P1|NOT COMPLETED|Overall Study||1
8179151|NCT02375347|20166870|P1|COMPLETED|Overall Study||12
8179152|NCT02375347|20166870|P1|STARTED|Overall Study||13
8179153|NCT02374957|20166876|P2|NOT COMPLETED|Overall Study||0
8179154|NCT02374957|20166877|P1|NOT COMPLETED|Overall Study||1
8179155|NCT02374957|20166876|P2|COMPLETED|Overall Study||9
8179156|NCT02374957|20166877|P1|COMPLETED|Overall Study||10
8179157|NCT02374957|20166876|P2|STARTED|Overall Study||9
8179158|NCT02374957|20166877|P1|STARTED|Overall Study||11
8179159|NCT02374671|20166906|P3|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3
8179160|NCT02374671|20166907|P2|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
8179161|NCT02374671|20166908|P1|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25
8179162|NCT02374671|20166906|P3|COMPLETED|Implantation- Nonrandomized & Randomized|(1) unilaterally implanted subject discontinued (1 eye)|23
8179163|NCT02374671|20166907|P2|COMPLETED|Implantation- Nonrandomized & Randomized||27
8179164|NCT02374671|20166908|P1|COMPLETED|Implantation- Nonrandomized & Randomized||281
8179165|NCT02374671|20166906|P3|STARTED|Implantation- Nonrandomized & Randomized|(3) subjects were unilaterally implanted|26
8179166|NCT02374671|20166907|P2|STARTED|Implantation- Nonrandomized & Randomized|(1) subject was unilaterally implanted|28
8179167|NCT02374671|20166908|P1|STARTED|Implantation- Nonrandomized & Randomized|(8) subjects were unilaterally implanted|306
8179168|NCT02374671|20166906|P3|NOT COMPLETED|Observation (Deferred Implantation)||5
8179169|NCT02374671|20166907|P2|NOT COMPLETED|Observation (Deferred Implantation)||0
8179170|NCT02374671|20166908|P1|NOT COMPLETED|Observation (Deferred Implantation)||0
8179171|NCT02374671|20166906|P3|COMPLETED|Observation (Deferred Implantation)||26
8179172|NCT02374671|20166907|P2|COMPLETED|Observation (Deferred Implantation)||0
8179173|NCT02374671|20166908|P1|COMPLETED|Observation (Deferred Implantation)||0
8179174|NCT02374671|20166906|P3|STARTED|Observation (Deferred Implantation)||31
8179175|NCT02374671|20166907|P2|STARTED|Observation (Deferred Implantation)||0
8179176|NCT02374671|20166908|P1|STARTED|Observation (Deferred Implantation)||0
8179177|NCT02374593|20166916|P2|NOT COMPLETED|Overall Study||0
8179178|NCT02374593|20166917|P1|NOT COMPLETED|Overall Study||2
8179179|NCT02374593|20166916|P2|COMPLETED|Overall Study||44
8179180|NCT02374593|20166917|P1|COMPLETED|Overall Study||22
8179181|NCT02374593|20166916|P2|STARTED|Overall Study||44
8179182|NCT02374593|20166917|P1|STARTED|Overall Study||24
8179183|NCT02374463|20166929|P2|NOT COMPLETED|Overall Study||3
8179184|NCT02374463|20166930|P1|NOT COMPLETED|Overall Study||3
8179185|NCT02374463|20166929|P2|COMPLETED|Overall Study||9
8179186|NCT02374463|20166930|P1|COMPLETED|Overall Study||12
8179187|NCT02374463|20166929|P2|STARTED|Overall Study||12
8179188|NCT02374463|20166930|P1|STARTED|Overall Study||15
8179189|NCT02374398|20166950|P4|NOT COMPLETED|Overall Study||0
8179190|NCT02374398|20166951|P3|NOT COMPLETED|Overall Study||3
8179191|NCT02374398|20166952|P2|NOT COMPLETED|Overall Study||1
8179192|NCT02374398|20166953|P1|NOT COMPLETED|Overall Study||2
8179193|NCT02374398|20166950|P4|COMPLETED|Overall Study||32
8179194|NCT02374398|20166951|P3|COMPLETED|Overall Study||29
8179195|NCT02374398|20166952|P2|COMPLETED|Overall Study||31
8179196|NCT02374398|20166953|P1|COMPLETED|Overall Study||29
8179197|NCT02374398|20166950|P4|STARTED|Overall Study||32
8179198|NCT02374398|20166951|P3|STARTED|Overall Study||32
8179199|NCT02374398|20166952|P2|STARTED|Overall Study||32
8179200|NCT02374398|20166953|P1|STARTED|Overall Study||31
8179201|NCT02374346|20166979|P1|NOT COMPLETED|Overall Study||48
8179202|NCT02374346|20166979|P1|COMPLETED|Overall Study||446
8179203|NCT02374346|20166979|P1|STARTED|Overall Study||494
8179204|NCT02374307|20166987|P2|NOT COMPLETED|6-months Follow-up||6
8179205|NCT02374307|20166988|P1|NOT COMPLETED|6-months Follow-up||3
8179206|NCT02374307|20166987|P2|COMPLETED|6-months Follow-up||64
8179207|NCT02374307|20166988|P1|COMPLETED|6-months Follow-up||71
8179208|NCT02374307|20166987|P2|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70
8179209|NCT02374307|20166988|P1|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74
8179210|NCT02374307|20166987|P2|NOT COMPLETED|3-months Follow-up||9
8179211|NCT02374307|20166988|P1|NOT COMPLETED|3-months Follow-up||8
8179212|NCT02374307|20166987|P2|COMPLETED|3-months Follow-up||69
8179213|NCT02374307|20166988|P1|COMPLETED|3-months Follow-up||69
8179214|NCT02374307|20166987|P2|STARTED|3-months Follow-up||78
8179215|NCT02374307|20166988|P1|STARTED|3-months Follow-up||77
8179216|NCT02374255|20167019|P4|NOT COMPLETED|Overall Study||0
8179217|NCT02374255|20167020|P3|NOT COMPLETED|Overall Study||0
8179218|NCT02374255|20167021|P2|NOT COMPLETED|Overall Study||0
8179219|NCT02374255|20167022|P1|NOT COMPLETED|Overall Study||2
8179220|NCT02374255|20167019|P4|COMPLETED|Overall Study||11
8179221|NCT02374255|20167020|P3|COMPLETED|Overall Study||11
8179222|NCT02374255|20167021|P2|COMPLETED|Overall Study||110
8179223|NCT02374255|20167022|P1|COMPLETED|Overall Study||153
8179224|NCT02374255|20167019|P4|STARTED|Overall Study||11
8179225|NCT02374255|20167020|P3|STARTED|Overall Study||11
8179226|NCT02374255|20167021|P2|STARTED|Overall Study||110
8179227|NCT02374255|20167022|P1|STARTED|Overall Study||155
8179228|NCT02374164|20167043|P3|NOT COMPLETED|Treatment Period 3||0
8179229|NCT02374164|20167044|P2|NOT COMPLETED|Treatment Period 3||0
8179230|NCT02374164|20167045|P1|NOT COMPLETED|Treatment Period 3||0
8179231|NCT02374164|20167043|P3|COMPLETED|Treatment Period 3||12
8179232|NCT02374164|20167044|P2|COMPLETED|Treatment Period 3||11
8179233|NCT02374164|20167045|P1|COMPLETED|Treatment Period 3||12
8179234|NCT02374164|20167043|P3|STARTED|Treatment Period 3||12
8179235|NCT02374164|20167044|P2|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
8179236|NCT02374164|20167045|P1|STARTED|Treatment Period 3||12
8179237|NCT02374164|20167043|P3|NOT COMPLETED|Treatment Period 2||0
8179238|NCT02374164|20167044|P2|NOT COMPLETED|Treatment Period 2||0
8179239|NCT02374164|20167045|P1|NOT COMPLETED|Treatment Period 2||0
8179240|NCT02374164|20167043|P3|COMPLETED|Treatment Period 2||12
8179241|NCT02374164|20167044|P2|COMPLETED|Treatment Period 2||12
8179242|NCT02374164|20167045|P1|COMPLETED|Treatment Period 2||12
8179243|NCT02374164|20167043|P3|STARTED|Treatment Period 2||12
8179244|NCT02374164|20167044|P2|STARTED|Treatment Period 2||12
8179245|NCT02374164|20167045|P1|STARTED|Treatment Period 2||12
8179246|NCT02374164|20167043|P3|NOT COMPLETED|Treatment Period 1||0
8179247|NCT02374164|20167044|P2|NOT COMPLETED|Treatment Period 1||0
8179248|NCT02374164|20167045|P1|NOT COMPLETED|Treatment Period 1||0
8179249|NCT02374164|20167043|P3|COMPLETED|Treatment Period 1||12
8179250|NCT02374164|20167044|P2|COMPLETED|Treatment Period 1||12
8179251|NCT02374164|20167045|P1|COMPLETED|Treatment Period 1||12
8179252|NCT02374164|20167043|P3|STARTED|Treatment Period 1||12
8179253|NCT02374164|20167044|P2|STARTED|Treatment Period 1||12
8179254|NCT02374164|20167045|P1|STARTED|Treatment Period 1||12
8179255|NCT02374138|20167064|P2|NOT COMPLETED|Twelve Month FollowUp||12
8179256|NCT02374138|20167065|P1|NOT COMPLETED|Twelve Month FollowUp||9
8179257|NCT02374138|20167064|P2|COMPLETED|Twelve Month FollowUp||95
8179258|NCT02374138|20167065|P1|COMPLETED|Twelve Month FollowUp||101
8179259|NCT02374138|20167064|P2|STARTED|Twelve Month FollowUp||107
8179260|NCT02374138|20167065|P1|STARTED|Twelve Month FollowUp||110
8179261|NCT02374138|20167064|P2|NOT COMPLETED|Six Month Follow Up||14
8179262|NCT02374138|20167065|P1|NOT COMPLETED|Six Month Follow Up||8
8179263|NCT02374138|20167064|P2|COMPLETED|Six Month Follow Up|6 Month Follow Up|93
8179264|NCT02374138|20167065|P1|COMPLETED|Six Month Follow Up|6 Month Follow Up|102
8179265|NCT02374138|20167064|P2|STARTED|Six Month Follow Up||107
8179266|NCT02374138|20167065|P1|STARTED|Six Month Follow Up||110
8179267|NCT02374099|20167123|P2|NOT COMPLETED|Overall Study||49
8179268|NCT02374099|20167124|P1|NOT COMPLETED|Overall Study||48
8179269|NCT02374099|20167123|P2|COMPLETED|Overall Study||0
8179270|NCT02374099|20167124|P1|COMPLETED|Overall Study||0
8179271|NCT02374099|20167123|P2|Participants Treated|Overall Study|1 participant randomized, but not treated|48
8179272|NCT02374099|20167124|P1|Participants Treated|Overall Study|2 participants randomized, but not treated|46
8179273|NCT02374099|20167123|P2|STARTED|Overall Study||49
8179274|NCT02374099|20167124|P1|STARTED|Overall Study||48
8179275|NCT02374060|20167143|P3|NOT COMPLETED|Overall Study||3
8179276|NCT02374060|20167144|P2|NOT COMPLETED|Overall Study||1
8179277|NCT02374060|20167145|P1|NOT COMPLETED|Overall Study||2
8179278|NCT02374060|20167143|P3|COMPLETED|Overall Study||61
8179279|NCT02374060|20167144|P2|COMPLETED|Overall Study||62
8179280|NCT02374060|20167145|P1|COMPLETED|Overall Study||63
8179281|NCT02374060|20167143|P3|STARTED|Overall Study||64
8179282|NCT02374060|20167144|P2|STARTED|Overall Study||63
8179283|NCT02374060|20167145|P1|STARTED|Overall Study||65
8179284|NCT02373865|20167197|P2|NOT COMPLETED|Overall Study||0
8179285|NCT02373865|20167198|P1|NOT COMPLETED|Overall Study||0
8179286|NCT02373865|20167197|P2|COMPLETED|Overall Study||2
8179287|NCT02373865|20167198|P1|COMPLETED|Overall Study||2
8179288|NCT02373865|20167197|P2|STARTED|Overall Study||2
8179289|NCT02373865|20167198|P1|STARTED|Overall Study||2
8179290|NCT02373852|20167208|P1|NOT COMPLETED|Overall Study||1
8179291|NCT02373852|20167208|P1|COMPLETED|Overall Study||11
8179292|NCT02373852|20167208|P1|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12
8179293|NCT02373813|20167216|P4|NOT COMPLETED|Double-Blind Treatment Period||4
8179294|NCT02373813|20167217|P3|NOT COMPLETED|Double-Blind Treatment Period||9
8179295|NCT02373813|20167218|P2|NOT COMPLETED|Double-Blind Treatment Period||13
8179296|NCT02373813|20167219|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8179297|NCT02373813|20167216|P4|COMPLETED|Double-Blind Treatment Period||47
8179298|NCT02373813|20167217|P3|COMPLETED|Double-Blind Treatment Period||92
8179299|NCT02373813|20167218|P2|COMPLETED|Double-Blind Treatment Period||88
8179300|NCT02373813|20167219|P1|COMPLETED|Double-Blind Treatment Period||0
8179301|NCT02373813|20167216|P4|Received Rescue Treatment|Double-Blind Treatment Period||15
8179302|NCT02373813|20167217|P3|Received Rescue Treatment|Double-Blind Treatment Period||36
8179303|NCT02373813|20167218|P2|Received Rescue Treatment|Double-Blind Treatment Period||52
8179304|NCT02373813|20167219|P1|Received Rescue Treatment|Double-Blind Treatment Period||0
8179305|NCT02373813|20167216|P4|Received Investigational Product (IP)|Double-Blind Treatment Period||51
8179306|NCT02373813|20167217|P3|Received Investigational Product (IP)|Double-Blind Treatment Period||100
8179307|NCT02373813|20167218|P2|Received Investigational Product (IP)|Double-Blind Treatment Period||101
8179308|NCT02373813|20167219|P1|Received Investigational Product (IP)|Double-Blind Treatment Period||0
8179309|NCT02373813|20167216|P4|STARTED|Double-Blind Treatment Period||51
8179310|NCT02373813|20167217|P3|STARTED|Double-Blind Treatment Period||101
8179311|NCT02373813|20167218|P2|STARTED|Double-Blind Treatment Period||101
8179312|NCT02373813|20167219|P1|STARTED|Double-Blind Treatment Period||0
8179313|NCT02373813|20167216|P4|NOT COMPLETED|Run-In Period||0
8179314|NCT02373813|20167217|P3|NOT COMPLETED|Run-In Period||0
8179315|NCT02373813|20167218|P2|NOT COMPLETED|Run-In Period||0
8179316|NCT02373813|20167219|P1|NOT COMPLETED|Run-In Period||116
8179317|NCT02373813|20167216|P4|COMPLETED|Run-In Period||0
8179318|NCT02373813|20167217|P3|COMPLETED|Run-In Period||0
8179319|NCT02373813|20167218|P2|COMPLETED|Run-In Period||0
8179320|NCT02373813|20167219|P1|COMPLETED|Run-In Period|1 participant who completed the run-in period had no end of study case report form.|255
8179321|NCT02373813|20167216|P4|Treated|Run-In Period||0
8179322|NCT02373813|20167217|P3|Treated|Run-In Period||0
8179323|NCT02373813|20167218|P2|Treated|Run-In Period||0
8179324|NCT02373813|20167219|P1|Treated|Run-In Period||368
8179325|NCT02373813|20167216|P4|STARTED|Run-In Period||0
8179326|NCT02373813|20167217|P3|STARTED|Run-In Period||0
8179327|NCT02373813|20167218|P2|STARTED|Run-In Period||0
8179328|NCT02373813|20167219|P1|STARTED|Run-In Period||371
8179329|NCT02373371|20167274|P2|NOT COMPLETED|Overall Study||0
8179330|NCT02373371|20167275|P1|NOT COMPLETED|Overall Study||0
8179331|NCT02373371|20167274|P2|COMPLETED|Overall Study||13
8179332|NCT02373371|20167275|P1|COMPLETED|Overall Study||13
8179333|NCT02373371|20167274|P2|STARTED|Overall Study||13
8179334|NCT02373371|20167275|P1|STARTED|Overall Study||13
8179335|NCT02373202|20167291|P4|NOT COMPLETED|Overall Study||1
8179336|NCT02373202|20167292|P3|NOT COMPLETED|Overall Study||3
8179337|NCT02373202|20167293|P2|NOT COMPLETED|Overall Study||6
8179338|NCT02373202|20167294|P1|NOT COMPLETED|Overall Study||2
8179339|NCT02373202|20167291|P4|COMPLETED|Overall Study||30
8179340|NCT02373202|20167292|P3|COMPLETED|Overall Study||27
8179341|NCT02373202|20167293|P2|COMPLETED|Overall Study||9
8179342|NCT02373202|20167294|P1|COMPLETED|Overall Study||13
8179343|NCT02373202|20167291|P4|STARTED|Overall Study||31
8179344|NCT02373202|20167292|P3|STARTED|Overall Study||30
8179345|NCT02373202|20167293|P2|STARTED|Overall Study||15
8179346|NCT02373202|20167294|P1|STARTED|Overall Study||15
8179347|NCT02373137|20167346|P2|NOT COMPLETED|Overall Study||1
8179348|NCT02373137|20167347|P1|NOT COMPLETED|Overall Study||1
8179349|NCT02373137|20167346|P2|COMPLETED|Overall Study||18
8179350|NCT02373137|20167347|P1|COMPLETED|Overall Study||18
8179351|NCT02373137|20167346|P2|12-Month Follow-Up|Overall Study||19
8179352|NCT02373137|20167347|P1|12-Month Follow-Up|Overall Study||19
8179353|NCT02373137|20167346|P2|6-Month Follow-Up|Overall Study||18
8179354|NCT02373137|20167347|P1|6-Month Follow-Up|Overall Study||19
8179355|NCT02373137|20167346|P2|3-Month Follow-Up|Overall Study||19
8179356|NCT02373137|20167347|P1|3-Month Follow-Up|Overall Study||19
8179357|NCT02373137|20167346|P2|STARTED|Overall Study||19
8179358|NCT02373137|20167347|P1|STARTED|Overall Study||19
8179359|NCT02373124|20167379|P1|NOT COMPLETED|Overall Study||1
8179360|NCT02373124|20167379|P1|COMPLETED|Overall Study||3
8179361|NCT02373124|20167379|P1|STARTED|Overall Study||4
8179362|NCT02373098|20167385|P2|NOT COMPLETED|Overall Study||0
8179363|NCT02373098|20167386|P1|NOT COMPLETED|Overall Study||12
8179364|NCT02373098|20167385|P2|COMPLETED|Overall Study||60
8179365|NCT02373098|20167386|P1|COMPLETED|Overall Study||54
8179366|NCT02373098|20167385|P2|STARTED|Overall Study||60
8179367|NCT02373098|20167386|P1|STARTED|Overall Study||66
8179368|NCT02372799|20167414|P3|NOT COMPLETED|Down-taper Period||2
8179369|NCT02372799|20167415|P2|NOT COMPLETED|Down-taper Period||2
8179370|NCT02372799|20167416|P1|NOT COMPLETED|Down-taper Period||1
8179371|NCT02372799|20167414|P3|COMPLETED|Down-taper Period||80
8179372|NCT02372799|20167415|P2|COMPLETED|Down-taper Period||157
8179373|NCT02372799|20167416|P1|COMPLETED|Down-taper Period||151
8179374|NCT02372799|20167414|P3|STARTED|Down-taper Period||82
8179375|NCT02372799|20167415|P2|STARTED|Down-taper Period||159
8179376|NCT02372799|20167416|P1|STARTED|Down-taper Period||152
8179377|NCT02372799|20167414|P3|NOT COMPLETED|Treatment Period||15
8179378|NCT02372799|20167415|P2|NOT COMPLETED|Treatment Period||32
8179379|NCT02372799|20167416|P1|NOT COMPLETED|Treatment Period||34
8179380|NCT02372799|20167414|P3|COMPLETED|Treatment Period||82
8179381|NCT02372799|20167415|P2|COMPLETED|Treatment Period||155
8179382|NCT02372799|20167416|P1|COMPLETED|Treatment Period||152
8179383|NCT02372799|20167414|P3|STARTED|Treatment Period||97
8179384|NCT02372799|20167415|P2|STARTED|Treatment Period||187
8179385|NCT02372799|20167416|P1|STARTED|Treatment Period||186
8179386|NCT02372682|20167429|P2|NOT COMPLETED|Overall Study||14
8179387|NCT02372682|20167430|P1|NOT COMPLETED|Overall Study||8
8179388|NCT02372682|20167429|P2|COMPLETED|Overall Study||79
8179389|NCT02372682|20167430|P1|COMPLETED|Overall Study||70
8179390|NCT02372682|20167429|P2|STARTED|Overall Study||93
8179391|NCT02372682|20167430|P1|STARTED|Overall Study||78
8179392|NCT02372396|20167445|P2|NOT COMPLETED|Overall Study||9
8179393|NCT02372396|20167446|P1|NOT COMPLETED|Overall Study||7
8179394|NCT02372396|20167445|P2|COMPLETED|Overall Study||11
8179395|NCT02372396|20167446|P1|COMPLETED|Overall Study||10
8179396|NCT02372396|20167445|P2|Began Intervention|Overall Study||14
8179397|NCT02372396|20167446|P1|Began Intervention|Overall Study||14
8179398|NCT02372396|20167445|P2|STARTED|Overall Study||20
8179399|NCT02372396|20167446|P1|STARTED|Overall Study||17
8179400|NCT02372344|20167452|P3|NOT COMPLETED|Period 3 (Visit 4)||0
8179401|NCT02372344|20167453|P2|NOT COMPLETED|Period 3 (Visit 4)||0
8179402|NCT02372344|20167454|P1|NOT COMPLETED|Period 3 (Visit 4)||0
8179403|NCT02372344|20167452|P3|COMPLETED|Period 3 (Visit 4)||14
8179404|NCT02372344|20167453|P2|COMPLETED|Period 3 (Visit 4)||14
8179405|NCT02372344|20167454|P1|COMPLETED|Period 3 (Visit 4)||14
8179406|NCT02372344|20167452|P3|STARTED|Period 3 (Visit 4)||14
8179407|NCT02372344|20167453|P2|STARTED|Period 3 (Visit 4)||14
8179408|NCT02372344|20167454|P1|STARTED|Period 3 (Visit 4)||14
8179409|NCT02372344|20167452|P3|NOT COMPLETED|Period 2 (Visit 3)||0
8179410|NCT02372344|20167453|P2|NOT COMPLETED|Period 2 (Visit 3)||0
8179411|NCT02372344|20167454|P1|NOT COMPLETED|Period 2 (Visit 3)||0
8179412|NCT02372344|20167452|P3|COMPLETED|Period 2 (Visit 3)||14
8179413|NCT02372344|20167453|P2|COMPLETED|Period 2 (Visit 3)||14
8179414|NCT02372344|20167454|P1|COMPLETED|Period 2 (Visit 3)||14
8179415|NCT02372344|20167452|P3|STARTED|Period 2 (Visit 3)||14
8179416|NCT02372344|20167453|P2|STARTED|Period 2 (Visit 3)||14
8179417|NCT02372344|20167454|P1|STARTED|Period 2 (Visit 3)||14
8179418|NCT02372344|20167452|P3|NOT COMPLETED|Period 1 (Visit 2)||0
8179419|NCT02372344|20167453|P2|NOT COMPLETED|Period 1 (Visit 2)||0
8179420|NCT02372344|20167454|P1|NOT COMPLETED|Period 1 (Visit 2)||0
8179421|NCT02372344|20167452|P3|COMPLETED|Period 1 (Visit 2)||14
8179422|NCT02372344|20167453|P2|COMPLETED|Period 1 (Visit 2)||14
8179423|NCT02372344|20167454|P1|COMPLETED|Period 1 (Visit 2)||14
8179424|NCT02372344|20167452|P3|STARTED|Period 1 (Visit 2)||14
8179425|NCT02372344|20167453|P2|STARTED|Period 1 (Visit 2)||14
8179426|NCT02372344|20167454|P1|STARTED|Period 1 (Visit 2)||14
8179427|NCT02372253|20167470|P2|NOT COMPLETED|Overall Study||0
8179428|NCT02372253|20167471|P1|NOT COMPLETED|Overall Study||2
8179429|NCT02372253|20167470|P2|COMPLETED|Overall Study||13
8179430|NCT02372253|20167471|P1|COMPLETED|Overall Study||11
8179431|NCT02372253|20167470|P2|STARTED|Overall Study||13
8179432|NCT02372253|20167471|P1|STARTED|Overall Study||13
8179433|NCT02372097|20167489|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
8179434|NCT02372097|20167490|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
8179435|NCT02372097|20167489|P2|COMPLETED|Second Intervention Period (8 Days)||12
8179436|NCT02372097|20167490|P1|COMPLETED|Second Intervention Period (8 Days)||12
8179437|NCT02372097|20167489|P2|STARTED|Second Intervention Period (8 Days)||12
8179438|NCT02372097|20167490|P1|STARTED|Second Intervention Period (8 Days)||12
8179439|NCT02372097|20167489|P2|NOT COMPLETED|Wash Out Period (13 Days)||0
8179440|NCT02372097|20167490|P1|NOT COMPLETED|Wash Out Period (13 Days)||0
8179441|NCT02372097|20167489|P2|COMPLETED|Wash Out Period (13 Days)||12
8179442|NCT02372097|20167490|P1|COMPLETED|Wash Out Period (13 Days)||12
8179443|NCT02372097|20167489|P2|STARTED|Wash Out Period (13 Days)||12
8179444|NCT02372097|20167490|P1|STARTED|Wash Out Period (13 Days)||12
8179445|NCT02372097|20167489|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
8179446|NCT02372097|20167490|P1|NOT COMPLETED|First Intervention Period (8 Days)||0
8179447|NCT02372097|20167489|P2|COMPLETED|First Intervention Period (8 Days)||12
8179448|NCT02372097|20167490|P1|COMPLETED|First Intervention Period (8 Days)||12
8179449|NCT02372097|20167489|P2|STARTED|First Intervention Period (8 Days)||12
8179450|NCT02372097|20167490|P1|STARTED|First Intervention Period (8 Days)||12
8179451|NCT02372071|20167516|P1|NOT COMPLETED|Overall Study||18
8179452|NCT02372071|20167516|P1|COMPLETED|Overall Study||93
8179453|NCT02372071|20167516|P1|STARTED|Overall Study||111
8179454|NCT02372058|20167521|P1|NOT COMPLETED|Overall Study||3
8179455|NCT02372058|20167521|P1|COMPLETED|Overall Study||100
8179456|NCT02372058|20167521|P1|STARTED|Overall Study||103
8179457|NCT02371980|20167527|P5|NOT COMPLETED|Double-blind Period||58
8179458|NCT02371980|20167528|P4|NOT COMPLETED|Double-blind Period||49
8179459|NCT02371980|20167529|P3|NOT COMPLETED|Double-blind Period||56
8179460|NCT02371980|20167530|P2|NOT COMPLETED|Double-blind Period||81
8179461|NCT02371980|20167531|P1|NOT COMPLETED|Double-blind Period||0
8179462|NCT02371980|20167527|P5|COMPLETED|Double-blind Period||86
8179463|NCT02371980|20167528|P4|COMPLETED|Double-blind Period||96
8179464|NCT02371980|20167529|P3|COMPLETED|Double-blind Period||84
8179465|NCT02371980|20167530|P2|COMPLETED|Double-blind Period||70
8179466|NCT02371980|20167531|P1|COMPLETED|Double-blind Period||0
8179467|NCT02371980|20167527|P5|STARTED|Double-blind Period||144
8179468|NCT02371980|20167528|P4|STARTED|Double-blind Period||145
8179469|NCT02371980|20167529|P3|STARTED|Double-blind Period||140
8179470|NCT02371980|20167530|P2|STARTED|Double-blind Period||151
8179471|NCT02371980|20167531|P1|STARTED|Double-blind Period||0
8179472|NCT02371980|20167527|P5|NOT COMPLETED|Open-label Period||0
8179473|NCT02371980|20167528|P4|NOT COMPLETED|Open-label Period||0
8179474|NCT02371980|20167529|P3|NOT COMPLETED|Open-label Period||0
8179475|NCT02371980|20167530|P2|NOT COMPLETED|Open-label Period||0
8179476|NCT02371980|20167531|P1|NOT COMPLETED|Open-label Period||526
8179477|NCT02371980|20167527|P5|COMPLETED|Open-label Period||0
8179478|NCT02371980|20167528|P4|COMPLETED|Open-label Period||0
8179479|NCT02371980|20167529|P3|COMPLETED|Open-label Period||0
8179480|NCT02371980|20167530|P2|COMPLETED|Open-label Period||0
8179481|NCT02371980|20167531|P1|COMPLETED|Open-label Period||580
8179482|NCT02371980|20167527|P5|STARTED|Open-label Period||0
8179483|NCT02371980|20167528|P4|STARTED|Open-label Period||0
8179484|NCT02371980|20167529|P3|STARTED|Open-label Period||0
8179485|NCT02371980|20167530|P2|STARTED|Open-label Period||0
8179486|NCT02371980|20167531|P1|STARTED|Open-label Period||1106
8179487|NCT02371876|20167558|P1|NOT COMPLETED|Overall Study||0
8179488|NCT02371876|20167558|P1|COMPLETED|Overall Study||134
8179489|NCT02371876|20167558|P1|STARTED|Overall Study||134
8179493|NCT02371785|20167573|P1|NOT COMPLETED|Overall Study||0
8179494|NCT02371785|20167573|P1|COMPLETED|Overall Study||20
8179495|NCT02371785|20167573|P1|STARTED|Overall Study||20
8179496|NCT02371759|20167591|P8|NOT COMPLETED|Overall Study||4
8179497|NCT02371759|20167592|P7|NOT COMPLETED|Overall Study||0
8179498|NCT02371759|20167593|P6|NOT COMPLETED|Overall Study||1
8179499|NCT02371759|20167594|P5|NOT COMPLETED|Overall Study||3
8179500|NCT02371759|20167595|P4|NOT COMPLETED|Overall Study||0
8179501|NCT02371759|20167596|P3|NOT COMPLETED|Overall Study||1
8179502|NCT02371759|20167597|P2|NOT COMPLETED|Overall Study||1
8179503|NCT02371759|20167598|P1|NOT COMPLETED|Overall Study||3
8179504|NCT02371759|20167591|P8|COMPLETED|Overall Study||24
8179505|NCT02371759|20167592|P7|COMPLETED|Overall Study||25
8179506|NCT02371759|20167593|P6|COMPLETED|Overall Study||25
8179507|NCT02371759|20167594|P5|COMPLETED|Overall Study||24
8179508|NCT02371759|20167595|P4|COMPLETED|Overall Study||31
8179509|NCT02371759|20167596|P3|COMPLETED|Overall Study||32
8179510|NCT02371759|20167597|P2|COMPLETED|Overall Study||30
8179511|NCT02371759|20167598|P1|COMPLETED|Overall Study||29
8179512|NCT02371759|20167591|P8|STARTED|Overall Study||28
8179513|NCT02371759|20167592|P7|STARTED|Overall Study||25
8179514|NCT02371759|20167593|P6|STARTED|Overall Study||26
8179515|NCT02371759|20167594|P5|STARTED|Overall Study||27
8179516|NCT02371759|20167595|P4|STARTED|Overall Study||31
8179517|NCT02371759|20167596|P3|STARTED|Overall Study||33
8179518|NCT02371759|20167597|P2|STARTED|Overall Study||31
8179519|NCT02371759|20167598|P1|STARTED|Overall Study||32
8179520|NCT02371746|20167815|P7|NOT COMPLETED|Overall Study||1
8179521|NCT02371746|20167816|P6|NOT COMPLETED|Overall Study||0
8179522|NCT02371746|20167817|P5|NOT COMPLETED|Overall Study||0
8179523|NCT02371746|20167818|P4|NOT COMPLETED|Overall Study||0
8179524|NCT02371746|20167819|P3|NOT COMPLETED|Overall Study||0
8179525|NCT02371746|20167820|P2|NOT COMPLETED|Overall Study||0
8179526|NCT02371746|20167821|P1|NOT COMPLETED|Overall Study||0
8179527|NCT02371746|20167815|P7|COMPLETED|Overall Study||8
8179528|NCT02371746|20167816|P6|COMPLETED|Overall Study||6
8179529|NCT02371746|20167817|P5|COMPLETED|Overall Study||5
8179530|NCT02371746|20167818|P4|COMPLETED|Overall Study||2
8179531|NCT02371746|20167819|P3|COMPLETED|Overall Study||2
8179532|NCT02371746|20167820|P2|COMPLETED|Overall Study||10
8179533|NCT02371746|20167821|P1|COMPLETED|Overall Study||7
8179534|NCT02371746|20167815|P7|STARTED|Overall Study||9
8179535|NCT02371746|20167816|P6|STARTED|Overall Study||6
8179536|NCT02371746|20167817|P5|STARTED|Overall Study||5
8179537|NCT02371746|20167818|P4|STARTED|Overall Study||2
8179538|NCT02371746|20167819|P3|STARTED|Overall Study||2
8179539|NCT02371746|20167820|P2|STARTED|Overall Study||10
8179540|NCT02371746|20167821|P1|STARTED|Overall Study||7
8179541|NCT02371668|20167839|P2|NOT COMPLETED|Overall Study||0
8179542|NCT02371668|20167840|P1|NOT COMPLETED|Overall Study||0
8179543|NCT02371668|20167839|P2|COMPLETED|Overall Study||42
8179544|NCT02371668|20167840|P1|COMPLETED|Overall Study||49
8179545|NCT02371668|20167839|P2|STARTED|Overall Study||42
8179546|NCT02371668|20167840|P1|STARTED|Overall Study||49
8179547|NCT02371629|20167864|P2|NOT COMPLETED|Overall Study||25
8179548|NCT02371629|20167865|P1|NOT COMPLETED|Overall Study||26
8179549|NCT02371629|20167864|P2|COMPLETED|Overall Study||363
8179550|NCT02371629|20167865|P1|COMPLETED|Overall Study||362
8179551|NCT02371629|20167864|P2|STARTED|Overall Study||388
8179552|NCT02371629|20167865|P1|STARTED|Overall Study||388
8179553|NCT02371616|20167901|P2|NOT COMPLETED|Overall Study||7
8179554|NCT02371616|20167902|P1|NOT COMPLETED|Overall Study||4
8179555|NCT02371616|20167901|P2|COMPLETED|Overall Study||147
8179556|NCT02371616|20167902|P1|COMPLETED|Overall Study||146
8179557|NCT02371616|20167901|P2|STARTED|Overall Study||154
8179558|NCT02371616|20167902|P1|STARTED|Overall Study||150
8179559|NCT02371395|20167914|P1|NOT COMPLETED|Overall Study||0
8179560|NCT02371395|20167914|P1|COMPLETED|Overall Study||1000
8179561|NCT02371395|20167914|P1|STARTED|Overall Study||1000
8179562|NCT02371356|20167923|P5|NOT COMPLETED|Overall Study||0
8179563|NCT02371356|20167924|P4|NOT COMPLETED|Overall Study||0
8179564|NCT02371356|20167925|P3|NOT COMPLETED|Overall Study||0
8179565|NCT02371356|20167926|P2|NOT COMPLETED|Overall Study||0
8179566|NCT02371356|20167927|P1|NOT COMPLETED|Overall Study||0
8179567|NCT02371356|20167923|P5|COMPLETED|Overall Study||72183
8179568|NCT02371356|20167924|P4|COMPLETED|Overall Study||7423
8179569|NCT02371356|20167925|P3|COMPLETED|Overall Study||2804
8179570|NCT02371356|20167926|P2|COMPLETED|Overall Study||7354
8179571|NCT02371356|20167927|P1|COMPLETED|Overall Study||1320
8179572|NCT02371356|20167923|P5|STARTED|Overall Study||72183
8179573|NCT02371356|20167924|P4|STARTED|Overall Study||7423
8179574|NCT02371356|20167925|P3|STARTED|Overall Study||2804
8179575|NCT02371356|20167926|P2|STARTED|Overall Study||7354
8179576|NCT02371356|20167927|P1|STARTED|Overall Study||1320
8179577|NCT02371187|20167946|P2|NOT COMPLETED|Overall Study||4
8179578|NCT02371187|20167947|P1|NOT COMPLETED|Overall Study||3
8179579|NCT02371187|20167946|P2|COMPLETED|Overall Study||15
8179580|NCT02371187|20167947|P1|COMPLETED|Overall Study||15
8179581|NCT02371187|20167946|P2|STARTED|Overall Study||19
8179582|NCT02371187|20167947|P1|STARTED|Overall Study||18
8179583|NCT02370914|20167961|P1|NOT COMPLETED|Overall Study||2
8179584|NCT02370914|20167961|P1|COMPLETED|Overall Study||82
8179585|NCT02370914|20167961|P1|STARTED|Overall Study||84
8179586|NCT02370888|20167969|P1|NOT COMPLETED|Overall Study||8
8179587|NCT02370888|20167969|P1|COMPLETED|Overall Study||1
8179588|NCT02370888|20167969|P1|Proceed to Treatment|Overall Study||3
8179589|NCT02370888|20167969|P1|STARTED|Overall Study||9
8179590|NCT02370784|20167979|P2|NOT COMPLETED|Overall Study||1
8179591|NCT02370784|20167980|P1|NOT COMPLETED|Overall Study||0
8179592|NCT02370784|20167979|P2|COMPLETED|Overall Study||13
8179593|NCT02370784|20167980|P1|COMPLETED|Overall Study||10
8179594|NCT02370784|20167979|P2|STARTED|Overall Study||14
8179595|NCT02370784|20167980|P1|STARTED|Overall Study||10
8179596|NCT02370667|20167995|P3|NOT COMPLETED|Overall Study||0
8179597|NCT02370667|20167996|P2|NOT COMPLETED|Overall Study||1
8179598|NCT02370667|20167997|P1|NOT COMPLETED|Overall Study||0
8179599|NCT02370667|20167995|P3|COMPLETED|Overall Study||10
8179600|NCT02370667|20167996|P2|COMPLETED|Overall Study||10
8179601|NCT02370667|20167997|P1|COMPLETED|Overall Study||10
8179602|NCT02370667|20167995|P3|STARTED|Overall Study||10
8179603|NCT02370667|20167996|P2|STARTED|Overall Study||11
8179604|NCT02370667|20167997|P1|STARTED|Overall Study||10
8179605|NCT02370641|20168061|P2|NOT COMPLETED|Overall Study||2
8179606|NCT02370641|20168062|P1|NOT COMPLETED|Overall Study||4
8179607|NCT02370641|20168061|P2|COMPLETED|Overall Study||6
8179608|NCT02370641|20168062|P1|COMPLETED|Overall Study||14
8179609|NCT02370641|20168061|P2|STARTED|Overall Study||8
8179610|NCT02370641|20168062|P1|STARTED|Overall Study||18
8179611|NCT02370615|20168070|P2|NOT COMPLETED|Overall Study||0
8179612|NCT02370615|20168071|P1|NOT COMPLETED|Overall Study||1
8179613|NCT02370615|20168070|P2|COMPLETED|Overall Study||18
8179614|NCT02370615|20168071|P1|COMPLETED|Overall Study||15
8179615|NCT02370615|20168070|P2|STARTED|Overall Study||18
8179616|NCT02370615|20168071|P1|STARTED|Overall Study||16
8179617|NCT02370602|20168114|P6|NOT COMPLETED|Overall Study||0
8179618|NCT02370602|20168115|P5|NOT COMPLETED|Overall Study||0
8179619|NCT02370602|20168116|P4|NOT COMPLETED|Overall Study||0
8179620|NCT02370602|20168117|P3|NOT COMPLETED|Overall Study||0
8179621|NCT02370602|20168118|P2|NOT COMPLETED|Overall Study||0
8179622|NCT02370602|20168119|P1|NOT COMPLETED|Overall Study||1
8179623|NCT02370602|20168114|P6|COMPLETED|Overall Study||2
8179624|NCT02370602|20168115|P5|COMPLETED|Overall Study||3
8179625|NCT02370602|20168116|P4|COMPLETED|Overall Study||3
8179626|NCT02370602|20168117|P3|COMPLETED|Overall Study||2
8179627|NCT02370602|20168118|P2|COMPLETED|Overall Study||2
8179628|NCT02370602|20168119|P1|COMPLETED|Overall Study||0
8179629|NCT02370602|20168114|P6|STARTED|Overall Study||2
8179630|NCT02370602|20168115|P5|STARTED|Overall Study||3
8179631|NCT02370602|20168116|P4|STARTED|Overall Study||3
8179632|NCT02370602|20168117|P3|STARTED|Overall Study||2
8179633|NCT02370602|20168118|P2|STARTED|Overall Study||2
8179634|NCT02370602|20168119|P1|STARTED|Overall Study||1
8179635|NCT02370537|20168213|P3|NOT COMPLETED|Part B||259
8179636|NCT02370537|20168214|P2|NOT COMPLETED|Part B||3
8179637|NCT02370537|20168215|P1|NOT COMPLETED|Part B||1
8179638|NCT02370537|20168213|P3|COMPLETED|Part B||23
8179639|NCT02370537|20168214|P2|COMPLETED|Part B||12
8179640|NCT02370537|20168215|P1|COMPLETED|Part B||15
8179641|NCT02370537|20168213|P3|Period 2 Sequence BA|Part B||12
8179642|NCT02370537|20168214|P2|Period 2 Sequence BA|Part B||7
8179643|NCT02370537|20168215|P1|Period 2 Sequence BA|Part B||7
8179644|NCT02370537|20168213|P3|Period 2 Sequence AB|Part B||11
8179645|NCT02370537|20168214|P2|Period 2 Sequence AB|Part B||5
8179646|NCT02370537|20168215|P1|Period 2 Sequence AB|Part B||8
8179647|NCT02370537|20168213|P3|Period 1 Sequence BA|Part B||12
8179648|NCT02370537|20168214|P2|Period 1 Sequence BA|Part B||7
8179649|NCT02370537|20168215|P1|Period 1 Sequence BA|Part B||7
8179650|NCT02370537|20168213|P3|Period 1 Sequence AB|Part B||11
8179651|NCT02370537|20168214|P2|Period 1 Sequence AB|Part B||6
8179652|NCT02370537|20168215|P1|Period 1 Sequence AB|Part B||8
8179653|NCT02370537|20168213|P3|Eligible for Randomisation|Part B||23
8179654|NCT02370537|20168214|P2|Eligible for Randomisation|Part B||13
8179655|NCT02370537|20168215|P1|Eligible for Randomisation|Part B||15
8179656|NCT02370537|20168213|P3|STARTED|Part B||282
8179657|NCT02370537|20168214|P2|STARTED|Part B||15
8179658|NCT02370537|20168215|P1|STARTED|Part B||16
8179659|NCT02370537|20168213|P3|NOT COMPLETED|Part A (Open-label Recruitment)||1
8179660|NCT02370537|20168214|P2|NOT COMPLETED|Part A (Open-label Recruitment)||1
8179661|NCT02370537|20168215|P1|NOT COMPLETED|Part A (Open-label Recruitment)||0
8179662|NCT02370537|20168213|P3|COMPLETED|Part A (Open-label Recruitment)||282
8179663|NCT02370537|20168214|P2|COMPLETED|Part A (Open-label Recruitment)||15
8179664|NCT02370537|20168215|P1|COMPLETED|Part A (Open-label Recruitment)||16
8179665|NCT02370537|20168213|P3|STARTED|Part A (Open-label Recruitment)||283
8179666|NCT02370537|20168214|P2|STARTED|Part A (Open-label Recruitment)||16
8179667|NCT02370537|20168215|P1|STARTED|Part A (Open-label Recruitment)||16
8179678|NCT02370420|20168319|P2|NOT COMPLETED|Overall Study||12
8179679|NCT02370420|20168320|P1|NOT COMPLETED|Overall Study||14
8179680|NCT02370420|20168319|P2|COMPLETED|Overall Study||15
8179681|NCT02370420|20168320|P1|COMPLETED|Overall Study||15
8179682|NCT02370420|20168319|P2|STARTED|Overall Study||27
8179683|NCT02370420|20168320|P1|STARTED|Overall Study||29
8179684|NCT02370407|20168332|P2|NOT COMPLETED|Overall Study||0
8179685|NCT02370407|20168333|P1|NOT COMPLETED|Overall Study||0
8179686|NCT02370407|20168332|P2|COMPLETED|Overall Study||20
8179687|NCT02370407|20168333|P1|COMPLETED|Overall Study||20
8179688|NCT02370407|20168332|P2|STARTED|Overall Study||20
8179689|NCT02370407|20168333|P1|STARTED|Overall Study||20
8179690|NCT02370394|20168357|P2|NOT COMPLETED|Overall Study||2
8179691|NCT02370394|20168358|P1|NOT COMPLETED|Overall Study||2
8179692|NCT02370394|20168357|P2|COMPLETED|Overall Study||23
8179693|NCT02370394|20168358|P1|COMPLETED|Overall Study||26
8179694|NCT02370394|20168357|P2|STARTED|Overall Study||25
8179695|NCT02370394|20168358|P1|STARTED|Overall Study||28
8179696|NCT02370368|20168374|P2|NOT COMPLETED|Overall Study||6
8179697|NCT02370368|20168375|P1|NOT COMPLETED|Overall Study||6
8179698|NCT02370368|20168374|P2|COMPLETED|Overall Study||7
8179699|NCT02370368|20168375|P1|COMPLETED|Overall Study||8
8179700|NCT02370368|20168374|P2|STARTED|Overall Study||13
8179701|NCT02370368|20168375|P1|STARTED|Overall Study||14
8179702|NCT02370251|20168385|P1|NOT COMPLETED|Overall Study||11
8179703|NCT02370251|20168385|P1|COMPLETED|Overall Study||52
8179704|NCT02370251|20168385|P1|STARTED|Overall Study||63
8179705|NCT02370160|20168391|P3|NOT COMPLETED|Overall Study||1
8179706|NCT02370160|20168392|P2|NOT COMPLETED|Overall Study||4
8179707|NCT02370160|20168393|P1|NOT COMPLETED|Overall Study||3
8179708|NCT02370160|20168391|P3|COMPLETED|Overall Study||2
8179709|NCT02370160|20168392|P2|COMPLETED|Overall Study||2
8179710|NCT02370160|20168393|P1|COMPLETED|Overall Study||6
8179711|NCT02370160|20168391|P3|STARTED|Overall Study||3
8179712|NCT02370160|20168392|P2|STARTED|Overall Study||6
8179713|NCT02370160|20168393|P1|STARTED|Overall Study||9
8179714|NCT02370121|20168417|P2|NOT COMPLETED|Overall Study||1
8179715|NCT02370121|20168418|P1|NOT COMPLETED|Overall Study||1
8179716|NCT02370121|20168417|P2|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
8179717|NCT02370121|20168418|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
8179718|NCT02370121|20168417|P2|STARTED|Overall Study||12
8179719|NCT02370121|20168418|P1|STARTED|Overall Study||12
8179720|NCT02370095|20168458|P2|NOT COMPLETED|Overall Study||1
8179721|NCT02370095|20168459|P1|NOT COMPLETED|Overall Study||0
8179722|NCT02370095|20168458|P2|COMPLETED|Overall Study||3
8179723|NCT02370095|20168459|P1|COMPLETED|Overall Study||10
8179724|NCT02370095|20168458|P2|STARTED|Overall Study||4
8179725|NCT02370095|20168459|P1|STARTED|Overall Study||10
8179732|NCT02370043|20168500|P6|NOT COMPLETED|Overall Study||1
8179733|NCT02370043|20168501|P5|NOT COMPLETED|Overall Study||1
8179734|NCT02370043|20168502|P4|NOT COMPLETED|Overall Study||0
8179735|NCT02370043|20168503|P3|NOT COMPLETED|Overall Study||0
8179736|NCT02370043|20168504|P2|NOT COMPLETED|Overall Study||0
8179737|NCT02370043|20168505|P1|NOT COMPLETED|Overall Study||0
8179738|NCT02370043|20168500|P6|COMPLETED|Overall Study||3
8179739|NCT02370043|20168501|P5|COMPLETED|Overall Study||2
8179740|NCT02370043|20168502|P4|COMPLETED|Overall Study||3
8179741|NCT02370043|20168503|P3|COMPLETED|Overall Study||3
8179742|NCT02370043|20168504|P2|COMPLETED|Overall Study||3
8179743|NCT02370043|20168505|P1|COMPLETED|Overall Study||3
8179744|NCT02370043|20168500|P6|STARTED|Overall Study||4
8179745|NCT02370043|20168501|P5|STARTED|Overall Study||3
8179746|NCT02370043|20168502|P4|STARTED|Overall Study||3
8179747|NCT02370043|20168503|P3|STARTED|Overall Study||3
8179748|NCT02370043|20168504|P2|STARTED|Overall Study||3
8179749|NCT02370043|20168505|P1|STARTED|Overall Study||3
8179750|NCT02370004|20168634|P1|NOT COMPLETED|Overall Study||1
8179751|NCT02370004|20168634|P1|COMPLETED|Overall Study||10
8179752|NCT02370004|20168634|P1|STARTED|Overall Study||11
8179765|NCT02369848|20168695|P1|NOT COMPLETED|Overall Study||4
8179766|NCT02369848|20168695|P1|COMPLETED|Overall Study||56
8179767|NCT02369848|20168695|P1|12 Month Primary Endpoint|Overall Study||30
8179768|NCT02369848|20168695|P1|30 Day Primary Safety Endpoint|Overall Study||58
8179769|NCT02369848|20168695|P1|STARTED|Overall Study||60
8179770|NCT02369835|20168711|P2|NOT COMPLETED|Overall Study||13
8179771|NCT02369835|20168712|P1|NOT COMPLETED|Overall Study||11
8179772|NCT02369835|20168711|P2|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55
8179773|NCT02369835|20168712|P1|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53
8179774|NCT02369835|20168711|P2|STARTED|Overall Study||68
8179775|NCT02369835|20168712|P1|STARTED|Overall Study||64
8179776|NCT02369796|20168727|P5|NOT COMPLETED|Overall Study||0
8179777|NCT02369796|20168728|P4|NOT COMPLETED|Overall Study||0
8179778|NCT02369796|20168729|P3|NOT COMPLETED|Overall Study||0
8179779|NCT02369796|20168730|P2|NOT COMPLETED|Overall Study||0
8179780|NCT02369796|20168731|P1|NOT COMPLETED|Overall Study||0
8179781|NCT02369796|20168727|P5|COMPLETED|Overall Study||3
8179782|NCT02369796|20168728|P4|COMPLETED|Overall Study||3
8179783|NCT02369796|20168729|P3|COMPLETED|Overall Study||3
8179784|NCT02369796|20168730|P2|COMPLETED|Overall Study||3
8179785|NCT02369796|20168731|P1|COMPLETED|Overall Study||3
8179786|NCT02369796|20168727|P5|STARTED|Overall Study||3
8179787|NCT02369796|20168728|P4|STARTED|Overall Study||3
8179788|NCT02369796|20168729|P3|STARTED|Overall Study||3
8179789|NCT02369796|20168730|P2|STARTED|Overall Study||3
8179790|NCT02369796|20168731|P1|STARTED|Overall Study||3
8179791|NCT02369744|20168772|P2|NOT COMPLETED|Overall Study||0
8179792|NCT02369744|20168773|P1|NOT COMPLETED|Overall Study||0
8179793|NCT02369744|20168772|P2|COMPLETED|Overall Study||0
8179794|NCT02369744|20168773|P1|COMPLETED|Overall Study||0
8179795|NCT02369744|20168772|P2|STARTED|Overall Study||0
8179796|NCT02369744|20168773|P1|STARTED|Overall Study||0
8179797|NCT02369510|20168788|P3|NOT COMPLETED|Overall Study||6
8179798|NCT02369510|20168789|P2|NOT COMPLETED|Overall Study||3
8179799|NCT02369510|20168790|P1|NOT COMPLETED|Overall Study||2
8179800|NCT02369510|20168788|P3|COMPLETED|Overall Study||17
8179801|NCT02369510|20168789|P2|COMPLETED|Overall Study||19
8179802|NCT02369510|20168790|P1|COMPLETED|Overall Study||21
8179803|NCT02369510|20168788|P3|STARTED|Overall Study||23
8179804|NCT02369510|20168789|P2|STARTED|Overall Study||22
8179805|NCT02369510|20168790|P1|STARTED|Overall Study||23
8179806|NCT02369484|20168819|P1|NOT COMPLETED|Overall Study||0
8179807|NCT02369484|20168819|P1|COMPLETED|Overall Study||13
8179808|NCT02369484|20168819|P1|STARTED|Overall Study||13
8179809|NCT02369341|20168829|P2|NOT COMPLETED|Overall Study||0
8179810|NCT02369341|20168830|P1|NOT COMPLETED|Overall Study||1
8179811|NCT02369341|20168829|P2|COMPLETED|Overall Study||57
8179812|NCT02369341|20168830|P1|COMPLETED|Overall Study||62
8179813|NCT02369341|20168829|P2|STARTED|Overall Study||57
8179814|NCT02369341|20168830|P1|STARTED|Overall Study||63
8179815|NCT02369211|20168886|P2|NOT COMPLETED|Overall Study||2
8179816|NCT02369211|20168887|P1|NOT COMPLETED|Overall Study||0
8179817|NCT02369211|20168886|P2|COMPLETED|Overall Study||41
8179818|NCT02369211|20168887|P1|COMPLETED|Overall Study||43
8179819|NCT02369211|20168886|P2|STARTED|Overall Study||43
8179820|NCT02369211|20168887|P1|STARTED|Overall Study||43
8179821|NCT02369172|20168899|P1|NOT COMPLETED|Overall Study||0
8179822|NCT02369172|20168899|P1|COMPLETED|Overall Study||24
8179823|NCT02369172|20168899|P1|STARTED|Overall Study||24
8179824|NCT02369068|20168973|P2|NOT COMPLETED|6 Months||1
8179825|NCT02369068|20168974|P1|NOT COMPLETED|6 Months||0
8179826|NCT02369068|20168973|P2|COMPLETED|6 Months||7
8179827|NCT02369068|20168974|P1|COMPLETED|6 Months||9
8179828|NCT02369068|20168973|P2|STARTED|6 Months||8
8179829|NCT02369068|20168974|P1|STARTED|6 Months||9
8179830|NCT02369068|20168973|P2|NOT COMPLETED|3 Months||2
8179831|NCT02369068|20168974|P1|NOT COMPLETED|3 Months||0
8179832|NCT02369068|20168973|P2|COMPLETED|3 Months||8
8179833|NCT02369068|20168974|P1|COMPLETED|3 Months||9
8179834|NCT02369068|20168973|P2|STARTED|3 Months||10
8179835|NCT02369068|20168974|P1|STARTED|3 Months||9
8179836|NCT02369068|20168973|P2|NOT COMPLETED|1 Month||1
8179837|NCT02369068|20168974|P1|NOT COMPLETED|1 Month||1
8179838|NCT02369068|20168973|P2|COMPLETED|1 Month||10
8179839|NCT02369068|20168974|P1|COMPLETED|1 Month||9
8179840|NCT02369068|20168973|P2|STARTED|1 Month||11
8179841|NCT02369068|20168974|P1|STARTED|1 Month||10
8179854|NCT02368691|20169027|P1|NOT COMPLETED|Overall Study||32
8179855|NCT02368691|20169027|P1|COMPLETED|Overall Study||0
8179856|NCT02368691|20169027|P1|STARTED|Overall Study|32 subjects were enrolled and received at least one dose of study drug|32
8179857|NCT02368457|20169040|P2|NOT COMPLETED|Overall Study||0
8179858|NCT02368457|20169041|P1|NOT COMPLETED|Overall Study||0
8179859|NCT02368457|20169040|P2|COMPLETED|Overall Study||12
8179860|NCT02368457|20169041|P1|COMPLETED|Overall Study||12
8179861|NCT02368457|20169040|P2|STARTED|Overall Study||12
8179862|NCT02368457|20169041|P1|STARTED|Overall Study||12
8179863|NCT02368431|20169051|P2|NOT COMPLETED|Overall Study||19
8179864|NCT02368431|20169052|P1|NOT COMPLETED|Overall Study||24
8179865|NCT02368431|20169051|P2|COMPLETED|Overall Study||27
8179866|NCT02368431|20169052|P1|COMPLETED|Overall Study||22
8179867|NCT02368431|20169051|P2|STARTED|Overall Study||46
8179868|NCT02368431|20169052|P1|STARTED|Overall Study||46
8179869|NCT02368314|20169072|P2|NOT COMPLETED|Overall Study||3
8179870|NCT02368314|20169073|P1|NOT COMPLETED|Overall Study||3
8179871|NCT02368314|20169072|P2|COMPLETED|Overall Study||57
8179872|NCT02368314|20169073|P1|COMPLETED|Overall Study||61
8179873|NCT02368314|20169072|P2|STARTED|Overall Study||60
8179874|NCT02368314|20169073|P1|STARTED|Overall Study||64
8179875|NCT02368210|20169085|P2|NOT COMPLETED|Overall Study||1
8179876|NCT02368210|20169086|P1|NOT COMPLETED|Overall Study||1
8179877|NCT02368210|20169085|P2|COMPLETED|Overall Study||75
8179878|NCT02368210|20169086|P1|COMPLETED|Overall Study||74
8179879|NCT02368210|20169085|P2|STARTED|Overall Study||76
8179880|NCT02368210|20169086|P1|STARTED|Overall Study||75
8179881|NCT02368093|20169104|P2|NOT COMPLETED|Overall Study||0
8179882|NCT02368093|20169105|P1|NOT COMPLETED|Overall Study||0
8179883|NCT02368093|20169104|P2|COMPLETED|Overall Study||24
8179884|NCT02368093|20169105|P1|COMPLETED|Overall Study||24
8179885|NCT02368093|20169104|P2|STARTED|Overall Study||24
8179886|NCT02368093|20169105|P1|STARTED|Overall Study||24
8179887|NCT02367911|20169113|P2|NOT COMPLETED|Overall Study||4
8179888|NCT02367911|20169114|P1|NOT COMPLETED|Overall Study||5
8179889|NCT02367911|20169113|P2|COMPLETED|Overall Study||69
8179890|NCT02367911|20169114|P1|COMPLETED|Overall Study||66
8179891|NCT02367911|20169113|P2|STARTED|Overall Study||73
8179892|NCT02367911|20169114|P1|STARTED|Overall Study||71
8179893|NCT02367885|20169125|P3|NOT COMPLETED|Overall Study||0
8179894|NCT02367885|20169126|P2|NOT COMPLETED|Overall Study||0
8179895|NCT02367885|20169127|P1|NOT COMPLETED|Overall Study||2
8179896|NCT02367885|20169125|P3|COMPLETED|Overall Study||33
8179897|NCT02367885|20169126|P2|COMPLETED|Overall Study||33
8179898|NCT02367885|20169127|P1|COMPLETED|Overall Study||31
8179899|NCT02367885|20169125|P3|STARTED|Overall Study||33
8179900|NCT02367885|20169126|P2|STARTED|Overall Study||33
8179901|NCT02367885|20169127|P1|STARTED|Overall Study||33
8179902|NCT02367872|20169200|P8|NOT COMPLETED|Overall Study||0
8179903|NCT02367872|20169201|P7|NOT COMPLETED|Overall Study||0
8179904|NCT02367872|20169202|P6|NOT COMPLETED|Overall Study||0
8179905|NCT02367872|20169203|P5|NOT COMPLETED|Overall Study||0
8179906|NCT02367872|20169204|P4|NOT COMPLETED|Overall Study||0
8179907|NCT02367872|20169205|P3|NOT COMPLETED|Overall Study||0
8179908|NCT02367872|20169206|P2|NOT COMPLETED|Overall Study||0
8179909|NCT02367872|20169207|P1|NOT COMPLETED|Overall Study||0
8179910|NCT02367872|20169200|P8|COMPLETED|Overall Study||6
8179911|NCT02367872|20169201|P7|COMPLETED|Overall Study||6
8179912|NCT02367872|20169202|P6|COMPLETED|Overall Study||6
8179913|NCT02367872|20169203|P5|COMPLETED|Overall Study||6
8179914|NCT02367872|20169204|P4|COMPLETED|Overall Study||6
8179915|NCT02367872|20169205|P3|COMPLETED|Overall Study||6
8179916|NCT02367872|20169206|P2|COMPLETED|Overall Study||6
8179917|NCT02367872|20169207|P1|COMPLETED|Overall Study||6
8179918|NCT02367872|20169200|P8|STARTED|Overall Study||6
8179919|NCT02367872|20169201|P7|STARTED|Overall Study||6
8179920|NCT02367872|20169202|P6|STARTED|Overall Study||6
8179921|NCT02367872|20169203|P5|STARTED|Overall Study||6
8179922|NCT02367872|20169204|P4|STARTED|Overall Study||6
8179923|NCT02367872|20169205|P3|STARTED|Overall Study||6
8179924|NCT02367872|20169206|P2|STARTED|Overall Study||6
8179925|NCT02367872|20169207|P1|STARTED|Overall Study||6
8179926|NCT02367859|20169360|P1|NOT COMPLETED|Overall Study||0
8179927|NCT02367859|20169360|P1|COMPLETED|Overall Study||1
8179928|NCT02367859|20169360|P1|STARTED|Overall Study||1
8179929|NCT02367833|20169370|P3|NOT COMPLETED|Overall Study||0
8179930|NCT02367833|20169371|P2|NOT COMPLETED|Overall Study||1
8179931|NCT02367833|20169372|P1|NOT COMPLETED|Overall Study||1
8179932|NCT02367833|20169370|P3|COMPLETED|Overall Study||8
8179933|NCT02367833|20169371|P2|COMPLETED|Overall Study||8
8179934|NCT02367833|20169372|P1|COMPLETED|Overall Study||8
8179935|NCT02367833|20169370|P3|STARTED|Overall Study||8
8179936|NCT02367833|20169371|P2|STARTED|Overall Study||9
8179937|NCT02367833|20169372|P1|STARTED|Overall Study||9
8179956|NCT02367729|20169437|P2|NOT COMPLETED|Overall Study||8
8179957|NCT02367729|20169438|P1|NOT COMPLETED|Overall Study||3
8179958|NCT02367729|20169437|P2|COMPLETED|Overall Study||47
8179959|NCT02367729|20169438|P1|COMPLETED|Overall Study||57
8179960|NCT02367729|20169437|P2|STARTED|Overall Study||55
8179961|NCT02367729|20169438|P1|STARTED|Overall Study||60
8179962|NCT02367716|20169454|P1|NOT COMPLETED|Overall Study||1
8179963|NCT02367716|20169454|P1|COMPLETED|Overall Study||120
8179964|NCT02367716|20169454|P1|STARTED|Overall Study||121
8179965|NCT02367599|20169463|P2|NOT COMPLETED|Overall Study||0
8179966|NCT02367599|20169464|P1|NOT COMPLETED|Overall Study||0
8179967|NCT02367599|20169463|P2|COMPLETED|Overall Study||48
8179968|NCT02367599|20169464|P1|COMPLETED|Overall Study||48
8179969|NCT02367599|20169463|P2|STARTED|Overall Study||48
8179970|NCT02367599|20169464|P1|STARTED|Overall Study||48
8179971|NCT02367521|20169478|P2|NOT COMPLETED|Overall Study||0
8179972|NCT02367521|20169479|P1|NOT COMPLETED|Overall Study||4
8179973|NCT02367521|20169478|P2|COMPLETED|Overall Study||17
8179974|NCT02367521|20169479|P1|COMPLETED|Overall Study||13
8179975|NCT02367521|20169478|P2|STARTED|Overall Study||17
8179976|NCT02367521|20169479|P1|STARTED|Overall Study||17
8179977|NCT02367430|20169531|P1|NOT COMPLETED|Overall Study||3
8179978|NCT02367430|20169531|P1|COMPLETED|Overall Study||11
8179979|NCT02367430|20169531|P1|STARTED|Overall Study||14
8179980|NCT02367391|20169538|P2|NOT COMPLETED|Overall Study||0
8179981|NCT02367391|20169539|P1|NOT COMPLETED|Overall Study||2
8179982|NCT02367391|20169538|P2|COMPLETED|Overall Study||76
8179983|NCT02367391|20169539|P1|COMPLETED|Overall Study||74
8179984|NCT02367391|20169538|P2|STARTED|Overall Study||76
8179985|NCT02367391|20169539|P1|STARTED|Overall Study||76
8179986|NCT02367352|20169557|P3|NOT COMPLETED|Overall Study||0
8179987|NCT02367352|20169558|P2|NOT COMPLETED|Overall Study||0
8179988|NCT02367352|20169559|P1|NOT COMPLETED|Overall Study||9
8179989|NCT02367352|20169557|P3|COMPLETED|Overall Study||0
8179990|NCT02367352|20169558|P2|COMPLETED|Overall Study||0
8179991|NCT02367352|20169559|P1|COMPLETED|Overall Study||0
8179992|NCT02367352|20169557|P3|STARTED|Overall Study||0
8179993|NCT02367352|20169558|P2|STARTED|Overall Study||0
8179994|NCT02367352|20169559|P1|STARTED|Overall Study||9
8179995|NCT02367170|20169598|P2|NOT COMPLETED|Overall Study||0
8179996|NCT02367170|20169599|P1|NOT COMPLETED|Overall Study||0
8179997|NCT02367170|20169598|P2|COMPLETED|Overall Study||0
8179998|NCT02367170|20169599|P1|COMPLETED|Overall Study||1
8179999|NCT02367170|20169598|P2|STARTED|Overall Study||0
8180000|NCT02367170|20169599|P1|STARTED|Overall Study||1
8180001|NCT02367131|20169609|P1|NOT COMPLETED|Overall Study||222
8180002|NCT02367131|20169609|P1|COMPLETED|Overall Study||201
8180003|NCT02367131|20169609|P1|STARTED|Overall Study|Started are the treated patients|423
8180010|NCT02367066|20169686|P2|NOT COMPLETED|Overall Study||0
8180011|NCT02367066|20169687|P1|NOT COMPLETED|Overall Study||0
8180012|NCT02367066|20169686|P2|COMPLETED|Overall Study||10
8180013|NCT02367066|20169687|P1|COMPLETED|Overall Study||10
8180014|NCT02367066|20169686|P2|STARTED|Overall Study||10
8180015|NCT02367066|20169687|P1|STARTED|Overall Study||10
8180016|NCT02367014|20169749|P4|NOT COMPLETED|Overall Study||0
8180017|NCT02367014|20169750|P3|NOT COMPLETED|Overall Study||0
8180018|NCT02367014|20169751|P2|NOT COMPLETED|Overall Study||0
8180019|NCT02367014|20169752|P1|NOT COMPLETED|Overall Study||0
8180020|NCT02367014|20169749|P4|COMPLETED|Overall Study||9
8180021|NCT02367014|20169750|P3|COMPLETED|Overall Study||9
8180022|NCT02367014|20169751|P2|COMPLETED|Overall Study||9
8180023|NCT02367014|20169752|P1|COMPLETED|Overall Study||9
8180024|NCT02367014|20169749|P4|STARTED|Overall Study||9
8180025|NCT02367014|20169750|P3|STARTED|Overall Study||9
8180026|NCT02367014|20169751|P2|STARTED|Overall Study||9
8180027|NCT02367014|20169752|P1|STARTED|Overall Study||9
8180028|NCT02366936|20169870|P1|NOT COMPLETED|Overall Study||8
8180029|NCT02366936|20169870|P1|COMPLETED|Overall Study||24
8180030|NCT02366936|20169870|P1|STARTED|Overall Study||32
8180031|NCT02366923|20169875|P1|NOT COMPLETED|Overall Study||6
8180032|NCT02366923|20169875|P1|COMPLETED|Overall Study||22
8180033|NCT02366923|20169875|P1|STARTED|Overall Study||28
8180034|NCT02366910|20169888|P1|NOT COMPLETED|Overall Study||5
8180035|NCT02366910|20169888|P1|COMPLETED|Overall Study||21
8180036|NCT02366910|20169888|P1|STARTED|Overall Study||26
8180037|NCT02366871|20169902|P2|NOT COMPLETED|Overall Study||0
8180038|NCT02366871|20169903|P1|NOT COMPLETED|Overall Study||0
8180039|NCT02366871|20169902|P2|COMPLETED|Overall Study||196
8180040|NCT02366871|20169903|P1|COMPLETED|Overall Study||204
8180041|NCT02366871|20169902|P2|STARTED|Overall Study||196
8180042|NCT02366871|20169903|P1|STARTED|Overall Study||204
8180043|NCT02366845|20169921|P2|NOT COMPLETED|Overall Study||0
8180044|NCT02366845|20169922|P1|NOT COMPLETED|Overall Study||0
8180045|NCT02366845|20169921|P2|COMPLETED|Overall Study||25
8180046|NCT02366845|20169922|P1|COMPLETED|Overall Study||25
8180047|NCT02366845|20169921|P2|STARTED|Overall Study||25
8180048|NCT02366845|20169922|P1|STARTED|Overall Study||25
8180049|NCT02366767|20169936|P2|NOT COMPLETED|Overall Study||0
8180050|NCT02366767|20169937|P1|NOT COMPLETED|Overall Study||1
8180051|NCT02366767|20169936|P2|COMPLETED|Overall Study||10
8180052|NCT02366767|20169937|P1|COMPLETED|Overall Study||10
8180053|NCT02366767|20169936|P2|STARTED|Overall Study||10
8180054|NCT02366767|20169937|P1|STARTED|Overall Study||11
8180055|NCT02366689|20169950|P3|NOT COMPLETED|Overall Study||2
8180056|NCT02366689|20169951|P2|NOT COMPLETED|Overall Study||3
8180057|NCT02366689|20169952|P1|NOT COMPLETED|Overall Study||4
8180058|NCT02366689|20169950|P3|COMPLETED|Overall Study||59
8180059|NCT02366689|20169951|P2|COMPLETED|Overall Study||55
8180060|NCT02366689|20169952|P1|COMPLETED|Overall Study||56
8180061|NCT02366689|20169950|P3|STARTED|Overall Study||61
8180062|NCT02366689|20169951|P2|STARTED|Overall Study||58
8180063|NCT02366689|20169952|P1|STARTED|Overall Study||60
8180064|NCT02366663|20169977|P2|NOT COMPLETED|Overall Study||0
8180065|NCT02366663|20169978|P1|NOT COMPLETED|Overall Study||0
8180066|NCT02366663|20169977|P2|COMPLETED|Overall Study||1
8180067|NCT02366663|20169978|P1|COMPLETED|Overall Study||2
8180068|NCT02366663|20169977|P2|STARTED|Overall Study||1
8180069|NCT02366663|20169978|P1|STARTED|Overall Study||2
8180070|NCT02366637|20170004|P2|NOT COMPLETED|Second Intervention Period||1
8180071|NCT02366637|20170005|P1|NOT COMPLETED|Second Intervention Period||1
8180072|NCT02366637|20170004|P2|COMPLETED|Second Intervention Period||0
8180073|NCT02366637|20170005|P1|COMPLETED|Second Intervention Period||0
8180074|NCT02366637|20170004|P2|STARTED|Second Intervention Period||1
8180075|NCT02366637|20170005|P1|STARTED|Second Intervention Period||1
8180076|NCT02366637|20170004|P2|NOT COMPLETED|Washout Period 28 to 49 Days||0
8180077|NCT02366637|20170005|P1|NOT COMPLETED|Washout Period 28 to 49 Days||0
8180078|NCT02366637|20170004|P2|COMPLETED|Washout Period 28 to 49 Days||1
8180079|NCT02366637|20170005|P1|COMPLETED|Washout Period 28 to 49 Days||1
8180080|NCT02366637|20170004|P2|STARTED|Washout Period 28 to 49 Days||1
8180081|NCT02366637|20170005|P1|STARTED|Washout Period 28 to 49 Days||1
8180082|NCT02366637|20170004|P2|NOT COMPLETED|First Intervention Period||5
8180083|NCT02366637|20170005|P1|NOT COMPLETED|First Intervention Period||6
8180084|NCT02366637|20170004|P2|COMPLETED|First Intervention Period||1
8180085|NCT02366637|20170005|P1|COMPLETED|First Intervention Period||1
8180086|NCT02366637|20170004|P2|STARTED|First Intervention Period||6
8180087|NCT02366637|20170005|P1|STARTED|First Intervention Period||7
8180088|NCT02366611|20170031|P2|NOT COMPLETED|Overall Study||0
8180089|NCT02366611|20170032|P1|NOT COMPLETED|Overall Study||2
8180090|NCT02366611|20170031|P2|COMPLETED|Overall Study||1
8180091|NCT02366611|20170032|P1|COMPLETED|Overall Study||8
8180092|NCT02366611|20170031|P2|STARTED|Overall Study||1
8180093|NCT02366611|20170032|P1|STARTED|Overall Study||10
8180094|NCT02366468|20170053|P2|NOT COMPLETED|Overall Study||9
8180095|NCT02366468|20170054|P1|NOT COMPLETED|Overall Study||6
8180096|NCT02366468|20170053|P2|COMPLETED|Overall Study||58
8180097|NCT02366468|20170054|P1|COMPLETED|Overall Study||62
8180098|NCT02366468|20170053|P2|Per Protocol Set (PPS)|Overall Study||61
8180099|NCT02366468|20170054|P1|Per Protocol Set (PPS)|Overall Study||62
8180100|NCT02366468|20170053|P2|Full Analysis Set (FAS)|Overall Study||66
8180101|NCT02366468|20170054|P1|Full Analysis Set (FAS)|Overall Study||67
8180102|NCT02366468|20170053|P2|STARTED|Overall Study||67
8180103|NCT02366468|20170054|P1|STARTED|Overall Study||68
8180104|NCT02366338|20170075|P3|NOT COMPLETED|Overall Study||0
8180105|NCT02366338|20170076|P2|NOT COMPLETED|Overall Study||0
8180106|NCT02366338|20170077|P1|NOT COMPLETED|Overall Study||0
8180107|NCT02366338|20170075|P3|COMPLETED|Overall Study||36
8180108|NCT02366338|20170076|P2|COMPLETED|Overall Study||39
8180109|NCT02366338|20170077|P1|COMPLETED|Overall Study||73
8180110|NCT02366338|20170075|P3|STARTED|Overall Study||36
8180111|NCT02366338|20170076|P2|STARTED|Overall Study||39
8180112|NCT02366338|20170077|P1|STARTED|Overall Study||73
8180126|NCT02365961|20170173|P2|NOT COMPLETED|Overall Study||0
8180127|NCT02365961|20170174|P1|NOT COMPLETED|Overall Study||0
8180128|NCT02365961|20170173|P2|COMPLETED|Overall Study||43
8180129|NCT02365961|20170174|P1|COMPLETED|Overall Study||41
8180130|NCT02365961|20170173|P2|STARTED|Overall Study||43
8180131|NCT02365961|20170174|P1|STARTED|Overall Study||41
8180132|NCT02365870|20170190|P2|NOT COMPLETED|Overall Study||0
8180133|NCT02365870|20170191|P1|NOT COMPLETED|Overall Study||0
8180134|NCT02365870|20170190|P2|COMPLETED|Overall Study||3
8180135|NCT02365870|20170191|P1|COMPLETED|Overall Study||1
8180136|NCT02365870|20170190|P2|STARTED|Overall Study||3
8180137|NCT02365870|20170191|P1|STARTED|Overall Study||1
8180138|NCT02365714|20170199|P1|NOT COMPLETED|Overall Study||0
8180139|NCT02365714|20170199|P1|COMPLETED|Overall Study||2
8180140|NCT02365714|20170199|P1|STARTED|Overall Study||2
8180141|NCT02365688|20170205|P1|NOT COMPLETED|Overall Study||0
8180142|NCT02365688|20170205|P1|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
8180143|NCT02365688|20170205|P1|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
8180144|NCT02365636|20170212|P3|NOT COMPLETED|Overall Study||3
8180145|NCT02365636|20170213|P2|NOT COMPLETED|Overall Study||7
8180146|NCT02365636|20170214|P1|NOT COMPLETED|Overall Study||6
8180147|NCT02365636|20170212|P3|COMPLETED|Overall Study||97
8180148|NCT02365636|20170213|P2|COMPLETED|Overall Study||93
8180149|NCT02365636|20170214|P1|COMPLETED|Overall Study||94
8180150|NCT02365636|20170212|P3|Full Analysis Set|Overall Study||100
8180151|NCT02365636|20170213|P2|Full Analysis Set|Overall Study||98
8180152|NCT02365636|20170214|P1|Full Analysis Set|Overall Study||100
8180153|NCT02365636|20170212|P3|Safety Population|Overall Study||100
8180154|NCT02365636|20170213|P2|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
8180155|NCT02365636|20170214|P1|Safety Population|Overall Study||100
8180156|NCT02365636|20170212|P3|STARTED|Overall Study||100
8180157|NCT02365636|20170213|P2|STARTED|Overall Study||100
8180158|NCT02365636|20170214|P1|STARTED|Overall Study||100
8180159|NCT02365584|20170260|P2|NOT COMPLETED|Overall Study||14
8180160|NCT02365584|20170261|P1|NOT COMPLETED|Overall Study||12
8180161|NCT02365584|20170260|P2|COMPLETED|Overall Study||8
8180162|NCT02365584|20170261|P1|COMPLETED|Overall Study||9
8180163|NCT02365584|20170260|P2|STARTED|Overall Study||22
8180164|NCT02365584|20170261|P1|STARTED|Overall Study||21
8180165|NCT02365558|20170285|P2|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
8180166|NCT02365558|20170286|P1|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
8180167|NCT02365558|20170285|P2|COMPLETED|Period 2 (Day 8 Through Day 20)||32
8180168|NCT02365558|20170286|P1|COMPLETED|Period 2 (Day 8 Through Day 20)||0
8180169|NCT02365558|20170285|P2|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
8180170|NCT02365558|20170286|P1|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
8180171|NCT02365558|20170285|P2|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
8180172|NCT02365558|20170286|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
8180173|NCT02365558|20170285|P2|COMPLETED|Period 1 (Day 1 Through Day 7)||0
8180174|NCT02365558|20170286|P1|COMPLETED|Period 1 (Day 1 Through Day 7)||33
8180175|NCT02365558|20170285|P2|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
8180176|NCT02365558|20170286|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
8180177|NCT02365558|20170285|P2|STARTED|Period 1 (Day 1 Through Day 7)||0
8180178|NCT02365558|20170286|P1|STARTED|Period 1 (Day 1 Through Day 7)||34
8180179|NCT02365519|20170299|P3|NOT COMPLETED|Randomized and Treated||1
8180180|NCT02365519|20170300|P2|NOT COMPLETED|Randomized and Treated||2
8180181|NCT02365519|20170301|P1|NOT COMPLETED|Randomized and Treated||0
8180182|NCT02365519|20170299|P3|COMPLETED|Randomized and Treated||64
8180183|NCT02365519|20170300|P2|COMPLETED|Randomized and Treated||67
8180184|NCT02365519|20170301|P1|COMPLETED|Randomized and Treated||0
8180185|NCT02365519|20170299|P3|STARTED|Randomized and Treated||65
8180186|NCT02365519|20170300|P2|STARTED|Randomized and Treated||69
8180187|NCT02365519|20170301|P1|STARTED|Randomized and Treated||0
8180188|NCT02365519|20170299|P3|NOT COMPLETED|Vehicle Run-In||0
8180189|NCT02365519|20170300|P2|NOT COMPLETED|Vehicle Run-In||0
8180190|NCT02365519|20170301|P1|NOT COMPLETED|Vehicle Run-In||79
8180191|NCT02365519|20170299|P3|COMPLETED|Vehicle Run-In||0
8180192|NCT02365519|20170300|P2|COMPLETED|Vehicle Run-In||0
8180193|NCT02365519|20170301|P1|COMPLETED|Vehicle Run-In||134
8180194|NCT02365519|20170299|P3|STARTED|Vehicle Run-In||0
8180195|NCT02365519|20170300|P2|STARTED|Vehicle Run-In||0
8180196|NCT02365519|20170301|P1|STARTED|Vehicle Run-In||213
8180197|NCT02365506|20170325|P3|NOT COMPLETED|Overall Study||1
8180198|NCT02365506|20170326|P2|NOT COMPLETED|Overall Study||0
8180199|NCT02365506|20170327|P1|NOT COMPLETED|Overall Study||0
8180200|NCT02365506|20170325|P3|COMPLETED|Overall Study||4
8180201|NCT02365506|20170326|P2|COMPLETED|Overall Study||4
8180202|NCT02365506|20170327|P1|COMPLETED|Overall Study||4
8180203|NCT02365506|20170325|P3|STARTED|Overall Study||5
8180204|NCT02365506|20170326|P2|STARTED|Overall Study||4
8180205|NCT02365506|20170327|P1|STARTED|Overall Study||4
8180206|NCT02365298|20170356|P2|NOT COMPLETED|Period 2||2
8180207|NCT02365298|20170357|P1|NOT COMPLETED|Period 2||2
8180208|NCT02365298|20170356|P2|COMPLETED|Period 2||12
8180209|NCT02365298|20170357|P1|COMPLETED|Period 2||12
8180210|NCT02365298|20170356|P2|STARTED|Period 2||14
8180211|NCT02365298|20170357|P1|STARTED|Period 2||14
8180212|NCT02365298|20170356|P2|NOT COMPLETED|Period 1||0
8180213|NCT02365298|20170357|P1|NOT COMPLETED|Period 1||0
8180214|NCT02365298|20170356|P2|COMPLETED|Period 1||14
8180215|NCT02365298|20170357|P1|COMPLETED|Period 1||14
8180216|NCT02365298|20170356|P2|STARTED|Period 1||14
8180217|NCT02365298|20170357|P1|STARTED|Period 1||14
8180218|NCT02365285|20170377|P4|NOT COMPLETED|Overall Study||2
8180219|NCT02365285|20170378|P3|NOT COMPLETED|Overall Study||1
8180220|NCT02365285|20170379|P2|NOT COMPLETED|Overall Study||1
8180221|NCT02365285|20170380|P1|NOT COMPLETED|Overall Study||0
8180222|NCT02365285|20170377|P4|COMPLETED|Overall Study||1
8180223|NCT02365285|20170378|P3|COMPLETED|Overall Study||6
8180224|NCT02365285|20170379|P2|COMPLETED|Overall Study||5
8180225|NCT02365285|20170380|P1|COMPLETED|Overall Study||7
8180226|NCT02365285|20170377|P4|STARTED|Overall Study||3
8180227|NCT02365285|20170378|P3|STARTED|Overall Study||7
8180228|NCT02365285|20170379|P2|STARTED|Overall Study||6
8180229|NCT02365285|20170380|P1|STARTED|Overall Study||7
8180230|NCT02365233|20170397|P3|NOT COMPLETED|Overall Study||2
8180231|NCT02365233|20170398|P2|NOT COMPLETED|Overall Study||2
8180232|NCT02365233|20170399|P1|NOT COMPLETED|Overall Study||1
8180233|NCT02365233|20170397|P3|COMPLETED|Overall Study||0
8180234|NCT02365233|20170398|P2|COMPLETED|Overall Study||0
8180235|NCT02365233|20170399|P1|COMPLETED|Overall Study||0
8180236|NCT02365233|20170397|P3|STARTED|Overall Study||2
8180237|NCT02365233|20170398|P2|STARTED|Overall Study||2
8180238|NCT02365233|20170399|P1|STARTED|Overall Study||1
8180239|NCT02365207|20170407|P1|NOT COMPLETED|Overall Study||2
8180240|NCT02365207|20170407|P1|COMPLETED|Overall Study||4
8180241|NCT02365207|20170407|P1|STARTED|Overall Study||6
8180242|NCT02364999|20170413|P2|NOT COMPLETED|Overall Study||173
8180243|NCT02364999|20170414|P1|NOT COMPLETED|Overall Study||165
8180244|NCT02364999|20170413|P2|COMPLETED|Overall Study||188
8180245|NCT02364999|20170414|P1|COMPLETED|Overall Study||193
8180246|NCT02364999|20170413|P2|Received Treatment|Overall Study||358
8180247|NCT02364999|20170414|P1|Received Treatment|Overall Study||356
8180248|NCT02364999|20170413|P2|STARTED|Overall Study||361
8180249|NCT02364999|20170414|P1|STARTED|Overall Study||358
8180250|NCT02364947|20170440|P3|NOT COMPLETED|Overall Study||26
8180251|NCT02364947|20170441|P2|NOT COMPLETED|Overall Study||45
8180252|NCT02364947|20170442|P1|NOT COMPLETED|Overall Study||59
8180253|NCT02364947|20170440|P3|COMPLETED|Overall Study||219
8180254|NCT02364947|20170441|P2|COMPLETED|Overall Study||139
8180255|NCT02364947|20170442|P1|COMPLETED|Overall Study||189
8180256|NCT02364947|20170440|P3|STARTED|Overall Study||245
8180257|NCT02364947|20170441|P2|STARTED|Overall Study||184
8180258|NCT02364947|20170442|P1|STARTED|Overall Study||248
8180259|NCT02364778|20170509|P1|NOT COMPLETED|Overall Study||0
8180260|NCT02364778|20170509|P1|COMPLETED|Overall Study||30
8180261|NCT02364778|20170509|P1|STARTED|Overall Study||30
8180262|NCT02364700|20170521|P1|NOT COMPLETED|Overall Study||0
8180263|NCT02364700|20170521|P1|COMPLETED|Overall Study||12
8180264|NCT02364700|20170521|P1|STARTED|Overall Study||12
8180265|NCT02364570|20170530|P16|NOT COMPLETED|Overall Study||0
8180266|NCT02364570|20170531|P15|NOT COMPLETED|Overall Study||0
8180267|NCT02364570|20170532|P14|NOT COMPLETED|Overall Study||0
8180268|NCT02364570|20170533|P13|NOT COMPLETED|Overall Study||0
8180269|NCT02364570|20170534|P12|NOT COMPLETED|Overall Study||0
8180270|NCT02364570|20170535|P11|NOT COMPLETED|Overall Study||0
8180271|NCT02364570|20170536|P10|NOT COMPLETED|Overall Study||0
8180272|NCT02364570|20170537|P9|NOT COMPLETED|Overall Study||0
8180273|NCT02364570|20170538|P8|NOT COMPLETED|Overall Study||0
8180274|NCT02364570|20170539|P7|NOT COMPLETED|Overall Study||0
8180275|NCT02364570|20170540|P6|NOT COMPLETED|Overall Study||0
8180276|NCT02364570|20170541|P5|NOT COMPLETED|Overall Study||0
8180277|NCT02364570|20170542|P4|NOT COMPLETED|Overall Study||0
8180278|NCT02364570|20170543|P3|NOT COMPLETED|Overall Study||0
8180279|NCT02364570|20170544|P2|NOT COMPLETED|Overall Study||0
8180280|NCT02364570|20170545|P1|NOT COMPLETED|Overall Study||0
8180281|NCT02364570|20170530|P16|COMPLETED|Overall Study||1
8180282|NCT02364570|20170531|P15|COMPLETED|Overall Study||1
8180283|NCT02364570|20170532|P14|COMPLETED|Overall Study||2
8180284|NCT02364570|20170533|P13|COMPLETED|Overall Study||1
8180285|NCT02364570|20170534|P12|COMPLETED|Overall Study||1
8180286|NCT02364570|20170535|P11|COMPLETED|Overall Study||1
8180287|NCT02364570|20170536|P10|COMPLETED|Overall Study||1
8180288|NCT02364570|20170537|P9|COMPLETED|Overall Study||2
8180289|NCT02364570|20170538|P8|COMPLETED|Overall Study||1
8180290|NCT02364570|20170539|P7|COMPLETED|Overall Study||2
8180291|NCT02364570|20170540|P6|COMPLETED|Overall Study||1
8180292|NCT02364570|20170541|P5|COMPLETED|Overall Study||1
8180293|NCT02364570|20170542|P4|COMPLETED|Overall Study||1
8180294|NCT02364570|20170543|P3|COMPLETED|Overall Study||2
8180295|NCT02364570|20170544|P2|COMPLETED|Overall Study||1
8180296|NCT02364570|20170545|P1|COMPLETED|Overall Study||1
8180297|NCT02364570|20170530|P16|STARTED|Overall Study||1
8180298|NCT02364570|20170531|P15|STARTED|Overall Study||1
8180299|NCT02364570|20170532|P14|STARTED|Overall Study||2
8180300|NCT02364570|20170533|P13|STARTED|Overall Study||1
8180301|NCT02364570|20170534|P12|STARTED|Overall Study||1
8180302|NCT02364570|20170535|P11|STARTED|Overall Study||1
8180303|NCT02364570|20170536|P10|STARTED|Overall Study||1
8180304|NCT02364570|20170537|P9|STARTED|Overall Study||2
8180305|NCT02364570|20170538|P8|STARTED|Overall Study||1
8180306|NCT02364570|20170539|P7|STARTED|Overall Study||2
8180307|NCT02364570|20170540|P6|STARTED|Overall Study||1
8180308|NCT02364570|20170541|P5|STARTED|Overall Study||1
8180309|NCT02364570|20170542|P4|STARTED|Overall Study||1
8180310|NCT02364570|20170543|P3|STARTED|Overall Study||2
8180311|NCT02364570|20170544|P2|STARTED|Overall Study||1
8180312|NCT02364570|20170545|P1|STARTED|Overall Study||1
8180313|NCT02364388|20170611|P1|NOT COMPLETED|Overall Study||8
8180314|NCT02364388|20170611|P1|COMPLETED|Overall Study||209
8180315|NCT02364388|20170611|P1|Excluded|Overall Study||8
8180316|NCT02364388|20170611|P1|Biopsied|Overall Study||209
8180317|NCT02364388|20170611|P1|STARTED|Overall Study||217
8180318|NCT02364336|20170618|P2|NOT COMPLETED|Overall Study||1
8180319|NCT02364336|20170619|P1|NOT COMPLETED|Overall Study||0
8180320|NCT02364336|20170618|P2|COMPLETED|Overall Study||11
8180321|NCT02364336|20170619|P1|COMPLETED|Overall Study||1
8180322|NCT02364336|20170618|P2|48 Weeks After End of Peginterferon|Overall Study||10
8180323|NCT02364336|20170619|P1|48 Weeks After End of Peginterferon|Overall Study||1
8180324|NCT02364336|20170618|P2|24 Weeks After End of Peginterferon|Overall Study||11
8180325|NCT02364336|20170619|P1|24 Weeks After End of Peginterferon|Overall Study||1
8180326|NCT02364336|20170618|P2|End of Peginterferon Treatment|Overall Study||11
8180327|NCT02364336|20170619|P1|End of Peginterferon Treatment|Overall Study||1
8180328|NCT02364336|20170618|P2|6 Hours Post First Peginterferon Inject|Overall Study||12
8180329|NCT02364336|20170619|P1|6 Hours Post First Peginterferon Inject|Overall Study||1
8180330|NCT02364336|20170618|P2|STARTED|Overall Study||12
8180331|NCT02364336|20170619|P1|STARTED|Overall Study||1
8180332|NCT02364180|20170632|P1|NOT COMPLETED|Overall Study||1
8180333|NCT02364180|20170632|P1|COMPLETED|Overall Study||10
8180334|NCT02364180|20170632|P1|STARTED|Overall Study||11
8180335|NCT02364076|20170636|P1|NOT COMPLETED|Overall Study||5
8180336|NCT02364076|20170636|P1|COMPLETED|Overall Study||40
8180337|NCT02364076|20170636|P1|STARTED|Overall Study||45
8180338|NCT02364037|20170645|P2|NOT COMPLETED|Overall Study||53
8180339|NCT02364037|20170646|P1|NOT COMPLETED|Overall Study||44
8180340|NCT02364037|20170645|P2|COMPLETED|Overall Study||453
8180341|NCT02364037|20170646|P1|COMPLETED|Overall Study||458
8180342|NCT02364037|20170645|P2|STARTED|Overall Study||506
8180343|NCT02364037|20170646|P1|STARTED|Overall Study||502
8180347|NCT02363959|20170679|P2|NOT COMPLETED|Overall Study||0
8180348|NCT02363959|20170680|P1|NOT COMPLETED|Overall Study||1
8180349|NCT02363959|20170679|P2|COMPLETED|Overall Study||10
8180350|NCT02363959|20170680|P1|COMPLETED|Overall Study||9
8180351|NCT02363959|20170679|P2|STARTED|Overall Study||10
8180352|NCT02363959|20170680|P1|STARTED|Overall Study||10
8180353|NCT02363946|20170709|P13|NOT COMPLETED|Overall Study||0
8180354|NCT02363946|20170710|P12|NOT COMPLETED|Overall Study||0
8180355|NCT02363946|20170711|P11|NOT COMPLETED|Overall Study||0
8180356|NCT02363946|20170712|P10|NOT COMPLETED|Overall Study||0
8180357|NCT02363946|20170713|P9|NOT COMPLETED|Overall Study||0
8180358|NCT02363946|20170714|P8|NOT COMPLETED|Overall Study||1
8180359|NCT02363946|20170715|P7|NOT COMPLETED|Overall Study||0
8180360|NCT02363946|20170716|P6|NOT COMPLETED|Overall Study||0
8180361|NCT02363946|20170717|P5|NOT COMPLETED|Overall Study||0
8180362|NCT02363946|20170718|P4|NOT COMPLETED|Overall Study||0
8180363|NCT02363946|20170719|P3|NOT COMPLETED|Overall Study||0
8180364|NCT02363946|20170720|P2|NOT COMPLETED|Overall Study||0
8180365|NCT02363946|20170721|P1|NOT COMPLETED|Overall Study||0
8180366|NCT02363946|20170709|P13|COMPLETED|Overall Study||4
8180367|NCT02363946|20170710|P12|COMPLETED|Overall Study||3
8180368|NCT02363946|20170711|P11|COMPLETED|Overall Study||4
8180369|NCT02363946|20170712|P10|COMPLETED|Overall Study||18
8180370|NCT02363946|20170713|P9|COMPLETED|Overall Study||4
8180371|NCT02363946|20170714|P8|COMPLETED|Overall Study||3
8180372|NCT02363946|20170715|P7|COMPLETED|Overall Study||4
8180373|NCT02363946|20170716|P6|COMPLETED|Overall Study||4
8180374|NCT02363946|20170717|P5|COMPLETED|Overall Study||4
8180375|NCT02363946|20170718|P4|COMPLETED|Overall Study||4
8180376|NCT02363946|20170719|P3|COMPLETED|Overall Study||4
8180377|NCT02363946|20170720|P2|COMPLETED|Overall Study||4
8180378|NCT02363946|20170721|P1|COMPLETED|Overall Study||4
8180379|NCT02363946|20170709|P13|STARTED|Overall Study||4
8180380|NCT02363946|20170710|P12|STARTED|Overall Study||3
8180381|NCT02363946|20170711|P11|STARTED|Overall Study||4
8180382|NCT02363946|20170712|P10|STARTED|Overall Study||18
8180383|NCT02363946|20170713|P9|STARTED|Overall Study||4
8180384|NCT02363946|20170714|P8|STARTED|Overall Study||4
8180385|NCT02363946|20170715|P7|STARTED|Overall Study||4
8180386|NCT02363946|20170716|P6|STARTED|Overall Study||4
8180387|NCT02363946|20170717|P5|STARTED|Overall Study||4
8180388|NCT02363946|20170718|P4|STARTED|Overall Study||4
8180389|NCT02363946|20170719|P3|STARTED|Overall Study||4
8180390|NCT02363946|20170720|P2|STARTED|Overall Study||4
8180391|NCT02363946|20170721|P1|STARTED|Overall Study||4
8180392|NCT02363933|20170907|P1|NOT COMPLETED|Overall Study||6
8180393|NCT02363933|20170907|P1|COMPLETED|Overall Study||2
8180394|NCT02363933|20170907|P1|STARTED|Overall Study||8
8180395|NCT02363907|20170912|P1|NOT COMPLETED|Overall Study||0
8180396|NCT02363907|20170912|P1|COMPLETED|Overall Study||30
8180397|NCT02363907|20170912|P1|STARTED|Overall Study||30
8180398|NCT02363803|20170918|P2|NOT COMPLETED|Period 2||0
8180399|NCT02363803|20170919|P1|NOT COMPLETED|Period 2||0
8180400|NCT02363803|20170918|P2|COMPLETED|Period 2||16
8180401|NCT02363803|20170919|P1|COMPLETED|Period 2||17
8180402|NCT02363803|20170918|P2|STARTED|Period 2|One participant did not return for Period 2 treatment|16
8180403|NCT02363803|20170919|P1|STARTED|Period 2||17
8180404|NCT02363803|20170918|P2|NOT COMPLETED|Period 1||0
8180405|NCT02363803|20170919|P1|NOT COMPLETED|Period 1||0
8180406|NCT02363803|20170918|P2|COMPLETED|Period 1||17
8180407|NCT02363803|20170919|P1|COMPLETED|Period 1||17
8180408|NCT02363803|20170918|P2|STARTED|Period 1||17
8180409|NCT02363803|20170919|P1|STARTED|Period 1||17
8180410|NCT02363621|20170939|P2|NOT COMPLETED|Overall Study||0
8180411|NCT02363621|20170940|P1|NOT COMPLETED|Overall Study||1
8180412|NCT02363621|20170939|P2|COMPLETED|Overall Study||50
8180413|NCT02363621|20170940|P1|COMPLETED|Overall Study||50
8180414|NCT02363621|20170939|P2|STARTED|Overall Study||50
8180415|NCT02363621|20170940|P1|STARTED|Overall Study||51
8180416|NCT02363478|20170950|P1|NOT COMPLETED|Overall Study||8
8180417|NCT02363478|20170950|P1|COMPLETED|Overall Study||22
8180418|NCT02363478|20170950|P1|STARTED|Overall Study||30
8180419|NCT02363439|20170957|P1|NOT COMPLETED|Overall Study||4
8180420|NCT02363439|20170957|P1|COMPLETED|Overall Study||1
8180421|NCT02363439|20170957|P1|STARTED|Overall Study||5
8180422|NCT02363322|20170963|P2|NOT COMPLETED|Overall Study||0
8180423|NCT02363322|20170964|P1|NOT COMPLETED|Overall Study||1
8180424|NCT02363322|20170963|P2|COMPLETED|Overall Study||36
8180425|NCT02363322|20170964|P1|COMPLETED|Overall Study||35
8180426|NCT02363322|20170963|P2|STARTED|Overall Study||36
8180427|NCT02363322|20170964|P1|STARTED|Overall Study||36
8180428|NCT02363283|20170974|P1|NOT COMPLETED|Overall Study||2
8180429|NCT02363283|20170974|P1|COMPLETED|Overall Study||35
8180430|NCT02363283|20170974|P1|STARTED|Overall Study||37
8180431|NCT02363270|20170984|P2|NOT COMPLETED|Overall Study||0
8180432|NCT02363270|20170985|P1|NOT COMPLETED|Overall Study||0
8180433|NCT02363270|20170984|P2|COMPLETED|Overall Study||24
8180434|NCT02363270|20170985|P1|COMPLETED|Overall Study||24
8180435|NCT02363270|20170984|P2|STARTED|Overall Study||24
8180436|NCT02363270|20170985|P1|STARTED|Overall Study||24
8180437|NCT02362789|20170993|P3|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
8180438|NCT02362789|20170994|P2|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
8180439|NCT02362789|20170995|P1|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
8180440|NCT02362789|20170993|P3|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
8180441|NCT02362789|20170994|P2|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
8180442|NCT02362789|20170995|P1|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
8180443|NCT02362789|20170993|P3|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
8180444|NCT02362789|20170994|P2|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
8180445|NCT02362789|20170995|P1|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
8180446|NCT02362789|20170993|P3|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
8180447|NCT02362789|20170994|P2|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
8180448|NCT02362789|20170995|P1|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
8180449|NCT02362789|20170993|P3|COMPLETED|Run-in Phase (Week 0 to 16)||0
8180450|NCT02362789|20170994|P2|COMPLETED|Run-in Phase (Week 0 to 16)||0
8180451|NCT02362789|20170995|P1|COMPLETED|Run-in Phase (Week 0 to 16)||128
8180452|NCT02362789|20170993|P3|STARTED|Run-in Phase (Week 0 to 16)||0
8180453|NCT02362789|20170994|P2|STARTED|Run-in Phase (Week 0 to 16)||0
8180454|NCT02362789|20170995|P1|STARTED|Run-in Phase (Week 0 to 16)||130
8180455|NCT02362724|20171004|P2|NOT COMPLETED|Overall Study||1
8180456|NCT02362724|20171005|P1|NOT COMPLETED|Overall Study||6
8180457|NCT02362724|20171004|P2|COMPLETED|Overall Study||29
8180458|NCT02362724|20171005|P1|COMPLETED|Overall Study||53
8180459|NCT02362724|20171004|P2|STARTED|Overall Study||30
8180460|NCT02362724|20171005|P1|STARTED|Overall Study||59
8180461|NCT02362672|20171043|P3|NOT COMPLETED|Double-blind Maintenance Phase||59
8180462|NCT02362672|20171044|P2|NOT COMPLETED|Double-blind Maintenance Phase||60
8180463|NCT02362672|20171045|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
8180464|NCT02362672|20171043|P3|COMPLETED|Double-blind Maintenance Phase||242
8180465|NCT02362672|20171044|P2|COMPLETED|Double-blind Maintenance Phase||249
8180466|NCT02362672|20171045|P1|COMPLETED|Double-blind Maintenance Phase||0
8180467|NCT02362672|20171043|P3|STARTED|Double-blind Maintenance Phase||301
8180468|NCT02362672|20171044|P2|STARTED|Double-blind Maintenance Phase||309
8180469|NCT02362672|20171045|P1|STARTED|Double-blind Maintenance Phase||0
8180470|NCT02362672|20171043|P3|NOT COMPLETED|Titration Phase||0
8180471|NCT02362672|20171044|P2|NOT COMPLETED|Titration Phase||0
8180472|NCT02362672|20171045|P1|NOT COMPLETED|Titration Phase||579
8180473|NCT02362672|20171043|P3|COMPLETED|Titration Phase||0
8180474|NCT02362672|20171044|P2|COMPLETED|Titration Phase||0
8180475|NCT02362672|20171045|P1|COMPLETED|Titration Phase||610
8180476|NCT02362672|20171043|P3|STARTED|Titration Phase||0
8180477|NCT02362672|20171044|P2|STARTED|Titration Phase||0
8180478|NCT02362672|20171045|P1|STARTED|Titration Phase||1189
8180479|NCT02362646|20171064|P2|NOT COMPLETED|Overall Study||24
8180480|NCT02362646|20171065|P1|NOT COMPLETED|Overall Study||38
8180481|NCT02362646|20171064|P2|COMPLETED|Overall Study||29
8180482|NCT02362646|20171065|P1|COMPLETED|Overall Study||68
8180483|NCT02362646|20171064|P2|STARTED|Overall Study||53
8180484|NCT02362646|20171065|P1|STARTED|Overall Study||106
8180485|NCT02362594|20171075|P2|NOT COMPLETED|Overall Study||225
8180486|NCT02362594|20171076|P1|NOT COMPLETED|Overall Study||250
8180487|NCT02362594|20171075|P2|COMPLETED|Overall Study||280
8180488|NCT02362594|20171076|P1|COMPLETED|Overall Study||264
8180489|NCT02362594|20171075|P2|Continuing Part 1 Adjuvant Therapy|Overall Study||21
8180490|NCT02362594|20171076|P1|Continuing Part 1 Adjuvant Therapy|Overall Study||41
8180491|NCT02362594|20171075|P2|Treated|Overall Study||502
8180492|NCT02362594|20171076|P1|Treated|Overall Study||509
8180493|NCT02362594|20171075|P2|STARTED|Overall Study||505
8180494|NCT02362594|20171076|P1|STARTED|Overall Study||514
8180513|NCT02362425|20171128|P4|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3
8180514|NCT02362425|20171129|P3|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1
8180515|NCT02362425|20171130|P2|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
8180516|NCT02362425|20171131|P1|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
8180517|NCT02362425|20171128|P4|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14
8180518|NCT02362425|20171129|P3|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15
8180519|NCT02362425|20171130|P2|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
8180520|NCT02362425|20171131|P1|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
8180521|NCT02362425|20171128|P4|STARTED|Phase 2 (up to 6 Months, Randomized)||17
8180522|NCT02362425|20171129|P3|STARTED|Phase 2 (up to 6 Months, Randomized)||16
8180523|NCT02362425|20171130|P2|STARTED|Phase 2 (up to 6 Months, Randomized)||0
8180524|NCT02362425|20171131|P1|STARTED|Phase 2 (up to 6 Months, Randomized)||0
8180525|NCT02362425|20171128|P4|NOT COMPLETED|Phase 1 (up to 6 Months)||0
8180526|NCT02362425|20171129|P3|NOT COMPLETED|Phase 1 (up to 6 Months)||0
8180527|NCT02362425|20171130|P2|NOT COMPLETED|Phase 1 (up to 6 Months)||0
8180528|NCT02362425|20171131|P1|NOT COMPLETED|Phase 1 (up to 6 Months)||16
8180529|NCT02362425|20171128|P4|COMPLETED|Phase 1 (up to 6 Months)||0
8180530|NCT02362425|20171129|P3|COMPLETED|Phase 1 (up to 6 Months)||0
8180531|NCT02362425|20171130|P2|COMPLETED|Phase 1 (up to 6 Months)||10
8180532|NCT02362425|20171131|P1|COMPLETED|Phase 1 (up to 6 Months)||37
8180533|NCT02362425|20171128|P4|STARTED|Phase 1 (up to 6 Months)||0
8180534|NCT02362425|20171129|P3|STARTED|Phase 1 (up to 6 Months)||0
8180535|NCT02362425|20171130|P2|STARTED|Phase 1 (up to 6 Months)||10
8180536|NCT02362425|20171131|P1|STARTED|Phase 1 (up to 6 Months)||53
8180537|NCT02362412|20171249|P2|NOT COMPLETED|Treatment Period III||1
8180538|NCT02362412|20171250|P1|NOT COMPLETED|Treatment Period III||0
8180539|NCT02362412|20171249|P2|COMPLETED|Treatment Period III||10
8180540|NCT02362412|20171250|P1|COMPLETED|Treatment Period III||9
8180541|NCT02362412|20171249|P2|TREATED|Treatment Period III||11
8180542|NCT02362412|20171250|P1|TREATED|Treatment Period III||9
8180543|NCT02362412|20171249|P2|STARTED|Treatment Period III||11
8180544|NCT02362412|20171250|P1|STARTED|Treatment Period III||9
8180545|NCT02362412|20171249|P2|NOT COMPLETED|Treatment Period II||0
8180546|NCT02362412|20171250|P1|NOT COMPLETED|Treatment Period II||0
8180547|NCT02362412|20171249|P2|COMPLETED|Treatment Period II||11
8180548|NCT02362412|20171250|P1|COMPLETED|Treatment Period II||9
8180549|NCT02362412|20171249|P2|TREATED|Treatment Period II||11
8180550|NCT02362412|20171250|P1|TREATED|Treatment Period II||9
8180551|NCT02362412|20171249|P2|STARTED|Treatment Period II||11
8180552|NCT02362412|20171250|P1|STARTED|Treatment Period II||9
8180553|NCT02362373|20171276|P1|NOT COMPLETED|Overall Study||0
8180554|NCT02362373|20171276|P1|COMPLETED|Overall Study||20
8180555|NCT02362373|20171276|P1|STARTED|Overall Study||20
8180556|NCT02362360|20171284|P2|NOT COMPLETED|Period 2||0
8180557|NCT02362360|20171285|P1|NOT COMPLETED|Period 2||0
8180558|NCT02362360|20171284|P2|COMPLETED|Period 2||25
8180559|NCT02362360|20171285|P1|COMPLETED|Period 2||23
8180560|NCT02362360|20171284|P2|STARTED|Period 2||25
8180561|NCT02362360|20171285|P1|STARTED|Period 2||23
8180562|NCT02362360|20171284|P2|NOT COMPLETED|Period 1||1
8180563|NCT02362360|20171285|P1|NOT COMPLETED|Period 1||3
8180564|NCT02362360|20171284|P2|COMPLETED|Period 1||25
8180565|NCT02362360|20171285|P1|COMPLETED|Period 1||23
8180566|NCT02362360|20171284|P2|STARTED|Period 1||26
8180567|NCT02362360|20171285|P1|STARTED|Period 1||26
8180568|NCT02362321|20171293|P2|NOT COMPLETED|Overall Study||0
8180569|NCT02362321|20171294|P1|NOT COMPLETED|Overall Study||4
8180570|NCT02362321|20171293|P2|COMPLETED|Overall Study||10
8180571|NCT02362321|20171294|P1|COMPLETED|Overall Study||6
8180572|NCT02362321|20171293|P2|STARTED|Overall Study||10
8180573|NCT02362321|20171294|P1|STARTED|Overall Study||10
8180574|NCT02362282|20171302|P2|NOT COMPLETED|Overall Study||0
8180575|NCT02362282|20171303|P1|NOT COMPLETED|Overall Study||1
8180576|NCT02362282|20171302|P2|COMPLETED|Overall Study||7
8180577|NCT02362282|20171303|P1|COMPLETED|Overall Study||4
8180578|NCT02362282|20171302|P2|STARTED|Overall Study||7
8180579|NCT02362282|20171303|P1|STARTED|Overall Study||5
8180580|NCT02362269|20171311|P2|NOT COMPLETED|Overall Study||6
8180581|NCT02362269|20171312|P1|NOT COMPLETED|Overall Study||1
8180582|NCT02362269|20171311|P2|COMPLETED|Overall Study||80
8180583|NCT02362269|20171312|P1|COMPLETED|Overall Study||82
8180584|NCT02362269|20171311|P2|STARTED|Overall Study||86
8180585|NCT02362269|20171312|P1|STARTED|Overall Study||83
8180586|NCT02362191|20171318|P1|NOT COMPLETED|Overall Study||2
8180587|NCT02362191|20171318|P1|COMPLETED|Overall Study||3
8180588|NCT02362191|20171318|P1|STARTED|Overall Study||5
8180589|NCT02362048|20171325|P2|NOT COMPLETED|Overall Study||40
8180590|NCT02362048|20171326|P1|NOT COMPLETED|Overall Study||37
8180591|NCT02362048|20171325|P2|COMPLETED|Overall Study||0
8180592|NCT02362048|20171326|P1|COMPLETED|Overall Study||0
8180593|NCT02362048|20171325|P2|Discontinued Study|Overall Study||40
8180594|NCT02362048|20171326|P1|Discontinued Study|Overall Study||37
8180595|NCT02362048|20171325|P2|Received Study Medication|Overall Study||38
8180596|NCT02362048|20171326|P1|Received Study Medication|Overall Study||35
8180597|NCT02362048|20171325|P2|Enrolled|Overall Study||40
8180598|NCT02362048|20171326|P1|Enrolled|Overall Study||37
8180599|NCT02362048|20171325|P2|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40
8180600|NCT02362048|20171326|P1|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37
8180607|NCT02361736|20171365|P2|NOT COMPLETED|Overall Study||1
8180608|NCT02361736|20171366|P1|NOT COMPLETED|Overall Study||1
8180609|NCT02361736|20171365|P2|COMPLETED|Overall Study||59
8180610|NCT02361736|20171366|P1|COMPLETED|Overall Study||59
8180611|NCT02361736|20171365|P2|STARTED|Overall Study||60
8180612|NCT02361736|20171366|P1|STARTED|Overall Study||60
8180613|NCT02361580|20171386|P2|NOT COMPLETED|Overall Study||3
8180614|NCT02361580|20171387|P1|NOT COMPLETED|Overall Study||6
8180615|NCT02361580|20171386|P2|COMPLETED|Overall Study||0
8180616|NCT02361580|20171387|P1|COMPLETED|Overall Study||0
8180617|NCT02361580|20171386|P2|STARTED|Overall Study||3
8180618|NCT02361580|20171387|P1|STARTED|Overall Study||6
8180619|NCT02361476|20171399|P2|NOT COMPLETED|Overall Study||0
8180620|NCT02361476|20171400|P1|NOT COMPLETED|Overall Study||0
8180621|NCT02361476|20171399|P2|COMPLETED|Overall Study||188
8180622|NCT02361476|20171400|P1|COMPLETED|Overall Study||191
8180623|NCT02361476|20171399|P2|STARTED|Overall Study||188
8180624|NCT02361476|20171400|P1|STARTED|Overall Study||191
8180625|NCT02361216|20171416|P2|NOT COMPLETED|12-month Follow-up||27
8180626|NCT02361216|20171417|P1|NOT COMPLETED|12-month Follow-up||52
8180627|NCT02361216|20171416|P2|COMPLETED|12-month Follow-up||130
8180628|NCT02361216|20171417|P1|COMPLETED|12-month Follow-up||489
8180629|NCT02361216|20171416|P2|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
8180630|NCT02361216|20171417|P1|STARTED|12-month Follow-up||541
8180631|NCT02361216|20171416|P2|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
8180632|NCT02361216|20171417|P1|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
8180633|NCT02361216|20171416|P2|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
8180634|NCT02361216|20171417|P1|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
8180635|NCT02361216|20171416|P2|STARTED|3 Day Treatment and 8 Week Follow/up||177
8180636|NCT02361216|20171417|P1|STARTED|3 Day Treatment and 8 Week Follow/up||552
8180637|NCT02360995|20171432|P3|NOT COMPLETED|Overall Study||2
8180638|NCT02360995|20171433|P2|NOT COMPLETED|Overall Study||1
8180639|NCT02360995|20171434|P1|NOT COMPLETED|Overall Study||2
8180640|NCT02360995|20171432|P3|COMPLETED|Overall Study||41
8180641|NCT02360995|20171433|P2|COMPLETED|Overall Study||42
8180642|NCT02360995|20171434|P1|COMPLETED|Overall Study||41
8180643|NCT02360995|20171432|P3|STARTED|Overall Study||43
8180644|NCT02360995|20171433|P2|STARTED|Overall Study||43
8180645|NCT02360995|20171434|P1|STARTED|Overall Study||43
8180646|NCT02360774|20171459|P2|NOT COMPLETED|Overall Study||2
8180647|NCT02360774|20171460|P1|NOT COMPLETED|Overall Study||3
8180648|NCT02360774|20171459|P2|COMPLETED|Overall Study||13
8180649|NCT02360774|20171460|P1|COMPLETED|Overall Study||12
8180650|NCT02360774|20171459|P2|STARTED|Overall Study||15
8180651|NCT02360774|20171460|P1|STARTED|Overall Study||15
8180652|NCT02360631|20171474|P2|NOT COMPLETED|Overall Study||26
8180653|NCT02360631|20171475|P1|NOT COMPLETED|Overall Study||33
8180654|NCT02360631|20171474|P2|COMPLETED|Overall Study||174
8180655|NCT02360631|20171475|P1|COMPLETED|Overall Study||267
8180656|NCT02360631|20171474|P2|Week 12|Overall Study||165
8180657|NCT02360631|20171475|P1|Week 12|Overall Study||249
8180658|NCT02360631|20171474|P2|STARTED|Overall Study||200
8180659|NCT02360631|20171475|P1|STARTED|Overall Study||300
8180660|NCT02360488|20171487|P2|NOT COMPLETED|Overall Study||7
8180661|NCT02360488|20171488|P1|NOT COMPLETED|Overall Study||3
8180662|NCT02360488|20171487|P2|COMPLETED|Overall Study||55
8180663|NCT02360488|20171488|P1|COMPLETED|Overall Study||59
8180664|NCT02360488|20171487|P2|STARTED|Overall Study||62
8180665|NCT02360488|20171488|P1|STARTED|Overall Study||62
8180666|NCT02360475|20171498|P4|NOT COMPLETED|Overall Study||5
8180667|NCT02360475|20171499|P3|NOT COMPLETED|Overall Study||8
8180668|NCT02360475|20171500|P2|NOT COMPLETED|Overall Study||13
8180669|NCT02360475|20171501|P1|NOT COMPLETED|Overall Study||4
8180670|NCT02360475|20171498|P4|COMPLETED|Overall Study||120
8180671|NCT02360475|20171499|P3|COMPLETED|Overall Study||117
8180672|NCT02360475|20171500|P2|COMPLETED|Overall Study||111
8180673|NCT02360475|20171501|P1|COMPLETED|Overall Study||122
8180674|NCT02360475|20171498|P4|STARTED|Overall Study||125
8180675|NCT02360475|20171499|P3|STARTED|Overall Study||125
8180676|NCT02360475|20171500|P2|STARTED|Overall Study||124
8180677|NCT02360475|20171501|P1|STARTED|Overall Study||126
8180678|NCT02360397|20171559|P1|NOT COMPLETED|Overall Study||4
8180679|NCT02360397|20171559|P1|COMPLETED|Overall Study||2
8180680|NCT02360397|20171559|P1|STARTED|Overall Study||6
8180681|NCT02360319|20171568|P2|NOT COMPLETED|Overall Study||61
8180682|NCT02360319|20171569|P1|NOT COMPLETED|Overall Study||88
8180683|NCT02360319|20171568|P2|COMPLETED|Overall Study||173
8180684|NCT02360319|20171569|P1|COMPLETED|Overall Study||167
8180685|NCT02360319|20171568|P2|STARTED|Overall Study||234
8180686|NCT02360319|20171569|P1|STARTED|Overall Study||255
8180687|NCT02360293|20171585|P2|NOT COMPLETED|Overall Study||96
8180688|NCT02360293|20171586|P1|NOT COMPLETED|Overall Study||76
8180689|NCT02360293|20171585|P2|COMPLETED|Overall Study||83
8180690|NCT02360293|20171586|P1|COMPLETED|Overall Study||102
8180691|NCT02360293|20171585|P2|12month Physical Activity|Overall Study||59
8180692|NCT02360293|20171586|P1|12month Physical Activity|Overall Study||68
8180693|NCT02360293|20171585|P2|12month f/u Survey|Overall Study||83
8180694|NCT02360293|20171586|P1|12month f/u Survey|Overall Study||102
8180695|NCT02360293|20171585|P2|6month Physical Activity|Overall Study||108
8180696|NCT02360293|20171586|P1|6month Physical Activity|Overall Study||122
8180697|NCT02360293|20171585|P2|6month f/u Survey|Overall Study||105
8180698|NCT02360293|20171586|P1|6month f/u Survey|Overall Study||110
8180699|NCT02360293|20171585|P2|STARTED|Overall Study||179
8180700|NCT02360293|20171586|P1|STARTED|Overall Study||178
8180707|NCT02360228|20171616|P3|NOT COMPLETED|Overall Study||1
8180708|NCT02360228|20171617|P2|NOT COMPLETED|Overall Study||1
8180709|NCT02360228|20171618|P1|NOT COMPLETED|Overall Study||1
8180710|NCT02360228|20171616|P3|COMPLETED|Overall Study||7
8180711|NCT02360228|20171617|P2|COMPLETED|Overall Study||7
8180712|NCT02360228|20171618|P1|COMPLETED|Overall Study||8
8180713|NCT02360228|20171616|P3|STARTED|Overall Study||8
8180714|NCT02360228|20171617|P2|STARTED|Overall Study||8
8180715|NCT02360228|20171618|P1|STARTED|Overall Study||9
8180764|NCT02360124|20171700|P3|NOT COMPLETED|Overall Study||26
8180765|NCT02360124|20171701|P2|NOT COMPLETED|Overall Study||12
8180766|NCT02360124|20171702|P1|NOT COMPLETED|Overall Study||28
8180767|NCT02360124|20171700|P3|COMPLETED|Overall Study||82
8180768|NCT02360124|20171701|P2|COMPLETED|Overall Study||95
8180769|NCT02360124|20171702|P1|COMPLETED|Overall Study||80
8180770|NCT02360124|20171700|P3|STARTED|Overall Study||108
8180771|NCT02360124|20171701|P2|STARTED|Overall Study||107
8180772|NCT02360124|20171702|P1|STARTED|Overall Study||108
8180773|NCT02360111|20171713|P1|NOT COMPLETED|Overall Study||2
8180774|NCT02360111|20171713|P1|COMPLETED|Overall Study||1
8180775|NCT02360111|20171713|P1|STARTED|Overall Study||3
8180776|NCT02360098|20171723|P1|NOT COMPLETED|Overall Study||7
8180777|NCT02360098|20171723|P1|COMPLETED|Overall Study||29
8180778|NCT02360098|20171723|P1|STARTED|Overall Study||36
8180779|NCT02360085|20171728|P1|NOT COMPLETED|Overall Study||16
8180780|NCT02360085|20171728|P1|COMPLETED|Overall Study||49
8180781|NCT02360085|20171728|P1|STARTED|Overall Study||65
8180782|NCT02360059|20171741|P2|NOT COMPLETED|Overall Study||0
8180783|NCT02360059|20171742|P1|NOT COMPLETED|Overall Study||0
8180784|NCT02360059|20171741|P2|COMPLETED|Overall Study||0
8180785|NCT02360059|20171742|P1|COMPLETED|Overall Study||1
8180786|NCT02360059|20171741|P2|STARTED|Overall Study||0
8180787|NCT02360059|20171742|P1|STARTED|Overall Study||1
8180788|NCT02359955|20171750|P2|NOT COMPLETED|Overall Study||0
8180789|NCT02359955|20171751|P1|NOT COMPLETED|Overall Study||0
8180790|NCT02359955|20171750|P2|COMPLETED|Overall Study||10
8180791|NCT02359955|20171751|P1|COMPLETED|Overall Study||10
8180792|NCT02359955|20171750|P2|STARTED|Overall Study||10
8180793|NCT02359955|20171751|P1|STARTED|Overall Study||10
8180794|NCT02359916|20171774|P7|NOT COMPLETED|Overall Study||0
8180795|NCT02359916|20171775|P6|NOT COMPLETED|Overall Study||0
8180796|NCT02359916|20171776|P5|NOT COMPLETED|Overall Study||0
8180797|NCT02359916|20171777|P4|NOT COMPLETED|Overall Study||0
8180798|NCT02359916|20171778|P3|NOT COMPLETED|Overall Study||0
8180799|NCT02359916|20171779|P2|NOT COMPLETED|Overall Study||0
8180800|NCT02359916|20171780|P1|NOT COMPLETED|Overall Study||0
8180801|NCT02359916|20171774|P7|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
8180802|NCT02359916|20171775|P6|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
8180803|NCT02359916|20171776|P5|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
8180804|NCT02359916|20171777|P4|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
8180805|NCT02359916|20171778|P3|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
8180806|NCT02359916|20171779|P2|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
8180807|NCT02359916|20171780|P1|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|0
8180808|NCT02359916|20171774|P7|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
8180809|NCT02359916|20171775|P6|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
8180810|NCT02359916|20171776|P5|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
8180811|NCT02359916|20171777|P4|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
8180812|NCT02359916|20171778|P3|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
8180813|NCT02359916|20171779|P2|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
8180814|NCT02359916|20171780|P1|STARTED|Overall Study|The number of unique individuals in this study is unknown|0
8180815|NCT02359903|20171802|P2|NOT COMPLETED|Overall Study||2
8180816|NCT02359903|20171803|P1|NOT COMPLETED|Overall Study||0
8180817|NCT02359903|20171802|P2|COMPLETED|Overall Study||43
8180818|NCT02359903|20171803|P1|COMPLETED|Overall Study||45
8180819|NCT02359903|20171802|P2|STARTED|Overall Study||45
8180820|NCT02359903|20171803|P1|STARTED|Overall Study||45
8180821|NCT02359890|20171811|P1|NOT COMPLETED|Overall Study||10
8180822|NCT02359890|20171811|P1|COMPLETED|Overall Study||155
8180823|NCT02359890|20171811|P1|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
8180824|NCT02359890|20171811|P1|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
8180825|NCT02359890|20171811|P1|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
8180826|NCT02359890|20171811|P1|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
8180827|NCT02359877|20171822|P4|NOT COMPLETED|Overall Study||3
8180828|NCT02359877|20171823|P3|NOT COMPLETED|Overall Study||0
8180829|NCT02359877|20171824|P2|NOT COMPLETED|Overall Study||0
8180830|NCT02359877|20171825|P1|NOT COMPLETED|Overall Study||1
8180831|NCT02359877|20171822|P4|COMPLETED|Overall Study||11
8180832|NCT02359877|20171823|P3|COMPLETED|Overall Study||6
8180833|NCT02359877|20171824|P2|COMPLETED|Overall Study||6
8180834|NCT02359877|20171825|P1|COMPLETED|Overall Study||33
8180835|NCT02359877|20171822|P4|STARTED|Overall Study||14
8180836|NCT02359877|20171823|P3|STARTED|Overall Study||6
8180837|NCT02359877|20171824|P2|STARTED|Overall Study||6
8180838|NCT02359877|20171825|P1|STARTED|Overall Study||34
8180839|NCT02359851|20171875|P1|NOT COMPLETED|Overall Study||2
8180840|NCT02359851|20171875|P1|COMPLETED|Overall Study||3
8180841|NCT02359851|20171875|P1|STARTED|Overall Study||5
8180842|NCT02359552|20171885|P2|NOT COMPLETED|Overall Study||4
8180843|NCT02359552|20171886|P1|NOT COMPLETED|Overall Study||3
8180844|NCT02359552|20171885|P2|COMPLETED|Overall Study||21
8180845|NCT02359552|20171886|P1|COMPLETED|Overall Study||22
8180846|NCT02359552|20171885|P2|STARTED|Overall Study||25
8180847|NCT02359552|20171886|P1|STARTED|Overall Study||25
8180848|NCT02359435|20171908|P2|NOT COMPLETED|Overall Study||4
8180849|NCT02359435|20171909|P1|NOT COMPLETED|Overall Study||4
8180850|NCT02359435|20171908|P2|COMPLETED|Overall Study||216
8180851|NCT02359435|20171909|P1|COMPLETED|Overall Study||216
8180852|NCT02359435|20171908|P2|STARTED|Overall Study||220
8180853|NCT02359435|20171909|P1|STARTED|Overall Study||220
8180854|NCT02359305|20171917|P2|NOT COMPLETED|Overall Study||0
8180855|NCT02359305|20171918|P1|NOT COMPLETED|Overall Study||0
8180856|NCT02359305|20171917|P2|COMPLETED|Overall Study||34
8180857|NCT02359305|20171918|P1|COMPLETED|Overall Study||34
8180858|NCT02359305|20171917|P2|STARTED|Overall Study||34
8180859|NCT02359305|20171918|P1|STARTED|Overall Study||34
8180860|NCT02359110|20171930|P2|NOT COMPLETED|Overall Study||0
8180861|NCT02359110|20171931|P1|NOT COMPLETED|Overall Study||0
8180862|NCT02359110|20171930|P2|COMPLETED|Overall Study||54
8180863|NCT02359110|20171931|P1|COMPLETED|Overall Study||55
8180864|NCT02359110|20171930|P2|STARTED|Overall Study||54
8180865|NCT02359110|20171931|P1|STARTED|Overall Study||55
8180866|NCT02359058|20171944|P3|NOT COMPLETED|Overall Study||0
8180867|NCT02359058|20171945|P2|NOT COMPLETED|Overall Study||0
8180868|NCT02359058|20171946|P1|NOT COMPLETED|Overall Study||0
8180869|NCT02359058|20171944|P3|COMPLETED|Overall Study||6
8180870|NCT02359058|20171945|P2|COMPLETED|Overall Study||6
8180871|NCT02359058|20171946|P1|COMPLETED|Overall Study||6
8180872|NCT02359058|20171944|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8180873|NCT02359058|20171945|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8180874|NCT02359058|20171946|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8180875|NCT02359058|20171944|P3|STARTED|Overall Study||6
8180876|NCT02359058|20171945|P2|STARTED|Overall Study||6
8180877|NCT02359058|20171946|P1|STARTED|Overall Study||6
8180878|NCT02359045|20171969|P2|NOT COMPLETED|Overall Study||3
8180879|NCT02359045|20171970|P1|NOT COMPLETED|Overall Study||4
8180880|NCT02359045|20171969|P2|COMPLETED|Overall Study||39
8180881|NCT02359045|20171970|P1|COMPLETED|Overall Study||36
8180882|NCT02359045|20171969|P2|STARTED|Overall Study||42
8180883|NCT02359045|20171970|P1|STARTED|Overall Study||40
8180887|NCT02359006|20172211|P2|NOT COMPLETED|Overall Study||3
8180888|NCT02359006|20172212|P1|NOT COMPLETED|Overall Study||4
8180889|NCT02359006|20172211|P2|COMPLETED|Overall Study||10
8180890|NCT02359006|20172212|P1|COMPLETED|Overall Study||10
8180891|NCT02359006|20172211|P2|STARTED|Overall Study||13
8180892|NCT02359006|20172212|P1|STARTED|Overall Study||14
8180893|NCT02358889|20172255|P3|NOT COMPLETED|Overall Study||1
8180894|NCT02358889|20172256|P2|NOT COMPLETED|Overall Study||2
8180895|NCT02358889|20172257|P1|NOT COMPLETED|Overall Study||0
8180896|NCT02358889|20172255|P3|COMPLETED|Overall Study||27
8180897|NCT02358889|20172256|P2|COMPLETED|Overall Study||28
8180898|NCT02358889|20172257|P1|COMPLETED|Overall Study||30
8180899|NCT02358889|20172255|P3|STARTED|Overall Study||28
8180900|NCT02358889|20172256|P2|STARTED|Overall Study||30
8180901|NCT02358889|20172257|P1|STARTED|Overall Study||30
8180902|NCT02358876|20172274|P1|NOT COMPLETED|Overall Study||2
8180903|NCT02358876|20172274|P1|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
8180904|NCT02358876|20172274|P1|STARTED|Overall Study||32
8180905|NCT02358863|20172278|P1|NOT COMPLETED|Overall Study||3
8180906|NCT02358863|20172278|P1|COMPLETED|Overall Study||10
8180907|NCT02358863|20172278|P1|STARTED|Overall Study||13
8180908|NCT02358668|20172285|P3|NOT COMPLETED|Overall Study||0
8180909|NCT02358668|20172286|P2|NOT COMPLETED|Overall Study||1
8180910|NCT02358668|20172287|P1|NOT COMPLETED|Overall Study||2
8180911|NCT02358668|20172285|P3|COMPLETED|Overall Study||12
8180912|NCT02358668|20172286|P2|COMPLETED|Overall Study||23
8180913|NCT02358668|20172287|P1|COMPLETED|Overall Study||22
8180914|NCT02358668|20172285|P3|STARTED|Overall Study||12
8180915|NCT02358668|20172286|P2|STARTED|Overall Study||24
8180916|NCT02358668|20172287|P1|STARTED|Overall Study||24
8180917|NCT02358603|20172429|P2|NOT COMPLETED|Overall Study||0
8180918|NCT02358603|20172430|P1|NOT COMPLETED|Overall Study||0
8180919|NCT02358603|20172429|P2|COMPLETED|Overall Study||8
8180920|NCT02358603|20172430|P1|COMPLETED|Overall Study||40
8180921|NCT02358603|20172429|P2|STARTED|Overall Study||8
8180922|NCT02358603|20172430|P1|STARTED|Overall Study||40
8180923|NCT02358473|20172436|P1|NOT COMPLETED|Overall Study||13
8180924|NCT02358473|20172436|P1|COMPLETED|Overall Study||0
8180925|NCT02358473|20172436|P1|STARTED|Overall Study||13
8180926|NCT02358369|20172448|P5|NOT COMPLETED|Treatment Period C||7
8180927|NCT02358369|20172449|P4|NOT COMPLETED|Treatment Period C||0
8180928|NCT02358369|20172450|P3|NOT COMPLETED|Treatment Period C||0
8180929|NCT02358369|20172451|P2|NOT COMPLETED|Treatment Period C||0
8180930|NCT02358369|20172452|P1|NOT COMPLETED|Treatment Period C||0
8180931|NCT02358369|20172448|P5|COMPLETED|Treatment Period C||106
8180932|NCT02358369|20172449|P4|COMPLETED|Treatment Period C||0
8180933|NCT02358369|20172450|P3|COMPLETED|Treatment Period C||0
8180934|NCT02358369|20172451|P2|COMPLETED|Treatment Period C||0
8180935|NCT02358369|20172452|P1|COMPLETED|Treatment Period C||0
8180936|NCT02358369|20172448|P5|STARTED|Treatment Period C||113
8180937|NCT02358369|20172449|P4|STARTED|Treatment Period C||0
8180938|NCT02358369|20172450|P3|STARTED|Treatment Period C||0
8180939|NCT02358369|20172451|P2|STARTED|Treatment Period C||0
8180940|NCT02358369|20172452|P1|STARTED|Treatment Period C||0
8180941|NCT02358369|20172448|P5|NOT COMPLETED|Treatment Period A/B||0
8180942|NCT02358369|20172449|P4|NOT COMPLETED|Treatment Period A/B||4
8180943|NCT02358369|20172450|P3|NOT COMPLETED|Treatment Period A/B||2
8180944|NCT02358369|20172451|P2|NOT COMPLETED|Treatment Period A/B||2
8180945|NCT02358369|20172452|P1|NOT COMPLETED|Treatment Period A/B||0
8180946|NCT02358369|20172448|P5|COMPLETED|Treatment Period A/B||0
8180947|NCT02358369|20172449|P4|COMPLETED|Treatment Period A/B||37
8180948|NCT02358369|20172450|P3|COMPLETED|Treatment Period A/B||38
8180949|NCT02358369|20172451|P2|COMPLETED|Treatment Period A/B||38
8180950|NCT02358369|20172452|P1|COMPLETED|Treatment Period A/B||0
8180951|NCT02358369|20172448|P5|STARTED|Treatment Period A/B||0
8180952|NCT02358369|20172449|P4|STARTED|Treatment Period A/B||41
8180953|NCT02358369|20172450|P3|STARTED|Treatment Period A/B||40
8180954|NCT02358369|20172451|P2|STARTED|Treatment Period A/B||40
8180955|NCT02358369|20172452|P1|STARTED|Treatment Period A/B||0
8180956|NCT02358369|20172448|P5|NOT COMPLETED|Pre-Randomization Washout Period||0
8180957|NCT02358369|20172449|P4|NOT COMPLETED|Pre-Randomization Washout Period||0
8180958|NCT02358369|20172450|P3|NOT COMPLETED|Pre-Randomization Washout Period||0
8180959|NCT02358369|20172451|P2|NOT COMPLETED|Pre-Randomization Washout Period||0
8180960|NCT02358369|20172452|P1|NOT COMPLETED|Pre-Randomization Washout Period||35
8180961|NCT02358369|20172448|P5|COMPLETED|Pre-Randomization Washout Period||0
8180962|NCT02358369|20172449|P4|COMPLETED|Pre-Randomization Washout Period||0
8180963|NCT02358369|20172450|P3|COMPLETED|Pre-Randomization Washout Period||0
8180964|NCT02358369|20172451|P2|COMPLETED|Pre-Randomization Washout Period||0
8180965|NCT02358369|20172452|P1|COMPLETED|Pre-Randomization Washout Period||121
8180966|NCT02358369|20172448|P5|STARTED|Pre-Randomization Washout Period||0
8180967|NCT02358369|20172449|P4|STARTED|Pre-Randomization Washout Period||0
8180968|NCT02358369|20172450|P3|STARTED|Pre-Randomization Washout Period||0
8180969|NCT02358369|20172451|P2|STARTED|Pre-Randomization Washout Period||0
8180970|NCT02358369|20172452|P1|STARTED|Pre-Randomization Washout Period||156
8180971|NCT02358343|20172498|P5|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
8180972|NCT02358343|20172499|P4|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
8180973|NCT02358343|20172500|P3|NOT COMPLETED|Comparative Efficacy Trial / Observation||5
8180974|NCT02358343|20172501|P2|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
8180975|NCT02358343|20172502|P1|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
8180976|NCT02358343|20172498|P5|COMPLETED|Comparative Efficacy Trial / Observation||18
8180977|NCT02358343|20172499|P4|COMPLETED|Comparative Efficacy Trial / Observation||58
8180978|NCT02358343|20172500|P3|COMPLETED|Comparative Efficacy Trial / Observation||55
8180979|NCT02358343|20172501|P2|COMPLETED|Comparative Efficacy Trial / Observation||0
8180980|NCT02358343|20172502|P1|COMPLETED|Comparative Efficacy Trial / Observation||0
8180981|NCT02358343|20172498|P5|STARTED|Comparative Efficacy Trial / Observation||20
8180982|NCT02358343|20172499|P4|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60
8180983|NCT02358343|20172500|P3|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60
8180984|NCT02358343|20172501|P2|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
8180985|NCT02358343|20172502|P1|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
8180986|NCT02358343|20172498|P5|NOT COMPLETED|Screening Intervention||0
8180987|NCT02358343|20172499|P4|NOT COMPLETED|Screening Intervention||0
8180988|NCT02358343|20172500|P3|NOT COMPLETED|Screening Intervention||0
8180989|NCT02358343|20172501|P2|NOT COMPLETED|Screening Intervention||8
8180990|NCT02358343|20172502|P1|NOT COMPLETED|Screening Intervention||6
8180991|NCT02358343|20172498|P5|COMPLETED|Screening Intervention||0
8180992|NCT02358343|20172499|P4|COMPLETED|Screening Intervention||0
8180993|NCT02358343|20172500|P3|COMPLETED|Screening Intervention||0
8180994|NCT02358343|20172501|P2|COMPLETED|Screening Intervention||84
8180995|NCT02358343|20172502|P1|COMPLETED|Screening Intervention||86
8180996|NCT02358343|20172498|P5|STARTED|Screening Intervention||0
8180997|NCT02358343|20172499|P4|STARTED|Screening Intervention||0
8180998|NCT02358343|20172500|P3|STARTED|Screening Intervention||0
8180999|NCT02358343|20172501|P2|STARTED|Screening Intervention|89 completed control visit|92
8181000|NCT02358343|20172502|P1|STARTED|Screening Intervention|90 completed engagement interview|92
8181001|NCT02358135|20172539|P2|NOT COMPLETED|Overall Study||19
8181002|NCT02358135|20172540|P1|NOT COMPLETED|Overall Study||15
8181003|NCT02358135|20172539|P2|COMPLETED|Overall Study||131
8181004|NCT02358135|20172540|P1|COMPLETED|Overall Study||135
8181005|NCT02358135|20172539|P2|Randomized|Overall Study||148
8181006|NCT02358135|20172540|P1|Randomized|Overall Study||148
8181007|NCT02358135|20172539|P2|STARTED|Overall Study||150
8181008|NCT02358135|20172540|P1|STARTED|Overall Study||150
8181009|NCT02358044|20172558|P2|NOT COMPLETED|Overall Study||7
8181010|NCT02358044|20172559|P1|NOT COMPLETED|Overall Study||2
8181011|NCT02358044|20172558|P2|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
8181012|NCT02358044|20172559|P1|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
8181013|NCT02358044|20172558|P2|Treated|Overall Study||126
8181014|NCT02358044|20172559|P1|Treated|Overall Study||129
8181015|NCT02358044|20172558|P2|STARTED|Overall Study||128
8181016|NCT02358044|20172559|P1|STARTED|Overall Study||129
8181017|NCT02358031|20172578|P3|NOT COMPLETED|Overall Study||300
8181018|NCT02358031|20172579|P2|NOT COMPLETED|Overall Study||281
8181019|NCT02358031|20172580|P1|NOT COMPLETED|Overall Study||301
8181020|NCT02358031|20172578|P3|COMPLETED|Overall Study||0
8181021|NCT02358031|20172579|P2|COMPLETED|Overall Study||0
8181022|NCT02358031|20172580|P1|COMPLETED|Overall Study||0
8181023|NCT02358031|20172578|P3|Pembro Combo v Control Efficacy Analyses|Overall Study||278
8181024|NCT02358031|20172579|P2|Pembro Combo v Control Efficacy Analyses|Overall Study||281
8181025|NCT02358031|20172580|P1|Pembro Combo v Control Efficacy Analyses|Overall Study||0
8181026|NCT02358031|20172578|P3|Pembro Mono v Control Efficacy Analyses|Overall Study||300
8181027|NCT02358031|20172579|P2|Pembro Mono v Control Efficacy Analyses|Overall Study||0
8181028|NCT02358031|20172580|P1|Pembro Mono v Control Efficacy Analyses|Overall Study||301
8181029|NCT02358031|20172578|P3|Treated|Overall Study||287
8181030|NCT02358031|20172579|P2|Treated|Overall Study||276
8181031|NCT02358031|20172580|P1|Treated|Overall Study||300
8181032|NCT02358031|20172578|P3|STARTED|Overall Study||300
8181033|NCT02358031|20172579|P2|STARTED|Overall Study||281
8181034|NCT02358031|20172580|P1|STARTED|Overall Study||301
8181035|NCT02357940|20172707|P2|NOT COMPLETED|Overall Study||2
8181036|NCT02357940|20172708|P1|NOT COMPLETED|Overall Study||0
8181037|NCT02357940|20172707|P2|COMPLETED|Overall Study||30
8181038|NCT02357940|20172708|P1|COMPLETED|Overall Study||9
8181039|NCT02357940|20172707|P2|STARTED|Overall Study||32
8181040|NCT02357940|20172708|P1|STARTED|Overall Study||9
8181041|NCT02357901|20172835|P4|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
8181042|NCT02357901|20172836|P3|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
8181043|NCT02357901|20172837|P2|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
8181044|NCT02357901|20172838|P1|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
8181045|NCT02357901|20172835|P4|COMPLETED|Treatment Period (Day 1 to Week 24)||34
8181046|NCT02357901|20172836|P3|COMPLETED|Treatment Period (Day 1 to Week 24)||129
8181047|NCT02357901|20172837|P2|COMPLETED|Treatment Period (Day 1 to Week 24)||125
8181048|NCT02357901|20172838|P1|COMPLETED|Treatment Period (Day 1 to Week 24)||0
8181049|NCT02357901|20172835|P4|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
8181050|NCT02357901|20172836|P3|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
8181051|NCT02357901|20172837|P2|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
8181052|NCT02357901|20172838|P1|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
8181053|NCT02357901|20172835|P4|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
8181054|NCT02357901|20172836|P3|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
8181055|NCT02357901|20172837|P2|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
8181056|NCT02357901|20172838|P1|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
8181057|NCT02357901|20172835|P4|STARTED|Treatment Period (Day 1 to Week 24)||100
8181058|NCT02357901|20172836|P3|STARTED|Treatment Period (Day 1 to Week 24)||201
8181059|NCT02357901|20172837|P2|STARTED|Treatment Period (Day 1 to Week 24)||203
8181060|NCT02357901|20172838|P1|STARTED|Treatment Period (Day 1 to Week 24)||0
8181061|NCT02357901|20172835|P4|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8181062|NCT02357901|20172836|P3|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8181063|NCT02357901|20172837|P2|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
8181064|NCT02357901|20172838|P1|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
8181065|NCT02357901|20172835|P4|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8181066|NCT02357901|20172836|P3|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8181067|NCT02357901|20172837|P2|COMPLETED|Run-In Period (Days -14 to Day -1)||0
8181068|NCT02357901|20172838|P1|COMPLETED|Run-In Period (Days -14 to Day -1)||504
8181069|NCT02357901|20172835|P4|STARTED|Run-In Period (Days -14 to Day -1)||0
8181070|NCT02357901|20172836|P3|STARTED|Run-In Period (Days -14 to Day -1)||0
8181071|NCT02357901|20172837|P2|STARTED|Run-In Period (Days -14 to Day -1)||0
8181072|NCT02357901|20172838|P1|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
8181093|NCT02357758|20172903|P3|NOT COMPLETED|Overall Study||7
8181094|NCT02357758|20172904|P2|NOT COMPLETED|Overall Study||0
8181095|NCT02357758|20172905|P1|NOT COMPLETED|Overall Study||16
8181096|NCT02357758|20172903|P3|COMPLETED|Overall Study||5
8181097|NCT02357758|20172904|P2|COMPLETED|Overall Study||20
8181098|NCT02357758|20172905|P1|COMPLETED|Overall Study||9
8181099|NCT02357758|20172903|P3|STARTED|Overall Study||12
8181100|NCT02357758|20172904|P2|STARTED|Overall Study||20
8181101|NCT02357758|20172905|P1|STARTED|Overall Study||25
8181102|NCT02357706|20172913|P2|NOT COMPLETED|Overall Study||0
8181103|NCT02357706|20172914|P1|NOT COMPLETED|Overall Study||0
8181104|NCT02357706|20172913|P2|COMPLETED|Overall Study||10
8181105|NCT02357706|20172914|P1|COMPLETED|Overall Study||10
8181106|NCT02357706|20172913|P2|STARTED|Overall Study||10
8181107|NCT02357706|20172914|P1|STARTED|Overall Study||10
8181108|NCT02357576|20172938|P2|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
8181109|NCT02357576|20172939|P1|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
8181110|NCT02357576|20172938|P2|COMPLETED|Neurodevelopmental Outcome Follow Up||2
8181111|NCT02357576|20172939|P1|COMPLETED|Neurodevelopmental Outcome Follow Up||6
8181112|NCT02357576|20172938|P2|STARTED|Neurodevelopmental Outcome Follow Up||7
8181113|NCT02357576|20172939|P1|STARTED|Neurodevelopmental Outcome Follow Up|1 patient exited the study after treatment completion and before returning for follow up visits.|11
8181114|NCT02357576|20172938|P2|NOT COMPLETED|Treatment Period||2
8181115|NCT02357576|20172939|P1|NOT COMPLETED|Treatment Period||0
8181116|NCT02357576|20172938|P2|COMPLETED|Treatment Period||7
8181117|NCT02357576|20172939|P1|COMPLETED|Treatment Period||12
8181118|NCT02357576|20172938|P2|STARTED|Treatment Period||9
8181119|NCT02357576|20172939|P1|STARTED|Treatment Period||12
8181120|NCT02357485|20172983|P1|NOT COMPLETED|Overall Study||0
8181121|NCT02357485|20172983|P1|COMPLETED|Overall Study||6
8181122|NCT02357485|20172983|P1|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
8181123|NCT02357459|20172994|P3|NOT COMPLETED|Overall Study||12
8181124|NCT02357459|20172995|P2|NOT COMPLETED|Overall Study||14
8181125|NCT02357459|20172996|P1|NOT COMPLETED|Overall Study||17
8181126|NCT02357459|20172994|P3|COMPLETED|Overall Study||150
8181127|NCT02357459|20172995|P2|COMPLETED|Overall Study||149
8181128|NCT02357459|20172996|P1|COMPLETED|Overall Study||144
8181129|NCT02357459|20172994|P3|STARTED|Overall Study||162
8181130|NCT02357459|20172995|P2|STARTED|Overall Study||163
8181131|NCT02357459|20172996|P1|STARTED|Overall Study||161
8181132|NCT02357420|20173042|P4|NOT COMPLETED|Overall Study||19
8181133|NCT02357420|20173043|P3|NOT COMPLETED|Overall Study||16
8181134|NCT02357420|20173044|P2|NOT COMPLETED|Overall Study||12
8181135|NCT02357420|20173045|P1|NOT COMPLETED|Overall Study||12
8181136|NCT02357420|20173042|P4|COMPLETED|Overall Study||63
8181137|NCT02357420|20173043|P3|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93
8181138|NCT02357420|20173044|P2|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86
8181139|NCT02357420|20173045|P1|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92
8181140|NCT02357420|20173042|P4|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81
8181141|NCT02357420|20173043|P3|Full Analysis Set (FAS)|Overall Study||109
8181142|NCT02357420|20173044|P2|Full Analysis Set (FAS)|Overall Study||98
8181143|NCT02357420|20173045|P1|Full Analysis Set (FAS)|Overall Study||104
8181144|NCT02357420|20173042|P4|STARTED|Overall Study||82
8181145|NCT02357420|20173043|P3|STARTED|Overall Study||109
8181146|NCT02357420|20173044|P2|STARTED|Overall Study||98
8181147|NCT02357420|20173045|P1|STARTED|Overall Study||104
8181148|NCT02357394|20173065|P2|NOT COMPLETED|Overall Study||0
8181149|NCT02357394|20173066|P1|NOT COMPLETED|Overall Study||0
8181150|NCT02357394|20173065|P2|COMPLETED|Overall Study||3
8181151|NCT02357394|20173066|P1|COMPLETED|Overall Study||4
8181152|NCT02357394|20173065|P2|STARTED|Overall Study||3
8181153|NCT02357394|20173066|P1|STARTED|Overall Study||4
8181154|NCT02357368|20173108|P4|NOT COMPLETED|Overall Study||3
8181155|NCT02357368|20173109|P3|NOT COMPLETED|Overall Study||1
8181156|NCT02357368|20173110|P2|NOT COMPLETED|Overall Study||3
8181157|NCT02357368|20173111|P1|NOT COMPLETED|Overall Study||6
8181158|NCT02357368|20173108|P4|COMPLETED|Overall Study||5
8181159|NCT02357368|20173109|P3|COMPLETED|Overall Study||13
8181160|NCT02357368|20173110|P2|COMPLETED|Overall Study||15
8181161|NCT02357368|20173111|P1|COMPLETED|Overall Study||13
8181162|NCT02357368|20173108|P4|STARTED|Overall Study||8
8181163|NCT02357368|20173109|P3|STARTED|Overall Study||14
8181164|NCT02357368|20173110|P2|STARTED|Overall Study||18
8181165|NCT02357368|20173111|P1|STARTED|Overall Study||19
8181166|NCT02357342|20173135|P2|NOT COMPLETED|Extension Study||0
8181167|NCT02357342|20173136|P1|NOT COMPLETED|Extension Study||0
8181168|NCT02357342|20173135|P2|COMPLETED|Extension Study||9
8181169|NCT02357342|20173136|P1|COMPLETED|Extension Study||4
8181170|NCT02357342|20173135|P2|STARTED|Extension Study||9
8181171|NCT02357342|20173136|P1|STARTED|Extension Study||4
8181172|NCT02357342|20173135|P2|NOT COMPLETED|First 6 Months||0
8181173|NCT02357342|20173136|P1|NOT COMPLETED|First 6 Months||2
8181174|NCT02357342|20173135|P2|COMPLETED|First 6 Months||20
8181175|NCT02357342|20173136|P1|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
8181176|NCT02357342|20173135|P2|STARTED|First 6 Months||20
8181177|NCT02357342|20173136|P1|STARTED|First 6 Months||20
8181178|NCT02357290|20173146|P1|NOT COMPLETED|Overall Study||26
8181179|NCT02357290|20173146|P1|COMPLETED|Overall Study||14
8181180|NCT02357290|20173146|P1|Exposed|Overall Study||26
8181181|NCT02357290|20173146|P1|STARTED|Overall Study||40
8181182|NCT02357264|20173153|P2|NOT COMPLETED|Overall Study||0
8181183|NCT02357264|20173154|P1|NOT COMPLETED|Overall Study||0
8181184|NCT02357264|20173153|P2|COMPLETED|Overall Study||130
8181185|NCT02357264|20173154|P1|COMPLETED|Overall Study||56
8181186|NCT02357264|20173153|P2|STARTED|Overall Study||130
8181187|NCT02357264|20173154|P1|STARTED|Overall Study||56
8181188|NCT02357173|20173163|P3|NOT COMPLETED|Overall Study||6
8181189|NCT02357173|20173164|P2|NOT COMPLETED|Overall Study||6
8181190|NCT02357173|20173165|P1|NOT COMPLETED|Overall Study||6
8181191|NCT02357173|20173163|P3|COMPLETED|Overall Study||16
8181192|NCT02357173|20173164|P2|COMPLETED|Overall Study||15
8181193|NCT02357173|20173165|P1|COMPLETED|Overall Study||19
8181194|NCT02357173|20173163|P3|STARTED|Overall Study||22
8181195|NCT02357173|20173164|P2|STARTED|Overall Study||21
8181196|NCT02357173|20173165|P1|STARTED|Overall Study||25
8181197|NCT02357147|20173184|P2|NOT COMPLETED|Maintenance Treatment Phase||29
8181198|NCT02357147|20173185|P1|NOT COMPLETED|Maintenance Treatment Phase||26
8181199|NCT02357147|20173184|P2|COMPLETED|Maintenance Treatment Phase||0
8181200|NCT02357147|20173185|P1|COMPLETED|Maintenance Treatment Phase||0
8181201|NCT02357147|20173184|P2|Treated|Maintenance Treatment Phase||29
8181202|NCT02357147|20173185|P1|Treated|Maintenance Treatment Phase||25
8181203|NCT02357147|20173184|P2|STARTED|Maintenance Treatment Phase||29
8181204|NCT02357147|20173185|P1|STARTED|Maintenance Treatment Phase||26
8181205|NCT02357147|20173184|P2|NOT COMPLETED|Combination Treatment Phase||27
8181206|NCT02357147|20173185|P1|NOT COMPLETED|Combination Treatment Phase||26
8181207|NCT02357147|20173184|P2|COMPLETED|Combination Treatment Phase||29
8181208|NCT02357147|20173185|P1|COMPLETED|Combination Treatment Phase||26
8181209|NCT02357147|20173184|P2|Treated|Combination Treatment Phase||54
8181210|NCT02357147|20173185|P1|Treated|Combination Treatment Phase||52
8181211|NCT02357147|20173184|P2|STARTED|Combination Treatment Phase||56
8181212|NCT02357147|20173185|P1|STARTED|Combination Treatment Phase||52
8181213|NCT02356900|20173197|P2|NOT COMPLETED|Overall Study||0
8181214|NCT02356900|20173198|P1|NOT COMPLETED|Overall Study||0
8181215|NCT02356900|20173197|P2|COMPLETED|Overall Study||10
8181216|NCT02356900|20173198|P1|COMPLETED|Overall Study||11
8181217|NCT02356900|20173197|P2|STARTED|Overall Study||10
8181218|NCT02356900|20173198|P1|STARTED|Overall Study||11
8181219|NCT02356887|20173216|P1|NOT COMPLETED|Overall Study||2
8181220|NCT02356887|20173216|P1|COMPLETED|Overall Study||10
8181221|NCT02356887|20173216|P1|STARTED|Overall Study||12
8181222|NCT02356783|20173233|P2|NOT COMPLETED|Overall Study||3
8181223|NCT02356783|20173234|P1|NOT COMPLETED|Overall Study||1
8181224|NCT02356783|20173233|P2|COMPLETED|Overall Study||14
8181225|NCT02356783|20173234|P1|COMPLETED|Overall Study||15
8181226|NCT02356783|20173233|P2|STARTED|Overall Study||17
8181227|NCT02356783|20173234|P1|STARTED|Overall Study||16
8181228|NCT02356692|20173242|P2|NOT COMPLETED|Overall Study||0
8181229|NCT02356692|20173243|P1|NOT COMPLETED|Overall Study||0
8181230|NCT02356692|20173242|P2|COMPLETED|Overall Study||60
8181231|NCT02356692|20173243|P1|COMPLETED|Overall Study||60
8181232|NCT02356692|20173242|P2|STARTED|Overall Study||60
8181233|NCT02356692|20173243|P1|STARTED|Overall Study||60
8181234|NCT02356588|20173255|P2|NOT COMPLETED|Overall Study||13
8181235|NCT02356588|20173256|P1|NOT COMPLETED|Overall Study||5
8181236|NCT02356588|20173255|P2|COMPLETED|Overall Study||41
8181237|NCT02356588|20173256|P1|COMPLETED|Overall Study||102
8181238|NCT02356588|20173255|P2|STARTED|Overall Study||54
8181239|NCT02356588|20173256|P1|STARTED|Overall Study||107
8181240|NCT02356575|20173290|P2|NOT COMPLETED|Overall Study||0
8181241|NCT02356575|20173291|P1|NOT COMPLETED|Overall Study||0
8181242|NCT02356575|20173290|P2|COMPLETED|Overall Study||80
8181243|NCT02356575|20173291|P1|COMPLETED|Overall Study||80
8181244|NCT02356575|20173290|P2|STARTED|Overall Study||80
8181245|NCT02356575|20173291|P1|STARTED|Overall Study||80
8181246|NCT02356562|20173373|P2|NOT COMPLETED|Overall Study||1
8181247|NCT02356562|20173374|P1|NOT COMPLETED|Overall Study||2
8181248|NCT02356562|20173373|P2|COMPLETED|Overall Study||6
8181249|NCT02356562|20173374|P1|COMPLETED|Overall Study||20
8181250|NCT02356562|20173373|P2|STARTED|Overall Study||7
8181251|NCT02356562|20173374|P1|STARTED|Overall Study||22
8181252|NCT02356484|20173384|P1|NOT COMPLETED|Overall Study||0
8181253|NCT02356484|20173384|P1|COMPLETED|Overall Study||138
8181254|NCT02356484|20173384|P1|STARTED|Overall Study||138
8181255|NCT02356471|20173388|P1|NOT COMPLETED|Overall Study||6
8181256|NCT02356471|20173388|P1|COMPLETED|Overall Study||28
8181257|NCT02356471|20173388|P1|STARTED|Overall Study||34
8181258|NCT02356211|20173403|P2|NOT COMPLETED|Overall Study||10
8181259|NCT02356211|20173404|P1|NOT COMPLETED|Overall Study||3
8181260|NCT02356211|20173403|P2|COMPLETED|Overall Study||42
8181261|NCT02356211|20173404|P1|COMPLETED|Overall Study||54
8181262|NCT02356211|20173403|P2|STARTED|Overall Study||52
8181263|NCT02356211|20173404|P1|STARTED|Overall Study||57
8181264|NCT02356198|20173412|P2|NOT COMPLETED|Overall Study||7
8181265|NCT02356198|20173413|P1|NOT COMPLETED|Overall Study||2
8181266|NCT02356198|20173412|P2|COMPLETED|Overall Study||98
8181267|NCT02356198|20173413|P1|COMPLETED|Overall Study||102
8181268|NCT02356198|20173412|P2|STARTED|Overall Study||105
8181269|NCT02356198|20173413|P1|STARTED|Overall Study||104
8181270|NCT02356107|20173427|P1|NOT COMPLETED|Overall Study||3
8181271|NCT02356107|20173427|P1|COMPLETED|Overall Study||12
8181272|NCT02356107|20173427|P1|STARTED|Overall Study||15
8181273|NCT02356003|20173431|P1|NOT COMPLETED|Overall Study||0
8181274|NCT02356003|20173431|P1|COMPLETED|Overall Study||10
8181275|NCT02356003|20173431|P1|STARTED|Overall Study||10
8181276|NCT02355977|20173440|P3|NOT COMPLETED|Overall Study||0
8181277|NCT02355977|20173441|P2|NOT COMPLETED|Overall Study||0
8181278|NCT02355977|20173442|P1|NOT COMPLETED|Overall Study||0
8181279|NCT02355977|20173440|P3|COMPLETED|Overall Study||23
8181280|NCT02355977|20173441|P2|COMPLETED|Overall Study||26
8181281|NCT02355977|20173442|P1|COMPLETED|Overall Study||21
8181282|NCT02355977|20173440|P3|STARTED|Overall Study||23
8181283|NCT02355977|20173441|P2|STARTED|Overall Study||26
8181284|NCT02355977|20173442|P1|STARTED|Overall Study||21
8181285|NCT02355886|20173458|P2|NOT COMPLETED|Overall Study||0
8181286|NCT02355886|20173459|P1|NOT COMPLETED|Overall Study||0
8181287|NCT02355886|20173458|P2|COMPLETED|Overall Study||12
8181288|NCT02355886|20173459|P1|COMPLETED|Overall Study||13
8181289|NCT02355886|20173458|P2|STARTED|Overall Study||12
8181290|NCT02355886|20173459|P1|STARTED|Overall Study||13
8181291|NCT02355743|20173469|P1|NOT COMPLETED|Overall Study||2
8181292|NCT02355743|20173469|P1|COMPLETED|Overall Study||6
8181293|NCT02355743|20173469|P1|STARTED|Overall Study||8
8181294|NCT02355691|20173477|P2|NOT COMPLETED|Overall Study||9
8181295|NCT02355691|20173478|P1|NOT COMPLETED|Overall Study||7
8181296|NCT02355691|20173477|P2|COMPLETED|Overall Study||0
8181297|NCT02355691|20173478|P1|COMPLETED|Overall Study||0
8181298|NCT02355691|20173477|P2|2nd Postop Visit|Overall Study||9
8181299|NCT02355691|20173478|P1|2nd Postop Visit|Overall Study||7
8181300|NCT02355691|20173477|P2|1st Postop Visit|Overall Study||9
8181301|NCT02355691|20173478|P1|1st Postop Visit|Overall Study||7
8181302|NCT02355691|20173477|P2|STARTED|Overall Study||9
8181303|NCT02355691|20173478|P1|STARTED|Overall Study||7
8181304|NCT02355665|20173488|P2|NOT COMPLETED|Overall Study||232
8181305|NCT02355665|20173489|P1|NOT COMPLETED|Overall Study||249
8181306|NCT02355665|20173488|P2|COMPLETED|Overall Study||365
8181307|NCT02355665|20173489|P1|COMPLETED|Overall Study||352
8181308|NCT02355665|20173488|P2|STARTED|Overall Study||597
8181309|NCT02355665|20173489|P1|STARTED|Overall Study||601
8181310|NCT02355275|20173921|P1|NOT COMPLETED|Overall Study||8
8181311|NCT02355275|20173921|P1|COMPLETED|Overall Study||14
8181312|NCT02355275|20173921|P1|STARTED|Overall Study||22
8181313|NCT02355158|20173926|P1|NOT COMPLETED|Overall Study||150
8181314|NCT02355158|20173926|P1|COMPLETED|Overall Study||47
8181315|NCT02355158|20173926|P1|STARTED|Overall Study||197
8181322|NCT02355028|20173947|P2|NOT COMPLETED|Overall Study||5
8181323|NCT02355028|20173948|P1|NOT COMPLETED|Overall Study||11
8181324|NCT02355028|20173947|P2|COMPLETED|Overall Study||41
8181325|NCT02355028|20173948|P1|COMPLETED|Overall Study||36
8181326|NCT02355028|20173947|P2|Treated|Overall Study||45
8181327|NCT02355028|20173948|P1|Treated|Overall Study||46
8181328|NCT02355028|20173947|P2|STARTED|Overall Study||46
8181329|NCT02355028|20173948|P1|STARTED|Overall Study||47
8181330|NCT02354976|20173984|P3|NOT COMPLETED|Overall Study||3
8181331|NCT02354976|20173985|P2|NOT COMPLETED|Overall Study||1
8181332|NCT02354976|20173986|P1|NOT COMPLETED|Overall Study||2
8181333|NCT02354976|20173984|P3|COMPLETED|Overall Study||23
8181334|NCT02354976|20173985|P2|COMPLETED|Overall Study||26
8181335|NCT02354976|20173986|P1|COMPLETED|Overall Study||23
8181336|NCT02354976|20173984|P3|STARTED|Overall Study||26
8181337|NCT02354976|20173985|P2|STARTED|Overall Study||27
8181338|NCT02354976|20173986|P1|STARTED|Overall Study||25
8181339|NCT02354924|20173997|P2|NOT COMPLETED|Overall Study||0
8181340|NCT02354924|20173998|P1|NOT COMPLETED|Overall Study||0
8181341|NCT02354924|20173997|P2|COMPLETED|Overall Study||20
8181342|NCT02354924|20173998|P1|COMPLETED|Overall Study||40
8181343|NCT02354924|20173997|P2|STARTED|Overall Study||20
8181344|NCT02354924|20173998|P1|STARTED|Overall Study||40
8181345|NCT02354859|20174010|P2|NOT COMPLETED|Overall Study||2
8181346|NCT02354859|20174011|P1|NOT COMPLETED|Overall Study||0
8181347|NCT02354859|20174010|P2|COMPLETED|Overall Study||57
8181348|NCT02354859|20174011|P1|COMPLETED|Overall Study||60
8181349|NCT02354859|20174010|P2|STARTED|Overall Study||59
8181350|NCT02354859|20174011|P1|STARTED|Overall Study||60
8181351|NCT02354833|20174029|P2|NOT COMPLETED|Overall Study||0
8181352|NCT02354833|20174030|P1|NOT COMPLETED|Overall Study||0
8181353|NCT02354833|20174029|P2|COMPLETED|Overall Study||43
8181354|NCT02354833|20174030|P1|COMPLETED|Overall Study||38
8181355|NCT02354833|20174029|P2|STARTED|Overall Study||43
8181356|NCT02354833|20174030|P1|STARTED|Overall Study||38
8181357|NCT02354781|20174042|P1|NOT COMPLETED|Overall Study||0
8181358|NCT02354781|20174042|P1|COMPLETED|Overall Study||3
8181359|NCT02354781|20174042|P1|STARTED|Overall Study||3
8181360|NCT02354690|20174049|P1|NOT COMPLETED|Overall Study||1
8181361|NCT02354690|20174049|P1|COMPLETED|Overall Study||12
8181362|NCT02354690|20174049|P1|STARTED|Overall Study||13
8181363|NCT02354599|20174063|P6|NOT COMPLETED|Overall Study||1
8181364|NCT02354599|20174064|P5|NOT COMPLETED|Overall Study||0
8181365|NCT02354599|20174065|P4|NOT COMPLETED|Overall Study||0
8181366|NCT02354599|20174066|P3|NOT COMPLETED|Overall Study||0
8181367|NCT02354599|20174067|P2|NOT COMPLETED|Overall Study||1
8181368|NCT02354599|20174068|P1|NOT COMPLETED|Overall Study||1
8181369|NCT02354599|20174063|P6|COMPLETED|Overall Study||5
8181370|NCT02354599|20174064|P5|COMPLETED|Overall Study||2
8181371|NCT02354599|20174065|P4|COMPLETED|Overall Study||6
8181372|NCT02354599|20174066|P3|COMPLETED|Overall Study||6
8181373|NCT02354599|20174067|P2|COMPLETED|Overall Study||5
8181374|NCT02354599|20174068|P1|COMPLETED|Overall Study||5
8181375|NCT02354599|20174063|P6|STARTED|Overall Study||6
8181376|NCT02354599|20174064|P5|STARTED|Overall Study||2
8181377|NCT02354599|20174065|P4|STARTED|Overall Study||6
8181378|NCT02354599|20174066|P3|STARTED|Overall Study||6
8181379|NCT02354599|20174067|P2|STARTED|Overall Study||6
8181380|NCT02354599|20174068|P1|STARTED|Overall Study||6
8181381|NCT02354586|20174138|P1|NOT COMPLETED|Overall Study||341
8181382|NCT02354586|20174138|P1|COMPLETED|Overall Study||122
8181383|NCT02354586|20174138|P1|Ongoing in Study|Overall Study||21
8181384|NCT02354586|20174138|P1|STARTED|Overall Study||463
8181385|NCT02354508|20174157|P3|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
8181386|NCT02354508|20174158|P2|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
8181387|NCT02354508|20174159|P1|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4
8181388|NCT02354508|20174157|P3|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|36
8181389|NCT02354508|20174158|P2|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|20
8181390|NCT02354508|20174159|P1|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|22
8181391|NCT02354508|20174157|P3|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
8181392|NCT02354508|20174158|P2|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
8181393|NCT02354508|20174159|P1|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|4
8181394|NCT02354508|20174157|P3|STARTED|Period 3: Post-treatment Follow up Phase||39
8181395|NCT02354508|20174158|P2|STARTED|Period 3: Post-treatment Follow up Phase||23
8181396|NCT02354508|20174159|P1|STARTED|Period 3: Post-treatment Follow up Phase||26
8181397|NCT02354508|20174157|P3|NOT COMPLETED|Period 2: Extension Phase||3
8181398|NCT02354508|20174158|P2|NOT COMPLETED|Period 2: Extension Phase||4
8181399|NCT02354508|20174159|P1|NOT COMPLETED|Period 2: Extension Phase||6
8181400|NCT02354508|20174157|P3|COMPLETED|Period 2: Extension Phase||36
8181401|NCT02354508|20174158|P2|COMPLETED|Period 2: Extension Phase||19
8181402|NCT02354508|20174159|P1|COMPLETED|Period 2: Extension Phase||20
8181403|NCT02354508|20174157|P3|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|39
8181404|NCT02354508|20174158|P2|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|23
8181405|NCT02354508|20174159|P1|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|26
8181406|NCT02354508|20174157|P3|NOT COMPLETED|Period 1: Core Phase||6
8181407|NCT02354508|20174158|P2|NOT COMPLETED|Period 1: Core Phase||2
8181408|NCT02354508|20174159|P1|NOT COMPLETED|Period 1: Core Phase||2
8181409|NCT02354508|20174157|P3|COMPLETED|Period 1: Core Phase||47
8181410|NCT02354508|20174158|P2|COMPLETED|Period 1: Core Phase||27
8181411|NCT02354508|20174159|P1|COMPLETED|Period 1: Core Phase||39
8181412|NCT02354508|20174157|P3|STARTED|Period 1: Core Phase||53
8181413|NCT02354508|20174158|P2|STARTED|Period 1: Core Phase||29
8181414|NCT02354508|20174159|P1|STARTED|Period 1: Core Phase||41
8181415|NCT02354482|20174237|P1|NOT COMPLETED|Reference||0
8181416|NCT02354482|20174237|P1|COMPLETED|Reference||2042
8181417|NCT02354482|20174237|P1|STARTED|Reference||2042
8181418|NCT02354482|20174237|P1|NOT COMPLETED|Assessment and Teach Back||0
8181419|NCT02354482|20174237|P1|COMPLETED|Assessment and Teach Back||508
8181420|NCT02354482|20174237|P1|STARTED|Assessment and Teach Back||508
8181421|NCT02354482|20174237|P1|NOT COMPLETED|Patient/Family Caregiver Assessment||0
8181422|NCT02354482|20174237|P1|COMPLETED|Patient/Family Caregiver Assessment||3093
8181423|NCT02354482|20174237|P1|STARTED|Patient/Family Caregiver Assessment||3093
8181424|NCT02354482|20174237|P1|NOT COMPLETED|Hospital-Based Trust and Plain Language||0
8181425|NCT02354482|20174237|P1|COMPLETED|Hospital-Based Trust and Plain Language||2090
8181426|NCT02354482|20174237|P1|STARTED|Hospital-Based Trust and Plain Language||2090
8181427|NCT02354482|20174237|P1|NOT COMPLETED|Home-Based Trust and Plain Language||0
8181428|NCT02354482|20174237|P1|COMPLETED|Home-Based Trust and Plain Language||1979
8181429|NCT02354482|20174237|P1|STARTED|Home-Based Trust and Plain Language||1979
8181430|NCT02354482|20174237|P1|NOT COMPLETED|Patient Communication and Care||0
8181431|NCT02354482|20174237|P1|COMPLETED|Patient Communication and Care||2158
8181432|NCT02354482|20174237|P1|STARTED|Patient Communication and Care||2158
8181433|NCT02354443|20174257|P1|NOT COMPLETED|Overall Study||0
8181434|NCT02354443|20174257|P1|COMPLETED|Overall Study||1
8181435|NCT02354443|20174257|P1|STARTED|Overall Study||1
8181436|NCT02354417|20174261|P1|NOT COMPLETED|Overall Study||1
8181437|NCT02354417|20174261|P1|COMPLETED|Overall Study||2
8181438|NCT02354417|20174261|P1|STARTED|Overall Study||3
8181439|NCT02354378|20174267|P2|NOT COMPLETED|Overall Study||4
8181440|NCT02354378|20174268|P1|NOT COMPLETED|Overall Study||34
8181441|NCT02354378|20174267|P2|COMPLETED|Overall Study||16
8181442|NCT02354378|20174268|P1|COMPLETED|Overall Study||30
8181443|NCT02354378|20174267|P2|STARTED|Overall Study||20
8181444|NCT02354378|20174268|P1|STARTED|Overall Study||64
8181445|NCT02354352|20174278|P2|NOT COMPLETED|Overall Study||3
8181446|NCT02354352|20174279|P1|NOT COMPLETED|Overall Study||3
8181447|NCT02354352|20174278|P2|COMPLETED|Overall Study||23
8181448|NCT02354352|20174279|P1|COMPLETED|Overall Study||23
8181449|NCT02354352|20174278|P2|9 Months|Overall Study||23
8181450|NCT02354352|20174279|P1|9 Months|Overall Study||25
8181451|NCT02354352|20174278|P2|6 Months|Overall Study||23
8181452|NCT02354352|20174279|P1|6 Months|Overall Study||25
8181453|NCT02354352|20174278|P2|3 Months|Overall Study||23
8181454|NCT02354352|20174279|P1|3 Months|Overall Study||25
8181455|NCT02354352|20174278|P2|2 Months|Overall Study||22
8181456|NCT02354352|20174279|P1|2 Months|Overall Study||24
8181457|NCT02354352|20174278|P2|1 Month|Overall Study||23
8181458|NCT02354352|20174279|P1|1 Month|Overall Study||24
8181459|NCT02354352|20174278|P2|2 Weeks|Overall Study||25
8181460|NCT02354352|20174279|P1|2 Weeks|Overall Study||26
8181461|NCT02354352|20174278|P2|STARTED|Overall Study||26
8181462|NCT02354352|20174279|P1|STARTED|Overall Study||26
8181463|NCT02354339|20174287|P2|NOT COMPLETED|Overall Study||0
8181464|NCT02354339|20174288|P1|NOT COMPLETED|Overall Study||0
8181465|NCT02354339|20174287|P2|COMPLETED|Overall Study||12
8181466|NCT02354339|20174288|P1|COMPLETED|Overall Study||12
8181467|NCT02354339|20174287|P2|STARTED|Overall Study||12
8181468|NCT02354339|20174288|P1|STARTED|Overall Study||12
8181469|NCT02354235|20174328|P2|NOT COMPLETED|Overall Study||7
8181470|NCT02354235|20174329|P1|NOT COMPLETED|Overall Study||3
8181471|NCT02354235|20174328|P2|COMPLETED|Overall Study||61
8181472|NCT02354235|20174329|P1|COMPLETED|Overall Study||67
8181473|NCT02354235|20174328|P2|STARTED|Overall Study||68
8181474|NCT02354235|20174329|P1|STARTED|Overall Study||70
8181475|NCT02354222|20174345|P2|NOT COMPLETED|Overall Study||11
8181476|NCT02354222|20174346|P1|NOT COMPLETED|Overall Study||4
8181477|NCT02354222|20174345|P2|COMPLETED|Overall Study||66
8181478|NCT02354222|20174346|P1|COMPLETED|Overall Study||73
8181479|NCT02354222|20174345|P2|STARTED|Overall Study||77
8181480|NCT02354222|20174346|P1|STARTED|Overall Study||77
8181481|NCT02354092|20174362|P2|NOT COMPLETED|Overall Study||0
8181482|NCT02354092|20174363|P1|NOT COMPLETED|Overall Study||0
8181483|NCT02354092|20174362|P2|COMPLETED|Overall Study||7
8181484|NCT02354092|20174363|P1|COMPLETED|Overall Study||7
8181485|NCT02354092|20174362|P2|STARTED|Overall Study||7
8181486|NCT02354092|20174363|P1|STARTED|Overall Study||7
8181487|NCT02353871|20174377|P2|NOT COMPLETED|Overall Study||9
8181488|NCT02353871|20174378|P1|NOT COMPLETED|Overall Study||3
8181489|NCT02353871|20174377|P2|COMPLETED|Overall Study||51
8181490|NCT02353871|20174378|P1|COMPLETED|Overall Study||122
8181491|NCT02353871|20174377|P2|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
8181492|NCT02353871|20174378|P1|STARTED|Overall Study|Randomised.|125
8181496|NCT02353806|20174403|P1|NOT COMPLETED|Overall Study||10
8181497|NCT02353806|20174403|P1|COMPLETED|Overall Study||6
8181498|NCT02353806|20174403|P1|STARTED|Overall Study||16
8181499|NCT02353780|20174421|P3|NOT COMPLETED|Overall Study||0
8181500|NCT02353780|20174422|P2|NOT COMPLETED|Overall Study||0
8181501|NCT02353780|20174423|P1|NOT COMPLETED|Overall Study||0
8181502|NCT02353780|20174421|P3|COMPLETED|Overall Study||3
8181503|NCT02353780|20174422|P2|COMPLETED|Overall Study||3
8181504|NCT02353780|20174423|P1|COMPLETED|Overall Study||3
8181505|NCT02353780|20174421|P3|STARTED|Overall Study||3
8181506|NCT02353780|20174422|P2|STARTED|Overall Study||3
8181507|NCT02353780|20174423|P1|STARTED|Overall Study||3
8181514|NCT02353572|20174471|P1|NOT COMPLETED|Overall Study||3
8181515|NCT02353572|20174471|P1|COMPLETED|Overall Study||0
8181516|NCT02353572|20174471|P1|STARTED|Overall Study||3
8181517|NCT02353468|20174475|P1|NOT COMPLETED|Overall Study||3
8181518|NCT02353468|20174475|P1|COMPLETED|Overall Study||0
8181519|NCT02353468|20174475|P1|STARTED|Overall Study||3
8181520|NCT02353442|20174481|P2|NOT COMPLETED|Overall Study||4
8181521|NCT02353442|20174482|P1|NOT COMPLETED|Overall Study||3
8181522|NCT02353442|20174481|P2|COMPLETED|Overall Study||27
8181523|NCT02353442|20174482|P1|COMPLETED|Overall Study||25
8181524|NCT02353442|20174481|P2|STARTED|Overall Study||31
8181525|NCT02353442|20174482|P1|STARTED|Overall Study||28
8181526|NCT02353299|20174496|P4|NOT COMPLETED|Fourth Intervention (1 Night)||0
8181527|NCT02353299|20174497|P3|NOT COMPLETED|Fourth Intervention (1 Night)||0
8181528|NCT02353299|20174498|P2|NOT COMPLETED|Fourth Intervention (1 Night)||0
8181529|NCT02353299|20174499|P1|NOT COMPLETED|Fourth Intervention (1 Night)||0
8181530|NCT02353299|20174496|P4|COMPLETED|Fourth Intervention (1 Night)||13
8181531|NCT02353299|20174497|P3|COMPLETED|Fourth Intervention (1 Night)||13
8181532|NCT02353299|20174498|P2|COMPLETED|Fourth Intervention (1 Night)||12
8181533|NCT02353299|20174499|P1|COMPLETED|Fourth Intervention (1 Night)||13
8181534|NCT02353299|20174496|P4|STARTED|Fourth Intervention (1 Night)||13
8181535|NCT02353299|20174497|P3|STARTED|Fourth Intervention (1 Night)||13
8181536|NCT02353299|20174498|P2|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
8181537|NCT02353299|20174499|P1|STARTED|Fourth Intervention (1 Night)||13
8181538|NCT02353299|20174496|P4|NOT COMPLETED|Third Intervention (1 Night)||0
8181539|NCT02353299|20174497|P3|NOT COMPLETED|Third Intervention (1 Night)||0
8181540|NCT02353299|20174498|P2|NOT COMPLETED|Third Intervention (1 Night)||0
8181541|NCT02353299|20174499|P1|NOT COMPLETED|Third Intervention (1 Night)||0
8181542|NCT02353299|20174496|P4|COMPLETED|Third Intervention (1 Night)||13
8181543|NCT02353299|20174497|P3|COMPLETED|Third Intervention (1 Night)||13
8181544|NCT02353299|20174498|P2|COMPLETED|Third Intervention (1 Night)||13
8181545|NCT02353299|20174499|P1|COMPLETED|Third Intervention (1 Night)||13
8181546|NCT02353299|20174496|P4|STARTED|Third Intervention (1 Night)||13
8181547|NCT02353299|20174497|P3|STARTED|Third Intervention (1 Night)||13
8181548|NCT02353299|20174498|P2|STARTED|Third Intervention (1 Night)||13
8181549|NCT02353299|20174499|P1|STARTED|Third Intervention (1 Night)||13
8181550|NCT02353299|20174496|P4|NOT COMPLETED|Second Intervention (1 Night)||0
8181551|NCT02353299|20174497|P3|NOT COMPLETED|Second Intervention (1 Night)||0
8181552|NCT02353299|20174498|P2|NOT COMPLETED|Second Intervention (1 Night)||0
8181553|NCT02353299|20174499|P1|NOT COMPLETED|Second Intervention (1 Night)||0
8181554|NCT02353299|20174496|P4|COMPLETED|Second Intervention (1 Night)||13
8181555|NCT02353299|20174497|P3|COMPLETED|Second Intervention (1 Night)||13
8181556|NCT02353299|20174498|P2|COMPLETED|Second Intervention (1 Night)||13
8181557|NCT02353299|20174499|P1|COMPLETED|Second Intervention (1 Night)||13
8181558|NCT02353299|20174496|P4|STARTED|Second Intervention (1 Night)||13
8181559|NCT02353299|20174497|P3|STARTED|Second Intervention (1 Night)||13
8181560|NCT02353299|20174498|P2|STARTED|Second Intervention (1 Night)||13
8181561|NCT02353299|20174499|P1|STARTED|Second Intervention (1 Night)||13
8181562|NCT02353299|20174496|P4|NOT COMPLETED|First Intervention (1 Night)||0
8181563|NCT02353299|20174497|P3|NOT COMPLETED|First Intervention (1 Night)||0
8181564|NCT02353299|20174498|P2|NOT COMPLETED|First Intervention (1 Night)||0
8181565|NCT02353299|20174499|P1|NOT COMPLETED|First Intervention (1 Night)||0
8181566|NCT02353299|20174496|P4|COMPLETED|First Intervention (1 Night)||13
8181567|NCT02353299|20174497|P3|COMPLETED|First Intervention (1 Night)||13
8181568|NCT02353299|20174498|P2|COMPLETED|First Intervention (1 Night)||13
8181569|NCT02353299|20174499|P1|COMPLETED|First Intervention (1 Night)||13
8181570|NCT02353299|20174496|P4|STARTED|First Intervention (1 Night)||13
8181571|NCT02353299|20174497|P3|STARTED|First Intervention (1 Night)||13
8181572|NCT02353299|20174498|P2|STARTED|First Intervention (1 Night)||13
8181573|NCT02353299|20174499|P1|STARTED|First Intervention (1 Night)||13
8181574|NCT02353169|20174537|P4|NOT COMPLETED|Overall Study||3
8181575|NCT02353169|20174538|P3|NOT COMPLETED|Overall Study||4
8181576|NCT02353169|20174539|P2|NOT COMPLETED|Overall Study||6
8181577|NCT02353169|20174540|P1|NOT COMPLETED|Overall Study||3
8181578|NCT02353169|20174537|P4|COMPLETED|Overall Study||12
8181579|NCT02353169|20174538|P3|COMPLETED|Overall Study||12
8181580|NCT02353169|20174539|P2|COMPLETED|Overall Study||12
8181581|NCT02353169|20174540|P1|COMPLETED|Overall Study||12
8181582|NCT02353169|20174537|P4|STARTED|Overall Study||15
8181583|NCT02353169|20174538|P3|STARTED|Overall Study||16
8181584|NCT02353169|20174539|P2|STARTED|Overall Study||18
8181585|NCT02353169|20174540|P1|STARTED|Overall Study||15
8181586|NCT02353091|20174560|P2|NOT COMPLETED|Overall Study||0
8181587|NCT02353091|20174561|P1|NOT COMPLETED|Overall Study||0
8181588|NCT02353091|20174560|P2|COMPLETED|Overall Study||13
8181589|NCT02353091|20174561|P1|COMPLETED|Overall Study||13
8181590|NCT02353091|20174560|P2|STARTED|Overall Study||13
8181591|NCT02353091|20174561|P1|STARTED|Overall Study||13
8181592|NCT02352974|20174599|P1|NOT COMPLETED|Extension||0
8181593|NCT02352974|20174599|P1|COMPLETED|Extension||3
8181594|NCT02352974|20174599|P1|STARTED|Extension|Only 3 out of the 12 patients who completed the main study continued in to the extension period.|3
8181595|NCT02352974|20174599|P1|NOT COMPLETED|Main Study||0
8181596|NCT02352974|20174599|P1|COMPLETED|Main Study||12
8181597|NCT02352974|20174599|P1|STARTED|Main Study||12
8181628|NCT02352922|20174695|P2|NOT COMPLETED|Overall Study||4
8181629|NCT02352922|20174696|P1|NOT COMPLETED|Overall Study||4
8181630|NCT02352922|20174695|P2|COMPLETED|Overall Study|Completed POD14 survey|28
8181631|NCT02352922|20174696|P1|COMPLETED|Overall Study|completed POD14 Survey|28
8181632|NCT02352922|20174695|P2|STARTED|Overall Study||32
8181633|NCT02352922|20174696|P1|STARTED|Overall Study||32
8181634|NCT02352844|20174730|P1|NOT COMPLETED|Overall Study||0
8181635|NCT02352844|20174730|P1|COMPLETED|Overall Study||12
8181636|NCT02352844|20174730|P1|STARTED|Overall Study||12
8181637|NCT02352831|20174738|P2|NOT COMPLETED|Overall Study||0
8181638|NCT02352831|20174739|P1|NOT COMPLETED|Overall Study||0
8181639|NCT02352831|20174738|P2|COMPLETED|Overall Study||10
8181640|NCT02352831|20174739|P1|COMPLETED|Overall Study||6
8181641|NCT02352831|20174738|P2|STARTED|Overall Study||10
8181642|NCT02352831|20174739|P1|STARTED|Overall Study||6
8181643|NCT02352779|20174762|P3|NOT COMPLETED|Overall Study||2
8181644|NCT02352779|20174763|P2|NOT COMPLETED|Overall Study||1
8181645|NCT02352779|20174764|P1|NOT COMPLETED|Overall Study||8
8181646|NCT02352779|20174762|P3|COMPLETED|Overall Study||33
8181647|NCT02352779|20174763|P2|COMPLETED|Overall Study||35
8181648|NCT02352779|20174764|P1|COMPLETED|Overall Study||29
8181649|NCT02352779|20174762|P3|STARTED|Overall Study||35
8181650|NCT02352779|20174763|P2|STARTED|Overall Study||36
8181651|NCT02352779|20174764|P1|STARTED|Overall Study||37
8181652|NCT02352493|20174790|P18|NOT COMPLETED|Overall Study||0
8181653|NCT02352493|20174791|P17|NOT COMPLETED|Overall Study||0
8181654|NCT02352493|20174792|P16|NOT COMPLETED|Overall Study||0
8181655|NCT02352493|20174793|P15|NOT COMPLETED|Overall Study||1
8181656|NCT02352493|20174794|P14|NOT COMPLETED|Overall Study||2
8181657|NCT02352493|20174795|P13|NOT COMPLETED|Overall Study||1
8181658|NCT02352493|20174796|P12|NOT COMPLETED|Overall Study||0
8181659|NCT02352493|20174797|P11|NOT COMPLETED|Overall Study||0
8181660|NCT02352493|20174798|P10|NOT COMPLETED|Overall Study||1
8181661|NCT02352493|20174799|P9|NOT COMPLETED|Overall Study||2
8181662|NCT02352493|20174800|P8|NOT COMPLETED|Overall Study||0
8181663|NCT02352493|20174801|P7|NOT COMPLETED|Overall Study||1
8181664|NCT02352493|20174802|P6|NOT COMPLETED|Overall Study||0
8181665|NCT02352493|20174803|P5|NOT COMPLETED|Overall Study||0
8181666|NCT02352493|20174804|P4|NOT COMPLETED|Overall Study||0
8181667|NCT02352493|20174805|P3|NOT COMPLETED|Overall Study||0
8181668|NCT02352493|20174806|P2|NOT COMPLETED|Overall Study||0
8181669|NCT02352493|20174807|P1|NOT COMPLETED|Overall Study||0
8181670|NCT02352493|20174790|P18|COMPLETED|Overall Study||3
8181671|NCT02352493|20174791|P17|COMPLETED|Overall Study||3
8181672|NCT02352493|20174792|P16|COMPLETED|Overall Study||3
8181673|NCT02352493|20174793|P15|COMPLETED|Overall Study||2
8181674|NCT02352493|20174794|P14|COMPLETED|Overall Study||1
8181675|NCT02352493|20174795|P13|COMPLETED|Overall Study||2
8181676|NCT02352493|20174796|P12|COMPLETED|Overall Study||3
8181677|NCT02352493|20174797|P11|COMPLETED|Overall Study||3
8181678|NCT02352493|20174798|P10|COMPLETED|Overall Study||5
8181679|NCT02352493|20174799|P9|COMPLETED|Overall Study||1
8181680|NCT02352493|20174800|P8|COMPLETED|Overall Study||3
8181681|NCT02352493|20174801|P7|COMPLETED|Overall Study||2
8181682|NCT02352493|20174802|P6|COMPLETED|Overall Study||3
8181683|NCT02352493|20174803|P5|COMPLETED|Overall Study||3
8181684|NCT02352493|20174804|P4|COMPLETED|Overall Study||3
8181685|NCT02352493|20174805|P3|COMPLETED|Overall Study||3
8181686|NCT02352493|20174806|P2|COMPLETED|Overall Study||3
8181687|NCT02352493|20174807|P1|COMPLETED|Overall Study||8
8181688|NCT02352493|20174790|P18|STARTED|Overall Study||3
8181689|NCT02352493|20174791|P17|STARTED|Overall Study||3
8181690|NCT02352493|20174792|P16|STARTED|Overall Study||3
8181691|NCT02352493|20174793|P15|STARTED|Overall Study||3
8181692|NCT02352493|20174794|P14|STARTED|Overall Study||3
8181693|NCT02352493|20174795|P13|STARTED|Overall Study||3
8181694|NCT02352493|20174796|P12|STARTED|Overall Study||3
8181695|NCT02352493|20174797|P11|STARTED|Overall Study||3
8181696|NCT02352493|20174798|P10|STARTED|Overall Study||6
8181697|NCT02352493|20174799|P9|STARTED|Overall Study||3
8181698|NCT02352493|20174800|P8|STARTED|Overall Study||3
8181699|NCT02352493|20174801|P7|STARTED|Overall Study||3
8181700|NCT02352493|20174802|P6|STARTED|Overall Study||3
8181701|NCT02352493|20174803|P5|STARTED|Overall Study||3
8181702|NCT02352493|20174804|P4|STARTED|Overall Study||3
8181703|NCT02352493|20174805|P3|STARTED|Overall Study||3
8181704|NCT02352493|20174806|P2|STARTED|Overall Study||3
8181705|NCT02352493|20174807|P1|STARTED|Overall Study||8
8181706|NCT02352363|20174997|P2|NOT COMPLETED|Overall Study||3
8181707|NCT02352363|20174998|P1|NOT COMPLETED|Overall Study||7
8181708|NCT02352363|20174997|P2|COMPLETED|Overall Study||127
8181709|NCT02352363|20174998|P1|COMPLETED|Overall Study||271
8181710|NCT02352363|20174997|P2|STARTED|Overall Study||130
8181711|NCT02352363|20174998|P1|STARTED|Overall Study||278
8181712|NCT02352298|20175010|P1|NOT COMPLETED|Overall Study||0
8181713|NCT02352298|20175010|P1|COMPLETED|Overall Study||52
8181714|NCT02352298|20175010|P1|STARTED|Overall Study||52
8181715|NCT02352103|20175017|P2|NOT COMPLETED|Overall Study||1
8181716|NCT02352103|20175018|P1|NOT COMPLETED|Overall Study||0
8181717|NCT02352103|20175017|P2|COMPLETED|Overall Study||59
8181718|NCT02352103|20175018|P1|COMPLETED|Overall Study||60
8181719|NCT02352103|20175017|P2|STARTED|Overall Study||60
8181720|NCT02352103|20175018|P1|STARTED|Overall Study||60
8181721|NCT02351960|20175040|P2|NOT COMPLETED|Overall Study||12
8181722|NCT02351960|20175041|P1|NOT COMPLETED|Overall Study||11
8181723|NCT02351960|20175040|P2|COMPLETED|Overall Study||76
8181724|NCT02351960|20175041|P1|COMPLETED|Overall Study||197
8181725|NCT02351960|20175040|P2|STARTED|Overall Study||88
8181726|NCT02351960|20175041|P1|STARTED|Overall Study||208
8181727|NCT02351934|20175062|P2|NOT COMPLETED|Follow-Up||10
8181728|NCT02351934|20175063|P1|NOT COMPLETED|Follow-Up||12
8181729|NCT02351934|20175062|P2|COMPLETED|Follow-Up||51
8181730|NCT02351934|20175063|P1|COMPLETED|Follow-Up||44
8181731|NCT02351934|20175062|P2|STARTED|Follow-Up||61
8181732|NCT02351934|20175063|P1|STARTED|Follow-Up||56
8181733|NCT02351934|20175062|P2|NOT COMPLETED|Allocation||0
8181734|NCT02351934|20175063|P1|NOT COMPLETED|Allocation||6
8181735|NCT02351934|20175062|P2|COMPLETED|Allocation||61
8181736|NCT02351934|20175063|P1|COMPLETED|Allocation||56
8181737|NCT02351934|20175062|P2|Received Allocation|Allocation||61
8181738|NCT02351934|20175063|P1|Received Allocation|Allocation||56
8181739|NCT02351934|20175062|P2|STARTED|Allocation||61
8181740|NCT02351934|20175063|P1|STARTED|Allocation||62
8181741|NCT02351817|20175079|P2|NOT COMPLETED|Period 2||2
8181742|NCT02351817|20175080|P1|NOT COMPLETED|Period 2||1
8181743|NCT02351817|20175079|P2|COMPLETED|Period 2||3
8181744|NCT02351817|20175080|P1|COMPLETED|Period 2||4
8181745|NCT02351817|20175079|P2|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
8181746|NCT02351817|20175080|P1|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
8181747|NCT02351817|20175079|P2|NOT COMPLETED|Period 1||3
8181748|NCT02351817|20175080|P1|NOT COMPLETED|Period 1||1
8181749|NCT02351817|20175079|P2|COMPLETED|Period 1||2
8181750|NCT02351817|20175080|P1|COMPLETED|Period 1||4
8181751|NCT02351817|20175079|P2|STARTED|Period 1||5
8181752|NCT02351817|20175080|P1|STARTED|Period 1||5
8181753|NCT02351817|20175079|P2|NOT COMPLETED|Baseline Period||0
8181754|NCT02351817|20175080|P1|NOT COMPLETED|Baseline Period||0
8181755|NCT02351817|20175079|P2|COMPLETED|Baseline Period||5
8181756|NCT02351817|20175080|P1|COMPLETED|Baseline Period||5
8181757|NCT02351817|20175079|P2|STARTED|Baseline Period||5
8181758|NCT02351817|20175080|P1|STARTED|Baseline Period||5
8181759|NCT02351739|20175089|P2|NOT COMPLETED|Overall Study||40
8181760|NCT02351739|20175090|P1|NOT COMPLETED|Overall Study||38
8181761|NCT02351739|20175089|P2|COMPLETED|Overall Study||0
8181762|NCT02351739|20175090|P1|COMPLETED|Overall Study||0
8181763|NCT02351739|20175089|P2|Discontinued Study|Overall Study||40
8181764|NCT02351739|20175090|P1|Discontinued Study|Overall Study||38
8181765|NCT02351739|20175089|P2|Received Study Medication|Overall Study||40
8181766|NCT02351739|20175090|P1|Received Study Medication|Overall Study||35
8181767|NCT02351739|20175089|P2|Enrolled|Overall Study||40
8181768|NCT02351739|20175090|P1|Enrolled|Overall Study||38
8181769|NCT02351739|20175089|P2|STARTED|Overall Study||40
8181770|NCT02351739|20175090|P1|STARTED|Overall Study||38
8181771|NCT02351505|20175096|P1|NOT COMPLETED|Overall Study||0
8181772|NCT02351505|20175096|P1|COMPLETED|Overall Study||1
8181773|NCT02351505|20175096|P1|STARTED|Overall Study||1
8181774|NCT02351271|20175109|P2|NOT COMPLETED|Overall Study||0
8181775|NCT02351271|20175110|P1|NOT COMPLETED|Overall Study||0
8181776|NCT02351271|20175109|P2|COMPLETED|Overall Study||62
8181777|NCT02351271|20175110|P1|COMPLETED|Overall Study||68
8181778|NCT02351271|20175109|P2|STARTED|Overall Study||62
8181779|NCT02351271|20175110|P1|STARTED|Overall Study||68
8181780|NCT02351258|20175122|P2|NOT COMPLETED|Intervention 2 (12 Months)||0
8181781|NCT02351258|20175123|P1|NOT COMPLETED|Intervention 2 (12 Months)||0
8181782|NCT02351258|20175122|P2|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181783|NCT02351258|20175123|P1|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181784|NCT02351258|20175122|P2|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181785|NCT02351258|20175123|P1|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181786|NCT02351258|20175122|P2|NOT COMPLETED|Washout (2-3 Months)||0
8181787|NCT02351258|20175123|P1|NOT COMPLETED|Washout (2-3 Months)||0
8181788|NCT02351258|20175122|P2|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181789|NCT02351258|20175123|P1|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181790|NCT02351258|20175122|P2|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181791|NCT02351258|20175123|P1|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181792|NCT02351258|20175122|P2|NOT COMPLETED|Intervention 1 (12 Months)||0
8181793|NCT02351258|20175123|P1|NOT COMPLETED|Intervention 1 (12 Months)||0
8181794|NCT02351258|20175122|P2|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181795|NCT02351258|20175123|P1|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181796|NCT02351258|20175122|P2|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181797|NCT02351258|20175123|P1|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|0
8181798|NCT02351167|20175141|P3|NOT COMPLETED|Overall Study||21
8181799|NCT02351167|20175142|P2|NOT COMPLETED|Overall Study||18
8181800|NCT02351167|20175143|P1|NOT COMPLETED|Overall Study||19
8181801|NCT02351167|20175141|P3|COMPLETED|Overall Study||252
8181802|NCT02351167|20175142|P2|COMPLETED|Overall Study||256
8181803|NCT02351167|20175143|P1|COMPLETED|Overall Study||256
8181804|NCT02351167|20175141|P3|STARTED|Overall Study||273
8181805|NCT02351167|20175142|P2|STARTED|Overall Study||274
8181806|NCT02351167|20175143|P1|STARTED|Overall Study||275
8181807|NCT02351063|20175185|P1|NOT COMPLETED|Overall Study||0
8181808|NCT02351063|20175185|P1|COMPLETED|Overall Study|Study terminated. No study data collected.|1
8181809|NCT02351063|20175185|P1|STARTED|Overall Study||1
8181810|NCT02351037|20175192|P3|NOT COMPLETED|Overall Study||0
8181811|NCT02351037|20175193|P2|NOT COMPLETED|Overall Study||0
8181812|NCT02351037|20175194|P1|NOT COMPLETED|Overall Study||0
8181813|NCT02351037|20175192|P3|COMPLETED|Overall Study||8
8181814|NCT02351037|20175193|P2|COMPLETED|Overall Study||21
8181815|NCT02351037|20175194|P1|COMPLETED|Overall Study||7
8181816|NCT02351037|20175192|P3|STARTED|Overall Study||8
8181817|NCT02351037|20175193|P2|STARTED|Overall Study||21
8181818|NCT02351037|20175194|P1|STARTED|Overall Study||7
8181819|NCT02350998|20175202|P1|NOT COMPLETED|Overall Study||0
8181820|NCT02350998|20175202|P1|COMPLETED|Overall Study||33
8181821|NCT02350998|20175202|P1|STARTED|Overall Study||33
8181822|NCT02350881|20175209|P1|NOT COMPLETED|Overall Study||0
8181823|NCT02350881|20175209|P1|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
8181824|NCT02350881|20175209|P1|STARTED|Overall Study|64 patients were included (6 bilateral)|64
8181837|NCT02350777|20175288|P2|NOT COMPLETED|Overall Study||0
8181838|NCT02350777|20175289|P1|NOT COMPLETED|Overall Study||0
8181839|NCT02350777|20175288|P2|COMPLETED|Overall Study||2
8181840|NCT02350777|20175289|P1|COMPLETED|Overall Study||2
8181841|NCT02350777|20175288|P2|STARTED|Overall Study||2
8181842|NCT02350777|20175289|P1|STARTED|Overall Study||2
8181843|NCT02350660|20175297|P2|NOT COMPLETED|Overall Study||0
8181844|NCT02350660|20175298|P1|NOT COMPLETED|Overall Study||0
8181845|NCT02350660|20175297|P2|COMPLETED|Overall Study||17
8181846|NCT02350660|20175298|P1|COMPLETED|Overall Study||7
8181847|NCT02350660|20175297|P2|STARTED|Overall Study||17
8181848|NCT02350660|20175298|P1|STARTED|Overall Study||7
8181849|NCT02350647|20175306|P2|NOT COMPLETED|Overall Study||6
8181850|NCT02350647|20175307|P1|NOT COMPLETED|Overall Study||6
8181851|NCT02350647|20175306|P2|COMPLETED|Overall Study||26
8181852|NCT02350647|20175307|P1|COMPLETED|Overall Study||26
8181853|NCT02350647|20175306|P2|STARTED|Overall Study||32
8181854|NCT02350647|20175307|P1|STARTED|Overall Study||32
8181855|NCT02350569|20175319|P1|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
8181856|NCT02350569|20175319|P1|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
8181857|NCT02350569|20175319|P1|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
8181858|NCT02350569|20175319|P1|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
8181859|NCT02350569|20175319|P1|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
8181860|NCT02350569|20175319|P1|STARTED|Main Study (LDV/SOF 4 Weeks)||16
8181861|NCT02350478|20175331|P2|NOT COMPLETED|Overall Study||1
8181862|NCT02350478|20175332|P1|NOT COMPLETED|Overall Study||5
8181863|NCT02350478|20175331|P2|COMPLETED|Overall Study||23
8181864|NCT02350478|20175332|P1|COMPLETED|Overall Study||20
8181865|NCT02350478|20175331|P2|STARTED|Overall Study||24
8181866|NCT02350478|20175332|P1|STARTED|Overall Study||25
8181867|NCT02350309|20175354|P6|NOT COMPLETED|Treatment Period 4 (2 Days)||1
8181868|NCT02350309|20175355|P5|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8181869|NCT02350309|20175356|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8181870|NCT02350309|20175357|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8181871|NCT02350309|20175358|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8181872|NCT02350309|20175359|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8181873|NCT02350309|20175354|P6|COMPLETED|Treatment Period 4 (2 Days)||11
8181874|NCT02350309|20175355|P5|COMPLETED|Treatment Period 4 (2 Days)||12
8181875|NCT02350309|20175356|P4|COMPLETED|Treatment Period 4 (2 Days)||11
8181876|NCT02350309|20175357|P3|COMPLETED|Treatment Period 4 (2 Days)||10
8181877|NCT02350309|20175358|P2|COMPLETED|Treatment Period 4 (2 Days)||11
8181878|NCT02350309|20175359|P1|COMPLETED|Treatment Period 4 (2 Days)||12
8181879|NCT02350309|20175354|P6|STARTED|Treatment Period 4 (2 Days)||12
8181880|NCT02350309|20175355|P5|STARTED|Treatment Period 4 (2 Days)||12
8181881|NCT02350309|20175356|P4|STARTED|Treatment Period 4 (2 Days)||11
8181882|NCT02350309|20175357|P3|STARTED|Treatment Period 4 (2 Days)||10
8181883|NCT02350309|20175358|P2|STARTED|Treatment Period 4 (2 Days)||11
8181884|NCT02350309|20175359|P1|STARTED|Treatment Period 4 (2 Days)||12
8181885|NCT02350309|20175354|P6|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8181886|NCT02350309|20175355|P5|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8181887|NCT02350309|20175356|P4|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8181888|NCT02350309|20175357|P3|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8181889|NCT02350309|20175358|P2|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8181890|NCT02350309|20175359|P1|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
8181891|NCT02350309|20175354|P6|COMPLETED|Washout Period 3 (12-16 Days)||12
8181892|NCT02350309|20175355|P5|COMPLETED|Washout Period 3 (12-16 Days)||12
8181893|NCT02350309|20175356|P4|COMPLETED|Washout Period 3 (12-16 Days)||11
8181894|NCT02350309|20175357|P3|COMPLETED|Washout Period 3 (12-16 Days)||10
8181895|NCT02350309|20175358|P2|COMPLETED|Washout Period 3 (12-16 Days)||11
8181896|NCT02350309|20175359|P1|COMPLETED|Washout Period 3 (12-16 Days)||12
8181897|NCT02350309|20175354|P6|STARTED|Washout Period 3 (12-16 Days)||12
8181898|NCT02350309|20175355|P5|STARTED|Washout Period 3 (12-16 Days)||12
8181899|NCT02350309|20175356|P4|STARTED|Washout Period 3 (12-16 Days)||11
8181900|NCT02350309|20175357|P3|STARTED|Washout Period 3 (12-16 Days)||10
8181901|NCT02350309|20175358|P2|STARTED|Washout Period 3 (12-16 Days)||11
8181902|NCT02350309|20175359|P1|STARTED|Washout Period 3 (12-16 Days)||12
8181903|NCT02350309|20175354|P6|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8181904|NCT02350309|20175355|P5|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8181905|NCT02350309|20175356|P4|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8181906|NCT02350309|20175357|P3|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8181907|NCT02350309|20175358|P2|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8181908|NCT02350309|20175359|P1|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8181909|NCT02350309|20175354|P6|COMPLETED|Treatment Period 3 (2 Days)||12
8181910|NCT02350309|20175355|P5|COMPLETED|Treatment Period 3 (2 Days)||12
8181911|NCT02350309|20175356|P4|COMPLETED|Treatment Period 3 (2 Days)||11
8181912|NCT02350309|20175357|P3|COMPLETED|Treatment Period 3 (2 Days)||10
8181913|NCT02350309|20175358|P2|COMPLETED|Treatment Period 3 (2 Days)||11
8181914|NCT02350309|20175359|P1|COMPLETED|Treatment Period 3 (2 Days)||12
8181915|NCT02350309|20175354|P6|STARTED|Treatment Period 3 (2 Days)||12
8181916|NCT02350309|20175355|P5|STARTED|Treatment Period 3 (2 Days)||12
8181917|NCT02350309|20175356|P4|STARTED|Treatment Period 3 (2 Days)||11
8181918|NCT02350309|20175357|P3|STARTED|Treatment Period 3 (2 Days)||10
8181919|NCT02350309|20175358|P2|STARTED|Treatment Period 3 (2 Days)||11
8181920|NCT02350309|20175359|P1|STARTED|Treatment Period 3 (2 Days)||12
8181921|NCT02350309|20175354|P6|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8181922|NCT02350309|20175355|P5|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8181923|NCT02350309|20175356|P4|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8181924|NCT02350309|20175357|P3|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8181925|NCT02350309|20175358|P2|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8181926|NCT02350309|20175359|P1|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
8181927|NCT02350309|20175354|P6|COMPLETED|Washout Period 2 (12-16 Days)||12
8181928|NCT02350309|20175355|P5|COMPLETED|Washout Period 2 (12-16 Days)||12
8181929|NCT02350309|20175356|P4|COMPLETED|Washout Period 2 (12-16 Days)||11
8181930|NCT02350309|20175357|P3|COMPLETED|Washout Period 2 (12-16 Days)||10
8181931|NCT02350309|20175358|P2|COMPLETED|Washout Period 2 (12-16 Days)||11
8181932|NCT02350309|20175359|P1|COMPLETED|Washout Period 2 (12-16 Days)||12
8181933|NCT02350309|20175354|P6|STARTED|Washout Period 2 (12-16 Days)||12
8181934|NCT02350309|20175355|P5|STARTED|Washout Period 2 (12-16 Days)||12
8181935|NCT02350309|20175356|P4|STARTED|Washout Period 2 (12-16 Days)||11
8181936|NCT02350309|20175357|P3|STARTED|Washout Period 2 (12-16 Days)||10
8181937|NCT02350309|20175358|P2|STARTED|Washout Period 2 (12-16 Days)||11
8181938|NCT02350309|20175359|P1|STARTED|Washout Period 2 (12-16 Days)||12
8181939|NCT02350309|20175354|P6|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8181940|NCT02350309|20175355|P5|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8181941|NCT02350309|20175356|P4|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8181942|NCT02350309|20175357|P3|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8181943|NCT02350309|20175358|P2|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8181944|NCT02350309|20175359|P1|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8181945|NCT02350309|20175354|P6|COMPLETED|Treatment Period 2 (2 Days)||12
8181946|NCT02350309|20175355|P5|COMPLETED|Treatment Period 2 (2 Days)||12
8181947|NCT02350309|20175356|P4|COMPLETED|Treatment Period 2 (2 Days)||11
8181948|NCT02350309|20175357|P3|COMPLETED|Treatment Period 2 (2 Days)||10
8181949|NCT02350309|20175358|P2|COMPLETED|Treatment Period 2 (2 Days)||11
8181950|NCT02350309|20175359|P1|COMPLETED|Treatment Period 2 (2 Days)||12
8181951|NCT02350309|20175354|P6|STARTED|Treatment Period 2 (2 Days)||12
8181952|NCT02350309|20175355|P5|STARTED|Treatment Period 2 (2 Days)||12
8181953|NCT02350309|20175356|P4|STARTED|Treatment Period 2 (2 Days)||11
8181954|NCT02350309|20175357|P3|STARTED|Treatment Period 2 (2 Days)||10
8181955|NCT02350309|20175358|P2|STARTED|Treatment Period 2 (2 Days)||11
8181956|NCT02350309|20175359|P1|STARTED|Treatment Period 2 (2 Days)||12
8181957|NCT02350309|20175354|P6|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8181958|NCT02350309|20175355|P5|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8181959|NCT02350309|20175356|P4|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8181960|NCT02350309|20175357|P3|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8181961|NCT02350309|20175358|P2|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8181962|NCT02350309|20175359|P1|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
8181963|NCT02350309|20175354|P6|COMPLETED|Washout Period 1 (12-16 Days)||12
8181964|NCT02350309|20175355|P5|COMPLETED|Washout Period 1 (12-16 Days)||12
8181965|NCT02350309|20175356|P4|COMPLETED|Washout Period 1 (12-16 Days)||11
8181966|NCT02350309|20175357|P3|COMPLETED|Washout Period 1 (12-16 Days)||10
8181967|NCT02350309|20175358|P2|COMPLETED|Washout Period 1 (12-16 Days)||11
8181968|NCT02350309|20175359|P1|COMPLETED|Washout Period 1 (12-16 Days)||12
8181969|NCT02350309|20175354|P6|STARTED|Washout Period 1 (12-16 Days)||12
8181970|NCT02350309|20175355|P5|STARTED|Washout Period 1 (12-16 Days)||12
8181971|NCT02350309|20175356|P4|STARTED|Washout Period 1 (12-16 Days)||11
8181972|NCT02350309|20175357|P3|STARTED|Washout Period 1 (12-16 Days)||10
8181973|NCT02350309|20175358|P2|STARTED|Washout Period 1 (12-16 Days)||11
8181974|NCT02350309|20175359|P1|STARTED|Washout Period 1 (12-16 Days)||12
8181975|NCT02350309|20175354|P6|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8181976|NCT02350309|20175355|P5|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8181977|NCT02350309|20175356|P4|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8181978|NCT02350309|20175357|P3|NOT COMPLETED|Treatment Period 1 (2 Days)||1
8181979|NCT02350309|20175358|P2|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8181980|NCT02350309|20175359|P1|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8181981|NCT02350309|20175354|P6|COMPLETED|Treatment Period 1 (2 Days)||12
8181982|NCT02350309|20175355|P5|COMPLETED|Treatment Period 1 (2 Days)||12
8181983|NCT02350309|20175356|P4|COMPLETED|Treatment Period 1 (2 Days)||11
8181984|NCT02350309|20175357|P3|COMPLETED|Treatment Period 1 (2 Days)||10
8181985|NCT02350309|20175358|P2|COMPLETED|Treatment Period 1 (2 Days)||11
8181986|NCT02350309|20175359|P1|COMPLETED|Treatment Period 1 (2 Days)||12
8181987|NCT02350309|20175354|P6|STARTED|Treatment Period 1 (2 Days)||12
8181988|NCT02350309|20175355|P5|STARTED|Treatment Period 1 (2 Days)||12
8181989|NCT02350309|20175356|P4|STARTED|Treatment Period 1 (2 Days)||11
8181990|NCT02350309|20175357|P3|STARTED|Treatment Period 1 (2 Days)||11
8181991|NCT02350309|20175358|P2|STARTED|Treatment Period 1 (2 Days)||11
8181992|NCT02350309|20175359|P1|STARTED|Treatment Period 1 (2 Days)||12
8181993|NCT02350127|20175400|P2|NOT COMPLETED|8-Month Assessment||9
8181994|NCT02350127|20175401|P1|NOT COMPLETED|8-Month Assessment||6
8181995|NCT02350127|20175400|P2|COMPLETED|8-Month Assessment||26
8181996|NCT02350127|20175401|P1|COMPLETED|8-Month Assessment||27
8181997|NCT02350127|20175400|P2|STARTED|8-Month Assessment||35
8181998|NCT02350127|20175401|P1|STARTED|8-Month Assessment||33
8181999|NCT02350127|20175400|P2|NOT COMPLETED|4-Month Assessment||9
8182000|NCT02350127|20175401|P1|NOT COMPLETED|4-Month Assessment||11
8182001|NCT02350127|20175400|P2|COMPLETED|4-Month Assessment||35
8182002|NCT02350127|20175401|P1|COMPLETED|4-Month Assessment||33
8182003|NCT02350127|20175400|P2|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to health issue (n=1)|43
8182004|NCT02350127|20175401|P1|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to time constraints (n=1) and lack of interest (n=1)|42
8182005|NCT02350127|20175400|P2|STARTED|4-Month Assessment||44
8182006|NCT02350127|20175401|P1|STARTED|4-Month Assessment||44
8182007|NCT02349789|20175440|P1|NOT COMPLETED|Overall Study||2
8182008|NCT02349789|20175440|P1|COMPLETED|Overall Study||9
8182009|NCT02349789|20175440|P1|STARTED|Overall Study||11
8182010|NCT02349711|20175451|P2|NOT COMPLETED|Overall Study||2
8182011|NCT02349711|20175452|P1|NOT COMPLETED|Overall Study||3
8182012|NCT02349711|20175451|P2|COMPLETED|Overall Study||84
8182013|NCT02349711|20175452|P1|COMPLETED|Overall Study||84
8182014|NCT02349711|20175451|P2|STARTED|Overall Study||86
8182015|NCT02349711|20175452|P1|STARTED|Overall Study||87
8182016|NCT02349685|20175467|P3|NOT COMPLETED|Overall Study||4
8182017|NCT02349685|20175468|P2|NOT COMPLETED|Overall Study||2
8182018|NCT02349685|20175469|P1|NOT COMPLETED|Overall Study||5
8182019|NCT02349685|20175467|P3|COMPLETED|Overall Study||37
8182020|NCT02349685|20175468|P2|COMPLETED|Overall Study||87
8182021|NCT02349685|20175469|P1|COMPLETED|Overall Study||84
8182022|NCT02349685|20175467|P3|STARTED|Overall Study||41
8182023|NCT02349685|20175468|P2|STARTED|Overall Study||89
8182024|NCT02349685|20175469|P1|STARTED|Overall Study||89
8182025|NCT02349646|20175480|P1|NOT COMPLETED|Overall Study||17
8182026|NCT02349646|20175480|P1|COMPLETED|Overall Study||16
8182027|NCT02349646|20175480|P1|Receive Permanent System|Overall Study||27
8182028|NCT02349646|20175480|P1|Received Trial System|Overall Study||24
8182029|NCT02349646|20175480|P1|STARTED|Overall Study||33
8182030|NCT02349542|20175485|P1|NOT COMPLETED|Overall Study||5
8182031|NCT02349542|20175485|P1|COMPLETED|Overall Study||15
8182032|NCT02349542|20175485|P1|STARTED|Overall Study||20
8182033|NCT02349477|20175492|P2|NOT COMPLETED|Overall Study||18
8182034|NCT02349477|20175493|P1|NOT COMPLETED|Overall Study||13
8182035|NCT02349477|20175492|P2|COMPLETED|Overall Study||28
8182036|NCT02349477|20175493|P1|COMPLETED|Overall Study||31
8182037|NCT02349477|20175492|P2|STARTED|Overall Study||46
8182038|NCT02349477|20175493|P1|STARTED|Overall Study||44
8182039|NCT02349451|20175509|P4|NOT COMPLETED|Overall Study||1
8182040|NCT02349451|20175510|P3|NOT COMPLETED|Overall Study||2
8182041|NCT02349451|20175511|P2|NOT COMPLETED|Overall Study||1
8182042|NCT02349451|20175512|P1|NOT COMPLETED|Overall Study||0
8182043|NCT02349451|20175509|P4|COMPLETED|Overall Study||72
8182044|NCT02349451|20175510|P3|COMPLETED|Overall Study||69
8182045|NCT02349451|20175511|P2|COMPLETED|Overall Study||71
8182046|NCT02349451|20175512|P1|COMPLETED|Overall Study||24
8182047|NCT02349451|20175509|P4|STARTED|Overall Study||73
8182048|NCT02349451|20175510|P3|STARTED|Overall Study||71
8182049|NCT02349451|20175511|P2|STARTED|Overall Study||72
8182050|NCT02349451|20175512|P1|STARTED|Overall Study||24
8182051|NCT02349438|20175548|P2|NOT COMPLETED|Period 2||0
8182052|NCT02349438|20175549|P1|NOT COMPLETED|Period 2||0
8182053|NCT02349438|20175548|P2|COMPLETED|Period 2||10
8182054|NCT02349438|20175549|P1|COMPLETED|Period 2||11
8182055|NCT02349438|20175548|P2|STARTED|Period 2||10
8182056|NCT02349438|20175549|P1|STARTED|Period 2||11
8182057|NCT02349438|20175548|P2|NOT COMPLETED|Period 1||0
8182058|NCT02349438|20175549|P1|NOT COMPLETED|Period 1||0
8182059|NCT02349438|20175548|P2|COMPLETED|Period 1||10
8182060|NCT02349438|20175549|P1|COMPLETED|Period 1||11
8182061|NCT02349438|20175548|P2|STARTED|Period 1||10
8182062|NCT02349438|20175549|P1|STARTED|Period 1||11
8182063|NCT02349425|20175563|P4|NOT COMPLETED|Period 2||0
8182064|NCT02349425|20175564|P3|NOT COMPLETED|Period 2||1
8182065|NCT02349425|20175565|P2|NOT COMPLETED|Period 2||1
8182066|NCT02349425|20175566|P1|NOT COMPLETED|Period 2||0
8182067|NCT02349425|20175563|P4|COMPLETED|Period 2||15
8182068|NCT02349425|20175564|P3|COMPLETED|Period 2||14
8182069|NCT02349425|20175565|P2|COMPLETED|Period 2||12
8182070|NCT02349425|20175566|P1|COMPLETED|Period 2||14
8182071|NCT02349425|20175563|P4|STARTED|Period 2||15
8182072|NCT02349425|20175564|P3|STARTED|Period 2||15
8182073|NCT02349425|20175565|P2|STARTED|Period 2||13
8182074|NCT02349425|20175566|P1|STARTED|Period 2||14
8182075|NCT02349425|20175563|P4|NOT COMPLETED|Period 1||0
8182076|NCT02349425|20175564|P3|NOT COMPLETED|Period 1||0
8182077|NCT02349425|20175565|P2|NOT COMPLETED|Period 1||1
8182078|NCT02349425|20175566|P1|NOT COMPLETED|Period 1||1
8182079|NCT02349425|20175563|P4|COMPLETED|Period 1||15
8182080|NCT02349425|20175564|P3|COMPLETED|Period 1||15
8182081|NCT02349425|20175565|P2|COMPLETED|Period 1||13
8182082|NCT02349425|20175566|P1|COMPLETED|Period 1||14
8182083|NCT02349425|20175563|P4|STARTED|Period 1||15
8182084|NCT02349425|20175564|P3|STARTED|Period 1||15
8182085|NCT02349425|20175565|P2|STARTED|Period 1||14
8182086|NCT02349425|20175566|P1|STARTED|Period 1||15
8182097|NCT02349360|20175757|P2|NOT COMPLETED|Overall Study||1
8182098|NCT02349360|20175758|P1|NOT COMPLETED|Overall Study||0
8182099|NCT02349360|20175757|P2|COMPLETED|Overall Study||20
8182100|NCT02349360|20175758|P1|COMPLETED|Overall Study||21
8182101|NCT02349360|20175757|P2|STARTED|Overall Study||21
8182102|NCT02349360|20175758|P1|STARTED|Overall Study||21
8182103|NCT02349295|20175769|P14|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||1
8182104|NCT02349295|20175770|P13|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||8
8182105|NCT02349295|20175771|P12|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||9
8182106|NCT02349295|20175772|P11|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182107|NCT02349295|20175773|P10|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182108|NCT02349295|20175774|P9|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182109|NCT02349295|20175775|P8|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182110|NCT02349295|20175776|P7|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182111|NCT02349295|20175777|P6|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182112|NCT02349295|20175778|P5|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182113|NCT02349295|20175779|P4|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182114|NCT02349295|20175780|P3|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182115|NCT02349295|20175781|P2|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182116|NCT02349295|20175782|P1|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182117|NCT02349295|20175769|P14|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||16
8182118|NCT02349295|20175770|P13|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||137
8182119|NCT02349295|20175771|P12|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||133
8182120|NCT02349295|20175772|P11|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182121|NCT02349295|20175773|P10|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182122|NCT02349295|20175774|P9|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182123|NCT02349295|20175775|P8|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182124|NCT02349295|20175776|P7|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182125|NCT02349295|20175777|P6|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182126|NCT02349295|20175778|P5|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182127|NCT02349295|20175779|P4|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182128|NCT02349295|20175780|P3|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182129|NCT02349295|20175781|P2|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182130|NCT02349295|20175782|P1|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
8182131|NCT02349295|20175769|P14|STARTED|Follow-Up Period (Up to 12-24 Weeks)|PBO participants who entered post-treatment follow-up.|17
8182132|NCT02349295|20175770|P13|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ4W participants who entered post-treatment follow-up.|145
8182133|NCT02349295|20175771|P12|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ2W participants who entered post-treatment follow-up.|142
8182134|NCT02349295|20175772|P11|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
8182135|NCT02349295|20175773|P10|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
8182136|NCT02349295|20175774|P9|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
8182137|NCT02349295|20175775|P8|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
8182138|NCT02349295|20175776|P7|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8182139|NCT02349295|20175777|P6|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8182140|NCT02349295|20175778|P5|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8182141|NCT02349295|20175779|P4|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8182142|NCT02349295|20175780|P3|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8182143|NCT02349295|20175781|P2|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8182144|NCT02349295|20175782|P1|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
8182145|NCT02349295|20175769|P14|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182146|NCT02349295|20175770|P13|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182147|NCT02349295|20175771|P12|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182148|NCT02349295|20175772|P11|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||23
8182149|NCT02349295|20175773|P10|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||26
8182150|NCT02349295|20175774|P9|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||41
8182151|NCT02349295|20175775|P8|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||52
8182152|NCT02349295|20175776|P7|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182153|NCT02349295|20175777|P6|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182154|NCT02349295|20175778|P5|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182155|NCT02349295|20175779|P4|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182156|NCT02349295|20175780|P3|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182157|NCT02349295|20175781|P2|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182158|NCT02349295|20175782|P1|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182159|NCT02349295|20175769|P14|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182160|NCT02349295|20175770|P13|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182161|NCT02349295|20175771|P12|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182162|NCT02349295|20175772|P11|COMPLETED|Long-Term Extension Period (Week 24-156)||23
8182163|NCT02349295|20175773|P10|COMPLETED|Long-Term Extension Period (Week 24-156)||20
8182164|NCT02349295|20175774|P9|COMPLETED|Long-Term Extension Period (Week 24-156)||70
8182165|NCT02349295|20175775|P8|COMPLETED|Long-Term Extension Period (Week 24-156)||55
8182166|NCT02349295|20175776|P7|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182167|NCT02349295|20175777|P6|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182168|NCT02349295|20175778|P5|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182169|NCT02349295|20175779|P4|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182170|NCT02349295|20175780|P3|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182171|NCT02349295|20175781|P2|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182172|NCT02349295|20175782|P1|COMPLETED|Long-Term Extension Period (Week 24-156)||0
8182173|NCT02349295|20175769|P14|STARTED|Long-Term Extension Period (Week 24-156)||0
8182174|NCT02349295|20175770|P13|STARTED|Long-Term Extension Period (Week 24-156)||0
8182175|NCT02349295|20175771|P12|STARTED|Long-Term Extension Period (Week 24-156)||0
8182176|NCT02349295|20175772|P11|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ4W participants who entered the long-term extension period.|46
8182177|NCT02349295|20175773|P10|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ2W participants who entered the long-term extension period.|46
8182178|NCT02349295|20175774|P9|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ4W participants who entered the long-term extension period.|111
8182179|NCT02349295|20175775|P8|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ2W participants who entered the long-term extension period.|107
8182180|NCT02349295|20175776|P7|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
8182181|NCT02349295|20175777|P6|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
8182182|NCT02349295|20175778|P5|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
8182183|NCT02349295|20175779|P4|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
8182184|NCT02349295|20175780|P3|STARTED|Long-Term Extension Period (Week 24-156)||0
8182185|NCT02349295|20175781|P2|STARTED|Long-Term Extension Period (Week 24-156)||0
8182186|NCT02349295|20175782|P1|STARTED|Long-Term Extension Period (Week 24-156)||0
8182187|NCT02349295|20175769|P14|NOT COMPLETED|IR (Week 16-24)||0
8182188|NCT02349295|20175770|P13|NOT COMPLETED|IR (Week 16-24)||0
8182189|NCT02349295|20175771|P12|NOT COMPLETED|IR (Week 16-24)||0
8182190|NCT02349295|20175772|P11|NOT COMPLETED|IR (Week 16-24)||0
8182191|NCT02349295|20175773|P10|NOT COMPLETED|IR (Week 16-24)||0
8182192|NCT02349295|20175774|P9|NOT COMPLETED|IR (Week 16-24)||0
8182193|NCT02349295|20175775|P8|NOT COMPLETED|IR (Week 16-24)||0
8182194|NCT02349295|20175776|P7|NOT COMPLETED|IR (Week 16-24)||0
8182195|NCT02349295|20175777|P6|NOT COMPLETED|IR (Week 16-24)||0
8182196|NCT02349295|20175778|P5|NOT COMPLETED|IR (Week 16-24)||0
8182197|NCT02349295|20175779|P4|NOT COMPLETED|IR (Week 16-24)||1
8182198|NCT02349295|20175780|P3|NOT COMPLETED|IR (Week 16-24)||0
8182199|NCT02349295|20175781|P2|NOT COMPLETED|IR (Week 16-24)||0
8182200|NCT02349295|20175782|P1|NOT COMPLETED|IR (Week 16-24)||0
8182201|NCT02349295|20175769|P14|COMPLETED|IR (Week 16-24)||0
8182202|NCT02349295|20175770|P13|COMPLETED|IR (Week 16-24)||0
8182203|NCT02349295|20175771|P12|COMPLETED|IR (Week 16-24)||0
8182204|NCT02349295|20175772|P11|COMPLETED|IR (Week 16-24)||0
8182205|NCT02349295|20175773|P10|COMPLETED|IR (Week 16-24)||0
8182206|NCT02349295|20175774|P9|COMPLETED|IR (Week 16-24)||0
8182207|NCT02349295|20175775|P8|COMPLETED|IR (Week 16-24)||0
8182208|NCT02349295|20175776|P7|COMPLETED|IR (Week 16-24)||16
8182209|NCT02349295|20175777|P6|COMPLETED|IR (Week 16-24)||16
8182210|NCT02349295|20175778|P5|COMPLETED|IR (Week 16-24)||15
8182211|NCT02349295|20175779|P4|COMPLETED|IR (Week 16-24)||16
8182212|NCT02349295|20175780|P3|COMPLETED|IR (Week 16-24)||0
8182213|NCT02349295|20175781|P2|COMPLETED|IR (Week 16-24)||0
8182214|NCT02349295|20175782|P1|COMPLETED|IR (Week 16-24)||0
8182215|NCT02349295|20175769|P14|STARTED|IR (Week 16-24)||0
8182216|NCT02349295|20175770|P13|STARTED|IR (Week 16-24)||0
8182217|NCT02349295|20175771|P12|STARTED|IR (Week 16-24)||0
8182218|NCT02349295|20175772|P11|STARTED|IR (Week 16-24)||0
8182219|NCT02349295|20175773|P10|STARTED|IR (Week 16-24)||0
8182220|NCT02349295|20175774|P9|STARTED|IR (Week 16-24)||0
8182221|NCT02349295|20175775|P8|STARTED|IR (Week 16-24)||0
8182222|NCT02349295|20175776|P7|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W.|16
8182223|NCT02349295|20175777|P6|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W.|16
8182224|NCT02349295|20175778|P5|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q4W only.|15
8182225|NCT02349295|20175779|P4|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q2W only.|17
8182226|NCT02349295|20175780|P3|STARTED|IR (Week 16-24)|Only IR participants were included.|0
8182227|NCT02349295|20175781|P2|STARTED|IR (Week 16-24)|Only IR participants were included.|0
8182228|NCT02349295|20175782|P1|STARTED|IR (Week 16-24)|Only IR participants were included.|0
8182229|NCT02349295|20175769|P14|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182230|NCT02349295|20175770|P13|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182231|NCT02349295|20175771|P12|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182232|NCT02349295|20175772|P11|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182233|NCT02349295|20175773|P10|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182234|NCT02349295|20175774|P9|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182235|NCT02349295|20175775|P8|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182236|NCT02349295|20175776|P7|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182237|NCT02349295|20175777|P6|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182238|NCT02349295|20175778|P5|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182239|NCT02349295|20175779|P4|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
8182240|NCT02349295|20175780|P3|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
8182241|NCT02349295|20175781|P2|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
8182242|NCT02349295|20175782|P1|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
8182243|NCT02349295|20175769|P14|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182244|NCT02349295|20175770|P13|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182245|NCT02349295|20175771|P12|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182246|NCT02349295|20175772|P11|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182247|NCT02349295|20175773|P10|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182248|NCT02349295|20175774|P9|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182249|NCT02349295|20175775|P8|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182250|NCT02349295|20175776|P7|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182251|NCT02349295|20175777|P6|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182252|NCT02349295|20175778|P5|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182253|NCT02349295|20175779|P4|COMPLETED|Double Blind Treatment (Week 0-24)||0
8182254|NCT02349295|20175780|P3|COMPLETED|Double Blind Treatment (Week 0-24)||94
8182255|NCT02349295|20175781|P2|COMPLETED|Double Blind Treatment (Week 0-24)||111
8182256|NCT02349295|20175782|P1|COMPLETED|Double Blind Treatment (Week 0-24)||109
8182257|NCT02349295|20175769|P14|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182258|NCT02349295|20175770|P13|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182259|NCT02349295|20175771|P12|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182260|NCT02349295|20175772|P11|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182261|NCT02349295|20175773|P10|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182262|NCT02349295|20175774|P9|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182263|NCT02349295|20175775|P8|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182264|NCT02349295|20175776|P7|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182265|NCT02349295|20175777|P6|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182266|NCT02349295|20175778|P5|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182267|NCT02349295|20175779|P4|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
8182268|NCT02349295|20175780|P3|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||118
8182269|NCT02349295|20175781|P2|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||122
8182270|NCT02349295|20175782|P1|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||123
8182271|NCT02349295|20175769|P14|STARTED|Double Blind Treatment (Week 0-24)||0
8182272|NCT02349295|20175770|P13|STARTED|Double Blind Treatment (Week 0-24)||0
8182273|NCT02349295|20175771|P12|STARTED|Double Blind Treatment (Week 0-24)||0
8182274|NCT02349295|20175772|P11|STARTED|Double Blind Treatment (Week 0-24)||0
8182275|NCT02349295|20175773|P10|STARTED|Double Blind Treatment (Week 0-24)||0
8182276|NCT02349295|20175774|P9|STARTED|Double Blind Treatment (Week 0-24)||0
8182277|NCT02349295|20175775|P8|STARTED|Double Blind Treatment (Week 0-24)||0
8182278|NCT02349295|20175776|P7|STARTED|Double Blind Treatment (Week 0-24)||0
8182279|NCT02349295|20175777|P6|STARTED|Double Blind Treatment (Week 0-24)||0
8182280|NCT02349295|20175778|P5|STARTED|Double Blind Treatment (Week 0-24)||0
8182281|NCT02349295|20175779|P4|STARTED|Double Blind Treatment (Week 0-24)||0
8182282|NCT02349295|20175780|P3|STARTED|Double Blind Treatment (Week 0-24)||118
8182283|NCT02349295|20175781|P2|STARTED|Double Blind Treatment (Week 0-24)||122
8182284|NCT02349295|20175782|P1|STARTED|Double Blind Treatment (Week 0-24)||123
8182285|NCT02349178|20175877|P1|NOT COMPLETED|Overall Study||0
8182286|NCT02349178|20175877|P1|COMPLETED|Overall Study||6
8182287|NCT02349178|20175877|P1|STARTED|Overall Study||6
8182288|NCT02349152|20175883|P2|NOT COMPLETED|Overall Study||4
8182289|NCT02349152|20175884|P1|NOT COMPLETED|Overall Study||6
8182290|NCT02349152|20175883|P2|COMPLETED|Overall Study||52
8182291|NCT02349152|20175884|P1|COMPLETED|Overall Study||54
8182292|NCT02349152|20175883|P2|STARTED|Overall Study||56
8182293|NCT02349152|20175884|P1|STARTED|Overall Study||60
8182294|NCT02349061|20175922|P3|NOT COMPLETED|Study Extension (Week 56 to Week 120)||3
8182295|NCT02349061|20175923|P2|NOT COMPLETED|Study Extension (Week 56 to Week 120)||5
8182296|NCT02349061|20175924|P1|NOT COMPLETED|Study Extension (Week 56 to Week 120)||0
8182297|NCT02349061|20175922|P3|COMPLETED|Study Extension (Week 56 to Week 120)||14
8182298|NCT02349061|20175923|P2|COMPLETED|Study Extension (Week 56 to Week 120)||24
8182299|NCT02349061|20175924|P1|COMPLETED|Study Extension (Week 56 to Week 120)||0
8182389|NCT02348658|20176040|P2|COMPLETED|Period 1 (7 Days)||6
8182300|NCT02349061|20175922|P3|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|17
8182301|NCT02349061|20175923|P2|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|29
8182302|NCT02349061|20175924|P1|STARTED|Study Extension (Week 56 to Week 120)||0
8182303|NCT02349061|20175922|P3|NOT COMPLETED|Main Study: Week 24 to 56||3
8182304|NCT02349061|20175923|P2|NOT COMPLETED|Main Study: Week 24 to 56||3
8182305|NCT02349061|20175924|P1|NOT COMPLETED|Main Study: Week 24 to 56||0
8182306|NCT02349061|20175922|P3|COMPLETED|Main Study: Week 24 to 56||30
8182307|NCT02349061|20175923|P2|COMPLETED|Main Study: Week 24 to 56||53
8182308|NCT02349061|20175924|P1|COMPLETED|Main Study: Week 24 to 56||0
8182309|NCT02349061|20175922|P3|STARTED|Main Study: Week 24 to 56||33
8182310|NCT02349061|20175923|P2|STARTED|Main Study: Week 24 to 56||56
8182311|NCT02349061|20175924|P1|STARTED|Main Study: Week 24 to 56||0
8182312|NCT02349061|20175922|P3|NOT COMPLETED|Main Study: PCP (Up to Week 24)||0
8182313|NCT02349061|20175923|P2|NOT COMPLETED|Main Study: PCP (Up to Week 24)||4
8182314|NCT02349061|20175924|P1|NOT COMPLETED|Main Study: PCP (Up to Week 24)||9
8182315|NCT02349061|20175922|P3|COMPLETED|Main Study: PCP (Up to Week 24)||0
8182316|NCT02349061|20175923|P2|COMPLETED|Main Study: PCP (Up to Week 24)||56
8182317|NCT02349061|20175924|P1|COMPLETED|Main Study: PCP (Up to Week 24)||33
8182318|NCT02349061|20175922|P3|STARTED|Main Study: PCP (Up to Week 24)||0
8182319|NCT02349061|20175923|P2|STARTED|Main Study: PCP (Up to Week 24)||60
8182320|NCT02349061|20175924|P1|STARTED|Main Study: PCP (Up to Week 24)||42
8182321|NCT02349048|20175944|P2|NOT COMPLETED|Overall Study||0
8182322|NCT02349048|20175945|P1|NOT COMPLETED|Overall Study||5
8182323|NCT02349048|20175944|P2|COMPLETED|Overall Study||9
8182324|NCT02349048|20175945|P1|COMPLETED|Overall Study||54
8182325|NCT02349048|20175944|P2|STARTED|Overall Study||9
8182326|NCT02349048|20175945|P1|STARTED|Overall Study||59
8182327|NCT02348918|20175974|P9|NOT COMPLETED|Overall Study||0
8182328|NCT02348918|20175975|P8|NOT COMPLETED|Overall Study||0
8182329|NCT02348918|20175976|P7|NOT COMPLETED|Overall Study||0
8182330|NCT02348918|20175977|P6|NOT COMPLETED|Overall Study||0
8182331|NCT02348918|20175978|P5|NOT COMPLETED|Overall Study||0
8182332|NCT02348918|20175979|P4|NOT COMPLETED|Overall Study||0
8182333|NCT02348918|20175980|P3|NOT COMPLETED|Overall Study||0
8182334|NCT02348918|20175981|P2|NOT COMPLETED|Overall Study||0
8182335|NCT02348918|20175982|P1|NOT COMPLETED|Overall Study||0
8182336|NCT02348918|20175974|P9|COMPLETED|Overall Study||15
8182337|NCT02348918|20175975|P8|COMPLETED|Overall Study||16
8182338|NCT02348918|20175976|P7|COMPLETED|Overall Study||13
8182339|NCT02348918|20175977|P6|COMPLETED|Overall Study||17
8182340|NCT02348918|20175978|P5|COMPLETED|Overall Study||19
8182341|NCT02348918|20175979|P4|COMPLETED|Overall Study||24
8182342|NCT02348918|20175980|P3|COMPLETED|Overall Study||42
8182343|NCT02348918|20175981|P2|COMPLETED|Overall Study||33
8182344|NCT02348918|20175982|P1|COMPLETED|Overall Study||39
8182345|NCT02348918|20175974|P9|STARTED|Overall Study||15
8182346|NCT02348918|20175975|P8|STARTED|Overall Study||16
8182347|NCT02348918|20175976|P7|STARTED|Overall Study||13
8182348|NCT02348918|20175977|P6|STARTED|Overall Study||17
8182349|NCT02348918|20175978|P5|STARTED|Overall Study||19
8182350|NCT02348918|20175979|P4|STARTED|Overall Study||24
8182351|NCT02348918|20175980|P3|STARTED|Overall Study||42
8182352|NCT02348918|20175981|P2|STARTED|Overall Study||33
8182353|NCT02348918|20175982|P1|STARTED|Overall Study||39
8182354|NCT02348840|20176006|P4|NOT COMPLETED|Overall Study||0
8182355|NCT02348840|20176007|P3|NOT COMPLETED|Overall Study||0
8182356|NCT02348840|20176008|P2|NOT COMPLETED|Overall Study||1
8182357|NCT02348840|20176009|P1|NOT COMPLETED|Overall Study||2
8182358|NCT02348840|20176006|P4|COMPLETED|Overall Study||374
8182359|NCT02348840|20176007|P3|COMPLETED|Overall Study||425
8182360|NCT02348840|20176008|P2|COMPLETED|Overall Study||20
8182361|NCT02348840|20176009|P1|COMPLETED|Overall Study||21
8182362|NCT02348840|20176006|P4|STARTED|Overall Study||374
8182363|NCT02348840|20176007|P3|STARTED|Overall Study||425
8182364|NCT02348840|20176008|P2|STARTED|Overall Study||21
8182365|NCT02348840|20176009|P1|STARTED|Overall Study||23
8182366|NCT02348723|20176023|P2|NOT COMPLETED|Overall Study||26
8182367|NCT02348723|20176024|P1|NOT COMPLETED|Overall Study||28
8182368|NCT02348723|20176023|P2|COMPLETED|Overall Study||312
8182369|NCT02348723|20176024|P1|COMPLETED|Overall Study||310
8182370|NCT02348723|20176023|P2|STARTED|Overall Study||338
8182371|NCT02348723|20176024|P1|STARTED|Overall Study||338
8182375|NCT02348658|20176040|P2|NOT COMPLETED|Period 2 (7 Days)||0
8182376|NCT02348658|20176041|P1|NOT COMPLETED|Period 2 (7 Days)||0
8182377|NCT02348658|20176040|P2|COMPLETED|Period 2 (7 Days)||6
8182378|NCT02348658|20176041|P1|COMPLETED|Period 2 (7 Days)||6
8182379|NCT02348658|20176040|P2|STARTED|Period 2 (7 Days)||6
8182380|NCT02348658|20176041|P1|STARTED|Period 2 (7 Days)||6
8182381|NCT02348658|20176040|P2|NOT COMPLETED|Washout Period (22 Days)||0
8182382|NCT02348658|20176041|P1|NOT COMPLETED|Washout Period (22 Days)||0
8182383|NCT02348658|20176040|P2|COMPLETED|Washout Period (22 Days)||6
8182384|NCT02348658|20176041|P1|COMPLETED|Washout Period (22 Days)||6
8182385|NCT02348658|20176040|P2|STARTED|Washout Period (22 Days)||6
8182386|NCT02348658|20176041|P1|STARTED|Washout Period (22 Days)||6
8182387|NCT02348658|20176040|P2|NOT COMPLETED|Period 1 (7 Days)||0
8182388|NCT02348658|20176041|P1|NOT COMPLETED|Period 1 (7 Days)||0
8182390|NCT02348658|20176041|P1|COMPLETED|Period 1 (7 Days)||6
8182391|NCT02348658|20176040|P2|STARTED|Period 1 (7 Days)||6
8182392|NCT02348658|20176041|P1|STARTED|Period 1 (7 Days)||6
8182393|NCT02348632|20176075|P2|NOT COMPLETED|Randomized Withdrawal Period||1
8182394|NCT02348632|20176076|P1|NOT COMPLETED|Randomized Withdrawal Period||3
8182395|NCT02348632|20176075|P2|COMPLETED|Randomized Withdrawal Period||141
8182396|NCT02348632|20176076|P1|COMPLETED|Randomized Withdrawal Period||137
8182397|NCT02348632|20176075|P2|STARTED|Randomized Withdrawal Period||142
8182398|NCT02348632|20176076|P1|STARTED|Randomized Withdrawal Period||140
8182399|NCT02348632|20176075|P2|NOT COMPLETED|Open-label Period||0
8182400|NCT02348632|20176076|P1|NOT COMPLETED|Open-label Period||185
8182401|NCT02348632|20176075|P2|COMPLETED|Open-label Period||0
8182402|NCT02348632|20176076|P1|COMPLETED|Open-label Period||458
8182403|NCT02348632|20176075|P2|STARTED|Open-label Period||0
8182404|NCT02348632|20176076|P1|STARTED|Open-label Period||643
8182405|NCT02348619|20176086|P2|NOT COMPLETED|Double-Blind Withdrawal Phase||0
8182406|NCT02348619|20176087|P1|NOT COMPLETED|Double-Blind Withdrawal Phase||2
8182407|NCT02348619|20176086|P2|COMPLETED|Double-Blind Withdrawal Phase||62
8182408|NCT02348619|20176087|P1|COMPLETED|Double-Blind Withdrawal Phase||60
8182409|NCT02348619|20176086|P2|STARTED|Double-Blind Withdrawal Phase||62
8182410|NCT02348619|20176087|P1|STARTED|Double-Blind Withdrawal Phase||62
8182411|NCT02348619|20176086|P2|NOT COMPLETED|Stable-Dose Phase||0
8182412|NCT02348619|20176087|P1|NOT COMPLETED|Stable-Dose Phase||33
8182413|NCT02348619|20176086|P2|COMPLETED|Stable-Dose Phase||0
8182414|NCT02348619|20176087|P1|COMPLETED|Stable-Dose Phase||124
8182415|NCT02348619|20176086|P2|STARTED|Stable-Dose Phase||0
8182416|NCT02348619|20176087|P1|STARTED|Stable-Dose Phase||157
8182417|NCT02348619|20176086|P2|NOT COMPLETED|Titration Phase||0
8182418|NCT02348619|20176087|P1|NOT COMPLETED|Titration Phase||17
8182419|NCT02348619|20176086|P2|COMPLETED|Titration Phase||0
8182420|NCT02348619|20176087|P1|COMPLETED|Titration Phase||157
8182421|NCT02348619|20176086|P2|STARTED|Titration Phase||0
8182422|NCT02348619|20176087|P1|STARTED|Titration Phase||174
8182423|NCT02348606|20176106|P5|NOT COMPLETED|Overall Study||18
8182424|NCT02348606|20176107|P4|NOT COMPLETED|Overall Study||24
8182425|NCT02348606|20176108|P3|NOT COMPLETED|Overall Study||11
8182426|NCT02348606|20176109|P2|NOT COMPLETED|Overall Study||8
8182427|NCT02348606|20176110|P1|NOT COMPLETED|Overall Study||9
8182428|NCT02348606|20176106|P5|COMPLETED|Overall Study||101
8182429|NCT02348606|20176107|P4|COMPLETED|Overall Study||94
8182430|NCT02348606|20176108|P3|COMPLETED|Overall Study||106
8182431|NCT02348606|20176109|P2|COMPLETED|Overall Study||54
8182432|NCT02348606|20176110|P1|COMPLETED|Overall Study||49
8182433|NCT02348606|20176106|P5|STARTED|Overall Study||119
8182434|NCT02348606|20176107|P4|STARTED|Overall Study||118
8182435|NCT02348606|20176108|P3|STARTED|Overall Study||117
8182436|NCT02348606|20176109|P2|STARTED|Overall Study||62
8182437|NCT02348606|20176110|P1|STARTED|Overall Study||58
8182438|NCT02348593|20176166|P4|NOT COMPLETED|Overall Study||7
8182439|NCT02348593|20176167|P3|NOT COMPLETED|Overall Study||16
8182440|NCT02348593|20176168|P2|NOT COMPLETED|Overall Study||8
8182441|NCT02348593|20176169|P1|NOT COMPLETED|Overall Study||10
8182442|NCT02348593|20176166|P4|COMPLETED|Overall Study||52
8182443|NCT02348593|20176167|P3|COMPLETED|Overall Study||43
8182444|NCT02348593|20176168|P2|COMPLETED|Overall Study||51
8182445|NCT02348593|20176169|P1|COMPLETED|Overall Study||49
8182446|NCT02348593|20176166|P4|STARTED|Overall Study||59
8182447|NCT02348593|20176167|P3|STARTED|Overall Study||59
8182448|NCT02348593|20176168|P2|STARTED|Overall Study||59
8182449|NCT02348593|20176169|P1|STARTED|Overall Study||59
8182450|NCT02348489|20176213|P2|NOT COMPLETED|Overall Study||367
8182451|NCT02348489|20176214|P1|NOT COMPLETED|Overall Study||353
8182452|NCT02348489|20176213|P2|COMPLETED|Overall Study||40
8182453|NCT02348489|20176214|P1|COMPLETED|Overall Study||55
8182454|NCT02348489|20176213|P2|STARTED|Overall Study||407
8182455|NCT02348489|20176214|P1|STARTED|Overall Study||408
8182456|NCT02348385|20176238|P2|NOT COMPLETED|Overall Study||0
8182457|NCT02348385|20176239|P1|NOT COMPLETED|Overall Study||0
8182458|NCT02348385|20176238|P2|COMPLETED|Overall Study||25
8182459|NCT02348385|20176239|P1|COMPLETED|Overall Study||24
8182460|NCT02348385|20176238|P2|STARTED|Overall Study||25
8182461|NCT02348385|20176239|P1|STARTED|Overall Study||24
8182462|NCT02348359|20176251|P4|NOT COMPLETED|Overall Study||12
8182463|NCT02348359|20176252|P3|NOT COMPLETED|Overall Study||14
8182464|NCT02348359|20176253|P2|NOT COMPLETED|Overall Study||17
8182465|NCT02348359|20176254|P1|NOT COMPLETED|Overall Study||11
8182466|NCT02348359|20176251|P4|COMPLETED|Overall Study||27
8182467|NCT02348359|20176252|P3|COMPLETED|Overall Study||25
8182468|NCT02348359|20176253|P2|COMPLETED|Overall Study||22
8182469|NCT02348359|20176254|P1|COMPLETED|Overall Study||29
8182470|NCT02348359|20176251|P4|STARTED|Overall Study||39
8182471|NCT02348359|20176252|P3|STARTED|Overall Study||39
8182472|NCT02348359|20176253|P2|STARTED|Overall Study||39
8182473|NCT02348359|20176254|P1|STARTED|Overall Study||40
8182480|NCT02348008|20176275|P3|NOT COMPLETED|Overall Study||19
8182481|NCT02348008|20176276|P2|NOT COMPLETED|Overall Study||10
8182482|NCT02348008|20176277|P1|NOT COMPLETED|Overall Study||3
8182483|NCT02348008|20176275|P3|COMPLETED|Overall Study||29
8182484|NCT02348008|20176276|P2|COMPLETED|Overall Study||0
8182485|NCT02348008|20176277|P1|COMPLETED|Overall Study||0
8182486|NCT02348008|20176275|P3|STARTED|Overall Study||48
8182487|NCT02348008|20176276|P2|STARTED|Overall Study||10
8182488|NCT02348008|20176277|P1|STARTED|Overall Study||3
8182489|NCT02347943|20176293|P3|NOT COMPLETED|Overall Study||45
8182490|NCT02347943|20176294|P2|NOT COMPLETED|Overall Study||67
8182491|NCT02347943|20176295|P1|NOT COMPLETED|Overall Study||140
8182492|NCT02347943|20176293|P3|COMPLETED|Overall Study||0
8182493|NCT02347943|20176294|P2|COMPLETED|Overall Study||0
8182494|NCT02347943|20176295|P1|COMPLETED|Overall Study||0
8182495|NCT02347943|20176293|P3|STARTED|Overall Study||45
8182496|NCT02347943|20176294|P2|STARTED|Overall Study||67
8182497|NCT02347943|20176295|P1|STARTED|Overall Study||140
8182498|NCT02347813|20176305|P2|NOT COMPLETED|Second Intervention, 24 Weeks||0
8182499|NCT02347813|20176306|P1|NOT COMPLETED|Second Intervention, 24 Weeks||0
8182500|NCT02347813|20176305|P2|COMPLETED|Second Intervention, 24 Weeks||4
8182501|NCT02347813|20176306|P1|COMPLETED|Second Intervention, 24 Weeks||4
8182502|NCT02347813|20176305|P2|STARTED|Second Intervention, 24 Weeks||4
8182503|NCT02347813|20176306|P1|STARTED|Second Intervention, 24 Weeks||4
8182504|NCT02347813|20176305|P2|NOT COMPLETED|First Intervention, 24 Weeks||2
8182505|NCT02347813|20176306|P1|NOT COMPLETED|First Intervention, 24 Weeks||2
8182506|NCT02347813|20176305|P2|COMPLETED|First Intervention, 24 Weeks||4
8182507|NCT02347813|20176306|P1|COMPLETED|First Intervention, 24 Weeks||4
8182508|NCT02347813|20176305|P2|STARTED|First Intervention, 24 Weeks||6
8182509|NCT02347813|20176306|P1|STARTED|First Intervention, 24 Weeks||6
8182510|NCT02347787|20176316|P2|NOT COMPLETED|9 Month Follow-Up||71
8182511|NCT02347787|20176317|P1|NOT COMPLETED|9 Month Follow-Up||61
8182512|NCT02347787|20176316|P2|COMPLETED|9 Month Follow-Up||233
8182513|NCT02347787|20176317|P1|COMPLETED|9 Month Follow-Up||227
8182514|NCT02347787|20176316|P2|STARTED|9 Month Follow-Up||304
8182515|NCT02347787|20176317|P1|STARTED|9 Month Follow-Up||288
8182516|NCT02347787|20176316|P2|NOT COMPLETED|6 Month Follow-Up||56
8182517|NCT02347787|20176317|P1|NOT COMPLETED|6 Month Follow-Up||66
8182518|NCT02347787|20176316|P2|COMPLETED|6 Month Follow-Up||248
8182519|NCT02347787|20176317|P1|COMPLETED|6 Month Follow-Up||222
8182520|NCT02347787|20176316|P2|STARTED|6 Month Follow-Up||304
8182521|NCT02347787|20176317|P1|STARTED|6 Month Follow-Up||288
8182522|NCT02347774|20176379|P3|NOT COMPLETED|On Study Treatment||36
8182523|NCT02347774|20176380|P2|NOT COMPLETED|On Study Treatment||31
8182524|NCT02347774|20176381|P1|NOT COMPLETED|On Study Treatment||24
8182525|NCT02347774|20176379|P3|COMPLETED|On Study Treatment||177
8182526|NCT02347774|20176380|P2|COMPLETED|On Study Treatment||183
8182527|NCT02347774|20176381|P1|COMPLETED|On Study Treatment||190
8182528|NCT02347774|20176379|P3|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
8182529|NCT02347774|20176380|P2|STARTED|On Study Treatment||214
8182530|NCT02347774|20176381|P1|STARTED|On Study Treatment||214
8182531|NCT02347774|20176379|P3|NOT COMPLETED|Study Participation||25
8182532|NCT02347774|20176380|P2|NOT COMPLETED|Study Participation||21
8182533|NCT02347774|20176381|P1|NOT COMPLETED|Study Participation||15
8182534|NCT02347774|20176379|P3|COMPLETED|Study Participation||188
8182535|NCT02347774|20176380|P2|COMPLETED|Study Participation||193
8182536|NCT02347774|20176381|P1|COMPLETED|Study Participation||199
8182537|NCT02347774|20176379|P3|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
8182538|NCT02347774|20176380|P2|STARTED|Study Participation||214
8182539|NCT02347774|20176381|P1|STARTED|Study Participation||214
8182540|NCT02347761|20176437|P3|NOT COMPLETED|On Study Treatment||42
8182541|NCT02347761|20176438|P2|NOT COMPLETED|On Study Treatment||23
8182542|NCT02347761|20176439|P1|NOT COMPLETED|On Study Treatment||27
8182543|NCT02347761|20176437|P3|COMPLETED|On Study Treatment||176
8182544|NCT02347761|20176438|P2|COMPLETED|On Study Treatment||194
8182545|NCT02347761|20176439|P1|COMPLETED|On Study Treatment||191
8182546|NCT02347761|20176437|P3|STARTED|On Study Treatment||218
8182547|NCT02347761|20176438|P2|STARTED|On Study Treatment||217
8182548|NCT02347761|20176439|P1|STARTED|On Study Treatment||218
8182549|NCT02347761|20176437|P3|NOT COMPLETED|All Collected||27
8182550|NCT02347761|20176438|P2|NOT COMPLETED|All Collected||14
8182551|NCT02347761|20176439|P1|NOT COMPLETED|All Collected||17
8182552|NCT02347761|20176437|P3|COMPLETED|All Collected||191
8182553|NCT02347761|20176438|P2|COMPLETED|All Collected||203
8182554|NCT02347761|20176439|P1|COMPLETED|All Collected||201
8182555|NCT02347761|20176437|P3|STARTED|All Collected||218
8182556|NCT02347761|20176438|P2|STARTED|All Collected||217
8182557|NCT02347761|20176439|P1|STARTED|All Collected||218
8182558|NCT02347657|20176500|P2|NOT COMPLETED|Overall Study||15
8182559|NCT02347657|20176501|P1|NOT COMPLETED|Overall Study||18
8182560|NCT02347657|20176500|P2|COMPLETED|Overall Study||236
8182561|NCT02347657|20176501|P1|COMPLETED|Overall Study||241
8182562|NCT02347657|20176500|P2|Treated|Overall Study||251
8182563|NCT02347657|20176501|P1|Treated|Overall Study||258
8182564|NCT02347657|20176500|P2|STARTED|Overall Study||251
8182565|NCT02347657|20176501|P1|STARTED|Overall Study||259
8182566|NCT02347631|20176528|P2|NOT COMPLETED|Second Intervention (2 Months)||4
8182567|NCT02347631|20176529|P1|NOT COMPLETED|Second Intervention (2 Months)||13
8182568|NCT02347631|20176528|P2|COMPLETED|Second Intervention (2 Months)||44
8182569|NCT02347631|20176529|P1|COMPLETED|Second Intervention (2 Months)||39
8182570|NCT02347631|20176528|P2|STARTED|Second Intervention (2 Months)||48
8182571|NCT02347631|20176529|P1|STARTED|Second Intervention (2 Months)||52
8182572|NCT02347631|20176528|P2|NOT COMPLETED|Washout 2 (1 Month)||3
8182573|NCT02347631|20176529|P1|NOT COMPLETED|Washout 2 (1 Month)||2
8182574|NCT02347631|20176528|P2|COMPLETED|Washout 2 (1 Month)||48
8182575|NCT02347631|20176529|P1|COMPLETED|Washout 2 (1 Month)||52
8182576|NCT02347631|20176528|P2|STARTED|Washout 2 (1 Month)||51
8182577|NCT02347631|20176529|P1|STARTED|Washout 2 (1 Month)||54
8182578|NCT02347631|20176528|P2|NOT COMPLETED|First Intervention (2 Months)||6
8182579|NCT02347631|20176529|P1|NOT COMPLETED|First Intervention (2 Months)||7
8182580|NCT02347631|20176528|P2|COMPLETED|First Intervention (2 Months)||51
8182581|NCT02347631|20176529|P1|COMPLETED|First Intervention (2 Months)||54
8182582|NCT02347631|20176528|P2|STARTED|First Intervention (2 Months)||57
8182583|NCT02347631|20176529|P1|STARTED|First Intervention (2 Months)||61
8182584|NCT02347631|20176528|P2|NOT COMPLETED|Washout 1 (1 Month)||0
8182585|NCT02347631|20176529|P1|NOT COMPLETED|Washout 1 (1 Month)||0
8182586|NCT02347631|20176528|P2|COMPLETED|Washout 1 (1 Month)||57
8182587|NCT02347631|20176529|P1|COMPLETED|Washout 1 (1 Month)||61
8182588|NCT02347631|20176528|P2|STARTED|Washout 1 (1 Month)||57
8182589|NCT02347631|20176529|P1|STARTED|Washout 1 (1 Month)||61
8182590|NCT02347605|20176543|P6|NOT COMPLETED|Overall Study||2
8182591|NCT02347605|20176544|P5|NOT COMPLETED|Overall Study||3
8182592|NCT02347605|20176545|P4|NOT COMPLETED|Overall Study||4
8182593|NCT02347605|20176546|P3|NOT COMPLETED|Overall Study||1
8182594|NCT02347605|20176547|P2|NOT COMPLETED|Overall Study||3
8182595|NCT02347605|20176548|P1|NOT COMPLETED|Overall Study||3
8182596|NCT02347605|20176543|P6|COMPLETED|Overall Study||7
8182597|NCT02347605|20176544|P5|COMPLETED|Overall Study||6
8182598|NCT02347605|20176545|P4|COMPLETED|Overall Study||6
8182599|NCT02347605|20176546|P3|COMPLETED|Overall Study||7
8182600|NCT02347605|20176547|P2|COMPLETED|Overall Study||7
8182601|NCT02347605|20176548|P1|COMPLETED|Overall Study||7
8182602|NCT02347605|20176543|P6|Completed Lab 2|Overall Study||8
8182603|NCT02347605|20176544|P5|Completed Lab 2|Overall Study||6
8182604|NCT02347605|20176545|P4|Completed Lab 2|Overall Study||7
8182605|NCT02347605|20176546|P3|Completed Lab 2|Overall Study||7
8182606|NCT02347605|20176547|P2|Completed Lab 2|Overall Study||7
8182607|NCT02347605|20176548|P1|Completed Lab 2|Overall Study||7
8182608|NCT02347605|20176543|P6|Completed Lab 1|Overall Study||9
8182609|NCT02347605|20176544|P5|Completed Lab 1|Overall Study||8
8182610|NCT02347605|20176545|P4|Completed Lab 1|Overall Study||10
8182611|NCT02347605|20176546|P3|Completed Lab 1|Overall Study||8
8182612|NCT02347605|20176547|P2|Completed Lab 1|Overall Study||10
8182613|NCT02347605|20176548|P1|Completed Lab 1|Overall Study||10
8182614|NCT02347605|20176543|P6|STARTED|Overall Study||9
8182615|NCT02347605|20176544|P5|STARTED|Overall Study||9
8182616|NCT02347605|20176545|P4|STARTED|Overall Study||10
8182617|NCT02347605|20176546|P3|STARTED|Overall Study||8
8182618|NCT02347605|20176547|P2|STARTED|Overall Study||10
8182619|NCT02347605|20176548|P1|STARTED|Overall Study||10
8182620|NCT02347488|20176559|P1|NOT COMPLETED|Overall Study||0
8182621|NCT02347488|20176559|P1|COMPLETED|Overall Study||30
8182622|NCT02347488|20176559|P1|STARTED|Overall Study||30
8182623|NCT02347345|20176572|P3|NOT COMPLETED|Overall Study||0
8182624|NCT02347345|20176573|P2|NOT COMPLETED|Overall Study||0
8182625|NCT02347345|20176574|P1|NOT COMPLETED|Overall Study||0
8182626|NCT02347345|20176572|P3|COMPLETED|Overall Study||12
8182627|NCT02347345|20176573|P2|COMPLETED|Overall Study||12
8182628|NCT02347345|20176574|P1|COMPLETED|Overall Study||10
8182629|NCT02347345|20176572|P3|STARTED|Overall Study||12
8182630|NCT02347345|20176573|P2|STARTED|Overall Study||12
8182631|NCT02347345|20176574|P1|STARTED|Overall Study||10
8182632|NCT02347332|20176590|P2|NOT COMPLETED|Overall Study||229
8182633|NCT02347332|20176591|P1|NOT COMPLETED|Overall Study||230
8182634|NCT02347332|20176590|P2|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0
8182635|NCT02347332|20176591|P1|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0
8182636|NCT02347332|20176590|P2|STARTED|Overall Study||229
8182637|NCT02347332|20176591|P1|STARTED|Overall Study||230
8182638|NCT02347189|20176605|P1|NOT COMPLETED|Overall Study||11
8182639|NCT02347189|20176605|P1|COMPLETED|Overall Study||28
8182640|NCT02347189|20176605|P1|Implanted > 24 Hours|Overall Study||30
8182641|NCT02347189|20176605|P1|Implanted|Overall Study||30
8182642|NCT02347189|20176605|P1|Catheterized|Overall Study||39
8182643|NCT02347189|20176605|P1|STARTED|Overall Study||39
8182644|NCT02347176|20176624|P4|NOT COMPLETED|Overall Study||4
8182645|NCT02347176|20176625|P3|NOT COMPLETED|Overall Study||8
8182646|NCT02347176|20176626|P2|NOT COMPLETED|Overall Study||10
8182647|NCT02347176|20176627|P1|NOT COMPLETED|Overall Study||12
8182648|NCT02347176|20176624|P4|COMPLETED|Overall Study||48
8182649|NCT02347176|20176625|P3|COMPLETED|Overall Study||43
8182650|NCT02347176|20176626|P2|COMPLETED|Overall Study||40
8182651|NCT02347176|20176627|P1|COMPLETED|Overall Study||39
8182652|NCT02347176|20176624|P4|STARTED|Overall Study||52
8182653|NCT02347176|20176625|P3|STARTED|Overall Study||51
8182654|NCT02347176|20176626|P2|STARTED|Overall Study||50
8182655|NCT02347176|20176627|P1|STARTED|Overall Study||51
8182656|NCT02347124|20176675|P2|NOT COMPLETED|Overall Study||99
8182657|NCT02347124|20176676|P1|NOT COMPLETED|Overall Study||93
8182658|NCT02347124|20176675|P2|COMPLETED|Overall Study||259
8182659|NCT02347124|20176676|P1|COMPLETED|Overall Study||267
8182660|NCT02347124|20176675|P2|2 Month Follow-up|Overall Study||275
8182661|NCT02347124|20176676|P1|2 Month Follow-up|Overall Study||298
8182662|NCT02347124|20176675|P2|STARTED|Overall Study||358
8182663|NCT02347124|20176676|P1|STARTED|Overall Study||360
8182664|NCT02347098|20176712|P2|NOT COMPLETED|Overall Study||8
8182665|NCT02347098|20176713|P1|NOT COMPLETED|Overall Study||7
8182666|NCT02347098|20176712|P2|COMPLETED|Overall Study||58
8182667|NCT02347098|20176713|P1|COMPLETED|Overall Study||56
8182668|NCT02347098|20176712|P2|STARTED|Overall Study||66
8182669|NCT02347098|20176713|P1|STARTED|Overall Study||63
8182670|NCT02347085|20176725|P1|NOT COMPLETED|Overall Study||10
8182671|NCT02347085|20176725|P1|COMPLETED|Overall Study||33
8182672|NCT02347085|20176725|P1|Placebo MDI|Overall Study||40
8182673|NCT02347085|20176725|P1|GFF MDI 14.4/9.6 µg|Overall Study||40
8182674|NCT02347085|20176725|P1|STARTED|Overall Study||43
8182675|NCT02347072|20176747|P1|NOT COMPLETED|Overall Study||18
8182676|NCT02347072|20176747|P1|COMPLETED|Overall Study||62
8182677|NCT02347072|20176747|P1|Spiriva Respimat 5 µg|Overall Study||73
8182678|NCT02347072|20176747|P1|Placebo MDI|Overall Study||72
8182679|NCT02347072|20176747|P1|GFF MDI 14.4/9.6 µg|Overall Study||75
8182680|NCT02347072|20176747|P1|STARTED|Overall Study||80
8182681|NCT02346877|20176781|P2|NOT COMPLETED|Overall Study||0
8182682|NCT02346877|20176782|P1|NOT COMPLETED|Overall Study||19
8182683|NCT02346877|20176781|P2|COMPLETED|Overall Study||0
8182684|NCT02346877|20176782|P1|COMPLETED|Overall Study||0
8182685|NCT02346877|20176781|P2|STARTED|Overall Study||0
8182686|NCT02346877|20176782|P1|STARTED|Overall Study||19
8182687|NCT02346721|20176792|P1|NOT COMPLETED|Overall Study||4
8182688|NCT02346721|20176792|P1|COMPLETED|Overall Study||107
8182689|NCT02346721|20176792|P1|STARTED|Overall Study||111
8182696|NCT02346643|20176812|P1|NOT COMPLETED|Overall Study||35
8182697|NCT02346643|20176812|P1|COMPLETED|Overall Study||6
8182698|NCT02346643|20176812|P1|Received Permanent System|Overall Study||31
8182699|NCT02346643|20176812|P1|Received Trial System|Overall Study||29
8182700|NCT02346643|20176812|P1|STARTED|Overall Study||41
8182701|NCT02346461|20176819|P2|NOT COMPLETED|Overall Study||0
8182702|NCT02346461|20176820|P1|NOT COMPLETED|Overall Study||0
8182703|NCT02346461|20176819|P2|COMPLETED|Overall Study||6
8182704|NCT02346461|20176820|P1|COMPLETED|Overall Study||6
8182705|NCT02346461|20176819|P2|STARTED|Overall Study||6
8182706|NCT02346461|20176820|P1|STARTED|Overall Study||6
8182707|NCT02346370|20176842|P3|NOT COMPLETED|Overall Study||4
8182708|NCT02346370|20176843|P2|NOT COMPLETED|Overall Study||4
8182709|NCT02346370|20176844|P1|NOT COMPLETED|Overall Study||8
8182710|NCT02346370|20176842|P3|COMPLETED|Overall Study||0
8182711|NCT02346370|20176843|P2|COMPLETED|Overall Study||0
8182712|NCT02346370|20176844|P1|COMPLETED|Overall Study||0
8182713|NCT02346370|20176842|P3|STARTED|Overall Study||4
8182714|NCT02346370|20176843|P2|STARTED|Overall Study||4
8182715|NCT02346370|20176844|P1|STARTED|Overall Study||8
8183109|NCT02345226|20177248|P2|NOT COMPLETED|Double-Blind Phase||71
8183110|NCT02345226|20177249|P1|NOT COMPLETED|Double-Blind Phase||69
8183028|NCT02346136|20176955|P2|NOT COMPLETED|Overall Study||23
8183029|NCT02346136|20176956|P1|NOT COMPLETED|Overall Study||22
8183030|NCT02346136|20176955|P2|COMPLETED|Overall Study||64
8183031|NCT02346136|20176956|P1|COMPLETED|Overall Study||71
8183032|NCT02346136|20176955|P2|STARTED|Overall Study||87
8183033|NCT02346136|20176956|P1|STARTED|Overall Study||93
8183034|NCT02345889|20176992|P4|NOT COMPLETED|Overall Study||16
8183035|NCT02345889|20176993|P3|NOT COMPLETED|Overall Study||20
8183036|NCT02345889|20176994|P2|NOT COMPLETED|Overall Study||17
8183037|NCT02345889|20176995|P1|NOT COMPLETED|Overall Study||21
8183038|NCT02345889|20176992|P4|COMPLETED|Overall Study||299
8183039|NCT02345889|20176993|P3|COMPLETED|Overall Study||295
8183040|NCT02345889|20176994|P2|COMPLETED|Overall Study||299
8183041|NCT02345889|20176995|P1|COMPLETED|Overall Study||295
8183042|NCT02345889|20176992|P4|STARTED|Overall Study||315
8183043|NCT02345889|20176993|P3|STARTED|Overall Study||315
8183044|NCT02345889|20176994|P2|STARTED|Overall Study||316
8183045|NCT02345889|20176995|P1|STARTED|Overall Study||316
8183046|NCT02345811|20177061|P2|NOT COMPLETED|Second Intervention||0
8183047|NCT02345811|20177062|P1|NOT COMPLETED|Second Intervention||0
8183048|NCT02345811|20177061|P2|COMPLETED|Second Intervention||16
8183049|NCT02345811|20177062|P1|COMPLETED|Second Intervention||16
8183050|NCT02345811|20177061|P2|STARTED|Second Intervention||16
8183051|NCT02345811|20177062|P1|STARTED|Second Intervention||16
8183052|NCT02345811|20177061|P2|NOT COMPLETED|First Intervention||1
8183053|NCT02345811|20177062|P1|NOT COMPLETED|First Intervention||1
8183054|NCT02345811|20177061|P2|COMPLETED|First Intervention||16
8183055|NCT02345811|20177062|P1|COMPLETED|First Intervention||16
8183056|NCT02345811|20177061|P2|STARTED|First Intervention||17
8183057|NCT02345811|20177062|P1|STARTED|First Intervention||17
8183058|NCT02345772|20177092|P1|NOT COMPLETED|Overall Study||4
8183059|NCT02345772|20177092|P1|COMPLETED|Overall Study||0
8183060|NCT02345772|20177092|P1|STARTED|Overall Study||4
8183061|NCT02345720|20177098|P1|NOT COMPLETED|Overall Study||0
8183062|NCT02345720|20177098|P1|COMPLETED|Overall Study||20
8183063|NCT02345720|20177098|P1|STARTED|Overall Study||20
8183064|NCT02345642|20177106|P2|NOT COMPLETED|Overall Study||0
8183065|NCT02345642|20177107|P1|NOT COMPLETED|Overall Study||0
8183066|NCT02345642|20177106|P2|COMPLETED|Overall Study||10
8183067|NCT02345642|20177107|P1|COMPLETED|Overall Study||10
8183068|NCT02345642|20177106|P2|STARTED|Overall Study||10
8183069|NCT02345642|20177107|P1|STARTED|Overall Study||10
8183070|NCT02345512|20177113|P1|NOT COMPLETED|Overall Study||2
8183071|NCT02345512|20177113|P1|COMPLETED|Overall Study||9
8183072|NCT02345512|20177113|P1|STARTED|Overall Study||11
8183073|NCT02345486|20177134|P2|NOT COMPLETED|Overall Study||0
8183074|NCT02345486|20177135|P1|NOT COMPLETED|Overall Study||0
8183075|NCT02345486|20177134|P2|COMPLETED|Overall Study||520
8183076|NCT02345486|20177135|P1|COMPLETED|Overall Study||454
8183077|NCT02345486|20177134|P2|STARTED|Overall Study||520
8183078|NCT02345486|20177135|P1|STARTED|Overall Study||454
8183079|NCT02345460|20177183|P1|NOT COMPLETED|Overall Study||0
8183080|NCT02345460|20177183|P1|COMPLETED|Overall Study||1
8183081|NCT02345460|20177183|P1|STARTED|Overall Study||1
8183082|NCT02345369|20177196|P2|NOT COMPLETED|Overall Study||0
8183083|NCT02345369|20177197|P1|NOT COMPLETED|Overall Study||0
8183084|NCT02345369|20177196|P2|COMPLETED|Overall Study||0
8183085|NCT02345369|20177197|P1|COMPLETED|Overall Study||0
8183086|NCT02345369|20177196|P2|STARTED|Overall Study||0
8183087|NCT02345369|20177197|P1|STARTED|Overall Study||0
8183088|NCT02345330|20177207|P1|NOT COMPLETED|Overall Study||3
8183089|NCT02345330|20177207|P1|COMPLETED|Overall Study||1
8183090|NCT02345330|20177207|P1|STARTED|Overall Study||4
8183091|NCT02345252|20177219|P2|NOT COMPLETED|Open-Label Extension Phase||0
8183092|NCT02345252|20177220|P1|NOT COMPLETED|Open-Label Extension Phase||0
8183093|NCT02345252|20177219|P2|COMPLETED|Open-Label Extension Phase||17
8183094|NCT02345252|20177220|P1|COMPLETED|Open-Label Extension Phase||19
8183095|NCT02345252|20177219|P2|STARTED|Open-Label Extension Phase|250 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|17
8183096|NCT02345252|20177220|P1|STARTED|Open-Label Extension Phase|257 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|19
8183097|NCT02345252|20177219|P2|NOT COMPLETED|Double-Blind Phase||49
8183098|NCT02345252|20177220|P1|NOT COMPLETED|Double-Blind Phase||40
8183099|NCT02345252|20177219|P2|COMPLETED|Double-Blind Phase||267
8183100|NCT02345252|20177220|P1|COMPLETED|Double-Blind Phase||276
8183101|NCT02345252|20177219|P2|STARTED|Double-Blind Phase||316
8183102|NCT02345252|20177220|P1|STARTED|Double-Blind Phase||316
8183103|NCT02345226|20177248|P2|NOT COMPLETED|Open-Label Extension Phase||1
8183104|NCT02345226|20177249|P1|NOT COMPLETED|Open-Label Extension Phase||0
8183105|NCT02345226|20177248|P2|COMPLETED|Open-Label Extension Phase||20
8183106|NCT02345226|20177249|P1|COMPLETED|Open-Label Extension Phase||25
8183107|NCT02345226|20177248|P2|STARTED|Open-Label Extension Phase|349 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|21
8183108|NCT02345226|20177249|P1|STARTED|Open-Label Extension Phase|346 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|25
8183111|NCT02345226|20177248|P2|COMPLETED|Double-Blind Phase||370
8183112|NCT02345226|20177249|P1|COMPLETED|Double-Blind Phase||371
8183113|NCT02345226|20177248|P2|STARTED|Double-Blind Phase||441
8183114|NCT02345226|20177249|P1|STARTED|Double-Blind Phase||440
8183115|NCT02345161|20177281|P2|NOT COMPLETED|Overall Study||57
8183116|NCT02345161|20177282|P1|NOT COMPLETED|Overall Study||45
8183117|NCT02345161|20177281|P2|COMPLETED|Overall Study||842
8183118|NCT02345161|20177282|P1|COMPLETED|Overall Study||866
8183119|NCT02345161|20177281|P2|STARTED|Overall Study||899
8183120|NCT02345161|20177282|P1|STARTED|Overall Study||911
8183121|NCT02345070|20177387|P3|NOT COMPLETED|Overall Study||23
8183122|NCT02345070|20177388|P2|NOT COMPLETED|Overall Study||11
8183123|NCT02345070|20177389|P1|NOT COMPLETED|Overall Study||20
8183124|NCT02345070|20177387|P3|COMPLETED|Overall Study||85
8183125|NCT02345070|20177388|P2|COMPLETED|Overall Study||98
8183126|NCT02345070|20177389|P1|COMPLETED|Overall Study||90
8183127|NCT02345070|20177387|P3|Treated|Overall Study||108
8183128|NCT02345070|20177388|P2|Treated|Overall Study||108
8183129|NCT02345070|20177389|P1|Treated|Overall Study||109
8183130|NCT02345070|20177387|P3|STARTED|Overall Study||108
8183131|NCT02345070|20177388|P2|STARTED|Overall Study||109
8183132|NCT02345070|20177389|P1|STARTED|Overall Study||110
8183133|NCT02345031|20177405|P2|NOT COMPLETED|Overall Study||1
8183134|NCT02345031|20177406|P1|NOT COMPLETED|Overall Study||1
8183135|NCT02345031|20177405|P2|COMPLETED|Overall Study||39
8183136|NCT02345031|20177406|P1|COMPLETED|Overall Study||37
8183137|NCT02345031|20177405|P2|STARTED|Overall Study||40
8183138|NCT02345031|20177406|P1|STARTED|Overall Study||38
8183139|NCT02344745|20177422|P2|NOT COMPLETED|Overall Study||0
8183140|NCT02344745|20177423|P1|NOT COMPLETED|Overall Study||2
8183141|NCT02344745|20177422|P2|COMPLETED|Overall Study||40
8183142|NCT02344745|20177423|P1|COMPLETED|Overall Study||38
8183143|NCT02344745|20177422|P2|STARTED|Overall Study||40
8183144|NCT02344745|20177423|P1|STARTED|Overall Study||40
8183145|NCT02344628|20177437|P2|NOT COMPLETED|Overall Study||86
8183146|NCT02344628|20177438|P1|NOT COMPLETED|Overall Study||91
8183147|NCT02344628|20177437|P2|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
8183148|NCT02344628|20177438|P1|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
8183149|NCT02344628|20177437|P2|STARTED|Overall Study||292
8183150|NCT02344628|20177438|P1|STARTED|Overall Study||291
8183151|NCT02344576|20177452|P4|NOT COMPLETED|12-Month Medical Record Follow-Up||0
8183152|NCT02344576|20177453|P3|NOT COMPLETED|12-Month Medical Record Follow-Up||0
8183153|NCT02344576|20177454|P2|NOT COMPLETED|12-Month Medical Record Follow-Up||0
8183154|NCT02344576|20177455|P1|NOT COMPLETED|12-Month Medical Record Follow-Up||0
8183155|NCT02344576|20177452|P4|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
8183156|NCT02344576|20177453|P3|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
8183157|NCT02344576|20177454|P2|COMPLETED|12-Month Medical Record Follow-Up||67
8183158|NCT02344576|20177455|P1|COMPLETED|12-Month Medical Record Follow-Up||98
8183159|NCT02344576|20177452|P4|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
8183160|NCT02344576|20177453|P3|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
8183161|NCT02344576|20177454|P2|STARTED|12-Month Medical Record Follow-Up||67
8183162|NCT02344576|20177455|P1|STARTED|12-Month Medical Record Follow-Up||98
8183163|NCT02344576|20177452|P4|NOT COMPLETED|6-Month Follow-Up||8
8183164|NCT02344576|20177453|P3|NOT COMPLETED|6-Month Follow-Up||14
8183165|NCT02344576|20177454|P2|NOT COMPLETED|6-Month Follow-Up||19
8183166|NCT02344576|20177455|P1|NOT COMPLETED|6-Month Follow-Up||19
8183167|NCT02344576|20177452|P4|COMPLETED|6-Month Follow-Up||50
8183168|NCT02344576|20177453|P3|COMPLETED|6-Month Follow-Up||78
8183169|NCT02344576|20177454|P2|COMPLETED|6-Month Follow-Up||67
8183170|NCT02344576|20177455|P1|COMPLETED|6-Month Follow-Up||98
8183171|NCT02344576|20177452|P4|Completed 6-Month Survey|6-Month Follow-Up||50
8183172|NCT02344576|20177453|P3|Completed 6-Month Survey|6-Month Follow-Up||78
8183173|NCT02344576|20177454|P2|Completed 6-Month Survey|6-Month Follow-Up||67
8183174|NCT02344576|20177455|P1|Completed 6-Month Survey|6-Month Follow-Up||98
8183175|NCT02344576|20177452|P4|STARTED|6-Month Follow-Up||58
8183176|NCT02344576|20177453|P3|STARTED|6-Month Follow-Up||92
8183177|NCT02344576|20177454|P2|STARTED|6-Month Follow-Up||86
8183178|NCT02344576|20177455|P1|STARTED|6-Month Follow-Up||117
8183179|NCT02344576|20177452|P4|NOT COMPLETED|1-Month Follow-Up||13
8183180|NCT02344576|20177453|P3|NOT COMPLETED|1-Month Follow-Up||19
8183181|NCT02344576|20177454|P2|NOT COMPLETED|1-Month Follow-Up||27
8183182|NCT02344576|20177455|P1|NOT COMPLETED|1-Month Follow-Up||18
8183183|NCT02344576|20177452|P4|COMPLETED|1-Month Follow-Up|Includes 5 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|58
8183184|NCT02344576|20177453|P3|COMPLETED|1-Month Follow-Up|Includes 3 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|92
8183185|NCT02344576|20177454|P2|COMPLETED|1-Month Follow-Up|Includes 7 patients who were still enrolled at 1-month but did not complete the 1-month survey.|86
8183186|NCT02344576|20177455|P1|COMPLETED|1-Month Follow-Up|Includes 13 patients who were still enrolled at 1-month but did not complete the 1-month survey.|117
8183187|NCT02344576|20177452|P4|Completed 1-Month Survey|1-Month Follow-Up||53
8183188|NCT02344576|20177453|P3|Completed 1-Month Survey|1-Month Follow-Up||89
8183189|NCT02344576|20177454|P2|Completed 1-Month Survey|1-Month Follow-Up||79
8183190|NCT02344576|20177455|P1|Completed 1-Month Survey|1-Month Follow-Up||104
8183191|NCT02344576|20177452|P4|STARTED|1-Month Follow-Up||71
8183192|NCT02344576|20177453|P3|STARTED|1-Month Follow-Up||111
8183193|NCT02344576|20177454|P2|STARTED|1-Month Follow-Up||113
8183194|NCT02344576|20177455|P1|STARTED|1-Month Follow-Up||135
8183195|NCT02344576|20177452|P4|NOT COMPLETED|Enrollment||0
8183196|NCT02344576|20177453|P3|NOT COMPLETED|Enrollment||0
8183197|NCT02344576|20177454|P2|NOT COMPLETED|Enrollment||8
8183198|NCT02344576|20177455|P1|NOT COMPLETED|Enrollment||7
8183199|NCT02344576|20177452|P4|COMPLETED|Enrollment||71
8183200|NCT02344576|20177453|P3|COMPLETED|Enrollment||111
8183201|NCT02344576|20177454|P2|COMPLETED|Enrollment||113
8183202|NCT02344576|20177455|P1|COMPLETED|Enrollment||135
8183203|NCT02344576|20177452|P4|Agreed to Survey Data Collection|Enrollment||71
8183204|NCT02344576|20177453|P3|Agreed to Survey Data Collection|Enrollment||111
8183205|NCT02344576|20177454|P2|Agreed to Survey Data Collection|Enrollment||113
8183206|NCT02344576|20177455|P1|Agreed to Survey Data Collection|Enrollment||135
8183207|NCT02344576|20177452|P4|STARTED|Enrollment||71
8183208|NCT02344576|20177453|P3|STARTED|Enrollment||111
8183209|NCT02344576|20177454|P2|STARTED|Enrollment|Includes 8 patients who agreed to medical record review only and were excluded from further analysis|121
8183210|NCT02344576|20177455|P1|STARTED|Enrollment|Includes 7 patients who agreed to medical record review only and were excluded from further analysis|142
8183220|NCT02344342|20177518|P4|NOT COMPLETED|Overall Study||10
8183221|NCT02344342|20177519|P3|NOT COMPLETED|Overall Study||14
8183222|NCT02344342|20177520|P2|NOT COMPLETED|Overall Study||9
8183223|NCT02344342|20177521|P1|NOT COMPLETED|Overall Study||11
8183224|NCT02344342|20177518|P4|COMPLETED|Overall Study||3
8183225|NCT02344342|20177519|P3|COMPLETED|Overall Study||0
8183226|NCT02344342|20177520|P2|COMPLETED|Overall Study||2
8183227|NCT02344342|20177521|P1|COMPLETED|Overall Study||2
8183228|NCT02344342|20177518|P4|STARTED|Overall Study||13
8183229|NCT02344342|20177519|P3|STARTED|Overall Study||14
8183230|NCT02344342|20177520|P2|STARTED|Overall Study||11
8183231|NCT02344342|20177521|P1|STARTED|Overall Study||13
8183232|NCT02344251|20177545|P2|NOT COMPLETED|Overall Study||0
8183233|NCT02344251|20177546|P1|NOT COMPLETED|Overall Study||0
8183234|NCT02344251|20177545|P2|COMPLETED|Overall Study||20
8183235|NCT02344251|20177546|P1|COMPLETED|Overall Study||20
8183236|NCT02344251|20177545|P2|STARTED|Overall Study||20
8183237|NCT02344251|20177546|P1|STARTED|Overall Study||20
8183238|NCT02344238|20177557|P3|NOT COMPLETED|Overall Study||0
8183239|NCT02344238|20177558|P2|NOT COMPLETED|Overall Study||0
8183240|NCT02344238|20177559|P1|NOT COMPLETED|Overall Study||0
8183241|NCT02344238|20177557|P3|COMPLETED|Overall Study||20
8183242|NCT02344238|20177558|P2|COMPLETED|Overall Study||20
8183243|NCT02344238|20177559|P1|COMPLETED|Overall Study||20
8183244|NCT02344238|20177557|P3|STARTED|Overall Study||20
8183245|NCT02344238|20177558|P2|STARTED|Overall Study||20
8183246|NCT02344238|20177559|P1|STARTED|Overall Study||20
8183247|NCT02344225|20177571|P3|NOT COMPLETED|Overall Study||0
8183248|NCT02344225|20177572|P2|NOT COMPLETED|Overall Study||0
8183249|NCT02344225|20177573|P1|NOT COMPLETED|Overall Study||0
8183250|NCT02344225|20177571|P3|COMPLETED|Overall Study||5
8183251|NCT02344225|20177572|P2|COMPLETED|Overall Study||3
8183252|NCT02344225|20177573|P1|COMPLETED|Overall Study||6
8183253|NCT02344225|20177571|P3|STARTED|Overall Study||5
8183254|NCT02344225|20177572|P2|STARTED|Overall Study||3
8183255|NCT02344225|20177573|P1|STARTED|Overall Study||6
8183256|NCT02344173|20177587|P1|NOT COMPLETED|12-month Visit||96
8183257|NCT02344173|20177587|P1|COMPLETED|12-month Visit||1932
8183258|NCT02344173|20177587|P1|STARTED|12-month Visit||2028
8183259|NCT02344173|20177587|P1|NOT COMPLETED|Procedure||7
8183260|NCT02344173|20177587|P1|COMPLETED|Procedure||2028
8183261|NCT02344173|20177587|P1|STARTED|Procedure||2035
8183262|NCT02344173|20177587|P1|NOT COMPLETED|Enrollment||0
8183263|NCT02344173|20177587|P1|COMPLETED|Enrollment||2035
8183264|NCT02344173|20177587|P1|STARTED|Enrollment||2035
8183265|NCT02344004|20177595|P2|NOT COMPLETED|Overall Study||14
8183266|NCT02344004|20177596|P1|NOT COMPLETED|Overall Study||61
8183267|NCT02344004|20177595|P2|COMPLETED|Overall Study||98
8183268|NCT02344004|20177596|P1|COMPLETED|Overall Study||163
8183269|NCT02344004|20177595|P2|STARTED|Overall Study||112
8183270|NCT02344004|20177596|P1|STARTED|Overall Study||224
8183271|NCT02343939|20177623|P9|NOT COMPLETED|Overall Study||7
8183272|NCT02343939|20177624|P8|NOT COMPLETED|Overall Study||37
8183273|NCT02343939|20177625|P7|NOT COMPLETED|Overall Study||15
8183274|NCT02343939|20177626|P6|NOT COMPLETED|Overall Study||17
8183275|NCT02343939|20177627|P5|NOT COMPLETED|Overall Study||8
8183276|NCT02343939|20177628|P4|NOT COMPLETED|Overall Study||6
8183277|NCT02343939|20177629|P3|NOT COMPLETED|Overall Study||5
8183278|NCT02343939|20177630|P2|NOT COMPLETED|Overall Study||48
8183279|NCT02343939|20177631|P1|NOT COMPLETED|Overall Study||3
8183280|NCT02343939|20177623|P9|COMPLETED|Overall Study||0
8183281|NCT02343939|20177624|P8|COMPLETED|Overall Study||0
8183282|NCT02343939|20177625|P7|COMPLETED|Overall Study||0
8183283|NCT02343939|20177626|P6|COMPLETED|Overall Study||0
8183284|NCT02343939|20177627|P5|COMPLETED|Overall Study||0
8183285|NCT02343939|20177628|P4|COMPLETED|Overall Study||0
8183286|NCT02343939|20177629|P3|COMPLETED|Overall Study||0
8183287|NCT02343939|20177630|P2|COMPLETED|Overall Study||2
8183288|NCT02343939|20177631|P1|COMPLETED|Overall Study||0
8183289|NCT02343939|20177623|P9|STARTED|Overall Study||7
8183290|NCT02343939|20177624|P8|STARTED|Overall Study||37
8183291|NCT02343939|20177625|P7|STARTED|Overall Study||15
8183292|NCT02343939|20177626|P6|STARTED|Overall Study||17
8183293|NCT02343939|20177627|P5|STARTED|Overall Study||8
8183294|NCT02343939|20177628|P4|STARTED|Overall Study||6
8183295|NCT02343939|20177629|P3|STARTED|Overall Study||5
8183296|NCT02343939|20177630|P2|STARTED|Overall Study||50
8183297|NCT02343939|20177631|P1|STARTED|Overall Study||3
8183298|NCT02343627|20177743|P2|NOT COMPLETED|Overall Study||1
8183299|NCT02343627|20177744|P1|NOT COMPLETED|Overall Study||12
8183300|NCT02343627|20177743|P2|COMPLETED|Overall Study||11
8183301|NCT02343627|20177744|P1|COMPLETED|Overall Study||23
8183302|NCT02343627|20177743|P2|STARTED|Overall Study||12
8183303|NCT02343627|20177744|P1|STARTED|Overall Study||35
8183304|NCT02343575|20177752|P2|NOT COMPLETED|Overall Study||0
8183305|NCT02343575|20177753|P1|NOT COMPLETED|Overall Study||0
8183306|NCT02343575|20177752|P2|COMPLETED|Overall Study||2
8183307|NCT02343575|20177753|P1|COMPLETED|Overall Study||1
8183308|NCT02343575|20177752|P2|STARTED|Overall Study||2
8183309|NCT02343575|20177753|P1|STARTED|Overall Study||1
8183310|NCT02343458|20177773|P4|NOT COMPLETED|Overall Study||38
8183311|NCT02343458|20177774|P3|NOT COMPLETED|Overall Study||63
8183312|NCT02343458|20177775|P2|NOT COMPLETED|Overall Study||66
8183313|NCT02343458|20177776|P1|NOT COMPLETED|Overall Study||61
8183314|NCT02343458|20177773|P4|COMPLETED|Overall Study||200
8183315|NCT02343458|20177774|P3|COMPLETED|Overall Study||417
8183316|NCT02343458|20177775|P2|COMPLETED|Overall Study||417
8183317|NCT02343458|20177776|P1|COMPLETED|Overall Study||494
8183318|NCT02343458|20177773|P4|STARTED|Overall Study||238
8183319|NCT02343458|20177774|P3|STARTED|Overall Study||480
8183320|NCT02343458|20177775|P2|STARTED|Overall Study||483
8183321|NCT02343458|20177776|P1|STARTED|Overall Study||555
8183322|NCT02343406|20177855|P5|NOT COMPLETED|Overall Study||5
8183323|NCT02343406|20177856|P4|NOT COMPLETED|Overall Study||26
8183324|NCT02343406|20177857|P3|NOT COMPLETED|Overall Study||58
8183325|NCT02343406|20177858|P2|NOT COMPLETED|Overall Study||86
8183326|NCT02343406|20177859|P1|NOT COMPLETED|Overall Study||88
8183327|NCT02343406|20177855|P5|COMPLETED|Overall Study||1
8183328|NCT02343406|20177856|P4|COMPLETED|Overall Study||0
8183329|NCT02343406|20177857|P3|COMPLETED|Overall Study||2
8183330|NCT02343406|20177858|P2|COMPLETED|Overall Study||0
8183331|NCT02343406|20177859|P1|COMPLETED|Overall Study||0
8183332|NCT02343406|20177855|P5|STARTED|Overall Study||6
8183333|NCT02343406|20177856|P4|STARTED|Overall Study||26
8183334|NCT02343406|20177857|P3|STARTED|Overall Study||60
8183335|NCT02343406|20177858|P2|STARTED|Overall Study||86
8183336|NCT02343406|20177859|P1|STARTED|Overall Study||88
8183337|NCT02343380|20177894|P2|NOT COMPLETED|Overall Study||0
8183338|NCT02343380|20177895|P1|NOT COMPLETED|Overall Study||0
8183339|NCT02343380|20177894|P2|COMPLETED|Overall Study|Morning test (second week)|10
8183340|NCT02343380|20177895|P1|COMPLETED|Overall Study|Evening test (second week)|10
8183341|NCT02343380|20177894|P2|STARTED|Overall Study|Evening test (first week)|10
8183342|NCT02343380|20177895|P1|STARTED|Overall Study|Morning test (first week)|10
8183343|NCT02343276|20177913|P2|NOT COMPLETED|Overall Study||0
8183344|NCT02343276|20177914|P1|NOT COMPLETED|Overall Study||0
8183345|NCT02343276|20177913|P2|COMPLETED|Overall Study||164
8183346|NCT02343276|20177914|P1|COMPLETED|Overall Study||164
8183347|NCT02343276|20177913|P2|STARTED|Overall Study||164
8183348|NCT02343276|20177914|P1|STARTED|Overall Study||164
8183349|NCT02343263|20177927|P3|NOT COMPLETED|Overall Study||1
8183350|NCT02343263|20177928|P2|NOT COMPLETED|Overall Study||3
8183351|NCT02343263|20177929|P1|NOT COMPLETED|Overall Study||5
8183352|NCT02343263|20177927|P3|COMPLETED|Overall Study||0
8183353|NCT02343263|20177928|P2|COMPLETED|Overall Study||0
8183354|NCT02343263|20177929|P1|COMPLETED|Overall Study|Study closed due for administrative reasons|0
8183355|NCT02343263|20177927|P3|STARTED|Overall Study||1
8183356|NCT02343263|20177928|P2|STARTED|Overall Study||3
8183357|NCT02343263|20177929|P1|STARTED|Overall Study|Study closed due for administrative reasons|5
8183358|NCT02343159|20177958|P3|NOT COMPLETED|Overall Study||30
8183359|NCT02343159|20177959|P2|NOT COMPLETED|Overall Study||26
8183360|NCT02343159|20177960|P1|NOT COMPLETED|Overall Study||26
8183361|NCT02343159|20177958|P3|COMPLETED|Overall Study||0
8183362|NCT02343159|20177959|P2|COMPLETED|Overall Study||1
8183363|NCT02343159|20177960|P1|COMPLETED|Overall Study||1
8183364|NCT02343159|20177958|P3|STARTED|Overall Study||30
8183365|NCT02343159|20177959|P2|STARTED|Overall Study||27
8183366|NCT02343159|20177960|P1|STARTED|Overall Study||27
8183367|NCT02343081|20177987|P2|NOT COMPLETED|Second Intervention (Day 4)||0
8183368|NCT02343081|20177988|P1|NOT COMPLETED|Second Intervention (Day 4)||0
8183369|NCT02343081|20177987|P2|COMPLETED|Second Intervention (Day 4)||8
8183370|NCT02343081|20177988|P1|COMPLETED|Second Intervention (Day 4)||8
8183371|NCT02343081|20177987|P2|Received Intervention|Second Intervention (Day 4)||8
8183372|NCT02343081|20177988|P1|Received Intervention|Second Intervention (Day 4)||8
8183373|NCT02343081|20177987|P2|STARTED|Second Intervention (Day 4)||8
8183374|NCT02343081|20177988|P1|STARTED|Second Intervention (Day 4)||8
8183375|NCT02343081|20177987|P2|NOT COMPLETED|Washout (10 Hours)||0
8183376|NCT02343081|20177988|P1|NOT COMPLETED|Washout (10 Hours)||0
8183377|NCT02343081|20177987|P2|COMPLETED|Washout (10 Hours)||8
8183378|NCT02343081|20177988|P1|COMPLETED|Washout (10 Hours)||8
8183379|NCT02343081|20177987|P2|STARTED|Washout (10 Hours)||8
8183380|NCT02343081|20177988|P1|STARTED|Washout (10 Hours)||8
8183381|NCT02343081|20177987|P2|NOT COMPLETED|First Intervention (Day 3)||0
8183382|NCT02343081|20177988|P1|NOT COMPLETED|First Intervention (Day 3)||0
8183383|NCT02343081|20177987|P2|COMPLETED|First Intervention (Day 3)||8
8183384|NCT02343081|20177988|P1|COMPLETED|First Intervention (Day 3)||8
8183385|NCT02343081|20177987|P2|Received Intervention|First Intervention (Day 3)||8
8183386|NCT02343081|20177988|P1|Received Intervention|First Intervention (Day 3)||8
8183387|NCT02343081|20177987|P2|STARTED|First Intervention (Day 3)||8
8183388|NCT02343081|20177988|P1|STARTED|First Intervention (Day 3)||8
8183389|NCT02343003|20178004|P2|NOT COMPLETED|Overall Study||7
8183390|NCT02343003|20178005|P1|NOT COMPLETED|Overall Study||18
8183391|NCT02343003|20178004|P2|COMPLETED|Overall Study||68
8183392|NCT02343003|20178005|P1|COMPLETED|Overall Study||58
8183393|NCT02343003|20178004|P2|STARTED|Overall Study||75
8183394|NCT02343003|20178005|P1|STARTED|Overall Study||76
8183395|NCT02342886|20178026|P5|NOT COMPLETED|Overall Study||3
8183396|NCT02342886|20178027|P4|NOT COMPLETED|Overall Study||9
8183397|NCT02342886|20178028|P3|NOT COMPLETED|Overall Study||15
8183398|NCT02342886|20178029|P2|NOT COMPLETED|Overall Study||8
8183399|NCT02342886|20178030|P1|NOT COMPLETED|Overall Study||8
8183400|NCT02342886|20178026|P5|COMPLETED|Overall Study||10
8183401|NCT02342886|20178027|P4|COMPLETED|Overall Study||59
8183402|NCT02342886|20178028|P3|COMPLETED|Overall Study||52
8183403|NCT02342886|20178029|P2|COMPLETED|Overall Study||63
8183404|NCT02342886|20178030|P1|COMPLETED|Overall Study||57
8183405|NCT02342886|20178026|P5|Completed Month 24 Follow-Up|Overall Study||10
8183406|NCT02342886|20178027|P4|Completed Month 24 Follow-Up|Overall Study||53
8183407|NCT02342886|20178028|P3|Completed Month 24 Follow-Up|Overall Study||46
8183408|NCT02342886|20178029|P2|Completed Month 24 Follow-Up|Overall Study||47
8183409|NCT02342886|20178030|P1|Completed Month 24 Follow-Up|Overall Study||40
8183410|NCT02342886|20178026|P5|Completed Month 12 Follow-Up|Overall Study||10
8183411|NCT02342886|20178027|P4|Completed Month 12 Follow-Up|Overall Study||57
8183412|NCT02342886|20178028|P3|Completed Month 12 Follow-Up|Overall Study||49
8183413|NCT02342886|20178029|P2|Completed Month 12 Follow-Up|Overall Study||52
8183414|NCT02342886|20178030|P1|Completed Month 12 Follow-Up|Overall Study||43
8183415|NCT02342886|20178026|P5|STARTED|Overall Study||13
8183416|NCT02342886|20178027|P4|STARTED|Overall Study||68
8183417|NCT02342886|20178028|P3|STARTED|Overall Study||67
8183418|NCT02342886|20178029|P2|STARTED|Overall Study||71
8183419|NCT02342886|20178030|P1|STARTED|Overall Study||65
8183420|NCT02342743|20178047|P1|NOT COMPLETED|Treatment Period||11
8183421|NCT02342743|20178047|P1|COMPLETED|Treatment Period||47
8183422|NCT02342743|20178047|P1|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58
8183423|NCT02342743|20178047|P1|NOT COMPLETED|Baseline Period||15
8183424|NCT02342743|20178047|P1|COMPLETED|Baseline Period||58
8183425|NCT02342743|20178047|P1|STARTED|Baseline Period||73
8183426|NCT02342704|20178060|P2|NOT COMPLETED|Overall Study||51
8183427|NCT02342704|20178061|P1|NOT COMPLETED|Overall Study||53
8183428|NCT02342704|20178060|P2|COMPLETED|Overall Study||3
8183429|NCT02342704|20178061|P1|COMPLETED|Overall Study||1
8183430|NCT02342704|20178060|P2|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
8183431|NCT02342704|20178061|P1|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
8183432|NCT02342678|20178089|P2|NOT COMPLETED|Overall Study||5
8183433|NCT02342678|20178090|P1|NOT COMPLETED|Overall Study||1
8183434|NCT02342678|20178089|P2|COMPLETED|Overall Study||23
8183435|NCT02342678|20178090|P1|COMPLETED|Overall Study||27
8183436|NCT02342678|20178089|P2|STARTED|Overall Study||28
8183437|NCT02342678|20178090|P1|STARTED|Overall Study||28
8183438|NCT02342561|20178110|P1|NOT COMPLETED|Overall Study||0
8183439|NCT02342561|20178110|P1|COMPLETED|Overall Study||20
8183440|NCT02342561|20178110|P1|STARTED|Overall Study||20
8183441|NCT02342548|20178121|P3|NOT COMPLETED|Overall Study||43
8183442|NCT02342548|20178122|P2|NOT COMPLETED|Overall Study||62
8183443|NCT02342548|20178123|P1|NOT COMPLETED|Overall Study||34
8183444|NCT02342548|20178121|P3|COMPLETED|Overall Study||23
8183445|NCT02342548|20178122|P2|COMPLETED|Overall Study||9
8183446|NCT02342548|20178123|P1|COMPLETED|Overall Study||17
8183447|NCT02342548|20178121|P3|STARTED|Overall Study||66
8183448|NCT02342548|20178122|P2|STARTED|Overall Study||71
8183449|NCT02342548|20178123|P1|STARTED|Overall Study||51
8183450|NCT02342535|20178161|P1|NOT COMPLETED|Overall Study||0
8183451|NCT02342535|20178161|P1|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
8183452|NCT02342535|20178161|P1|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
8183453|NCT02342418|20178167|P2|NOT COMPLETED|Overall Study||1
8183454|NCT02342418|20178168|P1|NOT COMPLETED|Overall Study||0
8183455|NCT02342418|20178167|P2|COMPLETED|Overall Study||9
8183456|NCT02342418|20178168|P1|COMPLETED|Overall Study||9
8183457|NCT02342418|20178167|P2|STARTED|Overall Study||10
8183458|NCT02342418|20178168|P1|STARTED|Overall Study||9
8183459|NCT02342379|20178176|P1|NOT COMPLETED|Overall Study||0
8183460|NCT02342379|20178176|P1|COMPLETED|Overall Study||35
8183461|NCT02342379|20178176|P1|STARTED|Overall Study||35
8183462|NCT02342314|20178183|P17|NOT COMPLETED|Part B||0
8183463|NCT02342314|20178184|P16|NOT COMPLETED|Part B||0
8183464|NCT02342314|20178185|P15|NOT COMPLETED|Part B||0
8183465|NCT02342314|20178186|P14|NOT COMPLETED|Part B||0
8183466|NCT02342314|20178187|P13|NOT COMPLETED|Part B||0
8183467|NCT02342314|20178188|P12|NOT COMPLETED|Part B||0
8183468|NCT02342314|20178189|P11|NOT COMPLETED|Part B||0
8183469|NCT02342314|20178190|P10|NOT COMPLETED|Part B||0
8183470|NCT02342314|20178191|P9|NOT COMPLETED|Part B||0
8183471|NCT02342314|20178192|P8|NOT COMPLETED|Part B||0
8183472|NCT02342314|20178193|P7|NOT COMPLETED|Part B||0
8183473|NCT02342314|20178194|P6|NOT COMPLETED|Part B||0
8183474|NCT02342314|20178195|P5|NOT COMPLETED|Part B||0
8183475|NCT02342314|20178196|P4|NOT COMPLETED|Part B||0
8183476|NCT02342314|20178197|P3|NOT COMPLETED|Part B||0
8183477|NCT02342314|20178198|P2|NOT COMPLETED|Part B||0
8183478|NCT02342314|20178199|P1|NOT COMPLETED|Part B||0
8183479|NCT02342314|20178183|P17|COMPLETED|Part B||6
8183480|NCT02342314|20178184|P16|COMPLETED|Part B||3
8183481|NCT02342314|20178185|P15|COMPLETED|Part B||3
8183482|NCT02342314|20178186|P14|COMPLETED|Part B||3
8183483|NCT02342314|20178187|P13|COMPLETED|Part B||3
8183484|NCT02342314|20178188|P12|COMPLETED|Part B||3
8183485|NCT02342314|20178189|P11|COMPLETED|Part B||3
8183486|NCT02342314|20178190|P10|COMPLETED|Part B||3
8183487|NCT02342314|20178191|P9|COMPLETED|Part B||3
8183488|NCT02342314|20178192|P8|COMPLETED|Part B||3
8183489|NCT02342314|20178193|P7|COMPLETED|Part B||11
8183490|NCT02342314|20178194|P6|COMPLETED|Part B||0
8183491|NCT02342314|20178195|P5|COMPLETED|Part B||0
8183492|NCT02342314|20178196|P4|COMPLETED|Part B||0
8183493|NCT02342314|20178197|P3|COMPLETED|Part B||0
8183494|NCT02342314|20178198|P2|COMPLETED|Part B||0
8183495|NCT02342314|20178199|P1|COMPLETED|Part B||0
8183496|NCT02342314|20178183|P17|STARTED|Part B|Participants received rGlucagon in Part B.|6
8183497|NCT02342314|20178184|P16|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183498|NCT02342314|20178185|P15|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183499|NCT02342314|20178186|P14|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183500|NCT02342314|20178187|P13|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183501|NCT02342314|20178188|P12|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183502|NCT02342314|20178189|P11|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183503|NCT02342314|20178190|P10|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183504|NCT02342314|20178191|P9|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183505|NCT02342314|20178192|P8|STARTED|Part B|Participants received LY3185643 in Part B.|3
8183506|NCT02342314|20178193|P7|STARTED|Part B|Participants received placebo in Part B.|11
8183507|NCT02342314|20178194|P6|STARTED|Part B|Participants received LY3143753 in Part A.|0
8183508|NCT02342314|20178195|P5|STARTED|Part B|Participants received LY3143753 in Part A.|0
8183509|NCT02342314|20178196|P4|STARTED|Part B|Participants received LY3143753 in Part A.|0
8183510|NCT02342314|20178197|P3|STARTED|Part B|Participants received LY3143753 in Part A.|0
8183511|NCT02342314|20178198|P2|STARTED|Part B|Participants received LY3143753 in Part A.|0
8183512|NCT02342314|20178199|P1|STARTED|Part B|Participants received placebo in Part A.|0
8183513|NCT02342314|20178183|P17|NOT COMPLETED|Part A||0
8183514|NCT02342314|20178184|P16|NOT COMPLETED|Part A||0
8183515|NCT02342314|20178185|P15|NOT COMPLETED|Part A||0
8183516|NCT02342314|20178186|P14|NOT COMPLETED|Part A||0
8183517|NCT02342314|20178187|P13|NOT COMPLETED|Part A||0
8183518|NCT02342314|20178188|P12|NOT COMPLETED|Part A||0
8183519|NCT02342314|20178189|P11|NOT COMPLETED|Part A||0
8183520|NCT02342314|20178190|P10|NOT COMPLETED|Part A||0
8183521|NCT02342314|20178191|P9|NOT COMPLETED|Part A||0
8183522|NCT02342314|20178192|P8|NOT COMPLETED|Part A||0
8183523|NCT02342314|20178193|P7|NOT COMPLETED|Part A||0
8183524|NCT02342314|20178194|P6|NOT COMPLETED|Part A||0
8183525|NCT02342314|20178195|P5|NOT COMPLETED|Part A||0
8183526|NCT02342314|20178196|P4|NOT COMPLETED|Part A||0
8183527|NCT02342314|20178197|P3|NOT COMPLETED|Part A||0
8183528|NCT02342314|20178198|P2|NOT COMPLETED|Part A||0
8183529|NCT02342314|20178199|P1|NOT COMPLETED|Part A||0
8183530|NCT02342314|20178183|P17|COMPLETED|Part A||0
8183531|NCT02342314|20178184|P16|COMPLETED|Part A||0
8183532|NCT02342314|20178185|P15|COMPLETED|Part A||0
8183533|NCT02342314|20178186|P14|COMPLETED|Part A||0
8183534|NCT02342314|20178187|P13|COMPLETED|Part A||0
8183535|NCT02342314|20178188|P12|COMPLETED|Part A||0
8183536|NCT02342314|20178189|P11|COMPLETED|Part A||0
8183537|NCT02342314|20178190|P10|COMPLETED|Part A||0
8183538|NCT02342314|20178191|P9|COMPLETED|Part A||0
8183539|NCT02342314|20178192|P8|COMPLETED|Part A||0
8183540|NCT02342314|20178193|P7|COMPLETED|Part A||0
8183541|NCT02342314|20178194|P6|COMPLETED|Part A||3
8183542|NCT02342314|20178195|P5|COMPLETED|Part A||6
8183543|NCT02342314|20178196|P4|COMPLETED|Part A||3
8183544|NCT02342314|20178197|P3|COMPLETED|Part A||3
8183545|NCT02342314|20178198|P2|COMPLETED|Part A||3
8183546|NCT02342314|20178199|P1|COMPLETED|Part A||6
8183547|NCT02342314|20178183|P17|STARTED|Part A||0
8183548|NCT02342314|20178184|P16|STARTED|Part A||0
8183549|NCT02342314|20178185|P15|STARTED|Part A||0
8183550|NCT02342314|20178186|P14|STARTED|Part A||0
8183551|NCT02342314|20178187|P13|STARTED|Part A||0
8183552|NCT02342314|20178188|P12|STARTED|Part A||0
8183553|NCT02342314|20178189|P11|STARTED|Part A||0
8183554|NCT02342314|20178190|P10|STARTED|Part A||0
8183555|NCT02342314|20178191|P9|STARTED|Part A||0
8183556|NCT02342314|20178192|P8|STARTED|Part A||0
8183557|NCT02342314|20178193|P7|STARTED|Part A||0
8183558|NCT02342314|20178194|P6|STARTED|Part A||3
8183559|NCT02342314|20178195|P5|STARTED|Part A||6
8183560|NCT02342314|20178196|P4|STARTED|Part A||3
8183561|NCT02342314|20178197|P3|STARTED|Part A||3
8183562|NCT02342314|20178198|P2|STARTED|Part A||3
8183563|NCT02342314|20178199|P1|STARTED|Part A||6
8183564|NCT02342288|20178347|P2|NOT COMPLETED|Overall Study||6
8183565|NCT02342288|20178348|P1|NOT COMPLETED|Overall Study||5
8183566|NCT02342288|20178347|P2|COMPLETED|Overall Study||27
8183567|NCT02342288|20178348|P1|COMPLETED|Overall Study||25
8183568|NCT02342288|20178347|P2|STARTED|Overall Study|various issues listed below caused removal of subjects|33
8183569|NCT02342288|20178348|P1|STARTED|Overall Study|16 patients were not randomized to either arm.|30
8183570|NCT02342223|20178354|P1|NOT COMPLETED|Overall Study||1
8183571|NCT02342223|20178354|P1|COMPLETED|Overall Study||19
8183572|NCT02342223|20178354|P1|STARTED|Overall Study||20
8183573|NCT02342197|20178365|P2|NOT COMPLETED|Overall Study||2
8183574|NCT02342197|20178366|P1|NOT COMPLETED|Overall Study||3
8183575|NCT02342197|20178365|P2|COMPLETED|Overall Study||28
8183576|NCT02342197|20178366|P1|COMPLETED|Overall Study||27
8183577|NCT02342197|20178365|P2|STARTED|Overall Study||30
8183578|NCT02342197|20178366|P1|STARTED|Overall Study||30
8183579|NCT02342171|20178374|P2|NOT COMPLETED|Overall Study||89
8183580|NCT02342171|20178375|P1|NOT COMPLETED|Overall Study||15
8183581|NCT02342171|20178374|P2|COMPLETED|Overall Study||418
8183582|NCT02342171|20178375|P1|COMPLETED|Overall Study||84
8183583|NCT02342171|20178374|P2|STARTED|Overall Study||507
8183584|NCT02342171|20178375|P1|STARTED|Overall Study||99
8183585|NCT02341859|20178391|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8183586|NCT02341859|20178392|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8183587|NCT02341859|20178391|P2|COMPLETED|Second Intervention (1 Day)||9
8183588|NCT02341859|20178392|P1|COMPLETED|Second Intervention (1 Day)||10
8183589|NCT02341859|20178391|P2|STARTED|Second Intervention (1 Day)||9
8183590|NCT02341859|20178392|P1|STARTED|Second Intervention (1 Day)||10
8183591|NCT02341859|20178391|P2|NOT COMPLETED|First Intervention (1 Day)||0
8183592|NCT02341859|20178392|P1|NOT COMPLETED|First Intervention (1 Day)||0
8183593|NCT02341859|20178391|P2|COMPLETED|First Intervention (1 Day)||9
8183594|NCT02341859|20178392|P1|COMPLETED|First Intervention (1 Day)||10
8183595|NCT02341859|20178391|P2|STARTED|First Intervention (1 Day)||9
8183596|NCT02341859|20178392|P1|STARTED|First Intervention (1 Day)||10
8183597|NCT02341599|20178550|P5|NOT COMPLETED|Overall Study||0
8183598|NCT02341599|20178551|P4|NOT COMPLETED|Overall Study||0
8183599|NCT02341599|20178552|P3|NOT COMPLETED|Overall Study||0
8183600|NCT02341599|20178553|P2|NOT COMPLETED|Overall Study||0
8183601|NCT02341599|20178554|P1|NOT COMPLETED|Overall Study||0
8183602|NCT02341599|20178550|P5|COMPLETED|Overall Study||8
8183603|NCT02341599|20178551|P4|COMPLETED|Overall Study||8
8183604|NCT02341599|20178552|P3|COMPLETED|Overall Study||8
8183605|NCT02341599|20178553|P2|COMPLETED|Overall Study||8
8183606|NCT02341599|20178554|P1|COMPLETED|Overall Study||8
8183607|NCT02341599|20178550|P5|STARTED|Overall Study||8
8183608|NCT02341599|20178551|P4|STARTED|Overall Study||8
8183609|NCT02341599|20178552|P3|STARTED|Overall Study||8
8183610|NCT02341599|20178553|P2|STARTED|Overall Study||8
8183611|NCT02341599|20178554|P1|STARTED|Overall Study||8
8183612|NCT02341495|20178622|P1|NOT COMPLETED|Overall Study||0
8183613|NCT02341495|20178622|P1|COMPLETED|Overall Study||4
8183614|NCT02341495|20178622|P1|STARTED|Overall Study||4
8183615|NCT02341482|20178629|P1|NOT COMPLETED|Overall Study||1
8183616|NCT02341482|20178629|P1|COMPLETED|Overall Study||12
8183617|NCT02341482|20178629|P1|STARTED|Overall Study||13
8183618|NCT02341456|20178658|P3|NOT COMPLETED|Overall Study||4
8183619|NCT02341456|20178659|P2|NOT COMPLETED|Overall Study||6
8183620|NCT02341456|20178660|P1|NOT COMPLETED|Overall Study||4
8183621|NCT02341456|20178658|P3|COMPLETED|Overall Study||2
8183622|NCT02341456|20178659|P2|COMPLETED|Overall Study||0
8183623|NCT02341456|20178660|P1|COMPLETED|Overall Study||3
8183624|NCT02341456|20178658|P3|STARTED|Overall Study||6
8183625|NCT02341456|20178659|P2|STARTED|Overall Study||6
8183626|NCT02341456|20178660|P1|STARTED|Overall Study||7
8183627|NCT02341417|20178785|P3|NOT COMPLETED|Overall Study||1
8183628|NCT02341417|20178786|P2|NOT COMPLETED|Overall Study||2
8183629|NCT02341417|20178787|P1|NOT COMPLETED|Overall Study||2
8183630|NCT02341417|20178785|P3|COMPLETED|Overall Study||0
8183631|NCT02341417|20178786|P2|COMPLETED|Overall Study||12
8183632|NCT02341417|20178787|P1|COMPLETED|Overall Study||11
8183633|NCT02341417|20178785|P3|STARTED|Overall Study||1
8183634|NCT02341417|20178786|P2|STARTED|Overall Study||14
8183635|NCT02341417|20178787|P1|STARTED|Overall Study||13
8183636|NCT02341144|20178831|P2|NOT COMPLETED|Overall Study||1
8183637|NCT02341144|20178832|P1|NOT COMPLETED|Overall Study||2
8183638|NCT02341144|20178831|P2|COMPLETED|Overall Study||30
8183639|NCT02341144|20178832|P1|COMPLETED|Overall Study||28
8183640|NCT02341144|20178831|P2|STARTED|Overall Study||31
8183641|NCT02341144|20178832|P1|STARTED|Overall Study||30
8183642|NCT02340975|20178852|P6|NOT COMPLETED|Overall Study||19
8183643|NCT02340975|20178853|P5|NOT COMPLETED|Overall Study||25
8183644|NCT02340975|20178854|P4|NOT COMPLETED|Overall Study||12
8183645|NCT02340975|20178855|P3|NOT COMPLETED|Overall Study||24
8183646|NCT02340975|20178856|P2|NOT COMPLETED|Overall Study||27
8183647|NCT02340975|20178857|P1|NOT COMPLETED|Overall Study||6
8183648|NCT02340975|20178852|P6|COMPLETED|Overall Study||0
8183649|NCT02340975|20178853|P5|COMPLETED|Overall Study||0
8183650|NCT02340975|20178854|P4|COMPLETED|Overall Study||0
8183651|NCT02340975|20178855|P3|COMPLETED|Overall Study||0
8183652|NCT02340975|20178856|P2|COMPLETED|Overall Study||0
8183653|NCT02340975|20178857|P1|COMPLETED|Overall Study||0
8183654|NCT02340975|20178852|P6|STARTED|Overall Study||19
8183655|NCT02340975|20178853|P5|STARTED|Overall Study||25
8183656|NCT02340975|20178854|P4|STARTED|Overall Study||12
8183657|NCT02340975|20178855|P3|STARTED|Overall Study||24
8183658|NCT02340975|20178856|P2|STARTED|Overall Study||27
8183659|NCT02340975|20178857|P1|STARTED|Overall Study||6
8183660|NCT02340962|20178971|P2|NOT COMPLETED|Overall Study||0
8183661|NCT02340962|20178972|P1|NOT COMPLETED|Overall Study||1
8183662|NCT02340962|20178971|P2|COMPLETED|Overall Study||12
8183663|NCT02340962|20178972|P1|COMPLETED|Overall Study||12
8183664|NCT02340962|20178971|P2|STARTED|Overall Study||12
8183665|NCT02340962|20178972|P1|STARTED|Overall Study||13
8183675|NCT02340806|20179021|P2|NOT COMPLETED|Overall Study||4
8183676|NCT02340806|20179022|P1|NOT COMPLETED|Overall Study||6
8183677|NCT02340806|20179021|P2|COMPLETED|Overall Study||108
8183678|NCT02340806|20179022|P1|COMPLETED|Overall Study||102
8183679|NCT02340806|20179021|P2|STARTED|Overall Study||112
8183680|NCT02340806|20179022|P1|STARTED|Overall Study||108
8183681|NCT02340780|20179048|P1|NOT COMPLETED|Overall Study||1
8183682|NCT02340780|20179048|P1|COMPLETED|Overall Study||13
8183683|NCT02340780|20179048|P1|STARTED|Overall Study|A total of 14 patients enrolled, one patient was found ineligible after the enrollment.|14
8183684|NCT02340767|20179062|P9|NOT COMPLETED|Overall Study||0
8183685|NCT02340767|20179063|P8|NOT COMPLETED|Overall Study||0
8183686|NCT02340767|20179064|P7|NOT COMPLETED|Overall Study||0
8183687|NCT02340767|20179065|P6|NOT COMPLETED|Overall Study||0
8183688|NCT02340767|20179066|P5|NOT COMPLETED|Overall Study||0
8183689|NCT02340767|20179067|P4|NOT COMPLETED|Overall Study||0
8183690|NCT02340767|20179068|P3|NOT COMPLETED|Overall Study||0
8183691|NCT02340767|20179069|P2|NOT COMPLETED|Overall Study||0
8183692|NCT02340767|20179070|P1|NOT COMPLETED|Overall Study||0
8183693|NCT02340767|20179062|P9|COMPLETED|Overall Study||531
8183694|NCT02340767|20179063|P8|COMPLETED|Overall Study||444
8183695|NCT02340767|20179064|P7|COMPLETED|Overall Study||525
8183696|NCT02340767|20179065|P6|COMPLETED|Overall Study||526
8183697|NCT02340767|20179066|P5|COMPLETED|Overall Study||474
8183698|NCT02340767|20179067|P4|COMPLETED|Overall Study||500
8183699|NCT02340767|20179068|P3|COMPLETED|Overall Study||29
8183700|NCT02340767|20179069|P2|COMPLETED|Overall Study||28
8183701|NCT02340767|20179070|P1|COMPLETED|Overall Study||28
8183702|NCT02340767|20179062|P9|STARTED|Overall Study||531
8183703|NCT02340767|20179063|P8|STARTED|Overall Study||444
8183704|NCT02340767|20179064|P7|STARTED|Overall Study||525
8183705|NCT02340767|20179065|P6|STARTED|Overall Study||526
8183706|NCT02340767|20179066|P5|STARTED|Overall Study||474
8183707|NCT02340767|20179067|P4|STARTED|Overall Study||500
8183708|NCT02340767|20179068|P3|STARTED|Overall Study||29
8183709|NCT02340767|20179069|P2|STARTED|Overall Study||28
8183710|NCT02340767|20179070|P1|STARTED|Overall Study||28
8183711|NCT02340728|20179088|P2|NOT COMPLETED|Overall Study||0
8183712|NCT02340728|20179089|P1|NOT COMPLETED|Overall Study||0
8183713|NCT02340728|20179088|P2|COMPLETED|Overall Study||11
8183714|NCT02340728|20179089|P1|COMPLETED|Overall Study||13
8183715|NCT02340728|20179088|P2|STARTED|Overall Study||11
8183716|NCT02340728|20179089|P1|STARTED|Overall Study||13
8183717|NCT02340715|20179099|P1|NOT COMPLETED|Overall Study||0
8183718|NCT02340715|20179099|P1|COMPLETED|Overall Study|158|158
8183719|NCT02340715|20179099|P1|STARTED|Overall Study|158|158
8183720|NCT02340663|20179105|P2|NOT COMPLETED|Overall Study||1
8183721|NCT02340663|20179106|P1|NOT COMPLETED|Overall Study||5
8183722|NCT02340663|20179105|P2|COMPLETED|Overall Study||31
8183723|NCT02340663|20179106|P1|COMPLETED|Overall Study||30
8183724|NCT02340663|20179105|P2|4 Month Follow-up, Assessments|Overall Study||31
8183725|NCT02340663|20179106|P1|4 Month Follow-up, Assessments|Overall Study||30
8183726|NCT02340663|20179105|P2|1 Week Follow-up, Assessments|Overall Study||31
8183727|NCT02340663|20179106|P1|1 Week Follow-up, Assessments|Overall Study||33
8183728|NCT02340663|20179105|P2|Splint Delivery, Assessments|Overall Study||31
8183729|NCT02340663|20179106|P1|Splint Delivery, Assessments|Overall Study||33
8183730|NCT02340663|20179105|P2|Clinical Exam, Impressions|Overall Study||32
8183731|NCT02340663|20179106|P1|Clinical Exam, Impressions|Overall Study||35
8183732|NCT02340663|20179105|P2|STARTED|Overall Study||32
8183733|NCT02340663|20179106|P1|STARTED|Overall Study||35
8183734|NCT02340520|20179162|P1|NOT COMPLETED|Overall Study||3
8183735|NCT02340520|20179162|P1|COMPLETED|Overall Study||8
8183736|NCT02340520|20179162|P1|STARTED|Overall Study||11
8183737|NCT02340338|20179174|P7|NOT COMPLETED|Overall Study||0
8183738|NCT02340338|20179175|P6|NOT COMPLETED|Overall Study||0
8183739|NCT02340338|20179176|P5|NOT COMPLETED|Overall Study||0
8183740|NCT02340338|20179177|P4|NOT COMPLETED|Overall Study||0
8183741|NCT02340338|20179178|P3|NOT COMPLETED|Overall Study||0
8183742|NCT02340338|20179179|P2|NOT COMPLETED|Overall Study||0
8183743|NCT02340338|20179180|P1|NOT COMPLETED|Overall Study||0
8183744|NCT02340338|20179174|P7|COMPLETED|Overall Study||12
8183745|NCT02340338|20179175|P6|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
8183746|NCT02340338|20179176|P5|COMPLETED|Overall Study||9
8183747|NCT02340338|20179177|P4|COMPLETED|Overall Study||9
8183748|NCT02340338|20179178|P3|COMPLETED|Overall Study||3
8183749|NCT02340338|20179179|P2|COMPLETED|Overall Study||2
8183750|NCT02340338|20179180|P1|COMPLETED|Overall Study||2
8183751|NCT02340338|20179174|P7|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
8183752|NCT02340338|20179175|P6|STARTED|Overall Study|9 vaccine + 3 placebo|9
8183753|NCT02340338|20179176|P5|STARTED|Overall Study|9 vaccine + 3 placebo|9
8183754|NCT02340338|20179177|P4|STARTED|Overall Study|9 vaccine + 3 placebo|9
8183755|NCT02340338|20179178|P3|STARTED|Overall Study|3 vaccine + 1 placebo|3
8183756|NCT02340338|20179179|P2|STARTED|Overall Study|2 vaccine + 1 placebo|2
8183757|NCT02340338|20179180|P1|STARTED|Overall Study|2 vaccine + 1 placebo|2
8183758|NCT02340299|20179205|P2|NOT COMPLETED|Overall Study||0
8183759|NCT02340299|20179206|P1|NOT COMPLETED|Overall Study||0
8183760|NCT02340299|20179205|P2|COMPLETED|Overall Study||2
8183761|NCT02340299|20179206|P1|COMPLETED|Overall Study||4
8183762|NCT02340299|20179205|P2|STARTED|Overall Study||2
8183763|NCT02340299|20179206|P1|STARTED|Overall Study||4
8183770|NCT02340104|20179239|P1|NOT COMPLETED|Overall Study||0
8183771|NCT02340104|20179239|P1|COMPLETED|Overall Study||8
8183772|NCT02340104|20179239|P1|STARTED|Overall Study||8
8183773|NCT02340091|20179244|P1|NOT COMPLETED|Overall Study||2
8183774|NCT02340091|20179244|P1|COMPLETED|Overall Study||60
8183775|NCT02340091|20179244|P1|STARTED|Overall Study|All Study Participants|62
8183776|NCT02340078|20179249|P1|NOT COMPLETED|Overall Study||1
8183777|NCT02340078|20179249|P1|COMPLETED|Overall Study||61
8183778|NCT02340078|20179249|P1|STARTED|Overall Study||62
8183779|NCT02340000|20179256|P2|NOT COMPLETED|Time Period 2||15
8183780|NCT02340000|20179257|P1|NOT COMPLETED|Time Period 2||19
8183781|NCT02340000|20179256|P2|COMPLETED|Time Period 2||52
8183782|NCT02340000|20179257|P1|COMPLETED|Time Period 2||50
8183783|NCT02340000|20179256|P2|STARTED|Time Period 2||67
8183784|NCT02340000|20179257|P1|STARTED|Time Period 2||69
8183785|NCT02340000|20179256|P2|NOT COMPLETED|Time Period 1||15
8183786|NCT02340000|20179257|P1|NOT COMPLETED|Time Period 1||12
8183787|NCT02340000|20179256|P2|COMPLETED|Time Period 1||74
8183788|NCT02340000|20179257|P1|COMPLETED|Time Period 1||78
8183789|NCT02340000|20179256|P2|STARTED|Time Period 1||89
8183790|NCT02340000|20179257|P1|STARTED|Time Period 1||90
8183791|NCT02339909|20179287|P3|NOT COMPLETED|Overall Study||71
8183792|NCT02339909|20179288|P2|NOT COMPLETED|Overall Study||63
8183793|NCT02339909|20179289|P1|NOT COMPLETED|Overall Study||89
8183794|NCT02339909|20179287|P3|COMPLETED|Overall Study||304
8183795|NCT02339909|20179288|P2|COMPLETED|Overall Study||312
8183796|NCT02339909|20179289|P1|COMPLETED|Overall Study||435
8183797|NCT02339909|20179287|P3|STARTED|Overall Study||375
8183798|NCT02339909|20179288|P2|STARTED|Overall Study||375
8183799|NCT02339909|20179289|P1|STARTED|Overall Study||524
8183800|NCT02339831|20179302|P2|NOT COMPLETED|Overall Study||7
8183801|NCT02339831|20179303|P1|NOT COMPLETED|Overall Study||20
8183802|NCT02339831|20179302|P2|COMPLETED|Overall Study||45
8183803|NCT02339831|20179303|P1|COMPLETED|Overall Study||38
8183804|NCT02339831|20179302|P2|Lost to Follow Up|Overall Study||7
8183805|NCT02339831|20179303|P1|Lost to Follow Up|Overall Study||20
8183806|NCT02339831|20179302|P2|STARTED|Overall Study||52
8183807|NCT02339831|20179303|P1|STARTED|Overall Study||58
8183808|NCT02339584|20179327|P2|NOT COMPLETED|Overall Study||15
8183809|NCT02339584|20179328|P1|NOT COMPLETED|Overall Study||15
8183810|NCT02339584|20179327|P2|COMPLETED|Overall Study||176
8183811|NCT02339584|20179328|P1|COMPLETED|Overall Study||173
8183812|NCT02339584|20179327|P2|STARTED|Overall Study||191
8183813|NCT02339584|20179328|P1|STARTED|Overall Study||188
8183814|NCT02339558|20179334|P1|NOT COMPLETED|Overall Study||0
8183815|NCT02339558|20179334|P1|COMPLETED|Overall Study||45
8183816|NCT02339558|20179334|P1|STARTED|Overall Study||45
8183817|NCT02339545|20179343|P1|NOT COMPLETED|Overall Study||0
8183818|NCT02339545|20179343|P1|COMPLETED|Overall Study||15
8183819|NCT02339545|20179343|P1|STARTED|Overall Study||15
8183838|NCT02339415|20179359|P2|NOT COMPLETED|Second Period||2
8183839|NCT02339415|20179360|P1|NOT COMPLETED|Second Period||1
8183840|NCT02339415|20179359|P2|COMPLETED|Second Period||18
8183841|NCT02339415|20179360|P1|COMPLETED|Second Period||19
8183842|NCT02339415|20179359|P2|STARTED|Second Period||20
8183843|NCT02339415|20179360|P1|STARTED|Second Period||20
8183844|NCT02339415|20179359|P2|NOT COMPLETED|Washout||0
8183845|NCT02339415|20179360|P1|NOT COMPLETED|Washout||0
8183846|NCT02339415|20179359|P2|COMPLETED|Washout||20
8183847|NCT02339415|20179360|P1|COMPLETED|Washout||20
8183848|NCT02339415|20179359|P2|STARTED|Washout||20
8183849|NCT02339415|20179360|P1|STARTED|Washout||20
8183850|NCT02339415|20179359|P2|NOT COMPLETED|First Period||2
8183851|NCT02339415|20179360|P1|NOT COMPLETED|First Period||2
8183852|NCT02339415|20179359|P2|COMPLETED|First Period||20
8183853|NCT02339415|20179360|P1|COMPLETED|First Period||20
8183854|NCT02339415|20179359|P2|Received at Least One Dose|First Period||20
8183855|NCT02339415|20179360|P1|Received at Least One Dose|First Period||21
8183856|NCT02339415|20179359|P2|STARTED|First Period||22
8183857|NCT02339415|20179360|P1|STARTED|First Period||22
8183858|NCT02339389|20179370|P1|NOT COMPLETED|Overall Study||16
8183859|NCT02339389|20179370|P1|COMPLETED|Overall Study||41
8183860|NCT02339389|20179370|P1|STARTED|Overall Study||57
8183861|NCT02339285|20179378|P3|NOT COMPLETED|Overall Study||2
8183862|NCT02339285|20179379|P2|NOT COMPLETED|Overall Study||3
8183863|NCT02339285|20179380|P1|NOT COMPLETED|Overall Study||1
8183864|NCT02339285|20179378|P3|COMPLETED|Overall Study||9
8183865|NCT02339285|20179379|P2|COMPLETED|Overall Study||8
8183866|NCT02339285|20179380|P1|COMPLETED|Overall Study||9
8183867|NCT02339285|20179378|P3|4 Week Follow-up Visit|Overall Study||9
8183868|NCT02339285|20179379|P2|4 Week Follow-up Visit|Overall Study||8
8183869|NCT02339285|20179380|P1|4 Week Follow-up Visit|Overall Study||9
8183870|NCT02339285|20179378|P3|2 Week Follow-up|Overall Study||10
8183871|NCT02339285|20179379|P2|2 Week Follow-up|Overall Study||10
8183872|NCT02339285|20179380|P1|2 Week Follow-up|Overall Study||9
8183873|NCT02339285|20179378|P3|Completed Intervention|Overall Study||10
8183874|NCT02339285|20179379|P2|Completed Intervention|Overall Study||10
8183875|NCT02339285|20179380|P1|Completed Intervention|Overall Study||10
8183876|NCT02339285|20179378|P3|STARTED|Overall Study||11
8183877|NCT02339285|20179379|P2|STARTED|Overall Study||11
8183878|NCT02339285|20179380|P1|STARTED|Overall Study||10
8183879|NCT02339246|20179408|P3|NOT COMPLETED|Third Period (7 Days)||0
8183880|NCT02339246|20179409|P2|NOT COMPLETED|Third Period (7 Days)||0
8183881|NCT02339246|20179410|P1|NOT COMPLETED|Third Period (7 Days)||0
8183882|NCT02339246|20179408|P3|COMPLETED|Third Period (7 Days)||0
8183883|NCT02339246|20179409|P2|COMPLETED|Third Period (7 Days)||16
8183884|NCT02339246|20179410|P1|COMPLETED|Third Period (7 Days)||15
8183885|NCT02339246|20179408|P3|STARTED|Third Period (7 Days)||0
8183886|NCT02339246|20179409|P2|STARTED|Third Period (7 Days)||16
8183887|NCT02339246|20179410|P1|STARTED|Third Period (7 Days)||15
8183888|NCT02339246|20179408|P3|NOT COMPLETED|Second Intervention (7 Days)||0
8183889|NCT02339246|20179409|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8183890|NCT02339246|20179410|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8183891|NCT02339246|20179408|P3|COMPLETED|Second Intervention (7 Days)||0
8183892|NCT02339246|20179409|P2|COMPLETED|Second Intervention (7 Days)||15
8183893|NCT02339246|20179410|P1|COMPLETED|Second Intervention (7 Days)||16
8183894|NCT02339246|20179408|P3|STARTED|Second Intervention (7 Days)||0
8183895|NCT02339246|20179409|P2|STARTED|Second Intervention (7 Days)||15
8183896|NCT02339246|20179410|P1|STARTED|Second Intervention (7 Days)||16
8183897|NCT02339246|20179408|P3|NOT COMPLETED|First Intervention (7 Days)||0
8183898|NCT02339246|20179409|P2|NOT COMPLETED|First Intervention (7 Days)||0
8183899|NCT02339246|20179410|P1|NOT COMPLETED|First Intervention (7 Days)||0
8183900|NCT02339246|20179408|P3|COMPLETED|First Intervention (7 Days)||31
8183901|NCT02339246|20179409|P2|COMPLETED|First Intervention (7 Days)||0
8183902|NCT02339246|20179410|P1|COMPLETED|First Intervention (7 Days)||0
8183903|NCT02339246|20179408|P3|STARTED|First Intervention (7 Days)||31
8183904|NCT02339246|20179409|P2|STARTED|First Intervention (7 Days)||0
8183905|NCT02339246|20179410|P1|STARTED|First Intervention (7 Days)||0
8183914|NCT02339038|20179453|P1|NOT COMPLETED|Overall Study||600
8183915|NCT02339038|20179453|P1|COMPLETED|Overall Study||0
8183916|NCT02339038|20179453|P1|STARTED|Overall Study||600
8183917|NCT02338973|20179457|P1|NOT COMPLETED|Overall Study||0
8183918|NCT02338973|20179457|P1|COMPLETED|Overall Study||4
8183919|NCT02338973|20179457|P1|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2
8183920|NCT02338973|20179457|P1|Rod-cone Dystrophy (RCD)|Overall Study||2
8183921|NCT02338973|20179457|P1|STARTED|Overall Study||4
8183922|NCT02338882|20179633|P2|NOT COMPLETED|Overall Study||3
8183923|NCT02338882|20179634|P1|NOT COMPLETED|Overall Study||7
8183924|NCT02338882|20179633|P2|COMPLETED|Overall Study||47
8183925|NCT02338882|20179634|P1|COMPLETED|Overall Study||43
8183926|NCT02338882|20179633|P2|STARTED|Overall Study||50
8183927|NCT02338882|20179634|P1|STARTED|Overall Study||50
8183928|NCT02338843|20179672|P2|NOT COMPLETED|Overall Study||58
8183929|NCT02338843|20179673|P1|NOT COMPLETED|Overall Study||44
8183930|NCT02338843|20179672|P2|COMPLETED|Overall Study||100
8183931|NCT02338843|20179673|P1|COMPLETED|Overall Study||119
8183932|NCT02338843|20179672|P2|STARTED|Overall Study||158
8183933|NCT02338843|20179673|P1|STARTED|Overall Study||163
8183934|NCT02338713|20179679|P1|NOT COMPLETED|Overall Study||0
8183935|NCT02338713|20179679|P1|COMPLETED|Overall Study||27
8183936|NCT02338713|20179679|P1|STARTED|Overall Study||27
8183937|NCT02338492|20179701|P1|NOT COMPLETED|Overall Study||45
8183938|NCT02338492|20179701|P1|COMPLETED|Overall Study||36
8183939|NCT02338492|20179701|P1|Treatment Failure|Overall Study||2
8183940|NCT02338492|20179701|P1|Device Implanted|Overall Study||79
8183941|NCT02338492|20179701|P1|Enrolled|Overall Study||81
8183942|NCT02338492|20179701|P1|STARTED|Overall Study||81
8183943|NCT02338362|20179717|P2|NOT COMPLETED|Overall Study||1
8183944|NCT02338362|20179718|P1|NOT COMPLETED|Overall Study||1
8183945|NCT02338362|20179717|P2|COMPLETED|Overall Study||10
8183946|NCT02338362|20179718|P1|COMPLETED|Overall Study||10
8183947|NCT02338362|20179717|P2|STARTED|Overall Study||11
8183948|NCT02338362|20179718|P1|STARTED|Overall Study||11
8183949|NCT02338336|20179734|P4|NOT COMPLETED|Overall Study||0
8183950|NCT02338336|20179735|P3|NOT COMPLETED|Overall Study||0
8183951|NCT02338336|20179736|P2|NOT COMPLETED|Overall Study||0
8183952|NCT02338336|20179737|P1|NOT COMPLETED|Overall Study||2
8183953|NCT02338336|20179734|P4|COMPLETED|Overall Study||4
8183954|NCT02338336|20179735|P3|COMPLETED|Overall Study||7
8183955|NCT02338336|20179736|P2|COMPLETED|Overall Study||17
8183956|NCT02338336|20179737|P1|COMPLETED|Overall Study||24
8183957|NCT02338336|20179734|P4|STARTED|Overall Study||4
8183958|NCT02338336|20179735|P3|STARTED|Overall Study||7
8183959|NCT02338336|20179736|P2|STARTED|Overall Study||17
8183960|NCT02338336|20179737|P1|STARTED|Overall Study||26
8183961|NCT02338193|20179748|P3|NOT COMPLETED|Overall Study||10
8183962|NCT02338193|20179749|P2|NOT COMPLETED|Overall Study||4
8183963|NCT02338193|20179750|P1|NOT COMPLETED|Overall Study||3
8183964|NCT02338193|20179748|P3|COMPLETED|Overall Study||15
8183965|NCT02338193|20179749|P2|COMPLETED|Overall Study||17
8183966|NCT02338193|20179750|P1|COMPLETED|Overall Study||17
8183967|NCT02338193|20179748|P3|STARTED|Overall Study||25
8183968|NCT02338193|20179749|P2|STARTED|Overall Study||21
8183969|NCT02338193|20179750|P1|STARTED|Overall Study||20
8183970|NCT02338154|20179803|P1|NOT COMPLETED|Overall Study||143
8183971|NCT02338154|20179803|P1|COMPLETED|Overall Study||373
8183972|NCT02338154|20179803|P1|INTUITY (Study Valve Cohort)|Overall Study||493
8183973|NCT02338154|20179803|P1|Enrolled Cohort (Intent to Treat)|Overall Study||516
8183974|NCT02338154|20179803|P1|STARTED|Overall Study||516
8183975|NCT02338076|20179899|P1|NOT COMPLETED|Overall Study||0
8183976|NCT02338076|20179899|P1|COMPLETED|Overall Study||20
8183977|NCT02338076|20179899|P1|STARTED|Overall Study||20
8183978|NCT02337959|20179917|P3|NOT COMPLETED|Overall Study||0
8183979|NCT02337959|20179918|P2|NOT COMPLETED|Overall Study||3
8183980|NCT02337959|20179919|P1|NOT COMPLETED|Overall Study||0
8183981|NCT02337959|20179917|P3|COMPLETED|Overall Study||7
8183982|NCT02337959|20179918|P2|COMPLETED|Overall Study||7
8183983|NCT02337959|20179919|P1|COMPLETED|Overall Study||10
8183984|NCT02337959|20179917|P3|STARTED|Overall Study||7
8183985|NCT02337959|20179918|P2|STARTED|Overall Study||10
8183986|NCT02337959|20179919|P1|STARTED|Overall Study||10
8183987|NCT02337946|20179927|P3|NOT COMPLETED|Protocol Treatment 2 Period||50
8183988|NCT02337946|20179928|P2|NOT COMPLETED|Protocol Treatment 2 Period||51
8183989|NCT02337946|20179929|P1|NOT COMPLETED|Protocol Treatment 2 Period||0
8183990|NCT02337946|20179927|P3|COMPLETED|Protocol Treatment 2 Period||7
8183991|NCT02337946|20179928|P2|COMPLETED|Protocol Treatment 2 Period||5
8183992|NCT02337946|20179929|P1|COMPLETED|Protocol Treatment 2 Period||0
8183993|NCT02337946|20179927|P3|Safety Population|Protocol Treatment 2 Period||54
8183994|NCT02337946|20179928|P2|Safety Population|Protocol Treatment 2 Period||56
8183995|NCT02337946|20179929|P1|Safety Population|Protocol Treatment 2 Period||0
8183996|NCT02337946|20179927|P3|STARTED|Protocol Treatment 2 Period||57
8183997|NCT02337946|20179928|P2|STARTED|Protocol Treatment 2 Period||56
8183998|NCT02337946|20179929|P1|STARTED|Protocol Treatment 2 Period||0
8183999|NCT02337946|20179927|P3|NOT COMPLETED|In-between Period||0
8184000|NCT02337946|20179928|P2|NOT COMPLETED|In-between Period||0
8184001|NCT02337946|20179929|P1|NOT COMPLETED|In-between Period||1
8184002|NCT02337946|20179927|P3|COMPLETED|In-between Period||0
8184003|NCT02337946|20179928|P2|COMPLETED|In-between Period||0
8184004|NCT02337946|20179929|P1|COMPLETED|In-between Period||113
8184005|NCT02337946|20179927|P3|STARTED|In-between Period||0
8184006|NCT02337946|20179928|P2|STARTED|In-between Period||0
8184007|NCT02337946|20179929|P1|STARTED|In-between Period||114
8184008|NCT02337946|20179927|P3|NOT COMPLETED|Protocol Treatment 1 Period||0
8184009|NCT02337946|20179928|P2|NOT COMPLETED|Protocol Treatment 1 Period||0
8184010|NCT02337946|20179929|P1|NOT COMPLETED|Protocol Treatment 1 Period||50
8184011|NCT02337946|20179927|P3|COMPLETED|Protocol Treatment 1 Period||0
8184012|NCT02337946|20179928|P2|COMPLETED|Protocol Treatment 1 Period||0
8184013|NCT02337946|20179929|P1|COMPLETED|Protocol Treatment 1 Period||114
8184014|NCT02337946|20179927|P3|STARTED|Protocol Treatment 1 Period||0
8184015|NCT02337946|20179928|P2|STARTED|Protocol Treatment 1 Period||0
8184016|NCT02337946|20179929|P1|STARTED|Protocol Treatment 1 Period||164
8184017|NCT02337933|20179953|P2|NOT COMPLETED|Overall Study||0
8184018|NCT02337933|20179954|P1|NOT COMPLETED|Overall Study||0
8184019|NCT02337933|20179953|P2|COMPLETED|Overall Study||12
8184020|NCT02337933|20179954|P1|COMPLETED|Overall Study||12
8184021|NCT02337933|20179953|P2|STARTED|Overall Study||12
8184022|NCT02337933|20179954|P1|STARTED|Overall Study||12
8184023|NCT02337907|20179990|P6|NOT COMPLETED|Overall Study||1
8184024|NCT02337907|20179991|P5|NOT COMPLETED|Overall Study||10
8184025|NCT02337907|20179992|P4|NOT COMPLETED|Overall Study||4
8184026|NCT02337907|20179993|P3|NOT COMPLETED|Overall Study||1
8184027|NCT02337907|20179994|P2|NOT COMPLETED|Overall Study||4
8184028|NCT02337907|20179995|P1|NOT COMPLETED|Overall Study||4
8184029|NCT02337907|20179990|P6|COMPLETED|Overall Study||4
8184030|NCT02337907|20179991|P5|COMPLETED|Overall Study||96
8184031|NCT02337907|20179992|P4|COMPLETED|Overall Study||51
8184032|NCT02337907|20179993|P3|COMPLETED|Overall Study||54
8184033|NCT02337907|20179994|P2|COMPLETED|Overall Study||49
8184034|NCT02337907|20179995|P1|COMPLETED|Overall Study||51
8184035|NCT02337907|20179990|P6|STARTED|Overall Study||5
8184036|NCT02337907|20179991|P5|STARTED|Overall Study||106
8184037|NCT02337907|20179992|P4|STARTED|Overall Study||55
8184038|NCT02337907|20179993|P3|STARTED|Overall Study||55
8184039|NCT02337907|20179994|P2|STARTED|Overall Study||53
8184040|NCT02337907|20179995|P1|STARTED|Overall Study||55
8184041|NCT02337764|20180030|P1|NOT COMPLETED|Overall Study||60
8184042|NCT02337764|20180030|P1|COMPLETED|Overall Study||162
8184043|NCT02337764|20180030|P1|STARTED|Overall Study||222
8184044|NCT02337751|20180043|P2|NOT COMPLETED|Overall Study||16
8184045|NCT02337751|20180044|P1|NOT COMPLETED|Overall Study||11
8184046|NCT02337751|20180043|P2|COMPLETED|Overall Study||87
8184047|NCT02337751|20180044|P1|COMPLETED|Overall Study||84
8184048|NCT02337751|20180043|P2|STARTED|Overall Study||103
8184049|NCT02337751|20180044|P1|STARTED|Overall Study||95
8184050|NCT02337738|20180063|P3|NOT COMPLETED|Overall Study||26
8184051|NCT02337738|20180064|P2|NOT COMPLETED|Overall Study||30
8184052|NCT02337738|20180065|P1|NOT COMPLETED|Overall Study||22
8184053|NCT02337738|20180063|P3|COMPLETED|Overall Study||103
8184054|NCT02337738|20180064|P2|COMPLETED|Overall Study||104
8184055|NCT02337738|20180065|P1|COMPLETED|Overall Study||119
8184056|NCT02337738|20180063|P3|STARTED|Overall Study||129
8184057|NCT02337738|20180064|P2|STARTED|Overall Study||134
8184058|NCT02337738|20180065|P1|STARTED|Overall Study||141
8184059|NCT02337725|20180105|P2|NOT COMPLETED|Overall Study||8
8184060|NCT02337725|20180106|P1|NOT COMPLETED|Overall Study||26
8184061|NCT02337725|20180105|P2|COMPLETED|Overall Study||110
8184062|NCT02337725|20180106|P1|COMPLETED|Overall Study||100
8184063|NCT02337725|20180105|P2|STARTED|Overall Study||118
8184064|NCT02337725|20180106|P1|STARTED|Overall Study||126
8184065|NCT02337491|20180130|P2|NOT COMPLETED|Overall Study||30
8184066|NCT02337491|20180131|P1|NOT COMPLETED|Overall Study||50
8184067|NCT02337491|20180130|P2|COMPLETED|Overall Study||0
8184068|NCT02337491|20180131|P1|COMPLETED|Overall Study||0
8184069|NCT02337491|20180130|P2|STARTED|Overall Study||30
8184070|NCT02337491|20180131|P1|STARTED|Overall Study||50
8184071|NCT02337478|20180145|P1|NOT COMPLETED|Overall Study||5
8184072|NCT02337478|20180145|P1|COMPLETED|Overall Study||0
8184073|NCT02337478|20180145|P1|STARTED|Overall Study||5
8184074|NCT02337387|20180155|P4|NOT COMPLETED|Overall Study||3
8184075|NCT02337387|20180156|P3|NOT COMPLETED|Overall Study||3
8184076|NCT02337387|20180157|P2|NOT COMPLETED|Overall Study||8
8184077|NCT02337387|20180158|P1|NOT COMPLETED|Overall Study||14
8184078|NCT02337387|20180155|P4|COMPLETED|Overall Study||0
8184079|NCT02337387|20180156|P3|COMPLETED|Overall Study||0
8184080|NCT02337387|20180157|P2|COMPLETED|Overall Study||0
8184081|NCT02337387|20180158|P1|COMPLETED|Overall Study||0
8184082|NCT02337387|20180155|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8184083|NCT02337387|20180156|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8184084|NCT02337387|20180157|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8184085|NCT02337387|20180158|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
8184086|NCT02337387|20180155|P4|STARTED|Overall Study||3
8184087|NCT02337387|20180156|P3|STARTED|Overall Study||3
8184088|NCT02337387|20180157|P2|STARTED|Overall Study||8
8184089|NCT02337387|20180158|P1|STARTED|Overall Study||14
8184090|NCT02337361|20180176|P2|NOT COMPLETED|6-month Follow-up||4
8184091|NCT02337361|20180177|P1|NOT COMPLETED|6-month Follow-up||2
8184092|NCT02337361|20180176|P2|COMPLETED|6-month Follow-up||68
8184093|NCT02337361|20180177|P1|COMPLETED|6-month Follow-up||78
8184094|NCT02337361|20180176|P2|STARTED|6-month Follow-up||72
8184095|NCT02337361|20180177|P1|STARTED|6-month Follow-up||80
8184096|NCT02337361|20180176|P2|NOT COMPLETED|3-month Follow-up||14
8184097|NCT02337361|20180177|P1|NOT COMPLETED|3-month Follow-up||19
8184098|NCT02337361|20180176|P2|COMPLETED|3-month Follow-up||72
8184099|NCT02337361|20180177|P1|COMPLETED|3-month Follow-up||80
8184100|NCT02337361|20180176|P2|STARTED|3-month Follow-up||86
8184101|NCT02337361|20180177|P1|STARTED|3-month Follow-up||99
8184102|NCT02337361|20180176|P2|NOT COMPLETED|Baseline Assessment||0
8184103|NCT02337361|20180177|P1|NOT COMPLETED|Baseline Assessment||0
8184104|NCT02337361|20180176|P2|COMPLETED|Baseline Assessment||86
8184105|NCT02337361|20180177|P1|COMPLETED|Baseline Assessment||99
8184106|NCT02337361|20180176|P2|STARTED|Baseline Assessment||86
8184107|NCT02337361|20180177|P1|STARTED|Baseline Assessment||99
8184108|NCT02337218|20180197|P2|NOT COMPLETED|Overall Study||0
8184109|NCT02337218|20180198|P1|NOT COMPLETED|Overall Study||0
8184110|NCT02337218|20180197|P2|COMPLETED|Overall Study||11
8184111|NCT02337218|20180198|P1|COMPLETED|Overall Study||17
8184112|NCT02337218|20180197|P2|STARTED|Overall Study||11
8184113|NCT02337218|20180198|P1|STARTED|Overall Study||17
8184114|NCT02337062|20180210|P2|NOT COMPLETED|Overall Study||19
8184115|NCT02337062|20180211|P1|NOT COMPLETED|Overall Study||17
8184116|NCT02337062|20180210|P2|COMPLETED|Overall Study||556
8184117|NCT02337062|20180211|P1|COMPLETED|Overall Study||555
8184118|NCT02337062|20180210|P2|STARTED|Overall Study||575
8184119|NCT02337062|20180211|P1|STARTED|Overall Study||572
8184120|NCT02336958|20180229|P2|NOT COMPLETED|Overall Study||0
8184121|NCT02336958|20180230|P1|NOT COMPLETED|Overall Study||0
8184122|NCT02336958|20180229|P2|COMPLETED|Overall Study||20
8184123|NCT02336958|20180230|P1|COMPLETED|Overall Study||20
8184124|NCT02336958|20180229|P2|STARTED|Overall Study||20
8184125|NCT02336958|20180230|P1|STARTED|Overall Study||20
8184126|NCT02336815|20180240|P2|NOT COMPLETED|Overall Study||123
8184127|NCT02336815|20180241|P1|NOT COMPLETED|Overall Study||79
8184128|NCT02336815|20180240|P2|COMPLETED|Overall Study||0
8184129|NCT02336815|20180241|P1|COMPLETED|Overall Study||0
8184130|NCT02336815|20180240|P2|STARTED|Overall Study||123
8184131|NCT02336815|20180241|P1|STARTED|Overall Study||79
8184132|NCT02336763|20180268|P1|NOT COMPLETED|Overall Study||0
8184133|NCT02336763|20180268|P1|COMPLETED|Overall Study||2
8184134|NCT02336763|20180268|P1|STARTED|Overall Study||2
8184135|NCT02336737|20180278|P1|NOT COMPLETED|Overall Study||13
8184136|NCT02336737|20180278|P1|COMPLETED|Overall Study||147
8184137|NCT02336737|20180278|P1|STARTED|Overall Study||160
8184138|NCT02336607|20180289|P4|NOT COMPLETED|Overall Study||87
8184139|NCT02336607|20180290|P3|NOT COMPLETED|Overall Study||6
8184140|NCT02336607|20180291|P2|NOT COMPLETED|Overall Study||10
8184141|NCT02336607|20180292|P1|NOT COMPLETED|Overall Study||4
8184142|NCT02336607|20180289|P4|COMPLETED|Overall Study||180
8184143|NCT02336607|20180290|P3|COMPLETED|Overall Study||86
8184144|NCT02336607|20180291|P2|COMPLETED|Overall Study||75
8184145|NCT02336607|20180292|P1|COMPLETED|Overall Study||81
8184146|NCT02336607|20180289|P4|Patients Included in Safety Population|Overall Study||260
8184147|NCT02336607|20180290|P3|Patients Included in Safety Population|Overall Study||92
8184148|NCT02336607|20180291|P2|Patients Included in Safety Population|Overall Study||85
8184149|NCT02336607|20180292|P1|Patients Included in Safety Population|Overall Study||85
8184150|NCT02336607|20180289|P4|Patients Included in PP Population|Overall Study||162
8184151|NCT02336607|20180290|P3|Patients Included in PP Population|Overall Study||75
8184152|NCT02336607|20180291|P2|Patients Included in PP Population|Overall Study||75
8184153|NCT02336607|20180292|P1|Patients Included in PP Population|Overall Study||78
8184154|NCT02336607|20180289|P4|Patients Included in ITT Population|Overall Study||222
8184155|NCT02336607|20180290|P3|Patients Included in ITT Population|Overall Study||91
8184156|NCT02336607|20180291|P2|Patients Included in ITT Population|Overall Study||84
8184157|NCT02336607|20180292|P1|Patients Included in ITT Population|Overall Study||84
8184158|NCT02336607|20180289|P4|STARTED|Overall Study||267
8184159|NCT02336607|20180290|P3|STARTED|Overall Study||92
8184160|NCT02336607|20180291|P2|STARTED|Overall Study||85
8184161|NCT02336607|20180292|P1|STARTED|Overall Study||85
8184162|NCT02336594|20180350|P4|NOT COMPLETED|Overall Study||0
8184163|NCT02336594|20180351|P3|NOT COMPLETED|Overall Study||0
8184164|NCT02336594|20180352|P2|NOT COMPLETED|Overall Study||0
8184165|NCT02336594|20180353|P1|NOT COMPLETED|Overall Study||0
8184166|NCT02336594|20180350|P4|COMPLETED|Overall Study||4
8184167|NCT02336594|20180351|P3|COMPLETED|Overall Study||4
8184168|NCT02336594|20180352|P2|COMPLETED|Overall Study||4
8184169|NCT02336594|20180353|P1|COMPLETED|Overall Study||3
8184170|NCT02336594|20180350|P4|STARTED|Overall Study||4
8184171|NCT02336594|20180351|P3|STARTED|Overall Study||4
8184172|NCT02336594|20180352|P2|STARTED|Overall Study||4
8184173|NCT02336594|20180353|P1|STARTED|Overall Study||3
8184174|NCT02336555|20180395|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8184175|NCT02336555|20180396|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8184176|NCT02336555|20180395|P2|COMPLETED|Treatment Period 2 (28 Days)||15
8184177|NCT02336555|20180396|P1|COMPLETED|Treatment Period 2 (28 Days)||16
8184178|NCT02336555|20180395|P2|STARTED|Treatment Period 2 (28 Days)||16
8184179|NCT02336555|20180396|P1|STARTED|Treatment Period 2 (28 Days)||16
8184180|NCT02336555|20180395|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8184181|NCT02336555|20180396|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||2
8184182|NCT02336555|20180395|P2|COMPLETED|Treatment Period 1 (28 Days)||16
8184183|NCT02336555|20180396|P1|COMPLETED|Treatment Period 1 (28 Days)||16
8184184|NCT02336555|20180395|P2|STARTED|Treatment Period 1 (28 Days)||17
8184185|NCT02336555|20180396|P1|STARTED|Treatment Period 1 (28 Days)||18
8184186|NCT02336451|20180409|P5|NOT COMPLETED|Overall Study||18
8184187|NCT02336451|20180410|P4|NOT COMPLETED|Overall Study||44
8184188|NCT02336451|20180411|P3|NOT COMPLETED|Overall Study||12
8184189|NCT02336451|20180412|P2|NOT COMPLETED|Overall Study||40
8184190|NCT02336451|20180413|P1|NOT COMPLETED|Overall Study||42
8184191|NCT02336451|20180409|P5|COMPLETED|Overall Study||0
8184192|NCT02336451|20180410|P4|COMPLETED|Overall Study||0
8184193|NCT02336451|20180411|P3|COMPLETED|Overall Study||0
8184194|NCT02336451|20180412|P2|COMPLETED|Overall Study||0
8184195|NCT02336451|20180413|P1|COMPLETED|Overall Study||0
8184196|NCT02336451|20180409|P5|STARTED|Overall Study||18
8184197|NCT02336451|20180410|P4|STARTED|Overall Study||44
8184198|NCT02336451|20180411|P3|STARTED|Overall Study||12
8184199|NCT02336451|20180412|P2|STARTED|Overall Study||40
8184200|NCT02336451|20180413|P1|STARTED|Overall Study||42
8184201|NCT02336438|20180557|P1|NOT COMPLETED|Overall Study||1
8184202|NCT02336438|20180557|P1|COMPLETED|Overall Study||10
8184203|NCT02336438|20180557|P1|STARTED|Overall Study||11
8184204|NCT02336425|20180570|P4|NOT COMPLETED|Overall Study||3
8184205|NCT02336425|20180571|P3|NOT COMPLETED|Overall Study||3
8184206|NCT02336425|20180572|P2|NOT COMPLETED|Overall Study||2
8184207|NCT02336425|20180573|P1|NOT COMPLETED|Overall Study||2
8184208|NCT02336425|20180570|P4|COMPLETED|Overall Study||0
8184209|NCT02336425|20180571|P3|COMPLETED|Overall Study||0
8184210|NCT02336425|20180572|P2|COMPLETED|Overall Study||0
8184211|NCT02336425|20180573|P1|COMPLETED|Overall Study||0
8184212|NCT02336425|20180570|P4|STARTED|Overall Study||3
8184213|NCT02336425|20180571|P3|STARTED|Overall Study||3
8184214|NCT02336425|20180572|P2|STARTED|Overall Study||2
8184215|NCT02336425|20180573|P1|STARTED|Overall Study||2
8184216|NCT02336373|20180623|P1|NOT COMPLETED|Overall Study||18
8184217|NCT02336373|20180623|P1|COMPLETED|Overall Study||14
8184218|NCT02336373|20180623|P1|STARTED|Overall Study||32
8184219|NCT02336360|20180638|P1|NOT COMPLETED|Overall Study||0
8184220|NCT02336360|20180638|P1|COMPLETED|Overall Study||6
8184221|NCT02336360|20180638|P1|STARTED|Overall Study||6
8184225|NCT02336178|20180666|P1|NOT COMPLETED|Overall Study||4
8184226|NCT02336178|20180666|P1|COMPLETED|Overall Study||66
8184227|NCT02336178|20180666|P1|STARTED|Overall Study||70
8184243|NCT02336074|20180795|P2|NOT COMPLETED|Overall Study||2
8184244|NCT02336074|20180796|P1|NOT COMPLETED|Overall Study||0
8184245|NCT02336074|20180795|P2|COMPLETED|Overall Study||28
8184246|NCT02336074|20180796|P1|COMPLETED|Overall Study||30
8184247|NCT02336074|20180795|P2|STARTED|Overall Study||30
8184248|NCT02336074|20180796|P1|STARTED|Overall Study||30
8184249|NCT02335983|20180819|P6|NOT COMPLETED|Overall Study||32
8184250|NCT02335983|20180820|P5|NOT COMPLETED|Overall Study||8
8184251|NCT02335983|20180821|P4|NOT COMPLETED|Overall Study||9
8184252|NCT02335983|20180822|P3|NOT COMPLETED|Overall Study||32
8184253|NCT02335983|20180823|P2|NOT COMPLETED|Overall Study||9
8184254|NCT02335983|20180824|P1|NOT COMPLETED|Overall Study||8
8184255|NCT02335983|20180819|P6|COMPLETED|Overall Study||1
8184256|NCT02335983|20180820|P5|COMPLETED|Overall Study||1
8184257|NCT02335983|20180821|P4|COMPLETED|Overall Study||0
8184258|NCT02335983|20180822|P3|COMPLETED|Overall Study||2
8184259|NCT02335983|20180823|P2|COMPLETED|Overall Study||3
8184260|NCT02335983|20180824|P1|COMPLETED|Overall Study||2
8184261|NCT02335983|20180819|P6|STARTED|Overall Study||33
8184262|NCT02335983|20180820|P5|STARTED|Overall Study||9
8184263|NCT02335983|20180821|P4|STARTED|Overall Study||9
8184264|NCT02335983|20180822|P3|STARTED|Overall Study||34
8184265|NCT02335983|20180823|P2|STARTED|Overall Study||12
8184266|NCT02335983|20180824|P1|STARTED|Overall Study||10
8184267|NCT02335710|20180908|P2|NOT COMPLETED|Overall Study||0
8184268|NCT02335710|20180909|P1|NOT COMPLETED|Overall Study||0
8184269|NCT02335710|20180908|P2|COMPLETED|Overall Study||10
8184270|NCT02335710|20180909|P1|COMPLETED|Overall Study||40
8184271|NCT02335710|20180908|P2|STARTED|Overall Study||10
8184272|NCT02335710|20180909|P1|STARTED|Overall Study||40
8184273|NCT02335658|20180931|P2|NOT COMPLETED|Overall Study||44
8184274|NCT02335658|20180932|P1|NOT COMPLETED|Overall Study||40
8184275|NCT02335658|20180931|P2|COMPLETED|Overall Study||59
8184276|NCT02335658|20180932|P1|COMPLETED|Overall Study|57 subjects in Cohort 1 and 59 subjects in Cohort 2 completed the study.|57
8184277|NCT02335658|20180931|P2|STARTED|Overall Study||103
8184278|NCT02335658|20180932|P1|STARTED|Overall Study|97 subjects in Cohort 1 and 103 subjects in Cohort 2 started to receive DSP-5423P.|97
8184279|NCT02335502|20180942|P1|NOT COMPLETED|Overall Study||17
8184280|NCT02335502|20180942|P1|COMPLETED|Overall Study||49
8184281|NCT02335502|20180942|P1|Receiving Permanent System|Overall Study||56
8184282|NCT02335502|20180942|P1|Received Trial System|Overall Study||65
8184283|NCT02335502|20180942|P1|STARTED|Overall Study||66
8184284|NCT02335489|20180947|P1|NOT COMPLETED|Overall Study||10
8184285|NCT02335489|20180947|P1|COMPLETED|Overall Study||0
8184286|NCT02335489|20180947|P1|Receiving Permanent System|Overall Study||8
8184287|NCT02335489|20180947|P1|Received Trial System|Overall Study||9
8184288|NCT02335489|20180947|P1|STARTED|Overall Study||10
8184292|NCT02335424|20180955|P1|NOT COMPLETED|Overall Study||374
8184293|NCT02335424|20180955|P1|COMPLETED|Overall Study||0
8184294|NCT02335424|20180955|P1|Treated|Overall Study||370
8184295|NCT02335424|20180955|P1|STARTED|Overall Study||374
8184296|NCT02335346|20180988|P1|NOT COMPLETED|Overall Study||12
8184297|NCT02335346|20180988|P1|COMPLETED|Overall Study||81
8184298|NCT02335346|20180988|P1|Received At Least 1 Dose of Study Drug|Overall Study||93
8184299|NCT02335346|20180988|P1|STARTED|Overall Study||93
8184300|NCT02335294|20181006|P6|NOT COMPLETED|Overall Study||1
8184301|NCT02335294|20181007|P5|NOT COMPLETED|Overall Study||2
8184302|NCT02335294|20181008|P4|NOT COMPLETED|Overall Study||3
8184303|NCT02335294|20181009|P3|NOT COMPLETED|Overall Study||1
8184304|NCT02335294|20181010|P2|NOT COMPLETED|Overall Study||4
8184305|NCT02335294|20181011|P1|NOT COMPLETED|Overall Study||3
8184306|NCT02335294|20181006|P6|COMPLETED|Overall Study||19
8184307|NCT02335294|20181007|P5|COMPLETED|Overall Study||39
8184308|NCT02335294|20181008|P4|COMPLETED|Overall Study||36
8184309|NCT02335294|20181009|P3|COMPLETED|Overall Study||18
8184310|NCT02335294|20181010|P2|COMPLETED|Overall Study||38
8184311|NCT02335294|20181011|P1|COMPLETED|Overall Study||36
8184312|NCT02335294|20181006|P6|STARTED|Overall Study||20
8184313|NCT02335294|20181007|P5|STARTED|Overall Study||41
8184314|NCT02335294|20181008|P4|STARTED|Overall Study||39
8184315|NCT02335294|20181009|P3|STARTED|Overall Study||19
8184316|NCT02335294|20181010|P2|STARTED|Overall Study||42
8184317|NCT02335294|20181011|P1|STARTED|Overall Study||39
8184318|NCT02335229|20181027|P1|NOT COMPLETED|Overall Study||7
8184319|NCT02335229|20181027|P1|COMPLETED|Overall Study||23
8184320|NCT02335229|20181027|P1|Received Permanent System|Overall Study||26
8184321|NCT02335229|20181027|P1|Received Trial System|Overall Study||10
8184322|NCT02335229|20181027|P1|STARTED|Overall Study||30
8184323|NCT02335216|20181032|P1|NOT COMPLETED|Overall Study||13
8184324|NCT02335216|20181032|P1|COMPLETED|Overall Study||9
8184325|NCT02335216|20181032|P1|Received Permanent System|Overall Study||13
8184326|NCT02335216|20181032|P1|Received Trial System|Overall Study||16
8184327|NCT02335216|20181032|P1|STARTED|Overall Study||22
8184328|NCT02335125|20181039|P2|NOT COMPLETED|Overall Study||0
8184329|NCT02335125|20181040|P1|NOT COMPLETED|Overall Study||0
8184330|NCT02335125|20181039|P2|COMPLETED|Overall Study||20
8184331|NCT02335125|20181040|P1|COMPLETED|Overall Study||20
8184332|NCT02335125|20181039|P2|STARTED|Overall Study||20
8184333|NCT02335125|20181040|P1|STARTED|Overall Study||20
8184334|NCT02334982|20181065|P7|NOT COMPLETED|Overall Study||0
8184335|NCT02334982|20181066|P6|NOT COMPLETED|Overall Study||0
8184336|NCT02334982|20181067|P5|NOT COMPLETED|Overall Study||0
8184337|NCT02334982|20181068|P4|NOT COMPLETED|Overall Study||0
8184338|NCT02334982|20181069|P3|NOT COMPLETED|Overall Study||0
8184339|NCT02334982|20181070|P2|NOT COMPLETED|Overall Study||0
8184340|NCT02334982|20181071|P1|NOT COMPLETED|Overall Study||0
8184341|NCT02334982|20181065|P7|COMPLETED|Overall Study||12
8184342|NCT02334982|20181066|P6|COMPLETED|Overall Study||6
8184343|NCT02334982|20181067|P5|COMPLETED|Overall Study||6
8184344|NCT02334982|20181068|P4|COMPLETED|Overall Study||6
8184345|NCT02334982|20181069|P3|COMPLETED|Overall Study||6
8184346|NCT02334982|20181070|P2|COMPLETED|Overall Study||5
8184347|NCT02334982|20181071|P1|COMPLETED|Overall Study||6
8184348|NCT02334982|20181065|P7|STARTED|Overall Study||12
8184349|NCT02334982|20181066|P6|STARTED|Overall Study||6
8184350|NCT02334982|20181067|P5|STARTED|Overall Study||6
8184351|NCT02334982|20181068|P4|STARTED|Overall Study||6
8184352|NCT02334982|20181069|P3|STARTED|Overall Study||6
8184353|NCT02334982|20181070|P2|STARTED|Overall Study||5
8184354|NCT02334982|20181071|P1|STARTED|Overall Study||6
8184355|NCT02334813|20181177|P2|NOT COMPLETED|Overall Study||1
8184356|NCT02334813|20181178|P1|NOT COMPLETED|Overall Study||3
8184357|NCT02334813|20181177|P2|COMPLETED|Overall Study||13
8184358|NCT02334813|20181178|P1|COMPLETED|Overall Study||9
8184359|NCT02334813|20181177|P2|STARTED|Overall Study||14
8184360|NCT02334813|20181178|P1|STARTED|Overall Study||12
8184361|NCT02334800|20181188|P4|NOT COMPLETED|Overall Study||0
8184362|NCT02334800|20181189|P3|NOT COMPLETED|Overall Study||0
8184363|NCT02334800|20181190|P2|NOT COMPLETED|Overall Study||0
8184364|NCT02334800|20181191|P1|NOT COMPLETED|Overall Study||0
8184365|NCT02334800|20181188|P4|COMPLETED|Overall Study||7
8184366|NCT02334800|20181189|P3|COMPLETED|Overall Study||7
8184367|NCT02334800|20181190|P2|COMPLETED|Overall Study||7
8184368|NCT02334800|20181191|P1|COMPLETED|Overall Study||7
8184369|NCT02334800|20181188|P4|Received Treatment|Overall Study||7
8184370|NCT02334800|20181189|P3|Received Treatment|Overall Study||7
8184371|NCT02334800|20181190|P2|Received Treatment|Overall Study||7
8184372|NCT02334800|20181191|P1|Received Treatment|Overall Study||7
8184373|NCT02334800|20181188|P4|STARTED|Overall Study||7
8184374|NCT02334800|20181189|P3|STARTED|Overall Study||7
8184375|NCT02334800|20181190|P2|STARTED|Overall Study||7
8184376|NCT02334800|20181191|P1|STARTED|Overall Study||7
8184377|NCT02334787|20181285|P4|NOT COMPLETED|Overall Study||0
8184378|NCT02334787|20181286|P3|NOT COMPLETED|Overall Study||0
8184379|NCT02334787|20181287|P2|NOT COMPLETED|Overall Study||0
8184380|NCT02334787|20181288|P1|NOT COMPLETED|Overall Study||0
8184381|NCT02334787|20181285|P4|COMPLETED|Overall Study||8
8184382|NCT02334787|20181286|P3|COMPLETED|Overall Study||8
8184383|NCT02334787|20181287|P2|COMPLETED|Overall Study||8
8184384|NCT02334787|20181288|P1|COMPLETED|Overall Study||8
8184385|NCT02334787|20181285|P4|STARTED|Overall Study||8
8184386|NCT02334787|20181286|P3|STARTED|Overall Study||8
8184387|NCT02334787|20181287|P2|STARTED|Overall Study||8
8184388|NCT02334787|20181288|P1|STARTED|Overall Study||8
8184389|NCT02334748|20181310|P1|NOT COMPLETED|Overall Study||8
8184390|NCT02334748|20181310|P1|COMPLETED|Overall Study||23
8184391|NCT02334748|20181310|P1|STARTED|Overall Study||31
8184392|NCT02334527|20181315|P1|NOT COMPLETED|Overall Study||0
8184393|NCT02334527|20181315|P1|COMPLETED|Overall Study||12
8184394|NCT02334527|20181315|P1|STARTED|Overall Study||12
8184395|NCT02334436|20181326|P2|NOT COMPLETED|Overall Study||1
8184396|NCT02334436|20181327|P1|NOT COMPLETED|Overall Study||9
8184397|NCT02334436|20181326|P2|COMPLETED|Overall Study||77
8184398|NCT02334436|20181327|P1|COMPLETED|Overall Study||237
8184399|NCT02334436|20181326|P2|STARTED|Overall Study||78
8184400|NCT02334436|20181327|P1|STARTED|Overall Study||246
8184401|NCT02334423|20181341|P2|NOT COMPLETED|Overall Study||3
8184402|NCT02334423|20181342|P1|NOT COMPLETED|Overall Study||10
8184403|NCT02334423|20181341|P2|COMPLETED|Overall Study||81
8184404|NCT02334423|20181342|P1|COMPLETED|Overall Study||236
8184405|NCT02334423|20181341|P2|STARTED|Overall Study||84
8184406|NCT02334423|20181342|P1|STARTED|Overall Study||246
8184407|NCT02334384|20181356|P2|NOT COMPLETED|Overall Study||1
8184408|NCT02334384|20181357|P1|NOT COMPLETED|Overall Study||1
8184409|NCT02334384|20181356|P2|COMPLETED|Overall Study||1
8184410|NCT02334384|20181357|P1|COMPLETED|Overall Study||3
8184411|NCT02334384|20181356|P2|STARTED|Overall Study||2
8184412|NCT02334384|20181357|P1|STARTED|Overall Study||4
8184413|NCT02334358|20181363|P1|NOT COMPLETED|Overall Study||9
8184414|NCT02334358|20181363|P1|COMPLETED|Overall Study||494
8184415|NCT02334358|20181363|P1|STARTED|Overall Study||503
8184416|NCT02334306|20181369|P2|NOT COMPLETED|Open-label Period||0
8184417|NCT02334306|20181370|P1|NOT COMPLETED|Open-label Period||0
8184418|NCT02334306|20181369|P2|COMPLETED|Open-label Period||14
8184419|NCT02334306|20181370|P1|COMPLETED|Open-label Period||15
8184420|NCT02334306|20181369|P2|STARTED|Open-label Period||14
8184421|NCT02334306|20181370|P1|STARTED|Open-label Period||15
8184422|NCT02334306|20181369|P2|NOT COMPLETED|Double-blind Period||2
8184423|NCT02334306|20181370|P1|NOT COMPLETED|Double-blind Period||1
8184424|NCT02334306|20181369|P2|COMPLETED|Double-blind Period||14
8184425|NCT02334306|20181370|P1|COMPLETED|Double-blind Period||15
8184426|NCT02334306|20181369|P2|STARTED|Double-blind Period||16
8184427|NCT02334306|20181370|P1|STARTED|Double-blind Period||16
8184428|NCT02334267|20181392|P2|NOT COMPLETED|Overall Study||0
8184429|NCT02334267|20181393|P1|NOT COMPLETED|Overall Study||1
8184430|NCT02334267|20181392|P2|COMPLETED|Overall Study||5
8184431|NCT02334267|20181393|P1|COMPLETED|Overall Study||5
8184432|NCT02334267|20181392|P2|STARTED|Overall Study||5
8184433|NCT02334267|20181393|P1|STARTED|Overall Study||6
8184434|NCT02334215|20181408|P3|NOT COMPLETED|Overall Study||15
8184435|NCT02334215|20181409|P2|NOT COMPLETED|Overall Study||6
8184436|NCT02334215|20181410|P1|NOT COMPLETED|Overall Study||7
8184437|NCT02334215|20181408|P3|COMPLETED|Overall Study||61
8184438|NCT02334215|20181409|P2|COMPLETED|Overall Study||68
8184439|NCT02334215|20181410|P1|COMPLETED|Overall Study||68
8184440|NCT02334215|20181408|P3|STARTED|Overall Study||76
8184441|NCT02334215|20181409|P2|STARTED|Overall Study||74
8184442|NCT02334215|20181410|P1|STARTED|Overall Study||75
8184443|NCT02334059|20181472|P3|NOT COMPLETED|Overall Study||0
8184444|NCT02334059|20181473|P2|NOT COMPLETED|Overall Study||0
8184445|NCT02334059|20181474|P1|NOT COMPLETED|Overall Study||0
8184446|NCT02334059|20181472|P3|COMPLETED|Overall Study||37
8184447|NCT02334059|20181473|P2|COMPLETED|Overall Study||34
8184448|NCT02334059|20181474|P1|COMPLETED|Overall Study||37
8184449|NCT02334059|20181472|P3|STARTED|Overall Study||37
8184450|NCT02334059|20181473|P2|STARTED|Overall Study||34
8184451|NCT02334059|20181474|P1|STARTED|Overall Study||37
8184452|NCT02333630|20181490|P2|NOT COMPLETED|Overall Study||2
8184453|NCT02333630|20181491|P1|NOT COMPLETED|Overall Study||5
8184454|NCT02333630|20181490|P2|COMPLETED|Overall Study||98
8184455|NCT02333630|20181491|P1|COMPLETED|Overall Study||95
8184456|NCT02333630|20181490|P2|STARTED|Overall Study||100
8184457|NCT02333630|20181491|P1|STARTED|Overall Study||100
8184458|NCT02333487|20181506|P3|NOT COMPLETED|Overall Study||0
8184459|NCT02333487|20181507|P2|NOT COMPLETED|Overall Study||2
8184460|NCT02333487|20181508|P1|NOT COMPLETED|Overall Study||0
8184461|NCT02333487|20181506|P3|COMPLETED|Overall Study||8
8184462|NCT02333487|20181507|P2|COMPLETED|Overall Study||6
8184463|NCT02333487|20181508|P1|COMPLETED|Overall Study||6
8184464|NCT02333487|20181506|P3|STARTED|Overall Study||8
8184465|NCT02333487|20181507|P2|STARTED|Overall Study||8
8184466|NCT02333487|20181508|P1|STARTED|Overall Study||6
8184467|NCT02333383|20181519|P1|NOT COMPLETED|Overall Study||41
8184468|NCT02333383|20181519|P1|COMPLETED|Overall Study||160
8184469|NCT02333383|20181519|P1|STARTED|Overall Study||201
8184470|NCT02333331|20181533|P4|NOT COMPLETED|Overall Study||3
8184471|NCT02333331|20181534|P3|NOT COMPLETED|Overall Study||18
8184472|NCT02333331|20181535|P2|NOT COMPLETED|Overall Study||6
8184473|NCT02333331|20181536|P1|NOT COMPLETED|Overall Study||2
8184474|NCT02333331|20181533|P4|COMPLETED|Overall Study||64
8184475|NCT02333331|20181534|P3|COMPLETED|Overall Study||95
8184476|NCT02333331|20181535|P2|COMPLETED|Overall Study||12
8184477|NCT02333331|20181536|P1|COMPLETED|Overall Study||17
8184478|NCT02333331|20181533|P4|STARTED|Overall Study||67
8184479|NCT02333331|20181534|P3|STARTED|Overall Study||113
8184480|NCT02333331|20181535|P2|STARTED|Overall Study||18
8184481|NCT02333331|20181536|P1|STARTED|Overall Study||19
8184496|NCT02333045|20181603|P2|NOT COMPLETED|Overall Study||0
8184497|NCT02333045|20181604|P1|NOT COMPLETED|Overall Study||0
8184498|NCT02333045|20181603|P2|COMPLETED|Overall Study||3
8184499|NCT02333045|20181604|P1|COMPLETED|Overall Study||1
8184500|NCT02333045|20181603|P2|STARTED|Overall Study||3
8184501|NCT02333045|20181604|P1|STARTED|Overall Study||1
8184502|NCT02332915|20181616|P2|NOT COMPLETED|Overall Study||6
8184503|NCT02332915|20181617|P1|NOT COMPLETED|Overall Study||6
8184504|NCT02332915|20181616|P2|COMPLETED|Overall Study||12
8184505|NCT02332915|20181617|P1|COMPLETED|Overall Study||12
8184506|NCT02332915|20181616|P2|STARTED|Overall Study||18
8184507|NCT02332915|20181617|P1|STARTED|Overall Study||18
8184508|NCT02332902|20181625|P1|NOT COMPLETED|Overall Study||7
8184509|NCT02332902|20181625|P1|COMPLETED|Overall Study||17
8184510|NCT02332902|20181625|P1|STARTED|Overall Study||24
8184511|NCT02332889|20181630|P1|NOT COMPLETED|Overall Study||1
8184512|NCT02332889|20181630|P1|COMPLETED|Overall Study||0
8184513|NCT02332889|20181630|P1|STARTED|Overall Study||1
8184514|NCT02332876|20181636|P2|NOT COMPLETED|Overall Study||1
8184515|NCT02332876|20181637|P1|NOT COMPLETED|Overall Study||1
8184516|NCT02332876|20181636|P2|COMPLETED|Overall Study||43
8184517|NCT02332876|20181637|P1|COMPLETED|Overall Study||42
8184518|NCT02332876|20181636|P2|STARTED|Overall Study||44
8184519|NCT02332876|20181637|P1|STARTED|Overall Study||43
8184520|NCT02332863|20181645|P2|NOT COMPLETED|Overall Study||0
8184521|NCT02332863|20181646|P1|NOT COMPLETED|Overall Study||0
8184522|NCT02332863|20181645|P2|COMPLETED|Overall Study||22
8184523|NCT02332863|20181646|P1|COMPLETED|Overall Study||22
8184524|NCT02332863|20181645|P2|STARTED|Overall Study||22
8184525|NCT02332863|20181646|P1|STARTED|Overall Study||22
8184526|NCT02332824|20181672|P6|NOT COMPLETED|Overall Study||1
8184527|NCT02332824|20181673|P5|NOT COMPLETED|Overall Study||4
8184528|NCT02332824|20181674|P4|NOT COMPLETED|Overall Study||2
8184529|NCT02332824|20181675|P3|NOT COMPLETED|Overall Study||2
8184530|NCT02332824|20181676|P2|NOT COMPLETED|Overall Study||1
8184531|NCT02332824|20181677|P1|NOT COMPLETED|Overall Study||6
8184532|NCT02332824|20181672|P6|COMPLETED|Overall Study||69
8184533|NCT02332824|20181673|P5|COMPLETED|Overall Study||65
8184534|NCT02332824|20181674|P4|COMPLETED|Overall Study||66
8184535|NCT02332824|20181675|P3|COMPLETED|Overall Study||72
8184536|NCT02332824|20181676|P2|COMPLETED|Overall Study||66
8184537|NCT02332824|20181677|P1|COMPLETED|Overall Study||61
8184538|NCT02332824|20181672|P6|STARTED|Overall Study||70
8184539|NCT02332824|20181673|P5|STARTED|Overall Study||69
8184540|NCT02332824|20181674|P4|STARTED|Overall Study||68
8184541|NCT02332824|20181675|P3|STARTED|Overall Study||74
8184542|NCT02332824|20181676|P2|STARTED|Overall Study||67
8184543|NCT02332824|20181677|P1|STARTED|Overall Study||67
8184544|NCT02332798|20181718|P3|NOT COMPLETED|Overall Study||1
8184545|NCT02332798|20181719|P2|NOT COMPLETED|Overall Study||2
8184546|NCT02332798|20181720|P1|NOT COMPLETED|Overall Study||1
8184547|NCT02332798|20181718|P3|COMPLETED|Overall Study||11
8184548|NCT02332798|20181719|P2|COMPLETED|Overall Study||12
8184549|NCT02332798|20181720|P1|COMPLETED|Overall Study||12
8184550|NCT02332798|20181718|P3|STARTED|Overall Study||12
8184551|NCT02332798|20181719|P2|STARTED|Overall Study||14
8184552|NCT02332798|20181720|P1|STARTED|Overall Study||13
8184553|NCT02332720|20181793|P23|NOT COMPLETED|Part C||0
8184554|NCT02332720|20181794|P22|NOT COMPLETED|Part C||0
8184555|NCT02332720|20181795|P21|NOT COMPLETED|Part C||0
8184556|NCT02332720|20181796|P20|NOT COMPLETED|Part C||0
8184557|NCT02332720|20181797|P19|NOT COMPLETED|Part C||0
8184558|NCT02332720|20181798|P18|NOT COMPLETED|Part C||0
8184559|NCT02332720|20181799|P17|NOT COMPLETED|Part C||0
8184560|NCT02332720|20181800|P16|NOT COMPLETED|Part C||0
8184561|NCT02332720|20181801|P15|NOT COMPLETED|Part C||0
8184562|NCT02332720|20181802|P14|NOT COMPLETED|Part C||0
8184563|NCT02332720|20181803|P13|NOT COMPLETED|Part C||0
8184564|NCT02332720|20181804|P12|NOT COMPLETED|Part C||0
8184565|NCT02332720|20181805|P11|NOT COMPLETED|Part C||0
8184566|NCT02332720|20181806|P10|NOT COMPLETED|Part C||0
8184567|NCT02332720|20181807|P9|NOT COMPLETED|Part C||0
8184568|NCT02332720|20181808|P8|NOT COMPLETED|Part C||0
8184569|NCT02332720|20181809|P7|NOT COMPLETED|Part C||0
8184570|NCT02332720|20181810|P6|NOT COMPLETED|Part C||0
8184571|NCT02332720|20181811|P5|NOT COMPLETED|Part C||0
8184572|NCT02332720|20181812|P4|NOT COMPLETED|Part C||0
8184573|NCT02332720|20181813|P3|NOT COMPLETED|Part C||0
8184574|NCT02332720|20181814|P2|NOT COMPLETED|Part C||0
8184575|NCT02332720|20181815|P1|NOT COMPLETED|Part C||0
8184576|NCT02332720|20181793|P23|COMPLETED|Part C||0
8184577|NCT02332720|20181794|P22|COMPLETED|Part C||0
8184578|NCT02332720|20181795|P21|COMPLETED|Part C||0
8184579|NCT02332720|20181796|P20|COMPLETED|Part C||0
8184580|NCT02332720|20181797|P19|COMPLETED|Part C||0
8184581|NCT02332720|20181798|P18|COMPLETED|Part C||0
8184582|NCT02332720|20181799|P17|COMPLETED|Part C||0
8184583|NCT02332720|20181800|P16|COMPLETED|Part C||0
8184584|NCT02332720|20181801|P15|COMPLETED|Part C||0
8184585|NCT02332720|20181802|P14|COMPLETED|Part C||0
8184586|NCT02332720|20181803|P13|COMPLETED|Part C||0
8184587|NCT02332720|20181804|P12|COMPLETED|Part C||0
8184588|NCT02332720|20181805|P11|COMPLETED|Part C||0
8184589|NCT02332720|20181806|P10|COMPLETED|Part C||0
8184590|NCT02332720|20181807|P9|COMPLETED|Part C||0
8184591|NCT02332720|20181808|P8|COMPLETED|Part C||0
8184592|NCT02332720|20181809|P7|COMPLETED|Part C||0
8184593|NCT02332720|20181810|P6|COMPLETED|Part C||0
8184594|NCT02332720|20181811|P5|COMPLETED|Part C||0
8184595|NCT02332720|20181812|P4|COMPLETED|Part C||2
8184596|NCT02332720|20181813|P3|COMPLETED|Part C||3
8184597|NCT02332720|20181814|P2|COMPLETED|Part C||1
8184598|NCT02332720|20181815|P1|COMPLETED|Part C||2
8184599|NCT02332720|20181793|P23|STARTED|Part C|Part B participants were not included in Part C.|0
8184600|NCT02332720|20181794|P22|STARTED|Part C||0
8184601|NCT02332720|20181795|P21|STARTED|Part C|Part B participants were not included in Part C.|0
8184602|NCT02332720|20181796|P20|STARTED|Part C|Part B participants were not included in Part C.|0
8184603|NCT02332720|20181797|P19|STARTED|Part C|Part B participants were not included in Part C.|0
8184604|NCT02332720|20181798|P18|STARTED|Part C|Part B participants were not included in Part C.|0
8184605|NCT02332720|20181799|P17|STARTED|Part C|Part B participants were not included in Part C.|0
8184606|NCT02332720|20181800|P16|STARTED|Part C|Part B participants were not included in Part C.|0
8184607|NCT02332720|20181801|P15|STARTED|Part C|Part B participants were not included in Part C.|0
8184608|NCT02332720|20181802|P14|STARTED|Part C|Part B participants were not included in Part C.|0
8184609|NCT02332720|20181803|P13|STARTED|Part C|Part B participants were not included in Part C.|0
8184610|NCT02332720|20181804|P12|STARTED|Part C|Part B participants were not included in Part C.|0
8184611|NCT02332720|20181805|P11|STARTED|Part C|Part B participants were not included in Part C.|0
8184612|NCT02332720|20181806|P10|STARTED|Part C|Part B participants were not included in Part C.|0
8184613|NCT02332720|20181807|P9|STARTED|Part C|Part B participants were not included in Part C.|0
8184614|NCT02332720|20181808|P8|STARTED|Part C|Part B participants were not included in Part C.|0
8184615|NCT02332720|20181809|P7|STARTED|Part C|Part B participants were not included in Part C.|0
8184616|NCT02332720|20181810|P6|STARTED|Part C|Part B participants were not included in Part C.|0
8184617|NCT02332720|20181811|P5|STARTED|Part C|Part B participants were not included in Part C.|0
8184618|NCT02332720|20181812|P4|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
8184619|NCT02332720|20181813|P3|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
8184620|NCT02332720|20181814|P2|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
8184621|NCT02332720|20181815|P1|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
8184622|NCT02332720|20181793|P23|NOT COMPLETED|Part A and Part B||0
8184623|NCT02332720|20181794|P22|NOT COMPLETED|Part A and Part B||0
8184624|NCT02332720|20181795|P21|NOT COMPLETED|Part A and Part B||0
8184625|NCT02332720|20181796|P20|NOT COMPLETED|Part A and Part B||1
8184626|NCT02332720|20181797|P19|NOT COMPLETED|Part A and Part B||1
8184627|NCT02332720|20181798|P18|NOT COMPLETED|Part A and Part B||1
8184628|NCT02332720|20181799|P17|NOT COMPLETED|Part A and Part B||0
8184629|NCT02332720|20181800|P16|NOT COMPLETED|Part A and Part B||1
8184630|NCT02332720|20181801|P15|NOT COMPLETED|Part A and Part B||0
8184631|NCT02332720|20181802|P14|NOT COMPLETED|Part A and Part B||0
8184632|NCT02332720|20181803|P13|NOT COMPLETED|Part A and Part B||0
8184633|NCT02332720|20181804|P12|NOT COMPLETED|Part A and Part B||0
8184634|NCT02332720|20181805|P11|NOT COMPLETED|Part A and Part B||0
8184635|NCT02332720|20181806|P10|NOT COMPLETED|Part A and Part B||0
8184636|NCT02332720|20181807|P9|NOT COMPLETED|Part A and Part B||0
8184637|NCT02332720|20181808|P8|NOT COMPLETED|Part A and Part B||1
8184638|NCT02332720|20181809|P7|NOT COMPLETED|Part A and Part B||1
8184639|NCT02332720|20181810|P6|NOT COMPLETED|Part A and Part B||3
8184640|NCT02332720|20181811|P5|NOT COMPLETED|Part A and Part B||0
8184641|NCT02332720|20181812|P4|NOT COMPLETED|Part A and Part B||0
8184642|NCT02332720|20181813|P3|NOT COMPLETED|Part A and Part B||0
8184643|NCT02332720|20181814|P2|NOT COMPLETED|Part A and Part B||0
8184644|NCT02332720|20181815|P1|NOT COMPLETED|Part A and Part B||1
8184645|NCT02332720|20181793|P23|COMPLETED|Part A and Part B||4
8184646|NCT02332720|20181794|P22|COMPLETED|Part A and Part B||0
8184647|NCT02332720|20181795|P21|COMPLETED|Part A and Part B||7
8184648|NCT02332720|20181796|P20|COMPLETED|Part A and Part B||24
8184649|NCT02332720|20181797|P19|COMPLETED|Part A and Part B||20
8184650|NCT02332720|20181798|P18|COMPLETED|Part A and Part B||13
8184651|NCT02332720|20181799|P17|COMPLETED|Part A and Part B||15
8184652|NCT02332720|20181800|P16|COMPLETED|Part A and Part B||13
8184653|NCT02332720|20181801|P15|COMPLETED|Part A and Part B||16
8184654|NCT02332720|20181802|P14|COMPLETED|Part A and Part B||13
8184655|NCT02332720|20181803|P13|COMPLETED|Part A and Part B||16
8184656|NCT02332720|20181804|P12|COMPLETED|Part A and Part B||15
8184657|NCT02332720|20181805|P11|COMPLETED|Part A and Part B||14
8184658|NCT02332720|20181806|P10|COMPLETED|Part A and Part B||14
8184659|NCT02332720|20181807|P9|COMPLETED|Part A and Part B||15
8184660|NCT02332720|20181808|P8|COMPLETED|Part A and Part B||34
8184661|NCT02332720|20181809|P7|COMPLETED|Part A and Part B||36
8184662|NCT02332720|20181810|P6|COMPLETED|Part A and Part B||33
8184663|NCT02332720|20181811|P5|COMPLETED|Part A and Part B||16
8184664|NCT02332720|20181812|P4|COMPLETED|Part A and Part B||22
8184665|NCT02332720|20181813|P3|COMPLETED|Part A and Part B||22
8184666|NCT02332720|20181814|P2|COMPLETED|Part A and Part B||21
8184667|NCT02332720|20181815|P1|COMPLETED|Part A and Part B||20
8184668|NCT02332720|20181793|P23|Treated|Part A and Part B||4
8184669|NCT02332720|20181794|P22|Treated|Part A and Part B||0
8184670|NCT02332720|20181795|P21|Treated|Part A and Part B||7
8184671|NCT02332720|20181796|P20|Treated|Part A and Part B||25
8184672|NCT02332720|20181797|P19|Treated|Part A and Part B||20
8184673|NCT02332720|20181798|P18|Treated|Part A and Part B||14
8184674|NCT02332720|20181799|P17|Treated|Part A and Part B||15
8184675|NCT02332720|20181800|P16|Treated|Part A and Part B||14
8184676|NCT02332720|20181801|P15|Treated|Part A and Part B||16
8184677|NCT02332720|20181802|P14|Treated|Part A and Part B||13
8184678|NCT02332720|20181803|P13|Treated|Part A and Part B||16
8184679|NCT02332720|20181804|P12|Treated|Part A and Part B||15
8184680|NCT02332720|20181805|P11|Treated|Part A and Part B||14
8184681|NCT02332720|20181806|P10|Treated|Part A and Part B||14
8184682|NCT02332720|20181807|P9|Treated|Part A and Part B||15
8184683|NCT02332720|20181808|P8|Treated|Part A and Part B||35
8184684|NCT02332720|20181809|P7|Treated|Part A and Part B||37
8184685|NCT02332720|20181810|P6|Treated|Part A and Part B||36
8184686|NCT02332720|20181811|P5|Treated|Part A and Part B||16
8184687|NCT02332720|20181812|P4|Treated|Part A and Part B||22
8184688|NCT02332720|20181813|P3|Treated|Part A and Part B||22
8184689|NCT02332720|20181814|P2|Treated|Part A and Part B||21
8184690|NCT02332720|20181815|P1|Treated|Part A and Part B||21
8184691|NCT02332720|20181793|P23|STARTED|Part A and Part B||4
8184692|NCT02332720|20181794|P22|STARTED|Part A and Part B||0
8184693|NCT02332720|20181795|P21|STARTED|Part A and Part B||7
8184694|NCT02332720|20181796|P20|STARTED|Part A and Part B||25
8184695|NCT02332720|20181797|P19|STARTED|Part A and Part B||21
8184696|NCT02332720|20181798|P18|STARTED|Part A and Part B||14
8184697|NCT02332720|20181799|P17|STARTED|Part A and Part B||15
8184698|NCT02332720|20181800|P16|STARTED|Part A and Part B||14
8184699|NCT02332720|20181801|P15|STARTED|Part A and Part B||16
8184700|NCT02332720|20181802|P14|STARTED|Part A and Part B||13
8184701|NCT02332720|20181803|P13|STARTED|Part A and Part B||16
8184702|NCT02332720|20181804|P12|STARTED|Part A and Part B||15
8184703|NCT02332720|20181805|P11|STARTED|Part A and Part B||14
8184704|NCT02332720|20181806|P10|STARTED|Part A and Part B||14
8184705|NCT02332720|20181807|P9|STARTED|Part A and Part B||15
8184706|NCT02332720|20181808|P8|STARTED|Part A and Part B||35
8184707|NCT02332720|20181809|P7|STARTED|Part A and Part B||37
8184708|NCT02332720|20181810|P6|STARTED|Part A and Part B||36
8184709|NCT02332720|20181811|P5|STARTED|Part A and Part B||16
8184710|NCT02332720|20181812|P4|STARTED|Part A and Part B||22
8184711|NCT02332720|20181813|P3|STARTED|Part A and Part B||22
8184712|NCT02332720|20181814|P2|STARTED|Part A and Part B||21
8184713|NCT02332720|20181815|P1|STARTED|Part A and Part B||21
8184714|NCT02332707|20181951|P18|NOT COMPLETED|Overall Study||0
8184715|NCT02332707|20181952|P17|NOT COMPLETED|Overall Study||0
8184716|NCT02332707|20181953|P16|NOT COMPLETED|Overall Study||0
8184717|NCT02332707|20181954|P15|NOT COMPLETED|Overall Study||0
8184718|NCT02332707|20181955|P14|NOT COMPLETED|Overall Study||0
8184719|NCT02332707|20181956|P13|NOT COMPLETED|Overall Study||5
8184720|NCT02332707|20181957|P12|NOT COMPLETED|Overall Study||0
8184721|NCT02332707|20181958|P11|NOT COMPLETED|Overall Study||2
8184722|NCT02332707|20181959|P10|NOT COMPLETED|Overall Study||3
8184723|NCT02332707|20181960|P9|NOT COMPLETED|Overall Study||0
8184724|NCT02332707|20181961|P8|NOT COMPLETED|Overall Study||0
8184725|NCT02332707|20181962|P7|NOT COMPLETED|Overall Study||0
8184726|NCT02332707|20181963|P6|NOT COMPLETED|Overall Study||1
8184727|NCT02332707|20181964|P5|NOT COMPLETED|Overall Study||0
8184728|NCT02332707|20181965|P4|NOT COMPLETED|Overall Study||1
8184729|NCT02332707|20181966|P3|NOT COMPLETED|Overall Study||1
8184730|NCT02332707|20181967|P2|NOT COMPLETED|Overall Study||0
8184731|NCT02332707|20181968|P1|NOT COMPLETED|Overall Study||0
8184732|NCT02332707|20181951|P18|COMPLETED|Overall Study||16
8184733|NCT02332707|20181952|P17|COMPLETED|Overall Study||30
8184734|NCT02332707|20181953|P16|COMPLETED|Overall Study||26
8184735|NCT02332707|20181954|P15|COMPLETED|Overall Study||16
8184736|NCT02332707|20181955|P14|COMPLETED|Overall Study||15
8184737|NCT02332707|20181956|P13|COMPLETED|Overall Study||35
8184738|NCT02332707|20181957|P12|COMPLETED|Overall Study||35
8184739|NCT02332707|20181958|P11|COMPLETED|Overall Study||29
8184740|NCT02332707|20181959|P10|COMPLETED|Overall Study||28
8184741|NCT02332707|20181960|P9|COMPLETED|Overall Study||48
8184742|NCT02332707|20181961|P8|COMPLETED|Overall Study||16
8184743|NCT02332707|20181962|P7|COMPLETED|Overall Study||15
8184744|NCT02332707|20181963|P6|COMPLETED|Overall Study||22
8184745|NCT02332707|20181964|P5|COMPLETED|Overall Study||23
8184746|NCT02332707|20181965|P4|COMPLETED|Overall Study||13
8184747|NCT02332707|20181966|P3|COMPLETED|Overall Study||15
8184748|NCT02332707|20181967|P2|COMPLETED|Overall Study||24
8184749|NCT02332707|20181968|P1|COMPLETED|Overall Study||23
8184750|NCT02332707|20181951|P18|STARTED|Overall Study||16
8184751|NCT02332707|20181952|P17|STARTED|Overall Study||30
8184752|NCT02332707|20181953|P16|STARTED|Overall Study||26
8184753|NCT02332707|20181954|P15|STARTED|Overall Study||16
8184754|NCT02332707|20181955|P14|STARTED|Overall Study||15
8184755|NCT02332707|20181956|P13|STARTED|Overall Study||40
8184756|NCT02332707|20181957|P12|STARTED|Overall Study||35
8184757|NCT02332707|20181958|P11|STARTED|Overall Study||31
8184758|NCT02332707|20181959|P10|STARTED|Overall Study||31
8184759|NCT02332707|20181960|P9|STARTED|Overall Study||48
8184760|NCT02332707|20181961|P8|STARTED|Overall Study||16
8184761|NCT02332707|20181962|P7|STARTED|Overall Study||15
8184762|NCT02332707|20181963|P6|STARTED|Overall Study||23
8184763|NCT02332707|20181964|P5|STARTED|Overall Study||23
8184764|NCT02332707|20181965|P4|STARTED|Overall Study||14
8184765|NCT02332707|20181966|P3|STARTED|Overall Study||16
8184766|NCT02332707|20181967|P2|STARTED|Overall Study||24
8184767|NCT02332707|20181968|P1|STARTED|Overall Study||23
8184768|NCT02332239|20182062|P2|NOT COMPLETED|Overall Study||6
8184769|NCT02332239|20182063|P1|NOT COMPLETED|Overall Study||4
8184770|NCT02332239|20182062|P2|COMPLETED|Overall Study||52
8184771|NCT02332239|20182063|P1|COMPLETED|Overall Study||54
8184772|NCT02332239|20182062|P2|STARTED|Overall Study||58
8184773|NCT02332239|20182063|P1|STARTED|Overall Study||58
8184774|NCT02331992|20182076|P1|NOT COMPLETED|Overall Study||0
8184775|NCT02331992|20182076|P1|COMPLETED|Overall Study||34
8184776|NCT02331992|20182076|P1|STARTED|Overall Study||34
8184777|NCT02331940|20182083|P2|NOT COMPLETED|Overall Study||5
8184778|NCT02331940|20182084|P1|NOT COMPLETED|Overall Study||7
8184779|NCT02331940|20182083|P2|COMPLETED|Overall Study||95
8184780|NCT02331940|20182084|P1|COMPLETED|Overall Study||93
8184781|NCT02331940|20182083|P2|STARTED|Overall Study||100
8184782|NCT02331940|20182084|P1|STARTED|Overall Study||100
8184783|NCT02331680|20182099|P3|NOT COMPLETED|Overall Study||15
8184784|NCT02331680|20182100|P2|NOT COMPLETED|Overall Study||4
8184785|NCT02331680|20182101|P1|NOT COMPLETED|Overall Study||6
8184786|NCT02331680|20182099|P3|COMPLETED|Overall Study||29
8184787|NCT02331680|20182100|P2|COMPLETED|Overall Study||36
8184788|NCT02331680|20182101|P1|COMPLETED|Overall Study||34
8184789|NCT02331680|20182099|P3|STARTED|Overall Study||44
8184790|NCT02331680|20182100|P2|STARTED|Overall Study||40
8184791|NCT02331680|20182101|P1|STARTED|Overall Study||40
8184792|NCT02331589|20182114|P2|NOT COMPLETED|Overall Study||5
8184793|NCT02331589|20182115|P1|NOT COMPLETED|Overall Study||5
8184794|NCT02331589|20182114|P2|COMPLETED|Overall Study||31
8184795|NCT02331589|20182115|P1|COMPLETED|Overall Study||34
8184796|NCT02331589|20182114|P2|STARTED|Overall Study||36
8184797|NCT02331589|20182115|P1|STARTED|Overall Study||39
8184798|NCT02331446|20182131|P4|NOT COMPLETED|Overall Study||3
8184799|NCT02331446|20182132|P3|NOT COMPLETED|Overall Study||3
8184800|NCT02331446|20182133|P2|NOT COMPLETED|Overall Study||5
8184801|NCT02331446|20182134|P1|NOT COMPLETED|Overall Study||4
8184802|NCT02331446|20182131|P4|COMPLETED|Overall Study||8
8184803|NCT02331446|20182132|P3|COMPLETED|Overall Study||8
8184804|NCT02331446|20182133|P2|COMPLETED|Overall Study||6
8184805|NCT02331446|20182134|P1|COMPLETED|Overall Study||5
8184806|NCT02331446|20182131|P4|STARTED|Overall Study||11
8184807|NCT02331446|20182132|P3|STARTED|Overall Study||11
8184808|NCT02331446|20182133|P2|STARTED|Overall Study||11
8184809|NCT02331446|20182134|P1|STARTED|Overall Study||9
8184810|NCT02331407|20182204|P1|NOT COMPLETED|Overall Study||0
8184811|NCT02331407|20182204|P1|COMPLETED|Overall Study||9
8184812|NCT02331407|20182204|P1|STARTED|Overall Study||9
8184813|NCT02331394|20182210|P1|NOT COMPLETED|Overall Study||1
8184814|NCT02331394|20182210|P1|COMPLETED|Overall Study|14 patients, 1 dropped out|14
8184815|NCT02331394|20182210|P1|STARTED|Overall Study||15
8184816|NCT02331368|20182221|P1|NOT COMPLETED|Overall Study||3
8184817|NCT02331368|20182221|P1|COMPLETED|Overall Study||29
8184818|NCT02331368|20182221|P1|STARTED|Overall Study||32
8184819|NCT02331108|20182233|P6|NOT COMPLETED|Overall Study||2
8184820|NCT02331108|20182234|P5|NOT COMPLETED|Overall Study||2
8184821|NCT02331108|20182235|P4|NOT COMPLETED|Overall Study||1
8184822|NCT02331108|20182236|P3|NOT COMPLETED|Overall Study||1
8184823|NCT02331108|20182237|P2|NOT COMPLETED|Overall Study||2
8184824|NCT02331108|20182238|P1|NOT COMPLETED|Overall Study||1
8184825|NCT02331108|20182233|P6|COMPLETED|Overall Study||50
8184826|NCT02331108|20182234|P5|COMPLETED|Overall Study||50
8184827|NCT02331108|20182235|P4|COMPLETED|Overall Study||50
8184828|NCT02331108|20182236|P3|COMPLETED|Overall Study||50
8184829|NCT02331108|20182237|P2|COMPLETED|Overall Study||50
8184830|NCT02331108|20182238|P1|COMPLETED|Overall Study||50
8184831|NCT02331108|20182233|P6|STARTED|Overall Study||52
8184832|NCT02331108|20182234|P5|STARTED|Overall Study||52
8184833|NCT02331108|20182235|P4|STARTED|Overall Study||51
8184834|NCT02331108|20182236|P3|STARTED|Overall Study||51
8184835|NCT02331108|20182237|P2|STARTED|Overall Study||52
8184836|NCT02331108|20182238|P1|STARTED|Overall Study||51
8184837|NCT02331095|20182262|P2|NOT COMPLETED|Overall Study||1
8184838|NCT02331095|20182263|P1|NOT COMPLETED|Overall Study||4
8184839|NCT02331095|20182262|P2|COMPLETED|Overall Study||9
8184840|NCT02331095|20182263|P1|COMPLETED|Overall Study||7
8184841|NCT02331095|20182262|P2|STARTED|Overall Study||10
8184842|NCT02331095|20182263|P1|STARTED|Overall Study||11
8184843|NCT02330978|20182289|P1|NOT COMPLETED|The Second Patient Included at Study||0
8184844|NCT02330978|20182289|P1|COMPLETED|The Second Patient Included at Study||1
8184845|NCT02330978|20182289|P1|STARTED|The Second Patient Included at Study||1
8184846|NCT02330978|20182289|P1|NOT COMPLETED|The First Patient Included at Study||0
8184847|NCT02330978|20182289|P1|COMPLETED|The First Patient Included at Study||1
8184848|NCT02330978|20182289|P1|STARTED|The First Patient Included at Study||1
8184849|NCT02330627|20182295|P2|NOT COMPLETED|Overall Study||1
8184850|NCT02330627|20182296|P1|NOT COMPLETED|Overall Study||1
8184851|NCT02330627|20182295|P2|COMPLETED|Overall Study||12
8184852|NCT02330627|20182296|P1|COMPLETED|Overall Study||15
8184853|NCT02330627|20182295|P2|STARTED|Overall Study||13
8184854|NCT02330627|20182296|P1|STARTED|Overall Study||16
8184855|NCT02330588|20182315|P5|NOT COMPLETED|Overall Study||19
8184856|NCT02330588|20182316|P4|NOT COMPLETED|Overall Study||22
8184857|NCT02330588|20182317|P3|NOT COMPLETED|Overall Study||15
8184858|NCT02330588|20182318|P2|NOT COMPLETED|Overall Study||18
8184859|NCT02330588|20182319|P1|NOT COMPLETED|Overall Study||16
8184860|NCT02330588|20182315|P5|COMPLETED|Overall Study||28
8184861|NCT02330588|20182316|P4|COMPLETED|Overall Study||24
8184862|NCT02330588|20182317|P3|COMPLETED|Overall Study||31
8184863|NCT02330588|20182318|P2|COMPLETED|Overall Study||25
8184864|NCT02330588|20182319|P1|COMPLETED|Overall Study||28
8184865|NCT02330588|20182315|P5|STARTED|Overall Study||47
8184866|NCT02330588|20182316|P4|STARTED|Overall Study||46
8184867|NCT02330588|20182317|P3|STARTED|Overall Study||46
8184868|NCT02330588|20182318|P2|STARTED|Overall Study||43
8184869|NCT02330588|20182319|P1|STARTED|Overall Study||44
8184870|NCT02330549|20182346|P2|NOT COMPLETED|Overall Study||1
8184871|NCT02330549|20182347|P1|NOT COMPLETED|Overall Study||4
8184872|NCT02330549|20182346|P2|COMPLETED|Overall Study||24
8184873|NCT02330549|20182347|P1|COMPLETED|Overall Study||16
8184874|NCT02330549|20182346|P2|STARTED|Overall Study||25
8184875|NCT02330549|20182347|P1|STARTED|Overall Study||20
8184876|NCT02330523|20182462|P2|NOT COMPLETED|Overall Study||0
8184877|NCT02330523|20182463|P1|NOT COMPLETED|Overall Study||0
8184878|NCT02330523|20182462|P2|COMPLETED|Overall Study||19
8184879|NCT02330523|20182463|P1|COMPLETED|Overall Study||21
8184880|NCT02330523|20182462|P2|STARTED|Overall Study||19
8184881|NCT02330523|20182463|P1|STARTED|Overall Study||21
8184882|NCT02330341|20182475|P2|NOT COMPLETED|Overall Study||1
8184883|NCT02330341|20182476|P1|NOT COMPLETED|Overall Study||0
8184884|NCT02330341|20182475|P2|COMPLETED|Overall Study||11
8184885|NCT02330341|20182476|P1|COMPLETED|Overall Study||12
8184886|NCT02330341|20182475|P2|STARTED|Overall Study||12
8184887|NCT02330341|20182476|P1|STARTED|Overall Study||12
8184888|NCT02330276|20182517|P3|NOT COMPLETED|Overall Study||0
8184889|NCT02330276|20182518|P2|NOT COMPLETED|Overall Study||0
8184890|NCT02330276|20182519|P1|NOT COMPLETED|Overall Study||0
8184891|NCT02330276|20182517|P3|COMPLETED|Overall Study||4
8184892|NCT02330276|20182518|P2|COMPLETED|Overall Study||4
8184893|NCT02330276|20182519|P1|COMPLETED|Overall Study||4
8184894|NCT02330276|20182517|P3|STARTED|Overall Study||4
8184895|NCT02330276|20182518|P2|STARTED|Overall Study||4
8184896|NCT02330276|20182519|P1|STARTED|Overall Study||4
8184897|NCT02330172|20182541|P2|NOT COMPLETED|Overall Study||1
8184898|NCT02330172|20182542|P1|NOT COMPLETED|Overall Study||3
8184899|NCT02330172|20182541|P2|COMPLETED|Overall Study||21
8184900|NCT02330172|20182542|P1|COMPLETED|Overall Study||19
8184901|NCT02330172|20182541|P2|STARTED|Overall Study||22
8184902|NCT02330172|20182542|P1|STARTED|Overall Study||22
8184903|NCT02330094|20182552|P2|NOT COMPLETED|Overall Study||0
8184904|NCT02330094|20182553|P1|NOT COMPLETED|Overall Study||0
8184905|NCT02330094|20182552|P2|COMPLETED|Overall Study||8
8184906|NCT02330094|20182553|P1|COMPLETED|Overall Study||8
8184907|NCT02330094|20182552|P2|STARTED|Overall Study||8
8184908|NCT02330094|20182553|P1|STARTED|Overall Study||8
8184909|NCT02330081|20182563|P1|NOT COMPLETED|Overall Study||8
8184910|NCT02330081|20182563|P1|COMPLETED|Overall Study||14
8184911|NCT02330081|20182563|P1|STARTED|Overall Study||22
8184912|NCT02330055|20182584|P2|NOT COMPLETED|Overall Study||9
8184913|NCT02330055|20182585|P1|NOT COMPLETED|Overall Study||10
8184914|NCT02330055|20182584|P2|COMPLETED|Overall Study||40
8184915|NCT02330055|20182585|P1|COMPLETED|Overall Study||40
8184916|NCT02330055|20182584|P2|STARTED|Overall Study||49
8184917|NCT02330055|20182585|P1|STARTED|Overall Study||50
8184918|NCT02329964|20182605|P2|NOT COMPLETED|Overall Study||0
8184919|NCT02329964|20182606|P1|NOT COMPLETED|Overall Study||0
8184920|NCT02329964|20182605|P2|COMPLETED|Overall Study||40
8184921|NCT02329964|20182606|P1|COMPLETED|Overall Study||40
8184922|NCT02329964|20182605|P2|STARTED|Overall Study||40
8184923|NCT02329964|20182606|P1|STARTED|Overall Study||40
8184924|NCT02329743|20182631|P3|NOT COMPLETED|Overall Study||8
8184925|NCT02329743|20182632|P2|NOT COMPLETED|Overall Study||7
8184926|NCT02329743|20182633|P1|NOT COMPLETED|Overall Study||6
8184927|NCT02329743|20182631|P3|COMPLETED|Overall Study||77
8184928|NCT02329743|20182632|P2|COMPLETED|Overall Study||80
8184929|NCT02329743|20182633|P1|COMPLETED|Overall Study||78
8184930|NCT02329743|20182631|P3|STARTED|Overall Study||85
8184931|NCT02329743|20182632|P2|STARTED|Overall Study||87
8184932|NCT02329743|20182633|P1|STARTED|Overall Study||84
8184933|NCT02329730|20182648|P12|NOT COMPLETED|Overall Study||0
8184934|NCT02329730|20182649|P11|NOT COMPLETED|Overall Study||0
8184935|NCT02329730|20182650|P10|NOT COMPLETED|Overall Study||1
8184936|NCT02329730|20182651|P9|NOT COMPLETED|Overall Study||1
8184937|NCT02329730|20182652|P8|NOT COMPLETED|Overall Study||1
8184938|NCT02329730|20182653|P7|NOT COMPLETED|Overall Study||1
8184939|NCT02329730|20182654|P6|NOT COMPLETED|Overall Study||2
8184940|NCT02329730|20182655|P5|NOT COMPLETED|Overall Study||3
8184941|NCT02329730|20182656|P4|NOT COMPLETED|Overall Study||0
8184942|NCT02329730|20182657|P3|NOT COMPLETED|Overall Study||0
8184943|NCT02329730|20182658|P2|NOT COMPLETED|Overall Study||0
8184944|NCT02329730|20182659|P1|NOT COMPLETED|Overall Study||0
8184945|NCT02329730|20182648|P12|COMPLETED|Overall Study||8
8184946|NCT02329730|20182649|P11|COMPLETED|Overall Study||8
8184947|NCT02329730|20182650|P10|COMPLETED|Overall Study||7
8184948|NCT02329730|20182651|P9|COMPLETED|Overall Study||7
8184949|NCT02329730|20182652|P8|COMPLETED|Overall Study||13
8184950|NCT02329730|20182653|P7|COMPLETED|Overall Study||13
8184951|NCT02329730|20182654|P6|COMPLETED|Overall Study||12
8184952|NCT02329730|20182655|P5|COMPLETED|Overall Study||11
8184953|NCT02329730|20182656|P4|COMPLETED|Overall Study||14
8184954|NCT02329730|20182657|P3|COMPLETED|Overall Study||14
8184955|NCT02329730|20182658|P2|COMPLETED|Overall Study||14
8184956|NCT02329730|20182659|P1|COMPLETED|Overall Study||14
8184957|NCT02329730|20182648|P12|STARTED|Overall Study||8
8184958|NCT02329730|20182649|P11|STARTED|Overall Study||8
8184959|NCT02329730|20182650|P10|STARTED|Overall Study||8
8184960|NCT02329730|20182651|P9|STARTED|Overall Study||8
8184961|NCT02329730|20182652|P8|STARTED|Overall Study||14
8184962|NCT02329730|20182653|P7|STARTED|Overall Study||14
8184963|NCT02329730|20182654|P6|STARTED|Overall Study||14
8184964|NCT02329730|20182655|P5|STARTED|Overall Study||14
8184965|NCT02329730|20182656|P4|STARTED|Overall Study||14
8184966|NCT02329730|20182657|P3|STARTED|Overall Study||14
8184967|NCT02329730|20182658|P2|STARTED|Overall Study||14
8184968|NCT02329730|20182659|P1|STARTED|Overall Study||14
8184969|NCT02329600|20182736|P3|NOT COMPLETED|Overall Study||0
8184970|NCT02329600|20182737|P2|NOT COMPLETED|Overall Study||0
8184971|NCT02329600|20182738|P1|NOT COMPLETED|Overall Study||0
8184972|NCT02329600|20182736|P3|COMPLETED|Overall Study||15
8184973|NCT02329600|20182737|P2|COMPLETED|Overall Study||15
8184974|NCT02329600|20182738|P1|COMPLETED|Overall Study||10
8184975|NCT02329600|20182736|P3|STARTED|Overall Study||15
8184976|NCT02329600|20182737|P2|STARTED|Overall Study||15
8184977|NCT02329600|20182738|P1|STARTED|Overall Study||10
8184978|NCT02329587|20182751|P2|NOT COMPLETED|1-month Follow-up||1
8184979|NCT02329587|20182752|P1|NOT COMPLETED|1-month Follow-up||0
8184980|NCT02329587|20182751|P2|COMPLETED|1-month Follow-up||5
8184981|NCT02329587|20182752|P1|COMPLETED|1-month Follow-up||4
8184982|NCT02329587|20182751|P2|STARTED|1-month Follow-up||6
8184983|NCT02329587|20182752|P1|STARTED|1-month Follow-up||4
8184984|NCT02329587|20182751|P2|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
8184985|NCT02329587|20182752|P1|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
8184986|NCT02329587|20182751|P2|COMPLETED|Baseline Thru Post-treatment Assessment||6
8184987|NCT02329587|20182752|P1|COMPLETED|Baseline Thru Post-treatment Assessment||4
8184988|NCT02329587|20182751|P2|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
8184989|NCT02329587|20182752|P1|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
8184990|NCT02329587|20182751|P2|STARTED|Baseline Thru Post-treatment Assessment||7
8184991|NCT02329587|20182752|P1|STARTED|Baseline Thru Post-treatment Assessment||5
8184992|NCT02329431|20182770|P2|NOT COMPLETED|Overall Study||13
8184993|NCT02329431|20182771|P1|NOT COMPLETED|Overall Study||20
8184994|NCT02329431|20182770|P2|COMPLETED|Overall Study||76
8184995|NCT02329431|20182771|P1|COMPLETED|Overall Study||72
8184996|NCT02329431|20182770|P2|Baseline Interview|Overall Study||85
8184997|NCT02329431|20182771|P1|Baseline Interview|Overall Study||87
8184998|NCT02329431|20182770|P2|STARTED|Overall Study||89
8184999|NCT02329431|20182771|P1|STARTED|Overall Study||92
8185000|NCT02329223|20182790|P3|NOT COMPLETED|Overall Study||6
8185001|NCT02329223|20182791|P2|NOT COMPLETED|Overall Study||3
8185002|NCT02329223|20182792|P1|NOT COMPLETED|Overall Study||1
8185003|NCT02329223|20182790|P3|COMPLETED|Overall Study||68
8185004|NCT02329223|20182791|P2|COMPLETED|Overall Study||68
8185005|NCT02329223|20182792|P1|COMPLETED|Overall Study||72
8185006|NCT02329223|20182790|P3|Safety Set|Overall Study||74
8185007|NCT02329223|20182791|P2|Safety Set|Overall Study||71
8185008|NCT02329223|20182792|P1|Safety Set|Overall Study||73
8185009|NCT02329223|20182790|P3|Full Analysis Set|Overall Study||74
8185010|NCT02329223|20182791|P2|Full Analysis Set|Overall Study||70
8185011|NCT02329223|20182792|P1|Full Analysis Set|Overall Study||73
8185012|NCT02329223|20182790|P3|STARTED|Overall Study||74
8185013|NCT02329223|20182791|P2|STARTED|Overall Study||71
8185014|NCT02329223|20182792|P1|STARTED|Overall Study||73
8185015|NCT02329015|20182825|P2|NOT COMPLETED|Overall Study||0
8185016|NCT02329015|20182826|P1|NOT COMPLETED|Overall Study||0
8185017|NCT02329015|20182825|P2|COMPLETED|Overall Study||64
8185018|NCT02329015|20182826|P1|COMPLETED|Overall Study||48
8185019|NCT02329015|20182825|P2|STARTED|Overall Study||64
8185020|NCT02329015|20182826|P1|STARTED|Overall Study||48
8185021|NCT02328937|20182842|P6|NOT COMPLETED|Period 3||0
8185022|NCT02328937|20182843|P5|NOT COMPLETED|Period 3||0
8185023|NCT02328937|20182844|P4|NOT COMPLETED|Period 3||0
8185024|NCT02328937|20182845|P3|NOT COMPLETED|Period 3||0
8185025|NCT02328937|20182846|P2|NOT COMPLETED|Period 3||0
8185026|NCT02328937|20182847|P1|NOT COMPLETED|Period 3||0
8185027|NCT02328937|20182842|P6|COMPLETED|Period 3||6
8185028|NCT02328937|20182843|P5|COMPLETED|Period 3||6
8185029|NCT02328937|20182844|P4|COMPLETED|Period 3||5
8185030|NCT02328937|20182845|P3|COMPLETED|Period 3||6
8185031|NCT02328937|20182846|P2|COMPLETED|Period 3||6
8185032|NCT02328937|20182847|P1|COMPLETED|Period 3||7
8185033|NCT02328937|20182842|P6|STARTED|Period 3||6
8185034|NCT02328937|20182843|P5|STARTED|Period 3||6
8185035|NCT02328937|20182844|P4|STARTED|Period 3||5
8185036|NCT02328937|20182845|P3|STARTED|Period 3||6
8185037|NCT02328937|20182846|P2|STARTED|Period 3||6
8185038|NCT02328937|20182847|P1|STARTED|Period 3||7
8185039|NCT02328937|20182842|P6|NOT COMPLETED|Period 2||0
8185040|NCT02328937|20182843|P5|NOT COMPLETED|Period 2||0
8185041|NCT02328937|20182844|P4|NOT COMPLETED|Period 2||0
8185042|NCT02328937|20182845|P3|NOT COMPLETED|Period 2||1
8185043|NCT02328937|20182846|P2|NOT COMPLETED|Period 2||0
8185044|NCT02328937|20182847|P1|NOT COMPLETED|Period 2||0
8185045|NCT02328937|20182842|P6|COMPLETED|Period 2||6
8185046|NCT02328937|20182843|P5|COMPLETED|Period 2||6
8185047|NCT02328937|20182844|P4|COMPLETED|Period 2||5
8185048|NCT02328937|20182845|P3|COMPLETED|Period 2||6
8185049|NCT02328937|20182846|P2|COMPLETED|Period 2||6
8185050|NCT02328937|20182847|P1|COMPLETED|Period 2||7
8185051|NCT02328937|20182842|P6|STARTED|Period 2||6
8185052|NCT02328937|20182843|P5|STARTED|Period 2||6
8185053|NCT02328937|20182844|P4|STARTED|Period 2||5
8185054|NCT02328937|20182845|P3|STARTED|Period 2||7
8185055|NCT02328937|20182846|P2|STARTED|Period 2||6
8185056|NCT02328937|20182847|P1|STARTED|Period 2||7
8185057|NCT02328937|20182842|P6|NOT COMPLETED|Period 1||0
8185058|NCT02328937|20182843|P5|NOT COMPLETED|Period 1||0
8185059|NCT02328937|20182844|P4|NOT COMPLETED|Period 1||1
8185060|NCT02328937|20182845|P3|NOT COMPLETED|Period 1||0
8185061|NCT02328937|20182846|P2|NOT COMPLETED|Period 1||0
8185062|NCT02328937|20182847|P1|NOT COMPLETED|Period 1||0
8185063|NCT02328937|20182842|P6|COMPLETED|Period 1||6
8185064|NCT02328937|20182843|P5|COMPLETED|Period 1||6
8185065|NCT02328937|20182844|P4|COMPLETED|Period 1||5
8185066|NCT02328937|20182845|P3|COMPLETED|Period 1||7
8185067|NCT02328937|20182846|P2|COMPLETED|Period 1||6
8185068|NCT02328937|20182847|P1|COMPLETED|Period 1||7
8185069|NCT02328937|20182842|P6|STARTED|Period 1||6
8185070|NCT02328937|20182843|P5|STARTED|Period 1||6
8185071|NCT02328937|20182844|P4|STARTED|Period 1||6
8185072|NCT02328937|20182845|P3|STARTED|Period 1||7
8185073|NCT02328937|20182846|P2|STARTED|Period 1||6
8185074|NCT02328937|20182847|P1|STARTED|Period 1||7
8185078|NCT02328547|20182867|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
8185079|NCT02328547|20182868|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
8185080|NCT02328547|20182867|P2|COMPLETED|Second Intervention (12 Weeks)||23
8185081|NCT02328547|20182868|P1|COMPLETED|Second Intervention (12 Weeks)||22
8185082|NCT02328547|20182867|P2|STARTED|Second Intervention (12 Weeks)||23
8185083|NCT02328547|20182868|P1|STARTED|Second Intervention (12 Weeks)||22
8185084|NCT02328547|20182867|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
8185085|NCT02328547|20182868|P1|NOT COMPLETED|First Intervention (12 Weeks)||3
8185086|NCT02328547|20182867|P2|COMPLETED|First Intervention (12 Weeks)||23
8185087|NCT02328547|20182868|P1|COMPLETED|First Intervention (12 Weeks)||22
8185088|NCT02328547|20182867|P2|STARTED|First Intervention (12 Weeks)||23
8185089|NCT02328547|20182868|P1|STARTED|First Intervention (12 Weeks)||25
8185090|NCT02328404|20182908|P2|NOT COMPLETED|Overall Study||1
8185091|NCT02328404|20182909|P1|NOT COMPLETED|Overall Study||1
8185092|NCT02328404|20182908|P2|COMPLETED|Overall Study||29
8185093|NCT02328404|20182909|P1|COMPLETED|Overall Study||29
8185094|NCT02328404|20182908|P2|STARTED|Overall Study||30
8185095|NCT02328404|20182909|P1|STARTED|Overall Study||30
8185096|NCT02328326|20182945|P2|NOT COMPLETED|Overall Study||8
8185097|NCT02328326|20182946|P1|NOT COMPLETED|Overall Study||22
8185098|NCT02328326|20182945|P2|COMPLETED|Overall Study||224
8185099|NCT02328326|20182946|P1|COMPLETED|Overall Study||224
8185100|NCT02328326|20182945|P2|6-month Follow Up|Overall Study|We were unable to reach 9 participants. 1 patient died, 1 care partner withdrew before completion.|221
8185101|NCT02328326|20182946|P1|6-month Follow Up|Overall Study|We were unable to reach 15 participants. 1 patient died, 1 care partner withdrew before completion.|221
8185102|NCT02328326|20182945|P2|STARTED|Overall Study|1 participant dyad withdrew from the study between assignment to control arm and 6-month follow up.|232
8185103|NCT02328326|20182946|P1|STARTED|Overall Study|3 participant dyads withdrew before 6-month follow up. 3 more care partners withdrew and 1 died.|246
8185107|NCT02328040|20182963|P2|NOT COMPLETED|Second Intervention (2 Days)||0
8185108|NCT02328040|20182964|P1|NOT COMPLETED|Second Intervention (2 Days)||0
8185109|NCT02328040|20182963|P2|COMPLETED|Second Intervention (2 Days)||8
8185110|NCT02328040|20182964|P1|COMPLETED|Second Intervention (2 Days)||7
8185111|NCT02328040|20182963|P2|STARTED|Second Intervention (2 Days)||8
8185112|NCT02328040|20182964|P1|STARTED|Second Intervention (2 Days)||7
8185113|NCT02328040|20182963|P2|NOT COMPLETED|First Intervention (2 Days)||1
8185114|NCT02328040|20182964|P1|NOT COMPLETED|First Intervention (2 Days)||1
8185115|NCT02328040|20182963|P2|COMPLETED|First Intervention (2 Days)||8
8185116|NCT02328040|20182964|P1|COMPLETED|First Intervention (2 Days)||7
8185117|NCT02328040|20182963|P2|STARTED|First Intervention (2 Days)||9
8185118|NCT02328040|20182964|P1|STARTED|First Intervention (2 Days)||8
8185119|NCT02328027|20182974|P2|NOT COMPLETED|Overall Study||1
8185120|NCT02328027|20182975|P1|NOT COMPLETED|Overall Study||0
8185121|NCT02328027|20182974|P2|COMPLETED|Overall Study||10
8185122|NCT02328027|20182975|P1|COMPLETED|Overall Study||5
8185123|NCT02328027|20182974|P2|STARTED|Overall Study||11
8185124|NCT02328027|20182975|P1|STARTED|Overall Study||5
8185125|NCT02327741|20182992|P2|NOT COMPLETED|Overall Study||0
8185126|NCT02327741|20182993|P1|NOT COMPLETED|Overall Study||0
8185127|NCT02327741|20182992|P2|COMPLETED|Overall Study||508
8185128|NCT02327741|20182993|P1|COMPLETED|Overall Study||502
8185129|NCT02327741|20182992|P2|STARTED|Overall Study||508
8185130|NCT02327741|20182993|P1|STARTED|Overall Study||502
8185131|NCT02327429|20183011|P1|NOT COMPLETED|Overall Study||2
8185132|NCT02327429|20183011|P1|COMPLETED|Overall Study||17
8185133|NCT02327429|20183011|P1|STARTED|Overall Study||19
8185134|NCT02327325|20183034|P3|NOT COMPLETED|Overall Study||5
8185135|NCT02327325|20183035|P2|NOT COMPLETED|Overall Study||4
8185136|NCT02327325|20183036|P1|NOT COMPLETED|Overall Study||1
8185137|NCT02327325|20183034|P3|COMPLETED|Overall Study||15
8185138|NCT02327325|20183035|P2|COMPLETED|Overall Study||16
8185139|NCT02327325|20183036|P1|COMPLETED|Overall Study||19
8185140|NCT02327325|20183034|P3|STARTED|Overall Study||20
8185141|NCT02327325|20183035|P2|STARTED|Overall Study||20
8185142|NCT02327325|20183036|P1|STARTED|Overall Study||20
8185143|NCT02327260|20183059|P3|NOT COMPLETED|Overall Study||2
8185144|NCT02327260|20183060|P2|NOT COMPLETED|Overall Study||4
8185145|NCT02327260|20183061|P1|NOT COMPLETED|Overall Study||6
8185146|NCT02327260|20183059|P3|COMPLETED|Overall Study||15
8185147|NCT02327260|20183060|P2|COMPLETED|Overall Study||20
8185148|NCT02327260|20183061|P1|COMPLETED|Overall Study||14
8185149|NCT02327260|20183059|P3|STARTED|Overall Study||17
8185150|NCT02327260|20183060|P2|STARTED|Overall Study||24
8185151|NCT02327260|20183061|P1|STARTED|Overall Study||20
8185152|NCT02327169|20183108|P15|NOT COMPLETED|Overall Study||10
8185153|NCT02327169|20183109|P14|NOT COMPLETED|Overall Study||7
8185154|NCT02327169|20183110|P13|NOT COMPLETED|Overall Study||1
8185155|NCT02327169|20183111|P12|NOT COMPLETED|Overall Study||7
8185156|NCT02327169|20183112|P11|NOT COMPLETED|Overall Study||6
8185157|NCT02327169|20183113|P10|NOT COMPLETED|Overall Study||8
8185158|NCT02327169|20183114|P9|NOT COMPLETED|Overall Study||6
8185159|NCT02327169|20183115|P8|NOT COMPLETED|Overall Study||4
8185160|NCT02327169|20183116|P7|NOT COMPLETED|Overall Study||3
8185161|NCT02327169|20183117|P6|NOT COMPLETED|Overall Study||4
8185162|NCT02327169|20183118|P5|NOT COMPLETED|Overall Study||8
8185163|NCT02327169|20183119|P4|NOT COMPLETED|Overall Study||3
8185164|NCT02327169|20183120|P3|NOT COMPLETED|Overall Study||7
8185165|NCT02327169|20183121|P2|NOT COMPLETED|Overall Study||3
8185166|NCT02327169|20183122|P1|NOT COMPLETED|Overall Study||4
8185167|NCT02327169|20183108|P15|COMPLETED|Overall Study||0
8185168|NCT02327169|20183109|P14|COMPLETED|Overall Study||0
8185169|NCT02327169|20183110|P13|COMPLETED|Overall Study||0
8185170|NCT02327169|20183111|P12|COMPLETED|Overall Study||0
8185171|NCT02327169|20183112|P11|COMPLETED|Overall Study||0
8185172|NCT02327169|20183113|P10|COMPLETED|Overall Study||0
8185173|NCT02327169|20183114|P9|COMPLETED|Overall Study||0
8185174|NCT02327169|20183115|P8|COMPLETED|Overall Study||0
8185175|NCT02327169|20183116|P7|COMPLETED|Overall Study||0
8185176|NCT02327169|20183117|P6|COMPLETED|Overall Study||0
8185177|NCT02327169|20183118|P5|COMPLETED|Overall Study||0
8185178|NCT02327169|20183119|P4|COMPLETED|Overall Study||0
8185179|NCT02327169|20183120|P3|COMPLETED|Overall Study||0
8185180|NCT02327169|20183121|P2|COMPLETED|Overall Study||0
8185181|NCT02327169|20183122|P1|COMPLETED|Overall Study||0
8185182|NCT02327169|20183108|P15|STARTED|Overall Study||10
8185183|NCT02327169|20183109|P14|STARTED|Overall Study||7
8185184|NCT02327169|20183110|P13|STARTED|Overall Study||1
8185185|NCT02327169|20183111|P12|STARTED|Overall Study||7
8185186|NCT02327169|20183112|P11|STARTED|Overall Study||6
8185187|NCT02327169|20183113|P10|STARTED|Overall Study||8
8185188|NCT02327169|20183114|P9|STARTED|Overall Study||6
8185189|NCT02327169|20183115|P8|STARTED|Overall Study||4
8185190|NCT02327169|20183116|P7|STARTED|Overall Study||3
8185191|NCT02327169|20183117|P6|STARTED|Overall Study||4
8185192|NCT02327169|20183118|P5|STARTED|Overall Study||8
8185193|NCT02327169|20183119|P4|STARTED|Overall Study||3
8185194|NCT02327169|20183120|P3|STARTED|Overall Study||7
8185195|NCT02327169|20183121|P2|STARTED|Overall Study||3
8185196|NCT02327169|20183122|P1|STARTED|Overall Study||4
8185197|NCT02327143|20183343|P2|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
8185198|NCT02327143|20183344|P1|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
8185199|NCT02327143|20183343|P2|COMPLETED|Day 1: Time 6 Hrs - to Day 9||11
8185200|NCT02327143|20183344|P1|COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
8185201|NCT02327143|20183343|P2|STARTED|Day 1: Time 6 Hrs - to Day 9||11
8185202|NCT02327143|20183344|P1|STARTED|Day 1: Time 6 Hrs - to Day 9||0
8185203|NCT02327143|20183343|P2|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
8185204|NCT02327143|20183344|P1|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
8185205|NCT02327143|20183343|P2|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
8185206|NCT02327143|20183344|P1|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
8185207|NCT02327143|20183343|P2|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
8185208|NCT02327143|20183344|P1|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
8185209|NCT02327130|20183352|P1|NOT COMPLETED|Overall Study||12
8185210|NCT02327130|20183352|P1|COMPLETED|Overall Study||20
8185211|NCT02327130|20183352|P1|STARTED|Overall Study||32
8185212|NCT02327117|20183361|P2|NOT COMPLETED|Overall Study||0
8185213|NCT02327117|20183362|P1|NOT COMPLETED|Overall Study||0
8185214|NCT02327117|20183361|P2|COMPLETED|Overall Study||45
8185215|NCT02327117|20183362|P1|COMPLETED|Overall Study||45
8185216|NCT02327117|20183361|P2|STARTED|Overall Study||45
8185217|NCT02327117|20183362|P1|STARTED|Overall Study||45
8185218|NCT02327013|20183371|P5|NOT COMPLETED|Overall Study||4
8185219|NCT02327013|20183372|P4|NOT COMPLETED|Overall Study||1
8185220|NCT02327013|20183373|P3|NOT COMPLETED|Overall Study||42
8185221|NCT02327013|20183374|P2|NOT COMPLETED|Overall Study||16
8185222|NCT02327013|20183375|P1|NOT COMPLETED|Overall Study||13
8185223|NCT02327013|20183371|P5|COMPLETED|Overall Study||12
8185224|NCT02327013|20183372|P4|COMPLETED|Overall Study||20
8185225|NCT02327013|20183373|P3|COMPLETED|Overall Study||54
8185226|NCT02327013|20183374|P2|COMPLETED|Overall Study||29
8185227|NCT02327013|20183375|P1|COMPLETED|Overall Study||36
8185228|NCT02327013|20183371|P5|STARTED|Overall Study||16
8185229|NCT02327013|20183372|P4|STARTED|Overall Study||21
8185230|NCT02327013|20183373|P3|STARTED|Overall Study||96
8185231|NCT02327013|20183374|P2|STARTED|Overall Study||45
8185232|NCT02327013|20183375|P1|STARTED|Overall Study||49
8185233|NCT02326844|20183548|P1|NOT COMPLETED|Overall Study||0
8185234|NCT02326844|20183548|P1|COMPLETED|Overall Study||3
8185235|NCT02326844|20183548|P1|STARTED|Overall Study||3
8185236|NCT02326649|20183557|P1|NOT COMPLETED|Overall Study||12
8185237|NCT02326649|20183557|P1|COMPLETED|Overall Study||21
8185238|NCT02326649|20183557|P1|STARTED|Overall Study||33
8185239|NCT02326597|20183563|P2|NOT COMPLETED|Overall Study||32
8185240|NCT02326597|20183564|P1|NOT COMPLETED|Overall Study||42
8185241|NCT02326597|20183563|P2|COMPLETED|Overall Study||28
8185242|NCT02326597|20183564|P1|COMPLETED|Overall Study||18
8185243|NCT02326597|20183563|P2|STARTED|Overall Study||60
8185244|NCT02326597|20183564|P1|STARTED|Overall Study||60
8185251|NCT02326298|20183610|P14|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
8185252|NCT02326298|20183611|P13|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19
8185253|NCT02326298|20183612|P12|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20
8185254|NCT02326298|20183613|P11|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185255|NCT02326298|20183614|P10|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185256|NCT02326298|20183615|P9|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185257|NCT02326298|20183616|P8|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185258|NCT02326298|20183617|P7|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185259|NCT02326298|20183618|P6|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185260|NCT02326298|20183619|P5|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185261|NCT02326298|20183620|P4|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185262|NCT02326298|20183621|P3|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185263|NCT02326298|20183622|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185264|NCT02326298|20183623|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185265|NCT02326298|20183610|P14|COMPLETED|Open-label Period (Week 48 to Week 144)||44
8185266|NCT02326298|20183611|P13|COMPLETED|Open-label Period (Week 48 to Week 144)||51
8185267|NCT02326298|20183612|P12|COMPLETED|Open-label Period (Week 48 to Week 144)||54
8185268|NCT02326298|20183613|P11|COMPLETED|Open-label Period (Week 48 to Week 144)||3
8185269|NCT02326298|20183614|P10|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185270|NCT02326298|20183615|P9|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185271|NCT02326298|20183616|P8|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185272|NCT02326298|20183617|P7|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185273|NCT02326298|20183618|P6|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185274|NCT02326298|20183619|P5|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185275|NCT02326298|20183620|P4|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185276|NCT02326298|20183621|P3|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185277|NCT02326298|20183622|P2|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185278|NCT02326298|20183623|P1|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185279|NCT02326298|20183610|P14|STARTED|Open-label Period (Week 48 to Week 144)||53
8185280|NCT02326298|20183611|P13|STARTED|Open-label Period (Week 48 to Week 144)||70
8185281|NCT02326298|20183612|P12|STARTED|Open-label Period (Week 48 to Week 144)||74
8185282|NCT02326298|20183613|P11|STARTED|Open-label Period (Week 48 to Week 144)||3
8185283|NCT02326298|20183614|P10|STARTED|Open-label Period (Week 48 to Week 144)||0
8185284|NCT02326298|20183615|P9|STARTED|Open-label Period (Week 48 to Week 144)||0
8185285|NCT02326298|20183616|P8|STARTED|Open-label Period (Week 48 to Week 144)||0
8185286|NCT02326298|20183617|P7|STARTED|Open-label Period (Week 48 to Week 144)||0
8185287|NCT02326298|20183618|P6|STARTED|Open-label Period (Week 48 to Week 144)||0
8185288|NCT02326298|20183619|P5|STARTED|Open-label Period (Week 48 to Week 144)||0
8185289|NCT02326298|20183620|P4|STARTED|Open-label Period (Week 48 to Week 144)||0
8185290|NCT02326298|20183621|P3|STARTED|Open-label Period (Week 48 to Week 144)||0
8185291|NCT02326298|20183622|P2|STARTED|Open-label Period (Week 48 to Week 144)||0
8185292|NCT02326298|20183623|P1|STARTED|Open-label Period (Week 48 to Week 144)||0
8185293|NCT02326298|20183610|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185294|NCT02326298|20183611|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185295|NCT02326298|20183612|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185296|NCT02326298|20183613|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185297|NCT02326298|20183614|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
8185298|NCT02326298|20183615|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8185299|NCT02326298|20183616|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8185300|NCT02326298|20183617|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
8185301|NCT02326298|20183618|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8185302|NCT02326298|20183619|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185303|NCT02326298|20183620|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185304|NCT02326298|20183621|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185305|NCT02326298|20183622|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185306|NCT02326298|20183623|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185307|NCT02326298|20183610|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185308|NCT02326298|20183611|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185309|NCT02326298|20183612|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185310|NCT02326298|20183613|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185311|NCT02326298|20183614|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||7
8185312|NCT02326298|20183615|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||13
8185313|NCT02326298|20183616|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||33
8185314|NCT02326298|20183617|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||70
8185315|NCT02326298|20183618|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||69
8185316|NCT02326298|20183619|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8185317|NCT02326298|20183620|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
8185318|NCT02326298|20183621|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185319|NCT02326298|20183622|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185320|NCT02326298|20183623|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185321|NCT02326298|20183610|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185322|NCT02326298|20183611|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185323|NCT02326298|20183612|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185324|NCT02326298|20183613|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185325|NCT02326298|20183614|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7
8185326|NCT02326298|20183615|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13
8185327|NCT02326298|20183616|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33
8185328|NCT02326298|20183617|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70
8185329|NCT02326298|20183618|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69
8185330|NCT02326298|20183619|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
8185331|NCT02326298|20183620|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
8185332|NCT02326298|20183621|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185333|NCT02326298|20183622|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185334|NCT02326298|20183623|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185335|NCT02326298|20183610|P14|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185336|NCT02326298|20183611|P13|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185337|NCT02326298|20183612|P12|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185338|NCT02326298|20183613|P11|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185339|NCT02326298|20183614|P10|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7
8185340|NCT02326298|20183615|P9|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13
8185341|NCT02326298|20183616|P8|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33
8185342|NCT02326298|20183617|P7|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70
8185343|NCT02326298|20183618|P6|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71
8185344|NCT02326298|20183619|P5|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
8185345|NCT02326298|20183620|P4|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
8185346|NCT02326298|20183621|P3|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185347|NCT02326298|20183622|P2|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185348|NCT02326298|20183623|P1|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185349|NCT02326298|20183610|P14|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185350|NCT02326298|20183611|P13|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185351|NCT02326298|20183612|P12|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185352|NCT02326298|20183613|P11|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185353|NCT02326298|20183614|P10|STARTED|Maintenance Period (Week 16 to Week 48)||8
8185354|NCT02326298|20183615|P9|STARTED|Maintenance Period (Week 16 to Week 48)||18
8185355|NCT02326298|20183616|P8|STARTED|Maintenance Period (Week 16 to Week 48)||38
8185356|NCT02326298|20183617|P7|STARTED|Maintenance Period (Week 16 to Week 48)||77
8185357|NCT02326298|20183618|P6|STARTED|Maintenance Period (Week 16 to Week 48)||74
8185358|NCT02326298|20183619|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
8185359|NCT02326298|20183620|P4|STARTED|Maintenance Period (Week 16 to Week 48)||3
8185360|NCT02326298|20183621|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185361|NCT02326298|20183622|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185362|NCT02326298|20183623|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185363|NCT02326298|20183610|P14|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185364|NCT02326298|20183611|P13|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185365|NCT02326298|20183612|P12|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185366|NCT02326298|20183613|P11|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185367|NCT02326298|20183614|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185368|NCT02326298|20183615|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185369|NCT02326298|20183616|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185370|NCT02326298|20183617|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185371|NCT02326298|20183618|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185372|NCT02326298|20183619|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185373|NCT02326298|20183620|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185374|NCT02326298|20183621|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
8185375|NCT02326298|20183622|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
8185376|NCT02326298|20183623|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5
8185377|NCT02326298|20183610|P14|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185378|NCT02326298|20183611|P13|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185379|NCT02326298|20183612|P12|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185380|NCT02326298|20183613|P11|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185381|NCT02326298|20183614|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185382|NCT02326298|20183615|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185383|NCT02326298|20183616|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185384|NCT02326298|20183617|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185385|NCT02326298|20183618|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185386|NCT02326298|20183619|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185387|NCT02326298|20183620|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185388|NCT02326298|20183621|P3|COMPLETED|Initial Period (Week 0 to Week 16)||85
8185389|NCT02326298|20183622|P2|COMPLETED|Initial Period (Week 0 to Week 16)||92
8185390|NCT02326298|20183623|P1|COMPLETED|Initial Period (Week 0 to Week 16)||46
8185391|NCT02326298|20183610|P14|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185392|NCT02326298|20183611|P13|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185393|NCT02326298|20183612|P12|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185394|NCT02326298|20183613|P11|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185395|NCT02326298|20183614|P10|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185396|NCT02326298|20183615|P9|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185397|NCT02326298|20183616|P8|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185398|NCT02326298|20183617|P7|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185399|NCT02326298|20183618|P6|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185400|NCT02326298|20183619|P5|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185401|NCT02326298|20183620|P4|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185402|NCT02326298|20183621|P3|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85
8185403|NCT02326298|20183622|P2|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92
8185404|NCT02326298|20183623|P1|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46
8185405|NCT02326298|20183610|P14|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185406|NCT02326298|20183611|P13|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185407|NCT02326298|20183612|P12|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185408|NCT02326298|20183613|P11|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185409|NCT02326298|20183614|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185410|NCT02326298|20183615|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185411|NCT02326298|20183616|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185412|NCT02326298|20183617|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185413|NCT02326298|20183618|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185414|NCT02326298|20183619|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185415|NCT02326298|20183620|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185416|NCT02326298|20183621|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||87
8185417|NCT02326298|20183622|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||92
8185418|NCT02326298|20183623|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||46
8185419|NCT02326298|20183610|P14|STARTED|Initial Period (Week 0 to Week 16)||0
8185420|NCT02326298|20183611|P13|STARTED|Initial Period (Week 0 to Week 16)||0
8185421|NCT02326298|20183612|P12|STARTED|Initial Period (Week 0 to Week 16)||0
8185422|NCT02326298|20183613|P11|STARTED|Initial Period (Week 0 to Week 16)||0
8185423|NCT02326298|20183614|P10|STARTED|Initial Period (Week 0 to Week 16)||0
8185424|NCT02326298|20183615|P9|STARTED|Initial Period (Week 0 to Week 16)||0
8185425|NCT02326298|20183616|P8|STARTED|Initial Period (Week 0 to Week 16)||0
8185426|NCT02326298|20183617|P7|STARTED|Initial Period (Week 0 to Week 16)||0
8185427|NCT02326298|20183618|P6|STARTED|Initial Period (Week 0 to Week 16)||0
8185428|NCT02326298|20183619|P5|STARTED|Initial Period (Week 0 to Week 16)||0
8185429|NCT02326298|20183620|P4|STARTED|Initial Period (Week 0 to Week 16)||0
8185430|NCT02326298|20183621|P3|STARTED|Initial Period (Week 0 to Week 16)||88
8185431|NCT02326298|20183622|P2|STARTED|Initial Period (Week 0 to Week 16)||95
8185432|NCT02326298|20183623|P1|STARTED|Initial Period (Week 0 to Week 16)||51
8185433|NCT02326272|20183646|P15|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
8185434|NCT02326272|20183647|P14|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185435|NCT02326272|20183648|P13|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11
8185436|NCT02326272|20183649|P12|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15
8185437|NCT02326272|20183650|P11|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3
8185438|NCT02326272|20183651|P10|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185439|NCT02326272|20183652|P9|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185440|NCT02326272|20183653|P8|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185441|NCT02326272|20183654|P7|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185442|NCT02326272|20183655|P6|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185443|NCT02326272|20183656|P5|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185444|NCT02326272|20183657|P4|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185445|NCT02326272|20183658|P3|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185446|NCT02326272|20183659|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185447|NCT02326272|20183660|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185448|NCT02326272|20183646|P15|COMPLETED|Open-label Period (Week 48 to Week 144)||31
8185449|NCT02326272|20183647|P14|COMPLETED|Open-label Period (Week 48 to Week 144)||1
8185450|NCT02326272|20183648|P13|COMPLETED|Open-label Period (Week 48 to Week 144)||48
8185451|NCT02326272|20183649|P12|COMPLETED|Open-label Period (Week 48 to Week 144)||51
8185452|NCT02326272|20183650|P11|COMPLETED|Open-label Period (Week 48 to Week 144)||2
8185453|NCT02326272|20183651|P10|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185454|NCT02326272|20183652|P9|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185455|NCT02326272|20183653|P8|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185456|NCT02326272|20183654|P7|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185457|NCT02326272|20183655|P6|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185458|NCT02326272|20183656|P5|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185459|NCT02326272|20183657|P4|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185460|NCT02326272|20183658|P3|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185461|NCT02326272|20183659|P2|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185462|NCT02326272|20183660|P1|COMPLETED|Open-label Period (Week 48 to Week 144)||0
8185463|NCT02326272|20183646|P15|STARTED|Open-label Period (Week 48 to Week 144)||40
8185464|NCT02326272|20183647|P14|STARTED|Open-label Period (Week 48 to Week 144)||1
8185465|NCT02326272|20183648|P13|STARTED|Open-label Period (Week 48 to Week 144)||59
8185466|NCT02326272|20183649|P12|STARTED|Open-label Period (Week 48 to Week 144)||66
8185467|NCT02326272|20183650|P11|STARTED|Open-label Period (Week 48 to Week 144)||5
8185468|NCT02326272|20183651|P10|STARTED|Open-label Period (Week 48 to Week 144)||0
8185469|NCT02326272|20183652|P9|STARTED|Open-label Period (Week 48 to Week 144)||0
8185470|NCT02326272|20183653|P8|STARTED|Open-label Period (Week 48 to Week 144)||0
8185471|NCT02326272|20183654|P7|STARTED|Open-label Period (Week 48 to Week 144)||0
8185472|NCT02326272|20183655|P6|STARTED|Open-label Period (Week 48 to Week 144)||0
8185473|NCT02326272|20183656|P5|STARTED|Open-label Period (Week 48 to Week 144)||0
8185474|NCT02326272|20183657|P4|STARTED|Open-label Period (Week 48 to Week 144)||0
8185475|NCT02326272|20183658|P3|STARTED|Open-label Period (Week 48 to Week 144)||0
8185476|NCT02326272|20183659|P2|STARTED|Open-label Period (Week 48 to Week 144)||0
8185477|NCT02326272|20183660|P1|STARTED|Open-label Period (Week 48 to Week 144)||0
8185478|NCT02326272|20183646|P15|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185479|NCT02326272|20183647|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185480|NCT02326272|20183648|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185481|NCT02326272|20183649|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185482|NCT02326272|20183650|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185483|NCT02326272|20183651|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8185484|NCT02326272|20183652|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8185485|NCT02326272|20183653|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
8185486|NCT02326272|20183654|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9
8185487|NCT02326272|20183655|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13
8185488|NCT02326272|20183656|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8185489|NCT02326272|20183657|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
8185490|NCT02326272|20183658|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185491|NCT02326272|20183659|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185492|NCT02326272|20183660|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185493|NCT02326272|20183646|P15|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185494|NCT02326272|20183647|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185495|NCT02326272|20183648|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185496|NCT02326272|20183649|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185497|NCT02326272|20183650|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185498|NCT02326272|20183651|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
8185499|NCT02326272|20183652|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
8185500|NCT02326272|20183653|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
8185501|NCT02326272|20183654|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||60
8185502|NCT02326272|20183655|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||63
8185503|NCT02326272|20183656|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
8185504|NCT02326272|20183657|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
8185505|NCT02326272|20183658|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185506|NCT02326272|20183659|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185507|NCT02326272|20183660|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8185508|NCT02326272|20183646|P15|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185509|NCT02326272|20183647|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185510|NCT02326272|20183648|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185511|NCT02326272|20183649|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185512|NCT02326272|20183650|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185513|NCT02326272|20183651|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10
8185514|NCT02326272|20183652|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
8185515|NCT02326272|20183653|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27
8185516|NCT02326272|20183654|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60
8185517|NCT02326272|20183655|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63
8185518|NCT02326272|20183656|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
8185519|NCT02326272|20183657|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
8185520|NCT02326272|20183658|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185521|NCT02326272|20183659|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185522|NCT02326272|20183660|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8185523|NCT02326272|20183646|P15|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185524|NCT02326272|20183647|P14|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185525|NCT02326272|20183648|P13|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185526|NCT02326272|20183649|P12|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185527|NCT02326272|20183650|P11|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185528|NCT02326272|20183651|P10|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10
8185529|NCT02326272|20183652|P9|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
8185530|NCT02326272|20183653|P8|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27
8185531|NCT02326272|20183654|P7|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61
8185532|NCT02326272|20183655|P6|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64
8185533|NCT02326272|20183656|P5|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
8185534|NCT02326272|20183657|P4|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
8185535|NCT02326272|20183658|P3|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185536|NCT02326272|20183659|P2|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185537|NCT02326272|20183660|P1|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
8185538|NCT02326272|20183646|P15|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185539|NCT02326272|20183647|P14|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185540|NCT02326272|20183648|P13|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185541|NCT02326272|20183649|P12|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185542|NCT02326272|20183650|P11|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185543|NCT02326272|20183651|P10|STARTED|Maintenance Period (Week 16 to Week 48)||12
8185544|NCT02326272|20183652|P9|STARTED|Maintenance Period (Week 16 to Week 48)||8
8185545|NCT02326272|20183653|P8|STARTED|Maintenance Period (Week 16 to Week 48)||34
8185546|NCT02326272|20183654|P7|STARTED|Maintenance Period (Week 16 to Week 48)||69
8185547|NCT02326272|20183655|P6|STARTED|Maintenance Period (Week 16 to Week 48)||76
8185548|NCT02326272|20183656|P5|STARTED|Maintenance Period (Week 16 to Week 48)||5
8185549|NCT02326272|20183657|P4|STARTED|Maintenance Period (Week 16 to Week 48)||6
8185550|NCT02326272|20183658|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185551|NCT02326272|20183659|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185552|NCT02326272|20183660|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
8185553|NCT02326272|20183646|P15|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185554|NCT02326272|20183647|P14|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185555|NCT02326272|20183648|P13|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185556|NCT02326272|20183649|P12|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185557|NCT02326272|20183650|P11|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185558|NCT02326272|20183651|P10|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185559|NCT02326272|20183652|P9|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185560|NCT02326272|20183653|P8|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185561|NCT02326272|20183654|P7|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185562|NCT02326272|20183655|P6|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185563|NCT02326272|20183656|P5|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185564|NCT02326272|20183657|P4|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
8185565|NCT02326272|20183658|P3|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
8185566|NCT02326272|20183659|P2|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
8185567|NCT02326272|20183660|P1|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
8185568|NCT02326272|20183646|P15|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185569|NCT02326272|20183647|P14|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185570|NCT02326272|20183648|P13|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185571|NCT02326272|20183649|P12|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185572|NCT02326272|20183650|P11|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185573|NCT02326272|20183651|P10|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185574|NCT02326272|20183652|P9|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185575|NCT02326272|20183653|P8|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185576|NCT02326272|20183654|P7|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185577|NCT02326272|20183655|P6|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185578|NCT02326272|20183656|P5|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185579|NCT02326272|20183657|P4|COMPLETED|Initial Period (Week 0 to Week 16)||0
8185580|NCT02326272|20183658|P3|COMPLETED|Initial Period (Week 0 to Week 16)||81
8185581|NCT02326272|20183659|P2|COMPLETED|Initial Period (Week 0 to Week 16)||84
8185582|NCT02326272|20183660|P1|COMPLETED|Initial Period (Week 0 to Week 16)||45
8185583|NCT02326272|20183646|P15|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185584|NCT02326272|20183647|P14|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185585|NCT02326272|20183648|P13|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185586|NCT02326272|20183649|P12|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185587|NCT02326272|20183650|P11|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185588|NCT02326272|20183651|P10|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185589|NCT02326272|20183652|P9|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185590|NCT02326272|20183653|P8|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185591|NCT02326272|20183654|P7|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185592|NCT02326272|20183655|P6|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185593|NCT02326272|20183656|P5|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185594|NCT02326272|20183657|P4|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
8185595|NCT02326272|20183658|P3|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
8185596|NCT02326272|20183659|P2|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
8185597|NCT02326272|20183660|P1|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
8185598|NCT02326272|20183646|P15|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185599|NCT02326272|20183647|P14|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185600|NCT02326272|20183648|P13|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185601|NCT02326272|20183649|P12|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185602|NCT02326272|20183650|P11|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185603|NCT02326272|20183651|P10|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185604|NCT02326272|20183652|P9|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185605|NCT02326272|20183653|P8|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185606|NCT02326272|20183654|P7|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185607|NCT02326272|20183655|P6|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185608|NCT02326272|20183656|P5|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185609|NCT02326272|20183657|P4|Completed Week 16|Initial Period (Week 0 to Week 16)||0
8185610|NCT02326272|20183658|P3|Completed Week 16|Initial Period (Week 0 to Week 16)||83
8185611|NCT02326272|20183659|P2|Completed Week 16|Initial Period (Week 0 to Week 16)||84
8185612|NCT02326272|20183660|P1|Completed Week 16|Initial Period (Week 0 to Week 16)||45
8185613|NCT02326272|20183646|P15|STARTED|Initial Period (Week 0 to Week 16)||0
8185614|NCT02326272|20183647|P14|STARTED|Initial Period (Week 0 to Week 16)||0
8185615|NCT02326272|20183648|P13|STARTED|Initial Period (Week 0 to Week 16)||0
8185616|NCT02326272|20183649|P12|STARTED|Initial Period (Week 0 to Week 16)||0
8185617|NCT02326272|20183650|P11|STARTED|Initial Period (Week 0 to Week 16)||0
8185618|NCT02326272|20183651|P10|STARTED|Initial Period (Week 0 to Week 16)||0
8185619|NCT02326272|20183652|P9|STARTED|Initial Period (Week 0 to Week 16)||0
8185620|NCT02326272|20183653|P8|STARTED|Initial Period (Week 0 to Week 16)||0
8185621|NCT02326272|20183654|P7|STARTED|Initial Period (Week 0 to Week 16)||0
8185622|NCT02326272|20183655|P6|STARTED|Initial Period (Week 0 to Week 16)||0
8185623|NCT02326272|20183656|P5|STARTED|Initial Period (Week 0 to Week 16)||0
8185624|NCT02326272|20183657|P4|STARTED|Initial Period (Week 0 to Week 16)||0
8185625|NCT02326272|20183658|P3|STARTED|Initial Period (Week 0 to Week 16)||87
8185626|NCT02326272|20183659|P2|STARTED|Initial Period (Week 0 to Week 16)||91
8185627|NCT02326272|20183660|P1|STARTED|Initial Period (Week 0 to Week 16)||49
8185628|NCT02326233|20183682|P2|NOT COMPLETED|Overall Study||1
8185629|NCT02326233|20183683|P1|NOT COMPLETED|Overall Study||0
8185630|NCT02326233|20183682|P2|COMPLETED|Overall Study||94
8185631|NCT02326233|20183683|P1|COMPLETED|Overall Study||95
8185632|NCT02326233|20183682|P2|STARTED|Overall Study||95
8185633|NCT02326233|20183683|P1|STARTED|Overall Study||95
8185634|NCT02326220|20183697|P3|NOT COMPLETED|Open-label Treatment Period||2
8185635|NCT02326220|20183698|P2|NOT COMPLETED|Open-label Treatment Period||0
8185636|NCT02326220|20183699|P1|NOT COMPLETED|Open-label Treatment Period||0
8185637|NCT02326220|20183697|P3|COMPLETED|Open-label Treatment Period||27
8185638|NCT02326220|20183698|P2|COMPLETED|Open-label Treatment Period||0
8185639|NCT02326220|20183699|P1|COMPLETED|Open-label Treatment Period||0
8185640|NCT02326220|20183697|P3|STARTED|Open-label Treatment Period|29 participants: 9 from Placebo and 20 from Alirocumab 150 mg arm entered in open-label period.|29
8185641|NCT02326220|20183698|P2|STARTED|Open-label Treatment Period||0
8185642|NCT02326220|20183699|P1|STARTED|Open-label Treatment Period||0
8185643|NCT02326220|20183697|P3|NOT COMPLETED|Double-blind Treatment Period||0
8185644|NCT02326220|20183698|P2|NOT COMPLETED|Double-blind Treatment Period||4
8185645|NCT02326220|20183699|P1|NOT COMPLETED|Double-blind Treatment Period||1
8185646|NCT02326220|20183697|P3|COMPLETED|Double-blind Treatment Period||0
8185647|NCT02326220|20183698|P2|COMPLETED|Double-blind Treatment Period||37
8185648|NCT02326220|20183699|P1|COMPLETED|Double-blind Treatment Period||20
8185649|NCT02326220|20183697|P3|STARTED|Double-blind Treatment Period||0
8185650|NCT02326220|20183698|P2|STARTED|Double-blind Treatment Period|Out of 41 participants, 20 participants entered in open label treatment period.|41
8185651|NCT02326220|20183699|P1|STARTED|Double-blind Treatment Period|Out of 21 participants, 9 participants entered in open label treatment period|21
8185652|NCT02326025|20183752|P2|NOT COMPLETED|Overall Study||5
8185653|NCT02326025|20183753|P1|NOT COMPLETED|Overall Study||5
8185654|NCT02326025|20183752|P2|COMPLETED|Overall Study||19
8185655|NCT02326025|20183753|P1|COMPLETED|Overall Study||20
8185656|NCT02326025|20183752|P2|Received at Least 1 Dose of Study Drug|Overall Study||24
8185657|NCT02326025|20183753|P1|Received at Least 1 Dose of Study Drug|Overall Study||25
8185658|NCT02326025|20183752|P2|STARTED|Overall Study||24
8185659|NCT02326025|20183753|P1|STARTED|Overall Study||25
8185660|NCT02325856|20183787|P2|NOT COMPLETED|Overall Study||27
8185661|NCT02325856|20183788|P1|NOT COMPLETED|Overall Study||20
8185662|NCT02325856|20183787|P2|COMPLETED|Overall Study||123
8185663|NCT02325856|20183788|P1|COMPLETED|Overall Study||128
8185664|NCT02325856|20183787|P2|STARTED|Overall Study||150
8185665|NCT02325856|20183788|P1|STARTED|Overall Study||148
8185666|NCT02325791|20183800|P4|NOT COMPLETED|Overall Study||26
8185667|NCT02325791|20183801|P3|NOT COMPLETED|Overall Study||25
8185668|NCT02325791|20183802|P2|NOT COMPLETED|Overall Study||25
8185669|NCT02325791|20183803|P1|NOT COMPLETED|Overall Study||0
8185670|NCT02325791|20183800|P4|COMPLETED|Overall Study||355
8185671|NCT02325791|20183801|P3|COMPLETED|Overall Study||360
8185672|NCT02325791|20183802|P2|COMPLETED|Overall Study||358
8185673|NCT02325791|20183803|P1|COMPLETED|Overall Study||23
8185674|NCT02325791|20183800|P4|STARTED|Overall Study||381
8185675|NCT02325791|20183801|P3|STARTED|Overall Study||385
8185676|NCT02325791|20183802|P2|STARTED|Overall Study||383
8185677|NCT02325791|20183803|P1|STARTED|Overall Study||23
8185678|NCT02325739|20183833|P11|NOT COMPLETED|Phase II Part||20
8185679|NCT02325739|20183834|P10|NOT COMPLETED|Phase II Part||36
8185680|NCT02325739|20183835|P9|NOT COMPLETED|Phase II Part||30
8185681|NCT02325739|20183836|P8|NOT COMPLETED|Phase II Part||0
8185682|NCT02325739|20183837|P7|NOT COMPLETED|Phase II Part||0
8185683|NCT02325739|20183838|P6|NOT COMPLETED|Phase II Part||0
8185684|NCT02325739|20183839|P5|NOT COMPLETED|Phase II Part||0
8185685|NCT02325739|20183840|P4|NOT COMPLETED|Phase II Part||0
8185686|NCT02325739|20183841|P3|NOT COMPLETED|Phase II Part||0
8185687|NCT02325739|20183842|P2|NOT COMPLETED|Phase II Part||0
8185688|NCT02325739|20183843|P1|NOT COMPLETED|Phase II Part||0
8185689|NCT02325739|20183833|P11|COMPLETED|Phase II Part||0
8185690|NCT02325739|20183834|P10|COMPLETED|Phase II Part||0
8185691|NCT02325739|20183835|P9|COMPLETED|Phase II Part||0
8185692|NCT02325739|20183836|P8|COMPLETED|Phase II Part||0
8185693|NCT02325739|20183837|P7|COMPLETED|Phase II Part||0
8185694|NCT02325739|20183838|P6|COMPLETED|Phase II Part||0
8185695|NCT02325739|20183839|P5|COMPLETED|Phase II Part||0
8185696|NCT02325739|20183840|P4|COMPLETED|Phase II Part||0
8185697|NCT02325739|20183841|P3|COMPLETED|Phase II Part||0
8185698|NCT02325739|20183842|P2|COMPLETED|Phase II Part||0
8185699|NCT02325739|20183843|P1|COMPLETED|Phase II Part||0
8185700|NCT02325739|20183833|P11|STARTED|Phase II Part||20
8185701|NCT02325739|20183834|P10|STARTED|Phase II Part||36
8185702|NCT02325739|20183835|P9|STARTED|Phase II Part||30
8185703|NCT02325739|20183836|P8|STARTED|Phase II Part||0
8185704|NCT02325739|20183837|P7|STARTED|Phase II Part||0
8185705|NCT02325739|20183838|P6|STARTED|Phase II Part||0
8185706|NCT02325739|20183839|P5|STARTED|Phase II Part||0
8185707|NCT02325739|20183840|P4|STARTED|Phase II Part||0
8185708|NCT02325739|20183841|P3|STARTED|Phase II Part||0
8185709|NCT02325739|20183842|P2|STARTED|Phase II Part||0
8185710|NCT02325739|20183843|P1|STARTED|Phase II Part||0
8185711|NCT02325739|20183833|P11|NOT COMPLETED|Phase I Part||0
8185712|NCT02325739|20183834|P10|NOT COMPLETED|Phase I Part||0
8185713|NCT02325739|20183835|P9|NOT COMPLETED|Phase I Part||0
8185714|NCT02325739|20183836|P8|NOT COMPLETED|Phase I Part||6
8185715|NCT02325739|20183837|P7|NOT COMPLETED|Phase I Part||6
8185716|NCT02325739|20183838|P6|NOT COMPLETED|Phase I Part||7
8185717|NCT02325739|20183839|P5|NOT COMPLETED|Phase I Part||19
8185718|NCT02325739|20183840|P4|NOT COMPLETED|Phase I Part||26
8185719|NCT02325739|20183841|P3|NOT COMPLETED|Phase I Part||5
8185720|NCT02325739|20183842|P2|NOT COMPLETED|Phase I Part||6
8185721|NCT02325739|20183843|P1|NOT COMPLETED|Phase I Part||11
8185722|NCT02325739|20183833|P11|COMPLETED|Phase I Part||0
8185723|NCT02325739|20183834|P10|COMPLETED|Phase I Part||0
8185724|NCT02325739|20183835|P9|COMPLETED|Phase I Part||0
8185725|NCT02325739|20183836|P8|COMPLETED|Phase I Part||0
8185726|NCT02325739|20183837|P7|COMPLETED|Phase I Part||0
8185727|NCT02325739|20183838|P6|COMPLETED|Phase I Part||0
8185728|NCT02325739|20183839|P5|COMPLETED|Phase I Part||0
8185729|NCT02325739|20183840|P4|COMPLETED|Phase I Part||0
8185730|NCT02325739|20183841|P3|COMPLETED|Phase I Part||0
8185731|NCT02325739|20183842|P2|COMPLETED|Phase I Part||0
8185732|NCT02325739|20183843|P1|COMPLETED|Phase I Part||0
8185733|NCT02325739|20183833|P11|STARTED|Phase I Part||0
8185734|NCT02325739|20183834|P10|STARTED|Phase I Part||0
8185735|NCT02325739|20183835|P9|STARTED|Phase I Part||0
8185736|NCT02325739|20183836|P8|STARTED|Phase I Part||6
8185737|NCT02325739|20183837|P7|STARTED|Phase I Part||6
8185738|NCT02325739|20183838|P6|STARTED|Phase I Part||7
8185739|NCT02325739|20183839|P5|STARTED|Phase I Part||19
8185740|NCT02325739|20183840|P4|STARTED|Phase I Part||26
8185741|NCT02325739|20183841|P3|STARTED|Phase I Part||5
8185742|NCT02325739|20183842|P2|STARTED|Phase I Part||6
8185743|NCT02325739|20183843|P1|STARTED|Phase I Part||11
8185744|NCT02325713|20183973|P16|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185745|NCT02325713|20183974|P15|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185746|NCT02325713|20183975|P14|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185747|NCT02325713|20183976|P13|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185748|NCT02325713|20183977|P12|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185749|NCT02325713|20183978|P11|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185750|NCT02325713|20183979|P10|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185751|NCT02325713|20183980|P9|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185752|NCT02325713|20183981|P8|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185753|NCT02325713|20183982|P7|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185754|NCT02325713|20183983|P6|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185755|NCT02325713|20183984|P5|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185756|NCT02325713|20183985|P4|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185757|NCT02325713|20183986|P3|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185758|NCT02325713|20183987|P2|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185759|NCT02325713|20183988|P1|NOT COMPLETED|Intervention Period 4 (2 Days)||0
8185760|NCT02325713|20183973|P16|COMPLETED|Intervention Period 4 (2 Days)||2
8185761|NCT02325713|20183974|P15|COMPLETED|Intervention Period 4 (2 Days)||2
8185762|NCT02325713|20183975|P14|COMPLETED|Intervention Period 4 (2 Days)||2
8185763|NCT02325713|20183976|P13|COMPLETED|Intervention Period 4 (2 Days)||2
8185764|NCT02325713|20183977|P12|COMPLETED|Intervention Period 4 (2 Days)||2
8185765|NCT02325713|20183978|P11|COMPLETED|Intervention Period 4 (2 Days)||1
8185766|NCT02325713|20183979|P10|COMPLETED|Intervention Period 4 (2 Days)||1
8185767|NCT02325713|20183980|P9|COMPLETED|Intervention Period 4 (2 Days)||2
8185768|NCT02325713|20183981|P8|COMPLETED|Intervention Period 4 (2 Days)||2
8185769|NCT02325713|20183982|P7|COMPLETED|Intervention Period 4 (2 Days)||2
8185770|NCT02325713|20183983|P6|COMPLETED|Intervention Period 4 (2 Days)||2
8185771|NCT02325713|20183984|P5|COMPLETED|Intervention Period 4 (2 Days)||2
8185772|NCT02325713|20183985|P4|COMPLETED|Intervention Period 4 (2 Days)||2
8185773|NCT02325713|20183986|P3|COMPLETED|Intervention Period 4 (2 Days)||2
8185774|NCT02325713|20183987|P2|COMPLETED|Intervention Period 4 (2 Days)||2
8185775|NCT02325713|20183988|P1|COMPLETED|Intervention Period 4 (2 Days)||1
8185776|NCT02325713|20183973|P16|STARTED|Intervention Period 4 (2 Days)||2
8185777|NCT02325713|20183974|P15|STARTED|Intervention Period 4 (2 Days)||2
8185778|NCT02325713|20183975|P14|STARTED|Intervention Period 4 (2 Days)||2
8185779|NCT02325713|20183976|P13|STARTED|Intervention Period 4 (2 Days)||2
8185780|NCT02325713|20183977|P12|STARTED|Intervention Period 4 (2 Days)||2
8185781|NCT02325713|20183978|P11|STARTED|Intervention Period 4 (2 Days)||1
8185782|NCT02325713|20183979|P10|STARTED|Intervention Period 4 (2 Days)||1
8185783|NCT02325713|20183980|P9|STARTED|Intervention Period 4 (2 Days)||2
8185784|NCT02325713|20183981|P8|STARTED|Intervention Period 4 (2 Days)||2
8185785|NCT02325713|20183982|P7|STARTED|Intervention Period 4 (2 Days)||2
8185786|NCT02325713|20183983|P6|STARTED|Intervention Period 4 (2 Days)||2
8185787|NCT02325713|20183984|P5|STARTED|Intervention Period 4 (2 Days)||2
8185788|NCT02325713|20183985|P4|STARTED|Intervention Period 4 (2 Days)||2
8185789|NCT02325713|20183986|P3|STARTED|Intervention Period 4 (2 Days)||2
8185790|NCT02325713|20183987|P2|STARTED|Intervention Period 4 (2 Days)||2
8185791|NCT02325713|20183988|P1|STARTED|Intervention Period 4 (2 Days)||1
8185792|NCT02325713|20183973|P16|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185793|NCT02325713|20183974|P15|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185794|NCT02325713|20183975|P14|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185795|NCT02325713|20183976|P13|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185796|NCT02325713|20183977|P12|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185797|NCT02325713|20183978|P11|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185798|NCT02325713|20183979|P10|NOT COMPLETED|Intervention Period 3 (2 Days)||1
8185799|NCT02325713|20183980|P9|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185800|NCT02325713|20183981|P8|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185801|NCT02325713|20183982|P7|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185802|NCT02325713|20183983|P6|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185803|NCT02325713|20183984|P5|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185804|NCT02325713|20183985|P4|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185805|NCT02325713|20183986|P3|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185806|NCT02325713|20183987|P2|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185807|NCT02325713|20183988|P1|NOT COMPLETED|Intervention Period 3 (2 Days)||0
8185808|NCT02325713|20183973|P16|COMPLETED|Intervention Period 3 (2 Days)||2
8185809|NCT02325713|20183974|P15|COMPLETED|Intervention Period 3 (2 Days)||2
8185810|NCT02325713|20183975|P14|COMPLETED|Intervention Period 3 (2 Days)||2
8185811|NCT02325713|20183976|P13|COMPLETED|Intervention Period 3 (2 Days)||2
8185812|NCT02325713|20183977|P12|COMPLETED|Intervention Period 3 (2 Days)||2
8185813|NCT02325713|20183978|P11|COMPLETED|Intervention Period 3 (2 Days)||1
8185814|NCT02325713|20183979|P10|COMPLETED|Intervention Period 3 (2 Days)||1
8185815|NCT02325713|20183980|P9|COMPLETED|Intervention Period 3 (2 Days)||2
8185816|NCT02325713|20183981|P8|COMPLETED|Intervention Period 3 (2 Days)||2
8185817|NCT02325713|20183982|P7|COMPLETED|Intervention Period 3 (2 Days)||2
8185818|NCT02325713|20183983|P6|COMPLETED|Intervention Period 3 (2 Days)||2
8185819|NCT02325713|20183984|P5|COMPLETED|Intervention Period 3 (2 Days)||2
8185820|NCT02325713|20183985|P4|COMPLETED|Intervention Period 3 (2 Days)||2
8185821|NCT02325713|20183986|P3|COMPLETED|Intervention Period 3 (2 Days)||2
8185822|NCT02325713|20183987|P2|COMPLETED|Intervention Period 3 (2 Days)||2
8185823|NCT02325713|20183988|P1|COMPLETED|Intervention Period 3 (2 Days)||1
8185824|NCT02325713|20183973|P16|STARTED|Intervention Period 3 (2 Days)||2
8185825|NCT02325713|20183974|P15|STARTED|Intervention Period 3 (2 Days)||2
8185826|NCT02325713|20183975|P14|STARTED|Intervention Period 3 (2 Days)||2
8185827|NCT02325713|20183976|P13|STARTED|Intervention Period 3 (2 Days)||2
8185828|NCT02325713|20183977|P12|STARTED|Intervention Period 3 (2 Days)||2
8185829|NCT02325713|20183978|P11|STARTED|Intervention Period 3 (2 Days)||1
8185830|NCT02325713|20183979|P10|STARTED|Intervention Period 3 (2 Days)||2
8185831|NCT02325713|20183980|P9|STARTED|Intervention Period 3 (2 Days)||2
8185832|NCT02325713|20183981|P8|STARTED|Intervention Period 3 (2 Days)||2
8185833|NCT02325713|20183982|P7|STARTED|Intervention Period 3 (2 Days)||2
8185834|NCT02325713|20183983|P6|STARTED|Intervention Period 3 (2 Days)||2
8185835|NCT02325713|20183984|P5|STARTED|Intervention Period 3 (2 Days)||2
8185836|NCT02325713|20183985|P4|STARTED|Intervention Period 3 (2 Days)||2
8185837|NCT02325713|20183986|P3|STARTED|Intervention Period 3 (2 Days)||2
8185838|NCT02325713|20183987|P2|STARTED|Intervention Period 3 (2 Days)||2
8185839|NCT02325713|20183988|P1|STARTED|Intervention Period 3 (2 Days)||1
8185840|NCT02325713|20183973|P16|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185841|NCT02325713|20183974|P15|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185842|NCT02325713|20183975|P14|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185843|NCT02325713|20183976|P13|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185844|NCT02325713|20183977|P12|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185845|NCT02325713|20183978|P11|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185846|NCT02325713|20183979|P10|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185847|NCT02325713|20183980|P9|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185848|NCT02325713|20183981|P8|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185849|NCT02325713|20183982|P7|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185850|NCT02325713|20183983|P6|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185851|NCT02325713|20183984|P5|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185852|NCT02325713|20183985|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185853|NCT02325713|20183986|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185854|NCT02325713|20183987|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||0
8185855|NCT02325713|20183988|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
8185856|NCT02325713|20183973|P16|COMPLETED|Intervention Period 2 (2 Days)||2
8185857|NCT02325713|20183974|P15|COMPLETED|Intervention Period 2 (2 Days)||2
8185858|NCT02325713|20183975|P14|COMPLETED|Intervention Period 2 (2 Days)||2
8185859|NCT02325713|20183976|P13|COMPLETED|Intervention Period 2 (2 Days)||2
8185860|NCT02325713|20183977|P12|COMPLETED|Intervention Period 2 (2 Days)||2
8185861|NCT02325713|20183978|P11|COMPLETED|Intervention Period 2 (2 Days)||1
8185862|NCT02325713|20183979|P10|COMPLETED|Intervention Period 2 (2 Days)||2
8185863|NCT02325713|20183980|P9|COMPLETED|Intervention Period 2 (2 Days)||2
8185864|NCT02325713|20183981|P8|COMPLETED|Intervention Period 2 (2 Days)||2
8185865|NCT02325713|20183982|P7|COMPLETED|Intervention Period 2 (2 Days)||2
8185866|NCT02325713|20183983|P6|COMPLETED|Intervention Period 2 (2 Days)||2
8185867|NCT02325713|20183984|P5|COMPLETED|Intervention Period 2 (2 Days)||2
8185868|NCT02325713|20183985|P4|COMPLETED|Intervention Period 2 (2 Days)||2
8185869|NCT02325713|20183986|P3|COMPLETED|Intervention Period 2 (2 Days)||2
8185870|NCT02325713|20183987|P2|COMPLETED|Intervention Period 2 (2 Days)||2
8185871|NCT02325713|20183988|P1|COMPLETED|Intervention Period 2 (2 Days)||1
8185872|NCT02325713|20183973|P16|STARTED|Intervention Period 2 (2 Days)||2
8185873|NCT02325713|20183974|P15|STARTED|Intervention Period 2 (2 Days)||2
8185874|NCT02325713|20183975|P14|STARTED|Intervention Period 2 (2 Days)||2
8185875|NCT02325713|20183976|P13|STARTED|Intervention Period 2 (2 Days)||2
8185876|NCT02325713|20183977|P12|STARTED|Intervention Period 2 (2 Days)||2
8185877|NCT02325713|20183978|P11|STARTED|Intervention Period 2 (2 Days)||1
8185878|NCT02325713|20183979|P10|STARTED|Intervention Period 2 (2 Days)||2
8185879|NCT02325713|20183980|P9|STARTED|Intervention Period 2 (2 Days)||2
8185880|NCT02325713|20183981|P8|STARTED|Intervention Period 2 (2 Days)||2
8185881|NCT02325713|20183982|P7|STARTED|Intervention Period 2 (2 Days)||2
8185882|NCT02325713|20183983|P6|STARTED|Intervention Period 2 (2 Days)||2
8185883|NCT02325713|20183984|P5|STARTED|Intervention Period 2 (2 Days)||2
8185884|NCT02325713|20183985|P4|STARTED|Intervention Period 2 (2 Days)||2
8185885|NCT02325713|20183986|P3|STARTED|Intervention Period 2 (2 Days)||2
8185886|NCT02325713|20183987|P2|STARTED|Intervention Period 2 (2 Days)||2
8185887|NCT02325713|20183988|P1|STARTED|Intervention Period 2 (2 Days)||2
8185888|NCT02325713|20183973|P16|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185889|NCT02325713|20183974|P15|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185890|NCT02325713|20183975|P14|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185891|NCT02325713|20183976|P13|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185892|NCT02325713|20183977|P12|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185893|NCT02325713|20183978|P11|NOT COMPLETED|Intervention Period 1 (2 Days)||1
8185894|NCT02325713|20183979|P10|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185895|NCT02325713|20183980|P9|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185896|NCT02325713|20183981|P8|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185897|NCT02325713|20183982|P7|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185898|NCT02325713|20183983|P6|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185899|NCT02325713|20183984|P5|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185900|NCT02325713|20183985|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185901|NCT02325713|20183986|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185902|NCT02325713|20183987|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185903|NCT02325713|20183988|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
8185904|NCT02325713|20183973|P16|COMPLETED|Intervention Period 1 (2 Days)||2
8185905|NCT02325713|20183974|P15|COMPLETED|Intervention Period 1 (2 Days)||2
8185906|NCT02325713|20183975|P14|COMPLETED|Intervention Period 1 (2 Days)||2
8185907|NCT02325713|20183976|P13|COMPLETED|Intervention Period 1 (2 Days)||2
8185908|NCT02325713|20183977|P12|COMPLETED|Intervention Period 1 (2 Days)||2
8185909|NCT02325713|20183978|P11|COMPLETED|Intervention Period 1 (2 Days)||1
8185910|NCT02325713|20183979|P10|COMPLETED|Intervention Period 1 (2 Days)||2
8185911|NCT02325713|20183980|P9|COMPLETED|Intervention Period 1 (2 Days)||2
8185912|NCT02325713|20183981|P8|COMPLETED|Intervention Period 1 (2 Days)||2
8185913|NCT02325713|20183982|P7|COMPLETED|Intervention Period 1 (2 Days)||2
8185914|NCT02325713|20183983|P6|COMPLETED|Intervention Period 1 (2 Days)||2
8185915|NCT02325713|20183984|P5|COMPLETED|Intervention Period 1 (2 Days)||2
8185916|NCT02325713|20183985|P4|COMPLETED|Intervention Period 1 (2 Days)||2
8185917|NCT02325713|20183986|P3|COMPLETED|Intervention Period 1 (2 Days)||2
8185918|NCT02325713|20183987|P2|COMPLETED|Intervention Period 1 (2 Days)||2
8185919|NCT02325713|20183988|P1|COMPLETED|Intervention Period 1 (2 Days)||2
8185920|NCT02325713|20183973|P16|STARTED|Intervention Period 1 (2 Days)||2
8185921|NCT02325713|20183974|P15|STARTED|Intervention Period 1 (2 Days)||2
8185922|NCT02325713|20183975|P14|STARTED|Intervention Period 1 (2 Days)||2
8185923|NCT02325713|20183976|P13|STARTED|Intervention Period 1 (2 Days)||2
8185924|NCT02325713|20183977|P12|STARTED|Intervention Period 1 (2 Days)||2
8185925|NCT02325713|20183978|P11|STARTED|Intervention Period 1 (2 Days)||2
8185926|NCT02325713|20183979|P10|STARTED|Intervention Period 1 (2 Days)||2
8185927|NCT02325713|20183980|P9|STARTED|Intervention Period 1 (2 Days)||2
8185928|NCT02325713|20183981|P8|STARTED|Intervention Period 1 (2 Days)||2
8185929|NCT02325713|20183982|P7|STARTED|Intervention Period 1 (2 Days)||2
8185930|NCT02325713|20183983|P6|STARTED|Intervention Period 1 (2 Days)||2
8185931|NCT02325713|20183984|P5|STARTED|Intervention Period 1 (2 Days)||2
8185932|NCT02325713|20183985|P4|STARTED|Intervention Period 1 (2 Days)||2
8185933|NCT02325713|20183986|P3|STARTED|Intervention Period 1 (2 Days)||2
8185934|NCT02325713|20183987|P2|STARTED|Intervention Period 1 (2 Days)||2
8185935|NCT02325713|20183988|P1|STARTED|Intervention Period 1 (2 Days)||2
8185936|NCT02325687|20184084|P3|NOT COMPLETED|Overall Study||6
8185937|NCT02325687|20184085|P2|NOT COMPLETED|Overall Study||3
8185938|NCT02325687|20184086|P1|NOT COMPLETED|Overall Study||4
8185939|NCT02325687|20184084|P3|COMPLETED|Overall Study||13
8185940|NCT02325687|20184085|P2|COMPLETED|Overall Study||12
8185941|NCT02325687|20184086|P1|COMPLETED|Overall Study||12
8185942|NCT02325687|20184084|P3|STARTED|Overall Study||19
8185943|NCT02325687|20184085|P2|STARTED|Overall Study||15
8185944|NCT02325687|20184086|P1|STARTED|Overall Study||16
8185945|NCT02325518|20184102|P2|NOT COMPLETED|Overall Study||3
8185946|NCT02325518|20184103|P1|NOT COMPLETED|Overall Study||4
8185947|NCT02325518|20184102|P2|COMPLETED|Overall Study||100
8185948|NCT02325518|20184103|P1|COMPLETED|Overall Study||94
8185949|NCT02325518|20184102|P2|Per Protocol Set (PPS)|Overall Study||97
8185950|NCT02325518|20184103|P1|Per Protocol Set (PPS)|Overall Study||92
8185951|NCT02325518|20184102|P2|Full Analysis Set (FAS)|Overall Study||101
8185952|NCT02325518|20184103|P1|Full Analysis Set (FAS)|Overall Study||98
8185953|NCT02325518|20184102|P2|Safety Set|Overall Study||103
8185954|NCT02325518|20184103|P1|Safety Set|Overall Study||98
8185955|NCT02325518|20184102|P2|STARTED|Overall Study||103
8185956|NCT02325518|20184103|P1|STARTED|Overall Study||98
8185957|NCT02325401|20184112|P3|NOT COMPLETED|Overall Study||1
8185958|NCT02325401|20184113|P2|NOT COMPLETED|Overall Study||1
8185959|NCT02325401|20184114|P1|NOT COMPLETED|Overall Study||0
8185960|NCT02325401|20184112|P3|COMPLETED|Overall Study||4
8185961|NCT02325401|20184113|P2|COMPLETED|Overall Study||8
8185962|NCT02325401|20184114|P1|COMPLETED|Overall Study||6
8185963|NCT02325401|20184112|P3|STARTED|Overall Study||5
8185964|NCT02325401|20184113|P2|STARTED|Overall Study||9
8185965|NCT02325401|20184114|P1|STARTED|Overall Study||6
8185966|NCT02325219|20184137|P5|NOT COMPLETED|After Controlled Period (Week 16 - 52)||1
8185967|NCT02325219|20184138|P4|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
8185968|NCT02325219|20184139|P3|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
8185969|NCT02325219|20184140|P2|NOT COMPLETED|After Controlled Period (Week 16 - 52)||3
8185970|NCT02325219|20184141|P1|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
8185971|NCT02325219|20184137|P5|COMPLETED|After Controlled Period (Week 16 - 52)||25
8185972|NCT02325219|20184138|P4|COMPLETED|After Controlled Period (Week 16 - 52)||26
8185973|NCT02325219|20184139|P3|COMPLETED|After Controlled Period (Week 16 - 52)||62
8185974|NCT02325219|20184140|P2|COMPLETED|After Controlled Period (Week 16 - 52)||60
8185975|NCT02325219|20184141|P1|COMPLETED|After Controlled Period (Week 16 - 52)||0
8185976|NCT02325219|20184137|P5|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 100 mg.|26
8185977|NCT02325219|20184138|P4|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 50 mg.|26
8185978|NCT02325219|20184139|P3|STARTED|After Controlled Period (Week 16 - 52)||62
8185979|NCT02325219|20184140|P2|STARTED|After Controlled Period (Week 16 - 52)||63
8185980|NCT02325219|20184141|P1|STARTED|After Controlled Period (Week 16 - 52)||0
8185981|NCT02325219|20184137|P5|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
8185982|NCT02325219|20184138|P4|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
8185983|NCT02325219|20184139|P3|NOT COMPLETED|Controlled Period (Week 0 - 16)||1
8185984|NCT02325219|20184140|P2|NOT COMPLETED|Controlled Period (Week 0 - 16)||2
8185985|NCT02325219|20184141|P1|NOT COMPLETED|Controlled Period (Week 0 - 16)||12
8185986|NCT02325219|20184137|P5|COMPLETED|Controlled Period (Week 0 - 16)||0
8185987|NCT02325219|20184138|P4|COMPLETED|Controlled Period (Week 0 - 16)||0
8185988|NCT02325219|20184139|P3|COMPLETED|Controlled Period (Week 0 - 16)||62
8185989|NCT02325219|20184140|P2|COMPLETED|Controlled Period (Week 0 - 16)||63
8185990|NCT02325219|20184141|P1|COMPLETED|Controlled Period (Week 0 - 16)||52
8185991|NCT02325219|20184137|P5|STARTED|Controlled Period (Week 0 - 16)||0
8185992|NCT02325219|20184138|P4|STARTED|Controlled Period (Week 0 - 16)||0
8185993|NCT02325219|20184139|P3|STARTED|Controlled Period (Week 0 - 16)||63
8185994|NCT02325219|20184140|P2|STARTED|Controlled Period (Week 0 - 16)||65
8185995|NCT02325219|20184141|P1|STARTED|Controlled Period (Week 0 - 16)||64
8185996|NCT02324972|20184315|P2|NOT COMPLETED|Overall Study||5
8185997|NCT02324972|20184316|P1|NOT COMPLETED|Overall Study||7
8185998|NCT02324972|20184315|P2|COMPLETED|Overall Study||23
8185999|NCT02324972|20184316|P1|COMPLETED|Overall Study||19
8186000|NCT02324972|20184315|P2|STARTED|Overall Study||28
8186001|NCT02324972|20184316|P1|STARTED|Overall Study||26
8186002|NCT02324842|20184333|P3|NOT COMPLETED|Overall Study||2
8186003|NCT02324842|20184334|P2|NOT COMPLETED|Overall Study||1
8186004|NCT02324842|20184335|P1|NOT COMPLETED|Overall Study||1
8186005|NCT02324842|20184333|P3|COMPLETED|Overall Study||13
8186006|NCT02324842|20184334|P2|COMPLETED|Overall Study||14
8186007|NCT02324842|20184335|P1|COMPLETED|Overall Study||14
8186008|NCT02324842|20184333|P3|STARTED|Overall Study||15
8186009|NCT02324842|20184334|P2|STARTED|Overall Study||15
8186010|NCT02324842|20184335|P1|STARTED|Overall Study||15
8186011|NCT02324816|20184364|P1|NOT COMPLETED|Overall Study||0
8186012|NCT02324816|20184364|P1|COMPLETED|Overall Study||19
8186013|NCT02324816|20184364|P1|STARTED|Overall Study||19
8186014|NCT02324699|20184369|P1|NOT COMPLETED|Overall Study||1
8186015|NCT02324699|20184369|P1|COMPLETED|Overall Study||0
8186016|NCT02324699|20184369|P1|STARTED|Overall Study||1
8186017|NCT02324673|20184379|P3|NOT COMPLETED|Overall Study||0
8186018|NCT02324673|20184380|P2|NOT COMPLETED|Overall Study||0
8186019|NCT02324673|20184381|P1|NOT COMPLETED|Overall Study||0
8186020|NCT02324673|20184379|P3|COMPLETED|Overall Study||21
8186021|NCT02324673|20184380|P2|COMPLETED|Overall Study||20
8186022|NCT02324673|20184381|P1|COMPLETED|Overall Study||20
8186023|NCT02324673|20184379|P3|STARTED|Overall Study||21
8186024|NCT02324673|20184380|P2|STARTED|Overall Study||20
8186025|NCT02324673|20184381|P1|STARTED|Overall Study||20
8186026|NCT02324660|20184482|P1|NOT COMPLETED|Overall Study||32
8186027|NCT02324660|20184482|P1|COMPLETED|Overall Study||137
8186028|NCT02324660|20184482|P1|STARTED|Overall Study||169
8186029|NCT02324569|20184489|P2|NOT COMPLETED|Overall Study||21
8186030|NCT02324569|20184490|P1|NOT COMPLETED|Overall Study||16
8186031|NCT02324569|20184489|P2|COMPLETED|Overall Study||103
8186032|NCT02324569|20184490|P1|COMPLETED|Overall Study||100
8186033|NCT02324569|20184489|P2|STARTED|Overall Study||124
8186034|NCT02324569|20184490|P1|STARTED|Overall Study||116
8186056|NCT02324465|20184552|P2|NOT COMPLETED|Overall Study||1
8186057|NCT02324465|20184553|P1|NOT COMPLETED|Overall Study||0
8186058|NCT02324465|20184552|P2|COMPLETED|Overall Study||21
8186059|NCT02324465|20184553|P1|COMPLETED|Overall Study||18
8186060|NCT02324465|20184552|P2|STARTED|Overall Study||22
8186061|NCT02324465|20184553|P1|STARTED|Overall Study||18
8186062|NCT02324361|20184567|P2|NOT COMPLETED|Overall Study||2
8186063|NCT02324361|20184568|P1|NOT COMPLETED|Overall Study||5
8186064|NCT02324361|20184567|P2|COMPLETED|Overall Study||22
8186065|NCT02324361|20184568|P1|COMPLETED|Overall Study||19
8186066|NCT02324361|20184567|P2|STARTED|Overall Study||24
8186067|NCT02324361|20184568|P1|STARTED|Overall Study||24
8186068|NCT02324335|20184582|P2|NOT COMPLETED|Overall Study||9
8186069|NCT02324335|20184583|P1|NOT COMPLETED|Overall Study||9
8186070|NCT02324335|20184582|P2|COMPLETED|Overall Study||20
8186071|NCT02324335|20184583|P1|COMPLETED|Overall Study||21
8186072|NCT02324335|20184582|P2|STARTED|Overall Study||29
8186073|NCT02324335|20184583|P1|STARTED|Overall Study||30
8186074|NCT02324270|20184598|P3|NOT COMPLETED|Overall Study||5
8186075|NCT02324270|20184599|P2|NOT COMPLETED|Overall Study||7
8186076|NCT02324270|20184600|P1|NOT COMPLETED|Overall Study||5
8186077|NCT02324270|20184598|P3|COMPLETED|Overall Study||216
8186078|NCT02324270|20184599|P2|COMPLETED|Overall Study||212
8186079|NCT02324270|20184600|P1|COMPLETED|Overall Study||213
8186080|NCT02324270|20184598|P3|PP Population|Overall Study||171
8186081|NCT02324270|20184599|P2|PP Population|Overall Study||177
8186082|NCT02324270|20184600|P1|PP Population|Overall Study||180
8186083|NCT02324270|20184598|P3|mITT Population|Overall Study||217
8186084|NCT02324270|20184599|P2|mITT Population|Overall Study||216
8186085|NCT02324270|20184600|P1|mITT Population|Overall Study||214
8186086|NCT02324270|20184598|P3|Safety Population|Overall Study||217
8186087|NCT02324270|20184599|P2|Safety Population|Overall Study||216
8186088|NCT02324270|20184600|P1|Safety Population|Overall Study||214
8186089|NCT02324270|20184598|P3|STARTED|Overall Study||221
8186090|NCT02324270|20184599|P2|STARTED|Overall Study||219
8186091|NCT02324270|20184600|P1|STARTED|Overall Study||218
8186092|NCT02324205|20184610|P1|NOT COMPLETED|Overall Study||37
8186093|NCT02324205|20184610|P1|COMPLETED|Overall Study||159
8186094|NCT02324205|20184610|P1|STARTED|Overall Study||196
8186095|NCT02324153|20184622|P2|NOT COMPLETED|Overall Study||1
8186096|NCT02324153|20184623|P1|NOT COMPLETED|Overall Study||8
8186097|NCT02324153|20184622|P2|COMPLETED|Overall Study||38
8186098|NCT02324153|20184623|P1|COMPLETED|Overall Study||33
8186099|NCT02324153|20184622|P2|STARTED|Overall Study||39
8186100|NCT02324153|20184623|P1|STARTED|Overall Study||41
8186101|NCT02324075|20184635|P2|NOT COMPLETED|Overall Study||9
8186102|NCT02324075|20184636|P1|NOT COMPLETED|Overall Study||3
8186103|NCT02324075|20184635|P2|COMPLETED|Overall Study||605
8186104|NCT02324075|20184636|P1|COMPLETED|Overall Study||609
8186105|NCT02324075|20184635|P2|STARTED|Overall Study||614
8186106|NCT02324075|20184636|P1|STARTED|Overall Study||612
8186107|NCT02324049|20184668|P1|NOT COMPLETED|Part C||11
8186108|NCT02324049|20184668|P1|COMPLETED|Part C||0
8186109|NCT02324049|20184668|P1|Safety Analysis Set|Part C||11
8186110|NCT02324049|20184668|P1|STARTED|Part C||11
8186111|NCT02324049|20184668|P1|NOT COMPLETED|Part B||0
8186112|NCT02324049|20184668|P1|COMPLETED|Part B||11
8186113|NCT02324049|20184668|P1|Safety Analysis Set|Part B||11
8186114|NCT02324049|20184668|P1|STARTED|Part B||11
8186115|NCT02324049|20184668|P1|NOT COMPLETED|Part A||0
8186116|NCT02324049|20184668|P1|COMPLETED|Part A||11
8186117|NCT02324049|20184668|P1|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
8186118|NCT02324049|20184668|P1|STARTED|Part A||11
8186119|NCT02323854|20184672|P1|NOT COMPLETED|Overall Study||0
8186120|NCT02323854|20184672|P1|COMPLETED|Overall Study||15
8186121|NCT02323854|20184672|P1|STARTED|Overall Study||15
8186122|NCT02323646|20184681|P3|NOT COMPLETED|Treatment Course 2||3
8186123|NCT02323646|20184682|P2|NOT COMPLETED|Treatment Course 2||1
8186124|NCT02323646|20184683|P1|NOT COMPLETED|Treatment Course 2||1
8186125|NCT02323646|20184681|P3|COMPLETED|Treatment Course 2||9
8186126|NCT02323646|20184682|P2|COMPLETED|Treatment Course 2||9
8186127|NCT02323646|20184683|P1|COMPLETED|Treatment Course 2||10
8186128|NCT02323646|20184681|P3|STARTED|Treatment Course 2||12
8186129|NCT02323646|20184682|P2|STARTED|Treatment Course 2||10
8186130|NCT02323646|20184683|P1|STARTED|Treatment Course 2||11
8186131|NCT02323646|20184681|P3|NOT COMPLETED|Treatment Course 1||3
8186132|NCT02323646|20184682|P2|NOT COMPLETED|Treatment Course 1||3
8186133|NCT02323646|20184683|P1|NOT COMPLETED|Treatment Course 1||3
8186134|NCT02323646|20184681|P3|COMPLETED|Treatment Course 1||12
8186135|NCT02323646|20184682|P2|COMPLETED|Treatment Course 1||10
8186136|NCT02323646|20184683|P1|COMPLETED|Treatment Course 1||11
8186137|NCT02323646|20184681|P3|STARTED|Treatment Course 1||15
8186138|NCT02323646|20184682|P2|STARTED|Treatment Course 1||13
8186139|NCT02323646|20184683|P1|STARTED|Treatment Course 1||14
8186140|NCT02323204|20184731|P4|NOT COMPLETED|6-month Follow-up Survey Completion||44
8186141|NCT02323204|20184732|P3|NOT COMPLETED|6-month Follow-up Survey Completion||41
8186142|NCT02323204|20184733|P2|NOT COMPLETED|6-month Follow-up Survey Completion||50
8186143|NCT02323204|20184734|P1|NOT COMPLETED|6-month Follow-up Survey Completion||49
8186144|NCT02323204|20184731|P4|COMPLETED|6-month Follow-up Survey Completion||112
8186145|NCT02323204|20184732|P3|COMPLETED|6-month Follow-up Survey Completion||113
8186146|NCT02323204|20184733|P2|COMPLETED|6-month Follow-up Survey Completion||96
8186147|NCT02323204|20184734|P1|COMPLETED|6-month Follow-up Survey Completion||96
8186148|NCT02323204|20184731|P4|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
8186149|NCT02323204|20184732|P3|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
8186150|NCT02323204|20184733|P2|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
8186151|NCT02323204|20184734|P1|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
8186152|NCT02323204|20184731|P4|NOT COMPLETED|3-month Follow-up Survey Completion||44
8186153|NCT02323204|20184732|P3|NOT COMPLETED|3-month Follow-up Survey Completion||41
8186154|NCT02323204|20184733|P2|NOT COMPLETED|3-month Follow-up Survey Completion||47
8186155|NCT02323204|20184734|P1|NOT COMPLETED|3-month Follow-up Survey Completion||54
8186156|NCT02323204|20184731|P4|COMPLETED|3-month Follow-up Survey Completion||112
8186157|NCT02323204|20184732|P3|COMPLETED|3-month Follow-up Survey Completion||113
8186158|NCT02323204|20184733|P2|COMPLETED|3-month Follow-up Survey Completion||99
8186159|NCT02323204|20184734|P1|COMPLETED|3-month Follow-up Survey Completion||91
8186160|NCT02323204|20184731|P4|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
8186161|NCT02323204|20184732|P3|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
8186162|NCT02323204|20184733|P2|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
8186163|NCT02323204|20184734|P1|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
8186164|NCT02323204|20184731|P4|NOT COMPLETED|6-week Follow-up Intervention Booster||36
8186165|NCT02323204|20184732|P3|NOT COMPLETED|6-week Follow-up Intervention Booster||0
8186166|NCT02323204|20184733|P2|NOT COMPLETED|6-week Follow-up Intervention Booster||43
8186167|NCT02323204|20184734|P1|NOT COMPLETED|6-week Follow-up Intervention Booster||0
8186168|NCT02323204|20184731|P4|COMPLETED|6-week Follow-up Intervention Booster||120
8186169|NCT02323204|20184732|P3|COMPLETED|6-week Follow-up Intervention Booster||0
8186170|NCT02323204|20184733|P2|COMPLETED|6-week Follow-up Intervention Booster||103
8186171|NCT02323204|20184734|P1|COMPLETED|6-week Follow-up Intervention Booster||0
8186172|NCT02323204|20184731|P4|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156
8186173|NCT02323204|20184732|P3|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
8186174|NCT02323204|20184733|P2|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146
8186265|NCT02322788|20184877|P3|COMPLETED|Visit 6||15
8186175|NCT02323204|20184734|P1|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
8186176|NCT02323204|20184731|P4|NOT COMPLETED|6-week Follow-up Survey Completion||37
8186177|NCT02323204|20184732|P3|NOT COMPLETED|6-week Follow-up Survey Completion||42
8186178|NCT02323204|20184733|P2|NOT COMPLETED|6-week Follow-up Survey Completion||36
8186179|NCT02323204|20184734|P1|NOT COMPLETED|6-week Follow-up Survey Completion||41
8186180|NCT02323204|20184731|P4|COMPLETED|6-week Follow-up Survey Completion||119
8186181|NCT02323204|20184732|P3|COMPLETED|6-week Follow-up Survey Completion||112
8186182|NCT02323204|20184733|P2|COMPLETED|6-week Follow-up Survey Completion||110
8186183|NCT02323204|20184734|P1|COMPLETED|6-week Follow-up Survey Completion||104
8186184|NCT02323204|20184731|P4|STARTED|6-week Follow-up Survey Completion||156
8186185|NCT02323204|20184732|P3|STARTED|6-week Follow-up Survey Completion||154
8186186|NCT02323204|20184733|P2|STARTED|6-week Follow-up Survey Completion||146
8186187|NCT02323204|20184734|P1|STARTED|6-week Follow-up Survey Completion||145
8186188|NCT02323204|20184731|P4|NOT COMPLETED|Baseline Survey Completion||3
8186189|NCT02323204|20184732|P3|NOT COMPLETED|Baseline Survey Completion||5
8186190|NCT02323204|20184733|P2|NOT COMPLETED|Baseline Survey Completion||9
8186191|NCT02323204|20184734|P1|NOT COMPLETED|Baseline Survey Completion||10
8186192|NCT02323204|20184731|P4|COMPLETED|Baseline Survey Completion||156
8186193|NCT02323204|20184732|P3|COMPLETED|Baseline Survey Completion||154
8186194|NCT02323204|20184733|P2|COMPLETED|Baseline Survey Completion||146
8186195|NCT02323204|20184734|P1|COMPLETED|Baseline Survey Completion||145
8186196|NCT02323204|20184731|P4|STARTED|Baseline Survey Completion||159
8186197|NCT02323204|20184732|P3|STARTED|Baseline Survey Completion||159
8186198|NCT02323204|20184733|P2|STARTED|Baseline Survey Completion||155
8186199|NCT02323204|20184734|P1|STARTED|Baseline Survey Completion||155
8186200|NCT02323048|20184789|P5|NOT COMPLETED|Overall Study||0
8186201|NCT02323048|20184790|P4|NOT COMPLETED|Overall Study||0
8186202|NCT02323048|20184791|P3|NOT COMPLETED|Overall Study||0
8186203|NCT02323048|20184792|P2|NOT COMPLETED|Overall Study||2
8186204|NCT02323048|20184793|P1|NOT COMPLETED|Overall Study||1
8186205|NCT02323048|20184789|P5|COMPLETED|Overall Study||9
8186206|NCT02323048|20184790|P4|COMPLETED|Overall Study||7
8186207|NCT02323048|20184791|P3|COMPLETED|Overall Study||23
8186208|NCT02323048|20184792|P2|COMPLETED|Overall Study||24
8186209|NCT02323048|20184793|P1|COMPLETED|Overall Study||24
8186210|NCT02323048|20184789|P5|STARTED|Overall Study||9
8186211|NCT02323048|20184790|P4|STARTED|Overall Study||7
8186212|NCT02323048|20184791|P3|STARTED|Overall Study||23
8186213|NCT02323048|20184792|P2|STARTED|Overall Study||26
8186214|NCT02323048|20184793|P1|STARTED|Overall Study||25
8186215|NCT02322892|20184807|P2|NOT COMPLETED|Overall Study||3
8186216|NCT02322892|20184808|P1|NOT COMPLETED|Overall Study||2
8186217|NCT02322892|20184807|P2|COMPLETED|Overall Study|Received thiamine|31
8186218|NCT02322892|20184808|P1|COMPLETED|Overall Study|Received placebo|33
8186219|NCT02322892|20184807|P2|STARTED|Overall Study|Number randomized|34
8186220|NCT02322892|20184808|P1|STARTED|Overall Study|Number randomized|35
8186221|NCT02322879|20184824|P2|NOT COMPLETED|Second Intervention||0
8186222|NCT02322879|20184825|P1|NOT COMPLETED|Second Intervention||0
8186223|NCT02322879|20184824|P2|COMPLETED|Second Intervention||10
8186224|NCT02322879|20184825|P1|COMPLETED|Second Intervention||10
8186225|NCT02322879|20184824|P2|STARTED|Second Intervention||10
8186226|NCT02322879|20184825|P1|STARTED|Second Intervention||10
8186227|NCT02322879|20184824|P2|NOT COMPLETED|Washout||0
8186228|NCT02322879|20184825|P1|NOT COMPLETED|Washout||0
8186229|NCT02322879|20184824|P2|COMPLETED|Washout||10
8186230|NCT02322879|20184825|P1|COMPLETED|Washout||10
8186231|NCT02322879|20184824|P2|STARTED|Washout||10
8186232|NCT02322879|20184825|P1|STARTED|Washout||10
8186233|NCT02322879|20184824|P2|NOT COMPLETED|First Intervention||0
8186234|NCT02322879|20184825|P1|NOT COMPLETED|First Intervention||1
8186235|NCT02322879|20184824|P2|COMPLETED|First Intervention||10
8186236|NCT02322879|20184825|P1|COMPLETED|First Intervention||10
8186237|NCT02322879|20184824|P2|STARTED|First Intervention||10
8186238|NCT02322879|20184825|P1|STARTED|First Intervention||11
8186239|NCT02322866|20184833|P2|NOT COMPLETED|Overall Study||86
8186240|NCT02322866|20184834|P1|NOT COMPLETED|Overall Study||71
8186241|NCT02322866|20184833|P2|COMPLETED|Overall Study||433
8186242|NCT02322866|20184834|P1|COMPLETED|Overall Study||444
8186243|NCT02322866|20184833|P2|STARTED|Overall Study||519
8186244|NCT02322866|20184834|P1|STARTED|Overall Study||515
8186260|NCT02322788|20184876|P4|NOT COMPLETED|Visit 6||0
8186261|NCT02322788|20184877|P3|NOT COMPLETED|Visit 6||0
8186262|NCT02322788|20184878|P2|NOT COMPLETED|Visit 6||0
8186263|NCT02322788|20184879|P1|NOT COMPLETED|Visit 6||0
8186264|NCT02322788|20184876|P4|COMPLETED|Visit 6||15
8186266|NCT02322788|20184878|P2|COMPLETED|Visit 6||16
8186267|NCT02322788|20184879|P1|COMPLETED|Visit 6||14
8186268|NCT02322788|20184876|P4|STARTED|Visit 6||15
8186269|NCT02322788|20184877|P3|STARTED|Visit 6||15
8186270|NCT02322788|20184878|P2|STARTED|Visit 6||16
8186271|NCT02322788|20184879|P1|STARTED|Visit 6||14
8186272|NCT02322788|20184876|P4|NOT COMPLETED|Visit 5||0
8186273|NCT02322788|20184877|P3|NOT COMPLETED|Visit 5||0
8186274|NCT02322788|20184878|P2|NOT COMPLETED|Visit 5||0
8186275|NCT02322788|20184879|P1|NOT COMPLETED|Visit 5||0
8186276|NCT02322788|20184876|P4|COMPLETED|Visit 5||14
8186277|NCT02322788|20184877|P3|COMPLETED|Visit 5||15
8186278|NCT02322788|20184878|P2|COMPLETED|Visit 5||15
8186279|NCT02322788|20184879|P1|COMPLETED|Visit 5||16
8186280|NCT02322788|20184876|P4|STARTED|Visit 5||14
8186281|NCT02322788|20184877|P3|STARTED|Visit 5||15
8186282|NCT02322788|20184878|P2|STARTED|Visit 5||15
8186283|NCT02322788|20184879|P1|STARTED|Visit 5||16
8186284|NCT02322788|20184876|P4|NOT COMPLETED|Visit 4||0
8186285|NCT02322788|20184877|P3|NOT COMPLETED|Visit 4||0
8186286|NCT02322788|20184878|P2|NOT COMPLETED|Visit 4||0
8186287|NCT02322788|20184879|P1|NOT COMPLETED|Visit 4||0
8186288|NCT02322788|20184876|P4|COMPLETED|Visit 4||15
8186289|NCT02322788|20184877|P3|COMPLETED|Visit 4||16
8186290|NCT02322788|20184878|P2|COMPLETED|Visit 4||14
8186291|NCT02322788|20184879|P1|COMPLETED|Visit 4||15
8186292|NCT02322788|20184876|P4|STARTED|Visit 4||15
8186293|NCT02322788|20184877|P3|STARTED|Visit 4||16
8186294|NCT02322788|20184878|P2|STARTED|Visit 4||14
8186295|NCT02322788|20184879|P1|STARTED|Visit 4||15
8186296|NCT02322788|20184876|P4|NOT COMPLETED|Visit 3||0
8186297|NCT02322788|20184877|P3|NOT COMPLETED|Visit 3||0
8186298|NCT02322788|20184878|P2|NOT COMPLETED|Visit 3||0
8186299|NCT02322788|20184879|P1|NOT COMPLETED|Visit 3||0
8186300|NCT02322788|20184876|P4|COMPLETED|Visit 3||16
8186301|NCT02322788|20184877|P3|COMPLETED|Visit 3||14
8186302|NCT02322788|20184878|P2|COMPLETED|Visit 3||15
8186303|NCT02322788|20184879|P1|COMPLETED|Visit 3||15
8186304|NCT02322788|20184876|P4|STARTED|Visit 3||16
8186305|NCT02322788|20184877|P3|STARTED|Visit 3||14
8186306|NCT02322788|20184878|P2|STARTED|Visit 3||15
8186307|NCT02322788|20184879|P1|STARTED|Visit 3||15
8186308|NCT02322775|20184891|P2|NOT COMPLETED|Overall Study||6
8186309|NCT02322775|20184892|P1|NOT COMPLETED|Overall Study||5
8186310|NCT02322775|20184891|P2|COMPLETED|Overall Study||99
8186311|NCT02322775|20184892|P1|COMPLETED|Overall Study||101
8186312|NCT02322775|20184891|P2|STARTED|Overall Study||105
8186313|NCT02322775|20184892|P1|STARTED|Overall Study||106
8186314|NCT02322749|20184918|P6|NOT COMPLETED|Period 3||0
8186315|NCT02322749|20184919|P5|NOT COMPLETED|Period 3||0
8186316|NCT02322749|20184920|P4|NOT COMPLETED|Period 3||0
8186317|NCT02322749|20184921|P3|NOT COMPLETED|Period 3||1
8186318|NCT02322749|20184922|P2|NOT COMPLETED|Period 3||0
8186319|NCT02322749|20184923|P1|NOT COMPLETED|Period 3||0
8186320|NCT02322749|20184918|P6|COMPLETED|Period 3||8
8186321|NCT02322749|20184919|P5|COMPLETED|Period 3||8
8186322|NCT02322749|20184920|P4|COMPLETED|Period 3||6
8186323|NCT02322749|20184921|P3|COMPLETED|Period 3||7
8186324|NCT02322749|20184922|P2|COMPLETED|Period 3||8
8186325|NCT02322749|20184923|P1|COMPLETED|Period 3||8
8186326|NCT02322749|20184918|P6|STARTED|Period 3||8
8186327|NCT02322749|20184919|P5|STARTED|Period 3||8
8186328|NCT02322749|20184920|P4|STARTED|Period 3||6
8186329|NCT02322749|20184921|P3|STARTED|Period 3||8
8186330|NCT02322749|20184922|P2|STARTED|Period 3||8
8186331|NCT02322749|20184923|P1|STARTED|Period 3||8
8186332|NCT02322749|20184918|P6|NOT COMPLETED|Period 2||0
8186333|NCT02322749|20184919|P5|NOT COMPLETED|Period 2||0
8186334|NCT02322749|20184920|P4|NOT COMPLETED|Period 2||2
8186335|NCT02322749|20184921|P3|NOT COMPLETED|Period 2||0
8186336|NCT02322749|20184922|P2|NOT COMPLETED|Period 2||0
8186337|NCT02322749|20184923|P1|NOT COMPLETED|Period 2||0
8186338|NCT02322749|20184918|P6|COMPLETED|Period 2||8
8186339|NCT02322749|20184919|P5|COMPLETED|Period 2||8
8186340|NCT02322749|20184920|P4|COMPLETED|Period 2||6
8186341|NCT02322749|20184921|P3|COMPLETED|Period 2||8
8186342|NCT02322749|20184922|P2|COMPLETED|Period 2||8
8186343|NCT02322749|20184923|P1|COMPLETED|Period 2||8
8186344|NCT02322749|20184918|P6|STARTED|Period 2||8
8186345|NCT02322749|20184919|P5|STARTED|Period 2||8
8186346|NCT02322749|20184920|P4|STARTED|Period 2||8
8186347|NCT02322749|20184921|P3|STARTED|Period 2||8
8186348|NCT02322749|20184922|P2|STARTED|Period 2||8
8186349|NCT02322749|20184923|P1|STARTED|Period 2||8
8186350|NCT02322749|20184918|P6|NOT COMPLETED|Period 1||0
8186351|NCT02322749|20184919|P5|NOT COMPLETED|Period 1||0
8186352|NCT02322749|20184920|P4|NOT COMPLETED|Period 1||0
8186353|NCT02322749|20184921|P3|NOT COMPLETED|Period 1||0
8186354|NCT02322749|20184922|P2|NOT COMPLETED|Period 1||0
8186355|NCT02322749|20184923|P1|NOT COMPLETED|Period 1||0
8186356|NCT02322749|20184918|P6|COMPLETED|Period 1||8
8186357|NCT02322749|20184919|P5|COMPLETED|Period 1||8
8186358|NCT02322749|20184920|P4|COMPLETED|Period 1||8
8186359|NCT02322749|20184921|P3|COMPLETED|Period 1||8
8186360|NCT02322749|20184922|P2|COMPLETED|Period 1||8
8186361|NCT02322749|20184923|P1|COMPLETED|Period 1||8
8186362|NCT02322749|20184918|P6|STARTED|Period 1||8
8186363|NCT02322749|20184919|P5|STARTED|Period 1||8
8186364|NCT02322749|20184920|P4|STARTED|Period 1||8
8186365|NCT02322749|20184921|P3|STARTED|Period 1||8
8186366|NCT02322749|20184922|P2|STARTED|Period 1||8
8186367|NCT02322749|20184923|P1|STARTED|Period 1||8
8186368|NCT02322710|20184948|P2|NOT COMPLETED|Overall Study||26
8186369|NCT02322710|20184949|P1|NOT COMPLETED|Overall Study||20
8186370|NCT02322710|20184948|P2|COMPLETED|Overall Study||73
8186371|NCT02322710|20184949|P1|COMPLETED|Overall Study||85
8186372|NCT02322710|20184948|P2|Full Analysis Population|Overall Study||98
8186373|NCT02322710|20184949|P1|Full Analysis Population|Overall Study||105
8186374|NCT02322710|20184948|P2|Safety Population|Overall Study||99
8186375|NCT02322710|20184949|P1|Safety Population|Overall Study||105
8186376|NCT02322710|20184948|P2|STARTED|Overall Study||99
8186377|NCT02322710|20184949|P1|STARTED|Overall Study||105
8186378|NCT02322528|20184955|P1|NOT COMPLETED|Overall Study||0
8186379|NCT02322528|20184955|P1|COMPLETED|Overall Study||10
8186380|NCT02322528|20184955|P1|STARTED|Overall Study||10
8186381|NCT02322411|20184962|P2|NOT COMPLETED|Overall Study||7
8186382|NCT02322411|20184963|P1|NOT COMPLETED|Overall Study||5
8186383|NCT02322411|20184962|P2|COMPLETED|Overall Study||9
8186384|NCT02322411|20184963|P1|COMPLETED|Overall Study||9
8186385|NCT02322411|20184962|P2|All Baseline Measures Analyzed|Overall Study||16
8186386|NCT02322411|20184963|P1|All Baseline Measures Analyzed|Overall Study||13
8186387|NCT02322411|20184962|P2|Randomized|Overall Study||16
8186388|NCT02322411|20184963|P1|Randomized|Overall Study||14
8186389|NCT02322411|20184962|P2|STARTED|Overall Study||16
8186390|NCT02322411|20184963|P1|STARTED|Overall Study||14
8186391|NCT02322333|20184983|P2|NOT COMPLETED|Overall Study||16
8186392|NCT02322333|20184984|P1|NOT COMPLETED|Overall Study||17
8186393|NCT02322333|20184983|P2|COMPLETED|Overall Study||61
8186394|NCT02322333|20184984|P1|COMPLETED|Overall Study||63
8186395|NCT02322333|20184983|P2|STARTED|Overall Study||77
8186396|NCT02322333|20184984|P1|STARTED|Overall Study||80
8186397|NCT02322320|20185007|P3|NOT COMPLETED|Overall Study||0
8186398|NCT02322320|20185008|P2|NOT COMPLETED|Overall Study||0
8186399|NCT02322320|20185009|P1|NOT COMPLETED|Overall Study||0
8186400|NCT02322320|20185007|P3|COMPLETED|Overall Study||89
8186401|NCT02322320|20185008|P2|COMPLETED|Overall Study||86
8186402|NCT02322320|20185009|P1|COMPLETED|Overall Study||98
8186403|NCT02322320|20185007|P3|STARTED|Overall Study||89
8186404|NCT02322320|20185008|P2|STARTED|Overall Study||86
8186405|NCT02322320|20185009|P1|STARTED|Overall Study||98
8186406|NCT02322281|20185032|P3|NOT COMPLETED|Overall Study||74
8186407|NCT02322281|20185033|P2|NOT COMPLETED|Overall Study||22
8186408|NCT02322281|20185034|P1|NOT COMPLETED|Overall Study||53
8186409|NCT02322281|20185032|P3|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8186410|NCT02322281|20185033|P2|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8186411|NCT02322281|20185034|P1|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8186412|NCT02322281|20185032|P3|Crossed Over to Rociletinib 625 mg BID|Overall Study||3
8186413|NCT02322281|20185033|P2|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
8186414|NCT02322281|20185034|P1|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
8186415|NCT02322281|20185032|P3|Crossed Over to Rociletinib 500 mg BID|Overall Study||36
8186416|NCT02322281|20185033|P2|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
8186417|NCT02322281|20185034|P1|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
8186418|NCT02322281|20185032|P3|STARTED|Overall Study||74
8186419|NCT02322281|20185033|P2|STARTED|Overall Study||22
8186420|NCT02322281|20185034|P1|STARTED|Overall Study||53
8186421|NCT02322242|20185057|P2|NOT COMPLETED|Overall Study||0
8186422|NCT02322242|20185058|P1|NOT COMPLETED|Overall Study||0
8186423|NCT02322242|20185057|P2|COMPLETED|Overall Study||90
8186424|NCT02322242|20185058|P1|COMPLETED|Overall Study||92
8186425|NCT02322242|20185057|P2|1 Week Follow-up|Overall Study|1 lost to follow-up for secondary outcomes|89
8186426|NCT02322242|20185058|P1|1 Week Follow-up|Overall Study|2 lost to follow-up for secondary outcomes|90
8186427|NCT02322242|20185057|P2|Primary Outcome|Overall Study||90
8186428|NCT02322242|20185058|P1|Primary Outcome|Overall Study||92
8186429|NCT02322242|20185057|P2|STARTED|Overall Study||90
8186430|NCT02322242|20185058|P1|STARTED|Overall Study||92
8186431|NCT02322229|20185082|P1|NOT COMPLETED|Overall Study||2
8186432|NCT02322229|20185082|P1|COMPLETED|Overall Study||50
8186433|NCT02322229|20185082|P1|STARTED|Overall Study||52
8186434|NCT02322216|20185094|P2|NOT COMPLETED|Overall Study||4
8186435|NCT02322216|20185095|P1|NOT COMPLETED|Overall Study||2
8186436|NCT02322216|20185094|P2|COMPLETED|Overall Study||123
8186437|NCT02322216|20185095|P1|COMPLETED|Overall Study||124
8186438|NCT02322216|20185094|P2|Per Protocol Set (PPS)|Overall Study||122
8186439|NCT02322216|20185095|P1|Per Protocol Set (PPS)|Overall Study||123
8186440|NCT02322216|20185094|P2|Treated (Safety Set)|Overall Study||126
8186441|NCT02322216|20185095|P1|Treated (Safety Set)|Overall Study||126
8186442|NCT02322216|20185094|P2|STARTED|Overall Study||127
8186443|NCT02322216|20185095|P1|STARTED|Overall Study||126
8186444|NCT02322190|20185102|P2|NOT COMPLETED|Overall Study||0
8186445|NCT02322190|20185103|P1|NOT COMPLETED|Overall Study||1
8186446|NCT02322190|20185102|P2|COMPLETED|Overall Study||0
8186447|NCT02322190|20185103|P1|COMPLETED|Overall Study||4
8186448|NCT02322190|20185102|P2|STARTED|Overall Study||0
8186449|NCT02322190|20185103|P1|STARTED|Overall Study||5
8186450|NCT02322047|20185115|P4|NOT COMPLETED|Overall Study||2
8186451|NCT02322047|20185116|P3|NOT COMPLETED|Overall Study||1
8186452|NCT02322047|20185117|P2|NOT COMPLETED|Overall Study||1
8186453|NCT02322047|20185118|P1|NOT COMPLETED|Overall Study||2
8186454|NCT02322047|20185115|P4|COMPLETED|Overall Study||7
8186455|NCT02322047|20185116|P3|COMPLETED|Overall Study||6
8186456|NCT02322047|20185117|P2|COMPLETED|Overall Study||6
8186457|NCT02322047|20185118|P1|COMPLETED|Overall Study||6
8186458|NCT02322047|20185115|P4|STARTED|Overall Study||9
8186459|NCT02322047|20185116|P3|STARTED|Overall Study||7
8186460|NCT02322047|20185117|P2|STARTED|Overall Study||7
8186461|NCT02322047|20185118|P1|STARTED|Overall Study||8
8186462|NCT02321930|20185140|P1|NOT COMPLETED|Overall Study||1
8186463|NCT02321930|20185140|P1|COMPLETED|Overall Study||24
8186464|NCT02321930|20185140|P1|STARTED|Overall Study||25
8186465|NCT02321800|20185150|P2|NOT COMPLETED|Overall Study||11
8186466|NCT02321800|20185151|P1|NOT COMPLETED|Overall Study||20
8186467|NCT02321800|20185150|P2|COMPLETED|Overall Study||138
8186468|NCT02321800|20185151|P1|COMPLETED|Overall Study||283
8186469|NCT02321800|20185150|P2|Received Study Drug|Overall Study||148
8186470|NCT02321800|20185151|P1|Received Study Drug|Overall Study||300
8186471|NCT02321800|20185150|P2|STARTED|Overall Study||149
8186472|NCT02321800|20185151|P1|STARTED|Overall Study||303
8186473|NCT02321748|20185201|P2|NOT COMPLETED|Overall Study||0
8186474|NCT02321748|20185202|P1|NOT COMPLETED|Overall Study||0
8186475|NCT02321748|20185201|P2|COMPLETED|Overall Study||12
8186476|NCT02321748|20185202|P1|COMPLETED|Overall Study||12
8186477|NCT02321748|20185201|P2|Second Intervention (4 Days)|Overall Study||12
8186478|NCT02321748|20185202|P1|Second Intervention (4 Days)|Overall Study||12
8186479|NCT02321748|20185201|P2|Wasout (2weeks)|Overall Study||12
8186480|NCT02321748|20185202|P1|Wasout (2weeks)|Overall Study||12
8186481|NCT02321748|20185201|P2|First Intervention (4 Days)|Overall Study||12
8186482|NCT02321748|20185202|P1|First Intervention (4 Days)|Overall Study||12
8186483|NCT02321748|20185201|P2|STARTED|Overall Study||12
8186484|NCT02321748|20185202|P1|STARTED|Overall Study||12
8186485|NCT02321527|20185234|P1|NOT COMPLETED|Overall Study||1
8186486|NCT02321527|20185234|P1|COMPLETED|Overall Study||20
8186487|NCT02321527|20185234|P1|STARTED|Overall Study||21
8186488|NCT02321462|20185240|P2|NOT COMPLETED|Overall Study||3
8186489|NCT02321462|20185241|P1|NOT COMPLETED|Overall Study||6
8186490|NCT02321462|20185240|P2|COMPLETED|Overall Study||146
8186491|NCT02321462|20185241|P1|COMPLETED|Overall Study||141
8186492|NCT02321462|20185240|P2|Safety Population|Overall Study||147
8186493|NCT02321462|20185241|P1|Safety Population|Overall Study||147
8186494|NCT02321462|20185240|P2|Treated Patients|Overall Study||147
8186495|NCT02321462|20185241|P1|Treated Patients|Overall Study||147
8186496|NCT02321462|20185240|P2|ITT Population|Overall Study||148
8186497|NCT02321462|20185241|P1|ITT Population|Overall Study||146
8186498|NCT02321462|20185240|P2|STARTED|Overall Study||149
8186499|NCT02321462|20185241|P1|STARTED|Overall Study||147
8186500|NCT02321436|20185263|P2|NOT COMPLETED|Overall Study||1
8186501|NCT02321436|20185264|P1|NOT COMPLETED|Overall Study||1
8186502|NCT02321436|20185263|P2|COMPLETED|Overall Study||13
8186503|NCT02321436|20185264|P1|COMPLETED|Overall Study||27
8186504|NCT02321436|20185263|P2|STARTED|Overall Study||14
8186505|NCT02321436|20185264|P1|STARTED|Overall Study||28
8186506|NCT02321319|20185280|P1|NOT COMPLETED|Overall Study||5
8186507|NCT02321319|20185280|P1|COMPLETED|Overall Study||0
8186508|NCT02321319|20185280|P1|STARTED|Overall Study||5
8186509|NCT02321111|20185284|P6|NOT COMPLETED|Infusion3||0
8186510|NCT02321111|20185285|P5|NOT COMPLETED|Infusion3||0
8186511|NCT02321111|20185286|P4|NOT COMPLETED|Infusion3||0
8186512|NCT02321111|20185287|P3|NOT COMPLETED|Infusion3||0
8186513|NCT02321111|20185288|P2|NOT COMPLETED|Infusion3||0
8186514|NCT02321111|20185289|P1|NOT COMPLETED|Infusion3||0
8186515|NCT02321111|20185284|P6|COMPLETED|Infusion3||0
8186516|NCT02321111|20185285|P5|COMPLETED|Infusion3||0
8186517|NCT02321111|20185286|P4|COMPLETED|Infusion3||1
8186518|NCT02321111|20185287|P3|COMPLETED|Infusion3||4
8186519|NCT02321111|20185288|P2|COMPLETED|Infusion3||4
8186520|NCT02321111|20185289|P1|COMPLETED|Infusion3||1
8186521|NCT02321111|20185284|P6|STARTED|Infusion3||0
8186522|NCT02321111|20185285|P5|STARTED|Infusion3||0
8186523|NCT02321111|20185286|P4|STARTED|Infusion3||1
8186524|NCT02321111|20185287|P3|STARTED|Infusion3||4
8186525|NCT02321111|20185288|P2|STARTED|Infusion3||4
8186526|NCT02321111|20185289|P1|STARTED|Infusion3||1
8186527|NCT02321111|20185284|P6|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186528|NCT02321111|20185285|P5|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186529|NCT02321111|20185286|P4|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186530|NCT02321111|20185287|P3|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186531|NCT02321111|20185288|P2|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186532|NCT02321111|20185289|P1|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186533|NCT02321111|20185284|P6|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186534|NCT02321111|20185285|P5|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
8186535|NCT02321111|20185286|P4|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
8186536|NCT02321111|20185287|P3|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
8186537|NCT02321111|20185288|P2|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
8186538|NCT02321111|20185289|P1|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
8186539|NCT02321111|20185284|P6|STARTED|Washout2 (3-4weeks Between Infusions)||0
8186540|NCT02321111|20185285|P5|STARTED|Washout2 (3-4weeks Between Infusions)||0
8186541|NCT02321111|20185286|P4|STARTED|Washout2 (3-4weeks Between Infusions)||1
8186542|NCT02321111|20185287|P3|STARTED|Washout2 (3-4weeks Between Infusions)||4
8186543|NCT02321111|20185288|P2|STARTED|Washout2 (3-4weeks Between Infusions)||4
8186544|NCT02321111|20185289|P1|STARTED|Washout2 (3-4weeks Between Infusions)||1
8186545|NCT02321111|20185284|P6|NOT COMPLETED|Infusion2||0
8186546|NCT02321111|20185285|P5|NOT COMPLETED|Infusion2||0
8186547|NCT02321111|20185286|P4|NOT COMPLETED|Infusion2||0
8186548|NCT02321111|20185287|P3|NOT COMPLETED|Infusion2||0
8186549|NCT02321111|20185288|P2|NOT COMPLETED|Infusion2||0
8186550|NCT02321111|20185289|P1|NOT COMPLETED|Infusion2||0
8186551|NCT02321111|20185284|P6|COMPLETED|Infusion2||0
8186552|NCT02321111|20185285|P5|COMPLETED|Infusion2||0
8186553|NCT02321111|20185286|P4|COMPLETED|Infusion2||1
8186554|NCT02321111|20185287|P3|COMPLETED|Infusion2||4
8186555|NCT02321111|20185288|P2|COMPLETED|Infusion2||4
8186556|NCT02321111|20185289|P1|COMPLETED|Infusion2||1
8186557|NCT02321111|20185284|P6|STARTED|Infusion2||0
8186558|NCT02321111|20185285|P5|STARTED|Infusion2||0
8186559|NCT02321111|20185286|P4|STARTED|Infusion2||1
8186560|NCT02321111|20185287|P3|STARTED|Infusion2||4
8186561|NCT02321111|20185288|P2|STARTED|Infusion2||4
8186562|NCT02321111|20185289|P1|STARTED|Infusion2||1
8186563|NCT02321111|20185284|P6|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186564|NCT02321111|20185285|P5|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186565|NCT02321111|20185286|P4|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186566|NCT02321111|20185287|P3|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186567|NCT02321111|20185288|P2|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186568|NCT02321111|20185289|P1|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186569|NCT02321111|20185284|P6|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186570|NCT02321111|20185285|P5|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
8186571|NCT02321111|20185286|P4|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
8186572|NCT02321111|20185287|P3|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
8186573|NCT02321111|20185288|P2|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
8186574|NCT02321111|20185289|P1|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
8186575|NCT02321111|20185284|P6|STARTED|Washout1 (3-4weeks Between Infusions)||0
8186576|NCT02321111|20185285|P5|STARTED|Washout1 (3-4weeks Between Infusions)||0
8186577|NCT02321111|20185286|P4|STARTED|Washout1 (3-4weeks Between Infusions)||1
8186578|NCT02321111|20185287|P3|STARTED|Washout1 (3-4weeks Between Infusions)||4
8186579|NCT02321111|20185288|P2|STARTED|Washout1 (3-4weeks Between Infusions)||4
8186580|NCT02321111|20185289|P1|STARTED|Washout1 (3-4weeks Between Infusions)||1
8186581|NCT02321111|20185284|P6|NOT COMPLETED|Infusion1||0
8186582|NCT02321111|20185285|P5|NOT COMPLETED|Infusion1||0
8186583|NCT02321111|20185286|P4|NOT COMPLETED|Infusion1||0
8186584|NCT02321111|20185287|P3|NOT COMPLETED|Infusion1||0
8186585|NCT02321111|20185288|P2|NOT COMPLETED|Infusion1||0
8186586|NCT02321111|20185289|P1|NOT COMPLETED|Infusion1||0
8186587|NCT02321111|20185284|P6|COMPLETED|Infusion1||0
8186588|NCT02321111|20185285|P5|COMPLETED|Infusion1||0
8186589|NCT02321111|20185286|P4|COMPLETED|Infusion1||1
8186590|NCT02321111|20185287|P3|COMPLETED|Infusion1||4
8186591|NCT02321111|20185288|P2|COMPLETED|Infusion1||4
8186592|NCT02321111|20185289|P1|COMPLETED|Infusion1||1
8186593|NCT02321111|20185284|P6|STARTED|Infusion1||0
8186594|NCT02321111|20185285|P5|STARTED|Infusion1||0
8186595|NCT02321111|20185286|P4|STARTED|Infusion1||1
8186596|NCT02321111|20185287|P3|STARTED|Infusion1||4
8186597|NCT02321111|20185288|P2|STARTED|Infusion1||4
8186598|NCT02321111|20185289|P1|STARTED|Infusion1||1
8186599|NCT02321098|20185312|P3|NOT COMPLETED|Additional 15 Months Treatment||8
8186600|NCT02321098|20185313|P2|NOT COMPLETED|Additional 15 Months Treatment||0
8186601|NCT02321098|20185314|P1|NOT COMPLETED|Additional 15 Months Treatment||0
8186602|NCT02321098|20185312|P3|COMPLETED|Additional 15 Months Treatment||21
8186603|NCT02321098|20185313|P2|COMPLETED|Additional 15 Months Treatment||0
8186604|NCT02321098|20185314|P1|COMPLETED|Additional 15 Months Treatment||0
8186605|NCT02321098|20185312|P3|STARTED|Additional 15 Months Treatment||29
8186606|NCT02321098|20185313|P2|STARTED|Additional 15 Months Treatment||0
8186607|NCT02321098|20185314|P1|STARTED|Additional 15 Months Treatment||0
8186608|NCT02321098|20185312|P3|NOT COMPLETED|12 Weeks Treament||0
8186609|NCT02321098|20185313|P2|NOT COMPLETED|12 Weeks Treament||1
8186610|NCT02321098|20185314|P1|NOT COMPLETED|12 Weeks Treament||1
8186611|NCT02321098|20185312|P3|COMPLETED|12 Weeks Treament||0
8186612|NCT02321098|20185313|P2|COMPLETED|12 Weeks Treament||23
8186613|NCT02321098|20185314|P1|COMPLETED|12 Weeks Treament||25
8186614|NCT02321098|20185312|P3|STARTED|12 Weeks Treament||0
8186615|NCT02321098|20185313|P2|STARTED|12 Weeks Treament||24
8186616|NCT02321098|20185314|P1|STARTED|12 Weeks Treament||26
8186617|NCT02320903|20185326|P3|NOT COMPLETED|Overall Study||16
8186618|NCT02320903|20185327|P2|NOT COMPLETED|Overall Study||16
8186619|NCT02320903|20185328|P1|NOT COMPLETED|Overall Study||8
8186620|NCT02320903|20185326|P3|COMPLETED|Overall Study||16
8186621|NCT02320903|20185327|P2|COMPLETED|Overall Study||16
8186622|NCT02320903|20185328|P1|COMPLETED|Overall Study||16
8186623|NCT02320903|20185326|P3|STARTED|Overall Study||32
8186624|NCT02320903|20185327|P2|STARTED|Overall Study||32
8186625|NCT02320903|20185328|P1|STARTED|Overall Study||24
8186626|NCT02320838|20185361|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8186627|NCT02320838|20185362|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8186628|NCT02320838|20185363|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8186629|NCT02320838|20185364|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8186630|NCT02320838|20185365|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8186631|NCT02320838|20185361|P5|COMPLETED|Third Intervention (1 Day)||7
8186632|NCT02320838|20185362|P4|COMPLETED|Third Intervention (1 Day)||7
8186633|NCT02320838|20185363|P3|COMPLETED|Third Intervention (1 Day)||8
8186634|NCT02320838|20185364|P2|COMPLETED|Third Intervention (1 Day)||8
8186635|NCT02320838|20185365|P1|COMPLETED|Third Intervention (1 Day)||8
8186636|NCT02320838|20185361|P5|STARTED|Third Intervention (1 Day)||7
8186637|NCT02320838|20185362|P4|STARTED|Third Intervention (1 Day)||7
8186638|NCT02320838|20185363|P3|STARTED|Third Intervention (1 Day)||8
8186639|NCT02320838|20185364|P2|STARTED|Third Intervention (1 Day)||8
8186640|NCT02320838|20185365|P1|STARTED|Third Intervention (1 Day)||8
8186641|NCT02320838|20185361|P5|NOT COMPLETED|Washout (1 Day)||0
8186642|NCT02320838|20185362|P4|NOT COMPLETED|Washout (1 Day)||0
8186643|NCT02320838|20185363|P3|NOT COMPLETED|Washout (1 Day)||0
8186644|NCT02320838|20185364|P2|NOT COMPLETED|Washout (1 Day)||0
8186645|NCT02320838|20185365|P1|NOT COMPLETED|Washout (1 Day)||0
8186646|NCT02320838|20185361|P5|COMPLETED|Washout (1 Day)||7
8186647|NCT02320838|20185362|P4|COMPLETED|Washout (1 Day)||7
8186648|NCT02320838|20185363|P3|COMPLETED|Washout (1 Day)||8
8186649|NCT02320838|20185364|P2|COMPLETED|Washout (1 Day)||8
8186650|NCT02320838|20185365|P1|COMPLETED|Washout (1 Day)||8
8186651|NCT02320838|20185361|P5|STARTED|Washout (1 Day)||7
8186652|NCT02320838|20185362|P4|STARTED|Washout (1 Day)||7
8186653|NCT02320838|20185363|P3|STARTED|Washout (1 Day)||8
8186654|NCT02320838|20185364|P2|STARTED|Washout (1 Day)||8
8186655|NCT02320838|20185365|P1|STARTED|Washout (1 Day)||8
8186656|NCT02320838|20185361|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8186657|NCT02320838|20185362|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8186658|NCT02320838|20185363|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8186659|NCT02320838|20185364|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8186660|NCT02320838|20185365|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8186661|NCT02320838|20185361|P5|COMPLETED|Second Intervention (1 Day)||7
8186662|NCT02320838|20185362|P4|COMPLETED|Second Intervention (1 Day)||7
8186663|NCT02320838|20185363|P3|COMPLETED|Second Intervention (1 Day)||8
8186664|NCT02320838|20185364|P2|COMPLETED|Second Intervention (1 Day)||8
8186665|NCT02320838|20185365|P1|COMPLETED|Second Intervention (1 Day)||8
8186666|NCT02320838|20185361|P5|STARTED|Second Intervention (1 Day)||7
8186667|NCT02320838|20185362|P4|STARTED|Second Intervention (1 Day)||7
8186668|NCT02320838|20185363|P3|STARTED|Second Intervention (1 Day)||8
8186669|NCT02320838|20185364|P2|STARTED|Second Intervention (1 Day)||8
8186670|NCT02320838|20185365|P1|STARTED|Second Intervention (1 Day)||8
8186671|NCT02320838|20185361|P5|NOT COMPLETED|Washout (1 Day)||0
8186672|NCT02320838|20185362|P4|NOT COMPLETED|Washout (1 Day)||0
8186673|NCT02320838|20185363|P3|NOT COMPLETED|Washout (1 Day)||0
8186674|NCT02320838|20185364|P2|NOT COMPLETED|Washout (1 Day)||0
8186675|NCT02320838|20185365|P1|NOT COMPLETED|Washout (1 Day)||0
8186676|NCT02320838|20185361|P5|COMPLETED|Washout (1 Day)||7
8186677|NCT02320838|20185362|P4|COMPLETED|Washout (1 Day)||7
8186678|NCT02320838|20185363|P3|COMPLETED|Washout (1 Day)||8
8186679|NCT02320838|20185364|P2|COMPLETED|Washout (1 Day)||8
8186680|NCT02320838|20185365|P1|COMPLETED|Washout (1 Day)||8
8186681|NCT02320838|20185361|P5|STARTED|Washout (1 Day)||7
8186682|NCT02320838|20185362|P4|STARTED|Washout (1 Day)||7
8186683|NCT02320838|20185363|P3|STARTED|Washout (1 Day)||8
8186684|NCT02320838|20185364|P2|STARTED|Washout (1 Day)||8
8186685|NCT02320838|20185365|P1|STARTED|Washout (1 Day)||8
8186686|NCT02320838|20185361|P5|NOT COMPLETED|First Intervention (1 Day)||0
8186687|NCT02320838|20185362|P4|NOT COMPLETED|First Intervention (1 Day)||0
8186688|NCT02320838|20185363|P3|NOT COMPLETED|First Intervention (1 Day)||0
8186689|NCT02320838|20185364|P2|NOT COMPLETED|First Intervention (1 Day)||0
8186690|NCT02320838|20185365|P1|NOT COMPLETED|First Intervention (1 Day)||0
8186691|NCT02320838|20185361|P5|COMPLETED|First Intervention (1 Day)||7
8186692|NCT02320838|20185362|P4|COMPLETED|First Intervention (1 Day)||7
8186693|NCT02320838|20185363|P3|COMPLETED|First Intervention (1 Day)||8
8186694|NCT02320838|20185364|P2|COMPLETED|First Intervention (1 Day)||8
8186695|NCT02320838|20185365|P1|COMPLETED|First Intervention (1 Day)||8
8186696|NCT02320838|20185361|P5|STARTED|First Intervention (1 Day)||7
8186697|NCT02320838|20185362|P4|STARTED|First Intervention (1 Day)||7
8186698|NCT02320838|20185363|P3|STARTED|First Intervention (1 Day)||8
8186699|NCT02320838|20185364|P2|STARTED|First Intervention (1 Day)||8
8186700|NCT02320838|20185365|P1|STARTED|First Intervention (1 Day)||8
8186701|NCT02320825|20185432|P2|NOT COMPLETED|Overall Study||0
8186702|NCT02320825|20185433|P1|NOT COMPLETED|Overall Study||0
8186703|NCT02320825|20185432|P2|COMPLETED|Overall Study||8
8186704|NCT02320825|20185433|P1|COMPLETED|Overall Study||8
8186705|NCT02320825|20185432|P2|STARTED|Overall Study||8
8186706|NCT02320825|20185433|P1|STARTED|Overall Study||8
8186707|NCT02320812|20185443|P1|NOT COMPLETED|Overall Study||0
8186708|NCT02320812|20185443|P1|COMPLETED|Overall Study||28
8186709|NCT02320812|20185443|P1|STARTED|Overall Study||28
8186710|NCT02320721|20185453|P2|NOT COMPLETED|Overall Study||34
8186711|NCT02320721|20185454|P1|NOT COMPLETED|Overall Study||27
8186712|NCT02320721|20185453|P2|COMPLETED|Overall Study||472
8186713|NCT02320721|20185454|P1|COMPLETED|Overall Study||481
8186714|NCT02320721|20185453|P2|Treated (Safety Population)|Overall Study||505
8186715|NCT02320721|20185454|P1|Treated (Safety Population)|Overall Study||508
8186716|NCT02320721|20185453|P2|STARTED|Overall Study||506
8186717|NCT02320721|20185454|P1|STARTED|Overall Study||508
8186718|NCT02320695|20185482|P1|NOT COMPLETED|Overall Study||0
8186719|NCT02320695|20185482|P1|COMPLETED|Overall Study||60
8186720|NCT02320695|20185482|P1|Pain Relief Ointment|Overall Study||60
8186721|NCT02320695|20185482|P1|Original Ointment|Overall Study||60
8186722|NCT02320695|20185482|P1|Antibiotic/Pain Relieving Ointment|Overall Study||60
8186723|NCT02320695|20185482|P1|Pain Relieving Cream|Overall Study||59
8186724|NCT02320695|20185482|P1|Alcohol|Overall Study||60
8186725|NCT02320695|20185482|P1|Saline|Overall Study||60
8186726|NCT02320695|20185482|P1|STARTED|Overall Study||60
8186727|NCT02320487|20185509|P1|NOT COMPLETED|Overall Study||21
8186821|NCT02319668|20185823|P2|COMPLETED|Overall Study||17
8186728|NCT02320487|20185509|P1|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
8186729|NCT02320487|20185509|P1|STARTED|Overall Study||102
8186730|NCT02320396|20185529|P2|NOT COMPLETED|Overall Study||4
8186731|NCT02320396|20185530|P1|NOT COMPLETED|Overall Study||4
8186732|NCT02320396|20185529|P2|COMPLETED|Overall Study||221
8186733|NCT02320396|20185530|P1|COMPLETED|Overall Study||220
8186734|NCT02320396|20185529|P2|Treated (Full Analysis Set)|Overall Study||225
8186735|NCT02320396|20185530|P1|Treated (Full Analysis Set)|Overall Study||223
8186736|NCT02320396|20185529|P2|STARTED|Overall Study||225
8186737|NCT02320396|20185530|P1|STARTED|Overall Study||224
8186738|NCT02320227|20185560|P1|NOT COMPLETED|Overall Study||0
8186739|NCT02320227|20185560|P1|COMPLETED|Overall Study||30
8186740|NCT02320227|20185560|P1|STARTED|Overall Study||30
8186741|NCT02320214|20185565|P1|NOT COMPLETED|Overall Study||0
8186742|NCT02320214|20185565|P1|COMPLETED|Overall Study||30
8186743|NCT02320214|20185565|P1|STARTED|Overall Study||30
8186744|NCT02320175|20185572|P2|NOT COMPLETED|Overall Study||0
8186745|NCT02320175|20185573|P1|NOT COMPLETED|Overall Study||0
8186746|NCT02320175|20185572|P2|COMPLETED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
8186747|NCT02320175|20185573|P1|COMPLETED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
8186748|NCT02320175|20185572|P2|STARTED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
8186749|NCT02320175|20185573|P1|STARTED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
8186750|NCT02320149|20185589|P2|NOT COMPLETED|Overall Study||80
8186751|NCT02320149|20185590|P1|NOT COMPLETED|Overall Study||63
8186752|NCT02320149|20185589|P2|COMPLETED|Overall Study||405
8186753|NCT02320149|20185590|P1|COMPLETED|Overall Study||420
8186754|NCT02320149|20185589|P2|STARTED|Overall Study||485
8186755|NCT02320149|20185590|P1|STARTED|Overall Study||483
8186756|NCT02320123|20185630|P2|NOT COMPLETED|Overall Study||11
8186757|NCT02320123|20185631|P1|NOT COMPLETED|Overall Study||10
8186758|NCT02320123|20185630|P2|COMPLETED|Overall Study||1
8186759|NCT02320123|20185631|P1|COMPLETED|Overall Study||0
8186760|NCT02320123|20185630|P2|STARTED|Overall Study||12
8186761|NCT02320123|20185631|P1|STARTED|Overall Study||10
8186762|NCT02319967|20185656|P3|NOT COMPLETED|Overall Study||45
8186763|NCT02319967|20185657|P2|NOT COMPLETED|Overall Study||44
8186764|NCT02319967|20185658|P1|NOT COMPLETED|Overall Study||48
8186765|NCT02319967|20185656|P3|COMPLETED|Overall Study||76
8186766|NCT02319967|20185657|P2|COMPLETED|Overall Study||82
8186767|NCT02319967|20185658|P1|COMPLETED|Overall Study||78
8186768|NCT02319967|20185656|P3|STARTED|Overall Study||121
8186769|NCT02319967|20185657|P2|STARTED|Overall Study||126
8186770|NCT02319967|20185658|P1|STARTED|Overall Study||126
8186771|NCT02319824|20185714|P1|NOT COMPLETED|Overall Study||0
8186772|NCT02319824|20185714|P1|COMPLETED|Overall Study||2
8186773|NCT02319824|20185714|P1|STARTED|Overall Study||2
8186774|NCT02319759|20185722|P5|NOT COMPLETED|Week 24 - 56||2
8186775|NCT02319759|20185723|P4|NOT COMPLETED|Week 24 - 56||2
8186776|NCT02319759|20185724|P3|NOT COMPLETED|Week 24 - 56||2
8186777|NCT02319759|20185725|P2|NOT COMPLETED|Week 24 - 56||1
8186778|NCT02319759|20185726|P1|NOT COMPLETED|Week 24 - 56||0
8186779|NCT02319759|20185722|P5|COMPLETED|Week 24 - 56||8
8186780|NCT02319759|20185723|P4|COMPLETED|Week 24 - 56||15
8186781|NCT02319759|20185724|P3|COMPLETED|Week 24 - 56||84
8186782|NCT02319759|20185725|P2|COMPLETED|Week 24 - 56||28
8186783|NCT02319759|20185726|P1|COMPLETED|Week 24 - 56||0
8186784|NCT02319759|20185722|P5|STARTED|Week 24 - 56||10
8186785|NCT02319759|20185723|P4|STARTED|Week 24 - 56||17
8186786|NCT02319759|20185724|P3|STARTED|Week 24 - 56||86
8186787|NCT02319759|20185725|P2|STARTED|Week 24 - 56||29
8186788|NCT02319759|20185726|P1|STARTED|Week 24 - 56||0
8186789|NCT02319759|20185722|P5|NOT COMPLETED|Week 16 - 24||0
8186790|NCT02319759|20185723|P4|NOT COMPLETED|Week 16 - 24||0
8186791|NCT02319759|20185724|P3|NOT COMPLETED|Week 16 - 24||3
8186792|NCT02319759|20185725|P2|NOT COMPLETED|Week 16 - 24||0
8186793|NCT02319759|20185726|P1|NOT COMPLETED|Week 16 - 24||2
8186794|NCT02319759|20185722|P5|COMPLETED|Week 16 - 24||10
8186795|NCT02319759|20185723|P4|COMPLETED|Week 16 - 24||17
8186796|NCT02319759|20185724|P3|COMPLETED|Week 16 - 24||86
8186797|NCT02319759|20185725|P2|COMPLETED|Week 16 - 24||0
8186798|NCT02319759|20185726|P1|COMPLETED|Week 16 - 24||29
8186799|NCT02319759|20185722|P5|STARTED|Week 16 - 24||10
8186800|NCT02319759|20185723|P4|STARTED|Week 16 - 24||17
8186801|NCT02319759|20185724|P3|STARTED|Week 16 - 24||89
8186802|NCT02319759|20185725|P2|STARTED|Week 16 - 24||0
8186803|NCT02319759|20185726|P1|STARTED|Week 16 - 24||31
8186804|NCT02319759|20185722|P5|NOT COMPLETED|Week 0 - 16||0
8186805|NCT02319759|20185723|P4|NOT COMPLETED|Week 0 - 16||0
8186806|NCT02319759|20185724|P3|NOT COMPLETED|Week 0 - 16||1
8186807|NCT02319759|20185725|P2|NOT COMPLETED|Week 0 - 16||0
8186808|NCT02319759|20185726|P1|NOT COMPLETED|Week 0 - 16||1
8186809|NCT02319759|20185722|P5|COMPLETED|Week 0 - 16||0
8186810|NCT02319759|20185723|P4|COMPLETED|Week 0 - 16||0
8186811|NCT02319759|20185724|P3|COMPLETED|Week 0 - 16||99
8186812|NCT02319759|20185725|P2|COMPLETED|Week 0 - 16||0
8186813|NCT02319759|20185726|P1|COMPLETED|Week 0 - 16||48
8186814|NCT02319759|20185722|P5|STARTED|Week 0 - 16||0
8186815|NCT02319759|20185723|P4|STARTED|Week 0 - 16||0
8186816|NCT02319759|20185724|P3|STARTED|Week 0 - 16||100
8186817|NCT02319759|20185725|P2|STARTED|Week 0 - 16||0
8186818|NCT02319759|20185726|P1|STARTED|Week 0 - 16||49
8186819|NCT02319668|20185823|P2|NOT COMPLETED|Overall Study||2
8186820|NCT02319668|20185824|P1|NOT COMPLETED|Overall Study||0
8186822|NCT02319668|20185824|P1|COMPLETED|Overall Study||19
8186823|NCT02319668|20185823|P2|STARTED|Overall Study||19
8186824|NCT02319668|20185824|P1|STARTED|Overall Study||19
8186825|NCT02319642|20185838|P2|NOT COMPLETED|Overall Study||6
8186826|NCT02319642|20185839|P1|NOT COMPLETED|Overall Study||4
8186827|NCT02319642|20185838|P2|COMPLETED|Overall Study||245
8186828|NCT02319642|20185839|P1|COMPLETED|Overall Study||91
8186829|NCT02319642|20185838|P2|STARTED|Overall Study||251
8186830|NCT02319642|20185839|P1|STARTED|Overall Study||95
8186831|NCT02319525|20185859|P2|NOT COMPLETED|Overall Study||1
8186832|NCT02319525|20185860|P1|NOT COMPLETED|Overall Study||2
8186833|NCT02319525|20185859|P2|COMPLETED|Overall Study||147
8186834|NCT02319525|20185860|P1|COMPLETED|Overall Study||151
8186835|NCT02319525|20185859|P2|Primary Research Completion|Overall Study||147
8186836|NCT02319525|20185860|P1|Primary Research Completion|Overall Study||151
8186837|NCT02319525|20185859|P2|STARTED|Overall Study||148
8186838|NCT02319525|20185860|P1|STARTED|Overall Study||153
8186839|NCT02319486|20185878|P1|NOT COMPLETED|Overall Study||0
8186840|NCT02319486|20185878|P1|COMPLETED|Overall Study||26
8186841|NCT02319486|20185878|P1|STARTED|Overall Study||26
8186842|NCT02319317|20185886|P2|NOT COMPLETED|Overall Study||0
8186843|NCT02319317|20185887|P1|NOT COMPLETED|Overall Study||0
8186844|NCT02319317|20185886|P2|COMPLETED|Overall Study||29
8186845|NCT02319317|20185887|P1|COMPLETED|Overall Study||31
8186846|NCT02319317|20185886|P2|STARTED|Overall Study||29
8186847|NCT02319317|20185887|P1|STARTED|Overall Study||31
8186848|NCT02319174|20185893|P1|NOT COMPLETED|Overall Study||1
8186849|NCT02319174|20185893|P1|COMPLETED|Overall Study||42
8186850|NCT02319174|20185893|P1|STARTED|Overall Study||43
8186851|NCT02319148|20185902|P4|NOT COMPLETED|Second Intervention Period||2
8186852|NCT02319148|20185903|P3|NOT COMPLETED|Second Intervention Period||1
8186853|NCT02319148|20185904|P2|NOT COMPLETED|Second Intervention Period||1
8186854|NCT02319148|20185905|P1|NOT COMPLETED|Second Intervention Period||0
8186855|NCT02319148|20185902|P4|COMPLETED|Second Intervention Period||6
8186856|NCT02319148|20185903|P3|COMPLETED|Second Intervention Period||6
8186857|NCT02319148|20185904|P2|COMPLETED|Second Intervention Period||6
8186858|NCT02319148|20185905|P1|COMPLETED|Second Intervention Period||0
8186859|NCT02319148|20185902|P4|STARTED|Second Intervention Period||8
8186860|NCT02319148|20185903|P3|STARTED|Second Intervention Period||7
8186861|NCT02319148|20185904|P2|STARTED|Second Intervention Period||7
8186862|NCT02319148|20185905|P1|STARTED|Second Intervention Period||0
8186863|NCT02319148|20185902|P4|NOT COMPLETED|Washout Period 4 Days||0
8186864|NCT02319148|20185903|P3|NOT COMPLETED|Washout Period 4 Days||0
8186865|NCT02319148|20185904|P2|NOT COMPLETED|Washout Period 4 Days||0
8186866|NCT02319148|20185905|P1|NOT COMPLETED|Washout Period 4 Days||0
8186867|NCT02319148|20185902|P4|COMPLETED|Washout Period 4 Days||0
8186868|NCT02319148|20185903|P3|COMPLETED|Washout Period 4 Days||0
8186869|NCT02319148|20185904|P2|COMPLETED|Washout Period 4 Days||0
8186870|NCT02319148|20185905|P1|COMPLETED|Washout Period 4 Days||22
8186871|NCT02319148|20185902|P4|STARTED|Washout Period 4 Days||0
8186872|NCT02319148|20185903|P3|STARTED|Washout Period 4 Days||0
8186873|NCT02319148|20185904|P2|STARTED|Washout Period 4 Days||0
8186874|NCT02319148|20185905|P1|STARTED|Washout Period 4 Days||22
8186875|NCT02319148|20185902|P4|NOT COMPLETED|First Intervention Period||0
8186876|NCT02319148|20185903|P3|NOT COMPLETED|First Intervention Period||0
8186877|NCT02319148|20185904|P2|NOT COMPLETED|First Intervention Period||0
8186878|NCT02319148|20185905|P1|NOT COMPLETED|First Intervention Period||0
8186879|NCT02319148|20185902|P4|COMPLETED|First Intervention Period||0
8186880|NCT02319148|20185903|P3|COMPLETED|First Intervention Period||0
8186881|NCT02319148|20185904|P2|COMPLETED|First Intervention Period||0
8186882|NCT02319148|20185905|P1|COMPLETED|First Intervention Period||22
8186883|NCT02319148|20185902|P4|STARTED|First Intervention Period||0
8186884|NCT02319148|20185903|P3|STARTED|First Intervention Period||0
8186885|NCT02319148|20185904|P2|STARTED|First Intervention Period||0
8186886|NCT02319148|20185905|P1|STARTED|First Intervention Period||22
8186887|NCT02319044|20185968|P3|NOT COMPLETED|Overall Study||67
8186888|NCT02319044|20185969|P2|NOT COMPLETED|Overall Study||60
8186889|NCT02319044|20185970|P1|NOT COMPLETED|Overall Study||122
8186890|NCT02319044|20185968|P3|COMPLETED|Overall Study||0
8186891|NCT02319044|20185969|P2|COMPLETED|Overall Study||7
8186892|NCT02319044|20185970|P1|COMPLETED|Overall Study||11
8186893|NCT02319044|20185968|P3|STARTED|Overall Study||67
8186894|NCT02319044|20185969|P2|STARTED|Overall Study||67
8186895|NCT02319044|20185970|P1|STARTED|Overall Study||133
8186896|NCT02319031|20186026|P2|NOT COMPLETED|Follow-Up Period||0
8186897|NCT02319031|20186027|P1|NOT COMPLETED|Follow-Up Period||0
8186898|NCT02319031|20186026|P2|COMPLETED|Follow-Up Period||26
8186899|NCT02319031|20186027|P1|COMPLETED|Follow-Up Period||23
8186900|NCT02319031|20186026|P2|STARTED|Follow-Up Period||26
8186901|NCT02319031|20186027|P1|STARTED|Follow-Up Period||23
8186902|NCT02319031|20186026|P2|NOT COMPLETED|Treatment Period||0
8186903|NCT02319031|20186027|P1|NOT COMPLETED|Treatment Period||1
8186904|NCT02319031|20186026|P2|COMPLETED|Treatment Period||26
8186905|NCT02319031|20186027|P1|COMPLETED|Treatment Period||23
8186906|NCT02319031|20186026|P2|STARTED|Treatment Period||26
8186907|NCT02319031|20186027|P1|STARTED|Treatment Period||24
8186908|NCT02319005|20186039|P2|NOT COMPLETED|Overall Study||15
8186909|NCT02319005|20186040|P1|NOT COMPLETED|Overall Study||48
8186910|NCT02319005|20186039|P2|COMPLETED|Overall Study||51
8186911|NCT02319005|20186040|P1|COMPLETED|Overall Study||92
8186912|NCT02319005|20186039|P2|STARTED|Overall Study||66
8186913|NCT02319005|20186040|P1|STARTED|Overall Study||140
8186914|NCT02318992|20186063|P3|NOT COMPLETED|Overall Study||4
8186915|NCT02318992|20186064|P2|NOT COMPLETED|Overall Study||2
8186916|NCT02318992|20186065|P1|NOT COMPLETED|Overall Study||2
8186917|NCT02318992|20186063|P3|COMPLETED|Overall Study||20
8186918|NCT02318992|20186064|P2|COMPLETED|Overall Study||25
8186919|NCT02318992|20186065|P1|COMPLETED|Overall Study||25
8186920|NCT02318992|20186063|P3|STARTED|Overall Study||24
8186921|NCT02318992|20186064|P2|STARTED|Overall Study||27
8186922|NCT02318992|20186065|P1|STARTED|Overall Study||27
8186923|NCT02318979|20186078|P2|NOT COMPLETED|Overall Study||0
8186924|NCT02318979|20186079|P1|NOT COMPLETED|Overall Study||0
8186925|NCT02318979|20186078|P2|COMPLETED|Overall Study||15
8186926|NCT02318979|20186079|P1|COMPLETED|Overall Study||15
8186927|NCT02318979|20186078|P2|STARTED|Overall Study||15
8186928|NCT02318979|20186079|P1|STARTED|Overall Study||15
8186929|NCT02318940|20186091|P2|NOT COMPLETED|Overall Study||0
8186930|NCT02318940|20186092|P1|NOT COMPLETED|Overall Study||1
8186931|NCT02318940|20186091|P2|COMPLETED|Overall Study||50
8186932|NCT02318940|20186092|P1|COMPLETED|Overall Study||49
8186933|NCT02318940|20186091|P2|STARTED|Overall Study||50
8186934|NCT02318940|20186092|P1|STARTED|Overall Study|in the last patient we lost the record.|50
8186935|NCT02318901|20186107|P3|NOT COMPLETED|Overall Study||10
8186936|NCT02318901|20186108|P2|NOT COMPLETED|Overall Study||1
8186937|NCT02318901|20186109|P1|NOT COMPLETED|Overall Study||5
8186938|NCT02318901|20186107|P3|COMPLETED|Overall Study||0
8186939|NCT02318901|20186108|P2|COMPLETED|Overall Study||0
8186940|NCT02318901|20186109|P1|COMPLETED|Overall Study||0
8186941|NCT02318901|20186107|P3|STARTED|Overall Study||10
8186942|NCT02318901|20186108|P2|STARTED|Overall Study||1
8186943|NCT02318901|20186109|P1|STARTED|Overall Study||5
8186944|NCT02318797|20186134|P2|NOT COMPLETED|Overall Study||102
8186945|NCT02318797|20186135|P1|NOT COMPLETED|Overall Study||88
8186946|NCT02318797|20186134|P2|COMPLETED|Overall Study||611
8186947|NCT02318797|20186135|P1|COMPLETED|Overall Study||428
8186948|NCT02318797|20186134|P2|STARTED|Overall Study||713
8186949|NCT02318797|20186135|P1|STARTED|Overall Study||516
8186950|NCT02318719|20186177|P5|NOT COMPLETED|Open-label Extension Phase||55
8186951|NCT02318719|20186178|P4|NOT COMPLETED|Open-label Extension Phase||0
8186952|NCT02318719|20186179|P3|NOT COMPLETED|Open-label Extension Phase||0
8186953|NCT02318719|20186180|P2|NOT COMPLETED|Open-label Extension Phase||0
8186954|NCT02318719|20186181|P1|NOT COMPLETED|Open-label Extension Phase||0
8186955|NCT02318719|20186177|P5|COMPLETED|Open-label Extension Phase||184
8186956|NCT02318719|20186178|P4|COMPLETED|Open-label Extension Phase||0
8186957|NCT02318719|20186179|P3|COMPLETED|Open-label Extension Phase||0
8186958|NCT02318719|20186180|P2|COMPLETED|Open-label Extension Phase||0
8186959|NCT02318719|20186181|P1|COMPLETED|Open-label Extension Phase||0
8186960|NCT02318719|20186177|P5|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|239
8186961|NCT02318719|20186178|P4|STARTED|Open-label Extension Phase||0
8186962|NCT02318719|20186179|P3|STARTED|Open-label Extension Phase||0
8186963|NCT02318719|20186180|P2|STARTED|Open-label Extension Phase||0
8186964|NCT02318719|20186181|P1|STARTED|Open-label Extension Phase||0
8186965|NCT02318719|20186177|P5|NOT COMPLETED|Double-blind Phase||0
8186966|NCT02318719|20186178|P4|NOT COMPLETED|Double-blind Phase||15
8186967|NCT02318719|20186179|P3|NOT COMPLETED|Double-blind Phase||25
8186968|NCT02318719|20186180|P2|NOT COMPLETED|Double-blind Phase||16
8186969|NCT02318719|20186181|P1|NOT COMPLETED|Double-blind Phase||38
8186970|NCT02318719|20186177|P5|COMPLETED|Double-blind Phase||0
8186971|NCT02318719|20186178|P4|COMPLETED|Double-blind Phase||140
8186972|NCT02318719|20186179|P3|COMPLETED|Double-blind Phase||128
8186973|NCT02318719|20186180|P2|COMPLETED|Double-blind Phase||137
8186974|NCT02318719|20186181|P1|COMPLETED|Double-blind Phase||266
8186975|NCT02318719|20186177|P5|Did Not Receive Treatment|Double-blind Phase||0
8186976|NCT02318719|20186178|P4|Did Not Receive Treatment|Double-blind Phase||0
8186977|NCT02318719|20186179|P3|Did Not Receive Treatment|Double-blind Phase||0
8186978|NCT02318719|20186180|P2|Did Not Receive Treatment|Double-blind Phase||1
8186979|NCT02318719|20186181|P1|Did Not Receive Treatment|Double-blind Phase||1
8186980|NCT02318719|20186177|P5|STARTED|Double-blind Phase||0
8186981|NCT02318719|20186178|P4|STARTED|Double-blind Phase||155
8186982|NCT02318719|20186179|P3|STARTED|Double-blind Phase||153
8186983|NCT02318719|20186180|P2|STARTED|Double-blind Phase||153
8186984|NCT02318719|20186181|P1|STARTED|Double-blind Phase||304
8186985|NCT02318706|20186197|P5|NOT COMPLETED|Open-label Extension Phase||42
8186986|NCT02318706|20186198|P4|NOT COMPLETED|Open-label Extension Phase||0
8186987|NCT02318706|20186199|P3|NOT COMPLETED|Open-label Extension Phase||0
8186988|NCT02318706|20186200|P2|NOT COMPLETED|Open-label Extension Phase||0
8186989|NCT02318706|20186201|P1|NOT COMPLETED|Open-label Extension Phase||0
8186990|NCT02318706|20186197|P5|COMPLETED|Open-label Extension Phase||172
8186991|NCT02318706|20186198|P4|COMPLETED|Open-label Extension Phase||0
8186992|NCT02318706|20186199|P3|COMPLETED|Open-label Extension Phase||0
8186993|NCT02318706|20186200|P2|COMPLETED|Open-label Extension Phase||0
8186994|NCT02318706|20186201|P1|COMPLETED|Open-label Extension Phase||0
8186995|NCT02318706|20186197|P5|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|214
8186996|NCT02318706|20186198|P4|STARTED|Open-label Extension Phase||0
8186997|NCT02318706|20186199|P3|STARTED|Open-label Extension Phase||0
8186998|NCT02318706|20186200|P2|STARTED|Open-label Extension Phase||0
8186999|NCT02318706|20186201|P1|STARTED|Open-label Extension Phase||0
8187000|NCT02318706|20186197|P5|NOT COMPLETED|Double-blind Phase||0
8187001|NCT02318706|20186198|P4|NOT COMPLETED|Double-blind Phase||24
8187002|NCT02318706|20186199|P3|NOT COMPLETED|Double-blind Phase||18
8187003|NCT02318706|20186200|P2|NOT COMPLETED|Double-blind Phase||12
8187004|NCT02318706|20186201|P1|NOT COMPLETED|Double-blind Phase||25
8187005|NCT02318706|20186197|P5|COMPLETED|Double-blind Phase||0
8187006|NCT02318706|20186198|P4|COMPLETED|Double-blind Phase||142
8187007|NCT02318706|20186199|P3|COMPLETED|Double-blind Phase||150
8187008|NCT02318706|20186200|P2|COMPLETED|Double-blind Phase||154
8187009|NCT02318706|20186201|P1|COMPLETED|Double-blind Phase||309
8187010|NCT02318706|20186197|P5|STARTED|Double-blind Phase||0
8187011|NCT02318706|20186198|P4|STARTED|Double-blind Phase||166
8187012|NCT02318706|20186199|P3|STARTED|Double-blind Phase||168
8187013|NCT02318706|20186200|P2|STARTED|Double-blind Phase||166
8187014|NCT02318706|20186201|P1|STARTED|Double-blind Phase||334
8187015|NCT02318693|20186215|P2|NOT COMPLETED|Overall Study||1
8187016|NCT02318693|20186216|P1|NOT COMPLETED|Overall Study||0
8187017|NCT02318693|20186215|P2|COMPLETED|Overall Study||26
8187018|NCT02318693|20186216|P1|COMPLETED|Overall Study||26
8187019|NCT02318693|20186215|P2|Treated|Overall Study|1 randomized participant did not receive treatment.|26
8187020|NCT02318693|20186216|P1|Treated|Overall Study||26
8187021|NCT02318693|20186215|P2|STARTED|Overall Study||27
8187022|NCT02318693|20186216|P1|STARTED|Overall Study||26
8187023|NCT02318667|20186230|P1|NOT COMPLETED|Overall Study||9
8187024|NCT02318667|20186230|P1|COMPLETED|Overall Study||29
8187025|NCT02318667|20186230|P1|STARTED|Overall Study||38
8187026|NCT02318602|20186249|P3|NOT COMPLETED|Overall Study||2
8187027|NCT02318602|20186250|P2|NOT COMPLETED|Overall Study||4
8187028|NCT02318602|20186251|P1|NOT COMPLETED|Overall Study||1
8187029|NCT02318602|20186249|P3|COMPLETED|Overall Study||15
8187030|NCT02318602|20186250|P2|COMPLETED|Overall Study||22
8187031|NCT02318602|20186251|P1|COMPLETED|Overall Study||8
8187032|NCT02318602|20186249|P3|STARTED|Overall Study||17
8187033|NCT02318602|20186250|P2|STARTED|Overall Study||26
8187034|NCT02318602|20186251|P1|STARTED|Overall Study||9
8187035|NCT02318368|20186284|P2|NOT COMPLETED|Overall Study||3
8187036|NCT02318368|20186285|P1|NOT COMPLETED|Overall Study||7
8187037|NCT02318368|20186284|P2|COMPLETED|Overall Study||0
8187038|NCT02318368|20186285|P1|COMPLETED|Overall Study||0
8187039|NCT02318368|20186284|P2|STARTED|Overall Study||3
8187040|NCT02318368|20186285|P1|STARTED|Overall Study||7
8187071|NCT02318303|20186375|P7|NOT COMPLETED|Overall Study||2
8187072|NCT02318303|20186376|P6|NOT COMPLETED|Overall Study||6
8187073|NCT02318303|20186377|P5|NOT COMPLETED|Overall Study||5
8187074|NCT02318303|20186378|P4|NOT COMPLETED|Overall Study||3
8187075|NCT02318303|20186379|P3|NOT COMPLETED|Overall Study||3
8187076|NCT02318303|20186380|P2|NOT COMPLETED|Overall Study||3
8187077|NCT02318303|20186381|P1|NOT COMPLETED|Overall Study||4
8187078|NCT02318303|20186375|P7|COMPLETED|Overall Study||158
8187079|NCT02318303|20186376|P6|COMPLETED|Overall Study||153
8187080|NCT02318303|20186377|P5|COMPLETED|Overall Study||152
8187081|NCT02318303|20186378|P4|COMPLETED|Overall Study||155
8187082|NCT02318303|20186379|P3|COMPLETED|Overall Study||157
8187083|NCT02318303|20186380|P2|COMPLETED|Overall Study||155
8187084|NCT02318303|20186381|P1|COMPLETED|Overall Study||155
8187085|NCT02318303|20186375|P7|STARTED|Overall Study||160
8187086|NCT02318303|20186376|P6|STARTED|Overall Study||159
8187087|NCT02318303|20186377|P5|STARTED|Overall Study||157
8187088|NCT02318303|20186378|P4|STARTED|Overall Study||158
8187089|NCT02318303|20186379|P3|STARTED|Overall Study||160
8187090|NCT02318303|20186380|P2|STARTED|Overall Study||158
8187091|NCT02318303|20186381|P1|STARTED|Overall Study||159
8187092|NCT02318277|20186405|P8|NOT COMPLETED|Overall Study||93
8187093|NCT02318277|20186406|P7|NOT COMPLETED|Overall Study||49
8187094|NCT02318277|20186407|P6|NOT COMPLETED|Overall Study||9
8187095|NCT02318277|20186408|P5|NOT COMPLETED|Overall Study||8
8187096|NCT02318277|20186409|P4|NOT COMPLETED|Overall Study||4
8187097|NCT02318277|20186410|P3|NOT COMPLETED|Overall Study||4
8187098|NCT02318277|20186411|P2|NOT COMPLETED|Overall Study||3
8187099|NCT02318277|20186412|P1|NOT COMPLETED|Overall Study||6
8187100|NCT02318277|20186405|P8|COMPLETED|Overall Study||0
8187101|NCT02318277|20186406|P7|COMPLETED|Overall Study||0
8187102|NCT02318277|20186407|P6|COMPLETED|Overall Study||0
8187103|NCT02318277|20186408|P5|COMPLETED|Overall Study||0
8187104|NCT02318277|20186409|P4|COMPLETED|Overall Study||0
8187105|NCT02318277|20186410|P3|COMPLETED|Overall Study||0
8187106|NCT02318277|20186411|P2|COMPLETED|Overall Study||0
8187107|NCT02318277|20186412|P1|COMPLETED|Overall Study||0
8187108|NCT02318277|20186405|P8|STARTED|Overall Study||93
8187109|NCT02318277|20186406|P7|STARTED|Overall Study||49
8187110|NCT02318277|20186407|P6|STARTED|Overall Study||9
8187111|NCT02318277|20186408|P5|STARTED|Overall Study||8
8187112|NCT02318277|20186409|P4|STARTED|Overall Study||4
8187113|NCT02318277|20186410|P3|STARTED|Overall Study||4
8187114|NCT02318277|20186411|P2|STARTED|Overall Study||3
8187115|NCT02318277|20186412|P1|STARTED|Overall Study||6
8187116|NCT02317809|20186475|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
8187117|NCT02317809|20186476|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
8187118|NCT02317809|20186475|P2|COMPLETED|Second Intervention Period (8 Days)||17
8187119|NCT02317809|20186476|P1|COMPLETED|Second Intervention Period (8 Days)||14
8187120|NCT02317809|20186475|P2|STARTED|Second Intervention Period (8 Days)||17
8187121|NCT02317809|20186476|P1|STARTED|Second Intervention Period (8 Days)||14
8187122|NCT02317809|20186475|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
8187123|NCT02317809|20186476|P1|NOT COMPLETED|First Intervention Period (8 Days)||3
8187124|NCT02317809|20186475|P2|COMPLETED|First Intervention Period (8 Days)||17
8187125|NCT02317809|20186476|P1|COMPLETED|First Intervention Period (8 Days)||14
8187126|NCT02317809|20186475|P2|STARTED|First Intervention Period (8 Days)||17
8187127|NCT02317809|20186476|P1|STARTED|First Intervention Period (8 Days)||17
8187128|NCT02317744|20186528|P2|NOT COMPLETED|Overall Study||2
8187129|NCT02317744|20186529|P1|NOT COMPLETED|Overall Study||1
8187130|NCT02317744|20186528|P2|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
8187131|NCT02317744|20186529|P1|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
8187132|NCT02317744|20186528|P2|Completed Treatment|Overall Study||7
8187133|NCT02317744|20186529|P1|Completed Treatment|Overall Study||10
8187134|NCT02317744|20186528|P2|STARTED|Overall Study||10
8187135|NCT02317744|20186529|P1|STARTED|Overall Study||12
8187136|NCT02317692|20186543|P2|NOT COMPLETED|Overall Study||0
8187137|NCT02317692|20186544|P1|NOT COMPLETED|Overall Study||6
8187138|NCT02317692|20186543|P2|COMPLETED|Overall Study||77
8187139|NCT02317692|20186544|P1|COMPLETED|Overall Study||63
8187140|NCT02317692|20186543|P2|STARTED|Overall Study||77
8187141|NCT02317692|20186544|P1|STARTED|Overall Study||69
8187142|NCT02317614|20186564|P2|NOT COMPLETED|Overall Study||2
8187143|NCT02317614|20186565|P1|NOT COMPLETED|Overall Study||3
8187144|NCT02317614|20186564|P2|COMPLETED|Overall Study||23
8187145|NCT02317614|20186565|P1|COMPLETED|Overall Study||23
8187146|NCT02317614|20186564|P2|STARTED|Overall Study||25
8187147|NCT02317614|20186565|P1|STARTED|Overall Study||26
8187148|NCT02317575|20186581|P5|NOT COMPLETED|Period 5||0
8187149|NCT02317575|20186582|P4|NOT COMPLETED|Period 5||0
8187150|NCT02317575|20186583|P3|NOT COMPLETED|Period 5||0
8187151|NCT02317575|20186584|P2|NOT COMPLETED|Period 5||0
8187152|NCT02317575|20186585|P1|NOT COMPLETED|Period 5||0
8187153|NCT02317575|20186581|P5|COMPLETED|Period 5||6
8187154|NCT02317575|20186582|P4|COMPLETED|Period 5||6
8187155|NCT02317575|20186583|P3|COMPLETED|Period 5||6
8187156|NCT02317575|20186584|P2|COMPLETED|Period 5||5
8187157|NCT02317575|20186585|P1|COMPLETED|Period 5||4
8187158|NCT02317575|20186581|P5|STARTED|Period 5||6
8187159|NCT02317575|20186582|P4|STARTED|Period 5||6
8187160|NCT02317575|20186583|P3|STARTED|Period 5||6
8187161|NCT02317575|20186584|P2|STARTED|Period 5||5
8187162|NCT02317575|20186585|P1|STARTED|Period 5||4
8187163|NCT02317575|20186581|P5|NOT COMPLETED|Period 4||0
8187164|NCT02317575|20186582|P4|NOT COMPLETED|Period 4||0
8187165|NCT02317575|20186583|P3|NOT COMPLETED|Period 4||0
8187166|NCT02317575|20186584|P2|NOT COMPLETED|Period 4||0
8187167|NCT02317575|20186585|P1|NOT COMPLETED|Period 4||0
8187168|NCT02317575|20186581|P5|COMPLETED|Period 4||6
8187169|NCT02317575|20186582|P4|COMPLETED|Period 4||6
8187170|NCT02317575|20186583|P3|COMPLETED|Period 4||6
8187171|NCT02317575|20186584|P2|COMPLETED|Period 4||5
8187172|NCT02317575|20186585|P1|COMPLETED|Period 4||4
8187173|NCT02317575|20186581|P5|STARTED|Period 4||6
8187174|NCT02317575|20186582|P4|STARTED|Period 4||6
8187175|NCT02317575|20186583|P3|STARTED|Period 4||6
8187176|NCT02317575|20186584|P2|STARTED|Period 4||5
8187177|NCT02317575|20186585|P1|STARTED|Period 4||4
8187178|NCT02317575|20186581|P5|NOT COMPLETED|Period 3||0
8187179|NCT02317575|20186582|P4|NOT COMPLETED|Period 3||0
8187180|NCT02317575|20186583|P3|NOT COMPLETED|Period 3||0
8187181|NCT02317575|20186584|P2|NOT COMPLETED|Period 3||0
8187182|NCT02317575|20186585|P1|NOT COMPLETED|Period 3||0
8187183|NCT02317575|20186581|P5|COMPLETED|Period 3||6
8187184|NCT02317575|20186582|P4|COMPLETED|Period 3||6
8187185|NCT02317575|20186583|P3|COMPLETED|Period 3||6
8187186|NCT02317575|20186584|P2|COMPLETED|Period 3||5
8187187|NCT02317575|20186585|P1|COMPLETED|Period 3||4
8187188|NCT02317575|20186581|P5|STARTED|Period 3||6
8187189|NCT02317575|20186582|P4|STARTED|Period 3||6
8187190|NCT02317575|20186583|P3|STARTED|Period 3||6
8187191|NCT02317575|20186584|P2|STARTED|Period 3||5
8187192|NCT02317575|20186585|P1|STARTED|Period 3||4
8187193|NCT02317575|20186581|P5|NOT COMPLETED|Period 2||0
8187194|NCT02317575|20186582|P4|NOT COMPLETED|Period 2||0
8187195|NCT02317575|20186583|P3|NOT COMPLETED|Period 2||0
8187196|NCT02317575|20186584|P2|NOT COMPLETED|Period 2||0
8187197|NCT02317575|20186585|P1|NOT COMPLETED|Period 2||0
8187198|NCT02317575|20186581|P5|COMPLETED|Period 2||6
8187199|NCT02317575|20186582|P4|COMPLETED|Period 2||6
8187200|NCT02317575|20186583|P3|COMPLETED|Period 2||6
8187201|NCT02317575|20186584|P2|COMPLETED|Period 2||5
8187202|NCT02317575|20186585|P1|COMPLETED|Period 2||4
8187203|NCT02317575|20186581|P5|STARTED|Period 2||6
8187204|NCT02317575|20186582|P4|STARTED|Period 2||6
8187205|NCT02317575|20186583|P3|STARTED|Period 2||6
8187206|NCT02317575|20186584|P2|STARTED|Period 2||5
8187207|NCT02317575|20186585|P1|STARTED|Period 2||4
8187208|NCT02317575|20186581|P5|NOT COMPLETED|Period 1||0
8187209|NCT02317575|20186582|P4|NOT COMPLETED|Period 1||0
8187210|NCT02317575|20186583|P3|NOT COMPLETED|Period 1||0
8187211|NCT02317575|20186584|P2|NOT COMPLETED|Period 1||1
8187212|NCT02317575|20186585|P1|NOT COMPLETED|Period 1||1
8187213|NCT02317575|20186581|P5|COMPLETED|Period 1||6
8187214|NCT02317575|20186582|P4|COMPLETED|Period 1||6
8187215|NCT02317575|20186583|P3|COMPLETED|Period 1||6
8187216|NCT02317575|20186584|P2|COMPLETED|Period 1||5
8187217|NCT02317575|20186585|P1|COMPLETED|Period 1||4
8187218|NCT02317575|20186581|P5|Received at Least 1 Dose of Study Drug|Period 1||6
8187219|NCT02317575|20186582|P4|Received at Least 1 Dose of Study Drug|Period 1||6
8187220|NCT02317575|20186583|P3|Received at Least 1 Dose of Study Drug|Period 1||6
8187221|NCT02317575|20186584|P2|Received at Least 1 Dose of Study Drug|Period 1||5
8187222|NCT02317575|20186585|P1|Received at Least 1 Dose of Study Drug|Period 1||5
8187223|NCT02317575|20186581|P5|STARTED|Period 1||6
8187224|NCT02317575|20186582|P4|STARTED|Period 1||6
8187225|NCT02317575|20186583|P3|STARTED|Period 1||6
8187226|NCT02317575|20186584|P2|STARTED|Period 1||6
8187227|NCT02317575|20186585|P1|STARTED|Period 1||5
8187228|NCT02317549|20186611|P2|NOT COMPLETED|Overall Study||0
8187229|NCT02317549|20186612|P1|NOT COMPLETED|Overall Study||0
8187230|NCT02317549|20186611|P2|COMPLETED|Overall Study||3
8187231|NCT02317549|20186612|P1|COMPLETED|Overall Study||5
8187232|NCT02317549|20186611|P2|STARTED|Overall Study||3
8187233|NCT02317549|20186612|P1|STARTED|Overall Study||5
8187234|NCT02317510|20186620|P2|NOT COMPLETED|Overall Study||1
8187235|NCT02317510|20186621|P1|NOT COMPLETED|Overall Study||0
8187236|NCT02317510|20186620|P2|COMPLETED|Overall Study||24
8187237|NCT02317510|20186621|P1|COMPLETED|Overall Study||25
8187238|NCT02317510|20186620|P2|STARTED|Overall Study||25
8187239|NCT02317510|20186621|P1|STARTED|Overall Study||25
8187240|NCT02317276|20186649|P1|NOT COMPLETED|Overall Study||6
8187241|NCT02317276|20186649|P1|COMPLETED|Overall Study||5
8187242|NCT02317276|20186649|P1|STARTED|Overall Study||11
8187243|NCT02317016|20186653|P1|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
8187244|NCT02317016|20186653|P1|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
8187245|NCT02317016|20186653|P1|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
8187246|NCT02317016|20186653|P1|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
8187247|NCT02317016|20186653|P1|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
8187248|NCT02317016|20186653|P1|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
8187249|NCT02317016|20186653|P1|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
8187250|NCT02317016|20186653|P1|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
8187251|NCT02317016|20186653|P1|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
8187252|NCT02317016|20186653|P1|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
8187253|NCT02317016|20186653|P1|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
8187254|NCT02317016|20186653|P1|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
8187255|NCT02316847|20186681|P2|NOT COMPLETED|Overall Study||86
8187256|NCT02316847|20186682|P1|NOT COMPLETED|Overall Study||9
8187257|NCT02316847|20186681|P2|COMPLETED|Overall Study||13
8187258|NCT02316847|20186682|P1|COMPLETED|Overall Study||0
8187259|NCT02316847|20186681|P2|STARTED|Overall Study||99
8187260|NCT02316847|20186682|P1|STARTED|Overall Study||9
8187261|NCT02316769|20186693|P2|NOT COMPLETED|Overall Study||0
8187262|NCT02316769|20186694|P1|NOT COMPLETED|Overall Study||2
8187263|NCT02316769|20186693|P2|COMPLETED|Overall Study||33
8187264|NCT02316769|20186694|P1|COMPLETED|Overall Study||31
8187265|NCT02316769|20186693|P2|STARTED|Overall Study||33
8187266|NCT02316769|20186694|P1|STARTED|Overall Study||33
8187267|NCT02316717|20186705|P3|NOT COMPLETED|Overall Study||3
8187268|NCT02316717|20186706|P2|NOT COMPLETED|Overall Study||7
8187269|NCT02316717|20186707|P1|NOT COMPLETED|Overall Study||11
8187270|NCT02316717|20186705|P3|COMPLETED|Overall Study||41
8187271|NCT02316717|20186706|P2|COMPLETED|Overall Study||39
8187272|NCT02316717|20186707|P1|COMPLETED|Overall Study||32
8187273|NCT02316717|20186705|P3|STARTED|Overall Study||44
8187274|NCT02316717|20186706|P2|STARTED|Overall Study||46
8187275|NCT02316717|20186707|P1|STARTED|Overall Study||43
8187276|NCT02316678|20186837|P2|NOT COMPLETED|Overall Study||0
8187277|NCT02316678|20186838|P1|NOT COMPLETED|Overall Study||0
8187278|NCT02316678|20186837|P2|COMPLETED|Overall Study||7694
8187279|NCT02316678|20186838|P1|COMPLETED|Overall Study||1879
8187280|NCT02316678|20186837|P2|STARTED|Overall Study||7694
8187281|NCT02316678|20186838|P1|STARTED|Overall Study||1879
8187282|NCT02316613|20186844|P1|NOT COMPLETED|Overall Study||104
8187283|NCT02316613|20186844|P1|COMPLETED|Overall Study||156
8187284|NCT02316613|20186844|P1|Overall Population|Overall Study||241
8187285|NCT02316613|20186844|P1|Safety Population|Overall Study||255
8187286|NCT02316613|20186844|P1|STARTED|Overall Study||260
8187287|NCT02316548|20186883|P2|NOT COMPLETED|Overall Study||1
8187288|NCT02316548|20186884|P1|NOT COMPLETED|Overall Study||0
8187289|NCT02316548|20186883|P2|COMPLETED|Overall Study|Eligible patients on study until study termination|6
8187290|NCT02316548|20186884|P1|COMPLETED|Overall Study|Eligible patients on study until study termination|6
8187291|NCT02316548|20186883|P2|Eligible With Adverse Event Data|Overall Study||2
8187292|NCT02316548|20186884|P1|Eligible With Adverse Event Data|Overall Study||4
8187293|NCT02316548|20186883|P2|Eligible With Disease Assessment|Overall Study||1
8187294|NCT02316548|20186884|P1|Eligible With Disease Assessment|Overall Study||4
8187295|NCT02316548|20186883|P2|Eligible Population|Overall Study||6
8187296|NCT02316548|20186884|P1|Eligible Population|Overall Study||6
8187297|NCT02316548|20186883|P2|STARTED|Overall Study|Randomized|7
8187298|NCT02316548|20186884|P1|STARTED|Overall Study|Randomized|6
8187299|NCT02316470|20186898|P4|NOT COMPLETED|Overall Study||2
8187300|NCT02316470|20186899|P3|NOT COMPLETED|Overall Study||5
8187301|NCT02316470|20186900|P2|NOT COMPLETED|Overall Study||6
8187302|NCT02316470|20186901|P1|NOT COMPLETED|Overall Study||5
8187303|NCT02316470|20186898|P4|COMPLETED|Overall Study||46
8187304|NCT02316470|20186899|P3|COMPLETED|Overall Study||147
8187305|NCT02316470|20186900|P2|COMPLETED|Overall Study||146
8187306|NCT02316470|20186901|P1|COMPLETED|Overall Study||143
8187307|NCT02316470|20186898|P4|STARTED|Overall Study||48
8187308|NCT02316470|20186899|P3|STARTED|Overall Study||152
8187309|NCT02316470|20186900|P2|STARTED|Overall Study||152
8187310|NCT02316470|20186901|P1|STARTED|Overall Study||148
8187311|NCT02316366|20186997|P2|NOT COMPLETED|Overall Study||0
8187312|NCT02316366|20186998|P1|NOT COMPLETED|Overall Study||0
8187313|NCT02316366|20186997|P2|COMPLETED|Overall Study||40
8187314|NCT02316366|20186998|P1|COMPLETED|Overall Study||40
8187315|NCT02316366|20186997|P2|STARTED|Overall Study||40
8187316|NCT02316366|20186998|P1|STARTED|Overall Study||40
8187317|NCT02316353|20187014|P2|NOT COMPLETED|Overall Study||8
8187318|NCT02316353|20187015|P1|NOT COMPLETED|Overall Study||8
8187319|NCT02316353|20187014|P2|COMPLETED|Overall Study||55
8187320|NCT02316353|20187015|P1|COMPLETED|Overall Study||55
8187321|NCT02316353|20187014|P2|STARTED|Overall Study||63
8187322|NCT02316353|20187015|P1|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
8187323|NCT02316171|20187035|P4|NOT COMPLETED|Overall Study||0
8187324|NCT02316171|20187036|P3|NOT COMPLETED|Overall Study||0
8187325|NCT02316171|20187037|P2|NOT COMPLETED|Overall Study||0
8187326|NCT02316171|20187038|P1|NOT COMPLETED|Overall Study||1
8187327|NCT02316171|20187035|P4|COMPLETED|Overall Study||3
8187328|NCT02316171|20187036|P3|COMPLETED|Overall Study||3
8187329|NCT02316171|20187037|P2|COMPLETED|Overall Study||6
8187330|NCT02316171|20187038|P1|COMPLETED|Overall Study||3
8187331|NCT02316171|20187035|P4|STARTED|Overall Study||3
8187332|NCT02316171|20187036|P3|STARTED|Overall Study||3
8187333|NCT02316171|20187037|P2|STARTED|Overall Study||6
8187334|NCT02316171|20187038|P1|STARTED|Overall Study||4
8187335|NCT02316002|20187044|P1|NOT COMPLETED|Overall Study||6
8187336|NCT02316002|20187044|P1|COMPLETED|Overall Study||45
8187337|NCT02316002|20187044|P1|STARTED|Overall Study||51
8187338|NCT02315989|20187048|P1|NOT COMPLETED|Overall Study||0
8187339|NCT02315989|20187048|P1|COMPLETED|Overall Study||6
8187340|NCT02315989|20187048|P1|STARTED|Overall Study||6
8187341|NCT02315872|20187058|P2|NOT COMPLETED|Overall Study||1
8187342|NCT02315872|20187059|P1|NOT COMPLETED|Overall Study||3
8187343|NCT02315872|20187058|P2|COMPLETED|Overall Study||3
8187344|NCT02315872|20187059|P1|COMPLETED|Overall Study||1
8187345|NCT02315872|20187058|P2|STARTED|Overall Study||4
8187346|NCT02315872|20187059|P1|STARTED|Overall Study||4
8187347|NCT02315755|20187071|P1|NOT COMPLETED|Overall Study||0
8187348|NCT02315755|20187071|P1|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102
8187349|NCT02315755|20187071|P1|STARTED|Overall Study||102
8187350|NCT02315703|20187108|P8|NOT COMPLETED|Overall Study||7
8187351|NCT02315703|20187109|P7|NOT COMPLETED|Overall Study||13
8187352|NCT02315703|20187110|P6|NOT COMPLETED|Overall Study||6
8187353|NCT02315703|20187111|P5|NOT COMPLETED|Overall Study||8
8187354|NCT02315703|20187112|P4|NOT COMPLETED|Overall Study||9
8187355|NCT02315703|20187113|P3|NOT COMPLETED|Overall Study||5
8187356|NCT02315703|20187114|P2|NOT COMPLETED|Overall Study||10
8187357|NCT02315703|20187115|P1|NOT COMPLETED|Overall Study||6
8187358|NCT02315703|20187108|P8|COMPLETED|Overall Study||42
8187359|NCT02315703|20187109|P7|COMPLETED|Overall Study||37
8187360|NCT02315703|20187110|P6|COMPLETED|Overall Study||43
8187361|NCT02315703|20187111|P5|COMPLETED|Overall Study||41
8187362|NCT02315703|20187112|P4|COMPLETED|Overall Study||39
8187363|NCT02315703|20187113|P3|COMPLETED|Overall Study||44
8187364|NCT02315703|20187114|P2|COMPLETED|Overall Study||39
8187365|NCT02315703|20187115|P1|COMPLETED|Overall Study||44
8187366|NCT02315703|20187108|P8|STARTED|Overall Study||49
8187367|NCT02315703|20187109|P7|STARTED|Overall Study||50
8187368|NCT02315703|20187110|P6|STARTED|Overall Study||49
8187369|NCT02315703|20187111|P5|STARTED|Overall Study||49
8187370|NCT02315703|20187112|P4|STARTED|Overall Study||48
8187371|NCT02315703|20187113|P3|STARTED|Overall Study||49
8187372|NCT02315703|20187114|P2|STARTED|Overall Study||49
8187373|NCT02315703|20187115|P1|STARTED|Overall Study||50
8187374|NCT02315664|20187215|P2|NOT COMPLETED|Overall Study||4
8187375|NCT02315664|20187216|P1|NOT COMPLETED|Overall Study||1
8187376|NCT02315664|20187215|P2|COMPLETED|Overall Study||27
8187377|NCT02315664|20187216|P1|COMPLETED|Overall Study||29
8187378|NCT02315664|20187215|P2|STARTED|Overall Study||31
8187379|NCT02315664|20187216|P1|STARTED|Overall Study||30
8187380|NCT02315625|20187238|P2|NOT COMPLETED|Second Intervention||1
8187381|NCT02315625|20187239|P1|NOT COMPLETED|Second Intervention||4
8187382|NCT02315625|20187238|P2|COMPLETED|Second Intervention||1
8187383|NCT02315625|20187239|P1|COMPLETED|Second Intervention||9
8187384|NCT02315625|20187238|P2|STARTED|Second Intervention||2
8187385|NCT02315625|20187239|P1|STARTED|Second Intervention||13
8187386|NCT02315625|20187238|P2|NOT COMPLETED|First Intervention||0
8187387|NCT02315625|20187239|P1|NOT COMPLETED|First Intervention||1
8187388|NCT02315625|20187238|P2|COMPLETED|First Intervention||2
8187389|NCT02315625|20187239|P1|COMPLETED|First Intervention||13
8187390|NCT02315625|20187238|P2|STARTED|First Intervention||2
8187391|NCT02315625|20187239|P1|STARTED|First Intervention||14
8187392|NCT02315560|20187253|P1|NOT COMPLETED|Overall Study||3
8187393|NCT02315560|20187253|P1|COMPLETED|Overall Study||22
8187394|NCT02315560|20187253|P1|STARTED|Overall Study||25
8187395|NCT02315430|20187258|P1|NOT COMPLETED|Overall Study||0
8187396|NCT02315430|20187258|P1|COMPLETED|Overall Study||13
8187397|NCT02315430|20187258|P1|STARTED|Overall Study||13
8187398|NCT02315352|20187268|P8|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187399|NCT02315352|20187269|P7|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187400|NCT02315352|20187270|P6|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187401|NCT02315352|20187271|P5|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187402|NCT02315352|20187272|P4|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187403|NCT02315352|20187273|P3|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187404|NCT02315352|20187274|P2|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187405|NCT02315352|20187275|P1|NOT COMPLETED|Fifth Intervention (Day 2)||0
8187406|NCT02315352|20187268|P8|COMPLETED|Fifth Intervention (Day 2)||8
8187407|NCT02315352|20187269|P7|COMPLETED|Fifth Intervention (Day 2)||9
8187408|NCT02315352|20187270|P6|COMPLETED|Fifth Intervention (Day 2)||7
8187409|NCT02315352|20187271|P5|COMPLETED|Fifth Intervention (Day 2)||8
8187410|NCT02315352|20187272|P4|COMPLETED|Fifth Intervention (Day 2)||8
8187411|NCT02315352|20187273|P3|COMPLETED|Fifth Intervention (Day 2)||7
8187412|NCT02315352|20187274|P2|COMPLETED|Fifth Intervention (Day 2)||0
8187413|NCT02315352|20187275|P1|COMPLETED|Fifth Intervention (Day 2)||0
8187414|NCT02315352|20187268|P8|STARTED|Fifth Intervention (Day 2)||8
8187415|NCT02315352|20187269|P7|STARTED|Fifth Intervention (Day 2)||9
8187416|NCT02315352|20187270|P6|STARTED|Fifth Intervention (Day 2)||7
8187417|NCT02315352|20187271|P5|STARTED|Fifth Intervention (Day 2)||8
8187418|NCT02315352|20187272|P4|STARTED|Fifth Intervention (Day 2)||8
8187419|NCT02315352|20187273|P3|STARTED|Fifth Intervention (Day 2)||7
8187420|NCT02315352|20187274|P2|STARTED|Fifth Intervention (Day 2)||0
8187421|NCT02315352|20187275|P1|STARTED|Fifth Intervention (Day 2)||0
8187422|NCT02315352|20187268|P8|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187423|NCT02315352|20187269|P7|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187424|NCT02315352|20187270|P6|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187425|NCT02315352|20187271|P5|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187426|NCT02315352|20187272|P4|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187427|NCT02315352|20187273|P3|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187428|NCT02315352|20187274|P2|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187429|NCT02315352|20187275|P1|NOT COMPLETED|Fourth Intervention (Day 2)||0
8187430|NCT02315352|20187268|P8|COMPLETED|Fourth Intervention (Day 2)||8
8187431|NCT02315352|20187269|P7|COMPLETED|Fourth Intervention (Day 2)||9
8187432|NCT02315352|20187270|P6|COMPLETED|Fourth Intervention (Day 2)||7
8187433|NCT02315352|20187271|P5|COMPLETED|Fourth Intervention (Day 2)||8
8187434|NCT02315352|20187272|P4|COMPLETED|Fourth Intervention (Day 2)||8
8187435|NCT02315352|20187273|P3|COMPLETED|Fourth Intervention (Day 2)||7
8187436|NCT02315352|20187274|P2|COMPLETED|Fourth Intervention (Day 2)||0
8187437|NCT02315352|20187275|P1|COMPLETED|Fourth Intervention (Day 2)||0
8187438|NCT02315352|20187268|P8|STARTED|Fourth Intervention (Day 2)||8
8187439|NCT02315352|20187269|P7|STARTED|Fourth Intervention (Day 2)||9
8187440|NCT02315352|20187270|P6|STARTED|Fourth Intervention (Day 2)||7
8187441|NCT02315352|20187271|P5|STARTED|Fourth Intervention (Day 2)||8
8187442|NCT02315352|20187272|P4|STARTED|Fourth Intervention (Day 2)||8
8187443|NCT02315352|20187273|P3|STARTED|Fourth Intervention (Day 2)||7
8187444|NCT02315352|20187274|P2|STARTED|Fourth Intervention (Day 2)||0
8187445|NCT02315352|20187275|P1|STARTED|Fourth Intervention (Day 2)||0
8187446|NCT02315352|20187268|P8|NOT COMPLETED|Third Intervention (Day 2)||0
8187447|NCT02315352|20187269|P7|NOT COMPLETED|Third Intervention (Day 2)||0
8187448|NCT02315352|20187270|P6|NOT COMPLETED|Third Intervention (Day 2)||0
8187449|NCT02315352|20187271|P5|NOT COMPLETED|Third Intervention (Day 2)||0
8187450|NCT02315352|20187272|P4|NOT COMPLETED|Third Intervention (Day 2)||0
8187451|NCT02315352|20187273|P3|NOT COMPLETED|Third Intervention (Day 2)||0
8187452|NCT02315352|20187274|P2|NOT COMPLETED|Third Intervention (Day 2)||0
8187453|NCT02315352|20187275|P1|NOT COMPLETED|Third Intervention (Day 2)||0
8187454|NCT02315352|20187268|P8|COMPLETED|Third Intervention (Day 2)||8
8187455|NCT02315352|20187269|P7|COMPLETED|Third Intervention (Day 2)||9
8187456|NCT02315352|20187270|P6|COMPLETED|Third Intervention (Day 2)||7
8187457|NCT02315352|20187271|P5|COMPLETED|Third Intervention (Day 2)||8
8187458|NCT02315352|20187272|P4|COMPLETED|Third Intervention (Day 2)||8
8187459|NCT02315352|20187273|P3|COMPLETED|Third Intervention (Day 2)||7
8187460|NCT02315352|20187274|P2|COMPLETED|Third Intervention (Day 2)||0
8187461|NCT02315352|20187275|P1|COMPLETED|Third Intervention (Day 2)||0
8187462|NCT02315352|20187268|P8|STARTED|Third Intervention (Day 2)||8
8187463|NCT02315352|20187269|P7|STARTED|Third Intervention (Day 2)||9
8187464|NCT02315352|20187270|P6|STARTED|Third Intervention (Day 2)||7
8187465|NCT02315352|20187271|P5|STARTED|Third Intervention (Day 2)||8
8187466|NCT02315352|20187272|P4|STARTED|Third Intervention (Day 2)||8
8187467|NCT02315352|20187273|P3|STARTED|Third Intervention (Day 2)||7
8187468|NCT02315352|20187274|P2|STARTED|Third Intervention (Day 2)||0
8187469|NCT02315352|20187275|P1|STARTED|Third Intervention (Day 2)||0
8187470|NCT02315352|20187268|P8|NOT COMPLETED|Second Intervention (Day 1)||0
8187471|NCT02315352|20187269|P7|NOT COMPLETED|Second Intervention (Day 1)||0
8187472|NCT02315352|20187270|P6|NOT COMPLETED|Second Intervention (Day 1)||0
8187473|NCT02315352|20187271|P5|NOT COMPLETED|Second Intervention (Day 1)||0
8187474|NCT02315352|20187272|P4|NOT COMPLETED|Second Intervention (Day 1)||0
8187475|NCT02315352|20187273|P3|NOT COMPLETED|Second Intervention (Day 1)||0
8187476|NCT02315352|20187274|P2|NOT COMPLETED|Second Intervention (Day 1)||0
8187477|NCT02315352|20187275|P1|NOT COMPLETED|Second Intervention (Day 1)||0
8187478|NCT02315352|20187268|P8|COMPLETED|Second Intervention (Day 1)||0
8187479|NCT02315352|20187269|P7|COMPLETED|Second Intervention (Day 1)||0
8187480|NCT02315352|20187270|P6|COMPLETED|Second Intervention (Day 1)||0
8187481|NCT02315352|20187271|P5|COMPLETED|Second Intervention (Day 1)||0
8187482|NCT02315352|20187272|P4|COMPLETED|Second Intervention (Day 1)||0
8187483|NCT02315352|20187273|P3|COMPLETED|Second Intervention (Day 1)||0
8187484|NCT02315352|20187274|P2|COMPLETED|Second Intervention (Day 1)||24
8187485|NCT02315352|20187275|P1|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
8187486|NCT02315352|20187268|P8|STARTED|Second Intervention (Day 1)||0
8187487|NCT02315352|20187269|P7|STARTED|Second Intervention (Day 1)||0
8187488|NCT02315352|20187270|P6|STARTED|Second Intervention (Day 1)||0
8187489|NCT02315352|20187271|P5|STARTED|Second Intervention (Day 1)||0
8187490|NCT02315352|20187272|P4|STARTED|Second Intervention (Day 1)||0
8187491|NCT02315352|20187273|P3|STARTED|Second Intervention (Day 1)||0
8187492|NCT02315352|20187274|P2|STARTED|Second Intervention (Day 1)||24
8187493|NCT02315352|20187275|P1|STARTED|Second Intervention (Day 1)||24
8187494|NCT02315352|20187268|P8|NOT COMPLETED|First Intervention (Day 1)||0
8187495|NCT02315352|20187269|P7|NOT COMPLETED|First Intervention (Day 1)||0
8187496|NCT02315352|20187270|P6|NOT COMPLETED|First Intervention (Day 1)||0
8187497|NCT02315352|20187271|P5|NOT COMPLETED|First Intervention (Day 1)||0
8187498|NCT02315352|20187272|P4|NOT COMPLETED|First Intervention (Day 1)||0
8187499|NCT02315352|20187273|P3|NOT COMPLETED|First Intervention (Day 1)||0
8187500|NCT02315352|20187274|P2|NOT COMPLETED|First Intervention (Day 1)||0
8187501|NCT02315352|20187275|P1|NOT COMPLETED|First Intervention (Day 1)||0
8187502|NCT02315352|20187268|P8|COMPLETED|First Intervention (Day 1)||0
8187503|NCT02315352|20187269|P7|COMPLETED|First Intervention (Day 1)||0
8187504|NCT02315352|20187270|P6|COMPLETED|First Intervention (Day 1)||0
8187505|NCT02315352|20187271|P5|COMPLETED|First Intervention (Day 1)||0
8187506|NCT02315352|20187272|P4|COMPLETED|First Intervention (Day 1)||0
8187507|NCT02315352|20187273|P3|COMPLETED|First Intervention (Day 1)||0
8187508|NCT02315352|20187274|P2|COMPLETED|First Intervention (Day 1)||24
8187509|NCT02315352|20187275|P1|COMPLETED|First Intervention (Day 1)||24
8187510|NCT02315352|20187268|P8|STARTED|First Intervention (Day 1)||0
8187511|NCT02315352|20187269|P7|STARTED|First Intervention (Day 1)||0
8187512|NCT02315352|20187270|P6|STARTED|First Intervention (Day 1)||0
8187513|NCT02315352|20187271|P5|STARTED|First Intervention (Day 1)||0
8187514|NCT02315352|20187272|P4|STARTED|First Intervention (Day 1)||0
8187515|NCT02315352|20187273|P3|STARTED|First Intervention (Day 1)||0
8187516|NCT02315352|20187274|P2|STARTED|First Intervention (Day 1)||24
8187517|NCT02315352|20187275|P1|STARTED|First Intervention (Day 1)||24
8187518|NCT02315261|20187302|P1|NOT COMPLETED|Overall Study||0
8187519|NCT02315261|20187302|P1|COMPLETED|Overall Study||364
8187520|NCT02315261|20187302|P1|STARTED|Overall Study||364
8187521|NCT02314936|20187313|P4|NOT COMPLETED|Overall Study||0
8187522|NCT02314936|20187314|P3|NOT COMPLETED|Overall Study||2
8187523|NCT02314936|20187315|P2|NOT COMPLETED|Overall Study||0
8187524|NCT02314936|20187316|P1|NOT COMPLETED|Overall Study||0
8187525|NCT02314936|20187313|P4|COMPLETED|Overall Study||48
8187526|NCT02314936|20187314|P3|COMPLETED|Overall Study||46
8187527|NCT02314936|20187315|P2|COMPLETED|Overall Study||48
8187528|NCT02314936|20187316|P1|COMPLETED|Overall Study||48
8187529|NCT02314936|20187313|P4|STARTED|Overall Study||48
8187530|NCT02314936|20187314|P3|STARTED|Overall Study||48
8187531|NCT02314936|20187315|P2|STARTED|Overall Study||48
8187532|NCT02314936|20187316|P1|STARTED|Overall Study||48
8187533|NCT02314923|20187512|P10|NOT COMPLETED|Overall Study||0
8187534|NCT02314923|20187513|P9|NOT COMPLETED|Overall Study||2
8187535|NCT02314923|20187514|P8|NOT COMPLETED|Overall Study||5
8187536|NCT02314923|20187515|P7|NOT COMPLETED|Overall Study||5
8187537|NCT02314923|20187516|P6|NOT COMPLETED|Overall Study||1
8187538|NCT02314923|20187517|P5|NOT COMPLETED|Overall Study||1
8187539|NCT02314923|20187518|P4|NOT COMPLETED|Overall Study||1
8187540|NCT02314923|20187519|P3|NOT COMPLETED|Overall Study||2
8187541|NCT02314923|20187520|P2|NOT COMPLETED|Overall Study||4
8187542|NCT02314923|20187521|P1|NOT COMPLETED|Overall Study||3
8187543|NCT02314923|20187512|P10|COMPLETED|Overall Study||20
8187544|NCT02314923|20187513|P9|COMPLETED|Overall Study||46
8187545|NCT02314923|20187514|P8|COMPLETED|Overall Study||42
8187546|NCT02314923|20187515|P7|COMPLETED|Overall Study||43
8187547|NCT02314923|20187516|P6|COMPLETED|Overall Study||19
8187548|NCT02314923|20187517|P5|COMPLETED|Overall Study||73
8187549|NCT02314923|20187518|P4|COMPLETED|Overall Study||63
8187550|NCT02314923|20187519|P3|COMPLETED|Overall Study||62
8187551|NCT02314923|20187520|P2|COMPLETED|Overall Study||60
8187552|NCT02314923|20187521|P1|COMPLETED|Overall Study||61
8187553|NCT02314923|20187512|P10|Treated|Overall Study||20
8187554|NCT02314923|20187513|P9|Treated|Overall Study||48
8187555|NCT02314923|20187514|P8|Treated|Overall Study||47
8187556|NCT02314923|20187515|P7|Treated|Overall Study|One participant did not receive vaccination due to missing blood sample at randomization.|47
8187557|NCT02314923|20187516|P6|Treated|Overall Study||20
8187558|NCT02314923|20187517|P5|Treated|Overall Study||74
8187559|NCT02314923|20187518|P4|Treated|Overall Study||64
8187560|NCT02314923|20187519|P3|Treated|Overall Study||64
8187561|NCT02314923|20187520|P2|Treated|Overall Study||64
8187562|NCT02314923|20187521|P1|Treated|Overall Study||64
8187563|NCT02314923|20187512|P10|STARTED|Overall Study||20
8187564|NCT02314923|20187513|P9|STARTED|Overall Study||48
8187565|NCT02314923|20187514|P8|STARTED|Overall Study||47
8187566|NCT02314923|20187515|P7|STARTED|Overall Study||48
8187567|NCT02314923|20187516|P6|STARTED|Overall Study||20
8187568|NCT02314923|20187517|P5|STARTED|Overall Study||74
8187569|NCT02314923|20187518|P4|STARTED|Overall Study||64
8187570|NCT02314923|20187519|P3|STARTED|Overall Study||64
8187571|NCT02314923|20187520|P2|STARTED|Overall Study||64
8187572|NCT02314923|20187521|P1|STARTED|Overall Study||64
8187573|NCT02314689|20187614|P1|NOT COMPLETED|Overall Study||0
8187574|NCT02314689|20187614|P1|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
8187575|NCT02314689|20187614|P1|STARTED|Overall Study||4
8187576|NCT02314637|20187620|P2|NOT COMPLETED|Overall Study||14
8187577|NCT02314637|20187621|P1|NOT COMPLETED|Overall Study||16
8187578|NCT02314637|20187620|P2|COMPLETED|Overall Study||75
8187579|NCT02314637|20187621|P1|COMPLETED|Overall Study||135
8187580|NCT02314637|20187620|P2|STARTED|Overall Study||89
8187581|NCT02314637|20187621|P1|STARTED|Overall Study||151
8187582|NCT02314598|20187631|P1|NOT COMPLETED|Overall Study||0
8187583|NCT02314598|20187631|P1|COMPLETED|Overall Study||46
8187584|NCT02314598|20187631|P1|STARTED|Overall Study||46
8187585|NCT02314546|20187640|P3|NOT COMPLETED|Overall Study||0
8187586|NCT02314546|20187641|P2|NOT COMPLETED|Overall Study||0
8187587|NCT02314546|20187642|P1|NOT COMPLETED|Overall Study||0
8187588|NCT02314546|20187640|P3|COMPLETED|Overall Study||5
8187589|NCT02314546|20187641|P2|COMPLETED|Overall Study||5
8187590|NCT02314546|20187642|P1|COMPLETED|Overall Study||5
8187591|NCT02314546|20187640|P3|STARTED|Overall Study||5
8187592|NCT02314546|20187641|P2|STARTED|Overall Study||5
8187593|NCT02314546|20187642|P1|STARTED|Overall Study||5
8187594|NCT02314520|20187670|P2|NOT COMPLETED|Overall Study||0
8187595|NCT02314520|20187671|P1|NOT COMPLETED|Overall Study||0
8187596|NCT02314520|20187670|P2|COMPLETED|Overall Study||80
8187597|NCT02314520|20187671|P1|COMPLETED|Overall Study||72
8187598|NCT02314520|20187670|P2|STARTED|Overall Study||80
8187599|NCT02314520|20187671|P1|STARTED|Overall Study||72
8187600|NCT02314260|20187683|P1|NOT COMPLETED|Overall Study||0
8187601|NCT02314260|20187683|P1|COMPLETED|Overall Study||80
8187602|NCT02314260|20187683|P1|STARTED|Overall Study||80
8187603|NCT02314247|20187692|P3|NOT COMPLETED|Overall Study||1
8187604|NCT02314247|20187693|P2|NOT COMPLETED|Overall Study||6
8187605|NCT02314247|20187694|P1|NOT COMPLETED|Overall Study||9
8187606|NCT02314247|20187692|P3|COMPLETED|Overall Study||0
8187607|NCT02314247|20187693|P2|COMPLETED|Overall Study||0
8187608|NCT02314247|20187694|P1|COMPLETED|Overall Study||0
8187609|NCT02314247|20187692|P3|STARTED|Overall Study||1
8187610|NCT02314247|20187693|P2|STARTED|Overall Study||6
8187611|NCT02314247|20187694|P1|STARTED|Overall Study||9
8187612|NCT02314143|20187719|P3|NOT COMPLETED|Overall Study||9
8187613|NCT02314143|20187720|P2|NOT COMPLETED|Overall Study||10
8187614|NCT02314143|20187721|P1|NOT COMPLETED|Overall Study||8
8187615|NCT02314143|20187719|P3|COMPLETED|Overall Study||7
8187616|NCT02314143|20187720|P2|COMPLETED|Overall Study||6
8187617|NCT02314143|20187721|P1|COMPLETED|Overall Study||8
8187618|NCT02314143|20187719|P3|STARTED|Overall Study||16
8187619|NCT02314143|20187720|P2|STARTED|Overall Study||16
8187620|NCT02314143|20187721|P1|STARTED|Overall Study||16
8187633|NCT02314104|20187799|P3|NOT COMPLETED|Overall Study||18
8187634|NCT02314104|20187800|P2|NOT COMPLETED|Overall Study||20
8187635|NCT02314104|20187801|P1|NOT COMPLETED|Overall Study||14
8187636|NCT02314104|20187799|P3|COMPLETED|Overall Study||53
8187637|NCT02314104|20187800|P2|COMPLETED|Overall Study||58
8187638|NCT02314104|20187801|P1|COMPLETED|Overall Study||57
8187639|NCT02314104|20187799|P3|STARTED|Overall Study||71
8187640|NCT02314104|20187800|P2|STARTED|Overall Study||78
8187641|NCT02314104|20187801|P1|STARTED|Overall Study||71
8187642|NCT02314052|20187821|P6|NOT COMPLETED|Cycles 6 -10.5||0
8187643|NCT02314052|20187822|P5|NOT COMPLETED|Cycles 6 -10.5||0
8187644|NCT02314052|20187823|P4|NOT COMPLETED|Cycles 6 -10.5||0
8187645|NCT02314052|20187824|P3|NOT COMPLETED|Cycles 6 -10.5||0
8187646|NCT02314052|20187825|P2|NOT COMPLETED|Cycles 6 -10.5||0
8187647|NCT02314052|20187826|P1|NOT COMPLETED|Cycles 6 -10.5||0
8187648|NCT02314052|20187821|P6|COMPLETED|Cycles 6 -10.5||0
8187649|NCT02314052|20187822|P5|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
8187650|NCT02314052|20187823|P4|COMPLETED|Cycles 6 -10.5||1
8187651|NCT02314052|20187824|P3|COMPLETED|Cycles 6 -10.5||0
8187652|NCT02314052|20187825|P2|COMPLETED|Cycles 6 -10.5||0
8187653|NCT02314052|20187826|P1|COMPLETED|Cycles 6 -10.5||0
8187654|NCT02314052|20187821|P6|STARTED|Cycles 6 -10.5||0
8187655|NCT02314052|20187822|P5|STARTED|Cycles 6 -10.5||2
8187656|NCT02314052|20187823|P4|STARTED|Cycles 6 -10.5||1
8187657|NCT02314052|20187824|P3|STARTED|Cycles 6 -10.5||0
8187658|NCT02314052|20187825|P2|STARTED|Cycles 6 -10.5||0
8187659|NCT02314052|20187826|P1|STARTED|Cycles 6 -10.5||0
8187660|NCT02314052|20187821|P6|NOT COMPLETED|Cycle Five||0
8187661|NCT02314052|20187822|P5|NOT COMPLETED|Cycle Five||0
8187662|NCT02314052|20187823|P4|NOT COMPLETED|Cycle Five||0
8187663|NCT02314052|20187824|P3|NOT COMPLETED|Cycle Five||1
8187664|NCT02314052|20187825|P2|NOT COMPLETED|Cycle Five||2
8187665|NCT02314052|20187826|P1|NOT COMPLETED|Cycle Five||0
8187666|NCT02314052|20187821|P6|COMPLETED|Cycle Five||0
8187667|NCT02314052|20187822|P5|COMPLETED|Cycle Five||2
8187668|NCT02314052|20187823|P4|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
8187669|NCT02314052|20187824|P3|COMPLETED|Cycle Five||0
8187670|NCT02314052|20187825|P2|COMPLETED|Cycle Five||0
8187671|NCT02314052|20187826|P1|COMPLETED|Cycle Five||0
8187672|NCT02314052|20187821|P6|STARTED|Cycle Five||0
8187673|NCT02314052|20187822|P5|STARTED|Cycle Five||2
8187674|NCT02314052|20187823|P4|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
8187675|NCT02314052|20187824|P3|STARTED|Cycle Five||1
8187676|NCT02314052|20187825|P2|STARTED|Cycle Five||2
8187677|NCT02314052|20187826|P1|STARTED|Cycle Five||0
8187678|NCT02314052|20187821|P6|NOT COMPLETED|Cycle Four||3
8187679|NCT02314052|20187822|P5|NOT COMPLETED|Cycle Four||0
8187680|NCT02314052|20187823|P4|NOT COMPLETED|Cycle Four||1
8187681|NCT02314052|20187824|P3|NOT COMPLETED|Cycle Four||1
8187682|NCT02314052|20187825|P2|NOT COMPLETED|Cycle Four||0
8187683|NCT02314052|20187826|P1|NOT COMPLETED|Cycle Four||3
8187684|NCT02314052|20187821|P6|COMPLETED|Cycle Four||0
8187685|NCT02314052|20187822|P5|COMPLETED|Cycle Four||2
8187686|NCT02314052|20187823|P4|COMPLETED|Cycle Four||0
8187687|NCT02314052|20187824|P3|COMPLETED|Cycle Four||1
8187688|NCT02314052|20187825|P2|COMPLETED|Cycle Four||2
8187689|NCT02314052|20187826|P1|COMPLETED|Cycle Four||0
8187690|NCT02314052|20187821|P6|STARTED|Cycle Four||3
8187691|NCT02314052|20187822|P5|STARTED|Cycle Four||2
8187692|NCT02314052|20187823|P4|STARTED|Cycle Four||1
8187693|NCT02314052|20187824|P3|STARTED|Cycle Four||2
8187694|NCT02314052|20187825|P2|STARTED|Cycle Four||2
8187695|NCT02314052|20187826|P1|STARTED|Cycle Four||3
8187696|NCT02314052|20187821|P6|NOT COMPLETED|Cycle Three||0
8187697|NCT02314052|20187822|P5|NOT COMPLETED|Cycle Three||0
8187698|NCT02314052|20187823|P4|NOT COMPLETED|Cycle Three||0
8187699|NCT02314052|20187824|P3|NOT COMPLETED|Cycle Three||0
8187700|NCT02314052|20187825|P2|NOT COMPLETED|Cycle Three||0
8187701|NCT02314052|20187826|P1|NOT COMPLETED|Cycle Three||0
8187702|NCT02314052|20187821|P6|COMPLETED|Cycle Three||3
8187703|NCT02314052|20187822|P5|COMPLETED|Cycle Three||2
8187704|NCT02314052|20187823|P4|COMPLETED|Cycle Three||1
8187705|NCT02314052|20187824|P3|COMPLETED|Cycle Three||2
8187706|NCT02314052|20187825|P2|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
8187707|NCT02314052|20187826|P1|COMPLETED|Cycle Three||3
8187708|NCT02314052|20187821|P6|STARTED|Cycle Three||3
8187709|NCT02314052|20187822|P5|STARTED|Cycle Three||2
8187710|NCT02314052|20187823|P4|STARTED|Cycle Three||1
8187711|NCT02314052|20187824|P3|STARTED|Cycle Three||2
8187712|NCT02314052|20187825|P2|STARTED|Cycle Three||2
8187713|NCT02314052|20187826|P1|STARTED|Cycle Three||3
8187714|NCT02314052|20187821|P6|NOT COMPLETED|Cycle Two||0
8187715|NCT02314052|20187822|P5|NOT COMPLETED|Cycle Two||4
8187716|NCT02314052|20187823|P4|NOT COMPLETED|Cycle Two||1
8187717|NCT02314052|20187824|P3|NOT COMPLETED|Cycle Two||1
8187718|NCT02314052|20187825|P2|NOT COMPLETED|Cycle Two||1
8187719|NCT02314052|20187826|P1|NOT COMPLETED|Cycle Two||0
8187720|NCT02314052|20187821|P6|COMPLETED|Cycle Two||3
8187721|NCT02314052|20187822|P5|COMPLETED|Cycle Two||2
8187722|NCT02314052|20187823|P4|COMPLETED|Cycle Two||1
8187723|NCT02314052|20187824|P3|COMPLETED|Cycle Two||2
8187724|NCT02314052|20187825|P2|COMPLETED|Cycle Two||2
8187725|NCT02314052|20187826|P1|COMPLETED|Cycle Two||3
8187726|NCT02314052|20187821|P6|STARTED|Cycle Two||3
8187727|NCT02314052|20187822|P5|STARTED|Cycle Two||6
8187728|NCT02314052|20187823|P4|STARTED|Cycle Two||2
8187729|NCT02314052|20187824|P3|STARTED|Cycle Two||3
8187730|NCT02314052|20187825|P2|STARTED|Cycle Two||3
8187731|NCT02314052|20187826|P1|STARTED|Cycle Two||3
8187732|NCT02314052|20187821|P6|NOT COMPLETED|Cycle One||0
8187733|NCT02314052|20187822|P5|NOT COMPLETED|Cycle One||0
8187734|NCT02314052|20187823|P4|NOT COMPLETED|Cycle One||1
8187735|NCT02314052|20187824|P3|NOT COMPLETED|Cycle One||0
8187736|NCT02314052|20187825|P2|NOT COMPLETED|Cycle One||0
8187737|NCT02314052|20187826|P1|NOT COMPLETED|Cycle One||0
8187738|NCT02314052|20187821|P6|COMPLETED|Cycle One||3
8187739|NCT02314052|20187822|P5|COMPLETED|Cycle One||6
8187740|NCT02314052|20187823|P4|COMPLETED|Cycle One||2
8187741|NCT02314052|20187824|P3|COMPLETED|Cycle One||3
8187742|NCT02314052|20187825|P2|COMPLETED|Cycle One||3
8187743|NCT02314052|20187826|P1|COMPLETED|Cycle One||3
8187744|NCT02314052|20187821|P6|STARTED|Cycle One||3
8187745|NCT02314052|20187822|P5|STARTED|Cycle One||6
8187746|NCT02314052|20187823|P4|STARTED|Cycle One||3
8187747|NCT02314052|20187824|P3|STARTED|Cycle One||3
8187748|NCT02314052|20187825|P2|STARTED|Cycle One||3
8187749|NCT02314052|20187826|P1|STARTED|Cycle One||3
8187750|NCT02314026|20187894|P1|NOT COMPLETED|Overall Study||28
8187751|NCT02314026|20187894|P1|COMPLETED|Overall Study||107
8187752|NCT02314026|20187894|P1|STARTED|Overall Study||135
8187759|NCT02313909|20187912|P2|NOT COMPLETED|Overall Study||50
8187760|NCT02313909|20187913|P1|NOT COMPLETED|Overall Study||57
8187761|NCT02313909|20187912|P2|COMPLETED|Overall Study||3554
8187762|NCT02313909|20187913|P1|COMPLETED|Overall Study||3552
8187763|NCT02313909|20187912|P2|Treated|Overall Study||3559
8187764|NCT02313909|20187913|P1|Treated|Overall Study||3562
8187765|NCT02313909|20187912|P2|STARTED|Overall Study||3604
8187766|NCT02313909|20187913|P1|STARTED|Overall Study||3609
8187767|NCT02313766|20187936|P3|NOT COMPLETED|Overall Study||0
8187768|NCT02313766|20187937|P2|NOT COMPLETED|Overall Study||3
8187769|NCT02313766|20187938|P1|NOT COMPLETED|Overall Study||1
8187770|NCT02313766|20187936|P3|COMPLETED|Overall Study||50
8187771|NCT02313766|20187937|P2|COMPLETED|Overall Study||47
8187772|NCT02313766|20187938|P1|COMPLETED|Overall Study||49
8187773|NCT02313766|20187936|P3|STARTED|Overall Study||50
8187774|NCT02313766|20187937|P2|STARTED|Overall Study||50
8187775|NCT02313766|20187938|P1|STARTED|Overall Study||50
8187776|NCT02313675|20187956|P4|NOT COMPLETED|Overall Study||0
8187777|NCT02313675|20187957|P3|NOT COMPLETED|Overall Study||0
8187778|NCT02313675|20187958|P2|NOT COMPLETED|Overall Study||0
8187779|NCT02313675|20187959|P1|NOT COMPLETED|Overall Study||0
8187780|NCT02313675|20187956|P4|COMPLETED|Overall Study||11
8187781|NCT02313675|20187957|P3|COMPLETED|Overall Study||11
8187782|NCT02313675|20187958|P2|COMPLETED|Overall Study||11
8187783|NCT02313675|20187959|P1|COMPLETED|Overall Study||11
8187784|NCT02313675|20187956|P4|STARTED|Overall Study||11
8187785|NCT02313675|20187957|P3|STARTED|Overall Study||11
8187786|NCT02313675|20187958|P2|STARTED|Overall Study||11
8187787|NCT02313675|20187959|P1|STARTED|Overall Study||11
8187794|NCT02313558|20187992|P2|NOT COMPLETED|Overall Study||4
8187795|NCT02313558|20187993|P1|NOT COMPLETED|Overall Study||6
8187796|NCT02313558|20187992|P2|COMPLETED|Overall Study||46
8187797|NCT02313558|20187993|P1|COMPLETED|Overall Study||44
8187798|NCT02313558|20187992|P2|STARTED|Overall Study||50
8187799|NCT02313558|20187993|P1|STARTED|Overall Study||50
8187800|NCT02313506|20188007|P2|NOT COMPLETED|Overall Study||0
8187801|NCT02313506|20188008|P1|NOT COMPLETED|Overall Study||0
8187802|NCT02313506|20188007|P2|COMPLETED|Overall Study||17
8187803|NCT02313506|20188008|P1|COMPLETED|Overall Study||17
8187804|NCT02313506|20188007|P2|STARTED|Overall Study||17
8187805|NCT02313506|20188008|P1|STARTED|Overall Study||17
8187806|NCT02313454|20188028|P2|NOT COMPLETED|Treatment 2||0
8187807|NCT02313454|20188029|P1|NOT COMPLETED|Treatment 2||0
8187808|NCT02313454|20188028|P2|COMPLETED|Treatment 2||10
8187809|NCT02313454|20188029|P1|COMPLETED|Treatment 2||8
8187810|NCT02313454|20188028|P2|STARTED|Treatment 2|1 participant did not receive the second application.|10
8187811|NCT02313454|20188029|P1|STARTED|Treatment 2|1 participant did not receive the second application.|8
8187812|NCT02313454|20188028|P2|NOT COMPLETED|Treatment 1||0
8187813|NCT02313454|20188029|P1|NOT COMPLETED|Treatment 1||0
8187814|NCT02313454|20188028|P2|COMPLETED|Treatment 1||11
8187815|NCT02313454|20188029|P1|COMPLETED|Treatment 1||9
8187816|NCT02313454|20188028|P2|STARTED|Treatment 1||11
8187817|NCT02313454|20188029|P1|STARTED|Treatment 1||9
8187818|NCT02313233|20188039|P2|NOT COMPLETED|Overall Study||3
8187819|NCT02313233|20188040|P1|NOT COMPLETED|Overall Study||2
8187820|NCT02313233|20188039|P2|COMPLETED|Overall Study||18
8187821|NCT02313233|20188040|P1|COMPLETED|Overall Study||18
8187822|NCT02313233|20188039|P2|STARTED|Overall Study||21
8187823|NCT02313233|20188040|P1|STARTED|Overall Study||20
8187824|NCT02313155|20188062|P2|NOT COMPLETED|Overall Study||1
8187825|NCT02313155|20188063|P1|NOT COMPLETED|Overall Study||0
8187826|NCT02313155|20188062|P2|COMPLETED|Overall Study||54
8187827|NCT02313155|20188063|P1|COMPLETED|Overall Study||55
8187828|NCT02313155|20188062|P2|STARTED|Overall Study||55
8187829|NCT02313155|20188063|P1|STARTED|Overall Study||55
8187830|NCT02312934|20188113|P2|NOT COMPLETED|Overall Study||0
8187831|NCT02312934|20188114|P1|NOT COMPLETED|Overall Study||2
8187832|NCT02312934|20188113|P2|COMPLETED|Overall Study||11
8187833|NCT02312934|20188114|P1|COMPLETED|Overall Study||9
8187834|NCT02312934|20188113|P2|STARTED|Overall Study||11
8187835|NCT02312934|20188114|P1|STARTED|Overall Study||11
8187836|NCT02312882|20188122|P1|NOT COMPLETED|Overall Study||4
8187837|NCT02312882|20188122|P1|COMPLETED|Overall Study||36
8187838|NCT02312882|20188122|P1|STARTED|Overall Study||40
8187839|NCT02312856|20188126|P1|NOT COMPLETED|Overall Study||4
8187840|NCT02312856|20188126|P1|COMPLETED|Overall Study||30
8187841|NCT02312856|20188126|P1|STARTED|Overall Study||34
8187842|NCT02312765|20188132|P2|NOT COMPLETED|Overall Study||36
8187843|NCT02312765|20188133|P1|NOT COMPLETED|Overall Study||55
8187844|NCT02312765|20188132|P2|COMPLETED|Overall Study||36
8187845|NCT02312765|20188133|P1|COMPLETED|Overall Study||19
8187846|NCT02312765|20188132|P2|STARTED|Overall Study||72
8187847|NCT02312765|20188133|P1|STARTED|Overall Study||74
8187848|NCT02312739|20188141|P2|NOT COMPLETED|Overall Study||2
8187849|NCT02312739|20188142|P1|NOT COMPLETED|Overall Study||6
8187850|NCT02312739|20188141|P2|COMPLETED|Overall Study||34
8187851|NCT02312739|20188142|P1|COMPLETED|Overall Study||30
8187852|NCT02312739|20188141|P2|Withdrawn Prior to Procedure|Overall Study||2
8187853|NCT02312739|20188142|P1|Withdrawn Prior to Procedure|Overall Study||6
8187854|NCT02312739|20188141|P2|STARTED|Overall Study||36
8187855|NCT02312739|20188142|P1|STARTED|Overall Study||36
8187856|NCT02312726|20188156|P3|NOT COMPLETED|Overall Study||67
8187857|NCT02312726|20188157|P2|NOT COMPLETED|Overall Study||0
8187858|NCT02312726|20188158|P1|NOT COMPLETED|Overall Study||0
8187859|NCT02312726|20188156|P3|COMPLETED|Overall Study||0
8187860|NCT02312726|20188157|P2|COMPLETED|Overall Study||30
8187861|NCT02312726|20188158|P1|COMPLETED|Overall Study||38
8187862|NCT02312726|20188156|P3|STARTED|Overall Study||67
8187863|NCT02312726|20188157|P2|STARTED|Overall Study||30
8187864|NCT02312726|20188158|P1|STARTED|Overall Study||38
8187865|NCT02312713|20188173|P3|NOT COMPLETED|Overall Study||5
8187866|NCT02312713|20188174|P2|NOT COMPLETED|Overall Study||30
8187867|NCT02312713|20188175|P1|NOT COMPLETED|Overall Study||11
8187868|NCT02312713|20188173|P3|COMPLETED|Overall Study||63
8187869|NCT02312713|20188174|P2|COMPLETED|Overall Study||112
8187870|NCT02312713|20188175|P1|COMPLETED|Overall Study||129
8187871|NCT02312713|20188173|P3|STARTED|Overall Study||68
8187872|NCT02312713|20188174|P2|STARTED|Overall Study||142
8187873|NCT02312713|20188175|P1|STARTED|Overall Study||140
8187874|NCT02312687|20188219|P1|NOT COMPLETED|Overall Study||1
8187875|NCT02312687|20188219|P1|COMPLETED|Overall Study||19
8187876|NCT02312687|20188219|P1|STARTED|Overall Study||20
8187877|NCT02312622|20188250|P3|NOT COMPLETED|Overall Study||0
8187878|NCT02312622|20188251|P2|NOT COMPLETED|Overall Study||0
8187879|NCT02312622|20188252|P1|NOT COMPLETED|Overall Study||0
8187880|NCT02312622|20188250|P3|COMPLETED|Overall Study||12
8187881|NCT02312622|20188251|P2|COMPLETED|Overall Study||3
8187882|NCT02312622|20188252|P1|COMPLETED|Overall Study||12
8187883|NCT02312622|20188250|P3|STARTED|Overall Study||12
8187884|NCT02312622|20188251|P2|STARTED|Overall Study||3
8187885|NCT02312622|20188252|P1|STARTED|Overall Study||12
8187886|NCT02312310|20188280|P4|NOT COMPLETED|Overall Study||0
8187887|NCT02312310|20188281|P3|NOT COMPLETED|Overall Study||3
8187888|NCT02312310|20188282|P2|NOT COMPLETED|Overall Study||2
8187889|NCT02312310|20188283|P1|NOT COMPLETED|Overall Study||2
8187890|NCT02312310|20188280|P4|COMPLETED|Overall Study||52
8187891|NCT02312310|20188281|P3|COMPLETED|Overall Study||50
8187892|NCT02312310|20188282|P2|COMPLETED|Overall Study||51
8187893|NCT02312310|20188283|P1|COMPLETED|Overall Study||51
8187894|NCT02312310|20188280|P4|STARTED|Overall Study||52
8187895|NCT02312310|20188281|P3|STARTED|Overall Study||53
8187896|NCT02312310|20188282|P2|STARTED|Overall Study||53
8187897|NCT02312310|20188283|P1|STARTED|Overall Study||53
8187898|NCT02312258|20188311|P2|NOT COMPLETED|Overall Study||359
8187899|NCT02312258|20188312|P1|NOT COMPLETED|Overall Study||251
8187900|NCT02312258|20188311|P2|COMPLETED|Overall Study||66
8187901|NCT02312258|20188312|P1|COMPLETED|Overall Study||30
8187902|NCT02312258|20188311|P2|STARTED|Overall Study||425
8187903|NCT02312258|20188312|P1|STARTED|Overall Study||281
8187904|NCT02312219|20188320|P2|NOT COMPLETED|Overall Study||6
8187905|NCT02312219|20188321|P1|NOT COMPLETED|Overall Study||1
8187906|NCT02312219|20188320|P2|COMPLETED|Overall Study||16
8187907|NCT02312219|20188321|P1|COMPLETED|Overall Study||12
8187908|NCT02312219|20188320|P2|STARTED|Overall Study||22
8187909|NCT02312219|20188321|P1|STARTED|Overall Study||13
8187910|NCT02312206|20188331|P2|NOT COMPLETED|Overall Study||130
8187911|NCT02312206|20188332|P1|NOT COMPLETED|Overall Study||130
8187912|NCT02312206|20188331|P2|COMPLETED|Overall Study||0
8187913|NCT02312206|20188332|P1|COMPLETED|Overall Study||0
8187914|NCT02312206|20188331|P2|Informed Consent Obtained|Overall Study||130
8187915|NCT02312206|20188332|P1|Informed Consent Obtained|Overall Study||130
8187916|NCT02312206|20188331|P2|STARTED|Overall Study||130
8187917|NCT02312206|20188332|P1|STARTED|Overall Study||130
8187918|NCT02312154|20188338|P1|NOT COMPLETED|Overall Study||1
8187919|NCT02312154|20188338|P1|COMPLETED|Overall Study||24
8187920|NCT02312154|20188338|P1|STARTED|Overall Study||25
8187921|NCT02312063|20188355|P2|NOT COMPLETED|Overall Study||1
8187922|NCT02312063|20188356|P1|NOT COMPLETED|Overall Study||0
8187923|NCT02312063|20188355|P2|COMPLETED|Overall Study||24
8187924|NCT02312063|20188356|P1|COMPLETED|Overall Study||23
8187925|NCT02312063|20188355|P2|STARTED|Overall Study||25
8187926|NCT02312063|20188356|P1|STARTED|Overall Study||23
8187927|NCT02311972|20188366|P2|NOT COMPLETED|Overall Study||0
8187928|NCT02311972|20188367|P1|NOT COMPLETED|Overall Study||0
8187929|NCT02311972|20188366|P2|COMPLETED|Overall Study||8
8187930|NCT02311972|20188367|P1|COMPLETED|Overall Study||12
8187931|NCT02311972|20188366|P2|STARTED|Overall Study||8
8187932|NCT02311972|20188367|P1|STARTED|Overall Study||12
8187933|NCT02311907|20188386|P2|NOT COMPLETED|Overall Study||0
8187934|NCT02311907|20188387|P1|NOT COMPLETED|Overall Study||0
8187935|NCT02311907|20188386|P2|COMPLETED|Overall Study||91
8187936|NCT02311907|20188387|P1|COMPLETED|Overall Study||94
8187937|NCT02311907|20188386|P2|STARTED|Overall Study||91
8187938|NCT02311907|20188387|P1|STARTED|Overall Study||94
8187939|NCT02311894|20188409|P1|NOT COMPLETED|Overall Study||4
8187940|NCT02311894|20188409|P1|COMPLETED|Overall Study||78
8187941|NCT02311894|20188409|P1|Modified ITT Population|Overall Study||81
8187942|NCT02311894|20188409|P1|STARTED|Overall Study||82
8187943|NCT02311881|20188421|P3|NOT COMPLETED|Overall Study||41
8187944|NCT02311881|20188422|P2|NOT COMPLETED|Overall Study||43
8187945|NCT02311881|20188423|P1|NOT COMPLETED|Overall Study||35
8187946|NCT02311881|20188421|P3|COMPLETED|Overall Study||196
8187947|NCT02311881|20188422|P2|COMPLETED|Overall Study||193
8187948|NCT02311881|20188423|P1|COMPLETED|Overall Study||200
8187949|NCT02311881|20188421|P3|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
8187950|NCT02311881|20188422|P2|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
8187951|NCT02311881|20188423|P1|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
8187952|NCT02311881|20188421|P3|STARTED|Overall Study|Started refers to all randomized participants.|237
8187953|NCT02311881|20188422|P2|STARTED|Overall Study|Started refers to all randomized participants.|236
8187954|NCT02311881|20188423|P1|STARTED|Overall Study|Started refers to all randomized participants.|235
8187955|NCT02311478|20188458|P1|NOT COMPLETED|Overall Study||7
8187956|NCT02311478|20188458|P1|COMPLETED|Overall Study||72
8187957|NCT02311478|20188458|P1|IUD Insertion|Overall Study||78
8187958|NCT02311478|20188458|P1|STARTED|Overall Study||79
8187975|NCT02311309|20188507|P3|NOT COMPLETED|Overall Study||0
8187976|NCT02311309|20188508|P2|NOT COMPLETED|Overall Study||0
8187977|NCT02311309|20188509|P1|NOT COMPLETED|Overall Study||0
8187978|NCT02311309|20188507|P3|COMPLETED|Overall Study||863
8187979|NCT02311309|20188508|P2|COMPLETED|Overall Study||35
8187980|NCT02311309|20188509|P1|COMPLETED|Overall Study||541
8187981|NCT02311309|20188507|P3|STARTED|Overall Study||863
8187982|NCT02311309|20188508|P2|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
8187983|NCT02311309|20188509|P1|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
8187984|NCT02311153|20188522|P2|NOT COMPLETED|Overall Study||7
8187985|NCT02311153|20188523|P1|NOT COMPLETED|Overall Study||5
8187986|NCT02311153|20188522|P2|COMPLETED|Overall Study||42
8187987|NCT02311153|20188523|P1|COMPLETED|Overall Study||48
8187988|NCT02311153|20188522|P2|STARTED|Overall Study||49
8187989|NCT02311153|20188523|P1|STARTED|Overall Study||53
8187990|NCT02310906|20188543|P4|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||8
8187991|NCT02310906|20188544|P3|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||2
8187992|NCT02310906|20188545|P2|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
8187993|NCT02310906|20188546|P1|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
8187994|NCT02310906|20188543|P4|COMPLETED|Part 2: Open Label Phase (168 Weeks)||6
8187995|NCT02310906|20188544|P3|COMPLETED|Part 2: Open Label Phase (168 Weeks)||23
8187996|NCT02310906|20188545|P2|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
8187997|NCT02310906|20188546|P1|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
8187998|NCT02310906|20188543|P4|STARTED|Part 2: Open Label Phase (168 Weeks)||14
8187999|NCT02310906|20188544|P3|STARTED|Part 2: Open Label Phase (168 Weeks)|4 participants from Part 1(Placebo) + 8 participants from Part 1(Golodirsen) +13 new participants|25
8188000|NCT02310906|20188545|P2|STARTED|Part 2: Open Label Phase (168 Weeks)||0
8188001|NCT02310906|20188546|P1|STARTED|Part 2: Open Label Phase (168 Weeks)||0
8188002|NCT02310906|20188543|P4|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8188003|NCT02310906|20188544|P3|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8188004|NCT02310906|20188545|P2|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8188005|NCT02310906|20188546|P1|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8188006|NCT02310906|20188543|P4|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8188007|NCT02310906|20188544|P3|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
8188008|NCT02310906|20188545|P2|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||8
8188009|NCT02310906|20188546|P1|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||4
8188010|NCT02310906|20188543|P4|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188011|NCT02310906|20188544|P3|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188012|NCT02310906|20188545|P2|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
8188013|NCT02310906|20188546|P1|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188014|NCT02310906|20188543|P4|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188015|NCT02310906|20188544|P3|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188016|NCT02310906|20188545|P2|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
8188017|NCT02310906|20188546|P1|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188018|NCT02310906|20188543|P4|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188019|NCT02310906|20188544|P3|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188020|NCT02310906|20188545|P2|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
8188021|NCT02310906|20188546|P1|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188022|NCT02310906|20188543|P4|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188023|NCT02310906|20188544|P3|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188024|NCT02310906|20188545|P2|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
8188025|NCT02310906|20188546|P1|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
8188026|NCT02310906|20188543|P4|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
8188027|NCT02310906|20188544|P3|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
8188028|NCT02310906|20188545|P2|STARTED|Part 1: Double Blind Phase (12 Weeks)||8
8188029|NCT02310906|20188546|P1|STARTED|Part 1: Double Blind Phase (12 Weeks)||4
8188030|NCT02310789|20188625|P1|NOT COMPLETED|Overall Study||1
8188031|NCT02310789|20188625|P1|COMPLETED|Overall Study||7
8188032|NCT02310789|20188625|P1|STARTED|Overall Study||8
8188033|NCT02310776|20188630|P1|NOT COMPLETED|Overall Study||0
8188034|NCT02310776|20188630|P1|COMPLETED|Overall Study||501
8188035|NCT02310776|20188630|P1|STARTED|Overall Study||501
8188036|NCT02310763|20188637|P3|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
8188037|NCT02310763|20188638|P2|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
8188038|NCT02310763|20188639|P1|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
8188039|NCT02310763|20188637|P3|COMPLETED|Period 2 (Weeks 49 to 96)||22
8188040|NCT02310763|20188638|P2|COMPLETED|Period 2 (Weeks 49 to 96)||21
8188041|NCT02310763|20188639|P1|COMPLETED|Period 2 (Weeks 49 to 96)||22
8188042|NCT02310763|20188637|P3|STARTED|Period 2 (Weeks 49 to 96)||38
8188043|NCT02310763|20188638|P2|STARTED|Period 2 (Weeks 49 to 96)||37
8188044|NCT02310763|20188639|P1|STARTED|Period 2 (Weeks 49 to 96)||38
8188045|NCT02310763|20188637|P3|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
8188046|NCT02310763|20188638|P2|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
8188047|NCT02310763|20188639|P1|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3
8188048|NCT02310763|20188637|P3|COMPLETED|Period 1 (Weeks 1 to 48)||38
8188049|NCT02310763|20188638|P2|COMPLETED|Period 1 (Weeks 1 to 48)||37
8188050|NCT02310763|20188639|P1|COMPLETED|Period 1 (Weeks 1 to 48)||38
8188051|NCT02310763|20188637|P3|STARTED|Period 1 (Weeks 1 to 48)||40
8188052|NCT02310763|20188638|P2|STARTED|Period 1 (Weeks 1 to 48)||39
8188053|NCT02310763|20188639|P1|STARTED|Period 1 (Weeks 1 to 48)||41
8188054|NCT02310750|20188842|P16|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188055|NCT02310750|20188843|P15|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188056|NCT02310750|20188844|P14|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188057|NCT02310750|20188845|P13|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188058|NCT02310750|20188846|P12|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188059|NCT02310750|20188847|P11|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188060|NCT02310750|20188848|P10|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188061|NCT02310750|20188849|P9|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188062|NCT02310750|20188850|P8|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188063|NCT02310750|20188851|P7|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188064|NCT02310750|20188852|P6|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188065|NCT02310750|20188853|P5|NOT COMPLETED|HP MAD and Fasted/Fed||1
8188066|NCT02310750|20188854|P4|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188067|NCT02310750|20188855|P3|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188068|NCT02310750|20188856|P2|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188069|NCT02310750|20188857|P1|NOT COMPLETED|HP MAD and Fasted/Fed||0
8188070|NCT02310750|20188842|P16|COMPLETED|HP MAD and Fasted/Fed||2
8188071|NCT02310750|20188843|P15|COMPLETED|HP MAD and Fasted/Fed||2
8188072|NCT02310750|20188844|P14|COMPLETED|HP MAD and Fasted/Fed||2
8188073|NCT02310750|20188845|P13|COMPLETED|HP MAD and Fasted/Fed||2
8188074|NCT02310750|20188846|P12|COMPLETED|HP MAD and Fasted/Fed||2
8188075|NCT02310750|20188847|P11|COMPLETED|HP MAD and Fasted/Fed||2
8188076|NCT02310750|20188848|P10|COMPLETED|HP MAD and Fasted/Fed||0
8188077|NCT02310750|20188849|P9|COMPLETED|HP MAD and Fasted/Fed||0
8188078|NCT02310750|20188850|P8|COMPLETED|HP MAD and Fasted/Fed||0
8188079|NCT02310750|20188851|P7|COMPLETED|HP MAD and Fasted/Fed||2
8188080|NCT02310750|20188852|P6|COMPLETED|HP MAD and Fasted/Fed||0
8188081|NCT02310750|20188853|P5|COMPLETED|HP MAD and Fasted/Fed||4
8188082|NCT02310750|20188854|P4|COMPLETED|HP MAD and Fasted/Fed||0
8188083|NCT02310750|20188855|P3|COMPLETED|HP MAD and Fasted/Fed||0
8188084|NCT02310750|20188856|P2|COMPLETED|HP MAD and Fasted/Fed||0
8188085|NCT02310750|20188857|P1|COMPLETED|HP MAD and Fasted/Fed||0
8188086|NCT02310750|20188842|P16|STARTED|HP MAD and Fasted/Fed||2
8188087|NCT02310750|20188843|P15|STARTED|HP MAD and Fasted/Fed||2
8188088|NCT02310750|20188844|P14|STARTED|HP MAD and Fasted/Fed||2
8188089|NCT02310750|20188845|P13|STARTED|HP MAD and Fasted/Fed||2
8188090|NCT02310750|20188846|P12|STARTED|HP MAD and Fasted/Fed||2
8188091|NCT02310750|20188847|P11|STARTED|HP MAD and Fasted/Fed||2
8188092|NCT02310750|20188848|P10|STARTED|HP MAD and Fasted/Fed||0
8188093|NCT02310750|20188849|P9|STARTED|HP MAD and Fasted/Fed||0
8188094|NCT02310750|20188850|P8|STARTED|HP MAD and Fasted/Fed||0
8188095|NCT02310750|20188851|P7|STARTED|HP MAD and Fasted/Fed||2
8188096|NCT02310750|20188852|P6|STARTED|HP MAD and Fasted/Fed||0
8188097|NCT02310750|20188853|P5|STARTED|HP MAD and Fasted/Fed||5
8188098|NCT02310750|20188854|P4|STARTED|HP MAD and Fasted/Fed||0
8188099|NCT02310750|20188855|P3|STARTED|HP MAD and Fasted/Fed||0
8188100|NCT02310750|20188856|P2|STARTED|HP MAD and Fasted/Fed||0
8188101|NCT02310750|20188857|P1|STARTED|HP MAD and Fasted/Fed||0
8188102|NCT02310750|20188842|P16|NOT COMPLETED|HP Washout 2||0
8188103|NCT02310750|20188843|P15|NOT COMPLETED|HP Washout 2||0
8188104|NCT02310750|20188844|P14|NOT COMPLETED|HP Washout 2||0
8188105|NCT02310750|20188845|P13|NOT COMPLETED|HP Washout 2||0
8188106|NCT02310750|20188846|P12|NOT COMPLETED|HP Washout 2||0
8188107|NCT02310750|20188847|P11|NOT COMPLETED|HP Washout 2||0
8188108|NCT02310750|20188848|P10|NOT COMPLETED|HP Washout 2||0
8188109|NCT02310750|20188849|P9|NOT COMPLETED|HP Washout 2||0
8188110|NCT02310750|20188850|P8|NOT COMPLETED|HP Washout 2||0
8188111|NCT02310750|20188851|P7|NOT COMPLETED|HP Washout 2||7
8188112|NCT02310750|20188852|P6|NOT COMPLETED|HP Washout 2||0
8188113|NCT02310750|20188853|P5|NOT COMPLETED|HP Washout 2||1
8188114|NCT02310750|20188854|P4|NOT COMPLETED|HP Washout 2||0
8188115|NCT02310750|20188855|P3|NOT COMPLETED|HP Washout 2||0
8188116|NCT02310750|20188856|P2|NOT COMPLETED|HP Washout 2||0
8188117|NCT02310750|20188857|P1|NOT COMPLETED|HP Washout 2||0
8188118|NCT02310750|20188842|P16|COMPLETED|HP Washout 2||2
8188119|NCT02310750|20188843|P15|COMPLETED|HP Washout 2||2
8188120|NCT02310750|20188844|P14|COMPLETED|HP Washout 2||2
8188121|NCT02310750|20188845|P13|COMPLETED|HP Washout 2||2
8188122|NCT02310750|20188846|P12|COMPLETED|HP Washout 2||2
8188123|NCT02310750|20188847|P11|COMPLETED|HP Washout 2||2
8188124|NCT02310750|20188848|P10|COMPLETED|HP Washout 2||0
8188125|NCT02310750|20188849|P9|COMPLETED|HP Washout 2||0
8188126|NCT02310750|20188850|P8|COMPLETED|HP Washout 2||0
8188127|NCT02310750|20188851|P7|COMPLETED|HP Washout 2||2
8188128|NCT02310750|20188852|P6|COMPLETED|HP Washout 2||0
8188129|NCT02310750|20188853|P5|COMPLETED|HP Washout 2||5
8188130|NCT02310750|20188854|P4|COMPLETED|HP Washout 2||0
8188131|NCT02310750|20188855|P3|COMPLETED|HP Washout 2||0
8188132|NCT02310750|20188856|P2|COMPLETED|HP Washout 2||0
8188133|NCT02310750|20188857|P1|COMPLETED|HP Washout 2||0
8188134|NCT02310750|20188842|P16|STARTED|HP Washout 2||2
8188135|NCT02310750|20188843|P15|STARTED|HP Washout 2||2
8188136|NCT02310750|20188844|P14|STARTED|HP Washout 2||2
8188137|NCT02310750|20188845|P13|STARTED|HP Washout 2||2
8188138|NCT02310750|20188846|P12|STARTED|HP Washout 2||2
8188139|NCT02310750|20188847|P11|STARTED|HP Washout 2||2
8188140|NCT02310750|20188848|P10|STARTED|HP Washout 2||0
8188141|NCT02310750|20188849|P9|STARTED|HP Washout 2||0
8188142|NCT02310750|20188850|P8|STARTED|HP Washout 2||0
8188143|NCT02310750|20188851|P7|STARTED|HP Washout 2||9
8188144|NCT02310750|20188852|P6|STARTED|HP Washout 2||0
8188145|NCT02310750|20188853|P5|STARTED|HP Washout 2||6
8188146|NCT02310750|20188854|P4|STARTED|HP Washout 2||0
8188147|NCT02310750|20188855|P3|STARTED|HP Washout 2||0
8188148|NCT02310750|20188856|P2|STARTED|HP Washout 2||0
8188149|NCT02310750|20188857|P1|STARTED|HP Washout 2||0
8188150|NCT02310750|20188842|P16|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188151|NCT02310750|20188843|P15|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188152|NCT02310750|20188844|P14|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188153|NCT02310750|20188845|P13|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188154|NCT02310750|20188846|P12|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188155|NCT02310750|20188847|P11|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188156|NCT02310750|20188848|P10|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
8188157|NCT02310750|20188849|P9|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
8188158|NCT02310750|20188850|P8|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188159|NCT02310750|20188851|P7|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188160|NCT02310750|20188852|P6|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188161|NCT02310750|20188853|P5|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188162|NCT02310750|20188854|P4|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
8188163|NCT02310750|20188855|P3|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188164|NCT02310750|20188856|P2|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188165|NCT02310750|20188857|P1|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188166|NCT02310750|20188842|P16|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188167|NCT02310750|20188843|P15|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188168|NCT02310750|20188844|P14|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188169|NCT02310750|20188845|P13|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188170|NCT02310750|20188846|P12|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188171|NCT02310750|20188847|P11|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188172|NCT02310750|20188848|P10|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
8188173|NCT02310750|20188849|P9|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
8188174|NCT02310750|20188850|P8|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
8188175|NCT02310750|20188851|P7|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
8188176|NCT02310750|20188852|P6|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
8188177|NCT02310750|20188853|P5|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
8188178|NCT02310750|20188854|P4|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
8188179|NCT02310750|20188855|P3|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
8188180|NCT02310750|20188856|P2|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188181|NCT02310750|20188857|P1|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188182|NCT02310750|20188842|P16|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188183|NCT02310750|20188843|P15|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188184|NCT02310750|20188844|P14|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188185|NCT02310750|20188845|P13|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188186|NCT02310750|20188846|P12|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188187|NCT02310750|20188847|P11|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
8188188|NCT02310750|20188848|P10|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
8188189|NCT02310750|20188849|P9|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
8188190|NCT02310750|20188850|P8|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
8188191|NCT02310750|20188851|P7|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
8188192|NCT02310750|20188852|P6|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
8188193|NCT02310750|20188853|P5|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
8188194|NCT02310750|20188854|P4|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
8188195|NCT02310750|20188855|P3|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
8188196|NCT02310750|20188856|P2|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188197|NCT02310750|20188857|P1|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
8188198|NCT02310750|20188842|P16|NOT COMPLETED|HP Washout 1||0
8188199|NCT02310750|20188843|P15|NOT COMPLETED|HP Washout 1||0
8188200|NCT02310750|20188844|P14|NOT COMPLETED|HP Washout 1||0
8188201|NCT02310750|20188845|P13|NOT COMPLETED|HP Washout 1||0
8188202|NCT02310750|20188846|P12|NOT COMPLETED|HP Washout 1||0
8188203|NCT02310750|20188847|P11|NOT COMPLETED|HP Washout 1||0
8188204|NCT02310750|20188848|P10|NOT COMPLETED|HP Washout 1||0
8188205|NCT02310750|20188849|P9|NOT COMPLETED|HP Washout 1||0
8188206|NCT02310750|20188850|P8|NOT COMPLETED|HP Washout 1||0
8188207|NCT02310750|20188851|P7|NOT COMPLETED|HP Washout 1||3
8188208|NCT02310750|20188852|P6|NOT COMPLETED|HP Washout 1||2
8188209|NCT02310750|20188853|P5|NOT COMPLETED|HP Washout 1||2
8188210|NCT02310750|20188854|P4|NOT COMPLETED|HP Washout 1||1
8188211|NCT02310750|20188855|P3|NOT COMPLETED|HP Washout 1||1
8188212|NCT02310750|20188856|P2|NOT COMPLETED|HP Washout 1||0
8188213|NCT02310750|20188857|P1|NOT COMPLETED|HP Washout 1||0
8188214|NCT02310750|20188842|P16|COMPLETED|HP Washout 1||2
8188215|NCT02310750|20188843|P15|COMPLETED|HP Washout 1||2
8188216|NCT02310750|20188844|P14|COMPLETED|HP Washout 1||2
8188217|NCT02310750|20188845|P13|COMPLETED|HP Washout 1||2
8188218|NCT02310750|20188846|P12|COMPLETED|HP Washout 1||2
8188219|NCT02310750|20188847|P11|COMPLETED|HP Washout 1||2
8188220|NCT02310750|20188848|P10|COMPLETED|HP Washout 1||0
8188221|NCT02310750|20188849|P9|COMPLETED|HP Washout 1||0
8188222|NCT02310750|20188850|P8|COMPLETED|HP Washout 1||0
8188223|NCT02310750|20188851|P7|COMPLETED|HP Washout 1||9
8188224|NCT02310750|20188852|P6|COMPLETED|HP Washout 1||6
8188225|NCT02310750|20188853|P5|COMPLETED|HP Washout 1||6
8188226|NCT02310750|20188854|P4|COMPLETED|HP Washout 1||4
8188227|NCT02310750|20188855|P3|COMPLETED|HP Washout 1||5
8188228|NCT02310750|20188856|P2|COMPLETED|HP Washout 1||0
8188229|NCT02310750|20188857|P1|COMPLETED|HP Washout 1||0
8188230|NCT02310750|20188842|P16|STARTED|HP Washout 1||2
8188231|NCT02310750|20188843|P15|STARTED|HP Washout 1||2
8188232|NCT02310750|20188844|P14|STARTED|HP Washout 1||2
8188233|NCT02310750|20188845|P13|STARTED|HP Washout 1||2
8188234|NCT02310750|20188846|P12|STARTED|HP Washout 1||2
8188235|NCT02310750|20188847|P11|STARTED|HP Washout 1||2
8188236|NCT02310750|20188848|P10|STARTED|HP Washout 1||0
8188237|NCT02310750|20188849|P9|STARTED|HP Washout 1||0
8188238|NCT02310750|20188850|P8|STARTED|HP Washout 1||0
8188239|NCT02310750|20188851|P7|STARTED|HP Washout 1||12
8188240|NCT02310750|20188852|P6|STARTED|HP Washout 1||8
8188241|NCT02310750|20188853|P5|STARTED|HP Washout 1||8
8188242|NCT02310750|20188854|P4|STARTED|HP Washout 1||5
8188243|NCT02310750|20188855|P3|STARTED|HP Washout 1||6
8188244|NCT02310750|20188856|P2|STARTED|HP Washout 1||0
8188245|NCT02310750|20188857|P1|STARTED|HP Washout 1||0
8188246|NCT02310750|20188842|P16|NOT COMPLETED|HP Period 1||0
8188247|NCT02310750|20188843|P15|NOT COMPLETED|HP Period 1||0
8188248|NCT02310750|20188844|P14|NOT COMPLETED|HP Period 1||0
8188249|NCT02310750|20188845|P13|NOT COMPLETED|HP Period 1||0
8188250|NCT02310750|20188846|P12|NOT COMPLETED|HP Period 1||0
8188251|NCT02310750|20188847|P11|NOT COMPLETED|HP Period 1||0
8188252|NCT02310750|20188848|P10|NOT COMPLETED|HP Period 1||0
8188253|NCT02310750|20188849|P9|NOT COMPLETED|HP Period 1||0
8188254|NCT02310750|20188850|P8|NOT COMPLETED|HP Period 1||0
8188255|NCT02310750|20188851|P7|NOT COMPLETED|HP Period 1||1
8188256|NCT02310750|20188852|P6|NOT COMPLETED|HP Period 1||0
8188257|NCT02310750|20188853|P5|NOT COMPLETED|HP Period 1||0
8188258|NCT02310750|20188854|P4|NOT COMPLETED|HP Period 1||1
8188259|NCT02310750|20188855|P3|NOT COMPLETED|HP Period 1||0
8188260|NCT02310750|20188856|P2|NOT COMPLETED|HP Period 1||0
8188261|NCT02310750|20188857|P1|NOT COMPLETED|HP Period 1||1
8188262|NCT02310750|20188842|P16|COMPLETED|HP Period 1||2
8188263|NCT02310750|20188843|P15|COMPLETED|HP Period 1||2
8188264|NCT02310750|20188844|P14|COMPLETED|HP Period 1||2
8188265|NCT02310750|20188845|P13|COMPLETED|HP Period 1||2
8188266|NCT02310750|20188846|P12|COMPLETED|HP Period 1||2
8188267|NCT02310750|20188847|P11|COMPLETED|HP Period 1||2
8188268|NCT02310750|20188848|P10|COMPLETED|HP Period 1||0
8188269|NCT02310750|20188849|P9|COMPLETED|HP Period 1||0
8188270|NCT02310750|20188850|P8|COMPLETED|HP Period 1||0
8188271|NCT02310750|20188851|P7|COMPLETED|HP Period 1||12
8188272|NCT02310750|20188852|P6|COMPLETED|HP Period 1||8
8188273|NCT02310750|20188853|P5|COMPLETED|HP Period 1||8
8188274|NCT02310750|20188854|P4|COMPLETED|HP Period 1||5
8188275|NCT02310750|20188855|P3|COMPLETED|HP Period 1||6
8188276|NCT02310750|20188856|P2|COMPLETED|HP Period 1||6
8188277|NCT02310750|20188857|P1|COMPLETED|HP Period 1||6
8188278|NCT02310750|20188842|P16|STARTED|HP Period 1||2
8188279|NCT02310750|20188843|P15|STARTED|HP Period 1||2
8188280|NCT02310750|20188844|P14|STARTED|HP Period 1||2
8188281|NCT02310750|20188845|P13|STARTED|HP Period 1||2
8188282|NCT02310750|20188846|P12|STARTED|HP Period 1||2
8188283|NCT02310750|20188847|P11|STARTED|HP Period 1||2
8188284|NCT02310750|20188848|P10|STARTED|HP Period 1||0
8188285|NCT02310750|20188849|P9|STARTED|HP Period 1||0
8188286|NCT02310750|20188850|P8|STARTED|HP Period 1||0
8188287|NCT02310750|20188851|P7|STARTED|HP Period 1||13
8188288|NCT02310750|20188852|P6|STARTED|HP Period 1||8
8188289|NCT02310750|20188853|P5|STARTED|HP Period 1||8
8188290|NCT02310750|20188854|P4|STARTED|HP Period 1||6
8188291|NCT02310750|20188855|P3|STARTED|HP Period 1||6
8188292|NCT02310750|20188856|P2|STARTED|HP Period 1||6
8188293|NCT02310750|20188857|P1|STARTED|HP Period 1||7
8188294|NCT02310672|20189296|P1|NOT COMPLETED|Overall Study||15
8188295|NCT02310672|20189296|P1|COMPLETED|Overall Study||72
8188296|NCT02310672|20189296|P1|STARTED|Overall Study||87
8188297|NCT02310646|20189309|P2|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
8188298|NCT02310646|20189310|P1|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
8188299|NCT02310646|20189309|P2|COMPLETED|Second Intervention (Day 8 - Day 14)||104
8188300|NCT02310646|20189310|P1|COMPLETED|Second Intervention (Day 8 - Day 14)||107
8188301|NCT02310646|20189309|P2|STARTED|Second Intervention (Day 8 - Day 14)||104
8188302|NCT02310646|20189310|P1|STARTED|Second Intervention (Day 8 - Day 14)||107
8188303|NCT02310646|20189309|P2|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
8188304|NCT02310646|20189310|P1|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
8188305|NCT02310646|20189309|P2|COMPLETED|First Intervention (Day 1 - Day 7)||104
8188306|NCT02310646|20189310|P1|COMPLETED|First Intervention (Day 1 - Day 7)||107
8188307|NCT02310646|20189309|P2|STARTED|First Intervention (Day 1 - Day 7)||104
8188308|NCT02310646|20189310|P1|STARTED|First Intervention (Day 1 - Day 7)||109
8188309|NCT02310581|20189338|P4|NOT COMPLETED|Overall Study||1
8188310|NCT02310581|20189339|P3|NOT COMPLETED|Overall Study||1
8188311|NCT02310581|20189340|P2|NOT COMPLETED|Overall Study||2
8188312|NCT02310581|20189341|P1|NOT COMPLETED|Overall Study||3
8188313|NCT02310581|20189338|P4|COMPLETED|Overall Study||9
8188314|NCT02310581|20189339|P3|COMPLETED|Overall Study||9
8188315|NCT02310581|20189340|P2|COMPLETED|Overall Study||9
8188316|NCT02310581|20189341|P1|COMPLETED|Overall Study||6
8188317|NCT02310581|20189338|P4|STARTED|Overall Study||10
8188318|NCT02310581|20189339|P3|STARTED|Overall Study||10
8188319|NCT02310581|20189340|P2|STARTED|Overall Study||11
8188320|NCT02310581|20189341|P1|STARTED|Overall Study||9
8188321|NCT02310568|20189380|P5|NOT COMPLETED|Stage 2 (4 Weeks)||1
8188322|NCT02310568|20189381|P4|NOT COMPLETED|Stage 2 (4 Weeks)||5
8188323|NCT02310568|20189382|P3|NOT COMPLETED|Stage 2 (4 Weeks)||1
8188324|NCT02310568|20189383|P2|NOT COMPLETED|Stage 2 (4 Weeks)||1
8188325|NCT02310568|20189384|P1|NOT COMPLETED|Stage 2 (4 Weeks)||1
8188326|NCT02310568|20189380|P5|COMPLETED|Stage 2 (4 Weeks)||19
8188327|NCT02310568|20189381|P4|COMPLETED|Stage 2 (4 Weeks)||17
8188328|NCT02310568|20189382|P3|COMPLETED|Stage 2 (4 Weeks)||13
8188329|NCT02310568|20189383|P2|COMPLETED|Stage 2 (4 Weeks)||12
8188330|NCT02310568|20189384|P1|COMPLETED|Stage 2 (4 Weeks)||11
8188331|NCT02310568|20189380|P5|STARTED|Stage 2 (4 Weeks)||20
8188332|NCT02310568|20189381|P4|STARTED|Stage 2 (4 Weeks)||22
8188333|NCT02310568|20189382|P3|STARTED|Stage 2 (4 Weeks)||14
8188334|NCT02310568|20189383|P2|STARTED|Stage 2 (4 Weeks)||13
8188335|NCT02310568|20189384|P1|STARTED|Stage 2 (4 Weeks)||12
8188336|NCT02310568|20189380|P5|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
8188337|NCT02310568|20189381|P4|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
8188338|NCT02310568|20189382|P3|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
8188339|NCT02310568|20189383|P2|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
8188340|NCT02310568|20189384|P1|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
8188341|NCT02310568|20189380|P5|COMPLETED|Stage 1 ( 4 Weeks)||20
8188342|NCT02310568|20189381|P4|COMPLETED|Stage 1 ( 4 Weeks)||22
8188343|NCT02310568|20189382|P3|COMPLETED|Stage 1 ( 4 Weeks)||14
8188344|NCT02310568|20189383|P2|COMPLETED|Stage 1 ( 4 Weeks)||13
8188345|NCT02310568|20189384|P1|COMPLETED|Stage 1 ( 4 Weeks)||12
8188346|NCT02310568|20189380|P5|STARTED|Stage 1 ( 4 Weeks)||21
8188347|NCT02310568|20189381|P4|STARTED|Stage 1 ( 4 Weeks)||24
8188348|NCT02310568|20189382|P3|STARTED|Stage 1 ( 4 Weeks)||15
8188349|NCT02310568|20189383|P2|STARTED|Stage 1 ( 4 Weeks)||15
8188350|NCT02310568|20189384|P1|STARTED|Stage 1 ( 4 Weeks)||15
8188351|NCT02310126|20189464|P2|NOT COMPLETED|Period 2 (15 Minutes)||0
8188352|NCT02310126|20189465|P1|NOT COMPLETED|Period 2 (15 Minutes)||0
8188353|NCT02310126|20189464|P2|COMPLETED|Period 2 (15 Minutes)||95
8188354|NCT02310126|20189465|P1|COMPLETED|Period 2 (15 Minutes)||94
8188355|NCT02310126|20189464|P2|Myopes|Period 2 (15 Minutes)||63
8188356|NCT02310126|20189465|P1|Myopes|Period 2 (15 Minutes)||56
8188357|NCT02310126|20189464|P2|Hyperopes|Period 2 (15 Minutes)||32
8188358|NCT02310126|20189465|P1|Hyperopes|Period 2 (15 Minutes)||38
8188359|NCT02310126|20189464|P2|STARTED|Period 2 (15 Minutes)||95
8188360|NCT02310126|20189465|P1|STARTED|Period 2 (15 Minutes)||94
8188361|NCT02310126|20189464|P2|NOT COMPLETED|Period 1 (15 Minutes)||2
8188362|NCT02310126|20189465|P1|NOT COMPLETED|Period 1 (15 Minutes)||0
8188363|NCT02310126|20189464|P2|COMPLETED|Period 1 (15 Minutes)||95
8188364|NCT02310126|20189465|P1|COMPLETED|Period 1 (15 Minutes)||94
8188365|NCT02310126|20189464|P2|Myopes|Period 1 (15 Minutes)||64
8188366|NCT02310126|20189465|P1|Myopes|Period 1 (15 Minutes)||56
8188367|NCT02310126|20189464|P2|Hyperopes|Period 1 (15 Minutes)||33
8188368|NCT02310126|20189465|P1|Hyperopes|Period 1 (15 Minutes)||38
8188369|NCT02310126|20189464|P2|STARTED|Period 1 (15 Minutes)||97
8188370|NCT02310126|20189465|P1|STARTED|Period 1 (15 Minutes)||94
8188374|NCT02309944|20189478|P2|NOT COMPLETED|Overall Study||0
8188375|NCT02309944|20189479|P1|NOT COMPLETED|Overall Study||0
8188376|NCT02309944|20189478|P2|COMPLETED|Overall Study||43
8188377|NCT02309944|20189479|P1|COMPLETED|Overall Study||38
8188378|NCT02309944|20189478|P2|STARTED|Overall Study||43
8188379|NCT02309944|20189479|P1|STARTED|Overall Study||38
8188380|NCT02309723|20189490|P3|NOT COMPLETED|Overall Study||24
8188381|NCT02309723|20189491|P2|NOT COMPLETED|Overall Study||23
8188382|NCT02309723|20189492|P1|NOT COMPLETED|Overall Study||24
8188383|NCT02309723|20189490|P3|COMPLETED|Overall Study||105
8188384|NCT02309723|20189491|P2|COMPLETED|Overall Study||105
8188385|NCT02309723|20189492|P1|COMPLETED|Overall Study||105
8188386|NCT02309723|20189490|P3|STARTED|Overall Study||129
8188387|NCT02309723|20189491|P2|STARTED|Overall Study||128
8188388|NCT02309723|20189492|P1|STARTED|Overall Study||129
8188389|NCT02309515|20189508|P2|NOT COMPLETED|Overall Study||1
8188390|NCT02309515|20189509|P1|NOT COMPLETED|Overall Study||0
8188391|NCT02309515|20189508|P2|COMPLETED|Overall Study||6
8188392|NCT02309515|20189509|P1|COMPLETED|Overall Study||5
8188393|NCT02309515|20189508|P2|STARTED|Overall Study||7
8188394|NCT02309515|20189509|P1|STARTED|Overall Study||5
8188395|NCT02309489|20189523|P2|NOT COMPLETED|Overall Study||14
8188396|NCT02309489|20189524|P1|NOT COMPLETED|Overall Study||15
8188397|NCT02309489|20189523|P2|COMPLETED|Overall Study||547
8188398|NCT02309489|20189524|P1|COMPLETED|Overall Study||568
8188399|NCT02309489|20189523|P2|Follow-up at 3 Months Postpartum|Overall Study||541
8188400|NCT02309489|20189524|P1|Follow-up at 3 Months Postpartum|Overall Study||560
8188401|NCT02309489|20189523|P2|STARTED|Overall Study||561
8188402|NCT02309489|20189524|P1|STARTED|Overall Study||583
8188403|NCT02309411|20189550|P3|NOT COMPLETED|Overall Study||0
8188404|NCT02309411|20189551|P2|NOT COMPLETED|Overall Study||1
8188405|NCT02309411|20189552|P1|NOT COMPLETED|Overall Study||2
8188406|NCT02309411|20189550|P3|COMPLETED|Overall Study||6
8188407|NCT02309411|20189551|P2|COMPLETED|Overall Study||14
8188408|NCT02309411|20189552|P1|COMPLETED|Overall Study||23
8188409|NCT02309411|20189550|P3|STARTED|Overall Study||6
8188410|NCT02309411|20189551|P2|STARTED|Overall Study||15
8188411|NCT02309411|20189552|P1|STARTED|Overall Study||25
8188412|NCT02309372|20189573|P2|NOT COMPLETED|Overall Study||2
8188413|NCT02309372|20189574|P1|NOT COMPLETED|Overall Study||3
8188414|NCT02309372|20189573|P2|COMPLETED|Overall Study||25
8188415|NCT02309372|20189574|P1|COMPLETED|Overall Study||24
8188416|NCT02309372|20189573|P2|STARTED|Overall Study||27
8188417|NCT02309372|20189574|P1|STARTED|Overall Study||27
8188418|NCT02309359|20189591|P5|NOT COMPLETED|Overall Study||9
8188419|NCT02309359|20189592|P4|NOT COMPLETED|Overall Study||12
8188420|NCT02309359|20189593|P3|NOT COMPLETED|Overall Study||11
8188421|NCT02309359|20189594|P2|NOT COMPLETED|Overall Study||8
8188422|NCT02309359|20189595|P1|NOT COMPLETED|Overall Study||12
8188423|NCT02309359|20189591|P5|COMPLETED|Overall Study||60
8188424|NCT02309359|20189592|P4|COMPLETED|Overall Study||57
8188425|NCT02309359|20189593|P3|COMPLETED|Overall Study||57
8188426|NCT02309359|20189594|P2|COMPLETED|Overall Study||62
8188427|NCT02309359|20189595|P1|COMPLETED|Overall Study||57
8188428|NCT02309359|20189591|P5|STARTED|Overall Study||69
8188429|NCT02309359|20189592|P4|STARTED|Overall Study||69
8188430|NCT02309359|20189593|P3|STARTED|Overall Study||68
8188431|NCT02309359|20189594|P2|STARTED|Overall Study||70
8188432|NCT02309359|20189595|P1|STARTED|Overall Study||69
8188433|NCT02309294|20189722|P1|NOT COMPLETED|Overall Study||2
8188434|NCT02309294|20189722|P1|COMPLETED|Overall Study||41
8188435|NCT02309294|20189722|P1|STARTED|Overall Study||43
8188436|NCT02309138|20189728|P2|NOT COMPLETED|Overall Study||18
8188437|NCT02309138|20189729|P1|NOT COMPLETED|Overall Study||48
8188438|NCT02309138|20189728|P2|COMPLETED|Overall Study||443
8188439|NCT02309138|20189729|P1|COMPLETED|Overall Study||412
8188440|NCT02309138|20189728|P2|STARTED|Overall Study||461
8188441|NCT02309138|20189729|P1|STARTED|Overall Study||460
8188442|NCT02309112|20189752|P3|NOT COMPLETED|Overall Study||1
8188443|NCT02309112|20189753|P2|NOT COMPLETED|Overall Study||1
8188444|NCT02309112|20189754|P1|NOT COMPLETED|Overall Study||1
8188445|NCT02309112|20189752|P3|COMPLETED|Overall Study||4
8188446|NCT02309112|20189753|P2|COMPLETED|Overall Study||4
8188447|NCT02309112|20189754|P1|COMPLETED|Overall Study||4
8188448|NCT02309112|20189752|P3|Completed Yoga Intervention|Overall Study||4
8188449|NCT02309112|20189753|P2|Completed Yoga Intervention|Overall Study||5
8188450|NCT02309112|20189754|P1|Completed Yoga Intervention|Overall Study||4
8188451|NCT02309112|20189752|P3|STARTED|Overall Study||5
8188452|NCT02309112|20189753|P2|STARTED|Overall Study||5
8188453|NCT02309112|20189754|P1|STARTED|Overall Study||5
8188454|NCT02309099|20189777|P2|NOT COMPLETED|Overall Study||0
8188455|NCT02309099|20189778|P1|NOT COMPLETED|Overall Study||2
8188456|NCT02309099|20189777|P2|COMPLETED|Overall Study||3
8188457|NCT02309099|20189778|P1|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
8188458|NCT02309099|20189777|P2|Cochlear Implant Use/Follow-Up|Overall Study||3
8188558|NCT02308748|20189855|P4|STARTED|Period 3||2
8188459|NCT02309099|20189778|P1|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
8188460|NCT02309099|20189777|P2|Initial Activation|Overall Study||3
8188461|NCT02309099|20189778|P1|Initial Activation|Overall Study||7
8188462|NCT02309099|20189777|P2|Cochlear Implantation|Overall Study||3
8188463|NCT02309099|20189778|P1|Cochlear Implantation|Overall Study||7
8188464|NCT02309099|20189777|P2|STARTED|Overall Study||3
8188465|NCT02309099|20189778|P1|STARTED|Overall Study||7
8188466|NCT02308839|20189824|P1|NOT COMPLETED|Overall Study||109
8188467|NCT02308839|20189824|P1|COMPLETED|Overall Study||72
8188468|NCT02308839|20189824|P1|STARTED|Overall Study||181
8188469|NCT02308787|20189834|P1|NOT COMPLETED|Overall Study||0
8188470|NCT02308787|20189834|P1|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
8188471|NCT02308787|20189834|P1|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
8188472|NCT02308748|20189849|P10|NOT COMPLETED|Period 5||0
8188473|NCT02308748|20189850|P9|NOT COMPLETED|Period 5||1
8188474|NCT02308748|20189851|P8|NOT COMPLETED|Period 5||0
8188475|NCT02308748|20189852|P7|NOT COMPLETED|Period 5||0
8188476|NCT02308748|20189853|P6|NOT COMPLETED|Period 5||0
8188477|NCT02308748|20189854|P5|NOT COMPLETED|Period 5||0
8188478|NCT02308748|20189855|P4|NOT COMPLETED|Period 5||0
8188479|NCT02308748|20189856|P3|NOT COMPLETED|Period 5||0
8188480|NCT02308748|20189857|P2|NOT COMPLETED|Period 5||0
8188481|NCT02308748|20189858|P1|NOT COMPLETED|Period 5||1
8188482|NCT02308748|20189849|P10|COMPLETED|Period 5||2
8188483|NCT02308748|20189850|P9|COMPLETED|Period 5||1
8188484|NCT02308748|20189851|P8|COMPLETED|Period 5||1
8188485|NCT02308748|20189852|P7|COMPLETED|Period 5||2
8188486|NCT02308748|20189853|P6|COMPLETED|Period 5||3
8188487|NCT02308748|20189854|P5|COMPLETED|Period 5||2
8188488|NCT02308748|20189855|P4|COMPLETED|Period 5||2
8188489|NCT02308748|20189856|P3|COMPLETED|Period 5||1
8188490|NCT02308748|20189857|P2|COMPLETED|Period 5||2
8188491|NCT02308748|20189858|P1|COMPLETED|Period 5||1
8188492|NCT02308748|20189849|P10|STARTED|Period 5||2
8188493|NCT02308748|20189850|P9|STARTED|Period 5||2
8188494|NCT02308748|20189851|P8|STARTED|Period 5||1
8188495|NCT02308748|20189852|P7|STARTED|Period 5||2
8188496|NCT02308748|20189853|P6|STARTED|Period 5||3
8188497|NCT02308748|20189854|P5|STARTED|Period 5||2
8188498|NCT02308748|20189855|P4|STARTED|Period 5||2
8188499|NCT02308748|20189856|P3|STARTED|Period 5||1
8188500|NCT02308748|20189857|P2|STARTED|Period 5||2
8188501|NCT02308748|20189858|P1|STARTED|Period 5||2
8188502|NCT02308748|20189849|P10|NOT COMPLETED|Period 4||0
8188503|NCT02308748|20189850|P9|NOT COMPLETED|Period 4||0
8188504|NCT02308748|20189851|P8|NOT COMPLETED|Period 4||0
8188505|NCT02308748|20189852|P7|NOT COMPLETED|Period 4||0
8188506|NCT02308748|20189853|P6|NOT COMPLETED|Period 4||0
8188507|NCT02308748|20189854|P5|NOT COMPLETED|Period 4||0
8188508|NCT02308748|20189855|P4|NOT COMPLETED|Period 4||0
8188509|NCT02308748|20189856|P3|NOT COMPLETED|Period 4||0
8188510|NCT02308748|20189857|P2|NOT COMPLETED|Period 4||0
8188511|NCT02308748|20189858|P1|NOT COMPLETED|Period 4||0
8188512|NCT02308748|20189849|P10|COMPLETED|Period 4||2
8188513|NCT02308748|20189850|P9|COMPLETED|Period 4||2
8188514|NCT02308748|20189851|P8|COMPLETED|Period 4||1
8188515|NCT02308748|20189852|P7|COMPLETED|Period 4||2
8188516|NCT02308748|20189853|P6|COMPLETED|Period 4||3
8188517|NCT02308748|20189854|P5|COMPLETED|Period 4||2
8188518|NCT02308748|20189855|P4|COMPLETED|Period 4||2
8188519|NCT02308748|20189856|P3|COMPLETED|Period 4||1
8188520|NCT02308748|20189857|P2|COMPLETED|Period 4||2
8188521|NCT02308748|20189858|P1|COMPLETED|Period 4||2
8188522|NCT02308748|20189849|P10|STARTED|Period 4||2
8188523|NCT02308748|20189850|P9|STARTED|Period 4||2
8188524|NCT02308748|20189851|P8|STARTED|Period 4||1
8188525|NCT02308748|20189852|P7|STARTED|Period 4||2
8188526|NCT02308748|20189853|P6|STARTED|Period 4||3
8188527|NCT02308748|20189854|P5|STARTED|Period 4||2
8188528|NCT02308748|20189855|P4|STARTED|Period 4||2
8188529|NCT02308748|20189856|P3|STARTED|Period 4||1
8188530|NCT02308748|20189857|P2|STARTED|Period 4||2
8188531|NCT02308748|20189858|P1|STARTED|Period 4||2
8188532|NCT02308748|20189849|P10|NOT COMPLETED|Period 3||1
8188533|NCT02308748|20189850|P9|NOT COMPLETED|Period 3||0
8188534|NCT02308748|20189851|P8|NOT COMPLETED|Period 3||0
8188535|NCT02308748|20189852|P7|NOT COMPLETED|Period 3||0
8188536|NCT02308748|20189853|P6|NOT COMPLETED|Period 3||0
8188537|NCT02308748|20189854|P5|NOT COMPLETED|Period 3||0
8188538|NCT02308748|20189855|P4|NOT COMPLETED|Period 3||0
8188539|NCT02308748|20189856|P3|NOT COMPLETED|Period 3||0
8188540|NCT02308748|20189857|P2|NOT COMPLETED|Period 3||0
8188541|NCT02308748|20189858|P1|NOT COMPLETED|Period 3||0
8188542|NCT02308748|20189849|P10|COMPLETED|Period 3||2
8188543|NCT02308748|20189850|P9|COMPLETED|Period 3||2
8188544|NCT02308748|20189851|P8|COMPLETED|Period 3||1
8188545|NCT02308748|20189852|P7|COMPLETED|Period 3||2
8188546|NCT02308748|20189853|P6|COMPLETED|Period 3||3
8188547|NCT02308748|20189854|P5|COMPLETED|Period 3||2
8188548|NCT02308748|20189855|P4|COMPLETED|Period 3||2
8188549|NCT02308748|20189856|P3|COMPLETED|Period 3||1
8188550|NCT02308748|20189857|P2|COMPLETED|Period 3||2
8188551|NCT02308748|20189858|P1|COMPLETED|Period 3||2
8188552|NCT02308748|20189849|P10|STARTED|Period 3||3
8188553|NCT02308748|20189850|P9|STARTED|Period 3||2
8188554|NCT02308748|20189851|P8|STARTED|Period 3||1
8188555|NCT02308748|20189852|P7|STARTED|Period 3||2
8188556|NCT02308748|20189853|P6|STARTED|Period 3||3
8188557|NCT02308748|20189854|P5|STARTED|Period 3||2
8188559|NCT02308748|20189856|P3|STARTED|Period 3||1
8188560|NCT02308748|20189857|P2|STARTED|Period 3||2
8188561|NCT02308748|20189858|P1|STARTED|Period 3||2
8188562|NCT02308748|20189849|P10|NOT COMPLETED|Period 2||0
8188563|NCT02308748|20189850|P9|NOT COMPLETED|Period 2||0
8188564|NCT02308748|20189851|P8|NOT COMPLETED|Period 2||1
8188565|NCT02308748|20189852|P7|NOT COMPLETED|Period 2||0
8188566|NCT02308748|20189853|P6|NOT COMPLETED|Period 2||0
8188567|NCT02308748|20189854|P5|NOT COMPLETED|Period 2||0
8188568|NCT02308748|20189855|P4|NOT COMPLETED|Period 2||0
8188569|NCT02308748|20189856|P3|NOT COMPLETED|Period 2||0
8188570|NCT02308748|20189857|P2|NOT COMPLETED|Period 2||0
8188571|NCT02308748|20189858|P1|NOT COMPLETED|Period 2||0
8188572|NCT02308748|20189849|P10|COMPLETED|Period 2||3
8188573|NCT02308748|20189850|P9|COMPLETED|Period 2||2
8188574|NCT02308748|20189851|P8|COMPLETED|Period 2||1
8188575|NCT02308748|20189852|P7|COMPLETED|Period 2||2
8188576|NCT02308748|20189853|P6|COMPLETED|Period 2||3
8188577|NCT02308748|20189854|P5|COMPLETED|Period 2||2
8188578|NCT02308748|20189855|P4|COMPLETED|Period 2||2
8188579|NCT02308748|20189856|P3|COMPLETED|Period 2||1
8188580|NCT02308748|20189857|P2|COMPLETED|Period 2||2
8188581|NCT02308748|20189858|P1|COMPLETED|Period 2||2
8188582|NCT02308748|20189849|P10|STARTED|Period 2||3
8188583|NCT02308748|20189850|P9|STARTED|Period 2||2
8188584|NCT02308748|20189851|P8|STARTED|Period 2||2
8188585|NCT02308748|20189852|P7|STARTED|Period 2||2
8188586|NCT02308748|20189853|P6|STARTED|Period 2||3
8188587|NCT02308748|20189854|P5|STARTED|Period 2||2
8188588|NCT02308748|20189855|P4|STARTED|Period 2||2
8188589|NCT02308748|20189856|P3|STARTED|Period 2||1
8188590|NCT02308748|20189857|P2|STARTED|Period 2||2
8188591|NCT02308748|20189858|P1|STARTED|Period 2||2
8188592|NCT02308748|20189849|P10|NOT COMPLETED|Period 1||0
8188593|NCT02308748|20189850|P9|NOT COMPLETED|Period 1||0
8188594|NCT02308748|20189851|P8|NOT COMPLETED|Period 1||0
8188595|NCT02308748|20189852|P7|NOT COMPLETED|Period 1||0
8188596|NCT02308748|20189853|P6|NOT COMPLETED|Period 1||0
8188597|NCT02308748|20189854|P5|NOT COMPLETED|Period 1||0
8188598|NCT02308748|20189855|P4|NOT COMPLETED|Period 1||0
8188599|NCT02308748|20189856|P3|NOT COMPLETED|Period 1||1
8188600|NCT02308748|20189857|P2|NOT COMPLETED|Period 1||0
8188601|NCT02308748|20189858|P1|NOT COMPLETED|Period 1||0
8188602|NCT02308748|20189849|P10|COMPLETED|Period 1||3
8188603|NCT02308748|20189850|P9|COMPLETED|Period 1||2
8188604|NCT02308748|20189851|P8|COMPLETED|Period 1||2
8188605|NCT02308748|20189852|P7|COMPLETED|Period 1||2
8188606|NCT02308748|20189853|P6|COMPLETED|Period 1||3
8188607|NCT02308748|20189854|P5|COMPLETED|Period 1||2
8188608|NCT02308748|20189855|P4|COMPLETED|Period 1||2
8188609|NCT02308748|20189856|P3|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
8188610|NCT02308748|20189857|P2|COMPLETED|Period 1||2
8188611|NCT02308748|20189858|P1|COMPLETED|Period 1||2
8188612|NCT02308748|20189849|P10|STARTED|Period 1||3
8188613|NCT02308748|20189850|P9|STARTED|Period 1||2
8188614|NCT02308748|20189851|P8|STARTED|Period 1||2
8188615|NCT02308748|20189852|P7|STARTED|Period 1||2
8188616|NCT02308748|20189853|P6|STARTED|Period 1||3
8188617|NCT02308748|20189854|P5|STARTED|Period 1||2
8188618|NCT02308748|20189855|P4|STARTED|Period 1||2
8188619|NCT02308748|20189856|P3|STARTED|Period 1||2
8188620|NCT02308748|20189857|P2|STARTED|Period 1||2
8188621|NCT02308748|20189858|P1|STARTED|Period 1||2
8188622|NCT02308696|20189872|P2|NOT COMPLETED|Overall Study||31
8188623|NCT02308696|20189873|P1|NOT COMPLETED|Overall Study||53
8188624|NCT02308696|20189872|P2|COMPLETED|Overall Study||203
8188625|NCT02308696|20189873|P1|COMPLETED|Overall Study||169
8188626|NCT02308696|20189872|P2|STARTED|Overall Study||234
8188627|NCT02308696|20189873|P1|STARTED|Overall Study||222
8188628|NCT02308540|20189907|P6|NOT COMPLETED|Overall Study||1
8188629|NCT02308540|20189908|P5|NOT COMPLETED|Overall Study||0
8188630|NCT02308540|20189909|P4|NOT COMPLETED|Overall Study||0
8188631|NCT02308540|20189910|P3|NOT COMPLETED|Overall Study||0
8188632|NCT02308540|20189911|P2|NOT COMPLETED|Overall Study||0
8188633|NCT02308540|20189912|P1|NOT COMPLETED|Overall Study||0
8188634|NCT02308540|20189907|P6|COMPLETED|Overall Study||99
8188635|NCT02308540|20189908|P5|COMPLETED|Overall Study||100
8188636|NCT02308540|20189909|P4|COMPLETED|Overall Study||56
8188637|NCT02308540|20189910|P3|COMPLETED|Overall Study||56
8188638|NCT02308540|20189911|P2|COMPLETED|Overall Study||17
8188639|NCT02308540|20189912|P1|COMPLETED|Overall Study||17
8188640|NCT02308540|20189907|P6|Vaccinated|Overall Study||100
8188641|NCT02308540|20189908|P5|Vaccinated|Overall Study||100
8188642|NCT02308540|20189909|P4|Vaccinated|Overall Study||56
8188643|NCT02308540|20189910|P3|Vaccinated|Overall Study||56
8188644|NCT02308540|20189911|P2|Vaccinated|Overall Study||17
8188645|NCT02308540|20189912|P1|Vaccinated|Overall Study||17
8188646|NCT02308540|20189907|P6|Randomized|Overall Study||100
8188647|NCT02308540|20189908|P5|Randomized|Overall Study||100
8188648|NCT02308540|20189909|P4|Randomized|Overall Study||56
8188649|NCT02308540|20189910|P3|Randomized|Overall Study||56
8188650|NCT02308540|20189911|P2|Randomized|Overall Study||17
8188651|NCT02308540|20189912|P1|Randomized|Overall Study||17
8188652|NCT02308540|20189907|P6|STARTED|Overall Study||100
8188653|NCT02308540|20189908|P5|STARTED|Overall Study||100
8188654|NCT02308540|20189909|P4|STARTED|Overall Study||56
8188655|NCT02308540|20189910|P3|STARTED|Overall Study||56
8188656|NCT02308540|20189911|P2|STARTED|Overall Study||17
8188657|NCT02308540|20189912|P1|STARTED|Overall Study||17
8188658|NCT02308475|20189976|P1|NOT COMPLETED|Overall Study||0
8188659|NCT02308475|20189976|P1|COMPLETED|Overall Study||2
8188660|NCT02308475|20189976|P1|STARTED|Overall Study||2
8188661|NCT02308371|20189984|P2|NOT COMPLETED|Overall Study||0
8188662|NCT02308371|20189985|P1|NOT COMPLETED|Overall Study||0
8188663|NCT02308371|20189984|P2|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
8188664|NCT02308371|20189985|P1|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
8188665|NCT02308371|20189984|P2|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
8188666|NCT02308371|20189985|P1|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
8188667|NCT02308228|20190001|P2|NOT COMPLETED|Overall Study||7
8188668|NCT02308228|20190002|P1|NOT COMPLETED|Overall Study||8
8188669|NCT02308228|20190001|P2|COMPLETED|Overall Study||48
8188670|NCT02308228|20190002|P1|COMPLETED|Overall Study||46
8188671|NCT02308228|20190001|P2|STARTED|Overall Study||55
8188672|NCT02308228|20190002|P1|STARTED|Overall Study||54
8188673|NCT02308189|20190016|P2|NOT COMPLETED|Overall Study||1
8188674|NCT02308189|20190017|P1|NOT COMPLETED|Overall Study||1
8188675|NCT02308189|20190016|P2|COMPLETED|Overall Study||14
8188676|NCT02308189|20190017|P1|COMPLETED|Overall Study||16
8188677|NCT02308189|20190016|P2|STARTED|Overall Study||15
8188678|NCT02308189|20190017|P1|STARTED|Overall Study||17
8188679|NCT02308163|20190031|P5|NOT COMPLETED|Overall Study||34
8188680|NCT02308163|20190032|P4|NOT COMPLETED|Overall Study||13
8188681|NCT02308163|20190033|P3|NOT COMPLETED|Overall Study||14
8188682|NCT02308163|20190034|P2|NOT COMPLETED|Overall Study||18
8188683|NCT02308163|20190035|P1|NOT COMPLETED|Overall Study||31
8188684|NCT02308163|20190031|P5|COMPLETED|Overall Study||167
8188685|NCT02308163|20190032|P4|COMPLETED|Overall Study||39
8188686|NCT02308163|20190033|P3|COMPLETED|Overall Study||36
8188687|NCT02308163|20190034|P2|COMPLETED|Overall Study||84
8188688|NCT02308163|20190035|P1|COMPLETED|Overall Study||73
8188689|NCT02308163|20190031|P5|STARTED|Overall Study||201
8188690|NCT02308163|20190032|P4|STARTED|Overall Study||52
8188691|NCT02308163|20190033|P3|STARTED|Overall Study||50
8188692|NCT02308163|20190034|P2|STARTED|Overall Study||102
8188693|NCT02308163|20190035|P1|STARTED|Overall Study||104
8188694|NCT02308124|20190345|P3|NOT COMPLETED|Overall Study||8
8188695|NCT02308124|20190346|P2|NOT COMPLETED|Overall Study||8
8188696|NCT02308124|20190347|P1|NOT COMPLETED|Overall Study||6
8188697|NCT02308124|20190345|P3|COMPLETED|Overall Study||21
8188698|NCT02308124|20190346|P2|COMPLETED|Overall Study||21
8188699|NCT02308124|20190347|P1|COMPLETED|Overall Study||23
8188700|NCT02308124|20190345|P3|STARTED|Overall Study||29
8188701|NCT02308124|20190346|P2|STARTED|Overall Study||29
8188702|NCT02308124|20190347|P1|STARTED|Overall Study||29
8188703|NCT02308046|20190369|P2|NOT COMPLETED|Overall Study||38
8188704|NCT02308046|20190370|P1|NOT COMPLETED|Overall Study||34
8188705|NCT02308046|20190369|P2|COMPLETED|Overall Study||67
8188706|NCT02308046|20190370|P1|COMPLETED|Overall Study||73
8188707|NCT02308046|20190369|P2|STARTED|Overall Study||105
8188708|NCT02308046|20190370|P1|STARTED|Overall Study||107
8188709|NCT02308033|20190386|P2|NOT COMPLETED|Overall Study||19
8188710|NCT02308033|20190387|P1|NOT COMPLETED|Overall Study||26
8188711|NCT02308033|20190386|P2|COMPLETED|Overall Study||83
8188712|NCT02308033|20190387|P1|COMPLETED|Overall Study||76
8188713|NCT02308033|20190386|P2|STARTED|Overall Study||102
8188714|NCT02308033|20190387|P1|STARTED|Overall Study||102
8188715|NCT02308020|20190407|P6|NOT COMPLETED|Overall Study||5
8188716|NCT02308020|20190408|P5|NOT COMPLETED|Overall Study||4
8188717|NCT02308020|20190409|P4|NOT COMPLETED|Overall Study||4
8188718|NCT02308020|20190410|P3|NOT COMPLETED|Overall Study||3
8188719|NCT02308020|20190411|P2|NOT COMPLETED|Overall Study||20
8188720|NCT02308020|20190412|P1|NOT COMPLETED|Overall Study||4
8188721|NCT02308020|20190407|P6|COMPLETED|Overall Study||12
8188722|NCT02308020|20190408|P5|COMPLETED|Overall Study||19
8188723|NCT02308020|20190409|P4|COMPLETED|Overall Study||24
8188724|NCT02308020|20190410|P3|COMPLETED|Overall Study||6
8188725|NCT02308020|20190411|P2|COMPLETED|Overall Study||38
8188726|NCT02308020|20190412|P1|COMPLETED|Overall Study||23
8188727|NCT02308020|20190407|P6|Received at Least One Dose of Study Drug|Overall Study||17
8188728|NCT02308020|20190408|P5|Received at Least One Dose of Study Drug|Overall Study||23
8188729|NCT02308020|20190409|P4|Received at Least One Dose of Study Drug|Overall Study||28
8188730|NCT02308020|20190410|P3|Received at Least One Dose of Study Drug|Overall Study||9
8188731|NCT02308020|20190411|P2|Received at Least One Dose of Study Drug|Overall Study||58
8188732|NCT02308020|20190412|P1|Received at Least One Dose of Study Drug|Overall Study||27
8188733|NCT02308020|20190407|P6|STARTED|Overall Study||17
8188734|NCT02308020|20190408|P5|STARTED|Overall Study||23
8188735|NCT02308020|20190409|P4|STARTED|Overall Study||28
8188736|NCT02308020|20190410|P3|STARTED|Overall Study||9
8188737|NCT02308020|20190411|P2|STARTED|Overall Study||58
8188738|NCT02308020|20190412|P1|STARTED|Overall Study||27
8188739|NCT02308007|20190469|P3|NOT COMPLETED|Overall Study||75
8188740|NCT02308007|20190470|P2|NOT COMPLETED|Overall Study||75
8188741|NCT02308007|20190471|P1|NOT COMPLETED|Overall Study||76
8188742|NCT02308007|20190469|P3|COMPLETED|Overall Study||82
8188743|NCT02308007|20190470|P2|COMPLETED|Overall Study||84
8188744|NCT02308007|20190471|P1|COMPLETED|Overall Study||83
8188745|NCT02308007|20190469|P3|STARTED|Overall Study||157
8188746|NCT02308007|20190470|P2|STARTED|Overall Study||159
8188747|NCT02308007|20190471|P1|STARTED|Overall Study||159
8188748|NCT02307916|20190496|P2|NOT COMPLETED|Overall Study||1
8188749|NCT02307916|20190497|P1|NOT COMPLETED|Overall Study||2
8188750|NCT02307916|20190496|P2|COMPLETED|Overall Study||14
8188751|NCT02307916|20190497|P1|COMPLETED|Overall Study||40
8188752|NCT02307916|20190496|P2|STARTED|Overall Study||15
8188753|NCT02307916|20190497|P1|STARTED|Overall Study||42
8188754|NCT02307838|20190514|P3|NOT COMPLETED|Overall Study||0
8188755|NCT02307838|20190515|P2|NOT COMPLETED|Overall Study||0
8188756|NCT02307838|20190516|P1|NOT COMPLETED|Overall Study||0
8188757|NCT02307838|20190514|P3|COMPLETED|Overall Study||55
8188758|NCT02307838|20190515|P2|COMPLETED|Overall Study||64
8188759|NCT02307838|20190516|P1|COMPLETED|Overall Study||56
8188760|NCT02307838|20190514|P3|STARTED|Overall Study||55
8188761|NCT02307838|20190515|P2|STARTED|Overall Study||64
8188762|NCT02307838|20190516|P1|STARTED|Overall Study||56
8188763|NCT02307682|20190562|P3|NOT COMPLETED|Overall Study||64
8188764|NCT02307682|20190563|P2|NOT COMPLETED|Overall Study||57
8188765|NCT02307682|20190564|P1|NOT COMPLETED|Overall Study||50
8188766|NCT02307682|20190562|P3|COMPLETED|Overall Study||297
8188767|NCT02307682|20190563|P2|COMPLETED|Overall Study||304
8188768|NCT02307682|20190564|P1|COMPLETED|Overall Study||310
8188769|NCT02307682|20190562|P3|Randomized and Treated|Overall Study||360
8188770|NCT02307682|20190563|P2|Randomized and Treated|Overall Study||360
8188771|NCT02307682|20190564|P1|Randomized and Treated|Overall Study||358
8188772|NCT02307682|20190562|P3|STARTED|Overall Study||361
8188773|NCT02307682|20190563|P2|STARTED|Overall Study||361
8188774|NCT02307682|20190564|P1|STARTED|Overall Study||360
8188775|NCT02307552|20190664|P1|NOT COMPLETED|Overall Study||0
8188776|NCT02307552|20190664|P1|COMPLETED|Overall Study||1
8188777|NCT02307552|20190664|P1|STARTED|Overall Study||1
8188778|NCT02307526|20190668|P1|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
8188779|NCT02307526|20190668|P1|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
8188780|NCT02307526|20190668|P1|STARTED|Day 2 - 60 mg of Pyridostigmine||10
8188781|NCT02307526|20190668|P1|NOT COMPLETED|Day 1 - No Drug||0
8188782|NCT02307526|20190668|P1|COMPLETED|Day 1 - No Drug||10
8188783|NCT02307526|20190668|P1|STARTED|Day 1 - No Drug||10
8188796|NCT02307318|20190722|P1|NOT COMPLETED|Overall Study||0
8188797|NCT02307318|20190722|P1|COMPLETED|Overall Study||51
8188798|NCT02307318|20190722|P1|STARTED|Overall Study||51
8188808|NCT02307188|20190742|P1|NOT COMPLETED|Overall Study||4
8188809|NCT02307188|20190742|P1|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
8188810|NCT02307188|20190742|P1|STARTED|Overall Study||5
8188811|NCT02307123|20190746|P1|NOT COMPLETED|Overall Study||0
8188812|NCT02307123|20190746|P1|COMPLETED|Overall Study||483
8188813|NCT02307123|20190746|P1|STARTED|Overall Study||483
8188814|NCT02306928|20190751|P1|NOT COMPLETED|Overall Study||0
8188815|NCT02306928|20190751|P1|COMPLETED|Overall Study||15
8188816|NCT02306928|20190751|P1|STARTED|Overall Study||15
8188817|NCT02306850|20190759|P1|NOT COMPLETED|Overall Study||2
8188818|NCT02306850|20190759|P1|COMPLETED|Overall Study||8
8188819|NCT02306850|20190759|P1|STARTED|Overall Study||10
8188820|NCT02306759|20190766|P2|NOT COMPLETED|Overall Study||0
8188821|NCT02306759|20190767|P1|NOT COMPLETED|Overall Study||0
8188822|NCT02306759|20190766|P2|COMPLETED|Overall Study||30
8188823|NCT02306759|20190767|P1|COMPLETED|Overall Study||30
8188824|NCT02306759|20190766|P2|STARTED|Overall Study||30
8188825|NCT02306759|20190767|P1|STARTED|Overall Study||30
8188826|NCT02306694|20190781|P1|NOT COMPLETED|Overall Study||4
8188827|NCT02306694|20190781|P1|COMPLETED|Overall Study||12
8188828|NCT02306694|20190781|P1|STARTED|Overall Study||16
8188829|NCT02306265|20190791|P1|NOT COMPLETED|Overall Study||1
8188830|NCT02306265|20190791|P1|COMPLETED|Overall Study||249
8188831|NCT02306265|20190791|P1|STARTED|Overall Study||250
8188832|NCT02305888|20190800|P3|NOT COMPLETED|Overall Study||1
8188833|NCT02305888|20190801|P2|NOT COMPLETED|Overall Study||1
8188834|NCT02305888|20190802|P1|NOT COMPLETED|Overall Study||0
8188835|NCT02305888|20190800|P3|COMPLETED|Overall Study||62
8188836|NCT02305888|20190801|P2|COMPLETED|Overall Study||62
8188837|NCT02305888|20190802|P1|COMPLETED|Overall Study||63
8188838|NCT02305888|20190800|P3|STARTED|Overall Study||63
8188839|NCT02305888|20190801|P2|STARTED|Overall Study||63
8188840|NCT02305888|20190802|P1|STARTED|Overall Study||63
8188841|NCT02305849|20190822|P4|NOT COMPLETED|Overall Study||19
8188842|NCT02305849|20190823|P3|NOT COMPLETED|Overall Study||18
8188843|NCT02305849|20190824|P2|NOT COMPLETED|Overall Study||28
8188844|NCT02305849|20190825|P1|NOT COMPLETED|Overall Study||27
8188845|NCT02305849|20190822|P4|COMPLETED|Overall Study||66
8188846|NCT02305849|20190823|P3|COMPLETED|Overall Study||67
8188847|NCT02305849|20190824|P2|COMPLETED|Overall Study||146
8188848|NCT02305849|20190825|P1|COMPLETED|Overall Study||148
8188849|NCT02305849|20190822|P4|STARTED|Overall Study||85
8188850|NCT02305849|20190823|P3|STARTED|Overall Study||85
8188851|NCT02305849|20190824|P2|STARTED|Overall Study||174
8188852|NCT02305849|20190825|P1|STARTED|Overall Study||175
8188853|NCT02305797|20191059|P2|NOT COMPLETED|Overall Study||38
8188854|NCT02305797|20191060|P1|NOT COMPLETED|Overall Study||45
8188855|NCT02305797|20191059|P2|COMPLETED|Overall Study||210
8188856|NCT02305797|20191060|P1|COMPLETED|Overall Study||202
8188857|NCT02305797|20191059|P2|STARTED|Overall Study||248
8188858|NCT02305797|20191060|P1|STARTED|Overall Study||247
8188859|NCT02305758|20191070|P2|NOT COMPLETED|Overall Study||65
8188860|NCT02305758|20191071|P1|NOT COMPLETED|Overall Study||65
8188861|NCT02305758|20191070|P2|COMPLETED|Overall Study||0
8188862|NCT02305758|20191071|P1|COMPLETED|Overall Study||0
8188863|NCT02305758|20191070|P2|STARTED|Overall Study||65
8188864|NCT02305758|20191071|P1|STARTED|Overall Study||65
8188865|NCT02305732|20191081|P1|NOT COMPLETED|Overall Study||18
8188866|NCT02305732|20191081|P1|COMPLETED|Overall Study||72
8188867|NCT02305732|20191081|P1|STARTED|Overall Study||90
8188868|NCT02305446|20191089|P1|NOT COMPLETED|Overall Study||1
8188869|NCT02305446|20191089|P1|COMPLETED|Overall Study||54
8188870|NCT02305446|20191089|P1|STARTED|Overall Study||55
8188871|NCT02305381|20191097|P3|NOT COMPLETED|Overall Study||7
8188872|NCT02305381|20191098|P2|NOT COMPLETED|Overall Study||5
8188873|NCT02305381|20191099|P1|NOT COMPLETED|Overall Study||5
8188874|NCT02305381|20191097|P3|COMPLETED|Overall Study|Subjects who completed the trial.|126
8188875|NCT02305381|20191098|P2|COMPLETED|Overall Study|Subjects who completed the trial.|127
8188876|NCT02305381|20191099|P1|COMPLETED|Overall Study|Subjects who completed the trial.|127
8188877|NCT02305381|20191097|P3|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
8188878|NCT02305381|20191098|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
8188879|NCT02305381|20191099|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
8188880|NCT02305381|20191097|P3|Exposed|Overall Study||133
8188881|NCT02305381|20191098|P2|Exposed|Overall Study||131
8188882|NCT02305381|20191099|P1|Exposed|Overall Study||132
8188883|NCT02305381|20191097|P3|STARTED|Overall Study||133
8188884|NCT02305381|20191098|P2|STARTED|Overall Study||132
8188885|NCT02305381|20191099|P1|STARTED|Overall Study||132
8188886|NCT02305329|20191132|P4|NOT COMPLETED|Overall Study||0
8188887|NCT02305329|20191133|P3|NOT COMPLETED|Overall Study||0
8188888|NCT02305329|20191134|P2|NOT COMPLETED|Overall Study||1
8188889|NCT02305329|20191135|P1|NOT COMPLETED|Overall Study||0
8188890|NCT02305329|20191132|P4|COMPLETED|Overall Study||14
8188891|NCT02305329|20191133|P3|COMPLETED|Overall Study||14
8188892|NCT02305329|20191134|P2|COMPLETED|Overall Study||13
8188893|NCT02305329|20191135|P1|COMPLETED|Overall Study||14
8188894|NCT02305329|20191132|P4|Period 2|Overall Study||14
8188895|NCT02305329|20191133|P3|Period 2|Overall Study||14
8188896|NCT02305329|20191134|P2|Period 2|Overall Study||13
8188897|NCT02305329|20191135|P1|Period 2|Overall Study||14
8188898|NCT02305329|20191132|P4|Period 1|Overall Study||14
8188899|NCT02305329|20191133|P3|Period 1|Overall Study||14
8188900|NCT02305329|20191134|P2|Period 1|Overall Study||14
8188901|NCT02305329|20191135|P1|Period 1|Overall Study||14
8188902|NCT02305329|20191132|P4|STARTED|Overall Study||14
8188903|NCT02305329|20191133|P3|STARTED|Overall Study||14
8188904|NCT02305329|20191134|P2|STARTED|Overall Study||14
8188905|NCT02305329|20191135|P1|STARTED|Overall Study||14
8188906|NCT02305316|20191159|P2|NOT COMPLETED|Overall Study||0
8188907|NCT02305316|20191160|P1|NOT COMPLETED|Overall Study||0
8188908|NCT02305316|20191159|P2|COMPLETED|Overall Study||14
8188909|NCT02305316|20191160|P1|COMPLETED|Overall Study||14
8188910|NCT02305316|20191159|P2|STARTED|Overall Study||14
8188911|NCT02305316|20191160|P1|STARTED|Overall Study||14
8188912|NCT02305277|20191178|P6|NOT COMPLETED|Overall Study||0
8188913|NCT02305277|20191179|P5|NOT COMPLETED|Overall Study||1
8188914|NCT02305277|20191180|P4|NOT COMPLETED|Overall Study||0
8188915|NCT02305277|20191181|P3|NOT COMPLETED|Overall Study||0
8188916|NCT02305277|20191182|P2|NOT COMPLETED|Overall Study||0
8188917|NCT02305277|20191183|P1|NOT COMPLETED|Overall Study||1
8188918|NCT02305277|20191178|P6|COMPLETED|Overall Study||14
8188919|NCT02305277|20191179|P5|COMPLETED|Overall Study||13
8188920|NCT02305277|20191180|P4|COMPLETED|Overall Study||14
8188921|NCT02305277|20191181|P3|COMPLETED|Overall Study||14
8188922|NCT02305277|20191182|P2|COMPLETED|Overall Study||14
8188923|NCT02305277|20191183|P1|COMPLETED|Overall Study||14
8188924|NCT02305277|20191178|P6|Received TBM|Overall Study||14
8188925|NCT02305277|20191179|P5|Received TBM|Overall Study||14
8188926|NCT02305277|20191180|P4|Received TBM|Overall Study||14
8188927|NCT02305277|20191181|P3|Received TBM|Overall Study||14
8188928|NCT02305277|20191182|P2|Received TBM|Overall Study||14
8188929|NCT02305277|20191183|P1|Received TBM|Overall Study||15
8188930|NCT02305277|20191178|P6|Received CM|Overall Study||14
8188931|NCT02305277|20191179|P5|Received CM|Overall Study||14
8188932|NCT02305277|20191180|P4|Received CM|Overall Study||14
8188933|NCT02305277|20191181|P3|Received CM|Overall Study||14
8188934|NCT02305277|20191182|P2|Received CM|Overall Study||14
8188935|NCT02305277|20191183|P1|Received CM|Overall Study||15
8188936|NCT02305277|20191178|P6|STARTED|Overall Study||14
8188937|NCT02305277|20191179|P5|STARTED|Overall Study||14
8188938|NCT02305277|20191180|P4|STARTED|Overall Study||14
8188939|NCT02305277|20191181|P3|STARTED|Overall Study||14
8188940|NCT02305277|20191182|P2|STARTED|Overall Study||14
8188941|NCT02305277|20191183|P1|STARTED|Overall Study||15
8188942|NCT02305238|20191212|P3|NOT COMPLETED|Overall Study||8
8188943|NCT02305238|20191213|P2|NOT COMPLETED|Overall Study||19
8188944|NCT02305238|20191214|P1|NOT COMPLETED|Overall Study||16
8188945|NCT02305238|20191212|P3|COMPLETED|Overall Study||0
8188946|NCT02305238|20191213|P2|COMPLETED|Overall Study||104
8188947|NCT02305238|20191214|P1|COMPLETED|Overall Study||108
8188948|NCT02305238|20191212|P3|BCVA Post-randomization Assessment|Overall Study||0
8188949|NCT02305238|20191213|P2|BCVA Post-randomization Assessment|Overall Study||123
8188950|NCT02305238|20191214|P1|BCVA Post-randomization Assessment|Overall Study||123
8188951|NCT02305238|20191212|P3|Randomized|Overall Study||0
8188952|NCT02305238|20191213|P2|Randomized|Overall Study||123
8188953|NCT02305238|20191214|P1|Randomized|Overall Study||124
8188954|NCT02305238|20191212|P3|Treated|Overall Study||7
8188955|NCT02305238|20191213|P2|Treated|Overall Study||123
8188956|NCT02305238|20191214|P1|Treated|Overall Study||124
8188957|NCT02305238|20191212|P3|STARTED|Overall Study||8
8188958|NCT02305238|20191213|P2|STARTED|Overall Study||123
8188959|NCT02305238|20191214|P1|STARTED|Overall Study||124
8188960|NCT02305017|20191231|P2|NOT COMPLETED|Overall Study||0
8188961|NCT02305017|20191232|P1|NOT COMPLETED|Overall Study||0
8188962|NCT02305017|20191231|P2|COMPLETED|Overall Study||14
8188963|NCT02305017|20191232|P1|COMPLETED|Overall Study||14
8188964|NCT02305017|20191231|P2|STARTED|Overall Study||14
8188965|NCT02305017|20191232|P1|STARTED|Overall Study||14
8188966|NCT02304926|20191246|P2|NOT COMPLETED|Overall Study||1
8188967|NCT02304926|20191247|P1|NOT COMPLETED|Overall Study||2
8188968|NCT02304926|20191246|P2|COMPLETED|Overall Study||19
8188969|NCT02304926|20191247|P1|COMPLETED|Overall Study||20
8188970|NCT02304926|20191246|P2|STARTED|Overall Study||20
8188971|NCT02304926|20191247|P1|STARTED|Overall Study||22
8188972|NCT02304705|20191293|P2|NOT COMPLETED|Overall Study||7
8188973|NCT02304705|20191294|P1|NOT COMPLETED|Overall Study||4
8188974|NCT02304705|20191293|P2|COMPLETED|Overall Study||10
8188975|NCT02304705|20191294|P1|COMPLETED|Overall Study||12
8188976|NCT02304705|20191293|P2|STARTED|Overall Study||17
8188977|NCT02304705|20191294|P1|STARTED|Overall Study||16
8188978|NCT02304484|20191300|P1|NOT COMPLETED|Overall Study||25
8188979|NCT02304484|20191300|P1|COMPLETED|Overall Study||745
8188980|NCT02304484|20191300|P1|STARTED|Overall Study||770
8188981|NCT02304432|20191305|P4|NOT COMPLETED|Second Open Label DCS||0
8188982|NCT02304432|20191306|P3|NOT COMPLETED|Second Open Label DCS||0
8188983|NCT02304432|20191307|P2|NOT COMPLETED|Second Open Label DCS||0
8188984|NCT02304432|20191308|P1|NOT COMPLETED|Second Open Label DCS||0
8188985|NCT02304432|20191305|P4|COMPLETED|Second Open Label DCS||2
8188986|NCT02304432|20191306|P3|COMPLETED|Second Open Label DCS||0
8188987|NCT02304432|20191307|P2|COMPLETED|Second Open Label DCS||0
8188988|NCT02304432|20191308|P1|COMPLETED|Second Open Label DCS||0
8188989|NCT02304432|20191305|P4|STARTED|Second Open Label DCS||2
8188990|NCT02304432|20191306|P3|STARTED|Second Open Label DCS||0
8188991|NCT02304432|20191307|P2|STARTED|Second Open Label DCS||0
8188992|NCT02304432|20191308|P1|STARTED|Second Open Label DCS||0
8188993|NCT02304432|20191305|P4|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
8188994|NCT02304432|20191306|P3|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
8188995|NCT02304432|20191307|P2|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
8188996|NCT02304432|20191308|P1|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
8188997|NCT02304432|20191305|P4|COMPLETED|Double-Blind DCS Placebo Crossover||0
8188998|NCT02304432|20191306|P3|COMPLETED|Double-Blind DCS Placebo Crossover||1
8188999|NCT02304432|20191307|P2|COMPLETED|Double-Blind DCS Placebo Crossover||1
8189000|NCT02304432|20191308|P1|COMPLETED|Double-Blind DCS Placebo Crossover||0
8189001|NCT02304432|20191305|P4|STARTED|Double-Blind DCS Placebo Crossover||0
8189002|NCT02304432|20191306|P3|STARTED|Double-Blind DCS Placebo Crossover||1
8189003|NCT02304432|20191307|P2|STARTED|Double-Blind DCS Placebo Crossover||1
8189004|NCT02304432|20191308|P1|STARTED|Double-Blind DCS Placebo Crossover||0
8189005|NCT02304432|20191305|P4|NOT COMPLETED|Open Label DCS||0
8189006|NCT02304432|20191306|P3|NOT COMPLETED|Open Label DCS||0
8189007|NCT02304432|20191307|P2|NOT COMPLETED|Open Label DCS||0
8189008|NCT02304432|20191308|P1|NOT COMPLETED|Open Label DCS||0
8189009|NCT02304432|20191305|P4|COMPLETED|Open Label DCS||0
8189010|NCT02304432|20191306|P3|COMPLETED|Open Label DCS||0
8189011|NCT02304432|20191307|P2|COMPLETED|Open Label DCS||0
8189012|NCT02304432|20191308|P1|COMPLETED|Open Label DCS||2
8189013|NCT02304432|20191305|P4|STARTED|Open Label DCS||0
8189014|NCT02304432|20191306|P3|STARTED|Open Label DCS||0
8189015|NCT02304432|20191307|P2|STARTED|Open Label DCS||0
8189016|NCT02304432|20191308|P1|STARTED|Open Label DCS||2
8189017|NCT02304406|20191340|P1|NOT COMPLETED|Overall Study||0
8189018|NCT02304406|20191340|P1|COMPLETED|Overall Study||449
8189019|NCT02304406|20191340|P1|STARTED|Overall Study||449
8189020|NCT02304380|20191363|P6|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189021|NCT02304380|20191364|P5|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189022|NCT02304380|20191365|P4|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189023|NCT02304380|20191366|P3|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189024|NCT02304380|20191367|P2|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189025|NCT02304380|20191368|P1|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189026|NCT02304380|20191363|P6|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189027|NCT02304380|20191364|P5|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189028|NCT02304380|20191365|P4|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189029|NCT02304380|20191366|P3|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189030|NCT02304380|20191367|P2|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
8189031|NCT02304380|20191368|P1|COMPLETED|ACO Stakeholder Interviews (Aim 1)||24
8189032|NCT02304380|20191363|P6|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8189033|NCT02304380|20191364|P5|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8189034|NCT02304380|20191365|P4|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8189035|NCT02304380|20191366|P3|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8189036|NCT02304380|20191367|P2|STARTED|ACO Stakeholder Interviews (Aim 1)||0
8189037|NCT02304380|20191368|P1|STARTED|ACO Stakeholder Interviews (Aim 1)||24
8189038|NCT02304380|20191363|P6|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189039|NCT02304380|20191364|P5|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189040|NCT02304380|20191365|P4|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189041|NCT02304380|20191366|P3|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189042|NCT02304380|20191367|P2|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189043|NCT02304380|20191368|P1|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189044|NCT02304380|20191363|P6|COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189045|NCT02304380|20191364|P5|COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189046|NCT02304380|20191365|P4|COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189047|NCT02304380|20191366|P3|COMPLETED|Interviews & Focus Groups (Aim 1)||33
8189048|NCT02304380|20191367|P2|COMPLETED|Interviews & Focus Groups (Aim 1)||35
8189049|NCT02304380|20191368|P1|COMPLETED|Interviews & Focus Groups (Aim 1)||0
8189050|NCT02304380|20191363|P6|STARTED|Interviews & Focus Groups (Aim 1)||0
8189051|NCT02304380|20191364|P5|STARTED|Interviews & Focus Groups (Aim 1)||0
8189052|NCT02304380|20191365|P4|STARTED|Interviews & Focus Groups (Aim 1)||0
8189053|NCT02304380|20191366|P3|STARTED|Interviews & Focus Groups (Aim 1)||33
8189054|NCT02304380|20191367|P2|STARTED|Interviews & Focus Groups (Aim 1)||35
8189055|NCT02304380|20191368|P1|STARTED|Interviews & Focus Groups (Aim 1)||0
8189056|NCT02304380|20191363|P6|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189057|NCT02304380|20191364|P5|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189058|NCT02304380|20191365|P4|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||34
8189059|NCT02304380|20191366|P3|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189060|NCT02304380|20191367|P2|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189061|NCT02304380|20191368|P1|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189062|NCT02304380|20191363|P6|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189063|NCT02304380|20191364|P5|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189064|NCT02304380|20191365|P4|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)|68 Caregivers/Patients of the 2,062 surveyed were included in the Interviews and Focus Group .|2062
8189065|NCT02304380|20191366|P3|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189066|NCT02304380|20191367|P2|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189067|NCT02304380|20191368|P1|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189068|NCT02304380|20191363|P6|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189069|NCT02304380|20191364|P5|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189070|NCT02304380|20191365|P4|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||2096
8189071|NCT02304380|20191366|P3|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189072|NCT02304380|20191367|P2|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189073|NCT02304380|20191368|P1|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
8189074|NCT02304380|20191363|P6|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189075|NCT02304380|20191364|P5|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189076|NCT02304380|20191365|P4|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189077|NCT02304380|20191366|P3|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189078|NCT02304380|20191367|P2|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189079|NCT02304380|20191368|P1|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189080|NCT02304380|20191363|P6|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|Not included in any other portion of the study.|47026
8189081|NCT02304380|20191364|P5|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|2,096 Caregivers of the 17,356 claims were included in the Caregiver Survey.|17356
8189082|NCT02304380|20191365|P4|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189083|NCT02304380|20191366|P3|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189084|NCT02304380|20191367|P2|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189085|NCT02304380|20191368|P1|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
8189086|NCT02304380|20191363|P6|STARTED|Pediatric Claims Data Analysis (Aim 3)||47026
8189087|NCT02304380|20191364|P5|STARTED|Pediatric Claims Data Analysis (Aim 3)||17356
8189088|NCT02304380|20191365|P4|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
8189089|NCT02304380|20191366|P3|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
8189090|NCT02304380|20191367|P2|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
8189091|NCT02304380|20191368|P1|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
8189097|NCT02304159|20191478|P2|NOT COMPLETED|Overall Study||2
8189098|NCT02304159|20191479|P1|NOT COMPLETED|Overall Study||2
8189099|NCT02304159|20191478|P2|COMPLETED|Overall Study||16
8189100|NCT02304159|20191479|P1|COMPLETED|Overall Study||19
8189101|NCT02304159|20191478|P2|STARTED|Overall Study||18
8189102|NCT02304159|20191479|P1|STARTED|Overall Study||21
8189103|NCT02303743|20191491|P2|NOT COMPLETED|Overall Study||0
8189104|NCT02303743|20191492|P1|NOT COMPLETED|Overall Study||0
8189105|NCT02303743|20191491|P2|COMPLETED|Overall Study||152
8189106|NCT02303743|20191492|P1|COMPLETED|Overall Study||108
8189107|NCT02303743|20191491|P2|STARTED|Overall Study||152
8189108|NCT02303743|20191492|P1|STARTED|Overall Study||108
8189115|NCT02303574|20191531|P10|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189116|NCT02303574|20191532|P9|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189117|NCT02303574|20191533|P8|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
8189118|NCT02303574|20191534|P7|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189119|NCT02303574|20191535|P6|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189120|NCT02303574|20191536|P5|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189121|NCT02303574|20191537|P4|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189122|NCT02303574|20191538|P3|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189123|NCT02303574|20191539|P2|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189124|NCT02303574|20191540|P1|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189125|NCT02303574|20191531|P10|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
8189126|NCT02303574|20191532|P9|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
8189127|NCT02303574|20191533|P8|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
8189128|NCT02303574|20191534|P7|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
8189129|NCT02303574|20191535|P6|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189130|NCT02303574|20191536|P5|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189131|NCT02303574|20191537|P4|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189132|NCT02303574|20191538|P3|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189133|NCT02303574|20191539|P2|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189134|NCT02303574|20191540|P1|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
8189135|NCT02303574|20191531|P10|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
8189136|NCT02303574|20191532|P9|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
8189137|NCT02303574|20191533|P8|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
8189138|NCT02303574|20191534|P7|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
8189139|NCT02303574|20191535|P6|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8189140|NCT02303574|20191536|P5|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8189141|NCT02303574|20191537|P4|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8189142|NCT02303574|20191538|P3|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8189143|NCT02303574|20191539|P2|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8189144|NCT02303574|20191540|P1|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
8189145|NCT02303574|20191531|P10|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189146|NCT02303574|20191532|P9|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189147|NCT02303574|20191533|P8|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189148|NCT02303574|20191534|P7|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189149|NCT02303574|20191535|P6|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189150|NCT02303574|20191536|P5|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189151|NCT02303574|20191537|P4|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189152|NCT02303574|20191538|P3|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189153|NCT02303574|20191539|P2|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189154|NCT02303574|20191540|P1|NOT COMPLETED|Part 1b (Fed State) - SAD||0
8189155|NCT02303574|20191531|P10|COMPLETED|Part 1b (Fed State) - SAD||3
8189156|NCT02303574|20191532|P9|COMPLETED|Part 1b (Fed State) - SAD||0
8189157|NCT02303574|20191533|P8|COMPLETED|Part 1b (Fed State) - SAD||0
8189158|NCT02303574|20191534|P7|COMPLETED|Part 1b (Fed State) - SAD||0
8189159|NCT02303574|20191535|P6|COMPLETED|Part 1b (Fed State) - SAD||5
8189160|NCT02303574|20191536|P5|COMPLETED|Part 1b (Fed State) - SAD||0
8189161|NCT02303574|20191537|P4|COMPLETED|Part 1b (Fed State) - SAD||0
8189162|NCT02303574|20191538|P3|COMPLETED|Part 1b (Fed State) - SAD||0
8189163|NCT02303574|20191539|P2|COMPLETED|Part 1b (Fed State) - SAD||0
8189164|NCT02303574|20191540|P1|COMPLETED|Part 1b (Fed State) - SAD||0
8189165|NCT02303574|20191531|P10|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
8189166|NCT02303574|20191532|P9|STARTED|Part 1b (Fed State) - SAD||0
8189167|NCT02303574|20191533|P8|STARTED|Part 1b (Fed State) - SAD||0
8189168|NCT02303574|20191534|P7|STARTED|Part 1b (Fed State) - SAD||0
8189169|NCT02303574|20191535|P6|STARTED|Part 1b (Fed State) - SAD||5
8189170|NCT02303574|20191536|P5|STARTED|Part 1b (Fed State) - SAD||0
8189171|NCT02303574|20191537|P4|STARTED|Part 1b (Fed State) - SAD||0
8189172|NCT02303574|20191538|P3|STARTED|Part 1b (Fed State) - SAD||0
8189173|NCT02303574|20191539|P2|STARTED|Part 1b (Fed State) - SAD||0
8189174|NCT02303574|20191540|P1|STARTED|Part 1b (Fed State) - SAD||0
8189175|NCT02303574|20191531|P10|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189176|NCT02303574|20191532|P9|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189177|NCT02303574|20191533|P8|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189178|NCT02303574|20191534|P7|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189179|NCT02303574|20191535|P6|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189180|NCT02303574|20191536|P5|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189181|NCT02303574|20191537|P4|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189182|NCT02303574|20191538|P3|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
8189183|NCT02303574|20191539|P2|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189184|NCT02303574|20191540|P1|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
8189185|NCT02303574|20191531|P10|COMPLETED|Part 1a (Fasted State)- SAD||15
8189186|NCT02303574|20191532|P9|COMPLETED|Part 1a (Fasted State)- SAD||0
8189187|NCT02303574|20191533|P8|COMPLETED|Part 1a (Fasted State)- SAD||0
8189188|NCT02303574|20191534|P7|COMPLETED|Part 1a (Fasted State)- SAD||0
8189189|NCT02303574|20191535|P6|COMPLETED|Part 1a (Fasted State)- SAD||0
8189190|NCT02303574|20191536|P5|COMPLETED|Part 1a (Fasted State)- SAD||6
8189191|NCT02303574|20191537|P4|COMPLETED|Part 1a (Fasted State)- SAD||6
8189192|NCT02303574|20191538|P3|COMPLETED|Part 1a (Fasted State)- SAD||5
8189193|NCT02303574|20191539|P2|COMPLETED|Part 1a (Fasted State)- SAD||6
8189194|NCT02303574|20191540|P1|COMPLETED|Part 1a (Fasted State)- SAD||6
8189195|NCT02303574|20191531|P10|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
8189196|NCT02303574|20191532|P9|STARTED|Part 1a (Fasted State)- SAD||0
8189197|NCT02303574|20191533|P8|STARTED|Part 1a (Fasted State)- SAD||0
8189198|NCT02303574|20191534|P7|STARTED|Part 1a (Fasted State)- SAD||0
8189199|NCT02303574|20191535|P6|STARTED|Part 1a (Fasted State)- SAD||0
8189200|NCT02303574|20191536|P5|STARTED|Part 1a (Fasted State)- SAD||6
8189201|NCT02303574|20191537|P4|STARTED|Part 1a (Fasted State)- SAD||6
8189202|NCT02303574|20191538|P3|STARTED|Part 1a (Fasted State)- SAD||6
8189203|NCT02303574|20191539|P2|STARTED|Part 1a (Fasted State)- SAD||6
8189204|NCT02303574|20191540|P1|STARTED|Part 1a (Fasted State)- SAD||6
8189205|NCT02303548|20191754|P2|NOT COMPLETED|Overall Study||0
8189206|NCT02303548|20191755|P1|NOT COMPLETED|Overall Study||0
8189207|NCT02303548|20191754|P2|COMPLETED|Overall Study||25
8189208|NCT02303548|20191755|P1|COMPLETED|Overall Study||25
8189209|NCT02303548|20191754|P2|STARTED|Overall Study||25
8189210|NCT02303548|20191755|P1|STARTED|Overall Study||25
8189211|NCT02303262|20191761|P1|NOT COMPLETED|Overall Study||2
8189212|NCT02303262|20191761|P1|COMPLETED|Overall Study||18
8189213|NCT02303262|20191761|P1|STARTED|Overall Study||20
8189214|NCT02303041|20191769|P2|NOT COMPLETED|Overall Study||2
8189215|NCT02303041|20191770|P1|NOT COMPLETED|Overall Study||1
8189216|NCT02303041|20191769|P2|COMPLETED|Overall Study||4
8189217|NCT02303041|20191770|P1|COMPLETED|Overall Study||3
8189218|NCT02303041|20191769|P2|STARTED|Overall Study||6
8189219|NCT02303041|20191770|P1|STARTED|Overall Study||4
8189220|NCT02302859|20191786|P2|NOT COMPLETED|Overall Study||2
8189221|NCT02302859|20191787|P1|NOT COMPLETED|Overall Study||1
8189222|NCT02302859|20191786|P2|COMPLETED|Overall Study||4
8189223|NCT02302859|20191787|P1|COMPLETED|Overall Study||1
8189224|NCT02302859|20191786|P2|STARTED|Overall Study||6
8189225|NCT02302859|20191787|P1|STARTED|Overall Study||2
8189226|NCT02302846|20191793|P1|NOT COMPLETED|Overall Study||1
8189227|NCT02302846|20191793|P1|COMPLETED|Overall Study||4
8189228|NCT02302846|20191793|P1|STARTED|Overall Study||5
8189229|NCT02302807|20191799|P2|NOT COMPLETED|Overall Study||467
8189230|NCT02302807|20191800|P1|NOT COMPLETED|Overall Study||464
8189231|NCT02302807|20191799|P2|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0
8189232|NCT02302807|20191800|P1|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0
8189233|NCT02302807|20191799|P2|Received Treatment|Overall Study||459
8189234|NCT02302807|20191800|P1|Received Treatment|Overall Study||443
8189235|NCT02302807|20191799|P2|STARTED|Overall Study||467
8189236|NCT02302807|20191800|P1|STARTED|Overall Study||464
8189237|NCT02302716|20191847|P2|NOT COMPLETED|Overall Study||19
8189238|NCT02302716|20191848|P1|NOT COMPLETED|Overall Study||19
8189239|NCT02302716|20191847|P2|COMPLETED|Overall Study||225
8189240|NCT02302716|20191848|P1|COMPLETED|Overall Study||230
8189241|NCT02302716|20191847|P2|Received at Least 1 Dose of Study Drug|Overall Study||244
8189242|NCT02302716|20191848|P1|Received at Least 1 Dose of Study Drug|Overall Study||249
8189243|NCT02302716|20191847|P2|STARTED|Overall Study||244
8189244|NCT02302716|20191848|P1|STARTED|Overall Study||249
8189245|NCT02302365|20191874|P1|NOT COMPLETED|0-24 Hour Period||0
8189246|NCT02302365|20191874|P1|COMPLETED|0-24 Hour Period||32
8189247|NCT02302365|20191874|P1|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
8189248|NCT02302365|20191874|P1|NOT COMPLETED|0-2 Hour Period||2
8189249|NCT02302365|20191874|P1|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
8189250|NCT02302365|20191874|P1|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
8189251|NCT02302339|20191896|P4|NOT COMPLETED|Overall Study||0
8189252|NCT02302339|20191897|P3|NOT COMPLETED|Overall Study||1
8189253|NCT02302339|20191898|P2|NOT COMPLETED|Overall Study||2
8189254|NCT02302339|20191899|P1|NOT COMPLETED|Overall Study||1
8189255|NCT02302339|20191896|P4|COMPLETED|Overall Study||7
8189256|NCT02302339|20191897|P3|COMPLETED|Overall Study||28
8189257|NCT02302339|20191898|P2|COMPLETED|Overall Study||32
8189258|NCT02302339|20191899|P1|COMPLETED|Overall Study||61
8189259|NCT02302339|20191896|P4|STARTED|Overall Study||7
8189260|NCT02302339|20191897|P3|STARTED|Overall Study||29
8189261|NCT02302339|20191898|P2|STARTED|Overall Study||34
8189262|NCT02302339|20191899|P1|STARTED|Overall Study||62
8189263|NCT02302222|20191932|P2|NOT COMPLETED|Overall Study||6
8189264|NCT02302222|20191933|P1|NOT COMPLETED|Overall Study||1
8189265|NCT02302222|20191932|P2|COMPLETED|Overall Study||31
8189266|NCT02302222|20191933|P1|COMPLETED|Overall Study||33
8189267|NCT02302222|20191932|P2|STARTED|Overall Study||37
8189268|NCT02302222|20191933|P1|STARTED|Overall Study||34
8189269|NCT02302092|20191941|P2|NOT COMPLETED|Overall Study||0
8189270|NCT02302092|20191942|P1|NOT COMPLETED|Overall Study||0
8189271|NCT02302092|20191941|P2|COMPLETED|Overall Study||7
8189272|NCT02302092|20191942|P1|COMPLETED|Overall Study||6
8189273|NCT02302092|20191941|P2|STARTED|Overall Study||7
8189274|NCT02302092|20191942|P1|STARTED|Overall Study||6
8189275|NCT02302066|20191972|P4|NOT COMPLETED|Overall Study||41
8189276|NCT02302066|20191973|P3|NOT COMPLETED|Overall Study||172
8189277|NCT02302066|20191974|P2|NOT COMPLETED|Overall Study||75
8189278|NCT02302066|20191975|P1|NOT COMPLETED|Overall Study||33
8189279|NCT02302066|20191972|P4|COMPLETED|Overall Study||158
8189280|NCT02302066|20191973|P3|COMPLETED|Overall Study||830
8189281|NCT02302066|20191974|P2|COMPLETED|Overall Study||323
8189282|NCT02302066|20191975|P1|COMPLETED|Overall Study||168
8189283|NCT02302066|20191972|P4|Per-Protocol Set (PPS)|Overall Study||81
8189284|NCT02302066|20191973|P3|Per-Protocol Set (PPS)|Overall Study||174
8189285|NCT02302066|20191974|P2|Per-Protocol Set (PPS)|Overall Study||171
8189286|NCT02302066|20191975|P1|Per-Protocol Set (PPS)|Overall Study||83
8189287|NCT02302066|20191972|P4|Immunogenicity Subset|Overall Study||94
8189288|NCT02302066|20191973|P3|Immunogenicity Subset|Overall Study||192
8189289|NCT02302066|20191974|P2|Immunogenicity Subset|Overall Study||187
8189290|NCT02302066|20191975|P1|Immunogenicity Subset|Overall Study||92
8189291|NCT02302066|20191972|P4|Safety Analysis Set|Overall Study||198
8189292|NCT02302066|20191973|P3|Safety Analysis Set|Overall Study||998
8189293|NCT02302066|20191974|P2|Safety Analysis Set|Overall Study||398
8189294|NCT02302066|20191975|P1|Safety Analysis Set|Overall Study||200
8189295|NCT02302066|20191972|P4|STARTED|Overall Study||199
8189296|NCT02302066|20191973|P3|STARTED|Overall Study||1002
8189297|NCT02302066|20191974|P2|STARTED|Overall Study||398
8189298|NCT02302066|20191975|P1|STARTED|Overall Study||201
8189299|NCT02301988|20192019|P2|NOT COMPLETED|Overall Study||9
8189300|NCT02301988|20192020|P1|NOT COMPLETED|Overall Study||10
8189301|NCT02301988|20192019|P2|COMPLETED|Overall Study||66
8189302|NCT02301988|20192020|P1|COMPLETED|Overall Study||66
8189303|NCT02301988|20192019|P2|STARTED|Overall Study||75
8189304|NCT02301988|20192020|P1|STARTED|Overall Study||76
8189305|NCT02301975|20192053|P3|NOT COMPLETED|Overall Study||22
8189306|NCT02301975|20192054|P2|NOT COMPLETED|Overall Study||25
8189307|NCT02301975|20192055|P1|NOT COMPLETED|Overall Study||31
8189308|NCT02301975|20192053|P3|COMPLETED|Overall Study||477
8189309|NCT02301975|20192054|P2|COMPLETED|Overall Study||476
8189310|NCT02301975|20192055|P1|COMPLETED|Overall Study||473
8189311|NCT02301975|20192053|P3|STARTED|Overall Study||499
8189312|NCT02301975|20192054|P2|STARTED|Overall Study||501
8189313|NCT02301975|20192055|P1|STARTED|Overall Study||504
8189314|NCT02301936|20192083|P2|NOT COMPLETED|Overall Study||0
8189315|NCT02301936|20192084|P1|NOT COMPLETED|Overall Study||1
8189316|NCT02301936|20192083|P2|COMPLETED|Overall Study||1
8189317|NCT02301936|20192084|P1|COMPLETED|Overall Study||8
8189318|NCT02301936|20192083|P2|STARTED|Overall Study||1
8189319|NCT02301936|20192084|P1|STARTED|Overall Study||9
8189320|NCT02301897|20192109|P3|NOT COMPLETED|Treatment Course 2||1
8189321|NCT02301897|20192110|P2|NOT COMPLETED|Treatment Course 2||5
8189322|NCT02301897|20192111|P1|NOT COMPLETED|Treatment Course 2||1
8189323|NCT02301897|20192109|P3|COMPLETED|Treatment Course 2||7
8189324|NCT02301897|20192110|P2|COMPLETED|Treatment Course 2||9
8189325|NCT02301897|20192111|P1|COMPLETED|Treatment Course 2||8
8189326|NCT02301897|20192109|P3|STARTED|Treatment Course 2||8
8189327|NCT02301897|20192110|P2|STARTED|Treatment Course 2||14
8189328|NCT02301897|20192111|P1|STARTED|Treatment Course 2||9
8189329|NCT02301897|20192109|P3|NOT COMPLETED|Treatment Course 1||6
8189330|NCT02301897|20192110|P2|NOT COMPLETED|Treatment Course 1||3
8189331|NCT02301897|20192111|P1|NOT COMPLETED|Treatment Course 1||3
8189332|NCT02301897|20192109|P3|COMPLETED|Treatment Course 1||8
8189333|NCT02301897|20192110|P2|COMPLETED|Treatment Course 1||14
8189334|NCT02301897|20192111|P1|COMPLETED|Treatment Course 1||9
8189335|NCT02301897|20192109|P3|STARTED|Treatment Course 1||14
8189336|NCT02301897|20192110|P2|STARTED|Treatment Course 1||17
8189337|NCT02301897|20192111|P1|STARTED|Treatment Course 1||12
8189338|NCT02301793|20192160|P2|NOT COMPLETED|During and Post Education Study Period||49
8189339|NCT02301793|20192161|P1|NOT COMPLETED|During and Post Education Study Period||83
8189340|NCT02301793|20192160|P2|COMPLETED|During and Post Education Study Period||396
8189341|NCT02301793|20192161|P1|COMPLETED|During and Post Education Study Period||405
8189342|NCT02301793|20192160|P2|STARTED|During and Post Education Study Period||445
8189343|NCT02301793|20192161|P1|STARTED|During and Post Education Study Period||488
8189344|NCT02301793|20192160|P2|NOT COMPLETED|Pre Education Study Period||0
8189345|NCT02301793|20192161|P1|NOT COMPLETED|Pre Education Study Period||0
8189346|NCT02301793|20192160|P2|COMPLETED|Pre Education Study Period|Nurses had not been randomized|0
8189347|NCT02301793|20192161|P1|COMPLETED|Pre Education Study Period|Nurses had not been randomized|0
8189348|NCT02301793|20192160|P2|STARTED|Pre Education Study Period|Nurses had not been randomized|0
8189349|NCT02301793|20192161|P1|STARTED|Pre Education Study Period|Nurses had not been randomized|0
8189350|NCT02301624|20192177|P2|NOT COMPLETED|Open-label Maintenance Phase||17
8189351|NCT02301624|20192178|P1|NOT COMPLETED|Open-label Maintenance Phase||12
8189352|NCT02301624|20192177|P2|COMPLETED|Open-label Maintenance Phase||44
8189353|NCT02301624|20192178|P1|COMPLETED|Open-label Maintenance Phase||43
8189354|NCT02301624|20192177|P2|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61
8189355|NCT02301624|20192178|P1|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55
8189356|NCT02301624|20192177|P2|STARTED|Open-label Maintenance Phase||61
8189357|NCT02301624|20192178|P1|STARTED|Open-label Maintenance Phase||55
8189358|NCT02301624|20192177|P2|NOT COMPLETED|Blind Induction Phase||0
8189359|NCT02301624|20192178|P1|NOT COMPLETED|Blind Induction Phase||1
8189360|NCT02301624|20192177|P2|COMPLETED|Blind Induction Phase||61
8189361|NCT02301624|20192178|P1|COMPLETED|Blind Induction Phase||55
8189362|NCT02301624|20192177|P2|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61
8189363|NCT02301624|20192178|P1|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56
8189364|NCT02301624|20192177|P2|STARTED|Blind Induction Phase||61
8189365|NCT02301624|20192178|P1|STARTED|Blind Induction Phase||56
8189366|NCT02301546|20192189|P2|NOT COMPLETED|Long Term Effectiveness (~1 Year)||7
8189367|NCT02301546|20192190|P1|NOT COMPLETED|Long Term Effectiveness (~1 Year)||12
8189368|NCT02301546|20192189|P2|COMPLETED|Long Term Effectiveness (~1 Year)||51
8189369|NCT02301546|20192190|P1|COMPLETED|Long Term Effectiveness (~1 Year)||43
8189370|NCT02301546|20192189|P2|STARTED|Long Term Effectiveness (~1 Year)||58
8189371|NCT02301546|20192190|P1|STARTED|Long Term Effectiveness (~1 Year)||55
8189372|NCT02301546|20192189|P2|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||15
8189373|NCT02301546|20192190|P1|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||18
8189374|NCT02301546|20192189|P2|COMPLETED|Short-term Effectiveness (~13 Weeks)||58
8189375|NCT02301546|20192190|P1|COMPLETED|Short-term Effectiveness (~13 Weeks)||55
8189376|NCT02301546|20192189|P2|STARTED|Short-term Effectiveness (~13 Weeks)||73
8189377|NCT02301546|20192190|P1|STARTED|Short-term Effectiveness (~13 Weeks)||73
8189378|NCT02301429|20192196|P1|NOT COMPLETED|Overall Study||3
8189379|NCT02301429|20192196|P1|COMPLETED|Overall Study||13
8189380|NCT02301429|20192196|P1|STARTED|Overall Study||16
8189381|NCT02301416|20192202|P2|NOT COMPLETED|Overall Study||0
8189382|NCT02301416|20192203|P1|NOT COMPLETED|Overall Study||10
8189383|NCT02301416|20192202|P2|COMPLETED|Overall Study||40
8189384|NCT02301416|20192203|P1|COMPLETED|Overall Study||15
8189385|NCT02301416|20192202|P2|STARTED|Overall Study||40
8189386|NCT02301416|20192203|P1|STARTED|Overall Study||25
8189387|NCT02301403|20192242|P2|NOT COMPLETED|Overall Study||41
8189388|NCT02301403|20192243|P1|NOT COMPLETED|Overall Study||28
8189389|NCT02301403|20192242|P2|COMPLETED|Overall Study||267
8189390|NCT02301403|20192243|P1|COMPLETED|Overall Study||287
8189391|NCT02301403|20192242|P2|STARTED|Overall Study||308
8189392|NCT02301403|20192243|P1|STARTED|Overall Study||315
8189393|NCT02301390|20192251|P2|NOT COMPLETED|Overall Study||13
8189394|NCT02301390|20192252|P1|NOT COMPLETED|Overall Study||10
8189395|NCT02301390|20192251|P2|COMPLETED|Overall Study||13
8189396|NCT02301390|20192252|P1|COMPLETED|Overall Study||17
8189397|NCT02301390|20192251|P2|STARTED|Overall Study||26
8189398|NCT02301390|20192252|P1|STARTED|Overall Study||27
8189399|NCT02301377|20192266|P2|NOT COMPLETED|Overall Study||0
8189400|NCT02301377|20192267|P1|NOT COMPLETED|Overall Study||0
8189401|NCT02301377|20192266|P2|COMPLETED|Overall Study||2
8189402|NCT02301377|20192267|P1|COMPLETED|Overall Study||3
8189403|NCT02301377|20192266|P2|STARTED|Overall Study||2
8189404|NCT02301377|20192267|P1|STARTED|Overall Study||3
8189405|NCT02301364|20192277|P1|NOT COMPLETED|Overall Study||0
8189406|NCT02301364|20192277|P1|COMPLETED|Overall Study||4
8189407|NCT02301364|20192277|P1|STARTED|Overall Study||4
8189408|NCT02301299|20192284|P1|NOT COMPLETED|Overall Study||0
8189409|NCT02301299|20192284|P1|COMPLETED|Overall Study||1322
8189410|NCT02301299|20192284|P1|STARTED|Overall Study||1322
8189411|NCT02301169|20192293|P2|NOT COMPLETED|Overall Study||0
8189412|NCT02301169|20192294|P1|NOT COMPLETED|Overall Study||1
8189413|NCT02301169|20192293|P2|COMPLETED|Overall Study||21
8189414|NCT02301169|20192294|P1|COMPLETED|Overall Study||20
8189415|NCT02301169|20192293|P2|STARTED|Overall Study||21
8189416|NCT02301169|20192294|P1|STARTED|Overall Study||21
8189417|NCT02301143|20192308|P2|NOT COMPLETED|Investigator's Choice||10
8189418|NCT02301143|20192309|P1|NOT COMPLETED|Investigator's Choice||0
8189419|NCT02301143|20192308|P2|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37
8189420|NCT02301143|20192309|P1|COMPLETED|Investigator's Choice||0
8189421|NCT02301143|20192308|P2|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47
8189422|NCT02301143|20192309|P1|STARTED|Investigator's Choice||0
8189423|NCT02301143|20192308|P2|NOT COMPLETED|Induction Period||0
8189424|NCT02301143|20192309|P1|NOT COMPLETED|Induction Period||45
8189425|NCT02301143|20192308|P2|COMPLETED|Induction Period||0
8189426|NCT02301143|20192309|P1|COMPLETED|Induction Period||62
8189427|NCT02301143|20192308|P2|STARTED|Induction Period||0
8189428|NCT02301143|20192309|P1|STARTED|Induction Period||107
8189429|NCT02301039|20192328|P3|NOT COMPLETED|Overall Study||0
8189430|NCT02301039|20192329|P2|NOT COMPLETED|Overall Study||0
8189431|NCT02301039|20192330|P1|NOT COMPLETED|Overall Study||0
8189432|NCT02301039|20192328|P3|COMPLETED|Overall Study||60
8189433|NCT02301039|20192329|P2|COMPLETED|Overall Study||42
8189434|NCT02301039|20192330|P1|COMPLETED|Overall Study||42
8189435|NCT02301039|20192328|P3|STARTED|Overall Study||60
8189436|NCT02301039|20192329|P2|STARTED|Overall Study||42
8189437|NCT02301039|20192330|P1|STARTED|Overall Study||42
8189438|NCT02300987|20192352|P2|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
8189439|NCT02300987|20192353|P1|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
8189440|NCT02300987|20192352|P2|COMPLETED|Secondary Phase : Cross-over to LEE011||1
8189441|NCT02300987|20192353|P1|COMPLETED|Secondary Phase : Cross-over to LEE011||0
8189442|NCT02300987|20192352|P2|STARTED|Secondary Phase : Cross-over to LEE011||2
8189443|NCT02300987|20192353|P1|STARTED|Secondary Phase : Cross-over to LEE011||1
8189444|NCT02300987|20192352|P2|NOT COMPLETED|Primary Phase : Prior to Cross-over||2
8189445|NCT02300987|20192353|P1|NOT COMPLETED|Primary Phase : Prior to Cross-over||6
8189446|NCT02300987|20192352|P2|COMPLETED|Primary Phase : Prior to Cross-over||0
8189447|NCT02300987|20192353|P1|COMPLETED|Primary Phase : Prior to Cross-over||2
8189448|NCT02300987|20192352|P2|STARTED|Primary Phase : Prior to Cross-over||2
8189449|NCT02300987|20192353|P1|STARTED|Primary Phase : Prior to Cross-over||8
8189450|NCT02300727|20192378|P6|NOT COMPLETED|Overall Study||0
8189451|NCT02300727|20192379|P5|NOT COMPLETED|Overall Study||0
8189452|NCT02300727|20192380|P4|NOT COMPLETED|Overall Study||1
8189453|NCT02300727|20192381|P3|NOT COMPLETED|Overall Study||0
8189454|NCT02300727|20192382|P2|NOT COMPLETED|Overall Study||0
8189455|NCT02300727|20192383|P1|NOT COMPLETED|Overall Study||0
8189456|NCT02300727|20192378|P6|COMPLETED|Overall Study||0
8189457|NCT02300727|20192379|P5|COMPLETED|Overall Study||0
8189458|NCT02300727|20192380|P4|COMPLETED|Overall Study||2
8189459|NCT02300727|20192381|P3|COMPLETED|Overall Study||3
8189460|NCT02300727|20192382|P2|COMPLETED|Overall Study||0
8189461|NCT02300727|20192383|P1|COMPLETED|Overall Study||0
8189462|NCT02300727|20192378|P6|STARTED|Overall Study||0
8189463|NCT02300727|20192379|P5|STARTED|Overall Study||0
8189464|NCT02300727|20192380|P4|STARTED|Overall Study||3
8189465|NCT02300727|20192381|P3|STARTED|Overall Study||3
8189466|NCT02300727|20192382|P2|STARTED|Overall Study||0
8189467|NCT02300727|20192383|P1|STARTED|Overall Study||0
8189468|NCT02300610|20192400|P3|NOT COMPLETED|Overall Study||1
8189469|NCT02300610|20192401|P2|NOT COMPLETED|Overall Study||0
8189470|NCT02300610|20192402|P1|NOT COMPLETED|Overall Study||1
8189471|NCT02300610|20192400|P3|COMPLETED|Overall Study||3
8189472|NCT02300610|20192401|P2|COMPLETED|Overall Study||3
8189473|NCT02300610|20192402|P1|COMPLETED|Overall Study||2
8189474|NCT02300610|20192400|P3|STARTED|Overall Study||4
8189475|NCT02300610|20192401|P2|STARTED|Overall Study||3
8189476|NCT02300610|20192402|P1|STARTED|Overall Study||3
8189477|NCT02300558|20192417|P1|NOT COMPLETED|Open-Label (OL) Extension Phase||32
8189478|NCT02300558|20192417|P1|COMPLETED|Open-Label (OL) Extension Phase||0
8189479|NCT02300558|20192417|P1|STARTED|Open-Label (OL) Extension Phase||32
8189480|NCT02300558|20192417|P1|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
8189481|NCT02300558|20192417|P1|COMPLETED|Single Blind Phase (24 Weeks)||35
8189482|NCT02300558|20192417|P1|STARTED|Single Blind Phase (24 Weeks)||41
8189483|NCT02300545|20192428|P1|NOT COMPLETED|Overall Study||0
8189484|NCT02300545|20192428|P1|COMPLETED|Overall Study||56
8189485|NCT02300545|20192428|P1|STARTED|Overall Study||56
8189486|NCT02300311|20192439|P2|NOT COMPLETED|Overall Study||0
8189487|NCT02300311|20192440|P1|NOT COMPLETED|Overall Study||19
8189488|NCT02300311|20192439|P2|COMPLETED|Overall Study||69
8189489|NCT02300311|20192440|P1|COMPLETED|Overall Study||50
8189490|NCT02300311|20192439|P2|STARTED|Overall Study||69
8189491|NCT02300311|20192440|P1|STARTED|Overall Study||69
8189492|NCT02300298|20192452|P2|NOT COMPLETED|Disposition for Docetaxel||10
8189493|NCT02300298|20192453|P1|NOT COMPLETED|Disposition for Docetaxel||0
8189494|NCT02300298|20192452|P2|COMPLETED|Disposition for Docetaxel||0
8189495|NCT02300298|20192453|P1|COMPLETED|Disposition for Docetaxel||0
8189496|NCT02300298|20192452|P2|STARTED|Disposition for Docetaxel||10
8189497|NCT02300298|20192453|P1|STARTED|Disposition for Docetaxel||0
8189498|NCT02300298|20192452|P2|NOT COMPLETED|Disposition for Nintedanib||0
8189499|NCT02300298|20192453|P1|NOT COMPLETED|Disposition for Nintedanib||10
8189500|NCT02300298|20192452|P2|COMPLETED|Disposition for Nintedanib||0
8189501|NCT02300298|20192453|P1|COMPLETED|Disposition for Nintedanib||0
8189502|NCT02300298|20192452|P2|STARTED|Disposition for Nintedanib||0
8189503|NCT02300298|20192453|P1|STARTED|Disposition for Nintedanib||10
8189504|NCT02300259|20192466|P3|NOT COMPLETED|Period 2||1
8189505|NCT02300259|20192467|P2|NOT COMPLETED|Period 2||0
8189506|NCT02300259|20192468|P1|NOT COMPLETED|Period 2||1
8189507|NCT02300259|20192466|P3|COMPLETED|Period 2||13
8189508|NCT02300259|20192467|P2|COMPLETED|Period 2||0
8189509|NCT02300259|20192468|P1|COMPLETED|Period 2||15
8189510|NCT02300259|20192466|P3|STARTED|Period 2||14
8189511|NCT02300259|20192467|P2|STARTED|Period 2|There was no period 2 for Group 2.|0
8189512|NCT02300259|20192468|P1|STARTED|Period 2||16
8189513|NCT02300259|20192466|P3|NOT COMPLETED|Period 1||2
8189514|NCT02300259|20192467|P2|NOT COMPLETED|Period 1||0
8189515|NCT02300259|20192468|P1|NOT COMPLETED|Period 1||0
8189516|NCT02300259|20192466|P3|COMPLETED|Period 1||14
8189517|NCT02300259|20192467|P2|COMPLETED|Period 1||16
8189518|NCT02300259|20192468|P1|COMPLETED|Period 1||16
8189519|NCT02300259|20192466|P3|Received at Least One Dose of Study Drug|Period 1||16
8189520|NCT02300259|20192467|P2|Received at Least One Dose of Study Drug|Period 1||16
8189521|NCT02300259|20192468|P1|Received at Least One Dose of Study Drug|Period 1||16
8189522|NCT02300259|20192466|P3|STARTED|Period 1||16
8189523|NCT02300259|20192467|P2|STARTED|Period 1||16
8189524|NCT02300259|20192468|P1|STARTED|Period 1||16
8189525|NCT02300129|20192497|P4|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
8189526|NCT02300129|20192498|P3|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
8189527|NCT02300129|20192499|P2|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
8189528|NCT02300129|20192500|P1|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
8189529|NCT02300129|20192497|P4|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
8189530|NCT02300129|20192498|P3|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
8189531|NCT02300129|20192499|P2|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
8189532|NCT02300129|20192500|P1|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
8189533|NCT02300129|20192497|P4|STARTED|Period 2 Treatment 2 (2 Weeks)||10
8189534|NCT02300129|20192498|P3|STARTED|Period 2 Treatment 2 (2 Weeks)||7
8189535|NCT02300129|20192499|P2|STARTED|Period 2 Treatment 2 (2 Weeks)||4
8189536|NCT02300129|20192500|P1|STARTED|Period 2 Treatment 2 (2 Weeks)||10
8189537|NCT02300129|20192497|P4|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
8189538|NCT02300129|20192498|P3|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
8189539|NCT02300129|20192499|P2|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
8189540|NCT02300129|20192500|P1|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
8189541|NCT02300129|20192497|P4|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
8189542|NCT02300129|20192498|P3|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
8189543|NCT02300129|20192499|P2|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
8189544|NCT02300129|20192500|P1|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
8189545|NCT02300129|20192497|P4|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
8189546|NCT02300129|20192498|P3|STARTED|Period 2 Treatment 1 (2 Weeks)||7
8189547|NCT02300129|20192499|P2|STARTED|Period 2 Treatment 1 (2 Weeks)||4
8189548|NCT02300129|20192500|P1|STARTED|Period 2 Treatment 1 (2 Weeks)||11
8189549|NCT02300129|20192497|P4|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
8189550|NCT02300129|20192498|P3|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
8189551|NCT02300129|20192499|P2|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
8189552|NCT02300129|20192500|P1|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
8189553|NCT02300129|20192497|P4|COMPLETED|Period 1 Session 3 (Day 5)||11
8189554|NCT02300129|20192498|P3|COMPLETED|Period 1 Session 3 (Day 5)||7
8189555|NCT02300129|20192499|P2|COMPLETED|Period 1 Session 3 (Day 5)||4
8189556|NCT02300129|20192500|P1|COMPLETED|Period 1 Session 3 (Day 5)||11
8189557|NCT02300129|20192497|P4|STARTED|Period 1 Session 3 (Day 5)||11
8189558|NCT02300129|20192498|P3|STARTED|Period 1 Session 3 (Day 5)||7
8189559|NCT02300129|20192499|P2|STARTED|Period 1 Session 3 (Day 5)||4
8189560|NCT02300129|20192500|P1|STARTED|Period 1 Session 3 (Day 5)||11
8189561|NCT02300129|20192497|P4|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
8189562|NCT02300129|20192498|P3|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
8189563|NCT02300129|20192499|P2|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
8189564|NCT02300129|20192500|P1|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
8189565|NCT02300129|20192497|P4|COMPLETED|Period 1 Session 2 (Day 3)||11
8189566|NCT02300129|20192498|P3|COMPLETED|Period 1 Session 2 (Day 3)||7
8189567|NCT02300129|20192499|P2|COMPLETED|Period 1 Session 2 (Day 3)||4
8189568|NCT02300129|20192500|P1|COMPLETED|Period 1 Session 2 (Day 3)||11
8189569|NCT02300129|20192497|P4|STARTED|Period 1 Session 2 (Day 3)||11
8189570|NCT02300129|20192498|P3|STARTED|Period 1 Session 2 (Day 3)||7
8189571|NCT02300129|20192499|P2|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
8189572|NCT02300129|20192500|P1|STARTED|Period 1 Session 2 (Day 3)||11
8189573|NCT02300129|20192497|P4|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
8189574|NCT02300129|20192498|P3|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
8189575|NCT02300129|20192499|P2|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
8189576|NCT02300129|20192500|P1|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
8189577|NCT02300129|20192497|P4|COMPLETED|Period 1 Session 1 (Day 1)||11
8189578|NCT02300129|20192498|P3|COMPLETED|Period 1 Session 1 (Day 1)||7
8189579|NCT02300129|20192499|P2|COMPLETED|Period 1 Session 1 (Day 1)||5
8189580|NCT02300129|20192500|P1|COMPLETED|Period 1 Session 1 (Day 1)||11
8189581|NCT02300129|20192497|P4|STARTED|Period 1 Session 1 (Day 1)||11
8189582|NCT02300129|20192498|P3|STARTED|Period 1 Session 1 (Day 1)||7
8189583|NCT02300129|20192499|P2|STARTED|Period 1 Session 1 (Day 1)||5
8189584|NCT02300129|20192500|P1|STARTED|Period 1 Session 1 (Day 1)||11
8189585|NCT02300103|20192510|P1|NOT COMPLETED|Overall Study||6
8189586|NCT02300103|20192510|P1|COMPLETED|Overall Study||63
8189587|NCT02300103|20192510|P1|STARTED|Overall Study||69
8189588|NCT02300077|20192522|P3|NOT COMPLETED|Overall Study||0
8189589|NCT02300077|20192523|P2|NOT COMPLETED|Overall Study||0
8189590|NCT02300077|20192524|P1|NOT COMPLETED|Overall Study||0
8189591|NCT02300077|20192522|P3|COMPLETED|Overall Study||21
8189592|NCT02300077|20192523|P2|COMPLETED|Overall Study||18
8189593|NCT02300077|20192524|P1|COMPLETED|Overall Study||21
8189594|NCT02300077|20192522|P3|STARTED|Overall Study||21
8189595|NCT02300077|20192523|P2|STARTED|Overall Study||18
8189596|NCT02300077|20192524|P1|STARTED|Overall Study||21
8189597|NCT02300025|20192545|P4|NOT COMPLETED|Overall Study||0
8189598|NCT02300025|20192546|P3|NOT COMPLETED|Overall Study||0
8189599|NCT02300025|20192547|P2|NOT COMPLETED|Overall Study||0
8189600|NCT02300025|20192548|P1|NOT COMPLETED|Overall Study||0
8189601|NCT02300025|20192545|P4|COMPLETED|Overall Study||6
8189602|NCT02300025|20192546|P3|COMPLETED|Overall Study||6
8189603|NCT02300025|20192547|P2|COMPLETED|Overall Study||6
8189604|NCT02300025|20192548|P1|COMPLETED|Overall Study||10
8189605|NCT02300025|20192545|P4|STARTED|Overall Study||6
8189606|NCT02300025|20192546|P3|STARTED|Overall Study||6
8189607|NCT02300025|20192547|P2|STARTED|Overall Study||6
8189608|NCT02300025|20192548|P1|STARTED|Overall Study||10
8189609|NCT02299934|20192590|P1|NOT COMPLETED|Overall Study||13
8189610|NCT02299934|20192590|P1|COMPLETED|Overall Study||0
8189611|NCT02299934|20192590|P1|STARTED|Overall Study||13
8189612|NCT02299869|20192605|P4|NOT COMPLETED|Overall Study||0
8189613|NCT02299869|20192606|P3|NOT COMPLETED|Overall Study||0
8189614|NCT02299869|20192607|P2|NOT COMPLETED|Overall Study||0
8189615|NCT02299869|20192608|P1|NOT COMPLETED|Overall Study||0
8189616|NCT02299869|20192605|P4|COMPLETED|Overall Study||10
8189617|NCT02299869|20192606|P3|COMPLETED|Overall Study||10
8189618|NCT02299869|20192607|P2|COMPLETED|Overall Study||10
8189619|NCT02299869|20192608|P1|COMPLETED|Overall Study||10
8189620|NCT02299869|20192605|P4|STARTED|Overall Study||10
8189621|NCT02299869|20192606|P3|STARTED|Overall Study||10
8189622|NCT02299869|20192607|P2|STARTED|Overall Study||10
8189623|NCT02299869|20192608|P1|STARTED|Overall Study||10
8189624|NCT02299791|20192633|P2|NOT COMPLETED|Overall Study||0
8189625|NCT02299791|20192634|P1|NOT COMPLETED|Overall Study||0
8189626|NCT02299791|20192633|P2|COMPLETED|Overall Study||2803
8189627|NCT02299791|20192634|P1|COMPLETED|Overall Study||2053
8189628|NCT02299791|20192633|P2|STARTED|Overall Study||2803
8189629|NCT02299791|20192634|P1|STARTED|Overall Study||2053
8189630|NCT02299635|20192640|P1|NOT COMPLETED|Overall Study||19
8189631|NCT02299635|20192640|P1|COMPLETED|Overall Study||0
8189632|NCT02299635|20192640|P1|STARTED|Overall Study||19
8189633|NCT02299570|20192662|P3|NOT COMPLETED|Overall Study||19
8189634|NCT02299570|20192663|P2|NOT COMPLETED|Overall Study||9
8189635|NCT02299570|20192664|P1|NOT COMPLETED|Overall Study||14
8189636|NCT02299570|20192662|P3|COMPLETED|Overall Study||25
8189637|NCT02299570|20192663|P2|COMPLETED|Overall Study||35
8189638|NCT02299570|20192664|P1|COMPLETED|Overall Study||31
8189639|NCT02299570|20192662|P3|STARTED|Overall Study||44
8189640|NCT02299570|20192663|P2|STARTED|Overall Study||44
8189641|NCT02299570|20192664|P1|STARTED|Overall Study||45
8189642|NCT02299479|20192684|P1|NOT COMPLETED|Overall Study||2
8189643|NCT02299479|20192684|P1|COMPLETED|Overall Study||18
8189644|NCT02299479|20192684|P1|STARTED|Overall Study||20
8189645|NCT02299427|20192692|P2|NOT COMPLETED|Overall Study||3
8189646|NCT02299427|20192693|P1|NOT COMPLETED|Overall Study||23
8189647|NCT02299427|20192692|P2|COMPLETED|Overall Study||31
8189648|NCT02299427|20192693|P1|COMPLETED|Overall Study||12
8189649|NCT02299427|20192692|P2|STARTED|Overall Study||34
8189650|NCT02299427|20192693|P1|STARTED|Overall Study||35
8189651|NCT02299388|20192703|P2|NOT COMPLETED|Overall Study||1
8189652|NCT02299388|20192704|P1|NOT COMPLETED|Overall Study||0
8189653|NCT02299388|20192703|P2|COMPLETED|Overall Study||4
8189654|NCT02299388|20192704|P1|COMPLETED|Overall Study||6
8189655|NCT02299388|20192703|P2|STARTED|Overall Study||5
8189656|NCT02299388|20192704|P1|STARTED|Overall Study||6
8189657|NCT02299375|20192714|P2|NOT COMPLETED|Overall Study||80
8189658|NCT02299375|20192715|P1|NOT COMPLETED|Overall Study||80
8189659|NCT02299375|20192714|P2|COMPLETED|Overall Study||10
8189660|NCT02299375|20192715|P1|COMPLETED|Overall Study||14
8189661|NCT02299375|20192714|P2|STARTED|Overall Study||90
8189662|NCT02299375|20192715|P1|STARTED|Overall Study||94
8189663|NCT02299349|20192765|P2|NOT COMPLETED|Overall Study||0
8189664|NCT02299349|20192766|P1|NOT COMPLETED|Overall Study||0
8189665|NCT02299349|20192765|P2|COMPLETED|Overall Study||35
8189666|NCT02299349|20192766|P1|COMPLETED|Overall Study||35
8189667|NCT02299349|20192765|P2|STARTED|Overall Study||35
8189668|NCT02299349|20192766|P1|STARTED|Overall Study||35
8189669|NCT02299336|20192774|P1|NOT COMPLETED|Overall Study||14
8189670|NCT02299336|20192774|P1|COMPLETED|Overall Study||46
8189671|NCT02299336|20192774|P1|STARTED|Overall Study||60
8189672|NCT02299297|20192790|P1|NOT COMPLETED|Overall Study||1
8189673|NCT02299297|20192790|P1|COMPLETED|Overall Study||11
8189674|NCT02299297|20192790|P1|STARTED|Overall Study||12
8189675|NCT02299258|20192800|P2|NOT COMPLETED|Overall Study||1
8189676|NCT02299258|20192801|P1|NOT COMPLETED|Overall Study||1
8189677|NCT02299258|20192800|P2|COMPLETED|Overall Study||30
8189678|NCT02299258|20192801|P1|COMPLETED|Overall Study||31
8189679|NCT02299258|20192800|P2|STARTED|Overall Study||31
8189680|NCT02299258|20192801|P1|STARTED|Overall Study||32
8189681|NCT02299206|20192809|P1|NOT COMPLETED|Overall Study||2
8189682|NCT02299206|20192809|P1|COMPLETED|Overall Study||2
8189683|NCT02299206|20192809|P1|STARTED|Overall Study||4
8189684|NCT02299167|20192817|P1|NOT COMPLETED|Overall Study||11
8189685|NCT02299167|20192817|P1|COMPLETED|Overall Study||24
8189686|NCT02299167|20192817|P1|Adverse Effects|Overall Study||24
8189687|NCT02299167|20192817|P1|Success Rate|Overall Study||24
8189688|NCT02299167|20192817|P1|Dural Puncture|Overall Study||24
8189689|NCT02299167|20192817|P1|STARTED|Overall Study||35
8189690|NCT02299089|20192829|P4|NOT COMPLETED|Overall Study||0
8189691|NCT02299089|20192830|P3|NOT COMPLETED|Overall Study||0
8189692|NCT02299089|20192831|P2|NOT COMPLETED|Overall Study||0
8189693|NCT02299089|20192832|P1|NOT COMPLETED|Overall Study||0
8189694|NCT02299089|20192829|P4|COMPLETED|Overall Study||4
8189695|NCT02299089|20192830|P3|COMPLETED|Overall Study||1
8189696|NCT02299089|20192831|P2|COMPLETED|Overall Study||4
8189697|NCT02299089|20192832|P1|COMPLETED|Overall Study||3
8189698|NCT02299089|20192829|P4|STARTED|Overall Study||4
8189699|NCT02299089|20192830|P3|STARTED|Overall Study||1
8189700|NCT02299089|20192831|P2|STARTED|Overall Study||4
8189701|NCT02299089|20192832|P1|STARTED|Overall Study||3
8189702|NCT02299076|20192878|P2|NOT COMPLETED|Overall Study||14
8189703|NCT02299076|20192879|P1|NOT COMPLETED|Overall Study||20
8189704|NCT02299076|20192878|P2|COMPLETED|Overall Study||212
8189705|NCT02299076|20192879|P1|COMPLETED|Overall Study||210
8189706|NCT02299076|20192878|P2|STARTED|Overall Study||226
8189707|NCT02299076|20192879|P1|STARTED|Overall Study||230
8189708|NCT02299050|20192887|P1|NOT COMPLETED|Overall Study||8
8189709|NCT02299050|20192887|P1|COMPLETED|Overall Study||15
8189710|NCT02299050|20192887|P1|STARTED|Overall Study||23
8189711|NCT02298946|20192900|P2|NOT COMPLETED|Overall Study||1
8189712|NCT02298946|20192901|P1|NOT COMPLETED|Overall Study||4
8189713|NCT02298946|20192900|P2|COMPLETED|Overall Study||8
8189714|NCT02298946|20192901|P1|COMPLETED|Overall Study||4
8189715|NCT02298946|20192900|P2|STARTED|Overall Study||9
8189716|NCT02298946|20192901|P1|STARTED|Overall Study||8
8189717|NCT02298933|20192925|P1|NOT COMPLETED|Overall Study||0
8189718|NCT02298933|20192925|P1|COMPLETED|Overall Study||10
8189719|NCT02298933|20192925|P1|STARTED|Overall Study||10
8189720|NCT02298868|20192929|P1|NOT COMPLETED|Overall Study||3
8189721|NCT02298868|20192929|P1|COMPLETED|Overall Study||7
8189722|NCT02298868|20192929|P1|STARTED|Overall Study||10
8189723|NCT02298842|20192943|P2|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
8189724|NCT02298842|20192944|P1|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
8189725|NCT02298842|20192943|P2|COMPLETED|Second Platelet Donation (Day 6-8)||30
8189726|NCT02298842|20192944|P1|COMPLETED|Second Platelet Donation (Day 6-8)||30
8189727|NCT02298842|20192943|P2|STARTED|Second Platelet Donation (Day 6-8)||36
8189728|NCT02298842|20192944|P1|STARTED|Second Platelet Donation (Day 6-8)||38
8189729|NCT02298842|20192943|P2|NOT COMPLETED|First Platelet Donation (Day 0)||5
8189730|NCT02298842|20192944|P1|NOT COMPLETED|First Platelet Donation (Day 0)||6
8189731|NCT02298842|20192943|P2|COMPLETED|First Platelet Donation (Day 0)||36
8189732|NCT02298842|20192944|P1|COMPLETED|First Platelet Donation (Day 0)||38
8189733|NCT02298842|20192943|P2|STARTED|First Platelet Donation (Day 0)||41
8189734|NCT02298842|20192944|P1|STARTED|First Platelet Donation (Day 0)||44
8189735|NCT02298803|20192970|P1|NOT COMPLETED|Overall Study||0
8189736|NCT02298803|20192970|P1|COMPLETED|Overall Study||30
8189737|NCT02298803|20192970|P1|STARTED|Overall Study||30
8189738|NCT02298361|20192982|P3|NOT COMPLETED|Overall Study||0
8189739|NCT02298361|20192983|P2|NOT COMPLETED|Overall Study||0
8189740|NCT02298361|20192984|P1|NOT COMPLETED|Overall Study||0
8189741|NCT02298361|20192982|P3|COMPLETED|Overall Study||12227
8189742|NCT02298361|20192983|P2|COMPLETED|Overall Study||12784
8189743|NCT02298361|20192984|P1|COMPLETED|Overall Study||2240
8189744|NCT02298361|20192982|P3|STARTED|Overall Study||12227
8189745|NCT02298361|20192983|P2|STARTED|Overall Study||12784
8189746|NCT02298361|20192984|P1|STARTED|Overall Study||2240
8189747|NCT02298322|20192998|P1|NOT COMPLETED|Overall Study||0
8189748|NCT02298322|20192998|P1|COMPLETED|Overall Study||60
8189749|NCT02298322|20192998|P1|STARTED|Overall Study||60
8189750|NCT02298192|20193007|P2|NOT COMPLETED|Overall Study||6
8189751|NCT02298192|20193008|P1|NOT COMPLETED|Overall Study||19
8189752|NCT02298192|20193007|P2|COMPLETED|Overall Study||204
8189753|NCT02298192|20193008|P1|COMPLETED|Overall Study||191
8189754|NCT02298192|20193007|P2|STARTED|Overall Study||210
8189755|NCT02298192|20193008|P1|STARTED|Overall Study||210
8189756|NCT02298179|20193032|P12|NOT COMPLETED|Overall Study||0
8189757|NCT02298179|20193033|P11|NOT COMPLETED|Overall Study||0
8189758|NCT02298179|20193034|P10|NOT COMPLETED|Overall Study||0
8189759|NCT02298179|20193035|P9|NOT COMPLETED|Overall Study||0
8189760|NCT02298179|20193036|P8|NOT COMPLETED|Overall Study||1
8189761|NCT02298179|20193037|P7|NOT COMPLETED|Overall Study||0
8189762|NCT02298179|20193038|P6|NOT COMPLETED|Overall Study||0
8189763|NCT02298179|20193039|P5|NOT COMPLETED|Overall Study||0
8189764|NCT02298179|20193040|P4|NOT COMPLETED|Overall Study||0
8189765|NCT02298179|20193041|P3|NOT COMPLETED|Overall Study||1
8189766|NCT02298179|20193042|P2|NOT COMPLETED|Overall Study||0
8189767|NCT02298179|20193043|P1|NOT COMPLETED|Overall Study||0
8189768|NCT02298179|20193032|P12|COMPLETED|Overall Study||24
8189769|NCT02298179|20193033|P11|COMPLETED|Overall Study||24
8189770|NCT02298179|20193034|P10|COMPLETED|Overall Study||24
8189771|NCT02298179|20193035|P9|COMPLETED|Overall Study||24
8189772|NCT02298179|20193036|P8|COMPLETED|Overall Study||23
8189773|NCT02298179|20193037|P7|COMPLETED|Overall Study||24
8189774|NCT02298179|20193038|P6|COMPLETED|Overall Study||24
8189775|NCT02298179|20193039|P5|COMPLETED|Overall Study||24
8189776|NCT02298179|20193040|P4|COMPLETED|Overall Study||24
8189777|NCT02298179|20193041|P3|COMPLETED|Overall Study||23
8189778|NCT02298179|20193042|P2|COMPLETED|Overall Study||24
8189779|NCT02298179|20193043|P1|COMPLETED|Overall Study||24
8189780|NCT02298179|20193032|P12|STARTED|Overall Study||24
8189781|NCT02298179|20193033|P11|STARTED|Overall Study||24
8189782|NCT02298179|20193034|P10|STARTED|Overall Study||24
8189783|NCT02298179|20193035|P9|STARTED|Overall Study||24
8189784|NCT02298179|20193036|P8|STARTED|Overall Study||24
8189785|NCT02298179|20193037|P7|STARTED|Overall Study||24
8189786|NCT02298179|20193038|P6|STARTED|Overall Study||24
8189787|NCT02298179|20193039|P5|STARTED|Overall Study||24
8189788|NCT02298179|20193040|P4|STARTED|Overall Study||24
8189789|NCT02298179|20193041|P3|STARTED|Overall Study||24
8189790|NCT02298179|20193042|P2|STARTED|Overall Study||24
8189791|NCT02298179|20193043|P1|STARTED|Overall Study||24
8189792|NCT02297841|20193285|P1|NOT COMPLETED|Overall Study||8
8189793|NCT02297841|20193285|P1|COMPLETED|Overall Study||201
8189794|NCT02297841|20193285|P1|Challenge Phase|Overall Study||201
8189795|NCT02297841|20193285|P1|Induction Phase|Overall Study||209
8189796|NCT02297841|20193285|P1|STARTED|Overall Study||209
8189797|NCT02297815|20193291|P2|NOT COMPLETED|Overall Study||140
8189798|NCT02297815|20193292|P1|NOT COMPLETED|Overall Study||236
8189799|NCT02297815|20193291|P2|COMPLETED|Overall Study||728
8189800|NCT02297815|20193292|P1|COMPLETED|Overall Study||1368
8189801|NCT02297815|20193291|P2|14-20 Day Interview|Overall Study||728
8189802|NCT02297815|20193292|P1|14-20 Day Interview|Overall Study||1368
8189803|NCT02297815|20193291|P2|5-10 Day Interview|Overall Study||868
8189804|NCT02297815|20193292|P1|5-10 Day Interview|Overall Study||1604
8189805|NCT02297815|20193291|P2|STARTED|Overall Study||868
8189806|NCT02297815|20193292|P1|STARTED|Overall Study||1604
8189807|NCT02297516|20193310|P2|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1
8189808|NCT02297516|20193311|P1|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0
8189809|NCT02297516|20193310|P2|COMPLETED|Combination Treatment Phase (up to 18 m)||30
8189810|NCT02297516|20193311|P1|COMPLETED|Combination Treatment Phase (up to 18 m)||31
8189811|NCT02297516|20193310|P2|STARTED|Combination Treatment Phase (up to 18 m)||31
8189812|NCT02297516|20193311|P1|STARTED|Combination Treatment Phase (up to 18 m)||31
8189813|NCT02297516|20193310|P2|NOT COMPLETED|Single Treatment Phase (6 Months)||2
8189814|NCT02297516|20193311|P1|NOT COMPLETED|Single Treatment Phase (6 Months)||1
8189815|NCT02297516|20193310|P2|COMPLETED|Single Treatment Phase (6 Months)||31
8189816|NCT02297516|20193311|P1|COMPLETED|Single Treatment Phase (6 Months)||31
8189817|NCT02297516|20193310|P2|STARTED|Single Treatment Phase (6 Months)||33
8189818|NCT02297516|20193311|P1|STARTED|Single Treatment Phase (6 Months)||32
8189819|NCT02297503|20193332|P2|NOT COMPLETED|Overall Study||4
8189820|NCT02297503|20193333|P1|NOT COMPLETED|Overall Study||2
8189821|NCT02297503|20193332|P2|COMPLETED|Overall Study||27
8189822|NCT02297503|20193333|P1|COMPLETED|Overall Study||28
8189823|NCT02297503|20193332|P2|Second Combined Treatment|Overall Study||28
8189824|NCT02297503|20193333|P1|Second Combined Treatment|Overall Study||28
8189825|NCT02297503|20193332|P2|First Combined Treatment|Overall Study||28
8189826|NCT02297503|20193333|P1|First Combined Treatment|Overall Study||28
8189827|NCT02297503|20193332|P2|Initial Single Treatment|Overall Study||31
8189828|NCT02297503|20193333|P1|Initial Single Treatment|Overall Study||29
8189829|NCT02297503|20193332|P2|STARTED|Overall Study||31
8189830|NCT02297503|20193333|P1|STARTED|Overall Study||30
8189831|NCT02297412|20193360|P2|NOT COMPLETED|Overall Study||1
8189832|NCT02297412|20193361|P1|NOT COMPLETED|Overall Study||1
8189833|NCT02297412|20193360|P2|COMPLETED|Overall Study||23
8189834|NCT02297412|20193361|P1|COMPLETED|Overall Study||22
8189835|NCT02297412|20193360|P2|STARTED|Overall Study||24
8189836|NCT02297412|20193361|P1|STARTED|Overall Study||23
8189837|NCT02297308|20193371|P1|NOT COMPLETED|Overall Study||0
8189838|NCT02297308|20193371|P1|COMPLETED|Overall Study||90
8189839|NCT02297308|20193371|P1|STARTED|Overall Study||90
8189840|NCT02297230|20193380|P4|NOT COMPLETED|Overall Study||0
8189841|NCT02297230|20193381|P3|NOT COMPLETED|Overall Study||0
8189842|NCT02297230|20193382|P2|NOT COMPLETED|Overall Study||0
8189843|NCT02297230|20193383|P1|NOT COMPLETED|Overall Study||0
8189844|NCT02297230|20193380|P4|COMPLETED|Overall Study||11
8189845|NCT02297230|20193381|P3|COMPLETED|Overall Study||11
8189846|NCT02297230|20193382|P2|COMPLETED|Overall Study||11
8189847|NCT02297230|20193383|P1|COMPLETED|Overall Study||11
8189848|NCT02297230|20193380|P4|STARTED|Overall Study||11
8189849|NCT02297230|20193381|P3|STARTED|Overall Study||11
8189850|NCT02297230|20193382|P2|STARTED|Overall Study||11
8189851|NCT02297230|20193383|P1|STARTED|Overall Study||11
8189852|NCT02297100|20193407|P2|NOT COMPLETED|Overall Study||0
8189853|NCT02297100|20193408|P1|NOT COMPLETED|Overall Study||0
8189854|NCT02297100|20193407|P2|COMPLETED|Overall Study||14
8189855|NCT02297100|20193408|P1|COMPLETED|Overall Study||13
8189856|NCT02297100|20193407|P2|STARTED|Overall Study||14
8189857|NCT02297100|20193408|P1|STARTED|Overall Study||13
8189858|NCT02296931|20193422|P2|NOT COMPLETED|Overall Study||2
8189859|NCT02296931|20193423|P1|NOT COMPLETED|Overall Study||0
8189860|NCT02296931|20193422|P2|COMPLETED|Overall Study||22
8189861|NCT02296931|20193423|P1|COMPLETED|Overall Study||10
8189862|NCT02296931|20193422|P2|STARTED|Overall Study||24
8189863|NCT02296931|20193423|P1|STARTED|Overall Study||10
8189864|NCT02296892|20193432|P3|NOT COMPLETED|Overall Study||5
8189865|NCT02296892|20193433|P2|NOT COMPLETED|Overall Study||4
8189866|NCT02296892|20193434|P1|NOT COMPLETED|Overall Study||12
8189867|NCT02296892|20193432|P3|COMPLETED|Overall Study||68
8189868|NCT02296892|20193433|P2|COMPLETED|Overall Study||59
8189869|NCT02296892|20193434|P1|COMPLETED|Overall Study||298
8189870|NCT02296892|20193432|P3|Complete Trial Treatment Period|Overall Study||69
8189871|NCT02296892|20193433|P2|Complete Trial Treatment Period|Overall Study||59
8189872|NCT02296892|20193434|P1|Complete Trial Treatment Period|Overall Study||303
8189873|NCT02296892|20193432|P3|Safety Population|Overall Study||69
8189874|NCT02296892|20193433|P2|Safety Population|Overall Study||59
8189875|NCT02296892|20193434|P1|Safety Population|Overall Study||303
8189876|NCT02296892|20193432|P3|STARTED|Overall Study||73
8189877|NCT02296892|20193433|P2|STARTED|Overall Study||63
8189878|NCT02296892|20193434|P1|STARTED|Overall Study||310
8189879|NCT02296853|20193453|P2|NOT COMPLETED|Overall Study||0
8189880|NCT02296853|20193454|P1|NOT COMPLETED|Overall Study||0
8189881|NCT02296853|20193453|P2|COMPLETED|Overall Study||10
8189882|NCT02296853|20193454|P1|COMPLETED|Overall Study||10
8189883|NCT02296853|20193453|P2|STARTED|Overall Study||10
8189884|NCT02296853|20193454|P1|STARTED|Overall Study||10
8189885|NCT02296840|20193470|P2|NOT COMPLETED|Overall Study||19
8189886|NCT02296840|20193471|P1|NOT COMPLETED|Overall Study||9
8189887|NCT02296840|20193470|P2|COMPLETED|Overall Study||8
8189888|NCT02296840|20193471|P1|COMPLETED|Overall Study||9
8189889|NCT02296840|20193470|P2|STARTED|Overall Study||27
8189890|NCT02296840|20193471|P1|STARTED|Overall Study||18
8189891|NCT02296775|20193482|P3|NOT COMPLETED|Recovery and Follow-up||4
8189892|NCT02296775|20193483|P2|NOT COMPLETED|Recovery and Follow-up||5
8189893|NCT02296775|20193484|P1|NOT COMPLETED|Recovery and Follow-up||5
8189894|NCT02296775|20193482|P3|COMPLETED|Recovery and Follow-up||79
8189895|NCT02296775|20193483|P2|COMPLETED|Recovery and Follow-up||79
8189896|NCT02296775|20193484|P1|COMPLETED|Recovery and Follow-up||82
8189897|NCT02296775|20193482|P3|STARTED|Recovery and Follow-up||83
8189898|NCT02296775|20193483|P2|STARTED|Recovery and Follow-up||84
8189899|NCT02296775|20193484|P1|STARTED|Recovery and Follow-up||87
8189900|NCT02296775|20193482|P3|NOT COMPLETED|Treatment and Evaluation||10
8189901|NCT02296775|20193483|P2|NOT COMPLETED|Treatment and Evaluation||8
8189902|NCT02296775|20193484|P1|NOT COMPLETED|Treatment and Evaluation||4
8189903|NCT02296775|20193482|P3|COMPLETED|Treatment and Evaluation||83
8189904|NCT02296775|20193483|P2|COMPLETED|Treatment and Evaluation||84
8189905|NCT02296775|20193484|P1|COMPLETED|Treatment and Evaluation||87
8189906|NCT02296775|20193482|P3|STARTED|Treatment and Evaluation||93
8189907|NCT02296775|20193483|P2|STARTED|Treatment and Evaluation||92
8189908|NCT02296775|20193484|P1|STARTED|Treatment and Evaluation||91
8189909|NCT02296606|20193552|P1|NOT COMPLETED|Overall Study||0
8189910|NCT02296606|20193552|P1|COMPLETED|Overall Study||127
8189911|NCT02296606|20193552|P1|STARTED|Overall Study||127
8189912|NCT02296502|20193560|P4|NOT COMPLETED|Overall Study||0
8189913|NCT02296502|20193561|P3|NOT COMPLETED|Overall Study||0
8189914|NCT02296502|20193562|P2|NOT COMPLETED|Overall Study||0
8189915|NCT02296502|20193563|P1|NOT COMPLETED|Overall Study||0
8189916|NCT02296502|20193560|P4|COMPLETED|Overall Study||160
8189917|NCT02296502|20193561|P3|COMPLETED|Overall Study||30
8189918|NCT02296502|20193562|P2|COMPLETED|Overall Study||1
8189919|NCT02296502|20193563|P1|COMPLETED|Overall Study||248
8189920|NCT02296502|20193560|P4|STARTED|Overall Study||160
8189921|NCT02296502|20193561|P3|STARTED|Overall Study||30
8189922|NCT02296502|20193562|P2|STARTED|Overall Study||1
8189923|NCT02296502|20193563|P1|STARTED|Overall Study||248
8189924|NCT02296476|20193579|P3|NOT COMPLETED|Overall Study||2
8189925|NCT02296476|20193580|P2|NOT COMPLETED|Overall Study||4
8189926|NCT02296476|20193581|P1|NOT COMPLETED|Overall Study||6
8189927|NCT02296476|20193579|P3|COMPLETED|Overall Study||0
8189928|NCT02296476|20193580|P2|COMPLETED|Overall Study||0
8189929|NCT02296476|20193581|P1|COMPLETED|Overall Study||0
8189930|NCT02296476|20193579|P3|STARTED|Overall Study||2
8189931|NCT02296476|20193580|P2|STARTED|Overall Study||4
8189932|NCT02296476|20193581|P1|STARTED|Overall Study||6
8189933|NCT02296424|20193636|P4|NOT COMPLETED|Part 2||0
8189934|NCT02296424|20193637|P3|NOT COMPLETED|Part 2||3
8189935|NCT02296424|20193638|P2|NOT COMPLETED|Part 2||0
8189936|NCT02296424|20193639|P1|NOT COMPLETED|Part 2||0
8189937|NCT02296424|20193636|P4|COMPLETED|Part 2||37
8189938|NCT02296424|20193637|P3|COMPLETED|Part 2||35
8189939|NCT02296424|20193638|P2|COMPLETED|Part 2||0
8189940|NCT02296424|20193639|P1|COMPLETED|Part 2||0
8189941|NCT02296424|20193636|P4|STARTED|Part 2||37
8189942|NCT02296424|20193637|P3|STARTED|Part 2||38
8189943|NCT02296424|20193638|P2|STARTED|Part 2||0
8189944|NCT02296424|20193639|P1|STARTED|Part 2||0
8189945|NCT02296424|20193636|P4|NOT COMPLETED|Part 1||0
8189946|NCT02296424|20193637|P3|NOT COMPLETED|Part 1||0
8189947|NCT02296424|20193638|P2|NOT COMPLETED|Part 1||33
8189948|NCT02296424|20193639|P1|NOT COMPLETED|Part 1||23
8189949|NCT02296424|20193636|P4|COMPLETED|Part 1||0
8189950|NCT02296424|20193637|P3|COMPLETED|Part 1||0
8189951|NCT02296424|20193638|P2|COMPLETED|Part 1||65
8189952|NCT02296424|20193639|P1|COMPLETED|Part 1||61
8189953|NCT02296424|20193636|P4|STARTED|Part 1||0
8189954|NCT02296424|20193637|P3|STARTED|Part 1||0
8189955|NCT02296424|20193638|P2|STARTED|Part 1||98
8189956|NCT02296424|20193639|P1|STARTED|Part 1|16 patients immediately went into Part II|84
8189957|NCT02296346|20193652|P2|NOT COMPLETED|Overall Study||6
8189958|NCT02296346|20193653|P1|NOT COMPLETED|Overall Study||5
8189959|NCT02296346|20193652|P2|COMPLETED|Overall Study||0
8189960|NCT02296346|20193653|P1|COMPLETED|Overall Study||2
8189961|NCT02296346|20193652|P2|STARTED|Overall Study||6
8189962|NCT02296346|20193653|P1|STARTED|Overall Study||7
8189963|NCT02296320|20193664|P3|NOT COMPLETED|Overall Study||37
8189964|NCT02296320|20193665|P2|NOT COMPLETED|Overall Study||5
8189965|NCT02296320|20193666|P1|NOT COMPLETED|Overall Study||35
8189966|NCT02296320|20193664|P3|COMPLETED|Overall Study||59
8189967|NCT02296320|20193665|P2|COMPLETED|Overall Study||10
8189968|NCT02296320|20193666|P1|COMPLETED|Overall Study||67
8189969|NCT02296320|20193664|P3|Treated|Overall Study||96
8189970|NCT02296320|20193665|P2|Treated|Overall Study||15
8189971|NCT02296320|20193666|P1|Treated|Overall Study||100
8189972|NCT02296320|20193664|P3|STARTED|Overall Study||96
8189973|NCT02296320|20193665|P2|STARTED|Overall Study||15
8189974|NCT02296320|20193666|P1|STARTED|Overall Study||102
8189975|NCT02296242|20193705|P5|NOT COMPLETED|Overall Study||21
8189976|NCT02296242|20193706|P4|NOT COMPLETED|Overall Study||14
8189977|NCT02296242|20193707|P3|NOT COMPLETED|Overall Study||7
8189978|NCT02296242|20193708|P2|NOT COMPLETED|Overall Study||6
8189979|NCT02296242|20193709|P1|NOT COMPLETED|Overall Study||5
8189980|NCT02296242|20193705|P5|COMPLETED|Overall Study||0
8189981|NCT02296242|20193706|P4|COMPLETED|Overall Study||0
8189982|NCT02296242|20193707|P3|COMPLETED|Overall Study||0
8189983|NCT02296242|20193708|P2|COMPLETED|Overall Study||0
8189984|NCT02296242|20193709|P1|COMPLETED|Overall Study||0
8189985|NCT02296242|20193705|P5|STARTED|Overall Study||21
8189986|NCT02296242|20193706|P4|STARTED|Overall Study||14
8189987|NCT02296242|20193707|P3|STARTED|Overall Study||7
8189988|NCT02296242|20193708|P2|STARTED|Overall Study||6
8189989|NCT02296242|20193709|P1|STARTED|Overall Study||5
8189990|NCT02296190|20193737|P6|NOT COMPLETED|Overall Study||0
8189991|NCT02296190|20193738|P5|NOT COMPLETED|Overall Study||16
8189992|NCT02296190|20193739|P4|NOT COMPLETED|Overall Study||23
8189993|NCT02296190|20193740|P3|NOT COMPLETED|Overall Study||12
8189994|NCT02296190|20193741|P2|NOT COMPLETED|Overall Study||21
8189995|NCT02296190|20193742|P1|NOT COMPLETED|Overall Study||14
8189996|NCT02296190|20193737|P6|COMPLETED|Overall Study||9
8189997|NCT02296190|20193738|P5|COMPLETED|Overall Study||20
8189998|NCT02296190|20193739|P4|COMPLETED|Overall Study||20
8189999|NCT02296190|20193740|P3|COMPLETED|Overall Study||23
8190000|NCT02296190|20193741|P2|COMPLETED|Overall Study||20
8190001|NCT02296190|20193742|P1|COMPLETED|Overall Study||21
8190002|NCT02296190|20193737|P6|STARTED|Overall Study||9
8190003|NCT02296190|20193738|P5|STARTED|Overall Study||36
8190004|NCT02296190|20193739|P4|STARTED|Overall Study||43
8190005|NCT02296190|20193740|P3|STARTED|Overall Study||35
8190006|NCT02296190|20193741|P2|STARTED|Overall Study||41
8190007|NCT02296190|20193742|P1|STARTED|Overall Study||35
8190008|NCT02296164|20193755|P1|NOT COMPLETED|Overall Study||110
8190009|NCT02296164|20193755|P1|COMPLETED|Overall Study||188
8190010|NCT02296164|20193755|P1|STARTED|Overall Study|2 patients not eligible as were not on Valchlor at time of study start|298
8190011|NCT02296138|20193761|P2|NOT COMPLETED|Overall Study||500
8190012|NCT02296138|20193762|P1|NOT COMPLETED|Overall Study||661
8190013|NCT02296138|20193761|P2|COMPLETED|Overall Study||3451
8190014|NCT02296138|20193762|P1|COMPLETED|Overall Study||3291
8190015|NCT02296138|20193761|P2|Treated|Overall Study||3939
8190016|NCT02296138|20193762|P1|Treated|Overall Study||3941
8190017|NCT02296138|20193761|P2|STARTED|Overall Study||3951
8190018|NCT02296138|20193762|P1|STARTED|Overall Study||3952
8190034|NCT02296099|20193848|P2|NOT COMPLETED|Overall Study||2
8190035|NCT02296099|20193849|P1|NOT COMPLETED|Overall Study||3
8190036|NCT02296099|20193848|P2|COMPLETED|Overall Study||55
8190037|NCT02296099|20193849|P1|COMPLETED|Overall Study||54
8190038|NCT02296099|20193848|P2|STARTED|Overall Study||57
8190039|NCT02296099|20193849|P1|STARTED|Overall Study||57
8190040|NCT02295995|20193875|P2|NOT COMPLETED|Overall Study||1
8190041|NCT02295995|20193876|P1|NOT COMPLETED|Overall Study||5
8190042|NCT02295995|20193875|P2|COMPLETED|Overall Study||17
8190043|NCT02295995|20193876|P1|COMPLETED|Overall Study||31
8190044|NCT02295995|20193875|P2|STARTED|Overall Study||18
8190045|NCT02295995|20193876|P1|STARTED|Overall Study||36
8190046|NCT02295774|20193887|P1|NOT COMPLETED|Overall Study||3
8190047|NCT02295774|20193887|P1|COMPLETED|Overall Study||10
8190048|NCT02295774|20193887|P1|STARTED|Overall Study||13
8190049|NCT02295735|20193894|P2|NOT COMPLETED|Overall Study||27
8190050|NCT02295735|20193895|P1|NOT COMPLETED|Overall Study||26
8190051|NCT02295735|20193894|P2|COMPLETED|Overall Study||210
8190052|NCT02295735|20193895|P1|COMPLETED|Overall Study||212
8190053|NCT02295735|20193894|P2|STARTED|Overall Study||237
8190054|NCT02295735|20193895|P1|STARTED|Overall Study||238
8190055|NCT02295644|20193927|P4|NOT COMPLETED|Overall Study||2
8190056|NCT02295644|20193928|P3|NOT COMPLETED|Overall Study||1
8190057|NCT02295644|20193929|P2|NOT COMPLETED|Overall Study||0
8190058|NCT02295644|20193930|P1|NOT COMPLETED|Overall Study||0
8190059|NCT02295644|20193927|P4|COMPLETED|Overall Study||5
8190060|NCT02295644|20193928|P3|COMPLETED|Overall Study||6
8190061|NCT02295644|20193929|P2|COMPLETED|Overall Study||7
8190062|NCT02295644|20193930|P1|COMPLETED|Overall Study||7
8190063|NCT02295644|20193927|P4|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
8190064|NCT02295644|20193928|P3|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
8190065|NCT02295644|20193929|P2|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
8190066|NCT02295644|20193930|P1|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
8190067|NCT02295553|20193952|P4|NOT COMPLETED|Overall Study||1
8190068|NCT02295553|20193953|P3|NOT COMPLETED|Overall Study||1
8190069|NCT02295553|20193954|P2|NOT COMPLETED|Overall Study||0
8190070|NCT02295553|20193955|P1|NOT COMPLETED|Overall Study||0
8190071|NCT02295553|20193952|P4|COMPLETED|Overall Study||13
8190072|NCT02295553|20193953|P3|COMPLETED|Overall Study||13
8190073|NCT02295553|20193954|P2|COMPLETED|Overall Study||14
8190074|NCT02295553|20193955|P1|COMPLETED|Overall Study||14
8190075|NCT02295553|20193952|P4|STARTED|Overall Study||14
8190076|NCT02295553|20193953|P3|STARTED|Overall Study||14
8190077|NCT02295553|20193954|P2|STARTED|Overall Study||14
8190078|NCT02295553|20193955|P1|STARTED|Overall Study||14
8190079|NCT02295280|20193979|P2|NOT COMPLETED|Overall Study||1
8190080|NCT02295280|20193980|P1|NOT COMPLETED|Overall Study||0
8190081|NCT02295280|20193979|P2|COMPLETED|Overall Study||34
8190082|NCT02295280|20193980|P1|COMPLETED|Overall Study||35
8190083|NCT02295280|20193979|P2|STARTED|Overall Study||35
8190084|NCT02295280|20193980|P1|STARTED|Overall Study||35
8190085|NCT02295020|20193988|P2|NOT COMPLETED|Overall Study||3
8190086|NCT02295020|20193989|P1|NOT COMPLETED|Overall Study||3
8190087|NCT02295020|20193988|P2|COMPLETED|Overall Study||17
8190088|NCT02295020|20193989|P1|COMPLETED|Overall Study||17
8190089|NCT02295020|20193988|P2|STARTED|Overall Study||20
8190090|NCT02295020|20193989|P1|STARTED|Overall Study||20
8190091|NCT02294981|20194019|P1|NOT COMPLETED|Overall Study||1
8190092|NCT02294981|20194019|P1|COMPLETED|Overall Study||3
8190093|NCT02294981|20194019|P1|STARTED|Overall Study||4
8190094|NCT02294786|20194025|P2|NOT COMPLETED|Overall Study||14
8190095|NCT02294786|20194026|P1|NOT COMPLETED|Overall Study||11
8190096|NCT02294786|20194025|P2|COMPLETED|Overall Study||18
8190097|NCT02294786|20194026|P1|COMPLETED|Overall Study||19
8190098|NCT02294786|20194025|P2|ITT Population|Overall Study||32
8190099|NCT02294786|20194026|P1|ITT Population|Overall Study||30
8190100|NCT02294786|20194025|P2|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33
8190101|NCT02294786|20194026|P1|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29
8190102|NCT02294786|20194025|P2|STARTED|Overall Study||32
8190103|NCT02294786|20194026|P1|STARTED|Overall Study||30
8190104|NCT02294773|20194073|P2|NOT COMPLETED|Overall Study||2
8190105|NCT02294773|20194074|P1|NOT COMPLETED|Overall Study||0
8190106|NCT02294773|20194073|P2|COMPLETED|Overall Study||4
8190107|NCT02294773|20194074|P1|COMPLETED|Overall Study||7
8190108|NCT02294773|20194073|P2|STARTED|Overall Study||6
8190109|NCT02294773|20194074|P1|STARTED|Overall Study||7
8190116|NCT02294682|20194143|P2|NOT COMPLETED|Overall Study||0
8190117|NCT02294682|20194144|P1|NOT COMPLETED|Overall Study||1
8190118|NCT02294682|20194143|P2|COMPLETED|Overall Study||53
8190119|NCT02294682|20194144|P1|COMPLETED|Overall Study||52
8190120|NCT02294682|20194143|P2|STARTED|Overall Study||53
8190121|NCT02294682|20194144|P1|STARTED|Overall Study||53
8190122|NCT02294604|20194187|P3|NOT COMPLETED|Overall Study||0
8190123|NCT02294604|20194188|P2|NOT COMPLETED|Overall Study||3
8190124|NCT02294604|20194189|P1|NOT COMPLETED|Overall Study||1
8190125|NCT02294604|20194187|P3|COMPLETED|Overall Study||80
8190126|NCT02294604|20194188|P2|COMPLETED|Overall Study||77
8190127|NCT02294604|20194189|P1|COMPLETED|Overall Study||79
8190128|NCT02294604|20194187|P3|STARTED|Overall Study||80
8190129|NCT02294604|20194188|P2|STARTED|Overall Study||80
8190130|NCT02294604|20194189|P1|STARTED|Overall Study||80
8190131|NCT02294474|20194208|P2|NOT COMPLETED|Overall Study||22
8190132|NCT02294474|20194209|P1|NOT COMPLETED|Overall Study||25
8190133|NCT02294474|20194208|P2|COMPLETED|Overall Study||230
8190134|NCT02294474|20194209|P1|COMPLETED|Overall Study||228
8190135|NCT02294474|20194208|P2|STARTED|Overall Study||252
8190136|NCT02294474|20194209|P1|STARTED|Overall Study||253
8190145|NCT02294396|20194290|P4|NOT COMPLETED|Overall Study||37
8190146|NCT02294396|20194291|P3|NOT COMPLETED|Overall Study||35
8190147|NCT02294396|20194292|P2|NOT COMPLETED|Overall Study||33
8190148|NCT02294396|20194293|P1|NOT COMPLETED|Overall Study||40
8190149|NCT02294396|20194290|P4|COMPLETED|Overall Study||123
8190150|NCT02294396|20194291|P3|COMPLETED|Overall Study||126
8190151|NCT02294396|20194292|P2|COMPLETED|Overall Study||128
8190152|NCT02294396|20194293|P1|COMPLETED|Overall Study||127
8190153|NCT02294396|20194290|P4|STARTED|Overall Study||160
8190154|NCT02294396|20194291|P3|STARTED|Overall Study||161
8190155|NCT02294396|20194292|P2|STARTED|Overall Study||161
8190156|NCT02294396|20194293|P1|STARTED|Overall Study||167
8190163|NCT02294253|20194378|P1|NOT COMPLETED|Overall Study||15
8190164|NCT02294253|20194378|P1|COMPLETED|Overall Study||15
8190165|NCT02294253|20194378|P1|STARTED|Overall Study||30
8190166|NCT02294227|20194385|P3|NOT COMPLETED|Overall Study||19
8190167|NCT02294227|20194386|P2|NOT COMPLETED|Overall Study||25
8190168|NCT02294227|20194387|P1|NOT COMPLETED|Overall Study||25
8190169|NCT02294227|20194385|P3|COMPLETED|Overall Study||95
8190170|NCT02294227|20194386|P2|COMPLETED|Overall Study||88
8190171|NCT02294227|20194387|P1|COMPLETED|Overall Study||89
8190172|NCT02294227|20194385|P3|STARTED|Overall Study||114
8190173|NCT02294227|20194386|P2|STARTED|Overall Study||113
8190174|NCT02294227|20194387|P1|STARTED|Overall Study||114
8190175|NCT02294175|20194413|P2|NOT COMPLETED|Overall Study||6
8190176|NCT02294175|20194414|P1|NOT COMPLETED|Overall Study||5
8190177|NCT02294175|20194413|P2|COMPLETED|Overall Study||16
8190178|NCT02294175|20194414|P1|COMPLETED|Overall Study||18
8190179|NCT02294175|20194413|P2|STARTED|Overall Study||22
8190180|NCT02294175|20194414|P1|STARTED|Overall Study||23
8190181|NCT02294058|20194441|P3|NOT COMPLETED|Overall Study||29
8190182|NCT02294058|20194442|P2|NOT COMPLETED|Overall Study||26
8190183|NCT02294058|20194443|P1|NOT COMPLETED|Overall Study||36
8190184|NCT02294058|20194441|P3|COMPLETED|Overall Study||418
8190185|NCT02294058|20194442|P2|COMPLETED|Overall Study||425
8190186|NCT02294058|20194443|P1|COMPLETED|Overall Study||412
8190187|NCT02294058|20194441|P3|Safety Population|Overall Study||448
8190188|NCT02294058|20194442|P2|Safety Population|Overall Study||453
8190189|NCT02294058|20194443|P1|Safety Population|Overall Study||445
8190190|NCT02294058|20194441|P3|STARTED|Overall Study||447
8190191|NCT02294058|20194442|P2|STARTED|Overall Study||451
8190192|NCT02294058|20194443|P1|STARTED|Overall Study||448
8190193|NCT02294019|20194481|P1|NOT COMPLETED|Overall Study||103
8190194|NCT02294019|20194481|P1|COMPLETED|Overall Study||635
8190195|NCT02294019|20194481|P1|STARTED|Overall Study||738
8190196|NCT02293902|20194489|P5|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
8190197|NCT02293902|20194490|P4|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
8190198|NCT02293902|20194491|P3|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
8190199|NCT02293902|20194492|P2|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
8190200|NCT02293902|20194493|P1|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
8190201|NCT02293902|20194489|P5|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
8190202|NCT02293902|20194490|P4|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
8190203|NCT02293902|20194491|P3|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
8190204|NCT02293902|20194492|P2|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
8190205|NCT02293902|20194493|P1|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
8190206|NCT02293902|20194489|P5|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
8190207|NCT02293902|20194490|P4|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
8190208|NCT02293902|20194491|P3|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
8190209|NCT02293902|20194492|P2|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
8190210|NCT02293902|20194493|P1|STARTED|Single-Blind Period (Week 25 to Week 52)||0
8190211|NCT02293902|20194489|P5|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
8190212|NCT02293902|20194490|P4|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
8190213|NCT02293902|20194491|P3|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
8190214|NCT02293902|20194492|P2|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
8190215|NCT02293902|20194493|P1|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
8190216|NCT02293902|20194489|P5|COMPLETED|Double-Blind Period (Up to Week 24)||0
8190217|NCT02293902|20194490|P4|COMPLETED|Double-Blind Period (Up to Week 24)||0
8190218|NCT02293902|20194491|P3|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
8190219|NCT02293902|20194492|P2|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
8190220|NCT02293902|20194493|P1|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
8190221|NCT02293902|20194489|P5|Rescued|Double-Blind Period (Up to Week 24)||0
8190222|NCT02293902|20194490|P4|Rescued|Double-Blind Period (Up to Week 24)||0
8190223|NCT02293902|20194491|P3|Rescued|Double-Blind Period (Up to Week 24)||8
8190224|NCT02293902|20194492|P2|Rescued|Double-Blind Period (Up to Week 24)||6
8190225|NCT02293902|20194493|P1|Rescued|Double-Blind Period (Up to Week 24)||44
8190226|NCT02293902|20194489|P5|Treated|Double-Blind Period (Up to Week 24)||0
8190227|NCT02293902|20194490|P4|Treated|Double-Blind Period (Up to Week 24)||0
8190228|NCT02293902|20194491|P3|Treated|Double-Blind Period (Up to Week 24)||80
8190229|NCT02293902|20194492|P2|Treated|Double-Blind Period (Up to Week 24)||81
8190230|NCT02293902|20194493|P1|Treated|Double-Blind Period (Up to Week 24)||81
8190231|NCT02293902|20194489|P5|STARTED|Double-Blind Period (Up to Week 24)||0
8190232|NCT02293902|20194490|P4|STARTED|Double-Blind Period (Up to Week 24)||0
8190233|NCT02293902|20194491|P3|STARTED|Double-Blind Period (Up to Week 24)||80
8190234|NCT02293902|20194492|P2|STARTED|Double-Blind Period (Up to Week 24)||81
8190235|NCT02293902|20194493|P1|STARTED|Double-Blind Period (Up to Week 24)||82
8190236|NCT02293863|20194555|P3|NOT COMPLETED|Overall Study||9
8190237|NCT02293863|20194556|P2|NOT COMPLETED|Overall Study||13
8190238|NCT02293863|20194557|P1|NOT COMPLETED|Overall Study||9
8190239|NCT02293863|20194555|P3|COMPLETED|Overall Study||38
8190240|NCT02293863|20194556|P2|COMPLETED|Overall Study||42
8190241|NCT02293863|20194557|P1|COMPLETED|Overall Study||47
8190242|NCT02293863|20194555|P3|STARTED|Overall Study||47
8190243|NCT02293863|20194556|P2|STARTED|Overall Study||55
8190244|NCT02293863|20194557|P1|STARTED|Overall Study||56
8190245|NCT02293798|20194620|P1|NOT COMPLETED|Overall Study||0
8190246|NCT02293798|20194620|P1|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13
8190247|NCT02293798|20194620|P1|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13
8190248|NCT02293538|20194626|P2|NOT COMPLETED|Overall Study||2
8190249|NCT02293538|20194627|P1|NOT COMPLETED|Overall Study||1
8190250|NCT02293538|20194626|P2|COMPLETED|Overall Study||69
8190251|NCT02293538|20194627|P1|COMPLETED|Overall Study||72
8190252|NCT02293538|20194626|P2|STARTED|Overall Study||71
8190253|NCT02293538|20194627|P1|STARTED|Overall Study||73
8190254|NCT02293512|20194644|P4|NOT COMPLETED|Overall Study||2
8190255|NCT02293512|20194645|P3|NOT COMPLETED|Overall Study||3
8190256|NCT02293512|20194646|P2|NOT COMPLETED|Overall Study||6
8190257|NCT02293512|20194647|P1|NOT COMPLETED|Overall Study||4
8190258|NCT02293512|20194644|P4|COMPLETED|Overall Study||8
8190259|NCT02293512|20194645|P3|COMPLETED|Overall Study||7
8190260|NCT02293512|20194646|P2|COMPLETED|Overall Study||4
8190261|NCT02293512|20194647|P1|COMPLETED|Overall Study||6
8190262|NCT02293512|20194644|P4|STARTED|Overall Study||10
8190263|NCT02293512|20194645|P3|STARTED|Overall Study||10
8190264|NCT02293512|20194646|P2|STARTED|Overall Study||10
8190265|NCT02293512|20194647|P1|STARTED|Overall Study||10
8190266|NCT02293460|20194657|P1|NOT COMPLETED|Overall Study||6
8190267|NCT02293460|20194657|P1|COMPLETED|Overall Study||37
8190268|NCT02293460|20194657|P1|STARTED|Overall Study||43
8190269|NCT02293395|20194663|P2|NOT COMPLETED|Overall Study||7
8190270|NCT02293395|20194664|P1|NOT COMPLETED|Overall Study||9
8190271|NCT02293395|20194663|P2|COMPLETED|Overall Study||1511
8190272|NCT02293395|20194664|P1|COMPLETED|Overall Study||1510
8190273|NCT02293395|20194663|P2|Treated|Overall Study||1506
8190274|NCT02293395|20194664|P1|Treated|Overall Study||1510
8190275|NCT02293395|20194663|P2|STARTED|Overall Study||1518
8190276|NCT02293395|20194664|P1|STARTED|Overall Study||1519
8190277|NCT02293044|20194670|P1|NOT COMPLETED|Overall Study||0
8190278|NCT02293044|20194670|P1|COMPLETED|Overall Study||15
8190279|NCT02293044|20194670|P1|STARTED|Overall Study||15
8190280|NCT02292927|20194677|P2|NOT COMPLETED|Overall Study||7
8190281|NCT02292927|20194678|P1|NOT COMPLETED|Overall Study||13
8190282|NCT02292927|20194677|P2|COMPLETED|Overall Study||5
8190283|NCT02292927|20194678|P1|COMPLETED|Overall Study||0
8190284|NCT02292927|20194677|P2|STARTED|Overall Study||12
8190285|NCT02292927|20194678|P1|STARTED|Overall Study||13
8190286|NCT02292849|20194695|P3|NOT COMPLETED|Overall Study||2
8190287|NCT02292849|20194696|P2|NOT COMPLETED|Overall Study||2
8190288|NCT02292849|20194697|P1|NOT COMPLETED|Overall Study||4
8190289|NCT02292849|20194695|P3|COMPLETED|Overall Study||8
8190290|NCT02292849|20194696|P2|COMPLETED|Overall Study||6
8190291|NCT02292849|20194697|P1|COMPLETED|Overall Study||7
8190292|NCT02292849|20194695|P3|STARTED|Overall Study||10
8190293|NCT02292849|20194696|P2|STARTED|Overall Study||8
8190294|NCT02292849|20194697|P1|STARTED|Overall Study||11
8190295|NCT02292784|20194708|P3|NOT COMPLETED|Overall Study||21
8190296|NCT02292784|20194709|P2|NOT COMPLETED|Overall Study||20
8190297|NCT02292784|20194710|P1|NOT COMPLETED|Overall Study||1
8190298|NCT02292784|20194708|P3|COMPLETED|Overall Study||28
8190299|NCT02292784|20194709|P2|COMPLETED|Overall Study||24
8190300|NCT02292784|20194710|P1|COMPLETED|Overall Study||4
8190301|NCT02292784|20194708|P3|STARTED|Overall Study||49
8190302|NCT02292784|20194709|P2|STARTED|Overall Study||44
8190303|NCT02292784|20194710|P1|STARTED|Overall Study||5
8190304|NCT02292771|20194777|P2|NOT COMPLETED|Overall Study||2
8190305|NCT02292771|20194778|P1|NOT COMPLETED|Overall Study||4
8190306|NCT02292771|20194777|P2|COMPLETED|Overall Study||48
8190307|NCT02292771|20194778|P1|COMPLETED|Overall Study||43
8190308|NCT02292771|20194777|P2|STARTED|Overall Study||50
8190309|NCT02292771|20194778|P1|STARTED|Overall Study||47
8190310|NCT02292758|20194870|P2|NOT COMPLETED|Overall Study||0
8190311|NCT02292758|20194871|P1|NOT COMPLETED|Overall Study||0
8190312|NCT02292758|20194870|P2|COMPLETED|Overall Study||17
8190313|NCT02292758|20194871|P1|COMPLETED|Overall Study||19
8190314|NCT02292758|20194870|P2|STARTED|Overall Study||17
8190315|NCT02292758|20194871|P1|STARTED|Overall Study||19
8190342|NCT02292446|20194969|P1|NOT COMPLETED|Overall Study||20
8190343|NCT02292446|20194969|P1|COMPLETED|Overall Study||141
8190344|NCT02292446|20194969|P1|STARTED|Overall Study||161
8190345|NCT02292433|20194985|P3|NOT COMPLETED|Third Intervention Period (7 Days)||0
8190346|NCT02292433|20194986|P2|NOT COMPLETED|Third Intervention Period (7 Days)||0
8190347|NCT02292433|20194987|P1|NOT COMPLETED|Third Intervention Period (7 Days)||0
8190348|NCT02292433|20194985|P3|COMPLETED|Third Intervention Period (7 Days)||4
8190349|NCT02292433|20194986|P2|COMPLETED|Third Intervention Period (7 Days)||4
8190350|NCT02292433|20194987|P1|COMPLETED|Third Intervention Period (7 Days)||4
8190351|NCT02292433|20194985|P3|STARTED|Third Intervention Period (7 Days)||4
8190352|NCT02292433|20194986|P2|STARTED|Third Intervention Period (7 Days)||4
8190353|NCT02292433|20194987|P1|STARTED|Third Intervention Period (7 Days)||4
8190354|NCT02292433|20194985|P3|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
8190355|NCT02292433|20194986|P2|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
8190356|NCT02292433|20194987|P1|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
8190357|NCT02292433|20194985|P3|COMPLETED|Second Washout Period (7 to 14 Days)||4
8190358|NCT02292433|20194986|P2|COMPLETED|Second Washout Period (7 to 14 Days)||4
8190359|NCT02292433|20194987|P1|COMPLETED|Second Washout Period (7 to 14 Days)||4
8190360|NCT02292433|20194985|P3|STARTED|Second Washout Period (7 to 14 Days)||4
8190361|NCT02292433|20194986|P2|STARTED|Second Washout Period (7 to 14 Days)||4
8190362|NCT02292433|20194987|P1|STARTED|Second Washout Period (7 to 14 Days)||4
8190363|NCT02292433|20194985|P3|NOT COMPLETED|Second Intervention Period (7 Days)||0
8190364|NCT02292433|20194986|P2|NOT COMPLETED|Second Intervention Period (7 Days)||0
8190365|NCT02292433|20194987|P1|NOT COMPLETED|Second Intervention Period (7 Days)||0
8190366|NCT02292433|20194985|P3|COMPLETED|Second Intervention Period (7 Days)||4
8190367|NCT02292433|20194986|P2|COMPLETED|Second Intervention Period (7 Days)||4
8190368|NCT02292433|20194987|P1|COMPLETED|Second Intervention Period (7 Days)||4
8190369|NCT02292433|20194985|P3|STARTED|Second Intervention Period (7 Days)||4
8190370|NCT02292433|20194986|P2|STARTED|Second Intervention Period (7 Days)||4
8190371|NCT02292433|20194987|P1|STARTED|Second Intervention Period (7 Days)||4
8190372|NCT02292433|20194985|P3|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
8190373|NCT02292433|20194986|P2|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
8190374|NCT02292433|20194987|P1|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
8190375|NCT02292433|20194985|P3|COMPLETED|First Washout Period (7 to 14 Days)||4
8190376|NCT02292433|20194986|P2|COMPLETED|First Washout Period (7 to 14 Days)||4
8190377|NCT02292433|20194987|P1|COMPLETED|First Washout Period (7 to 14 Days)||4
8190378|NCT02292433|20194985|P3|STARTED|First Washout Period (7 to 14 Days)||4
8190379|NCT02292433|20194986|P2|STARTED|First Washout Period (7 to 14 Days)||4
8190380|NCT02292433|20194987|P1|STARTED|First Washout Period (7 to 14 Days)||4
8190381|NCT02292433|20194985|P3|NOT COMPLETED|First Intervention Period (7 Days)||0
8190382|NCT02292433|20194986|P2|NOT COMPLETED|First Intervention Period (7 Days)||0
8190383|NCT02292433|20194987|P1|NOT COMPLETED|First Intervention Period (7 Days)||0
8190384|NCT02292433|20194985|P3|COMPLETED|First Intervention Period (7 Days)||4
8190385|NCT02292433|20194986|P2|COMPLETED|First Intervention Period (7 Days)||4
8190386|NCT02292433|20194987|P1|COMPLETED|First Intervention Period (7 Days)||4
8190387|NCT02292433|20194985|P3|STARTED|First Intervention Period (7 Days)||4
8190388|NCT02292433|20194986|P2|STARTED|First Intervention Period (7 Days)||4
8190389|NCT02292433|20194987|P1|STARTED|First Intervention Period (7 Days)||4
8190390|NCT02292212|20195058|P1|NOT COMPLETED|Post-ViE Phase||0
8190391|NCT02292212|20195058|P1|COMPLETED|Post-ViE Phase||14
8190392|NCT02292212|20195058|P1|STARTED|Post-ViE Phase||14
8190393|NCT02292212|20195058|P1|NOT COMPLETED|ViE Phase||3
8190394|NCT02292212|20195058|P1|COMPLETED|ViE Phase||14
8190395|NCT02292212|20195058|P1|STARTED|ViE Phase||17
8190396|NCT02292212|20195058|P1|NOT COMPLETED|Pre-ViE Phase||0
8190397|NCT02292212|20195058|P1|COMPLETED|Pre-ViE Phase||17
8190398|NCT02292212|20195058|P1|STARTED|Pre-ViE Phase||17
8190399|NCT02292186|20195090|P1|NOT COMPLETED|Overall Study||18
8190400|NCT02292186|20195090|P1|COMPLETED|Overall Study||7
8190401|NCT02292186|20195090|P1|STARTED|Overall Study||25
8190402|NCT02292082|20195100|P2|NOT COMPLETED|Overall Study||0
8190403|NCT02292082|20195101|P1|NOT COMPLETED|Overall Study||0
8190404|NCT02292082|20195100|P2|COMPLETED|Overall Study||55
8190405|NCT02292082|20195101|P1|COMPLETED|Overall Study||56
8190406|NCT02292082|20195100|P2|STARTED|Overall Study||55
8190407|NCT02292082|20195101|P1|STARTED|Overall Study||56
8190408|NCT02291913|20195127|P1|NOT COMPLETED|Overall Study||48
8190409|NCT02291913|20195127|P1|COMPLETED|Overall Study||0
8190410|NCT02291913|20195127|P1|STARTED|Overall Study||48
8190411|NCT02291861|20195140|P4|NOT COMPLETED|Overall Study||10
8190412|NCT02291861|20195141|P3|NOT COMPLETED|Overall Study||9
8190413|NCT02291861|20195142|P2|NOT COMPLETED|Overall Study||8
8190414|NCT02291861|20195143|P1|NOT COMPLETED|Overall Study||7
8190415|NCT02291861|20195140|P4|COMPLETED|Overall Study||65
8190416|NCT02291861|20195141|P3|COMPLETED|Overall Study||65
8190417|NCT02291861|20195142|P2|COMPLETED|Overall Study||67
8190418|NCT02291861|20195143|P1|COMPLETED|Overall Study||67
8190419|NCT02291861|20195140|P4|Modified Intent to Treat Pop (mITT)|Overall Study||55
8190420|NCT02291861|20195141|P3|Modified Intent to Treat Pop (mITT)|Overall Study||49
8190421|NCT02291861|20195142|P2|Modified Intent to Treat Pop (mITT)|Overall Study||60
8190422|NCT02291861|20195143|P1|Modified Intent to Treat Pop (mITT)|Overall Study||58
8190423|NCT02291861|20195140|P4|Safety Population|Overall Study||74
8190424|NCT02291861|20195141|P3|Safety Population|Overall Study||73
8190425|NCT02291861|20195142|P2|Safety Population|Overall Study||74
8190426|NCT02291861|20195143|P1|Safety Population|Overall Study||72
8190427|NCT02291861|20195140|P4|STARTED|Overall Study||75
8190428|NCT02291861|20195141|P3|STARTED|Overall Study||74
8190429|NCT02291861|20195142|P2|STARTED|Overall Study||75
8190430|NCT02291861|20195143|P1|STARTED|Overall Study||74
8190431|NCT02291718|20195184|P3|NOT COMPLETED|Overall Study||0
8190432|NCT02291718|20195185|P2|NOT COMPLETED|Overall Study||0
8190433|NCT02291718|20195186|P1|NOT COMPLETED|Overall Study||0
8190434|NCT02291718|20195184|P3|COMPLETED|Overall Study||50
8190435|NCT02291718|20195185|P2|COMPLETED|Overall Study||50
8190436|NCT02291718|20195186|P1|COMPLETED|Overall Study||50
8190437|NCT02291718|20195184|P3|STARTED|Overall Study||50
8190438|NCT02291718|20195185|P2|STARTED|Overall Study||50
8190439|NCT02291718|20195186|P1|STARTED|Overall Study||50
8190440|NCT02291679|20195206|P3|NOT COMPLETED|Overall Study||59
8190441|NCT02291679|20195207|P2|NOT COMPLETED|Overall Study||42
8190442|NCT02291679|20195208|P1|NOT COMPLETED|Overall Study||44
8190443|NCT02291679|20195206|P3|COMPLETED|Overall Study||352
8190444|NCT02291679|20195207|P2|COMPLETED|Overall Study||369
8190445|NCT02291679|20195208|P1|COMPLETED|Overall Study||357
8190446|NCT02291679|20195206|P3|STARTED|Overall Study||411
8190447|NCT02291679|20195207|P2|STARTED|Overall Study||411
8190448|NCT02291679|20195208|P1|STARTED|Overall Study||401
8190449|NCT02291549|20195239|P2|NOT COMPLETED|Overall Study||1
8190450|NCT02291549|20195240|P1|NOT COMPLETED|Overall Study||1
8190451|NCT02291549|20195239|P2|COMPLETED|Overall Study||98
8190452|NCT02291549|20195240|P1|COMPLETED|Overall Study||200
8190453|NCT02291549|20195239|P2|STARTED|Overall Study||99
8190454|NCT02291549|20195240|P1|STARTED|Overall Study||201
8190455|NCT02291510|20195262|P4|NOT COMPLETED|Overall Study||1
8190456|NCT02291510|20195263|P3|NOT COMPLETED|Overall Study||0
8190457|NCT02291510|20195264|P2|NOT COMPLETED|Overall Study||0
8190458|NCT02291510|20195265|P1|NOT COMPLETED|Overall Study||0
8190459|NCT02291510|20195262|P4|COMPLETED|Overall Study||4
8190460|NCT02291510|20195263|P3|COMPLETED|Overall Study||5
8190461|NCT02291510|20195264|P2|COMPLETED|Overall Study||5
8190462|NCT02291510|20195265|P1|COMPLETED|Overall Study||5
8190463|NCT02291510|20195262|P4|Completed Treatment D|Overall Study||5
8190464|NCT02291510|20195263|P3|Completed Treatment D|Overall Study||5
8190465|NCT02291510|20195264|P2|Completed Treatment D|Overall Study||5
8190466|NCT02291510|20195265|P1|Completed Treatment D|Overall Study||5
8190467|NCT02291510|20195262|P4|Completed Treatment C|Overall Study||4
8190468|NCT02291510|20195263|P3|Completed Treatment C|Overall Study||5
8190469|NCT02291510|20195264|P2|Completed Treatment C|Overall Study||5
8190470|NCT02291510|20195265|P1|Completed Treatment C|Overall Study||5
8190471|NCT02291510|20195262|P4|Completed Treatment B|Overall Study||4
8190472|NCT02291510|20195263|P3|Completed Treatment B|Overall Study||5
8190473|NCT02291510|20195264|P2|Completed Treatment B|Overall Study||5
8190474|NCT02291510|20195265|P1|Completed Treatment B|Overall Study||5
8190475|NCT02291510|20195262|P4|Completed Treatment A|Overall Study||5
8190476|NCT02291510|20195263|P3|Completed Treatment A|Overall Study||5
8190477|NCT02291510|20195264|P2|Completed Treatment A|Overall Study||5
8190478|NCT02291510|20195265|P1|Completed Treatment A|Overall Study||5
8190479|NCT02291510|20195262|P4|STARTED|Overall Study||5
8190480|NCT02291510|20195263|P3|STARTED|Overall Study||5
8190481|NCT02291510|20195264|P2|STARTED|Overall Study||5
8190482|NCT02291510|20195265|P1|STARTED|Overall Study||5
8190483|NCT02291419|20195281|P2|NOT COMPLETED|Overall Study||5
8190484|NCT02291419|20195282|P1|NOT COMPLETED|Overall Study||1
8190485|NCT02291419|20195281|P2|COMPLETED|Overall Study||0
8190486|NCT02291419|20195282|P1|COMPLETED|Overall Study||0
8190487|NCT02291419|20195281|P2|STARTED|Overall Study||5
8190488|NCT02291419|20195282|P1|STARTED|Overall Study||1
8190585|NCT02291237|20195394|P2|NOT COMPLETED|Overall Study||86
8190586|NCT02291237|20195395|P1|NOT COMPLETED|Overall Study||86
8190587|NCT02291237|20195394|P2|COMPLETED|Overall Study||0
8190588|NCT02291237|20195395|P1|COMPLETED|Overall Study||0
8190589|NCT02291237|20195394|P2|STARTED|Overall Study||86
8190590|NCT02291237|20195395|P1|STARTED|Overall Study||86
8190591|NCT02291029|20195417|P6|NOT COMPLETED|Overall Study||0
8190592|NCT02291029|20195418|P5|NOT COMPLETED|Overall Study||0
8190593|NCT02291029|20195419|P4|NOT COMPLETED|Overall Study||0
8190594|NCT02291029|20195420|P3|NOT COMPLETED|Overall Study||1
8190595|NCT02291029|20195421|P2|NOT COMPLETED|Overall Study||1
8190596|NCT02291029|20195422|P1|NOT COMPLETED|Overall Study||0
8190597|NCT02291029|20195417|P6|COMPLETED|Overall Study||12
8190598|NCT02291029|20195418|P5|COMPLETED|Overall Study||13
8190599|NCT02291029|20195419|P4|COMPLETED|Overall Study||11
8190600|NCT02291029|20195420|P3|COMPLETED|Overall Study||20
8190601|NCT02291029|20195421|P2|COMPLETED|Overall Study||3
8190602|NCT02291029|20195422|P1|COMPLETED|Overall Study||8
8190603|NCT02291029|20195417|P6|STARTED|Overall Study||12
8190604|NCT02291029|20195418|P5|STARTED|Overall Study||13
8190605|NCT02291029|20195419|P4|STARTED|Overall Study||11
8190606|NCT02291029|20195420|P3|STARTED|Overall Study||21
8190607|NCT02291029|20195421|P2|STARTED|Overall Study||4
8190608|NCT02291029|20195422|P1|STARTED|Overall Study||8
8190609|NCT02291016|20195468|P2|NOT COMPLETED|Visit 2||0
8190610|NCT02291016|20195469|P1|NOT COMPLETED|Visit 2||1
8190611|NCT02291016|20195468|P2|COMPLETED|Visit 2||5
8190612|NCT02291016|20195469|P1|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1
8190613|NCT02291016|20195468|P2|STARTED|Visit 2||5
8190614|NCT02291016|20195469|P1|STARTED|Visit 2||2
8190615|NCT02291016|20195468|P2|NOT COMPLETED|Visit 1||0
8190616|NCT02291016|20195469|P1|NOT COMPLETED|Visit 1||0
8190617|NCT02291016|20195468|P2|COMPLETED|Visit 1||5
8190618|NCT02291016|20195469|P1|COMPLETED|Visit 1||2
8190619|NCT02291016|20195468|P2|STARTED|Visit 1||5
8190620|NCT02291016|20195469|P1|STARTED|Visit 1||2
8190621|NCT02290925|20195493|P2|NOT COMPLETED|Second Period of 3 Months||4
8190622|NCT02290925|20195494|P1|NOT COMPLETED|Second Period of 3 Months||1
8190623|NCT02290925|20195493|P2|COMPLETED|Second Period of 3 Months||65
8190624|NCT02290925|20195494|P1|COMPLETED|Second Period of 3 Months||57
8190625|NCT02290925|20195493|P2|STARTED|Second Period of 3 Months||69
8190626|NCT02290925|20195494|P1|STARTED|Second Period of 3 Months||58
8190627|NCT02290925|20195493|P2|NOT COMPLETED|First Period of Three Months||2
8190628|NCT02290925|20195494|P1|NOT COMPLETED|First Period of Three Months||4
8190629|NCT02290925|20195493|P2|COMPLETED|First Period of Three Months||69
8190630|NCT02290925|20195494|P1|COMPLETED|First Period of Three Months||58
8190631|NCT02290925|20195493|P2|STARTED|First Period of Three Months||71
8190632|NCT02290925|20195494|P1|STARTED|First Period of Three Months||62
8190633|NCT02290873|20195509|P3|NOT COMPLETED|Overall Study||2
8190634|NCT02290873|20195510|P2|NOT COMPLETED|Overall Study||1
8190635|NCT02290873|20195511|P1|NOT COMPLETED|Overall Study||2
8190636|NCT02290873|20195509|P3|COMPLETED|Overall Study||101
8190637|NCT02290873|20195510|P2|COMPLETED|Overall Study||59
8190638|NCT02290873|20195511|P1|COMPLETED|Overall Study||296
8190639|NCT02290873|20195509|P3|Safety Population|Overall Study||102
8190640|NCT02290873|20195510|P2|Safety Population|Overall Study||60
8190641|NCT02290873|20195511|P1|Safety Population|Overall Study||296
8190642|NCT02290873|20195509|P3|Modified Intention to Treat (mITT)|Overall Study||102
8190643|NCT02290873|20195510|P2|Modified Intention to Treat (mITT)|Overall Study||60
8190644|NCT02290873|20195511|P1|Modified Intention to Treat (mITT)|Overall Study||296
8190645|NCT02290873|20195509|P3|STARTED|Overall Study||103
8190646|NCT02290873|20195510|P2|STARTED|Overall Study||60
8190647|NCT02290873|20195511|P1|STARTED|Overall Study||298
8190648|NCT02290821|20195530|P2|NOT COMPLETED|Overall Study||3
8190649|NCT02290821|20195531|P1|NOT COMPLETED|Overall Study||6
8190650|NCT02290821|20195530|P2|COMPLETED|Overall Study||103
8190651|NCT02290821|20195531|P1|COMPLETED|Overall Study||103
8190652|NCT02290821|20195530|P2|STARTED|Overall Study||106
8190653|NCT02290821|20195531|P1|STARTED|Overall Study||109
8190654|NCT02290691|20195539|P2|NOT COMPLETED|Overall Study||9
8190655|NCT02290691|20195540|P1|NOT COMPLETED|Overall Study||8
8190656|NCT02290691|20195539|P2|COMPLETED|Overall Study||479
8190657|NCT02290691|20195540|P1|COMPLETED|Overall Study||488
8190658|NCT02290691|20195539|P2|STARTED|Overall Study||488
8190659|NCT02290691|20195540|P1|STARTED|Overall Study||496
8190660|NCT02290613|20195556|P2|NOT COMPLETED|Overall Study||4
8190661|NCT02290613|20195557|P1|NOT COMPLETED|Overall Study||2
8190662|NCT02290613|20195556|P2|COMPLETED|Overall Study||15
8190663|NCT02290613|20195557|P1|COMPLETED|Overall Study||17
8190664|NCT02290613|20195556|P2|STARTED|Overall Study||19
8190665|NCT02290613|20195557|P1|STARTED|Overall Study||19
8190666|NCT02290574|20195605|P1|NOT COMPLETED|Overall Study||1
8190667|NCT02290574|20195605|P1|COMPLETED|Overall Study||13
8190668|NCT02290574|20195605|P1|STARTED|Overall Study||14
8190669|NCT02290509|20195615|P2|NOT COMPLETED|Overall Study||14
8190670|NCT02290509|20195616|P1|NOT COMPLETED|Overall Study||49
8190671|NCT02290509|20195615|P2|COMPLETED|Overall Study||325
8190672|NCT02290509|20195616|P1|COMPLETED|Overall Study||962
8190673|NCT02290509|20195615|P2|STARTED|Overall Study||339
8190674|NCT02290509|20195616|P1|STARTED|Overall Study||1011
8190675|NCT02290444|20195630|P2|NOT COMPLETED|Overall Study||2
8190676|NCT02290444|20195631|P1|NOT COMPLETED|Overall Study||1
8190677|NCT02290444|20195630|P2|COMPLETED|Overall Study||32
8190678|NCT02290444|20195631|P1|COMPLETED|Overall Study||29
8190679|NCT02290444|20195630|P2|STARTED|Overall Study||34
8190680|NCT02290444|20195631|P1|STARTED|Overall Study||30
8190681|NCT02290431|20195653|P1|NOT COMPLETED|Overall Study||27
8190682|NCT02290431|20195653|P1|COMPLETED|Overall Study||4
8190683|NCT02290431|20195653|P1|Entered Treatment Phase 2|Overall Study||17
8190684|NCT02290431|20195653|P1|Subjects Entered Survival f/u Phase|Overall Study||24
8190685|NCT02290431|20195653|P1|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31
8190686|NCT02290431|20195653|P1|Subjects Completed Study Per Protocol|Overall Study||8
8190687|NCT02290431|20195653|P1|Subjects. Discont. Prematurely|Overall Study||27
8190688|NCT02290431|20195653|P1|STARTED|Overall Study||31
8190689|NCT02290340|20195676|P4|NOT COMPLETED|Overall Study||2
8190690|NCT02290340|20195677|P3|NOT COMPLETED|Overall Study||0
8190691|NCT02290340|20195678|P2|NOT COMPLETED|Overall Study||0
8190692|NCT02290340|20195679|P1|NOT COMPLETED|Overall Study||2
8190693|NCT02290340|20195676|P4|COMPLETED|Overall Study||30
8190694|NCT02290340|20195677|P3|COMPLETED|Overall Study||31
8190695|NCT02290340|20195678|P2|COMPLETED|Overall Study||8
8190696|NCT02290340|20195679|P1|COMPLETED|Overall Study||16
8190697|NCT02290340|20195676|P4|STARTED|Overall Study||32
8190698|NCT02290340|20195677|P3|STARTED|Overall Study||31
8190699|NCT02290340|20195678|P2|STARTED|Overall Study||8
8190700|NCT02290340|20195679|P1|STARTED|Overall Study||18
8190701|NCT02290223|20195724|P2|NOT COMPLETED|12 Months||11
8190702|NCT02290223|20195725|P1|NOT COMPLETED|12 Months||16
8190703|NCT02290223|20195724|P2|COMPLETED|12 Months||176
8190704|NCT02290223|20195725|P1|COMPLETED|12 Months||166
8190705|NCT02290223|20195724|P2|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187
8190706|NCT02290223|20195725|P1|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182
8190707|NCT02290223|20195724|P2|NOT COMPLETED|6 Months||6
8190708|NCT02290223|20195725|P1|NOT COMPLETED|6 Months||16
8190709|NCT02290223|20195724|P2|COMPLETED|6 Months||181
8190710|NCT02290223|20195725|P1|COMPLETED|6 Months||173
8190711|NCT02290223|20195724|P2|STARTED|6 Months||187
8190712|NCT02290223|20195725|P1|STARTED|6 Months||189
8190713|NCT02290223|20195724|P2|NOT COMPLETED|Baseline||0
8190714|NCT02290223|20195725|P1|NOT COMPLETED|Baseline||0
8190715|NCT02290223|20195724|P2|COMPLETED|Baseline||187
8190716|NCT02290223|20195725|P1|COMPLETED|Baseline||189
8190717|NCT02290223|20195724|P2|STARTED|Baseline||187
8190718|NCT02290223|20195725|P1|STARTED|Baseline||189
8190719|NCT02290184|20195785|P2|NOT COMPLETED|Overall Study||0
8190720|NCT02290184|20195786|P1|NOT COMPLETED|Overall Study||0
8190721|NCT02290184|20195785|P2|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23
8190722|NCT02290184|20195786|P1|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22
8190723|NCT02290184|20195785|P2|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23
8190724|NCT02290184|20195786|P1|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22
8190725|NCT02290184|20195785|P2|STARTED|Overall Study||23
8190726|NCT02290184|20195786|P1|STARTED|Overall Study||22
8190727|NCT02290106|20195800|P2|NOT COMPLETED|Overall Study||2
8190728|NCT02290106|20195801|P1|NOT COMPLETED|Overall Study||1
8190729|NCT02290106|20195800|P2|COMPLETED|Overall Study||23
8190730|NCT02290106|20195801|P1|COMPLETED|Overall Study||24
8190731|NCT02290106|20195800|P2|STARTED|Overall Study||25
8190732|NCT02290106|20195801|P1|STARTED|Overall Study||25
8190733|NCT02289989|20195821|P2|NOT COMPLETED|Overall Study||0
8190734|NCT02289989|20195822|P1|NOT COMPLETED|Overall Study||0
8190735|NCT02289989|20195821|P2|COMPLETED|Overall Study||1
8190736|NCT02289989|20195822|P1|COMPLETED|Overall Study||0
8190737|NCT02289989|20195821|P2|STARTED|Overall Study||1
8190738|NCT02289989|20195822|P1|STARTED|Overall Study||0
8190739|NCT02289963|20195840|P2|NOT COMPLETED|Overall Study||10
8190740|NCT02289963|20195841|P1|NOT COMPLETED|Overall Study||5
8190741|NCT02289963|20195840|P2|COMPLETED|Overall Study||87
8190742|NCT02289963|20195841|P1|COMPLETED|Overall Study||97
8190743|NCT02289963|20195840|P2|Treated|Overall Study||97
8190744|NCT02289963|20195841|P1|Treated|Overall Study||102
8190745|NCT02289963|20195840|P2|STARTED|Overall Study|Randomized|97
8190746|NCT02289963|20195841|P1|STARTED|Overall Study|Randomized|102
8190747|NCT02289898|20195892|P3|NOT COMPLETED|Overall Study||56
8190748|NCT02289898|20195893|P2|NOT COMPLETED|Overall Study||53
8190749|NCT02289898|20195894|P1|NOT COMPLETED|Overall Study||52
8190750|NCT02289898|20195892|P3|COMPLETED|Overall Study||9
8190751|NCT02289898|20195893|P2|COMPLETED|Overall Study||18
8190752|NCT02289898|20195894|P1|COMPLETED|Overall Study||16
8190753|NCT02289898|20195892|P3|STARTED|Overall Study||65
8190754|NCT02289898|20195893|P2|STARTED|Overall Study||71
8190755|NCT02289898|20195894|P1|STARTED|Overall Study||68
8190756|NCT02289833|20195903|P2|NOT COMPLETED|Overall Study||17
8190757|NCT02289833|20195904|P1|NOT COMPLETED|Overall Study||27
8190758|NCT02289833|20195903|P2|COMPLETED|Overall Study||3
8190759|NCT02289833|20195904|P1|COMPLETED|Overall Study||2
8190760|NCT02289833|20195903|P2|STARTED|Overall Study||20
8190761|NCT02289833|20195904|P1|STARTED|Overall Study||29
8190762|NCT02289820|20195940|P7|NOT COMPLETED|Overall Study||2
8190763|NCT02289820|20195941|P6|NOT COMPLETED|Overall Study||1
8190764|NCT02289820|20195942|P5|NOT COMPLETED|Overall Study||0
8190765|NCT02289820|20195943|P4|NOT COMPLETED|Overall Study||2
8190766|NCT02289820|20195944|P3|NOT COMPLETED|Overall Study||6
8190767|NCT02289820|20195945|P2|NOT COMPLETED|Overall Study||2
8190768|NCT02289820|20195946|P1|NOT COMPLETED|Overall Study||2
8190769|NCT02289820|20195940|P7|COMPLETED|Overall Study||37
8190770|NCT02289820|20195941|P6|COMPLETED|Overall Study||39
8190771|NCT02289820|20195942|P5|COMPLETED|Overall Study||40
8190772|NCT02289820|20195943|P4|COMPLETED|Overall Study||37
8190773|NCT02289820|20195944|P3|COMPLETED|Overall Study||38
8190774|NCT02289820|20195945|P2|COMPLETED|Overall Study||18
8190775|NCT02289820|20195946|P1|COMPLETED|Overall Study||37
8190776|NCT02289820|20195940|P7|STARTED|Overall Study||39
8190777|NCT02289820|20195941|P6|STARTED|Overall Study||40
8190778|NCT02289820|20195942|P5|STARTED|Overall Study||40
8190779|NCT02289820|20195943|P4|STARTED|Overall Study||39
8190780|NCT02289820|20195944|P3|STARTED|Overall Study||44
8190781|NCT02289820|20195945|P2|STARTED|Overall Study||20
8190782|NCT02289820|20195946|P1|STARTED|Overall Study||39
8190783|NCT02289755|20196057|P1|NOT COMPLETED|Follow up Period [4 Days]||0
8190784|NCT02289755|20196057|P1|COMPLETED|Follow up Period [4 Days]||16
8190785|NCT02289755|20196057|P1|STARTED|Follow up Period [4 Days]||16
8190786|NCT02289755|20196057|P1|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
8190787|NCT02289755|20196057|P1|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
8190788|NCT02289755|20196057|P1|STARTED|ALLN-177 Treatment Period [4 Days]||16
8190789|NCT02289755|20196057|P1|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
8190790|NCT02289755|20196057|P1|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
8190791|NCT02289755|20196057|P1|STARTED|Baseline Period [No Treatment, 3 Days]||16
8190792|NCT02289742|20196064|P4|NOT COMPLETED|Third Wear Period||1
8190793|NCT02289742|20196065|P3|NOT COMPLETED|Third Wear Period||0
8190794|NCT02289742|20196066|P2|NOT COMPLETED|Third Wear Period||1
8190795|NCT02289742|20196067|P1|NOT COMPLETED|Third Wear Period||0
8190796|NCT02289742|20196064|P4|COMPLETED|Third Wear Period||8
8190797|NCT02289742|20196065|P3|COMPLETED|Third Wear Period||11
8190798|NCT02289742|20196066|P2|COMPLETED|Third Wear Period||10
8190799|NCT02289742|20196067|P1|COMPLETED|Third Wear Period||11
8190800|NCT02289742|20196064|P4|STARTED|Third Wear Period||9
8190801|NCT02289742|20196065|P3|STARTED|Third Wear Period||11
8190802|NCT02289742|20196066|P2|STARTED|Third Wear Period||11
8190803|NCT02289742|20196067|P1|STARTED|Third Wear Period||11
8190804|NCT02289742|20196064|P4|NOT COMPLETED|Second Wear Period||0
8190805|NCT02289742|20196065|P3|NOT COMPLETED|Second Wear Period||0
8190806|NCT02289742|20196066|P2|NOT COMPLETED|Second Wear Period||0
8190807|NCT02289742|20196067|P1|NOT COMPLETED|Second Wear Period||0
8190808|NCT02289742|20196064|P4|COMPLETED|Second Wear Period||9
8190809|NCT02289742|20196065|P3|COMPLETED|Second Wear Period||11
8190810|NCT02289742|20196066|P2|COMPLETED|Second Wear Period||11
8190811|NCT02289742|20196067|P1|COMPLETED|Second Wear Period||11
8190812|NCT02289742|20196064|P4|STARTED|Second Wear Period||9
8190813|NCT02289742|20196065|P3|STARTED|Second Wear Period||11
8190814|NCT02289742|20196066|P2|STARTED|Second Wear Period||11
8190815|NCT02289742|20196067|P1|STARTED|Second Wear Period||11
8190816|NCT02289742|20196064|P4|NOT COMPLETED|First Wear Period||1
8190817|NCT02289742|20196065|P3|NOT COMPLETED|First Wear Period||1
8190818|NCT02289742|20196066|P2|NOT COMPLETED|First Wear Period||1
8190819|NCT02289742|20196067|P1|NOT COMPLETED|First Wear Period||0
8190820|NCT02289742|20196064|P4|COMPLETED|First Wear Period||9
8190821|NCT02289742|20196065|P3|COMPLETED|First Wear Period||11
8190822|NCT02289742|20196066|P2|COMPLETED|First Wear Period||11
8190823|NCT02289742|20196067|P1|COMPLETED|First Wear Period||11
8190824|NCT02289742|20196064|P4|Treated|First Wear Period||9
8190825|NCT02289742|20196065|P3|Treated|First Wear Period||12
8190826|NCT02289742|20196066|P2|Treated|First Wear Period||11
8190827|NCT02289742|20196067|P1|Treated|First Wear Period||11
8190828|NCT02289742|20196064|P4|STARTED|First Wear Period||10
8190829|NCT02289742|20196065|P3|STARTED|First Wear Period||12
8190830|NCT02289742|20196066|P2|STARTED|First Wear Period||12
8190831|NCT02289742|20196067|P1|STARTED|First Wear Period||11
8190832|NCT02289729|20196084|P1|NOT COMPLETED|Overall Study||6
8190833|NCT02289729|20196084|P1|COMPLETED|Overall Study||53
8190834|NCT02289729|20196084|P1|STARTED|Overall Study||59
8190835|NCT02289690|20196148|P10|NOT COMPLETED|Overall Study||61
8190836|NCT02289690|20196149|P9|NOT COMPLETED|Overall Study||59
8190837|NCT02289690|20196150|P8|NOT COMPLETED|Overall Study||61
8190838|NCT02289690|20196151|P7|NOT COMPLETED|Overall Study||4
8190839|NCT02289690|20196152|P6|NOT COMPLETED|Overall Study||14
8190840|NCT02289690|20196153|P5|NOT COMPLETED|Overall Study||8
8190841|NCT02289690|20196154|P4|NOT COMPLETED|Overall Study||3
8190842|NCT02289690|20196155|P3|NOT COMPLETED|Overall Study||4
8190843|NCT02289690|20196156|P2|NOT COMPLETED|Overall Study||3
8190844|NCT02289690|20196157|P1|NOT COMPLETED|Overall Study||4
8190845|NCT02289690|20196148|P10|COMPLETED|Overall Study||0
8190846|NCT02289690|20196149|P9|COMPLETED|Overall Study||0
8190847|NCT02289690|20196150|P8|COMPLETED|Overall Study||0
8190848|NCT02289690|20196151|P7|COMPLETED|Overall Study||0
8190849|NCT02289690|20196152|P6|COMPLETED|Overall Study||0
8190850|NCT02289690|20196153|P5|COMPLETED|Overall Study||0
8190851|NCT02289690|20196154|P4|COMPLETED|Overall Study||0
8190852|NCT02289690|20196155|P3|COMPLETED|Overall Study||0
8190853|NCT02289690|20196156|P2|COMPLETED|Overall Study||0
8190854|NCT02289690|20196157|P1|COMPLETED|Overall Study||0
8190855|NCT02289690|20196148|P10|Received Study Drug|Overall Study||60
8190856|NCT02289690|20196149|P9|Received Study Drug|Overall Study||58
8190857|NCT02289690|20196150|P8|Received Study Drug|Overall Study||60
8190858|NCT02289690|20196151|P7|Received Study Drug|Overall Study||4
8190859|NCT02289690|20196152|P6|Received Study Drug|Overall Study||14
8190860|NCT02289690|20196153|P5|Received Study Drug|Overall Study||8
8190861|NCT02289690|20196154|P4|Received Study Drug|Overall Study||3
8190862|NCT02289690|20196155|P3|Received Study Drug|Overall Study||4
8190863|NCT02289690|20196156|P2|Received Study Drug|Overall Study||3
8190864|NCT02289690|20196157|P1|Received Study Drug|Overall Study||4
8190865|NCT02289690|20196148|P10|STARTED|Overall Study||61
8190866|NCT02289690|20196149|P9|STARTED|Overall Study||59
8190867|NCT02289690|20196150|P8|STARTED|Overall Study||61
8190868|NCT02289690|20196151|P7|STARTED|Overall Study||4
8190869|NCT02289690|20196152|P6|STARTED|Overall Study||14
8190870|NCT02289690|20196153|P5|STARTED|Overall Study||8
8190871|NCT02289690|20196154|P4|STARTED|Overall Study||3
8190872|NCT02289690|20196155|P3|STARTED|Overall Study||4
8190873|NCT02289690|20196156|P2|STARTED|Overall Study||3
8190874|NCT02289690|20196157|P1|STARTED|Overall Study||4
8190875|NCT02289469|20196245|P2|NOT COMPLETED|Overall Study||0
8190876|NCT02289469|20196246|P1|NOT COMPLETED|Overall Study||6
8190877|NCT02289469|20196245|P2|COMPLETED|Overall Study||244
8190878|NCT02289469|20196246|P1|COMPLETED|Overall Study||244
8190879|NCT02289469|20196245|P2|STARTED|Overall Study||244
8190880|NCT02289469|20196246|P1|STARTED|Overall Study||250
8190881|NCT02289456|20196254|P1|NOT COMPLETED|Monotherapy Period||16
8190882|NCT02289456|20196254|P1|COMPLETED|Monotherapy Period||0
8190883|NCT02289456|20196254|P1|STARTED|Monotherapy Period||16
8190884|NCT02289456|20196254|P1|NOT COMPLETED|Induction Period||24
8190885|NCT02289456|20196254|P1|COMPLETED|Induction Period||16
8190886|NCT02289456|20196254|P1|Treated Population|Induction Period||40
8190887|NCT02289456|20196254|P1|STARTED|Induction Period||40
8190888|NCT02289417|20196277|P9|NOT COMPLETED|Extension Phase Weeks 52-104||6
8190889|NCT02289417|20196278|P8|NOT COMPLETED|Extension Phase Weeks 52-104||7
8190890|NCT02289417|20196279|P7|NOT COMPLETED|Extension Phase Weeks 52-104||0
8190891|NCT02289417|20196280|P6|NOT COMPLETED|Extension Phase Weeks 52-104||0
8190892|NCT02289417|20196281|P5|NOT COMPLETED|Extension Phase Weeks 52-104||0
8190893|NCT02289417|20196282|P4|NOT COMPLETED|Extension Phase Weeks 52-104||0
8190894|NCT02289417|20196283|P3|NOT COMPLETED|Extension Phase Weeks 52-104||0
8190895|NCT02289417|20196284|P2|NOT COMPLETED|Extension Phase Weeks 52-104||0
8190896|NCT02289417|20196285|P1|NOT COMPLETED|Extension Phase Weeks 52-104||0
8190897|NCT02289417|20196277|P9|COMPLETED|Extension Phase Weeks 52-104||48
8190898|NCT02289417|20196278|P8|COMPLETED|Extension Phase Weeks 52-104||38
8190899|NCT02289417|20196279|P7|COMPLETED|Extension Phase Weeks 52-104||0
8190900|NCT02289417|20196280|P6|COMPLETED|Extension Phase Weeks 52-104||0
8190901|NCT02289417|20196281|P5|COMPLETED|Extension Phase Weeks 52-104||0
8190902|NCT02289417|20196282|P4|COMPLETED|Extension Phase Weeks 52-104||0
8190903|NCT02289417|20196283|P3|COMPLETED|Extension Phase Weeks 52-104||0
8190904|NCT02289417|20196284|P2|COMPLETED|Extension Phase Weeks 52-104||0
8190905|NCT02289417|20196285|P1|COMPLETED|Extension Phase Weeks 52-104||0
8190906|NCT02289417|20196277|P9|STARTED|Extension Phase Weeks 52-104||54
8190907|NCT02289417|20196278|P8|STARTED|Extension Phase Weeks 52-104||45
8190908|NCT02289417|20196279|P7|STARTED|Extension Phase Weeks 52-104||0
8190909|NCT02289417|20196280|P6|STARTED|Extension Phase Weeks 52-104||0
8190910|NCT02289417|20196281|P5|STARTED|Extension Phase Weeks 52-104||0
8190911|NCT02289417|20196282|P4|STARTED|Extension Phase Weeks 52-104||0
8190912|NCT02289417|20196283|P3|STARTED|Extension Phase Weeks 52-104||0
8190913|NCT02289417|20196284|P2|STARTED|Extension Phase Weeks 52-104||0
8190914|NCT02289417|20196285|P1|STARTED|Extension Phase Weeks 52-104||0
8190915|NCT02289417|20196277|P9|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
8190916|NCT02289417|20196278|P8|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
8190917|NCT02289417|20196279|P7|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
8190918|NCT02289417|20196280|P6|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
8190919|NCT02289417|20196281|P5|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
8190920|NCT02289417|20196282|P4|NOT COMPLETED|Active Treatment Phase Weeks 12-52||9
8190921|NCT02289417|20196283|P3|NOT COMPLETED|Active Treatment Phase Weeks 12-52||10
8190922|NCT02289417|20196284|P2|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
8190923|NCT02289417|20196285|P1|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
8190924|NCT02289417|20196277|P9|COMPLETED|Active Treatment Phase Weeks 12-52||0
8190925|NCT02289417|20196278|P8|COMPLETED|Active Treatment Phase Weeks 12-52||0
8190926|NCT02289417|20196279|P7|COMPLETED|Active Treatment Phase Weeks 12-52||5
8190927|NCT02289417|20196280|P6|COMPLETED|Active Treatment Phase Weeks 12-52||7
8190928|NCT02289417|20196281|P5|COMPLETED|Active Treatment Phase Weeks 12-52||20
8190929|NCT02289417|20196282|P4|COMPLETED|Active Treatment Phase Weeks 12-52||17
8190930|NCT02289417|20196283|P3|COMPLETED|Active Treatment Phase Weeks 12-52||32
8190931|NCT02289417|20196284|P2|COMPLETED|Active Treatment Phase Weeks 12-52||39
8190932|NCT02289417|20196285|P1|COMPLETED|Active Treatment Phase Weeks 12-52||0
8190933|NCT02289417|20196277|P9|STARTED|Active Treatment Phase Weeks 12-52||0
8190934|NCT02289417|20196278|P8|STARTED|Active Treatment Phase Weeks 12-52||0
8190935|NCT02289417|20196279|P7|STARTED|Active Treatment Phase Weeks 12-52|Week 12 TMS were missing for 3 participants|7
8190936|NCT02289417|20196280|P6|STARTED|Active Treatment Phase Weeks 12-52|1 participant went only to Week 20|12
8190937|NCT02289417|20196281|P5|STARTED|Active Treatment Phase Weeks 12-52||25
8190938|NCT02289417|20196282|P4|STARTED|Active Treatment Phase Weeks 12-52||26
8190939|NCT02289417|20196283|P3|STARTED|Active Treatment Phase Weeks 12-52||42
8190940|NCT02289417|20196284|P2|STARTED|Active Treatment Phase Weeks 12-52||41
8190941|NCT02289417|20196285|P1|STARTED|Active Treatment Phase Weeks 12-52||0
8190942|NCT02289417|20196277|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190943|NCT02289417|20196278|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190944|NCT02289417|20196279|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190945|NCT02289417|20196280|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190946|NCT02289417|20196281|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190947|NCT02289417|20196282|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190948|NCT02289417|20196283|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||3
8190949|NCT02289417|20196284|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||4
8190950|NCT02289417|20196285|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||7
8190951|NCT02289417|20196277|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190952|NCT02289417|20196278|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190953|NCT02289417|20196279|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190954|NCT02289417|20196280|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190955|NCT02289417|20196281|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190956|NCT02289417|20196282|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
8190957|NCT02289417|20196283|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-12||52
8190958|NCT02289417|20196284|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-12||53
8190959|NCT02289417|20196285|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-12||51
8190960|NCT02289417|20196277|P9|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8190961|NCT02289417|20196278|P8|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8190962|NCT02289417|20196279|P7|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8190963|NCT02289417|20196280|P6|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8190964|NCT02289417|20196281|P5|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8190965|NCT02289417|20196282|P4|STARTED|Placebo-Controlled Phase Weeks 0-12||0
8190966|NCT02289417|20196283|P3|STARTED|Placebo-Controlled Phase Weeks 0-12||55
8190967|NCT02289417|20196284|P2|STARTED|Placebo-Controlled Phase Weeks 0-12||57
8190968|NCT02289417|20196285|P1|STARTED|Placebo-Controlled Phase Weeks 0-12||58
8190969|NCT02289352|20196334|P3|NOT COMPLETED|Overall Study||0
8190970|NCT02289352|20196335|P2|NOT COMPLETED|Overall Study||1
8190971|NCT02289352|20196336|P1|NOT COMPLETED|Overall Study||1
8190972|NCT02289352|20196334|P3|COMPLETED|Overall Study||64
8190973|NCT02289352|20196335|P2|COMPLETED|Overall Study||198
8190974|NCT02289352|20196336|P1|COMPLETED|Overall Study||198
8190975|NCT02289352|20196334|P3|PP Population|Overall Study||54
8190976|NCT02289352|20196335|P2|PP Population|Overall Study||173
8190977|NCT02289352|20196336|P1|PP Population|Overall Study||173
8190978|NCT02289352|20196334|P3|mITT Population|Overall Study||58
8190979|NCT02289352|20196335|P2|mITT Population|Overall Study||193
8190980|NCT02289352|20196336|P1|mITT Population|Overall Study||191
8190981|NCT02289352|20196334|P3|Safety Population|Overall Study||64
8190982|NCT02289352|20196335|P2|Safety Population|Overall Study||199
8190983|NCT02289352|20196336|P1|Safety Population|Overall Study||199
8190984|NCT02289352|20196334|P3|STARTED|Overall Study||64
8190985|NCT02289352|20196335|P2|STARTED|Overall Study||199
8190986|NCT02289352|20196336|P1|STARTED|Overall Study||199
8190987|NCT02289222|20196347|P1|NOT COMPLETED|Overall Study||0
8190988|NCT02289222|20196347|P1|COMPLETED|Overall Study||48
8190989|NCT02289222|20196347|P1|STARTED|Overall Study||48
8190990|NCT02289157|20196355|P2|NOT COMPLETED|Overall Study||0
8190991|NCT02289157|20196356|P1|NOT COMPLETED|Overall Study||0
8190992|NCT02289157|20196355|P2|COMPLETED|Overall Study||219
8190993|NCT02289157|20196356|P1|COMPLETED|Overall Study||222
8190994|NCT02289157|20196355|P2|No Post op Check or Follow up Phone Call|Overall Study||4
8190995|NCT02289157|20196356|P1|No Post op Check or Follow up Phone Call|Overall Study||2
8190996|NCT02289157|20196355|P2|STARTED|Overall Study||219
8190997|NCT02289157|20196356|P1|STARTED|Overall Study||222
8190998|NCT02289105|20196390|P2|NOT COMPLETED|Overall Study||0
8190999|NCT02289105|20196391|P1|NOT COMPLETED|Overall Study||0
8191000|NCT02289105|20196390|P2|COMPLETED|Overall Study||637
8191001|NCT02289105|20196391|P1|COMPLETED|Overall Study||642
8191002|NCT02289105|20196390|P2|STARTED|Overall Study||637
8191003|NCT02289105|20196391|P1|STARTED|Overall Study||642
8191004|NCT02289079|20196403|P2|NOT COMPLETED|Overall Study||1
8191005|NCT02289079|20196404|P1|NOT COMPLETED|Overall Study||2
8191006|NCT02289079|20196403|P2|COMPLETED|Overall Study||29
8191007|NCT02289079|20196404|P1|COMPLETED|Overall Study||28
8191008|NCT02289079|20196403|P2|STARTED|Overall Study||30
8191009|NCT02289079|20196404|P1|STARTED|Overall Study||30
8191010|NCT02288819|20196416|P1|NOT COMPLETED|Overall Study||0
8191011|NCT02288819|20196416|P1|COMPLETED|Overall Study||50
8191012|NCT02288819|20196416|P1|STARTED|Overall Study||50
8191013|NCT02288559|20196433|P4|NOT COMPLETED|Overall Study||2
8191014|NCT02288559|20196434|P3|NOT COMPLETED|Overall Study||11
8191015|NCT02288559|20196435|P2|NOT COMPLETED|Overall Study||1
8191016|NCT02288559|20196436|P1|NOT COMPLETED|Overall Study||1
8191017|NCT02288559|20196433|P4|COMPLETED|Overall Study||20
8191018|NCT02288559|20196434|P3|COMPLETED|Overall Study||35
8191019|NCT02288559|20196435|P2|COMPLETED|Overall Study||10
8191020|NCT02288559|20196436|P1|COMPLETED|Overall Study||9
8191021|NCT02288559|20196433|P4|STARTED|Overall Study||22
8191022|NCT02288559|20196434|P3|STARTED|Overall Study||46
8191023|NCT02288559|20196435|P2|STARTED|Overall Study||11
8191024|NCT02288559|20196436|P1|STARTED|Overall Study||10
8191025|NCT02288364|20196462|P2|NOT COMPLETED|Overall Study||0
8191026|NCT02288364|20196463|P1|NOT COMPLETED|Overall Study||0
8191027|NCT02288364|20196462|P2|COMPLETED|Overall Study||44
8191028|NCT02288364|20196463|P1|COMPLETED|Overall Study||42
8191029|NCT02288364|20196462|P2|STARTED|Overall Study||44
8191030|NCT02288364|20196463|P1|STARTED|Overall Study||42
8191031|NCT02288325|20196487|P3|NOT COMPLETED|Double-blind Treatment Period||26
8191032|NCT02288325|20196488|P2|NOT COMPLETED|Double-blind Treatment Period||24
8191033|NCT02288325|20196489|P1|NOT COMPLETED|Double-blind Treatment Period||0
8191034|NCT02288325|20196487|P3|COMPLETED|Double-blind Treatment Period||139
8191035|NCT02288325|20196488|P2|COMPLETED|Double-blind Treatment Period||135
8191036|NCT02288325|20196489|P1|COMPLETED|Double-blind Treatment Period||0
8191037|NCT02288325|20196487|P3|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
8191038|NCT02288325|20196488|P2|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
8191039|NCT02288325|20196489|P1|STARTED|Double-blind Treatment Period||0
8191040|NCT02288325|20196487|P3|NOT COMPLETED|Stabilization Period||0
8191041|NCT02288325|20196488|P2|NOT COMPLETED|Stabilization Period||0
8191042|NCT02288325|20196489|P1|NOT COMPLETED|Stabilization Period||98
8191043|NCT02288325|20196487|P3|COMPLETED|Stabilization Period||0
8191044|NCT02288325|20196488|P2|COMPLETED|Stabilization Period||0
8191045|NCT02288325|20196489|P1|COMPLETED|Stabilization Period||331
8191046|NCT02288325|20196487|P3|STARTED|Stabilization Period||0
8191047|NCT02288325|20196488|P2|STARTED|Stabilization Period||0
8191048|NCT02288325|20196489|P1|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
8191049|NCT02288325|20196487|P3|NOT COMPLETED|Run-in Period||0
8191050|NCT02288325|20196488|P2|NOT COMPLETED|Run-in Period||0
8191051|NCT02288325|20196489|P1|NOT COMPLETED|Run-in Period||145
8191052|NCT02288325|20196487|P3|COMPLETED|Run-in Period||0
8191053|NCT02288325|20196488|P2|COMPLETED|Run-in Period||0
8191054|NCT02288325|20196489|P1|COMPLETED|Run-in Period||499
8191055|NCT02288325|20196487|P3|STARTED|Run-in Period||0
8191056|NCT02288325|20196488|P2|STARTED|Run-in Period||0
8191057|NCT02288325|20196489|P1|STARTED|Run-in Period||644
8191058|NCT02288312|20196499|P3|NOT COMPLETED|Overall Study||0
8191059|NCT02288312|20196500|P2|NOT COMPLETED|Overall Study||0
8191060|NCT02288312|20196501|P1|NOT COMPLETED|Overall Study||1
8191061|NCT02288312|20196499|P3|COMPLETED|Overall Study||6
8191062|NCT02288312|20196500|P2|COMPLETED|Overall Study||6
8191063|NCT02288312|20196501|P1|COMPLETED|Overall Study||5
8191064|NCT02288312|20196499|P3|STARTED|Overall Study||6
8191065|NCT02288312|20196500|P2|STARTED|Overall Study||6
8191066|NCT02288312|20196501|P1|STARTED|Overall Study||6
8191067|NCT02288273|20196520|P2|NOT COMPLETED|Overall Study||8
8191068|NCT02288273|20196521|P1|NOT COMPLETED|Overall Study||8
8191069|NCT02288273|20196520|P2|COMPLETED|Overall Study||48
8191070|NCT02288273|20196521|P1|COMPLETED|Overall Study||53
8191071|NCT02288273|20196520|P2|STARTED|Overall Study||56
8191072|NCT02288273|20196521|P1|STARTED|Overall Study||61
8191073|NCT02288182|20196541|P2|NOT COMPLETED|Overall Study||2
8191074|NCT02288182|20196542|P1|NOT COMPLETED|Overall Study||0
8191075|NCT02288182|20196541|P2|COMPLETED|Overall Study||25
8191076|NCT02288182|20196542|P1|COMPLETED|Overall Study||25
8191077|NCT02288182|20196541|P2|STARTED|Overall Study||27
8191078|NCT02288182|20196542|P1|STARTED|Overall Study||25
8191091|NCT02288091|20196571|P1|NOT COMPLETED|Overall Study||8
8191092|NCT02288091|20196571|P1|COMPLETED|Overall Study||24
8191093|NCT02288091|20196571|P1|Randomized/Treated|Overall Study||25
8191094|NCT02288091|20196571|P1|STARTED|Overall Study||32
8191095|NCT02287922|20196583|P4|NOT COMPLETED|Overall Study||7
8191096|NCT02287922|20196584|P3|NOT COMPLETED|Overall Study||7
8191097|NCT02287922|20196585|P2|NOT COMPLETED|Overall Study||2
8191098|NCT02287922|20196586|P1|NOT COMPLETED|Overall Study||3
8191099|NCT02287922|20196583|P4|COMPLETED|Overall Study||57
8191100|NCT02287922|20196584|P3|COMPLETED|Overall Study||56
8191101|NCT02287922|20196585|P2|COMPLETED|Overall Study||60
8191102|NCT02287922|20196586|P1|COMPLETED|Overall Study||59
8191103|NCT02287922|20196583|P4|STARTED|Overall Study||64
8191104|NCT02287922|20196584|P3|STARTED|Overall Study||63
8191105|NCT02287922|20196585|P2|STARTED|Overall Study||62
8191106|NCT02287922|20196586|P1|STARTED|Overall Study||62
8191107|NCT02287909|20196679|P4|NOT COMPLETED|Overall Study||1
8191108|NCT02287909|20196680|P3|NOT COMPLETED|Overall Study||0
8191109|NCT02287909|20196681|P2|NOT COMPLETED|Overall Study||1
8191110|NCT02287909|20196682|P1|NOT COMPLETED|Overall Study||2
8191111|NCT02287909|20196679|P4|COMPLETED|Overall Study||19
8191112|NCT02287909|20196680|P3|COMPLETED|Overall Study||20
8191113|NCT02287909|20196681|P2|COMPLETED|Overall Study||19
8191114|NCT02287909|20196682|P1|COMPLETED|Overall Study||18
8191115|NCT02287909|20196679|P4|STARTED|Overall Study||20
8191116|NCT02287909|20196680|P3|STARTED|Overall Study||20
8191117|NCT02287909|20196681|P2|STARTED|Overall Study||20
8191118|NCT02287909|20196682|P1|STARTED|Overall Study||20
8191119|NCT02287896|20196694|P2|NOT COMPLETED|Second Injection Visit||1
8191120|NCT02287896|20196695|P1|NOT COMPLETED|Second Injection Visit||0
8191121|NCT02287896|20196694|P2|COMPLETED|Second Injection Visit||25
8191122|NCT02287896|20196695|P1|COMPLETED|Second Injection Visit||36
8191123|NCT02287896|20196694|P2|STARTED|Second Injection Visit||26
8191124|NCT02287896|20196695|P1|STARTED|Second Injection Visit||36
8191125|NCT02287896|20196694|P2|NOT COMPLETED|First Injection Visit||0
8191126|NCT02287896|20196695|P1|NOT COMPLETED|First Injection Visit||0
8191127|NCT02287896|20196694|P2|COMPLETED|First Injection Visit||26
8191128|NCT02287896|20196695|P1|COMPLETED|First Injection Visit||36
8191129|NCT02287896|20196694|P2|STARTED|First Injection Visit||26
8191130|NCT02287896|20196695|P1|STARTED|First Injection Visit||36
8191131|NCT02287896|20196694|P2|NOT COMPLETED|Screening Visit V1||0
8191132|NCT02287896|20196695|P1|NOT COMPLETED|Screening Visit V1||0
8191133|NCT02287896|20196694|P2|COMPLETED|Screening Visit V1||26
8191134|NCT02287896|20196695|P1|COMPLETED|Screening Visit V1||36
8191135|NCT02287896|20196694|P2|STARTED|Screening Visit V1||26
8191136|NCT02287896|20196695|P1|STARTED|Screening Visit V1||36
8191137|NCT02287883|20196713|P2|NOT COMPLETED|Overall Study||426
8191138|NCT02287883|20196714|P1|NOT COMPLETED|Overall Study||459
8191139|NCT02287883|20196713|P2|COMPLETED|Overall Study||669
8191140|NCT02287883|20196714|P1|COMPLETED|Overall Study||622
8191141|NCT02287883|20196713|P2|One-year Follow-up Survey|Overall Study||669
8191142|NCT02287883|20196714|P1|One-year Follow-up Survey|Overall Study||622
8191143|NCT02287883|20196713|P2|STARTED|Overall Study||1095
8191144|NCT02287883|20196714|P1|STARTED|Overall Study||1081
8191145|NCT02287818|20196726|P2|NOT COMPLETED|Overall Study||13
8191146|NCT02287818|20196727|P1|NOT COMPLETED|Overall Study||7
8191147|NCT02287818|20196726|P2|COMPLETED|Overall Study||54
8191148|NCT02287818|20196727|P1|COMPLETED|Overall Study||53
8191149|NCT02287818|20196726|P2|STARTED|Overall Study||67
8191150|NCT02287818|20196727|P1|STARTED|Overall Study||60
8191151|NCT02287779|20196741|P8|NOT COMPLETED|Overall Study||0
8191152|NCT02287779|20196742|P7|NOT COMPLETED|Overall Study||0
8191153|NCT02287779|20196743|P6|NOT COMPLETED|Overall Study||0
8191154|NCT02287779|20196744|P5|NOT COMPLETED|Overall Study||0
8191155|NCT02287779|20196745|P4|NOT COMPLETED|Overall Study||0
8191156|NCT02287779|20196746|P3|NOT COMPLETED|Overall Study||0
8191157|NCT02287779|20196747|P2|NOT COMPLETED|Overall Study||0
8191158|NCT02287779|20196748|P1|NOT COMPLETED|Overall Study||0
8191159|NCT02287779|20196741|P8|COMPLETED|Overall Study||9
8191160|NCT02287779|20196742|P7|COMPLETED|Overall Study||9
8191161|NCT02287779|20196743|P6|COMPLETED|Overall Study||9
8191162|NCT02287779|20196744|P5|COMPLETED|Overall Study||9
8191163|NCT02287779|20196745|P4|COMPLETED|Overall Study||9
8191164|NCT02287779|20196746|P3|COMPLETED|Overall Study||9
8191165|NCT02287779|20196747|P2|COMPLETED|Overall Study||9
8191166|NCT02287779|20196748|P1|COMPLETED|Overall Study||21
8191167|NCT02287779|20196741|P8|STARTED|Overall Study||9
8191168|NCT02287779|20196742|P7|STARTED|Overall Study||9
8191169|NCT02287779|20196743|P6|STARTED|Overall Study||9
8191170|NCT02287779|20196744|P5|STARTED|Overall Study||9
8191171|NCT02287779|20196745|P4|STARTED|Overall Study||9
8191172|NCT02287779|20196746|P3|STARTED|Overall Study||9
8191173|NCT02287779|20196747|P2|STARTED|Overall Study||9
8191174|NCT02287779|20196748|P1|STARTED|Overall Study||21
8191175|NCT02287688|20196886|P1|NOT COMPLETED|Overall Study||0
8191176|NCT02287688|20196886|P1|COMPLETED|Overall Study||138
8191177|NCT02287688|20196886|P1|STARTED|Overall Study||138
8191178|NCT02287675|20196897|P2|NOT COMPLETED|Overall Study||0
8191179|NCT02287675|20196898|P1|NOT COMPLETED|Overall Study||0
8191180|NCT02287675|20196897|P2|COMPLETED|Overall Study||18
8191181|NCT02287675|20196898|P1|COMPLETED|Overall Study||22
8191182|NCT02287675|20196897|P2|STARTED|Overall Study||18
8191183|NCT02287675|20196898|P1|STARTED|Overall Study||22
8191184|NCT02287636|20196914|P1|NOT COMPLETED|Overall Study||0
8191185|NCT02287636|20196914|P1|COMPLETED|Overall Study||13
8191186|NCT02287636|20196914|P1|STARTED|Overall Study||13
8191187|NCT02287623|20196925|P2|NOT COMPLETED|Overall Study||1
8191188|NCT02287623|20196926|P1|NOT COMPLETED|Overall Study||0
8191189|NCT02287623|20196925|P2|COMPLETED|Overall Study||29
8191190|NCT02287623|20196926|P1|COMPLETED|Overall Study||30
8191191|NCT02287623|20196925|P2|STARTED|Overall Study||30
8191192|NCT02287623|20196926|P1|STARTED|Overall Study||30
8191193|NCT02287610|20196942|P1|NOT COMPLETED|Overall Study||16
8191194|NCT02287610|20196942|P1|COMPLETED|Overall Study||48
8191195|NCT02287610|20196942|P1|Per Protocol Follow-Up|Overall Study||56
8191196|NCT02287610|20196942|P1|STARTED|Overall Study||64
8191197|NCT02287584|20196978|P6|NOT COMPLETED|the Open-label Phase||57
8191198|NCT02287584|20196979|P5|NOT COMPLETED|the Open-label Phase||62
8191199|NCT02287584|20196980|P4|NOT COMPLETED|the Open-label Phase||57
8191200|NCT02287584|20196981|P3|NOT COMPLETED|the Open-label Phase||0
8191201|NCT02287584|20196982|P2|NOT COMPLETED|the Open-label Phase||0
8191202|NCT02287584|20196983|P1|NOT COMPLETED|the Open-label Phase||0
8191203|NCT02287584|20196978|P6|COMPLETED|the Open-label Phase||104
8191204|NCT02287584|20196979|P5|COMPLETED|the Open-label Phase||87
8191205|NCT02287584|20196980|P4|COMPLETED|the Open-label Phase||81
8191206|NCT02287584|20196981|P3|COMPLETED|the Open-label Phase||0
8191207|NCT02287584|20196982|P2|COMPLETED|the Open-label Phase||0
8191208|NCT02287584|20196983|P1|COMPLETED|the Open-label Phase||0
8191209|NCT02287584|20196978|P6|Treated|the Open-label Phase||157
8191210|NCT02287584|20196979|P5|Treated|the Open-label Phase||143
8191211|NCT02287584|20196980|P4|Treated|the Open-label Phase||131
8191212|NCT02287584|20196981|P3|Treated|the Open-label Phase||0
8191213|NCT02287584|20196982|P2|Treated|the Open-label Phase||0
8191214|NCT02287584|20196983|P1|Treated|the Open-label Phase||0
8191215|NCT02287584|20196978|P6|STARTED|the Open-label Phase||161
8191216|NCT02287584|20196979|P5|STARTED|the Open-label Phase||149
8191217|NCT02287584|20196980|P4|STARTED|the Open-label Phase||138
8191218|NCT02287584|20196981|P3|STARTED|the Open-label Phase||0
8191219|NCT02287584|20196982|P2|STARTED|the Open-label Phase||0
8191220|NCT02287584|20196983|P1|STARTED|the Open-label Phase||0
8191221|NCT02287584|20196978|P6|NOT COMPLETED|the Double-blind Phase||0
8191222|NCT02287584|20196979|P5|NOT COMPLETED|the Double-blind Phase||0
8191223|NCT02287584|20196980|P4|NOT COMPLETED|the Double-blind Phase||0
8191224|NCT02287584|20196981|P3|NOT COMPLETED|the Double-blind Phase||33
8191225|NCT02287584|20196982|P2|NOT COMPLETED|the Double-blind Phase||47
8191226|NCT02287584|20196983|P1|NOT COMPLETED|the Double-blind Phase||52
8191227|NCT02287584|20196978|P6|COMPLETED|the Double-blind Phase||0
8191228|NCT02287584|20196979|P5|COMPLETED|the Double-blind Phase||0
8191229|NCT02287584|20196980|P4|COMPLETED|the Double-blind Phase||0
8191230|NCT02287584|20196981|P3|COMPLETED|the Double-blind Phase||161
8191231|NCT02287584|20196982|P2|COMPLETED|the Double-blind Phase||149
8191232|NCT02287584|20196983|P1|COMPLETED|the Double-blind Phase||138
8191233|NCT02287584|20196978|P6|STARTED|the Double-blind Phase||0
8191234|NCT02287584|20196979|P5|STARTED|the Double-blind Phase||0
8191235|NCT02287584|20196980|P4|STARTED|the Double-blind Phase||0
8191236|NCT02287584|20196981|P3|STARTED|the Double-blind Phase||194
8191237|NCT02287584|20196982|P2|STARTED|the Double-blind Phase||196
8191238|NCT02287584|20196983|P1|STARTED|the Double-blind Phase||190
8191239|NCT02287467|20197002|P2|NOT COMPLETED|Overall Study||9
8191240|NCT02287467|20197003|P1|NOT COMPLETED|Overall Study||12
8191241|NCT02287467|20197002|P2|COMPLETED|Overall Study||152
8191242|NCT02287467|20197003|P1|COMPLETED|Overall Study||156
8191243|NCT02287467|20197002|P2|STARTED|Overall Study||161
8191244|NCT02287467|20197003|P1|STARTED|Overall Study||168
8191245|NCT02287415|20197045|P1|NOT COMPLETED|Overall Study||0
8191246|NCT02287415|20197045|P1|COMPLETED|Overall Study||13
8191247|NCT02287415|20197045|P1|STARTED|Overall Study||13
8191248|NCT02287402|20197051|P1|NOT COMPLETED|Follow-up||3
8191249|NCT02287402|20197051|P1|COMPLETED|Follow-up||103
8191250|NCT02287402|20197051|P1|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
8191251|NCT02287402|20197051|P1|NOT COMPLETED|Treatment Period||27
8191252|NCT02287402|20197051|P1|COMPLETED|Treatment Period||170
8191253|NCT02287402|20197051|P1|STARTED|Treatment Period||197
8191254|NCT02287376|20197066|P1|NOT COMPLETED|Overall Study||0
8191255|NCT02287376|20197066|P1|COMPLETED|Overall Study||25
8191256|NCT02287376|20197066|P1|STARTED|Overall Study||25
8191257|NCT02287350|20197109|P1|NOT COMPLETED|Overall Study||3
8191258|NCT02287350|20197109|P1|COMPLETED|Overall Study||48
8191259|NCT02287350|20197109|P1|STARTED|Overall Study||51
8191260|NCT02287038|20197156|P2|NOT COMPLETED|Overall Study||3
8191261|NCT02287038|20197157|P1|NOT COMPLETED|Overall Study||5
8191262|NCT02287038|20197156|P2|COMPLETED|Overall Study||18
8191263|NCT02287038|20197157|P1|COMPLETED|Overall Study||18
8191264|NCT02287038|20197156|P2|STARTED|Overall Study||21
8191265|NCT02287038|20197157|P1|STARTED|Overall Study||23
8191266|NCT02287025|20197167|P2|NOT COMPLETED|Overall Study||9
8191267|NCT02287025|20197168|P1|NOT COMPLETED|Overall Study||10
8191268|NCT02287025|20197167|P2|COMPLETED|Overall Study||2
8191269|NCT02287025|20197168|P1|COMPLETED|Overall Study||2
8191270|NCT02287025|20197167|P2|STARTED|Overall Study||11
8191271|NCT02287025|20197168|P1|STARTED|Overall Study||12
8191272|NCT02286960|20197179|P2|NOT COMPLETED|Overall Study||3
8191273|NCT02286960|20197180|P1|NOT COMPLETED|Overall Study||3
8191274|NCT02286960|20197179|P2|COMPLETED|Overall Study||14
8191275|NCT02286960|20197180|P1|COMPLETED|Overall Study||16
8191276|NCT02286960|20197179|P2|STARTED|Overall Study||17
8191277|NCT02286960|20197180|P1|STARTED|Overall Study||19
8191278|NCT02286947|20197192|P1|NOT COMPLETED|Overall Study||2
8191279|NCT02286947|20197192|P1|COMPLETED|Overall Study||22
8191280|NCT02286947|20197192|P1|STARTED|Overall Study||24
8191281|NCT02286921|20197203|P2|NOT COMPLETED|Overall Study||0
8191282|NCT02286921|20197204|P1|NOT COMPLETED|Overall Study||0
8191283|NCT02286921|20197203|P2|COMPLETED|Overall Study||101
8191284|NCT02286921|20197204|P1|COMPLETED|Overall Study||94
8191285|NCT02286921|20197203|P2|STARTED|Overall Study||101
8191286|NCT02286921|20197204|P1|STARTED|Overall Study||94
8191287|NCT02286895|20197238|P2|NOT COMPLETED|Assessed for Measles Seroconversion||39
8191288|NCT02286895|20197239|P1|NOT COMPLETED|Assessed for Measles Seroconversion||48
8191289|NCT02286895|20197238|P2|COMPLETED|Assessed for Measles Seroconversion||261
8191290|NCT02286895|20197239|P1|COMPLETED|Assessed for Measles Seroconversion||252
8191291|NCT02286895|20197238|P2|STARTED|Assessed for Measles Seroconversion||300
8191292|NCT02286895|20197239|P1|STARTED|Assessed for Measles Seroconversion||300
8191293|NCT02286895|20197238|P2|NOT COMPLETED|Randomized and Vaccinated||0
8191294|NCT02286895|20197239|P1|NOT COMPLETED|Randomized and Vaccinated||0
8191295|NCT02286895|20197238|P2|COMPLETED|Randomized and Vaccinated||300
8191296|NCT02286895|20197239|P1|COMPLETED|Randomized and Vaccinated||300
8191297|NCT02286895|20197238|P2|STARTED|Randomized and Vaccinated||300
8191298|NCT02286895|20197239|P1|STARTED|Randomized and Vaccinated||300
8191299|NCT02286726|20197284|P3|NOT COMPLETED|Overall Study||0
8191300|NCT02286726|20197285|P2|NOT COMPLETED|Overall Study||0
8191301|NCT02286726|20197286|P1|NOT COMPLETED|Overall Study||0
8191302|NCT02286726|20197284|P3|COMPLETED|Overall Study||16
8191303|NCT02286726|20197285|P2|COMPLETED|Overall Study||24
8191304|NCT02286726|20197286|P1|COMPLETED|Overall Study||16
8191305|NCT02286726|20197284|P3|STARTED|Overall Study||16
8191306|NCT02286726|20197285|P2|STARTED|Overall Study||24
8191307|NCT02286726|20197286|P1|STARTED|Overall Study||16
8191326|NCT02286518|20197326|P14|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191327|NCT02286518|20197327|P13|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191328|NCT02286518|20197328|P12|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191329|NCT02286518|20197329|P11|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191330|NCT02286518|20197330|P10|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191331|NCT02286518|20197331|P9|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191332|NCT02286518|20197332|P8|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191333|NCT02286518|20197333|P7|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191334|NCT02286518|20197334|P6|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191335|NCT02286518|20197335|P5|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191336|NCT02286518|20197336|P4|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191337|NCT02286518|20197337|P3|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191338|NCT02286518|20197338|P2|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191339|NCT02286518|20197339|P1|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191340|NCT02286518|20197326|P14|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191341|NCT02286518|20197327|P13|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191342|NCT02286518|20197328|P12|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191343|NCT02286518|20197329|P11|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191344|NCT02286518|20197330|P10|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191345|NCT02286518|20197331|P9|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
8191346|NCT02286518|20197332|P8|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
8191347|NCT02286518|20197333|P7|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191348|NCT02286518|20197334|P6|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191349|NCT02286518|20197335|P5|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191350|NCT02286518|20197336|P4|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191351|NCT02286518|20197337|P3|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191352|NCT02286518|20197338|P2|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191353|NCT02286518|20197339|P1|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
8191354|NCT02286518|20197326|P14|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191355|NCT02286518|20197327|P13|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191356|NCT02286518|20197328|P12|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191357|NCT02286518|20197329|P11|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191358|NCT02286518|20197330|P10|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191359|NCT02286518|20197331|P9|STARTED|Crossover Treatment (Part 2: 3 Days)||6
8191360|NCT02286518|20197332|P8|STARTED|Crossover Treatment (Part 2: 3 Days)||6
8191361|NCT02286518|20197333|P7|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191362|NCT02286518|20197334|P6|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191363|NCT02286518|20197335|P5|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191364|NCT02286518|20197336|P4|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191365|NCT02286518|20197337|P3|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191366|NCT02286518|20197338|P2|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191367|NCT02286518|20197339|P1|STARTED|Crossover Treatment (Part 2: 3 Days)||0
8191368|NCT02286518|20197326|P14|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191369|NCT02286518|20197327|P13|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191370|NCT02286518|20197328|P12|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191371|NCT02286518|20197329|P11|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191372|NCT02286518|20197330|P10|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191373|NCT02286518|20197331|P9|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191374|NCT02286518|20197332|P8|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191375|NCT02286518|20197333|P7|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191376|NCT02286518|20197334|P6|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191377|NCT02286518|20197335|P5|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191378|NCT02286518|20197336|P4|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191379|NCT02286518|20197337|P3|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191380|NCT02286518|20197338|P2|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191381|NCT02286518|20197339|P1|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191382|NCT02286518|20197326|P14|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191383|NCT02286518|20197327|P13|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191384|NCT02286518|20197328|P12|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191385|NCT02286518|20197329|P11|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191386|NCT02286518|20197330|P10|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191387|NCT02286518|20197331|P9|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
8191388|NCT02286518|20197332|P8|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
8191389|NCT02286518|20197333|P7|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191390|NCT02286518|20197334|P6|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191391|NCT02286518|20197335|P5|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191392|NCT02286518|20197336|P4|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191393|NCT02286518|20197337|P3|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191394|NCT02286518|20197338|P2|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191395|NCT02286518|20197339|P1|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
8191396|NCT02286518|20197326|P14|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191397|NCT02286518|20197327|P13|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191398|NCT02286518|20197328|P12|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191399|NCT02286518|20197329|P11|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191400|NCT02286518|20197330|P10|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191401|NCT02286518|20197331|P9|STARTED|Washout Crossover Period(Part 2:14 Days)||6
8191402|NCT02286518|20197332|P8|STARTED|Washout Crossover Period(Part 2:14 Days)||6
8191403|NCT02286518|20197333|P7|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191404|NCT02286518|20197334|P6|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191405|NCT02286518|20197335|P5|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191406|NCT02286518|20197336|P4|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191407|NCT02286518|20197337|P3|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191408|NCT02286518|20197338|P2|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191409|NCT02286518|20197339|P1|STARTED|Washout Crossover Period(Part 2:14 Days)||0
8191410|NCT02286518|20197326|P14|NOT COMPLETED|All Parts (16 Days)||0
8191411|NCT02286518|20197327|P13|NOT COMPLETED|All Parts (16 Days)||0
8191412|NCT02286518|20197328|P12|NOT COMPLETED|All Parts (16 Days)||0
8191413|NCT02286518|20197329|P11|NOT COMPLETED|All Parts (16 Days)||0
8191414|NCT02286518|20197330|P10|NOT COMPLETED|All Parts (16 Days)||0
8191415|NCT02286518|20197331|P9|NOT COMPLETED|All Parts (16 Days)||0
8191416|NCT02286518|20197332|P8|NOT COMPLETED|All Parts (16 Days)||0
8191417|NCT02286518|20197333|P7|NOT COMPLETED|All Parts (16 Days)||0
8191418|NCT02286518|20197334|P6|NOT COMPLETED|All Parts (16 Days)||0
8191419|NCT02286518|20197335|P5|NOT COMPLETED|All Parts (16 Days)||0
8191420|NCT02286518|20197336|P4|NOT COMPLETED|All Parts (16 Days)||0
8191421|NCT02286518|20197337|P3|NOT COMPLETED|All Parts (16 Days)||0
8191422|NCT02286518|20197338|P2|NOT COMPLETED|All Parts (16 Days)||0
8191423|NCT02286518|20197339|P1|NOT COMPLETED|All Parts (16 Days)||0
8191424|NCT02286518|20197326|P14|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191425|NCT02286518|20197327|P13|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191426|NCT02286518|20197328|P12|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191427|NCT02286518|20197329|P11|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191428|NCT02286518|20197330|P10|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
8191429|NCT02286518|20197331|P9|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
8191430|NCT02286518|20197332|P8|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
8191431|NCT02286518|20197333|P7|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191432|NCT02286518|20197334|P6|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191433|NCT02286518|20197335|P5|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191434|NCT02286518|20197336|P4|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191435|NCT02286518|20197337|P3|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191436|NCT02286518|20197338|P2|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191437|NCT02286518|20197339|P1|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
8191438|NCT02286518|20197326|P14|STARTED|All Parts (16 Days)||6
8191439|NCT02286518|20197327|P13|STARTED|All Parts (16 Days)||6
8191440|NCT02286518|20197328|P12|STARTED|All Parts (16 Days)||6
8191441|NCT02286518|20197329|P11|STARTED|All Parts (16 Days)||6
8191442|NCT02286518|20197330|P10|STARTED|All Parts (16 Days)||4
8191443|NCT02286518|20197331|P9|STARTED|All Parts (16 Days)||6
8191444|NCT02286518|20197332|P8|STARTED|All Parts (16 Days)||6
8191445|NCT02286518|20197333|P7|STARTED|All Parts (16 Days)||6
8191446|NCT02286518|20197334|P6|STARTED|All Parts (16 Days)||6
8191447|NCT02286518|20197335|P5|STARTED|All Parts (16 Days)||6
8191448|NCT02286518|20197336|P4|STARTED|All Parts (16 Days)||6
8191449|NCT02286518|20197337|P3|STARTED|All Parts (16 Days)||6
8191450|NCT02286518|20197338|P2|STARTED|All Parts (16 Days)||6
8191451|NCT02286518|20197339|P1|STARTED|All Parts (16 Days)||6
8191452|NCT02286466|20197481|P2|NOT COMPLETED|Overall Study||10
8191453|NCT02286466|20197482|P1|NOT COMPLETED|Overall Study||7
8191454|NCT02286466|20197481|P2|COMPLETED|Overall Study||63
8191455|NCT02286466|20197482|P1|COMPLETED|Overall Study||65
8191456|NCT02286466|20197481|P2|Post Self-report|Overall Study||68
8191457|NCT02286466|20197482|P1|Post Self-report|Overall Study||67
8191458|NCT02286466|20197481|P2|Baseline Clinician Assessment|Overall Study||72
8191459|NCT02286466|20197482|P1|Baseline Clinician Assessment|Overall Study||72
8191460|NCT02286466|20197481|P2|STARTED|Overall Study||73
8191461|NCT02286466|20197482|P1|STARTED|Overall Study||72
8191462|NCT02286193|20197494|P1|NOT COMPLETED|Overall Study||204
8191463|NCT02286193|20197494|P1|COMPLETED|Overall Study||418
8191464|NCT02286193|20197494|P1|STARTED|Overall Study||622
8191465|NCT02286102|20197501|P2|NOT COMPLETED|Overall Study||1
8191466|NCT02286102|20197502|P1|NOT COMPLETED|Overall Study||1
8191467|NCT02286102|20197501|P2|COMPLETED|Overall Study||33
8191468|NCT02286102|20197502|P1|COMPLETED|Overall Study||35
8191469|NCT02286102|20197501|P2|STARTED|Overall Study||34
8191470|NCT02286102|20197502|P1|STARTED|Overall Study||36
8191471|NCT02285998|20197514|P2|NOT COMPLETED|Overall Study||253
8191472|NCT02285998|20197515|P1|NOT COMPLETED|Overall Study||246
8191473|NCT02285998|20197514|P2|COMPLETED|Overall Study||4236
8191474|NCT02285998|20197515|P1|COMPLETED|Overall Study||4228
8191475|NCT02285998|20197514|P2|STARTED|Overall Study||4489
8191476|NCT02285998|20197515|P1|STARTED|Overall Study||4474
8191477|NCT02285920|20197543|P4|NOT COMPLETED|Overall Study||1
8191478|NCT02285920|20197544|P3|NOT COMPLETED|Overall Study||5
8191479|NCT02285920|20197545|P2|NOT COMPLETED|Overall Study||4
8191480|NCT02285920|20197546|P1|NOT COMPLETED|Overall Study||4
8191481|NCT02285920|20197543|P4|COMPLETED|Overall Study||24
8191482|NCT02285920|20197544|P3|COMPLETED|Overall Study||21
8191483|NCT02285920|20197545|P2|COMPLETED|Overall Study||23
8191484|NCT02285920|20197546|P1|COMPLETED|Overall Study||47
8191485|NCT02285920|20197543|P4|STARTED|Overall Study||25
8191486|NCT02285920|20197544|P3|STARTED|Overall Study||26
8191487|NCT02285920|20197545|P2|STARTED|Overall Study||27
8191488|NCT02285920|20197546|P1|STARTED|Overall Study||51
8191489|NCT02285907|20197608|P1|NOT COMPLETED|Overall Study||0
8191490|NCT02285907|20197608|P1|COMPLETED|Overall Study||21
8191491|NCT02285907|20197608|P1|Began 4th Intervention|Overall Study||21
8191492|NCT02285907|20197608|P1|Began 3rd Intervention|Overall Study||21
8191493|NCT02285907|20197608|P1|Began 2nd Intervention|Overall Study||21
8191494|NCT02285907|20197608|P1|Began 1st Intervention|Overall Study||21
8191495|NCT02285907|20197608|P1|STARTED|Overall Study||21
8191496|NCT02285855|20197636|P2|NOT COMPLETED|Overall Study||1
8191497|NCT02285855|20197637|P1|NOT COMPLETED|Overall Study||2
8191498|NCT02285855|20197636|P2|COMPLETED|Overall Study||1
8191499|NCT02285855|20197637|P1|COMPLETED|Overall Study||14
8191500|NCT02285855|20197636|P2|Randomized|Overall Study||2
8191501|NCT02285855|20197637|P1|Randomized|Overall Study||16
8191502|NCT02285855|20197636|P2|STARTED|Overall Study||2
8191503|NCT02285855|20197637|P1|STARTED|Overall Study||16
8191504|NCT02285777|20197645|P2|NOT COMPLETED|Overall Study||3
8191505|NCT02285777|20197646|P1|NOT COMPLETED|Overall Study||5
8191506|NCT02285777|20197645|P2|COMPLETED|Overall Study||91
8191507|NCT02285777|20197646|P1|COMPLETED|Overall Study||90
8191508|NCT02285777|20197645|P2|STARTED|Overall Study||94
8191509|NCT02285777|20197646|P1|STARTED|Overall Study||95
8191510|NCT02285634|20197702|P4|NOT COMPLETED|Overall Study||1
8191511|NCT02285634|20197703|P3|NOT COMPLETED|Overall Study||4
8191512|NCT02285634|20197704|P2|NOT COMPLETED|Overall Study||0
8191513|NCT02285634|20197705|P1|NOT COMPLETED|Overall Study||0
8191514|NCT02285634|20197702|P4|COMPLETED|Overall Study||17
8191515|NCT02285634|20197703|P3|COMPLETED|Overall Study||11
8191516|NCT02285634|20197704|P2|COMPLETED|Overall Study||20
8191517|NCT02285634|20197705|P1|COMPLETED|Overall Study||15
8191518|NCT02285634|20197702|P4|STARTED|Overall Study||18
8191519|NCT02285634|20197703|P3|STARTED|Overall Study||15
8191520|NCT02285634|20197704|P2|STARTED|Overall Study||20
8191521|NCT02285634|20197705|P1|STARTED|Overall Study||15
8191522|NCT02285283|20197729|P2|NOT COMPLETED|Overall Study||9
8191523|NCT02285283|20197730|P1|NOT COMPLETED|Overall Study||4
8191524|NCT02285283|20197729|P2|COMPLETED|Overall Study||20
8191525|NCT02285283|20197730|P1|COMPLETED|Overall Study||25
8191526|NCT02285283|20197729|P2|STARTED|Overall Study||29
8191527|NCT02285283|20197730|P1|STARTED|Overall Study||29
8191528|NCT02285270|20197738|P1|NOT COMPLETED|Overall Study||5
8191529|NCT02285270|20197738|P1|COMPLETED|Overall Study||5
8191530|NCT02285270|20197738|P1|STARTED|Overall Study||10
8191531|NCT02285153|20197746|P2|NOT COMPLETED|Overall Study||0
8191532|NCT02285153|20197747|P1|NOT COMPLETED|Overall Study||1
8191533|NCT02285153|20197746|P2|COMPLETED|Overall Study||8
8191534|NCT02285153|20197747|P1|COMPLETED|Overall Study||6
8191535|NCT02285153|20197746|P2|STARTED|Overall Study||8
8191536|NCT02285153|20197747|P1|STARTED|Overall Study||7
8191546|NCT02285062|20197829|P2|NOT COMPLETED|Overall Study||84
8191547|NCT02285062|20197830|P1|NOT COMPLETED|Overall Study||78
8191548|NCT02285062|20197829|P2|COMPLETED|Overall Study||201
8191549|NCT02285062|20197830|P1|COMPLETED|Overall Study||207
8191550|NCT02285062|20197829|P2|Ongoing Study Treatment|Overall Study||0
8191551|NCT02285062|20197830|P1|Ongoing Study Treatment|Overall Study||0
8191552|NCT02285062|20197829|P2|Received Study Treatment|Overall Study||284
8191553|NCT02285062|20197830|P1|Received Study Treatment|Overall Study||283
8191554|NCT02285062|20197829|P2|STARTED|Overall Study||285
8191555|NCT02285062|20197830|P1|STARTED|Overall Study||285
8191556|NCT02285023|20197866|P1|NOT COMPLETED|Overall Study||0
8191557|NCT02285023|20197866|P1|COMPLETED|Overall Study||166
8191558|NCT02285023|20197866|P1|STARTED|Overall Study||166
8191559|NCT02285010|20197878|P2|NOT COMPLETED|Overall Study||1
8191560|NCT02285010|20197879|P1|NOT COMPLETED|Overall Study||5
8191561|NCT02285010|20197878|P2|COMPLETED|Overall Study||61
8191562|NCT02285010|20197879|P1|COMPLETED|Overall Study||58
8191563|NCT02285010|20197878|P2|STARTED|Overall Study||62
8191564|NCT02285010|20197879|P1|STARTED|Overall Study||63
8191565|NCT02284906|20197896|P3|NOT COMPLETED|Overall Study||19
8191566|NCT02284906|20197897|P2|NOT COMPLETED|Overall Study||18
8191567|NCT02284906|20197898|P1|NOT COMPLETED|Overall Study||3
8191568|NCT02284906|20197896|P3|COMPLETED|Overall Study||0
8191569|NCT02284906|20197897|P2|COMPLETED|Overall Study||0
8191570|NCT02284906|20197898|P1|COMPLETED|Overall Study||0
8191571|NCT02284906|20197896|P3|STARTED|Overall Study||19
8191572|NCT02284906|20197897|P2|STARTED|Overall Study||18
8191573|NCT02284906|20197898|P1|STARTED|Overall Study||3
8191574|NCT02284893|20197911|P2|NOT COMPLETED|52 Week (Long Term)||13
8191575|NCT02284893|20197912|P1|NOT COMPLETED|52 Week (Long Term)||11
8191576|NCT02284893|20197911|P2|COMPLETED|52 Week (Long Term)||180
8191577|NCT02284893|20197912|P1|COMPLETED|52 Week (Long Term)||198
8191578|NCT02284893|20197911|P2|STARTED|52 Week (Long Term)||193
8191579|NCT02284893|20197912|P1|STARTED|52 Week (Long Term)||209
8191580|NCT02284893|20197911|P2|NOT COMPLETED|26 Week (Short Term)||31
8191581|NCT02284893|20197912|P1|NOT COMPLETED|26 Week (Short Term)||19
8191582|NCT02284893|20197911|P2|COMPLETED|26 Week (Short Term)||198
8191583|NCT02284893|20197912|P1|COMPLETED|26 Week (Short Term)||213
8191584|NCT02284893|20197911|P2|STARTED|26 Week (Short Term)||229
8191585|NCT02284893|20197912|P1|STARTED|26 Week (Short Term)||232
8191586|NCT02284880|20197926|P4|NOT COMPLETED|Overall Study||0
8191587|NCT02284880|20197927|P3|NOT COMPLETED|Overall Study||2
8191588|NCT02284880|20197928|P2|NOT COMPLETED|Overall Study||0
8191589|NCT02284880|20197929|P1|NOT COMPLETED|Overall Study||0
8191590|NCT02284880|20197926|P4|COMPLETED|Overall Study||10
8191591|NCT02284880|20197927|P3|COMPLETED|Overall Study||8
8191592|NCT02284880|20197928|P2|COMPLETED|Overall Study||9
8191593|NCT02284880|20197929|P1|COMPLETED|Overall Study||11
8191594|NCT02284880|20197926|P4|Second Period (4 Days)|Overall Study||10
8191595|NCT02284880|20197927|P3|Second Period (4 Days)|Overall Study||8
8191596|NCT02284880|20197928|P2|Second Period (4 Days)|Overall Study||9
8191597|NCT02284880|20197929|P1|Second Period (4 Days)|Overall Study||11
8191598|NCT02284880|20197926|P4|Wash-out Period (7 Days)|Overall Study||10
8191599|NCT02284880|20197927|P3|Wash-out Period (7 Days)|Overall Study||10
8191600|NCT02284880|20197928|P2|Wash-out Period (7 Days)|Overall Study||9
8191601|NCT02284880|20197929|P1|Wash-out Period (7 Days)|Overall Study||11
8191602|NCT02284880|20197926|P4|First Period (4 Days)|Overall Study||10
8191603|NCT02284880|20197927|P3|First Period (4 Days)|Overall Study||10
8191604|NCT02284880|20197928|P2|First Period (4 Days)|Overall Study||9
8191605|NCT02284880|20197929|P1|First Period (4 Days)|Overall Study||11
8191606|NCT02284880|20197926|P4|STARTED|Overall Study||10
8191607|NCT02284880|20197927|P3|STARTED|Overall Study||10
8191608|NCT02284880|20197928|P2|STARTED|Overall Study||9
8191609|NCT02284880|20197929|P1|STARTED|Overall Study||11
8191610|NCT02284867|20197945|P2|NOT COMPLETED|Overall Study||0
8191611|NCT02284867|20197946|P1|NOT COMPLETED|Overall Study||0
8191612|NCT02284867|20197945|P2|COMPLETED|Overall Study||30
8191613|NCT02284867|20197946|P1|COMPLETED|Overall Study||30
8191614|NCT02284867|20197945|P2|STARTED|Overall Study||30
8191615|NCT02284867|20197946|P1|STARTED|Overall Study||30
8191616|NCT02284854|20197956|P2|NOT COMPLETED|Overall Study||0
8191617|NCT02284854|20197957|P1|NOT COMPLETED|Overall Study||5
8191618|NCT02284854|20197956|P2|COMPLETED|Overall Study||20
8191619|NCT02284854|20197957|P1|COMPLETED|Overall Study||18
8191620|NCT02284854|20197956|P2|STARTED|Overall Study||20
8191621|NCT02284854|20197957|P1|STARTED|Overall Study||23
8191622|NCT02284828|20197974|P1|NOT COMPLETED|Overall Study||4
8191623|NCT02284828|20197974|P1|COMPLETED|Overall Study||22
8191624|NCT02284828|20197974|P1|STARTED|Overall Study||26
8191625|NCT02284568|20197989|P3|NOT COMPLETED|Overall Study||95
8191626|NCT02284568|20197990|P2|NOT COMPLETED|Overall Study||46
8191627|NCT02284568|20197991|P1|NOT COMPLETED|Overall Study||31
8191628|NCT02284568|20197989|P3|COMPLETED|Overall Study||0
8191629|NCT02284568|20197990|P2|COMPLETED|Overall Study||93
8191630|NCT02284568|20197991|P1|COMPLETED|Overall Study||109
8191631|NCT02284568|20197989|P3|Completed Week 48 MRI - on Treatment|Overall Study||0
8191632|NCT02284568|20197990|P2|Completed Week 48 MRI - on Treatment|Overall Study||107
8191633|NCT02284568|20197991|P1|Completed Week 48 MRI - on Treatment|Overall Study||113
8191634|NCT02284568|20197989|P3|Safety Population|Overall Study||95
8191635|NCT02284568|20197990|P2|Safety Population|Overall Study||138
8191636|NCT02284568|20197991|P1|Safety Population|Overall Study||140
8191637|NCT02284568|20197989|P3|STARTED|Overall Study|Intent to treat (ITT) population|95
8191638|NCT02284568|20197990|P2|STARTED|Overall Study|Intent to treat (ITT) population|139
8191639|NCT02284568|20197991|P1|STARTED|Overall Study|Intent to treat (ITT) population|140
8191640|NCT02284555|20198017|P1|NOT COMPLETED|Overall Study||0
8191641|NCT02284555|20198017|P1|COMPLETED|Overall Study||12
8191642|NCT02284555|20198017|P1|STARTED|Overall Study||12
8191651|NCT02284464|20198035|P2|NOT COMPLETED|Overall Study||17
8191652|NCT02284464|20198036|P1|NOT COMPLETED|Overall Study||13
8191653|NCT02284464|20198035|P2|COMPLETED|Overall Study||36
8191654|NCT02284464|20198036|P1|COMPLETED|Overall Study||39
8191655|NCT02284464|20198035|P2|STARTED|Overall Study||53
8191656|NCT02284464|20198036|P1|STARTED|Overall Study||52
8191657|NCT02284399|20198064|P2|NOT COMPLETED|Overall Study||0
8191658|NCT02284399|20198065|P1|NOT COMPLETED|Overall Study||0
8191659|NCT02284399|20198064|P2|COMPLETED|Overall Study||3074
8191660|NCT02284399|20198065|P1|COMPLETED|Overall Study||1414
8191661|NCT02284399|20198064|P2|STARTED|Overall Study||3074
8191662|NCT02284399|20198065|P1|STARTED|Overall Study||1414
8191666|NCT02284373|20198085|P3|NOT COMPLETED|Overall Study||0
8191667|NCT02284373|20198086|P2|NOT COMPLETED|Overall Study||3
8191668|NCT02284373|20198087|P1|NOT COMPLETED|Overall Study||0
8191669|NCT02284373|20198085|P3|COMPLETED|Overall Study||29
8191670|NCT02284373|20198086|P2|COMPLETED|Overall Study||2
8191671|NCT02284373|20198087|P1|COMPLETED|Overall Study||5
8191672|NCT02284373|20198085|P3|STARTED|Overall Study||29
8191673|NCT02284373|20198086|P2|STARTED|Overall Study||5
8191674|NCT02284373|20198087|P1|STARTED|Overall Study||5
8191675|NCT02284347|20198095|P1|NOT COMPLETED|Overall Study||3
8191676|NCT02284347|20198095|P1|COMPLETED|Overall Study||48
8191677|NCT02284347|20198095|P1|STARTED|Overall Study||51
8191678|NCT02284243|20198103|P2|NOT COMPLETED|Overall Study||3
8191679|NCT02284243|20198104|P1|NOT COMPLETED|Overall Study||4
8191680|NCT02284243|20198103|P2|COMPLETED|Overall Study||81
8191681|NCT02284243|20198104|P1|COMPLETED|Overall Study||80
8191682|NCT02284243|20198103|P2|STARTED|Overall Study||84
8191683|NCT02284243|20198104|P1|STARTED|Overall Study||84
8191684|NCT02284178|20198124|P2|NOT COMPLETED|Overall Study||54
8191685|NCT02284178|20198125|P1|NOT COMPLETED|Overall Study||49
8191686|NCT02284178|20198124|P2|COMPLETED|Overall Study||204
8191687|NCT02284178|20198125|P1|COMPLETED|Overall Study||206
8191688|NCT02284178|20198124|P2|STARTED|Overall Study||258
8191689|NCT02284178|20198125|P1|STARTED|Overall Study||255
8191690|NCT02284165|20198148|P3|NOT COMPLETED|Overall Study||0
8191691|NCT02284165|20198149|P2|NOT COMPLETED|Overall Study||0
8191692|NCT02284165|20198150|P1|NOT COMPLETED|Overall Study||0
8191693|NCT02284165|20198148|P3|COMPLETED|Overall Study||70996
8191694|NCT02284165|20198149|P2|COMPLETED|Overall Study||40272
8191695|NCT02284165|20198150|P1|COMPLETED|Overall Study||36448
8191696|NCT02284165|20198148|P3|STARTED|Overall Study||70996
8191697|NCT02284165|20198149|P2|STARTED|Overall Study||40272
8191698|NCT02284165|20198150|P1|STARTED|Overall Study||36448
8191705|NCT02284009|20198179|P2|NOT COMPLETED|Overall Study||10
8191706|NCT02284009|20198180|P1|NOT COMPLETED|Overall Study||6
8191707|NCT02284009|20198179|P2|COMPLETED|Overall Study||40
8191708|NCT02284009|20198180|P1|COMPLETED|Overall Study||11
8191709|NCT02284009|20198179|P2|STARTED|Overall Study||50
8191710|NCT02284009|20198180|P1|STARTED|Overall Study||17
8191711|NCT02283840|20198225|P3|NOT COMPLETED|Overall Study||0
8191712|NCT02283840|20198226|P2|NOT COMPLETED|Overall Study||1
8191713|NCT02283840|20198227|P1|NOT COMPLETED|Overall Study||0
8191714|NCT02283840|20198225|P3|COMPLETED|Overall Study||20
8191715|NCT02283840|20198226|P2|COMPLETED|Overall Study||19
8191716|NCT02283840|20198227|P1|COMPLETED|Overall Study||20
8191717|NCT02283840|20198225|P3|STARTED|Overall Study||20
8191718|NCT02283840|20198226|P2|STARTED|Overall Study||20
8191719|NCT02283840|20198227|P1|STARTED|Overall Study||20
8191720|NCT02283827|20198246|P2|NOT COMPLETED|Overall Study||3
8191721|NCT02283827|20198247|P1|NOT COMPLETED|Overall Study||1
8191722|NCT02283827|20198246|P2|COMPLETED|Overall Study||13
8191723|NCT02283827|20198247|P1|COMPLETED|Overall Study||15
8191724|NCT02283827|20198246|P2|STARTED|Overall Study||16
8191725|NCT02283827|20198247|P1|STARTED|Overall Study||16
8191726|NCT02283814|20198264|P2|NOT COMPLETED|Overall Study||2
8191727|NCT02283814|20198265|P1|NOT COMPLETED|Overall Study||3
8191728|NCT02283814|20198264|P2|COMPLETED|Overall Study||14
8191729|NCT02283814|20198265|P1|COMPLETED|Overall Study||13
8191730|NCT02283814|20198264|P2|STARTED|Overall Study||16
8191731|NCT02283814|20198265|P1|STARTED|Overall Study||16
8191732|NCT02283788|20198279|P4|NOT COMPLETED|Overall Study||2
8191733|NCT02283788|20198280|P3|NOT COMPLETED|Overall Study||5
8191734|NCT02283788|20198281|P2|NOT COMPLETED|Overall Study||4
8191735|NCT02283788|20198282|P1|NOT COMPLETED|Overall Study||1
8191736|NCT02283788|20198279|P4|COMPLETED|Overall Study||14
8191737|NCT02283788|20198280|P3|COMPLETED|Overall Study||12
8191738|NCT02283788|20198281|P2|COMPLETED|Overall Study||13
8191739|NCT02283788|20198282|P1|COMPLETED|Overall Study||16
8191740|NCT02283788|20198279|P4|STARTED|Overall Study||16
8191741|NCT02283788|20198280|P3|STARTED|Overall Study||17
8191742|NCT02283788|20198281|P2|STARTED|Overall Study||17
8191743|NCT02283788|20198282|P1|STARTED|Overall Study||17
8191744|NCT02283762|20198294|P2|NOT COMPLETED|Long-term Extension Phase (LTE)||14
8191745|NCT02283762|20198295|P1|NOT COMPLETED|Long-term Extension Phase (LTE)||10
8191746|NCT02283762|20198294|P2|COMPLETED|Long-term Extension Phase (LTE)||31
8191747|NCT02283762|20198295|P1|COMPLETED|Long-term Extension Phase (LTE)||32
8191748|NCT02283762|20198294|P2|STARTED|Long-term Extension Phase (LTE)|Of the 46 patients who completed the main treatment phase, 1 patient did not enter the LTE phase|45
8191749|NCT02283762|20198295|P1|STARTED|Long-term Extension Phase (LTE)||42
8191750|NCT02283762|20198294|P2|NOT COMPLETED|Main Treatment Phase (MT)||15
8191751|NCT02283762|20198295|P1|NOT COMPLETED|Main Treatment Phase (MT)||18
8191752|NCT02283762|20198294|P2|COMPLETED|Main Treatment Phase (MT)||46
8191753|NCT02283762|20198295|P1|COMPLETED|Main Treatment Phase (MT)||42
8191754|NCT02283762|20198294|P2|STARTED|Main Treatment Phase (MT)||61
8191755|NCT02283762|20198295|P1|STARTED|Main Treatment Phase (MT)||60
8191759|NCT02283658|20198319|P1|NOT COMPLETED|Overall Study||1
8191760|NCT02283658|20198319|P1|COMPLETED|Overall Study||19
8191761|NCT02283658|20198319|P1|STARTED|Overall Study||20
8191762|NCT02283528|20198330|P2|NOT COMPLETED|Overall Study||0
8191763|NCT02283528|20198331|P1|NOT COMPLETED|Overall Study||0
8191764|NCT02283528|20198330|P2|COMPLETED|Overall Study||24
8191765|NCT02283528|20198331|P1|COMPLETED|Overall Study||26
8191766|NCT02283528|20198330|P2|STARTED|Overall Study||24
8191767|NCT02283528|20198331|P1|STARTED|Overall Study||26
8191768|NCT02283411|20198341|P1|NOT COMPLETED|Overall Study||31
8191769|NCT02283411|20198341|P1|COMPLETED|Overall Study||125
8191770|NCT02283411|20198341|P1|STARTED|Overall Study||156
8191774|NCT02282982|20198410|P1|NOT COMPLETED|Overall Study||206
8191775|NCT02282982|20198410|P1|COMPLETED|Overall Study||153
8191776|NCT02282982|20198410|P1|Attended Follow-up Visit|Overall Study||349
8191777|NCT02282982|20198410|P1|Attended Visit 5|Overall Study||83
8191778|NCT02282982|20198410|P1|Attended Visit 4|Overall Study||194
8191779|NCT02282982|20198410|P1|Attended Visit 3|Overall Study||298
8191780|NCT02282982|20198410|P1|Attended Visit 2|Overall Study||341
8191781|NCT02282982|20198410|P1|Attended Visit 1|Overall Study||359
8191782|NCT02282982|20198410|P1|STARTED|Overall Study||359
8191783|NCT02282930|20198425|P1|NOT COMPLETED|Overall Study||1
8191784|NCT02282930|20198425|P1|COMPLETED|Overall Study||19
8191785|NCT02282930|20198425|P1|STARTED|Overall Study||20
8191786|NCT02282904|20198430|P1|NOT COMPLETED|Overall Study||0
8191787|NCT02282904|20198430|P1|COMPLETED|Overall Study|Patient accrual was stopped early, and the protocol closed after completing followup|7
8191788|NCT02282904|20198430|P1|STARTED|Overall Study||7
8191789|NCT02282813|20198438|P3|NOT COMPLETED|Overall Study||3
8191790|NCT02282813|20198439|P2|NOT COMPLETED|Overall Study||23
8191791|NCT02282813|20198440|P1|NOT COMPLETED|Overall Study||12
8191792|NCT02282813|20198438|P3|COMPLETED|Overall Study||39
8191793|NCT02282813|20198439|P2|COMPLETED|Overall Study||130
8191794|NCT02282813|20198440|P1|COMPLETED|Overall Study||91
8191795|NCT02282813|20198438|P3|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
8191796|NCT02282813|20198439|P2|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
8191797|NCT02282813|20198440|P1|STARTED|Overall Study|ITT Population|103
8191798|NCT02282722|20198459|P2|NOT COMPLETED|Overall Study||19
8191799|NCT02282722|20198460|P1|NOT COMPLETED|Overall Study||23
8191800|NCT02282722|20198459|P2|COMPLETED|Overall Study||73
8191801|NCT02282722|20198460|P1|COMPLETED|Overall Study||71
8191802|NCT02282722|20198459|P2|3-month Assessment|Overall Study||73
8191803|NCT02282722|20198460|P1|3-month Assessment|Overall Study||71
8191804|NCT02282722|20198459|P2|2-week Assessment|Overall Study||75
8191805|NCT02282722|20198460|P1|2-week Assessment|Overall Study||79
8191806|NCT02282722|20198459|P2|STARTED|Overall Study||92
8191807|NCT02282722|20198460|P1|STARTED|Overall Study||94
8191808|NCT02282631|20198486|P2|NOT COMPLETED|Overall Study||0
8191809|NCT02282631|20198487|P1|NOT COMPLETED|Overall Study||2
8191810|NCT02282631|20198486|P2|COMPLETED|Overall Study||15
8191811|NCT02282631|20198487|P1|COMPLETED|Overall Study||12
8191812|NCT02282631|20198486|P2|STARTED|Overall Study||15
8191813|NCT02282631|20198487|P1|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
8191814|NCT02282605|20198528|P3|NOT COMPLETED|Overall Study||0
8191815|NCT02282605|20198529|P2|NOT COMPLETED|Overall Study||0
8191816|NCT02282605|20198530|P1|NOT COMPLETED|Overall Study||3
8191817|NCT02282605|20198528|P3|COMPLETED|Overall Study||24
8191818|NCT02282605|20198529|P2|COMPLETED|Overall Study||12
8191819|NCT02282605|20198530|P1|COMPLETED|Overall Study||24
8191820|NCT02282605|20198528|P3|STARTED|Overall Study||24
8191821|NCT02282605|20198529|P2|STARTED|Overall Study||12
8191822|NCT02282605|20198530|P1|STARTED|Overall Study||27
8191823|NCT02282527|20198552|P2|NOT COMPLETED|Overall Study||1
8191824|NCT02282527|20198553|P1|NOT COMPLETED|Overall Study||1
8191825|NCT02282527|20198552|P2|COMPLETED|Overall Study||15
8191826|NCT02282527|20198553|P1|COMPLETED|Overall Study||15
8191827|NCT02282527|20198552|P2|STARTED|Overall Study||16
8191828|NCT02282527|20198553|P1|STARTED|Overall Study||16
8191829|NCT02282514|20198563|P1|NOT COMPLETED|Overall Study||0
8191830|NCT02282514|20198563|P1|COMPLETED|Overall Study||23
8191831|NCT02282514|20198563|P1|STARTED|Overall Study||23
8191832|NCT02282293|20198571|P2|NOT COMPLETED|Overall Study||3
8191833|NCT02282293|20198572|P1|NOT COMPLETED|Overall Study||3
8191834|NCT02282293|20198571|P2|COMPLETED|Overall Study||97
8191835|NCT02282293|20198572|P1|COMPLETED|Overall Study||97
8191836|NCT02282293|20198571|P2|STARTED|Overall Study||100
8191837|NCT02282293|20198572|P1|STARTED|Overall Study||100
8191838|NCT02282163|20198590|P1|NOT COMPLETED|Overall Study||1
8191839|NCT02282163|20198590|P1|COMPLETED|Overall Study||12
8191840|NCT02282163|20198590|P1|STARTED|Overall Study||13
8191841|NCT02282111|20198605|P2|NOT COMPLETED|Overall Study||8
8191842|NCT02282111|20198606|P1|NOT COMPLETED|Overall Study||7
8191843|NCT02282111|20198605|P2|COMPLETED|Overall Study||22
8191844|NCT02282111|20198606|P1|COMPLETED|Overall Study||19
8191845|NCT02282111|20198605|P2|STARTED|Overall Study||30
8191846|NCT02282111|20198606|P1|STARTED|Overall Study||26
8191858|NCT02281851|20198679|P2|NOT COMPLETED|Overall Study||0
8191859|NCT02281851|20198680|P1|NOT COMPLETED|Overall Study||0
8191860|NCT02281851|20198679|P2|COMPLETED|Overall Study||10
8191861|NCT02281851|20198680|P1|COMPLETED|Overall Study||4
8191862|NCT02281851|20198679|P2|STARTED|Overall Study||10
8191863|NCT02281851|20198680|P1|STARTED|Overall Study||4
8191864|NCT02281773|20198691|P5|NOT COMPLETED|Overall Study||30
8191865|NCT02281773|20198692|P4|NOT COMPLETED|Overall Study||21
8191866|NCT02281773|20198693|P3|NOT COMPLETED|Overall Study||18
8191867|NCT02281773|20198694|P2|NOT COMPLETED|Overall Study||15
8191868|NCT02281773|20198695|P1|NOT COMPLETED|Overall Study||11
8191869|NCT02281773|20198691|P5|COMPLETED|Overall Study||143
8191870|NCT02281773|20198692|P4|COMPLETED|Overall Study||65
8191871|NCT02281773|20198693|P3|COMPLETED|Overall Study||67
8191872|NCT02281773|20198694|P2|COMPLETED|Overall Study||70
8191873|NCT02281773|20198695|P1|COMPLETED|Overall Study||76
8191874|NCT02281773|20198691|P5|STARTED|Overall Study|Started are the treated patients|173
8191875|NCT02281773|20198692|P4|STARTED|Overall Study||86
8191876|NCT02281773|20198693|P3|STARTED|Overall Study||85
8191877|NCT02281773|20198694|P2|STARTED|Overall Study|Started are the treated patients|85
8191878|NCT02281773|20198695|P1|STARTED|Overall Study||87
8191879|NCT02281591|20198756|P4|NOT COMPLETED|Overall Study||0
8191880|NCT02281591|20198757|P3|NOT COMPLETED|Overall Study||0
8191881|NCT02281591|20198758|P2|NOT COMPLETED|Overall Study||0
8191882|NCT02281591|20198759|P1|NOT COMPLETED|Overall Study||0
8191883|NCT02281591|20198756|P4|COMPLETED|Overall Study||8
8191884|NCT02281591|20198757|P3|COMPLETED|Overall Study||8
8191885|NCT02281591|20198758|P2|COMPLETED|Overall Study||8
8191886|NCT02281591|20198759|P1|COMPLETED|Overall Study||8
8191887|NCT02281591|20198756|P4|STARTED|Overall Study||8
8191888|NCT02281591|20198757|P3|STARTED|Overall Study||8
8191889|NCT02281591|20198758|P2|STARTED|Overall Study||8
8191890|NCT02281591|20198759|P1|STARTED|Overall Study||8
8191891|NCT02281552|20198783|P2|NOT COMPLETED|Overall Study||10
8191892|NCT02281552|20198784|P1|NOT COMPLETED|Overall Study||4
8191893|NCT02281552|20198783|P2|COMPLETED|Overall Study||95
8191894|NCT02281552|20198784|P1|COMPLETED|Overall Study||100
8191895|NCT02281552|20198783|P2|STARTED|Overall Study||105
8191896|NCT02281552|20198784|P1|STARTED|Overall Study||104
8191897|NCT02281526|20198824|P2|NOT COMPLETED|Overall Study||0
8191898|NCT02281526|20198825|P1|NOT COMPLETED|Overall Study||1
8191899|NCT02281526|20198824|P2|COMPLETED|Overall Study||8
8191900|NCT02281526|20198825|P1|COMPLETED|Overall Study||8
8191901|NCT02281526|20198824|P2|STARTED|Overall Study||8
8191902|NCT02281526|20198825|P1|STARTED|Overall Study||9
8191903|NCT02281500|20198833|P1|NOT COMPLETED|Overall Study||0
8191904|NCT02281500|20198833|P1|COMPLETED|Overall Study||22
8191905|NCT02281500|20198833|P1|STARTED|Overall Study||22
8191906|NCT02281448|20198864|P2|NOT COMPLETED|Overall Study||1
8191907|NCT02281448|20198865|P1|NOT COMPLETED|Overall Study||2
8191908|NCT02281448|20198864|P2|COMPLETED|Overall Study||9
8191909|NCT02281448|20198865|P1|COMPLETED|Overall Study||8
8191910|NCT02281448|20198864|P2|STARTED|Overall Study||10
8191911|NCT02281448|20198865|P1|STARTED|Overall Study||10
8191912|NCT02281422|20198878|P5|NOT COMPLETED|Overall Study||0
8191913|NCT02281422|20198879|P4|NOT COMPLETED|Overall Study||0
8191914|NCT02281422|20198880|P3|NOT COMPLETED|Overall Study||0
8191915|NCT02281422|20198881|P2|NOT COMPLETED|Overall Study||0
8191916|NCT02281422|20198882|P1|NOT COMPLETED|Overall Study||0
8191917|NCT02281422|20198878|P5|COMPLETED|Overall Study||8
8191918|NCT02281422|20198879|P4|COMPLETED|Overall Study||8
8191919|NCT02281422|20198880|P3|COMPLETED|Overall Study||8
8191920|NCT02281422|20198881|P2|COMPLETED|Overall Study||8
8191921|NCT02281422|20198882|P1|COMPLETED|Overall Study||8
8191922|NCT02281422|20198878|P5|STARTED|Overall Study||8
8191923|NCT02281422|20198879|P4|STARTED|Overall Study||8
8191924|NCT02281422|20198880|P3|STARTED|Overall Study||8
8191925|NCT02281422|20198881|P2|STARTED|Overall Study||8
8191926|NCT02281422|20198882|P1|STARTED|Overall Study||8
8191927|NCT02281357|20198906|P2|NOT COMPLETED|Overall Study||4
8191928|NCT02281357|20198907|P1|NOT COMPLETED|Overall Study||7
8191929|NCT02281357|20198906|P2|COMPLETED|Overall Study||66
8191930|NCT02281357|20198907|P1|COMPLETED|Overall Study||63
8191931|NCT02281357|20198906|P2|STARTED|Overall Study||70
8191932|NCT02281357|20198907|P1|STARTED|Overall Study||70
8191933|NCT02281344|20198919|P1|NOT COMPLETED|Overall Study||0
8191934|NCT02281344|20198919|P1|COMPLETED|Overall Study||6
8191935|NCT02281344|20198919|P1|STARTED|Overall Study||6
8191936|NCT02281318|20198926|P2|NOT COMPLETED|Overall Study||5
8191937|NCT02281318|20198927|P1|NOT COMPLETED|Overall Study||14
8191938|NCT02281318|20198926|P2|COMPLETED|Overall Study||269
8191939|NCT02281318|20198927|P1|COMPLETED|Overall Study||263
8191940|NCT02281318|20198926|P2|STARTED|Overall Study||274
8191941|NCT02281318|20198927|P1|STARTED|Overall Study||277
8191942|NCT02281136|20198939|P1|NOT COMPLETED|Overall Study||0
8191943|NCT02281136|20198939|P1|COMPLETED|Overall Study||29
8191944|NCT02281136|20198939|P1|STARTED|Overall Study||29
8191957|NCT02280863|20199034|P2|NOT COMPLETED|Integrated Platform||1
8191958|NCT02280863|20199035|P1|NOT COMPLETED|Integrated Platform||0
8191959|NCT02280863|20199034|P2|COMPLETED|Integrated Platform||14
8191960|NCT02280863|20199035|P1|COMPLETED|Integrated Platform||9
8191961|NCT02280863|20199034|P2|STARTED|Integrated Platform||15
8191962|NCT02280863|20199035|P1|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
8191963|NCT02280863|20199034|P2|NOT COMPLETED|Android Platform||0
8191964|NCT02280863|20199035|P1|NOT COMPLETED|Android Platform||0
8191965|NCT02280863|20199034|P2|COMPLETED|Android Platform||0
8191966|NCT02280863|20199035|P1|COMPLETED|Android Platform||8
8191967|NCT02280863|20199034|P2|STARTED|Android Platform||0
8191968|NCT02280863|20199035|P1|STARTED|Android Platform||8
8191969|NCT02280811|20199065|P5|NOT COMPLETED|Retreated at the MTD||0
8191970|NCT02280811|20199066|P4|NOT COMPLETED|Retreated at the MTD||0
8191971|NCT02280811|20199067|P3|NOT COMPLETED|Retreated at the MTD||0
8191972|NCT02280811|20199068|P2|NOT COMPLETED|Retreated at the MTD||0
8191973|NCT02280811|20199069|P1|NOT COMPLETED|Retreated at the MTD||0
8191974|NCT02280811|20199065|P5|COMPLETED|Retreated at the MTD||1
8191975|NCT02280811|20199066|P4|COMPLETED|Retreated at the MTD||0
8191976|NCT02280811|20199067|P3|COMPLETED|Retreated at the MTD||0
8191977|NCT02280811|20199068|P2|COMPLETED|Retreated at the MTD||0
8191978|NCT02280811|20199069|P1|COMPLETED|Retreated at the MTD||0
8191979|NCT02280811|20199065|P5|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
8191980|NCT02280811|20199066|P4|STARTED|Retreated at the MTD||0
8191981|NCT02280811|20199067|P3|STARTED|Retreated at the MTD||0
8191982|NCT02280811|20199068|P2|STARTED|Retreated at the MTD||0
8191983|NCT02280811|20199069|P1|STARTED|Retreated at the MTD||0
8191984|NCT02280811|20199065|P5|NOT COMPLETED|Drug Administration||0
8191985|NCT02280811|20199066|P4|NOT COMPLETED|Drug Administration||0
8191986|NCT02280811|20199067|P3|NOT COMPLETED|Drug Administration||0
8191987|NCT02280811|20199068|P2|NOT COMPLETED|Drug Administration||0
8191988|NCT02280811|20199069|P1|NOT COMPLETED|Drug Administration||0
8191989|NCT02280811|20199065|P5|COMPLETED|Drug Administration||2
8191990|NCT02280811|20199066|P4|COMPLETED|Drug Administration||6
8191991|NCT02280811|20199067|P3|COMPLETED|Drug Administration||1
8191992|NCT02280811|20199068|P2|COMPLETED|Drug Administration||2
8191993|NCT02280811|20199069|P1|COMPLETED|Drug Administration||1
8191994|NCT02280811|20199065|P5|STARTED|Drug Administration||2
8191995|NCT02280811|20199066|P4|STARTED|Drug Administration||6
8191996|NCT02280811|20199067|P3|STARTED|Drug Administration||1
8191997|NCT02280811|20199068|P2|STARTED|Drug Administration||2
8191998|NCT02280811|20199069|P1|STARTED|Drug Administration||1
8191999|NCT02280655|20199110|P2|NOT COMPLETED|Overall Study||0
8192000|NCT02280655|20199111|P1|NOT COMPLETED|Overall Study||0
8192001|NCT02280655|20199110|P2|COMPLETED|Overall Study||18
8192002|NCT02280655|20199111|P1|COMPLETED|Overall Study||25
8192003|NCT02280655|20199110|P2|STARTED|Overall Study||18
8192004|NCT02280655|20199111|P1|STARTED|Overall Study||25
8192005|NCT02280499|20199119|P1|NOT COMPLETED|Overall Study||61
8192006|NCT02280499|20199119|P1|COMPLETED|Overall Study||26
8192007|NCT02280499|20199119|P1|STARTED|Overall Study||87
8192008|NCT02280473|20199127|P2|NOT COMPLETED|Overall Study||3
8192009|NCT02280473|20199128|P1|NOT COMPLETED|Overall Study||1
8192010|NCT02280473|20199127|P2|COMPLETED|Overall Study||91
8192011|NCT02280473|20199128|P1|COMPLETED|Overall Study||93
8192012|NCT02280473|20199127|P2|STARTED|Overall Study||94
8192013|NCT02280473|20199128|P1|STARTED|Overall Study||94
8192014|NCT02280421|20199144|P2|NOT COMPLETED|Second Intervention(2 Weeks)||0
8192015|NCT02280421|20199145|P1|NOT COMPLETED|Second Intervention(2 Weeks)||0
8192016|NCT02280421|20199144|P2|COMPLETED|Second Intervention(2 Weeks)||12
8192017|NCT02280421|20199145|P1|COMPLETED|Second Intervention(2 Weeks)||12
8192018|NCT02280421|20199144|P2|Received Intervention|Second Intervention(2 Weeks)||12
8192019|NCT02280421|20199145|P1|Received Intervention|Second Intervention(2 Weeks)||12
8192020|NCT02280421|20199144|P2|STARTED|Second Intervention(2 Weeks)||12
8192021|NCT02280421|20199145|P1|STARTED|Second Intervention(2 Weeks)||12
8192022|NCT02280421|20199144|P2|NOT COMPLETED|Washout (2 Weeks)||1
8192023|NCT02280421|20199145|P1|NOT COMPLETED|Washout (2 Weeks)||1
8192024|NCT02280421|20199144|P2|COMPLETED|Washout (2 Weeks)||11
8192025|NCT02280421|20199145|P1|COMPLETED|Washout (2 Weeks)||11
8192026|NCT02280421|20199144|P2|STARTED|Washout (2 Weeks)||12
8192027|NCT02280421|20199145|P1|STARTED|Washout (2 Weeks)||12
8192028|NCT02280421|20199144|P2|NOT COMPLETED|First Intervention(2 Weeks)||0
8192029|NCT02280421|20199145|P1|NOT COMPLETED|First Intervention(2 Weeks)||0
8192030|NCT02280421|20199144|P2|COMPLETED|First Intervention(2 Weeks)||12
8192031|NCT02280421|20199145|P1|COMPLETED|First Intervention(2 Weeks)||12
8192032|NCT02280421|20199144|P2|Received Intervention|First Intervention(2 Weeks)||12
8192033|NCT02280421|20199145|P1|Received Intervention|First Intervention(2 Weeks)||12
8192034|NCT02280421|20199144|P2|STARTED|First Intervention(2 Weeks)||12
8192035|NCT02280421|20199145|P1|STARTED|First Intervention(2 Weeks)||12
8192036|NCT02280408|20199211|P4|NOT COMPLETED|Overall Study||0
8192037|NCT02280408|20199212|P3|NOT COMPLETED|Overall Study||0
8192038|NCT02280408|20199213|P2|NOT COMPLETED|Overall Study||2
8192039|NCT02280408|20199214|P1|NOT COMPLETED|Overall Study||0
8192040|NCT02280408|20199211|P4|COMPLETED|Overall Study||9
8192041|NCT02280408|20199212|P3|COMPLETED|Overall Study||10
8192042|NCT02280408|20199213|P2|COMPLETED|Overall Study||8
8192043|NCT02280408|20199214|P1|COMPLETED|Overall Study||10
8192044|NCT02280408|20199211|P4|Vaccination 2|Overall Study||9
8192045|NCT02280408|20199212|P3|Vaccination 2|Overall Study||10
8192046|NCT02280408|20199213|P2|Vaccination 2|Overall Study||10
8192047|NCT02280408|20199214|P1|Vaccination 2|Overall Study||10
8192048|NCT02280408|20199211|P4|Vaccination 1|Overall Study||9
8192049|NCT02280408|20199212|P3|Vaccination 1|Overall Study||10
8192050|NCT02280408|20199213|P2|Vaccination 1|Overall Study||10
8192051|NCT02280408|20199214|P1|Vaccination 1|Overall Study||10
8192052|NCT02280408|20199211|P4|STARTED|Overall Study||9
8192053|NCT02280408|20199212|P3|STARTED|Overall Study||10
8192054|NCT02280408|20199213|P2|STARTED|Overall Study||10
8192055|NCT02280408|20199214|P1|STARTED|Overall Study||10
8192056|NCT02280304|20199286|P2|NOT COMPLETED|Overall Study||8
8192057|NCT02280304|20199287|P1|NOT COMPLETED|Overall Study||7
8192058|NCT02280304|20199286|P2|COMPLETED|Overall Study|A non completer received the allocated intervention before being lost to follow-up.|10
8192059|NCT02280304|20199287|P1|COMPLETED|Overall Study||12
8192060|NCT02280304|20199286|P2|STARTED|Overall Study||18
8192061|NCT02280304|20199287|P1|STARTED|Overall Study||19
8192062|NCT02280291|20199308|P4|NOT COMPLETED|Overall Study||8
8192063|NCT02280291|20199309|P3|NOT COMPLETED|Overall Study||3
8192064|NCT02280291|20199310|P2|NOT COMPLETED|Overall Study||2
8192065|NCT02280291|20199311|P1|NOT COMPLETED|Overall Study||4
8192066|NCT02280291|20199308|P4|COMPLETED|Overall Study||18
8192067|NCT02280291|20199309|P3|COMPLETED|Overall Study||21
8192068|NCT02280291|20199310|P2|COMPLETED|Overall Study||23
8192069|NCT02280291|20199311|P1|COMPLETED|Overall Study||21
8192070|NCT02280291|20199308|P4|STARTED|Overall Study||26
8192071|NCT02280291|20199309|P3|STARTED|Overall Study||24
8192072|NCT02280291|20199310|P2|STARTED|Overall Study||25
8192073|NCT02280291|20199311|P1|STARTED|Overall Study||25
8192074|NCT02280252|20199323|P1|NOT COMPLETED|Overall Study||0
8192075|NCT02280252|20199323|P1|COMPLETED|Overall Study||0
8192076|NCT02280252|20199323|P1|STARTED|Overall Study||0
8192077|NCT02280226|20199330|P1|NOT COMPLETED|Overall Study||0
8192078|NCT02280226|20199330|P1|COMPLETED|Overall Study||17
8192079|NCT02280226|20199330|P1|STARTED|Overall Study||17
8192080|NCT02280200|20199337|P2|NOT COMPLETED|Overall Study||3
8192081|NCT02280200|20199338|P1|NOT COMPLETED|Overall Study||3
8192082|NCT02280200|20199337|P2|COMPLETED|Overall Study||10
8192083|NCT02280200|20199338|P1|COMPLETED|Overall Study||12
8192084|NCT02280200|20199337|P2|STARTED|Overall Study||13
8192085|NCT02280200|20199338|P1|STARTED|Overall Study||15
8192086|NCT02280187|20199352|P1|NOT COMPLETED|Overall Study||218
8192087|NCT02280187|20199352|P1|COMPLETED|Overall Study||182
8192088|NCT02280187|20199352|P1|STARTED|Overall Study||400
8192089|NCT02280122|20199370|P3|NOT COMPLETED|Overall Study||0
8192090|NCT02280122|20199371|P2|NOT COMPLETED|Overall Study||0
8192091|NCT02280122|20199372|P1|NOT COMPLETED|Overall Study||0
8192092|NCT02280122|20199370|P3|COMPLETED|Overall Study||30
8192093|NCT02280122|20199371|P2|COMPLETED|Overall Study||15
8192094|NCT02280122|20199372|P1|COMPLETED|Overall Study||15
8192095|NCT02280122|20199370|P3|STARTED|Overall Study||30
8192096|NCT02280122|20199371|P2|STARTED|Overall Study||15
8192097|NCT02280122|20199372|P1|STARTED|Overall Study||15
8192098|NCT02280096|20199380|P2|NOT COMPLETED|Overall Study||1
8192099|NCT02280096|20199381|P1|NOT COMPLETED|Overall Study||2
8192100|NCT02280096|20199380|P2|COMPLETED|Overall Study||10
8192101|NCT02280096|20199381|P1|COMPLETED|Overall Study||11
8192102|NCT02280096|20199380|P2|STARTED|Overall Study||11
8192103|NCT02280096|20199381|P1|STARTED|Overall Study||13
8192104|NCT02280044|20199411|P2|NOT COMPLETED|Overall Study||2
8192105|NCT02280044|20199412|P1|NOT COMPLETED|Overall Study||0
8192106|NCT02280044|20199411|P2|COMPLETED|Overall Study||13
8192107|NCT02280044|20199412|P1|COMPLETED|Overall Study||15
8192108|NCT02280044|20199411|P2|STARTED|Overall Study||15
8192109|NCT02280044|20199412|P1|STARTED|Overall Study||15
8192110|NCT02279862|20199422|P2|NOT COMPLETED|Overall Study||25
8192111|NCT02279862|20199423|P1|NOT COMPLETED|Overall Study||26
8192112|NCT02279862|20199422|P2|COMPLETED|Overall Study|Completed treatment in induction period|2
8192113|NCT02279862|20199423|P1|COMPLETED|Overall Study|Completed treatment in induction period|0
8192114|NCT02279862|20199422|P2|Treated|Overall Study||26
8192115|NCT02279862|20199423|P1|Treated|Overall Study||25
8192116|NCT02279862|20199422|P2|STARTED|Overall Study||27
8192117|NCT02279862|20199423|P1|STARTED|Overall Study||26
8192118|NCT02279732|20199441|P2|NOT COMPLETED|Overall Study||106
8192119|NCT02279732|20199442|P1|NOT COMPLETED|Overall Study||98
8192120|NCT02279732|20199441|P2|COMPLETED|Overall Study||0
8192121|NCT02279732|20199442|P1|COMPLETED|Overall Study||0
8192122|NCT02279732|20199441|P2|STARTED|Overall Study||106
8192123|NCT02279732|20199442|P1|STARTED|Overall Study||98
8192124|NCT02279667|20199455|P3|NOT COMPLETED|Overall Study||0
8192125|NCT02279667|20199456|P2|NOT COMPLETED|Overall Study||0
8192126|NCT02279667|20199457|P1|NOT COMPLETED|Overall Study||0
8192127|NCT02279667|20199455|P3|COMPLETED|Overall Study||6
8192128|NCT02279667|20199456|P2|COMPLETED|Overall Study||6
8192129|NCT02279667|20199457|P1|COMPLETED|Overall Study||6
8192130|NCT02279667|20199455|P3|STARTED|Overall Study||6
8192131|NCT02279667|20199456|P2|STARTED|Overall Study||6
8192132|NCT02279667|20199457|P1|STARTED|Overall Study||6
8192133|NCT02279641|20199477|P2|NOT COMPLETED|Overall Study||0
8192134|NCT02279641|20199478|P1|NOT COMPLETED|Overall Study||0
8192135|NCT02279641|20199477|P2|COMPLETED|Overall Study||6
8192136|NCT02279641|20199478|P1|COMPLETED|Overall Study||6
8192137|NCT02279641|20199477|P2|STARTED|Overall Study||6
8192138|NCT02279641|20199478|P1|STARTED|Overall Study||6
8192139|NCT02279498|20199534|P2|NOT COMPLETED|Overall Study||4
8192140|NCT02279498|20199535|P1|NOT COMPLETED|Overall Study||18
8192141|NCT02279498|20199534|P2|COMPLETED|Overall Study||59
8192142|NCT02279498|20199535|P1|COMPLETED|Overall Study||47
8192143|NCT02279498|20199534|P2|STARTED|Overall Study||63
8192144|NCT02279498|20199535|P1|STARTED|Overall Study||65
8192145|NCT02279420|20199544|P1|NOT COMPLETED|Overall Study||23
8192146|NCT02279420|20199544|P1|COMPLETED|Overall Study||50
8192147|NCT02279420|20199544|P1|STARTED|Overall Study||73
8192148|NCT02279407|20199552|P4|NOT COMPLETED|Overall Study||1
8192149|NCT02279407|20199553|P3|NOT COMPLETED|Overall Study||5
8192150|NCT02279407|20199554|P2|NOT COMPLETED|Overall Study||1
8192151|NCT02279407|20199555|P1|NOT COMPLETED|Overall Study||2
8192152|NCT02279407|20199552|P4|COMPLETED|Overall Study||20
8192153|NCT02279407|20199553|P3|COMPLETED|Overall Study||15
8192154|NCT02279407|20199554|P2|COMPLETED|Overall Study||20
8192155|NCT02279407|20199555|P1|COMPLETED|Overall Study||20
8192156|NCT02279407|20199552|P4|STARTED|Overall Study||21
8192157|NCT02279407|20199553|P3|STARTED|Overall Study||20
8192158|NCT02279407|20199554|P2|STARTED|Overall Study||21
8192159|NCT02279407|20199555|P1|STARTED|Overall Study||22
8192160|NCT02279173|20199566|P1|NOT COMPLETED|Overall Study||94
8192161|NCT02279173|20199566|P1|COMPLETED|Overall Study||109
8192162|NCT02279173|20199566|P1|Enrolled Under Protocol Supplement|Overall Study||79
8192163|NCT02279173|20199566|P1|Received Treatment|Overall Study||203
8192164|NCT02279173|20199566|P1|STARTED|Overall Study||203
8192165|NCT02279160|20199585|P2|NOT COMPLETED|Overall Study||2
8192166|NCT02279160|20199586|P1|NOT COMPLETED|Overall Study||6
8192167|NCT02279160|20199585|P2|COMPLETED|Overall Study||19
8192168|NCT02279160|20199586|P1|COMPLETED|Overall Study||34
8192169|NCT02279160|20199585|P2|STARTED|Overall Study||21
8192170|NCT02279160|20199586|P1|STARTED|Overall Study||40
8192171|NCT02279108|20199596|P2|NOT COMPLETED|Overall Study||1
8192172|NCT02279108|20199597|P1|NOT COMPLETED|Overall Study||0
8192173|NCT02279108|20199596|P2|COMPLETED|Overall Study||49
8192174|NCT02279108|20199597|P1|COMPLETED|Overall Study||50
8192175|NCT02279108|20199596|P2|STARTED|Overall Study||50
8192176|NCT02279108|20199597|P1|STARTED|Overall Study||50
8192177|NCT02279082|20199619|P1|NOT COMPLETED|Overall Study||33
8192178|NCT02279082|20199619|P1|COMPLETED|Overall Study||134
8192179|NCT02279082|20199619|P1|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
8192180|NCT02279043|20199626|P3|NOT COMPLETED|Overall Study||0
8192181|NCT02279043|20199627|P2|NOT COMPLETED|Overall Study||89
8192182|NCT02279043|20199628|P1|NOT COMPLETED|Overall Study||47
8192183|NCT02279043|20199626|P3|COMPLETED|Overall Study||140
8192184|NCT02279043|20199627|P2|COMPLETED|Overall Study||226
8192185|NCT02279043|20199628|P1|COMPLETED|Overall Study||128
8192186|NCT02279043|20199626|P3|STARTED|Overall Study||140
8192187|NCT02279043|20199627|P2|STARTED|Overall Study||315
8192188|NCT02279043|20199628|P1|STARTED|Overall Study||175
8192189|NCT02278952|20199658|P1|NOT COMPLETED|Overall Study||6
8192190|NCT02278952|20199658|P1|COMPLETED|Overall Study|The number of biopsy samples assayed during the time the patient was enrolled in the study.|44
8192191|NCT02278952|20199658|P1|STARTED|Overall Study|The number of biopsy procedures performed during the time the patient was enrolled in the study.|50
8192192|NCT02278939|20199670|P2|NOT COMPLETED|Overall Study||1
8192193|NCT02278939|20199671|P1|NOT COMPLETED|Overall Study||5
8192194|NCT02278939|20199670|P2|COMPLETED|Overall Study||33
8192195|NCT02278939|20199671|P1|COMPLETED|Overall Study||28
8192196|NCT02278939|20199670|P2|STARTED|Overall Study||34
8192197|NCT02278939|20199671|P1|STARTED|Overall Study||33
8192198|NCT02278783|20199683|P1|NOT COMPLETED|Overall Study||0
8192199|NCT02278783|20199683|P1|COMPLETED|Overall Study||1
8192200|NCT02278783|20199683|P1|STARTED|Overall Study||1
8192201|NCT02278640|20199690|P1|NOT COMPLETED|Overall Study||0
8192202|NCT02278640|20199690|P1|COMPLETED|Overall Study||40
8192203|NCT02278640|20199690|P1|STARTED|Overall Study||40
8192204|NCT02278614|20199699|P2|NOT COMPLETED|Overall Study||5
8192205|NCT02278614|20199700|P1|NOT COMPLETED|Overall Study||5
8192206|NCT02278614|20199699|P2|COMPLETED|Overall Study||110
8192207|NCT02278614|20199700|P1|COMPLETED|Overall Study||122
8192208|NCT02278614|20199699|P2|STARTED|Overall Study||115
8192209|NCT02278614|20199700|P1|STARTED|Overall Study||127
8192210|NCT02278562|20199709|P3|NOT COMPLETED|Overall Study||0
8192211|NCT02278562|20199710|P2|NOT COMPLETED|Overall Study||0
8192212|NCT02278562|20199711|P1|NOT COMPLETED|Overall Study||0
8192213|NCT02278562|20199709|P3|COMPLETED|Overall Study||8
8192214|NCT02278562|20199710|P2|COMPLETED|Overall Study||7
8192215|NCT02278562|20199711|P1|COMPLETED|Overall Study||9
8192216|NCT02278562|20199709|P3|STARTED|Overall Study||8
8192217|NCT02278562|20199710|P2|STARTED|Overall Study||7
8192218|NCT02278562|20199711|P1|STARTED|Overall Study||9
8192219|NCT02278484|20199725|P1|NOT COMPLETED|Overall Study||0
8192220|NCT02278484|20199725|P1|COMPLETED|Overall Study||50
8192221|NCT02278484|20199725|P1|STARTED|Overall Study||50
8192228|NCT02278367|20199753|P2|NOT COMPLETED|Overall Study||0
8192229|NCT02278367|20199754|P1|NOT COMPLETED|Overall Study||10
8192230|NCT02278367|20199753|P2|COMPLETED|Overall Study||110
8192231|NCT02278367|20199754|P1|COMPLETED|Overall Study||59
8192232|NCT02278367|20199753|P2|STARTED|Overall Study||110
8192233|NCT02278367|20199754|P1|STARTED|Overall Study||69
8192234|NCT02278354|20199764|P2|NOT COMPLETED|Overall Study||3
8192235|NCT02278354|20199765|P1|NOT COMPLETED|Overall Study||4
8192236|NCT02278354|20199764|P2|COMPLETED|Overall Study||20
8192237|NCT02278354|20199765|P1|COMPLETED|Overall Study||8
8192238|NCT02278354|20199764|P2|Flortaucipir PET Scan|Overall Study||20
8192239|NCT02278354|20199765|P1|Flortaucipir PET Scan|Overall Study||10
8192240|NCT02278354|20199764|P2|STARTED|Overall Study||23
8192241|NCT02278354|20199765|P1|STARTED|Overall Study||12
8192250|NCT02278328|20199874|P3|NOT COMPLETED|Third Washout (1 Week)||0
8192251|NCT02278328|20199875|P2|NOT COMPLETED|Third Washout (1 Week)||0
8192252|NCT02278328|20199876|P1|NOT COMPLETED|Third Washout (1 Week)||0
8192253|NCT02278328|20199874|P3|COMPLETED|Third Washout (1 Week)||6
8192254|NCT02278328|20199875|P2|COMPLETED|Third Washout (1 Week)||6
8192255|NCT02278328|20199876|P1|COMPLETED|Third Washout (1 Week)||9
8192256|NCT02278328|20199874|P3|STARTED|Third Washout (1 Week)||6
8192257|NCT02278328|20199875|P2|STARTED|Third Washout (1 Week)||6
8192258|NCT02278328|20199876|P1|STARTED|Third Washout (1 Week)||9
8192259|NCT02278328|20199874|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8192260|NCT02278328|20199875|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8192261|NCT02278328|20199876|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8192262|NCT02278328|20199874|P3|COMPLETED|Third Intervention (1 Day)||6
8192263|NCT02278328|20199875|P2|COMPLETED|Third Intervention (1 Day)||6
8192264|NCT02278328|20199876|P1|COMPLETED|Third Intervention (1 Day)||9
8192265|NCT02278328|20199874|P3|STARTED|Third Intervention (1 Day)||6
8192266|NCT02278328|20199875|P2|STARTED|Third Intervention (1 Day)||6
8192267|NCT02278328|20199876|P1|STARTED|Third Intervention (1 Day)||9
8192268|NCT02278328|20199874|P3|NOT COMPLETED|Second Washout (1 Week)||0
8192269|NCT02278328|20199875|P2|NOT COMPLETED|Second Washout (1 Week)||0
8192270|NCT02278328|20199876|P1|NOT COMPLETED|Second Washout (1 Week)||0
8192271|NCT02278328|20199874|P3|COMPLETED|Second Washout (1 Week)||6
8192272|NCT02278328|20199875|P2|COMPLETED|Second Washout (1 Week)||6
8192273|NCT02278328|20199876|P1|COMPLETED|Second Washout (1 Week)||9
8192274|NCT02278328|20199874|P3|STARTED|Second Washout (1 Week)||6
8192275|NCT02278328|20199875|P2|STARTED|Second Washout (1 Week)||6
8192276|NCT02278328|20199876|P1|STARTED|Second Washout (1 Week)||9
8192277|NCT02278328|20199874|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8192278|NCT02278328|20199875|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8192279|NCT02278328|20199876|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8192280|NCT02278328|20199874|P3|COMPLETED|Second Intervention (1 Day)||6
8192281|NCT02278328|20199875|P2|COMPLETED|Second Intervention (1 Day)||6
8192282|NCT02278328|20199876|P1|COMPLETED|Second Intervention (1 Day)||9
8192283|NCT02278328|20199874|P3|STARTED|Second Intervention (1 Day)||6
8192284|NCT02278328|20199875|P2|STARTED|Second Intervention (1 Day)||6
8192285|NCT02278328|20199876|P1|STARTED|Second Intervention (1 Day)||9
8192286|NCT02278328|20199874|P3|NOT COMPLETED|Washout (1 Week)||0
8192287|NCT02278328|20199875|P2|NOT COMPLETED|Washout (1 Week)||0
8192288|NCT02278328|20199876|P1|NOT COMPLETED|Washout (1 Week)||0
8192289|NCT02278328|20199874|P3|COMPLETED|Washout (1 Week)||6
8192290|NCT02278328|20199875|P2|COMPLETED|Washout (1 Week)||6
8192291|NCT02278328|20199876|P1|COMPLETED|Washout (1 Week)||9
8192292|NCT02278328|20199874|P3|STARTED|Washout (1 Week)||6
8192293|NCT02278328|20199875|P2|STARTED|Washout (1 Week)||6
8192294|NCT02278328|20199876|P1|STARTED|Washout (1 Week)||9
8192295|NCT02278328|20199874|P3|NOT COMPLETED|First Intervention (1 Day)||0
8192296|NCT02278328|20199875|P2|NOT COMPLETED|First Intervention (1 Day)||0
8192297|NCT02278328|20199876|P1|NOT COMPLETED|First Intervention (1 Day)||0
8192298|NCT02278328|20199874|P3|COMPLETED|First Intervention (1 Day)||6
8192299|NCT02278328|20199875|P2|COMPLETED|First Intervention (1 Day)||6
8192300|NCT02278328|20199876|P1|COMPLETED|First Intervention (1 Day)||9
8192301|NCT02278328|20199874|P3|STARTED|First Intervention (1 Day)||6
8192302|NCT02278328|20199875|P2|STARTED|First Intervention (1 Day)||6
8192303|NCT02278328|20199876|P1|STARTED|First Intervention (1 Day)||9
8192304|NCT02278328|20199874|P3|NOT COMPLETED|Neuropsych Screening||2
8192305|NCT02278328|20199875|P2|NOT COMPLETED|Neuropsych Screening||1
8192306|NCT02278328|20199876|P1|NOT COMPLETED|Neuropsych Screening||1
8192307|NCT02278328|20199874|P3|COMPLETED|Neuropsych Screening||6
8192308|NCT02278328|20199875|P2|COMPLETED|Neuropsych Screening||6
8192309|NCT02278328|20199876|P1|COMPLETED|Neuropsych Screening||9
8192310|NCT02278328|20199874|P3|STARTED|Neuropsych Screening||8
8192311|NCT02278328|20199875|P2|STARTED|Neuropsych Screening||7
8192312|NCT02278328|20199876|P1|STARTED|Neuropsych Screening||10
8192313|NCT02278263|20199889|P3|NOT COMPLETED|Overall Study||9
8192314|NCT02278263|20199890|P2|NOT COMPLETED|Overall Study||0
8192315|NCT02278263|20199891|P1|NOT COMPLETED|Overall Study||7
8192316|NCT02278263|20199889|P3|COMPLETED|Overall Study||51
8192317|NCT02278263|20199890|P2|COMPLETED|Overall Study|Correction|60
8192318|NCT02278263|20199891|P1|COMPLETED|Overall Study||23
8192319|NCT02278263|20199889|P3|STARTED|Overall Study||60
8192320|NCT02278263|20199890|P2|STARTED|Overall Study||60
8192321|NCT02278263|20199891|P1|STARTED|Overall Study||30
8192322|NCT02278237|20199917|P1|NOT COMPLETED|Overall Study||7
8192323|NCT02278237|20199917|P1|COMPLETED|Overall Study||83
8192324|NCT02278237|20199917|P1|STARTED|Overall Study||90
8192325|NCT02278146|20199923|P2|NOT COMPLETED|Overall Study||2
8192326|NCT02278146|20199924|P1|NOT COMPLETED|Overall Study||0
8192327|NCT02278146|20199923|P2|COMPLETED|Overall Study||8
8192328|NCT02278146|20199924|P1|COMPLETED|Overall Study||6
8192329|NCT02278146|20199923|P2|STARTED|Overall Study||10
8192330|NCT02278146|20199924|P1|STARTED|Overall Study||6
8192337|NCT02278003|20199953|P2|NOT COMPLETED|Overall Study||0
8192338|NCT02278003|20199954|P1|NOT COMPLETED|Overall Study||19
8192339|NCT02278003|20199953|P2|COMPLETED|Overall Study||20
8192340|NCT02278003|20199954|P1|COMPLETED|Overall Study||30
8192341|NCT02278003|20199953|P2|STARTED|Overall Study||20
8192342|NCT02278003|20199954|P1|STARTED|Overall Study||49
8192343|NCT02277990|20199964|P2|NOT COMPLETED|Overall Study||376
8192344|NCT02277990|20199965|P1|NOT COMPLETED|Overall Study||366
8192345|NCT02277990|20199964|P2|COMPLETED|Overall Study||3112
8192346|NCT02277990|20199965|P1|COMPLETED|Overall Study||3129
8192347|NCT02277990|20199964|P2|STARTED|Overall Study||3488
8192348|NCT02277990|20199965|P1|STARTED|Overall Study||3495
8192349|NCT02277925|20199979|P2|NOT COMPLETED|Overall Study||15
8192350|NCT02277925|20199980|P1|NOT COMPLETED|Overall Study||7
8192351|NCT02277925|20199979|P2|COMPLETED|Overall Study||87
8192352|NCT02277925|20199980|P1|COMPLETED|Overall Study||95
8192353|NCT02277925|20199979|P2|Surgery|Overall Study||101
8192354|NCT02277925|20199980|P1|Surgery|Overall Study||99
8192355|NCT02277925|20199979|P2|STARTED|Overall Study||102
8192356|NCT02277925|20199980|P1|STARTED|Overall Study||102
8192357|NCT02277769|20199993|P3|NOT COMPLETED|Overall Study||18
8192358|NCT02277769|20199994|P2|NOT COMPLETED|Overall Study||13
8192359|NCT02277769|20199995|P1|NOT COMPLETED|Overall Study||46
8192360|NCT02277769|20199993|P3|COMPLETED|Overall Study||221
8192361|NCT02277769|20199994|P2|COMPLETED|Overall Study||220
8192362|NCT02277769|20199995|P1|COMPLETED|Overall Study||190
8192363|NCT02277769|20199993|P3|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
8192364|NCT02277769|20199994|P2|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
8192365|NCT02277769|20199995|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
8192366|NCT02277769|20199993|P3|Treated|Overall Study||239
8192367|NCT02277769|20199994|P2|Treated|Overall Study||233
8192368|NCT02277769|20199995|P1|Treated|Overall Study||235
8192369|NCT02277769|20199993|P3|STARTED|Overall Study||239
8192370|NCT02277769|20199994|P2|STARTED|Overall Study||233
8192371|NCT02277769|20199995|P1|STARTED|Overall Study||236
8192372|NCT02277743|20200066|P3|NOT COMPLETED|Overall Study||26
8192373|NCT02277743|20200067|P2|NOT COMPLETED|Overall Study||16
8192374|NCT02277743|20200068|P1|NOT COMPLETED|Overall Study||40
8192375|NCT02277743|20200066|P3|COMPLETED|Overall Study||197
8192376|NCT02277743|20200067|P2|COMPLETED|Overall Study||208
8192377|NCT02277743|20200068|P1|COMPLETED|Overall Study||184
8192378|NCT02277743|20200066|P3|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
8192379|NCT02277743|20200067|P2|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
8192380|NCT02277743|20200068|P1|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
8192381|NCT02277743|20200066|P3|Treated|Overall Study||223
8192382|NCT02277743|20200067|P2|Treated|Overall Study||223
8192383|NCT02277743|20200068|P1|Treated|Overall Study||223
8192384|NCT02277743|20200066|P3|STARTED|Overall Study||223
8192385|NCT02277743|20200067|P2|STARTED|Overall Study||224
8192386|NCT02277743|20200068|P1|STARTED|Overall Study||224
8192387|NCT02277691|20200136|P1|NOT COMPLETED|Overall Study||46
8192388|NCT02277691|20200136|P1|COMPLETED|Overall Study||295
8192389|NCT02277691|20200136|P1|STARTED|Overall Study||341
8192390|NCT02277665|20200148|P2|NOT COMPLETED|Overall Study||0
8192391|NCT02277665|20200149|P1|NOT COMPLETED|Overall Study||0
8192392|NCT02277665|20200148|P2|COMPLETED|Overall Study||34
8192393|NCT02277665|20200149|P1|COMPLETED|Overall Study||33
8192394|NCT02277665|20200148|P2|STARTED|Overall Study||34
8192395|NCT02277665|20200149|P1|STARTED|Overall Study||33
8192396|NCT02277639|20200167|P2|NOT COMPLETED|Overall Study||0
8192397|NCT02277639|20200168|P1|NOT COMPLETED|Overall Study||0
8192398|NCT02277639|20200167|P2|COMPLETED|Overall Study||2
8192399|NCT02277639|20200168|P1|COMPLETED|Overall Study||0
8192400|NCT02277639|20200167|P2|STARTED|Overall Study||2
8192401|NCT02277639|20200168|P1|STARTED|Overall Study||0
8192402|NCT02277626|20200174|P2|NOT COMPLETED|Overall Study||0
8192403|NCT02277626|20200175|P1|NOT COMPLETED|Overall Study||0
8192404|NCT02277626|20200174|P2|COMPLETED|Overall Study||9
8192405|NCT02277626|20200175|P1|COMPLETED|Overall Study||6
8192406|NCT02277626|20200174|P2|STARTED|Overall Study||9
8192407|NCT02277626|20200175|P1|STARTED|Overall Study||6
8192408|NCT02277548|20200191|P2|NOT COMPLETED|Overall Study||2
8192409|NCT02277548|20200192|P1|NOT COMPLETED|Overall Study||0
8192410|NCT02277548|20200191|P2|COMPLETED|Overall Study||9
8192411|NCT02277548|20200192|P1|COMPLETED|Overall Study||9
8192412|NCT02277548|20200191|P2|STARTED|Overall Study||11
8192413|NCT02277548|20200192|P1|STARTED|Overall Study||9
8192414|NCT02277444|20200198|P1|NOT COMPLETED|Overall Study||130
8192415|NCT02277444|20200198|P1|COMPLETED|Overall Study||0
8192416|NCT02277444|20200198|P1|Treated|Overall Study||127
8192417|NCT02277444|20200198|P1|STARTED|Overall Study||130
8192418|NCT02277249|20200207|P2|NOT COMPLETED|Overall Study||0
8192419|NCT02277249|20200208|P1|NOT COMPLETED|Overall Study||0
8192420|NCT02277249|20200207|P2|COMPLETED|Overall Study||30
8192421|NCT02277249|20200208|P1|COMPLETED|Overall Study||30
8192422|NCT02277249|20200207|P2|STARTED|Overall Study||30
8192423|NCT02277249|20200208|P1|STARTED|Overall Study||30
8192424|NCT02277119|20200217|P3|NOT COMPLETED|Overall Study||8
8192425|NCT02277119|20200218|P2|NOT COMPLETED|Overall Study||4
8192426|NCT02277119|20200219|P1|NOT COMPLETED|Overall Study||3
8192427|NCT02277119|20200217|P3|COMPLETED|Overall Study||19
8192428|NCT02277119|20200218|P2|COMPLETED|Overall Study||20
8192429|NCT02277119|20200219|P1|COMPLETED|Overall Study||55
8192430|NCT02277119|20200217|P3|STARTED|Overall Study||27
8192431|NCT02277119|20200218|P2|STARTED|Overall Study||24
8192432|NCT02277119|20200219|P1|STARTED|Overall Study||58
8192433|NCT02277093|20200236|P1|NOT COMPLETED|Overall Study||0
8192434|NCT02277093|20200236|P1|COMPLETED|Overall Study||11
8192435|NCT02277093|20200236|P1|STARTED|Overall Study||11
8192436|NCT02277054|20200244|P1|NOT COMPLETED|Overall Study||0
8192437|NCT02277054|20200244|P1|COMPLETED|Overall Study||5
8192438|NCT02277054|20200244|P1|STARTED|Overall Study||5
8192439|NCT02276963|20200250|P1|NOT COMPLETED|Overall Study||3
8192440|NCT02276963|20200250|P1|COMPLETED|Overall Study||3
8192441|NCT02276963|20200250|P1|STARTED|Overall Study||6
8192442|NCT02276872|20200257|P3|NOT COMPLETED|Overall Study||0
8192443|NCT02276872|20200258|P2|NOT COMPLETED|Overall Study||0
8192444|NCT02276872|20200259|P1|NOT COMPLETED|Overall Study||1
8192445|NCT02276872|20200257|P3|COMPLETED|Overall Study||12
8192446|NCT02276872|20200258|P2|COMPLETED|Overall Study||10
8192447|NCT02276872|20200259|P1|COMPLETED|Overall Study||9
8192448|NCT02276872|20200257|P3|STARTED|Overall Study||12
8192449|NCT02276872|20200258|P2|STARTED|Overall Study||10
8192450|NCT02276872|20200259|P1|STARTED|Overall Study||10
8192451|NCT02276807|20200335|P2|NOT COMPLETED|Overall Study||17
8192452|NCT02276807|20200336|P1|NOT COMPLETED|Overall Study||18
8192453|NCT02276807|20200335|P2|COMPLETED|Overall Study||55
8192454|NCT02276807|20200336|P1|COMPLETED|Overall Study||50
8192455|NCT02276807|20200335|P2|12-week Assessment|Overall Study||63
8192456|NCT02276807|20200336|P1|12-week Assessment|Overall Study||57
8192457|NCT02276807|20200335|P2|STARTED|Overall Study||72
8192458|NCT02276807|20200336|P1|STARTED|Overall Study||68
8192459|NCT02276638|20200353|P3|NOT COMPLETED|Overall Study||0
8192460|NCT02276638|20200354|P2|NOT COMPLETED|Overall Study||0
8192461|NCT02276638|20200355|P1|NOT COMPLETED|Overall Study||0
8192462|NCT02276638|20200353|P3|COMPLETED|Overall Study||23
8192463|NCT02276638|20200354|P2|COMPLETED|Overall Study||28
8192464|NCT02276638|20200355|P1|COMPLETED|Overall Study||28
8192465|NCT02276638|20200353|P3|STARTED|Overall Study||23
8192466|NCT02276638|20200354|P2|STARTED|Overall Study||28
8192467|NCT02276638|20200355|P1|STARTED|Overall Study||28
8192468|NCT02276612|20200371|P2|NOT COMPLETED|Overall Study||0
8192469|NCT02276612|20200372|P1|NOT COMPLETED|Overall Study||4
8192470|NCT02276612|20200371|P2|COMPLETED|Overall Study||10
8192471|NCT02276612|20200372|P1|COMPLETED|Overall Study||46
8192472|NCT02276612|20200371|P2|STARTED|Overall Study||10
8192473|NCT02276612|20200372|P1|STARTED|Overall Study||50
8192474|NCT02276560|20200395|P3|NOT COMPLETED|Overall Study||0
8192475|NCT02276560|20200396|P2|NOT COMPLETED|Overall Study||0
8192476|NCT02276560|20200397|P1|NOT COMPLETED|Overall Study||1
8192477|NCT02276560|20200395|P3|COMPLETED|Overall Study||0
8192478|NCT02276560|20200396|P2|COMPLETED|Overall Study||0
8192479|NCT02276560|20200397|P1|COMPLETED|Overall Study||0
8192480|NCT02276560|20200395|P3|STARTED|Overall Study||0
8192481|NCT02276560|20200396|P2|STARTED|Overall Study||0
8192482|NCT02276560|20200397|P1|STARTED|Overall Study||1
8192483|NCT02276482|20200407|P2|NOT COMPLETED|Overall Study||1
8192484|NCT02276482|20200408|P1|NOT COMPLETED|Overall Study||3
8192485|NCT02276482|20200407|P2|COMPLETED|Overall Study||28
8192486|NCT02276482|20200408|P1|COMPLETED|Overall Study||88
8192487|NCT02276482|20200407|P2|STARTED|Overall Study||29
8192488|NCT02276482|20200408|P1|STARTED|Overall Study||91
8192489|NCT02276274|20200432|P2|NOT COMPLETED|Second Intervention Period||0
8192490|NCT02276274|20200433|P1|NOT COMPLETED|Second Intervention Period||0
8192491|NCT02276274|20200432|P2|COMPLETED|Second Intervention Period||6
8192492|NCT02276274|20200433|P1|COMPLETED|Second Intervention Period||6
8192493|NCT02276274|20200432|P2|STARTED|Second Intervention Period||6
8192494|NCT02276274|20200433|P1|STARTED|Second Intervention Period||6
8192495|NCT02276274|20200432|P2|NOT COMPLETED|Washout Period (at Least 15 Days)||0
8192496|NCT02276274|20200433|P1|NOT COMPLETED|Washout Period (at Least 15 Days)||0
8192497|NCT02276274|20200432|P2|COMPLETED|Washout Period (at Least 15 Days)||6
8192498|NCT02276274|20200433|P1|COMPLETED|Washout Period (at Least 15 Days)||6
8192499|NCT02276274|20200432|P2|STARTED|Washout Period (at Least 15 Days)||6
8192500|NCT02276274|20200433|P1|STARTED|Washout Period (at Least 15 Days)||6
8192501|NCT02276274|20200432|P2|NOT COMPLETED|First Intervention Period||0
8192502|NCT02276274|20200433|P1|NOT COMPLETED|First Intervention Period||0
8192503|NCT02276274|20200432|P2|COMPLETED|First Intervention Period||6
8192504|NCT02276274|20200433|P1|COMPLETED|First Intervention Period||6
8192505|NCT02276274|20200432|P2|STARTED|First Intervention Period||6
8192506|NCT02276274|20200433|P1|STARTED|First Intervention Period||6
8192507|NCT02276222|20200543|P2|NOT COMPLETED|Overall Study||64
8192508|NCT02276222|20200544|P1|NOT COMPLETED|Overall Study||185
8192509|NCT02276222|20200543|P2|COMPLETED|Overall Study||402
8192510|NCT02276222|20200544|P1|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
8192511|NCT02276222|20200543|P2|STARTED|Overall Study||466
8192512|NCT02276222|20200544|P1|STARTED|Overall Study||621
8192513|NCT02276053|20200568|P1|NOT COMPLETED|Overall Study||14
8192514|NCT02276053|20200568|P1|COMPLETED|Overall Study||79
8192515|NCT02276053|20200568|P1|STARTED|Overall Study||93
8192516|NCT02276040|20200584|P1|NOT COMPLETED|Overall Study||15
8192517|NCT02276040|20200584|P1|COMPLETED|Overall Study||11
8192518|NCT02276040|20200584|P1|STARTED|Overall Study||26
8192519|NCT02276027|20200592|P4|NOT COMPLETED|Overall Study||22
8192520|NCT02276027|20200593|P3|NOT COMPLETED|Overall Study||20
8192521|NCT02276027|20200594|P2|NOT COMPLETED|Overall Study||16
8192522|NCT02276027|20200595|P1|NOT COMPLETED|Overall Study||2
8192523|NCT02276027|20200592|P4|COMPLETED|Overall Study||0
8192524|NCT02276027|20200593|P3|COMPLETED|Overall Study||6
8192525|NCT02276027|20200594|P2|COMPLETED|Overall Study||0
8192526|NCT02276027|20200595|P1|COMPLETED|Overall Study||0
8192527|NCT02276027|20200592|P4|STARTED|Overall Study||22
8192528|NCT02276027|20200593|P3|STARTED|Overall Study||26
8192529|NCT02276027|20200594|P2|STARTED|Overall Study||16
8192530|NCT02276027|20200595|P1|STARTED|Overall Study||2
8192531|NCT02275923|20200637|P1|NOT COMPLETED|Overall Study||2
8192532|NCT02275923|20200637|P1|COMPLETED|Overall Study||7
8192533|NCT02275923|20200637|P1|STARTED|Overall Study||9
8192548|NCT02275767|20200684|P3|NOT COMPLETED|Overall Study||3
8192549|NCT02275767|20200685|P2|NOT COMPLETED|Overall Study||4
8192550|NCT02275767|20200686|P1|NOT COMPLETED|Overall Study||2
8192551|NCT02275767|20200684|P3|COMPLETED|Overall Study||19
8192552|NCT02275767|20200685|P2|COMPLETED|Overall Study||18
8192553|NCT02275767|20200686|P1|COMPLETED|Overall Study||20
8192554|NCT02275767|20200684|P3|STARTED|Overall Study||22
8192555|NCT02275767|20200685|P2|STARTED|Overall Study||22
8192556|NCT02275767|20200686|P1|STARTED|Overall Study||22
8192557|NCT02275611|20200701|P4|NOT COMPLETED|Outpatient Drinking||0
8192558|NCT02275611|20200702|P3|NOT COMPLETED|Outpatient Drinking||0
8192559|NCT02275611|20200703|P2|NOT COMPLETED|Outpatient Drinking||0
8192560|NCT02275611|20200704|P1|NOT COMPLETED|Outpatient Drinking||0
8192561|NCT02275611|20200701|P4|COMPLETED|Outpatient Drinking||3
8192562|NCT02275611|20200702|P3|COMPLETED|Outpatient Drinking||6
8192563|NCT02275611|20200703|P2|COMPLETED|Outpatient Drinking||0
8192564|NCT02275611|20200704|P1|COMPLETED|Outpatient Drinking||0
8192565|NCT02275611|20200701|P4|STARTED|Outpatient Drinking||3
8192566|NCT02275611|20200702|P3|STARTED|Outpatient Drinking||6
8192567|NCT02275611|20200703|P2|STARTED|Outpatient Drinking||0
8192568|NCT02275611|20200704|P1|STARTED|Outpatient Drinking||0
8192569|NCT02275611|20200701|P4|NOT COMPLETED|Inpatient Withdrawal||0
8192570|NCT02275611|20200702|P3|NOT COMPLETED|Inpatient Withdrawal||0
8192571|NCT02275611|20200703|P2|NOT COMPLETED|Inpatient Withdrawal||0
8192572|NCT02275611|20200704|P1|NOT COMPLETED|Inpatient Withdrawal||1
8192573|NCT02275611|20200701|P4|COMPLETED|Inpatient Withdrawal||0
8192574|NCT02275611|20200702|P3|COMPLETED|Inpatient Withdrawal||0
8192575|NCT02275611|20200703|P2|COMPLETED|Inpatient Withdrawal||4
8192576|NCT02275611|20200704|P1|COMPLETED|Inpatient Withdrawal||4
8192577|NCT02275611|20200701|P4|STARTED|Inpatient Withdrawal||0
8192578|NCT02275611|20200702|P3|STARTED|Inpatient Withdrawal||0
8192579|NCT02275611|20200703|P2|STARTED|Inpatient Withdrawal||4
8192580|NCT02275611|20200704|P1|STARTED|Inpatient Withdrawal||5
8192581|NCT02275546|20200716|P2|NOT COMPLETED|Treatment Period 2||2
8192582|NCT02275546|20200717|P1|NOT COMPLETED|Treatment Period 2||2
8192583|NCT02275546|20200716|P2|COMPLETED|Treatment Period 2||81
8192584|NCT02275546|20200717|P1|COMPLETED|Treatment Period 2||79
8192585|NCT02275546|20200716|P2|STARTED|Treatment Period 2||83
8192586|NCT02275546|20200717|P1|STARTED|Treatment Period 2||81
8192587|NCT02275546|20200716|P2|NOT COMPLETED|Treatment Period 1||0
8192588|NCT02275546|20200717|P1|NOT COMPLETED|Treatment Period 1||0
8192589|NCT02275546|20200716|P2|COMPLETED|Treatment Period 1||83
8192590|NCT02275546|20200717|P1|COMPLETED|Treatment Period 1||81
8192591|NCT02275546|20200716|P2|STARTED|Treatment Period 1||83
8192592|NCT02275546|20200717|P1|STARTED|Treatment Period 1||81
8192593|NCT02275481|20200727|P2|NOT COMPLETED|Overall Study||3
8192594|NCT02275481|20200728|P1|NOT COMPLETED|Overall Study||9
8192595|NCT02275481|20200727|P2|COMPLETED|Overall Study||31
8192596|NCT02275481|20200728|P1|COMPLETED|Overall Study||23
8192597|NCT02275481|20200727|P2|STARTED|Overall Study||34
8192598|NCT02275481|20200728|P1|STARTED|Overall Study||32
8192599|NCT02275364|20200734|P2|NOT COMPLETED|Period 4||0
8192600|NCT02275364|20200735|P1|NOT COMPLETED|Period 4||0
8192601|NCT02275364|20200734|P2|COMPLETED|Period 4||14
8192602|NCT02275364|20200735|P1|COMPLETED|Period 4||12
8192603|NCT02275364|20200734|P2|STARTED|Period 4||14
8192604|NCT02275364|20200735|P1|STARTED|Period 4||12
8192605|NCT02275364|20200734|P2|NOT COMPLETED|Period 3||0
8192606|NCT02275364|20200735|P1|NOT COMPLETED|Period 3||0
8192607|NCT02275364|20200734|P2|COMPLETED|Period 3||14
8192608|NCT02275364|20200735|P1|COMPLETED|Period 3||12
8192609|NCT02275364|20200734|P2|STARTED|Period 3||14
8192610|NCT02275364|20200735|P1|STARTED|Period 3||12
8192611|NCT02275364|20200734|P2|NOT COMPLETED|Washout Period 2||0
8192612|NCT02275364|20200735|P1|NOT COMPLETED|Washout Period 2||0
8192613|NCT02275364|20200734|P2|COMPLETED|Washout Period 2||14
8192614|NCT02275364|20200735|P1|COMPLETED|Washout Period 2||12
8192615|NCT02275364|20200734|P2|STARTED|Washout Period 2||14
8192616|NCT02275364|20200735|P1|STARTED|Washout Period 2||12
8192617|NCT02275364|20200734|P2|NOT COMPLETED|Period 2||0
8192618|NCT02275364|20200735|P1|NOT COMPLETED|Period 2||0
8192619|NCT02275364|20200734|P2|COMPLETED|Period 2||14
8192620|NCT02275364|20200735|P1|COMPLETED|Period 2||12
8192621|NCT02275364|20200734|P2|STARTED|Period 2||14
8192622|NCT02275364|20200735|P1|STARTED|Period 2||12
8192623|NCT02275364|20200734|P2|NOT COMPLETED|Washout Period 1||0
8192624|NCT02275364|20200735|P1|NOT COMPLETED|Washout Period 1||0
8192625|NCT02275364|20200734|P2|COMPLETED|Washout Period 1||14
8192626|NCT02275364|20200735|P1|COMPLETED|Washout Period 1||12
8192627|NCT02275364|20200734|P2|STARTED|Washout Period 1||14
8192628|NCT02275364|20200735|P1|STARTED|Washout Period 1||12
8192629|NCT02275364|20200734|P2|NOT COMPLETED|Period 1||0
8192630|NCT02275364|20200735|P1|NOT COMPLETED|Period 1||2
8192631|NCT02275364|20200734|P2|COMPLETED|Period 1||14
8192632|NCT02275364|20200735|P1|COMPLETED|Period 1||12
8192633|NCT02275364|20200734|P2|STARTED|Period 1||14
8192634|NCT02275364|20200735|P1|STARTED|Period 1||14
8192635|NCT02275338|20200764|P1|NOT COMPLETED|Overall Study||33
8192636|NCT02275338|20200764|P1|COMPLETED|Overall Study||19
8192637|NCT02275338|20200764|P1|Started Phase 2|Overall Study||21
8192638|NCT02275338|20200764|P1|Completed Phase 1|Overall Study||25
8192639|NCT02275338|20200764|P1|STARTED|Overall Study||52
8192640|NCT02275156|20200779|P3|NOT COMPLETED|Overall Study||0
8192641|NCT02275156|20200780|P2|NOT COMPLETED|Overall Study||0
8192642|NCT02275156|20200781|P1|NOT COMPLETED|Overall Study||0
8192643|NCT02275156|20200779|P3|COMPLETED|Overall Study||6
8192644|NCT02275156|20200780|P2|COMPLETED|Overall Study||6
8192645|NCT02275156|20200781|P1|COMPLETED|Overall Study||6
8192646|NCT02275156|20200779|P3|STARTED|Overall Study||6
8192647|NCT02275156|20200780|P2|STARTED|Overall Study||6
8192648|NCT02275156|20200781|P1|STARTED|Overall Study||6
8192649|NCT02275117|20200813|P5|NOT COMPLETED|Overall Study||36
8192650|NCT02275117|20200814|P4|NOT COMPLETED|Overall Study||33
8192651|NCT02275117|20200815|P3|NOT COMPLETED|Overall Study||42
8192652|NCT02275117|20200816|P2|NOT COMPLETED|Overall Study||37
8192653|NCT02275117|20200817|P1|NOT COMPLETED|Overall Study||34
8192654|NCT02275117|20200813|P5|COMPLETED|Overall Study||98
8192655|NCT02275117|20200814|P4|COMPLETED|Overall Study||100
8192656|NCT02275117|20200815|P3|COMPLETED|Overall Study||92
8192657|NCT02275117|20200816|P2|COMPLETED|Overall Study||96
8192658|NCT02275117|20200817|P1|COMPLETED|Overall Study||97
8192659|NCT02275117|20200813|P5|Randomized and Treated|Overall Study||121
8192660|NCT02275117|20200814|P4|Randomized and Treated|Overall Study||130
8192661|NCT02275117|20200815|P3|Randomized and Treated|Overall Study||122
8192662|NCT02275117|20200816|P2|Randomized and Treated|Overall Study||123
8192663|NCT02275117|20200817|P1|Randomized and Treated|Overall Study||120
8192664|NCT02275117|20200813|P5|STARTED|Overall Study||134
8192665|NCT02275117|20200814|P4|STARTED|Overall Study||133
8192666|NCT02275117|20200815|P3|STARTED|Overall Study||134
8192667|NCT02275117|20200816|P2|STARTED|Overall Study||133
8192668|NCT02275117|20200817|P1|STARTED|Overall Study||131
8192669|NCT02275065|20200929|P5|NOT COMPLETED|Overall Study||0
8192670|NCT02275065|20200930|P4|NOT COMPLETED|Overall Study||1
8192671|NCT02275065|20200931|P3|NOT COMPLETED|Overall Study||1
8192672|NCT02275065|20200932|P2|NOT COMPLETED|Overall Study||0
8192673|NCT02275065|20200933|P1|NOT COMPLETED|Overall Study||1
8192674|NCT02275065|20200929|P5|COMPLETED|Overall Study||4
8192675|NCT02275065|20200930|P4|COMPLETED|Overall Study||4
8192676|NCT02275065|20200931|P3|COMPLETED|Overall Study||4
8192677|NCT02275065|20200932|P2|COMPLETED|Overall Study||4
8192678|NCT02275065|20200933|P1|COMPLETED|Overall Study||4
8192679|NCT02275065|20200929|P5|STARTED|Overall Study||4
8192680|NCT02275065|20200930|P4|STARTED|Overall Study||5
8192681|NCT02275065|20200931|P3|STARTED|Overall Study||5
8192682|NCT02275065|20200932|P2|STARTED|Overall Study||4
8192683|NCT02275065|20200933|P1|STARTED|Overall Study||5
8192684|NCT02275052|20201014|P4|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
8192685|NCT02275052|20201015|P3|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
8192686|NCT02275052|20201016|P2|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
8192687|NCT02275052|20201017|P1|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
8192688|NCT02275052|20201014|P4|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
8192689|NCT02275052|20201015|P3|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
8192690|NCT02275052|20201016|P2|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
8192691|NCT02275052|20201017|P1|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
8192692|NCT02275052|20201014|P4|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
8192693|NCT02275052|20201015|P3|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
8192694|NCT02275052|20201016|P2|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
8192695|NCT02275052|20201017|P1|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
8192696|NCT02275052|20201014|P4|NOT COMPLETED|Washout Period (12-17 Days)||0
8192697|NCT02275052|20201015|P3|NOT COMPLETED|Washout Period (12-17 Days)||0
8192698|NCT02275052|20201016|P2|NOT COMPLETED|Washout Period (12-17 Days)||0
8192699|NCT02275052|20201017|P1|NOT COMPLETED|Washout Period (12-17 Days)||4
8192700|NCT02275052|20201014|P4|COMPLETED|Washout Period (12-17 Days)||0
8192701|NCT02275052|20201015|P3|COMPLETED|Washout Period (12-17 Days)||0
8192702|NCT02275052|20201016|P2|COMPLETED|Washout Period (12-17 Days)||93
8192703|NCT02275052|20201017|P1|COMPLETED|Washout Period (12-17 Days)||86
8192704|NCT02275052|20201014|P4|STARTED|Washout Period (12-17 Days)||0
8192705|NCT02275052|20201015|P3|STARTED|Washout Period (12-17 Days)||0
8192706|NCT02275052|20201016|P2|STARTED|Washout Period (12-17 Days)||93
8192707|NCT02275052|20201017|P1|STARTED|Washout Period (12-17 Days)||90
8192708|NCT02275052|20201014|P4|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
8192709|NCT02275052|20201015|P3|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
8192710|NCT02275052|20201016|P2|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
8192711|NCT02275052|20201017|P1|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
8192712|NCT02275052|20201014|P4|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
8192713|NCT02275052|20201015|P3|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
8192714|NCT02275052|20201016|P2|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
8192715|NCT02275052|20201017|P1|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
8192716|NCT02275052|20201014|P4|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
8192717|NCT02275052|20201015|P3|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
8192718|NCT02275052|20201016|P2|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
8192719|NCT02275052|20201017|P1|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
8192720|NCT02274948|20201031|P2|NOT COMPLETED|Overall Study||91
8192721|NCT02274948|20201032|P1|NOT COMPLETED|Overall Study||98
8192722|NCT02274948|20201031|P2|COMPLETED|Overall Study||82
8192723|NCT02274948|20201032|P1|COMPLETED|Overall Study||68
8192724|NCT02274948|20201031|P2|STARTED|Overall Study||173
8192725|NCT02274948|20201032|P1|STARTED|Overall Study||166
8192726|NCT02274870|20201048|P2|NOT COMPLETED|Overall Study||0
8192727|NCT02274870|20201049|P1|NOT COMPLETED|Overall Study||0
8192728|NCT02274870|20201048|P2|COMPLETED|Overall Study||33
8192729|NCT02274870|20201049|P1|COMPLETED|Overall Study||32
8192730|NCT02274870|20201048|P2|STARTED|Overall Study||33
8192731|NCT02274870|20201049|P1|STARTED|Overall Study||32
8192732|NCT02274857|20201075|P2|NOT COMPLETED|Overall Study||6
8192733|NCT02274857|20201076|P1|NOT COMPLETED|Overall Study||20
8192734|NCT02274857|20201075|P2|COMPLETED|Overall Study||165
8192735|NCT02274857|20201076|P1|COMPLETED|Overall Study||159
8192736|NCT02274857|20201075|P2|Completed Per Protocol|Overall Study||114
8192737|NCT02274857|20201076|P1|Completed Per Protocol|Overall Study||102
8192738|NCT02274857|20201075|P2|STARTED|Overall Study||171
8192739|NCT02274857|20201076|P1|STARTED|Overall Study||179
8192740|NCT02274844|20201091|P2|NOT COMPLETED|Overall Study||32
8192741|NCT02274844|20201092|P1|NOT COMPLETED|Overall Study||38
8192742|NCT02274844|20201091|P2|COMPLETED|Overall Study||238
8192743|NCT02274844|20201092|P1|COMPLETED|Overall Study||165
8192744|NCT02274844|20201091|P2|STARTED|Overall Study||270
8192745|NCT02274844|20201092|P1|STARTED|Overall Study||203
8192746|NCT02274792|20201128|P1|NOT COMPLETED|Overall Study||25
8192747|NCT02274792|20201128|P1|COMPLETED|Overall Study||107
8192748|NCT02274792|20201128|P1|Received Treatment|Overall Study||131
8192749|NCT02274792|20201128|P1|STARTED|Overall Study||132
8192750|NCT02274766|20201138|P2|NOT COMPLETED|Overall Study||9
8192751|NCT02274766|20201139|P1|NOT COMPLETED|Overall Study||4
8192752|NCT02274766|20201138|P2|COMPLETED|Overall Study||29
8192753|NCT02274766|20201139|P1|COMPLETED|Overall Study||35
8192754|NCT02274766|20201138|P2|Received Study Drug|Overall Study||37
8192755|NCT02274766|20201139|P1|Received Study Drug|Overall Study||38
8192756|NCT02274766|20201138|P2|STARTED|Overall Study||38
8192757|NCT02274766|20201139|P1|STARTED|Overall Study||39
8192758|NCT02274688|20201149|P2|NOT COMPLETED|Overall Study||13
8192759|NCT02274688|20201150|P1|NOT COMPLETED|Overall Study||14
8192760|NCT02274688|20201149|P2|COMPLETED|Overall Study||72
8192761|NCT02274688|20201150|P1|COMPLETED|Overall Study||72
8192762|NCT02274688|20201149|P2|STARTED|Overall Study||85
8192763|NCT02274688|20201150|P1|STARTED|Overall Study||86
8192764|NCT02274675|20201172|P1|NOT COMPLETED|Overall Study||0
8192765|NCT02274675|20201172|P1|COMPLETED|Overall Study||7
8192766|NCT02274675|20201172|P1|STARTED|Overall Study||7
8192767|NCT02274649|20201184|P2|NOT COMPLETED|Overall Study||12
8192768|NCT02274649|20201185|P1|NOT COMPLETED|Overall Study||24
8192769|NCT02274649|20201184|P2|COMPLETED|Overall Study||81
8192770|NCT02274649|20201185|P1|COMPLETED|Overall Study||77
8192771|NCT02274649|20201184|P2|STARTED|Overall Study||93
8192772|NCT02274649|20201185|P1|STARTED|Overall Study||101
8192773|NCT02274558|20201206|P3|NOT COMPLETED|Overall Study||9
8192774|NCT02274558|20201207|P2|NOT COMPLETED|Overall Study||13
8192775|NCT02274558|20201208|P1|NOT COMPLETED|Overall Study||7
8192776|NCT02274558|20201206|P3|COMPLETED|Overall Study||71
8192777|NCT02274558|20201207|P2|COMPLETED|Overall Study||63
8192778|NCT02274558|20201208|P1|COMPLETED|Overall Study||71
8192779|NCT02274558|20201206|P3|Included in the Safety Analysis Set|Overall Study||79
8192780|NCT02274558|20201207|P2|Included in the Safety Analysis Set|Overall Study||72
8192781|NCT02274558|20201208|P1|Included in the Safety Analysis Set|Overall Study||76
8192782|NCT02274558|20201206|P3|STARTED|Overall Study||80
8192783|NCT02274558|20201207|P2|STARTED|Overall Study||76
8192784|NCT02274558|20201208|P1|STARTED|Overall Study||78
8192785|NCT02274493|20201222|P1|NOT COMPLETED|Overall Study||1
8192786|NCT02274493|20201222|P1|COMPLETED|Overall Study||14
8192787|NCT02274493|20201222|P1|STARTED|Overall Study||15
8192788|NCT02274311|20201229|P1|NOT COMPLETED|Three Months of Clomiphene Wash-out||1
8192789|NCT02274311|20201229|P1|COMPLETED|Three Months of Clomiphene Wash-out||15
8192790|NCT02274311|20201229|P1|STARTED|Three Months of Clomiphene Wash-out||16
8192791|NCT02274311|20201229|P1|NOT COMPLETED|Three Months of Clomiphene Treatment||0
8192792|NCT02274311|20201229|P1|COMPLETED|Three Months of Clomiphene Treatment||16
8192793|NCT02274311|20201229|P1|STARTED|Three Months of Clomiphene Treatment||16
8192794|NCT02273973|20201237|P2|NOT COMPLETED|Overall Study||8
8192795|NCT02273973|20201238|P1|NOT COMPLETED|Overall Study||9
8192796|NCT02273973|20201237|P2|COMPLETED|Overall Study||160
8192797|NCT02273973|20201238|P1|COMPLETED|Overall Study||157
8192798|NCT02273973|20201237|P2|STARTED|Overall Study||168
8192799|NCT02273973|20201238|P1|STARTED|Overall Study||166
8192800|NCT02273960|20201282|P4|NOT COMPLETED|Long Term Extension||1
8192801|NCT02273960|20201283|P3|NOT COMPLETED|Long Term Extension||0
8192802|NCT02273960|20201284|P2|NOT COMPLETED|Long Term Extension||0
8192803|NCT02273960|20201285|P1|NOT COMPLETED|Long Term Extension||0
8192804|NCT02273960|20201282|P4|COMPLETED|Long Term Extension||3
8192805|NCT02273960|20201283|P3|COMPLETED|Long Term Extension||1
8192806|NCT02273960|20201284|P2|COMPLETED|Long Term Extension||0
8192807|NCT02273960|20201285|P1|COMPLETED|Long Term Extension||0
8192808|NCT02273960|20201282|P4|STARTED|Long Term Extension||4
8192809|NCT02273960|20201283|P3|STARTED|Long Term Extension||1
8192810|NCT02273960|20201284|P2|STARTED|Long Term Extension||0
8192811|NCT02273960|20201285|P1|STARTED|Long Term Extension||0
8192812|NCT02273960|20201282|P4|NOT COMPLETED|Short Term Period||6
8192813|NCT02273960|20201283|P3|NOT COMPLETED|Short Term Period||4
8192814|NCT02273960|20201284|P2|NOT COMPLETED|Short Term Period||6
8192815|NCT02273960|20201285|P1|NOT COMPLETED|Short Term Period||5
8192816|NCT02273960|20201282|P4|COMPLETED|Short Term Period||4
8192817|NCT02273960|20201283|P3|COMPLETED|Short Term Period||1
8192818|NCT02273960|20201284|P2|COMPLETED|Short Term Period||0
8192819|NCT02273960|20201285|P1|COMPLETED|Short Term Period||0
8192820|NCT02273960|20201282|P4|STARTED|Short Term Period||10
8192821|NCT02273960|20201283|P3|STARTED|Short Term Period||5
8192822|NCT02273960|20201284|P2|STARTED|Short Term Period||6
8192823|NCT02273960|20201285|P1|STARTED|Short Term Period||5
8192830|NCT02273752|20201352|P1|NOT COMPLETED|Overall Study||2
8192831|NCT02273752|20201352|P1|COMPLETED|Overall Study||0
8192832|NCT02273752|20201352|P1|STARTED|Overall Study||2
8192833|NCT02273323|20201363|P2|NOT COMPLETED|Overall Study||0
8192834|NCT02273323|20201364|P1|NOT COMPLETED|Overall Study||0
8192835|NCT02273323|20201363|P2|COMPLETED|Overall Study||15
8192836|NCT02273323|20201364|P1|COMPLETED|Overall Study||15
8192837|NCT02273323|20201363|P2|STARTED|Overall Study||15
8192838|NCT02273323|20201364|P1|STARTED|Overall Study||15
8192839|NCT02273310|20201382|P2|NOT COMPLETED|Overall Study||3
8192840|NCT02273310|20201383|P1|NOT COMPLETED|Overall Study||18
8192841|NCT02273310|20201382|P2|COMPLETED|Overall Study||38
8192842|NCT02273310|20201383|P1|COMPLETED|Overall Study||24
8192843|NCT02273310|20201382|P2|STARTED|Overall Study||41
8192844|NCT02273310|20201383|P1|STARTED|Overall Study||42
8192845|NCT02273206|20201396|P2|NOT COMPLETED|Overall Study||42
8192846|NCT02273206|20201397|P1|NOT COMPLETED|Overall Study||25
8192847|NCT02273206|20201396|P2|COMPLETED|Overall Study||337
8192848|NCT02273206|20201397|P1|COMPLETED|Overall Study||353
8192849|NCT02273206|20201396|P2|STARTED|Overall Study||379
8192850|NCT02273206|20201397|P1|STARTED|Overall Study||378
8192851|NCT02273180|20201443|P2|NOT COMPLETED|Overall Study||19
8192852|NCT02273180|20201444|P1|NOT COMPLETED|Overall Study||27
8192853|NCT02273180|20201443|P2|COMPLETED|Overall Study||235
8192854|NCT02273180|20201444|P1|COMPLETED|Overall Study||226
8192855|NCT02273180|20201443|P2|Treated|Overall Study||254
8192856|NCT02273180|20201444|P1|Treated|Overall Study||252
8192857|NCT02273180|20201443|P2|STARTED|Overall Study||254
8192858|NCT02273180|20201444|P1|STARTED|Overall Study||253
8192859|NCT02273167|20201469|P3|NOT COMPLETED|Overall Study||21
8192860|NCT02273167|20201470|P2|NOT COMPLETED|Overall Study||23
8192861|NCT02273167|20201471|P1|NOT COMPLETED|Overall Study||24
8192862|NCT02273167|20201469|P3|COMPLETED|Overall Study||262
8192863|NCT02273167|20201470|P2|COMPLETED|Overall Study||260
8192864|NCT02273167|20201471|P1|COMPLETED|Overall Study||259
8192865|NCT02273167|20201469|P3|STARTED|Overall Study||283
8192866|NCT02273167|20201470|P2|STARTED|Overall Study||283
8192867|NCT02273167|20201471|P1|STARTED|Overall Study||283
8192868|NCT02273141|20201496|P2|NOT COMPLETED|Overall Study||25
8192869|NCT02273141|20201497|P1|NOT COMPLETED|Overall Study||17
8192870|NCT02273141|20201496|P2|COMPLETED|Overall Study||233
8192871|NCT02273141|20201497|P1|COMPLETED|Overall Study||240
8192872|NCT02273141|20201496|P2|STARTED|Overall Study||258
8192873|NCT02273141|20201497|P1|STARTED|Overall Study||257
8192874|NCT02273115|20201517|P4|NOT COMPLETED|Overall Study||1
8192875|NCT02273115|20201518|P3|NOT COMPLETED|Overall Study||0
8192876|NCT02273115|20201519|P2|NOT COMPLETED|Overall Study||0
8192877|NCT02273115|20201520|P1|NOT COMPLETED|Overall Study||0
8192878|NCT02273115|20201517|P4|COMPLETED|Overall Study||71
8192879|NCT02273115|20201518|P3|COMPLETED|Overall Study||67
8192880|NCT02273115|20201519|P2|COMPLETED|Overall Study||90
8192881|NCT02273115|20201520|P1|COMPLETED|Overall Study||94
8192882|NCT02273115|20201517|P4|STARTED|Overall Study||72
8192883|NCT02273115|20201518|P3|STARTED|Overall Study||67
8192884|NCT02273115|20201519|P2|STARTED|Overall Study||90
8192885|NCT02273115|20201520|P1|STARTED|Overall Study||94
8192886|NCT02273063|20201562|P1|NOT COMPLETED|Overall Study||5
8192887|NCT02273063|20201562|P1|COMPLETED|Overall Study||35
8192888|NCT02273063|20201562|P1|STARTED|Overall Study||40
8192889|NCT02273050|20201570|P3|NOT COMPLETED|Overall Study||29
8192890|NCT02273050|20201571|P2|NOT COMPLETED|Overall Study||22
8192891|NCT02273050|20201572|P1|NOT COMPLETED|Overall Study||24
8192892|NCT02273050|20201570|P3|COMPLETED|Overall Study||185
8192893|NCT02273050|20201571|P2|COMPLETED|Overall Study||194
8192894|NCT02273050|20201572|P1|COMPLETED|Overall Study||186
8192895|NCT02273050|20201570|P3|STARTED|Overall Study||214
8192896|NCT02273050|20201571|P2|STARTED|Overall Study||216
8192897|NCT02273050|20201572|P1|STARTED|Overall Study||210
8192898|NCT02273037|20201600|P2|NOT COMPLETED|Overall Study||8
8192899|NCT02273037|20201601|P1|NOT COMPLETED|Overall Study||8
8192900|NCT02273037|20201600|P2|COMPLETED|Overall Study||992
8192901|NCT02273037|20201601|P1|COMPLETED|Overall Study||979
8192902|NCT02273037|20201600|P2|STARTED|Overall Study||1000
8192903|NCT02273037|20201601|P1|STARTED|Overall Study||987
8192904|NCT02272985|20201611|P1|NOT COMPLETED|Overall Study||3
8192905|NCT02272985|20201611|P1|COMPLETED|Overall Study||12
8192906|NCT02272985|20201611|P1|STARTED|Overall Study||15
8192907|NCT02272816|20201616|P1|NOT COMPLETED|Overall Study||1
8192908|NCT02272816|20201616|P1|COMPLETED|Overall Study||47
8192909|NCT02272816|20201616|P1|STARTED|Overall Study||48
8192910|NCT02272803|20201624|P2|NOT COMPLETED|Overall Study||17
8192911|NCT02272803|20201625|P1|NOT COMPLETED|Overall Study||9
8192912|NCT02272803|20201624|P2|COMPLETED|Overall Study|Completed = Still receiving treatment|25
8192913|NCT02272803|20201625|P1|COMPLETED|Overall Study|Completed = Still receiving treatment|31
8192914|NCT02272803|20201624|P2|STARTED|Overall Study||42
8192915|NCT02272803|20201625|P1|STARTED|Overall Study||40
8192934|NCT02272777|20201783|P2|NOT COMPLETED|Overall Study||4
8192935|NCT02272777|20201784|P1|NOT COMPLETED|Overall Study||4
8192936|NCT02272777|20201783|P2|COMPLETED|Overall Study||109
8192937|NCT02272777|20201784|P1|COMPLETED|Overall Study||108
8192938|NCT02272777|20201783|P2|STARTED|Overall Study||113
8192939|NCT02272777|20201784|P1|STARTED|Overall Study||112
8192940|NCT02272725|20201792|P2|NOT COMPLETED|Overall Study||0
8192941|NCT02272725|20201793|P1|NOT COMPLETED|Overall Study||2
8192942|NCT02272725|20201792|P2|COMPLETED|Overall Study||42
8192943|NCT02272725|20201793|P1|COMPLETED|Overall Study||47
8192944|NCT02272725|20201792|P2|STARTED|Overall Study||42
8192945|NCT02272725|20201793|P1|STARTED|Overall Study||49
8192946|NCT02272686|20201803|P1|NOT COMPLETED|Overall Study||0
8192947|NCT02272686|20201803|P1|COMPLETED|Overall Study||1
8192948|NCT02272686|20201803|P1|STARTED|Overall Study||1
8192949|NCT02272413|20201810|P2|NOT COMPLETED|Post-switch Period||46
8192950|NCT02272413|20201811|P1|NOT COMPLETED|Post-switch Period||42
8192951|NCT02272413|20201810|P2|COMPLETED|Post-switch Period||0
8192952|NCT02272413|20201811|P1|COMPLETED|Post-switch Period||0
8192953|NCT02272413|20201810|P2|STARTED|Post-switch Period|Started for this period|46
8192954|NCT02272413|20201811|P1|STARTED|Post-switch Period|Started for this period|42
8192955|NCT02272413|20201810|P2|NOT COMPLETED|Pre-switch Period||282
8192956|NCT02272413|20201811|P1|NOT COMPLETED|Pre-switch Period||293
8192957|NCT02272413|20201810|P2|COMPLETED|Pre-switch Period||46
8192958|NCT02272413|20201811|P1|COMPLETED|Pre-switch Period||42
8192959|NCT02272413|20201810|P2|STARTED|Pre-switch Period|Started for this period|328
8192960|NCT02272413|20201811|P1|STARTED|Pre-switch Period|Started for this period|335
8192961|NCT02272413|20201810|P2|NOT COMPLETED|Randomized Through Treatment Start||5
8192962|NCT02272413|20201811|P1|NOT COMPLETED|Randomized Through Treatment Start||3
8192963|NCT02272413|20201810|P2|COMPLETED|Randomized Through Treatment Start||328
8192964|NCT02272413|20201811|P1|COMPLETED|Randomized Through Treatment Start||335
8192965|NCT02272413|20201810|P2|Treated|Randomized Through Treatment Start||328
8192966|NCT02272413|20201811|P1|Treated|Randomized Through Treatment Start||335
8192967|NCT02272413|20201810|P2|STARTED|Randomized Through Treatment Start|Started for this period|333
8192968|NCT02272413|20201811|P1|STARTED|Randomized Through Treatment Start|Started for this period|338
8192969|NCT02272244|20201829|P2|NOT COMPLETED|Overall Study||0
8192970|NCT02272244|20201830|P1|NOT COMPLETED|Overall Study||0
8192971|NCT02272244|20201829|P2|COMPLETED|Overall Study||197
8192972|NCT02272244|20201830|P1|COMPLETED|Overall Study||203
8192973|NCT02272244|20201829|P2|STARTED|Overall Study||197
8192974|NCT02272244|20201830|P1|STARTED|Overall Study||203
8192975|NCT02271984|20201842|P12|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192976|NCT02271984|20201843|P11|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192977|NCT02271984|20201844|P10|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192978|NCT02271984|20201845|P9|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192979|NCT02271984|20201846|P8|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192980|NCT02271984|20201847|P7|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192981|NCT02271984|20201848|P6|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192982|NCT02271984|20201849|P5|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192983|NCT02271984|20201850|P4|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192984|NCT02271984|20201851|P3|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192985|NCT02271984|20201852|P2|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192986|NCT02271984|20201853|P1|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
8192987|NCT02271984|20201842|P12|COMPLETED|Fifth Intervention Period (1 Day)||3
8192988|NCT02271984|20201843|P11|COMPLETED|Fifth Intervention Period (1 Day)||3
8192989|NCT02271984|20201844|P10|COMPLETED|Fifth Intervention Period (1 Day)||3
8192990|NCT02271984|20201845|P9|COMPLETED|Fifth Intervention Period (1 Day)||3
8192991|NCT02271984|20201846|P8|COMPLETED|Fifth Intervention Period (1 Day)||2
8192992|NCT02271984|20201847|P7|COMPLETED|Fifth Intervention Period (1 Day)||3
8192993|NCT02271984|20201848|P6|COMPLETED|Fifth Intervention Period (1 Day)||2
8192994|NCT02271984|20201849|P5|COMPLETED|Fifth Intervention Period (1 Day)||3
8192995|NCT02271984|20201850|P4|COMPLETED|Fifth Intervention Period (1 Day)||3
8192996|NCT02271984|20201851|P3|COMPLETED|Fifth Intervention Period (1 Day)||3
8192997|NCT02271984|20201852|P2|COMPLETED|Fifth Intervention Period (1 Day)||3
8192998|NCT02271984|20201853|P1|COMPLETED|Fifth Intervention Period (1 Day)||3
8192999|NCT02271984|20201842|P12|STARTED|Fifth Intervention Period (1 Day)||3
8193000|NCT02271984|20201843|P11|STARTED|Fifth Intervention Period (1 Day)||3
8193001|NCT02271984|20201844|P10|STARTED|Fifth Intervention Period (1 Day)||3
8193002|NCT02271984|20201845|P9|STARTED|Fifth Intervention Period (1 Day)||3
8193003|NCT02271984|20201846|P8|STARTED|Fifth Intervention Period (1 Day)||2
8193004|NCT02271984|20201847|P7|STARTED|Fifth Intervention Period (1 Day)||3
8193005|NCT02271984|20201848|P6|STARTED|Fifth Intervention Period (1 Day)||2
8193006|NCT02271984|20201849|P5|STARTED|Fifth Intervention Period (1 Day)||3
8193007|NCT02271984|20201850|P4|STARTED|Fifth Intervention Period (1 Day)||3
8193008|NCT02271984|20201851|P3|STARTED|Fifth Intervention Period (1 Day)||3
8193009|NCT02271984|20201852|P2|STARTED|Fifth Intervention Period (1 Day)||3
8193010|NCT02271984|20201853|P1|STARTED|Fifth Intervention Period (1 Day)||3
8193011|NCT02271984|20201842|P12|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193012|NCT02271984|20201843|P11|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193013|NCT02271984|20201844|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193014|NCT02271984|20201845|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193015|NCT02271984|20201846|P8|NOT COMPLETED|Washout Period 4 (7 Days)||1
8193016|NCT02271984|20201847|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193017|NCT02271984|20201848|P6|NOT COMPLETED|Washout Period 4 (7 Days)||1
8193018|NCT02271984|20201849|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193019|NCT02271984|20201850|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193020|NCT02271984|20201851|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193021|NCT02271984|20201852|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193022|NCT02271984|20201853|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
8193023|NCT02271984|20201842|P12|COMPLETED|Washout Period 4 (7 Days)||3
8193024|NCT02271984|20201843|P11|COMPLETED|Washout Period 4 (7 Days)||3
8193025|NCT02271984|20201844|P10|COMPLETED|Washout Period 4 (7 Days)||3
8193026|NCT02271984|20201845|P9|COMPLETED|Washout Period 4 (7 Days)||3
8193027|NCT02271984|20201846|P8|COMPLETED|Washout Period 4 (7 Days)||2
8193028|NCT02271984|20201847|P7|COMPLETED|Washout Period 4 (7 Days)||3
8193029|NCT02271984|20201848|P6|COMPLETED|Washout Period 4 (7 Days)||2
8193030|NCT02271984|20201849|P5|COMPLETED|Washout Period 4 (7 Days)||3
8193031|NCT02271984|20201850|P4|COMPLETED|Washout Period 4 (7 Days)||3
8193032|NCT02271984|20201851|P3|COMPLETED|Washout Period 4 (7 Days)||3
8193033|NCT02271984|20201852|P2|COMPLETED|Washout Period 4 (7 Days)||3
8193034|NCT02271984|20201853|P1|COMPLETED|Washout Period 4 (7 Days)||3
8193035|NCT02271984|20201842|P12|STARTED|Washout Period 4 (7 Days)||3
8193036|NCT02271984|20201843|P11|STARTED|Washout Period 4 (7 Days)||3
8193037|NCT02271984|20201844|P10|STARTED|Washout Period 4 (7 Days)||3
8193038|NCT02271984|20201845|P9|STARTED|Washout Period 4 (7 Days)||3
8193039|NCT02271984|20201846|P8|STARTED|Washout Period 4 (7 Days)||3
8193040|NCT02271984|20201847|P7|STARTED|Washout Period 4 (7 Days)||3
8193041|NCT02271984|20201848|P6|STARTED|Washout Period 4 (7 Days)||3
8193042|NCT02271984|20201849|P5|STARTED|Washout Period 4 (7 Days)||3
8193043|NCT02271984|20201850|P4|STARTED|Washout Period 4 (7 Days)||3
8193044|NCT02271984|20201851|P3|STARTED|Washout Period 4 (7 Days)||3
8193045|NCT02271984|20201852|P2|STARTED|Washout Period 4 (7 Days)||3
8193046|NCT02271984|20201853|P1|STARTED|Washout Period 4 (7 Days)||3
8193047|NCT02271984|20201842|P12|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193048|NCT02271984|20201843|P11|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193049|NCT02271984|20201844|P10|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193050|NCT02271984|20201845|P9|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193051|NCT02271984|20201846|P8|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193052|NCT02271984|20201847|P7|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193053|NCT02271984|20201848|P6|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193054|NCT02271984|20201849|P5|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193055|NCT02271984|20201850|P4|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193056|NCT02271984|20201851|P3|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193057|NCT02271984|20201852|P2|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193058|NCT02271984|20201853|P1|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
8193059|NCT02271984|20201842|P12|COMPLETED|Fourth Intervention Period (Day 1)||3
8193060|NCT02271984|20201843|P11|COMPLETED|Fourth Intervention Period (Day 1)||3
8193061|NCT02271984|20201844|P10|COMPLETED|Fourth Intervention Period (Day 1)||3
8193062|NCT02271984|20201845|P9|COMPLETED|Fourth Intervention Period (Day 1)||3
8193063|NCT02271984|20201846|P8|COMPLETED|Fourth Intervention Period (Day 1)||3
8193064|NCT02271984|20201847|P7|COMPLETED|Fourth Intervention Period (Day 1)||3
8193065|NCT02271984|20201848|P6|COMPLETED|Fourth Intervention Period (Day 1)||3
8193066|NCT02271984|20201849|P5|COMPLETED|Fourth Intervention Period (Day 1)||3
8193067|NCT02271984|20201850|P4|COMPLETED|Fourth Intervention Period (Day 1)||3
8193068|NCT02271984|20201851|P3|COMPLETED|Fourth Intervention Period (Day 1)||3
8193069|NCT02271984|20201852|P2|COMPLETED|Fourth Intervention Period (Day 1)||3
8193070|NCT02271984|20201853|P1|COMPLETED|Fourth Intervention Period (Day 1)||3
8193071|NCT02271984|20201842|P12|STARTED|Fourth Intervention Period (Day 1)||3
8193072|NCT02271984|20201843|P11|STARTED|Fourth Intervention Period (Day 1)||3
8193073|NCT02271984|20201844|P10|STARTED|Fourth Intervention Period (Day 1)||3
8193074|NCT02271984|20201845|P9|STARTED|Fourth Intervention Period (Day 1)||3
8193075|NCT02271984|20201846|P8|STARTED|Fourth Intervention Period (Day 1)||3
8193076|NCT02271984|20201847|P7|STARTED|Fourth Intervention Period (Day 1)||3
8193077|NCT02271984|20201848|P6|STARTED|Fourth Intervention Period (Day 1)||3
8193078|NCT02271984|20201849|P5|STARTED|Fourth Intervention Period (Day 1)||3
8193079|NCT02271984|20201850|P4|STARTED|Fourth Intervention Period (Day 1)||3
8193080|NCT02271984|20201851|P3|STARTED|Fourth Intervention Period (Day 1)||3
8193081|NCT02271984|20201852|P2|STARTED|Fourth Intervention Period (Day 1)||3
8193082|NCT02271984|20201853|P1|STARTED|Fourth Intervention Period (Day 1)||3
8193083|NCT02271984|20201842|P12|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193084|NCT02271984|20201843|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193085|NCT02271984|20201844|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193086|NCT02271984|20201845|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193087|NCT02271984|20201846|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193088|NCT02271984|20201847|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193089|NCT02271984|20201848|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193090|NCT02271984|20201849|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193091|NCT02271984|20201850|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193092|NCT02271984|20201851|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193093|NCT02271984|20201852|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193094|NCT02271984|20201853|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8193095|NCT02271984|20201842|P12|COMPLETED|Washout Period 3 (7 Days)||3
8193096|NCT02271984|20201843|P11|COMPLETED|Washout Period 3 (7 Days)||3
8193097|NCT02271984|20201844|P10|COMPLETED|Washout Period 3 (7 Days)||3
8193098|NCT02271984|20201845|P9|COMPLETED|Washout Period 3 (7 Days)||3
8193099|NCT02271984|20201846|P8|COMPLETED|Washout Period 3 (7 Days)||3
8193100|NCT02271984|20201847|P7|COMPLETED|Washout Period 3 (7 Days)||3
8193101|NCT02271984|20201848|P6|COMPLETED|Washout Period 3 (7 Days)||3
8193102|NCT02271984|20201849|P5|COMPLETED|Washout Period 3 (7 Days)||3
8193103|NCT02271984|20201850|P4|COMPLETED|Washout Period 3 (7 Days)||3
8193104|NCT02271984|20201851|P3|COMPLETED|Washout Period 3 (7 Days)||3
8193105|NCT02271984|20201852|P2|COMPLETED|Washout Period 3 (7 Days)||3
8193106|NCT02271984|20201853|P1|COMPLETED|Washout Period 3 (7 Days)||3
8193107|NCT02271984|20201842|P12|STARTED|Washout Period 3 (7 Days)||3
8193108|NCT02271984|20201843|P11|STARTED|Washout Period 3 (7 Days)||3
8193109|NCT02271984|20201844|P10|STARTED|Washout Period 3 (7 Days)||3
8193110|NCT02271984|20201845|P9|STARTED|Washout Period 3 (7 Days)||3
8193111|NCT02271984|20201846|P8|STARTED|Washout Period 3 (7 Days)||3
8193112|NCT02271984|20201847|P7|STARTED|Washout Period 3 (7 Days)||3
8193113|NCT02271984|20201848|P6|STARTED|Washout Period 3 (7 Days)||3
8193114|NCT02271984|20201849|P5|STARTED|Washout Period 3 (7 Days)||3
8193115|NCT02271984|20201850|P4|STARTED|Washout Period 3 (7 Days)||3
8193116|NCT02271984|20201851|P3|STARTED|Washout Period 3 (7 Days)||3
8193117|NCT02271984|20201852|P2|STARTED|Washout Period 3 (7 Days)||3
8193118|NCT02271984|20201853|P1|STARTED|Washout Period 3 (7 Days)||3
8193119|NCT02271984|20201842|P12|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193120|NCT02271984|20201843|P11|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193121|NCT02271984|20201844|P10|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193122|NCT02271984|20201845|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193123|NCT02271984|20201846|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193124|NCT02271984|20201847|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193125|NCT02271984|20201848|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193126|NCT02271984|20201849|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193127|NCT02271984|20201850|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193128|NCT02271984|20201851|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193129|NCT02271984|20201852|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193130|NCT02271984|20201853|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
8193131|NCT02271984|20201842|P12|COMPLETED|Third Intervention Period (1 Day)||3
8193132|NCT02271984|20201843|P11|COMPLETED|Third Intervention Period (1 Day)||3
8193133|NCT02271984|20201844|P10|COMPLETED|Third Intervention Period (1 Day)||3
8193134|NCT02271984|20201845|P9|COMPLETED|Third Intervention Period (1 Day)||3
8193135|NCT02271984|20201846|P8|COMPLETED|Third Intervention Period (1 Day)||3
8193136|NCT02271984|20201847|P7|COMPLETED|Third Intervention Period (1 Day)||3
8193137|NCT02271984|20201848|P6|COMPLETED|Third Intervention Period (1 Day)||3
8193138|NCT02271984|20201849|P5|COMPLETED|Third Intervention Period (1 Day)||3
8193139|NCT02271984|20201850|P4|COMPLETED|Third Intervention Period (1 Day)||3
8193140|NCT02271984|20201851|P3|COMPLETED|Third Intervention Period (1 Day)||3
8193141|NCT02271984|20201852|P2|COMPLETED|Third Intervention Period (1 Day)||3
8193142|NCT02271984|20201853|P1|COMPLETED|Third Intervention Period (1 Day)||3
8193143|NCT02271984|20201842|P12|STARTED|Third Intervention Period (1 Day)||3
8193144|NCT02271984|20201843|P11|STARTED|Third Intervention Period (1 Day)||3
8193145|NCT02271984|20201844|P10|STARTED|Third Intervention Period (1 Day)||3
8193146|NCT02271984|20201845|P9|STARTED|Third Intervention Period (1 Day)||3
8193147|NCT02271984|20201846|P8|STARTED|Third Intervention Period (1 Day)||3
8193148|NCT02271984|20201847|P7|STARTED|Third Intervention Period (1 Day)||3
8193149|NCT02271984|20201848|P6|STARTED|Third Intervention Period (1 Day)||3
8193150|NCT02271984|20201849|P5|STARTED|Third Intervention Period (1 Day)||3
8193151|NCT02271984|20201850|P4|STARTED|Third Intervention Period (1 Day)||3
8193152|NCT02271984|20201851|P3|STARTED|Third Intervention Period (1 Day)||3
8193153|NCT02271984|20201852|P2|STARTED|Third Intervention Period (1 Day)||3
8193154|NCT02271984|20201853|P1|STARTED|Third Intervention Period (1 Day)||3
8193155|NCT02271984|20201842|P12|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193156|NCT02271984|20201843|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193157|NCT02271984|20201844|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193158|NCT02271984|20201845|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193159|NCT02271984|20201846|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193160|NCT02271984|20201847|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193161|NCT02271984|20201848|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193162|NCT02271984|20201849|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193163|NCT02271984|20201850|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193164|NCT02271984|20201851|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193165|NCT02271984|20201852|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193166|NCT02271984|20201853|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8193167|NCT02271984|20201842|P12|COMPLETED|Washout Period 2 (7 Days)||3
8193168|NCT02271984|20201843|P11|COMPLETED|Washout Period 2 (7 Days)||3
8193169|NCT02271984|20201844|P10|COMPLETED|Washout Period 2 (7 Days)||3
8193170|NCT02271984|20201845|P9|COMPLETED|Washout Period 2 (7 Days)||3
8193171|NCT02271984|20201846|P8|COMPLETED|Washout Period 2 (7 Days)||3
8193172|NCT02271984|20201847|P7|COMPLETED|Washout Period 2 (7 Days)||3
8193173|NCT02271984|20201848|P6|COMPLETED|Washout Period 2 (7 Days)||3
8193174|NCT02271984|20201849|P5|COMPLETED|Washout Period 2 (7 Days)||3
8193175|NCT02271984|20201850|P4|COMPLETED|Washout Period 2 (7 Days)||3
8193176|NCT02271984|20201851|P3|COMPLETED|Washout Period 2 (7 Days)||3
8193177|NCT02271984|20201852|P2|COMPLETED|Washout Period 2 (7 Days)||3
8193178|NCT02271984|20201853|P1|COMPLETED|Washout Period 2 (7 Days)||3
8193179|NCT02271984|20201842|P12|STARTED|Washout Period 2 (7 Days)||3
8193180|NCT02271984|20201843|P11|STARTED|Washout Period 2 (7 Days)||3
8193181|NCT02271984|20201844|P10|STARTED|Washout Period 2 (7 Days)||3
8193182|NCT02271984|20201845|P9|STARTED|Washout Period 2 (7 Days)||3
8193183|NCT02271984|20201846|P8|STARTED|Washout Period 2 (7 Days)||3
8193184|NCT02271984|20201847|P7|STARTED|Washout Period 2 (7 Days)||3
8193185|NCT02271984|20201848|P6|STARTED|Washout Period 2 (7 Days)||3
8193186|NCT02271984|20201849|P5|STARTED|Washout Period 2 (7 Days)||3
8193187|NCT02271984|20201850|P4|STARTED|Washout Period 2 (7 Days)||3
8193188|NCT02271984|20201851|P3|STARTED|Washout Period 2 (7 Days)||3
8193189|NCT02271984|20201852|P2|STARTED|Washout Period 2 (7 Days)||3
8193190|NCT02271984|20201853|P1|STARTED|Washout Period 2 (7 Days)||3
8193191|NCT02271984|20201842|P12|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193192|NCT02271984|20201843|P11|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193193|NCT02271984|20201844|P10|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193194|NCT02271984|20201845|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193195|NCT02271984|20201846|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193196|NCT02271984|20201847|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193197|NCT02271984|20201848|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193198|NCT02271984|20201849|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193199|NCT02271984|20201850|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193200|NCT02271984|20201851|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193201|NCT02271984|20201852|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193202|NCT02271984|20201853|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
8193203|NCT02271984|20201842|P12|COMPLETED|Second Intervention Period (1 Day)||3
8193204|NCT02271984|20201843|P11|COMPLETED|Second Intervention Period (1 Day)||3
8193205|NCT02271984|20201844|P10|COMPLETED|Second Intervention Period (1 Day)||3
8193206|NCT02271984|20201845|P9|COMPLETED|Second Intervention Period (1 Day)||3
8193207|NCT02271984|20201846|P8|COMPLETED|Second Intervention Period (1 Day)||3
8193208|NCT02271984|20201847|P7|COMPLETED|Second Intervention Period (1 Day)||3
8193209|NCT02271984|20201848|P6|COMPLETED|Second Intervention Period (1 Day)||3
8193210|NCT02271984|20201849|P5|COMPLETED|Second Intervention Period (1 Day)||3
8193211|NCT02271984|20201850|P4|COMPLETED|Second Intervention Period (1 Day)||3
8193212|NCT02271984|20201851|P3|COMPLETED|Second Intervention Period (1 Day)||3
8193213|NCT02271984|20201852|P2|COMPLETED|Second Intervention Period (1 Day)||3
8193214|NCT02271984|20201853|P1|COMPLETED|Second Intervention Period (1 Day)||3
8193215|NCT02271984|20201842|P12|STARTED|Second Intervention Period (1 Day)||3
8193216|NCT02271984|20201843|P11|STARTED|Second Intervention Period (1 Day)||3
8193217|NCT02271984|20201844|P10|STARTED|Second Intervention Period (1 Day)||3
8193218|NCT02271984|20201845|P9|STARTED|Second Intervention Period (1 Day)||3
8193219|NCT02271984|20201846|P8|STARTED|Second Intervention Period (1 Day)||3
8193220|NCT02271984|20201847|P7|STARTED|Second Intervention Period (1 Day)||3
8193221|NCT02271984|20201848|P6|STARTED|Second Intervention Period (1 Day)||3
8193222|NCT02271984|20201849|P5|STARTED|Second Intervention Period (1 Day)||3
8193223|NCT02271984|20201850|P4|STARTED|Second Intervention Period (1 Day)||3
8193224|NCT02271984|20201851|P3|STARTED|Second Intervention Period (1 Day)||3
8193225|NCT02271984|20201852|P2|STARTED|Second Intervention Period (1 Day)||3
8193226|NCT02271984|20201853|P1|STARTED|Second Intervention Period (1 Day)||3
8193227|NCT02271984|20201842|P12|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193228|NCT02271984|20201843|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193229|NCT02271984|20201844|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193230|NCT02271984|20201845|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193231|NCT02271984|20201846|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193232|NCT02271984|20201847|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193233|NCT02271984|20201848|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193234|NCT02271984|20201849|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193235|NCT02271984|20201850|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193236|NCT02271984|20201851|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193237|NCT02271984|20201852|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193238|NCT02271984|20201853|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8193239|NCT02271984|20201842|P12|COMPLETED|Washout Period 1 (7 Days)||3
8193240|NCT02271984|20201843|P11|COMPLETED|Washout Period 1 (7 Days)||3
8193241|NCT02271984|20201844|P10|COMPLETED|Washout Period 1 (7 Days)||3
8193242|NCT02271984|20201845|P9|COMPLETED|Washout Period 1 (7 Days)||3
8193243|NCT02271984|20201846|P8|COMPLETED|Washout Period 1 (7 Days)||3
8193244|NCT02271984|20201847|P7|COMPLETED|Washout Period 1 (7 Days)||3
8193245|NCT02271984|20201848|P6|COMPLETED|Washout Period 1 (7 Days)||3
8193246|NCT02271984|20201849|P5|COMPLETED|Washout Period 1 (7 Days)||3
8193247|NCT02271984|20201850|P4|COMPLETED|Washout Period 1 (7 Days)||3
8193248|NCT02271984|20201851|P3|COMPLETED|Washout Period 1 (7 Days)||3
8193249|NCT02271984|20201852|P2|COMPLETED|Washout Period 1 (7 Days)||3
8193250|NCT02271984|20201853|P1|COMPLETED|Washout Period 1 (7 Days)||3
8193251|NCT02271984|20201842|P12|STARTED|Washout Period 1 (7 Days)||3
8193252|NCT02271984|20201843|P11|STARTED|Washout Period 1 (7 Days)||3
8193253|NCT02271984|20201844|P10|STARTED|Washout Period 1 (7 Days)||3
8193254|NCT02271984|20201845|P9|STARTED|Washout Period 1 (7 Days)||3
8193255|NCT02271984|20201846|P8|STARTED|Washout Period 1 (7 Days)||3
8193256|NCT02271984|20201847|P7|STARTED|Washout Period 1 (7 Days)||3
8193257|NCT02271984|20201848|P6|STARTED|Washout Period 1 (7 Days)||3
8193258|NCT02271984|20201849|P5|STARTED|Washout Period 1 (7 Days)||3
8193259|NCT02271984|20201850|P4|STARTED|Washout Period 1 (7 Days)||3
8193260|NCT02271984|20201851|P3|STARTED|Washout Period 1 (7 Days)||3
8193261|NCT02271984|20201852|P2|STARTED|Washout Period 1 (7 Days)||3
8193262|NCT02271984|20201853|P1|STARTED|Washout Period 1 (7 Days)||3
8193263|NCT02271984|20201842|P12|NOT COMPLETED|First Intervention Period (1 Day)||0
8193264|NCT02271984|20201843|P11|NOT COMPLETED|First Intervention Period (1 Day)||0
8193265|NCT02271984|20201844|P10|NOT COMPLETED|First Intervention Period (1 Day)||0
8193266|NCT02271984|20201845|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
8193267|NCT02271984|20201846|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
8193268|NCT02271984|20201847|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
8193269|NCT02271984|20201848|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
8193270|NCT02271984|20201849|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
8193271|NCT02271984|20201850|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
8193272|NCT02271984|20201851|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
8193273|NCT02271984|20201852|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
8193274|NCT02271984|20201853|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
8193275|NCT02271984|20201842|P12|COMPLETED|First Intervention Period (1 Day)||3
8193276|NCT02271984|20201843|P11|COMPLETED|First Intervention Period (1 Day)||3
8193277|NCT02271984|20201844|P10|COMPLETED|First Intervention Period (1 Day)||3
8193278|NCT02271984|20201845|P9|COMPLETED|First Intervention Period (1 Day)||3
8193279|NCT02271984|20201846|P8|COMPLETED|First Intervention Period (1 Day)||3
8193280|NCT02271984|20201847|P7|COMPLETED|First Intervention Period (1 Day)||3
8193281|NCT02271984|20201848|P6|COMPLETED|First Intervention Period (1 Day)||3
8193282|NCT02271984|20201849|P5|COMPLETED|First Intervention Period (1 Day)||3
8193283|NCT02271984|20201850|P4|COMPLETED|First Intervention Period (1 Day)||3
8193284|NCT02271984|20201851|P3|COMPLETED|First Intervention Period (1 Day)||3
8193285|NCT02271984|20201852|P2|COMPLETED|First Intervention Period (1 Day)||3
8193286|NCT02271984|20201853|P1|COMPLETED|First Intervention Period (1 Day)||3
8193287|NCT02271984|20201842|P12|STARTED|First Intervention Period (1 Day)||3
8193288|NCT02271984|20201843|P11|STARTED|First Intervention Period (1 Day)||3
8193289|NCT02271984|20201844|P10|STARTED|First Intervention Period (1 Day)||3
8193290|NCT02271984|20201845|P9|STARTED|First Intervention Period (1 Day)||3
8193291|NCT02271984|20201846|P8|STARTED|First Intervention Period (1 Day)||3
8193292|NCT02271984|20201847|P7|STARTED|First Intervention Period (1 Day)||3
8193293|NCT02271984|20201848|P6|STARTED|First Intervention Period (1 Day)||3
8193294|NCT02271984|20201849|P5|STARTED|First Intervention Period (1 Day)||3
8193295|NCT02271984|20201850|P4|STARTED|First Intervention Period (1 Day)||3
8193296|NCT02271984|20201851|P3|STARTED|First Intervention Period (1 Day)||3
8193297|NCT02271984|20201852|P2|STARTED|First Intervention Period (1 Day)||3
8193298|NCT02271984|20201853|P1|STARTED|First Intervention Period (1 Day)||3
8193299|NCT02271945|20201942|P2|NOT COMPLETED|Overall Study||5
8193300|NCT02271945|20201943|P1|NOT COMPLETED|Overall Study||5
8193301|NCT02271945|20201942|P2|COMPLETED|Overall Study||0
8193302|NCT02271945|20201943|P1|COMPLETED|Overall Study||0
8193303|NCT02271945|20201942|P2|STARTED|Overall Study||5
8193304|NCT02271945|20201943|P1|STARTED|Overall Study||5
8193305|NCT02271906|20201979|P1|NOT COMPLETED|Overall Study||0
8193306|NCT02271906|20201979|P1|COMPLETED|Overall Study||2
8193307|NCT02271906|20201979|P1|STARTED|Overall Study||2
8193308|NCT02271880|20201986|P2|NOT COMPLETED|Overall Study||4
8193309|NCT02271880|20201987|P1|NOT COMPLETED|Overall Study||3
8193310|NCT02271880|20201986|P2|COMPLETED|Overall Study||0
8193311|NCT02271880|20201987|P1|COMPLETED|Overall Study||0
8193312|NCT02271880|20201986|P2|STARTED|Overall Study||4
8193313|NCT02271880|20201987|P1|STARTED|Overall Study||3
8193314|NCT02271854|20202017|P1|NOT COMPLETED|Overall Study||4
8193315|NCT02271854|20202017|P1|COMPLETED|Overall Study||98
8193316|NCT02271854|20202017|P1|STARTED|Overall Study||102
8193317|NCT02271698|20202028|P4|NOT COMPLETED|Overall Study||0
8193318|NCT02271698|20202029|P3|NOT COMPLETED|Overall Study||0
8193319|NCT02271698|20202030|P2|NOT COMPLETED|Overall Study||0
8193320|NCT02271698|20202031|P1|NOT COMPLETED|Overall Study||0
8193321|NCT02271698|20202028|P4|COMPLETED|Overall Study||11
8193322|NCT02271698|20202029|P3|COMPLETED|Overall Study||10
8193323|NCT02271698|20202030|P2|COMPLETED|Overall Study||10
8193324|NCT02271698|20202031|P1|COMPLETED|Overall Study||11
8193325|NCT02271698|20202028|P4|STARTED|Overall Study||11
8193326|NCT02271698|20202029|P3|STARTED|Overall Study||10
8193327|NCT02271698|20202030|P2|STARTED|Overall Study||10
8193328|NCT02271698|20202031|P1|STARTED|Overall Study||11
8193329|NCT02271529|20202057|P1|NOT COMPLETED|Overall Study||1
8193330|NCT02271529|20202057|P1|COMPLETED|Overall Study||39
8193331|NCT02271529|20202057|P1|STARTED|Overall Study||40
8193332|NCT02271477|20202063|P2|NOT COMPLETED|Overall Study||0
8193333|NCT02271477|20202064|P1|NOT COMPLETED|Overall Study||0
8193334|NCT02271477|20202063|P2|COMPLETED|Overall Study||80
8193335|NCT02271477|20202064|P1|COMPLETED|Overall Study||80
8193336|NCT02271477|20202063|P2|STARTED|Overall Study||80
8193337|NCT02271477|20202064|P1|STARTED|Overall Study||80
8193338|NCT02271451|20202078|P2|NOT COMPLETED|Overall Study||1
8193339|NCT02271451|20202079|P1|NOT COMPLETED|Overall Study||0
8193340|NCT02271451|20202078|P2|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7
8193341|NCT02271451|20202079|P1|COMPLETED|Overall Study||7
8193342|NCT02271451|20202078|P2|STARTED|Overall Study||8
8193343|NCT02271451|20202079|P1|STARTED|Overall Study||7
8193344|NCT02271425|20202085|P1|NOT COMPLETED|Overall Study||0
8193345|NCT02271425|20202085|P1|COMPLETED|Overall Study||8
8193346|NCT02271425|20202085|P1|STARTED|Overall Study||8
8193347|NCT02271386|20202094|P4|NOT COMPLETED|Intervention Period- 8 Months||0
8193348|NCT02271386|20202095|P3|NOT COMPLETED|Intervention Period- 8 Months||0
8193349|NCT02271386|20202096|P2|NOT COMPLETED|Intervention Period- 8 Months||0
8193350|NCT02271386|20202097|P1|NOT COMPLETED|Intervention Period- 8 Months||0
8193351|NCT02271386|20202094|P4|COMPLETED|Intervention Period- 8 Months||197
8193352|NCT02271386|20202095|P3|COMPLETED|Intervention Period- 8 Months||202
8193353|NCT02271386|20202096|P2|COMPLETED|Intervention Period- 8 Months||52
8193354|NCT02271386|20202097|P1|COMPLETED|Intervention Period- 8 Months||53
8193355|NCT02271386|20202094|P4|STARTED|Intervention Period- 8 Months||197
8193356|NCT02271386|20202095|P3|STARTED|Intervention Period- 8 Months||202
8193357|NCT02271386|20202096|P2|STARTED|Intervention Period- 8 Months||52
8193358|NCT02271386|20202097|P1|STARTED|Intervention Period- 8 Months||53
8193359|NCT02271386|20202094|P4|NOT COMPLETED|Baseline Period- 8 Months||0
8193360|NCT02271386|20202095|P3|NOT COMPLETED|Baseline Period- 8 Months||0
8193361|NCT02271386|20202096|P2|NOT COMPLETED|Baseline Period- 8 Months||0
8193362|NCT02271386|20202097|P1|NOT COMPLETED|Baseline Period- 8 Months||0
8193363|NCT02271386|20202094|P4|COMPLETED|Baseline Period- 8 Months||191
8193364|NCT02271386|20202095|P3|COMPLETED|Baseline Period- 8 Months||200
8193365|NCT02271386|20202096|P2|COMPLETED|Baseline Period- 8 Months||52
8193366|NCT02271386|20202097|P1|COMPLETED|Baseline Period- 8 Months||53
8193367|NCT02271386|20202094|P4|STARTED|Baseline Period- 8 Months||191
8193368|NCT02271386|20202095|P3|STARTED|Baseline Period- 8 Months||200
8193369|NCT02271386|20202096|P2|STARTED|Baseline Period- 8 Months||52
8193370|NCT02271386|20202097|P1|STARTED|Baseline Period- 8 Months||53
8193371|NCT02271217|20202162|P3|NOT COMPLETED|Overall Study||12
8193372|NCT02271217|20202163|P2|NOT COMPLETED|Overall Study||13
8193373|NCT02271217|20202164|P1|NOT COMPLETED|Overall Study||11
8193374|NCT02271217|20202162|P3|COMPLETED|Overall Study||113
8193375|NCT02271217|20202163|P2|COMPLETED|Overall Study||113
8193376|NCT02271217|20202164|P1|COMPLETED|Overall Study||115
8193377|NCT02271217|20202162|P3|STARTED|Overall Study||125
8193378|NCT02271217|20202163|P2|STARTED|Overall Study||126
8193379|NCT02271217|20202164|P1|STARTED|Overall Study||126
8193380|NCT02270983|20202178|P3|NOT COMPLETED|Overall Study||12
8193381|NCT02270983|20202179|P2|NOT COMPLETED|Overall Study||7
8193382|NCT02270983|20202180|P1|NOT COMPLETED|Overall Study||9
8193383|NCT02270983|20202178|P3|COMPLETED|Overall Study||76
8193384|NCT02270983|20202179|P2|COMPLETED|Overall Study||80
8193385|NCT02270983|20202180|P1|COMPLETED|Overall Study||70
8193386|NCT02270983|20202178|P3|STARTED|Overall Study||88
8193387|NCT02270983|20202179|P2|STARTED|Overall Study||87
8193388|NCT02270983|20202180|P1|STARTED|Overall Study||79
8193389|NCT02270957|20202205|P2|NOT COMPLETED|Overall Study||4
8193390|NCT02270957|20202206|P1|NOT COMPLETED|Overall Study||4
8193391|NCT02270957|20202205|P2|COMPLETED|Overall Study||31
8193392|NCT02270957|20202206|P1|COMPLETED|Overall Study||27
8193393|NCT02270957|20202205|P2|STARTED|Overall Study||35
8193394|NCT02270957|20202206|P1|STARTED|Overall Study||31
8193395|NCT02270944|20202218|P2|NOT COMPLETED|Overall Study||5
8193396|NCT02270944|20202219|P1|NOT COMPLETED|Overall Study||11
8193397|NCT02270944|20202218|P2|COMPLETED|Overall Study||516
8193398|NCT02270944|20202219|P1|COMPLETED|Overall Study||518
8193399|NCT02270944|20202218|P2|STARTED|Overall Study||521
8193400|NCT02270944|20202219|P1|STARTED|Overall Study||529
8193436|NCT02270684|20202284|P2|NOT COMPLETED|Overall Study||3
8193437|NCT02270684|20202285|P1|NOT COMPLETED|Overall Study||1
8193438|NCT02270684|20202284|P2|COMPLETED|Overall Study||0
8193439|NCT02270684|20202285|P1|COMPLETED|Overall Study||0
8193440|NCT02270684|20202284|P2|STARTED|Overall Study||3
8193441|NCT02270684|20202285|P1|STARTED|Overall Study||1
8193442|NCT02270671|20202293|P2|NOT COMPLETED|Overall Study||5
8193443|NCT02270671|20202294|P1|NOT COMPLETED|Overall Study||5
8193444|NCT02270671|20202293|P2|COMPLETED|Overall Study||61
8193445|NCT02270671|20202294|P1|COMPLETED|Overall Study||59
8193446|NCT02270671|20202293|P2|STARTED|Overall Study||66
8193447|NCT02270671|20202294|P1|STARTED|Overall Study||64
8193448|NCT02270645|20202310|P2|NOT COMPLETED|Overall Study||0
8193449|NCT02270645|20202311|P1|NOT COMPLETED|Overall Study||2
8193450|NCT02270645|20202310|P2|COMPLETED|Overall Study||4
8193451|NCT02270645|20202311|P1|COMPLETED|Overall Study||6
8193452|NCT02270645|20202310|P2|STARTED|Overall Study||4
8193453|NCT02270645|20202311|P1|STARTED|Overall Study||8
8193454|NCT02270515|20202319|P1|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
8193455|NCT02270515|20202319|P1|COMPLETED|Intervention Period 3: 12-18 Months||103
8193456|NCT02270515|20202319|P1|STARTED|Intervention Period 3: 12-18 Months||127
8193457|NCT02270515|20202319|P1|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
8193458|NCT02270515|20202319|P1|COMPLETED|Intervention Period 2: 6-12 Months||127
8193459|NCT02270515|20202319|P1|STARTED|Intervention Period 2: 6-12 Months||159
8193460|NCT02270515|20202319|P1|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
8193461|NCT02270515|20202319|P1|COMPLETED|Intervention Period 1: 0-6 Months||159
8193462|NCT02270515|20202319|P1|STARTED|Intervention Period 1: 0-6 Months||175
8193463|NCT02270255|20202336|P2|NOT COMPLETED|Overall Study||0
8193464|NCT02270255|20202337|P1|NOT COMPLETED|Overall Study||1
8193465|NCT02270255|20202336|P2|COMPLETED|Overall Study||22
8193466|NCT02270255|20202337|P1|COMPLETED|Overall Study||21
8193467|NCT02270255|20202336|P2|Complete Data From Home Survey|Overall Study||22
8193468|NCT02270255|20202337|P1|Complete Data From Home Survey|Overall Study||21
8193469|NCT02270255|20202336|P2|Complete Data at Discharge PACU|Overall Study||22
8193470|NCT02270255|20202337|P1|Complete Data at Discharge PACU|Overall Study||22
8193471|NCT02270255|20202336|P2|STARTED|Overall Study||22
8193472|NCT02270255|20202337|P1|STARTED|Overall Study||22
8193473|NCT02270242|20202347|P2|NOT COMPLETED|Overall Study||53
8193474|NCT02270242|20202348|P1|NOT COMPLETED|Overall Study||59
8193475|NCT02270242|20202347|P2|COMPLETED|Overall Study||3511
8193476|NCT02270242|20202348|P1|COMPLETED|Overall Study||3496
8193477|NCT02270242|20202347|P2|STARTED|Overall Study||3564
8193478|NCT02270242|20202348|P1|STARTED|Overall Study||3555
8193479|NCT02270060|20202359|P3|NOT COMPLETED|Overall Study||0
8193480|NCT02270060|20202360|P2|NOT COMPLETED|Overall Study||0
8193481|NCT02270060|20202361|P1|NOT COMPLETED|Overall Study||0
8193482|NCT02270060|20202359|P3|COMPLETED|Overall Study||20
8193483|NCT02270060|20202360|P2|COMPLETED|Overall Study||20
8193484|NCT02270060|20202361|P1|COMPLETED|Overall Study||20
8193485|NCT02270060|20202359|P3|STARTED|Overall Study||20
8193486|NCT02270060|20202360|P2|STARTED|Overall Study||20
8193487|NCT02270060|20202361|P1|STARTED|Overall Study||20
8193488|NCT02269943|20202389|P2|NOT COMPLETED|Follow-Up Survival Period||26
8193489|NCT02269943|20202390|P1|NOT COMPLETED|Follow-Up Survival Period||5
8193490|NCT02269943|20202389|P2|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
8193491|NCT02269943|20202390|P1|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
8193492|NCT02269943|20202389|P2|STARTED|Follow-Up Survival Period||26
8193493|NCT02269943|20202390|P1|STARTED|Follow-Up Survival Period||5
8193494|NCT02269943|20202389|P2|NOT COMPLETED|Treatment Period||30
8193495|NCT02269943|20202390|P1|NOT COMPLETED|Treatment Period||6
8193496|NCT02269943|20202389|P2|COMPLETED|Treatment Period|Not applicable according to the study design|0
8193497|NCT02269943|20202390|P1|COMPLETED|Treatment Period|Not applicable according to the study design|0
8193498|NCT02269943|20202389|P2|Investigational Product (IP) Stopped|Treatment Period||30
8193499|NCT02269943|20202390|P1|Investigational Product (IP) Stopped|Treatment Period||6
8193500|NCT02269943|20202389|P2|STARTED|Treatment Period||30
8193501|NCT02269943|20202390|P1|STARTED|Treatment Period||6
8193502|NCT02269917|20202420|P2|NOT COMPLETED|Overall Study||383
8193503|NCT02269917|20202421|P1|NOT COMPLETED|Overall Study||766
8193504|NCT02269917|20202420|P2|COMPLETED|Overall Study||0
8193505|NCT02269917|20202421|P1|COMPLETED|Overall Study||0
8193506|NCT02269917|20202420|P2|Treated|Overall Study||378
8193507|NCT02269917|20202421|P1|Treated|Overall Study||763
8193508|NCT02269917|20202420|P2|STARTED|Overall Study||383
8193509|NCT02269917|20202421|P1|STARTED|Overall Study||766
8193510|NCT02269787|20202474|P2|NOT COMPLETED|Overall Study||10
8193511|NCT02269787|20202475|P1|NOT COMPLETED|Overall Study||22
8193512|NCT02269787|20202474|P2|COMPLETED|Overall Study||140
8193513|NCT02269787|20202475|P1|COMPLETED|Overall Study||126
8193514|NCT02269787|20202474|P2|STARTED|Overall Study||150
8193515|NCT02269787|20202475|P1|STARTED|Overall Study||148
8193516|NCT02269709|20202481|P1|NOT COMPLETED|Six Month Follow-up||12
8193517|NCT02269709|20202481|P1|COMPLETED|Six Month Follow-up||5
8193518|NCT02269709|20202481|P1|STARTED|Six Month Follow-up||17
8193519|NCT02269709|20202481|P1|NOT COMPLETED|Prior to Hospital Discharge||0
8193520|NCT02269709|20202481|P1|COMPLETED|Prior to Hospital Discharge||17
8193521|NCT02269709|20202481|P1|STARTED|Prior to Hospital Discharge||17
8193522|NCT02269709|20202481|P1|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
8193523|NCT02269709|20202481|P1|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
8193524|NCT02269709|20202481|P1|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
8193525|NCT02269709|20202481|P1|NOT COMPLETED|Time of Enrollment||3
8193526|NCT02269709|20202481|P1|COMPLETED|Time of Enrollment||18
8193527|NCT02269709|20202481|P1|STARTED|Time of Enrollment||21
8193528|NCT02269657|20202486|P1|NOT COMPLETED|Overall Study||3
8193529|NCT02269657|20202486|P1|COMPLETED|Overall Study||37
8193530|NCT02269657|20202486|P1|STARTED|Overall Study||40
8193531|NCT02269631|20202502|P2|NOT COMPLETED|Overall Study||0
8193532|NCT02269631|20202503|P1|NOT COMPLETED|Overall Study||0
8193533|NCT02269631|20202502|P2|COMPLETED|Overall Study||5
8193534|NCT02269631|20202503|P1|COMPLETED|Overall Study||7
8193535|NCT02269631|20202502|P2|STARTED|Overall Study||5
8193536|NCT02269631|20202503|P1|STARTED|Overall Study||7
8193537|NCT02269488|20202517|P1|NOT COMPLETED|Overall Study||0
8193538|NCT02269488|20202517|P1|COMPLETED|Overall Study||100
8193539|NCT02269488|20202517|P1|STARTED|Overall Study||100
8193540|NCT02269475|20202523|P2|NOT COMPLETED|Overall Study||1
8193541|NCT02269475|20202524|P1|NOT COMPLETED|Overall Study||3
8193542|NCT02269475|20202523|P2|COMPLETED|Overall Study||432
8193543|NCT02269475|20202524|P1|COMPLETED|Overall Study||865
8193544|NCT02269475|20202523|P2|Per Protocol Population|Overall Study||430
8193545|NCT02269475|20202524|P1|Per Protocol Population|Overall Study||849
8193546|NCT02269475|20202523|P2|Received IP (Safety Population)|Overall Study||433
8193547|NCT02269475|20202524|P1|Received IP (Safety Population)|Overall Study||868
8193548|NCT02269475|20202523|P2|STARTED|Overall Study||433
8193549|NCT02269475|20202524|P1|STARTED|Overall Study||868
8193550|NCT02269423|20202539|P4|NOT COMPLETED|Overall Study||1
8193551|NCT02269423|20202540|P3|NOT COMPLETED|Overall Study||0
8193552|NCT02269423|20202541|P2|NOT COMPLETED|Overall Study||1
8193553|NCT02269423|20202542|P1|NOT COMPLETED|Overall Study||0
8193554|NCT02269423|20202539|P4|COMPLETED|Overall Study||8
8193555|NCT02269423|20202540|P3|COMPLETED|Overall Study||10
8193556|NCT02269423|20202541|P2|COMPLETED|Overall Study||9
8193557|NCT02269423|20202542|P1|COMPLETED|Overall Study||10
8193558|NCT02269423|20202539|P4|STARTED|Overall Study||9
8193559|NCT02269423|20202540|P3|STARTED|Overall Study||10
8193560|NCT02269423|20202541|P2|STARTED|Overall Study||10
8193561|NCT02269423|20202542|P1|STARTED|Overall Study||10
8193562|NCT02269241|20202604|P1|NOT COMPLETED|Overall Study||1200
8193563|NCT02269241|20202604|P1|COMPLETED|Overall Study||352
8193564|NCT02269241|20202604|P1|STARTED|Overall Study||1552
8193565|NCT02269098|20202618|P2|NOT COMPLETED|Overall Study||9
8193566|NCT02269098|20202619|P1|NOT COMPLETED|Overall Study||14
8193567|NCT02269098|20202618|P2|COMPLETED|Overall Study||41
8193568|NCT02269098|20202619|P1|COMPLETED|Overall Study||37
8193569|NCT02269098|20202618|P2|STARTED|Overall Study||50
8193570|NCT02269098|20202619|P1|STARTED|Overall Study||51
8193571|NCT02268994|20202635|P2|NOT COMPLETED|Overall Study||35
8193572|NCT02268994|20202636|P1|NOT COMPLETED|Overall Study||31
8193573|NCT02268994|20202635|P2|COMPLETED|Overall Study||81
8193574|NCT02268994|20202636|P1|COMPLETED|Overall Study||86
8193575|NCT02268994|20202635|P2|STARTED|Overall Study||116
8193576|NCT02268994|20202636|P1|STARTED|Overall Study||117
8193577|NCT02268955|20202654|P2|NOT COMPLETED|Overall Study||2
8193578|NCT02268955|20202655|P1|NOT COMPLETED|Overall Study||2
8193579|NCT02268955|20202654|P2|COMPLETED|Overall Study||9
8193580|NCT02268955|20202655|P1|COMPLETED|Overall Study||9
8193581|NCT02268955|20202654|P2|STARTED|Overall Study||11
8193582|NCT02268955|20202655|P1|STARTED|Overall Study||11
8193583|NCT02268942|20202661|P1|NOT COMPLETED|Overall Study||0
8193584|NCT02268942|20202661|P1|COMPLETED|Overall Study||144
8193585|NCT02268942|20202661|P1|STARTED|Overall Study||144
8193586|NCT02268877|20202668|P2|NOT COMPLETED|Overall Study||5
8193587|NCT02268877|20202669|P1|NOT COMPLETED|Overall Study||4
8193588|NCT02268877|20202668|P2|COMPLETED|Overall Study|106 patients received the intervention.|106
8193589|NCT02268877|20202669|P1|COMPLETED|Overall Study||118
8193590|NCT02268877|20202668|P2|STARTED|Overall Study|111 patients were randomized to this arm.|111
8193591|NCT02268877|20202669|P1|STARTED|Overall Study||122
8193592|NCT02268864|20202680|P3|NOT COMPLETED|Overall Study||0
8193593|NCT02268864|20202681|P2|NOT COMPLETED|Overall Study||1
8193594|NCT02268864|20202682|P1|NOT COMPLETED|Overall Study||2
8193595|NCT02268864|20202680|P3|COMPLETED|Overall Study||64
8193596|NCT02268864|20202681|P2|COMPLETED|Overall Study||24
8193597|NCT02268864|20202682|P1|COMPLETED|Overall Study||15
8193598|NCT02268864|20202680|P3|STARTED|Overall Study||64
8193599|NCT02268864|20202681|P2|STARTED|Overall Study||25
8193600|NCT02268864|20202682|P1|STARTED|Overall Study||17
8193601|NCT02268851|20202710|P6|NOT COMPLETED|Overall Study||11
8193602|NCT02268851|20202711|P5|NOT COMPLETED|Overall Study||7
8193603|NCT02268851|20202712|P4|NOT COMPLETED|Overall Study||3
8193604|NCT02268851|20202713|P3|NOT COMPLETED|Overall Study||1
8193605|NCT02268851|20202714|P2|NOT COMPLETED|Overall Study||3
8193606|NCT02268851|20202715|P1|NOT COMPLETED|Overall Study||1
8193607|NCT02268851|20202710|P6|COMPLETED|Overall Study||4
8193608|NCT02268851|20202711|P5|COMPLETED|Overall Study||8
8193609|NCT02268851|20202712|P4|COMPLETED|Overall Study||0
8193610|NCT02268851|20202713|P3|COMPLETED|Overall Study||3
8193611|NCT02268851|20202714|P2|COMPLETED|Overall Study||0
8193612|NCT02268851|20202715|P1|COMPLETED|Overall Study||2
8193613|NCT02268851|20202710|P6|STARTED|Overall Study||15
8193614|NCT02268851|20202711|P5|STARTED|Overall Study||15
8193615|NCT02268851|20202712|P4|STARTED|Overall Study||3
8193616|NCT02268851|20202713|P3|STARTED|Overall Study||4
8193617|NCT02268851|20202714|P2|STARTED|Overall Study||3
8193618|NCT02268851|20202715|P1|STARTED|Overall Study||3
8193619|NCT02268812|20202733|P4|NOT COMPLETED|Overall Study||14
8193620|NCT02268812|20202734|P3|NOT COMPLETED|Overall Study||9
8193621|NCT02268812|20202735|P2|NOT COMPLETED|Overall Study||32
8193622|NCT02268812|20202736|P1|NOT COMPLETED|Overall Study||16
8193623|NCT02268812|20202733|P4|COMPLETED|Overall Study||26
8193624|NCT02268812|20202734|P3|COMPLETED|Overall Study||21
8193625|NCT02268812|20202735|P2|COMPLETED|Overall Study||40
8193626|NCT02268812|20202736|P1|COMPLETED|Overall Study||61
8193627|NCT02268812|20202733|P4|STARTED|Overall Study||40
8193628|NCT02268812|20202734|P3|STARTED|Overall Study||30
8193629|NCT02268812|20202735|P2|STARTED|Overall Study||72
8193630|NCT02268812|20202736|P1|STARTED|Overall Study||77
8193631|NCT02268786|20202768|P2|NOT COMPLETED|Overall Study||18
8193632|NCT02268786|20202769|P1|NOT COMPLETED|Overall Study||56
8193633|NCT02268786|20202768|P2|COMPLETED|Overall Study||313
8193634|NCT02268786|20202769|P1|COMPLETED|Overall Study||274
8193635|NCT02268786|20202768|P2|STARTED|Overall Study||331
8193636|NCT02268786|20202769|P1|STARTED|Overall Study||330
8193637|NCT02268526|20202778|P3|NOT COMPLETED|Overall Study||5
8193638|NCT02268526|20202779|P2|NOT COMPLETED|Overall Study||21
8193639|NCT02268526|20202780|P1|NOT COMPLETED|Overall Study||1
8193640|NCT02268526|20202778|P3|COMPLETED|Overall Study||16
8193641|NCT02268526|20202779|P2|COMPLETED|Overall Study||38
8193642|NCT02268526|20202780|P1|COMPLETED|Overall Study||5
8193643|NCT02268526|20202778|P3|PD Analysis Set (Cohort 2)|Overall Study||17
8193644|NCT02268526|20202779|P2|PD Analysis Set (Cohort 2)|Overall Study||42
8193645|NCT02268526|20202780|P1|PD Analysis Set (Cohort 2)|Overall Study||0
8193646|NCT02268526|20202778|P3|STARTED|Overall Study||21
8193647|NCT02268526|20202779|P2|STARTED|Overall Study||59
8193648|NCT02268526|20202780|P1|STARTED|Overall Study||6
8193649|NCT02268396|20202801|P1|NOT COMPLETED|Overall Study||12
8193650|NCT02268396|20202801|P1|COMPLETED|Overall Study||126
8193651|NCT02268396|20202801|P1|STARTED|Overall Study||138
8193652|NCT02268214|20202813|P3|NOT COMPLETED|Overall Study||42
8193653|NCT02268214|20202814|P2|NOT COMPLETED|Overall Study||41
8193654|NCT02268214|20202815|P1|NOT COMPLETED|Overall Study||42
8193655|NCT02268214|20202813|P3|COMPLETED|Overall Study||218
8193656|NCT02268214|20202814|P2|COMPLETED|Overall Study||255
8193657|NCT02268214|20202815|P1|COMPLETED|Overall Study||235
8193658|NCT02268214|20202813|P3|COMPLETED 24 WEEK PERIOD|Overall Study||232
8193659|NCT02268214|20202814|P2|COMPLETED 24 WEEK PERIOD|Overall Study||273
8193660|NCT02268214|20202815|P1|COMPLETED 24 WEEK PERIOD|Overall Study||252
8193661|NCT02268214|20202813|P3|STARTED|Overall Study||260
8193662|NCT02268214|20202814|P2|STARTED|Overall Study||296
8193663|NCT02268214|20202815|P1|STARTED|Overall Study||277
8193664|NCT02268175|20202843|P2|NOT COMPLETED|Overall Study||0
8193665|NCT02268175|20202844|P1|NOT COMPLETED|Overall Study||0
8193666|NCT02268175|20202843|P2|COMPLETED|Overall Study||25
8193667|NCT02268175|20202844|P1|COMPLETED|Overall Study||50
8193668|NCT02268175|20202843|P2|STARTED|Overall Study||25
8193669|NCT02268175|20202844|P1|STARTED|Overall Study||50
8193670|NCT02268058|20202862|P4|NOT COMPLETED|Overall Study||0
8193671|NCT02268058|20202863|P3|NOT COMPLETED|Overall Study||0
8193672|NCT02268058|20202864|P2|NOT COMPLETED|Overall Study||0
8193673|NCT02268058|20202865|P1|NOT COMPLETED|Overall Study||1
8193674|NCT02268058|20202862|P4|COMPLETED|Overall Study||20
8193675|NCT02268058|20202863|P3|COMPLETED|Overall Study||20
8193676|NCT02268058|20202864|P2|COMPLETED|Overall Study||20
8193677|NCT02268058|20202865|P1|COMPLETED|Overall Study||19
8193678|NCT02268058|20202862|P4|STARTED|Overall Study||20
8193679|NCT02268058|20202863|P3|STARTED|Overall Study||20
8193680|NCT02268058|20202864|P2|STARTED|Overall Study||20
8193681|NCT02268058|20202865|P1|STARTED|Overall Study||20
8193682|NCT02268045|20202889|P2|NOT COMPLETED|Overall Study||20
8193683|NCT02268045|20202890|P1|NOT COMPLETED|Overall Study||16
8193684|NCT02268045|20202889|P2|COMPLETED|Overall Study||116
8193685|NCT02268045|20202890|P1|COMPLETED|Overall Study||120
8193686|NCT02268045|20202889|P2|STARTED|Overall Study||136
8193687|NCT02268045|20202890|P1|STARTED|Overall Study||136
8193688|NCT02267850|20202914|P2|NOT COMPLETED|Overall Study||2
8193689|NCT02267850|20202915|P1|NOT COMPLETED|Overall Study||1
8193690|NCT02267850|20202914|P2|COMPLETED|Overall Study||12
8193691|NCT02267850|20202915|P1|COMPLETED|Overall Study||14
8193692|NCT02267850|20202914|P2|STARTED|Overall Study||14
8193693|NCT02267850|20202915|P1|STARTED|Overall Study||15
8193694|NCT02267837|20202923|P2|NOT COMPLETED|Overall Study||0
8193695|NCT02267837|20202924|P1|NOT COMPLETED|Overall Study||0
8193696|NCT02267837|20202923|P2|COMPLETED|Overall Study||9
8193697|NCT02267837|20202924|P1|COMPLETED|Overall Study||11
8193698|NCT02267837|20202923|P2|STARTED|Overall Study||9
8193699|NCT02267837|20202924|P1|STARTED|Overall Study||11
8193700|NCT02267824|20202932|P2|NOT COMPLETED|Overall Study||1
8193701|NCT02267824|20202933|P1|NOT COMPLETED|Overall Study||10
8193702|NCT02267824|20202932|P2|COMPLETED|Overall Study||17
8193703|NCT02267824|20202933|P1|COMPLETED|Overall Study||73
8193704|NCT02267824|20202932|P2|STARTED|Overall Study||18
8193705|NCT02267824|20202933|P1|STARTED|Overall Study||83
8193706|NCT02267811|20202941|P2|NOT COMPLETED|Overall Study||2
8193707|NCT02267811|20202942|P1|NOT COMPLETED|Overall Study||1
8193708|NCT02267811|20202941|P2|COMPLETED|Overall Study||15
8193709|NCT02267811|20202942|P1|COMPLETED|Overall Study||15
8193710|NCT02267811|20202941|P2|STARTED|Overall Study||17
8193711|NCT02267811|20202942|P1|STARTED|Overall Study||16
8193712|NCT02267772|20202954|P2|NOT COMPLETED|Overall Study||0
8193713|NCT02267772|20202955|P1|NOT COMPLETED|Overall Study||2
8193714|NCT02267772|20202954|P2|COMPLETED|Overall Study||52
8193715|NCT02267772|20202955|P1|COMPLETED|Overall Study||48
8193716|NCT02267772|20202954|P2|Received Study Drug|Overall Study||52
8193717|NCT02267772|20202955|P1|Received Study Drug|Overall Study||48
8193718|NCT02267772|20202954|P2|Randomized|Overall Study||52
8193719|NCT02267772|20202955|P1|Randomized|Overall Study||50
8193720|NCT02267772|20202954|P2|STARTED|Overall Study||52
8193721|NCT02267772|20202955|P1|STARTED|Overall Study||50
8193722|NCT02267746|20202978|P3|NOT COMPLETED|Overall Study||21
8193723|NCT02267746|20202979|P2|NOT COMPLETED|Overall Study||22
8193724|NCT02267746|20202980|P1|NOT COMPLETED|Overall Study||21
8193725|NCT02267746|20202978|P3|COMPLETED|Overall Study||278
8193726|NCT02267746|20202979|P2|COMPLETED|Overall Study||274
8193727|NCT02267746|20202980|P1|COMPLETED|Overall Study||277
8193728|NCT02267746|20202978|P3|STARTED|Overall Study||299
8193729|NCT02267746|20202979|P2|STARTED|Overall Study||296
8193730|NCT02267746|20202980|P1|STARTED|Overall Study||298
8193731|NCT02267629|20202994|P1|NOT COMPLETED|Overall Study||0
8193732|NCT02267629|20202994|P1|COMPLETED|Overall Study||7
8193733|NCT02267629|20202994|P1|STARTED|Overall Study||7
8193737|NCT02267577|20203003|P1|NOT COMPLETED|Overall Study||4
8193738|NCT02267577|20203003|P1|COMPLETED|Overall Study||81
8193739|NCT02267577|20203003|P1|STARTED|Overall Study||85
8193740|NCT02267538|20203010|P2|NOT COMPLETED|Overall Study||0
8193741|NCT02267538|20203011|P1|NOT COMPLETED|Overall Study||0
8193742|NCT02267538|20203010|P2|COMPLETED|Overall Study||143
8193743|NCT02267538|20203011|P1|COMPLETED|Overall Study||142
8193744|NCT02267538|20203010|P2|STARTED|Overall Study||143
8193745|NCT02267538|20203011|P1|STARTED|Overall Study||142
8193746|NCT02267447|20203031|P2|NOT COMPLETED|Overall Study||0
8193747|NCT02267447|20203032|P1|NOT COMPLETED|Overall Study||0
8193748|NCT02267447|20203031|P2|COMPLETED|Overall Study||26968
8193749|NCT02267447|20203032|P1|COMPLETED|Overall Study||77251
8193750|NCT02267447|20203031|P2|STARTED|Overall Study||26968
8193751|NCT02267447|20203032|P1|STARTED|Overall Study||77251
8193752|NCT02267382|20203045|P5|NOT COMPLETED|Overall Study||7
8193753|NCT02267382|20203046|P4|NOT COMPLETED|Overall Study||6
8193754|NCT02267382|20203047|P3|NOT COMPLETED|Overall Study||9
8193755|NCT02267382|20203048|P2|NOT COMPLETED|Overall Study||10
8193756|NCT02267382|20203049|P1|NOT COMPLETED|Overall Study||7
8193757|NCT02267382|20203045|P5|COMPLETED|Overall Study||39
8193758|NCT02267382|20203046|P4|COMPLETED|Overall Study||35
8193759|NCT02267382|20203047|P3|COMPLETED|Overall Study||34
8193760|NCT02267382|20203048|P2|COMPLETED|Overall Study||33
8193761|NCT02267382|20203049|P1|COMPLETED|Overall Study||35
8193762|NCT02267382|20203045|P5|STARTED|Overall Study||46
8193763|NCT02267382|20203046|P4|STARTED|Overall Study||41
8193764|NCT02267382|20203047|P3|STARTED|Overall Study||43
8193765|NCT02267382|20203048|P2|STARTED|Overall Study||43
8193766|NCT02267382|20203049|P1|STARTED|Overall Study||42
8193767|NCT02267356|20203066|P5|NOT COMPLETED|Study Extension||0
8193768|NCT02267356|20203067|P4|NOT COMPLETED|Study Extension||2
8193769|NCT02267356|20203068|P3|NOT COMPLETED|Study Extension||1
8193770|NCT02267356|20203069|P2|NOT COMPLETED|Study Extension||0
8193771|NCT02267356|20203070|P1|NOT COMPLETED|Study Extension||1
8193772|NCT02267356|20203066|P5|COMPLETED|Study Extension||26
8193773|NCT02267356|20203067|P4|COMPLETED|Study Extension||30
8193774|NCT02267356|20203068|P3|COMPLETED|Study Extension||29
8193775|NCT02267356|20203069|P2|COMPLETED|Study Extension||37
8193776|NCT02267356|20203070|P1|COMPLETED|Study Extension||32
8193777|NCT02267356|20203066|P5|STARTED|Study Extension||26
8193778|NCT02267356|20203067|P4|STARTED|Study Extension||32
8193779|NCT02267356|20203068|P3|STARTED|Study Extension||30
8193780|NCT02267356|20203069|P2|STARTED|Study Extension||37
8193781|NCT02267356|20203070|P1|STARTED|Study Extension||33
8193782|NCT02267356|20203066|P5|NOT COMPLETED|Initial Study||5
8193783|NCT02267356|20203067|P4|NOT COMPLETED|Initial Study||11
8193784|NCT02267356|20203068|P3|NOT COMPLETED|Initial Study||10
8193785|NCT02267356|20203069|P2|NOT COMPLETED|Initial Study||5
8193786|NCT02267356|20203070|P1|NOT COMPLETED|Initial Study||6
8193787|NCT02267356|20203066|P5|COMPLETED|Initial Study||42
8193788|NCT02267356|20203067|P4|COMPLETED|Initial Study||43
8193789|NCT02267356|20203068|P3|COMPLETED|Initial Study||42
8193790|NCT02267356|20203069|P2|COMPLETED|Initial Study||48
8193791|NCT02267356|20203070|P1|COMPLETED|Initial Study||47
8193792|NCT02267356|20203066|P5|STARTED|Initial Study||47
8193793|NCT02267356|20203067|P4|STARTED|Initial Study||54
8193794|NCT02267356|20203068|P3|STARTED|Initial Study||52
8193795|NCT02267356|20203069|P2|STARTED|Initial Study||53
8193796|NCT02267356|20203070|P1|STARTED|Initial Study||53
8193797|NCT02267317|20203090|P6|NOT COMPLETED|Infusion2||0
8193798|NCT02267317|20203091|P5|NOT COMPLETED|Infusion2||0
8193799|NCT02267317|20203092|P4|NOT COMPLETED|Infusion2||0
8193800|NCT02267317|20203093|P3|NOT COMPLETED|Infusion2||0
8193801|NCT02267317|20203094|P2|NOT COMPLETED|Infusion2||0
8193802|NCT02267317|20203095|P1|NOT COMPLETED|Infusion2||0
8193803|NCT02267317|20203090|P6|COMPLETED|Infusion2||1
8193804|NCT02267317|20203091|P5|COMPLETED|Infusion2||0
8193805|NCT02267317|20203092|P4|COMPLETED|Infusion2||2
8193806|NCT02267317|20203093|P3|COMPLETED|Infusion2||1
8193807|NCT02267317|20203094|P2|COMPLETED|Infusion2||3
8193808|NCT02267317|20203095|P1|COMPLETED|Infusion2||6
8193809|NCT02267317|20203090|P6|STARTED|Infusion2||1
8193810|NCT02267317|20203091|P5|STARTED|Infusion2||0
8193811|NCT02267317|20203092|P4|STARTED|Infusion2||2
8193812|NCT02267317|20203093|P3|STARTED|Infusion2||1
8193813|NCT02267317|20203094|P2|STARTED|Infusion2||3
8193814|NCT02267317|20203095|P1|STARTED|Infusion2||6
8193815|NCT02267317|20203090|P6|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8193816|NCT02267317|20203091|P5|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8193817|NCT02267317|20203092|P4|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8193818|NCT02267317|20203093|P3|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8193819|NCT02267317|20203094|P2|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
8193820|NCT02267317|20203095|P1|NOT COMPLETED|Washout (3-4weeks Between Infusions)||2
8193821|NCT02267317|20203090|P6|COMPLETED|Washout (3-4weeks Between Infusions)||1
8193822|NCT02267317|20203091|P5|COMPLETED|Washout (3-4weeks Between Infusions)||0
8193823|NCT02267317|20203092|P4|COMPLETED|Washout (3-4weeks Between Infusions)||2
8193824|NCT02267317|20203093|P3|COMPLETED|Washout (3-4weeks Between Infusions)||1
8193825|NCT02267317|20203094|P2|COMPLETED|Washout (3-4weeks Between Infusions)||3
8193826|NCT02267317|20203095|P1|COMPLETED|Washout (3-4weeks Between Infusions)||6
8193827|NCT02267317|20203090|P6|STARTED|Washout (3-4weeks Between Infusions)||1
8193828|NCT02267317|20203091|P5|STARTED|Washout (3-4weeks Between Infusions)||0
8193829|NCT02267317|20203092|P4|STARTED|Washout (3-4weeks Between Infusions)||2
8193830|NCT02267317|20203093|P3|STARTED|Washout (3-4weeks Between Infusions)||1
8193831|NCT02267317|20203094|P2|STARTED|Washout (3-4weeks Between Infusions)||3
8193832|NCT02267317|20203095|P1|STARTED|Washout (3-4weeks Between Infusions)||8
8193833|NCT02267317|20203090|P6|NOT COMPLETED|Infusion1||0
8193834|NCT02267317|20203091|P5|NOT COMPLETED|Infusion1||0
8193835|NCT02267317|20203092|P4|NOT COMPLETED|Infusion1||0
8193836|NCT02267317|20203093|P3|NOT COMPLETED|Infusion1||0
8193837|NCT02267317|20203094|P2|NOT COMPLETED|Infusion1||0
8193838|NCT02267317|20203095|P1|NOT COMPLETED|Infusion1||0
8193839|NCT02267317|20203090|P6|COMPLETED|Infusion1||1
8193840|NCT02267317|20203091|P5|COMPLETED|Infusion1||0
8193841|NCT02267317|20203092|P4|COMPLETED|Infusion1||2
8193842|NCT02267317|20203093|P3|COMPLETED|Infusion1||1
8193843|NCT02267317|20203094|P2|COMPLETED|Infusion1||3
8193844|NCT02267317|20203095|P1|COMPLETED|Infusion1||8
8193845|NCT02267317|20203090|P6|STARTED|Infusion1||1
8193846|NCT02267317|20203091|P5|STARTED|Infusion1||0
8193847|NCT02267317|20203092|P4|STARTED|Infusion1||2
8193848|NCT02267317|20203093|P3|STARTED|Infusion1||1
8193849|NCT02267317|20203094|P2|STARTED|Infusion1||3
8193850|NCT02267317|20203095|P1|STARTED|Infusion1||8
8193851|NCT02267278|20203145|P1|NOT COMPLETED|Overall Study||5
8193852|NCT02267278|20203145|P1|COMPLETED|Overall Study||20
8193853|NCT02267278|20203145|P1|STARTED|Overall Study||25
8193854|NCT02267226|20203150|P1|NOT COMPLETED|Overall Study||7
8193855|NCT02267226|20203150|P1|COMPLETED|Overall Study||18
8193856|NCT02267226|20203150|P1|Surgical Prophylaxis Population|Overall Study||9
8193857|NCT02267226|20203150|P1|FAS-Bleeding Population|Overall Study||24
8193858|NCT02267226|20203150|P1|SAFETY Population|Overall Study||25
8193859|NCT02267226|20203150|P1|STARTED|Overall Study||25
8193860|NCT02267187|20203169|P1|NOT COMPLETED|Overall Study||5
8193861|NCT02267187|20203169|P1|COMPLETED|Overall Study||10
8193862|NCT02267187|20203169|P1|STARTED|Overall Study||15
8193863|NCT02267135|20203177|P2|NOT COMPLETED|Period 2 (Randomized Set)||1
8193864|NCT02267135|20203178|P1|NOT COMPLETED|Period 2 (Randomized Set)||4
8193865|NCT02267135|20203177|P2|COMPLETED|Period 2 (Randomized Set)||46
8193866|NCT02267135|20203178|P1|COMPLETED|Period 2 (Randomized Set)||46
8193867|NCT02267135|20203177|P2|STARTED|Period 2 (Randomized Set)||47
8193868|NCT02267135|20203178|P1|STARTED|Period 2 (Randomized Set)||50
8193869|NCT02267135|20203177|P2|NOT COMPLETED|Period 1 (Randomized Set)||4
8193870|NCT02267135|20203178|P1|NOT COMPLETED|Period 1 (Randomized Set)||1
8193871|NCT02267135|20203177|P2|COMPLETED|Period 1 (Randomized Set)||47
8193872|NCT02267135|20203178|P1|COMPLETED|Period 1 (Randomized Set)||50
8193873|NCT02267135|20203177|P2|STARTED|Period 1 (Randomized Set)||51
8193874|NCT02267135|20203178|P1|STARTED|Period 1 (Randomized Set)||51
8193875|NCT02267083|20203209|P1|NOT COMPLETED|Overall Study||19
8193876|NCT02267083|20203209|P1|COMPLETED|Overall Study||3
8193877|NCT02267083|20203209|P1|STARTED|Overall Study||22
8193878|NCT02266914|20203216|P1|NOT COMPLETED|Overall Study||9
8193879|NCT02266914|20203216|P1|COMPLETED|Overall Study||0
8193880|NCT02266914|20203216|P1|STARTED|Overall Study||9
8193881|NCT02266888|20203222|P4|NOT COMPLETED|Overall Study||7
8193882|NCT02266888|20203223|P3|NOT COMPLETED|Overall Study||11
8193883|NCT02266888|20203224|P2|NOT COMPLETED|Overall Study||4
8193884|NCT02266888|20203225|P1|NOT COMPLETED|Overall Study||7
8193885|NCT02266888|20203222|P4|COMPLETED|Overall Study||0
8193886|NCT02266888|20203223|P3|COMPLETED|Overall Study||0
8193887|NCT02266888|20203224|P2|COMPLETED|Overall Study||8
8193888|NCT02266888|20203225|P1|COMPLETED|Overall Study||8
8193889|NCT02266888|20203222|P4|STARTED|Overall Study||7
8193890|NCT02266888|20203223|P3|STARTED|Overall Study||11
8193891|NCT02266888|20203224|P2|STARTED|Overall Study||12
8193892|NCT02266888|20203225|P1|STARTED|Overall Study||15
8193893|NCT02266875|20203259|P2|NOT COMPLETED|Overall Study||0
8193894|NCT02266875|20203260|P1|NOT COMPLETED|Overall Study||11
8193895|NCT02266875|20203259|P2|COMPLETED|Overall Study||30
8193896|NCT02266875|20203260|P1|COMPLETED|Overall Study||29
8193897|NCT02266875|20203259|P2|STARTED|Overall Study||30
8193898|NCT02266875|20203260|P1|STARTED|Overall Study||40
8193899|NCT02266810|20203272|P2|NOT COMPLETED|Overall Study||1
8193900|NCT02266810|20203273|P1|NOT COMPLETED|Overall Study||1
8193901|NCT02266810|20203272|P2|COMPLETED|Overall Study|sinus sides|79
8193902|NCT02266810|20203273|P1|COMPLETED|Overall Study|sinus sides|79
8193903|NCT02266810|20203272|P2|STARTED|Overall Study|sinus sides|80
8193904|NCT02266810|20203273|P1|STARTED|Overall Study|sinus sides|80
8193905|NCT02266797|20203299|P2|NOT COMPLETED|Overall Study||1
8193906|NCT02266797|20203300|P1|NOT COMPLETED|Overall Study||0
8193907|NCT02266797|20203299|P2|COMPLETED|Overall Study||2
8193908|NCT02266797|20203300|P1|COMPLETED|Overall Study||1
8193909|NCT02266797|20203299|P2|STARTED|Overall Study||3
8193910|NCT02266797|20203300|P1|STARTED|Overall Study||1
8193911|NCT02266706|20203325|P9|NOT COMPLETED|Overall Study||0
8193912|NCT02266706|20203326|P8|NOT COMPLETED|Overall Study||0
8193913|NCT02266706|20203327|P7|NOT COMPLETED|Overall Study||1
8193914|NCT02266706|20203328|P6|NOT COMPLETED|Overall Study||2
8193915|NCT02266706|20203329|P5|NOT COMPLETED|Overall Study||0
8193916|NCT02266706|20203330|P4|NOT COMPLETED|Overall Study||1
8193917|NCT02266706|20203331|P3|NOT COMPLETED|Overall Study||1
8193918|NCT02266706|20203332|P2|NOT COMPLETED|Overall Study||1
8193919|NCT02266706|20203333|P1|NOT COMPLETED|Overall Study||0
8193920|NCT02266706|20203325|P9|COMPLETED|Overall Study||4
8193921|NCT02266706|20203326|P8|COMPLETED|Overall Study||2
8193922|NCT02266706|20203327|P7|COMPLETED|Overall Study||7
8193923|NCT02266706|20203328|P6|COMPLETED|Overall Study||5
8193924|NCT02266706|20203329|P5|COMPLETED|Overall Study||1
8193925|NCT02266706|20203330|P4|COMPLETED|Overall Study||3
8193926|NCT02266706|20203331|P3|COMPLETED|Overall Study||3
8193927|NCT02266706|20203332|P2|COMPLETED|Overall Study||6
8193928|NCT02266706|20203333|P1|COMPLETED|Overall Study||6
8193929|NCT02266706|20203325|P9|Treated|Overall Study||4
8193930|NCT02266706|20203326|P8|Treated|Overall Study||2
8193931|NCT02266706|20203327|P7|Treated|Overall Study||7
8193932|NCT02266706|20203328|P6|Treated|Overall Study||5
8193933|NCT02266706|20203329|P5|Treated|Overall Study||1
8193934|NCT02266706|20203330|P4|Treated|Overall Study||3
8193935|NCT02266706|20203331|P3|Treated|Overall Study||3
8193936|NCT02266706|20203332|P2|Treated|Overall Study||6
8193937|NCT02266706|20203333|P1|Treated|Overall Study||6
8193938|NCT02266706|20203325|P9|STARTED|Overall Study||4
8193939|NCT02266706|20203326|P8|STARTED|Overall Study||2
8193940|NCT02266706|20203327|P7|STARTED|Overall Study||8
8193941|NCT02266706|20203328|P6|STARTED|Overall Study||7
8193942|NCT02266706|20203329|P5|STARTED|Overall Study||1
8193943|NCT02266706|20203330|P4|STARTED|Overall Study||4
8193944|NCT02266706|20203331|P3|STARTED|Overall Study||4
8193945|NCT02266706|20203332|P2|STARTED|Overall Study||7
8193946|NCT02266706|20203333|P1|STARTED|Overall Study||6
8193947|NCT02266576|20203526|P2|NOT COMPLETED|Overall Study||15
8193948|NCT02266576|20203527|P1|NOT COMPLETED|Overall Study||17
8193949|NCT02266576|20203526|P2|COMPLETED|Overall Study||90
8193950|NCT02266576|20203527|P1|COMPLETED|Overall Study||85
8193951|NCT02266576|20203526|P2|STARTED|Overall Study||105
8193952|NCT02266576|20203527|P1|STARTED|Overall Study||102
8193953|NCT02266472|20203545|P2|NOT COMPLETED|Period 2+ Washout||0
8193954|NCT02266472|20203546|P1|NOT COMPLETED|Period 2+ Washout||0
8193955|NCT02266472|20203545|P2|COMPLETED|Period 2+ Washout||15
8193956|NCT02266472|20203546|P1|COMPLETED|Period 2+ Washout||15
8193957|NCT02266472|20203545|P2|STARTED|Period 2+ Washout||15
8193958|NCT02266472|20203546|P1|STARTED|Period 2+ Washout||15
8193959|NCT02266472|20203545|P2|NOT COMPLETED|Period 1+ Washout||0
8193960|NCT02266472|20203546|P1|NOT COMPLETED|Period 1+ Washout||0
8193961|NCT02266472|20203545|P2|COMPLETED|Period 1+ Washout||15
8193962|NCT02266472|20203546|P1|COMPLETED|Period 1+ Washout||15
8193963|NCT02266472|20203545|P2|STARTED|Period 1+ Washout||15
8193964|NCT02266472|20203546|P1|STARTED|Period 1+ Washout||15
8193965|NCT02266433|20203564|P2|NOT COMPLETED|Overall Study||53
8193966|NCT02266433|20203565|P1|NOT COMPLETED|Overall Study||59
8193967|NCT02266433|20203564|P2|COMPLETED|Overall Study||65
8193968|NCT02266433|20203565|P1|COMPLETED|Overall Study||68
8193969|NCT02266433|20203564|P2|STARTED|Overall Study||118
8193970|NCT02266433|20203565|P1|STARTED|Overall Study||127
8193971|NCT02266381|20203682|P3|NOT COMPLETED|Overall Study||4
8193972|NCT02266381|20203683|P2|NOT COMPLETED|Overall Study||5
8193973|NCT02266381|20203684|P1|NOT COMPLETED|Overall Study||3
8193974|NCT02266381|20203682|P3|COMPLETED|Overall Study||146
8193975|NCT02266381|20203683|P2|COMPLETED|Overall Study||145
8193976|NCT02266381|20203684|P1|COMPLETED|Overall Study||147
8193977|NCT02266381|20203682|P3|STARTED|Overall Study||150
8193978|NCT02266381|20203683|P2|STARTED|Overall Study||150
8193979|NCT02266381|20203684|P1|STARTED|Overall Study||150
8193980|NCT02266277|20203707|P6|NOT COMPLETED|Overall Study||0
8193981|NCT02266277|20203708|P5|NOT COMPLETED|Overall Study||0
8193982|NCT02266277|20203709|P4|NOT COMPLETED|Overall Study||0
8193983|NCT02266277|20203710|P3|NOT COMPLETED|Overall Study||0
8193984|NCT02266277|20203711|P2|NOT COMPLETED|Overall Study||0
8193985|NCT02266277|20203712|P1|NOT COMPLETED|Overall Study||0
8193986|NCT02266277|20203707|P6|COMPLETED|Overall Study||5000
8193987|NCT02266277|20203708|P5|COMPLETED|Overall Study||5000
8193988|NCT02266277|20203709|P4|COMPLETED|Overall Study||5000
8193989|NCT02266277|20203710|P3|COMPLETED|Overall Study||5000
8193990|NCT02266277|20203711|P2|COMPLETED|Overall Study||5000
8193991|NCT02266277|20203712|P1|COMPLETED|Overall Study||5000
8193992|NCT02266277|20203707|P6|STARTED|Overall Study||5000
8193993|NCT02266277|20203708|P5|STARTED|Overall Study||5000
8193994|NCT02266277|20203709|P4|STARTED|Overall Study||5000
8193995|NCT02266277|20203710|P3|STARTED|Overall Study||5000
8193996|NCT02266277|20203711|P2|STARTED|Overall Study||5000
8193997|NCT02266277|20203712|P1|STARTED|Overall Study||5000
8193998|NCT02266225|20203734|P1|NOT COMPLETED|Overall Study||16
8193999|NCT02266225|20203734|P1|COMPLETED|Overall Study||32
8194000|NCT02266225|20203734|P1|Enrolled in Intervention|Overall Study||44
8194001|NCT02266225|20203734|P1|STARTED|Overall Study||48
8194002|NCT02266147|20203759|P4|NOT COMPLETED|PART 2: Dose Expansion||9
8194003|NCT02266147|20203760|P3|NOT COMPLETED|PART 2: Dose Expansion||0
8194004|NCT02266147|20203761|P2|NOT COMPLETED|PART 2: Dose Expansion||0
8194005|NCT02266147|20203762|P1|NOT COMPLETED|PART 2: Dose Expansion||7
8194006|NCT02266147|20203759|P4|COMPLETED|PART 2: Dose Expansion||0
8194007|NCT02266147|20203760|P3|COMPLETED|PART 2: Dose Expansion||0
8194008|NCT02266147|20203761|P2|COMPLETED|PART 2: Dose Expansion||0
8194009|NCT02266147|20203762|P1|COMPLETED|PART 2: Dose Expansion||0
8194010|NCT02266147|20203759|P4|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|9
8194011|NCT02266147|20203760|P3|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
8194012|NCT02266147|20203761|P2|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
8194013|NCT02266147|20203762|P1|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|7
8194014|NCT02266147|20203759|P4|NOT COMPLETED|PART 1: Dose Escalation||4
8194015|NCT02266147|20203760|P3|NOT COMPLETED|PART 1: Dose Escalation||3
8194016|NCT02266147|20203761|P2|NOT COMPLETED|PART 1: Dose Escalation||3
8194017|NCT02266147|20203762|P1|NOT COMPLETED|PART 1: Dose Escalation||1
8194018|NCT02266147|20203759|P4|COMPLETED|PART 1: Dose Escalation||0
8194019|NCT02266147|20203760|P3|COMPLETED|PART 1: Dose Escalation||0
8194020|NCT02266147|20203761|P2|COMPLETED|PART 1: Dose Escalation||0
8194021|NCT02266147|20203762|P1|COMPLETED|PART 1: Dose Escalation||2
8194022|NCT02266147|20203759|P4|STARTED|PART 1: Dose Escalation||4
8194023|NCT02266147|20203760|P3|STARTED|PART 1: Dose Escalation||3
8194024|NCT02266147|20203761|P2|STARTED|PART 1: Dose Escalation||3
8194025|NCT02266147|20203762|P1|STARTED|PART 1: Dose Escalation||3
8194026|NCT02266108|20203794|P2|NOT COMPLETED|Overall Study||0
8194027|NCT02266108|20203795|P1|NOT COMPLETED|Overall Study||0
8194028|NCT02266108|20203794|P2|COMPLETED|Overall Study||71
8194029|NCT02266108|20203795|P1|COMPLETED|Overall Study||80
8194030|NCT02266108|20203794|P2|STARTED|Overall Study||71
8194031|NCT02266108|20203795|P1|STARTED|Overall Study||80
8194032|NCT02266004|20203805|P1|NOT COMPLETED|Overall Study||2
8194033|NCT02266004|20203805|P1|COMPLETED|Overall Study||7
8194034|NCT02266004|20203805|P1|STARTED|Overall Study||9
8194035|NCT02265965|20203822|P2|NOT COMPLETED|Overall Study||0
8194036|NCT02265965|20203823|P1|NOT COMPLETED|Overall Study||0
8194037|NCT02265965|20203822|P2|COMPLETED|Overall Study||11
8194038|NCT02265965|20203823|P1|COMPLETED|Overall Study||7
8194039|NCT02265965|20203822|P2|STARTED|Overall Study||11
8194040|NCT02265965|20203823|P1|STARTED|Overall Study||7
8194041|NCT02265952|20203843|P2|NOT COMPLETED|Open Label Extension (OLE) Period||8
8194042|NCT02265952|20203844|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
8194043|NCT02265952|20203843|P2|COMPLETED|Open Label Extension (OLE) Period||0
8194044|NCT02265952|20203844|P1|COMPLETED|Open Label Extension (OLE) Period||0
8194045|NCT02265952|20203843|P2|STARTED|Open Label Extension (OLE) Period||8
8194046|NCT02265952|20203844|P1|STARTED|Open Label Extension (OLE) Period||0
8194047|NCT02265952|20203843|P2|NOT COMPLETED|Main Study Period||0
8194048|NCT02265952|20203844|P1|NOT COMPLETED|Main Study Period||0
8194049|NCT02265952|20203843|P2|COMPLETED|Main Study Period||0
8194050|NCT02265952|20203844|P1|COMPLETED|Main Study Period||9
8194051|NCT02265952|20203843|P2|STARTED|Main Study Period||0
8194052|NCT02265952|20203844|P1|STARTED|Main Study Period||9
8194053|NCT02265913|20203873|P3|NOT COMPLETED|Overall Study||545
8194054|NCT02265913|20203874|P2|NOT COMPLETED|Overall Study||551
8194055|NCT02265913|20203875|P1|NOT COMPLETED|Overall Study||564
8194056|NCT02265913|20203873|P3|COMPLETED|Overall Study||813
8194057|NCT02265913|20203874|P2|COMPLETED|Overall Study||810
8194058|NCT02265913|20203875|P1|COMPLETED|Overall Study||793
8194059|NCT02265913|20203873|P3|STARTED|Overall Study||1358
8194060|NCT02265913|20203874|P2|STARTED|Overall Study||1361
8194061|NCT02265913|20203875|P1|STARTED|Overall Study||1357
8194062|NCT02265848|20203885|P2|NOT COMPLETED|Overall Study||0
8194063|NCT02265848|20203886|P1|NOT COMPLETED|Overall Study||0
8194064|NCT02265848|20203885|P2|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
8194065|NCT02265848|20203886|P1|COMPLETED|Overall Study||11
8194066|NCT02265848|20203885|P2|STARTED|Overall Study||11
8194067|NCT02265848|20203886|P1|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
8194068|NCT02265796|20203900|P2|NOT COMPLETED|Overall Study||1
8194069|NCT02265796|20203901|P1|NOT COMPLETED|Overall Study||3
8194070|NCT02265796|20203900|P2|COMPLETED|Overall Study||24
8194071|NCT02265796|20203901|P1|COMPLETED|Overall Study||22
8194072|NCT02265796|20203900|P2|STARTED|Overall Study||25
8194073|NCT02265796|20203901|P1|STARTED|Overall Study||25
8194074|NCT02265783|20203911|P1|NOT COMPLETED|Overall Study||0
8194075|NCT02265783|20203911|P1|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
8194076|NCT02265783|20203911|P1|STARTED|Overall Study||20
8194077|NCT02265744|20203920|P5|NOT COMPLETED|Overall Study||13
8194078|NCT02265744|20203921|P4|NOT COMPLETED|Overall Study||23
8194079|NCT02265744|20203922|P3|NOT COMPLETED|Overall Study||17
8194080|NCT02265744|20203923|P2|NOT COMPLETED|Overall Study||15
8194081|NCT02265744|20203924|P1|NOT COMPLETED|Overall Study||20
8194082|NCT02265744|20203920|P5|COMPLETED|Overall Study||58
8194083|NCT02265744|20203921|P4|COMPLETED|Overall Study||47
8194084|NCT02265744|20203922|P3|COMPLETED|Overall Study||51
8194085|NCT02265744|20203923|P2|COMPLETED|Overall Study||53
8194086|NCT02265744|20203924|P1|COMPLETED|Overall Study||49
8194087|NCT02265744|20203920|P5|STARTED|Overall Study||71
8194088|NCT02265744|20203921|P4|STARTED|Overall Study||70
8194089|NCT02265744|20203922|P3|STARTED|Overall Study||68
8194090|NCT02265744|20203923|P2|STARTED|Overall Study||68
8194091|NCT02265744|20203924|P1|STARTED|Overall Study||69
8194092|NCT02265705|20204103|P7|NOT COMPLETED|Follow-up Period||11
8194093|NCT02265705|20204104|P6|NOT COMPLETED|Follow-up Period||1
8194094|NCT02265705|20204105|P5|NOT COMPLETED|Follow-up Period||0
8194095|NCT02265705|20204106|P4|NOT COMPLETED|Follow-up Period||0
8194096|NCT02265705|20204107|P3|NOT COMPLETED|Follow-up Period||0
8194097|NCT02265705|20204108|P2|NOT COMPLETED|Follow-up Period||0
8194098|NCT02265705|20204109|P1|NOT COMPLETED|Follow-up Period||0
8194099|NCT02265705|20204103|P7|COMPLETED|Follow-up Period||47
8194100|NCT02265705|20204104|P6|COMPLETED|Follow-up Period||1
8194101|NCT02265705|20204105|P5|COMPLETED|Follow-up Period||0
8194102|NCT02265705|20204106|P4|COMPLETED|Follow-up Period||0
8194103|NCT02265705|20204107|P3|COMPLETED|Follow-up Period||0
8194104|NCT02265705|20204108|P2|COMPLETED|Follow-up Period||0
8194105|NCT02265705|20204109|P1|COMPLETED|Follow-up Period||0
8194106|NCT02265705|20204103|P7|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58
8194107|NCT02265705|20204104|P6|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2
8194108|NCT02265705|20204105|P5|STARTED|Follow-up Period||0
8194109|NCT02265705|20204106|P4|STARTED|Follow-up Period||0
8194110|NCT02265705|20204107|P3|STARTED|Follow-up Period||0
8194111|NCT02265705|20204108|P2|STARTED|Follow-up Period||0
8194112|NCT02265705|20204109|P1|STARTED|Follow-up Period||0
8194113|NCT02265705|20204103|P7|NOT COMPLETED|Open Label Period||0
8194114|NCT02265705|20204104|P6|NOT COMPLETED|Open Label Period||0
8194115|NCT02265705|20204105|P5|NOT COMPLETED|Open Label Period||5
8194116|NCT02265705|20204106|P4|NOT COMPLETED|Open Label Period||2
8194117|NCT02265705|20204107|P3|NOT COMPLETED|Open Label Period||0
8194118|NCT02265705|20204108|P2|NOT COMPLETED|Open Label Period||0
8194119|NCT02265705|20204109|P1|NOT COMPLETED|Open Label Period||0
8194120|NCT02265705|20204103|P7|COMPLETED|Open Label Period||0
8194121|NCT02265705|20204104|P6|COMPLETED|Open Label Period||0
8194122|NCT02265705|20204105|P5|COMPLETED|Open Label Period||115
8194123|NCT02265705|20204106|P4|COMPLETED|Open Label Period||72
8194124|NCT02265705|20204107|P3|COMPLETED|Open Label Period||0
8194125|NCT02265705|20204108|P2|COMPLETED|Open Label Period||0
8194126|NCT02265705|20204109|P1|COMPLETED|Open Label Period||0
8194127|NCT02265705|20204103|P7|STARTED|Open Label Period||0
8194128|NCT02265705|20204104|P6|STARTED|Open Label Period||0
8194129|NCT02265705|20204105|P5|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120
8194130|NCT02265705|20204106|P4|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74
8194131|NCT02265705|20204107|P3|STARTED|Open Label Period||0
8194132|NCT02265705|20204108|P2|STARTED|Open Label Period||0
8194133|NCT02265705|20204109|P1|STARTED|Open Label Period||0
8194134|NCT02265705|20204103|P7|NOT COMPLETED|Rescue Period||0
8194135|NCT02265705|20204104|P6|NOT COMPLETED|Rescue Period||0
8194136|NCT02265705|20204105|P5|NOT COMPLETED|Rescue Period||0
8194137|NCT02265705|20204106|P4|NOT COMPLETED|Rescue Period||0
8194138|NCT02265705|20204107|P3|NOT COMPLETED|Rescue Period||3
8194139|NCT02265705|20204108|P2|NOT COMPLETED|Rescue Period||0
8194140|NCT02265705|20204109|P1|NOT COMPLETED|Rescue Period||0
8194141|NCT02265705|20204103|P7|COMPLETED|Rescue Period||0
8194142|NCT02265705|20204104|P6|COMPLETED|Rescue Period||0
8194143|NCT02265705|20204105|P5|COMPLETED|Rescue Period||0
8194144|NCT02265705|20204106|P4|COMPLETED|Rescue Period||0
8194145|NCT02265705|20204107|P3|COMPLETED|Rescue Period||74
8194146|NCT02265705|20204108|P2|COMPLETED|Rescue Period||0
8194147|NCT02265705|20204109|P1|COMPLETED|Rescue Period||0
8194148|NCT02265705|20204103|P7|STARTED|Rescue Period||0
8194149|NCT02265705|20204104|P6|STARTED|Rescue Period||0
8194150|NCT02265705|20204105|P5|STARTED|Rescue Period||0
8194151|NCT02265705|20204106|P4|STARTED|Rescue Period||0
8194152|NCT02265705|20204107|P3|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77
8194153|NCT02265705|20204108|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8194154|NCT02265705|20204109|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8194155|NCT02265705|20204103|P7|NOT COMPLETED|Treatment Period Week 0-24||0
8194156|NCT02265705|20204104|P6|NOT COMPLETED|Treatment Period Week 0-24||0
8194157|NCT02265705|20204105|P5|NOT COMPLETED|Treatment Period Week 0-24||0
8194158|NCT02265705|20204106|P4|NOT COMPLETED|Treatment Period Week 0-24||0
8194159|NCT02265705|20204107|P3|NOT COMPLETED|Treatment Period Week 0-24||0
8194160|NCT02265705|20204108|P2|NOT COMPLETED|Treatment Period Week 0-24||9
8194161|NCT02265705|20204109|P1|NOT COMPLETED|Treatment Period Week 0-24||12
8194162|NCT02265705|20204103|P7|COMPLETED|Treatment Period Week 0-24||0
8194163|NCT02265705|20204104|P6|COMPLETED|Treatment Period Week 0-24||0
8194164|NCT02265705|20204105|P5|COMPLETED|Treatment Period Week 0-24||0
8194165|NCT02265705|20204106|P4|COMPLETED|Treatment Period Week 0-24||0
8194166|NCT02265705|20204107|P3|COMPLETED|Treatment Period Week 0-24||0
8194167|NCT02265705|20204108|P2|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136
8194168|NCT02265705|20204109|P1|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133
8194169|NCT02265705|20204103|P7|Rescued|Treatment Period Week 0-24||0
8194170|NCT02265705|20204104|P6|Rescued|Treatment Period Week 0-24||0
8194171|NCT02265705|20204105|P5|Rescued|Treatment Period Week 0-24||0
8194172|NCT02265705|20204106|P4|Rescued|Treatment Period Week 0-24||0
8194173|NCT02265705|20204107|P3|Rescued|Treatment Period Week 0-24||0
8194174|NCT02265705|20204108|P2|Rescued|Treatment Period Week 0-24||17
8194175|NCT02265705|20204109|P1|Rescued|Treatment Period Week 0-24||59
8194176|NCT02265705|20204103|P7|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8194177|NCT02265705|20204104|P6|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8194178|NCT02265705|20204105|P5|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8194179|NCT02265705|20204106|P4|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8194180|NCT02265705|20204107|P3|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
8194181|NCT02265705|20204108|P2|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
8194182|NCT02265705|20204109|P1|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
8194183|NCT02265705|20204103|P7|STARTED|Treatment Period Week 0-24||0
8194184|NCT02265705|20204104|P6|STARTED|Treatment Period Week 0-24||0
8194185|NCT02265705|20204105|P5|STARTED|Treatment Period Week 0-24||0
8194186|NCT02265705|20204106|P4|STARTED|Treatment Period Week 0-24||0
8194187|NCT02265705|20204107|P3|STARTED|Treatment Period Week 0-24||0
8194188|NCT02265705|20204108|P2|STARTED|Treatment Period Week 0-24||145
8194189|NCT02265705|20204109|P1|STARTED|Treatment Period Week 0-24||145
8194190|NCT02265510|20204148|P14|NOT COMPLETED|Overall Study||10
8194191|NCT02265510|20204149|P13|NOT COMPLETED|Overall Study||9
8194192|NCT02265510|20204150|P12|NOT COMPLETED|Overall Study||16
8194193|NCT02265510|20204151|P11|NOT COMPLETED|Overall Study||5
8194194|NCT02265510|20204152|P10|NOT COMPLETED|Overall Study||7
8194195|NCT02265510|20204153|P9|NOT COMPLETED|Overall Study||4
8194196|NCT02265510|20204154|P8|NOT COMPLETED|Overall Study||4
8194197|NCT02265510|20204155|P7|NOT COMPLETED|Overall Study||3
8194198|NCT02265510|20204156|P6|NOT COMPLETED|Overall Study||6
8194199|NCT02265510|20204157|P5|NOT COMPLETED|Overall Study||3
8194200|NCT02265510|20204158|P4|NOT COMPLETED|Overall Study||4
8194201|NCT02265510|20204159|P3|NOT COMPLETED|Overall Study||6
8194202|NCT02265510|20204160|P2|NOT COMPLETED|Overall Study||3
8194203|NCT02265510|20204161|P1|NOT COMPLETED|Overall Study||3
8194204|NCT02265510|20204148|P14|COMPLETED|Overall Study||0
8194205|NCT02265510|20204149|P13|COMPLETED|Overall Study||0
8194206|NCT02265510|20204150|P12|COMPLETED|Overall Study||0
8194207|NCT02265510|20204151|P11|COMPLETED|Overall Study||0
8194208|NCT02265510|20204152|P10|COMPLETED|Overall Study||0
8194209|NCT02265510|20204153|P9|COMPLETED|Overall Study||0
8194210|NCT02265510|20204154|P8|COMPLETED|Overall Study||0
8194211|NCT02265510|20204155|P7|COMPLETED|Overall Study||0
8194212|NCT02265510|20204156|P6|COMPLETED|Overall Study||0
8194213|NCT02265510|20204157|P5|COMPLETED|Overall Study||0
8194214|NCT02265510|20204158|P4|COMPLETED|Overall Study||0
8194215|NCT02265510|20204159|P3|COMPLETED|Overall Study||0
8194216|NCT02265510|20204160|P2|COMPLETED|Overall Study||0
8194217|NCT02265510|20204161|P1|COMPLETED|Overall Study||0
8194218|NCT02265510|20204148|P14|STARTED|Overall Study||10
8194219|NCT02265510|20204149|P13|STARTED|Overall Study||9
8194220|NCT02265510|20204150|P12|STARTED|Overall Study||16
8194221|NCT02265510|20204151|P11|STARTED|Overall Study||5
8194222|NCT02265510|20204152|P10|STARTED|Overall Study||7
8194223|NCT02265510|20204153|P9|STARTED|Overall Study||4
8194224|NCT02265510|20204154|P8|STARTED|Overall Study||4
8194225|NCT02265510|20204155|P7|STARTED|Overall Study||3
8194226|NCT02265510|20204156|P6|STARTED|Overall Study||6
8194227|NCT02265510|20204157|P5|STARTED|Overall Study||3
8194228|NCT02265510|20204158|P4|STARTED|Overall Study||4
8194229|NCT02265510|20204159|P3|STARTED|Overall Study||6
8194230|NCT02265510|20204160|P2|STARTED|Overall Study||3
8194231|NCT02265510|20204161|P1|STARTED|Overall Study||3
8194232|NCT02265341|20204249|P1|NOT COMPLETED|Overall Study||0
8194233|NCT02265341|20204249|P1|COMPLETED|Overall Study||12
8194234|NCT02265341|20204249|P1|STARTED|Overall Study||12
8194235|NCT02265237|20204261|P4|NOT COMPLETED|As Treated (Overall Study)||1
8194236|NCT02265237|20204262|P3|NOT COMPLETED|As Treated (Overall Study)||10
8194237|NCT02265237|20204263|P2|NOT COMPLETED|As Treated (Overall Study)||3
8194238|NCT02265237|20204264|P1|NOT COMPLETED|As Treated (Overall Study)||5
8194239|NCT02265237|20204261|P4|COMPLETED|As Treated (Overall Study)||2
8194240|NCT02265237|20204262|P3|COMPLETED|As Treated (Overall Study)||51
8194241|NCT02265237|20204263|P2|COMPLETED|As Treated (Overall Study)||57
8194242|NCT02265237|20204264|P1|COMPLETED|As Treated (Overall Study)||55
8194243|NCT02265237|20204261|P4|STARTED|As Treated (Overall Study)||3
8194244|NCT02265237|20204262|P3|STARTED|As Treated (Overall Study)||61
8194245|NCT02265237|20204263|P2|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
8194246|NCT02265237|20204264|P1|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
8194247|NCT02265237|20204261|P4|NOT COMPLETED|As Enrolled (Overall Study)||1
8194248|NCT02265237|20204262|P3|NOT COMPLETED|As Enrolled (Overall Study)||10
8194249|NCT02265237|20204263|P2|NOT COMPLETED|As Enrolled (Overall Study)||3
8194250|NCT02265237|20204264|P1|NOT COMPLETED|As Enrolled (Overall Study)||5
8194251|NCT02265237|20204261|P4|COMPLETED|As Enrolled (Overall Study)||2
8194252|NCT02265237|20204262|P3|COMPLETED|As Enrolled (Overall Study)||51
8194253|NCT02265237|20204263|P2|COMPLETED|As Enrolled (Overall Study)||58
8194254|NCT02265237|20204264|P1|COMPLETED|As Enrolled (Overall Study)||54
8194255|NCT02265237|20204261|P4|STARTED|As Enrolled (Overall Study)||3
8194256|NCT02265237|20204262|P3|STARTED|As Enrolled (Overall Study)||61
8194257|NCT02265237|20204263|P2|STARTED|As Enrolled (Overall Study)||61
8194258|NCT02265237|20204264|P1|STARTED|As Enrolled (Overall Study)||59
8194259|NCT02264977|20204283|P1|NOT COMPLETED|Overall Study||5
8194260|NCT02264977|20204283|P1|COMPLETED|Overall Study||4
8194261|NCT02264977|20204283|P1|STARTED|Overall Study||9
8194262|NCT02264821|20204294|P3|NOT COMPLETED|Overall Study||6
8194263|NCT02264821|20204295|P2|NOT COMPLETED|Overall Study||3
8194264|NCT02264821|20204296|P1|NOT COMPLETED|Overall Study||1
8194265|NCT02264821|20204294|P3|COMPLETED|Overall Study||58
8194266|NCT02264821|20204295|P2|COMPLETED|Overall Study||61
8194267|NCT02264821|20204296|P1|COMPLETED|Overall Study||63
8194268|NCT02264821|20204294|P3|STARTED|Overall Study|Double Blind|64
8194269|NCT02264821|20204295|P2|STARTED|Overall Study|Double Blind|64
8194270|NCT02264821|20204296|P1|STARTED|Overall Study|Double Blind|64
8194271|NCT02264639|20204312|P5|NOT COMPLETED|Overall Study||1
8194272|NCT02264639|20204313|P4|NOT COMPLETED|Overall Study||0
8194273|NCT02264639|20204314|P3|NOT COMPLETED|Overall Study||1
8194274|NCT02264639|20204315|P2|NOT COMPLETED|Overall Study||0
8194275|NCT02264639|20204316|P1|NOT COMPLETED|Overall Study||2
8194276|NCT02264639|20204312|P5|COMPLETED|Overall Study||3
8194277|NCT02264639|20204313|P4|COMPLETED|Overall Study||1
8194278|NCT02264639|20204314|P3|COMPLETED|Overall Study||0
8194279|NCT02264639|20204315|P2|COMPLETED|Overall Study||1
8194280|NCT02264639|20204316|P1|COMPLETED|Overall Study||0
8194281|NCT02264639|20204312|P5|STARTED|Overall Study|Subjects in this arm participated in Cohort 4 only; single-dose phase was not applicable.|4
8194282|NCT02264639|20204313|P4|STARTED|Overall Study|Subject in this arm participated in Cohorts 3 and 4; single-dose phase was not applicable.|1
8194283|NCT02264639|20204314|P3|STARTED|Overall Study|Subject in this arm participated in Cohorts 2, 3 and 4.|1
8194284|NCT02264639|20204315|P2|STARTED|Overall Study|Subject in this arm participated in Cohort 2 only.|1
8194285|NCT02264639|20204316|P1|STARTED|Overall Study|Subjects in this arm participated in Cohort 1 only.|2
8194286|NCT02264574|20204334|P2|NOT COMPLETED|Overall Study||30
8194287|NCT02264574|20204335|P1|NOT COMPLETED|Overall Study||29
8194288|NCT02264574|20204334|P2|COMPLETED|Overall Study||86
8194289|NCT02264574|20204335|P1|COMPLETED|Overall Study||84
8194290|NCT02264574|20204334|P2|STARTED|Overall Study||116
8194291|NCT02264574|20204335|P1|STARTED|Overall Study||113
8194292|NCT02264353|20204371|P2|NOT COMPLETED|Overall Study||0
8194293|NCT02264353|20204372|P1|NOT COMPLETED|Overall Study||3
8194294|NCT02264353|20204371|P2|COMPLETED|Overall Study||24
8194295|NCT02264353|20204372|P1|COMPLETED|Overall Study||17
8194296|NCT02264353|20204371|P2|STARTED|Overall Study||24
8194297|NCT02264353|20204372|P1|STARTED|Overall Study||20
8194298|NCT02264249|20204385|P3|NOT COMPLETED|Overall Study||0
8194299|NCT02264249|20204386|P2|NOT COMPLETED|Overall Study||0
8194300|NCT02264249|20204387|P1|NOT COMPLETED|Overall Study||0
8194301|NCT02264249|20204385|P3|COMPLETED|Overall Study||241
8194302|NCT02264249|20204386|P2|COMPLETED|Overall Study||187
8194303|NCT02264249|20204387|P1|COMPLETED|Overall Study||21
8194304|NCT02264249|20204385|P3|STARTED|Overall Study||241
8194305|NCT02264249|20204386|P2|STARTED|Overall Study||187
8194306|NCT02264249|20204387|P1|STARTED|Overall Study||21
8194307|NCT02263911|20204401|P4|NOT COMPLETED|Period 5||0
8194308|NCT02263911|20204402|P3|NOT COMPLETED|Period 5||0
8194309|NCT02263911|20204403|P2|NOT COMPLETED|Period 5||0
8194310|NCT02263911|20204404|P1|NOT COMPLETED|Period 5||0
8194311|NCT02263911|20204401|P4|COMPLETED|Period 5||4
8194312|NCT02263911|20204402|P3|COMPLETED|Period 5||4
8194313|NCT02263911|20204403|P2|COMPLETED|Period 5||4
8194314|NCT02263911|20204404|P1|COMPLETED|Period 5||4
8194315|NCT02263911|20204401|P4|STARTED|Period 5||4
8194316|NCT02263911|20204402|P3|STARTED|Period 5||4
8194317|NCT02263911|20204403|P2|STARTED|Period 5||4
8194318|NCT02263911|20204404|P1|STARTED|Period 5||4
8194319|NCT02263911|20204401|P4|NOT COMPLETED|Period 4 Washout||0
8194320|NCT02263911|20204402|P3|NOT COMPLETED|Period 4 Washout||0
8194321|NCT02263911|20204403|P2|NOT COMPLETED|Period 4 Washout||0
8194322|NCT02263911|20204404|P1|NOT COMPLETED|Period 4 Washout||0
8194323|NCT02263911|20204401|P4|COMPLETED|Period 4 Washout||4
8194324|NCT02263911|20204402|P3|COMPLETED|Period 4 Washout||4
8194325|NCT02263911|20204403|P2|COMPLETED|Period 4 Washout||4
8194326|NCT02263911|20204404|P1|COMPLETED|Period 4 Washout||4
8194327|NCT02263911|20204401|P4|STARTED|Period 4 Washout||4
8194328|NCT02263911|20204402|P3|STARTED|Period 4 Washout||4
8194329|NCT02263911|20204403|P2|STARTED|Period 4 Washout||4
8194330|NCT02263911|20204404|P1|STARTED|Period 4 Washout||4
8194331|NCT02263911|20204401|P4|NOT COMPLETED|Period 4||0
8194332|NCT02263911|20204402|P3|NOT COMPLETED|Period 4||0
8194333|NCT02263911|20204403|P2|NOT COMPLETED|Period 4||0
8194334|NCT02263911|20204404|P1|NOT COMPLETED|Period 4||0
8194335|NCT02263911|20204401|P4|COMPLETED|Period 4||4
8194336|NCT02263911|20204402|P3|COMPLETED|Period 4||4
8194337|NCT02263911|20204403|P2|COMPLETED|Period 4||4
8194338|NCT02263911|20204404|P1|COMPLETED|Period 4||4
8194339|NCT02263911|20204401|P4|STARTED|Period 4||4
8194340|NCT02263911|20204402|P3|STARTED|Period 4||4
8194341|NCT02263911|20204403|P2|STARTED|Period 4||4
8194342|NCT02263911|20204404|P1|STARTED|Period 4||4
8194343|NCT02263911|20204401|P4|NOT COMPLETED|Period 3 Washout||0
8194344|NCT02263911|20204402|P3|NOT COMPLETED|Period 3 Washout||0
8194345|NCT02263911|20204403|P2|NOT COMPLETED|Period 3 Washout||0
8194346|NCT02263911|20204404|P1|NOT COMPLETED|Period 3 Washout||0
8194347|NCT02263911|20204401|P4|COMPLETED|Period 3 Washout||4
8194348|NCT02263911|20204402|P3|COMPLETED|Period 3 Washout||4
8194349|NCT02263911|20204403|P2|COMPLETED|Period 3 Washout||4
8194350|NCT02263911|20204404|P1|COMPLETED|Period 3 Washout||4
8194351|NCT02263911|20204401|P4|STARTED|Period 3 Washout||4
8194352|NCT02263911|20204402|P3|STARTED|Period 3 Washout||4
8194353|NCT02263911|20204403|P2|STARTED|Period 3 Washout||4
8194354|NCT02263911|20204404|P1|STARTED|Period 3 Washout||4
8194355|NCT02263911|20204401|P4|NOT COMPLETED|Period 3||0
8194356|NCT02263911|20204402|P3|NOT COMPLETED|Period 3||0
8194357|NCT02263911|20204403|P2|NOT COMPLETED|Period 3||0
8194358|NCT02263911|20204404|P1|NOT COMPLETED|Period 3||0
8194359|NCT02263911|20204401|P4|COMPLETED|Period 3||4
8194360|NCT02263911|20204402|P3|COMPLETED|Period 3||4
8194361|NCT02263911|20204403|P2|COMPLETED|Period 3||4
8194362|NCT02263911|20204404|P1|COMPLETED|Period 3||4
8194363|NCT02263911|20204401|P4|STARTED|Period 3||4
8194364|NCT02263911|20204402|P3|STARTED|Period 3||4
8194365|NCT02263911|20204403|P2|STARTED|Period 3||4
8194366|NCT02263911|20204404|P1|STARTED|Period 3||4
8194367|NCT02263911|20204401|P4|NOT COMPLETED|Period 2 Washout||0
8194368|NCT02263911|20204402|P3|NOT COMPLETED|Period 2 Washout||0
8194369|NCT02263911|20204403|P2|NOT COMPLETED|Period 2 Washout||0
8194370|NCT02263911|20204404|P1|NOT COMPLETED|Period 2 Washout||0
8194371|NCT02263911|20204401|P4|COMPLETED|Period 2 Washout||4
8194372|NCT02263911|20204402|P3|COMPLETED|Period 2 Washout||4
8194373|NCT02263911|20204403|P2|COMPLETED|Period 2 Washout||4
8194374|NCT02263911|20204404|P1|COMPLETED|Period 2 Washout||4
8194375|NCT02263911|20204401|P4|STARTED|Period 2 Washout||4
8194376|NCT02263911|20204402|P3|STARTED|Period 2 Washout||4
8194377|NCT02263911|20204403|P2|STARTED|Period 2 Washout||4
8194378|NCT02263911|20204404|P1|STARTED|Period 2 Washout||4
8194379|NCT02263911|20204401|P4|NOT COMPLETED|Period 2||0
8194380|NCT02263911|20204402|P3|NOT COMPLETED|Period 2||0
8194381|NCT02263911|20204403|P2|NOT COMPLETED|Period 2||0
8194382|NCT02263911|20204404|P1|NOT COMPLETED|Period 2||0
8194383|NCT02263911|20204401|P4|COMPLETED|Period 2||4
8194384|NCT02263911|20204402|P3|COMPLETED|Period 2||4
8194385|NCT02263911|20204403|P2|COMPLETED|Period 2||4
8194386|NCT02263911|20204404|P1|COMPLETED|Period 2||4
8194387|NCT02263911|20204401|P4|STARTED|Period 2||4
8194388|NCT02263911|20204402|P3|STARTED|Period 2||4
8194389|NCT02263911|20204403|P2|STARTED|Period 2||4
8194390|NCT02263911|20204404|P1|STARTED|Period 2||4
8194391|NCT02263911|20204401|P4|NOT COMPLETED|Period 1 Washout||0
8194392|NCT02263911|20204402|P3|NOT COMPLETED|Period 1 Washout||0
8194393|NCT02263911|20204403|P2|NOT COMPLETED|Period 1 Washout||0
8194394|NCT02263911|20204404|P1|NOT COMPLETED|Period 1 Washout||0
8194395|NCT02263911|20204401|P4|COMPLETED|Period 1 Washout||4
8194396|NCT02263911|20204402|P3|COMPLETED|Period 1 Washout||4
8194397|NCT02263911|20204403|P2|COMPLETED|Period 1 Washout||4
8194398|NCT02263911|20204404|P1|COMPLETED|Period 1 Washout||4
8194399|NCT02263911|20204401|P4|STARTED|Period 1 Washout||4
8194400|NCT02263911|20204402|P3|STARTED|Period 1 Washout||4
8194401|NCT02263911|20204403|P2|STARTED|Period 1 Washout||4
8194402|NCT02263911|20204404|P1|STARTED|Period 1 Washout||4
8194403|NCT02263911|20204401|P4|NOT COMPLETED|Period 1||0
8194404|NCT02263911|20204402|P3|NOT COMPLETED|Period 1||0
8194405|NCT02263911|20204403|P2|NOT COMPLETED|Period 1||0
8194406|NCT02263911|20204404|P1|NOT COMPLETED|Period 1||0
8194407|NCT02263911|20204401|P4|COMPLETED|Period 1||4
8194408|NCT02263911|20204402|P3|COMPLETED|Period 1||4
8194409|NCT02263911|20204403|P2|COMPLETED|Period 1||4
8194410|NCT02263911|20204404|P1|COMPLETED|Period 1||4
8194411|NCT02263911|20204401|P4|STARTED|Period 1||4
8194412|NCT02263911|20204402|P3|STARTED|Period 1||4
8194413|NCT02263911|20204403|P2|STARTED|Period 1||4
8194414|NCT02263911|20204404|P1|STARTED|Period 1||4
8194415|NCT02263833|20204426|P1|NOT COMPLETED|Overall Study||0
8194416|NCT02263833|20204426|P1|COMPLETED|Overall Study||742
8194417|NCT02263833|20204426|P1|STARTED|Overall Study||742
8194418|NCT02263547|20204431|P1|NOT COMPLETED|Overall Study||3
8194419|NCT02263547|20204431|P1|COMPLETED|Overall Study||11
8194420|NCT02263547|20204431|P1|STARTED|Overall Study||14
8194421|NCT02263365|20204438|P2|NOT COMPLETED|Overall Study||18
8194422|NCT02263365|20204439|P1|NOT COMPLETED|Overall Study||22
8194423|NCT02263365|20204438|P2|COMPLETED|Overall Study||0
8194424|NCT02263365|20204439|P1|COMPLETED|Overall Study||0
8194425|NCT02263365|20204438|P2|STARTED|Overall Study||18
8194426|NCT02263365|20204439|P1|STARTED|Overall Study||22
8194427|NCT02263326|20204453|P2|NOT COMPLETED|Overall Study||1
8194428|NCT02263326|20204454|P1|NOT COMPLETED|Overall Study||1
8194429|NCT02263326|20204453|P2|COMPLETED|Overall Study||44
8194430|NCT02263326|20204454|P1|COMPLETED|Overall Study||43
8194431|NCT02263326|20204453|P2|STARTED|Overall Study||45
8194432|NCT02263326|20204454|P1|STARTED|Overall Study||44
8194433|NCT02263131|20204476|P2|NOT COMPLETED|Overall Study||1
8194434|NCT02263131|20204477|P1|NOT COMPLETED|Overall Study||10
8194435|NCT02263131|20204476|P2|COMPLETED|Overall Study||68
8194436|NCT02263131|20204477|P1|COMPLETED|Overall Study||337
8194437|NCT02263131|20204476|P2|STARTED|Overall Study||69
8194438|NCT02263131|20204477|P1|STARTED|Overall Study||347
8194439|NCT02263118|20204499|P4|NOT COMPLETED|Overall Study||2
8194440|NCT02263118|20204500|P3|NOT COMPLETED|Overall Study||8
8194441|NCT02263118|20204501|P2|NOT COMPLETED|Overall Study||8
8194442|NCT02263118|20204502|P1|NOT COMPLETED|Overall Study||4
8194443|NCT02263118|20204499|P4|COMPLETED|Overall Study||12
8194444|NCT02263118|20204500|P3|COMPLETED|Overall Study||22
8194445|NCT02263118|20204501|P2|COMPLETED|Overall Study||24
8194446|NCT02263118|20204502|P1|COMPLETED|Overall Study||20
8194447|NCT02263118|20204499|P4|STARTED|Overall Study||14
8194448|NCT02263118|20204500|P3|STARTED|Overall Study||30
8194449|NCT02263118|20204501|P2|STARTED|Overall Study||32
8194450|NCT02263118|20204502|P1|STARTED|Overall Study||24
8194451|NCT02263079|20204527|P3|NOT COMPLETED|Overall Study||0
8194452|NCT02263079|20204528|P2|NOT COMPLETED|Overall Study||8
8194453|NCT02263079|20204529|P1|NOT COMPLETED|Overall Study||3
8194454|NCT02263079|20204527|P3|COMPLETED|Overall Study|Completed study but not included in the analysis|3
8194455|NCT02263079|20204528|P2|COMPLETED|Overall Study||25
8194456|NCT02263079|20204529|P1|COMPLETED|Overall Study||23
8194457|NCT02263079|20204527|P3|STARTED|Overall Study||3
8194458|NCT02263079|20204528|P2|STARTED|Overall Study||33
8194459|NCT02263079|20204529|P1|STARTED|Overall Study||26
8194460|NCT02263040|20204557|P2|NOT COMPLETED|Overall Study||0
8194461|NCT02263040|20204558|P1|NOT COMPLETED|Overall Study||0
8194462|NCT02263040|20204557|P2|COMPLETED|Overall Study||83
8194463|NCT02263040|20204558|P1|COMPLETED|Overall Study||87
8194464|NCT02263040|20204557|P2|STARTED|Overall Study||83
8194465|NCT02263040|20204558|P1|STARTED|Overall Study||87
8194466|NCT02263014|20204588|P2|NOT COMPLETED|Overall Study||0
8194467|NCT02263014|20204589|P1|NOT COMPLETED|Overall Study||0
8194468|NCT02263014|20204588|P2|COMPLETED|Overall Study||208
8194469|NCT02263014|20204589|P1|COMPLETED|Overall Study||44
8194470|NCT02263014|20204588|P2|STARTED|Overall Study||208
8194471|NCT02263014|20204589|P1|STARTED|Overall Study||44
8194472|NCT02262754|20204600|P3|NOT COMPLETED|Overall Study||9
8194473|NCT02262754|20204601|P2|NOT COMPLETED|Overall Study||9
8194474|NCT02262754|20204602|P1|NOT COMPLETED|Overall Study||16
8194475|NCT02262754|20204600|P3|COMPLETED|Overall Study||65
8194476|NCT02262754|20204601|P2|COMPLETED|Overall Study||65
8194477|NCT02262754|20204602|P1|COMPLETED|Overall Study||58
8194478|NCT02262754|20204600|P3|STARTED|Overall Study||74
8194479|NCT02262754|20204601|P2|STARTED|Overall Study||74
8194480|NCT02262754|20204602|P1|STARTED|Overall Study||74
8194481|NCT02262728|20204677|P2|NOT COMPLETED|Follow-up Phase (3 Years)||3
8194482|NCT02262728|20204678|P1|NOT COMPLETED|Follow-up Phase (3 Years)||4
8194483|NCT02262728|20204677|P2|COMPLETED|Follow-up Phase (3 Years)||18
8194484|NCT02262728|20204678|P1|COMPLETED|Follow-up Phase (3 Years)||15
8194485|NCT02262728|20204677|P2|STARTED|Follow-up Phase (3 Years)||21
8194486|NCT02262728|20204678|P1|STARTED|Follow-up Phase (3 Years)||19
8194487|NCT02262728|20204677|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
8194488|NCT02262728|20204678|P1|NOT COMPLETED|Treatment Period (12 Weeks)||0
8194489|NCT02262728|20204677|P2|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21
8194490|NCT02262728|20204678|P1|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19
8194491|NCT02262728|20204677|P2|STARTED|Treatment Period (12 Weeks)||21
8194492|NCT02262728|20204678|P1|STARTED|Treatment Period (12 Weeks)||19
8194493|NCT02262507|20204708|P1|NOT COMPLETED|Overall Study||0
8194494|NCT02262507|20204708|P1|COMPLETED|Overall Study||410
8194495|NCT02262507|20204708|P1|STARTED|Overall Study||410
8194496|NCT02262377|20204715|P2|NOT COMPLETED|Overall Study||6
8194497|NCT02262377|20204716|P1|NOT COMPLETED|Overall Study||12
8194498|NCT02262377|20204715|P2|COMPLETED|Overall Study||73
8194499|NCT02262377|20204716|P1|COMPLETED|Overall Study||68
8194500|NCT02262377|20204715|P2|STARTED|Overall Study||79
8194501|NCT02262377|20204716|P1|STARTED|Overall Study||80
8194502|NCT02262364|20204731|P1|NOT COMPLETED|Follow-Up Through 12 Months||0
8194503|NCT02262364|20204731|P1|COMPLETED|Follow-Up Through 12 Months||10
8194504|NCT02262364|20204731|P1|STARTED|Follow-Up Through 12 Months||10
8194505|NCT02262364|20204731|P1|NOT COMPLETED|Injection With APS||0
8194506|NCT02262364|20204731|P1|COMPLETED|Injection With APS||10
8194507|NCT02262364|20204731|P1|STARTED|Injection With APS||10
8194508|NCT02262364|20204731|P1|NOT COMPLETED|Blood Draw for Device Processing||1
8194509|NCT02262364|20204731|P1|COMPLETED|Blood Draw for Device Processing||10
8194510|NCT02262364|20204731|P1|STARTED|Blood Draw for Device Processing||11
8194511|NCT02262364|20204731|P1|NOT COMPLETED|Study Enrollment||0
8194512|NCT02262364|20204731|P1|COMPLETED|Study Enrollment||11
8194513|NCT02262364|20204731|P1|STARTED|Study Enrollment||11
8194514|NCT02262260|20204740|P2|NOT COMPLETED|Overall Study||10
8194515|NCT02262260|20204741|P1|NOT COMPLETED|Overall Study||11
8194516|NCT02262260|20204740|P2|COMPLETED|Overall Study||32
8194517|NCT02262260|20204741|P1|COMPLETED|Overall Study||34
8194518|NCT02262260|20204740|P2|STARTED|Overall Study||42
8194519|NCT02262260|20204741|P1|STARTED|Overall Study||45
8194520|NCT02262130|20204759|P1|NOT COMPLETED|Overall Study||0
8194521|NCT02262130|20204759|P1|COMPLETED|Overall Study||10
8194522|NCT02262130|20204759|P1|STARTED|Overall Study||10
8194523|NCT02262078|20204769|P2|NOT COMPLETED|Overall Study||0
8194524|NCT02262078|20204770|P1|NOT COMPLETED|Overall Study||0
8194525|NCT02262078|20204769|P2|COMPLETED|Overall Study||13
8194526|NCT02262078|20204770|P1|COMPLETED|Overall Study||13
8194527|NCT02262078|20204769|P2|STARTED|Overall Study||13
8194528|NCT02262078|20204770|P1|STARTED|Overall Study||13
8194529|NCT02262039|20204778|P2|NOT COMPLETED|Overall Study||0
8194530|NCT02262039|20204779|P1|NOT COMPLETED|Overall Study||0
8194531|NCT02262039|20204778|P2|COMPLETED|Overall Study||27
8194532|NCT02262039|20204779|P1|COMPLETED|Overall Study||14
8194533|NCT02262039|20204778|P2|STARTED|Overall Study||27
8194534|NCT02262039|20204779|P1|STARTED|Overall Study||14
8194535|NCT02262000|20204799|P2|NOT COMPLETED|Overall Study||0
8194536|NCT02262000|20204800|P1|NOT COMPLETED|Overall Study||0
8194537|NCT02262000|20204799|P2|COMPLETED|Overall Study||0
8194538|NCT02262000|20204800|P1|COMPLETED|Overall Study||3
8194539|NCT02262000|20204799|P2|STARTED|Overall Study||0
8194540|NCT02262000|20204800|P1|STARTED|Overall Study||3
8194541|NCT02261974|20204810|P2|NOT COMPLETED|Overall Study||7
8194542|NCT02261974|20204811|P1|NOT COMPLETED|Overall Study||15
8194543|NCT02261974|20204810|P2|COMPLETED|Overall Study||56
8194544|NCT02261974|20204811|P1|COMPLETED|Overall Study||108
8194545|NCT02261974|20204810|P2|Treated|Overall Study||57
8194546|NCT02261974|20204811|P1|Treated|Overall Study||117
8194547|NCT02261974|20204810|P2|STARTED|Overall Study||63
8194548|NCT02261974|20204811|P1|STARTED|Overall Study||123
8194549|NCT02261948|20204827|P2|NOT COMPLETED|Overall Study||0
8194550|NCT02261948|20204828|P1|NOT COMPLETED|Overall Study||0
8194551|NCT02261948|20204827|P2|COMPLETED|Overall Study||19
8194552|NCT02261948|20204828|P1|COMPLETED|Overall Study||23
8194553|NCT02261948|20204827|P2|STARTED|Overall Study||19
8194554|NCT02261948|20204828|P1|STARTED|Overall Study||23
8194555|NCT02261818|20204838|P1|NOT COMPLETED|Overall Study||3
8194556|NCT02261818|20204838|P1|COMPLETED|Overall Study||27
8194557|NCT02261818|20204838|P1|STARTED|Overall Study||30
8194558|NCT02261805|20204842|P3|NOT COMPLETED|Overall Study||0
8194559|NCT02261805|20204843|P2|NOT COMPLETED|Overall Study||0
8194560|NCT02261805|20204844|P1|NOT COMPLETED|Overall Study||0
8194561|NCT02261805|20204842|P3|COMPLETED|Overall Study||2
8194562|NCT02261805|20204843|P2|COMPLETED|Overall Study||6
8194563|NCT02261805|20204844|P1|COMPLETED|Overall Study||3
8194564|NCT02261805|20204842|P3|STARTED|Overall Study||2
8194565|NCT02261805|20204843|P2|STARTED|Overall Study||6
8194566|NCT02261805|20204844|P1|STARTED|Overall Study||3
8194567|NCT02261714|20204852|P1|NOT COMPLETED|Overall Study||28
8194568|NCT02261714|20204852|P1|COMPLETED|Overall Study||4
8194569|NCT02261714|20204852|P1|STARTED|Overall Study||32
8194570|NCT02261597|20204861|P2|NOT COMPLETED|Overall Study||0
8194571|NCT02261597|20204862|P1|NOT COMPLETED|Overall Study||0
8194572|NCT02261597|20204861|P2|COMPLETED|Overall Study||22
8194573|NCT02261597|20204862|P1|COMPLETED|Overall Study||22
8194574|NCT02261597|20204861|P2|STARTED|Overall Study||22
8194575|NCT02261597|20204862|P1|STARTED|Overall Study||22
8194576|NCT02261493|20204875|P3|NOT COMPLETED|Overall Study||26
8194577|NCT02261493|20204876|P2|NOT COMPLETED|Overall Study||47
8194578|NCT02261493|20204877|P1|NOT COMPLETED|Overall Study||30
8194579|NCT02261493|20204875|P3|COMPLETED|Overall Study||287
8194580|NCT02261493|20204876|P2|COMPLETED|Overall Study||271
8194581|NCT02261493|20204877|P1|COMPLETED|Overall Study||126
8194582|NCT02261493|20204875|P3|STARTED|Overall Study||313
8194583|NCT02261493|20204876|P2|STARTED|Overall Study||318
8194584|NCT02261493|20204877|P1|STARTED|Overall Study||156
8194585|NCT02261467|20204905|P2|NOT COMPLETED|Overall Study||37
8194586|NCT02261467|20204906|P1|NOT COMPLETED|Overall Study||21
8194587|NCT02261467|20204905|P2|COMPLETED|Overall Study||253
8194588|NCT02261467|20204906|P1|COMPLETED|Overall Study||80
8194589|NCT02261467|20204905|P2|STARTED|Overall Study||290
8194590|NCT02261467|20204906|P1|STARTED|Overall Study||101
8194591|NCT02261428|20204926|P2|NOT COMPLETED|Overall Study||0
8194592|NCT02261428|20204927|P1|NOT COMPLETED|Overall Study||0
8194593|NCT02261428|20204926|P2|COMPLETED|Overall Study||10
8194594|NCT02261428|20204927|P1|COMPLETED|Overall Study||10
8194595|NCT02261428|20204926|P2|STARTED|Overall Study|Washout (30 minutes)|10
8194596|NCT02261428|20204927|P1|STARTED|Overall Study|Washout (30 minutes)|10
8194597|NCT02260986|20204948|P3|NOT COMPLETED|Overall Study||41
8194598|NCT02260986|20204949|P2|NOT COMPLETED|Overall Study||13
8194599|NCT02260986|20204950|P1|NOT COMPLETED|Overall Study||90
8194600|NCT02260986|20204948|P3|COMPLETED|Overall Study||278
8194601|NCT02260986|20204949|P2|COMPLETED|Overall Study||93
8194602|NCT02260986|20204950|P1|COMPLETED|Overall Study||225
8194603|NCT02260986|20204948|P3|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
8194604|NCT02260986|20204949|P2|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
8194605|NCT02260986|20204950|P1|Safety Population|Overall Study||315
8194606|NCT02260986|20204948|P3|STARTED|Overall Study||319
8194607|NCT02260986|20204949|P2|STARTED|Overall Study||106
8194608|NCT02260986|20204950|P1|STARTED|Overall Study||315
8194609|NCT02260934|20205068|P2|NOT COMPLETED|Overall Study||4
8194610|NCT02260934|20205069|P1|NOT COMPLETED|Overall Study||3
8194611|NCT02260934|20205068|P2|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|17
8194612|NCT02260934|20205069|P1|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|19
8194613|NCT02260934|20205068|P2|STARTED|Overall Study||21
8194614|NCT02260934|20205069|P1|STARTED|Overall Study||22
8194623|NCT02260882|20205132|P2|NOT COMPLETED|Overall Study||1
8194624|NCT02260882|20205133|P1|NOT COMPLETED|Overall Study||0
8194625|NCT02260882|20205132|P2|COMPLETED|Overall Study||81
8194626|NCT02260882|20205133|P1|COMPLETED|Overall Study||161
8194627|NCT02260882|20205132|P2|STARTED|Overall Study||82
8194628|NCT02260882|20205133|P1|STARTED|Overall Study||161
8194629|NCT02260817|20205157|P2|NOT COMPLETED|Overall Study||37
8194630|NCT02260817|20205158|P1|NOT COMPLETED|Overall Study||0
8194631|NCT02260817|20205157|P2|COMPLETED|Overall Study||58
8194632|NCT02260817|20205158|P1|COMPLETED|Overall Study||14
8194633|NCT02260817|20205157|P2|STARTED|Overall Study||95
8194634|NCT02260817|20205158|P1|STARTED|Overall Study||14
8194635|NCT02260791|20205206|P2|NOT COMPLETED|Overall Study||34
8194636|NCT02260791|20205207|P1|NOT COMPLETED|Overall Study||33
8194637|NCT02260791|20205206|P2|COMPLETED|Overall Study||328
8194638|NCT02260791|20205207|P1|COMPLETED|Overall Study||333
8194639|NCT02260791|20205206|P2|STARTED|Overall Study||362
8194640|NCT02260791|20205207|P1|STARTED|Overall Study||366
8194641|NCT02260648|20205246|P3|NOT COMPLETED|Overall Study||8
8194642|NCT02260648|20205247|P2|NOT COMPLETED|Overall Study||13
8194643|NCT02260648|20205248|P1|NOT COMPLETED|Overall Study||18
8194644|NCT02260648|20205246|P3|COMPLETED|Overall Study||42
8194645|NCT02260648|20205247|P2|COMPLETED|Overall Study||33
8194646|NCT02260648|20205248|P1|COMPLETED|Overall Study||35
8194647|NCT02260648|20205246|P3|Received at Least One Dose of Study Drug|Overall Study||50
8194648|NCT02260648|20205247|P2|Received at Least One Dose of Study Drug|Overall Study||46
8194649|NCT02260648|20205248|P1|Received at Least One Dose of Study Drug|Overall Study||53
8194650|NCT02260648|20205246|P3|STARTED|Overall Study||50
8194651|NCT02260648|20205247|P2|STARTED|Overall Study||46
8194652|NCT02260648|20205248|P1|STARTED|Overall Study||53
8194653|NCT02260635|20205276|P2|NOT COMPLETED|Open-Label Extension||25
8194654|NCT02260635|20205277|P1|NOT COMPLETED|Open-Label Extension||26
8194655|NCT02260635|20205276|P2|COMPLETED|Open-Label Extension||0
8194656|NCT02260635|20205277|P1|COMPLETED|Open-Label Extension||0
8194657|NCT02260635|20205276|P2|Received at Least One Dose of Study Drug|Open-Label Extension||25
8194658|NCT02260635|20205277|P1|Received at Least One Dose of Study Drug|Open-Label Extension||26
8194659|NCT02260635|20205276|P2|STARTED|Open-Label Extension||25
8194660|NCT02260635|20205277|P1|STARTED|Open-Label Extension||26
8194661|NCT02260635|20205276|P2|NOT COMPLETED|Double-Blind Treatment Period||2
8194662|NCT02260635|20205277|P1|NOT COMPLETED|Double-Blind Treatment Period||1
8194663|NCT02260635|20205276|P2|COMPLETED|Double-Blind Treatment Period||25
8194664|NCT02260635|20205277|P1|COMPLETED|Double-Blind Treatment Period||26
8194665|NCT02260635|20205276|P2|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
8194666|NCT02260635|20205277|P1|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
8194667|NCT02260635|20205276|P2|STARTED|Double-Blind Treatment Period||27
8194668|NCT02260635|20205277|P1|STARTED|Double-Blind Treatment Period||27
8194669|NCT02260622|20205299|P2|NOT COMPLETED|Overall Study||0
8194670|NCT02260622|20205300|P1|NOT COMPLETED|Overall Study||0
8194671|NCT02260622|20205299|P2|COMPLETED|Overall Study||9
8194672|NCT02260622|20205300|P1|COMPLETED|Overall Study||11
8194673|NCT02260622|20205299|P2|STARTED|Overall Study||9
8194674|NCT02260622|20205300|P1|STARTED|Overall Study||11
8194675|NCT02260492|20205329|P3|NOT COMPLETED|Overall Study||5
8194676|NCT02260492|20205330|P2|NOT COMPLETED|Overall Study||13
8194677|NCT02260492|20205331|P1|NOT COMPLETED|Overall Study||23
8194678|NCT02260492|20205329|P3|COMPLETED|Overall Study||37
8194679|NCT02260492|20205330|P2|COMPLETED|Overall Study||406
8194680|NCT02260492|20205331|P1|COMPLETED|Overall Study||395
8194681|NCT02260492|20205329|P3|Completed Day 1|Overall Study||42
8194682|NCT02260492|20205330|P2|Completed Day 1|Overall Study||419
8194683|NCT02260492|20205331|P1|Completed Day 1|Overall Study||418
8194684|NCT02260492|20205329|P3|STARTED|Overall Study||42
8194685|NCT02260492|20205330|P2|STARTED|Overall Study||419
8194686|NCT02260492|20205331|P1|STARTED|Overall Study||418
8194687|NCT02260440|20205345|P1|NOT COMPLETED|Overall Study||0
8194688|NCT02260440|20205345|P1|COMPLETED|Overall Study||31
8194689|NCT02260440|20205345|P1|STARTED|Overall Study||31
8194690|NCT02260401|20205353|P2|NOT COMPLETED|Overall Study||12
8194691|NCT02260401|20205354|P1|NOT COMPLETED|Overall Study||5
8194692|NCT02260401|20205353|P2|COMPLETED|Overall Study||73
8194693|NCT02260401|20205354|P1|COMPLETED|Overall Study||75
8194694|NCT02260401|20205353|P2|STARTED|Overall Study||85
8194695|NCT02260401|20205354|P1|STARTED|Overall Study||80
8194696|NCT02260388|20205364|P4|NOT COMPLETED|Overall Study||4
8194697|NCT02260388|20205365|P3|NOT COMPLETED|Overall Study||3
8194698|NCT02260388|20205366|P2|NOT COMPLETED|Overall Study||8
8194699|NCT02260388|20205367|P1|NOT COMPLETED|Overall Study||2
8194700|NCT02260388|20205364|P4|COMPLETED|Overall Study||65
8194701|NCT02260388|20205365|P3|COMPLETED|Overall Study||70
8194702|NCT02260388|20205366|P2|COMPLETED|Overall Study||118
8194703|NCT02260388|20205367|P1|COMPLETED|Overall Study||132
8194704|NCT02260388|20205364|P4|STARTED|Overall Study||69
8194705|NCT02260388|20205365|P3|STARTED|Overall Study||73
8194706|NCT02260388|20205366|P2|STARTED|Overall Study||126
8194707|NCT02260388|20205367|P1|STARTED|Overall Study||134
8194708|NCT02260180|20205396|P3|NOT COMPLETED|Overall Study||1
8194709|NCT02260180|20205397|P2|NOT COMPLETED|Overall Study||0
8194710|NCT02260180|20205398|P1|NOT COMPLETED|Overall Study||2
8194711|NCT02260180|20205396|P3|COMPLETED|Overall Study||40
8194712|NCT02260180|20205397|P2|COMPLETED|Overall Study||39
8194713|NCT02260180|20205398|P1|COMPLETED|Overall Study||37
8194714|NCT02260180|20205396|P3|STARTED|Overall Study||41
8194715|NCT02260180|20205397|P2|STARTED|Overall Study||39
8194716|NCT02260180|20205398|P1|STARTED|Overall Study||39
8194717|NCT02260154|20205409|P1|NOT COMPLETED|Overall Study||2
8194718|NCT02260154|20205409|P1|COMPLETED|Overall Study||218
8194719|NCT02260154|20205409|P1|STARTED|Overall Study||220
8194720|NCT02259699|20205425|P2|NOT COMPLETED|Overall Study||20
8194721|NCT02259699|20205426|P1|NOT COMPLETED|Overall Study||27
8194722|NCT02259699|20205425|P2|COMPLETED|Overall Study||40
8194723|NCT02259699|20205426|P1|COMPLETED|Overall Study||37
8194724|NCT02259699|20205425|P2|STARTED|Overall Study||60
8194725|NCT02259699|20205426|P1|STARTED|Overall Study||64
8194726|NCT02259608|20205441|P1|NOT COMPLETED|Overall Study||0
8194727|NCT02259608|20205441|P1|COMPLETED|Overall Study||15
8194728|NCT02259608|20205441|P1|STARTED|Overall Study||15
8194729|NCT02259582|20205449|P3|NOT COMPLETED|Overall Study||21
8194730|NCT02259582|20205450|P2|NOT COMPLETED|Overall Study||17
8194731|NCT02259582|20205451|P1|NOT COMPLETED|Overall Study||16
8194732|NCT02259582|20205449|P3|COMPLETED|Overall Study||8
8194733|NCT02259582|20205450|P2|COMPLETED|Overall Study||11
8194734|NCT02259582|20205451|P1|COMPLETED|Overall Study||9
8194735|NCT02259582|20205449|P3|STARTED|Overall Study||29
8194736|NCT02259582|20205450|P2|STARTED|Overall Study||28
8194737|NCT02259582|20205451|P1|STARTED|Overall Study||25
8194738|NCT02259400|20205461|P2|NOT COMPLETED|Overall Study||2
8194739|NCT02259400|20205462|P1|NOT COMPLETED|Overall Study||0
8194740|NCT02259400|20205461|P2|COMPLETED|Overall Study||60
8194741|NCT02259400|20205462|P1|COMPLETED|Overall Study||62
8194742|NCT02259400|20205461|P2|STARTED|Overall Study||62
8194743|NCT02259400|20205462|P1|STARTED|Overall Study||62
8194744|NCT02259348|20205494|P1|NOT COMPLETED|Overall Study||10
8194745|NCT02259348|20205494|P1|COMPLETED|Overall Study||2
8194746|NCT02259348|20205494|P1|One Year Post-transplant|Overall Study||2
8194747|NCT02259348|20205494|P1|STARTED|Overall Study||12
8194748|NCT02259114|20205511|P5|NOT COMPLETED|Overall Study||6
8194749|NCT02259114|20205512|P4|NOT COMPLETED|Overall Study||3
8194750|NCT02259114|20205513|P3|NOT COMPLETED|Overall Study||13
8194751|NCT02259114|20205514|P2|NOT COMPLETED|Overall Study||4
8194752|NCT02259114|20205515|P1|NOT COMPLETED|Overall Study||21
8194753|NCT02259114|20205511|P5|COMPLETED|Overall Study||0
8194754|NCT02259114|20205512|P4|COMPLETED|Overall Study||0
8194755|NCT02259114|20205513|P3|COMPLETED|Overall Study||0
8194756|NCT02259114|20205514|P2|COMPLETED|Overall Study||0
8194757|NCT02259114|20205515|P1|COMPLETED|Overall Study||0
8194758|NCT02259114|20205511|P5|Treated|Overall Study||6
8194759|NCT02259114|20205512|P4|Treated|Overall Study||3
8194760|NCT02259114|20205513|P3|Treated|Overall Study||13
8194761|NCT02259114|20205514|P2|Treated|Overall Study||4
8194762|NCT02259114|20205515|P1|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
8194763|NCT02259114|20205511|P5|STARTED|Overall Study||6
8194764|NCT02259114|20205512|P4|STARTED|Overall Study||3
8194765|NCT02259114|20205513|P3|STARTED|Overall Study||13
8194766|NCT02259114|20205514|P2|STARTED|Overall Study||4
8194767|NCT02259114|20205515|P1|STARTED|Overall Study||21
8194768|NCT02259088|20205574|P2|NOT COMPLETED|Overall Study||14
8194769|NCT02259088|20205575|P1|NOT COMPLETED|Overall Study||28
8194770|NCT02259088|20205574|P2|COMPLETED|Overall Study||63
8194771|NCT02259088|20205575|P1|COMPLETED|Overall Study||279
8194772|NCT02259088|20205574|P2|Treated (Safety Analysis Set)|Overall Study||75
8194773|NCT02259088|20205575|P1|Treated (Safety Analysis Set)|Overall Study||307
8194774|NCT02259088|20205574|P2|Full Analysis Set|Overall Study||77
8194775|NCT02259088|20205575|P1|Full Analysis Set|Overall Study||307
8194776|NCT02259088|20205574|P2|STARTED|Overall Study||77
8194777|NCT02259088|20205575|P1|STARTED|Overall Study||307
8194778|NCT02259010|20205620|P1|NOT COMPLETED|Overall Study||5
8194779|NCT02259010|20205620|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19
8194780|NCT02259010|20205620|P1|STARTED|Overall Study||24
8194781|NCT02258659|20205645|P1|NOT COMPLETED|Overall Study||1
8194782|NCT02258659|20205645|P1|COMPLETED|Overall Study||61
8194783|NCT02258659|20205645|P1|STARTED|Overall Study||62
8194784|NCT02258542|20205662|P4|NOT COMPLETED|Overall Study||5
8194785|NCT02258542|20205663|P3|NOT COMPLETED|Overall Study||8
8194786|NCT02258542|20205664|P2|NOT COMPLETED|Overall Study||49
8194787|NCT02258542|20205665|P1|NOT COMPLETED|Overall Study||42
8194788|NCT02258542|20205662|P4|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92
8194789|NCT02258542|20205663|P3|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92
8194790|NCT02258542|20205664|P2|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924
8194791|NCT02258542|20205665|P1|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911
8194792|NCT02258542|20205662|P4|Adolescents Only|Overall Study||0
8194793|NCT02258542|20205663|P3|Adolescents Only|Overall Study||0
8194794|NCT02258542|20205664|P2|Adolescents Only|Overall Study||61
8194795|NCT02258542|20205665|P1|Adolescents Only|Overall Study||25
8194796|NCT02258542|20205662|P4|Treated|Overall Study||97
8194797|NCT02258542|20205663|P3|Treated|Overall Study||100
8194798|NCT02258542|20205664|P2|Treated|Overall Study||971
8194799|NCT02258542|20205665|P1|Treated|Overall Study||953
8194800|NCT02258542|20205662|P4|STARTED|Overall Study||97
8194801|NCT02258542|20205663|P3|STARTED|Overall Study||100
8194802|NCT02258542|20205664|P2|STARTED|Overall Study||973
8194803|NCT02258542|20205665|P1|STARTED|Overall Study||953
8194804|NCT02258529|20205889|P1|NOT COMPLETED|Overall Study||10
8194805|NCT02258529|20205889|P1|COMPLETED|Overall Study||0
8194806|NCT02258529|20205889|P1|STARTED|Overall Study||10
8194807|NCT02258477|20205901|P4|NOT COMPLETED|Fourth Intervention (1 Week)||0
8194808|NCT02258477|20205902|P3|NOT COMPLETED|Fourth Intervention (1 Week)||0
8194809|NCT02258477|20205903|P2|NOT COMPLETED|Fourth Intervention (1 Week)||0
8194810|NCT02258477|20205904|P1|NOT COMPLETED|Fourth Intervention (1 Week)||0
8194811|NCT02258477|20205901|P4|COMPLETED|Fourth Intervention (1 Week)||8
8194812|NCT02258477|20205902|P3|COMPLETED|Fourth Intervention (1 Week)||8
8194813|NCT02258477|20205903|P2|COMPLETED|Fourth Intervention (1 Week)||8
8194814|NCT02258477|20205904|P1|COMPLETED|Fourth Intervention (1 Week)||9
8194815|NCT02258477|20205901|P4|STARTED|Fourth Intervention (1 Week)||8
8194816|NCT02258477|20205902|P3|STARTED|Fourth Intervention (1 Week)||8
8194817|NCT02258477|20205903|P2|STARTED|Fourth Intervention (1 Week)||8
8194818|NCT02258477|20205904|P1|STARTED|Fourth Intervention (1 Week)||9
8194819|NCT02258477|20205901|P4|NOT COMPLETED|Third Intervention (1 Week)||0
8194820|NCT02258477|20205902|P3|NOT COMPLETED|Third Intervention (1 Week)||0
8194821|NCT02258477|20205903|P2|NOT COMPLETED|Third Intervention (1 Week)||0
8194822|NCT02258477|20205904|P1|NOT COMPLETED|Third Intervention (1 Week)||0
8194823|NCT02258477|20205901|P4|COMPLETED|Third Intervention (1 Week)||8
8194824|NCT02258477|20205902|P3|COMPLETED|Third Intervention (1 Week)||8
8194825|NCT02258477|20205903|P2|COMPLETED|Third Intervention (1 Week)||8
8194826|NCT02258477|20205904|P1|COMPLETED|Third Intervention (1 Week)||9
8194827|NCT02258477|20205901|P4|STARTED|Third Intervention (1 Week)||8
8194828|NCT02258477|20205902|P3|STARTED|Third Intervention (1 Week)||8
8194829|NCT02258477|20205903|P2|STARTED|Third Intervention (1 Week)||8
8194830|NCT02258477|20205904|P1|STARTED|Third Intervention (1 Week)||9
8194831|NCT02258477|20205901|P4|NOT COMPLETED|Second Intervention (1 Week)||1
8194832|NCT02258477|20205902|P3|NOT COMPLETED|Second Intervention (1 Week)||1
8194833|NCT02258477|20205903|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8194834|NCT02258477|20205904|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8194835|NCT02258477|20205901|P4|COMPLETED|Second Intervention (1 Week)||8
8194836|NCT02258477|20205902|P3|COMPLETED|Second Intervention (1 Week)||8
8194837|NCT02258477|20205903|P2|COMPLETED|Second Intervention (1 Week)||8
8194838|NCT02258477|20205904|P1|COMPLETED|Second Intervention (1 Week)||9
8194839|NCT02258477|20205901|P4|STARTED|Second Intervention (1 Week)||9
8194840|NCT02258477|20205902|P3|STARTED|Second Intervention (1 Week)||9
8194841|NCT02258477|20205903|P2|STARTED|Second Intervention (1 Week)||8
8194842|NCT02258477|20205904|P1|STARTED|Second Intervention (1 Week)||9
8194843|NCT02258477|20205901|P4|NOT COMPLETED|First Intervention (1 Week)||0
8194844|NCT02258477|20205902|P3|NOT COMPLETED|First Intervention (1 Week)||0
8194845|NCT02258477|20205903|P2|NOT COMPLETED|First Intervention (1 Week)||1
8194846|NCT02258477|20205904|P1|NOT COMPLETED|First Intervention (1 Week)||1
8194847|NCT02258477|20205901|P4|COMPLETED|First Intervention (1 Week)||9
8194848|NCT02258477|20205902|P3|COMPLETED|First Intervention (1 Week)||9
8194849|NCT02258477|20205903|P2|COMPLETED|First Intervention (1 Week)||8
8194850|NCT02258477|20205904|P1|COMPLETED|First Intervention (1 Week)||9
8194851|NCT02258477|20205901|P4|STARTED|First Intervention (1 Week)||9
8194852|NCT02258477|20205902|P3|STARTED|First Intervention (1 Week)||9
8194853|NCT02258477|20205903|P2|STARTED|First Intervention (1 Week)||9
8194854|NCT02258477|20205904|P1|STARTED|First Intervention (1 Week)||10
8194855|NCT02258464|20205921|P2|NOT COMPLETED|Overall Study||25
8194856|NCT02258464|20205922|P1|NOT COMPLETED|Overall Study||17
8194857|NCT02258464|20205921|P2|COMPLETED|Overall Study||25
8194858|NCT02258464|20205922|P1|COMPLETED|Overall Study||32
8194859|NCT02258464|20205921|P2|STARTED|Overall Study||50
8194860|NCT02258464|20205922|P1|STARTED|Overall Study||49
8194861|NCT02258412|20205947|P3|NOT COMPLETED|Overall Study||0
8194862|NCT02258412|20205948|P2|NOT COMPLETED|Overall Study||0
8194863|NCT02258412|20205949|P1|NOT COMPLETED|Overall Study||0
8194864|NCT02258412|20205947|P3|COMPLETED|Overall Study||61
8194865|NCT02258412|20205948|P2|COMPLETED|Overall Study||25
8194866|NCT02258412|20205949|P1|COMPLETED|Overall Study||26
8194867|NCT02258412|20205947|P3|STARTED|Overall Study||61
8194868|NCT02258412|20205948|P2|STARTED|Overall Study||25
8194869|NCT02258412|20205949|P1|STARTED|Overall Study||26
8194870|NCT02258373|20205958|P2|NOT COMPLETED|Overall Study||2
8194871|NCT02258373|20205959|P1|NOT COMPLETED|Overall Study||7
8194872|NCT02258373|20205958|P2|COMPLETED|Overall Study||75
8194873|NCT02258373|20205959|P1|COMPLETED|Overall Study||142
8194874|NCT02258373|20205958|P2|STARTED|Overall Study||77
8194875|NCT02258373|20205959|P1|STARTED|Overall Study||149
8194876|NCT02258334|20206003|P4|NOT COMPLETED|Overall Study||0
8194877|NCT02258334|20206004|P3|NOT COMPLETED|Overall Study||0
8194878|NCT02258334|20206005|P2|NOT COMPLETED|Overall Study||0
8194879|NCT02258334|20206006|P1|NOT COMPLETED|Overall Study||1
8194880|NCT02258334|20206003|P4|COMPLETED|Overall Study||52
8194881|NCT02258334|20206004|P3|COMPLETED|Overall Study||52
8194882|NCT02258334|20206005|P2|COMPLETED|Overall Study||54
8194883|NCT02258334|20206006|P1|COMPLETED|Overall Study||49
8194884|NCT02258334|20206003|P4|STARTED|Overall Study||52
8194885|NCT02258334|20206004|P3|STARTED|Overall Study||52
8194886|NCT02258334|20206005|P2|STARTED|Overall Study||54
8194887|NCT02258334|20206006|P1|STARTED|Overall Study||50
8194891|NCT02258217|20206036|P1|NOT COMPLETED|Overall Study||0
8194892|NCT02258217|20206036|P1|COMPLETED|Overall Study||30
8194893|NCT02258217|20206036|P1|STARTED|Overall Study||30
8194894|NCT02258152|20206050|P2|NOT COMPLETED|Overall Study||4
8194895|NCT02258152|20206051|P1|NOT COMPLETED|Overall Study||6
8194896|NCT02258152|20206050|P2|COMPLETED|Overall Study||34
8194897|NCT02258152|20206051|P1|COMPLETED|Overall Study||38
8194898|NCT02258152|20206050|P2|STARTED|Overall Study||38
8194899|NCT02258152|20206051|P1|STARTED|Overall Study||44
8194900|NCT02258139|20206059|P1|NOT COMPLETED|Overall Study||8
8194901|NCT02258139|20206059|P1|COMPLETED|Overall Study||30
8194902|NCT02258139|20206059|P1|STARTED|Overall Study||38
8194903|NCT02257970|20206069|P4|NOT COMPLETED|Part 3||7
8194904|NCT02257970|20206070|P3|NOT COMPLETED|Part 3||7
8194905|NCT02257970|20206071|P2|NOT COMPLETED|Part 3||0
8194906|NCT02257970|20206072|P1|NOT COMPLETED|Part 3||0
8194907|NCT02257970|20206069|P4|COMPLETED|Part 3||14
8194908|NCT02257970|20206070|P3|COMPLETED|Part 3||16
8194909|NCT02257970|20206071|P2|COMPLETED|Part 3||0
8194910|NCT02257970|20206072|P1|COMPLETED|Part 3||0
8194911|NCT02257970|20206069|P4|STARTED|Part 3||21
8194912|NCT02257970|20206070|P3|STARTED|Part 3||23
8194913|NCT02257970|20206071|P2|STARTED|Part 3||0
8194914|NCT02257970|20206072|P1|STARTED|Part 3||0
8194915|NCT02257970|20206069|P4|NOT COMPLETED|Part 2||0
8194916|NCT02257970|20206070|P3|NOT COMPLETED|Part 2||0
8194917|NCT02257970|20206071|P2|NOT COMPLETED|Part 2||7
8194918|NCT02257970|20206072|P1|NOT COMPLETED|Part 2||0
8194919|NCT02257970|20206069|P4|COMPLETED|Part 2||0
8194920|NCT02257970|20206070|P3|COMPLETED|Part 2||0
8194921|NCT02257970|20206071|P2|COMPLETED|Part 2||16
8194922|NCT02257970|20206072|P1|COMPLETED|Part 2||0
8194923|NCT02257970|20206069|P4|STARTED|Part 2||0
8194924|NCT02257970|20206070|P3|STARTED|Part 2||0
8194925|NCT02257970|20206071|P2|STARTED|Part 2||23
8194926|NCT02257970|20206072|P1|STARTED|Part 2||0
8194927|NCT02257970|20206069|P4|NOT COMPLETED|Part 1||0
8194928|NCT02257970|20206070|P3|NOT COMPLETED|Part 1||0
8194929|NCT02257970|20206071|P2|NOT COMPLETED|Part 1||0
8194930|NCT02257970|20206072|P1|NOT COMPLETED|Part 1||0
8194931|NCT02257970|20206069|P4|COMPLETED|Part 1||0
8194932|NCT02257970|20206070|P3|COMPLETED|Part 1||0
8194933|NCT02257970|20206071|P2|COMPLETED|Part 1||0
8194934|NCT02257970|20206072|P1|COMPLETED|Part 1||50
8194935|NCT02257970|20206069|P4|STARTED|Part 1||0
8194936|NCT02257970|20206070|P3|STARTED|Part 1||0
8194937|NCT02257970|20206071|P2|STARTED|Part 1||0
8194938|NCT02257970|20206072|P1|STARTED|Part 1||50
8194939|NCT02257918|20206098|P3|NOT COMPLETED|Overall Study||2
8194940|NCT02257918|20206099|P2|NOT COMPLETED|Overall Study||1
8194941|NCT02257918|20206100|P1|NOT COMPLETED|Overall Study||4
8194942|NCT02257918|20206098|P3|COMPLETED|Overall Study||39
8194943|NCT02257918|20206099|P2|COMPLETED|Overall Study||66
8194944|NCT02257918|20206100|P1|COMPLETED|Overall Study||68
8194945|NCT02257918|20206098|P3|Test of Cure Visit|Overall Study||40
8194946|NCT02257918|20206099|P2|Test of Cure Visit|Overall Study||67
8194947|NCT02257918|20206100|P1|Test of Cure Visit|Overall Study||72
8194948|NCT02257918|20206098|P3|STARTED|Overall Study||41
8194949|NCT02257918|20206099|P2|STARTED|Overall Study||67
8194950|NCT02257918|20206100|P1|STARTED|Overall Study||72
8194951|NCT02257684|20206150|P1|NOT COMPLETED|Overall Study||4
8194952|NCT02257684|20206150|P1|COMPLETED|Overall Study||0
8194953|NCT02257684|20206150|P1|STARTED|Overall Study||4
8194954|NCT02257632|20206160|P2|NOT COMPLETED|Overall Study||3
8194955|NCT02257632|20206161|P1|NOT COMPLETED|Overall Study||1
8194956|NCT02257632|20206160|P2|COMPLETED|Overall Study||19
8194957|NCT02257632|20206161|P1|COMPLETED|Overall Study||18
8194958|NCT02257632|20206160|P2|Per-Protocol Set (PPS)|Overall Study||20
8194959|NCT02257632|20206161|P1|Per-Protocol Set (PPS)|Overall Study||17
8194960|NCT02257632|20206160|P2|Safety Set (SAF)|Overall Study||21
8194961|NCT02257632|20206161|P1|Safety Set (SAF)|Overall Study||19
8194962|NCT02257632|20206160|P2|Full Analysis Set (FAS)|Overall Study||21
8194963|NCT02257632|20206161|P1|Full Analysis Set (FAS)|Overall Study||19
8194964|NCT02257632|20206160|P2|STARTED|Overall Study||22
8194965|NCT02257632|20206161|P1|STARTED|Overall Study||19
8194966|NCT02257541|20206178|P5|NOT COMPLETED|Overall Study||0
8194967|NCT02257541|20206179|P4|NOT COMPLETED|Overall Study||0
8194968|NCT02257541|20206180|P3|NOT COMPLETED|Overall Study||0
8194969|NCT02257541|20206181|P2|NOT COMPLETED|Overall Study||0
8194970|NCT02257541|20206182|P1|NOT COMPLETED|Overall Study||0
8194971|NCT02257541|20206178|P5|COMPLETED|Overall Study||1
8194972|NCT02257541|20206179|P4|COMPLETED|Overall Study||3
8194973|NCT02257541|20206180|P3|COMPLETED|Overall Study||1
8194974|NCT02257541|20206181|P2|COMPLETED|Overall Study||8
8194975|NCT02257541|20206182|P1|COMPLETED|Overall Study||3
8194976|NCT02257541|20206178|P5|STARTED|Overall Study||1
8194977|NCT02257541|20206179|P4|STARTED|Overall Study||3
8194978|NCT02257541|20206180|P3|STARTED|Overall Study||1
8194979|NCT02257541|20206181|P2|STARTED|Overall Study||8
8194980|NCT02257541|20206182|P1|STARTED|Overall Study||3
8194984|NCT02257489|20206217|P9|NOT COMPLETED|Overall Study||0
8194985|NCT02257489|20206218|P8|NOT COMPLETED|Overall Study||0
8194986|NCT02257489|20206219|P7|NOT COMPLETED|Overall Study||0
8194987|NCT02257489|20206220|P6|NOT COMPLETED|Overall Study||0
8194988|NCT02257489|20206221|P5|NOT COMPLETED|Overall Study||0
8194989|NCT02257489|20206222|P4|NOT COMPLETED|Overall Study||1
8194990|NCT02257489|20206223|P3|NOT COMPLETED|Overall Study||0
8194991|NCT02257489|20206224|P2|NOT COMPLETED|Overall Study||0
8194992|NCT02257489|20206225|P1|NOT COMPLETED|Overall Study||0
8194993|NCT02257489|20206217|P9|COMPLETED|Overall Study||6
8194994|NCT02257489|20206218|P8|COMPLETED|Overall Study||10
8194995|NCT02257489|20206219|P7|COMPLETED|Overall Study||6
8194996|NCT02257489|20206220|P6|COMPLETED|Overall Study||6
8194997|NCT02257489|20206221|P5|COMPLETED|Overall Study||6
8194998|NCT02257489|20206222|P4|COMPLETED|Overall Study||5
8194999|NCT02257489|20206223|P3|COMPLETED|Overall Study||6
8195000|NCT02257489|20206224|P2|COMPLETED|Overall Study||6
8195001|NCT02257489|20206225|P1|COMPLETED|Overall Study||6
8195002|NCT02257489|20206217|P9|STARTED|Overall Study||6
8195003|NCT02257489|20206218|P8|STARTED|Overall Study||10
8195004|NCT02257489|20206219|P7|STARTED|Overall Study||6
8195005|NCT02257489|20206220|P6|STARTED|Overall Study||6
8195006|NCT02257489|20206221|P5|STARTED|Overall Study||6
8195007|NCT02257489|20206222|P4|STARTED|Overall Study||6
8195008|NCT02257489|20206223|P3|STARTED|Overall Study||6
8195009|NCT02257489|20206224|P2|STARTED|Overall Study||6
8195010|NCT02257489|20206225|P1|STARTED|Overall Study||6
8195011|NCT02257385|20206261|P2|NOT COMPLETED|Overall Study||22
8195012|NCT02257385|20206262|P1|NOT COMPLETED|Overall Study||22
8195013|NCT02257385|20206261|P2|COMPLETED|Overall Study||457
8195014|NCT02257385|20206262|P1|COMPLETED|Overall Study||460
8195015|NCT02257385|20206261|P2|STARTED|Overall Study||479
8195016|NCT02257385|20206262|P1|STARTED|Overall Study||482
8195017|NCT02257372|20206272|P2|NOT COMPLETED|Overall Study||10
8195018|NCT02257372|20206273|P1|NOT COMPLETED|Overall Study||7
8195019|NCT02257372|20206272|P2|COMPLETED|Overall Study||109
8195020|NCT02257372|20206273|P1|COMPLETED|Overall Study||110
8195021|NCT02257372|20206272|P2|STARTED|Overall Study||119
8195022|NCT02257372|20206273|P1|STARTED|Overall Study||117
8195023|NCT02257099|20206281|P1|NOT COMPLETED|Overall Study||0
8195024|NCT02257099|20206281|P1|COMPLETED|Overall Study||20
8195025|NCT02257099|20206281|P1|STARTED|Overall Study||20
8195026|NCT02256982|20206290|P2|NOT COMPLETED|Overall Study||1
8195027|NCT02256982|20206291|P1|NOT COMPLETED|Overall Study||0
8195028|NCT02256982|20206290|P2|COMPLETED|Overall Study||1
8195029|NCT02256982|20206291|P1|COMPLETED|Overall Study||1
8195030|NCT02256982|20206290|P2|STARTED|Overall Study||2
8195031|NCT02256982|20206291|P1|STARTED|Overall Study||1
8195032|NCT02256969|20206300|P3|NOT COMPLETED|Overall Study||1
8195033|NCT02256969|20206301|P2|NOT COMPLETED|Overall Study||1
8195034|NCT02256969|20206302|P1|NOT COMPLETED|Overall Study||2
8195035|NCT02256969|20206300|P3|COMPLETED|Overall Study||14
8195036|NCT02256969|20206301|P2|COMPLETED|Overall Study||14
8195037|NCT02256969|20206302|P1|COMPLETED|Overall Study||13
8195038|NCT02256969|20206300|P3|STARTED|Overall Study||15
8195039|NCT02256969|20206301|P2|STARTED|Overall Study||15
8195040|NCT02256969|20206302|P1|STARTED|Overall Study||15
8195041|NCT02256917|20206319|P1|NOT COMPLETED|Prophylactic Treatment Phase II||4
8195042|NCT02256917|20206319|P1|COMPLETED|Prophylactic Treatment Phase II||52
8195043|NCT02256917|20206319|P1|STARTED|Prophylactic Treatment Phase II||56
8195044|NCT02256917|20206319|P1|NOT COMPLETED|Prophylactic Treatment Phase I||1
8195045|NCT02256917|20206319|P1|COMPLETED|Prophylactic Treatment Phase I||56
8195046|NCT02256917|20206319|P1|STARTED|Prophylactic Treatment Phase I||57
8195047|NCT02256917|20206319|P1|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0
8195048|NCT02256917|20206319|P1|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58
8195049|NCT02256917|20206319|P1|STARTED|Pharmacokinetic (PK) Evaluation Phase||58
8195050|NCT02256891|20206340|P2|NOT COMPLETED|Overall Study||13
8195051|NCT02256891|20206341|P1|NOT COMPLETED|Overall Study||12
8195052|NCT02256891|20206340|P2|COMPLETED|Overall Study||29
8195053|NCT02256891|20206341|P1|COMPLETED|Overall Study||43
8195054|NCT02256891|20206340|P2|STARTED|Overall Study||42
8195055|NCT02256891|20206341|P1|STARTED|Overall Study||55
8195056|NCT02256839|20206367|P2|NOT COMPLETED|Overall Study||3
8195057|NCT02256839|20206368|P1|NOT COMPLETED|Overall Study||2
8195058|NCT02256839|20206367|P2|COMPLETED|Overall Study||212
8195059|NCT02256839|20206368|P1|COMPLETED|Overall Study||51
8195060|NCT02256839|20206367|P2|STARTED|Overall Study||215
8195061|NCT02256839|20206368|P1|STARTED|Overall Study||53
8195062|NCT02256553|20206374|P1|NOT COMPLETED|Period III||3
8195063|NCT02256553|20206374|P1|COMPLETED|Period III||91
8195064|NCT02256553|20206374|P1|STARTED|Period III||94
8195065|NCT02256553|20206374|P1|NOT COMPLETED|Period II||2
8195066|NCT02256553|20206374|P1|COMPLETED|Period II||94
8195067|NCT02256553|20206374|P1|STARTED|Period II||96
8195068|NCT02256553|20206374|P1|NOT COMPLETED|Period I||6
8195069|NCT02256553|20206374|P1|COMPLETED|Period I||96
8195070|NCT02256553|20206374|P1|STARTED|Period I||102
8195071|NCT02256540|20206383|P3|NOT COMPLETED|Overall Study||2
8195072|NCT02256540|20206384|P2|NOT COMPLETED|Overall Study||1
8195073|NCT02256540|20206385|P1|NOT COMPLETED|Overall Study||0
8195074|NCT02256540|20206383|P3|COMPLETED|Overall Study||4
8195075|NCT02256540|20206384|P2|COMPLETED|Overall Study||5
8195076|NCT02256540|20206385|P1|COMPLETED|Overall Study||6
8195077|NCT02256540|20206383|P3|STARTED|Overall Study||6
8195078|NCT02256540|20206384|P2|STARTED|Overall Study||6
8195079|NCT02256540|20206385|P1|STARTED|Overall Study||6
8195080|NCT02256488|20206403|P4|NOT COMPLETED|Overall Study||6
8195081|NCT02256488|20206404|P3|NOT COMPLETED|Overall Study||10
8195082|NCT02256488|20206405|P2|NOT COMPLETED|Overall Study||6
8195083|NCT02256488|20206406|P1|NOT COMPLETED|Overall Study||8
8195084|NCT02256488|20206403|P4|COMPLETED|Overall Study||384
8195085|NCT02256488|20206404|P3|COMPLETED|Overall Study||382
8195086|NCT02256488|20206405|P2|COMPLETED|Overall Study||386
8195087|NCT02256488|20206406|P1|COMPLETED|Overall Study||379
8195088|NCT02256488|20206403|P4|STARTED|Overall Study||390
8195089|NCT02256488|20206404|P3|STARTED|Overall Study||392
8195090|NCT02256488|20206405|P2|STARTED|Overall Study||392
8195091|NCT02256488|20206406|P1|STARTED|Overall Study||387
8195092|NCT02256436|20206422|P2|NOT COMPLETED|Overall Study||272
8195093|NCT02256436|20206423|P1|NOT COMPLETED|Overall Study||270
8195094|NCT02256436|20206422|P2|COMPLETED|Overall Study||0
8195095|NCT02256436|20206423|P1|COMPLETED|Overall Study||0
8195096|NCT02256436|20206422|P2|Treated|Overall Study||255
8195097|NCT02256436|20206423|P1|Treated|Overall Study||266
8195098|NCT02256436|20206422|P2|STARTED|Overall Study||272
8195099|NCT02256436|20206423|P1|STARTED|Overall Study||270
8195100|NCT02256384|20206459|P1|NOT COMPLETED|Overall Study||14
8195101|NCT02256384|20206459|P1|COMPLETED|Overall Study||62
8195102|NCT02256384|20206459|P1|STARTED|Overall Study||76
8195103|NCT02256358|20206470|P2|NOT COMPLETED|Overall Study||1
8195104|NCT02256358|20206471|P1|NOT COMPLETED|Overall Study||0
8195105|NCT02256358|20206470|P2|COMPLETED|Overall Study||33
8195106|NCT02256358|20206471|P1|COMPLETED|Overall Study||34
8195107|NCT02256358|20206470|P2|STARTED|Overall Study||34
8195108|NCT02256358|20206471|P1|STARTED|Overall Study||34
8195109|NCT02256345|20206479|P2|NOT COMPLETED|Overall Study||0
8195110|NCT02256345|20206480|P1|NOT COMPLETED|Overall Study||0
8195111|NCT02256345|20206479|P2|COMPLETED|Overall Study||3
8195112|NCT02256345|20206480|P1|COMPLETED|Overall Study||9
8195113|NCT02256345|20206479|P2|STARTED|Overall Study||3
8195114|NCT02256345|20206480|P1|STARTED|Overall Study||9
8195115|NCT02256267|20206492|P1|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
8195116|NCT02256267|20206492|P1|COMPLETED|Period 2 (Day 7 to Day 14)||22
8195117|NCT02256267|20206492|P1|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
8195118|NCT02256267|20206492|P1|STARTED|Period 2 (Day 7 to Day 14)||23
8195119|NCT02256267|20206492|P1|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
8195120|NCT02256267|20206492|P1|COMPLETED|Period 2 (Day 1 to Day 6)||23
8195121|NCT02256267|20206492|P1|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
8195122|NCT02256267|20206492|P1|STARTED|Period 2 (Day 1 to Day 6)||23
8195123|NCT02256267|20206492|P1|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
8195124|NCT02256267|20206492|P1|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
8195125|NCT02256267|20206492|P1|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
8195126|NCT02256267|20206492|P1|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
8195127|NCT02256189|20206503|P2|NOT COMPLETED|Overall Study||0
8195128|NCT02256189|20206504|P1|NOT COMPLETED|Overall Study||0
8195129|NCT02256189|20206503|P2|COMPLETED|Overall Study||13
8195130|NCT02256189|20206504|P1|COMPLETED|Overall Study||15
8195131|NCT02256189|20206503|P2|STARTED|Overall Study||13
8195132|NCT02256189|20206504|P1|STARTED|Overall Study||15
8195133|NCT02256111|20206514|P2|NOT COMPLETED|Overall Study||0
8195134|NCT02256111|20206515|P1|NOT COMPLETED|Overall Study||0
8195135|NCT02256111|20206514|P2|COMPLETED|Overall Study||13
8195136|NCT02256111|20206515|P1|COMPLETED|Overall Study||13
8195137|NCT02256111|20206514|P2|STARTED|Overall Study||13
8195138|NCT02256111|20206515|P1|STARTED|Overall Study||13
8195139|NCT02256072|20206550|P2|NOT COMPLETED|Overall Study||29
8195140|NCT02256072|20206551|P1|NOT COMPLETED|Overall Study||42
8195141|NCT02256072|20206550|P2|COMPLETED|Overall Study||162
8195142|NCT02256072|20206551|P1|COMPLETED|Overall Study|Completed the 3-month follow-up|152
8195143|NCT02256072|20206550|P2|Completed 1 Month Follow-Up|Overall Study||179
8195144|NCT02256072|20206551|P1|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
8195145|NCT02256072|20206550|P2|STARTED|Overall Study||191
8195146|NCT02256072|20206551|P1|STARTED|Overall Study||194
8195147|NCT02255981|20206565|P1|NOT COMPLETED|Overall Study||4
8195148|NCT02255981|20206565|P1|COMPLETED|Overall Study|2 eyes of the final 29 subjects were excluded.|29
8195149|NCT02255981|20206565|P1|STARTED|Overall Study|Both eyes of each patient were included except 2 that not were treatable|33
8195150|NCT02255760|20206580|P5|NOT COMPLETED|Overall Study||0
8195151|NCT02255760|20206581|P4|NOT COMPLETED|Overall Study||0
8195152|NCT02255760|20206582|P3|NOT COMPLETED|Overall Study||0
8195153|NCT02255760|20206583|P2|NOT COMPLETED|Overall Study||1
8195154|NCT02255760|20206584|P1|NOT COMPLETED|Overall Study||0
8195155|NCT02255760|20206580|P5|COMPLETED|Overall Study||9
8195156|NCT02255760|20206581|P4|COMPLETED|Overall Study||15
8195157|NCT02255760|20206582|P3|COMPLETED|Overall Study||15
8195158|NCT02255760|20206583|P2|COMPLETED|Overall Study||2
8195159|NCT02255760|20206584|P1|COMPLETED|Overall Study||14
8195160|NCT02255760|20206580|P5|STARTED|Overall Study||9
8195161|NCT02255760|20206581|P4|STARTED|Overall Study||15
8195162|NCT02255760|20206582|P3|STARTED|Overall Study||15
8195163|NCT02255760|20206583|P2|STARTED|Overall Study||3
8195164|NCT02255760|20206584|P1|STARTED|Overall Study||14
8195165|NCT02255565|20206639|P3|NOT COMPLETED|Overall Study||0
8195166|NCT02255565|20206640|P2|NOT COMPLETED|Overall Study||1
8195167|NCT02255565|20206641|P1|NOT COMPLETED|Overall Study||0
8195168|NCT02255565|20206639|P3|COMPLETED|Overall Study||9
8195169|NCT02255565|20206640|P2|COMPLETED|Overall Study||8
8195170|NCT02255565|20206641|P1|COMPLETED|Overall Study||9
8195171|NCT02255565|20206639|P3|STARTED|Overall Study||9
8195172|NCT02255565|20206640|P2|STARTED|Overall Study||9
8195173|NCT02255565|20206641|P1|STARTED|Overall Study||9
8195174|NCT02255552|20206702|P2|NOT COMPLETED|Overall Study||15
8195175|NCT02255552|20206703|P1|NOT COMPLETED|Overall Study||1
8195176|NCT02255552|20206702|P2|COMPLETED|Overall Study||15
8195177|NCT02255552|20206703|P1|COMPLETED|Overall Study||78
8195178|NCT02255552|20206702|P2|STARTED|Overall Study||30
8195179|NCT02255552|20206703|P1|STARTED|Overall Study||79
8195222|NCT02255357|20206857|P2|NOT COMPLETED|Overall Study||10
8195223|NCT02255357|20206858|P1|NOT COMPLETED|Overall Study||7
8195224|NCT02255357|20206857|P2|COMPLETED|Overall Study||5
8195225|NCT02255357|20206858|P1|COMPLETED|Overall Study||4
8195226|NCT02255357|20206857|P2|STARTED|Overall Study||15
8195227|NCT02255357|20206858|P1|STARTED|Overall Study||11
8195228|NCT02255279|20206866|P2|NOT COMPLETED|Overall Study||9
8195229|NCT02255279|20206867|P1|NOT COMPLETED|Overall Study||5
8195230|NCT02255279|20206866|P2|COMPLETED|Overall Study||134
8195231|NCT02255279|20206867|P1|COMPLETED|Overall Study||139
8195232|NCT02255279|20206866|P2|STARTED|Overall Study||143
8195233|NCT02255279|20206867|P1|STARTED|Overall Study||144
8195234|NCT02255175|20206895|P2|NOT COMPLETED|Overall Study||12
8195235|NCT02255175|20206896|P1|NOT COMPLETED|Overall Study||17
8195236|NCT02255175|20206895|P2|COMPLETED|Overall Study||19
8195237|NCT02255175|20206896|P1|COMPLETED|Overall Study||16
8195238|NCT02255175|20206895|P2|STARTED|Overall Study||31
8195239|NCT02255175|20206896|P1|STARTED|Overall Study||33
8195240|NCT02255149|20206920|P1|NOT COMPLETED|Overall Study||5
8195241|NCT02255149|20206920|P1|COMPLETED|Overall Study||5
8195242|NCT02255149|20206920|P1|STARTED|Overall Study||10
8195243|NCT02255110|20206924|P1|NOT COMPLETED|Overall Study||0
8195244|NCT02255110|20206924|P1|COMPLETED|Overall Study||6
8195245|NCT02255110|20206924|P1|STARTED|Overall Study||6
8195250|NCT02254772|20206957|P1|NOT COMPLETED|Overall Study||2
8195251|NCT02254772|20206957|P1|COMPLETED|Overall Study||7
8195252|NCT02254772|20206957|P1|STARTED|Overall Study||9
8195253|NCT02254681|20206963|P1|NOT COMPLETED|Overall Study||6
8195254|NCT02254681|20206963|P1|COMPLETED|Overall Study||0
8195255|NCT02254681|20206963|P1|STARTED|Overall Study||6
8195256|NCT02254551|20206973|P1|NOT COMPLETED|Maintenance||0
8195257|NCT02254551|20206973|P1|COMPLETED|Maintenance||0
8195258|NCT02254551|20206973|P1|STARTED|Maintenance||0
8195259|NCT02254551|20206973|P1|NOT COMPLETED|Expansion||0
8195260|NCT02254551|20206973|P1|COMPLETED|Expansion||0
8195261|NCT02254551|20206973|P1|STARTED|Expansion||0
8195262|NCT02254551|20206973|P1|NOT COMPLETED|Dose Escalation||3
8195263|NCT02254551|20206973|P1|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
8195264|NCT02254551|20206973|P1|Cohort 3: LDE225 800mg|Dose Escalation||0
8195265|NCT02254551|20206973|P1|Cohort 2: LDE225 600mg|Dose Escalation||0
8195266|NCT02254551|20206973|P1|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
8195267|NCT02254551|20206973|P1|STARTED|Dose Escalation||7
8195268|NCT02254486|20206983|P2|NOT COMPLETED|Overall Study||55
8195269|NCT02254486|20206984|P1|NOT COMPLETED|Overall Study||50
8195270|NCT02254486|20206983|P2|COMPLETED|Overall Study||255
8195271|NCT02254486|20206984|P1|COMPLETED|Overall Study||261
8195272|NCT02254486|20206983|P2|STARTED|Overall Study||310
8195273|NCT02254486|20206984|P1|STARTED|Overall Study||311
8195274|NCT02254473|20207002|P2|NOT COMPLETED|Overall Study||1
8195275|NCT02254473|20207003|P1|NOT COMPLETED|Overall Study||2
8195276|NCT02254473|20207002|P2|COMPLETED|Overall Study||2
8195277|NCT02254473|20207003|P1|COMPLETED|Overall Study||7
8195278|NCT02254473|20207002|P2|STARTED|Overall Study||3
8195279|NCT02254473|20207003|P1|STARTED|Overall Study||9
8195280|NCT02254460|20207023|P2|NOT COMPLETED|Overall Study||0
8195281|NCT02254460|20207024|P1|NOT COMPLETED|Overall Study||1
8195282|NCT02254460|20207023|P2|COMPLETED|Overall Study||12
8195283|NCT02254460|20207024|P1|COMPLETED|Overall Study||12
8195284|NCT02254460|20207023|P2|STARTED|Overall Study||12
8195285|NCT02254460|20207024|P1|STARTED|Overall Study||13
8195286|NCT02254421|20207032|P2|NOT COMPLETED|Overall Study||3
8195287|NCT02254421|20207033|P1|NOT COMPLETED|Overall Study||2
8195288|NCT02254421|20207032|P2|COMPLETED|Overall Study||26
8195289|NCT02254421|20207033|P1|COMPLETED|Overall Study||29
8195290|NCT02254421|20207032|P2|STARTED|Overall Study||29
8195291|NCT02254421|20207033|P1|STARTED|Overall Study||31
8195292|NCT02254408|20207047|P2|NOT COMPLETED|Overall Study||10
8195293|NCT02254408|20207048|P1|NOT COMPLETED|Overall Study||8
8195294|NCT02254408|20207047|P2|COMPLETED|Overall Study||83
8195295|NCT02254408|20207048|P1|COMPLETED|Overall Study||88
8195296|NCT02254408|20207047|P2|STARTED|Overall Study||93
8195297|NCT02254408|20207048|P1|STARTED|Overall Study||96
8195298|NCT02254304|20207060|P2|NOT COMPLETED|Overall Study||4
8195299|NCT02254304|20207061|P1|NOT COMPLETED|Overall Study||14
8195300|NCT02254304|20207060|P2|COMPLETED|Overall Study||13
8195301|NCT02254304|20207061|P1|COMPLETED|Overall Study||75
8195302|NCT02254304|20207060|P2|STARTED|Overall Study||17
8195303|NCT02254304|20207061|P1|STARTED|Overall Study||89
8195304|NCT02254291|20207121|P3|NOT COMPLETED|Overall Study||2
8195305|NCT02254291|20207122|P2|NOT COMPLETED|Overall Study||3
8195306|NCT02254291|20207123|P1|NOT COMPLETED|Overall Study||0
8195307|NCT02254291|20207121|P3|COMPLETED|Overall Study||101
8195308|NCT02254291|20207122|P2|COMPLETED|Overall Study||99
8195309|NCT02254291|20207123|P1|COMPLETED|Overall Study||103
8195310|NCT02254291|20207121|P3|Exposed|Overall Study||103
8195311|NCT02254291|20207122|P2|Exposed|Overall Study||102
8195312|NCT02254291|20207123|P1|Exposed|Overall Study||103
8195313|NCT02254291|20207121|P3|STARTED|Overall Study||103
8195314|NCT02254291|20207122|P2|STARTED|Overall Study||102
8195315|NCT02254291|20207123|P1|STARTED|Overall Study||103
8195316|NCT02254278|20207139|P2|NOT COMPLETED|Overall Study||1
8195317|NCT02254278|20207140|P1|NOT COMPLETED|Overall Study||1
8195318|NCT02254278|20207139|P2|COMPLETED|Overall Study||149
8195319|NCT02254278|20207140|P1|COMPLETED|Overall Study||157
8195320|NCT02254278|20207139|P2|Negative Post-treatment PET|Overall Study||57
8195321|NCT02254278|20207140|P1|Negative Post-treatment PET|Overall Study||58
8195322|NCT02254278|20207139|P2|Started Study Treatment|Overall Study||147
8195323|NCT02254278|20207140|P1|Started Study Treatment|Overall Study||152
8195324|NCT02254278|20207139|P2|Eligible|Overall Study||149
8195325|NCT02254278|20207140|P1|Eligible|Overall Study||157
8195326|NCT02254278|20207139|P2|STARTED|Overall Study||150
8195327|NCT02254278|20207140|P1|STARTED|Overall Study||158
8195328|NCT02254265|20207160|P3|NOT COMPLETED|Overall Study||8
8195329|NCT02254265|20207161|P2|NOT COMPLETED|Overall Study||12
8195330|NCT02254265|20207162|P1|NOT COMPLETED|Overall Study||9
8195331|NCT02254265|20207160|P3|COMPLETED|Overall Study||144
8195332|NCT02254265|20207161|P2|COMPLETED|Overall Study||140
8195333|NCT02254265|20207162|P1|COMPLETED|Overall Study||142
8195334|NCT02254265|20207160|P3|STARTED|Overall Study||152
8195335|NCT02254265|20207161|P2|STARTED|Overall Study||152
8195336|NCT02254265|20207162|P1|STARTED|Overall Study||151
8195337|NCT02254252|20207187|P2|NOT COMPLETED|Overall Study||2
8195338|NCT02254252|20207188|P1|NOT COMPLETED|Overall Study||3
8195339|NCT02254252|20207187|P2|COMPLETED|Overall Study||25
8195340|NCT02254252|20207188|P1|COMPLETED|Overall Study||24
8195341|NCT02254252|20207187|P2|STARTED|Overall Study||27
8195342|NCT02254252|20207188|P1|STARTED|Overall Study||27
8195343|NCT02253992|20207201|P3|NOT COMPLETED|Overall Study||144
8195344|NCT02253992|20207202|P2|NOT COMPLETED|Overall Study||4
8195345|NCT02253992|20207203|P1|NOT COMPLETED|Overall Study||6
8195346|NCT02253992|20207201|P3|COMPLETED|Overall Study||6
8195347|NCT02253992|20207202|P2|COMPLETED|Overall Study||0
8195348|NCT02253992|20207203|P1|COMPLETED|Overall Study||0
8195349|NCT02253992|20207201|P3|STARTED|Overall Study||150
8195350|NCT02253992|20207202|P2|STARTED|Overall Study||4
8195351|NCT02253992|20207203|P1|STARTED|Overall Study||6
8195352|NCT02253654|20207269|P2|NOT COMPLETED|Overall Study||18
8195353|NCT02253654|20207270|P1|NOT COMPLETED|Overall Study||23
8195354|NCT02253654|20207269|P2|COMPLETED|Overall Study||90
8195355|NCT02253654|20207270|P1|COMPLETED|Overall Study||85
8195356|NCT02253654|20207269|P2|Received Treatment|Overall Study||107
8195357|NCT02253654|20207270|P1|Received Treatment|Overall Study||104
8195358|NCT02253654|20207269|P2|STARTED|Overall Study||108
8195359|NCT02253654|20207270|P1|STARTED|Overall Study||108
8195360|NCT02253537|20207290|P1|NOT COMPLETED|Overall Study||0
8195361|NCT02253537|20207290|P1|COMPLETED|Overall Study||15
8195362|NCT02253537|20207290|P1|STARTED|Overall Study||15
8195363|NCT02253433|20207296|P2|NOT COMPLETED|Overall Study||55
8195364|NCT02253433|20207297|P1|NOT COMPLETED|Overall Study||16
8195365|NCT02253433|20207296|P2|COMPLETED|Overall Study||79
8195366|NCT02253433|20207297|P1|COMPLETED|Overall Study||114
8195367|NCT02253433|20207296|P2|STARTED|Overall Study||134
8195368|NCT02253433|20207297|P1|STARTED|Overall Study||130
8195369|NCT02253394|20207307|P2|NOT COMPLETED|Overall Study||0
8195370|NCT02253394|20207308|P1|NOT COMPLETED|Overall Study||0
8195371|NCT02253394|20207307|P2|COMPLETED|Overall Study||2
8195372|NCT02253394|20207308|P1|COMPLETED|Overall Study||0
8195373|NCT02253394|20207307|P2|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2
8195374|NCT02253394|20207308|P1|STARTED|Overall Study||0
8195375|NCT02253173|20207318|P4|NOT COMPLETED|Overall Study||14
8195376|NCT02253173|20207319|P3|NOT COMPLETED|Overall Study||13
8195377|NCT02253173|20207320|P2|NOT COMPLETED|Overall Study||17
8195378|NCT02253173|20207321|P1|NOT COMPLETED|Overall Study||16
8195379|NCT02253173|20207318|P4|COMPLETED|Overall Study||178
8195380|NCT02253173|20207319|P3|COMPLETED|Overall Study||177
8195381|NCT02253173|20207320|P2|COMPLETED|Overall Study||174
8195382|NCT02253173|20207321|P1|COMPLETED|Overall Study||175
8195383|NCT02253173|20207318|P4|STARTED|Overall Study||192
8195384|NCT02253173|20207319|P3|STARTED|Overall Study||190
8195385|NCT02253173|20207320|P2|STARTED|Overall Study||191
8195386|NCT02253173|20207321|P1|STARTED|Overall Study||191
8195387|NCT02253160|20207518|P3|NOT COMPLETED|Overall Study||0
8195388|NCT02253160|20207519|P2|NOT COMPLETED|Overall Study||0
8195389|NCT02253160|20207520|P1|NOT COMPLETED|Overall Study||0
8195390|NCT02253160|20207518|P3|COMPLETED|Overall Study||10
8195391|NCT02253160|20207519|P2|COMPLETED|Overall Study||12
8195392|NCT02253160|20207520|P1|COMPLETED|Overall Study||1
8195393|NCT02253160|20207518|P3|STARTED|Overall Study||10
8195394|NCT02253160|20207519|P2|STARTED|Overall Study||12
8195395|NCT02253160|20207520|P1|STARTED|Overall Study||1
8195396|NCT02253147|20207556|P1|NOT COMPLETED|Overall Study||47
8195397|NCT02253147|20207556|P1|COMPLETED|Overall Study||71
8195398|NCT02253147|20207556|P1|N Patients at W52|Overall Study||84
8195399|NCT02253147|20207556|P1|N Patients at W36|Overall Study||86
8195400|NCT02253147|20207556|P1|N Patients at W24 (Primary Outcome)|Overall Study||88
8195401|NCT02253147|20207556|P1|STARTED|Overall Study||118
8195402|NCT02252965|20207590|P2|NOT COMPLETED|Overall Study||43
8195403|NCT02252965|20207591|P1|NOT COMPLETED|Overall Study||40
8195404|NCT02252965|20207590|P2|COMPLETED|Overall Study||222
8195405|NCT02252965|20207591|P1|COMPLETED|Overall Study||227
8195406|NCT02252965|20207590|P2|Safety Population|Overall Study||264
8195407|NCT02252965|20207591|P1|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
8195408|NCT02252965|20207590|P2|STARTED|Overall Study||265
8195409|NCT02252965|20207591|P1|STARTED|Overall Study||267
8195410|NCT02252939|20207618|P1|NOT COMPLETED|Overall Study||3
8195411|NCT02252939|20207618|P1|COMPLETED|Overall Study||59
8195412|NCT02252939|20207618|P1|STARTED|Overall Study||62
8195413|NCT02252744|20207627|P1|NOT COMPLETED|Overall Study||0
8195414|NCT02252744|20207627|P1|COMPLETED|Overall Study||286
8195415|NCT02252744|20207627|P1|STARTED|Overall Study||286
8195416|NCT02252718|20207631|P1|NOT COMPLETED|Overall Study||0
8195417|NCT02252718|20207631|P1|COMPLETED|Overall Study||100
8195418|NCT02252718|20207631|P1|STARTED|Overall Study||100
8195419|NCT02252666|20207635|P1|NOT COMPLETED|Overall Study||0
8195420|NCT02252666|20207635|P1|COMPLETED|Overall Study||6
8195421|NCT02252666|20207635|P1|STARTED|Overall Study||6
8195422|NCT02252588|20207659|P2|NOT COMPLETED|Overall Study||0
8195423|NCT02252588|20207660|P1|NOT COMPLETED|Overall Study||4
8195424|NCT02252588|20207659|P2|COMPLETED|Overall Study||20
8195425|NCT02252588|20207660|P1|COMPLETED|Overall Study||20
8195426|NCT02252588|20207659|P2|STARTED|Overall Study||20
8195427|NCT02252588|20207660|P1|STARTED|Overall Study||24
8195428|NCT02252562|20207672|P2|NOT COMPLETED|Overall Study||0
8195429|NCT02252562|20207673|P1|NOT COMPLETED|Overall Study||0
8195430|NCT02252562|20207672|P2|COMPLETED|Overall Study||1636
8195431|NCT02252562|20207673|P1|COMPLETED|Overall Study||1620
8195432|NCT02252562|20207672|P2|STARTED|Overall Study||1636
8195433|NCT02252562|20207673|P1|STARTED|Overall Study||1620
8195434|NCT02252536|20207688|P2|NOT COMPLETED|Overall Study||3
8195435|NCT02252536|20207689|P1|NOT COMPLETED|Overall Study||5
8195436|NCT02252536|20207688|P2|COMPLETED|Overall Study||170
8195437|NCT02252536|20207689|P1|COMPLETED|Overall Study||168
8195438|NCT02252536|20207688|P2|STARTED|Overall Study||173
8195439|NCT02252536|20207689|P1|STARTED|Overall Study||173
8195440|NCT02252445|20207723|P2|NOT COMPLETED|Overall Study||0
8195441|NCT02252445|20207724|P1|NOT COMPLETED|Overall Study||0
8195442|NCT02252445|20207723|P2|COMPLETED|Overall Study||41
8195443|NCT02252445|20207724|P1|COMPLETED|Overall Study||41
8195444|NCT02252445|20207723|P2|STARTED|Overall Study||41
8195445|NCT02252445|20207724|P1|STARTED|Overall Study||41
8195446|NCT02252406|20207750|P2|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||1
8195447|NCT02252406|20207751|P1|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||3
8195448|NCT02252406|20207750|P2|COMPLETED|Titrated to Ranolazine 1000mg BID||13
8195449|NCT02252406|20207751|P1|COMPLETED|Titrated to Ranolazine 1000mg BID||9
8195450|NCT02252406|20207750|P2|STARTED|Titrated to Ranolazine 1000mg BID||14
8195451|NCT02252406|20207751|P1|STARTED|Titrated to Ranolazine 1000mg BID||12
8195452|NCT02252406|20207750|P2|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||3
8195453|NCT02252406|20207751|P1|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||4
8195454|NCT02252406|20207750|P2|COMPLETED|Starting Dose Ranolazine 500 mg BID||14
8195455|NCT02252406|20207751|P1|COMPLETED|Starting Dose Ranolazine 500 mg BID||12
8195456|NCT02252406|20207750|P2|STARTED|Starting Dose Ranolazine 500 mg BID||17
8195457|NCT02252406|20207751|P1|STARTED|Starting Dose Ranolazine 500 mg BID||16
8195458|NCT02252354|20207761|P2|NOT COMPLETED|Overall Study||0
8195459|NCT02252354|20207762|P1|NOT COMPLETED|Overall Study||0
8195460|NCT02252354|20207761|P2|COMPLETED|Overall Study||6
8195461|NCT02252354|20207762|P1|COMPLETED|Overall Study||6
8195462|NCT02252354|20207761|P2|STARTED|Overall Study||6
8195463|NCT02252354|20207762|P1|STARTED|Overall Study||6
8195464|NCT02252211|20207809|P3|NOT COMPLETED|Overall Study||1
8195465|NCT02252211|20207810|P2|NOT COMPLETED|Overall Study||3
8195466|NCT02252211|20207811|P1|NOT COMPLETED|Overall Study||5
8195467|NCT02252211|20207809|P3|COMPLETED|Overall Study||0
8195468|NCT02252211|20207810|P2|COMPLETED|Overall Study||0
8195469|NCT02252211|20207811|P1|COMPLETED|Overall Study||0
8195470|NCT02252211|20207809|P3|Received Further Doses (Through Dose 24)|Overall Study||0
8195471|NCT02252211|20207810|P2|Received Further Doses (Through Dose 24)|Overall Study||0
8195472|NCT02252211|20207811|P1|Received Further Doses (Through Dose 24)|Overall Study||1
8195473|NCT02252211|20207809|P3|Received Dose 4 (Day 36)|Overall Study||0
8195474|NCT02252211|20207810|P2|Received Dose 4 (Day 36)|Overall Study||1
8195475|NCT02252211|20207811|P1|Received Dose 4 (Day 36)|Overall Study||1
8195476|NCT02252211|20207809|P3|Received Dose 3 (Day 22)|Overall Study||0
8195477|NCT02252211|20207810|P2|Received Dose 3 (Day 22)|Overall Study||3
8195478|NCT02252211|20207811|P1|Received Dose 3 (Day 22)|Overall Study||3
8195479|NCT02252211|20207809|P3|Received Dose 2 (Day 8)|Overall Study||0
8195480|NCT02252211|20207810|P2|Received Dose 2 (Day 8)|Overall Study||3
8195481|NCT02252211|20207811|P1|Received Dose 2 (Day 8)|Overall Study||4
8195482|NCT02252211|20207809|P3|Received Dose 1 (Day 1)|Overall Study||0
8195483|NCT02252211|20207810|P2|Received Dose 1 (Day 1)|Overall Study||3
8195484|NCT02252211|20207811|P1|Received Dose 1 (Day 1)|Overall Study||4
8195485|NCT02252211|20207809|P3|STARTED|Overall Study||1
8195486|NCT02252211|20207810|P2|STARTED|Overall Study||3
8195487|NCT02252211|20207811|P1|STARTED|Overall Study||5
8195496|NCT02252146|20207861|P1|NOT COMPLETED|Overall Study||6
8195497|NCT02252146|20207861|P1|COMPLETED|Overall Study||0
8195498|NCT02252146|20207861|P1|STARTED|Overall Study||6
8195499|NCT02252133|20207865|P2|NOT COMPLETED|Period 2||0
8195500|NCT02252133|20207866|P1|NOT COMPLETED|Period 2||0
8195501|NCT02252133|20207865|P2|COMPLETED|Period 2||24
8195502|NCT02252133|20207866|P1|COMPLETED|Period 2||23
8195503|NCT02252133|20207865|P2|STARTED|Period 2||24
8195504|NCT02252133|20207866|P1|STARTED|Period 2||23
8195505|NCT02252133|20207865|P2|NOT COMPLETED|Period 1||0
8195506|NCT02252133|20207866|P1|NOT COMPLETED|Period 1||0
8195507|NCT02252133|20207865|P2|COMPLETED|Period 1||24
8195508|NCT02252133|20207866|P1|COMPLETED|Period 1||23
8195509|NCT02252133|20207865|P2|STARTED|Period 1||24
8195510|NCT02252133|20207866|P1|STARTED|Period 1||23
8195511|NCT02252068|20207875|P3|NOT COMPLETED|Overall Study||0
8195512|NCT02252068|20207876|P2|NOT COMPLETED|Overall Study||0
8195513|NCT02252068|20207877|P1|NOT COMPLETED|Overall Study||2
8195514|NCT02252068|20207875|P3|COMPLETED|Overall Study||13
8195515|NCT02252068|20207876|P2|COMPLETED|Overall Study||13
8195516|NCT02252068|20207877|P1|COMPLETED|Overall Study||3
8195517|NCT02252068|20207875|P3|STARTED|Overall Study||13
8195518|NCT02252068|20207876|P2|STARTED|Overall Study||13
8195519|NCT02252068|20207877|P1|STARTED|Overall Study||5
8195528|NCT02252016|20207943|P2|NOT COMPLETED|Overall Study||3
8195529|NCT02252016|20207944|P1|NOT COMPLETED|Overall Study||3
8195530|NCT02252016|20207943|P2|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
8195531|NCT02252016|20207944|P1|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
8195532|NCT02252016|20207943|P2|STARTED|Overall Study||52
8195533|NCT02252016|20207944|P1|STARTED|Overall Study||107
8195534|NCT02251990|20207958|P2|NOT COMPLETED|Period 3 (DTG Follow-up)||0
8195535|NCT02251990|20207959|P1|NOT COMPLETED|Period 3 (DTG Follow-up)||0
8195536|NCT02251990|20207958|P2|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
8195537|NCT02251990|20207959|P1|COMPLETED|Period 3 (DTG Follow-up)||0
8195538|NCT02251990|20207958|P2|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
8195539|NCT02251990|20207959|P1|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
8195540|NCT02251990|20207958|P2|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
8195541|NCT02251990|20207959|P1|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
8195542|NCT02251990|20207958|P2|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
8195543|NCT02251990|20207959|P1|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
8195544|NCT02251990|20207958|P2|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
8195545|NCT02251990|20207959|P1|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
8195546|NCT02251990|20207958|P2|NOT COMPLETED|Period 1 (Double-blind [DB])||1
8195547|NCT02251990|20207959|P1|NOT COMPLETED|Period 1 (Double-blind [DB])||8
8195548|NCT02251990|20207958|P2|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
8195549|NCT02251990|20207959|P1|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
8195550|NCT02251990|20207958|P2|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
8195551|NCT02251990|20207959|P1|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
8195552|NCT02251990|20207958|P2|STARTED|Period 1 (Double-blind [DB])||123
8195553|NCT02251990|20207959|P1|STARTED|Period 1 (Double-blind [DB])||366
8195554|NCT02251938|20207974|P1|NOT COMPLETED|Overall Study||17
8195555|NCT02251938|20207974|P1|COMPLETED|Overall Study||43
8195556|NCT02251938|20207974|P1|STARTED|Overall Study||60
8195557|NCT02251912|20207987|P2|NOT COMPLETED|Overall Study||5
8195558|NCT02251912|20207988|P1|NOT COMPLETED|Overall Study||2
8195559|NCT02251912|20207987|P2|COMPLETED|Overall Study||5
8195560|NCT02251912|20207988|P1|COMPLETED|Overall Study||10
8195561|NCT02251912|20207987|P2|STARTED|Overall Study||10
8195562|NCT02251912|20207988|P1|STARTED|Overall Study||12
8195563|NCT02251886|20208002|P4|NOT COMPLETED|Overall Study||0
8195564|NCT02251886|20208003|P3|NOT COMPLETED|Overall Study||0
8195565|NCT02251886|20208004|P2|NOT COMPLETED|Overall Study||0
8195566|NCT02251886|20208005|P1|NOT COMPLETED|Overall Study||0
8195567|NCT02251886|20208002|P4|COMPLETED|Overall Study||54
8195568|NCT02251886|20208003|P3|COMPLETED|Overall Study||44
8195569|NCT02251886|20208004|P2|COMPLETED|Overall Study||54
8195570|NCT02251886|20208005|P1|COMPLETED|Overall Study||48
8195571|NCT02251886|20208002|P4|STARTED|Overall Study||54
8195572|NCT02251886|20208003|P3|STARTED|Overall Study||44
8195573|NCT02251886|20208004|P2|STARTED|Overall Study||54
8195574|NCT02251886|20208005|P1|STARTED|Overall Study||48
8195575|NCT02251743|20208017|P2|NOT COMPLETED|Overall Study||1
8195576|NCT02251743|20208018|P1|NOT COMPLETED|Overall Study||1
8195577|NCT02251743|20208017|P2|COMPLETED|Overall Study||58
8195578|NCT02251743|20208018|P1|COMPLETED|Overall Study||84
8195579|NCT02251743|20208017|P2|STARTED|Overall Study||59
8195580|NCT02251743|20208018|P1|STARTED|Overall Study||85
8195581|NCT02251717|20208026|P2|NOT COMPLETED|Overall Study||1
8195582|NCT02251717|20208027|P1|NOT COMPLETED|Overall Study||1
8195583|NCT02251717|20208026|P2|COMPLETED|Overall Study||56
8195584|NCT02251717|20208027|P1|COMPLETED|Overall Study||56
8195585|NCT02251717|20208026|P2|STARTED|Overall Study||57
8195586|NCT02251717|20208027|P1|STARTED|Overall Study||57
8195587|NCT02251652|20208039|P1|NOT COMPLETED|Overall Study||1
8195588|NCT02251652|20208039|P1|COMPLETED|Overall Study||16
8195589|NCT02251652|20208039|P1|STARTED|Overall Study||17
8195590|NCT02251613|20208049|P1|NOT COMPLETED|Overall Study||0
8195591|NCT02251613|20208049|P1|COMPLETED|Overall Study||50
8195592|NCT02251613|20208049|P1|STARTED|Overall Study||50
8195593|NCT02251561|20208057|P1|NOT COMPLETED|Overall Study||0
8195594|NCT02251561|20208057|P1|COMPLETED|Overall Study||28
8195595|NCT02251561|20208057|P1|STARTED|Overall Study||28
8195599|NCT02251496|20208073|P2|NOT COMPLETED|Overall Study||4
8195600|NCT02251496|20208074|P1|NOT COMPLETED|Overall Study||5
8195601|NCT02251496|20208073|P2|COMPLETED|Overall Study||11
8195602|NCT02251496|20208074|P1|COMPLETED|Overall Study||14
8195603|NCT02251496|20208073|P2|STARTED|Overall Study||15
8195604|NCT02251496|20208074|P1|STARTED|Overall Study||19
8195605|NCT02251379|20208084|P2|NOT COMPLETED|Overall Study||20
8195606|NCT02251379|20208085|P1|NOT COMPLETED|Overall Study||20
8195607|NCT02251379|20208084|P2|COMPLETED|Overall Study||58
8195608|NCT02251379|20208085|P1|COMPLETED|Overall Study||57
8195609|NCT02251379|20208084|P2|STARTED|Overall Study||78
8195610|NCT02251379|20208085|P1|STARTED|Overall Study||77
8195611|NCT02251275|20208106|P5|NOT COMPLETED|Overall Study||1
8195612|NCT02251275|20208107|P4|NOT COMPLETED|Overall Study||1
8195613|NCT02251275|20208108|P3|NOT COMPLETED|Overall Study||94
8195614|NCT02251275|20208109|P2|NOT COMPLETED|Overall Study||147
8195615|NCT02251275|20208110|P1|NOT COMPLETED|Overall Study||72
8195616|NCT02251275|20208106|P5|COMPLETED|Overall Study||2
8195617|NCT02251275|20208107|P4|COMPLETED|Overall Study||5
8195618|NCT02251275|20208108|P3|COMPLETED|Overall Study||624
8195619|NCT02251275|20208109|P2|COMPLETED|Overall Study||423
8195620|NCT02251275|20208110|P1|COMPLETED|Overall Study||434
8195621|NCT02251275|20208106|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
8195622|NCT02251275|20208107|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8195623|NCT02251275|20208108|P3|Received at Least 1 Dose of Study Drug|Overall Study||717
8195624|NCT02251275|20208109|P2|Received at Least 1 Dose of Study Drug|Overall Study||569
8195625|NCT02251275|20208110|P1|Received at Least 1 Dose of Study Drug|Overall Study||505
8195626|NCT02251275|20208106|P5|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3
8195627|NCT02251275|20208107|P4|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6
8195628|NCT02251275|20208108|P3|STARTED|Overall Study||718
8195629|NCT02251275|20208109|P2|STARTED|Overall Study||570
8195630|NCT02251275|20208110|P1|STARTED|Overall Study||506
8195631|NCT02251236|20208125|P3|NOT COMPLETED|Overall Study||0
8195632|NCT02251236|20208126|P2|NOT COMPLETED|Overall Study||0
8195633|NCT02251236|20208127|P1|NOT COMPLETED|Overall Study||0
8195634|NCT02251236|20208125|P3|COMPLETED|Overall Study||0
8195635|NCT02251236|20208126|P2|COMPLETED|Overall Study||5
8195636|NCT02251236|20208127|P1|COMPLETED|Overall Study||9
8195637|NCT02251236|20208125|P3|STARTED|Overall Study||0
8195638|NCT02251236|20208126|P2|STARTED|Overall Study||5
8195639|NCT02251236|20208127|P1|STARTED|Overall Study||9
8195640|NCT02250807|20208144|P1|NOT COMPLETED|Overall Study||0
8195641|NCT02250807|20208144|P1|COMPLETED|Overall Study||40
8195642|NCT02250807|20208144|P1|STARTED|Overall Study||40
8195643|NCT02250703|20208156|P2|NOT COMPLETED|Overall Study||1
8195644|NCT02250703|20208157|P1|NOT COMPLETED|Overall Study||1
8195645|NCT02250703|20208156|P2|COMPLETED|Overall Study||36
8195646|NCT02250703|20208157|P1|COMPLETED|Overall Study||37
8195647|NCT02250703|20208156|P2|STARTED|Overall Study||37
8195648|NCT02250703|20208157|P1|STARTED|Overall Study||38
8195649|NCT02250612|20208174|P5|NOT COMPLETED|Overall Study||1
8195650|NCT02250612|20208175|P4|NOT COMPLETED|Overall Study||0
8195651|NCT02250612|20208176|P3|NOT COMPLETED|Overall Study||2
8195652|NCT02250612|20208177|P2|NOT COMPLETED|Overall Study||2
8195653|NCT02250612|20208178|P1|NOT COMPLETED|Overall Study||1
8195654|NCT02250612|20208174|P5|COMPLETED|Overall Study||36
8195655|NCT02250612|20208175|P4|COMPLETED|Overall Study||33
8195656|NCT02250612|20208176|P3|COMPLETED|Overall Study||35
8195657|NCT02250612|20208177|P2|COMPLETED|Overall Study||38
8195658|NCT02250612|20208178|P1|COMPLETED|Overall Study||36
8195659|NCT02250612|20208174|P5|STARTED|Overall Study||37
8195660|NCT02250612|20208175|P4|STARTED|Overall Study||33
8195661|NCT02250612|20208176|P3|STARTED|Overall Study||37
8195662|NCT02250612|20208177|P2|STARTED|Overall Study||40
8195663|NCT02250612|20208178|P1|STARTED|Overall Study||37
8195664|NCT02250521|20208200|P1|NOT COMPLETED|Overall Study||1
8195665|NCT02250521|20208200|P1|COMPLETED|Overall Study||99
8195666|NCT02250521|20208200|P1|STARTED|Overall Study||100
8195667|NCT02250443|20208214|P1|NOT COMPLETED|Overall Study||10
8195668|NCT02250443|20208214|P1|COMPLETED|Overall Study||0
8195669|NCT02250443|20208214|P1|STARTED|Overall Study||10
8195670|NCT02250417|20208227|P2|NOT COMPLETED|Second Intervention (1 Night)||0
8195671|NCT02250417|20208228|P1|NOT COMPLETED|Second Intervention (1 Night)||0
8195672|NCT02250417|20208227|P2|COMPLETED|Second Intervention (1 Night)||6
8195673|NCT02250417|20208228|P1|COMPLETED|Second Intervention (1 Night)||6
8195674|NCT02250417|20208227|P2|STARTED|Second Intervention (1 Night)||6
8195675|NCT02250417|20208228|P1|STARTED|Second Intervention (1 Night)||6
8195676|NCT02250417|20208227|P2|NOT COMPLETED|First Intervention (1 Night)||0
8195677|NCT02250417|20208228|P1|NOT COMPLETED|First Intervention (1 Night)||0
8195678|NCT02250417|20208227|P2|COMPLETED|First Intervention (1 Night)||6
8195679|NCT02250417|20208228|P1|COMPLETED|First Intervention (1 Night)||6
8195680|NCT02250417|20208227|P2|STARTED|First Intervention (1 Night)||6
8195681|NCT02250417|20208228|P1|STARTED|First Intervention (1 Night)||6
8195703|NCT02250274|20208278|P2|NOT COMPLETED|Overall Study||6
8195704|NCT02250274|20208279|P1|NOT COMPLETED|Overall Study||7
8195705|NCT02250274|20208278|P2|COMPLETED|Overall Study||40
8195706|NCT02250274|20208279|P1|COMPLETED|Overall Study||78
8195707|NCT02250274|20208278|P2|STARTED|Overall Study||46
8195708|NCT02250274|20208279|P1|STARTED|Overall Study||85
8195709|NCT02250183|20208295|P1|NOT COMPLETED|Overall Study||8
8195710|NCT02250183|20208295|P1|COMPLETED|Overall Study||13
8195711|NCT02250183|20208295|P1|STARTED|Overall Study||21
8195712|NCT02250092|20208306|P2|NOT COMPLETED|Overall Study||0
8195713|NCT02250092|20208307|P1|NOT COMPLETED|Overall Study||0
8195714|NCT02250092|20208306|P2|COMPLETED|Overall Study||10
8195715|NCT02250092|20208307|P1|COMPLETED|Overall Study||10
8195716|NCT02250092|20208306|P2|STARTED|Overall Study||10
8195717|NCT02250092|20208307|P1|STARTED|Overall Study||10
8195730|NCT02249793|20208343|P1|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0
8195731|NCT02249793|20208343|P1|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6
8195732|NCT02249793|20208343|P1|STARTED|Session 2, 48-Hours Healthy Volunteers||6
8195733|NCT02249793|20208343|P1|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0
8195734|NCT02249793|20208343|P1|COMPLETED|Session 1, 48-hours Healthy Volunteers||6
8195735|NCT02249793|20208343|P1|STARTED|Session 1, 48-hours Healthy Volunteers||6
8195736|NCT02249767|20208368|P3|NOT COMPLETED|Overall Study||8
8195737|NCT02249767|20208369|P2|NOT COMPLETED|Overall Study||9
8195738|NCT02249767|20208370|P1|NOT COMPLETED|Overall Study||8
8195739|NCT02249767|20208368|P3|COMPLETED|Overall Study||107
8195740|NCT02249767|20208369|P2|COMPLETED|Overall Study||220
8195741|NCT02249767|20208370|P1|COMPLETED|Overall Study||222
8195742|NCT02249767|20208368|P3|STARTED|Overall Study||115
8195743|NCT02249767|20208369|P2|STARTED|Overall Study||229
8195744|NCT02249767|20208370|P1|STARTED|Overall Study||230
8195745|NCT02249728|20208378|P1|NOT COMPLETED|Part Two (up to 6 Days)||0
8195746|NCT02249728|20208378|P1|COMPLETED|Part Two (up to 6 Days)||6
8195747|NCT02249728|20208378|P1|STARTED|Part Two (up to 6 Days)||6
8195748|NCT02249728|20208378|P1|NOT COMPLETED|Part One (4 Days)||0
8195749|NCT02249728|20208378|P1|COMPLETED|Part One (4 Days)||6
8195750|NCT02249728|20208378|P1|STARTED|Part One (4 Days)||6
8195751|NCT02249585|20208391|P3|NOT COMPLETED|Overall Study||0
8195752|NCT02249585|20208392|P2|NOT COMPLETED|Overall Study||0
8195753|NCT02249585|20208393|P1|NOT COMPLETED|Overall Study||0
8195754|NCT02249585|20208391|P3|COMPLETED|Overall Study||44
8195755|NCT02249585|20208392|P2|COMPLETED|Overall Study||44
8195756|NCT02249585|20208393|P1|COMPLETED|Overall Study||43
8195757|NCT02249585|20208391|P3|STARTED|Overall Study||44
8195758|NCT02249585|20208392|P2|STARTED|Overall Study||44
8195759|NCT02249585|20208393|P1|STARTED|Overall Study||43
8195760|NCT02249377|20208418|P2|NOT COMPLETED|Overall Study||24
8195761|NCT02249377|20208419|P1|NOT COMPLETED|Overall Study||25
8195762|NCT02249377|20208418|P2|COMPLETED|Overall Study||1
8195763|NCT02249377|20208419|P1|COMPLETED|Overall Study||0
8195764|NCT02249377|20208418|P2|STARTED|Overall Study||25
8195765|NCT02249377|20208419|P1|STARTED|Overall Study||25
8195766|NCT02249182|20208436|P5|NOT COMPLETED|Treatment Phase||0
8195767|NCT02249182|20208437|P4|NOT COMPLETED|Treatment Phase||0
8195768|NCT02249182|20208438|P3|NOT COMPLETED|Treatment Phase||0
8195769|NCT02249182|20208439|P2|NOT COMPLETED|Treatment Phase||0
8195770|NCT02249182|20208440|P1|NOT COMPLETED|Treatment Phase||4
8195771|NCT02249182|20208436|P5|COMPLETED|Treatment Phase||34
8195772|NCT02249182|20208437|P4|COMPLETED|Treatment Phase||2
8195773|NCT02249182|20208438|P3|COMPLETED|Treatment Phase||1
8195774|NCT02249182|20208439|P2|COMPLETED|Treatment Phase||89
8195775|NCT02249182|20208440|P1|COMPLETED|Treatment Phase||96
8195776|NCT02249182|20208436|P5|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34
8195777|NCT02249182|20208437|P4|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2
8195778|NCT02249182|20208438|P3|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1
8195779|NCT02249182|20208439|P2|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89
8195780|NCT02249182|20208440|P1|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100
8195781|NCT02249182|20208436|P5|NOT COMPLETED|PK Lead-In Phase||0
8195782|NCT02249182|20208437|P4|NOT COMPLETED|PK Lead-In Phase||0
8195783|NCT02249182|20208438|P3|NOT COMPLETED|PK Lead-In Phase||0
8195784|NCT02249182|20208439|P2|NOT COMPLETED|PK Lead-In Phase||0
8195785|NCT02249182|20208440|P1|NOT COMPLETED|PK Lead-In Phase||0
8195786|NCT02249182|20208436|P5|COMPLETED|PK Lead-In Phase||17
8195787|NCT02249182|20208437|P4|COMPLETED|PK Lead-In Phase||0
8195788|NCT02249182|20208438|P3|COMPLETED|PK Lead-In Phase||0
8195789|NCT02249182|20208439|P2|COMPLETED|PK Lead-In Phase||12
8195790|NCT02249182|20208440|P1|COMPLETED|PK Lead-In Phase||10
8195791|NCT02249182|20208436|P5|STARTED|PK Lead-In Phase||17
8195792|NCT02249182|20208437|P4|STARTED|PK Lead-In Phase||0
8195793|NCT02249182|20208438|P3|STARTED|PK Lead-In Phase||0
8195794|NCT02249182|20208439|P2|STARTED|PK Lead-In Phase||12
8195795|NCT02249182|20208440|P1|STARTED|PK Lead-In Phase||10
8195796|NCT02249143|20208528|P2|NOT COMPLETED|Overall Study||4
8195797|NCT02249143|20208529|P1|NOT COMPLETED|Overall Study||2
8195798|NCT02249143|20208528|P2|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
8195799|NCT02249143|20208529|P1|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
8195800|NCT02249143|20208528|P2|STARTED|Overall Study|randomized|26
8195801|NCT02249143|20208529|P1|STARTED|Overall Study||24
8195802|NCT02249104|20208555|P1|NOT COMPLETED|Overall Study||3
8195803|NCT02249104|20208555|P1|COMPLETED|Overall Study||25
8195804|NCT02249104|20208555|P1|STARTED|Overall Study||28
8195805|NCT02249065|20208564|P1|NOT COMPLETED|Overall Study||29
8195806|NCT02249065|20208564|P1|COMPLETED|Overall Study||176
8195807|NCT02249065|20208564|P1|Treated|Overall Study||181
8195808|NCT02249065|20208564|P1|STARTED|Overall Study||205
8195809|NCT02249052|20208572|P1|NOT COMPLETED|Overall Study||0
8195810|NCT02249052|20208572|P1|COMPLETED|Overall Study||19
8195811|NCT02249052|20208572|P1|STARTED|Overall Study||19
8195812|NCT02248974|20208590|P2|NOT COMPLETED|1-Month Follow-Up||3
8195813|NCT02248974|20208591|P1|NOT COMPLETED|1-Month Follow-Up||2
8195814|NCT02248974|20208590|P2|COMPLETED|1-Month Follow-Up||31
8195815|NCT02248974|20208591|P1|COMPLETED|1-Month Follow-Up||27
8195816|NCT02248974|20208590|P2|STARTED|1-Month Follow-Up||34
8195817|NCT02248974|20208591|P1|STARTED|1-Month Follow-Up||29
8195818|NCT02248974|20208590|P2|NOT COMPLETED|1-Week Follow-Up||17
8195819|NCT02248974|20208591|P1|NOT COMPLETED|1-Week Follow-Up||8
8195820|NCT02248974|20208590|P2|COMPLETED|1-Week Follow-Up||34
8195821|NCT02248974|20208591|P1|COMPLETED|1-Week Follow-Up||29
8195822|NCT02248974|20208590|P2|STARTED|1-Week Follow-Up||51
8195823|NCT02248974|20208591|P1|STARTED|1-Week Follow-Up||37
8195824|NCT02248974|20208590|P2|NOT COMPLETED|1-Day Follow-Up||0
8195825|NCT02248974|20208591|P1|NOT COMPLETED|1-Day Follow-Up||10
8195826|NCT02248974|20208590|P2|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
8195827|NCT02248974|20208591|P1|COMPLETED|1-Day Follow-Up||37
8195828|NCT02248974|20208590|P2|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
8195829|NCT02248974|20208591|P1|STARTED|1-Day Follow-Up||47
8195830|NCT02248974|20208590|P2|NOT COMPLETED|Baseline||0
8195831|NCT02248974|20208591|P1|NOT COMPLETED|Baseline||0
8195832|NCT02248974|20208590|P2|COMPLETED|Baseline||51
8195833|NCT02248974|20208591|P1|COMPLETED|Baseline||47
8195834|NCT02248974|20208590|P2|STARTED|Baseline||51
8195835|NCT02248974|20208591|P1|STARTED|Baseline||47
8195836|NCT02248961|20208669|P2|NOT COMPLETED|Overall Study||2
8195837|NCT02248961|20208670|P1|NOT COMPLETED|Overall Study||3
8195838|NCT02248961|20208669|P2|COMPLETED|Overall Study||88
8195839|NCT02248961|20208670|P1|COMPLETED|Overall Study||86
8195840|NCT02248961|20208669|P2|STARTED|Overall Study||90
8195841|NCT02248961|20208670|P1|STARTED|Overall Study||89
8195842|NCT02248922|20208690|P2|NOT COMPLETED|Overall Study||0
8195843|NCT02248922|20208691|P1|NOT COMPLETED|Overall Study||0
8195844|NCT02248922|20208690|P2|COMPLETED|Overall Study||12
8195845|NCT02248922|20208691|P1|COMPLETED|Overall Study||5
8195846|NCT02248922|20208690|P2|STARTED|Overall Study||12
8195847|NCT02248922|20208691|P1|STARTED|Overall Study||5
8195848|NCT02248857|20208705|P3|NOT COMPLETED|6 Month||17
8195849|NCT02248857|20208706|P2|NOT COMPLETED|6 Month||29
8195850|NCT02248857|20208707|P1|NOT COMPLETED|6 Month||28
8195851|NCT02248857|20208705|P3|COMPLETED|6 Month||106
8195852|NCT02248857|20208706|P2|COMPLETED|6 Month||136
8195853|NCT02248857|20208707|P1|COMPLETED|6 Month||120
8195854|NCT02248857|20208705|P3|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123
8195855|NCT02248857|20208706|P2|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165
8195856|NCT02248857|20208707|P1|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148
8195857|NCT02248857|20208705|P3|NOT COMPLETED|3 Month||31
8195858|NCT02248857|20208706|P2|NOT COMPLETED|3 Month||34
8195859|NCT02248857|20208707|P1|NOT COMPLETED|3 Month||46
8195860|NCT02248857|20208705|P3|COMPLETED|3 Month||96
8195861|NCT02248857|20208706|P2|COMPLETED|3 Month||134
8195862|NCT02248857|20208707|P1|COMPLETED|3 Month||111
8195863|NCT02248857|20208705|P3|STARTED|3 Month||127
8195864|NCT02248857|20208706|P2|STARTED|3 Month||168
8195865|NCT02248857|20208707|P1|STARTED|3 Month||157
8195866|NCT02248857|20208705|P3|NOT COMPLETED|Baseline||0
8195867|NCT02248857|20208706|P2|NOT COMPLETED|Baseline||0
8195868|NCT02248857|20208707|P1|NOT COMPLETED|Baseline||0
8195869|NCT02248857|20208705|P3|COMPLETED|Baseline||127
8195870|NCT02248857|20208706|P2|COMPLETED|Baseline||168
8195871|NCT02248857|20208707|P1|COMPLETED|Baseline||157
8195872|NCT02248857|20208705|P3|STARTED|Baseline||127
8195873|NCT02248857|20208706|P2|STARTED|Baseline||168
8195874|NCT02248857|20208707|P1|STARTED|Baseline||157
8195875|NCT02248818|20208744|P9|NOT COMPLETED|Randomised Study||0
8195876|NCT02248818|20208745|P8|NOT COMPLETED|Randomised Study||0
8195877|NCT02248818|20208746|P7|NOT COMPLETED|Randomised Study||0
8195878|NCT02248818|20208747|P6|NOT COMPLETED|Randomised Study||8
8195879|NCT02248818|20208748|P5|NOT COMPLETED|Randomised Study||0
8195880|NCT02248818|20208749|P4|NOT COMPLETED|Randomised Study||0
8195881|NCT02248818|20208750|P3|NOT COMPLETED|Randomised Study||0
8195882|NCT02248818|20208751|P2|NOT COMPLETED|Randomised Study||0
8195883|NCT02248818|20208752|P1|NOT COMPLETED|Randomised Study||0
8195884|NCT02248818|20208744|P9|COMPLETED|Randomised Study||0
8195885|NCT02248818|20208745|P8|COMPLETED|Randomised Study||4
8195886|NCT02248818|20208746|P7|COMPLETED|Randomised Study||6
8195887|NCT02248818|20208747|P6|COMPLETED|Randomised Study||0
8195888|NCT02248818|20208748|P5|COMPLETED|Randomised Study||6
8195889|NCT02248818|20208749|P4|COMPLETED|Randomised Study||6
8195890|NCT02248818|20208750|P3|COMPLETED|Randomised Study||6
8195891|NCT02248818|20208751|P2|COMPLETED|Randomised Study||6
8195892|NCT02248818|20208752|P1|COMPLETED|Randomised Study||6
8195893|NCT02248818|20208744|P9|STARTED|Randomised Study||0
8195894|NCT02248818|20208745|P8|STARTED|Randomised Study||4
8195895|NCT02248818|20208746|P7|STARTED|Randomised Study||6
8195896|NCT02248818|20208747|P6|STARTED|Randomised Study||8
8195897|NCT02248818|20208748|P5|STARTED|Randomised Study||6
8195898|NCT02248818|20208749|P4|STARTED|Randomised Study||6
8195899|NCT02248818|20208750|P3|STARTED|Randomised Study||6
8195900|NCT02248818|20208751|P2|STARTED|Randomised Study||6
8195901|NCT02248818|20208752|P1|STARTED|Randomised Study||6
8195902|NCT02248818|20208744|P9|NOT COMPLETED|Screening||107
8195903|NCT02248818|20208745|P8|NOT COMPLETED|Screening||0
8195904|NCT02248818|20208746|P7|NOT COMPLETED|Screening||0
8195905|NCT02248818|20208747|P6|NOT COMPLETED|Screening||0
8195906|NCT02248818|20208748|P5|NOT COMPLETED|Screening||0
8195907|NCT02248818|20208749|P4|NOT COMPLETED|Screening||0
8195908|NCT02248818|20208750|P3|NOT COMPLETED|Screening||0
8195909|NCT02248818|20208751|P2|NOT COMPLETED|Screening||0
8195910|NCT02248818|20208752|P1|NOT COMPLETED|Screening||0
8195911|NCT02248818|20208744|P9|COMPLETED|Screening||48
8195912|NCT02248818|20208745|P8|COMPLETED|Screening||0
8195913|NCT02248818|20208746|P7|COMPLETED|Screening||0
8195914|NCT02248818|20208747|P6|COMPLETED|Screening||0
8195915|NCT02248818|20208748|P5|COMPLETED|Screening||0
8195916|NCT02248818|20208749|P4|COMPLETED|Screening||0
8195917|NCT02248818|20208750|P3|COMPLETED|Screening||0
8195918|NCT02248818|20208751|P2|COMPLETED|Screening||0
8195919|NCT02248818|20208752|P1|COMPLETED|Screening||0
8195920|NCT02248818|20208744|P9|STARTED|Screening||155
8195921|NCT02248818|20208745|P8|STARTED|Screening||0
8195922|NCT02248818|20208746|P7|STARTED|Screening||0
8195923|NCT02248818|20208747|P6|STARTED|Screening||0
8195924|NCT02248818|20208748|P5|STARTED|Screening||0
8195925|NCT02248818|20208749|P4|STARTED|Screening||0
8195926|NCT02248818|20208750|P3|STARTED|Screening||0
8195927|NCT02248818|20208751|P2|STARTED|Screening||0
8195928|NCT02248818|20208752|P1|STARTED|Screening||0
8195929|NCT02248766|20208890|P1|NOT COMPLETED|Overall Study||0
8195930|NCT02248766|20208890|P1|COMPLETED|Overall Study||30
8195931|NCT02248766|20208890|P1|STARTED|Overall Study||30
8195932|NCT02248740|20208904|P2|NOT COMPLETED|Overall Study||18
8195933|NCT02248740|20208905|P1|NOT COMPLETED|Overall Study||18
8195934|NCT02248740|20208904|P2|COMPLETED|Overall Study||0
8195935|NCT02248740|20208905|P1|COMPLETED|Overall Study||0
8195936|NCT02248740|20208904|P2|STARTED|Overall Study||18
8195937|NCT02248740|20208905|P1|STARTED|Overall Study||18
8195938|NCT02248727|20208915|P1|NOT COMPLETED|Overall Study||0
8195939|NCT02248727|20208915|P1|COMPLETED|Overall Study||30
8195940|NCT02248727|20208915|P1|STARTED|Overall Study||30
8195941|NCT02248714|20208928|P2|NOT COMPLETED|Overall Study||4
8195942|NCT02248714|20208929|P1|NOT COMPLETED|Overall Study||4
8195943|NCT02248714|20208928|P2|COMPLETED|Overall Study||61
8195944|NCT02248714|20208929|P1|COMPLETED|Overall Study||62
8195945|NCT02248714|20208928|P2|STARTED|Overall Study||65
8195946|NCT02248714|20208929|P1|STARTED|Overall Study||66
8195947|NCT02248675|20208967|P2|NOT COMPLETED|Overall Study||1
8195948|NCT02248675|20208968|P1|NOT COMPLETED|Overall Study||3
8195949|NCT02248675|20208967|P2|COMPLETED|Overall Study||27
8195950|NCT02248675|20208968|P1|COMPLETED|Overall Study||23
8195951|NCT02248675|20208967|P2|STARTED|Overall Study||28
8195952|NCT02248675|20208968|P1|STARTED|Overall Study||26
8195953|NCT02248662|20208982|P2|NOT COMPLETED|Overall Study||30515
8195954|NCT02248662|20208983|P1|NOT COMPLETED|Overall Study||4563
8195955|NCT02248662|20208982|P2|COMPLETED|Overall Study||2679
8195956|NCT02248662|20208983|P1|COMPLETED|Overall Study||757
8195957|NCT02248662|20208982|P2|STARTED|Overall Study||33194
8195958|NCT02248662|20208983|P1|STARTED|Overall Study||5320
8195959|NCT02248649|20208995|P2|NOT COMPLETED|Overall Study||21
8195960|NCT02248649|20208996|P1|NOT COMPLETED|Overall Study||21
8195961|NCT02248649|20208995|P2|COMPLETED|Overall Study||59
8195962|NCT02248649|20208996|P1|COMPLETED|Overall Study||59
8195963|NCT02248649|20208995|P2|STARTED|Overall Study||80
8195964|NCT02248649|20208996|P1|STARTED|Overall Study||80
8195965|NCT02248636|20209008|P2|NOT COMPLETED|Overall Study||3
8195966|NCT02248636|20209009|P1|NOT COMPLETED|Overall Study||6
8195967|NCT02248636|20209008|P2|COMPLETED|Overall Study||32
8195968|NCT02248636|20209009|P1|COMPLETED|Overall Study||20
8195969|NCT02248636|20209008|P2|STARTED|Overall Study||35
8195970|NCT02248636|20209009|P1|STARTED|Overall Study||26
8195971|NCT02248558|20209027|P2|NOT COMPLETED|Overall Study||45
8195972|NCT02248558|20209028|P1|NOT COMPLETED|Overall Study||52
8195973|NCT02248558|20209027|P2|COMPLETED|Overall Study||307
8195974|NCT02248558|20209028|P1|COMPLETED|Overall Study||317
8195975|NCT02248558|20209027|P2|STARTED|Overall Study||352
8195976|NCT02248558|20209028|P1|STARTED|Overall Study||369
8195977|NCT02248480|20209040|P2|NOT COMPLETED|Overall Study||14
8195978|NCT02248480|20209041|P1|NOT COMPLETED|Overall Study||17
8195979|NCT02248480|20209040|P2|COMPLETED|Overall Study||162
8195980|NCT02248480|20209041|P1|COMPLETED|Overall Study||161
8195981|NCT02248480|20209040|P2|Efficacy Population|Overall Study||176
8195982|NCT02248480|20209041|P1|Efficacy Population|Overall Study||177
8195983|NCT02248480|20209040|P2|STARTED|Overall Study||176
8195984|NCT02248480|20209041|P1|STARTED|Overall Study||178
8195985|NCT02248285|20209081|P2|NOT COMPLETED|Overall Study||287
8195986|NCT02248285|20209082|P1|NOT COMPLETED|Overall Study||101
8195987|NCT02248285|20209081|P2|COMPLETED|Overall Study||571
8195988|NCT02248285|20209082|P1|COMPLETED|Overall Study||586
8195989|NCT02248285|20209081|P2|STARTED|Overall Study||858
8195990|NCT02248285|20209082|P1|STARTED|Overall Study||687
8195991|NCT02248246|20209088|P1|NOT COMPLETED|Overall Study||0
8195992|NCT02248246|20209088|P1|COMPLETED|Overall Study||40
8195993|NCT02248246|20209088|P1|STARTED|Overall Study||40
8195994|NCT02248103|20209095|P2|NOT COMPLETED|Overall Study||0
8195995|NCT02248103|20209096|P1|NOT COMPLETED|Overall Study||0
8195996|NCT02248103|20209095|P2|COMPLETED|Overall Study||10
8195997|NCT02248103|20209096|P1|COMPLETED|Overall Study||10
8195998|NCT02248103|20209095|P2|STARTED|Overall Study||10
8195999|NCT02248103|20209096|P1|STARTED|Overall Study||10
8196000|NCT02247960|20209108|P2|NOT COMPLETED|Catheter Removed||10
8196001|NCT02247960|20209109|P1|NOT COMPLETED|Catheter Removed||7
8196002|NCT02247960|20209108|P2|COMPLETED|Catheter Removed||74
8196003|NCT02247960|20209109|P1|COMPLETED|Catheter Removed||76
8196004|NCT02247960|20209108|P2|STARTED|Catheter Removed||84
8196005|NCT02247960|20209109|P1|STARTED|Catheter Removed||83
8196006|NCT02247960|20209108|P2|NOT COMPLETED|Patient Consent and Randomization||6
8196007|NCT02247960|20209109|P1|NOT COMPLETED|Patient Consent and Randomization||2
8196008|NCT02247960|20209108|P2|COMPLETED|Patient Consent and Randomization||84
8196009|NCT02247960|20209109|P1|COMPLETED|Patient Consent and Randomization||83
8196010|NCT02247960|20209108|P2|STARTED|Patient Consent and Randomization||90
8196011|NCT02247960|20209109|P1|STARTED|Patient Consent and Randomization||85
8196012|NCT02247804|20209122|P3|NOT COMPLETED|Treatment Period 3||10
8196013|NCT02247804|20209123|P2|NOT COMPLETED|Treatment Period 3||10
8196014|NCT02247804|20209124|P1|NOT COMPLETED|Treatment Period 3||11
8196015|NCT02247804|20209122|P3|COMPLETED|Treatment Period 3||167
8196016|NCT02247804|20209123|P2|COMPLETED|Treatment Period 3||173
8196017|NCT02247804|20209124|P1|COMPLETED|Treatment Period 3||147
8196018|NCT02247804|20209122|P3|STARTED|Treatment Period 3||177
8196019|NCT02247804|20209123|P2|STARTED|Treatment Period 3||183
8196020|NCT02247804|20209124|P1|STARTED|Treatment Period 3||158
8196021|NCT02247804|20209122|P3|NOT COMPLETED|Treatment Period 2||8
8196022|NCT02247804|20209123|P2|NOT COMPLETED|Treatment Period 2||5
8196023|NCT02247804|20209124|P1|NOT COMPLETED|Treatment Period 2||8
8196024|NCT02247804|20209122|P3|COMPLETED|Treatment Period 2||179
8196025|NCT02247804|20209123|P2|COMPLETED|Treatment Period 2||186
8196026|NCT02247804|20209124|P1|COMPLETED|Treatment Period 2||164
8196027|NCT02247804|20209122|P3|STARTED|Treatment Period 2||187
8196028|NCT02247804|20209123|P2|STARTED|Treatment Period 2||191
8196029|NCT02247804|20209124|P1|STARTED|Treatment Period 2||172
8196030|NCT02247804|20209122|P3|NOT COMPLETED|Treatment Period 1||8
8196031|NCT02247804|20209123|P2|NOT COMPLETED|Treatment Period 1||4
8196032|NCT02247804|20209124|P1|NOT COMPLETED|Treatment Period 1||22
8196033|NCT02247804|20209122|P3|COMPLETED|Treatment Period 1||190
8196034|NCT02247804|20209123|P2|COMPLETED|Treatment Period 1||194
8196035|NCT02247804|20209124|P1|COMPLETED|Treatment Period 1||176
8196036|NCT02247804|20209122|P3|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
8196037|NCT02247804|20209123|P2|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
8196038|NCT02247804|20209124|P1|Received (Sham or Bimatoprost SR)|Treatment Period 1||193
8196039|NCT02247804|20209122|P3|STARTED|Treatment Period 1||198
8196040|NCT02247804|20209123|P2|STARTED|Treatment Period 1||198
8196041|NCT02247804|20209124|P1|STARTED|Treatment Period 1||198
8196042|NCT02247765|20209153|P1|NOT COMPLETED|Overall Study||0
8196043|NCT02247765|20209153|P1|COMPLETED|Overall Study||18
8196044|NCT02247765|20209153|P1|STARTED|Overall Study||18
8196045|NCT02247739|20209158|P6|NOT COMPLETED|Overall Study||1
8196046|NCT02247739|20209159|P5|NOT COMPLETED|Overall Study||1
8196047|NCT02247739|20209160|P4|NOT COMPLETED|Overall Study||0
8196048|NCT02247739|20209161|P3|NOT COMPLETED|Overall Study||1
8196049|NCT02247739|20209162|P2|NOT COMPLETED|Overall Study||3
8196050|NCT02247739|20209163|P1|NOT COMPLETED|Overall Study||0
8196051|NCT02247739|20209158|P6|COMPLETED|Overall Study||4
8196052|NCT02247739|20209159|P5|COMPLETED|Overall Study||5
8196053|NCT02247739|20209160|P4|COMPLETED|Overall Study||5
8196054|NCT02247739|20209161|P3|COMPLETED|Overall Study||4
8196055|NCT02247739|20209162|P2|COMPLETED|Overall Study||3
8196056|NCT02247739|20209163|P1|COMPLETED|Overall Study||5
8196057|NCT02247739|20209158|P6|STARTED|Overall Study||5
8196058|NCT02247739|20209159|P5|STARTED|Overall Study||6
8196059|NCT02247739|20209160|P4|STARTED|Overall Study||5
8196060|NCT02247739|20209161|P3|STARTED|Overall Study||5
8196061|NCT02247739|20209162|P2|STARTED|Overall Study||6
8196062|NCT02247739|20209163|P1|STARTED|Overall Study||5
8196063|NCT02247531|20209182|P3|NOT COMPLETED|Overall Study||110
8196064|NCT02247531|20209183|P2|NOT COMPLETED|Overall Study||125
8196065|NCT02247531|20209184|P1|NOT COMPLETED|Overall Study||106
8196066|NCT02247531|20209182|P3|COMPLETED|Overall Study||214
8196067|NCT02247531|20209183|P2|COMPLETED|Overall Study||205
8196068|NCT02247531|20209184|P1|COMPLETED|Overall Study||215
8196069|NCT02247531|20209182|P3|STARTED|Overall Study||324
8196070|NCT02247531|20209183|P2|STARTED|Overall Study||330
8196071|NCT02247531|20209184|P1|STARTED|Overall Study||321
8196072|NCT02247479|20209234|P3|NOT COMPLETED|Overall Study||138
8196073|NCT02247479|20209235|P2|NOT COMPLETED|Overall Study||138
8196074|NCT02247479|20209236|P1|NOT COMPLETED|Overall Study||142
8196075|NCT02247479|20209234|P3|COMPLETED|Overall Study||165
8196076|NCT02247479|20209235|P2|COMPLETED|Overall Study||160
8196077|NCT02247479|20209236|P1|COMPLETED|Overall Study||163
8196078|NCT02247479|20209234|P3|STARTED|Overall Study||303
8196079|NCT02247479|20209235|P2|STARTED|Overall Study||298
8196080|NCT02247479|20209236|P1|STARTED|Overall Study||305
8196081|NCT02247466|20209285|P2|NOT COMPLETED|Overall Study||3
8196082|NCT02247466|20209286|P1|NOT COMPLETED|Overall Study||0
8196083|NCT02247466|20209285|P2|COMPLETED|Overall Study||15
8196084|NCT02247466|20209286|P1|COMPLETED|Overall Study||19
8196085|NCT02247466|20209285|P2|STARTED|Overall Study||18
8196086|NCT02247466|20209286|P1|STARTED|Overall Study||19
8196087|NCT02247440|20209304|P1|NOT COMPLETED|Overall Study||4
8196088|NCT02247440|20209304|P1|COMPLETED|Overall Study||14
8196089|NCT02247440|20209304|P1|STARTED|Overall Study||18
8196099|NCT02247245|20209340|P4|NOT COMPLETED|Overall Study||0
8196100|NCT02247245|20209341|P3|NOT COMPLETED|Overall Study||0
8196101|NCT02247245|20209342|P2|NOT COMPLETED|Overall Study||0
8196102|NCT02247245|20209343|P1|NOT COMPLETED|Overall Study||0
8196103|NCT02247245|20209340|P4|COMPLETED|Overall Study||7
8196104|NCT02247245|20209341|P3|COMPLETED|Overall Study||7
8196105|NCT02247245|20209342|P2|COMPLETED|Overall Study||13
8196106|NCT02247245|20209343|P1|COMPLETED|Overall Study||13
8196107|NCT02247245|20209340|P4|STARTED|Overall Study||7
8196108|NCT02247245|20209341|P3|STARTED|Overall Study||7
8196109|NCT02247245|20209342|P2|STARTED|Overall Study||13
8196110|NCT02247245|20209343|P1|STARTED|Overall Study||13
8196111|NCT02247063|20209355|P2|NOT COMPLETED|Overall Study||0
8196112|NCT02247063|20209356|P1|NOT COMPLETED|Overall Study||0
8196113|NCT02247063|20209355|P2|COMPLETED|Overall Study||12
8196114|NCT02247063|20209356|P1|COMPLETED|Overall Study||12
8196115|NCT02247063|20209355|P2|STARTED|Overall Study||12
8196116|NCT02247063|20209356|P1|STARTED|Overall Study||12
8196117|NCT02247011|20209366|P1|NOT COMPLETED|Overall Study||125
8196118|NCT02247011|20209366|P1|COMPLETED|Overall Study||975
8196119|NCT02247011|20209366|P1|STARTED|Overall Study||1100
8196120|NCT02246998|20209387|P4|NOT COMPLETED|Overall Study||2
8196121|NCT02246998|20209388|P3|NOT COMPLETED|Overall Study||3
8196122|NCT02246998|20209389|P2|NOT COMPLETED|Overall Study||3
8196123|NCT02246998|20209390|P1|NOT COMPLETED|Overall Study||2
8196124|NCT02246998|20209387|P4|COMPLETED|Overall Study||16
8196125|NCT02246998|20209388|P3|COMPLETED|Overall Study||15
8196126|NCT02246998|20209389|P2|COMPLETED|Overall Study||15
8196127|NCT02246998|20209390|P1|COMPLETED|Overall Study||16
8196128|NCT02246998|20209387|P4|STARTED|Overall Study||18
8196129|NCT02246998|20209388|P3|STARTED|Overall Study||18
8196130|NCT02246998|20209389|P2|STARTED|Overall Study||18
8196131|NCT02246998|20209390|P1|STARTED|Overall Study||18
8196132|NCT02246777|20209500|P1|NOT COMPLETED|Overall Study||3
8196133|NCT02246777|20209500|P1|COMPLETED|Overall Study||29
8196134|NCT02246777|20209500|P1|STARTED|Overall Study||32
8196135|NCT02246764|20209516|P3|NOT COMPLETED|Overall Study||4
8196136|NCT02246764|20209517|P2|NOT COMPLETED|Overall Study||32
8196137|NCT02246764|20209518|P1|NOT COMPLETED|Overall Study||18
8196138|NCT02246764|20209516|P3|COMPLETED|Overall Study||19
8196139|NCT02246764|20209517|P2|COMPLETED|Overall Study||4
8196140|NCT02246764|20209518|P1|COMPLETED|Overall Study||16
8196141|NCT02246764|20209516|P3|STARTED|Overall Study||23
8196142|NCT02246764|20209517|P2|STARTED|Overall Study||36
8196143|NCT02246764|20209518|P1|STARTED|Overall Study||34
8196144|NCT02246673|20209531|P5|NOT COMPLETED|Overall Study||1
8196145|NCT02246673|20209532|P4|NOT COMPLETED|Overall Study||2
8196146|NCT02246673|20209533|P3|NOT COMPLETED|Overall Study||0
8196147|NCT02246673|20209534|P2|NOT COMPLETED|Overall Study||0
8196148|NCT02246673|20209535|P1|NOT COMPLETED|Overall Study||1
8196149|NCT02246673|20209531|P5|COMPLETED|Overall Study||11
8196150|NCT02246673|20209532|P4|COMPLETED|Overall Study||12
8196151|NCT02246673|20209533|P3|COMPLETED|Overall Study||12
8196152|NCT02246673|20209534|P2|COMPLETED|Overall Study||12
8196153|NCT02246673|20209535|P1|COMPLETED|Overall Study||13
8196154|NCT02246673|20209531|P5|STARTED|Overall Study||12
8196155|NCT02246673|20209532|P4|STARTED|Overall Study||14
8196156|NCT02246673|20209533|P3|STARTED|Overall Study||12
8196157|NCT02246673|20209534|P2|STARTED|Overall Study||12
8196158|NCT02246673|20209535|P1|STARTED|Overall Study||14
8196159|NCT02246660|20209643|P3|NOT COMPLETED|Overall Study||1
8196160|NCT02246660|20209644|P2|NOT COMPLETED|Overall Study||1
8196161|NCT02246660|20209645|P1|NOT COMPLETED|Overall Study||0
8196162|NCT02246660|20209643|P3|COMPLETED|Overall Study||21
8196163|NCT02246660|20209644|P2|COMPLETED|Overall Study||20
8196164|NCT02246660|20209645|P1|COMPLETED|Overall Study||23
8196165|NCT02246660|20209643|P3|STARTED|Overall Study||22
8196166|NCT02246660|20209644|P2|STARTED|Overall Study||21
8196167|NCT02246660|20209645|P1|STARTED|Overall Study||23
8196168|NCT02246647|20209655|P2|NOT COMPLETED|Overall Study||1
8196169|NCT02246647|20209656|P1|NOT COMPLETED|Overall Study||1
8196170|NCT02246647|20209655|P2|COMPLETED|Overall Study||19
8196171|NCT02246647|20209656|P1|COMPLETED|Overall Study||18
8196172|NCT02246647|20209655|P2|STARTED|Overall Study||20
8196173|NCT02246647|20209656|P1|STARTED|Overall Study||19
8196182|NCT02246608|20209719|P2|NOT COMPLETED|Overall Study||10
8196183|NCT02246608|20209720|P1|NOT COMPLETED|Overall Study||12
8196184|NCT02246608|20209719|P2|COMPLETED|Overall Study||11
8196185|NCT02246608|20209720|P1|COMPLETED|Overall Study||10
8196186|NCT02246608|20209719|P2|STARTED|Overall Study||21
8196187|NCT02246608|20209720|P1|STARTED|Overall Study||22
8196188|NCT02246582|20209728|P2|NOT COMPLETED|Overall Study||4
8196189|NCT02246582|20209729|P1|NOT COMPLETED|Overall Study||3
8196190|NCT02246582|20209728|P2|COMPLETED|Overall Study||41
8196191|NCT02246582|20209729|P1|COMPLETED|Overall Study||41
8196192|NCT02246582|20209728|P2|STARTED|Overall Study||45
8196193|NCT02246582|20209729|P1|STARTED|Overall Study||44
8196194|NCT02246439|20209737|P2|NOT COMPLETED|Overall Study||11
8196195|NCT02246439|20209738|P1|NOT COMPLETED|Overall Study||12
8196196|NCT02246439|20209737|P2|COMPLETED|Overall Study||118
8196197|NCT02246439|20209738|P1|COMPLETED|Overall Study||180
8196198|NCT02246439|20209737|P2|Randomized|Overall Study||132
8196199|NCT02246439|20209738|P1|Randomized|Overall Study||198
8196200|NCT02246439|20209737|P2|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129
8196201|NCT02246439|20209738|P1|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192
8196202|NCT02246413|20209776|P2|NOT COMPLETED|24-months (Secondary Outcome)||32
8196203|NCT02246413|20209777|P1|NOT COMPLETED|24-months (Secondary Outcome)||51
8196204|NCT02246413|20209776|P2|COMPLETED|24-months (Secondary Outcome)||173
8196205|NCT02246413|20209777|P1|COMPLETED|24-months (Secondary Outcome)||153
8196206|NCT02246413|20209776|P2|STARTED|24-months (Secondary Outcome)||205
8196207|NCT02246413|20209777|P1|STARTED|24-months (Secondary Outcome)||204
8196208|NCT02246413|20209776|P2|NOT COMPLETED|12-months (Primary Outcome)||30
8196209|NCT02246413|20209777|P1|NOT COMPLETED|12-months (Primary Outcome)||35
8196210|NCT02246413|20209776|P2|COMPLETED|12-months (Primary Outcome)||175
8196211|NCT02246413|20209777|P1|COMPLETED|12-months (Primary Outcome)||169
8196212|NCT02246413|20209776|P2|STARTED|12-months (Primary Outcome)||205
8196213|NCT02246413|20209777|P1|STARTED|12-months (Primary Outcome)||204
8196214|NCT02246309|20209857|P2|NOT COMPLETED|Overall Study||0
8196215|NCT02246309|20209858|P1|NOT COMPLETED|Overall Study||0
8196216|NCT02246309|20209857|P2|COMPLETED|Overall Study||15
8196217|NCT02246309|20209858|P1|COMPLETED|Overall Study||16
8196218|NCT02246309|20209857|P2|STARTED|Overall Study||15
8196219|NCT02246309|20209858|P1|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
8196220|NCT02246218|20209870|P2|NOT COMPLETED|Overall Study||6
8196221|NCT02246218|20209871|P1|NOT COMPLETED|Overall Study||4
8196222|NCT02246218|20209870|P2|COMPLETED|Overall Study||10
8196223|NCT02246218|20209871|P1|COMPLETED|Overall Study||6
8196224|NCT02246218|20209870|P2|STARTED|Overall Study||16
8196225|NCT02246218|20209871|P1|STARTED|Overall Study||10
8196226|NCT02246166|20209931|P2|NOT COMPLETED|Overall Study||0
8196227|NCT02246166|20209932|P1|NOT COMPLETED|Overall Study||1
8196228|NCT02246166|20209931|P2|COMPLETED|Overall Study||27
8196229|NCT02246166|20209932|P1|COMPLETED|Overall Study||25
8196230|NCT02246166|20209931|P2|STARTED|Overall Study||27
8196231|NCT02246166|20209932|P1|STARTED|Overall Study||26
8196232|NCT02246114|20209968|P2|NOT COMPLETED|Overall Study||0
8196233|NCT02246114|20209969|P1|NOT COMPLETED|Overall Study||1
8196234|NCT02246114|20209968|P2|COMPLETED|Overall Study||0
8196235|NCT02246114|20209969|P1|COMPLETED|Overall Study||0
8196236|NCT02246114|20209968|P2|STARTED|Overall Study||0
8196237|NCT02246114|20209969|P1|STARTED|Overall Study||1
8196238|NCT02246062|20209979|P4|NOT COMPLETED|Overall Study||0
8196239|NCT02246062|20209980|P3|NOT COMPLETED|Overall Study||0
8196240|NCT02246062|20209981|P2|NOT COMPLETED|Overall Study||0
8196241|NCT02246062|20209982|P1|NOT COMPLETED|Overall Study||0
8196242|NCT02246062|20209979|P4|COMPLETED|Overall Study||21
8196243|NCT02246062|20209980|P3|COMPLETED|Overall Study||21
8196244|NCT02246062|20209981|P2|COMPLETED|Overall Study||21
8196245|NCT02246062|20209982|P1|COMPLETED|Overall Study||21
8196246|NCT02246062|20209979|P4|STARTED|Overall Study||21
8196247|NCT02246062|20209980|P3|STARTED|Overall Study||21
8196248|NCT02246062|20209981|P2|STARTED|Overall Study||21
8196249|NCT02246062|20209982|P1|STARTED|Overall Study||21
8196250|NCT02246010|20210002|P2|NOT COMPLETED|Overall Study||0
8196251|NCT02246010|20210003|P1|NOT COMPLETED|Overall Study||0
8196252|NCT02246010|20210002|P2|COMPLETED|Overall Study||2
8196253|NCT02246010|20210003|P1|COMPLETED|Overall Study||4
8196254|NCT02246010|20210002|P2|STARTED|Overall Study||2
8196255|NCT02246010|20210003|P1|STARTED|Overall Study||4
8196256|NCT02245737|20210020|P3|NOT COMPLETED|Overall Study||571
8196257|NCT02245737|20210021|P2|NOT COMPLETED|Overall Study||555
8196258|NCT02245737|20210022|P1|NOT COMPLETED|Overall Study||553
8196259|NCT02245737|20210020|P3|COMPLETED|Overall Study||168
8196260|NCT02245737|20210021|P2|COMPLETED|Overall Study||184
8196261|NCT02245737|20210022|P1|COMPLETED|Overall Study||187
8196262|NCT02245737|20210020|P3|Received at Least 1 Dose of Study Drug|Overall Study||735
8196263|NCT02245737|20210021|P2|Received at Least 1 Dose of Study Drug|Overall Study||736
8196264|NCT02245737|20210022|P1|Received at Least 1 Dose of Study Drug|Overall Study||738
8196265|NCT02245737|20210020|P3|STARTED|Overall Study||739
8196266|NCT02245737|20210021|P2|STARTED|Overall Study||739
8196267|NCT02245737|20210022|P1|STARTED|Overall Study||740
8196268|NCT02245672|20210080|P3|NOT COMPLETED|Overall Study||5
8196269|NCT02245672|20210081|P2|NOT COMPLETED|Overall Study||13
8196270|NCT02245672|20210082|P1|NOT COMPLETED|Overall Study||13
8196271|NCT02245672|20210080|P3|COMPLETED|Overall Study||98
8196272|NCT02245672|20210081|P2|COMPLETED|Overall Study||500
8196273|NCT02245672|20210082|P1|COMPLETED|Overall Study||499
8196274|NCT02245672|20210080|P3|STARTED|Overall Study||103
8196275|NCT02245672|20210081|P2|STARTED|Overall Study||513
8196276|NCT02245672|20210082|P1|STARTED|Overall Study||512
8196277|NCT02245620|20210101|P2|NOT COMPLETED|Overall Study||1
8196278|NCT02245620|20210102|P1|NOT COMPLETED|Overall Study||1
8196279|NCT02245620|20210101|P2|COMPLETED|Overall Study||20
8196280|NCT02245620|20210102|P1|COMPLETED|Overall Study||19
8196281|NCT02245620|20210101|P2|STARTED|Overall Study||21
8196282|NCT02245620|20210102|P1|STARTED|Overall Study||20
8196283|NCT02245568|20210114|P1|NOT COMPLETED|Overall Study||853
8196284|NCT02245568|20210114|P1|COMPLETED|Overall Study||60
8196285|NCT02245568|20210114|P1|STARTED|Overall Study||913
8196286|NCT02245516|20210120|P2|NOT COMPLETED|Overall Study||3
8196287|NCT02245516|20210121|P1|NOT COMPLETED|Overall Study||0
8196288|NCT02245516|20210120|P2|COMPLETED|Overall Study||4
8196289|NCT02245516|20210121|P1|COMPLETED|Overall Study||9
8196290|NCT02245516|20210120|P2|STARTED|Overall Study||7
8196291|NCT02245516|20210121|P1|STARTED|Overall Study||9
8196292|NCT02245412|20210136|P3|NOT COMPLETED|Follow-Up Period||2
8196293|NCT02245412|20210137|P2|NOT COMPLETED|Follow-Up Period||2
8196294|NCT02245412|20210138|P1|NOT COMPLETED|Follow-Up Period||5
8196295|NCT02245412|20210136|P3|COMPLETED|Follow-Up Period||0
8196296|NCT02245412|20210137|P2|COMPLETED|Follow-Up Period||2
8196297|NCT02245412|20210138|P1|COMPLETED|Follow-Up Period||8
8196298|NCT02245412|20210136|P3|STARTED|Follow-Up Period||2
8196299|NCT02245412|20210137|P2|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4
8196300|NCT02245412|20210138|P1|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13
8196301|NCT02245412|20210136|P3|NOT COMPLETED|Treatment Period||0
8196302|NCT02245412|20210137|P2|NOT COMPLETED|Treatment Period||3
8196303|NCT02245412|20210138|P1|NOT COMPLETED|Treatment Period||5
8196304|NCT02245412|20210136|P3|COMPLETED|Treatment Period||2
8196305|NCT02245412|20210137|P2|COMPLETED|Treatment Period||3
8196306|NCT02245412|20210138|P1|COMPLETED|Treatment Period||12
8196307|NCT02245412|20210136|P3|Modified Full Analysis Set (mFAS)|Treatment Period||2
8196308|NCT02245412|20210137|P2|Modified Full Analysis Set (mFAS)|Treatment Period||6
8196309|NCT02245412|20210138|P1|Modified Full Analysis Set (mFAS)|Treatment Period||16
8196310|NCT02245412|20210136|P3|Received at Least 1 Dose of Study Drug|Treatment Period||2
8196311|NCT02245412|20210137|P2|Received at Least 1 Dose of Study Drug|Treatment Period||6
8196312|NCT02245412|20210138|P1|Received at Least 1 Dose of Study Drug|Treatment Period||17
8196313|NCT02245412|20210136|P3|STARTED|Treatment Period||2
8196314|NCT02245412|20210137|P2|STARTED|Treatment Period||6
8196315|NCT02245412|20210138|P1|STARTED|Treatment Period||17
8196316|NCT02245360|20210157|P2|NOT COMPLETED|Overall Study||2
8196317|NCT02245360|20210158|P1|NOT COMPLETED|Overall Study||5
8196318|NCT02245360|20210157|P2|COMPLETED|Overall Study||52
8196319|NCT02245360|20210158|P1|COMPLETED|Overall Study||48
8196320|NCT02245360|20210157|P2|STARTED|Overall Study||54
8196321|NCT02245360|20210158|P1|STARTED|Overall Study||53
8196322|NCT02245308|20210168|P2|NOT COMPLETED|Overall Study||0
8196323|NCT02245308|20210169|P1|NOT COMPLETED|Overall Study||0
8196324|NCT02245308|20210168|P2|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64
8196325|NCT02245308|20210169|P1|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63
8196326|NCT02245308|20210168|P2|STARTED|Overall Study||64
8196327|NCT02245308|20210169|P1|STARTED|Overall Study||63
8196328|NCT02245217|20210177|P1|NOT COMPLETED|Overall Study||2
8196329|NCT02245217|20210177|P1|COMPLETED|Overall Study||7
8196330|NCT02245217|20210177|P1|STARTED|Overall Study||9
8196331|NCT02244996|20210185|P2|NOT COMPLETED|Overall Study||6
8196332|NCT02244996|20210186|P1|NOT COMPLETED|Overall Study||2
8196333|NCT02244996|20210185|P2|COMPLETED|Overall Study||19
8196334|NCT02244996|20210186|P1|COMPLETED|Overall Study||23
8196335|NCT02244996|20210185|P2|STARTED|Overall Study||25
8196336|NCT02244996|20210186|P1|STARTED|Overall Study||25
8196337|NCT02244957|20210200|P2|NOT COMPLETED|Overall Study||0
8196338|NCT02244957|20210201|P1|NOT COMPLETED|Overall Study||1
8196339|NCT02244957|20210200|P2|COMPLETED|Overall Study||16
8196340|NCT02244957|20210201|P1|COMPLETED|Overall Study||6
8196341|NCT02244957|20210200|P2|STARTED|Overall Study||16
8196342|NCT02244957|20210201|P1|STARTED|Overall Study||7
8196343|NCT02244944|20210245|P1|NOT COMPLETED|Overall Study||2
8196344|NCT02244944|20210245|P1|COMPLETED|Overall Study||0
8196345|NCT02244944|20210245|P1|STARTED|Overall Study||2
8196346|NCT02244918|20210253|P2|NOT COMPLETED|Overall Study||0
8196347|NCT02244918|20210254|P1|NOT COMPLETED|Overall Study||0
8196348|NCT02244918|20210253|P2|COMPLETED|Overall Study||93
8196349|NCT02244918|20210254|P1|COMPLETED|Overall Study||185
8196350|NCT02244918|20210253|P2|Week 12|Overall Study||83
8196351|NCT02244918|20210254|P1|Week 12|Overall Study||160
8196352|NCT02244918|20210253|P2|STARTED|Overall Study||93
8196353|NCT02244918|20210254|P1|STARTED|Overall Study||185
8196354|NCT02244840|20210270|P1|NOT COMPLETED|Overall Study||0
8196355|NCT02244840|20210270|P1|COMPLETED|Overall Study||40
8196356|NCT02244840|20210270|P1|STARTED|Overall Study||40
8196357|NCT02244619|20210276|P2|NOT COMPLETED|Overall Study||21
8196358|NCT02244619|20210277|P1|NOT COMPLETED|Overall Study||8
8196359|NCT02244619|20210276|P2|COMPLETED|Overall Study||245
8196360|NCT02244619|20210277|P1|COMPLETED|Overall Study||241
8196361|NCT02244619|20210276|P2|STARTED|Overall Study||266
8196362|NCT02244619|20210277|P1|STARTED|Overall Study||249
8196363|NCT02244580|20210295|P1|NOT COMPLETED|Overall Study||241
8196364|NCT02244580|20210295|P1|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
8196365|NCT02244580|20210295|P1|STARTED|Overall Study||1010
8196366|NCT02244424|20210305|P2|NOT COMPLETED|Overall Study||10
8196367|NCT02244424|20210306|P1|NOT COMPLETED|Overall Study||20
8196368|NCT02244424|20210305|P2|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52
8196369|NCT02244424|20210306|P1|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82
8196370|NCT02244424|20210305|P2|Mothers|Overall Study||31
8196371|NCT02244424|20210306|P1|Mothers|Overall Study||51
8196372|NCT02244424|20210305|P2|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31
8196373|NCT02244424|20210306|P1|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51
8196374|NCT02244424|20210305|P2|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62
8196375|NCT02244424|20210306|P1|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102
8196376|NCT02243943|20210314|P2|NOT COMPLETED|Overall Study||0
8196377|NCT02243943|20210315|P1|NOT COMPLETED|Overall Study||0
8196378|NCT02243943|20210314|P2|COMPLETED|Overall Study||50
8196379|NCT02243943|20210315|P1|COMPLETED|Overall Study||50
8196380|NCT02243943|20210314|P2|STARTED|Overall Study||50
8196381|NCT02243943|20210315|P1|STARTED|Overall Study||50
8196382|NCT02243696|20210325|P1|NOT COMPLETED|Overall Study||1694
8196383|NCT02243696|20210325|P1|COMPLETED|Overall Study||0
8196384|NCT02243696|20210325|P1|STARTED|Overall Study||1694
8196397|NCT02243579|20210346|P1|NOT COMPLETED|Overall Study||20
8196398|NCT02243579|20210346|P1|COMPLETED|Overall Study||4
8196399|NCT02243579|20210346|P1|STARTED|Overall Study||24
8196400|NCT02243527|20210357|P2|NOT COMPLETED|Overall Study||0
8196401|NCT02243527|20210358|P1|NOT COMPLETED|Overall Study||0
8196402|NCT02243527|20210357|P2|COMPLETED|Overall Study||13
8196403|NCT02243527|20210358|P1|COMPLETED|Overall Study||12
8196404|NCT02243527|20210357|P2|STARTED|Overall Study||13
8196405|NCT02243527|20210358|P1|STARTED|Overall Study||12
8196412|NCT02243306|20210393|P2|NOT COMPLETED|Overall Study||3
8196413|NCT02243306|20210394|P1|NOT COMPLETED|Overall Study||0
8196414|NCT02243306|20210393|P2|COMPLETED|Overall Study||4
8196415|NCT02243306|20210394|P1|COMPLETED|Overall Study||1
8196416|NCT02243306|20210393|P2|STARTED|Overall Study||7
8196417|NCT02243306|20210394|P1|STARTED|Overall Study||1
8196561|NCT02243202|20210654|P4|NOT COMPLETED|Overall Study||23
8196562|NCT02243202|20210655|P3|NOT COMPLETED|Overall Study||31
8196563|NCT02243202|20210656|P2|NOT COMPLETED|Overall Study||25
8196564|NCT02243202|20210657|P1|NOT COMPLETED|Overall Study||25
8196565|NCT02243202|20210654|P4|COMPLETED|Overall Study||61
8196566|NCT02243202|20210655|P3|COMPLETED|Overall Study||53
8196567|NCT02243202|20210656|P2|COMPLETED|Overall Study||60
8196568|NCT02243202|20210657|P1|COMPLETED|Overall Study||57
8196569|NCT02243202|20210654|P4|Treated|Overall Study||83
8196570|NCT02243202|20210655|P3|Treated|Overall Study||84
8196571|NCT02243202|20210656|P2|Treated|Overall Study||85
8196572|NCT02243202|20210657|P1|Treated|Overall Study||82
8196573|NCT02243202|20210654|P4|STARTED|Overall Study||84
8196574|NCT02243202|20210655|P3|STARTED|Overall Study||84
8196575|NCT02243202|20210656|P2|STARTED|Overall Study||85
8196576|NCT02243202|20210657|P1|STARTED|Overall Study||82
8196577|NCT02243176|20210693|P2|NOT COMPLETED|Overall Study||15
8196578|NCT02243176|20210694|P1|NOT COMPLETED|Overall Study||14
8196579|NCT02243176|20210693|P2|COMPLETED|Overall Study||229
8196580|NCT02243176|20210694|P1|COMPLETED|Overall Study||230
8196581|NCT02243176|20210693|P2|STARTED|Overall Study||244
8196582|NCT02243176|20210694|P1|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
8196583|NCT02243046|20210719|P3|NOT COMPLETED|Overall Study||4
8196584|NCT02243046|20210720|P2|NOT COMPLETED|Overall Study||1
8196585|NCT02243046|20210721|P1|NOT COMPLETED|Overall Study||1
8196586|NCT02243046|20210719|P3|COMPLETED|Overall Study||49
8196587|NCT02243046|20210720|P2|COMPLETED|Overall Study||53
8196588|NCT02243046|20210721|P1|COMPLETED|Overall Study||54
8196589|NCT02243046|20210719|P3|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
8196590|NCT02243046|20210720|P2|6 Month|Overall Study||53
8196591|NCT02243046|20210721|P1|6 Month|Overall Study||54
8196592|NCT02243046|20210719|P3|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
8196593|NCT02243046|20210720|P2|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
8196594|NCT02243046|20210721|P1|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
8196595|NCT02243046|20210719|P3|STARTED|Overall Study||53
8196596|NCT02243046|20210720|P2|STARTED|Overall Study||54
8196597|NCT02243046|20210721|P1|STARTED|Overall Study||55
8196604|NCT02243007|20210757|P2|NOT COMPLETED|Overall Study||0
8196605|NCT02243007|20210758|P1|NOT COMPLETED|Overall Study||0
8196606|NCT02243007|20210757|P2|COMPLETED|Overall Study||3
8196607|NCT02243007|20210758|P1|COMPLETED|Overall Study||4
8196608|NCT02243007|20210757|P2|STARTED|Overall Study||3
8196609|NCT02243007|20210758|P1|STARTED|Overall Study||4
8196610|NCT02242994|20210780|P1|NOT COMPLETED|Overall Study||0
8196611|NCT02242994|20210780|P1|COMPLETED|Overall Study||5
8196612|NCT02242994|20210780|P1|STARTED|Overall Study||5
8196613|NCT02242981|20210785|P1|NOT COMPLETED|Overall Study||1
8196614|NCT02242981|20210785|P1|COMPLETED|Overall Study||5
8196615|NCT02242981|20210785|P1|Received Study Drug|Overall Study||6
8196616|NCT02242981|20210785|P1|STARTED|Overall Study||6
8196629|NCT02242903|20210832|P7|NOT COMPLETED|Overall Study||0
8196630|NCT02242903|20210833|P6|NOT COMPLETED|Overall Study||0
8196631|NCT02242903|20210834|P5|NOT COMPLETED|Overall Study||0
8196632|NCT02242903|20210835|P4|NOT COMPLETED|Overall Study||0
8196633|NCT02242903|20210836|P3|NOT COMPLETED|Overall Study||0
8196634|NCT02242903|20210837|P2|NOT COMPLETED|Overall Study||0
8196635|NCT02242903|20210838|P1|NOT COMPLETED|Overall Study||1
8196636|NCT02242903|20210832|P7|COMPLETED|Overall Study||6
8196637|NCT02242903|20210833|P6|COMPLETED|Overall Study||6
8196638|NCT02242903|20210834|P5|COMPLETED|Overall Study||6
8196639|NCT02242903|20210835|P4|COMPLETED|Overall Study||6
8196640|NCT02242903|20210836|P3|COMPLETED|Overall Study||6
8196641|NCT02242903|20210837|P2|COMPLETED|Overall Study||6
8196642|NCT02242903|20210838|P1|COMPLETED|Overall Study||11
8196643|NCT02242903|20210832|P7|Received at Least One Dose of Study Drug|Overall Study||6
8196644|NCT02242903|20210833|P6|Received at Least One Dose of Study Drug|Overall Study||6
8196645|NCT02242903|20210834|P5|Received at Least One Dose of Study Drug|Overall Study||6
8196646|NCT02242903|20210835|P4|Received at Least One Dose of Study Drug|Overall Study||6
8196647|NCT02242903|20210836|P3|Received at Least One Dose of Study Drug|Overall Study||6
8196648|NCT02242903|20210837|P2|Received at Least One Dose of Study Drug|Overall Study||6
8196649|NCT02242903|20210838|P1|Received at Least One Dose of Study Drug|Overall Study||12
8196650|NCT02242903|20210832|P7|STARTED|Overall Study||6
8196651|NCT02242903|20210833|P6|STARTED|Overall Study||6
8196652|NCT02242903|20210834|P5|STARTED|Overall Study||6
8196653|NCT02242903|20210835|P4|STARTED|Overall Study||6
8196654|NCT02242903|20210836|P3|STARTED|Overall Study||6
8196655|NCT02242903|20210837|P2|STARTED|Overall Study||6
8196656|NCT02242903|20210838|P1|STARTED|Overall Study||12
8196657|NCT02242643|20210868|P2|NOT COMPLETED|Overall Study||78
8196658|NCT02242643|20210869|P1|NOT COMPLETED|Overall Study||75
8196659|NCT02242643|20210868|P2|COMPLETED|Overall Study||1139
8196660|NCT02242643|20210869|P1|COMPLETED|Overall Study||1132
8196661|NCT02242643|20210868|P2|STARTED|Overall Study||1217
8196662|NCT02242643|20210869|P1|STARTED|Overall Study||1207
8196663|NCT02242630|20210905|P4|NOT COMPLETED|Overall Study||0
8196664|NCT02242630|20210906|P3|NOT COMPLETED|Overall Study||0
8196665|NCT02242630|20210907|P2|NOT COMPLETED|Overall Study||0
8196666|NCT02242630|20210908|P1|NOT COMPLETED|Overall Study||0
8196667|NCT02242630|20210905|P4|COMPLETED|Overall Study||16
8196668|NCT02242630|20210906|P3|COMPLETED|Overall Study||15
8196669|NCT02242630|20210907|P2|COMPLETED|Overall Study||15
8196670|NCT02242630|20210908|P1|COMPLETED|Overall Study||15
8196671|NCT02242630|20210905|P4|STARTED|Overall Study||16
8196672|NCT02242630|20210906|P3|STARTED|Overall Study||15
8196673|NCT02242630|20210907|P2|STARTED|Overall Study||15
8196674|NCT02242630|20210908|P1|STARTED|Overall Study||15
8196675|NCT02242487|20210924|P2|NOT COMPLETED|Overall Study||47
8196676|NCT02242487|20210925|P1|NOT COMPLETED|Overall Study||62
8196677|NCT02242487|20210924|P2|COMPLETED|Overall Study||117
8196678|NCT02242487|20210925|P1|COMPLETED|Overall Study||99
8196679|NCT02242487|20210924|P2|STARTED|Overall Study||164
8196680|NCT02242487|20210925|P1|STARTED|Overall Study||161
8196681|NCT02242305|20210941|P2|NOT COMPLETED|Overall Study||10
8196682|NCT02242305|20210942|P1|NOT COMPLETED|Overall Study||6
8196683|NCT02242305|20210941|P2|COMPLETED|Overall Study||141
8196684|NCT02242305|20210942|P1|COMPLETED|Overall Study||145
8196685|NCT02242305|20210941|P2|STARTED|Overall Study||151
8196686|NCT02242305|20210942|P1|STARTED|Overall Study||151
8196687|NCT02242201|20210963|P3|NOT COMPLETED|Overall Study||1
8196688|NCT02242201|20210964|P2|NOT COMPLETED|Overall Study||1
8196689|NCT02242201|20210965|P1|NOT COMPLETED|Overall Study||4
8196690|NCT02242201|20210963|P3|COMPLETED|Overall Study||54
8196691|NCT02242201|20210964|P2|COMPLETED|Overall Study||54
8196692|NCT02242201|20210965|P1|COMPLETED|Overall Study||51
8196693|NCT02242201|20210963|P3|STARTED|Overall Study||55
8196694|NCT02242201|20210964|P2|STARTED|Overall Study||55
8196695|NCT02242201|20210965|P1|STARTED|Overall Study||55
8196696|NCT02242019|20210997|P1|NOT COMPLETED|Overall Study||0
8196697|NCT02242019|20210997|P1|COMPLETED|Overall Study||109
8196698|NCT02242019|20210997|P1|STARTED|Overall Study||109
8196699|NCT02241889|20211003|P6|NOT COMPLETED|Overall Study||1
8196700|NCT02241889|20211004|P5|NOT COMPLETED|Overall Study||0
8196701|NCT02241889|20211005|P4|NOT COMPLETED|Overall Study||0
8196702|NCT02241889|20211006|P3|NOT COMPLETED|Overall Study||1
8196703|NCT02241889|20211007|P2|NOT COMPLETED|Overall Study||0
8196704|NCT02241889|20211008|P1|NOT COMPLETED|Overall Study||0
8196705|NCT02241889|20211003|P6|COMPLETED|Overall Study||3
8196706|NCT02241889|20211004|P5|COMPLETED|Overall Study||5
8196707|NCT02241889|20211005|P4|COMPLETED|Overall Study||3
8196708|NCT02241889|20211006|P3|COMPLETED|Overall Study||2
8196709|NCT02241889|20211007|P2|COMPLETED|Overall Study||4
8196710|NCT02241889|20211008|P1|COMPLETED|Overall Study||4
8196711|NCT02241889|20211003|P6|STARTED|Overall Study||4
8196712|NCT02241889|20211004|P5|STARTED|Overall Study||5
8196713|NCT02241889|20211005|P4|STARTED|Overall Study||3
8196714|NCT02241889|20211006|P3|STARTED|Overall Study||3
8196715|NCT02241889|20211007|P2|STARTED|Overall Study||4
8196716|NCT02241889|20211008|P1|STARTED|Overall Study||4
8196717|NCT02241785|20211043|P1|NOT COMPLETED|Overall Study||47
8196718|NCT02241785|20211043|P1|COMPLETED|Overall Study||0
8196719|NCT02241785|20211043|P1|STARTED|Overall Study||47
8196720|NCT02241733|20211053|P2|NOT COMPLETED|Overall Study||10
8196721|NCT02241733|20211054|P1|NOT COMPLETED|Overall Study||15
8196722|NCT02241733|20211053|P2|COMPLETED|Overall Study||30
8196723|NCT02241733|20211054|P1|COMPLETED|Overall Study||25
8196724|NCT02241733|20211053|P2|STARTED|Overall Study||40
8196725|NCT02241733|20211054|P1|STARTED|Overall Study||40
8196726|NCT02241720|20211066|P1|NOT COMPLETED|Overall Study||4
8196727|NCT02241720|20211066|P1|COMPLETED|Overall Study||1
8196728|NCT02241720|20211066|P1|STARTED|Overall Study||5
8196729|NCT02241655|20211072|P2|NOT COMPLETED|Overall Study||0
8196730|NCT02241655|20211073|P1|NOT COMPLETED|Overall Study||0
8196731|NCT02241655|20211072|P2|COMPLETED|Overall Study||618
8196732|NCT02241655|20211073|P1|COMPLETED|Overall Study||614
8196733|NCT02241655|20211072|P2|STARTED|Overall Study||618
8196734|NCT02241655|20211073|P1|STARTED|Overall Study||614
8196735|NCT02241551|20211093|P2|NOT COMPLETED|Overall Study||0
8196736|NCT02241551|20211094|P1|NOT COMPLETED|Overall Study||1
8196737|NCT02241551|20211093|P2|COMPLETED|Overall Study||0
8196738|NCT02241551|20211094|P1|COMPLETED|Overall Study||0
8196739|NCT02241551|20211093|P2|STARTED|Overall Study||0
8196740|NCT02241551|20211094|P1|STARTED|Overall Study||1
8196741|NCT02241512|20211116|P2|NOT COMPLETED|Overall Study||0
8196742|NCT02241512|20211117|P1|NOT COMPLETED|Overall Study||1
8196743|NCT02241512|20211116|P2|COMPLETED|Overall Study||29
8196744|NCT02241512|20211117|P1|COMPLETED|Overall Study||29
8196745|NCT02241512|20211116|P2|STARTED|Overall Study||29
8196746|NCT02241512|20211117|P1|STARTED|Overall Study||30
8196747|NCT02241486|20211129|P1|NOT COMPLETED|Overall Study||0
8196748|NCT02241486|20211129|P1|COMPLETED|Overall Study||2
8196749|NCT02241486|20211129|P1|STARTED|Overall Study||2
8196750|NCT02241343|20211133|P1|NOT COMPLETED|Overall Study||1
8196751|NCT02241343|20211133|P1|COMPLETED|Overall Study||0
8196752|NCT02241343|20211133|P1|STARTED|Overall Study||1
8196753|NCT02241187|20211138|P1|NOT COMPLETED|Overall Study||2
8196754|NCT02241187|20211138|P1|COMPLETED|Overall Study||0
8196755|NCT02241187|20211138|P1|STARTED|Overall Study||2
8196756|NCT02240810|20211145|P2|NOT COMPLETED|Overall Study||60
8196757|NCT02240810|20211146|P1|NOT COMPLETED|Overall Study||60
8196758|NCT02240810|20211145|P2|COMPLETED|Overall Study||2621
8196759|NCT02240810|20211146|P1|COMPLETED|Overall Study||1441
8196760|NCT02240810|20211145|P2|STARTED|Overall Study|correct typo|2681
8196761|NCT02240810|20211146|P1|STARTED|Overall Study||1501
8196762|NCT02240706|20211170|P7|NOT COMPLETED|Overall Study||0
8196763|NCT02240706|20211171|P6|NOT COMPLETED|Overall Study||0
8196764|NCT02240706|20211172|P5|NOT COMPLETED|Overall Study||11
8196765|NCT02240706|20211173|P4|NOT COMPLETED|Overall Study||4
8196766|NCT02240706|20211174|P3|NOT COMPLETED|Overall Study||6
8196767|NCT02240706|20211175|P2|NOT COMPLETED|Overall Study||3
8196768|NCT02240706|20211176|P1|NOT COMPLETED|Overall Study||3
8196769|NCT02240706|20211170|P7|COMPLETED|Overall Study||0
8196770|NCT02240706|20211171|P6|COMPLETED|Overall Study||0
8196771|NCT02240706|20211172|P5|COMPLETED|Overall Study||0
8196772|NCT02240706|20211173|P4|COMPLETED|Overall Study||0
8196773|NCT02240706|20211174|P3|COMPLETED|Overall Study||0
8196774|NCT02240706|20211175|P2|COMPLETED|Overall Study||0
8196775|NCT02240706|20211176|P1|COMPLETED|Overall Study||0
8196776|NCT02240706|20211170|P7|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
8196777|NCT02240706|20211171|P6|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
8196778|NCT02240706|20211172|P5|STARTED|Overall Study||11
8196779|NCT02240706|20211173|P4|STARTED|Overall Study||4
8196780|NCT02240706|20211174|P3|STARTED|Overall Study||6
8196781|NCT02240706|20211175|P2|STARTED|Overall Study||3
8196782|NCT02240706|20211176|P1|STARTED|Overall Study||3
8196783|NCT02240693|20211236|P5|NOT COMPLETED|Overall Study||1
8196784|NCT02240693|20211237|P4|NOT COMPLETED|Overall Study||1
8196785|NCT02240693|20211238|P3|NOT COMPLETED|Overall Study||4
8196786|NCT02240693|20211239|P2|NOT COMPLETED|Overall Study||0
8196787|NCT02240693|20211240|P1|NOT COMPLETED|Overall Study||0
8196788|NCT02240693|20211236|P5|COMPLETED|Overall Study||42
8196789|NCT02240693|20211237|P4|COMPLETED|Overall Study||20
8196790|NCT02240693|20211238|P3|COMPLETED|Overall Study||17
8196791|NCT02240693|20211239|P2|COMPLETED|Overall Study||21
8196792|NCT02240693|20211240|P1|COMPLETED|Overall Study||22
8196793|NCT02240693|20211236|P5|STARTED|Overall Study||43
8196794|NCT02240693|20211237|P4|STARTED|Overall Study||21
8196795|NCT02240693|20211238|P3|STARTED|Overall Study||21
8196796|NCT02240693|20211239|P2|STARTED|Overall Study||21
8196797|NCT02240693|20211240|P1|STARTED|Overall Study||22
8196798|NCT02240680|20211276|P4|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
8196799|NCT02240680|20211277|P3|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
8196800|NCT02240680|20211278|P2|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
8196801|NCT02240680|20211279|P1|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
8196802|NCT02240680|20211276|P4|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
8196803|NCT02240680|20211277|P3|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
8196804|NCT02240680|20211278|P2|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
8196805|NCT02240680|20211279|P1|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
8196806|NCT02240680|20211276|P4|STARTED|Japanese Patients (Up to 52 Weeks)||52
8196807|NCT02240680|20211277|P3|STARTED|Japanese Patients (Up to 52 Weeks)||50
8196808|NCT02240680|20211278|P2|STARTED|Japanese Patients (Up to 52 Weeks)||0
8196809|NCT02240680|20211279|P1|STARTED|Japanese Patients (Up to 52 Weeks)||0
8196810|NCT02240680|20211276|P4|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
8196811|NCT02240680|20211277|P3|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
8196812|NCT02240680|20211278|P2|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
8196813|NCT02240680|20211279|P1|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
8196814|NCT02240680|20211276|P4|COMPLETED|Overall Study (Up to 24 Weeks)||0
8196815|NCT02240680|20211277|P3|COMPLETED|Overall Study (Up to 24 Weeks)||0
8196816|NCT02240680|20211278|P2|COMPLETED|Overall Study (Up to 24 Weeks)||143
8196817|NCT02240680|20211279|P1|COMPLETED|Overall Study (Up to 24 Weeks)||136
8196818|NCT02240680|20211276|P4|STARTED|Overall Study (Up to 24 Weeks)||0
8196819|NCT02240680|20211277|P3|STARTED|Overall Study (Up to 24 Weeks)||0
8196820|NCT02240680|20211278|P2|STARTED|Overall Study (Up to 24 Weeks)||151
8196821|NCT02240680|20211279|P1|STARTED|Overall Study (Up to 24 Weeks)||151
8196822|NCT02240667|20211299|P2|NOT COMPLETED|Overall Study||0
8196823|NCT02240667|20211300|P1|NOT COMPLETED|Overall Study||0
8196824|NCT02240667|20211299|P2|COMPLETED|Overall Study||650
8196825|NCT02240667|20211300|P1|COMPLETED|Overall Study||771
8196826|NCT02240667|20211299|P2|STARTED|Overall Study||650
8196827|NCT02240667|20211300|P1|STARTED|Overall Study||771
8196828|NCT02240654|20211315|P5|NOT COMPLETED|Overall Study||0
8196829|NCT02240654|20211316|P4|NOT COMPLETED|Overall Study||0
8196830|NCT02240654|20211317|P3|NOT COMPLETED|Overall Study||0
8196831|NCT02240654|20211318|P2|NOT COMPLETED|Overall Study||0
8196832|NCT02240654|20211319|P1|NOT COMPLETED|Overall Study||0
8196833|NCT02240654|20211315|P5|COMPLETED|Overall Study||1285
8196834|NCT02240654|20211316|P4|COMPLETED|Overall Study||2150
8196835|NCT02240654|20211317|P3|COMPLETED|Overall Study||28619
8196836|NCT02240654|20211318|P2|COMPLETED|Overall Study||2813
8196837|NCT02240654|20211319|P1|COMPLETED|Overall Study||1706
8196838|NCT02240654|20211315|P5|STARTED|Overall Study||1285
8196839|NCT02240654|20211316|P4|STARTED|Overall Study||2150
8196840|NCT02240654|20211317|P3|STARTED|Overall Study||28619
8196841|NCT02240654|20211318|P2|STARTED|Overall Study||2813
8196842|NCT02240654|20211319|P1|STARTED|Overall Study||1706
8196843|NCT02240628|20211333|P2|NOT COMPLETED|Overall Study||5
8196844|NCT02240628|20211334|P1|NOT COMPLETED|Overall Study||6
8196845|NCT02240628|20211333|P2|COMPLETED|Overall Study||33
8196846|NCT02240628|20211334|P1|COMPLETED|Overall Study||32
8196847|NCT02240628|20211333|P2|STARTED|Overall Study||38
8196848|NCT02240628|20211334|P1|STARTED|Overall Study||38
8196849|NCT02240589|20211344|P2|NOT COMPLETED|Overall Study||2
8196850|NCT02240589|20211345|P1|NOT COMPLETED|Overall Study||2
8196851|NCT02240589|20211344|P2|COMPLETED|Overall Study||4
8196852|NCT02240589|20211345|P1|COMPLETED|Overall Study||3
8196853|NCT02240589|20211344|P2|STARTED|Overall Study||6
8196854|NCT02240589|20211345|P1|STARTED|Overall Study||5
8196855|NCT02240368|20211368|P3|NOT COMPLETED|Overall Study||1
8196856|NCT02240368|20211369|P2|NOT COMPLETED|Overall Study||0
8196857|NCT02240368|20211370|P1|NOT COMPLETED|Overall Study||1
8196858|NCT02240368|20211368|P3|COMPLETED|Overall Study||18
8196859|NCT02240368|20211369|P2|COMPLETED|Overall Study||22
8196860|NCT02240368|20211370|P1|COMPLETED|Overall Study||8
8196861|NCT02240368|20211368|P3|STARTED|Overall Study||19
8196862|NCT02240368|20211369|P2|STARTED|Overall Study||22
8196863|NCT02240368|20211370|P1|STARTED|Overall Study||9
8196864|NCT02240329|20211387|P1|NOT COMPLETED|Overall Study||0
8196865|NCT02240329|20211387|P1|COMPLETED|Overall Study||4
8196866|NCT02240329|20211387|P1|Determination of Urge to Cough|Overall Study||4
8196867|NCT02240329|20211387|P1|STARTED|Overall Study||4
8196868|NCT02240186|20211392|P1|NOT COMPLETED|Overall Study||27
8196869|NCT02240186|20211392|P1|COMPLETED|Overall Study||23
8196870|NCT02240186|20211392|P1|STARTED|Overall Study||50
8196871|NCT02240121|20211402|P2|NOT COMPLETED|Overall Study||20
8196872|NCT02240121|20211403|P1|NOT COMPLETED|Overall Study||18
8196873|NCT02240121|20211402|P2|COMPLETED|Overall Study||20
8196874|NCT02240121|20211403|P1|COMPLETED|Overall Study||22
8196875|NCT02240121|20211402|P2|STARTED|Overall Study||40
8196876|NCT02240121|20211403|P1|STARTED|Overall Study||40
8196877|NCT02240108|20211431|P2|NOT COMPLETED|Overall Study||25
8196878|NCT02240108|20211432|P1|NOT COMPLETED|Overall Study||14
8196879|NCT02240108|20211431|P2|COMPLETED|Overall Study||21
8196880|NCT02240108|20211432|P1|COMPLETED|Overall Study||21
8196881|NCT02240108|20211431|P2|Intent-to-treat (ITT) Population|Overall Study||45
8196882|NCT02240108|20211432|P1|Intent-to-treat (ITT) Population|Overall Study||35
8196883|NCT02240108|20211431|P2|STARTED|Overall Study||46
8196884|NCT02240108|20211432|P1|STARTED|Overall Study||35
8196885|NCT02240030|20211461|P3|NOT COMPLETED|Overall Study||15
8196886|NCT02240030|20211462|P2|NOT COMPLETED|Overall Study||17
8196887|NCT02240030|20211463|P1|NOT COMPLETED|Overall Study||17
8196888|NCT02240030|20211461|P3|COMPLETED|Overall Study||97
8196889|NCT02240030|20211462|P2|COMPLETED|Overall Study||97
8196890|NCT02240030|20211463|P1|COMPLETED|Overall Study||96
8196891|NCT02240030|20211461|P3|STARTED|Overall Study||112
8196892|NCT02240030|20211462|P2|STARTED|Overall Study||114
8196893|NCT02240030|20211463|P1|STARTED|Overall Study||113
8196894|NCT02239978|20211487|P2|NOT COMPLETED|Overall Study||0
8196895|NCT02239978|20211488|P1|NOT COMPLETED|Overall Study||2
8196896|NCT02239978|20211487|P2|COMPLETED|Overall Study||12
8196897|NCT02239978|20211488|P1|COMPLETED|Overall Study||28
8196898|NCT02239978|20211487|P2|STARTED|Overall Study||12
8196899|NCT02239978|20211488|P1|STARTED|Overall Study||30
8196900|NCT02239939|20211505|P2|NOT COMPLETED|Overall Study||2
8196901|NCT02239939|20211506|P1|NOT COMPLETED|Overall Study||2
8196902|NCT02239939|20211505|P2|COMPLETED|Overall Study||15
8196903|NCT02239939|20211506|P1|COMPLETED|Overall Study||18
8196904|NCT02239939|20211505|P2|STARTED|Overall Study||17
8196905|NCT02239939|20211506|P1|STARTED|Overall Study||20
8196906|NCT02239926|20211522|P2|NOT COMPLETED|Overall Study||1
8196907|NCT02239926|20211523|P1|NOT COMPLETED|Overall Study||0
8196908|NCT02239926|20211522|P2|COMPLETED|Overall Study||1
8196909|NCT02239926|20211523|P1|COMPLETED|Overall Study||0
8196910|NCT02239926|20211522|P2|STARTED|Overall Study||2
8196911|NCT02239926|20211523|P1|STARTED|Overall Study||0
8196912|NCT02239770|20211537|P6|NOT COMPLETED|Part 2||0
8196913|NCT02239770|20211538|P5|NOT COMPLETED|Part 2||0
8196914|NCT02239770|20211539|P4|NOT COMPLETED|Part 2||0
8196915|NCT02239770|20211540|P3|NOT COMPLETED|Part 2||0
8196916|NCT02239770|20211541|P2|NOT COMPLETED|Part 2||0
8196917|NCT02239770|20211542|P1|NOT COMPLETED|Part 2||0
8196918|NCT02239770|20211537|P6|COMPLETED|Part 2||4
8196919|NCT02239770|20211538|P5|COMPLETED|Part 2||4
8196920|NCT02239770|20211539|P4|COMPLETED|Part 2||4
8196921|NCT02239770|20211540|P3|COMPLETED|Part 2||0
8196922|NCT02239770|20211541|P2|COMPLETED|Part 2||0
8196923|NCT02239770|20211542|P1|COMPLETED|Part 2||0
8196924|NCT02239770|20211537|P6|STARTED|Part 2||4
8196925|NCT02239770|20211538|P5|STARTED|Part 2||4
8196926|NCT02239770|20211539|P4|STARTED|Part 2||4
8196927|NCT02239770|20211540|P3|STARTED|Part 2||0
8196928|NCT02239770|20211541|P2|STARTED|Part 2||0
8196929|NCT02239770|20211542|P1|STARTED|Part 2||0
8196930|NCT02239770|20211537|P6|NOT COMPLETED|Part 1||0
8196931|NCT02239770|20211538|P5|NOT COMPLETED|Part 1||0
8196932|NCT02239770|20211539|P4|NOT COMPLETED|Part 1||0
8196933|NCT02239770|20211540|P3|NOT COMPLETED|Part 1||0
8196934|NCT02239770|20211541|P2|NOT COMPLETED|Part 1||0
8196935|NCT02239770|20211542|P1|NOT COMPLETED|Part 1||0
8196936|NCT02239770|20211537|P6|COMPLETED|Part 1||0
8196937|NCT02239770|20211538|P5|COMPLETED|Part 1||0
8196938|NCT02239770|20211539|P4|COMPLETED|Part 1||0
8196939|NCT02239770|20211540|P3|COMPLETED|Part 1||4
8196940|NCT02239770|20211541|P2|COMPLETED|Part 1||4
8196941|NCT02239770|20211542|P1|COMPLETED|Part 1||4
8196942|NCT02239770|20211537|P6|STARTED|Part 1||0
8196943|NCT02239770|20211538|P5|STARTED|Part 1||0
8196944|NCT02239770|20211539|P4|STARTED|Part 1||0
8196945|NCT02239770|20211540|P3|STARTED|Part 1||4
8196946|NCT02239770|20211541|P2|STARTED|Part 1||4
8196947|NCT02239770|20211542|P1|STARTED|Part 1||4
8196948|NCT02239744|20211570|P2|NOT COMPLETED|Period 2||0
8196949|NCT02239744|20211571|P1|NOT COMPLETED|Period 2||0
8196950|NCT02239744|20211570|P2|COMPLETED|Period 2||18
8196951|NCT02239744|20211571|P1|COMPLETED|Period 2||17
8196952|NCT02239744|20211570|P2|STARTED|Period 2||18
8196953|NCT02239744|20211571|P1|STARTED|Period 2||17
8196954|NCT02239744|20211570|P2|NOT COMPLETED|Period 1||0
8196955|NCT02239744|20211571|P1|NOT COMPLETED|Period 1||0
8196956|NCT02239744|20211570|P2|COMPLETED|Period 1||18
8196957|NCT02239744|20211571|P1|COMPLETED|Period 1||17
8196958|NCT02239744|20211570|P2|STARTED|Period 1||18
8196959|NCT02239744|20211571|P1|STARTED|Period 1||17
8196960|NCT02239692|20211585|P2|NOT COMPLETED|Overall Study||13
8196961|NCT02239692|20211586|P1|NOT COMPLETED|Overall Study||6
8196962|NCT02239692|20211585|P2|COMPLETED|Overall Study||118
8196963|NCT02239692|20211586|P1|COMPLETED|Overall Study||67
8196964|NCT02239692|20211585|P2|Safety Analysis Set|Overall Study||125
8196965|NCT02239692|20211586|P1|Safety Analysis Set|Overall Study||70
8196966|NCT02239692|20211585|P2|Per-protocol Analysis Set|Overall Study||120
8196967|NCT02239692|20211586|P1|Per-protocol Analysis Set|Overall Study||66
8196968|NCT02239692|20211585|P2|Intention-to-treat Analysis Set|Overall Study||131
8196969|NCT02239692|20211586|P1|Intention-to-treat Analysis Set|Overall Study||73
8196970|NCT02239692|20211585|P2|STARTED|Overall Study||131
8196971|NCT02239692|20211586|P1|STARTED|Overall Study||73
8196972|NCT02239679|20211605|P3|NOT COMPLETED|Overall Study||1
8196973|NCT02239679|20211606|P2|NOT COMPLETED|Overall Study||3
8196974|NCT02239679|20211607|P1|NOT COMPLETED|Overall Study||3
8196975|NCT02239679|20211605|P3|COMPLETED|Overall Study||53
8196976|NCT02239679|20211606|P2|COMPLETED|Overall Study||56
8196977|NCT02239679|20211607|P1|COMPLETED|Overall Study||50
8196978|NCT02239679|20211605|P3|STARTED|Overall Study||54
8196979|NCT02239679|20211606|P2|STARTED|Overall Study||59
8196980|NCT02239679|20211607|P1|STARTED|Overall Study||53
8196981|NCT02239640|20211819|P1|NOT COMPLETED|Overall Study||217
8196982|NCT02239640|20211819|P1|COMPLETED|Overall Study||767
8196983|NCT02239640|20211819|P1|STARTED|Overall Study||984
8196984|NCT02239627|20211831|P2|NOT COMPLETED|Overall Study||0
8196985|NCT02239627|20211832|P1|NOT COMPLETED|Overall Study||0
8196986|NCT02239627|20211831|P2|COMPLETED|Overall Study||0
8196987|NCT02239627|20211832|P1|COMPLETED|Overall Study||0
8196988|NCT02239627|20211831|P2|STARTED|Overall Study||0
8196989|NCT02239627|20211832|P1|STARTED|Overall Study||0
8196990|NCT02239601|20211846|P2|NOT COMPLETED|Overall Study||6
8196991|NCT02239601|20211847|P1|NOT COMPLETED|Overall Study||7
8196992|NCT02239601|20211846|P2|COMPLETED|Overall Study||26
8196993|NCT02239601|20211847|P1|COMPLETED|Overall Study||22
8196994|NCT02239601|20211846|P2|STARTED|Overall Study||32
8196995|NCT02239601|20211847|P1|STARTED|Overall Study||29
8196996|NCT02239562|20211871|P6|NOT COMPLETED|Overall Study||0
8196997|NCT02239562|20211872|P5|NOT COMPLETED|Overall Study||0
8196998|NCT02239562|20211873|P4|NOT COMPLETED|Overall Study||0
8196999|NCT02239562|20211874|P3|NOT COMPLETED|Overall Study||0
8197000|NCT02239562|20211875|P2|NOT COMPLETED|Overall Study||0
8197001|NCT02239562|20211876|P1|NOT COMPLETED|Overall Study||0
8197002|NCT02239562|20211871|P6|COMPLETED|Overall Study||6
8197003|NCT02239562|20211872|P5|COMPLETED|Overall Study||6
8197004|NCT02239562|20211873|P4|COMPLETED|Overall Study||6
8197005|NCT02239562|20211874|P3|COMPLETED|Overall Study||6
8197006|NCT02239562|20211875|P2|COMPLETED|Overall Study||6
8197007|NCT02239562|20211876|P1|COMPLETED|Overall Study||6
8197008|NCT02239562|20211871|P6|STARTED|Overall Study||6
8197009|NCT02239562|20211872|P5|STARTED|Overall Study||6
8197010|NCT02239562|20211873|P4|STARTED|Overall Study||6
8197011|NCT02239562|20211874|P3|STARTED|Overall Study||6
8197012|NCT02239562|20211875|P2|STARTED|Overall Study||6
8197013|NCT02239562|20211876|P1|STARTED|Overall Study||6
8197014|NCT02239536|20211900|P2|NOT COMPLETED|Overall Study||17
8197015|NCT02239536|20211901|P1|NOT COMPLETED|Overall Study||23
8197016|NCT02239536|20211900|P2|COMPLETED|Overall Study||155
8197017|NCT02239536|20211901|P1|COMPLETED|Overall Study||167
8197018|NCT02239536|20211900|P2|STARTED|Overall Study||172
8197019|NCT02239536|20211901|P1|STARTED|Overall Study||190
8197020|NCT02239510|20211911|P2|NOT COMPLETED|Overall Study||1
8197021|NCT02239510|20211912|P1|NOT COMPLETED|Overall Study||2
8197022|NCT02239510|20211911|P2|COMPLETED|Overall Study||3
8197023|NCT02239510|20211912|P1|COMPLETED|Overall Study||3
8197024|NCT02239510|20211911|P2|STARTED|Overall Study||4
8197025|NCT02239510|20211912|P1|STARTED|Overall Study||5
8197026|NCT02239380|20211924|P1|NOT COMPLETED|Overall Study||0
8197027|NCT02239380|20211924|P1|COMPLETED|Overall Study||26
8197028|NCT02239380|20211924|P1|STARTED|Overall Study||26
8197029|NCT02239328|20211934|P1|NOT COMPLETED|Overall Study||8
8197030|NCT02239328|20211934|P1|COMPLETED|Overall Study||174
8197031|NCT02239328|20211934|P1|STARTED|Overall Study||182
8197032|NCT02239289|20211938|P1|NOT COMPLETED|Overall Study||0
8197033|NCT02239289|20211938|P1|COMPLETED|Overall Study||21
8197034|NCT02239289|20211938|P1|STARTED|Overall Study||21
8197035|NCT02239120|20211959|P2|NOT COMPLETED|Overall Study||72
8197036|NCT02239120|20211960|P1|NOT COMPLETED|Overall Study||75
8197037|NCT02239120|20211959|P2|COMPLETED|Overall Study||2623
8197038|NCT02239120|20211960|P1|COMPLETED|Overall Study||2620
8197039|NCT02239120|20211959|P2|STARTED|Overall Study||2695
8197040|NCT02239120|20211960|P1|STARTED|Overall Study||2695
8197041|NCT02239094|20211984|P1|NOT COMPLETED|Overall Study||2
8197042|NCT02239094|20211984|P1|COMPLETED|Overall Study||18
8197043|NCT02239094|20211984|P1|STARTED|Overall Study||20
8197044|NCT02238977|20211991|P2|NOT COMPLETED|Overall Study||0
8197045|NCT02238977|20211992|P1|NOT COMPLETED|Overall Study||0
8197046|NCT02238977|20211991|P2|COMPLETED|Overall Study||1
8197047|NCT02238977|20211992|P1|COMPLETED|Overall Study||0
8197048|NCT02238977|20211991|P2|STARTED|Overall Study||1
8197049|NCT02238977|20211992|P1|STARTED|Overall Study||0
8197050|NCT02238925|20211998|P1|NOT COMPLETED|Overall Study||25
8197051|NCT02238925|20211998|P1|COMPLETED|Overall Study||1
8197052|NCT02238925|20211998|P1|STARTED|Overall Study||26
8197053|NCT02238847|20212008|P2|NOT COMPLETED|Overall Study||24
8197054|NCT02238847|20212009|P1|NOT COMPLETED|Overall Study||22
8197055|NCT02238847|20212008|P2|COMPLETED|Overall Study||36
8197056|NCT02238847|20212009|P1|COMPLETED|Overall Study||37
8197057|NCT02238847|20212008|P2|STARTED|Overall Study||60
8197058|NCT02238847|20212009|P1|STARTED|Overall Study||59
8197059|NCT02238782|20212033|P1|NOT COMPLETED|Overall Study||0
8197060|NCT02238782|20212033|P1|COMPLETED|Overall Study||12
8197061|NCT02238782|20212033|P1|Subjects Treated|Overall Study||12
8197062|NCT02238782|20212033|P1|STARTED|Overall Study||12
8197063|NCT02238483|20212039|P2|NOT COMPLETED|Overall Study||14
8197064|NCT02238483|20212040|P1|NOT COMPLETED|Overall Study||15
8197065|NCT02238483|20212039|P2|COMPLETED|Overall Study||91
8197066|NCT02238483|20212040|P1|COMPLETED|Overall Study||93
8197067|NCT02238483|20212039|P2|STARTED|Overall Study||105
8197068|NCT02238483|20212040|P1|STARTED|Overall Study||108
8197069|NCT02238379|20212078|P2|NOT COMPLETED|Overall Study||0
8197070|NCT02238379|20212079|P1|NOT COMPLETED|Overall Study||1
8197071|NCT02238379|20212078|P2|COMPLETED|Overall Study||14
8197072|NCT02238379|20212079|P1|COMPLETED|Overall Study||11
8197073|NCT02238379|20212078|P2|STARTED|Overall Study||14
8197074|NCT02238379|20212079|P1|STARTED|Overall Study||12
8197075|NCT02238080|20212105|P1|NOT COMPLETED|Overall Study||25
8197076|NCT02238080|20212105|P1|COMPLETED|Overall Study||172
8197077|NCT02238080|20212105|P1|STARTED|Overall Study||197
8197078|NCT02238067|20212119|P1|NOT COMPLETED|Overall Study||45
8197079|NCT02238067|20212119|P1|COMPLETED|Overall Study||151
8197080|NCT02238067|20212119|P1|STARTED|Overall Study||196
8197081|NCT02238028|20212142|P2|NOT COMPLETED|Overall Study||2
8197082|NCT02238028|20212143|P1|NOT COMPLETED|Overall Study||2
8197083|NCT02238028|20212142|P2|COMPLETED|Overall Study||12
8197084|NCT02238028|20212143|P1|COMPLETED|Overall Study||12
8197085|NCT02238028|20212142|P2|STARTED|Overall Study||14
8197086|NCT02238028|20212143|P1|STARTED|Overall Study||14
8197087|NCT02237989|20212164|P2|NOT COMPLETED|Overall Study||0
8197088|NCT02237989|20212165|P1|NOT COMPLETED|Overall Study||0
8197089|NCT02237989|20212164|P2|COMPLETED|Overall Study||20
8197090|NCT02237989|20212165|P1|COMPLETED|Overall Study||19
8197091|NCT02237989|20212164|P2|STARTED|Overall Study||20
8197092|NCT02237989|20212165|P1|STARTED|Overall Study||19
8197093|NCT02237950|20212181|P2|NOT COMPLETED|Overall Study||48
8197094|NCT02237950|20212182|P1|NOT COMPLETED|Overall Study||48
8197095|NCT02237950|20212181|P2|COMPLETED|Overall Study||243
8197096|NCT02237950|20212182|P1|COMPLETED|Overall Study||247
8197097|NCT02237950|20212181|P2|STARTED|Overall Study||291
8197098|NCT02237950|20212182|P1|STARTED|Overall Study||295
8197099|NCT02237911|20212207|P3|NOT COMPLETED|Overall Study||3
8197100|NCT02237911|20212208|P2|NOT COMPLETED|Overall Study||8
8197101|NCT02237911|20212209|P1|NOT COMPLETED|Overall Study||7
8197102|NCT02237911|20212207|P3|COMPLETED|Overall Study||45
8197103|NCT02237911|20212208|P2|COMPLETED|Overall Study||88
8197104|NCT02237911|20212209|P1|COMPLETED|Overall Study||89
8197105|NCT02237911|20212207|P3|6 Months|Overall Study||45
8197106|NCT02237911|20212208|P2|6 Months|Overall Study||88
8197107|NCT02237911|20212209|P1|6 Months|Overall Study||89
8197108|NCT02237911|20212207|P3|3 Months|Overall Study||44
8197109|NCT02237911|20212208|P2|3 Months|Overall Study||87
8197110|NCT02237911|20212209|P1|3 Months|Overall Study||90
8197111|NCT02237911|20212207|P3|STARTED|Overall Study||48
8197112|NCT02237911|20212208|P2|STARTED|Overall Study||96
8197113|NCT02237911|20212209|P1|STARTED|Overall Study||96
8197114|NCT02237898|20212225|P2|NOT COMPLETED|Overall Study||12
8197115|NCT02237898|20212226|P1|NOT COMPLETED|Overall Study||7
8197116|NCT02237898|20212225|P2|COMPLETED|Overall Study||2
8197117|NCT02237898|20212226|P1|COMPLETED|Overall Study||5
8197118|NCT02237898|20212225|P2|Completed 15 Month Follow-up|Overall Study||8
8197119|NCT02237898|20212226|P1|Completed 15 Month Follow-up|Overall Study||8
8197120|NCT02237898|20212225|P2|Completed 9 Month Follow-up|Overall Study||7
8197121|NCT02237898|20212226|P1|Completed 9 Month Follow-up|Overall Study||6
8197122|NCT02237898|20212225|P2|Completed 3 Month Follow-up|Overall Study||6
8197123|NCT02237898|20212226|P1|Completed 3 Month Follow-up|Overall Study||6
8197124|NCT02237898|20212225|P2|Completed 12 Weeks of CM|Overall Study||2
8197125|NCT02237898|20212226|P1|Completed 12 Weeks of CM|Overall Study||7
8197126|NCT02237898|20212225|P2|STARTED|Overall Study||14
8197127|NCT02237898|20212226|P1|STARTED|Overall Study||12
8197128|NCT02237196|20212249|P4|NOT COMPLETED|Overall Study||11
8197129|NCT02237196|20212250|P3|NOT COMPLETED|Overall Study||10
8197130|NCT02237196|20212251|P2|NOT COMPLETED|Overall Study||6
8197131|NCT02237196|20212252|P1|NOT COMPLETED|Overall Study||8
8197132|NCT02237196|20212249|P4|COMPLETED|Overall Study||17
8197133|NCT02237196|20212250|P3|COMPLETED|Overall Study||20
8197134|NCT02237196|20212251|P2|COMPLETED|Overall Study||25
8197135|NCT02237196|20212252|P1|COMPLETED|Overall Study||24
8197136|NCT02237196|20212249|P4|STARTED|Overall Study||28
8197137|NCT02237196|20212250|P3|STARTED|Overall Study||30
8197138|NCT02237196|20212251|P2|STARTED|Overall Study||31
8197139|NCT02237196|20212252|P1|STARTED|Overall Study||32
8197140|NCT02237118|20212296|P2|NOT COMPLETED|Overall Study||1
8197141|NCT02237118|20212297|P1|NOT COMPLETED|Overall Study||1
8197142|NCT02237118|20212296|P2|COMPLETED|Overall Study||62
8197143|NCT02237118|20212297|P1|COMPLETED|Overall Study||59
8197144|NCT02237118|20212296|P2|STARTED|Overall Study||63
8197145|NCT02237118|20212297|P1|STARTED|Overall Study||60
8197146|NCT02237092|20212311|P1|NOT COMPLETED|Overall Study||0
8197147|NCT02237092|20212311|P1|COMPLETED|Overall Study||196
8197148|NCT02237092|20212311|P1|STARTED|Overall Study||196
8197149|NCT02237001|20212328|P1|NOT COMPLETED|Overall Study||11
8197150|NCT02237001|20212328|P1|COMPLETED|Overall Study||19
8197151|NCT02237001|20212328|P1|24 Month Follow-up|Overall Study||19
8197152|NCT02237001|20212328|P1|12 Month Follow-up|Overall Study||21
8197153|NCT02237001|20212328|P1|6 Month Follow-up|Overall Study||27
8197154|NCT02237001|20212328|P1|STARTED|Overall Study||30
8197155|NCT02236767|20212340|P1|NOT COMPLETED|Overall Study||0
8197156|NCT02236767|20212340|P1|COMPLETED|Overall Study||1
8197157|NCT02236767|20212340|P1|STARTED|Overall Study||1
8197158|NCT02236611|20212346|P2|NOT COMPLETED|Overall Study||34
8197159|NCT02236611|20212347|P1|NOT COMPLETED|Overall Study||26
8197160|NCT02236611|20212346|P2|COMPLETED|Overall Study||484
8197161|NCT02236611|20212347|P1|COMPLETED|Overall Study||490
8197162|NCT02236611|20212346|P2|STARTED|Overall Study||518
8197163|NCT02236611|20212347|P1|STARTED|Overall Study||516
8197164|NCT02236598|20212355|P2|NOT COMPLETED|Overall Study||2
8197165|NCT02236598|20212356|P1|NOT COMPLETED|Overall Study||0
8197166|NCT02236598|20212355|P2|COMPLETED|Overall Study||12
8197167|NCT02236598|20212356|P1|COMPLETED|Overall Study||15
8197168|NCT02236598|20212355|P2|STARTED|Overall Study||14
8197169|NCT02236598|20212356|P1|STARTED|Overall Study||15
8197170|NCT02236559|20212370|P2|NOT COMPLETED|Overall Study||12
8197171|NCT02236559|20212371|P1|NOT COMPLETED|Overall Study||12
8197172|NCT02236559|20212370|P2|COMPLETED|Overall Study||104
8197173|NCT02236559|20212371|P1|COMPLETED|Overall Study||100
8197174|NCT02236559|20212370|P2|STARTED|Overall Study||116
8197175|NCT02236559|20212371|P1|STARTED|Overall Study||112
8197176|NCT02236546|20212397|P1|NOT COMPLETED|Overall Study||0
8197177|NCT02236546|20212397|P1|COMPLETED|Overall Study||3
8197178|NCT02236546|20212397|P1|STARTED|Overall Study||3
8197179|NCT02236520|20212408|P4|NOT COMPLETED|Overall Study||1
8197180|NCT02236520|20212409|P3|NOT COMPLETED|Overall Study||0
8197181|NCT02236520|20212410|P2|NOT COMPLETED|Overall Study||5
8197182|NCT02236520|20212411|P1|NOT COMPLETED|Overall Study||2
8197183|NCT02236520|20212408|P4|COMPLETED|Overall Study||14
8197184|NCT02236520|20212409|P3|COMPLETED|Overall Study||15
8197185|NCT02236520|20212410|P2|COMPLETED|Overall Study||8
8197186|NCT02236520|20212411|P1|COMPLETED|Overall Study||14
8197187|NCT02236520|20212408|P4|STARTED|Overall Study||15
8197188|NCT02236520|20212409|P3|STARTED|Overall Study||15
8197189|NCT02236520|20212410|P2|STARTED|Overall Study||13
8197190|NCT02236520|20212411|P1|STARTED|Overall Study||16
8197191|NCT02236338|20212423|P2|NOT COMPLETED|Overall Study||0
8197192|NCT02236338|20212424|P1|NOT COMPLETED|Overall Study||0
8197193|NCT02236338|20212423|P2|COMPLETED|Overall Study||100
8197194|NCT02236338|20212424|P1|COMPLETED|Overall Study||100
8197195|NCT02236338|20212423|P2|STARTED|Overall Study||100
8197196|NCT02236338|20212424|P1|STARTED|Overall Study||100
8197197|NCT02236130|20212438|P2|NOT COMPLETED|Overall Study||12
8197198|NCT02236130|20212439|P1|NOT COMPLETED|Overall Study||7
8197199|NCT02236130|20212438|P2|COMPLETED|Overall Study||15
8197200|NCT02236130|20212439|P1|COMPLETED|Overall Study||15
8197201|NCT02236130|20212438|P2|STARTED|Overall Study||27
8197202|NCT02236130|20212439|P1|STARTED|Overall Study||22
8197203|NCT02235987|20212447|P1|NOT COMPLETED|Overall Study||1
8197204|NCT02235987|20212447|P1|COMPLETED|Overall Study||19
8197205|NCT02235987|20212447|P1|Received 1800 µg DG3173|Overall Study||19
8197206|NCT02235987|20212447|P1|Received 900 µg DG3173|Overall Study||19
8197207|NCT02235987|20212447|P1|Received 300 µg DG3173|Overall Study||20
8197208|NCT02235987|20212447|P1|Received 100 µg DG3173|Overall Study||20
8197209|NCT02235987|20212447|P1|Received Octreotide|Overall Study||20
8197210|NCT02235987|20212447|P1|STARTED|Overall Study||20
8197211|NCT02235870|20212462|P2|NOT COMPLETED|Overall Study||61
8197212|NCT02235870|20212463|P1|NOT COMPLETED|Overall Study||38
8197213|NCT02235870|20212462|P2|COMPLETED|Overall Study||128
8197214|NCT02235870|20212463|P1|COMPLETED|Overall Study||160
8197215|NCT02235870|20212462|P2|Crossover (Week 24)|Overall Study||138
8197216|NCT02235870|20212463|P1|Crossover (Week 24)|Overall Study||170
8197217|NCT02235870|20212462|P2|Completed Phase I (Week 24)|Overall Study||179
8197218|NCT02235870|20212463|P1|Completed Phase I (Week 24)|Overall Study||182
8197219|NCT02235870|20212462|P2|STARTED|Overall Study||189
8197220|NCT02235870|20212463|P1|STARTED|Overall Study||198
8197221|NCT02235831|20212472|P6|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8197222|NCT02235831|20212473|P5|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8197223|NCT02235831|20212474|P4|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8197224|NCT02235831|20212475|P3|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8197225|NCT02235831|20212476|P2|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8197226|NCT02235831|20212477|P1|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
8197227|NCT02235831|20212472|P6|COMPLETED|Period 3, Third 5 Days of Wear||4
8197228|NCT02235831|20212473|P5|COMPLETED|Period 3, Third 5 Days of Wear||4
8197229|NCT02235831|20212474|P4|COMPLETED|Period 3, Third 5 Days of Wear||4
8197230|NCT02235831|20212475|P3|COMPLETED|Period 3, Third 5 Days of Wear||4
8197231|NCT02235831|20212476|P2|COMPLETED|Period 3, Third 5 Days of Wear||4
8197232|NCT02235831|20212477|P1|COMPLETED|Period 3, Third 5 Days of Wear||4
8197233|NCT02235831|20212472|P6|STARTED|Period 3, Third 5 Days of Wear||4
8197234|NCT02235831|20212473|P5|STARTED|Period 3, Third 5 Days of Wear||4
8197235|NCT02235831|20212474|P4|STARTED|Period 3, Third 5 Days of Wear||4
8197236|NCT02235831|20212475|P3|STARTED|Period 3, Third 5 Days of Wear||4
8197237|NCT02235831|20212476|P2|STARTED|Period 3, Third 5 Days of Wear||4
8197238|NCT02235831|20212477|P1|STARTED|Period 3, Third 5 Days of Wear||4
8197239|NCT02235831|20212472|P6|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8197240|NCT02235831|20212473|P5|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8197241|NCT02235831|20212474|P4|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8197242|NCT02235831|20212475|P3|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8197243|NCT02235831|20212476|P2|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8197244|NCT02235831|20212477|P1|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
8197245|NCT02235831|20212472|P6|COMPLETED|Period 2, Second 5 Days of Wear||4
8197246|NCT02235831|20212473|P5|COMPLETED|Period 2, Second 5 Days of Wear||4
8197247|NCT02235831|20212474|P4|COMPLETED|Period 2, Second 5 Days of Wear||4
8197248|NCT02235831|20212475|P3|COMPLETED|Period 2, Second 5 Days of Wear||4
8197249|NCT02235831|20212476|P2|COMPLETED|Period 2, Second 5 Days of Wear||4
8197250|NCT02235831|20212477|P1|COMPLETED|Period 2, Second 5 Days of Wear||4
8197251|NCT02235831|20212472|P6|STARTED|Period 2, Second 5 Days of Wear||4
8197252|NCT02235831|20212473|P5|STARTED|Period 2, Second 5 Days of Wear||4
8197253|NCT02235831|20212474|P4|STARTED|Period 2, Second 5 Days of Wear||4
8197254|NCT02235831|20212475|P3|STARTED|Period 2, Second 5 Days of Wear||4
8197255|NCT02235831|20212476|P2|STARTED|Period 2, Second 5 Days of Wear||4
8197256|NCT02235831|20212477|P1|STARTED|Period 2, Second 5 Days of Wear||4
8197257|NCT02235831|20212472|P6|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8197258|NCT02235831|20212473|P5|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8197259|NCT02235831|20212474|P4|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8197260|NCT02235831|20212475|P3|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8197261|NCT02235831|20212476|P2|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8197262|NCT02235831|20212477|P1|NOT COMPLETED|Period 1, First 5 Days of Wear||0
8197263|NCT02235831|20212472|P6|COMPLETED|Period 1, First 5 Days of Wear||4
8197264|NCT02235831|20212473|P5|COMPLETED|Period 1, First 5 Days of Wear||4
8197265|NCT02235831|20212474|P4|COMPLETED|Period 1, First 5 Days of Wear||4
8197266|NCT02235831|20212475|P3|COMPLETED|Period 1, First 5 Days of Wear||4
8197267|NCT02235831|20212476|P2|COMPLETED|Period 1, First 5 Days of Wear||4
8197268|NCT02235831|20212477|P1|COMPLETED|Period 1, First 5 Days of Wear||4
8197269|NCT02235831|20212472|P6|STARTED|Period 1, First 5 Days of Wear||4
8197270|NCT02235831|20212473|P5|STARTED|Period 1, First 5 Days of Wear||4
8197271|NCT02235831|20212474|P4|STARTED|Period 1, First 5 Days of Wear||4
8197272|NCT02235831|20212475|P3|STARTED|Period 1, First 5 Days of Wear||4
8197273|NCT02235831|20212476|P2|STARTED|Period 1, First 5 Days of Wear||4
8197274|NCT02235831|20212477|P1|STARTED|Period 1, First 5 Days of Wear||4
8197275|NCT02235493|20212484|P1|NOT COMPLETED|Overall Study||0
8197276|NCT02235493|20212484|P1|COMPLETED|Overall Study||6
8197277|NCT02235493|20212484|P1|STARTED|Overall Study||6
8197278|NCT02235454|20212489|P1|NOT COMPLETED|Overall Study||2
8197279|NCT02235454|20212489|P1|COMPLETED|Overall Study||55
8197280|NCT02235454|20212489|P1|STARTED|Overall Study||57
8197281|NCT02235311|20212495|P2|NOT COMPLETED|Overall Study||2
8197282|NCT02235311|20212496|P1|NOT COMPLETED|Overall Study||0
8197283|NCT02235311|20212495|P2|COMPLETED|Overall Study||0
8197284|NCT02235311|20212496|P1|COMPLETED|Overall Study||1
8197285|NCT02235311|20212495|P2|STARTED|Overall Study||2
8197286|NCT02235311|20212496|P1|STARTED|Overall Study||1
8197287|NCT02235285|20212508|P1|NOT COMPLETED|Overall Study||13
8197288|NCT02235285|20212508|P1|COMPLETED|Overall Study||149
8197289|NCT02235285|20212508|P1|STARTED|Overall Study||162
8197290|NCT02235077|20212514|P2|NOT COMPLETED|Overall Study||19
8197291|NCT02235077|20212515|P1|NOT COMPLETED|Overall Study||18
8197292|NCT02235077|20212514|P2|COMPLETED|Overall Study||159
8197293|NCT02235077|20212515|P1|COMPLETED|Overall Study||164
8197294|NCT02235077|20212514|P2|STARTED|Overall Study||178
8197295|NCT02235077|20212515|P1|STARTED|Overall Study||182
8197296|NCT02235064|20212543|P2|NOT COMPLETED|Overall Study||0
8197297|NCT02235064|20212544|P1|NOT COMPLETED|Overall Study||0
8197298|NCT02235064|20212543|P2|COMPLETED|Overall Study||1
8197299|NCT02235064|20212544|P1|COMPLETED|Overall Study||1
8197300|NCT02235064|20212543|P2|STARTED|Overall Study||1
8197301|NCT02235064|20212544|P1|STARTED|Overall Study||1
8197302|NCT02234843|20212580|P10|NOT COMPLETED|Overall Study||0
8197303|NCT02234843|20212581|P9|NOT COMPLETED|Overall Study||1
8197304|NCT02234843|20212582|P8|NOT COMPLETED|Overall Study||2
8197305|NCT02234843|20212583|P7|NOT COMPLETED|Overall Study||2
8197306|NCT02234843|20212584|P6|NOT COMPLETED|Overall Study||13
8197307|NCT02234843|20212585|P5|NOT COMPLETED|Overall Study||2
8197308|NCT02234843|20212586|P4|NOT COMPLETED|Overall Study||5
8197309|NCT02234843|20212587|P3|NOT COMPLETED|Overall Study||3
8197310|NCT02234843|20212588|P2|NOT COMPLETED|Overall Study||6
8197311|NCT02234843|20212589|P1|NOT COMPLETED|Overall Study||22
8197312|NCT02234843|20212580|P10|COMPLETED|Overall Study||8
8197313|NCT02234843|20212581|P9|COMPLETED|Overall Study||8
8197314|NCT02234843|20212582|P8|COMPLETED|Overall Study||20
8197315|NCT02234843|20212583|P7|COMPLETED|Overall Study||32
8197316|NCT02234843|20212584|P6|COMPLETED|Overall Study||79
8197317|NCT02234843|20212585|P5|COMPLETED|Overall Study||14
8197318|NCT02234843|20212586|P4|COMPLETED|Overall Study||16
8197319|NCT02234843|20212587|P3|COMPLETED|Overall Study||44
8197320|NCT02234843|20212588|P2|COMPLETED|Overall Study||61
8197321|NCT02234843|20212589|P1|COMPLETED|Overall Study||162
8197322|NCT02234843|20212580|P10|STARTED|Overall Study||8
8197323|NCT02234843|20212581|P9|STARTED|Overall Study||9
8197324|NCT02234843|20212582|P8|STARTED|Overall Study||22
8197325|NCT02234843|20212583|P7|STARTED|Overall Study||34
8197326|NCT02234843|20212584|P6|STARTED|Overall Study||92
8197327|NCT02234843|20212585|P5|STARTED|Overall Study||16
8197328|NCT02234843|20212586|P4|STARTED|Overall Study||21
8197329|NCT02234843|20212587|P3|STARTED|Overall Study||47
8197330|NCT02234843|20212588|P2|STARTED|Overall Study||67
8197331|NCT02234843|20212589|P1|STARTED|Overall Study||184
8197332|NCT02234752|20212696|P1|NOT COMPLETED|Overall Study||1
8197333|NCT02234752|20212696|P1|COMPLETED|Overall Study||2
8197334|NCT02234752|20212696|P1|STARTED|Overall Study||3
8197335|NCT02234713|20212709|P2|NOT COMPLETED|Overall Study||5
8197336|NCT02234713|20212710|P1|NOT COMPLETED|Overall Study||6
8197337|NCT02234713|20212709|P2|COMPLETED|Overall Study||27
8197338|NCT02234713|20212710|P1|COMPLETED|Overall Study||25
8197339|NCT02234713|20212709|P2|STARTED|Overall Study||32
8197340|NCT02234713|20212710|P1|STARTED|Overall Study||31
8197341|NCT02234687|20212735|P3|NOT COMPLETED|Overall Study||4
8197342|NCT02234687|20212736|P2|NOT COMPLETED|Overall Study||4
8197343|NCT02234687|20212737|P1|NOT COMPLETED|Overall Study||6
8197344|NCT02234687|20212735|P3|COMPLETED|Overall Study||0
8197345|NCT02234687|20212736|P2|COMPLETED|Overall Study||0
8197346|NCT02234687|20212737|P1|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
8197347|NCT02234687|20212735|P3|STARTED|Overall Study||4
8197348|NCT02234687|20212736|P2|STARTED|Overall Study||4
8197349|NCT02234687|20212737|P1|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
8197350|NCT02234622|20212747|P2|NOT COMPLETED|Overall Study||36
8197351|NCT02234622|20212748|P1|NOT COMPLETED|Overall Study||43
8197352|NCT02234622|20212747|P2|COMPLETED|Overall Study||68
8197353|NCT02234622|20212748|P1|COMPLETED|Overall Study||65
8197354|NCT02234622|20212747|P2|STARTED|Overall Study||104
8197355|NCT02234622|20212748|P1|STARTED|Overall Study||108
8197356|NCT02234596|20212766|P1|NOT COMPLETED|Overall Study||2
8197357|NCT02234596|20212766|P1|COMPLETED|Overall Study||32
8197358|NCT02234596|20212766|P1|STARTED|Overall Study||34
8197359|NCT02234583|20212774|P2|NOT COMPLETED|Overall Study||556
8197360|NCT02234583|20212775|P1|NOT COMPLETED|Overall Study||413
8197361|NCT02234583|20212774|P2|COMPLETED|Overall Study||685
8197362|NCT02234583|20212775|P1|COMPLETED|Overall Study||434
8197363|NCT02234583|20212774|P2|STARTED|Overall Study||1241
8197364|NCT02234583|20212775|P1|STARTED|Overall Study||847
8197365|NCT02234570|20212811|P8|NOT COMPLETED|Overall Study||0
8197366|NCT02234570|20212812|P7|NOT COMPLETED|Overall Study||0
8197367|NCT02234570|20212813|P6|NOT COMPLETED|Overall Study||0
8197368|NCT02234570|20212814|P5|NOT COMPLETED|Overall Study||0
8197369|NCT02234570|20212815|P4|NOT COMPLETED|Overall Study||0
8197370|NCT02234570|20212816|P3|NOT COMPLETED|Overall Study||0
8197371|NCT02234570|20212817|P2|NOT COMPLETED|Overall Study||0
8197372|NCT02234570|20212818|P1|NOT COMPLETED|Overall Study||0
8197373|NCT02234570|20212811|P8|COMPLETED|Overall Study||14
8197374|NCT02234570|20212812|P7|COMPLETED|Overall Study||8
8197375|NCT02234570|20212813|P6|COMPLETED|Overall Study||8
8197376|NCT02234570|20212814|P5|COMPLETED|Overall Study||8
8197377|NCT02234570|20212815|P4|COMPLETED|Overall Study||8
8197378|NCT02234570|20212816|P3|COMPLETED|Overall Study||8
8197379|NCT02234570|20212817|P2|COMPLETED|Overall Study||8
8197380|NCT02234570|20212818|P1|COMPLETED|Overall Study||8
8197381|NCT02234570|20212811|P8|STARTED|Overall Study||14
8197382|NCT02234570|20212812|P7|STARTED|Overall Study||8
8197383|NCT02234570|20212813|P6|STARTED|Overall Study||8
8197384|NCT02234570|20212814|P5|STARTED|Overall Study||8
8197385|NCT02234570|20212815|P4|STARTED|Overall Study||8
8197386|NCT02234570|20212816|P3|STARTED|Overall Study||8
8197387|NCT02234570|20212817|P2|STARTED|Overall Study||8
8197388|NCT02234570|20212818|P1|STARTED|Overall Study||8
8197389|NCT02234479|20212894|P2|NOT COMPLETED|Overall Study||3
8197390|NCT02234479|20212895|P1|NOT COMPLETED|Overall Study||1
8197391|NCT02234479|20212894|P2|COMPLETED|Overall Study||15
8197392|NCT02234479|20212895|P1|COMPLETED|Overall Study||15
8197393|NCT02234479|20212894|P2|STARTED|Overall Study||18
8197394|NCT02234479|20212895|P1|STARTED|Overall Study||16
8197395|NCT02234427|20212901|P1|NOT COMPLETED|Overall Study||1
8197396|NCT02234427|20212901|P1|COMPLETED|Overall Study|One individual withdrew after first visit|33
8197397|NCT02234427|20212901|P1|STARTED|Overall Study||34
8197398|NCT02234362|20212905|P1|NOT COMPLETED|Overall Study||26
8197399|NCT02234362|20212905|P1|COMPLETED|Overall Study||21
8197400|NCT02234362|20212905|P1|Received at Least One Dose of Medication|Overall Study||27
8197401|NCT02234362|20212905|P1|STARTED|Overall Study||47
8197402|NCT02234323|20212922|P1|NOT COMPLETED|All Treated||18
8197403|NCT02234323|20212922|P1|COMPLETED|All Treated||85
8197404|NCT02234323|20212922|P1|Immune Tolerance Induction (ITI)|All Treated|1/81 on episodic and 14/89 on prophylactic regimen had inhibitors and were switched directly to ITI.|15
8197405|NCT02234323|20212922|P1|Prophylactic Treatment Regimen|All Treated|69 participants among the 81 who started in episodic regimen, switched to the prophylactic regimen.|89
8197406|NCT02234323|20212922|P1|Episodic Treatment Regimen|All Treated|Participants were treated in more than one regimen and counted in all categories wherever applicable|81
8197407|NCT02234323|20212922|P1|STARTED|All Treated||103
8197408|NCT02234323|20212922|P1|NOT COMPLETED|All Enrolled||5
8197409|NCT02234323|20212922|P1|COMPLETED|All Enrolled|These participants received at least one dose of study drug.|103
8197410|NCT02234323|20212922|P1|STARTED|All Enrolled||108
8197411|NCT02234310|20212935|P1|NOT COMPLETED|Overall Study||6
8197412|NCT02234310|20212935|P1|COMPLETED|Overall Study||27
8197413|NCT02234310|20212935|P1|Prophylactic Treatment Regimen|Overall Study|17 participants among the 22 who started in episodic regimen, switched to the prophylactic regimen.|28
8197414|NCT02234310|20212935|P1|Episodic Treatment Regimen|Overall Study|Participants were treated in more than one regimen and counted in all categories wherever applicable|22
8197415|NCT02234310|20212935|P1|STARTED|Overall Study||33
8197416|NCT02234284|20212949|P2|NOT COMPLETED|Overall Study||9
8197417|NCT02234284|20212950|P1|NOT COMPLETED|Overall Study||25
8197418|NCT02234284|20212949|P2|COMPLETED|Overall Study||83
8197419|NCT02234284|20212950|P1|COMPLETED|Overall Study||75
8197420|NCT02234284|20212949|P2|STARTED|Overall Study||92
8197421|NCT02234284|20212950|P1|STARTED|Overall Study||100
8197422|NCT02234180|20212998|P2|NOT COMPLETED|Overall Study||0
8197423|NCT02234180|20212999|P1|NOT COMPLETED|Overall Study||0
8197424|NCT02234180|20212998|P2|COMPLETED|Overall Study||1
8197425|NCT02234180|20212999|P1|COMPLETED|Overall Study||2
8197426|NCT02234180|20212998|P2|STARTED|Overall Study||1
8197427|NCT02234180|20212999|P1|STARTED|Overall Study||2
8197428|NCT02234141|20213009|P7|NOT COMPLETED|Long-Term Treatment Period||10
8197429|NCT02234141|20213010|P6|NOT COMPLETED|Long-Term Treatment Period||12
8197430|NCT02234141|20213011|P5|NOT COMPLETED|Long-Term Treatment Period||10
8197431|NCT02234141|20213012|P4|NOT COMPLETED|Long-Term Treatment Period||0
8197432|NCT02234141|20213013|P3|NOT COMPLETED|Long-Term Treatment Period||33
8197433|NCT02234141|20213014|P2|NOT COMPLETED|Long-Term Treatment Period||31
8197434|NCT02234141|20213015|P1|NOT COMPLETED|Long-Term Treatment Period||33
8197435|NCT02234141|20213009|P7|COMPLETED|Long-Term Treatment Period||0
8197436|NCT02234141|20213010|P6|COMPLETED|Long-Term Treatment Period||0
8197437|NCT02234141|20213011|P5|COMPLETED|Long-Term Treatment Period||0
8197438|NCT02234141|20213012|P4|COMPLETED|Long-Term Treatment Period||0
8197439|NCT02234141|20213013|P3|COMPLETED|Long-Term Treatment Period||0
8197440|NCT02234141|20213014|P2|COMPLETED|Long-Term Treatment Period||0
8197441|NCT02234141|20213015|P1|COMPLETED|Long-Term Treatment Period||0
8197442|NCT02234141|20213009|P7|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
8197443|NCT02234141|20213010|P6|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12
8197444|NCT02234141|20213011|P5|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
8197445|NCT02234141|20213012|P4|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0
8197446|NCT02234141|20213013|P3|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
8197447|NCT02234141|20213014|P2|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31
8197448|NCT02234141|20213015|P1|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
8197449|NCT02234141|20213009|P7|NOT COMPLETED|Treatment Period (24 Weeks)||0
8197450|NCT02234141|20213010|P6|NOT COMPLETED|Treatment Period (24 Weeks)||0
8197451|NCT02234141|20213011|P5|NOT COMPLETED|Treatment Period (24 Weeks)||0
8197452|NCT02234141|20213012|P4|NOT COMPLETED|Treatment Period (24 Weeks)||5
8197453|NCT02234141|20213013|P3|NOT COMPLETED|Treatment Period (24 Weeks)||2
8197454|NCT02234141|20213014|P2|NOT COMPLETED|Treatment Period (24 Weeks)||6
8197455|NCT02234141|20213015|P1|NOT COMPLETED|Treatment Period (24 Weeks)||4
8197456|NCT02234141|20213009|P7|COMPLETED|Treatment Period (24 Weeks)||0
8197457|NCT02234141|20213010|P6|COMPLETED|Treatment Period (24 Weeks)||0
8197458|NCT02234141|20213011|P5|COMPLETED|Treatment Period (24 Weeks)||0
8197459|NCT02234141|20213012|P4|COMPLETED|Treatment Period (24 Weeks)||32
8197460|NCT02234141|20213013|P3|COMPLETED|Treatment Period (24 Weeks)||35
8197461|NCT02234141|20213014|P2|COMPLETED|Treatment Period (24 Weeks)||32
8197462|NCT02234141|20213015|P1|COMPLETED|Treatment Period (24 Weeks)||35
8197463|NCT02234141|20213009|P7|STARTED|Treatment Period (24 Weeks)||0
8197464|NCT02234141|20213010|P6|STARTED|Treatment Period (24 Weeks)||0
8197465|NCT02234141|20213011|P5|STARTED|Treatment Period (24 Weeks)||0
8197466|NCT02234141|20213012|P4|STARTED|Treatment Period (24 Weeks)||37
8197467|NCT02234141|20213013|P3|STARTED|Treatment Period (24 Weeks)||37
8197468|NCT02234141|20213014|P2|STARTED|Treatment Period (24 Weeks)||38
8197469|NCT02234141|20213015|P1|STARTED|Treatment Period (24 Weeks)||39
8197470|NCT02234128|20213100|P3|NOT COMPLETED|Overall Study||4
8197471|NCT02234128|20213101|P2|NOT COMPLETED|Overall Study||2
8197472|NCT02234128|20213102|P1|NOT COMPLETED|Overall Study||5
8197473|NCT02234128|20213100|P3|COMPLETED|Overall Study||48
8197474|NCT02234128|20213101|P2|COMPLETED|Overall Study||29
8197475|NCT02234128|20213102|P1|COMPLETED|Overall Study||30
8197476|NCT02234128|20213100|P3|STARTED|Overall Study||52
8197477|NCT02234128|20213101|P2|STARTED|Overall Study||31
8197478|NCT02234128|20213102|P1|STARTED|Overall Study||35
8197479|NCT02234115|20213113|P1|NOT COMPLETED|Overall Study||15
8197480|NCT02234115|20213113|P1|COMPLETED|Overall Study||122
8197481|NCT02234115|20213113|P1|PK Subgroup|Overall Study||31
8197482|NCT02234115|20213113|P1|PP|Overall Study||124
8197483|NCT02234115|20213113|P1|ITT|Overall Study||137
8197484|NCT02234115|20213113|P1|STARTED|Overall Study||137
8197485|NCT02234063|20213120|P2|NOT COMPLETED|Overall Study||43
8197486|NCT02234063|20213121|P1|NOT COMPLETED|Overall Study||255
8197487|NCT02234063|20213120|P2|COMPLETED|Overall Study||212
8197488|NCT02234063|20213121|P1|COMPLETED|Overall Study||1540
8197489|NCT02234063|20213120|P2|STARTED|Overall Study||255
8197490|NCT02234063|20213121|P1|STARTED|Overall Study||1795
8197491|NCT02234011|20213141|P1|NOT COMPLETED|Overall Study||0
8197492|NCT02234011|20213141|P1|COMPLETED|Overall Study||0
8197493|NCT02234011|20213141|P1|STARTED|Overall Study||0
8197494|NCT02233998|20213148|P3|NOT COMPLETED|Overall Study||0
8197495|NCT02233998|20213149|P2|NOT COMPLETED|Overall Study||0
8197496|NCT02233998|20213150|P1|NOT COMPLETED|Overall Study||0
8197497|NCT02233998|20213148|P3|COMPLETED|Overall Study||53
8197498|NCT02233998|20213149|P2|COMPLETED|Overall Study||52
8197499|NCT02233998|20213150|P1|COMPLETED|Overall Study||53
8197500|NCT02233998|20213148|P3|STARTED|Overall Study||53
8197501|NCT02233998|20213149|P2|STARTED|Overall Study||52
8197502|NCT02233998|20213150|P1|STARTED|Overall Study||53
8197503|NCT02233985|20213184|P2|NOT COMPLETED|Overall Study||0
8197504|NCT02233985|20213185|P1|NOT COMPLETED|Overall Study||0
8197505|NCT02233985|20213184|P2|COMPLETED|Overall Study||31
8197506|NCT02233985|20213185|P1|COMPLETED|Overall Study||33
8197507|NCT02233985|20213184|P2|STARTED|Overall Study||31
8197508|NCT02233985|20213185|P1|STARTED|Overall Study||33
8197509|NCT02233842|20213193|P1|NOT COMPLETED|Questionnaire 3 Version 2||0
8197510|NCT02233842|20213193|P1|COMPLETED|Questionnaire 3 Version 2||5
8197511|NCT02233842|20213193|P1|STARTED|Questionnaire 3 Version 2||5
8197512|NCT02233842|20213193|P1|NOT COMPLETED|Questionnaire 3 Version 1||0
8197513|NCT02233842|20213193|P1|COMPLETED|Questionnaire 3 Version 1||5
8197514|NCT02233842|20213193|P1|STARTED|Questionnaire 3 Version 1||5
8197515|NCT02233842|20213193|P1|NOT COMPLETED|Questionnaire 2 Version 2||0
8197516|NCT02233842|20213193|P1|COMPLETED|Questionnaire 2 Version 2||5
8197517|NCT02233842|20213193|P1|STARTED|Questionnaire 2 Version 2||5
8197518|NCT02233842|20213193|P1|NOT COMPLETED|Questionnaire 2 Version 1||0
8197519|NCT02233842|20213193|P1|COMPLETED|Questionnaire 2 Version 1||5
8197520|NCT02233842|20213193|P1|STARTED|Questionnaire 2 Version 1||5
8197521|NCT02233842|20213193|P1|NOT COMPLETED|Questionnaire 1 Version 2||0
8197522|NCT02233842|20213193|P1|COMPLETED|Questionnaire 1 Version 2||5
8197523|NCT02233842|20213193|P1|STARTED|Questionnaire 1 Version 2||5
8197524|NCT02233842|20213193|P1|NOT COMPLETED|Questionnaire 1 Version 1||0
8197525|NCT02233842|20213193|P1|COMPLETED|Questionnaire 1 Version 1||5
8197526|NCT02233842|20213193|P1|STARTED|Questionnaire 1 Version 1||5
8197527|NCT02233803|20213200|P2|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
8197528|NCT02233803|20213201|P1|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
8197529|NCT02233803|20213200|P2|COMPLETED|Treatment Period 2 (4-Wks)||91
8197530|NCT02233803|20213201|P1|COMPLETED|Treatment Period 2 (4-Wks)||93
8197531|NCT02233803|20213200|P2|STARTED|Treatment Period 2 (4-Wks)||93
8197532|NCT02233803|20213201|P1|STARTED|Treatment Period 2 (4-Wks)||95
8197533|NCT02233803|20213200|P2|NOT COMPLETED|Washout Period (4-Wks)||2
8197534|NCT02233803|20213201|P1|NOT COMPLETED|Washout Period (4-Wks)||2
8197535|NCT02233803|20213200|P2|COMPLETED|Washout Period (4-Wks)||93
8197536|NCT02233803|20213201|P1|COMPLETED|Washout Period (4-Wks)||95
8197537|NCT02233803|20213200|P2|STARTED|Washout Period (4-Wks)||95
8197538|NCT02233803|20213201|P1|STARTED|Washout Period (4-Wks)||97
8197539|NCT02233803|20213200|P2|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
8197540|NCT02233803|20213201|P1|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
8197541|NCT02233803|20213200|P2|COMPLETED|Treatment Period 1 (4-Wks)||95
8197542|NCT02233803|20213201|P1|COMPLETED|Treatment Period 1 (4-Wks)||97
8197543|NCT02233803|20213200|P2|STARTED|Treatment Period 1 (4-Wks)||99
8197544|NCT02233803|20213201|P1|STARTED|Treatment Period 1 (4-Wks)||100
8197545|NCT02233751|20213213|P2|NOT COMPLETED|Overall Study||0
8197546|NCT02233751|20213214|P1|NOT COMPLETED|Overall Study||0
8197547|NCT02233751|20213213|P2|COMPLETED|Overall Study||6
8197548|NCT02233751|20213214|P1|COMPLETED|Overall Study||6
8197549|NCT02233751|20213213|P2|STARTED|Overall Study||6
8197550|NCT02233751|20213214|P1|STARTED|Overall Study||6
8197551|NCT02233738|20213234|P2|NOT COMPLETED|Overall Study||16
8197552|NCT02233738|20213235|P1|NOT COMPLETED|Overall Study||8
8197553|NCT02233738|20213234|P2|COMPLETED|Overall Study||75
8197554|NCT02233738|20213235|P1|COMPLETED|Overall Study||85
8197555|NCT02233738|20213234|P2|6 Month Follow-Up|Overall Study||75
8197556|NCT02233738|20213235|P1|6 Month Follow-Up|Overall Study||85
8197557|NCT02233738|20213234|P2|3 Month Follow-Up|Overall Study||77
8197558|NCT02233738|20213235|P1|3 Month Follow-Up|Overall Study||87
8197559|NCT02233738|20213234|P2|1 Month Follow-Up|Overall Study||82
8197560|NCT02233738|20213235|P1|1 Month Follow-Up|Overall Study||89
8197561|NCT02233738|20213234|P2|STARTED|Overall Study||91
8197562|NCT02233738|20213235|P1|STARTED|Overall Study||93
8197563|NCT02233647|20213405|P1|NOT COMPLETED|Overall Study||1
8197564|NCT02233647|20213405|P1|COMPLETED|Overall Study||10
8197565|NCT02233647|20213405|P1|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
8197566|NCT02233647|20213405|P1|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
8197567|NCT02233647|20213405|P1|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
8197568|NCT02233647|20213405|P1|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
8197569|NCT02233647|20213405|P1|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
8197570|NCT02233647|20213405|P1|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
8197571|NCT02233647|20213405|P1|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
8197572|NCT02233647|20213405|P1|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
8197573|NCT02233647|20213405|P1|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
8197574|NCT02233647|20213405|P1|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
8197575|NCT02233647|20213405|P1|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8197576|NCT02233647|20213405|P1|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8197577|NCT02233647|20213405|P1|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8197578|NCT02233647|20213405|P1|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8197579|NCT02233647|20213405|P1|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
8197580|NCT02233647|20213405|P1|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
8197581|NCT02233647|20213405|P1|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
8197582|NCT02233647|20213405|P1|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
8197583|NCT02233647|20213405|P1|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
8197584|NCT02233647|20213405|P1|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
8197585|NCT02233647|20213405|P1|STARTED|Overall Study||11
8197586|NCT02233543|20213434|P2|NOT COMPLETED|Period 2||1
8197587|NCT02233543|20213435|P1|NOT COMPLETED|Period 2||2
8197588|NCT02233543|20213434|P2|COMPLETED|Period 2||12
8197589|NCT02233543|20213435|P1|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
8197590|NCT02233543|20213434|P2|STARTED|Period 2||13
8197591|NCT02233543|20213435|P1|STARTED|Period 2||19
8197592|NCT02233543|20213434|P2|NOT COMPLETED|Period 1||3
8197593|NCT02233543|20213435|P1|NOT COMPLETED|Period 1||3
8197594|NCT02233543|20213434|P2|COMPLETED|Period 1||13
8197595|NCT02233543|20213435|P1|COMPLETED|Period 1||19
8197596|NCT02233543|20213434|P2|STARTED|Period 1||16
8197597|NCT02233543|20213435|P1|STARTED|Period 1||22
8197598|NCT02233517|20213445|P2|NOT COMPLETED|Overall Study||4
8197599|NCT02233517|20213446|P1|NOT COMPLETED|Overall Study||7
8197600|NCT02233517|20213445|P2|COMPLETED|Overall Study||13
8197601|NCT02233517|20213446|P1|COMPLETED|Overall Study||12
8197602|NCT02233517|20213445|P2|STARTED|Overall Study||17
8197603|NCT02233517|20213446|P1|STARTED|Overall Study||19
8197604|NCT02233478|20213472|P6|NOT COMPLETED|Third Intervention (1 Day)||0
8197605|NCT02233478|20213473|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8197606|NCT02233478|20213474|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8197607|NCT02233478|20213475|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8197608|NCT02233478|20213476|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8197609|NCT02233478|20213477|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8197610|NCT02233478|20213472|P6|COMPLETED|Third Intervention (1 Day)||3
8197611|NCT02233478|20213473|P5|COMPLETED|Third Intervention (1 Day)||3
8197612|NCT02233478|20213474|P4|COMPLETED|Third Intervention (1 Day)||3
8197613|NCT02233478|20213475|P3|COMPLETED|Third Intervention (1 Day)||3
8197614|NCT02233478|20213476|P2|COMPLETED|Third Intervention (1 Day)||3
8197615|NCT02233478|20213477|P1|COMPLETED|Third Intervention (1 Day)||3
8197616|NCT02233478|20213472|P6|STARTED|Third Intervention (1 Day)||3
8197617|NCT02233478|20213473|P5|STARTED|Third Intervention (1 Day)||3
8197618|NCT02233478|20213474|P4|STARTED|Third Intervention (1 Day)||3
8197619|NCT02233478|20213475|P3|STARTED|Third Intervention (1 Day)||3
8197620|NCT02233478|20213476|P2|STARTED|Third Intervention (1 Day)||3
8197621|NCT02233478|20213477|P1|STARTED|Third Intervention (1 Day)||3
8197622|NCT02233478|20213472|P6|NOT COMPLETED|Washout (7 Days)||0
8197623|NCT02233478|20213473|P5|NOT COMPLETED|Washout (7 Days)||0
8197624|NCT02233478|20213474|P4|NOT COMPLETED|Washout (7 Days)||0
8197625|NCT02233478|20213475|P3|NOT COMPLETED|Washout (7 Days)||0
8197626|NCT02233478|20213476|P2|NOT COMPLETED|Washout (7 Days)||0
8197627|NCT02233478|20213477|P1|NOT COMPLETED|Washout (7 Days)||0
8197628|NCT02233478|20213472|P6|COMPLETED|Washout (7 Days)||3
8197629|NCT02233478|20213473|P5|COMPLETED|Washout (7 Days)||3
8197630|NCT02233478|20213474|P4|COMPLETED|Washout (7 Days)||3
8197631|NCT02233478|20213475|P3|COMPLETED|Washout (7 Days)||3
8197632|NCT02233478|20213476|P2|COMPLETED|Washout (7 Days)||3
8197633|NCT02233478|20213477|P1|COMPLETED|Washout (7 Days)||3
8197634|NCT02233478|20213472|P6|STARTED|Washout (7 Days)||3
8197635|NCT02233478|20213473|P5|STARTED|Washout (7 Days)||3
8197636|NCT02233478|20213474|P4|STARTED|Washout (7 Days)||3
8197637|NCT02233478|20213475|P3|STARTED|Washout (7 Days)||3
8197638|NCT02233478|20213476|P2|STARTED|Washout (7 Days)||3
8197639|NCT02233478|20213477|P1|STARTED|Washout (7 Days)||3
8197640|NCT02233478|20213472|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8197641|NCT02233478|20213473|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8197642|NCT02233478|20213474|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8197643|NCT02233478|20213475|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8197644|NCT02233478|20213476|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8197645|NCT02233478|20213477|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8197646|NCT02233478|20213472|P6|COMPLETED|Second Intervention (1 Day)||3
8197647|NCT02233478|20213473|P5|COMPLETED|Second Intervention (1 Day)||3
8197648|NCT02233478|20213474|P4|COMPLETED|Second Intervention (1 Day)||3
8197649|NCT02233478|20213475|P3|COMPLETED|Second Intervention (1 Day)||3
8197650|NCT02233478|20213476|P2|COMPLETED|Second Intervention (1 Day)||3
8197651|NCT02233478|20213477|P1|COMPLETED|Second Intervention (1 Day)||3
8197652|NCT02233478|20213472|P6|STARTED|Second Intervention (1 Day)||3
8197653|NCT02233478|20213473|P5|STARTED|Second Intervention (1 Day)||3
8197654|NCT02233478|20213474|P4|STARTED|Second Intervention (1 Day)||3
8197655|NCT02233478|20213475|P3|STARTED|Second Intervention (1 Day)||3
8197656|NCT02233478|20213476|P2|STARTED|Second Intervention (1 Day)||3
8197657|NCT02233478|20213477|P1|STARTED|Second Intervention (1 Day)||3
8197658|NCT02233478|20213472|P6|NOT COMPLETED|Washout (7 Days)||0
8197659|NCT02233478|20213473|P5|NOT COMPLETED|Washout (7 Days)||0
8197660|NCT02233478|20213474|P4|NOT COMPLETED|Washout (7 Days)||0
8197661|NCT02233478|20213475|P3|NOT COMPLETED|Washout (7 Days)||0
8197662|NCT02233478|20213476|P2|NOT COMPLETED|Washout (7 Days)||0
8197663|NCT02233478|20213477|P1|NOT COMPLETED|Washout (7 Days)||0
8197664|NCT02233478|20213472|P6|COMPLETED|Washout (7 Days)||3
8197665|NCT02233478|20213473|P5|COMPLETED|Washout (7 Days)||3
8197666|NCT02233478|20213474|P4|COMPLETED|Washout (7 Days)||3
8197667|NCT02233478|20213475|P3|COMPLETED|Washout (7 Days)||3
8197668|NCT02233478|20213476|P2|COMPLETED|Washout (7 Days)||3
8197669|NCT02233478|20213477|P1|COMPLETED|Washout (7 Days)||3
8197670|NCT02233478|20213472|P6|STARTED|Washout (7 Days)||3
8197671|NCT02233478|20213473|P5|STARTED|Washout (7 Days)||3
8197672|NCT02233478|20213474|P4|STARTED|Washout (7 Days)||3
8197673|NCT02233478|20213475|P3|STARTED|Washout (7 Days)||3
8197674|NCT02233478|20213476|P2|STARTED|Washout (7 Days)||3
8197675|NCT02233478|20213477|P1|STARTED|Washout (7 Days)||3
8197676|NCT02233478|20213472|P6|NOT COMPLETED|First Intervention (1 Day)||0
8197677|NCT02233478|20213473|P5|NOT COMPLETED|First Intervention (1 Day)||0
8197678|NCT02233478|20213474|P4|NOT COMPLETED|First Intervention (1 Day)||0
8197679|NCT02233478|20213475|P3|NOT COMPLETED|First Intervention (1 Day)||0
8197680|NCT02233478|20213476|P2|NOT COMPLETED|First Intervention (1 Day)||0
8197681|NCT02233478|20213477|P1|NOT COMPLETED|First Intervention (1 Day)||0
8197682|NCT02233478|20213472|P6|COMPLETED|First Intervention (1 Day)||3
8197683|NCT02233478|20213473|P5|COMPLETED|First Intervention (1 Day)||3
8197684|NCT02233478|20213474|P4|COMPLETED|First Intervention (1 Day)||3
8197685|NCT02233478|20213475|P3|COMPLETED|First Intervention (1 Day)||3
8197686|NCT02233478|20213476|P2|COMPLETED|First Intervention (1 Day)||3
8197687|NCT02233478|20213477|P1|COMPLETED|First Intervention (1 Day)||3
8197688|NCT02233478|20213472|P6|STARTED|First Intervention (1 Day)||3
8197689|NCT02233478|20213473|P5|STARTED|First Intervention (1 Day)||3
8197690|NCT02233478|20213474|P4|STARTED|First Intervention (1 Day)||3
8197691|NCT02233478|20213475|P3|STARTED|First Intervention (1 Day)||3
8197692|NCT02233478|20213476|P2|STARTED|First Intervention (1 Day)||3
8197693|NCT02233478|20213477|P1|STARTED|First Intervention (1 Day)||3
8197694|NCT02233413|20213487|P2|NOT COMPLETED|Overall Study||14
8197695|NCT02233413|20213488|P1|NOT COMPLETED|Overall Study||11
8197696|NCT02233413|20213487|P2|COMPLETED|Overall Study||19
8197697|NCT02233413|20213488|P1|COMPLETED|Overall Study||24
8197698|NCT02233413|20213487|P2|STARTED|Overall Study||33
8197699|NCT02233413|20213488|P1|STARTED|Overall Study||35
8197700|NCT02233309|20213500|P1|NOT COMPLETED|Overall Study||5
8197701|NCT02233309|20213500|P1|COMPLETED|Overall Study||31
8197702|NCT02233309|20213500|P1|STARTED|Overall Study||36
8197703|NCT02233296|20213506|P2|NOT COMPLETED|Overall Study||0
8197704|NCT02233296|20213507|P1|NOT COMPLETED|Overall Study||0
8197705|NCT02233296|20213506|P2|COMPLETED|Overall Study||14
8197706|NCT02233296|20213507|P1|COMPLETED|Overall Study||16
8197707|NCT02233296|20213506|P2|STARTED|Overall Study||14
8197708|NCT02233296|20213507|P1|STARTED|Overall Study||16
8197709|NCT02233101|20213525|P2|NOT COMPLETED|Overall Study||1
8197710|NCT02233101|20213526|P1|NOT COMPLETED|Overall Study||12
8197711|NCT02233101|20213525|P2|COMPLETED|Overall Study||80
8197712|NCT02233101|20213526|P1|COMPLETED|Overall Study||74
8197713|NCT02233101|20213525|P2|STARTED|Overall Study||81
8197714|NCT02233101|20213526|P1|STARTED|Overall Study||86
8197715|NCT02232984|20213534|P1|NOT COMPLETED|Overall Study||77
8197716|NCT02232984|20213534|P1|COMPLETED|Overall Study|Total number of subjects who completed study|672
8197717|NCT02232984|20213534|P1|Successfully Implanted|Overall Study|Successfully implanted subjects|675
8197718|NCT02232984|20213534|P1|STARTED|Overall Study|Enrolled subjects|749
8197719|NCT02232893|20213545|P2|NOT COMPLETED|Overall Study||7
8197720|NCT02232893|20213546|P1|NOT COMPLETED|Overall Study||4
8197721|NCT02232893|20213545|P2|COMPLETED|Overall Study||27
8197722|NCT02232893|20213546|P1|COMPLETED|Overall Study||31
8197723|NCT02232893|20213545|P2|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|19
8197724|NCT02232893|20213546|P1|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|24
8197725|NCT02232893|20213545|P2|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|32
8197726|NCT02232893|20213546|P1|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|34
8197727|NCT02232893|20213545|P2|STARTED|Overall Study||34
8197728|NCT02232893|20213546|P1|STARTED|Overall Study||35
8197729|NCT02232880|20213552|P1|NOT COMPLETED|Overall Study||1
8197730|NCT02232880|20213552|P1|COMPLETED|Overall Study||0
8197731|NCT02232880|20213552|P1|STARTED|Overall Study||1
8197732|NCT02232802|20213561|P2|NOT COMPLETED|Washout||0
8197733|NCT02232802|20213562|P1|NOT COMPLETED|Washout||0
8197734|NCT02232802|20213561|P2|COMPLETED|Washout||22
8197735|NCT02232802|20213562|P1|COMPLETED|Washout||22
8197736|NCT02232802|20213561|P2|STARTED|Washout||22
8197737|NCT02232802|20213562|P1|STARTED|Washout||22
8197738|NCT02232802|20213561|P2|NOT COMPLETED|Period 2||0
8197739|NCT02232802|20213562|P1|NOT COMPLETED|Period 2||0
8197740|NCT02232802|20213561|P2|COMPLETED|Period 2||22
8197741|NCT02232802|20213562|P1|COMPLETED|Period 2||22
8197742|NCT02232802|20213561|P2|STARTED|Period 2||22
8197743|NCT02232802|20213562|P1|STARTED|Period 2||22
8197744|NCT02232802|20213561|P2|NOT COMPLETED|Washout||0
8197745|NCT02232802|20213562|P1|NOT COMPLETED|Washout||0
8197746|NCT02232802|20213561|P2|COMPLETED|Washout||22
8197747|NCT02232802|20213562|P1|COMPLETED|Washout||22
8197748|NCT02232802|20213561|P2|STARTED|Washout||22
8197749|NCT02232802|20213562|P1|STARTED|Washout||22
8197750|NCT02232802|20213561|P2|NOT COMPLETED|Period 1||1
8197751|NCT02232802|20213562|P1|NOT COMPLETED|Period 1||2
8197752|NCT02232802|20213561|P2|COMPLETED|Period 1||22
8197753|NCT02232802|20213562|P1|COMPLETED|Period 1||22
8197754|NCT02232802|20213561|P2|STARTED|Period 1||23
8197755|NCT02232802|20213562|P1|STARTED|Period 1||24
8197756|NCT02232698|20213628|P2|NOT COMPLETED|Overall Study||20
8197757|NCT02232698|20213629|P1|NOT COMPLETED|Overall Study||10
8197758|NCT02232698|20213628|P2|COMPLETED|Overall Study||101
8197759|NCT02232698|20213629|P1|COMPLETED|Overall Study||110
8197760|NCT02232698|20213628|P2|STARTED|Overall Study||121
8197761|NCT02232698|20213629|P1|STARTED|Overall Study||120
8197762|NCT02232425|20213652|P2|NOT COMPLETED|Overall Study||8
8197763|NCT02232425|20213653|P1|NOT COMPLETED|Overall Study||14
8197764|NCT02232425|20213652|P2|COMPLETED|Overall Study||22
8197765|NCT02232425|20213653|P1|COMPLETED|Overall Study||44
8197766|NCT02232425|20213652|P2|STARTED|Overall Study||30
8197767|NCT02232425|20213653|P1|STARTED|Overall Study||58
8197795|NCT02232178|20213700|P3|NOT COMPLETED|Overall Study||1
8197796|NCT02232178|20213701|P2|NOT COMPLETED|Overall Study||1
8197797|NCT02232178|20213702|P1|NOT COMPLETED|Overall Study||1
8197798|NCT02232178|20213700|P3|COMPLETED|Overall Study||12
8197799|NCT02232178|20213701|P2|COMPLETED|Overall Study||24
8197800|NCT02232178|20213702|P1|COMPLETED|Overall Study||25
8197801|NCT02232178|20213700|P3|Safety Population|Overall Study||12
8197802|NCT02232178|20213701|P2|Safety Population|Overall Study||24
8197803|NCT02232178|20213702|P1|Safety Population|Overall Study||26
8197804|NCT02232178|20213700|P3|Per Protocol PK Population|Overall Study||11
8197805|NCT02232178|20213701|P2|Per Protocol PK Population|Overall Study||24
8197806|NCT02232178|20213702|P1|Per Protocol PK Population|Overall Study||26
8197807|NCT02232178|20213700|P3|STARTED|Overall Study||13
8197808|NCT02232178|20213701|P2|STARTED|Overall Study||25
8197809|NCT02232178|20213702|P1|STARTED|Overall Study||26
8197810|NCT02232126|20213721|P2|NOT COMPLETED|Overall Study||0
8197811|NCT02232126|20213722|P1|NOT COMPLETED|Overall Study||0
8197812|NCT02232126|20213721|P2|COMPLETED|Overall Study||90
8197813|NCT02232126|20213722|P1|COMPLETED|Overall Study||91
8197814|NCT02232126|20213721|P2|STARTED|Overall Study||90
8197815|NCT02232126|20213722|P1|STARTED|Overall Study||91
8197816|NCT02232087|20213730|P6|NOT COMPLETED|Overall Study||3
8197817|NCT02232087|20213731|P5|NOT COMPLETED|Overall Study||1
8197818|NCT02232087|20213732|P4|NOT COMPLETED|Overall Study||1
8197819|NCT02232087|20213733|P3|NOT COMPLETED|Overall Study||0
8197820|NCT02232087|20213734|P2|NOT COMPLETED|Overall Study||2
8197821|NCT02232087|20213735|P1|NOT COMPLETED|Overall Study||2
8197822|NCT02232087|20213730|P6|COMPLETED|Overall Study||6
8197823|NCT02232087|20213731|P5|COMPLETED|Overall Study||7
8197824|NCT02232087|20213732|P4|COMPLETED|Overall Study||7
8197825|NCT02232087|20213733|P3|COMPLETED|Overall Study||8
8197826|NCT02232087|20213734|P2|COMPLETED|Overall Study||8
8197827|NCT02232087|20213735|P1|COMPLETED|Overall Study||7
8197828|NCT02232087|20213730|P6|STARTED|Overall Study||9
8197829|NCT02232087|20213731|P5|STARTED|Overall Study||8
8197830|NCT02232087|20213732|P4|STARTED|Overall Study||8
8197831|NCT02232087|20213733|P3|STARTED|Overall Study||8
8197832|NCT02232087|20213734|P2|STARTED|Overall Study||10
8197833|NCT02232087|20213735|P1|STARTED|Overall Study||9
8197834|NCT02232074|20213771|P2|NOT COMPLETED|Overall Study||45
8197835|NCT02232074|20213772|P1|NOT COMPLETED|Overall Study||41
8197836|NCT02232074|20213771|P2|COMPLETED|Overall Study||107
8197837|NCT02232074|20213772|P1|COMPLETED|Overall Study||113
8197838|NCT02232074|20213771|P2|STARTED|Overall Study||152
8197839|NCT02232074|20213772|P1|STARTED|Overall Study||154
8197840|NCT02232022|20213818|P1|NOT COMPLETED|Overall Study||2
8197841|NCT02232022|20213818|P1|COMPLETED|Overall Study||51
8197842|NCT02232022|20213818|P1|STARTED|Overall Study||53
8197843|NCT02232009|20213827|P1|NOT COMPLETED|Overall Study||0
8197844|NCT02232009|20213827|P1|COMPLETED|Overall Study||9
8197845|NCT02232009|20213827|P1|STARTED|Overall Study||9
8197846|NCT02231918|20213839|P3|NOT COMPLETED|Overall Study||1
8197847|NCT02231918|20213840|P2|NOT COMPLETED|Overall Study||1
8197848|NCT02231918|20213841|P1|NOT COMPLETED|Overall Study||0
8197849|NCT02231918|20213839|P3|COMPLETED|Overall Study||1
8197850|NCT02231918|20213840|P2|COMPLETED|Overall Study||14
8197851|NCT02231918|20213841|P1|COMPLETED|Overall Study||9
8197852|NCT02231918|20213839|P3|STARTED|Overall Study||2
8197853|NCT02231918|20213840|P2|STARTED|Overall Study||15
8197854|NCT02231918|20213841|P1|STARTED|Overall Study||9
8197855|NCT02231892|20213906|P3|NOT COMPLETED|Overall Study||45
8197856|NCT02231892|20213907|P2|NOT COMPLETED|Overall Study||12
8197857|NCT02231892|20213908|P1|NOT COMPLETED|Overall Study||11
8197858|NCT02231892|20213906|P3|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency Beh phase, but are only counted in Hi Freq MRI.|25
8197859|NCT02231892|20213907|P2|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency MRI phase, but are only counted in Hi Freq MRI.|5
8197860|NCT02231892|20213908|P1|COMPLETED|Overall Study||6
8197861|NCT02231892|20213906|P3|110% MT|Overall Study||27
8197862|NCT02231892|20213907|P2|110% MT|Overall Study||5
8197863|NCT02231892|20213908|P1|110% MT|Overall Study||7
8197864|NCT02231892|20213906|P3|100% MT|Overall Study||25
8197865|NCT02231892|20213907|P2|100% MT|Overall Study||6
8197866|NCT02231892|20213908|P1|100% MT|Overall Study||7
8197867|NCT02231892|20213906|P3|Sham|Overall Study||26
8197868|NCT02231892|20213907|P2|Sham|Overall Study||5
8197869|NCT02231892|20213908|P1|Sham|Overall Study||8
8197870|NCT02231892|20213906|P3|STARTED|Overall Study||70
8197871|NCT02231892|20213907|P2|STARTED|Overall Study||17
8197872|NCT02231892|20213908|P1|STARTED|Overall Study||17
8197873|NCT02231762|20213925|P4|NOT COMPLETED|Maintenance Phase||5
8197874|NCT02231762|20213926|P3|NOT COMPLETED|Maintenance Phase||5
8197875|NCT02231762|20213927|P2|NOT COMPLETED|Maintenance Phase||3
8197876|NCT02231762|20213928|P1|NOT COMPLETED|Maintenance Phase||0
8197877|NCT02231762|20213925|P4|COMPLETED|Maintenance Phase||7
8197878|NCT02231762|20213926|P3|COMPLETED|Maintenance Phase||9
8197879|NCT02231762|20213927|P2|COMPLETED|Maintenance Phase||8
8197880|NCT02231762|20213928|P1|COMPLETED|Maintenance Phase||0
8197881|NCT02231762|20213925|P4|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12
8197882|NCT02231762|20213926|P3|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14
8197883|NCT02231762|20213927|P2|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11
8197884|NCT02231762|20213928|P1|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0
8197885|NCT02231762|20213925|P4|NOT COMPLETED|Combination Phase||0
8197886|NCT02231762|20213926|P3|NOT COMPLETED|Combination Phase||0
8197887|NCT02231762|20213927|P2|NOT COMPLETED|Combination Phase||0
8197888|NCT02231762|20213928|P1|NOT COMPLETED|Combination Phase||20
8197889|NCT02231762|20213925|P4|COMPLETED|Combination Phase||0
8197890|NCT02231762|20213926|P3|COMPLETED|Combination Phase||0
8197891|NCT02231762|20213927|P2|COMPLETED|Combination Phase||0
8197892|NCT02231762|20213928|P1|COMPLETED|Combination Phase||37
8197893|NCT02231762|20213925|P4|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
8197894|NCT02231762|20213926|P3|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
8197895|NCT02231762|20213927|P2|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
8197896|NCT02231762|20213928|P1|STARTED|Combination Phase||57
8197897|NCT02231749|20213961|P2|NOT COMPLETED|Overall Study||449
8197898|NCT02231749|20213962|P1|NOT COMPLETED|Overall Study||422
8197899|NCT02231749|20213961|P2|COMPLETED|Overall Study||97
8197900|NCT02231749|20213962|P1|COMPLETED|Overall Study||128
8197901|NCT02231749|20213961|P2|Received Treatment|Overall Study||535
8197902|NCT02231749|20213962|P1|Received Treatment|Overall Study||547
8197903|NCT02231749|20213961|P2|STARTED|Overall Study||546
8197904|NCT02231749|20213962|P1|STARTED|Overall Study||550
8197905|NCT02231580|20213980|P2|NOT COMPLETED|Overall Study||0
8197906|NCT02231580|20213981|P1|NOT COMPLETED|Overall Study||5
8197907|NCT02231580|20213980|P2|COMPLETED|Overall Study||3
8197908|NCT02231580|20213981|P1|COMPLETED|Overall Study||9
8197909|NCT02231580|20213980|P2|Cohort 2|Overall Study||1
8197910|NCT02231580|20213981|P1|Cohort 2|Overall Study||6
8197911|NCT02231580|20213980|P2|Cohort 1|Overall Study||2
8197912|NCT02231580|20213981|P1|Cohort 1|Overall Study||8
8197913|NCT02231580|20213980|P2|STARTED|Overall Study||3
8197914|NCT02231580|20213981|P1|STARTED|Overall Study||14
8197915|NCT02231177|20214037|P6|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8197916|NCT02231177|20214038|P5|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8197917|NCT02231177|20214039|P4|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8197918|NCT02231177|20214040|P3|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8197919|NCT02231177|20214041|P2|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8197920|NCT02231177|20214042|P1|NOT COMPLETED|Treatment Period 3 (21 Days)||0
8197921|NCT02231177|20214037|P6|COMPLETED|Treatment Period 3 (21 Days)||9
8197922|NCT02231177|20214038|P5|COMPLETED|Treatment Period 3 (21 Days)||8
8197923|NCT02231177|20214039|P4|COMPLETED|Treatment Period 3 (21 Days)||7
8197924|NCT02231177|20214040|P3|COMPLETED|Treatment Period 3 (21 Days)||8
8197925|NCT02231177|20214041|P2|COMPLETED|Treatment Period 3 (21 Days)||7
8197926|NCT02231177|20214042|P1|COMPLETED|Treatment Period 3 (21 Days)||8
8197927|NCT02231177|20214037|P6|STARTED|Treatment Period 3 (21 Days)||9
8197928|NCT02231177|20214038|P5|STARTED|Treatment Period 3 (21 Days)||8
8197929|NCT02231177|20214039|P4|STARTED|Treatment Period 3 (21 Days)||7
8197930|NCT02231177|20214040|P3|STARTED|Treatment Period 3 (21 Days)||8
8197931|NCT02231177|20214041|P2|STARTED|Treatment Period 3 (21 Days)||7
8197932|NCT02231177|20214042|P1|STARTED|Treatment Period 3 (21 Days)||8
8197933|NCT02231177|20214037|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8197934|NCT02231177|20214038|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8197935|NCT02231177|20214039|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8197936|NCT02231177|20214040|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8197937|NCT02231177|20214041|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8197938|NCT02231177|20214042|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8197939|NCT02231177|20214037|P6|COMPLETED|Treatment Period 2 (21 Days)||9
8197940|NCT02231177|20214038|P5|COMPLETED|Treatment Period 2 (21 Days)||8
8197941|NCT02231177|20214039|P4|COMPLETED|Treatment Period 2 (21 Days)||7
8197942|NCT02231177|20214040|P3|COMPLETED|Treatment Period 2 (21 Days)||8
8197943|NCT02231177|20214041|P2|COMPLETED|Treatment Period 2 (21 Days)||7
8197944|NCT02231177|20214042|P1|COMPLETED|Treatment Period 2 (21 Days)||8
8197945|NCT02231177|20214037|P6|STARTED|Treatment Period 2 (21 Days)||9
8197946|NCT02231177|20214038|P5|STARTED|Treatment Period 2 (21 Days)||8
8197947|NCT02231177|20214039|P4|STARTED|Treatment Period 2 (21 Days)||7
8197948|NCT02231177|20214040|P3|STARTED|Treatment Period 2 (21 Days)||8
8197949|NCT02231177|20214041|P2|STARTED|Treatment Period 2 (21 Days)||7
8197950|NCT02231177|20214042|P1|STARTED|Treatment Period 2 (21 Days)||8
8197951|NCT02231177|20214037|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8197952|NCT02231177|20214038|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8197953|NCT02231177|20214039|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8197954|NCT02231177|20214040|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8197955|NCT02231177|20214041|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8197956|NCT02231177|20214042|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8197957|NCT02231177|20214037|P6|COMPLETED|Treatment Period 1 (21 Days)||9
8197958|NCT02231177|20214038|P5|COMPLETED|Treatment Period 1 (21 Days)||8
8197959|NCT02231177|20214039|P4|COMPLETED|Treatment Period 1 (21 Days)||7
8197960|NCT02231177|20214040|P3|COMPLETED|Treatment Period 1 (21 Days)||8
8197961|NCT02231177|20214041|P2|COMPLETED|Treatment Period 1 (21 Days)||7
8197962|NCT02231177|20214042|P1|COMPLETED|Treatment Period 1 (21 Days)||8
8197963|NCT02231177|20214037|P6|STARTED|Treatment Period 1 (21 Days)||9
8197964|NCT02231177|20214038|P5|STARTED|Treatment Period 1 (21 Days)||8
8197965|NCT02231177|20214039|P4|STARTED|Treatment Period 1 (21 Days)||7
8197966|NCT02231177|20214040|P3|STARTED|Treatment Period 1 (21 Days)||8
8197967|NCT02231177|20214041|P2|STARTED|Treatment Period 1 (21 Days)||7
8197968|NCT02231177|20214042|P1|STARTED|Treatment Period 1 (21 Days)||8
8197969|NCT02231164|20214098|P2|NOT COMPLETED|Overall Study||6
8197970|NCT02231164|20214099|P1|NOT COMPLETED|Overall Study||6
8197971|NCT02231164|20214098|P2|COMPLETED|Overall Study||0
8197972|NCT02231164|20214099|P1|COMPLETED|Overall Study||0
8197973|NCT02231164|20214098|P2|STARTED|Overall Study||6
8197974|NCT02231164|20214099|P1|STARTED|Overall Study||6
8197975|NCT02230995|20214107|P2|NOT COMPLETED|Period 2 + Washout||0
8197976|NCT02230995|20214108|P1|NOT COMPLETED|Period 2 + Washout||0
8197977|NCT02230995|20214107|P2|COMPLETED|Period 2 + Washout||15
8197978|NCT02230995|20214108|P1|COMPLETED|Period 2 + Washout||15
8197979|NCT02230995|20214107|P2|STARTED|Period 2 + Washout||15
8197980|NCT02230995|20214108|P1|STARTED|Period 2 + Washout||15
8197981|NCT02230995|20214107|P2|NOT COMPLETED|Period 1 + Washout||0
8197982|NCT02230995|20214108|P1|NOT COMPLETED|Period 1 + Washout||0
8197983|NCT02230995|20214107|P2|COMPLETED|Period 1 + Washout||15
8197984|NCT02230995|20214108|P1|COMPLETED|Period 1 + Washout||15
8197985|NCT02230995|20214107|P2|STARTED|Period 1 + Washout||15
8197986|NCT02230995|20214108|P1|STARTED|Period 1 + Washout||15
8197987|NCT02230956|20214127|P3|NOT COMPLETED|Overall Study||7
8197988|NCT02230956|20214128|P2|NOT COMPLETED|Overall Study||6
8197989|NCT02230956|20214129|P1|NOT COMPLETED|Overall Study||5
8197990|NCT02230956|20214127|P3|COMPLETED|Overall Study||82
8197991|NCT02230956|20214128|P2|COMPLETED|Overall Study||37
8197992|NCT02230956|20214129|P1|COMPLETED|Overall Study||39
8197993|NCT02230956|20214127|P3|STARTED|Overall Study||89
8197994|NCT02230956|20214128|P2|STARTED|Overall Study||43
8197995|NCT02230956|20214129|P1|STARTED|Overall Study||44
8197996|NCT02230904|20214151|P2|NOT COMPLETED|Overall Study||1
8197997|NCT02230904|20214152|P1|NOT COMPLETED|Overall Study||0
8197998|NCT02230904|20214151|P2|COMPLETED|Overall Study||27
8197999|NCT02230904|20214152|P1|COMPLETED|Overall Study||29
8198000|NCT02230904|20214151|P2|STARTED|Overall Study||28
8198001|NCT02230904|20214152|P1|STARTED|Overall Study||29
8198002|NCT02230761|20214174|P2|NOT COMPLETED|Overall Study||1
8198003|NCT02230761|20214175|P1|NOT COMPLETED|Overall Study||0
8198004|NCT02230761|20214174|P2|COMPLETED|Overall Study||29
8198005|NCT02230761|20214175|P1|COMPLETED|Overall Study||60
8198006|NCT02230761|20214174|P2|STARTED|Overall Study||30
8198007|NCT02230761|20214175|P1|STARTED|Overall Study||60
8198008|NCT02230683|20214185|P1|NOT COMPLETED|Overall Study||1
8198009|NCT02230683|20214185|P1|COMPLETED|Overall Study||22
8198010|NCT02230683|20214185|P1|STARTED|Overall Study||23
8198011|NCT02230670|20214202|P2|NOT COMPLETED|Overall Study||8
8198012|NCT02230670|20214203|P1|NOT COMPLETED|Overall Study||4
8198013|NCT02230670|20214202|P2|COMPLETED|Overall Study||34
8198014|NCT02230670|20214203|P1|COMPLETED|Overall Study||40
8198015|NCT02230670|20214202|P2|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
8198016|NCT02230670|20214203|P1|STARTED|Overall Study||44
8198017|NCT02230579|20214220|P7|NOT COMPLETED|Overall Study||0
8198018|NCT02230579|20214221|P6|NOT COMPLETED|Overall Study||0
8198019|NCT02230579|20214222|P5|NOT COMPLETED|Overall Study||0
8198020|NCT02230579|20214223|P4|NOT COMPLETED|Overall Study||0
8198021|NCT02230579|20214224|P3|NOT COMPLETED|Overall Study||0
8198022|NCT02230579|20214225|P2|NOT COMPLETED|Overall Study||0
8198023|NCT02230579|20214226|P1|NOT COMPLETED|Overall Study||0
8198024|NCT02230579|20214220|P7|COMPLETED|Overall Study||12
8198025|NCT02230579|20214221|P6|COMPLETED|Overall Study||6
8198026|NCT02230579|20214222|P5|COMPLETED|Overall Study||6
8198027|NCT02230579|20214223|P4|COMPLETED|Overall Study||6
8198028|NCT02230579|20214224|P3|COMPLETED|Overall Study||6
8198029|NCT02230579|20214225|P2|COMPLETED|Overall Study||6
8198030|NCT02230579|20214226|P1|COMPLETED|Overall Study||6
8198031|NCT02230579|20214220|P7|STARTED|Overall Study||12
8198032|NCT02230579|20214221|P6|STARTED|Overall Study||6
8198033|NCT02230579|20214222|P5|STARTED|Overall Study||6
8198034|NCT02230579|20214223|P4|STARTED|Overall Study||6
8198035|NCT02230579|20214224|P3|STARTED|Overall Study||6
8198036|NCT02230579|20214225|P2|STARTED|Overall Study||6
8198037|NCT02230579|20214226|P1|STARTED|Overall Study||6
8198038|NCT02230566|20214264|P4|NOT COMPLETED|Overall Study||0
8198039|NCT02230566|20214265|P3|NOT COMPLETED|Overall Study||0
8198040|NCT02230566|20214266|P2|NOT COMPLETED|Overall Study||0
8198041|NCT02230566|20214267|P1|NOT COMPLETED|Overall Study||0
8198042|NCT02230566|20214264|P4|COMPLETED|Overall Study||3
8198043|NCT02230566|20214265|P3|COMPLETED|Overall Study||3
8198044|NCT02230566|20214266|P2|COMPLETED|Overall Study||3
8198045|NCT02230566|20214267|P1|COMPLETED|Overall Study||3
8198046|NCT02230566|20214264|P4|STARTED|Overall Study||3
8198047|NCT02230566|20214265|P3|STARTED|Overall Study||3
8198048|NCT02230566|20214266|P2|STARTED|Overall Study||3
8198049|NCT02230566|20214267|P1|STARTED|Overall Study||3
8198050|NCT02230540|20214282|P2|NOT COMPLETED|Overall Study||0
8198051|NCT02230540|20214283|P1|NOT COMPLETED|Overall Study||0
8198052|NCT02230540|20214282|P2|COMPLETED|Overall Study||0
8198053|NCT02230540|20214283|P1|COMPLETED|Overall Study||8
8198054|NCT02230540|20214282|P2|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
8198055|NCT02230540|20214283|P1|STARTED|Overall Study||8
8198056|NCT02230384|20214289|P2|NOT COMPLETED|Phase 2 Wash Out||0
8198057|NCT02230384|20214290|P1|NOT COMPLETED|Phase 2 Wash Out||0
8198058|NCT02230384|20214289|P2|COMPLETED|Phase 2 Wash Out||30
8198059|NCT02230384|20214290|P1|COMPLETED|Phase 2 Wash Out||26
8198060|NCT02230384|20214289|P2|STARTED|Phase 2 Wash Out||30
8198061|NCT02230384|20214290|P1|STARTED|Phase 2 Wash Out||26
8198062|NCT02230384|20214289|P2|NOT COMPLETED|Phase 2 - Switch||1
8198063|NCT02230384|20214290|P1|NOT COMPLETED|Phase 2 - Switch||3
8198064|NCT02230384|20214289|P2|COMPLETED|Phase 2 - Switch||30
8198065|NCT02230384|20214290|P1|COMPLETED|Phase 2 - Switch||26
8198066|NCT02230384|20214289|P2|STARTED|Phase 2 - Switch||31
8198067|NCT02230384|20214290|P1|STARTED|Phase 2 - Switch||29
8198068|NCT02230384|20214289|P2|NOT COMPLETED|Phase 1 Wash Out||0
8198069|NCT02230384|20214290|P1|NOT COMPLETED|Phase 1 Wash Out||0
8198070|NCT02230384|20214289|P2|COMPLETED|Phase 1 Wash Out||31
8198071|NCT02230384|20214290|P1|COMPLETED|Phase 1 Wash Out||29
8198072|NCT02230384|20214289|P2|STARTED|Phase 1 Wash Out||31
8198073|NCT02230384|20214290|P1|STARTED|Phase 1 Wash Out||29
8198074|NCT02230384|20214289|P2|NOT COMPLETED|Phase 1||1
8198075|NCT02230384|20214290|P1|NOT COMPLETED|Phase 1||1
8198076|NCT02230384|20214289|P2|COMPLETED|Phase 1||31
8198077|NCT02230384|20214290|P1|COMPLETED|Phase 1||29
8198078|NCT02230384|20214289|P2|STARTED|Phase 1||32
8198079|NCT02230384|20214290|P1|STARTED|Phase 1||30
8198080|NCT02230332|20214310|P2|NOT COMPLETED|Overall Study||1
8198081|NCT02230332|20214311|P1|NOT COMPLETED|Overall Study||4
8198082|NCT02230332|20214310|P2|COMPLETED|Overall Study||39
8198083|NCT02230332|20214311|P1|COMPLETED|Overall Study||34
8198084|NCT02230332|20214310|P2|STARTED|Overall Study||40
8198085|NCT02230332|20214311|P1|STARTED|Overall Study||38
8198086|NCT02230306|20214327|P1|NOT COMPLETED|Overall Study||1
8198087|NCT02230306|20214327|P1|COMPLETED|Overall Study||4
8198088|NCT02230306|20214327|P1|STARTED|Overall Study||5
8198089|NCT02230085|20214338|P1|NOT COMPLETED|Overall Study||4
8198090|NCT02230085|20214338|P1|COMPLETED|Overall Study||106
8198091|NCT02230085|20214338|P1|STARTED|Overall Study||110
8198095|NCT02229851|20214366|P7|NOT COMPLETED|Extension Phase (Open-label Phase)||3
8198096|NCT02229851|20214367|P6|NOT COMPLETED|Extension Phase (Open-label Phase)||5
8198097|NCT02229851|20214368|P5|NOT COMPLETED|Extension Phase (Open-label Phase)||5
8198098|NCT02229851|20214369|P4|NOT COMPLETED|Extension Phase (Open-label Phase)||2
8198099|NCT02229851|20214370|P3|NOT COMPLETED|Extension Phase (Open-label Phase)||0
8198100|NCT02229851|20214371|P2|NOT COMPLETED|Extension Phase (Open-label Phase)||0
8198101|NCT02229851|20214372|P1|NOT COMPLETED|Extension Phase (Open-label Phase)||0
8198102|NCT02229851|20214366|P7|COMPLETED|Extension Phase (Open-label Phase)||48
8198103|NCT02229851|20214367|P6|COMPLETED|Extension Phase (Open-label Phase)||47
8198179|NCT02229513|20214824|P1|NOT COMPLETED|Overall Study||0
8198104|NCT02229851|20214368|P5|COMPLETED|Extension Phase (Open-label Phase)||109
8198105|NCT02229851|20214369|P4|COMPLETED|Extension Phase (Open-label Phase)||53
8198106|NCT02229851|20214370|P3|COMPLETED|Extension Phase (Open-label Phase)||0
8198107|NCT02229851|20214371|P2|COMPLETED|Extension Phase (Open-label Phase)||0
8198108|NCT02229851|20214372|P1|COMPLETED|Extension Phase (Open-label Phase)||0
8198109|NCT02229851|20214366|P7|STARTED|Extension Phase (Open-label Phase)||51
8198110|NCT02229851|20214367|P6|STARTED|Extension Phase (Open-label Phase)||52
8198111|NCT02229851|20214368|P5|STARTED|Extension Phase (Open-label Phase)||114
8198112|NCT02229851|20214369|P4|STARTED|Extension Phase (Open-label Phase)||55
8198113|NCT02229851|20214370|P3|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
8198114|NCT02229851|20214371|P2|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
8198115|NCT02229851|20214372|P1|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
8198116|NCT02229851|20214366|P7|NOT COMPLETED|Main Phase (Double-blind Phase)||0
8198117|NCT02229851|20214367|P6|NOT COMPLETED|Main Phase (Double-blind Phase)||0
8198118|NCT02229851|20214368|P5|NOT COMPLETED|Main Phase (Double-blind Phase)||0
8198119|NCT02229851|20214369|P4|NOT COMPLETED|Main Phase (Double-blind Phase)||0
8198120|NCT02229851|20214370|P3|NOT COMPLETED|Main Phase (Double-blind Phase)||6
8198121|NCT02229851|20214371|P2|NOT COMPLETED|Main Phase (Double-blind Phase)||16
8198122|NCT02229851|20214372|P1|NOT COMPLETED|Main Phase (Double-blind Phase)||6
8198123|NCT02229851|20214366|P7|COMPLETED|Main Phase (Double-blind Phase)||0
8198124|NCT02229851|20214367|P6|COMPLETED|Main Phase (Double-blind Phase)||0
8198125|NCT02229851|20214368|P5|COMPLETED|Main Phase (Double-blind Phase)||0
8198126|NCT02229851|20214369|P4|COMPLETED|Main Phase (Double-blind Phase)||0
8198127|NCT02229851|20214370|P3|COMPLETED|Main Phase (Double-blind Phase)||114
8198128|NCT02229851|20214371|P2|COMPLETED|Main Phase (Double-blind Phase)||103
8198129|NCT02229851|20214372|P1|COMPLETED|Main Phase (Double-blind Phase)||55
8198130|NCT02229851|20214366|P7|Safety Analysis Set|Main Phase (Double-blind Phase)||0
8198131|NCT02229851|20214367|P6|Safety Analysis Set|Main Phase (Double-blind Phase)||0
8198132|NCT02229851|20214368|P5|Safety Analysis Set|Main Phase (Double-blind Phase)||0
8198133|NCT02229851|20214369|P4|Safety Analysis Set|Main Phase (Double-blind Phase)||0
8198134|NCT02229851|20214370|P3|Safety Analysis Set|Main Phase (Double-blind Phase)||120
8198135|NCT02229851|20214371|P2|Safety Analysis Set|Main Phase (Double-blind Phase)||119
8198136|NCT02229851|20214372|P1|Safety Analysis Set|Main Phase (Double-blind Phase)||61
8198137|NCT02229851|20214366|P7|Full Analysis Set|Main Phase (Double-blind Phase)||0
8198138|NCT02229851|20214367|P6|Full Analysis Set|Main Phase (Double-blind Phase)||0
8198139|NCT02229851|20214368|P5|Full Analysis Set|Main Phase (Double-blind Phase)||0
8198140|NCT02229851|20214369|P4|Full Analysis Set|Main Phase (Double-blind Phase)||0
8198141|NCT02229851|20214370|P3|Full Analysis Set|Main Phase (Double-blind Phase)||120
8198142|NCT02229851|20214371|P2|Full Analysis Set|Main Phase (Double-blind Phase)||119
8198143|NCT02229851|20214372|P1|Full Analysis Set|Main Phase (Double-blind Phase)||61
8198144|NCT02229851|20214366|P7|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
8198145|NCT02229851|20214367|P6|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
8198146|NCT02229851|20214368|P5|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
8198147|NCT02229851|20214369|P4|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
8198148|NCT02229851|20214370|P3|STARTED|Main Phase (Double-blind Phase)||120
8198149|NCT02229851|20214371|P2|STARTED|Main Phase (Double-blind Phase)||119
8198150|NCT02229851|20214372|P1|STARTED|Main Phase (Double-blind Phase)||61
8198151|NCT02229552|20214804|P1|NOT COMPLETED|2-Year Follow up||26
8198152|NCT02229552|20214804|P1|COMPLETED|2-Year Follow up||205
8198153|NCT02229552|20214804|P1|STARTED|2-Year Follow up|All baseline participants were eligible for year 2 follow up, regardless of completion of year 1.|231
8198154|NCT02229552|20214804|P1|NOT COMPLETED|1-year Follow up||25
8198155|NCT02229552|20214804|P1|COMPLETED|1-year Follow up||206
8198156|NCT02229552|20214804|P1|STARTED|1-year Follow up||231
8198157|NCT02229552|20214804|P1|NOT COMPLETED|Baseline||6
8198158|NCT02229552|20214804|P1|COMPLETED|Baseline||231
8198159|NCT02229552|20214804|P1|STARTED|Baseline||237
8198160|NCT02229539|20214811|P3|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
8198161|NCT02229539|20214812|P2|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
8198162|NCT02229539|20214813|P1|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
8198163|NCT02229539|20214811|P3|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
8198164|NCT02229539|20214812|P2|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
8198165|NCT02229539|20214813|P1|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
8198166|NCT02229539|20214811|P3|STARTED|Cycle 2 (Optional Continuation Phase)||32
8198167|NCT02229539|20214812|P2|STARTED|Cycle 2 (Optional Continuation Phase)||36
8198168|NCT02229539|20214813|P1|STARTED|Cycle 2 (Optional Continuation Phase)||35
8198169|NCT02229539|20214811|P3|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
8198170|NCT02229539|20214812|P2|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
8198171|NCT02229539|20214813|P1|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
8198172|NCT02229539|20214811|P3|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
8198173|NCT02229539|20214812|P2|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
8198174|NCT02229539|20214813|P1|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
8198175|NCT02229539|20214811|P3|STARTED|Cycle 1 (Treatment Per Protocol)||75
8198176|NCT02229539|20214812|P2|STARTED|Cycle 1 (Treatment Per Protocol)||76
8198177|NCT02229539|20214813|P1|STARTED|Cycle 1 (Treatment Per Protocol)||77
8198178|NCT02229513|20214823|P2|NOT COMPLETED|Overall Study||0
8198180|NCT02229513|20214823|P2|COMPLETED|Overall Study||100
8198181|NCT02229513|20214824|P1|COMPLETED|Overall Study||100
8198182|NCT02229513|20214823|P2|STARTED|Overall Study||100
8198183|NCT02229513|20214824|P1|STARTED|Overall Study||100
8198184|NCT02229487|20214860|P2|NOT COMPLETED|Overall Study||0
8198185|NCT02229487|20214861|P1|NOT COMPLETED|Overall Study||0
8198186|NCT02229487|20214860|P2|COMPLETED|Overall Study||27
8198187|NCT02229487|20214861|P1|COMPLETED|Overall Study||24
8198188|NCT02229487|20214860|P2|STARTED|Overall Study||27
8198189|NCT02229487|20214861|P1|STARTED|Overall Study||24
8198190|NCT02229474|20214869|P2|NOT COMPLETED|Overall Study||3
8198191|NCT02229474|20214870|P1|NOT COMPLETED|Overall Study||0
8198192|NCT02229474|20214869|P2|COMPLETED|Overall Study||15
8198193|NCT02229474|20214870|P1|COMPLETED|Overall Study||16
8198194|NCT02229474|20214869|P2|STARTED|Overall Study||18
8198195|NCT02229474|20214870|P1|STARTED|Overall Study||16
8198196|NCT02229461|20214903|P6|NOT COMPLETED|Overall Study||0
8198197|NCT02229461|20214904|P5|NOT COMPLETED|Overall Study||0
8198198|NCT02229461|20214905|P4|NOT COMPLETED|Overall Study||0
8198199|NCT02229461|20214906|P3|NOT COMPLETED|Overall Study||0
8198200|NCT02229461|20214907|P2|NOT COMPLETED|Overall Study||0
8198201|NCT02229461|20214908|P1|NOT COMPLETED|Overall Study||0
8198202|NCT02229461|20214903|P6|COMPLETED|Overall Study||17
8198203|NCT02229461|20214904|P5|COMPLETED|Overall Study||17
8198204|NCT02229461|20214905|P4|COMPLETED|Overall Study||17
8198205|NCT02229461|20214906|P3|COMPLETED|Overall Study||17
8198206|NCT02229461|20214907|P2|COMPLETED|Overall Study||17
8198207|NCT02229461|20214908|P1|COMPLETED|Overall Study||17
8198208|NCT02229461|20214903|P6|STARTED|Overall Study|Randomized and received treatment|17
8198209|NCT02229461|20214904|P5|STARTED|Overall Study|Randomized and received treatment|17
8198210|NCT02229461|20214905|P4|STARTED|Overall Study|Randomized and received treatment|17
8198211|NCT02229461|20214906|P3|STARTED|Overall Study|Randomized and received treatment|17
8198212|NCT02229461|20214907|P2|STARTED|Overall Study|Randomized and received treatment|17
8198213|NCT02229461|20214908|P1|STARTED|Overall Study|Randomized and received treatment|17
8198214|NCT02229396|20214944|P3|NOT COMPLETED|Overall Study||95
8198215|NCT02229396|20214945|P2|NOT COMPLETED|Overall Study||77
8198216|NCT02229396|20214946|P1|NOT COMPLETED|Overall Study||78
8198217|NCT02229396|20214944|P3|COMPLETED|Overall Study||136
8198218|NCT02229396|20214945|P2|COMPLETED|Overall Study||154
8198219|NCT02229396|20214946|P1|COMPLETED|Overall Study||155
8198220|NCT02229396|20214944|P3|Completed 52-Week Study Period|Overall Study||177
8198221|NCT02229396|20214945|P2|Completed 52-Week Study Period|Overall Study||193
8198222|NCT02229396|20214946|P1|Completed 52-Week Study Period|Overall Study||194
8198223|NCT02229396|20214944|P3|Completed 28-Week Study Period|Overall Study||193
8198224|NCT02229396|20214945|P2|Completed 28-Week Study Period|Overall Study||202
8198225|NCT02229396|20214946|P1|Completed 28-Week Study Period|Overall Study||208
8198226|NCT02229396|20214944|P3|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
8198227|NCT02229396|20214945|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
8198228|NCT02229396|20214946|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
8198229|NCT02229396|20214944|P3|Safety Analysis Set|Overall Study||230
8198230|NCT02229396|20214945|P2|Safety Analysis Set|Overall Study||231
8198231|NCT02229396|20214946|P1|Safety Analysis Set|Overall Study||233
8198232|NCT02229396|20214944|P3|Randomization Code Allocated|Overall Study||231
8198233|NCT02229396|20214945|P2|Randomization Code Allocated|Overall Study||231
8198234|NCT02229396|20214946|P1|Randomization Code Allocated|Overall Study||233
8198235|NCT02229396|20214944|P3|STARTED|Overall Study||231
8198236|NCT02229396|20214945|P2|STARTED|Overall Study||231
8198237|NCT02229396|20214946|P1|STARTED|Overall Study||233
8198238|NCT02229383|20214977|P2|NOT COMPLETED|Overall Study||22
8198239|NCT02229383|20214978|P1|NOT COMPLETED|Overall Study||20
8198240|NCT02229383|20214977|P2|COMPLETED|Overall Study||207
8198241|NCT02229383|20214978|P1|COMPLETED|Overall Study||212
8198242|NCT02229383|20214977|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||228
8198243|NCT02229383|20214978|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||230
8198244|NCT02229383|20214977|P2|Safety Analysis Set|Overall Study||229
8198245|NCT02229383|20214978|P1|Safety Analysis Set|Overall Study||231
8198246|NCT02229383|20214977|P2|Received Treatment|Overall Study||229
8198247|NCT02229383|20214978|P1|Received Treatment|Overall Study||231
8198248|NCT02229383|20214977|P2|STARTED|Overall Study||229
8198249|NCT02229383|20214978|P1|STARTED|Overall Study||232
8198250|NCT02229318|20214996|P1|NOT COMPLETED|Overall Study||0
8198251|NCT02229318|20214996|P1|COMPLETED|Overall Study|September 15th 2014 11 completed|11
8198252|NCT02229318|20214996|P1|STARTED|Overall Study|September 6th 2014 11 enrolled|11
8198253|NCT02229227|20215003|P2|NOT COMPLETED|Overall Study||62
8198254|NCT02229227|20215004|P1|NOT COMPLETED|Overall Study||51
8198255|NCT02229227|20215003|P2|COMPLETED|Overall Study||350
8198256|NCT02229227|20215004|P1|COMPLETED|Overall Study||351
8198257|NCT02229227|20215003|P2|STARTED|Overall Study||412
8198258|NCT02229227|20215004|P1|STARTED|Overall Study||402
8198259|NCT02229214|20215089|P2|NOT COMPLETED|Overall Study||0
8198260|NCT02229214|20215090|P1|NOT COMPLETED|Overall Study||6
8198261|NCT02229214|20215089|P2|COMPLETED|Overall Study||10
8198262|NCT02229214|20215090|P1|COMPLETED|Overall Study||35
8198263|NCT02229214|20215089|P2|STARTED|Overall Study||10
8198264|NCT02229214|20215090|P1|STARTED|Overall Study||41
8198265|NCT02228980|20215114|P4|NOT COMPLETED|Overall Study||3
8198266|NCT02228980|20215115|P3|NOT COMPLETED|Overall Study||2
8198267|NCT02228980|20215116|P2|NOT COMPLETED|Overall Study||3
8198268|NCT02228980|20215117|P1|NOT COMPLETED|Overall Study||24
8198269|NCT02228980|20215114|P4|COMPLETED|Overall Study||148
8198270|NCT02228980|20215115|P3|COMPLETED|Overall Study||149
8198271|NCT02228980|20215116|P2|COMPLETED|Overall Study||147
8198272|NCT02228980|20215117|P1|COMPLETED|Overall Study||126
8198273|NCT02228980|20215114|P4|STARTED|Overall Study||151
8198274|NCT02228980|20215115|P3|STARTED|Overall Study||151
8198275|NCT02228980|20215116|P2|STARTED|Overall Study||150
8198276|NCT02228980|20215117|P1|STARTED|Overall Study||150
8198277|NCT02228967|20215141|P2|NOT COMPLETED|Overall Study||160
8198278|NCT02228967|20215142|P1|NOT COMPLETED|Overall Study||159
8198279|NCT02228967|20215141|P2|COMPLETED|Overall Study||228
8198280|NCT02228967|20215142|P1|COMPLETED|Overall Study||244
8198281|NCT02228967|20215141|P2|STARTED|Overall Study||388
8198282|NCT02228967|20215142|P1|STARTED|Overall Study||403
8198283|NCT02228824|20215188|P2|NOT COMPLETED|Overall Study||22
8198284|NCT02228824|20215189|P1|NOT COMPLETED|Overall Study||29
8198285|NCT02228824|20215188|P2|COMPLETED|Overall Study||98
8198286|NCT02228824|20215189|P1|COMPLETED|Overall Study||89
8198287|NCT02228824|20215188|P2|STARTED|Overall Study||120
8198288|NCT02228824|20215189|P1|STARTED|Overall Study||118
8198289|NCT02228720|20215203|P1|NOT COMPLETED|Open Label - Day 90||0
8198290|NCT02228720|20215203|P1|COMPLETED|Open Label - Day 90||14
8198291|NCT02228720|20215203|P1|STARTED|Open Label - Day 90||14
8198292|NCT02228720|20215203|P1|NOT COMPLETED|Open Label - Day 30||1
8198293|NCT02228720|20215203|P1|COMPLETED|Open Label - Day 30||14
8198294|NCT02228720|20215203|P1|STARTED|Open Label - Day 30||15
8198295|NCT02228720|20215203|P1|NOT COMPLETED|Open Label - Baseline||0
8198296|NCT02228720|20215203|P1|COMPLETED|Open Label - Baseline||15
8198297|NCT02228720|20215203|P1|STARTED|Open Label - Baseline||15
8198304|NCT02228590|20215226|P1|NOT COMPLETED|Overall Study||1
8198305|NCT02228590|20215226|P1|COMPLETED|Overall Study||19
8198306|NCT02228590|20215226|P1|STARTED|Overall Study||20
8198307|NCT02228564|20215239|P1|NOT COMPLETED|Overall Study||49
8198308|NCT02228564|20215239|P1|COMPLETED|Overall Study||106
8198309|NCT02228564|20215239|P1|STARTED|Overall Study||155
8198310|NCT02228499|20215256|P2|NOT COMPLETED|Overall Study||26
8198311|NCT02228499|20215257|P1|NOT COMPLETED|Overall Study||23
8198312|NCT02228499|20215256|P2|COMPLETED|Overall Study||10
8198313|NCT02228499|20215257|P1|COMPLETED|Overall Study||7
8198314|NCT02228499|20215256|P2|STARTED|Overall Study||36
8198315|NCT02228499|20215257|P1|STARTED|Overall Study||30
8198316|NCT02228460|20215263|P1|NOT COMPLETED|Overall Study||2
8198317|NCT02228460|20215263|P1|COMPLETED|Overall Study||9
8198318|NCT02228460|20215263|P1|STARTED|Overall Study||11
8198319|NCT02228395|20215286|P3|NOT COMPLETED|Third Intervention Period||0
8198320|NCT02228395|20215287|P2|NOT COMPLETED|Third Intervention Period||0
8198321|NCT02228395|20215288|P1|NOT COMPLETED|Third Intervention Period||0
8198322|NCT02228395|20215286|P3|COMPLETED|Third Intervention Period||3
8198323|NCT02228395|20215287|P2|COMPLETED|Third Intervention Period||3
8198324|NCT02228395|20215288|P1|COMPLETED|Third Intervention Period||3
8198325|NCT02228395|20215286|P3|STARTED|Third Intervention Period||3
8198326|NCT02228395|20215287|P2|STARTED|Third Intervention Period||3
8198327|NCT02228395|20215288|P1|STARTED|Third Intervention Period||3
8198328|NCT02228395|20215286|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8198329|NCT02228395|20215287|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8198330|NCT02228395|20215288|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8198331|NCT02228395|20215286|P3|COMPLETED|Washout Period (at Least 10 Days)||3
8198332|NCT02228395|20215287|P2|COMPLETED|Washout Period (at Least 10 Days)||3
8198333|NCT02228395|20215288|P1|COMPLETED|Washout Period (at Least 10 Days)||3
8198334|NCT02228395|20215286|P3|STARTED|Washout Period (at Least 10 Days)||3
8198335|NCT02228395|20215287|P2|STARTED|Washout Period (at Least 10 Days)||3
8198336|NCT02228395|20215288|P1|STARTED|Washout Period (at Least 10 Days)||3
8198337|NCT02228395|20215286|P3|NOT COMPLETED|Second Intervention Period||0
8198338|NCT02228395|20215287|P2|NOT COMPLETED|Second Intervention Period||0
8198339|NCT02228395|20215288|P1|NOT COMPLETED|Second Intervention Period||0
8198340|NCT02228395|20215286|P3|COMPLETED|Second Intervention Period||3
8198341|NCT02228395|20215287|P2|COMPLETED|Second Intervention Period||3
8198342|NCT02228395|20215288|P1|COMPLETED|Second Intervention Period||3
8198343|NCT02228395|20215286|P3|STARTED|Second Intervention Period||3
8198344|NCT02228395|20215287|P2|STARTED|Second Intervention Period||3
8198345|NCT02228395|20215288|P1|STARTED|Second Intervention Period||3
8198346|NCT02228395|20215286|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8198347|NCT02228395|20215287|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8198348|NCT02228395|20215288|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
8198349|NCT02228395|20215286|P3|COMPLETED|Washout Period (at Least 10 Days)||3
8198350|NCT02228395|20215287|P2|COMPLETED|Washout Period (at Least 10 Days)||3
8198351|NCT02228395|20215288|P1|COMPLETED|Washout Period (at Least 10 Days)||3
8198352|NCT02228395|20215286|P3|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
8198353|NCT02228395|20215287|P2|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
8198354|NCT02228395|20215288|P1|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
8198355|NCT02228395|20215286|P3|NOT COMPLETED|First Intervention Period||1
8198356|NCT02228395|20215287|P2|NOT COMPLETED|First Intervention Period||1
8198357|NCT02228395|20215288|P1|NOT COMPLETED|First Intervention Period||1
8198358|NCT02228395|20215286|P3|COMPLETED|First Intervention Period||2
8198359|NCT02228395|20215287|P2|COMPLETED|First Intervention Period||2
8198360|NCT02228395|20215288|P1|COMPLETED|First Intervention Period||2
8198361|NCT02228395|20215286|P3|STARTED|First Intervention Period||3
8198362|NCT02228395|20215287|P2|STARTED|First Intervention Period||3
8198363|NCT02228395|20215288|P1|STARTED|First Intervention Period||3
8198364|NCT02228174|20215352|P1|NOT COMPLETED|Overall Study||5
8198365|NCT02228174|20215352|P1|COMPLETED|Overall Study||142
8198366|NCT02228174|20215352|P1|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143
8198367|NCT02228174|20215352|P1|STARTED|Overall Study||147
8198368|NCT02228096|20215374|P1|NOT COMPLETED|Overall Study||71
8198369|NCT02228096|20215374|P1|COMPLETED|Overall Study|Completed = study follow-up completed|4
8198370|NCT02228096|20215374|P1|Enrolled and Infused|Overall Study||64
8198371|NCT02228096|20215374|P1|Enrolled But Not Infused|Overall Study||11
8198372|NCT02228096|20215374|P1|Enrolled Into Long-term f/u Protocol|Overall Study||31
8198373|NCT02228096|20215374|P1|STARTED|Overall Study||75
8198374|NCT02227875|20215476|P2|NOT COMPLETED|Overall Study||33
8198375|NCT02227875|20215477|P1|NOT COMPLETED|Overall Study||37
8198376|NCT02227875|20215476|P2|COMPLETED|Overall Study||250
8198377|NCT02227875|20215477|P1|COMPLETED|Overall Study||240
8198378|NCT02227875|20215476|P2|STARTED|Overall Study||283
8198379|NCT02227875|20215477|P1|STARTED|Overall Study||277
8198380|NCT02227862|20215497|P2|NOT COMPLETED|Overall Study||22
8198381|NCT02227862|20215498|P1|NOT COMPLETED|Overall Study||19
8198382|NCT02227862|20215497|P2|COMPLETED|Overall Study||256
8198383|NCT02227862|20215498|P1|COMPLETED|Overall Study||261
8198384|NCT02227862|20215497|P2|Week 24|Overall Study||263
8198385|NCT02227862|20215498|P1|Week 24|Overall Study||269
8198386|NCT02227862|20215497|P2|STARTED|Overall Study||278
8198387|NCT02227862|20215498|P1|STARTED|Overall Study||280
8198388|NCT02227849|20215528|P1|NOT COMPLETED|Overall Study||8
8198389|NCT02227849|20215528|P1|COMPLETED|Overall Study||63
8198390|NCT02227849|20215528|P1|STARTED|Overall Study||71
8198391|NCT02227836|20215536|P1|NOT COMPLETED|Overall Study||0
8198392|NCT02227836|20215536|P1|COMPLETED|Overall Study||8
8198393|NCT02227836|20215536|P1|STARTED|Overall Study||8
8198394|NCT02227810|20215542|P2|NOT COMPLETED|Overall Study||5
8198395|NCT02227810|20215543|P1|NOT COMPLETED|Overall Study||2
8198396|NCT02227810|20215542|P2|COMPLETED|Overall Study||29
8198397|NCT02227810|20215543|P1|COMPLETED|Overall Study||17
8198398|NCT02227810|20215542|P2|STARTED|Overall Study||34
8198399|NCT02227810|20215543|P1|STARTED|Overall Study||19
8198400|NCT02227784|20215559|P5|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
8198401|NCT02227784|20215560|P4|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8198402|NCT02227784|20215561|P3|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8198403|NCT02227784|20215562|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8198404|NCT02227784|20215563|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8198405|NCT02227784|20215559|P5|COMPLETED|Open-Label Extension Phase (OLE)||0
8198406|NCT02227784|20215560|P4|COMPLETED|Open-Label Extension Phase (OLE)||0
8198407|NCT02227784|20215561|P3|COMPLETED|Open-Label Extension Phase (OLE)||0
8198408|NCT02227784|20215562|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
8198409|NCT02227784|20215563|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
8198410|NCT02227784|20215559|P5|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
8198411|NCT02227784|20215560|P4|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
8198412|NCT02227784|20215561|P3|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
8198413|NCT02227784|20215562|P2|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
8198414|NCT02227784|20215563|P1|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
8198415|NCT02227784|20215559|P5|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
8198416|NCT02227784|20215560|P4|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
8198417|NCT02227784|20215561|P3|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
8198418|NCT02227784|20215562|P2|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
8198419|NCT02227784|20215563|P1|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
8198420|NCT02227784|20215559|P5|NOT COMPLETED|Double-Blind Phase||0
8198421|NCT02227784|20215560|P4|NOT COMPLETED|Double-Blind Phase||39
8198422|NCT02227784|20215561|P3|NOT COMPLETED|Double-Blind Phase||21
8198423|NCT02227784|20215562|P2|NOT COMPLETED|Double-Blind Phase||18
8198424|NCT02227784|20215563|P1|NOT COMPLETED|Double-Blind Phase||40
8198425|NCT02227784|20215559|P5|COMPLETED|Double-Blind Phase||0
8198426|NCT02227784|20215560|P4|COMPLETED|Double-Blind Phase||88
8198427|NCT02227784|20215561|P3|COMPLETED|Double-Blind Phase||41
8198428|NCT02227784|20215562|P2|COMPLETED|Double-Blind Phase||36
8198429|NCT02227784|20215563|P1|COMPLETED|Double-Blind Phase||83
8198430|NCT02227784|20215559|P5|STARTED|Double-Blind Phase||0
8198431|NCT02227784|20215560|P4|STARTED|Double-Blind Phase||127
8198432|NCT02227784|20215561|P3|STARTED|Double-Blind Phase||62
8198433|NCT02227784|20215562|P2|STARTED|Double-Blind Phase||54
8198434|NCT02227784|20215563|P1|STARTED|Double-Blind Phase||123
8198435|NCT02227758|20215598|P1|NOT COMPLETED|Overall Study||67
8198436|NCT02227758|20215598|P1|COMPLETED|Overall Study||45
8198437|NCT02227758|20215598|P1|STARTED|Overall Study||112
8198438|NCT02227706|20215612|P2|NOT COMPLETED|Overall Study||0
8198439|NCT02227706|20215613|P1|NOT COMPLETED|Overall Study||0
8198440|NCT02227706|20215612|P2|COMPLETED|Overall Study||20
8198441|NCT02227706|20215613|P1|COMPLETED|Overall Study||20
8198442|NCT02227706|20215612|P2|STARTED|Overall Study||20
8198443|NCT02227706|20215613|P1|STARTED|Overall Study||20
8198444|NCT02227693|20215659|P4|NOT COMPLETED|Overall Study||0
8198445|NCT02227693|20215660|P3|NOT COMPLETED|Overall Study||0
8198446|NCT02227693|20215661|P2|NOT COMPLETED|Overall Study||0
8198447|NCT02227693|20215662|P1|NOT COMPLETED|Overall Study||0
8198448|NCT02227693|20215659|P4|COMPLETED|Overall Study||10
8198449|NCT02227693|20215660|P3|COMPLETED|Overall Study||11
8198450|NCT02227693|20215661|P2|COMPLETED|Overall Study||7
8198451|NCT02227693|20215662|P1|COMPLETED|Overall Study||11
8198452|NCT02227693|20215659|P4|STARTED|Overall Study||10
8198453|NCT02227693|20215660|P3|STARTED|Overall Study||11
8198454|NCT02227693|20215661|P2|STARTED|Overall Study||7
8198455|NCT02227693|20215662|P1|STARTED|Overall Study||11
8198456|NCT02227485|20215718|P2|NOT COMPLETED|Second Follow-up||2
8198457|NCT02227485|20215719|P1|NOT COMPLETED|Second Follow-up||2
8198458|NCT02227485|20215718|P2|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
8198459|NCT02227485|20215719|P1|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
8198460|NCT02227485|20215718|P2|STARTED|Second Follow-up||38
8198461|NCT02227485|20215719|P1|STARTED|Second Follow-up||36
8198462|NCT02227485|20215718|P2|NOT COMPLETED|First Follow-up||2
8198463|NCT02227485|20215719|P1|NOT COMPLETED|First Follow-up||4
8198464|NCT02227485|20215718|P2|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
8198465|NCT02227485|20215719|P1|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
8198466|NCT02227485|20215718|P2|STARTED|First Follow-up||40
8198467|NCT02227485|20215719|P1|STARTED|First Follow-up||40
8198468|NCT02227368|20215737|P2|NOT COMPLETED|Overall Study||4
8198469|NCT02227368|20215738|P1|NOT COMPLETED|Overall Study||2
8198470|NCT02227368|20215737|P2|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
8198471|NCT02227368|20215738|P1|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
8198472|NCT02227368|20215737|P2|Sujects Who Completed Treatment|Overall Study||17
8198473|NCT02227368|20215738|P1|Sujects Who Completed Treatment|Overall Study||10
8198474|NCT02227368|20215737|P2|Sujects Who Received Treatment|Overall Study||24
8198475|NCT02227368|20215738|P1|Sujects Who Received Treatment|Overall Study||16
8198476|NCT02227368|20215737|P2|STARTED|Overall Study||24
8198477|NCT02227368|20215738|P1|STARTED|Overall Study||16
8198478|NCT02227329|20215748|P2|NOT COMPLETED|Overall Study||0
8198479|NCT02227329|20215749|P1|NOT COMPLETED|Overall Study||0
8198480|NCT02227329|20215748|P2|COMPLETED|Overall Study||20
8198481|NCT02227329|20215749|P1|COMPLETED|Overall Study||18
8198482|NCT02227329|20215748|P2|STARTED|Overall Study||20
8198483|NCT02227329|20215749|P1|STARTED|Overall Study||18
8198484|NCT02227316|20215759|P4|NOT COMPLETED|Overall Study||0
8198485|NCT02227316|20215760|P3|NOT COMPLETED|Overall Study||0
8198486|NCT02227316|20215761|P2|NOT COMPLETED|Overall Study||0
8198487|NCT02227316|20215762|P1|NOT COMPLETED|Overall Study||0
8198488|NCT02227316|20215759|P4|COMPLETED|Overall Study||16
8198489|NCT02227316|20215760|P3|COMPLETED|Overall Study||16
8198490|NCT02227316|20215761|P2|COMPLETED|Overall Study||4
8198491|NCT02227316|20215762|P1|COMPLETED|Overall Study||4
8198492|NCT02227316|20215759|P4|STARTED|Overall Study||16
8198493|NCT02227316|20215760|P3|STARTED|Overall Study||16
8198494|NCT02227316|20215761|P2|STARTED|Overall Study||4
8198495|NCT02227316|20215762|P1|STARTED|Overall Study||4
8198502|NCT02227147|20215861|P2|NOT COMPLETED|Follow-up Period||5
8198503|NCT02227147|20215862|P1|NOT COMPLETED|Follow-up Period||3
8198504|NCT02227147|20215861|P2|COMPLETED|Follow-up Period||16
8198505|NCT02227147|20215862|P1|COMPLETED|Follow-up Period||15
8198506|NCT02227147|20215861|P2|STARTED|Follow-up Period||21
8198507|NCT02227147|20215862|P1|STARTED|Follow-up Period||18
8198508|NCT02227147|20215861|P2|NOT COMPLETED|Controlled Treatment Period||3
8198509|NCT02227147|20215862|P1|NOT COMPLETED|Controlled Treatment Period||6
8198510|NCT02227147|20215861|P2|COMPLETED|Controlled Treatment Period||21
8198511|NCT02227147|20215862|P1|COMPLETED|Controlled Treatment Period||18
8198512|NCT02227147|20215861|P2|STARTED|Controlled Treatment Period||24
8198513|NCT02227147|20215862|P1|STARTED|Controlled Treatment Period||24
8198514|NCT02227121|20215885|P1|NOT COMPLETED|Overall Study||0
8198515|NCT02227121|20215885|P1|COMPLETED|Overall Study||16
8198516|NCT02227121|20215885|P1|STARTED|Overall Study||16
8198517|NCT02227108|20215889|P1|NOT COMPLETED|Overall Study||31
8198518|NCT02227108|20215889|P1|COMPLETED|Overall Study||1
8198519|NCT02227108|20215889|P1|Treated|Overall Study||30
8198520|NCT02227108|20215889|P1|STARTED|Overall Study||32
8198521|NCT02226965|20215916|P1|NOT COMPLETED|Overall Study||41
8198522|NCT02226965|20215916|P1|COMPLETED|Overall Study||4
8198523|NCT02226965|20215916|P1|STARTED|Overall Study||45
8198524|NCT02226653|20215928|P2|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
8198525|NCT02226653|20215929|P1|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
8198526|NCT02226653|20215928|P2|COMPLETED|Washout Period 5 (at Least 21 Days)||23
8198527|NCT02226653|20215929|P1|COMPLETED|Washout Period 5 (at Least 21 Days)||23
8198528|NCT02226653|20215928|P2|STARTED|Washout Period 5 (at Least 21 Days)||23
8198529|NCT02226653|20215929|P1|STARTED|Washout Period 5 (at Least 21 Days)||23
8198530|NCT02226653|20215928|P2|NOT COMPLETED|Treatment Period 5 Fed State||1
8198531|NCT02226653|20215929|P1|NOT COMPLETED|Treatment Period 5 Fed State||0
8198532|NCT02226653|20215928|P2|COMPLETED|Treatment Period 5 Fed State||23
8198533|NCT02226653|20215929|P1|COMPLETED|Treatment Period 5 Fed State||23
8198534|NCT02226653|20215928|P2|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
8198535|NCT02226653|20215929|P1|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
8198536|NCT02226653|20215928|P2|STARTED|Treatment Period 5 Fed State||24
8198537|NCT02226653|20215929|P1|STARTED|Treatment Period 5 Fed State||23
8198538|NCT02226653|20215928|P2|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
8198539|NCT02226653|20215929|P1|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
8198540|NCT02226653|20215928|P2|COMPLETED|Washout Period 4 (at Least 21 Days)||24
8198541|NCT02226653|20215929|P1|COMPLETED|Washout Period 4 (at Least 21 Days)||23
8198542|NCT02226653|20215928|P2|STARTED|Washout Period 4 (at Least 21 Days)||24
8198543|NCT02226653|20215929|P1|STARTED|Washout Period 4 (at Least 21 Days)||23
8198544|NCT02226653|20215928|P2|NOT COMPLETED|Treatment Period 4 Fasted State||0
8198545|NCT02226653|20215929|P1|NOT COMPLETED|Treatment Period 4 Fasted State||0
8198546|NCT02226653|20215928|P2|COMPLETED|Treatment Period 4 Fasted State||24
8198547|NCT02226653|20215929|P1|COMPLETED|Treatment Period 4 Fasted State||23
8198548|NCT02226653|20215928|P2|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
8198549|NCT02226653|20215929|P1|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
8198550|NCT02226653|20215928|P2|STARTED|Treatment Period 4 Fasted State||24
8198551|NCT02226653|20215929|P1|STARTED|Treatment Period 4 Fasted State||23
8198552|NCT02226653|20215928|P2|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
8198553|NCT02226653|20215929|P1|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
8198554|NCT02226653|20215928|P2|COMPLETED|Washout Period 3 (at Least 21 Days)||24
8198555|NCT02226653|20215929|P1|COMPLETED|Washout Period 3 (at Least 21 Days)||23
8198556|NCT02226653|20215928|P2|STARTED|Washout Period 3 (at Least 21 Days)||24
8198557|NCT02226653|20215929|P1|STARTED|Washout Period 3 (at Least 21 Days)||23
8198558|NCT02226653|20215928|P2|NOT COMPLETED|Treatment Period 3 Fasted State||0
8198559|NCT02226653|20215929|P1|NOT COMPLETED|Treatment Period 3 Fasted State||0
8198560|NCT02226653|20215928|P2|COMPLETED|Treatment Period 3 Fasted State||24
8198561|NCT02226653|20215929|P1|COMPLETED|Treatment Period 3 Fasted State||23
8198562|NCT02226653|20215928|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
8198563|NCT02226653|20215929|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
8198564|NCT02226653|20215928|P2|STARTED|Treatment Period 3 Fasted State||24
8198565|NCT02226653|20215929|P1|STARTED|Treatment Period 3 Fasted State||23
8198566|NCT02226653|20215928|P2|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
8198567|NCT02226653|20215929|P1|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
8198568|NCT02226653|20215928|P2|COMPLETED|Washout Period 2 (at Least 21 Days)||24
8198569|NCT02226653|20215929|P1|COMPLETED|Washout Period 2 (at Least 21 Days)||23
8198570|NCT02226653|20215928|P2|STARTED|Washout Period 2 (at Least 21 Days)||24
8198571|NCT02226653|20215929|P1|STARTED|Washout Period 2 (at Least 21 Days)||23
8198572|NCT02226653|20215928|P2|NOT COMPLETED|Treatment Period 2 Fasted State||0
8198573|NCT02226653|20215929|P1|NOT COMPLETED|Treatment Period 2 Fasted State||1
8198574|NCT02226653|20215928|P2|COMPLETED|Treatment Period 2 Fasted State||24
8198575|NCT02226653|20215929|P1|COMPLETED|Treatment Period 2 Fasted State||23
8198576|NCT02226653|20215928|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
8198577|NCT02226653|20215929|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
8198578|NCT02226653|20215928|P2|STARTED|Treatment Period 2 Fasted State||24
8198579|NCT02226653|20215929|P1|STARTED|Treatment Period 2 Fasted State||24
8198580|NCT02226653|20215928|P2|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
8198581|NCT02226653|20215929|P1|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
8198582|NCT02226653|20215928|P2|COMPLETED|Washout Period 1 (at Least 21 Days)||24
8198583|NCT02226653|20215929|P1|COMPLETED|Washout Period 1 (at Least 21 Days)||24
8198584|NCT02226653|20215928|P2|STARTED|Washout Period 1 (at Least 21 Days)||24
8198585|NCT02226653|20215929|P1|STARTED|Washout Period 1 (at Least 21 Days)||24
8198586|NCT02226653|20215928|P2|NOT COMPLETED|Treatment Period 1 Fasted State||0
8198587|NCT02226653|20215929|P1|NOT COMPLETED|Treatment Period 1 Fasted State||0
8198588|NCT02226653|20215928|P2|COMPLETED|Treatment Period 1 Fasted State||24
8198589|NCT02226653|20215929|P1|COMPLETED|Treatment Period 1 Fasted State||24
8198590|NCT02226653|20215928|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
8198591|NCT02226653|20215929|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
8198592|NCT02226653|20215928|P2|STARTED|Treatment Period 1 Fasted State||24
8198593|NCT02226653|20215929|P1|STARTED|Treatment Period 1 Fasted State||24
8198594|NCT02226562|20215953|P2|NOT COMPLETED|Overall Study||1
8198595|NCT02226562|20215954|P1|NOT COMPLETED|Overall Study||0
8198596|NCT02226562|20215953|P2|COMPLETED|Overall Study|Lost to follow up|95
8198597|NCT02226562|20215954|P1|COMPLETED|Overall Study||95
8198598|NCT02226562|20215953|P2|STARTED|Overall Study||96
8198599|NCT02226562|20215954|P1|STARTED|Overall Study||95
8198600|NCT02226549|20215972|P2|NOT COMPLETED|Overall Study||1
8198601|NCT02226549|20215973|P1|NOT COMPLETED|Overall Study||1
8198602|NCT02226549|20215972|P2|COMPLETED|Overall Study||23
8198603|NCT02226549|20215973|P1|COMPLETED|Overall Study||22
8198604|NCT02226549|20215972|P2|STARTED|Overall Study||24
8198605|NCT02226549|20215973|P1|STARTED|Overall Study||23
8198606|NCT02226198|20215983|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
8198607|NCT02226198|20215984|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
8198608|NCT02226198|20215985|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
8198609|NCT02226198|20215983|P3|COMPLETED|Maintenance Phase (12 Weeks)||0
8198610|NCT02226198|20215984|P2|COMPLETED|Maintenance Phase (12 Weeks)||0
8198611|NCT02226198|20215985|P1|COMPLETED|Maintenance Phase (12 Weeks)||13
8198612|NCT02226198|20215983|P3|STARTED|Maintenance Phase (12 Weeks)||0
8198613|NCT02226198|20215984|P2|STARTED|Maintenance Phase (12 Weeks)||0
8198614|NCT02226198|20215985|P1|STARTED|Maintenance Phase (12 Weeks)||13
8198615|NCT02226198|20215983|P3|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
8198616|NCT02226198|20215984|P2|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
8198617|NCT02226198|20215985|P1|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
8198618|NCT02226198|20215983|P3|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
8198619|NCT02226198|20215984|P2|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
8198620|NCT02226198|20215985|P1|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
8198621|NCT02226198|20215983|P3|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
8198622|NCT02226198|20215984|P2|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
8198623|NCT02226198|20215985|P1|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
8198624|NCT02226198|20215983|P3|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
8198625|NCT02226198|20215984|P2|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
8198626|NCT02226198|20215985|P1|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
8198627|NCT02226198|20215983|P3|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
8198628|NCT02226198|20215984|P2|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
8198629|NCT02226198|20215985|P1|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
8198630|NCT02226198|20215983|P3|STARTED|Cross-Over: First Intervention (6 Weeks)||7
8198631|NCT02226198|20215984|P2|STARTED|Cross-Over: First Intervention (6 Weeks)||7
8198632|NCT02226198|20215985|P1|STARTED|Cross-Over: First Intervention (6 Weeks)||0
8198633|NCT02226198|20215983|P3|NOT COMPLETED|Lead-in Phase||0
8198634|NCT02226198|20215984|P2|NOT COMPLETED|Lead-in Phase||0
8198635|NCT02226198|20215985|P1|NOT COMPLETED|Lead-in Phase||1
8198636|NCT02226198|20215983|P3|COMPLETED|Lead-in Phase||0
8198637|NCT02226198|20215984|P2|COMPLETED|Lead-in Phase||0
8198638|NCT02226198|20215985|P1|COMPLETED|Lead-in Phase||10
8198639|NCT02226198|20215983|P3|STARTED|Lead-in Phase||0
8198640|NCT02226198|20215984|P2|STARTED|Lead-in Phase||0
8198641|NCT02226198|20215985|P1|STARTED|Lead-in Phase||11
8198642|NCT02226172|20216058|P1|NOT COMPLETED|Overall Study||17
8198643|NCT02226172|20216058|P1|COMPLETED|Overall Study||4
8198644|NCT02226172|20216058|P1|STARTED|Overall Study||21
8198651|NCT02226120|20216122|P1|NOT COMPLETED|Overall Study||320
8198652|NCT02226120|20216122|P1|COMPLETED|Overall Study||1660
8198653|NCT02226120|20216122|P1|STARTED|Overall Study||1980
8198654|NCT02226003|20216129|P3|NOT COMPLETED|Overall Study||6
8198655|NCT02226003|20216130|P2|NOT COMPLETED|Overall Study||1
8198656|NCT02226003|20216131|P1|NOT COMPLETED|Overall Study||2
8198657|NCT02226003|20216129|P3|COMPLETED|Overall Study||91
8198658|NCT02226003|20216130|P2|COMPLETED|Overall Study||95
8198659|NCT02226003|20216131|P1|COMPLETED|Overall Study||96
8198660|NCT02226003|20216129|P3|STARTED|Overall Study||97
8198661|NCT02226003|20216130|P2|STARTED|Overall Study||96
8198662|NCT02226003|20216131|P1|STARTED|Overall Study||98
8198666|NCT02225860|20216176|P2|NOT COMPLETED|Overall Study||0
8198667|NCT02225860|20216177|P1|NOT COMPLETED|Overall Study||1
8198668|NCT02225860|20216176|P2|COMPLETED|Overall Study||17
8198669|NCT02225860|20216177|P1|COMPLETED|Overall Study||16
8198670|NCT02225860|20216176|P2|STARTED|Overall Study||17
8198671|NCT02225860|20216177|P1|STARTED|Overall Study||17
8198672|NCT02225743|20216187|P1|NOT COMPLETED|Overall Study||18
8198673|NCT02225743|20216187|P1|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102
8198674|NCT02225743|20216187|P1|STARTED|Overall Study||120
8198675|NCT02225587|20216193|P2|NOT COMPLETED|Overall Study||38
8198676|NCT02225587|20216194|P1|NOT COMPLETED|Overall Study||28
8198677|NCT02225587|20216193|P2|COMPLETED|Overall Study||162
8198678|NCT02225587|20216194|P1|COMPLETED|Overall Study||172
8198679|NCT02225587|20216193|P2|Vaccination 3|Overall Study||164
8198680|NCT02225587|20216194|P1|Vaccination 3|Overall Study||172
8198681|NCT02225587|20216193|P2|Vaccination 2|Overall Study||185
8198682|NCT02225587|20216194|P1|Vaccination 2|Overall Study||188
8198683|NCT02225587|20216193|P2|STARTED|Overall Study||200
8198684|NCT02225587|20216194|P1|STARTED|Overall Study||200
8198685|NCT02225353|20216223|P3|NOT COMPLETED|Overall Study||15
8198686|NCT02225353|20216224|P2|NOT COMPLETED|Overall Study||6
8198687|NCT02225353|20216225|P1|NOT COMPLETED|Overall Study||4
8198688|NCT02225353|20216223|P3|COMPLETED|Overall Study||75
8198689|NCT02225353|20216224|P2|COMPLETED|Overall Study||84
8198690|NCT02225353|20216225|P1|COMPLETED|Overall Study||87
8198691|NCT02225353|20216223|P3|STARTED|Overall Study||90
8198692|NCT02225353|20216224|P2|STARTED|Overall Study||90
8198693|NCT02225353|20216225|P1|STARTED|Overall Study||91
8198694|NCT02225132|20216248|P1|NOT COMPLETED|Overall Study||0
8198695|NCT02225132|20216248|P1|COMPLETED|Overall Study||10
8198696|NCT02225132|20216248|P1|STARTED|Overall Study||10
8198697|NCT02225106|20216253|P1|NOT COMPLETED|Overall Study||0
8198698|NCT02225106|20216253|P1|COMPLETED|Overall Study||11
8198699|NCT02225106|20216253|P1|STARTED|Overall Study||11
8198700|NCT02225080|20216257|P1|NOT COMPLETED|Overall Study||0
8198701|NCT02225080|20216257|P1|COMPLETED|Overall Study||100
8198702|NCT02225080|20216257|P1|STARTED|Overall Study||100
8198703|NCT02224846|20216266|P2|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
8198704|NCT02224846|20216267|P1|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
8198705|NCT02224846|20216266|P2|COMPLETED|Period 2 (Month 12 to Month 24)||283
8198706|NCT02224846|20216267|P1|COMPLETED|Period 2 (Month 12 to Month 24)||131
8198707|NCT02224846|20216266|P2|STARTED|Period 2 (Month 12 to Month 24)||357
8198708|NCT02224846|20216267|P1|STARTED|Period 2 (Month 12 to Month 24)||173
8198709|NCT02224846|20216266|P2|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
8198710|NCT02224846|20216267|P1|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
8198711|NCT02224846|20216266|P2|COMPLETED|Period 2 (Month 3 to Month 12)||357
8198712|NCT02224846|20216267|P1|COMPLETED|Period 2 (Month 3 to Month 12)||173
8198713|NCT02224846|20216266|P2|STARTED|Period 2 (Month 3 to Month 12)||388
8198714|NCT02224846|20216267|P1|STARTED|Period 2 (Month 3 to Month 12)||192
8198715|NCT02224846|20216266|P2|NOT COMPLETED|Period 1 (Month 3)||36
8198716|NCT02224846|20216267|P1|NOT COMPLETED|Period 1 (Month 3)||19
8198717|NCT02224846|20216266|P2|COMPLETED|Period 1 (Month 3)||388
8198718|NCT02224846|20216267|P1|COMPLETED|Period 1 (Month 3)||192
8198719|NCT02224846|20216266|P2|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
8198720|NCT02224846|20216267|P1|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
8198721|NCT02224846|20216266|P2|STARTED|Period 1 (Month 3)||424
8198722|NCT02224846|20216267|P1|STARTED|Period 1 (Month 3)||211
8198723|NCT02224820|20216287|P1|NOT COMPLETED|Overall Study||0
8198724|NCT02224820|20216287|P1|COMPLETED|Overall Study|One patient did not receive full dose|8
8198725|NCT02224820|20216287|P1|STARTED|Overall Study||8
8198726|NCT02224755|20216297|P2|NOT COMPLETED|Two Year Follow up Post-implant||226
8198727|NCT02224755|20216298|P1|NOT COMPLETED|Two Year Follow up Post-implant||258
8198728|NCT02224755|20216297|P2|COMPLETED|Two Year Follow up Post-implant||289
8198729|NCT02224755|20216298|P1|COMPLETED|Two Year Follow up Post-implant||247
8198730|NCT02224755|20216297|P2|STARTED|Two Year Follow up Post-implant||515
8198731|NCT02224755|20216298|P1|STARTED|Two Year Follow up Post-implant||505
8198732|NCT02224755|20216297|P2|NOT COMPLETED|Randomization to Device Implant||1
8198733|NCT02224755|20216298|P1|NOT COMPLETED|Randomization to Device Implant||7
8198734|NCT02224755|20216297|P2|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515
8198735|NCT02224755|20216298|P1|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505
8198736|NCT02224755|20216297|P2|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516
8198737|NCT02224755|20216298|P1|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512
8198738|NCT02224729|20216322|P1|NOT COMPLETED|Overall Study||0
8198739|NCT02224729|20216322|P1|COMPLETED|Overall Study||24
8198740|NCT02224729|20216322|P1|STARTED|Overall Study||24
8198741|NCT02224703|20216333|P3|NOT COMPLETED|Overall Study||0
8198742|NCT02224703|20216334|P2|NOT COMPLETED|Overall Study||6
8198743|NCT02224703|20216335|P1|NOT COMPLETED|Overall Study||3
8198744|NCT02224703|20216333|P3|COMPLETED|Overall Study||65
8198745|NCT02224703|20216334|P2|COMPLETED|Overall Study||61
8198746|NCT02224703|20216335|P1|COMPLETED|Overall Study||64
8198747|NCT02224703|20216333|P3|Intent to Treat (ITT) Analysis Set|Overall Study||65
8198748|NCT02224703|20216334|P2|Intent to Treat (ITT) Analysis Set|Overall Study||67
8198749|NCT02224703|20216335|P1|Intent to Treat (ITT) Analysis Set|Overall Study||66
8198750|NCT02224703|20216333|P3|Safety Analysis Set|Overall Study||65
8198751|NCT02224703|20216334|P2|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69
8198752|NCT02224703|20216335|P1|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64
8198753|NCT02224703|20216333|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
8198754|NCT02224703|20216334|P2|Received at Least 1 Dose of Study Drug|Overall Study||67
8198755|NCT02224703|20216335|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
8198756|NCT02224703|20216333|P3|STARTED|Overall Study||65
8198757|NCT02224703|20216334|P2|STARTED|Overall Study||67
8198758|NCT02224703|20216335|P1|STARTED|Overall Study||67
8198759|NCT02224690|20216354|P2|NOT COMPLETED|Overall Study||1
8198760|NCT02224690|20216355|P1|NOT COMPLETED|Overall Study||14
8198761|NCT02224690|20216354|P2|COMPLETED|Overall Study||84
8198762|NCT02224690|20216355|P1|COMPLETED|Overall Study||72
8198763|NCT02224690|20216354|P2|Intent to Treat (ITT) Analysis Set|Overall Study||85
8198764|NCT02224690|20216355|P1|Intent to Treat (ITT) Analysis Set|Overall Study||86
8198765|NCT02224690|20216354|P2|Safety Analysis Set|Overall Study||85
8198766|NCT02224690|20216355|P1|Safety Analysis Set|Overall Study||86
8198767|NCT02224690|20216354|P2|STARTED|Overall Study||85
8198768|NCT02224690|20216355|P1|STARTED|Overall Study||86
8198769|NCT02224664|20216367|P5|NOT COMPLETED|Dose Escalation Period (21 Days)||11
8198770|NCT02224664|20216368|P4|NOT COMPLETED|Dose Escalation Period (21 Days)||3
8198771|NCT02224664|20216369|P3|NOT COMPLETED|Dose Escalation Period (21 Days)||2
8198772|NCT02224664|20216370|P2|NOT COMPLETED|Dose Escalation Period (21 Days)||0
8198773|NCT02224664|20216371|P1|NOT COMPLETED|Dose Escalation Period (21 Days)||0
8198774|NCT02224664|20216367|P5|COMPLETED|Dose Escalation Period (21 Days)||8
8198775|NCT02224664|20216368|P4|COMPLETED|Dose Escalation Period (21 Days)||3
8198776|NCT02224664|20216369|P3|COMPLETED|Dose Escalation Period (21 Days)||9
8198777|NCT02224664|20216370|P2|COMPLETED|Dose Escalation Period (21 Days)||9
8198778|NCT02224664|20216371|P1|COMPLETED|Dose Escalation Period (21 Days)||0
8198779|NCT02224664|20216367|P5|STARTED|Dose Escalation Period (21 Days)||19
8198780|NCT02224664|20216368|P4|STARTED|Dose Escalation Period (21 Days)||6
8198781|NCT02224664|20216369|P3|STARTED|Dose Escalation Period (21 Days)||11
8198782|NCT02224664|20216370|P2|STARTED|Dose Escalation Period (21 Days)||9
8198783|NCT02224664|20216371|P1|STARTED|Dose Escalation Period (21 Days)||0
8198784|NCT02224664|20216367|P5|NOT COMPLETED|Lead-in Period (3 Days)||0
8198785|NCT02224664|20216368|P4|NOT COMPLETED|Lead-in Period (3 Days)||0
8198786|NCT02224664|20216369|P3|NOT COMPLETED|Lead-in Period (3 Days)||0
8198787|NCT02224664|20216370|P2|NOT COMPLETED|Lead-in Period (3 Days)||0
8198788|NCT02224664|20216371|P1|NOT COMPLETED|Lead-in Period (3 Days)||5
8198789|NCT02224664|20216367|P5|COMPLETED|Lead-in Period (3 Days)||0
8198790|NCT02224664|20216368|P4|COMPLETED|Lead-in Period (3 Days)||0
8198791|NCT02224664|20216369|P3|COMPLETED|Lead-in Period (3 Days)||0
8198792|NCT02224664|20216370|P2|COMPLETED|Lead-in Period (3 Days)||0
8198793|NCT02224664|20216371|P1|COMPLETED|Lead-in Period (3 Days)||45
8198794|NCT02224664|20216367|P5|STARTED|Lead-in Period (3 Days)||0
8198795|NCT02224664|20216368|P4|STARTED|Lead-in Period (3 Days)||0
8198796|NCT02224664|20216369|P3|STARTED|Lead-in Period (3 Days)||0
8198797|NCT02224664|20216370|P2|STARTED|Lead-in Period (3 Days)||0
8198798|NCT02224664|20216371|P1|STARTED|Lead-in Period (3 Days)||50
8198799|NCT02224638|20216453|P2|NOT COMPLETED|Overall Study||1
8198800|NCT02224638|20216454|P1|NOT COMPLETED|Overall Study||1
8198801|NCT02224638|20216453|P2|COMPLETED|Overall Study||9
8198802|NCT02224638|20216454|P1|COMPLETED|Overall Study||10
8198803|NCT02224638|20216453|P2|STARTED|Overall Study||10
8198804|NCT02224638|20216454|P1|STARTED|Overall Study||11
8198805|NCT02224625|20216462|P1|NOT COMPLETED|Sensitization||55
8198806|NCT02224625|20216462|P1|COMPLETED|Sensitization||194
8198807|NCT02224625|20216462|P1|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
8198808|NCT02224625|20216462|P1|NOT COMPLETED|Irritation||6
8198809|NCT02224625|20216462|P1|COMPLETED|Irritation||33
8198810|NCT02224625|20216462|P1|STARTED|Irritation||39
8198811|NCT02224612|20216474|P2|NOT COMPLETED|Overall Study||0
8198812|NCT02224612|20216475|P1|NOT COMPLETED|Overall Study||0
8198813|NCT02224612|20216474|P2|COMPLETED|Overall Study||48
8198814|NCT02224612|20216475|P1|COMPLETED|Overall Study||48
8198815|NCT02224612|20216474|P2|STARTED|Overall Study||48
8198816|NCT02224612|20216475|P1|STARTED|Overall Study||48
8198817|NCT02224599|20216483|P1|NOT COMPLETED|Overall Study||2
8198818|NCT02224599|20216483|P1|COMPLETED|Overall Study||1
8198819|NCT02224599|20216483|P1|STARTED|Overall Study||3
8198820|NCT02224560|20216492|P3|NOT COMPLETED|Overall Study||2
8198821|NCT02224560|20216493|P2|NOT COMPLETED|Overall Study||2
8198822|NCT02224560|20216494|P1|NOT COMPLETED|Overall Study||9
8198823|NCT02224560|20216492|P3|COMPLETED|Overall Study||74
8198824|NCT02224560|20216493|P2|COMPLETED|Overall Study||71
8198825|NCT02224560|20216494|P1|COMPLETED|Overall Study||67
8198826|NCT02224560|20216492|P3|Intent to Treat (ITT) Analysis Set|Overall Study||76
8198827|NCT02224560|20216493|P2|Intent to Treat (ITT) Analysis Set|Overall Study||73
8198828|NCT02224560|20216494|P1|Intent to Treat (ITT) Analysis Set|Overall Study||76
8198829|NCT02224560|20216492|P3|Safety Analysis Set|Overall Study||76
8198830|NCT02224560|20216493|P2|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
8198831|NCT02224560|20216494|P1|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
8198832|NCT02224560|20216492|P3|STARTED|Overall Study||76
8198833|NCT02224560|20216493|P2|STARTED|Overall Study||73
8198834|NCT02224560|20216494|P1|STARTED|Overall Study||76
8198835|NCT02224508|20216513|P2|NOT COMPLETED|Overall Study||0
8198836|NCT02224508|20216514|P1|NOT COMPLETED|Overall Study||0
8198837|NCT02224508|20216513|P2|COMPLETED|Overall Study||653
8198838|NCT02224508|20216514|P1|COMPLETED|Overall Study||935
8198839|NCT02224508|20216513|P2|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
8198840|NCT02224508|20216514|P1|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
8198841|NCT02224404|20216524|P1|NOT COMPLETED|Overall Study||0
8198842|NCT02224404|20216524|P1|COMPLETED|Overall Study||21
8198843|NCT02224404|20216524|P1|STARTED|Overall Study||21
8198844|NCT02224313|20216531|P2|NOT COMPLETED|Overall Study||1
8198845|NCT02224313|20216532|P1|NOT COMPLETED|Overall Study||3
8198846|NCT02224313|20216531|P2|COMPLETED|Overall Study||9
8198847|NCT02224313|20216532|P1|COMPLETED|Overall Study||7
8198848|NCT02224313|20216531|P2|STARTED|Overall Study||10
8198849|NCT02224313|20216532|P1|STARTED|Overall Study||10
8198850|NCT02224274|20216542|P2|NOT COMPLETED|Overall Study||0
8198851|NCT02224274|20216543|P1|NOT COMPLETED|Overall Study||1
8198852|NCT02224274|20216542|P2|COMPLETED|Overall Study||20
8198853|NCT02224274|20216543|P1|COMPLETED|Overall Study||16
8198854|NCT02224274|20216542|P2|STARTED|Overall Study||20
8198855|NCT02224274|20216543|P1|STARTED|Overall Study||17
8198856|NCT02224157|20216555|P2|NOT COMPLETED|Overall Study||111
8198857|NCT02224157|20216556|P1|NOT COMPLETED|Overall Study||110
8198858|NCT02224157|20216555|P2|COMPLETED|Overall Study||1983
8198859|NCT02224157|20216556|P1|COMPLETED|Overall Study||1985
8198860|NCT02224157|20216555|P2|Patients Who Completed Treatment|Overall Study||1903
8198861|NCT02224157|20216556|P1|Patients Who Completed Treatment|Overall Study||1924
8198862|NCT02224157|20216555|P2|STARTED|Overall Study||2094
8198863|NCT02224157|20216556|P1|STARTED|Overall Study||2095
8198864|NCT02224053|20216580|P1|NOT COMPLETED|AZD9291 Alone||0
8198865|NCT02224053|20216580|P1|COMPLETED|AZD9291 Alone||47
8198866|NCT02224053|20216580|P1|STARTED|AZD9291 Alone||47
8198867|NCT02224053|20216580|P1|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
8198868|NCT02224053|20216580|P1|COMPLETED|AZD9291 and Omeprazole Co-administration||47
8198869|NCT02224053|20216580|P1|STARTED|AZD9291 and Omeprazole Co-administration||68
8198870|NCT02223871|20216612|P1|NOT COMPLETED|Overall Study||0
8198871|NCT02223871|20216612|P1|COMPLETED|Overall Study||8
8198872|NCT02223871|20216612|P1|STARTED|Overall Study||8
8198873|NCT02223858|20216626|P2|NOT COMPLETED|Overall Study||26
8198874|NCT02223858|20216627|P1|NOT COMPLETED|Overall Study||24
8198875|NCT02223858|20216626|P2|COMPLETED|Overall Study||154
8198876|NCT02223858|20216627|P1|COMPLETED|Overall Study||156
8198877|NCT02223858|20216626|P2|6-month Follow-up|Overall Study||154
8198878|NCT02223858|20216627|P1|6-month Follow-up|Overall Study||156
8198879|NCT02223858|20216626|P2|3-month Follow-up|Overall Study||154
8198880|NCT02223858|20216627|P1|3-month Follow-up|Overall Study||155
8198881|NCT02223858|20216626|P2|1-month Follow-up|Overall Study||150
8198882|NCT02223858|20216627|P1|1-month Follow-up|Overall Study||156
8198883|NCT02223858|20216626|P2|STARTED|Overall Study||180
8198884|NCT02223858|20216627|P1|STARTED|Overall Study||180
8198885|NCT02223793|20216640|P3|NOT COMPLETED|Overall Study||13
8198886|NCT02223793|20216641|P2|NOT COMPLETED|Overall Study||9
8198887|NCT02223793|20216642|P1|NOT COMPLETED|Overall Study||17
8198888|NCT02223793|20216640|P3|COMPLETED|Overall Study||185
8198889|NCT02223793|20216641|P2|COMPLETED|Overall Study||190
8198890|NCT02223793|20216642|P1|COMPLETED|Overall Study||168
8198891|NCT02223793|20216640|P3|STARTED|Overall Study||198
8198892|NCT02223793|20216641|P2|STARTED|Overall Study||199
8198893|NCT02223793|20216642|P1|STARTED|Overall Study||185
8198894|NCT02223754|20216655|P2|NOT COMPLETED|Period 2||3
8198895|NCT02223754|20216656|P1|NOT COMPLETED|Period 2||3
8198896|NCT02223754|20216655|P2|COMPLETED|Period 2||141
8198897|NCT02223754|20216656|P1|COMPLETED|Period 2||156
8198898|NCT02223754|20216655|P2|STARTED|Period 2||144
8198899|NCT02223754|20216656|P1|STARTED|Period 2||159
8198900|NCT02223754|20216655|P2|NOT COMPLETED|Period 1||15
8198901|NCT02223754|20216656|P1|NOT COMPLETED|Period 1||4
8198902|NCT02223754|20216655|P2|COMPLETED|Period 1||144
8198903|NCT02223754|20216656|P1|COMPLETED|Period 1||159
8198904|NCT02223754|20216655|P2|STARTED|Period 1||159
8198905|NCT02223754|20216656|P1|STARTED|Period 1||163
8198906|NCT02223715|20216676|P1|NOT COMPLETED|Overall Study||104
8198907|NCT02223715|20216676|P1|COMPLETED|Overall Study||496
8198908|NCT02223715|20216676|P1|STARTED|Overall Study||600
8198909|NCT02223702|20216685|P2|NOT COMPLETED|Overall Study||4
8198910|NCT02223702|20216686|P1|NOT COMPLETED|Overall Study||1
8198911|NCT02223702|20216685|P2|COMPLETED|Overall Study||15
8198912|NCT02223702|20216686|P1|COMPLETED|Overall Study||19
8198913|NCT02223702|20216685|P2|STARTED|Overall Study||19
8198914|NCT02223702|20216686|P1|STARTED|Overall Study||20
8198915|NCT02223689|20216694|P1|NOT COMPLETED|Overall Study||0
8198916|NCT02223689|20216694|P1|COMPLETED|Overall Study||35
8198917|NCT02223689|20216694|P1|STARTED|Overall Study||35
8198918|NCT02223650|20216701|P2|NOT COMPLETED|Overall Study||0
8198919|NCT02223650|20216702|P1|NOT COMPLETED|Overall Study||0
8198920|NCT02223650|20216701|P2|COMPLETED|Overall Study||31
8198921|NCT02223650|20216702|P1|COMPLETED|Overall Study||27
8198922|NCT02223650|20216701|P2|STARTED|Overall Study||31
8198923|NCT02223650|20216702|P1|STARTED|Overall Study||27
8198924|NCT02223637|20216732|P1|NOT COMPLETED|Overall Study||0
8198925|NCT02223637|20216732|P1|COMPLETED|Overall Study||82
8198926|NCT02223637|20216732|P1|STARTED|Overall Study||82
8198927|NCT02223546|20216755|P1|NOT COMPLETED|Overall Study||0
8198928|NCT02223546|20216755|P1|COMPLETED|Overall Study||15
8198929|NCT02223546|20216755|P1|STARTED|Overall Study||15
8198930|NCT02223520|20216762|P2|NOT COMPLETED|Overall Study||0
8198931|NCT02223520|20216763|P1|NOT COMPLETED|Overall Study||0
8198932|NCT02223520|20216762|P2|COMPLETED|Overall Study|107 neonates of these parents were enrolled. 6 were lost to follow-up.|160
8198933|NCT02223520|20216763|P1|COMPLETED|Overall Study|101 neonates of these parents were enrolled. 12 were lost to follow-up.|147
8198934|NCT02223520|20216762|P2|STARTED|Overall Study||160
8198935|NCT02223520|20216763|P1|STARTED|Overall Study||147
8198936|NCT02223455|20216772|P3|NOT COMPLETED|Overall Study||0
8198937|NCT02223455|20216773|P2|NOT COMPLETED|Overall Study||0
8198938|NCT02223455|20216774|P1|NOT COMPLETED|Overall Study||0
8198939|NCT02223455|20216772|P3|COMPLETED|Overall Study|Participant level data not collected.|0
8198940|NCT02223455|20216773|P2|COMPLETED|Overall Study|Participant level data not collected.|0
8198941|NCT02223455|20216774|P1|COMPLETED|Overall Study|Participant level data not collected.|0
8198942|NCT02223455|20216772|P3|STARTED|Overall Study|Participant level data not collected.|0
8198943|NCT02223455|20216773|P2|STARTED|Overall Study|Participant level data not collected.|0
8198944|NCT02223455|20216774|P1|STARTED|Overall Study|Participant level data not collected.|0
8198945|NCT02223429|20216786|P4|NOT COMPLETED|Overall Study||0
8198946|NCT02223429|20216787|P3|NOT COMPLETED|Overall Study||0
8198947|NCT02223429|20216788|P2|NOT COMPLETED|Overall Study||0
8198948|NCT02223429|20216789|P1|NOT COMPLETED|Overall Study||1
8198949|NCT02223429|20216786|P4|COMPLETED|Overall Study||8
8198950|NCT02223429|20216787|P3|COMPLETED|Overall Study||8
8198951|NCT02223429|20216788|P2|COMPLETED|Overall Study||8
8198952|NCT02223429|20216789|P1|COMPLETED|Overall Study||7
8198953|NCT02223429|20216786|P4|STARTED|Overall Study||8
8198954|NCT02223429|20216787|P3|STARTED|Overall Study||8
8198955|NCT02223429|20216788|P2|STARTED|Overall Study||8
8198956|NCT02223429|20216789|P1|STARTED|Overall Study||8
8198957|NCT02223390|20216819|P2|NOT COMPLETED|Overall Study||4
8198958|NCT02223390|20216820|P1|NOT COMPLETED|Overall Study||9
8198959|NCT02223390|20216819|P2|COMPLETED|Overall Study||28
8198960|NCT02223390|20216820|P1|COMPLETED|Overall Study||23
8198961|NCT02223390|20216819|P2|STARTED|Overall Study||32
8198962|NCT02223390|20216820|P1|STARTED|Overall Study||32
8198963|NCT02223364|20216831|P3|NOT COMPLETED|Overall Study||3
8198964|NCT02223364|20216832|P2|NOT COMPLETED|Overall Study||0
8198965|NCT02223364|20216833|P1|NOT COMPLETED|Overall Study||5
8198966|NCT02223364|20216831|P3|COMPLETED|Overall Study||52
8198967|NCT02223364|20216832|P2|COMPLETED|Overall Study||55
8198968|NCT02223364|20216833|P1|COMPLETED|Overall Study||50
8198969|NCT02223364|20216831|P3|STARTED|Overall Study||55
8198970|NCT02223364|20216832|P2|STARTED|Overall Study||55
8198971|NCT02223364|20216833|P1|STARTED|Overall Study||55
8198972|NCT02223351|20216885|P2|NOT COMPLETED|Overall Study||0
8198973|NCT02223351|20216886|P1|NOT COMPLETED|Overall Study||0
8198974|NCT02223351|20216885|P2|COMPLETED|Overall Study||24
8198975|NCT02223351|20216886|P1|COMPLETED|Overall Study||24
8198976|NCT02223351|20216885|P2|Second Intervention (8 Days)|Overall Study||24
8198977|NCT02223351|20216886|P1|Second Intervention (8 Days)|Overall Study||24
8198978|NCT02223351|20216885|P2|Wasout (2weeks)|Overall Study||24
8198979|NCT02223351|20216886|P1|Wasout (2weeks)|Overall Study||24
8198980|NCT02223351|20216885|P2|First Intervention (8 Days)|Overall Study||24
8198981|NCT02223351|20216886|P1|First Intervention (8 Days)|Overall Study||24
8198982|NCT02223351|20216885|P2|STARTED|Overall Study||24
8198983|NCT02223351|20216886|P1|STARTED|Overall Study||24
8198984|NCT02223338|20216946|P2|NOT COMPLETED|Overall Study||0
8198985|NCT02223338|20216947|P1|NOT COMPLETED|Overall Study||0
8198986|NCT02223338|20216946|P2|COMPLETED|Overall Study||60
8198987|NCT02223338|20216947|P1|COMPLETED|Overall Study||60
8198988|NCT02223338|20216946|P2|STARTED|Overall Study||60
8198989|NCT02223338|20216947|P1|STARTED|Overall Study||60
8198990|NCT02223260|20216955|P1|NOT COMPLETED|Overall Study||0
8198991|NCT02223260|20216955|P1|COMPLETED|Overall Study||8
8198992|NCT02223260|20216955|P1|STARTED|Overall Study||8
8198993|NCT02223065|20216973|P2|NOT COMPLETED|Overall Study||0
8198994|NCT02223065|20216974|P1|NOT COMPLETED|Overall Study||0
8198995|NCT02223065|20216973|P2|COMPLETED|Overall Study||18
8198996|NCT02223065|20216974|P1|COMPLETED|Overall Study||18
8198997|NCT02223065|20216973|P2|STARTED|Overall Study||18
8198998|NCT02223065|20216974|P1|STARTED|Overall Study||18
8198999|NCT02222922|20216999|P9|NOT COMPLETED|Overall Study||6
8199000|NCT02222922|20217000|P8|NOT COMPLETED|Overall Study||4
8199001|NCT02222922|20217001|P7|NOT COMPLETED|Overall Study||2
8199002|NCT02222922|20217002|P6|NOT COMPLETED|Overall Study||3
8199003|NCT02222922|20217003|P5|NOT COMPLETED|Overall Study||38
8199004|NCT02222922|20217004|P4|NOT COMPLETED|Overall Study||3
8199005|NCT02222922|20217005|P3|NOT COMPLETED|Overall Study||1
8199006|NCT02222922|20217006|P2|NOT COMPLETED|Overall Study||0
8199007|NCT02222922|20217007|P1|NOT COMPLETED|Overall Study||1
8199008|NCT02222922|20216999|P9|COMPLETED|Overall Study||6
8199009|NCT02222922|20217000|P8|COMPLETED|Overall Study||6
8199010|NCT02222922|20217001|P7|COMPLETED|Overall Study||1
8199011|NCT02222922|20217002|P6|COMPLETED|Overall Study||3
8199012|NCT02222922|20217003|P5|COMPLETED|Overall Study||58
8199013|NCT02222922|20217004|P4|COMPLETED|Overall Study||2
8199014|NCT02222922|20217005|P3|COMPLETED|Overall Study||1
8199015|NCT02222922|20217006|P2|COMPLETED|Overall Study||2
8199016|NCT02222922|20217007|P1|COMPLETED|Overall Study||1
8199017|NCT02222922|20216999|P9|Received Treatment|Overall Study||12
8199018|NCT02222922|20217000|P8|Received Treatment|Overall Study||10
8199019|NCT02222922|20217001|P7|Received Treatment|Overall Study||3
8199020|NCT02222922|20217002|P6|Received Treatment|Overall Study||6
8199021|NCT02222922|20217003|P5|Received Treatment|Overall Study||96
8199022|NCT02222922|20217004|P4|Received Treatment|Overall Study||4
8199023|NCT02222922|20217005|P3|Received Treatment|Overall Study||2
8199024|NCT02222922|20217006|P2|Received Treatment|Overall Study||2
8199025|NCT02222922|20217007|P1|Received Treatment|Overall Study||2
8199026|NCT02222922|20216999|P9|STARTED|Overall Study||12
8199027|NCT02222922|20217000|P8|STARTED|Overall Study||10
8199028|NCT02222922|20217001|P7|STARTED|Overall Study||3
8199029|NCT02222922|20217002|P6|STARTED|Overall Study||6
8199030|NCT02222922|20217003|P5|STARTED|Overall Study||96
8199031|NCT02222922|20217004|P4|STARTED|Overall Study||5
8199032|NCT02222922|20217005|P3|STARTED|Overall Study||2
8199033|NCT02222922|20217006|P2|STARTED|Overall Study||2
8199034|NCT02222922|20217007|P1|STARTED|Overall Study||2
8199035|NCT02222870|20217357|P2|NOT COMPLETED|Overall Study||0
8199036|NCT02222870|20217358|P1|NOT COMPLETED|Overall Study||0
8199037|NCT02222870|20217357|P2|COMPLETED|Overall Study||30
8199038|NCT02222870|20217358|P1|COMPLETED|Overall Study||30
8199039|NCT02222870|20217357|P2|STARTED|Overall Study||30
8199040|NCT02222870|20217358|P1|STARTED|Overall Study||30
8199041|NCT02222818|20217374|P2|NOT COMPLETED|Period 2||0
8199042|NCT02222818|20217375|P1|NOT COMPLETED|Period 2||0
8199043|NCT02222818|20217374|P2|COMPLETED|Period 2|End of CAFR evaluation period|30
8199044|NCT02222818|20217375|P1|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
8199045|NCT02222818|20217374|P2|STARTED|Period 2|Start of CAFR evaluation period|30
8199046|NCT02222818|20217375|P1|STARTED|Period 2|Start of CAFRPlus evaluation period|33
8199047|NCT02222818|20217374|P2|NOT COMPLETED|Period 1||3
8199048|NCT02222818|20217375|P1|NOT COMPLETED|Period 1||0
8199049|NCT02222818|20217374|P2|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
8199050|NCT02222818|20217375|P1|COMPLETED|Period 1|End of CAFR evaluation period|33
8199051|NCT02222818|20217374|P2|STARTED|Period 1|Start of CAFRPlus evaluation period|33
8199052|NCT02222818|20217375|P1|STARTED|Period 1|Start of CAFR evaluation period|33
8199053|NCT02222714|20217387|P5|NOT COMPLETED|Overall Study||7
8199054|NCT02222714|20217388|P4|NOT COMPLETED|Overall Study||4
8199055|NCT02222714|20217389|P3|NOT COMPLETED|Overall Study||4
8199056|NCT02222714|20217390|P2|NOT COMPLETED|Overall Study||2
8199057|NCT02222714|20217391|P1|NOT COMPLETED|Overall Study||0
8199058|NCT02222714|20217387|P5|COMPLETED|Overall Study||37
8199059|NCT02222714|20217388|P4|COMPLETED|Overall Study||11
8199060|NCT02222714|20217389|P3|COMPLETED|Overall Study||8
8199061|NCT02222714|20217390|P2|COMPLETED|Overall Study||22
8199062|NCT02222714|20217391|P1|COMPLETED|Overall Study||15
8199063|NCT02222714|20217387|P5|STARTED|Overall Study||44
8199064|NCT02222714|20217388|P4|STARTED|Overall Study||15
8199065|NCT02222714|20217389|P3|STARTED|Overall Study||12
8199066|NCT02222714|20217390|P2|STARTED|Overall Study||24
8199067|NCT02222714|20217391|P1|STARTED|Overall Study||15
8199068|NCT02222688|20217437|P7|NOT COMPLETED|Overall Study||1
8199069|NCT02222688|20217438|P6|NOT COMPLETED|Overall Study||0
8199070|NCT02222688|20217439|P5|NOT COMPLETED|Overall Study||1
8199071|NCT02222688|20217440|P4|NOT COMPLETED|Overall Study||2
8199072|NCT02222688|20217441|P3|NOT COMPLETED|Overall Study||0
8199073|NCT02222688|20217442|P2|NOT COMPLETED|Overall Study||0
8199074|NCT02222688|20217443|P1|NOT COMPLETED|Overall Study||1
8199075|NCT02222688|20217437|P7|COMPLETED|Overall Study||5
8199076|NCT02222688|20217438|P6|COMPLETED|Overall Study||3
8199077|NCT02222688|20217439|P5|COMPLETED|Overall Study||2
8199078|NCT02222688|20217440|P4|COMPLETED|Overall Study||3
8199079|NCT02222688|20217441|P3|COMPLETED|Overall Study||3
8199080|NCT02222688|20217442|P2|COMPLETED|Overall Study||3
8199081|NCT02222688|20217443|P1|COMPLETED|Overall Study||3
8199082|NCT02222688|20217437|P7|STARTED|Overall Study||6
8199083|NCT02222688|20217438|P6|STARTED|Overall Study||3
8199084|NCT02222688|20217439|P5|STARTED|Overall Study||3
8199085|NCT02222688|20217440|P4|STARTED|Overall Study||5
8199086|NCT02222688|20217441|P3|STARTED|Overall Study||3
8199087|NCT02222688|20217442|P2|STARTED|Overall Study||3
8199088|NCT02222688|20217443|P1|STARTED|Overall Study||4
8199089|NCT02222558|20217481|P6|NOT COMPLETED|Period 3||1
8199090|NCT02222558|20217482|P5|NOT COMPLETED|Period 3||0
8199091|NCT02222558|20217483|P4|NOT COMPLETED|Period 3||0
8199092|NCT02222558|20217484|P3|NOT COMPLETED|Period 3||0
8199093|NCT02222558|20217485|P2|NOT COMPLETED|Period 3||0
8199094|NCT02222558|20217486|P1|NOT COMPLETED|Period 3||0
8199095|NCT02222558|20217481|P6|COMPLETED|Period 3||7
8199096|NCT02222558|20217482|P5|COMPLETED|Period 3||8
8199097|NCT02222558|20217483|P4|COMPLETED|Period 3||1
8199098|NCT02222558|20217484|P3|COMPLETED|Period 3||4
8199099|NCT02222558|20217485|P2|COMPLETED|Period 3||0
8199100|NCT02222558|20217486|P1|COMPLETED|Period 3||0
8199101|NCT02222558|20217481|P6|STARTED|Period 3||8
8199102|NCT02222558|20217482|P5|STARTED|Period 3||8
8199103|NCT02222558|20217483|P4|STARTED|Period 3||1
8199104|NCT02222558|20217484|P3|STARTED|Period 3||4
8199105|NCT02222558|20217485|P2|STARTED|Period 3||0
8199106|NCT02222558|20217486|P1|STARTED|Period 3||0
8199107|NCT02222558|20217481|P6|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199108|NCT02222558|20217482|P5|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199109|NCT02222558|20217483|P4|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199110|NCT02222558|20217484|P3|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199111|NCT02222558|20217485|P2|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199112|NCT02222558|20217486|P1|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199113|NCT02222558|20217481|P6|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199114|NCT02222558|20217482|P5|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199115|NCT02222558|20217483|P4|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199116|NCT02222558|20217484|P3|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199117|NCT02222558|20217485|P2|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
8199118|NCT02222558|20217486|P1|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
8199119|NCT02222558|20217481|P6|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8199120|NCT02222558|20217482|P5|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8199121|NCT02222558|20217483|P4|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8199122|NCT02222558|20217484|P3|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8199123|NCT02222558|20217485|P2|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
8199124|NCT02222558|20217486|P1|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
8199125|NCT02222558|20217481|P6|NOT COMPLETED|Period 1: Single Dose||0
8199126|NCT02222558|20217482|P5|NOT COMPLETED|Period 1: Single Dose||0
8199127|NCT02222558|20217483|P4|NOT COMPLETED|Period 1: Single Dose||0
8199128|NCT02222558|20217484|P3|NOT COMPLETED|Period 1: Single Dose||0
8199129|NCT02222558|20217485|P2|NOT COMPLETED|Period 1: Single Dose||0
8199130|NCT02222558|20217486|P1|NOT COMPLETED|Period 1: Single Dose||4
8199131|NCT02222558|20217481|P6|COMPLETED|Period 1: Single Dose||0
8199132|NCT02222558|20217482|P5|COMPLETED|Period 1: Single Dose||0
8199133|NCT02222558|20217483|P4|COMPLETED|Period 1: Single Dose||0
8199134|NCT02222558|20217484|P3|COMPLETED|Period 1: Single Dose||0
8199135|NCT02222558|20217485|P2|COMPLETED|Period 1: Single Dose||0
8199136|NCT02222558|20217486|P1|COMPLETED|Period 1: Single Dose||21
8199137|NCT02222558|20217481|P6|STARTED|Period 1: Single Dose||0
8199138|NCT02222558|20217482|P5|STARTED|Period 1: Single Dose||0
8199139|NCT02222558|20217483|P4|STARTED|Period 1: Single Dose||0
8199140|NCT02222558|20217484|P3|STARTED|Period 1: Single Dose||0
8199141|NCT02222558|20217485|P2|STARTED|Period 1: Single Dose||0
8199142|NCT02222558|20217486|P1|STARTED|Period 1: Single Dose||25
8199143|NCT02222493|20217502|P2|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
8199144|NCT02222493|20217503|P1|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
8199145|NCT02222493|20217502|P2|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
8199146|NCT02222493|20217503|P1|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
8199147|NCT02222493|20217502|P2|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
8199148|NCT02222493|20217503|P1|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
8199149|NCT02222493|20217502|P2|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
8199150|NCT02222493|20217503|P1|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
8199151|NCT02222493|20217502|P2|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
8199152|NCT02222493|20217503|P1|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
8199153|NCT02222493|20217502|P2|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
8199154|NCT02222493|20217503|P1|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
8199155|NCT02222493|20217502|P2|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
8199156|NCT02222493|20217503|P1|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
8199157|NCT02222493|20217502|P2|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
8199158|NCT02222493|20217503|P1|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
8199159|NCT02222493|20217502|P2|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
8199160|NCT02222493|20217503|P1|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
8199161|NCT02222493|20217502|P2|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
8199162|NCT02222493|20217503|P1|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
8199163|NCT02222337|20217621|P2|NOT COMPLETED|Overall Study||24
8199164|NCT02222337|20217622|P1|NOT COMPLETED|Overall Study||26
8199165|NCT02222337|20217621|P2|COMPLETED|Overall Study||108
8199166|NCT02222337|20217622|P1|COMPLETED|Overall Study||114
8199167|NCT02222337|20217621|P2|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132
8199168|NCT02222337|20217622|P1|STARTED|Overall Study||140
8199169|NCT02222246|20217654|P2|NOT COMPLETED|Overall Study||27
8199170|NCT02222246|20217655|P1|NOT COMPLETED|Overall Study||27
8199171|NCT02222246|20217654|P2|COMPLETED|Overall Study||26
8199172|NCT02222246|20217655|P1|COMPLETED|Overall Study||26
8199173|NCT02222246|20217654|P2|STARTED|Overall Study||53
8199174|NCT02222246|20217655|P1|STARTED|Overall Study||53
8199175|NCT02222207|20217683|P1|NOT COMPLETED|Overall Study||4
8199176|NCT02222207|20217683|P1|COMPLETED|Overall Study||48
8199177|NCT02222207|20217683|P1|Treated and Valid for Full Analysis Set|Overall Study||51
8199178|NCT02222207|20217683|P1|STARTED|Overall Study||52
8199179|NCT02222181|20217690|P1|NOT COMPLETED|Overall Study||108
8199180|NCT02222181|20217690|P1|COMPLETED|Overall Study||55
8199181|NCT02222181|20217690|P1|STARTED|Overall Study||163
8199182|NCT02222129|20217702|P2|NOT COMPLETED|Overall Study||0
8199183|NCT02222129|20217703|P1|NOT COMPLETED|Overall Study||0
8199184|NCT02222129|20217702|P2|COMPLETED|Overall Study||106
8199185|NCT02222129|20217703|P1|COMPLETED|Overall Study||100
8199186|NCT02222129|20217702|P2|STARTED|Overall Study||106
8199187|NCT02222129|20217703|P1|STARTED|Overall Study||100
8199188|NCT02221947|20217711|P2|NOT COMPLETED|Overall Study||0
8199189|NCT02221947|20217712|P1|NOT COMPLETED|Overall Study||0
8199190|NCT02221947|20217711|P2|COMPLETED|Overall Study||3
8199191|NCT02221947|20217712|P1|COMPLETED|Overall Study||6
8199192|NCT02221947|20217711|P2|STARTED|Overall Study||3
8199193|NCT02221947|20217712|P1|STARTED|Overall Study||6
8199194|NCT02221882|20217730|P6|NOT COMPLETED|Overall Study||2
8199195|NCT02221882|20217731|P5|NOT COMPLETED|Overall Study||2
8199196|NCT02221882|20217732|P4|NOT COMPLETED|Overall Study||2
8199197|NCT02221882|20217733|P3|NOT COMPLETED|Overall Study||4
8199198|NCT02221882|20217734|P2|NOT COMPLETED|Overall Study||1
8199199|NCT02221882|20217735|P1|NOT COMPLETED|Overall Study||0
8199200|NCT02221882|20217730|P6|COMPLETED|Overall Study||2
8199201|NCT02221882|20217731|P5|COMPLETED|Overall Study||3
8199202|NCT02221882|20217732|P4|COMPLETED|Overall Study||1
8199203|NCT02221882|20217733|P3|COMPLETED|Overall Study||7
8199204|NCT02221882|20217734|P2|COMPLETED|Overall Study||2
8199205|NCT02221882|20217735|P1|COMPLETED|Overall Study||3
8199206|NCT02221882|20217730|P6|Received at Least One Dose of Study Drug|Overall Study||4
8199207|NCT02221882|20217731|P5|Received at Least One Dose of Study Drug|Overall Study||5
8199208|NCT02221882|20217732|P4|Received at Least One Dose of Study Drug|Overall Study||3
8199209|NCT02221882|20217733|P3|Received at Least One Dose of Study Drug|Overall Study||11
8199210|NCT02221882|20217734|P2|Received at Least One Dose of Study Drug|Overall Study||3
8199211|NCT02221882|20217735|P1|Received at Least One Dose of Study Drug|Overall Study||3
8199212|NCT02221882|20217730|P6|STARTED|Overall Study||4
8199213|NCT02221882|20217731|P5|STARTED|Overall Study||5
8199214|NCT02221882|20217732|P4|STARTED|Overall Study||3
8199215|NCT02221882|20217733|P3|STARTED|Overall Study||11
8199216|NCT02221882|20217734|P2|STARTED|Overall Study||3
8199217|NCT02221882|20217735|P1|STARTED|Overall Study||3
8199218|NCT02221869|20217778|P3|NOT COMPLETED|Overall Study||10
8199219|NCT02221869|20217779|P2|NOT COMPLETED|Overall Study||0
8199220|NCT02221869|20217780|P1|NOT COMPLETED|Overall Study||1
8199221|NCT02221869|20217778|P3|COMPLETED|Overall Study||33
8199222|NCT02221869|20217779|P2|COMPLETED|Overall Study||32
8199223|NCT02221869|20217780|P1|COMPLETED|Overall Study||30
8199224|NCT02221869|20217778|P3|STARTED|Overall Study||43
8199225|NCT02221869|20217779|P2|STARTED|Overall Study||32
8199226|NCT02221869|20217780|P1|STARTED|Overall Study||31
8199227|NCT02221817|20217796|P2|NOT COMPLETED|Overall Study||0
8199228|NCT02221817|20217797|P1|NOT COMPLETED|Overall Study||0
8199229|NCT02221817|20217796|P2|COMPLETED|Overall Study||0
8199230|NCT02221817|20217797|P1|COMPLETED|Overall Study||0
8199231|NCT02221817|20217796|P2|STARTED|Overall Study||0
8199232|NCT02221817|20217797|P1|STARTED|Overall Study||0
8199233|NCT02221739|20217809|P1|NOT COMPLETED|Overall Study||18
8199234|NCT02221739|20217809|P1|COMPLETED|Overall Study||21
8199235|NCT02221739|20217809|P1|STARTED|Overall Study||39
8199236|NCT02221674|20217817|P3|NOT COMPLETED|Overall Study||0
8199237|NCT02221674|20217818|P2|NOT COMPLETED|Overall Study||0
8199238|NCT02221674|20217819|P1|NOT COMPLETED|Overall Study||1
8199239|NCT02221674|20217817|P3|COMPLETED|Overall Study||5
8199240|NCT02221674|20217818|P2|COMPLETED|Overall Study||6
8199241|NCT02221674|20217819|P1|COMPLETED|Overall Study||7
8199242|NCT02221674|20217817|P3|STARTED|Overall Study||5
8199243|NCT02221674|20217818|P2|STARTED|Overall Study||6
8199244|NCT02221674|20217819|P1|STARTED|Overall Study||8
8199245|NCT02221648|20217835|P2|NOT COMPLETED|Overall Study||3
8199246|NCT02221648|20217836|P1|NOT COMPLETED|Overall Study||3
8199247|NCT02221648|20217835|P2|COMPLETED|Overall Study||18
8199248|NCT02221648|20217836|P1|COMPLETED|Overall Study||19
8199249|NCT02221648|20217835|P2|STARTED|Overall Study||21
8199250|NCT02221648|20217836|P1|STARTED|Overall Study||22
8199251|NCT02221557|20217846|P1|NOT COMPLETED|Overall Study||3
8199252|NCT02221557|20217846|P1|COMPLETED|Overall Study||5
8199253|NCT02221557|20217846|P1|STARTED|Overall Study||8
8199254|NCT02221349|20217852|P2|NOT COMPLETED|Overall Study||0
8199255|NCT02221349|20217853|P1|NOT COMPLETED|Overall Study||1
8199256|NCT02221349|20217852|P2|COMPLETED|Overall Study||15
8199257|NCT02221349|20217853|P1|COMPLETED|Overall Study||14
8199258|NCT02221349|20217852|P2|STARTED|Overall Study||15
8199259|NCT02221349|20217853|P1|STARTED|Overall Study||15
8199260|NCT02221284|20217865|P1|NOT COMPLETED|Overall Study||61
8199261|NCT02221284|20217865|P1|COMPLETED|Overall Study||903
8199262|NCT02221284|20217865|P1|STARTED|Overall Study||964
8199263|NCT02221219|20217897|P4|NOT COMPLETED|Overall Study||0
8199264|NCT02221219|20217898|P3|NOT COMPLETED|Overall Study||0
8199265|NCT02221219|20217899|P2|NOT COMPLETED|Overall Study||0
8199266|NCT02221219|20217900|P1|NOT COMPLETED|Overall Study||0
8199267|NCT02221219|20217897|P4|COMPLETED|Overall Study||92
8199268|NCT02221219|20217898|P3|COMPLETED|Overall Study||41
8199269|NCT02221219|20217899|P2|COMPLETED|Overall Study||87
8199270|NCT02221219|20217900|P1|COMPLETED|Overall Study||36
8199271|NCT02221219|20217897|P4|STARTED|Overall Study||92
8199272|NCT02221219|20217898|P3|STARTED|Overall Study||41
8199273|NCT02221219|20217899|P2|STARTED|Overall Study||87
8199274|NCT02221219|20217900|P1|STARTED|Overall Study||36
8199275|NCT02221037|20217914|P4|NOT COMPLETED|Overall Study||0
8199276|NCT02221037|20217915|P3|NOT COMPLETED|Overall Study||1
8199277|NCT02221037|20217916|P2|NOT COMPLETED|Overall Study||0
8199278|NCT02221037|20217917|P1|NOT COMPLETED|Overall Study||0
8199279|NCT02221037|20217914|P4|COMPLETED|Overall Study||9
8199280|NCT02221037|20217915|P3|COMPLETED|Overall Study||7
8199281|NCT02221037|20217916|P2|COMPLETED|Overall Study||11
8199282|NCT02221037|20217917|P1|COMPLETED|Overall Study||5
8199283|NCT02221037|20217914|P4|STARTED|Overall Study||9
8199284|NCT02221037|20217915|P3|STARTED|Overall Study||8
8199285|NCT02221037|20217916|P2|STARTED|Overall Study||11
8199286|NCT02221037|20217917|P1|STARTED|Overall Study||5
8199287|NCT02220998|20218003|P2|NOT COMPLETED|Overall Study||11
8199288|NCT02220998|20218004|P1|NOT COMPLETED|Overall Study||7
8199289|NCT02220998|20218003|P2|COMPLETED|Overall Study||123
8199290|NCT02220998|20218004|P1|COMPLETED|Overall Study||128
8199291|NCT02220998|20218003|P2|STARTED|Overall Study||134
8199292|NCT02220998|20218004|P1|STARTED|Overall Study||135
8199293|NCT02220920|20218022|P2|NOT COMPLETED|Overall Study||3
8199294|NCT02220920|20218023|P1|NOT COMPLETED|Overall Study||3
8199295|NCT02220920|20218022|P2|COMPLETED|Overall Study||67
8199296|NCT02220920|20218023|P1|COMPLETED|Overall Study||73
8199297|NCT02220920|20218022|P2|STARTED|Overall Study||70
8199298|NCT02220920|20218023|P1|STARTED|Overall Study||76
8199299|NCT02220907|20218037|P1|NOT COMPLETED|Overall Study||11
8199300|NCT02220907|20218037|P1|COMPLETED|Overall Study||142
8199301|NCT02220907|20218037|P1|STARTED|Overall Study||153
8199302|NCT02220894|20218046|P2|NOT COMPLETED|Overall Study||637
8199303|NCT02220894|20218047|P1|NOT COMPLETED|Overall Study||637
8199304|NCT02220894|20218046|P2|COMPLETED|Overall Study||0
8199305|NCT02220894|20218047|P1|COMPLETED|Overall Study||0
8199306|NCT02220894|20218046|P2|Treated|Overall Study||615
8199307|NCT02220894|20218047|P1|Treated|Overall Study||636
8199308|NCT02220894|20218046|P2|STARTED|Overall Study||637
8199309|NCT02220894|20218047|P1|STARTED|Overall Study|1 additional participant was randomized in error|637
8199313|NCT02220764|20218083|P2|NOT COMPLETED|Overall Study||1
8199314|NCT02220764|20218084|P1|NOT COMPLETED|Overall Study||4
8199315|NCT02220764|20218083|P2|COMPLETED|Overall Study||7
8199316|NCT02220764|20218084|P1|COMPLETED|Overall Study||20
8199317|NCT02220764|20218083|P2|STARTED|Overall Study||8
8199318|NCT02220764|20218084|P1|STARTED|Overall Study||24
8199319|NCT02220725|20218098|P4|NOT COMPLETED|Overall Study||2
8199320|NCT02220725|20218099|P3|NOT COMPLETED|Overall Study||0
8199321|NCT02220725|20218100|P2|NOT COMPLETED|Overall Study||0
8199322|NCT02220725|20218101|P1|NOT COMPLETED|Overall Study||0
8199323|NCT02220725|20218098|P4|COMPLETED|Overall Study||24
8199324|NCT02220725|20218099|P3|COMPLETED|Overall Study||13
8199325|NCT02220725|20218100|P2|COMPLETED|Overall Study||27
8199326|NCT02220725|20218101|P1|COMPLETED|Overall Study||14
8199327|NCT02220725|20218098|P4|STARTED|Overall Study||26
8199328|NCT02220725|20218099|P3|STARTED|Overall Study||13
8199329|NCT02220725|20218100|P2|STARTED|Overall Study||27
8199330|NCT02220725|20218101|P1|STARTED|Overall Study||14
8199331|NCT02220712|20218129|P1|NOT COMPLETED|Overall Study||4
8199332|NCT02220712|20218129|P1|COMPLETED|Overall Study||13
8199333|NCT02220712|20218129|P1|STARTED|Overall Study||17
8199334|NCT02220205|20218139|P2|NOT COMPLETED|Overall Study||0
8199335|NCT02220205|20218140|P1|NOT COMPLETED|Overall Study||1
8199336|NCT02220205|20218139|P2|COMPLETED|Overall Study||30
8199337|NCT02220205|20218140|P1|COMPLETED|Overall Study||29
8199338|NCT02220205|20218139|P2|STARTED|Overall Study||30
8199339|NCT02220205|20218140|P1|STARTED|Overall Study||30
8199340|NCT02219997|20218150|P3|NOT COMPLETED|Second Filter||0
8199341|NCT02219997|20218151|P2|NOT COMPLETED|Second Filter||0
8199342|NCT02219997|20218152|P1|NOT COMPLETED|Second Filter||0
8199343|NCT02219997|20218150|P3|COMPLETED|Second Filter||18
8199344|NCT02219997|20218151|P2|COMPLETED|Second Filter||17
8199345|NCT02219997|20218152|P1|COMPLETED|Second Filter||0
8199346|NCT02219997|20218150|P3|STARTED|Second Filter||18
8199347|NCT02219997|20218151|P2|STARTED|Second Filter||17
8199348|NCT02219997|20218152|P1|STARTED|Second Filter||0
8199349|NCT02219997|20218150|P3|NOT COMPLETED|First Filter||0
8199350|NCT02219997|20218151|P2|NOT COMPLETED|First Filter||0
8199351|NCT02219997|20218152|P1|NOT COMPLETED|First Filter||0
8199352|NCT02219997|20218150|P3|COMPLETED|First Filter||18
8199353|NCT02219997|20218151|P2|COMPLETED|First Filter||17
8199354|NCT02219997|20218152|P1|COMPLETED|First Filter||33
8199355|NCT02219997|20218150|P3|STARTED|First Filter||18
8199356|NCT02219997|20218151|P2|STARTED|First Filter||17
8199357|NCT02219997|20218152|P1|STARTED|First Filter||33
8199358|NCT02219932|20218165|P2|NOT COMPLETED|Overall Study||51
8199359|NCT02219932|20218166|P1|NOT COMPLETED|Overall Study||65
8199360|NCT02219932|20218165|P2|COMPLETED|Overall Study||266
8199361|NCT02219932|20218166|P1|COMPLETED|Overall Study||254
8199362|NCT02219932|20218165|P2|Randomized, Not Treated|Overall Study||1
8199363|NCT02219932|20218166|P1|Randomized, Not Treated|Overall Study||0
8199364|NCT02219932|20218165|P2|STARTED|Overall Study||317
8199365|NCT02219932|20218166|P1|STARTED|Overall Study||319
8199366|NCT02219685|20218182|P2|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
8199367|NCT02219685|20218183|P1|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
8199368|NCT02219685|20218182|P2|COMPLETED|Open-Label (After Posttreatment Week 4)||14
8199369|NCT02219685|20218183|P1|COMPLETED|Open-Label (After Posttreatment Week 4)||0
8199370|NCT02219685|20218182|P2|STARTED|Open-Label (After Posttreatment Week 4)||14
8199371|NCT02219685|20218183|P1|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
8199372|NCT02219685|20218182|P2|NOT COMPLETED|Blinded Treatment Phase||0
8199373|NCT02219685|20218183|P1|NOT COMPLETED|Blinded Treatment Phase||2
8199374|NCT02219685|20218182|P2|COMPLETED|Blinded Treatment Phase||14
8199375|NCT02219685|20218183|P1|COMPLETED|Blinded Treatment Phase||24
8199376|NCT02219685|20218182|P2|STARTED|Blinded Treatment Phase||14
8199377|NCT02219685|20218183|P1|STARTED|Blinded Treatment Phase||26
8199378|NCT02219516|20218231|P4|NOT COMPLETED|Overall Study||0
8199379|NCT02219516|20218232|P3|NOT COMPLETED|Overall Study||0
8199380|NCT02219516|20218233|P2|NOT COMPLETED|Overall Study||0
8199381|NCT02219516|20218234|P1|NOT COMPLETED|Overall Study||0
8199382|NCT02219516|20218231|P4|COMPLETED|Overall Study||8
8199383|NCT02219516|20218232|P3|COMPLETED|Overall Study||7
8199384|NCT02219516|20218233|P2|COMPLETED|Overall Study||8
8199385|NCT02219516|20218234|P1|COMPLETED|Overall Study||8
8199386|NCT02219516|20218231|P4|STARTED|Overall Study||8
8199387|NCT02219516|20218232|P3|STARTED|Overall Study||7
8199388|NCT02219516|20218233|P2|STARTED|Overall Study||8
8199389|NCT02219516|20218234|P1|STARTED|Overall Study||8
8199393|NCT02219477|20218289|P3|NOT COMPLETED|Overall Study||1
8199394|NCT02219477|20218290|P2|NOT COMPLETED|Overall Study||2
8199395|NCT02219477|20218291|P1|NOT COMPLETED|Overall Study||0
8199396|NCT02219477|20218289|P3|COMPLETED|Overall Study||2
8199397|NCT02219477|20218290|P2|COMPLETED|Overall Study||22
8199398|NCT02219477|20218291|P1|COMPLETED|Overall Study||9
8199399|NCT02219477|20218289|P3|STARTED|Overall Study||3
8199400|NCT02219477|20218290|P2|STARTED|Overall Study||24
8199401|NCT02219477|20218291|P1|STARTED|Overall Study||9
8199402|NCT02219464|20218319|P2|NOT COMPLETED|Overall Study||0
8199403|NCT02219464|20218320|P1|NOT COMPLETED|Overall Study||3
8199404|NCT02219464|20218319|P2|COMPLETED|Overall Study||30
8199405|NCT02219464|20218320|P1|COMPLETED|Overall Study||27
8199406|NCT02219464|20218319|P2|STARTED|Overall Study||30
8199407|NCT02219464|20218320|P1|STARTED|Overall Study||30
8199408|NCT02219334|20218330|P2|NOT COMPLETED|Overall Study||3
8199409|NCT02219334|20218331|P1|NOT COMPLETED|Overall Study||8
8199410|NCT02219334|20218330|P2|COMPLETED|Overall Study||20
8199411|NCT02219334|20218331|P1|COMPLETED|Overall Study||24
8199412|NCT02219334|20218330|P2|STARTED|Overall Study||23
8199413|NCT02219334|20218331|P1|STARTED|Overall Study||32
8199414|NCT02219321|20218343|P2|NOT COMPLETED|Overall Study||0
8199415|NCT02219321|20218344|P1|NOT COMPLETED|Overall Study||0
8199416|NCT02219321|20218343|P2|COMPLETED|Overall Study||2
8199417|NCT02219321|20218344|P1|COMPLETED|Overall Study||1
8199418|NCT02219321|20218343|P2|STARTED|Overall Study||2
8199419|NCT02219321|20218344|P1|STARTED|Overall Study||1
8199420|NCT02219308|20218354|P2|NOT COMPLETED|Overall Study||2
8199421|NCT02219308|20218355|P1|NOT COMPLETED|Overall Study||1
8199422|NCT02219308|20218354|P2|COMPLETED|Overall Study||33
8199423|NCT02219308|20218355|P1|COMPLETED|Overall Study||31
8199424|NCT02219308|20218354|P2|STARTED|Overall Study||35
8199425|NCT02219308|20218355|P1|STARTED|Overall Study||32
8199426|NCT02219282|20218365|P2|NOT COMPLETED|Overall Study||1
8199427|NCT02219282|20218366|P1|NOT COMPLETED|Overall Study||1
8199428|NCT02219282|20218365|P2|COMPLETED|Overall Study||32
8199429|NCT02219282|20218366|P1|COMPLETED|Overall Study||32
8199430|NCT02219282|20218365|P2|STARTED|Overall Study||33
8199431|NCT02219282|20218366|P1|STARTED|Overall Study||33
8199432|NCT02219256|20218392|P12|NOT COMPLETED|Overall Study||0
8199433|NCT02219256|20218393|P11|NOT COMPLETED|Overall Study||0
8199434|NCT02219256|20218394|P10|NOT COMPLETED|Overall Study||0
8199435|NCT02219256|20218395|P9|NOT COMPLETED|Overall Study||0
8199436|NCT02219256|20218396|P8|NOT COMPLETED|Overall Study||0
8199437|NCT02219256|20218397|P7|NOT COMPLETED|Overall Study||0
8199438|NCT02219256|20218398|P6|NOT COMPLETED|Overall Study||0
8199439|NCT02219256|20218399|P5|NOT COMPLETED|Overall Study||0
8199440|NCT02219256|20218400|P4|NOT COMPLETED|Overall Study||0
8199441|NCT02219256|20218401|P3|NOT COMPLETED|Overall Study||0
8199442|NCT02219256|20218402|P2|NOT COMPLETED|Overall Study||0
8199443|NCT02219256|20218403|P1|NOT COMPLETED|Overall Study||0
8199444|NCT02219256|20218392|P12|COMPLETED|Overall Study||6
8199445|NCT02219256|20218393|P11|COMPLETED|Overall Study||6
8199446|NCT02219256|20218394|P10|COMPLETED|Overall Study||6
8199447|NCT02219256|20218395|P9|COMPLETED|Overall Study||6
8199448|NCT02219256|20218396|P8|COMPLETED|Overall Study||8
8199449|NCT02219256|20218397|P7|COMPLETED|Overall Study||6
8199450|NCT02219256|20218398|P6|COMPLETED|Overall Study||6
8199451|NCT02219256|20218399|P5|COMPLETED|Overall Study||6
8199452|NCT02219256|20218400|P4|COMPLETED|Overall Study||4
8199453|NCT02219256|20218401|P3|COMPLETED|Overall Study||4
8199454|NCT02219256|20218402|P2|COMPLETED|Overall Study||4
8199455|NCT02219256|20218403|P1|COMPLETED|Overall Study||12
8199456|NCT02219256|20218392|P12|STARTED|Overall Study||6
8199457|NCT02219256|20218393|P11|STARTED|Overall Study||6
8199458|NCT02219256|20218394|P10|STARTED|Overall Study||6
8199459|NCT02219256|20218395|P9|STARTED|Overall Study||6
8199460|NCT02219256|20218396|P8|STARTED|Overall Study||8
8199461|NCT02219256|20218397|P7|STARTED|Overall Study||6
8199462|NCT02219256|20218398|P6|STARTED|Overall Study||6
8199463|NCT02219256|20218399|P5|STARTED|Overall Study||6
8199464|NCT02219256|20218400|P4|STARTED|Overall Study||4
8199465|NCT02219256|20218401|P3|STARTED|Overall Study||4
8199466|NCT02219256|20218402|P2|STARTED|Overall Study||4
8199467|NCT02219256|20218403|P1|STARTED|Overall Study||12
8199468|NCT02219087|20218515|P2|NOT COMPLETED|Overall Study||1
8199469|NCT02219087|20218516|P1|NOT COMPLETED|Overall Study||0
8199470|NCT02219087|20218515|P2|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
8199471|NCT02219087|20218516|P1|COMPLETED|Overall Study||30
8199472|NCT02219087|20218515|P2|STARTED|Overall Study||30
8199473|NCT02219087|20218516|P1|STARTED|Overall Study||30
8199474|NCT02219048|20218536|P2|NOT COMPLETED|Overall Study||21
8199475|NCT02219048|20218537|P1|NOT COMPLETED|Overall Study||21
8199476|NCT02219048|20218536|P2|COMPLETED|Overall Study||4
8199477|NCT02219048|20218537|P1|COMPLETED|Overall Study||5
8199478|NCT02219048|20218536|P2|STARTED|Overall Study||25
8199479|NCT02219048|20218537|P1|STARTED|Overall Study||26
8199480|NCT02219009|20218563|P2|NOT COMPLETED|Overall Study||8
8199481|NCT02219009|20218564|P1|NOT COMPLETED|Overall Study||10
8199482|NCT02219009|20218563|P2|COMPLETED|Overall Study||22
8199483|NCT02219009|20218564|P1|COMPLETED|Overall Study||27
8199484|NCT02219009|20218563|P2|STARTED|Overall Study||30
8199485|NCT02219009|20218564|P1|STARTED|Overall Study||37
8199486|NCT02218736|20218576|P2|NOT COMPLETED|Overall Study||9
8199487|NCT02218736|20218577|P1|NOT COMPLETED|Overall Study||12
8199488|NCT02218736|20218576|P2|COMPLETED|Overall Study||35
8199489|NCT02218736|20218577|P1|COMPLETED|Overall Study||33
8199490|NCT02218736|20218576|P2|STARTED|Overall Study||44
8199491|NCT02218736|20218577|P1|STARTED|Overall Study||45
8199492|NCT02218697|20218589|P2|NOT COMPLETED|Overall Study||6
8199493|NCT02218697|20218590|P1|NOT COMPLETED|Overall Study||2
8199494|NCT02218697|20218589|P2|COMPLETED|Overall Study||171
8199495|NCT02218697|20218590|P1|COMPLETED|Overall Study||177
8199496|NCT02218697|20218589|P2|STARTED|Overall Study||177
8199497|NCT02218697|20218590|P1|STARTED|Overall Study||179
8199498|NCT02218541|20218630|P2|NOT COMPLETED|Overall Study||2
8199499|NCT02218541|20218631|P1|NOT COMPLETED|Overall Study||6
8199500|NCT02218541|20218630|P2|COMPLETED|Overall Study||9
8199501|NCT02218541|20218631|P1|COMPLETED|Overall Study||5
8199502|NCT02218541|20218630|P2|STARTED|Overall Study||11
8199503|NCT02218541|20218631|P1|STARTED|Overall Study||11
8199504|NCT02218489|20218643|P2|NOT COMPLETED|Overall Study||3
8199505|NCT02218489|20218644|P1|NOT COMPLETED|Overall Study||5
8199506|NCT02218489|20218643|P2|COMPLETED|Overall Study||101
8199507|NCT02218489|20218644|P1|COMPLETED|Overall Study||96
8199508|NCT02218489|20218643|P2|STARTED|Overall Study||104
8199509|NCT02218489|20218644|P1|STARTED|Overall Study||101
8199510|NCT02218463|20218662|P2|NOT COMPLETED|Overall Study||3
8199511|NCT02218463|20218663|P1|NOT COMPLETED|Overall Study||3
8199512|NCT02218463|20218662|P2|COMPLETED|Overall Study||19
8199513|NCT02218463|20218663|P1|COMPLETED|Overall Study||18
8199514|NCT02218463|20218662|P2|STARTED|Overall Study||22
8199515|NCT02218463|20218663|P1|STARTED|Overall Study||21
8199516|NCT02218424|20218673|P2|NOT COMPLETED|Overall Study||0
8199517|NCT02218424|20218674|P1|NOT COMPLETED|Overall Study||0
8199518|NCT02218424|20218673|P2|COMPLETED|Overall Study||30
8199519|NCT02218424|20218674|P1|COMPLETED|Overall Study||30
8199520|NCT02218424|20218673|P2|STARTED|Overall Study||30
8199521|NCT02218424|20218674|P1|STARTED|Overall Study||30
8199522|NCT02218372|20218696|P2|NOT COMPLETED|Overall Study||6
8199523|NCT02218372|20218697|P1|NOT COMPLETED|Overall Study||5
8199524|NCT02218372|20218696|P2|COMPLETED|Overall Study||42
8199525|NCT02218372|20218697|P1|COMPLETED|Overall Study||95
8199526|NCT02218372|20218696|P2|Treated|Overall Study||44
8199527|NCT02218372|20218697|P1|Treated|Overall Study||98
8199528|NCT02218372|20218696|P2|STARTED|Overall Study||48
8199529|NCT02218372|20218697|P1|STARTED|Overall Study||100
8199530|NCT02218320|20218755|P2|NOT COMPLETED|Overall Study||0
8199531|NCT02218320|20218756|P1|NOT COMPLETED|Overall Study||0
8199532|NCT02218320|20218755|P2|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
8199533|NCT02218320|20218756|P1|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
8199534|NCT02218320|20218755|P2|STARTED|Overall Study|First participant contact on this arm was December 2014|10
8199535|NCT02218320|20218756|P1|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
8199536|NCT02218307|20218768|P2|NOT COMPLETED|Overall Study||1
8199537|NCT02218307|20218769|P1|NOT COMPLETED|Overall Study||9
8199538|NCT02218307|20218768|P2|COMPLETED|Overall Study||33
8199539|NCT02218307|20218769|P1|COMPLETED|Overall Study||25
8199540|NCT02218307|20218768|P2|STARTED|Overall Study||34
8199541|NCT02218307|20218769|P1|STARTED|Overall Study||34
8199542|NCT02218268|20218777|P2|NOT COMPLETED|Final Phase (2 Hours)||0
8199543|NCT02218268|20218778|P1|NOT COMPLETED|Final Phase (2 Hours)||0
8199544|NCT02218268|20218777|P2|COMPLETED|Final Phase (2 Hours)||21
8199545|NCT02218268|20218778|P1|COMPLETED|Final Phase (2 Hours)||19
8199546|NCT02218268|20218777|P2|STARTED|Final Phase (2 Hours)||21
8199547|NCT02218268|20218778|P1|STARTED|Final Phase (2 Hours)||19
8199548|NCT02218268|20218777|P2|NOT COMPLETED|24 Hour Washout||9
8199549|NCT02218268|20218778|P1|NOT COMPLETED|24 Hour Washout||11
8199550|NCT02218268|20218777|P2|COMPLETED|24 Hour Washout||21
8199551|NCT02218268|20218778|P1|COMPLETED|24 Hour Washout||19
8199552|NCT02218268|20218777|P2|STARTED|24 Hour Washout||30
8199553|NCT02218268|20218778|P1|STARTED|24 Hour Washout||30
8199554|NCT02218268|20218777|P2|NOT COMPLETED|First Phase (2 Hours)||0
8199555|NCT02218268|20218778|P1|NOT COMPLETED|First Phase (2 Hours)||0
8199556|NCT02218268|20218777|P2|COMPLETED|First Phase (2 Hours)||30
8199557|NCT02218268|20218778|P1|COMPLETED|First Phase (2 Hours)||30
8199558|NCT02218268|20218777|P2|STARTED|First Phase (2 Hours)||30
8199559|NCT02218268|20218778|P1|STARTED|First Phase (2 Hours)||30
8199560|NCT02218242|20218784|P1|NOT COMPLETED|Overall Study||0
8199561|NCT02218242|20218784|P1|COMPLETED|Overall Study||9
8199562|NCT02218242|20218784|P1|STARTED|Overall Study||9
8199563|NCT02218216|20218790|P3|NOT COMPLETED|Overall Study||0
8199564|NCT02218216|20218791|P2|NOT COMPLETED|Overall Study||0
8199565|NCT02218216|20218792|P1|NOT COMPLETED|Overall Study||6
8199566|NCT02218216|20218790|P3|COMPLETED|Overall Study||3
8199567|NCT02218216|20218791|P2|COMPLETED|Overall Study||2
8199568|NCT02218216|20218792|P1|COMPLETED|Overall Study||8
8199569|NCT02218216|20218790|P3|STARTED|Overall Study||3
8199570|NCT02218216|20218791|P2|STARTED|Overall Study||2
8199571|NCT02218216|20218792|P1|STARTED|Overall Study||14
8199572|NCT02218203|20218800|P1|NOT COMPLETED|Overall Study||0
8199573|NCT02218203|20218800|P1|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
8199574|NCT02218203|20218800|P1|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
8199575|NCT02218203|20218800|P1|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
8199576|NCT02218203|20218800|P1|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
8199577|NCT02218203|20218800|P1|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
8199578|NCT02218203|20218800|P1|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
8199579|NCT02218203|20218800|P1|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
8199580|NCT02218203|20218800|P1|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
8199581|NCT02218203|20218800|P1|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
8199582|NCT02218203|20218800|P1|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
8199583|NCT02218203|20218800|P1|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
8199584|NCT02218203|20218800|P1|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
8199585|NCT02218203|20218800|P1|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
8199586|NCT02218203|20218800|P1|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
8199587|NCT02218203|20218800|P1|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
8199588|NCT02218203|20218800|P1|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
8199589|NCT02218203|20218800|P1|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
8199590|NCT02218203|20218800|P1|STARTED|Overall Study||26
8199591|NCT02218190|20218824|P2|NOT COMPLETED|Overall Study||0
8199592|NCT02218190|20218825|P1|NOT COMPLETED|Overall Study||0
8199593|NCT02218190|20218824|P2|COMPLETED|Overall Study||13
8199594|NCT02218190|20218825|P1|COMPLETED|Overall Study||13
8199595|NCT02218190|20218824|P2|STARTED|Overall Study||13
8199596|NCT02218190|20218825|P1|STARTED|Overall Study||13
8199600|NCT02218008|20218845|P6|NOT COMPLETED|Stage 2 (S2)||6
8199601|NCT02218008|20218846|P5|NOT COMPLETED|Stage 2 (S2)||4
8199602|NCT02218008|20218847|P4|NOT COMPLETED|Stage 2 (S2)||4
8199603|NCT02218008|20218848|P3|NOT COMPLETED|Stage 2 (S2)||0
8199604|NCT02218008|20218849|P2|NOT COMPLETED|Stage 2 (S2)||0
8199605|NCT02218008|20218850|P1|NOT COMPLETED|Stage 2 (S2)||0
8199606|NCT02218008|20218845|P6|COMPLETED|Stage 2 (S2)||57
8199607|NCT02218008|20218846|P5|COMPLETED|Stage 2 (S2)||58
8199608|NCT02218008|20218847|P4|COMPLETED|Stage 2 (S2)||58
8199609|NCT02218008|20218848|P3|COMPLETED|Stage 2 (S2)||0
8199610|NCT02218008|20218849|P2|COMPLETED|Stage 2 (S2)||0
8199611|NCT02218008|20218850|P1|COMPLETED|Stage 2 (S2)||0
8199612|NCT02218008|20218845|P6|STARTED|Stage 2 (S2)||63
8199613|NCT02218008|20218846|P5|STARTED|Stage 2 (S2)||62
8199614|NCT02218008|20218847|P4|STARTED|Stage 2 (S2)||62
8199615|NCT02218008|20218848|P3|STARTED|Stage 2 (S2)||0
8199616|NCT02218008|20218849|P2|STARTED|Stage 2 (S2)||0
8199617|NCT02218008|20218850|P1|STARTED|Stage 2 (S2)||0
8199618|NCT02218008|20218845|P6|NOT COMPLETED|Stage 1 (S1)||0
8199619|NCT02218008|20218846|P5|NOT COMPLETED|Stage 1 (S1)||0
8199620|NCT02218008|20218847|P4|NOT COMPLETED|Stage 1 (S1)||0
8199621|NCT02218008|20218848|P3|NOT COMPLETED|Stage 1 (S1)||15
8199622|NCT02218008|20218849|P2|NOT COMPLETED|Stage 1 (S1)||7
8199623|NCT02218008|20218850|P1|NOT COMPLETED|Stage 1 (S1)||22
8199624|NCT02218008|20218845|P6|COMPLETED|Stage 1 (S1)||0
8199625|NCT02218008|20218846|P5|COMPLETED|Stage 1 (S1)||0
8199626|NCT02218008|20218847|P4|COMPLETED|Stage 1 (S1)||0
8199627|NCT02218008|20218848|P3|COMPLETED|Stage 1 (S1)||48
8199628|NCT02218008|20218849|P2|COMPLETED|Stage 1 (S1)||56
8199629|NCT02218008|20218850|P1|COMPLETED|Stage 1 (S1)||258
8199630|NCT02218008|20218845|P6|STARTED|Stage 1 (S1)||0
8199631|NCT02218008|20218846|P5|STARTED|Stage 1 (S1)||0
8199632|NCT02218008|20218847|P4|STARTED|Stage 1 (S1)||0
8199633|NCT02218008|20218848|P3|STARTED|Stage 1 (S1)||63
8199634|NCT02218008|20218849|P2|STARTED|Stage 1 (S1)||63
8199635|NCT02218008|20218850|P1|STARTED|Stage 1 (S1)||280
8199636|NCT02217982|20218896|P2|NOT COMPLETED|Overall Study||1
8199637|NCT02217982|20218897|P1|NOT COMPLETED|Overall Study||1
8199638|NCT02217982|20218896|P2|COMPLETED|Overall Study||3
8199639|NCT02217982|20218897|P1|COMPLETED|Overall Study|Trial closed before patient finished|0
8199640|NCT02217982|20218896|P2|STARTED|Overall Study||4
8199641|NCT02217982|20218897|P1|STARTED|Overall Study||1
8199642|NCT02217904|20218910|P7|NOT COMPLETED|Overall Study||0
8199643|NCT02217904|20218911|P6|NOT COMPLETED|Overall Study||0
8199644|NCT02217904|20218912|P5|NOT COMPLETED|Overall Study||0
8199645|NCT02217904|20218913|P4|NOT COMPLETED|Overall Study||0
8199646|NCT02217904|20218914|P3|NOT COMPLETED|Overall Study||0
8199647|NCT02217904|20218915|P2|NOT COMPLETED|Overall Study||0
8199648|NCT02217904|20218916|P1|NOT COMPLETED|Overall Study||0
8199649|NCT02217904|20218910|P7|COMPLETED|Overall Study||0
8199650|NCT02217904|20218911|P6|COMPLETED|Overall Study||0
8199651|NCT02217904|20218912|P5|COMPLETED|Overall Study||6
8199652|NCT02217904|20218913|P4|COMPLETED|Overall Study||6
8199653|NCT02217904|20218914|P3|COMPLETED|Overall Study||6
8199654|NCT02217904|20218915|P2|COMPLETED|Overall Study||6
8199655|NCT02217904|20218916|P1|COMPLETED|Overall Study||6
8199656|NCT02217904|20218910|P7|STARTED|Overall Study||0
8199657|NCT02217904|20218911|P6|STARTED|Overall Study||0
8199658|NCT02217904|20218912|P5|STARTED|Overall Study||6
8199659|NCT02217904|20218913|P4|STARTED|Overall Study||6
8199660|NCT02217904|20218914|P3|STARTED|Overall Study||6
8199661|NCT02217904|20218915|P2|STARTED|Overall Study||6
8199662|NCT02217904|20218916|P1|STARTED|Overall Study||6
8199663|NCT02217878|20218980|P2|NOT COMPLETED|Overall Study||2
8199664|NCT02217878|20218981|P1|NOT COMPLETED|Overall Study||2
8199665|NCT02217878|20218980|P2|COMPLETED|Overall Study||35
8199666|NCT02217878|20218981|P1|COMPLETED|Overall Study||35
8199667|NCT02217878|20218980|P2|STARTED|Overall Study||37
8199668|NCT02217878|20218981|P1|STARTED|Overall Study||37
8199669|NCT02217800|20219061|P1|NOT COMPLETED|Overall Study||0
8199670|NCT02217800|20219061|P1|COMPLETED|Overall Study||8
8199671|NCT02217800|20219061|P1|STARTED|Overall Study||8
8199672|NCT02217618|20219073|P1|NOT COMPLETED|Overall Study||0
8199673|NCT02217618|20219073|P1|COMPLETED|Overall Study||16
8199674|NCT02217618|20219073|P1|Received Study Drug|Overall Study||16
8199675|NCT02217618|20219073|P1|STARTED|Overall Study||16
8199676|NCT02217566|20219079|P1|NOT COMPLETED|Overall Study||11
8199677|NCT02217566|20219079|P1|COMPLETED|Overall Study||35
8199678|NCT02217566|20219079|P1|STARTED|Overall Study||46
8199679|NCT02217527|20219090|P2|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
8199680|NCT02217527|20219091|P1|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
8199681|NCT02217527|20219090|P2|COMPLETED|Drug Condition 2: Second Study Phase||14
8199682|NCT02217527|20219091|P1|COMPLETED|Drug Condition 2: Second Study Phase||17
8199683|NCT02217527|20219090|P2|STARTED|Drug Condition 2: Second Study Phase||15
8199684|NCT02217527|20219091|P1|STARTED|Drug Condition 2: Second Study Phase||17
8199685|NCT02217527|20219090|P2|NOT COMPLETED|Drug Condition 1: First Study Phase||3
8199686|NCT02217527|20219091|P1|NOT COMPLETED|Drug Condition 1: First Study Phase||1
8199687|NCT02217527|20219090|P2|COMPLETED|Drug Condition 1: First Study Phase||15
8199688|NCT02217527|20219091|P1|COMPLETED|Drug Condition 1: First Study Phase||17
8199689|NCT02217527|20219090|P2|STARTED|Drug Condition 1: First Study Phase||18
8199690|NCT02217527|20219091|P1|STARTED|Drug Condition 1: First Study Phase||18
8199691|NCT02217475|20219104|P3|NOT COMPLETED|Treatment Period 2 (Year 2)||12
8199692|NCT02217475|20219105|P2|NOT COMPLETED|Treatment Period 2 (Year 2)||2
8199693|NCT02217475|20219106|P1|NOT COMPLETED|Treatment Period 2 (Year 2)||2
8199694|NCT02217475|20219104|P3|COMPLETED|Treatment Period 2 (Year 2)||109
8199695|NCT02217475|20219105|P2|COMPLETED|Treatment Period 2 (Year 2)||59
8199696|NCT02217475|20219106|P1|COMPLETED|Treatment Period 2 (Year 2)||58
8199697|NCT02217475|20219104|P3|STARTED|Treatment Period 2 (Year 2)||121
8199698|NCT02217475|20219105|P2|STARTED|Treatment Period 2 (Year 2)||61
8199699|NCT02217475|20219106|P1|STARTED|Treatment Period 2 (Year 2)||60
8199700|NCT02217475|20219104|P3|NOT COMPLETED|Discontinued After Period 1||3
8199701|NCT02217475|20219105|P2|NOT COMPLETED|Discontinued After Period 1||3
8199702|NCT02217475|20219106|P1|NOT COMPLETED|Discontinued After Period 1||2
8199703|NCT02217475|20219104|P3|COMPLETED|Discontinued After Period 1||121
8199704|NCT02217475|20219105|P2|COMPLETED|Discontinued After Period 1||61
8199705|NCT02217475|20219106|P1|COMPLETED|Discontinued After Period 1||60
8199706|NCT02217475|20219104|P3|STARTED|Discontinued After Period 1||124
8199707|NCT02217475|20219105|P2|STARTED|Discontinued After Period 1||64
8199708|NCT02217475|20219106|P1|STARTED|Discontinued After Period 1||62
8199709|NCT02217475|20219104|P3|NOT COMPLETED|Treatment Period 1 (Year 1)||21
8199710|NCT02217475|20219105|P2|NOT COMPLETED|Treatment Period 1 (Year 1)||8
8199711|NCT02217475|20219106|P1|NOT COMPLETED|Treatment Period 1 (Year 1)||10
8199712|NCT02217475|20219104|P3|COMPLETED|Treatment Period 1 (Year 1)||124
8199713|NCT02217475|20219105|P2|COMPLETED|Treatment Period 1 (Year 1)||64
8199714|NCT02217475|20219106|P1|COMPLETED|Treatment Period 1 (Year 1)||62
8199715|NCT02217475|20219104|P3|Safety Analysis Set|Treatment Period 1 (Year 1)||144
8199716|NCT02217475|20219105|P2|Safety Analysis Set|Treatment Period 1 (Year 1)||72
8199717|NCT02217475|20219106|P1|Safety Analysis Set|Treatment Period 1 (Year 1)||72
8199718|NCT02217475|20219104|P3|STARTED|Treatment Period 1 (Year 1)||145
8199719|NCT02217475|20219105|P2|STARTED|Treatment Period 1 (Year 1)||72
8199720|NCT02217475|20219106|P1|STARTED|Treatment Period 1 (Year 1)||72
8199721|NCT02217436|20219223|P2|NOT COMPLETED|Overall Study||2
8199722|NCT02217436|20219224|P1|NOT COMPLETED|Overall Study||1
8199723|NCT02217436|20219223|P2|COMPLETED|Overall Study||38
8199724|NCT02217436|20219224|P1|COMPLETED|Overall Study||39
8199725|NCT02217436|20219223|P2|STARTED|Overall Study||40
8199726|NCT02217436|20219224|P1|STARTED|Overall Study||40
8199727|NCT02217410|20219235|P3|NOT COMPLETED|Overall Study||5
8199728|NCT02217410|20219236|P2|NOT COMPLETED|Overall Study||4
8199729|NCT02217410|20219237|P1|NOT COMPLETED|Overall Study||1
8199730|NCT02217410|20219235|P3|COMPLETED|Overall Study||13
8199731|NCT02217410|20219236|P2|COMPLETED|Overall Study||30
8199732|NCT02217410|20219237|P1|COMPLETED|Overall Study||6
8199733|NCT02217410|20219235|P3|STARTED|Overall Study||18
8199734|NCT02217410|20219236|P2|STARTED|Overall Study||34
8199735|NCT02217410|20219237|P1|STARTED|Overall Study||7
8199736|NCT02217280|20219260|P1|NOT COMPLETED|Overall Study||4
8199737|NCT02217280|20219260|P1|COMPLETED|Overall Study||16
8199738|NCT02217280|20219260|P1|STARTED|Overall Study||20
8199739|NCT02216812|20219267|P2|NOT COMPLETED|Overall Study||5
8199740|NCT02216812|20219268|P1|NOT COMPLETED|Overall Study||10
8199741|NCT02216812|20219267|P2|COMPLETED|Overall Study||62
8199742|NCT02216812|20219268|P1|COMPLETED|Overall Study||57
8199743|NCT02216812|20219267|P2|STARTED|Overall Study||67
8199744|NCT02216812|20219268|P1|STARTED|Overall Study||67
8199745|NCT02216773|20219284|P2|NOT COMPLETED|Overall Study||5
8199746|NCT02216773|20219285|P1|NOT COMPLETED|Overall Study||12
8199747|NCT02216773|20219284|P2|COMPLETED|Overall Study||24
8199748|NCT02216773|20219285|P1|COMPLETED|Overall Study||16
8199749|NCT02216773|20219284|P2|Underwent Procedure (PVE/RALPPS)|Overall Study||26
8199750|NCT02216773|20219285|P1|Underwent Procedure (PVE/RALPPS)|Overall Study||24
8199751|NCT02216773|20219284|P2|STARTED|Overall Study||29
8199752|NCT02216773|20219285|P1|STARTED|Overall Study||28
8199753|NCT02216695|20219295|P1|NOT COMPLETED|Overall Study||0
8199754|NCT02216695|20219295|P1|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
8199755|NCT02216695|20219295|P1|STARTED|Overall Study||64882
8199756|NCT02216591|20219306|P2|NOT COMPLETED|Overall Study||1
8199757|NCT02216591|20219307|P1|NOT COMPLETED|Overall Study||0
8199758|NCT02216591|20219306|P2|COMPLETED|Overall Study||9
8199759|NCT02216591|20219307|P1|COMPLETED|Overall Study||11
8199760|NCT02216591|20219306|P2|STARTED|Overall Study||10
8199761|NCT02216591|20219307|P1|STARTED|Overall Study||11
8199762|NCT02216526|20219320|P3|NOT COMPLETED|Overall Study||8
8199763|NCT02216526|20219321|P2|NOT COMPLETED|Overall Study||3
8199764|NCT02216526|20219322|P1|NOT COMPLETED|Overall Study||5
8199765|NCT02216526|20219320|P3|COMPLETED|Overall Study||36
8199766|NCT02216526|20219321|P2|COMPLETED|Overall Study||41
8199767|NCT02216526|20219322|P1|COMPLETED|Overall Study||40
8199768|NCT02216526|20219320|P3|STARTED|Overall Study||44
8199769|NCT02216526|20219321|P2|STARTED|Overall Study||44
8199770|NCT02216526|20219322|P1|STARTED|Overall Study||45
8199771|NCT02216422|20219432|P1|NOT COMPLETED|Overall Study||0
8199772|NCT02216422|20219432|P1|COMPLETED|Overall Study||36
8199773|NCT02216422|20219432|P1|STARTED|Overall Study||36
8199774|NCT02216357|20219440|P2|NOT COMPLETED|Overall Study||1
8199775|NCT02216357|20219441|P1|NOT COMPLETED|Overall Study||2
8199776|NCT02216357|20219440|P2|COMPLETED|Overall Study||4
8199777|NCT02216357|20219441|P1|COMPLETED|Overall Study||12
8199778|NCT02216357|20219440|P2|STARTED|Overall Study||5
8199779|NCT02216357|20219441|P1|STARTED|Overall Study||14
8199780|NCT02216214|20219467|P2|NOT COMPLETED|Overall Study||36
8199781|NCT02216214|20219468|P1|NOT COMPLETED|Overall Study||43
8199782|NCT02216214|20219467|P2|COMPLETED|Overall Study||409
8199783|NCT02216214|20219468|P1|COMPLETED|Overall Study||400
8199784|NCT02216214|20219467|P2|Treated|Overall Study||445
8199785|NCT02216214|20219468|P1|Treated|Overall Study||442
8199786|NCT02216214|20219467|P2|STARTED|Overall Study||445
8199787|NCT02216214|20219468|P1|STARTED|Overall Study||443
8199788|NCT02216136|20219527|P3|NOT COMPLETED|Overall Study||0
8199789|NCT02216136|20219528|P2|NOT COMPLETED|Overall Study||0
8199790|NCT02216136|20219529|P1|NOT COMPLETED|Overall Study||0
8199791|NCT02216136|20219527|P3|COMPLETED|Overall Study||0
8199792|NCT02216136|20219528|P2|COMPLETED|Overall Study||90
8199793|NCT02216136|20219529|P1|COMPLETED|Overall Study||72
8199794|NCT02216136|20219527|P3|STARTED|Overall Study||0
8199795|NCT02216136|20219528|P2|STARTED|Overall Study||90
8199796|NCT02216136|20219529|P1|STARTED|Overall Study||72
8199797|NCT02216123|20219539|P2|NOT COMPLETED|Overall Study||2
8199798|NCT02216123|20219540|P1|NOT COMPLETED|Overall Study||6
8199799|NCT02216123|20219539|P2|COMPLETED|Overall Study||83
8199800|NCT02216123|20219540|P1|COMPLETED|Overall Study||160
8199801|NCT02216123|20219539|P2|STARTED|Overall Study||85
8199802|NCT02216123|20219540|P1|STARTED|Overall Study||166
8199803|NCT02216097|20219606|P2|NOT COMPLETED|Overall Study||0
8199804|NCT02216097|20219607|P1|NOT COMPLETED|Overall Study||0
8199805|NCT02216097|20219606|P2|COMPLETED|Overall Study||6
8199806|NCT02216097|20219607|P1|COMPLETED|Overall Study||8
8199807|NCT02216097|20219606|P2|STARTED|Overall Study||6
8199808|NCT02216097|20219607|P1|STARTED|Overall Study||8
8199809|NCT02215967|20219633|P4|NOT COMPLETED|Overall Study||3
8199810|NCT02215967|20219634|P3|NOT COMPLETED|Overall Study||1
8199811|NCT02215967|20219635|P2|NOT COMPLETED|Overall Study||0
8199812|NCT02215967|20219636|P1|NOT COMPLETED|Overall Study||0
8199813|NCT02215967|20219633|P4|COMPLETED|Overall Study||16
8199814|NCT02215967|20219634|P3|COMPLETED|Overall Study||4
8199815|NCT02215967|20219635|P2|COMPLETED|Overall Study||3
8199816|NCT02215967|20219636|P1|COMPLETED|Overall Study||3
8199817|NCT02215967|20219633|P4|STARTED|Overall Study||19
8199818|NCT02215967|20219634|P3|STARTED|Overall Study||5
8199819|NCT02215967|20219635|P2|STARTED|Overall Study||3
8199820|NCT02215967|20219636|P1|STARTED|Overall Study||3
8199821|NCT02215954|20219657|P3|NOT COMPLETED|Overall Study||6
8199822|NCT02215954|20219658|P2|NOT COMPLETED|Overall Study||1
8199823|NCT02215954|20219659|P1|NOT COMPLETED|Overall Study||1
8199824|NCT02215954|20219657|P3|COMPLETED|Overall Study||205
8199825|NCT02215954|20219658|P2|COMPLETED|Overall Study||211
8199826|NCT02215954|20219659|P1|COMPLETED|Overall Study||213
8199827|NCT02215954|20219657|P3|Safety Analysis Set|Overall Study||208
8199828|NCT02215954|20219658|P2|Safety Analysis Set|Overall Study||211
8199829|NCT02215954|20219659|P1|Safety Analysis Set|Overall Study||213
8199830|NCT02215954|20219657|P3|Per Protocol (PP) Analysis Set|Overall Study||205
8199831|NCT02215954|20219658|P2|Per Protocol (PP) Analysis Set|Overall Study||208
8199832|NCT02215954|20219659|P1|Per Protocol (PP) Analysis Set|Overall Study||212
8199833|NCT02215954|20219657|P3|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
8199834|NCT02215954|20219658|P2|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
8199835|NCT02215954|20219659|P1|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
8199836|NCT02215954|20219657|P3|STARTED|Overall Study||211
8199837|NCT02215954|20219658|P2|STARTED|Overall Study||212
8199838|NCT02215954|20219659|P1|STARTED|Overall Study||214
8199839|NCT02215616|20219683|P4|NOT COMPLETED|Overall Study||13
8199840|NCT02215616|20219684|P3|NOT COMPLETED|Overall Study||14
8199841|NCT02215616|20219685|P2|NOT COMPLETED|Overall Study||17
8199842|NCT02215616|20219686|P1|NOT COMPLETED|Overall Study||11
8199843|NCT02215616|20219683|P4|COMPLETED|Overall Study||17
8199844|NCT02215616|20219684|P3|COMPLETED|Overall Study||93
8199845|NCT02215616|20219685|P2|COMPLETED|Overall Study||90
8199846|NCT02215616|20219686|P1|COMPLETED|Overall Study||97
8199847|NCT02215616|20219683|P4|Received at Least 1 Dose of Study Drug|Overall Study||29
8199848|NCT02215616|20219684|P3|Received at Least 1 Dose of Study Drug|Overall Study||106
8199849|NCT02215616|20219685|P2|Received at Least 1 Dose of Study Drug|Overall Study||107
8199850|NCT02215616|20219686|P1|Received at Least 1 Dose of Study Drug|Overall Study||108
8199851|NCT02215616|20219683|P4|STARTED|Overall Study||30
8199852|NCT02215616|20219684|P3|STARTED|Overall Study||107
8199853|NCT02215616|20219685|P2|STARTED|Overall Study||107
8199854|NCT02215616|20219686|P1|STARTED|Overall Study||108
8199855|NCT02215369|20219700|P1|NOT COMPLETED|Overall Study||42
8199856|NCT02215369|20219700|P1|COMPLETED|Overall Study||70
8199857|NCT02215369|20219700|P1|STARTED|Overall Study||112
8199858|NCT02215252|20219708|P3|NOT COMPLETED|Overall Study||4
8199859|NCT02215252|20219709|P2|NOT COMPLETED|Overall Study||8
8199860|NCT02215252|20219710|P1|NOT COMPLETED|Overall Study||2
8199861|NCT02215252|20219708|P3|COMPLETED|Overall Study||41
8199862|NCT02215252|20219709|P2|COMPLETED|Overall Study||38
8199863|NCT02215252|20219710|P1|COMPLETED|Overall Study||42
8199864|NCT02215252|20219708|P3|STARTED|Overall Study||45
8199865|NCT02215252|20219709|P2|STARTED|Overall Study||46
8199866|NCT02215252|20219710|P1|STARTED|Overall Study||44
8199867|NCT02215200|20219770|P3|NOT COMPLETED|Overall Study||1
8199868|NCT02215200|20219771|P2|NOT COMPLETED|Overall Study||1
8199869|NCT02215200|20219772|P1|NOT COMPLETED|Overall Study||0
8199870|NCT02215200|20219770|P3|COMPLETED|Overall Study||30
8199871|NCT02215200|20219771|P2|COMPLETED|Overall Study||28
8199872|NCT02215200|20219772|P1|COMPLETED|Overall Study||29
8199873|NCT02215200|20219770|P3|STARTED|Overall Study||31
8199874|NCT02215200|20219771|P2|STARTED|Overall Study||29
8199875|NCT02215200|20219772|P1|STARTED|Overall Study||29
8199876|NCT02215161|20219780|P1|NOT COMPLETED|Overall Study||0
8199877|NCT02215161|20219780|P1|COMPLETED|Overall Study||14
8199878|NCT02215161|20219780|P1|STARTED|Overall Study||14
8199879|NCT02215096|20219798|P5|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
8199880|NCT02215096|20219799|P4|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
8199881|NCT02215096|20219800|P3|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
8199882|NCT02215096|20219801|P2|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
8199883|NCT02215096|20219802|P1|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||0
8199884|NCT02215096|20219798|P5|COMPLETED|Combination TP (Up to Maximum 654 Days)||1
8199885|NCT02215096|20219799|P4|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
8199886|NCT02215096|20219800|P3|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
8199887|NCT02215096|20219801|P2|COMPLETED|Combination TP (Up to Maximum 654 Days)||9
8199888|NCT02215096|20219802|P1|COMPLETED|Combination TP (Up to Maximum 654 Days)||0
8199889|NCT02215096|20219798|P5|STARTED|Combination TP (Up to Maximum 654 Days)||2
8199890|NCT02215096|20219799|P4|STARTED|Combination TP (Up to Maximum 654 Days)||12
8199891|NCT02215096|20219800|P3|STARTED|Combination TP (Up to Maximum 654 Days)||11
8199892|NCT02215096|20219801|P2|STARTED|Combination TP (Up to Maximum 654 Days)||11
8199893|NCT02215096|20219802|P1|STARTED|Combination TP (Up to Maximum 654 Days)||0
8199894|NCT02215096|20219798|P5|NOT COMPLETED|Run-In Period (Up to Week 2)||0
8199895|NCT02215096|20219799|P4|NOT COMPLETED|Run-In Period (Up to Week 2)||0
8199896|NCT02215096|20219800|P3|NOT COMPLETED|Run-In Period (Up to Week 2)||0
8199897|NCT02215096|20219801|P2|NOT COMPLETED|Run-In Period (Up to Week 2)||0
8199898|NCT02215096|20219802|P1|NOT COMPLETED|Run-In Period (Up to Week 2)||1
8199899|NCT02215096|20219798|P5|COMPLETED|Run-In Period (Up to Week 2)||0
8199900|NCT02215096|20219799|P4|COMPLETED|Run-In Period (Up to Week 2)||0
8199901|NCT02215096|20219800|P3|COMPLETED|Run-In Period (Up to Week 2)||0
8199902|NCT02215096|20219801|P2|COMPLETED|Run-In Period (Up to Week 2)||0
8199903|NCT02215096|20219802|P1|COMPLETED|Run-In Period (Up to Week 2)||36
8199904|NCT02215096|20219798|P5|STARTED|Run-In Period (Up to Week 2)||0
8199905|NCT02215096|20219799|P4|STARTED|Run-In Period (Up to Week 2)||0
8199906|NCT02215096|20219800|P3|STARTED|Run-In Period (Up to Week 2)||0
8199907|NCT02215096|20219801|P2|STARTED|Run-In Period (Up to Week 2)||0
8199908|NCT02215096|20219802|P1|STARTED|Run-In Period (Up to Week 2)||37
8199909|NCT02215070|20219887|P1|NOT COMPLETED|Overall Study||6
8199910|NCT02215070|20219887|P1|COMPLETED|Overall Study||20
8199911|NCT02215070|20219887|P1|STARTED|Overall Study||26
8199912|NCT02214628|20219895|P2|NOT COMPLETED|Overall Study||29
8199913|NCT02214628|20219896|P1|NOT COMPLETED|Overall Study||27
8199914|NCT02214628|20219895|P2|COMPLETED|Overall Study||9
8199915|NCT02214628|20219896|P1|COMPLETED|Overall Study||36
8199916|NCT02214628|20219895|P2|STARTED|Overall Study||38
8199917|NCT02214628|20219896|P1|STARTED|Overall Study||63
8199918|NCT02214615|20219906|P2|NOT COMPLETED|Second Intervention||0
8199919|NCT02214615|20219907|P1|NOT COMPLETED|Second Intervention||0
8199920|NCT02214615|20219906|P2|COMPLETED|Second Intervention||1
8199921|NCT02214615|20219907|P1|COMPLETED|Second Intervention||1
8199922|NCT02214615|20219906|P2|STARTED|Second Intervention||1
8199923|NCT02214615|20219907|P1|STARTED|Second Intervention||1
8199924|NCT02214615|20219906|P2|NOT COMPLETED|Washout||0
8199925|NCT02214615|20219907|P1|NOT COMPLETED|Washout||0
8199926|NCT02214615|20219906|P2|COMPLETED|Washout||1
8199927|NCT02214615|20219907|P1|COMPLETED|Washout||1
8199928|NCT02214615|20219906|P2|STARTED|Washout||1
8199929|NCT02214615|20219907|P1|STARTED|Washout||1
8199930|NCT02214615|20219906|P2|NOT COMPLETED|First Intervention||0
8199931|NCT02214615|20219907|P1|NOT COMPLETED|First Intervention||0
8199932|NCT02214615|20219906|P2|COMPLETED|First Intervention||1
8199933|NCT02214615|20219907|P1|COMPLETED|First Intervention||1
8199934|NCT02214615|20219906|P2|STARTED|First Intervention||1
8199935|NCT02214615|20219907|P1|STARTED|First Intervention||1
8199936|NCT02214420|20219917|P2|NOT COMPLETED|Overall Study||0
8199937|NCT02214420|20219918|P1|NOT COMPLETED|Overall Study||1
8199938|NCT02214420|20219917|P2|COMPLETED|Overall Study||10
8199939|NCT02214420|20219918|P1|COMPLETED|Overall Study||13
8199940|NCT02214420|20219917|P2|STARTED|Overall Study||10
8199941|NCT02214420|20219918|P1|STARTED|Overall Study||14
8199942|NCT02214290|20219924|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8199943|NCT02214290|20219925|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8199944|NCT02214290|20219924|P2|COMPLETED|Second Intervention (7 Days)||8
8199945|NCT02214290|20219925|P1|COMPLETED|Second Intervention (7 Days)||8
8199946|NCT02214290|20219924|P2|STARTED|Second Intervention (7 Days)||8
8199947|NCT02214290|20219925|P1|STARTED|Second Intervention (7 Days)||8
8199948|NCT02214290|20219924|P2|NOT COMPLETED|Washout (14 Days)||0
8199949|NCT02214290|20219925|P1|NOT COMPLETED|Washout (14 Days)||0
8199950|NCT02214290|20219924|P2|COMPLETED|Washout (14 Days)||8
8199951|NCT02214290|20219925|P1|COMPLETED|Washout (14 Days)||8
8199952|NCT02214290|20219924|P2|STARTED|Washout (14 Days)||8
8199953|NCT02214290|20219925|P1|STARTED|Washout (14 Days)||8
8199954|NCT02214290|20219924|P2|NOT COMPLETED|First Intervention (7 Days)||0
8199955|NCT02214290|20219925|P1|NOT COMPLETED|First Intervention (7 Days)||0
8199956|NCT02214290|20219924|P2|COMPLETED|First Intervention (7 Days)||8
8199957|NCT02214290|20219925|P1|COMPLETED|First Intervention (7 Days)||8
8199958|NCT02214290|20219924|P2|STARTED|First Intervention (7 Days)||8
8199959|NCT02214290|20219925|P1|STARTED|First Intervention (7 Days)||8
8199960|NCT02214277|20219938|P3|NOT COMPLETED|Overall Study||34
8199961|NCT02214277|20219939|P2|NOT COMPLETED|Overall Study||25
8199962|NCT02214277|20219940|P1|NOT COMPLETED|Overall Study||19
8199963|NCT02214277|20219938|P3|COMPLETED|Overall Study||85
8199964|NCT02214277|20219939|P2|COMPLETED|Overall Study||96
8199965|NCT02214277|20219940|P1|COMPLETED|Overall Study||104
8199966|NCT02214277|20219938|P3|STARTED|Overall Study||119
8199967|NCT02214277|20219939|P2|STARTED|Overall Study||121
8199968|NCT02214277|20219940|P1|STARTED|Overall Study||123
8199969|NCT02214238|20219950|P2|NOT COMPLETED|Overall Study||6
8199970|NCT02214238|20219951|P1|NOT COMPLETED|Overall Study||6
8199971|NCT02214238|20219950|P2|COMPLETED|Overall Study||17
8199972|NCT02214238|20219951|P1|COMPLETED|Overall Study||20
8199973|NCT02214238|20219950|P2|STARTED|Overall Study||23
8199974|NCT02214238|20219951|P1|STARTED|Overall Study||26
8199975|NCT02214225|20219964|P3|NOT COMPLETED|Overall Study||22
8199976|NCT02214225|20219965|P2|NOT COMPLETED|Overall Study||19
8199977|NCT02214225|20219966|P1|NOT COMPLETED|Overall Study||55
8199978|NCT02214225|20219964|P3|COMPLETED|Overall Study||850
8199979|NCT02214225|20219965|P2|COMPLETED|Overall Study||852
8199980|NCT02214225|20219966|P1|COMPLETED|Overall Study||1686
8199981|NCT02214225|20219964|P3|STARTED|Overall Study||872
8199982|NCT02214225|20219965|P2|STARTED|Overall Study||871
8199983|NCT02214225|20219966|P1|STARTED|Overall Study||1741
8199984|NCT02214186|20220025|P2|NOT COMPLETED|Overall Study||2
8199985|NCT02214186|20220026|P1|NOT COMPLETED|Overall Study||2
8199986|NCT02214186|20220025|P2|COMPLETED|Overall Study||21
8199987|NCT02214186|20220026|P1|COMPLETED|Overall Study||21
8199988|NCT02214186|20220025|P2|STARTED|Overall Study||23
8199989|NCT02214186|20220026|P1|STARTED|Overall Study||23
8199990|NCT02214147|20220051|P3|NOT COMPLETED|Overall Study||0
8199991|NCT02214147|20220052|P2|NOT COMPLETED|Overall Study||0
8199992|NCT02214147|20220053|P1|NOT COMPLETED|Overall Study||0
8199993|NCT02214147|20220051|P3|COMPLETED|Overall Study||8
8199994|NCT02214147|20220052|P2|COMPLETED|Overall Study||12
8199995|NCT02214147|20220053|P1|COMPLETED|Overall Study||16
8199996|NCT02214147|20220051|P3|STARTED|Overall Study||8
8199997|NCT02214147|20220052|P2|STARTED|Overall Study||12
8199998|NCT02214147|20220053|P1|STARTED|Overall Study||16
8199999|NCT02214121|20220094|P3|NOT COMPLETED|Part B||1
8200000|NCT02214121|20220095|P2|NOT COMPLETED|Part B||3
8200001|NCT02214121|20220096|P1|NOT COMPLETED|Part B||0
8200002|NCT02214121|20220094|P3|COMPLETED|Part B||7
8200003|NCT02214121|20220095|P2|COMPLETED|Part B||14
8200004|NCT02214121|20220096|P1|COMPLETED|Part B||0
8200005|NCT02214121|20220094|P3|STARTED|Part B||8
8200006|NCT02214121|20220095|P2|STARTED|Part B||17
8200007|NCT02214121|20220096|P1|STARTED|Part B||0
8200008|NCT02214121|20220094|P3|NOT COMPLETED|Part A||0
8200009|NCT02214121|20220095|P2|NOT COMPLETED|Part A||0
8200010|NCT02214121|20220096|P1|NOT COMPLETED|Part A||7
8200011|NCT02214121|20220094|P3|COMPLETED|Part A||0
8200012|NCT02214121|20220095|P2|COMPLETED|Part A||0
8200013|NCT02214121|20220096|P1|COMPLETED|Part A||39
8200014|NCT02214121|20220094|P3|STARTED|Part A||0
8200015|NCT02214121|20220095|P2|STARTED|Part A||0
8200016|NCT02214121|20220096|P1|STARTED|Part A||46
8200017|NCT02214017|20220175|P2|NOT COMPLETED|Overall Study||0
8200018|NCT02214017|20220176|P1|NOT COMPLETED|Overall Study||0
8200019|NCT02214017|20220175|P2|COMPLETED|Overall Study||18
8200020|NCT02214017|20220176|P1|COMPLETED|Overall Study||22
8200021|NCT02214017|20220175|P2|STARTED|Overall Study||18
8200022|NCT02214017|20220176|P1|STARTED|Overall Study||22
8200026|NCT02213900|20220192|P2|NOT COMPLETED|Overall Study||0
8200027|NCT02213900|20220193|P1|NOT COMPLETED|Overall Study||0
8200028|NCT02213900|20220192|P2|COMPLETED|Overall Study||67
8200029|NCT02213900|20220193|P1|COMPLETED|Overall Study||68
8200030|NCT02213900|20220192|P2|STARTED|Overall Study||67
8200031|NCT02213900|20220193|P1|STARTED|Overall Study||68
8200032|NCT02213666|20220205|P1|NOT COMPLETED|Overall Study||1
8200033|NCT02213666|20220205|P1|COMPLETED|Overall Study||71
8200034|NCT02213666|20220205|P1|STARTED|Overall Study||72
8200035|NCT02213510|20220211|P2|NOT COMPLETED|Overall Study||1
8200036|NCT02213510|20220212|P1|NOT COMPLETED|Overall Study||1
8200037|NCT02213510|20220211|P2|COMPLETED|Overall Study||18
8200038|NCT02213510|20220212|P1|COMPLETED|Overall Study||20
8200039|NCT02213510|20220211|P2|STARTED|Overall Study||19
8200040|NCT02213510|20220212|P1|STARTED|Overall Study||21
8200041|NCT02213263|20220240|P2|NOT COMPLETED|Overall Study||26
8200042|NCT02213263|20220241|P1|NOT COMPLETED|Overall Study||28
8200043|NCT02213263|20220240|P2|COMPLETED|Overall Study||170
8200044|NCT02213263|20220241|P1|COMPLETED|Overall Study||170
8200045|NCT02213263|20220240|P2|Treated|Overall Study||196
8200046|NCT02213263|20220241|P1|Treated|Overall Study||197
8200047|NCT02213263|20220240|P2|STARTED|Overall Study||196
8200048|NCT02213263|20220241|P1|STARTED|Overall Study||198
8200049|NCT02213250|20220277|P2|NOT COMPLETED|Overall Study||0
8200050|NCT02213250|20220278|P1|NOT COMPLETED|Overall Study||0
8200051|NCT02213250|20220277|P2|COMPLETED|Overall Study||8
8200052|NCT02213250|20220278|P1|COMPLETED|Overall Study||4
8200053|NCT02213250|20220277|P2|STARTED|Overall Study||8
8200054|NCT02213250|20220278|P1|STARTED|Overall Study||4
8200055|NCT02213198|20220309|P2|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
8200056|NCT02213198|20220310|P1|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
8200057|NCT02213198|20220309|P2|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
8200058|NCT02213198|20220310|P1|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
8200059|NCT02213198|20220309|P2|STARTED|Follow up 2 6 Months Post TCC Treatment||67
8200060|NCT02213198|20220310|P1|STARTED|Follow up 2 6 Months Post TCC Treatment||125
8200061|NCT02213198|20220309|P2|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
8200062|NCT02213198|20220310|P1|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
8200063|NCT02213198|20220309|P2|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
8200064|NCT02213198|20220310|P1|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
8200065|NCT02213198|20220309|P2|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
8200066|NCT02213198|20220310|P1|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
8200067|NCT02213198|20220309|P2|NOT COMPLETED|Baseline||51
8200068|NCT02213198|20220310|P1|NOT COMPLETED|Baseline||88
8200069|NCT02213198|20220309|P2|COMPLETED|Baseline||108
8200070|NCT02213198|20220310|P1|COMPLETED|Baseline||218
8200071|NCT02213198|20220309|P2|STARTED|Baseline||159
8200072|NCT02213198|20220310|P1|STARTED|Baseline||306
8200073|NCT02213133|20220321|P3|NOT COMPLETED|Overall Study||3
8200074|NCT02213133|20220322|P2|NOT COMPLETED|Overall Study||5
8200075|NCT02213133|20220323|P1|NOT COMPLETED|Overall Study||37
8200076|NCT02213133|20220321|P3|COMPLETED|Overall Study||0
8200077|NCT02213133|20220322|P2|COMPLETED|Overall Study||0
8200078|NCT02213133|20220323|P1|COMPLETED|Overall Study||0
8200079|NCT02213133|20220321|P3|Treated|Overall Study||1
8200080|NCT02213133|20220322|P2|Treated|Overall Study||4
8200081|NCT02213133|20220323|P1|Treated|Overall Study||33
8200082|NCT02213133|20220321|P3|STARTED|Overall Study||3
8200083|NCT02213133|20220322|P2|STARTED|Overall Study||5
8200084|NCT02213133|20220323|P1|STARTED|Overall Study||37
8200085|NCT02213094|20220339|P2|NOT COMPLETED|Overall Study||0
8200086|NCT02213094|20220340|P1|NOT COMPLETED|Overall Study||1
8200087|NCT02213094|20220339|P2|COMPLETED|Overall Study||5
8200088|NCT02213094|20220340|P1|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
8200089|NCT02213094|20220339|P2|STARTED|Overall Study||5
8200090|NCT02213094|20220340|P1|STARTED|Overall Study||5
8200091|NCT02213055|20220348|P2|NOT COMPLETED|Overall Study||0
8200092|NCT02213055|20220349|P1|NOT COMPLETED|Overall Study||39
8200093|NCT02213055|20220348|P2|COMPLETED|Overall Study||0
8200094|NCT02213055|20220349|P1|COMPLETED|Overall Study||58
8200095|NCT02213055|20220348|P2|STARTED|Overall Study||0
8200096|NCT02213055|20220349|P1|STARTED|Overall Study||97
8200097|NCT02212977|20220357|P2|NOT COMPLETED|Overall Study||6
8200098|NCT02212977|20220358|P1|NOT COMPLETED|Overall Study||5
8200099|NCT02212977|20220357|P2|COMPLETED|Overall Study||48
8200100|NCT02212977|20220358|P1|COMPLETED|Overall Study||50
8200101|NCT02212977|20220357|P2|STARTED|Overall Study||54
8200102|NCT02212977|20220358|P1|STARTED|Overall Study||55
8200103|NCT02212834|20220374|P2|NOT COMPLETED|Overall Study||0
8200104|NCT02212834|20220375|P1|NOT COMPLETED|Overall Study||0
8200105|NCT02212834|20220374|P2|COMPLETED|Overall Study||2506
8200106|NCT02212834|20220375|P1|COMPLETED|Overall Study||33938
8200107|NCT02212834|20220374|P2|STARTED|Overall Study||2506
8200108|NCT02212834|20220375|P1|STARTED|Overall Study||33938
8200109|NCT02212730|20220383|P2|NOT COMPLETED|Overall Study||1
8200110|NCT02212730|20220384|P1|NOT COMPLETED|Overall Study||2
8200111|NCT02212730|20220383|P2|COMPLETED|Overall Study||3
8200112|NCT02212730|20220384|P1|COMPLETED|Overall Study||4
8200113|NCT02212730|20220383|P2|Received Post-RCC Pembrolizumab|Overall Study||1
8200114|NCT02212730|20220384|P1|Received Post-RCC Pembrolizumab|Overall Study||1
8200115|NCT02212730|20220383|P2|Underwent RCC|Overall Study||3
8200116|NCT02212730|20220384|P1|Underwent RCC|Overall Study||4
8200117|NCT02212730|20220383|P2|Received Neoadjuvant Pembrolizumab|Overall Study||0
8200118|NCT02212730|20220384|P1|Received Neoadjuvant Pembrolizumab|Overall Study||4
8200119|NCT02212730|20220383|P2|STARTED|Overall Study||4
8200120|NCT02212730|20220384|P1|STARTED|Overall Study||6
8200121|NCT02212678|20220406|P1|NOT COMPLETED|Overall Study||1
8200122|NCT02212678|20220406|P1|COMPLETED|Overall Study||7
8200123|NCT02212678|20220406|P1|STARTED|Overall Study||8
8200124|NCT02212587|20220410|P1|NOT COMPLETED|Overall Study||1
8200125|NCT02212587|20220410|P1|COMPLETED|Overall Study||9
8200126|NCT02212587|20220410|P1|STARTED|Overall Study||10
8200127|NCT02212457|20220426|P6|NOT COMPLETED|Overall Study||13
8200128|NCT02212457|20220427|P5|NOT COMPLETED|Overall Study||15
8200129|NCT02212457|20220428|P4|NOT COMPLETED|Overall Study||11
8200130|NCT02212457|20220429|P3|NOT COMPLETED|Overall Study||16
8200131|NCT02212457|20220430|P2|NOT COMPLETED|Overall Study||21
8200132|NCT02212457|20220431|P1|NOT COMPLETED|Overall Study||19
8200133|NCT02212457|20220426|P6|COMPLETED|Overall Study||147
8200134|NCT02212457|20220427|P5|COMPLETED|Overall Study||137
8200135|NCT02212457|20220428|P4|COMPLETED|Overall Study||123
8200136|NCT02212457|20220429|P3|COMPLETED|Overall Study||141
8200137|NCT02212457|20220430|P2|COMPLETED|Overall Study||211
8200138|NCT02212457|20220431|P1|COMPLETED|Overall Study||209
8200139|NCT02212457|20220426|P6|STARTED|Overall Study||160
8200140|NCT02212457|20220427|P5|STARTED|Overall Study||152
8200141|NCT02212457|20220428|P4|STARTED|Overall Study||134
8200142|NCT02212457|20220429|P3|STARTED|Overall Study||157
8200143|NCT02212457|20220430|P2|STARTED|Overall Study||232
8200144|NCT02212457|20220431|P1|STARTED|Overall Study||228
8200145|NCT02212301|20220555|P2|NOT COMPLETED|Period 2||0
8200146|NCT02212301|20220556|P1|NOT COMPLETED|Period 2||0
8200147|NCT02212301|20220555|P2|COMPLETED|Period 2||21
8200148|NCT02212301|20220556|P1|COMPLETED|Period 2||21
8200149|NCT02212301|20220555|P2|STARTED|Period 2||21
8200150|NCT02212301|20220556|P1|STARTED|Period 2||21
8200151|NCT02212301|20220555|P2|NOT COMPLETED|Period 1||1
8200152|NCT02212301|20220556|P1|NOT COMPLETED|Period 1||0
8200153|NCT02212301|20220555|P2|COMPLETED|Period 1||21
8200154|NCT02212301|20220556|P1|COMPLETED|Period 1||21
8200155|NCT02212301|20220555|P2|STARTED|Period 1||22
8200156|NCT02212301|20220556|P1|STARTED|Period 1||21
8200157|NCT02212197|20220567|P3|NOT COMPLETED|Overall Study||0
8200158|NCT02212197|20220568|P2|NOT COMPLETED|Overall Study||0
8200159|NCT02212197|20220569|P1|NOT COMPLETED|Overall Study||1
8200160|NCT02212197|20220567|P3|COMPLETED|Overall Study||17
8200161|NCT02212197|20220568|P2|COMPLETED|Overall Study||15
8200162|NCT02212197|20220569|P1|COMPLETED|Overall Study||18
8200163|NCT02212197|20220567|P3|STARTED|Overall Study||17
8200164|NCT02212197|20220568|P2|STARTED|Overall Study||15
8200165|NCT02212197|20220569|P1|STARTED|Overall Study||19
8200166|NCT02212106|20220594|P2|NOT COMPLETED|Overall Study||4
8200167|NCT02212106|20220595|P1|NOT COMPLETED|Overall Study||10
8200168|NCT02212106|20220594|P2|COMPLETED|Overall Study||96
8200169|NCT02212106|20220595|P1|COMPLETED|Overall Study||292
8200170|NCT02212106|20220594|P2|STARTED|Overall Study||100
8200171|NCT02212106|20220595|P1|STARTED|Overall Study||302
8200172|NCT02212028|20220613|P2|NOT COMPLETED|Overall Study||0
8200173|NCT02212028|20220614|P1|NOT COMPLETED|Overall Study||0
8200174|NCT02212028|20220613|P2|COMPLETED|Overall Study||26
8200175|NCT02212028|20220614|P1|COMPLETED|Overall Study||26
8200176|NCT02212028|20220613|P2|STARTED|Overall Study||26
8200177|NCT02212028|20220614|P1|STARTED|Overall Study||26
8200178|NCT02211638|20220622|P1|NOT COMPLETED|Overall Study||983
8200179|NCT02211638|20220622|P1|COMPLETED|Overall Study||17130
8200180|NCT02211638|20220622|P1|STARTED|Overall Study||18113
8200181|NCT02211534|20220633|P2|NOT COMPLETED|Overall Study||5
8200182|NCT02211534|20220634|P1|NOT COMPLETED|Overall Study||13
8200183|NCT02211534|20220633|P2|COMPLETED|Overall Study||6
8200184|NCT02211534|20220634|P1|COMPLETED|Overall Study||11
8200185|NCT02211534|20220633|P2|STARTED|Overall Study||11
8200186|NCT02211534|20220634|P1|STARTED|Overall Study||24
8200187|NCT02211495|20220656|P2|NOT COMPLETED|Overall Study||0
8200188|NCT02211495|20220657|P1|NOT COMPLETED|Overall Study||0
8200189|NCT02211495|20220656|P2|COMPLETED|Overall Study||4
8200190|NCT02211495|20220657|P1|COMPLETED|Overall Study||4
8200191|NCT02211495|20220656|P2|STARTED|Overall Study||4
8200192|NCT02211495|20220657|P1|STARTED|Overall Study||4
8200193|NCT02211313|20220669|P2|NOT COMPLETED|Overall Study||3
8200194|NCT02211313|20220670|P1|NOT COMPLETED|Overall Study||6
8200195|NCT02211313|20220669|P2|COMPLETED|Overall Study||20
8200196|NCT02211313|20220670|P1|COMPLETED|Overall Study||12
8200197|NCT02211313|20220669|P2|STARTED|Overall Study||23
8200198|NCT02211313|20220670|P1|STARTED|Overall Study||18
8200199|NCT02211261|20220687|P11|NOT COMPLETED|Overall Study||0
8200200|NCT02211261|20220688|P10|NOT COMPLETED|Overall Study||2
8200201|NCT02211261|20220689|P9|NOT COMPLETED|Overall Study||0
8200202|NCT02211261|20220690|P8|NOT COMPLETED|Overall Study||1
8200203|NCT02211261|20220691|P7|NOT COMPLETED|Overall Study||0
8200204|NCT02211261|20220692|P6|NOT COMPLETED|Overall Study||1
8200205|NCT02211261|20220693|P5|NOT COMPLETED|Overall Study||2
8200206|NCT02211261|20220694|P4|NOT COMPLETED|Overall Study||0
8200207|NCT02211261|20220695|P3|NOT COMPLETED|Overall Study||1
8200208|NCT02211261|20220696|P2|NOT COMPLETED|Overall Study||0
8200209|NCT02211261|20220697|P1|NOT COMPLETED|Overall Study||0
8200210|NCT02211261|20220687|P11|COMPLETED|Overall Study||8
8200211|NCT02211261|20220688|P10|COMPLETED|Overall Study||14
8200212|NCT02211261|20220689|P9|COMPLETED|Overall Study||8
8200213|NCT02211261|20220690|P8|COMPLETED|Overall Study||7
8200214|NCT02211261|20220691|P7|COMPLETED|Overall Study||6
8200215|NCT02211261|20220692|P6|COMPLETED|Overall Study||1
8200216|NCT02211261|20220693|P5|COMPLETED|Overall Study||7
8200217|NCT02211261|20220694|P4|COMPLETED|Overall Study||6
8200218|NCT02211261|20220695|P3|COMPLETED|Overall Study||5
8200219|NCT02211261|20220696|P2|COMPLETED|Overall Study||6
8200220|NCT02211261|20220697|P1|COMPLETED|Overall Study||9
8200221|NCT02211261|20220687|P11|STARTED|Overall Study||8
8200222|NCT02211261|20220688|P10|STARTED|Overall Study||16
8200223|NCT02211261|20220689|P9|STARTED|Overall Study||8
8200224|NCT02211261|20220690|P8|STARTED|Overall Study||8
8200225|NCT02211261|20220691|P7|STARTED|Overall Study||6
8200226|NCT02211261|20220692|P6|STARTED|Overall Study||2
8200227|NCT02211261|20220693|P5|STARTED|Overall Study||9
8200228|NCT02211261|20220694|P4|STARTED|Overall Study||6
8200229|NCT02211261|20220695|P3|STARTED|Overall Study||6
8200230|NCT02211261|20220696|P2|STARTED|Overall Study||6
8200231|NCT02211261|20220697|P1|STARTED|Overall Study||9
8200232|NCT02211131|20220820|P2|NOT COMPLETED|Overall Study||76
8200233|NCT02211131|20220821|P1|NOT COMPLETED|Overall Study||74
8200234|NCT02211131|20220820|P2|COMPLETED|Overall Study||0
8200235|NCT02211131|20220821|P1|COMPLETED|Overall Study||0
8200236|NCT02211131|20220820|P2|STARTED|Overall Study||76
8200237|NCT02211131|20220821|P1|STARTED|Overall Study||74
8200238|NCT02211014|20220855|P2|NOT COMPLETED|Overall Study||6
8200239|NCT02211014|20220856|P1|NOT COMPLETED|Overall Study||2
8200240|NCT02211014|20220855|P2|COMPLETED|Overall Study||8
8200241|NCT02211014|20220856|P1|COMPLETED|Overall Study||11
8200242|NCT02211014|20220855|P2|STARTED|Overall Study||14
8200243|NCT02211014|20220856|P1|STARTED|Overall Study||13
8200244|NCT02210780|20220882|P2|NOT COMPLETED|Overall Study||8
8200245|NCT02210780|20220883|P1|NOT COMPLETED|Overall Study||5
8200246|NCT02210780|20220882|P2|COMPLETED|Overall Study||89
8200247|NCT02210780|20220883|P1|COMPLETED|Overall Study||92
8200248|NCT02210780|20220882|P2|STARTED|Overall Study||97
8200249|NCT02210780|20220883|P1|STARTED|Overall Study||97
8200250|NCT02210689|20220912|P3|NOT COMPLETED|Overall Study||23
8200251|NCT02210689|20220913|P2|NOT COMPLETED|Overall Study||47
8200252|NCT02210689|20220914|P1|NOT COMPLETED|Overall Study||52
8200253|NCT02210689|20220912|P3|COMPLETED|Overall Study||99
8200254|NCT02210689|20220913|P2|COMPLETED|Overall Study||193
8200255|NCT02210689|20220914|P1|COMPLETED|Overall Study||190
8200256|NCT02210689|20220912|P3|PP Population|Overall Study||84
8200257|NCT02210689|20220913|P2|PP Population|Overall Study||169
8200258|NCT02210689|20220914|P1|PP Population|Overall Study||164
8200259|NCT02210689|20220912|P3|mITT Population|Overall Study||107
8200260|NCT02210689|20220913|P2|mITT Population|Overall Study||207
8200261|NCT02210689|20220914|P1|mITT Population|Overall Study||199
8200262|NCT02210689|20220912|P3|Safety Population|Overall Study||122
8200263|NCT02210689|20220913|P2|Safety Population|Overall Study||236
8200264|NCT02210689|20220914|P1|Safety Population|Overall Study||233
8200265|NCT02210689|20220912|P3|STARTED|Overall Study||122
8200266|NCT02210689|20220913|P2|STARTED|Overall Study||240
8200267|NCT02210689|20220914|P1|STARTED|Overall Study||242
8200271|NCT02210208|20220937|P1|NOT COMPLETED|Period B (Donor Site)||7
8200272|NCT02210208|20220937|P1|COMPLETED|Period B (Donor Site)||12
8200273|NCT02210208|20220937|P1|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
8200274|NCT02210208|20220937|P1|NOT COMPLETED|Period A (Graft Site)||2
8200275|NCT02210208|20220937|P1|COMPLETED|Period A (Graft Site)||23
8200276|NCT02210208|20220937|P1|STARTED|Period A (Graft Site)||25
8200277|NCT02210195|20220946|P2|NOT COMPLETED|Overall Study||0
8200278|NCT02210195|20220947|P1|NOT COMPLETED|Overall Study||4
8200279|NCT02210195|20220946|P2|COMPLETED|Overall Study||10
8200280|NCT02210195|20220947|P1|COMPLETED|Overall Study||6
8200281|NCT02210195|20220946|P2|STARTED|Overall Study||10
8200282|NCT02210195|20220947|P1|STARTED|Overall Study||10
8200289|NCT02210065|20221030|P1|NOT COMPLETED|Overall Study||0
8200290|NCT02210065|20221030|P1|COMPLETED|Overall Study||1
8200291|NCT02210065|20221030|P1|STARTED|Overall Study||1
8200292|NCT02210052|20221035|P1|NOT COMPLETED|Overall Study||0
8200293|NCT02210052|20221035|P1|COMPLETED|Overall Study||6
8200294|NCT02210052|20221035|P1|STARTED|Overall Study||6
8200295|NCT02210039|20221039|P1|NOT COMPLETED|Overall Study||0
8200296|NCT02210039|20221039|P1|COMPLETED|Overall Study||6
8200297|NCT02210039|20221039|P1|STARTED|Overall Study||6
8200298|NCT02210000|20221045|P2|NOT COMPLETED|Overall Study||21
8200299|NCT02210000|20221046|P1|NOT COMPLETED|Overall Study||19
8200300|NCT02210000|20221045|P2|COMPLETED|Overall Study||36
8200301|NCT02210000|20221046|P1|COMPLETED|Overall Study||38
8200302|NCT02210000|20221045|P2|STARTED|Overall Study||57
8200303|NCT02210000|20221046|P1|STARTED|Overall Study||57
8200304|NCT02209948|20221070|P2|NOT COMPLETED|Overall Study||0
8200305|NCT02209948|20221071|P1|NOT COMPLETED|Overall Study||0
8200306|NCT02209948|20221070|P2|COMPLETED|Overall Study||79
8200307|NCT02209948|20221071|P1|COMPLETED|Overall Study||80
8200308|NCT02209948|20221070|P2|Discontinued Due to Progression|Overall Study||39
8200309|NCT02209948|20221071|P1|Discontinued Due to Progression|Overall Study||31
8200310|NCT02209948|20221070|P2|Lost to Follow up|Overall Study||1
8200311|NCT02209948|20221071|P1|Lost to Follow up|Overall Study||0
8200312|NCT02209948|20221070|P2|Recieved Alocated Intervention|Overall Study||79
8200313|NCT02209948|20221071|P1|Recieved Alocated Intervention|Overall Study||80
8200314|NCT02209948|20221070|P2|STARTED|Overall Study||79
8200315|NCT02209948|20221071|P1|STARTED|Overall Study||80
8200316|NCT02209766|20221093|P5|NOT COMPLETED|Overall Study||0
8200317|NCT02209766|20221094|P4|NOT COMPLETED|Overall Study||1
8200318|NCT02209766|20221095|P3|NOT COMPLETED|Overall Study||0
8200319|NCT02209766|20221096|P2|NOT COMPLETED|Overall Study||0
8200320|NCT02209766|20221097|P1|NOT COMPLETED|Overall Study||0
8200321|NCT02209766|20221093|P5|COMPLETED|Overall Study||6
8200322|NCT02209766|20221094|P4|COMPLETED|Overall Study||2
8200323|NCT02209766|20221095|P3|COMPLETED|Overall Study||6
8200324|NCT02209766|20221096|P2|COMPLETED|Overall Study||3
8200325|NCT02209766|20221097|P1|COMPLETED|Overall Study||6
8200326|NCT02209766|20221093|P5|STARTED|Overall Study||6
8200327|NCT02209766|20221094|P4|STARTED|Overall Study||3
8200328|NCT02209766|20221095|P3|STARTED|Overall Study||6
8200329|NCT02209766|20221096|P2|STARTED|Overall Study||3
8200330|NCT02209766|20221097|P1|STARTED|Overall Study||6
8200331|NCT02209610|20221145|P2|NOT COMPLETED|Overall Study||0
8200332|NCT02209610|20221146|P1|NOT COMPLETED|Overall Study||0
8200333|NCT02209610|20221145|P2|COMPLETED|Overall Study||16
8200334|NCT02209610|20221146|P1|COMPLETED|Overall Study||16
8200335|NCT02209610|20221145|P2|STARTED|Overall Study||16
8200336|NCT02209610|20221146|P1|STARTED|Overall Study||16
8200337|NCT02209597|20221156|P1|NOT COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||0
8200338|NCT02209597|20221156|P1|COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
8200339|NCT02209597|20221156|P1|STARTED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
8200340|NCT02209597|20221156|P1|NOT COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||0
8200341|NCT02209597|20221156|P1|COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
8200342|NCT02209597|20221156|P1|STARTED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
8200343|NCT02209597|20221156|P1|NOT COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||4
8200344|NCT02209597|20221156|P1|COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||67
8200345|NCT02209597|20221156|P1|STARTED|Phase 2 (Randomized: 1 Brand, 3 Generic)||71
8200346|NCT02209597|20221156|P1|NOT COMPLETED|Phase 1 Current Tx (Non-randomized)||3
8200347|NCT02209597|20221156|P1|COMPLETED|Phase 1 Current Tx (Non-randomized)||71
8200348|NCT02209597|20221156|P1|STARTED|Phase 1 Current Tx (Non-randomized)||74
8200349|NCT02209532|20221168|P2|NOT COMPLETED|Overall Study||1
8200350|NCT02209532|20221169|P1|NOT COMPLETED|Overall Study||3
8200351|NCT02209532|20221168|P2|COMPLETED|Overall Study||89
8200352|NCT02209532|20221169|P1|COMPLETED|Overall Study||87
8200353|NCT02209532|20221168|P2|STARTED|Overall Study||90
8200354|NCT02209532|20221169|P1|STARTED|Overall Study||90
8200355|NCT02209519|20221187|P2|NOT COMPLETED|Overall Study||0
8200356|NCT02209519|20221188|P1|NOT COMPLETED|Overall Study||0
8200357|NCT02209519|20221187|P2|COMPLETED|Overall Study||107
8200358|NCT02209519|20221188|P1|COMPLETED|Overall Study||107
8200359|NCT02209519|20221187|P2|STARTED|Overall Study||107
8200360|NCT02209519|20221188|P1|STARTED|Overall Study||107
8200361|NCT02209506|20221201|P5|NOT COMPLETED|Overall Study||1
8200362|NCT02209506|20221202|P4|NOT COMPLETED|Overall Study||0
8200363|NCT02209506|20221203|P3|NOT COMPLETED|Overall Study||0
8200364|NCT02209506|20221204|P2|NOT COMPLETED|Overall Study||0
8200365|NCT02209506|20221205|P1|NOT COMPLETED|Overall Study||0
8200366|NCT02209506|20221201|P5|COMPLETED|Overall Study||5
8200367|NCT02209506|20221202|P4|COMPLETED|Overall Study||2
8200368|NCT02209506|20221203|P3|COMPLETED|Overall Study||6
8200369|NCT02209506|20221204|P2|COMPLETED|Overall Study||6
8200370|NCT02209506|20221205|P1|COMPLETED|Overall Study||3
8200371|NCT02209506|20221201|P5|STARTED|Overall Study||6
8200372|NCT02209506|20221202|P4|STARTED|Overall Study||2
8200373|NCT02209506|20221203|P3|STARTED|Overall Study||6
8200374|NCT02209506|20221204|P2|STARTED|Overall Study||6
8200375|NCT02209506|20221205|P1|STARTED|Overall Study||3
8200376|NCT02209454|20221280|P2|NOT COMPLETED|Second Period||0
8200377|NCT02209454|20221281|P1|NOT COMPLETED|Second Period||1
8200378|NCT02209454|20221280|P2|COMPLETED|Second Period||13
8200379|NCT02209454|20221281|P1|COMPLETED|Second Period||12
8200380|NCT02209454|20221280|P2|STARTED|Second Period||13
8200381|NCT02209454|20221281|P1|STARTED|Second Period||13
8200382|NCT02209454|20221280|P2|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
8200383|NCT02209454|20221281|P1|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
8200384|NCT02209454|20221280|P2|COMPLETED|Washout Period a Minimum of a 7 Day||13
8200385|NCT02209454|20221281|P1|COMPLETED|Washout Period a Minimum of a 7 Day||13
8200386|NCT02209454|20221280|P2|STARTED|Washout Period a Minimum of a 7 Day||13
8200387|NCT02209454|20221281|P1|STARTED|Washout Period a Minimum of a 7 Day||13
8200388|NCT02209454|20221280|P2|NOT COMPLETED|First Period||0
8200389|NCT02209454|20221281|P1|NOT COMPLETED|First Period||0
8200390|NCT02209454|20221280|P2|COMPLETED|First Period||13
8200391|NCT02209454|20221281|P1|COMPLETED|First Period||13
8200392|NCT02209454|20221280|P2|STARTED|First Period||13
8200393|NCT02209454|20221281|P1|STARTED|First Period||13
8200394|NCT02209272|20221297|P2|NOT COMPLETED|Overall Study||0
8200395|NCT02209272|20221298|P1|NOT COMPLETED|Overall Study||0
8200396|NCT02209272|20221297|P2|COMPLETED|Overall Study||36
8200397|NCT02209272|20221298|P1|COMPLETED|Overall Study||32
8200398|NCT02209272|20221297|P2|STARTED|Overall Study||36
8200399|NCT02209272|20221298|P1|STARTED|Overall Study||32
8200400|NCT02209259|20221311|P3|NOT COMPLETED|Overall Study||0
8200401|NCT02209259|20221312|P2|NOT COMPLETED|Overall Study||0
8200402|NCT02209259|20221313|P1|NOT COMPLETED|Overall Study||0
8200403|NCT02209259|20221311|P3|COMPLETED|Overall Study||56
8200404|NCT02209259|20221312|P2|COMPLETED|Overall Study||56
8200405|NCT02209259|20221313|P1|COMPLETED|Overall Study||56
8200406|NCT02209259|20221311|P3|STARTED|Overall Study||56
8200407|NCT02209259|20221312|P2|STARTED|Overall Study||56
8200408|NCT02209259|20221313|P1|STARTED|Overall Study||56
8200409|NCT02209181|20221331|P4|NOT COMPLETED|Overall Study||0
8200410|NCT02209181|20221332|P3|NOT COMPLETED|Overall Study||1
8200411|NCT02209181|20221333|P2|NOT COMPLETED|Overall Study||1
8200412|NCT02209181|20221334|P1|NOT COMPLETED|Overall Study||1
8200413|NCT02209181|20221331|P4|COMPLETED|Overall Study||66
8200414|NCT02209181|20221332|P3|COMPLETED|Overall Study||68
8200415|NCT02209181|20221333|P2|COMPLETED|Overall Study||66
8200416|NCT02209181|20221334|P1|COMPLETED|Overall Study||66
8200417|NCT02209181|20221331|P4|STARTED|Overall Study||66
8200418|NCT02209181|20221332|P3|STARTED|Overall Study||69
8200419|NCT02209181|20221333|P2|STARTED|Overall Study||67
8200420|NCT02209181|20221334|P1|STARTED|Overall Study||67
8200421|NCT02209064|20221496|P1|NOT COMPLETED|Overall Study||0
8200422|NCT02209064|20221496|P1|COMPLETED|Overall Study||25
8200423|NCT02209064|20221496|P1|STARTED|Overall Study||25
8200424|NCT02208999|20221505|P1|NOT COMPLETED|Overall Study||1
8200425|NCT02208999|20221505|P1|COMPLETED|Overall Study||105
8200426|NCT02208999|20221505|P1|STARTED|Overall Study||106
8200427|NCT02208843|20221527|P1|NOT COMPLETED|Overall Study||60
8200428|NCT02208843|20221527|P1|COMPLETED|Overall Study||0
8200429|NCT02208843|20221527|P1|STARTED|Overall Study||60
8200430|NCT02208349|20221535|P2|NOT COMPLETED|Sixth 6 Month||0
8200431|NCT02208349|20221536|P1|NOT COMPLETED|Sixth 6 Month||0
8200432|NCT02208349|20221535|P2|COMPLETED|Sixth 6 Month||2
8200433|NCT02208349|20221536|P1|COMPLETED|Sixth 6 Month||3
8200434|NCT02208349|20221535|P2|STARTED|Sixth 6 Month||2
8200435|NCT02208349|20221536|P1|STARTED|Sixth 6 Month||3
8200436|NCT02208349|20221535|P2|NOT COMPLETED|Fifth 6 Month||0
8200437|NCT02208349|20221536|P1|NOT COMPLETED|Fifth 6 Month||0
8200438|NCT02208349|20221535|P2|COMPLETED|Fifth 6 Month||2
8200439|NCT02208349|20221536|P1|COMPLETED|Fifth 6 Month||7
8200440|NCT02208349|20221535|P2|STARTED|Fifth 6 Month||2
8200441|NCT02208349|20221536|P1|STARTED|Fifth 6 Month||7
8200442|NCT02208349|20221535|P2|NOT COMPLETED|Fourth 6 Month||0
8200443|NCT02208349|20221536|P1|NOT COMPLETED|Fourth 6 Month||0
8200444|NCT02208349|20221535|P2|COMPLETED|Fourth 6 Month||2
8200445|NCT02208349|20221536|P1|COMPLETED|Fourth 6 Month||14
8200446|NCT02208349|20221535|P2|STARTED|Fourth 6 Month||2
8200447|NCT02208349|20221536|P1|STARTED|Fourth 6 Month||14
8200448|NCT02208349|20221535|P2|NOT COMPLETED|Third 6 Month||0
8200449|NCT02208349|20221536|P1|NOT COMPLETED|Third 6 Month||0
8200450|NCT02208349|20221535|P2|COMPLETED|Third 6 Month||3
8200451|NCT02208349|20221536|P1|COMPLETED|Third 6 Month||6
8200452|NCT02208349|20221535|P2|STARTED|Third 6 Month||3
8200453|NCT02208349|20221536|P1|STARTED|Third 6 Month||6
8200454|NCT02208349|20221535|P2|NOT COMPLETED|Second 6 Months||0
8200455|NCT02208349|20221536|P1|NOT COMPLETED|Second 6 Months||0
8200456|NCT02208349|20221535|P2|COMPLETED|Second 6 Months||7
8200457|NCT02208349|20221536|P1|COMPLETED|Second 6 Months||11
8200458|NCT02208349|20221535|P2|STARTED|Second 6 Months||7
8200459|NCT02208349|20221536|P1|STARTED|Second 6 Months||11
8200460|NCT02208349|20221535|P2|NOT COMPLETED|Initial 6 Months||0
8200461|NCT02208349|20221536|P1|NOT COMPLETED|Initial 6 Months||0
8200462|NCT02208349|20221535|P2|COMPLETED|Initial 6 Months||9
8200463|NCT02208349|20221536|P1|COMPLETED|Initial 6 Months||16
8200464|NCT02208349|20221535|P2|STARTED|Initial 6 Months||9
8200465|NCT02208349|20221536|P1|STARTED|Initial 6 Months||16
8200466|NCT02208310|20221546|P2|NOT COMPLETED|Overall Study||5
8200467|NCT02208310|20221547|P1|NOT COMPLETED|Overall Study||6
8200468|NCT02208310|20221546|P2|COMPLETED|Overall Study||0
8200469|NCT02208310|20221547|P1|COMPLETED|Overall Study||0
8200470|NCT02208310|20221546|P2|Day 180|Overall Study||1
8200471|NCT02208310|20221547|P1|Day 180|Overall Study||0
8200472|NCT02208310|20221546|P2|STARTED|Overall Study||5
8200473|NCT02208310|20221547|P1|STARTED|Overall Study||6
8200474|NCT02208297|20221579|P2|NOT COMPLETED|Overall Study||56
8200475|NCT02208297|20221580|P1|NOT COMPLETED|Overall Study||22
8200476|NCT02208297|20221579|P2|COMPLETED|Overall Study||107
8200477|NCT02208297|20221580|P1|COMPLETED|Overall Study||141
8200478|NCT02208297|20221579|P2|STARTED|Overall Study||163
8200479|NCT02208297|20221580|P1|STARTED|Overall Study||163
8200480|NCT02208089|20221598|P2|NOT COMPLETED|Overall Study||0
8200481|NCT02208089|20221599|P1|NOT COMPLETED|Overall Study||7
8200482|NCT02208089|20221598|P2|COMPLETED|Overall Study||47
8200483|NCT02208089|20221599|P1|COMPLETED|Overall Study||40
8200484|NCT02208089|20221598|P2|STARTED|Overall Study||47
8200485|NCT02208089|20221599|P1|STARTED|Overall Study||47
8200486|NCT02208063|20221615|P2|NOT COMPLETED|Overall Study||11
8200487|NCT02208063|20221616|P1|NOT COMPLETED|Overall Study||12
8200488|NCT02208063|20221615|P2|COMPLETED|Overall Study||50
8200489|NCT02208063|20221616|P1|COMPLETED|Overall Study||48
8200490|NCT02208063|20221615|P2|Microbiological All Treated|Overall Study||52
8200491|NCT02208063|20221616|P1|Microbiological All Treated|Overall Study||47
8200492|NCT02208063|20221615|P2|Randomized and Treated|Overall Study||60
8200493|NCT02208063|20221616|P1|Randomized and Treated|Overall Study||58
8200494|NCT02208063|20221615|P2|STARTED|Overall Study||61
8200495|NCT02208063|20221616|P1|STARTED|Overall Study||60
8200496|NCT02208037|20221631|P3|NOT COMPLETED|Overall Study||1
8200497|NCT02208037|20221632|P2|NOT COMPLETED|Overall Study||1
8200498|NCT02208037|20221633|P1|NOT COMPLETED|Overall Study||4
8200499|NCT02208037|20221631|P3|COMPLETED|Overall Study||92
8200500|NCT02208037|20221632|P2|COMPLETED|Overall Study||92
8200501|NCT02208037|20221633|P1|COMPLETED|Overall Study||89
8200502|NCT02208037|20221631|P3|STARTED|Overall Study||93
8200503|NCT02208037|20221632|P2|STARTED|Overall Study||93
8200504|NCT02208037|20221633|P1|STARTED|Overall Study||93
8200505|NCT02207972|20221682|P2|NOT COMPLETED|Overall Study||0
8200506|NCT02207972|20221683|P1|NOT COMPLETED|Overall Study||0
8200507|NCT02207972|20221682|P2|COMPLETED|Overall Study||24
8200508|NCT02207972|20221683|P1|COMPLETED|Overall Study||22
8200509|NCT02207972|20221682|P2|STARTED|Overall Study||24
8200510|NCT02207972|20221683|P1|STARTED|Overall Study||22
8200511|NCT02207907|20221695|P2|NOT COMPLETED|Overall Study||8
8200512|NCT02207907|20221696|P1|NOT COMPLETED|Overall Study||11
8200513|NCT02207907|20221695|P2|COMPLETED|Overall Study||115
8200514|NCT02207907|20221696|P1|COMPLETED|Overall Study||113
8200515|NCT02207907|20221695|P2|STARTED|Overall Study||123
8200516|NCT02207907|20221696|P1|STARTED|Overall Study||124
8200517|NCT02207829|20221714|P2|NOT COMPLETED|Overall Study||34
8200518|NCT02207829|20221715|P1|NOT COMPLETED|Overall Study||42
8200519|NCT02207829|20221714|P2|COMPLETED|Overall Study||474
8200520|NCT02207829|20221715|P1|COMPLETED|Overall Study||467
8200521|NCT02207829|20221714|P2|STARTED|Overall Study||508
8200522|NCT02207829|20221715|P1|STARTED|Overall Study||509
8200523|NCT02207816|20221724|P3|NOT COMPLETED|Overall Study||67
8200524|NCT02207816|20221725|P2|NOT COMPLETED|Overall Study||86
8200525|NCT02207816|20221726|P1|NOT COMPLETED|Overall Study||51
8200526|NCT02207816|20221724|P3|COMPLETED|Overall Study||961
8200527|NCT02207816|20221725|P2|COMPLETED|Overall Study||924
8200528|NCT02207816|20221726|P1|COMPLETED|Overall Study||995
8200529|NCT02207816|20221724|P3|STARTED|Overall Study||1028
8200530|NCT02207816|20221725|P2|STARTED|Overall Study||1010
8200531|NCT02207816|20221726|P1|STARTED|Overall Study||1046
8200532|NCT02207803|20221871|P2|NOT COMPLETED|Overall Study||17
8200533|NCT02207803|20221872|P1|NOT COMPLETED|Overall Study||15
8200534|NCT02207803|20221871|P2|COMPLETED|Overall Study||108
8200535|NCT02207803|20221872|P1|COMPLETED|Overall Study||110
8200536|NCT02207803|20221871|P2|STARTED|Overall Study||125
8200537|NCT02207803|20221872|P1|STARTED|Overall Study||125
8200538|NCT02207725|20221884|P4|NOT COMPLETED|Overall Study||1
8200539|NCT02207725|20221885|P3|NOT COMPLETED|Overall Study||1
8200540|NCT02207725|20221886|P2|NOT COMPLETED|Overall Study||1
8200541|NCT02207725|20221887|P1|NOT COMPLETED|Overall Study||0
8200542|NCT02207725|20221884|P4|COMPLETED|Overall Study||24
8200543|NCT02207725|20221885|P3|COMPLETED|Overall Study||8
8200544|NCT02207725|20221886|P2|COMPLETED|Overall Study||24
8200545|NCT02207725|20221887|P1|COMPLETED|Overall Study||9
8200546|NCT02207725|20221884|P4|STARTED|Overall Study||25
8200547|NCT02207725|20221885|P3|STARTED|Overall Study||9
8200548|NCT02207725|20221886|P2|STARTED|Overall Study||25
8200549|NCT02207725|20221887|P1|STARTED|Overall Study||9
8200550|NCT02207634|20221917|P2|NOT COMPLETED|Overall Study||31
8200551|NCT02207634|20221918|P1|NOT COMPLETED|Overall Study||22
8200552|NCT02207634|20221917|P2|COMPLETED|Overall Study||953
8200553|NCT02207634|20221918|P1|COMPLETED|Overall Study||968
8200554|NCT02207634|20221917|P2|Received Treatment|Overall Study||983
8200555|NCT02207634|20221918|P1|Received Treatment|Overall Study||990
8200556|NCT02207634|20221917|P2|STARTED|Overall Study||984
8200557|NCT02207634|20221918|P1|STARTED|Overall Study||990
8200558|NCT02207621|20221933|P3|NOT COMPLETED|Overall Study||168
8200559|NCT02207621|20221934|P2|NOT COMPLETED|Overall Study||47
8200560|NCT02207621|20221935|P1|NOT COMPLETED|Overall Study||105
8200561|NCT02207621|20221933|P3|COMPLETED|Overall Study||86
8200562|NCT02207621|20221934|P2|COMPLETED|Overall Study||204
8200563|NCT02207621|20221935|P1|COMPLETED|Overall Study||146
8200564|NCT02207621|20221933|P3|STARTED|Overall Study||254
8200565|NCT02207621|20221934|P2|STARTED|Overall Study||251
8200566|NCT02207621|20221935|P1|STARTED|Overall Study||251
8200567|NCT02207608|20221948|P2|NOT COMPLETED|Overall Study||0
8200568|NCT02207608|20221949|P1|NOT COMPLETED|Overall Study||1
8200569|NCT02207608|20221948|P2|COMPLETED|Overall Study||15
8200570|NCT02207608|20221949|P1|COMPLETED|Overall Study||14
8200571|NCT02207608|20221948|P2|STARTED|Overall Study||15
8200572|NCT02207608|20221949|P1|STARTED|Overall Study||15
8200591|NCT02207530|20221981|P1|NOT COMPLETED|Overall Study||91
8200592|NCT02207530|20221981|P1|COMPLETED|Overall Study||21
8200593|NCT02207530|20221981|P1|STARTED|Overall Study||112
8200594|NCT02207491|20221995|P2|NOT COMPLETED|Overall Study||13
8200595|NCT02207491|20221996|P1|NOT COMPLETED|Overall Study||31
8200596|NCT02207491|20221995|P2|COMPLETED|Overall Study||196
8200597|NCT02207491|20221996|P1|COMPLETED|Overall Study||171
8200598|NCT02207491|20221995|P2|STARTED|Overall Study||209
8200599|NCT02207491|20221996|P1|STARTED|Overall Study||202
8200600|NCT02207478|20222006|P2|NOT COMPLETED|Overall Study||0
8200601|NCT02207478|20222007|P1|NOT COMPLETED|Overall Study||0
8200602|NCT02207478|20222006|P2|COMPLETED|Overall Study||46
8200603|NCT02207478|20222007|P1|COMPLETED|Overall Study||40
8200604|NCT02207478|20222006|P2|STARTED|Overall Study||46
8200605|NCT02207478|20222007|P1|STARTED|Overall Study||40
8200606|NCT02207413|20222021|P6|NOT COMPLETED|Overall Study||13
8200607|NCT02207413|20222022|P5|NOT COMPLETED|Overall Study||7
8200608|NCT02207413|20222023|P4|NOT COMPLETED|Overall Study||1
8200609|NCT02207413|20222024|P3|NOT COMPLETED|Overall Study||0
8200610|NCT02207413|20222025|P2|NOT COMPLETED|Overall Study||0
8200611|NCT02207413|20222026|P1|NOT COMPLETED|Overall Study||1
8200612|NCT02207413|20222021|P6|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
8200839|NCT02206607|20222352|P5|STARTED|Fourth Intervention Period||10
8200613|NCT02207413|20222022|P5|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
8200614|NCT02207413|20222023|P4|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
8200615|NCT02207413|20222024|P3|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
8200616|NCT02207413|20222025|P2|COMPLETED|Overall Study||60
8200617|NCT02207413|20222026|P1|COMPLETED|Overall Study||59
8200618|NCT02207413|20222021|P6|STARTED|Overall Study||474
8200619|NCT02207413|20222022|P5|STARTED|Overall Study||466
8200620|NCT02207413|20222023|P4|STARTED|Overall Study||411
8200621|NCT02207413|20222024|P3|STARTED|Overall Study||410
8200622|NCT02207413|20222025|P2|STARTED|Overall Study||60
8200623|NCT02207413|20222026|P1|STARTED|Overall Study||60
8200624|NCT02207400|20222122|P2|NOT COMPLETED|Overall Study||14
8200625|NCT02207400|20222123|P1|NOT COMPLETED|Overall Study||16
8200626|NCT02207400|20222122|P2|COMPLETED|Overall Study||109
8200627|NCT02207400|20222123|P1|COMPLETED|Overall Study||107
8200628|NCT02207400|20222122|P2|STARTED|Overall Study||123
8200629|NCT02207400|20222123|P1|STARTED|Overall Study||123
8200630|NCT02207374|20222144|P3|NOT COMPLETED|Overall Study||6
8200631|NCT02207374|20222145|P2|NOT COMPLETED|Overall Study||10
8200632|NCT02207374|20222146|P1|NOT COMPLETED|Overall Study||6
8200633|NCT02207374|20222144|P3|COMPLETED|Overall Study||115
8200634|NCT02207374|20222145|P2|COMPLETED|Overall Study||231
8200635|NCT02207374|20222146|P1|COMPLETED|Overall Study||233
8200636|NCT02207374|20222144|P3|Exposed|Overall Study||120
8200637|NCT02207374|20222145|P2|Exposed|Overall Study||241
8200638|NCT02207374|20222146|P1|Exposed|Overall Study||239
8200639|NCT02207374|20222144|P3|STARTED|Overall Study||121
8200640|NCT02207374|20222145|P2|STARTED|Overall Study||241
8200641|NCT02207374|20222146|P1|STARTED|Overall Study||239
8200642|NCT02207322|20222162|P2|NOT COMPLETED|Overall Study||10
8200643|NCT02207322|20222163|P1|NOT COMPLETED|Overall Study||9
8200644|NCT02207322|20222162|P2|COMPLETED|Overall Study|6-month|71
8200645|NCT02207322|20222163|P1|COMPLETED|Overall Study|6-month|70
8200646|NCT02207322|20222162|P2|3-month|Overall Study||75
8200647|NCT02207322|20222163|P1|3-month|Overall Study||74
8200648|NCT02207322|20222162|P2|Week-2|Overall Study||80
8200649|NCT02207322|20222163|P1|Week-2|Overall Study||77
8200650|NCT02207322|20222162|P2|STARTED|Overall Study||81
8200651|NCT02207322|20222163|P1|STARTED|Overall Study||79
8200799|NCT02207088|20222293|P1|NOT COMPLETED|Overall Study||2
8200800|NCT02207088|20222293|P1|COMPLETED|Overall Study||66
8200801|NCT02207088|20222293|P1|STARTED|Overall Study||68
8200802|NCT02206828|20222299|P1|NOT COMPLETED|Overall Study||7
8200803|NCT02206828|20222299|P1|COMPLETED|Overall Study||93
8200804|NCT02206828|20222299|P1|STARTED|Overall Study||100
8200805|NCT02206776|20222328|P2|NOT COMPLETED|Overall Study||0
8200806|NCT02206776|20222329|P1|NOT COMPLETED|Overall Study||0
8200807|NCT02206776|20222328|P2|COMPLETED|Overall Study||1
8200808|NCT02206776|20222329|P1|COMPLETED|Overall Study||1
8200809|NCT02206776|20222328|P2|STARTED|Overall Study||1
8200810|NCT02206776|20222329|P1|STARTED|Overall Study||1
8200811|NCT02206620|20222335|P2|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2
8200812|NCT02206620|20222336|P1|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0
8200813|NCT02206620|20222335|P2|COMPLETED|Phase II - Second Intervention (6 Weeks)||24
8200814|NCT02206620|20222336|P1|COMPLETED|Phase II - Second Intervention (6 Weeks)||21
8200815|NCT02206620|20222335|P2|STARTED|Phase II - Second Intervention (6 Weeks)||26
8200816|NCT02206620|20222336|P1|STARTED|Phase II - Second Intervention (6 Weeks)||21
8200817|NCT02206620|20222335|P2|NOT COMPLETED|Washout (6 Weeks)||0
8200818|NCT02206620|20222336|P1|NOT COMPLETED|Washout (6 Weeks)||0
8200819|NCT02206620|20222335|P2|COMPLETED|Washout (6 Weeks)||26
8200820|NCT02206620|20222336|P1|COMPLETED|Washout (6 Weeks)||21
8200821|NCT02206620|20222335|P2|STARTED|Washout (6 Weeks)||26
8200822|NCT02206620|20222336|P1|STARTED|Washout (6 Weeks)||21
8200823|NCT02206620|20222335|P2|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
8200824|NCT02206620|20222336|P1|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
8200825|NCT02206620|20222335|P2|COMPLETED|Phase I - First Intervention (6 Weeks)||26
8200826|NCT02206620|20222336|P1|COMPLETED|Phase I - First Intervention (6 Weeks)||21
8200827|NCT02206620|20222335|P2|STARTED|Phase I - First Intervention (6 Weeks)||27
8200828|NCT02206620|20222336|P1|STARTED|Phase I - First Intervention (6 Weeks)||22
8200829|NCT02206607|20222352|P5|NOT COMPLETED|Fourth Intervention Period||0
8200830|NCT02206607|20222353|P4|NOT COMPLETED|Fourth Intervention Period||0
8200831|NCT02206607|20222354|P3|NOT COMPLETED|Fourth Intervention Period||0
8200832|NCT02206607|20222355|P2|NOT COMPLETED|Fourth Intervention Period||0
8200833|NCT02206607|20222356|P1|NOT COMPLETED|Fourth Intervention Period||0
8200834|NCT02206607|20222352|P5|COMPLETED|Fourth Intervention Period||10
8200835|NCT02206607|20222353|P4|COMPLETED|Fourth Intervention Period||10
8200836|NCT02206607|20222354|P3|COMPLETED|Fourth Intervention Period||9
8200837|NCT02206607|20222355|P2|COMPLETED|Fourth Intervention Period||9
8200838|NCT02206607|20222356|P1|COMPLETED|Fourth Intervention Period||0
8200840|NCT02206607|20222353|P4|STARTED|Fourth Intervention Period||10
8200841|NCT02206607|20222354|P3|STARTED|Fourth Intervention Period||9
8200842|NCT02206607|20222355|P2|STARTED|Fourth Intervention Period||9
8200843|NCT02206607|20222356|P1|STARTED|Fourth Intervention Period||0
8200844|NCT02206607|20222352|P5|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8200845|NCT02206607|20222353|P4|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8200846|NCT02206607|20222354|P3|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8200847|NCT02206607|20222355|P2|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8200848|NCT02206607|20222356|P1|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
8200849|NCT02206607|20222352|P5|COMPLETED|Third Washout Period 5 to 10 Days||10
8200850|NCT02206607|20222353|P4|COMPLETED|Third Washout Period 5 to 10 Days||10
8200851|NCT02206607|20222354|P3|COMPLETED|Third Washout Period 5 to 10 Days||9
8200852|NCT02206607|20222355|P2|COMPLETED|Third Washout Period 5 to 10 Days||9
8200853|NCT02206607|20222356|P1|COMPLETED|Third Washout Period 5 to 10 Days||0
8200854|NCT02206607|20222352|P5|STARTED|Third Washout Period 5 to 10 Days||10
8200855|NCT02206607|20222353|P4|STARTED|Third Washout Period 5 to 10 Days||10
8200856|NCT02206607|20222354|P3|STARTED|Third Washout Period 5 to 10 Days||9
8200857|NCT02206607|20222355|P2|STARTED|Third Washout Period 5 to 10 Days||9
8200858|NCT02206607|20222356|P1|STARTED|Third Washout Period 5 to 10 Days||0
8200859|NCT02206607|20222352|P5|NOT COMPLETED|Third Intervention Period||0
8200860|NCT02206607|20222353|P4|NOT COMPLETED|Third Intervention Period||0
8200861|NCT02206607|20222354|P3|NOT COMPLETED|Third Intervention Period||0
8200862|NCT02206607|20222355|P2|NOT COMPLETED|Third Intervention Period||0
8200863|NCT02206607|20222356|P1|NOT COMPLETED|Third Intervention Period||0
8200864|NCT02206607|20222352|P5|COMPLETED|Third Intervention Period||10
8200865|NCT02206607|20222353|P4|COMPLETED|Third Intervention Period||10
8200866|NCT02206607|20222354|P3|COMPLETED|Third Intervention Period||9
8200867|NCT02206607|20222355|P2|COMPLETED|Third Intervention Period||9
8200868|NCT02206607|20222356|P1|COMPLETED|Third Intervention Period||0
8200869|NCT02206607|20222352|P5|STARTED|Third Intervention Period||10
8200870|NCT02206607|20222353|P4|STARTED|Third Intervention Period||10
8200871|NCT02206607|20222354|P3|STARTED|Third Intervention Period||9
8200872|NCT02206607|20222355|P2|STARTED|Third Intervention Period||9
8200873|NCT02206607|20222356|P1|STARTED|Third Intervention Period||0
8200874|NCT02206607|20222352|P5|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8200875|NCT02206607|20222353|P4|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8200876|NCT02206607|20222354|P3|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8200877|NCT02206607|20222355|P2|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8200878|NCT02206607|20222356|P1|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
8200879|NCT02206607|20222352|P5|COMPLETED|Second Washout Period 5 to 10 Days||10
8200880|NCT02206607|20222353|P4|COMPLETED|Second Washout Period 5 to 10 Days||10
8200881|NCT02206607|20222354|P3|COMPLETED|Second Washout Period 5 to 10 Days||9
8200882|NCT02206607|20222355|P2|COMPLETED|Second Washout Period 5 to 10 Days||9
8200883|NCT02206607|20222356|P1|COMPLETED|Second Washout Period 5 to 10 Days||0
8200884|NCT02206607|20222352|P5|STARTED|Second Washout Period 5 to 10 Days||10
8200885|NCT02206607|20222353|P4|STARTED|Second Washout Period 5 to 10 Days||10
8200886|NCT02206607|20222354|P3|STARTED|Second Washout Period 5 to 10 Days||9
8200887|NCT02206607|20222355|P2|STARTED|Second Washout Period 5 to 10 Days||9
8200888|NCT02206607|20222356|P1|STARTED|Second Washout Period 5 to 10 Days||0
8200889|NCT02206607|20222352|P5|NOT COMPLETED|Second Intervention Period||0
8200890|NCT02206607|20222353|P4|NOT COMPLETED|Second Intervention Period||1
8200891|NCT02206607|20222354|P3|NOT COMPLETED|Second Intervention Period||0
8200892|NCT02206607|20222355|P2|NOT COMPLETED|Second Intervention Period||0
8200893|NCT02206607|20222356|P1|NOT COMPLETED|Second Intervention Period||0
8200894|NCT02206607|20222352|P5|COMPLETED|Second Intervention Period||10
8200895|NCT02206607|20222353|P4|COMPLETED|Second Intervention Period||10
8200896|NCT02206607|20222354|P3|COMPLETED|Second Intervention Period||9
8200897|NCT02206607|20222355|P2|COMPLETED|Second Intervention Period||9
8200898|NCT02206607|20222356|P1|COMPLETED|Second Intervention Period||0
8200899|NCT02206607|20222352|P5|STARTED|Second Intervention Period||10
8200900|NCT02206607|20222353|P4|STARTED|Second Intervention Period||11
8200901|NCT02206607|20222354|P3|STARTED|Second Intervention Period||9
8200902|NCT02206607|20222355|P2|STARTED|Second Intervention Period||9
8200903|NCT02206607|20222356|P1|STARTED|Second Intervention Period||0
8200904|NCT02206607|20222352|P5|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8200905|NCT02206607|20222353|P4|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8200906|NCT02206607|20222354|P3|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8200907|NCT02206607|20222355|P2|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8200908|NCT02206607|20222356|P1|NOT COMPLETED|First Washout Period 5 to 10 Days||0
8200909|NCT02206607|20222352|P5|COMPLETED|First Washout Period 5 to 10 Days||10
8200910|NCT02206607|20222353|P4|COMPLETED|First Washout Period 5 to 10 Days||11
8200911|NCT02206607|20222354|P3|COMPLETED|First Washout Period 5 to 10 Days||9
8200912|NCT02206607|20222355|P2|COMPLETED|First Washout Period 5 to 10 Days||9
8200913|NCT02206607|20222356|P1|COMPLETED|First Washout Period 5 to 10 Days||0
8200914|NCT02206607|20222352|P5|STARTED|First Washout Period 5 to 10 Days||10
8200915|NCT02206607|20222353|P4|STARTED|First Washout Period 5 to 10 Days||11
8200916|NCT02206607|20222354|P3|STARTED|First Washout Period 5 to 10 Days||9
8200917|NCT02206607|20222355|P2|STARTED|First Washout Period 5 to 10 Days||9
8200918|NCT02206607|20222356|P1|STARTED|First Washout Period 5 to 10 Days||0
8200919|NCT02206607|20222352|P5|NOT COMPLETED|First Intervention Period||0
8200920|NCT02206607|20222353|P4|NOT COMPLETED|First Intervention Period||0
8200921|NCT02206607|20222354|P3|NOT COMPLETED|First Intervention Period||0
8200922|NCT02206607|20222355|P2|NOT COMPLETED|First Intervention Period||0
8200923|NCT02206607|20222356|P1|NOT COMPLETED|First Intervention Period||0
8200924|NCT02206607|20222352|P5|COMPLETED|First Intervention Period||10
8200925|NCT02206607|20222353|P4|COMPLETED|First Intervention Period||11
8200926|NCT02206607|20222354|P3|COMPLETED|First Intervention Period||9
8200927|NCT02206607|20222355|P2|COMPLETED|First Intervention Period||9
8200928|NCT02206607|20222356|P1|COMPLETED|First Intervention Period||0
8200929|NCT02206607|20222352|P5|STARTED|First Intervention Period||10
8200930|NCT02206607|20222353|P4|STARTED|First Intervention Period||11
8200931|NCT02206607|20222354|P3|STARTED|First Intervention Period||9
8200932|NCT02206607|20222355|P2|STARTED|First Intervention Period||9
8200933|NCT02206607|20222356|P1|STARTED|First Intervention Period||0
8200934|NCT02206607|20222352|P5|NOT COMPLETED|Open-Label Run-In||0
8200935|NCT02206607|20222353|P4|NOT COMPLETED|Open-Label Run-In||0
8200936|NCT02206607|20222354|P3|NOT COMPLETED|Open-Label Run-In||0
8200937|NCT02206607|20222355|P2|NOT COMPLETED|Open-Label Run-In||0
8200938|NCT02206607|20222356|P1|NOT COMPLETED|Open-Label Run-In||3
8200939|NCT02206607|20222352|P5|COMPLETED|Open-Label Run-In||0
8200940|NCT02206607|20222353|P4|COMPLETED|Open-Label Run-In||0
8200941|NCT02206607|20222354|P3|COMPLETED|Open-Label Run-In||0
8200942|NCT02206607|20222355|P2|COMPLETED|Open-Label Run-In||0
8200943|NCT02206607|20222356|P1|COMPLETED|Open-Label Run-In||39
8200944|NCT02206607|20222352|P5|STARTED|Open-Label Run-In||0
8200945|NCT02206607|20222353|P4|STARTED|Open-Label Run-In||0
8200946|NCT02206607|20222354|P3|STARTED|Open-Label Run-In||0
8200947|NCT02206607|20222355|P2|STARTED|Open-Label Run-In||0
8200948|NCT02206607|20222356|P1|STARTED|Open-Label Run-In||42
8200949|NCT02206217|20222410|P2|NOT COMPLETED|Overall Study||14
8200950|NCT02206217|20222411|P1|NOT COMPLETED|Overall Study||9
8200951|NCT02206217|20222410|P2|COMPLETED|Overall Study||79
8200952|NCT02206217|20222411|P1|COMPLETED|Overall Study||81
8200953|NCT02206217|20222410|P2|STARTED|Overall Study||93
8200954|NCT02206217|20222411|P1|STARTED|Overall Study||90
8200955|NCT02206152|20222419|P1|NOT COMPLETED|NAC, Then Placebo||0
8200956|NCT02206152|20222419|P1|COMPLETED|NAC, Then Placebo||10
8200957|NCT02206152|20222419|P1|STARTED|NAC, Then Placebo||10
8200958|NCT02206152|20222419|P1|NOT COMPLETED|Placebo, Then NAC||0
8200959|NCT02206152|20222419|P1|COMPLETED|Placebo, Then NAC||10
8200960|NCT02206152|20222419|P1|STARTED|Placebo, Then NAC||10
8200961|NCT02206152|20222419|P1|NOT COMPLETED|Pre-Randomization||2
8200962|NCT02206152|20222419|P1|COMPLETED|Pre-Randomization||20
8200963|NCT02206152|20222419|P1|STARTED|Pre-Randomization||22
8200964|NCT02205983|20222429|P4|NOT COMPLETED|Overall Study||0
8200965|NCT02205983|20222430|P3|NOT COMPLETED|Overall Study||0
8200966|NCT02205983|20222431|P2|NOT COMPLETED|Overall Study||0
8200967|NCT02205983|20222432|P1|NOT COMPLETED|Overall Study||0
8200968|NCT02205983|20222429|P4|COMPLETED|Overall Study||13
8200969|NCT02205983|20222430|P3|COMPLETED|Overall Study||13
8200970|NCT02205983|20222431|P2|COMPLETED|Overall Study||12
8200971|NCT02205983|20222432|P1|COMPLETED|Overall Study||12
8200972|NCT02205983|20222429|P4|STARTED|Overall Study||13
8200973|NCT02205983|20222430|P3|STARTED|Overall Study||13
8200974|NCT02205983|20222431|P2|STARTED|Overall Study||12
8200975|NCT02205983|20222432|P1|STARTED|Overall Study||12
8200976|NCT02205814|20222446|P4|NOT COMPLETED|Overall Study||4
8200977|NCT02205814|20222447|P3|NOT COMPLETED|Overall Study||5
8200978|NCT02205814|20222448|P2|NOT COMPLETED|Overall Study||1
8200979|NCT02205814|20222449|P1|NOT COMPLETED|Overall Study||2
8200980|NCT02205814|20222446|P4|COMPLETED|Overall Study||104
8200981|NCT02205814|20222447|P3|COMPLETED|Overall Study||103
8200982|NCT02205814|20222448|P2|COMPLETED|Overall Study||109
8200983|NCT02205814|20222449|P1|COMPLETED|Overall Study||108
8200984|NCT02205814|20222446|P4|STARTED|Overall Study||108
8200985|NCT02205814|20222447|P3|STARTED|Overall Study||108
8200986|NCT02205814|20222448|P2|STARTED|Overall Study||110
8200987|NCT02205814|20222449|P1|STARTED|Overall Study||110
8200988|NCT02205801|20222475|P4|NOT COMPLETED|Overall Study||0
8200989|NCT02205801|20222476|P3|NOT COMPLETED|Overall Study||0
8200990|NCT02205801|20222477|P2|NOT COMPLETED|Overall Study||0
8200991|NCT02205801|20222478|P1|NOT COMPLETED|Overall Study||0
8200992|NCT02205801|20222475|P4|COMPLETED|Overall Study||8
8200993|NCT02205801|20222476|P3|COMPLETED|Overall Study||9
8200994|NCT02205801|20222477|P2|COMPLETED|Overall Study||8
8200995|NCT02205801|20222478|P1|COMPLETED|Overall Study||11
8200996|NCT02205801|20222475|P4|STARTED|Overall Study||8
8200997|NCT02205801|20222476|P3|STARTED|Overall Study||9
8200998|NCT02205801|20222477|P2|STARTED|Overall Study||8
8200999|NCT02205801|20222478|P1|STARTED|Overall Study||11
8201000|NCT02205476|20222502|P2|NOT COMPLETED|Overall Study||3
8201001|NCT02205476|20222503|P1|NOT COMPLETED|Overall Study||7
8201002|NCT02205476|20222502|P2|COMPLETED|Overall Study||0
8201003|NCT02205476|20222503|P1|COMPLETED|Overall Study||0
8201004|NCT02205476|20222502|P2|STARTED|Overall Study||3
8201005|NCT02205476|20222503|P1|STARTED|Overall Study||7
8201006|NCT02205333|20222542|P9|NOT COMPLETED|Overall Study||0
8201007|NCT02205333|20222543|P8|NOT COMPLETED|Overall Study||2
8201008|NCT02205333|20222544|P7|NOT COMPLETED|Overall Study||5
8201009|NCT02205333|20222545|P6|NOT COMPLETED|Overall Study||3
8201010|NCT02205333|20222546|P5|NOT COMPLETED|Overall Study||5
8201011|NCT02205333|20222547|P4|NOT COMPLETED|Overall Study||7
8201012|NCT02205333|20222548|P3|NOT COMPLETED|Overall Study||2
8201013|NCT02205333|20222549|P2|NOT COMPLETED|Overall Study||6
8201014|NCT02205333|20222550|P1|NOT COMPLETED|Overall Study||6
8201015|NCT02205333|20222542|P9|COMPLETED|Overall Study||1
8201016|NCT02205333|20222543|P8|COMPLETED|Overall Study||1
8201017|NCT02205333|20222544|P7|COMPLETED|Overall Study||2
8201018|NCT02205333|20222545|P6|COMPLETED|Overall Study||4
8201019|NCT02205333|20222546|P5|COMPLETED|Overall Study||1
8201020|NCT02205333|20222547|P4|COMPLETED|Overall Study||0
8201021|NCT02205333|20222548|P3|COMPLETED|Overall Study||1
8201022|NCT02205333|20222549|P2|COMPLETED|Overall Study||0
8201023|NCT02205333|20222550|P1|COMPLETED|Overall Study||2
8201024|NCT02205333|20222542|P9|STARTED|Overall Study||1
8201025|NCT02205333|20222543|P8|STARTED|Overall Study||3
8201026|NCT02205333|20222544|P7|STARTED|Overall Study||7
8201027|NCT02205333|20222545|P6|STARTED|Overall Study||7
8201028|NCT02205333|20222546|P5|STARTED|Overall Study||6
8201029|NCT02205333|20222547|P4|STARTED|Overall Study||7
8201030|NCT02205333|20222548|P3|STARTED|Overall Study||3
8201031|NCT02205333|20222549|P2|STARTED|Overall Study||6
8201032|NCT02205333|20222550|P1|STARTED|Overall Study||8
8201033|NCT02205307|20222725|P2|NOT COMPLETED|Overall Study||6
8201034|NCT02205307|20222726|P1|NOT COMPLETED|Overall Study||17
8201035|NCT02205307|20222725|P2|COMPLETED|Overall Study||163
8201036|NCT02205307|20222726|P1|COMPLETED|Overall Study||161
8201037|NCT02205307|20222725|P2|STARTED|Overall Study||169
8201038|NCT02205307|20222726|P1|STARTED|Overall Study||178
8201039|NCT02205177|20222738|P2|NOT COMPLETED|Overall Study||0
8201040|NCT02205177|20222739|P1|NOT COMPLETED|Overall Study||2
8201041|NCT02205177|20222738|P2|COMPLETED|Overall Study||2
8201042|NCT02205177|20222739|P1|COMPLETED|Overall Study||6
8201043|NCT02205177|20222738|P2|STARTED|Overall Study||2
8201044|NCT02205177|20222739|P1|STARTED|Overall Study||8
8201051|NCT02204917|20222758|P1|NOT COMPLETED|Overall Study||1
8201052|NCT02204917|20222758|P1|COMPLETED|Overall Study||30
8201053|NCT02204917|20222758|P1|STARTED|Overall Study||31
8201054|NCT02204761|20222765|P1|NOT COMPLETED|Overall Study||0
8201055|NCT02204761|20222765|P1|COMPLETED|Overall Study||6
8201056|NCT02204761|20222765|P1|STARTED|Overall Study||6
8201057|NCT02204748|20222772|P1|NOT COMPLETED|Overall Study||0
8201058|NCT02204748|20222772|P1|COMPLETED|Overall Study||5
8201059|NCT02204748|20222772|P1|STARTED|Overall Study||5
8201060|NCT02204657|20222786|P2|NOT COMPLETED|Overall Study||0
8201061|NCT02204657|20222787|P1|NOT COMPLETED|Overall Study||7
8201062|NCT02204657|20222786|P2|COMPLETED|Overall Study||25
8201063|NCT02204657|20222787|P1|COMPLETED|Overall Study||25
8201064|NCT02204657|20222786|P2|STARTED|Overall Study||25
8201065|NCT02204657|20222787|P1|STARTED|Overall Study||32
8201072|NCT02204566|20222847|P1|NOT COMPLETED|Overall Study||4
8201073|NCT02204566|20222847|P1|COMPLETED|Overall Study||1
8201074|NCT02204566|20222847|P1|STARTED|Overall Study||5
8201075|NCT02204449|20222853|P2|NOT COMPLETED|Overall Study||11
8201076|NCT02204449|20222854|P1|NOT COMPLETED|Overall Study||7
8201077|NCT02204449|20222853|P2|COMPLETED|Overall Study||37
8201078|NCT02204449|20222854|P1|COMPLETED|Overall Study||39
8201079|NCT02204449|20222853|P2|STARTED|Overall Study||48
8201080|NCT02204449|20222854|P1|STARTED|Overall Study||46
8201081|NCT02204410|20222864|P1|NOT COMPLETED|Overall Study||11
8201082|NCT02204410|20222864|P1|COMPLETED|Overall Study||10
8201083|NCT02204410|20222864|P1|STARTED|Overall Study||21
8201084|NCT02204371|20222869|P1|NOT COMPLETED|Overall Study||1
8201085|NCT02204371|20222869|P1|COMPLETED|Overall Study||6
8201086|NCT02204371|20222869|P1|STARTED|Overall Study||7
8201087|NCT02204319|20222892|P1|NOT COMPLETED|Overall Study||3
8201088|NCT02204319|20222892|P1|COMPLETED|Overall Study|3 did not complete study.|7
8201089|NCT02204319|20222892|P1|STARTED|Overall Study||10
8201090|NCT02204293|20222900|P6|NOT COMPLETED|LTE Phase||7
8201091|NCT02204293|20222901|P5|NOT COMPLETED|LTE Phase||0
8201092|NCT02204293|20222902|P4|NOT COMPLETED|LTE Phase||0
8201093|NCT02204293|20222903|P3|NOT COMPLETED|LTE Phase||0
8201094|NCT02204293|20222904|P2|NOT COMPLETED|LTE Phase||0
8201095|NCT02204293|20222905|P1|NOT COMPLETED|LTE Phase||0
8201096|NCT02204293|20222900|P6|COMPLETED|LTE Phase||0
8201097|NCT02204293|20222901|P5|COMPLETED|LTE Phase||0
8201098|NCT02204293|20222902|P4|COMPLETED|LTE Phase||0
8201099|NCT02204293|20222903|P3|COMPLETED|LTE Phase||0
8201100|NCT02204293|20222904|P2|COMPLETED|LTE Phase||0
8201101|NCT02204293|20222905|P1|COMPLETED|LTE Phase||0
8201102|NCT02204293|20222900|P6|STARTED|LTE Phase||7
8201103|NCT02204293|20222901|P5|STARTED|LTE Phase||0
8201104|NCT02204293|20222902|P4|STARTED|LTE Phase||0
8201105|NCT02204293|20222903|P3|STARTED|LTE Phase||0
8201106|NCT02204293|20222904|P2|STARTED|LTE Phase||0
8201107|NCT02204293|20222905|P1|STARTED|LTE Phase||0
8201108|NCT02204293|20222900|P6|NOT COMPLETED|Core Study Part 2||0
8201109|NCT02204293|20222901|P5|NOT COMPLETED|Core Study Part 2||0
8201110|NCT02204293|20222902|P4|NOT COMPLETED|Core Study Part 2||0
8201111|NCT02204293|20222903|P3|NOT COMPLETED|Core Study Part 2||0
8201112|NCT02204293|20222904|P2|NOT COMPLETED|Core Study Part 2||0
8201113|NCT02204293|20222905|P1|NOT COMPLETED|Core Study Part 2||0
8201114|NCT02204293|20222900|P6|COMPLETED|Core Study Part 2||0
8201115|NCT02204293|20222901|P5|COMPLETED|Core Study Part 2||7
8201116|NCT02204293|20222902|P4|COMPLETED|Core Study Part 2||4
8201117|NCT02204293|20222903|P3|COMPLETED|Core Study Part 2||12
8201118|NCT02204293|20222904|P2|COMPLETED|Core Study Part 2||0
8201119|NCT02204293|20222905|P1|COMPLETED|Core Study Part 2||0
8201120|NCT02204293|20222900|P6|Safety Population|Core Study Part 2||0
8201121|NCT02204293|20222901|P5|Safety Population|Core Study Part 2||7
8201122|NCT02204293|20222902|P4|Safety Population|Core Study Part 2||2
8201123|NCT02204293|20222903|P3|Safety Population|Core Study Part 2|Included 2 participants from placebo arm who received canakinumab at Week 4.|14
8201124|NCT02204293|20222904|P2|Safety Population|Core Study Part 2||0
8201125|NCT02204293|20222905|P1|Safety Population|Core Study Part 2||0
8201126|NCT02204293|20222900|P6|STARTED|Core Study Part 2||0
8201127|NCT02204293|20222901|P5|STARTED|Core Study Part 2||7
8201128|NCT02204293|20222902|P4|STARTED|Core Study Part 2||4
8201129|NCT02204293|20222903|P3|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|12
8201130|NCT02204293|20222904|P2|STARTED|Core Study Part 2||0
8201131|NCT02204293|20222905|P1|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|0
8201132|NCT02204293|20222900|P6|NOT COMPLETED|Core Study Part I||0
8201133|NCT02204293|20222901|P5|NOT COMPLETED|Core Study Part I||0
8201134|NCT02204293|20222902|P4|NOT COMPLETED|Core Study Part I||0
8201135|NCT02204293|20222903|P3|NOT COMPLETED|Core Study Part I||0
8201136|NCT02204293|20222904|P2|NOT COMPLETED|Core Study Part I||3
8201137|NCT02204293|20222905|P1|NOT COMPLETED|Core Study Part I||2
8201138|NCT02204293|20222900|P6|COMPLETED|Core Study Part I||0
8201139|NCT02204293|20222901|P5|COMPLETED|Core Study Part I||0
8201140|NCT02204293|20222902|P4|COMPLETED|Core Study Part I||0
8201141|NCT02204293|20222903|P3|COMPLETED|Core Study Part I||0
8201142|NCT02204293|20222904|P2|COMPLETED|Core Study Part I||14
8201143|NCT02204293|20222905|P1|COMPLETED|Core Study Part I||17
8201144|NCT02204293|20222900|P6|Safety Population|Core Study Part I||0
8201145|NCT02204293|20222901|P5|Safety Population|Core Study Part I||0
8201146|NCT02204293|20222902|P4|Safety Population|Core Study Part I||0
8201147|NCT02204293|20222903|P3|Safety Population|Core Study Part I||0
8201148|NCT02204293|20222904|P2|Safety Population|Core Study Part I||15
8201149|NCT02204293|20222905|P1|Safety Population|Core Study Part I|2 participants from placebo arm received canakinumab at Week 4, included in Safety population.|20
8201150|NCT02204293|20222900|P6|Intention-to-treat Population|Core Study Part I||0
8201151|NCT02204293|20222901|P5|Intention-to-treat Population|Core Study Part I||0
8201152|NCT02204293|20222902|P4|Intention-to-treat Population|Core Study Part I||0
8201153|NCT02204293|20222903|P3|Intention-to-treat Population|Core Study Part I||0
8201154|NCT02204293|20222904|P2|Intention-to-treat Population|Core Study Part I||17
8201155|NCT02204293|20222905|P1|Intention-to-treat Population|Core Study Part I|One participant left the study before treatment was started.|18
8201156|NCT02204293|20222900|P6|STARTED|Core Study Part I||0
8201157|NCT02204293|20222901|P5|STARTED|Core Study Part I||0
8201158|NCT02204293|20222902|P4|STARTED|Core Study Part I||0
8201159|NCT02204293|20222903|P3|STARTED|Core Study Part I||0
8201160|NCT02204293|20222904|P2|STARTED|Core Study Part I||17
8201161|NCT02204293|20222905|P1|STARTED|Core Study Part I||19
8201162|NCT02204176|20222974|P3|NOT COMPLETED|Overall Study||16
8201163|NCT02204176|20222975|P2|NOT COMPLETED|Overall Study||12
8201164|NCT02204176|20222976|P1|NOT COMPLETED|Overall Study||10
8201165|NCT02204176|20222974|P3|COMPLETED|Overall Study||58
8201166|NCT02204176|20222975|P2|COMPLETED|Overall Study||61
8201167|NCT02204176|20222976|P1|COMPLETED|Overall Study||64
8201168|NCT02204176|20222974|P3|STARTED|Overall Study||74
8201169|NCT02204176|20222975|P2|STARTED|Overall Study||73
8201170|NCT02204176|20222976|P1|STARTED|Overall Study||74
8201171|NCT02204150|20222999|P1|NOT COMPLETED|Overall Study||0
8201172|NCT02204150|20222999|P1|COMPLETED|Overall Study||56
8201173|NCT02204150|20222999|P1|STARTED|Overall Study||56
8201174|NCT02204124|20223005|P2|NOT COMPLETED|Overall Study||0
8201175|NCT02204124|20223006|P1|NOT COMPLETED|Overall Study||0
8201176|NCT02204124|20223005|P2|COMPLETED|Overall Study||19
8201177|NCT02204124|20223006|P1|COMPLETED|Overall Study||13
8201178|NCT02204124|20223005|P2|STARTED|Overall Study||19
8201179|NCT02204124|20223006|P1|STARTED|Overall Study||13
8201180|NCT02204007|20223026|P2|NOT COMPLETED|Overall Study||1
8201181|NCT02204007|20223027|P1|NOT COMPLETED|Overall Study||1
8201182|NCT02204007|20223026|P2|COMPLETED|Overall Study||17
8201183|NCT02204007|20223027|P1|COMPLETED|Overall Study||17
8201184|NCT02204007|20223026|P2|STARTED|Overall Study||18
8201185|NCT02204007|20223027|P1|STARTED|Overall Study||18
8201186|NCT02203916|20223038|P3|NOT COMPLETED|Overall Study||11
8201187|NCT02203916|20223039|P2|NOT COMPLETED|Overall Study||10
8201188|NCT02203916|20223040|P1|NOT COMPLETED|Overall Study||8
8201189|NCT02203916|20223038|P3|COMPLETED|Overall Study||120
8201190|NCT02203916|20223039|P2|COMPLETED|Overall Study||122
8201191|NCT02203916|20223040|P1|COMPLETED|Overall Study||57
8201192|NCT02203916|20223038|P3|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
8201193|NCT02203916|20223039|P2|Safety Analysis Set (SAS)|Overall Study||132
8201194|NCT02203916|20223040|P1|Safety Analysis Set (SAS)|Overall Study||65
8201195|NCT02203916|20223038|P3|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
8201196|NCT02203916|20223039|P2|Full Analysis Set (FAS)|Overall Study||132
8201197|NCT02203916|20223040|P1|Full Analysis Set (FAS)|Overall Study||65
8201198|NCT02203916|20223038|P3|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
8201199|NCT02203916|20223039|P2|STARTED|Overall Study||132
8201200|NCT02203916|20223040|P1|STARTED|Overall Study||65
8201201|NCT02203851|20223060|P1|NOT COMPLETED|Overall Study||11
8201202|NCT02203851|20223060|P1|COMPLETED|Overall Study||99
8201203|NCT02203851|20223060|P1|STARTED|Overall Study||110
8201204|NCT02203838|20223098|P4|NOT COMPLETED|Overall Study||18
8201205|NCT02203838|20223099|P3|NOT COMPLETED|Overall Study||16
8201206|NCT02203838|20223100|P2|NOT COMPLETED|Overall Study||22
8201207|NCT02203838|20223101|P1|NOT COMPLETED|Overall Study||210
8201208|NCT02203838|20223098|P4|COMPLETED|Overall Study||15
8201209|NCT02203838|20223099|P3|COMPLETED|Overall Study||15
8201210|NCT02203838|20223100|P2|COMPLETED|Overall Study||6
8201211|NCT02203838|20223101|P1|COMPLETED|Overall Study||198
8201212|NCT02203838|20223098|P4|STARTED|Overall Study||33
8201213|NCT02203838|20223099|P3|STARTED|Overall Study||31
8201214|NCT02203838|20223100|P2|STARTED|Overall Study||28
8201215|NCT02203838|20223101|P1|STARTED|Overall Study||408
8201216|NCT02203786|20223135|P4|NOT COMPLETED|Overall Study||0
8201217|NCT02203786|20223136|P3|NOT COMPLETED|Overall Study||2
8201218|NCT02203786|20223137|P2|NOT COMPLETED|Overall Study||0
8201219|NCT02203786|20223138|P1|NOT COMPLETED|Overall Study||0
8201220|NCT02203786|20223135|P4|COMPLETED|Overall Study||15
8201221|NCT02203786|20223136|P3|COMPLETED|Overall Study||15
8201222|NCT02203786|20223137|P2|COMPLETED|Overall Study||15
8201223|NCT02203786|20223138|P1|COMPLETED|Overall Study||15
8201224|NCT02203786|20223135|P4|STARTED|Overall Study||15
8201225|NCT02203786|20223136|P3|STARTED|Overall Study||17
8201226|NCT02203786|20223137|P2|STARTED|Overall Study||15
8201227|NCT02203786|20223138|P1|STARTED|Overall Study||15
8201228|NCT02203747|20223170|P2|NOT COMPLETED|Overall Study||0
8201229|NCT02203747|20223171|P1|NOT COMPLETED|Overall Study||0
8201230|NCT02203747|20223170|P2|COMPLETED|Overall Study||34
8201231|NCT02203747|20223171|P1|COMPLETED|Overall Study||45
8201232|NCT02203747|20223170|P2|STARTED|Overall Study||34
8201233|NCT02203747|20223171|P1|STARTED|Overall Study||45
8201234|NCT02203721|20223181|P2|NOT COMPLETED|Overall Study||3
8201235|NCT02203721|20223182|P1|NOT COMPLETED|Overall Study||1
8201236|NCT02203721|20223181|P2|COMPLETED|Overall Study||148
8201237|NCT02203721|20223182|P1|COMPLETED|Overall Study||147
8201238|NCT02203721|20223181|P2|STARTED|Overall Study||151
8201239|NCT02203721|20223182|P1|STARTED|Overall Study||148
8201240|NCT02203630|20223192|P2|NOT COMPLETED|Overall Study||0
8201241|NCT02203630|20223193|P1|NOT COMPLETED|Overall Study||0
8201242|NCT02203630|20223192|P2|COMPLETED|Overall Study||9
8201243|NCT02203630|20223193|P1|COMPLETED|Overall Study||8
8201244|NCT02203630|20223192|P2|STARTED|Overall Study||9
8201245|NCT02203630|20223193|P1|STARTED|Overall Study||8
8201246|NCT02203591|20223271|P8|NOT COMPLETED|Overall Study||13
8201247|NCT02203591|20223272|P7|NOT COMPLETED|Overall Study||29
8201248|NCT02203591|20223273|P6|NOT COMPLETED|Overall Study||35
8201249|NCT02203591|20223274|P5|NOT COMPLETED|Overall Study||34
8201250|NCT02203591|20223275|P4|NOT COMPLETED|Overall Study||45
8201251|NCT02203591|20223276|P3|NOT COMPLETED|Overall Study||151
8201252|NCT02203591|20223277|P2|NOT COMPLETED|Overall Study||142
8201253|NCT02203591|20223278|P1|NOT COMPLETED|Overall Study||147
8201254|NCT02203591|20223271|P8|COMPLETED|Overall Study||61
8201255|NCT02203591|20223272|P7|COMPLETED|Overall Study||219
8201256|NCT02203591|20223273|P6|COMPLETED|Overall Study||209
8201257|NCT02203591|20223274|P5|COMPLETED|Overall Study||208
8201258|NCT02203591|20223275|P4|COMPLETED|Overall Study||59
8201259|NCT02203591|20223276|P3|COMPLETED|Overall Study||196
8201260|NCT02203591|20223277|P2|COMPLETED|Overall Study||202
8201261|NCT02203591|20223278|P1|COMPLETED|Overall Study||196
8201262|NCT02203591|20223271|P8|STARTED|Overall Study||74
8201263|NCT02203591|20223272|P7|STARTED|Overall Study||248
8201264|NCT02203591|20223273|P6|STARTED|Overall Study||244
8201265|NCT02203591|20223274|P5|STARTED|Overall Study||242
8201266|NCT02203591|20223275|P4|STARTED|Overall Study||104
8201267|NCT02203591|20223276|P3|STARTED|Overall Study||347
8201268|NCT02203591|20223277|P2|STARTED|Overall Study||344
8201269|NCT02203591|20223278|P1|STARTED|Overall Study||343
8201270|NCT02203578|20223363|P1|NOT COMPLETED|Overall Study||0
8201271|NCT02203578|20223363|P1|COMPLETED|Overall Study||1
8201272|NCT02203578|20223363|P1|STARTED|Overall Study||1
8201273|NCT02203565|20223375|P1|NOT COMPLETED|Overall Study||1
8201274|NCT02203565|20223375|P1|COMPLETED|Overall Study||19
8201275|NCT02203565|20223375|P1|STARTED|Overall Study||20
8201276|NCT02203357|20223382|P3|NOT COMPLETED|Overall Study||70
8201277|NCT02203357|20223383|P2|NOT COMPLETED|Overall Study||66
8201278|NCT02203357|20223384|P1|NOT COMPLETED|Overall Study||58
8201279|NCT02203357|20223382|P3|COMPLETED|Overall Study||55
8201280|NCT02203357|20223383|P2|COMPLETED|Overall Study||45
8201281|NCT02203357|20223384|P1|COMPLETED|Overall Study||59
8201282|NCT02203357|20223382|P3|mon24|Overall Study||55
8201283|NCT02203357|20223383|P2|mon24|Overall Study||45
8201284|NCT02203357|20223384|P1|mon24|Overall Study||59
8201285|NCT02203357|20223382|P3|mon12|Overall Study||122
8201286|NCT02203357|20223383|P2|mon12|Overall Study||101
8201287|NCT02203357|20223384|P1|mon12|Overall Study||113
8201288|NCT02203357|20223382|P3|mon7/2/3|Overall Study||124
8201289|NCT02203357|20223383|P2|mon7/2/3|Overall Study||110
8201290|NCT02203357|20223384|P1|mon7/2/3|Overall Study||114
8201291|NCT02203357|20223382|P3|STARTED|Overall Study||125
8201292|NCT02203357|20223383|P2|STARTED|Overall Study||111
8201293|NCT02203357|20223384|P1|STARTED|Overall Study||117
8201294|NCT02203331|20223407|P6|NOT COMPLETED|Overall Study||7
8201295|NCT02203331|20223408|P5|NOT COMPLETED|Overall Study||7
8201296|NCT02203331|20223409|P4|NOT COMPLETED|Overall Study||7
8201297|NCT02203331|20223410|P3|NOT COMPLETED|Overall Study||5
8201298|NCT02203331|20223411|P2|NOT COMPLETED|Overall Study||14
8201299|NCT02203331|20223412|P1|NOT COMPLETED|Overall Study||7
8201300|NCT02203331|20223407|P6|COMPLETED|Overall Study||46
8201301|NCT02203331|20223408|P5|COMPLETED|Overall Study||46
8201302|NCT02203331|20223409|P4|COMPLETED|Overall Study||46
8201303|NCT02203331|20223410|P3|COMPLETED|Overall Study||50
8201304|NCT02203331|20223411|P2|COMPLETED|Overall Study||39
8201305|NCT02203331|20223412|P1|COMPLETED|Overall Study||45
8201306|NCT02203331|20223407|P6|Treated|Overall Study||53
8201307|NCT02203331|20223408|P5|Treated|Overall Study||50
8201308|NCT02203331|20223409|P4|Treated|Overall Study||49
8201309|NCT02203331|20223410|P3|Treated|Overall Study||54
8201310|NCT02203331|20223411|P2|Treated|Overall Study||50
8201311|NCT02203331|20223412|P1|Treated|Overall Study||49
8201312|NCT02203331|20223407|P6|STARTED|Overall Study||53
8201313|NCT02203331|20223408|P5|STARTED|Overall Study||53
8201314|NCT02203331|20223409|P4|STARTED|Overall Study||53
8201315|NCT02203331|20223410|P3|STARTED|Overall Study||55
8201316|NCT02203331|20223411|P2|STARTED|Overall Study||53
8201317|NCT02203331|20223412|P1|STARTED|Overall Study||52
8201318|NCT02203162|20223462|P1|NOT COMPLETED|Overall Study||0
8201319|NCT02203162|20223462|P1|COMPLETED|Overall Study||30
8201320|NCT02203162|20223462|P1|STARTED|Overall Study||30
8201321|NCT02203149|20223471|P5|NOT COMPLETED|Part 2||1
8201322|NCT02203149|20223472|P4|NOT COMPLETED|Part 2||3
8201323|NCT02203149|20223473|P3|NOT COMPLETED|Part 2||1
8201324|NCT02203149|20223474|P2|NOT COMPLETED|Part 2||0
8201325|NCT02203149|20223475|P1|NOT COMPLETED|Part 2||0
8201326|NCT02203149|20223471|P5|COMPLETED|Part 2||34
8201327|NCT02203149|20223472|P4|COMPLETED|Part 2||71
8201328|NCT02203149|20223473|P3|COMPLETED|Part 2||226
8201329|NCT02203149|20223474|P2|COMPLETED|Part 2||0
8201330|NCT02203149|20223475|P1|COMPLETED|Part 2||0
8201331|NCT02203149|20223471|P5|Started Deferred Active Treatment|Part 2||0
8201332|NCT02203149|20223472|P4|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
8201333|NCT02203149|20223473|P3|Started Deferred Active Treatment|Part 2||0
8201334|NCT02203149|20223474|P2|Started Deferred Active Treatment|Part 2||0
8201335|NCT02203149|20223475|P1|Started Deferred Active Treatment|Part 2||0
8201336|NCT02203149|20223471|P5|STARTED|Part 2||35
8201337|NCT02203149|20223472|P4|STARTED|Part 2||74
8201338|NCT02203149|20223473|P3|STARTED|Part 2||227
8201339|NCT02203149|20223474|P2|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
8201340|NCT02203149|20223475|P1|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
8201341|NCT02203149|20223471|P5|NOT COMPLETED|Part 1||0
8201342|NCT02203149|20223472|P4|NOT COMPLETED|Part 1||0
8201343|NCT02203149|20223473|P3|NOT COMPLETED|Part 1||0
8201344|NCT02203149|20223474|P2|NOT COMPLETED|Part 1||1
8201345|NCT02203149|20223475|P1|NOT COMPLETED|Part 1||0
8201346|NCT02203149|20223471|P5|COMPLETED|Part 1||0
8201347|NCT02203149|20223472|P4|COMPLETED|Part 1||0
8201348|NCT02203149|20223473|P3|COMPLETED|Part 1||0
8201349|NCT02203149|20223474|P2|COMPLETED|Part 1||31
8201350|NCT02203149|20223475|P1|COMPLETED|Part 1||31
8201351|NCT02203149|20223471|P5|STARTED|Part 1||0
8201352|NCT02203149|20223472|P4|STARTED|Part 1||0
8201353|NCT02203149|20223473|P3|STARTED|Part 1||0
8201354|NCT02203149|20223474|P2|STARTED|Part 1||32
8201355|NCT02203149|20223475|P1|STARTED|Part 1||31
8201356|NCT02203071|20223510|P2|NOT COMPLETED|Overall Study||1
8201357|NCT02203071|20223511|P1|NOT COMPLETED|Overall Study||3
8201358|NCT02203071|20223510|P2|COMPLETED|Overall Study||5
8201359|NCT02203071|20223511|P1|COMPLETED|Overall Study||10
8201360|NCT02203071|20223510|P2|STARTED|Overall Study||6
8201361|NCT02203071|20223511|P1|STARTED|Overall Study||13
8201362|NCT02203032|20223527|P4|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
8201363|NCT02203032|20223528|P3|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
8201364|NCT02203032|20223529|P2|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
8201365|NCT02203032|20223530|P1|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
8201366|NCT02203032|20223527|P4|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
8201367|NCT02203032|20223528|P3|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
8201368|NCT02203032|20223529|P2|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
8201369|NCT02203032|20223530|P1|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
8201370|NCT02203032|20223527|P4|STARTED|Blinded Phase (Week 16 to Week 44)||585
8201371|NCT02203032|20223528|P3|STARTED|Blinded Phase (Week 16 to Week 44)||133
8201372|NCT02203032|20223529|P2|STARTED|Blinded Phase (Week 16 to Week 44)||135
8201373|NCT02203032|20223530|P1|STARTED|Blinded Phase (Week 16 to Week 44)||0
8201374|NCT02203032|20223527|P4|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8201375|NCT02203032|20223528|P3|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8201376|NCT02203032|20223529|P2|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8201377|NCT02203032|20223530|P1|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
8201378|NCT02203032|20223527|P4|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8201379|NCT02203032|20223528|P3|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8201380|NCT02203032|20223529|P2|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
8201381|NCT02203032|20223530|P1|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
8201382|NCT02203032|20223527|P4|Treated|Open Label Run-in (Week 0 to Week 16)||0
8201383|NCT02203032|20223528|P3|Treated|Open Label Run-in (Week 0 to Week 16)||0
8201384|NCT02203032|20223529|P2|Treated|Open Label Run-in (Week 0 to Week 16)||0
8201385|NCT02203032|20223530|P1|Treated|Open Label Run-in (Week 0 to Week 16)||871
8201386|NCT02203032|20223527|P4|STARTED|Open Label Run-in (Week 0 to Week 16)||0
8201387|NCT02203032|20223528|P3|STARTED|Open Label Run-in (Week 0 to Week 16)||0
8201388|NCT02203032|20223529|P2|STARTED|Open Label Run-in (Week 0 to Week 16)||0
8201389|NCT02203032|20223530|P1|STARTED|Open Label Run-in (Week 0 to Week 16)||872
8201390|NCT02203019|20223546|P2|NOT COMPLETED|Overall Study||0
8201391|NCT02203019|20223547|P1|NOT COMPLETED|Overall Study||0
8201392|NCT02203019|20223546|P2|COMPLETED|Overall Study||17
8201393|NCT02203019|20223547|P1|COMPLETED|Overall Study||19
8201394|NCT02203019|20223546|P2|STARTED|Overall Study||17
8201395|NCT02203019|20223547|P1|STARTED|Overall Study||19
8201396|NCT02202980|20223573|P14|NOT COMPLETED|Overall Study||0
8201397|NCT02202980|20223574|P13|NOT COMPLETED|Overall Study||11
8201398|NCT02202980|20223575|P12|NOT COMPLETED|Overall Study||3
8201399|NCT02202980|20223576|P11|NOT COMPLETED|Overall Study||0
8201400|NCT02202980|20223577|P10|NOT COMPLETED|Overall Study||0
8201401|NCT02202980|20223578|P9|NOT COMPLETED|Overall Study||4
8201402|NCT02202980|20223579|P8|NOT COMPLETED|Overall Study||3
8201403|NCT02202980|20223580|P7|NOT COMPLETED|Overall Study||11
8201404|NCT02202980|20223581|P6|NOT COMPLETED|Overall Study||1
8201405|NCT02202980|20223582|P5|NOT COMPLETED|Overall Study||6
8201406|NCT02202980|20223583|P4|NOT COMPLETED|Overall Study||4
8201407|NCT02202980|20223584|P3|NOT COMPLETED|Overall Study||10
8201408|NCT02202980|20223585|P2|NOT COMPLETED|Overall Study||2
8201409|NCT02202980|20223586|P1|NOT COMPLETED|Overall Study||1
8201410|NCT02202980|20223573|P14|COMPLETED|Overall Study||4
8201411|NCT02202980|20223574|P13|COMPLETED|Overall Study||19
8201412|NCT02202980|20223575|P12|COMPLETED|Overall Study||25
8201413|NCT02202980|20223576|P11|COMPLETED|Overall Study||19
8201414|NCT02202980|20223577|P10|COMPLETED|Overall Study||17
8201415|NCT02202980|20223578|P9|COMPLETED|Overall Study||14
8201416|NCT02202980|20223579|P8|COMPLETED|Overall Study||12
8201417|NCT02202980|20223580|P7|COMPLETED|Overall Study||4
8201418|NCT02202980|20223581|P6|COMPLETED|Overall Study||14
8201419|NCT02202980|20223582|P5|COMPLETED|Overall Study||7
8201420|NCT02202980|20223583|P4|COMPLETED|Overall Study||28
8201421|NCT02202980|20223584|P3|COMPLETED|Overall Study||17
8201422|NCT02202980|20223585|P2|COMPLETED|Overall Study||24
8201423|NCT02202980|20223586|P1|COMPLETED|Overall Study||13
8201424|NCT02202980|20223573|P14|STARTED|Overall Study||4
8201425|NCT02202980|20223574|P13|STARTED|Overall Study||30
8201426|NCT02202980|20223575|P12|STARTED|Overall Study||28
8201427|NCT02202980|20223576|P11|STARTED|Overall Study||19
8201428|NCT02202980|20223577|P10|STARTED|Overall Study||17
8201429|NCT02202980|20223578|P9|STARTED|Overall Study||18
8201430|NCT02202980|20223579|P8|STARTED|Overall Study||15
8201431|NCT02202980|20223580|P7|STARTED|Overall Study||15
8201432|NCT02202980|20223581|P6|STARTED|Overall Study||15
8201433|NCT02202980|20223582|P5|STARTED|Overall Study||13
8201434|NCT02202980|20223583|P4|STARTED|Overall Study||32
8201435|NCT02202980|20223584|P3|STARTED|Overall Study||27
8201436|NCT02202980|20223585|P2|STARTED|Overall Study||26
8201437|NCT02202980|20223586|P1|STARTED|Overall Study||14
8201438|NCT02202850|20223674|P2|NOT COMPLETED|Overall Study||6
8201439|NCT02202850|20223675|P1|NOT COMPLETED|Overall Study||24
8201440|NCT02202850|20223674|P2|COMPLETED|Overall Study||8
8201441|NCT02202850|20223675|P1|COMPLETED|Overall Study||46
8201442|NCT02202850|20223674|P2|STARTED|Overall Study||14
8201443|NCT02202850|20223675|P1|STARTED|Overall Study||70
8201444|NCT02202837|20223727|P2|NOT COMPLETED|Overall Study||5
8201445|NCT02202837|20223728|P1|NOT COMPLETED|Overall Study||53
8201446|NCT02202837|20223727|P2|COMPLETED|Overall Study||12
8201447|NCT02202837|20223728|P1|COMPLETED|Overall Study||87
8201448|NCT02202837|20223727|P2|STARTED|Overall Study||17
8201449|NCT02202837|20223728|P1|STARTED|Overall Study||140
8201450|NCT02202785|20223779|P3|NOT COMPLETED|Overall Study||17
8201451|NCT02202785|20223780|P2|NOT COMPLETED|Overall Study||15
8201452|NCT02202785|20223781|P1|NOT COMPLETED|Overall Study||11
8201453|NCT02202785|20223779|P3|COMPLETED|Overall Study||0
8201454|NCT02202785|20223780|P2|COMPLETED|Overall Study||0
8201455|NCT02202785|20223781|P1|COMPLETED|Overall Study||0
8201456|NCT02202785|20223779|P3|STARTED|Overall Study||17
8201457|NCT02202785|20223780|P2|STARTED|Overall Study||15
8201458|NCT02202785|20223781|P1|STARTED|Overall Study||11
8201459|NCT02202759|20223818|P3|NOT COMPLETED|Overall Study||14
8201460|NCT02202759|20223819|P2|NOT COMPLETED|Overall Study||15
8201461|NCT02202759|20223820|P1|NOT COMPLETED|Overall Study||9
8201462|NCT02202759|20223818|P3|COMPLETED|Overall Study||0
8201463|NCT02202759|20223819|P2|COMPLETED|Overall Study||0
8201464|NCT02202759|20223820|P1|COMPLETED|Overall Study||0
8201465|NCT02202759|20223818|P3|STARTED|Overall Study||14
8201466|NCT02202759|20223819|P2|STARTED|Overall Study||15
8201467|NCT02202759|20223820|P1|STARTED|Overall Study||9
8201468|NCT02202746|20223856|P2|NOT COMPLETED|Overall Study||0
8201469|NCT02202746|20223857|P1|NOT COMPLETED|Overall Study||0
8201470|NCT02202746|20223856|P2|COMPLETED|Overall Study||69
8201471|NCT02202746|20223857|P1|COMPLETED|Overall Study||109
8201472|NCT02202746|20223856|P2|STARTED|Overall Study||69
8201473|NCT02202746|20223857|P1|STARTED|Overall Study||109
8201474|NCT02202616|20223887|P1|NOT COMPLETED|Overall Study||100
8201475|NCT02202616|20223887|P1|COMPLETED|Overall Study||301
8201476|NCT02202616|20223887|P1|Intent to Treat Set (ITT)|Overall Study||338
8201477|NCT02202616|20223887|P1|STARTED|Overall Study||401
8201478|NCT02202551|20223902|P4|NOT COMPLETED|Overall Study||22
8201479|NCT02202551|20223903|P3|NOT COMPLETED|Overall Study||10
8201480|NCT02202551|20223904|P2|NOT COMPLETED|Overall Study||37
8201481|NCT02202551|20223905|P1|NOT COMPLETED|Overall Study||25
8201482|NCT02202551|20223902|P4|COMPLETED|Overall Study||39
8201483|NCT02202551|20223903|P3|COMPLETED|Overall Study||14
8201484|NCT02202551|20223904|P2|COMPLETED|Overall Study||41
8201485|NCT02202551|20223905|P1|COMPLETED|Overall Study||35
8201486|NCT02202551|20223902|P4|STARTED|Overall Study||61
8201487|NCT02202551|20223903|P3|STARTED|Overall Study||24
8201488|NCT02202551|20223904|P2|STARTED|Overall Study||78
8201489|NCT02202551|20223905|P1|STARTED|Overall Study||60
8201490|NCT02202538|20223923|P1|NOT COMPLETED|Overall Study||8
8201491|NCT02202538|20223923|P1|COMPLETED|Overall Study||45
8201492|NCT02202538|20223923|P1|Screen Failure|Overall Study||2
8201493|NCT02202538|20223923|P1|STARTED|Overall Study||53
8201494|NCT02202499|20223937|P3|NOT COMPLETED|Overall Study||2
8201495|NCT02202499|20223938|P2|NOT COMPLETED|Overall Study||0
8201496|NCT02202499|20223939|P1|NOT COMPLETED|Overall Study||2
8201497|NCT02202499|20223937|P3|COMPLETED|Overall Study||19
8201498|NCT02202499|20223938|P2|COMPLETED|Overall Study||20
8201499|NCT02202499|20223939|P1|COMPLETED|Overall Study||19
8201500|NCT02202499|20223937|P3|STARTED|Overall Study||21
8201501|NCT02202499|20223938|P2|STARTED|Overall Study||20
8201502|NCT02202499|20223939|P1|STARTED|Overall Study||21
8201515|NCT02202317|20224093|P1|NOT COMPLETED|Overall Study||1
8201516|NCT02202317|20224093|P1|COMPLETED|Overall Study||8
8201517|NCT02202317|20224093|P1|STARTED|Overall Study||9
8201518|NCT02202252|20224101|P2|NOT COMPLETED|Overall Study||0
8201519|NCT02202252|20224102|P1|NOT COMPLETED|Overall Study||0
8201520|NCT02202252|20224101|P2|COMPLETED|Overall Study||30
8201521|NCT02202252|20224102|P1|COMPLETED|Overall Study||30
8201522|NCT02202252|20224101|P2|STARTED|Overall Study||30
8201523|NCT02202252|20224102|P1|STARTED|Overall Study||30
8201524|NCT02202161|20224120|P8|NOT COMPLETED|Overall Study||6
8201525|NCT02202161|20224121|P7|NOT COMPLETED|Overall Study||0
8201526|NCT02202161|20224122|P6|NOT COMPLETED|Overall Study||1
8201527|NCT02202161|20224123|P5|NOT COMPLETED|Overall Study||1
8201528|NCT02202161|20224124|P4|NOT COMPLETED|Overall Study||0
8201529|NCT02202161|20224125|P3|NOT COMPLETED|Overall Study||0
8201530|NCT02202161|20224126|P2|NOT COMPLETED|Overall Study||1
8201531|NCT02202161|20224127|P1|NOT COMPLETED|Overall Study||1
8201532|NCT02202161|20224120|P8|COMPLETED|Overall Study||0
8201533|NCT02202161|20224121|P7|COMPLETED|Overall Study||13
8201534|NCT02202161|20224122|P6|COMPLETED|Overall Study||9
8201535|NCT02202161|20224123|P5|COMPLETED|Overall Study||8
8201536|NCT02202161|20224124|P4|COMPLETED|Overall Study||9
8201537|NCT02202161|20224125|P3|COMPLETED|Overall Study||5
8201538|NCT02202161|20224126|P2|COMPLETED|Overall Study||4
8201539|NCT02202161|20224127|P1|COMPLETED|Overall Study||12
8201540|NCT02202161|20224120|P8|STARTED|Overall Study||6
8201541|NCT02202161|20224121|P7|STARTED|Overall Study||13
8201542|NCT02202161|20224122|P6|STARTED|Overall Study||10
8201543|NCT02202161|20224123|P5|STARTED|Overall Study||9
8201544|NCT02202161|20224124|P4|STARTED|Overall Study||9
8201545|NCT02202161|20224125|P3|STARTED|Overall Study||5
8201546|NCT02202161|20224126|P2|STARTED|Overall Study||5
8201547|NCT02202161|20224127|P1|STARTED|Overall Study||13
8201548|NCT02202135|20224281|P1|NOT COMPLETED|Overall Study||0
8201549|NCT02202135|20224281|P1|COMPLETED|Overall Study||4
8201550|NCT02202135|20224281|P1|STARTED|Overall Study||4
8201551|NCT02202109|20224287|P2|NOT COMPLETED|Overall Study||87
8201552|NCT02202109|20224288|P1|NOT COMPLETED|Overall Study||90
8201553|NCT02202109|20224287|P2|COMPLETED|Overall Study||213
8201554|NCT02202109|20224288|P1|COMPLETED|Overall Study||212
8201555|NCT02202109|20224287|P2|STARTED|Overall Study||300
8201556|NCT02202109|20224288|P1|STARTED|Overall Study||302
8201557|NCT02202044|20224298|P1|NOT COMPLETED|Overall Study||0
8201558|NCT02202044|20224298|P1|COMPLETED|Overall Study||0
8201559|NCT02202044|20224298|P1|STARTED|Overall Study||0
8201560|NCT02202031|20224305|P2|NOT COMPLETED|Overall Study||5
8201561|NCT02202031|20224306|P1|NOT COMPLETED|Overall Study||5
8201562|NCT02202031|20224305|P2|COMPLETED|Overall Study||74
8201563|NCT02202031|20224306|P1|COMPLETED|Overall Study||77
8201564|NCT02202031|20224305|P2|STARTED|Overall Study||79
8201565|NCT02202031|20224306|P1|STARTED|Overall Study||82
8201566|NCT02201953|20224354|P2|NOT COMPLETED|Overall Study||56
8201567|NCT02201953|20224355|P1|NOT COMPLETED|Overall Study||20
8201568|NCT02201953|20224354|P2|COMPLETED|Overall Study||224
8201569|NCT02201953|20224355|P1|COMPLETED|Overall Study||258
8201570|NCT02201953|20224354|P2|STARTED|Overall Study||280
8201571|NCT02201953|20224355|P1|STARTED|Overall Study||278
8201572|NCT02201940|20224373|P2|NOT COMPLETED|Overall Study||116
8201573|NCT02201940|20224374|P1|NOT COMPLETED|Overall Study||12
8201574|NCT02201940|20224373|P2|COMPLETED|Overall Study||0
8201575|NCT02201940|20224374|P1|COMPLETED|Overall Study||613
8201576|NCT02201940|20224373|P2|STARTED|Overall Study||116
8201577|NCT02201940|20224374|P1|STARTED|Overall Study||625
8201578|NCT02201901|20224393|P3|NOT COMPLETED|Overall Study||13
8201579|NCT02201901|20224394|P2|NOT COMPLETED|Overall Study||9
8201580|NCT02201901|20224395|P1|NOT COMPLETED|Overall Study||15
8201581|NCT02201901|20224393|P3|COMPLETED|Overall Study||77
8201582|NCT02201901|20224394|P2|COMPLETED|Overall Study||79
8201583|NCT02201901|20224395|P1|COMPLETED|Overall Study||75
8201584|NCT02201901|20224393|P3|STARTED|Overall Study||90
8201585|NCT02201901|20224394|P2|STARTED|Overall Study||88
8201586|NCT02201901|20224395|P1|STARTED|Overall Study||90
8201587|NCT02201784|20224426|P2|NOT COMPLETED|Overall Study||0
8201588|NCT02201784|20224427|P1|NOT COMPLETED|Overall Study||2
8201589|NCT02201784|20224426|P2|COMPLETED|Overall Study||30
8201590|NCT02201784|20224427|P1|COMPLETED|Overall Study||28
8201591|NCT02201784|20224426|P2|STARTED|Overall Study||30
8201592|NCT02201784|20224427|P1|STARTED|Overall Study||30
8201593|NCT02201771|20224444|P3|NOT COMPLETED|Overall Study||10
8201594|NCT02201771|20224445|P2|NOT COMPLETED|Overall Study||10
8201595|NCT02201771|20224446|P1|NOT COMPLETED|Overall Study||13
8201596|NCT02201771|20224444|P3|COMPLETED|Overall Study||156
8201597|NCT02201771|20224445|P2|COMPLETED|Overall Study||158
8201598|NCT02201771|20224446|P1|COMPLETED|Overall Study||153
8201599|NCT02201771|20224444|P3|STARTED|Overall Study||166
8201600|NCT02201771|20224445|P2|STARTED|Overall Study||168
8201601|NCT02201771|20224446|P1|STARTED|Overall Study||166
8201602|NCT02201524|20224473|P4|NOT COMPLETED|Overall Study||4
8201603|NCT02201524|20224474|P3|NOT COMPLETED|Overall Study||4
8201604|NCT02201524|20224475|P2|NOT COMPLETED|Overall Study||3
8201605|NCT02201524|20224476|P1|NOT COMPLETED|Overall Study||2
8201606|NCT02201524|20224473|P4|COMPLETED|Overall Study||10
8201607|NCT02201524|20224474|P3|COMPLETED|Overall Study||12
8201608|NCT02201524|20224475|P2|COMPLETED|Overall Study||12
8201609|NCT02201524|20224476|P1|COMPLETED|Overall Study||12
8201610|NCT02201524|20224473|P4|STARTED|Overall Study||14
8201611|NCT02201524|20224474|P3|STARTED|Overall Study||16
8201612|NCT02201524|20224475|P2|STARTED|Overall Study||15
8201613|NCT02201524|20224476|P1|STARTED|Overall Study||14
8201614|NCT02201472|20224558|P1|NOT COMPLETED|Overall Study||2
8201615|NCT02201472|20224558|P1|COMPLETED|Overall Study||0
8201616|NCT02201472|20224558|P1|STARTED|Overall Study||2
8201617|NCT02201446|20224564|P2|NOT COMPLETED|Overall Study||0
8201618|NCT02201446|20224565|P1|NOT COMPLETED|Overall Study||0
8201619|NCT02201446|20224564|P2|COMPLETED|Overall Study||58
8201620|NCT02201446|20224565|P1|COMPLETED|Overall Study||81
8201621|NCT02201446|20224564|P2|STARTED|Overall Study||58
8201622|NCT02201446|20224565|P1|STARTED|Overall Study||81
8201623|NCT02201420|20224593|P1|NOT COMPLETED|Overall Study||0
8201624|NCT02201420|20224593|P1|COMPLETED|Overall Study||5
8201625|NCT02201420|20224593|P1|STARTED|Overall Study||5
8201626|NCT02201394|20224598|P1|NOT COMPLETED|Maintenance Dose||0
8201627|NCT02201394|20224598|P1|COMPLETED|Maintenance Dose||20
8201628|NCT02201394|20224598|P1|STARTED|Maintenance Dose||20
8201629|NCT02201394|20224598|P1|NOT COMPLETED|Loading Dose||0
8201630|NCT02201394|20224598|P1|COMPLETED|Loading Dose||20
8201631|NCT02201394|20224598|P1|STARTED|Loading Dose||20
8201632|NCT02201329|20224605|P1|NOT COMPLETED|Overall Study||5
8201633|NCT02201329|20224605|P1|COMPLETED|Overall Study||0
8201634|NCT02201329|20224605|P1|STARTED|Overall Study||5
8201635|NCT02201290|20224613|P1|NOT COMPLETED|Overall Study||5
8201636|NCT02201290|20224613|P1|COMPLETED|Overall Study||4
8201637|NCT02201290|20224613|P1|STARTED|Overall Study||9
8201638|NCT02201277|20224619|P2|NOT COMPLETED|Overall Study||5
8201639|NCT02201277|20224620|P1|NOT COMPLETED|Overall Study||7
8201640|NCT02201277|20224619|P2|COMPLETED|Overall Study||16
8201641|NCT02201277|20224620|P1|COMPLETED|Overall Study||17
8201642|NCT02201277|20224619|P2|Failed Retrieval (Referred Elsewhere)|Overall Study||0
8201643|NCT02201277|20224620|P1|Failed Retrieval (Referred Elsewhere)|Overall Study||1
8201644|NCT02201277|20224619|P2|Complicated Retrieval|Overall Study||0
8201645|NCT02201277|20224620|P1|Complicated Retrieval|Overall Study||2
8201646|NCT02201277|20224619|P2|Death (Before Removal)|Overall Study||4
8201647|NCT02201277|20224620|P1|Death (Before Removal)|Overall Study||3
8201648|NCT02201277|20224619|P2|Lost to Follow up|Overall Study||1
8201649|NCT02201277|20224620|P1|Lost to Follow up|Overall Study||2
8201650|NCT02201277|20224619|P2|Filter Ruled to be Permanent|Overall Study||2
8201651|NCT02201277|20224620|P1|Filter Ruled to be Permanent|Overall Study||2
8201652|NCT02201277|20224619|P2|Signed ICF But Did Not Enroll|Overall Study||1
8201653|NCT02201277|20224620|P1|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0
8201654|NCT02201277|20224619|P2|Filter Retrieval|Overall Study||16
8201655|NCT02201277|20224620|P1|Filter Retrieval|Overall Study||17
8201656|NCT02201277|20224619|P2|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21
8201657|NCT02201277|20224620|P1|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24
8201658|NCT02201212|20224640|P1|NOT COMPLETED|Overall Study||0
8201659|NCT02201212|20224640|P1|COMPLETED|Overall Study||30
8201660|NCT02201212|20224640|P1|STARTED|Overall Study||30
8201661|NCT02201108|20224650|P2|NOT COMPLETED|Overall Study||7
8201662|NCT02201108|20224651|P1|NOT COMPLETED|Overall Study||4
8201663|NCT02201108|20224650|P2|COMPLETED|Overall Study||102
8201664|NCT02201108|20224651|P1|COMPLETED|Overall Study||53
8201665|NCT02201108|20224650|P2|On-going Participants|Overall Study||58
8201666|NCT02201108|20224651|P1|On-going Participants|Overall Study||0
8201667|NCT02201108|20224650|P2|STARTED|Overall Study||109
8201668|NCT02201108|20224651|P1|STARTED|Overall Study||57
8201669|NCT02201056|20224703|P7|NOT COMPLETED|Overall Study||0
8201670|NCT02201056|20224704|P6|NOT COMPLETED|Overall Study||0
8201671|NCT02201056|20224705|P5|NOT COMPLETED|Overall Study||0
8201672|NCT02201056|20224706|P4|NOT COMPLETED|Overall Study||0
8201673|NCT02201056|20224707|P3|NOT COMPLETED|Overall Study||0
8201674|NCT02201056|20224708|P2|NOT COMPLETED|Overall Study||0
8201675|NCT02201056|20224709|P1|NOT COMPLETED|Overall Study||0
8201676|NCT02201056|20224703|P7|COMPLETED|Overall Study||6
8201677|NCT02201056|20224704|P6|COMPLETED|Overall Study||6
8201678|NCT02201056|20224705|P5|COMPLETED|Overall Study||6
8201679|NCT02201056|20224706|P4|COMPLETED|Overall Study||6
8201680|NCT02201056|20224707|P3|COMPLETED|Overall Study||6
8201681|NCT02201056|20224708|P2|COMPLETED|Overall Study||6
8201682|NCT02201056|20224709|P1|COMPLETED|Overall Study||12
8201683|NCT02201056|20224703|P7|STARTED|Overall Study||6
8201684|NCT02201056|20224704|P6|STARTED|Overall Study||6
8201685|NCT02201056|20224705|P5|STARTED|Overall Study||6
8201686|NCT02201056|20224706|P4|STARTED|Overall Study||6
8201687|NCT02201056|20224707|P3|STARTED|Overall Study||6
8201688|NCT02201056|20224708|P2|STARTED|Overall Study||6
8201689|NCT02201056|20224709|P1|STARTED|Overall Study||12
8201690|NCT02200770|20224766|P2|NOT COMPLETED|Open-label Period (OLP)||162
8201691|NCT02200770|20224767|P1|NOT COMPLETED|Open-label Period (OLP)||51
8201692|NCT02200770|20224766|P2|COMPLETED|Open-label Period (OLP)||0
8201693|NCT02200770|20224767|P1|COMPLETED|Open-label Period (OLP)||0
8201694|NCT02200770|20224766|P2|STARTED|Open-label Period (OLP)|Enrolment into OLP was optional; out of 169 participants who completed RCP, only 162 entered in OLP.|162
8201695|NCT02200770|20224767|P1|STARTED|Open-label Period (OLP)|Enrolment into OLP was optional; out of 54 participants who completed RCP, only 51 entered in OLP.|51
8201696|NCT02200770|20224766|P2|NOT COMPLETED|Randomized-controlled Period (RCP)||6
8201697|NCT02200770|20224767|P1|NOT COMPLETED|Randomized-controlled Period (RCP)||2
8201698|NCT02200770|20224766|P2|COMPLETED|Randomized-controlled Period (RCP)||169
8201699|NCT02200770|20224767|P1|COMPLETED|Randomized-controlled Period (RCP)||54
8201700|NCT02200770|20224766|P2|Treated|Randomized-controlled Period (RCP)||174
8201701|NCT02200770|20224767|P1|Treated|Randomized-controlled Period (RCP)||56
8201702|NCT02200770|20224766|P2|STARTED|Randomized-controlled Period (RCP)||175
8201703|NCT02200770|20224767|P1|STARTED|Randomized-controlled Period (RCP)||56
8201716|NCT02200536|20224824|P3|NOT COMPLETED|Overall Study||0
8201717|NCT02200536|20224825|P2|NOT COMPLETED|Overall Study||0
8201718|NCT02200536|20224826|P1|NOT COMPLETED|Overall Study||0
8201719|NCT02200536|20224824|P3|COMPLETED|Overall Study||30
8201720|NCT02200536|20224825|P2|COMPLETED|Overall Study||30
8201721|NCT02200536|20224826|P1|COMPLETED|Overall Study||32
8201722|NCT02200536|20224824|P3|STARTED|Overall Study||30
8201723|NCT02200536|20224825|P2|STARTED|Overall Study||30
8201724|NCT02200536|20224826|P1|STARTED|Overall Study||32
8201725|NCT02200523|20224839|P2|NOT COMPLETED|Overall Study||0
8201726|NCT02200523|20224840|P1|NOT COMPLETED|Overall Study||0
8201727|NCT02200523|20224839|P2|COMPLETED|Overall Study||20
8201728|NCT02200523|20224840|P1|COMPLETED|Overall Study||20
8201729|NCT02200523|20224839|P2|STARTED|Overall Study||20
8201730|NCT02200523|20224840|P1|STARTED|Overall Study||20
8201731|NCT02200510|20224848|P2|NOT COMPLETED|Overall Study||3
8201732|NCT02200510|20224849|P1|NOT COMPLETED|Overall Study||9
8201733|NCT02200510|20224848|P2|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
8201734|NCT02200510|20224849|P1|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
8201735|NCT02200510|20224848|P2|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
8201736|NCT02200510|20224849|P1|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
8201737|NCT02200458|20224855|P1|NOT COMPLETED|Overall Study||0
8201738|NCT02200458|20224855|P1|COMPLETED|Overall Study||62
8201739|NCT02200458|20224855|P1|STARTED|Overall Study||62
8201749|NCT02200328|20224880|P2|NOT COMPLETED|Overall Study||33
8201750|NCT02200328|20224881|P1|NOT COMPLETED|Overall Study||43
8201751|NCT02200328|20224880|P2|COMPLETED|Overall Study||0
8201752|NCT02200328|20224881|P1|COMPLETED|Overall Study||0
8201753|NCT02200328|20224880|P2|STARTED|Overall Study||33
8201754|NCT02200328|20224881|P1|STARTED|Overall Study||43
8201755|NCT02200211|20224893|P4|NOT COMPLETED|Overall Study||2
8201756|NCT02200211|20224894|P3|NOT COMPLETED|Overall Study||1
8201757|NCT02200211|20224895|P2|NOT COMPLETED|Overall Study||7
8201758|NCT02200211|20224896|P1|NOT COMPLETED|Overall Study||8
8201759|NCT02200211|20224893|P4|COMPLETED|Overall Study||58
8201760|NCT02200211|20224894|P3|COMPLETED|Overall Study||39
8201761|NCT02200211|20224895|P2|COMPLETED|Overall Study||188
8201762|NCT02200211|20224896|P1|COMPLETED|Overall Study||182
8201763|NCT02200211|20224893|P4|Included in 16-week Primary Analysis|Overall Study||56
8201764|NCT02200211|20224894|P3|Included in 16-week Primary Analysis|Overall Study||39
8201765|NCT02200211|20224895|P2|Included in 16-week Primary Analysis|Overall Study||186
8201766|NCT02200211|20224896|P1|Included in 16-week Primary Analysis|Overall Study||177
8201767|NCT02200211|20224893|P4|STARTED|Overall Study||60
8201768|NCT02200211|20224894|P3|STARTED|Overall Study||40
8201769|NCT02200211|20224895|P2|STARTED|Overall Study||195
8201770|NCT02200211|20224896|P1|STARTED|Overall Study||190
8201771|NCT02200055|20224992|P1|NOT COMPLETED|Overall Study||0
8201772|NCT02200055|20224992|P1|COMPLETED|Overall Study||86
8201773|NCT02200055|20224992|P1|STARTED|Overall Study||86
8201774|NCT02200042|20225009|P2|NOT COMPLETED|Overall Study||1
8201775|NCT02200042|20225010|P1|NOT COMPLETED|Overall Study||0
8201776|NCT02200042|20225009|P2|COMPLETED|Overall Study||0
8201777|NCT02200042|20225010|P1|COMPLETED|Overall Study||0
8201778|NCT02200042|20225009|P2|STARTED|Overall Study||1
8201779|NCT02200042|20225010|P1|STARTED|Overall Study||0
8201780|NCT02199964|20225028|P2|NOT COMPLETED|Overall Study||0
8201781|NCT02199964|20225029|P1|NOT COMPLETED|Overall Study||0
8201782|NCT02199964|20225028|P2|COMPLETED|Overall Study||2
8201783|NCT02199964|20225029|P1|COMPLETED|Overall Study||2
8201784|NCT02199964|20225028|P2|STARTED|Overall Study||2
8201785|NCT02199964|20225029|P1|STARTED|Overall Study||2
8201786|NCT02199795|20225039|P2|NOT COMPLETED|Overall Study||0
8201787|NCT02199795|20225040|P1|NOT COMPLETED|Overall Study||2
8201788|NCT02199795|20225039|P2|COMPLETED|Overall Study||3
8201789|NCT02199795|20225040|P1|COMPLETED|Overall Study||2
8201790|NCT02199795|20225039|P2|STARTED|Overall Study||3
8201791|NCT02199795|20225040|P1|STARTED|Overall Study||4
8201792|NCT02199717|20225052|P1|NOT COMPLETED|Overall Study||0
8201793|NCT02199717|20225052|P1|COMPLETED|Overall Study||66
8201794|NCT02199717|20225052|P1|STARTED|Overall Study||66
8201795|NCT02199691|20225063|P4|NOT COMPLETED|Overall Study||30
8201796|NCT02199691|20225064|P3|NOT COMPLETED|Overall Study||27
8201797|NCT02199691|20225065|P2|NOT COMPLETED|Overall Study||7
8201798|NCT02199691|20225066|P1|NOT COMPLETED|Overall Study||10
8201799|NCT02199691|20225063|P4|COMPLETED|Overall Study||270
8201800|NCT02199691|20225064|P3|COMPLETED|Overall Study||376
8201801|NCT02199691|20225065|P2|COMPLETED|Overall Study||500
8201802|NCT02199691|20225066|P1|COMPLETED|Overall Study||495
8201803|NCT02199691|20225063|P4|Safety Analysis Set (SafAS)|Overall Study||296
8201804|NCT02199691|20225064|P3|Safety Analysis Set (SafAS)|Overall Study||392
8201805|NCT02199691|20225065|P2|Safety Analysis Set (SafAS)|Overall Study||501
8201806|NCT02199691|20225066|P1|Safety Analysis Set (SafAS)|Overall Study||503
8201807|NCT02199691|20225063|P4|STARTED|Overall Study||300
8201808|NCT02199691|20225064|P3|STARTED|Overall Study||403
8201809|NCT02199691|20225065|P2|STARTED|Overall Study||507
8201810|NCT02199691|20225066|P1|STARTED|Overall Study||505
8201811|NCT02199652|20225088|P2|NOT COMPLETED|Overall Study||7
8201812|NCT02199652|20225089|P1|NOT COMPLETED|Overall Study||7
8201813|NCT02199652|20225088|P2|COMPLETED|Overall Study||3
8201814|NCT02199652|20225089|P1|COMPLETED|Overall Study||3
8201815|NCT02199652|20225088|P2|STARTED|Overall Study||10
8201816|NCT02199652|20225089|P1|STARTED|Overall Study||10
8201820|NCT02199509|20225108|P2|NOT COMPLETED|Overall Study||1
8201821|NCT02199509|20225109|P1|NOT COMPLETED|Overall Study||1
8201822|NCT02199509|20225108|P2|COMPLETED|Overall Study||3
8201823|NCT02199509|20225109|P1|COMPLETED|Overall Study||2
8201824|NCT02199509|20225108|P2|STARTED|Overall Study||4
8201825|NCT02199509|20225109|P1|STARTED|Overall Study||3
8201826|NCT02199496|20225123|P2|NOT COMPLETED|Ustekinumab-Multi-dose||0
8201827|NCT02199496|20225124|P1|NOT COMPLETED|Ustekinumab-Multi-dose||0
8201828|NCT02199496|20225123|P2|COMPLETED|Ustekinumab-Multi-dose||2
8201829|NCT02199496|20225124|P1|COMPLETED|Ustekinumab-Multi-dose||3
8201830|NCT02199496|20225123|P2|STARTED|Ustekinumab-Multi-dose|Cohort 2 only participated in multi-dose phase 2|2
8201831|NCT02199496|20225124|P1|STARTED|Ustekinumab-Multi-dose||3
8201832|NCT02199496|20225123|P2|NOT COMPLETED|Ustekinumab-Single Dose||0
8201833|NCT02199496|20225124|P1|NOT COMPLETED|Ustekinumab-Single Dose||0
8201834|NCT02199496|20225123|P2|COMPLETED|Ustekinumab-Single Dose||0
8201835|NCT02199496|20225124|P1|COMPLETED|Ustekinumab-Single Dose||3
8201836|NCT02199496|20225123|P2|STARTED|Ustekinumab-Single Dose||0
8201837|NCT02199496|20225124|P1|STARTED|Ustekinumab-Single Dose||3
8201838|NCT02199314|20225132|P1|NOT COMPLETED|Overall Study||16
8201839|NCT02199314|20225132|P1|COMPLETED|Overall Study||14
8201840|NCT02199314|20225132|P1|STARTED|Overall Study||30
8201841|NCT02199197|20225138|P2|NOT COMPLETED|Overall Study||2
8201842|NCT02199197|20225139|P1|NOT COMPLETED|Overall Study||0
8201843|NCT02199197|20225138|P2|COMPLETED|Overall Study||12
8201844|NCT02199197|20225139|P1|COMPLETED|Overall Study||35
8201845|NCT02199197|20225138|P2|STARTED|Overall Study||14
8201846|NCT02199197|20225139|P1|STARTED|Overall Study||35
8201847|NCT02199080|20225159|P1|NOT COMPLETED|Overall Study||12
8201848|NCT02199080|20225159|P1|COMPLETED|Overall Study||2494
8201849|NCT02199080|20225159|P1|STARTED|Overall Study||2506
8201850|NCT02199041|20225169|P1|NOT COMPLETED|Overall Study||0
8201851|NCT02199041|20225169|P1|COMPLETED|Overall Study||12
8201852|NCT02199041|20225169|P1|STARTED|Overall Study||12
8201853|NCT02199028|20225184|P2|NOT COMPLETED|Week 4||0
8201854|NCT02199028|20225185|P1|NOT COMPLETED|Week 4||0
8201855|NCT02199028|20225184|P2|COMPLETED|Week 4||15
8201856|NCT02199028|20225185|P1|COMPLETED|Week 4||13
8201857|NCT02199028|20225184|P2|STARTED|Week 4||15
8201858|NCT02199028|20225185|P1|STARTED|Week 4||13
8201859|NCT02199028|20225184|P2|NOT COMPLETED|Week 3||0
8201860|NCT02199028|20225185|P1|NOT COMPLETED|Week 3||1
8201861|NCT02199028|20225184|P2|COMPLETED|Week 3||15
8201862|NCT02199028|20225185|P1|COMPLETED|Week 3||13
8201863|NCT02199028|20225184|P2|STARTED|Week 3||15
8201864|NCT02199028|20225185|P1|STARTED|Week 3||14
8201865|NCT02199028|20225184|P2|NOT COMPLETED|Week 2||0
8201866|NCT02199028|20225185|P1|NOT COMPLETED|Week 2||0
8201867|NCT02199028|20225184|P2|COMPLETED|Week 2||15
8201868|NCT02199028|20225185|P1|COMPLETED|Week 2||14
8201869|NCT02199028|20225184|P2|STARTED|Week 2||15
8201870|NCT02199028|20225185|P1|STARTED|Week 2||14
8201871|NCT02199028|20225184|P2|NOT COMPLETED|Week 1||0
8201872|NCT02199028|20225185|P1|NOT COMPLETED|Week 1||1
8201873|NCT02199028|20225184|P2|COMPLETED|Week 1||15
8201874|NCT02199028|20225185|P1|COMPLETED|Week 1||14
8201875|NCT02199028|20225184|P2|STARTED|Week 1||15
8201876|NCT02199028|20225185|P1|STARTED|Week 1||15
8201877|NCT02198963|20225194|P1|NOT COMPLETED|Overall Study||7
8201878|NCT02198963|20225194|P1|COMPLETED|Overall Study||36
8201879|NCT02198963|20225194|P1|STARTED|Overall Study||43
8201880|NCT02198833|20225205|P2|NOT COMPLETED|Overall Study||0
8201881|NCT02198833|20225206|P1|NOT COMPLETED|Overall Study||0
8201882|NCT02198833|20225205|P2|COMPLETED|Overall Study||1
8201883|NCT02198833|20225206|P1|COMPLETED|Overall Study||1
8201884|NCT02198833|20225205|P2|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
8201885|NCT02198833|20225206|P1|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
8201886|NCT02198651|20225218|P5|NOT COMPLETED|Open-label Rescue Period||0
8201887|NCT02198651|20225219|P4|NOT COMPLETED|Open-label Rescue Period||3
8201888|NCT02198651|20225220|P3|NOT COMPLETED|Open-label Rescue Period||0
8201889|NCT02198651|20225221|P2|NOT COMPLETED|Open-label Rescue Period||0
8201890|NCT02198651|20225222|P1|NOT COMPLETED|Open-label Rescue Period||0
8201891|NCT02198651|20225218|P5|COMPLETED|Open-label Rescue Period||8
8201892|NCT02198651|20225219|P4|COMPLETED|Open-label Rescue Period||28
8201893|NCT02198651|20225220|P3|COMPLETED|Open-label Rescue Period||0
8201894|NCT02198651|20225221|P2|COMPLETED|Open-label Rescue Period||0
8201895|NCT02198651|20225222|P1|COMPLETED|Open-label Rescue Period||0
8201896|NCT02198651|20225218|P5|Correctly Entered Open-label Rescue|Open-label Rescue Period||8
8201897|NCT02198651|20225219|P4|Correctly Entered Open-label Rescue|Open-label Rescue Period||30
8201898|NCT02198651|20225220|P3|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
8201899|NCT02198651|20225221|P2|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
8201900|NCT02198651|20225222|P1|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
8201901|NCT02198651|20225218|P5|STARTED|Open-label Rescue Period||8
8201902|NCT02198651|20225219|P4|STARTED|Open-label Rescue Period||31
8201903|NCT02198651|20225220|P3|STARTED|Open-label Rescue Period||0
8201904|NCT02198651|20225221|P2|STARTED|Open-label Rescue Period||0
8201905|NCT02198651|20225222|P1|STARTED|Open-label Rescue Period||0
8201906|NCT02198651|20225218|P5|NOT COMPLETED|Double-blind Period||0
8201907|NCT02198651|20225219|P4|NOT COMPLETED|Double-blind Period||0
8201908|NCT02198651|20225220|P3|NOT COMPLETED|Double-blind Period||1
8201909|NCT02198651|20225221|P2|NOT COMPLETED|Double-blind Period||9
8201910|NCT02198651|20225222|P1|NOT COMPLETED|Double-blind Period||0
8201911|NCT02198651|20225218|P5|COMPLETED|Double-blind Period||0
8201912|NCT02198651|20225219|P4|COMPLETED|Double-blind Period||0
8201913|NCT02198651|20225220|P3|COMPLETED|Double-blind Period||19
8201914|NCT02198651|20225221|P2|COMPLETED|Double-blind Period||93
8201915|NCT02198651|20225222|P1|COMPLETED|Double-blind Period||0
8201916|NCT02198651|20225218|P5|STARTED|Double-blind Period||0
8201917|NCT02198651|20225219|P4|STARTED|Double-blind Period||0
8201918|NCT02198651|20225220|P3|STARTED|Double-blind Period||20
8201919|NCT02198651|20225221|P2|STARTED|Double-blind Period||102
8201920|NCT02198651|20225222|P1|STARTED|Double-blind Period||0
8201921|NCT02198651|20225218|P5|NOT COMPLETED|Lead-in Period||0
8201922|NCT02198651|20225219|P4|NOT COMPLETED|Lead-in Period||0
8201923|NCT02198651|20225220|P3|NOT COMPLETED|Lead-in Period||0
8201924|NCT02198651|20225221|P2|NOT COMPLETED|Lead-in Period||0
8201925|NCT02198651|20225222|P1|NOT COMPLETED|Lead-in Period||37
8201926|NCT02198651|20225218|P5|COMPLETED|Lead-in Period||0
8201927|NCT02198651|20225219|P4|COMPLETED|Lead-in Period||0
8201928|NCT02198651|20225220|P3|COMPLETED|Lead-in Period||0
8201929|NCT02198651|20225221|P2|COMPLETED|Lead-in Period||0
8201930|NCT02198651|20225222|P1|COMPLETED|Lead-in Period||112
8201931|NCT02198651|20225218|P5|Participants Treated in Lead-In Period|Lead-in Period||0
8201932|NCT02198651|20225219|P4|Participants Treated in Lead-In Period|Lead-in Period||0
8201933|NCT02198651|20225220|P3|Participants Treated in Lead-In Period|Lead-in Period||0
8201934|NCT02198651|20225221|P2|Participants Treated in Lead-In Period|Lead-in Period||0
8201935|NCT02198651|20225222|P1|Participants Treated in Lead-In Period|Lead-in Period||146
8201936|NCT02198651|20225218|P5|STARTED|Lead-in Period||0
8201937|NCT02198651|20225219|P4|STARTED|Lead-in Period||0
8201938|NCT02198651|20225220|P3|STARTED|Lead-in Period||0
8201939|NCT02198651|20225221|P2|STARTED|Lead-in Period||0
8201940|NCT02198651|20225222|P1|STARTED|Lead-in Period||149
8201941|NCT02198430|20225307|P2|NOT COMPLETED|Overall Study||0
8201942|NCT02198430|20225308|P1|NOT COMPLETED|Overall Study||0
8201943|NCT02198430|20225307|P2|COMPLETED|Overall Study||51
8201944|NCT02198430|20225308|P1|COMPLETED|Overall Study||53
8201945|NCT02198430|20225307|P2|STARTED|Overall Study||51
8201946|NCT02198430|20225308|P1|STARTED|Overall Study||53
8201947|NCT02198235|20225323|P3|NOT COMPLETED|Overall Study||2
8201948|NCT02198235|20225324|P2|NOT COMPLETED|Overall Study||2
8201949|NCT02198235|20225325|P1|NOT COMPLETED|Overall Study||3
8201950|NCT02198235|20225323|P3|COMPLETED|Overall Study||28
8201951|NCT02198235|20225324|P2|COMPLETED|Overall Study||28
8201952|NCT02198235|20225325|P1|COMPLETED|Overall Study||27
8201953|NCT02198235|20225323|P3|STARTED|Overall Study||30
8201954|NCT02198235|20225324|P2|STARTED|Overall Study||30
8201955|NCT02198235|20225325|P1|STARTED|Overall Study||30
8201956|NCT02198040|20225345|P3|NOT COMPLETED|Overall Study||1
8201957|NCT02198040|20225346|P2|NOT COMPLETED|Overall Study||1
8201958|NCT02198040|20225347|P1|NOT COMPLETED|Overall Study||0
8201959|NCT02198040|20225345|P3|COMPLETED|Overall Study||8
8201960|NCT02198040|20225346|P2|COMPLETED|Overall Study||8
8201961|NCT02198040|20225347|P1|COMPLETED|Overall Study||9
8201962|NCT02198040|20225345|P3|STARTED|Overall Study||9
8201963|NCT02198040|20225346|P2|STARTED|Overall Study||9
8201964|NCT02198040|20225347|P1|STARTED|Overall Study||9
8201965|NCT02197897|20225373|P1|NOT COMPLETED|Overall Study||1
8201966|NCT02197897|20225373|P1|COMPLETED|Overall Study||14
8201967|NCT02197897|20225373|P1|STARTED|Overall Study||15
8201968|NCT02197806|20225381|P4|NOT COMPLETED|Overall Study||1
8201969|NCT02197806|20225382|P3|NOT COMPLETED|Overall Study||0
8201970|NCT02197806|20225383|P2|NOT COMPLETED|Overall Study||1
8201971|NCT02197806|20225384|P1|NOT COMPLETED|Overall Study||0
8201972|NCT02197806|20225381|P4|COMPLETED|Overall Study||16
8201973|NCT02197806|20225382|P3|COMPLETED|Overall Study||16
8201974|NCT02197806|20225383|P2|COMPLETED|Overall Study||16
8201975|NCT02197806|20225384|P1|COMPLETED|Overall Study||15
8201976|NCT02197806|20225381|P4|STARTED|Overall Study||17
8201977|NCT02197806|20225382|P3|STARTED|Overall Study||16
8201978|NCT02197806|20225383|P2|STARTED|Overall Study||17
8201979|NCT02197806|20225384|P1|STARTED|Overall Study||15
8201980|NCT02197767|20225394|P1|NOT COMPLETED|Overall Study||0
8201981|NCT02197767|20225394|P1|COMPLETED|Overall Study||11
8201982|NCT02197767|20225394|P1|STARTED|Overall Study||11
8201983|NCT02197572|20225399|P1|NOT COMPLETED|Overall Study||44
8201984|NCT02197572|20225399|P1|COMPLETED|Overall Study||0
8201985|NCT02197572|20225399|P1|STARTED|Overall Study||44
8201986|NCT02197520|20225416|P2|NOT COMPLETED|Period 2||2
8201987|NCT02197520|20225417|P1|NOT COMPLETED|Period 2||1
8201988|NCT02197520|20225416|P2|COMPLETED|Period 2||10
8201989|NCT02197520|20225417|P1|COMPLETED|Period 2||10
8201990|NCT02197520|20225416|P2|STARTED|Period 2||12
8201991|NCT02197520|20225417|P1|STARTED|Period 2||11
8201992|NCT02197520|20225416|P2|NOT COMPLETED|Period 1||0
8201993|NCT02197520|20225417|P1|NOT COMPLETED|Period 1||1
8201994|NCT02197520|20225416|P2|COMPLETED|Period 1||12
8201995|NCT02197520|20225417|P1|COMPLETED|Period 1||11
8201996|NCT02197520|20225416|P2|STARTED|Period 1||12
8201997|NCT02197520|20225417|P1|STARTED|Period 1||12
8201998|NCT02197481|20225435|P2|NOT COMPLETED|Overall Study||0
8201999|NCT02197481|20225436|P1|NOT COMPLETED|Overall Study||0
8202000|NCT02197481|20225435|P2|COMPLETED|Overall Study||43
8202001|NCT02197481|20225436|P1|COMPLETED|Overall Study|February 2016|43
8202002|NCT02197481|20225435|P2|STARTED|Overall Study||43
8202003|NCT02197481|20225436|P1|STARTED|Overall Study|October 2014|43
8202004|NCT02197455|20225456|P1|NOT COMPLETED|Overall Study||0
8202005|NCT02197455|20225456|P1|COMPLETED|Overall Study||30
8202006|NCT02197455|20225456|P1|STARTED|Overall Study||30
8202007|NCT02197416|20225464|P3|NOT COMPLETED|Overall Study||8
8202008|NCT02197416|20225465|P2|NOT COMPLETED|Overall Study||4
8202009|NCT02197416|20225466|P1|NOT COMPLETED|Overall Study||1
8202010|NCT02197416|20225464|P3|COMPLETED|Overall Study||153
8202011|NCT02197416|20225465|P2|COMPLETED|Overall Study||39
8202012|NCT02197416|20225466|P1|COMPLETED|Overall Study||8
8202013|NCT02197416|20225464|P3|STARTED|Overall Study||161
8202014|NCT02197416|20225465|P2|STARTED|Overall Study||43
8202015|NCT02197416|20225466|P1|STARTED|Overall Study||9
8202016|NCT02197377|20225504|P2|NOT COMPLETED|Overall Study||3
8202017|NCT02197377|20225505|P1|NOT COMPLETED|Overall Study||0
8202018|NCT02197377|20225504|P2|COMPLETED|Overall Study||27
8202019|NCT02197377|20225505|P1|COMPLETED|Overall Study||30
8202020|NCT02197377|20225504|P2|STARTED|Overall Study||30
8202021|NCT02197377|20225505|P1|STARTED|Overall Study||30
8202022|NCT02197273|20225515|P2|NOT COMPLETED|Overall Study||0
8202023|NCT02197273|20225516|P1|NOT COMPLETED|Overall Study||0
8202024|NCT02197273|20225515|P2|COMPLETED|Overall Study||104
8202025|NCT02197273|20225516|P1|COMPLETED|Overall Study||107
8202026|NCT02197273|20225515|P2|STARTED|Overall Study||104
8202027|NCT02197273|20225516|P1|STARTED|Overall Study||107
8202052|NCT02197130|20225593|P3|NOT COMPLETED|Overall Study||32
8202053|NCT02197130|20225594|P2|NOT COMPLETED|Overall Study||8
8202054|NCT02197130|20225595|P1|NOT COMPLETED|Overall Study||16
8202055|NCT02197130|20225593|P3|COMPLETED|Overall Study||56
8202056|NCT02197130|20225594|P2|COMPLETED|Overall Study||81
8202057|NCT02197130|20225595|P1|COMPLETED|Overall Study||79
8202058|NCT02197130|20225593|P3|Received Treatment|Overall Study||87
8202059|NCT02197130|20225594|P2|Received Treatment|Overall Study||88
8202060|NCT02197130|20225595|P1|Received Treatment|Overall Study||95
8202061|NCT02197130|20225593|P3|STARTED|Overall Study||88
8202062|NCT02197130|20225594|P2|STARTED|Overall Study||89
8202063|NCT02197130|20225595|P1|STARTED|Overall Study||95
8202064|NCT02197078|20225657|P12|NOT COMPLETED|Overall Study||0
8202065|NCT02197078|20225658|P11|NOT COMPLETED|Overall Study||0
8202066|NCT02197078|20225659|P10|NOT COMPLETED|Overall Study||0
8202067|NCT02197078|20225660|P9|NOT COMPLETED|Overall Study||0
8202068|NCT02197078|20225661|P8|NOT COMPLETED|Overall Study||0
8202069|NCT02197078|20225662|P7|NOT COMPLETED|Overall Study||0
8202070|NCT02197078|20225663|P6|NOT COMPLETED|Overall Study||0
8202071|NCT02197078|20225664|P5|NOT COMPLETED|Overall Study||0
8202072|NCT02197078|20225665|P4|NOT COMPLETED|Overall Study||0
8202073|NCT02197078|20225666|P3|NOT COMPLETED|Overall Study||0
8202074|NCT02197078|20225667|P2|NOT COMPLETED|Overall Study||0
8202075|NCT02197078|20225668|P1|NOT COMPLETED|Overall Study||0
8202076|NCT02197078|20225657|P12|COMPLETED|Overall Study||15742
8202077|NCT02197078|20225658|P11|COMPLETED|Overall Study||15742
8202078|NCT02197078|20225659|P10|COMPLETED|Overall Study||18996
8202079|NCT02197078|20225660|P9|COMPLETED|Overall Study||18996
8202080|NCT02197078|20225661|P8|COMPLETED|Overall Study||25135
8202081|NCT02197078|20225662|P7|COMPLETED|Overall Study||25135
8202082|NCT02197078|20225663|P6|COMPLETED|Overall Study||9538
8202083|NCT02197078|20225664|P5|COMPLETED|Overall Study||9538
8202084|NCT02197078|20225665|P4|COMPLETED|Overall Study||10614
8202085|NCT02197078|20225666|P3|COMPLETED|Overall Study||10614
8202086|NCT02197078|20225667|P2|COMPLETED|Overall Study||14688
8202087|NCT02197078|20225668|P1|COMPLETED|Overall Study||14688
8202088|NCT02197078|20225657|P12|STARTED|Overall Study||15742
8202089|NCT02197078|20225658|P11|STARTED|Overall Study||15742
8202090|NCT02197078|20225659|P10|STARTED|Overall Study||18996
8202091|NCT02197078|20225660|P9|STARTED|Overall Study||18996
8202092|NCT02197078|20225661|P8|STARTED|Overall Study||25135
8202093|NCT02197078|20225662|P7|STARTED|Overall Study||25135
8202094|NCT02197078|20225663|P6|STARTED|Overall Study||9538
8202095|NCT02197078|20225664|P5|STARTED|Overall Study||9538
8202096|NCT02197078|20225665|P4|STARTED|Overall Study||10614
8202097|NCT02197078|20225666|P3|STARTED|Overall Study||10614
8202098|NCT02197078|20225667|P2|STARTED|Overall Study||14688
8202099|NCT02197078|20225668|P1|STARTED|Overall Study||14688
8202100|NCT02197065|20225780|P2|NOT COMPLETED|Overall Study||0
8202101|NCT02197065|20225781|P1|NOT COMPLETED|Overall Study||0
8202102|NCT02197065|20225780|P2|COMPLETED|Overall Study||10
8202103|NCT02197065|20225781|P1|COMPLETED|Overall Study||10
8202104|NCT02197065|20225780|P2|STARTED|Overall Study||10
8202105|NCT02197065|20225781|P1|STARTED|Overall Study||10
8202106|NCT02196922|20225792|P2|NOT COMPLETED|Overall Study||0
8202107|NCT02196922|20225793|P1|NOT COMPLETED|Overall Study||0
8202108|NCT02196922|20225792|P2|COMPLETED|Overall Study||46
8202109|NCT02196922|20225793|P1|COMPLETED|Overall Study||58
8202110|NCT02196922|20225792|P2|STARTED|Overall Study||46
8202111|NCT02196922|20225793|P1|STARTED|Overall Study||58
8202112|NCT02196857|20225803|P1|NOT COMPLETED|Overall Study||0
8202113|NCT02196857|20225803|P1|COMPLETED|Overall Study||16
8202114|NCT02196857|20225803|P1|STARTED|Overall Study||16
8202115|NCT02196831|20225810|P2|NOT COMPLETED|Overall Study||4
8202116|NCT02196831|20225811|P1|NOT COMPLETED|Overall Study||9
8202117|NCT02196831|20225810|P2|COMPLETED|Overall Study||26
8202118|NCT02196831|20225811|P1|COMPLETED|Overall Study||21
8202119|NCT02196831|20225810|P2|Received Follow-up Imaging|Overall Study||28
8202120|NCT02196831|20225811|P1|Received Follow-up Imaging|Overall Study||26
8202121|NCT02196831|20225810|P2|STARTED|Overall Study||30
8202122|NCT02196831|20225811|P1|STARTED|Overall Study||30
8202123|NCT02196766|20225824|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8202124|NCT02196766|20225825|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8202125|NCT02196766|20225824|P2|COMPLETED|Second Intervention (7 Days)||15
8202126|NCT02196766|20225825|P1|COMPLETED|Second Intervention (7 Days)||15
8202127|NCT02196766|20225824|P2|STARTED|Second Intervention (7 Days)||15
8202128|NCT02196766|20225825|P1|STARTED|Second Intervention (7 Days)||15
8202129|NCT02196766|20225824|P2|NOT COMPLETED|First Intervention (7 Days)||0
8202130|NCT02196766|20225825|P1|NOT COMPLETED|First Intervention (7 Days)||0
8202131|NCT02196766|20225824|P2|COMPLETED|First Intervention (7 Days)||15
8202132|NCT02196766|20225825|P1|COMPLETED|First Intervention (7 Days)||15
8202133|NCT02196766|20225824|P2|STARTED|First Intervention (7 Days)||15
8202134|NCT02196766|20225825|P1|STARTED|First Intervention (7 Days)||15
8202135|NCT02196714|20225841|P4|NOT COMPLETED|Overall Study||0
8202136|NCT02196714|20225842|P3|NOT COMPLETED|Overall Study||1
8202137|NCT02196714|20225843|P2|NOT COMPLETED|Overall Study||0
8202138|NCT02196714|20225844|P1|NOT COMPLETED|Overall Study||0
8202139|NCT02196714|20225841|P4|COMPLETED|Overall Study||24
8202140|NCT02196714|20225842|P3|COMPLETED|Overall Study||23
8202141|NCT02196714|20225843|P2|COMPLETED|Overall Study||23
8202142|NCT02196714|20225844|P1|COMPLETED|Overall Study||24
8202143|NCT02196714|20225841|P4|STARTED|Overall Study||24
8202144|NCT02196714|20225842|P3|STARTED|Overall Study||24
8202145|NCT02196714|20225843|P2|STARTED|Overall Study||23
8202146|NCT02196714|20225844|P1|STARTED|Overall Study||24
8202147|NCT02196701|20225966|P1|NOT COMPLETED|Overall Study||3
8202148|NCT02196701|20225966|P1|COMPLETED|Overall Study||43
8202149|NCT02196701|20225966|P1|STARTED|Overall Study||46
8202150|NCT02196688|20226024|P2|NOT COMPLETED|Overall Study||1
8202151|NCT02196688|20226025|P1|NOT COMPLETED|Overall Study||7
8202152|NCT02196688|20226024|P2|COMPLETED|Overall Study||23
8202153|NCT02196688|20226025|P1|COMPLETED|Overall Study||40
8202154|NCT02196688|20226024|P2|STARTED|Overall Study||24
8202155|NCT02196688|20226025|P1|STARTED|Overall Study||47
8202156|NCT02196675|20226040|P3|NOT COMPLETED|Overall Study||1
8202157|NCT02196675|20226041|P2|NOT COMPLETED|Overall Study||2
8202158|NCT02196675|20226042|P1|NOT COMPLETED|Overall Study||2
8202159|NCT02196675|20226040|P3|COMPLETED|Overall Study||7
8202160|NCT02196675|20226041|P2|COMPLETED|Overall Study||68
8202161|NCT02196675|20226042|P1|COMPLETED|Overall Study||25
8202162|NCT02196675|20226040|P3|STARTED|Overall Study||8
8202163|NCT02196675|20226041|P2|STARTED|Overall Study||70
8202164|NCT02196675|20226042|P1|STARTED|Overall Study||27
8202165|NCT02196558|20226065|P3|NOT COMPLETED|Extension Phase (40 Weeks)||1
8202166|NCT02196558|20226066|P2|NOT COMPLETED|Extension Phase (40 Weeks)||3
8202167|NCT02196558|20226067|P1|NOT COMPLETED|Extension Phase (40 Weeks)||2
8202168|NCT02196558|20226065|P3|COMPLETED|Extension Phase (40 Weeks)||5
8202169|NCT02196558|20226066|P2|COMPLETED|Extension Phase (40 Weeks)||8
8202170|NCT02196558|20226067|P1|COMPLETED|Extension Phase (40 Weeks)||9
8202171|NCT02196558|20226065|P3|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|6
8202172|NCT02196558|20226066|P2|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
8202173|NCT02196558|20226067|P1|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
8202174|NCT02196558|20226065|P3|NOT COMPLETED|Treatment Phase (12 Weeks)||2
8202175|NCT02196558|20226066|P2|NOT COMPLETED|Treatment Phase (12 Weeks)||3
8202176|NCT02196558|20226067|P1|NOT COMPLETED|Treatment Phase (12 Weeks)||0
8202177|NCT02196558|20226065|P3|COMPLETED|Treatment Phase (12 Weeks)||8
8202178|NCT02196558|20226066|P2|COMPLETED|Treatment Phase (12 Weeks)||12
8202179|NCT02196558|20226067|P1|COMPLETED|Treatment Phase (12 Weeks)||12
8202180|NCT02196558|20226065|P3|STARTED|Treatment Phase (12 Weeks)||10
8202181|NCT02196558|20226066|P2|STARTED|Treatment Phase (12 Weeks)||15
8202182|NCT02196558|20226067|P1|STARTED|Treatment Phase (12 Weeks)||12
8202183|NCT02196506|20226083|P4|NOT COMPLETED|Phase A+||14
8202184|NCT02196506|20226084|P3|NOT COMPLETED|Phase A+||0
8202185|NCT02196506|20226085|P2|NOT COMPLETED|Phase A+||0
8202186|NCT02196506|20226086|P1|NOT COMPLETED|Phase A+||0
8202187|NCT02196506|20226083|P4|COMPLETED|Phase A+||308
8202188|NCT02196506|20226084|P3|COMPLETED|Phase A+||0
8202189|NCT02196506|20226085|P2|COMPLETED|Phase A+||0
8202190|NCT02196506|20226086|P1|COMPLETED|Phase A+||0
8202191|NCT02196506|20226083|P4|STARTED|Phase A+||322
8202192|NCT02196506|20226084|P3|STARTED|Phase A+||0
8202193|NCT02196506|20226085|P2|STARTED|Phase A+||0
8202194|NCT02196506|20226086|P1|STARTED|Phase A+||0
8202195|NCT02196506|20226083|P4|NOT COMPLETED|Phase B||0
8202196|NCT02196506|20226084|P3|NOT COMPLETED|Phase B||6
8202197|NCT02196506|20226085|P2|NOT COMPLETED|Phase B||15
8202198|NCT02196506|20226086|P1|NOT COMPLETED|Phase B||0
8202199|NCT02196506|20226083|P4|COMPLETED|Phase B||0
8202200|NCT02196506|20226084|P3|COMPLETED|Phase B||196
8202201|NCT02196506|20226085|P2|COMPLETED|Phase B||177
8202202|NCT02196506|20226086|P1|COMPLETED|Phase B||0
8202203|NCT02196506|20226083|P4|STARTED|Phase B||0
8202204|NCT02196506|20226084|P3|STARTED|Phase B||202
8202205|NCT02196506|20226085|P2|STARTED|Phase B||192
8202206|NCT02196506|20226086|P1|STARTED|Phase B||0
8202207|NCT02196506|20226083|P4|NOT COMPLETED|Phase A||0
8202208|NCT02196506|20226084|P3|NOT COMPLETED|Phase A||0
8202209|NCT02196506|20226085|P2|NOT COMPLETED|Phase A||0
8202210|NCT02196506|20226086|P1|NOT COMPLETED|Phase A||121
8202211|NCT02196506|20226083|P4|COMPLETED|Phase A||0
8202212|NCT02196506|20226084|P3|COMPLETED|Phase A||0
8202213|NCT02196506|20226085|P2|COMPLETED|Phase A||0
8202214|NCT02196506|20226086|P1|COMPLETED|Phase A||716
8202215|NCT02196506|20226083|P4|STARTED|Phase A||0
8202216|NCT02196506|20226084|P3|STARTED|Phase A||0
8202217|NCT02196506|20226085|P2|STARTED|Phase A||0
8202218|NCT02196506|20226086|P1|STARTED|Phase A||837
8202219|NCT02196259|20226101|P3|NOT COMPLETED|Overall Study||1
8202220|NCT02196259|20226102|P2|NOT COMPLETED|Overall Study||3
8202221|NCT02196259|20226103|P1|NOT COMPLETED|Overall Study||0
8202222|NCT02196259|20226101|P3|COMPLETED|Overall Study||2
8202223|NCT02196259|20226102|P2|COMPLETED|Overall Study||4
8202224|NCT02196259|20226103|P1|COMPLETED|Overall Study||3
8202225|NCT02196259|20226101|P3|STARTED|Overall Study||3
8202226|NCT02196259|20226102|P2|STARTED|Overall Study||7
8202227|NCT02196259|20226103|P1|STARTED|Overall Study||3
8202228|NCT02196168|20226112|P2|NOT COMPLETED|Overall Study||0
8202229|NCT02196168|20226113|P1|NOT COMPLETED|Overall Study||0
8202230|NCT02196168|20226112|P2|COMPLETED|Overall Study||0
8202231|NCT02196168|20226113|P1|COMPLETED|Overall Study||6
8202232|NCT02196168|20226112|P2|STARTED|Overall Study||0
8202233|NCT02196168|20226113|P1|STARTED|Overall Study||6
8202234|NCT02196077|20226131|P1|NOT COMPLETED|Overall Study||47
8202235|NCT02196077|20226131|P1|COMPLETED|Overall Study||133
8202236|NCT02196077|20226131|P1|FF MDI 9.6 μg|Overall Study||157
8202237|NCT02196077|20226131|P1|BD MDI 320 μg|Overall Study||108
8202238|NCT02196077|20226131|P1|BFF MDI 80/9.6 μg|Overall Study||103
8202239|NCT02196077|20226131|P1|BFF MDI 160/9.6 μg|Overall Study||106
8202240|NCT02196077|20226131|P1|BFF MDI 320/9.6 μg|Overall Study||155
8202241|NCT02196077|20226131|P1|STARTED|Overall Study||180
8202242|NCT02195986|20226181|P3|NOT COMPLETED|Overall Study||2
8202243|NCT02195986|20226182|P2|NOT COMPLETED|Overall Study||5
8202244|NCT02195986|20226183|P1|NOT COMPLETED|Overall Study||3
8202245|NCT02195986|20226181|P3|COMPLETED|Overall Study||71
8202246|NCT02195986|20226182|P2|COMPLETED|Overall Study||142
8202247|NCT02195986|20226183|P1|COMPLETED|Overall Study||143
8202248|NCT02195986|20226181|P3|STARTED|Overall Study||73
8202249|NCT02195986|20226182|P2|STARTED|Overall Study||147
8202250|NCT02195986|20226183|P1|STARTED|Overall Study||146
8202251|NCT02195895|20226198|P1|NOT COMPLETED|Overall Study||0
8202252|NCT02195895|20226198|P1|COMPLETED|Overall Study||17
8202253|NCT02195895|20226198|P1|STARTED|Overall Study||17
8202254|NCT02195869|20226206|P1|NOT COMPLETED|Overall Study||42
8202255|NCT02195869|20226206|P1|COMPLETED|Overall Study||0
8202256|NCT02195869|20226206|P1|All-Treated Population|Overall Study||42
8202257|NCT02195869|20226206|P1|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42
8202258|NCT02195713|20226219|P2|NOT COMPLETED|Overall Study||0
8202259|NCT02195713|20226220|P1|NOT COMPLETED|Overall Study||0
8202260|NCT02195713|20226219|P2|COMPLETED|Overall Study||10
8202261|NCT02195713|20226220|P1|COMPLETED|Overall Study||10
8202262|NCT02195713|20226219|P2|STARTED|Overall Study||10
8202263|NCT02195713|20226220|P1|STARTED|Overall Study||10
8202264|NCT02195700|20226228|P2|NOT COMPLETED|Overall Study||7
8202265|NCT02195700|20226229|P1|NOT COMPLETED|Overall Study||6
8202266|NCT02195700|20226228|P2|COMPLETED|Overall Study||52
8202267|NCT02195700|20226229|P1|COMPLETED|Overall Study||52
8202268|NCT02195700|20226228|P2|Maintenance Period|Overall Study||54
8202269|NCT02195700|20226229|P1|Maintenance Period|Overall Study||53
8202270|NCT02195700|20226228|P2|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
8202271|NCT02195700|20226229|P1|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
8202272|NCT02195700|20226228|P2|Safety and ITT Populations|Overall Study||59
8202273|NCT02195700|20226229|P1|Safety and ITT Populations|Overall Study||58
8202274|NCT02195700|20226228|P2|STARTED|Overall Study||59
8202275|NCT02195700|20226229|P1|STARTED|Overall Study||58
8202276|NCT02195687|20226251|P2|NOT COMPLETED|Overall Study||2
8202277|NCT02195687|20226252|P1|NOT COMPLETED|Overall Study||5
8202278|NCT02195687|20226251|P2|COMPLETED|Overall Study||99
8202279|NCT02195687|20226252|P1|COMPLETED|Overall Study||311
8202280|NCT02195687|20226251|P2|STARTED|Overall Study||101
8202281|NCT02195687|20226252|P1|STARTED|Overall Study||316
8202282|NCT02195622|20226270|P2|NOT COMPLETED|Overall Study||0
8202283|NCT02195622|20226271|P1|NOT COMPLETED|Overall Study||0
8202284|NCT02195622|20226270|P2|COMPLETED|Overall Study||37
8202285|NCT02195622|20226271|P1|COMPLETED|Overall Study||37
8202286|NCT02195622|20226270|P2|STARTED|Overall Study||37
8202287|NCT02195622|20226271|P1|STARTED|Overall Study||37
8202288|NCT02195583|20226277|P1|NOT COMPLETED|Overall Study||9
8202289|NCT02195583|20226277|P1|COMPLETED|Overall Study||53
8202290|NCT02195583|20226277|P1|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
8202291|NCT02195583|20226277|P1|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
8202292|NCT02195583|20226277|P1|Sodium Fluoride (250 Ppm)|Overall Study||55
8202383|NCT02195011|20226768|P1|STARTED|Overall Study||25
8202293|NCT02195583|20226277|P1|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
8202294|NCT02195583|20226277|P1|Sodium Fluoride (0 Ppm)|Overall Study||59
8202295|NCT02195583|20226277|P1|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
8202296|NCT02195583|20226277|P1|STARTED|Overall Study||62
8202297|NCT02195531|20226312|P3|NOT COMPLETED|Overall Study||1
8202298|NCT02195531|20226313|P2|NOT COMPLETED|Overall Study||1
8202299|NCT02195531|20226314|P1|NOT COMPLETED|Overall Study||1
8202300|NCT02195531|20226312|P3|COMPLETED|Overall Study||55
8202301|NCT02195531|20226313|P2|COMPLETED|Overall Study||48
8202302|NCT02195531|20226314|P1|COMPLETED|Overall Study||63
8202303|NCT02195531|20226312|P3|STARTED|Overall Study||56
8202304|NCT02195531|20226313|P2|STARTED|Overall Study||49
8202305|NCT02195531|20226314|P1|STARTED|Overall Study||64
8202306|NCT02195518|20226339|P1|NOT COMPLETED|Overall Study||9
8202307|NCT02195518|20226339|P1|COMPLETED|Overall Study||204
8202308|NCT02195518|20226339|P1|STARTED|Overall Study||213
8202317|NCT02195427|20226401|P2|NOT COMPLETED|Overall Study||27
8202318|NCT02195427|20226402|P1|NOT COMPLETED|Overall Study||26
8202319|NCT02195427|20226401|P2|COMPLETED|Overall Study||47
8202320|NCT02195427|20226402|P1|COMPLETED|Overall Study||47
8202321|NCT02195427|20226401|P2|N Patients at W52|Overall Study||56
8202322|NCT02195427|20226402|P1|N Patients at W52|Overall Study||63
8202323|NCT02195427|20226401|P2|N Patients at W36|Overall Study||59
8202324|NCT02195427|20226402|P1|N Patients at W36|Overall Study||65
8202325|NCT02195427|20226401|P2|N Patients at W24 (Primary Outcome)|Overall Study||62
8202326|NCT02195427|20226402|P1|N Patients at W24 (Primary Outcome)|Overall Study||67
8202327|NCT02195427|20226401|P2|STARTED|Overall Study||74
8202328|NCT02195427|20226402|P1|STARTED|Overall Study||73
8202329|NCT02195414|20226464|P1|NOT COMPLETED|Overall Study||0
8202330|NCT02195414|20226464|P1|COMPLETED|Overall Study||31
8202331|NCT02195414|20226464|P1|Primary Endpoint|Overall Study||31
8202332|NCT02195414|20226464|P1|STARTED|Overall Study||31
8202366|NCT02195310|20226745|P2|NOT COMPLETED|Overall Study||16
8202367|NCT02195310|20226746|P1|NOT COMPLETED|Overall Study||20
8202368|NCT02195310|20226745|P2|COMPLETED|Overall Study||153
8202369|NCT02195310|20226746|P1|COMPLETED|Overall Study||153
8202370|NCT02195310|20226745|P2|STARTED|Overall Study||169
8202371|NCT02195310|20226746|P1|STARTED|Overall Study||173
8202378|NCT02195011|20226767|P2|NOT COMPLETED|Overall Study||1
8202379|NCT02195011|20226768|P1|NOT COMPLETED|Overall Study||25
8202380|NCT02195011|20226767|P2|COMPLETED|Overall Study||0
8202381|NCT02195011|20226768|P1|COMPLETED|Overall Study||0
8202382|NCT02195011|20226767|P2|STARTED|Overall Study||1
8202384|NCT02194998|20226784|P4|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
8202385|NCT02194998|20226785|P3|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
8202386|NCT02194998|20226786|P2|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
8202387|NCT02194998|20226787|P1|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
8202388|NCT02194998|20226784|P4|COMPLETED|Post-HCV Treatment Follow-Up||4
8202389|NCT02194998|20226785|P3|COMPLETED|Post-HCV Treatment Follow-Up||14
8202390|NCT02194998|20226786|P2|COMPLETED|Post-HCV Treatment Follow-Up||5
8202391|NCT02194998|20226787|P1|COMPLETED|Post-HCV Treatment Follow-Up||20
8202392|NCT02194998|20226784|P4|STARTED|Post-HCV Treatment Follow-Up||4
8202393|NCT02194998|20226785|P3|STARTED|Post-HCV Treatment Follow-Up||15
8202394|NCT02194998|20226786|P2|STARTED|Post-HCV Treatment Follow-Up||5
8202395|NCT02194998|20226787|P1|STARTED|Post-HCV Treatment Follow-Up||21
8202396|NCT02194998|20226784|P4|NOT COMPLETED|On-HCV Treatment||0
8202397|NCT02194998|20226785|P3|NOT COMPLETED|On-HCV Treatment||0
8202398|NCT02194998|20226786|P2|NOT COMPLETED|On-HCV Treatment||1
8202399|NCT02194998|20226787|P1|NOT COMPLETED|On-HCV Treatment||0
8202400|NCT02194998|20226784|P4|COMPLETED|On-HCV Treatment||4
8202401|NCT02194998|20226785|P3|COMPLETED|On-HCV Treatment||15
8202402|NCT02194998|20226786|P2|COMPLETED|On-HCV Treatment||5
8202403|NCT02194998|20226787|P1|COMPLETED|On-HCV Treatment||21
8202404|NCT02194998|20226784|P4|STARTED|On-HCV Treatment||4
8202405|NCT02194998|20226785|P3|STARTED|On-HCV Treatment||15
8202406|NCT02194998|20226786|P2|STARTED|On-HCV Treatment||6
8202407|NCT02194998|20226787|P1|STARTED|On-HCV Treatment||21
8202408|NCT02194985|20226849|P1|NOT COMPLETED|Overall Study||11
8202409|NCT02194985|20226849|P1|COMPLETED|Overall Study||73
8202410|NCT02194985|20226849|P1|Received at Least 1 Dose of Study Drug|Overall Study||84
8202411|NCT02194985|20226849|P1|STARTED|Overall Study||84
8202412|NCT02194933|20226863|P2|NOT COMPLETED|Overall Study||9
8202413|NCT02194933|20226864|P1|NOT COMPLETED|Overall Study||3
8202414|NCT02194933|20226863|P2|COMPLETED|Overall Study||10
8202415|NCT02194933|20226864|P1|COMPLETED|Overall Study||16
8202416|NCT02194933|20226863|P2|STARTED|Overall Study||19
8202417|NCT02194933|20226864|P1|STARTED|Overall Study||19
8202418|NCT02194699|20226918|P2|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
8202419|NCT02194699|20226919|P1|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
8202420|NCT02194699|20226918|P2|COMPLETED|With Potential to Receive 52 Weeks of IP||365
8202421|NCT02194699|20226919|P1|COMPLETED|With Potential to Receive 52 Weeks of IP||370
8202422|NCT02194699|20226918|P2|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
8202423|NCT02194699|20226919|P1|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
8202424|NCT02194699|20226918|P2|NOT COMPLETED|Randomised||11
8202425|NCT02194699|20226919|P1|NOT COMPLETED|Randomised||8
8202426|NCT02194699|20226918|P2|COMPLETED|Randomised||417
8202427|NCT02194699|20226919|P1|COMPLETED|Randomised||420
8202428|NCT02194699|20226918|P2|STARTED|Randomised||428
8202429|NCT02194699|20226919|P1|STARTED|Randomised||428
8202430|NCT02194621|20227027|P3|NOT COMPLETED|Overall Study||9
8202431|NCT02194621|20227028|P2|NOT COMPLETED|Overall Study||6
8202432|NCT02194621|20227029|P1|NOT COMPLETED|Overall Study||6
8202433|NCT02194621|20227027|P3|COMPLETED|Overall Study||34
8202434|NCT02194621|20227028|P2|COMPLETED|Overall Study||36
8202435|NCT02194621|20227029|P1|COMPLETED|Overall Study||37
8202436|NCT02194621|20227027|P3|STARTED|Overall Study||43
8202437|NCT02194621|20227028|P2|STARTED|Overall Study||42
8202438|NCT02194621|20227029|P1|STARTED|Overall Study||43
8202439|NCT02194465|20227053|P7|NOT COMPLETED|Overall Study||2
8202440|NCT02194465|20227054|P6|NOT COMPLETED|Overall Study||4
8202441|NCT02194465|20227055|P5|NOT COMPLETED|Overall Study||9
8202442|NCT02194465|20227056|P4|NOT COMPLETED|Overall Study||8
8202443|NCT02194465|20227057|P3|NOT COMPLETED|Overall Study||8
8202444|NCT02194465|20227058|P2|NOT COMPLETED|Overall Study||7
8202445|NCT02194465|20227059|P1|NOT COMPLETED|Overall Study||9
8202446|NCT02194465|20227053|P7|COMPLETED|Overall Study||24
8202447|NCT02194465|20227054|P6|COMPLETED|Overall Study||21
8202448|NCT02194465|20227055|P5|COMPLETED|Overall Study||42
8202449|NCT02194465|20227056|P4|COMPLETED|Overall Study||41
8202450|NCT02194465|20227057|P3|COMPLETED|Overall Study||44
8202451|NCT02194465|20227058|P2|COMPLETED|Overall Study||43
8202452|NCT02194465|20227059|P1|COMPLETED|Overall Study||42
8202453|NCT02194465|20227053|P7|Received at Least 1 Dose of Study Drug|Overall Study||26
8202454|NCT02194465|20227054|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
8202455|NCT02194465|20227055|P5|Received at Least 1 Dose of Study Drug|Overall Study||51
8202456|NCT02194465|20227056|P4|Received at Least 1 Dose of Study Drug|Overall Study||49
8202457|NCT02194465|20227057|P3|Received at Least 1 Dose of Study Drug|Overall Study||51
8202458|NCT02194465|20227058|P2|Received at Least 1 Dose of Study Drug|Overall Study||50
8202459|NCT02194465|20227059|P1|Received at Least 1 Dose of Study Drug|Overall Study||51
8202460|NCT02194465|20227053|P7|STARTED|Overall Study||26
8202461|NCT02194465|20227054|P6|STARTED|Overall Study||25
8202462|NCT02194465|20227055|P5|STARTED|Overall Study||51
8202463|NCT02194465|20227056|P4|STARTED|Overall Study||49
8202464|NCT02194465|20227057|P3|STARTED|Overall Study||52
8202465|NCT02194465|20227058|P2|STARTED|Overall Study||50
8202466|NCT02194465|20227059|P1|STARTED|Overall Study||51
8202467|NCT02194088|20227102|P2|NOT COMPLETED|Overall Study||0
8202468|NCT02194088|20227103|P1|NOT COMPLETED|Overall Study||0
8202469|NCT02194088|20227102|P2|COMPLETED|Overall Study||25
8202470|NCT02194088|20227103|P1|COMPLETED|Overall Study||75
8202471|NCT02194088|20227102|P2|STARTED|Overall Study||25
8202472|NCT02194088|20227103|P1|STARTED|Overall Study||75
8202473|NCT02194062|20227116|P3|NOT COMPLETED|Overall Study||5
8202474|NCT02194062|20227117|P2|NOT COMPLETED|Overall Study||2
8202475|NCT02194062|20227118|P1|NOT COMPLETED|Overall Study||2
8202476|NCT02194062|20227116|P3|COMPLETED|Overall Study||7
8202477|NCT02194062|20227117|P2|COMPLETED|Overall Study||8
8202478|NCT02194062|20227118|P1|COMPLETED|Overall Study||8
8202479|NCT02194062|20227116|P3|STARTED|Overall Study||12
8202480|NCT02194062|20227117|P2|STARTED|Overall Study||10
8202481|NCT02194062|20227118|P1|STARTED|Overall Study||10
8202482|NCT02193880|20227129|P1|NOT COMPLETED|Overall Study||3
8202483|NCT02193880|20227129|P1|COMPLETED|Overall Study||4
8202484|NCT02193880|20227129|P1|STARTED|Overall Study||7
8202485|NCT02193867|20227134|P1|NOT COMPLETED|Overall Study||4
8202486|NCT02193867|20227134|P1|COMPLETED|Overall Study||6
8202487|NCT02193867|20227134|P1|Completed 18 Months Of Treatment|Overall Study||8
8202488|NCT02193867|20227134|P1|Received At Least 1 Dose Of Study Drug|Overall Study||10
8202489|NCT02193867|20227134|P1|STARTED|Overall Study||10
8202490|NCT02193828|20227152|P4|NOT COMPLETED|Overall Study||1
8202491|NCT02193828|20227153|P3|NOT COMPLETED|Overall Study||1
8202492|NCT02193828|20227154|P2|NOT COMPLETED|Overall Study||0
8202493|NCT02193828|20227155|P1|NOT COMPLETED|Overall Study||0
8202494|NCT02193828|20227152|P4|COMPLETED|Overall Study||16
8202495|NCT02193828|20227153|P3|COMPLETED|Overall Study||22
8202496|NCT02193828|20227154|P2|COMPLETED|Overall Study||18
8202497|NCT02193828|20227155|P1|COMPLETED|Overall Study||18
8202498|NCT02193828|20227152|P4|STARTED|Overall Study||17
8202499|NCT02193828|20227153|P3|STARTED|Overall Study||23
8202500|NCT02193828|20227154|P2|STARTED|Overall Study||18
8202501|NCT02193828|20227155|P1|STARTED|Overall Study||18
8202502|NCT02193815|20227193|P1|NOT COMPLETED|Overall Study||0
8202503|NCT02193815|20227193|P1|COMPLETED|Overall Study||15
8202504|NCT02193815|20227193|P1|STARTED|Overall Study||15
8202505|NCT02193776|20227232|P4|NOT COMPLETED|Overall Study||2
8202506|NCT02193776|20227233|P3|NOT COMPLETED|Overall Study||2
8202507|NCT02193776|20227234|P2|NOT COMPLETED|Overall Study||7
8202508|NCT02193776|20227235|P1|NOT COMPLETED|Overall Study||8
8202509|NCT02193776|20227232|P4|COMPLETED|Overall Study||58
8202510|NCT02193776|20227233|P3|COMPLETED|Overall Study||59
8202511|NCT02193776|20227234|P2|COMPLETED|Overall Study||53
8202512|NCT02193776|20227235|P1|COMPLETED|Overall Study||51
8202513|NCT02193776|20227232|P4|Completed Day 140 Follow-up|Overall Study||58
8202514|NCT02193776|20227233|P3|Completed Day 140 Follow-up|Overall Study||58
8202515|NCT02193776|20227234|P2|Completed Day 140 Follow-up|Overall Study||52
8202516|NCT02193776|20227235|P1|Completed Day 140 Follow-up|Overall Study||52
8202517|NCT02193776|20227232|P4|Completed Day 70 Follow-up|Overall Study||60
8202518|NCT02193776|20227233|P3|Completed Day 70 Follow-up|Overall Study||60
8202519|NCT02193776|20227234|P2|Completed Day 70 Follow-up|Overall Study||56
8202520|NCT02193776|20227235|P1|Completed Day 70 Follow-up|Overall Study||54
8202521|NCT02193776|20227232|P4|STARTED|Overall Study||60
8202522|NCT02193776|20227233|P3|STARTED|Overall Study||61
8202523|NCT02193776|20227234|P2|STARTED|Overall Study||60
8202524|NCT02193776|20227235|P1|STARTED|Overall Study||59
8202525|NCT02193490|20227251|P2|NOT COMPLETED|Overall Study||2
8202526|NCT02193490|20227252|P1|NOT COMPLETED|Overall Study||4
8202527|NCT02193490|20227251|P2|COMPLETED|Overall Study||20
8202528|NCT02193490|20227252|P1|COMPLETED|Overall Study||21
8202529|NCT02193490|20227251|P2|STARTED|Overall Study||22
8202530|NCT02193490|20227252|P1|STARTED|Overall Study||25
8202531|NCT02193178|20227262|P1|NOT COMPLETED|Overall Study||2
8202532|NCT02193178|20227262|P1|COMPLETED|Overall Study||13
8202533|NCT02193178|20227262|P1|STARTED|Overall Study||15
8202534|NCT02193165|20227312|P3|NOT COMPLETED|6 Week Product Use||0
8202535|NCT02193165|20227313|P2|NOT COMPLETED|6 Week Product Use||1
8202536|NCT02193165|20227314|P1|NOT COMPLETED|6 Week Product Use||0
8202537|NCT02193165|20227312|P3|COMPLETED|6 Week Product Use||39
8202538|NCT02193165|20227313|P2|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
8202539|NCT02193165|20227314|P1|COMPLETED|6 Week Product Use||39
8202540|NCT02193165|20227312|P3|STARTED|6 Week Product Use||39
8202541|NCT02193165|20227313|P2|STARTED|6 Week Product Use||39
8202542|NCT02193165|20227314|P1|STARTED|6 Week Product Use||39
8202543|NCT02193165|20227312|P3|NOT COMPLETED|4 Week Product Use||1
8202544|NCT02193165|20227313|P2|NOT COMPLETED|4 Week Product Use||1
8202545|NCT02193165|20227314|P1|NOT COMPLETED|4 Week Product Use||1
8202546|NCT02193165|20227312|P3|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
8202547|NCT02193165|20227313|P2|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
8202548|NCT02193165|20227314|P1|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
8202549|NCT02193165|20227312|P3|STARTED|4 Week Product Use||40
8202550|NCT02193165|20227313|P2|STARTED|4 Week Product Use||40
8202551|NCT02193165|20227314|P1|STARTED|4 Week Product Use||40
8202552|NCT02193152|20227337|P1|NOT COMPLETED|Overall Study||0
8202553|NCT02193152|20227337|P1|COMPLETED|Overall Study||16
8202554|NCT02193152|20227337|P1|STARTED|Overall Study||16
8202555|NCT02193087|20227349|P4|NOT COMPLETED|Overall Study||79
8202556|NCT02193087|20227350|P3|NOT COMPLETED|Overall Study||7
8202557|NCT02193087|20227351|P2|NOT COMPLETED|Overall Study||14
8202558|NCT02193087|20227352|P1|NOT COMPLETED|Overall Study||37
8202559|NCT02193087|20227349|P4|COMPLETED|Overall Study||524
8202560|NCT02193087|20227350|P3|COMPLETED|Overall Study||93
8202561|NCT02193087|20227351|P2|COMPLETED|Overall Study||86
8202562|NCT02193087|20227352|P1|COMPLETED|Overall Study||162
8202563|NCT02193087|20227349|P4|Received Vaccination|Overall Study||602
8202564|NCT02193087|20227350|P3|Received Vaccination|Overall Study||100
8202565|NCT02193087|20227351|P2|Received Vaccination|Overall Study||97
8202566|NCT02193087|20227352|P1|Received Vaccination|Overall Study||197
8202567|NCT02193087|20227349|P4|STARTED|Overall Study||603
8202568|NCT02193087|20227350|P3|STARTED|Overall Study||100
8202569|NCT02193087|20227351|P2|STARTED|Overall Study||100
8202570|NCT02193087|20227352|P1|STARTED|Overall Study||199
8202581|NCT02192905|20227430|P1|NOT COMPLETED|Overall Study||1
8202582|NCT02192905|20227430|P1|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
8202583|NCT02192905|20227430|P1|STARTED|Overall Study||43
8202584|NCT02192879|20227444|P3|NOT COMPLETED|Overall Study||0
8202585|NCT02192879|20227445|P2|NOT COMPLETED|Overall Study||0
8202586|NCT02192879|20227446|P1|NOT COMPLETED|Overall Study||0
8202587|NCT02192879|20227444|P3|COMPLETED|Overall Study||3
8202588|NCT02192879|20227445|P2|COMPLETED|Overall Study||4
8202589|NCT02192879|20227446|P1|COMPLETED|Overall Study||3
8202590|NCT02192879|20227444|P3|STARTED|Overall Study||3
8202591|NCT02192879|20227445|P2|STARTED|Overall Study||4
8202592|NCT02192879|20227446|P1|STARTED|Overall Study||3
8202593|NCT02192814|20227472|P1|NOT COMPLETED|Overall Study||0
8202594|NCT02192814|20227472|P1|COMPLETED|Overall Study||9
8202595|NCT02192814|20227472|P1|STARTED|Overall Study||9
8202596|NCT02192775|20227483|P1|NOT COMPLETED|Overall Study||2
8202597|NCT02192775|20227483|P1|COMPLETED|Overall Study||0
8202598|NCT02192775|20227483|P1|STARTED|Overall Study||2
8202599|NCT02192684|20227489|P2|NOT COMPLETED|Overall Study||0
8202600|NCT02192684|20227490|P1|NOT COMPLETED|Overall Study||0
8202601|NCT02192684|20227489|P2|COMPLETED|Overall Study||15
8202602|NCT02192684|20227490|P1|COMPLETED|Overall Study||30
8202603|NCT02192684|20227489|P2|STARTED|Overall Study||15
8202604|NCT02192684|20227490|P1|STARTED|Overall Study||30
8202605|NCT02192606|20227498|P2|NOT COMPLETED|Overall Study||4
8202606|NCT02192606|20227499|P1|NOT COMPLETED|Overall Study||2
8202607|NCT02192606|20227498|P2|COMPLETED|Overall Study||24
8202608|NCT02192606|20227499|P1|COMPLETED|Overall Study||27
8202609|NCT02192606|20227498|P2|STARTED|Overall Study||28
8202610|NCT02192606|20227499|P1|STARTED|Overall Study||29
8202611|NCT02192541|20227509|P2|NOT COMPLETED|Overall Study||0
8202612|NCT02192541|20227510|P1|NOT COMPLETED|Overall Study||0
8202613|NCT02192541|20227509|P2|COMPLETED|Overall Study||3
8202614|NCT02192541|20227510|P1|COMPLETED|Overall Study||2
8202615|NCT02192541|20227509|P2|Evaluable for Response|Overall Study||3
8202616|NCT02192541|20227510|P1|Evaluable for Response|Overall Study||1
8202617|NCT02192541|20227509|P2|Treated|Overall Study||3
8202618|NCT02192541|20227510|P1|Treated|Overall Study||2
8202619|NCT02192541|20227509|P2|STARTED|Overall Study||3
8202620|NCT02192541|20227510|P1|STARTED|Overall Study||2
8202621|NCT02192307|20227532|P2|NOT COMPLETED|Overall Study||0
8202622|NCT02192307|20227533|P1|NOT COMPLETED|Overall Study||0
8202623|NCT02192307|20227532|P2|COMPLETED|Overall Study||30
8202624|NCT02192307|20227533|P1|COMPLETED|Overall Study||30
8202625|NCT02192307|20227532|P2|STARTED|Overall Study||30
8202626|NCT02192307|20227533|P1|STARTED|Overall Study||30
8202627|NCT02192190|20227547|P6|NOT COMPLETED|Overall Study||29
8202628|NCT02192190|20227548|P5|NOT COMPLETED|Overall Study||30
8202629|NCT02192190|20227549|P4|NOT COMPLETED|Overall Study||26
8202630|NCT02192190|20227550|P3|NOT COMPLETED|Overall Study||25
8202631|NCT02192190|20227551|P2|NOT COMPLETED|Overall Study||29
8202632|NCT02192190|20227552|P1|NOT COMPLETED|Overall Study||54
8202633|NCT02192190|20227547|P6|COMPLETED|Overall Study||9
8202634|NCT02192190|20227548|P5|COMPLETED|Overall Study||9
8202635|NCT02192190|20227549|P4|COMPLETED|Overall Study||12
8202636|NCT02192190|20227550|P3|COMPLETED|Overall Study||13
8202637|NCT02192190|20227551|P2|COMPLETED|Overall Study||10
8202638|NCT02192190|20227552|P1|COMPLETED|Overall Study||22
8202639|NCT02192190|20227547|P6|Received at Least 1 Dose of Study Drug|Overall Study||37
8202640|NCT02192190|20227548|P5|Received at Least 1 Dose of Study Drug|Overall Study||38
8202641|NCT02192190|20227549|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
8202642|NCT02192190|20227550|P3|Received at Least 1 Dose of Study Drug|Overall Study||38
8202643|NCT02192190|20227551|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
8202644|NCT02192190|20227552|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
8202645|NCT02192190|20227547|P6|STARTED|Overall Study||38
8202646|NCT02192190|20227548|P5|STARTED|Overall Study||39
8202647|NCT02192190|20227549|P4|STARTED|Overall Study||38
8202648|NCT02192190|20227550|P3|STARTED|Overall Study||38
8202649|NCT02192190|20227551|P2|STARTED|Overall Study||39
8202650|NCT02192190|20227552|P1|STARTED|Overall Study||76
8202651|NCT02192164|20227596|P1|NOT COMPLETED|Overall Study||14
8202652|NCT02192164|20227596|P1|COMPLETED|Overall Study||112
8202653|NCT02192164|20227596|P1|Etanercept Treated Population|Overall Study||112
8202654|NCT02192164|20227596|P1|STARTED|Overall Study||126
8202655|NCT02192099|20227612|P1|NOT COMPLETED|Overall Study||61
8202656|NCT02192099|20227612|P1|COMPLETED|Overall Study||0
8202657|NCT02192099|20227612|P1|STARTED|Overall Study||61
8202658|NCT02191865|20227619|P3|NOT COMPLETED|Overall Study||0
8202659|NCT02191865|20227620|P2|NOT COMPLETED|Overall Study||0
8202660|NCT02191865|20227621|P1|NOT COMPLETED|Overall Study||0
8202661|NCT02191865|20227619|P3|COMPLETED|Overall Study||17
8202662|NCT02191865|20227620|P2|COMPLETED|Overall Study||8
8202663|NCT02191865|20227621|P1|COMPLETED|Overall Study||8
8202664|NCT02191865|20227619|P3|STARTED|Overall Study||17
8202665|NCT02191865|20227620|P2|STARTED|Overall Study||8
8202666|NCT02191865|20227621|P1|STARTED|Overall Study||8
8202670|NCT02191605|20227651|P5|NOT COMPLETED|Overall Study||4
8202671|NCT02191605|20227652|P4|NOT COMPLETED|Overall Study||3
8202672|NCT02191605|20227653|P3|NOT COMPLETED|Overall Study||7
8202673|NCT02191605|20227654|P2|NOT COMPLETED|Overall Study||4
8202674|NCT02191605|20227655|P1|NOT COMPLETED|Overall Study||9
8202675|NCT02191605|20227651|P5|COMPLETED|Overall Study||3
8202676|NCT02191605|20227652|P4|COMPLETED|Overall Study||5
8202677|NCT02191605|20227653|P3|COMPLETED|Overall Study||8
8202678|NCT02191605|20227654|P2|COMPLETED|Overall Study||11
8202679|NCT02191605|20227655|P1|COMPLETED|Overall Study||6
8202680|NCT02191605|20227651|P5|Completed Intervention Portion|Overall Study||7
8202681|NCT02191605|20227652|P4|Completed Intervention Portion|Overall Study||8
8202682|NCT02191605|20227653|P3|Completed Intervention Portion|Overall Study||15
8202683|NCT02191605|20227654|P2|Completed Intervention Portion|Overall Study||15
8202684|NCT02191605|20227655|P1|Completed Intervention Portion|Overall Study||15
8202685|NCT02191605|20227651|P5|STARTED|Overall Study||7
8202686|NCT02191605|20227652|P4|STARTED|Overall Study||8
8202687|NCT02191605|20227653|P3|STARTED|Overall Study||15
8202688|NCT02191605|20227654|P2|STARTED|Overall Study||15
8202689|NCT02191605|20227655|P1|STARTED|Overall Study||15
8202690|NCT02191579|20227674|P2|NOT COMPLETED|Treatment 2||25
8202691|NCT02191579|20227675|P1|NOT COMPLETED|Treatment 2||0
8202692|NCT02191579|20227674|P2|COMPLETED|Treatment 2||55
8202693|NCT02191579|20227675|P1|COMPLETED|Treatment 2||0
8202694|NCT02191579|20227674|P2|STARTED|Treatment 2||80
8202695|NCT02191579|20227675|P1|STARTED|Treatment 2||0
8202696|NCT02191579|20227674|P2|NOT COMPLETED|Treatment 1||58
8202697|NCT02191579|20227675|P1|NOT COMPLETED|Treatment 1||27
8202698|NCT02191579|20227674|P2|COMPLETED|Treatment 1||84
8202699|NCT02191579|20227675|P1|COMPLETED|Treatment 1||113
8202700|NCT02191579|20227674|P2|STARTED|Treatment 1||142
8202701|NCT02191579|20227675|P1|STARTED|Treatment 1||140
8202702|NCT02191397|20227689|P2|NOT COMPLETED|Overall Study||70
8202703|NCT02191397|20227690|P1|NOT COMPLETED|Overall Study||83
8202704|NCT02191397|20227689|P2|COMPLETED|Overall Study||198
8202705|NCT02191397|20227690|P1|COMPLETED|Overall Study||183
8202706|NCT02191397|20227689|P2|STARTED|Overall Study||268
8202707|NCT02191397|20227690|P1|STARTED|Overall Study||266
8202708|NCT02191267|20227751|P3|NOT COMPLETED|Overall Study||0
8202709|NCT02191267|20227752|P2|NOT COMPLETED|Overall Study||0
8202710|NCT02191267|20227753|P1|NOT COMPLETED|Overall Study||1
8202711|NCT02191267|20227751|P3|COMPLETED|Overall Study||4
8202712|NCT02191267|20227752|P2|COMPLETED|Overall Study||6
8202713|NCT02191267|20227753|P1|COMPLETED|Overall Study||19
8202714|NCT02191267|20227751|P3|STARTED|Overall Study||4
8202715|NCT02191267|20227752|P2|STARTED|Overall Study||6
8202716|NCT02191267|20227753|P1|STARTED|Overall Study||20
8202717|NCT02191137|20227764|P1|NOT COMPLETED|Follow-up||5
8202718|NCT02191137|20227764|P1|COMPLETED|Follow-up||60
8202719|NCT02191137|20227764|P1|STARTED|Follow-up||65
8202720|NCT02191137|20227764|P1|NOT COMPLETED|Treatment||10
8202721|NCT02191137|20227764|P1|COMPLETED|Treatment||65
8202722|NCT02191137|20227764|P1|STARTED|Treatment||75
8202723|NCT02191046|20227794|P2|NOT COMPLETED|Overall Study||1
8202724|NCT02191046|20227795|P1|NOT COMPLETED|Overall Study||5
8202725|NCT02191046|20227794|P2|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
8202726|NCT02191046|20227795|P1|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
8202727|NCT02191046|20227794|P2|STARTED|Overall Study||39
8202728|NCT02191046|20227795|P1|STARTED|Overall Study||41
8202729|NCT02191033|20227803|P2|NOT COMPLETED|Overall Study||1
8202730|NCT02191033|20227804|P1|NOT COMPLETED|Overall Study||2
8202731|NCT02191033|20227803|P2|COMPLETED|Overall Study||19
8202732|NCT02191033|20227804|P1|COMPLETED|Overall Study||18
8202733|NCT02191033|20227803|P2|STARTED|Overall Study||20
8202734|NCT02191033|20227804|P1|STARTED|Overall Study||20
8202735|NCT02190903|20227816|P2|NOT COMPLETED|Overall Study||0
8202736|NCT02190903|20227817|P1|NOT COMPLETED|Overall Study||0
8202737|NCT02190903|20227816|P2|COMPLETED|Overall Study||6
8202738|NCT02190903|20227817|P1|COMPLETED|Overall Study||6
8202739|NCT02190903|20227816|P2|STARTED|Overall Study||6
8202740|NCT02190903|20227817|P1|STARTED|Overall Study||6
8202750|NCT02190721|20227902|P3|NOT COMPLETED|Overall Study||0
8202751|NCT02190721|20227903|P2|NOT COMPLETED|Overall Study||1
8202752|NCT02190721|20227904|P1|NOT COMPLETED|Overall Study||0
8202753|NCT02190721|20227902|P3|COMPLETED|Overall Study||18
8202754|NCT02190721|20227903|P2|COMPLETED|Overall Study||29
8202755|NCT02190721|20227904|P1|COMPLETED|Overall Study||2
8202756|NCT02190721|20227902|P3|Completed 90 Day Follow-up|Overall Study||18
8202757|NCT02190721|20227903|P2|Completed 90 Day Follow-up|Overall Study||29
8202758|NCT02190721|20227904|P1|Completed 90 Day Follow-up|Overall Study||2
8202759|NCT02190721|20227902|P3|Completed 30 Day Follow-up|Overall Study||18
8202760|NCT02190721|20227903|P2|Completed 30 Day Follow-up|Overall Study||29
8202761|NCT02190721|20227904|P1|Completed 30 Day Follow-up|Overall Study||2
8202762|NCT02190721|20227902|P3|Completed Treatment|Overall Study||18
8202763|NCT02190721|20227903|P2|Completed Treatment|Overall Study||30
8202764|NCT02190721|20227904|P1|Completed Treatment|Overall Study||2
8202765|NCT02190721|20227902|P3|STARTED|Overall Study||18
8202766|NCT02190721|20227903|P2|STARTED|Overall Study||30
8202767|NCT02190721|20227904|P1|STARTED|Overall Study||2
8202768|NCT02190604|20228027|P19|NOT COMPLETED|Part 3 (Patients)||0
8202769|NCT02190604|20228028|P18|NOT COMPLETED|Part 3 (Patients)||0
8202770|NCT02190604|20228029|P17|NOT COMPLETED|Part 3 (Patients)||0
8202771|NCT02190604|20228030|P16|NOT COMPLETED|Part 3 (Patients)||0
8202772|NCT02190604|20228031|P15|NOT COMPLETED|Part 3 (Patients)||0
8202773|NCT02190604|20228032|P14|NOT COMPLETED|Part 3 (Patients)||0
8202774|NCT02190604|20228033|P13|NOT COMPLETED|Part 3 (Patients)||0
8202775|NCT02190604|20228034|P12|NOT COMPLETED|Part 3 (Patients)||0
8202776|NCT02190604|20228035|P11|NOT COMPLETED|Part 3 (Patients)||0
8202777|NCT02190604|20228036|P10|NOT COMPLETED|Part 3 (Patients)||0
8202778|NCT02190604|20228037|P9|NOT COMPLETED|Part 3 (Patients)||0
8202779|NCT02190604|20228038|P8|NOT COMPLETED|Part 3 (Patients)||0
8202780|NCT02190604|20228039|P7|NOT COMPLETED|Part 3 (Patients)||0
8202781|NCT02190604|20228040|P6|NOT COMPLETED|Part 3 (Patients)||0
8202782|NCT02190604|20228041|P5|NOT COMPLETED|Part 3 (Patients)||0
8202783|NCT02190604|20228042|P4|NOT COMPLETED|Part 3 (Patients)||0
8202784|NCT02190604|20228043|P3|NOT COMPLETED|Part 3 (Patients)||0
8202785|NCT02190604|20228044|P2|NOT COMPLETED|Part 3 (Patients)||0
8202786|NCT02190604|20228045|P1|NOT COMPLETED|Part 3 (Patients)||0
8202787|NCT02190604|20228027|P19|COMPLETED|Part 3 (Patients)||12
8202788|NCT02190604|20228028|P18|COMPLETED|Part 3 (Patients)||19
8202789|NCT02190604|20228029|P17|COMPLETED|Part 3 (Patients)||12
8202790|NCT02190604|20228030|P16|COMPLETED|Part 3 (Patients)||6
8202791|NCT02190604|20228031|P15|COMPLETED|Part 3 (Patients)||0
8202792|NCT02190604|20228032|P14|COMPLETED|Part 3 (Patients)||0
8202793|NCT02190604|20228033|P13|COMPLETED|Part 3 (Patients)||0
8202794|NCT02190604|20228034|P12|COMPLETED|Part 3 (Patients)||0
8202795|NCT02190604|20228035|P11|COMPLETED|Part 3 (Patients)||0
8202796|NCT02190604|20228036|P10|COMPLETED|Part 3 (Patients)||0
8202797|NCT02190604|20228037|P9|COMPLETED|Part 3 (Patients)||0
8202798|NCT02190604|20228038|P8|COMPLETED|Part 3 (Patients)||0
8202799|NCT02190604|20228039|P7|COMPLETED|Part 3 (Patients)||0
8202800|NCT02190604|20228040|P6|COMPLETED|Part 3 (Patients)||0
8202801|NCT02190604|20228041|P5|COMPLETED|Part 3 (Patients)||0
8202802|NCT02190604|20228042|P4|COMPLETED|Part 3 (Patients)||0
8202803|NCT02190604|20228043|P3|COMPLETED|Part 3 (Patients)||0
8202804|NCT02190604|20228044|P2|COMPLETED|Part 3 (Patients)||0
8202805|NCT02190604|20228045|P1|COMPLETED|Part 3 (Patients)||0
8202806|NCT02190604|20228027|P19|STARTED|Part 3 (Patients)||12
8202807|NCT02190604|20228028|P18|STARTED|Part 3 (Patients)||19
8202808|NCT02190604|20228029|P17|STARTED|Part 3 (Patients)||12
8202809|NCT02190604|20228030|P16|STARTED|Part 3 (Patients)||6
8202810|NCT02190604|20228031|P15|STARTED|Part 3 (Patients)||0
8202811|NCT02190604|20228032|P14|STARTED|Part 3 (Patients)||0
8202812|NCT02190604|20228033|P13|STARTED|Part 3 (Patients)||0
8202813|NCT02190604|20228034|P12|STARTED|Part 3 (Patients)||0
8202814|NCT02190604|20228035|P11|STARTED|Part 3 (Patients)||0
8202815|NCT02190604|20228036|P10|STARTED|Part 3 (Patients)||0
8202816|NCT02190604|20228037|P9|STARTED|Part 3 (Patients)||0
8202817|NCT02190604|20228038|P8|STARTED|Part 3 (Patients)||0
8202818|NCT02190604|20228039|P7|STARTED|Part 3 (Patients)||0
8202819|NCT02190604|20228040|P6|STARTED|Part 3 (Patients)||0
8202820|NCT02190604|20228041|P5|STARTED|Part 3 (Patients)||0
8202821|NCT02190604|20228042|P4|STARTED|Part 3 (Patients)||0
8202822|NCT02190604|20228043|P3|STARTED|Part 3 (Patients)||0
8202823|NCT02190604|20228044|P2|STARTED|Part 3 (Patients)||0
8202824|NCT02190604|20228045|P1|STARTED|Part 3 (Patients)||0
8202825|NCT02190604|20228027|P19|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202826|NCT02190604|20228028|P18|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202827|NCT02190604|20228029|P17|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202828|NCT02190604|20228030|P16|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202829|NCT02190604|20228031|P15|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
8202830|NCT02190604|20228032|P14|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
8202831|NCT02190604|20228033|P13|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202832|NCT02190604|20228034|P12|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202833|NCT02190604|20228035|P11|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202834|NCT02190604|20228036|P10|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202835|NCT02190604|20228037|P9|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202836|NCT02190604|20228038|P8|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202837|NCT02190604|20228039|P7|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202838|NCT02190604|20228040|P6|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202839|NCT02190604|20228041|P5|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202840|NCT02190604|20228042|P4|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202841|NCT02190604|20228043|P3|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202842|NCT02190604|20228044|P2|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202843|NCT02190604|20228045|P1|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202844|NCT02190604|20228027|P19|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202845|NCT02190604|20228028|P18|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202846|NCT02190604|20228029|P17|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202847|NCT02190604|20228030|P16|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
8202848|NCT02190604|20228031|P15|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
8202849|NCT02190604|20228032|P14|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
8202850|NCT02190604|20228033|P13|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202851|NCT02190604|20228034|P12|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202852|NCT02190604|20228035|P11|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202853|NCT02190604|20228036|P10|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202854|NCT02190604|20228037|P9|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
8202855|NCT02190604|20228038|P8|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202856|NCT02190604|20228039|P7|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202857|NCT02190604|20228040|P6|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202858|NCT02190604|20228041|P5|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202859|NCT02190604|20228042|P4|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202860|NCT02190604|20228043|P3|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202861|NCT02190604|20228044|P2|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202862|NCT02190604|20228045|P1|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
8202863|NCT02190604|20228027|P19|STARTED|Part 1 and 2 (Healthy Volunteers)||0
8202864|NCT02190604|20228028|P18|STARTED|Part 1 and 2 (Healthy Volunteers)||0
8202865|NCT02190604|20228029|P17|STARTED|Part 1 and 2 (Healthy Volunteers)||0
8202866|NCT02190604|20228030|P16|STARTED|Part 1 and 2 (Healthy Volunteers)||0
8202867|NCT02190604|20228031|P15|STARTED|Part 1 and 2 (Healthy Volunteers)||10
8202868|NCT02190604|20228032|P14|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202869|NCT02190604|20228033|P13|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202870|NCT02190604|20228034|P12|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202871|NCT02190604|20228035|P11|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202872|NCT02190604|20228036|P10|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202873|NCT02190604|20228037|P9|STARTED|Part 1 and 2 (Healthy Volunteers)||16
8202874|NCT02190604|20228038|P8|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202875|NCT02190604|20228039|P7|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202876|NCT02190604|20228040|P6|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202877|NCT02190604|20228041|P5|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202878|NCT02190604|20228042|P4|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202879|NCT02190604|20228043|P3|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202880|NCT02190604|20228044|P2|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202881|NCT02190604|20228045|P1|STARTED|Part 1 and 2 (Healthy Volunteers)||6
8202882|NCT02190591|20228236|P2|NOT COMPLETED|Overall Study||11
8202883|NCT02190591|20228237|P1|NOT COMPLETED|Overall Study||2
8202884|NCT02190591|20228236|P2|COMPLETED|Overall Study||91
8202885|NCT02190591|20228237|P1|COMPLETED|Overall Study||100
8202886|NCT02190591|20228236|P2|STARTED|Overall Study||102
8202887|NCT02190591|20228237|P1|STARTED|Overall Study||102
8202888|NCT02190552|20228247|P1|NOT COMPLETED|Overall Study||4
8202889|NCT02190552|20228247|P1|COMPLETED|Overall Study||36
8202890|NCT02190552|20228247|P1|STARTED|Overall Study||40
8202891|NCT02190435|20228260|P2|NOT COMPLETED|Overall Study||0
8202892|NCT02190435|20228261|P1|NOT COMPLETED|Overall Study||15
8202893|NCT02190435|20228260|P2|COMPLETED|Overall Study||24
8202894|NCT02190435|20228261|P1|COMPLETED|Overall Study||26
8202895|NCT02190435|20228260|P2|STARTED|Overall Study||24
8202896|NCT02190435|20228261|P1|STARTED|Overall Study||41
8202897|NCT02190279|20228272|P3|NOT COMPLETED|Overall Study||3
8202898|NCT02190279|20228273|P2|NOT COMPLETED|Overall Study||0
8202899|NCT02190279|20228274|P1|NOT COMPLETED|Overall Study||3
8202900|NCT02190279|20228272|P3|COMPLETED|Overall Study||28
8202901|NCT02190279|20228273|P2|COMPLETED|Overall Study||69
8202902|NCT02190279|20228274|P1|COMPLETED|Overall Study||13
8202903|NCT02190279|20228272|P3|STARTED|Overall Study||31
8202904|NCT02190279|20228273|P2|STARTED|Overall Study||69
8202905|NCT02190279|20228274|P1|STARTED|Overall Study||16
8202906|NCT02190045|20228295|P2|NOT COMPLETED|Overall Study||0
8202907|NCT02190045|20228296|P1|NOT COMPLETED|Overall Study||3
8202908|NCT02190045|20228295|P2|COMPLETED|Overall Study||15
8202909|NCT02190045|20228296|P1|COMPLETED|Overall Study||12
8202910|NCT02190045|20228295|P2|STARTED|Overall Study||15
8202911|NCT02190045|20228296|P1|STARTED|Overall Study||15
8202912|NCT02189954|20228304|P2|NOT COMPLETED|Overall Study||0
8202913|NCT02189954|20228305|P1|NOT COMPLETED|Overall Study||0
8202914|NCT02189954|20228304|P2|COMPLETED|Overall Study||45
8202915|NCT02189954|20228305|P1|COMPLETED|Overall Study||45
8202916|NCT02189954|20228304|P2|STARTED|Overall Study||45
8202917|NCT02189954|20228305|P1|STARTED|Overall Study||45
8202918|NCT02189941|20228313|P3|NOT COMPLETED|Overall Study||1
8202919|NCT02189941|20228314|P2|NOT COMPLETED|Overall Study||0
8202920|NCT02189941|20228315|P1|NOT COMPLETED|Overall Study||0
8202921|NCT02189941|20228313|P3|COMPLETED|Overall Study||2
8202922|NCT02189941|20228314|P2|COMPLETED|Overall Study||4
8202923|NCT02189941|20228315|P1|COMPLETED|Overall Study||4
8202924|NCT02189941|20228313|P3|STARTED|Overall Study||3
8202925|NCT02189941|20228314|P2|STARTED|Overall Study||4
8202926|NCT02189941|20228315|P1|STARTED|Overall Study||4
8202927|NCT02189915|20228338|P1|NOT COMPLETED|Overall Study||3
8202928|NCT02189915|20228338|P1|COMPLETED|Overall Study||11
8202929|NCT02189915|20228338|P1|STARTED|Overall Study||14
8202930|NCT02189889|20228345|P2|NOT COMPLETED|Overall Study||0
8202931|NCT02189889|20228346|P1|NOT COMPLETED|Overall Study||0
8202932|NCT02189889|20228345|P2|COMPLETED|Overall Study||3
8202933|NCT02189889|20228346|P1|COMPLETED|Overall Study||2
8202934|NCT02189889|20228345|P2|STARTED|Overall Study||3
8202935|NCT02189889|20228346|P1|STARTED|Overall Study||2
8202936|NCT02189863|20228360|P2|NOT COMPLETED|Second 2 Weeks||0
8202937|NCT02189863|20228361|P1|NOT COMPLETED|Second 2 Weeks||0
8202938|NCT02189863|20228360|P2|COMPLETED|Second 2 Weeks||13
8202939|NCT02189863|20228361|P1|COMPLETED|Second 2 Weeks||8
8202940|NCT02189863|20228360|P2|STARTED|Second 2 Weeks||13
8202941|NCT02189863|20228361|P1|STARTED|Second 2 Weeks||8
8202942|NCT02189863|20228360|P2|NOT COMPLETED|First 2 Weeks||2
8202943|NCT02189863|20228361|P1|NOT COMPLETED|First 2 Weeks||4
8202944|NCT02189863|20228360|P2|COMPLETED|First 2 Weeks||13
8202945|NCT02189863|20228361|P1|COMPLETED|First 2 Weeks||8
8202946|NCT02189863|20228360|P2|STARTED|First 2 Weeks||15
8202947|NCT02189863|20228361|P1|STARTED|First 2 Weeks||12
8202948|NCT02189837|20228376|P4|NOT COMPLETED|Overall Study||2
8202949|NCT02189837|20228377|P3|NOT COMPLETED|Overall Study||3
8202950|NCT02189837|20228378|P2|NOT COMPLETED|Overall Study||1
8202951|NCT02189837|20228379|P1|NOT COMPLETED|Overall Study||2
8202952|NCT02189837|20228376|P4|COMPLETED|Overall Study||19
8202953|NCT02189837|20228377|P3|COMPLETED|Overall Study||20
8202954|NCT02189837|20228378|P2|COMPLETED|Overall Study||22
8202955|NCT02189837|20228379|P1|COMPLETED|Overall Study||20
8202956|NCT02189837|20228376|P4|Received Treatment|Overall Study||20
8202957|NCT02189837|20228377|P3|Received Treatment|Overall Study||22
8202958|NCT02189837|20228378|P2|Received Treatment|Overall Study||22
8202959|NCT02189837|20228379|P1|Received Treatment|Overall Study||21
8202960|NCT02189837|20228376|P4|STARTED|Overall Study||21
8202961|NCT02189837|20228377|P3|STARTED|Overall Study||23
8202962|NCT02189837|20228378|P2|STARTED|Overall Study||23
8202963|NCT02189837|20228379|P1|STARTED|Overall Study||22
8202964|NCT02189759|20228409|P4|NOT COMPLETED|Overall Study||5
8202965|NCT02189759|20228410|P3|NOT COMPLETED|Overall Study||2
8202966|NCT02189759|20228411|P2|NOT COMPLETED|Overall Study||0
8202967|NCT02189759|20228412|P1|NOT COMPLETED|Overall Study||0
8202968|NCT02189759|20228409|P4|COMPLETED|Overall Study||84
8202969|NCT02189759|20228410|P3|COMPLETED|Overall Study||81
8202970|NCT02189759|20228411|P2|COMPLETED|Overall Study||101
8202971|NCT02189759|20228412|P1|COMPLETED|Overall Study||102
8202972|NCT02189759|20228409|P4|STARTED|Overall Study||89
8202973|NCT02189759|20228410|P3|STARTED|Overall Study||83
8202974|NCT02189759|20228411|P2|STARTED|Overall Study||101
8202975|NCT02189759|20228412|P1|STARTED|Overall Study||102
8202976|NCT02189668|20228432|P2|NOT COMPLETED|Overall Study||0
8202977|NCT02189668|20228433|P1|NOT COMPLETED|Overall Study||0
8202978|NCT02189668|20228432|P2|COMPLETED|Overall Study||9
8202979|NCT02189668|20228433|P1|COMPLETED|Overall Study||5
8202980|NCT02189668|20228432|P2|STARTED|Overall Study||9
8202981|NCT02189668|20228433|P1|STARTED|Overall Study||5
8202982|NCT02189629|20228441|P1|NOT COMPLETED|Overall Study||105
8202983|NCT02189629|20228441|P1|COMPLETED|Overall Study||348
8202984|NCT02189629|20228441|P1|STARTED|Overall Study||453
8202985|NCT02189473|20228448|P2|NOT COMPLETED|Overall Study||25
8202986|NCT02189473|20228449|P1|NOT COMPLETED|Overall Study||23
8202987|NCT02189473|20228448|P2|COMPLETED|Overall Study||77
8202988|NCT02189473|20228449|P1|COMPLETED|Overall Study||78
8202989|NCT02189473|20228448|P2|STARTED|Overall Study||102
8202990|NCT02189473|20228449|P1|STARTED|Overall Study||101
8202991|NCT02189382|20228471|P2|NOT COMPLETED|Overall Study||0
8202992|NCT02189382|20228472|P1|NOT COMPLETED|Overall Study||0
8202993|NCT02189382|20228471|P2|COMPLETED|Overall Study||35
8202994|NCT02189382|20228472|P1|COMPLETED|Overall Study||35
8202995|NCT02189382|20228471|P2|STARTED|Overall Study||35
8202996|NCT02189382|20228472|P1|STARTED|Overall Study||35
8202997|NCT02189317|20228482|P2|NOT COMPLETED|Overall Study||0
8202998|NCT02189317|20228483|P1|NOT COMPLETED|Overall Study||0
8202999|NCT02189317|20228482|P2|COMPLETED|Overall Study||16
8203000|NCT02189317|20228483|P1|COMPLETED|Overall Study||16
8203001|NCT02189317|20228482|P2|STARTED|Overall Study||16
8203002|NCT02189317|20228483|P1|STARTED|Overall Study||16
8203003|NCT02189252|20228497|P4|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8203004|NCT02189252|20228498|P3|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8203005|NCT02189252|20228499|P2|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8203006|NCT02189252|20228500|P1|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
8203007|NCT02189252|20228497|P4|COMPLETED|Period 2 (Visit6b, Week 12)||4
8203008|NCT02189252|20228498|P3|COMPLETED|Period 2 (Visit6b, Week 12)||3
8203009|NCT02189252|20228499|P2|COMPLETED|Period 2 (Visit6b, Week 12)||2
8203010|NCT02189252|20228500|P1|COMPLETED|Period 2 (Visit6b, Week 12)||4
8203011|NCT02189252|20228497|P4|STARTED|Period 2 (Visit6b, Week 12)||4
8203012|NCT02189252|20228498|P3|STARTED|Period 2 (Visit6b, Week 12)||3
8203013|NCT02189252|20228499|P2|STARTED|Period 2 (Visit6b, Week 12)||2
8203014|NCT02189252|20228500|P1|STARTED|Period 2 (Visit6b, Week 12)||4
8203015|NCT02189252|20228497|P4|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
8203016|NCT02189252|20228498|P3|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
8203017|NCT02189252|20228499|P2|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
8203018|NCT02189252|20228500|P1|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
8203019|NCT02189252|20228497|P4|COMPLETED|Period 1 (Visit 4b, Week 4)||4
8203020|NCT02189252|20228498|P3|COMPLETED|Period 1 (Visit 4b, Week 4)||3
8203021|NCT02189252|20228499|P2|COMPLETED|Period 1 (Visit 4b, Week 4)||2
8203022|NCT02189252|20228500|P1|COMPLETED|Period 1 (Visit 4b, Week 4)||4
8203023|NCT02189252|20228497|P4|STARTED|Period 1 (Visit 4b, Week 4)||4
8203024|NCT02189252|20228498|P3|STARTED|Period 1 (Visit 4b, Week 4)||3
8203025|NCT02189252|20228499|P2|STARTED|Period 1 (Visit 4b, Week 4)||4
8203026|NCT02189252|20228500|P1|STARTED|Period 1 (Visit 4b, Week 4)||4
8203027|NCT02189161|20228532|P1|NOT COMPLETED|Overall Study||0
8203028|NCT02189161|20228532|P1|COMPLETED|Overall Study||10
8203029|NCT02189161|20228532|P1|STARTED|Overall Study||10
8203030|NCT02189122|20228540|P2|NOT COMPLETED|Overall Study||0
8203031|NCT02189122|20228541|P1|NOT COMPLETED|Overall Study||0
8203032|NCT02189122|20228540|P2|COMPLETED|Overall Study||18
8203033|NCT02189122|20228541|P1|COMPLETED|Overall Study||18
8203034|NCT02189122|20228540|P2|STARTED|Overall Study||18
8203035|NCT02189122|20228541|P1|STARTED|Overall Study||18
8203036|NCT02188849|20228559|P2|NOT COMPLETED|Overall Study||8
8203037|NCT02188849|20228560|P1|NOT COMPLETED|Overall Study||3
8203038|NCT02188849|20228559|P2|COMPLETED|Overall Study||17
8203039|NCT02188849|20228560|P1|COMPLETED|Overall Study||22
8203040|NCT02188849|20228559|P2|STARTED|Overall Study||25
8203041|NCT02188849|20228560|P1|STARTED|Overall Study||25
8203042|NCT02188784|20228574|P2|NOT COMPLETED|Overall Study||13
8203043|NCT02188784|20228575|P1|NOT COMPLETED|Overall Study||9
8203044|NCT02188784|20228574|P2|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
8203045|NCT02188784|20228575|P1|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
8203046|NCT02188784|20228574|P2|STARTED|Overall Study||114
8203047|NCT02188784|20228575|P1|STARTED|Overall Study||111
8203048|NCT02188719|20228595|P4|NOT COMPLETED|Overall Study||0
8203049|NCT02188719|20228596|P3|NOT COMPLETED|Overall Study||0
8203050|NCT02188719|20228597|P2|NOT COMPLETED|Overall Study||1
8203051|NCT02188719|20228598|P1|NOT COMPLETED|Overall Study||0
8203052|NCT02188719|20228595|P4|COMPLETED|Overall Study||0
8203053|NCT02188719|20228596|P3|COMPLETED|Overall Study||0
8203054|NCT02188719|20228597|P2|COMPLETED|Overall Study||8
8203055|NCT02188719|20228598|P1|COMPLETED|Overall Study||6
8203056|NCT02188719|20228595|P4|STARTED|Overall Study||0
8203057|NCT02188719|20228596|P3|STARTED|Overall Study||0
8203058|NCT02188719|20228597|P2|STARTED|Overall Study||9
8203059|NCT02188719|20228598|P1|STARTED|Overall Study||6
8203060|NCT02188589|20228622|P1|NOT COMPLETED|Overall Study||5
8203061|NCT02188589|20228622|P1|COMPLETED|Overall Study||25
8203062|NCT02188589|20228622|P1|24 Months|Overall Study||25
8203063|NCT02188589|20228622|P1|12 Months|Overall Study||30
8203064|NCT02188589|20228622|P1|6 Months|Overall Study||30
8203065|NCT02188589|20228622|P1|STARTED|Overall Study||30
8203066|NCT02188576|20228630|P2|NOT COMPLETED|Overall Study||0
8203067|NCT02188576|20228631|P1|NOT COMPLETED|Overall Study||0
8203068|NCT02188576|20228630|P2|COMPLETED|Overall Study||34
8203069|NCT02188576|20228631|P1|COMPLETED|Overall Study||32
8203070|NCT02188576|20228630|P2|STARTED|Overall Study||34
8203071|NCT02188576|20228631|P1|STARTED|Overall Study||32
8203072|NCT02188160|20228641|P2|NOT COMPLETED|Overall Study||1
8203073|NCT02188160|20228642|P1|NOT COMPLETED|Overall Study||1
8203074|NCT02188160|20228641|P2|COMPLETED|Overall Study||76
8203075|NCT02188160|20228642|P1|COMPLETED|Overall Study||72
8203076|NCT02188160|20228641|P2|STARTED|Overall Study||77
8203077|NCT02188160|20228642|P1|STARTED|Overall Study||73
8203078|NCT02187887|20228658|P2|NOT COMPLETED|Overall Study||4
8203079|NCT02187887|20228659|P1|NOT COMPLETED|Overall Study||5
8203080|NCT02187887|20228658|P2|COMPLETED|Overall Study||396
8203081|NCT02187887|20228659|P1|COMPLETED|Overall Study||388
8203082|NCT02187887|20228658|P2|STARTED|Overall Study||400
8203083|NCT02187887|20228659|P1|STARTED|Overall Study||393
8203084|NCT02187861|20228671|P4|NOT COMPLETED|Overall Study||32
8203085|NCT02187861|20228672|P3|NOT COMPLETED|Overall Study||32
8203086|NCT02187861|20228673|P2|NOT COMPLETED|Overall Study||48
8203087|NCT02187861|20228674|P1|NOT COMPLETED|Overall Study||6
8203088|NCT02187861|20228671|P4|COMPLETED|Overall Study||19
8203089|NCT02187861|20228672|P3|COMPLETED|Overall Study||19
8203090|NCT02187861|20228673|P2|COMPLETED|Overall Study||4
8203091|NCT02187861|20228674|P1|COMPLETED|Overall Study||3
8203092|NCT02187861|20228671|P4|Treated|Overall Study||50
8203093|NCT02187861|20228672|P3|Treated|Overall Study||49
8203094|NCT02187861|20228673|P2|Treated|Overall Study||52
8203095|NCT02187861|20228674|P1|Treated|Overall Study||9
8203096|NCT02187861|20228671|P4|STARTED|Overall Study||51
8203097|NCT02187861|20228672|P3|STARTED|Overall Study||51
8203098|NCT02187861|20228673|P2|STARTED|Overall Study||52
8203099|NCT02187861|20228674|P1|STARTED|Overall Study||9
8203100|NCT02187809|20228770|P1|NOT COMPLETED|Overall Study||3
8203101|NCT02187809|20228770|P1|COMPLETED|Overall Study||0
8203102|NCT02187809|20228770|P1|Treated|Overall Study||1
8203103|NCT02187809|20228770|P1|STARTED|Overall Study||3
8203104|NCT02187783|20228780|P1|NOT COMPLETED|Overall Study||106
8203105|NCT02187783|20228780|P1|COMPLETED|Overall Study||0
8203106|NCT02187783|20228780|P1|Patients With Solid Tumors|Overall Study||105
8203107|NCT02187783|20228780|P1|STARTED|Overall Study||106
8203108|NCT02187744|20228791|P2|NOT COMPLETED|Treatment||5
8203109|NCT02187744|20228792|P1|NOT COMPLETED|Treatment||4
8203110|NCT02187744|20228791|P2|COMPLETED|Treatment||107
8203111|NCT02187744|20228792|P1|COMPLETED|Treatment||109
8203112|NCT02187744|20228791|P2|STARTED|Treatment||112
8203113|NCT02187744|20228792|P1|STARTED|Treatment||113
8203114|NCT02187744|20228791|P2|NOT COMPLETED|Study||6
8203115|NCT02187744|20228792|P1|NOT COMPLETED|Study||4
8203116|NCT02187744|20228791|P2|COMPLETED|Study||106
8203117|NCT02187744|20228792|P1|COMPLETED|Study||109
8203118|NCT02187744|20228791|P2|STARTED|Study|Received treatment|112
8203119|NCT02187744|20228792|P1|STARTED|Study|Received treatment|113
8203120|NCT02187471|20228812|P4|NOT COMPLETED|Overall Study||80
8203121|NCT02187471|20228813|P3|NOT COMPLETED|Overall Study||86
8203122|NCT02187471|20228814|P2|NOT COMPLETED|Overall Study||82
8203123|NCT02187471|20228815|P1|NOT COMPLETED|Overall Study||76
8203124|NCT02187471|20228812|P4|COMPLETED|Overall Study||246
8203125|NCT02187471|20228813|P3|COMPLETED|Overall Study||240
8203126|NCT02187471|20228814|P2|COMPLETED|Overall Study||242
8203127|NCT02187471|20228815|P1|COMPLETED|Overall Study||249
8203128|NCT02187471|20228812|P4|STARTED|Overall Study||326
8203129|NCT02187471|20228813|P3|STARTED|Overall Study||326
8203130|NCT02187471|20228814|P2|STARTED|Overall Study||324
8203131|NCT02187471|20228815|P1|STARTED|Overall Study||325
8203132|NCT02187172|20228871|P2|NOT COMPLETED|Overall Study||6
8203133|NCT02187172|20228872|P1|NOT COMPLETED|Overall Study||3
8203134|NCT02187172|20228871|P2|COMPLETED|Overall Study||15
8203135|NCT02187172|20228872|P1|COMPLETED|Overall Study||19
8203136|NCT02187172|20228871|P2|RCT Phase Completed|Overall Study||19
8203137|NCT02187172|20228872|P1|RCT Phase Completed|Overall Study||22
8203138|NCT02187172|20228871|P2|STARTED|Overall Study||21
8203139|NCT02187172|20228872|P1|STARTED|Overall Study||22
8203140|NCT02187159|20229040|P4|NOT COMPLETED|Overall Study||96
8203141|NCT02187159|20229041|P3|NOT COMPLETED|Overall Study||77
8203142|NCT02187159|20229042|P2|NOT COMPLETED|Overall Study||79
8203143|NCT02187159|20229043|P1|NOT COMPLETED|Overall Study||69
8203144|NCT02187159|20229040|P4|COMPLETED|Overall Study||221
8203145|NCT02187159|20229041|P3|COMPLETED|Overall Study||241
8203146|NCT02187159|20229042|P2|COMPLETED|Overall Study||238
8203147|NCT02187159|20229043|P1|COMPLETED|Overall Study||249
8203148|NCT02187159|20229040|P4|STARTED|Overall Study||317
8203149|NCT02187159|20229041|P3|STARTED|Overall Study||318
8203150|NCT02187159|20229042|P2|STARTED|Overall Study||317
8203151|NCT02187159|20229043|P1|STARTED|Overall Study||318
8203152|NCT02187055|20229100|P3|NOT COMPLETED|Overall Study||74
8203153|NCT02187055|20229101|P2|NOT COMPLETED|Overall Study||73
8203154|NCT02187055|20229102|P1|NOT COMPLETED|Overall Study||69
8203155|NCT02187055|20229100|P3|COMPLETED|Overall Study||312
8203156|NCT02187055|20229101|P2|COMPLETED|Overall Study||303
8203157|NCT02187055|20229102|P1|COMPLETED|Overall Study||315
8203158|NCT02187055|20229100|P3|STARTED|Overall Study|Treated|386
8203159|NCT02187055|20229101|P2|STARTED|Overall Study|Treated|376
8203160|NCT02187055|20229102|P1|STARTED|Overall Study|Treated|384
8203161|NCT02187042|20229202|P2|NOT COMPLETED|Overall Study||14
8203162|NCT02187042|20229203|P1|NOT COMPLETED|Overall Study||13
8203163|NCT02187042|20229202|P2|COMPLETED|Overall Study||13
8203164|NCT02187042|20229203|P1|COMPLETED|Overall Study||29
8203165|NCT02187042|20229202|P2|STARTED|Overall Study||27
8203166|NCT02187042|20229203|P1|STARTED|Overall Study||42
8203167|NCT02187029|20229249|P4|NOT COMPLETED|Overall Study||3
8203168|NCT02187029|20229250|P3|NOT COMPLETED|Overall Study||11
8203169|NCT02187029|20229251|P2|NOT COMPLETED|Overall Study||1
8203170|NCT02187029|20229252|P1|NOT COMPLETED|Overall Study||1
8203171|NCT02187029|20229249|P4|COMPLETED|Overall Study||6
8203172|NCT02187029|20229250|P3|COMPLETED|Overall Study||0
8203173|NCT02187029|20229251|P2|COMPLETED|Overall Study||2
8203174|NCT02187029|20229252|P1|COMPLETED|Overall Study||6
8203175|NCT02187029|20229249|P4|STARTED|Overall Study||9
8203176|NCT02187029|20229250|P3|STARTED|Overall Study||11
8203177|NCT02187029|20229251|P2|STARTED|Overall Study||3
8203178|NCT02187029|20229252|P1|STARTED|Overall Study||7
8203179|NCT02187016|20229328|P4|NOT COMPLETED|Overall Study||0
8203180|NCT02187016|20229329|P3|NOT COMPLETED|Overall Study||1
8203181|NCT02187016|20229330|P2|NOT COMPLETED|Overall Study||2
8203182|NCT02187016|20229331|P1|NOT COMPLETED|Overall Study||1
8203183|NCT02187016|20229328|P4|COMPLETED|Overall Study||51
8203184|NCT02187016|20229329|P3|COMPLETED|Overall Study||78
8203185|NCT02187016|20229330|P2|COMPLETED|Overall Study||78
8203186|NCT02187016|20229331|P1|COMPLETED|Overall Study||79
8203187|NCT02187016|20229328|P4|STARTED|Overall Study||51
8203188|NCT02187016|20229329|P3|STARTED|Overall Study||79
8203189|NCT02187016|20229330|P2|STARTED|Overall Study||80
8203190|NCT02187016|20229331|P1|STARTED|Overall Study||80
8203191|NCT02186938|20229363|P2|NOT COMPLETED|Overall Study||3
8203192|NCT02186938|20229364|P1|NOT COMPLETED|Overall Study||9
8203193|NCT02186938|20229363|P2|COMPLETED|Overall Study||44
8203194|NCT02186938|20229364|P1|COMPLETED|Overall Study||38
8203195|NCT02186938|20229363|P2|STARTED|Overall Study||47
8203196|NCT02186938|20229364|P1|STARTED|Overall Study|2012|47
8203197|NCT02186873|20229374|P2|NOT COMPLETED|Overall Study||8
8203198|NCT02186873|20229375|P1|NOT COMPLETED|Overall Study||9
8203199|NCT02186873|20229374|P2|COMPLETED|Overall Study||97
8203200|NCT02186873|20229375|P1|COMPLETED|Overall Study||94
8203201|NCT02186873|20229374|P2|End of Control Period|Overall Study|Participants continued to receive golimumab|105
8203202|NCT02186873|20229375|P1|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
8203203|NCT02186873|20229374|P2|STARTED|Overall Study||105
8203204|NCT02186873|20229375|P1|STARTED|Overall Study||103
8203205|NCT02186847|20229400|P2|NOT COMPLETED|Overall Study||0
8203206|NCT02186847|20229401|P1|NOT COMPLETED|Overall Study||3
8203207|NCT02186847|20229400|P2|COMPLETED|Overall Study||86
8203208|NCT02186847|20229401|P1|COMPLETED|Overall Study||81
8203209|NCT02186847|20229400|P2|Eligible and Started Protocol Treatment|Overall Study||82
8203210|NCT02186847|20229401|P1|Eligible and Started Protocol Treatment|Overall Study||76
8203211|NCT02186847|20229400|P2|Eligible Population|Overall Study||86
8203212|NCT02186847|20229401|P1|Eligible Population|Overall Study||81
8203213|NCT02186847|20229400|P2|STARTED|Overall Study||86
8203214|NCT02186847|20229401|P1|STARTED|Overall Study||84
8203251|NCT02186808|20229431|P1|NOT COMPLETED|Overall Study||13
8203252|NCT02186808|20229431|P1|COMPLETED|Overall Study||67
8203253|NCT02186808|20229431|P1|STARTED|Overall Study||80
8203254|NCT02186795|20229438|P2|NOT COMPLETED|Overall Study||0
8203255|NCT02186795|20229439|P1|NOT COMPLETED|Overall Study||0
8203256|NCT02186795|20229438|P2|COMPLETED|Overall Study||24
8203257|NCT02186795|20229439|P1|COMPLETED|Overall Study||24
8203258|NCT02186795|20229438|P2|STARTED|Overall Study||24
8203259|NCT02186795|20229439|P1|STARTED|Overall Study||24
8203266|NCT02186652|20229456|P2|NOT COMPLETED|Overall Study||0
8203267|NCT02186652|20229457|P1|NOT COMPLETED|Overall Study||2
8203268|NCT02186652|20229456|P2|COMPLETED|Overall Study||22
8203269|NCT02186652|20229457|P1|COMPLETED|Overall Study||17
8203270|NCT02186652|20229456|P2|STARTED|Overall Study||22
8203271|NCT02186652|20229457|P1|STARTED|Overall Study||19
8203272|NCT02186587|20229484|P2|NOT COMPLETED|Overall Study||0
8203273|NCT02186587|20229485|P1|NOT COMPLETED|Overall Study||5
8203274|NCT02186587|20229484|P2|COMPLETED|Overall Study||0
8203275|NCT02186587|20229485|P1|COMPLETED|Overall Study||23
8203276|NCT02186587|20229484|P2|STARTED|Overall Study||0
8203277|NCT02186587|20229485|P1|STARTED|Overall Study||28
8203278|NCT02186561|20229490|P1|NOT COMPLETED|3 - Year Post Index Procedure Visit||13
8203279|NCT02186561|20229490|P1|COMPLETED|3 - Year Post Index Procedure Visit||128
8203280|NCT02186561|20229490|P1|STARTED|3 - Year Post Index Procedure Visit||141
8203281|NCT02186561|20229490|P1|NOT COMPLETED|2 - Year Post Index Procedure Visit||7
8203282|NCT02186561|20229490|P1|COMPLETED|2 - Year Post Index Procedure Visit||134
8203283|NCT02186561|20229490|P1|STARTED|2 - Year Post Index Procedure Visit||141
8203284|NCT02186561|20229490|P1|NOT COMPLETED|1- Year Post Index Procedure Visit||2
8203285|NCT02186561|20229490|P1|COMPLETED|1- Year Post Index Procedure Visit||139
8203286|NCT02186561|20229490|P1|STARTED|1- Year Post Index Procedure Visit||141
8203287|NCT02186561|20229490|P1|NOT COMPLETED|180- Day Post Index Procedure Visit||7
8203288|NCT02186561|20229490|P1|COMPLETED|180- Day Post Index Procedure Visit||134
8203289|NCT02186561|20229490|P1|STARTED|180- Day Post Index Procedure Visit||141
8203290|NCT02186561|20229490|P1|NOT COMPLETED|30-Day Post Index Procedure Visit||1
8203291|NCT02186561|20229490|P1|COMPLETED|30-Day Post Index Procedure Visit||140
8203292|NCT02186561|20229490|P1|STARTED|30-Day Post Index Procedure Visit||141
8203293|NCT02186561|20229490|P1|NOT COMPLETED|Subjects Implanted With Device||0
8203294|NCT02186561|20229490|P1|COMPLETED|Subjects Implanted With Device||141
8203295|NCT02186561|20229490|P1|STARTED|Subjects Implanted With Device||141
8203296|NCT02186561|20229490|P1|NOT COMPLETED|Enrollment||56
8203297|NCT02186561|20229490|P1|COMPLETED|Enrollment||141
8203298|NCT02186561|20229490|P1|STARTED|Enrollment||197
8203299|NCT02186509|20229500|P1|NOT COMPLETED|Overall Study||0
8203300|NCT02186509|20229500|P1|COMPLETED|Overall Study||17
8203301|NCT02186509|20229500|P1|STARTED|Overall Study||17
8203302|NCT02186301|20229510|P3|NOT COMPLETED|Overall Study||50
8203303|NCT02186301|20229511|P2|NOT COMPLETED|Overall Study||30
8203304|NCT02186301|20229512|P1|NOT COMPLETED|Overall Study||20
8203305|NCT02186301|20229510|P3|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8203306|NCT02186301|20229511|P2|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8203307|NCT02186301|20229512|P1|COMPLETED|Overall Study|Patients who are off study for any reason.|0
8203308|NCT02186301|20229510|P3|STARTED|Overall Study||50
8203309|NCT02186301|20229511|P2|STARTED|Overall Study||30
8203310|NCT02186301|20229512|P1|STARTED|Overall Study||20
8203311|NCT02186223|20229528|P1|NOT COMPLETED|Overall Study||21
8203312|NCT02186223|20229528|P1|COMPLETED|Overall Study||151
8203313|NCT02186223|20229528|P1|Device Placed|Overall Study||163
8203314|NCT02186223|20229528|P1|STARTED|Overall Study||172
8203315|NCT02186210|20229539|P2|NOT COMPLETED|Overall Study||0
8203316|NCT02186210|20229540|P1|NOT COMPLETED|Overall Study||0
8203317|NCT02186210|20229539|P2|COMPLETED|Overall Study||20
8203318|NCT02186210|20229540|P1|COMPLETED|Overall Study||20
8203319|NCT02186210|20229539|P2|STARTED|Overall Study||20
8203320|NCT02186210|20229540|P1|STARTED|Overall Study||20
8203321|NCT02186171|20229550|P2|NOT COMPLETED|Overall Study||15
8203322|NCT02186171|20229551|P1|NOT COMPLETED|Overall Study||4
8203323|NCT02186171|20229550|P2|COMPLETED|Overall Study||148
8203324|NCT02186171|20229551|P1|COMPLETED|Overall Study||78
8203325|NCT02186171|20229550|P2|Received Treatment|Overall Study||163
8203326|NCT02186171|20229551|P1|Received Treatment|Overall Study||81
8203327|NCT02186171|20229550|P2|STARTED|Overall Study||163
8203328|NCT02186171|20229551|P1|STARTED|Overall Study||82
8203329|NCT02185794|20229573|P6|NOT COMPLETED|Overall Study||16
8203330|NCT02185794|20229574|P5|NOT COMPLETED|Overall Study||3
8203331|NCT02185794|20229575|P4|NOT COMPLETED|Overall Study||8
8203332|NCT02185794|20229576|P3|NOT COMPLETED|Overall Study||16
8203333|NCT02185794|20229577|P2|NOT COMPLETED|Overall Study||13
8203334|NCT02185794|20229578|P1|NOT COMPLETED|Overall Study||5
8203335|NCT02185794|20229573|P6|COMPLETED|Overall Study||0
8203336|NCT02185794|20229574|P5|COMPLETED|Overall Study||4
8203337|NCT02185794|20229575|P4|COMPLETED|Overall Study||8
8203338|NCT02185794|20229576|P3|COMPLETED|Overall Study||17
8203339|NCT02185794|20229577|P2|COMPLETED|Overall Study||7
8203340|NCT02185794|20229578|P1|COMPLETED|Overall Study||4
8203341|NCT02185794|20229573|P6|STARTED|Overall Study||16
8203342|NCT02185794|20229574|P5|STARTED|Overall Study||7
8203343|NCT02185794|20229575|P4|STARTED|Overall Study||16
8203344|NCT02185794|20229576|P3|STARTED|Overall Study||33
8203345|NCT02185794|20229577|P2|STARTED|Overall Study||20
8203346|NCT02185794|20229578|P1|STARTED|Overall Study||9
8203347|NCT02185729|20229650|P1|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
8203348|NCT02185729|20229650|P1|COMPLETED|24 Hours Into Dextrose Infusion||12
8203349|NCT02185729|20229650|P1|STARTED|24 Hours Into Dextrose Infusion||12
8203350|NCT02185729|20229650|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
8203351|NCT02185729|20229650|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
8203352|NCT02185729|20229650|P1|STARTED|4 Hours Into Dextrose Infusion||12
8203353|NCT02185729|20229650|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
8203354|NCT02185729|20229650|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
8203355|NCT02185729|20229650|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
8203356|NCT02185729|20229650|P1|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
8203357|NCT02185729|20229650|P1|COMPLETED|24 Hours Into ClinOleic Infusion||12
8203358|NCT02185729|20229650|P1|STARTED|24 Hours Into ClinOleic Infusion||12
8203359|NCT02185729|20229650|P1|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
8203360|NCT02185729|20229650|P1|COMPLETED|4 Hours Into ClinOleic Infusion||12
8203361|NCT02185729|20229650|P1|STARTED|4 Hours Into ClinOleic Infusion||12
8203362|NCT02185729|20229650|P1|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
8203363|NCT02185729|20229650|P1|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
8203364|NCT02185729|20229650|P1|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
8203365|NCT02185729|20229650|P1|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
8203366|NCT02185729|20229650|P1|COMPLETED|24 Hours Into Intralipid Infusion||12
8203367|NCT02185729|20229650|P1|STARTED|24 Hours Into Intralipid Infusion||12
8203368|NCT02185729|20229650|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
8203369|NCT02185729|20229650|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
8203370|NCT02185729|20229650|P1|STARTED|4 Hours Into Intralipid Infusion||12
8203371|NCT02185729|20229650|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
8203372|NCT02185729|20229650|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
8203373|NCT02185729|20229650|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
8203374|NCT02185729|20229650|P1|NOT COMPLETED|24 Hours Into Saline Infusion||0
8203375|NCT02185729|20229650|P1|COMPLETED|24 Hours Into Saline Infusion||12
8203376|NCT02185729|20229650|P1|STARTED|24 Hours Into Saline Infusion||12
8203377|NCT02185729|20229650|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
8203378|NCT02185729|20229650|P1|COMPLETED|4 Hours Into Saline Infusion||12
8203379|NCT02185729|20229650|P1|STARTED|4 Hours Into Saline Infusion||12
8203380|NCT02185729|20229650|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
8203381|NCT02185729|20229650|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
8203382|NCT02185729|20229650|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
8203383|NCT02185534|20229671|P6|NOT COMPLETED|Third Period||0
8203384|NCT02185534|20229672|P5|NOT COMPLETED|Third Period||0
8203385|NCT02185534|20229673|P4|NOT COMPLETED|Third Period||0
8203386|NCT02185534|20229674|P3|NOT COMPLETED|Third Period||0
8203387|NCT02185534|20229675|P2|NOT COMPLETED|Third Period||0
8203388|NCT02185534|20229676|P1|NOT COMPLETED|Third Period||0
8203389|NCT02185534|20229671|P6|COMPLETED|Third Period||13
8203390|NCT02185534|20229672|P5|COMPLETED|Third Period||13
8203391|NCT02185534|20229673|P4|COMPLETED|Third Period||13
8203392|NCT02185534|20229674|P3|COMPLETED|Third Period||14
8203393|NCT02185534|20229675|P2|COMPLETED|Third Period||14
8203394|NCT02185534|20229676|P1|COMPLETED|Third Period||13
8203395|NCT02185534|20229671|P6|STARTED|Third Period||13
8203396|NCT02185534|20229672|P5|STARTED|Third Period||13
8203397|NCT02185534|20229673|P4|STARTED|Third Period||13
8203398|NCT02185534|20229674|P3|STARTED|Third Period||14
8203399|NCT02185534|20229675|P2|STARTED|Third Period||14
8203400|NCT02185534|20229676|P1|STARTED|Third Period||13
8203401|NCT02185534|20229671|P6|NOT COMPLETED|Second Washout Period||0
8203402|NCT02185534|20229672|P5|NOT COMPLETED|Second Washout Period||0
8203403|NCT02185534|20229673|P4|NOT COMPLETED|Second Washout Period||0
8203404|NCT02185534|20229674|P3|NOT COMPLETED|Second Washout Period||0
8203405|NCT02185534|20229675|P2|NOT COMPLETED|Second Washout Period||0
8203406|NCT02185534|20229676|P1|NOT COMPLETED|Second Washout Period||0
8203407|NCT02185534|20229671|P6|COMPLETED|Second Washout Period||13
8203408|NCT02185534|20229672|P5|COMPLETED|Second Washout Period||13
8203409|NCT02185534|20229673|P4|COMPLETED|Second Washout Period||13
8203410|NCT02185534|20229674|P3|COMPLETED|Second Washout Period||14
8203411|NCT02185534|20229675|P2|COMPLETED|Second Washout Period||14
8203412|NCT02185534|20229676|P1|COMPLETED|Second Washout Period||13
8203413|NCT02185534|20229671|P6|STARTED|Second Washout Period||13
8203414|NCT02185534|20229672|P5|STARTED|Second Washout Period||13
8203415|NCT02185534|20229673|P4|STARTED|Second Washout Period||13
8203416|NCT02185534|20229674|P3|STARTED|Second Washout Period||14
8203417|NCT02185534|20229675|P2|STARTED|Second Washout Period||14
8203418|NCT02185534|20229676|P1|STARTED|Second Washout Period||13
8203419|NCT02185534|20229671|P6|NOT COMPLETED|Second Period||0
8203420|NCT02185534|20229672|P5|NOT COMPLETED|Second Period||0
8203421|NCT02185534|20229673|P4|NOT COMPLETED|Second Period||0
8203422|NCT02185534|20229674|P3|NOT COMPLETED|Second Period||0
8203423|NCT02185534|20229675|P2|NOT COMPLETED|Second Period||0
8203424|NCT02185534|20229676|P1|NOT COMPLETED|Second Period||0
8203425|NCT02185534|20229671|P6|COMPLETED|Second Period||13
8203426|NCT02185534|20229672|P5|COMPLETED|Second Period||13
8203427|NCT02185534|20229673|P4|COMPLETED|Second Period||13
8203428|NCT02185534|20229674|P3|COMPLETED|Second Period||14
8203429|NCT02185534|20229675|P2|COMPLETED|Second Period||14
8203430|NCT02185534|20229676|P1|COMPLETED|Second Period||13
8203431|NCT02185534|20229671|P6|STARTED|Second Period||13
8203432|NCT02185534|20229672|P5|STARTED|Second Period||13
8203433|NCT02185534|20229673|P4|STARTED|Second Period||13
8203434|NCT02185534|20229674|P3|STARTED|Second Period||14
8203435|NCT02185534|20229675|P2|STARTED|Second Period||14
8203436|NCT02185534|20229676|P1|STARTED|Second Period||13
8203437|NCT02185534|20229671|P6|NOT COMPLETED|First Washout Period||1
8203438|NCT02185534|20229672|P5|NOT COMPLETED|First Washout Period||1
8203439|NCT02185534|20229673|P4|NOT COMPLETED|First Washout Period||0
8203440|NCT02185534|20229674|P3|NOT COMPLETED|First Washout Period||0
8203441|NCT02185534|20229675|P2|NOT COMPLETED|First Washout Period||0
8203442|NCT02185534|20229676|P1|NOT COMPLETED|First Washout Period||1
8203443|NCT02185534|20229671|P6|COMPLETED|First Washout Period||13
8203444|NCT02185534|20229672|P5|COMPLETED|First Washout Period||13
8203445|NCT02185534|20229673|P4|COMPLETED|First Washout Period||13
8203446|NCT02185534|20229674|P3|COMPLETED|First Washout Period||14
8203447|NCT02185534|20229675|P2|COMPLETED|First Washout Period||14
8203448|NCT02185534|20229676|P1|COMPLETED|First Washout Period||13
8203449|NCT02185534|20229671|P6|STARTED|First Washout Period||14
8203450|NCT02185534|20229672|P5|STARTED|First Washout Period||14
8203451|NCT02185534|20229673|P4|STARTED|First Washout Period||13
8203452|NCT02185534|20229674|P3|STARTED|First Washout Period||14
8203453|NCT02185534|20229675|P2|STARTED|First Washout Period||14
8203454|NCT02185534|20229676|P1|STARTED|First Washout Period||14
8203455|NCT02185534|20229671|P6|NOT COMPLETED|First Period||0
8203456|NCT02185534|20229672|P5|NOT COMPLETED|First Period||0
8203457|NCT02185534|20229673|P4|NOT COMPLETED|First Period||1
8203458|NCT02185534|20229674|P3|NOT COMPLETED|First Period||0
8203459|NCT02185534|20229675|P2|NOT COMPLETED|First Period||0
8203460|NCT02185534|20229676|P1|NOT COMPLETED|First Period||0
8203461|NCT02185534|20229671|P6|COMPLETED|First Period||14
8203462|NCT02185534|20229672|P5|COMPLETED|First Period||14
8203463|NCT02185534|20229673|P4|COMPLETED|First Period||13
8203464|NCT02185534|20229674|P3|COMPLETED|First Period||14
8203465|NCT02185534|20229675|P2|COMPLETED|First Period||14
8203466|NCT02185534|20229676|P1|COMPLETED|First Period||14
8203467|NCT02185534|20229671|P6|STARTED|First Period||14
8203468|NCT02185534|20229672|P5|STARTED|First Period||14
8203469|NCT02185534|20229673|P4|STARTED|First Period||14
8203470|NCT02185534|20229674|P3|STARTED|First Period||14
8203471|NCT02185534|20229675|P2|STARTED|First Period||14
8203472|NCT02185534|20229676|P1|STARTED|First Period||14
8203473|NCT02185521|20229691|P1|NOT COMPLETED|Overall Study||2
8203474|NCT02185521|20229691|P1|COMPLETED|Overall Study||125
8203475|NCT02185521|20229691|P1|STARTED|Overall Study||127
8203476|NCT02185339|20229698|P2|NOT COMPLETED|Overall Study||1
8203477|NCT02185339|20229699|P1|NOT COMPLETED|Overall Study||0
8203478|NCT02185339|20229698|P2|COMPLETED|Overall Study||30
8203479|NCT02185339|20229699|P1|COMPLETED|Overall Study||30
8203480|NCT02185339|20229698|P2|STARTED|Overall Study||31
8203481|NCT02185339|20229699|P1|STARTED|Overall Study||30
8203482|NCT02185183|20229721|P1|NOT COMPLETED|Overall Study||0
8203483|NCT02185183|20229721|P1|COMPLETED|Overall Study||14
8203484|NCT02185183|20229721|P1|STARTED|Overall Study||14
8203485|NCT02185131|20229727|P2|NOT COMPLETED|Overall Study||1
8203486|NCT02185131|20229728|P1|NOT COMPLETED|Overall Study||1
8203487|NCT02185131|20229727|P2|COMPLETED|Overall Study||8
8203488|NCT02185131|20229728|P1|COMPLETED|Overall Study||6
8203489|NCT02185131|20229727|P2|STARTED|Overall Study||9
8203490|NCT02185131|20229728|P1|STARTED|Overall Study||7
8203491|NCT02185105|20229736|P1|NOT COMPLETED|Overall Study||0
8203492|NCT02185105|20229736|P1|COMPLETED|Overall Study||30
8203493|NCT02185105|20229736|P1|STARTED|Overall Study||30
8203494|NCT02185053|20229779|P3|NOT COMPLETED|Donepezil Dose Maintenance Phase||3
8203495|NCT02185053|20229780|P2|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
8203496|NCT02185053|20229781|P1|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
8203497|NCT02185053|20229779|P3|COMPLETED|Donepezil Dose Maintenance Phase||30
8203498|NCT02185053|20229780|P2|COMPLETED|Donepezil Dose Maintenance Phase||0
8203499|NCT02185053|20229781|P1|COMPLETED|Donepezil Dose Maintenance Phase||0
8203500|NCT02185053|20229779|P3|STARTED|Donepezil Dose Maintenance Phase||33
8203501|NCT02185053|20229780|P2|STARTED|Donepezil Dose Maintenance Phase||0
8203502|NCT02185053|20229781|P1|STARTED|Donepezil Dose Maintenance Phase||0
8203503|NCT02185053|20229779|P3|NOT COMPLETED|Donepezil Dose Escalation Phase||0
8203504|NCT02185053|20229780|P2|NOT COMPLETED|Donepezil Dose Escalation Phase||5
8203505|NCT02185053|20229781|P1|NOT COMPLETED|Donepezil Dose Escalation Phase||0
8203506|NCT02185053|20229779|P3|COMPLETED|Donepezil Dose Escalation Phase||0
8203507|NCT02185053|20229780|P2|COMPLETED|Donepezil Dose Escalation Phase||33
8203508|NCT02185053|20229781|P1|COMPLETED|Donepezil Dose Escalation Phase||0
8203509|NCT02185053|20229779|P3|STARTED|Donepezil Dose Escalation Phase||0
8203510|NCT02185053|20229780|P2|STARTED|Donepezil Dose Escalation Phase||38
8203511|NCT02185053|20229781|P1|STARTED|Donepezil Dose Escalation Phase||0
8203512|NCT02185053|20229779|P3|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
8203513|NCT02185053|20229780|P2|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
8203514|NCT02185053|20229781|P1|NOT COMPLETED|Solifenacin Dose Escalation Phase||3
8203515|NCT02185053|20229779|P3|COMPLETED|Solifenacin Dose Escalation Phase||0
8203516|NCT02185053|20229780|P2|COMPLETED|Solifenacin Dose Escalation Phase||0
8203517|NCT02185053|20229781|P1|COMPLETED|Solifenacin Dose Escalation Phase||38
8203518|NCT02185053|20229779|P3|STARTED|Solifenacin Dose Escalation Phase||0
8203519|NCT02185053|20229780|P2|STARTED|Solifenacin Dose Escalation Phase||0
8203520|NCT02185053|20229781|P1|STARTED|Solifenacin Dose Escalation Phase||41
8203521|NCT02185040|20229795|P7|NOT COMPLETED|Active Treatment Extension Phase||7
8203522|NCT02185040|20229796|P6|NOT COMPLETED|Active Treatment Extension Phase||3
8203523|NCT02185040|20229797|P5|NOT COMPLETED|Active Treatment Extension Phase||0
8203524|NCT02185040|20229798|P4|NOT COMPLETED|Active Treatment Extension Phase||0
8203525|NCT02185040|20229799|P3|NOT COMPLETED|Active Treatment Extension Phase||0
8203526|NCT02185040|20229800|P2|NOT COMPLETED|Active Treatment Extension Phase||0
8203527|NCT02185040|20229801|P1|NOT COMPLETED|Active Treatment Extension Phase||0
8203528|NCT02185040|20229795|P7|COMPLETED|Active Treatment Extension Phase||1
8203529|NCT02185040|20229796|P6|COMPLETED|Active Treatment Extension Phase||6
8203530|NCT02185040|20229797|P5|COMPLETED|Active Treatment Extension Phase||0
8203531|NCT02185040|20229798|P4|COMPLETED|Active Treatment Extension Phase||0
8203532|NCT02185040|20229799|P3|COMPLETED|Active Treatment Extension Phase||0
8203533|NCT02185040|20229800|P2|COMPLETED|Active Treatment Extension Phase||0
8203534|NCT02185040|20229801|P1|COMPLETED|Active Treatment Extension Phase||0
8203535|NCT02185040|20229795|P7|STARTED|Active Treatment Extension Phase||8
8203536|NCT02185040|20229796|P6|STARTED|Active Treatment Extension Phase||9
8203537|NCT02185040|20229797|P5|STARTED|Active Treatment Extension Phase||0
8203538|NCT02185040|20229798|P4|STARTED|Active Treatment Extension Phase||0
8203539|NCT02185040|20229799|P3|STARTED|Active Treatment Extension Phase||0
8203540|NCT02185040|20229800|P2|STARTED|Active Treatment Extension Phase||0
8203541|NCT02185040|20229801|P1|STARTED|Active Treatment Extension Phase||0
8203542|NCT02185040|20229795|P7|NOT COMPLETED|Part 1 Treatment Phase||0
8203543|NCT02185040|20229796|P6|NOT COMPLETED|Part 1 Treatment Phase||0
8203544|NCT02185040|20229797|P5|NOT COMPLETED|Part 1 Treatment Phase||3
8203545|NCT02185040|20229798|P4|NOT COMPLETED|Part 1 Treatment Phase||2
8203546|NCT02185040|20229799|P3|NOT COMPLETED|Part 1 Treatment Phase||1
8203547|NCT02185040|20229800|P2|NOT COMPLETED|Part 1 Treatment Phase||2
8203548|NCT02185040|20229801|P1|NOT COMPLETED|Part 1 Treatment Phase||1
8203549|NCT02185040|20229795|P7|COMPLETED|Part 1 Treatment Phase||0
8203550|NCT02185040|20229796|P6|COMPLETED|Part 1 Treatment Phase||0
8203551|NCT02185040|20229797|P5|COMPLETED|Part 1 Treatment Phase||6
8203552|NCT02185040|20229798|P4|COMPLETED|Part 1 Treatment Phase||7
8203553|NCT02185040|20229799|P3|COMPLETED|Part 1 Treatment Phase||7
8203554|NCT02185040|20229800|P2|COMPLETED|Part 1 Treatment Phase||6
8203555|NCT02185040|20229801|P1|COMPLETED|Part 1 Treatment Phase||7
8203556|NCT02185040|20229795|P7|STARTED|Part 1 Treatment Phase||0
8203557|NCT02185040|20229796|P6|STARTED|Part 1 Treatment Phase||0
8203558|NCT02185040|20229797|P5|STARTED|Part 1 Treatment Phase||9
8203559|NCT02185040|20229798|P4|STARTED|Part 1 Treatment Phase||9
8203560|NCT02185040|20229799|P3|STARTED|Part 1 Treatment Phase||8
8203561|NCT02185040|20229800|P2|STARTED|Part 1 Treatment Phase||8
8203562|NCT02185040|20229801|P1|STARTED|Part 1 Treatment Phase||8
8203563|NCT02185014|20229855|P1|NOT COMPLETED|Overall Study||54
8203564|NCT02185014|20229855|P1|COMPLETED|Overall Study||198
8203565|NCT02185014|20229855|P1|STARTED|Overall Study||252
8203566|NCT02184988|20229859|P1|NOT COMPLETED|Overall Study||55
8203567|NCT02184988|20229859|P1|COMPLETED|Overall Study||297
8203568|NCT02184988|20229859|P1|STARTED|Overall Study||352
8203569|NCT02184624|20229869|P5|NOT COMPLETED|Overall Study||0
8203570|NCT02184624|20229870|P4|NOT COMPLETED|Overall Study||0
8203571|NCT02184624|20229871|P3|NOT COMPLETED|Overall Study||0
8203572|NCT02184624|20229872|P2|NOT COMPLETED|Overall Study||0
8203573|NCT02184624|20229873|P1|NOT COMPLETED|Overall Study||0
8203574|NCT02184624|20229869|P5|COMPLETED|Overall Study||98
8203575|NCT02184624|20229870|P4|COMPLETED|Overall Study||118
8203576|NCT02184624|20229871|P3|COMPLETED|Overall Study||100
8203577|NCT02184624|20229872|P2|COMPLETED|Overall Study||80
8203578|NCT02184624|20229873|P1|COMPLETED|Overall Study||171
8203579|NCT02184624|20229869|P5|STARTED|Overall Study||98
8203580|NCT02184624|20229870|P4|STARTED|Overall Study||118
8203581|NCT02184624|20229871|P3|STARTED|Overall Study||100
8203582|NCT02184624|20229872|P2|STARTED|Overall Study||80
8203583|NCT02184624|20229873|P1|STARTED|Overall Study||171
8203584|NCT02184611|20229917|P2|NOT COMPLETED|Overall Study||28
8203585|NCT02184611|20229918|P1|NOT COMPLETED|Overall Study||21
8203586|NCT02184611|20229917|P2|COMPLETED|Overall Study||177
8203587|NCT02184611|20229918|P1|COMPLETED|Overall Study||80
8203588|NCT02184611|20229917|P2|STARTED|Overall Study||205
8203589|NCT02184611|20229918|P1|STARTED|Overall Study||101
8203590|NCT02184572|20229954|P2|NOT COMPLETED|Overall Study||30
8203591|NCT02184572|20229955|P1|NOT COMPLETED|Overall Study||47
8203592|NCT02184572|20229954|P2|COMPLETED|Overall Study||542
8203593|NCT02184572|20229955|P1|COMPLETED|Overall Study||1117
8203594|NCT02184572|20229954|P2|STARTED|Overall Study||572
8203595|NCT02184572|20229955|P1|STARTED|Overall Study||1164
8203596|NCT02184494|20229994|P3|NOT COMPLETED|Overall Study||0
8203597|NCT02184494|20229995|P2|NOT COMPLETED|Overall Study||2
8203598|NCT02184494|20229996|P1|NOT COMPLETED|Overall Study||1
8203599|NCT02184494|20229994|P3|COMPLETED|Overall Study||8
8203600|NCT02184494|20229995|P2|COMPLETED|Overall Study||11
8203601|NCT02184494|20229996|P1|COMPLETED|Overall Study||12
8203602|NCT02184494|20229994|P3|STARTED|Overall Study||8
8203603|NCT02184494|20229995|P2|STARTED|Overall Study||13
8203604|NCT02184494|20229996|P1|STARTED|Overall Study||13
8203605|NCT02184455|20230016|P1|NOT COMPLETED|Overall Study||1
8203606|NCT02184455|20230016|P1|COMPLETED|Overall Study||10
8203607|NCT02184455|20230016|P1|STARTED|Overall Study||11
8203608|NCT02184442|20230027|P2|NOT COMPLETED|Overall Study||76
8203609|NCT02184442|20230028|P1|NOT COMPLETED|Overall Study||64
8203610|NCT02184442|20230027|P2|COMPLETED|Overall Study||200
8203611|NCT02184442|20230028|P1|COMPLETED|Overall Study||220
8203612|NCT02184442|20230027|P2|Valve-Implant|Overall Study||263
8203613|NCT02184442|20230028|P1|Valve-Implant|Overall Study||280
8203614|NCT02184442|20230027|P2|As-Treated|Overall Study||271
8203615|NCT02184442|20230028|P1|As-Treated|Overall Study||282
8203616|NCT02184442|20230027|P2|STARTED|Overall Study||276
8203617|NCT02184442|20230028|P1|STARTED|Overall Study||284
8203618|NCT02184208|20230040|P1|NOT COMPLETED|Overall Study||56
8203619|NCT02184208|20230040|P1|COMPLETED|Overall Study||222
8203620|NCT02184208|20230040|P1|STARTED|Overall Study||278
8203627|NCT02184169|20230075|P2|NOT COMPLETED|Overall Study||0
8203628|NCT02184169|20230076|P1|NOT COMPLETED|Overall Study||0
8203629|NCT02184169|20230075|P2|COMPLETED|Overall Study||6
8203630|NCT02184169|20230076|P1|COMPLETED|Overall Study||21
8203631|NCT02184169|20230075|P2|STARTED|Overall Study||6
8203632|NCT02184169|20230076|P1|STARTED|Overall Study||21
8203633|NCT02184143|20230086|P2|NOT COMPLETED|Overall Study||7
8203634|NCT02184143|20230087|P1|NOT COMPLETED|Overall Study||10
8203635|NCT02184143|20230086|P2|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117
8203636|NCT02184143|20230087|P1|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114
8203637|NCT02184143|20230086|P2|STARTED|Overall Study|124 participants randomized; 121 received intervention|124
8203638|NCT02184143|20230087|P1|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124
8203639|NCT02183792|20230101|P2|NOT COMPLETED|Overall Study||0
8203640|NCT02183792|20230102|P1|NOT COMPLETED|Overall Study||0
8203641|NCT02183792|20230101|P2|COMPLETED|Overall Study||15
8203642|NCT02183792|20230102|P1|COMPLETED|Overall Study||18
8203643|NCT02183792|20230101|P2|STARTED|Overall Study||15
8203644|NCT02183792|20230102|P1|STARTED|Overall Study||18
8203645|NCT02183675|20230116|P6|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8203646|NCT02183675|20230117|P5|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8203647|NCT02183675|20230118|P4|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8203648|NCT02183675|20230119|P3|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8203649|NCT02183675|20230120|P2|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8203650|NCT02183675|20230121|P1|NOT COMPLETED|Treatment Period 3 (10 Days)||0
8203651|NCT02183675|20230116|P6|COMPLETED|Treatment Period 3 (10 Days)||4
8203652|NCT02183675|20230117|P5|COMPLETED|Treatment Period 3 (10 Days)||6
8203653|NCT02183675|20230118|P4|COMPLETED|Treatment Period 3 (10 Days)||6
8203654|NCT02183675|20230119|P3|COMPLETED|Treatment Period 3 (10 Days)||6
8203655|NCT02183675|20230120|P2|COMPLETED|Treatment Period 3 (10 Days)||6
8203656|NCT02183675|20230121|P1|COMPLETED|Treatment Period 3 (10 Days)||6
8203657|NCT02183675|20230116|P6|STARTED|Treatment Period 3 (10 Days)||4
8203658|NCT02183675|20230117|P5|STARTED|Treatment Period 3 (10 Days)||6
8203659|NCT02183675|20230118|P4|STARTED|Treatment Period 3 (10 Days)||6
8203660|NCT02183675|20230119|P3|STARTED|Treatment Period 3 (10 Days)||6
8203661|NCT02183675|20230120|P2|STARTED|Treatment Period 3 (10 Days)||6
8203662|NCT02183675|20230121|P1|STARTED|Treatment Period 3 (10 Days)||6
8203663|NCT02183675|20230116|P6|NOT COMPLETED|Treatment Period 2 (10 Days)||2
8203664|NCT02183675|20230117|P5|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8203665|NCT02183675|20230118|P4|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8203666|NCT02183675|20230119|P3|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8203667|NCT02183675|20230120|P2|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8203668|NCT02183675|20230121|P1|NOT COMPLETED|Treatment Period 2 (10 Days)||0
8203669|NCT02183675|20230116|P6|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
8203670|NCT02183675|20230117|P5|COMPLETED|Treatment Period 2 (10 Days)||6
8203671|NCT02183675|20230118|P4|COMPLETED|Treatment Period 2 (10 Days)||6
8203672|NCT02183675|20230119|P3|COMPLETED|Treatment Period 2 (10 Days)||6
8203673|NCT02183675|20230120|P2|COMPLETED|Treatment Period 2 (10 Days)||6
8203674|NCT02183675|20230121|P1|COMPLETED|Treatment Period 2 (10 Days)||6
8203675|NCT02183675|20230116|P6|STARTED|Treatment Period 2 (10 Days)||6
8203676|NCT02183675|20230117|P5|STARTED|Treatment Period 2 (10 Days)||6
8203677|NCT02183675|20230118|P4|STARTED|Treatment Period 2 (10 Days)||6
8203678|NCT02183675|20230119|P3|STARTED|Treatment Period 2 (10 Days)||6
8203679|NCT02183675|20230120|P2|STARTED|Treatment Period 2 (10 Days)||6
8203680|NCT02183675|20230121|P1|STARTED|Treatment Period 2 (10 Days)||6
8203681|NCT02183675|20230116|P6|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8203682|NCT02183675|20230117|P5|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8203683|NCT02183675|20230118|P4|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8203684|NCT02183675|20230119|P3|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8203685|NCT02183675|20230120|P2|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8203686|NCT02183675|20230121|P1|NOT COMPLETED|Treatment Period 1 (10 Days)||0
8203687|NCT02183675|20230116|P6|COMPLETED|Treatment Period 1 (10 Days)||6
8203688|NCT02183675|20230117|P5|COMPLETED|Treatment Period 1 (10 Days)||6
8203689|NCT02183675|20230118|P4|COMPLETED|Treatment Period 1 (10 Days)||6
8203690|NCT02183675|20230119|P3|COMPLETED|Treatment Period 1 (10 Days)||6
8203691|NCT02183675|20230120|P2|COMPLETED|Treatment Period 1 (10 Days)||6
8203692|NCT02183675|20230121|P1|COMPLETED|Treatment Period 1 (10 Days)||6
8203693|NCT02183675|20230116|P6|STARTED|Treatment Period 1 (10 Days)||6
8203694|NCT02183675|20230117|P5|STARTED|Treatment Period 1 (10 Days)||6
8203695|NCT02183675|20230118|P4|STARTED|Treatment Period 1 (10 Days)||6
8203696|NCT02183675|20230119|P3|STARTED|Treatment Period 1 (10 Days)||6
8203697|NCT02183675|20230120|P2|STARTED|Treatment Period 1 (10 Days)||6
8203698|NCT02183675|20230121|P1|STARTED|Treatment Period 1 (10 Days)||6
8203699|NCT02183519|20230145|P2|NOT COMPLETED|Overall Study||3
8203700|NCT02183519|20230146|P1|NOT COMPLETED|Overall Study||3
8203701|NCT02183519|20230145|P2|COMPLETED|Overall Study||13
8203702|NCT02183519|20230146|P1|COMPLETED|Overall Study||25
8203703|NCT02183519|20230145|P2|STARTED|Overall Study||16
8203704|NCT02183519|20230146|P1|STARTED|Overall Study||28
8203705|NCT02182999|20230154|P2|NOT COMPLETED|Overall Study||3
8203706|NCT02182999|20230155|P1|NOT COMPLETED|Overall Study||5
8203707|NCT02182999|20230154|P2|COMPLETED|Overall Study||22
8203708|NCT02182999|20230155|P1|COMPLETED|Overall Study||20
8203709|NCT02182999|20230154|P2|STARTED|Overall Study||25
8203710|NCT02182999|20230155|P1|STARTED|Overall Study||25
8203711|NCT02182973|20230171|P2|NOT COMPLETED|Overall Study||0
8203712|NCT02182973|20230172|P1|NOT COMPLETED|Overall Study||3
8203713|NCT02182973|20230171|P2|COMPLETED|Overall Study||9
8203714|NCT02182973|20230172|P1|COMPLETED|Overall Study||9
8203715|NCT02182973|20230171|P2|STARTED|Overall Study||9
8203716|NCT02182973|20230172|P1|STARTED|Overall Study||12
8203717|NCT02182895|20230184|P2|NOT COMPLETED|Overall Study||4
8203718|NCT02182895|20230185|P1|NOT COMPLETED|Overall Study||2
8203719|NCT02182895|20230184|P2|COMPLETED|Overall Study||33
8203720|NCT02182895|20230185|P1|COMPLETED|Overall Study||33
8203721|NCT02182895|20230184|P2|STARTED|Overall Study||37
8203722|NCT02182895|20230185|P1|STARTED|Overall Study||35
8203723|NCT02182843|20230205|P1|NOT COMPLETED|Overall Study||10
8203724|NCT02182843|20230205|P1|COMPLETED|Overall Study||71
8203725|NCT02182843|20230205|P1|STARTED|Overall Study||81
8203726|NCT02182830|20230212|P2|NOT COMPLETED|Overall Study||15
8203727|NCT02182830|20230213|P1|NOT COMPLETED|Overall Study||15
8203728|NCT02182830|20230212|P2|COMPLETED|Overall Study||68
8203729|NCT02182830|20230213|P1|COMPLETED|Overall Study||68
8203730|NCT02182830|20230212|P2|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
8203731|NCT02182830|20230213|P1|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
8203732|NCT02182830|20230212|P2|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
8203826|NCT02181673|20230548|P3|NOT COMPLETED|Week 24-Week 60||17
8203733|NCT02182830|20230213|P1|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
8203734|NCT02182830|20230212|P2|STARTED|Overall Study||83
8203735|NCT02182830|20230213|P1|STARTED|Overall Study||83
8203736|NCT02182804|20230239|P1|NOT COMPLETED|Overall Study||0
8203737|NCT02182804|20230239|P1|COMPLETED|Overall Study||44
8203738|NCT02182804|20230239|P1|STARTED|Overall Study||44
8203739|NCT02182492|20230245|P2|NOT COMPLETED|Overall Study||8
8203740|NCT02182492|20230246|P1|NOT COMPLETED|Overall Study||7
8203741|NCT02182492|20230245|P2|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
8203742|NCT02182492|20230246|P1|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
8203743|NCT02182492|20230245|P2|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
8203744|NCT02182492|20230246|P1|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
8203745|NCT02182440|20230258|P4|NOT COMPLETED|Overall Study||30
8203746|NCT02182440|20230259|P3|NOT COMPLETED|Overall Study||11
8203747|NCT02182440|20230260|P2|NOT COMPLETED|Overall Study||14
8203748|NCT02182440|20230261|P1|NOT COMPLETED|Overall Study||45
8203749|NCT02182440|20230258|P4|COMPLETED|Overall Study||81
8203750|NCT02182440|20230259|P3|COMPLETED|Overall Study||24
8203751|NCT02182440|20230260|P2|COMPLETED|Overall Study||25
8203752|NCT02182440|20230261|P1|COMPLETED|Overall Study||71
8203753|NCT02182440|20230258|P4|Safety Population|Overall Study||109
8203754|NCT02182440|20230259|P3|Safety Population|Overall Study||35
8203755|NCT02182440|20230260|P2|Safety Population|Overall Study||38
8203756|NCT02182440|20230261|P1|Safety Population|Overall Study||112
8203757|NCT02182440|20230258|P4|ITTinterim|Overall Study||29
8203758|NCT02182440|20230259|P3|ITTinterim|Overall Study||32
8203759|NCT02182440|20230260|P2|ITTinterim|Overall Study||31
8203760|NCT02182440|20230261|P1|ITTinterim|Overall Study||30
8203761|NCT02182440|20230258|P4|ITTcombined|Overall Study||111
8203762|NCT02182440|20230259|P3|ITTcombined|Overall Study||32
8203763|NCT02182440|20230260|P2|ITTcombined|Overall Study||31
8203764|NCT02182440|20230261|P1|ITTcombined|Overall Study||116
8203765|NCT02182440|20230258|P4|STARTED|Overall Study||111
8203766|NCT02182440|20230259|P3|STARTED|Overall Study||35
8203767|NCT02182440|20230260|P2|STARTED|Overall Study||39
8203768|NCT02182440|20230261|P1|STARTED|Overall Study||116
8203769|NCT02182115|20230293|P2|NOT COMPLETED|Overall Study||0
8203770|NCT02182115|20230294|P1|NOT COMPLETED|Overall Study||0
8203771|NCT02182115|20230293|P2|COMPLETED|Overall Study||57
8203772|NCT02182115|20230294|P1|COMPLETED|Overall Study||53
8203773|NCT02182115|20230293|P2|STARTED|Overall Study||57
8203774|NCT02182115|20230294|P1|STARTED|Overall Study||53
8203775|NCT02181842|20230300|P1|NOT COMPLETED|Overall Study||2
8203776|NCT02181842|20230300|P1|COMPLETED|Overall Study||244
8203777|NCT02181842|20230300|P1|STARTED|Overall Study||246
8203778|NCT02181816|20230317|P1|NOT COMPLETED|Overall Study||59
8203779|NCT02181816|20230317|P1|COMPLETED|Overall Study||1031
8203780|NCT02181816|20230317|P1|STARTED|Overall Study||1090
8203781|NCT02181803|20230332|P9|NOT COMPLETED|Overall Study||0
8203782|NCT02181803|20230333|P8|NOT COMPLETED|Overall Study||1
8203783|NCT02181803|20230334|P7|NOT COMPLETED|Overall Study||1
8203784|NCT02181803|20230335|P6|NOT COMPLETED|Overall Study||0
8203785|NCT02181803|20230336|P5|NOT COMPLETED|Overall Study||0
8203786|NCT02181803|20230337|P4|NOT COMPLETED|Overall Study||2
8203787|NCT02181803|20230338|P3|NOT COMPLETED|Overall Study||0
8203788|NCT02181803|20230339|P2|NOT COMPLETED|Overall Study||4
8203789|NCT02181803|20230340|P1|NOT COMPLETED|Overall Study||0
8203790|NCT02181803|20230332|P9|COMPLETED|Overall Study||2
8203791|NCT02181803|20230333|P8|COMPLETED|Overall Study||0
8203792|NCT02181803|20230334|P7|COMPLETED|Overall Study||8
8203793|NCT02181803|20230335|P6|COMPLETED|Overall Study||6
8203794|NCT02181803|20230336|P5|COMPLETED|Overall Study||6
8203795|NCT02181803|20230337|P4|COMPLETED|Overall Study||11
8203796|NCT02181803|20230338|P3|COMPLETED|Overall Study||4
8203797|NCT02181803|20230339|P2|COMPLETED|Overall Study||9
8203798|NCT02181803|20230340|P1|COMPLETED|Overall Study||1
8203799|NCT02181803|20230332|P9|STARTED|Overall Study||2
8203800|NCT02181803|20230333|P8|STARTED|Overall Study||1
8203801|NCT02181803|20230334|P7|STARTED|Overall Study||9
8203802|NCT02181803|20230335|P6|STARTED|Overall Study||6
8203803|NCT02181803|20230336|P5|STARTED|Overall Study||6
8203804|NCT02181803|20230337|P4|STARTED|Overall Study||13
8203805|NCT02181803|20230338|P3|STARTED|Overall Study||4
8203806|NCT02181803|20230339|P2|STARTED|Overall Study||13
8203807|NCT02181803|20230340|P1|STARTED|Overall Study||1
8203814|NCT02181738|20230504|P4|NOT COMPLETED|Overall Study||2
8203815|NCT02181738|20230505|P3|NOT COMPLETED|Overall Study||10
8203816|NCT02181738|20230506|P2|NOT COMPLETED|Overall Study||9
8203817|NCT02181738|20230507|P1|NOT COMPLETED|Overall Study||2
8203818|NCT02181738|20230504|P4|COMPLETED|Overall Study||49
8203819|NCT02181738|20230505|P3|COMPLETED|Overall Study||90
8203820|NCT02181738|20230506|P2|COMPLETED|Overall Study||71
8203821|NCT02181738|20230507|P1|COMPLETED|Overall Study||61
8203822|NCT02181738|20230504|P4|STARTED|Overall Study||51
8203823|NCT02181738|20230505|P3|STARTED|Overall Study||100
8203824|NCT02181738|20230506|P2|STARTED|Overall Study||80
8203825|NCT02181738|20230507|P1|STARTED|Overall Study||63
8203827|NCT02181673|20230549|P2|NOT COMPLETED|Week 24-Week 60||8
8203828|NCT02181673|20230550|P1|NOT COMPLETED|Week 24-Week 60||0
8203829|NCT02181673|20230548|P3|COMPLETED|Week 24-Week 60||213
8203830|NCT02181673|20230549|P2|COMPLETED|Week 24-Week 60||214
8203831|NCT02181673|20230550|P1|COMPLETED|Week 24-Week 60||0
8203832|NCT02181673|20230548|P3|Treated|Week 24-Week 60||230
8203833|NCT02181673|20230549|P2|Treated|Week 24-Week 60||220
8203834|NCT02181673|20230550|P1|Treated|Week 24-Week 60||0
8203835|NCT02181673|20230548|P3|STARTED|Week 24-Week 60||230
8203836|NCT02181673|20230549|P2|STARTED|Week 24-Week 60||222
8203837|NCT02181673|20230550|P1|STARTED|Week 24-Week 60||0
8203838|NCT02181673|20230548|P3|NOT COMPLETED|Up to Week 24||11
8203839|NCT02181673|20230549|P2|NOT COMPLETED|Up to Week 24||0
8203840|NCT02181673|20230550|P1|NOT COMPLETED|Up to Week 24||17
8203841|NCT02181673|20230548|P3|COMPLETED|Up to Week 24||230
8203842|NCT02181673|20230549|P2|COMPLETED|Up to Week 24||0
8203843|NCT02181673|20230550|P1|COMPLETED|Up to Week 24||222
8203844|NCT02181673|20230548|P3|Treated|Up to Week 24||240
8203845|NCT02181673|20230549|P2|Treated|Up to Week 24||0
8203846|NCT02181673|20230550|P1|Treated|Up to Week 24||239
8203847|NCT02181673|20230548|P3|STARTED|Up to Week 24||241
8203848|NCT02181673|20230549|P2|STARTED|Up to Week 24||0
8203849|NCT02181673|20230550|P1|STARTED|Up to Week 24||239
8203850|NCT02181634|20230577|P1|NOT COMPLETED|Overall Study||72
8203851|NCT02181634|20230577|P1|COMPLETED|Overall Study||2
8203852|NCT02181634|20230577|P1|Eligible and Treated|Overall Study||73
8203853|NCT02181634|20230577|P1|STARTED|Overall Study||74
8203854|NCT02181530|20230588|P1|NOT COMPLETED|Overall Study||0
8203855|NCT02181530|20230588|P1|COMPLETED|Overall Study||43
8203856|NCT02181530|20230588|P1|STARTED|Overall Study||43
8203857|NCT02181517|20230601|P3|NOT COMPLETED|Overall Study||0
8203858|NCT02181517|20230602|P2|NOT COMPLETED|Overall Study||0
8203859|NCT02181517|20230603|P1|NOT COMPLETED|Overall Study||0
8203860|NCT02181517|20230601|P3|COMPLETED|Overall Study||5
8203861|NCT02181517|20230602|P2|COMPLETED|Overall Study||10
8203862|NCT02181517|20230603|P1|COMPLETED|Overall Study||10
8203863|NCT02181517|20230601|P3|STARTED|Overall Study||5
8203864|NCT02181517|20230602|P2|STARTED|Overall Study||10
8203865|NCT02181517|20230603|P1|STARTED|Overall Study||10
8203866|NCT02181504|20230626|P3|NOT COMPLETED|Overall Study||1
8203867|NCT02181504|20230627|P2|NOT COMPLETED|Overall Study||1
8203868|NCT02181504|20230628|P1|NOT COMPLETED|Overall Study||1
8203869|NCT02181504|20230626|P3|COMPLETED|Overall Study||4
8203870|NCT02181504|20230627|P2|COMPLETED|Overall Study||9
8203871|NCT02181504|20230628|P1|COMPLETED|Overall Study||9
8203872|NCT02181504|20230626|P3|STARTED|Overall Study||5
8203873|NCT02181504|20230627|P2|STARTED|Overall Study||10
8203874|NCT02181504|20230628|P1|STARTED|Overall Study||10
8203875|NCT02181426|20230652|P4|NOT COMPLETED|Overall Study||0
8203876|NCT02181426|20230653|P3|NOT COMPLETED|Overall Study||0
8203877|NCT02181426|20230654|P2|NOT COMPLETED|Overall Study||0
8203878|NCT02181426|20230655|P1|NOT COMPLETED|Overall Study||0
8203879|NCT02181426|20230652|P4|COMPLETED|Overall Study||28
8203880|NCT02181426|20230653|P3|COMPLETED|Overall Study||28
8203881|NCT02181426|20230654|P2|COMPLETED|Overall Study||28
8203882|NCT02181426|20230655|P1|COMPLETED|Overall Study||28
8203883|NCT02181426|20230652|P4|STARTED|Overall Study||28
8203884|NCT02181426|20230653|P3|STARTED|Overall Study||28
8203885|NCT02181426|20230654|P2|STARTED|Overall Study||28
8203886|NCT02181426|20230655|P1|STARTED|Overall Study||28
8203899|NCT02181400|20230677|P3|NOT COMPLETED|Overall Study||0
8203900|NCT02181400|20230678|P2|NOT COMPLETED|Overall Study||0
8203901|NCT02181400|20230679|P1|NOT COMPLETED|Overall Study||0
8203902|NCT02181400|20230677|P3|COMPLETED|Overall Study||7
8203903|NCT02181400|20230678|P2|COMPLETED|Overall Study||7
8203904|NCT02181400|20230679|P1|COMPLETED|Overall Study||7
8203905|NCT02181400|20230677|P3|STARTED|Overall Study||7
8203906|NCT02181400|20230678|P2|STARTED|Overall Study||7
8203907|NCT02181400|20230679|P1|STARTED|Overall Study||7
8203908|NCT02181387|20230704|P2|NOT COMPLETED|Overall Study||4
8203909|NCT02181387|20230705|P1|NOT COMPLETED|Overall Study||2
8203910|NCT02181387|20230704|P2|COMPLETED|Overall Study||15
8203911|NCT02181387|20230705|P1|COMPLETED|Overall Study||12
8203912|NCT02181387|20230704|P2|STARTED|Overall Study||19
8203913|NCT02181387|20230705|P1|STARTED|Overall Study||14
8203914|NCT02181296|20230713|P2|NOT COMPLETED|Overall Study||6
8203915|NCT02181296|20230714|P1|NOT COMPLETED|Overall Study||7
8203916|NCT02181296|20230713|P2|COMPLETED|Overall Study||19
8203917|NCT02181296|20230714|P1|COMPLETED|Overall Study||18
8203918|NCT02181296|20230713|P2|STARTED|Overall Study||25
8203919|NCT02181296|20230714|P1|STARTED|Overall Study||25
8203920|NCT02181231|20230728|P2|NOT COMPLETED|Overall Study||0
8203921|NCT02181231|20230729|P1|NOT COMPLETED|Overall Study||2
8203922|NCT02181231|20230728|P2|COMPLETED|Overall Study||6
8203923|NCT02181231|20230729|P1|COMPLETED|Overall Study||10
8203924|NCT02181231|20230728|P2|STARTED|Overall Study||6
8203925|NCT02181231|20230729|P1|STARTED|Overall Study||12
8203926|NCT02181140|20230745|P1|NOT COMPLETED|Overall Study||0
8203927|NCT02181140|20230745|P1|COMPLETED|Overall Study||56
8203928|NCT02181140|20230745|P1|STARTED|Overall Study||56
8203929|NCT02181127|20230751|P1|NOT COMPLETED|Overall Study||0
8203930|NCT02181127|20230751|P1|COMPLETED|Overall Study||22
8203931|NCT02181127|20230751|P1|STARTED|Overall Study||22
8203932|NCT02181075|20230797|P2|NOT COMPLETED|Overall Study||0
8203933|NCT02181075|20230798|P1|NOT COMPLETED|Overall Study||0
8203934|NCT02181075|20230797|P2|COMPLETED|Overall Study||4
8203935|NCT02181075|20230798|P1|COMPLETED|Overall Study||6
8203936|NCT02181075|20230797|P2|STARTED|Overall Study||4
8203937|NCT02181075|20230798|P1|STARTED|Overall Study||6
8203938|NCT02180893|20230816|P2|NOT COMPLETED|Overall Study||7
8203939|NCT02180893|20230817|P1|NOT COMPLETED|Overall Study||3
8203940|NCT02180893|20230816|P2|COMPLETED|Overall Study||23
8203941|NCT02180893|20230817|P1|COMPLETED|Overall Study||27
8203942|NCT02180893|20230816|P2|STARTED|Overall Study||30
8203943|NCT02180893|20230817|P1|STARTED|Overall Study||30
8203944|NCT02180828|20230831|P2|NOT COMPLETED|Overall Study||7
8203945|NCT02180828|20230832|P1|NOT COMPLETED|Overall Study||5
8203946|NCT02180828|20230831|P2|COMPLETED|Overall Study||113
8203947|NCT02180828|20230832|P1|COMPLETED|Overall Study||115
8203948|NCT02180828|20230831|P2|STARTED|Overall Study||120
8203949|NCT02180828|20230832|P1|STARTED|Overall Study||120
8203964|NCT02180659|20230871|P2|NOT COMPLETED|Overall Study||5
8203965|NCT02180659|20230872|P1|NOT COMPLETED|Overall Study||6
8203966|NCT02180659|20230871|P2|COMPLETED|Overall Study||84
8203967|NCT02180659|20230872|P1|COMPLETED|Overall Study||81
8203968|NCT02180659|20230871|P2|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
8203969|NCT02180659|20230872|P1|STARTED|Overall Study||87
8203970|NCT02180646|20230894|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8203971|NCT02180646|20230895|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8203972|NCT02180646|20230894|P2|COMPLETED|Second Intervention (7 Days)||6
8203973|NCT02180646|20230895|P1|COMPLETED|Second Intervention (7 Days)||6
8203974|NCT02180646|20230894|P2|STARTED|Second Intervention (7 Days)||6
8203975|NCT02180646|20230895|P1|STARTED|Second Intervention (7 Days)||6
8203976|NCT02180646|20230894|P2|NOT COMPLETED|Washout (7 Days)||0
8203977|NCT02180646|20230895|P1|NOT COMPLETED|Washout (7 Days)||0
8203978|NCT02180646|20230894|P2|COMPLETED|Washout (7 Days)||6
8203979|NCT02180646|20230895|P1|COMPLETED|Washout (7 Days)||6
8203980|NCT02180646|20230894|P2|STARTED|Washout (7 Days)||6
8203981|NCT02180646|20230895|P1|STARTED|Washout (7 Days)||6
8203982|NCT02180646|20230894|P2|NOT COMPLETED|First Intervention (7 Days)||0
8203983|NCT02180646|20230895|P1|NOT COMPLETED|First Intervention (7 Days)||0
8203984|NCT02180646|20230894|P2|COMPLETED|First Intervention (7 Days)||6
8203985|NCT02180646|20230895|P1|COMPLETED|First Intervention (7 Days)||6
8203986|NCT02180646|20230894|P2|STARTED|First Intervention (7 Days)||6
8203987|NCT02180646|20230895|P1|STARTED|First Intervention (7 Days)||6
8203988|NCT02180438|20230907|P1|NOT COMPLETED|Overall Study||1
8203989|NCT02180438|20230907|P1|COMPLETED|Overall Study||29
8203990|NCT02180438|20230907|P1|STARTED|Overall Study||30
8203991|NCT02180230|20230922|P1|NOT COMPLETED|Overall Study||7
8203992|NCT02180230|20230922|P1|COMPLETED|Overall Study||31
8203993|NCT02180230|20230922|P1|STARTED|Overall Study||38
8203994|NCT02180217|20230930|P3|NOT COMPLETED|Overall Study||38
8203995|NCT02180217|20230931|P2|NOT COMPLETED|Overall Study||8
8203996|NCT02180217|20230932|P1|NOT COMPLETED|Overall Study||12
8203997|NCT02180217|20230930|P3|COMPLETED|Overall Study||28
8203998|NCT02180217|20230931|P2|COMPLETED|Overall Study||27
8203999|NCT02180217|20230932|P1|COMPLETED|Overall Study||24
8204000|NCT02180217|20230930|P3|Completed Ext. Phase|Overall Study||25
8204001|NCT02180217|20230931|P2|Completed Ext. Phase|Overall Study||24
8204002|NCT02180217|20230932|P1|Completed Ext. Phase|Overall Study||23
8204003|NCT02180217|20230930|P3|Discontinued Extension Phase|Overall Study||16
8204004|NCT02180217|20230931|P2|Discontinued Extension Phase|Overall Study||6
8204005|NCT02180217|20230932|P1|Discontinued Extension Phase|Overall Study||12
8204006|NCT02180217|20230930|P3|Completed W48, Entered Ext. Phase|Overall Study||41
8204007|NCT02180217|20230931|P2|Completed W48, Entered Ext. Phase|Overall Study||30
8204008|NCT02180217|20230932|P1|Completed W48, Entered Ext. Phase|Overall Study||35
8204009|NCT02180217|20230930|P3|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
8204010|NCT02180217|20230931|P2|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
8204011|NCT02180217|20230932|P1|Completed W48, Did Not Enter Ext. Phase|Overall Study||1
8204012|NCT02180217|20230930|P3|Completed Week 48 (Core Phase)|Overall Study||44
8204013|NCT02180217|20230931|P2|Completed Week 48 (Core Phase)|Overall Study||33
8204014|NCT02180217|20230932|P1|Completed Week 48 (Core Phase)|Overall Study||36
8204015|NCT02180217|20230930|P3|Discontinued Prior to W48 But After W26|Overall Study||3
8204016|NCT02180217|20230931|P2|Discontinued Prior to W48 But After W26|Overall Study||2
8204017|NCT02180217|20230932|P1|Discontinued Prior to W48 But After W26|Overall Study||0
8204018|NCT02180217|20230930|P3|Discont. at/Prior to W26 But After W12|Overall Study||12
8204019|NCT02180217|20230931|P2|Discont. at/Prior to W26 But After W12|Overall Study||0
8204020|NCT02180217|20230932|P1|Discont. at/Prior to W26 But After W12|Overall Study||0
8204021|NCT02180217|20230930|P3|Discontinued at/Prior to Week 12 (W12)|Overall Study||7
8204022|NCT02180217|20230931|P2|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
8204023|NCT02180217|20230932|P1|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
8204024|NCT02180217|20230930|P3|STARTED|Overall Study||66
8204025|NCT02180217|20230931|P2|STARTED|Overall Study||35
8204026|NCT02180217|20230932|P1|STARTED|Overall Study||36
8204027|NCT02180100|20231004|P2|NOT COMPLETED|Overall Study||4
8204028|NCT02180100|20231005|P1|NOT COMPLETED|Overall Study||12
8204029|NCT02180100|20231004|P2|COMPLETED|Overall Study||66
8204030|NCT02180100|20231005|P1|COMPLETED|Overall Study||58
8204031|NCT02180100|20231004|P2|STARTED|Overall Study||70
8204032|NCT02180100|20231005|P1|STARTED|Overall Study||70
8204033|NCT02180061|20231015|P2|NOT COMPLETED|Overall Study||8
8204034|NCT02180061|20231016|P1|NOT COMPLETED|Overall Study||25
8204035|NCT02180061|20231015|P2|COMPLETED|Overall Study||0
8204036|NCT02180061|20231016|P1|COMPLETED|Overall Study||9
8204037|NCT02180061|20231015|P2|STARTED|Overall Study||8
8204038|NCT02180061|20231016|P1|STARTED|Overall Study||34
8204039|NCT02179918|20231035|P5|NOT COMPLETED|Overall Study||8
8204040|NCT02179918|20231036|P4|NOT COMPLETED|Overall Study||3
8204041|NCT02179918|20231037|P3|NOT COMPLETED|Overall Study||2
8204042|NCT02179918|20231038|P2|NOT COMPLETED|Overall Study||3
8204043|NCT02179918|20231039|P1|NOT COMPLETED|Overall Study||4
8204044|NCT02179918|20231035|P5|COMPLETED|Overall Study||1
8204045|NCT02179918|20231036|P4|COMPLETED|Overall Study||0
8204046|NCT02179918|20231037|P3|COMPLETED|Overall Study||1
8204047|NCT02179918|20231038|P2|COMPLETED|Overall Study||0
8204048|NCT02179918|20231039|P1|COMPLETED|Overall Study||1
8204049|NCT02179918|20231035|P5|STARTED|Overall Study||9
8204050|NCT02179918|20231036|P4|STARTED|Overall Study||3
8204051|NCT02179918|20231037|P3|STARTED|Overall Study||3
8204052|NCT02179918|20231038|P2|STARTED|Overall Study||3
8204053|NCT02179918|20231039|P1|STARTED|Overall Study||5
8204054|NCT02179892|20231165|P2|NOT COMPLETED|Overall Study||0
8204055|NCT02179892|20231166|P1|NOT COMPLETED|Overall Study||0
8204056|NCT02179892|20231165|P2|COMPLETED|Overall Study||4
8204057|NCT02179892|20231166|P1|COMPLETED|Overall Study||5
8204058|NCT02179892|20231165|P2|STARTED|Overall Study||4
8204059|NCT02179892|20231166|P1|STARTED|Overall Study||5
8204060|NCT02179788|20231180|P2|NOT COMPLETED|Overall Study||0
8204061|NCT02179788|20231181|P1|NOT COMPLETED|Overall Study||0
8204062|NCT02179788|20231180|P2|COMPLETED|Overall Study||5
8204063|NCT02179788|20231181|P1|COMPLETED|Overall Study||10
8204064|NCT02179788|20231180|P2|STARTED|Overall Study||5
8204065|NCT02179788|20231181|P1|STARTED|Overall Study||10
8204066|NCT02179671|20231192|P5|NOT COMPLETED|Overall Study||13
8204067|NCT02179671|20231193|P4|NOT COMPLETED|Overall Study||13
8204068|NCT02179671|20231194|P3|NOT COMPLETED|Overall Study||1
8204069|NCT02179671|20231195|P2|NOT COMPLETED|Overall Study||1
8204070|NCT02179671|20231196|P1|NOT COMPLETED|Overall Study||1
8204071|NCT02179671|20231192|P5|COMPLETED|Overall Study||1
8204072|NCT02179671|20231193|P4|COMPLETED|Overall Study||1
8204073|NCT02179671|20231194|P3|COMPLETED|Overall Study||1
8204074|NCT02179671|20231195|P2|COMPLETED|Overall Study||0
8204075|NCT02179671|20231196|P1|COMPLETED|Overall Study||0
8204076|NCT02179671|20231192|P5|STARTED|Overall Study||14
8204077|NCT02179671|20231193|P4|STARTED|Overall Study||14
8204078|NCT02179671|20231194|P3|STARTED|Overall Study||2
8204079|NCT02179671|20231195|P2|STARTED|Overall Study||1
8204080|NCT02179671|20231196|P1|STARTED|Overall Study||1
8204081|NCT02179515|20231231|P3|NOT COMPLETED|Overall Study||14
8204082|NCT02179515|20231232|P2|NOT COMPLETED|Overall Study||16
8204083|NCT02179515|20231233|P1|NOT COMPLETED|Overall Study||2
8204084|NCT02179515|20231231|P3|COMPLETED|Overall Study||4
8204085|NCT02179515|20231232|P2|COMPLETED|Overall Study||1
8204086|NCT02179515|20231233|P1|COMPLETED|Overall Study||1
8204087|NCT02179515|20231231|P3|STARTED|Overall Study||18
8204088|NCT02179515|20231232|P2|STARTED|Overall Study||17
8204089|NCT02179515|20231233|P1|STARTED|Overall Study||3
8204090|NCT02179424|20231276|P4|NOT COMPLETED|Overall Study||0
8204091|NCT02179424|20231277|P3|NOT COMPLETED|Overall Study||0
8204092|NCT02179424|20231278|P2|NOT COMPLETED|Overall Study||0
8204093|NCT02179424|20231279|P1|NOT COMPLETED|Overall Study||0
8204094|NCT02179424|20231276|P4|COMPLETED|Overall Study||39
8204095|NCT02179424|20231277|P3|COMPLETED|Overall Study||516
8204096|NCT02179424|20231278|P2|COMPLETED|Overall Study||11
8204097|NCT02179424|20231279|P1|COMPLETED|Overall Study||76
8204098|NCT02179424|20231276|P4|STARTED|Overall Study||39
8204099|NCT02179424|20231277|P3|STARTED|Overall Study||516
8204100|NCT02179424|20231278|P2|STARTED|Overall Study||11
8204101|NCT02179424|20231279|P1|STARTED|Overall Study||76
8204102|NCT02179398|20231296|P2|NOT COMPLETED|Overall Study||4
8204103|NCT02179398|20231297|P1|NOT COMPLETED|Overall Study||3
8204104|NCT02179398|20231296|P2|COMPLETED|Overall Study||140
8204105|NCT02179398|20231297|P1|COMPLETED|Overall Study||131
8204106|NCT02179398|20231296|P2|STARTED|Overall Study||144
8204107|NCT02179398|20231297|P1|STARTED|Overall Study||134
8204108|NCT02179190|20231315|P1|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
8204109|NCT02179190|20231315|P1|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
8204110|NCT02179190|20231315|P1|STARTED|Follow-Up Post Barrel VRD Implanted||120
8204111|NCT02179190|20231315|P1|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
8204112|NCT02179190|20231315|P1|COMPLETED|Index Procedure With Barrel VRD Attempt||120
8204113|NCT02179190|20231315|P1|STARTED|Index Procedure With Barrel VRD Attempt||127
8204114|NCT02179190|20231315|P1|NOT COMPLETED|Enrollment||11
8204115|NCT02179190|20231315|P1|COMPLETED|Enrollment||127
8204116|NCT02179190|20231315|P1|STARTED|Enrollment||138
8204117|NCT02179177|20231328|P2|NOT COMPLETED|Overall Study||2
8204118|NCT02179177|20231329|P1|NOT COMPLETED|Overall Study||2
8204119|NCT02179177|20231328|P2|COMPLETED|Overall Study||6
8204120|NCT02179177|20231329|P1|COMPLETED|Overall Study||6
8204121|NCT02179177|20231328|P2|STARTED|Overall Study||8
8204122|NCT02179177|20231329|P1|STARTED|Overall Study||8
8204123|NCT02179047|20231343|P2|NOT COMPLETED|Overall Study||0
8204124|NCT02179047|20231344|P1|NOT COMPLETED|Overall Study||7
8204125|NCT02179047|20231343|P2|COMPLETED|Overall Study||20
8204126|NCT02179047|20231344|P1|COMPLETED|Overall Study||187
8204127|NCT02179047|20231343|P2|STARTED|Overall Study||20
8204128|NCT02179047|20231344|P1|STARTED|Overall Study||194
8204129|NCT02178995|20231369|P9|NOT COMPLETED|Open Label||0
8204130|NCT02178995|20231370|P8|NOT COMPLETED|Open Label||0
8204131|NCT02178995|20231371|P7|NOT COMPLETED|Open Label||0
8204132|NCT02178995|20231372|P6|NOT COMPLETED|Open Label||0
8204133|NCT02178995|20231373|P5|NOT COMPLETED|Open Label||0
8204134|NCT02178995|20231374|P4|NOT COMPLETED|Open Label||0
8204135|NCT02178995|20231375|P3|NOT COMPLETED|Open Label||0
8204136|NCT02178995|20231376|P2|NOT COMPLETED|Open Label||0
8204137|NCT02178995|20231377|P1|NOT COMPLETED|Open Label||2
8204138|NCT02178995|20231369|P9|COMPLETED|Open Label||0
8204139|NCT02178995|20231370|P8|COMPLETED|Open Label||0
8204140|NCT02178995|20231371|P7|COMPLETED|Open Label||0
8204141|NCT02178995|20231372|P6|COMPLETED|Open Label||0
8204142|NCT02178995|20231373|P5|COMPLETED|Open Label||0
8204143|NCT02178995|20231374|P4|COMPLETED|Open Label||0
8204144|NCT02178995|20231375|P3|COMPLETED|Open Label||0
8204145|NCT02178995|20231376|P2|COMPLETED|Open Label||14
8204146|NCT02178995|20231377|P1|COMPLETED|Open Label||28
8204147|NCT02178995|20231369|P9|STARTED|Open Label||0
8204148|NCT02178995|20231370|P8|STARTED|Open Label||0
8204149|NCT02178995|20231371|P7|STARTED|Open Label||0
8204150|NCT02178995|20231372|P6|STARTED|Open Label||0
8204151|NCT02178995|20231373|P5|STARTED|Open Label||0
8204152|NCT02178995|20231374|P4|STARTED|Open Label||0
8204153|NCT02178995|20231375|P3|STARTED|Open Label||0
8204154|NCT02178995|20231376|P2|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
8204155|NCT02178995|20231377|P1|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
8204156|NCT02178995|20231369|P9|NOT COMPLETED|Double Blind||1
8204157|NCT02178995|20231370|P8|NOT COMPLETED|Double Blind||2
8204158|NCT02178995|20231371|P7|NOT COMPLETED|Double Blind||0
8204159|NCT02178995|20231372|P6|NOT COMPLETED|Double Blind||1
8204160|NCT02178995|20231373|P5|NOT COMPLETED|Double Blind||0
8204161|NCT02178995|20231374|P4|NOT COMPLETED|Double Blind||0
8204162|NCT02178995|20231375|P3|NOT COMPLETED|Double Blind||0
8204163|NCT02178995|20231376|P2|NOT COMPLETED|Double Blind||1
8204164|NCT02178995|20231377|P1|NOT COMPLETED|Double Blind||0
8204165|NCT02178995|20231369|P9|COMPLETED|Double Blind||0
8204166|NCT02178995|20231370|P8|COMPLETED|Double Blind||4
8204167|NCT02178995|20231371|P7|COMPLETED|Double Blind||5
8204168|NCT02178995|20231372|P6|COMPLETED|Double Blind||5
8204169|NCT02178995|20231373|P5|COMPLETED|Double Blind||6
8204170|NCT02178995|20231374|P4|COMPLETED|Double Blind||6
8204171|NCT02178995|20231375|P3|COMPLETED|Double Blind||5
8204172|NCT02178995|20231376|P2|COMPLETED|Double Blind||15
8204173|NCT02178995|20231377|P1|COMPLETED|Double Blind||0
8204174|NCT02178995|20231369|P9|STARTED|Double Blind||1
8204175|NCT02178995|20231370|P8|STARTED|Double Blind||6
8204176|NCT02178995|20231371|P7|STARTED|Double Blind||5
8204177|NCT02178995|20231372|P6|STARTED|Double Blind||6
8204178|NCT02178995|20231373|P5|STARTED|Double Blind||6
8204179|NCT02178995|20231374|P4|STARTED|Double Blind||6
8204180|NCT02178995|20231375|P3|STARTED|Double Blind||5
8204181|NCT02178995|20231376|P2|STARTED|Double Blind||16
8204182|NCT02178995|20231377|P1|STARTED|Double Blind||0
8204183|NCT02178800|20231450|P2|NOT COMPLETED|Overall Study||6
8204184|NCT02178800|20231451|P1|NOT COMPLETED|Overall Study||20
8204185|NCT02178800|20231450|P2|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
8204186|NCT02178800|20231451|P1|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
8204187|NCT02178800|20231450|P2|STARTED|Overall Study||48
8204188|NCT02178800|20231451|P1|STARTED|Overall Study||151
8204189|NCT02178787|20231485|P2|NOT COMPLETED|Overall Study||9
8204190|NCT02178787|20231486|P1|NOT COMPLETED|Overall Study||5
8204191|NCT02178787|20231485|P2|COMPLETED|Overall Study||30
8204192|NCT02178787|20231486|P1|COMPLETED|Overall Study||30
8204193|NCT02178787|20231485|P2|STARTED|Overall Study||39
8204194|NCT02178787|20231486|P1|STARTED|Overall Study||35
8204210|NCT02178709|20231515|P1|NOT COMPLETED|Overall Study||16
8204211|NCT02178709|20231515|P1|COMPLETED|Overall Study||32
8204212|NCT02178709|20231515|P1|STARTED|Overall Study||48
8204213|NCT02178696|20231526|P2|NOT COMPLETED|Open-label Antidepressant||7
8204214|NCT02178696|20231527|P1|NOT COMPLETED|Open-label Antidepressant||6
8204215|NCT02178696|20231526|P2|COMPLETED|Open-label Antidepressant||13
8204216|NCT02178696|20231527|P1|COMPLETED|Open-label Antidepressant||14
8204217|NCT02178696|20231526|P2|STARTED|Open-label Antidepressant||20
8204218|NCT02178696|20231527|P1|STARTED|Open-label Antidepressant||20
8204219|NCT02178696|20231526|P2|NOT COMPLETED|Second Assignment After Crossover||0
8204220|NCT02178696|20231527|P1|NOT COMPLETED|Second Assignment After Crossover||0
8204221|NCT02178696|20231526|P2|COMPLETED|Second Assignment After Crossover||20
8204222|NCT02178696|20231527|P1|COMPLETED|Second Assignment After Crossover||20
8204223|NCT02178696|20231526|P2|STARTED|Second Assignment After Crossover||20
8204224|NCT02178696|20231527|P1|STARTED|Second Assignment After Crossover||20
8204225|NCT02178696|20231526|P2|NOT COMPLETED|First Assignment and Washout||0
8204226|NCT02178696|20231527|P1|NOT COMPLETED|First Assignment and Washout||0
8204227|NCT02178696|20231526|P2|COMPLETED|First Assignment and Washout||20
8204228|NCT02178696|20231527|P1|COMPLETED|First Assignment and Washout||20
8204229|NCT02178696|20231526|P2|STARTED|First Assignment and Washout||20
8204230|NCT02178696|20231527|P1|STARTED|First Assignment and Washout||20
8204231|NCT02178592|20231542|P2|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||3
8204232|NCT02178592|20231543|P1|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||12
8204233|NCT02178592|20231542|P2|COMPLETED|OLE Phase (Week 52 to Week 252)||16
8204234|NCT02178592|20231543|P1|COMPLETED|OLE Phase (Week 52 to Week 252)||35
8204235|NCT02178592|20231542|P2|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 16 participants from EFV arm did not enter OLE from Randomized Phase.|19
8204236|NCT02178592|20231543|P1|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 3 participants from DTG arm did not enter OLE from Randomized Phase.|47
8204237|NCT02178592|20231542|P2|NOT COMPLETED|Randomized Phase (Up to Week 52)||9
8204238|NCT02178592|20231543|P1|NOT COMPLETED|Randomized Phase (Up to Week 52)||19
8204239|NCT02178592|20231542|P2|COMPLETED|Randomized Phase (Up to Week 52)||35
8204240|NCT02178592|20231543|P1|COMPLETED|Randomized Phase (Up to Week 52)||50
8204241|NCT02178592|20231542|P2|STARTED|Randomized Phase (Up to Week 52)||44
8204242|NCT02178592|20231543|P1|STARTED|Randomized Phase (Up to Week 52)||69
8204243|NCT02178553|20231585|P2|NOT COMPLETED|Overall Study||10
8204244|NCT02178553|20231586|P1|NOT COMPLETED|Overall Study||8
8204245|NCT02178553|20231585|P2|COMPLETED|Overall Study||39
8204246|NCT02178553|20231586|P1|COMPLETED|Overall Study||45
8204247|NCT02178553|20231585|P2|STARTED|Overall Study||49
8204248|NCT02178553|20231586|P1|STARTED|Overall Study||53
8204249|NCT02178540|20231598|P1|NOT COMPLETED|Overall Study||0
8204250|NCT02178540|20231598|P1|COMPLETED|Overall Study||45
8204251|NCT02178540|20231598|P1|STARTED|Overall Study||45
8204252|NCT02178475|20231605|P1|NOT COMPLETED|Overall Study||129
8204253|NCT02178475|20231605|P1|COMPLETED|Overall Study||814
8204254|NCT02178475|20231605|P1|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
8204255|NCT02178475|20231605|P1|STARTED|Overall Study||943
8204256|NCT02178241|20231625|P1|NOT COMPLETED|Overall Study||0
8204257|NCT02178241|20231625|P1|COMPLETED|Overall Study||24
8204258|NCT02178241|20231625|P1|STARTED|Overall Study||24
8204259|NCT02178059|20231632|P2|NOT COMPLETED|Second Intervention||0
8204260|NCT02178059|20231633|P1|NOT COMPLETED|Second Intervention||0
8204261|NCT02178059|20231632|P2|COMPLETED|Second Intervention||17
8204262|NCT02178059|20231633|P1|COMPLETED|Second Intervention||16
8204263|NCT02178059|20231632|P2|STARTED|Second Intervention||17
8204264|NCT02178059|20231633|P1|STARTED|Second Intervention||16
8204265|NCT02178059|20231632|P2|NOT COMPLETED|Washout||0
8204266|NCT02178059|20231633|P1|NOT COMPLETED|Washout||1
8204267|NCT02178059|20231632|P2|COMPLETED|Washout||17
8204268|NCT02178059|20231633|P1|COMPLETED|Washout||16
8204269|NCT02178059|20231632|P2|STARTED|Washout||17
8204270|NCT02178059|20231633|P1|STARTED|Washout||17
8204271|NCT02178059|20231632|P2|NOT COMPLETED|First Intervention||0
8204272|NCT02178059|20231633|P1|NOT COMPLETED|First Intervention||0
8204273|NCT02178059|20231632|P2|COMPLETED|First Intervention||17
8204274|NCT02178059|20231633|P1|COMPLETED|First Intervention||17
8204275|NCT02178059|20231632|P2|STARTED|First Intervention||17
8204276|NCT02178059|20231633|P1|STARTED|First Intervention||17
8204277|NCT02177942|20231651|P2|NOT COMPLETED|Overall Study||88
8204278|NCT02177942|20231652|P1|NOT COMPLETED|Overall Study||77
8204279|NCT02177942|20231651|P2|COMPLETED|Overall Study||178
8204280|NCT02177942|20231652|P1|COMPLETED|Overall Study||185
8204281|NCT02177942|20231651|P2|STARTED|Overall Study||266
8204282|NCT02177942|20231652|P1|STARTED|Overall Study||262
8204286|NCT02177812|20231689|P9|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204287|NCT02177812|20231690|P8|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204288|NCT02177812|20231691|P7|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204289|NCT02177812|20231692|P6|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204290|NCT02177812|20231693|P5|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204291|NCT02177812|20231694|P4|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204292|NCT02177812|20231695|P3|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204293|NCT02177812|20231696|P2|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204294|NCT02177812|20231697|P1|NOT COMPLETED|Part 2 (Up to 14 Months)||0
8204295|NCT02177812|20231689|P9|COMPLETED|Part 2 (Up to 14 Months)||0
8204296|NCT02177812|20231690|P8|COMPLETED|Part 2 (Up to 14 Months)||0
8204297|NCT02177812|20231691|P7|COMPLETED|Part 2 (Up to 14 Months)||0
8204298|NCT02177812|20231692|P6|COMPLETED|Part 2 (Up to 14 Months)||0
8204299|NCT02177812|20231693|P5|COMPLETED|Part 2 (Up to 14 Months)||0
8204300|NCT02177812|20231694|P4|COMPLETED|Part 2 (Up to 14 Months)||0
8204301|NCT02177812|20231695|P3|COMPLETED|Part 2 (Up to 14 Months)||0
8204302|NCT02177812|20231696|P2|COMPLETED|Part 2 (Up to 14 Months)||0
8204303|NCT02177812|20231697|P1|COMPLETED|Part 2 (Up to 14 Months)||0
8204304|NCT02177812|20231689|P9|STARTED|Part 2 (Up to 14 Months)||0
8204305|NCT02177812|20231690|P8|STARTED|Part 2 (Up to 14 Months)||0
8204306|NCT02177812|20231691|P7|STARTED|Part 2 (Up to 14 Months)||0
8204307|NCT02177812|20231692|P6|STARTED|Part 2 (Up to 14 Months)||0
8204308|NCT02177812|20231693|P5|STARTED|Part 2 (Up to 14 Months)||0
8204309|NCT02177812|20231694|P4|STARTED|Part 2 (Up to 14 Months)||0
8204310|NCT02177812|20231695|P3|STARTED|Part 2 (Up to 14 Months)||0
8204311|NCT02177812|20231696|P2|STARTED|Part 2 (Up to 14 Months)||0
8204312|NCT02177812|20231697|P1|STARTED|Part 2 (Up to 14 Months)||0
8204313|NCT02177812|20231689|P9|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
8204314|NCT02177812|20231690|P8|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2
8204315|NCT02177812|20231691|P7|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9
8204316|NCT02177812|20231692|P6|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3
8204317|NCT02177812|20231693|P5|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
8204318|NCT02177812|20231694|P4|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
8204319|NCT02177812|20231695|P3|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
8204320|NCT02177812|20231696|P2|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
8204321|NCT02177812|20231697|P1|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
8204322|NCT02177812|20231689|P9|COMPLETED|Part 1 (Median of 4 Weeks)||0
8204323|NCT02177812|20231690|P8|COMPLETED|Part 1 (Median of 4 Weeks)||4
8204324|NCT02177812|20231691|P7|COMPLETED|Part 1 (Median of 4 Weeks)||1
8204325|NCT02177812|20231692|P6|COMPLETED|Part 1 (Median of 4 Weeks)||1
8204326|NCT02177812|20231693|P5|COMPLETED|Part 1 (Median of 4 Weeks)||5
8204327|NCT02177812|20231694|P4|COMPLETED|Part 1 (Median of 4 Weeks)||4
8204328|NCT02177812|20231695|P3|COMPLETED|Part 1 (Median of 4 Weeks)||7
8204329|NCT02177812|20231696|P2|COMPLETED|Part 1 (Median of 4 Weeks)||2
8204330|NCT02177812|20231697|P1|COMPLETED|Part 1 (Median of 4 Weeks)||1
8204331|NCT02177812|20231689|P9|STARTED|Part 1 (Median of 4 Weeks)||0
8204332|NCT02177812|20231690|P8|STARTED|Part 1 (Median of 4 Weeks)||6
8204333|NCT02177812|20231691|P7|STARTED|Part 1 (Median of 4 Weeks)||10
8204334|NCT02177812|20231692|P6|STARTED|Part 1 (Median of 4 Weeks)||4
8204335|NCT02177812|20231693|P5|STARTED|Part 1 (Median of 4 Weeks)||6
8204336|NCT02177812|20231694|P4|STARTED|Part 1 (Median of 4 Weeks)||5
8204337|NCT02177812|20231695|P3|STARTED|Part 1 (Median of 4 Weeks)||7
8204338|NCT02177812|20231696|P2|STARTED|Part 1 (Median of 4 Weeks)||2
8204339|NCT02177812|20231697|P1|STARTED|Part 1 (Median of 4 Weeks)||1
8204340|NCT02177786|20231914|P4|NOT COMPLETED|Overall Study||13
8204341|NCT02177786|20231915|P3|NOT COMPLETED|Overall Study||18
8204342|NCT02177786|20231916|P2|NOT COMPLETED|Overall Study||14
8204343|NCT02177786|20231917|P1|NOT COMPLETED|Overall Study||6
8204344|NCT02177786|20231914|P4|COMPLETED|Overall Study||72
8204345|NCT02177786|20231915|P3|COMPLETED|Overall Study||66
8204346|NCT02177786|20231916|P2|COMPLETED|Overall Study||70
8204347|NCT02177786|20231917|P1|COMPLETED|Overall Study||75
8204348|NCT02177786|20231914|P4|Randomized and Treated|Overall Study||85
8204349|NCT02177786|20231915|P3|Randomized and Treated|Overall Study||83
8204350|NCT02177786|20231916|P2|Randomized and Treated|Overall Study||84
8204351|NCT02177786|20231917|P1|Randomized and Treated|Overall Study||81
8204352|NCT02177786|20231914|P4|STARTED|Overall Study||85
8204353|NCT02177786|20231915|P3|STARTED|Overall Study||84
8204354|NCT02177786|20231916|P2|STARTED|Overall Study||84
8204355|NCT02177786|20231917|P1|STARTED|Overall Study||81
8204356|NCT02177773|20231931|P1|NOT COMPLETED|Overall Study||0
8204357|NCT02177773|20231931|P1|COMPLETED|Overall Study||300
8204358|NCT02177773|20231931|P1|STARTED|Overall Study||300
8204359|NCT02177266|20231940|P2|NOT COMPLETED|Overall Study||1
8204360|NCT02177266|20231941|P1|NOT COMPLETED|Overall Study||1
8204361|NCT02177266|20231940|P2|COMPLETED|Overall Study||0
8204362|NCT02177266|20231941|P1|COMPLETED|Overall Study||0
8204363|NCT02177266|20231940|P2|STARTED|Overall Study||1
8204364|NCT02177266|20231941|P1|STARTED|Overall Study||1
8204365|NCT02177201|20231953|P2|NOT COMPLETED|Overall Study||3
8204366|NCT02177201|20231954|P1|NOT COMPLETED|Overall Study||3
8204367|NCT02177201|20231953|P2|COMPLETED|Overall Study||77
8204368|NCT02177201|20231954|P1|COMPLETED|Overall Study||77
8204369|NCT02177201|20231953|P2|STARTED|Overall Study||80
8204370|NCT02177201|20231954|P1|STARTED|Overall Study||80
8204380|NCT02177032|20231998|P4|NOT COMPLETED|Overall Study||0
8204381|NCT02177032|20231999|P3|NOT COMPLETED|Overall Study||3
8204382|NCT02177032|20232000|P2|NOT COMPLETED|Overall Study||2
8204383|NCT02177032|20232001|P1|NOT COMPLETED|Overall Study||5
8204384|NCT02177032|20231998|P4|COMPLETED|Overall Study||88
8204385|NCT02177032|20231999|P3|COMPLETED|Overall Study||351
8204386|NCT02177032|20232000|P2|COMPLETED|Overall Study||86
8204387|NCT02177032|20232001|P1|COMPLETED|Overall Study||350
8204388|NCT02177032|20231998|P4|STARTED|Overall Study||88
8204389|NCT02177032|20231999|P3|STARTED|Overall Study||354
8204390|NCT02177032|20232000|P2|STARTED|Overall Study||88
8204391|NCT02177032|20232001|P1|STARTED|Overall Study||355
8204392|NCT02176928|20232037|P2|NOT COMPLETED|Overall Study||4
8204393|NCT02176928|20232038|P1|NOT COMPLETED|Overall Study||2
8204394|NCT02176928|20232037|P2|COMPLETED|Overall Study||17
8204395|NCT02176928|20232038|P1|COMPLETED|Overall Study||19
8204396|NCT02176928|20232037|P2|STARTED|Overall Study||21
8204397|NCT02176928|20232038|P1|STARTED|Overall Study||21
8204398|NCT02176837|20232044|P1|NOT COMPLETED|Overall Study||6
8204399|NCT02176837|20232044|P1|COMPLETED|Overall Study||0
8204400|NCT02176837|20232044|P1|STARTED|Overall Study||6
8204401|NCT02176655|20232048|P1|NOT COMPLETED|Overall Study||6
8204402|NCT02176655|20232048|P1|COMPLETED|Overall Study||25
8204403|NCT02176655|20232048|P1|STARTED|Overall Study||31
8204404|NCT02176642|20232071|P2|NOT COMPLETED|Overall Study||1
8204405|NCT02176642|20232072|P1|NOT COMPLETED|Overall Study||0
8204406|NCT02176642|20232071|P2|COMPLETED|Overall Study||16
8204407|NCT02176642|20232072|P1|COMPLETED|Overall Study||18
8204408|NCT02176642|20232071|P2|STARTED|Overall Study||17
8204409|NCT02176642|20232072|P1|STARTED|Overall Study||18
8204410|NCT02176525|20232102|P8|NOT COMPLETED|Overall Study||0
8204411|NCT02176525|20232103|P7|NOT COMPLETED|Overall Study||1
8204412|NCT02176525|20232104|P6|NOT COMPLETED|Overall Study||1
8204413|NCT02176525|20232105|P5|NOT COMPLETED|Overall Study||1
8204414|NCT02176525|20232106|P4|NOT COMPLETED|Overall Study||1
8204415|NCT02176525|20232107|P3|NOT COMPLETED|Overall Study||0
8204416|NCT02176525|20232108|P2|NOT COMPLETED|Overall Study||0
8204417|NCT02176525|20232109|P1|NOT COMPLETED|Overall Study||1
8204418|NCT02176525|20232102|P8|COMPLETED|Overall Study||10
8204419|NCT02176525|20232103|P7|COMPLETED|Overall Study||8
8204420|NCT02176525|20232104|P6|COMPLETED|Overall Study||5
8204421|NCT02176525|20232105|P5|COMPLETED|Overall Study||7
8204422|NCT02176525|20232106|P4|COMPLETED|Overall Study||8
8204423|NCT02176525|20232107|P3|COMPLETED|Overall Study||9
8204424|NCT02176525|20232108|P2|COMPLETED|Overall Study||9
8204425|NCT02176525|20232109|P1|COMPLETED|Overall Study||14
8204426|NCT02176525|20232102|P8|STARTED|Overall Study||10
8204427|NCT02176525|20232103|P7|STARTED|Overall Study||9
8204428|NCT02176525|20232104|P6|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
8204429|NCT02176525|20232105|P5|STARTED|Overall Study||8
8204430|NCT02176525|20232106|P4|STARTED|Overall Study||9
8204431|NCT02176525|20232107|P3|STARTED|Overall Study||9
8204432|NCT02176525|20232108|P2|STARTED|Overall Study||9
8204433|NCT02176525|20232109|P1|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
8204434|NCT02176486|20232289|P3|NOT COMPLETED|Overall Study||0
8204435|NCT02176486|20232290|P2|NOT COMPLETED|Overall Study||0
8204436|NCT02176486|20232291|P1|NOT COMPLETED|Overall Study||0
8204437|NCT02176486|20232289|P3|COMPLETED|Overall Study||4
8204438|NCT02176486|20232290|P2|COMPLETED|Overall Study||5
8204439|NCT02176486|20232291|P1|COMPLETED|Overall Study||3
8204440|NCT02176486|20232289|P3|STARTED|Overall Study||4
8204441|NCT02176486|20232290|P2|STARTED|Overall Study||5
8204442|NCT02176486|20232291|P1|STARTED|Overall Study||3
8204443|NCT02176421|20232325|P1|NOT COMPLETED|Overall Study||5
8204444|NCT02176421|20232325|P1|COMPLETED|Overall Study||75
8204445|NCT02176421|20232325|P1|STARTED|Overall Study||80
8204446|NCT02176408|20232336|P2|NOT COMPLETED|Overall Study||4
8204447|NCT02176408|20232337|P1|NOT COMPLETED|Overall Study||6
8204448|NCT02176408|20232336|P2|COMPLETED|Overall Study||12
8204449|NCT02176408|20232337|P1|COMPLETED|Overall Study||9
8204450|NCT02176408|20232336|P2|STARTED|Overall Study||16
8204451|NCT02176408|20232337|P1|STARTED|Overall Study||15
8204464|NCT02176356|20232366|P1|NOT COMPLETED|Overall Study||23
8204465|NCT02176356|20232366|P1|COMPLETED|Overall Study||93
8204466|NCT02176356|20232366|P1|Eligible and Received Treatment|Overall Study||100
8204467|NCT02176356|20232366|P1|STARTED|Overall Study||116
8204468|NCT02176343|20232383|P1|NOT COMPLETED|Overall Study||0
8204469|NCT02176343|20232383|P1|COMPLETED|Overall Study||31
8204470|NCT02176343|20232383|P1|STARTED|Overall Study||31
8204471|NCT02176291|20232396|P2|NOT COMPLETED|Overall Study||0
8204472|NCT02176291|20232397|P1|NOT COMPLETED|Overall Study||5
8204473|NCT02176291|20232396|P2|COMPLETED|Overall Study||11
8204474|NCT02176291|20232397|P1|COMPLETED|Overall Study||15
8204475|NCT02176291|20232396|P2|STARTED|Overall Study||11
8204476|NCT02176291|20232397|P1|STARTED|Overall Study||20
8204477|NCT02176226|20232405|P1|NOT COMPLETED|Overall Study||9
8204478|NCT02176226|20232405|P1|COMPLETED|Overall Study||96
8204479|NCT02176226|20232405|P1|STARTED|Overall Study||105
8204480|NCT02176083|20232413|P2|NOT COMPLETED|Overall Study||0
8204481|NCT02176083|20232414|P1|NOT COMPLETED|Overall Study||0
8204482|NCT02176083|20232413|P2|COMPLETED|Overall Study||27
8204483|NCT02176083|20232414|P1|COMPLETED|Overall Study||11
8204484|NCT02176083|20232413|P2|STARTED|Overall Study||27
8204485|NCT02176083|20232414|P1|STARTED|Overall Study||11
8204486|NCT02176031|20232420|P1|NOT COMPLETED|Overall Study||12
8204487|NCT02176031|20232420|P1|COMPLETED|Overall Study||9
8204488|NCT02176031|20232420|P1|STARTED|Overall Study||21
8204489|NCT02176018|20232431|P2|NOT COMPLETED|Overall Study||6
8204490|NCT02176018|20232432|P1|NOT COMPLETED|Overall Study||5
8204491|NCT02176018|20232431|P2|COMPLETED|Overall Study||17
8204492|NCT02176018|20232432|P1|COMPLETED|Overall Study||17
8204493|NCT02176018|20232431|P2|STARTED|Overall Study||23
8204494|NCT02176018|20232432|P1|STARTED|Overall Study||22
8204495|NCT02176005|20232460|P4|NOT COMPLETED|Overall Study||0
8204496|NCT02176005|20232461|P3|NOT COMPLETED|Overall Study||0
8204497|NCT02176005|20232462|P2|NOT COMPLETED|Overall Study||0
8204498|NCT02176005|20232463|P1|NOT COMPLETED|Overall Study||0
8204499|NCT02176005|20232460|P4|COMPLETED|Overall Study||8
8204500|NCT02176005|20232461|P3|COMPLETED|Overall Study||8
8204501|NCT02176005|20232462|P2|COMPLETED|Overall Study||14
8204502|NCT02176005|20232463|P1|COMPLETED|Overall Study||14
8204503|NCT02176005|20232460|P4|STARTED|Overall Study||8
8204504|NCT02176005|20232461|P3|STARTED|Overall Study||8
8204505|NCT02176005|20232462|P2|STARTED|Overall Study||14
8204506|NCT02176005|20232463|P1|STARTED|Overall Study||14
8204507|NCT02175979|20232491|P2|NOT COMPLETED|Overall Study||8
8204508|NCT02175979|20232492|P1|NOT COMPLETED|Overall Study||7
8204509|NCT02175979|20232491|P2|COMPLETED|Overall Study||132
8204510|NCT02175979|20232492|P1|COMPLETED|Overall Study||133
8204511|NCT02175979|20232491|P2|STARTED|Overall Study||140
8204512|NCT02175979|20232492|P1|STARTED|Overall Study||140
8204513|NCT02175966|20232516|P2|NOT COMPLETED|Follow-up Period||6
8204514|NCT02175966|20232517|P1|NOT COMPLETED|Follow-up Period||10
8204515|NCT02175966|20232516|P2|COMPLETED|Follow-up Period||8
8204516|NCT02175966|20232517|P1|COMPLETED|Follow-up Period||4
8204517|NCT02175966|20232516|P2|STARTED|Follow-up Period||14
8204518|NCT02175966|20232517|P1|STARTED|Follow-up Period||14
8204519|NCT02175966|20232516|P2|NOT COMPLETED|Treatment Period||0
8204520|NCT02175966|20232517|P1|NOT COMPLETED|Treatment Period||0
8204521|NCT02175966|20232516|P2|COMPLETED|Treatment Period||14
8204522|NCT02175966|20232517|P1|COMPLETED|Treatment Period||14
8204523|NCT02175966|20232516|P2|STARTED|Treatment Period||14
8204524|NCT02175966|20232517|P1|STARTED|Treatment Period||14
8204525|NCT02175771|20232545|P9|NOT COMPLETED|Treatment Period||6
8204526|NCT02175771|20232546|P8|NOT COMPLETED|Treatment Period||17
8204527|NCT02175771|20232547|P7|NOT COMPLETED|Treatment Period||5
8204528|NCT02175771|20232548|P6|NOT COMPLETED|Treatment Period||10
8204529|NCT02175771|20232549|P5|NOT COMPLETED|Treatment Period||5
8204530|NCT02175771|20232550|P4|NOT COMPLETED|Treatment Period||13
8204531|NCT02175771|20232551|P3|NOT COMPLETED|Treatment Period||7
8204532|NCT02175771|20232552|P2|NOT COMPLETED|Treatment Period||16
8204533|NCT02175771|20232553|P1|NOT COMPLETED|Treatment Period||0
8204534|NCT02175771|20232545|P9|COMPLETED|Treatment Period||38
8204535|NCT02175771|20232546|P8|COMPLETED|Treatment Period||116
8204536|NCT02175771|20232547|P7|COMPLETED|Treatment Period||36
8204537|NCT02175771|20232548|P6|COMPLETED|Treatment Period||110
8204538|NCT02175771|20232549|P5|COMPLETED|Treatment Period||36
8204539|NCT02175771|20232550|P4|COMPLETED|Treatment Period||113
8204540|NCT02175771|20232551|P3|COMPLETED|Treatment Period||35
8204541|NCT02175771|20232552|P2|COMPLETED|Treatment Period||111
8204542|NCT02175771|20232553|P1|COMPLETED|Treatment Period||0
8204543|NCT02175771|20232545|P9|STARTED|Treatment Period||44
8204544|NCT02175771|20232546|P8|STARTED|Treatment Period||133
8204545|NCT02175771|20232547|P7|STARTED|Treatment Period||41
8204546|NCT02175771|20232548|P6|STARTED|Treatment Period||120
8204547|NCT02175771|20232549|P5|STARTED|Treatment Period||41
8204548|NCT02175771|20232550|P4|STARTED|Treatment Period||126
8204549|NCT02175771|20232551|P3|STARTED|Treatment Period||42
8204550|NCT02175771|20232552|P2|STARTED|Treatment Period||127
8204551|NCT02175771|20232553|P1|STARTED|Treatment Period||0
8204552|NCT02175771|20232545|P9|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204553|NCT02175771|20232546|P8|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204554|NCT02175771|20232547|P7|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204555|NCT02175771|20232548|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204556|NCT02175771|20232549|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204557|NCT02175771|20232550|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204558|NCT02175771|20232551|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204559|NCT02175771|20232552|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8204560|NCT02175771|20232553|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||84
8204561|NCT02175771|20232545|P9|COMPLETED|Run-In Period (Pre-assignment)||0
8204562|NCT02175771|20232546|P8|COMPLETED|Run-In Period (Pre-assignment)||0
8204563|NCT02175771|20232547|P7|COMPLETED|Run-In Period (Pre-assignment)||0
8204564|NCT02175771|20232548|P6|COMPLETED|Run-In Period (Pre-assignment)||0
8204565|NCT02175771|20232549|P5|COMPLETED|Run-In Period (Pre-assignment)||0
8204566|NCT02175771|20232550|P4|COMPLETED|Run-In Period (Pre-assignment)||0
8204567|NCT02175771|20232551|P3|COMPLETED|Run-In Period (Pre-assignment)||0
8204568|NCT02175771|20232552|P2|COMPLETED|Run-In Period (Pre-assignment)||0
8204569|NCT02175771|20232553|P1|COMPLETED|Run-In Period (Pre-assignment)||674
8204570|NCT02175771|20232545|P9|STARTED|Run-In Period (Pre-assignment)||0
8204571|NCT02175771|20232546|P8|STARTED|Run-In Period (Pre-assignment)||0
8204572|NCT02175771|20232547|P7|STARTED|Run-In Period (Pre-assignment)||0
8204573|NCT02175771|20232548|P6|STARTED|Run-In Period (Pre-assignment)||0
8204574|NCT02175771|20232549|P5|STARTED|Run-In Period (Pre-assignment)||0
8204575|NCT02175771|20232550|P4|STARTED|Run-In Period (Pre-assignment)||0
8204576|NCT02175771|20232551|P3|STARTED|Run-In Period (Pre-assignment)||0
8204577|NCT02175771|20232552|P2|STARTED|Run-In Period (Pre-assignment)||0
8204578|NCT02175771|20232553|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
8204579|NCT02175758|20232617|P6|NOT COMPLETED|Treatment Phase||0
8204580|NCT02175758|20232618|P5|NOT COMPLETED|Treatment Phase||1
8204581|NCT02175758|20232619|P4|NOT COMPLETED|Treatment Phase||0
8204582|NCT02175758|20232620|P3|NOT COMPLETED|Treatment Phase||0
8204583|NCT02175758|20232621|P2|NOT COMPLETED|Treatment Phase||1
8204584|NCT02175758|20232622|P1|NOT COMPLETED|Treatment Phase||0
8204585|NCT02175758|20232617|P6|COMPLETED|Treatment Phase||8
8204586|NCT02175758|20232618|P5|COMPLETED|Treatment Phase||4
8204587|NCT02175758|20232619|P4|COMPLETED|Treatment Phase||28
8204588|NCT02175758|20232620|P3|COMPLETED|Treatment Phase||13
8204589|NCT02175758|20232621|P2|COMPLETED|Treatment Phase||38
8204590|NCT02175758|20232622|P1|COMPLETED|Treatment Phase||13
8204591|NCT02175758|20232617|P6|STARTED|Treatment Phase||8
8204592|NCT02175758|20232618|P5|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5
8204593|NCT02175758|20232619|P4|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28
8204594|NCT02175758|20232620|P3|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
8204595|NCT02175758|20232621|P2|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39
8204596|NCT02175758|20232622|P1|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
8204597|NCT02175758|20232617|P6|NOT COMPLETED|PK Lead-in Phase||0
8204598|NCT02175758|20232618|P5|NOT COMPLETED|PK Lead-in Phase||0
8204599|NCT02175758|20232619|P4|NOT COMPLETED|PK Lead-in Phase||0
8204600|NCT02175758|20232620|P3|NOT COMPLETED|PK Lead-in Phase||0
8204601|NCT02175758|20232621|P2|NOT COMPLETED|PK Lead-in Phase||0
8204602|NCT02175758|20232622|P1|NOT COMPLETED|PK Lead-in Phase||0
8204603|NCT02175758|20232617|P6|COMPLETED|PK Lead-in Phase||8
8204604|NCT02175758|20232618|P5|COMPLETED|PK Lead-in Phase||4
8204605|NCT02175758|20232619|P4|COMPLETED|PK Lead-in Phase||10
8204606|NCT02175758|20232620|P3|COMPLETED|PK Lead-in Phase||2
8204607|NCT02175758|20232621|P2|COMPLETED|PK Lead-in Phase||6
8204608|NCT02175758|20232622|P1|COMPLETED|PK Lead-in Phase||4
8204609|NCT02175758|20232617|P6|STARTED|PK Lead-in Phase||8
8204610|NCT02175758|20232618|P5|STARTED|PK Lead-in Phase||4
8204611|NCT02175758|20232619|P4|STARTED|PK Lead-in Phase||10
8204612|NCT02175758|20232620|P3|STARTED|PK Lead-in Phase||2
8204613|NCT02175758|20232621|P2|STARTED|PK Lead-in Phase||6
8204614|NCT02175758|20232622|P1|STARTED|PK Lead-in Phase||4
8204615|NCT02175745|20232725|P1|NOT COMPLETED|Overall Study||1
8204616|NCT02175745|20232725|P1|COMPLETED|Overall Study||1
8204617|NCT02175745|20232725|P1|STARTED|Overall Study||2
8204618|NCT02175628|20232732|P2|NOT COMPLETED|Overall Study||0
8204619|NCT02175628|20232733|P1|NOT COMPLETED|Overall Study||0
8204620|NCT02175628|20232732|P2|COMPLETED|Overall Study||17
8204621|NCT02175628|20232733|P1|COMPLETED|Overall Study||6
8204622|NCT02175628|20232732|P2|STARTED|Overall Study||17
8204623|NCT02175628|20232733|P1|STARTED|Overall Study||6
8204624|NCT02175472|20232749|P2|NOT COMPLETED|Overall Study||2
8204625|NCT02175472|20232750|P1|NOT COMPLETED|Overall Study||7
8204626|NCT02175472|20232749|P2|COMPLETED|Overall Study||45
8204627|NCT02175472|20232750|P1|COMPLETED|Overall Study||38
8204628|NCT02175472|20232749|P2|STARTED|Overall Study||47
8204629|NCT02175472|20232750|P1|STARTED|Overall Study||45
8204630|NCT02175368|20232764|P1|NOT COMPLETED|Overall Study||1
8204631|NCT02175368|20232764|P1|COMPLETED|Overall Study||27
8204632|NCT02175368|20232764|P1|STARTED|Overall Study||28
8204633|NCT02175277|20232769|P1|NOT COMPLETED|Overall Study||1
8204634|NCT02175277|20232769|P1|COMPLETED|Overall Study||8
8204635|NCT02175277|20232769|P1|STARTED|Overall Study||9
8204636|NCT02175225|20232775|P2|NOT COMPLETED|Overall Study||11
8204637|NCT02175225|20232776|P1|NOT COMPLETED|Overall Study||8
8204638|NCT02175225|20232775|P2|COMPLETED|Overall Study||138
8204639|NCT02175225|20232776|P1|COMPLETED|Overall Study||137
8204640|NCT02175225|20232775|P2|180 Day Outcome Obtained|Overall Study||135
8204641|NCT02175225|20232776|P1|180 Day Outcome Obtained|Overall Study||135
8204642|NCT02175225|20232775|P2|90 Day Outcome Obtained|Overall Study||143
8204643|NCT02175225|20232776|P1|90 Day Outcome Obtained|Overall Study||140
8204644|NCT02175225|20232775|P2|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147
8204645|NCT02175225|20232776|P1|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144
8204646|NCT02175225|20232775|P2|STARTED|Overall Study||149
8204647|NCT02175225|20232776|P1|STARTED|Overall Study||145
8204648|NCT02175212|20232810|P2|NOT COMPLETED|Overall Study||147
8204649|NCT02175212|20232811|P1|NOT COMPLETED|Overall Study||163
8204650|NCT02175212|20232810|P2|COMPLETED|Overall Study||31
8204651|NCT02175212|20232811|P1|COMPLETED|Overall Study||14
8204652|NCT02175212|20232810|P2|STARTED|Overall Study||178
8204653|NCT02175212|20232811|P1|STARTED|Overall Study||177
8204654|NCT02175199|20232827|P2|NOT COMPLETED|Overall Study||5
8204655|NCT02175199|20232828|P1|NOT COMPLETED|Overall Study||3
8204656|NCT02175199|20232827|P2|COMPLETED|Overall Study||71
8204657|NCT02175199|20232828|P1|COMPLETED|Overall Study||71
8204658|NCT02175199|20232827|P2|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
8204659|NCT02175199|20232828|P1|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
8204660|NCT02175199|20232827|P2|STARTED|Overall Study||76
8204661|NCT02175199|20232828|P1|STARTED|Overall Study||74
8204662|NCT02175121|20232842|P5|NOT COMPLETED|Overall Study||1
8204663|NCT02175121|20232843|P4|NOT COMPLETED|Overall Study||1
8204664|NCT02175121|20232844|P3|NOT COMPLETED|Overall Study||2
8204665|NCT02175121|20232845|P2|NOT COMPLETED|Overall Study||1
8204666|NCT02175121|20232846|P1|NOT COMPLETED|Overall Study||1
8204667|NCT02175121|20232842|P5|COMPLETED|Overall Study||33
8204668|NCT02175121|20232843|P4|COMPLETED|Overall Study||34
8204669|NCT02175121|20232844|P3|COMPLETED|Overall Study||32
8204670|NCT02175121|20232845|P2|COMPLETED|Overall Study||34
8204671|NCT02175121|20232846|P1|COMPLETED|Overall Study||33
8204672|NCT02175121|20232842|P5|STARTED|Overall Study||34
8204673|NCT02175121|20232843|P4|STARTED|Overall Study||35
8204674|NCT02175121|20232844|P3|STARTED|Overall Study||34
8204675|NCT02175121|20232845|P2|STARTED|Overall Study||35
8204676|NCT02175121|20232846|P1|STARTED|Overall Study||34
8204677|NCT02174913|20232975|P2|NOT COMPLETED|Overall Study||0
8204678|NCT02174913|20232976|P1|NOT COMPLETED|Overall Study||0
8204679|NCT02174913|20232975|P2|COMPLETED|Overall Study||17
8204680|NCT02174913|20232976|P1|COMPLETED|Overall Study||17
8204681|NCT02174913|20232975|P2|STARTED|Overall Study||17
8204682|NCT02174913|20232976|P1|STARTED|Overall Study||17
8204683|NCT02174861|20232984|P1|NOT COMPLETED|Overall Study||158
8204684|NCT02174861|20232984|P1|COMPLETED|Overall Study||451
8204685|NCT02174861|20232984|P1|Enrolled in CHU Substudy|Overall Study||53
8204686|NCT02174861|20232984|P1|STARTED|Overall Study||609
8204687|NCT02174848|20232998|P2|NOT COMPLETED|Overall Study||6
8204688|NCT02174848|20232999|P1|NOT COMPLETED|Overall Study||7
8204689|NCT02174848|20232998|P2|COMPLETED|Overall Study||38
8204690|NCT02174848|20232999|P1|COMPLETED|Overall Study||17
8204691|NCT02174848|20232998|P2|Provided Post-baseline Efficacy Data|Overall Study||43
8204692|NCT02174848|20232999|P1|Provided Post-baseline Efficacy Data|Overall Study||19
8204693|NCT02174848|20232998|P2|STARTED|Overall Study||44
8204694|NCT02174848|20232999|P1|STARTED|Overall Study||24
8204695|NCT02174731|20233016|P2|NOT COMPLETED|Overall Study||65
8204696|NCT02174731|20233017|P1|NOT COMPLETED|Overall Study||69
8204697|NCT02174731|20233016|P2|COMPLETED|Overall Study||990
8204698|NCT02174731|20233017|P1|COMPLETED|Overall Study||982
8204699|NCT02174731|20233016|P2|Received Treatment|Overall Study||1053
8204700|NCT02174731|20233017|P1|Received Treatment|Overall Study||1048
8204701|NCT02174731|20233016|P2|STARTED|Overall Study||1055
8204702|NCT02174731|20233017|P1|STARTED|Overall Study||1051
8204703|NCT02174627|20233039|P2|NOT COMPLETED|Overall Study||130
8204704|NCT02174627|20233040|P1|NOT COMPLETED|Overall Study||84
8204705|NCT02174627|20233039|P2|COMPLETED|Overall Study||1247
8204706|NCT02174627|20233040|P1|COMPLETED|Overall Study||1300
8204707|NCT02174627|20233039|P2|Discontinued Treatment|Overall Study||801
8204708|NCT02174627|20233040|P1|Discontinued Treatment|Overall Study||499
8204709|NCT02174627|20233039|P2|Received Treatment|Overall Study||1376
8204710|NCT02174627|20233040|P1|Received Treatment|Overall Study||1384
8204711|NCT02174627|20233039|P2|STARTED|Overall Study||1377
8204712|NCT02174627|20233040|P1|STARTED|Overall Study||1384
8204713|NCT02174562|20233068|P2|NOT COMPLETED|Overall Study||5
8204714|NCT02174562|20233069|P1|NOT COMPLETED|Overall Study||9
8204715|NCT02174562|20233068|P2|COMPLETED|Overall Study||46
8204716|NCT02174562|20233069|P1|COMPLETED|Overall Study||41
8204717|NCT02174562|20233068|P2|STARTED|Overall Study||51
8204718|NCT02174562|20233069|P1|STARTED|Overall Study||50
8204719|NCT02174523|20233079|P2|NOT COMPLETED|Overall Study||0
8204720|NCT02174523|20233080|P1|NOT COMPLETED|Overall Study||1
8204721|NCT02174523|20233079|P2|COMPLETED|Overall Study||4
8204722|NCT02174523|20233080|P1|COMPLETED|Overall Study||9
8204723|NCT02174523|20233079|P2|STARTED|Overall Study||4
8204724|NCT02174523|20233080|P1|STARTED|Overall Study||10
8204725|NCT02174510|20233111|P4|NOT COMPLETED|Overall Study||0
8204726|NCT02174510|20233112|P3|NOT COMPLETED|Overall Study||0
8204727|NCT02174510|20233113|P2|NOT COMPLETED|Overall Study||0
8204728|NCT02174510|20233114|P1|NOT COMPLETED|Overall Study||0
8204729|NCT02174510|20233111|P4|COMPLETED|Overall Study||9
8204730|NCT02174510|20233112|P3|COMPLETED|Overall Study||12
8204731|NCT02174510|20233113|P2|COMPLETED|Overall Study||8
8204732|NCT02174510|20233114|P1|COMPLETED|Overall Study||8
8204733|NCT02174510|20233111|P4|STARTED|Overall Study||9
8204734|NCT02174510|20233112|P3|STARTED|Overall Study||12
8204735|NCT02174510|20233113|P2|STARTED|Overall Study||8
8204736|NCT02174510|20233114|P1|STARTED|Overall Study||8
8204737|NCT02174432|20233144|P1|NOT COMPLETED|Overall Study||20
8204738|NCT02174432|20233144|P1|COMPLETED|Overall Study||16
8204739|NCT02174432|20233144|P1|STARTED|Overall Study||36
8204740|NCT02174419|20233151|P3|NOT COMPLETED|Overall Study||2
8204741|NCT02174419|20233152|P2|NOT COMPLETED|Overall Study||6
8204742|NCT02174419|20233153|P1|NOT COMPLETED|Overall Study||4
8204743|NCT02174419|20233151|P3|COMPLETED|Overall Study||20
8204744|NCT02174419|20233152|P2|COMPLETED|Overall Study||12
8204745|NCT02174419|20233153|P1|COMPLETED|Overall Study||18
8204746|NCT02174419|20233151|P3|STARTED|Overall Study||22
8204747|NCT02174419|20233152|P2|STARTED|Overall Study||18
8204748|NCT02174419|20233153|P1|STARTED|Overall Study||22
8204749|NCT02174276|20233165|P4|NOT COMPLETED|OTEP (Weeks 48 to 144)||2
8204750|NCT02174276|20233166|P3|NOT COMPLETED|OTEP (Weeks 48 to 144)||3
8204751|NCT02174276|20233167|P2|NOT COMPLETED|OTEP (Weeks 48 to 144)||0
8204752|NCT02174276|20233168|P1|NOT COMPLETED|OTEP (Weeks 48 to 144)||1
8204753|NCT02174276|20233165|P4|COMPLETED|OTEP (Weeks 48 to 144)||50
8204754|NCT02174276|20233166|P3|COMPLETED|OTEP (Weeks 48 to 144)||48
8204755|NCT02174276|20233167|P2|COMPLETED|OTEP (Weeks 48 to 144)||54
8204756|NCT02174276|20233168|P1|COMPLETED|OTEP (Weeks 48 to 144)||25
8204757|NCT02174276|20233165|P4|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52
8204758|NCT02174276|20233166|P3|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51
8204759|NCT02174276|20233167|P2|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54
8204760|NCT02174276|20233168|P1|STARTED|OTEP (Weeks 48 to 144)||26
8204761|NCT02174276|20233165|P4|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0
8204762|NCT02174276|20233166|P3|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3
8204763|NCT02174276|20233167|P2|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
8204764|NCT02174276|20233168|P1|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
8204765|NCT02174276|20233165|P4|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55
8204766|NCT02174276|20233166|P3|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53
8204767|NCT02174276|20233167|P2|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56
8204768|NCT02174276|20233168|P1|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26
8204769|NCT02174276|20233165|P4|STARTED|Study Treatment Phase (Weeks 1 to 48)||55
8204770|NCT02174276|20233166|P3|STARTED|Study Treatment Phase (Weeks 1 to 48)||56
8204771|NCT02174276|20233167|P2|STARTED|Study Treatment Phase (Weeks 1 to 48)||57
8204772|NCT02174276|20233168|P1|STARTED|Study Treatment Phase (Weeks 1 to 48)||27
8204773|NCT02174198|20233252|P2|NOT COMPLETED|Overall Study||0
8204774|NCT02174198|20233253|P1|NOT COMPLETED|Overall Study||0
8204775|NCT02174198|20233252|P2|COMPLETED|Overall Study||16
8204776|NCT02174198|20233253|P1|COMPLETED|Overall Study||16
8204777|NCT02174198|20233252|P2|STARTED|Overall Study||16
8204778|NCT02174198|20233253|P1|STARTED|Overall Study||16
8204779|NCT02173769|20233275|P1|NOT COMPLETED|Overall Study||4
8204780|NCT02173769|20233275|P1|COMPLETED|Overall Study||1854
8204781|NCT02173769|20233275|P1|STARTED|Overall Study||1858
8204782|NCT02173704|20233288|P2|NOT COMPLETED|Overall Study||4
8204783|NCT02173704|20233289|P1|NOT COMPLETED|Overall Study||13
8204784|NCT02173704|20233288|P2|COMPLETED|Overall Study||71
8204785|NCT02173704|20233289|P1|COMPLETED|Overall Study||137
8204786|NCT02173704|20233288|P2|STARTED|Overall Study||75
8204787|NCT02173704|20233289|P1|STARTED|Overall Study||150
8204788|NCT02173548|20233317|P2|NOT COMPLETED|Overall Study||2
8204789|NCT02173548|20233318|P1|NOT COMPLETED|Overall Study||1
8204790|NCT02173548|20233317|P2|COMPLETED|Overall Study||8
8204791|NCT02173548|20233318|P1|COMPLETED|Overall Study||20
8204792|NCT02173548|20233317|P2|STARTED|Overall Study||10
8204793|NCT02173548|20233318|P1|STARTED|Overall Study||21
8204794|NCT02173535|20233358|P20|NOT COMPLETED|Period 5||0
8204795|NCT02173535|20233359|P19|NOT COMPLETED|Period 5||0
8204796|NCT02173535|20233360|P18|NOT COMPLETED|Period 5||0
8204797|NCT02173535|20233361|P17|NOT COMPLETED|Period 5||0
8204798|NCT02173535|20233362|P16|NOT COMPLETED|Period 5||0
8204799|NCT02173535|20233363|P15|NOT COMPLETED|Period 5||0
8204800|NCT02173535|20233364|P14|NOT COMPLETED|Period 5||0
8204801|NCT02173535|20233365|P13|NOT COMPLETED|Period 5||0
8204802|NCT02173535|20233366|P12|NOT COMPLETED|Period 5||0
8204803|NCT02173535|20233367|P11|NOT COMPLETED|Period 5||0
8204804|NCT02173535|20233368|P10|NOT COMPLETED|Period 5||0
8204805|NCT02173535|20233369|P9|NOT COMPLETED|Period 5||0
8204806|NCT02173535|20233370|P8|NOT COMPLETED|Period 5||0
8204807|NCT02173535|20233371|P7|NOT COMPLETED|Period 5||0
8204808|NCT02173535|20233372|P6|NOT COMPLETED|Period 5||0
8204809|NCT02173535|20233373|P5|NOT COMPLETED|Period 5||0
8204810|NCT02173535|20233374|P4|NOT COMPLETED|Period 5||0
8204811|NCT02173535|20233375|P3|NOT COMPLETED|Period 5||0
8204812|NCT02173535|20233376|P2|NOT COMPLETED|Period 5||0
8204813|NCT02173535|20233377|P1|NOT COMPLETED|Period 5||0
8204814|NCT02173535|20233358|P20|COMPLETED|Period 5||12
8204815|NCT02173535|20233359|P19|COMPLETED|Period 5||12
8204816|NCT02173535|20233360|P18|COMPLETED|Period 5||12
8204817|NCT02173535|20233361|P17|COMPLETED|Period 5||12
8204818|NCT02173535|20233362|P16|COMPLETED|Period 5||12
8204819|NCT02173535|20233363|P15|COMPLETED|Period 5||12
8204820|NCT02173535|20233364|P14|COMPLETED|Period 5||12
8204821|NCT02173535|20233365|P13|COMPLETED|Period 5||12
8204822|NCT02173535|20233366|P12|COMPLETED|Period 5||12
8204823|NCT02173535|20233367|P11|COMPLETED|Period 5||12
8204824|NCT02173535|20233368|P10|COMPLETED|Period 5||12
8204825|NCT02173535|20233369|P9|COMPLETED|Period 5||12
8204826|NCT02173535|20233370|P8|COMPLETED|Period 5||12
8204827|NCT02173535|20233371|P7|COMPLETED|Period 5||12
8204828|NCT02173535|20233372|P6|COMPLETED|Period 5||12
8204829|NCT02173535|20233373|P5|COMPLETED|Period 5||12
8204830|NCT02173535|20233374|P4|COMPLETED|Period 5||12
8204831|NCT02173535|20233375|P3|COMPLETED|Period 5||12
8204832|NCT02173535|20233376|P2|COMPLETED|Period 5||12
8204833|NCT02173535|20233377|P1|COMPLETED|Period 5||12
8204834|NCT02173535|20233358|P20|STARTED|Period 5||12
8204835|NCT02173535|20233359|P19|STARTED|Period 5||12
8204836|NCT02173535|20233360|P18|STARTED|Period 5||12
8204837|NCT02173535|20233361|P17|STARTED|Period 5||12
8204838|NCT02173535|20233362|P16|STARTED|Period 5||12
8204839|NCT02173535|20233363|P15|STARTED|Period 5||12
8204840|NCT02173535|20233364|P14|STARTED|Period 5||12
8204841|NCT02173535|20233365|P13|STARTED|Period 5||12
8204842|NCT02173535|20233366|P12|STARTED|Period 5||12
8204843|NCT02173535|20233367|P11|STARTED|Period 5||12
8204844|NCT02173535|20233368|P10|STARTED|Period 5||12
8204845|NCT02173535|20233369|P9|STARTED|Period 5||12
8204846|NCT02173535|20233370|P8|STARTED|Period 5||12
8204847|NCT02173535|20233371|P7|STARTED|Period 5||12
8204848|NCT02173535|20233372|P6|STARTED|Period 5||12
8204849|NCT02173535|20233373|P5|STARTED|Period 5||12
8204850|NCT02173535|20233374|P4|STARTED|Period 5||12
8204851|NCT02173535|20233375|P3|STARTED|Period 5||12
8204852|NCT02173535|20233376|P2|STARTED|Period 5||12
8204853|NCT02173535|20233377|P1|STARTED|Period 5||12
8204854|NCT02173535|20233358|P20|NOT COMPLETED|Period 4||0
8204855|NCT02173535|20233359|P19|NOT COMPLETED|Period 4||0
8204856|NCT02173535|20233360|P18|NOT COMPLETED|Period 4||0
8204857|NCT02173535|20233361|P17|NOT COMPLETED|Period 4||0
8204858|NCT02173535|20233362|P16|NOT COMPLETED|Period 4||0
8204859|NCT02173535|20233363|P15|NOT COMPLETED|Period 4||0
8204860|NCT02173535|20233364|P14|NOT COMPLETED|Period 4||0
8204861|NCT02173535|20233365|P13|NOT COMPLETED|Period 4||0
8204862|NCT02173535|20233366|P12|NOT COMPLETED|Period 4||0
8204863|NCT02173535|20233367|P11|NOT COMPLETED|Period 4||0
8204864|NCT02173535|20233368|P10|NOT COMPLETED|Period 4||0
8204865|NCT02173535|20233369|P9|NOT COMPLETED|Period 4||0
8204866|NCT02173535|20233370|P8|NOT COMPLETED|Period 4||0
8204867|NCT02173535|20233371|P7|NOT COMPLETED|Period 4||0
8204868|NCT02173535|20233372|P6|NOT COMPLETED|Period 4||0
8204869|NCT02173535|20233373|P5|NOT COMPLETED|Period 4||0
8204870|NCT02173535|20233374|P4|NOT COMPLETED|Period 4||0
8204871|NCT02173535|20233375|P3|NOT COMPLETED|Period 4||0
8204872|NCT02173535|20233376|P2|NOT COMPLETED|Period 4||0
8204873|NCT02173535|20233377|P1|NOT COMPLETED|Period 4||0
8204874|NCT02173535|20233358|P20|COMPLETED|Period 4||12
8204875|NCT02173535|20233359|P19|COMPLETED|Period 4||12
8204876|NCT02173535|20233360|P18|COMPLETED|Period 4||12
8204877|NCT02173535|20233361|P17|COMPLETED|Period 4||12
8204878|NCT02173535|20233362|P16|COMPLETED|Period 4||12
8204879|NCT02173535|20233363|P15|COMPLETED|Period 4||12
8204880|NCT02173535|20233364|P14|COMPLETED|Period 4||12
8204881|NCT02173535|20233365|P13|COMPLETED|Period 4||12
8204882|NCT02173535|20233366|P12|COMPLETED|Period 4||12
8204883|NCT02173535|20233367|P11|COMPLETED|Period 4||12
8204884|NCT02173535|20233368|P10|COMPLETED|Period 4||12
8204885|NCT02173535|20233369|P9|COMPLETED|Period 4||12
8204886|NCT02173535|20233370|P8|COMPLETED|Period 4||12
8204887|NCT02173535|20233371|P7|COMPLETED|Period 4||12
8204888|NCT02173535|20233372|P6|COMPLETED|Period 4||12
8204889|NCT02173535|20233373|P5|COMPLETED|Period 4||12
8204890|NCT02173535|20233374|P4|COMPLETED|Period 4||12
8204891|NCT02173535|20233375|P3|COMPLETED|Period 4||12
8204892|NCT02173535|20233376|P2|COMPLETED|Period 4||12
8204893|NCT02173535|20233377|P1|COMPLETED|Period 4||12
8204894|NCT02173535|20233358|P20|STARTED|Period 4||12
8204895|NCT02173535|20233359|P19|STARTED|Period 4||12
8204896|NCT02173535|20233360|P18|STARTED|Period 4||12
8204897|NCT02173535|20233361|P17|STARTED|Period 4||12
8204898|NCT02173535|20233362|P16|STARTED|Period 4||12
8204899|NCT02173535|20233363|P15|STARTED|Period 4||12
8204900|NCT02173535|20233364|P14|STARTED|Period 4||12
8204901|NCT02173535|20233365|P13|STARTED|Period 4||12
8204902|NCT02173535|20233366|P12|STARTED|Period 4||12
8204903|NCT02173535|20233367|P11|STARTED|Period 4||12
8204904|NCT02173535|20233368|P10|STARTED|Period 4||12
8204905|NCT02173535|20233369|P9|STARTED|Period 4||12
8204906|NCT02173535|20233370|P8|STARTED|Period 4||12
8204907|NCT02173535|20233371|P7|STARTED|Period 4||12
8204908|NCT02173535|20233372|P6|STARTED|Period 4||12
8204909|NCT02173535|20233373|P5|STARTED|Period 4||12
8204910|NCT02173535|20233374|P4|STARTED|Period 4||12
8204911|NCT02173535|20233375|P3|STARTED|Period 4||12
8204912|NCT02173535|20233376|P2|STARTED|Period 4||12
8204913|NCT02173535|20233377|P1|STARTED|Period 4||12
8204914|NCT02173535|20233358|P20|NOT COMPLETED|Period 3||0
8204915|NCT02173535|20233359|P19|NOT COMPLETED|Period 3||0
8204916|NCT02173535|20233360|P18|NOT COMPLETED|Period 3||0
8204917|NCT02173535|20233361|P17|NOT COMPLETED|Period 3||0
8204918|NCT02173535|20233362|P16|NOT COMPLETED|Period 3||0
8204919|NCT02173535|20233363|P15|NOT COMPLETED|Period 3||0
8204920|NCT02173535|20233364|P14|NOT COMPLETED|Period 3||0
8204921|NCT02173535|20233365|P13|NOT COMPLETED|Period 3||0
8204922|NCT02173535|20233366|P12|NOT COMPLETED|Period 3||0
8204923|NCT02173535|20233367|P11|NOT COMPLETED|Period 3||0
8204924|NCT02173535|20233368|P10|NOT COMPLETED|Period 3||0
8204925|NCT02173535|20233369|P9|NOT COMPLETED|Period 3||0
8204926|NCT02173535|20233370|P8|NOT COMPLETED|Period 3||0
8204927|NCT02173535|20233371|P7|NOT COMPLETED|Period 3||0
8204928|NCT02173535|20233372|P6|NOT COMPLETED|Period 3||0
8204929|NCT02173535|20233373|P5|NOT COMPLETED|Period 3||0
8204930|NCT02173535|20233374|P4|NOT COMPLETED|Period 3||0
8204931|NCT02173535|20233375|P3|NOT COMPLETED|Period 3||0
8204932|NCT02173535|20233376|P2|NOT COMPLETED|Period 3||0
8204933|NCT02173535|20233377|P1|NOT COMPLETED|Period 3||0
8204934|NCT02173535|20233358|P20|COMPLETED|Period 3||12
8204935|NCT02173535|20233359|P19|COMPLETED|Period 3||12
8204936|NCT02173535|20233360|P18|COMPLETED|Period 3||12
8204937|NCT02173535|20233361|P17|COMPLETED|Period 3||12
8204938|NCT02173535|20233362|P16|COMPLETED|Period 3||12
8204939|NCT02173535|20233363|P15|COMPLETED|Period 3||12
8204940|NCT02173535|20233364|P14|COMPLETED|Period 3||12
8204941|NCT02173535|20233365|P13|COMPLETED|Period 3||12
8204942|NCT02173535|20233366|P12|COMPLETED|Period 3||12
8204943|NCT02173535|20233367|P11|COMPLETED|Period 3||12
8204944|NCT02173535|20233368|P10|COMPLETED|Period 3||12
8204945|NCT02173535|20233369|P9|COMPLETED|Period 3||12
8204946|NCT02173535|20233370|P8|COMPLETED|Period 3||12
8204947|NCT02173535|20233371|P7|COMPLETED|Period 3||12
8204948|NCT02173535|20233372|P6|COMPLETED|Period 3||12
8204949|NCT02173535|20233373|P5|COMPLETED|Period 3||12
8204950|NCT02173535|20233374|P4|COMPLETED|Period 3||12
8204951|NCT02173535|20233375|P3|COMPLETED|Period 3||12
8204952|NCT02173535|20233376|P2|COMPLETED|Period 3||12
8204953|NCT02173535|20233377|P1|COMPLETED|Period 3||12
8204954|NCT02173535|20233358|P20|STARTED|Period 3||12
8204955|NCT02173535|20233359|P19|STARTED|Period 3||12
8204956|NCT02173535|20233360|P18|STARTED|Period 3||12
8204957|NCT02173535|20233361|P17|STARTED|Period 3||12
8204958|NCT02173535|20233362|P16|STARTED|Period 3||12
8204959|NCT02173535|20233363|P15|STARTED|Period 3||12
8204960|NCT02173535|20233364|P14|STARTED|Period 3||12
8204961|NCT02173535|20233365|P13|STARTED|Period 3||12
8204962|NCT02173535|20233366|P12|STARTED|Period 3||12
8204963|NCT02173535|20233367|P11|STARTED|Period 3||12
8204964|NCT02173535|20233368|P10|STARTED|Period 3||12
8204965|NCT02173535|20233369|P9|STARTED|Period 3||12
8204966|NCT02173535|20233370|P8|STARTED|Period 3||12
8204967|NCT02173535|20233371|P7|STARTED|Period 3||12
8204968|NCT02173535|20233372|P6|STARTED|Period 3||12
8204969|NCT02173535|20233373|P5|STARTED|Period 3||12
8204970|NCT02173535|20233374|P4|STARTED|Period 3||12
8204971|NCT02173535|20233375|P3|STARTED|Period 3||12
8204972|NCT02173535|20233376|P2|STARTED|Period 3||12
8204973|NCT02173535|20233377|P1|STARTED|Period 3||12
8204974|NCT02173535|20233358|P20|NOT COMPLETED|Period 2||0
8204975|NCT02173535|20233359|P19|NOT COMPLETED|Period 2||0
8204976|NCT02173535|20233360|P18|NOT COMPLETED|Period 2||0
8204977|NCT02173535|20233361|P17|NOT COMPLETED|Period 2||0
8204978|NCT02173535|20233362|P16|NOT COMPLETED|Period 2||0
8204979|NCT02173535|20233363|P15|NOT COMPLETED|Period 2||0
8204980|NCT02173535|20233364|P14|NOT COMPLETED|Period 2||0
8204981|NCT02173535|20233365|P13|NOT COMPLETED|Period 2||0
8204982|NCT02173535|20233366|P12|NOT COMPLETED|Period 2||0
8204983|NCT02173535|20233367|P11|NOT COMPLETED|Period 2||0
8204984|NCT02173535|20233368|P10|NOT COMPLETED|Period 2||0
8204985|NCT02173535|20233369|P9|NOT COMPLETED|Period 2||0
8204986|NCT02173535|20233370|P8|NOT COMPLETED|Period 2||0
8204987|NCT02173535|20233371|P7|NOT COMPLETED|Period 2||0
8204988|NCT02173535|20233372|P6|NOT COMPLETED|Period 2||0
8204989|NCT02173535|20233373|P5|NOT COMPLETED|Period 2||0
8204990|NCT02173535|20233374|P4|NOT COMPLETED|Period 2||0
8204991|NCT02173535|20233375|P3|NOT COMPLETED|Period 2||0
8204992|NCT02173535|20233376|P2|NOT COMPLETED|Period 2||0
8204993|NCT02173535|20233377|P1|NOT COMPLETED|Period 2||0
8204994|NCT02173535|20233358|P20|COMPLETED|Period 2||12
8204995|NCT02173535|20233359|P19|COMPLETED|Period 2||12
8204996|NCT02173535|20233360|P18|COMPLETED|Period 2||12
8204997|NCT02173535|20233361|P17|COMPLETED|Period 2||12
8204998|NCT02173535|20233362|P16|COMPLETED|Period 2||12
8204999|NCT02173535|20233363|P15|COMPLETED|Period 2||12
8205000|NCT02173535|20233364|P14|COMPLETED|Period 2||12
8205001|NCT02173535|20233365|P13|COMPLETED|Period 2||12
8205002|NCT02173535|20233366|P12|COMPLETED|Period 2||12
8205003|NCT02173535|20233367|P11|COMPLETED|Period 2||12
8205004|NCT02173535|20233368|P10|COMPLETED|Period 2||12
8205005|NCT02173535|20233369|P9|COMPLETED|Period 2||12
8205006|NCT02173535|20233370|P8|COMPLETED|Period 2||12
8205007|NCT02173535|20233371|P7|COMPLETED|Period 2||12
8205008|NCT02173535|20233372|P6|COMPLETED|Period 2||12
8205009|NCT02173535|20233373|P5|COMPLETED|Period 2||12
8205010|NCT02173535|20233374|P4|COMPLETED|Period 2||12
8205011|NCT02173535|20233375|P3|COMPLETED|Period 2||12
8205012|NCT02173535|20233376|P2|COMPLETED|Period 2||12
8205013|NCT02173535|20233377|P1|COMPLETED|Period 2||12
8205014|NCT02173535|20233358|P20|STARTED|Period 2||12
8205015|NCT02173535|20233359|P19|STARTED|Period 2||12
8205016|NCT02173535|20233360|P18|STARTED|Period 2||12
8205017|NCT02173535|20233361|P17|STARTED|Period 2||12
8205018|NCT02173535|20233362|P16|STARTED|Period 2||12
8205019|NCT02173535|20233363|P15|STARTED|Period 2||12
8205020|NCT02173535|20233364|P14|STARTED|Period 2||12
8205021|NCT02173535|20233365|P13|STARTED|Period 2||12
8205022|NCT02173535|20233366|P12|STARTED|Period 2||12
8205023|NCT02173535|20233367|P11|STARTED|Period 2||12
8205024|NCT02173535|20233368|P10|STARTED|Period 2||12
8205025|NCT02173535|20233369|P9|STARTED|Period 2||12
8205026|NCT02173535|20233370|P8|STARTED|Period 2||12
8205027|NCT02173535|20233371|P7|STARTED|Period 2||12
8205028|NCT02173535|20233372|P6|STARTED|Period 2||12
8205029|NCT02173535|20233373|P5|STARTED|Period 2||12
8205030|NCT02173535|20233374|P4|STARTED|Period 2||12
8205031|NCT02173535|20233375|P3|STARTED|Period 2||12
8205032|NCT02173535|20233376|P2|STARTED|Period 2||12
8205033|NCT02173535|20233377|P1|STARTED|Period 2||12
8205034|NCT02173535|20233358|P20|NOT COMPLETED|Period 1||0
8205035|NCT02173535|20233359|P19|NOT COMPLETED|Period 1||0
8205036|NCT02173535|20233360|P18|NOT COMPLETED|Period 1||0
8205037|NCT02173535|20233361|P17|NOT COMPLETED|Period 1||0
8205038|NCT02173535|20233362|P16|NOT COMPLETED|Period 1||0
8205039|NCT02173535|20233363|P15|NOT COMPLETED|Period 1||0
8205040|NCT02173535|20233364|P14|NOT COMPLETED|Period 1||0
8205041|NCT02173535|20233365|P13|NOT COMPLETED|Period 1||0
8205042|NCT02173535|20233366|P12|NOT COMPLETED|Period 1||0
8205043|NCT02173535|20233367|P11|NOT COMPLETED|Period 1||0
8205044|NCT02173535|20233368|P10|NOT COMPLETED|Period 1||0
8205045|NCT02173535|20233369|P9|NOT COMPLETED|Period 1||0
8205046|NCT02173535|20233370|P8|NOT COMPLETED|Period 1||0
8205047|NCT02173535|20233371|P7|NOT COMPLETED|Period 1||0
8205048|NCT02173535|20233372|P6|NOT COMPLETED|Period 1||0
8205049|NCT02173535|20233373|P5|NOT COMPLETED|Period 1||0
8205050|NCT02173535|20233374|P4|NOT COMPLETED|Period 1||0
8205051|NCT02173535|20233375|P3|NOT COMPLETED|Period 1||0
8205052|NCT02173535|20233376|P2|NOT COMPLETED|Period 1||0
8205053|NCT02173535|20233377|P1|NOT COMPLETED|Period 1||0
8205054|NCT02173535|20233358|P20|COMPLETED|Period 1||12
8205055|NCT02173535|20233359|P19|COMPLETED|Period 1||12
8205056|NCT02173535|20233360|P18|COMPLETED|Period 1||12
8205057|NCT02173535|20233361|P17|COMPLETED|Period 1||12
8205058|NCT02173535|20233362|P16|COMPLETED|Period 1||12
8205059|NCT02173535|20233363|P15|COMPLETED|Period 1||12
8205060|NCT02173535|20233364|P14|COMPLETED|Period 1||12
8205061|NCT02173535|20233365|P13|COMPLETED|Period 1||12
8205062|NCT02173535|20233366|P12|COMPLETED|Period 1||12
8205063|NCT02173535|20233367|P11|COMPLETED|Period 1||12
8205064|NCT02173535|20233368|P10|COMPLETED|Period 1||12
8205065|NCT02173535|20233369|P9|COMPLETED|Period 1||12
8205066|NCT02173535|20233370|P8|COMPLETED|Period 1||12
8205067|NCT02173535|20233371|P7|COMPLETED|Period 1||12
8205068|NCT02173535|20233372|P6|COMPLETED|Period 1||12
8205069|NCT02173535|20233373|P5|COMPLETED|Period 1||12
8205070|NCT02173535|20233374|P4|COMPLETED|Period 1||12
8205071|NCT02173535|20233375|P3|COMPLETED|Period 1||12
8205072|NCT02173535|20233376|P2|COMPLETED|Period 1||12
8205073|NCT02173535|20233377|P1|COMPLETED|Period 1||12
8205074|NCT02173535|20233358|P20|STARTED|Period 1||12
8205075|NCT02173535|20233359|P19|STARTED|Period 1||12
8205076|NCT02173535|20233360|P18|STARTED|Period 1||12
8205077|NCT02173535|20233361|P17|STARTED|Period 1||12
8205078|NCT02173535|20233362|P16|STARTED|Period 1||12
8205079|NCT02173535|20233363|P15|STARTED|Period 1||12
8205080|NCT02173535|20233364|P14|STARTED|Period 1||12
8205081|NCT02173535|20233365|P13|STARTED|Period 1||12
8205082|NCT02173535|20233366|P12|STARTED|Period 1||12
8205083|NCT02173535|20233367|P11|STARTED|Period 1||12
8205084|NCT02173535|20233368|P10|STARTED|Period 1||12
8205085|NCT02173535|20233369|P9|STARTED|Period 1||12
8205086|NCT02173535|20233370|P8|STARTED|Period 1||12
8205087|NCT02173535|20233371|P7|STARTED|Period 1||12
8205088|NCT02173535|20233372|P6|STARTED|Period 1||12
8205089|NCT02173535|20233373|P5|STARTED|Period 1||12
8205090|NCT02173535|20233374|P4|STARTED|Period 1||12
8205091|NCT02173535|20233375|P3|STARTED|Period 1||12
8205092|NCT02173535|20233376|P2|STARTED|Period 1||12
8205093|NCT02173535|20233377|P1|STARTED|Period 1||12
8205094|NCT02173522|20233416|P2|NOT COMPLETED|Overall Study||0
8205095|NCT02173522|20233417|P1|NOT COMPLETED|Overall Study||0
8205096|NCT02173522|20233416|P2|COMPLETED|Overall Study||0
8205097|NCT02173522|20233417|P1|COMPLETED|Overall Study||4
8205098|NCT02173522|20233416|P2|STARTED|Overall Study||0
8205099|NCT02173522|20233417|P1|STARTED|Overall Study||4
8205100|NCT02173392|20233437|P2|NOT COMPLETED|Overall Study||4
8205101|NCT02173392|20233438|P1|NOT COMPLETED|Overall Study||14
8205102|NCT02173392|20233437|P2|COMPLETED|Overall Study||68
8205103|NCT02173392|20233438|P1|COMPLETED|Overall Study||59
8205104|NCT02173392|20233437|P2|STARTED|Overall Study||72
8205105|NCT02173392|20233438|P1|STARTED|Overall Study||73
8205112|NCT02173158|20233695|P1|NOT COMPLETED|Safety Phase||0
8205113|NCT02173158|20233695|P1|COMPLETED|Safety Phase||8
8205114|NCT02173158|20233695|P1|STARTED|Safety Phase||8
8205115|NCT02173158|20233695|P1|NOT COMPLETED|Efficacy Phase||1
8205116|NCT02173158|20233695|P1|COMPLETED|Efficacy Phase||8
8205117|NCT02173158|20233695|P1|STARTED|Efficacy Phase||9
8205118|NCT02173054|20233712|P3|NOT COMPLETED|Overall Study||1
8205119|NCT02173054|20233713|P2|NOT COMPLETED|Overall Study||0
8205120|NCT02173054|20233714|P1|NOT COMPLETED|Overall Study||1
8205121|NCT02173054|20233712|P3|COMPLETED|Overall Study||39
8205122|NCT02173054|20233713|P2|COMPLETED|Overall Study||40
8205123|NCT02173054|20233714|P1|COMPLETED|Overall Study||39
8205124|NCT02173054|20233712|P3|STARTED|Overall Study||40
8205125|NCT02173054|20233713|P2|STARTED|Overall Study||40
8205126|NCT02173054|20233714|P1|STARTED|Overall Study||40
8205127|NCT02172820|20233736|P2|NOT COMPLETED|Overall Study||0
8205128|NCT02172820|20233737|P1|NOT COMPLETED|Overall Study||0
8205129|NCT02172820|20233736|P2|COMPLETED|Overall Study||65
8205130|NCT02172820|20233737|P1|COMPLETED|Overall Study||65
8205131|NCT02172820|20233736|P2|STARTED|Overall Study||65
8205132|NCT02172820|20233737|P1|STARTED|Overall Study||65
8205133|NCT02172755|20233749|P2|NOT COMPLETED|Overall Study||4
8205134|NCT02172755|20233750|P1|NOT COMPLETED|Overall Study||2
8205135|NCT02172755|20233749|P2|COMPLETED|Overall Study||12
8205136|NCT02172755|20233750|P1|COMPLETED|Overall Study||12
8205137|NCT02172755|20233749|P2|STARTED|Overall Study||16
8205138|NCT02172755|20233750|P1|STARTED|Overall Study||14
8205139|NCT02172742|20233762|P2|NOT COMPLETED|Overall Study||0
8205140|NCT02172742|20233763|P1|NOT COMPLETED|Overall Study||1
8205141|NCT02172742|20233762|P2|COMPLETED|Overall Study||6
8205142|NCT02172742|20233763|P1|COMPLETED|Overall Study||6
8205143|NCT02172742|20233762|P2|STARTED|Overall Study||6
8205144|NCT02172742|20233763|P1|STARTED|Overall Study||7
8205145|NCT02172664|20233770|P2|NOT COMPLETED|Overall Study||6
8205146|NCT02172664|20233771|P1|NOT COMPLETED|Overall Study||6
8205147|NCT02172664|20233770|P2|COMPLETED|Overall Study||27
8205148|NCT02172664|20233771|P1|COMPLETED|Overall Study||27
8205149|NCT02172664|20233770|P2|STARTED|Overall Study||33
8205150|NCT02172664|20233771|P1|STARTED|Overall Study||33
8205151|NCT02172625|20233780|P2|NOT COMPLETED|Overall Study||3
8205152|NCT02172625|20233781|P1|NOT COMPLETED|Overall Study||0
8205153|NCT02172625|20233780|P2|COMPLETED|Overall Study||16
8205154|NCT02172625|20233781|P1|COMPLETED|Overall Study||19
8205155|NCT02172625|20233780|P2|STARTED|Overall Study||19
8205156|NCT02172625|20233781|P1|STARTED|Overall Study||19
8205157|NCT02172040|20233803|P4|NOT COMPLETED|Overall Study||1
8205158|NCT02172040|20233804|P3|NOT COMPLETED|Overall Study||2
8205159|NCT02172040|20233805|P2|NOT COMPLETED|Overall Study||3
8205160|NCT02172040|20233806|P1|NOT COMPLETED|Overall Study||0
8205161|NCT02172040|20233803|P4|COMPLETED|Overall Study||26
8205162|NCT02172040|20233804|P3|COMPLETED|Overall Study||29
8205163|NCT02172040|20233805|P2|COMPLETED|Overall Study||42
8205164|NCT02172040|20233806|P1|COMPLETED|Overall Study||49
8205165|NCT02172040|20233803|P4|STARTED|Overall Study||27
8205166|NCT02172040|20233804|P3|STARTED|Overall Study||31
8205167|NCT02172040|20233805|P2|STARTED|Overall Study||45
8205168|NCT02172040|20233806|P1|STARTED|Overall Study||49
8205169|NCT02171819|20233855|P3|NOT COMPLETED|Overall Study||0
8205170|NCT02171819|20233856|P2|NOT COMPLETED|Overall Study||0
8205171|NCT02171819|20233857|P1|NOT COMPLETED|Overall Study||0
8205172|NCT02171819|20233855|P3|COMPLETED|Overall Study||12
8205173|NCT02171819|20233856|P2|COMPLETED|Overall Study||32
8205174|NCT02171819|20233857|P1|COMPLETED|Overall Study||31
8205175|NCT02171819|20233855|P3|STARTED|Overall Study||12
8205176|NCT02171819|20233856|P2|STARTED|Overall Study||32
8205177|NCT02171819|20233857|P1|STARTED|Overall Study||31
8205178|NCT02171611|20233892|P6|NOT COMPLETED|Overall Study||0
8205179|NCT02171611|20233893|P5|NOT COMPLETED|Overall Study||0
8205180|NCT02171611|20233894|P4|NOT COMPLETED|Overall Study||0
8205181|NCT02171611|20233895|P3|NOT COMPLETED|Overall Study||0
8205182|NCT02171611|20233896|P2|NOT COMPLETED|Overall Study||0
8205183|NCT02171611|20233897|P1|NOT COMPLETED|Overall Study||0
8205184|NCT02171611|20233892|P6|COMPLETED|Overall Study||5
8205185|NCT02171611|20233893|P5|COMPLETED|Overall Study||5
8205186|NCT02171611|20233894|P4|COMPLETED|Overall Study||5
8205187|NCT02171611|20233895|P3|COMPLETED|Overall Study||5
8205188|NCT02171611|20233896|P2|COMPLETED|Overall Study||5
8205189|NCT02171611|20233897|P1|COMPLETED|Overall Study||5
8205190|NCT02171611|20233892|P6|STARTED|Overall Study||5
8205191|NCT02171611|20233893|P5|STARTED|Overall Study||5
8205192|NCT02171611|20233894|P4|STARTED|Overall Study||5
8205193|NCT02171611|20233895|P3|STARTED|Overall Study||5
8205194|NCT02171611|20233896|P2|STARTED|Overall Study||5
8205195|NCT02171611|20233897|P1|STARTED|Overall Study||5
8205196|NCT02171260|20233969|P4|NOT COMPLETED|Overall Study||5
8205197|NCT02171260|20233970|P3|NOT COMPLETED|Overall Study||5
8205198|NCT02171260|20233971|P2|NOT COMPLETED|Overall Study||6
8205199|NCT02171260|20233972|P1|NOT COMPLETED|Overall Study||6
8205200|NCT02171260|20233969|P4|COMPLETED|Overall Study||0
8205201|NCT02171260|20233970|P3|COMPLETED|Overall Study||0
8205202|NCT02171260|20233971|P2|COMPLETED|Overall Study||0
8205203|NCT02171260|20233972|P1|COMPLETED|Overall Study||0
8205204|NCT02171260|20233969|P4|STARTED|Overall Study||5
8205205|NCT02171260|20233970|P3|STARTED|Overall Study||5
8205206|NCT02171260|20233971|P2|STARTED|Overall Study||6
8205207|NCT02171260|20233972|P1|STARTED|Overall Study||6
8205208|NCT02171247|20234029|P2|NOT COMPLETED|Overall Study||0
8205209|NCT02171247|20234030|P1|NOT COMPLETED|Overall Study||0
8205210|NCT02171247|20234029|P2|COMPLETED|Overall Study||17
8205211|NCT02171247|20234030|P1|COMPLETED|Overall Study||16
8205212|NCT02171247|20234029|P2|STARTED|Overall Study||17
8205213|NCT02171247|20234030|P1|STARTED|Overall Study||16
8205214|NCT02171234|20234047|P5|NOT COMPLETED|Overall Study||0
8205215|NCT02171234|20234048|P4|NOT COMPLETED|Overall Study||0
8205216|NCT02171234|20234049|P3|NOT COMPLETED|Overall Study||0
8205217|NCT02171234|20234050|P2|NOT COMPLETED|Overall Study||0
8205218|NCT02171234|20234051|P1|NOT COMPLETED|Overall Study||0
8205219|NCT02171234|20234047|P5|COMPLETED|Overall Study||6
8205220|NCT02171234|20234048|P4|COMPLETED|Overall Study||6
8205221|NCT02171234|20234049|P3|COMPLETED|Overall Study||6
8205222|NCT02171234|20234050|P2|COMPLETED|Overall Study||6
8205223|NCT02171234|20234051|P1|COMPLETED|Overall Study||8
8205224|NCT02171234|20234047|P5|STARTED|Overall Study||6
8205225|NCT02171234|20234048|P4|STARTED|Overall Study||6
8205226|NCT02171234|20234049|P3|STARTED|Overall Study||6
8205227|NCT02171234|20234050|P2|STARTED|Overall Study||6
8205228|NCT02171234|20234051|P1|STARTED|Overall Study||8
8205229|NCT02171195|20234080|P9|NOT COMPLETED|Overall Study||0
8205230|NCT02171195|20234081|P8|NOT COMPLETED|Overall Study||0
8205231|NCT02171195|20234082|P7|NOT COMPLETED|Overall Study||0
8205232|NCT02171195|20234083|P6|NOT COMPLETED|Overall Study||0
8205233|NCT02171195|20234084|P5|NOT COMPLETED|Overall Study||0
8205234|NCT02171195|20234085|P4|NOT COMPLETED|Overall Study||0
8205235|NCT02171195|20234086|P3|NOT COMPLETED|Overall Study||0
8205236|NCT02171195|20234087|P2|NOT COMPLETED|Overall Study||0
8205237|NCT02171195|20234088|P1|NOT COMPLETED|Overall Study||0
8205238|NCT02171195|20234080|P9|COMPLETED|Overall Study||6
8205239|NCT02171195|20234081|P8|COMPLETED|Overall Study||6
8205240|NCT02171195|20234082|P7|COMPLETED|Overall Study||6
8205241|NCT02171195|20234083|P6|COMPLETED|Overall Study||6
8205242|NCT02171195|20234084|P5|COMPLETED|Overall Study||6
8205243|NCT02171195|20234085|P4|COMPLETED|Overall Study||6
8205244|NCT02171195|20234086|P3|COMPLETED|Overall Study||6
8205245|NCT02171195|20234087|P2|COMPLETED|Overall Study||6
8205246|NCT02171195|20234088|P1|COMPLETED|Overall Study||16
8205247|NCT02171195|20234080|P9|STARTED|Overall Study||6
8205248|NCT02171195|20234081|P8|STARTED|Overall Study||6
8205249|NCT02171195|20234082|P7|STARTED|Overall Study||6
8205250|NCT02171195|20234083|P6|STARTED|Overall Study||6
8205251|NCT02171195|20234084|P5|STARTED|Overall Study||6
8205252|NCT02171195|20234085|P4|STARTED|Overall Study||6
8205253|NCT02171195|20234086|P3|STARTED|Overall Study||6
8205254|NCT02171195|20234087|P2|STARTED|Overall Study||6
8205255|NCT02171195|20234088|P1|STARTED|Overall Study||16
8205256|NCT02171130|20234108|P1|NOT COMPLETED|Overall Study||28
8205257|NCT02171130|20234108|P1|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101
8205258|NCT02171130|20234108|P1|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87
8205259|NCT02171130|20234108|P1|Received at Least One Dose of Study Drug|Overall Study||87
8205260|NCT02171130|20234108|P1|STARTED|Overall Study||129
8205261|NCT02170870|20234122|P6|NOT COMPLETED|Overall Study||0
8205262|NCT02170870|20234123|P5|NOT COMPLETED|Overall Study||0
8205263|NCT02170870|20234124|P4|NOT COMPLETED|Overall Study||0
8205264|NCT02170870|20234125|P3|NOT COMPLETED|Overall Study||0
8205265|NCT02170870|20234126|P2|NOT COMPLETED|Overall Study||0
8205266|NCT02170870|20234127|P1|NOT COMPLETED|Overall Study||0
8205267|NCT02170870|20234122|P6|COMPLETED|Overall Study||20
8205268|NCT02170870|20234123|P5|COMPLETED|Overall Study||20
8205269|NCT02170870|20234124|P4|COMPLETED|Overall Study||20
8205270|NCT02170870|20234125|P3|COMPLETED|Overall Study||20
8205271|NCT02170870|20234126|P2|COMPLETED|Overall Study||11
8205272|NCT02170870|20234127|P1|COMPLETED|Overall Study||13
8205273|NCT02170870|20234122|P6|STARTED|Overall Study||20
8205274|NCT02170870|20234123|P5|STARTED|Overall Study||20
8205275|NCT02170870|20234124|P4|STARTED|Overall Study||20
8205276|NCT02170870|20234125|P3|STARTED|Overall Study||20
8205277|NCT02170870|20234126|P2|STARTED|Overall Study||11
8205278|NCT02170870|20234127|P1|STARTED|Overall Study||13
8205279|NCT02170779|20234149|P2|NOT COMPLETED|Overall Study||1
8205280|NCT02170779|20234150|P1|NOT COMPLETED|Overall Study||1
8205281|NCT02170779|20234149|P2|COMPLETED|Overall Study||19
8205282|NCT02170779|20234150|P1|COMPLETED|Overall Study||19
8205283|NCT02170779|20234149|P2|STARTED|Overall Study||20
8205284|NCT02170779|20234150|P1|STARTED|Overall Study||20
8205285|NCT02170727|20234174|P2|NOT COMPLETED|Overall Study||0
8205286|NCT02170727|20234175|P1|NOT COMPLETED|Overall Study||3
8205287|NCT02170727|20234174|P2|COMPLETED|Overall Study||31
8205288|NCT02170727|20234175|P1|COMPLETED|Overall Study||135
8205289|NCT02170727|20234174|P2|STARTED|Overall Study||31
8205290|NCT02170727|20234175|P1|STARTED|Overall Study||138
8205291|NCT02170688|20234206|P5|NOT COMPLETED|Overall Study||0
8205292|NCT02170688|20234207|P4|NOT COMPLETED|Overall Study||2
8205293|NCT02170688|20234208|P3|NOT COMPLETED|Overall Study||4
8205294|NCT02170688|20234209|P2|NOT COMPLETED|Overall Study||3
8205295|NCT02170688|20234210|P1|NOT COMPLETED|Overall Study||4
8205296|NCT02170688|20234206|P5|COMPLETED|Overall Study||25
8205297|NCT02170688|20234207|P4|COMPLETED|Overall Study||25
8205298|NCT02170688|20234208|P3|COMPLETED|Overall Study||25
8205299|NCT02170688|20234209|P2|COMPLETED|Overall Study||26
8205300|NCT02170688|20234210|P1|COMPLETED|Overall Study||25
8205301|NCT02170688|20234206|P5|STARTED|Overall Study||25
8205302|NCT02170688|20234207|P4|STARTED|Overall Study||27
8205303|NCT02170688|20234208|P3|STARTED|Overall Study||29
8205304|NCT02170688|20234209|P2|STARTED|Overall Study||29
8205305|NCT02170688|20234210|P1|STARTED|Overall Study||29
8205306|NCT02170662|20234229|P2|NOT COMPLETED|Overall Study||0
8205307|NCT02170662|20234230|P1|NOT COMPLETED|Overall Study||0
8205308|NCT02170662|20234229|P2|COMPLETED|Overall Study||6
8205309|NCT02170662|20234230|P1|COMPLETED|Overall Study||3
8205310|NCT02170662|20234229|P2|STARTED|Overall Study||6
8205311|NCT02170662|20234230|P1|STARTED|Overall Study||3
8205312|NCT02170649|20234242|P1|NOT COMPLETED|Fed Period||0
8205313|NCT02170649|20234242|P1|COMPLETED|Fed Period||12
8205314|NCT02170649|20234242|P1|STARTED|Fed Period||12
8205315|NCT02170649|20234242|P1|NOT COMPLETED|Fasting Period||0
8205316|NCT02170649|20234242|P1|COMPLETED|Fasting Period||12
8205317|NCT02170649|20234242|P1|STARTED|Fasting Period||12
8205318|NCT02170532|20234249|P1|NOT COMPLETED|Overall Study||0
8205319|NCT02170532|20234249|P1|COMPLETED|Overall Study||10
8205320|NCT02170532|20234249|P1|STARTED|Overall Study||10
8205321|NCT02170519|20234279|P2|NOT COMPLETED|Overall Study||0
8205322|NCT02170519|20234280|P1|NOT COMPLETED|Overall Study||0
8205323|NCT02170519|20234279|P2|COMPLETED|Overall Study||5
8205324|NCT02170519|20234280|P1|COMPLETED|Overall Study||22
8205325|NCT02170519|20234279|P2|STARTED|Overall Study||5
8205326|NCT02170519|20234280|P1|STARTED|Overall Study||22
8205327|NCT02170389|20234296|P1|NOT COMPLETED|Overall Study||1
8205328|NCT02170389|20234296|P1|COMPLETED|Overall Study||4
8205329|NCT02170389|20234296|P1|STARTED|Overall Study||5
8205330|NCT02170376|20234306|P5|NOT COMPLETED|Overall Study||0
8205331|NCT02170376|20234307|P4|NOT COMPLETED|Overall Study||0
8205332|NCT02170376|20234308|P3|NOT COMPLETED|Overall Study||0
8205333|NCT02170376|20234309|P2|NOT COMPLETED|Overall Study||1
8205334|NCT02170376|20234310|P1|NOT COMPLETED|Overall Study||0
8205335|NCT02170376|20234306|P5|COMPLETED|Overall Study||16
8205336|NCT02170376|20234307|P4|COMPLETED|Overall Study||16
8205337|NCT02170376|20234308|P3|COMPLETED|Overall Study||16
8205338|NCT02170376|20234309|P2|COMPLETED|Overall Study||15
8205339|NCT02170376|20234310|P1|COMPLETED|Overall Study||16
8205340|NCT02170376|20234306|P5|Pharmacokinetic Population|Overall Study||16
8205341|NCT02170376|20234307|P4|Pharmacokinetic Population|Overall Study||16
8205342|NCT02170376|20234308|P3|Pharmacokinetic Population|Overall Study||16
8205343|NCT02170376|20234309|P2|Pharmacokinetic Population|Overall Study||15
8205344|NCT02170376|20234310|P1|Pharmacokinetic Population|Overall Study||16
8205345|NCT02170376|20234306|P5|STARTED|Overall Study||16
8205346|NCT02170376|20234307|P4|STARTED|Overall Study||16
8205347|NCT02170376|20234308|P3|STARTED|Overall Study||16
8205348|NCT02170376|20234309|P2|STARTED|Overall Study||16
8205349|NCT02170376|20234310|P1|STARTED|Overall Study||16
8205350|NCT02170363|20234347|P1|NOT COMPLETED|Overall Study||0
8205351|NCT02170363|20234347|P1|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
8205352|NCT02170363|20234347|P1|STARTED|Overall Study||50
8205353|NCT02170298|20234361|P2|NOT COMPLETED|Overall Study||1
8205354|NCT02170298|20234362|P1|NOT COMPLETED|Overall Study||1
8205355|NCT02170298|20234361|P2|COMPLETED|Overall Study||4
8205356|NCT02170298|20234362|P1|COMPLETED|Overall Study||0
8205357|NCT02170298|20234361|P2|STARTED|Overall Study||5
8205358|NCT02170298|20234362|P1|STARTED|Overall Study||1
8205359|NCT02170220|20234372|P2|NOT COMPLETED|Overall Study||0
8205360|NCT02170220|20234373|P1|NOT COMPLETED|Overall Study||0
8205361|NCT02170220|20234372|P2|COMPLETED|Overall Study||6
8205362|NCT02170220|20234373|P1|COMPLETED|Overall Study||6
8205363|NCT02170220|20234372|P2|STARTED|Overall Study||6
8205364|NCT02170220|20234373|P1|STARTED|Overall Study||6
8205365|NCT02170207|20234399|P1|NOT COMPLETED|Overall Study||5
8205366|NCT02170207|20234399|P1|COMPLETED|Overall Study||58
8205367|NCT02170207|20234399|P1|STARTED|Overall Study||63
8205368|NCT02170077|20234410|P3|NOT COMPLETED|Overall Study||12
8205369|NCT02170077|20234411|P2|NOT COMPLETED|Overall Study||13
8205370|NCT02170077|20234412|P1|NOT COMPLETED|Overall Study||9
8205371|NCT02170077|20234410|P3|COMPLETED|Overall Study||35
8205372|NCT02170077|20234411|P2|COMPLETED|Overall Study||34
8205373|NCT02170077|20234412|P1|COMPLETED|Overall Study||41
8205374|NCT02170077|20234410|P3|Intent to Treat (ITT) Population|Overall Study||47
8205375|NCT02170077|20234411|P2|Intent to Treat (ITT) Population|Overall Study||46
8205376|NCT02170077|20234412|P1|Intent to Treat (ITT) Population|Overall Study||50
8205377|NCT02170077|20234410|P3|STARTED|Overall Study||47
8205378|NCT02170077|20234411|P2|STARTED|Overall Study||47
8205379|NCT02170077|20234412|P1|STARTED|Overall Study||50
8205380|NCT02170064|20234423|P3|NOT COMPLETED|Overall Study||1
8205381|NCT02170064|20234424|P2|NOT COMPLETED|Overall Study||2
8205382|NCT02170064|20234425|P1|NOT COMPLETED|Overall Study||6
8205383|NCT02170064|20234423|P3|COMPLETED|Overall Study||10
8205384|NCT02170064|20234424|P2|COMPLETED|Overall Study||7
8205385|NCT02170064|20234425|P1|COMPLETED|Overall Study||9
8205386|NCT02170064|20234423|P3|Efficacy Population (EP)|Overall Study||10
8205387|NCT02170064|20234424|P2|Efficacy Population (EP)|Overall Study||8
8205388|NCT02170064|20234425|P1|Efficacy Population (EP)|Overall Study||11
8205389|NCT02170064|20234423|P3|Pharmacokinetic Population (PKP)|Overall Study||10
8205390|NCT02170064|20234424|P2|Pharmacokinetic Population (PKP)|Overall Study||8
8205391|NCT02170064|20234425|P1|Pharmacokinetic Population (PKP)|Overall Study||11
8205392|NCT02170064|20234423|P3|Safety Population (SP)|Overall Study||11
8205393|NCT02170064|20234424|P2|Safety Population (SP)|Overall Study||8
8205394|NCT02170064|20234425|P1|Safety Population (SP)|Overall Study||12
8205395|NCT02170064|20234423|P3|STARTED|Overall Study||11
8205396|NCT02170064|20234424|P2|STARTED|Overall Study||9
8205397|NCT02170064|20234425|P1|STARTED|Overall Study||15
8205408|NCT02170025|20234462|P2|NOT COMPLETED|Overall Study||0
8205409|NCT02170025|20234463|P1|NOT COMPLETED|Overall Study||2
8205410|NCT02170025|20234462|P2|COMPLETED|Overall Study||7
8205411|NCT02170025|20234463|P1|COMPLETED|Overall Study||12
8205412|NCT02170025|20234462|P2|STARTED|Overall Study||7
8205413|NCT02170025|20234463|P1|STARTED|Overall Study||14
8205414|NCT02169895|20234475|P4|NOT COMPLETED|Overall Study||2
8205415|NCT02169895|20234476|P3|NOT COMPLETED|Overall Study||0
8205416|NCT02169895|20234477|P2|NOT COMPLETED|Overall Study||0
8205417|NCT02169895|20234478|P1|NOT COMPLETED|Overall Study||0
8205418|NCT02169895|20234475|P4|COMPLETED|Overall Study||2
8205419|NCT02169895|20234476|P3|COMPLETED|Overall Study||4
8205420|NCT02169895|20234477|P2|COMPLETED|Overall Study||4
8205421|NCT02169895|20234478|P1|COMPLETED|Overall Study||4
8205422|NCT02169895|20234475|P4|Placebo|Overall Study||4
8205423|NCT02169895|20234476|P3|Placebo|Overall Study||4
8205424|NCT02169895|20234477|P2|Placebo|Overall Study||4
8205425|NCT02169895|20234478|P1|Placebo|Overall Study||4
8205426|NCT02169895|20234475|P4|100 mg BIA 9-1067|Overall Study||2
8205427|NCT02169895|20234476|P3|100 mg BIA 9-1067|Overall Study||4
8205428|NCT02169895|20234477|P2|100 mg BIA 9-1067|Overall Study||4
8205429|NCT02169895|20234478|P1|100 mg BIA 9-1067|Overall Study||4
8205430|NCT02169895|20234475|P4|50 mg BIA 9-1067|Overall Study||4
8205431|NCT02169895|20234476|P3|50 mg BIA 9-1067|Overall Study||4
8205432|NCT02169895|20234477|P2|50 mg BIA 9-1067|Overall Study||4
8205433|NCT02169895|20234478|P1|50 mg BIA 9-1067|Overall Study||4
8205434|NCT02169895|20234475|P4|25 mg BIA 9-1067|Overall Study||4
8205435|NCT02169895|20234476|P3|25 mg BIA 9-1067|Overall Study||4
8205436|NCT02169895|20234477|P2|25 mg BIA 9-1067|Overall Study||4
8205437|NCT02169895|20234478|P1|25 mg BIA 9-1067|Overall Study||4
8205438|NCT02169895|20234475|P4|STARTED|Overall Study||4
8205439|NCT02169895|20234476|P3|STARTED|Overall Study||4
8205440|NCT02169895|20234477|P2|STARTED|Overall Study||4
8205441|NCT02169895|20234478|P1|STARTED|Overall Study||4
8205442|NCT02169869|20234498|P2|NOT COMPLETED|Overall Study||0
8205443|NCT02169869|20234499|P1|NOT COMPLETED|Overall Study||0
8205444|NCT02169869|20234498|P2|COMPLETED|Overall Study||16
8205445|NCT02169869|20234499|P1|COMPLETED|Overall Study||17
8205446|NCT02169869|20234498|P2|STARTED|Overall Study||16
8205447|NCT02169869|20234499|P1|STARTED|Overall Study||17
8205448|NCT02169674|20234507|P2|NOT COMPLETED|Overall Study||78
8205449|NCT02169674|20234508|P1|NOT COMPLETED|Overall Study||32
8205450|NCT02169674|20234507|P2|COMPLETED|Overall Study||135
8205451|NCT02169674|20234508|P1|COMPLETED|Overall Study||105
8205452|NCT02169674|20234507|P2|STARTED|Overall Study||213
8205453|NCT02169674|20234508|P1|STARTED|Overall Study||137
8205454|NCT02169505|20234522|P1|NOT COMPLETED|Overall Study||1
8205455|NCT02169505|20234522|P1|COMPLETED|Overall Study||1
8205456|NCT02169505|20234522|P1|STARTED|Overall Study||2
8205457|NCT02169479|20234537|P4|NOT COMPLETED|Overall Study||0
8205458|NCT02169479|20234538|P3|NOT COMPLETED|Overall Study||0
8205459|NCT02169479|20234539|P2|NOT COMPLETED|Overall Study||1
8205460|NCT02169479|20234540|P1|NOT COMPLETED|Overall Study||1
8205461|NCT02169479|20234537|P4|COMPLETED|Overall Study||4
8205462|NCT02169479|20234538|P3|COMPLETED|Overall Study||4
8205463|NCT02169479|20234539|P2|COMPLETED|Overall Study||3
8205464|NCT02169479|20234540|P1|COMPLETED|Overall Study||3
8205465|NCT02169479|20234537|P4|Placebo|Overall Study||4
8205466|NCT02169479|20234538|P3|Placebo|Overall Study||4
8205467|NCT02169479|20234539|P2|Placebo|Overall Study||3
8205468|NCT02169479|20234540|P1|Placebo|Overall Study||3
8205469|NCT02169479|20234537|P4|100 mg BIA 9-1067|Overall Study||4
8205470|NCT02169479|20234538|P3|100 mg BIA 9-1067|Overall Study||4
8205471|NCT02169479|20234539|P2|100 mg BIA 9-1067|Overall Study||4
8205472|NCT02169479|20234540|P1|100 mg BIA 9-1067|Overall Study||3
8205473|NCT02169479|20234537|P4|50 mg BIA 9-1067|Overall Study||4
8205474|NCT02169479|20234538|P3|50 mg BIA 9-1067|Overall Study||4
8205475|NCT02169479|20234539|P2|50 mg BIA 9-1067|Overall Study||4
8205476|NCT02169479|20234540|P1|50 mg BIA 9-1067|Overall Study||4
8205477|NCT02169479|20234537|P4|25 mg BIA 9-1067|Overall Study||4
8205478|NCT02169479|20234538|P3|25 mg BIA 9-1067|Overall Study||4
8205479|NCT02169479|20234539|P2|25 mg BIA 9-1067|Overall Study||3
8205480|NCT02169479|20234540|P1|25 mg BIA 9-1067|Overall Study||4
8205481|NCT02169479|20234537|P4|STARTED|Overall Study||4
8205482|NCT02169479|20234538|P3|STARTED|Overall Study||4
8205483|NCT02169479|20234539|P2|STARTED|Overall Study||4
8205484|NCT02169479|20234540|P1|STARTED|Overall Study||4
8205485|NCT02169466|20234562|P4|NOT COMPLETED|Overall Study||0
8205486|NCT02169466|20234563|P3|NOT COMPLETED|Overall Study||0
8205487|NCT02169466|20234564|P2|NOT COMPLETED|Overall Study||1
8205488|NCT02169466|20234565|P1|NOT COMPLETED|Overall Study||1
8205489|NCT02169466|20234562|P4|COMPLETED|Overall Study||5
8205490|NCT02169466|20234563|P3|COMPLETED|Overall Study||5
8205491|NCT02169466|20234564|P2|COMPLETED|Overall Study||5
8205492|NCT02169466|20234565|P1|COMPLETED|Overall Study||5
8205493|NCT02169466|20234562|P4|Placebo|Overall Study||5
8205494|NCT02169466|20234563|P3|Placebo|Overall Study||5
8205495|NCT02169466|20234564|P2|Placebo|Overall Study||6
8205496|NCT02169466|20234565|P1|Placebo|Overall Study||5
8205497|NCT02169466|20234562|P4|100 mg BIA 9-1067|Overall Study||5
8205498|NCT02169466|20234563|P3|100 mg BIA 9-1067|Overall Study||5
8205499|NCT02169466|20234564|P2|100 mg BIA 9-1067|Overall Study||6
8205500|NCT02169466|20234565|P1|100 mg BIA 9-1067|Overall Study||6
8205501|NCT02169466|20234562|P4|50 mg BIA 9-1067|Overall Study||5
8205502|NCT02169466|20234563|P3|50 mg BIA 9-1067|Overall Study||5
8205503|NCT02169466|20234564|P2|50 mg BIA 9-1067|Overall Study||6
8205504|NCT02169466|20234565|P1|50 mg BIA 9-1067|Overall Study||6
8205505|NCT02169466|20234562|P4|25 mg BIA 9-1067|Overall Study||5
8205506|NCT02169466|20234563|P3|25 mg BIA 9-1067|Overall Study||5
8205507|NCT02169466|20234564|P2|25 mg BIA 9-1067|Overall Study||5
8205508|NCT02169466|20234565|P1|25 mg BIA 9-1067|Overall Study||6
8205509|NCT02169466|20234562|P4|STARTED|Overall Study||5
8205510|NCT02169466|20234563|P3|STARTED|Overall Study||5
8205511|NCT02169466|20234564|P2|STARTED|Overall Study||6
8205512|NCT02169466|20234565|P1|STARTED|Overall Study||6
8205513|NCT02169453|20234591|P4|NOT COMPLETED|Overall Study||0
8205514|NCT02169453|20234592|P3|NOT COMPLETED|Overall Study||1
8205515|NCT02169453|20234593|P2|NOT COMPLETED|Overall Study||0
8205516|NCT02169453|20234594|P1|NOT COMPLETED|Overall Study||0
8205517|NCT02169453|20234591|P4|COMPLETED|Overall Study||3
8205518|NCT02169453|20234592|P3|COMPLETED|Overall Study||2
8205519|NCT02169453|20234593|P2|COMPLETED|Overall Study||3
8205520|NCT02169453|20234594|P1|COMPLETED|Overall Study||3
8205521|NCT02169453|20234591|P4|Placebo|Overall Study||3
8205522|NCT02169453|20234592|P3|Placebo|Overall Study||3
8205523|NCT02169453|20234593|P2|Placebo|Overall Study||3
8205524|NCT02169453|20234594|P1|Placebo|Overall Study||3
8205525|NCT02169453|20234591|P4|100 mg BIA 9-1067|Overall Study||3
8205526|NCT02169453|20234592|P3|100 mg BIA 9-1067|Overall Study||3
8205527|NCT02169453|20234593|P2|100 mg BIA 9-1067|Overall Study||3
8205528|NCT02169453|20234594|P1|100 mg BIA 9-1067|Overall Study||3
8205529|NCT02169453|20234591|P4|50 mg BIA 9-1067|Overall Study||3
8205530|NCT02169453|20234592|P3|50 mg BIA 9-1067|Overall Study||2
8205531|NCT02169453|20234593|P2|50 mg BIA 9-1067|Overall Study||3
8205532|NCT02169453|20234594|P1|50 mg BIA 9-1067|Overall Study||3
8205533|NCT02169453|20234591|P4|25 mg BIA 9-1067|Overall Study||3
8205534|NCT02169453|20234592|P3|25 mg BIA 9-1067|Overall Study||3
8205535|NCT02169453|20234593|P2|25 mg BIA 9-1067|Overall Study||3
8205536|NCT02169453|20234594|P1|25 mg BIA 9-1067|Overall Study||3
8205537|NCT02169453|20234591|P4|STARTED|Overall Study||3
8205538|NCT02169453|20234592|P3|STARTED|Overall Study||3
8205539|NCT02169453|20234593|P2|STARTED|Overall Study||3
8205540|NCT02169453|20234594|P1|STARTED|Overall Study||3
8205541|NCT02169440|20234626|P2|NOT COMPLETED|Overall Study||0
8205542|NCT02169440|20234627|P1|NOT COMPLETED|Overall Study||0
8205543|NCT02169440|20234626|P2|COMPLETED|Overall Study||10
8205544|NCT02169440|20234627|P1|COMPLETED|Overall Study||10
8205545|NCT02169440|20234626|P2|STARTED|Overall Study||10
8205546|NCT02169440|20234627|P1|STARTED|Overall Study||10
8205547|NCT02169427|20234640|P1|NOT COMPLETED|Overall Study||0
8205548|NCT02169427|20234640|P1|COMPLETED|Overall Study||6
8205549|NCT02169427|20234640|P1|STARTED|Overall Study||6
8205550|NCT02169414|20234650|P4|NOT COMPLETED|Overall Study||0
8205551|NCT02169414|20234651|P3|NOT COMPLETED|Overall Study||0
8205552|NCT02169414|20234652|P2|NOT COMPLETED|Overall Study||1
8205553|NCT02169414|20234653|P1|NOT COMPLETED|Overall Study||1
8205554|NCT02169414|20234650|P4|COMPLETED|Overall Study||18
8205555|NCT02169414|20234651|P3|COMPLETED|Overall Study||18
8205556|NCT02169414|20234652|P2|COMPLETED|Overall Study||18
8205557|NCT02169414|20234653|P1|COMPLETED|Overall Study||18
8205558|NCT02169414|20234650|P4|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
8205559|NCT02169414|20234651|P3|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
8205560|NCT02169414|20234652|P2|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
8205561|NCT02169414|20234653|P1|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
8205562|NCT02169414|20234650|P4|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
8205563|NCT02169414|20234651|P3|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
8205564|NCT02169414|20234652|P2|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
8205565|NCT02169414|20234653|P1|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
8205566|NCT02169414|20234650|P4|STARTED|Overall Study||18
8205567|NCT02169414|20234651|P3|STARTED|Overall Study||18
8205568|NCT02169414|20234652|P2|STARTED|Overall Study||19
8205569|NCT02169414|20234653|P1|STARTED|Overall Study||19
8205570|NCT02169336|20234694|P3|NOT COMPLETED|Overall Study||3
8205571|NCT02169336|20234695|P2|NOT COMPLETED|Overall Study||4
8205572|NCT02169336|20234696|P1|NOT COMPLETED|Overall Study||4
8205573|NCT02169336|20234694|P3|COMPLETED|Overall Study||29
8205574|NCT02169336|20234695|P2|COMPLETED|Overall Study||28
8205575|NCT02169336|20234696|P1|COMPLETED|Overall Study||27
8205576|NCT02169336|20234694|P3|STARTED|Overall Study||32
8205577|NCT02169336|20234695|P2|STARTED|Overall Study||32
8205578|NCT02169336|20234696|P1|STARTED|Overall Study||31
8205579|NCT02169284|20234706|P2|NOT COMPLETED|Overall Study||1
8205580|NCT02169284|20234707|P1|NOT COMPLETED|Overall Study||0
8205581|NCT02169284|20234706|P2|COMPLETED|Overall Study||12
8205582|NCT02169284|20234707|P1|COMPLETED|Overall Study||24
8205583|NCT02169284|20234706|P2|STARTED|Overall Study||13
8205584|NCT02169284|20234707|P1|STARTED|Overall Study||24
8205585|NCT02169271|20234733|P2|NOT COMPLETED|Overall Study||2
8205586|NCT02169271|20234734|P1|NOT COMPLETED|Overall Study||1
8205587|NCT02169271|20234733|P2|COMPLETED|Overall Study||47
8205588|NCT02169271|20234734|P1|COMPLETED|Overall Study||48
8205589|NCT02169271|20234733|P2|STARTED|Overall Study||49
8205590|NCT02169271|20234734|P1|STARTED|Overall Study||49
8205594|NCT02169115|20234770|P3|NOT COMPLETED|Overall Study||0
8205595|NCT02169115|20234771|P2|NOT COMPLETED|Overall Study||0
8205596|NCT02169115|20234772|P1|NOT COMPLETED|Overall Study||0
8205597|NCT02169115|20234770|P3|COMPLETED|Overall Study||21
8205598|NCT02169115|20234771|P2|COMPLETED|Overall Study||21
8205599|NCT02169115|20234772|P1|COMPLETED|Overall Study||19
8205600|NCT02169115|20234770|P3|STARTED|Overall Study||21
8205601|NCT02169115|20234771|P2|STARTED|Overall Study||21
8205602|NCT02169115|20234772|P1|STARTED|Overall Study||19
8205603|NCT02168946|20234800|P2|NOT COMPLETED|Overall Study||5
8205604|NCT02168946|20234801|P1|NOT COMPLETED|Overall Study||12
8205605|NCT02168946|20234800|P2|COMPLETED|Overall Study||20
8205606|NCT02168946|20234801|P1|COMPLETED|Overall Study||38
8205607|NCT02168946|20234800|P2|STARTED|Overall Study||25
8205608|NCT02168946|20234801|P1|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
8205609|NCT02168933|20234837|P1|NOT COMPLETED|Overall Study||1
8205610|NCT02168933|20234837|P1|COMPLETED|Overall Study||7
8205611|NCT02168933|20234837|P1|STARTED|Overall Study||8
8205612|NCT02168855|20234847|P2|NOT COMPLETED|Overall Study||11
8205613|NCT02168855|20234848|P1|NOT COMPLETED|Overall Study||12
8205614|NCT02168855|20234847|P2|COMPLETED|Overall Study||177
8205615|NCT02168855|20234848|P1|COMPLETED|Overall Study||169
8205616|NCT02168855|20234847|P2|STARTED|Overall Study||188
8205617|NCT02168855|20234848|P1|STARTED|Overall Study||181
8205618|NCT02168842|20234860|P2|NOT COMPLETED|Overall Study||8
8205619|NCT02168842|20234861|P1|NOT COMPLETED|Overall Study||8
8205620|NCT02168842|20234860|P2|COMPLETED|Overall Study||158
8205621|NCT02168842|20234861|P1|COMPLETED|Overall Study||162
8205622|NCT02168842|20234860|P2|STARTED|Overall Study||166
8205623|NCT02168842|20234861|P1|STARTED|Overall Study||170
8205624|NCT02168816|20234919|P2|NOT COMPLETED|Overall Study||2
8205625|NCT02168816|20234920|P1|NOT COMPLETED|Overall Study||2
8205626|NCT02168816|20234919|P2|COMPLETED|Overall Study||5
8205627|NCT02168816|20234920|P1|COMPLETED|Overall Study||3
8205628|NCT02168816|20234919|P2|STARTED|Overall Study||7
8205629|NCT02168816|20234920|P1|STARTED|Overall Study||5
8205630|NCT02168803|20234931|P3|NOT COMPLETED|Overall Study||6
8205631|NCT02168803|20234932|P2|NOT COMPLETED|Overall Study||3
8205632|NCT02168803|20234933|P1|NOT COMPLETED|Overall Study||2
8205633|NCT02168803|20234931|P3|COMPLETED|Overall Study||33
8205634|NCT02168803|20234932|P2|COMPLETED|Overall Study||29
8205635|NCT02168803|20234933|P1|COMPLETED|Overall Study||28
8205636|NCT02168803|20234931|P3|Received at Least 1 Dose of Study Drug|Overall Study||39
8205637|NCT02168803|20234932|P2|Received at Least 1 Dose of Study Drug|Overall Study||32
8205638|NCT02168803|20234933|P1|Received at Least 1 Dose of Study Drug|Overall Study||30
8205639|NCT02168803|20234931|P3|STARTED|Overall Study||39
8205640|NCT02168803|20234932|P2|STARTED|Overall Study||32
8205641|NCT02168803|20234933|P1|STARTED|Overall Study||30
8205642|NCT02168777|20234963|P3|NOT COMPLETED|Overall Study||11
8205643|NCT02168777|20234964|P2|NOT COMPLETED|Overall Study||7
8205644|NCT02168777|20234965|P1|NOT COMPLETED|Overall Study||2
8205645|NCT02168777|20234963|P3|COMPLETED|Overall Study||0
8205646|NCT02168777|20234964|P2|COMPLETED|Overall Study||0
8205647|NCT02168777|20234965|P1|COMPLETED|Overall Study||0
8205648|NCT02168777|20234963|P3|STARTED|Overall Study||11
8205649|NCT02168777|20234964|P2|STARTED|Overall Study||7
8205650|NCT02168777|20234965|P1|STARTED|Overall Study||2
8205651|NCT02168660|20235045|P3|NOT COMPLETED|Overall Study||15
8205652|NCT02168660|20235046|P2|NOT COMPLETED|Overall Study||17
8205653|NCT02168660|20235047|P1|NOT COMPLETED|Overall Study||16
8205654|NCT02168660|20235045|P3|COMPLETED|Overall Study||21
8205655|NCT02168660|20235046|P2|COMPLETED|Overall Study||18
8205656|NCT02168660|20235047|P1|COMPLETED|Overall Study||22
8205657|NCT02168660|20235045|P3|STARTED|Overall Study||36
8205658|NCT02168660|20235046|P2|STARTED|Overall Study||35
8205659|NCT02168660|20235047|P1|STARTED|Overall Study||38
8205660|NCT02168491|20235061|P1|NOT COMPLETED|Overall Study||1
8205661|NCT02168491|20235061|P1|COMPLETED|Overall Study||8
8205662|NCT02168491|20235061|P1|STARTED|Overall Study||9
8205663|NCT02168478|20235067|P1|NOT COMPLETED|Overall Study||4
8205664|NCT02168478|20235067|P1|COMPLETED|Overall Study||202
8205665|NCT02168478|20235067|P1|STARTED|Overall Study||206
8205666|NCT02168439|20235073|P2|NOT COMPLETED|Overall Study||2
8205667|NCT02168439|20235074|P1|NOT COMPLETED|Overall Study||0
8205668|NCT02168439|20235073|P2|COMPLETED|Overall Study||18
8205669|NCT02168439|20235074|P1|COMPLETED|Overall Study||20
8205670|NCT02168439|20235073|P2|STARTED|Overall Study||20
8205671|NCT02168439|20235074|P1|STARTED|Overall Study||20
8205672|NCT02168387|20235092|P2|NOT COMPLETED|Overall Study||3
8205673|NCT02168387|20235093|P1|NOT COMPLETED|Overall Study||7
8205674|NCT02168387|20235092|P2|COMPLETED|Overall Study||16
8205675|NCT02168387|20235093|P1|COMPLETED|Overall Study||13
8205676|NCT02168387|20235092|P2|STARTED|Overall Study||19
8205677|NCT02168387|20235093|P1|STARTED|Overall Study||20
8205678|NCT02168361|20235105|P2|NOT COMPLETED|Overall Study||10
8205679|NCT02168361|20235106|P1|NOT COMPLETED|Overall Study||5
8205680|NCT02168361|20235105|P2|COMPLETED|Overall Study||21
8205681|NCT02168361|20235106|P1|COMPLETED|Overall Study||57
8205682|NCT02168361|20235105|P2|STARTED|Overall Study||31
8205683|NCT02168361|20235106|P1|STARTED|Overall Study||62
8205684|NCT02168309|20235116|P2|NOT COMPLETED|Overall Study||0
8205685|NCT02168309|20235117|P1|NOT COMPLETED|Overall Study||0
8205686|NCT02168309|20235116|P2|COMPLETED|Overall Study||25
8205687|NCT02168309|20235117|P1|COMPLETED|Overall Study||25
8205688|NCT02168309|20235116|P2|STARTED|Overall Study||25
8205689|NCT02168309|20235117|P1|STARTED|Overall Study||25
8205690|NCT02168270|20235125|P1|NOT COMPLETED|Overall Study||4
8205691|NCT02168270|20235125|P1|COMPLETED|Overall Study||0
8205692|NCT02168270|20235125|P1|STARTED|Overall Study||4
8205693|NCT02168153|20235134|P2|NOT COMPLETED|Overall Study||0
8205694|NCT02168153|20235135|P1|NOT COMPLETED|Overall Study||3
8205695|NCT02168153|20235134|P2|COMPLETED|Overall Study||60
8205696|NCT02168153|20235135|P1|COMPLETED|Overall Study||57
8205697|NCT02168153|20235134|P2|STARTED|Overall Study||60
8205698|NCT02168153|20235135|P1|STARTED|Overall Study||60
8205699|NCT02168101|20235152|P3|NOT COMPLETED|Overall Study||1
8205700|NCT02168101|20235153|P2|NOT COMPLETED|Overall Study||2
8205701|NCT02168101|20235154|P1|NOT COMPLETED|Overall Study||2
8205702|NCT02168101|20235152|P3|COMPLETED|Overall Study||2
8205703|NCT02168101|20235153|P2|COMPLETED|Overall Study||1
8205704|NCT02168101|20235154|P1|COMPLETED|Overall Study||1
8205705|NCT02168101|20235152|P3|STARTED|Overall Study||3
8205706|NCT02168101|20235153|P2|STARTED|Overall Study||3
8205707|NCT02168101|20235154|P1|STARTED|Overall Study||3
8205708|NCT02168062|20235176|P3|NOT COMPLETED|Overall Study||0
8205709|NCT02168062|20235177|P2|NOT COMPLETED|Overall Study||0
8205710|NCT02168062|20235178|P1|NOT COMPLETED|Overall Study||0
8205711|NCT02168062|20235176|P3|COMPLETED|Overall Study||8
8205712|NCT02168062|20235177|P2|COMPLETED|Overall Study||26
8205713|NCT02168062|20235178|P1|COMPLETED|Overall Study||23
8205714|NCT02168062|20235176|P3|STARTED|Overall Study||8
8205715|NCT02168062|20235177|P2|STARTED|Overall Study||26
8205716|NCT02168062|20235178|P1|STARTED|Overall Study||23
8205717|NCT02167893|20235224|P1|NOT COMPLETED|Overall Study||163
8205718|NCT02167893|20235224|P1|COMPLETED|Overall Study||11125
8205719|NCT02167893|20235224|P1|STARTED|Overall Study||11288
8205720|NCT02167867|20235235|P2|NOT COMPLETED|Overall Study||0
8205721|NCT02167867|20235236|P1|NOT COMPLETED|Overall Study||0
8205722|NCT02167867|20235235|P2|COMPLETED|Overall Study||22
8205723|NCT02167867|20235236|P1|COMPLETED|Overall Study||22
8205724|NCT02167867|20235235|P2|STARTED|Overall Study||22
8205725|NCT02167867|20235236|P1|STARTED|Overall Study||22
8205726|NCT02167815|20235244|P2|NOT COMPLETED|Overall Study||0
8205727|NCT02167815|20235245|P1|NOT COMPLETED|Overall Study||0
8205728|NCT02167815|20235244|P2|COMPLETED|Overall Study||21
8205729|NCT02167815|20235245|P1|COMPLETED|Overall Study||9
8205730|NCT02167815|20235244|P2|STARTED|Overall Study||21
8205731|NCT02167815|20235245|P1|STARTED|Overall Study||9
8205732|NCT02167594|20235259|P3|NOT COMPLETED|Overall Study||0
8205733|NCT02167594|20235260|P2|NOT COMPLETED|Overall Study||1
8205734|NCT02167594|20235261|P1|NOT COMPLETED|Overall Study||2
8205735|NCT02167594|20235259|P3|COMPLETED|Overall Study||3
8205736|NCT02167594|20235260|P2|COMPLETED|Overall Study||5
8205737|NCT02167594|20235261|P1|COMPLETED|Overall Study||18
8205738|NCT02167594|20235259|P3|STARTED|Overall Study||3
8205739|NCT02167594|20235260|P2|STARTED|Overall Study||6
8205740|NCT02167594|20235261|P1|STARTED|Overall Study||20
8205741|NCT02167451|20235270|P1|NOT COMPLETED|Overall Study||1
8205742|NCT02167451|20235270|P1|COMPLETED|Overall Study||30
8205743|NCT02167451|20235270|P1|STARTED|Overall Study||31
8205744|NCT02167256|20235287|P2|NOT COMPLETED|Overall Study||10
8205745|NCT02167256|20235288|P1|NOT COMPLETED|Overall Study||21
8205746|NCT02167256|20235287|P2|COMPLETED|Overall Study||70
8205747|NCT02167256|20235288|P1|COMPLETED|Overall Study||58
8205748|NCT02167256|20235287|P2|STARTED|Overall Study||80
8205749|NCT02167256|20235288|P1|STARTED|Overall Study||79
8205750|NCT02167217|20235304|P1|NOT COMPLETED|Overall Study||2
8205751|NCT02167217|20235304|P1|COMPLETED|Overall Study||23
8205752|NCT02167217|20235304|P1|STARTED|Overall Study||25
8205753|NCT02167204|20235308|P1|NOT COMPLETED|Overall Study||0
8205754|NCT02167204|20235308|P1|COMPLETED|Overall Study||9
8205755|NCT02167204|20235308|P1|STARTED|Overall Study||9
8205756|NCT02167139|20235321|P4|NOT COMPLETED|Transition-extension||5
8205757|NCT02167139|20235322|P3|NOT COMPLETED|Transition-extension||8
8205758|NCT02167139|20235323|P2|NOT COMPLETED|Transition-extension||0
8205759|NCT02167139|20235324|P1|NOT COMPLETED|Transition-extension||6
8205760|NCT02167139|20235321|P4|COMPLETED|Transition-extension||124
8205761|NCT02167139|20235322|P3|COMPLETED|Transition-extension||117
8205762|NCT02167139|20235323|P2|COMPLETED|Transition-extension||0
8205763|NCT02167139|20235324|P1|COMPLETED|Transition-extension||248
8205764|NCT02167139|20235321|P4|STARTED|Transition-extension||129
8205765|NCT02167139|20235322|P3|STARTED|Transition-extension||125
8205766|NCT02167139|20235323|P2|STARTED|Transition-extension||0
8205767|NCT02167139|20235324|P1|STARTED|Transition-extension||254
8205768|NCT02167139|20235321|P4|NOT COMPLETED|Randomised, Double-blind||0
8205769|NCT02167139|20235322|P3|NOT COMPLETED|Randomised, Double-blind||0
8205770|NCT02167139|20235323|P2|NOT COMPLETED|Randomised, Double-blind||19
8205771|NCT02167139|20235324|P1|NOT COMPLETED|Randomised, Double-blind||17
8205772|NCT02167139|20235321|P4|COMPLETED|Randomised, Double-blind||0
8205773|NCT02167139|20235322|P3|COMPLETED|Randomised, Double-blind||0
8205774|NCT02167139|20235323|P2|COMPLETED|Randomised, Double-blind||254
8205775|NCT02167139|20235324|P1|COMPLETED|Randomised, Double-blind||254
8205776|NCT02167139|20235321|P4|STARTED|Randomised, Double-blind||0
8205777|NCT02167139|20235322|P3|STARTED|Randomised, Double-blind||0
8205778|NCT02167139|20235323|P2|STARTED|Randomised, Double-blind||273
8205779|NCT02167139|20235324|P1|STARTED|Randomised, Double-blind||271
8205786|NCT02167035|20235359|P2|NOT COMPLETED|Overall Study||6
8205787|NCT02167035|20235360|P1|NOT COMPLETED|Overall Study||5
8205788|NCT02167035|20235359|P2|COMPLETED|Overall Study||16
8205789|NCT02167035|20235360|P1|COMPLETED|Overall Study||16
8205790|NCT02167035|20235359|P2|STARTED|Overall Study||22
8205791|NCT02167035|20235360|P1|STARTED|Overall Study||21
8205792|NCT02166697|20235368|P1|NOT COMPLETED|Overall Study||347
8205793|NCT02166697|20235368|P1|COMPLETED|Overall Study||13804
8205794|NCT02166697|20235368|P1|STARTED|Overall Study||14151
8205800|NCT02166476|20235384|P2|NOT COMPLETED|Overall Study||23
8205801|NCT02166476|20235385|P1|NOT COMPLETED|Overall Study||14
8205802|NCT02166476|20235384|P2|COMPLETED|Overall Study||250
8205803|NCT02166476|20235385|P1|COMPLETED|Overall Study||258
8205804|NCT02166476|20235384|P2|Received at Least 1 Dose of Study Drug|Overall Study||273
8205805|NCT02166476|20235385|P1|Received at Least 1 Dose of Study Drug|Overall Study||272
8205806|NCT02166476|20235384|P2|STARTED|Overall Study||273
8205807|NCT02166476|20235385|P1|STARTED|Overall Study||272
8205808|NCT02166346|20235418|P2|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
8205809|NCT02166346|20235419|P1|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
8205810|NCT02166346|20235418|P2|COMPLETED|Intervention - Phase 2 (After Crossover)||6
8205811|NCT02166346|20235419|P1|COMPLETED|Intervention - Phase 2 (After Crossover)||7
8205812|NCT02166346|20235418|P2|STARTED|Intervention - Phase 2 (After Crossover)||6
8205813|NCT02166346|20235419|P1|STARTED|Intervention - Phase 2 (After Crossover)||8
8205814|NCT02166346|20235418|P2|NOT COMPLETED|Intervention - Phase 1||2
8205815|NCT02166346|20235419|P1|NOT COMPLETED|Intervention - Phase 1||0
8205816|NCT02166346|20235418|P2|COMPLETED|Intervention - Phase 1||6
8205817|NCT02166346|20235419|P1|COMPLETED|Intervention - Phase 1||8
8205818|NCT02166346|20235418|P2|STARTED|Intervention - Phase 1||8
8205819|NCT02166346|20235419|P1|STARTED|Intervention - Phase 1||8
8205820|NCT02166346|20235418|P2|NOT COMPLETED|Screening and Randomization||4
8205821|NCT02166346|20235419|P1|NOT COMPLETED|Screening and Randomization||4
8205822|NCT02166346|20235418|P2|COMPLETED|Screening and Randomization||8
8205823|NCT02166346|20235419|P1|COMPLETED|Screening and Randomization||8
8205824|NCT02166346|20235418|P2|STARTED|Screening and Randomization||12
8205825|NCT02166346|20235419|P1|STARTED|Screening and Randomization||12
8205826|NCT02166047|20235439|P12|NOT COMPLETED|Overall Study||0
8205827|NCT02166047|20235440|P11|NOT COMPLETED|Overall Study||2
8205828|NCT02166047|20235441|P10|NOT COMPLETED|Overall Study||0
8205829|NCT02166047|20235442|P9|NOT COMPLETED|Overall Study||0
8205830|NCT02166047|20235443|P8|NOT COMPLETED|Overall Study||0
8205831|NCT02166047|20235444|P7|NOT COMPLETED|Overall Study||2
8205832|NCT02166047|20235445|P6|NOT COMPLETED|Overall Study||0
8205833|NCT02166047|20235446|P5|NOT COMPLETED|Overall Study||1
8205834|NCT02166047|20235447|P4|NOT COMPLETED|Overall Study||0
8205835|NCT02166047|20235448|P3|NOT COMPLETED|Overall Study||2
8205836|NCT02166047|20235449|P2|NOT COMPLETED|Overall Study||1
8205837|NCT02166047|20235450|P1|NOT COMPLETED|Overall Study||0
8205838|NCT02166047|20235439|P12|COMPLETED|Overall Study||6
8205839|NCT02166047|20235440|P11|COMPLETED|Overall Study||12
8205840|NCT02166047|20235441|P10|COMPLETED|Overall Study||17
8205841|NCT02166047|20235442|P9|COMPLETED|Overall Study||16
8205842|NCT02166047|20235443|P8|COMPLETED|Overall Study||5
8205843|NCT02166047|20235444|P7|COMPLETED|Overall Study||15
8205844|NCT02166047|20235445|P6|COMPLETED|Overall Study||17
8205845|NCT02166047|20235446|P5|COMPLETED|Overall Study||17
8205846|NCT02166047|20235447|P4|COMPLETED|Overall Study||5
8205847|NCT02166047|20235448|P3|COMPLETED|Overall Study||14
8205848|NCT02166047|20235449|P2|COMPLETED|Overall Study||14
8205849|NCT02166047|20235450|P1|COMPLETED|Overall Study||16
8205850|NCT02166047|20235439|P12|STARTED|Overall Study||6
8205851|NCT02166047|20235440|P11|STARTED|Overall Study||14
8205852|NCT02166047|20235441|P10|STARTED|Overall Study||17
8205853|NCT02166047|20235442|P9|STARTED|Overall Study||16
8205854|NCT02166047|20235443|P8|STARTED|Overall Study||5
8205855|NCT02166047|20235444|P7|STARTED|Overall Study||17
8205856|NCT02166047|20235445|P6|STARTED|Overall Study||17
8205857|NCT02166047|20235446|P5|STARTED|Overall Study||18
8205858|NCT02166047|20235447|P4|STARTED|Overall Study||5
8205859|NCT02166047|20235448|P3|STARTED|Overall Study||16
8205860|NCT02166047|20235449|P2|STARTED|Overall Study||15
8205861|NCT02166047|20235450|P1|STARTED|Overall Study||16
8205862|NCT02165904|20235572|P1|NOT COMPLETED|Overall Study||0
8205863|NCT02165904|20235572|P1|COMPLETED|Overall Study||10
8205864|NCT02165904|20235572|P1|STARTED|Overall Study||10
8205865|NCT02165839|20235593|P2|NOT COMPLETED|Overall Study||0
8205866|NCT02165839|20235594|P1|NOT COMPLETED|Overall Study||0
8205867|NCT02165839|20235593|P2|COMPLETED|Overall Study||73
8205868|NCT02165839|20235594|P1|COMPLETED|Overall Study||66
8205869|NCT02165839|20235593|P2|STARTED|Overall Study||73
8205870|NCT02165839|20235594|P1|STARTED|Overall Study||66
8205871|NCT02165826|20235617|P3|NOT COMPLETED|Down-Titration Period||7
8205872|NCT02165826|20235618|P2|NOT COMPLETED|Down-Titration Period||11
8205873|NCT02165826|20235619|P1|NOT COMPLETED|Down-Titration Period||7
8205874|NCT02165826|20235617|P3|COMPLETED|Down-Titration Period||31
8205875|NCT02165826|20235618|P2|COMPLETED|Down-Titration Period||28
8205876|NCT02165826|20235619|P1|COMPLETED|Down-Titration Period||20
8205877|NCT02165826|20235617|P3|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
8205878|NCT02165826|20235618|P2|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
8205879|NCT02165826|20235619|P1|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
8205880|NCT02165826|20235617|P3|STARTED|Down-Titration Period||38
8205881|NCT02165826|20235618|P2|STARTED|Down-Titration Period||39
8205882|NCT02165826|20235619|P1|STARTED|Down-Titration Period||27
8205883|NCT02165826|20235617|P3|NOT COMPLETED|Main Treatment Period||109
8205884|NCT02165826|20235618|P2|NOT COMPLETED|Main Treatment Period||90
8205885|NCT02165826|20235619|P1|NOT COMPLETED|Main Treatment Period||81
8205886|NCT02165826|20235617|P3|COMPLETED|Main Treatment Period||334
8205887|NCT02165826|20235618|P2|COMPLETED|Main Treatment Period||349
8205888|NCT02165826|20235619|P1|COMPLETED|Main Treatment Period||360
8205889|NCT02165826|20235617|P3|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
8205890|NCT02165826|20235618|P2|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
8205891|NCT02165826|20235619|P1|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
8205892|NCT02165826|20235617|P3|STARTED|Main Treatment Period||443
8205893|NCT02165826|20235618|P2|STARTED|Main Treatment Period||439
8205894|NCT02165826|20235619|P1|STARTED|Main Treatment Period||441
8205895|NCT02165761|20235678|P2|NOT COMPLETED|Overall Study||14
8205896|NCT02165761|20235679|P1|NOT COMPLETED|Overall Study||19
8205897|NCT02165761|20235678|P2|COMPLETED|Overall Study||5
8205898|NCT02165761|20235679|P1|COMPLETED|Overall Study||4
8205899|NCT02165761|20235678|P2|STARTED|Overall Study||19
8205900|NCT02165761|20235679|P1|STARTED|Overall Study||23
8205901|NCT02165735|20235687|P2|NOT COMPLETED|Overall Study||14
8205902|NCT02165735|20235688|P1|NOT COMPLETED|Overall Study||16
8205903|NCT02165735|20235687|P2|COMPLETED|Overall Study||166
8205904|NCT02165735|20235688|P1|COMPLETED|Overall Study||164
8205905|NCT02165735|20235687|P2|STARTED|Overall Study||180
8205906|NCT02165735|20235688|P1|STARTED|Overall Study||180
8205907|NCT02165722|20235716|P2|NOT COMPLETED|Overall Study||0
8205908|NCT02165722|20235717|P1|NOT COMPLETED|Overall Study||0
8205909|NCT02165722|20235716|P2|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
8205910|NCT02165722|20235717|P1|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
8205911|NCT02165722|20235716|P2|STARTED|Overall Study||2202
8205912|NCT02165722|20235717|P1|STARTED|Overall Study||1971
8205913|NCT02165605|20235729|P1|NOT COMPLETED|Overall Study||0
8205914|NCT02165605|20235729|P1|COMPLETED|Overall Study||28
8205915|NCT02165605|20235729|P1|STARTED|Overall Study||28
8205916|NCT02165462|20235742|P1|NOT COMPLETED|Overall Study||0
8205917|NCT02165462|20235742|P1|COMPLETED|Overall Study||17
8205918|NCT02165462|20235742|P1|STARTED|Overall Study||17
8205928|NCT02165384|20235787|P1|NOT COMPLETED|Overall Study||0
8205929|NCT02165384|20235787|P1|COMPLETED|Overall Study||199
8205930|NCT02165384|20235787|P1|STARTED|Overall Study||199
8205931|NCT02165202|20235794|P2|NOT COMPLETED|Injection Phase||6
8205932|NCT02165202|20235795|P1|NOT COMPLETED|Injection Phase||10
8205933|NCT02165202|20235794|P2|COMPLETED|Injection Phase||36
8205934|NCT02165202|20235795|P1|COMPLETED|Injection Phase||70
8205935|NCT02165202|20235794|P2|STARTED|Injection Phase|Participants who received at least one injection.|42
8205936|NCT02165202|20235795|P1|STARTED|Injection Phase|Participants who received at least one injection.|80
8205937|NCT02165202|20235794|P2|NOT COMPLETED|Oral Phase||3
8205938|NCT02165202|20235795|P1|NOT COMPLETED|Oral Phase||11
8205939|NCT02165202|20235794|P2|COMPLETED|Oral Phase||42
8205940|NCT02165202|20235795|P1|COMPLETED|Oral Phase||80
8205941|NCT02165202|20235794|P2|STARTED|Oral Phase|Participants Enrolled in the study|45
8205942|NCT02165202|20235795|P1|STARTED|Oral Phase|Participants Enrolled in the study|91
8205943|NCT02165124|20235801|P1|NOT COMPLETED|Overall Study||5
8205944|NCT02165124|20235801|P1|COMPLETED|Overall Study||15
8205945|NCT02165124|20235801|P1|STARTED|Overall Study||20
8205946|NCT02165111|20235807|P2|NOT COMPLETED|Overall Study||0
8205947|NCT02165111|20235808|P1|NOT COMPLETED|Overall Study||0
8205948|NCT02165111|20235807|P2|COMPLETED|Overall Study||40
8205949|NCT02165111|20235808|P1|COMPLETED|Overall Study||40
8205950|NCT02165111|20235807|P2|STARTED|Overall Study||40
8205951|NCT02165111|20235808|P1|STARTED|Overall Study||40
8205952|NCT02165072|20235824|P1|NOT COMPLETED|Overall Study||0
8205953|NCT02165072|20235824|P1|COMPLETED|Overall Study||30
8205954|NCT02165072|20235824|P1|STARTED|Overall Study||30
8205955|NCT02164981|20235832|P3|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
8205956|NCT02164981|20235833|P2|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
8205957|NCT02164981|20235834|P1|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
8205958|NCT02164981|20235832|P3|COMPLETED|Phase 2 (Day 14 - Day 28)||18
8205959|NCT02164981|20235833|P2|COMPLETED|Phase 2 (Day 14 - Day 28)||12
8205960|NCT02164981|20235834|P1|COMPLETED|Phase 2 (Day 14 - Day 28)||16
8205961|NCT02164981|20235832|P3|STARTED|Phase 2 (Day 14 - Day 28)||18
8205962|NCT02164981|20235833|P2|STARTED|Phase 2 (Day 14 - Day 28)||14
8205963|NCT02164981|20235834|P1|STARTED|Phase 2 (Day 14 - Day 28)||18
8205964|NCT02164981|20235832|P3|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
8205965|NCT02164981|20235833|P2|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
8205966|NCT02164981|20235834|P1|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
8205967|NCT02164981|20235832|P3|COMPLETED|Phase 1 (Day 0 - Day 14)||18
8205968|NCT02164981|20235833|P2|COMPLETED|Phase 1 (Day 0 - Day 14)||14
8205969|NCT02164981|20235834|P1|COMPLETED|Phase 1 (Day 0 - Day 14)||18
8205970|NCT02164981|20235832|P3|STARTED|Phase 1 (Day 0 - Day 14)||18
8205971|NCT02164981|20235833|P2|STARTED|Phase 1 (Day 0 - Day 14)||16
8205972|NCT02164981|20235834|P1|STARTED|Phase 1 (Day 0 - Day 14)||18
8205973|NCT02164981|20235832|P3|NOT COMPLETED|Started||0
8205974|NCT02164981|20235833|P2|NOT COMPLETED|Started||3
8205975|NCT02164981|20235834|P1|NOT COMPLETED|Started||5
8205976|NCT02164981|20235832|P3|COMPLETED|Started||18
8205977|NCT02164981|20235833|P2|COMPLETED|Started||16
8205978|NCT02164981|20235834|P1|COMPLETED|Started||18
8205979|NCT02164981|20235832|P3|STARTED|Started||18
8205980|NCT02164981|20235833|P2|STARTED|Started||19
8205981|NCT02164981|20235834|P1|STARTED|Started||23
8205982|NCT02164929|20235907|P4|NOT COMPLETED|Overall Study||2
8205983|NCT02164929|20235908|P3|NOT COMPLETED|Overall Study||1
8205984|NCT02164929|20235909|P2|NOT COMPLETED|Overall Study||0
8205985|NCT02164929|20235910|P1|NOT COMPLETED|Overall Study||1
8205986|NCT02164929|20235907|P4|COMPLETED|Overall Study||2
8205987|NCT02164929|20235908|P3|COMPLETED|Overall Study||4
8205988|NCT02164929|20235909|P2|COMPLETED|Overall Study||3
8205989|NCT02164929|20235910|P1|COMPLETED|Overall Study||3
8205990|NCT02164929|20235907|P4|STARTED|Overall Study||4
8205991|NCT02164929|20235908|P3|STARTED|Overall Study||5
8205992|NCT02164929|20235909|P2|STARTED|Overall Study||3
8205993|NCT02164929|20235910|P1|STARTED|Overall Study||4
8205994|NCT02164916|20235954|P2|NOT COMPLETED|Overall Study||54
8205995|NCT02164916|20235955|P1|NOT COMPLETED|Overall Study||52
8205996|NCT02164916|20235954|P2|COMPLETED|Overall Study||0
8205997|NCT02164916|20235955|P1|COMPLETED|Overall Study||0
8205998|NCT02164916|20235954|P2|Cross-over to Arm II|Overall Study||0
8205999|NCT02164916|20235955|P1|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
8206000|NCT02164916|20235954|P2|Eligible|Overall Study||49
8206001|NCT02164916|20235955|P1|Eligible|Overall Study||50
8206002|NCT02164916|20235954|P2|STARTED|Overall Study||54
8206003|NCT02164916|20235955|P1|STARTED|Overall Study||52
8206004|NCT02164864|20235975|P3|NOT COMPLETED|Overall Study||132
8206005|NCT02164864|20235976|P2|NOT COMPLETED|Overall Study||60
8206006|NCT02164864|20235977|P1|NOT COMPLETED|Overall Study||95
8206007|NCT02164864|20235975|P3|COMPLETED|Overall Study||849
8206008|NCT02164864|20235976|P2|COMPLETED|Overall Study||703
8206009|NCT02164864|20235977|P1|COMPLETED|Overall Study||886
8206010|NCT02164864|20235975|P3|STARTED|Overall Study|Started are the Randomised/entered patients.|981
8206011|NCT02164864|20235976|P2|STARTED|Overall Study|Started are the Randomised/entered patients.|763
8206012|NCT02164864|20235977|P1|STARTED|Overall Study|Started are the Randomised/entered patients.|981
8206013|NCT02164721|20236036|P1|NOT COMPLETED|Overall Study||0
8206014|NCT02164721|20236036|P1|COMPLETED|Overall Study||30
8206015|NCT02164721|20236036|P1|STARTED|Overall Study||30
8206016|NCT02164539|20236052|P7|NOT COMPLETED|Treatment Phase C (1 Week)||2
8206017|NCT02164539|20236053|P6|NOT COMPLETED|Treatment Phase C (1 Week)||0
8206018|NCT02164539|20236054|P5|NOT COMPLETED|Treatment Phase C (1 Week)||0
8206019|NCT02164539|20236055|P4|NOT COMPLETED|Treatment Phase C (1 Week)||0
8206020|NCT02164539|20236056|P3|NOT COMPLETED|Treatment Phase C (1 Week)||0
8206021|NCT02164539|20236057|P2|NOT COMPLETED|Treatment Phase C (1 Week)||0
8206022|NCT02164539|20236058|P1|NOT COMPLETED|Treatment Phase C (1 Week)||1
8206023|NCT02164539|20236052|P7|COMPLETED|Treatment Phase C (1 Week)||78
8206024|NCT02164539|20236053|P6|COMPLETED|Treatment Phase C (1 Week)||82
8206025|NCT02164539|20236054|P5|COMPLETED|Treatment Phase C (1 Week)||84
8206026|NCT02164539|20236055|P4|COMPLETED|Treatment Phase C (1 Week)||0
8206027|NCT02164539|20236056|P3|COMPLETED|Treatment Phase C (1 Week)||0
8206028|NCT02164539|20236057|P2|COMPLETED|Treatment Phase C (1 Week)||0
8206029|NCT02164539|20236058|P1|COMPLETED|Treatment Phase C (1 Week)||78
8206030|NCT02164539|20236052|P7|STARTED|Treatment Phase C (1 Week)||80
8206031|NCT02164539|20236053|P6|STARTED|Treatment Phase C (1 Week)||82
8206032|NCT02164539|20236054|P5|STARTED|Treatment Phase C (1 Week)||84
8206033|NCT02164539|20236055|P4|STARTED|Treatment Phase C (1 Week)||0
8206034|NCT02164539|20236056|P3|STARTED|Treatment Phase C (1 Week)||0
8206035|NCT02164539|20236057|P2|STARTED|Treatment Phase C (1 Week)||0
8206036|NCT02164539|20236058|P1|STARTED|Treatment Phase C (1 Week)||79
8206037|NCT02164539|20236052|P7|NOT COMPLETED|Treatment Phase B (1 Week)||1
8206038|NCT02164539|20236053|P6|NOT COMPLETED|Treatment Phase B (1 Week)||0
8206039|NCT02164539|20236054|P5|NOT COMPLETED|Treatment Phase B (1 Week)||3
8206040|NCT02164539|20236055|P4|NOT COMPLETED|Treatment Phase B (1 Week)||0
8206041|NCT02164539|20236056|P3|NOT COMPLETED|Treatment Phase B (1 Week)||0
8206042|NCT02164539|20236057|P2|NOT COMPLETED|Treatment Phase B (1 Week)||0
8206043|NCT02164539|20236058|P1|NOT COMPLETED|Treatment Phase B (1 Week)||0
8206044|NCT02164539|20236052|P7|COMPLETED|Treatment Phase B (1 Week)||162
8206045|NCT02164539|20236053|P6|COMPLETED|Treatment Phase B (1 Week)||0
8206046|NCT02164539|20236054|P5|COMPLETED|Treatment Phase B (1 Week)||163
8206047|NCT02164539|20236055|P4|COMPLETED|Treatment Phase B (1 Week)||0
8206048|NCT02164539|20236056|P3|COMPLETED|Treatment Phase B (1 Week)||0
8206049|NCT02164539|20236057|P2|COMPLETED|Treatment Phase B (1 Week)||0
8206050|NCT02164539|20236058|P1|COMPLETED|Treatment Phase B (1 Week)||0
8206051|NCT02164539|20236052|P7|STARTED|Treatment Phase B (1 Week)||163
8206052|NCT02164539|20236053|P6|STARTED|Treatment Phase B (1 Week)||0
8206053|NCT02164539|20236054|P5|STARTED|Treatment Phase B (1 Week)||166
8206054|NCT02164539|20236055|P4|STARTED|Treatment Phase B (1 Week)||0
8206055|NCT02164539|20236056|P3|STARTED|Treatment Phase B (1 Week)||0
8206056|NCT02164539|20236057|P2|STARTED|Treatment Phase B (1 Week)||0
8206057|NCT02164539|20236058|P1|STARTED|Treatment Phase B (1 Week)||0
8206058|NCT02164539|20236052|P7|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
8206059|NCT02164539|20236053|P6|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
8206060|NCT02164539|20236054|P5|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
8206061|NCT02164539|20236055|P4|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
8206062|NCT02164539|20236056|P3|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
8206063|NCT02164539|20236057|P2|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
8206064|NCT02164539|20236058|P1|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
8206065|NCT02164539|20236052|P7|COMPLETED|Treatment Phase A (4 Weeks)||0
8206066|NCT02164539|20236053|P6|COMPLETED|Treatment Phase A (4 Weeks)||83
8206067|NCT02164539|20236054|P5|COMPLETED|Treatment Phase A (4 Weeks)||82
8206068|NCT02164539|20236055|P4|COMPLETED|Treatment Phase A (4 Weeks)||44
8206069|NCT02164539|20236056|P3|COMPLETED|Treatment Phase A (4 Weeks)||39
8206070|NCT02164539|20236057|P2|COMPLETED|Treatment Phase A (4 Weeks)||42
8206071|NCT02164539|20236058|P1|COMPLETED|Treatment Phase A (4 Weeks)||39
8206072|NCT02164539|20236052|P7|STARTED|Treatment Phase A (4 Weeks)||0
8206073|NCT02164539|20236053|P6|STARTED|Treatment Phase A (4 Weeks)||84
8206074|NCT02164539|20236054|P5|STARTED|Treatment Phase A (4 Weeks)||85
8206075|NCT02164539|20236055|P4|STARTED|Treatment Phase A (4 Weeks)||46
8206076|NCT02164539|20236056|P3|STARTED|Treatment Phase A (4 Weeks)||40
8206077|NCT02164539|20236057|P2|STARTED|Treatment Phase A (4 Weeks)||42
8206078|NCT02164539|20236058|P1|STARTED|Treatment Phase A (4 Weeks)||41
8206079|NCT02164513|20236106|P3|NOT COMPLETED|Overall Study||295
8206080|NCT02164513|20236107|P2|NOT COMPLETED|Overall Study||536
8206081|NCT02164513|20236108|P1|NOT COMPLETED|Overall Study||437
8206082|NCT02164513|20236106|P3|COMPLETED|Overall Study||1775
8206083|NCT02164513|20236107|P2|COMPLETED|Overall Study||3598
8206084|NCT02164513|20236108|P1|COMPLETED|Overall Study||3714
8206085|NCT02164513|20236106|P3|WIP :Did Not Complete Study Treatment|Overall Study||0
8206086|NCT02164513|20236107|P2|WIP :Did Not Complete Study Treatment|Overall Study||1
8206087|NCT02164513|20236108|P1|WIP :Did Not Complete Study Treatment|Overall Study||1
8206088|NCT02164513|20236106|P3|WIP: Withdrawal by Participant|Overall Study||153
8206089|NCT02164513|20236107|P2|WIP: Withdrawal by Participant|Overall Study||296
8206090|NCT02164513|20236108|P1|WIP: Withdrawal by Participant|Overall Study||250
8206091|NCT02164513|20236106|P3|WIP: Investigator Discretion|Overall Study||15
8206092|NCT02164513|20236107|P2|WIP: Investigator Discretion|Overall Study||36
8206093|NCT02164513|20236108|P1|WIP: Investigator Discretion|Overall Study||33
8206094|NCT02164513|20236106|P3|WIP: Lost to Follow-up|Overall Study||14
8206095|NCT02164513|20236107|P2|WIP: Lost to Follow-up|Overall Study||25
8206096|NCT02164513|20236108|P1|WIP: Lost to Follow-up|Overall Study||21
8206097|NCT02164513|20236106|P3|WIP: Study Closed/Terminated|Overall Study||5
8206098|NCT02164513|20236107|P2|WIP: Study Closed/Terminated|Overall Study||2
8206099|NCT02164513|20236108|P1|WIP: Study Closed/Terminated|Overall Study||5
8206100|NCT02164513|20236106|P3|WIP (Other): Stopping Criteria Reached|Overall Study||2
8206101|NCT02164513|20236107|P2|WIP (Other): Stopping Criteria Reached|Overall Study||1
8206102|NCT02164513|20236108|P1|WIP (Other): Stopping Criteria Reached|Overall Study||4
8206103|NCT02164513|20236106|P3|Withdrew IP: Protocol Deviation|Overall Study||19
8206104|NCT02164513|20236107|P2|Withdrew IP: Protocol Deviation|Overall Study||41
8206105|NCT02164513|20236108|P1|Withdrew IP: Protocol Deviation|Overall Study||32
8206106|NCT02164513|20236106|P3|WIP: Lack of Efficacy|Overall Study||172
8206107|NCT02164513|20236107|P2|WIP: Lack of Efficacy|Overall Study||313
8206108|NCT02164513|20236108|P1|WIP: Lack of Efficacy|Overall Study||163
8206109|NCT02164513|20236106|P3|Withdrew IP (WIP): Adverse Event|Overall Study||186
8206110|NCT02164513|20236107|P2|Withdrew IP (WIP): Adverse Event|Overall Study||325
8206111|NCT02164513|20236108|P1|Withdrew IP (WIP): Adverse Event|Overall Study||249
8206112|NCT02164513|20236106|P3|Not Completed IP|Overall Study||566
8206113|NCT02164513|20236107|P2|Not Completed IP|Overall Study||1040
8206114|NCT02164513|20236108|P1|Not Completed IP|Overall Study||758
8206115|NCT02164513|20236106|P3|Completed Investigational Product (IP)|Overall Study||1504
8206116|NCT02164513|20236107|P2|Completed Investigational Product (IP)|Overall Study||3094
8206117|NCT02164513|20236108|P1|Completed Investigational Product (IP)|Overall Study||3393
8206118|NCT02164513|20236106|P3|STARTED|Overall Study||2070
8206119|NCT02164513|20236107|P2|STARTED|Overall Study||4134
8206120|NCT02164513|20236108|P1|STARTED|Overall Study||4151
8206121|NCT02164396|20236133|P3|NOT COMPLETED|Overall Study||0
8206122|NCT02164396|20236134|P2|NOT COMPLETED|Overall Study||0
8206123|NCT02164396|20236135|P1|NOT COMPLETED|Overall Study||0
8206124|NCT02164396|20236133|P3|COMPLETED|Overall Study||10
8206125|NCT02164396|20236134|P2|COMPLETED|Overall Study||10
8206126|NCT02164396|20236135|P1|COMPLETED|Overall Study||10
8206127|NCT02164396|20236133|P3|STARTED|Overall Study||10
8206128|NCT02164396|20236134|P2|STARTED|Overall Study||10
8206129|NCT02164396|20236135|P1|STARTED|Overall Study||10
8206130|NCT02164383|20236145|P2|NOT COMPLETED|Overall Study||0
8206131|NCT02164383|20236146|P1|NOT COMPLETED|Overall Study||1
8206132|NCT02164383|20236145|P2|COMPLETED|Overall Study||14
8206133|NCT02164383|20236146|P1|COMPLETED|Overall Study||15
8206134|NCT02164383|20236145|P2|STARTED|Overall Study||14
8206135|NCT02164383|20236146|P1|STARTED|Overall Study||16
8206136|NCT02164318|20236156|P4|NOT COMPLETED|Overall Study||1
8206137|NCT02164318|20236157|P3|NOT COMPLETED|Overall Study||0
8206138|NCT02164318|20236158|P2|NOT COMPLETED|Overall Study||1
8206139|NCT02164318|20236159|P1|NOT COMPLETED|Overall Study||0
8206140|NCT02164318|20236156|P4|COMPLETED|Overall Study||2
8206141|NCT02164318|20236157|P3|COMPLETED|Overall Study||1
8206142|NCT02164318|20236158|P2|COMPLETED|Overall Study||2
8206143|NCT02164318|20236159|P1|COMPLETED|Overall Study||4
8206144|NCT02164318|20236156|P4|STARTED|Overall Study||3
8206145|NCT02164318|20236157|P3|STARTED|Overall Study||1
8206146|NCT02164318|20236158|P2|STARTED|Overall Study||3
8206147|NCT02164318|20236159|P1|STARTED|Overall Study||4
8206157|NCT02163993|20236194|P5|NOT COMPLETED|Post-treatment Period||3
8206158|NCT02163993|20236195|P4|NOT COMPLETED|Post-treatment Period||2
8206159|NCT02163993|20236196|P3|NOT COMPLETED|Post-treatment Period||4
8206160|NCT02163993|20236197|P2|NOT COMPLETED|Post-treatment Period||6
8206161|NCT02163993|20236198|P1|NOT COMPLETED|Post-treatment Period||4
8206162|NCT02163993|20236194|P5|COMPLETED|Post-treatment Period||62
8206163|NCT02163993|20236195|P4|COMPLETED|Post-treatment Period||61
8206164|NCT02163993|20236196|P3|COMPLETED|Post-treatment Period||62
8206165|NCT02163993|20236197|P2|COMPLETED|Post-treatment Period||55
8206166|NCT02163993|20236198|P1|COMPLETED|Post-treatment Period||121
8206167|NCT02163993|20236194|P5|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
8206168|NCT02163993|20236195|P4|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
8206169|NCT02163993|20236196|P3|STARTED|Post-treatment Period||66
8206170|NCT02163993|20236197|P2|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
8206171|NCT02163993|20236198|P1|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
8206172|NCT02163993|20236194|P5|NOT COMPLETED|Treatment Period||7
8206173|NCT02163993|20236195|P4|NOT COMPLETED|Treatment Period||9
8206174|NCT02163993|20236196|P3|NOT COMPLETED|Treatment Period||2
8206175|NCT02163993|20236197|P2|NOT COMPLETED|Treatment Period||9
8206176|NCT02163993|20236198|P1|NOT COMPLETED|Treatment Period||12
8206177|NCT02163993|20236194|P5|COMPLETED|Treatment Period||62
8206178|NCT02163993|20236195|P4|COMPLETED|Treatment Period||62
8206179|NCT02163993|20236196|P3|COMPLETED|Treatment Period||66
8206180|NCT02163993|20236197|P2|COMPLETED|Treatment Period||59
8206181|NCT02163993|20236198|P1|COMPLETED|Treatment Period||126
8206182|NCT02163993|20236194|P5|Received at Least 1 Dose of Study Drug|Treatment Period||67
8206183|NCT02163993|20236195|P4|Received at Least 1 Dose of Study Drug|Treatment Period||70
8206184|NCT02163993|20236196|P3|Received at Least 1 Dose of Study Drug|Treatment Period||68
8206185|NCT02163993|20236197|P2|Received at Least 1 Dose of Study Drug|Treatment Period||68
8206186|NCT02163993|20236198|P1|Received at Least 1 Dose of Study Drug|Treatment Period||137
8206187|NCT02163993|20236194|P5|STARTED|Treatment Period||69
8206188|NCT02163993|20236195|P4|STARTED|Treatment Period||71
8206189|NCT02163993|20236196|P3|STARTED|Treatment Period||68
8206190|NCT02163993|20236197|P2|STARTED|Treatment Period||68
8206191|NCT02163993|20236198|P1|STARTED|Treatment Period||138
8206192|NCT02163967|20236274|P6|NOT COMPLETED|Third Intervention/Day 3||0
8206193|NCT02163967|20236275|P5|NOT COMPLETED|Third Intervention/Day 3||0
8206194|NCT02163967|20236276|P4|NOT COMPLETED|Third Intervention/Day 3||0
8206195|NCT02163967|20236277|P3|NOT COMPLETED|Third Intervention/Day 3||0
8206196|NCT02163967|20236278|P2|NOT COMPLETED|Third Intervention/Day 3||0
8206197|NCT02163967|20236279|P1|NOT COMPLETED|Third Intervention/Day 3||0
8206198|NCT02163967|20236274|P6|COMPLETED|Third Intervention/Day 3||3
8206199|NCT02163967|20236275|P5|COMPLETED|Third Intervention/Day 3||3
8206200|NCT02163967|20236276|P4|COMPLETED|Third Intervention/Day 3||4
8206201|NCT02163967|20236277|P3|COMPLETED|Third Intervention/Day 3||2
8206202|NCT02163967|20236278|P2|COMPLETED|Third Intervention/Day 3||3
8206203|NCT02163967|20236279|P1|COMPLETED|Third Intervention/Day 3||3
8206204|NCT02163967|20236274|P6|STARTED|Third Intervention/Day 3||3
8206205|NCT02163967|20236275|P5|STARTED|Third Intervention/Day 3||3
8206206|NCT02163967|20236276|P4|STARTED|Third Intervention/Day 3||4
8206207|NCT02163967|20236277|P3|STARTED|Third Intervention/Day 3||2
8206208|NCT02163967|20236278|P2|STARTED|Third Intervention/Day 3||3
8206209|NCT02163967|20236279|P1|STARTED|Third Intervention/Day 3||3
8206210|NCT02163967|20236274|P6|NOT COMPLETED|Second Intevention/Day 2||0
8206211|NCT02163967|20236275|P5|NOT COMPLETED|Second Intevention/Day 2||0
8206212|NCT02163967|20236276|P4|NOT COMPLETED|Second Intevention/Day 2||0
8206213|NCT02163967|20236277|P3|NOT COMPLETED|Second Intevention/Day 2||0
8206214|NCT02163967|20236278|P2|NOT COMPLETED|Second Intevention/Day 2||0
8206215|NCT02163967|20236279|P1|NOT COMPLETED|Second Intevention/Day 2||0
8206216|NCT02163967|20236274|P6|COMPLETED|Second Intevention/Day 2||3
8206217|NCT02163967|20236275|P5|COMPLETED|Second Intevention/Day 2||3
8206218|NCT02163967|20236276|P4|COMPLETED|Second Intevention/Day 2||4
8206219|NCT02163967|20236277|P3|COMPLETED|Second Intevention/Day 2||2
8206220|NCT02163967|20236278|P2|COMPLETED|Second Intevention/Day 2||4
8206221|NCT02163967|20236279|P1|COMPLETED|Second Intevention/Day 2||3
8206222|NCT02163967|20236274|P6|STARTED|Second Intevention/Day 2||3
8206223|NCT02163967|20236275|P5|STARTED|Second Intevention/Day 2||3
8206224|NCT02163967|20236276|P4|STARTED|Second Intevention/Day 2||4
8206225|NCT02163967|20236277|P3|STARTED|Second Intevention/Day 2||2
8206226|NCT02163967|20236278|P2|STARTED|Second Intevention/Day 2||4
8206227|NCT02163967|20236279|P1|STARTED|Second Intevention/Day 2||3
8206228|NCT02163967|20236274|P6|NOT COMPLETED|First Intervention/ Day 1||0
8206229|NCT02163967|20236275|P5|NOT COMPLETED|First Intervention/ Day 1||0
8206230|NCT02163967|20236276|P4|NOT COMPLETED|First Intervention/ Day 1||0
8206231|NCT02163967|20236277|P3|NOT COMPLETED|First Intervention/ Day 1||0
8206232|NCT02163967|20236278|P2|NOT COMPLETED|First Intervention/ Day 1||0
8206233|NCT02163967|20236279|P1|NOT COMPLETED|First Intervention/ Day 1||0
8206234|NCT02163967|20236274|P6|COMPLETED|First Intervention/ Day 1||3
8206235|NCT02163967|20236275|P5|COMPLETED|First Intervention/ Day 1||3
8206236|NCT02163967|20236276|P4|COMPLETED|First Intervention/ Day 1||4
8206237|NCT02163967|20236277|P3|COMPLETED|First Intervention/ Day 1||3
8206238|NCT02163967|20236278|P2|COMPLETED|First Intervention/ Day 1||4
8206239|NCT02163967|20236279|P1|COMPLETED|First Intervention/ Day 1||4
8206240|NCT02163967|20236274|P6|STARTED|First Intervention/ Day 1||3
8206241|NCT02163967|20236275|P5|STARTED|First Intervention/ Day 1||3
8206242|NCT02163967|20236276|P4|STARTED|First Intervention/ Day 1||4
8206243|NCT02163967|20236277|P3|STARTED|First Intervention/ Day 1||3
8206244|NCT02163967|20236278|P2|STARTED|First Intervention/ Day 1||4
8206245|NCT02163967|20236279|P1|STARTED|First Intervention/ Day 1||4
8206246|NCT02163915|20236301|P5|NOT COMPLETED|Overall Study||4
8206247|NCT02163915|20236302|P4|NOT COMPLETED|Overall Study||3
8206248|NCT02163915|20236303|P3|NOT COMPLETED|Overall Study||2
8206249|NCT02163915|20236304|P2|NOT COMPLETED|Overall Study||0
8206250|NCT02163915|20236305|P1|NOT COMPLETED|Overall Study||3
8206251|NCT02163915|20236301|P5|COMPLETED|Overall Study||6
8206252|NCT02163915|20236302|P4|COMPLETED|Overall Study||6
8206253|NCT02163915|20236303|P3|COMPLETED|Overall Study||8
8206254|NCT02163915|20236304|P2|COMPLETED|Overall Study||8
8206255|NCT02163915|20236305|P1|COMPLETED|Overall Study||7
8206256|NCT02163915|20236301|P5|STARTED|Overall Study||10
8206257|NCT02163915|20236302|P4|STARTED|Overall Study||9
8206258|NCT02163915|20236303|P3|STARTED|Overall Study||10
8206259|NCT02163915|20236304|P2|STARTED|Overall Study||8
8206260|NCT02163915|20236305|P1|STARTED|Overall Study||10
8206261|NCT02163902|20236360|P2|NOT COMPLETED|Overall Study||13
8206262|NCT02163902|20236361|P1|NOT COMPLETED|Overall Study||11
8206263|NCT02163902|20236360|P2|COMPLETED|Overall Study||98
8206264|NCT02163902|20236361|P1|COMPLETED|Overall Study||102
8206265|NCT02163902|20236360|P2|STARTED|Overall Study||111
8206266|NCT02163902|20236361|P1|STARTED|Overall Study||113
8206267|NCT02163837|20236377|P1|NOT COMPLETED|Day 28 of Rifaximin Treatment||0
8206268|NCT02163837|20236377|P1|COMPLETED|Day 28 of Rifaximin Treatment||15
8206269|NCT02163837|20236377|P1|STARTED|Day 28 of Rifaximin Treatment||15
8206270|NCT02163837|20236377|P1|NOT COMPLETED|Before Rifaximin||0
8206271|NCT02163837|20236377|P1|COMPLETED|Before Rifaximin||15
8206272|NCT02163837|20236377|P1|STARTED|Before Rifaximin||15
8206273|NCT02163811|20236387|P2|NOT COMPLETED|Overall Study||16
8206274|NCT02163811|20236388|P1|NOT COMPLETED|Overall Study||36
8206275|NCT02163811|20236387|P2|COMPLETED|Overall Study||60
8206276|NCT02163811|20236388|P1|COMPLETED|Overall Study||35
8206277|NCT02163811|20236387|P2|STARTED|Overall Study||76
8206278|NCT02163811|20236388|P1|STARTED|Overall Study||71
8206306|NCT02163577|20236449|P2|NOT COMPLETED|Overall Study||0
8206307|NCT02163577|20236450|P1|NOT COMPLETED|Overall Study||0
8206308|NCT02163577|20236449|P2|COMPLETED|Overall Study||26
8206309|NCT02163577|20236450|P1|COMPLETED|Overall Study||26
8206310|NCT02163577|20236449|P2|STARTED|Overall Study||26
8206311|NCT02163577|20236450|P1|STARTED|Overall Study||26
8206312|NCT02163538|20236514|P2|NOT COMPLETED|Overall Study||1
8206313|NCT02163538|20236515|P1|NOT COMPLETED|Overall Study||1
8206314|NCT02163538|20236514|P2|COMPLETED|Overall Study||70
8206315|NCT02163538|20236515|P1|COMPLETED|Overall Study||70
8206316|NCT02163538|20236514|P2|STARTED|Overall Study||71
8206317|NCT02163538|20236515|P1|STARTED|Overall Study||71
8206318|NCT02163499|20236531|P1|NOT COMPLETED|Extended Dosing Phase: ZS||280
8206319|NCT02163499|20236531|P1|COMPLETED|Extended Dosing Phase: ZS||466
8206320|NCT02163499|20236531|P1|STARTED|Extended Dosing Phase: ZS||746
8206321|NCT02163499|20236531|P1|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
8206322|NCT02163499|20236531|P1|COMPLETED|Acute Phase: ZS 10 g TID||746
8206323|NCT02163499|20236531|P1|STARTED|Acute Phase: ZS 10 g TID||751
8206324|NCT02163486|20236541|P2|NOT COMPLETED|Overall Study||2
8206325|NCT02163486|20236542|P1|NOT COMPLETED|Overall Study||1
8206326|NCT02163486|20236541|P2|COMPLETED|Overall Study||50
8206327|NCT02163486|20236542|P1|COMPLETED|Overall Study||50
8206328|NCT02163486|20236541|P2|STARTED|Overall Study||52
8206329|NCT02163486|20236542|P1|STARTED|Overall Study||51
8206330|NCT02163447|20236559|P3|NOT COMPLETED|Overall Study||3
8206331|NCT02163447|20236560|P2|NOT COMPLETED|Overall Study||6
8206332|NCT02163447|20236561|P1|NOT COMPLETED|Overall Study||6
8206333|NCT02163447|20236559|P3|COMPLETED|Overall Study||97
8206334|NCT02163447|20236560|P2|COMPLETED|Overall Study||88
8206335|NCT02163447|20236561|P1|COMPLETED|Overall Study||100
8206336|NCT02163447|20236559|P3|Infants Born|Overall Study||100
8206337|NCT02163447|20236560|P2|Infants Born|Overall Study||93
8206338|NCT02163447|20236561|P1|Infants Born|Overall Study||101
8206339|NCT02163447|20236559|P3|STARTED|Overall Study||100
8206340|NCT02163447|20236560|P2|STARTED|Overall Study||94
8206341|NCT02163447|20236561|P1|STARTED|Overall Study||106
8206342|NCT02163421|20236626|P4|NOT COMPLETED|Overall Study||0
8206343|NCT02163421|20236627|P3|NOT COMPLETED|Overall Study||0
8206344|NCT02163421|20236628|P2|NOT COMPLETED|Overall Study||0
8206345|NCT02163421|20236629|P1|NOT COMPLETED|Overall Study||0
8206346|NCT02163421|20236626|P4|COMPLETED|Overall Study||12
8206347|NCT02163421|20236627|P3|COMPLETED|Overall Study||12
8206348|NCT02163421|20236628|P2|COMPLETED|Overall Study||12
8206349|NCT02163421|20236629|P1|COMPLETED|Overall Study||12
8206350|NCT02163421|20236626|P4|STARTED|Overall Study||12
8206351|NCT02163421|20236627|P3|STARTED|Overall Study||12
8206352|NCT02163421|20236628|P2|STARTED|Overall Study||12
8206353|NCT02163421|20236629|P1|STARTED|Overall Study||12
8206357|NCT02163187|20236645|P2|NOT COMPLETED|Overall Study||0
8206358|NCT02163187|20236646|P1|NOT COMPLETED|Overall Study||2
8206359|NCT02163187|20236645|P2|COMPLETED|Overall Study||0
8206360|NCT02163187|20236646|P1|COMPLETED|Overall Study||2
8206361|NCT02163187|20236645|P2|Treatment|Overall Study||0
8206362|NCT02163187|20236646|P1|Treatment|Overall Study||2
8206363|NCT02163187|20236645|P2|STARTED|Overall Study||0
8206364|NCT02163187|20236646|P1|STARTED|Overall Study||4
8206365|NCT02163057|20236656|P2|NOT COMPLETED|Overall Study||5
8206366|NCT02163057|20236657|P1|NOT COMPLETED|Overall Study||3
8206367|NCT02163057|20236656|P2|COMPLETED|Overall Study||11
8206368|NCT02163057|20236657|P1|COMPLETED|Overall Study||3
8206369|NCT02163057|20236656|P2|STARTED|Overall Study||16
8206370|NCT02163057|20236657|P1|STARTED|Overall Study||6
8206371|NCT02162992|20236679|P2|NOT COMPLETED|Overall Study||1
8206372|NCT02162992|20236680|P1|NOT COMPLETED|Overall Study||5
8206373|NCT02162992|20236679|P2|COMPLETED|Overall Study||99
8206374|NCT02162992|20236680|P1|COMPLETED|Overall Study||46
8206375|NCT02162992|20236679|P2|STARTED|Overall Study||100
8206376|NCT02162992|20236680|P1|STARTED|Overall Study||51
8206377|NCT02162979|20236690|P2|NOT COMPLETED|Overall Study||0
8206378|NCT02162979|20236691|P1|NOT COMPLETED|Overall Study||0
8206379|NCT02162979|20236690|P2|COMPLETED|Overall Study||0
8206380|NCT02162979|20236691|P1|COMPLETED|Overall Study||0
8206381|NCT02162979|20236690|P2|STARTED|Overall Study||0
8206382|NCT02162979|20236691|P1|STARTED|Overall Study||0
8206383|NCT02162862|20236704|P3|NOT COMPLETED|Overall Study||4
8206384|NCT02162862|20236705|P2|NOT COMPLETED|Overall Study||11
8206385|NCT02162862|20236706|P1|NOT COMPLETED|Overall Study||0
8206386|NCT02162862|20236704|P3|COMPLETED|Overall Study||29
8206387|NCT02162862|20236705|P2|COMPLETED|Overall Study||24
8206388|NCT02162862|20236706|P1|COMPLETED|Overall Study||31
8206389|NCT02162862|20236704|P3|STARTED|Overall Study||33
8206390|NCT02162862|20236705|P2|STARTED|Overall Study||35
8206391|NCT02162862|20236706|P1|STARTED|Overall Study||31
8206392|NCT02162771|20236719|P2|NOT COMPLETED|Maintenance Study Period (Part 2)||22
8206393|NCT02162771|20236720|P1|NOT COMPLETED|Maintenance Study Period (Part 2)||16
8206394|NCT02162771|20236719|P2|COMPLETED|Maintenance Study Period (Part 2)||38
8206395|NCT02162771|20236720|P1|COMPLETED|Maintenance Study Period (Part 2)||46
8206396|NCT02162771|20236719|P2|STARTED|Maintenance Study Period (Part 2)|Two subjects did not enter this period due to Withdrawal by subject and Non-responder, 1 for each.|60
8206397|NCT02162771|20236720|P1|STARTED|Maintenance Study Period (Part 2)||62
8206398|NCT02162771|20236719|P2|NOT COMPLETED|Core Study Period (Part 2)||8
8206399|NCT02162771|20236720|P1|NOT COMPLETED|Core Study Period (Part 2)||8
8206400|NCT02162771|20236719|P2|COMPLETED|Core Study Period (Part 2)||62
8206401|NCT02162771|20236720|P1|COMPLETED|Core Study Period (Part 2)||62
8206402|NCT02162771|20236719|P2|STARTED|Core Study Period (Part 2)||70
8206403|NCT02162771|20236720|P1|STARTED|Core Study Period (Part 2)||70
8206404|NCT02162758|20236734|P2|NOT COMPLETED|Overall Study||1
8206405|NCT02162758|20236735|P1|NOT COMPLETED|Overall Study||0
8206406|NCT02162758|20236734|P2|COMPLETED|Overall Study||2
8206407|NCT02162758|20236735|P1|COMPLETED|Overall Study||3
8206408|NCT02162758|20236734|P2|STARTED|Overall Study||3
8206409|NCT02162758|20236735|P1|STARTED|Overall Study||3
8206416|NCT02162680|20236795|P3|NOT COMPLETED|Overall Study||0
8206417|NCT02162680|20236796|P2|NOT COMPLETED|Overall Study||0
8206418|NCT02162680|20236797|P1|NOT COMPLETED|Overall Study||0
8206419|NCT02162680|20236795|P3|COMPLETED|Overall Study||32
8206420|NCT02162680|20236796|P2|COMPLETED|Overall Study||33
8206421|NCT02162680|20236797|P1|COMPLETED|Overall Study||33
8206422|NCT02162680|20236795|P3|STARTED|Overall Study||32
8206423|NCT02162680|20236796|P2|STARTED|Overall Study||33
8206424|NCT02162680|20236797|P1|STARTED|Overall Study||33
8206425|NCT02162667|20236807|P2|NOT COMPLETED|Adjuvant Period||13
8206426|NCT02162667|20236808|P1|NOT COMPLETED|Adjuvant Period||12
8206427|NCT02162667|20236807|P2|COMPLETED|Adjuvant Period||255
8206428|NCT02162667|20236808|P1|COMPLETED|Adjuvant Period||248
8206429|NCT02162667|20236807|P2|STARTED|Adjuvant Period||268
8206430|NCT02162667|20236808|P1|STARTED|Adjuvant Period||260
8206431|NCT02162667|20236807|P2|NOT COMPLETED|Neoadjuvant Period||17
8206432|NCT02162667|20236808|P1|NOT COMPLETED|Neoadjuvant Period||14
8206433|NCT02162667|20236807|P2|COMPLETED|Neoadjuvant Period||267
8206434|NCT02162667|20236808|P1|COMPLETED|Neoadjuvant Period||264
8206435|NCT02162667|20236807|P2|STARTED|Neoadjuvant Period||284
8206436|NCT02162667|20236808|P1|STARTED|Neoadjuvant Period||278
8206440|NCT02162446|20236840|P1|NOT COMPLETED|Overall Study||0
8206441|NCT02162446|20236840|P1|COMPLETED|Overall Study||12
8206442|NCT02162446|20236840|P1|STARTED|Overall Study||12
8206443|NCT02162433|20236875|P4|NOT COMPLETED|Overall Study||1
8206444|NCT02162433|20236876|P3|NOT COMPLETED|Overall Study||2
8206445|NCT02162433|20236877|P2|NOT COMPLETED|Overall Study||2
8206446|NCT02162433|20236878|P1|NOT COMPLETED|Overall Study||1
8206447|NCT02162433|20236875|P4|COMPLETED|Overall Study||22
8206448|NCT02162433|20236876|P3|COMPLETED|Overall Study||21
8206449|NCT02162433|20236877|P2|COMPLETED|Overall Study||21
8206450|NCT02162433|20236878|P1|COMPLETED|Overall Study||22
8206451|NCT02162433|20236875|P4|STARTED|Overall Study||23
8206452|NCT02162433|20236876|P3|STARTED|Overall Study||23
8206453|NCT02162433|20236877|P2|STARTED|Overall Study||23
8206454|NCT02162433|20236878|P1|STARTED|Overall Study||23
8206455|NCT02161757|20236915|P3|NOT COMPLETED|Treatment Through Study Completion||39
8206456|NCT02161757|20236916|P2|NOT COMPLETED|Treatment Through Study Completion||43
8206457|NCT02161757|20236917|P1|NOT COMPLETED|Treatment Through Study Completion||57
8206458|NCT02161757|20236915|P3|COMPLETED|Treatment Through Study Completion||361
8206459|NCT02161757|20236916|P2|COMPLETED|Treatment Through Study Completion||361
8206460|NCT02161757|20236917|P1|COMPLETED|Treatment Through Study Completion||341
8206461|NCT02161757|20236915|P3|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
8206462|NCT02161757|20236916|P2|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
8206463|NCT02161757|20236917|P1|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
8206464|NCT02161757|20236915|P3|STARTED|Treatment Through Study Completion||400
8206465|NCT02161757|20236916|P2|STARTED|Treatment Through Study Completion||404
8206466|NCT02161757|20236917|P1|STARTED|Treatment Through Study Completion||398
8206467|NCT02161757|20236915|P3|NOT COMPLETED|Randomised Through Start Treatment||0
8206468|NCT02161757|20236916|P2|NOT COMPLETED|Randomised Through Start Treatment||2
8206469|NCT02161757|20236917|P1|NOT COMPLETED|Randomised Through Start Treatment||3
8206470|NCT02161757|20236915|P3|COMPLETED|Randomised Through Start Treatment||400
8206471|NCT02161757|20236916|P2|COMPLETED|Randomised Through Start Treatment||404
8206472|NCT02161757|20236917|P1|COMPLETED|Randomised Through Start Treatment||398
8206473|NCT02161757|20236915|P3|STARTED|Randomised Through Start Treatment||400
8206474|NCT02161757|20236916|P2|STARTED|Randomised Through Start Treatment||406
8206475|NCT02161757|20236917|P1|STARTED|Randomised Through Start Treatment||401
8206476|NCT02161731|20236975|P2|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
8206477|NCT02161731|20236976|P1|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
8206478|NCT02161731|20236975|P2|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
8206479|NCT02161731|20236976|P1|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
8206480|NCT02161731|20236975|P2|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
8206481|NCT02161731|20236976|P1|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
8206482|NCT02161731|20236975|P2|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
8206483|NCT02161731|20236976|P1|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
8206484|NCT02161731|20236975|P2|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
8206485|NCT02161731|20236976|P1|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
8206486|NCT02161731|20236975|P2|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
8206487|NCT02161731|20236976|P1|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
8206488|NCT02161731|20236975|P2|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
8206489|NCT02161731|20236976|P1|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
8206490|NCT02161731|20236975|P2|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
8206491|NCT02161731|20236976|P1|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
8206492|NCT02161705|20236995|P2|NOT COMPLETED|Overall Study||0
8206493|NCT02161705|20236996|P1|NOT COMPLETED|Overall Study||0
8206494|NCT02161705|20236995|P2|COMPLETED|Overall Study||9
8206495|NCT02161705|20236996|P1|COMPLETED|Overall Study||9
8206496|NCT02161705|20236995|P2|STARTED|Overall Study||9
8206497|NCT02161705|20236996|P1|STARTED|Overall Study||9
8206498|NCT02161575|20237004|P1|NOT COMPLETED|Overall Study||11
8206499|NCT02161575|20237004|P1|COMPLETED|Overall Study||92
8206500|NCT02161575|20237004|P1|Safety (SAF) Population|Overall Study||100
8206501|NCT02161575|20237004|P1|Full Analysis Set (FAS) Population|Overall Study||100
8206502|NCT02161575|20237004|P1|STARTED|Overall Study||103
8206503|NCT02161562|20237024|P2|NOT COMPLETED|Overall Study||17
8206504|NCT02161562|20237025|P1|NOT COMPLETED|Overall Study||26
8206505|NCT02161562|20237024|P2|COMPLETED|Overall Study||119
8206506|NCT02161562|20237025|P1|COMPLETED|Overall Study||152
8206507|NCT02161562|20237024|P2|STARTED|Overall Study||136
8206508|NCT02161562|20237025|P1|STARTED|Overall Study||178
8206509|NCT02161549|20237053|P2|NOT COMPLETED|Overall Study||2
8206510|NCT02161549|20237054|P1|NOT COMPLETED|Overall Study||6
8206511|NCT02161549|20237053|P2|COMPLETED|Overall Study||29
8206512|NCT02161549|20237054|P1|COMPLETED|Overall Study||34
8206513|NCT02161549|20237053|P2|STARTED|Overall Study||31
8206514|NCT02161549|20237054|P1|STARTED|Overall Study||40
8206515|NCT02161536|20237063|P3|NOT COMPLETED|Overall Study||0
8206516|NCT02161536|20237064|P2|NOT COMPLETED|Overall Study||0
8206517|NCT02161536|20237065|P1|NOT COMPLETED|Overall Study||0
8206518|NCT02161536|20237063|P3|COMPLETED|Overall Study||20
8206519|NCT02161536|20237064|P2|COMPLETED|Overall Study||21
8206520|NCT02161536|20237065|P1|COMPLETED|Overall Study||6
8206521|NCT02161536|20237063|P3|STARTED|Overall Study||20
8206522|NCT02161536|20237064|P2|STARTED|Overall Study||21
8206523|NCT02161536|20237065|P1|STARTED|Overall Study||6
8206524|NCT02161484|20237075|P2|NOT COMPLETED|Overall Study||3
8206525|NCT02161484|20237076|P1|NOT COMPLETED|Overall Study||4
8206526|NCT02161484|20237075|P2|COMPLETED|Overall Study||2
8206527|NCT02161484|20237076|P1|COMPLETED|Overall Study||1
8206528|NCT02161484|20237075|P2|STARTED|Overall Study||5
8206529|NCT02161484|20237076|P1|STARTED|Overall Study||5
8206530|NCT02161458|20237102|P4|NOT COMPLETED|Overall Study||0
8206531|NCT02161458|20237103|P3|NOT COMPLETED|Overall Study||5
8206532|NCT02161458|20237104|P2|NOT COMPLETED|Overall Study||6
8206533|NCT02161458|20237105|P1|NOT COMPLETED|Overall Study||0
8206534|NCT02161458|20237102|P4|COMPLETED|Overall Study||8
8206535|NCT02161458|20237103|P3|COMPLETED|Overall Study||28
8206536|NCT02161458|20237104|P2|COMPLETED|Overall Study||29
8206537|NCT02161458|20237105|P1|COMPLETED|Overall Study||22
8206538|NCT02161458|20237102|P4|STARTED|Overall Study||8
8206539|NCT02161458|20237103|P3|STARTED|Overall Study||33
8206540|NCT02161458|20237104|P2|STARTED|Overall Study||35
8206541|NCT02161458|20237105|P1|STARTED|Overall Study||22
8206542|NCT02161406|20237117|P2|NOT COMPLETED|Overall Study||9
8206543|NCT02161406|20237118|P1|NOT COMPLETED|Overall Study||10
8206544|NCT02161406|20237117|P2|COMPLETED|Overall Study||35
8206545|NCT02161406|20237118|P1|COMPLETED|Overall Study||34
8206546|NCT02161406|20237117|P2|STARTED|Overall Study||44
8206547|NCT02161406|20237118|P1|STARTED|Overall Study||44
8206548|NCT02161185|20237192|P1|NOT COMPLETED|Treatment Phase||7
8206549|NCT02161185|20237192|P1|COMPLETED|Treatment Phase||0
8206550|NCT02161185|20237192|P1|STARTED|Treatment Phase||7
8206551|NCT02161185|20237192|P1|NOT COMPLETED|Test Dose Phase||0
8206552|NCT02161185|20237192|P1|COMPLETED|Test Dose Phase||7
8206553|NCT02161185|20237192|P1|STARTED|Test Dose Phase||7
8206554|NCT02161146|20237202|P5|NOT COMPLETED|Overall Study||1
8206555|NCT02161146|20237203|P4|NOT COMPLETED|Overall Study||3
8206556|NCT02161146|20237204|P3|NOT COMPLETED|Overall Study||0
8206557|NCT02161146|20237205|P2|NOT COMPLETED|Overall Study||4
8206558|NCT02161146|20237206|P1|NOT COMPLETED|Overall Study||1
8206559|NCT02161146|20237202|P5|COMPLETED|Overall Study||48
8206560|NCT02161146|20237203|P4|COMPLETED|Overall Study||45
8206561|NCT02161146|20237204|P3|COMPLETED|Overall Study||49
8206562|NCT02161146|20237205|P2|COMPLETED|Overall Study||43
8206563|NCT02161146|20237206|P1|COMPLETED|Overall Study||46
8206564|NCT02161146|20237202|P5|STARTED|Overall Study||49
8206565|NCT02161146|20237203|P4|STARTED|Overall Study||48
8206566|NCT02161146|20237204|P3|STARTED|Overall Study||49
8206567|NCT02161146|20237205|P2|STARTED|Overall Study||47
8206568|NCT02161146|20237206|P1|STARTED|Overall Study||47
8206569|NCT02161133|20237221|P2|NOT COMPLETED|Overall Study||11
8206570|NCT02161133|20237222|P1|NOT COMPLETED|Overall Study||19
8206571|NCT02161133|20237221|P2|COMPLETED|Overall Study||122
8206572|NCT02161133|20237222|P1|COMPLETED|Overall Study||116
8206573|NCT02161133|20237221|P2|STARTED|Overall Study||133
8206574|NCT02161133|20237222|P1|STARTED|Overall Study||135
8206575|NCT02161016|20237242|P1|NOT COMPLETED|Overall Study||1
8206576|NCT02161016|20237242|P1|COMPLETED|Overall Study||0
8206577|NCT02161016|20237242|P1|STARTED|Overall Study||1
8206578|NCT02160990|20237252|P2|NOT COMPLETED|Overall Study||0
8206579|NCT02160990|20237253|P1|NOT COMPLETED|Overall Study||0
8206580|NCT02160990|20237252|P2|COMPLETED|Overall Study||10
8206581|NCT02160990|20237253|P1|COMPLETED|Overall Study||10
8206582|NCT02160990|20237252|P2|STARTED|Overall Study||10
8206583|NCT02160990|20237253|P1|STARTED|Overall Study||10
8206584|NCT02160977|20237273|P2|NOT COMPLETED|Six Months After Surgery||1
8206585|NCT02160977|20237274|P1|NOT COMPLETED|Six Months After Surgery||2
8206586|NCT02160977|20237273|P2|COMPLETED|Six Months After Surgery||42
8206587|NCT02160977|20237274|P1|COMPLETED|Six Months After Surgery||42
8206588|NCT02160977|20237273|P2|STARTED|Six Months After Surgery||43
8206589|NCT02160977|20237274|P1|STARTED|Six Months After Surgery||44
8206590|NCT02160977|20237273|P2|NOT COMPLETED|Three Months After Surgery||2
8206591|NCT02160977|20237274|P1|NOT COMPLETED|Three Months After Surgery||0
8206592|NCT02160977|20237273|P2|COMPLETED|Three Months After Surgery||43
8206593|NCT02160977|20237274|P1|COMPLETED|Three Months After Surgery||44
8206594|NCT02160977|20237273|P2|STARTED|Three Months After Surgery||45
8206595|NCT02160977|20237274|P1|STARTED|Three Months After Surgery||44
8206596|NCT02160977|20237273|P2|NOT COMPLETED|Six Weeks After Surgery||0
8206597|NCT02160977|20237274|P1|NOT COMPLETED|Six Weeks After Surgery||1
8206598|NCT02160977|20237273|P2|COMPLETED|Six Weeks After Surgery||45
8206599|NCT02160977|20237274|P1|COMPLETED|Six Weeks After Surgery||44
8206600|NCT02160977|20237273|P2|STARTED|Six Weeks After Surgery||45
8206601|NCT02160977|20237274|P1|STARTED|Six Weeks After Surgery||45
8206602|NCT02160977|20237273|P2|NOT COMPLETED|One Week After Surgery||0
8206603|NCT02160977|20237274|P1|NOT COMPLETED|One Week After Surgery||0
8206604|NCT02160977|20237273|P2|COMPLETED|One Week After Surgery||45
8206605|NCT02160977|20237274|P1|COMPLETED|One Week After Surgery||45
8206606|NCT02160977|20237273|P2|STARTED|One Week After Surgery||45
8206607|NCT02160977|20237274|P1|STARTED|One Week After Surgery||45
8206608|NCT02160899|20237290|P6|NOT COMPLETED|Overall Study||0
8206609|NCT02160899|20237291|P5|NOT COMPLETED|Overall Study||2
8206610|NCT02160899|20237292|P4|NOT COMPLETED|Overall Study||1
8206611|NCT02160899|20237293|P3|NOT COMPLETED|Overall Study||0
8206612|NCT02160899|20237294|P2|NOT COMPLETED|Overall Study||1
8206613|NCT02160899|20237295|P1|NOT COMPLETED|Overall Study||0
8206614|NCT02160899|20237290|P6|COMPLETED|Overall Study||8
8206615|NCT02160899|20237291|P5|COMPLETED|Overall Study||0
8206616|NCT02160899|20237292|P4|COMPLETED|Overall Study||2
8206617|NCT02160899|20237293|P3|COMPLETED|Overall Study||21
8206618|NCT02160899|20237294|P2|COMPLETED|Overall Study||3
8206619|NCT02160899|20237295|P1|COMPLETED|Overall Study||26
8206620|NCT02160899|20237290|P6|STARTED|Overall Study||8
8206621|NCT02160899|20237291|P5|STARTED|Overall Study||2
8206622|NCT02160899|20237292|P4|STARTED|Overall Study||3
8206623|NCT02160899|20237293|P3|STARTED|Overall Study||21
8206624|NCT02160899|20237294|P2|STARTED|Overall Study||4
8206625|NCT02160899|20237295|P1|STARTED|Overall Study||26
8206626|NCT02160873|20237317|P2|NOT COMPLETED|Overall Study||0
8206627|NCT02160873|20237318|P1|NOT COMPLETED|Overall Study||0
8206628|NCT02160873|20237317|P2|COMPLETED|Overall Study||6
8206629|NCT02160873|20237318|P1|COMPLETED|Overall Study||6
8206630|NCT02160873|20237317|P2|STARTED|Overall Study||6
8206631|NCT02160873|20237318|P1|STARTED|Overall Study||6
8206632|NCT02160847|20237332|P2|NOT COMPLETED|Overall Study||0
8206633|NCT02160847|20237333|P1|NOT COMPLETED|Overall Study||0
8206634|NCT02160847|20237332|P2|COMPLETED|Overall Study||16
8206635|NCT02160847|20237333|P1|COMPLETED|Overall Study||16
8206636|NCT02160847|20237332|P2|STARTED|Overall Study||16
8206637|NCT02160847|20237333|P1|STARTED|Overall Study||16
8206638|NCT02160808|20237343|P2|NOT COMPLETED|Overall Study||0
8206639|NCT02160808|20237344|P1|NOT COMPLETED|Overall Study||0
8206640|NCT02160808|20237343|P2|COMPLETED|Overall Study||83
8206641|NCT02160808|20237344|P1|COMPLETED|Overall Study||87
8206642|NCT02160808|20237343|P2|STARTED|Overall Study||83
8206643|NCT02160808|20237344|P1|STARTED|Overall Study||87
8206644|NCT02160626|20237357|P3|NOT COMPLETED|Overall Study||1
8206645|NCT02160626|20237358|P2|NOT COMPLETED|Overall Study||1
8206646|NCT02160626|20237359|P1|NOT COMPLETED|Overall Study||1
8206647|NCT02160626|20237357|P3|COMPLETED|Overall Study||56
8206648|NCT02160626|20237358|P2|COMPLETED|Overall Study||56
8206649|NCT02160626|20237359|P1|COMPLETED|Overall Study||57
8206650|NCT02160626|20237357|P3|STARTED|Overall Study||57
8206651|NCT02160626|20237358|P2|STARTED|Overall Study||57
8206652|NCT02160626|20237359|P1|STARTED|Overall Study||58
8206653|NCT02160535|20237373|P1|NOT COMPLETED|Overall Study||3
8206654|NCT02160535|20237373|P1|COMPLETED|Overall Study||10
8206655|NCT02160535|20237373|P1|STARTED|Overall Study||13
8206656|NCT02160314|20237382|P2|NOT COMPLETED|Overall Study||13
8206657|NCT02160314|20237383|P1|NOT COMPLETED|Overall Study||1
8206658|NCT02160314|20237382|P2|COMPLETED|Overall Study||59
8206659|NCT02160314|20237383|P1|COMPLETED|Overall Study||72
8206660|NCT02160314|20237382|P2|STARTED|Overall Study||72
8206661|NCT02160314|20237383|P1|STARTED|Overall Study||73
8206662|NCT02160288|20237391|P2|NOT COMPLETED|Overall Study||0
8206663|NCT02160288|20237392|P1|NOT COMPLETED|Overall Study||0
8206664|NCT02160288|20237391|P2|COMPLETED|Overall Study||0
8206665|NCT02160288|20237392|P1|COMPLETED|Overall Study||1
8206666|NCT02160288|20237391|P2|STARTED|Overall Study||0
8206667|NCT02160288|20237392|P1|STARTED|Overall Study||1
8206668|NCT02160145|20237418|P3|NOT COMPLETED|Randomized Double-blind Period||28
8206669|NCT02160145|20237419|P2|NOT COMPLETED|Randomized Double-blind Period||29
8206670|NCT02160145|20237420|P1|NOT COMPLETED|Randomized Double-blind Period||0
8206671|NCT02160145|20237418|P3|COMPLETED|Randomized Double-blind Period||659
8206672|NCT02160145|20237419|P2|COMPLETED|Randomized Double-blind Period||654
8206673|NCT02160145|20237420|P1|COMPLETED|Randomized Double-blind Period||0
8206674|NCT02160145|20237418|P3|Off-treatment Completers|Randomized Double-blind Period||22
8206675|NCT02160145|20237419|P2|Off-treatment Completers|Randomized Double-blind Period||76
8206676|NCT02160145|20237420|P1|Off-treatment Completers|Randomized Double-blind Period||0
8206677|NCT02160145|20237418|P3|On-treatment Completers|Randomized Double-blind Period||637
8206678|NCT02160145|20237419|P2|On-treatment Completers|Randomized Double-blind Period||578
8206679|NCT02160145|20237420|P1|On-treatment Completers|Randomized Double-blind Period||0
8206680|NCT02160145|20237418|P3|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
8206681|NCT02160145|20237419|P2|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
8206682|NCT02160145|20237420|P1|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
8206683|NCT02160145|20237418|P3|NOT COMPLETED|Prerandomization Single-blind Period||0
8206684|NCT02160145|20237419|P2|NOT COMPLETED|Prerandomization Single-blind Period||0
8206685|NCT02160145|20237420|P1|NOT COMPLETED|Prerandomization Single-blind Period||149
8206686|NCT02160145|20237418|P3|COMPLETED|Prerandomization Single-blind Period||0
8206687|NCT02160145|20237419|P2|COMPLETED|Prerandomization Single-blind Period||0
8206688|NCT02160145|20237420|P1|COMPLETED|Prerandomization Single-blind Period||1370
8206689|NCT02160145|20237418|P3|Randomized|Prerandomization Single-blind Period||0
8206690|NCT02160145|20237419|P2|Randomized|Prerandomization Single-blind Period||0
8206691|NCT02160145|20237420|P1|Randomized|Prerandomization Single-blind Period||1370
8206692|NCT02160145|20237418|P3|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
8206693|NCT02160145|20237419|P2|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
8206694|NCT02160145|20237420|P1|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
8206695|NCT02160145|20237418|P3|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
8206696|NCT02160145|20237419|P2|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
8206697|NCT02160145|20237420|P1|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
8206698|NCT02160145|20237418|P3|STARTED|Prerandomization Single-blind Period||0
8206699|NCT02160145|20237419|P2|STARTED|Prerandomization Single-blind Period||0
8206700|NCT02160145|20237420|P1|STARTED|Prerandomization Single-blind Period||1519
8206701|NCT02160041|20237433|P1|NOT COMPLETED|Overall Study||84
8206702|NCT02160041|20237433|P1|COMPLETED|Overall Study||0
8206703|NCT02160041|20237433|P1|STARTED|Overall Study||84
8206704|NCT02160002|20237445|P2|NOT COMPLETED|Overall Study||1
8206705|NCT02160002|20237446|P1|NOT COMPLETED|Overall Study||2
8206706|NCT02160002|20237445|P2|COMPLETED|Overall Study||178
8206707|NCT02160002|20237446|P1|COMPLETED|Overall Study||185
8206708|NCT02160002|20237445|P2|Primary Outcome|Overall Study||178
8206709|NCT02160002|20237446|P1|Primary Outcome|Overall Study||185
8206710|NCT02160002|20237445|P2|STARTED|Overall Study||179
8206711|NCT02160002|20237446|P1|STARTED|Overall Study||187
8206712|NCT02159976|20237478|P2|NOT COMPLETED|Overall Study||25
8206713|NCT02159976|20237479|P1|NOT COMPLETED|Overall Study||30
8206714|NCT02159976|20237478|P2|COMPLETED|Overall Study||170
8206715|NCT02159976|20237479|P1|COMPLETED|Overall Study||165
8206716|NCT02159976|20237478|P2|STARTED|Overall Study||195
8206717|NCT02159976|20237479|P1|STARTED|Overall Study||195
8206718|NCT02159950|20237493|P2|NOT COMPLETED|Overall Study||2
8206719|NCT02159950|20237494|P1|NOT COMPLETED|Overall Study||0
8206720|NCT02159950|20237493|P2|COMPLETED|Overall Study||0
8206721|NCT02159950|20237494|P1|COMPLETED|Overall Study||0
8206722|NCT02159950|20237493|P2|STARTED|Overall Study||2
8206723|NCT02159950|20237494|P1|STARTED|Overall Study||0
8206724|NCT02159898|20237528|P2|NOT COMPLETED|Overall Study||0
8206725|NCT02159898|20237529|P1|NOT COMPLETED|Overall Study||1
8206726|NCT02159898|20237528|P2|COMPLETED|Overall Study||30
8206727|NCT02159898|20237529|P1|COMPLETED|Overall Study||29
8206728|NCT02159898|20237528|P2|STARTED|Overall Study||30
8206729|NCT02159898|20237529|P1|STARTED|Overall Study||30
8206730|NCT02159859|20237537|P1|NOT COMPLETED|Overall Study||0
8206731|NCT02159859|20237537|P1|COMPLETED|Overall Study||7
8206732|NCT02159859|20237537|P1|STARTED|Overall Study||7
8206733|NCT02159807|20237553|P3|NOT COMPLETED|Overall Study||3
8206734|NCT02159807|20237554|P2|NOT COMPLETED|Overall Study||1
8206735|NCT02159807|20237555|P1|NOT COMPLETED|Overall Study||1
8206736|NCT02159807|20237553|P3|COMPLETED|Overall Study||48
8206737|NCT02159807|20237554|P2|COMPLETED|Overall Study||51
8206738|NCT02159807|20237555|P1|COMPLETED|Overall Study||66
8206739|NCT02159807|20237553|P3|STARTED|Overall Study||51
8206740|NCT02159807|20237554|P2|STARTED|Overall Study||52
8206741|NCT02159807|20237555|P1|STARTED|Overall Study||67
8206742|NCT02159768|20237569|P1|NOT COMPLETED|Overall Study||0
8206743|NCT02159768|20237569|P1|COMPLETED|Overall Study|Completed 27 July 2015|30
8206744|NCT02159768|20237569|P1|STARTED|Overall Study|Started 16 July 2014|30
8206745|NCT02159729|20237576|P2|NOT COMPLETED|Overall Study||21
8206746|NCT02159729|20237577|P1|NOT COMPLETED|Overall Study||42
8206747|NCT02159729|20237576|P2|COMPLETED|Overall Study||44
8206748|NCT02159729|20237577|P1|COMPLETED|Overall Study||98
8206749|NCT02159729|20237576|P2|STARTED|Overall Study||65
8206750|NCT02159729|20237577|P1|STARTED|Overall Study||140
8206751|NCT02159703|20237589|P1|NOT COMPLETED|Overall Study||0
8206752|NCT02159703|20237589|P1|COMPLETED|Overall Study||60
8206753|NCT02159703|20237589|P1|STARTED|Overall Study||60
8206754|NCT02159547|20237595|P2|NOT COMPLETED|Overall Study||0
8206755|NCT02159547|20237596|P1|NOT COMPLETED|Overall Study||0
8206756|NCT02159547|20237595|P2|COMPLETED|Overall Study||112
8206757|NCT02159547|20237596|P1|COMPLETED|Overall Study||112
8206758|NCT02159547|20237595|P2|STARTED|Overall Study||112
8206759|NCT02159547|20237596|P1|STARTED|Overall Study||112
8206764|NCT02159482|20237625|P1|NOT COMPLETED|Overall Study||5
8206765|NCT02159482|20237625|P1|COMPLETED|Overall Study||6
8206766|NCT02159482|20237625|P1|STARTED|Overall Study||11
8206767|NCT02159469|20237630|P1|NOT COMPLETED|Overall Study||53
8206768|NCT02159469|20237630|P1|COMPLETED|Overall Study||97
8206769|NCT02159469|20237630|P1|Completed 12 Week|Overall Study||137
8206770|NCT02159469|20237630|P1|STARTED|Overall Study||150
8206771|NCT02159365|20237635|P1|NOT COMPLETED|Overall Study||70
8206772|NCT02159365|20237635|P1|COMPLETED|Overall Study|Completed = Still on treatment|0
8206773|NCT02159365|20237635|P1|STARTED|Overall Study||70
8206774|NCT02159352|20237642|P2|NOT COMPLETED|Overall Study||2
8206775|NCT02159352|20237643|P1|NOT COMPLETED|Overall Study||3
8206776|NCT02159352|20237642|P2|COMPLETED|Overall Study||12
8206777|NCT02159352|20237643|P1|COMPLETED|Overall Study||11
8206778|NCT02159352|20237642|P2|Phase 2 (Day 5-14)|Overall Study||12
8206779|NCT02159352|20237643|P1|Phase 2 (Day 5-14)|Overall Study||11
8206780|NCT02159352|20237642|P2|Phase 1 (Day 1- 4)|Overall Study||14
8206781|NCT02159352|20237643|P1|Phase 1 (Day 1- 4)|Overall Study||14
8206782|NCT02159352|20237642|P2|STARTED|Overall Study||14
8206783|NCT02159352|20237643|P1|STARTED|Overall Study||14
8206784|NCT02159183|20237695|P2|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1
8206785|NCT02159183|20237696|P1|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3
8206786|NCT02159183|20237695|P2|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20
8206787|NCT02159183|20237696|P1|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19
8206788|NCT02159183|20237695|P2|STARTED|Analysis of Primary Endpoint (12 Mts)||21
8206789|NCT02159183|20237696|P1|STARTED|Analysis of Primary Endpoint (12 Mts)||22
8206790|NCT02159183|20237695|P2|NOT COMPLETED|Analysis After the 36 Months Follow-up||2
8206791|NCT02159183|20237696|P1|NOT COMPLETED|Analysis After the 36 Months Follow-up||3
8206792|NCT02159183|20237695|P2|COMPLETED|Analysis After the 36 Months Follow-up||19
8206793|NCT02159183|20237696|P1|COMPLETED|Analysis After the 36 Months Follow-up||19
8206794|NCT02159183|20237695|P2|STARTED|Analysis After the 36 Months Follow-up||21
8206795|NCT02159183|20237696|P1|STARTED|Analysis After the 36 Months Follow-up||22
8206796|NCT02159118|20237722|P2|NOT COMPLETED|Overall Study||0
8206797|NCT02159118|20237723|P1|NOT COMPLETED|Overall Study||0
8206798|NCT02159118|20237722|P2|COMPLETED|Overall Study||22
8206799|NCT02159118|20237723|P1|COMPLETED|Overall Study||22
8206800|NCT02159118|20237722|P2|STARTED|Overall Study||22
8206801|NCT02159118|20237723|P1|STARTED|Overall Study||22
8206802|NCT02159079|20237747|P2|NOT COMPLETED|Overall Study||0
8206803|NCT02159079|20237748|P1|NOT COMPLETED|Overall Study||0
8206804|NCT02159079|20237747|P2|COMPLETED|Overall Study||15
8206805|NCT02159079|20237748|P1|COMPLETED|Overall Study||15
8206806|NCT02159079|20237747|P2|STARTED|Overall Study||15
8206807|NCT02159079|20237748|P1|STARTED|Overall Study||15
8206808|NCT02159053|20237769|P3|NOT COMPLETED|Overall Study||20
8206809|NCT02159053|20237770|P2|NOT COMPLETED|Overall Study||21
8206810|NCT02159053|20237771|P1|NOT COMPLETED|Overall Study||20
8206811|NCT02159053|20237769|P3|COMPLETED|Overall Study||97
8206812|NCT02159053|20237770|P2|COMPLETED|Overall Study||96
8206813|NCT02159053|20237771|P1|COMPLETED|Overall Study||96
8206814|NCT02159053|20237769|P3|Paticipants Week 16 Onwards|Overall Study||113
8206815|NCT02159053|20237770|P2|Paticipants Week 16 Onwards|Overall Study||117
8206816|NCT02159053|20237771|P1|Paticipants Week 16 Onwards|Overall Study||116
8206817|NCT02159053|20237769|P3|STARTED|Overall Study||117
8206818|NCT02159053|20237770|P2|STARTED|Overall Study||117
8206819|NCT02159053|20237771|P1|STARTED|Overall Study||116
8206820|NCT02159040|20237808|P1|NOT COMPLETED|Overall Study||1
8206821|NCT02159040|20237808|P1|COMPLETED|Overall Study||0
8206822|NCT02159040|20237808|P1|STARTED|Overall Study||1
8206823|NCT02158975|20237821|P1|NOT COMPLETED|Overall Study||1
8206824|NCT02158975|20237821|P1|COMPLETED|Overall Study||12
8206825|NCT02158975|20237821|P1|STARTED|Overall Study||13
8206826|NCT02158949|20237831|P2|NOT COMPLETED|Overall Study||11
8206827|NCT02158949|20237832|P1|NOT COMPLETED|Overall Study||6
8206828|NCT02158949|20237831|P2|COMPLETED|Overall Study||13
8206829|NCT02158949|20237832|P1|COMPLETED|Overall Study||18
8206830|NCT02158949|20237831|P2|STARTED|Overall Study||24
8206831|NCT02158949|20237832|P1|STARTED|Overall Study||24
8206832|NCT02158936|20237848|P2|NOT COMPLETED|Overall Study||177
8206833|NCT02158936|20237849|P1|NOT COMPLETED|Overall Study||179
8206834|NCT02158936|20237848|P2|COMPLETED|Overall Study||0
8206835|NCT02158936|20237849|P1|COMPLETED|Overall Study||0
8206836|NCT02158936|20237848|P2|Untreated|Overall Study||0
8206837|NCT02158936|20237849|P1|Untreated|Overall Study||2
8206838|NCT02158936|20237848|P2|Treated|Overall Study||177
8206839|NCT02158936|20237849|P1|Treated|Overall Study||177
8206840|NCT02158936|20237848|P2|STARTED|Overall Study||177
8206841|NCT02158936|20237849|P1|STARTED|Overall Study||179
8206842|NCT02158884|20237891|P1|NOT COMPLETED|12 Month Assessment||17
8206843|NCT02158884|20237891|P1|COMPLETED|12 Month Assessment||64
8206844|NCT02158884|20237891|P1|STARTED|12 Month Assessment||81
8206845|NCT02158884|20237891|P1|NOT COMPLETED|6 Month Assessment||20
8206846|NCT02158884|20237891|P1|COMPLETED|6 Month Assessment||61
8206847|NCT02158884|20237891|P1|STARTED|6 Month Assessment||81
8206848|NCT02158884|20237891|P1|NOT COMPLETED|Post Intervention (~4 Weeks)||10
8206849|NCT02158884|20237891|P1|COMPLETED|Post Intervention (~4 Weeks)||71
8206850|NCT02158884|20237891|P1|STARTED|Post Intervention (~4 Weeks)||81
8206851|NCT02158884|20237891|P1|NOT COMPLETED|Intervention: IDEO and PT Program||6
8206852|NCT02158884|20237891|P1|COMPLETED|Intervention: IDEO and PT Program||81
8206853|NCT02158884|20237891|P1|STARTED|Intervention: IDEO and PT Program||87
8206854|NCT02158884|20237891|P1|NOT COMPLETED|Baseline Assessment||4
8206855|NCT02158884|20237891|P1|COMPLETED|Baseline Assessment||87
8206856|NCT02158884|20237891|P1|STARTED|Baseline Assessment||91
8206857|NCT02158806|20237926|P2|NOT COMPLETED|Overall Study||5
8206858|NCT02158806|20237927|P1|NOT COMPLETED|Overall Study||4
8206859|NCT02158806|20237926|P2|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
8206860|NCT02158806|20237927|P1|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
8206861|NCT02158806|20237926|P2|STARTED|Overall Study||126
8206862|NCT02158806|20237927|P1|STARTED|Overall Study||125
8206863|NCT02158728|20237947|P1|NOT COMPLETED|Overall Study||27
8206864|NCT02158728|20237947|P1|COMPLETED|Overall Study||53
8206865|NCT02158728|20237947|P1|STARTED|Overall Study||80
8206866|NCT02158663|20237953|P2|NOT COMPLETED|Overall Study||4
8206867|NCT02158663|20237954|P1|NOT COMPLETED|Overall Study||5
8206868|NCT02158663|20237953|P2|COMPLETED|Overall Study||18
8206869|NCT02158663|20237954|P1|COMPLETED|Overall Study||17
8206870|NCT02158663|20237953|P2|STARTED|Overall Study||22
8206871|NCT02158663|20237954|P1|STARTED|Overall Study||22
8206872|NCT02158572|20237962|P1|NOT COMPLETED|Overall Study||1043
8206873|NCT02158572|20237962|P1|COMPLETED|Overall Study||989
8206874|NCT02158572|20237962|P1|STARTED|Overall Study||2032
8206875|NCT02158546|20237977|P4|NOT COMPLETED|Overall Study||6
8206876|NCT02158546|20237978|P3|NOT COMPLETED|Overall Study||4
8206877|NCT02158546|20237979|P2|NOT COMPLETED|Overall Study||17
8206878|NCT02158546|20237980|P1|NOT COMPLETED|Overall Study||19
8206879|NCT02158546|20237977|P4|COMPLETED|Overall Study||13
8206880|NCT02158546|20237978|P3|COMPLETED|Overall Study||14
8206881|NCT02158546|20237979|P2|COMPLETED|Overall Study||136
8206882|NCT02158546|20237980|P1|COMPLETED|Overall Study||133
8206883|NCT02158546|20237977|P4|STARTED|Overall Study||19
8206884|NCT02158546|20237978|P3|STARTED|Overall Study||18
8206885|NCT02158546|20237979|P2|STARTED|Overall Study||153
8206886|NCT02158546|20237980|P1|STARTED|Overall Study||152
8206887|NCT02158533|20237999|P6|NOT COMPLETED|Stage 2||6
8206888|NCT02158533|20238000|P5|NOT COMPLETED|Stage 2||4
8206889|NCT02158533|20238001|P4|NOT COMPLETED|Stage 2||3
8206890|NCT02158533|20238002|P3|NOT COMPLETED|Stage 2||0
8206891|NCT02158533|20238003|P2|NOT COMPLETED|Stage 2||0
8206892|NCT02158533|20238004|P1|NOT COMPLETED|Stage 2||0
8206893|NCT02158533|20237999|P6|COMPLETED|Stage 2||50
8206894|NCT02158533|20238000|P5|COMPLETED|Stage 2||52
8206895|NCT02158533|20238001|P4|COMPLETED|Stage 2||53
8206896|NCT02158533|20238002|P3|COMPLETED|Stage 2||0
8206897|NCT02158533|20238003|P2|COMPLETED|Stage 2||0
8206898|NCT02158533|20238004|P1|COMPLETED|Stage 2||0
8206899|NCT02158533|20237999|P6|STARTED|Stage 2||56
8206900|NCT02158533|20238000|P5|STARTED|Stage 2||56
8206901|NCT02158533|20238001|P4|STARTED|Stage 2||56
8206902|NCT02158533|20238002|P3|STARTED|Stage 2||0
8206903|NCT02158533|20238003|P2|STARTED|Stage 2||0
8206904|NCT02158533|20238004|P1|STARTED|Stage 2||0
8206905|NCT02158533|20237999|P6|NOT COMPLETED|Stage 1||0
8206906|NCT02158533|20238000|P5|NOT COMPLETED|Stage 1||0
8206907|NCT02158533|20238001|P4|NOT COMPLETED|Stage 1||0
8206908|NCT02158533|20238002|P3|NOT COMPLETED|Stage 1||8
8206909|NCT02158533|20238003|P2|NOT COMPLETED|Stage 1||8
8206910|NCT02158533|20238004|P1|NOT COMPLETED|Stage 1||14
8206911|NCT02158533|20237999|P6|COMPLETED|Stage 1||0
8206912|NCT02158533|20238000|P5|COMPLETED|Stage 1||0
8206913|NCT02158533|20238001|P4|COMPLETED|Stage 1||0
8206914|NCT02158533|20238002|P3|COMPLETED|Stage 1||52
8206915|NCT02158533|20238003|P2|COMPLETED|Stage 1||51
8206916|NCT02158533|20238004|P1|COMPLETED|Stage 1||251
8206917|NCT02158533|20237999|P6|STARTED|Stage 1||0
8206918|NCT02158533|20238000|P5|STARTED|Stage 1||0
8206919|NCT02158533|20238001|P4|STARTED|Stage 1||0
8206920|NCT02158533|20238002|P3|STARTED|Stage 1||60
8206921|NCT02158533|20238003|P2|STARTED|Stage 1||59
8206922|NCT02158533|20238004|P1|STARTED|Stage 1||265
8206923|NCT02158520|20238038|P2|NOT COMPLETED|Overall Study||0
8206924|NCT02158520|20238039|P1|NOT COMPLETED|Overall Study||0
8206925|NCT02158520|20238038|P2|COMPLETED|Overall Study||12
8206926|NCT02158520|20238039|P1|COMPLETED|Overall Study||12
8206927|NCT02158520|20238038|P2|Crossover Cohort|Overall Study||6
8206928|NCT02158520|20238039|P1|Crossover Cohort|Overall Study||4
8206929|NCT02158520|20238038|P2|Eligible for Crossover With AE Evaluated|Overall Study||7
8206930|NCT02158520|20238039|P1|Eligible for Crossover With AE Evaluated|Overall Study||7
8206931|NCT02158520|20238038|P2|Eligible for Crossover|Overall Study||8
8206932|NCT02158520|20238039|P1|Eligible for Crossover|Overall Study||8
8206933|NCT02158520|20238038|P2|AE Evaluated Prior to Crossover|Overall Study||12
8206934|NCT02158520|20238039|P1|AE Evaluated Prior to Crossover|Overall Study||12
8206935|NCT02158520|20238038|P2|STARTED|Overall Study||12
8206936|NCT02158520|20238039|P1|STARTED|Overall Study||12
8206937|NCT02158494|20238055|P2|NOT COMPLETED|Overall Study||1
8206938|NCT02158494|20238056|P1|NOT COMPLETED|Overall Study||0
8206939|NCT02158494|20238055|P2|COMPLETED|Overall Study||21
8206940|NCT02158494|20238056|P1|COMPLETED|Overall Study||22
8206941|NCT02158494|20238055|P2|STARTED|Overall Study||22
8206942|NCT02158494|20238056|P1|STARTED|Overall Study||22
8206943|NCT02158442|20238080|P2|NOT COMPLETED|Overall Study||0
8206944|NCT02158442|20238081|P1|NOT COMPLETED|Overall Study||2
8206945|NCT02158442|20238080|P2|COMPLETED|Overall Study||7
8206946|NCT02158442|20238081|P1|COMPLETED|Overall Study||6
8206947|NCT02158442|20238080|P2|STARTED|Overall Study||7
8206948|NCT02158442|20238081|P1|STARTED|Overall Study||8
8206949|NCT02158364|20238087|P1|NOT COMPLETED|Overall Study||60
8206950|NCT02158364|20238087|P1|COMPLETED|Overall Study||3271
8206951|NCT02158364|20238087|P1|STARTED|Overall Study||3331
8206952|NCT02158273|20238094|P2|NOT COMPLETED|Overall Study||3
8206953|NCT02158273|20238095|P1|NOT COMPLETED|Overall Study||3
8206954|NCT02158273|20238094|P2|COMPLETED|Overall Study||22
8206955|NCT02158273|20238095|P1|COMPLETED|Overall Study||22
8206956|NCT02158273|20238094|P2|STARTED|Overall Study||25
8206957|NCT02158273|20238095|P1|STARTED|Overall Study||25
8206958|NCT02158247|20238105|P1|NOT COMPLETED|Overall Study||5
8206959|NCT02158247|20238105|P1|COMPLETED|Overall Study||176
8206960|NCT02158247|20238105|P1|STARTED|Overall Study||181
8206970|NCT02158039|20238134|P1|NOT COMPLETED|Overall Study||10
8206971|NCT02158039|20238134|P1|COMPLETED|Overall Study||23
8206972|NCT02158039|20238134|P1|STARTED|Overall Study||33
8206973|NCT02157948|20238141|P2|NOT COMPLETED|Overall Study||9
8206974|NCT02157948|20238142|P1|NOT COMPLETED|Overall Study||9
8206975|NCT02157948|20238141|P2|COMPLETED|Overall Study||188
8206976|NCT02157948|20238142|P1|COMPLETED|Overall Study||188
8206977|NCT02157948|20238141|P2|Received Treatment|Overall Study||196
8206978|NCT02157948|20238142|P1|Received Treatment|Overall Study||196
8206979|NCT02157948|20238141|P2|STARTED|Overall Study||197
8206980|NCT02157948|20238142|P1|STARTED|Overall Study||197
8206981|NCT02157935|20238154|P2|NOT COMPLETED|Overall Study||65
8206982|NCT02157935|20238155|P1|NOT COMPLETED|Overall Study||39
8206983|NCT02157935|20238154|P2|COMPLETED|Overall Study||548
8206984|NCT02157935|20238155|P1|COMPLETED|Overall Study||567
8206985|NCT02157935|20238154|P2|STARTED|Overall Study||613
8206986|NCT02157935|20238155|P1|STARTED|Overall Study||606
8206987|NCT02157909|20238173|P2|NOT COMPLETED|Overall Study||0
8206988|NCT02157909|20238174|P1|NOT COMPLETED|Overall Study||0
8206989|NCT02157909|20238173|P2|COMPLETED|Overall Study||66
8206990|NCT02157909|20238174|P1|COMPLETED|Overall Study||66
8206991|NCT02157909|20238173|P2|STARTED|Overall Study||66
8206992|NCT02157909|20238174|P1|STARTED|Overall Study||66
8207002|NCT02157779|20238212|P2|NOT COMPLETED|Overall Study||11
8207003|NCT02157779|20238213|P1|NOT COMPLETED|Overall Study||24
8207004|NCT02157779|20238212|P2|COMPLETED|Overall Study||34
8207005|NCT02157779|20238213|P1|COMPLETED|Overall Study||23
8207006|NCT02157779|20238212|P2|STARTED|Overall Study||45
8207007|NCT02157779|20238213|P1|STARTED|Overall Study||47
8207008|NCT02157623|20238235|P1|NOT COMPLETED|Overall Study||0
8207009|NCT02157623|20238235|P1|COMPLETED|Overall Study||3
8207010|NCT02157623|20238235|P1|STARTED|Overall Study|3 patients, each received red light on half of body and blue light on the contralateral side.|3
8207011|NCT02157519|20238247|P2|NOT COMPLETED|Overall Study||1
8207012|NCT02157519|20238248|P1|NOT COMPLETED|Overall Study||11
8207013|NCT02157519|20238247|P2|COMPLETED|Overall Study||89
8207014|NCT02157519|20238248|P1|COMPLETED|Overall Study||80
8207015|NCT02157519|20238247|P2|MEMScap Collected|Overall Study||86
8207016|NCT02157519|20238248|P1|MEMScap Collected|Overall Study||84
8207017|NCT02157519|20238247|P2|STARTED|Overall Study||90
8207018|NCT02157519|20238248|P1|STARTED|Overall Study||91
8207019|NCT02157506|20238271|P5|NOT COMPLETED|Overall Study||0
8207020|NCT02157506|20238272|P4|NOT COMPLETED|Overall Study||0
8207021|NCT02157506|20238273|P3|NOT COMPLETED|Overall Study||1
8207022|NCT02157506|20238274|P2|NOT COMPLETED|Overall Study||1
8207023|NCT02157506|20238275|P1|NOT COMPLETED|Overall Study||0
8207024|NCT02157506|20238271|P5|COMPLETED|Overall Study||7
8207025|NCT02157506|20238272|P4|COMPLETED|Overall Study||12
8207026|NCT02157506|20238273|P3|COMPLETED|Overall Study||8
8207027|NCT02157506|20238274|P2|COMPLETED|Overall Study||5
8207028|NCT02157506|20238275|P1|COMPLETED|Overall Study||12
8207029|NCT02157506|20238271|P5|STARTED|Overall Study||7
8207030|NCT02157506|20238272|P4|STARTED|Overall Study||12
8207031|NCT02157506|20238273|P3|STARTED|Overall Study||9
8207032|NCT02157506|20238274|P2|STARTED|Overall Study||6
8207033|NCT02157506|20238275|P1|STARTED|Overall Study||12
8207034|NCT02157376|20238334|P2|NOT COMPLETED|Overall Study||18
8207035|NCT02157376|20238335|P1|NOT COMPLETED|Overall Study||22
8207036|NCT02157376|20238334|P2|COMPLETED|Overall Study||138
8207037|NCT02157376|20238335|P1|COMPLETED|Overall Study||133
8207038|NCT02157376|20238334|P2|STARTED|Overall Study||156
8207039|NCT02157376|20238335|P1|STARTED|Overall Study||155
8207040|NCT02157298|20238345|P2|NOT COMPLETED|Overall Study||2
8207041|NCT02157298|20238346|P1|NOT COMPLETED|Overall Study||4
8207042|NCT02157298|20238345|P2|COMPLETED|Overall Study||58
8207043|NCT02157298|20238346|P1|COMPLETED|Overall Study||119
8207044|NCT02157298|20238345|P2|STARTED|Overall Study||60
8207045|NCT02157298|20238346|P1|STARTED|Overall Study||123
8207046|NCT02157168|20238363|P3|NOT COMPLETED|Overall Study||0
8207047|NCT02157168|20238364|P2|NOT COMPLETED|Overall Study||0
8207048|NCT02157168|20238365|P1|NOT COMPLETED|Overall Study||0
8207049|NCT02157168|20238363|P3|COMPLETED|Overall Study||1362
8207050|NCT02157168|20238364|P2|COMPLETED|Overall Study||159
8207051|NCT02157168|20238365|P1|COMPLETED|Overall Study||746
8207052|NCT02157168|20238363|P3|STARTED|Overall Study||1362
8207053|NCT02157168|20238364|P2|STARTED|Overall Study||159
8207054|NCT02157168|20238365|P1|STARTED|Overall Study||746
8207055|NCT02157116|20238385|P1|NOT COMPLETED|Overall Study||9
8207056|NCT02157116|20238385|P1|COMPLETED|Overall Study||4
8207057|NCT02157116|20238385|P1|STARTED|Overall Study|signed consent form|13
8207058|NCT02157103|20238394|P1|NOT COMPLETED|Overall Study||0
8207059|NCT02157103|20238394|P1|COMPLETED|Overall Study||3
8207060|NCT02157103|20238394|P1|STARTED|Overall Study||3
8207061|NCT02156908|20238402|P2|NOT COMPLETED|Overall Study||0
8207062|NCT02156908|20238403|P1|NOT COMPLETED|Overall Study||0
8207063|NCT02156908|20238402|P2|COMPLETED|Overall Study||3
8207064|NCT02156908|20238403|P1|COMPLETED|Overall Study||5
8207065|NCT02156908|20238402|P2|STARTED|Overall Study||3
8207066|NCT02156908|20238403|P1|STARTED|Overall Study||5
8207067|NCT02156804|20238411|P1|NOT COMPLETED|Overall Study||1
8207068|NCT02156804|20238411|P1|COMPLETED|Overall Study||1008
8207069|NCT02156804|20238411|P1|STARTED|Overall Study||1009
8207070|NCT02156687|20238421|P2|NOT COMPLETED|Overall Study||5
8207071|NCT02156687|20238422|P1|NOT COMPLETED|Overall Study||10
8207072|NCT02156687|20238421|P2|COMPLETED|Overall Study||24
8207073|NCT02156687|20238422|P1|COMPLETED|Overall Study||20
8207074|NCT02156687|20238421|P2|STARTED|Overall Study||29
8207075|NCT02156687|20238422|P1|STARTED|Overall Study||30
8207076|NCT02156674|20238442|P1|NOT COMPLETED|Overall Study||0
8207077|NCT02156674|20238442|P1|COMPLETED|Overall Study||1
8207078|NCT02156674|20238442|P1|STARTED|Overall Study||1
8207079|NCT02156492|20238453|P3|NOT COMPLETED|Period 3||0
8207080|NCT02156492|20238454|P2|NOT COMPLETED|Period 3||1
8207081|NCT02156492|20238455|P1|NOT COMPLETED|Period 3||0
8207082|NCT02156492|20238453|P3|COMPLETED|Period 3||22
8207083|NCT02156492|20238454|P2|COMPLETED|Period 3||22
8207084|NCT02156492|20238455|P1|COMPLETED|Period 3||0
8207085|NCT02156492|20238453|P3|STARTED|Period 3||22
8207086|NCT02156492|20238454|P2|STARTED|Period 3||23
8207087|NCT02156492|20238455|P1|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
8207088|NCT02156492|20238453|P3|NOT COMPLETED|Period 2||0
8207089|NCT02156492|20238454|P2|NOT COMPLETED|Period 2||0
8207090|NCT02156492|20238455|P1|NOT COMPLETED|Period 2||0
8207091|NCT02156492|20238453|P3|COMPLETED|Period 2||22
8207092|NCT02156492|20238454|P2|COMPLETED|Period 2||23
8207093|NCT02156492|20238455|P1|COMPLETED|Period 2||16
8207094|NCT02156492|20238453|P3|STARTED|Period 2||22
8207095|NCT02156492|20238454|P2|STARTED|Period 2||23
8207096|NCT02156492|20238455|P1|STARTED|Period 2||16
8207097|NCT02156492|20238453|P3|NOT COMPLETED|Period 1||0
8207098|NCT02156492|20238454|P2|NOT COMPLETED|Period 1||1
8207099|NCT02156492|20238455|P1|NOT COMPLETED|Period 1||0
8207100|NCT02156492|20238453|P3|COMPLETED|Period 1||22
8207101|NCT02156492|20238454|P2|COMPLETED|Period 1||23
8207102|NCT02156492|20238455|P1|COMPLETED|Period 1||16
8207103|NCT02156492|20238453|P3|Received at Least One Dose of Study Drug|Period 1||22
8207104|NCT02156492|20238454|P2|Received at Least One Dose of Study Drug|Period 1||24
8207105|NCT02156492|20238455|P1|Received at Least One Dose of Study Drug|Period 1||16
8207106|NCT02156492|20238453|P3|STARTED|Period 1||22
8207107|NCT02156492|20238454|P2|STARTED|Period 1||24
8207108|NCT02156492|20238455|P1|STARTED|Period 1||16
8207109|NCT02156466|20238481|P5|NOT COMPLETED|Overall Study||0
8207110|NCT02156466|20238482|P4|NOT COMPLETED|Overall Study||2
8207111|NCT02156466|20238483|P3|NOT COMPLETED|Overall Study||1
8207112|NCT02156466|20238484|P2|NOT COMPLETED|Overall Study||0
8207113|NCT02156466|20238485|P1|NOT COMPLETED|Overall Study||0
8207114|NCT02156466|20238481|P5|COMPLETED|Overall Study||8
8207115|NCT02156466|20238482|P4|COMPLETED|Overall Study||7
8207116|NCT02156466|20238483|P3|COMPLETED|Overall Study||7
8207117|NCT02156466|20238484|P2|COMPLETED|Overall Study||8
8207118|NCT02156466|20238485|P1|COMPLETED|Overall Study||8
8207119|NCT02156466|20238481|P5|STARTED|Overall Study||8
8207120|NCT02156466|20238482|P4|STARTED|Overall Study||9
8207121|NCT02156466|20238483|P3|STARTED|Overall Study||8
8207122|NCT02156466|20238484|P2|STARTED|Overall Study||8
8207123|NCT02156466|20238485|P1|STARTED|Overall Study||8
8207124|NCT02156271|20238666|P2|NOT COMPLETED|Overall Study||3
8207125|NCT02156271|20238667|P1|NOT COMPLETED|Overall Study||4
8207126|NCT02156271|20238666|P2|COMPLETED|Overall Study||10
8207127|NCT02156271|20238667|P1|COMPLETED|Overall Study||22
8207128|NCT02156271|20238666|P2|STARTED|Overall Study||13
8207129|NCT02156271|20238667|P1|STARTED|Overall Study||26
8207130|NCT02156258|20238702|P3|NOT COMPLETED|Overall Study||111
8207131|NCT02156258|20238703|P2|NOT COMPLETED|Overall Study||79
8207132|NCT02156258|20238704|P1|NOT COMPLETED|Overall Study||32
8207133|NCT02156258|20238702|P3|COMPLETED|Overall Study||244
8207134|NCT02156258|20238703|P2|COMPLETED|Overall Study||124
8207135|NCT02156258|20238704|P1|COMPLETED|Overall Study||642
8207136|NCT02156258|20238702|P3|STARTED|Overall Study||355
8207137|NCT02156258|20238703|P2|STARTED|Overall Study||203
8207138|NCT02156258|20238704|P1|STARTED|Overall Study||674
8207139|NCT02156167|20238712|P1|NOT COMPLETED|Overall Study||0
8207140|NCT02156167|20238712|P1|COMPLETED|Overall Study||15
8207141|NCT02156167|20238712|P1|STARTED|Overall Study||15
8207142|NCT02156076|20238720|P4|NOT COMPLETED|Follow-up Period||0
8207143|NCT02156076|20238721|P3|NOT COMPLETED|Follow-up Period||0
8207144|NCT02156076|20238722|P2|NOT COMPLETED|Follow-up Period||0
8207145|NCT02156076|20238723|P1|NOT COMPLETED|Follow-up Period||1
8207146|NCT02156076|20238720|P4|COMPLETED|Follow-up Period||4
8207147|NCT02156076|20238721|P3|COMPLETED|Follow-up Period||4
8207148|NCT02156076|20238722|P2|COMPLETED|Follow-up Period||5
8207149|NCT02156076|20238723|P1|COMPLETED|Follow-up Period||6
8207150|NCT02156076|20238720|P4|STARTED|Follow-up Period||4
8207151|NCT02156076|20238721|P3|STARTED|Follow-up Period||4
8207152|NCT02156076|20238722|P2|STARTED|Follow-up Period||5
8207153|NCT02156076|20238723|P1|STARTED|Follow-up Period||7
8207154|NCT02156076|20238720|P4|NOT COMPLETED|Treatment Period||2
8207155|NCT02156076|20238721|P3|NOT COMPLETED|Treatment Period||2
8207156|NCT02156076|20238722|P2|NOT COMPLETED|Treatment Period||2
8207157|NCT02156076|20238723|P1|NOT COMPLETED|Treatment Period||0
8207158|NCT02156076|20238720|P4|COMPLETED|Treatment Period||4
8207159|NCT02156076|20238721|P3|COMPLETED|Treatment Period||4
8207160|NCT02156076|20238722|P2|COMPLETED|Treatment Period||5
8207161|NCT02156076|20238723|P1|COMPLETED|Treatment Period||7
8207162|NCT02156076|20238720|P4|STARTED|Treatment Period||6
8207163|NCT02156076|20238721|P3|STARTED|Treatment Period||6
8207164|NCT02156076|20238722|P2|STARTED|Treatment Period||7
8207165|NCT02156076|20238723|P1|STARTED|Treatment Period||7
8207166|NCT02155985|20238780|P3|NOT COMPLETED|Overall Study||1
8207167|NCT02155985|20238781|P2|NOT COMPLETED|Overall Study||0
8207168|NCT02155985|20238782|P1|NOT COMPLETED|Overall Study||1
8207169|NCT02155985|20238780|P3|COMPLETED|Overall Study||39
8207170|NCT02155985|20238781|P2|COMPLETED|Overall Study||41
8207171|NCT02155985|20238782|P1|COMPLETED|Overall Study||39
8207172|NCT02155985|20238780|P3|STARTED|Overall Study||40
8207173|NCT02155985|20238781|P2|STARTED|Overall Study||41
8207174|NCT02155985|20238782|P1|STARTED|Overall Study||40
8207175|NCT02155881|20238849|P2|NOT COMPLETED|Overall Study||4
8207176|NCT02155881|20238850|P1|NOT COMPLETED|Overall Study||2
8207177|NCT02155881|20238849|P2|COMPLETED|Overall Study||36
8207178|NCT02155881|20238850|P1|COMPLETED|Overall Study||38
8207179|NCT02155881|20238849|P2|STARTED|Overall Study||40
8207180|NCT02155881|20238850|P1|STARTED|Overall Study||40
8207187|NCT02155738|20238895|P4|NOT COMPLETED|Overall Study||1
8207188|NCT02155738|20238896|P3|NOT COMPLETED|Overall Study||0
8207189|NCT02155738|20238897|P2|NOT COMPLETED|Overall Study||0
8207190|NCT02155738|20238898|P1|NOT COMPLETED|Overall Study||1
8207191|NCT02155738|20238895|P4|COMPLETED|Overall Study||50
8207192|NCT02155738|20238896|P3|COMPLETED|Overall Study||51
8207193|NCT02155738|20238897|P2|COMPLETED|Overall Study||52
8207194|NCT02155738|20238898|P1|COMPLETED|Overall Study||49
8207195|NCT02155738|20238895|P4|STARTED|Overall Study||51
8207196|NCT02155738|20238896|P3|STARTED|Overall Study||51
8207197|NCT02155738|20238897|P2|STARTED|Overall Study||52
8207198|NCT02155738|20238898|P1|STARTED|Overall Study||50
8207199|NCT02155725|20238918|P2|NOT COMPLETED|Follow-up Period||11
8207200|NCT02155725|20238919|P1|NOT COMPLETED|Follow-up Period||17
8207201|NCT02155725|20238918|P2|COMPLETED|Follow-up Period||202
8207202|NCT02155725|20238919|P1|COMPLETED|Follow-up Period||207
8207203|NCT02155725|20238918|P2|STARTED|Follow-up Period||213
8207204|NCT02155725|20238919|P1|STARTED|Follow-up Period||224
8207205|NCT02155725|20238918|P2|NOT COMPLETED|Treatment Period||0
8207206|NCT02155725|20238919|P1|NOT COMPLETED|Treatment Period||0
8207207|NCT02155725|20238918|P2|COMPLETED|Treatment Period||213
8207208|NCT02155725|20238919|P1|COMPLETED|Treatment Period||224
8207209|NCT02155725|20238918|P2|STARTED|Treatment Period||213
8207210|NCT02155725|20238919|P1|STARTED|Treatment Period||224
8207223|NCT02155660|20238946|P4|NOT COMPLETED|Overall Study||61
8207224|NCT02155660|20238947|P3|NOT COMPLETED|Overall Study||60
8207225|NCT02155660|20238948|P2|NOT COMPLETED|Overall Study||73
8207226|NCT02155660|20238949|P1|NOT COMPLETED|Overall Study||58
8207227|NCT02155660|20238946|P4|COMPLETED|Overall Study||507
8207228|NCT02155660|20238947|P3|COMPLETED|Overall Study||502
8207229|NCT02155660|20238948|P2|COMPLETED|Overall Study||489
8207230|NCT02155660|20238949|P1|COMPLETED|Overall Study||504
8207231|NCT02155660|20238946|P4|STARTED|Overall Study||568
8207232|NCT02155660|20238947|P3|STARTED|Overall Study||562
8207233|NCT02155660|20238948|P2|STARTED|Overall Study||562
8207234|NCT02155660|20238949|P1|STARTED|Overall Study||562
8207241|NCT02155608|20239061|P2|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
8207242|NCT02155608|20239062|P1|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
8207243|NCT02155608|20239061|P2|COMPLETED|1b: 1 Week Blinded Post Treatment||28
8207244|NCT02155608|20239062|P1|COMPLETED|1b: 1 Week Blinded Post Treatment||31
8207245|NCT02155608|20239061|P2|STARTED|1b: 1 Week Blinded Post Treatment||29
8207246|NCT02155608|20239062|P1|STARTED|1b: 1 Week Blinded Post Treatment||32
8207247|NCT02155608|20239061|P2|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1
8207248|NCT02155608|20239062|P1|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0
8207249|NCT02155608|20239061|P2|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29
8207250|NCT02155608|20239062|P1|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32
8207251|NCT02155608|20239061|P2|STARTED|1a: 4 Week Double Blind Sham Controlled||30
8207252|NCT02155608|20239062|P1|STARTED|1a: 4 Week Double Blind Sham Controlled||32
8207253|NCT02155543|20239101|P7|NOT COMPLETED|Overall Study||0
8207254|NCT02155543|20239102|P6|NOT COMPLETED|Overall Study||0
8207255|NCT02155543|20239103|P5|NOT COMPLETED|Overall Study||0
8207256|NCT02155543|20239104|P4|NOT COMPLETED|Overall Study||0
8207257|NCT02155543|20239105|P3|NOT COMPLETED|Overall Study||0
8207258|NCT02155543|20239106|P2|NOT COMPLETED|Overall Study||0
8207259|NCT02155543|20239107|P1|NOT COMPLETED|Overall Study||0
8207260|NCT02155543|20239101|P7|COMPLETED|Overall Study||9
8207261|NCT02155543|20239102|P6|COMPLETED|Overall Study||3
8207262|NCT02155543|20239103|P5|COMPLETED|Overall Study||3
8207263|NCT02155543|20239104|P4|COMPLETED|Overall Study||9
8207264|NCT02155543|20239105|P3|COMPLETED|Overall Study||9
8207265|NCT02155543|20239106|P2|COMPLETED|Overall Study||9
8207266|NCT02155543|20239107|P1|COMPLETED|Overall Study||9
8207267|NCT02155543|20239101|P7|STARTED|Overall Study||9
8207268|NCT02155543|20239102|P6|STARTED|Overall Study||3
8207269|NCT02155543|20239103|P5|STARTED|Overall Study||3
8207270|NCT02155543|20239104|P4|STARTED|Overall Study||9
8207271|NCT02155543|20239105|P3|STARTED|Overall Study||9
8207272|NCT02155543|20239106|P2|STARTED|Overall Study||9
8207273|NCT02155543|20239107|P1|STARTED|Overall Study||9
8207274|NCT02155465|20239127|P7|NOT COMPLETED|Overall Study||0
8207275|NCT02155465|20239128|P6|NOT COMPLETED|Overall Study||0
8207276|NCT02155465|20239129|P5|NOT COMPLETED|Overall Study||0
8207277|NCT02155465|20239130|P4|NOT COMPLETED|Overall Study||0
8207278|NCT02155465|20239131|P3|NOT COMPLETED|Overall Study||0
8207279|NCT02155465|20239132|P2|NOT COMPLETED|Overall Study||0
8207280|NCT02155465|20239133|P1|NOT COMPLETED|Overall Study||0
8207281|NCT02155465|20239127|P7|COMPLETED|Overall Study||5
8207282|NCT02155465|20239128|P6|COMPLETED|Overall Study||2
8207283|NCT02155465|20239129|P5|COMPLETED|Overall Study||1
8207284|NCT02155465|20239130|P4|COMPLETED|Overall Study||2
8207285|NCT02155465|20239131|P3|COMPLETED|Overall Study||6
8207286|NCT02155465|20239132|P2|COMPLETED|Overall Study||3
8207287|NCT02155465|20239133|P1|COMPLETED|Overall Study||3
8207288|NCT02155465|20239127|P7|STARTED|Overall Study||5
8207289|NCT02155465|20239128|P6|STARTED|Overall Study||2
8207290|NCT02155465|20239129|P5|STARTED|Overall Study||1
8207291|NCT02155465|20239130|P4|STARTED|Overall Study||2
8207292|NCT02155465|20239131|P3|STARTED|Overall Study||6
8207293|NCT02155465|20239132|P2|STARTED|Overall Study||3
8207294|NCT02155465|20239133|P1|STARTED|Overall Study||3
8207295|NCT02155335|20239153|P2|NOT COMPLETED|Period 2||0
8207296|NCT02155335|20239154|P1|NOT COMPLETED|Period 2||0
8207297|NCT02155335|20239153|P2|COMPLETED|Period 2||49
8207298|NCT02155335|20239154|P1|COMPLETED|Period 2||50
8207299|NCT02155335|20239153|P2|STARTED|Period 2||49
8207300|NCT02155335|20239154|P1|STARTED|Period 2||50
8207301|NCT02155335|20239153|P2|NOT COMPLETED|Period 1||1
8207302|NCT02155335|20239154|P1|NOT COMPLETED|Period 1||0
8207303|NCT02155335|20239153|P2|COMPLETED|Period 1||49
8207304|NCT02155335|20239154|P1|COMPLETED|Period 1||50
8207305|NCT02155335|20239153|P2|Treated|Period 1||49
8207306|NCT02155335|20239154|P1|Treated|Period 1||50
8207307|NCT02155335|20239153|P2|STARTED|Period 1||50
8207308|NCT02155335|20239154|P1|STARTED|Period 1||50
8207309|NCT02155322|20239159|P1|NOT COMPLETED|Overall Study||14
8207310|NCT02155322|20239159|P1|COMPLETED|Overall Study||19
8207311|NCT02155322|20239159|P1|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
8207312|NCT02155322|20239159|P1|STARTED|Overall Study||33
8207313|NCT02155309|20239166|P3|NOT COMPLETED|Overall Study||1
8207314|NCT02155309|20239167|P2|NOT COMPLETED|Overall Study||0
8207315|NCT02155309|20239168|P1|NOT COMPLETED|Overall Study||0
8207316|NCT02155309|20239166|P3|COMPLETED|Overall Study||12
8207317|NCT02155309|20239167|P2|COMPLETED|Overall Study||10
8207318|NCT02155309|20239168|P1|COMPLETED|Overall Study||13
8207319|NCT02155309|20239166|P3|STARTED|Overall Study||13
8207320|NCT02155309|20239167|P2|STARTED|Overall Study||10
8207321|NCT02155309|20239168|P1|STARTED|Overall Study||13
8207322|NCT02155283|20239175|P1|NOT COMPLETED|Overall Study||7
8207323|NCT02155283|20239175|P1|COMPLETED|Overall Study||9
8207324|NCT02155283|20239175|P1|STARTED|Overall Study||16
8207325|NCT02155257|20239183|P3|NOT COMPLETED|Overall Study||0
8207326|NCT02155257|20239184|P2|NOT COMPLETED|Overall Study||0
8207327|NCT02155257|20239185|P1|NOT COMPLETED|Overall Study||0
8207328|NCT02155257|20239183|P3|COMPLETED|Overall Study||10
8207329|NCT02155257|20239184|P2|COMPLETED|Overall Study||10
8207330|NCT02155257|20239185|P1|COMPLETED|Overall Study||10
8207331|NCT02155257|20239183|P3|STARTED|Overall Study||10
8207332|NCT02155257|20239184|P2|STARTED|Overall Study||10
8207333|NCT02155257|20239185|P1|STARTED|Overall Study||10
8207334|NCT02155101|20239201|P2|NOT COMPLETED|Overall Study||1
8207335|NCT02155101|20239202|P1|NOT COMPLETED|Overall Study||0
8207336|NCT02155101|20239201|P2|COMPLETED|Overall Study||80
8207337|NCT02155101|20239202|P1|COMPLETED|Overall Study||39
8207338|NCT02155101|20239201|P2|STARTED|Overall Study||81
8207339|NCT02155101|20239202|P1|STARTED|Overall Study||39
8207340|NCT02155010|20239214|P2|NOT COMPLETED|Overall Study||6
8207341|NCT02155010|20239215|P1|NOT COMPLETED|Overall Study||6
8207342|NCT02155010|20239214|P2|COMPLETED|Overall Study||31
8207343|NCT02155010|20239215|P1|COMPLETED|Overall Study||31
8207344|NCT02155010|20239214|P2|STARTED|Overall Study||37
8207345|NCT02155010|20239215|P1|STARTED|Overall Study||37
8207346|NCT02154906|20239225|P2|NOT COMPLETED|Overall Study||3
8207347|NCT02154906|20239226|P1|NOT COMPLETED|Overall Study||2
8207348|NCT02154906|20239225|P2|COMPLETED|Overall Study||17
8207349|NCT02154906|20239226|P1|COMPLETED|Overall Study||19
8207350|NCT02154906|20239225|P2|STARTED|Overall Study||20
8207351|NCT02154906|20239226|P1|STARTED|Overall Study||21
8207352|NCT02154763|20239236|P2|NOT COMPLETED|Overall Study||14
8207353|NCT02154763|20239237|P1|NOT COMPLETED|Overall Study||14
8207354|NCT02154763|20239236|P2|COMPLETED|Overall Study||46
8207355|NCT02154763|20239237|P1|COMPLETED|Overall Study||46
8207356|NCT02154763|20239236|P2|STARTED|Overall Study||60
8207357|NCT02154763|20239237|P1|STARTED|Overall Study||60
8207358|NCT02154581|20239351|P2|NOT COMPLETED|Overall Study||8
8207359|NCT02154581|20239352|P1|NOT COMPLETED|Overall Study||7
8207360|NCT02154581|20239351|P2|COMPLETED|Overall Study||12
8207361|NCT02154581|20239352|P1|COMPLETED|Overall Study||14
8207362|NCT02154581|20239351|P2|STARTED|Overall Study||20
8207363|NCT02154581|20239352|P1|STARTED|Overall Study||21
8207364|NCT02154477|20239370|P2|NOT COMPLETED|Overall Study||0
8207365|NCT02154477|20239371|P1|NOT COMPLETED|Overall Study||0
8207366|NCT02154477|20239370|P2|COMPLETED|Overall Study||8
8207367|NCT02154477|20239371|P1|COMPLETED|Overall Study||6
8207368|NCT02154477|20239370|P2|STARTED|Overall Study||8
8207369|NCT02154477|20239371|P1|STARTED|Overall Study||6
8207370|NCT02154425|20239377|P1|NOT COMPLETED|Sampling Period||0
8207371|NCT02154425|20239377|P1|COMPLETED|Sampling Period||17
8207372|NCT02154425|20239377|P1|STARTED|Sampling Period||17
8207373|NCT02154425|20239377|P1|NOT COMPLETED|Screening Period||1
8207374|NCT02154425|20239377|P1|COMPLETED|Screening Period||17
8207375|NCT02154425|20239377|P1|STARTED|Screening Period||18
8207376|NCT02154386|20239409|P2|NOT COMPLETED|Overall Study||2
8207377|NCT02154386|20239410|P1|NOT COMPLETED|Overall Study||1
8207378|NCT02154386|20239409|P2|COMPLETED|Overall Study||21
8207379|NCT02154386|20239410|P1|COMPLETED|Overall Study||22
8207380|NCT02154386|20239409|P2|STARTED|Overall Study||23
8207381|NCT02154386|20239410|P1|STARTED|Overall Study||23
8207382|NCT02154347|20239422|P2|NOT COMPLETED|Open-label Period||25
8207383|NCT02154347|20239423|P1|NOT COMPLETED|Open-label Period||7
8207384|NCT02154347|20239422|P2|COMPLETED|Open-label Period||88
8207385|NCT02154347|20239423|P1|COMPLETED|Open-label Period||50
8207386|NCT02154347|20239422|P2|STARTED|Open-label Period||113
8207387|NCT02154347|20239423|P1|STARTED|Open-label Period||57
8207388|NCT02154347|20239422|P2|NOT COMPLETED|Double-blind Period||4
8207389|NCT02154347|20239423|P1|NOT COMPLETED|Double-blind Period||3
8207390|NCT02154347|20239422|P2|COMPLETED|Double-blind Period||114
8207391|NCT02154347|20239423|P1|COMPLETED|Double-blind Period||57
8207392|NCT02154347|20239422|P2|STARTED|Double-blind Period||118
8207393|NCT02154347|20239423|P1|STARTED|Double-blind Period||60
8207394|NCT02154243|20239433|P3|NOT COMPLETED|Overall Study||0
8207395|NCT02154243|20239434|P2|NOT COMPLETED|Overall Study||0
8207396|NCT02154243|20239435|P1|NOT COMPLETED|Overall Study||0
8207397|NCT02154243|20239433|P3|COMPLETED|Overall Study||4
8207398|NCT02154243|20239434|P2|COMPLETED|Overall Study||4
8207399|NCT02154243|20239435|P1|COMPLETED|Overall Study||5
8207400|NCT02154243|20239433|P3|STARTED|Overall Study||4
8207401|NCT02154243|20239434|P2|STARTED|Overall Study||4
8207402|NCT02154243|20239435|P1|STARTED|Overall Study||5
8207403|NCT02154139|20239446|P1|NOT COMPLETED|Overall Study||7
8207404|NCT02154139|20239446|P1|COMPLETED|Overall Study||644
8207405|NCT02154139|20239446|P1|STARTED|Overall Study||651
8207406|NCT02154087|20239454|P1|NOT COMPLETED|Overall Study||1
8207407|NCT02154087|20239454|P1|COMPLETED|Overall Study||0
8207408|NCT02154087|20239454|P1|STARTED|Overall Study||1
8207409|NCT02154061|20239460|P2|NOT COMPLETED|Overall Study||0
8207410|NCT02154061|20239461|P1|NOT COMPLETED|Overall Study||2
8207411|NCT02154061|20239460|P2|COMPLETED|Overall Study||17
8207412|NCT02154061|20239461|P1|COMPLETED|Overall Study||14
8207413|NCT02154061|20239460|P2|STARTED|Overall Study||17
8207414|NCT02154061|20239461|P1|STARTED|Overall Study||16
8207415|NCT02154048|20239470|P3|NOT COMPLETED|Overall Study||0
8207416|NCT02154048|20239471|P2|NOT COMPLETED|Overall Study||0
8207417|NCT02154048|20239472|P1|NOT COMPLETED|Overall Study||0
8207418|NCT02154048|20239470|P3|COMPLETED|Overall Study||1
8207419|NCT02154048|20239471|P2|COMPLETED|Overall Study||2
8207420|NCT02154048|20239472|P1|COMPLETED|Overall Study||2
8207421|NCT02154048|20239470|P3|STARTED|Overall Study||1
8207422|NCT02154048|20239471|P2|STARTED|Overall Study||2
8207423|NCT02154048|20239472|P1|STARTED|Overall Study||2
8207424|NCT02153983|20239486|P6|NOT COMPLETED|Overall Study||0
8207425|NCT02153983|20239487|P5|NOT COMPLETED|Overall Study||0
8207426|NCT02153983|20239488|P4|NOT COMPLETED|Overall Study||0
8207427|NCT02153983|20239489|P3|NOT COMPLETED|Overall Study||2
8207428|NCT02153983|20239490|P2|NOT COMPLETED|Overall Study||3
8207429|NCT02153983|20239491|P1|NOT COMPLETED|Overall Study||0
8207430|NCT02153983|20239486|P6|COMPLETED|Overall Study||1
8207431|NCT02153983|20239487|P5|COMPLETED|Overall Study||19
8207432|NCT02153983|20239488|P4|COMPLETED|Overall Study||13
8207433|NCT02153983|20239489|P3|COMPLETED|Overall Study||2
8207434|NCT02153983|20239490|P2|COMPLETED|Overall Study||18
8207435|NCT02153983|20239491|P1|COMPLETED|Overall Study||19
8207436|NCT02153983|20239486|P6|STARTED|Overall Study||1
8207437|NCT02153983|20239487|P5|STARTED|Overall Study||19
8207438|NCT02153983|20239488|P4|STARTED|Overall Study||13
8207439|NCT02153983|20239489|P3|STARTED|Overall Study||4
8207440|NCT02153983|20239490|P2|STARTED|Overall Study||21
8207441|NCT02153983|20239491|P1|STARTED|Overall Study||19
8207442|NCT02153918|20239508|P1|NOT COMPLETED|Overall Study||1
8207443|NCT02153918|20239508|P1|COMPLETED|Overall Study||26
8207444|NCT02153918|20239508|P1|STARTED|Overall Study||27
8207445|NCT02153905|20239519|P2|NOT COMPLETED|Overall Study||0
8207446|NCT02153905|20239520|P1|NOT COMPLETED|Overall Study||1
8207447|NCT02153905|20239519|P2|COMPLETED|Overall Study||2
8207448|NCT02153905|20239520|P1|COMPLETED|Overall Study||0
8207449|NCT02153905|20239519|P2|STARTED|Overall Study||2
8207450|NCT02153905|20239520|P1|STARTED|Overall Study||1
8207451|NCT02153827|20239538|P2|NOT COMPLETED|Overall Study||9
8207452|NCT02153827|20239539|P1|NOT COMPLETED|Overall Study||3
8207453|NCT02153827|20239538|P2|COMPLETED|Overall Study||14
8207454|NCT02153827|20239539|P1|COMPLETED|Overall Study||22
8207455|NCT02153827|20239538|P2|STARTED|Overall Study||23
8207456|NCT02153827|20239539|P1|STARTED|Overall Study||25
8207457|NCT02153788|20239555|P2|NOT COMPLETED|Overall Study||1
8207458|NCT02153788|20239556|P1|NOT COMPLETED|Overall Study||2
8207459|NCT02153788|20239555|P2|COMPLETED|Overall Study||18
8207460|NCT02153788|20239556|P1|COMPLETED|Overall Study||23
8207461|NCT02153788|20239555|P2|STARTED|Overall Study||19
8207462|NCT02153788|20239556|P1|STARTED|Overall Study||25
8207463|NCT02153736|20239576|P2|NOT COMPLETED|Overall Study||2
8207464|NCT02153736|20239577|P1|NOT COMPLETED|Overall Study||2
8207465|NCT02153736|20239576|P2|COMPLETED|Overall Study||5
8207466|NCT02153736|20239577|P1|COMPLETED|Overall Study||5
8207467|NCT02153736|20239576|P2|STARTED|Overall Study||7
8207468|NCT02153736|20239577|P1|STARTED|Overall Study||7
8207469|NCT02153723|20239593|P1|NOT COMPLETED|Overall Study||0
8207470|NCT02153723|20239593|P1|COMPLETED|Overall Study||10
8207471|NCT02153723|20239593|P1|STARTED|Overall Study||10
8207472|NCT02153710|20239604|P2|NOT COMPLETED|Overall Study||0
8207473|NCT02153710|20239605|P1|NOT COMPLETED|Overall Study||0
8207474|NCT02153710|20239604|P2|COMPLETED|Overall Study||30
8207475|NCT02153710|20239605|P1|COMPLETED|Overall Study||28
8207476|NCT02153710|20239604|P2|STARTED|Overall Study||30
8207477|NCT02153710|20239605|P1|STARTED|Overall Study||28
8207478|NCT02153671|20239617|P2|NOT COMPLETED|Overall Study||0
8207479|NCT02153671|20239618|P1|NOT COMPLETED|Overall Study||0
8207480|NCT02153671|20239617|P2|COMPLETED|Overall Study||24
8207481|NCT02153671|20239618|P1|COMPLETED|Overall Study||19
8207482|NCT02153671|20239617|P2|STARTED|Overall Study||24
8207483|NCT02153671|20239618|P1|STARTED|Overall Study||19
8207484|NCT02153645|20239697|P3|NOT COMPLETED|Overall Study||10
8207485|NCT02153645|20239698|P2|NOT COMPLETED|Overall Study||10
8207486|NCT02153645|20239699|P1|NOT COMPLETED|Overall Study||13
8207487|NCT02153645|20239697|P3|COMPLETED|Overall Study||18
8207488|NCT02153645|20239698|P2|COMPLETED|Overall Study||19
8207489|NCT02153645|20239699|P1|COMPLETED|Overall Study||17
8207490|NCT02153645|20239697|P3|STARTED|Overall Study||28
8207491|NCT02153645|20239698|P2|STARTED|Overall Study||29
8207492|NCT02153645|20239699|P1|STARTED|Overall Study||30
8207493|NCT02153632|20239713|P3|NOT COMPLETED|Overall Study||19
8207494|NCT02153632|20239714|P2|NOT COMPLETED|Overall Study||19
8207495|NCT02153632|20239715|P1|NOT COMPLETED|Overall Study||18
8207496|NCT02153632|20239713|P3|COMPLETED|Overall Study||25
8207497|NCT02153632|20239714|P2|COMPLETED|Overall Study||27
8207498|NCT02153632|20239715|P1|COMPLETED|Overall Study||27
8207499|NCT02153632|20239713|P3|STARTED|Overall Study||44
8207500|NCT02153632|20239714|P2|STARTED|Overall Study||46
8207501|NCT02153632|20239715|P1|STARTED|Overall Study||45
8207502|NCT02153528|20239728|P2|NOT COMPLETED|Overall Study||0
8207503|NCT02153528|20239729|P1|NOT COMPLETED|Overall Study||0
8207504|NCT02153528|20239728|P2|COMPLETED|Overall Study||353
8207505|NCT02153528|20239729|P1|COMPLETED|Overall Study||348
8207506|NCT02153528|20239728|P2|STARTED|Overall Study||353
8207507|NCT02153528|20239729|P1|STARTED|Overall Study||348
8207508|NCT02153489|20239751|P2|NOT COMPLETED|Period 2||0
8207509|NCT02153489|20239752|P1|NOT COMPLETED|Period 2||0
8207510|NCT02153489|20239751|P2|COMPLETED|Period 2||15
8207511|NCT02153489|20239752|P1|COMPLETED|Period 2||15
8207512|NCT02153489|20239751|P2|STARTED|Period 2||15
8207513|NCT02153489|20239752|P1|STARTED|Period 2||15
8207514|NCT02153489|20239751|P2|NOT COMPLETED|Period 1||0
8207515|NCT02153489|20239752|P1|NOT COMPLETED|Period 1||0
8207516|NCT02153489|20239751|P2|COMPLETED|Period 1||15
8207517|NCT02153489|20239752|P1|COMPLETED|Period 1||15
8207518|NCT02153489|20239751|P2|STARTED|Period 1||15
8207519|NCT02153489|20239752|P1|STARTED|Period 1||15
8207520|NCT02153476|20239792|P2|NOT COMPLETED|Overall Study||0
8207521|NCT02153476|20239793|P1|NOT COMPLETED|Overall Study||1
8207522|NCT02153476|20239792|P2|COMPLETED|Overall Study||22
8207523|NCT02153476|20239793|P1|COMPLETED|Overall Study||22
8207524|NCT02153476|20239792|P2|STARTED|Overall Study||22
8207525|NCT02153476|20239793|P1|STARTED|Overall Study||23
8207526|NCT02153398|20239804|P5|NOT COMPLETED|Overall Study||0
8207527|NCT02153398|20239805|P4|NOT COMPLETED|Overall Study||1
8207528|NCT02153398|20239806|P3|NOT COMPLETED|Overall Study||1
8207529|NCT02153398|20239807|P2|NOT COMPLETED|Overall Study||0
8207530|NCT02153398|20239808|P1|NOT COMPLETED|Overall Study||1
8207531|NCT02153398|20239804|P5|COMPLETED|Overall Study||10
8207532|NCT02153398|20239805|P4|COMPLETED|Overall Study||9
8207533|NCT02153398|20239806|P3|COMPLETED|Overall Study||9
8207534|NCT02153398|20239807|P2|COMPLETED|Overall Study||10
8207535|NCT02153398|20239808|P1|COMPLETED|Overall Study||9
8207536|NCT02153398|20239804|P5|STARTED|Overall Study||10
8207537|NCT02153398|20239805|P4|STARTED|Overall Study||10
8207538|NCT02153398|20239806|P3|STARTED|Overall Study||10
8207539|NCT02153398|20239807|P2|STARTED|Overall Study||10
8207540|NCT02153398|20239808|P1|STARTED|Overall Study||10
8207541|NCT02153359|20239930|P2|NOT COMPLETED|Intervention 2 (1 Month)||2
8207542|NCT02153359|20239931|P1|NOT COMPLETED|Intervention 2 (1 Month)||0
8207543|NCT02153359|20239930|P2|COMPLETED|Intervention 2 (1 Month)||10
8207544|NCT02153359|20239931|P1|COMPLETED|Intervention 2 (1 Month)||11
8207545|NCT02153359|20239930|P2|STARTED|Intervention 2 (1 Month)||12
8207546|NCT02153359|20239931|P1|STARTED|Intervention 2 (1 Month)||11
8207547|NCT02153359|20239930|P2|NOT COMPLETED|Washout (at Least 1 Month)||0
8207548|NCT02153359|20239931|P1|NOT COMPLETED|Washout (at Least 1 Month)||0
8207549|NCT02153359|20239930|P2|COMPLETED|Washout (at Least 1 Month)||12
8207550|NCT02153359|20239931|P1|COMPLETED|Washout (at Least 1 Month)||11
8207551|NCT02153359|20239930|P2|STARTED|Washout (at Least 1 Month)||12
8207552|NCT02153359|20239931|P1|STARTED|Washout (at Least 1 Month)||11
8207553|NCT02153359|20239930|P2|NOT COMPLETED|Intervention 1 (1 Month)||0
8207554|NCT02153359|20239931|P1|NOT COMPLETED|Intervention 1 (1 Month)||0
8207555|NCT02153359|20239930|P2|COMPLETED|Intervention 1 (1 Month)||12
8207556|NCT02153359|20239931|P1|COMPLETED|Intervention 1 (1 Month)||11
8207557|NCT02153359|20239930|P2|STARTED|Intervention 1 (1 Month)||12
8207558|NCT02153359|20239931|P1|STARTED|Intervention 1 (1 Month)||11
8207559|NCT02153346|20239965|P1|NOT COMPLETED|Overall Study||11
8207560|NCT02153346|20239965|P1|COMPLETED|Overall Study||90
8207561|NCT02153346|20239965|P1|STARTED|Overall Study||101
8207562|NCT02153112|20239982|P10|NOT COMPLETED|Overall Study||14
8207563|NCT02153112|20239983|P9|NOT COMPLETED|Overall Study||15
8207564|NCT02153112|20239984|P8|NOT COMPLETED|Overall Study||2
8207565|NCT02153112|20239985|P7|NOT COMPLETED|Overall Study||8
8207566|NCT02153112|20239986|P6|NOT COMPLETED|Overall Study||2
8207567|NCT02153112|20239987|P5|NOT COMPLETED|Overall Study||3
8207568|NCT02153112|20239988|P4|NOT COMPLETED|Overall Study||2
8207569|NCT02153112|20239989|P3|NOT COMPLETED|Overall Study||3
8207570|NCT02153112|20239990|P2|NOT COMPLETED|Overall Study||2
8207571|NCT02153112|20239991|P1|NOT COMPLETED|Overall Study||4
8207572|NCT02153112|20239982|P10|COMPLETED|Overall Study||166
8207573|NCT02153112|20239983|P9|COMPLETED|Overall Study||165
8207574|NCT02153112|20239984|P8|COMPLETED|Overall Study||58
8207575|NCT02153112|20239985|P7|COMPLETED|Overall Study||52
8207576|NCT02153112|20239986|P6|COMPLETED|Overall Study||58
8207577|NCT02153112|20239987|P5|COMPLETED|Overall Study||57
8207578|NCT02153112|20239988|P4|COMPLETED|Overall Study||57
8207579|NCT02153112|20239989|P3|COMPLETED|Overall Study||58
8207580|NCT02153112|20239990|P2|COMPLETED|Overall Study||57
8207581|NCT02153112|20239991|P1|COMPLETED|Overall Study||57
8207582|NCT02153112|20239982|P10|STARTED|Overall Study||180
8207583|NCT02153112|20239983|P9|STARTED|Overall Study||180
8207584|NCT02153112|20239984|P8|STARTED|Overall Study||60
8207585|NCT02153112|20239985|P7|STARTED|Overall Study||60
8207586|NCT02153112|20239986|P6|STARTED|Overall Study||60
8207587|NCT02153112|20239987|P5|STARTED|Overall Study||60
8207588|NCT02153112|20239988|P4|STARTED|Overall Study||59
8207589|NCT02153112|20239989|P3|STARTED|Overall Study||61
8207590|NCT02153112|20239990|P2|STARTED|Overall Study||59
8207591|NCT02153112|20239991|P1|STARTED|Overall Study||61
8207592|NCT02153099|20240270|P7|NOT COMPLETED|Overall Study||0
8207593|NCT02153099|20240271|P6|NOT COMPLETED|Overall Study||0
8207594|NCT02153099|20240272|P5|NOT COMPLETED|Overall Study||0
8207595|NCT02153099|20240273|P4|NOT COMPLETED|Overall Study||0
8207596|NCT02153099|20240274|P3|NOT COMPLETED|Overall Study||0
8207597|NCT02153099|20240275|P2|NOT COMPLETED|Overall Study||0
8207598|NCT02153099|20240276|P1|NOT COMPLETED|Overall Study||0
8207599|NCT02153099|20240270|P7|COMPLETED|Overall Study||12
8207600|NCT02153099|20240271|P6|COMPLETED|Overall Study||6
8207601|NCT02153099|20240272|P5|COMPLETED|Overall Study||6
8207602|NCT02153099|20240273|P4|COMPLETED|Overall Study||6
8207603|NCT02153099|20240274|P3|COMPLETED|Overall Study||6
8207604|NCT02153099|20240275|P2|COMPLETED|Overall Study||6
8207605|NCT02153099|20240276|P1|COMPLETED|Overall Study||6
8207606|NCT02153099|20240270|P7|STARTED|Overall Study||12
8207607|NCT02153099|20240271|P6|STARTED|Overall Study||6
8207608|NCT02153099|20240272|P5|STARTED|Overall Study||6
8207609|NCT02153099|20240273|P4|STARTED|Overall Study||6
8207610|NCT02153099|20240274|P3|STARTED|Overall Study||6
8207611|NCT02153099|20240275|P2|STARTED|Overall Study||6
8207612|NCT02153099|20240276|P1|STARTED|Overall Study||6
8207613|NCT02153086|20240330|P1|NOT COMPLETED|Overall Study||4
8207614|NCT02153086|20240330|P1|COMPLETED|Overall Study||232
8207615|NCT02153086|20240330|P1|STARTED|Overall Study||236
8207616|NCT02153073|20240344|P1|NOT COMPLETED|Overall Study||298
8207617|NCT02153073|20240344|P1|COMPLETED|Overall Study||2786
8207618|NCT02153073|20240344|P1|STARTED|Overall Study||3084
8207619|NCT02152826|20240359|P2|NOT COMPLETED|Overall Study||1
8207620|NCT02152826|20240360|P1|NOT COMPLETED|Overall Study||1
8207621|NCT02152826|20240359|P2|COMPLETED|Overall Study||34
8207622|NCT02152826|20240360|P1|COMPLETED|Overall Study||44
8207623|NCT02152826|20240359|P2|STARTED|Overall Study||35
8207624|NCT02152826|20240360|P1|STARTED|Overall Study||45
8207625|NCT02152761|20240372|P4|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||2
8207626|NCT02152761|20240373|P3|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||0
8207627|NCT02152761|20240374|P2|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||7
8207628|NCT02152761|20240375|P1|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||4
8207629|NCT02152761|20240372|P4|COMPLETED|Epoch: Post-treatment Follow-up Epoch||66
8207630|NCT02152761|20240373|P3|COMPLETED|Epoch: Post-treatment Follow-up Epoch||30
8207631|NCT02152761|20240374|P2|COMPLETED|Epoch: Post-treatment Follow-up Epoch||47
8207632|NCT02152761|20240375|P1|COMPLETED|Epoch: Post-treatment Follow-up Epoch||63
8207633|NCT02152761|20240372|P4|STARTED|Epoch: Post-treatment Follow-up Epoch||68
8207634|NCT02152761|20240373|P3|STARTED|Epoch: Post-treatment Follow-up Epoch||30
8207635|NCT02152761|20240374|P2|STARTED|Epoch: Post-treatment Follow-up Epoch||54
8207636|NCT02152761|20240375|P1|STARTED|Epoch: Post-treatment Follow-up Epoch||67
8207637|NCT02152761|20240372|P4|NOT COMPLETED|Epoch: Treatment Epoch||8
8207638|NCT02152761|20240373|P3|NOT COMPLETED|Epoch: Treatment Epoch||5
8207639|NCT02152761|20240374|P2|NOT COMPLETED|Epoch: Treatment Epoch||20
8207640|NCT02152761|20240375|P1|NOT COMPLETED|Epoch: Treatment Epoch||11
8207641|NCT02152761|20240372|P4|COMPLETED|Epoch: Treatment Epoch||64
8207642|NCT02152761|20240373|P3|COMPLETED|Epoch: Treatment Epoch||29
8207643|NCT02152761|20240374|P2|COMPLETED|Epoch: Treatment Epoch||50
8207644|NCT02152761|20240375|P1|COMPLETED|Epoch: Treatment Epoch||64
8207645|NCT02152761|20240372|P4|STARTED|Epoch: Treatment Epoch||72
8207646|NCT02152761|20240373|P3|STARTED|Epoch: Treatment Epoch||34
8207647|NCT02152761|20240374|P2|STARTED|Epoch: Treatment Epoch||70
8207648|NCT02152761|20240375|P1|STARTED|Epoch: Treatment Epoch||75
8207649|NCT02152696|20240399|P3|NOT COMPLETED|Overall Study||1
8207650|NCT02152696|20240400|P2|NOT COMPLETED|Overall Study||1
8207651|NCT02152696|20240401|P1|NOT COMPLETED|Overall Study||0
8207652|NCT02152696|20240399|P3|COMPLETED|Overall Study||81
8207653|NCT02152696|20240400|P2|COMPLETED|Overall Study||86
8207654|NCT02152696|20240401|P1|COMPLETED|Overall Study||86
8207655|NCT02152696|20240399|P3|STARTED|Overall Study||82
8207656|NCT02152696|20240400|P2|STARTED|Overall Study||87
8207657|NCT02152696|20240401|P1|STARTED|Overall Study||86
8207675|NCT02152605|20240435|P2|NOT COMPLETED|Overall Study||18
8207676|NCT02152605|20240436|P1|NOT COMPLETED|Overall Study||19
8207677|NCT02152605|20240435|P2|COMPLETED|Overall Study||230
8207678|NCT02152605|20240436|P1|COMPLETED|Overall Study||229
8207679|NCT02152605|20240435|P2|STARTED|Overall Study||248
8207680|NCT02152605|20240436|P1|STARTED|Overall Study||248
8207681|NCT02152566|20240446|P1|NOT COMPLETED|Overall Study||3
8207682|NCT02152566|20240446|P1|COMPLETED|Overall Study||3
8207683|NCT02152566|20240446|P1|STARTED|Overall Study||6
8207684|NCT02152540|20240452|P2|NOT COMPLETED|Overall Study||0
8207685|NCT02152540|20240453|P1|NOT COMPLETED|Overall Study||0
8207686|NCT02152540|20240452|P2|COMPLETED|Overall Study||16
8207687|NCT02152540|20240453|P1|COMPLETED|Overall Study||17
8207688|NCT02152540|20240452|P2|STARTED|Overall Study||16
8207689|NCT02152540|20240453|P1|STARTED|Overall Study||17
8207690|NCT02152384|20240469|P2|NOT COMPLETED|Period 2||0
8207691|NCT02152384|20240470|P1|NOT COMPLETED|Period 2||0
8207692|NCT02152384|20240469|P2|COMPLETED|Period 2||12
8207693|NCT02152384|20240470|P1|COMPLETED|Period 2||13
8207694|NCT02152384|20240469|P2|STARTED|Period 2||12
8207695|NCT02152384|20240470|P1|STARTED|Period 2||13
8207696|NCT02152384|20240469|P2|NOT COMPLETED|Period 1||2
8207697|NCT02152384|20240470|P1|NOT COMPLETED|Period 1||1
8207698|NCT02152384|20240469|P2|COMPLETED|Period 1||12
8207699|NCT02152384|20240470|P1|COMPLETED|Period 1||13
8207700|NCT02152384|20240469|P2|Received at Least 1 Dose of Study Drug|Period 1||14
8207701|NCT02152384|20240470|P1|Received at Least 1 Dose of Study Drug|Period 1||14
8207702|NCT02152384|20240469|P2|STARTED|Period 1||14
8207703|NCT02152384|20240470|P1|STARTED|Period 1||14
8207704|NCT02152384|20240469|P2|NOT COMPLETED|Run In (1-5 Week Transition)||0
8207705|NCT02152384|20240470|P1|NOT COMPLETED|Run In (1-5 Week Transition)||0
8207706|NCT02152384|20240469|P2|COMPLETED|Run In (1-5 Week Transition)||14
8207707|NCT02152384|20240470|P1|COMPLETED|Run In (1-5 Week Transition)||14
8207708|NCT02152384|20240469|P2|STARTED|Run In (1-5 Week Transition)||14
8207709|NCT02152384|20240470|P1|STARTED|Run In (1-5 Week Transition)||14
8207710|NCT02152371|20240490|P2|NOT COMPLETED|Overall Study||16
8207711|NCT02152371|20240491|P1|NOT COMPLETED|Overall Study||12
8207712|NCT02152371|20240490|P2|COMPLETED|Overall Study||134
8207713|NCT02152371|20240491|P1|COMPLETED|Overall Study||138
8207714|NCT02152371|20240490|P2|Received at Least 1 Dose of Study Drug.|Overall Study||150
8207715|NCT02152371|20240491|P1|Received at Least 1 Dose of Study Drug.|Overall Study||150
8207716|NCT02152371|20240490|P2|STARTED|Overall Study||150
8207717|NCT02152371|20240491|P1|STARTED|Overall Study||150
8207729|NCT02152007|20240550|P1|NOT COMPLETED|Overall Study||1
8207730|NCT02152007|20240550|P1|COMPLETED|Overall Study||14
8207731|NCT02152007|20240550|P1|STARTED|Overall Study||15
8207732|NCT02151994|20240559|P13|NOT COMPLETED|Food Effect (FE): Fed||0
8207733|NCT02151994|20240560|P12|NOT COMPLETED|Food Effect (FE): Fed||0
8207734|NCT02151994|20240561|P11|NOT COMPLETED|Food Effect (FE): Fed||0
8207735|NCT02151994|20240562|P10|NOT COMPLETED|Food Effect (FE): Fed||0
8207736|NCT02151994|20240563|P9|NOT COMPLETED|Food Effect (FE): Fed||0
8207737|NCT02151994|20240564|P8|NOT COMPLETED|Food Effect (FE): Fed||0
8207738|NCT02151994|20240565|P7|NOT COMPLETED|Food Effect (FE): Fed||0
8207739|NCT02151994|20240566|P6|NOT COMPLETED|Food Effect (FE): Fed||0
8207740|NCT02151994|20240567|P5|NOT COMPLETED|Food Effect (FE): Fed||0
8207741|NCT02151994|20240568|P4|NOT COMPLETED|Food Effect (FE): Fed||0
8207742|NCT02151994|20240569|P3|NOT COMPLETED|Food Effect (FE): Fed||0
8207743|NCT02151994|20240570|P2|NOT COMPLETED|Food Effect (FE): Fed||0
8207744|NCT02151994|20240571|P1|NOT COMPLETED|Food Effect (FE): Fed||0
8207745|NCT02151994|20240559|P13|COMPLETED|Food Effect (FE): Fed||12
8207746|NCT02151994|20240560|P12|COMPLETED|Food Effect (FE): Fed||0
8207747|NCT02151994|20240561|P11|COMPLETED|Food Effect (FE): Fed||0
8207748|NCT02151994|20240562|P10|COMPLETED|Food Effect (FE): Fed||0
8207749|NCT02151994|20240563|P9|COMPLETED|Food Effect (FE): Fed||0
8207750|NCT02151994|20240564|P8|COMPLETED|Food Effect (FE): Fed||0
8207751|NCT02151994|20240565|P7|COMPLETED|Food Effect (FE): Fed||0
8207752|NCT02151994|20240566|P6|COMPLETED|Food Effect (FE): Fed||0
8207753|NCT02151994|20240567|P5|COMPLETED|Food Effect (FE): Fed||0
8207754|NCT02151994|20240568|P4|COMPLETED|Food Effect (FE): Fed||0
8207755|NCT02151994|20240569|P3|COMPLETED|Food Effect (FE): Fed||0
8207756|NCT02151994|20240570|P2|COMPLETED|Food Effect (FE): Fed||0
8207757|NCT02151994|20240571|P1|COMPLETED|Food Effect (FE): Fed||0
8207758|NCT02151994|20240559|P13|STARTED|Food Effect (FE): Fed||12
8207759|NCT02151994|20240560|P12|STARTED|Food Effect (FE): Fed||0
8207760|NCT02151994|20240561|P11|STARTED|Food Effect (FE): Fed||0
8207761|NCT02151994|20240562|P10|STARTED|Food Effect (FE): Fed||0
8207762|NCT02151994|20240563|P9|STARTED|Food Effect (FE): Fed||0
8207763|NCT02151994|20240564|P8|STARTED|Food Effect (FE): Fed||0
8207764|NCT02151994|20240565|P7|STARTED|Food Effect (FE): Fed||0
8207765|NCT02151994|20240566|P6|STARTED|Food Effect (FE): Fed||0
8207766|NCT02151994|20240567|P5|STARTED|Food Effect (FE): Fed||0
8207767|NCT02151994|20240568|P4|STARTED|Food Effect (FE): Fed||0
8207768|NCT02151994|20240569|P3|STARTED|Food Effect (FE): Fed||0
8207769|NCT02151994|20240570|P2|STARTED|Food Effect (FE): Fed||0
8207770|NCT02151994|20240571|P1|STARTED|Food Effect (FE): Fed||0
8207771|NCT02151994|20240559|P13|NOT COMPLETED|Food Effect (FE): Fasted||0
8207772|NCT02151994|20240560|P12|NOT COMPLETED|Food Effect (FE): Fasted||0
8207773|NCT02151994|20240561|P11|NOT COMPLETED|Food Effect (FE): Fasted||0
8207774|NCT02151994|20240562|P10|NOT COMPLETED|Food Effect (FE): Fasted||0
8207775|NCT02151994|20240563|P9|NOT COMPLETED|Food Effect (FE): Fasted||0
8207776|NCT02151994|20240564|P8|NOT COMPLETED|Food Effect (FE): Fasted||0
8207777|NCT02151994|20240565|P7|NOT COMPLETED|Food Effect (FE): Fasted||0
8207778|NCT02151994|20240566|P6|NOT COMPLETED|Food Effect (FE): Fasted||0
8207779|NCT02151994|20240567|P5|NOT COMPLETED|Food Effect (FE): Fasted||0
8207780|NCT02151994|20240568|P4|NOT COMPLETED|Food Effect (FE): Fasted||0
8207781|NCT02151994|20240569|P3|NOT COMPLETED|Food Effect (FE): Fasted||0
8207782|NCT02151994|20240570|P2|NOT COMPLETED|Food Effect (FE): Fasted||0
8207783|NCT02151994|20240571|P1|NOT COMPLETED|Food Effect (FE): Fasted||0
8207784|NCT02151994|20240559|P13|COMPLETED|Food Effect (FE): Fasted||0
8207785|NCT02151994|20240560|P12|COMPLETED|Food Effect (FE): Fasted||12
8207786|NCT02151994|20240561|P11|COMPLETED|Food Effect (FE): Fasted||0
8207787|NCT02151994|20240562|P10|COMPLETED|Food Effect (FE): Fasted||0
8207788|NCT02151994|20240563|P9|COMPLETED|Food Effect (FE): Fasted||0
8207789|NCT02151994|20240564|P8|COMPLETED|Food Effect (FE): Fasted||0
8207790|NCT02151994|20240565|P7|COMPLETED|Food Effect (FE): Fasted||0
8207791|NCT02151994|20240566|P6|COMPLETED|Food Effect (FE): Fasted||0
8207792|NCT02151994|20240567|P5|COMPLETED|Food Effect (FE): Fasted||0
8207793|NCT02151994|20240568|P4|COMPLETED|Food Effect (FE): Fasted||0
8207794|NCT02151994|20240569|P3|COMPLETED|Food Effect (FE): Fasted||0
8207795|NCT02151994|20240570|P2|COMPLETED|Food Effect (FE): Fasted||0
8207796|NCT02151994|20240571|P1|COMPLETED|Food Effect (FE): Fasted||0
8207797|NCT02151994|20240559|P13|STARTED|Food Effect (FE): Fasted||0
8207798|NCT02151994|20240560|P12|STARTED|Food Effect (FE): Fasted||12
8207799|NCT02151994|20240561|P11|STARTED|Food Effect (FE): Fasted||0
8207800|NCT02151994|20240562|P10|STARTED|Food Effect (FE): Fasted||0
8207801|NCT02151994|20240563|P9|STARTED|Food Effect (FE): Fasted||0
8207802|NCT02151994|20240564|P8|STARTED|Food Effect (FE): Fasted||0
8207803|NCT02151994|20240565|P7|STARTED|Food Effect (FE): Fasted||0
8207804|NCT02151994|20240566|P6|STARTED|Food Effect (FE): Fasted||0
8207805|NCT02151994|20240567|P5|STARTED|Food Effect (FE): Fasted||0
8207806|NCT02151994|20240568|P4|STARTED|Food Effect (FE): Fasted||0
8207807|NCT02151994|20240569|P3|STARTED|Food Effect (FE): Fasted||0
8207808|NCT02151994|20240570|P2|STARTED|Food Effect (FE): Fasted||0
8207809|NCT02151994|20240571|P1|STARTED|Food Effect (FE): Fasted||0
8207810|NCT02151994|20240559|P13|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207811|NCT02151994|20240560|P12|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207812|NCT02151994|20240561|P11|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207813|NCT02151994|20240562|P10|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207814|NCT02151994|20240563|P9|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207815|NCT02151994|20240564|P8|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207816|NCT02151994|20240565|P7|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207817|NCT02151994|20240566|P6|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207818|NCT02151994|20240567|P5|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207819|NCT02151994|20240568|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207820|NCT02151994|20240569|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207821|NCT02151994|20240570|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207822|NCT02151994|20240571|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
8207823|NCT02151994|20240559|P13|COMPLETED|Multiple Ascending Dose (MAD)||0
8207824|NCT02151994|20240560|P12|COMPLETED|Multiple Ascending Dose (MAD)||0
8207825|NCT02151994|20240561|P11|COMPLETED|Multiple Ascending Dose (MAD)||0
8207826|NCT02151994|20240562|P10|COMPLETED|Multiple Ascending Dose (MAD)||0
8207827|NCT02151994|20240563|P9|COMPLETED|Multiple Ascending Dose (MAD)||6
8207828|NCT02151994|20240564|P8|COMPLETED|Multiple Ascending Dose (MAD)||0
8207829|NCT02151994|20240565|P7|COMPLETED|Multiple Ascending Dose (MAD)||6
8207830|NCT02151994|20240566|P6|COMPLETED|Multiple Ascending Dose (MAD)||6
8207831|NCT02151994|20240567|P5|COMPLETED|Multiple Ascending Dose (MAD)||6
8207832|NCT02151994|20240568|P4|COMPLETED|Multiple Ascending Dose (MAD)||6
8207833|NCT02151994|20240569|P3|COMPLETED|Multiple Ascending Dose (MAD)||0
8207834|NCT02151994|20240570|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
8207835|NCT02151994|20240571|P1|COMPLETED|Multiple Ascending Dose (MAD)||10
8207836|NCT02151994|20240559|P13|STARTED|Multiple Ascending Dose (MAD)||0
8207837|NCT02151994|20240560|P12|STARTED|Multiple Ascending Dose (MAD)||0
8207838|NCT02151994|20240561|P11|STARTED|Multiple Ascending Dose (MAD)||0
8207839|NCT02151994|20240562|P10|STARTED|Multiple Ascending Dose (MAD)||0
8207840|NCT02151994|20240563|P9|STARTED|Multiple Ascending Dose (MAD)||6
8207841|NCT02151994|20240564|P8|STARTED|Multiple Ascending Dose (MAD)||0
8207842|NCT02151994|20240565|P7|STARTED|Multiple Ascending Dose (MAD)||6
8207843|NCT02151994|20240566|P6|STARTED|Multiple Ascending Dose (MAD)||6
8207844|NCT02151994|20240567|P5|STARTED|Multiple Ascending Dose (MAD)||6
8207845|NCT02151994|20240568|P4|STARTED|Multiple Ascending Dose (MAD)||6
8207846|NCT02151994|20240569|P3|STARTED|Multiple Ascending Dose (MAD)||0
8207847|NCT02151994|20240570|P2|STARTED|Multiple Ascending Dose (MAD)||0
8207848|NCT02151994|20240571|P1|STARTED|Multiple Ascending Dose (MAD)||10
8207849|NCT02151994|20240559|P13|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207850|NCT02151994|20240560|P12|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207851|NCT02151994|20240561|P11|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207852|NCT02151994|20240562|P10|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207853|NCT02151994|20240563|P9|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207854|NCT02151994|20240564|P8|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207855|NCT02151994|20240565|P7|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207856|NCT02151994|20240566|P6|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207857|NCT02151994|20240567|P5|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207858|NCT02151994|20240568|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207859|NCT02151994|20240569|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207860|NCT02151994|20240570|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207861|NCT02151994|20240571|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
8207862|NCT02151994|20240559|P13|COMPLETED|Single Ascending Dose (SAD)||0
8207863|NCT02151994|20240560|P12|COMPLETED|Single Ascending Dose (SAD)||0
8207864|NCT02151994|20240561|P11|COMPLETED|Single Ascending Dose (SAD)||6
8207865|NCT02151994|20240562|P10|COMPLETED|Single Ascending Dose (SAD)||6
8207866|NCT02151994|20240563|P9|COMPLETED|Single Ascending Dose (SAD)||0
8207867|NCT02151994|20240564|P8|COMPLETED|Single Ascending Dose (SAD)||6
8207868|NCT02151994|20240565|P7|COMPLETED|Single Ascending Dose (SAD)||6
8207869|NCT02151994|20240566|P6|COMPLETED|Single Ascending Dose (SAD)||6
8207870|NCT02151994|20240567|P5|COMPLETED|Single Ascending Dose (SAD)||6
8207871|NCT02151994|20240568|P4|COMPLETED|Single Ascending Dose (SAD)||6
8207872|NCT02151994|20240569|P3|COMPLETED|Single Ascending Dose (SAD)||6
8207873|NCT02151994|20240570|P2|COMPLETED|Single Ascending Dose (SAD)||6
8207874|NCT02151994|20240571|P1|COMPLETED|Single Ascending Dose (SAD)||18
8207875|NCT02151994|20240559|P13|STARTED|Single Ascending Dose (SAD)||0
8207876|NCT02151994|20240560|P12|STARTED|Single Ascending Dose (SAD)||0
8207877|NCT02151994|20240561|P11|STARTED|Single Ascending Dose (SAD)||6
8207878|NCT02151994|20240562|P10|STARTED|Single Ascending Dose (SAD)||6
8207879|NCT02151994|20240563|P9|STARTED|Single Ascending Dose (SAD)||0
8207880|NCT02151994|20240564|P8|STARTED|Single Ascending Dose (SAD)||6
8207881|NCT02151994|20240565|P7|STARTED|Single Ascending Dose (SAD)||6
8207882|NCT02151994|20240566|P6|STARTED|Single Ascending Dose (SAD)||6
8207883|NCT02151994|20240567|P5|STARTED|Single Ascending Dose (SAD)||6
8207884|NCT02151994|20240568|P4|STARTED|Single Ascending Dose (SAD)||6
8207885|NCT02151994|20240569|P3|STARTED|Single Ascending Dose (SAD)||6
8207886|NCT02151994|20240570|P2|STARTED|Single Ascending Dose (SAD)||6
8207887|NCT02151994|20240571|P1|STARTED|Single Ascending Dose (SAD)||18
8207900|NCT02151903|20240630|P2|NOT COMPLETED|Overall Study||1
8207901|NCT02151903|20240631|P1|NOT COMPLETED|Overall Study||3
8207902|NCT02151903|20240630|P2|COMPLETED|Overall Study||1
8207903|NCT02151903|20240631|P1|COMPLETED|Overall Study||0
8207904|NCT02151903|20240630|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
8207905|NCT02151903|20240631|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8207906|NCT02151903|20240630|P2|STARTED|Overall Study||2
8207907|NCT02151903|20240631|P1|STARTED|Overall Study||3
8207908|NCT02151877|20240649|P2|NOT COMPLETED|Overall Study||0
8207909|NCT02151877|20240650|P1|NOT COMPLETED|Overall Study||0
8207910|NCT02151877|20240649|P2|COMPLETED|Overall Study||12
8207911|NCT02151877|20240650|P1|COMPLETED|Overall Study||12
8207912|NCT02151877|20240649|P2|STARTED|Overall Study||12
8207913|NCT02151877|20240650|P1|STARTED|Overall Study||12
8207914|NCT02151851|20240668|P2|NOT COMPLETED|Overall Study||130
8207915|NCT02151851|20240669|P1|NOT COMPLETED|Overall Study||76
8207916|NCT02151851|20240668|P2|COMPLETED|Overall Study||186
8207917|NCT02151851|20240669|P1|COMPLETED|Overall Study||38
8207918|NCT02151851|20240668|P2|Included in the Safety Set|Overall Study||316
8207919|NCT02151851|20240669|P1|Included in the Safety Set|Overall Study||113
8207920|NCT02151851|20240668|P2|STARTED|Overall Study||316
8207921|NCT02151851|20240669|P1|STARTED|Overall Study||114
8207922|NCT02151786|20240681|P1|NOT COMPLETED|Overall Study||36
8207923|NCT02151786|20240681|P1|COMPLETED|Overall Study||1084
8207924|NCT02151786|20240681|P1|STARTED|Overall Study||1120
8207925|NCT02151773|20240692|P1|NOT COMPLETED|Overall Study||64
8207926|NCT02151773|20240692|P1|COMPLETED|Overall Study||3429
8207927|NCT02151773|20240692|P1|STARTED|Overall Study||3493
8207928|NCT02151682|20240699|P6|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7
8207929|NCT02151682|20240700|P5|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207930|NCT02151682|20240701|P4|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207931|NCT02151682|20240702|P3|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207932|NCT02151682|20240703|P2|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207933|NCT02151682|20240704|P1|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207934|NCT02151682|20240699|P6|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19
8207935|NCT02151682|20240700|P5|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207936|NCT02151682|20240701|P4|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207937|NCT02151682|20240702|P3|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207938|NCT02151682|20240703|P2|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207939|NCT02151682|20240704|P1|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
8207940|NCT02151682|20240699|P6|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26
8207941|NCT02151682|20240700|P5|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
8207942|NCT02151682|20240701|P4|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
8207943|NCT02151682|20240702|P3|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
8207944|NCT02151682|20240703|P2|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
8207945|NCT02151682|20240704|P1|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
8207946|NCT02151682|20240699|P6|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
8207947|NCT02151682|20240700|P5|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
8207948|NCT02151682|20240701|P4|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4
8207949|NCT02151682|20240702|P3|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28
8207950|NCT02151682|20240703|P2|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
8207951|NCT02151682|20240704|P1|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
8207952|NCT02151682|20240699|P6|COMPLETED|Part 2: Tapent. Extension or Observation||0
8207953|NCT02151682|20240700|P5|COMPLETED|Part 2: Tapent. Extension or Observation||14
8207954|NCT02151682|20240701|P4|COMPLETED|Part 2: Tapent. Extension or Observation||14
8207955|NCT02151682|20240702|P3|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8
8207956|NCT02151682|20240703|P2|COMPLETED|Part 2: Tapent. Extension or Observation||0
8207957|NCT02151682|20240704|P1|COMPLETED|Part 2: Tapent. Extension or Observation||0
8207958|NCT02151682|20240699|P6|STARTED|Part 2: Tapent. Extension or Observation||0
8207959|NCT02151682|20240700|P5|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14
8207960|NCT02151682|20240701|P4|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18
8207961|NCT02151682|20240702|P3|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36
8207962|NCT02151682|20240703|P2|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
8207963|NCT02151682|20240704|P1|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
8207964|NCT02151682|20240699|P6|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207965|NCT02151682|20240700|P5|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207966|NCT02151682|20240701|P4|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207967|NCT02151682|20240702|P3|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207968|NCT02151682|20240703|P2|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5
8207969|NCT02151682|20240704|P1|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2
8207970|NCT02151682|20240699|P6|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207971|NCT02151682|20240700|P5|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207972|NCT02151682|20240701|P4|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207973|NCT02151682|20240702|P3|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
8207974|NCT02151682|20240703|P2|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40
8207975|NCT02151682|20240704|P1|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22
8207976|NCT02151682|20240699|P6|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
8207977|NCT02151682|20240700|P5|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
8207978|NCT02151682|20240701|P4|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
8207979|NCT02151682|20240702|P3|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
8207980|NCT02151682|20240703|P2|STARTED|Part 1: 14 Days Morphine or Tapentadol||45
8207981|NCT02151682|20240704|P1|STARTED|Part 1: 14 Days Morphine or Tapentadol||24
8207982|NCT02151643|20240754|P5|NOT COMPLETED|Overall Study||3
8207983|NCT02151643|20240755|P4|NOT COMPLETED|Overall Study||7
8207984|NCT02151643|20240756|P3|NOT COMPLETED|Overall Study||4
8207985|NCT02151643|20240757|P2|NOT COMPLETED|Overall Study||4
8207986|NCT02151643|20240758|P1|NOT COMPLETED|Overall Study||6
8207987|NCT02151643|20240754|P5|COMPLETED|Overall Study||35
8207988|NCT02151643|20240755|P4|COMPLETED|Overall Study||32
8207989|NCT02151643|20240756|P3|COMPLETED|Overall Study||21
8207990|NCT02151643|20240757|P2|COMPLETED|Overall Study||21
8207991|NCT02151643|20240758|P1|COMPLETED|Overall Study||20
8207992|NCT02151643|20240754|P5|STARTED|Overall Study||38
8207993|NCT02151643|20240755|P4|STARTED|Overall Study||39
8207994|NCT02151643|20240756|P3|STARTED|Overall Study||25
8207995|NCT02151643|20240757|P2|STARTED|Overall Study||25
8207996|NCT02151643|20240758|P1|STARTED|Overall Study||26
8207997|NCT02151591|20240797|P2|NOT COMPLETED|Overall Study||3
8207998|NCT02151591|20240798|P1|NOT COMPLETED|Overall Study||6
8207999|NCT02151591|20240797|P2|COMPLETED|Overall Study||10
8208000|NCT02151591|20240798|P1|COMPLETED|Overall Study||7
8208001|NCT02151591|20240797|P2|STARTED|Overall Study||13
8208002|NCT02151591|20240798|P1|STARTED|Overall Study||13
8208003|NCT02151526|20240810|P2|NOT COMPLETED|Overall Study||0
8208004|NCT02151526|20240811|P1|NOT COMPLETED|Overall Study||0
8208005|NCT02151526|20240810|P2|COMPLETED|Overall Study||4
8208006|NCT02151526|20240811|P1|COMPLETED|Overall Study||3
8208007|NCT02151526|20240810|P2|STARTED|Overall Study||4
8208008|NCT02151526|20240811|P1|STARTED|Overall Study||3
8208009|NCT02151487|20240848|P4|NOT COMPLETED|Overall Study||3
8208010|NCT02151487|20240849|P3|NOT COMPLETED|Overall Study||4
8208011|NCT02151487|20240850|P2|NOT COMPLETED|Overall Study||5
8208012|NCT02151487|20240851|P1|NOT COMPLETED|Overall Study||2
8208013|NCT02151487|20240848|P4|COMPLETED|Overall Study||20
8208014|NCT02151487|20240849|P3|COMPLETED|Overall Study||16
8208015|NCT02151487|20240850|P2|COMPLETED|Overall Study||22
8208016|NCT02151487|20240851|P1|COMPLETED|Overall Study||25
8208017|NCT02151487|20240848|P4|STARTED|Overall Study||23
8208018|NCT02151487|20240849|P3|STARTED|Overall Study||20
8208019|NCT02151487|20240850|P2|STARTED|Overall Study||27
8208020|NCT02151487|20240851|P1|STARTED|Overall Study||27
8208021|NCT02151461|20240869|P4|NOT COMPLETED|Overall Study||4
8208022|NCT02151461|20240870|P3|NOT COMPLETED|Overall Study||3
8208023|NCT02151461|20240871|P2|NOT COMPLETED|Overall Study||1
8208024|NCT02151461|20240872|P1|NOT COMPLETED|Overall Study||6
8208025|NCT02151461|20240869|P4|COMPLETED|Overall Study||19
8208026|NCT02151461|20240870|P3|COMPLETED|Overall Study||21
8208027|NCT02151461|20240871|P2|COMPLETED|Overall Study||24
8208028|NCT02151461|20240872|P1|COMPLETED|Overall Study||18
8208029|NCT02151461|20240869|P4|STARTED|Overall Study||23
8208030|NCT02151461|20240870|P3|STARTED|Overall Study||24
8208031|NCT02151461|20240871|P2|STARTED|Overall Study||25
8208032|NCT02151461|20240872|P1|STARTED|Overall Study||24
8208033|NCT02151448|20240910|P1|NOT COMPLETED|Phase 2||0
8208034|NCT02151448|20240910|P1|COMPLETED|Phase 2||55
8208035|NCT02151448|20240910|P1|STARTED|Phase 2||55
8208036|NCT02151448|20240910|P1|NOT COMPLETED|Phase 1||0
8208037|NCT02151448|20240910|P1|COMPLETED|Phase 1||9
8208038|NCT02151448|20240910|P1|STARTED|Phase 1||9
8208039|NCT02151383|20240928|P3|NOT COMPLETED|Overall Study||0
8208040|NCT02151383|20240929|P2|NOT COMPLETED|Overall Study||0
8208041|NCT02151383|20240930|P1|NOT COMPLETED|Overall Study||0
8208042|NCT02151383|20240928|P3|COMPLETED|Overall Study||1
8208043|NCT02151383|20240929|P2|COMPLETED|Overall Study||3
8208044|NCT02151383|20240930|P1|COMPLETED|Overall Study||8
8208045|NCT02151383|20240928|P3|High-dose|Overall Study||0
8208046|NCT02151383|20240929|P2|High-dose|Overall Study||0
8208047|NCT02151383|20240930|P1|High-dose|Overall Study||6
8208048|NCT02151383|20240928|P3|Low-dose|Overall Study||1
8208049|NCT02151383|20240929|P2|Low-dose|Overall Study||3
8208050|NCT02151383|20240930|P1|Low-dose|Overall Study||2
8208051|NCT02151383|20240928|P3|STARTED|Overall Study||1
8208052|NCT02151383|20240929|P2|STARTED|Overall Study||3
8208053|NCT02151383|20240930|P1|STARTED|Overall Study||8
8208054|NCT02151331|20240988|P2|NOT COMPLETED|Overall Study||40
8208055|NCT02151331|20240989|P1|NOT COMPLETED|Overall Study||32
8208056|NCT02151331|20240988|P2|COMPLETED|Overall Study||52
8208057|NCT02151331|20240989|P1|COMPLETED|Overall Study||45
8208058|NCT02151331|20240988|P2|STARTED|Overall Study||92
8208059|NCT02151331|20240989|P1|STARTED|Overall Study||77
8208060|NCT02151266|20241004|P3|NOT COMPLETED|Overall Study||7
8208061|NCT02151266|20241005|P2|NOT COMPLETED|Overall Study||15
8208062|NCT02151266|20241006|P1|NOT COMPLETED|Overall Study||8
8208063|NCT02151266|20241004|P3|COMPLETED|Overall Study||14
8208064|NCT02151266|20241005|P2|COMPLETED|Overall Study||14
8208065|NCT02151266|20241006|P1|COMPLETED|Overall Study||11
8208066|NCT02151266|20241004|P3|STARTED|Overall Study||21
8208067|NCT02151266|20241005|P2|STARTED|Overall Study||29
8208068|NCT02151266|20241006|P1|STARTED|Overall Study||19
8208069|NCT02151253|20241032|P2|NOT COMPLETED|Overall Study||0
8208070|NCT02151253|20241033|P1|NOT COMPLETED|Overall Study||0
8208071|NCT02151253|20241032|P2|COMPLETED|Overall Study||15
8208072|NCT02151253|20241033|P1|COMPLETED|Overall Study||13
8208073|NCT02151253|20241032|P2|STARTED|Overall Study||15
8208074|NCT02151253|20241033|P1|STARTED|Overall Study||13
8208075|NCT02151149|20241049|P2|NOT COMPLETED|Follow-Up Period||37
8208076|NCT02151149|20241050|P1|NOT COMPLETED|Follow-Up Period||39
8208077|NCT02151149|20241049|P2|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
8208078|NCT02151149|20241050|P1|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
8208079|NCT02151149|20241049|P2|STARTED|Follow-Up Period||55
8208080|NCT02151149|20241050|P1|STARTED|Follow-Up Period||58
8208081|NCT02151149|20241049|P2|NOT COMPLETED|Treatment Period||71
8208082|NCT02151149|20241050|P1|NOT COMPLETED|Treatment Period||70
8208083|NCT02151149|20241049|P2|COMPLETED|Treatment Period||1
8208084|NCT02151149|20241050|P1|COMPLETED|Treatment Period||1
8208085|NCT02151149|20241049|P2|Treated Population|Treatment Period||70
8208086|NCT02151149|20241050|P1|Treated Population|Treatment Period||68
8208087|NCT02151149|20241049|P2|STARTED|Treatment Period|2 participants did not receive treatment|72
8208088|NCT02151149|20241050|P1|STARTED|Treatment Period|3 participants did not receive treatment|71
8208089|NCT02151110|20241082|P8|NOT COMPLETED|Overall Study||3
8208090|NCT02151110|20241083|P7|NOT COMPLETED|Overall Study||0
8208091|NCT02151110|20241084|P6|NOT COMPLETED|Overall Study||0
8208092|NCT02151110|20241085|P5|NOT COMPLETED|Overall Study||0
8208093|NCT02151110|20241086|P4|NOT COMPLETED|Overall Study||0
8208094|NCT02151110|20241087|P3|NOT COMPLETED|Overall Study||0
8208095|NCT02151110|20241088|P2|NOT COMPLETED|Overall Study||0
8208096|NCT02151110|20241089|P1|NOT COMPLETED|Overall Study||0
8208097|NCT02151110|20241082|P8|COMPLETED|Overall Study||5
8208098|NCT02151110|20241083|P7|COMPLETED|Overall Study||8
8208099|NCT02151110|20241084|P6|COMPLETED|Overall Study||8
8208100|NCT02151110|20241085|P5|COMPLETED|Overall Study||8
8208101|NCT02151110|20241086|P4|COMPLETED|Overall Study||8
8208102|NCT02151110|20241087|P3|COMPLETED|Overall Study||2
8208103|NCT02151110|20241088|P2|COMPLETED|Overall Study||2
8208104|NCT02151110|20241089|P1|COMPLETED|Overall Study||12
8208105|NCT02151110|20241082|P8|STARTED|Overall Study||8
8208106|NCT02151110|20241083|P7|STARTED|Overall Study||8
8208107|NCT02151110|20241084|P6|STARTED|Overall Study||8
8208108|NCT02151110|20241085|P5|STARTED|Overall Study||8
8208109|NCT02151110|20241086|P4|STARTED|Overall Study||8
8208110|NCT02151110|20241087|P3|STARTED|Overall Study||2
8208111|NCT02151110|20241088|P2|STARTED|Overall Study||2
8208112|NCT02151110|20241089|P1|STARTED|Overall Study||12
8208113|NCT02151058|20241182|P3|NOT COMPLETED|Overall Study||5
8208114|NCT02151058|20241183|P2|NOT COMPLETED|Overall Study||1
8208115|NCT02151058|20241184|P1|NOT COMPLETED|Overall Study||2
8208116|NCT02151058|20241182|P3|COMPLETED|Overall Study||86
8208117|NCT02151058|20241183|P2|COMPLETED|Overall Study||90
8208118|NCT02151058|20241184|P1|COMPLETED|Overall Study||43
8208119|NCT02151058|20241182|P3|STARTED|Overall Study||91
8208120|NCT02151058|20241183|P2|STARTED|Overall Study||91
8208121|NCT02151058|20241184|P1|STARTED|Overall Study||45
8208122|NCT02150954|20241218|P2|NOT COMPLETED|Overall Study||0
8208123|NCT02150954|20241219|P1|NOT COMPLETED|Overall Study||1
8208124|NCT02150954|20241218|P2|COMPLETED|Overall Study||59
8208125|NCT02150954|20241219|P1|COMPLETED|Overall Study||57
8208126|NCT02150954|20241218|P2|STARTED|Overall Study||59
8208127|NCT02150954|20241219|P1|STARTED|Overall Study||58
8208128|NCT02150863|20241244|P3|NOT COMPLETED|Overall Study||0
8208129|NCT02150863|20241245|P2|NOT COMPLETED|Overall Study||1
8208130|NCT02150863|20241246|P1|NOT COMPLETED|Overall Study||0
8208131|NCT02150863|20241244|P3|COMPLETED|Overall Study||0
8208132|NCT02150863|20241245|P2|COMPLETED|Overall Study||0
8208133|NCT02150863|20241246|P1|COMPLETED|Overall Study||0
8208134|NCT02150863|20241244|P3|STARTED|Overall Study||0
8208135|NCT02150863|20241245|P2|STARTED|Overall Study||1
8208136|NCT02150863|20241246|P1|STARTED|Overall Study||0
8208137|NCT02150837|20241256|P2|NOT COMPLETED|Overall Study||125
8208138|NCT02150837|20241257|P1|NOT COMPLETED|Overall Study||25
8208139|NCT02150837|20241256|P2|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185
8208140|NCT02150837|20241257|P1|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37
8208141|NCT02150837|20241256|P2|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310
8208142|NCT02150837|20241257|P1|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62
8208143|NCT02150759|20241429|P2|NOT COMPLETED|Overall Study||2
8208144|NCT02150759|20241430|P1|NOT COMPLETED|Overall Study||1
8208145|NCT02150759|20241429|P2|COMPLETED|Overall Study||21
8208146|NCT02150759|20241430|P1|COMPLETED|Overall Study||22
8208147|NCT02150759|20241429|P2|STARTED|Overall Study||23
8208148|NCT02150759|20241430|P1|STARTED|Overall Study||23
8208149|NCT02150499|20241440|P2|NOT COMPLETED|Overall Study||0
8208150|NCT02150499|20241441|P1|NOT COMPLETED|Overall Study||0
8208151|NCT02150499|20241440|P2|COMPLETED|Overall Study||9
8208152|NCT02150499|20241441|P1|COMPLETED|Overall Study||9
8208153|NCT02150499|20241440|P2|STARTED|Overall Study||9
8208154|NCT02150499|20241441|P1|STARTED|Overall Study||9
8208155|NCT02150460|20241463|P2|NOT COMPLETED|Overall Study||0
8208156|NCT02150460|20241464|P1|NOT COMPLETED|Overall Study||0
8208157|NCT02150460|20241463|P2|COMPLETED|Overall Study||50
8208158|NCT02150460|20241464|P1|COMPLETED|Overall Study||50
8208159|NCT02150460|20241463|P2|STARTED|Overall Study||50
8208160|NCT02150460|20241464|P1|STARTED|Overall Study||50
8208161|NCT02150343|20241492|P4|NOT COMPLETED|Overall Study||10
8208162|NCT02150343|20241493|P3|NOT COMPLETED|Overall Study||12
8208163|NCT02150343|20241494|P2|NOT COMPLETED|Overall Study||20
8208164|NCT02150343|20241495|P1|NOT COMPLETED|Overall Study||21
8208165|NCT02150343|20241492|P4|COMPLETED|Overall Study||168
8208166|NCT02150343|20241493|P3|COMPLETED|Overall Study||166
8208167|NCT02150343|20241494|P2|COMPLETED|Overall Study||158
8208168|NCT02150343|20241495|P1|COMPLETED|Overall Study||159
8208169|NCT02150343|20241492|P4|STARTED|Overall Study||178
8208170|NCT02150343|20241493|P3|STARTED|Overall Study||178
8208171|NCT02150343|20241494|P2|STARTED|Overall Study||178
8208172|NCT02150343|20241495|P1|STARTED|Overall Study||180
8208173|NCT02150213|20241533|P1|NOT COMPLETED|Overall Study||2
8208174|NCT02150213|20241533|P1|COMPLETED|Overall Study||57
8208175|NCT02150213|20241533|P1|STARTED|Overall Study||59
8208176|NCT02150109|20241538|P1|NOT COMPLETED|Overall Study||0
8208177|NCT02150109|20241538|P1|COMPLETED|Overall Study||372
8208178|NCT02150109|20241538|P1|STARTED|Overall Study||372
8208179|NCT02150057|20241552|P2|NOT COMPLETED|Overall Study||4
8208180|NCT02150057|20241553|P1|NOT COMPLETED|Overall Study||6
8208181|NCT02150057|20241552|P2|COMPLETED|Overall Study||22
8208182|NCT02150057|20241553|P1|COMPLETED|Overall Study||19
8208183|NCT02150057|20241552|P2|STARTED|Overall Study||26
8208184|NCT02150057|20241553|P1|STARTED|Overall Study||25
8208185|NCT02150044|20241559|P1|NOT COMPLETED|Overall Study||0
8208186|NCT02150044|20241559|P1|COMPLETED|Overall Study||29
8208187|NCT02150044|20241559|P1|Study Cohort|Overall Study||13
8208188|NCT02150044|20241559|P1|Lead-In Subjects|Overall Study||16
8208189|NCT02150044|20241559|P1|STARTED|Overall Study||29
8208190|NCT02149875|20241568|P3|NOT COMPLETED|Overall Study||9
8208191|NCT02149875|20241569|P2|NOT COMPLETED|Overall Study||8
8208192|NCT02149875|20241570|P1|NOT COMPLETED|Overall Study||7
8208193|NCT02149875|20241568|P3|COMPLETED|Overall Study||20
8208194|NCT02149875|20241569|P2|COMPLETED|Overall Study||20
8208195|NCT02149875|20241570|P1|COMPLETED|Overall Study||20
8208196|NCT02149875|20241568|P3|STARTED|Overall Study||29
8208197|NCT02149875|20241569|P2|STARTED|Overall Study||28
8208198|NCT02149875|20241570|P1|STARTED|Overall Study||27
8208199|NCT02149836|20241581|P1|NOT COMPLETED|Overall Study||1
8208200|NCT02149836|20241581|P1|COMPLETED|Overall Study||17
8208201|NCT02149836|20241581|P1|STARTED|Overall Study||18
8208202|NCT02149524|20241590|P2|NOT COMPLETED|Overall Study||57
8208203|NCT02149524|20241591|P1|NOT COMPLETED|Overall Study||54
8208204|NCT02149524|20241590|P2|COMPLETED|Overall Study||380
8208205|NCT02149524|20241591|P1|COMPLETED|Overall Study||384
8208206|NCT02149524|20241590|P2|STARTED|Overall Study||437
8208207|NCT02149524|20241591|P1|STARTED|Overall Study||438
8208208|NCT02149420|20241608|P3|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
8208209|NCT02149420|20241609|P2|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
8208210|NCT02149420|20241610|P1|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1
8208211|NCT02149420|20241608|P3|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
8208212|NCT02149420|20241609|P2|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
8208213|NCT02149420|20241610|P1|COMPLETED|Open Label VAY736 10 mg/kg Extension||4
8208214|NCT02149420|20241608|P3|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
8208215|NCT02149420|20241609|P2|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
8208216|NCT02149420|20241610|P1|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5
8208217|NCT02149420|20241608|P3|NOT COMPLETED|Core Study||2
8208218|NCT02149420|20241609|P2|NOT COMPLETED|Core Study||1
8208219|NCT02149420|20241610|P1|NOT COMPLETED|Core Study||0
8208220|NCT02149420|20241608|P3|COMPLETED|Core Study||10
8208221|NCT02149420|20241609|P2|COMPLETED|Core Study||5
8208222|NCT02149420|20241610|P1|COMPLETED|Core Study||9
8208223|NCT02149420|20241608|P3|PD (Pharmacodynamics) Analysis Set|Core Study||12
8208224|NCT02149420|20241609|P2|PD (Pharmacodynamics) Analysis Set|Core Study||6
8208225|NCT02149420|20241610|P1|PD (Pharmacodynamics) Analysis Set|Core Study||9
8208226|NCT02149420|20241608|P3|PK Analysis Set|Core Study||12
8208227|NCT02149420|20241609|P2|PK Analysis Set|Core Study||6
8208228|NCT02149420|20241610|P1|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5
8208229|NCT02149420|20241608|P3|Safety Analysis Set|Core Study||12
8208230|NCT02149420|20241609|P2|Safety Analysis Set|Core Study||6
8208231|NCT02149420|20241610|P1|Safety Analysis Set|Core Study||9
8208232|NCT02149420|20241608|P3|STARTED|Core Study||12
8208233|NCT02149420|20241609|P2|STARTED|Core Study||6
8208234|NCT02149420|20241610|P1|STARTED|Core Study||9
8208235|NCT02149342|20241660|P1|NOT COMPLETED|Overall Study||0
8208236|NCT02149342|20241660|P1|COMPLETED|Overall Study|14 patients|14
8208237|NCT02149342|20241660|P1|STARTED|Overall Study|14 patients|14
8208238|NCT02149303|20241672|P1|NOT COMPLETED|Overall Study||0
8208239|NCT02149303|20241672|P1|COMPLETED|Overall Study||191
8208240|NCT02149303|20241672|P1|STARTED|Overall Study||191
8208241|NCT02149290|20241678|P1|NOT COMPLETED|Overall Study||0
8208242|NCT02149290|20241678|P1|COMPLETED|Overall Study||198
8208243|NCT02149290|20241678|P1|STARTED|Overall Study||198
8208244|NCT02149264|20241686|P1|NOT COMPLETED|Overall Study||20
8208245|NCT02149264|20241686|P1|COMPLETED|Overall Study||139
8208246|NCT02149264|20241686|P1|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
8208247|NCT02149199|20241702|P3|NOT COMPLETED|Overall Study||147
8208248|NCT02149199|20241703|P2|NOT COMPLETED|Overall Study||193
8208249|NCT02149199|20241704|P1|NOT COMPLETED|Overall Study||133
8208250|NCT02149199|20241702|P3|COMPLETED|Overall Study||1135
8208251|NCT02149199|20241703|P2|COMPLETED|Overall Study||1084
8208252|NCT02149199|20241704|P1|COMPLETED|Overall Study||1144
8208253|NCT02149199|20241702|P3|STARTED|Overall Study||1282
8208254|NCT02149199|20241703|P2|STARTED|Overall Study||1277
8208255|NCT02149199|20241704|P1|STARTED|Overall Study||1277
8208259|NCT02149108|20241783|P2|NOT COMPLETED|Overall Study||383
8208260|NCT02149108|20241784|P1|NOT COMPLETED|Overall Study||380
8208261|NCT02149108|20241783|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
8208262|NCT02149108|20241784|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
8208263|NCT02149108|20241783|P2|STARTED|Overall Study|Randomised patients.|386
8208264|NCT02149108|20241784|P1|STARTED|Overall Study|Randomised patients.|382
8208265|NCT02148952|20241798|P2|NOT COMPLETED|Follow-Up||279
8208266|NCT02148952|20241799|P1|NOT COMPLETED|Follow-Up||265
8208267|NCT02148952|20241798|P2|COMPLETED|Follow-Up||77347
8208268|NCT02148952|20241799|P1|COMPLETED|Follow-Up||79798
8208269|NCT02148952|20241798|P2|STARTED|Follow-Up||77626
8208270|NCT02148952|20241799|P1|STARTED|Follow-Up||80063
8208271|NCT02148952|20241798|P2|NOT COMPLETED|Assessing Eligibility and Consent||3147
8208272|NCT02148952|20241799|P1|NOT COMPLETED|Assessing Eligibility and Consent||3103
8208273|NCT02148952|20241798|P2|COMPLETED|Assessing Eligibility and Consent||77626
8208274|NCT02148952|20241799|P1|COMPLETED|Assessing Eligibility and Consent||80063
8208275|NCT02148952|20241798|P2|STARTED|Assessing Eligibility and Consent||80773
8208276|NCT02148952|20241799|P1|STARTED|Assessing Eligibility and Consent||83166
8208277|NCT02148874|20241857|P2|NOT COMPLETED|Overall Study||2
8208278|NCT02148874|20241858|P1|NOT COMPLETED|Overall Study||7
8208279|NCT02148874|20241857|P2|COMPLETED|Overall Study||84
8208280|NCT02148874|20241858|P1|COMPLETED|Overall Study||194
8208281|NCT02148874|20241857|P2|STARTED|Overall Study||86
8208282|NCT02148874|20241858|P1|STARTED|Overall Study||201
8208283|NCT02148835|20241870|P2|NOT COMPLETED|Overall Study||0
8208284|NCT02148835|20241871|P1|NOT COMPLETED|Overall Study||0
8208285|NCT02148835|20241870|P2|COMPLETED|Overall Study||22
8208286|NCT02148835|20241871|P1|COMPLETED|Overall Study||22
8208287|NCT02148835|20241870|P2|STARTED|Overall Study||22
8208288|NCT02148835|20241871|P1|STARTED|Overall Study||22
8208289|NCT02148809|20241877|P1|NOT COMPLETED|Overall Study||0
8208290|NCT02148809|20241877|P1|COMPLETED|Overall Study||14
8208291|NCT02148809|20241877|P1|STARTED|Overall Study||14
8208292|NCT02148718|20241882|P1|NOT COMPLETED|Overall Study||31
8208293|NCT02148718|20241882|P1|COMPLETED|Overall Study||55
8208294|NCT02148718|20241882|P1|STARTED|Overall Study||86
8208295|NCT02148588|20241903|P1|NOT COMPLETED|Overall Study||0
8208296|NCT02148588|20241903|P1|COMPLETED|Overall Study||8
8208297|NCT02148588|20241903|P1|STARTED|Overall Study||8
8208298|NCT02148523|20241915|P3|NOT COMPLETED|Overall Study||0
8208299|NCT02148523|20241916|P2|NOT COMPLETED|Overall Study||0
8208300|NCT02148523|20241917|P1|NOT COMPLETED|Overall Study||0
8208301|NCT02148523|20241915|P3|COMPLETED|Overall Study||67
8208302|NCT02148523|20241916|P2|COMPLETED|Overall Study||67
8208303|NCT02148523|20241917|P1|COMPLETED|Overall Study||67
8208304|NCT02148523|20241915|P3|STARTED|Overall Study||67
8208305|NCT02148523|20241916|P2|STARTED|Overall Study||67
8208306|NCT02148523|20241917|P1|STARTED|Overall Study||67
8208307|NCT02148445|20241930|P2|NOT COMPLETED|Overall Study||3
8208308|NCT02148445|20241931|P1|NOT COMPLETED|Overall Study||1
8208309|NCT02148445|20241930|P2|COMPLETED|Overall Study||197
8208310|NCT02148445|20241931|P1|COMPLETED|Overall Study||197
8208311|NCT02148445|20241930|P2|STARTED|Overall Study||200
8208312|NCT02148445|20241931|P1|STARTED|Overall Study||198
8208313|NCT02148302|20241969|P2|NOT COMPLETED|Overall Study||0
8208314|NCT02148302|20241970|P1|NOT COMPLETED|Overall Study||0
8208315|NCT02148302|20241969|P2|COMPLETED|Overall Study||66
8208316|NCT02148302|20241970|P1|COMPLETED|Overall Study||57
8208317|NCT02148302|20241969|P2|STARTED|Overall Study||66
8208318|NCT02148302|20241970|P1|STARTED|Overall Study||57
8208319|NCT02148250|20241982|P2|NOT COMPLETED|Period 2||0
8208320|NCT02148250|20241983|P1|NOT COMPLETED|Period 2||0
8208321|NCT02148250|20241982|P2|COMPLETED|Period 2||6
8208322|NCT02148250|20241983|P1|COMPLETED|Period 2||6
8208323|NCT02148250|20241982|P2|STARTED|Period 2||6
8208324|NCT02148250|20241983|P1|STARTED|Period 2||6
8208325|NCT02148250|20241982|P2|NOT COMPLETED|Period 1||0
8208326|NCT02148250|20241983|P1|NOT COMPLETED|Period 1||0
8208327|NCT02148250|20241982|P2|COMPLETED|Period 1||6
8208328|NCT02148250|20241983|P1|COMPLETED|Period 1||6
8208329|NCT02148250|20241982|P2|STARTED|Period 1||6
8208330|NCT02148250|20241983|P1|STARTED|Period 1||6
8208331|NCT02148250|20241982|P2|NOT COMPLETED|Screening||0
8208332|NCT02148250|20241983|P1|NOT COMPLETED|Screening||5
8208333|NCT02148250|20241982|P2|COMPLETED|Screening||0
8208334|NCT02148250|20241983|P1|COMPLETED|Screening||12
8208335|NCT02148250|20241982|P2|STARTED|Screening||0
8208336|NCT02148250|20241983|P1|STARTED|Screening||17
8208337|NCT02148211|20241997|P1|NOT COMPLETED|Overall Study||352
8208338|NCT02148211|20241997|P1|COMPLETED|Overall Study||155
8208339|NCT02148211|20241997|P1|STARTED|Overall Study||507
8208340|NCT02148133|20242006|P1|NOT COMPLETED|Overall Study||5
8208341|NCT02148133|20242006|P1|COMPLETED|Overall Study||16
8208342|NCT02148133|20242006|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||21
8208343|NCT02148133|20242006|P1|Safety Set (SS)|Overall Study||21
8208344|NCT02148133|20242006|P1|STARTED|Overall Study||21
8208345|NCT02148107|20242028|P3|NOT COMPLETED|Overall Study||0
8208346|NCT02148107|20242029|P2|NOT COMPLETED|Overall Study||0
8208347|NCT02148107|20242030|P1|NOT COMPLETED|Overall Study||0
8208348|NCT02148107|20242028|P3|COMPLETED|Overall Study||3
8208349|NCT02148107|20242029|P2|COMPLETED|Overall Study||7
8208350|NCT02148107|20242030|P1|COMPLETED|Overall Study||8
8208351|NCT02148107|20242028|P3|STARTED|Overall Study||3
8208352|NCT02148107|20242029|P2|STARTED|Overall Study||7
8208353|NCT02148107|20242030|P1|STARTED|Overall Study||8
8208354|NCT02147990|20242049|P3|NOT COMPLETED|Overall Study||0
8208355|NCT02147990|20242050|P2|NOT COMPLETED|Overall Study||0
8208356|NCT02147990|20242051|P1|NOT COMPLETED|Overall Study||0
8208357|NCT02147990|20242049|P3|COMPLETED|Overall Study||63
8208358|NCT02147990|20242050|P2|COMPLETED|Overall Study||100
8208359|NCT02147990|20242051|P1|COMPLETED|Overall Study||154
8208360|NCT02147990|20242049|P3|STARTED|Overall Study||63
8208361|NCT02147990|20242050|P2|STARTED|Overall Study||100
8208362|NCT02147990|20242051|P1|STARTED|Overall Study||154
8208363|NCT02147899|20242116|P3|NOT COMPLETED|Overall Study||0
8208364|NCT02147899|20242117|P2|NOT COMPLETED|Overall Study||0
8208365|NCT02147899|20242118|P1|NOT COMPLETED|Overall Study||0
8208366|NCT02147899|20242116|P3|COMPLETED|Overall Study||72
8208367|NCT02147899|20242117|P2|COMPLETED|Overall Study||72
8208368|NCT02147899|20242118|P1|COMPLETED|Overall Study||71
8208369|NCT02147899|20242116|P3|STARTED|Overall Study||72
8208370|NCT02147899|20242117|P2|STARTED|Overall Study||72
8208371|NCT02147899|20242118|P1|STARTED|Overall Study||71
8208372|NCT02147834|20242137|P2|NOT COMPLETED|Overall Study||0
8208373|NCT02147834|20242138|P1|NOT COMPLETED|Overall Study||0
8208374|NCT02147834|20242137|P2|COMPLETED|Overall Study||2
8208375|NCT02147834|20242138|P1|COMPLETED|Overall Study||3
8208376|NCT02147834|20242137|P2|STARTED|Overall Study||2
8208377|NCT02147834|20242138|P1|STARTED|Overall Study||3
8208378|NCT02147769|20242148|P1|NOT COMPLETED|Overall Study||0
8208379|NCT02147769|20242148|P1|COMPLETED|Overall Study||111
8208380|NCT02147769|20242148|P1|STARTED|Overall Study||111
8208381|NCT02147691|20242155|P2|NOT COMPLETED|Overall Study||1
8208382|NCT02147691|20242156|P1|NOT COMPLETED|Overall Study||4
8208383|NCT02147691|20242155|P2|COMPLETED|Overall Study||11
8208384|NCT02147691|20242156|P1|COMPLETED|Overall Study||6
8208385|NCT02147691|20242155|P2|STARTED|Overall Study||12
8208386|NCT02147691|20242156|P1|STARTED|Overall Study||10
8208387|NCT02147613|20242202|P2|NOT COMPLETED|Overall Study||3
8208388|NCT02147613|20242203|P1|NOT COMPLETED|Overall Study||1
8208389|NCT02147613|20242202|P2|COMPLETED|Overall Study||6
8208390|NCT02147613|20242203|P1|COMPLETED|Overall Study||9
8208391|NCT02147613|20242202|P2|STARTED|Overall Study||9
8208392|NCT02147613|20242203|P1|STARTED|Overall Study||10
8208393|NCT02147587|20242215|P2|NOT COMPLETED|Overall Study||5
8208394|NCT02147587|20242216|P1|NOT COMPLETED|Overall Study||11
8208395|NCT02147587|20242215|P2|COMPLETED|Overall Study||50
8208396|NCT02147587|20242216|P1|COMPLETED|Overall Study||46
8208397|NCT02147587|20242215|P2|STARTED|Overall Study||55
8208398|NCT02147587|20242216|P1|STARTED|Overall Study||57
8208399|NCT02147561|20242236|P1|NOT COMPLETED|Overall Study||4
8208400|NCT02147561|20242236|P1|COMPLETED|Overall Study||276
8208401|NCT02147561|20242236|P1|STARTED|Overall Study||280
8208402|NCT02147522|20242244|P2|NOT COMPLETED|Overall Study||48
8208403|NCT02147522|20242245|P1|NOT COMPLETED|Overall Study||56
8208404|NCT02147522|20242244|P2|COMPLETED|Overall Study||122
8208405|NCT02147522|20242245|P1|COMPLETED|Overall Study||122
8208406|NCT02147522|20242244|P2|STARTED|Overall Study||170
8208407|NCT02147522|20242245|P1|STARTED|Overall Study||178
8208408|NCT02147353|20242257|P2|NOT COMPLETED|Overall Study||0
8208409|NCT02147353|20242258|P1|NOT COMPLETED|Overall Study||9
8208410|NCT02147353|20242257|P2|COMPLETED|Overall Study||21
8208411|NCT02147353|20242258|P1|COMPLETED|Overall Study||12
8208412|NCT02147353|20242257|P2|STARTED|Overall Study||21
8208413|NCT02147353|20242258|P1|STARTED|Overall Study||21
8208414|NCT02147301|20242276|P1|NOT COMPLETED|Overall Study||0
8208415|NCT02147301|20242276|P1|COMPLETED|Overall Study||17
8208416|NCT02147301|20242276|P1|STARTED|Overall Study||17
8208417|NCT02147288|20242291|P10|NOT COMPLETED|Overall Study||0
8208418|NCT02147288|20242292|P9|NOT COMPLETED|Overall Study||0
8208419|NCT02147288|20242293|P8|NOT COMPLETED|Overall Study||0
8208420|NCT02147288|20242294|P7|NOT COMPLETED|Overall Study||0
8208421|NCT02147288|20242295|P6|NOT COMPLETED|Overall Study||0
8208422|NCT02147288|20242296|P5|NOT COMPLETED|Overall Study||0
8208423|NCT02147288|20242297|P4|NOT COMPLETED|Overall Study||0
8208424|NCT02147288|20242298|P3|NOT COMPLETED|Overall Study||0
8208425|NCT02147288|20242299|P2|NOT COMPLETED|Overall Study||2
8208426|NCT02147288|20242300|P1|NOT COMPLETED|Overall Study||1
8208427|NCT02147288|20242291|P10|COMPLETED|Overall Study||0
8208428|NCT02147288|20242292|P9|COMPLETED|Overall Study||0
8208429|NCT02147288|20242293|P8|COMPLETED|Overall Study||0
8208430|NCT02147288|20242294|P7|COMPLETED|Overall Study||0
8208431|NCT02147288|20242295|P6|COMPLETED|Overall Study||0
8208432|NCT02147288|20242296|P5|COMPLETED|Overall Study||0
8208433|NCT02147288|20242297|P4|COMPLETED|Overall Study||0
8208434|NCT02147288|20242298|P3|COMPLETED|Overall Study||0
8208435|NCT02147288|20242299|P2|COMPLETED|Overall Study||22
8208436|NCT02147288|20242300|P1|COMPLETED|Overall Study||21
8208437|NCT02147288|20242291|P10|STARTED|Overall Study||0
8208438|NCT02147288|20242292|P9|STARTED|Overall Study||0
8208439|NCT02147288|20242293|P8|STARTED|Overall Study||0
8208440|NCT02147288|20242294|P7|STARTED|Overall Study||0
8208441|NCT02147288|20242295|P6|STARTED|Overall Study||0
8208442|NCT02147288|20242296|P5|STARTED|Overall Study||0
8208443|NCT02147288|20242297|P4|STARTED|Overall Study||0
8208444|NCT02147288|20242298|P3|STARTED|Overall Study||0
8208445|NCT02147288|20242299|P2|STARTED|Overall Study||24
8208446|NCT02147288|20242300|P1|STARTED|Overall Study||22
8208447|NCT02147197|20242309|P3|NOT COMPLETED|Overall Study||9
8208448|NCT02147197|20242310|P2|NOT COMPLETED|Overall Study||6
8208449|NCT02147197|20242311|P1|NOT COMPLETED|Overall Study||9
8208450|NCT02147197|20242309|P3|COMPLETED|Overall Study||39
8208451|NCT02147197|20242310|P2|COMPLETED|Overall Study||47
8208452|NCT02147197|20242311|P1|COMPLETED|Overall Study||47
8208453|NCT02147197|20242309|P3|STARTED|Overall Study||48
8208454|NCT02147197|20242310|P2|STARTED|Overall Study||53
8208455|NCT02147197|20242311|P1|STARTED|Overall Study||56
8208456|NCT02147184|20242330|P2|NOT COMPLETED|Overall Study||27
8208457|NCT02147184|20242331|P1|NOT COMPLETED|Overall Study||49
8208458|NCT02147184|20242330|P2|COMPLETED|Overall Study||110
8208459|NCT02147184|20242331|P1|COMPLETED|Overall Study||78
8208460|NCT02147184|20242330|P2|STARTED|Overall Study||137
8208461|NCT02147184|20242331|P1|STARTED|Overall Study||127
8208462|NCT02147158|20242355|P6|NOT COMPLETED|Off-Treatment Interval 2||4
8208463|NCT02147158|20242356|P5|NOT COMPLETED|Off-Treatment Interval 2||2
8208464|NCT02147158|20242357|P4|NOT COMPLETED|Off-Treatment Interval 2||11
8208465|NCT02147158|20242358|P3|NOT COMPLETED|Off-Treatment Interval 2||10
8208466|NCT02147158|20242359|P2|NOT COMPLETED|Off-Treatment Interval 2||4
8208467|NCT02147158|20242360|P1|NOT COMPLETED|Off-Treatment Interval 2||4
8208468|NCT02147158|20242355|P6|COMPLETED|Off-Treatment Interval 2||39
8208469|NCT02147158|20242356|P5|COMPLETED|Off-Treatment Interval 2||39
8208470|NCT02147158|20242357|P4|COMPLETED|Off-Treatment Interval 2||66
8208471|NCT02147158|20242358|P3|COMPLETED|Off-Treatment Interval 2||69
8208472|NCT02147158|20242359|P2|COMPLETED|Off-Treatment Interval 2||25
8208473|NCT02147158|20242360|P1|COMPLETED|Off-Treatment Interval 2||36
8208474|NCT02147158|20242355|P6|STARTED|Off-Treatment Interval 2||43
8208475|NCT02147158|20242356|P5|STARTED|Off-Treatment Interval 2||41
8208476|NCT02147158|20242357|P4|STARTED|Off-Treatment Interval 2||77
8208477|NCT02147158|20242358|P3|STARTED|Off-Treatment Interval 2||79
8208478|NCT02147158|20242359|P2|STARTED|Off-Treatment Interval 2||29
8208479|NCT02147158|20242360|P1|STARTED|Off-Treatment Interval 2||40
8208480|NCT02147158|20242355|P6|NOT COMPLETED|Treatment Course 2||2
8208481|NCT02147158|20242356|P5|NOT COMPLETED|Treatment Course 2||0
8208482|NCT02147158|20242357|P4|NOT COMPLETED|Treatment Course 2||5
8208483|NCT02147158|20242358|P3|NOT COMPLETED|Treatment Course 2||5
8208484|NCT02147158|20242359|P2|NOT COMPLETED|Treatment Course 2||5
8208485|NCT02147158|20242360|P1|NOT COMPLETED|Treatment Course 2||1
8208486|NCT02147158|20242355|P6|COMPLETED|Treatment Course 2||43
8208487|NCT02147158|20242356|P5|COMPLETED|Treatment Course 2||41
8208488|NCT02147158|20242357|P4|COMPLETED|Treatment Course 2||77
8208489|NCT02147158|20242358|P3|COMPLETED|Treatment Course 2||79
8208490|NCT02147158|20242359|P2|COMPLETED|Treatment Course 2||29
8208491|NCT02147158|20242360|P1|COMPLETED|Treatment Course 2||40
8208492|NCT02147158|20242355|P6|STARTED|Treatment Course 2||45
8208493|NCT02147158|20242356|P5|STARTED|Treatment Course 2||41
8208494|NCT02147158|20242357|P4|STARTED|Treatment Course 2||82
8208495|NCT02147158|20242358|P3|STARTED|Treatment Course 2||84
8208496|NCT02147158|20242359|P2|STARTED|Treatment Course 2||34
8208497|NCT02147158|20242360|P1|STARTED|Treatment Course 2||41
8208498|NCT02147158|20242355|P6|NOT COMPLETED|Off-Treatment Interval 1||5
8208499|NCT02147158|20242356|P5|NOT COMPLETED|Off-Treatment Interval 1||8
8208500|NCT02147158|20242357|P4|NOT COMPLETED|Off-Treatment Interval 1||15
8208501|NCT02147158|20242358|P3|NOT COMPLETED|Off-Treatment Interval 1||15
8208502|NCT02147158|20242359|P2|NOT COMPLETED|Off-Treatment Interval 1||4
8208503|NCT02147158|20242360|P1|NOT COMPLETED|Off-Treatment Interval 1||10
8208504|NCT02147158|20242355|P6|COMPLETED|Off-Treatment Interval 1||45
8208505|NCT02147158|20242356|P5|COMPLETED|Off-Treatment Interval 1||41
8208506|NCT02147158|20242357|P4|COMPLETED|Off-Treatment Interval 1||82
8208507|NCT02147158|20242358|P3|COMPLETED|Off-Treatment Interval 1||84
8208508|NCT02147158|20242359|P2|COMPLETED|Off-Treatment Interval 1||34
8208509|NCT02147158|20242360|P1|COMPLETED|Off-Treatment Interval 1||41
8208510|NCT02147158|20242355|P6|STARTED|Off-Treatment Interval 1||50
8208511|NCT02147158|20242356|P5|STARTED|Off-Treatment Interval 1||49
8208512|NCT02147158|20242357|P4|STARTED|Off-Treatment Interval 1||97
8208513|NCT02147158|20242358|P3|STARTED|Off-Treatment Interval 1||99
8208514|NCT02147158|20242359|P2|STARTED|Off-Treatment Interval 1||38
8208515|NCT02147158|20242360|P1|STARTED|Off-Treatment Interval 1||51
8208516|NCT02147158|20242355|P6|NOT COMPLETED|Treatment Course 1||8
8208517|NCT02147158|20242356|P5|NOT COMPLETED|Treatment Course 1||6
8208518|NCT02147158|20242357|P4|NOT COMPLETED|Treatment Course 1||13
8208519|NCT02147158|20242358|P3|NOT COMPLETED|Treatment Course 1||8
8208520|NCT02147158|20242359|P2|NOT COMPLETED|Treatment Course 1||9
8208521|NCT02147158|20242360|P1|NOT COMPLETED|Treatment Course 1||4
8208522|NCT02147158|20242355|P6|COMPLETED|Treatment Course 1||50
8208523|NCT02147158|20242356|P5|COMPLETED|Treatment Course 1||49
8208524|NCT02147158|20242357|P4|COMPLETED|Treatment Course 1||97
8208525|NCT02147158|20242358|P3|COMPLETED|Treatment Course 1||99
8208526|NCT02147158|20242359|P2|COMPLETED|Treatment Course 1||38
8208527|NCT02147158|20242360|P1|COMPLETED|Treatment Course 1||51
8208528|NCT02147158|20242355|P6|STARTED|Treatment Course 1||58
8208529|NCT02147158|20242356|P5|STARTED|Treatment Course 1||55
8208530|NCT02147158|20242357|P4|STARTED|Treatment Course 1||110
8208531|NCT02147158|20242358|P3|STARTED|Treatment Course 1||107
8208532|NCT02147158|20242359|P2|STARTED|Treatment Course 1||47
8208533|NCT02147158|20242360|P1|STARTED|Treatment Course 1||55
8208534|NCT02147132|20242389|P4|NOT COMPLETED|Overall Study||0
8208535|NCT02147132|20242390|P3|NOT COMPLETED|Overall Study||0
8208536|NCT02147132|20242391|P2|NOT COMPLETED|Overall Study||0
8208537|NCT02147132|20242392|P1|NOT COMPLETED|Overall Study||1
8208538|NCT02147132|20242389|P4|COMPLETED|Overall Study||2
8208539|NCT02147132|20242390|P3|COMPLETED|Overall Study||1
8208540|NCT02147132|20242391|P2|COMPLETED|Overall Study||2
8208541|NCT02147132|20242392|P1|COMPLETED|Overall Study||1
8208542|NCT02147132|20242389|P4|STARTED|Overall Study||2
8208543|NCT02147132|20242390|P3|STARTED|Overall Study||1
8208544|NCT02147132|20242391|P2|STARTED|Overall Study||2
8208545|NCT02147132|20242392|P1|STARTED|Overall Study||2
8208546|NCT02147093|20242412|P2|NOT COMPLETED|Period 2||0
8208547|NCT02147093|20242413|P1|NOT COMPLETED|Period 2||2
8208548|NCT02147093|20242412|P2|COMPLETED|Period 2||19
8208549|NCT02147093|20242413|P1|COMPLETED|Period 2||18
8208550|NCT02147093|20242412|P2|STARTED|Period 2||19
8208551|NCT02147093|20242413|P1|STARTED|Period 2||20
8208552|NCT02147093|20242412|P2|NOT COMPLETED|Period 1||1
8208553|NCT02147093|20242413|P1|NOT COMPLETED|Period 1||0
8208554|NCT02147093|20242412|P2|COMPLETED|Period 1||19
8208555|NCT02147093|20242413|P1|COMPLETED|Period 1||20
8208556|NCT02147093|20242412|P2|STARTED|Period 1||20
8208557|NCT02147093|20242413|P1|STARTED|Period 1||20
8208558|NCT02147067|20242423|P2|NOT COMPLETED|Overall Study||2
8208559|NCT02147067|20242424|P1|NOT COMPLETED|Overall Study||2
8208560|NCT02147067|20242423|P2|COMPLETED|Overall Study||11
8208561|NCT02147067|20242424|P1|COMPLETED|Overall Study||11
8208562|NCT02147067|20242423|P2|STARTED|Overall Study||13
8208563|NCT02147067|20242424|P1|STARTED|Overall Study||13
8208564|NCT02146833|20242450|P1|NOT COMPLETED|Overall Study||11
8208565|NCT02146833|20242450|P1|COMPLETED|Overall Study||9
8208566|NCT02146833|20242450|P1|STARTED|Overall Study||20
8208567|NCT02146599|20242462|P1|NOT COMPLETED|Overall Study||5
8208568|NCT02146599|20242462|P1|COMPLETED|Overall Study||296
8208569|NCT02146599|20242462|P1|STARTED|Overall Study||301
8208570|NCT02146482|20242468|P2|NOT COMPLETED|Overall Study||0
8208571|NCT02146482|20242469|P1|NOT COMPLETED|Overall Study||0
8208572|NCT02146482|20242468|P2|COMPLETED|Overall Study||25
8208573|NCT02146482|20242469|P1|COMPLETED|Overall Study||21
8208574|NCT02146482|20242468|P2|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
8208575|NCT02146482|20242469|P1|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
8208576|NCT02146430|20242479|P4|NOT COMPLETED|Overall Study||99
8208577|NCT02146430|20242480|P3|NOT COMPLETED|Overall Study||82
8208578|NCT02146430|20242481|P2|NOT COMPLETED|Overall Study||87
8208579|NCT02146430|20242482|P1|NOT COMPLETED|Overall Study||67
8208580|NCT02146430|20242479|P4|COMPLETED|Overall Study||224
8208581|NCT02146430|20242480|P3|COMPLETED|Overall Study||242
8208582|NCT02146430|20242481|P2|COMPLETED|Overall Study||236
8208583|NCT02146430|20242482|P1|COMPLETED|Overall Study||256
8208584|NCT02146430|20242479|P4|Modified Intent to Treat Set (mITT)|Overall Study||319
8208585|NCT02146430|20242480|P3|Modified Intent to Treat Set (mITT)|Overall Study||319
8208586|NCT02146430|20242481|P2|Modified Intent to Treat Set (mITT)|Overall Study||317
8208587|NCT02146430|20242482|P1|Modified Intent to Treat Set (mITT)|Overall Study||318
8208588|NCT02146430|20242479|P4|Safety Analysis Set|Overall Study||320
8208589|NCT02146430|20242480|P3|Safety Analysis Set|Overall Study||320
8208590|NCT02146430|20242481|P2|Safety Analysis Set|Overall Study||318
8208591|NCT02146430|20242482|P1|Safety Analysis Set|Overall Study||318
8208592|NCT02146430|20242479|P4|STARTED|Overall Study||323
8208593|NCT02146430|20242480|P3|STARTED|Overall Study||324
8208594|NCT02146430|20242481|P2|STARTED|Overall Study||323
8208595|NCT02146430|20242482|P1|STARTED|Overall Study||323
8208596|NCT02146365|20242542|P8|NOT COMPLETED|Overall Study||1
8208597|NCT02146365|20242543|P7|NOT COMPLETED|Overall Study||0
8208598|NCT02146365|20242544|P6|NOT COMPLETED|Overall Study||1
8208599|NCT02146365|20242545|P5|NOT COMPLETED|Overall Study||2
8208600|NCT02146365|20242546|P4|NOT COMPLETED|Overall Study||9
8208601|NCT02146365|20242547|P3|NOT COMPLETED|Overall Study||7
8208602|NCT02146365|20242548|P2|NOT COMPLETED|Overall Study||4
8208603|NCT02146365|20242549|P1|NOT COMPLETED|Overall Study||4
8208604|NCT02146365|20242542|P8|COMPLETED|Overall Study||24
8208605|NCT02146365|20242543|P7|COMPLETED|Overall Study||25
8208606|NCT02146365|20242544|P6|COMPLETED|Overall Study||24
8208607|NCT02146365|20242545|P5|COMPLETED|Overall Study||22
8208608|NCT02146365|20242546|P4|COMPLETED|Overall Study||41
8208609|NCT02146365|20242547|P3|COMPLETED|Overall Study||43
8208610|NCT02146365|20242548|P2|COMPLETED|Overall Study||45
8208611|NCT02146365|20242549|P1|COMPLETED|Overall Study||45
8208612|NCT02146365|20242542|P8|STARTED|Overall Study||25
8208613|NCT02146365|20242543|P7|STARTED|Overall Study||25
8208614|NCT02146365|20242544|P6|STARTED|Overall Study||25
8208615|NCT02146365|20242545|P5|STARTED|Overall Study||24
8208616|NCT02146365|20242546|P4|STARTED|Overall Study||50
8208617|NCT02146365|20242547|P3|STARTED|Overall Study||50
8208618|NCT02146365|20242548|P2|STARTED|Overall Study||49
8208619|NCT02146365|20242549|P1|STARTED|Overall Study||49
8208620|NCT02146352|20242675|P1|NOT COMPLETED|Overall Study||2
8208621|NCT02146352|20242675|P1|COMPLETED|Overall Study||28
8208622|NCT02146352|20242675|P1|7 Days Post-stent Removal|Overall Study||28
8208623|NCT02146352|20242675|P1|30 or 60 Days Post-procedure|Overall Study||30
8208624|NCT02146352|20242675|P1|STARTED|Overall Study||30
8208625|NCT02146326|20242693|P4|NOT COMPLETED|Overall Study||48
8208626|NCT02146326|20242694|P3|NOT COMPLETED|Overall Study||43
8208627|NCT02146326|20242695|P2|NOT COMPLETED|Overall Study||37
8208628|NCT02146326|20242696|P1|NOT COMPLETED|Overall Study||28
8208629|NCT02146326|20242693|P4|COMPLETED|Overall Study||210
8208630|NCT02146326|20242694|P3|COMPLETED|Overall Study||168
8208631|NCT02146326|20242695|P2|COMPLETED|Overall Study||66
8208632|NCT02146326|20242696|P1|COMPLETED|Overall Study||61
8208633|NCT02146326|20242693|P4|12 Months|Overall Study||210
8208634|NCT02146326|20242694|P3|12 Months|Overall Study||168
8208635|NCT02146326|20242695|P2|12 Months|Overall Study||66
8208636|NCT02146326|20242696|P1|12 Months|Overall Study||61
8208637|NCT02146326|20242693|P4|6 Months|Overall Study||235
8208638|NCT02146326|20242694|P3|6 Months|Overall Study||186
8208639|NCT02146326|20242695|P2|6 Months|Overall Study||71
8208640|NCT02146326|20242696|P1|6 Months|Overall Study||71
8208641|NCT02146326|20242693|P4|3 Months|Overall Study||0
8208642|NCT02146326|20242694|P3|3 Months|Overall Study||0
8208643|NCT02146326|20242695|P2|3 Months|Overall Study||83
8208644|NCT02146326|20242696|P1|3 Months|Overall Study||71
8208645|NCT02146326|20242693|P4|Baseline|Overall Study||258
8208646|NCT02146326|20242694|P3|Baseline|Overall Study||211
8208647|NCT02146326|20242695|P2|Baseline|Overall Study||103
8208648|NCT02146326|20242696|P1|Baseline|Overall Study||89
8208649|NCT02146326|20242693|P4|STARTED|Overall Study||258
8208650|NCT02146326|20242694|P3|STARTED|Overall Study||211
8208651|NCT02146326|20242695|P2|STARTED|Overall Study||103
8208652|NCT02146326|20242696|P1|STARTED|Overall Study||89
8208653|NCT02146274|20242858|P1|NOT COMPLETED|Overall Study||73
8208654|NCT02146274|20242858|P1|COMPLETED|Overall Study||1804
8208655|NCT02146274|20242858|P1|STARTED|Overall Study||1877
8208656|NCT02146248|20242865|P1|NOT COMPLETED|Overall Study||2
8208657|NCT02146248|20242865|P1|COMPLETED|Overall Study||9
8208658|NCT02146248|20242865|P1|HSG 5|Overall Study||1
8208659|NCT02146248|20242865|P1|HSG 4|Overall Study||7
8208660|NCT02146248|20242865|P1|HSG 3|Overall Study||9
8208661|NCT02146248|20242865|P1|HSG 2|Overall Study||10
8208662|NCT02146248|20242865|P1|HSG 1|Overall Study||10
8208663|NCT02146248|20242865|P1|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
8208664|NCT02146248|20242865|P1|Enrolled|Overall Study||11
8208665|NCT02146248|20242865|P1|STARTED|Overall Study||11
8208666|NCT02146131|20242875|P2|NOT COMPLETED|Overall Study||56
8208667|NCT02146131|20242876|P1|NOT COMPLETED|Overall Study||61
8208668|NCT02146131|20242875|P2|COMPLETED|Overall Study||113
8208669|NCT02146131|20242876|P1|COMPLETED|Overall Study||109
8208670|NCT02146131|20242875|P2|STARTED|Overall Study||169
8208671|NCT02146131|20242876|P1|STARTED|Overall Study||170
8208672|NCT02146105|20242882|P1|NOT COMPLETED|Overall Study||6
8208673|NCT02146105|20242882|P1|COMPLETED|Overall Study||39
8208674|NCT02146105|20242882|P1|STARTED|Overall Study||45
8208675|NCT02146001|20242888|P2|NOT COMPLETED|Overall Study||0
8208676|NCT02146001|20242889|P1|NOT COMPLETED|Overall Study||0
8208677|NCT02146001|20242888|P2|COMPLETED|Overall Study||19
8208678|NCT02146001|20242889|P1|COMPLETED|Overall Study||19
8208679|NCT02146001|20242888|P2|STARTED|Overall Study||19
8208680|NCT02146001|20242889|P1|STARTED|Overall Study||19
8208681|NCT02145754|20242899|P1|NOT COMPLETED|Overall Study||0
8208682|NCT02145754|20242899|P1|COMPLETED|Overall Study||235
8208683|NCT02145754|20242899|P1|STARTED|Overall Study||235
8208684|NCT02145676|20242906|P3|NOT COMPLETED|Overall Study||0
8208685|NCT02145676|20242907|P2|NOT COMPLETED|Overall Study||0
8208686|NCT02145676|20242908|P1|NOT COMPLETED|Overall Study||0
8208687|NCT02145676|20242906|P3|COMPLETED|Overall Study||18
8208688|NCT02145676|20242907|P2|COMPLETED|Overall Study||18
8208689|NCT02145676|20242908|P1|COMPLETED|Overall Study||17
8208690|NCT02145676|20242906|P3|STARTED|Overall Study||18
8208691|NCT02145676|20242907|P2|STARTED|Overall Study||18
8208692|NCT02145676|20242908|P1|STARTED|Overall Study||17
8208693|NCT02145468|20242933|P2|NOT COMPLETED|Overall Study||8
8208694|NCT02145468|20242934|P1|NOT COMPLETED|Overall Study||5
8208695|NCT02145468|20242933|P2|COMPLETED|Overall Study||1723
8208696|NCT02145468|20242934|P1|COMPLETED|Overall Study||1753
8208697|NCT02145468|20242933|P2|STARTED|Overall Study||1731
8208698|NCT02145468|20242934|P1|STARTED|Overall Study||1758
8208699|NCT02145429|20242992|P2|NOT COMPLETED|Overall Study||11
8208700|NCT02145429|20242993|P1|NOT COMPLETED|Overall Study||16
8208701|NCT02145429|20242992|P2|COMPLETED|Overall Study||79
8208702|NCT02145429|20242993|P1|COMPLETED|Overall Study||75
8208703|NCT02145429|20242992|P2|STARTED|Overall Study||90
8208704|NCT02145429|20242993|P1|STARTED|Overall Study||91
8208765|NCT02145390|20243024|P1|NOT COMPLETED|Overall Study||1
8208766|NCT02145390|20243024|P1|COMPLETED|Overall Study||0
8208767|NCT02145390|20243024|P1|STARTED|Overall Study||1
8208768|NCT02145299|20243035|P2|NOT COMPLETED|Overall Study||0
8208769|NCT02145299|20243036|P1|NOT COMPLETED|Overall Study||0
8208770|NCT02145299|20243035|P2|COMPLETED|Overall Study||2
8208771|NCT02145299|20243036|P1|COMPLETED|Overall Study||6
8208772|NCT02145299|20243035|P2|STARTED|Overall Study||2
8208773|NCT02145299|20243036|P1|STARTED|Overall Study||6
8208774|NCT02145247|20243064|P2|NOT COMPLETED|Overall Study||0
8208775|NCT02145247|20243065|P1|NOT COMPLETED|Overall Study||0
8208776|NCT02145247|20243064|P2|COMPLETED|Overall Study||19
8208777|NCT02145247|20243065|P1|COMPLETED|Overall Study||20
8208778|NCT02145247|20243064|P2|STARTED|Overall Study||19
8208779|NCT02145247|20243065|P1|STARTED|Overall Study||20
8208780|NCT02145182|20243073|P2|NOT COMPLETED|Overall Study||16
8208781|NCT02145182|20243074|P1|NOT COMPLETED|Overall Study||18
8208782|NCT02145182|20243073|P2|COMPLETED|Overall Study||130
8208783|NCT02145182|20243074|P1|COMPLETED|Overall Study||124
8208784|NCT02145182|20243073|P2|Received at Least 1 Dose of Study Drug|Overall Study||146
8208785|NCT02145182|20243074|P1|Received at Least 1 Dose of Study Drug|Overall Study||142
8208786|NCT02145182|20243073|P2|STARTED|Overall Study||146
8208787|NCT02145182|20243074|P1|STARTED|Overall Study||142
8208788|NCT02145169|20243088|P1|NOT COMPLETED|Overall Study||0
8208789|NCT02145169|20243088|P1|COMPLETED|Overall Study||0
8208790|NCT02145169|20243088|P1|STARTED|Overall Study||0
8208791|NCT02145156|20243107|P3|NOT COMPLETED|Overall Study||41
8208792|NCT02145156|20243108|P2|NOT COMPLETED|Overall Study||52
8208793|NCT02145156|20243109|P1|NOT COMPLETED|Overall Study||60
8208794|NCT02145156|20243107|P3|COMPLETED|Overall Study||398
8208795|NCT02145156|20243108|P2|COMPLETED|Overall Study||373
8208796|NCT02145156|20243109|P1|COMPLETED|Overall Study||370
8208797|NCT02145156|20243107|P3|STARTED|Overall Study||439
8208798|NCT02145156|20243108|P2|STARTED|Overall Study||425
8208799|NCT02145156|20243109|P1|STARTED|Overall Study||430
8208800|NCT02145078|20243150|P1|NOT COMPLETED|Overall Study||4
8208801|NCT02145078|20243150|P1|COMPLETED|Overall Study||0
8208802|NCT02145078|20243150|P1|STARTED|Overall Study||4
8208803|NCT02145039|20243158|P1|NOT COMPLETED|Overall Study||0
8208804|NCT02145039|20243158|P1|COMPLETED|Overall Study||2
8208805|NCT02145039|20243158|P1|STARTED|Overall Study||2
8208806|NCT02145026|20243167|P1|NOT COMPLETED|Overall Study||12
8208807|NCT02145026|20243167|P1|COMPLETED|Overall Study||88
8208808|NCT02145026|20243167|P1|STARTED|Overall Study||100
8208809|NCT02144714|20243177|P3|NOT COMPLETED|Overall Study||0
8208810|NCT02144714|20243178|P2|NOT COMPLETED|Overall Study||0
8208811|NCT02144714|20243179|P1|NOT COMPLETED|Overall Study||0
8208812|NCT02144714|20243177|P3|COMPLETED|Overall Study||63
8208813|NCT02144714|20243178|P2|COMPLETED|Overall Study||63
8208814|NCT02144714|20243179|P1|COMPLETED|Overall Study||63
8208815|NCT02144714|20243177|P3|STARTED|Overall Study||63
8208816|NCT02144714|20243178|P2|STARTED|Overall Study||63
8208817|NCT02144714|20243179|P1|STARTED|Overall Study||63
8208830|NCT02144610|20243226|P2|NOT COMPLETED|Overall Study||22
8208831|NCT02144610|20243227|P1|NOT COMPLETED|Overall Study||23
8208832|NCT02144610|20243226|P2|COMPLETED|Overall Study||1
8208833|NCT02144610|20243227|P1|COMPLETED|Overall Study||0
8208834|NCT02144610|20243226|P2|STARTED|Overall Study||23
8208835|NCT02144610|20243227|P1|STARTED|Overall Study||23
8208836|NCT02144519|20243257|P2|NOT COMPLETED|Year 3||0
8208837|NCT02144519|20243258|P1|NOT COMPLETED|Year 3||0
8208838|NCT02144519|20243257|P2|COMPLETED|Year 3||760
8208839|NCT02144519|20243258|P1|COMPLETED|Year 3||894
8208840|NCT02144519|20243257|P2|STARTED|Year 3||760
8208841|NCT02144519|20243258|P1|STARTED|Year 3||894
8208842|NCT02144519|20243257|P2|NOT COMPLETED|Year 2||0
8208843|NCT02144519|20243258|P1|NOT COMPLETED|Year 2||0
8208844|NCT02144519|20243257|P2|COMPLETED|Year 2||864
8208845|NCT02144519|20243258|P1|COMPLETED|Year 2||763
8208846|NCT02144519|20243257|P2|STARTED|Year 2||864
8208847|NCT02144519|20243258|P1|STARTED|Year 2||763
8208848|NCT02144519|20243257|P2|NOT COMPLETED|Year 1||0
8208849|NCT02144519|20243258|P1|NOT COMPLETED|Year 1||0
8208850|NCT02144519|20243257|P2|COMPLETED|Year 1||870
8208851|NCT02144519|20243258|P1|COMPLETED|Year 1||895
8208852|NCT02144519|20243257|P2|STARTED|Year 1||870
8208853|NCT02144519|20243258|P1|STARTED|Year 1||895
8208854|NCT02144337|20243268|P2|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
8208855|NCT02144337|20243269|P1|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
8208856|NCT02144337|20243268|P2|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
8208857|NCT02144337|20243269|P1|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
8208858|NCT02144337|20243268|P2|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
8208859|NCT02144337|20243269|P1|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
8208860|NCT02144337|20243268|P2|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
8208861|NCT02144337|20243269|P1|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
8208862|NCT02144337|20243268|P2|COMPLETED|T2 Follow-up (Post-intervention)||4
8208863|NCT02144337|20243269|P1|COMPLETED|T2 Follow-up (Post-intervention)||4
8208864|NCT02144337|20243268|P2|STARTED|T2 Follow-up (Post-intervention)||5
8208865|NCT02144337|20243269|P1|STARTED|T2 Follow-up (Post-intervention)||8
8208866|NCT02144337|20243268|P2|NOT COMPLETED|Baseline 0 Months||0
8208867|NCT02144337|20243269|P1|NOT COMPLETED|Baseline 0 Months||0
8208868|NCT02144337|20243268|P2|COMPLETED|Baseline 0 Months||5
8208869|NCT02144337|20243269|P1|COMPLETED|Baseline 0 Months||8
8208870|NCT02144337|20243268|P2|STARTED|Baseline 0 Months||5
8208871|NCT02144337|20243269|P1|STARTED|Baseline 0 Months||8
8208872|NCT02144285|20243289|P10|NOT COMPLETED|Overall Study||0
8208873|NCT02144285|20243290|P9|NOT COMPLETED|Overall Study||0
8208874|NCT02144285|20243291|P8|NOT COMPLETED|Overall Study||0
8208875|NCT02144285|20243292|P7|NOT COMPLETED|Overall Study||0
8208876|NCT02144285|20243293|P6|NOT COMPLETED|Overall Study||0
8208877|NCT02144285|20243294|P5|NOT COMPLETED|Overall Study||1
8208878|NCT02144285|20243295|P4|NOT COMPLETED|Overall Study||0
8208879|NCT02144285|20243296|P3|NOT COMPLETED|Overall Study||0
8208880|NCT02144285|20243297|P2|NOT COMPLETED|Overall Study||0
8208881|NCT02144285|20243298|P1|NOT COMPLETED|Overall Study||0
8208882|NCT02144285|20243289|P10|COMPLETED|Overall Study||6
8208883|NCT02144285|20243290|P9|COMPLETED|Overall Study||2
8208884|NCT02144285|20243291|P8|COMPLETED|Overall Study||6
8208885|NCT02144285|20243292|P7|COMPLETED|Overall Study||6
8208886|NCT02144285|20243293|P6|COMPLETED|Overall Study||6
8208887|NCT02144285|20243294|P5|COMPLETED|Overall Study||5
8208888|NCT02144285|20243295|P4|COMPLETED|Overall Study||6
8208889|NCT02144285|20243296|P3|COMPLETED|Overall Study||6
8208890|NCT02144285|20243297|P2|COMPLETED|Overall Study||6
8208891|NCT02144285|20243298|P1|COMPLETED|Overall Study||14
8208892|NCT02144285|20243289|P10|Received At Least One Dose of Study Drug|Overall Study||6
8208893|NCT02144285|20243290|P9|Received At Least One Dose of Study Drug|Overall Study||2
8208894|NCT02144285|20243291|P8|Received At Least One Dose of Study Drug|Overall Study||6
8208895|NCT02144285|20243292|P7|Received At Least One Dose of Study Drug|Overall Study||6
8208896|NCT02144285|20243293|P6|Received At Least One Dose of Study Drug|Overall Study||6
8208897|NCT02144285|20243294|P5|Received At Least One Dose of Study Drug|Overall Study||6
8208898|NCT02144285|20243295|P4|Received At Least One Dose of Study Drug|Overall Study||6
8208899|NCT02144285|20243296|P3|Received At Least One Dose of Study Drug|Overall Study||6
8208900|NCT02144285|20243297|P2|Received At Least One Dose of Study Drug|Overall Study||6
8208901|NCT02144285|20243298|P1|Received At Least One Dose of Study Drug|Overall Study||14
8208902|NCT02144285|20243289|P10|STARTED|Overall Study||6
8208903|NCT02144285|20243290|P9|STARTED|Overall Study||2
8208904|NCT02144285|20243291|P8|STARTED|Overall Study||6
8208905|NCT02144285|20243292|P7|STARTED|Overall Study||6
8208906|NCT02144285|20243293|P6|STARTED|Overall Study||6
8208907|NCT02144285|20243294|P5|STARTED|Overall Study||6
8208908|NCT02144285|20243295|P4|STARTED|Overall Study||6
8208909|NCT02144285|20243296|P3|STARTED|Overall Study||6
8208910|NCT02144285|20243297|P2|STARTED|Overall Study||6
8208911|NCT02144285|20243298|P1|STARTED|Overall Study||14
8208912|NCT02144259|20243371|P3|NOT COMPLETED|Overall Study||18
8208913|NCT02144259|20243372|P2|NOT COMPLETED|Overall Study||5
8208914|NCT02144259|20243373|P1|NOT COMPLETED|Overall Study||10
8208915|NCT02144259|20243371|P3|COMPLETED|Overall Study||16
8208916|NCT02144259|20243372|P2|COMPLETED|Overall Study||28
8208917|NCT02144259|20243373|P1|COMPLETED|Overall Study||23
8208918|NCT02144259|20243371|P3|STARTED|Overall Study||34
8208919|NCT02144259|20243372|P2|STARTED|Overall Study||33
8208920|NCT02144259|20243373|P1|STARTED|Overall Study||33
8208921|NCT02144233|20243389|P2|NOT COMPLETED|Overall Study||0
8208922|NCT02144233|20243390|P1|NOT COMPLETED|Overall Study||0
8208923|NCT02144233|20243389|P2|COMPLETED|Overall Study||38
8208924|NCT02144233|20243390|P1|COMPLETED|Overall Study|The last participant was assessed at month 3 due to early study stop|39
8208925|NCT02144233|20243389|P2|STARTED|Overall Study||38
8208926|NCT02144233|20243390|P1|STARTED|Overall Study||39
8208927|NCT02144220|20243424|P1|NOT COMPLETED|Overall Study||19
8208928|NCT02144220|20243424|P1|COMPLETED|Overall Study||258
8208929|NCT02144220|20243424|P1|STARTED|Overall Study||277
8208930|NCT02144155|20243432|P1|NOT COMPLETED|Overall Study||0
8208931|NCT02144155|20243432|P1|COMPLETED|Overall Study||14
8208932|NCT02144155|20243432|P1|STARTED|Overall Study||14
8208933|NCT02144077|20243443|P2|NOT COMPLETED|Overall Study||11
8208934|NCT02144077|20243444|P1|NOT COMPLETED|Overall Study||10
8208935|NCT02144077|20243443|P2|COMPLETED|Overall Study||132
8208936|NCT02144077|20243444|P1|COMPLETED|Overall Study||128
8208937|NCT02144077|20243443|P2|STARTED|Overall Study||143
8208938|NCT02144077|20243444|P1|STARTED|Overall Study||138
8208939|NCT02144012|20243462|P2|NOT COMPLETED|Overall Study||15
8208940|NCT02144012|20243463|P1|NOT COMPLETED|Overall Study||34
8208941|NCT02144012|20243462|P2|COMPLETED|Overall Study||0
8208942|NCT02144012|20243463|P1|COMPLETED|Overall Study||0
8208943|NCT02144012|20243462|P2|STARTED|Overall Study||15
8208944|NCT02144012|20243463|P1|STARTED|Overall Study||34
8208945|NCT02143973|20243498|P1|NOT COMPLETED|Overall Study||66
8208946|NCT02143973|20243498|P1|COMPLETED|Overall Study||101
8208947|NCT02143973|20243498|P1|STARTED|Overall Study||167
8208948|NCT02143947|20243504|P2|NOT COMPLETED|Overall Study||2
8208949|NCT02143947|20243505|P1|NOT COMPLETED|Overall Study||4
8208950|NCT02143947|20243504|P2|COMPLETED|Overall Study||42
8208951|NCT02143947|20243505|P1|COMPLETED|Overall Study||32
8208952|NCT02143947|20243504|P2|STARTED|Overall Study||44
8208953|NCT02143947|20243505|P1|STARTED|Overall Study||36
8208954|NCT02143843|20243517|P1|NOT COMPLETED|Overall Study||12
8208955|NCT02143843|20243517|P1|COMPLETED|Overall Study||63
8208956|NCT02143843|20243517|P1|STARTED|Overall Study||75
8208957|NCT02143778|20243522|P1|NOT COMPLETED|Overall Study||3
8208958|NCT02143778|20243522|P1|COMPLETED|Overall Study||243
8208959|NCT02143778|20243522|P1|STARTED|Overall Study||246
8208988|NCT02143648|20243615|P3|NOT COMPLETED|Overall Study||24
8208989|NCT02143648|20243616|P2|NOT COMPLETED|Overall Study||42
8208990|NCT02143648|20243617|P1|NOT COMPLETED|Overall Study||54
8208991|NCT02143648|20243615|P3|COMPLETED|Overall Study||101
8208992|NCT02143648|20243616|P2|COMPLETED|Overall Study||78
8208993|NCT02143648|20243617|P1|COMPLETED|Overall Study||74
8208994|NCT02143648|20243615|P3|STARTED|Overall Study||125
8208995|NCT02143648|20243616|P2|STARTED|Overall Study||120
8208996|NCT02143648|20243617|P1|STARTED|Overall Study||128
8208997|NCT02143583|20243628|P3|NOT COMPLETED|Overall Study||2
8208998|NCT02143583|20243629|P2|NOT COMPLETED|Overall Study||0
8208999|NCT02143583|20243630|P1|NOT COMPLETED|Overall Study||1
8209000|NCT02143583|20243628|P3|COMPLETED|Overall Study||66
8209001|NCT02143583|20243629|P2|COMPLETED|Overall Study||66
8209002|NCT02143583|20243630|P1|COMPLETED|Overall Study||61
8209003|NCT02143583|20243628|P3|STARTED|Overall Study||68
8209004|NCT02143583|20243629|P2|STARTED|Overall Study||66
8209005|NCT02143583|20243630|P1|STARTED|Overall Study||62
8209006|NCT02143310|20243641|P1|NOT COMPLETED|Overall Study||107
8209007|NCT02143310|20243641|P1|COMPLETED|Overall Study||102
8209008|NCT02143310|20243641|P1|STARTED|Overall Study||209
8209009|NCT02143141|20243653|P2|NOT COMPLETED|Overall Study||0
8209010|NCT02143141|20243654|P1|NOT COMPLETED|Overall Study||1
8209011|NCT02143141|20243653|P2|COMPLETED|Overall Study||6
8209012|NCT02143141|20243654|P1|COMPLETED|Overall Study||6
8209013|NCT02143141|20243653|P2|STARTED|Overall Study||6
8209014|NCT02143141|20243654|P1|STARTED|Overall Study||7
8209015|NCT02143102|20243666|P2|NOT COMPLETED|Overall Study||0
8209016|NCT02143102|20243667|P1|NOT COMPLETED|Overall Study||11
8209017|NCT02143102|20243666|P2|COMPLETED|Overall Study||28
8209018|NCT02143102|20243667|P1|COMPLETED|Overall Study||86
8209019|NCT02143102|20243666|P2|STARTED|Overall Study||28
8209020|NCT02143102|20243667|P1|STARTED|Overall Study||97
8209021|NCT02143024|20243677|P2|NOT COMPLETED|Overall Study||1
8209022|NCT02143024|20243678|P1|NOT COMPLETED|Overall Study||2
8209023|NCT02143024|20243677|P2|COMPLETED|Overall Study||7
8209024|NCT02143024|20243678|P1|COMPLETED|Overall Study||13
8209025|NCT02143024|20243677|P2|Received Treatment|Overall Study||7
8209026|NCT02143024|20243678|P1|Received Treatment|Overall Study||13
8209027|NCT02143024|20243677|P2|STARTED|Overall Study||8
8209028|NCT02143024|20243678|P1|STARTED|Overall Study||15
8209029|NCT02142894|20243684|P1|NOT COMPLETED|Overall Study||8
8209030|NCT02142894|20243684|P1|COMPLETED|Overall Study||25
8209031|NCT02142894|20243684|P1|STARTED|Overall Study||33
8209040|NCT02142712|20243704|P4|NOT COMPLETED|Overall Study||0
8209041|NCT02142712|20243705|P3|NOT COMPLETED|Overall Study||1
8209042|NCT02142712|20243706|P2|NOT COMPLETED|Overall Study||1
8209043|NCT02142712|20243707|P1|NOT COMPLETED|Overall Study||1
8209044|NCT02142712|20243704|P4|COMPLETED|Overall Study||0
8209045|NCT02142712|20243705|P3|COMPLETED|Overall Study||0
8209046|NCT02142712|20243706|P2|COMPLETED|Overall Study||0
8209047|NCT02142712|20243707|P1|COMPLETED|Overall Study||0
8209048|NCT02142712|20243704|P4|STARTED|Overall Study||0
8209049|NCT02142712|20243705|P3|STARTED|Overall Study||1
8209050|NCT02142712|20243706|P2|STARTED|Overall Study||1
8209051|NCT02142712|20243707|P1|STARTED|Overall Study||1
8209055|NCT02142504|20243735|P3|NOT COMPLETED|Overall Study||43
8209056|NCT02142504|20243736|P2|NOT COMPLETED|Overall Study||42
8209057|NCT02142504|20243737|P1|NOT COMPLETED|Overall Study||31
8209058|NCT02142504|20243735|P3|COMPLETED|Overall Study||111
8209059|NCT02142504|20243736|P2|COMPLETED|Overall Study||105
8209060|NCT02142504|20243737|P1|COMPLETED|Overall Study||122
8209061|NCT02142504|20243735|P3|Received Booster (Second Vaccination)|Overall Study||116
8209062|NCT02142504|20243736|P2|Received Booster (Second Vaccination)|Overall Study||109
8209063|NCT02142504|20243737|P1|Received Booster (Second Vaccination)|Overall Study||126
8209064|NCT02142504|20243735|P3|Randomized and Received Treatment|Overall Study||154
8209065|NCT02142504|20243736|P2|Randomized and Received Treatment|Overall Study||145
8209066|NCT02142504|20243737|P1|Randomized and Received Treatment|Overall Study||153
8209067|NCT02142504|20243735|P3|STARTED|Overall Study||154
8209068|NCT02142504|20243736|P2|STARTED|Overall Study||147
8209069|NCT02142504|20243737|P1|STARTED|Overall Study||153
8209070|NCT02142387|20243825|P2|NOT COMPLETED|Overall Study||7630
8209071|NCT02142387|20243826|P1|NOT COMPLETED|Overall Study||1065
8209072|NCT02142387|20243825|P2|COMPLETED|Overall Study||8641
8209073|NCT02142387|20243826|P1|COMPLETED|Overall Study|Limited to the case where OHCA occurred in the private place.|1486
8209074|NCT02142387|20243825|P2|STARTED|Overall Study||16271
8209075|NCT02142387|20243826|P1|STARTED|Overall Study|Out-of-hospital cardiac arrest (OHCA) patients with presumed cardiac etiology.|2551
8209076|NCT02142361|20243836|P3|NOT COMPLETED|Overall Study||0
8209077|NCT02142361|20243837|P2|NOT COMPLETED|Overall Study||0
8209078|NCT02142361|20243838|P1|NOT COMPLETED|Overall Study||0
8209079|NCT02142361|20243836|P3|COMPLETED|Overall Study||20
8209080|NCT02142361|20243837|P2|COMPLETED|Overall Study||20
8209081|NCT02142361|20243838|P1|COMPLETED|Overall Study||20
8209082|NCT02142361|20243836|P3|STARTED|Overall Study||20
8209083|NCT02142361|20243837|P2|STARTED|Overall Study||20
8209084|NCT02142361|20243838|P1|STARTED|Overall Study||20
8209085|NCT02142283|20243939|P2|NOT COMPLETED|Overall Study||21
8209086|NCT02142283|20243940|P1|NOT COMPLETED|Overall Study||21
8209087|NCT02142283|20243939|P2|COMPLETED|Overall Study||78
8209088|NCT02142283|20243940|P1|COMPLETED|Overall Study||86
8209089|NCT02142283|20243939|P2|STARTED|Overall Study||99
8209090|NCT02142283|20243940|P1|STARTED|Overall Study||107
8209091|NCT02142153|20243970|P10|NOT COMPLETED|Overall Study||0
8209092|NCT02142153|20243971|P9|NOT COMPLETED|Overall Study||0
8209093|NCT02142153|20243972|P8|NOT COMPLETED|Overall Study||0
8209094|NCT02142153|20243973|P7|NOT COMPLETED|Overall Study||0
8209095|NCT02142153|20243974|P6|NOT COMPLETED|Overall Study||0
8209096|NCT02142153|20243975|P5|NOT COMPLETED|Overall Study||0
8209097|NCT02142153|20243976|P4|NOT COMPLETED|Overall Study||0
8209098|NCT02142153|20243977|P3|NOT COMPLETED|Overall Study||0
8209099|NCT02142153|20243978|P2|NOT COMPLETED|Overall Study||0
8209100|NCT02142153|20243979|P1|NOT COMPLETED|Overall Study||0
8209101|NCT02142153|20243970|P10|COMPLETED|Overall Study||2
8209102|NCT02142153|20243971|P9|COMPLETED|Overall Study||6
8209103|NCT02142153|20243972|P8|COMPLETED|Overall Study||2
8209104|NCT02142153|20243973|P7|COMPLETED|Overall Study||6
8209105|NCT02142153|20243974|P6|COMPLETED|Overall Study||2
8209106|NCT02142153|20243975|P5|COMPLETED|Overall Study||6
8209107|NCT02142153|20243976|P4|COMPLETED|Overall Study||2
8209108|NCT02142153|20243977|P3|COMPLETED|Overall Study||6
8209109|NCT02142153|20243978|P2|COMPLETED|Overall Study||2
8209110|NCT02142153|20243979|P1|COMPLETED|Overall Study||6
8209111|NCT02142153|20243970|P10|STARTED|Overall Study||2
8209112|NCT02142153|20243971|P9|STARTED|Overall Study||6
8209113|NCT02142153|20243972|P8|STARTED|Overall Study||2
8209114|NCT02142153|20243973|P7|STARTED|Overall Study||6
8209115|NCT02142153|20243974|P6|STARTED|Overall Study||2
8209116|NCT02142153|20243975|P5|STARTED|Overall Study||6
8209117|NCT02142153|20243976|P4|STARTED|Overall Study||2
8209118|NCT02142153|20243977|P3|STARTED|Overall Study||6
8209119|NCT02142153|20243978|P2|STARTED|Overall Study||2
8209120|NCT02142153|20243979|P1|STARTED|Overall Study||6
8209121|NCT02142049|20244016|P5|NOT COMPLETED|Overall Study||0
8209122|NCT02142049|20244017|P4|NOT COMPLETED|Overall Study||0
8209123|NCT02142049|20244018|P3|NOT COMPLETED|Overall Study||0
8209124|NCT02142049|20244019|P2|NOT COMPLETED|Overall Study||0
8209125|NCT02142049|20244020|P1|NOT COMPLETED|Overall Study||0
8209126|NCT02142049|20244016|P5|COMPLETED|Overall Study||20
8209127|NCT02142049|20244017|P4|COMPLETED|Overall Study||6
8209128|NCT02142049|20244018|P3|COMPLETED|Overall Study||3
8209129|NCT02142049|20244019|P2|COMPLETED|Overall Study||3
8209130|NCT02142049|20244020|P1|COMPLETED|Overall Study||3
8209131|NCT02142049|20244016|P5|STARTED|Overall Study||20
8209132|NCT02142049|20244017|P4|STARTED|Overall Study||6
8209133|NCT02142049|20244018|P3|STARTED|Overall Study||3
8209134|NCT02142049|20244019|P2|STARTED|Overall Study||3
8209135|NCT02142049|20244020|P1|STARTED|Overall Study||3
8209136|NCT02141997|20244049|P4|NOT COMPLETED|Overall Study||1
8209137|NCT02141997|20244050|P3|NOT COMPLETED|Overall Study||3
8209138|NCT02141997|20244051|P2|NOT COMPLETED|Overall Study||6
8209139|NCT02141997|20244052|P1|NOT COMPLETED|Overall Study||3
8209140|NCT02141997|20244049|P4|COMPLETED|Overall Study||54
8209141|NCT02141997|20244050|P3|COMPLETED|Overall Study||53
8209142|NCT02141997|20244051|P2|COMPLETED|Overall Study||49
8209143|NCT02141997|20244052|P1|COMPLETED|Overall Study||53
8209144|NCT02141997|20244049|P4|STARTED|Overall Study||55
8209145|NCT02141997|20244050|P3|STARTED|Overall Study||56
8209146|NCT02141997|20244051|P2|STARTED|Overall Study||55
8209147|NCT02141997|20244052|P1|STARTED|Overall Study||56
8209148|NCT02141984|20244090|P1|NOT COMPLETED|Overall Study||2
8209149|NCT02141984|20244090|P1|COMPLETED|Overall Study||26
8209150|NCT02141984|20244090|P1|STARTED|Overall Study||28
8209151|NCT02141867|20244097|P1|NOT COMPLETED|Overall Study||94
8209152|NCT02141867|20244097|P1|COMPLETED|Overall Study||3927
8209153|NCT02141867|20244097|P1|STARTED|Overall Study||4021
8209154|NCT02141854|20244109|P6|NOT COMPLETED|Treatment Period||38
8209155|NCT02141854|20244110|P5|NOT COMPLETED|Treatment Period||10
8209156|NCT02141854|20244111|P4|NOT COMPLETED|Treatment Period||11
8209157|NCT02141854|20244112|P3|NOT COMPLETED|Treatment Period||9
8209158|NCT02141854|20244113|P2|NOT COMPLETED|Treatment Period||10
8209159|NCT02141854|20244114|P1|NOT COMPLETED|Treatment Period||0
8209160|NCT02141854|20244109|P6|COMPLETED|Treatment Period||107
8209161|NCT02141854|20244110|P5|COMPLETED|Treatment Period||136
8209162|NCT02141854|20244111|P4|COMPLETED|Treatment Period||135
8209163|NCT02141854|20244112|P3|COMPLETED|Treatment Period||136
8209164|NCT02141854|20244113|P2|COMPLETED|Treatment Period||136
8209165|NCT02141854|20244114|P1|COMPLETED|Treatment Period||0
8209166|NCT02141854|20244109|P6|Full Analysis Set|Treatment Period||143
8209167|NCT02141854|20244110|P5|Full Analysis Set|Treatment Period||145
8209168|NCT02141854|20244111|P4|Full Analysis Set|Treatment Period||146
8209169|NCT02141854|20244112|P3|Full Analysis Set|Treatment Period||141
8209170|NCT02141854|20244113|P2|Full Analysis Set|Treatment Period||145
8209171|NCT02141854|20244114|P1|Full Analysis Set|Treatment Period||0
8209172|NCT02141854|20244109|P6|Safety Population|Treatment Period||144
8209173|NCT02141854|20244110|P5|Safety Population|Treatment Period||145
8209174|NCT02141854|20244111|P4|Safety Population|Treatment Period||146
8209175|NCT02141854|20244112|P3|Safety Population|Treatment Period||143
8209176|NCT02141854|20244113|P2|Safety Population|Treatment Period||145
8209177|NCT02141854|20244114|P1|Safety Population|Treatment Period||0
8209178|NCT02141854|20244109|P6|Intent to Treat Population|Treatment Period||145
8209179|NCT02141854|20244110|P5|Intent to Treat Population|Treatment Period||146
8209180|NCT02141854|20244111|P4|Intent to Treat Population|Treatment Period||146
8209181|NCT02141854|20244112|P3|Intent to Treat Population|Treatment Period||145
8209182|NCT02141854|20244113|P2|Intent to Treat Population|Treatment Period||146
8209183|NCT02141854|20244114|P1|Intent to Treat Population|Treatment Period||0
8209184|NCT02141854|20244109|P6|STARTED|Treatment Period||145
8209185|NCT02141854|20244110|P5|STARTED|Treatment Period||146
8209186|NCT02141854|20244111|P4|STARTED|Treatment Period||146
8209187|NCT02141854|20244112|P3|STARTED|Treatment Period||145
8209188|NCT02141854|20244113|P2|STARTED|Treatment Period||146
8209189|NCT02141854|20244114|P1|STARTED|Treatment Period||0
8209190|NCT02141854|20244109|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209191|NCT02141854|20244110|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209192|NCT02141854|20244111|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209193|NCT02141854|20244112|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209194|NCT02141854|20244113|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209195|NCT02141854|20244114|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||154
8209196|NCT02141854|20244109|P6|COMPLETED|Run-In Period (Pre-assignment)||0
8209197|NCT02141854|20244110|P5|COMPLETED|Run-In Period (Pre-assignment)||0
8209198|NCT02141854|20244111|P4|COMPLETED|Run-In Period (Pre-assignment)||0
8209199|NCT02141854|20244112|P3|COMPLETED|Run-In Period (Pre-assignment)||0
8209200|NCT02141854|20244113|P2|COMPLETED|Run-In Period (Pre-assignment)||0
8209201|NCT02141854|20244114|P1|COMPLETED|Run-In Period (Pre-assignment)||728
8209202|NCT02141854|20244109|P6|STARTED|Run-In Period (Pre-assignment)||0
8209203|NCT02141854|20244110|P5|STARTED|Run-In Period (Pre-assignment)||0
8209204|NCT02141854|20244111|P4|STARTED|Run-In Period (Pre-assignment)||0
8209205|NCT02141854|20244112|P3|STARTED|Run-In Period (Pre-assignment)||0
8209206|NCT02141854|20244113|P2|STARTED|Run-In Period (Pre-assignment)||0
8209207|NCT02141854|20244114|P1|STARTED|Run-In Period (Pre-assignment)||882
8209208|NCT02141659|20244172|P6|NOT COMPLETED|Overall Study||2
8209209|NCT02141659|20244173|P5|NOT COMPLETED|Overall Study||2
8209210|NCT02141659|20244174|P4|NOT COMPLETED|Overall Study||0
8209211|NCT02141659|20244175|P3|NOT COMPLETED|Overall Study||0
8209212|NCT02141659|20244176|P2|NOT COMPLETED|Overall Study||1
8209213|NCT02141659|20244177|P1|NOT COMPLETED|Overall Study||0
8209214|NCT02141659|20244172|P6|COMPLETED|Overall Study||13
8209215|NCT02141659|20244173|P5|COMPLETED|Overall Study||13
8209216|NCT02141659|20244174|P4|COMPLETED|Overall Study||3
8209217|NCT02141659|20244175|P3|COMPLETED|Overall Study||3
8209218|NCT02141659|20244176|P2|COMPLETED|Overall Study||3
8209219|NCT02141659|20244177|P1|COMPLETED|Overall Study||3
8209220|NCT02141659|20244172|P6|STARTED|Overall Study||15
8209221|NCT02141659|20244173|P5|STARTED|Overall Study||15
8209222|NCT02141659|20244174|P4|STARTED|Overall Study||3
8209223|NCT02141659|20244175|P3|STARTED|Overall Study||3
8209224|NCT02141659|20244176|P2|STARTED|Overall Study||4
8209225|NCT02141659|20244177|P1|STARTED|Overall Study||3
8209226|NCT02141633|20244233|P2|NOT COMPLETED|Overall Study||0
8209227|NCT02141633|20244234|P1|NOT COMPLETED|Overall Study||1
8209228|NCT02141633|20244233|P2|COMPLETED|Overall Study||15
8209229|NCT02141633|20244234|P1|COMPLETED|Overall Study||15
8209230|NCT02141633|20244233|P2|STARTED|Overall Study||15
8209231|NCT02141633|20244234|P1|STARTED|Overall Study||16
8209232|NCT02141620|20244242|P2|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
8209233|NCT02141620|20244243|P1|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
8209234|NCT02141620|20244242|P2|COMPLETED|Treatment Condition 2 (7 Days)||7
8209235|NCT02141620|20244243|P1|COMPLETED|Treatment Condition 2 (7 Days)||7
8209236|NCT02141620|20244242|P2|STARTED|Treatment Condition 2 (7 Days)||7
8209237|NCT02141620|20244243|P1|STARTED|Treatment Condition 2 (7 Days)||7
8209238|NCT02141620|20244242|P2|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
8209239|NCT02141620|20244243|P1|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
8209240|NCT02141620|20244242|P2|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
8209241|NCT02141620|20244243|P1|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
8209242|NCT02141620|20244242|P2|STARTED|Treatment Condition 1 (7 Days)||7
8209243|NCT02141620|20244243|P1|STARTED|Treatment Condition 1 (7 Days)||8
8209244|NCT02141581|20244304|P3|NOT COMPLETED|Overall Study||0
8209245|NCT02141581|20244305|P2|NOT COMPLETED|Overall Study||0
8209246|NCT02141581|20244306|P1|NOT COMPLETED|Overall Study||0
8209247|NCT02141581|20244304|P3|COMPLETED|Overall Study||25
8209248|NCT02141581|20244305|P2|COMPLETED|Overall Study||19
8209249|NCT02141581|20244306|P1|COMPLETED|Overall Study||42
8209250|NCT02141581|20244304|P3|STARTED|Overall Study||25
8209251|NCT02141581|20244305|P2|STARTED|Overall Study||19
8209252|NCT02141581|20244306|P1|STARTED|Overall Study||42
8209253|NCT02141555|20244319|P2|NOT COMPLETED|Overall Study||0
8209254|NCT02141555|20244320|P1|NOT COMPLETED|Overall Study||0
8209255|NCT02141555|20244319|P2|COMPLETED|Overall Study||2
8209256|NCT02141555|20244320|P1|COMPLETED|Overall Study||2
8209257|NCT02141555|20244319|P2|STARTED|Overall Study||2
8209258|NCT02141555|20244320|P1|STARTED|Overall Study||2
8209259|NCT02141516|20244335|P3|NOT COMPLETED|Overall Study||0
8209260|NCT02141516|20244336|P2|NOT COMPLETED|Overall Study||5
8209261|NCT02141516|20244337|P1|NOT COMPLETED|Overall Study||0
8209262|NCT02141516|20244335|P3|COMPLETED|Overall Study||87
8209263|NCT02141516|20244336|P2|COMPLETED|Overall Study||107
8209264|NCT02141516|20244337|P1|COMPLETED|Overall Study||40
8209265|NCT02141516|20244335|P3|STARTED|Overall Study||87
8209266|NCT02141516|20244336|P2|STARTED|Overall Study||112
8209267|NCT02141516|20244337|P1|STARTED|Overall Study||40
8209268|NCT02141490|20244388|P3|NOT COMPLETED|Overall Study||0
8209269|NCT02141490|20244389|P2|NOT COMPLETED|Overall Study||0
8209270|NCT02141490|20244390|P1|NOT COMPLETED|Overall Study||4
8209271|NCT02141490|20244388|P3|COMPLETED|Overall Study||3
8209272|NCT02141490|20244389|P2|COMPLETED|Overall Study||6
8209273|NCT02141490|20244390|P1|COMPLETED|Overall Study||30
8209274|NCT02141490|20244388|P3|STARTED|Overall Study||3
8209275|NCT02141490|20244389|P2|STARTED|Overall Study||6
8209276|NCT02141490|20244390|P1|STARTED|Overall Study||34
8209277|NCT02141451|20244407|P4|NOT COMPLETED|Overall Study||9
8209278|NCT02141451|20244408|P3|NOT COMPLETED|Overall Study||5
8209279|NCT02141451|20244409|P2|NOT COMPLETED|Overall Study||2
8209280|NCT02141451|20244410|P1|NOT COMPLETED|Overall Study||0
8209281|NCT02141451|20244407|P4|COMPLETED|Overall Study||7
8209282|NCT02141451|20244408|P3|COMPLETED|Overall Study||2
8209283|NCT02141451|20244409|P2|COMPLETED|Overall Study||2
8209284|NCT02141451|20244410|P1|COMPLETED|Overall Study||3
8209285|NCT02141451|20244407|P4|STARTED|Overall Study||16
8209286|NCT02141451|20244408|P3|STARTED|Overall Study||7
8209287|NCT02141451|20244409|P2|STARTED|Overall Study||4
8209288|NCT02141451|20244410|P1|STARTED|Overall Study||3
8209289|NCT02141399|20244435|P1|NOT COMPLETED|Overall Study||744
8209290|NCT02141399|20244435|P1|COMPLETED|Overall Study||741
8209291|NCT02141399|20244435|P1|STARTED|Overall Study||1485
8209292|NCT02141360|20244441|P3|NOT COMPLETED|Overall Study||0
8209293|NCT02141360|20244442|P2|NOT COMPLETED|Overall Study||0
8209294|NCT02141360|20244443|P1|NOT COMPLETED|Overall Study||7
8209295|NCT02141360|20244441|P3|COMPLETED|Overall Study||6
8209296|NCT02141360|20244442|P2|COMPLETED|Overall Study||6
8209297|NCT02141360|20244443|P1|COMPLETED|Overall Study||4
8209298|NCT02141360|20244441|P3|STARTED|Overall Study||6
8209299|NCT02141360|20244442|P2|STARTED|Overall Study||6
8209300|NCT02141360|20244443|P1|STARTED|Overall Study||11
8209301|NCT02141295|20244454|P3|NOT COMPLETED|Overall Study||95
8209302|NCT02141295|20244455|P2|NOT COMPLETED|Overall Study||94
8209303|NCT02141295|20244456|P1|NOT COMPLETED|Overall Study||6
8209304|NCT02141295|20244454|P3|COMPLETED|Overall Study||0
8209305|NCT02141295|20244455|P2|COMPLETED|Overall Study||0
8209306|NCT02141295|20244456|P1|COMPLETED|Overall Study||2
8209307|NCT02141295|20244454|P3|STARTED|Overall Study||95
8209308|NCT02141295|20244455|P2|STARTED|Overall Study||94
8209309|NCT02141295|20244456|P1|STARTED|Overall Study||8
8209310|NCT02141217|20244492|P2|NOT COMPLETED|Overall Study||8
8209311|NCT02141217|20244493|P1|NOT COMPLETED|Overall Study||11
8209312|NCT02141217|20244492|P2|COMPLETED|Overall Study||229
8209313|NCT02141217|20244493|P1|COMPLETED|Overall Study||223
8209314|NCT02141217|20244492|P2|ITT Population-Actual Treatment Received|Overall Study||235
8209315|NCT02141217|20244493|P1|ITT Population-Actual Treatment Received|Overall Study||236
8209316|NCT02141217|20244492|P2|ITT Population-Randomized Treatment Arm|Overall Study||237
8209317|NCT02141217|20244493|P1|ITT Population-Randomized Treatment Arm|Overall Study||234
8209318|NCT02141217|20244492|P2|STARTED|Overall Study||237
8209319|NCT02141217|20244493|P1|STARTED|Overall Study||234
8209320|NCT02141204|20244513|P2|NOT COMPLETED|Overall Study||15
8209321|NCT02141204|20244514|P1|NOT COMPLETED|Overall Study||15
8209322|NCT02141204|20244513|P2|COMPLETED|Overall Study||210
8209323|NCT02141204|20244514|P1|COMPLETED|Overall Study||209
8209324|NCT02141204|20244513|P2|STARTED|Overall Study||225
8209325|NCT02141204|20244514|P1|STARTED|Overall Study||224
8209326|NCT02140957|20244530|P2|NOT COMPLETED|Overall Study||23
8209327|NCT02140957|20244531|P1|NOT COMPLETED|Overall Study||27
8209328|NCT02140957|20244530|P2|COMPLETED|Overall Study||99
8209329|NCT02140957|20244531|P1|COMPLETED|Overall Study||102
8209330|NCT02140957|20244530|P2|STARTED|Overall Study||122
8209331|NCT02140957|20244531|P1|STARTED|Overall Study||129
8209332|NCT02140788|20244541|P4|NOT COMPLETED|Overall Study||0
8209333|NCT02140788|20244542|P3|NOT COMPLETED|Overall Study||0
8209334|NCT02140788|20244543|P2|NOT COMPLETED|Overall Study||0
8209335|NCT02140788|20244544|P1|NOT COMPLETED|Overall Study||0
8209336|NCT02140788|20244541|P4|COMPLETED|Overall Study||0
8209337|NCT02140788|20244542|P3|COMPLETED|Overall Study||0
8209338|NCT02140788|20244543|P2|COMPLETED|Overall Study||0
8209339|NCT02140788|20244544|P1|COMPLETED|Overall Study||0
8209340|NCT02140788|20244541|P4|STARTED|Overall Study||0
8209341|NCT02140788|20244542|P3|STARTED|Overall Study||0
8209342|NCT02140788|20244543|P2|STARTED|Overall Study||0
8209343|NCT02140788|20244544|P1|STARTED|Overall Study||0
8209344|NCT02140775|20244572|P2|NOT COMPLETED|Overall Study||7
8209345|NCT02140775|20244573|P1|NOT COMPLETED|Overall Study||30
8209346|NCT02140775|20244572|P2|COMPLETED|Overall Study||22
8209347|NCT02140775|20244573|P1|COMPLETED|Overall Study||57
8209348|NCT02140775|20244572|P2|STARTED|Overall Study||29
8209349|NCT02140775|20244573|P1|STARTED|Overall Study||87
8209350|NCT02140762|20244585|P2|NOT COMPLETED|Overall Study||12
8209351|NCT02140762|20244586|P1|NOT COMPLETED|Overall Study||17
8209352|NCT02140762|20244585|P2|COMPLETED|Overall Study||139
8209353|NCT02140762|20244586|P1|COMPLETED|Overall Study||137
8209354|NCT02140762|20244585|P2|STARTED|Overall Study||151
8209355|NCT02140762|20244586|P1|STARTED|Overall Study||154
8209356|NCT02140645|20244652|P6|NOT COMPLETED|Overall Study||70896
8209357|NCT02140645|20244653|P5|NOT COMPLETED|Overall Study||3286
8209358|NCT02140645|20244654|P4|NOT COMPLETED|Overall Study||13833
8209359|NCT02140645|20244655|P3|NOT COMPLETED|Overall Study||4236
8209360|NCT02140645|20244656|P2|NOT COMPLETED|Overall Study||61654
8209361|NCT02140645|20244657|P1|NOT COMPLETED|Overall Study||5489
8209362|NCT02140645|20244652|P6|COMPLETED|Overall Study||3050
8209363|NCT02140645|20244653|P5|COMPLETED|Overall Study||150
8209364|NCT02140645|20244654|P4|COMPLETED|Overall Study||530
8209365|NCT02140645|20244655|P3|COMPLETED|Overall Study||205
8209366|NCT02140645|20244656|P2|COMPLETED|Overall Study||3041
8209367|NCT02140645|20244657|P1|COMPLETED|Overall Study||243
8209368|NCT02140645|20244652|P6|STARTED|Overall Study||73946
8209369|NCT02140645|20244653|P5|STARTED|Overall Study||3436
8209370|NCT02140645|20244654|P4|STARTED|Overall Study||14363
8209371|NCT02140645|20244655|P3|STARTED|Overall Study||4441
8209372|NCT02140645|20244656|P2|STARTED|Overall Study||64695
8209373|NCT02140645|20244657|P1|STARTED|Overall Study||5732
8209374|NCT02140593|20244746|P2|NOT COMPLETED|Overall Study||0
8209375|NCT02140593|20244747|P1|NOT COMPLETED|Overall Study||0
8209376|NCT02140593|20244746|P2|COMPLETED|Overall Study||65
8209377|NCT02140593|20244747|P1|COMPLETED|Overall Study||63
8209378|NCT02140593|20244746|P2|STARTED|Overall Study||65
8209379|NCT02140593|20244747|P1|STARTED|Overall Study||63
8209380|NCT02140567|20244755|P1|NOT COMPLETED|Overall Study||6
8209381|NCT02140567|20244755|P1|COMPLETED|Overall Study||134
8209382|NCT02140567|20244755|P1|STARTED|Overall Study||140
8209383|NCT02140411|20244760|P1|NOT COMPLETED|Overall Study||1
8209384|NCT02140411|20244760|P1|COMPLETED|Overall Study||20
8209385|NCT02140411|20244760|P1|STARTED|Overall Study||21
8209386|NCT02140372|20244769|P1|NOT COMPLETED|Overall Study||0
8209387|NCT02140372|20244769|P1|COMPLETED|Overall Study||10
8209388|NCT02140372|20244769|P1|STARTED|Overall Study||10
8209389|NCT02140164|20244780|P1|NOT COMPLETED|Overall Study||2
8209390|NCT02140164|20244780|P1|COMPLETED|Overall Study||5
8209391|NCT02140164|20244780|P1|STARTED|Overall Study||7
8209392|NCT02140060|20244801|P6|NOT COMPLETED|Overall Study||1
8209393|NCT02140060|20244802|P5|NOT COMPLETED|Overall Study||1
8209394|NCT02140060|20244803|P4|NOT COMPLETED|Overall Study||2
8209395|NCT02140060|20244804|P3|NOT COMPLETED|Overall Study||0
8209396|NCT02140060|20244805|P2|NOT COMPLETED|Overall Study||0
8209397|NCT02140060|20244806|P1|NOT COMPLETED|Overall Study||0
8209398|NCT02140060|20244801|P6|COMPLETED|Overall Study||43
8209399|NCT02140060|20244802|P5|COMPLETED|Overall Study||44
8209400|NCT02140060|20244803|P4|COMPLETED|Overall Study||43
8209401|NCT02140060|20244804|P3|COMPLETED|Overall Study||44
8209402|NCT02140060|20244805|P2|COMPLETED|Overall Study||44
8209403|NCT02140060|20244806|P1|COMPLETED|Overall Study||44
8209404|NCT02140060|20244801|P6|STARTED|Overall Study||44
8209405|NCT02140060|20244802|P5|STARTED|Overall Study||45
8209406|NCT02140060|20244803|P4|STARTED|Overall Study||45
8209407|NCT02140060|20244804|P3|STARTED|Overall Study||44
8209408|NCT02140060|20244805|P2|STARTED|Overall Study||44
8209409|NCT02140060|20244806|P1|STARTED|Overall Study||44
8209410|NCT02139982|20244831|P10|NOT COMPLETED|Overall Study||0
8209411|NCT02139982|20244832|P9|NOT COMPLETED|Overall Study||0
8209412|NCT02139982|20244833|P8|NOT COMPLETED|Overall Study||0
8209413|NCT02139982|20244834|P7|NOT COMPLETED|Overall Study||0
8209414|NCT02139982|20244835|P6|NOT COMPLETED|Overall Study||0
8209415|NCT02139982|20244836|P5|NOT COMPLETED|Overall Study||0
8209416|NCT02139982|20244837|P4|NOT COMPLETED|Overall Study||1
8209417|NCT02139982|20244838|P3|NOT COMPLETED|Overall Study||0
8209418|NCT02139982|20244839|P2|NOT COMPLETED|Overall Study||1
8209419|NCT02139982|20244840|P1|NOT COMPLETED|Overall Study||0
8209420|NCT02139982|20244831|P10|COMPLETED|Overall Study||13
8209421|NCT02139982|20244832|P9|COMPLETED|Overall Study||13
8209422|NCT02139982|20244833|P8|COMPLETED|Overall Study||13
8209423|NCT02139982|20244834|P7|COMPLETED|Overall Study||13
8209424|NCT02139982|20244835|P6|COMPLETED|Overall Study||13
8209425|NCT02139982|20244836|P5|COMPLETED|Overall Study||13
8209426|NCT02139982|20244837|P4|COMPLETED|Overall Study||7
8209427|NCT02139982|20244838|P3|COMPLETED|Overall Study||8
8209428|NCT02139982|20244839|P2|COMPLETED|Overall Study||7
8209429|NCT02139982|20244840|P1|COMPLETED|Overall Study||8
8209430|NCT02139982|20244831|P10|STARTED|Overall Study||13
8209431|NCT02139982|20244832|P9|STARTED|Overall Study||13
8209432|NCT02139982|20244833|P8|STARTED|Overall Study||13
8209433|NCT02139982|20244834|P7|STARTED|Overall Study||13
8209434|NCT02139982|20244835|P6|STARTED|Overall Study||13
8209435|NCT02139982|20244836|P5|STARTED|Overall Study||13
8209436|NCT02139982|20244837|P4|STARTED|Overall Study||8
8209437|NCT02139982|20244838|P3|STARTED|Overall Study||8
8209438|NCT02139982|20244839|P2|STARTED|Overall Study||8
8209439|NCT02139982|20244840|P1|STARTED|Overall Study||8
8209440|NCT02139969|20244882|P1|NOT COMPLETED|Overall Study||0
8209441|NCT02139969|20244882|P1|COMPLETED|Overall Study||956
8209442|NCT02139969|20244882|P1|STARTED|Overall Study||956
8209443|NCT02139943|20244904|P3|NOT COMPLETED|Overall Study||7
8209444|NCT02139943|20244905|P2|NOT COMPLETED|Overall Study||6
8209445|NCT02139943|20244906|P1|NOT COMPLETED|Overall Study||10
8209446|NCT02139943|20244904|P3|COMPLETED|Overall Study||110
8209447|NCT02139943|20244905|P2|COMPLETED|Overall Study||111
8209448|NCT02139943|20244906|P1|COMPLETED|Overall Study||107
8209449|NCT02139943|20244904|P3|STARTED|Overall Study||117
8209450|NCT02139943|20244905|P2|STARTED|Overall Study||117
8209451|NCT02139943|20244906|P1|STARTED|Overall Study||117
8209452|NCT02139878|20244917|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8209453|NCT02139878|20244918|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8209454|NCT02139878|20244917|P2|COMPLETED|Second Intervention (7 Days)||10
8209455|NCT02139878|20244918|P1|COMPLETED|Second Intervention (7 Days)||9
8209456|NCT02139878|20244917|P2|STARTED|Second Intervention (7 Days)||10
8209457|NCT02139878|20244918|P1|STARTED|Second Intervention (7 Days)||9
8209458|NCT02139878|20244917|P2|NOT COMPLETED|Washout Period (8 Days)||0
8209459|NCT02139878|20244918|P1|NOT COMPLETED|Washout Period (8 Days)||0
8209460|NCT02139878|20244917|P2|COMPLETED|Washout Period (8 Days)||10
8209461|NCT02139878|20244918|P1|COMPLETED|Washout Period (8 Days)||9
8209462|NCT02139878|20244917|P2|STARTED|Washout Period (8 Days)||10
8209463|NCT02139878|20244918|P1|STARTED|Washout Period (8 Days)||9
8209464|NCT02139878|20244917|P2|NOT COMPLETED|First Intervention (7 Days)||0
8209465|NCT02139878|20244918|P1|NOT COMPLETED|First Intervention (7 Days)||1
8209466|NCT02139878|20244917|P2|COMPLETED|First Intervention (7 Days)||10
8209467|NCT02139878|20244918|P1|COMPLETED|First Intervention (7 Days)||9
8209468|NCT02139878|20244917|P2|STARTED|First Intervention (7 Days)||10
8209469|NCT02139878|20244918|P1|STARTED|First Intervention (7 Days)||10
8209470|NCT02139826|20244926|P1|NOT COMPLETED|Overall Study||1
8209471|NCT02139826|20244926|P1|COMPLETED|Overall Study||11
8209472|NCT02139826|20244926|P1|STARTED|Overall Study||12
8209473|NCT02139800|20244959|P2|NOT COMPLETED|Overall Study||21
8209474|NCT02139800|20244960|P1|NOT COMPLETED|Overall Study||13
8209475|NCT02139800|20244959|P2|COMPLETED|Overall Study||215
8209476|NCT02139800|20244960|P1|COMPLETED|Overall Study||211
8209477|NCT02139800|20244959|P2|STARTED|Overall Study||236
8209478|NCT02139800|20244960|P1|STARTED|Overall Study||224
8209479|NCT02139644|20244971|P6|NOT COMPLETED|Treatment Period||17
8209480|NCT02139644|20244972|P5|NOT COMPLETED|Treatment Period||8
8209481|NCT02139644|20244973|P4|NOT COMPLETED|Treatment Period||9
8209482|NCT02139644|20244974|P3|NOT COMPLETED|Treatment Period||8
8209483|NCT02139644|20244975|P2|NOT COMPLETED|Treatment Period||3
8209484|NCT02139644|20244976|P1|NOT COMPLETED|Treatment Period||0
8209485|NCT02139644|20244971|P6|COMPLETED|Treatment Period||113
8209486|NCT02139644|20244972|P5|COMPLETED|Treatment Period||121
8209487|NCT02139644|20244973|P4|COMPLETED|Treatment Period||121
8209488|NCT02139644|20244974|P3|COMPLETED|Treatment Period||121
8209489|NCT02139644|20244975|P2|COMPLETED|Treatment Period||126
8209490|NCT02139644|20244976|P1|COMPLETED|Treatment Period||0
8209491|NCT02139644|20244971|P6|STARTED|Treatment Period|Randomized|130
8209492|NCT02139644|20244972|P5|STARTED|Treatment Period|Randomized|129
8209493|NCT02139644|20244973|P4|STARTED|Treatment Period|Randomized|130
8209494|NCT02139644|20244974|P3|STARTED|Treatment Period|Randomized|129
8209495|NCT02139644|20244975|P2|STARTED|Treatment Period|Randomized|129
8209496|NCT02139644|20244976|P1|STARTED|Treatment Period||0
8209497|NCT02139644|20244971|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209498|NCT02139644|20244972|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209499|NCT02139644|20244973|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209500|NCT02139644|20244974|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209501|NCT02139644|20244975|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
8209502|NCT02139644|20244976|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||140
8209503|NCT02139644|20244971|P6|COMPLETED|Run-In Period (Pre-assignment)||0
8209504|NCT02139644|20244972|P5|COMPLETED|Run-In Period (Pre-assignment)||0
8209505|NCT02139644|20244973|P4|COMPLETED|Run-In Period (Pre-assignment)||0
8209506|NCT02139644|20244974|P3|COMPLETED|Run-In Period (Pre-assignment)||0
8209507|NCT02139644|20244975|P2|COMPLETED|Run-In Period (Pre-assignment)||0
8209508|NCT02139644|20244976|P1|COMPLETED|Run-In Period (Pre-assignment)||647
8209509|NCT02139644|20244971|P6|STARTED|Run-In Period (Pre-assignment)||0
8209510|NCT02139644|20244972|P5|STARTED|Run-In Period (Pre-assignment)||0
8209511|NCT02139644|20244973|P4|STARTED|Run-In Period (Pre-assignment)||0
8209512|NCT02139644|20244974|P3|STARTED|Run-In Period (Pre-assignment)||0
8209513|NCT02139644|20244975|P2|STARTED|Run-In Period (Pre-assignment)||0
8209514|NCT02139644|20244976|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
8209515|NCT02139592|20245028|P1|NOT COMPLETED|Overall Study||8
8209516|NCT02139592|20245028|P1|COMPLETED|Overall Study||284
8209517|NCT02139592|20245028|P1|STARTED|Overall Study||292
8209518|NCT02139540|20245036|P2|NOT COMPLETED|Overall Study||0
8209519|NCT02139540|20245037|P1|NOT COMPLETED|Overall Study||1
8209520|NCT02139540|20245036|P2|COMPLETED|Overall Study||10
8209521|NCT02139540|20245037|P1|COMPLETED|Overall Study||10
8209522|NCT02139540|20245036|P2|STARTED|Overall Study||10
8209523|NCT02139540|20245037|P1|STARTED|Overall Study||11
8209527|NCT02139306|20245054|P2|NOT COMPLETED|Overall Study||14
8209528|NCT02139306|20245055|P1|NOT COMPLETED|Overall Study||13
8209529|NCT02139306|20245054|P2|COMPLETED|Overall Study||125
8209530|NCT02139306|20245055|P1|COMPLETED|Overall Study||127
8209531|NCT02139306|20245054|P2|STARTED|Overall Study||139
8209532|NCT02139306|20245055|P1|STARTED|Overall Study||140
8209533|NCT02139228|20245081|P2|NOT COMPLETED|Overall Study||0
8209534|NCT02139228|20245082|P1|NOT COMPLETED|Overall Study||0
8209535|NCT02139228|20245081|P2|COMPLETED|Overall Study||211
8209536|NCT02139228|20245082|P1|COMPLETED|Overall Study||215
8209537|NCT02139228|20245081|P2|STARTED|Overall Study||211
8209538|NCT02139228|20245082|P1|STARTED|Overall Study||215
8209539|NCT02139176|20245092|P2|NOT COMPLETED|Overall Study||0
8209540|NCT02139176|20245093|P1|NOT COMPLETED|Overall Study||0
8209541|NCT02139176|20245092|P2|COMPLETED|Overall Study||100
8209542|NCT02139176|20245093|P1|COMPLETED|Overall Study||100
8209543|NCT02139176|20245092|P2|STARTED|Overall Study||100
8209544|NCT02139176|20245093|P1|STARTED|Overall Study||100
8209545|NCT02139137|20245105|P2|NOT COMPLETED|Overall Study||10
8209546|NCT02139137|20245106|P1|NOT COMPLETED|Overall Study||7
8209547|NCT02139137|20245105|P2|COMPLETED|Overall Study||10
8209548|NCT02139137|20245106|P1|COMPLETED|Overall Study||15
8209549|NCT02139137|20245105|P2|STARTED|Overall Study||20
8209550|NCT02139137|20245106|P1|STARTED|Overall Study||22
8209551|NCT02139124|20245125|P5|NOT COMPLETED|Overall Study||13
8209552|NCT02139124|20245126|P4|NOT COMPLETED|Overall Study||12
8209553|NCT02139124|20245127|P3|NOT COMPLETED|Overall Study||4
8209554|NCT02139124|20245128|P2|NOT COMPLETED|Overall Study||4
8209555|NCT02139124|20245129|P1|NOT COMPLETED|Overall Study||9
8209556|NCT02139124|20245125|P5|COMPLETED|Overall Study||61
8209557|NCT02139124|20245126|P4|COMPLETED|Overall Study||61
8209558|NCT02139124|20245127|P3|COMPLETED|Overall Study||69
8209559|NCT02139124|20245128|P2|COMPLETED|Overall Study||73
8209560|NCT02139124|20245129|P1|COMPLETED|Overall Study||69
8209561|NCT02139124|20245125|P5|STARTED|Overall Study||74
8209562|NCT02139124|20245126|P4|STARTED|Overall Study||73
8209563|NCT02139124|20245127|P3|STARTED|Overall Study||73
8209564|NCT02139124|20245128|P2|STARTED|Overall Study||77
8209565|NCT02139124|20245129|P1|STARTED|Overall Study||78
8209566|NCT02139046|20245146|P5|NOT COMPLETED|Overall Study||57
8209567|NCT02139046|20245147|P4|NOT COMPLETED|Overall Study||68
8209568|NCT02139046|20245148|P3|NOT COMPLETED|Overall Study||59
8209569|NCT02139046|20245149|P2|NOT COMPLETED|Overall Study||54
8209570|NCT02139046|20245150|P1|NOT COMPLETED|Overall Study||62
8209571|NCT02139046|20245146|P5|COMPLETED|Overall Study||301
8209572|NCT02139046|20245147|P4|COMPLETED|Overall Study||290
8209573|NCT02139046|20245148|P3|COMPLETED|Overall Study||298
8209574|NCT02139046|20245149|P2|COMPLETED|Overall Study||305
8209575|NCT02139046|20245150|P1|COMPLETED|Overall Study|Completed=Completed Study Drug|296
8209576|NCT02139046|20245146|P5|Full Analysis Set|Overall Study||357
8209577|NCT02139046|20245147|P4|Full Analysis Set|Overall Study||357
8209578|NCT02139046|20245148|P3|Full Analysis Set|Overall Study||355
8209579|NCT02139046|20245149|P2|Full Analysis Set|Overall Study||357
8209580|NCT02139046|20245150|P1|Full Analysis Set|Overall Study||357
8209581|NCT02139046|20245146|P5|Safety Analysis Set|Overall Study||357
8209582|NCT02139046|20245147|P4|Safety Analysis Set|Overall Study||357
8209583|NCT02139046|20245148|P3|Safety Analysis Set|Overall Study||355
8209584|NCT02139046|20245149|P2|Safety Analysis Set|Overall Study||358
8209585|NCT02139046|20245150|P1|Safety Analysis Set|Overall Study||356
8209586|NCT02139046|20245146|P5|STARTED|Overall Study||358
8209587|NCT02139046|20245147|P4|STARTED|Overall Study||358
8209588|NCT02139046|20245148|P3|STARTED|Overall Study||357
8209589|NCT02139046|20245149|P2|STARTED|Overall Study||359
8209590|NCT02139046|20245150|P1|STARTED|Overall Study||358
8209591|NCT02139007|20245174|P2|NOT COMPLETED|Patient Participant Recruitment||1
8209592|NCT02139007|20245175|P1|NOT COMPLETED|Patient Participant Recruitment||2
8209593|NCT02139007|20245174|P2|COMPLETED|Patient Participant Recruitment||13
8209594|NCT02139007|20245175|P1|COMPLETED|Patient Participant Recruitment||11
8209595|NCT02139007|20245174|P2|STARTED|Patient Participant Recruitment||14
8209596|NCT02139007|20245175|P1|STARTED|Patient Participant Recruitment||13
8209597|NCT02139007|20245174|P2|NOT COMPLETED|Study Site Recruitment||4
8209598|NCT02139007|20245175|P1|NOT COMPLETED|Study Site Recruitment||3
8209599|NCT02139007|20245174|P2|COMPLETED|Study Site Recruitment||1
8209600|NCT02139007|20245175|P1|COMPLETED|Study Site Recruitment||1
8209601|NCT02139007|20245174|P2|STARTED|Study Site Recruitment||5
8209602|NCT02139007|20245175|P1|STARTED|Study Site Recruitment||4
8209603|NCT02138916|20245191|P3|NOT COMPLETED|Overall Study||59
8209604|NCT02138916|20245192|P2|NOT COMPLETED|Overall Study||60
8209605|NCT02138916|20245193|P1|NOT COMPLETED|Overall Study||57
8209606|NCT02138916|20245191|P3|COMPLETED|Overall Study||491
8209607|NCT02138916|20245192|P2|COMPLETED|Overall Study||492
8209608|NCT02138916|20245193|P1|COMPLETED|Overall Study||497
8209609|NCT02138916|20245191|P3|STARTED|Overall Study||550
8209610|NCT02138916|20245192|P2|STARTED|Overall Study||552
8209611|NCT02138916|20245193|P1|STARTED|Overall Study||554
8209618|NCT02138838|20245299|P2|NOT COMPLETED|Overall Study||11
8209619|NCT02138838|20245300|P1|NOT COMPLETED|Overall Study||8
8209620|NCT02138838|20245299|P2|COMPLETED|Overall Study||16
8209621|NCT02138838|20245300|P1|COMPLETED|Overall Study||20
8209622|NCT02138838|20245299|P2|Received Study Drug|Overall Study||25
8209623|NCT02138838|20245300|P1|Received Study Drug|Overall Study||28
8209624|NCT02138838|20245299|P2|STARTED|Overall Study||27
8209625|NCT02138838|20245300|P1|STARTED|Overall Study||28
8209626|NCT02138825|20245318|P2|NOT COMPLETED|Safety Follow-up||17
8209627|NCT02138825|20245319|P1|NOT COMPLETED|Safety Follow-up||22
8209628|NCT02138825|20245318|P2|COMPLETED|Safety Follow-up||47
8209629|NCT02138825|20245319|P1|COMPLETED|Safety Follow-up||50
8209630|NCT02138825|20245318|P2|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
8209631|NCT02138825|20245319|P1|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
8209632|NCT02138825|20245318|P2|NOT COMPLETED|Long-term Extension||38
8209633|NCT02138825|20245319|P1|NOT COMPLETED|Long-term Extension||32
8209634|NCT02138825|20245318|P2|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
8209635|NCT02138825|20245319|P1|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
8209636|NCT02138825|20245318|P2|STARTED|Long-term Extension||38
8209637|NCT02138825|20245319|P1|STARTED|Long-term Extension||32
8209638|NCT02138825|20245318|P2|NOT COMPLETED|Main Study Treatment||35
8209639|NCT02138825|20245319|P1|NOT COMPLETED|Main Study Treatment||40
8209640|NCT02138825|20245318|P2|COMPLETED|Main Study Treatment||39
8209641|NCT02138825|20245319|P1|COMPLETED|Main Study Treatment||33
8209642|NCT02138825|20245318|P2|STARTED|Main Study Treatment|safety population|74
8209643|NCT02138825|20245319|P1|STARTED|Main Study Treatment|safety population|73
8209644|NCT02138786|20245336|P3|NOT COMPLETED|Overall Study||8
8209645|NCT02138786|20245337|P2|NOT COMPLETED|Overall Study||15
8209646|NCT02138786|20245338|P1|NOT COMPLETED|Overall Study||3
8209647|NCT02138786|20245336|P3|COMPLETED|Overall Study||0
8209648|NCT02138786|20245337|P2|COMPLETED|Overall Study||0
8209649|NCT02138786|20245338|P1|COMPLETED|Overall Study||0
8209650|NCT02138786|20245336|P3|STARTED|Overall Study||8
8209651|NCT02138786|20245337|P2|STARTED|Overall Study||15
8209652|NCT02138786|20245338|P1|STARTED|Overall Study||3
8209653|NCT02138747|20245355|P4|NOT COMPLETED|Treatment Period 2||3
8209654|NCT02138747|20245356|P3|NOT COMPLETED|Treatment Period 2||2
8209655|NCT02138747|20245357|P2|NOT COMPLETED|Treatment Period 2||7
8209656|NCT02138747|20245358|P1|NOT COMPLETED|Treatment Period 2||17
8209657|NCT02138747|20245355|P4|COMPLETED|Treatment Period 2||24
8209658|NCT02138747|20245356|P3|COMPLETED|Treatment Period 2||24
8209659|NCT02138747|20245357|P2|COMPLETED|Treatment Period 2||125
8209660|NCT02138747|20245358|P1|COMPLETED|Treatment Period 2||121
8209661|NCT02138747|20245355|P4|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
8209662|NCT02138747|20245356|P3|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
8209663|NCT02138747|20245357|P2|STARTED|Treatment Period 2||132
8209664|NCT02138747|20245358|P1|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
8209665|NCT02138747|20245355|P4|NOT COMPLETED|Treatment Period 1||4
8209666|NCT02138747|20245356|P3|NOT COMPLETED|Treatment Period 1||4
8209667|NCT02138747|20245357|P2|NOT COMPLETED|Treatment Period 1||25
8209668|NCT02138747|20245358|P1|NOT COMPLETED|Treatment Period 1||20
8209669|NCT02138747|20245355|P4|COMPLETED|Treatment Period 1||28
8209670|NCT02138747|20245356|P3|COMPLETED|Treatment Period 1||27
8209671|NCT02138747|20245357|P2|COMPLETED|Treatment Period 1||132
8209672|NCT02138747|20245358|P1|COMPLETED|Treatment Period 1||136
8209673|NCT02138747|20245355|P4|STARTED|Treatment Period 1||32
8209674|NCT02138747|20245356|P3|STARTED|Treatment Period 1||31
8209675|NCT02138747|20245357|P2|STARTED|Treatment Period 1||157
8209676|NCT02138747|20245358|P1|STARTED|Treatment Period 1||156
8209677|NCT02138578|20245393|P3|NOT COMPLETED|Overall Study||0
8209678|NCT02138578|20245394|P2|NOT COMPLETED|Overall Study||0
8209679|NCT02138578|20245395|P1|NOT COMPLETED|Overall Study||0
8209680|NCT02138578|20245393|P3|COMPLETED|Overall Study||3
8209681|NCT02138578|20245394|P2|COMPLETED|Overall Study||0
8209682|NCT02138578|20245395|P1|COMPLETED|Overall Study||1
8209683|NCT02138578|20245393|P3|STARTED|Overall Study||3
8209684|NCT02138578|20245394|P2|STARTED|Overall Study||0
8209685|NCT02138578|20245395|P1|STARTED|Overall Study||1
8209686|NCT02138461|20245423|P2|NOT COMPLETED|Overall Study||0
8209687|NCT02138461|20245424|P1|NOT COMPLETED|Overall Study||0
8209688|NCT02138461|20245423|P2|COMPLETED|Overall Study||110
8209689|NCT02138461|20245424|P1|COMPLETED|Overall Study||101
8209690|NCT02138461|20245423|P2|STARTED|Overall Study||110
8209691|NCT02138461|20245424|P1|STARTED|Overall Study||101
8209692|NCT02138253|20245432|P2|NOT COMPLETED|Overall Study||4
8209693|NCT02138253|20245433|P1|NOT COMPLETED|Overall Study||9
8209694|NCT02138253|20245432|P2|COMPLETED|Overall Study||19
8209695|NCT02138253|20245433|P1|COMPLETED|Overall Study||32
8209696|NCT02138253|20245432|P2|STARTED|Overall Study||23
8209697|NCT02138253|20245433|P1|STARTED|Overall Study||41
8209698|NCT02138240|20245461|P1|NOT COMPLETED|Overall Study||0
8209699|NCT02138240|20245461|P1|COMPLETED|Overall Study||34
8209700|NCT02138240|20245461|P1|STARTED|Overall Study||34
8209701|NCT02138227|20245473|P2|NOT COMPLETED|Overall Study||0
8209702|NCT02138227|20245474|P1|NOT COMPLETED|Overall Study||0
8209703|NCT02138227|20245473|P2|COMPLETED|Overall Study||218
8209704|NCT02138227|20245474|P1|COMPLETED|Overall Study||55
8209705|NCT02138227|20245473|P2|STARTED|Overall Study||218
8209706|NCT02138227|20245474|P1|STARTED|Overall Study||55
8209707|NCT02138214|20245508|P3|NOT COMPLETED|Overall Study||4
8209708|NCT02138214|20245509|P2|NOT COMPLETED|Overall Study||4
8209709|NCT02138214|20245510|P1|NOT COMPLETED|Overall Study||0
8209710|NCT02138214|20245508|P3|COMPLETED|Overall Study||26
8209711|NCT02138214|20245509|P2|COMPLETED|Overall Study||26
8209712|NCT02138214|20245510|P1|COMPLETED|Overall Study||30
8209713|NCT02138214|20245508|P3|Analyzed for Baseline Measures|Overall Study||30
8209714|NCT02138214|20245509|P2|Analyzed for Baseline Measures|Overall Study||29
8209715|NCT02138214|20245510|P1|Analyzed for Baseline Measures|Overall Study||30
8209716|NCT02138214|20245508|P3|STARTED|Overall Study||30
8209717|NCT02138214|20245509|P2|STARTED|Overall Study||30
8209718|NCT02138214|20245510|P1|STARTED|Overall Study||30
8209719|NCT02138136|20245531|P1|NOT COMPLETED|Overall Study||139
8209720|NCT02138136|20245531|P1|COMPLETED|Overall Study||280
8209721|NCT02138136|20245531|P1|Modified Intent to Treat (mITT)|Overall Study||418
8209722|NCT02138136|20245531|P1|Safety Analysis Set|Overall Study||419
8209723|NCT02138136|20245531|P1|STARTED|Overall Study||419
8209724|NCT02138110|20245538|P1|NOT COMPLETED|Overall Scaffold Implantation||3
8209725|NCT02138110|20245538|P1|COMPLETED|Overall Scaffold Implantation||16
8209726|NCT02138110|20245538|P1|6-month Follow-Up|Overall Scaffold Implantation||16
8209727|NCT02138110|20245538|P1|STARTED|Overall Scaffold Implantation||19
8209728|NCT02138110|20245538|P1|NOT COMPLETED|Enrolled for Scaffold Implantation||1
8209729|NCT02138110|20245538|P1|COMPLETED|Enrolled for Scaffold Implantation||19
8209730|NCT02138110|20245538|P1|STARTED|Enrolled for Scaffold Implantation||20
8209731|NCT02138110|20245538|P1|NOT COMPLETED|Enrolled in Study||0
8209732|NCT02138110|20245538|P1|COMPLETED|Enrolled in Study||20
8209733|NCT02138110|20245538|P1|STARTED|Enrolled in Study||20
8209734|NCT02138097|20245566|P2|NOT COMPLETED|Overall Study||0
8209735|NCT02138097|20245567|P1|NOT COMPLETED|Overall Study||0
8209736|NCT02138097|20245566|P2|COMPLETED|Overall Study||459722
8209737|NCT02138097|20245567|P1|COMPLETED|Overall Study||155345
8209738|NCT02138097|20245566|P2|STARTED|Overall Study||459722
8209739|NCT02138097|20245567|P1|STARTED|Overall Study||155345
8209740|NCT02138006|20245759|P2|NOT COMPLETED|Overall Study||0
8209741|NCT02138006|20245760|P1|NOT COMPLETED|Overall Study||0
8209742|NCT02138006|20245759|P2|COMPLETED|Overall Study||54
8209743|NCT02138006|20245760|P1|COMPLETED|Overall Study||48
8209744|NCT02138006|20245759|P2|STARTED|Overall Study||54
8209745|NCT02138006|20245760|P1|STARTED|Overall Study||48
8209746|NCT02137785|20245770|P2|NOT COMPLETED|Overall Study||4
8209747|NCT02137785|20245771|P1|NOT COMPLETED|Overall Study||3
8209748|NCT02137785|20245770|P2|COMPLETED|Overall Study||130
8209749|NCT02137785|20245771|P1|COMPLETED|Overall Study||132
8209750|NCT02137785|20245770|P2|STARTED|Overall Study||134
8209751|NCT02137785|20245771|P1|STARTED|Overall Study||135
8209752|NCT02137772|20245879|P2|NOT COMPLETED|Overall Study||75
8209753|NCT02137772|20245880|P1|NOT COMPLETED|Overall Study||132
8209754|NCT02137772|20245879|P2|COMPLETED|Overall Study||119
8209755|NCT02137772|20245880|P1|COMPLETED|Overall Study||244
8209756|NCT02137772|20245879|P2|Treated Participants|Overall Study||192
8209757|NCT02137772|20245880|P1|Treated Participants|Overall Study||373
8209758|NCT02137772|20245879|P2|STARTED|Overall Study|Randomized participants|194
8209759|NCT02137772|20245880|P1|STARTED|Overall Study|Randomized participants|376
8209760|NCT02137603|20245906|P2|NOT COMPLETED|Overall Study||0
8209761|NCT02137603|20245907|P1|NOT COMPLETED|Overall Study||2
8209762|NCT02137603|20245906|P2|COMPLETED|Overall Study||18
8209763|NCT02137603|20245907|P1|COMPLETED|Overall Study||16
8209764|NCT02137603|20245906|P2|STARTED|Overall Study||18
8209765|NCT02137603|20245907|P1|STARTED|Overall Study||18
8209766|NCT02137512|20245915|P1|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
8209767|NCT02137512|20245915|P1|COMPLETED|5-Month 24/7 Closed-Loop||14
8209768|NCT02137512|20245915|P1|STARTED|5-Month 24/7 Closed-Loop||14
8209769|NCT02137512|20245915|P1|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
8209770|NCT02137512|20245915|P1|COMPLETED|2-Week 24/7 Closed-Loop||30
8209771|NCT02137512|20245915|P1|STARTED|2-Week 24/7 Closed-Loop||30
8209772|NCT02137512|20245915|P1|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
8209773|NCT02137512|20245915|P1|COMPLETED|2-Week Overnight-Only Closed-Loop||30
8209774|NCT02137512|20245915|P1|STARTED|2-Week Overnight-Only Closed-Loop||30
8209775|NCT02137512|20245915|P1|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
8209776|NCT02137512|20245915|P1|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
8209777|NCT02137512|20245915|P1|STARTED|2-Week Baseline Sensor-Augmented Pump||30
8209778|NCT02137499|20246072|P4|NOT COMPLETED|Overall Study||0
8209779|NCT02137499|20246073|P3|NOT COMPLETED|Overall Study||0
8209780|NCT02137499|20246074|P2|NOT COMPLETED|Overall Study||0
8209781|NCT02137499|20246075|P1|NOT COMPLETED|Overall Study||0
8209782|NCT02137499|20246072|P4|COMPLETED|Overall Study||10
8209783|NCT02137499|20246073|P3|COMPLETED|Overall Study||10
8209784|NCT02137499|20246074|P2|COMPLETED|Overall Study||10
8209785|NCT02137499|20246075|P1|COMPLETED|Overall Study||10
8209786|NCT02137499|20246072|P4|STARTED|Overall Study||10
8209787|NCT02137499|20246073|P3|STARTED|Overall Study||10
8209788|NCT02137499|20246074|P2|STARTED|Overall Study||10
8209789|NCT02137499|20246075|P1|STARTED|Overall Study||10
8209790|NCT02137486|20246095|P2|NOT COMPLETED|Overall Study||0
8209791|NCT02137486|20246096|P1|NOT COMPLETED|Overall Study||0
8209792|NCT02137486|20246095|P2|COMPLETED|Overall Study||102
8209793|NCT02137486|20246096|P1|COMPLETED|Overall Study||112
8209794|NCT02137486|20246095|P2|STARTED|Overall Study||102
8209795|NCT02137486|20246096|P1|STARTED|Overall Study||112
8209796|NCT02137447|20246112|P1|NOT COMPLETED|Overall Study||0
8209797|NCT02137447|20246112|P1|COMPLETED|Overall Study||10
8209798|NCT02137447|20246112|P1|STARTED|Overall Study||10
8209799|NCT02137382|20246117|P2|NOT COMPLETED|Cross-over Period 2||0
8209800|NCT02137382|20246118|P1|NOT COMPLETED|Cross-over Period 2||0
8209801|NCT02137382|20246117|P2|COMPLETED|Cross-over Period 2||21
8209802|NCT02137382|20246118|P1|COMPLETED|Cross-over Period 2||18
8209803|NCT02137382|20246117|P2|STARTED|Cross-over Period 2||21
8209804|NCT02137382|20246118|P1|STARTED|Cross-over Period 2||18
8209805|NCT02137382|20246117|P2|NOT COMPLETED|Wash Out||0
8209806|NCT02137382|20246118|P1|NOT COMPLETED|Wash Out||0
8209807|NCT02137382|20246117|P2|COMPLETED|Wash Out||21
8209808|NCT02137382|20246118|P1|COMPLETED|Wash Out||18
8209809|NCT02137382|20246117|P2|STARTED|Wash Out||21
8209810|NCT02137382|20246118|P1|STARTED|Wash Out||18
8209811|NCT02137382|20246117|P2|NOT COMPLETED|Cross-over Period 1||0
8209812|NCT02137382|20246118|P1|NOT COMPLETED|Cross-over Period 1||2
8209813|NCT02137382|20246117|P2|COMPLETED|Cross-over Period 1||21
8209814|NCT02137382|20246118|P1|COMPLETED|Cross-over Period 1||18
8209815|NCT02137382|20246117|P2|STARTED|Cross-over Period 1||21
8209816|NCT02137382|20246118|P1|STARTED|Cross-over Period 1||20
8209817|NCT02137369|20246138|P2|NOT COMPLETED|Overall Study||2
8209818|NCT02137369|20246139|P1|NOT COMPLETED|Overall Study||8
8209819|NCT02137369|20246138|P2|COMPLETED|Overall Study||9
8209820|NCT02137369|20246139|P1|COMPLETED|Overall Study||41
8209821|NCT02137369|20246138|P2|STARTED|Overall Study||11
8209822|NCT02137369|20246139|P1|STARTED|Overall Study||49
8209823|NCT02137226|20246149|P5|NOT COMPLETED|Period 2 (Re - Randomization)||9
8209824|NCT02137226|20246150|P4|NOT COMPLETED|Period 2 (Re - Randomization)||8
8209825|NCT02137226|20246151|P3|NOT COMPLETED|Period 2 (Re - Randomization)||17
8209826|NCT02137226|20246152|P2|NOT COMPLETED|Period 2 (Re - Randomization)||0
8209827|NCT02137226|20246153|P1|NOT COMPLETED|Period 2 (Re - Randomization)||0
8209828|NCT02137226|20246149|P5|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
8209829|NCT02137226|20246150|P4|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
8209830|NCT02137226|20246151|P3|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
8209831|NCT02137226|20246152|P2|COMPLETED|Period 2 (Re - Randomization)||0
8209832|NCT02137226|20246153|P1|COMPLETED|Period 2 (Re - Randomization)||0
8209833|NCT02137226|20246149|P5|STARTED|Period 2 (Re - Randomization)||147
8209834|NCT02137226|20246150|P4|STARTED|Period 2 (Re - Randomization)||148
8209835|NCT02137226|20246151|P3|STARTED|Period 2 (Re - Randomization)||298
8209836|NCT02137226|20246152|P2|STARTED|Period 2 (Re - Randomization)||0
8209837|NCT02137226|20246153|P1|STARTED|Period 2 (Re - Randomization)||0
8209838|NCT02137226|20246149|P5|NOT COMPLETED|Period 1 (Initial Randomization)||0
8209839|NCT02137226|20246150|P4|NOT COMPLETED|Period 1 (Initial Randomization)||0
8209840|NCT02137226|20246151|P3|NOT COMPLETED|Period 1 (Initial Randomization)||0
8209841|NCT02137226|20246152|P2|NOT COMPLETED|Period 1 (Initial Randomization)||16
8209842|NCT02137226|20246153|P1|NOT COMPLETED|Period 1 (Initial Randomization)||20
8209843|NCT02137226|20246149|P5|COMPLETED|Period 1 (Initial Randomization)||0
8209844|NCT02137226|20246150|P4|COMPLETED|Period 1 (Initial Randomization)||0
8209845|NCT02137226|20246151|P3|COMPLETED|Period 1 (Initial Randomization)||0
8209846|NCT02137226|20246152|P2|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
8209847|NCT02137226|20246153|P1|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
8209848|NCT02137226|20246149|P5|STARTED|Period 1 (Initial Randomization)||0
8209849|NCT02137226|20246150|P4|STARTED|Period 1 (Initial Randomization)||0
8209850|NCT02137226|20246151|P3|STARTED|Period 1 (Initial Randomization)||0
8209851|NCT02137226|20246152|P2|STARTED|Period 1 (Initial Randomization)||321
8209852|NCT02137226|20246153|P1|STARTED|Period 1 (Initial Randomization)||324
8209853|NCT02137096|20246165|P1|NOT COMPLETED|Overall Study||0
8209854|NCT02137096|20246165|P1|COMPLETED|Overall Study||1
8209855|NCT02137096|20246165|P1|STARTED|Overall Study||1
8209856|NCT02136914|20246171|P2|NOT COMPLETED|Overall Study||21
8209857|NCT02136914|20246172|P1|NOT COMPLETED|Overall Study||21
8209858|NCT02136914|20246171|P2|COMPLETED|Overall Study||42
8209859|NCT02136914|20246172|P1|COMPLETED|Overall Study||42
8209860|NCT02136914|20246171|P2|Received Study Drug|Overall Study||63
8209861|NCT02136914|20246172|P1|Received Study Drug|Overall Study||60
8209862|NCT02136914|20246171|P2|STARTED|Overall Study||63
8209863|NCT02136914|20246172|P1|STARTED|Overall Study||63
8209864|NCT02136810|20246186|P1|NOT COMPLETED|Overall Study||0
8209865|NCT02136810|20246186|P1|COMPLETED|Overall Study||200
8209866|NCT02136810|20246186|P1|STARTED|Overall Study||200
8209867|NCT02136680|20246192|P2|NOT COMPLETED|Overall Study||29
8209868|NCT02136680|20246193|P1|NOT COMPLETED|Overall Study||32
8209869|NCT02136680|20246192|P2|COMPLETED|Overall Study||56
8209870|NCT02136680|20246193|P1|COMPLETED|Overall Study||80
8209871|NCT02136680|20246192|P2|Interview 3|Overall Study||56
8209872|NCT02136680|20246193|P1|Interview 3|Overall Study||80
8209873|NCT02136680|20246192|P2|Interview 2|Overall Study||70
8209874|NCT02136680|20246193|P1|Interview 2|Overall Study||97
8209875|NCT02136680|20246192|P2|Interview 1|Overall Study||85
8209876|NCT02136680|20246193|P1|Interview 1|Overall Study||112
8209877|NCT02136680|20246192|P2|STARTED|Overall Study||85
8209878|NCT02136680|20246193|P1|STARTED|Overall Study||112
8209879|NCT02136576|20246210|P3|NOT COMPLETED|Overall Study||0
8209880|NCT02136576|20246211|P2|NOT COMPLETED|Overall Study||0
8209881|NCT02136576|20246212|P1|NOT COMPLETED|Overall Study||2
8209882|NCT02136576|20246210|P3|COMPLETED|Overall Study||13
8209883|NCT02136576|20246211|P2|COMPLETED|Overall Study||13
8209884|NCT02136576|20246212|P1|COMPLETED|Overall Study||11
8209885|NCT02136576|20246210|P3|STARTED|Overall Study||13
8209886|NCT02136576|20246211|P2|STARTED|Overall Study||13
8209887|NCT02136576|20246212|P1|STARTED|Overall Study||13
8209888|NCT02136498|20246222|P2|NOT COMPLETED|Overall Study||0
8209889|NCT02136498|20246223|P1|NOT COMPLETED|Overall Study||0
8209890|NCT02136498|20246222|P2|COMPLETED|Overall Study||33
8209891|NCT02136498|20246223|P1|COMPLETED|Overall Study||33
8209892|NCT02136498|20246222|P2|STARTED|Overall Study||33
8209893|NCT02136498|20246223|P1|STARTED|Overall Study||33
8209894|NCT02136420|20246235|P10|NOT COMPLETED|Overall Study||0
8209895|NCT02136420|20246236|P9|NOT COMPLETED|Overall Study||0
8209896|NCT02136420|20246237|P8|NOT COMPLETED|Overall Study||0
8209897|NCT02136420|20246238|P7|NOT COMPLETED|Overall Study||0
8209898|NCT02136420|20246239|P6|NOT COMPLETED|Overall Study||0
8209899|NCT02136420|20246240|P5|NOT COMPLETED|Overall Study||0
8209900|NCT02136420|20246241|P4|NOT COMPLETED|Overall Study||0
8209901|NCT02136420|20246242|P3|NOT COMPLETED|Overall Study||0
8209902|NCT02136420|20246243|P2|NOT COMPLETED|Overall Study||0
8209903|NCT02136420|20246244|P1|NOT COMPLETED|Overall Study||1
8209904|NCT02136420|20246235|P10|COMPLETED|Overall Study||5
8209905|NCT02136420|20246236|P9|COMPLETED|Overall Study||5
8209906|NCT02136420|20246237|P8|COMPLETED|Overall Study||0
8209907|NCT02136420|20246238|P7|COMPLETED|Overall Study||0
8209908|NCT02136420|20246239|P6|COMPLETED|Overall Study||0
8209909|NCT02136420|20246240|P5|COMPLETED|Overall Study||10
8209910|NCT02136420|20246241|P4|COMPLETED|Overall Study||0
8209911|NCT02136420|20246242|P3|COMPLETED|Overall Study||0
8209912|NCT02136420|20246243|P2|COMPLETED|Overall Study||0
8209913|NCT02136420|20246244|P1|COMPLETED|Overall Study||9
8209914|NCT02136420|20246235|P10|STARTED|Overall Study||5
8209915|NCT02136420|20246236|P9|STARTED|Overall Study||5
8209916|NCT02136420|20246237|P8|STARTED|Overall Study||0
8209917|NCT02136420|20246238|P7|STARTED|Overall Study||0
8209918|NCT02136420|20246239|P6|STARTED|Overall Study||0
8209919|NCT02136420|20246240|P5|STARTED|Overall Study||10
8209920|NCT02136420|20246241|P4|STARTED|Overall Study||0
8209921|NCT02136420|20246242|P3|STARTED|Overall Study||0
8209922|NCT02136420|20246243|P2|STARTED|Overall Study||0
8209923|NCT02136420|20246244|P1|STARTED|Overall Study||10
8209924|NCT02136238|20246266|P3|NOT COMPLETED|Overall Study||0
8209925|NCT02136238|20246267|P2|NOT COMPLETED|Overall Study||0
8209926|NCT02136238|20246268|P1|NOT COMPLETED|Overall Study||0
8209927|NCT02136238|20246266|P3|COMPLETED|Overall Study||10
8209928|NCT02136238|20246267|P2|COMPLETED|Overall Study||4
8209929|NCT02136238|20246268|P1|COMPLETED|Overall Study||4
8209930|NCT02136238|20246266|P3|STARTED|Overall Study||10
8209931|NCT02136238|20246267|P2|STARTED|Overall Study||4
8209932|NCT02136238|20246268|P1|STARTED|Overall Study||4
8209941|NCT02136004|20246300|P1|NOT COMPLETED|Overall Study||1
8209942|NCT02136004|20246300|P1|COMPLETED|Overall Study||219
8209943|NCT02136004|20246300|P1|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
8209944|NCT02135900|20246311|P1|NOT COMPLETED|Overall Study||0
8209945|NCT02135900|20246311|P1|COMPLETED|Overall Study||32
8209946|NCT02135900|20246311|P1|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
8209947|NCT02135861|20246321|P3|NOT COMPLETED|Overall Study||0
8209948|NCT02135861|20246322|P2|NOT COMPLETED|Overall Study||0
8209949|NCT02135861|20246323|P1|NOT COMPLETED|Overall Study||0
8209950|NCT02135861|20246321|P3|COMPLETED|Overall Study||3
8209951|NCT02135861|20246322|P2|COMPLETED|Overall Study||12
8209952|NCT02135861|20246323|P1|COMPLETED|Overall Study||21
8209953|NCT02135861|20246321|P3|STARTED|Overall Study||3
8209954|NCT02135861|20246322|P2|STARTED|Overall Study||12
8209955|NCT02135861|20246323|P1|STARTED|Overall Study||21
8209956|NCT02135848|20246344|P2|NOT COMPLETED|Overall Study||1
8209957|NCT02135848|20246345|P1|NOT COMPLETED|Overall Study||3
8209958|NCT02135848|20246344|P2|COMPLETED|Overall Study||19
8209959|NCT02135848|20246345|P1|COMPLETED|Overall Study||23
8209960|NCT02135848|20246344|P2|STARTED|Overall Study||20
8209961|NCT02135848|20246345|P1|STARTED|Overall Study||26
8209962|NCT02135692|20246403|P1|NOT COMPLETED|Overall Study||339
8209963|NCT02135692|20246403|P1|COMPLETED|Overall Study||0
8209964|NCT02135692|20246403|P1|STARTED|Overall Study||339
8209965|NCT02135614|20246422|P2|NOT COMPLETED|Overall Study||5
8209966|NCT02135614|20246423|P1|NOT COMPLETED|Overall Study||8
8209967|NCT02135614|20246422|P2|COMPLETED|Overall Study||90
8209968|NCT02135614|20246423|P1|COMPLETED|Overall Study||86
8209969|NCT02135614|20246422|P2|STARTED|Overall Study||95
8209970|NCT02135614|20246423|P1|STARTED|Overall Study||94
8209971|NCT02135445|20246437|P2|NOT COMPLETED|Overall Study||0
8209972|NCT02135445|20246438|P1|NOT COMPLETED|Overall Study||2
8209973|NCT02135445|20246437|P2|COMPLETED|Overall Study||38
8209974|NCT02135445|20246438|P1|COMPLETED|Overall Study||63
8209975|NCT02135445|20246437|P2|STARTED|Overall Study||38
8209976|NCT02135445|20246438|P1|STARTED|Overall Study||65
8209977|NCT02135432|20246489|P2|NOT COMPLETED|Overall Study||0
8209978|NCT02135432|20246490|P1|NOT COMPLETED|Overall Study||0
8209979|NCT02135432|20246489|P2|COMPLETED|Overall Study||4
8209980|NCT02135432|20246490|P1|COMPLETED|Overall Study||8
8209981|NCT02135432|20246489|P2|STARTED|Overall Study||4
8209982|NCT02135432|20246490|P1|STARTED|Overall Study||8
8209983|NCT02135146|20246504|P2|NOT COMPLETED|Overall Study||0
8209984|NCT02135146|20246505|P1|NOT COMPLETED|Overall Study||0
8209985|NCT02135146|20246504|P2|COMPLETED|Overall Study||20
8209986|NCT02135146|20246505|P1|COMPLETED|Overall Study||20
8209987|NCT02135146|20246504|P2|STARTED|Overall Study||20
8209988|NCT02135146|20246505|P1|STARTED|Overall Study||20
8209989|NCT02135107|20246523|P4|NOT COMPLETED|Maintenance Therapy Period||20
8209990|NCT02135107|20246524|P3|NOT COMPLETED|Maintenance Therapy Period||15
8209991|NCT02135107|20246525|P2|NOT COMPLETED|Maintenance Therapy Period||0
8209992|NCT02135107|20246526|P1|NOT COMPLETED|Maintenance Therapy Period||0
8209993|NCT02135107|20246523|P4|COMPLETED|Maintenance Therapy Period||161
8209994|NCT02135107|20246524|P3|COMPLETED|Maintenance Therapy Period||163
8209995|NCT02135107|20246525|P2|COMPLETED|Maintenance Therapy Period||0
8209996|NCT02135107|20246526|P1|COMPLETED|Maintenance Therapy Period||0
8209997|NCT02135107|20246523|P4|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
8209998|NCT02135107|20246524|P3|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
8209999|NCT02135107|20246525|P2|STARTED|Maintenance Therapy Period|Treatment Phase only|0
8210000|NCT02135107|20246526|P1|STARTED|Maintenance Therapy Period|Treatment Phase only|0
8210001|NCT02135107|20246523|P4|NOT COMPLETED|Treatment Period||0
8210002|NCT02135107|20246524|P3|NOT COMPLETED|Treatment Period||0
8210003|NCT02135107|20246525|P2|NOT COMPLETED|Treatment Period||26
8210004|NCT02135107|20246526|P1|NOT COMPLETED|Treatment Period||132
8210005|NCT02135107|20246523|P4|COMPLETED|Treatment Period||0
8210006|NCT02135107|20246524|P3|COMPLETED|Treatment Period||0
8210007|NCT02135107|20246525|P2|COMPLETED|Treatment Period||54
8210008|NCT02135107|20246526|P1|COMPLETED|Treatment Period||305
8210009|NCT02135107|20246523|P4|STARTED|Treatment Period||0
8210010|NCT02135107|20246524|P3|STARTED|Treatment Period||0
8210011|NCT02135107|20246525|P2|STARTED|Treatment Period||80
8210012|NCT02135107|20246526|P1|STARTED|Treatment Period||437
8210013|NCT02135094|20246554|P2|NOT COMPLETED|Overall Study||0
8210014|NCT02135094|20246555|P1|NOT COMPLETED|Overall Study||0
8210015|NCT02135094|20246554|P2|COMPLETED|Overall Study||8
8210016|NCT02135094|20246555|P1|COMPLETED|Overall Study||25
8210017|NCT02135094|20246554|P2|Week 4|Overall Study||8
8210018|NCT02135094|20246555|P1|Week 4|Overall Study||25
8210019|NCT02135094|20246554|P2|Week 3|Overall Study||8
8210020|NCT02135094|20246555|P1|Week 3|Overall Study||25
8210021|NCT02135094|20246554|P2|Week 2|Overall Study||8
8210022|NCT02135094|20246555|P1|Week 2|Overall Study||25
8210023|NCT02135094|20246554|P2|STARTED|Overall Study||8
8210024|NCT02135094|20246555|P1|STARTED|Overall Study||25
8210025|NCT02135029|20246572|P3|NOT COMPLETED|Overall Study||3
8210026|NCT02135029|20246573|P2|NOT COMPLETED|Overall Study||5
8210027|NCT02135029|20246574|P1|NOT COMPLETED|Overall Study||4
8210028|NCT02135029|20246572|P3|COMPLETED|Overall Study||34
8210029|NCT02135029|20246573|P2|COMPLETED|Overall Study||69
8210030|NCT02135029|20246574|P1|COMPLETED|Overall Study||69
8210031|NCT02135029|20246572|P3|Treated|Overall Study||36
8210032|NCT02135029|20246573|P2|Treated|Overall Study||74
8210033|NCT02135029|20246574|P1|Treated|Overall Study||73
8210034|NCT02135029|20246572|P3|STARTED|Overall Study||37
8210035|NCT02135029|20246573|P2|STARTED|Overall Study||74
8210036|NCT02135029|20246574|P1|STARTED|Overall Study||73
8210037|NCT02135016|20246657|P3|NOT COMPLETED|Overall Study||0
8210038|NCT02135016|20246658|P2|NOT COMPLETED|Overall Study||0
8210039|NCT02135016|20246659|P1|NOT COMPLETED|Overall Study||0
8210040|NCT02135016|20246657|P3|COMPLETED|Overall Study||15
8210041|NCT02135016|20246658|P2|COMPLETED|Overall Study||15
8210042|NCT02135016|20246659|P1|COMPLETED|Overall Study||15
8210043|NCT02135016|20246657|P3|STARTED|Overall Study||15
8210044|NCT02135016|20246658|P2|STARTED|Overall Study||15
8210045|NCT02135016|20246659|P1|STARTED|Overall Study||15
8210046|NCT02134977|20246679|P1|NOT COMPLETED|Overall Study||102
8210047|NCT02134977|20246679|P1|COMPLETED|Overall Study||2714
8210048|NCT02134977|20246679|P1|STARTED|Overall Study||2816
8210049|NCT02134951|20246702|P2|NOT COMPLETED|Overall Study||0
8210050|NCT02134951|20246703|P1|NOT COMPLETED|Overall Study||0
8210051|NCT02134951|20246702|P2|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
8210052|NCT02134951|20246703|P1|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
8210053|NCT02134951|20246702|P2|STARTED|Overall Study||20
8210054|NCT02134951|20246703|P1|STARTED|Overall Study||39
8210063|NCT02134912|20246732|P2|NOT COMPLETED|Overall Study||0
8210064|NCT02134912|20246733|P1|NOT COMPLETED|Overall Study||0
8210065|NCT02134912|20246732|P2|COMPLETED|Overall Study||0
8210066|NCT02134912|20246733|P1|COMPLETED|Overall Study||0
8210067|NCT02134912|20246732|P2|STARTED|Overall Study||0
8210068|NCT02134912|20246733|P1|STARTED|Overall Study||0
8210069|NCT02134756|20246751|P2|NOT COMPLETED|Overall Study||2
8210070|NCT02134756|20246752|P1|NOT COMPLETED|Overall Study||1
8210071|NCT02134756|20246751|P2|COMPLETED|Overall Study||13
8210072|NCT02134756|20246752|P1|COMPLETED|Overall Study||14
8210073|NCT02134756|20246751|P2|STARTED|Overall Study||15
8210074|NCT02134756|20246752|P1|STARTED|Overall Study||15
8210075|NCT02134717|20246762|P1|NOT COMPLETED|Overall Study||0
8210076|NCT02134717|20246762|P1|COMPLETED|Overall Study||3
8210077|NCT02134717|20246762|P1|STARTED|Overall Study||3
8210078|NCT02134587|20246768|P1|NOT COMPLETED|Overall Study||30
8210079|NCT02134587|20246768|P1|COMPLETED|Overall Study||173
8210080|NCT02134587|20246768|P1|STARTED|Overall Study||203
8210081|NCT02134522|20246777|P1|NOT COMPLETED|Overall Study||0
8210082|NCT02134522|20246777|P1|COMPLETED|Overall Study||1
8210083|NCT02134522|20246777|P1|STARTED|Overall Study||1
8210084|NCT02134353|20246784|P2|NOT COMPLETED|Overall Study||24
8210085|NCT02134353|20246785|P1|NOT COMPLETED|Overall Study||26
8210086|NCT02134353|20246784|P2|COMPLETED|Overall Study||190
8210087|NCT02134353|20246785|P1|COMPLETED|Overall Study||183
8210088|NCT02134353|20246784|P2|STARTED|Overall Study||214
8210089|NCT02134353|20246785|P1|STARTED|Overall Study||209
8210090|NCT02134314|20246811|P2|NOT COMPLETED|Overall Study||1
8210091|NCT02134314|20246812|P1|NOT COMPLETED|Overall Study||1
8210092|NCT02134314|20246811|P2|COMPLETED|Overall Study||34
8210093|NCT02134314|20246812|P1|COMPLETED|Overall Study||34
8210094|NCT02134314|20246811|P2|STARTED|Overall Study||35
8210095|NCT02134314|20246812|P1|STARTED|Overall Study||35
8210096|NCT02134210|20246844|P2|NOT COMPLETED|Part Two: Weeks 13-48||28
8210097|NCT02134210|20246845|P1|NOT COMPLETED|Part Two: Weeks 13-48||30
8210098|NCT02134210|20246844|P2|COMPLETED|Part Two: Weeks 13-48||227
8210099|NCT02134210|20246845|P1|COMPLETED|Part Two: Weeks 13-48||211
8210100|NCT02134210|20246844|P2|STARTED|Part Two: Weeks 13-48||255
8210101|NCT02134210|20246845|P1|STARTED|Part Two: Weeks 13-48||241
8210102|NCT02134210|20246844|P2|NOT COMPLETED|Part One: Weeks 0-12||6
8210103|NCT02134210|20246845|P1|NOT COMPLETED|Part One: Weeks 0-12||19
8210104|NCT02134210|20246844|P2|COMPLETED|Part One: Weeks 0-12||255
8210105|NCT02134210|20246845|P1|COMPLETED|Part One: Weeks 0-12||241
8210106|NCT02134210|20246844|P2|STARTED|Part One: Weeks 0-12||261
8210107|NCT02134210|20246845|P1|STARTED|Part One: Weeks 0-12||260
8210108|NCT02134184|20246878|P3|NOT COMPLETED|Overall Study||0
8210109|NCT02134184|20246879|P2|NOT COMPLETED|Overall Study||0
8210110|NCT02134184|20246880|P1|NOT COMPLETED|Overall Study||0
8210111|NCT02134184|20246878|P3|COMPLETED|Overall Study||8
8210112|NCT02134184|20246879|P2|COMPLETED|Overall Study||37
8210113|NCT02134184|20246880|P1|COMPLETED|Overall Study||33
8210114|NCT02134184|20246878|P3|STARTED|Overall Study||8
8210115|NCT02134184|20246879|P2|STARTED|Overall Study||37
8210116|NCT02134184|20246880|P1|STARTED|Overall Study||33
8210117|NCT02134119|20246893|P2|NOT COMPLETED|Overall Study||0
8210118|NCT02134119|20246894|P1|NOT COMPLETED|Overall Study||0
8210119|NCT02134119|20246893|P2|COMPLETED|Overall Study||15
8210120|NCT02134119|20246894|P1|COMPLETED|Overall Study||30
8210121|NCT02134119|20246893|P2|STARTED|Overall Study||15
8210122|NCT02134119|20246894|P1|STARTED|Overall Study||30
8210123|NCT02134028|20246940|P8|NOT COMPLETED|Overall Study||3
8210124|NCT02134028|20246941|P7|NOT COMPLETED|Overall Study||4
8210125|NCT02134028|20246942|P6|NOT COMPLETED|Overall Study||14
8210126|NCT02134028|20246943|P5|NOT COMPLETED|Overall Study||14
8210127|NCT02134028|20246944|P4|NOT COMPLETED|Overall Study||105
8210128|NCT02134028|20246945|P3|NOT COMPLETED|Overall Study||52
8210129|NCT02134028|20246946|P2|NOT COMPLETED|Overall Study||42
8210130|NCT02134028|20246947|P1|NOT COMPLETED|Overall Study||9
8210131|NCT02134028|20246940|P8|COMPLETED|Overall Study||11
8210132|NCT02134028|20246941|P7|COMPLETED|Overall Study||15
8210133|NCT02134028|20246942|P6|COMPLETED|Overall Study||76
8210134|NCT02134028|20246943|P5|COMPLETED|Overall Study||83
8210135|NCT02134028|20246944|P4|COMPLETED|Overall Study||908
8210136|NCT02134028|20246945|P3|COMPLETED|Overall Study||465
8210137|NCT02134028|20246946|P2|COMPLETED|Overall Study||379
8210138|NCT02134028|20246947|P1|COMPLETED|Overall Study||102
8210139|NCT02134028|20246940|P8|STARTED|Overall Study||14
8210140|NCT02134028|20246941|P7|STARTED|Overall Study||19
8210141|NCT02134028|20246942|P6|STARTED|Overall Study||90
8210142|NCT02134028|20246943|P5|STARTED|Overall Study||97
8210143|NCT02134028|20246944|P4|STARTED|Overall Study||1013
8210144|NCT02134028|20246945|P3|STARTED|Overall Study||517
8210145|NCT02134028|20246946|P2|STARTED|Overall Study||421
8210146|NCT02134028|20246947|P1|STARTED|Overall Study||111
8210147|NCT02134015|20247105|P2|NOT COMPLETED|Overall Study||74
8210148|NCT02134015|20247106|P1|NOT COMPLETED|Overall Study||71
8210149|NCT02134015|20247105|P2|COMPLETED|Overall Study||0
8210150|NCT02134015|20247106|P1|COMPLETED|Overall Study||0
8210151|NCT02134015|20247105|P2|STARTED|Overall Study||74
8210152|NCT02134015|20247106|P1|STARTED|Overall Study||71
8210153|NCT02133781|20247129|P3|NOT COMPLETED|Overall Study||0
8210154|NCT02133781|20247130|P2|NOT COMPLETED|Overall Study||0
8210155|NCT02133781|20247131|P1|NOT COMPLETED|Overall Study||0
8210156|NCT02133781|20247129|P3|COMPLETED|Overall Study||21
8210157|NCT02133781|20247130|P2|COMPLETED|Overall Study||24
8210158|NCT02133781|20247131|P1|COMPLETED|Overall Study||6
8210159|NCT02133781|20247129|P3|STARTED|Overall Study||21
8210160|NCT02133781|20247130|P2|STARTED|Overall Study||24
8210161|NCT02133781|20247131|P1|STARTED|Overall Study||6
8210168|NCT02133664|20247171|P2|NOT COMPLETED|Overall Study||7
8210169|NCT02133664|20247172|P1|NOT COMPLETED|Overall Study||5
8210170|NCT02133664|20247171|P2|COMPLETED|Overall Study||21
8210171|NCT02133664|20247172|P1|COMPLETED|Overall Study||21
8210172|NCT02133664|20247171|P2|STARTED|Overall Study||28
8210173|NCT02133664|20247172|P1|STARTED|Overall Study||26
8210174|NCT02133534|20247184|P1|NOT COMPLETED|Overall Study||0
8210175|NCT02133534|20247184|P1|COMPLETED|Overall Study||1
8210176|NCT02133534|20247184|P1|STARTED|Overall Study||1
8210177|NCT02133508|20247188|P1|NOT COMPLETED|Overall Study||15
8210178|NCT02133508|20247188|P1|COMPLETED|Overall Study||141
8210179|NCT02133508|20247188|P1|STARTED|Overall Study||156
8210180|NCT02133352|20247196|P1|NOT COMPLETED|Longer Term Extension||6
8210181|NCT02133352|20247196|P1|COMPLETED|Longer Term Extension||4
8210182|NCT02133352|20247196|P1|STARTED|Longer Term Extension||10
8210183|NCT02133352|20247196|P1|NOT COMPLETED|Main Study (180 Day)||0
8210184|NCT02133352|20247196|P1|COMPLETED|Main Study (180 Day)||10
8210185|NCT02133352|20247196|P1|STARTED|Main Study (180 Day)||10
8210186|NCT02133235|20247207|P2|NOT COMPLETED|Overall Study||0
8210187|NCT02133235|20247208|P1|NOT COMPLETED|Overall Study||0
8210188|NCT02133235|20247207|P2|COMPLETED|Overall Study||57
8210189|NCT02133235|20247208|P1|COMPLETED|Overall Study||55
8210190|NCT02133235|20247207|P2|STARTED|Overall Study||57
8210191|NCT02133235|20247208|P1|STARTED|Overall Study||55
8210213|NCT02133066|20247272|P2|NOT COMPLETED|Overall Study||0
8210214|NCT02133066|20247273|P1|NOT COMPLETED|Overall Study||0
8210215|NCT02133066|20247272|P2|COMPLETED|Overall Study||64
8210216|NCT02133066|20247273|P1|COMPLETED|Overall Study||64
8210217|NCT02133066|20247272|P2|STARTED|Overall Study||64
8210218|NCT02133066|20247273|P1|STARTED|Overall Study||64
8210219|NCT02133001|20247287|P2|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3
8210220|NCT02133001|20247288|P1|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2
8210221|NCT02133001|20247287|P2|COMPLETED|Follow-Up Phase (Day 26-81)||24
8210222|NCT02133001|20247288|P1|COMPLETED|Follow-Up Phase (Day 26-81)||20
8210223|NCT02133001|20247287|P2|STARTED|Follow-Up Phase (Day 26-81)||27
8210224|NCT02133001|20247288|P1|STARTED|Follow-Up Phase (Day 26-81)||22
8210225|NCT02133001|20247287|P2|NOT COMPLETED|Double Blind (Day 1-25)||9
8210226|NCT02133001|20247288|P1|NOT COMPLETED|Double Blind (Day 1-25)||10
8210227|NCT02133001|20247287|P2|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27
8210228|NCT02133001|20247288|P1|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22
8210229|NCT02133001|20247287|P2|Safety|Double Blind (Day 1-25)||35
8210230|NCT02133001|20247288|P1|Safety|Double Blind (Day 1-25)||31
8210231|NCT02133001|20247287|P2|STARTED|Double Blind (Day 1-25)||36
8210232|NCT02133001|20247288|P1|STARTED|Double Blind (Day 1-25)||32
8210233|NCT02132949|20247336|P2|NOT COMPLETED|Adjuvant Treatment Period||167
8210234|NCT02132949|20247337|P1|NOT COMPLETED|Adjuvant Treatment Period||149
8210235|NCT02132949|20247336|P2|COMPLETED|Adjuvant Treatment Period||23
8210236|NCT02132949|20247337|P1|COMPLETED|Adjuvant Treatment Period||29
8210237|NCT02132949|20247336|P2|STARTED|Adjuvant Treatment Period|Includes a participant who did not complete neoadjuvant treatment but started adjuvant treatment.|190
8210238|NCT02132949|20247337|P1|STARTED|Adjuvant Treatment Period|At clinical cutoff (03 March 2016), some participants had not yet received adjuvant treatment.|178
8210239|NCT02132949|20247336|P2|NOT COMPLETED|Neoadjuvant Treatment Period||12
8210240|NCT02132949|20247337|P1|NOT COMPLETED|Neoadjuvant Treatment Period||17
8210241|NCT02132949|20247336|P2|COMPLETED|Neoadjuvant Treatment Period||189
8210242|NCT02132949|20247337|P1|COMPLETED|Neoadjuvant Treatment Period||182
8210243|NCT02132949|20247336|P2|No Treatment|Neoadjuvant Treatment Period||3
8210244|NCT02132949|20247337|P1|No Treatment|Neoadjuvant Treatment Period||1
8210245|NCT02132949|20247336|P2|STARTED|Neoadjuvant Treatment Period||201
8210246|NCT02132949|20247337|P1|STARTED|Neoadjuvant Treatment Period|A participant enrolled in Cohort B received Cohort A treatment, hence counted under Cohort A.|199
8210247|NCT02132936|20247369|P4|NOT COMPLETED|Overall Study||14
8210248|NCT02132936|20247370|P3|NOT COMPLETED|Overall Study||14
8210249|NCT02132936|20247371|P2|NOT COMPLETED|Overall Study||9
8210250|NCT02132936|20247372|P1|NOT COMPLETED|Overall Study||10
8210251|NCT02132936|20247369|P4|COMPLETED|Overall Study||29
8210252|NCT02132936|20247370|P3|COMPLETED|Overall Study||174
8210253|NCT02132936|20247371|P2|COMPLETED|Overall Study||38
8210254|NCT02132936|20247372|P1|COMPLETED|Overall Study||175
8210255|NCT02132936|20247369|P4|STARTED|Overall Study||43
8210256|NCT02132936|20247370|P3|STARTED|Overall Study||188
8210257|NCT02132936|20247371|P2|STARTED|Overall Study||47
8210258|NCT02132936|20247372|P1|STARTED|Overall Study||185
8210259|NCT02132910|20247390|P2|NOT COMPLETED|Overall Study||0
8210260|NCT02132910|20247391|P1|NOT COMPLETED|Overall Study||0
8210261|NCT02132910|20247390|P2|COMPLETED|Overall Study||34
8210262|NCT02132910|20247391|P1|COMPLETED|Overall Study||34
8210263|NCT02132910|20247390|P2|STARTED|Overall Study||34
8210264|NCT02132910|20247391|P1|STARTED|Overall Study||34
8210265|NCT02132884|20247405|P2|NOT COMPLETED|Overall Study||0
8210266|NCT02132884|20247406|P1|NOT COMPLETED|Overall Study||0
8210267|NCT02132884|20247405|P2|COMPLETED|Overall Study||0
8210268|NCT02132884|20247406|P1|COMPLETED|Overall Study||0
8210269|NCT02132884|20247405|P2|STARTED|Overall Study||0
8210270|NCT02132884|20247406|P1|STARTED|Overall Study||0
8210271|NCT02132832|20247418|P2|NOT COMPLETED|Overall Study||7
8210272|NCT02132832|20247419|P1|NOT COMPLETED|Overall Study||3
8210273|NCT02132832|20247418|P2|COMPLETED|Overall Study||16
8210274|NCT02132832|20247419|P1|COMPLETED|Overall Study||16
8210275|NCT02132832|20247418|P2|STARTED|Overall Study||23
8210276|NCT02132832|20247419|P1|STARTED|Overall Study||19
8210277|NCT02132767|20247449|P2|NOT COMPLETED|Overall Study||15
8210278|NCT02132767|20247450|P1|NOT COMPLETED|Overall Study||17
8210279|NCT02132767|20247449|P2|COMPLETED|Overall Study||246
8210280|NCT02132767|20247450|P1|COMPLETED|Overall Study||245
8210281|NCT02132767|20247449|P2|STARTED|Overall Study||261
8210282|NCT02132767|20247450|P1|STARTED|Overall Study||262
8210283|NCT02132676|20247472|P2|NOT COMPLETED|Overall Study||0
8210284|NCT02132676|20247473|P1|NOT COMPLETED|Overall Study||0
8210285|NCT02132676|20247472|P2|COMPLETED|Overall Study||809
8210286|NCT02132676|20247473|P1|COMPLETED|Overall Study||727
8210287|NCT02132676|20247472|P2|STARTED|Overall Study||809
8210288|NCT02132676|20247473|P1|STARTED|Overall Study||727
8210289|NCT02132650|20247505|P2|NOT COMPLETED|Overall Study||4
8210290|NCT02132650|20247506|P1|NOT COMPLETED|Overall Study||3
8210291|NCT02132650|20247505|P2|COMPLETED|Overall Study||14
8210292|NCT02132650|20247506|P1|COMPLETED|Overall Study||17
8210293|NCT02132650|20247505|P2|Post-Intervention Assessment|Overall Study||17
8210294|NCT02132650|20247506|P1|Post-Intervention Assessment|Overall Study||19
8210295|NCT02132650|20247505|P2|STARTED|Overall Study||18
8210296|NCT02132650|20247506|P1|STARTED|Overall Study||20
8210297|NCT02132637|20247516|P2|NOT COMPLETED|Study Period 2 (Crossover)||1
8210298|NCT02132637|20247517|P1|NOT COMPLETED|Study Period 2 (Crossover)||2
8210299|NCT02132637|20247516|P2|COMPLETED|Study Period 2 (Crossover)||29
8210300|NCT02132637|20247517|P1|COMPLETED|Study Period 2 (Crossover)||31
8210301|NCT02132637|20247516|P2|STARTED|Study Period 2 (Crossover)||30
8210302|NCT02132637|20247517|P1|STARTED|Study Period 2 (Crossover)||33
8210303|NCT02132637|20247516|P2|NOT COMPLETED|Study Period 1||4
8210304|NCT02132637|20247517|P1|NOT COMPLETED|Study Period 1||1
8210305|NCT02132637|20247516|P2|COMPLETED|Study Period 1||30
8210306|NCT02132637|20247517|P1|COMPLETED|Study Period 1||33
8210307|NCT02132637|20247516|P2|Received at Least One Dose of Study Drug|Study Period 1||34
8210308|NCT02132637|20247517|P1|Received at Least One Dose of Study Drug|Study Period 1||34
8210309|NCT02132637|20247516|P2|STARTED|Study Period 1||34
8210310|NCT02132637|20247517|P1|STARTED|Study Period 1||34
8210311|NCT02132611|20247541|P1|NOT COMPLETED|Overall Study||2
8210312|NCT02132611|20247541|P1|COMPLETED|Overall Study||98
8210313|NCT02132611|20247541|P1|STARTED|Overall Study||100
8210317|NCT02132572|20247558|P1|NOT COMPLETED|Overall Study||0
8210318|NCT02132572|20247558|P1|COMPLETED|Overall Study||201
8210319|NCT02132572|20247558|P1|STARTED|Overall Study||201
8210320|NCT02132533|20247564|P2|NOT COMPLETED|Overall Study||0
8210321|NCT02132533|20247565|P1|NOT COMPLETED|Overall Study||0
8210322|NCT02132533|20247564|P2|COMPLETED|Overall Study||42
8210323|NCT02132533|20247565|P1|COMPLETED|Overall Study||46
8210324|NCT02132533|20247564|P2|STARTED|Overall Study||42
8210325|NCT02132533|20247565|P1|STARTED|Overall Study||46
8210326|NCT02132520|20247580|P3|NOT COMPLETED|Overall Study||0
8210327|NCT02132520|20247581|P2|NOT COMPLETED|Overall Study||0
8210328|NCT02132520|20247582|P1|NOT COMPLETED|Overall Study||0
8210329|NCT02132520|20247580|P3|COMPLETED|Overall Study||2
8210330|NCT02132520|20247581|P2|COMPLETED|Overall Study||1
8210331|NCT02132520|20247582|P1|COMPLETED|Overall Study||0
8210332|NCT02132520|20247580|P3|STARTED|Overall Study||2
8210333|NCT02132520|20247581|P2|STARTED|Overall Study||1
8210334|NCT02132520|20247582|P1|STARTED|Overall Study||0
8210335|NCT02132468|20247595|P1|NOT COMPLETED|Overall Study||7
8210336|NCT02132468|20247595|P1|COMPLETED|Overall Study||11
8210337|NCT02132468|20247595|P1|STARTED|Overall Study||18
8210338|NCT02132247|20247604|P2|NOT COMPLETED|Overall Study||0
8210339|NCT02132247|20247605|P1|NOT COMPLETED|Overall Study||1
8210340|NCT02132247|20247604|P2|COMPLETED|Overall Study||52
8210341|NCT02132247|20247605|P1|COMPLETED|Overall Study||51
8210342|NCT02132247|20247604|P2|STARTED|Overall Study||52
8210343|NCT02132247|20247605|P1|STARTED|Overall Study||52
8210344|NCT02132195|20247620|P3|NOT COMPLETED|Rescue Therapy||11
8210345|NCT02132195|20247621|P2|NOT COMPLETED|Rescue Therapy||0
8210346|NCT02132195|20247622|P1|NOT COMPLETED|Rescue Therapy||0
8210347|NCT02132195|20247620|P3|COMPLETED|Rescue Therapy||2
8210348|NCT02132195|20247621|P2|COMPLETED|Rescue Therapy||0
8210349|NCT02132195|20247622|P1|COMPLETED|Rescue Therapy||0
8210350|NCT02132195|20247620|P3|STARTED|Rescue Therapy||13
8210351|NCT02132195|20247621|P2|STARTED|Rescue Therapy||0
8210352|NCT02132195|20247622|P1|STARTED|Rescue Therapy||0
8210353|NCT02132195|20247620|P3|NOT COMPLETED|Initial Assignment||0
8210354|NCT02132195|20247621|P2|NOT COMPLETED|Initial Assignment||0
8210355|NCT02132195|20247622|P1|NOT COMPLETED|Initial Assignment||14
8210356|NCT02132195|20247620|P3|COMPLETED|Initial Assignment||0
8210357|NCT02132195|20247621|P2|COMPLETED|Initial Assignment||16
8210358|NCT02132195|20247622|P1|COMPLETED|Initial Assignment||1
8210359|NCT02132195|20247620|P3|STARTED|Initial Assignment||0
8210360|NCT02132195|20247621|P2|STARTED|Initial Assignment||16
8210361|NCT02132195|20247622|P1|STARTED|Initial Assignment||15
8210362|NCT02132169|20247638|P2|NOT COMPLETED|Overall Study||9
8210363|NCT02132169|20247639|P1|NOT COMPLETED|Overall Study||15
8210364|NCT02132169|20247638|P2|COMPLETED|Overall Study||162
8210365|NCT02132169|20247639|P1|COMPLETED|Overall Study||326
8210366|NCT02132169|20247638|P2|STARTED|Overall Study||171
8210367|NCT02132169|20247639|P1|STARTED|Overall Study||341
8210368|NCT02132117|20247653|P2|NOT COMPLETED|Overall Study||5
8210369|NCT02132117|20247654|P1|NOT COMPLETED|Overall Study||11
8210370|NCT02132117|20247653|P2|COMPLETED|Overall Study||216
8210371|NCT02132117|20247654|P1|COMPLETED|Overall Study||213
8210372|NCT02132117|20247653|P2|STARTED|Overall Study||221
8210373|NCT02132117|20247654|P1|STARTED|Overall Study||224
8210374|NCT02131766|20247670|P1|NOT COMPLETED|Overall Study||4
8210375|NCT02131766|20247670|P1|COMPLETED|Overall Study||40
8210376|NCT02131766|20247670|P1|STARTED|Overall Study||44
8210377|NCT02131662|20247686|P5|NOT COMPLETED|Overall Study||18
8210378|NCT02131662|20247687|P4|NOT COMPLETED|Overall Study||21
8210379|NCT02131662|20247688|P3|NOT COMPLETED|Overall Study||7
8210380|NCT02131662|20247689|P2|NOT COMPLETED|Overall Study||14
8210381|NCT02131662|20247690|P1|NOT COMPLETED|Overall Study||8
8210382|NCT02131662|20247686|P5|COMPLETED|Overall Study||43
8210383|NCT02131662|20247687|P4|COMPLETED|Overall Study||41
8210384|NCT02131662|20247688|P3|COMPLETED|Overall Study||56
8210385|NCT02131662|20247689|P2|COMPLETED|Overall Study||47
8210386|NCT02131662|20247690|P1|COMPLETED|Overall Study||54
8210387|NCT02131662|20247686|P5|Completed Follow-up|Overall Study||44
8210388|NCT02131662|20247687|P4|Completed Follow-up|Overall Study||42
8210389|NCT02131662|20247688|P3|Completed Follow-up|Overall Study||56
8210390|NCT02131662|20247689|P2|Completed Follow-up|Overall Study||47
8210391|NCT02131662|20247690|P1|Completed Follow-up|Overall Study||54
8210392|NCT02131662|20247686|P5|Completed Treatment|Overall Study||52
8210393|NCT02131662|20247687|P4|Completed Treatment|Overall Study||56
8210394|NCT02131662|20247688|P3|Completed Treatment|Overall Study||61
8210395|NCT02131662|20247689|P2|Completed Treatment|Overall Study||60
8210396|NCT02131662|20247690|P1|Completed Treatment|Overall Study||57
8210397|NCT02131662|20247686|P5|Treated|Overall Study||58
8210398|NCT02131662|20247687|P4|Treated|Overall Study||60
8210399|NCT02131662|20247688|P3|Treated|Overall Study||61
8210400|NCT02131662|20247689|P2|Treated|Overall Study||61
8210401|NCT02131662|20247690|P1|Treated|Overall Study||60
8210402|NCT02131662|20247686|P5|STARTED|Overall Study||61
8210403|NCT02131662|20247687|P4|STARTED|Overall Study||62
8210404|NCT02131662|20247688|P3|STARTED|Overall Study||63
8210405|NCT02131662|20247689|P2|STARTED|Overall Study||61
8210406|NCT02131662|20247690|P1|STARTED|Overall Study||62
8210407|NCT02131636|20247736|P2|NOT COMPLETED|Overall Study||5
8210408|NCT02131636|20247737|P1|NOT COMPLETED|Overall Study||12
8210409|NCT02131636|20247736|P2|COMPLETED|Overall Study||213
8210410|NCT02131636|20247737|P1|COMPLETED|Overall Study||210
8210411|NCT02131636|20247736|P2|STARTED|Overall Study||218
8210412|NCT02131636|20247737|P1|STARTED|Overall Study||222
8210413|NCT02131532|20247753|P1|NOT COMPLETED|Overall Study||4
8210414|NCT02131532|20247753|P1|COMPLETED|Overall Study||8
8210415|NCT02131532|20247753|P1|STARTED|Overall Study||12
8210416|NCT02131402|20247772|P1|NOT COMPLETED|Overall Study||0
8210417|NCT02131402|20247772|P1|COMPLETED|Overall Study||60
8210418|NCT02131402|20247772|P1|STARTED|Overall Study||60
8210419|NCT02131324|20247845|P2|NOT COMPLETED|Overall Study||3
8210420|NCT02131324|20247846|P1|NOT COMPLETED|Overall Study||2
8210421|NCT02131324|20247845|P2|COMPLETED|Overall Study||23
8210422|NCT02131324|20247846|P1|COMPLETED|Overall Study||22
8210423|NCT02131324|20247845|P2|Analyzed|Overall Study||24
8210424|NCT02131324|20247846|P1|Analyzed|Overall Study||22
8210425|NCT02131324|20247845|P2|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
8210426|NCT02131324|20247846|P1|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
8210427|NCT02131311|20247852|P1|NOT COMPLETED|Overall Study||4
8210428|NCT02131311|20247852|P1|COMPLETED|Overall Study||86
8210429|NCT02131311|20247852|P1|STARTED|Overall Study||90
8210430|NCT02131272|20247864|P2|NOT COMPLETED|Overall Study||2
8210431|NCT02131272|20247865|P1|NOT COMPLETED|Overall Study||1
8210432|NCT02131272|20247864|P2|COMPLETED|Overall Study||20
8210433|NCT02131272|20247865|P1|COMPLETED|Overall Study||19
8210434|NCT02131272|20247864|P2|STARTED|Overall Study||22
8210435|NCT02131272|20247865|P1|STARTED|Overall Study||20
8210436|NCT02131259|20247883|P1|NOT COMPLETED|Overall Study||1225
8210437|NCT02131259|20247883|P1|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
8210438|NCT02131259|20247883|P1|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
8210439|NCT02131233|20247890|P2|NOT COMPLETED|Overall Study||42
8210440|NCT02131233|20247891|P1|NOT COMPLETED|Overall Study||66
8210441|NCT02131233|20247890|P2|COMPLETED|Overall Study|Completed to Week 96|227
8210442|NCT02131233|20247891|P1|COMPLETED|Overall Study|Completed to Week 96|467
8210443|NCT02131233|20247890|P2|Treated|Overall Study||266
8210444|NCT02131233|20247891|P1|Treated|Overall Study||531
8210445|NCT02131233|20247890|P2|STARTED|Overall Study|Enrolled participants|269
8210446|NCT02131233|20247891|P1|STARTED|Overall Study|Enrolled participants|533
8210447|NCT02131155|20247925|P2|NOT COMPLETED|Overall Study||11
8210448|NCT02131155|20247926|P1|NOT COMPLETED|Overall Study||25
8210449|NCT02131155|20247925|P2|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
8210450|NCT02131155|20247926|P1|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
8210451|NCT02131155|20247925|P2|STARTED|Overall Study|Started are treated patients.|11
8210452|NCT02131155|20247926|P1|STARTED|Overall Study|Started are treated patients.|25
8210453|NCT02131129|20247940|P2|NOT COMPLETED|Overall Study||0
8210454|NCT02131129|20247941|P1|NOT COMPLETED|Overall Study||1
8210455|NCT02131129|20247940|P2|COMPLETED|Overall Study||10
8210456|NCT02131129|20247941|P1|COMPLETED|Overall Study||9
8210457|NCT02131129|20247940|P2|STARTED|Overall Study||10
8210458|NCT02131129|20247941|P1|STARTED|Overall Study||10
8210459|NCT02131064|20247959|P2|NOT COMPLETED|Overall Study||34
8210460|NCT02131064|20247960|P1|NOT COMPLETED|Overall Study||25
8210461|NCT02131064|20247959|P2|COMPLETED|Overall Study||189
8210462|NCT02131064|20247960|P1|COMPLETED|Overall Study||196
8210463|NCT02131064|20247959|P2|STARTED|Overall Study||223
8210464|NCT02131064|20247960|P1|STARTED|Overall Study||221
8210465|NCT02130999|20248000|P2|NOT COMPLETED|Overall Study||0
8210466|NCT02130999|20248001|P1|NOT COMPLETED|Overall Study||0
8210467|NCT02130999|20248000|P2|COMPLETED|Overall Study||8
8210468|NCT02130999|20248001|P1|COMPLETED|Overall Study||6
8210469|NCT02130999|20248000|P2|STARTED|Overall Study||8
8210470|NCT02130999|20248001|P1|STARTED|Overall Study||6
8210471|NCT02130986|20248029|P2|NOT COMPLETED|Overall Study||164
8210472|NCT02130986|20248030|P1|NOT COMPLETED|Overall Study||155
8210473|NCT02130986|20248029|P2|COMPLETED|Overall Study||670
8210474|NCT02130986|20248030|P1|COMPLETED|Overall Study||675
8210475|NCT02130986|20248029|P2|STARTED|Overall Study||834
8210476|NCT02130986|20248030|P1|STARTED|Overall Study||830
8210477|NCT02130765|20248044|P4|NOT COMPLETED|Overall Study||0
8210478|NCT02130765|20248045|P3|NOT COMPLETED|Overall Study||0
8210479|NCT02130765|20248046|P2|NOT COMPLETED|Overall Study||0
8210480|NCT02130765|20248047|P1|NOT COMPLETED|Overall Study||4
8210481|NCT02130765|20248044|P4|COMPLETED|Overall Study||19
8210482|NCT02130765|20248045|P3|COMPLETED|Overall Study||26
8210483|NCT02130765|20248046|P2|COMPLETED|Overall Study||8
8210484|NCT02130765|20248047|P1|COMPLETED|Overall Study||7
8210485|NCT02130765|20248044|P4|STARTED|Overall Study||19
8210486|NCT02130765|20248045|P3|STARTED|Overall Study||26
8210487|NCT02130765|20248046|P2|STARTED|Overall Study||8
8210488|NCT02130765|20248047|P1|STARTED|Overall Study||11
8210489|NCT02130635|20248075|P9|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210490|NCT02130635|20248076|P8|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210491|NCT02130635|20248077|P7|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210492|NCT02130635|20248078|P6|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210493|NCT02130635|20248079|P5|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210494|NCT02130635|20248080|P4|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210495|NCT02130635|20248081|P3|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210496|NCT02130635|20248082|P2|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210497|NCT02130635|20248083|P1|NOT COMPLETED|Part B-Dose-Response Relationship||0
8210498|NCT02130635|20248075|P9|COMPLETED|Part B-Dose-Response Relationship||5
8210499|NCT02130635|20248076|P8|COMPLETED|Part B-Dose-Response Relationship||5
8210500|NCT02130635|20248077|P7|COMPLETED|Part B-Dose-Response Relationship||6
8210501|NCT02130635|20248078|P6|COMPLETED|Part B-Dose-Response Relationship||5
8210502|NCT02130635|20248079|P5|COMPLETED|Part B-Dose-Response Relationship||5
8210503|NCT02130635|20248080|P4|COMPLETED|Part B-Dose-Response Relationship||5
8210504|NCT02130635|20248081|P3|COMPLETED|Part B-Dose-Response Relationship||5
8210505|NCT02130635|20248082|P2|COMPLETED|Part B-Dose-Response Relationship||0
8210506|NCT02130635|20248083|P1|COMPLETED|Part B-Dose-Response Relationship||0
8210507|NCT02130635|20248075|P9|STARTED|Part B-Dose-Response Relationship||5
8210508|NCT02130635|20248076|P8|STARTED|Part B-Dose-Response Relationship||5
8210509|NCT02130635|20248077|P7|STARTED|Part B-Dose-Response Relationship||6
8210510|NCT02130635|20248078|P6|STARTED|Part B-Dose-Response Relationship||5
8210511|NCT02130635|20248079|P5|STARTED|Part B-Dose-Response Relationship||5
8210512|NCT02130635|20248080|P4|STARTED|Part B-Dose-Response Relationship||5
8210513|NCT02130635|20248081|P3|STARTED|Part B-Dose-Response Relationship||5
8210514|NCT02130635|20248082|P2|STARTED|Part B-Dose-Response Relationship||0
8210515|NCT02130635|20248083|P1|STARTED|Part B-Dose-Response Relationship||0
8210516|NCT02130635|20248075|P9|NOT COMPLETED|Part A-Safety and Tolerability||0
8210517|NCT02130635|20248076|P8|NOT COMPLETED|Part A-Safety and Tolerability||0
8210518|NCT02130635|20248077|P7|NOT COMPLETED|Part A-Safety and Tolerability||0
8210519|NCT02130635|20248078|P6|NOT COMPLETED|Part A-Safety and Tolerability||0
8210520|NCT02130635|20248079|P5|NOT COMPLETED|Part A-Safety and Tolerability||0
8210521|NCT02130635|20248080|P4|NOT COMPLETED|Part A-Safety and Tolerability||0
8210522|NCT02130635|20248081|P3|NOT COMPLETED|Part A-Safety and Tolerability||0
8210523|NCT02130635|20248082|P2|NOT COMPLETED|Part A-Safety and Tolerability||0
8210524|NCT02130635|20248083|P1|NOT COMPLETED|Part A-Safety and Tolerability||0
8210525|NCT02130635|20248075|P9|COMPLETED|Part A-Safety and Tolerability||0
8210526|NCT02130635|20248076|P8|COMPLETED|Part A-Safety and Tolerability||0
8210527|NCT02130635|20248077|P7|COMPLETED|Part A-Safety and Tolerability||0
8210528|NCT02130635|20248078|P6|COMPLETED|Part A-Safety and Tolerability||0
8210529|NCT02130635|20248079|P5|COMPLETED|Part A-Safety and Tolerability||0
8210530|NCT02130635|20248080|P4|COMPLETED|Part A-Safety and Tolerability||0
8210531|NCT02130635|20248081|P3|COMPLETED|Part A-Safety and Tolerability||0
8210532|NCT02130635|20248082|P2|COMPLETED|Part A-Safety and Tolerability||21
8210533|NCT02130635|20248083|P1|COMPLETED|Part A-Safety and Tolerability||7
8210534|NCT02130635|20248075|P9|STARTED|Part A-Safety and Tolerability||0
8210535|NCT02130635|20248076|P8|STARTED|Part A-Safety and Tolerability||0
8210536|NCT02130635|20248077|P7|STARTED|Part A-Safety and Tolerability||0
8210537|NCT02130635|20248078|P6|STARTED|Part A-Safety and Tolerability||0
8210538|NCT02130635|20248079|P5|STARTED|Part A-Safety and Tolerability||0
8210539|NCT02130635|20248080|P4|STARTED|Part A-Safety and Tolerability||0
8210540|NCT02130635|20248081|P3|STARTED|Part A-Safety and Tolerability||0
8210541|NCT02130635|20248082|P2|STARTED|Part A-Safety and Tolerability||21
8210542|NCT02130635|20248083|P1|STARTED|Part A-Safety and Tolerability||7
8210543|NCT02130622|20248257|P2|NOT COMPLETED|Overall Study||0
8210544|NCT02130622|20248258|P1|NOT COMPLETED|Overall Study||0
8210545|NCT02130622|20248257|P2|COMPLETED|Overall Study||1
8210546|NCT02130622|20248258|P1|COMPLETED|Overall Study||2
8210547|NCT02130622|20248257|P2|STARTED|Overall Study||1
8210548|NCT02130622|20248258|P1|STARTED|Overall Study||2
8210549|NCT02130583|20248272|P2|NOT COMPLETED|Overall Study||7
8210550|NCT02130583|20248273|P1|NOT COMPLETED|Overall Study||9
8210551|NCT02130583|20248272|P2|COMPLETED|Overall Study||19
8210552|NCT02130583|20248273|P1|COMPLETED|Overall Study||17
8210553|NCT02130583|20248272|P2|STARTED|Overall Study||26
8210554|NCT02130583|20248273|P1|STARTED|Overall Study||26
8210555|NCT02130570|20248293|P2|NOT COMPLETED|Overall Study||13
8210556|NCT02130570|20248294|P1|NOT COMPLETED|Overall Study||9
8210557|NCT02130570|20248293|P2|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679
8210558|NCT02130570|20248294|P1|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978
8210559|NCT02130570|20248293|P2|STARTED|Overall Study||692
8210560|NCT02130570|20248294|P1|STARTED|Overall Study||987
8210571|NCT02130284|20248345|P1|NOT COMPLETED|Overall Study||9
8210572|NCT02130284|20248345|P1|COMPLETED|Overall Study||71
8210573|NCT02130284|20248345|P1|STARTED|Overall Study||80
8210574|NCT02130258|20248358|P2|NOT COMPLETED|Overall Study||0
8210575|NCT02130258|20248359|P1|NOT COMPLETED|Overall Study||0
8210576|NCT02130258|20248358|P2|COMPLETED|Overall Study||11
8210577|NCT02130258|20248359|P1|COMPLETED|Overall Study||9
8210578|NCT02130258|20248358|P2|STARTED|Overall Study||11
8210579|NCT02130258|20248359|P1|STARTED|Overall Study||9
8210580|NCT02130193|20248371|P3|NOT COMPLETED|Part B: 52-week Double-blind Period||8
8210581|NCT02130193|20248372|P2|NOT COMPLETED|Part B: 52-week Double-blind Period||10
8210582|NCT02130193|20248373|P1|NOT COMPLETED|Part B: 52-week Double-blind Period||0
8210583|NCT02130193|20248371|P3|COMPLETED|Part B: 52-week Double-blind Period||37
8210584|NCT02130193|20248372|P2|COMPLETED|Part B: 52-week Double-blind Period||38
8210585|NCT02130193|20248373|P1|COMPLETED|Part B: 52-week Double-blind Period||0
8210586|NCT02130193|20248371|P3|STARTED|Part B: 52-week Double-blind Period||45
8210587|NCT02130193|20248372|P2|STARTED|Part B: 52-week Double-blind Period||48
8210588|NCT02130193|20248373|P1|STARTED|Part B: 52-week Double-blind Period||0
8210589|NCT02130193|20248371|P3|NOT COMPLETED|Part A: 4-week Open-label Period||0
8210590|NCT02130193|20248372|P2|NOT COMPLETED|Part A: 4-week Open-label Period||0
8210591|NCT02130193|20248373|P1|NOT COMPLETED|Part A: 4-week Open-label Period||0
8210592|NCT02130193|20248371|P3|COMPLETED|Part A: 4-week Open-label Period||0
8210593|NCT02130193|20248372|P2|COMPLETED|Part A: 4-week Open-label Period||0
8210594|NCT02130193|20248373|P1|COMPLETED|Part A: 4-week Open-label Period||9
8210595|NCT02130193|20248371|P3|STARTED|Part A: 4-week Open-label Period||0
8210596|NCT02130193|20248372|P2|STARTED|Part A: 4-week Open-label Period||0
8210597|NCT02130193|20248373|P1|STARTED|Part A: 4-week Open-label Period||9
8210598|NCT02130063|20248439|P2|NOT COMPLETED|Overall Study||17
8210599|NCT02130063|20248440|P1|NOT COMPLETED|Overall Study||25
8210600|NCT02130063|20248439|P2|COMPLETED|Overall Study||152
8210601|NCT02130063|20248440|P1|COMPLETED|Overall Study||317
8210602|NCT02130063|20248439|P2|STARTED|Overall Study||169
8210603|NCT02130063|20248440|P1|STARTED|Overall Study||342
8210604|NCT02130024|20248454|P2|NOT COMPLETED|Overall Study||31
8210605|NCT02130024|20248455|P1|NOT COMPLETED|Overall Study||25
8210606|NCT02130024|20248454|P2|COMPLETED|Overall Study||108
8210607|NCT02130024|20248455|P1|COMPLETED|Overall Study||117
8210608|NCT02130024|20248454|P2|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137
8210609|NCT02130024|20248455|P1|Full Analysis Set (FAS)|Overall Study||141
8210610|NCT02130024|20248454|P2|Safety Set|Overall Study||139
8210611|NCT02130024|20248455|P1|Safety Set|Overall Study|One randomized patient did not receive treatment|141
8210612|NCT02130024|20248454|P2|STARTED|Overall Study||139
8210613|NCT02130024|20248455|P1|STARTED|Overall Study||142
8210614|NCT02129803|20248489|P2|NOT COMPLETED|Overall Study||3
8210615|NCT02129803|20248490|P1|NOT COMPLETED|Overall Study||6
8210616|NCT02129803|20248489|P2|COMPLETED|Overall Study||9
8210617|NCT02129803|20248490|P1|COMPLETED|Overall Study||6
8210618|NCT02129803|20248489|P2|STARTED|Overall Study||12
8210619|NCT02129803|20248490|P1|STARTED|Overall Study||12
8210620|NCT02129777|20248503|P7|NOT COMPLETED|Open-Label Period||48
8210621|NCT02129777|20248504|P6|NOT COMPLETED|Open-Label Period||12
8210622|NCT02129777|20248505|P5|NOT COMPLETED|Open-Label Period||0
8210623|NCT02129777|20248506|P4|NOT COMPLETED|Open-Label Period||0
8210624|NCT02129777|20248507|P3|NOT COMPLETED|Open-Label Period||0
8210625|NCT02129777|20248508|P2|NOT COMPLETED|Open-Label Period||0
8210626|NCT02129777|20248509|P1|NOT COMPLETED|Open-Label Period||0
8210627|NCT02129777|20248503|P7|COMPLETED|Open-Label Period||0
8210628|NCT02129777|20248504|P6|COMPLETED|Open-Label Period||0
8210629|NCT02129777|20248505|P5|COMPLETED|Open-Label Period||0
8210630|NCT02129777|20248506|P4|COMPLETED|Open-Label Period||0
8210631|NCT02129777|20248507|P3|COMPLETED|Open-Label Period||0
8210632|NCT02129777|20248508|P2|COMPLETED|Open-Label Period||0
8210633|NCT02129777|20248509|P1|COMPLETED|Open-Label Period||0
8210634|NCT02129777|20248503|P7|STARTED|Open-Label Period||48
8210635|NCT02129777|20248504|P6|STARTED|Open-Label Period||12
8210636|NCT02129777|20248505|P5|STARTED|Open-Label Period||0
8210637|NCT02129777|20248506|P4|STARTED|Open-Label Period||0
8210638|NCT02129777|20248507|P3|STARTED|Open-Label Period||0
8210639|NCT02129777|20248508|P2|STARTED|Open-Label Period||0
8210640|NCT02129777|20248509|P1|STARTED|Open-Label Period||0
8210641|NCT02129777|20248503|P7|NOT COMPLETED|Double-Blind Period||0
8210642|NCT02129777|20248504|P6|NOT COMPLETED|Double-Blind Period||0
8210643|NCT02129777|20248505|P5|NOT COMPLETED|Double-Blind Period||7
8210644|NCT02129777|20248506|P4|NOT COMPLETED|Double-Blind Period||7
8210645|NCT02129777|20248507|P3|NOT COMPLETED|Double-Blind Period||4
8210646|NCT02129777|20248508|P2|NOT COMPLETED|Double-Blind Period||8
8210647|NCT02129777|20248509|P1|NOT COMPLETED|Double-Blind Period||7
8210648|NCT02129777|20248503|P7|COMPLETED|Double-Blind Period||0
8210649|NCT02129777|20248504|P6|COMPLETED|Double-Blind Period||0
8210650|NCT02129777|20248505|P5|COMPLETED|Double-Blind Period||18
8210651|NCT02129777|20248506|P4|COMPLETED|Double-Blind Period||18
8210652|NCT02129777|20248507|P3|COMPLETED|Double-Blind Period||20
8210653|NCT02129777|20248508|P2|COMPLETED|Double-Blind Period||16
8210654|NCT02129777|20248509|P1|COMPLETED|Double-Blind Period||17
8210655|NCT02129777|20248503|P7|STARTED|Double-Blind Period||0
8210656|NCT02129777|20248504|P6|STARTED|Double-Blind Period||0
8210657|NCT02129777|20248505|P5|STARTED|Double-Blind Period||25
8210658|NCT02129777|20248506|P4|STARTED|Double-Blind Period||25
8210659|NCT02129777|20248507|P3|STARTED|Double-Blind Period||24
8210660|NCT02129777|20248508|P2|STARTED|Double-Blind Period||24
8210661|NCT02129777|20248509|P1|STARTED|Double-Blind Period||24
8210662|NCT02129725|20248615|P2|NOT COMPLETED|Overall Study||3
8210663|NCT02129725|20248616|P1|NOT COMPLETED|Overall Study||2
8210664|NCT02129725|20248615|P2|COMPLETED|Overall Study||4
8210665|NCT02129725|20248616|P1|COMPLETED|Overall Study||6
8210666|NCT02129725|20248615|P2|STARTED|Overall Study||7
8210667|NCT02129725|20248616|P1|STARTED|Overall Study||8
8210683|NCT02129608|20248676|P3|NOT COMPLETED|Overall Study||3
8210684|NCT02129608|20248677|P2|NOT COMPLETED|Overall Study||1
8210685|NCT02129608|20248678|P1|NOT COMPLETED|Overall Study||0
8210686|NCT02129608|20248676|P3|COMPLETED|Overall Study||12
8210687|NCT02129608|20248677|P2|COMPLETED|Overall Study||13
8210688|NCT02129608|20248678|P1|COMPLETED|Overall Study||15
8210689|NCT02129608|20248676|P3|End of Treatment|Overall Study||12
8210690|NCT02129608|20248677|P2|End of Treatment|Overall Study||13
8210691|NCT02129608|20248678|P1|End of Treatment|Overall Study||15
8210692|NCT02129608|20248676|P3|STARTED|Overall Study||15
8210693|NCT02129608|20248677|P2|STARTED|Overall Study||14
8210694|NCT02129608|20248678|P1|STARTED|Overall Study||15
8210695|NCT02129556|20248692|P4|NOT COMPLETED|Overall Study||0
8210696|NCT02129556|20248693|P3|NOT COMPLETED|Overall Study||3
8210697|NCT02129556|20248694|P2|NOT COMPLETED|Overall Study||0
8210698|NCT02129556|20248695|P1|NOT COMPLETED|Overall Study||0
8210699|NCT02129556|20248692|P4|COMPLETED|Overall Study||12
8210700|NCT02129556|20248693|P3|COMPLETED|Overall Study||37
8210701|NCT02129556|20248694|P2|COMPLETED|Overall Study||3
8210702|NCT02129556|20248695|P1|COMPLETED|Overall Study||3
8210703|NCT02129556|20248692|P4|STARTED|Overall Study||12
8210704|NCT02129556|20248693|P3|STARTED|Overall Study||40
8210705|NCT02129556|20248694|P2|STARTED|Overall Study||3
8210706|NCT02129556|20248695|P1|STARTED|Overall Study||3
8210707|NCT02129478|20248719|P1|NOT COMPLETED|Overall Study||0
8210708|NCT02129478|20248719|P1|COMPLETED|Overall Study||15
8210709|NCT02129478|20248719|P1|STARTED|Overall Study||15
8210710|NCT02129205|20248735|P10|NOT COMPLETED|Overall Study||0
8210711|NCT02129205|20248736|P9|NOT COMPLETED|Overall Study||2
8210712|NCT02129205|20248737|P8|NOT COMPLETED|Overall Study||2
8210713|NCT02129205|20248738|P7|NOT COMPLETED|Overall Study||4
8210714|NCT02129205|20248739|P6|NOT COMPLETED|Overall Study||4
8210715|NCT02129205|20248740|P5|NOT COMPLETED|Overall Study||3
8210716|NCT02129205|20248741|P4|NOT COMPLETED|Overall Study||0
8210717|NCT02129205|20248742|P3|NOT COMPLETED|Overall Study||0
8210718|NCT02129205|20248743|P2|NOT COMPLETED|Overall Study||0
8210719|NCT02129205|20248744|P1|NOT COMPLETED|Overall Study||1
8210720|NCT02129205|20248735|P10|COMPLETED|Overall Study||0
8210721|NCT02129205|20248736|P9|COMPLETED|Overall Study||0
8210722|NCT02129205|20248737|P8|COMPLETED|Overall Study||4
8210723|NCT02129205|20248738|P7|COMPLETED|Overall Study||2
8210724|NCT02129205|20248739|P6|COMPLETED|Overall Study||7
8210725|NCT02129205|20248740|P5|COMPLETED|Overall Study||4
8210726|NCT02129205|20248741|P4|COMPLETED|Overall Study||2
8210727|NCT02129205|20248742|P3|COMPLETED|Overall Study||2
8210728|NCT02129205|20248743|P2|COMPLETED|Overall Study||2
8210729|NCT02129205|20248744|P1|COMPLETED|Overall Study||1
8210730|NCT02129205|20248735|P10|STARTED|Overall Study||0
8210731|NCT02129205|20248736|P9|STARTED|Overall Study||2
8210732|NCT02129205|20248737|P8|STARTED|Overall Study||6
8210733|NCT02129205|20248738|P7|STARTED|Overall Study||6
8210734|NCT02129205|20248739|P6|STARTED|Overall Study||11
8210735|NCT02129205|20248740|P5|STARTED|Overall Study||7
8210736|NCT02129205|20248741|P4|STARTED|Overall Study||2
8210737|NCT02129205|20248742|P3|STARTED|Overall Study||2
8210738|NCT02129205|20248743|P2|STARTED|Overall Study||2
8210739|NCT02129205|20248744|P1|STARTED|Overall Study||2
8210740|NCT02129192|20248897|P2|NOT COMPLETED|Period 5||0
8210741|NCT02129192|20248898|P1|NOT COMPLETED|Period 5||0
8210742|NCT02129192|20248897|P2|COMPLETED|Period 5||0
8210743|NCT02129192|20248898|P1|COMPLETED|Period 5||36
8210744|NCT02129192|20248897|P2|STARTED|Period 5|This sequence consists of only 4 periods.|0
8210745|NCT02129192|20248898|P1|STARTED|Period 5||36
8210746|NCT02129192|20248897|P2|NOT COMPLETED|Period 4 Including Washout Period||0
8210747|NCT02129192|20248898|P1|NOT COMPLETED|Period 4 Including Washout Period||0
8210748|NCT02129192|20248897|P2|COMPLETED|Period 4 Including Washout Period||35
8210749|NCT02129192|20248898|P1|COMPLETED|Period 4 Including Washout Period||36
8210750|NCT02129192|20248897|P2|STARTED|Period 4 Including Washout Period||35
8210751|NCT02129192|20248898|P1|STARTED|Period 4 Including Washout Period||36
8210752|NCT02129192|20248897|P2|NOT COMPLETED|Period 3 Including Washout Period||0
8210753|NCT02129192|20248898|P1|NOT COMPLETED|Period 3 Including Washout Period||0
8210754|NCT02129192|20248897|P2|COMPLETED|Period 3 Including Washout Period||35
8210755|NCT02129192|20248898|P1|COMPLETED|Period 3 Including Washout Period||36
8210756|NCT02129192|20248897|P2|STARTED|Period 3 Including Washout Period||35
8210757|NCT02129192|20248898|P1|STARTED|Period 3 Including Washout Period||36
8210758|NCT02129192|20248897|P2|NOT COMPLETED|Period 2 Including Washout Period||0
8210759|NCT02129192|20248898|P1|NOT COMPLETED|Period 2 Including Washout Period||0
8210760|NCT02129192|20248897|P2|COMPLETED|Period 2 Including Washout Period||35
8210761|NCT02129192|20248898|P1|COMPLETED|Period 2 Including Washout Period||36
8210762|NCT02129192|20248897|P2|STARTED|Period 2 Including Washout Period||35
8210763|NCT02129192|20248898|P1|STARTED|Period 2 Including Washout Period||36
8210764|NCT02129192|20248897|P2|NOT COMPLETED|Period 1 Including Washout Period||1
8210765|NCT02129192|20248898|P1|NOT COMPLETED|Period 1 Including Washout Period||0
8210766|NCT02129192|20248897|P2|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
8210767|NCT02129192|20248898|P1|COMPLETED|Period 1 Including Washout Period||36
8210768|NCT02129192|20248897|P2|STARTED|Period 1 Including Washout Period||36
8210769|NCT02129192|20248898|P1|STARTED|Period 1 Including Washout Period||36
8210770|NCT02129062|20248915|P1|NOT COMPLETED|Overall Study||3
8210771|NCT02129062|20248915|P1|COMPLETED|Overall Study||0
8210772|NCT02129062|20248915|P1|STARTED|Overall Study||3
8210773|NCT02128997|20248922|P2|NOT COMPLETED|Overall Study||11
8210774|NCT02128997|20248923|P1|NOT COMPLETED|Overall Study||6
8210775|NCT02128997|20248922|P2|COMPLETED|Overall Study||58
8210776|NCT02128997|20248923|P1|COMPLETED|Overall Study||61
8210777|NCT02128997|20248922|P2|STARTED|Overall Study||69
8210778|NCT02128997|20248923|P1|STARTED|Overall Study||67
8210779|NCT02128932|20248938|P3|NOT COMPLETED|Overall Study||18
8210780|NCT02128932|20248939|P2|NOT COMPLETED|Overall Study||19
8210781|NCT02128932|20248940|P1|NOT COMPLETED|Overall Study||27
8210782|NCT02128932|20248938|P3|COMPLETED|Overall Study||342
8210783|NCT02128932|20248939|P2|COMPLETED|Overall Study||341
8210784|NCT02128932|20248940|P1|COMPLETED|Overall Study||335
8210785|NCT02128932|20248938|P3|STARTED|Overall Study||360
8210786|NCT02128932|20248939|P2|STARTED|Overall Study||360
8210787|NCT02128932|20248940|P1|STARTED|Overall Study||362
8210788|NCT02128919|20248971|P2|NOT COMPLETED|Overall Study||1
8210789|NCT02128919|20248972|P1|NOT COMPLETED|Overall Study||3
8210790|NCT02128919|20248971|P2|COMPLETED|Overall Study||15
8210791|NCT02128919|20248972|P1|COMPLETED|Overall Study||14
8210792|NCT02128919|20248971|P2|STARTED|Overall Study||16
8210793|NCT02128919|20248972|P1|STARTED|Overall Study||17
8210794|NCT02128867|20248985|P3|NOT COMPLETED|Overall Study||4
8210795|NCT02128867|20248986|P2|NOT COMPLETED|Overall Study||2
8210796|NCT02128867|20248987|P1|NOT COMPLETED|Overall Study||3
8210797|NCT02128867|20248985|P3|COMPLETED|Overall Study||50
8210798|NCT02128867|20248986|P2|COMPLETED|Overall Study||50
8210799|NCT02128867|20248987|P1|COMPLETED|Overall Study||50
8210800|NCT02128867|20248985|P3|STARTED|Overall Study||54
8210801|NCT02128867|20248986|P2|STARTED|Overall Study||52
8210802|NCT02128867|20248987|P1|STARTED|Overall Study||53
8210803|NCT02128828|20248995|P1|NOT COMPLETED|Overall Study||3
8210804|NCT02128828|20248995|P1|COMPLETED|Overall Study||17
8210805|NCT02128828|20248995|P1|STARTED|Overall Study||20
8210812|NCT02128724|20249048|P4|NOT COMPLETED|Overall Study||3
8210813|NCT02128724|20249049|P3|NOT COMPLETED|Overall Study||0
8210814|NCT02128724|20249050|P2|NOT COMPLETED|Overall Study||1
8210815|NCT02128724|20249051|P1|NOT COMPLETED|Overall Study||1
8210816|NCT02128724|20249048|P4|COMPLETED|Overall Study||7
8210817|NCT02128724|20249049|P3|COMPLETED|Overall Study||3
8210818|NCT02128724|20249050|P2|COMPLETED|Overall Study||3
8210819|NCT02128724|20249051|P1|COMPLETED|Overall Study||3
8210820|NCT02128724|20249048|P4|STARTED|Overall Study||10
8210821|NCT02128724|20249049|P3|STARTED|Overall Study||3
8210822|NCT02128724|20249050|P2|STARTED|Overall Study||4
8210823|NCT02128724|20249051|P1|STARTED|Overall Study||4
8210824|NCT02128542|20249106|P2|NOT COMPLETED|Overall Study||0
8210825|NCT02128542|20249107|P1|NOT COMPLETED|Overall Study||4
8210826|NCT02128542|20249106|P2|COMPLETED|Overall Study||19
8210827|NCT02128542|20249107|P1|COMPLETED|Overall Study||43
8210828|NCT02128542|20249106|P2|STARTED|Overall Study||19
8210829|NCT02128542|20249107|P1|STARTED|Overall Study||47
8210830|NCT02128490|20249125|P5|NOT COMPLETED|Overall Study||7
8210831|NCT02128490|20249126|P4|NOT COMPLETED|Overall Study||6
8210832|NCT02128490|20249127|P3|NOT COMPLETED|Overall Study||5
8210833|NCT02128490|20249128|P2|NOT COMPLETED|Overall Study||6
8210834|NCT02128490|20249129|P1|NOT COMPLETED|Overall Study||5
8210835|NCT02128490|20249125|P5|COMPLETED|Overall Study||31
8210836|NCT02128490|20249126|P4|COMPLETED|Overall Study||31
8210837|NCT02128490|20249127|P3|COMPLETED|Overall Study||34
8210838|NCT02128490|20249128|P2|COMPLETED|Overall Study||31
8210839|NCT02128490|20249129|P1|COMPLETED|Overall Study||33
8210840|NCT02128490|20249125|P5|STARTED|Overall Study||38
8210841|NCT02128490|20249126|P4|STARTED|Overall Study||37
8210842|NCT02128490|20249127|P3|STARTED|Overall Study||39
8210843|NCT02128490|20249128|P2|STARTED|Overall Study||37
8210844|NCT02128490|20249129|P1|STARTED|Overall Study||38
8210845|NCT02128269|20249151|P1|NOT COMPLETED|Follow-up||0
8210846|NCT02128269|20249151|P1|COMPLETED|Follow-up||9
8210847|NCT02128269|20249151|P1|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
8210848|NCT02128269|20249151|P1|NOT COMPLETED|Treatment Period||2
8210849|NCT02128269|20249151|P1|COMPLETED|Treatment Period||7
8210850|NCT02128269|20249151|P1|STARTED|Treatment Period||9
8210851|NCT02128217|20249157|P2|NOT COMPLETED|Overall Study||1
8210852|NCT02128217|20249158|P1|NOT COMPLETED|Overall Study||0
8210853|NCT02128217|20249157|P2|COMPLETED|Overall Study||26
8210854|NCT02128217|20249158|P1|COMPLETED|Overall Study||17
8210855|NCT02128217|20249157|P2|STARTED|Overall Study||27
8210856|NCT02128217|20249158|P1|STARTED|Overall Study||17
8210857|NCT02128074|20249200|P1|NOT COMPLETED|Overall Study||6
8210858|NCT02128074|20249200|P1|COMPLETED|Overall Study||26
8210859|NCT02128074|20249200|P1|STARTED|Overall Study||32
8210860|NCT02127970|20249206|P2|NOT COMPLETED|Overall Study||27
8210861|NCT02127970|20249207|P1|NOT COMPLETED|Overall Study||26
8210862|NCT02127970|20249206|P2|COMPLETED|Overall Study||322
8210863|NCT02127970|20249207|P1|COMPLETED|Overall Study||323
8210864|NCT02127970|20249206|P2|STARTED|Overall Study||349
8210865|NCT02127970|20249207|P1|STARTED|Overall Study||349
8210866|NCT02127931|20249229|P1|NOT COMPLETED|Overall Study||1
8210867|NCT02127931|20249229|P1|COMPLETED|Overall Study||17
8210868|NCT02127931|20249229|P1|STARTED|Overall Study||18
8210869|NCT02127892|20249239|P4|NOT COMPLETED|Overall Study||0
8210870|NCT02127892|20249240|P3|NOT COMPLETED|Overall Study||0
8210871|NCT02127892|20249241|P2|NOT COMPLETED|Overall Study||1
8210872|NCT02127892|20249242|P1|NOT COMPLETED|Overall Study||1
8210873|NCT02127892|20249239|P4|COMPLETED|Overall Study||0
8210874|NCT02127892|20249240|P3|COMPLETED|Overall Study||0
8210875|NCT02127892|20249241|P2|COMPLETED|Overall Study||1
8210876|NCT02127892|20249242|P1|COMPLETED|Overall Study||6
8210877|NCT02127892|20249239|P4|STARTED|Overall Study||0
8210878|NCT02127892|20249240|P3|STARTED|Overall Study||0
8210879|NCT02127892|20249241|P2|STARTED|Overall Study||2
8210880|NCT02127892|20249242|P1|STARTED|Overall Study||7
8210881|NCT02127723|20249268|P1|NOT COMPLETED|Overall Study||1
8210882|NCT02127723|20249268|P1|COMPLETED|Overall Study||19
8210883|NCT02127723|20249268|P1|STARTED|Overall Study||20
8210893|NCT02127632|20249322|P2|NOT COMPLETED|Overall Study||0
8210894|NCT02127632|20249323|P1|NOT COMPLETED|Overall Study||0
8210895|NCT02127632|20249322|P2|COMPLETED|Overall Study||50
8210896|NCT02127632|20249323|P1|COMPLETED|Overall Study||50
8210897|NCT02127632|20249322|P2|STARTED|Overall Study||50
8210898|NCT02127632|20249323|P1|STARTED|Overall Study||50
8210899|NCT02127567|20249333|P1|NOT COMPLETED|Overall Study||0
8210900|NCT02127567|20249333|P1|COMPLETED|Overall Study||41
8210901|NCT02127567|20249333|P1|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
8210902|NCT02127372|20249355|P2|NOT COMPLETED|Overall Study||0
8210903|NCT02127372|20249356|P1|NOT COMPLETED|Overall Study||1
8210904|NCT02127372|20249355|P2|COMPLETED|Overall Study||28
8210905|NCT02127372|20249356|P1|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
8210906|NCT02127372|20249355|P2|Started Study Treatment|Overall Study||28
8210907|NCT02127372|20249356|P1|Started Study Treatment|Overall Study||15
8210908|NCT02127372|20249355|P2|STARTED|Overall Study|Signed Consent|28
8210909|NCT02127372|20249356|P1|STARTED|Overall Study|Signed Consent|15
8210910|NCT02127307|20249366|P1|NOT COMPLETED|Overall Study||308
8210911|NCT02127307|20249366|P1|COMPLETED|Overall Study||656
8210912|NCT02127307|20249366|P1|STARTED|Overall Study||964
8210913|NCT02127281|20249372|P2|NOT COMPLETED|Overall Study||0
8210914|NCT02127281|20249373|P1|NOT COMPLETED|Overall Study||1
8210915|NCT02127281|20249372|P2|COMPLETED|Overall Study||80
8210916|NCT02127281|20249373|P1|COMPLETED|Overall Study||79
8210917|NCT02127281|20249372|P2|STARTED|Overall Study||80
8210918|NCT02127281|20249373|P1|STARTED|Overall Study||80
8210919|NCT02127125|20249408|P9|NOT COMPLETED|Overall Study||0
8210920|NCT02127125|20249409|P8|NOT COMPLETED|Overall Study||0
8210921|NCT02127125|20249410|P7|NOT COMPLETED|Overall Study||0
8210922|NCT02127125|20249411|P6|NOT COMPLETED|Overall Study||3
8210923|NCT02127125|20249412|P5|NOT COMPLETED|Overall Study||3
8210924|NCT02127125|20249413|P4|NOT COMPLETED|Overall Study||1
8210925|NCT02127125|20249414|P3|NOT COMPLETED|Overall Study||1
8210926|NCT02127125|20249415|P2|NOT COMPLETED|Overall Study||0
8210927|NCT02127125|20249416|P1|NOT COMPLETED|Overall Study||0
8210928|NCT02127125|20249408|P9|COMPLETED|Overall Study||1
8210929|NCT02127125|20249409|P8|COMPLETED|Overall Study||0
8210930|NCT02127125|20249410|P7|COMPLETED|Overall Study||2
8210931|NCT02127125|20249411|P6|COMPLETED|Overall Study||9
8210932|NCT02127125|20249412|P5|COMPLETED|Overall Study||9
8210933|NCT02127125|20249413|P4|COMPLETED|Overall Study||10
8210934|NCT02127125|20249414|P3|COMPLETED|Overall Study||8
8210935|NCT02127125|20249415|P2|COMPLETED|Overall Study||8
8210936|NCT02127125|20249416|P1|COMPLETED|Overall Study||6
8210937|NCT02127125|20249408|P9|STARTED|Overall Study||1
8210938|NCT02127125|20249409|P8|STARTED|Overall Study||0
8210939|NCT02127125|20249410|P7|STARTED|Overall Study||2
8210940|NCT02127125|20249411|P6|STARTED|Overall Study||12
8210941|NCT02127125|20249412|P5|STARTED|Overall Study||12
8210942|NCT02127125|20249413|P4|STARTED|Overall Study||11
8210943|NCT02127125|20249414|P3|STARTED|Overall Study||9
8210944|NCT02127125|20249415|P2|STARTED|Overall Study||8
8210945|NCT02127125|20249416|P1|STARTED|Overall Study||6
8210952|NCT02126878|20249470|P3|NOT COMPLETED|Overall Study||0
8210953|NCT02126878|20249471|P2|NOT COMPLETED|Overall Study||0
8210954|NCT02126878|20249472|P1|NOT COMPLETED|Overall Study||0
8210955|NCT02126878|20249470|P3|COMPLETED|Overall Study||0
8210956|NCT02126878|20249471|P2|COMPLETED|Overall Study||0
8210957|NCT02126878|20249472|P1|COMPLETED|Overall Study||0
8210958|NCT02126878|20249470|P3|STARTED|Overall Study||0
8210959|NCT02126878|20249471|P2|STARTED|Overall Study||0
8210960|NCT02126878|20249472|P1|STARTED|Overall Study||0
8210961|NCT02126839|20249488|P2|NOT COMPLETED|Overall Study||14
8210962|NCT02126839|20249489|P1|NOT COMPLETED|Overall Study||10
8210963|NCT02126839|20249488|P2|COMPLETED|Overall Study||80
8210964|NCT02126839|20249489|P1|COMPLETED|Overall Study||82
8210965|NCT02126839|20249488|P2|Full Analysis Set|Overall Study||92
8210966|NCT02126839|20249489|P1|Full Analysis Set|Overall Study||92
8210967|NCT02126839|20249488|P2|Safety Population|Overall Study||93
8210968|NCT02126839|20249489|P1|Safety Population|Overall Study||92
8210969|NCT02126839|20249488|P2|STARTED|Overall Study||94
8210970|NCT02126839|20249489|P1|STARTED|Overall Study||92
8210971|NCT02126826|20249506|P7|NOT COMPLETED|Overall Study||0
8210972|NCT02126826|20249507|P6|NOT COMPLETED|Overall Study||0
8210973|NCT02126826|20249508|P5|NOT COMPLETED|Overall Study||0
8210974|NCT02126826|20249509|P4|NOT COMPLETED|Overall Study||1
8210975|NCT02126826|20249510|P3|NOT COMPLETED|Overall Study||0
8210976|NCT02126826|20249511|P2|NOT COMPLETED|Overall Study||0
8210977|NCT02126826|20249512|P1|NOT COMPLETED|Overall Study||0
8210978|NCT02126826|20249506|P7|COMPLETED|Overall Study||8
8210979|NCT02126826|20249507|P6|COMPLETED|Overall Study||9
8210980|NCT02126826|20249508|P5|COMPLETED|Overall Study||5
8210981|NCT02126826|20249509|P4|COMPLETED|Overall Study||8
8210982|NCT02126826|20249510|P3|COMPLETED|Overall Study||9
8210983|NCT02126826|20249511|P2|COMPLETED|Overall Study||9
8210984|NCT02126826|20249512|P1|COMPLETED|Overall Study||9
8210985|NCT02126826|20249506|P7|STARTED|Overall Study||8
8210986|NCT02126826|20249507|P6|STARTED|Overall Study||9
8210987|NCT02126826|20249508|P5|STARTED|Overall Study||5
8210988|NCT02126826|20249509|P4|STARTED|Overall Study||9
8210989|NCT02126826|20249510|P3|STARTED|Overall Study||9
8210990|NCT02126826|20249511|P2|STARTED|Overall Study||9
8210991|NCT02126826|20249512|P1|STARTED|Overall Study||9
8210992|NCT02126748|20249566|P3|NOT COMPLETED|Overall Study||5
8210993|NCT02126748|20249567|P2|NOT COMPLETED|Overall Study||3
8210994|NCT02126748|20249568|P1|NOT COMPLETED|Overall Study||2
8210995|NCT02126748|20249566|P3|COMPLETED|Overall Study||31
8210996|NCT02126748|20249567|P2|COMPLETED|Overall Study||31
8210997|NCT02126748|20249568|P1|COMPLETED|Overall Study||31
8210998|NCT02126748|20249566|P3|STARTED|Overall Study||36
8210999|NCT02126748|20249567|P2|STARTED|Overall Study||34
8211000|NCT02126748|20249568|P1|STARTED|Overall Study||33
8211001|NCT02126670|20249580|P4|NOT COMPLETED|Overall Study||1
8211002|NCT02126670|20249581|P3|NOT COMPLETED|Overall Study||0
8211003|NCT02126670|20249582|P2|NOT COMPLETED|Overall Study||0
8211004|NCT02126670|20249583|P1|NOT COMPLETED|Overall Study||1
8211005|NCT02126670|20249580|P4|COMPLETED|Overall Study||24
8211006|NCT02126670|20249581|P3|COMPLETED|Overall Study||25
8211007|NCT02126670|20249582|P2|COMPLETED|Overall Study||24
8211008|NCT02126670|20249583|P1|COMPLETED|Overall Study||25
8211009|NCT02126670|20249580|P4|STARTED|Overall Study||25
8211010|NCT02126670|20249581|P3|STARTED|Overall Study||25
8211011|NCT02126670|20249582|P2|STARTED|Overall Study||24
8211012|NCT02126670|20249583|P1|STARTED|Overall Study||26
8211013|NCT02126319|20249599|P2|NOT COMPLETED|Overall Study||24
8211014|NCT02126319|20249600|P1|NOT COMPLETED|Overall Study||21
8211015|NCT02126319|20249599|P2|COMPLETED|Overall Study||43
8211016|NCT02126319|20249600|P1|COMPLETED|Overall Study||40
8211017|NCT02126319|20249599|P2|STARTED|Overall Study||67
8211018|NCT02126319|20249600|P1|STARTED|Overall Study||61
8211019|NCT02126306|20249626|P2|NOT COMPLETED|Overall Study||0
8211020|NCT02126306|20249627|P1|NOT COMPLETED|Overall Study||0
8211021|NCT02126306|20249626|P2|COMPLETED|Overall Study||13
8211022|NCT02126306|20249627|P1|COMPLETED|Overall Study||10
8211023|NCT02126306|20249626|P2|STARTED|Overall Study||13
8211024|NCT02126306|20249627|P1|STARTED|Overall Study||10
8211025|NCT02125877|20249635|P2|NOT COMPLETED|Overall Study||10
8211026|NCT02125877|20249636|P1|NOT COMPLETED|Overall Study||13
8211027|NCT02125877|20249635|P2|COMPLETED|Overall Study||77
8211028|NCT02125877|20249636|P1|COMPLETED|Overall Study||73
8211029|NCT02125877|20249635|P2|Safety Set|Overall Study||87
8211030|NCT02125877|20249636|P1|Safety Set|Overall Study||86
8211031|NCT02125877|20249635|P2|Pharmacokinetic Subset A|Overall Study||15
8211032|NCT02125877|20249636|P1|Pharmacokinetic Subset A|Overall Study||16
8211033|NCT02125877|20249635|P2|Pharmacokinetic Analysis Set|Overall Study||83
8211034|NCT02125877|20249636|P1|Pharmacokinetic Analysis Set|Overall Study||83
8211035|NCT02125877|20249635|P2|STARTED|Overall Study||87
8211036|NCT02125877|20249636|P1|STARTED|Overall Study||86
8211037|NCT02125838|20249666|P2|NOT COMPLETED|Overall Study||4
8211038|NCT02125838|20249667|P1|NOT COMPLETED|Overall Study||4
8211039|NCT02125838|20249666|P2|COMPLETED|Overall Study|Analysed (n=50 )|50
8211040|NCT02125838|20249667|P1|COMPLETED|Overall Study|Analysed (n=50 )|50
8211041|NCT02125838|20249666|P2|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
8211042|NCT02125838|20249667|P1|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
8211043|NCT02125734|20249685|P2|NOT COMPLETED|Period 2||1
8211044|NCT02125734|20249686|P1|NOT COMPLETED|Period 2||0
8211045|NCT02125734|20249685|P2|COMPLETED|Period 2||47
8211046|NCT02125734|20249686|P1|COMPLETED|Period 2||40
8211047|NCT02125734|20249685|P2|STARTED|Period 2||48
8211048|NCT02125734|20249686|P1|STARTED|Period 2||40
8211049|NCT02125734|20249685|P2|NOT COMPLETED|Period 1||0
8211050|NCT02125734|20249686|P1|NOT COMPLETED|Period 1||0
8211051|NCT02125734|20249685|P2|COMPLETED|Period 1||48
8211052|NCT02125734|20249686|P1|COMPLETED|Period 1||40
8211053|NCT02125734|20249685|P2|STARTED|Period 1||48
8211054|NCT02125734|20249686|P1|STARTED|Period 1||40
8211055|NCT02125604|20249696|P1|NOT COMPLETED|Overall Study||31
8211056|NCT02125604|20249696|P1|COMPLETED|Overall Study||180
8211057|NCT02125604|20249696|P1|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
8211072|NCT02125331|20249744|P2|NOT COMPLETED|Overall Study||0
8211073|NCT02125331|20249745|P1|NOT COMPLETED|Overall Study||5
8211074|NCT02125331|20249744|P2|COMPLETED|Overall Study||25
8211075|NCT02125331|20249745|P1|COMPLETED|Overall Study||53
8211076|NCT02125331|20249744|P2|STARTED|Overall Study||25
8211077|NCT02125331|20249745|P1|STARTED|Overall Study||58
8211171|NCT02124889|20249806|P2|NOT COMPLETED|Overall Study||0
8211172|NCT02124889|20249807|P1|NOT COMPLETED|Overall Study||0
8211173|NCT02124889|20249806|P2|COMPLETED|Overall Study||12
8211174|NCT02124889|20249807|P1|COMPLETED|Overall Study||12
8211175|NCT02124889|20249806|P2|STARTED|Overall Study||12
8211176|NCT02124889|20249807|P1|STARTED|Overall Study||12
8211177|NCT02124863|20249813|P1|NOT COMPLETED|Overall Study||17
8211178|NCT02124863|20249813|P1|COMPLETED|Overall Study||50
8211179|NCT02124863|20249813|P1|STARTED|Overall Study||67
8211180|NCT02124811|20249821|P2|NOT COMPLETED|Overall Study||2
8211181|NCT02124811|20249822|P1|NOT COMPLETED|Overall Study||3
8211182|NCT02124811|20249821|P2|COMPLETED|Overall Study||3
8211183|NCT02124811|20249822|P1|COMPLETED|Overall Study||2
8211184|NCT02124811|20249821|P2|STARTED|Overall Study||5
8211185|NCT02124811|20249822|P1|STARTED|Overall Study||5
8211186|NCT02124798|20249838|P1|NOT COMPLETED|Overall Study||4
8211187|NCT02124798|20249838|P1|COMPLETED|Overall Study||91
8211188|NCT02124798|20249838|P1|STARTED|Overall Study||95
8211189|NCT02124707|20249844|P1|NOT COMPLETED|Overall Study||7
8211190|NCT02124707|20249844|P1|COMPLETED|Overall Study||7
8211191|NCT02124707|20249844|P1|STARTED|Overall Study||14
8211192|NCT02124603|20249852|P1|NOT COMPLETED|Overall Study||0
8211193|NCT02124603|20249852|P1|COMPLETED|Overall Study||120
8211194|NCT02124603|20249852|P1|STARTED|Overall Study||120
8211195|NCT02124564|20249858|P1|NOT COMPLETED|Taper Period||0
8211196|NCT02124564|20249858|P1|COMPLETED|Taper Period||2
8211197|NCT02124564|20249858|P1|STARTED|Taper Period||2
8211198|NCT02124564|20249858|P1|NOT COMPLETED|Treatment Period||7
8211199|NCT02124564|20249858|P1|COMPLETED|Treatment Period||12
8211200|NCT02124564|20249858|P1|Started Follow-Up Period|Treatment Period||13
8211201|NCT02124564|20249858|P1|Started Evaluation Period|Treatment Period||17
8211202|NCT02124564|20249858|P1|Started Monotherapy Period|Treatment Period||17
8211203|NCT02124564|20249858|P1|Started AED Withdrawal Period|Treatment Period||19
8211204|NCT02124564|20249858|P1|Started Titration Period|Treatment Period||19
8211205|NCT02124564|20249858|P1|Started Treatment Period|Treatment Period||19
8211206|NCT02124564|20249858|P1|STARTED|Treatment Period||19
8211207|NCT02124512|20249870|P2|NOT COMPLETED|Overall Study||0
8211208|NCT02124512|20249871|P1|NOT COMPLETED|Overall Study||0
8211209|NCT02124512|20249870|P2|COMPLETED|Overall Study||6
8211210|NCT02124512|20249871|P1|COMPLETED|Overall Study||6
8211211|NCT02124512|20249870|P2|STARTED|Overall Study||6
8211212|NCT02124512|20249871|P1|STARTED|Overall Study||6
8211213|NCT02124460|20249881|P2|NOT COMPLETED|Overall Study||24
8211214|NCT02124460|20249882|P1|NOT COMPLETED|Overall Study||33
8211215|NCT02124460|20249881|P2|COMPLETED|Overall Study||336
8211216|NCT02124460|20249882|P1|COMPLETED|Overall Study||328
8211217|NCT02124460|20249881|P2|STARTED|Overall Study||360
8211218|NCT02124460|20249882|P1|STARTED|Overall Study||361
8211219|NCT02124304|20249914|P2|NOT COMPLETED|Overall Study||0
8211220|NCT02124304|20249915|P1|NOT COMPLETED|Overall Study||0
8211221|NCT02124304|20249914|P2|COMPLETED|Overall Study||15
8211222|NCT02124304|20249915|P1|COMPLETED|Overall Study||15
8211223|NCT02124304|20249914|P2|STARTED|Overall Study||15
8211224|NCT02124304|20249915|P1|STARTED|Overall Study||15
8211225|NCT02124265|20249923|P1|NOT COMPLETED|Overall Study||1
8211226|NCT02124265|20249923|P1|COMPLETED|Overall Study||2
8211227|NCT02124265|20249923|P1|STARTED|Overall Study||3
8211228|NCT02124161|20249929|P2|NOT COMPLETED|Overall Study||15
8211229|NCT02124161|20249930|P1|NOT COMPLETED|Overall Study||16
8211230|NCT02124161|20249929|P2|COMPLETED|Overall Study||426
8211231|NCT02124161|20249930|P1|COMPLETED|Overall Study||425
8211232|NCT02124161|20249929|P2|Vaccination 2|Overall Study||432
8211233|NCT02124161|20249930|P1|Vaccination 2|Overall Study||431
8211234|NCT02124161|20249929|P2|Vaccination 1|Overall Study||437
8211235|NCT02124161|20249930|P1|Vaccination 1|Overall Study||439
8211236|NCT02124161|20249929|P2|STARTED|Overall Study||441
8211237|NCT02124161|20249930|P1|STARTED|Overall Study||441
8211238|NCT02124122|20249962|P2|NOT COMPLETED|Overall Study||0
8211239|NCT02124122|20249963|P1|NOT COMPLETED|Overall Study||0
8211240|NCT02124122|20249962|P2|COMPLETED|Overall Study||19
8211241|NCT02124122|20249963|P1|COMPLETED|Overall Study||41
8211242|NCT02124122|20249962|P2|STARTED|Overall Study||19
8211243|NCT02124122|20249963|P1|STARTED|Overall Study||41
8211244|NCT02124083|20249971|P1|NOT COMPLETED|Overall Study||1
8211245|NCT02124083|20249971|P1|COMPLETED|Overall Study||11
8211246|NCT02124083|20249971|P1|STARTED|Overall Study||12
8211247|NCT02124044|20249982|P2|NOT COMPLETED|Overall Study||1
8211248|NCT02124044|20249983|P1|NOT COMPLETED|Overall Study||0
8211249|NCT02124044|20249982|P2|COMPLETED|Overall Study||9
8211250|NCT02124044|20249983|P1|COMPLETED|Overall Study||20
8211251|NCT02124044|20249982|P2|STARTED|Overall Study||10
8211252|NCT02124044|20249983|P1|STARTED|Overall Study||20
8211253|NCT02124018|20249992|P3|NOT COMPLETED|Overall Study||0
8211254|NCT02124018|20249993|P2|NOT COMPLETED|Overall Study||0
8211255|NCT02124018|20249994|P1|NOT COMPLETED|Overall Study||0
8211256|NCT02124018|20249992|P3|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41
8211257|NCT02124018|20249993|P2|COMPLETED|Overall Study||111
8211258|NCT02124018|20249994|P1|COMPLETED|Overall Study||371
8211259|NCT02124018|20249992|P3|STARTED|Overall Study||41
8211260|NCT02124018|20249993|P2|STARTED|Overall Study||111
8211261|NCT02124018|20249994|P1|STARTED|Overall Study||371
8211262|NCT02123966|20250005|P1|NOT COMPLETED|Overall Study||1
8211263|NCT02123966|20250005|P1|COMPLETED|Overall Study||9
8211264|NCT02123966|20250005|P1|STARTED|Overall Study||10
8211265|NCT02123849|20250012|P2|NOT COMPLETED|Overall Study||9
8211266|NCT02123849|20250013|P1|NOT COMPLETED|Overall Study||4
8211267|NCT02123849|20250012|P2|COMPLETED|Overall Study||18
8211268|NCT02123849|20250013|P1|COMPLETED|Overall Study||23
8211269|NCT02123849|20250012|P2|STARTED|Overall Study||27
8211270|NCT02123849|20250013|P1|STARTED|Overall Study||27
8211271|NCT02123797|20250039|P5|NOT COMPLETED|6-month Follow up (Cumulative Counts)||3
8211272|NCT02123797|20250040|P4|NOT COMPLETED|6-month Follow up (Cumulative Counts)||113
8211273|NCT02123797|20250041|P3|NOT COMPLETED|6-month Follow up (Cumulative Counts)||66
8211274|NCT02123797|20250042|P2|NOT COMPLETED|6-month Follow up (Cumulative Counts)||128
8211275|NCT02123797|20250043|P1|NOT COMPLETED|6-month Follow up (Cumulative Counts)||55
8211276|NCT02123797|20250039|P5|COMPLETED|6-month Follow up (Cumulative Counts)||5
8211277|NCT02123797|20250040|P4|COMPLETED|6-month Follow up (Cumulative Counts)||31
8211278|NCT02123797|20250041|P3|COMPLETED|6-month Follow up (Cumulative Counts)||34
8211279|NCT02123797|20250042|P2|COMPLETED|6-month Follow up (Cumulative Counts)||178
8211280|NCT02123797|20250043|P1|COMPLETED|6-month Follow up (Cumulative Counts)||101
8211281|NCT02123797|20250039|P5|STARTED|6-month Follow up (Cumulative Counts)|Clinical providers received 12 month follow-up rather than 6-month follow-up at this stage.|8
8211282|NCT02123797|20250040|P4|STARTED|6-month Follow up (Cumulative Counts)||144
8211283|NCT02123797|20250041|P3|STARTED|6-month Follow up (Cumulative Counts)||100
8211284|NCT02123797|20250042|P2|STARTED|6-month Follow up (Cumulative Counts)||306
8211285|NCT02123797|20250043|P1|STARTED|6-month Follow up (Cumulative Counts)||156
8211286|NCT02123797|20250039|P5|NOT COMPLETED|3-month Follow up (Cumulative Counts)||3
8211287|NCT02123797|20250040|P4|NOT COMPLETED|3-month Follow up (Cumulative Counts)||82
8211288|NCT02123797|20250041|P3|NOT COMPLETED|3-month Follow up (Cumulative Counts)||50
8211289|NCT02123797|20250042|P2|NOT COMPLETED|3-month Follow up (Cumulative Counts)||117
8211290|NCT02123797|20250043|P1|NOT COMPLETED|3-month Follow up (Cumulative Counts)||57
8211291|NCT02123797|20250039|P5|COMPLETED|3-month Follow up (Cumulative Counts)||8
8211292|NCT02123797|20250040|P4|COMPLETED|3-month Follow up (Cumulative Counts)||62
8211293|NCT02123797|20250041|P3|COMPLETED|3-month Follow up (Cumulative Counts)||50
8211294|NCT02123797|20250042|P2|COMPLETED|3-month Follow up (Cumulative Counts)||189
8211295|NCT02123797|20250043|P1|COMPLETED|3-month Follow up (Cumulative Counts)||99
8211296|NCT02123797|20250039|P5|STARTED|3-month Follow up (Cumulative Counts)|Clinical providers received 6 month follow-up rather than 3 month follow-up at this stage.|11
8211297|NCT02123797|20250040|P4|STARTED|3-month Follow up (Cumulative Counts)||144
8211298|NCT02123797|20250041|P3|STARTED|3-month Follow up (Cumulative Counts)||100
8211299|NCT02123797|20250042|P2|STARTED|3-month Follow up (Cumulative Counts)||306
8211300|NCT02123797|20250043|P1|STARTED|3-month Follow up (Cumulative Counts)||156
8211301|NCT02123797|20250039|P5|NOT COMPLETED|Baseline Intervention||0
8211302|NCT02123797|20250040|P4|NOT COMPLETED|Baseline Intervention||0
8211303|NCT02123797|20250041|P3|NOT COMPLETED|Baseline Intervention||0
8211304|NCT02123797|20250042|P2|NOT COMPLETED|Baseline Intervention||42
8211305|NCT02123797|20250043|P1|NOT COMPLETED|Baseline Intervention||22
8211306|NCT02123797|20250039|P5|COMPLETED|Baseline Intervention||11
8211307|NCT02123797|20250040|P4|COMPLETED|Baseline Intervention||144
8211308|NCT02123797|20250041|P3|COMPLETED|Baseline Intervention||100
8211309|NCT02123797|20250042|P2|COMPLETED|Baseline Intervention||306
8211310|NCT02123797|20250043|P1|COMPLETED|Baseline Intervention||156
8211311|NCT02123797|20250039|P5|STARTED|Baseline Intervention||11
8211312|NCT02123797|20250040|P4|STARTED|Baseline Intervention||144
8211313|NCT02123797|20250041|P3|STARTED|Baseline Intervention||100
8211314|NCT02123797|20250042|P2|STARTED|Baseline Intervention||348
8211315|NCT02123797|20250043|P1|STARTED|Baseline Intervention||178
8211316|NCT02123745|20250142|P1|NOT COMPLETED|Overall Study||0
8211317|NCT02123745|20250142|P1|COMPLETED|Overall Study||71
8211318|NCT02123745|20250142|P1|STARTED|Overall Study||71
8211319|NCT02123576|20250152|P2|NOT COMPLETED|Overall Study||0
8211320|NCT02123576|20250153|P1|NOT COMPLETED|Overall Study||1
8211321|NCT02123576|20250152|P2|COMPLETED|Overall Study||6
8211322|NCT02123576|20250153|P1|COMPLETED|Overall Study||5
8211323|NCT02123576|20250152|P2|STARTED|Overall Study||6
8211324|NCT02123576|20250153|P1|STARTED|Overall Study||6
8211325|NCT02123511|20250171|P2|NOT COMPLETED|Overall Study||4
8211326|NCT02123511|20250172|P1|NOT COMPLETED|Overall Study||2
8211327|NCT02123511|20250171|P2|COMPLETED|Overall Study||12
8211328|NCT02123511|20250172|P1|COMPLETED|Overall Study||16
8211329|NCT02123511|20250171|P2|Eligible Patients|Overall Study||15
8211330|NCT02123511|20250172|P1|Eligible Patients|Overall Study||17
8211331|NCT02123511|20250171|P2|STARTED|Overall Study||16
8211332|NCT02123511|20250172|P1|STARTED|Overall Study||18
8211333|NCT02123472|20250196|P2|NOT COMPLETED|Period 2 (7 Days)||1
8211334|NCT02123472|20250197|P1|NOT COMPLETED|Period 2 (7 Days)||0
8211335|NCT02123472|20250196|P2|COMPLETED|Period 2 (7 Days)||13
8211336|NCT02123472|20250197|P1|COMPLETED|Period 2 (7 Days)||14
8211337|NCT02123472|20250196|P2|STARTED|Period 2 (7 Days)||14
8211338|NCT02123472|20250197|P1|STARTED|Period 2 (7 Days)||14
8211339|NCT02123472|20250196|P2|NOT COMPLETED|Washout Period (1 Day)||0
8211340|NCT02123472|20250197|P1|NOT COMPLETED|Washout Period (1 Day)||0
8211341|NCT02123472|20250196|P2|COMPLETED|Washout Period (1 Day)||14
8211342|NCT02123472|20250197|P1|COMPLETED|Washout Period (1 Day)||14
8211343|NCT02123472|20250196|P2|STARTED|Washout Period (1 Day)||14
8211344|NCT02123472|20250197|P1|STARTED|Washout Period (1 Day)||14
8211345|NCT02123472|20250196|P2|NOT COMPLETED|Period 1 (7 Days)||0
8211346|NCT02123472|20250197|P1|NOT COMPLETED|Period 1 (7 Days)||0
8211347|NCT02123472|20250196|P2|COMPLETED|Period 1 (7 Days)||14
8211348|NCT02123472|20250197|P1|COMPLETED|Period 1 (7 Days)||14
8211349|NCT02123472|20250196|P2|STARTED|Period 1 (7 Days)||14
8211350|NCT02123472|20250197|P1|STARTED|Period 1 (7 Days)||14
8211351|NCT02123459|20250207|P2|NOT COMPLETED|Period 2 (7 Days)||0
8211352|NCT02123459|20250208|P1|NOT COMPLETED|Period 2 (7 Days)||0
8211353|NCT02123459|20250207|P2|COMPLETED|Period 2 (7 Days)||14
8211354|NCT02123459|20250208|P1|COMPLETED|Period 2 (7 Days)||13
8211355|NCT02123459|20250207|P2|STARTED|Period 2 (7 Days)||14
8211356|NCT02123459|20250208|P1|STARTED|Period 2 (7 Days)||13
8211357|NCT02123459|20250207|P2|NOT COMPLETED|Washout Period (1 Day)||0
8211358|NCT02123459|20250208|P1|NOT COMPLETED|Washout Period (1 Day)||1
8211359|NCT02123459|20250207|P2|COMPLETED|Washout Period (1 Day)||14
8211360|NCT02123459|20250208|P1|COMPLETED|Washout Period (1 Day)||13
8211361|NCT02123459|20250207|P2|STARTED|Washout Period (1 Day)||14
8211362|NCT02123459|20250208|P1|STARTED|Washout Period (1 Day)||14
8211363|NCT02123459|20250207|P2|NOT COMPLETED|Period 1 (7 Days)||0
8211364|NCT02123459|20250208|P1|NOT COMPLETED|Period 1 (7 Days)||0
8211365|NCT02123459|20250207|P2|COMPLETED|Period 1 (7 Days)||14
8211366|NCT02123459|20250208|P1|COMPLETED|Period 1 (7 Days)||14
8211367|NCT02123459|20250207|P2|STARTED|Period 1 (7 Days)||14
8211368|NCT02123459|20250208|P1|STARTED|Period 1 (7 Days)||14
8211369|NCT02123446|20250218|P2|NOT COMPLETED|Period 2 (7 Days)||0
8211370|NCT02123446|20250219|P1|NOT COMPLETED|Period 2 (7 Days)||0
8211371|NCT02123446|20250218|P2|COMPLETED|Period 2 (7 Days)||14
8211372|NCT02123446|20250219|P1|COMPLETED|Period 2 (7 Days)||13
8211373|NCT02123446|20250218|P2|STARTED|Period 2 (7 Days)||14
8211374|NCT02123446|20250219|P1|STARTED|Period 2 (7 Days)||13
8211375|NCT02123446|20250218|P2|NOT COMPLETED|Washout Period (1 Day)||0
8211376|NCT02123446|20250219|P1|NOT COMPLETED|Washout Period (1 Day)||1
8211377|NCT02123446|20250218|P2|COMPLETED|Washout Period (1 Day)||14
8211378|NCT02123446|20250219|P1|COMPLETED|Washout Period (1 Day)||13
8211379|NCT02123446|20250218|P2|STARTED|Washout Period (1 Day)||14
8211380|NCT02123446|20250219|P1|STARTED|Washout Period (1 Day)||14
8211381|NCT02123446|20250218|P2|NOT COMPLETED|Period 1 (7 Days)||0
8211382|NCT02123446|20250219|P1|NOT COMPLETED|Period 1 (7 Days)||0
8211383|NCT02123446|20250218|P2|COMPLETED|Period 1 (7 Days)||14
8211384|NCT02123446|20250219|P1|COMPLETED|Period 1 (7 Days)||14
8211385|NCT02123446|20250218|P2|STARTED|Period 1 (7 Days)||14
8211386|NCT02123446|20250219|P1|STARTED|Period 1 (7 Days)||14
8211387|NCT02123329|20250231|P2|NOT COMPLETED|12 Month Outcome Measure||79
8211388|NCT02123329|20250232|P1|NOT COMPLETED|12 Month Outcome Measure||64
8211389|NCT02123329|20250231|P2|COMPLETED|12 Month Outcome Measure||88
8211390|NCT02123329|20250232|P1|COMPLETED|12 Month Outcome Measure||83
8211391|NCT02123329|20250231|P2|STARTED|12 Month Outcome Measure||167
8211392|NCT02123329|20250232|P1|STARTED|12 Month Outcome Measure||147
8211393|NCT02123329|20250231|P2|NOT COMPLETED|6 Month Outcome Measure||67
8211394|NCT02123329|20250232|P1|NOT COMPLETED|6 Month Outcome Measure||48
8211395|NCT02123329|20250231|P2|COMPLETED|6 Month Outcome Measure||100
8211396|NCT02123329|20250232|P1|COMPLETED|6 Month Outcome Measure||99
8211397|NCT02123329|20250231|P2|STARTED|6 Month Outcome Measure||167
8211398|NCT02123329|20250232|P1|STARTED|6 Month Outcome Measure||147
8211399|NCT02123329|20250231|P2|NOT COMPLETED|3 Month Outcome Measure||66
8211400|NCT02123329|20250232|P1|NOT COMPLETED|3 Month Outcome Measure||49
8211401|NCT02123329|20250231|P2|COMPLETED|3 Month Outcome Measure||101
8211402|NCT02123329|20250232|P1|COMPLETED|3 Month Outcome Measure||98
8211403|NCT02123329|20250231|P2|STARTED|3 Month Outcome Measure||167
8211404|NCT02123329|20250232|P1|STARTED|3 Month Outcome Measure||147
8211405|NCT02123251|20250260|P2|NOT COMPLETED|Overall Study||30
8211406|NCT02123251|20250261|P1|NOT COMPLETED|Overall Study||34
8211407|NCT02123251|20250260|P2|COMPLETED|Overall Study||131
8211408|NCT02123251|20250261|P1|COMPLETED|Overall Study||125
8211409|NCT02123251|20250260|P2|STARTED|Overall Study||161
8211410|NCT02123251|20250261|P1|STARTED|Overall Study||159
8211411|NCT02123134|20250287|P2|NOT COMPLETED|Overall Study||3
8211412|NCT02123134|20250288|P1|NOT COMPLETED|Overall Study||3
8211413|NCT02123134|20250287|P2|COMPLETED|Overall Study||24
8211414|NCT02123134|20250288|P1|COMPLETED|Overall Study||25
8211415|NCT02123134|20250287|P2|STARTED|Overall Study||27
8211416|NCT02123134|20250288|P1|STARTED|Overall Study||28
8211417|NCT02123017|20250309|P3|NOT COMPLETED|Overall Study||0
8211418|NCT02123017|20250310|P2|NOT COMPLETED|Overall Study||0
8211419|NCT02123017|20250311|P1|NOT COMPLETED|Overall Study||0
8211420|NCT02123017|20250309|P3|COMPLETED|Overall Study||12
8211421|NCT02123017|20250310|P2|COMPLETED|Overall Study||12
8211422|NCT02123017|20250311|P1|COMPLETED|Overall Study||8
8211423|NCT02123017|20250309|P3|STARTED|Overall Study||12
8211424|NCT02123017|20250310|P2|STARTED|Overall Study||12
8211425|NCT02123017|20250311|P1|STARTED|Overall Study||8
8211432|NCT02122887|20250345|P2|NOT COMPLETED|Overall Study||2
8211433|NCT02122887|20250346|P1|NOT COMPLETED|Overall Study||20
8211434|NCT02122887|20250345|P2|COMPLETED|Overall Study||39
8211435|NCT02122887|20250346|P1|COMPLETED|Overall Study||40
8211436|NCT02122887|20250345|P2|STARTED|Overall Study||41
8211437|NCT02122887|20250346|P1|STARTED|Overall Study||60
8211438|NCT02122796|20250368|P2|NOT COMPLETED|Visit 2||1
8211439|NCT02122796|20250369|P1|NOT COMPLETED|Visit 2||3
8211440|NCT02122796|20250368|P2|COMPLETED|Visit 2||14
8211441|NCT02122796|20250369|P1|COMPLETED|Visit 2||12
8211442|NCT02122796|20250368|P2|STARTED|Visit 2||15
8211443|NCT02122796|20250369|P1|STARTED|Visit 2||15
8211444|NCT02122796|20250368|P2|NOT COMPLETED|Visit 1||0
8211445|NCT02122796|20250369|P1|NOT COMPLETED|Visit 1||0
8211446|NCT02122796|20250368|P2|COMPLETED|Visit 1||15
8211447|NCT02122796|20250369|P1|COMPLETED|Visit 1||15
8211448|NCT02122796|20250368|P2|STARTED|Visit 1||15
8211449|NCT02122796|20250369|P1|STARTED|Visit 1||15
8211456|NCT02122770|20250399|P6|NOT COMPLETED|Part B: Standard of Care||13
8211457|NCT02122770|20250400|P5|NOT COMPLETED|Part B: Standard of Care||23
8211458|NCT02122770|20250401|P4|NOT COMPLETED|Part B: Standard of Care||0
8211459|NCT02122770|20250402|P3|NOT COMPLETED|Part B: Standard of Care||0
8211460|NCT02122770|20250403|P2|NOT COMPLETED|Part B: Standard of Care||0
8211461|NCT02122770|20250404|P1|NOT COMPLETED|Part B: Standard of Care||0
8211462|NCT02122770|20250399|P6|COMPLETED|Part B: Standard of Care||0
8211463|NCT02122770|20250400|P5|COMPLETED|Part B: Standard of Care||0
8211464|NCT02122770|20250401|P4|COMPLETED|Part B: Standard of Care||0
8211465|NCT02122770|20250402|P3|COMPLETED|Part B: Standard of Care||0
8211466|NCT02122770|20250403|P2|COMPLETED|Part B: Standard of Care||0
8211467|NCT02122770|20250404|P1|COMPLETED|Part B: Standard of Care||0
8211468|NCT02122770|20250399|P6|STARTED|Part B: Standard of Care||13
8211469|NCT02122770|20250400|P5|STARTED|Part B: Standard of Care||23
8211470|NCT02122770|20250401|P4|STARTED|Part B: Standard of Care||0
8211471|NCT02122770|20250402|P3|STARTED|Part B: Standard of Care||0
8211472|NCT02122770|20250403|P2|STARTED|Part B: Standard of Care||0
8211473|NCT02122770|20250404|P1|STARTED|Part B: Standard of Care||0
8211474|NCT02122770|20250399|P6|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
8211475|NCT02122770|20250400|P5|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
8211476|NCT02122770|20250401|P4|NOT COMPLETED|Part A: Drug-drug Interaction 2||3
8211477|NCT02122770|20250402|P3|NOT COMPLETED|Part A: Drug-drug Interaction 2||2
8211478|NCT02122770|20250403|P2|NOT COMPLETED|Part A: Drug-drug Interaction 2||6
8211479|NCT02122770|20250404|P1|NOT COMPLETED|Part A: Drug-drug Interaction 2||4
8211480|NCT02122770|20250399|P6|COMPLETED|Part A: Drug-drug Interaction 2||0
8211481|NCT02122770|20250400|P5|COMPLETED|Part A: Drug-drug Interaction 2||0
8211482|NCT02122770|20250401|P4|COMPLETED|Part A: Drug-drug Interaction 2||16
8211483|NCT02122770|20250402|P3|COMPLETED|Part A: Drug-drug Interaction 2||4
8211484|NCT02122770|20250403|P2|COMPLETED|Part A: Drug-drug Interaction 2||7
8211485|NCT02122770|20250404|P1|COMPLETED|Part A: Drug-drug Interaction 2||9
8211486|NCT02122770|20250399|P6|STARTED|Part A: Drug-drug Interaction 2||0
8211487|NCT02122770|20250400|P5|STARTED|Part A: Drug-drug Interaction 2||0
8211488|NCT02122770|20250401|P4|STARTED|Part A: Drug-drug Interaction 2||19
8211489|NCT02122770|20250402|P3|STARTED|Part A: Drug-drug Interaction 2||6
8211490|NCT02122770|20250403|P2|STARTED|Part A: Drug-drug Interaction 2||13
8211491|NCT02122770|20250404|P1|STARTED|Part A: Drug-drug Interaction 2||13
8211492|NCT02122549|20250484|P1|NOT COMPLETED|Overall Study||0
8211493|NCT02122549|20250484|P1|COMPLETED|Overall Study||59
8211494|NCT02122549|20250484|P1|STARTED|Overall Study||59
8211495|NCT02122471|20250491|P3|NOT COMPLETED|Overall Study||44
8211496|NCT02122471|20250492|P2|NOT COMPLETED|Overall Study||51
8211497|NCT02122471|20250493|P1|NOT COMPLETED|Overall Study||39
8211498|NCT02122471|20250491|P3|COMPLETED|Overall Study||405
8211499|NCT02122471|20250492|P2|COMPLETED|Overall Study||392
8211500|NCT02122471|20250493|P1|COMPLETED|Overall Study||406
8211501|NCT02122471|20250491|P3|STARTED|Overall Study||449
8211502|NCT02122471|20250492|P2|STARTED|Overall Study||443
8211503|NCT02122471|20250493|P1|STARTED|Overall Study||445
8211504|NCT02122445|20250513|P1|NOT COMPLETED|Overall Study||0
8211505|NCT02122445|20250513|P1|COMPLETED|Overall Study||20
8211506|NCT02122445|20250513|P1|STARTED|Overall Study||20
8211507|NCT02122406|20250518|P1|NOT COMPLETED|Overall Study||0
8211508|NCT02122406|20250518|P1|COMPLETED|Overall Study||200
8211509|NCT02122406|20250518|P1|STARTED|Overall Study||200
8211510|NCT02122380|20250524|P2|NOT COMPLETED|Second Intervention (30 Days)||2
8211511|NCT02122380|20250525|P1|NOT COMPLETED|Second Intervention (30 Days)||0
8211512|NCT02122380|20250524|P2|COMPLETED|Second Intervention (30 Days)||7
8211513|NCT02122380|20250525|P1|COMPLETED|Second Intervention (30 Days)||9
8211514|NCT02122380|20250524|P2|STARTED|Second Intervention (30 Days)||9
8211515|NCT02122380|20250525|P1|STARTED|Second Intervention (30 Days)||9
8211516|NCT02122380|20250524|P2|NOT COMPLETED|Washout (8 Weeks)||2
8211517|NCT02122380|20250525|P1|NOT COMPLETED|Washout (8 Weeks)||1
8211518|NCT02122380|20250524|P2|COMPLETED|Washout (8 Weeks)||9
8211519|NCT02122380|20250525|P1|COMPLETED|Washout (8 Weeks)||9
8211520|NCT02122380|20250524|P2|STARTED|Washout (8 Weeks)||11
8211521|NCT02122380|20250525|P1|STARTED|Washout (8 Weeks)||10
8211522|NCT02122380|20250524|P2|NOT COMPLETED|First Intervention (30 Days)||1
8211523|NCT02122380|20250525|P1|NOT COMPLETED|First Intervention (30 Days)||1
8211524|NCT02122380|20250524|P2|COMPLETED|First Intervention (30 Days)||11
8211525|NCT02122380|20250525|P1|COMPLETED|First Intervention (30 Days)||10
8211526|NCT02122380|20250524|P2|STARTED|First Intervention (30 Days)||12
8211527|NCT02122380|20250525|P1|STARTED|First Intervention (30 Days)||11
8211528|NCT02122341|20250541|P2|NOT COMPLETED|Overall Study||0
8211529|NCT02122341|20250542|P1|NOT COMPLETED|Overall Study||0
8211530|NCT02122341|20250541|P2|COMPLETED|Overall Study||18
8211531|NCT02122341|20250542|P1|COMPLETED|Overall Study||17
8211532|NCT02122341|20250541|P2|STARTED|Overall Study||18
8211533|NCT02122341|20250542|P1|STARTED|Overall Study||17
8211534|NCT02122146|20250564|P8|NOT COMPLETED|Part 3: Expansion||0
8211535|NCT02122146|20250565|P7|NOT COMPLETED|Part 3: Expansion||0
8211536|NCT02122146|20250566|P6|NOT COMPLETED|Part 3: Expansion||0
8211537|NCT02122146|20250567|P5|NOT COMPLETED|Part 3: Expansion||0
8211538|NCT02122146|20250568|P4|NOT COMPLETED|Part 3: Expansion||0
8211539|NCT02122146|20250569|P3|NOT COMPLETED|Part 3: Expansion||0
8211540|NCT02122146|20250570|P2|NOT COMPLETED|Part 3: Expansion||0
8211541|NCT02122146|20250571|P1|NOT COMPLETED|Part 3: Expansion||0
8211542|NCT02122146|20250564|P8|COMPLETED|Part 3: Expansion||0
8211543|NCT02122146|20250565|P7|COMPLETED|Part 3: Expansion||0
8211544|NCT02122146|20250566|P6|COMPLETED|Part 3: Expansion||0
8211545|NCT02122146|20250567|P5|COMPLETED|Part 3: Expansion||0
8211546|NCT02122146|20250568|P4|COMPLETED|Part 3: Expansion||0
8211547|NCT02122146|20250569|P3|COMPLETED|Part 3: Expansion||0
8211548|NCT02122146|20250570|P2|COMPLETED|Part 3: Expansion||0
8211549|NCT02122146|20250571|P1|COMPLETED|Part 3: Expansion||0
8211550|NCT02122146|20250564|P8|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211551|NCT02122146|20250565|P7|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211552|NCT02122146|20250566|P6|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211553|NCT02122146|20250567|P5|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211554|NCT02122146|20250568|P4|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211555|NCT02122146|20250569|P3|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211556|NCT02122146|20250570|P2|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211557|NCT02122146|20250571|P1|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
8211558|NCT02122146|20250564|P8|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211559|NCT02122146|20250565|P7|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211560|NCT02122146|20250566|P6|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211561|NCT02122146|20250567|P5|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211562|NCT02122146|20250568|P4|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211563|NCT02122146|20250569|P3|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211564|NCT02122146|20250570|P2|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211565|NCT02122146|20250571|P1|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
8211566|NCT02122146|20250564|P8|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211567|NCT02122146|20250565|P7|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211568|NCT02122146|20250566|P6|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211569|NCT02122146|20250567|P5|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211570|NCT02122146|20250568|P4|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211571|NCT02122146|20250569|P3|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211572|NCT02122146|20250570|P2|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211573|NCT02122146|20250571|P1|COMPLETED|Part 2: Maximum Tolerated Dose||0
8211574|NCT02122146|20250564|P8|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211575|NCT02122146|20250565|P7|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211576|NCT02122146|20250566|P6|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211577|NCT02122146|20250567|P5|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211578|NCT02122146|20250568|P4|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211579|NCT02122146|20250569|P3|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211580|NCT02122146|20250570|P2|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211581|NCT02122146|20250571|P1|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
8211582|NCT02122146|20250564|P8|NOT COMPLETED|Part 1: Dose Escalation||2
8211583|NCT02122146|20250565|P7|NOT COMPLETED|Part 1: Dose Escalation||1
8211584|NCT02122146|20250566|P6|NOT COMPLETED|Part 1: Dose Escalation||1
8211585|NCT02122146|20250567|P5|NOT COMPLETED|Part 1: Dose Escalation||1
8211586|NCT02122146|20250568|P4|NOT COMPLETED|Part 1: Dose Escalation||1
8211587|NCT02122146|20250569|P3|NOT COMPLETED|Part 1: Dose Escalation||2
8211588|NCT02122146|20250570|P2|NOT COMPLETED|Part 1: Dose Escalation||1
8211589|NCT02122146|20250571|P1|NOT COMPLETED|Part 1: Dose Escalation||1
8211590|NCT02122146|20250564|P8|COMPLETED|Part 1: Dose Escalation||6
8211591|NCT02122146|20250565|P7|COMPLETED|Part 1: Dose Escalation||0
8211592|NCT02122146|20250566|P6|COMPLETED|Part 1: Dose Escalation||5
8211593|NCT02122146|20250567|P5|COMPLETED|Part 1: Dose Escalation||3
8211594|NCT02122146|20250568|P4|COMPLETED|Part 1: Dose Escalation||3
8211595|NCT02122146|20250569|P3|COMPLETED|Part 1: Dose Escalation||2
8211596|NCT02122146|20250570|P2|COMPLETED|Part 1: Dose Escalation||1
8211597|NCT02122146|20250571|P1|COMPLETED|Part 1: Dose Escalation||1
8211598|NCT02122146|20250564|P8|STARTED|Part 1: Dose Escalation||8
8211599|NCT02122146|20250565|P7|STARTED|Part 1: Dose Escalation||1
8211600|NCT02122146|20250566|P6|STARTED|Part 1: Dose Escalation||6
8211601|NCT02122146|20250567|P5|STARTED|Part 1: Dose Escalation||4
8211602|NCT02122146|20250568|P4|STARTED|Part 1: Dose Escalation||4
8211603|NCT02122146|20250569|P3|STARTED|Part 1: Dose Escalation||4
8211604|NCT02122146|20250570|P2|STARTED|Part 1: Dose Escalation||2
8211605|NCT02122146|20250571|P1|STARTED|Part 1: Dose Escalation||2
8211606|NCT02121912|20250808|P2|NOT COMPLETED|Overall Study||0
8211607|NCT02121912|20250809|P1|NOT COMPLETED|Overall Study||4
8211608|NCT02121912|20250808|P2|COMPLETED|Overall Study||25
8211609|NCT02121912|20250809|P1|COMPLETED|Overall Study||21
8211610|NCT02121912|20250808|P2|STARTED|Overall Study||25
8211611|NCT02121912|20250809|P1|STARTED|Overall Study||25
8211612|NCT02121860|20250823|P4|NOT COMPLETED|Overall Study||0
8211613|NCT02121860|20250824|P3|NOT COMPLETED|Overall Study||0
8211614|NCT02121860|20250825|P2|NOT COMPLETED|Overall Study||0
8211615|NCT02121860|20250826|P1|NOT COMPLETED|Overall Study||0
8211616|NCT02121860|20250823|P4|COMPLETED|Overall Study||8
8211617|NCT02121860|20250824|P3|COMPLETED|Overall Study||8
8211618|NCT02121860|20250825|P2|COMPLETED|Overall Study||12
8211619|NCT02121860|20250826|P1|COMPLETED|Overall Study||8
8211620|NCT02121860|20250823|P4|STARTED|Overall Study||8
8211621|NCT02121860|20250824|P3|STARTED|Overall Study||8
8211622|NCT02121860|20250825|P2|STARTED|Overall Study||12
8211623|NCT02121860|20250826|P1|STARTED|Overall Study||8
8211624|NCT02121847|20250845|P1|NOT COMPLETED|Overall Study||3
8211625|NCT02121847|20250845|P1|COMPLETED|Overall Study||37
8211626|NCT02121847|20250845|P1|STARTED|Overall Study||40
8211627|NCT02121834|20250871|P7|NOT COMPLETED|Overall Study||0
8211628|NCT02121834|20250872|P6|NOT COMPLETED|Overall Study||0
8211629|NCT02121834|20250873|P5|NOT COMPLETED|Overall Study||0
8211630|NCT02121834|20250874|P4|NOT COMPLETED|Overall Study||0
8211631|NCT02121834|20250875|P3|NOT COMPLETED|Overall Study||2
8211632|NCT02121834|20250876|P2|NOT COMPLETED|Overall Study||2
8211633|NCT02121834|20250877|P1|NOT COMPLETED|Overall Study||0
8211634|NCT02121834|20250871|P7|COMPLETED|Overall Study||3
8211635|NCT02121834|20250872|P6|COMPLETED|Overall Study||9
8211636|NCT02121834|20250873|P5|COMPLETED|Overall Study||9
8211637|NCT02121834|20250874|P4|COMPLETED|Overall Study||10
8211638|NCT02121834|20250875|P3|COMPLETED|Overall Study||7
8211639|NCT02121834|20250876|P2|COMPLETED|Overall Study||9
8211640|NCT02121834|20250877|P1|COMPLETED|Overall Study||12
8211641|NCT02121834|20250871|P7|Received at Least One Dose of Study Drug|Overall Study||3
8211642|NCT02121834|20250872|P6|Received at Least One Dose of Study Drug|Overall Study||9
8211643|NCT02121834|20250873|P5|Received at Least One Dose of Study Drug|Overall Study||9
8211644|NCT02121834|20250874|P4|Received at Least One Dose of Study Drug|Overall Study||10
8211645|NCT02121834|20250875|P3|Received at Least One Dose of Study Drug|Overall Study||9
8211646|NCT02121834|20250876|P2|Received at Least One Dose of Study Drug|Overall Study||11
8211647|NCT02121834|20250877|P1|Received at Least One Dose of Study Drug|Overall Study||12
8211648|NCT02121834|20250871|P7|STARTED|Overall Study||3
8211649|NCT02121834|20250872|P6|STARTED|Overall Study||9
8211650|NCT02121834|20250873|P5|STARTED|Overall Study||9
8211651|NCT02121834|20250874|P4|STARTED|Overall Study||10
8211652|NCT02121834|20250875|P3|STARTED|Overall Study||9
8211653|NCT02121834|20250876|P2|STARTED|Overall Study||11
8211654|NCT02121834|20250877|P1|STARTED|Overall Study||12
8211655|NCT02121808|20250903|P1|NOT COMPLETED|Overall Study||3
8211656|NCT02121808|20250903|P1|COMPLETED|Overall Study||17
8211657|NCT02121808|20250903|P1|STARTED|Overall Study||20
8211658|NCT02121795|20250914|P2|NOT COMPLETED|Open-Label Phase||10
8211659|NCT02121795|20250915|P1|NOT COMPLETED|Open-Label Phase||12
8211660|NCT02121795|20250914|P2|COMPLETED|Open-Label Phase||21
8211661|NCT02121795|20250915|P1|COMPLETED|Open-Label Phase||21
8211662|NCT02121795|20250914|P2|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|31
8211663|NCT02121795|20250915|P1|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|33
8211664|NCT02121795|20250914|P2|NOT COMPLETED|Double-Blind Phase||34
8211665|NCT02121795|20250915|P1|NOT COMPLETED|Double-Blind Phase||38
8211666|NCT02121795|20250914|P2|COMPLETED|Double-Blind Phase||300
8211667|NCT02121795|20250915|P1|COMPLETED|Double-Blind Phase||296
8211668|NCT02121795|20250914|P2|Safety Analysis Set|Double-Blind Phase||330
8211669|NCT02121795|20250915|P1|Safety Analysis Set|Double-Blind Phase||333
8211670|NCT02121795|20250914|P2|STARTED|Double-Blind Phase||334
8211671|NCT02121795|20250915|P1|STARTED|Double-Blind Phase||334
8211672|NCT02121756|20250943|P2|NOT COMPLETED|Overall Study||2
8211673|NCT02121756|20250944|P1|NOT COMPLETED|Overall Study||6
8211674|NCT02121756|20250943|P2|COMPLETED|Overall Study||17
8211675|NCT02121756|20250944|P1|COMPLETED|Overall Study||15
8211676|NCT02121756|20250943|P2|STARTED|Overall Study||19
8211677|NCT02121756|20250944|P1|STARTED|Overall Study||21
8211678|NCT02121535|20250981|P2|NOT COMPLETED|Period 4 (8 Trial Days)||0
8211679|NCT02121535|20250982|P1|NOT COMPLETED|Period 4 (8 Trial Days)||0
8211680|NCT02121535|20250981|P2|COMPLETED|Period 4 (8 Trial Days)||35
8211681|NCT02121535|20250982|P1|COMPLETED|Period 4 (8 Trial Days)||35
8211682|NCT02121535|20250981|P2|STARTED|Period 4 (8 Trial Days)||35
8211683|NCT02121535|20250982|P1|STARTED|Period 4 (8 Trial Days)||35
8211684|NCT02121535|20250981|P2|NOT COMPLETED|Period 3 (8 Trial Days)||0
8211685|NCT02121535|20250982|P1|NOT COMPLETED|Period 3 (8 Trial Days)||1
8211686|NCT02121535|20250981|P2|COMPLETED|Period 3 (8 Trial Days)||35
8211687|NCT02121535|20250982|P1|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
8211688|NCT02121535|20250981|P2|STARTED|Period 3 (8 Trial Days)||35
8211689|NCT02121535|20250982|P1|STARTED|Period 3 (8 Trial Days)||36
8211690|NCT02121535|20250981|P2|NOT COMPLETED|Period 2 (8 Trial Days)||0
8211691|NCT02121535|20250982|P1|NOT COMPLETED|Period 2 (8 Trial Days)||0
8211692|NCT02121535|20250981|P2|COMPLETED|Period 2 (8 Trial Days)||35
8211693|NCT02121535|20250982|P1|COMPLETED|Period 2 (8 Trial Days)||36
8211694|NCT02121535|20250981|P2|STARTED|Period 2 (8 Trial Days)||35
8211695|NCT02121535|20250982|P1|STARTED|Period 2 (8 Trial Days)||36
8211696|NCT02121535|20250981|P2|NOT COMPLETED|Period 1 (8 Trial Days)||1
8211697|NCT02121535|20250982|P1|NOT COMPLETED|Period 1 (8 Trial Days)||0
8211698|NCT02121535|20250981|P2|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
8211699|NCT02121535|20250982|P1|COMPLETED|Period 1 (8 Trial Days)||36
8211700|NCT02121535|20250981|P2|STARTED|Period 1 (8 Trial Days)||36
8211701|NCT02121535|20250982|P1|STARTED|Period 1 (8 Trial Days)||36
8211702|NCT02121522|20251005|P1|NOT COMPLETED|Overall Study||1
8211703|NCT02121522|20251005|P1|COMPLETED|Overall Study||13
8211704|NCT02121522|20251005|P1|STARTED|Overall Study||14
8211705|NCT02121509|20251012|P4|NOT COMPLETED|Treatment Period-2 (4 Days)||0
8211706|NCT02121509|20251013|P3|NOT COMPLETED|Treatment Period-2 (4 Days)||0
8211707|NCT02121509|20251014|P2|NOT COMPLETED|Treatment Period-2 (4 Days)||0
8211708|NCT02121509|20251015|P1|NOT COMPLETED|Treatment Period-2 (4 Days)||0
8211709|NCT02121509|20251012|P4|COMPLETED|Treatment Period-2 (4 Days)||8
8211710|NCT02121509|20251013|P3|COMPLETED|Treatment Period-2 (4 Days)||8
8211711|NCT02121509|20251014|P2|COMPLETED|Treatment Period-2 (4 Days)||24
8211712|NCT02121509|20251015|P1|COMPLETED|Treatment Period-2 (4 Days)||28
8211713|NCT02121509|20251012|P4|STARTED|Treatment Period-2 (4 Days)||8
8211714|NCT02121509|20251013|P3|STARTED|Treatment Period-2 (4 Days)||8
8211715|NCT02121509|20251014|P2|STARTED|Treatment Period-2 (4 Days)||24
8211716|NCT02121509|20251015|P1|STARTED|Treatment Period-2 (4 Days)||28
8211717|NCT02121509|20251012|P4|NOT COMPLETED|Washout Period (35 Days)||0
8211718|NCT02121509|20251013|P3|NOT COMPLETED|Washout Period (35 Days)||0
8211719|NCT02121509|20251014|P2|NOT COMPLETED|Washout Period (35 Days)||4
8211720|NCT02121509|20251015|P1|NOT COMPLETED|Washout Period (35 Days)||2
8211721|NCT02121509|20251012|P4|COMPLETED|Washout Period (35 Days)||8
8211722|NCT02121509|20251013|P3|COMPLETED|Washout Period (35 Days)||8
8211723|NCT02121509|20251014|P2|COMPLETED|Washout Period (35 Days)||24
8211724|NCT02121509|20251015|P1|COMPLETED|Washout Period (35 Days)||28
8211725|NCT02121509|20251012|P4|STARTED|Washout Period (35 Days)||8
8211726|NCT02121509|20251013|P3|STARTED|Washout Period (35 Days)||8
8211727|NCT02121509|20251014|P2|STARTED|Washout Period (35 Days)||28
8211728|NCT02121509|20251015|P1|STARTED|Washout Period (35 Days)||30
8211729|NCT02121509|20251012|P4|NOT COMPLETED|Treatment Period-1 (4 Days)||0
8211730|NCT02121509|20251013|P3|NOT COMPLETED|Treatment Period-1 (4 Days)||0
8211731|NCT02121509|20251014|P2|NOT COMPLETED|Treatment Period-1 (4 Days)||0
8211732|NCT02121509|20251015|P1|NOT COMPLETED|Treatment Period-1 (4 Days)||0
8211733|NCT02121509|20251012|P4|COMPLETED|Treatment Period-1 (4 Days)||8
8211734|NCT02121509|20251013|P3|COMPLETED|Treatment Period-1 (4 Days)||8
8211735|NCT02121509|20251014|P2|COMPLETED|Treatment Period-1 (4 Days)||28
8211736|NCT02121509|20251015|P1|COMPLETED|Treatment Period-1 (4 Days)||30
8211737|NCT02121509|20251012|P4|STARTED|Treatment Period-1 (4 Days)||8
8211738|NCT02121509|20251013|P3|STARTED|Treatment Period-1 (4 Days)||8
8211739|NCT02121509|20251014|P2|STARTED|Treatment Period-1 (4 Days)||28
8211740|NCT02121509|20251015|P1|STARTED|Treatment Period-1 (4 Days)||30
8211741|NCT02121483|20251048|P3|NOT COMPLETED|Overall Study||0
8211742|NCT02121483|20251049|P2|NOT COMPLETED|Overall Study||0
8211743|NCT02121483|20251050|P1|NOT COMPLETED|Overall Study||0
8211744|NCT02121483|20251048|P3|COMPLETED|Overall Study||10
8211745|NCT02121483|20251049|P2|COMPLETED|Overall Study||8
8211746|NCT02121483|20251050|P1|COMPLETED|Overall Study||9
8211747|NCT02121483|20251048|P3|STARTED|Overall Study||10
8211748|NCT02121483|20251049|P2|STARTED|Overall Study||8
8211749|NCT02121483|20251050|P1|STARTED|Overall Study||9
8211750|NCT02121418|20251079|P1|NOT COMPLETED|Overall Study||0
8211751|NCT02121418|20251079|P1|COMPLETED|Overall Study||12
8211752|NCT02121418|20251079|P1|STARTED|Overall Study||12
8211753|NCT02121392|20251086|P2|NOT COMPLETED|After Placement of AC Block vs Sham||3
8211754|NCT02121392|20251087|P1|NOT COMPLETED|After Placement of AC Block vs Sham||3
8211755|NCT02121392|20251086|P2|COMPLETED|After Placement of AC Block vs Sham||38
8211756|NCT02121392|20251087|P1|COMPLETED|After Placement of AC Block vs Sham||32
8211757|NCT02121392|20251086|P2|STARTED|After Placement of AC Block vs Sham||41
8211758|NCT02121392|20251087|P1|STARTED|After Placement of AC Block vs Sham||35
8211759|NCT02121392|20251086|P2|NOT COMPLETED|Prior to Intervention||41
8211760|NCT02121392|20251087|P1|NOT COMPLETED|Prior to Intervention||48
8211761|NCT02121392|20251086|P2|COMPLETED|Prior to Intervention||41
8211762|NCT02121392|20251087|P1|COMPLETED|Prior to Intervention||35
8211763|NCT02121392|20251086|P2|STARTED|Prior to Intervention||82
8211764|NCT02121392|20251087|P1|STARTED|Prior to Intervention||83
8211765|NCT02121301|20251112|P3|NOT COMPLETED|Overall Study||1
8211766|NCT02121301|20251113|P2|NOT COMPLETED|Overall Study||4
8211767|NCT02121301|20251114|P1|NOT COMPLETED|Overall Study||1
8211768|NCT02121301|20251112|P3|COMPLETED|Overall Study||30
8211769|NCT02121301|20251113|P2|COMPLETED|Overall Study||26
8211770|NCT02121301|20251114|P1|COMPLETED|Overall Study||29
8211771|NCT02121301|20251112|P3|STARTED|Overall Study||31
8211772|NCT02121301|20251113|P2|STARTED|Overall Study||30
8211773|NCT02121301|20251114|P1|STARTED|Overall Study||30
8211774|NCT02121262|20251127|P2|NOT COMPLETED|Overall Study||10
8211775|NCT02121262|20251128|P1|NOT COMPLETED|Overall Study||31
8211776|NCT02121262|20251127|P2|COMPLETED|Overall Study||135
8211777|NCT02121262|20251128|P1|COMPLETED|Overall Study||108
8211778|NCT02121262|20251127|P2|Modified Intent-to-treat Population|Overall Study||145
8211779|NCT02121262|20251128|P1|Modified Intent-to-treat Population|Overall Study||127
8211780|NCT02121262|20251127|P2|Treated|Overall Study||145
8211781|NCT02121262|20251128|P1|Treated|Overall Study||129
8211782|NCT02121262|20251127|P2|STARTED|Overall Study||145
8211783|NCT02121262|20251128|P1|STARTED|Overall Study||139
8211784|NCT02121210|20251142|P2|NOT COMPLETED|Overall Study||9
8211785|NCT02121210|20251143|P1|NOT COMPLETED|Overall Study||7
8211786|NCT02121210|20251142|P2|COMPLETED|Overall Study||58
8211787|NCT02121210|20251143|P1|COMPLETED|Overall Study||58
8211788|NCT02121210|20251142|P2|STARTED|Overall Study||67
8211789|NCT02121210|20251143|P1|STARTED|Overall Study||65
8211790|NCT02121067|20251151|P1|NOT COMPLETED|Overall Study||0
8211791|NCT02121067|20251151|P1|COMPLETED|Overall Study||50
8211792|NCT02121067|20251151|P1|STARTED|Overall Study||50
8211793|NCT02121041|20251159|P2|NOT COMPLETED|Overall Study||6
8211794|NCT02121041|20251160|P1|NOT COMPLETED|Overall Study||1
8211795|NCT02121041|20251159|P2|COMPLETED|Overall Study||8
8211796|NCT02121041|20251160|P1|COMPLETED|Overall Study||13
8211797|NCT02121041|20251159|P2|STARTED|Overall Study||14
8211798|NCT02121041|20251160|P1|STARTED|Overall Study||14
8211799|NCT02120950|20251168|P3|NOT COMPLETED|Overall Study||15
8211800|NCT02120950|20251169|P2|NOT COMPLETED|Overall Study||14
8211801|NCT02120950|20251170|P1|NOT COMPLETED|Overall Study||20
8211802|NCT02120950|20251168|P3|COMPLETED|Overall Study||0
8211803|NCT02120950|20251169|P2|COMPLETED|Overall Study|Completed Treatment (Week 96)|147
8211804|NCT02120950|20251170|P1|COMPLETED|Overall Study|Completed Treatment (Week 96)|137
8211805|NCT02120950|20251168|P3|STARTED|Overall Study||15
8211806|NCT02120950|20251169|P2|STARTED|Overall Study||161
8211807|NCT02120950|20251170|P1|STARTED|Overall Study||157
8211808|NCT02120924|20251206|P3|NOT COMPLETED|Overall Study||29
8211809|NCT02120924|20251207|P2|NOT COMPLETED|Overall Study||46
8211810|NCT02120924|20251208|P1|NOT COMPLETED|Overall Study||42
8211811|NCT02120924|20251206|P3|COMPLETED|Overall Study||173
8211812|NCT02120924|20251207|P2|COMPLETED|Overall Study||357
8211813|NCT02120924|20251208|P1|COMPLETED|Overall Study||362
8211814|NCT02120924|20251206|P3|STARTED|Overall Study||202
8211815|NCT02120924|20251207|P2|STARTED|Overall Study||403
8211816|NCT02120924|20251208|P1|STARTED|Overall Study||404
8211817|NCT02120898|20251222|P3|NOT COMPLETED|Overall Study||4
8211818|NCT02120898|20251223|P2|NOT COMPLETED|Overall Study||6
8211819|NCT02120898|20251224|P1|NOT COMPLETED|Overall Study||9
8211820|NCT02120898|20251222|P3|COMPLETED|Overall Study||89
8211821|NCT02120898|20251223|P2|COMPLETED|Overall Study||181
8211822|NCT02120898|20251224|P1|COMPLETED|Overall Study||178
8211823|NCT02120898|20251222|P3|Intent-to-Treat (ITT) Population|Overall Study||93
8211824|NCT02120898|20251223|P2|Intent-to-Treat (ITT) Population|Overall Study||185
8211825|NCT02120898|20251224|P1|Intent-to-Treat (ITT) Population|Overall Study||183
8211826|NCT02120898|20251222|P3|Safety Population|Overall Study||93
8211827|NCT02120898|20251223|P2|Safety Population|Overall Study||187
8211828|NCT02120898|20251224|P1|Safety Population|Overall Study||187
8211829|NCT02120898|20251222|P3|STARTED|Overall Study||93
8211830|NCT02120898|20251223|P2|STARTED|Overall Study||187
8211831|NCT02120898|20251224|P1|STARTED|Overall Study||187
8211832|NCT02120833|20251246|P2|NOT COMPLETED|Overall Study||1
8211833|NCT02120833|20251247|P1|NOT COMPLETED|Overall Study||4
8211834|NCT02120833|20251246|P2|COMPLETED|Overall Study||11
8211835|NCT02120833|20251247|P1|COMPLETED|Overall Study||35
8211836|NCT02120833|20251246|P2|STARTED|Overall Study||12
8211837|NCT02120833|20251247|P1|STARTED|Overall Study||39
8211838|NCT02120794|20251401|P1|NOT COMPLETED|Overall Study||58
8211839|NCT02120794|20251401|P1|COMPLETED|Overall Study||136
8211840|NCT02120794|20251401|P1|STARTED|Overall Study||194
8211841|NCT02120716|20251410|P2|NOT COMPLETED|Overall Study||0
8211842|NCT02120716|20251411|P1|NOT COMPLETED|Overall Study||1
8211843|NCT02120716|20251410|P2|COMPLETED|Overall Study||19
8211844|NCT02120716|20251411|P1|COMPLETED|Overall Study||30
8211845|NCT02120716|20251410|P2|STARTED|Overall Study||19
8211846|NCT02120716|20251411|P1|STARTED|Overall Study||31
8211847|NCT02120664|20251425|P5|NOT COMPLETED|Overall Study||0
8211848|NCT02120664|20251426|P4|NOT COMPLETED|Overall Study||1
8211849|NCT02120664|20251427|P3|NOT COMPLETED|Overall Study||0
8211850|NCT02120664|20251428|P2|NOT COMPLETED|Overall Study||0
8211851|NCT02120664|20251429|P1|NOT COMPLETED|Overall Study||0
8211852|NCT02120664|20251425|P5|COMPLETED|Overall Study||10
8211853|NCT02120664|20251426|P4|COMPLETED|Overall Study||3
8211854|NCT02120664|20251427|P3|COMPLETED|Overall Study||7
8211855|NCT02120664|20251428|P2|COMPLETED|Overall Study||4
8211856|NCT02120664|20251429|P1|COMPLETED|Overall Study||10
8211857|NCT02120664|20251425|P5|STARTED|Overall Study||10
8211858|NCT02120664|20251426|P4|STARTED|Overall Study||4
8211859|NCT02120664|20251427|P3|STARTED|Overall Study||7
8211860|NCT02120664|20251428|P2|STARTED|Overall Study||4
8211861|NCT02120664|20251429|P1|STARTED|Overall Study||10
8211862|NCT02120625|20251447|P1|NOT COMPLETED|Overall Study||2
8211863|NCT02120625|20251447|P1|COMPLETED|Overall Study||6
8211864|NCT02120625|20251447|P1|STARTED|Overall Study||8
8211865|NCT02120456|20251463|P9|NOT COMPLETED|Part 2 Double-blind Phase||1
8211866|NCT02120456|20251464|P8|NOT COMPLETED|Part 2 Double-blind Phase||0
8211867|NCT02120456|20251465|P7|NOT COMPLETED|Part 2 Double-blind Phase||2
8211868|NCT02120456|20251466|P6|NOT COMPLETED|Part 2 Double-blind Phase||0
8211869|NCT02120456|20251467|P5|NOT COMPLETED|Part 2 Double-blind Phase||0
8211870|NCT02120456|20251468|P4|NOT COMPLETED|Part 2 Double-blind Phase||0
8211871|NCT02120456|20251469|P3|NOT COMPLETED|Part 2 Double-blind Phase||0
8211872|NCT02120456|20251470|P2|NOT COMPLETED|Part 2 Double-blind Phase||0
8211873|NCT02120456|20251471|P1|NOT COMPLETED|Part 2 Double-blind Phase||0
8211874|NCT02120456|20251463|P9|COMPLETED|Part 2 Double-blind Phase||62
8211875|NCT02120456|20251464|P8|COMPLETED|Part 2 Double-blind Phase||60
8211876|NCT02120456|20251465|P7|COMPLETED|Part 2 Double-blind Phase||30
8211877|NCT02120456|20251466|P6|COMPLETED|Part 2 Double-blind Phase||0
8211878|NCT02120456|20251467|P5|COMPLETED|Part 2 Double-blind Phase||0
8211879|NCT02120456|20251468|P4|COMPLETED|Part 2 Double-blind Phase||0
8211880|NCT02120456|20251469|P3|COMPLETED|Part 2 Double-blind Phase||0
8211881|NCT02120456|20251470|P2|COMPLETED|Part 2 Double-blind Phase||0
8211882|NCT02120456|20251471|P1|COMPLETED|Part 2 Double-blind Phase||0
8211883|NCT02120456|20251463|P9|STARTED|Part 2 Double-blind Phase||63
8211884|NCT02120456|20251464|P8|STARTED|Part 2 Double-blind Phase||60
8211885|NCT02120456|20251465|P7|STARTED|Part 2 Double-blind Phase||32
8211886|NCT02120456|20251466|P6|STARTED|Part 2 Double-blind Phase||0
8211887|NCT02120456|20251467|P5|STARTED|Part 2 Double-blind Phase||0
8211888|NCT02120456|20251468|P4|STARTED|Part 2 Double-blind Phase||0
8211889|NCT02120456|20251469|P3|STARTED|Part 2 Double-blind Phase||0
8211890|NCT02120456|20251470|P2|STARTED|Part 2 Double-blind Phase||0
8211891|NCT02120456|20251471|P1|STARTED|Part 2 Double-blind Phase||0
8211892|NCT02120456|20251463|P9|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211893|NCT02120456|20251464|P8|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211894|NCT02120456|20251465|P7|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211895|NCT02120456|20251466|P6|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211896|NCT02120456|20251467|P5|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211897|NCT02120456|20251468|P4|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211898|NCT02120456|20251469|P3|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211899|NCT02120456|20251470|P2|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211900|NCT02120456|20251471|P1|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211901|NCT02120456|20251463|P9|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211902|NCT02120456|20251464|P8|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211903|NCT02120456|20251465|P7|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8211904|NCT02120456|20251466|P6|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9
8211905|NCT02120456|20251467|P5|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8211906|NCT02120456|20251468|P4|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8211907|NCT02120456|20251469|P3|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8211908|NCT02120456|20251470|P2|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8211909|NCT02120456|20251471|P1|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8211910|NCT02120456|20251463|P9|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8211911|NCT02120456|20251464|P8|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8211912|NCT02120456|20251465|P7|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8211913|NCT02120456|20251466|P6|STARTED|Part 1 Open-label, Dose-escalation Phase||9
8211914|NCT02120456|20251467|P5|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8211915|NCT02120456|20251468|P4|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8211916|NCT02120456|20251469|P3|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8211917|NCT02120456|20251470|P2|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8211918|NCT02120456|20251471|P1|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8211919|NCT02120443|20251497|P1|NOT COMPLETED|Overall Study||0
8211920|NCT02120443|20251497|P1|COMPLETED|Overall Study||43
8211921|NCT02120443|20251497|P1|STARTED|Overall Study||43
8211922|NCT02120417|20251505|P2|NOT COMPLETED|Overall Study||68
8211923|NCT02120417|20251506|P1|NOT COMPLETED|Overall Study||60
8211924|NCT02120417|20251505|P2|COMPLETED|Overall Study||5
8211925|NCT02120417|20251506|P1|COMPLETED|Overall Study||16
8211926|NCT02120417|20251505|P2|STARTED|Overall Study||73
8211927|NCT02120417|20251506|P1|STARTED|Overall Study||76
8211952|NCT02120300|20251678|P4|NOT COMPLETED|Overall Study||1
8211953|NCT02120300|20251679|P3|NOT COMPLETED|Overall Study||0
8211954|NCT02120300|20251680|P2|NOT COMPLETED|Overall Study||0
8211955|NCT02120300|20251681|P1|NOT COMPLETED|Overall Study||3
8211956|NCT02120300|20251678|P4|COMPLETED|Overall Study||5
8211957|NCT02120300|20251679|P3|COMPLETED|Overall Study||10
8211958|NCT02120300|20251680|P2|COMPLETED|Overall Study||5
8211959|NCT02120300|20251681|P1|COMPLETED|Overall Study||98
8211960|NCT02120300|20251678|P4|STARTED|Overall Study||6
8211961|NCT02120300|20251679|P3|STARTED|Overall Study||10
8211962|NCT02120300|20251680|P2|STARTED|Overall Study||5
8211963|NCT02120300|20251681|P1|STARTED|Overall Study||101
8211964|NCT02120287|20251717|P1|NOT COMPLETED|Overall Study||0
8211965|NCT02120287|20251717|P1|COMPLETED|Overall Study||16
8211966|NCT02120287|20251717|P1|STARTED|Overall Study||16
8211967|NCT02120261|20251737|P2|NOT COMPLETED|Overall Study||0
8211968|NCT02120261|20251738|P1|NOT COMPLETED|Overall Study||0
8211969|NCT02120261|20251737|P2|COMPLETED|Overall Study||25
8211970|NCT02120261|20251738|P1|COMPLETED|Overall Study||23
8211971|NCT02120261|20251737|P2|STARTED|Overall Study||25
8211972|NCT02120261|20251738|P1|STARTED|Overall Study||23
8211983|NCT02120027|20251763|P2|NOT COMPLETED|Overall Study||119
8211984|NCT02120027|20251764|P1|NOT COMPLETED|Overall Study||116
8211985|NCT02120027|20251763|P2|COMPLETED|Overall Study||160
8211986|NCT02120027|20251764|P1|COMPLETED|Overall Study||161
8211987|NCT02120027|20251763|P2|STARTED|Overall Study||279
8211988|NCT02120027|20251764|P1|STARTED|Overall Study||277
8211989|NCT02120001|20251780|P2|NOT COMPLETED|Overall Study||0
8211990|NCT02120001|20251781|P1|NOT COMPLETED|Overall Study||0
8211991|NCT02120001|20251780|P2|COMPLETED|Overall Study||19
8211992|NCT02120001|20251781|P1|COMPLETED|Overall Study||17
8211993|NCT02120001|20251780|P2|STARTED|Overall Study||19
8211994|NCT02120001|20251781|P1|STARTED|Overall Study||17
8211995|NCT02119936|20251789|P1|NOT COMPLETED|Overall Study||10
8211996|NCT02119936|20251789|P1|COMPLETED|Overall Study||0
8211997|NCT02119936|20251789|P1|STARTED|Overall Study||10
8211998|NCT02119871|20251800|P2|NOT COMPLETED|Overall Study||0
8211999|NCT02119871|20251801|P1|NOT COMPLETED|Overall Study||0
8212000|NCT02119871|20251800|P2|COMPLETED|Overall Study||10
8212001|NCT02119871|20251801|P1|COMPLETED|Overall Study||10
8212002|NCT02119871|20251800|P2|STARTED|Overall Study||10
8212003|NCT02119871|20251801|P1|STARTED|Overall Study||10
8212004|NCT02119676|20251823|P4|NOT COMPLETED|Overall Study||101
8212005|NCT02119676|20251824|P3|NOT COMPLETED|Overall Study||97
8212006|NCT02119676|20251825|P2|NOT COMPLETED|Overall Study||86
8212007|NCT02119676|20251826|P1|NOT COMPLETED|Overall Study||83
8212008|NCT02119676|20251823|P4|COMPLETED|Overall Study||10
8212009|NCT02119676|20251824|P3|COMPLETED|Overall Study||13
8212010|NCT02119676|20251825|P2|COMPLETED|Overall Study||2
8212011|NCT02119676|20251826|P1|COMPLETED|Overall Study||4
8212012|NCT02119676|20251823|P4|Treated Patients|Overall Study||106
8212013|NCT02119676|20251824|P3|Treated Patients|Overall Study||106
8212014|NCT02119676|20251825|P2|Treated Patients|Overall Study||86
8212015|NCT02119676|20251826|P1|Treated Patients|Overall Study||85
8212016|NCT02119676|20251823|P4|STARTED|Overall Study||111
8212017|NCT02119676|20251824|P3|STARTED|Overall Study||110
8212018|NCT02119676|20251825|P2|STARTED|Overall Study||88
8212019|NCT02119676|20251826|P1|STARTED|Overall Study||87
8212020|NCT02119663|20251858|P2|NOT COMPLETED|Overall Study||41
8212021|NCT02119663|20251859|P1|NOT COMPLETED|Overall Study||40
8212022|NCT02119663|20251858|P2|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
8212023|NCT02119663|20251859|P1|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
8212024|NCT02119663|20251858|P2|STARTED|Overall Study||43
8212025|NCT02119663|20251859|P1|STARTED|Overall Study||43
8212026|NCT02119650|20251877|P2|NOT COMPLETED|Overall Study||26
8212027|NCT02119650|20251878|P1|NOT COMPLETED|Overall Study||25
8212028|NCT02119650|20251877|P2|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
8212029|NCT02119650|20251878|P1|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
8212030|NCT02119650|20251877|P2|STARTED|Overall Study||37
8212031|NCT02119650|20251878|P1|STARTED|Overall Study||39
8212032|NCT02119455|20251894|P2|NOT COMPLETED|Overall Study||3
8212033|NCT02119455|20251895|P1|NOT COMPLETED|Overall Study||0
8212034|NCT02119455|20251894|P2|COMPLETED|Overall Study||17
8212035|NCT02119455|20251895|P1|COMPLETED|Overall Study||20
8212036|NCT02119455|20251894|P2|STARTED|Overall Study||20
8212037|NCT02119455|20251895|P1|STARTED|Overall Study||20
8212038|NCT02119442|20251909|P1|NOT COMPLETED|Overall Study||0
8212039|NCT02119442|20251909|P1|COMPLETED|Overall Study||90
8212040|NCT02119442|20251909|P1|STARTED|Overall Study||90
8212041|NCT02119325|20251913|P2|NOT COMPLETED|Period 2||0
8212042|NCT02119325|20251914|P1|NOT COMPLETED|Period 2||0
8212043|NCT02119325|20251913|P2|COMPLETED|Period 2||47
8212044|NCT02119325|20251914|P1|COMPLETED|Period 2||48
8212045|NCT02119325|20251913|P2|STARTED|Period 2||47
8212046|NCT02119325|20251914|P1|STARTED|Period 2||48
8212047|NCT02119325|20251913|P2|NOT COMPLETED|Washout Period 1||1
8212048|NCT02119325|20251914|P1|NOT COMPLETED|Washout Period 1||0
8212049|NCT02119325|20251913|P2|COMPLETED|Washout Period 1||47
8212050|NCT02119325|20251914|P1|COMPLETED|Washout Period 1||48
8212051|NCT02119325|20251913|P2|STARTED|Washout Period 1||48
8212052|NCT02119325|20251914|P1|STARTED|Washout Period 1||48
8212053|NCT02119325|20251913|P2|NOT COMPLETED|Period 1||0
8212054|NCT02119325|20251914|P1|NOT COMPLETED|Period 1||0
8212055|NCT02119325|20251913|P2|COMPLETED|Period 1||48
8212056|NCT02119325|20251914|P1|COMPLETED|Period 1||48
8212057|NCT02119325|20251913|P2|STARTED|Period 1||48
8212058|NCT02119325|20251914|P1|STARTED|Period 1||48
8212059|NCT02119299|20251958|P1|NOT COMPLETED|Overall Study||9
8212060|NCT02119299|20251958|P1|COMPLETED|Overall Study||67
8212061|NCT02119299|20251958|P1|STARTED|Overall Study||76
8212062|NCT02119286|20251972|P3|NOT COMPLETED|Overall Study||7
8212063|NCT02119286|20251973|P2|NOT COMPLETED|Overall Study||11
8212064|NCT02119286|20251974|P1|NOT COMPLETED|Overall Study||26
8212065|NCT02119286|20251972|P3|COMPLETED|Overall Study||200
8212066|NCT02119286|20251973|P2|COMPLETED|Overall Study||195
8212067|NCT02119286|20251974|P1|COMPLETED|Overall Study||180
8212068|NCT02119286|20251972|P3|STARTED|Overall Study||207
8212069|NCT02119286|20251973|P2|STARTED|Overall Study||206
8212070|NCT02119286|20251974|P1|STARTED|Overall Study||206
8212071|NCT02119260|20251992|P7|NOT COMPLETED|Overall Study||0
8212072|NCT02119260|20251993|P6|NOT COMPLETED|Overall Study||0
8212073|NCT02119260|20251994|P5|NOT COMPLETED|Overall Study||0
8212074|NCT02119260|20251995|P4|NOT COMPLETED|Overall Study||0
8212075|NCT02119260|20251996|P3|NOT COMPLETED|Overall Study||1
8212076|NCT02119260|20251997|P2|NOT COMPLETED|Overall Study||1
8212077|NCT02119260|20251998|P1|NOT COMPLETED|Overall Study||1
8212078|NCT02119260|20251992|P7|COMPLETED|Overall Study||2
8212079|NCT02119260|20251993|P6|COMPLETED|Overall Study||6
8212080|NCT02119260|20251994|P5|COMPLETED|Overall Study||13
8212081|NCT02119260|20251995|P4|COMPLETED|Overall Study||10
8212082|NCT02119260|20251996|P3|COMPLETED|Overall Study||7
8212083|NCT02119260|20251997|P2|COMPLETED|Overall Study||11
8212084|NCT02119260|20251998|P1|COMPLETED|Overall Study||8
8212085|NCT02119260|20251992|P7|STARTED|Overall Study||2
8212086|NCT02119260|20251993|P6|STARTED|Overall Study||6
8212087|NCT02119260|20251994|P5|STARTED|Overall Study||13
8212088|NCT02119260|20251995|P4|STARTED|Overall Study||10
8212089|NCT02119260|20251996|P3|STARTED|Overall Study||8
8212090|NCT02119260|20251997|P2|STARTED|Overall Study||12
8212091|NCT02119260|20251998|P1|STARTED|Overall Study||9
8212092|NCT02119156|20252071|P3|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7
8212093|NCT02119156|20252072|P2|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10
8212094|NCT02119156|20252073|P1|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
8212095|NCT02119156|20252071|P3|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3
8212096|NCT02119156|20252072|P2|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6
8212097|NCT02119156|20252073|P1|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
8212188|NCT02118714|20252356|P1|STARTED|Overall Study||20
8212098|NCT02119156|20252071|P3|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|10
8212099|NCT02119156|20252072|P2|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|16
8212100|NCT02119156|20252073|P1|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Long-term discontinuation participants were not allowed in Maintenance period|0
8212101|NCT02119156|20252071|P3|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1
8212102|NCT02119156|20252072|P2|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2
8212103|NCT02119156|20252073|P1|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6
8212104|NCT02119156|20252071|P3|COMPLETED|Treatment Phase (Up to 52 Weeks)||11
8212105|NCT02119156|20252072|P2|COMPLETED|Treatment Phase (Up to 52 Weeks)||27
8212106|NCT02119156|20252073|P1|COMPLETED|Treatment Phase (Up to 52 Weeks)||33
8212107|NCT02119156|20252071|P3|STARTED|Treatment Phase (Up to 52 Weeks)||12
8212108|NCT02119156|20252072|P2|STARTED|Treatment Phase (Up to 52 Weeks)||29
8212109|NCT02119156|20252073|P1|STARTED|Treatment Phase (Up to 52 Weeks)||39
8212110|NCT02119104|20252131|P1|NOT COMPLETED|Overall Study||16
8212111|NCT02119104|20252131|P1|COMPLETED|Overall Study||1071
8212112|NCT02119104|20252131|P1|STARTED|Overall Study||1087
8212113|NCT02119026|20252137|P2|NOT COMPLETED|2nd-line Treatment||2
8212114|NCT02119026|20252138|P1|NOT COMPLETED|2nd-line Treatment||9
8212115|NCT02119026|20252137|P2|COMPLETED|2nd-line Treatment||22
8212116|NCT02119026|20252138|P1|COMPLETED|2nd-line Treatment||23
8212117|NCT02119026|20252137|P2|STARTED|2nd-line Treatment||24
8212118|NCT02119026|20252138|P1|STARTED|2nd-line Treatment||32
8212119|NCT02119026|20252137|P2|NOT COMPLETED|1st-line Treatment||38
8212120|NCT02119026|20252138|P1|NOT COMPLETED|1st-line Treatment||26
8212121|NCT02119026|20252137|P2|COMPLETED|1st-line Treatment||24
8212122|NCT02119026|20252138|P1|COMPLETED|1st-line Treatment||32
8212123|NCT02119026|20252137|P2|STARTED|1st-line Treatment||62
8212124|NCT02119026|20252138|P1|STARTED|1st-line Treatment||58
8212125|NCT02118961|20252162|P2|NOT COMPLETED|Overall Study||0
8212126|NCT02118961|20252163|P1|NOT COMPLETED|Overall Study||1
8212127|NCT02118961|20252162|P2|COMPLETED|Overall Study||222
8212128|NCT02118961|20252163|P1|COMPLETED|Overall Study||223
8212129|NCT02118961|20252162|P2|STARTED|Overall Study||222
8212130|NCT02118961|20252163|P1|STARTED|Overall Study||224
8212131|NCT02118896|20252191|P10|NOT COMPLETED|Overall Study||2
8212132|NCT02118896|20252192|P9|NOT COMPLETED|Overall Study||4
8212133|NCT02118896|20252193|P8|NOT COMPLETED|Overall Study||2
8212134|NCT02118896|20252194|P7|NOT COMPLETED|Overall Study||2
8212135|NCT02118896|20252195|P6|NOT COMPLETED|Overall Study||28
8212136|NCT02118896|20252196|P5|NOT COMPLETED|Overall Study||17
8212137|NCT02118896|20252197|P4|NOT COMPLETED|Overall Study||24
8212138|NCT02118896|20252198|P3|NOT COMPLETED|Overall Study||14
8212139|NCT02118896|20252199|P2|NOT COMPLETED|Overall Study||15
8212140|NCT02118896|20252200|P1|NOT COMPLETED|Overall Study||17
8212141|NCT02118896|20252191|P10|COMPLETED|Overall Study||7
8212142|NCT02118896|20252192|P9|COMPLETED|Overall Study||84
8212143|NCT02118896|20252193|P8|COMPLETED|Overall Study||105
8212144|NCT02118896|20252194|P7|COMPLETED|Overall Study||83
8212145|NCT02118896|20252195|P6|COMPLETED|Overall Study||163
8212146|NCT02118896|20252196|P5|COMPLETED|Overall Study||113
8212147|NCT02118896|20252197|P4|COMPLETED|Overall Study||55
8212148|NCT02118896|20252198|P3|COMPLETED|Overall Study||53
8212149|NCT02118896|20252199|P2|COMPLETED|Overall Study||32
8212150|NCT02118896|20252200|P1|COMPLETED|Overall Study||30
8212151|NCT02118896|20252191|P10|STARTED|Overall Study||9
8212152|NCT02118896|20252192|P9|STARTED|Overall Study||88
8212153|NCT02118896|20252193|P8|STARTED|Overall Study||107
8212154|NCT02118896|20252194|P7|STARTED|Overall Study||85
8212155|NCT02118896|20252195|P6|STARTED|Overall Study||191
8212156|NCT02118896|20252196|P5|STARTED|Overall Study||130
8212157|NCT02118896|20252197|P4|STARTED|Overall Study||79
8212158|NCT02118896|20252198|P3|STARTED|Overall Study||67
8212159|NCT02118896|20252199|P2|STARTED|Overall Study||47
8212160|NCT02118896|20252200|P1|STARTED|Overall Study||47
8212161|NCT02118831|20252275|P3|NOT COMPLETED|Overall Study||0
8212162|NCT02118831|20252276|P2|NOT COMPLETED|Overall Study||0
8212163|NCT02118831|20252277|P1|NOT COMPLETED|Overall Study||0
8212164|NCT02118831|20252275|P3|COMPLETED|Overall Study||20
8212165|NCT02118831|20252276|P2|COMPLETED|Overall Study||15
8212166|NCT02118831|20252277|P1|COMPLETED|Overall Study||21
8212167|NCT02118831|20252275|P3|STARTED|Overall Study||20
8212168|NCT02118831|20252276|P2|STARTED|Overall Study||15
8212169|NCT02118831|20252277|P1|STARTED|Overall Study||21
8212170|NCT02118792|20252290|P2|NOT COMPLETED|Overall Study||37
8212171|NCT02118792|20252291|P1|NOT COMPLETED|Overall Study||31
8212172|NCT02118792|20252290|P2|COMPLETED|Overall Study||213
8212173|NCT02118792|20252291|P1|COMPLETED|Overall Study||483
8212174|NCT02118792|20252290|P2|Treated|Overall Study||250
8212175|NCT02118792|20252291|P1|Treated|Overall Study||513
8212176|NCT02118792|20252290|P2|STARTED|Overall Study||250
8212177|NCT02118792|20252291|P1|STARTED|Overall Study||514
8212178|NCT02118766|20252333|P2|NOT COMPLETED|Overall Study||31
8212179|NCT02118766|20252334|P1|NOT COMPLETED|Overall Study||30
8212180|NCT02118766|20252333|P2|COMPLETED|Overall Study||225
8212181|NCT02118766|20252334|P1|COMPLETED|Overall Study||477
8212182|NCT02118766|20252333|P2|Treated|Overall Study||256
8212183|NCT02118766|20252334|P1|Treated|Overall Study||503
8212184|NCT02118766|20252333|P2|STARTED|Overall Study||256
8212185|NCT02118766|20252334|P1|STARTED|Overall Study||507
8212186|NCT02118714|20252356|P1|NOT COMPLETED|Overall Study||3
8212187|NCT02118714|20252356|P1|COMPLETED|Overall Study||17
8212189|NCT02118610|20252372|P2|NOT COMPLETED|Overall Study||1
8212190|NCT02118610|20252373|P1|NOT COMPLETED|Overall Study||1
8212191|NCT02118610|20252372|P2|COMPLETED|Overall Study||32
8212192|NCT02118610|20252373|P1|COMPLETED|Overall Study||29
8212193|NCT02118610|20252372|P2|STARTED|Overall Study||33
8212194|NCT02118610|20252373|P1|STARTED|Overall Study||30
8212195|NCT02118597|20252381|P1|NOT COMPLETED|Overall Study||16
8212196|NCT02118597|20252381|P1|COMPLETED|Overall Study||3
8212197|NCT02118597|20252381|P1|STARTED|Overall Study||19
8212198|NCT02118441|20252397|P2|NOT COMPLETED|Overall Study||1
8212199|NCT02118441|20252398|P1|NOT COMPLETED|Overall Study||3
8212200|NCT02118441|20252397|P2|COMPLETED|Overall Study||63
8212201|NCT02118441|20252398|P1|COMPLETED|Overall Study||62
8212202|NCT02118441|20252397|P2|STARTED|Overall Study||64
8212203|NCT02118441|20252398|P1|STARTED|Overall Study||65
8212204|NCT02118428|20252412|P3|NOT COMPLETED|Overall Study||1
8212205|NCT02118428|20252413|P2|NOT COMPLETED|Overall Study||9
8212206|NCT02118428|20252414|P1|NOT COMPLETED|Overall Study||13
8212207|NCT02118428|20252412|P3|COMPLETED|Overall Study||0
8212208|NCT02118428|20252413|P2|COMPLETED|Overall Study||104
8212209|NCT02118428|20252414|P1|COMPLETED|Overall Study||100
8212210|NCT02118428|20252412|P3|Received Study Transfusion|Overall Study||0
8212211|NCT02118428|20252413|P2|Received Study Transfusion|Overall Study||112
8212212|NCT02118428|20252414|P1|Received Study Transfusion|Overall Study||111
8212213|NCT02118428|20252412|P3|STARTED|Overall Study||1
8212214|NCT02118428|20252413|P2|STARTED|Overall Study||113
8212215|NCT02118428|20252414|P1|STARTED|Overall Study||113
8212216|NCT02118012|20252454|P2|NOT COMPLETED|Overall Study||2
8212217|NCT02118012|20252455|P1|NOT COMPLETED|Overall Study||0
8212218|NCT02118012|20252454|P2|COMPLETED|Overall Study||10
8212219|NCT02118012|20252455|P1|COMPLETED|Overall Study||12
8212220|NCT02118012|20252454|P2|Day 14|Overall Study||10
8212221|NCT02118012|20252455|P1|Day 14|Overall Study||12
8212222|NCT02118012|20252454|P2|Day 5|Overall Study||11
8212223|NCT02118012|20252455|P1|Day 5|Overall Study||12
8212224|NCT02118012|20252454|P2|STARTED|Overall Study||12
8212225|NCT02118012|20252455|P1|STARTED|Overall Study||12
8212226|NCT02117999|20252469|P2|NOT COMPLETED|Overall Study||0
8212227|NCT02117999|20252470|P1|NOT COMPLETED|Overall Study||0
8212228|NCT02117999|20252469|P2|COMPLETED|Overall Study||10
8212229|NCT02117999|20252470|P1|COMPLETED|Overall Study||20
8212230|NCT02117999|20252469|P2|Mean Kmax Change in Corneal Topography|Overall Study||10
8212231|NCT02117999|20252470|P1|Mean Kmax Change in Corneal Topography|Overall Study||20
8212232|NCT02117999|20252469|P2|STARTED|Overall Study||10
8212233|NCT02117999|20252470|P1|STARTED|Overall Study||20
8212234|NCT02117934|20252488|P2|NOT COMPLETED|Overall Study||215
8212235|NCT02117934|20252489|P1|NOT COMPLETED|Overall Study||500
8212236|NCT02117934|20252488|P2|COMPLETED|Overall Study||2567
8212237|NCT02117934|20252489|P1|COMPLETED|Overall Study||5092
8212238|NCT02117934|20252488|P2|STARTED|Overall Study||2782
8212239|NCT02117934|20252489|P1|STARTED|Overall Study||5592
8212240|NCT02117687|20252499|P2|NOT COMPLETED|Overall Study||4
8212241|NCT02117687|20252500|P1|NOT COMPLETED|Overall Study||1
8212242|NCT02117687|20252499|P2|COMPLETED|Overall Study||36
8212243|NCT02117687|20252500|P1|COMPLETED|Overall Study||39
8212244|NCT02117687|20252499|P2|STARTED|Overall Study||40
8212245|NCT02117687|20252500|P1|STARTED|Overall Study||40
8212246|NCT02117648|20252532|P1|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
8212247|NCT02117648|20252532|P1|COMPLETED|Abemaciclib Safety-Extension Phase||0
8212248|NCT02117648|20252532|P1|STARTED|Abemaciclib Safety-Extension Phase||20
8212249|NCT02117648|20252532|P1|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
8212250|NCT02117648|20252532|P1|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
8212251|NCT02117648|20252532|P1|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
8212252|NCT02117648|20252532|P1|STARTED|Abemaciclib + Clarithromycin Period 2||24
8212253|NCT02117648|20252532|P1|NOT COMPLETED|Abemaciclib Alone Period 1||2
8212254|NCT02117648|20252532|P1|COMPLETED|Abemaciclib Alone Period 1||24
8212255|NCT02117648|20252532|P1|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
8212256|NCT02117648|20252532|P1|STARTED|Abemaciclib Alone Period 1||26
8212257|NCT02117570|20252545|P3|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
8212258|NCT02117570|20252546|P2|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
8212259|NCT02117570|20252547|P1|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
8212260|NCT02117570|20252545|P3|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
8212261|NCT02117570|20252546|P2|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
8212262|NCT02117570|20252547|P1|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
8212263|NCT02117570|20252545|P3|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
8212264|NCT02117570|20252546|P2|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
8212265|NCT02117570|20252547|P1|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
8212266|NCT02117570|20252545|P3|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
8212267|NCT02117570|20252546|P2|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
8212268|NCT02117570|20252547|P1|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
8212269|NCT02117570|20252545|P3|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
8212270|NCT02117570|20252546|P2|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
8212271|NCT02117570|20252547|P1|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
8212272|NCT02117570|20252545|P3|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
8212273|NCT02117570|20252546|P2|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
8212274|NCT02117570|20252547|P1|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
8212275|NCT02117570|20252545|P3|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
8212276|NCT02117570|20252546|P2|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
8212277|NCT02117570|20252547|P1|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
8212278|NCT02117570|20252545|P3|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
8212279|NCT02117570|20252546|P2|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
8212280|NCT02117570|20252547|P1|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
8212281|NCT02117570|20252545|P3|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
8212282|NCT02117570|20252546|P2|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
8212283|NCT02117570|20252547|P1|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
8212284|NCT02117570|20252545|P3|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
8212285|NCT02117570|20252546|P2|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
8212286|NCT02117570|20252547|P1|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
8212287|NCT02117570|20252545|P3|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
8212288|NCT02117570|20252546|P2|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
8212289|NCT02117570|20252547|P1|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
8212290|NCT02117570|20252545|P3|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
8212291|NCT02117570|20252546|P2|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
8212292|NCT02117570|20252547|P1|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
8212293|NCT02117544|20252597|P2|NOT COMPLETED|Period 2||0
8212294|NCT02117544|20252598|P1|NOT COMPLETED|Period 2||0
8212295|NCT02117544|20252597|P2|COMPLETED|Period 2||55
8212296|NCT02117544|20252598|P1|COMPLETED|Period 2||52
8212297|NCT02117544|20252597|P2|STARTED|Period 2||55
8212298|NCT02117544|20252598|P1|STARTED|Period 2||52
8212299|NCT02117544|20252597|P2|NOT COMPLETED|Period 1||0
8212300|NCT02117544|20252598|P1|NOT COMPLETED|Period 1||2
8212301|NCT02117544|20252597|P2|COMPLETED|Period 1||55
8212302|NCT02117544|20252598|P1|COMPLETED|Period 1||52
8212303|NCT02117544|20252597|P2|Treated|Period 1||55
8212304|NCT02117544|20252598|P1|Treated|Period 1||52
8212305|NCT02117544|20252597|P2|STARTED|Period 1||55
8212306|NCT02117544|20252598|P1|STARTED|Period 1||54
8212307|NCT02117479|20252613|P2|NOT COMPLETED|Overall Study||156
8212308|NCT02117479|20252614|P1|NOT COMPLETED|Overall Study||156
8212309|NCT02117479|20252613|P2|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
8212310|NCT02117479|20252614|P1|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
8212311|NCT02117479|20252613|P2|STARTED|Overall Study||160
8212312|NCT02117479|20252614|P1|STARTED|Overall Study||161
8212313|NCT02117427|20252633|P3|NOT COMPLETED|Overall Study||0
8212314|NCT02117427|20252634|P2|NOT COMPLETED|Overall Study||5
8212315|NCT02117427|20252635|P1|NOT COMPLETED|Overall Study||5
8212316|NCT02117427|20252633|P3|COMPLETED|Overall Study||0
8212317|NCT02117427|20252634|P2|COMPLETED|Overall Study||0
8212318|NCT02117427|20252635|P1|COMPLETED|Overall Study||1
8212319|NCT02117427|20252633|P3|Long Term Safety Follow-up|Overall Study||0
8212320|NCT02117427|20252634|P2|Long Term Safety Follow-up|Overall Study||0
8212321|NCT02117427|20252635|P1|Long Term Safety Follow-up|Overall Study||1
8212322|NCT02117427|20252633|P3|Safety Follow-up|Overall Study||0
8212323|NCT02117427|20252634|P2|Safety Follow-up|Overall Study||0
8212324|NCT02117427|20252635|P1|Safety Follow-up|Overall Study||1
8212325|NCT02117427|20252633|P3|Implantation & Efficacy|Overall Study||0
8212326|NCT02117427|20252634|P2|Implantation & Efficacy|Overall Study||4
8212327|NCT02117427|20252635|P1|Implantation & Efficacy|Overall Study||6
8212328|NCT02117427|20252633|P3|Run in Phase & Harvest|Overall Study||0
8212329|NCT02117427|20252634|P2|Run in Phase & Harvest|Overall Study||4
8212330|NCT02117427|20252635|P1|Run in Phase & Harvest|Overall Study||6
8212331|NCT02117427|20252633|P3|STARTED|Overall Study||0
8212332|NCT02117427|20252634|P2|STARTED|Overall Study||5
8212333|NCT02117427|20252635|P1|STARTED|Overall Study||6
8212334|NCT02117414|20252645|P2|NOT COMPLETED|Overall Study||6
8212335|NCT02117414|20252646|P1|NOT COMPLETED|Overall Study||15
8212336|NCT02117414|20252645|P2|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
8212337|NCT02117414|20252646|P1|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
8212338|NCT02117414|20252645|P2|STARTED|Overall Study|Subjects randomized to the Control group.|88
8212339|NCT02117414|20252646|P1|STARTED|Overall Study|Subjects randomized to the MRI group.|175
8212340|NCT02117349|20252666|P2|NOT COMPLETED|Overall Study||1
8212341|NCT02117349|20252667|P1|NOT COMPLETED|Overall Study||3
8212342|NCT02117349|20252666|P2|COMPLETED|Overall Study||17
8212343|NCT02117349|20252667|P1|COMPLETED|Overall Study||34
8212344|NCT02117349|20252666|P2|Modified Intent-to-treat (mITT)|Overall Study||18
8212345|NCT02117349|20252667|P1|Modified Intent-to-treat (mITT)|Overall Study||36
8212346|NCT02117349|20252666|P2|Safety Population|Overall Study||18
8212347|NCT02117349|20252667|P1|Safety Population|Overall Study||36
8212348|NCT02117349|20252666|P2|Intent-to-treat Population|Overall Study||18
8212349|NCT02117349|20252667|P1|Intent-to-treat Population|Overall Study||37
8212350|NCT02117349|20252666|P2|STARTED|Overall Study||18
8212351|NCT02117349|20252667|P1|STARTED|Overall Study||37
8212352|NCT02117310|20252677|P1|NOT COMPLETED|Overall Study||0
8212353|NCT02117310|20252677|P1|COMPLETED|Overall Study||5
8212354|NCT02117310|20252677|P1|STARTED|Overall Study||5
8212355|NCT02117193|20252681|P1|NOT COMPLETED|Overall Study||0
8212356|NCT02117193|20252681|P1|COMPLETED|Overall Study||10
8212357|NCT02117193|20252681|P1|Placebo Intake + Sleep Deprivation|Overall Study||10
8212358|NCT02117193|20252681|P1|Alcohol Intake + Sleep Deprivation|Overall Study||10
8212359|NCT02117193|20252681|P1|Placebo Intake + Normal Sleep|Overall Study||10
8212360|NCT02117193|20252681|P1|Alcohol Intake + Normal Sleep|Overall Study||10
8212361|NCT02117193|20252681|P1|STARTED|Overall Study||10
8212362|NCT02117050|20252703|P1|NOT COMPLETED|Overall Study||1
8212363|NCT02117050|20252703|P1|COMPLETED|Overall Study||0
8212364|NCT02117050|20252703|P1|STARTED|Overall Study||1
8212365|NCT02117024|20252717|P2|NOT COMPLETED|Overall Study||20
8212366|NCT02117024|20252718|P1|NOT COMPLETED|Overall Study||44
8212367|NCT02117024|20252717|P2|COMPLETED|Overall Study||1
8212368|NCT02117024|20252718|P1|COMPLETED|Overall Study||1
8212369|NCT02117024|20252717|P2|STARTED|Overall Study||21
8212370|NCT02117024|20252718|P1|STARTED|Overall Study||45
8212371|NCT02116972|20252745|P3|NOT COMPLETED|Overall Study||19
8212372|NCT02116972|20252746|P2|NOT COMPLETED|Overall Study||17
8212373|NCT02116972|20252747|P1|NOT COMPLETED|Overall Study||19
8212374|NCT02116972|20252745|P3|COMPLETED|Overall Study||85
8212375|NCT02116972|20252746|P2|COMPLETED|Overall Study||87
8212376|NCT02116972|20252747|P1|COMPLETED|Overall Study||83
8212377|NCT02116972|20252745|P3|STARTED|Overall Study||104
8212378|NCT02116972|20252746|P2|STARTED|Overall Study||104
8212379|NCT02116972|20252747|P1|STARTED|Overall Study||102
8212380|NCT02116803|20252779|P2|NOT COMPLETED|Overall Study||2
8212381|NCT02116803|20252780|P1|NOT COMPLETED|Overall Study||10
8212382|NCT02116803|20252779|P2|COMPLETED|Overall Study||0
8212383|NCT02116803|20252780|P1|COMPLETED|Overall Study||0
8212384|NCT02116803|20252779|P2|STARTED|Overall Study||2
8212385|NCT02116803|20252780|P1|STARTED|Overall Study||10
8212386|NCT02116660|20252788|P2|NOT COMPLETED|Overall Study||4
8212387|NCT02116660|20252789|P1|NOT COMPLETED|Overall Study||2
8212388|NCT02116660|20252788|P2|COMPLETED|Overall Study||1
8212389|NCT02116660|20252789|P1|COMPLETED|Overall Study||4
8212390|NCT02116660|20252788|P2|STARTED|Overall Study||5
8212391|NCT02116660|20252789|P1|STARTED|Overall Study||6
8212392|NCT02116621|20252833|P2|NOT COMPLETED|Twelve Month Follow-up||12
8212393|NCT02116621|20252834|P1|NOT COMPLETED|Twelve Month Follow-up||16
8212394|NCT02116621|20252833|P2|COMPLETED|Twelve Month Follow-up||86
8212395|NCT02116621|20252834|P1|COMPLETED|Twelve Month Follow-up||84
8212396|NCT02116621|20252833|P2|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
8212397|NCT02116621|20252834|P1|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
8212398|NCT02116621|20252833|P2|NOT COMPLETED|Six Month Follow-up||3
8212399|NCT02116621|20252834|P1|NOT COMPLETED|Six Month Follow-up||4
8212400|NCT02116621|20252833|P2|COMPLETED|Six Month Follow-up||97
8212401|NCT02116621|20252834|P1|COMPLETED|Six Month Follow-up||99
8212402|NCT02116621|20252833|P2|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
8212403|NCT02116621|20252834|P1|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
8212404|NCT02116621|20252833|P2|NOT COMPLETED|Three Month Follow-up||7
8212405|NCT02116621|20252834|P1|NOT COMPLETED|Three Month Follow-up||19
8212406|NCT02116621|20252833|P2|COMPLETED|Three Month Follow-up||96
8212407|NCT02116621|20252834|P1|COMPLETED|Three Month Follow-up||89
8212408|NCT02116621|20252833|P2|STARTED|Three Month Follow-up||103
8212409|NCT02116621|20252834|P1|STARTED|Three Month Follow-up||108
8212410|NCT02116621|20252833|P2|NOT COMPLETED|Baseline||4
8212411|NCT02116621|20252834|P1|NOT COMPLETED|Baseline||0
8212412|NCT02116621|20252833|P2|COMPLETED|Baseline||103
8212413|NCT02116621|20252834|P1|COMPLETED|Baseline||108
8212414|NCT02116621|20252833|P2|Completed Intervention Period|Baseline||103
8212415|NCT02116621|20252834|P1|Completed Intervention Period|Baseline||95
8212416|NCT02116621|20252833|P2|Completed Baseline Visit|Baseline||103
8212417|NCT02116621|20252834|P1|Completed Baseline Visit|Baseline||108
8212418|NCT02116621|20252833|P2|STARTED|Baseline||107
8212419|NCT02116621|20252834|P1|STARTED|Baseline||108
8212420|NCT02116582|20252922|P1|NOT COMPLETED|Overall Study||215
8212421|NCT02116582|20252922|P1|COMPLETED|Overall Study||0
8212422|NCT02116582|20252922|P1|Treated|Overall Study||214
8212423|NCT02116582|20252922|P1|STARTED|Overall Study||215
8212424|NCT02116530|20252932|P2|NOT COMPLETED|Overall Study||4
8212425|NCT02116530|20252933|P1|NOT COMPLETED|Overall Study||9
8212426|NCT02116530|20252932|P2|COMPLETED|Overall Study||184
8212427|NCT02116530|20252933|P1|COMPLETED|Overall Study||183
8212428|NCT02116530|20252932|P2|STARTED|Overall Study||188
8212429|NCT02116530|20252933|P1|STARTED|Overall Study||192
8212430|NCT02116361|20252951|P4|NOT COMPLETED|Overall Study||31
8212431|NCT02116361|20252952|P3|NOT COMPLETED|Overall Study||26
8212432|NCT02116361|20252953|P2|NOT COMPLETED|Overall Study||31
8212433|NCT02116361|20252954|P1|NOT COMPLETED|Overall Study||31
8212434|NCT02116361|20252951|P4|COMPLETED|Overall Study||34
8212435|NCT02116361|20252952|P3|COMPLETED|Overall Study||33
8212436|NCT02116361|20252953|P2|COMPLETED|Overall Study||34
8212437|NCT02116361|20252954|P1|COMPLETED|Overall Study||38
8212438|NCT02116361|20252951|P4|STARTED|Overall Study||65
8212439|NCT02116361|20252952|P3|STARTED|Overall Study||59
8212440|NCT02116361|20252953|P2|STARTED|Overall Study||65
8212441|NCT02116361|20252954|P1|STARTED|Overall Study||69
8212442|NCT02116322|20252984|P1|NOT COMPLETED|Overall Study||0
8212443|NCT02116322|20252984|P1|COMPLETED|Overall Study||1
8212444|NCT02116322|20252984|P1|STARTED|Overall Study||1
8212445|NCT02116309|20252991|P2|NOT COMPLETED|Overall Study||1
8212446|NCT02116309|20252992|P1|NOT COMPLETED|Overall Study||0
8212447|NCT02116309|20252991|P2|COMPLETED|Overall Study||477
8212448|NCT02116309|20252992|P1|COMPLETED|Overall Study||482
8212449|NCT02116309|20252991|P2|STARTED|Overall Study||478
8212450|NCT02116309|20252992|P1|STARTED|Overall Study||482
8212463|NCT02115984|20253027|P2|NOT COMPLETED|Overall Study||7
8212464|NCT02115984|20253028|P1|NOT COMPLETED|Overall Study||6
8212465|NCT02115984|20253027|P2|COMPLETED|Overall Study||16
8212466|NCT02115984|20253028|P1|COMPLETED|Overall Study||51
8212467|NCT02115984|20253027|P2|STARTED|Overall Study||23
8212468|NCT02115984|20253028|P1|STARTED|Overall Study||57
8212469|NCT02115828|20253034|P1|NOT COMPLETED|Overall Study||0
8212470|NCT02115828|20253034|P1|COMPLETED|Overall Study||9
8212471|NCT02115828|20253034|P1|STARTED|Overall Study||9
8212472|NCT02115815|20253049|P7|NOT COMPLETED|Overall Study||0
8212473|NCT02115815|20253050|P6|NOT COMPLETED|Overall Study||2
8212474|NCT02115815|20253051|P5|NOT COMPLETED|Overall Study||0
8212475|NCT02115815|20253052|P4|NOT COMPLETED|Overall Study||0
8212476|NCT02115815|20253053|P3|NOT COMPLETED|Overall Study||0
8212477|NCT02115815|20253054|P2|NOT COMPLETED|Overall Study||0
8212478|NCT02115815|20253055|P1|NOT COMPLETED|Overall Study||2
8212479|NCT02115815|20253049|P7|COMPLETED|Overall Study||20
8212480|NCT02115815|20253050|P6|COMPLETED|Overall Study||20
8212481|NCT02115815|20253051|P5|COMPLETED|Overall Study||20
8212482|NCT02115815|20253052|P4|COMPLETED|Overall Study||20
8212483|NCT02115815|20253053|P3|COMPLETED|Overall Study||20
8212484|NCT02115815|20253054|P2|COMPLETED|Overall Study||20
8212485|NCT02115815|20253055|P1|COMPLETED|Overall Study||22
8212486|NCT02115815|20253049|P7|STARTED|Overall Study||20
8212487|NCT02115815|20253050|P6|STARTED|Overall Study||22
8212488|NCT02115815|20253051|P5|STARTED|Overall Study||20
8212489|NCT02115815|20253052|P4|STARTED|Overall Study||20
8212490|NCT02115815|20253053|P3|STARTED|Overall Study||20
8212491|NCT02115815|20253054|P2|STARTED|Overall Study||20
8212492|NCT02115815|20253055|P1|STARTED|Overall Study||24
8212493|NCT02115750|20253150|P2|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12
8212494|NCT02115750|20253151|P1|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11
8212495|NCT02115750|20253150|P2|COMPLETED|Part 2: All Subjects Receive CHS-0214||272
8212496|NCT02115750|20253151|P1|COMPLETED|Part 2: All Subjects Receive CHS-0214||269
8212497|NCT02115750|20253150|P2|STARTED|Part 2: All Subjects Receive CHS-0214||284
8212498|NCT02115750|20253151|P1|STARTED|Part 2: All Subjects Receive CHS-0214||280
8212499|NCT02115750|20253150|P2|NOT COMPLETED|Part 1||12
8212500|NCT02115750|20253151|P1|NOT COMPLETED|Part 1||22
8212501|NCT02115750|20253150|P2|COMPLETED|Part 1||312
8212502|NCT02115750|20253151|P1|COMPLETED|Part 1||301
8212503|NCT02115750|20253150|P2|STARTED|Part 1||324
8212504|NCT02115750|20253151|P1|STARTED|Part 1||323
8212505|NCT02115646|20253169|P1|NOT COMPLETED|Overall Study||7
8212506|NCT02115646|20253169|P1|COMPLETED|Overall Study||22
8212507|NCT02115646|20253169|P1|STARTED|Overall Study||29
8212508|NCT02115633|20253184|P2|NOT COMPLETED|Overall Study||0
8212509|NCT02115633|20253185|P1|NOT COMPLETED|Overall Study||0
8212510|NCT02115633|20253184|P2|COMPLETED|Overall Study||16
8212511|NCT02115633|20253185|P1|COMPLETED|Overall Study||15
8212512|NCT02115633|20253184|P2|STARTED|Overall Study||16
8212513|NCT02115633|20253185|P1|STARTED|Overall Study||15
8212514|NCT02115607|20253197|P1|NOT COMPLETED|Overall Study||1
8212515|NCT02115607|20253197|P1|COMPLETED|Overall Study||16
8212516|NCT02115607|20253197|P1|STARTED|Overall Study||17
8212517|NCT02115581|20253206|P2|NOT COMPLETED|Overall Study||0
8212518|NCT02115581|20253207|P1|NOT COMPLETED|Overall Study||0
8212519|NCT02115581|20253206|P2|COMPLETED|Overall Study||21
8212520|NCT02115581|20253207|P1|COMPLETED|Overall Study||17
8212521|NCT02115581|20253206|P2|STARTED|Overall Study||21
8212522|NCT02115581|20253207|P1|STARTED|Overall Study||17
8212526|NCT02115386|20253223|P1|NOT COMPLETED|Overall Study||7
8212527|NCT02115386|20253223|P1|COMPLETED|Overall Study||0
8212528|NCT02115386|20253223|P1|STARTED|Overall Study||7
8212529|NCT02115373|20253236|P3|NOT COMPLETED|Overall Study||0
8212530|NCT02115373|20253237|P2|NOT COMPLETED|Overall Study||0
8212531|NCT02115373|20253238|P1|NOT COMPLETED|Overall Study||0
8212532|NCT02115373|20253236|P3|COMPLETED|Overall Study||49
8212533|NCT02115373|20253237|P2|COMPLETED|Overall Study||13
8212534|NCT02115373|20253238|P1|COMPLETED|Overall Study||4
8212535|NCT02115373|20253236|P3|STARTED|Overall Study||49
8212536|NCT02115373|20253237|P2|STARTED|Overall Study||13
8212537|NCT02115373|20253238|P1|STARTED|Overall Study||4
8212538|NCT02115347|20253304|P3|NOT COMPLETED|Overall Study||0
8212539|NCT02115347|20253305|P2|NOT COMPLETED|Overall Study||0
8212540|NCT02115347|20253306|P1|NOT COMPLETED|Overall Study||0
8212541|NCT02115347|20253304|P3|COMPLETED|Overall Study||0
8212542|NCT02115347|20253305|P2|COMPLETED|Overall Study||8
8212543|NCT02115347|20253306|P1|COMPLETED|Overall Study||8
8212544|NCT02115347|20253304|P3|STARTED|Overall Study||0
8212545|NCT02115347|20253305|P2|STARTED|Overall Study||8
8212546|NCT02115347|20253306|P1|STARTED|Overall Study||8
8212547|NCT02115321|20253326|P2|NOT COMPLETED|Overall Study||0
8212548|NCT02115321|20253327|P1|NOT COMPLETED|Overall Study||1
8212549|NCT02115321|20253326|P2|COMPLETED|Overall Study||10
8212550|NCT02115321|20253327|P1|COMPLETED|Overall Study||29
8212551|NCT02115321|20253326|P2|STARTED|Overall Study||10
8212552|NCT02115321|20253327|P1|STARTED|Overall Study||30
8212553|NCT02115308|20253349|P2|NOT COMPLETED|Overall Study||2
8212554|NCT02115308|20253350|P1|NOT COMPLETED|Overall Study||2
8212555|NCT02115308|20253349|P2|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
8212556|NCT02115308|20253350|P1|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
8212557|NCT02115308|20253349|P2|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
8212558|NCT02115308|20253350|P1|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
8212559|NCT02115269|20253366|P1|NOT COMPLETED|Overall Study||57
8212560|NCT02115269|20253366|P1|COMPLETED|Overall Study||702
8212561|NCT02115269|20253366|P1|STARTED|Overall Study||759
8212562|NCT02115256|20253386|P2|NOT COMPLETED|Overall Study||1
8212563|NCT02115256|20253387|P1|NOT COMPLETED|Overall Study||0
8212564|NCT02115256|20253386|P2|COMPLETED|Overall Study||2
8212565|NCT02115256|20253387|P1|COMPLETED|Overall Study||3
8212566|NCT02115256|20253386|P2|STARTED|Overall Study||3
8212567|NCT02115256|20253387|P1|STARTED|Overall Study||3
8212568|NCT02115113|20253399|P3|NOT COMPLETED|Participants Randomized||0
8212569|NCT02115113|20253400|P2|NOT COMPLETED|Participants Randomized||0
8212570|NCT02115113|20253401|P1|NOT COMPLETED|Participants Randomized||2
8212571|NCT02115113|20253399|P3|COMPLETED|Participants Randomized||0
8212572|NCT02115113|20253400|P2|COMPLETED|Participants Randomized||26
8212573|NCT02115113|20253401|P1|COMPLETED|Participants Randomized||22
8212574|NCT02115113|20253399|P3|STARTED|Participants Randomized||0
8212575|NCT02115113|20253400|P2|STARTED|Participants Randomized||26
8212576|NCT02115113|20253401|P1|STARTED|Participants Randomized||24
8212577|NCT02115113|20253399|P3|NOT COMPLETED|Participants in Run-in Period||10
8212578|NCT02115113|20253400|P2|NOT COMPLETED|Participants in Run-in Period||0
8212579|NCT02115113|20253401|P1|NOT COMPLETED|Participants in Run-in Period||0
8212580|NCT02115113|20253399|P3|COMPLETED|Participants in Run-in Period||68
8212581|NCT02115113|20253400|P2|COMPLETED|Participants in Run-in Period||0
8212582|NCT02115113|20253401|P1|COMPLETED|Participants in Run-in Period||0
8212583|NCT02115113|20253399|P3|STARTED|Participants in Run-in Period||78
8212584|NCT02115113|20253400|P2|STARTED|Participants in Run-in Period||0
8212585|NCT02115113|20253401|P1|STARTED|Participants in Run-in Period||0
8212586|NCT02115048|20253416|P2|NOT COMPLETED|Overall Study||0
8212587|NCT02115048|20253417|P1|NOT COMPLETED|Overall Study||0
8212588|NCT02115048|20253416|P2|COMPLETED|Overall Study||21
8212589|NCT02115048|20253417|P1|COMPLETED|Overall Study||23
8212590|NCT02115048|20253416|P2|STARTED|Overall Study||21
8212591|NCT02115048|20253417|P1|STARTED|Overall Study||23
8212592|NCT02114931|20253433|P2|NOT COMPLETED|Overall Study||30
8212593|NCT02114931|20253434|P1|NOT COMPLETED|Overall Study||25
8212594|NCT02114931|20253433|P2|COMPLETED|Overall Study||207
8212595|NCT02114931|20253434|P1|COMPLETED|Overall Study||205
8212596|NCT02114931|20253433|P2|Received Treatment|Overall Study||237
8212597|NCT02114931|20253434|P1|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
8212598|NCT02114931|20253433|P2|STARTED|Overall Study||237
8212599|NCT02114931|20253434|P1|STARTED|Overall Study||230
8212600|NCT02114892|20253450|P2|NOT COMPLETED|Overall Study||2
8212601|NCT02114892|20253451|P1|NOT COMPLETED|Overall Study||1
8212602|NCT02114892|20253450|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
8212603|NCT02114892|20253451|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
8212604|NCT02114892|20253450|P2|STARTED|Overall Study||12
8212605|NCT02114892|20253451|P1|STARTED|Overall Study||12
8212606|NCT02114879|20253487|P2|NOT COMPLETED|Overall Study||24
8212607|NCT02114879|20253488|P1|NOT COMPLETED|Overall Study||19
8212608|NCT02114879|20253487|P2|COMPLETED|Overall Study||90
8212609|NCT02114879|20253488|P1|COMPLETED|Overall Study||96
8212610|NCT02114879|20253487|P2|STARTED|Overall Study||114
8212611|NCT02114879|20253488|P1|STARTED|Overall Study||115
8212612|NCT02114697|20253506|P2|NOT COMPLETED|Overall Study||4
8212613|NCT02114697|20253507|P1|NOT COMPLETED|Overall Study||5
8212614|NCT02114697|20253506|P2|COMPLETED|Overall Study||0
8212615|NCT02114697|20253507|P1|COMPLETED|Overall Study||0
8212616|NCT02114697|20253506|P2|Completed Month 18 Visit|Overall Study||1
8212617|NCT02114697|20253507|P1|Completed Month 18 Visit|Overall Study||0
8212618|NCT02114697|20253506|P2|STARTED|Overall Study||4
8212619|NCT02114697|20253507|P1|STARTED|Overall Study||5
8212620|NCT02114684|20253515|P2|NOT COMPLETED|Overall Study||10
8212621|NCT02114684|20253516|P1|NOT COMPLETED|Overall Study||12
8212622|NCT02114684|20253515|P2|COMPLETED|Overall Study||88
8212623|NCT02114684|20253516|P1|COMPLETED|Overall Study||86
8212624|NCT02114684|20253515|P2|STARTED|Overall Study||98
8212625|NCT02114684|20253516|P1|STARTED|Overall Study||98
8212626|NCT02114515|20253534|P2|NOT COMPLETED|Overall Study||150
8212627|NCT02114515|20253535|P1|NOT COMPLETED|Overall Study||133
8212628|NCT02114515|20253534|P2|COMPLETED|Overall Study||368
8212629|NCT02114515|20253535|P1|COMPLETED|Overall Study||378
8212630|NCT02114515|20253534|P2|STARTED|Overall Study||518
8212631|NCT02114515|20253535|P1|STARTED|Overall Study||511
8212632|NCT02114385|20253581|P2|NOT COMPLETED|Overall Study||8
8212633|NCT02114385|20253582|P1|NOT COMPLETED|Overall Study||3
8212634|NCT02114385|20253581|P2|COMPLETED|Overall Study||243
8212635|NCT02114385|20253582|P1|COMPLETED|Overall Study||246
8212636|NCT02114385|20253581|P2|Vaccinated|Overall Study||251
8212637|NCT02114385|20253582|P1|Vaccinated|Overall Study||249
8212638|NCT02114385|20253581|P2|STARTED|Overall Study||251
8212639|NCT02114385|20253582|P1|STARTED|Overall Study||249
8212640|NCT02114307|20253606|P2|NOT COMPLETED|Overall Study||0
8212641|NCT02114307|20253607|P1|NOT COMPLETED|Overall Study||1
8212642|NCT02114307|20253606|P2|COMPLETED|Overall Study||11
8212643|NCT02114307|20253607|P1|COMPLETED|Overall Study||10
8212644|NCT02114307|20253606|P2|STARTED|Overall Study||11
8212645|NCT02114307|20253607|P1|STARTED|Overall Study||11
8212646|NCT02114268|20253623|P6|NOT COMPLETED|Overall Study||3
8212647|NCT02114268|20253624|P5|NOT COMPLETED|Overall Study||0
8212648|NCT02114268|20253625|P4|NOT COMPLETED|Overall Study||0
8212649|NCT02114268|20253626|P3|NOT COMPLETED|Overall Study||1
8212650|NCT02114268|20253627|P2|NOT COMPLETED|Overall Study||1
8212651|NCT02114268|20253628|P1|NOT COMPLETED|Overall Study||6
8212652|NCT02114268|20253623|P6|COMPLETED|Overall Study||75
8212653|NCT02114268|20253624|P5|COMPLETED|Overall Study||6
8212654|NCT02114268|20253625|P4|COMPLETED|Overall Study||6
8212655|NCT02114268|20253626|P3|COMPLETED|Overall Study||5
8212656|NCT02114268|20253627|P2|COMPLETED|Overall Study||5
8212657|NCT02114268|20253628|P1|COMPLETED|Overall Study||28
8212658|NCT02114268|20253623|P6|STARTED|Overall Study||78
8212659|NCT02114268|20253624|P5|STARTED|Overall Study||6
8212660|NCT02114268|20253625|P4|STARTED|Overall Study||6
8212661|NCT02114268|20253626|P3|STARTED|Overall Study||6
8212662|NCT02114268|20253627|P2|STARTED|Overall Study||6
8212663|NCT02114268|20253628|P1|STARTED|Overall Study||34
8212664|NCT02114216|20253681|P3|NOT COMPLETED|Overall Study||0
8212665|NCT02114216|20253682|P2|NOT COMPLETED|Overall Study||0
8212666|NCT02114216|20253683|P1|NOT COMPLETED|Overall Study||0
8212667|NCT02114216|20253681|P3|COMPLETED|Overall Study||14
8212668|NCT02114216|20253682|P2|COMPLETED|Overall Study||45
8212669|NCT02114216|20253683|P1|COMPLETED|Overall Study||16
8212670|NCT02114216|20253681|P3|STARTED|Overall Study||14
8212671|NCT02114216|20253682|P2|STARTED|Overall Study||45
8212672|NCT02114216|20253683|P1|STARTED|Overall Study||16
8212673|NCT02114203|20253697|P3|NOT COMPLETED|Overall Study||0
8212674|NCT02114203|20253698|P2|NOT COMPLETED|Overall Study||2
8212675|NCT02114203|20253699|P1|NOT COMPLETED|Overall Study||0
8212676|NCT02114203|20253697|P3|COMPLETED|Overall Study||7
8212677|NCT02114203|20253698|P2|COMPLETED|Overall Study||14
8212678|NCT02114203|20253699|P1|COMPLETED|Overall Study||7
8212679|NCT02114203|20253697|P3|STARTED|Overall Study||7
8212680|NCT02114203|20253698|P2|STARTED|Overall Study||16
8212681|NCT02114203|20253699|P1|STARTED|Overall Study||7
8212682|NCT02114177|20253733|P2|NOT COMPLETED|Overall Study||4
8212683|NCT02114177|20253734|P1|NOT COMPLETED|Overall Study||9
8212684|NCT02114177|20253733|P2|COMPLETED|Overall Study||151
8212685|NCT02114177|20253734|P1|COMPLETED|Overall Study||146
8212686|NCT02114177|20253733|P2|STARTED|Overall Study||155
8212687|NCT02114177|20253734|P1|STARTED|Overall Study||155
8212688|NCT02114151|20253758|P1|NOT COMPLETED|Overall Study||7
8212689|NCT02114151|20253758|P1|COMPLETED|Overall Study||96
8212690|NCT02114151|20253758|P1|STARTED|Overall Study||103
8212691|NCT02113956|20253775|P2|NOT COMPLETED|3 Month Post-intervention||2
8212692|NCT02113956|20253776|P1|NOT COMPLETED|3 Month Post-intervention||4
8212693|NCT02113956|20253775|P2|COMPLETED|3 Month Post-intervention||146
8212694|NCT02113956|20253776|P1|COMPLETED|3 Month Post-intervention||137
8212695|NCT02113956|20253775|P2|STARTED|3 Month Post-intervention||148
8212696|NCT02113956|20253776|P1|STARTED|3 Month Post-intervention||141
8212697|NCT02113956|20253775|P2|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4
8212698|NCT02113956|20253776|P1|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9
8212699|NCT02113956|20253775|P2|COMPLETED|Intervention End (5 Weeks Post Baseline)||148
8212700|NCT02113956|20253776|P1|COMPLETED|Intervention End (5 Weeks Post Baseline)||141
8212701|NCT02113956|20253775|P2|STARTED|Intervention End (5 Weeks Post Baseline)||152
8212702|NCT02113956|20253776|P1|STARTED|Intervention End (5 Weeks Post Baseline)||150
8212703|NCT02113579|20253810|P2|NOT COMPLETED|Overall Study||4
8212704|NCT02113579|20253811|P1|NOT COMPLETED|Overall Study||10
8212705|NCT02113579|20253810|P2|COMPLETED|Overall Study||185
8212706|NCT02113579|20253811|P1|COMPLETED|Overall Study||176
8212707|NCT02113579|20253810|P2|STARTED|Overall Study||189
8212708|NCT02113579|20253811|P1|STARTED|Overall Study||186
8212709|NCT02113449|20253835|P1|NOT COMPLETED|Overall Study||4
8212710|NCT02113449|20253835|P1|COMPLETED|Overall Study||143
8212711|NCT02113449|20253835|P1|STARTED|Overall Study||147
8212712|NCT02113436|20253851|P4|NOT COMPLETED|Period 2: 16 Weeks||11
8212713|NCT02113436|20253852|P3|NOT COMPLETED|Period 2: 16 Weeks||9
8212714|NCT02113436|20253853|P2|NOT COMPLETED|Period 2: 16 Weeks||0
8212715|NCT02113436|20253854|P1|NOT COMPLETED|Period 2: 16 Weeks||0
8212716|NCT02113436|20253851|P4|COMPLETED|Period 2: 16 Weeks||136
8212717|NCT02113436|20253852|P3|COMPLETED|Period 2: 16 Weeks||132
8212718|NCT02113436|20253853|P2|COMPLETED|Period 2: 16 Weeks||0
8212719|NCT02113436|20253854|P1|COMPLETED|Period 2: 16 Weeks||0
8212720|NCT02113436|20253851|P4|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|147
8212721|NCT02113436|20253852|P3|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|141
8212722|NCT02113436|20253853|P2|STARTED|Period 2: 16 Weeks||0
8212723|NCT02113436|20253854|P1|STARTED|Period 2: 16 Weeks||0
8212724|NCT02113436|20253851|P4|NOT COMPLETED|Period 1: 8 Weeks||0
8212725|NCT02113436|20253852|P3|NOT COMPLETED|Period 1: 8 Weeks||0
8212726|NCT02113436|20253853|P2|NOT COMPLETED|Period 1: 8 Weeks||2
8212727|NCT02113436|20253854|P1|NOT COMPLETED|Period 1: 8 Weeks||8
8212728|NCT02113436|20253851|P4|COMPLETED|Period 1: 8 Weeks||0
8212729|NCT02113436|20253852|P3|COMPLETED|Period 1: 8 Weeks||0
8212730|NCT02113436|20253853|P2|COMPLETED|Period 1: 8 Weeks||148
8212731|NCT02113436|20253854|P1|COMPLETED|Period 1: 8 Weeks||142
8212732|NCT02113436|20253851|P4|STARTED|Period 1: 8 Weeks||0
8212733|NCT02113436|20253852|P3|STARTED|Period 1: 8 Weeks||0
8212734|NCT02113436|20253853|P2|STARTED|Period 1: 8 Weeks||150
8212735|NCT02113436|20253854|P1|STARTED|Period 1: 8 Weeks||150
8212736|NCT02113410|20253877|P2|NOT COMPLETED|Overall Study||3
8212737|NCT02113410|20253878|P1|NOT COMPLETED|Overall Study||16
8212738|NCT02113410|20253877|P2|COMPLETED|Overall Study||63
8212739|NCT02113410|20253878|P1|COMPLETED|Overall Study||49
8212740|NCT02113410|20253877|P2|STARTED|Overall Study||66
8212741|NCT02113410|20253878|P1|STARTED|Overall Study||65
8212742|NCT02113241|20253904|P2|NOT COMPLETED|Overall Study||1
8212743|NCT02113241|20253905|P1|NOT COMPLETED|Overall Study||0
8212744|NCT02113241|20253904|P2|COMPLETED|Overall Study||11
8212745|NCT02113241|20253905|P1|COMPLETED|Overall Study||12
8212746|NCT02113241|20253904|P2|STARTED|Overall Study||12
8212747|NCT02113241|20253905|P1|STARTED|Overall Study||12
8212748|NCT02113189|20253960|P3|NOT COMPLETED|Overall Study||3
8212749|NCT02113189|20253961|P2|NOT COMPLETED|Overall Study||1
8212750|NCT02113189|20253962|P1|NOT COMPLETED|Overall Study||2
8212751|NCT02113189|20253960|P3|COMPLETED|Overall Study||2
8212752|NCT02113189|20253961|P2|COMPLETED|Overall Study||3
8212753|NCT02113189|20253962|P1|COMPLETED|Overall Study||2
8212754|NCT02113189|20253960|P3|STARTED|Overall Study||5
8212755|NCT02113189|20253961|P2|STARTED|Overall Study||4
8212756|NCT02113189|20253962|P1|STARTED|Overall Study||4
8212757|NCT02113124|20253978|P2|NOT COMPLETED|Overall Study||1
8212758|NCT02113124|20253979|P1|NOT COMPLETED|Overall Study||1
8212759|NCT02113124|20253978|P2|COMPLETED|Overall Study||24
8212760|NCT02113124|20253979|P1|COMPLETED|Overall Study||17
8212761|NCT02113124|20253978|P2|STARTED|Overall Study||25
8212762|NCT02113124|20253979|P1|STARTED|Overall Study||18
8212763|NCT02113007|20253985|P1|NOT COMPLETED|Overall Study||2
8212764|NCT02113007|20253985|P1|COMPLETED|Overall Study||0
8212765|NCT02113007|20253985|P1|STARTED|Overall Study||2
8212766|NCT02112994|20253991|P3|NOT COMPLETED|Overall Study||3
8212767|NCT02112994|20253992|P2|NOT COMPLETED|Overall Study||2
8212768|NCT02112994|20253993|P1|NOT COMPLETED|Overall Study||0
8212769|NCT02112994|20253991|P3|COMPLETED|Overall Study||6
8212770|NCT02112994|20253992|P2|COMPLETED|Overall Study||14
8212771|NCT02112994|20253993|P1|COMPLETED|Overall Study||6
8212772|NCT02112994|20253991|P3|Completed 96-week Treatment Period|Overall Study||8
8212773|NCT02112994|20253992|P2|Completed 96-week Treatment Period|Overall Study||14
8212774|NCT02112994|20253993|P1|Completed 96-week Treatment Period|Overall Study||6
8212775|NCT02112994|20253991|P3|Received 3 mg/kg QW|Overall Study||1
8212776|NCT02112994|20253992|P2|Received 3 mg/kg QW|Overall Study||1
8212777|NCT02112994|20253993|P1|Received 3 mg/kg QW|Overall Study||2
8212778|NCT02112994|20253991|P3|Received 3 mg/kg QOW|Overall Study||3
8212779|NCT02112994|20253992|P2|Received 3 mg/kg QOW|Overall Study||5
8212780|NCT02112994|20253993|P1|Received 3 mg/kg QOW|Overall Study||3
8212781|NCT02112994|20253991|P3|Received 1 mg/kg QW|Overall Study||0
8212782|NCT02112994|20253992|P2|Received 1 mg/kg QW|Overall Study||1
8212783|NCT02112994|20253993|P1|Received 1 mg/kg QW|Overall Study||1
8212784|NCT02112994|20253991|P3|Received 1 mg/kg QOW|Overall Study||9
8212785|NCT02112994|20253992|P2|Received 1 mg/kg QOW|Overall Study||16
8212786|NCT02112994|20253993|P1|Received 1 mg/kg QOW|Overall Study||6
8212787|NCT02112994|20253991|P3|Received 0.35 mg/kg QOW|Overall Study||1
8212788|NCT02112994|20253992|P2|Received 0.35 mg/kg QOW|Overall Study||0
8212789|NCT02112994|20253993|P1|Received 0.35 mg/kg QOW|Overall Study||0
8212790|NCT02112994|20253991|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
8212791|NCT02112994|20253992|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
8212792|NCT02112994|20253993|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8212793|NCT02112994|20253991|P3|STARTED|Overall Study||9
8212794|NCT02112994|20253992|P2|STARTED|Overall Study||16
8212795|NCT02112994|20253993|P1|STARTED|Overall Study||6
8212802|NCT02112838|20254037|P3|NOT COMPLETED|Overall Study||1
8212803|NCT02112838|20254038|P2|NOT COMPLETED|Overall Study||2
8212804|NCT02112838|20254039|P1|NOT COMPLETED|Overall Study||5
8212805|NCT02112838|20254037|P3|COMPLETED|Overall Study||24
8212806|NCT02112838|20254038|P2|COMPLETED|Overall Study||24
8212807|NCT02112838|20254039|P1|COMPLETED|Overall Study||20
8212808|NCT02112838|20254037|P3|STARTED|Overall Study||25
8212809|NCT02112838|20254038|P2|STARTED|Overall Study||26
8212810|NCT02112838|20254039|P1|STARTED|Overall Study||25
8212825|NCT02112448|20254100|P2|NOT COMPLETED|Overall Study||10
8212826|NCT02112448|20254101|P1|NOT COMPLETED|Overall Study||8
8212827|NCT02112448|20254100|P2|COMPLETED|Overall Study||30
8212828|NCT02112448|20254101|P1|COMPLETED|Overall Study||30
8212829|NCT02112448|20254100|P2|STARTED|Overall Study||40
8212830|NCT02112448|20254101|P1|STARTED|Overall Study||38
8212831|NCT02112370|20254111|P2|NOT COMPLETED|Overall Study||0
8212832|NCT02112370|20254112|P1|NOT COMPLETED|Overall Study||0
8212833|NCT02112370|20254111|P2|COMPLETED|Overall Study||74
8212834|NCT02112370|20254112|P1|COMPLETED|Overall Study||74
8212835|NCT02112370|20254111|P2|STARTED|Overall Study||74
8212836|NCT02112370|20254112|P1|STARTED|Overall Study||74
8212837|NCT02112045|20254134|P2|NOT COMPLETED|Overall Study||0
8212838|NCT02112045|20254135|P1|NOT COMPLETED|Overall Study||1
8212839|NCT02112045|20254134|P2|COMPLETED|Overall Study||45
8212840|NCT02112045|20254135|P1|COMPLETED|Overall Study||44
8212841|NCT02112045|20254134|P2|STARTED|Overall Study||45
8212842|NCT02112045|20254135|P1|STARTED|Overall Study||45
8212843|NCT02111993|20254155|P2|NOT COMPLETED|Overall Study||4
8212844|NCT02111993|20254156|P1|NOT COMPLETED|Overall Study||5
8212845|NCT02111993|20254155|P2|COMPLETED|Overall Study||26
8212846|NCT02111993|20254156|P1|COMPLETED|Overall Study||25
8212847|NCT02111993|20254155|P2|STARTED|Overall Study||30
8212848|NCT02111993|20254156|P1|STARTED|Overall Study||30
8212849|NCT02111980|20254166|P1|NOT COMPLETED|Overall Study||0
8212850|NCT02111980|20254166|P1|COMPLETED|Overall Study||50
8212851|NCT02111980|20254166|P1|STARTED|Overall Study||50
8212852|NCT02111863|20254189|P1|NOT COMPLETED|Overall Study||0
8212853|NCT02111863|20254189|P1|COMPLETED|Overall Study||6
8212854|NCT02111863|20254189|P1|STARTED|Overall Study||6
8212855|NCT02111811|20254197|P2|NOT COMPLETED|Follow up Period (Aim 2)||17
8212856|NCT02111811|20254198|P1|NOT COMPLETED|Follow up Period (Aim 2)||28
8212857|NCT02111811|20254197|P2|COMPLETED|Follow up Period (Aim 2)||97
8212858|NCT02111811|20254198|P1|COMPLETED|Follow up Period (Aim 2)||111
8212859|NCT02111811|20254197|P2|STARTED|Follow up Period (Aim 2)|All subjects were approached for followup, 1 patient completed the 2nd followup and not the first.|114
8212860|NCT02111811|20254198|P1|STARTED|Follow up Period (Aim 2)||139
8212861|NCT02111811|20254197|P2|NOT COMPLETED|Treatment Phase||18
8212862|NCT02111811|20254198|P1|NOT COMPLETED|Treatment Phase||24
8212863|NCT02111811|20254197|P2|COMPLETED|Treatment Phase||96
8212864|NCT02111811|20254198|P1|COMPLETED|Treatment Phase||115
8212865|NCT02111811|20254197|P2|STARTED|Treatment Phase||114
8212866|NCT02111811|20254198|P1|STARTED|Treatment Phase||139
8212867|NCT02111785|20254211|P4|NOT COMPLETED|Overall Study||0
8212868|NCT02111785|20254212|P3|NOT COMPLETED|Overall Study||0
8212869|NCT02111785|20254213|P2|NOT COMPLETED|Overall Study||1
8212870|NCT02111785|20254214|P1|NOT COMPLETED|Overall Study||0
8212871|NCT02111785|20254211|P4|COMPLETED|Overall Study||1
8212872|NCT02111785|20254212|P3|COMPLETED|Overall Study||1
8212873|NCT02111785|20254213|P2|COMPLETED|Overall Study||4
8212874|NCT02111785|20254214|P1|COMPLETED|Overall Study||3
8212875|NCT02111785|20254211|P4|STARTED|Overall Study||1
8212876|NCT02111785|20254212|P3|STARTED|Overall Study||1
8212877|NCT02111785|20254213|P2|STARTED|Overall Study||5
8212878|NCT02111785|20254214|P1|STARTED|Overall Study||3
8212879|NCT02111772|20254242|P2|NOT COMPLETED|Overall Study||0
8212880|NCT02111772|20254243|P1|NOT COMPLETED|Overall Study||0
8212881|NCT02111772|20254242|P2|COMPLETED|Overall Study||14
8212882|NCT02111772|20254243|P1|COMPLETED|Overall Study||12
8212883|NCT02111772|20254242|P2|STARTED|Overall Study||14
8212884|NCT02111772|20254243|P1|STARTED|Overall Study||12
8212885|NCT02111746|20254253|P2|NOT COMPLETED|Overall Study||2
8212886|NCT02111746|20254254|P1|NOT COMPLETED|Overall Study||3
8212887|NCT02111746|20254253|P2|COMPLETED|Overall Study||169
8212888|NCT02111746|20254254|P1|COMPLETED|Overall Study||169
8212889|NCT02111746|20254253|P2|STARTED|Overall Study||171
8212890|NCT02111746|20254254|P1|STARTED|Overall Study||172
8212891|NCT02111603|20254276|P1|NOT COMPLETED|Overall Study||1
8212892|NCT02111603|20254276|P1|COMPLETED|Overall Study||12
8212893|NCT02111603|20254276|P1|STARTED|Overall Study||13
8212894|NCT02111564|20254287|P2|NOT COMPLETED|Overall Study||143
8212895|NCT02111564|20254288|P1|NOT COMPLETED|Overall Study||131
8212896|NCT02111564|20254287|P2|COMPLETED|Overall Study||5869
8212897|NCT02111564|20254288|P1|COMPLETED|Overall Study||5876
8212898|NCT02111564|20254287|P2|Treated|Overall Study||5980
8212899|NCT02111564|20254288|P1|Treated|Overall Study||5982
8212900|NCT02111564|20254287|P2|STARTED|Overall Study||6012
8212901|NCT02111564|20254288|P1|STARTED|Overall Study||6007
8212902|NCT02111447|20254310|P4|NOT COMPLETED|Overall Study||0
8212903|NCT02111447|20254311|P3|NOT COMPLETED|Overall Study||0
8212904|NCT02111447|20254312|P2|NOT COMPLETED|Overall Study||0
8212905|NCT02111447|20254313|P1|NOT COMPLETED|Overall Study||0
8212906|NCT02111447|20254310|P4|COMPLETED|Overall Study||0
8212907|NCT02111447|20254311|P3|COMPLETED|Overall Study||1
8212908|NCT02111447|20254312|P2|COMPLETED|Overall Study||5
8212909|NCT02111447|20254313|P1|COMPLETED|Overall Study||0
8212910|NCT02111447|20254310|P4|STARTED|Overall Study||0
8212911|NCT02111447|20254311|P3|STARTED|Overall Study||1
8212912|NCT02111447|20254312|P2|STARTED|Overall Study||5
8212913|NCT02111447|20254313|P1|STARTED|Overall Study||0
8212914|NCT02111369|20254327|P1|NOT COMPLETED|Overall Study||3
8212915|NCT02111369|20254327|P1|COMPLETED|Overall Study||15
8212916|NCT02111369|20254327|P1|STARTED|Overall Study||18
8212917|NCT02111252|20254335|P1|NOT COMPLETED|Overall Study||0
8212918|NCT02111252|20254335|P1|COMPLETED|Overall Study||55
8212919|NCT02111252|20254335|P1|STARTED|Overall Study||55
8212920|NCT02111213|20254351|P2|NOT COMPLETED|Overall Study||6
8212921|NCT02111213|20254352|P1|NOT COMPLETED|Overall Study||6
8212922|NCT02111213|20254351|P2|COMPLETED|Overall Study||117
8212923|NCT02111213|20254352|P1|COMPLETED|Overall Study||116
8212924|NCT02111213|20254351|P2|STARTED|Overall Study||123
8212925|NCT02111213|20254352|P1|STARTED|Overall Study||122
8212926|NCT02111200|20254366|P4|NOT COMPLETED|Overall Study||0
8212927|NCT02111200|20254367|P3|NOT COMPLETED|Overall Study||0
8212928|NCT02111200|20254368|P2|NOT COMPLETED|Overall Study||0
8212929|NCT02111200|20254369|P1|NOT COMPLETED|Overall Study||0
8212930|NCT02111200|20254366|P4|COMPLETED|Overall Study||1
8212931|NCT02111200|20254367|P3|COMPLETED|Overall Study||1
8212932|NCT02111200|20254368|P2|COMPLETED|Overall Study||2
8212933|NCT02111200|20254369|P1|COMPLETED|Overall Study||3
8212934|NCT02111200|20254366|P4|STARTED|Overall Study||1
8212935|NCT02111200|20254367|P3|STARTED|Overall Study||1
8212936|NCT02111200|20254368|P2|STARTED|Overall Study||2
8212937|NCT02111200|20254369|P1|STARTED|Overall Study||3
8212938|NCT02111187|20254385|P2|NOT COMPLETED|Overall Study||0
8212939|NCT02111187|20254386|P1|NOT COMPLETED|Overall Study||0
8212940|NCT02111187|20254385|P2|COMPLETED|Overall Study||7
8212941|NCT02111187|20254386|P1|COMPLETED|Overall Study||7
8212942|NCT02111187|20254385|P2|STARTED|Overall Study||7
8212943|NCT02111187|20254386|P1|STARTED|Overall Study||7
8212944|NCT02111174|20254400|P2|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
8212945|NCT02111174|20254401|P1|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
8212946|NCT02111174|20254400|P2|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
8212947|NCT02111174|20254401|P1|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
8212948|NCT02111174|20254400|P2|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
8212949|NCT02111174|20254401|P1|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
8212950|NCT02111174|20254400|P2|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
8212951|NCT02111174|20254401|P1|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
8212952|NCT02111174|20254400|P2|NOT COMPLETED|Treatment and Primary Outcome||2
8212953|NCT02111174|20254401|P1|NOT COMPLETED|Treatment and Primary Outcome||3
8212954|NCT02111174|20254400|P2|COMPLETED|Treatment and Primary Outcome||16
8212955|NCT02111174|20254401|P1|COMPLETED|Treatment and Primary Outcome||15
8212956|NCT02111174|20254400|P2|STARTED|Treatment and Primary Outcome||18
8212957|NCT02111174|20254401|P1|STARTED|Treatment and Primary Outcome||18
8212958|NCT02111096|20254430|P3|NOT COMPLETED|Overall Study||66
8212959|NCT02111096|20254431|P2|NOT COMPLETED|Overall Study||41
8212960|NCT02111096|20254432|P1|NOT COMPLETED|Overall Study||64
8212961|NCT02111096|20254430|P3|COMPLETED|Overall Study||2
8212962|NCT02111096|20254431|P2|COMPLETED|Overall Study||0
8212963|NCT02111096|20254432|P1|COMPLETED|Overall Study||1
8212964|NCT02111096|20254430|P3|Received at Least 1 Dose of Study Drug|Overall Study||68
8212965|NCT02111096|20254431|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
8212966|NCT02111096|20254432|P1|Received at Least 1 Dose of Study Drug|Overall Study||65
8212967|NCT02111096|20254430|P3|STARTED|Overall Study||68
8212968|NCT02111096|20254431|P2|STARTED|Overall Study||41
8212969|NCT02111096|20254432|P1|STARTED|Overall Study||65
8212970|NCT02111083|20254480|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
8212971|NCT02111083|20254481|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
8212972|NCT02111083|20254480|P2|COMPLETED|Fourth Intervention (1 Day)||18
8212973|NCT02111083|20254481|P1|COMPLETED|Fourth Intervention (1 Day)||18
8212974|NCT02111083|20254480|P2|STARTED|Fourth Intervention (1 Day)||18
8212975|NCT02111083|20254481|P1|STARTED|Fourth Intervention (1 Day)||18
8212976|NCT02111083|20254480|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
8212977|NCT02111083|20254481|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
8212978|NCT02111083|20254480|P2|COMPLETED|Interval Between Dosing (7-8 Days)||18
8212979|NCT02111083|20254481|P1|COMPLETED|Interval Between Dosing (7-8 Days)||18
8212980|NCT02111083|20254480|P2|STARTED|Interval Between Dosing (7-8 Days)||19
8212981|NCT02111083|20254481|P1|STARTED|Interval Between Dosing (7-8 Days)||19
8212982|NCT02111083|20254480|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8212983|NCT02111083|20254481|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8212984|NCT02111083|20254480|P2|COMPLETED|Third Intervention (1 Day)||19
8212985|NCT02111083|20254481|P1|COMPLETED|Third Intervention (1 Day)||19
8212986|NCT02111083|20254480|P2|STARTED|Third Intervention (1 Day)||19
8212987|NCT02111083|20254481|P1|STARTED|Third Intervention (1 Day)||19
8212988|NCT02111083|20254480|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
8212989|NCT02111083|20254481|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
8212990|NCT02111083|20254480|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
8212991|NCT02111083|20254481|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
8212992|NCT02111083|20254480|P2|STARTED|Interval Between Dosing (7-8 Days)||19
8212993|NCT02111083|20254481|P1|STARTED|Interval Between Dosing (7-8 Days)||19
8212994|NCT02111083|20254480|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8212995|NCT02111083|20254481|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8212996|NCT02111083|20254480|P2|COMPLETED|Second Intervention (1 Day)||19
8212997|NCT02111083|20254481|P1|COMPLETED|Second Intervention (1 Day)||19
8212998|NCT02111083|20254480|P2|STARTED|Second Intervention (1 Day)||19
8212999|NCT02111083|20254481|P1|STARTED|Second Intervention (1 Day)||19
8213000|NCT02111083|20254480|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
8213001|NCT02111083|20254481|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
8213002|NCT02111083|20254480|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
8213003|NCT02111083|20254481|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
8213004|NCT02111083|20254480|P2|STARTED|Interval Between Dosing (7-8 Days)||19
8213005|NCT02111083|20254481|P1|STARTED|Interval Between Dosing (7-8 Days)||19
8213006|NCT02111083|20254480|P2|NOT COMPLETED|First Intervention (1 Day)||0
8213007|NCT02111083|20254481|P1|NOT COMPLETED|First Intervention (1 Day)||0
8213008|NCT02111083|20254480|P2|COMPLETED|First Intervention (1 Day)||19
8213009|NCT02111083|20254481|P1|COMPLETED|First Intervention (1 Day)||19
8213010|NCT02111083|20254480|P2|STARTED|First Intervention (1 Day)||19
8213011|NCT02111083|20254481|P1|STARTED|First Intervention (1 Day)||19
8213012|NCT02110901|20254501|P2|NOT COMPLETED|Overall Study||14
8213013|NCT02110901|20254502|P1|NOT COMPLETED|Overall Study||30
8213014|NCT02110901|20254501|P2|COMPLETED|Overall Study||88
8213015|NCT02110901|20254502|P1|COMPLETED|Overall Study||179
8213016|NCT02110901|20254501|P2|STARTED|Overall Study||102
8213017|NCT02110901|20254502|P1|STARTED|Overall Study||209
8213018|NCT02110706|20254516|P2|NOT COMPLETED|Overall Study||4
8213019|NCT02110706|20254517|P1|NOT COMPLETED|Overall Study||5
8213020|NCT02110706|20254516|P2|COMPLETED|Overall Study||23
8213021|NCT02110706|20254517|P1|COMPLETED|Overall Study||20
8213022|NCT02110706|20254516|P2|No. Completing Study Through Week 52|Overall Study||24
8213023|NCT02110706|20254517|P1|No. Completing Study Through Week 52|Overall Study||23
8213024|NCT02110706|20254516|P2|STARTED|Overall Study||27
8213025|NCT02110706|20254517|P1|STARTED|Overall Study||25
8213026|NCT02110693|20254529|P2|NOT COMPLETED|Overall Study||29
8213027|NCT02110693|20254530|P1|NOT COMPLETED|Overall Study||28
8213028|NCT02110693|20254529|P2|COMPLETED|Overall Study||1002
8213029|NCT02110693|20254530|P1|COMPLETED|Overall Study||998
8213030|NCT02110693|20254529|P2|STARTED|Overall Study||1031
8213031|NCT02110693|20254530|P1|STARTED|Overall Study||1026
8213032|NCT02110485|20254557|P2|NOT COMPLETED|Overall Study||19
8213033|NCT02110485|20254558|P1|NOT COMPLETED|Overall Study||7
8213034|NCT02110485|20254557|P2|COMPLETED|Overall Study||83
8213035|NCT02110485|20254558|P1|COMPLETED|Overall Study||91
8213036|NCT02110485|20254557|P2|STARTED|Overall Study||102
8213037|NCT02110485|20254558|P1|STARTED|Overall Study||98
8213038|NCT02110381|20254576|P2|NOT COMPLETED|Dual Modality||1
8213039|NCT02110381|20254577|P1|NOT COMPLETED|Dual Modality||2
8213040|NCT02110381|20254576|P2|COMPLETED|Dual Modality||7
8213041|NCT02110381|20254577|P1|COMPLETED|Dual Modality||5
8213042|NCT02110381|20254576|P2|Began Active Treatment|Dual Modality||7
8213043|NCT02110381|20254577|P1|Began Active Treatment|Dual Modality||7
8213044|NCT02110381|20254576|P2|STARTED|Dual Modality||8
8213045|NCT02110381|20254577|P1|STARTED|Dual Modality||7
8213046|NCT02110381|20254576|P2|NOT COMPLETED|Single Modality||1
8213047|NCT02110381|20254577|P1|NOT COMPLETED|Single Modality||2
8213048|NCT02110381|20254576|P2|COMPLETED|Single Modality||8
8213049|NCT02110381|20254577|P1|COMPLETED|Single Modality||7
8213050|NCT02110381|20254576|P2|STARTED|Single Modality||9
8213051|NCT02110381|20254577|P1|STARTED|Single Modality||9
8213052|NCT02110277|20254588|P1|NOT COMPLETED|Overall Study||2
8213053|NCT02110277|20254588|P1|COMPLETED|Overall Study||0
8213054|NCT02110277|20254588|P1|STARTED|Overall Study||2
8213055|NCT02110264|20254596|P3|NOT COMPLETED|Overall Study||9
8213056|NCT02110264|20254597|P2|NOT COMPLETED|Overall Study||12
8213057|NCT02110264|20254598|P1|NOT COMPLETED|Overall Study||18
8213058|NCT02110264|20254596|P3|COMPLETED|Overall Study||39
8213059|NCT02110264|20254597|P2|COMPLETED|Overall Study||38
8213060|NCT02110264|20254598|P1|COMPLETED|Overall Study||35
8213061|NCT02110264|20254596|P3|STARTED|Overall Study||48
8213062|NCT02110264|20254597|P2|STARTED|Overall Study||50
8213063|NCT02110264|20254598|P1|STARTED|Overall Study||53
8213076|NCT02110225|20254621|P3|NOT COMPLETED|Overall Study||0
8213077|NCT02110225|20254622|P2|NOT COMPLETED|Overall Study||1
8213078|NCT02110225|20254623|P1|NOT COMPLETED|Overall Study||0
8213079|NCT02110225|20254621|P3|COMPLETED|Overall Study||10
8213080|NCT02110225|20254622|P2|COMPLETED|Overall Study||19
8213081|NCT02110225|20254623|P1|COMPLETED|Overall Study||20
8213082|NCT02110225|20254621|P3|STARTED|Overall Study||10
8213083|NCT02110225|20254622|P2|STARTED|Overall Study||20
8213084|NCT02110225|20254623|P1|STARTED|Overall Study||20
8213085|NCT02110147|20254675|P1|NOT COMPLETED|Overall Study||0
8213086|NCT02110147|20254675|P1|COMPLETED|Overall Study||4
8213087|NCT02110147|20254675|P1|STARTED|Overall Study||4
8213088|NCT02110095|20254681|P1|NOT COMPLETED|Overall Study||7
8213089|NCT02110095|20254681|P1|COMPLETED|Overall Study||8
8213090|NCT02110095|20254681|P1|STARTED|Overall Study||15
8213091|NCT02109939|20254688|P2|NOT COMPLETED|Overall Study||110
8213092|NCT02109939|20254689|P1|NOT COMPLETED|Overall Study||121
8213093|NCT02109939|20254688|P2|COMPLETED|Overall Study||607
8213094|NCT02109939|20254689|P1|COMPLETED|Overall Study||560
8213095|NCT02109939|20254688|P2|STARTED|Overall Study||717
8213096|NCT02109939|20254689|P1|STARTED|Overall Study||681
8213097|NCT02109809|20254712|P1|NOT COMPLETED|Overall Study||3
8213098|NCT02109809|20254712|P1|COMPLETED|Overall Study||1
8213099|NCT02109809|20254712|P1|STARTED|Overall Study||4
8213100|NCT02109731|20254718|P1|NOT COMPLETED|Overall Study||0
8213101|NCT02109731|20254718|P1|COMPLETED|Overall Study||15
8213102|NCT02109731|20254718|P1|STARTED|Overall Study||15
8213103|NCT02109640|20254724|P2|NOT COMPLETED|Overall Study||0
8213104|NCT02109640|20254725|P1|NOT COMPLETED|Overall Study||0
8213105|NCT02109640|20254724|P2|COMPLETED|Overall Study||23
8213106|NCT02109640|20254725|P1|COMPLETED|Overall Study||27
8213107|NCT02109640|20254724|P2|STARTED|Overall Study||23
8213108|NCT02109640|20254725|P1|STARTED|Overall Study||27
8213109|NCT02109562|20254738|P3|NOT COMPLETED|Overall Study||35
8213110|NCT02109562|20254739|P2|NOT COMPLETED|Overall Study||34
8213111|NCT02109562|20254740|P1|NOT COMPLETED|Overall Study||26
8213112|NCT02109562|20254738|P3|COMPLETED|Overall Study||84
8213113|NCT02109562|20254739|P2|COMPLETED|Overall Study||85
8213114|NCT02109562|20254740|P1|COMPLETED|Overall Study||90
8213115|NCT02109562|20254738|P3|Intent to Treat (ITT)|Overall Study||112
8213116|NCT02109562|20254739|P2|Intent to Treat (ITT)|Overall Study||114
8213117|NCT02109562|20254740|P1|Intent to Treat (ITT)|Overall Study||111
8213118|NCT02109562|20254738|P3|Safety|Overall Study||118
8213119|NCT02109562|20254739|P2|Safety|Overall Study||117
8213120|NCT02109562|20254740|P1|Safety|Overall Study||115
8213121|NCT02109562|20254738|P3|STARTED|Overall Study||119
8213122|NCT02109562|20254739|P2|STARTED|Overall Study||119
8213123|NCT02109562|20254740|P1|STARTED|Overall Study||116
8213124|NCT02109497|20254754|P1|NOT COMPLETED|Overall Study||1
8213125|NCT02109497|20254754|P1|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
8213126|NCT02109497|20254754|P1|STARTED|Overall Study||18
8213127|NCT02109484|20254767|P8|NOT COMPLETED|Overall Study||3
8213128|NCT02109484|20254768|P7|NOT COMPLETED|Overall Study||3
8213129|NCT02109484|20254769|P6|NOT COMPLETED|Overall Study||1
8213130|NCT02109484|20254770|P5|NOT COMPLETED|Overall Study||4
8213131|NCT02109484|20254771|P4|NOT COMPLETED|Overall Study||1
8213132|NCT02109484|20254772|P3|NOT COMPLETED|Overall Study||0
8213133|NCT02109484|20254773|P2|NOT COMPLETED|Overall Study||0
8213134|NCT02109484|20254774|P1|NOT COMPLETED|Overall Study||0
8213135|NCT02109484|20254767|P8|COMPLETED|Overall Study||47
8213136|NCT02109484|20254768|P7|COMPLETED|Overall Study||47
8213137|NCT02109484|20254769|P6|COMPLETED|Overall Study||11
8213138|NCT02109484|20254770|P5|COMPLETED|Overall Study||46
8213139|NCT02109484|20254771|P4|COMPLETED|Overall Study||11
8213140|NCT02109484|20254772|P3|COMPLETED|Overall Study||12
8213141|NCT02109484|20254773|P2|COMPLETED|Overall Study||13
8213142|NCT02109484|20254774|P1|COMPLETED|Overall Study||5
8213143|NCT02109484|20254767|P8|STARTED|Overall Study||50
8213144|NCT02109484|20254768|P7|STARTED|Overall Study||50
8213145|NCT02109484|20254769|P6|STARTED|Overall Study||12
8213146|NCT02109484|20254770|P5|STARTED|Overall Study||50
8213147|NCT02109484|20254771|P4|STARTED|Overall Study||12
8213148|NCT02109484|20254772|P3|STARTED|Overall Study||12
8213149|NCT02109484|20254773|P2|STARTED|Overall Study||13
8213150|NCT02109484|20254774|P1|STARTED|Overall Study||5
8213151|NCT02109458|20254823|P1|NOT COMPLETED|Overall Study||0
8213152|NCT02109458|20254823|P1|COMPLETED|Overall Study||24
8213153|NCT02109458|20254823|P1|STARTED|Overall Study||24
8213154|NCT02109445|20254830|P1|NOT COMPLETED|Overall Study||3
8213155|NCT02109445|20254830|P1|COMPLETED|Overall Study||0
8213156|NCT02109445|20254830|P1|STARTED|Overall Study||3
8213157|NCT02109432|20254863|P1|NOT COMPLETED|Overall Study||1
8213158|NCT02109432|20254863|P1|COMPLETED|Overall Study||6
8213159|NCT02109432|20254863|P1|STARTED|Overall Study||7
8213160|NCT02109419|20254867|P1|NOT COMPLETED|Overall Study||0
8213161|NCT02109419|20254867|P1|COMPLETED|Overall Study||57
8213162|NCT02109419|20254867|P1|STARTED|Overall Study||57
8213181|NCT02109159|20254888|P2|NOT COMPLETED|Overall Study||0
8213182|NCT02109159|20254889|P1|NOT COMPLETED|Overall Study||0
8213183|NCT02109159|20254888|P2|COMPLETED|Overall Study||4175
8213184|NCT02109159|20254889|P1|COMPLETED|Overall Study||4178
8213185|NCT02109159|20254888|P2|STARTED|Overall Study||4175
8213186|NCT02109159|20254889|P1|STARTED|Overall Study||4178
8213187|NCT02109133|20254899|P2|NOT COMPLETED|Overall Study||0
8213188|NCT02109133|20254900|P1|NOT COMPLETED|Overall Study||1
8213189|NCT02109133|20254899|P2|COMPLETED|Overall Study||34
8213190|NCT02109133|20254900|P1|COMPLETED|Overall Study||32
8213191|NCT02109133|20254899|P2|STARTED|Overall Study||34
8213192|NCT02109133|20254900|P1|STARTED|Overall Study||33
8213193|NCT02109107|20254912|P1|NOT COMPLETED|Overall Study||2
8213194|NCT02109107|20254912|P1|COMPLETED|Overall Study||52
8213195|NCT02109107|20254912|P1|STARTED|Overall Study||54
8213196|NCT02109042|20254919|P1|NOT COMPLETED|Overall Study||15
8213197|NCT02109042|20254919|P1|COMPLETED|Overall Study||0
8213198|NCT02109042|20254919|P1|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
8213199|NCT02109042|20254919|P1|Received 180 mg Loading Dose|Overall Study||15
8213200|NCT02109042|20254919|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
8213201|NCT02109042|20254919|P1|STARTED|Overall Study||15
8213202|NCT02109029|20254928|P6|NOT COMPLETED|Part B||1
8213203|NCT02109029|20254929|P5|NOT COMPLETED|Part B||1
8213204|NCT02109029|20254930|P4|NOT COMPLETED|Part B||0
8213205|NCT02109029|20254931|P3|NOT COMPLETED|Part B||0
8213206|NCT02109029|20254932|P2|NOT COMPLETED|Part B||0
8213207|NCT02109029|20254933|P1|NOT COMPLETED|Part B||0
8213208|NCT02109029|20254928|P6|COMPLETED|Part B||5
8213209|NCT02109029|20254929|P5|COMPLETED|Part B||5
8213210|NCT02109029|20254930|P4|COMPLETED|Part B||0
8213211|NCT02109029|20254931|P3|COMPLETED|Part B||0
8213212|NCT02109029|20254932|P2|COMPLETED|Part B||0
8213213|NCT02109029|20254933|P1|COMPLETED|Part B||0
8213214|NCT02109029|20254928|P6|Received at Least One Dose of Study Drug|Part B||6
8213215|NCT02109029|20254929|P5|Received at Least One Dose of Study Drug|Part B||6
8213216|NCT02109029|20254930|P4|Received at Least One Dose of Study Drug|Part B||0
8213217|NCT02109029|20254931|P3|Received at Least One Dose of Study Drug|Part B||0
8213218|NCT02109029|20254932|P2|Received at Least One Dose of Study Drug|Part B||0
8213219|NCT02109029|20254933|P1|Received at Least One Dose of Study Drug|Part B||0
8213220|NCT02109029|20254928|P6|STARTED|Part B|New participants entered Part B.|6
8213221|NCT02109029|20254929|P5|STARTED|Part B|New participants entered Part B.|6
8213222|NCT02109029|20254930|P4|STARTED|Part B||0
8213223|NCT02109029|20254931|P3|STARTED|Part B||0
8213224|NCT02109029|20254932|P2|STARTED|Part B||0
8213225|NCT02109029|20254933|P1|STARTED|Part B||0
8213226|NCT02109029|20254928|P6|NOT COMPLETED|Part A||0
8213227|NCT02109029|20254929|P5|NOT COMPLETED|Part A||0
8213228|NCT02109029|20254930|P4|NOT COMPLETED|Part A||0
8213229|NCT02109029|20254931|P3|NOT COMPLETED|Part A||0
8213230|NCT02109029|20254932|P2|NOT COMPLETED|Part A||0
8213231|NCT02109029|20254933|P1|NOT COMPLETED|Part A||0
8213232|NCT02109029|20254928|P6|COMPLETED|Part A||0
8213233|NCT02109029|20254929|P5|COMPLETED|Part A||0
8213234|NCT02109029|20254930|P4|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
8213235|NCT02109029|20254931|P3|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
8213236|NCT02109029|20254932|P2|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
8213237|NCT02109029|20254933|P1|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
8213238|NCT02109029|20254928|P6|Received One Dose of Study Drug|Part A||0
8213239|NCT02109029|20254929|P5|Received One Dose of Study Drug|Part A||0
8213240|NCT02109029|20254930|P4|Received One Dose of Study Drug|Part A||4
8213241|NCT02109029|20254931|P3|Received One Dose of Study Drug|Part A||4
8213242|NCT02109029|20254932|P2|Received One Dose of Study Drug|Part A||2
8213243|NCT02109029|20254933|P1|Received One Dose of Study Drug|Part A||2
8213244|NCT02109029|20254928|P6|STARTED|Part A||0
8213245|NCT02109029|20254929|P5|STARTED|Part A||0
8213246|NCT02109029|20254930|P4|STARTED|Part A||4
8213247|NCT02109029|20254931|P3|STARTED|Part A||4
8213248|NCT02109029|20254932|P2|STARTED|Part A||2
8213249|NCT02109029|20254933|P1|STARTED|Part A||2
8213250|NCT02108977|20254947|P2|NOT COMPLETED|Overall Study||1
8213251|NCT02108977|20254948|P1|NOT COMPLETED|Overall Study||10
8213252|NCT02108977|20254947|P2|COMPLETED|Overall Study||19
8213253|NCT02108977|20254948|P1|COMPLETED|Overall Study||8
8213254|NCT02108977|20254947|P2|STARTED|Overall Study||20
8213255|NCT02108977|20254948|P1|STARTED|Overall Study||18
8213280|NCT02108951|20254996|P1|NOT COMPLETED|Overall Study||16
8213281|NCT02108951|20254996|P1|COMPLETED|Overall Study||4
8213282|NCT02108951|20254996|P1|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
8213283|NCT02108912|20255015|P2|NOT COMPLETED|Overall Study||1
8213284|NCT02108912|20255016|P1|NOT COMPLETED|Overall Study||3
8213285|NCT02108912|20255015|P2|COMPLETED|Overall Study||6
8213286|NCT02108912|20255016|P1|COMPLETED|Overall Study||6
8213287|NCT02108912|20255015|P2|STARTED|Overall Study||7
8213288|NCT02108912|20255016|P1|STARTED|Overall Study||9
8213289|NCT02108691|20255026|P2|NOT COMPLETED|Overall Study||9
8213290|NCT02108691|20255027|P1|NOT COMPLETED|Overall Study||8
8213291|NCT02108691|20255026|P2|COMPLETED|Overall Study||31
8213292|NCT02108691|20255027|P1|COMPLETED|Overall Study||32
8213293|NCT02108691|20255026|P2|STARTED|Overall Study||40
8213294|NCT02108691|20255027|P1|STARTED|Overall Study||40
8213310|NCT02108288|20255093|P3|NOT COMPLETED|Overall Study||0
8213311|NCT02108288|20255094|P2|NOT COMPLETED|Overall Study||0
8213312|NCT02108288|20255095|P1|NOT COMPLETED|Overall Study||0
8213313|NCT02108288|20255093|P3|COMPLETED|Overall Study||10
8213314|NCT02108288|20255094|P2|COMPLETED|Overall Study||10
8213315|NCT02108288|20255095|P1|COMPLETED|Overall Study||10
8213316|NCT02108288|20255093|P3|STARTED|Overall Study||10
8213317|NCT02108288|20255094|P2|STARTED|Overall Study||10
8213318|NCT02108288|20255095|P1|STARTED|Overall Study||10
8213319|NCT02108223|20255111|P3|NOT COMPLETED|Overall Study||0
8213320|NCT02108223|20255112|P2|NOT COMPLETED|Overall Study||0
8213321|NCT02108223|20255113|P1|NOT COMPLETED|Overall Study||0
8213322|NCT02108223|20255111|P3|COMPLETED|Overall Study||35
8213323|NCT02108223|20255112|P2|COMPLETED|Overall Study||50
8213324|NCT02108223|20255113|P1|COMPLETED|Overall Study||52
8213325|NCT02108223|20255111|P3|STARTED|Overall Study||35
8213326|NCT02108223|20255112|P2|STARTED|Overall Study||50
8213327|NCT02108223|20255113|P1|STARTED|Overall Study||52
8213328|NCT02108171|20255135|P2|NOT COMPLETED|Overall Study||0
8213329|NCT02108171|20255136|P1|NOT COMPLETED|Overall Study||0
8213330|NCT02108171|20255135|P2|COMPLETED|Overall Study||41
8213331|NCT02108171|20255136|P1|COMPLETED|Overall Study||40
8213332|NCT02108171|20255135|P2|STARTED|Overall Study||41
8213333|NCT02108171|20255136|P1|STARTED|Overall Study||40
8213334|NCT02107898|20255238|P2|NOT COMPLETED|Overall Study||12
8213335|NCT02107898|20255239|P1|NOT COMPLETED|Overall Study||6
8213336|NCT02107898|20255238|P2|COMPLETED|Overall Study||132
8213337|NCT02107898|20255239|P1|COMPLETED|Overall Study||66
8213338|NCT02107898|20255238|P2|Treated|Overall Study||143
8213339|NCT02107898|20255239|P1|Treated|Overall Study||72
8213340|NCT02107898|20255238|P2|STARTED|Overall Study|Randomized|144
8213341|NCT02107898|20255239|P1|STARTED|Overall Study|Randomized|72
8213342|NCT02107859|20255291|P1|NOT COMPLETED|Overall Study||61
8213343|NCT02107859|20255291|P1|COMPLETED|Overall Study||0
8213344|NCT02107859|20255291|P1|Intent-to-treat (ITT) Population|Overall Study||60
8213345|NCT02107859|20255291|P1|As-treated Population|Overall Study||61
8213346|NCT02107859|20255291|P1|STARTED|Overall Study||61
8213347|NCT02107703|20255307|P2|NOT COMPLETED|Overall Study||175
8213348|NCT02107703|20255308|P1|NOT COMPLETED|Overall Study||361
8213349|NCT02107703|20255307|P2|COMPLETED|Overall Study||48
8213350|NCT02107703|20255308|P1|COMPLETED|Overall Study||85
8213351|NCT02107703|20255307|P2|Received at Least 1 Dose of Study Drug|Overall Study||223
8213352|NCT02107703|20255308|P1|Received at Least 1 Dose of Study Drug|Overall Study||441
8213353|NCT02107703|20255307|P2|STARTED|Overall Study||223
8213354|NCT02107703|20255308|P1|STARTED|Overall Study||446
8213355|NCT02107599|20255333|P1|NOT COMPLETED|Overall Study||0
8213356|NCT02107599|20255333|P1|COMPLETED|Overall Study||96
8213357|NCT02107599|20255333|P1|STARTED|Overall Study||96
8213358|NCT02107482|20255340|P1|NOT COMPLETED|Overall Study||4
8213359|NCT02107482|20255340|P1|COMPLETED|Overall Study||17
8213360|NCT02107482|20255340|P1|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
8213361|NCT02107443|20255348|P2|NOT COMPLETED|Overall Study||83
8213362|NCT02107443|20255349|P1|NOT COMPLETED|Overall Study||98
8213363|NCT02107443|20255348|P2|COMPLETED|Overall Study||167
8213364|NCT02107443|20255349|P1|COMPLETED|Overall Study||198
8213365|NCT02107443|20255348|P2|STARTED|Overall Study||250
8213366|NCT02107443|20255349|P1|STARTED|Overall Study||296
8213367|NCT02107339|20255365|P2|NOT COMPLETED|Overall Study||4
8213368|NCT02107339|20255366|P1|NOT COMPLETED|Overall Study||1
8213369|NCT02107339|20255365|P2|COMPLETED|Overall Study||53
8213370|NCT02107339|20255366|P1|COMPLETED|Overall Study||62
8213371|NCT02107339|20255365|P2|STARTED|Overall Study||57
8213372|NCT02107339|20255366|P1|STARTED|Overall Study||63
8213373|NCT02107313|20255402|P2|NOT COMPLETED|Overall Study||1
8213374|NCT02107313|20255403|P1|NOT COMPLETED|Overall Study||0
8213375|NCT02107313|20255402|P2|COMPLETED|Overall Study||8
8213376|NCT02107313|20255403|P1|COMPLETED|Overall Study||9
8213377|NCT02107313|20255402|P2|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
8213378|NCT02107313|20255403|P1|STARTED|Overall Study||9
8213379|NCT02107300|20255413|P2|NOT COMPLETED|Overall Study||0
8213380|NCT02107300|20255414|P1|NOT COMPLETED|Overall Study||0
8213381|NCT02107300|20255413|P2|COMPLETED|Overall Study||15
8213382|NCT02107300|20255414|P1|COMPLETED|Overall Study||16
8213383|NCT02107300|20255413|P2|STARTED|Overall Study||15
8213384|NCT02107300|20255414|P1|STARTED|Overall Study||16
8213385|NCT02107274|20255424|P2|NOT COMPLETED|Control Phase||2
8213386|NCT02107274|20255425|P1|NOT COMPLETED|Control Phase||3
8213387|NCT02107274|20255424|P2|COMPLETED|Control Phase||35
8213388|NCT02107274|20255425|P1|COMPLETED|Control Phase||33
8213389|NCT02107274|20255424|P2|STARTED|Control Phase||37
8213390|NCT02107274|20255425|P1|STARTED|Control Phase||36
8213391|NCT02107274|20255424|P2|NOT COMPLETED|Treatment vs. Placebo||2
8213392|NCT02107274|20255425|P1|NOT COMPLETED|Treatment vs. Placebo||3
8213393|NCT02107274|20255424|P2|COMPLETED|Treatment vs. Placebo||37
8213394|NCT02107274|20255425|P1|COMPLETED|Treatment vs. Placebo||36
8213395|NCT02107274|20255424|P2|STARTED|Treatment vs. Placebo||39
8213396|NCT02107274|20255425|P1|STARTED|Treatment vs. Placebo||39
8213397|NCT02107196|20255439|P2|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
8213398|NCT02107196|20255440|P1|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
8213399|NCT02107196|20255439|P2|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
8213400|NCT02107196|20255440|P1|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
8213401|NCT02107196|20255439|P2|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
8213402|NCT02107196|20255440|P1|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
8213403|NCT02107196|20255439|P2|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
8213404|NCT02107196|20255440|P1|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
8213405|NCT02107196|20255439|P2|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
8213406|NCT02107196|20255440|P1|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
8213407|NCT02107196|20255439|P2|NOT COMPLETED|12-week Treatment Period||39
8213408|NCT02107196|20255440|P1|NOT COMPLETED|12-week Treatment Period||44
8213409|NCT02107196|20255439|P2|COMPLETED|12-week Treatment Period||225
8213410|NCT02107196|20255440|P1|COMPLETED|12-week Treatment Period||227
8213411|NCT02107196|20255439|P2|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
8213412|NCT02107196|20255440|P1|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
8213413|NCT02107196|20255439|P2|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
8213414|NCT02107196|20255440|P1|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
8213415|NCT02107196|20255439|P2|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
8213416|NCT02107196|20255440|P1|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
8213417|NCT02107157|20255456|P3|NOT COMPLETED|Overall Study||0
8213418|NCT02107157|20255457|P2|NOT COMPLETED|Overall Study||1
8213419|NCT02107157|20255458|P1|NOT COMPLETED|Overall Study||5
8213420|NCT02107157|20255456|P3|COMPLETED|Overall Study||4
8213421|NCT02107157|20255457|P2|COMPLETED|Overall Study||11
8213422|NCT02107157|20255458|P1|COMPLETED|Overall Study||6
8213423|NCT02107157|20255456|P3|STARTED|Overall Study||4
8213424|NCT02107157|20255457|P2|STARTED|Overall Study||12
8213425|NCT02107157|20255458|P1|STARTED|Overall Study||11
8213426|NCT02107131|20255468|P2|NOT COMPLETED|Overall Study||9
8213427|NCT02107131|20255469|P1|NOT COMPLETED|Overall Study||8
8213428|NCT02107131|20255468|P2|COMPLETED|Overall Study||11
8213429|NCT02107131|20255469|P1|COMPLETED|Overall Study||12
8213430|NCT02107131|20255468|P2|STARTED|Overall Study||20
8213431|NCT02107131|20255469|P1|STARTED|Overall Study||20
8213432|NCT02107092|20255481|P1|NOT COMPLETED|Overall Study||44
8213433|NCT02107092|20255481|P1|COMPLETED|Overall Study||79
8213434|NCT02107092|20255481|P1|STARTED|Overall Study||123
8213435|NCT02107014|20255486|P1|NOT COMPLETED|Overall Study||1
8213436|NCT02107014|20255486|P1|COMPLETED|Overall Study||8
8213437|NCT02107014|20255486|P1|STARTED|Overall Study||9
8213438|NCT02106975|20255556|P2|NOT COMPLETED|Overall Study||39
8213439|NCT02106975|20255557|P1|NOT COMPLETED|Overall Study||25
8213440|NCT02106975|20255556|P2|COMPLETED|Overall Study||44
8213441|NCT02106975|20255557|P1|COMPLETED|Overall Study||59
8213442|NCT02106975|20255556|P2|STARTED|Overall Study||83
8213443|NCT02106975|20255557|P1|STARTED|Overall Study||84
8213444|NCT02106962|20255605|P2|NOT COMPLETED|Overall Study||0
8213445|NCT02106962|20255606|P1|NOT COMPLETED|Overall Study||0
8213446|NCT02106962|20255605|P2|COMPLETED|Overall Study||9
8213447|NCT02106962|20255606|P1|COMPLETED|Overall Study||8
8213448|NCT02106962|20255605|P2|STARTED|Overall Study||9
8213449|NCT02106962|20255606|P1|STARTED|Overall Study||8
8213450|NCT02106923|20255617|P6|NOT COMPLETED|Overall Study||1
8213451|NCT02106923|20255618|P5|NOT COMPLETED|Overall Study||0
8213452|NCT02106923|20255619|P4|NOT COMPLETED|Overall Study||0
8213453|NCT02106923|20255620|P3|NOT COMPLETED|Overall Study||0
8213454|NCT02106923|20255621|P2|NOT COMPLETED|Overall Study||0
8213455|NCT02106923|20255622|P1|NOT COMPLETED|Overall Study||0
8213456|NCT02106923|20255617|P6|COMPLETED|Overall Study||11
8213457|NCT02106923|20255618|P5|COMPLETED|Overall Study||12
8213458|NCT02106923|20255619|P4|COMPLETED|Overall Study||12
8213459|NCT02106923|20255620|P3|COMPLETED|Overall Study||12
8213460|NCT02106923|20255621|P2|COMPLETED|Overall Study||12
8213461|NCT02106923|20255622|P1|COMPLETED|Overall Study||12
8213462|NCT02106923|20255617|P6|STARTED|Overall Study||12
8213463|NCT02106923|20255618|P5|STARTED|Overall Study||12
8213464|NCT02106923|20255619|P4|STARTED|Overall Study||12
8213465|NCT02106923|20255620|P3|STARTED|Overall Study||12
8213466|NCT02106923|20255621|P2|STARTED|Overall Study||12
8213467|NCT02106923|20255622|P1|STARTED|Overall Study||12
8213468|NCT02106910|20255668|P2|NOT COMPLETED|Overall Study||1
8213469|NCT02106910|20255669|P1|NOT COMPLETED|Overall Study||1
8213470|NCT02106910|20255668|P2|COMPLETED|Overall Study||88
8213471|NCT02106910|20255669|P1|COMPLETED|Overall Study||48
8213472|NCT02106910|20255668|P2|STARTED|Overall Study||89
8213473|NCT02106910|20255669|P1|STARTED|Overall Study||49
8213474|NCT02106884|20255685|P2|NOT COMPLETED|Overall Study||1
8213475|NCT02106884|20255686|P1|NOT COMPLETED|Overall Study||0
8213476|NCT02106884|20255685|P2|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73
8213477|NCT02106884|20255686|P1|COMPLETED|Overall Study||72
8213478|NCT02106884|20255685|P2|STARTED|Overall Study||74
8213479|NCT02106884|20255686|P1|STARTED|Overall Study||72
8213480|NCT02106832|20255710|P4|NOT COMPLETED|Overall Study||15
8213481|NCT02106832|20255711|P3|NOT COMPLETED|Overall Study||16
8213482|NCT02106832|20255712|P2|NOT COMPLETED|Overall Study||25
8213483|NCT02106832|20255713|P1|NOT COMPLETED|Overall Study||23
8213484|NCT02106832|20255710|P4|COMPLETED|Overall Study||73
8213485|NCT02106832|20255711|P3|COMPLETED|Overall Study||70
8213486|NCT02106832|20255712|P2|COMPLETED|Overall Study||151
8213487|NCT02106832|20255713|P1|COMPLETED|Overall Study||148
8213488|NCT02106832|20255710|P4|Participants Received Treatment|Overall Study||88
8213489|NCT02106832|20255711|P3|Participants Received Treatment|Overall Study||86
8213490|NCT02106832|20255712|P2|Participants Received Treatment|Overall Study||174
8213491|NCT02106832|20255713|P1|Participants Received Treatment|Overall Study||171
8213492|NCT02106832|20255710|P4|STARTED|Overall Study||88
8213493|NCT02106832|20255711|P3|STARTED|Overall Study||86
8213494|NCT02106832|20255712|P2|STARTED|Overall Study||176
8213495|NCT02106832|20255713|P1|STARTED|Overall Study||171
8213496|NCT02106728|20255748|P2|NOT COMPLETED|Overall Study||0
8213497|NCT02106728|20255749|P1|NOT COMPLETED|Overall Study||0
8213498|NCT02106728|20255748|P2|COMPLETED|Overall Study||47
8213499|NCT02106728|20255749|P1|COMPLETED|Overall Study||70
8213500|NCT02106728|20255748|P2|STARTED|Overall Study||47
8213501|NCT02106728|20255749|P1|STARTED|Overall Study||70
8213502|NCT02106494|20255765|P2|NOT COMPLETED|Overall Study||25
8213503|NCT02106494|20255766|P1|NOT COMPLETED|Overall Study||26
8213504|NCT02106494|20255765|P2|COMPLETED|Overall Study||446
8213505|NCT02106494|20255766|P1|COMPLETED|Overall Study||445
8213506|NCT02106494|20255765|P2|Efficacy Population|Overall Study||452
8213507|NCT02106494|20255766|P1|Efficacy Population|Overall Study||450
8213508|NCT02106494|20255765|P2|Safety Population|Overall Study||459
8213509|NCT02106494|20255766|P1|Safety Population|Overall Study||456
8213510|NCT02106494|20255765|P2|STARTED|Overall Study||471
8213511|NCT02106494|20255766|P1|STARTED|Overall Study||471
8213512|NCT02106455|20255780|P1|NOT COMPLETED|Overall Study||8
8213513|NCT02106455|20255780|P1|COMPLETED|Overall Study||307
8213514|NCT02106455|20255780|P1|STARTED|Overall Study||315
8213515|NCT02106442|20255794|P1|NOT COMPLETED|Overall Study||37
8213516|NCT02106442|20255794|P1|COMPLETED|Overall Study||542
8213517|NCT02106442|20255794|P1|STARTED|Overall Study||579
8213518|NCT02106403|20255812|P6|NOT COMPLETED|Follow-Up Visit 3||1
8213519|NCT02106403|20255813|P5|NOT COMPLETED|Follow-Up Visit 3||0
8213520|NCT02106403|20255814|P4|NOT COMPLETED|Follow-Up Visit 3||0
8213521|NCT02106403|20255815|P3|NOT COMPLETED|Follow-Up Visit 3||0
8213522|NCT02106403|20255816|P2|NOT COMPLETED|Follow-Up Visit 3||0
8213523|NCT02106403|20255817|P1|NOT COMPLETED|Follow-Up Visit 3||0
8213524|NCT02106403|20255812|P6|COMPLETED|Follow-Up Visit 3||8
8213525|NCT02106403|20255813|P5|COMPLETED|Follow-Up Visit 3||8
8213526|NCT02106403|20255814|P4|COMPLETED|Follow-Up Visit 3||8
8213527|NCT02106403|20255815|P3|COMPLETED|Follow-Up Visit 3||9
8213528|NCT02106403|20255816|P2|COMPLETED|Follow-Up Visit 3||8
8213529|NCT02106403|20255817|P1|COMPLETED|Follow-Up Visit 3||8
8213530|NCT02106403|20255812|P6|STARTED|Follow-Up Visit 3||9
8213531|NCT02106403|20255813|P5|STARTED|Follow-Up Visit 3||8
8213532|NCT02106403|20255814|P4|STARTED|Follow-Up Visit 3||8
8213533|NCT02106403|20255815|P3|STARTED|Follow-Up Visit 3||9
8213534|NCT02106403|20255816|P2|STARTED|Follow-Up Visit 3||8
8213535|NCT02106403|20255817|P1|STARTED|Follow-Up Visit 3||8
8213536|NCT02106403|20255812|P6|NOT COMPLETED|Follow-Up Visit 2||0
8213537|NCT02106403|20255813|P5|NOT COMPLETED|Follow-Up Visit 2||0
8213538|NCT02106403|20255814|P4|NOT COMPLETED|Follow-Up Visit 2||0
8213539|NCT02106403|20255815|P3|NOT COMPLETED|Follow-Up Visit 2||0
8213540|NCT02106403|20255816|P2|NOT COMPLETED|Follow-Up Visit 2||0
8213541|NCT02106403|20255817|P1|NOT COMPLETED|Follow-Up Visit 2||0
8213542|NCT02106403|20255812|P6|COMPLETED|Follow-Up Visit 2||9
8213543|NCT02106403|20255813|P5|COMPLETED|Follow-Up Visit 2||8
8213544|NCT02106403|20255814|P4|COMPLETED|Follow-Up Visit 2||8
8213545|NCT02106403|20255815|P3|COMPLETED|Follow-Up Visit 2||9
8213546|NCT02106403|20255816|P2|COMPLETED|Follow-Up Visit 2||8
8213547|NCT02106403|20255817|P1|COMPLETED|Follow-Up Visit 2||8
8213548|NCT02106403|20255812|P6|STARTED|Follow-Up Visit 2||9
8213549|NCT02106403|20255813|P5|STARTED|Follow-Up Visit 2||8
8213550|NCT02106403|20255814|P4|STARTED|Follow-Up Visit 2||8
8213551|NCT02106403|20255815|P3|STARTED|Follow-Up Visit 2||9
8213552|NCT02106403|20255816|P2|STARTED|Follow-Up Visit 2||8
8213553|NCT02106403|20255817|P1|STARTED|Follow-Up Visit 2||8
8213554|NCT02106403|20255812|P6|NOT COMPLETED|Visit 1, Treatment Period 3||0
8213555|NCT02106403|20255813|P5|NOT COMPLETED|Visit 1, Treatment Period 3||0
8213556|NCT02106403|20255814|P4|NOT COMPLETED|Visit 1, Treatment Period 3||0
8213557|NCT02106403|20255815|P3|NOT COMPLETED|Visit 1, Treatment Period 3||0
8213558|NCT02106403|20255816|P2|NOT COMPLETED|Visit 1, Treatment Period 3||0
8213559|NCT02106403|20255817|P1|NOT COMPLETED|Visit 1, Treatment Period 3||0
8213560|NCT02106403|20255812|P6|COMPLETED|Visit 1, Treatment Period 3||9
8213561|NCT02106403|20255813|P5|COMPLETED|Visit 1, Treatment Period 3||8
8213562|NCT02106403|20255814|P4|COMPLETED|Visit 1, Treatment Period 3||8
8213563|NCT02106403|20255815|P3|COMPLETED|Visit 1, Treatment Period 3||9
8213564|NCT02106403|20255816|P2|COMPLETED|Visit 1, Treatment Period 3||8
8213565|NCT02106403|20255817|P1|COMPLETED|Visit 1, Treatment Period 3||8
8213566|NCT02106403|20255812|P6|STARTED|Visit 1, Treatment Period 3||9
8213567|NCT02106403|20255813|P5|STARTED|Visit 1, Treatment Period 3||8
8213568|NCT02106403|20255814|P4|STARTED|Visit 1, Treatment Period 3||8
8213569|NCT02106403|20255815|P3|STARTED|Visit 1, Treatment Period 3||9
8213570|NCT02106403|20255816|P2|STARTED|Visit 1, Treatment Period 3||8
8213571|NCT02106403|20255817|P1|STARTED|Visit 1, Treatment Period 3||8
8213572|NCT02106403|20255812|P6|NOT COMPLETED|Visit 1, Treatment Period 2||0
8213573|NCT02106403|20255813|P5|NOT COMPLETED|Visit 1, Treatment Period 2||0
8213574|NCT02106403|20255814|P4|NOT COMPLETED|Visit 1, Treatment Period 2||0
8213575|NCT02106403|20255815|P3|NOT COMPLETED|Visit 1, Treatment Period 2||0
8213576|NCT02106403|20255816|P2|NOT COMPLETED|Visit 1, Treatment Period 2||0
8213577|NCT02106403|20255817|P1|NOT COMPLETED|Visit 1, Treatment Period 2||0
8213578|NCT02106403|20255812|P6|COMPLETED|Visit 1, Treatment Period 2||9
8213579|NCT02106403|20255813|P5|COMPLETED|Visit 1, Treatment Period 2||8
8213580|NCT02106403|20255814|P4|COMPLETED|Visit 1, Treatment Period 2||8
8213581|NCT02106403|20255815|P3|COMPLETED|Visit 1, Treatment Period 2||9
8213582|NCT02106403|20255816|P2|COMPLETED|Visit 1, Treatment Period 2||8
8213583|NCT02106403|20255817|P1|COMPLETED|Visit 1, Treatment Period 2||8
8213584|NCT02106403|20255812|P6|STARTED|Visit 1, Treatment Period 2||9
8213585|NCT02106403|20255813|P5|STARTED|Visit 1, Treatment Period 2||8
8213586|NCT02106403|20255814|P4|STARTED|Visit 1, Treatment Period 2||8
8213587|NCT02106403|20255815|P3|STARTED|Visit 1, Treatment Period 2||9
8213588|NCT02106403|20255816|P2|STARTED|Visit 1, Treatment Period 2||8
8213589|NCT02106403|20255817|P1|STARTED|Visit 1, Treatment Period 2||8
8213590|NCT02106403|20255812|P6|NOT COMPLETED|Visit 1, Treatment Period 1||0
8213591|NCT02106403|20255813|P5|NOT COMPLETED|Visit 1, Treatment Period 1||0
8213592|NCT02106403|20255814|P4|NOT COMPLETED|Visit 1, Treatment Period 1||0
8213593|NCT02106403|20255815|P3|NOT COMPLETED|Visit 1, Treatment Period 1||0
8213594|NCT02106403|20255816|P2|NOT COMPLETED|Visit 1, Treatment Period 1||0
8213595|NCT02106403|20255817|P1|NOT COMPLETED|Visit 1, Treatment Period 1||0
8213596|NCT02106403|20255812|P6|COMPLETED|Visit 1, Treatment Period 1||9
8213597|NCT02106403|20255813|P5|COMPLETED|Visit 1, Treatment Period 1||8
8213598|NCT02106403|20255814|P4|COMPLETED|Visit 1, Treatment Period 1||8
8213599|NCT02106403|20255815|P3|COMPLETED|Visit 1, Treatment Period 1||9
8213600|NCT02106403|20255816|P2|COMPLETED|Visit 1, Treatment Period 1||8
8213601|NCT02106403|20255817|P1|COMPLETED|Visit 1, Treatment Period 1||8
8213602|NCT02106403|20255812|P6|STARTED|Visit 1, Treatment Period 1||9
8213603|NCT02106403|20255813|P5|STARTED|Visit 1, Treatment Period 1||8
8213604|NCT02106403|20255814|P4|STARTED|Visit 1, Treatment Period 1||8
8213605|NCT02106403|20255815|P3|STARTED|Visit 1, Treatment Period 1||9
8213606|NCT02106403|20255816|P2|STARTED|Visit 1, Treatment Period 1||8
8213607|NCT02106403|20255817|P1|STARTED|Visit 1, Treatment Period 1||8
8213608|NCT02106390|20255840|P3|NOT COMPLETED|Overall Study||43
8213609|NCT02106390|20255841|P2|NOT COMPLETED|Overall Study||48
8213610|NCT02106390|20255842|P1|NOT COMPLETED|Overall Study||49
8213611|NCT02106390|20255840|P3|COMPLETED|Overall Study||205
8213612|NCT02106390|20255841|P2|COMPLETED|Overall Study||202
8213613|NCT02106390|20255842|P1|COMPLETED|Overall Study||203
8213614|NCT02106390|20255840|P3|STARTED|Overall Study||248
8213615|NCT02106390|20255841|P2|STARTED|Overall Study||250
8213616|NCT02106390|20255842|P1|STARTED|Overall Study||252
8213617|NCT02106351|20255919|P3|NOT COMPLETED|Treatment Cycle 4||2
8213618|NCT02106351|20255920|P2|NOT COMPLETED|Treatment Cycle 4||1
8213619|NCT02106351|20255921|P1|NOT COMPLETED|Treatment Cycle 4||0
8213620|NCT02106351|20255919|P3|COMPLETED|Treatment Cycle 4||31
8213621|NCT02106351|20255920|P2|COMPLETED|Treatment Cycle 4||21
8213622|NCT02106351|20255921|P1|COMPLETED|Treatment Cycle 4||0
8213623|NCT02106351|20255919|P3|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|33
8213624|NCT02106351|20255920|P2|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|22
8213625|NCT02106351|20255921|P1|STARTED|Treatment Cycle 4||0
8213626|NCT02106351|20255919|P3|NOT COMPLETED|Treatment Cycle 3||5
8213627|NCT02106351|20255920|P2|NOT COMPLETED|Treatment Cycle 3||4
8213628|NCT02106351|20255921|P1|NOT COMPLETED|Treatment Cycle 3||0
8213629|NCT02106351|20255919|P3|COMPLETED|Treatment Cycle 3||53
8213630|NCT02106351|20255920|P2|COMPLETED|Treatment Cycle 3||45
8213631|NCT02106351|20255921|P1|COMPLETED|Treatment Cycle 3||0
8213632|NCT02106351|20255919|P3|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|58
8213633|NCT02106351|20255920|P2|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|49
8213634|NCT02106351|20255921|P1|STARTED|Treatment Cycle 3||0
8213635|NCT02106351|20255919|P3|NOT COMPLETED|Treatment Cycle 2||3
8213636|NCT02106351|20255920|P2|NOT COMPLETED|Treatment Cycle 2||5
8213637|NCT02106351|20255921|P1|NOT COMPLETED|Treatment Cycle 2||0
8213638|NCT02106351|20255919|P3|COMPLETED|Treatment Cycle 2||87
8213639|NCT02106351|20255920|P2|COMPLETED|Treatment Cycle 2||83
8213640|NCT02106351|20255921|P1|COMPLETED|Treatment Cycle 2||0
8213641|NCT02106351|20255919|P3|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|90
8213642|NCT02106351|20255920|P2|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|88
8213643|NCT02106351|20255921|P1|STARTED|Treatment Cycle 2|Subjects who received Dysport 2 U/kg in TC 1 were randomised to receive 8 or 16 U/kg in TCs 2-4.|0
8213644|NCT02106351|20255919|P3|NOT COMPLETED|Treatment Cycle 1||4
8213645|NCT02106351|20255920|P2|NOT COMPLETED|Treatment Cycle 1||3
8213646|NCT02106351|20255921|P1|NOT COMPLETED|Treatment Cycle 1||5
8213647|NCT02106351|20255919|P3|COMPLETED|Treatment Cycle 1||67
8213648|NCT02106351|20255920|P2|COMPLETED|Treatment Cycle 1||67
8213649|NCT02106351|20255921|P1|COMPLETED|Treatment Cycle 1||66
8213650|NCT02106351|20255919|P3|Received Treatment in TC 1|Treatment Cycle 1||70
8213651|NCT02106351|20255920|P2|Received Treatment in TC 1|Treatment Cycle 1||70
8213652|NCT02106351|20255921|P1|Received Treatment in TC 1|Treatment Cycle 1||70
8213653|NCT02106351|20255919|P3|STARTED|Treatment Cycle 1||71
8213654|NCT02106351|20255920|P2|STARTED|Treatment Cycle 1||70
8213655|NCT02106351|20255921|P1|STARTED|Treatment Cycle 1||71
8213656|NCT02106325|20255964|P2|NOT COMPLETED|Phase 3||1
8213657|NCT02106325|20255965|P1|NOT COMPLETED|Phase 3||2
8213658|NCT02106325|20255964|P2|COMPLETED|Phase 3||2
8213659|NCT02106325|20255965|P1|COMPLETED|Phase 3||0
8213660|NCT02106325|20255964|P2|STARTED|Phase 3||3
8213661|NCT02106325|20255965|P1|STARTED|Phase 3||2
8213662|NCT02106325|20255964|P2|NOT COMPLETED|Phase 2||3
8213663|NCT02106325|20255965|P1|NOT COMPLETED|Phase 2||2
8213664|NCT02106325|20255964|P2|COMPLETED|Phase 2||1
8213665|NCT02106325|20255965|P1|COMPLETED|Phase 2||2
8213666|NCT02106325|20255964|P2|STARTED|Phase 2||4
8213667|NCT02106325|20255965|P1|STARTED|Phase 2||4
8213668|NCT02106325|20255964|P2|NOT COMPLETED|Phase 1||2
8213669|NCT02106325|20255965|P1|NOT COMPLETED|Phase 1||2
8213670|NCT02106325|20255964|P2|COMPLETED|Phase 1||1
8213671|NCT02106325|20255965|P1|COMPLETED|Phase 1||3
8213672|NCT02106325|20255964|P2|STARTED|Phase 1||3
8213673|NCT02106325|20255965|P1|STARTED|Phase 1||5
8213674|NCT02106156|20255990|P3|NOT COMPLETED|Overall Study||0
8213675|NCT02106156|20255991|P2|NOT COMPLETED|Overall Study||40
8213676|NCT02106156|20255992|P1|NOT COMPLETED|Overall Study||2549
8213677|NCT02106156|20255990|P3|COMPLETED|Overall Study||518
8213678|NCT02106156|20255991|P2|COMPLETED|Overall Study||50
8213679|NCT02106156|20255992|P1|COMPLETED|Overall Study||7071
8213680|NCT02106156|20255990|P3|STARTED|Overall Study||518
8213681|NCT02106156|20255991|P2|STARTED|Overall Study||90
8213682|NCT02106156|20255992|P1|STARTED|Overall Study||9620
8213683|NCT02105987|20256016|P6|NOT COMPLETED|Continuation Phase||0
8213684|NCT02105987|20256017|P5|NOT COMPLETED|Continuation Phase||1
8213685|NCT02105987|20256018|P4|NOT COMPLETED|Continuation Phase||0
8213686|NCT02105987|20256019|P3|NOT COMPLETED|Continuation Phase||0
8213687|NCT02105987|20256020|P2|NOT COMPLETED|Continuation Phase||0
8213688|NCT02105987|20256021|P1|NOT COMPLETED|Continuation Phase||0
8213689|NCT02105987|20256016|P6|COMPLETED|Continuation Phase||23
8213690|NCT02105987|20256017|P5|COMPLETED|Continuation Phase||13
8213691|NCT02105987|20256018|P4|COMPLETED|Continuation Phase||0
8213692|NCT02105987|20256019|P3|COMPLETED|Continuation Phase||0
8213693|NCT02105987|20256020|P2|COMPLETED|Continuation Phase||0
8213694|NCT02105987|20256021|P1|COMPLETED|Continuation Phase||0
8213695|NCT02105987|20256016|P6|STARTED|Continuation Phase||23
8213696|NCT02105987|20256017|P5|STARTED|Continuation Phase||14
8213697|NCT02105987|20256018|P4|STARTED|Continuation Phase||0
8213698|NCT02105987|20256019|P3|STARTED|Continuation Phase||0
8213699|NCT02105987|20256020|P2|STARTED|Continuation Phase||0
8213700|NCT02105987|20256021|P1|STARTED|Continuation Phase||0
8213701|NCT02105987|20256016|P6|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
8213702|NCT02105987|20256017|P5|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
8213703|NCT02105987|20256018|P4|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
8213704|NCT02105987|20256019|P3|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
8213705|NCT02105987|20256020|P2|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
8213706|NCT02105987|20256021|P1|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
8213707|NCT02105987|20256016|P6|COMPLETED|Late Switch Phase (24 Weeks)||0
8213708|NCT02105987|20256017|P5|COMPLETED|Late Switch Phase (24 Weeks)||0
8213709|NCT02105987|20256018|P4|COMPLETED|Late Switch Phase (24 Weeks)||230
8213710|NCT02105987|20256019|P3|COMPLETED|Late Switch Phase (24 Weeks)||230
8213711|NCT02105987|20256020|P2|COMPLETED|Late Switch Phase (24 Weeks)||0
8213712|NCT02105987|20256021|P1|COMPLETED|Late Switch Phase (24 Weeks)||0
8213713|NCT02105987|20256016|P6|STARTED|Late Switch Phase (24 Weeks)||0
8213714|NCT02105987|20256017|P5|STARTED|Late Switch Phase (24 Weeks)||0
8213715|NCT02105987|20256018|P4|STARTED|Late Switch Phase (24 Weeks)||244
8213716|NCT02105987|20256019|P3|STARTED|Late Switch Phase (24 Weeks)||275
8213717|NCT02105987|20256020|P2|STARTED|Late Switch Phase (24 Weeks)||0
8213718|NCT02105987|20256021|P1|STARTED|Late Switch Phase (24 Weeks)||0
8213719|NCT02105987|20256016|P6|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
8213720|NCT02105987|20256017|P5|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
8213721|NCT02105987|20256018|P4|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
8213722|NCT02105987|20256019|P3|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
8213723|NCT02105987|20256020|P2|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
8213724|NCT02105987|20256021|P1|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
8213725|NCT02105987|20256016|P6|COMPLETED|Early Switch Phase (24 Weeks)||0
8213726|NCT02105987|20256017|P5|COMPLETED|Early Switch Phase (24 Weeks)||0
8213727|NCT02105987|20256018|P4|COMPLETED|Early Switch Phase (24 Weeks)||0
8213728|NCT02105987|20256019|P3|COMPLETED|Early Switch Phase (24 Weeks)||0
8213729|NCT02105987|20256020|P2|COMPLETED|Early Switch Phase (24 Weeks)||244
8213730|NCT02105987|20256021|P1|COMPLETED|Early Switch Phase (24 Weeks)||239
8213731|NCT02105987|20256016|P6|STARTED|Early Switch Phase (24 Weeks)||0
8213732|NCT02105987|20256017|P5|STARTED|Early Switch Phase (24 Weeks)||0
8213733|NCT02105987|20256018|P4|STARTED|Early Switch Phase (24 Weeks)||0
8213734|NCT02105987|20256019|P3|STARTED|Early Switch Phase (24 Weeks)||0
8213735|NCT02105987|20256020|P2|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
8213736|NCT02105987|20256021|P1|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
8213737|NCT02105974|20256075|P3|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
8213738|NCT02105974|20256076|P2|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
8213739|NCT02105974|20256077|P1|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
8213740|NCT02105974|20256075|P3|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
8213741|NCT02105974|20256076|P2|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
8213742|NCT02105974|20256077|P1|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
8213743|NCT02105974|20256075|P3|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
8213744|NCT02105974|20256076|P2|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
8213745|NCT02105974|20256077|P1|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
8213746|NCT02105974|20256075|P3|STARTED|12 Week (Wk) Treatment Period (TP)||814
8213747|NCT02105974|20256076|P2|STARTED|12 Week (Wk) Treatment Period (TP)||806
8213748|NCT02105974|20256077|P1|STARTED|12 Week (Wk) Treatment Period (TP)||0
8213749|NCT02105974|20256075|P3|NOT COMPLETED|2 Week Run-in Period||0
8213750|NCT02105974|20256076|P2|NOT COMPLETED|2 Week Run-in Period||0
8213751|NCT02105974|20256077|P1|NOT COMPLETED|2 Week Run-in Period||801
8213752|NCT02105974|20256075|P3|COMPLETED|2 Week Run-in Period||0
8213753|NCT02105974|20256076|P2|COMPLETED|2 Week Run-in Period||0
8213754|NCT02105974|20256077|P1|COMPLETED|2 Week Run-in Period||1622
8213755|NCT02105974|20256075|P3|STARTED|2 Week Run-in Period||0
8213756|NCT02105974|20256076|P2|STARTED|2 Week Run-in Period||0
8213757|NCT02105974|20256077|P1|STARTED|2 Week Run-in Period||2423
8213758|NCT02105961|20256090|P3|NOT COMPLETED|Overall Study||30
8213759|NCT02105961|20256091|P2|NOT COMPLETED|Overall Study||17
8213760|NCT02105961|20256092|P1|NOT COMPLETED|Overall Study||41
8213761|NCT02105961|20256090|P3|COMPLETED|Overall Study||195
8213762|NCT02105961|20256091|P2|COMPLETED|Overall Study||206
8213763|NCT02105961|20256092|P1|COMPLETED|Overall Study||185
8213764|NCT02105961|20256090|P3|Withdrew IP Due to: Site Closed|Overall Study||1
8213765|NCT02105961|20256091|P2|Withdrew IP Due to: Site Closed|Overall Study||0
8213766|NCT02105961|20256092|P1|Withdrew IP Due to: Site Closed|Overall Study||1
8213767|NCT02105961|20256090|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
8213768|NCT02105961|20256091|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
8213769|NCT02105961|20256092|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
8213770|NCT02105961|20256090|P3|Withdrew IP Due to: Physician Decision|Overall Study||1
8213771|NCT02105961|20256091|P2|Withdrew IP Due to: Physician Decision|Overall Study||3
8213772|NCT02105961|20256092|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
8213773|NCT02105961|20256090|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
8213774|NCT02105961|20256091|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
8213775|NCT02105961|20256092|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
8213776|NCT02105961|20256090|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||1
8213777|NCT02105961|20256091|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||0
8213778|NCT02105961|20256092|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||2
8213779|NCT02105961|20256090|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
8213780|NCT02105961|20256091|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
8213781|NCT02105961|20256092|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
8213782|NCT02105961|20256090|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
8213783|NCT02105961|20256091|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||1
8213784|NCT02105961|20256092|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||1
8213785|NCT02105961|20256090|P3|Withdrew IP Due to: Adverse Event|Overall Study||25
8213786|NCT02105961|20256091|P2|Withdrew IP Due to: Adverse Event|Overall Study||9
8213787|NCT02105961|20256092|P1|Withdrew IP Due to: Adverse Event|Overall Study||27
8213788|NCT02105961|20256090|P3|Not Completed IP|Overall Study||42
8213789|NCT02105961|20256091|P2|Not Completed IP|Overall Study||27
8213790|NCT02105961|20256092|P1|Not Completed IP|Overall Study||56
8213791|NCT02105961|20256090|P3|Completed Investigational Product (IP)|Overall Study||183
8213792|NCT02105961|20256091|P2|Completed Investigational Product (IP)|Overall Study||196
8213793|NCT02105961|20256092|P1|Completed Investigational Product (IP)|Overall Study||170
8213794|NCT02105961|20256090|P3|STARTED|Overall Study||225
8213795|NCT02105961|20256091|P2|STARTED|Overall Study||223
8213796|NCT02105961|20256092|P1|STARTED|Overall Study||226
8213797|NCT02105948|20256116|P4|NOT COMPLETED|Overall Study||27
8213798|NCT02105948|20256117|P3|NOT COMPLETED|Overall Study||28
8213799|NCT02105948|20256118|P2|NOT COMPLETED|Overall Study||20
8213800|NCT02105948|20256119|P1|NOT COMPLETED|Overall Study||27
8213801|NCT02105948|20256116|P4|COMPLETED|Overall Study||157
8213802|NCT02105948|20256117|P3|COMPLETED|Overall Study||162
8213803|NCT02105948|20256118|P2|COMPLETED|Overall Study||213
8213804|NCT02105948|20256119|P1|COMPLETED|Overall Study||202
8213805|NCT02105948|20256116|P4|Withdrew IP Due to: Stopping Criteria|Overall Study||1
8213806|NCT02105948|20256117|P3|Withdrew IP Due to: Stopping Criteria|Overall Study||0
8213807|NCT02105948|20256118|P2|Withdrew IP Due to: Stopping Criteria|Overall Study||0
8213808|NCT02105948|20256119|P1|Withdrew IP Due to: Stopping Criteria|Overall Study||0
8213809|NCT02105948|20256116|P4|Withdrew IP Due to: Physician Decision|Overall Study||2
8213810|NCT02105948|20256117|P3|Withdrew IP Due to: Physician Decision|Overall Study||4
8213811|NCT02105948|20256118|P2|Withdrew IP Due to: Physician Decision|Overall Study||1
8213812|NCT02105948|20256119|P1|Withdrew IP Due to: Physician Decision|Overall Study||2
8213813|NCT02105948|20256116|P4|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
8213814|NCT02105948|20256117|P3|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
8213815|NCT02105948|20256118|P2|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
8213816|NCT02105948|20256119|P1|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
8213817|NCT02105948|20256116|P4|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
8213818|NCT02105948|20256117|P3|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
8213819|NCT02105948|20256118|P2|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
8213820|NCT02105948|20256119|P1|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
8213821|NCT02105948|20256116|P4|Withdrew IP Due to: Protocol Deviation|Overall Study||0
8213822|NCT02105948|20256117|P3|Withdrew IP Due to: Protocol Deviation|Overall Study||3
8213823|NCT02105948|20256118|P2|Withdrew IP Due to: Protocol Deviation|Overall Study||3
8213824|NCT02105948|20256119|P1|Withdrew IP Due to: Protocol Deviation|Overall Study||1
8213825|NCT02105948|20256116|P4|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
8213826|NCT02105948|20256117|P3|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
8213827|NCT02105948|20256118|P2|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
8213828|NCT02105948|20256119|P1|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
8213829|NCT02105948|20256116|P4|Withdrew IP Due to: Adverse Event|Overall Study||13
8213830|NCT02105948|20256117|P3|Withdrew IP Due to: Adverse Event|Overall Study||15
8213831|NCT02105948|20256118|P2|Withdrew IP Due to: Adverse Event|Overall Study||16
8213832|NCT02105948|20256119|P1|Withdrew IP Due to: Adverse Event|Overall Study||20
8213833|NCT02105948|20256116|P4|Not Completed IP|Overall Study||35
8213834|NCT02105948|20256117|P3|Not Completed IP|Overall Study||42
8213835|NCT02105948|20256118|P2|Not Completed IP|Overall Study||30
8213836|NCT02105948|20256119|P1|Not Completed IP|Overall Study||44
8213837|NCT02105948|20256116|P4|Completed Investigational Product (IP)|Overall Study||149
8213838|NCT02105948|20256117|P3|Completed Investigational Product (IP)|Overall Study||148
8213839|NCT02105948|20256118|P2|Completed Investigational Product (IP)|Overall Study||203
8213840|NCT02105948|20256119|P1|Completed Investigational Product (IP)|Overall Study||185
8213841|NCT02105948|20256116|P4|STARTED|Overall Study||184
8213842|NCT02105948|20256117|P3|STARTED|Overall Study||190
8213843|NCT02105948|20256118|P2|STARTED|Overall Study||233
8213844|NCT02105948|20256119|P1|STARTED|Overall Study||229
8213845|NCT02105740|20256147|P2|NOT COMPLETED|Overall Study||1
8213846|NCT02105740|20256148|P1|NOT COMPLETED|Overall Study||0
8213847|NCT02105740|20256147|P2|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
8213848|NCT02105740|20256148|P1|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
8213849|NCT02105740|20256147|P2|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
8213850|NCT02105740|20256148|P1|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
8213851|NCT02105740|20256147|P2|STARTED|Overall Study|Application of EVA and HADS scales|12
8213852|NCT02105740|20256148|P1|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
8213865|NCT02105688|20256187|P2|NOT COMPLETED|Part B: Observational Follow-up||20
8213866|NCT02105688|20256188|P1|NOT COMPLETED|Part B: Observational Follow-up||37
8213867|NCT02105688|20256187|P2|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|48
8213868|NCT02105688|20256188|P1|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|94
8213869|NCT02105688|20256187|P2|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|68
8213870|NCT02105688|20256188|P1|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|131
8213871|NCT02105688|20256187|P2|NOT COMPLETED|Part A: Double-Blind||17
8213872|NCT02105688|20256188|P1|NOT COMPLETED|Part A: Double-Blind||20
8213873|NCT02105688|20256187|P2|COMPLETED|Part A: Double-Blind|Completed Part A|83
8213874|NCT02105688|20256188|P1|COMPLETED|Part A: Double-Blind|Completed Part A|181
8213875|NCT02105688|20256187|P2|STARTED|Part A: Double-Blind||100
8213876|NCT02105688|20256188|P1|STARTED|Part A: Double-Blind||201
8213880|NCT02105636|20256210|P2|NOT COMPLETED|Overall Study||108
8213881|NCT02105636|20256211|P1|NOT COMPLETED|Overall Study||195
8213882|NCT02105636|20256210|P2|COMPLETED|Overall Study|Completed=Still on Treatment|3
8213883|NCT02105636|20256211|P1|COMPLETED|Overall Study|Completed=Still on Treatment|41
8213884|NCT02105636|20256210|P2|STARTED|Overall Study||111
8213885|NCT02105636|20256211|P1|STARTED|Overall Study||236
8213886|NCT02105558|20256223|P2|NOT COMPLETED|Overall Study||0
8213887|NCT02105558|20256224|P1|NOT COMPLETED|Overall Study||0
8213888|NCT02105558|20256223|P2|COMPLETED|Overall Study||28
8213889|NCT02105558|20256224|P1|COMPLETED|Overall Study||15
8213890|NCT02105558|20256223|P2|STARTED|Overall Study||28
8213891|NCT02105558|20256224|P1|STARTED|Overall Study||15
8213892|NCT02105467|20256254|P2|NOT COMPLETED|Period 3||1
8213893|NCT02105467|20256255|P1|NOT COMPLETED|Period 3||0
8213894|NCT02105467|20256254|P2|COMPLETED|Period 3||102
8213895|NCT02105467|20256255|P1|COMPLETED|Period 3||0
8213896|NCT02105467|20256254|P2|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
8213897|NCT02105467|20256255|P1|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
8213898|NCT02105467|20256254|P2|NOT COMPLETED|Period 2||2
8213899|NCT02105467|20256255|P1|NOT COMPLETED|Period 2||2
8213900|NCT02105467|20256254|P2|COMPLETED|Period 2||102
8213901|NCT02105467|20256255|P1|COMPLETED|Period 2||312
8213902|NCT02105467|20256254|P2|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
8213903|NCT02105467|20256255|P1|STARTED|Period 2||314
8213904|NCT02105467|20256254|P2|NOT COMPLETED|Period 1||0
8213905|NCT02105467|20256255|P1|NOT COMPLETED|Period 1||2
8213906|NCT02105467|20256254|P2|COMPLETED|Period 1||105
8213907|NCT02105467|20256255|P1|COMPLETED|Period 1||314
8213908|NCT02105467|20256254|P2|STARTED|Period 1||105
8213909|NCT02105467|20256255|P1|STARTED|Period 1||316
8213910|NCT02105454|20256267|P1|NOT COMPLETED|Overall Study||1
8213911|NCT02105454|20256267|P1|COMPLETED|Overall Study||78
8213912|NCT02105454|20256267|P1|STARTED|Overall Study||79
8213913|NCT02105415|20256276|P2|NOT COMPLETED|Overall Study||5
8213914|NCT02105415|20256277|P1|NOT COMPLETED|Overall Study||3
8213915|NCT02105415|20256276|P2|COMPLETED|Overall Study||79
8213916|NCT02105415|20256277|P1|COMPLETED|Overall Study||73
8213917|NCT02105415|20256276|P2|STARTED|Overall Study||84
8213918|NCT02105415|20256277|P1|STARTED|Overall Study||76
8213919|NCT02105324|20256299|P2|NOT COMPLETED|Period 2||0
8213920|NCT02105324|20256300|P1|NOT COMPLETED|Period 2||0
8213921|NCT02105324|20256299|P2|COMPLETED|Period 2||10
8213922|NCT02105324|20256300|P1|COMPLETED|Period 2||9
8213923|NCT02105324|20256299|P2|STARTED|Period 2||10
8213924|NCT02105324|20256300|P1|STARTED|Period 2||9
8213925|NCT02105324|20256299|P2|NOT COMPLETED|Period 1||0
8213926|NCT02105324|20256300|P1|NOT COMPLETED|Period 1||0
8213927|NCT02105324|20256299|P2|COMPLETED|Period 1||10
8213928|NCT02105324|20256300|P1|COMPLETED|Period 1||9
8213929|NCT02105324|20256299|P2|STARTED|Period 1||10
8213930|NCT02105324|20256300|P1|STARTED|Period 1||9
8213931|NCT02105285|20256379|P3|NOT COMPLETED|Overall Study||0
8213932|NCT02105285|20256380|P2|NOT COMPLETED|Overall Study||2
8213933|NCT02105285|20256381|P1|NOT COMPLETED|Overall Study||2
8213934|NCT02105285|20256379|P3|COMPLETED|Overall Study||37
8213935|NCT02105285|20256380|P2|COMPLETED|Overall Study||76
8213936|NCT02105285|20256381|P1|COMPLETED|Overall Study||76
8213937|NCT02105285|20256379|P3|STARTED|Overall Study||37
8213938|NCT02105285|20256380|P2|STARTED|Overall Study||78
8213939|NCT02105285|20256381|P1|STARTED|Overall Study||78
8213940|NCT02105272|20256400|P2|NOT COMPLETED|Overall Study||3
8213941|NCT02105272|20256401|P1|NOT COMPLETED|Overall Study||5
8213942|NCT02105272|20256400|P2|COMPLETED|Overall Study||116
8213943|NCT02105272|20256401|P1|COMPLETED|Overall Study||113
8213944|NCT02105272|20256400|P2|STARTED|Overall Study||119
8213945|NCT02105272|20256401|P1|STARTED|Overall Study||118
8213946|NCT02105246|20256419|P2|NOT COMPLETED|Overall Study||0
8213947|NCT02105246|20256420|P1|NOT COMPLETED|Overall Study||0
8213948|NCT02105246|20256419|P2|COMPLETED|Overall Study||597
8213949|NCT02105246|20256420|P1|COMPLETED|Overall Study||557
8213950|NCT02105246|20256419|P2|STARTED|Overall Study||597
8213951|NCT02105246|20256420|P1|STARTED|Overall Study||557
8213955|NCT02105012|20256437|P1|NOT COMPLETED|Overall Study||33
8213956|NCT02105012|20256437|P1|COMPLETED|Overall Study||114
8213957|NCT02105012|20256437|P1|Placebo MDI|Overall Study||127
8213958|NCT02105012|20256437|P1|BD MDI 40 µg|Overall Study||63
8213959|NCT02105012|20256437|P1|BD MDI 80 µg|Overall Study||64
8213960|NCT02105012|20256437|P1|BD MDI 160 µg|Overall Study||132
8213961|NCT02105012|20256437|P1|BD MDI 320 µg|Overall Study||124
8213962|NCT02105012|20256437|P1|STARTED|Overall Study||147
8213963|NCT02104947|20256471|P2|NOT COMPLETED|Overall Study||56
8213964|NCT02104947|20256472|P1|NOT COMPLETED|Overall Study||79
8213965|NCT02104947|20256471|P2|COMPLETED|Overall Study||146
8213966|NCT02104947|20256472|P1|COMPLETED|Overall Study||222
8213967|NCT02104947|20256471|P2|STARTED|Overall Study||202
8213968|NCT02104947|20256472|P1|STARTED|Overall Study||301
8213969|NCT02104895|20256490|P2|NOT COMPLETED|Overall Study||14
8213970|NCT02104895|20256491|P1|NOT COMPLETED|Overall Study||0
8213971|NCT02104895|20256490|P2|COMPLETED|Overall Study||246
8213972|NCT02104895|20256491|P1|COMPLETED|Overall Study||260
8213973|NCT02104895|20256490|P2|STARTED|Overall Study||260
8213974|NCT02104895|20256491|P1|STARTED|Overall Study||260
8213975|NCT02104830|20256504|P3|NOT COMPLETED|Overall Study||7
8213976|NCT02104830|20256505|P2|NOT COMPLETED|Overall Study||7
8213977|NCT02104830|20256506|P1|NOT COMPLETED|Overall Study||4
8213978|NCT02104830|20256504|P3|COMPLETED|Overall Study||36
8213979|NCT02104830|20256505|P2|COMPLETED|Overall Study||36
8213980|NCT02104830|20256506|P1|COMPLETED|Overall Study||38
8213981|NCT02104830|20256504|P3|STARTED|Overall Study||43
8213982|NCT02104830|20256505|P2|STARTED|Overall Study||43
8213983|NCT02104830|20256506|P1|STARTED|Overall Study||42
8213984|NCT02104804|20256531|P2|NOT COMPLETED|Overall Study||19
8213985|NCT02104804|20256532|P1|NOT COMPLETED|Overall Study||16
8213986|NCT02104804|20256531|P2|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
8213987|NCT02104804|20256532|P1|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
8213988|NCT02104804|20256531|P2|STARTED|Overall Study|Number of patients who were randomized|232
8213989|NCT02104804|20256532|P1|STARTED|Overall Study|Number of patients who were randomized|234
8213990|NCT02104765|20256555|P7|NOT COMPLETED|Overall Study||1
8213991|NCT02104765|20256556|P6|NOT COMPLETED|Overall Study||0
8213992|NCT02104765|20256557|P5|NOT COMPLETED|Overall Study||1
8213993|NCT02104765|20256558|P4|NOT COMPLETED|Overall Study||1
8213994|NCT02104765|20256559|P3|NOT COMPLETED|Overall Study||1
8213995|NCT02104765|20256560|P2|NOT COMPLETED|Overall Study||0
8213996|NCT02104765|20256561|P1|NOT COMPLETED|Overall Study||0
8213997|NCT02104765|20256555|P7|COMPLETED|Overall Study||7
8213998|NCT02104765|20256556|P6|COMPLETED|Overall Study||2
8213999|NCT02104765|20256557|P5|COMPLETED|Overall Study||7
8214000|NCT02104765|20256558|P4|COMPLETED|Overall Study||6
8214001|NCT02104765|20256559|P3|COMPLETED|Overall Study||5
8214002|NCT02104765|20256560|P2|COMPLETED|Overall Study||6
8214003|NCT02104765|20256561|P1|COMPLETED|Overall Study||8
8214004|NCT02104765|20256555|P7|Received at Least 1 Dose of Study Drug|Overall Study||8
8214005|NCT02104765|20256556|P6|Received at Least 1 Dose of Study Drug|Overall Study||2
8214006|NCT02104765|20256557|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
8214007|NCT02104765|20256558|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
8214008|NCT02104765|20256559|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8214009|NCT02104765|20256560|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8214010|NCT02104765|20256561|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8214011|NCT02104765|20256555|P7|STARTED|Overall Study||8
8214012|NCT02104765|20256556|P6|STARTED|Overall Study||2
8214013|NCT02104765|20256557|P5|STARTED|Overall Study||8
8214014|NCT02104765|20256558|P4|STARTED|Overall Study||7
8214015|NCT02104765|20256559|P3|STARTED|Overall Study||6
8214016|NCT02104765|20256560|P2|STARTED|Overall Study||6
8214017|NCT02104765|20256561|P1|STARTED|Overall Study||8
8214018|NCT02104752|20256589|P2|NOT COMPLETED|Overall Study||2
8214019|NCT02104752|20256590|P1|NOT COMPLETED|Overall Study||1
8214020|NCT02104752|20256589|P2|COMPLETED|Overall Study||19
8214021|NCT02104752|20256590|P1|COMPLETED|Overall Study||17
8214022|NCT02104752|20256589|P2|STARTED|Overall Study||21
8214023|NCT02104752|20256590|P1|STARTED|Overall Study||18
8214024|NCT02104739|20256604|P7|NOT COMPLETED|Extension Phase (6 Weeks)||1
8214025|NCT02104739|20256605|P6|NOT COMPLETED|Extension Phase (6 Weeks)||0
8214026|NCT02104739|20256606|P5|NOT COMPLETED|Extension Phase (6 Weeks)||0
8214027|NCT02104739|20256607|P4|NOT COMPLETED|Extension Phase (6 Weeks)||0
8214028|NCT02104739|20256608|P3|NOT COMPLETED|Extension Phase (6 Weeks)||0
8214029|NCT02104739|20256609|P2|NOT COMPLETED|Extension Phase (6 Weeks)||0
8214030|NCT02104739|20256610|P1|NOT COMPLETED|Extension Phase (6 Weeks)||0
8214031|NCT02104739|20256604|P7|COMPLETED|Extension Phase (6 Weeks)||7
8214032|NCT02104739|20256605|P6|COMPLETED|Extension Phase (6 Weeks)||0
8214033|NCT02104739|20256606|P5|COMPLETED|Extension Phase (6 Weeks)||0
8214034|NCT02104739|20256607|P4|COMPLETED|Extension Phase (6 Weeks)||0
8214035|NCT02104739|20256608|P3|COMPLETED|Extension Phase (6 Weeks)||0
8214036|NCT02104739|20256609|P2|COMPLETED|Extension Phase (6 Weeks)||0
8214037|NCT02104739|20256610|P1|COMPLETED|Extension Phase (6 Weeks)||0
8214038|NCT02104739|20256604|P7|STARTED|Extension Phase (6 Weeks)||8
8214039|NCT02104739|20256605|P6|STARTED|Extension Phase (6 Weeks)||0
8214040|NCT02104739|20256606|P5|STARTED|Extension Phase (6 Weeks)||0
8214041|NCT02104739|20256607|P4|STARTED|Extension Phase (6 Weeks)||0
8214042|NCT02104739|20256608|P3|STARTED|Extension Phase (6 Weeks)||0
8214043|NCT02104739|20256609|P2|STARTED|Extension Phase (6 Weeks)||0
8214044|NCT02104739|20256610|P1|STARTED|Extension Phase (6 Weeks)||0
8214045|NCT02104739|20256604|P7|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
8214046|NCT02104739|20256605|P6|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214047|NCT02104739|20256606|P5|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214048|NCT02104739|20256607|P4|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214049|NCT02104739|20256608|P3|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214050|NCT02104739|20256609|P2|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214051|NCT02104739|20256610|P1|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214052|NCT02104739|20256604|P7|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
8214053|NCT02104739|20256605|P6|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214054|NCT02104739|20256606|P5|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214055|NCT02104739|20256607|P4|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214056|NCT02104739|20256608|P3|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214057|NCT02104739|20256609|P2|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214058|NCT02104739|20256610|P1|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
8214059|NCT02104739|20256604|P7|STARTED|Washout (Min of 10 and Max of 323 Days)||8
8214060|NCT02104739|20256605|P6|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8214061|NCT02104739|20256606|P5|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8214062|NCT02104739|20256607|P4|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8214063|NCT02104739|20256608|P3|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8214064|NCT02104739|20256609|P2|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8214065|NCT02104739|20256610|P1|STARTED|Washout (Min of 10 and Max of 323 Days)||0
8214066|NCT02104739|20256604|P7|NOT COMPLETED|Third Intervention (1 Day)||0
8214067|NCT02104739|20256605|P6|NOT COMPLETED|Third Intervention (1 Day)||0
8214068|NCT02104739|20256606|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8214069|NCT02104739|20256607|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8214070|NCT02104739|20256608|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8214071|NCT02104739|20256609|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8214072|NCT02104739|20256610|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8214073|NCT02104739|20256604|P7|COMPLETED|Third Intervention (1 Day)||0
8214074|NCT02104739|20256605|P6|COMPLETED|Third Intervention (1 Day)||2
8214075|NCT02104739|20256606|P5|COMPLETED|Third Intervention (1 Day)||0
8214076|NCT02104739|20256607|P4|COMPLETED|Third Intervention (1 Day)||7
8214077|NCT02104739|20256608|P3|COMPLETED|Third Intervention (1 Day)||2
8214078|NCT02104739|20256609|P2|COMPLETED|Third Intervention (1 Day)||4
8214079|NCT02104739|20256610|P1|COMPLETED|Third Intervention (1 Day)||1
8214080|NCT02104739|20256604|P7|STARTED|Third Intervention (1 Day)||0
8214081|NCT02104739|20256605|P6|STARTED|Third Intervention (1 Day)||2
8214082|NCT02104739|20256606|P5|STARTED|Third Intervention (1 Day)||0
8214083|NCT02104739|20256607|P4|STARTED|Third Intervention (1 Day)||7
8214084|NCT02104739|20256608|P3|STARTED|Third Intervention (1 Day)||2
8214085|NCT02104739|20256609|P2|STARTED|Third Intervention (1 Day)||4
8214086|NCT02104739|20256610|P1|STARTED|Third Intervention (1 Day)||1
8214087|NCT02104739|20256604|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214088|NCT02104739|20256605|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214089|NCT02104739|20256606|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214090|NCT02104739|20256607|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214091|NCT02104739|20256608|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214092|NCT02104739|20256609|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214093|NCT02104739|20256610|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214094|NCT02104739|20256604|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214095|NCT02104739|20256605|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
8214096|NCT02104739|20256606|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214097|NCT02104739|20256607|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
8214098|NCT02104739|20256608|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
8214099|NCT02104739|20256609|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
8214100|NCT02104739|20256610|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
8214101|NCT02104739|20256604|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
8214102|NCT02104739|20256605|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
8214103|NCT02104739|20256606|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
8214104|NCT02104739|20256607|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
8214105|NCT02104739|20256608|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
8214106|NCT02104739|20256609|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
8214107|NCT02104739|20256610|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
8214108|NCT02104739|20256604|P7|NOT COMPLETED|Second Intervention (1 Day)||0
8214109|NCT02104739|20256605|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8214110|NCT02104739|20256606|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8214111|NCT02104739|20256607|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8214112|NCT02104739|20256608|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8214113|NCT02104739|20256609|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8214114|NCT02104739|20256610|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8214115|NCT02104739|20256604|P7|COMPLETED|Second Intervention (1 Day)||0
8214116|NCT02104739|20256605|P6|COMPLETED|Second Intervention (1 Day)||2
8214117|NCT02104739|20256606|P5|COMPLETED|Second Intervention (1 Day)||0
8214118|NCT02104739|20256607|P4|COMPLETED|Second Intervention (1 Day)||7
8214119|NCT02104739|20256608|P3|COMPLETED|Second Intervention (1 Day)||2
8214120|NCT02104739|20256609|P2|COMPLETED|Second Intervention (1 Day)||4
8214121|NCT02104739|20256610|P1|COMPLETED|Second Intervention (1 Day)||1
8214122|NCT02104739|20256604|P7|STARTED|Second Intervention (1 Day)||0
8214123|NCT02104739|20256605|P6|STARTED|Second Intervention (1 Day)||2
8214124|NCT02104739|20256606|P5|STARTED|Second Intervention (1 Day)||0
8214125|NCT02104739|20256607|P4|STARTED|Second Intervention (1 Day)||7
8214126|NCT02104739|20256608|P3|STARTED|Second Intervention (1 Day)||2
8214127|NCT02104739|20256609|P2|STARTED|Second Intervention (1 Day)||4
8214128|NCT02104739|20256610|P1|STARTED|Second Intervention (1 Day)||1
8214129|NCT02104739|20256604|P7|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214130|NCT02104739|20256605|P6|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214131|NCT02104739|20256606|P5|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214132|NCT02104739|20256607|P4|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214133|NCT02104739|20256608|P3|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214134|NCT02104739|20256609|P2|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214135|NCT02104739|20256610|P1|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214136|NCT02104739|20256604|P7|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214137|NCT02104739|20256605|P6|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
8214138|NCT02104739|20256606|P5|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
8214139|NCT02104739|20256607|P4|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
8214140|NCT02104739|20256608|P3|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
8214141|NCT02104739|20256609|P2|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
8214142|NCT02104739|20256610|P1|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
8214143|NCT02104739|20256604|P7|STARTED|Washout (Min of 10 and Max of 107 Days)||0
8214144|NCT02104739|20256605|P6|STARTED|Washout (Min of 10 and Max of 107 Days)||2
8214145|NCT02104739|20256606|P5|STARTED|Washout (Min of 10 and Max of 107 Days)||0
8214146|NCT02104739|20256607|P4|STARTED|Washout (Min of 10 and Max of 107 Days)||7
8214147|NCT02104739|20256608|P3|STARTED|Washout (Min of 10 and Max of 107 Days)||2
8214148|NCT02104739|20256609|P2|STARTED|Washout (Min of 10 and Max of 107 Days)||4
8214149|NCT02104739|20256610|P1|STARTED|Washout (Min of 10 and Max of 107 Days)||1
8214150|NCT02104739|20256604|P7|NOT COMPLETED|First Intervention (1 Day)||0
8214151|NCT02104739|20256605|P6|NOT COMPLETED|First Intervention (1 Day)||0
8214152|NCT02104739|20256606|P5|NOT COMPLETED|First Intervention (1 Day)||0
8214153|NCT02104739|20256607|P4|NOT COMPLETED|First Intervention (1 Day)||1
8214154|NCT02104739|20256608|P3|NOT COMPLETED|First Intervention (1 Day)||0
8214155|NCT02104739|20256609|P2|NOT COMPLETED|First Intervention (1 Day)||1
8214156|NCT02104739|20256610|P1|NOT COMPLETED|First Intervention (1 Day)||0
8214157|NCT02104739|20256604|P7|COMPLETED|First Intervention (1 Day)||0
8214158|NCT02104739|20256605|P6|COMPLETED|First Intervention (1 Day)||3
8214159|NCT02104739|20256606|P5|COMPLETED|First Intervention (1 Day)||0
8214160|NCT02104739|20256607|P4|COMPLETED|First Intervention (1 Day)||7
8214161|NCT02104739|20256608|P3|COMPLETED|First Intervention (1 Day)||2
8214162|NCT02104739|20256609|P2|COMPLETED|First Intervention (1 Day)||4
8214163|NCT02104739|20256610|P1|COMPLETED|First Intervention (1 Day)||2
8214164|NCT02104739|20256604|P7|STARTED|First Intervention (1 Day)||0
8214165|NCT02104739|20256605|P6|STARTED|First Intervention (1 Day)||3
8214166|NCT02104739|20256606|P5|STARTED|First Intervention (1 Day)||0
8214167|NCT02104739|20256607|P4|STARTED|First Intervention (1 Day)||8
8214168|NCT02104739|20256608|P3|STARTED|First Intervention (1 Day)||2
8214169|NCT02104739|20256609|P2|STARTED|First Intervention (1 Day)||5
8214170|NCT02104739|20256610|P1|STARTED|First Intervention (1 Day)||2
8214171|NCT02104583|20256673|P5|NOT COMPLETED|Overall Study||12
8214172|NCT02104583|20256674|P4|NOT COMPLETED|Overall Study||17
8214173|NCT02104583|20256675|P3|NOT COMPLETED|Overall Study||16
8214174|NCT02104583|20256676|P2|NOT COMPLETED|Overall Study||11
8214175|NCT02104583|20256677|P1|NOT COMPLETED|Overall Study||18
8214176|NCT02104583|20256673|P5|COMPLETED|Overall Study||63
8214177|NCT02104583|20256674|P4|COMPLETED|Overall Study||57
8214178|NCT02104583|20256675|P3|COMPLETED|Overall Study||54
8214179|NCT02104583|20256676|P2|COMPLETED|Overall Study||35
8214180|NCT02104583|20256677|P1|COMPLETED|Overall Study||30
8214181|NCT02104583|20256673|P5|STARTED|Overall Study||75
8214182|NCT02104583|20256674|P4|STARTED|Overall Study||74
8214183|NCT02104583|20256675|P3|STARTED|Overall Study||70
8214184|NCT02104583|20256676|P2|STARTED|Overall Study||46
8214185|NCT02104583|20256677|P1|STARTED|Overall Study||48
8214186|NCT02104505|20256740|P2|NOT COMPLETED|Second Intervention (14 Days)||1
8214187|NCT02104505|20256741|P1|NOT COMPLETED|Second Intervention (14 Days)||2
8214188|NCT02104505|20256740|P2|COMPLETED|Second Intervention (14 Days)||7
8214189|NCT02104505|20256741|P1|COMPLETED|Second Intervention (14 Days)||8
8214190|NCT02104505|20256740|P2|STARTED|Second Intervention (14 Days)||8
8214191|NCT02104505|20256741|P1|STARTED|Second Intervention (14 Days)||10
8214192|NCT02104505|20256740|P2|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
8214193|NCT02104505|20256741|P1|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
8214194|NCT02104505|20256740|P2|COMPLETED|Washout (Minimum 3 Weeks)||8
8214195|NCT02104505|20256741|P1|COMPLETED|Washout (Minimum 3 Weeks)||10
8214196|NCT02104505|20256740|P2|STARTED|Washout (Minimum 3 Weeks)||8
8214197|NCT02104505|20256741|P1|STARTED|Washout (Minimum 3 Weeks)||10
8214198|NCT02104505|20256740|P2|NOT COMPLETED|First Intervention (14 Days)||3
8214199|NCT02104505|20256741|P1|NOT COMPLETED|First Intervention (14 Days)||2
8214200|NCT02104505|20256740|P2|COMPLETED|First Intervention (14 Days)||8
8214201|NCT02104505|20256741|P1|COMPLETED|First Intervention (14 Days)||10
8214202|NCT02104505|20256740|P2|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
8214203|NCT02104505|20256741|P1|STARTED|First Intervention (14 Days)||12
8214207|NCT02104414|20256779|P3|NOT COMPLETED|Overall Study||0
8214208|NCT02104414|20256780|P2|NOT COMPLETED|Overall Study||0
8214209|NCT02104414|20256781|P1|NOT COMPLETED|Overall Study||0
8214210|NCT02104414|20256779|P3|COMPLETED|Overall Study||2
8214211|NCT02104414|20256780|P2|COMPLETED|Overall Study||4
8214212|NCT02104414|20256781|P1|COMPLETED|Overall Study||5
8214213|NCT02104414|20256779|P3|STARTED|Overall Study||2
8214214|NCT02104414|20256780|P2|STARTED|Overall Study||4
8214215|NCT02104414|20256781|P1|STARTED|Overall Study||5
8214216|NCT02104219|20256804|P1|NOT COMPLETED|Overall Study||0
8214217|NCT02104219|20256804|P1|COMPLETED|Overall Study||32
8214218|NCT02104219|20256804|P1|STARTED|Overall Study||32
8214219|NCT02104180|20256813|P2|NOT COMPLETED|Overall Study||0
8214220|NCT02104180|20256814|P1|NOT COMPLETED|Overall Study||1
8214221|NCT02104180|20256813|P2|COMPLETED|Overall Study||31
8214222|NCT02104180|20256814|P1|COMPLETED|Overall Study||30
8214223|NCT02104180|20256813|P2|STARTED|Overall Study||31
8214224|NCT02104180|20256814|P1|STARTED|Overall Study||31
8214225|NCT02104167|20256820|P1|NOT COMPLETED|Overall Study||0
8214226|NCT02104167|20256820|P1|COMPLETED|Overall Study||110
8214227|NCT02104167|20256820|P1|STARTED|Overall Study||110
8214228|NCT02104141|20256825|P1|NOT COMPLETED|Overall Study||0
8214229|NCT02104141|20256825|P1|COMPLETED|Overall Study||51
8214230|NCT02104141|20256825|P1|STARTED|Overall Study||51
8214231|NCT02103855|20256830|P1|NOT COMPLETED|Overall Study||2
8214232|NCT02103855|20256830|P1|COMPLETED|Overall Study||4
8214233|NCT02103855|20256830|P1|STARTED|Overall Study||6
8214234|NCT02103816|20256838|P1|NOT COMPLETED|Overall Study||8
8214235|NCT02103816|20256838|P1|COMPLETED|Overall Study||13
8214236|NCT02103816|20256838|P1|STARTED|Overall Study||21
8214237|NCT02103608|20256844|P1|NOT COMPLETED|Overall Study||2
8214238|NCT02103608|20256844|P1|COMPLETED|Overall Study||15
8214239|NCT02103608|20256844|P1|STARTED|Overall Study||17
8214240|NCT02103478|20256855|P9|NOT COMPLETED|Overall Study||14
8214241|NCT02103478|20256856|P8|NOT COMPLETED|Overall Study||16
8214242|NCT02103478|20256857|P7|NOT COMPLETED|Overall Study||25
8214243|NCT02103478|20256858|P6|NOT COMPLETED|Overall Study||25
8214244|NCT02103478|20256859|P5|NOT COMPLETED|Overall Study||19
8214245|NCT02103478|20256860|P4|NOT COMPLETED|Overall Study||6
8214246|NCT02103478|20256861|P3|NOT COMPLETED|Overall Study||6
8214247|NCT02103478|20256862|P2|NOT COMPLETED|Overall Study||6
8214248|NCT02103478|20256863|P1|NOT COMPLETED|Overall Study||7
8214249|NCT02103478|20256855|P9|COMPLETED|Overall Study||0
8214250|NCT02103478|20256856|P8|COMPLETED|Overall Study||0
8214251|NCT02103478|20256857|P7|COMPLETED|Overall Study||0
8214252|NCT02103478|20256858|P6|COMPLETED|Overall Study||0
8214253|NCT02103478|20256859|P5|COMPLETED|Overall Study||0
8214254|NCT02103478|20256860|P4|COMPLETED|Overall Study||0
8214255|NCT02103478|20256861|P3|COMPLETED|Overall Study||0
8214256|NCT02103478|20256862|P2|COMPLETED|Overall Study||0
8214257|NCT02103478|20256863|P1|COMPLETED|Overall Study||0
8214258|NCT02103478|20256855|P9|STARTED|Overall Study||14
8214259|NCT02103478|20256856|P8|STARTED|Overall Study||16
8214260|NCT02103478|20256857|P7|STARTED|Overall Study||25
8214261|NCT02103478|20256858|P6|STARTED|Overall Study||25
8214262|NCT02103478|20256859|P5|STARTED|Overall Study||19
8214263|NCT02103478|20256860|P4|STARTED|Overall Study||6
8214264|NCT02103478|20256861|P3|STARTED|Overall Study||6
8214265|NCT02103478|20256862|P2|STARTED|Overall Study||6
8214266|NCT02103478|20256863|P1|STARTED|Overall Study||7
8214267|NCT02103439|20256972|P2|NOT COMPLETED|Overall Study||3
8214268|NCT02103439|20256973|P1|NOT COMPLETED|Overall Study||3
8214269|NCT02103439|20256972|P2|COMPLETED|Overall Study||67
8214270|NCT02103439|20256973|P1|COMPLETED|Overall Study||67
8214271|NCT02103439|20256972|P2|STARTED|Overall Study||70
8214272|NCT02103439|20256973|P1|STARTED|Overall Study||70
8214273|NCT02103309|20256993|P2|NOT COMPLETED|Overall Study||0
8214274|NCT02103309|20256994|P1|NOT COMPLETED|Overall Study||0
8214275|NCT02103309|20256993|P2|COMPLETED|Overall Study||22
8214276|NCT02103309|20256994|P1|COMPLETED|Overall Study||20
8214277|NCT02103309|20256993|P2|STARTED|Overall Study||22
8214278|NCT02103309|20256994|P1|STARTED|Overall Study||20
8214279|NCT02103270|20257009|P3|NOT COMPLETED|Overall Study||24
8214280|NCT02103270|20257010|P2|NOT COMPLETED|Overall Study||6
8214281|NCT02103270|20257011|P1|NOT COMPLETED|Overall Study||9
8214282|NCT02103270|20257009|P3|COMPLETED|Overall Study||1
8214283|NCT02103270|20257010|P2|COMPLETED|Overall Study||29
8214284|NCT02103270|20257011|P1|COMPLETED|Overall Study||51
8214285|NCT02103270|20257009|P3|STARTED|Overall Study||25
8214286|NCT02103270|20257010|P2|STARTED|Overall Study||35
8214287|NCT02103270|20257011|P1|STARTED|Overall Study||60
8214300|NCT02103127|20257073|P1|NOT COMPLETED|Overall Study||3
8214301|NCT02103127|20257073|P1|COMPLETED|Overall Study||17
8214302|NCT02103127|20257073|P1|STARTED|Overall Study||20
8214303|NCT02103114|20257082|P2|NOT COMPLETED|Overall Study||1
8214304|NCT02103114|20257083|P1|NOT COMPLETED|Overall Study||0
8214305|NCT02103114|20257082|P2|COMPLETED|Overall Study||19
8214306|NCT02103114|20257083|P1|COMPLETED|Overall Study||20
8214307|NCT02103114|20257082|P2|STARTED|Overall Study||20
8214308|NCT02103114|20257083|P1|STARTED|Overall Study||20
8214309|NCT02103062|20257139|P2|NOT COMPLETED|Overall Study||23
8214310|NCT02103062|20257140|P1|NOT COMPLETED|Overall Study||18
8214311|NCT02103062|20257139|P2|COMPLETED|Overall Study||0
8214312|NCT02103062|20257140|P1|COMPLETED|Overall Study||0
8214313|NCT02103062|20257139|P2|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
8214314|NCT02103062|20257140|P1|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
8214315|NCT02103062|20257139|P2|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
8214316|NCT02103062|20257140|P1|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
8214317|NCT02103062|20257139|P2|STARTED|Overall Study||23
8214318|NCT02103062|20257140|P1|STARTED|Overall Study||18
8214319|NCT02102932|20257166|P8|NOT COMPLETED|Overall Study||0
8214320|NCT02102932|20257167|P7|NOT COMPLETED|Overall Study||0
8214321|NCT02102932|20257168|P6|NOT COMPLETED|Overall Study||0
8214322|NCT02102932|20257169|P5|NOT COMPLETED|Overall Study||0
8214323|NCT02102932|20257170|P4|NOT COMPLETED|Overall Study||0
8214324|NCT02102932|20257171|P3|NOT COMPLETED|Overall Study||0
8214325|NCT02102932|20257172|P2|NOT COMPLETED|Overall Study||0
8214326|NCT02102932|20257173|P1|NOT COMPLETED|Overall Study||0
8214327|NCT02102932|20257166|P8|COMPLETED|Overall Study||12
8214328|NCT02102932|20257167|P7|COMPLETED|Overall Study||12
8214329|NCT02102932|20257168|P6|COMPLETED|Overall Study||12
8214330|NCT02102932|20257169|P5|COMPLETED|Overall Study||12
8214331|NCT02102932|20257170|P4|COMPLETED|Overall Study||12
8214332|NCT02102932|20257171|P3|COMPLETED|Overall Study||12
8214333|NCT02102932|20257172|P2|COMPLETED|Overall Study||12
8214334|NCT02102932|20257173|P1|COMPLETED|Overall Study||12
8214335|NCT02102932|20257166|P8|STARTED|Overall Study||12
8214336|NCT02102932|20257167|P7|STARTED|Overall Study||12
8214337|NCT02102932|20257168|P6|STARTED|Overall Study||12
8214338|NCT02102932|20257169|P5|STARTED|Overall Study||12
8214339|NCT02102932|20257170|P4|STARTED|Overall Study||12
8214340|NCT02102932|20257171|P3|STARTED|Overall Study||12
8214341|NCT02102932|20257172|P2|STARTED|Overall Study||12
8214342|NCT02102932|20257173|P1|STARTED|Overall Study||12
8214343|NCT02102724|20257233|P2|NOT COMPLETED|Overall Study||1
8214344|NCT02102724|20257234|P1|NOT COMPLETED|Overall Study||2
8214345|NCT02102724|20257233|P2|COMPLETED|Overall Study||18
8214346|NCT02102724|20257234|P1|COMPLETED|Overall Study||16
8214347|NCT02102724|20257233|P2|STARTED|Overall Study||19
8214348|NCT02102724|20257234|P1|STARTED|Overall Study||18
8214349|NCT02102490|20257240|P1|NOT COMPLETED|Overall Study||7
8214350|NCT02102490|20257240|P1|COMPLETED|Overall Study||125
8214351|NCT02102490|20257240|P1|Received at Least 1 Dose of Study Drug|Overall Study||132
8214352|NCT02102490|20257240|P1|STARTED|Overall Study||132
8214353|NCT02102464|20257254|P3|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
8214354|NCT02102464|20257255|P2|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
8214355|NCT02102464|20257256|P1|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
8214356|NCT02102464|20257254|P3|COMPLETED|Crossover LipiFlow Treatment of Control||25
8214357|NCT02102464|20257255|P2|COMPLETED|Crossover LipiFlow Treatment of Control||0
8214358|NCT02102464|20257256|P1|COMPLETED|Crossover LipiFlow Treatment of Control||0
8214359|NCT02102464|20257254|P3|STARTED|Crossover LipiFlow Treatment of Control||25
8214360|NCT02102464|20257255|P2|STARTED|Crossover LipiFlow Treatment of Control||0
8214361|NCT02102464|20257256|P1|STARTED|Crossover LipiFlow Treatment of Control||0
8214362|NCT02102464|20257254|P3|NOT COMPLETED|Randomized Study||0
8214363|NCT02102464|20257255|P2|NOT COMPLETED|Randomized Study||1
8214364|NCT02102464|20257256|P1|NOT COMPLETED|Randomized Study||0
8214365|NCT02102464|20257254|P3|COMPLETED|Randomized Study||0
8214366|NCT02102464|20257255|P2|COMPLETED|Randomized Study||25
8214367|NCT02102464|20257256|P1|COMPLETED|Randomized Study||29
8214368|NCT02102464|20257254|P3|STARTED|Randomized Study||0
8214369|NCT02102464|20257255|P2|STARTED|Randomized Study||26
8214370|NCT02102464|20257256|P1|STARTED|Randomized Study||29
8214371|NCT02102399|20257275|P2|NOT COMPLETED|Overall Study||4
8214372|NCT02102399|20257276|P1|NOT COMPLETED|Overall Study||6
8214373|NCT02102399|20257275|P2|COMPLETED|Overall Study||17
8214374|NCT02102399|20257276|P1|COMPLETED|Overall Study||14
8214375|NCT02102399|20257275|P2|STARTED|Overall Study||21
8214376|NCT02102399|20257276|P1|STARTED|Overall Study||20
8214377|NCT02102230|20257327|P3|NOT COMPLETED|Overall Study||17
8214378|NCT02102230|20257328|P2|NOT COMPLETED|Overall Study||17
8214379|NCT02102230|20257329|P1|NOT COMPLETED|Overall Study||17
8214380|NCT02102230|20257327|P3|COMPLETED|Overall Study||24
8214381|NCT02102230|20257328|P2|COMPLETED|Overall Study||11
8214382|NCT02102230|20257329|P1|COMPLETED|Overall Study||25
8214383|NCT02102230|20257327|P3|STARTED|Overall Study||41
8214384|NCT02102230|20257328|P2|STARTED|Overall Study||28
8214385|NCT02102230|20257329|P1|STARTED|Overall Study||42
8214386|NCT02102204|20257346|P1|NOT COMPLETED|Overall Study||304
8214387|NCT02102204|20257346|P1|COMPLETED|Overall Study||598
8214388|NCT02102204|20257346|P1|Received Etelcalcetide|Overall Study||884
8214389|NCT02102204|20257346|P1|STARTED|Overall Study||902
8214390|NCT02102100|20257357|P2|NOT COMPLETED|Overall Study||7
8214391|NCT02102100|20257358|P1|NOT COMPLETED|Overall Study||9
8214392|NCT02102100|20257357|P2|COMPLETED|Overall Study||18
8214393|NCT02102100|20257358|P1|COMPLETED|Overall Study||23
8214394|NCT02102100|20257357|P2|STARTED|Overall Study||25
8214395|NCT02102100|20257358|P1|STARTED|Overall Study||32
8214396|NCT02101983|20257366|P2|NOT COMPLETED|Overall Study||0
8214397|NCT02101983|20257367|P1|NOT COMPLETED|Overall Study||1
8214398|NCT02101983|20257366|P2|COMPLETED|Overall Study||6
8214399|NCT02101983|20257367|P1|COMPLETED|Overall Study||4
8214400|NCT02101983|20257366|P2|STARTED|Overall Study||6
8214401|NCT02101983|20257367|P1|STARTED|Overall Study||5
8214402|NCT02101918|20257377|P1|NOT COMPLETED|Overall Study||0
8214403|NCT02101918|20257377|P1|COMPLETED|Overall Study||22
8214404|NCT02101918|20257377|P1|STARTED|Overall Study||22
8214413|NCT02101554|20257413|P3|NOT COMPLETED|Overall Study||1
8214414|NCT02101554|20257414|P2|NOT COMPLETED|Overall Study||5
8214415|NCT02101554|20257415|P1|NOT COMPLETED|Overall Study||3
8214416|NCT02101554|20257413|P3|COMPLETED|Overall Study||2
8214417|NCT02101554|20257414|P2|COMPLETED|Overall Study||5
8214418|NCT02101554|20257415|P1|COMPLETED|Overall Study||3
8214419|NCT02101554|20257413|P3|STARTED|Overall Study||3
8214420|NCT02101554|20257414|P2|STARTED|Overall Study||10
8214421|NCT02101554|20257415|P1|STARTED|Overall Study||6
8214422|NCT02101515|20257497|P2|NOT COMPLETED|Overall Study||0
8214423|NCT02101515|20257498|P1|NOT COMPLETED|Overall Study||0
8214424|NCT02101515|20257497|P2|COMPLETED|Overall Study||41
8214425|NCT02101515|20257498|P1|COMPLETED|Overall Study||37
8214426|NCT02101515|20257497|P2|STARTED|Overall Study||41
8214427|NCT02101515|20257498|P1|STARTED|Overall Study||37
8214428|NCT02101437|20257540|P4|NOT COMPLETED|Overall Study||0
8214429|NCT02101437|20257541|P3|NOT COMPLETED|Overall Study||0
8214430|NCT02101437|20257542|P2|NOT COMPLETED|Overall Study||0
8214431|NCT02101437|20257543|P1|NOT COMPLETED|Overall Study||0
8214432|NCT02101437|20257540|P4|COMPLETED|Overall Study||49
8214433|NCT02101437|20257541|P3|COMPLETED|Overall Study||52
8214434|NCT02101437|20257542|P2|COMPLETED|Overall Study||54
8214435|NCT02101437|20257543|P1|COMPLETED|Overall Study||20
8214436|NCT02101437|20257540|P4|STARTED|Overall Study||49
8214437|NCT02101437|20257541|P3|STARTED|Overall Study||52
8214438|NCT02101437|20257542|P2|STARTED|Overall Study||54
8214439|NCT02101437|20257543|P1|STARTED|Overall Study||20
8214440|NCT02101411|20257556|P3|NOT COMPLETED|Overall Study||10
8214441|NCT02101411|20257557|P2|NOT COMPLETED|Overall Study||7
8214442|NCT02101411|20257558|P1|NOT COMPLETED|Overall Study||4
8214443|NCT02101411|20257556|P3|COMPLETED|Overall Study||104
8214444|NCT02101411|20257557|P2|COMPLETED|Overall Study||102
8214445|NCT02101411|20257558|P1|COMPLETED|Overall Study||107
8214446|NCT02101411|20257556|P3|STARTED|Overall Study||114
8214447|NCT02101411|20257557|P2|STARTED|Overall Study||109
8214448|NCT02101411|20257558|P1|STARTED|Overall Study||111
8214449|NCT02101359|20257568|P2|NOT COMPLETED|Overall Study||19
8214450|NCT02101359|20257569|P1|NOT COMPLETED|Overall Study||29
8214451|NCT02101359|20257568|P2|COMPLETED|Overall Study||277
8214452|NCT02101359|20257569|P1|COMPLETED|Overall Study||266
8214453|NCT02101359|20257568|P2|STARTED|Overall Study||296
8214454|NCT02101359|20257569|P1|STARTED|Overall Study||295
8214455|NCT02101294|20257575|P1|NOT COMPLETED|Overall Study||11
8214456|NCT02101294|20257575|P1|COMPLETED|Overall Study||20
8214457|NCT02101294|20257575|P1|STARTED|Overall Study||31
8214458|NCT02101281|20257584|P2|NOT COMPLETED|Overall Study||1
8214459|NCT02101281|20257585|P1|NOT COMPLETED|Overall Study||0
8214460|NCT02101281|20257584|P2|COMPLETED|Overall Study||19
8214461|NCT02101281|20257585|P1|COMPLETED|Overall Study||20
8214462|NCT02101281|20257584|P2|STARTED|Overall Study||20
8214463|NCT02101281|20257585|P1|STARTED|Overall Study||20
8214464|NCT02101190|20257627|P2|NOT COMPLETED|Overall Study||0
8214465|NCT02101190|20257628|P1|NOT COMPLETED|Overall Study||0
8214466|NCT02101190|20257627|P2|COMPLETED|Overall Study||8
8214467|NCT02101190|20257628|P1|COMPLETED|Overall Study||8
8214468|NCT02101190|20257627|P2|STARTED|Overall Study||8
8214469|NCT02101190|20257628|P1|STARTED|Overall Study||8
8214470|NCT02101112|20257638|P6|NOT COMPLETED|Overall Study||0
8214471|NCT02101112|20257639|P5|NOT COMPLETED|Overall Study||1
8214472|NCT02101112|20257640|P4|NOT COMPLETED|Overall Study||0
8214473|NCT02101112|20257641|P3|NOT COMPLETED|Overall Study||1
8214474|NCT02101112|20257642|P2|NOT COMPLETED|Overall Study||0
8214475|NCT02101112|20257643|P1|NOT COMPLETED|Overall Study||0
8214476|NCT02101112|20257638|P6|COMPLETED|Overall Study||5
8214477|NCT02101112|20257639|P5|COMPLETED|Overall Study||5
8214478|NCT02101112|20257640|P4|COMPLETED|Overall Study||5
8214479|NCT02101112|20257641|P3|COMPLETED|Overall Study||5
8214480|NCT02101112|20257642|P2|COMPLETED|Overall Study||5
8214481|NCT02101112|20257643|P1|COMPLETED|Overall Study||6
8214482|NCT02101112|20257638|P6|STARTED|Overall Study||5
8214483|NCT02101112|20257639|P5|STARTED|Overall Study||6
8214484|NCT02101112|20257640|P4|STARTED|Overall Study||5
8214485|NCT02101112|20257641|P3|STARTED|Overall Study||6
8214486|NCT02101112|20257642|P2|STARTED|Overall Study||5
8214487|NCT02101112|20257643|P1|STARTED|Overall Study||6
8214488|NCT02101021|20257673|P5|NOT COMPLETED|Overall Study||4
8214489|NCT02101021|20257674|P4|NOT COMPLETED|Overall Study||3
8214490|NCT02101021|20257675|P3|NOT COMPLETED|Overall Study||7
8214491|NCT02101021|20257676|P2|NOT COMPLETED|Overall Study||4
8214492|NCT02101021|20257677|P1|NOT COMPLETED|Overall Study||7
8214493|NCT02101021|20257673|P5|COMPLETED|Overall Study||0
8214494|NCT02101021|20257674|P4|COMPLETED|Overall Study||0
8214495|NCT02101021|20257675|P3|COMPLETED|Overall Study||0
8214496|NCT02101021|20257676|P2|COMPLETED|Overall Study||0
8214497|NCT02101021|20257677|P1|COMPLETED|Overall Study||0
8214498|NCT02101021|20257673|P5|STARTED|Overall Study||4
8214499|NCT02101021|20257674|P4|STARTED|Overall Study||3
8214500|NCT02101021|20257675|P3|STARTED|Overall Study||7
8214501|NCT02101021|20257676|P2|STARTED|Overall Study||4
8214502|NCT02101021|20257677|P1|STARTED|Overall Study||7
8214503|NCT02101008|20257719|P1|NOT COMPLETED|Overall Study||0
8214504|NCT02101008|20257719|P1|COMPLETED|Overall Study||12
8214505|NCT02101008|20257719|P1|STARTED|Overall Study||12
8214509|NCT02100930|20257736|P1|NOT COMPLETED|Overall Study||0
8214510|NCT02100930|20257736|P1|COMPLETED|Overall Study||69
8214511|NCT02100930|20257736|P1|STARTED|Overall Study||69
8214512|NCT02100839|20257743|P2|NOT COMPLETED|Multiple Ascending Dose||0
8214513|NCT02100839|20257744|P1|NOT COMPLETED|Multiple Ascending Dose||4
8214514|NCT02100839|20257743|P2|COMPLETED|Multiple Ascending Dose||3
8214515|NCT02100839|20257744|P1|COMPLETED|Multiple Ascending Dose||9
8214516|NCT02100839|20257743|P2|STARTED|Multiple Ascending Dose||3
8214517|NCT02100839|20257744|P1|STARTED|Multiple Ascending Dose||13
8214518|NCT02100839|20257743|P2|NOT COMPLETED|Single Ascending Dose||0
8214519|NCT02100839|20257744|P1|NOT COMPLETED|Single Ascending Dose||0
8214520|NCT02100839|20257743|P2|COMPLETED|Single Ascending Dose||12
8214521|NCT02100839|20257744|P1|COMPLETED|Single Ascending Dose||24
8214522|NCT02100839|20257743|P2|STARTED|Single Ascending Dose||12
8214523|NCT02100839|20257744|P1|STARTED|Single Ascending Dose||24
8214524|NCT02100826|20257756|P2|NOT COMPLETED|Period 2 (7 Days)||0
8214525|NCT02100826|20257757|P1|NOT COMPLETED|Period 2 (7 Days)||0
8214526|NCT02100826|20257756|P2|COMPLETED|Period 2 (7 Days)||14
8214527|NCT02100826|20257757|P1|COMPLETED|Period 2 (7 Days)||14
8214528|NCT02100826|20257756|P2|STARTED|Period 2 (7 Days)||14
8214529|NCT02100826|20257757|P1|STARTED|Period 2 (7 Days)||14
8214530|NCT02100826|20257756|P2|NOT COMPLETED|Washout Period (1 Day)||0
8214531|NCT02100826|20257757|P1|NOT COMPLETED|Washout Period (1 Day)||0
8214532|NCT02100826|20257756|P2|COMPLETED|Washout Period (1 Day)||14
8214533|NCT02100826|20257757|P1|COMPLETED|Washout Period (1 Day)||14
8214534|NCT02100826|20257756|P2|STARTED|Washout Period (1 Day)||14
8214535|NCT02100826|20257757|P1|STARTED|Washout Period (1 Day)||14
8214536|NCT02100826|20257756|P2|NOT COMPLETED|Period 1 (7 Days)||0
8214537|NCT02100826|20257757|P1|NOT COMPLETED|Period 1 (7 Days)||0
8214538|NCT02100826|20257756|P2|COMPLETED|Period 1 (7 Days)||14
8214539|NCT02100826|20257757|P1|COMPLETED|Period 1 (7 Days)||14
8214540|NCT02100826|20257756|P2|STARTED|Period 1 (7 Days)||14
8214541|NCT02100826|20257757|P1|STARTED|Period 1 (7 Days)||14
8214542|NCT02100813|20257775|P8|NOT COMPLETED|Overall Study||1
8214543|NCT02100813|20257776|P7|NOT COMPLETED|Overall Study||0
8214544|NCT02100813|20257777|P6|NOT COMPLETED|Overall Study||0
8214545|NCT02100813|20257778|P5|NOT COMPLETED|Overall Study||0
8214546|NCT02100813|20257779|P4|NOT COMPLETED|Overall Study||0
8214547|NCT02100813|20257780|P3|NOT COMPLETED|Overall Study||0
8214548|NCT02100813|20257781|P2|NOT COMPLETED|Overall Study||0
8214549|NCT02100813|20257782|P1|NOT COMPLETED|Overall Study||0
8214550|NCT02100813|20257775|P8|COMPLETED|Overall Study||66
8214551|NCT02100813|20257776|P7|COMPLETED|Overall Study||64
8214552|NCT02100813|20257777|P6|COMPLETED|Overall Study||32
8214553|NCT02100813|20257778|P5|COMPLETED|Overall Study||12
8214554|NCT02100813|20257779|P4|COMPLETED|Overall Study||12
8214555|NCT02100813|20257780|P3|COMPLETED|Overall Study||12
8214556|NCT02100813|20257781|P2|COMPLETED|Overall Study||11
8214557|NCT02100813|20257782|P1|COMPLETED|Overall Study||10
8214558|NCT02100813|20257775|P8|STARTED|Overall Study||67
8214559|NCT02100813|20257776|P7|STARTED|Overall Study||64
8214560|NCT02100813|20257777|P6|STARTED|Overall Study||32
8214561|NCT02100813|20257778|P5|STARTED|Overall Study||12
8214562|NCT02100813|20257779|P4|STARTED|Overall Study||12
8214563|NCT02100813|20257780|P3|STARTED|Overall Study||12
8214564|NCT02100813|20257781|P2|STARTED|Overall Study||11
8214565|NCT02100813|20257782|P1|STARTED|Overall Study||10
8214566|NCT02100748|20257818|P12|NOT COMPLETED|Overall Study||0
8214567|NCT02100748|20257819|P11|NOT COMPLETED|Overall Study||2
8214568|NCT02100748|20257820|P10|NOT COMPLETED|Overall Study||2
8214569|NCT02100748|20257821|P9|NOT COMPLETED|Overall Study||3
8214570|NCT02100748|20257822|P8|NOT COMPLETED|Overall Study||4
8214571|NCT02100748|20257823|P7|NOT COMPLETED|Overall Study||2
8214572|NCT02100748|20257824|P6|NOT COMPLETED|Overall Study||0
8214573|NCT02100748|20257825|P5|NOT COMPLETED|Overall Study||2
8214574|NCT02100748|20257826|P4|NOT COMPLETED|Overall Study||1
8214575|NCT02100748|20257827|P3|NOT COMPLETED|Overall Study||1
8214576|NCT02100748|20257828|P2|NOT COMPLETED|Overall Study||1
8214577|NCT02100748|20257829|P1|NOT COMPLETED|Overall Study||2
8214578|NCT02100748|20257818|P12|COMPLETED|Overall Study||39
8214579|NCT02100748|20257819|P11|COMPLETED|Overall Study||26
8214580|NCT02100748|20257820|P10|COMPLETED|Overall Study||29
8214581|NCT02100748|20257821|P9|COMPLETED|Overall Study||33
8214582|NCT02100748|20257822|P8|COMPLETED|Overall Study||34
8214583|NCT02100748|20257823|P7|COMPLETED|Overall Study||18
8214584|NCT02100748|20257824|P6|COMPLETED|Overall Study||23
8214585|NCT02100748|20257825|P5|COMPLETED|Overall Study||23
8214586|NCT02100748|20257826|P4|COMPLETED|Overall Study||21
8214587|NCT02100748|20257827|P3|COMPLETED|Overall Study||21
8214588|NCT02100748|20257828|P2|COMPLETED|Overall Study||23
8214589|NCT02100748|20257829|P1|COMPLETED|Overall Study||23
8214590|NCT02100748|20257818|P12|STARTED|Overall Study||39
8214591|NCT02100748|20257819|P11|STARTED|Overall Study||28
8214592|NCT02100748|20257820|P10|STARTED|Overall Study||31
8214593|NCT02100748|20257821|P9|STARTED|Overall Study||36
8214594|NCT02100748|20257822|P8|STARTED|Overall Study||38
8214595|NCT02100748|20257823|P7|STARTED|Overall Study||20
8214596|NCT02100748|20257824|P6|STARTED|Overall Study||23
8214597|NCT02100748|20257825|P5|STARTED|Overall Study||25
8214598|NCT02100748|20257826|P4|STARTED|Overall Study||22
8214599|NCT02100748|20257827|P3|STARTED|Overall Study||22
8214600|NCT02100748|20257828|P2|STARTED|Overall Study||24
8214601|NCT02100748|20257829|P1|STARTED|Overall Study||25
8214602|NCT02100670|20257859|P4|NOT COMPLETED|Overall Study||1
8214603|NCT02100670|20257860|P3|NOT COMPLETED|Overall Study||4
8214604|NCT02100670|20257861|P2|NOT COMPLETED|Overall Study||7
8214605|NCT02100670|20257862|P1|NOT COMPLETED|Overall Study||13
8214606|NCT02100670|20257859|P4|COMPLETED|Overall Study||75
8214607|NCT02100670|20257860|P3|COMPLETED|Overall Study||74
8214608|NCT02100670|20257861|P2|COMPLETED|Overall Study||106
8214609|NCT02100670|20257862|P1|COMPLETED|Overall Study||105
8214610|NCT02100670|20257859|P4|STARTED|Overall Study||76
8214611|NCT02100670|20257860|P3|STARTED|Overall Study||78
8214612|NCT02100670|20257861|P2|STARTED|Overall Study||113
8214613|NCT02100670|20257862|P1|STARTED|Overall Study||118
8214614|NCT02100657|20257925|P3|NOT COMPLETED|Cohort 3: Dose Level 3||27
8214615|NCT02100657|20257926|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
8214616|NCT02100657|20257927|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
8214617|NCT02100657|20257925|P3|COMPLETED|Cohort 3: Dose Level 3||0
8214618|NCT02100657|20257926|P2|COMPLETED|Cohort 3: Dose Level 3||0
8214619|NCT02100657|20257927|P1|COMPLETED|Cohort 3: Dose Level 3||0
8214620|NCT02100657|20257925|P3|STARTED|Cohort 3: Dose Level 3||27
8214621|NCT02100657|20257926|P2|STARTED|Cohort 3: Dose Level 3||0
8214622|NCT02100657|20257927|P1|STARTED|Cohort 3: Dose Level 3||0
8214623|NCT02100657|20257925|P3|NOT COMPLETED|Cohort 2: Dose Level 2||0
8214624|NCT02100657|20257926|P2|NOT COMPLETED|Cohort 2: Dose Level 2||4
8214625|NCT02100657|20257927|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
8214626|NCT02100657|20257925|P3|COMPLETED|Cohort 2: Dose Level 2||0
8214627|NCT02100657|20257926|P2|COMPLETED|Cohort 2: Dose Level 2||0
8214628|NCT02100657|20257927|P1|COMPLETED|Cohort 2: Dose Level 2||0
8214629|NCT02100657|20257925|P3|STARTED|Cohort 2: Dose Level 2||0
8214630|NCT02100657|20257926|P2|STARTED|Cohort 2: Dose Level 2||4
8214631|NCT02100657|20257927|P1|STARTED|Cohort 2: Dose Level 2||0
8214632|NCT02100657|20257925|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
8214633|NCT02100657|20257926|P2|NOT COMPLETED|Cohort 1: Dose Level 1||0
8214634|NCT02100657|20257927|P1|NOT COMPLETED|Cohort 1: Dose Level 1||8
8214635|NCT02100657|20257925|P3|COMPLETED|Cohort 1: Dose Level 1||0
8214636|NCT02100657|20257926|P2|COMPLETED|Cohort 1: Dose Level 1||0
8214637|NCT02100657|20257927|P1|COMPLETED|Cohort 1: Dose Level 1||0
8214638|NCT02100657|20257925|P3|STARTED|Cohort 1: Dose Level 1||0
8214639|NCT02100657|20257926|P2|STARTED|Cohort 1: Dose Level 1||0
8214640|NCT02100657|20257927|P1|STARTED|Cohort 1: Dose Level 1||8
8214641|NCT02100644|20257965|P3|NOT COMPLETED|LTG and VPA Maintenance Phase||0
8214642|NCT02100644|20257966|P2|NOT COMPLETED|LTG and VPA Maintenance Phase||0
8214643|NCT02100644|20257967|P1|NOT COMPLETED|LTG and VPA Maintenance Phase||0
8214644|NCT02100644|20257965|P3|COMPLETED|LTG and VPA Maintenance Phase||20
8214645|NCT02100644|20257966|P2|COMPLETED|LTG and VPA Maintenance Phase||0
8214646|NCT02100644|20257967|P1|COMPLETED|LTG and VPA Maintenance Phase||0
8214647|NCT02100644|20257965|P3|STARTED|LTG and VPA Maintenance Phase||20
8214648|NCT02100644|20257966|P2|STARTED|LTG and VPA Maintenance Phase||0
8214649|NCT02100644|20257967|P1|STARTED|LTG and VPA Maintenance Phase||0
8214650|NCT02100644|20257965|P3|NOT COMPLETED|VPA Reduction Phase||0
8214651|NCT02100644|20257966|P2|NOT COMPLETED|VPA Reduction Phase||0
8214652|NCT02100644|20257967|P1|NOT COMPLETED|VPA Reduction Phase||0
8214653|NCT02100644|20257965|P3|COMPLETED|VPA Reduction Phase||0
8214654|NCT02100644|20257966|P2|COMPLETED|VPA Reduction Phase||20
8214655|NCT02100644|20257967|P1|COMPLETED|VPA Reduction Phase||0
8214656|NCT02100644|20257965|P3|STARTED|VPA Reduction Phase||0
8214657|NCT02100644|20257966|P2|STARTED|VPA Reduction Phase||20
8214658|NCT02100644|20257967|P1|STARTED|VPA Reduction Phase||0
8214659|NCT02100644|20257965|P3|NOT COMPLETED|LTG Escalation Phase||0
8214660|NCT02100644|20257966|P2|NOT COMPLETED|LTG Escalation Phase||0
8214661|NCT02100644|20257967|P1|NOT COMPLETED|LTG Escalation Phase||13
8214662|NCT02100644|20257965|P3|COMPLETED|LTG Escalation Phase||0
8214663|NCT02100644|20257966|P2|COMPLETED|LTG Escalation Phase||0
8214664|NCT02100644|20257967|P1|COMPLETED|LTG Escalation Phase||20
8214665|NCT02100644|20257965|P3|STARTED|LTG Escalation Phase||0
8214666|NCT02100644|20257966|P2|STARTED|LTG Escalation Phase||0
8214667|NCT02100644|20257967|P1|STARTED|LTG Escalation Phase||33
8214668|NCT02100579|20257979|P2|NOT COMPLETED|Overall Study||0
8214669|NCT02100579|20257980|P1|NOT COMPLETED|Overall Study||0
8214670|NCT02100579|20257979|P2|COMPLETED|Overall Study||20
8214671|NCT02100579|20257980|P1|COMPLETED|Overall Study||20
8214672|NCT02100579|20257979|P2|STARTED|Overall Study||20
8214673|NCT02100579|20257980|P1|STARTED|Overall Study||20
8214674|NCT02100514|20257992|P5|NOT COMPLETED|Extension Period||0
8214675|NCT02100514|20257993|P4|NOT COMPLETED|Extension Period||0
8214676|NCT02100514|20257994|P3|NOT COMPLETED|Extension Period||2
8214677|NCT02100514|20257995|P2|NOT COMPLETED|Extension Period||0
8214678|NCT02100514|20257996|P1|NOT COMPLETED|Extension Period||0
8214679|NCT02100514|20257992|P5|COMPLETED|Extension Period||56
8214680|NCT02100514|20257993|P4|COMPLETED|Extension Period||33
8214681|NCT02100514|20257994|P3|COMPLETED|Extension Period||42
8214682|NCT02100514|20257995|P2|COMPLETED|Extension Period||0
8214683|NCT02100514|20257996|P1|COMPLETED|Extension Period||0
8214684|NCT02100514|20257992|P5|STARTED|Extension Period||56
8214685|NCT02100514|20257993|P4|STARTED|Extension Period||33
8214686|NCT02100514|20257994|P3|STARTED|Extension Period||44
8214687|NCT02100514|20257995|P2|STARTED|Extension Period||0
8214688|NCT02100514|20257996|P1|STARTED|Extension Period||0
8214689|NCT02100514|20257992|P5|NOT COMPLETED|Treatment Period||0
8214690|NCT02100514|20257993|P4|NOT COMPLETED|Treatment Period||0
8214691|NCT02100514|20257994|P3|NOT COMPLETED|Treatment Period||0
8214692|NCT02100514|20257995|P2|NOT COMPLETED|Treatment Period||74
8214693|NCT02100514|20257996|P1|NOT COMPLETED|Treatment Period||29
8214694|NCT02100514|20257992|P5|COMPLETED|Treatment Period||0
8214695|NCT02100514|20257993|P4|COMPLETED|Treatment Period||0
8214696|NCT02100514|20257994|P3|COMPLETED|Treatment Period||0
8214697|NCT02100514|20257995|P2|COMPLETED|Treatment Period||425
8214698|NCT02100514|20257996|P1|COMPLETED|Treatment Period||218
8214699|NCT02100514|20257992|P5|STARTED|Treatment Period||0
8214700|NCT02100514|20257993|P4|STARTED|Treatment Period||0
8214701|NCT02100514|20257994|P3|STARTED|Treatment Period||0
8214702|NCT02100514|20257995|P2|STARTED|Treatment Period||499
8214703|NCT02100514|20257996|P1|STARTED|Treatment Period||247
8214704|NCT02100475|20258064|P2|NOT COMPLETED|Overall Study||2
8214705|NCT02100475|20258065|P1|NOT COMPLETED|Overall Study||2
8214706|NCT02100475|20258064|P2|COMPLETED|Overall Study||13
8214707|NCT02100475|20258065|P1|COMPLETED|Overall Study||14
8214708|NCT02100475|20258064|P2|STARTED|Overall Study||15
8214709|NCT02100475|20258065|P1|STARTED|Overall Study||16
8214710|NCT02100410|20258075|P6|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8214711|NCT02100410|20258076|P5|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8214712|NCT02100410|20258077|P4|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8214713|NCT02100410|20258078|P3|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8214714|NCT02100410|20258079|P2|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8214715|NCT02100410|20258080|P1|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
8214716|NCT02100410|20258075|P6|COMPLETED|Exposure Pair 3, 30 Minutes||9
8214717|NCT02100410|20258076|P5|COMPLETED|Exposure Pair 3, 30 Minutes||8
8214718|NCT02100410|20258077|P4|COMPLETED|Exposure Pair 3, 30 Minutes||8
8214719|NCT02100410|20258078|P3|COMPLETED|Exposure Pair 3, 30 Minutes||8
8214720|NCT02100410|20258079|P2|COMPLETED|Exposure Pair 3, 30 Minutes||8
8214721|NCT02100410|20258080|P1|COMPLETED|Exposure Pair 3, 30 Minutes||8
8214722|NCT02100410|20258075|P6|STARTED|Exposure Pair 3, 30 Minutes||9
8214723|NCT02100410|20258076|P5|STARTED|Exposure Pair 3, 30 Minutes||8
8214724|NCT02100410|20258077|P4|STARTED|Exposure Pair 3, 30 Minutes||8
8214725|NCT02100410|20258078|P3|STARTED|Exposure Pair 3, 30 Minutes||8
8214726|NCT02100410|20258079|P2|STARTED|Exposure Pair 3, 30 Minutes||8
8214727|NCT02100410|20258080|P1|STARTED|Exposure Pair 3, 30 Minutes||8
8214728|NCT02100410|20258075|P6|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8214729|NCT02100410|20258076|P5|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8214730|NCT02100410|20258077|P4|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8214731|NCT02100410|20258078|P3|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8214732|NCT02100410|20258079|P2|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8214733|NCT02100410|20258080|P1|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
8214734|NCT02100410|20258075|P6|COMPLETED|Exposure Pair 2, 30 Minutes||9
8214735|NCT02100410|20258076|P5|COMPLETED|Exposure Pair 2, 30 Minutes||8
8214736|NCT02100410|20258077|P4|COMPLETED|Exposure Pair 2, 30 Minutes||8
8214737|NCT02100410|20258078|P3|COMPLETED|Exposure Pair 2, 30 Minutes||8
8214738|NCT02100410|20258079|P2|COMPLETED|Exposure Pair 2, 30 Minutes||8
8214739|NCT02100410|20258080|P1|COMPLETED|Exposure Pair 2, 30 Minutes||8
8214740|NCT02100410|20258075|P6|STARTED|Exposure Pair 2, 30 Minutes||9
8214741|NCT02100410|20258076|P5|STARTED|Exposure Pair 2, 30 Minutes||8
8214742|NCT02100410|20258077|P4|STARTED|Exposure Pair 2, 30 Minutes||8
8214743|NCT02100410|20258078|P3|STARTED|Exposure Pair 2, 30 Minutes||8
8214744|NCT02100410|20258079|P2|STARTED|Exposure Pair 2, 30 Minutes||8
8214745|NCT02100410|20258080|P1|STARTED|Exposure Pair 2, 30 Minutes||8
8214746|NCT02100410|20258075|P6|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8214747|NCT02100410|20258076|P5|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8214748|NCT02100410|20258077|P4|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8214749|NCT02100410|20258078|P3|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8214750|NCT02100410|20258079|P2|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8214751|NCT02100410|20258080|P1|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
8214752|NCT02100410|20258075|P6|COMPLETED|Exposure Pair 1, 30 Minutes||9
8214753|NCT02100410|20258076|P5|COMPLETED|Exposure Pair 1, 30 Minutes||8
8214754|NCT02100410|20258077|P4|COMPLETED|Exposure Pair 1, 30 Minutes||8
8214755|NCT02100410|20258078|P3|COMPLETED|Exposure Pair 1, 30 Minutes||8
8214756|NCT02100410|20258079|P2|COMPLETED|Exposure Pair 1, 30 Minutes||8
8214757|NCT02100410|20258080|P1|COMPLETED|Exposure Pair 1, 30 Minutes||8
8214758|NCT02100410|20258075|P6|STARTED|Exposure Pair 1, 30 Minutes||9
8214759|NCT02100410|20258076|P5|STARTED|Exposure Pair 1, 30 Minutes||8
8214760|NCT02100410|20258077|P4|STARTED|Exposure Pair 1, 30 Minutes||8
8214761|NCT02100410|20258078|P3|STARTED|Exposure Pair 1, 30 Minutes||8
8214762|NCT02100410|20258079|P2|STARTED|Exposure Pair 1, 30 Minutes||8
8214763|NCT02100410|20258080|P1|STARTED|Exposure Pair 1, 30 Minutes||8
8214764|NCT02100319|20258096|P1|NOT COMPLETED|Overall Study||16
8214765|NCT02100319|20258096|P1|COMPLETED|Overall Study||371
8214766|NCT02100319|20258096|P1|STARTED|Overall Study||387
8214767|NCT02100280|20258107|P2|NOT COMPLETED|Overall Study||4
8214768|NCT02100280|20258108|P1|NOT COMPLETED|Overall Study||4
8214769|NCT02100280|20258107|P2|COMPLETED|Overall Study||44
8214770|NCT02100280|20258108|P1|COMPLETED|Overall Study||44
8214771|NCT02100280|20258107|P2|STARTED|Overall Study||48
8214772|NCT02100280|20258108|P1|STARTED|Overall Study||48
8214773|NCT02100228|20258124|P2|NOT COMPLETED|Overall Study||90
8214774|NCT02100228|20258125|P1|NOT COMPLETED|Overall Study||75
8214775|NCT02100228|20258124|P2|COMPLETED|Overall Study||657
8214776|NCT02100228|20258125|P1|COMPLETED|Overall Study||678
8214777|NCT02100228|20258124|P2|STARTED|Overall Study|721 treated with Usual Care|747
8214778|NCT02100228|20258125|P1|STARTED|Overall Study|735 treated with Apixaban|753
8214779|NCT02100189|20258151|P1|NOT COMPLETED|Overall Study||0
8214780|NCT02100189|20258151|P1|COMPLETED|Overall Study||50
8214781|NCT02100189|20258151|P1|STARTED|Overall Study||50
8214782|NCT02100124|20258161|P3|NOT COMPLETED|Overall Study||3
8214783|NCT02100124|20258162|P2|NOT COMPLETED|Overall Study||11
8214784|NCT02100124|20258163|P1|NOT COMPLETED|Overall Study||6
8214785|NCT02100124|20258161|P3|COMPLETED|Overall Study||323
8214786|NCT02100124|20258162|P2|COMPLETED|Overall Study||318
8214787|NCT02100124|20258163|P1|COMPLETED|Overall Study||323
8214788|NCT02100124|20258161|P3|STARTED|Overall Study||326
8214789|NCT02100124|20258162|P2|STARTED|Overall Study||329
8214790|NCT02100124|20258163|P1|STARTED|Overall Study||329
8214791|NCT02100072|20258180|P1|NOT COMPLETED|Overall Study||0
8214792|NCT02100072|20258180|P1|COMPLETED|Overall Study||5
8214793|NCT02100072|20258180|P1|STARTED|Overall Study||5
8214794|NCT02100007|20258184|P1|NOT COMPLETED|Overall Study||0
8214795|NCT02100007|20258184|P1|COMPLETED|Overall Study||46
8214796|NCT02100007|20258184|P1|STARTED|Overall Study||46
8214800|NCT02099838|20258220|P2|NOT COMPLETED|Overall Study||2
8214801|NCT02099838|20258221|P1|NOT COMPLETED|Overall Study||4
8214802|NCT02099838|20258220|P2|COMPLETED|Overall Study||49
8214803|NCT02099838|20258221|P1|COMPLETED|Overall Study||43
8214804|NCT02099838|20258220|P2|STARTED|Overall Study||51
8214805|NCT02099838|20258221|P1|STARTED|Overall Study||47
8214806|NCT02099799|20258253|P2|NOT COMPLETED|Overall Study||24
8214807|NCT02099799|20258254|P1|NOT COMPLETED|Overall Study||15
8214808|NCT02099799|20258253|P2|COMPLETED|Overall Study||54
8214809|NCT02099799|20258254|P1|COMPLETED|Overall Study||60
8214810|NCT02099799|20258253|P2|STARTED|Overall Study||78
8214811|NCT02099799|20258254|P1|STARTED|Overall Study||75
8214812|NCT02099786|20258268|P2|NOT COMPLETED|Overall Study||8
8214813|NCT02099786|20258269|P1|NOT COMPLETED|Overall Study||3
8214814|NCT02099786|20258268|P2|COMPLETED|Overall Study||15
8214815|NCT02099786|20258269|P1|COMPLETED|Overall Study||21
8214816|NCT02099786|20258268|P2|Program Eval 3|Overall Study|One year post randomization|15
8214817|NCT02099786|20258269|P1|Program Eval 3|Overall Study|One year post randomization|21
8214818|NCT02099786|20258268|P2|Program Eval 2|Overall Study|One month post randomization|19
8214819|NCT02099786|20258269|P1|Program Eval 2|Overall Study|One month post randomization|23
8214820|NCT02099786|20258268|P2|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23
8214821|NCT02099786|20258269|P1|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24
8214822|NCT02099786|20258268|P2|STARTED|Overall Study||23
8214823|NCT02099786|20258269|P1|STARTED|Overall Study||24
8214824|NCT02099721|20258287|P6|NOT COMPLETED|Overall Study||20
8214825|NCT02099721|20258288|P5|NOT COMPLETED|Overall Study||27
8214826|NCT02099721|20258289|P4|NOT COMPLETED|Overall Study||71
8214827|NCT02099721|20258290|P3|NOT COMPLETED|Overall Study||85
8214828|NCT02099721|20258291|P2|NOT COMPLETED|Overall Study||127
8214829|NCT02099721|20258292|P1|NOT COMPLETED|Overall Study||76
8214830|NCT02099721|20258287|P6|COMPLETED|Overall Study||432
8214831|NCT02099721|20258288|P5|COMPLETED|Overall Study||304
8214832|NCT02099721|20258289|P4|COMPLETED|Overall Study||774
8214833|NCT02099721|20258290|P3|COMPLETED|Overall Study||983
8214834|NCT02099721|20258291|P2|COMPLETED|Overall Study|Not implanted secondary patients were automatically exited.|0
8214835|NCT02099721|20258292|P1|COMPLETED|Overall Study||990
8214836|NCT02099721|20258287|P6|STARTED|Overall Study||452
8214837|NCT02099721|20258288|P5|STARTED|Overall Study||331
8214838|NCT02099721|20258289|P4|STARTED|Overall Study||845
8214839|NCT02099721|20258290|P3|STARTED|Overall Study||1068
8214840|NCT02099721|20258291|P2|STARTED|Overall Study||127
8214841|NCT02099721|20258292|P1|STARTED|Overall Study||1066
8214842|NCT02099708|20258304|P1|NOT COMPLETED|Overall Study||200
8214843|NCT02099708|20258304|P1|COMPLETED|Overall Study||3302
8214844|NCT02099708|20258304|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
8214845|NCT02099708|20258304|P1|STARTED|Overall Study|Number of cases.|3502
8214846|NCT02099682|20258315|P1|NOT COMPLETED|Overall Study||111
8214847|NCT02099682|20258315|P1|COMPLETED|Overall Study||3255
8214848|NCT02099682|20258315|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
8214849|NCT02099682|20258315|P1|STARTED|Overall Study|Number of cases.|3366
8214850|NCT02099461|20258329|P3|NOT COMPLETED|Overall Study||0
8214851|NCT02099461|20258330|P2|NOT COMPLETED|Overall Study||0
8214852|NCT02099461|20258331|P1|NOT COMPLETED|Overall Study||0
8214853|NCT02099461|20258329|P3|COMPLETED|Overall Study||28
8214854|NCT02099461|20258330|P2|COMPLETED|Overall Study||27
8214855|NCT02099461|20258331|P1|COMPLETED|Overall Study||27
8214856|NCT02099461|20258329|P3|STARTED|Overall Study||28
8214857|NCT02099461|20258330|P2|STARTED|Overall Study||27
8214858|NCT02099461|20258331|P1|STARTED|Overall Study||27
8214859|NCT02099344|20258341|P2|NOT COMPLETED|Overall Study||0
8214860|NCT02099344|20258342|P1|NOT COMPLETED|Overall Study||1
8214861|NCT02099344|20258341|P2|COMPLETED|Overall Study||0
8214862|NCT02099344|20258342|P1|COMPLETED|Overall Study||0
8214863|NCT02099344|20258341|P2|STARTED|Overall Study||0
8214864|NCT02099344|20258342|P1|STARTED|Overall Study||1
8214865|NCT02099318|20258352|P2|NOT COMPLETED|Overall Study||0
8214866|NCT02099318|20258353|P1|NOT COMPLETED|Overall Study||0
8214867|NCT02099318|20258352|P2|COMPLETED|Overall Study||20
8214868|NCT02099318|20258353|P1|COMPLETED|Overall Study||20
8214869|NCT02099318|20258352|P2|STARTED|Overall Study||20
8214870|NCT02099318|20258353|P1|STARTED|Overall Study||20
8214871|NCT02099266|20258367|P1|NOT COMPLETED|Overall Study||0
8214872|NCT02099266|20258367|P1|COMPLETED|Overall Study||15
8214873|NCT02099266|20258367|P1|STARTED|Overall Study||15
8214874|NCT02099110|20258379|P5|NOT COMPLETED|Overall Study||27
8214875|NCT02099110|20258380|P4|NOT COMPLETED|Overall Study||22
8214876|NCT02099110|20258381|P3|NOT COMPLETED|Overall Study||28
8214877|NCT02099110|20258382|P2|NOT COMPLETED|Overall Study||31
8214878|NCT02099110|20258383|P1|NOT COMPLETED|Overall Study||24
8214879|NCT02099110|20258379|P5|COMPLETED|Overall Study||218
8214880|NCT02099110|20258380|P4|COMPLETED|Overall Study||221
8214881|NCT02099110|20258381|P3|COMPLETED|Overall Study||219
8214882|NCT02099110|20258382|P2|COMPLETED|Overall Study||217
8214883|NCT02099110|20258383|P1|COMPLETED|Overall Study||226
8214884|NCT02099110|20258379|P5|Treated|Overall Study||244
8214885|NCT02099110|20258380|P4|Treated|Overall Study||243
8214886|NCT02099110|20258381|P3|Treated|Overall Study||247
8214887|NCT02099110|20258382|P2|Treated|Overall Study||248
8214888|NCT02099110|20258383|P1|Treated|Overall Study||250
8214889|NCT02099110|20258379|P5|STARTED|Overall Study||245
8214890|NCT02099110|20258380|P4|STARTED|Overall Study||243
8214891|NCT02099110|20258381|P3|STARTED|Overall Study||247
8214892|NCT02099110|20258382|P2|STARTED|Overall Study||248
8214893|NCT02099110|20258383|P1|STARTED|Overall Study||250
8214894|NCT02099084|20258430|P2|NOT COMPLETED|Second Intervention||0
8214895|NCT02099084|20258431|P1|NOT COMPLETED|Second Intervention||0
8214896|NCT02099084|20258430|P2|COMPLETED|Second Intervention||4
8214897|NCT02099084|20258431|P1|COMPLETED|Second Intervention||4
8214898|NCT02099084|20258430|P2|STARTED|Second Intervention||4
8214899|NCT02099084|20258431|P1|STARTED|Second Intervention||4
8214900|NCT02099084|20258430|P2|NOT COMPLETED|Washout Period of 14 Days||0
8214901|NCT02099084|20258431|P1|NOT COMPLETED|Washout Period of 14 Days||0
8214902|NCT02099084|20258430|P2|COMPLETED|Washout Period of 14 Days||4
8214903|NCT02099084|20258431|P1|COMPLETED|Washout Period of 14 Days||4
8214904|NCT02099084|20258430|P2|STARTED|Washout Period of 14 Days||4
8214905|NCT02099084|20258431|P1|STARTED|Washout Period of 14 Days||4
8214906|NCT02099084|20258430|P2|NOT COMPLETED|First Intervention||0
8214907|NCT02099084|20258431|P1|NOT COMPLETED|First Intervention||0
8214908|NCT02099084|20258430|P2|COMPLETED|First Intervention||4
8214909|NCT02099084|20258431|P1|COMPLETED|First Intervention||4
8214910|NCT02099084|20258430|P2|STARTED|First Intervention||4
8214911|NCT02099084|20258431|P1|STARTED|First Intervention||4
8214912|NCT02099006|20258449|P1|NOT COMPLETED|Overall Study||1
8214913|NCT02099006|20258449|P1|COMPLETED|Overall Study||8
8214914|NCT02099006|20258449|P1|Received Gabapentin|Overall Study||8
8214915|NCT02099006|20258449|P1|Received Ketamine|Overall Study||6
8214916|NCT02099006|20258449|P1|Received Loperamide|Overall Study||7
8214917|NCT02099006|20258449|P1|Received Ketoprofen|Overall Study||3
8214918|NCT02099006|20258449|P1|Received Amitriptyline/ Baclofen|Overall Study||7
8214919|NCT02099006|20258449|P1|Received Placebo|Overall Study||9
8214920|NCT02099006|20258449|P1|STARTED|Overall Study||9
8214921|NCT02098993|20258459|P2|NOT COMPLETED|Overall Study||0
8214922|NCT02098993|20258460|P1|NOT COMPLETED|Overall Study||0
8214923|NCT02098993|20258459|P2|COMPLETED|Overall Study||3
8214924|NCT02098993|20258460|P1|COMPLETED|Overall Study||4
8214925|NCT02098993|20258459|P2|STARTED|Overall Study||3
8214926|NCT02098993|20258460|P1|STARTED|Overall Study||4
8214927|NCT02098746|20258484|P1|NOT COMPLETED|Overall Study||5
8214928|NCT02098746|20258484|P1|COMPLETED|Overall Study||289
8214929|NCT02098746|20258484|P1|STARTED|Overall Study||294
8214930|NCT02098733|20258492|P1|NOT COMPLETED|Overall Study||10
8214931|NCT02098733|20258492|P1|COMPLETED|Overall Study||1158
8214932|NCT02098733|20258492|P1|STARTED|Overall Study||1168
8214933|NCT02098395|20258506|P4|NOT COMPLETED|Overall Study||27
8214934|NCT02098395|20258507|P3|NOT COMPLETED|Overall Study||42
8214935|NCT02098395|20258508|P2|NOT COMPLETED|Overall Study||32
8214936|NCT02098395|20258509|P1|NOT COMPLETED|Overall Study||26
8214937|NCT02098395|20258506|P4|COMPLETED|Overall Study||180
8214938|NCT02098395|20258507|P3|COMPLETED|Overall Study||165
8214939|NCT02098395|20258508|P2|COMPLETED|Overall Study||177
8214940|NCT02098395|20258509|P1|COMPLETED|Overall Study||186
8214941|NCT02098395|20258506|P4|Exposed|Overall Study||206
8214942|NCT02098395|20258507|P3|Exposed|Overall Study||206
8214943|NCT02098395|20258508|P2|Exposed|Overall Study||209
8214944|NCT02098395|20258509|P1|Exposed|Overall Study||211
8214945|NCT02098395|20258506|P4|STARTED|Overall Study||207
8214946|NCT02098395|20258507|P3|STARTED|Overall Study||207
8214947|NCT02098395|20258508|P2|STARTED|Overall Study||209
8214948|NCT02098395|20258509|P1|STARTED|Overall Study||212
8214949|NCT02098369|20258530|P3|NOT COMPLETED|Overall Study||5
8214950|NCT02098369|20258531|P2|NOT COMPLETED|Overall Study||9
8214951|NCT02098369|20258532|P1|NOT COMPLETED|Overall Study||7
8214952|NCT02098369|20258530|P3|COMPLETED|Overall Study||143
8214953|NCT02098369|20258531|P2|COMPLETED|Overall Study||145
8214954|NCT02098369|20258532|P1|COMPLETED|Overall Study||135
8214955|NCT02098369|20258530|P3|STARTED|Overall Study||148
8214956|NCT02098369|20258531|P2|STARTED|Overall Study||154
8214957|NCT02098369|20258532|P1|STARTED|Overall Study||142
8214958|NCT02098304|20258561|P1|NOT COMPLETED|Overall Study||0
8214959|NCT02098304|20258561|P1|COMPLETED|Overall Study||42
8214960|NCT02098304|20258561|P1|STARTED|Overall Study||42
8214961|NCT02098109|20258570|P2|NOT COMPLETED|Overall Study||0
8214962|NCT02098109|20258571|P1|NOT COMPLETED|Overall Study||3
8214963|NCT02098109|20258570|P2|COMPLETED|Overall Study||51
8214964|NCT02098109|20258571|P1|COMPLETED|Overall Study||46
8214965|NCT02098109|20258570|P2|STARTED|Overall Study||51
8214966|NCT02098109|20258571|P1|STARTED|Overall Study||49
8214967|NCT02097992|20258597|P4|NOT COMPLETED|Treatment 3 (4 Weeks)||0
8214968|NCT02097992|20258598|P3|NOT COMPLETED|Treatment 3 (4 Weeks)||0
8214969|NCT02097992|20258599|P2|NOT COMPLETED|Treatment 3 (4 Weeks)||0
8214970|NCT02097992|20258600|P1|NOT COMPLETED|Treatment 3 (4 Weeks)||0
8214971|NCT02097992|20258597|P4|COMPLETED|Treatment 3 (4 Weeks)||2
8214972|NCT02097992|20258598|P3|COMPLETED|Treatment 3 (4 Weeks)||4
8214973|NCT02097992|20258599|P2|COMPLETED|Treatment 3 (4 Weeks)||3
8214974|NCT02097992|20258600|P1|COMPLETED|Treatment 3 (4 Weeks)||2
8214975|NCT02097992|20258597|P4|STARTED|Treatment 3 (4 Weeks)||2
8214976|NCT02097992|20258598|P3|STARTED|Treatment 3 (4 Weeks)||4
8214977|NCT02097992|20258599|P2|STARTED|Treatment 3 (4 Weeks)||3
8214978|NCT02097992|20258600|P1|STARTED|Treatment 3 (4 Weeks)||2
8214979|NCT02097992|20258597|P4|NOT COMPLETED|Washout (4 Weeks)||0
8214980|NCT02097992|20258598|P3|NOT COMPLETED|Washout (4 Weeks)||0
8214981|NCT02097992|20258599|P2|NOT COMPLETED|Washout (4 Weeks)||0
8214982|NCT02097992|20258600|P1|NOT COMPLETED|Washout (4 Weeks)||0
8214983|NCT02097992|20258597|P4|COMPLETED|Washout (4 Weeks)||2
8214984|NCT02097992|20258598|P3|COMPLETED|Washout (4 Weeks)||4
8214985|NCT02097992|20258599|P2|COMPLETED|Washout (4 Weeks)||3
8214986|NCT02097992|20258600|P1|COMPLETED|Washout (4 Weeks)||2
8214987|NCT02097992|20258597|P4|STARTED|Washout (4 Weeks)||2
8214988|NCT02097992|20258598|P3|STARTED|Washout (4 Weeks)||4
8214989|NCT02097992|20258599|P2|STARTED|Washout (4 Weeks)||3
8214990|NCT02097992|20258600|P1|STARTED|Washout (4 Weeks)||2
8214991|NCT02097992|20258597|P4|NOT COMPLETED|Treatment 2 (4 Weeks)||0
8214992|NCT02097992|20258598|P3|NOT COMPLETED|Treatment 2 (4 Weeks)||0
8214993|NCT02097992|20258599|P2|NOT COMPLETED|Treatment 2 (4 Weeks)||0
8214994|NCT02097992|20258600|P1|NOT COMPLETED|Treatment 2 (4 Weeks)||0
8214995|NCT02097992|20258597|P4|COMPLETED|Treatment 2 (4 Weeks)||2
8214996|NCT02097992|20258598|P3|COMPLETED|Treatment 2 (4 Weeks)||4
8214997|NCT02097992|20258599|P2|COMPLETED|Treatment 2 (4 Weeks)||3
8214998|NCT02097992|20258600|P1|COMPLETED|Treatment 2 (4 Weeks)||2
8214999|NCT02097992|20258597|P4|STARTED|Treatment 2 (4 Weeks)||2
8215000|NCT02097992|20258598|P3|STARTED|Treatment 2 (4 Weeks)||4
8215001|NCT02097992|20258599|P2|STARTED|Treatment 2 (4 Weeks)||3
8215002|NCT02097992|20258600|P1|STARTED|Treatment 2 (4 Weeks)||2
8215003|NCT02097992|20258597|P4|NOT COMPLETED|Treatment 1 (1 Day)||0
8215004|NCT02097992|20258598|P3|NOT COMPLETED|Treatment 1 (1 Day)||0
8215005|NCT02097992|20258599|P2|NOT COMPLETED|Treatment 1 (1 Day)||0
8215006|NCT02097992|20258600|P1|NOT COMPLETED|Treatment 1 (1 Day)||0
8215007|NCT02097992|20258597|P4|COMPLETED|Treatment 1 (1 Day)||2
8215008|NCT02097992|20258598|P3|COMPLETED|Treatment 1 (1 Day)||4
8215009|NCT02097992|20258599|P2|COMPLETED|Treatment 1 (1 Day)||3
8215010|NCT02097992|20258600|P1|COMPLETED|Treatment 1 (1 Day)||2
8215011|NCT02097992|20258597|P4|STARTED|Treatment 1 (1 Day)||2
8215012|NCT02097992|20258598|P3|STARTED|Treatment 1 (1 Day)||4
8215013|NCT02097992|20258599|P2|STARTED|Treatment 1 (1 Day)||3
8215014|NCT02097992|20258600|P1|STARTED|Treatment 1 (1 Day)||2
8215015|NCT02097849|20258610|P2|NOT COMPLETED|Overall Study||0
8215016|NCT02097849|20258611|P1|NOT COMPLETED|Overall Study||0
8215017|NCT02097849|20258610|P2|COMPLETED|Overall Study||38
8215018|NCT02097849|20258611|P1|COMPLETED|Overall Study||33
8215019|NCT02097849|20258610|P2|STARTED|Overall Study||38
8215020|NCT02097849|20258611|P1|STARTED|Overall Study||33
8215021|NCT02097823|20258649|P2|NOT COMPLETED|Overall Study||1
8215022|NCT02097823|20258650|P1|NOT COMPLETED|Overall Study||1
8215023|NCT02097823|20258649|P2|COMPLETED|Overall Study||3
8215024|NCT02097823|20258650|P1|COMPLETED|Overall Study||10
8215025|NCT02097823|20258649|P2|STARTED|Overall Study||4
8215026|NCT02097823|20258650|P1|STARTED|Overall Study||11
8215027|NCT02097745|20258665|P1|NOT COMPLETED|Overall Study||178
8215028|NCT02097745|20258665|P1|COMPLETED|Overall Study||157
8215029|NCT02097745|20258665|P1|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
8215036|NCT02097719|20258703|P2|NOT COMPLETED|Overall Study||1
8215037|NCT02097719|20258704|P1|NOT COMPLETED|Overall Study||3
8215038|NCT02097719|20258703|P2|COMPLETED|Overall Study||50
8215039|NCT02097719|20258704|P1|COMPLETED|Overall Study||46
8215040|NCT02097719|20258703|P2|STARTED|Overall Study||51
8215041|NCT02097719|20258704|P1|STARTED|Overall Study||49
8215042|NCT02097641|20258712|P2|NOT COMPLETED|Overall Study||0
8215043|NCT02097641|20258713|P1|NOT COMPLETED|Overall Study||0
8215044|NCT02097641|20258712|P2|COMPLETED|Overall Study||20
8215045|NCT02097641|20258713|P1|COMPLETED|Overall Study||40
8215046|NCT02097641|20258712|P2|STARTED|Overall Study||20
8215047|NCT02097641|20258713|P1|STARTED|Overall Study||40
8215048|NCT02097537|20258755|P1|NOT COMPLETED|Overall Study||0
8215049|NCT02097537|20258755|P1|COMPLETED|Overall Study||10
8215050|NCT02097537|20258755|P1|Follow-Up|Overall Study||10
8215051|NCT02097537|20258755|P1|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
8215052|NCT02097537|20258755|P1|STARTED|Overall Study||10
8215053|NCT02097472|20258769|P8|NOT COMPLETED|Assessed for Immunogenicity||1
8215054|NCT02097472|20258770|P7|NOT COMPLETED|Assessed for Immunogenicity||2
8215055|NCT02097472|20258771|P6|NOT COMPLETED|Assessed for Immunogenicity||2
8215056|NCT02097472|20258772|P5|NOT COMPLETED|Assessed for Immunogenicity||0
8215057|NCT02097472|20258773|P4|NOT COMPLETED|Assessed for Immunogenicity||2
8215058|NCT02097472|20258774|P3|NOT COMPLETED|Assessed for Immunogenicity||1
8215059|NCT02097472|20258775|P2|NOT COMPLETED|Assessed for Immunogenicity||0
8215060|NCT02097472|20258776|P1|NOT COMPLETED|Assessed for Immunogenicity||0
8215061|NCT02097472|20258769|P8|COMPLETED|Assessed for Immunogenicity||49
8215062|NCT02097472|20258770|P7|COMPLETED|Assessed for Immunogenicity||47
8215063|NCT02097472|20258771|P6|COMPLETED|Assessed for Immunogenicity||48
8215064|NCT02097472|20258772|P5|COMPLETED|Assessed for Immunogenicity||50
8215065|NCT02097472|20258773|P4|COMPLETED|Assessed for Immunogenicity||48
8215066|NCT02097472|20258774|P3|COMPLETED|Assessed for Immunogenicity||17
8215067|NCT02097472|20258775|P2|COMPLETED|Assessed for Immunogenicity||18
8215068|NCT02097472|20258776|P1|COMPLETED|Assessed for Immunogenicity||18
8215069|NCT02097472|20258769|P8|STARTED|Assessed for Immunogenicity||50
8215070|NCT02097472|20258770|P7|STARTED|Assessed for Immunogenicity||49
8215071|NCT02097472|20258771|P6|STARTED|Assessed for Immunogenicity||50
8215072|NCT02097472|20258772|P5|STARTED|Assessed for Immunogenicity||50
8215073|NCT02097472|20258773|P4|STARTED|Assessed for Immunogenicity||50
8215074|NCT02097472|20258774|P3|STARTED|Assessed for Immunogenicity||18
8215075|NCT02097472|20258775|P2|STARTED|Assessed for Immunogenicity||18
8215076|NCT02097472|20258776|P1|STARTED|Assessed for Immunogenicity||18
8215077|NCT02097472|20258769|P8|NOT COMPLETED|Received Vaccination 2||0
8215078|NCT02097472|20258770|P7|NOT COMPLETED|Received Vaccination 2||1
8215079|NCT02097472|20258771|P6|NOT COMPLETED|Received Vaccination 2||0
8215080|NCT02097472|20258772|P5|NOT COMPLETED|Received Vaccination 2||0
8215081|NCT02097472|20258773|P4|NOT COMPLETED|Received Vaccination 2||0
8215082|NCT02097472|20258774|P3|NOT COMPLETED|Received Vaccination 2||0
8215083|NCT02097472|20258775|P2|NOT COMPLETED|Received Vaccination 2||0
8215084|NCT02097472|20258776|P1|NOT COMPLETED|Received Vaccination 2||0
8215085|NCT02097472|20258769|P8|COMPLETED|Received Vaccination 2||50
8215086|NCT02097472|20258770|P7|COMPLETED|Received Vaccination 2||49
8215087|NCT02097472|20258771|P6|COMPLETED|Received Vaccination 2||50
8215088|NCT02097472|20258772|P5|COMPLETED|Received Vaccination 2||50
8215089|NCT02097472|20258773|P4|COMPLETED|Received Vaccination 2||50
8215090|NCT02097472|20258774|P3|COMPLETED|Received Vaccination 2||18
8215091|NCT02097472|20258775|P2|COMPLETED|Received Vaccination 2||18
8215092|NCT02097472|20258776|P1|COMPLETED|Received Vaccination 2||18
8215093|NCT02097472|20258769|P8|STARTED|Received Vaccination 2||50
8215094|NCT02097472|20258770|P7|STARTED|Received Vaccination 2||50
8215095|NCT02097472|20258771|P6|STARTED|Received Vaccination 2||50
8215096|NCT02097472|20258772|P5|STARTED|Received Vaccination 2||50
8215097|NCT02097472|20258773|P4|STARTED|Received Vaccination 2||50
8215098|NCT02097472|20258774|P3|STARTED|Received Vaccination 2||18
8215099|NCT02097472|20258775|P2|STARTED|Received Vaccination 2||18
8215100|NCT02097472|20258776|P1|STARTED|Received Vaccination 2||18
8215101|NCT02097472|20258769|P8|NOT COMPLETED|Received Vaccination 1||0
8215102|NCT02097472|20258770|P7|NOT COMPLETED|Received Vaccination 1||0
8215103|NCT02097472|20258771|P6|NOT COMPLETED|Received Vaccination 1||0
8215104|NCT02097472|20258772|P5|NOT COMPLETED|Received Vaccination 1||0
8215105|NCT02097472|20258773|P4|NOT COMPLETED|Received Vaccination 1||0
8215106|NCT02097472|20258774|P3|NOT COMPLETED|Received Vaccination 1||0
8215107|NCT02097472|20258775|P2|NOT COMPLETED|Received Vaccination 1||0
8215108|NCT02097472|20258776|P1|NOT COMPLETED|Received Vaccination 1||0
8215109|NCT02097472|20258769|P8|COMPLETED|Received Vaccination 1||50
8215110|NCT02097472|20258770|P7|COMPLETED|Received Vaccination 1||50
8215111|NCT02097472|20258771|P6|COMPLETED|Received Vaccination 1||50
8215112|NCT02097472|20258772|P5|COMPLETED|Received Vaccination 1||50
8215113|NCT02097472|20258773|P4|COMPLETED|Received Vaccination 1||50
8215114|NCT02097472|20258774|P3|COMPLETED|Received Vaccination 1||18
8215115|NCT02097472|20258775|P2|COMPLETED|Received Vaccination 1||18
8215116|NCT02097472|20258776|P1|COMPLETED|Received Vaccination 1||18
8215117|NCT02097472|20258769|P8|STARTED|Received Vaccination 1||50
8215118|NCT02097472|20258770|P7|STARTED|Received Vaccination 1||50
8215119|NCT02097472|20258771|P6|STARTED|Received Vaccination 1||50
8215120|NCT02097472|20258772|P5|STARTED|Received Vaccination 1||50
8215121|NCT02097472|20258773|P4|STARTED|Received Vaccination 1||50
8215122|NCT02097472|20258774|P3|STARTED|Received Vaccination 1||18
8215123|NCT02097472|20258775|P2|STARTED|Received Vaccination 1||18
8215124|NCT02097472|20258776|P1|STARTED|Received Vaccination 1||18
8215125|NCT02097420|20259197|P1|NOT COMPLETED|Overall Study||14
8215126|NCT02097420|20259197|P1|COMPLETED|Overall Study||6
8215127|NCT02097420|20259197|P1|STARTED|Overall Study||20
8215128|NCT02097303|20259210|P1|NOT COMPLETED|Overall Study||5
8215129|NCT02097303|20259210|P1|COMPLETED|Overall Study||31
8215130|NCT02097303|20259210|P1|STARTED|Overall Study||36
8215131|NCT02097290|20259220|P1|NOT COMPLETED|Overall Study||17
8215132|NCT02097290|20259220|P1|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
8215133|NCT02097290|20259220|P1|STARTED|Overall Study||210
8215134|NCT02097277|20259235|P5|NOT COMPLETED|Overall Study||1
8215135|NCT02097277|20259236|P4|NOT COMPLETED|Overall Study||4
8215136|NCT02097277|20259237|P3|NOT COMPLETED|Overall Study||2
8215137|NCT02097277|20259238|P2|NOT COMPLETED|Overall Study||3
8215138|NCT02097277|20259239|P1|NOT COMPLETED|Overall Study||2
8215139|NCT02097277|20259235|P5|COMPLETED|Overall Study||23
8215140|NCT02097277|20259236|P4|COMPLETED|Overall Study||20
8215141|NCT02097277|20259237|P3|COMPLETED|Overall Study||22
8215142|NCT02097277|20259238|P2|COMPLETED|Overall Study||21
8215143|NCT02097277|20259239|P1|COMPLETED|Overall Study||22
8215144|NCT02097277|20259235|P5|STARTED|Overall Study||24
8215145|NCT02097277|20259236|P4|STARTED|Overall Study||24
8215146|NCT02097277|20259237|P3|STARTED|Overall Study||24
8215147|NCT02097277|20259238|P2|STARTED|Overall Study||24
8215148|NCT02097277|20259239|P1|STARTED|Overall Study||24
8215149|NCT02097238|20259322|P1|NOT COMPLETED|Overall Study||19
8215150|NCT02097238|20259322|P1|COMPLETED|Overall Study||0
8215151|NCT02097238|20259322|P1|STARTED|Overall Study||19
8215152|NCT02097134|20259331|P1|NOT COMPLETED|Overall Study||9
8215153|NCT02097134|20259331|P1|COMPLETED|Overall Study||5
8215154|NCT02097134|20259331|P1|STARTED|Overall Study||14
8215155|NCT02097108|20259339|P1|NOT COMPLETED|Overall Study||2
8215156|NCT02097108|20259339|P1|COMPLETED|Overall Study||9
8215157|NCT02097108|20259339|P1|STARTED|Overall Study||11
8215158|NCT02097056|20259346|P1|NOT COMPLETED|Overall Study||58
8215159|NCT02097056|20259346|P1|COMPLETED|Overall Study||113
8215160|NCT02097056|20259346|P1|ParticipantsTreated|Overall Study||170
8215161|NCT02097056|20259346|P1|STARTED|Overall Study||171
8215162|NCT02097030|20259354|P2|NOT COMPLETED|Second Intervention (3 Days)||0
8215163|NCT02097030|20259355|P1|NOT COMPLETED|Second Intervention (3 Days)||0
8215164|NCT02097030|20259354|P2|COMPLETED|Second Intervention (3 Days)||16
8215165|NCT02097030|20259355|P1|COMPLETED|Second Intervention (3 Days)||14
8215166|NCT02097030|20259354|P2|STARTED|Second Intervention (3 Days)||16
8215167|NCT02097030|20259355|P1|STARTED|Second Intervention (3 Days)||14
8215168|NCT02097030|20259354|P2|NOT COMPLETED|First Intervention (3 Days)||1
8215169|NCT02097030|20259355|P1|NOT COMPLETED|First Intervention (3 Days)||1
8215170|NCT02097030|20259354|P2|COMPLETED|First Intervention (3 Days)||16
8215171|NCT02097030|20259355|P1|COMPLETED|First Intervention (3 Days)||14
8215172|NCT02097030|20259354|P2|STARTED|First Intervention (3 Days)||17
8215173|NCT02097030|20259355|P1|STARTED|First Intervention (3 Days)||15
8215174|NCT02096952|20259416|P1|NOT COMPLETED|Overall Study||1
8215175|NCT02096952|20259416|P1|COMPLETED|Overall Study||14
8215176|NCT02096952|20259416|P1|STARTED|Overall Study||15
8215177|NCT02096900|20259422|P2|NOT COMPLETED|Overall Study||2
8215178|NCT02096900|20259423|P1|NOT COMPLETED|Overall Study||4
8215179|NCT02096900|20259422|P2|COMPLETED|Overall Study||42
8215180|NCT02096900|20259423|P1|COMPLETED|Overall Study||38
8215181|NCT02096900|20259422|P2|STARTED|Overall Study|Allocated to Zolpidem|44
8215182|NCT02096900|20259423|P1|STARTED|Overall Study|Allocated to Midazolam|42
8215183|NCT02096861|20259441|P4|NOT COMPLETED|Overall Study||10
8215184|NCT02096861|20259442|P3|NOT COMPLETED|Overall Study||17
8215185|NCT02096861|20259443|P2|NOT COMPLETED|Overall Study||15
8215186|NCT02096861|20259444|P1|NOT COMPLETED|Overall Study||12
8215187|NCT02096861|20259441|P4|COMPLETED|Overall Study||45
8215188|NCT02096861|20259442|P3|COMPLETED|Overall Study||37
8215189|NCT02096861|20259443|P2|COMPLETED|Overall Study||40
8215190|NCT02096861|20259444|P1|COMPLETED|Overall Study||44
8215191|NCT02096861|20259441|P4|Drug Switching at Week 30|Overall Study||47
8215192|NCT02096861|20259442|P3|Drug Switching at Week 30|Overall Study||41
8215193|NCT02096861|20259443|P2|Drug Switching at Week 30|Overall Study||44
8215194|NCT02096861|20259444|P1|Drug Switching at Week 30|Overall Study||48
8215195|NCT02096861|20259441|P4|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
8215196|NCT02096861|20259442|P3|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
8215197|NCT02096861|20259443|P2|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
8215198|NCT02096861|20259444|P1|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
8215199|NCT02096835|20259475|P3|NOT COMPLETED|Overall Study||1
8215200|NCT02096835|20259476|P2|NOT COMPLETED|Overall Study||0
8215201|NCT02096835|20259477|P1|NOT COMPLETED|Overall Study||3
8215202|NCT02096835|20259475|P3|COMPLETED|Overall Study||50
8215203|NCT02096835|20259476|P2|COMPLETED|Overall Study||53
8215204|NCT02096835|20259477|P1|COMPLETED|Overall Study||50
8215205|NCT02096835|20259475|P3|STARTED|Overall Study||51
8215206|NCT02096835|20259476|P2|STARTED|Overall Study||53
8215207|NCT02096835|20259477|P1|STARTED|Overall Study||53
8215208|NCT02096744|20259494|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||1
8215209|NCT02096744|20259495|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8215210|NCT02096744|20259494|P2|COMPLETED|Treatment Period 3 (7 Days)||27
8215211|NCT02096744|20259495|P1|COMPLETED|Treatment Period 3 (7 Days)||28
8215212|NCT02096744|20259494|P2|STARTED|Treatment Period 3 (7 Days)||28
8215213|NCT02096744|20259495|P1|STARTED|Treatment Period 3 (7 Days)||28
8215214|NCT02096744|20259494|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
8215215|NCT02096744|20259495|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
8215216|NCT02096744|20259494|P2|COMPLETED|Washout Period 2 (3 Days)||28
8215217|NCT02096744|20259495|P1|COMPLETED|Washout Period 2 (3 Days)||28
8215218|NCT02096744|20259494|P2|STARTED|Washout Period 2 (3 Days)||28
8215219|NCT02096744|20259495|P1|STARTED|Washout Period 2 (3 Days)||28
8215220|NCT02096744|20259494|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8215221|NCT02096744|20259495|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8215222|NCT02096744|20259494|P2|COMPLETED|Treatment Period 2 (7 Days)||28
8215223|NCT02096744|20259495|P1|COMPLETED|Treatment Period 2 (7 Days)||28
8215224|NCT02096744|20259494|P2|STARTED|Treatment Period 2 (7 Days)||28
8215225|NCT02096744|20259495|P1|STARTED|Treatment Period 2 (7 Days)||28
8215226|NCT02096744|20259494|P2|NOT COMPLETED|Washout Period 1(7 Days)||0
8215227|NCT02096744|20259495|P1|NOT COMPLETED|Washout Period 1(7 Days)||0
8215228|NCT02096744|20259494|P2|COMPLETED|Washout Period 1(7 Days)||28
8215229|NCT02096744|20259495|P1|COMPLETED|Washout Period 1(7 Days)||28
8215230|NCT02096744|20259494|P2|STARTED|Washout Period 1(7 Days)||28
8215231|NCT02096744|20259495|P1|STARTED|Washout Period 1(7 Days)||28
8215232|NCT02096744|20259494|P2|NOT COMPLETED|Treatment Period 1(7 Days)||1
8215233|NCT02096744|20259495|P1|NOT COMPLETED|Treatment Period 1(7 Days)||1
8215234|NCT02096744|20259494|P2|COMPLETED|Treatment Period 1(7 Days)||28
8215235|NCT02096744|20259495|P1|COMPLETED|Treatment Period 1(7 Days)||28
8215236|NCT02096744|20259494|P2|STARTED|Treatment Period 1(7 Days)||29
8215237|NCT02096744|20259495|P1|STARTED|Treatment Period 1(7 Days)||29
8215238|NCT02096731|20259510|P2|NOT COMPLETED|Overall Study||0
8215239|NCT02096731|20259511|P1|NOT COMPLETED|Overall Study||0
8215240|NCT02096731|20259510|P2|COMPLETED|Overall Study||88955
8215241|NCT02096731|20259511|P1|COMPLETED|Overall Study||26442
8215242|NCT02096731|20259510|P2|STARTED|Overall Study||88955
8215243|NCT02096731|20259511|P1|STARTED|Overall Study||26442
8215244|NCT02096718|20259528|P3|NOT COMPLETED|Overall Study||0
8215245|NCT02096718|20259529|P2|NOT COMPLETED|Overall Study||0
8215246|NCT02096718|20259530|P1|NOT COMPLETED|Overall Study||0
8215247|NCT02096718|20259528|P3|COMPLETED|Overall Study||14
8215248|NCT02096718|20259529|P2|COMPLETED|Overall Study||8
8215249|NCT02096718|20259530|P1|COMPLETED|Overall Study||8
8215250|NCT02096718|20259528|P3|STARTED|Overall Study||14
8215251|NCT02096718|20259529|P2|STARTED|Overall Study||8
8215252|NCT02096718|20259530|P1|STARTED|Overall Study||8
8215253|NCT02096705|20259549|P2|NOT COMPLETED|Follow-up||4
8215254|NCT02096705|20259550|P1|NOT COMPLETED|Follow-up||4
8215255|NCT02096705|20259549|P2|COMPLETED|Follow-up||135
8215256|NCT02096705|20259550|P1|COMPLETED|Follow-up||125
8215257|NCT02096705|20259549|P2|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
8215258|NCT02096705|20259550|P1|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
8215259|NCT02096705|20259549|P2|NOT COMPLETED|Treatment||5
8215260|NCT02096705|20259550|P1|NOT COMPLETED|Treatment||9
8215261|NCT02096705|20259549|P2|COMPLETED|Treatment||134
8215262|NCT02096705|20259550|P1|COMPLETED|Treatment||124
8215263|NCT02096705|20259549|P2|STARTED|Treatment||139
8215264|NCT02096705|20259550|P1|STARTED|Treatment||133
8215265|NCT02096692|20259562|P1|NOT COMPLETED|Overall Study||4
8215266|NCT02096692|20259562|P1|COMPLETED|Overall Study||150
8215267|NCT02096692|20259562|P1|STARTED|Overall Study||154
8215268|NCT02096679|20259568|P1|NOT COMPLETED|Overall Study||0
8215269|NCT02096679|20259568|P1|COMPLETED|Overall Study||8
8215270|NCT02096679|20259568|P1|STARTED|Overall Study||8
8215277|NCT02096575|20259604|P3|NOT COMPLETED|Overall Study||5
8215278|NCT02096575|20259605|P2|NOT COMPLETED|Overall Study||0
8215279|NCT02096575|20259606|P1|NOT COMPLETED|Overall Study||0
8215280|NCT02096575|20259604|P3|COMPLETED|Overall Study||0
8215281|NCT02096575|20259605|P2|COMPLETED|Overall Study||67
8215282|NCT02096575|20259606|P1|COMPLETED|Overall Study||68
8215283|NCT02096575|20259604|P3|STARTED|Overall Study||5
8215284|NCT02096575|20259605|P2|STARTED|Overall Study||67
8215285|NCT02096575|20259606|P1|STARTED|Overall Study||68
8215286|NCT02096471|20259620|P1|NOT COMPLETED|Overall Study||13
8215287|NCT02096471|20259620|P1|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6
8215288|NCT02096471|20259620|P1|STARTED|Overall Study||19
8215289|NCT02096458|20259631|P1|NOT COMPLETED|Overall Study||0
8215290|NCT02096458|20259631|P1|COMPLETED|Overall Study||8
8215291|NCT02096458|20259631|P1|STARTED|Overall Study||8
8215292|NCT02096276|20259637|P2|NOT COMPLETED|Overall Study||0
8215293|NCT02096276|20259638|P1|NOT COMPLETED|Overall Study||0
8215294|NCT02096276|20259637|P2|COMPLETED|Overall Study||55
8215295|NCT02096276|20259638|P1|COMPLETED|Overall Study||250
8215296|NCT02096276|20259637|P2|STARTED|Overall Study||55
8215297|NCT02096276|20259638|P1|STARTED|Overall Study||250
8215298|NCT02096263|20259647|P3|NOT COMPLETED|Overall Study||39
8215299|NCT02096263|20259648|P2|NOT COMPLETED|Overall Study||36
8215300|NCT02096263|20259649|P1|NOT COMPLETED|Overall Study||34
8215301|NCT02096263|20259647|P3|COMPLETED|Overall Study||157
8215302|NCT02096263|20259648|P2|COMPLETED|Overall Study||158
8215303|NCT02096263|20259649|P1|COMPLETED|Overall Study||161
8215304|NCT02096263|20259647|P3|STARTED|Overall Study||196
8215305|NCT02096263|20259648|P2|STARTED|Overall Study||194
8215306|NCT02096263|20259649|P1|STARTED|Overall Study||195
8215307|NCT02096107|20259785|P2|NOT COMPLETED|Overall Study||0
8215308|NCT02096107|20259786|P1|NOT COMPLETED|Overall Study||0
8215309|NCT02096107|20259785|P2|COMPLETED|Overall Study||30
8215310|NCT02096107|20259786|P1|COMPLETED|Overall Study||30
8215311|NCT02096107|20259785|P2|STARTED|Overall Study||30
8215312|NCT02096107|20259786|P1|STARTED|Overall Study||30
8215313|NCT02096081|20259804|P2|NOT COMPLETED|Overall Study||4
8215314|NCT02096081|20259805|P1|NOT COMPLETED|Overall Study||3
8215315|NCT02096081|20259804|P2|COMPLETED|Overall Study||124
8215316|NCT02096081|20259805|P1|COMPLETED|Overall Study||119
8215317|NCT02096081|20259804|P2|STARTED|Overall Study||128
8215318|NCT02096081|20259805|P1|STARTED|Overall Study||122
8215319|NCT02096042|20259837|P3|NOT COMPLETED|Overall Study||0
8215320|NCT02096042|20259838|P2|NOT COMPLETED|Overall Study||0
8215321|NCT02096042|20259839|P1|NOT COMPLETED|Overall Study||1
8215322|NCT02096042|20259837|P3|COMPLETED|Overall Study||0
8215323|NCT02096042|20259838|P2|COMPLETED|Overall Study||0
8215324|NCT02096042|20259839|P1|COMPLETED|Overall Study||0
8215325|NCT02096042|20259837|P3|STARTED|Overall Study||0
8215326|NCT02096042|20259838|P2|STARTED|Overall Study||0
8215327|NCT02096042|20259839|P1|STARTED|Overall Study||1
8215328|NCT02096029|20259848|P2|NOT COMPLETED|Overall Study||0
8215329|NCT02096029|20259849|P1|NOT COMPLETED|Overall Study||0
8215330|NCT02096029|20259848|P2|COMPLETED|Overall Study||593
8215331|NCT02096029|20259849|P1|COMPLETED|Overall Study||652
8215332|NCT02096029|20259848|P2|STARTED|Overall Study||593
8215333|NCT02096029|20259849|P1|STARTED|Overall Study||652
8215334|NCT02096003|20259861|P2|NOT COMPLETED|Overall Study||3
8215335|NCT02096003|20259862|P1|NOT COMPLETED|Overall Study||2
8215336|NCT02096003|20259861|P2|COMPLETED|Overall Study||37
8215337|NCT02096003|20259862|P1|COMPLETED|Overall Study||38
8215338|NCT02096003|20259861|P2|STARTED|Overall Study||40
8215339|NCT02096003|20259862|P1|STARTED|Overall Study||40
8215340|NCT02095951|20259878|P2|NOT COMPLETED|Overall Study||6
8215341|NCT02095951|20259879|P1|NOT COMPLETED|Overall Study||9
8215342|NCT02095951|20259878|P2|COMPLETED|Overall Study||8
8215343|NCT02095951|20259879|P1|COMPLETED|Overall Study||4
8215344|NCT02095951|20259878|P2|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
8215345|NCT02095951|20259879|P1|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
8215346|NCT02095873|20259899|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
8215347|NCT02095873|20259900|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
8215348|NCT02095873|20259899|P2|COMPLETED|Second Intervention (8 Weeks)||16
8215349|NCT02095873|20259900|P1|COMPLETED|Second Intervention (8 Weeks)||13
8215350|NCT02095873|20259899|P2|STARTED|Second Intervention (8 Weeks)||16
8215351|NCT02095873|20259900|P1|STARTED|Second Intervention (8 Weeks)||15
8215352|NCT02095873|20259899|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
8215353|NCT02095873|20259900|P1|NOT COMPLETED|First Intervention (8 Weeks)||1
8215354|NCT02095873|20259899|P2|COMPLETED|First Intervention (8 Weeks)||16
8215355|NCT02095873|20259900|P1|COMPLETED|First Intervention (8 Weeks)||15
8215356|NCT02095873|20259899|P2|STARTED|First Intervention (8 Weeks)||16
8215357|NCT02095873|20259900|P1|STARTED|First Intervention (8 Weeks)||16
8215358|NCT02095691|20259912|P1|NOT COMPLETED|Overall Study||1
8215359|NCT02095691|20259912|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
8215360|NCT02095691|20259912|P1|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
8215367|NCT02095561|20259951|P2|NOT COMPLETED|Overall Study||0
8215368|NCT02095561|20259952|P1|NOT COMPLETED|Overall Study||0
8215369|NCT02095561|20259951|P2|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
8215370|NCT02095561|20259952|P1|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
8215371|NCT02095561|20259951|P2|HPV Tested at Health Centers|Overall Study||599
8215372|NCT02095561|20259952|P1|HPV Tested at Health Centers|Overall Study||99
8215373|NCT02095561|20259951|P2|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
8215374|NCT02095561|20259952|P1|HPV Self-tested Women|Overall Study||2519
8215375|NCT02095561|20259951|P2|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
8215376|NCT02095561|20259952|P1|Self-testing Acceptability|Overall Study||2616
8215377|NCT02095561|20259951|P2|STARTED|Overall Study||2964
8215378|NCT02095561|20259952|P1|STARTED|Overall Study||3049
8215379|NCT02095535|20259964|P1|NOT COMPLETED|Analysis||0
8215380|NCT02095535|20259964|P1|COMPLETED|Analysis||18
8215381|NCT02095535|20259964|P1|STARTED|Analysis||18
8215382|NCT02095535|20259964|P1|NOT COMPLETED|Recruitment||2
8215383|NCT02095535|20259964|P1|COMPLETED|Recruitment||18
8215384|NCT02095535|20259964|P1|STARTED|Recruitment||20
8215385|NCT02095340|20259971|P3|NOT COMPLETED|Overall Study||0
8215386|NCT02095340|20259972|P2|NOT COMPLETED|Overall Study||0
8215387|NCT02095340|20259973|P1|NOT COMPLETED|Overall Study||0
8215388|NCT02095340|20259971|P3|COMPLETED|Overall Study||105
8215389|NCT02095340|20259972|P2|COMPLETED|Overall Study||54
8215390|NCT02095340|20259973|P1|COMPLETED|Overall Study||51
8215391|NCT02095340|20259971|P3|STARTED|Overall Study||105
8215392|NCT02095340|20259972|P2|STARTED|Overall Study|Mother (not the child) received the training.|54
8215393|NCT02095340|20259973|P1|STARTED|Overall Study|Mother (not the child) received the training.|51
8215394|NCT02095223|20259986|P2|NOT COMPLETED|Overall Study||0
8215395|NCT02095223|20259987|P1|NOT COMPLETED|Overall Study||1
8215396|NCT02095223|20259986|P2|COMPLETED|Overall Study||2
8215397|NCT02095223|20259987|P1|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
8215398|NCT02095223|20259986|P2|STARTED|Overall Study||2
8215399|NCT02095223|20259987|P1|STARTED|Overall Study||2
8215400|NCT02095197|20259997|P2|NOT COMPLETED|Overall Study||3
8215401|NCT02095197|20259998|P1|NOT COMPLETED|Overall Study||0
8215402|NCT02095197|20259997|P2|COMPLETED|Overall Study||36
8215403|NCT02095197|20259998|P1|COMPLETED|Overall Study||40
8215404|NCT02095197|20259997|P2|STARTED|Overall Study||39
8215405|NCT02095197|20259998|P1|STARTED|Overall Study||40
8215406|NCT02095158|20260010|P1|NOT COMPLETED|Overall Study||75
8215407|NCT02095158|20260010|P1|COMPLETED|Overall Study||365
8215408|NCT02095158|20260010|P1|STARTED|Overall Study||440
8215409|NCT02095145|20260017|P2|NOT COMPLETED|Overall Study||0
8215410|NCT02095145|20260018|P1|NOT COMPLETED|Overall Study||1
8215411|NCT02095145|20260017|P2|COMPLETED|Overall Study||15
8215412|NCT02095145|20260018|P1|COMPLETED|Overall Study||14
8215413|NCT02095145|20260017|P2|STARTED|Overall Study||15
8215414|NCT02095145|20260018|P1|STARTED|Overall Study||15
8215415|NCT02095106|20260064|P2|NOT COMPLETED|Second Intervention (14 Days)||1
8215416|NCT02095106|20260065|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8215417|NCT02095106|20260064|P2|COMPLETED|Second Intervention (14 Days)||12
8215418|NCT02095106|20260065|P1|COMPLETED|Second Intervention (14 Days)||14
8215419|NCT02095106|20260064|P2|STARTED|Second Intervention (14 Days)||13
8215420|NCT02095106|20260065|P1|STARTED|Second Intervention (14 Days)||14
8215421|NCT02095106|20260064|P2|NOT COMPLETED|First Intervention (14 Days)||0
8215422|NCT02095106|20260065|P1|NOT COMPLETED|First Intervention (14 Days)||0
8215423|NCT02095106|20260064|P2|COMPLETED|First Intervention (14 Days)||13
8215424|NCT02095106|20260065|P1|COMPLETED|First Intervention (14 Days)||14
8215425|NCT02095106|20260064|P2|STARTED|First Intervention (14 Days)||13
8215426|NCT02095106|20260065|P1|STARTED|First Intervention (14 Days)||14
8215427|NCT02094937|20260081|P4|NOT COMPLETED|12 Weeks in Period 2||12
8215428|NCT02094937|20260082|P3|NOT COMPLETED|12 Weeks in Period 2||12
8215429|NCT02094937|20260083|P2|NOT COMPLETED|12 Weeks in Period 2||11
8215430|NCT02094937|20260084|P1|NOT COMPLETED|12 Weeks in Period 2||0
8215431|NCT02094937|20260081|P4|COMPLETED|12 Weeks in Period 2||112
8215432|NCT02094937|20260082|P3|COMPLETED|12 Weeks in Period 2||112
8215433|NCT02094937|20260083|P2|COMPLETED|12 Weeks in Period 2||112
8215434|NCT02094937|20260084|P1|COMPLETED|12 Weeks in Period 2||0
8215435|NCT02094937|20260081|P4|STARTED|12 Weeks in Period 2||124
8215436|NCT02094937|20260082|P3|STARTED|12 Weeks in Period 2||124
8215437|NCT02094937|20260083|P2|STARTED|12 Weeks in Period 2||123
8215438|NCT02094937|20260084|P1|STARTED|12 Weeks in Period 2||0
8215439|NCT02094937|20260081|P4|NOT COMPLETED|8 Weeks in Period 1||0
8215440|NCT02094937|20260082|P3|NOT COMPLETED|8 Weeks in Period 1||0
8215441|NCT02094937|20260083|P2|NOT COMPLETED|8 Weeks in Period 1||0
8215442|NCT02094937|20260084|P1|NOT COMPLETED|8 Weeks in Period 1||60
8215443|NCT02094937|20260081|P4|COMPLETED|8 Weeks in Period 1||0
8215444|NCT02094937|20260082|P3|COMPLETED|8 Weeks in Period 1||0
8215445|NCT02094937|20260083|P2|COMPLETED|8 Weeks in Period 1||0
8215446|NCT02094937|20260084|P1|COMPLETED|8 Weeks in Period 1||370
8215447|NCT02094937|20260081|P4|STARTED|8 Weeks in Period 1||0
8215448|NCT02094937|20260082|P3|STARTED|8 Weeks in Period 1||0
8215449|NCT02094937|20260083|P2|STARTED|8 Weeks in Period 1||0
8215450|NCT02094937|20260084|P1|STARTED|8 Weeks in Period 1||430
8215451|NCT02094898|20260114|P1|NOT COMPLETED|Overall Study||5
8215452|NCT02094898|20260114|P1|COMPLETED|Overall Study||7
8215453|NCT02094898|20260114|P1|STARTED|Overall Study||12
8215454|NCT02094885|20260161|P2|NOT COMPLETED|Overall Study||5
8215455|NCT02094885|20260162|P1|NOT COMPLETED|Overall Study||2
8215456|NCT02094885|20260161|P2|COMPLETED|Overall Study||122
8215457|NCT02094885|20260162|P1|COMPLETED|Overall Study||123
8215458|NCT02094885|20260161|P2|STARTED|Overall Study||127
8215459|NCT02094885|20260162|P1|STARTED|Overall Study||125
8215460|NCT02094872|20260174|P1|NOT COMPLETED|Overall Study||29
8215461|NCT02094872|20260174|P1|COMPLETED|Overall Study||20
8215462|NCT02094872|20260174|P1|Patients Treated With MEK162|Overall Study||20
8215463|NCT02094872|20260174|P1|Received Standard of Care|Overall Study|7 standard-of-care patients crossed-over and received targeted therapy.|9
8215464|NCT02094872|20260174|P1|Received Targeted Therapy|Overall Study||20
8215465|NCT02094872|20260174|P1|Received Tumor-board Recommendation|Overall Study|1 individual withdrew consent after biopsy.|36
8215466|NCT02094872|20260174|P1|Received Biopsy|Overall Study||37
8215467|NCT02094872|20260174|P1|STARTED|Overall Study||49
8215468|NCT02094755|20260179|P1|NOT COMPLETED|Overall Study||0
8215469|NCT02094755|20260179|P1|COMPLETED|Overall Study||100
8215470|NCT02094755|20260179|P1|STARTED|Overall Study||100
8215471|NCT02094716|20260186|P3|NOT COMPLETED|Overall Study||4
8215472|NCT02094716|20260187|P2|NOT COMPLETED|Overall Study||7
8215473|NCT02094716|20260188|P1|NOT COMPLETED|Overall Study||2
8215474|NCT02094716|20260186|P3|COMPLETED|Overall Study||40
8215475|NCT02094716|20260187|P2|COMPLETED|Overall Study||36
8215476|NCT02094716|20260188|P1|COMPLETED|Overall Study||41
8215477|NCT02094716|20260186|P3|Received Second Dose at Day 14|Overall Study||17
8215478|NCT02094716|20260187|P2|Received Second Dose at Day 14|Overall Study||10
8215479|NCT02094716|20260188|P1|Received Second Dose at Day 14|Overall Study||15
8215480|NCT02094716|20260186|P3|STARTED|Overall Study||44
8215481|NCT02094716|20260187|P2|STARTED|Overall Study||43
8215482|NCT02094716|20260188|P1|STARTED|Overall Study||43
8215483|NCT02094677|20260210|P2|NOT COMPLETED|Overall Study||1
8215484|NCT02094677|20260211|P1|NOT COMPLETED|Overall Study||3
8215485|NCT02094677|20260210|P2|COMPLETED|Overall Study||30
8215486|NCT02094677|20260211|P1|COMPLETED|Overall Study||40
8215487|NCT02094677|20260210|P2|STARTED|Overall Study||31
8215488|NCT02094677|20260211|P1|STARTED|Overall Study||43
8215489|NCT02094664|20260275|P2|NOT COMPLETED|Overall Study||0
8215490|NCT02094664|20260276|P1|NOT COMPLETED|Overall Study||0
8215491|NCT02094664|20260275|P2|COMPLETED|Overall Study||16
8215492|NCT02094664|20260276|P1|COMPLETED|Overall Study||16
8215493|NCT02094664|20260275|P2|STARTED|Overall Study||16
8215494|NCT02094664|20260276|P1|STARTED|Overall Study||16
8215495|NCT02094612|20260290|P2|NOT COMPLETED|Overall Study||70
8215496|NCT02094612|20260291|P1|NOT COMPLETED|Overall Study||79
8215497|NCT02094612|20260290|P2|COMPLETED|Overall Study||25
8215498|NCT02094612|20260291|P1|COMPLETED|Overall Study||33
8215499|NCT02094612|20260290|P2|6 Month Follow up|Overall Study||25
8215500|NCT02094612|20260291|P1|6 Month Follow up|Overall Study||33
8215501|NCT02094612|20260290|P2|3 Month Follow up|Overall Study||43
8215502|NCT02094612|20260291|P1|3 Month Follow up|Overall Study||50
8215503|NCT02094612|20260290|P2|1 Month Follow up|Overall Study||50
8215504|NCT02094612|20260291|P1|1 Month Follow up|Overall Study||67
8215505|NCT02094612|20260290|P2|STARTED|Overall Study||95
8215506|NCT02094612|20260291|P1|STARTED|Overall Study||112
8215515|NCT02094534|20260346|P2|NOT COMPLETED|Overall Study||0
8215516|NCT02094534|20260347|P1|NOT COMPLETED|Overall Study||0
8215517|NCT02094534|20260346|P2|COMPLETED|Overall Study||10
8215518|NCT02094534|20260347|P1|COMPLETED|Overall Study||15
8215519|NCT02094534|20260346|P2|STARTED|Overall Study||10
8215520|NCT02094534|20260347|P1|STARTED|Overall Study||15
8215521|NCT02094443|20260357|P2|NOT COMPLETED|Overall Study||17
8215522|NCT02094443|20260358|P1|NOT COMPLETED|Overall Study||15
8215523|NCT02094443|20260357|P2|COMPLETED|Overall Study||9
8215524|NCT02094443|20260358|P1|COMPLETED|Overall Study||11
8215525|NCT02094443|20260357|P2|Completed at Week 24|Overall Study||8
8215526|NCT02094443|20260358|P1|Completed at Week 24|Overall Study||11
8215527|NCT02094443|20260357|P2|Completed at Week 12|Overall Study||1
8215528|NCT02094443|20260358|P1|Completed at Week 12|Overall Study||0
8215529|NCT02094443|20260357|P2|STARTED|Overall Study||26
8215530|NCT02094443|20260358|P1|STARTED|Overall Study||26
8215531|NCT02094352|20260378|P2|NOT COMPLETED|Overall Study||0
8215532|NCT02094352|20260379|P1|NOT COMPLETED|Overall Study||0
8215533|NCT02094352|20260378|P2|COMPLETED|Overall Study||1
8215534|NCT02094352|20260379|P1|COMPLETED|Overall Study||2
8215535|NCT02094352|20260378|P2|STARTED|Overall Study||1
8215536|NCT02094352|20260379|P1|STARTED|Overall Study||2
8215537|NCT02094326|20260385|P1|NOT COMPLETED|Overall Study||0
8215538|NCT02094326|20260385|P1|COMPLETED|Overall Study||301
8215539|NCT02094326|20260385|P1|STARTED|Overall Study||301
8215540|NCT02094300|20260394|P1|NOT COMPLETED|Overall Study||20
8215541|NCT02094300|20260394|P1|COMPLETED|Overall Study||6
8215542|NCT02094300|20260394|P1|30 Days|Overall Study||24
8215543|NCT02094300|20260394|P1|STARTED|Overall Study||26
8215555|NCT02093949|20260416|P2|NOT COMPLETED|Overall Study||0
8215556|NCT02093949|20260417|P1|NOT COMPLETED|Overall Study||0
8215557|NCT02093949|20260416|P2|COMPLETED|Overall Study||47
8215558|NCT02093949|20260417|P1|COMPLETED|Overall Study||105
8215559|NCT02093949|20260416|P2|STARTED|Overall Study||47
8215560|NCT02093949|20260417|P1|STARTED|Overall Study||105
8215591|NCT02093897|20260499|P1|NOT COMPLETED|Overall Study||19
8215592|NCT02093897|20260499|P1|COMPLETED|Overall Study||65
8215593|NCT02093897|20260499|P1|STARTED|Overall Study||84
8215594|NCT02093819|20260527|P8|NOT COMPLETED|Overall Study||0
8215595|NCT02093819|20260528|P7|NOT COMPLETED|Overall Study||0
8215596|NCT02093819|20260529|P6|NOT COMPLETED|Overall Study||0
8215597|NCT02093819|20260530|P5|NOT COMPLETED|Overall Study||0
8215598|NCT02093819|20260531|P4|NOT COMPLETED|Overall Study||0
8215599|NCT02093819|20260532|P3|NOT COMPLETED|Overall Study||0
8215600|NCT02093819|20260533|P2|NOT COMPLETED|Overall Study||0
8215601|NCT02093819|20260534|P1|NOT COMPLETED|Overall Study||0
8215602|NCT02093819|20260527|P8|COMPLETED|Overall Study||6
8215603|NCT02093819|20260528|P7|COMPLETED|Overall Study||5
8215604|NCT02093819|20260529|P6|COMPLETED|Overall Study||6
8215605|NCT02093819|20260530|P5|COMPLETED|Overall Study||6
8215606|NCT02093819|20260531|P4|COMPLETED|Overall Study||6
8215607|NCT02093819|20260532|P3|COMPLETED|Overall Study||10
8215608|NCT02093819|20260533|P2|COMPLETED|Overall Study||6
8215609|NCT02093819|20260534|P1|COMPLETED|Overall Study||15
8215610|NCT02093819|20260527|P8|STARTED|Overall Study||6
8215611|NCT02093819|20260528|P7|STARTED|Overall Study||5
8215612|NCT02093819|20260529|P6|STARTED|Overall Study||6
8215613|NCT02093819|20260530|P5|STARTED|Overall Study||6
8215614|NCT02093819|20260531|P4|STARTED|Overall Study||6
8215615|NCT02093819|20260532|P3|STARTED|Overall Study||10
8215616|NCT02093819|20260533|P2|STARTED|Overall Study||6
8215617|NCT02093819|20260534|P1|STARTED|Overall Study||15
8215618|NCT02093793|20260571|P3|NOT COMPLETED|Overall Study||3
8215619|NCT02093793|20260572|P2|NOT COMPLETED|Overall Study||10
8215620|NCT02093793|20260573|P1|NOT COMPLETED|Overall Study||7
8215621|NCT02093793|20260571|P3|COMPLETED|Overall Study||65
8215622|NCT02093793|20260572|P2|COMPLETED|Overall Study||80
8215623|NCT02093793|20260573|P1|COMPLETED|Overall Study||91
8215624|NCT02093793|20260571|P3|STARTED|Overall Study||68
8215625|NCT02093793|20260572|P2|STARTED|Overall Study||90
8215626|NCT02093793|20260573|P1|STARTED|Overall Study||98
8215627|NCT02093702|20260583|P2|NOT COMPLETED|Overall Study||0
8215628|NCT02093702|20260584|P1|NOT COMPLETED|Overall Study||0
8215629|NCT02093702|20260583|P2|COMPLETED|Overall Study||3
8215630|NCT02093702|20260584|P1|COMPLETED|Overall Study||2
8215631|NCT02093702|20260583|P2|STARTED|Overall Study||3
8215632|NCT02093702|20260584|P1|STARTED|Overall Study||2
8215633|NCT02093689|20260615|P3|NOT COMPLETED|Overall Study||0
8215634|NCT02093689|20260616|P2|NOT COMPLETED|Overall Study||0
8215635|NCT02093689|20260617|P1|NOT COMPLETED|Overall Study||4
8215636|NCT02093689|20260615|P3|COMPLETED|Overall Study||0
8215637|NCT02093689|20260616|P2|COMPLETED|Overall Study||0
8215638|NCT02093689|20260617|P1|COMPLETED|Overall Study||14
8215639|NCT02093689|20260615|P3|STARTED|Overall Study||0
8215640|NCT02093689|20260616|P2|STARTED|Overall Study||0
8215641|NCT02093689|20260617|P1|STARTED|Overall Study||18
8215707|NCT02093520|20260656|P2|NOT COMPLETED|Overall Study||22
8215708|NCT02093520|20260657|P1|NOT COMPLETED|Overall Study||6
8215709|NCT02093520|20260656|P2|COMPLETED|Overall Study||131
8215710|NCT02093520|20260657|P1|COMPLETED|Overall Study||143
8215711|NCT02093520|20260656|P2|STARTED|Overall Study||153
8215712|NCT02093520|20260657|P1|STARTED|Overall Study||149
8215713|NCT02093390|20260669|P2|NOT COMPLETED|Overall Study||1
8215714|NCT02093390|20260670|P1|NOT COMPLETED|Overall Study||0
8215715|NCT02093390|20260669|P2|COMPLETED|Overall Study||19
8215716|NCT02093390|20260670|P1|COMPLETED|Overall Study||20
8215717|NCT02093390|20260669|P2|STARTED|Overall Study||20
8215718|NCT02093390|20260670|P1|STARTED|Overall Study||20
8215719|NCT02093351|20260709|P4|NOT COMPLETED|Part B||63
8215720|NCT02093351|20260710|P3|NOT COMPLETED|Part B||0
8215721|NCT02093351|20260711|P2|NOT COMPLETED|Part B||0
8215722|NCT02093351|20260712|P1|NOT COMPLETED|Part B||0
8215723|NCT02093351|20260709|P4|COMPLETED|Part B||6
8215724|NCT02093351|20260710|P3|COMPLETED|Part B||0
8215725|NCT02093351|20260711|P2|COMPLETED|Part B||0
8215726|NCT02093351|20260712|P1|COMPLETED|Part B||0
8215727|NCT02093351|20260709|P4|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69
8215728|NCT02093351|20260710|P3|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
8215729|NCT02093351|20260711|P2|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
8215730|NCT02093351|20260712|P1|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
8215731|NCT02093351|20260709|P4|NOT COMPLETED|Part A||0
8215732|NCT02093351|20260710|P3|NOT COMPLETED|Part A||3
8215733|NCT02093351|20260711|P2|NOT COMPLETED|Part A||2
8215734|NCT02093351|20260712|P1|NOT COMPLETED|Part A||2
8215735|NCT02093351|20260709|P4|COMPLETED|Part A||0
8215736|NCT02093351|20260710|P3|COMPLETED|Part A||23
8215737|NCT02093351|20260711|P2|COMPLETED|Part A||21
8215738|NCT02093351|20260712|P1|COMPLETED|Part A||28
8215739|NCT02093351|20260709|P4|Completing Treatment Period 3|Part A||0
8215740|NCT02093351|20260710|P3|Completing Treatment Period 3|Part A||23
8215741|NCT02093351|20260711|P2|Completing Treatment Period 3|Part A||21
8215742|NCT02093351|20260712|P1|Completing Treatment Period 3|Part A||28
8215743|NCT02093351|20260709|P4|Completing Treatment Period 2|Part A||0
8215744|NCT02093351|20260710|P3|Completing Treatment Period 2|Part A||23
8215745|NCT02093351|20260711|P2|Completing Treatment Period 2|Part A||21
8215746|NCT02093351|20260712|P1|Completing Treatment Period 2|Part A||29
8215747|NCT02093351|20260709|P4|Completing Treatment Period 1|Part A||0
8215748|NCT02093351|20260710|P3|Completing Treatment Period 1|Part A||23
8215749|NCT02093351|20260711|P2|Completing Treatment Period 1|Part A||22
8215750|NCT02093351|20260712|P1|Completing Treatment Period 1|Part A||29
8215751|NCT02093351|20260709|P4|STARTED|Part A||0
8215752|NCT02093351|20260710|P3|STARTED|Part A||26
8215753|NCT02093351|20260711|P2|STARTED|Part A||23
8215754|NCT02093351|20260712|P1|STARTED|Part A||30
8215755|NCT02093234|20260745|P3|NOT COMPLETED|Overall Study||4
8215756|NCT02093234|20260746|P2|NOT COMPLETED|Overall Study||4
8215757|NCT02093234|20260747|P1|NOT COMPLETED|Overall Study||3
8215758|NCT02093234|20260745|P3|COMPLETED|Overall Study||50
8215759|NCT02093234|20260746|P2|COMPLETED|Overall Study||52
8215760|NCT02093234|20260747|P1|COMPLETED|Overall Study||53
8215761|NCT02093234|20260745|P3|STARTED|Overall Study||54
8215762|NCT02093234|20260746|P2|STARTED|Overall Study||56
8215763|NCT02093234|20260747|P1|STARTED|Overall Study||56
8215764|NCT02093221|20260769|P5|NOT COMPLETED|Overall Study||8
8215765|NCT02093221|20260770|P4|NOT COMPLETED|Overall Study||8
8215766|NCT02093221|20260771|P3|NOT COMPLETED|Overall Study||9
8215767|NCT02093221|20260772|P2|NOT COMPLETED|Overall Study||8
8215768|NCT02093221|20260773|P1|NOT COMPLETED|Overall Study||10
8215769|NCT02093221|20260769|P5|COMPLETED|Overall Study||7
8215770|NCT02093221|20260770|P4|COMPLETED|Overall Study||7
8215771|NCT02093221|20260771|P3|COMPLETED|Overall Study||6
8215772|NCT02093221|20260772|P2|COMPLETED|Overall Study||8
8215773|NCT02093221|20260773|P1|COMPLETED|Overall Study||5
8215774|NCT02093221|20260769|P5|STARTED|Overall Study||15
8215775|NCT02093221|20260770|P4|STARTED|Overall Study||15
8215776|NCT02093221|20260771|P3|STARTED|Overall Study||15
8215777|NCT02093221|20260772|P2|STARTED|Overall Study||16
8215778|NCT02093221|20260773|P1|STARTED|Overall Study||15
8215779|NCT02093026|20260810|P1|NOT COMPLETED|Overall Study||193
8215780|NCT02093026|20260810|P1|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
8215781|NCT02093026|20260810|P1|STARTED|Overall Study||465
8215782|NCT02092961|20260832|P3|NOT COMPLETED|Overall Study||16
8215783|NCT02092961|20260833|P2|NOT COMPLETED|Overall Study||14
8215784|NCT02092961|20260834|P1|NOT COMPLETED|Overall Study||21
8215785|NCT02092961|20260832|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
8215786|NCT02092961|20260833|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
8215787|NCT02092961|20260834|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
8215788|NCT02092961|20260832|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
8215789|NCT02092961|20260833|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
8215790|NCT02092961|20260834|P1|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
8215791|NCT02092961|20260832|P3|STARTED|Overall Study|Patients who received treatment|29
8215792|NCT02092961|20260833|P2|STARTED|Overall Study|Patients who received treatment|28
8215793|NCT02092961|20260834|P1|STARTED|Overall Study|Patients who received treatment|33
8215794|NCT02092909|20260859|P4|NOT COMPLETED|Overall Study||6
8215795|NCT02092909|20260860|P3|NOT COMPLETED|Overall Study||9
8215796|NCT02092909|20260861|P2|NOT COMPLETED|Overall Study||3
8215797|NCT02092909|20260862|P1|NOT COMPLETED|Overall Study||1
8215798|NCT02092909|20260859|P4|COMPLETED|Overall Study||0
8215799|NCT02092909|20260860|P3|COMPLETED|Overall Study||5
8215800|NCT02092909|20260861|P2|COMPLETED|Overall Study||2
8215801|NCT02092909|20260862|P1|COMPLETED|Overall Study||5
8215802|NCT02092909|20260859|P4|STARTED|Overall Study||6
8215803|NCT02092909|20260860|P3|STARTED|Overall Study||14
8215804|NCT02092909|20260861|P2|STARTED|Overall Study||5
8215805|NCT02092909|20260862|P1|STARTED|Overall Study||6
8215806|NCT02092857|20260891|P3|NOT COMPLETED|Overall Study||13
8215807|NCT02092857|20260892|P2|NOT COMPLETED|Overall Study||12
8215808|NCT02092857|20260893|P1|NOT COMPLETED|Overall Study||10
8215809|NCT02092857|20260891|P3|COMPLETED|Overall Study||16
8215810|NCT02092857|20260892|P2|COMPLETED|Overall Study||18
8215811|NCT02092857|20260893|P1|COMPLETED|Overall Study||20
8215812|NCT02092857|20260891|P3|STARTED|Overall Study||29
8215813|NCT02092857|20260892|P2|STARTED|Overall Study||30
8215814|NCT02092857|20260893|P1|STARTED|Overall Study||30
8215815|NCT02092662|20260903|P2|NOT COMPLETED|Overall Study||0
8215816|NCT02092662|20260904|P1|NOT COMPLETED|Overall Study||13
8215817|NCT02092662|20260903|P2|COMPLETED|Overall Study||19
8215818|NCT02092662|20260904|P1|COMPLETED|Overall Study||25
8215819|NCT02092662|20260903|P2|Recruited|Overall Study||19
8215820|NCT02092662|20260904|P1|Recruited|Overall Study||38
8215821|NCT02092662|20260903|P2|STARTED|Overall Study||19
8215822|NCT02092662|20260904|P1|STARTED|Overall Study||38
8215823|NCT02092649|20260913|P2|NOT COMPLETED|Overall Study||0
8215824|NCT02092649|20260914|P1|NOT COMPLETED|Overall Study||0
8215825|NCT02092649|20260913|P2|COMPLETED|Overall Study|13 participants finished study|13
8215826|NCT02092649|20260914|P1|COMPLETED|Overall Study|13 participants finished study|13
8215827|NCT02092649|20260913|P2|STARTED|Overall Study|13 participants recruited|13
8215828|NCT02092649|20260914|P1|STARTED|Overall Study|13 participants recruited|13
8215829|NCT02092610|20260932|P2|NOT COMPLETED|Overall Study||12
8215830|NCT02092610|20260933|P1|NOT COMPLETED|Overall Study||8
8215831|NCT02092610|20260932|P2|COMPLETED|Overall Study||40
8215832|NCT02092610|20260933|P1|COMPLETED|Overall Study||17
8215833|NCT02092610|20260932|P2|STARTED|Overall Study||52
8215834|NCT02092610|20260933|P1|STARTED|Overall Study||25
8215835|NCT02092441|20260947|P2|NOT COMPLETED|Overall Study||0
8215836|NCT02092441|20260948|P1|NOT COMPLETED|Overall Study||0
8215837|NCT02092441|20260947|P2|COMPLETED|Overall Study||43
8215838|NCT02092441|20260948|P1|COMPLETED|Overall Study||37
8215839|NCT02092441|20260947|P2|STARTED|Overall Study||43
8215840|NCT02092441|20260948|P1|STARTED|Overall Study||37
8215841|NCT02092415|20260958|P1|NOT COMPLETED|Overall Study||0
8215842|NCT02092415|20260958|P1|COMPLETED|Overall Study||10
8215843|NCT02092415|20260958|P1|STARTED|Overall Study||10
8215844|NCT02092389|20260963|P1|NOT COMPLETED|Overall Study||6
8215845|NCT02092389|20260963|P1|COMPLETED|Overall Study||4
8215846|NCT02092389|20260963|P1|STARTED|Overall Study||10
8215847|NCT02092350|20260975|P2|NOT COMPLETED|Overall Study||12
8215848|NCT02092350|20260976|P1|NOT COMPLETED|Overall Study||10
8215849|NCT02092350|20260975|P2|COMPLETED|Overall Study||102
8215850|NCT02092350|20260976|P1|COMPLETED|Overall Study||113
8215851|NCT02092350|20260975|P2|STARTED|Overall Study||114
8215852|NCT02092350|20260976|P1|STARTED|Overall Study||123
8215853|NCT02092324|20260993|P1|NOT COMPLETED|Overall Study||19
8215854|NCT02092324|20260993|P1|COMPLETED|Overall Study||32
8215855|NCT02092324|20260993|P1|Mutant CSF3R|Overall Study||26
8215856|NCT02092324|20260993|P1|Wildtype CSF3R|Overall Study||23
8215857|NCT02092324|20260993|P1|End of Cycle 6|Overall Study|This study has an accrual goal of 25 evaluable subjects who reach cycle 7, week 1.|25
8215858|NCT02092324|20260993|P1|STARTED|Overall Study||51
8215859|NCT02092311|20261013|P2|NOT COMPLETED|Overall Study||0
8215860|NCT02092311|20261014|P1|NOT COMPLETED|Overall Study||0
8215861|NCT02092311|20261013|P2|COMPLETED|Overall Study||285
8215862|NCT02092311|20261014|P1|COMPLETED|Overall Study||285
8215863|NCT02092311|20261013|P2|STARTED|Overall Study||285
8215864|NCT02092311|20261014|P1|STARTED|Overall Study||285
8215865|NCT02092285|20261024|P1|NOT COMPLETED|Maintenance Phase & Follow-up||110
8215866|NCT02092285|20261024|P1|COMPLETED|Maintenance Phase & Follow-up||60
8215867|NCT02092285|20261024|P1|STARTED|Maintenance Phase & Follow-up||170
8215868|NCT02092285|20261024|P1|NOT COMPLETED|Induction Phase||35
8215869|NCT02092285|20261024|P1|COMPLETED|Induction Phase||170
8215870|NCT02092285|20261024|P1|STARTED|Induction Phase||205
8215871|NCT02092220|20261028|P2|NOT COMPLETED|Period 2||1
8215872|NCT02092220|20261029|P1|NOT COMPLETED|Period 2||1
8215873|NCT02092220|20261028|P2|COMPLETED|Period 2||19
8215874|NCT02092220|20261029|P1|COMPLETED|Period 2||20
8215875|NCT02092220|20261028|P2|STARTED|Period 2||20
8215876|NCT02092220|20261029|P1|STARTED|Period 2||21
8215877|NCT02092220|20261028|P2|NOT COMPLETED|Period 1||2
8215878|NCT02092220|20261029|P1|NOT COMPLETED|Period 1||0
8215879|NCT02092220|20261028|P2|COMPLETED|Period 1||20
8215880|NCT02092220|20261029|P1|COMPLETED|Period 1||21
8215881|NCT02092220|20261028|P2|STARTED|Period 1||22
8215882|NCT02092220|20261029|P1|STARTED|Period 1||21
8215883|NCT02092168|20261089|P2|NOT COMPLETED|Overall Study||0
8215884|NCT02092168|20261090|P1|NOT COMPLETED|Overall Study||0
8215885|NCT02092168|20261089|P2|COMPLETED|Overall Study||12
8215886|NCT02092168|20261090|P1|COMPLETED|Overall Study||12
8215887|NCT02092168|20261089|P2|STARTED|Overall Study||12
8215888|NCT02092168|20261090|P1|STARTED|Overall Study||12
8215889|NCT02092116|20261102|P2|NOT COMPLETED|Overall Study||4
8215890|NCT02092116|20261103|P1|NOT COMPLETED|Overall Study||0
8215891|NCT02092116|20261102|P2|COMPLETED|Overall Study||16
8215892|NCT02092116|20261103|P1|COMPLETED|Overall Study||6
8215893|NCT02092116|20261102|P2|STARTED|Overall Study||20
8215894|NCT02092116|20261103|P1|STARTED|Overall Study||6
8215895|NCT02092025|20261112|P1|NOT COMPLETED|Overall Study||68
8215896|NCT02092025|20261112|P1|COMPLETED|Overall Study||3369
8215897|NCT02092025|20261112|P1|STARTED|Overall Study||3437
8215898|NCT02091986|20261121|P3|NOT COMPLETED|Overall Study||8
8215899|NCT02091986|20261122|P2|NOT COMPLETED|Overall Study||11
8215900|NCT02091986|20261123|P1|NOT COMPLETED|Overall Study||7
8215901|NCT02091986|20261121|P3|COMPLETED|Overall Study||84
8215902|NCT02091986|20261122|P2|COMPLETED|Overall Study||84
8215903|NCT02091986|20261123|P1|COMPLETED|Overall Study||85
8215904|NCT02091986|20261121|P3|STARTED|Overall Study||92
8215905|NCT02091986|20261122|P2|STARTED|Overall Study||95
8215906|NCT02091986|20261123|P1|STARTED|Overall Study||92
8215911|NCT02091921|20261181|P1|NOT COMPLETED|Overall Study||3
8215912|NCT02091921|20261181|P1|COMPLETED|Overall Study||50
8215913|NCT02091921|20261181|P1|STARTED|Overall Study||53
8215914|NCT02091869|20261190|P2|NOT COMPLETED|Overall Study||3
8215915|NCT02091869|20261191|P1|NOT COMPLETED|Overall Study||0
8215916|NCT02091869|20261190|P2|COMPLETED|Overall Study||14
8215917|NCT02091869|20261191|P1|COMPLETED|Overall Study||17
8215918|NCT02091869|20261190|P2|STARTED|Overall Study||17
8215919|NCT02091869|20261191|P1|STARTED|Overall Study||17
8215920|NCT02091856|20261206|P3|NOT COMPLETED|Follow-up Assessment||0
8215921|NCT02091856|20261207|P2|NOT COMPLETED|Follow-up Assessment||3
8215922|NCT02091856|20261208|P1|NOT COMPLETED|Follow-up Assessment||5
8215923|NCT02091856|20261206|P3|COMPLETED|Follow-up Assessment||0
8215924|NCT02091856|20261207|P2|COMPLETED|Follow-up Assessment||9
8215925|NCT02091856|20261208|P1|COMPLETED|Follow-up Assessment||10
8215926|NCT02091856|20261206|P3|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
8215927|NCT02091856|20261207|P2|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
8215928|NCT02091856|20261208|P1|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
8215929|NCT02091856|20261206|P3|NOT COMPLETED|Active Intervention Interval||7
8215930|NCT02091856|20261207|P2|NOT COMPLETED|Active Intervention Interval||7
8215931|NCT02091856|20261208|P1|NOT COMPLETED|Active Intervention Interval||19
8215932|NCT02091856|20261206|P3|COMPLETED|Active Intervention Interval||19
8215933|NCT02091856|20261207|P2|COMPLETED|Active Intervention Interval||12
8215934|NCT02091856|20261208|P1|COMPLETED|Active Intervention Interval||15
8215935|NCT02091856|20261206|P3|STARTED|Active Intervention Interval||26
8215936|NCT02091856|20261207|P2|STARTED|Active Intervention Interval||19
8215937|NCT02091856|20261208|P1|STARTED|Active Intervention Interval||34
8215938|NCT02091778|20261228|P1|NOT COMPLETED|Overall Study||1
8215939|NCT02091778|20261228|P1|COMPLETED|Overall Study||20
8215940|NCT02091778|20261228|P1|STARTED|Overall Study||21
8215941|NCT02091752|20261232|P1|NOT COMPLETED|Overall Study||3
8215942|NCT02091752|20261232|P1|COMPLETED|Overall Study||0
8215943|NCT02091752|20261232|P1|STARTED|Overall Study||3
8215944|NCT02091739|20261246|P5|NOT COMPLETED|EP: 48 Weeks||14
8215945|NCT02091739|20261247|P4|NOT COMPLETED|EP: 48 Weeks||8
8215946|NCT02091739|20261248|P3|NOT COMPLETED|EP: 48 Weeks||0
8215947|NCT02091739|20261249|P2|NOT COMPLETED|EP: 48 Weeks||0
8215948|NCT02091739|20261250|P1|NOT COMPLETED|EP: 48 Weeks||0
8215949|NCT02091739|20261246|P5|COMPLETED|EP: 48 Weeks||75
8215950|NCT02091739|20261247|P4|COMPLETED|EP: 48 Weeks||76
8215951|NCT02091739|20261248|P3|COMPLETED|EP: 48 Weeks||0
8215952|NCT02091739|20261249|P2|COMPLETED|EP: 48 Weeks||0
8215953|NCT02091739|20261250|P1|COMPLETED|EP: 48 Weeks||0
8215954|NCT02091739|20261246|P5|STARTED|EP: 48 Weeks||89
8215955|NCT02091739|20261247|P4|STARTED|EP: 48 Weeks||84
8215956|NCT02091739|20261248|P3|STARTED|EP: 48 Weeks||0
8215957|NCT02091739|20261249|P2|STARTED|EP: 48 Weeks||0
8215958|NCT02091739|20261250|P1|STARTED|EP: 48 Weeks||0
8215959|NCT02091739|20261246|P5|NOT COMPLETED|MP: 16 Weeks||0
8215960|NCT02091739|20261247|P4|NOT COMPLETED|MP: 16 Weeks||0
8215961|NCT02091739|20261248|P3|NOT COMPLETED|MP: 16 Weeks||2
8215962|NCT02091739|20261249|P2|NOT COMPLETED|MP: 16 Weeks||5
8215963|NCT02091739|20261250|P1|NOT COMPLETED|MP: 16 Weeks||4
8215964|NCT02091739|20261246|P5|COMPLETED|MP: 16 Weeks||0
8215965|NCT02091739|20261247|P4|COMPLETED|MP: 16 Weeks||0
8215966|NCT02091739|20261248|P3|COMPLETED|MP: 16 Weeks||72
8215967|NCT02091739|20261249|P2|COMPLETED|MP: 16 Weeks||69
8215968|NCT02091739|20261250|P1|COMPLETED|MP: 16 Weeks||32
8215969|NCT02091739|20261246|P5|STARTED|MP: 16 Weeks||0
8215970|NCT02091739|20261247|P4|STARTED|MP: 16 Weeks||0
8215971|NCT02091739|20261248|P3|STARTED|MP: 16 Weeks||74
8215972|NCT02091739|20261249|P2|STARTED|MP: 16 Weeks||74
8215973|NCT02091739|20261250|P1|STARTED|MP: 16 Weeks||36
8215974|NCT02091726|20261269|P1|NOT COMPLETED|Overall Study||6
8215975|NCT02091726|20261269|P1|COMPLETED|Overall Study||104
8215976|NCT02091726|20261269|P1|4 Week Followup|Overall Study||104
8215977|NCT02091726|20261269|P1|1 Week Followup|Overall Study||110
8215978|NCT02091726|20261269|P1|STARTED|Overall Study||110
8215979|NCT02091531|20261277|P1|NOT COMPLETED|Overall Study||0
8215980|NCT02091531|20261277|P1|COMPLETED|Overall Study||9
8215981|NCT02091531|20261277|P1|STARTED|Overall Study||9
8215982|NCT02091466|20261285|P2|NOT COMPLETED|Overall Study||0
8215983|NCT02091466|20261286|P1|NOT COMPLETED|Overall Study||0
8215984|NCT02091466|20261285|P2|COMPLETED|Overall Study||20
8215985|NCT02091466|20261286|P1|COMPLETED|Overall Study||20
8215986|NCT02091466|20261285|P2|STARTED|Overall Study||20
8215987|NCT02091466|20261286|P1|STARTED|Overall Study||20
8215988|NCT02091440|20261292|P1|NOT COMPLETED|Overall Study||2
8215989|NCT02091440|20261292|P1|COMPLETED|Overall Study||4
8215990|NCT02091440|20261292|P1|Overall Survival at 180 Days|Overall Study||6
8215991|NCT02091440|20261292|P1|Primary Endpoint (Success at 180 Days)|Overall Study||6
8215992|NCT02091440|20261292|P1|STARTED|Overall Study||6
8215993|NCT02091414|20261302|P1|NOT COMPLETED|Overall Study||4
8215994|NCT02091414|20261302|P1|COMPLETED|Overall Study||32
8215995|NCT02091414|20261302|P1|STARTED|Overall Study||36
8215996|NCT02091375|20261316|P2|NOT COMPLETED|Overall Study||3
8215997|NCT02091375|20261317|P1|NOT COMPLETED|Overall Study||9
8215998|NCT02091375|20261316|P2|COMPLETED|Overall Study||56
8215999|NCT02091375|20261317|P1|COMPLETED|Overall Study||52
8216000|NCT02091375|20261316|P2|Intention to Treat (ITT) Analysis Set|Overall Study||59
8216001|NCT02091375|20261317|P1|Intention to Treat (ITT) Analysis Set|Overall Study||61
8216002|NCT02091375|20261316|P2|Safety Analysis Set|Overall Study||59
8216003|NCT02091375|20261317|P1|Safety Analysis Set|Overall Study||61
8216004|NCT02091375|20261316|P2|STARTED|Overall Study||59
8216005|NCT02091375|20261317|P1|STARTED|Overall Study||61
8216006|NCT02091362|20261347|P2|NOT COMPLETED|Period 2||2
8216007|NCT02091362|20261348|P1|NOT COMPLETED|Period 2||2
8216008|NCT02091362|20261347|P2|COMPLETED|Period 2||128
8216009|NCT02091362|20261348|P1|COMPLETED|Period 2||125
8216010|NCT02091362|20261347|P2|STARTED|Period 2||130
8216011|NCT02091362|20261348|P1|STARTED|Period 2||127
8216012|NCT02091362|20261347|P2|NOT COMPLETED|Wash-out||3
8216013|NCT02091362|20261348|P1|NOT COMPLETED|Wash-out||1
8216014|NCT02091362|20261347|P2|COMPLETED|Wash-out||130
8216015|NCT02091362|20261348|P1|COMPLETED|Wash-out||127
8216016|NCT02091362|20261347|P2|STARTED|Wash-out||133
8216017|NCT02091362|20261348|P1|STARTED|Wash-out||128
8216018|NCT02091362|20261347|P2|NOT COMPLETED|Period 1||4
8216019|NCT02091362|20261348|P1|NOT COMPLETED|Period 1||5
8216020|NCT02091362|20261347|P2|COMPLETED|Period 1||133
8216021|NCT02091362|20261348|P1|COMPLETED|Period 1||128
8216022|NCT02091362|20261347|P2|STARTED|Period 1||137
8216023|NCT02091362|20261348|P1|STARTED|Period 1||133
8216024|NCT02091284|20261370|P2|NOT COMPLETED|Overall Study||1
8216025|NCT02091284|20261371|P1|NOT COMPLETED|Overall Study||3
8216026|NCT02091284|20261370|P2|COMPLETED|Overall Study||22
8216027|NCT02091284|20261371|P1|COMPLETED|Overall Study||23
8216028|NCT02091284|20261370|P2|STARTED|Overall Study|One subject from this group discontinued the protocol|23
8216029|NCT02091284|20261371|P1|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26
8216030|NCT02091206|20261393|P4|NOT COMPLETED|Taper Period||2
8216031|NCT02091206|20261394|P3|NOT COMPLETED|Taper Period||0
8216032|NCT02091206|20261395|P2|NOT COMPLETED|Taper Period||0
8216033|NCT02091206|20261396|P1|NOT COMPLETED|Taper Period||1
8216034|NCT02091206|20261393|P4|COMPLETED|Taper Period||5
8216035|NCT02091206|20261394|P3|COMPLETED|Taper Period||8
8216036|NCT02091206|20261395|P2|COMPLETED|Taper Period||7
8216037|NCT02091206|20261396|P1|COMPLETED|Taper Period||9
8216038|NCT02091206|20261393|P4|STARTED|Taper Period||7
8216039|NCT02091206|20261394|P3|STARTED|Taper Period||8
8216040|NCT02091206|20261395|P2|STARTED|Taper Period||7
8216041|NCT02091206|20261396|P1|STARTED|Taper Period||10
8216042|NCT02091206|20261393|P4|NOT COMPLETED|Treatment Period||0
8216043|NCT02091206|20261394|P3|NOT COMPLETED|Treatment Period||1
8216044|NCT02091206|20261395|P2|NOT COMPLETED|Treatment Period||1
8216045|NCT02091206|20261396|P1|NOT COMPLETED|Treatment Period||0
8216046|NCT02091206|20261393|P4|COMPLETED|Treatment Period||7
8216047|NCT02091206|20261394|P3|COMPLETED|Treatment Period||8
8216048|NCT02091206|20261395|P2|COMPLETED|Treatment Period||7
8216049|NCT02091206|20261396|P1|COMPLETED|Treatment Period||10
8216050|NCT02091206|20261393|P4|Safety Analysis Set|Treatment Period||7
8216051|NCT02091206|20261394|P3|Safety Analysis Set|Treatment Period||9
8216052|NCT02091206|20261395|P2|Safety Analysis Set|Treatment Period||8
8216053|NCT02091206|20261396|P1|Safety Analysis Set|Treatment Period||10
8216054|NCT02091206|20261393|P4|STARTED|Treatment Period||7
8216055|NCT02091206|20261394|P3|STARTED|Treatment Period||9
8216056|NCT02091206|20261395|P2|STARTED|Treatment Period||8
8216057|NCT02091206|20261396|P1|STARTED|Treatment Period||10
8216058|NCT02091167|20261415|P2|NOT COMPLETED|Overall Study||2
8216059|NCT02091167|20261416|P1|NOT COMPLETED|Overall Study||0
8216060|NCT02091167|20261415|P2|COMPLETED|Overall Study||14
8216061|NCT02091167|20261416|P1|COMPLETED|Overall Study||19
8216062|NCT02091167|20261415|P2|STARTED|Overall Study||16
8216063|NCT02091167|20261416|P1|STARTED|Overall Study||19
8216064|NCT02091102|20261424|P1|NOT COMPLETED|Overall Study||0
8216065|NCT02091102|20261424|P1|COMPLETED|Overall Study||20
8216066|NCT02091102|20261424|P1|STARTED|Overall Study||20
8216067|NCT02091089|20261432|P1|NOT COMPLETED|Overall Study||2
8216068|NCT02091089|20261432|P1|COMPLETED|Overall Study||18
8216069|NCT02091089|20261432|P1|STARTED|Overall Study||20
8216070|NCT02090959|20261440|P1|NOT COMPLETED|Overall Study||151
8216071|NCT02090959|20261440|P1|COMPLETED|Overall Study||68
8216072|NCT02090959|20261440|P1|As-treated Population|Overall Study||218
8216073|NCT02090959|20261440|P1|STARTED|Overall Study||219
8216074|NCT02090894|20261462|P1|NOT COMPLETED|Overall Study||0
8216075|NCT02090894|20261462|P1|COMPLETED|Overall Study||11
8216076|NCT02090894|20261462|P1|STARTED|Overall Study||11
8216077|NCT02090855|20261467|P1|NOT COMPLETED|Overall Study||2
8216078|NCT02090855|20261467|P1|COMPLETED|Overall Study||106
8216079|NCT02090855|20261467|P1|STARTED|Overall Study||108
8216080|NCT02090777|20261474|P1|NOT COMPLETED|Overall Study||0
8216081|NCT02090777|20261474|P1|COMPLETED|Overall Study||4
8216082|NCT02090777|20261474|P1|STARTED|Overall Study||4
8216083|NCT02090764|20261480|P2|NOT COMPLETED|Overall Study||20
8216084|NCT02090764|20261481|P1|NOT COMPLETED|Overall Study||6
8216085|NCT02090764|20261480|P2|COMPLETED|Overall Study||186
8216086|NCT02090764|20261481|P1|COMPLETED|Overall Study||200
8216087|NCT02090764|20261480|P2|STARTED|Overall Study||206
8216088|NCT02090764|20261481|P1|STARTED|Overall Study||206
8216089|NCT02090725|20261487|P1|NOT COMPLETED|Overall Study||4
8216090|NCT02090725|20261487|P1|COMPLETED|Overall Study||0
8216091|NCT02090725|20261487|P1|STARTED|Overall Study||4
8216092|NCT02090426|20261493|P2|NOT COMPLETED|Overall Study||6
8216093|NCT02090426|20261494|P1|NOT COMPLETED|Overall Study||12
8216094|NCT02090426|20261493|P2|COMPLETED|Overall Study||393
8216095|NCT02090426|20261494|P1|COMPLETED|Overall Study||389
8216096|NCT02090426|20261493|P2|Analysis Population|Overall Study||393
8216097|NCT02090426|20261494|P1|Analysis Population|Overall Study||389
8216098|NCT02090426|20261493|P2|STARTED|Overall Study||399
8216099|NCT02090426|20261494|P1|STARTED|Overall Study||401
8216100|NCT02090413|20261525|P3|NOT COMPLETED|Overall Study||23
8216101|NCT02090413|20261526|P2|NOT COMPLETED|Overall Study||20
8216102|NCT02090413|20261527|P1|NOT COMPLETED|Overall Study||19
8216103|NCT02090413|20261525|P3|COMPLETED|Overall Study||57
8216104|NCT02090413|20261526|P2|COMPLETED|Overall Study||60
8216105|NCT02090413|20261527|P1|COMPLETED|Overall Study||62
8216106|NCT02090413|20261525|P3|STARTED|Overall Study||80
8216107|NCT02090413|20261526|P2|STARTED|Overall Study||80
8216108|NCT02090413|20261527|P1|STARTED|Overall Study||81
8216109|NCT02090283|20261604|P3|NOT COMPLETED|Overall Study||10
8216110|NCT02090283|20261605|P2|NOT COMPLETED|Overall Study||15
8216111|NCT02090283|20261606|P1|NOT COMPLETED|Overall Study||17
8216112|NCT02090283|20261604|P3|COMPLETED|Overall Study||0
8216113|NCT02090283|20261605|P2|COMPLETED|Overall Study||0
8216114|NCT02090283|20261606|P1|COMPLETED|Overall Study||0
8216115|NCT02090283|20261604|P3|Received At Least 1 Dose Of Study Drug|Overall Study||10
8216116|NCT02090283|20261605|P2|Received At Least 1 Dose Of Study Drug|Overall Study||15
8216117|NCT02090283|20261606|P1|Received At Least 1 Dose Of Study Drug|Overall Study||17
8216118|NCT02090283|20261604|P3|STARTED|Overall Study||10
8216119|NCT02090283|20261605|P2|STARTED|Overall Study||15
8216120|NCT02090283|20261606|P1|STARTED|Overall Study||17
8216121|NCT02090088|20261617|P1|NOT COMPLETED|Overall Study||0
8216122|NCT02090088|20261617|P1|COMPLETED|Overall Study||4
8216123|NCT02090088|20261617|P1|Gave Birth|Overall Study||4
8216124|NCT02090088|20261617|P1|STARTED|Overall Study||4
8216125|NCT02090075|20261631|P2|NOT COMPLETED|Overall Study||3
8216126|NCT02090075|20261632|P1|NOT COMPLETED|Overall Study||7
8216127|NCT02090075|20261631|P2|COMPLETED|Overall Study||30
8216128|NCT02090075|20261632|P1|COMPLETED|Overall Study||26
8216129|NCT02090075|20261631|P2|STARTED|Overall Study||33
8216130|NCT02090075|20261632|P1|STARTED|Overall Study||33
8216131|NCT02089997|20261640|P1|NOT COMPLETED|Overall Study||246
8216132|NCT02089997|20261640|P1|COMPLETED|Overall Study||3058
8216133|NCT02089997|20261640|P1|STARTED|Overall Study||3304
8216134|NCT02089737|20261655|P1|NOT COMPLETED|Overall Study||6
8216135|NCT02089737|20261655|P1|COMPLETED|Overall Study||3085
8216136|NCT02089737|20261655|P1|STARTED|Overall Study||3091
8216137|NCT02089659|20261664|P3|NOT COMPLETED|Overall Study||0
8216138|NCT02089659|20261665|P2|NOT COMPLETED|Overall Study||0
8216139|NCT02089659|20261666|P1|NOT COMPLETED|Overall Study||0
8216140|NCT02089659|20261664|P3|COMPLETED|Overall Study||0
8216141|NCT02089659|20261665|P2|COMPLETED|Overall Study||8
8216142|NCT02089659|20261666|P1|COMPLETED|Overall Study||8
8216143|NCT02089659|20261664|P3|STARTED|Overall Study||0
8216144|NCT02089659|20261665|P2|STARTED|Overall Study||8
8216145|NCT02089659|20261666|P1|STARTED|Overall Study||8
8216146|NCT02089464|20261680|P2|NOT COMPLETED|Overall Study||16
8216147|NCT02089464|20261681|P1|NOT COMPLETED|Overall Study||28
8216148|NCT02089464|20261680|P2|COMPLETED|Overall Study||51
8216149|NCT02089464|20261681|P1|COMPLETED|Overall Study||104
8216150|NCT02089464|20261680|P2|STARTED|Overall Study||67
8216151|NCT02089464|20261681|P1|STARTED|Overall Study||132
8216152|NCT02089347|20261705|P2|NOT COMPLETED|Overall Study||0
8216153|NCT02089347|20261706|P1|NOT COMPLETED|Overall Study||1
8216154|NCT02089347|20261705|P2|COMPLETED|Overall Study||178
8216155|NCT02089347|20261706|P1|COMPLETED|Overall Study||355
8216156|NCT02089347|20261705|P2|STARTED|Overall Study||178
8216157|NCT02089347|20261706|P1|STARTED|Overall Study||356
8216158|NCT02089334|20261732|P4|NOT COMPLETED|Overall Study||7
8216159|NCT02089334|20261733|P3|NOT COMPLETED|Overall Study||1
8216160|NCT02089334|20261734|P2|NOT COMPLETED|Overall Study||0
8216161|NCT02089334|20261735|P1|NOT COMPLETED|Overall Study||0
8216162|NCT02089334|20261732|P4|COMPLETED|Overall Study||6
8216163|NCT02089334|20261733|P3|COMPLETED|Overall Study||3
8216164|NCT02089334|20261734|P2|COMPLETED|Overall Study||4
8216165|NCT02089334|20261735|P1|COMPLETED|Overall Study||3
8216166|NCT02089334|20261732|P4|Received Study Drug|Overall Study||11
8216167|NCT02089334|20261733|P3|Received Study Drug|Overall Study||3
8216168|NCT02089334|20261734|P2|Received Study Drug|Overall Study||4
8216169|NCT02089334|20261735|P1|Received Study Drug|Overall Study||3
8216170|NCT02089334|20261732|P4|STARTED|Overall Study||13
8216171|NCT02089334|20261733|P3|STARTED|Overall Study||4
8216172|NCT02089334|20261734|P2|STARTED|Overall Study||4
8216173|NCT02089334|20261735|P1|STARTED|Overall Study||3
8216174|NCT02089191|20261752|P2|NOT COMPLETED|Period 2, Second 12 Hours||0
8216175|NCT02089191|20261753|P1|NOT COMPLETED|Period 2, Second 12 Hours||0
8216176|NCT02089191|20261752|P2|COMPLETED|Period 2, Second 12 Hours||15
8216177|NCT02089191|20261753|P1|COMPLETED|Period 2, Second 12 Hours||15
8216178|NCT02089191|20261752|P2|STARTED|Period 2, Second 12 Hours||15
8216179|NCT02089191|20261753|P1|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
8216180|NCT02089191|20261752|P2|NOT COMPLETED|Period 1, First 12 Hours||0
8216181|NCT02089191|20261753|P1|NOT COMPLETED|Period 1, First 12 Hours||0
8216182|NCT02089191|20261752|P2|COMPLETED|Period 1, First 12 Hours||15
8216183|NCT02089191|20261753|P1|COMPLETED|Period 1, First 12 Hours||16
8216184|NCT02089191|20261752|P2|STARTED|Period 1, First 12 Hours||15
8216185|NCT02089191|20261753|P1|STARTED|Period 1, First 12 Hours||16
8216186|NCT02089113|20261763|P2|NOT COMPLETED|Overall Study||0
8216187|NCT02089113|20261764|P1|NOT COMPLETED|Overall Study||1
8216188|NCT02089113|20261763|P2|COMPLETED|Overall Study||80
8216189|NCT02089113|20261764|P1|COMPLETED|Overall Study||160
8216190|NCT02089113|20261763|P2|STARTED|Overall Study||80
8216191|NCT02089113|20261764|P1|STARTED|Overall Study||161
8216192|NCT02088957|20261772|P2|NOT COMPLETED|Overall Study||0
8216193|NCT02088957|20261773|P1|NOT COMPLETED|Overall Study||1
8216194|NCT02088957|20261772|P2|COMPLETED|Overall Study||0
8216195|NCT02088957|20261773|P1|COMPLETED|Overall Study||0
8216196|NCT02088957|20261772|P2|STARTED|Overall Study||0
8216197|NCT02088957|20261773|P1|STARTED|Overall Study||1
8216198|NCT02088905|20261791|P2|NOT COMPLETED|Overall Study||1
8216199|NCT02088905|20261792|P1|NOT COMPLETED|Overall Study||5
8216200|NCT02088905|20261791|P2|COMPLETED|Overall Study||9
8216201|NCT02088905|20261792|P1|COMPLETED|Overall Study||8
8216202|NCT02088905|20261791|P2|Week 9|Overall Study||9
8216203|NCT02088905|20261792|P1|Week 9|Overall Study||10
8216204|NCT02088905|20261791|P2|STARTED|Overall Study||10
8216205|NCT02088905|20261792|P1|STARTED|Overall Study||13
8216206|NCT02088788|20261814|P2|NOT COMPLETED|Overall Study||41
8216207|NCT02088788|20261815|P1|NOT COMPLETED|Overall Study||30
8216208|NCT02088788|20261814|P2|COMPLETED|Overall Study||89
8216209|NCT02088788|20261815|P1|COMPLETED|Overall Study||105
8216210|NCT02088788|20261814|P2|STARTED|Overall Study||130
8216211|NCT02088788|20261815|P1|STARTED|Overall Study||135
8216212|NCT02088541|20261828|P5|NOT COMPLETED|Overall Study||58
8216213|NCT02088541|20261829|P4|NOT COMPLETED|Overall Study||44
8216214|NCT02088541|20261830|P3|NOT COMPLETED|Overall Study||117
8216215|NCT02088541|20261831|P2|NOT COMPLETED|Overall Study||27
8216216|NCT02088541|20261832|P1|NOT COMPLETED|Overall Study||71
8216217|NCT02088541|20261828|P5|COMPLETED|Overall Study||0
8216218|NCT02088541|20261829|P4|COMPLETED|Overall Study||0
8216219|NCT02088541|20261830|P3|COMPLETED|Overall Study||0
8216220|NCT02088541|20261831|P2|COMPLETED|Overall Study||0
8216221|NCT02088541|20261832|P1|COMPLETED|Overall Study||0
8216222|NCT02088541|20261828|P5|Intent-to-treat (ITT) Population|Overall Study||57
8216223|NCT02088541|20261829|P4|Intent-to-treat (ITT) Population|Overall Study||0
8216224|NCT02088541|20261830|P3|Intent-to-treat (ITT) Population|Overall Study|1 randomized to Selinexor 60mg (PV>=5) but treated with physician choice 2, counted under this arm.|118
8216225|NCT02088541|20261831|P2|Intent-to-treat (ITT) Population|Overall Study||0
8216226|NCT02088541|20261832|P1|Intent-to-treat (ITT) Population|Overall Study||0
8216227|NCT02088541|20261828|P5|Safety Population|Overall Study||45
8216228|NCT02088541|20261829|P4|Safety Population|Overall Study||39
8216229|NCT02088541|20261830|P3|Safety Population|Overall Study||115
8216230|NCT02088541|20261831|P2|Safety Population|Overall Study||27
8216231|NCT02088541|20261832|P1|Safety Population|Overall Study||71
8216232|NCT02088541|20261828|P5|STARTED|Overall Study||58
8216233|NCT02088541|20261829|P4|STARTED|Overall Study||44
8216234|NCT02088541|20261830|P3|STARTED|Overall Study||117
8216235|NCT02088541|20261831|P2|STARTED|Overall Study||27
8216236|NCT02088541|20261832|P1|STARTED|Overall Study||71
8216237|NCT02088385|20261865|P2|NOT COMPLETED|Overall Study||0
8216238|NCT02088385|20261866|P1|NOT COMPLETED|Overall Study||0
8216239|NCT02088385|20261865|P2|COMPLETED|Overall Study||10
8216240|NCT02088385|20261866|P1|COMPLETED|Overall Study||10
8216241|NCT02088385|20261865|P2|STARTED|Overall Study||10
8216242|NCT02088385|20261866|P1|STARTED|Overall Study||10
8216243|NCT02088216|20261876|P2|NOT COMPLETED|Overall Study||10
8216244|NCT02088216|20261877|P1|NOT COMPLETED|Overall Study||12
8216245|NCT02088216|20261876|P2|COMPLETED|Overall Study||70
8216246|NCT02088216|20261877|P1|COMPLETED|Overall Study||69
8216247|NCT02088216|20261876|P2|STARTED|Overall Study||80
8216248|NCT02088216|20261877|P1|STARTED|Overall Study||81
8216249|NCT02088177|20261903|P1|NOT COMPLETED|Overall Study||3
8216250|NCT02088177|20261903|P1|COMPLETED|Overall Study||9
8216251|NCT02088177|20261903|P1|STARTED|Overall Study||12
8216252|NCT02088073|20261913|P5|NOT COMPLETED|Maintanance Phase||7
8216253|NCT02088073|20261914|P4|NOT COMPLETED|Maintanance Phase||7
8216254|NCT02088073|20261915|P3|NOT COMPLETED|Maintanance Phase||5
8216255|NCT02088073|20261916|P2|NOT COMPLETED|Maintanance Phase||10
8216256|NCT02088073|20261917|P1|NOT COMPLETED|Maintanance Phase||0
8216257|NCT02088073|20261913|P5|COMPLETED|Maintanance Phase||49
8216258|NCT02088073|20261914|P4|COMPLETED|Maintanance Phase||44
8216259|NCT02088073|20261915|P3|COMPLETED|Maintanance Phase||40
8216260|NCT02088073|20261916|P2|COMPLETED|Maintanance Phase||75
8216261|NCT02088073|20261917|P1|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
8216262|NCT02088073|20261913|P5|STARTED|Maintanance Phase||56
8216263|NCT02088073|20261914|P4|STARTED|Maintanance Phase||51
8216264|NCT02088073|20261915|P3|STARTED|Maintanance Phase||45
8216265|NCT02088073|20261916|P2|STARTED|Maintanance Phase||85
8216266|NCT02088073|20261917|P1|STARTED|Maintanance Phase||0
8216267|NCT02088073|20261913|P5|NOT COMPLETED|Acute Phase||0
8216268|NCT02088073|20261914|P4|NOT COMPLETED|Acute Phase||0
8216269|NCT02088073|20261915|P3|NOT COMPLETED|Acute Phase||0
8216270|NCT02088073|20261916|P2|NOT COMPLETED|Acute Phase||0
8216271|NCT02088073|20261917|P1|NOT COMPLETED|Acute Phase||7
8216272|NCT02088073|20261913|P5|COMPLETED|Acute Phase||0
8216273|NCT02088073|20261914|P4|COMPLETED|Acute Phase||0
8216274|NCT02088073|20261915|P3|COMPLETED|Acute Phase||0
8216275|NCT02088073|20261916|P2|COMPLETED|Acute Phase||0
8216276|NCT02088073|20261917|P1|COMPLETED|Acute Phase||251
8216277|NCT02088073|20261913|P5|STARTED|Acute Phase||0
8216278|NCT02088073|20261914|P4|STARTED|Acute Phase||0
8216279|NCT02088073|20261915|P3|STARTED|Acute Phase||0
8216280|NCT02088073|20261916|P2|STARTED|Acute Phase||0
8216281|NCT02088073|20261917|P1|STARTED|Acute Phase||258
8216282|NCT02088047|20261971|P2|NOT COMPLETED|Overall Study||0
8216283|NCT02088047|20261972|P1|NOT COMPLETED|Overall Study||1
8216284|NCT02088047|20261971|P2|COMPLETED|Overall Study||1
8216285|NCT02088047|20261972|P1|COMPLETED|Overall Study||2
8216286|NCT02088047|20261971|P2|STARTED|Overall Study||1
8216287|NCT02088047|20261972|P1|STARTED|Overall Study||3
8216288|NCT02088034|20261981|P3|NOT COMPLETED|Overall Study||2
8216289|NCT02088034|20261982|P2|NOT COMPLETED|Overall Study||2
8216290|NCT02088034|20261983|P1|NOT COMPLETED|Overall Study||3
8216291|NCT02088034|20261981|P3|COMPLETED|Overall Study||27
8216292|NCT02088034|20261982|P2|COMPLETED|Overall Study||28
8216293|NCT02088034|20261983|P1|COMPLETED|Overall Study||30
8216294|NCT02088034|20261981|P3|STARTED|Overall Study||29
8216295|NCT02088034|20261982|P2|STARTED|Overall Study||30
8216296|NCT02088034|20261983|P1|STARTED|Overall Study||33
8216297|NCT02087995|20261991|P1|NOT COMPLETED|Overall Study||0
8216298|NCT02087995|20261991|P1|COMPLETED|Overall Study||51
8216299|NCT02087995|20261991|P1|STARTED|Overall Study||51
8216300|NCT02087956|20261997|P2|NOT COMPLETED|Overall Study||5
8216301|NCT02087956|20261998|P1|NOT COMPLETED|Overall Study||6
8216302|NCT02087956|20261997|P2|COMPLETED|Overall Study||107
8216303|NCT02087956|20261998|P1|COMPLETED|Overall Study||105
8216304|NCT02087956|20261997|P2|STARTED|Overall Study||112
8216305|NCT02087956|20261998|P1|STARTED|Overall Study||111
8216306|NCT02087943|20262013|P5|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
8216307|NCT02087943|20262014|P4|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
8216308|NCT02087943|20262015|P3|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
8216309|NCT02087943|20262016|P2|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
8216310|NCT02087943|20262017|P1|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
8216311|NCT02087943|20262013|P5|COMPLETED|Observational Follow-up Phase Week 24-30||22
8216312|NCT02087943|20262014|P4|COMPLETED|Observational Follow-up Phase Week 24-30||23
8216313|NCT02087943|20262015|P3|COMPLETED|Observational Follow-up Phase Week 24-30||45
8216314|NCT02087943|20262016|P2|COMPLETED|Observational Follow-up Phase Week 24-30||46
8216315|NCT02087943|20262017|P1|COMPLETED|Observational Follow-up Phase Week 24-30||0
8216316|NCT02087943|20262013|P5|STARTED|Observational Follow-up Phase Week 24-30||23
8216317|NCT02087943|20262014|P4|STARTED|Observational Follow-up Phase Week 24-30||24
8216318|NCT02087943|20262015|P3|STARTED|Observational Follow-up Phase Week 24-30||48
8216319|NCT02087943|20262016|P2|STARTED|Observational Follow-up Phase Week 24-30||46
8216320|NCT02087943|20262017|P1|STARTED|Observational Follow-up Phase Week 24-30||0
8216321|NCT02087943|20262013|P5|NOT COMPLETED|Active Treatment Phase Week 12-24||2
8216322|NCT02087943|20262014|P4|NOT COMPLETED|Active Treatment Phase Week 12-24||2
8216323|NCT02087943|20262015|P3|NOT COMPLETED|Active Treatment Phase Week 12-24||5
8216324|NCT02087943|20262016|P2|NOT COMPLETED|Active Treatment Phase Week 12-24||4
8216325|NCT02087943|20262017|P1|NOT COMPLETED|Active Treatment Phase Week 12-24||0
8216326|NCT02087943|20262013|P5|COMPLETED|Active Treatment Phase Week 12-24||21
8216327|NCT02087943|20262014|P4|COMPLETED|Active Treatment Phase Week 12-24||22
8216328|NCT02087943|20262015|P3|COMPLETED|Active Treatment Phase Week 12-24||44
8216329|NCT02087943|20262016|P2|COMPLETED|Active Treatment Phase Week 12-24||42
8216330|NCT02087943|20262017|P1|COMPLETED|Active Treatment Phase Week 12-24||0
8216331|NCT02087943|20262013|P5|STARTED|Active Treatment Phase Week 12-24||23
8216332|NCT02087943|20262014|P4|STARTED|Active Treatment Phase Week 12-24||24
8216333|NCT02087943|20262015|P3|STARTED|Active Treatment Phase Week 12-24||49
8216334|NCT02087943|20262016|P2|STARTED|Active Treatment Phase Week 12-24||46
8216335|NCT02087943|20262017|P1|STARTED|Active Treatment Phase Week 12-24||0
8216336|NCT02087943|20262013|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
8216337|NCT02087943|20262014|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
8216338|NCT02087943|20262015|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
8216339|NCT02087943|20262016|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
8216340|NCT02087943|20262017|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
8216341|NCT02087943|20262013|P5|COMPLETED|Placebo-Controlled Phase Week 0-12||0
8216342|NCT02087943|20262014|P4|COMPLETED|Placebo-Controlled Phase Week 0-12||0
8216343|NCT02087943|20262015|P3|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
8216344|NCT02087943|20262016|P2|COMPLETED|Placebo-Controlled Phase Week 0-12||46
8216345|NCT02087943|20262017|P1|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
8216346|NCT02087943|20262013|P5|Safety Population|Placebo-Controlled Phase Week 0-12||0
8216347|NCT02087943|20262014|P4|Safety Population|Placebo-Controlled Phase Week 0-12||0
8216348|NCT02087943|20262015|P3|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
8216349|NCT02087943|20262016|P2|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
8216350|NCT02087943|20262017|P1|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
8216351|NCT02087943|20262013|P5|STARTED|Placebo-Controlled Phase Week 0-12||0
8216352|NCT02087943|20262014|P4|STARTED|Placebo-Controlled Phase Week 0-12||0
8216353|NCT02087943|20262015|P3|STARTED|Placebo-Controlled Phase Week 0-12||63
8216354|NCT02087943|20262016|P2|STARTED|Placebo-Controlled Phase Week 0-12||58
8216355|NCT02087943|20262017|P1|STARTED|Placebo-Controlled Phase Week 0-12||64
8216356|NCT02087904|20262045|P4|NOT COMPLETED|Overall Study||25
8216357|NCT02087904|20262046|P3|NOT COMPLETED|Overall Study||22
8216358|NCT02087904|20262047|P2|NOT COMPLETED|Overall Study||19
8216359|NCT02087904|20262048|P1|NOT COMPLETED|Overall Study||25
8216360|NCT02087904|20262045|P4|COMPLETED|Overall Study||64
8216361|NCT02087904|20262046|P3|COMPLETED|Overall Study||65
8216362|NCT02087904|20262047|P2|COMPLETED|Overall Study||70
8216363|NCT02087904|20262048|P1|COMPLETED|Overall Study||60
8216364|NCT02087904|20262045|P4|STARTED|Overall Study||89
8216365|NCT02087904|20262046|P3|STARTED|Overall Study||87
8216366|NCT02087904|20262047|P2|STARTED|Overall Study||89
8216367|NCT02087904|20262048|P1|STARTED|Overall Study||85
8216368|NCT02087774|20262164|P2|NOT COMPLETED|Overall Study||20
8216369|NCT02087774|20262165|P1|NOT COMPLETED|Overall Study||8
8216370|NCT02087774|20262164|P2|COMPLETED|Overall Study||130
8216371|NCT02087774|20262165|P1|COMPLETED|Overall Study||142
8216372|NCT02087774|20262164|P2|STARTED|Overall Study||150
8216373|NCT02087774|20262165|P1|STARTED|Overall Study||150
8216374|NCT02087748|20262173|P1|NOT COMPLETED|Overall Study||0
8216375|NCT02087748|20262173|P1|COMPLETED|Overall Study||24
8216376|NCT02087748|20262173|P1|STARTED|Overall Study||24
8216377|NCT02087670|20262185|P2|NOT COMPLETED|Overall Study||2
8216378|NCT02087670|20262186|P1|NOT COMPLETED|Overall Study||3
8216379|NCT02087670|20262185|P2|COMPLETED|Overall Study||20
8216380|NCT02087670|20262186|P1|COMPLETED|Overall Study||17
8216381|NCT02087670|20262185|P2|STARTED|Overall Study||22
8216382|NCT02087670|20262186|P1|STARTED|Overall Study||20
8216383|NCT02087514|20262200|P6|NOT COMPLETED|Overall Study||1
8216384|NCT02087514|20262201|P5|NOT COMPLETED|Overall Study||0
8216385|NCT02087514|20262202|P4|NOT COMPLETED|Overall Study||2
8216386|NCT02087514|20262203|P3|NOT COMPLETED|Overall Study||3
8216387|NCT02087514|20262204|P2|NOT COMPLETED|Overall Study||0
8216388|NCT02087514|20262205|P1|NOT COMPLETED|Overall Study||2
8216389|NCT02087514|20262200|P6|COMPLETED|Overall Study||9
8216390|NCT02087514|20262201|P5|COMPLETED|Overall Study||10
8216391|NCT02087514|20262202|P4|COMPLETED|Overall Study||8
8216392|NCT02087514|20262203|P3|COMPLETED|Overall Study||7
8216393|NCT02087514|20262204|P2|COMPLETED|Overall Study||10
8216394|NCT02087514|20262205|P1|COMPLETED|Overall Study||8
8216395|NCT02087514|20262200|P6|STARTED|Overall Study||10
8216396|NCT02087514|20262201|P5|STARTED|Overall Study||10
8216397|NCT02087514|20262202|P4|STARTED|Overall Study||10
8216398|NCT02087514|20262203|P3|STARTED|Overall Study||10
8216399|NCT02087514|20262204|P2|STARTED|Overall Study||10
8216400|NCT02087514|20262205|P1|STARTED|Overall Study||10
8216413|NCT02087241|20262253|P4|NOT COMPLETED|Overall Study||7
8216414|NCT02087241|20262254|P3|NOT COMPLETED|Overall Study||1
8216415|NCT02087241|20262255|P2|NOT COMPLETED|Overall Study||3
8216416|NCT02087241|20262256|P1|NOT COMPLETED|Overall Study||3
8216417|NCT02087241|20262253|P4|COMPLETED|Overall Study||0
8216418|NCT02087241|20262254|P3|COMPLETED|Overall Study||0
8216419|NCT02087241|20262255|P2|COMPLETED|Overall Study||0
8216420|NCT02087241|20262256|P1|COMPLETED|Overall Study||0
8216421|NCT02087241|20262253|P4|STARTED|Overall Study||7
8216422|NCT02087241|20262254|P3|STARTED|Overall Study||1
8216423|NCT02087241|20262255|P2|STARTED|Overall Study||3
8216424|NCT02087241|20262256|P1|STARTED|Overall Study||3
8216425|NCT02087176|20262282|P1|NOT COMPLETED|Overall Study||32
8216426|NCT02087176|20262282|P1|COMPLETED|Overall Study|The sponsor terminated the study early.|0
8216427|NCT02087176|20262282|P1|STARTED|Overall Study||32
8216428|NCT02087163|20262287|P1|NOT COMPLETED|Overall Study||17
8216429|NCT02087163|20262287|P1|COMPLETED|Overall Study||73
8216430|NCT02087163|20262287|P1|STARTED|Overall Study||90
8216431|NCT02087150|20262295|P3|NOT COMPLETED|Overall Study||11
8216432|NCT02087150|20262296|P2|NOT COMPLETED|Overall Study||34
8216433|NCT02087150|20262297|P1|NOT COMPLETED|Overall Study||10
8216434|NCT02087150|20262295|P3|COMPLETED|Overall Study||69
8216435|NCT02087150|20262296|P2|COMPLETED|Overall Study||128
8216436|NCT02087150|20262297|P1|COMPLETED|Overall Study||71
8216437|NCT02087150|20262295|P3|Received a Crossover MM ETBC Procedure|Overall Study||70
8216438|NCT02087150|20262296|P2|Received a Crossover MM ETBC Procedure|Overall Study||0
8216439|NCT02087150|20262297|P1|Received a Crossover MM ETBC Procedure|Overall Study||0
8216440|NCT02087150|20262295|P3|Had a Lead-in or Randomized ETBC Proc|Overall Study||0
8216441|NCT02087150|20262296|P2|Had a Lead-in or Randomized ETBC Proc|Overall Study||149
8216442|NCT02087150|20262297|P1|Had a Lead-in or Randomized ETBC Proc|Overall Study||80
8216443|NCT02087150|20262295|P3|STARTED|Overall Study||80
8216444|NCT02087150|20262296|P2|STARTED|Overall Study||162
8216445|NCT02087150|20262297|P1|STARTED|Overall Study||81
8216446|NCT02087085|20262316|P2|NOT COMPLETED|Overall Study||116
8216447|NCT02087085|20262317|P1|NOT COMPLETED|Overall Study||120
8216448|NCT02087085|20262316|P2|COMPLETED|Overall Study||40
8216449|NCT02087085|20262317|P1|COMPLETED|Overall Study||34
8216450|NCT02087085|20262316|P2|STARTED|Overall Study||156
8216451|NCT02087085|20262317|P1|STARTED|Overall Study||154
8216452|NCT02087059|20262327|P1|NOT COMPLETED|Overall Study||7
8216453|NCT02087059|20262327|P1|COMPLETED|Overall Study||44
8216454|NCT02087059|20262327|P1|STARTED|Overall Study||51
8216455|NCT02086968|20262337|P2|NOT COMPLETED|Overall Study||13
8216456|NCT02086968|20262338|P1|NOT COMPLETED|Overall Study||8
8216457|NCT02086968|20262337|P2|COMPLETED|Overall Study||85
8216458|NCT02086968|20262338|P1|COMPLETED|Overall Study||92
8216459|NCT02086968|20262337|P2|STARTED|Overall Study||98
8216460|NCT02086968|20262338|P1|STARTED|Overall Study||100
8216461|NCT02086786|20262346|P2|NOT COMPLETED|Overall Study||16
8216462|NCT02086786|20262347|P1|NOT COMPLETED|Overall Study||18
8216463|NCT02086786|20262346|P2|COMPLETED|Overall Study||19
8216464|NCT02086786|20262347|P1|COMPLETED|Overall Study||17
8216465|NCT02086786|20262346|P2|STARTED|Overall Study||35
8216466|NCT02086786|20262347|P1|STARTED|Overall Study||35
8216467|NCT02086708|20262371|P1|NOT COMPLETED|Overall Study||0
8216468|NCT02086708|20262371|P1|COMPLETED|Overall Study||24
8216469|NCT02086708|20262371|P1|STARTED|Overall Study||24
8216470|NCT02086682|20262385|P2|NOT COMPLETED|Overall Study||0
8216471|NCT02086682|20262386|P1|NOT COMPLETED|Overall Study||0
8216472|NCT02086682|20262385|P2|COMPLETED|Overall Study||182
8216473|NCT02086682|20262386|P1|COMPLETED|Overall Study||156
8216474|NCT02086682|20262385|P2|STARTED|Overall Study||182
8216475|NCT02086682|20262386|P1|STARTED|Overall Study||156
8216476|NCT02086591|20262392|P1|NOT COMPLETED|Overall Study||5
8216477|NCT02086591|20262392|P1|COMPLETED|Overall Study||2
8216478|NCT02086591|20262392|P1|STARTED|Overall Study||7
8216479|NCT02086565|20262400|P2|NOT COMPLETED|Overall Study||12
8216480|NCT02086565|20262401|P1|NOT COMPLETED|Overall Study||16
8216481|NCT02086565|20262400|P2|COMPLETED|Overall Study||138
8216482|NCT02086565|20262401|P1|COMPLETED|Overall Study||135
8216483|NCT02086565|20262400|P2|STARTED|Overall Study||150
8216484|NCT02086565|20262401|P1|STARTED|Overall Study||151
8216488|NCT02086500|20262424|P2|NOT COMPLETED|Overall Study||0
8216489|NCT02086500|20262425|P1|NOT COMPLETED|Overall Study||0
8216490|NCT02086500|20262424|P2|COMPLETED|Overall Study||456
8216491|NCT02086500|20262425|P1|COMPLETED|Overall Study||447
8216492|NCT02086500|20262424|P2|STARTED|Overall Study||456
8216493|NCT02086500|20262425|P1|STARTED|Overall Study||447
8216494|NCT02086331|20262443|P1|NOT COMPLETED|Overall Study||0
8216495|NCT02086331|20262443|P1|COMPLETED|Overall Study||5
8216496|NCT02086331|20262443|P1|STARTED|Overall Study||5
8216500|NCT02086162|20262464|P2|NOT COMPLETED|Overall Study||7
8216501|NCT02086162|20262465|P1|NOT COMPLETED|Overall Study||10
8216502|NCT02086162|20262464|P2|COMPLETED|Overall Study||77
8216503|NCT02086162|20262465|P1|COMPLETED|Overall Study||68
8216504|NCT02086162|20262464|P2|STARTED|Overall Study||84
8216505|NCT02086162|20262465|P1|STARTED|Overall Study||78
8216506|NCT02086110|20262477|P2|NOT COMPLETED|Overall Study||1
8216507|NCT02086110|20262478|P1|NOT COMPLETED|Overall Study||1
8216508|NCT02086110|20262477|P2|COMPLETED|Overall Study||5
8216509|NCT02086110|20262478|P1|COMPLETED|Overall Study||4
8216510|NCT02086110|20262477|P2|STARTED|Overall Study||6
8216511|NCT02086110|20262478|P1|STARTED|Overall Study||5
8216512|NCT02085785|20262489|P2|NOT COMPLETED|Overall Study||2
8216513|NCT02085785|20262490|P1|NOT COMPLETED|Overall Study||2
8216514|NCT02085785|20262489|P2|COMPLETED|Overall Study||6
8216515|NCT02085785|20262490|P1|COMPLETED|Overall Study||5
8216516|NCT02085785|20262489|P2|STARTED|Overall Study||8
8216517|NCT02085785|20262490|P1|STARTED|Overall Study||7
8216518|NCT02085720|20262502|P1|NOT COMPLETED|Overall Study||0
8216519|NCT02085720|20262502|P1|COMPLETED|Overall Study||819
8216520|NCT02085720|20262502|P1|STARTED|Overall Study||819
8216521|NCT02085551|20262510|P1|NOT COMPLETED|Overall Study||0
8216522|NCT02085551|20262510|P1|COMPLETED|Overall Study||85
8216523|NCT02085551|20262510|P1|STARTED|Overall Study||85
8216524|NCT02085473|20262519|P4|NOT COMPLETED|Overall Study||0
8216525|NCT02085473|20262520|P3|NOT COMPLETED|Overall Study||0
8216526|NCT02085473|20262521|P2|NOT COMPLETED|Overall Study||0
8216527|NCT02085473|20262522|P1|NOT COMPLETED|Overall Study||0
8216528|NCT02085473|20262519|P4|COMPLETED|Overall Study||15
8216529|NCT02085473|20262520|P3|COMPLETED|Overall Study||15
8216530|NCT02085473|20262521|P2|COMPLETED|Overall Study||15
8216531|NCT02085473|20262522|P1|COMPLETED|Overall Study||15
8216532|NCT02085473|20262519|P4|STARTED|Overall Study||15
8216533|NCT02085473|20262520|P3|STARTED|Overall Study||15
8216534|NCT02085473|20262521|P2|STARTED|Overall Study||15
8216535|NCT02085473|20262522|P1|STARTED|Overall Study||15
8216536|NCT02085447|20262584|P1|NOT COMPLETED|Overall Study||4
8216537|NCT02085447|20262584|P1|COMPLETED|Overall Study||26
8216538|NCT02085447|20262584|P1|STARTED|Overall Study||30
8216539|NCT02085356|20262613|P4|NOT COMPLETED|Overall Study||0
8216540|NCT02085356|20262614|P3|NOT COMPLETED|Overall Study||0
8216541|NCT02085356|20262615|P2|NOT COMPLETED|Overall Study||0
8216542|NCT02085356|20262616|P1|NOT COMPLETED|Overall Study||0
8216543|NCT02085356|20262613|P4|COMPLETED|Overall Study||361
8216544|NCT02085356|20262614|P3|COMPLETED|Overall Study||681
8216545|NCT02085356|20262615|P2|COMPLETED|Overall Study||348
8216546|NCT02085356|20262616|P1|COMPLETED|Overall Study||577
8216547|NCT02085356|20262613|P4|STARTED|Overall Study||361
8216548|NCT02085356|20262614|P3|STARTED|Overall Study||681
8216549|NCT02085356|20262615|P2|STARTED|Overall Study||348
8216550|NCT02085356|20262616|P1|STARTED|Overall Study||577
8216551|NCT02085252|20262644|P2|NOT COMPLETED|Overall Study||4
8216552|NCT02085252|20262645|P1|NOT COMPLETED|Overall Study||1
8216553|NCT02085252|20262644|P2|COMPLETED|Overall Study||53
8216554|NCT02085252|20262645|P1|COMPLETED|Overall Study||57
8216555|NCT02085252|20262644|P2|STARTED|Overall Study||57
8216556|NCT02085252|20262645|P1|STARTED|Overall Study||58
8216557|NCT02085161|20262669|P4|NOT COMPLETED|Overall Study||10
8216558|NCT02085161|20262670|P3|NOT COMPLETED|Overall Study||5
8216559|NCT02085161|20262671|P2|NOT COMPLETED|Overall Study||10
8216560|NCT02085161|20262672|P1|NOT COMPLETED|Overall Study||12
8216561|NCT02085161|20262669|P4|COMPLETED|Overall Study||66
8216562|NCT02085161|20262670|P3|COMPLETED|Overall Study||71
8216563|NCT02085161|20262671|P2|COMPLETED|Overall Study||66
8216564|NCT02085161|20262672|P1|COMPLETED|Overall Study||64
8216565|NCT02085161|20262669|P4|STARTED|Overall Study||76
8216566|NCT02085161|20262670|P3|STARTED|Overall Study||76
8216567|NCT02085161|20262671|P2|STARTED|Overall Study||76
8216568|NCT02085161|20262672|P1|STARTED|Overall Study||76
8216569|NCT02085135|20262713|P2|NOT COMPLETED|Overall Study||9
8216570|NCT02085135|20262714|P1|NOT COMPLETED|Overall Study||11
8216571|NCT02085135|20262713|P2|COMPLETED|Overall Study||23
8216572|NCT02085135|20262714|P1|COMPLETED|Overall Study||23
8216573|NCT02085135|20262713|P2|STARTED|Overall Study||32
8216574|NCT02085135|20262714|P1|STARTED|Overall Study||34
8216575|NCT02084797|20262720|P1|NOT COMPLETED|Overall Study||0
8216576|NCT02084797|20262720|P1|COMPLETED|Overall Study||10
8216577|NCT02084797|20262720|P1|STARTED|Overall Study||10
8216578|NCT02084706|20262729|P2|NOT COMPLETED|Overall Study||0
8216579|NCT02084706|20262730|P1|NOT COMPLETED|Overall Study||0
8216580|NCT02084706|20262729|P2|COMPLETED|Overall Study||31
8216581|NCT02084706|20262730|P1|COMPLETED|Overall Study||29
8216582|NCT02084706|20262729|P2|STARTED|Overall Study||31
8216583|NCT02084706|20262730|P1|STARTED|Overall Study||29
8216584|NCT02084628|20262736|P1|NOT COMPLETED|Overall Study||0
8216585|NCT02084628|20262736|P1|COMPLETED|Overall Study||1
8216586|NCT02084628|20262736|P1|STARTED|Overall Study||1
8216587|NCT02084511|20262753|P4|NOT COMPLETED|Overall Study||0
8216588|NCT02084511|20262754|P3|NOT COMPLETED|Overall Study||0
8216589|NCT02084511|20262755|P2|NOT COMPLETED|Overall Study||0
8216590|NCT02084511|20262756|P1|NOT COMPLETED|Overall Study||0
8216591|NCT02084511|20262753|P4|COMPLETED|Overall Study||20
8216592|NCT02084511|20262754|P3|COMPLETED|Overall Study||20
8216593|NCT02084511|20262755|P2|COMPLETED|Overall Study||20
8216594|NCT02084511|20262756|P1|COMPLETED|Overall Study||20
8216595|NCT02084511|20262753|P4|STARTED|Overall Study||20
8216596|NCT02084511|20262754|P3|STARTED|Overall Study||20
8216597|NCT02084511|20262755|P2|STARTED|Overall Study||20
8216598|NCT02084511|20262756|P1|STARTED|Overall Study||20
8216599|NCT02084238|20262786|P1|NOT COMPLETED|Overall Study||2
8216600|NCT02084238|20262786|P1|COMPLETED|Overall Study||38
8216601|NCT02084238|20262786|P1|STARTED|Overall Study||40
8216602|NCT02084160|20262797|P1|NOT COMPLETED|Overall Study||0
8216603|NCT02084160|20262797|P1|COMPLETED|Overall Study||579
8216604|NCT02084160|20262797|P1|STARTED|Overall Study||579
8216605|NCT02084147|20262801|P1|NOT COMPLETED|Overall Study||0
8216606|NCT02084147|20262801|P1|COMPLETED|Overall Study||72
8216607|NCT02084147|20262801|P1|STARTED|Overall Study||72
8216608|NCT02084134|20262811|P2|NOT COMPLETED|Overall Study||3
8216609|NCT02084134|20262812|P1|NOT COMPLETED|Overall Study||4
8216610|NCT02084134|20262811|P2|COMPLETED|Overall Study||17
8216611|NCT02084134|20262812|P1|COMPLETED|Overall Study||19
8216612|NCT02084134|20262811|P2|STARTED|Overall Study||20
8216613|NCT02084134|20262812|P1|STARTED|Overall Study||23
8216614|NCT02084082|20262822|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216615|NCT02084082|20262823|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216616|NCT02084082|20262824|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216617|NCT02084082|20262825|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216618|NCT02084082|20262822|P4|COMPLETED|Treatment Period 2 (4 Days)||6
8216619|NCT02084082|20262823|P3|COMPLETED|Treatment Period 2 (4 Days)||7
8216620|NCT02084082|20262824|P2|COMPLETED|Treatment Period 2 (4 Days)||26
8216621|NCT02084082|20262825|P1|COMPLETED|Treatment Period 2 (4 Days)||26
8216622|NCT02084082|20262822|P4|STARTED|Treatment Period 2 (4 Days)||6
8216623|NCT02084082|20262823|P3|STARTED|Treatment Period 2 (4 Days)||7
8216624|NCT02084082|20262824|P2|STARTED|Treatment Period 2 (4 Days)||26
8216625|NCT02084082|20262825|P1|STARTED|Treatment Period 2 (4 Days)||26
8216626|NCT02084082|20262822|P4|NOT COMPLETED|Washout Period 1 (35 Days)||2
8216627|NCT02084082|20262823|P3|NOT COMPLETED|Washout Period 1 (35 Days)||1
8216628|NCT02084082|20262824|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
8216629|NCT02084082|20262825|P1|NOT COMPLETED|Washout Period 1 (35 Days)||0
8216630|NCT02084082|20262822|P4|COMPLETED|Washout Period 1 (35 Days)||6
8216631|NCT02084082|20262823|P3|COMPLETED|Washout Period 1 (35 Days)||7
8216632|NCT02084082|20262824|P2|COMPLETED|Washout Period 1 (35 Days)||26
8216633|NCT02084082|20262825|P1|COMPLETED|Washout Period 1 (35 Days)||26
8216634|NCT02084082|20262822|P4|STARTED|Washout Period 1 (35 Days)||8
8216635|NCT02084082|20262823|P3|STARTED|Washout Period 1 (35 Days)||8
8216636|NCT02084082|20262824|P2|STARTED|Washout Period 1 (35 Days)||26
8216637|NCT02084082|20262825|P1|STARTED|Washout Period 1 (35 Days)||26
8216638|NCT02084082|20262822|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8216639|NCT02084082|20262823|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8216640|NCT02084082|20262824|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8216641|NCT02084082|20262825|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8216642|NCT02084082|20262822|P4|COMPLETED|Treatment Period 1 (4 Days)||8
8216643|NCT02084082|20262823|P3|COMPLETED|Treatment Period 1 (4 Days)||8
8216644|NCT02084082|20262824|P2|COMPLETED|Treatment Period 1 (4 Days)||26
8216645|NCT02084082|20262825|P1|COMPLETED|Treatment Period 1 (4 Days)||26
8216646|NCT02084082|20262822|P4|STARTED|Treatment Period 1 (4 Days)||8
8216647|NCT02084082|20262823|P3|STARTED|Treatment Period 1 (4 Days)||8
8216648|NCT02084082|20262824|P2|STARTED|Treatment Period 1 (4 Days)||26
8216649|NCT02084082|20262825|P1|STARTED|Treatment Period 1 (4 Days)||26
8216650|NCT02084069|20262857|P2|NOT COMPLETED|Overall Study||0
8216651|NCT02084069|20262858|P1|NOT COMPLETED|Overall Study||0
8216652|NCT02084069|20262857|P2|COMPLETED|Overall Study||29
8216653|NCT02084069|20262858|P1|COMPLETED|Overall Study||29
8216654|NCT02084069|20262857|P2|STARTED|Overall Study||29
8216655|NCT02084069|20262858|P1|STARTED|Overall Study||29
8216656|NCT02084056|20262866|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216657|NCT02084056|20262867|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216658|NCT02084056|20262868|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216659|NCT02084056|20262869|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8216660|NCT02084056|20262866|P4|COMPLETED|Treatment Period 2 (4 Days)||8
8216661|NCT02084056|20262867|P3|COMPLETED|Treatment Period 2 (4 Days)||8
8216662|NCT02084056|20262868|P2|COMPLETED|Treatment Period 2 (4 Days)||30
8216663|NCT02084056|20262869|P1|COMPLETED|Treatment Period 2 (4 Days)||26
8216664|NCT02084056|20262866|P4|STARTED|Treatment Period 2 (4 Days)||8
8216665|NCT02084056|20262867|P3|STARTED|Treatment Period 2 (4 Days)||8
8216666|NCT02084056|20262868|P2|STARTED|Treatment Period 2 (4 Days)||30
8216667|NCT02084056|20262869|P1|STARTED|Treatment Period 2 (4 Days)||26
8216668|NCT02084056|20262866|P4|NOT COMPLETED|Washout Period 1 (35 Days)||0
8216669|NCT02084056|20262867|P3|NOT COMPLETED|Washout Period 1 (35 Days)||0
8216670|NCT02084056|20262868|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
8216671|NCT02084056|20262869|P1|NOT COMPLETED|Washout Period 1 (35 Days)||1
8216672|NCT02084056|20262866|P4|COMPLETED|Washout Period 1 (35 Days)||8
8216673|NCT02084056|20262867|P3|COMPLETED|Washout Period 1 (35 Days)||8
8216674|NCT02084056|20262868|P2|COMPLETED|Washout Period 1 (35 Days)||30
8216675|NCT02084056|20262869|P1|COMPLETED|Washout Period 1 (35 Days)||26
8216676|NCT02084056|20262866|P4|STARTED|Washout Period 1 (35 Days)||8
8216677|NCT02084056|20262867|P3|STARTED|Washout Period 1 (35 Days)||8
8216678|NCT02084056|20262868|P2|STARTED|Washout Period 1 (35 Days)||30
8216679|NCT02084056|20262869|P1|STARTED|Washout Period 1 (35 Days)||27
8216680|NCT02084056|20262866|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8216681|NCT02084056|20262867|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8216682|NCT02084056|20262868|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8216683|NCT02084056|20262869|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||1
8216684|NCT02084056|20262866|P4|COMPLETED|Treatment Period 1 (4 Days)||8
8216685|NCT02084056|20262867|P3|COMPLETED|Treatment Period 1 (4 Days)||8
8216686|NCT02084056|20262868|P2|COMPLETED|Treatment Period 1 (4 Days)||30
8216687|NCT02084056|20262869|P1|COMPLETED|Treatment Period 1 (4 Days)||27
8216688|NCT02084056|20262866|P4|STARTED|Treatment Period 1 (4 Days)||8
8216689|NCT02084056|20262867|P3|STARTED|Treatment Period 1 (4 Days)||8
8216690|NCT02084056|20262868|P2|STARTED|Treatment Period 1 (4 Days)||30
8216691|NCT02084056|20262869|P1|STARTED|Treatment Period 1 (4 Days)||28
8216692|NCT02083965|20262901|P2|NOT COMPLETED|Treatment Period||0
8216693|NCT02083965|20262902|P1|NOT COMPLETED|Treatment Period||1
8216694|NCT02083965|20262901|P2|COMPLETED|Treatment Period||8
8216695|NCT02083965|20262902|P1|COMPLETED|Treatment Period||9
8216696|NCT02083965|20262901|P2|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
8216697|NCT02083965|20262902|P1|STARTED|Treatment Period||10
8216698|NCT02083965|20262901|P2|NOT COMPLETED|PK Period 2||0
8216699|NCT02083965|20262902|P1|NOT COMPLETED|PK Period 2||0
8216700|NCT02083965|20262901|P2|COMPLETED|PK Period 2||9
8216701|NCT02083965|20262902|P1|COMPLETED|PK Period 2||10
8216702|NCT02083965|20262901|P2|STARTED|PK Period 2||9
8216703|NCT02083965|20262902|P1|STARTED|PK Period 2||10
8216704|NCT02083965|20262901|P2|NOT COMPLETED|Washout Period||0
8216705|NCT02083965|20262902|P1|NOT COMPLETED|Washout Period||0
8216706|NCT02083965|20262901|P2|COMPLETED|Washout Period||9
8216707|NCT02083965|20262902|P1|COMPLETED|Washout Period||10
8216708|NCT02083965|20262901|P2|STARTED|Washout Period||9
8216709|NCT02083965|20262902|P1|STARTED|Washout Period||10
8216710|NCT02083965|20262901|P2|NOT COMPLETED|PK Period 1||0
8216711|NCT02083965|20262902|P1|NOT COMPLETED|PK Period 1||0
8216712|NCT02083965|20262901|P2|COMPLETED|PK Period 1||9
8216713|NCT02083965|20262902|P1|COMPLETED|PK Period 1||10
8216714|NCT02083965|20262901|P2|STARTED|PK Period 1||9
8216715|NCT02083965|20262902|P1|STARTED|PK Period 1||10
8216716|NCT02083861|20262960|P2|NOT COMPLETED|Overall Study||3
8216717|NCT02083861|20262961|P1|NOT COMPLETED|Overall Study||6
8216718|NCT02083861|20262960|P2|COMPLETED|Overall Study||33
8216719|NCT02083861|20262961|P1|COMPLETED|Overall Study||51
8216720|NCT02083861|20262960|P2|Treated|Overall Study||35
8216721|NCT02083861|20262961|P1|Treated|Overall Study||55
8216722|NCT02083861|20262960|P2|STARTED|Overall Study||36
8216723|NCT02083861|20262961|P1|STARTED|Overall Study||57
8216724|NCT02083809|20262975|P2|NOT COMPLETED|Overall Study||2
8216725|NCT02083809|20262976|P1|NOT COMPLETED|Overall Study||4
8216726|NCT02083809|20262975|P2|COMPLETED|Overall Study||82
8216727|NCT02083809|20262976|P1|COMPLETED|Overall Study||78
8216728|NCT02083809|20262975|P2|STARTED|Overall Study||84
8216729|NCT02083809|20262976|P1|STARTED|Overall Study||82
8216730|NCT02083783|20262984|P2|NOT COMPLETED|Overall Study||0
8216731|NCT02083783|20262985|P1|NOT COMPLETED|Overall Study||1
8216732|NCT02083783|20262984|P2|COMPLETED|Overall Study||48
8216733|NCT02083783|20262985|P1|COMPLETED|Overall Study||51
8216734|NCT02083783|20262984|P2|STARTED|Overall Study||48
8216735|NCT02083783|20262985|P1|STARTED|Overall Study||52
8216736|NCT02083679|20262997|P4|NOT COMPLETED|Overall Study||0
8216737|NCT02083679|20262998|P3|NOT COMPLETED|Overall Study||0
8216738|NCT02083679|20262999|P2|NOT COMPLETED|Overall Study||0
8216739|NCT02083679|20263000|P1|NOT COMPLETED|Overall Study||0
8216740|NCT02083679|20262997|P4|COMPLETED|Overall Study||3
8216741|NCT02083679|20262998|P3|COMPLETED|Overall Study||3
8216742|NCT02083679|20262999|P2|COMPLETED|Overall Study||6
8216743|NCT02083679|20263000|P1|COMPLETED|Overall Study||3
8216744|NCT02083679|20262997|P4|STARTED|Overall Study||3
8216745|NCT02083679|20262998|P3|STARTED|Overall Study||3
8216746|NCT02083679|20262999|P2|STARTED|Overall Study||6
8216747|NCT02083679|20263000|P1|STARTED|Overall Study||3
8216748|NCT02083653|20263017|P3|NOT COMPLETED|Overall Study||84
8216749|NCT02083653|20263018|P2|NOT COMPLETED|Overall Study||85
8216750|NCT02083653|20263019|P1|NOT COMPLETED|Overall Study||82
8216751|NCT02083653|20263017|P3|COMPLETED|Overall Study||1
8216752|NCT02083653|20263018|P2|COMPLETED|Overall Study||1
8216753|NCT02083653|20263019|P1|COMPLETED|Overall Study||1
8216754|NCT02083653|20263017|P3|STARTED|Overall Study||85
8216755|NCT02083653|20263018|P2|STARTED|Overall Study||86
8216756|NCT02083653|20263019|P1|STARTED|Overall Study||83
8216757|NCT02083406|20263065|P3|NOT COMPLETED|Overall Study||0
8216758|NCT02083406|20263066|P2|NOT COMPLETED|Overall Study||0
8216759|NCT02083406|20263067|P1|NOT COMPLETED|Overall Study||0
8216760|NCT02083406|20263065|P3|COMPLETED|Overall Study||7
8216761|NCT02083406|20263066|P2|COMPLETED|Overall Study||8
8216762|NCT02083406|20263067|P1|COMPLETED|Overall Study||7
8216763|NCT02083406|20263065|P3|STARTED|Overall Study||7
8216764|NCT02083406|20263066|P2|STARTED|Overall Study||8
8216765|NCT02083406|20263067|P1|STARTED|Overall Study||7
8216766|NCT02083380|20263087|P3|NOT COMPLETED|Overall Study||84
8216767|NCT02083380|20263088|P2|NOT COMPLETED|Overall Study||95
8216768|NCT02083380|20263089|P1|NOT COMPLETED|Overall Study||91
8216769|NCT02083380|20263087|P3|COMPLETED|Overall Study||65
8216770|NCT02083380|20263088|P2|COMPLETED|Overall Study||56
8216771|NCT02083380|20263089|P1|COMPLETED|Overall Study||57
8216772|NCT02083380|20263087|P3|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
8216773|NCT02083380|20263088|P2|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
8216774|NCT02083380|20263089|P1|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
8216775|NCT02083263|20263184|P2|NOT COMPLETED|Overall Study||0
8216776|NCT02083263|20263185|P1|NOT COMPLETED|Overall Study||0
8216777|NCT02083263|20263184|P2|COMPLETED|Overall Study||16
8216778|NCT02083263|20263185|P1|COMPLETED|Overall Study||16
8216779|NCT02083263|20263184|P2|STARTED|Overall Study||16
8216780|NCT02083263|20263185|P1|STARTED|Overall Study||16
8216781|NCT02083185|20263194|P3|NOT COMPLETED|Overall Study||7
8216782|NCT02083185|20263195|P2|NOT COMPLETED|Overall Study||29
8216783|NCT02083185|20263196|P1|NOT COMPLETED|Overall Study||20
8216784|NCT02083185|20263194|P3|COMPLETED|Overall Study||17
8216785|NCT02083185|20263195|P2|COMPLETED|Overall Study||27
8216786|NCT02083185|20263196|P1|COMPLETED|Overall Study||36
8216787|NCT02083185|20263194|P3|Safety Population|Overall Study||24
8216788|NCT02083185|20263195|P2|Safety Population|Overall Study||54
8216789|NCT02083185|20263196|P1|Safety Population|Overall Study||56
8216790|NCT02083185|20263194|P3|STARTED|Overall Study||24
8216791|NCT02083185|20263195|P2|STARTED|Overall Study||56
8216792|NCT02083185|20263196|P1|STARTED|Overall Study||56
8216793|NCT02083107|20263254|P3|NOT COMPLETED|Overall Study||0
8216794|NCT02083107|20263255|P2|NOT COMPLETED|Overall Study||0
8216795|NCT02083107|20263256|P1|NOT COMPLETED|Overall Study||0
8216796|NCT02083107|20263254|P3|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
8216797|NCT02083107|20263255|P2|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
8216798|NCT02083107|20263256|P1|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
8216799|NCT02083107|20263254|P3|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
8216800|NCT02083107|20263255|P2|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
8216801|NCT02083107|20263256|P1|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
8216802|NCT02082977|20263301|P10|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216803|NCT02082977|20263302|P9|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216804|NCT02082977|20263303|P8|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216805|NCT02082977|20263304|P7|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216806|NCT02082977|20263305|P6|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216807|NCT02082977|20263306|P5|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216808|NCT02082977|20263307|P4|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216809|NCT02082977|20263308|P3|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216810|NCT02082977|20263309|P2|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216811|NCT02082977|20263310|P1|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
8216812|NCT02082977|20263301|P10|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216813|NCT02082977|20263302|P9|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216814|NCT02082977|20263303|P8|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216815|NCT02082977|20263304|P7|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216816|NCT02082977|20263305|P6|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216817|NCT02082977|20263306|P5|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216818|NCT02082977|20263307|P4|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216819|NCT02082977|20263308|P3|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216820|NCT02082977|20263309|P2|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216821|NCT02082977|20263310|P1|COMPLETED|Part 2 (Up to 3.2 Years)||0
8216822|NCT02082977|20263301|P10|STARTED|Part 2 (Up to 3.2 Years)||0
8216823|NCT02082977|20263302|P9|STARTED|Part 2 (Up to 3.2 Years)||0
8216824|NCT02082977|20263303|P8|STARTED|Part 2 (Up to 3.2 Years)||0
8216825|NCT02082977|20263304|P7|STARTED|Part 2 (Up to 3.2 Years)||0
8216826|NCT02082977|20263305|P6|STARTED|Part 2 (Up to 3.2 Years)||0
8216827|NCT02082977|20263306|P5|STARTED|Part 2 (Up to 3.2 Years)||0
8216828|NCT02082977|20263307|P4|STARTED|Part 2 (Up to 3.2 Years)||0
8216829|NCT02082977|20263308|P3|STARTED|Part 2 (Up to 3.2 Years)||0
8216830|NCT02082977|20263309|P2|STARTED|Part 2 (Up to 3.2 Years)||0
8216831|NCT02082977|20263310|P1|STARTED|Part 2 (Up to 3.2 Years)||0
8216832|NCT02082977|20263301|P10|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
8216833|NCT02082977|20263302|P9|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
8216834|NCT02082977|20263303|P8|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5
8216835|NCT02082977|20263304|P7|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6
8216836|NCT02082977|20263305|P6|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
8216837|NCT02082977|20263306|P5|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
8216838|NCT02082977|20263307|P4|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
8216839|NCT02082977|20263308|P3|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
8216840|NCT02082977|20263309|P2|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
8216841|NCT02082977|20263310|P1|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
8216842|NCT02082977|20263301|P10|COMPLETED|Part 1 (Up to 3.2 Years)||0
8216843|NCT02082977|20263302|P9|COMPLETED|Part 1 (Up to 3.2 Years)||4
8216844|NCT02082977|20263303|P8|COMPLETED|Part 1 (Up to 3.2 Years)||7
8216845|NCT02082977|20263304|P7|COMPLETED|Part 1 (Up to 3.2 Years)||4
8216846|NCT02082977|20263305|P6|COMPLETED|Part 1 (Up to 3.2 Years)||1
8216847|NCT02082977|20263306|P5|COMPLETED|Part 1 (Up to 3.2 Years)||2
8216848|NCT02082977|20263307|P4|COMPLETED|Part 1 (Up to 3.2 Years)||1
8216849|NCT02082977|20263308|P3|COMPLETED|Part 1 (Up to 3.2 Years)||1
8216850|NCT02082977|20263309|P2|COMPLETED|Part 1 (Up to 3.2 Years)||1
8216851|NCT02082977|20263310|P1|COMPLETED|Part 1 (Up to 3.2 Years)||1
8216852|NCT02082977|20263301|P10|STARTED|Part 1 (Up to 3.2 Years)||0
8216853|NCT02082977|20263302|P9|STARTED|Part 1 (Up to 3.2 Years)||7
8216854|NCT02082977|20263303|P8|STARTED|Part 1 (Up to 3.2 Years)||12
8216855|NCT02082977|20263304|P7|STARTED|Part 1 (Up to 3.2 Years)||10
8216856|NCT02082977|20263305|P6|STARTED|Part 1 (Up to 3.2 Years)||4
8216857|NCT02082977|20263306|P5|STARTED|Part 1 (Up to 3.2 Years)||3
8216858|NCT02082977|20263307|P4|STARTED|Part 1 (Up to 3.2 Years)||1
8216859|NCT02082977|20263308|P3|STARTED|Part 1 (Up to 3.2 Years)||1
8216860|NCT02082977|20263309|P2|STARTED|Part 1 (Up to 3.2 Years)||1
8216861|NCT02082977|20263310|P1|STARTED|Part 1 (Up to 3.2 Years)||2
8216862|NCT02082912|20263564|P2|NOT COMPLETED|Overall Study||1
8216863|NCT02082912|20263565|P1|NOT COMPLETED|Overall Study||0
8216864|NCT02082912|20263564|P2|COMPLETED|Overall Study||6
8216865|NCT02082912|20263565|P1|COMPLETED|Overall Study||7
8216866|NCT02082912|20263564|P2|STARTED|Overall Study||7
8216867|NCT02082912|20263565|P1|STARTED|Overall Study||7
8216868|NCT02082769|20263582|P3|NOT COMPLETED|Overall Study||36
8216869|NCT02082769|20263583|P2|NOT COMPLETED|Overall Study||27
8216870|NCT02082769|20263584|P1|NOT COMPLETED|Overall Study||24
8216871|NCT02082769|20263582|P3|COMPLETED|Overall Study||132
8216872|NCT02082769|20263583|P2|COMPLETED|Overall Study||141
8216873|NCT02082769|20263584|P1|COMPLETED|Overall Study||144
8216874|NCT02082769|20263582|P3|STARTED|Overall Study||168
8216875|NCT02082769|20263583|P2|STARTED|Overall Study||168
8216876|NCT02082769|20263584|P1|STARTED|Overall Study||168
8216883|NCT02082522|20263613|P2|NOT COMPLETED|Overall Study||13
8216884|NCT02082522|20263614|P1|NOT COMPLETED|Overall Study||15
8216885|NCT02082522|20263613|P2|COMPLETED|Overall Study||0
8216886|NCT02082522|20263614|P1|COMPLETED|Overall Study||0
8216887|NCT02082522|20263613|P2|STARTED|Overall Study||13
8216888|NCT02082522|20263614|P1|STARTED|Overall Study||15
8216889|NCT02082483|20263664|P2|NOT COMPLETED|Overall Study||6
8216890|NCT02082483|20263665|P1|NOT COMPLETED|Overall Study||6
8216891|NCT02082483|20263664|P2|COMPLETED|Overall Study||67
8216892|NCT02082483|20263665|P1|COMPLETED|Overall Study||65
8216893|NCT02082483|20263664|P2|STARTED|Overall Study||73
8216894|NCT02082483|20263665|P1|STARTED|Overall Study||71
8216895|NCT02082392|20263682|P2|NOT COMPLETED|Overall Study||0
8216896|NCT02082392|20263683|P1|NOT COMPLETED|Overall Study||0
8216897|NCT02082392|20263682|P2|COMPLETED|Overall Study||1
8216898|NCT02082392|20263683|P1|COMPLETED|Overall Study||2
8216899|NCT02082392|20263682|P2|STARTED|Overall Study||1
8216900|NCT02082392|20263683|P1|STARTED|Overall Study||2
8216901|NCT02082340|20263717|P2|NOT COMPLETED|Overall Study||1
8216902|NCT02082340|20263718|P1|NOT COMPLETED|Overall Study||1
8216903|NCT02082340|20263717|P2|COMPLETED|Overall Study||197
8216904|NCT02082340|20263718|P1|COMPLETED|Overall Study||193
8216905|NCT02082340|20263717|P2|STARTED|Overall Study||198
8216906|NCT02082340|20263718|P1|STARTED|Overall Study||194
8216907|NCT02082288|20263724|P1|NOT COMPLETED|Overall Study||0
8216908|NCT02082288|20263724|P1|COMPLETED|Overall Study||243
8216909|NCT02082288|20263724|P1|STARTED|Overall Study||243
8216910|NCT02082262|20263728|P1|NOT COMPLETED|Overall Study||51
8216911|NCT02082262|20263728|P1|COMPLETED|Overall Study||89
8216912|NCT02082262|20263728|P1|STARTED|Overall Study||140
8216913|NCT02082210|20263738|P6|NOT COMPLETED|Overall Study||2
8216914|NCT02082210|20263739|P5|NOT COMPLETED|Overall Study||3
8216915|NCT02082210|20263740|P4|NOT COMPLETED|Overall Study||6
8216916|NCT02082210|20263741|P3|NOT COMPLETED|Overall Study||3
8216917|NCT02082210|20263742|P2|NOT COMPLETED|Overall Study||0
8216918|NCT02082210|20263743|P1|NOT COMPLETED|Overall Study||0
8216919|NCT02082210|20263738|P6|COMPLETED|Overall Study||13
8216920|NCT02082210|20263739|P5|COMPLETED|Overall Study||12
8216921|NCT02082210|20263740|P4|COMPLETED|Overall Study||39
8216922|NCT02082210|20263741|P3|COMPLETED|Overall Study||13
8216923|NCT02082210|20263742|P2|COMPLETED|Overall Study||3
8216924|NCT02082210|20263743|P1|COMPLETED|Overall Study||3
8216925|NCT02082210|20263738|P6|Received at Least One Dose of Study Drug|Overall Study||15
8216926|NCT02082210|20263739|P5|Received at Least One Dose of Study Drug|Overall Study||15
8216927|NCT02082210|20263740|P4|Received at Least One Dose of Study Drug|Overall Study||45
8216928|NCT02082210|20263741|P3|Received at Least One Dose of Study Drug|Overall Study||16
8216929|NCT02082210|20263742|P2|Received at Least One Dose of Study Drug|Overall Study||3
8216930|NCT02082210|20263743|P1|Received at Least One Dose of Study Drug|Overall Study||3
8216931|NCT02082210|20263738|P6|STARTED|Overall Study||15
8216932|NCT02082210|20263739|P5|STARTED|Overall Study||15
8216933|NCT02082210|20263740|P4|STARTED|Overall Study||45
8216934|NCT02082210|20263741|P3|STARTED|Overall Study||16
8216935|NCT02082210|20263742|P2|STARTED|Overall Study||3
8216936|NCT02082210|20263743|P1|STARTED|Overall Study||3
8216937|NCT02082184|20263791|P2|NOT COMPLETED|Overall Study||13
8216938|NCT02082184|20263792|P1|NOT COMPLETED|Overall Study||10
8216939|NCT02082184|20263791|P2|COMPLETED|Overall Study||62
8216940|NCT02082184|20263792|P1|COMPLETED|Overall Study||139
8216941|NCT02082184|20263791|P2|STARTED|Overall Study||75
8216942|NCT02082184|20263792|P1|STARTED|Overall Study||149
8216943|NCT02082158|20263817|P6|NOT COMPLETED|Overall Study||7
8216944|NCT02082158|20263818|P5|NOT COMPLETED|Overall Study||4
8216945|NCT02082158|20263819|P4|NOT COMPLETED|Overall Study||4
8216946|NCT02082158|20263820|P3|NOT COMPLETED|Overall Study||14
8216947|NCT02082158|20263821|P2|NOT COMPLETED|Overall Study||8
8216948|NCT02082158|20263822|P1|NOT COMPLETED|Overall Study||8
8216949|NCT02082158|20263817|P6|COMPLETED|Overall Study||56
8216950|NCT02082158|20263818|P5|COMPLETED|Overall Study||64
8216951|NCT02082158|20263819|P4|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
8216952|NCT02082158|20263820|P3|COMPLETED|Overall Study||38
8216953|NCT02082158|20263821|P2|COMPLETED|Overall Study||53
8216954|NCT02082158|20263822|P1|COMPLETED|Overall Study||58
8216955|NCT02082158|20263817|P6|STARTED|Overall Study||63
8216956|NCT02082158|20263818|P5|STARTED|Overall Study||68
8216957|NCT02082158|20263819|P4|STARTED|Overall Study||72
8216958|NCT02082158|20263820|P3|STARTED|Overall Study||52
8216959|NCT02082158|20263821|P2|STARTED|Overall Study||61
8216960|NCT02082158|20263822|P1|STARTED|Overall Study||66
8216961|NCT02082145|20263844|P2|NOT COMPLETED|Overall Study||0
8216962|NCT02082145|20263845|P1|NOT COMPLETED|Overall Study||0
8216963|NCT02082145|20263844|P2|COMPLETED|Overall Study||9
8216964|NCT02082145|20263845|P1|COMPLETED|Overall Study||5
8216965|NCT02082145|20263844|P2|STARTED|Overall Study||9
8216966|NCT02082145|20263845|P1|STARTED|Overall Study||5
8216967|NCT02082119|20263857|P1|NOT COMPLETED|Overall Study||0
8216968|NCT02082119|20263857|P1|COMPLETED|Overall Study||82
8216969|NCT02082119|20263857|P1|STARTED|Overall Study||82
8216970|NCT02081963|20263863|P2|NOT COMPLETED|Overall Study||4
8216971|NCT02081963|20263864|P1|NOT COMPLETED|Overall Study||5
8216972|NCT02081963|20263863|P2|COMPLETED|Overall Study||69
8216973|NCT02081963|20263864|P1|COMPLETED|Overall Study||74
8216974|NCT02081963|20263863|P2|STARTED|Overall Study||73
8216975|NCT02081963|20263864|P1|STARTED|Overall Study||79
8216976|NCT02081950|20263878|P1|NOT COMPLETED|Treatment Period 2||0
8216977|NCT02081950|20263878|P1|COMPLETED|Treatment Period 2||14
8216978|NCT02081950|20263878|P1|STARTED|Treatment Period 2||14
8216979|NCT02081950|20263878|P1|NOT COMPLETED|Treatment Period 1||0
8216980|NCT02081950|20263878|P1|COMPLETED|Treatment Period 1||14
8216981|NCT02081950|20263878|P1|STARTED|Treatment Period 1||14
8216982|NCT02081859|20263952|P2|NOT COMPLETED|Overall Study||31
8216983|NCT02081859|20263953|P1|NOT COMPLETED|Overall Study||34
8216984|NCT02081859|20263952|P2|COMPLETED|Overall Study||119
8216985|NCT02081859|20263953|P1|COMPLETED|Overall Study||116
8216986|NCT02081859|20263952|P2|STARTED|Overall Study||150
8216987|NCT02081859|20263953|P1|STARTED|Overall Study||150
8216988|NCT02081846|20263963|P2|NOT COMPLETED|Overall Study||0
8216989|NCT02081846|20263964|P1|NOT COMPLETED|Overall Study||2
8216990|NCT02081846|20263963|P2|COMPLETED|Overall Study||749
8216991|NCT02081846|20263964|P1|COMPLETED|Overall Study||749
8216992|NCT02081846|20263963|P2|STARTED|Overall Study||749
8216993|NCT02081846|20263964|P1|STARTED|Overall Study||751
8216994|NCT02081807|20263990|P8|NOT COMPLETED|Overall Study||0
8216995|NCT02081807|20263991|P7|NOT COMPLETED|Overall Study||0
8216996|NCT02081807|20263992|P6|NOT COMPLETED|Overall Study||0
8216997|NCT02081807|20263993|P5|NOT COMPLETED|Overall Study||0
8216998|NCT02081807|20263994|P4|NOT COMPLETED|Overall Study||0
8216999|NCT02081807|20263995|P3|NOT COMPLETED|Overall Study||0
8217000|NCT02081807|20263996|P2|NOT COMPLETED|Overall Study||0
8217001|NCT02081807|20263997|P1|NOT COMPLETED|Overall Study||0
8217002|NCT02081807|20263990|P8|COMPLETED|Overall Study||19729
8217003|NCT02081807|20263991|P7|COMPLETED|Overall Study||40207
8217004|NCT02081807|20263992|P6|COMPLETED|Overall Study||76055
8217005|NCT02081807|20263993|P5|COMPLETED|Overall Study||27456
8217006|NCT02081807|20263994|P4|COMPLETED|Overall Study||9112
8217007|NCT02081807|20263995|P3|COMPLETED|Overall Study||14852
8217008|NCT02081807|20263996|P2|COMPLETED|Overall Study||26149
8217009|NCT02081807|20263997|P1|COMPLETED|Overall Study||7668
8217010|NCT02081807|20263990|P8|STARTED|Overall Study||19729
8217011|NCT02081807|20263991|P7|STARTED|Overall Study||40207
8217012|NCT02081807|20263992|P6|STARTED|Overall Study||76055
8217013|NCT02081807|20263993|P5|STARTED|Overall Study||27456
8217014|NCT02081807|20263994|P4|STARTED|Overall Study||9112
8217015|NCT02081807|20263995|P3|STARTED|Overall Study||14852
8217016|NCT02081807|20263996|P2|STARTED|Overall Study||26149
8217017|NCT02081807|20263997|P1|STARTED|Overall Study||7668
8217018|NCT02081690|20264133|P1|NOT COMPLETED|Overall Study||7
8217019|NCT02081690|20264133|P1|COMPLETED|Overall Study||81
8217020|NCT02081690|20264133|P1|STARTED|Overall Study||88
8217021|NCT02081677|20264144|P4|NOT COMPLETED|Overall Study||0
8217022|NCT02081677|20264145|P3|NOT COMPLETED|Overall Study||2
8217023|NCT02081677|20264146|P2|NOT COMPLETED|Overall Study||1
8217024|NCT02081677|20264147|P1|NOT COMPLETED|Overall Study||1
8217025|NCT02081677|20264144|P4|COMPLETED|Overall Study||19
8217026|NCT02081677|20264145|P3|COMPLETED|Overall Study||17
8217027|NCT02081677|20264146|P2|COMPLETED|Overall Study||18
8217028|NCT02081677|20264147|P1|COMPLETED|Overall Study||18
8217029|NCT02081677|20264144|P4|STARTED|Overall Study||19
8217030|NCT02081677|20264145|P3|STARTED|Overall Study||19
8217031|NCT02081677|20264146|P2|STARTED|Overall Study||19
8217032|NCT02081677|20264147|P1|STARTED|Overall Study||19
8217033|NCT02081638|20264239|P2|NOT COMPLETED|Overall Study||7
8217034|NCT02081638|20264240|P1|NOT COMPLETED|Overall Study||2
8217035|NCT02081638|20264239|P2|COMPLETED|Overall Study||20
8217036|NCT02081638|20264240|P1|COMPLETED|Overall Study||24
8217037|NCT02081638|20264239|P2|STARTED|Overall Study||27
8217038|NCT02081638|20264240|P1|STARTED|Overall Study||26
8217039|NCT02081599|20264252|P2|NOT COMPLETED|Period 2：Open-label Period||4
8217040|NCT02081599|20264253|P1|NOT COMPLETED|Period 2：Open-label Period||6
8217041|NCT02081599|20264252|P2|COMPLETED|Period 2：Open-label Period||71
8217042|NCT02081599|20264253|P1|COMPLETED|Period 2：Open-label Period||57
8217043|NCT02081599|20264252|P2|STARTED|Period 2：Open-label Period||75
8217044|NCT02081599|20264253|P1|STARTED|Period 2：Open-label Period||63
8217045|NCT02081599|20264252|P2|NOT COMPLETED|Period 1：Double-blind Period||2
8217046|NCT02081599|20264253|P1|NOT COMPLETED|Period 1：Double-blind Period||8
8217047|NCT02081599|20264252|P2|COMPLETED|Period 1：Double-blind Period||75
8217048|NCT02081599|20264253|P1|COMPLETED|Period 1：Double-blind Period||63
8217049|NCT02081599|20264252|P2|STARTED|Period 1：Double-blind Period||77
8217050|NCT02081599|20264253|P1|STARTED|Period 1：Double-blind Period||71
8217051|NCT02081586|20264271|P4|NOT COMPLETED|Overall Study||1
8217052|NCT02081586|20264272|P3|NOT COMPLETED|Overall Study||1
8217053|NCT02081586|20264273|P2|NOT COMPLETED|Overall Study||1
8217054|NCT02081586|20264274|P1|NOT COMPLETED|Overall Study||0
8217055|NCT02081586|20264271|P4|COMPLETED|Overall Study||2
8217056|NCT02081586|20264272|P3|COMPLETED|Overall Study||3
8217057|NCT02081586|20264273|P2|COMPLETED|Overall Study||2
8217058|NCT02081586|20264274|P1|COMPLETED|Overall Study||3
8217059|NCT02081586|20264271|P4|STARTED|Overall Study||3
8217060|NCT02081586|20264272|P3|STARTED|Overall Study||4
8217061|NCT02081586|20264273|P2|STARTED|Overall Study||3
8217062|NCT02081586|20264274|P1|STARTED|Overall Study||3
8217063|NCT02081573|20264301|P1|NOT COMPLETED|Overall Study||0
8217064|NCT02081573|20264301|P1|COMPLETED|Overall Study||10
8217065|NCT02081573|20264301|P1|STARTED|Overall Study||10
8217066|NCT02081534|20264317|P7|NOT COMPLETED|Overall Study||4
8217067|NCT02081534|20264318|P6|NOT COMPLETED|Overall Study||9
8217068|NCT02081534|20264319|P5|NOT COMPLETED|Overall Study||4
8217069|NCT02081534|20264320|P4|NOT COMPLETED|Overall Study||13
8217070|NCT02081534|20264321|P3|NOT COMPLETED|Overall Study||4
8217071|NCT02081534|20264322|P2|NOT COMPLETED|Overall Study||8
8217072|NCT02081534|20264323|P1|NOT COMPLETED|Overall Study||5
8217073|NCT02081534|20264317|P7|COMPLETED|Overall Study||22
8217074|NCT02081534|20264318|P6|COMPLETED|Overall Study||12
8217075|NCT02081534|20264319|P5|COMPLETED|Overall Study||18
8217076|NCT02081534|20264320|P4|COMPLETED|Overall Study||13
8217077|NCT02081534|20264321|P3|COMPLETED|Overall Study||19
8217078|NCT02081534|20264322|P2|COMPLETED|Overall Study||13
8217079|NCT02081534|20264323|P1|COMPLETED|Overall Study||18
8217080|NCT02081534|20264317|P7|STARTED|Overall Study||26
8217081|NCT02081534|20264318|P6|STARTED|Overall Study||21
8217082|NCT02081534|20264319|P5|STARTED|Overall Study||22
8217083|NCT02081534|20264320|P4|STARTED|Overall Study||26
8217084|NCT02081534|20264321|P3|STARTED|Overall Study||23
8217085|NCT02081534|20264322|P2|STARTED|Overall Study||21
8217086|NCT02081534|20264323|P1|STARTED|Overall Study||23
8217087|NCT02081456|20264348|P2|NOT COMPLETED|Overall Study||0
8217088|NCT02081456|20264349|P1|NOT COMPLETED|Overall Study||0
8217089|NCT02081456|20264348|P2|COMPLETED|Overall Study||12
8217090|NCT02081456|20264349|P1|COMPLETED|Overall Study||11
8217091|NCT02081456|20264348|P2|STARTED|Overall Study||12
8217092|NCT02081456|20264349|P1|STARTED|Overall Study||11
8217093|NCT02081443|20264363|P2|NOT COMPLETED|Overall Study||0
8217094|NCT02081443|20264364|P1|NOT COMPLETED|Overall Study||0
8217095|NCT02081443|20264363|P2|COMPLETED|Overall Study||30
8217096|NCT02081443|20264364|P1|COMPLETED|Overall Study||30
8217097|NCT02081443|20264363|P2|STARTED|Overall Study||30
8217098|NCT02081443|20264364|P1|STARTED|Overall Study||30
8217099|NCT02081417|20264376|P2|NOT COMPLETED|Overall Study||51
8217100|NCT02081417|20264377|P1|NOT COMPLETED|Overall Study||56
8217101|NCT02081417|20264376|P2|COMPLETED|Overall Study||115
8217102|NCT02081417|20264377|P1|COMPLETED|Overall Study||107
8217103|NCT02081417|20264376|P2|6-Month Follow-Up|Overall Study||92
8217104|NCT02081417|20264377|P1|6-Month Follow-Up|Overall Study||82
8217105|NCT02081417|20264376|P2|3-Month Follow-Up|Overall Study||95
8217106|NCT02081417|20264377|P1|3-Month Follow-Up|Overall Study||94
8217107|NCT02081417|20264376|P2|1st Interview Completed|Overall Study||145
8217108|NCT02081417|20264377|P1|1st Interview Completed|Overall Study||146
8217109|NCT02081417|20264376|P2|STARTED|Overall Study||166
8217110|NCT02081417|20264377|P1|STARTED|Overall Study|Randomized to intervention|163
8217111|NCT02081391|20264397|P4|NOT COMPLETED|24-hour Treatment and Trial Completion||0
8217112|NCT02081391|20264398|P3|NOT COMPLETED|24-hour Treatment and Trial Completion||1
8217113|NCT02081391|20264399|P2|NOT COMPLETED|24-hour Treatment and Trial Completion||18
8217114|NCT02081391|20264400|P1|NOT COMPLETED|24-hour Treatment and Trial Completion||27
8217115|NCT02081391|20264397|P4|COMPLETED|24-hour Treatment and Trial Completion||4
8217116|NCT02081391|20264398|P3|COMPLETED|24-hour Treatment and Trial Completion||9
8217117|NCT02081391|20264399|P2|COMPLETED|24-hour Treatment and Trial Completion||28
8217118|NCT02081391|20264400|P1|COMPLETED|24-hour Treatment and Trial Completion||63
8217119|NCT02081391|20264397|P4|STARTED|24-hour Treatment and Trial Completion||4
8217120|NCT02081391|20264398|P3|STARTED|24-hour Treatment and Trial Completion||10
8217121|NCT02081391|20264399|P2|STARTED|24-hour Treatment and Trial Completion||46
8217122|NCT02081391|20264400|P1|STARTED|24-hour Treatment and Trial Completion||90
8217123|NCT02081391|20264397|P4|NOT COMPLETED|12-hour Treatment||0
8217124|NCT02081391|20264398|P3|NOT COMPLETED|12-hour Treatment||1
8217125|NCT02081391|20264399|P2|NOT COMPLETED|12-hour Treatment||6
8217126|NCT02081391|20264400|P1|NOT COMPLETED|12-hour Treatment||18
8217127|NCT02081391|20264397|P4|COMPLETED|12-hour Treatment||4
8217128|NCT02081391|20264398|P3|COMPLETED|12-hour Treatment||10
8217129|NCT02081391|20264399|P2|COMPLETED|12-hour Treatment||46
8217130|NCT02081391|20264400|P1|COMPLETED|12-hour Treatment||90
8217131|NCT02081391|20264397|P4|STARTED|12-hour Treatment||4
8217132|NCT02081391|20264398|P3|STARTED|12-hour Treatment||11
8217133|NCT02081391|20264399|P2|STARTED|12-hour Treatment||52
8217134|NCT02081391|20264400|P1|STARTED|12-hour Treatment||108
8217135|NCT02081365|20264454|P2|NOT COMPLETED|Overall Study||23
8217136|NCT02081365|20264455|P1|NOT COMPLETED|Overall Study||30
8217137|NCT02081365|20264454|P2|COMPLETED|Overall Study||54
8217138|NCT02081365|20264455|P1|COMPLETED|Overall Study||44
8217139|NCT02081365|20264454|P2|Received Allocated Intervention|Overall Study||59
8217140|NCT02081365|20264455|P1|Received Allocated Intervention|Overall Study||46
8217141|NCT02081365|20264454|P2|STARTED|Overall Study||77
8217142|NCT02081365|20264455|P1|STARTED|Overall Study||74
8217143|NCT02081248|20264469|P2|NOT COMPLETED|Overall Study||13
8217144|NCT02081248|20264470|P1|NOT COMPLETED|Overall Study||22
8217145|NCT02081248|20264469|P2|COMPLETED|Overall Study||87
8217146|NCT02081248|20264470|P1|COMPLETED|Overall Study||76
8217147|NCT02081248|20264469|P2|STARTED|Overall Study||100
8217148|NCT02081248|20264470|P1|STARTED|Overall Study||98
8217149|NCT02081183|20264494|P2|NOT COMPLETED|Overall Study||4
8217150|NCT02081183|20264495|P1|NOT COMPLETED|Overall Study||4
8217151|NCT02081183|20264494|P2|COMPLETED|Overall Study||2
8217152|NCT02081183|20264495|P1|COMPLETED|Overall Study||1
8217153|NCT02081183|20264494|P2|STARTED|Overall Study||6
8217154|NCT02081183|20264495|P1|STARTED|Overall Study||5
8217155|NCT02081079|20264511|P2|NOT COMPLETED|Overall Study||2
8217156|NCT02081079|20264512|P1|NOT COMPLETED|Overall Study||4
8217157|NCT02081079|20264511|P2|COMPLETED|Overall Study||39
8217158|NCT02081079|20264512|P1|COMPLETED|Overall Study||40
8217159|NCT02081079|20264511|P2|STARTED|Overall Study||41
8217160|NCT02081079|20264512|P1|STARTED|Overall Study||44
8217161|NCT02081014|20264534|P6|NOT COMPLETED|Overall Study||0
8217162|NCT02081014|20264535|P5|NOT COMPLETED|Overall Study||0
8217163|NCT02081014|20264536|P4|NOT COMPLETED|Overall Study||0
8217164|NCT02081014|20264537|P3|NOT COMPLETED|Overall Study||0
8217165|NCT02081014|20264538|P2|NOT COMPLETED|Overall Study||0
8217166|NCT02081014|20264539|P1|NOT COMPLETED|Overall Study||0
8217167|NCT02081014|20264534|P6|COMPLETED|Overall Study||2
8217168|NCT02081014|20264535|P5|COMPLETED|Overall Study||2
8217169|NCT02081014|20264536|P4|COMPLETED|Overall Study||2
8217170|NCT02081014|20264537|P3|COMPLETED|Overall Study||2
8217171|NCT02081014|20264538|P2|COMPLETED|Overall Study||2
8217172|NCT02081014|20264539|P1|COMPLETED|Overall Study||2
8217173|NCT02081014|20264534|P6|STARTED|Overall Study||2
8217174|NCT02081014|20264535|P5|STARTED|Overall Study||2
8217175|NCT02081014|20264536|P4|STARTED|Overall Study||2
8217176|NCT02081014|20264537|P3|STARTED|Overall Study||2
8217177|NCT02081014|20264538|P2|STARTED|Overall Study||2
8217178|NCT02081014|20264539|P1|STARTED|Overall Study||2
8217179|NCT02081001|20264585|P12|NOT COMPLETED|Overall Study||0
8217180|NCT02081001|20264586|P11|NOT COMPLETED|Overall Study||0
8217181|NCT02081001|20264587|P10|NOT COMPLETED|Overall Study||0
8217182|NCT02081001|20264588|P9|NOT COMPLETED|Overall Study||0
8217183|NCT02081001|20264589|P8|NOT COMPLETED|Overall Study||0
8217184|NCT02081001|20264590|P7|NOT COMPLETED|Overall Study||0
8217185|NCT02081001|20264591|P6|NOT COMPLETED|Overall Study||0
8217186|NCT02081001|20264592|P5|NOT COMPLETED|Overall Study||1
8217187|NCT02081001|20264593|P4|NOT COMPLETED|Overall Study||0
8217188|NCT02081001|20264594|P3|NOT COMPLETED|Overall Study||0
8217189|NCT02081001|20264595|P2|NOT COMPLETED|Overall Study||0
8217190|NCT02081001|20264596|P1|NOT COMPLETED|Overall Study||0
8217191|NCT02081001|20264585|P12|COMPLETED|Overall Study||1
8217192|NCT02081001|20264586|P11|COMPLETED|Overall Study||2
8217193|NCT02081001|20264587|P10|COMPLETED|Overall Study||1
8217194|NCT02081001|20264588|P9|COMPLETED|Overall Study||2
8217195|NCT02081001|20264589|P8|COMPLETED|Overall Study||1
8217196|NCT02081001|20264590|P7|COMPLETED|Overall Study||2
8217197|NCT02081001|20264591|P6|COMPLETED|Overall Study||1
8217198|NCT02081001|20264592|P5|COMPLETED|Overall Study||2
8217199|NCT02081001|20264593|P4|COMPLETED|Overall Study||1
8217200|NCT02081001|20264594|P3|COMPLETED|Overall Study||2
8217201|NCT02081001|20264595|P2|COMPLETED|Overall Study||1
8217202|NCT02081001|20264596|P1|COMPLETED|Overall Study||2
8217203|NCT02081001|20264585|P12|STARTED|Overall Study||1
8217204|NCT02081001|20264586|P11|STARTED|Overall Study||2
8217205|NCT02081001|20264587|P10|STARTED|Overall Study||1
8217206|NCT02081001|20264588|P9|STARTED|Overall Study||2
8217207|NCT02081001|20264589|P8|STARTED|Overall Study||1
8217208|NCT02081001|20264590|P7|STARTED|Overall Study||2
8217209|NCT02081001|20264591|P6|STARTED|Overall Study||1
8217210|NCT02081001|20264592|P5|STARTED|Overall Study||3
8217211|NCT02081001|20264593|P4|STARTED|Overall Study||1
8217212|NCT02081001|20264594|P3|STARTED|Overall Study||2
8217213|NCT02081001|20264595|P2|STARTED|Overall Study||1
8217214|NCT02081001|20264596|P1|STARTED|Overall Study||2
8217215|NCT02080871|20264660|P1|NOT COMPLETED|Overall Study||2
8217216|NCT02080871|20264660|P1|COMPLETED|Overall Study||132
8217217|NCT02080871|20264660|P1|STARTED|Overall Study||134
8217218|NCT02080832|20264744|P3|NOT COMPLETED|Overall Study||16
8217219|NCT02080832|20264745|P2|NOT COMPLETED|Overall Study||12
8217220|NCT02080832|20264746|P1|NOT COMPLETED|Overall Study||9
8217221|NCT02080832|20264744|P3|COMPLETED|Overall Study||6
8217222|NCT02080832|20264745|P2|COMPLETED|Overall Study||5
8217223|NCT02080832|20264746|P1|COMPLETED|Overall Study||6
8217224|NCT02080832|20264744|P3|STARTED|Overall Study||22
8217225|NCT02080832|20264745|P2|STARTED|Overall Study||17
8217226|NCT02080832|20264746|P1|STARTED|Overall Study||15
8217227|NCT02080819|20264763|P3|NOT COMPLETED|Overall Study||22
8217228|NCT02080819|20264764|P2|NOT COMPLETED|Overall Study||26
8217229|NCT02080819|20264765|P1|NOT COMPLETED|Overall Study||25
8217230|NCT02080819|20264763|P3|COMPLETED|Overall Study||11
8217231|NCT02080819|20264764|P2|COMPLETED|Overall Study||9
8217232|NCT02080819|20264765|P1|COMPLETED|Overall Study||38
8217233|NCT02080819|20264763|P3|STARTED|Overall Study||33
8217234|NCT02080819|20264764|P2|STARTED|Overall Study||35
8217235|NCT02080819|20264765|P1|STARTED|Overall Study||63
8217236|NCT02080780|20264773|P1|NOT COMPLETED|Overall Study||0
8217237|NCT02080780|20264773|P1|COMPLETED|Overall Study||24
8217238|NCT02080780|20264773|P1|STARTED|Overall Study||24
8217239|NCT02080637|20264782|P2|NOT COMPLETED|Overall Study||0
8217240|NCT02080637|20264783|P1|NOT COMPLETED|Overall Study||0
8217241|NCT02080637|20264782|P2|COMPLETED|Overall Study||3
8217242|NCT02080637|20264783|P1|COMPLETED|Overall Study||13
8217243|NCT02080637|20264782|P2|STARTED|Overall Study||3
8217244|NCT02080637|20264783|P1|STARTED|Overall Study||13
8217245|NCT02080546|20264796|P2|NOT COMPLETED|Overall Study||11
8217246|NCT02080546|20264797|P1|NOT COMPLETED|Overall Study||8
8217247|NCT02080546|20264796|P2|COMPLETED|Overall Study||52
8217248|NCT02080546|20264797|P1|COMPLETED|Overall Study||49
8217249|NCT02080546|20264796|P2|STARTED|Overall Study||63
8217250|NCT02080546|20264797|P1|STARTED|Overall Study||57
8217251|NCT02080507|20264807|P2|NOT COMPLETED|Overall Study||0
8217252|NCT02080507|20264808|P1|NOT COMPLETED|Overall Study||0
8217253|NCT02080507|20264807|P2|COMPLETED|Overall Study||7
8217254|NCT02080507|20264808|P1|COMPLETED|Overall Study||5
8217255|NCT02080507|20264807|P2|STARTED|Overall Study||7
8217256|NCT02080507|20264808|P1|STARTED|Overall Study||5
8217257|NCT02080481|20264818|P2|NOT COMPLETED|Overall Study||0
8217258|NCT02080481|20264819|P1|NOT COMPLETED|Overall Study||1
8217259|NCT02080481|20264818|P2|COMPLETED|Overall Study||67
8217260|NCT02080481|20264819|P1|COMPLETED|Overall Study||67
8217261|NCT02080481|20264818|P2|STARTED|Overall Study||67
8217262|NCT02080481|20264819|P1|STARTED|Overall Study||68
8217263|NCT02080468|20264833|P2|NOT COMPLETED|Overall Study||2
8217264|NCT02080468|20264834|P1|NOT COMPLETED|Overall Study||2
8217265|NCT02080468|20264833|P2|COMPLETED|Overall Study||14
8217266|NCT02080468|20264834|P1|COMPLETED|Overall Study||14
8217267|NCT02080468|20264833|P2|STARTED|Overall Study||16
8217268|NCT02080468|20264834|P1|STARTED|Overall Study||16
8217269|NCT02080455|20264900|P2|NOT COMPLETED|Overall Study||0
8217270|NCT02080455|20264901|P1|NOT COMPLETED|Overall Study||0
8217271|NCT02080455|20264900|P2|COMPLETED|Overall Study||16
8217272|NCT02080455|20264901|P1|COMPLETED|Overall Study||16
8217273|NCT02080455|20264900|P2|STARTED|Overall Study||16
8217274|NCT02080455|20264901|P1|STARTED|Overall Study||16
8217275|NCT02080312|20264965|P1|NOT COMPLETED|Overall Study||0
8217276|NCT02080312|20264965|P1|COMPLETED|Overall Study||6
8217277|NCT02080312|20264965|P1|STARTED|Overall Study||6
8217278|NCT02080273|20264974|P3|NOT COMPLETED|Overall Study||0
8217279|NCT02080273|20264975|P2|NOT COMPLETED|Overall Study||0
8217280|NCT02080273|20264976|P1|NOT COMPLETED|Overall Study||0
8217281|NCT02080273|20264974|P3|COMPLETED|Overall Study||45
8217282|NCT02080273|20264975|P2|COMPLETED|Overall Study||45
8217283|NCT02080273|20264976|P1|COMPLETED|Overall Study||45
8217284|NCT02080273|20264974|P3|STARTED|Overall Study||45
8217285|NCT02080273|20264975|P2|STARTED|Overall Study||45
8217286|NCT02080273|20264976|P1|STARTED|Overall Study||45
8217287|NCT02080260|20265005|P1|NOT COMPLETED|Overall Study||19
8217380|NCT02079636|20265209|P1|NOT COMPLETED|Overall Study||3
8217288|NCT02080260|20265005|P1|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1
8217289|NCT02080260|20265005|P1|STARTED|Overall Study||20
8217290|NCT02080195|20265013|P1|NOT COMPLETED|Overall Study||0
8217291|NCT02080195|20265013|P1|COMPLETED|Overall Study||1
8217292|NCT02080195|20265013|P1|STARTED|Overall Study||1
8217293|NCT02080091|20265022|P1|NOT COMPLETED|Overall Study||25
8217294|NCT02080091|20265022|P1|COMPLETED|Overall Study||0
8217295|NCT02080091|20265022|P1|STARTED|Overall Study||25
8217296|NCT02079987|20265030|P2|NOT COMPLETED|Overall Study||0
8217297|NCT02079987|20265031|P1|NOT COMPLETED|Overall Study||0
8217298|NCT02079987|20265030|P2|COMPLETED|Overall Study||544
8217299|NCT02079987|20265031|P1|COMPLETED|Overall Study||557
8217300|NCT02079987|20265030|P2|STARTED|Overall Study||544
8217301|NCT02079987|20265031|P1|STARTED|Overall Study||557
8217302|NCT02079909|20265050|P3|NOT COMPLETED|Overall Study||18
8217303|NCT02079909|20265051|P2|NOT COMPLETED|Overall Study||49
8217304|NCT02079909|20265052|P1|NOT COMPLETED|Overall Study||38
8217305|NCT02079909|20265050|P3|COMPLETED|Overall Study||140
8217306|NCT02079909|20265051|P2|COMPLETED|Overall Study||117
8217307|NCT02079909|20265052|P1|COMPLETED|Overall Study||120
8217308|NCT02079909|20265050|P3|STARTED|Overall Study||158
8217309|NCT02079909|20265051|P2|STARTED|Overall Study||166
8217310|NCT02079909|20265052|P1|STARTED|Overall Study||158
8217311|NCT02079844|20265069|P3|NOT COMPLETED|Treatment Period 3||0
8217312|NCT02079844|20265070|P2|NOT COMPLETED|Treatment Period 3||0
8217313|NCT02079844|20265071|P1|NOT COMPLETED|Treatment Period 3||0
8217314|NCT02079844|20265069|P3|COMPLETED|Treatment Period 3||5
8217315|NCT02079844|20265070|P2|COMPLETED|Treatment Period 3||5
8217316|NCT02079844|20265071|P1|COMPLETED|Treatment Period 3||5
8217317|NCT02079844|20265069|P3|STARTED|Treatment Period 3||5
8217318|NCT02079844|20265070|P2|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
8217319|NCT02079844|20265071|P1|STARTED|Treatment Period 3||5
8217320|NCT02079844|20265069|P3|NOT COMPLETED|Treatment Period 2||0
8217321|NCT02079844|20265070|P2|NOT COMPLETED|Treatment Period 2||1
8217322|NCT02079844|20265071|P1|NOT COMPLETED|Treatment Period 2||0
8217323|NCT02079844|20265069|P3|COMPLETED|Treatment Period 2||5
8217324|NCT02079844|20265070|P2|COMPLETED|Treatment Period 2||6
8217325|NCT02079844|20265071|P1|COMPLETED|Treatment Period 2||5
8217326|NCT02079844|20265069|P3|STARTED|Treatment Period 2||5
8217327|NCT02079844|20265070|P2|STARTED|Treatment Period 2||7
8217328|NCT02079844|20265071|P1|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
8217329|NCT02079844|20265069|P3|NOT COMPLETED|Treatment Period 1||2
8217330|NCT02079844|20265070|P2|NOT COMPLETED|Treatment Period 1||0
8217331|NCT02079844|20265071|P1|NOT COMPLETED|Treatment Period 1||0
8217332|NCT02079844|20265069|P3|COMPLETED|Treatment Period 1||5
8217333|NCT02079844|20265070|P2|COMPLETED|Treatment Period 1||7
8217334|NCT02079844|20265071|P1|COMPLETED|Treatment Period 1||6
8217335|NCT02079844|20265069|P3|STARTED|Treatment Period 1||7
8217336|NCT02079844|20265070|P2|STARTED|Treatment Period 1||7
8217337|NCT02079844|20265071|P1|STARTED|Treatment Period 1||6
8217338|NCT02079805|20265129|P2|NOT COMPLETED|Overall Study||2
8217339|NCT02079805|20265130|P1|NOT COMPLETED|Overall Study||0
8217340|NCT02079805|20265129|P2|COMPLETED|Overall Study||15
8217341|NCT02079805|20265130|P1|COMPLETED|Overall Study||16
8217342|NCT02079805|20265129|P2|STARTED|Overall Study||17
8217343|NCT02079805|20265130|P1|STARTED|Overall Study||16
8217344|NCT02079766|20265150|P2|NOT COMPLETED|Overall Study||0
8217345|NCT02079766|20265151|P1|NOT COMPLETED|Overall Study||2
8217346|NCT02079766|20265150|P2|COMPLETED|Overall Study||11
8217347|NCT02079766|20265151|P1|COMPLETED|Overall Study||28
8217348|NCT02079766|20265150|P2|STARTED|Overall Study||11
8217349|NCT02079766|20265151|P1|STARTED|Overall Study||30
8217350|NCT02079649|20265162|P4|NOT COMPLETED|Overall Study||2
8217351|NCT02079649|20265163|P3|NOT COMPLETED|Overall Study||1
8217352|NCT02079649|20265164|P2|NOT COMPLETED|Overall Study||0
8217353|NCT02079649|20265165|P1|NOT COMPLETED|Overall Study||1
8217354|NCT02079649|20265162|P4|COMPLETED|Overall Study||38
8217355|NCT02079649|20265163|P3|COMPLETED|Overall Study||40
8217356|NCT02079649|20265164|P2|COMPLETED|Overall Study||41
8217357|NCT02079649|20265165|P1|COMPLETED|Overall Study||41
8217358|NCT02079649|20265162|P4|Treated|Overall Study||40
8217359|NCT02079649|20265163|P3|Treated|Overall Study||40
8217360|NCT02079649|20265164|P2|Treated|Overall Study||41
8217361|NCT02079649|20265165|P1|Treated|Overall Study||41
8217362|NCT02079649|20265162|P4|STARTED|Overall Study||40
8217363|NCT02079649|20265163|P3|STARTED|Overall Study||41
8217364|NCT02079649|20265164|P2|STARTED|Overall Study||41
8217365|NCT02079649|20265165|P1|STARTED|Overall Study||42
8217366|NCT02079636|20265195|P15|NOT COMPLETED|Overall Study||5
8217367|NCT02079636|20265196|P14|NOT COMPLETED|Overall Study||0
8217368|NCT02079636|20265197|P13|NOT COMPLETED|Overall Study||3
8217369|NCT02079636|20265198|P12|NOT COMPLETED|Overall Study||2
8217370|NCT02079636|20265199|P11|NOT COMPLETED|Overall Study||2
8217371|NCT02079636|20265200|P10|NOT COMPLETED|Overall Study||3
8217372|NCT02079636|20265201|P9|NOT COMPLETED|Overall Study||0
8217373|NCT02079636|20265202|P8|NOT COMPLETED|Overall Study||1
8217374|NCT02079636|20265203|P7|NOT COMPLETED|Overall Study||1
8217375|NCT02079636|20265204|P6|NOT COMPLETED|Overall Study||6
8217376|NCT02079636|20265205|P5|NOT COMPLETED|Overall Study||2
8217377|NCT02079636|20265206|P4|NOT COMPLETED|Overall Study||12
8217378|NCT02079636|20265207|P3|NOT COMPLETED|Overall Study||0
8217379|NCT02079636|20265208|P2|NOT COMPLETED|Overall Study||2
8217381|NCT02079636|20265195|P15|COMPLETED|Overall Study||12
8217382|NCT02079636|20265196|P14|COMPLETED|Overall Study||3
8217383|NCT02079636|20265197|P13|COMPLETED|Overall Study||5
8217384|NCT02079636|20265198|P12|COMPLETED|Overall Study||4
8217385|NCT02079636|20265199|P11|COMPLETED|Overall Study||8
8217386|NCT02079636|20265200|P10|COMPLETED|Overall Study||6
8217387|NCT02079636|20265201|P9|COMPLETED|Overall Study||3
8217388|NCT02079636|20265202|P8|COMPLETED|Overall Study||3
8217389|NCT02079636|20265203|P7|COMPLETED|Overall Study||11
8217390|NCT02079636|20265204|P6|COMPLETED|Overall Study||13
8217391|NCT02079636|20265205|P5|COMPLETED|Overall Study||2
8217392|NCT02079636|20265206|P4|COMPLETED|Overall Study||9
8217393|NCT02079636|20265207|P3|COMPLETED|Overall Study||3
8217394|NCT02079636|20265208|P2|COMPLETED|Overall Study||13
8217395|NCT02079636|20265209|P1|COMPLETED|Overall Study||5
8217396|NCT02079636|20265195|P15|Received at Least One Dose of Study Drug|Overall Study||17
8217397|NCT02079636|20265196|P14|Received at Least One Dose of Study Drug|Overall Study||3
8217398|NCT02079636|20265197|P13|Received at Least One Dose of Study Drug|Overall Study||8
8217399|NCT02079636|20265198|P12|Received at Least One Dose of Study Drug|Overall Study||6
8217400|NCT02079636|20265199|P11|Received at Least One Dose of Study Drug|Overall Study||10
8217401|NCT02079636|20265200|P10|Received at Least One Dose of Study Drug|Overall Study||9
8217402|NCT02079636|20265201|P9|Received at Least One Dose of Study Drug|Overall Study||3
8217403|NCT02079636|20265202|P8|Received at Least One Dose of Study Drug|Overall Study||4
8217404|NCT02079636|20265203|P7|Received at Least One Dose of Study Drug|Overall Study||12
8217405|NCT02079636|20265204|P6|Received at Least One Dose of Study Drug|Overall Study||19
8217406|NCT02079636|20265205|P5|Received at Least One Dose of Study Drug|Overall Study||4
8217407|NCT02079636|20265206|P4|Received at Least One Dose of Study Drug|Overall Study||21
8217408|NCT02079636|20265207|P3|Received at Least One Dose of Study Drug|Overall Study||3
8217409|NCT02079636|20265208|P2|Received at Least One Dose of Study Drug|Overall Study||15
8217410|NCT02079636|20265209|P1|Received at Least One Dose of Study Drug|Overall Study||8
8217411|NCT02079636|20265195|P15|STARTED|Overall Study||17
8217412|NCT02079636|20265196|P14|STARTED|Overall Study||3
8217413|NCT02079636|20265197|P13|STARTED|Overall Study||8
8217414|NCT02079636|20265198|P12|STARTED|Overall Study||6
8217415|NCT02079636|20265199|P11|STARTED|Overall Study||10
8217416|NCT02079636|20265200|P10|STARTED|Overall Study||9
8217417|NCT02079636|20265201|P9|STARTED|Overall Study||3
8217418|NCT02079636|20265202|P8|STARTED|Overall Study||4
8217419|NCT02079636|20265203|P7|STARTED|Overall Study||12
8217420|NCT02079636|20265204|P6|STARTED|Overall Study||19
8217421|NCT02079636|20265205|P5|STARTED|Overall Study||4
8217422|NCT02079636|20265206|P4|STARTED|Overall Study||21
8217423|NCT02079636|20265207|P3|STARTED|Overall Study||3
8217424|NCT02079636|20265208|P2|STARTED|Overall Study||15
8217425|NCT02079636|20265209|P1|STARTED|Overall Study||8
8217426|NCT02079610|20265320|P2|NOT COMPLETED|Overall Study||1
8217427|NCT02079610|20265321|P1|NOT COMPLETED|Overall Study||1
8217428|NCT02079610|20265320|P2|COMPLETED|Overall Study||16
8217429|NCT02079610|20265321|P1|COMPLETED|Overall Study||18
8217430|NCT02079610|20265320|P2|STARTED|Overall Study||17
8217431|NCT02079610|20265321|P1|STARTED|Overall Study||19
8217432|NCT02079532|20265331|P1|NOT COMPLETED|Overall Study||29
8217433|NCT02079532|20265331|P1|COMPLETED|Overall Study||273
8217434|NCT02079532|20265331|P1|STARTED|Overall Study||302
8217435|NCT02079519|20265353|P1|NOT COMPLETED|Overall Study||10
8217436|NCT02079519|20265353|P1|COMPLETED|Overall Study||0
8217437|NCT02079519|20265353|P1|STARTED|Overall Study||10
8217438|NCT02079311|20265359|P2|NOT COMPLETED|Overall Study||1
8217439|NCT02079311|20265360|P1|NOT COMPLETED|Overall Study||0
8217440|NCT02079311|20265359|P2|COMPLETED|Overall Study||26
8217441|NCT02079311|20265360|P1|COMPLETED|Overall Study||28
8217442|NCT02079311|20265359|P2|STARTED|Overall Study||27
8217443|NCT02079311|20265360|P1|STARTED|Overall Study||28
8217444|NCT02079246|20265366|P2|NOT COMPLETED|OLEX-MEM||19
8217445|NCT02079246|20265367|P1|NOT COMPLETED|OLEX-MEM||0
8217446|NCT02079246|20265366|P2|COMPLETED|OLEX-MEM||82
8217447|NCT02079246|20265367|P1|COMPLETED|OLEX-MEM||0
8217448|NCT02079246|20265366|P2|STARTED|OLEX-MEM||101
8217449|NCT02079246|20265367|P1|STARTED|OLEX-MEM||0
8217450|NCT02079246|20265366|P2|NOT COMPLETED|OLEX||0
8217451|NCT02079246|20265367|P1|NOT COMPLETED|OLEX||228
8217452|NCT02079246|20265366|P2|COMPLETED|OLEX||0
8217453|NCT02079246|20265367|P1|COMPLETED|OLEX||1235
8217454|NCT02079246|20265366|P2|STARTED|OLEX||0
8217455|NCT02079246|20265367|P1|STARTED|OLEX||1463
8217456|NCT02079077|20265386|P2|NOT COMPLETED|Overall Study||9
8217457|NCT02079077|20265387|P1|NOT COMPLETED|Overall Study||6
8217458|NCT02079077|20265386|P2|COMPLETED|Overall Study||39
8217459|NCT02079077|20265387|P1|COMPLETED|Overall Study||37
8217460|NCT02079077|20265386|P2|STARTED|Overall Study||48
8217461|NCT02079077|20265387|P1|STARTED|Overall Study||43
8217462|NCT02079038|20265397|P2|NOT COMPLETED|Completed 6 Months||1
8217463|NCT02079038|20265398|P1|NOT COMPLETED|Completed 6 Months||2
8217464|NCT02079038|20265397|P2|COMPLETED|Completed 6 Months||50
8217465|NCT02079038|20265398|P1|COMPLETED|Completed 6 Months||103
8217466|NCT02079038|20265397|P2|STARTED|Completed 6 Months||51
8217467|NCT02079038|20265398|P1|STARTED|Completed 6 Months||105
8217468|NCT02079038|20265397|P2|NOT COMPLETED|Modified Intent to Treat Population||5
8217469|NCT02079038|20265398|P1|NOT COMPLETED|Modified Intent to Treat Population||7
8217470|NCT02079038|20265397|P2|COMPLETED|Modified Intent to Treat Population||51
8217566|NCT02078219|20265853|P2|COMPLETED|Overall Study||36
8217471|NCT02079038|20265398|P1|COMPLETED|Modified Intent to Treat Population||105
8217472|NCT02079038|20265397|P2|STARTED|Modified Intent to Treat Population||56
8217473|NCT02079038|20265398|P1|STARTED|Modified Intent to Treat Population||112
8217474|NCT02079025|20265406|P2|NOT COMPLETED|Overall Study||0
8217475|NCT02079025|20265407|P1|NOT COMPLETED|Overall Study||0
8217476|NCT02079025|20265406|P2|COMPLETED|Overall Study||837
8217477|NCT02079025|20265407|P1|COMPLETED|Overall Study||839
8217478|NCT02079025|20265406|P2|STARTED|Overall Study||837
8217479|NCT02079025|20265407|P1|STARTED|Overall Study||839
8217480|NCT02078960|20265419|P3|NOT COMPLETED|Follow-up Period||0
8217481|NCT02078960|20265420|P2|NOT COMPLETED|Follow-up Period||1
8217482|NCT02078960|20265421|P1|NOT COMPLETED|Follow-up Period||2
8217483|NCT02078960|20265419|P3|COMPLETED|Follow-up Period||1
8217484|NCT02078960|20265420|P2|COMPLETED|Follow-up Period||1
8217485|NCT02078960|20265421|P1|COMPLETED|Follow-up Period||0
8217486|NCT02078960|20265419|P3|STARTED|Follow-up Period||1
8217487|NCT02078960|20265420|P2|STARTED|Follow-up Period||2
8217488|NCT02078960|20265421|P1|STARTED|Follow-up Period||2
8217489|NCT02078960|20265419|P3|NOT COMPLETED|Treatment Period||3
8217490|NCT02078960|20265420|P2|NOT COMPLETED|Treatment Period||3
8217491|NCT02078960|20265421|P1|NOT COMPLETED|Treatment Period||2
8217492|NCT02078960|20265419|P3|COMPLETED|Treatment Period||1
8217493|NCT02078960|20265420|P2|COMPLETED|Treatment Period||1
8217494|NCT02078960|20265421|P1|COMPLETED|Treatment Period||0
8217495|NCT02078960|20265419|P3|STARTED|Treatment Period||4
8217496|NCT02078960|20265420|P2|STARTED|Treatment Period||4
8217497|NCT02078960|20265421|P1|STARTED|Treatment Period||2
8217498|NCT02078882|20265443|P1|NOT COMPLETED|Overall Study||0
8217499|NCT02078882|20265443|P1|COMPLETED|Overall Study||16
8217500|NCT02078882|20265443|P1|STARTED|Overall Study||16
8217501|NCT02078817|20265455|P1|NOT COMPLETED|Overall Study||1
8217502|NCT02078817|20265455|P1|COMPLETED|Overall Study||13
8217503|NCT02078817|20265455|P1|STARTED|Overall Study||14
8217504|NCT02078752|20265477|P10|NOT COMPLETED|Overall Study||10
8217505|NCT02078752|20265478|P9|NOT COMPLETED|Overall Study||0
8217506|NCT02078752|20265479|P8|NOT COMPLETED|Overall Study||3
8217507|NCT02078752|20265480|P7|NOT COMPLETED|Overall Study||2
8217508|NCT02078752|20265481|P6|NOT COMPLETED|Overall Study||4
8217509|NCT02078752|20265482|P5|NOT COMPLETED|Overall Study||1
8217510|NCT02078752|20265483|P4|NOT COMPLETED|Overall Study||2
8217511|NCT02078752|20265484|P3|NOT COMPLETED|Overall Study||1
8217512|NCT02078752|20265485|P2|NOT COMPLETED|Overall Study||7
8217513|NCT02078752|20265486|P1|NOT COMPLETED|Overall Study||2
8217514|NCT02078752|20265477|P10|COMPLETED|Overall Study||2
8217515|NCT02078752|20265478|P9|COMPLETED|Overall Study||2
8217516|NCT02078752|20265479|P8|COMPLETED|Overall Study||3
8217517|NCT02078752|20265480|P7|COMPLETED|Overall Study||1
8217518|NCT02078752|20265481|P6|COMPLETED|Overall Study||5
8217519|NCT02078752|20265482|P5|COMPLETED|Overall Study||2
8217520|NCT02078752|20265483|P4|COMPLETED|Overall Study||5
8217521|NCT02078752|20265484|P3|COMPLETED|Overall Study||1
8217522|NCT02078752|20265485|P2|COMPLETED|Overall Study||6
8217523|NCT02078752|20265486|P1|COMPLETED|Overall Study||1
8217524|NCT02078752|20265477|P10|STARTED|Overall Study||12
8217525|NCT02078752|20265478|P9|STARTED|Overall Study||2
8217526|NCT02078752|20265479|P8|STARTED|Overall Study||6
8217527|NCT02078752|20265480|P7|STARTED|Overall Study||3
8217528|NCT02078752|20265481|P6|STARTED|Overall Study||9
8217529|NCT02078752|20265482|P5|STARTED|Overall Study||3
8217530|NCT02078752|20265483|P4|STARTED|Overall Study||7
8217531|NCT02078752|20265484|P3|STARTED|Overall Study||2
8217532|NCT02078752|20265485|P2|STARTED|Overall Study||13
8217533|NCT02078752|20265486|P1|STARTED|Overall Study||3
8217534|NCT02078713|20265762|P4|NOT COMPLETED|Overall Study||0
8217535|NCT02078713|20265763|P3|NOT COMPLETED|Overall Study||0
8217536|NCT02078713|20265764|P2|NOT COMPLETED|Overall Study||61
8217537|NCT02078713|20265765|P1|NOT COMPLETED|Overall Study||52
8217538|NCT02078713|20265762|P4|COMPLETED|Overall Study||13
8217539|NCT02078713|20265763|P3|COMPLETED|Overall Study||15
8217540|NCT02078713|20265764|P2|COMPLETED|Overall Study||290
8217541|NCT02078713|20265765|P1|COMPLETED|Overall Study||355
8217542|NCT02078713|20265762|P4|STARTED|Overall Study||13
8217543|NCT02078713|20265763|P3|STARTED|Overall Study||15
8217544|NCT02078713|20265764|P2|STARTED|Overall Study||351
8217545|NCT02078713|20265765|P1|STARTED|Overall Study||407
8217546|NCT02078557|20265817|P1|NOT COMPLETED|Overall Study||0
8217547|NCT02078557|20265817|P1|COMPLETED|Overall Study||4
8217548|NCT02078557|20265817|P1|STARTED|Overall Study||4
8217549|NCT02078492|20265826|P3|NOT COMPLETED|Overall Study||0
8217550|NCT02078492|20265827|P2|NOT COMPLETED|Overall Study||0
8217551|NCT02078492|20265828|P1|NOT COMPLETED|Overall Study||0
8217552|NCT02078492|20265826|P3|COMPLETED|Overall Study||80
8217553|NCT02078492|20265827|P2|COMPLETED|Overall Study||80
8217554|NCT02078492|20265828|P1|COMPLETED|Overall Study||80
8217555|NCT02078492|20265826|P3|STARTED|Overall Study||80
8217556|NCT02078492|20265827|P2|STARTED|Overall Study||80
8217557|NCT02078492|20265828|P1|STARTED|Overall Study||80
8217558|NCT02078219|20265850|P5|NOT COMPLETED|Overall Study||2
8217559|NCT02078219|20265851|P4|NOT COMPLETED|Overall Study||4
8217560|NCT02078219|20265852|P3|NOT COMPLETED|Overall Study||6
8217561|NCT02078219|20265853|P2|NOT COMPLETED|Overall Study||4
8217562|NCT02078219|20265854|P1|NOT COMPLETED|Overall Study||3
8217563|NCT02078219|20265850|P5|COMPLETED|Overall Study||39
8217564|NCT02078219|20265851|P4|COMPLETED|Overall Study||37
8217565|NCT02078219|20265852|P3|COMPLETED|Overall Study||35
8217567|NCT02078219|20265854|P1|COMPLETED|Overall Study||38
8217568|NCT02078219|20265850|P5|STARTED|Overall Study||41
8217569|NCT02078219|20265851|P4|STARTED|Overall Study||41
8217570|NCT02078219|20265852|P3|STARTED|Overall Study||41
8217571|NCT02078219|20265853|P2|STARTED|Overall Study||40
8217572|NCT02078219|20265854|P1|STARTED|Overall Study||41
8217573|NCT02078193|20265881|P1|NOT COMPLETED|Overall Study||0
8217574|NCT02078193|20265881|P1|COMPLETED|Overall Study||3
8217575|NCT02078193|20265881|P1|STARTED|Overall Study||3
8217576|NCT02078180|20265887|P1|NOT COMPLETED|Overall Study||5
8217577|NCT02078180|20265887|P1|COMPLETED|Overall Study||29
8217578|NCT02078180|20265887|P1|XL 300|Overall Study||32
8217579|NCT02078180|20265887|P1|XL 150|Overall Study||31
8217580|NCT02078180|20265887|P1|SR150|Overall Study||32
8217581|NCT02078180|20265887|P1|SR100|Overall Study||31
8217582|NCT02078180|20265887|P1|IR100|Overall Study||31
8217583|NCT02078180|20265887|P1|IR75|Overall Study||30
8217584|NCT02078180|20265887|P1|STARTED|Overall Study||34
8217585|NCT02077465|20265904|P2|NOT COMPLETED|Overall Study||1
8217586|NCT02077465|20265905|P1|NOT COMPLETED|Overall Study||1
8217587|NCT02077465|20265904|P2|COMPLETED|Overall Study||2
8217588|NCT02077465|20265905|P1|COMPLETED|Overall Study||7
8217589|NCT02077465|20265904|P2|STARTED|Overall Study||3
8217590|NCT02077465|20265905|P1|STARTED|Overall Study||8
8217591|NCT02077374|20265928|P2|NOT COMPLETED|Overall Study||2
8217592|NCT02077374|20265929|P1|NOT COMPLETED|Overall Study||0
8217593|NCT02077374|20265928|P2|COMPLETED|Overall Study||17
8217594|NCT02077374|20265929|P1|COMPLETED|Overall Study||19
8217595|NCT02077374|20265928|P2|STARTED|Overall Study||19
8217596|NCT02077374|20265929|P1|STARTED|Overall Study||19
8217597|NCT02077140|20265950|P5|NOT COMPLETED|Overall Study||5
8217598|NCT02077140|20265951|P4|NOT COMPLETED|Overall Study||4
8217599|NCT02077140|20265952|P3|NOT COMPLETED|Overall Study||2
8217600|NCT02077140|20265953|P2|NOT COMPLETED|Overall Study||2
8217601|NCT02077140|20265954|P1|NOT COMPLETED|Overall Study||4
8217602|NCT02077140|20265950|P5|COMPLETED|Overall Study||43
8217603|NCT02077140|20265951|P4|COMPLETED|Overall Study||32
8217604|NCT02077140|20265952|P3|COMPLETED|Overall Study||34
8217605|NCT02077140|20265953|P2|COMPLETED|Overall Study||34
8217606|NCT02077140|20265954|P1|COMPLETED|Overall Study||32
8217607|NCT02077140|20265950|P5|STARTED|Overall Study||48
8217608|NCT02077140|20265951|P4|STARTED|Overall Study||36
8217609|NCT02077140|20265952|P3|STARTED|Overall Study||36
8217610|NCT02077140|20265953|P2|STARTED|Overall Study||36
8217611|NCT02077140|20265954|P1|STARTED|Overall Study||36
8217612|NCT02076919|20266053|P4|NOT COMPLETED|Overall Study||0
8217613|NCT02076919|20266054|P3|NOT COMPLETED|Overall Study||0
8217614|NCT02076919|20266055|P2|NOT COMPLETED|Overall Study||0
8217615|NCT02076919|20266056|P1|NOT COMPLETED|Overall Study||0
8217616|NCT02076919|20266053|P4|COMPLETED|Overall Study||12
8217617|NCT02076919|20266054|P3|COMPLETED|Overall Study||36
8217618|NCT02076919|20266055|P2|COMPLETED|Overall Study||8
8217619|NCT02076919|20266056|P1|COMPLETED|Overall Study||24
8217620|NCT02076919|20266053|P4|STARTED|Overall Study||12
8217621|NCT02076919|20266054|P3|STARTED|Overall Study||36
8217622|NCT02076919|20266055|P2|STARTED|Overall Study||8
8217623|NCT02076919|20266056|P1|STARTED|Overall Study||24
8217624|NCT02076776|20266157|P3|NOT COMPLETED|Overall Study||0
8217625|NCT02076776|20266158|P2|NOT COMPLETED|Overall Study||2
8217626|NCT02076776|20266159|P1|NOT COMPLETED|Overall Study||1
8217627|NCT02076776|20266157|P3|COMPLETED|Overall Study||6
8217628|NCT02076776|20266158|P2|COMPLETED|Overall Study||6
8217629|NCT02076776|20266159|P1|COMPLETED|Overall Study||5
8217630|NCT02076776|20266157|P3|STARTED|Overall Study||6
8217631|NCT02076776|20266158|P2|STARTED|Overall Study||8
8217632|NCT02076776|20266159|P1|STARTED|Overall Study||6
8217633|NCT02076425|20266175|P2|NOT COMPLETED|Overall Study||24
8217634|NCT02076425|20266176|P1|NOT COMPLETED|Overall Study||14
8217635|NCT02076425|20266175|P2|COMPLETED|Overall Study||91
8217636|NCT02076425|20266176|P1|COMPLETED|Overall Study||100
8217637|NCT02076425|20266175|P2|STARTED|Overall Study||115
8217638|NCT02076425|20266176|P1|STARTED|Overall Study||114
8217639|NCT02076412|20266188|P2|NOT COMPLETED|Overall Study||22
8217640|NCT02076412|20266189|P1|NOT COMPLETED|Overall Study||37
8217641|NCT02076412|20266188|P2|COMPLETED|Overall Study||2
8217642|NCT02076412|20266189|P1|COMPLETED|Overall Study||13
8217643|NCT02076412|20266188|P2|STARTED|Overall Study||24
8217644|NCT02076412|20266189|P1|STARTED|Overall Study||50
8217645|NCT02076399|20266209|P2|NOT COMPLETED|Overall Study||24
8217646|NCT02076399|20266210|P1|NOT COMPLETED|Overall Study||39
8217647|NCT02076399|20266209|P2|COMPLETED|Overall Study||1
8217648|NCT02076399|20266210|P1|COMPLETED|Overall Study||12
8217649|NCT02076399|20266209|P2|STARTED|Overall Study||25
8217650|NCT02076399|20266210|P1|STARTED|Overall Study||51
8217651|NCT02076334|20266232|P4|NOT COMPLETED|Overall Study||1
8217652|NCT02076334|20266233|P3|NOT COMPLETED|Overall Study||1
8217653|NCT02076334|20266234|P2|NOT COMPLETED|Overall Study||1
8217654|NCT02076334|20266235|P1|NOT COMPLETED|Overall Study||1
8217655|NCT02076334|20266232|P4|COMPLETED|Overall Study||20
8217656|NCT02076334|20266233|P3|COMPLETED|Overall Study||20
8217657|NCT02076334|20266234|P2|COMPLETED|Overall Study||20
8217658|NCT02076334|20266235|P1|COMPLETED|Overall Study||20
8217659|NCT02076334|20266232|P4|STARTED|Overall Study||21
8217660|NCT02076334|20266233|P3|STARTED|Overall Study||21
8217661|NCT02076334|20266234|P2|STARTED|Overall Study||21
8217662|NCT02076334|20266235|P1|STARTED|Overall Study||21
8217663|NCT02076321|20266251|P2|NOT COMPLETED|Overall Study||2
8217664|NCT02076321|20266252|P1|NOT COMPLETED|Overall Study||5
8217665|NCT02076321|20266251|P2|COMPLETED|Overall Study||49
8217666|NCT02076321|20266252|P1|COMPLETED|Overall Study||46
8217667|NCT02076321|20266251|P2|STARTED|Overall Study||51
8217668|NCT02076321|20266252|P1|STARTED|Overall Study||51
8217669|NCT02076243|20266258|P1|NOT COMPLETED|Overall Study||2
8217670|NCT02076243|20266258|P1|COMPLETED|Overall Study||0
8217671|NCT02076243|20266258|P1|STARTED|Overall Study||2
8217672|NCT02076178|20266268|P2|NOT COMPLETED|Injection Phase||7
8217673|NCT02076178|20266269|P1|NOT COMPLETED|Injection Phase||1
8217674|NCT02076178|20266268|P2|COMPLETED|Injection Phase||87
8217675|NCT02076178|20266269|P1|COMPLETED|Injection Phase||20
8217676|NCT02076178|20266268|P2|STARTED|Injection Phase||94
8217677|NCT02076178|20266269|P1|STARTED|Injection Phase||21
8217678|NCT02076178|20266268|P2|NOT COMPLETED|Oral Phase||12
8217679|NCT02076178|20266269|P1|NOT COMPLETED|Oral Phase||0
8217680|NCT02076178|20266268|P2|COMPLETED|Oral Phase||94
8217681|NCT02076178|20266269|P1|COMPLETED|Oral Phase||21
8217682|NCT02076178|20266268|P2|STARTED|Oral Phase||106
8217683|NCT02076178|20266269|P1|STARTED|Oral Phase||21
8217684|NCT02076165|20266303|P2|NOT COMPLETED|Overall Study||6
8217685|NCT02076165|20266304|P1|NOT COMPLETED|Overall Study||8
8217686|NCT02076165|20266303|P2|COMPLETED|Overall Study||69
8217687|NCT02076165|20266304|P1|COMPLETED|Overall Study||66
8217688|NCT02076165|20266303|P2|STARTED|Overall Study||75
8217689|NCT02076165|20266304|P1|STARTED|Overall Study||74
8217690|NCT02076100|20266335|P7|NOT COMPLETED|Overall Study||0
8217691|NCT02076100|20266336|P6|NOT COMPLETED|Overall Study||0
8217692|NCT02076100|20266337|P5|NOT COMPLETED|Overall Study||0
8217693|NCT02076100|20266338|P4|NOT COMPLETED|Overall Study||0
8217694|NCT02076100|20266339|P3|NOT COMPLETED|Overall Study||0
8217695|NCT02076100|20266340|P2|NOT COMPLETED|Overall Study||0
8217696|NCT02076100|20266341|P1|NOT COMPLETED|Overall Study||0
8217697|NCT02076100|20266335|P7|COMPLETED|Overall Study||4
8217698|NCT02076100|20266336|P6|COMPLETED|Overall Study||3
8217699|NCT02076100|20266337|P5|COMPLETED|Overall Study||3
8217700|NCT02076100|20266338|P4|COMPLETED|Overall Study||3
8217701|NCT02076100|20266339|P3|COMPLETED|Overall Study||3
8217702|NCT02076100|20266340|P2|COMPLETED|Overall Study||3
8217703|NCT02076100|20266341|P1|COMPLETED|Overall Study||3
8217704|NCT02076100|20266335|P7|STARTED|Overall Study||4
8217705|NCT02076100|20266336|P6|STARTED|Overall Study||3
8217706|NCT02076100|20266337|P5|STARTED|Overall Study||3
8217707|NCT02076100|20266338|P4|STARTED|Overall Study||3
8217708|NCT02076100|20266339|P3|STARTED|Overall Study||3
8217709|NCT02076100|20266340|P2|STARTED|Overall Study||3
8217710|NCT02076100|20266341|P1|STARTED|Overall Study||3
8217711|NCT02076022|20266374|P2|NOT COMPLETED|Overall Study||0
8217712|NCT02076022|20266375|P1|NOT COMPLETED|Overall Study||2
8217713|NCT02076022|20266374|P2|COMPLETED|Overall Study||3
8217714|NCT02076022|20266375|P1|COMPLETED|Overall Study||5
8217715|NCT02076022|20266374|P2|STARTED|Overall Study||3
8217716|NCT02076022|20266375|P1|STARTED|Overall Study||7
8217731|NCT02075658|20266467|P2|NOT COMPLETED|Overall Study||2
8217732|NCT02075658|20266468|P1|NOT COMPLETED|Overall Study||2
8217733|NCT02075658|20266467|P2|COMPLETED|Overall Study||28
8217734|NCT02075658|20266468|P1|COMPLETED|Overall Study||28
8217735|NCT02075658|20266467|P2|STARTED|Overall Study||30
8217736|NCT02075658|20266468|P1|STARTED|Overall Study||30
8217737|NCT02075632|20266478|P2|NOT COMPLETED|Overall Study||5
8217738|NCT02075632|20266479|P1|NOT COMPLETED|Overall Study||1
8217739|NCT02075632|20266478|P2|COMPLETED|Overall Study||143
8217740|NCT02075632|20266479|P1|COMPLETED|Overall Study||161
8217741|NCT02075632|20266478|P2|STARTED|Overall Study||148
8217742|NCT02075632|20266479|P1|STARTED|Overall Study||162
8217743|NCT02075606|20266489|P1|NOT COMPLETED|Overall Study||10
8217744|NCT02075606|20266489|P1|COMPLETED|Overall Study||40
8217745|NCT02075606|20266489|P1|STARTED|Overall Study||50
8217746|NCT02075541|20266513|P2|NOT COMPLETED|Overall Study||8
8217747|NCT02075541|20266514|P1|NOT COMPLETED|Overall Study||4
8217748|NCT02075541|20266513|P2|COMPLETED|Overall Study||64
8217749|NCT02075541|20266514|P1|COMPLETED|Overall Study||69
8217750|NCT02075541|20266513|P2|STARTED|Overall Study||72
8217751|NCT02075541|20266514|P1|STARTED|Overall Study||73
8217761|NCT02075476|20266602|P2|NOT COMPLETED|Overall Study||5
8217762|NCT02075476|20266603|P1|NOT COMPLETED|Overall Study||3
8217763|NCT02075476|20266602|P2|COMPLETED|Overall Study||15
8217764|NCT02075476|20266603|P1|COMPLETED|Overall Study||17
8217765|NCT02075476|20266602|P2|STARTED|Overall Study||20
8217766|NCT02075476|20266603|P1|STARTED|Overall Study||20
8217767|NCT02075463|20266613|P1|NOT COMPLETED|Overall Study||8
8217768|NCT02075463|20266613|P1|COMPLETED|Overall Study||7
8217769|NCT02075463|20266613|P1|STARTED|Overall Study||15
8217770|NCT02075411|20266642|P4|NOT COMPLETED|Overall Study||0
8217771|NCT02075411|20266643|P3|NOT COMPLETED|Overall Study||0
8217772|NCT02075411|20266644|P2|NOT COMPLETED|Overall Study||0
8217773|NCT02075411|20266645|P1|NOT COMPLETED|Overall Study||0
8217774|NCT02075411|20266642|P4|COMPLETED|Overall Study||1
8217775|NCT02075411|20266643|P3|COMPLETED|Overall Study||0
8217776|NCT02075411|20266644|P2|COMPLETED|Overall Study||0
8217777|NCT02075411|20266645|P1|COMPLETED|Overall Study||0
8217778|NCT02075411|20266642|P4|STARTED|Overall Study||1
8217779|NCT02075411|20266643|P3|STARTED|Overall Study||0
8217780|NCT02075411|20266644|P2|STARTED|Overall Study||0
8217781|NCT02075411|20266645|P1|STARTED|Overall Study||0
8217782|NCT02075320|20266663|P1|NOT COMPLETED|Overall Study||2
8217783|NCT02075320|20266663|P1|COMPLETED|Overall Study||48
8217784|NCT02075320|20266663|P1|STARTED|Overall Study||50
8217785|NCT02075255|20266673|P3|NOT COMPLETED|Overall Study||3
8217786|NCT02075255|20266674|P2|NOT COMPLETED|Overall Study||4
8217787|NCT02075255|20266675|P1|NOT COMPLETED|Overall Study||4
8217788|NCT02075255|20266673|P3|COMPLETED|Overall Study||72
8217789|NCT02075255|20266674|P2|COMPLETED|Overall Study||69
8217790|NCT02075255|20266675|P1|COMPLETED|Overall Study||68
8217791|NCT02075255|20266673|P3|STARTED|Overall Study||75
8217792|NCT02075255|20266674|P2|STARTED|Overall Study||73
8217793|NCT02075255|20266675|P1|STARTED|Overall Study||72
8217794|NCT02075203|20266785|P3|NOT COMPLETED|Overall Study||1
8217795|NCT02075203|20266786|P2|NOT COMPLETED|Overall Study||0
8217796|NCT02075203|20266787|P1|NOT COMPLETED|Overall Study||3
8217797|NCT02075203|20266785|P3|COMPLETED|Overall Study||328
8217798|NCT02075203|20266786|P2|COMPLETED|Overall Study||330
8217799|NCT02075203|20266787|P1|COMPLETED|Overall Study||327
8217800|NCT02075203|20266785|P3|STARTED|Overall Study||329
8217801|NCT02075203|20266786|P2|STARTED|Overall Study||330
8217802|NCT02075203|20266787|P1|STARTED|Overall Study||330
8217803|NCT02075125|20266806|P2|NOT COMPLETED|Overall Study||1
8217804|NCT02075125|20266807|P1|NOT COMPLETED|Overall Study||0
8217805|NCT02075125|20266806|P2|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
8217806|NCT02075125|20266807|P1|COMPLETED|Overall Study||19
8217807|NCT02075125|20266806|P2|STARTED|Overall Study||20
8217808|NCT02075125|20266807|P1|STARTED|Overall Study||19
8217809|NCT02075073|20266828|P3|NOT COMPLETED|Overall Study||0
8217810|NCT02075073|20266829|P2|NOT COMPLETED|Overall Study||1
8217811|NCT02075073|20266830|P1|NOT COMPLETED|Overall Study||0
8217812|NCT02075073|20266828|P3|COMPLETED|Overall Study||36
8217813|NCT02075073|20266829|P2|COMPLETED|Overall Study||36
8217814|NCT02075073|20266830|P1|COMPLETED|Overall Study||36
8217815|NCT02075073|20266828|P3|STARTED|Overall Study||36
8217816|NCT02075073|20266829|P2|STARTED|Overall Study||37
8217817|NCT02075073|20266830|P1|STARTED|Overall Study||36
8217818|NCT02075021|20266847|P1|NOT COMPLETED|Overall Study||0
8217819|NCT02075021|20266847|P1|COMPLETED|Overall Study||3
8217820|NCT02075021|20266847|P1|STARTED|Overall Study||3
8217821|NCT02075008|20266852|P1|NOT COMPLETED|Overall Study||176
8217822|NCT02075008|20266852|P1|COMPLETED|Overall Study||94
8217823|NCT02075008|20266852|P1|STARTED|Overall Study||270
8217824|NCT02074995|20266856|P3|NOT COMPLETED|Overall Study||0
8217825|NCT02074995|20266857|P2|NOT COMPLETED|Overall Study||0
8217826|NCT02074995|20266858|P1|NOT COMPLETED|Overall Study||0
8217827|NCT02074995|20266856|P3|COMPLETED|Overall Study||0
8217828|NCT02074995|20266857|P2|COMPLETED|Overall Study||0
8217829|NCT02074995|20266858|P1|COMPLETED|Overall Study||1
8217830|NCT02074995|20266856|P3|STARTED|Overall Study||0
8217831|NCT02074995|20266857|P2|STARTED|Overall Study||0
8217832|NCT02074995|20266858|P1|STARTED|Overall Study||1
8217833|NCT02074982|20266875|P2|NOT COMPLETED|Overall Study||54
8217834|NCT02074982|20266876|P1|NOT COMPLETED|Overall Study||51
8217835|NCT02074982|20266875|P2|COMPLETED|Overall Study||285
8217836|NCT02074982|20266876|P1|COMPLETED|Overall Study||286
8217837|NCT02074982|20266875|P2|Safety Set (SF)|Overall Study||336
8217838|NCT02074982|20266876|P1|Safety Set (SF)|Overall Study||335
8217839|NCT02074982|20266875|P2|Full Analysis Set (FAS)|Overall Study||339
8217840|NCT02074982|20266876|P1|Full Analysis Set (FAS)|Overall Study||336
8217841|NCT02074982|20266875|P2|STARTED|Overall Study||339
8217842|NCT02074982|20266876|P1|STARTED|Overall Study||337
8217843|NCT02074904|20266888|P2|NOT COMPLETED|Overall Study||0
8217844|NCT02074904|20266889|P1|NOT COMPLETED|Overall Study||0
8217845|NCT02074904|20266888|P2|COMPLETED|Overall Study||0
8217846|NCT02074904|20266889|P1|COMPLETED|Overall Study||1
8217847|NCT02074904|20266888|P2|STARTED|Overall Study||0
8217848|NCT02074904|20266889|P1|STARTED|Overall Study||1
8217849|NCT02074735|20266905|P2|NOT COMPLETED|Overall Study||4
8217850|NCT02074735|20266906|P1|NOT COMPLETED|Overall Study||3
8217851|NCT02074735|20266905|P2|COMPLETED|Overall Study||29
8217852|NCT02074735|20266906|P1|COMPLETED|Overall Study||26
8217853|NCT02074735|20266905|P2|STARTED|Overall Study||33
8217854|NCT02074735|20266906|P1|STARTED|Overall Study||29
8217855|NCT02074709|20266914|P2|NOT COMPLETED|Overall Study||1
8217856|NCT02074709|20266915|P1|NOT COMPLETED|Overall Study||1
8217857|NCT02074709|20266914|P2|COMPLETED|Overall Study||29
8217858|NCT02074709|20266915|P1|COMPLETED|Overall Study||29
8217859|NCT02074709|20266914|P2|STARTED|Overall Study||30
8217860|NCT02074709|20266915|P1|STARTED|Overall Study||30
8217861|NCT02074553|20266923|P8|NOT COMPLETED|Intervention Period 4||0
8217862|NCT02074553|20266924|P7|NOT COMPLETED|Intervention Period 4||0
8217863|NCT02074553|20266925|P6|NOT COMPLETED|Intervention Period 4||0
8217864|NCT02074553|20266926|P5|NOT COMPLETED|Intervention Period 4||0
8217865|NCT02074553|20266927|P4|NOT COMPLETED|Intervention Period 4||0
8217866|NCT02074553|20266928|P3|NOT COMPLETED|Intervention Period 4||0
8217867|NCT02074553|20266929|P2|NOT COMPLETED|Intervention Period 4||0
8217868|NCT02074553|20266930|P1|NOT COMPLETED|Intervention Period 4||0
8217869|NCT02074553|20266923|P8|COMPLETED|Intervention Period 4||11
8217870|NCT02074553|20266924|P7|COMPLETED|Intervention Period 4||11
8217871|NCT02074553|20266925|P6|COMPLETED|Intervention Period 4||10
8217872|NCT02074553|20266926|P5|COMPLETED|Intervention Period 4||12
8217873|NCT02074553|20266927|P4|COMPLETED|Intervention Period 4||11
8217874|NCT02074553|20266928|P3|COMPLETED|Intervention Period 4||11
8217875|NCT02074553|20266929|P2|COMPLETED|Intervention Period 4||12
8217876|NCT02074553|20266930|P1|COMPLETED|Intervention Period 4||11
8217877|NCT02074553|20266923|P8|STARTED|Intervention Period 4||11
8217878|NCT02074553|20266924|P7|STARTED|Intervention Period 4||11
8217879|NCT02074553|20266925|P6|STARTED|Intervention Period 4||10
8217880|NCT02074553|20266926|P5|STARTED|Intervention Period 4||12
8217881|NCT02074553|20266927|P4|STARTED|Intervention Period 4||11
8217882|NCT02074553|20266928|P3|STARTED|Intervention Period 4||11
8217883|NCT02074553|20266929|P2|STARTED|Intervention Period 4||12
8217884|NCT02074553|20266930|P1|STARTED|Intervention Period 4||11
8217885|NCT02074553|20266923|P8|NOT COMPLETED|Washout Period 3||1
8217886|NCT02074553|20266924|P7|NOT COMPLETED|Washout Period 3||0
8217887|NCT02074553|20266925|P6|NOT COMPLETED|Washout Period 3||0
8217888|NCT02074553|20266926|P5|NOT COMPLETED|Washout Period 3||0
8217889|NCT02074553|20266927|P4|NOT COMPLETED|Washout Period 3||0
8217890|NCT02074553|20266928|P3|NOT COMPLETED|Washout Period 3||0
8217891|NCT02074553|20266929|P2|NOT COMPLETED|Washout Period 3||0
8217892|NCT02074553|20266930|P1|NOT COMPLETED|Washout Period 3||0
8217893|NCT02074553|20266923|P8|COMPLETED|Washout Period 3||11
8217894|NCT02074553|20266924|P7|COMPLETED|Washout Period 3||11
8217895|NCT02074553|20266925|P6|COMPLETED|Washout Period 3||10
8217896|NCT02074553|20266926|P5|COMPLETED|Washout Period 3||12
8217897|NCT02074553|20266927|P4|COMPLETED|Washout Period 3||11
8217898|NCT02074553|20266928|P3|COMPLETED|Washout Period 3||11
8217899|NCT02074553|20266929|P2|COMPLETED|Washout Period 3||12
8217900|NCT02074553|20266930|P1|COMPLETED|Washout Period 3||11
8217901|NCT02074553|20266923|P8|STARTED|Washout Period 3||12
8217902|NCT02074553|20266924|P7|STARTED|Washout Period 3||11
8217903|NCT02074553|20266925|P6|STARTED|Washout Period 3||10
8217904|NCT02074553|20266926|P5|STARTED|Washout Period 3||12
8217905|NCT02074553|20266927|P4|STARTED|Washout Period 3||11
8217906|NCT02074553|20266928|P3|STARTED|Washout Period 3||11
8217907|NCT02074553|20266929|P2|STARTED|Washout Period 3||12
8217908|NCT02074553|20266930|P1|STARTED|Washout Period 3||11
8217909|NCT02074553|20266923|P8|NOT COMPLETED|Intervention Period 3||0
8217910|NCT02074553|20266924|P7|NOT COMPLETED|Intervention Period 3||0
8217911|NCT02074553|20266925|P6|NOT COMPLETED|Intervention Period 3||0
8217912|NCT02074553|20266926|P5|NOT COMPLETED|Intervention Period 3||0
8217913|NCT02074553|20266927|P4|NOT COMPLETED|Intervention Period 3||0
8217914|NCT02074553|20266928|P3|NOT COMPLETED|Intervention Period 3||0
8217915|NCT02074553|20266929|P2|NOT COMPLETED|Intervention Period 3||0
8217916|NCT02074553|20266930|P1|NOT COMPLETED|Intervention Period 3||0
8217917|NCT02074553|20266923|P8|COMPLETED|Intervention Period 3||12
8217918|NCT02074553|20266924|P7|COMPLETED|Intervention Period 3||11
8217919|NCT02074553|20266925|P6|COMPLETED|Intervention Period 3||10
8217920|NCT02074553|20266926|P5|COMPLETED|Intervention Period 3||12
8217921|NCT02074553|20266927|P4|COMPLETED|Intervention Period 3||11
8217922|NCT02074553|20266928|P3|COMPLETED|Intervention Period 3||11
8217923|NCT02074553|20266929|P2|COMPLETED|Intervention Period 3||12
8217924|NCT02074553|20266930|P1|COMPLETED|Intervention Period 3||11
8217925|NCT02074553|20266923|P8|STARTED|Intervention Period 3||12
8217926|NCT02074553|20266924|P7|STARTED|Intervention Period 3||11
8217927|NCT02074553|20266925|P6|STARTED|Intervention Period 3||10
8217928|NCT02074553|20266926|P5|STARTED|Intervention Period 3||12
8217929|NCT02074553|20266927|P4|STARTED|Intervention Period 3||11
8217930|NCT02074553|20266928|P3|STARTED|Intervention Period 3||11
8217931|NCT02074553|20266929|P2|STARTED|Intervention Period 3||12
8217932|NCT02074553|20266930|P1|STARTED|Intervention Period 3||11
8217933|NCT02074553|20266923|P8|NOT COMPLETED|Washout Period 2||0
8217934|NCT02074553|20266924|P7|NOT COMPLETED|Washout Period 2||1
8217935|NCT02074553|20266925|P6|NOT COMPLETED|Washout Period 2||1
8217936|NCT02074553|20266926|P5|NOT COMPLETED|Washout Period 2||0
8217937|NCT02074553|20266927|P4|NOT COMPLETED|Washout Period 2||0
8217938|NCT02074553|20266928|P3|NOT COMPLETED|Washout Period 2||1
8217939|NCT02074553|20266929|P2|NOT COMPLETED|Washout Period 2||0
8217940|NCT02074553|20266930|P1|NOT COMPLETED|Washout Period 2||0
8217941|NCT02074553|20266923|P8|COMPLETED|Washout Period 2||12
8217942|NCT02074553|20266924|P7|COMPLETED|Washout Period 2||11
8217943|NCT02074553|20266925|P6|COMPLETED|Washout Period 2||10
8217944|NCT02074553|20266926|P5|COMPLETED|Washout Period 2||12
8217945|NCT02074553|20266927|P4|COMPLETED|Washout Period 2||11
8217946|NCT02074553|20266928|P3|COMPLETED|Washout Period 2||11
8217947|NCT02074553|20266929|P2|COMPLETED|Washout Period 2||12
8217948|NCT02074553|20266930|P1|COMPLETED|Washout Period 2||11
8217949|NCT02074553|20266923|P8|STARTED|Washout Period 2||12
8217950|NCT02074553|20266924|P7|STARTED|Washout Period 2||12
8217951|NCT02074553|20266925|P6|STARTED|Washout Period 2||11
8217952|NCT02074553|20266926|P5|STARTED|Washout Period 2||12
8217953|NCT02074553|20266927|P4|STARTED|Washout Period 2||11
8217954|NCT02074553|20266928|P3|STARTED|Washout Period 2||12
8217955|NCT02074553|20266929|P2|STARTED|Washout Period 2||12
8217956|NCT02074553|20266930|P1|STARTED|Washout Period 2||11
8217957|NCT02074553|20266923|P8|NOT COMPLETED|Intervention Period 2||0
8217958|NCT02074553|20266924|P7|NOT COMPLETED|Intervention Period 2||0
8217959|NCT02074553|20266925|P6|NOT COMPLETED|Intervention Period 2||0
8217960|NCT02074553|20266926|P5|NOT COMPLETED|Intervention Period 2||0
8217961|NCT02074553|20266927|P4|NOT COMPLETED|Intervention Period 2||0
8217962|NCT02074553|20266928|P3|NOT COMPLETED|Intervention Period 2||0
8217963|NCT02074553|20266929|P2|NOT COMPLETED|Intervention Period 2||0
8217964|NCT02074553|20266930|P1|NOT COMPLETED|Intervention Period 2||0
8217965|NCT02074553|20266923|P8|COMPLETED|Intervention Period 2||12
8217966|NCT02074553|20266924|P7|COMPLETED|Intervention Period 2||12
8217967|NCT02074553|20266925|P6|COMPLETED|Intervention Period 2||11
8217968|NCT02074553|20266926|P5|COMPLETED|Intervention Period 2||12
8217969|NCT02074553|20266927|P4|COMPLETED|Intervention Period 2||11
8217970|NCT02074553|20266928|P3|COMPLETED|Intervention Period 2||12
8217971|NCT02074553|20266929|P2|COMPLETED|Intervention Period 2||12
8217972|NCT02074553|20266930|P1|COMPLETED|Intervention Period 2||11
8217973|NCT02074553|20266923|P8|STARTED|Intervention Period 2||12
8217974|NCT02074553|20266924|P7|STARTED|Intervention Period 2||12
8217975|NCT02074553|20266925|P6|STARTED|Intervention Period 2||11
8217976|NCT02074553|20266926|P5|STARTED|Intervention Period 2||12
8217977|NCT02074553|20266927|P4|STARTED|Intervention Period 2||11
8217978|NCT02074553|20266928|P3|STARTED|Intervention Period 2||12
8217979|NCT02074553|20266929|P2|STARTED|Intervention Period 2||12
8217980|NCT02074553|20266930|P1|STARTED|Intervention Period 2||11
8217981|NCT02074553|20266923|P8|NOT COMPLETED|Washout Period 1||0
8217982|NCT02074553|20266924|P7|NOT COMPLETED|Washout Period 1||0
8217983|NCT02074553|20266925|P6|NOT COMPLETED|Washout Period 1||1
8217984|NCT02074553|20266926|P5|NOT COMPLETED|Washout Period 1||0
8217985|NCT02074553|20266927|P4|NOT COMPLETED|Washout Period 1||1
8217986|NCT02074553|20266928|P3|NOT COMPLETED|Washout Period 1||0
8217987|NCT02074553|20266929|P2|NOT COMPLETED|Washout Period 1||0
8217988|NCT02074553|20266930|P1|NOT COMPLETED|Washout Period 1||1
8217989|NCT02074553|20266923|P8|COMPLETED|Washout Period 1||12
8217990|NCT02074553|20266924|P7|COMPLETED|Washout Period 1||12
8217991|NCT02074553|20266925|P6|COMPLETED|Washout Period 1||11
8217992|NCT02074553|20266926|P5|COMPLETED|Washout Period 1||12
8217993|NCT02074553|20266927|P4|COMPLETED|Washout Period 1||11
8217994|NCT02074553|20266928|P3|COMPLETED|Washout Period 1||12
8217995|NCT02074553|20266929|P2|COMPLETED|Washout Period 1||12
8217996|NCT02074553|20266930|P1|COMPLETED|Washout Period 1||11
8217997|NCT02074553|20266923|P8|STARTED|Washout Period 1||12
8217998|NCT02074553|20266924|P7|STARTED|Washout Period 1||12
8217999|NCT02074553|20266925|P6|STARTED|Washout Period 1||12
8218000|NCT02074553|20266926|P5|STARTED|Washout Period 1||12
8218001|NCT02074553|20266927|P4|STARTED|Washout Period 1||12
8218002|NCT02074553|20266928|P3|STARTED|Washout Period 1||12
8218003|NCT02074553|20266929|P2|STARTED|Washout Period 1||12
8218004|NCT02074553|20266930|P1|STARTED|Washout Period 1||12
8218005|NCT02074553|20266923|P8|NOT COMPLETED|Intervention Period 1||0
8218006|NCT02074553|20266924|P7|NOT COMPLETED|Intervention Period 1||0
8218007|NCT02074553|20266925|P6|NOT COMPLETED|Intervention Period 1||0
8218008|NCT02074553|20266926|P5|NOT COMPLETED|Intervention Period 1||0
8218009|NCT02074553|20266927|P4|NOT COMPLETED|Intervention Period 1||1
8218010|NCT02074553|20266928|P3|NOT COMPLETED|Intervention Period 1||0
8218011|NCT02074553|20266929|P2|NOT COMPLETED|Intervention Period 1||0
8218012|NCT02074553|20266930|P1|NOT COMPLETED|Intervention Period 1||0
8218013|NCT02074553|20266923|P8|COMPLETED|Intervention Period 1||12
8218014|NCT02074553|20266924|P7|COMPLETED|Intervention Period 1||12
8218015|NCT02074553|20266925|P6|COMPLETED|Intervention Period 1||12
8218016|NCT02074553|20266926|P5|COMPLETED|Intervention Period 1||12
8218017|NCT02074553|20266927|P4|COMPLETED|Intervention Period 1||12
8218018|NCT02074553|20266928|P3|COMPLETED|Intervention Period 1||12
8218019|NCT02074553|20266929|P2|COMPLETED|Intervention Period 1||12
8218020|NCT02074553|20266930|P1|COMPLETED|Intervention Period 1||12
8218021|NCT02074553|20266923|P8|STARTED|Intervention Period 1||12
8218022|NCT02074553|20266924|P7|STARTED|Intervention Period 1||12
8218023|NCT02074553|20266925|P6|STARTED|Intervention Period 1||12
8218024|NCT02074553|20266926|P5|STARTED|Intervention Period 1||12
8218025|NCT02074553|20266927|P4|STARTED|Intervention Period 1||13
8218026|NCT02074553|20266928|P3|STARTED|Intervention Period 1||12
8218027|NCT02074553|20266929|P2|STARTED|Intervention Period 1||12
8218028|NCT02074553|20266930|P1|STARTED|Intervention Period 1||12
8218029|NCT02074514|20267112|P2|NOT COMPLETED|Overall Study||4
8218030|NCT02074514|20267113|P1|NOT COMPLETED|Overall Study||3
8218031|NCT02074514|20267112|P2|COMPLETED|Overall Study||54
8218032|NCT02074514|20267113|P1|COMPLETED|Overall Study||56
8218033|NCT02074514|20267112|P2|STARTED|Overall Study||58
8218034|NCT02074514|20267113|P1|STARTED|Overall Study||59
8218035|NCT02074384|20267134|P3|NOT COMPLETED|Overall Study||0
8218036|NCT02074384|20267135|P2|NOT COMPLETED|Overall Study||0
8218037|NCT02074384|20267136|P1|NOT COMPLETED|Overall Study||0
8218038|NCT02074384|20267134|P3|COMPLETED|Overall Study||17
8218039|NCT02074384|20267135|P2|COMPLETED|Overall Study||70
8218040|NCT02074384|20267136|P1|COMPLETED|Overall Study||74
8218041|NCT02074384|20267134|P3|STARTED|Overall Study||17
8218042|NCT02074384|20267135|P2|STARTED|Overall Study||70
8218043|NCT02074384|20267136|P1|STARTED|Overall Study||74
8218044|NCT02074358|20267144|P6|NOT COMPLETED|Overall Study||0
8218045|NCT02074358|20267145|P5|NOT COMPLETED|Overall Study||0
8218046|NCT02074358|20267146|P4|NOT COMPLETED|Overall Study||0
8218047|NCT02074358|20267147|P3|NOT COMPLETED|Overall Study||0
8218048|NCT02074358|20267148|P2|NOT COMPLETED|Overall Study||0
8218049|NCT02074358|20267149|P1|NOT COMPLETED|Overall Study||0
8218050|NCT02074358|20267144|P6|COMPLETED|Overall Study||2
8218051|NCT02074358|20267145|P5|COMPLETED|Overall Study||3
8218052|NCT02074358|20267146|P4|COMPLETED|Overall Study||2
8218053|NCT02074358|20267147|P3|COMPLETED|Overall Study||2
8218054|NCT02074358|20267148|P2|COMPLETED|Overall Study||3
8218055|NCT02074358|20267149|P1|COMPLETED|Overall Study||3
8218056|NCT02074358|20267144|P6|STARTED|Overall Study||2
8218057|NCT02074358|20267145|P5|STARTED|Overall Study||3
8218058|NCT02074358|20267146|P4|STARTED|Overall Study||2
8218059|NCT02074358|20267147|P3|STARTED|Overall Study||2
8218060|NCT02074358|20267148|P2|STARTED|Overall Study||3
8218061|NCT02074358|20267149|P1|STARTED|Overall Study||3
8218062|NCT02074345|20267238|P1|NOT COMPLETED|Overall Study||0
8218063|NCT02074345|20267238|P1|COMPLETED|Overall Study||31
8218064|NCT02074345|20267238|P1|STARTED|Overall Study||31
8218065|NCT02074059|20267254|P6|NOT COMPLETED|Overall Study||1
8218066|NCT02074059|20267255|P5|NOT COMPLETED|Overall Study||1
8218067|NCT02074059|20267256|P4|NOT COMPLETED|Overall Study||0
8218068|NCT02074059|20267257|P3|NOT COMPLETED|Overall Study||0
8218069|NCT02074059|20267258|P2|NOT COMPLETED|Overall Study||0
8218070|NCT02074059|20267259|P1|NOT COMPLETED|Overall Study||0
8218071|NCT02074059|20267254|P6|COMPLETED|Overall Study||39
8218072|NCT02074059|20267255|P5|COMPLETED|Overall Study||7
8218073|NCT02074059|20267256|P4|COMPLETED|Overall Study||8
8218074|NCT02074059|20267257|P3|COMPLETED|Overall Study||8
8218075|NCT02074059|20267258|P2|COMPLETED|Overall Study||8
8218076|NCT02074059|20267259|P1|COMPLETED|Overall Study||8
8218077|NCT02074059|20267254|P6|STARTED|Overall Study||40
8218078|NCT02074059|20267255|P5|STARTED|Overall Study||8
8218079|NCT02074059|20267256|P4|STARTED|Overall Study||8
8218080|NCT02074059|20267257|P3|STARTED|Overall Study||8
8218081|NCT02074059|20267258|P2|STARTED|Overall Study||8
8218082|NCT02074059|20267259|P1|STARTED|Overall Study||8
8218083|NCT02073968|20267297|P1|NOT COMPLETED|Overall Study||0
8218084|NCT02073968|20267297|P1|COMPLETED|Overall Study||35
8218085|NCT02073968|20267297|P1|STARTED|Overall Study||35
8218086|NCT02073929|20267303|P2|NOT COMPLETED|Overall Study||3
8218087|NCT02073929|20267304|P1|NOT COMPLETED|Overall Study||4
8218088|NCT02073929|20267303|P2|COMPLETED|Overall Study||21
8218089|NCT02073929|20267304|P1|COMPLETED|Overall Study||44
8218090|NCT02073929|20267303|P2|STARTED|Overall Study||24
8218091|NCT02073929|20267304|P1|STARTED|Overall Study||48
8218092|NCT02073747|20267332|P2|NOT COMPLETED|Overall Study||1
8218093|NCT02073747|20267333|P1|NOT COMPLETED|Overall Study||1
8218094|NCT02073747|20267332|P2|COMPLETED|Overall Study||14
8218095|NCT02073747|20267333|P1|COMPLETED|Overall Study||14
8218096|NCT02073747|20267332|P2|STARTED|Overall Study||15
8218097|NCT02073747|20267333|P1|STARTED|Overall Study||15
8218098|NCT02073682|20267341|P2|NOT COMPLETED|Overall Study||370
8218099|NCT02073682|20267342|P1|NOT COMPLETED|Overall Study||322
8218100|NCT02073682|20267341|P2|COMPLETED|Overall Study||154
8218101|NCT02073682|20267342|P1|COMPLETED|Overall Study||200
8218102|NCT02073682|20267341|P2|STARTED|Overall Study||524
8218103|NCT02073682|20267342|P1|STARTED|Overall Study||522
8218104|NCT02073656|20267360|P1|NOT COMPLETED|Retreatment Substudy||0
8218105|NCT02073656|20267360|P1|COMPLETED|Retreatment Substudy||9
8218106|NCT02073656|20267360|P1|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
8218107|NCT02073656|20267360|P1|NOT COMPLETED|Primary Study||8
8218108|NCT02073656|20267360|P1|COMPLETED|Primary Study||327
8218109|NCT02073656|20267360|P1|STARTED|Primary Study||335
8218110|NCT02073643|20267376|P1|NOT COMPLETED|Overall Study||24
8218111|NCT02073643|20267376|P1|COMPLETED|Overall Study||180
8218112|NCT02073643|20267376|P1|STARTED|Overall Study||204
8218225|NCT02072668|20267646|P1|NOT COMPLETED|First Intervention||0
8218137|NCT02073461|20267403|P3|NOT COMPLETED|Overall Study||1
8218138|NCT02073461|20267404|P2|NOT COMPLETED|Overall Study||1
8218139|NCT02073461|20267405|P1|NOT COMPLETED|Overall Study||4
8218140|NCT02073461|20267403|P3|COMPLETED|Overall Study||78
8218141|NCT02073461|20267404|P2|COMPLETED|Overall Study||77
8218142|NCT02073461|20267405|P1|COMPLETED|Overall Study||75
8218143|NCT02073461|20267403|P3|STARTED|Overall Study||79
8218144|NCT02073461|20267404|P2|STARTED|Overall Study||78
8218145|NCT02073461|20267405|P1|STARTED|Overall Study||79
8218146|NCT02073448|20267434|P3|NOT COMPLETED|Overall Study||5
8218147|NCT02073448|20267435|P2|NOT COMPLETED|Overall Study||12
8218148|NCT02073448|20267436|P1|NOT COMPLETED|Overall Study||2
8218149|NCT02073448|20267434|P3|COMPLETED|Overall Study||99
8218150|NCT02073448|20267435|P2|COMPLETED|Overall Study||200
8218151|NCT02073448|20267436|P1|COMPLETED|Overall Study||99
8218152|NCT02073448|20267434|P3|STARTED|Overall Study||104
8218153|NCT02073448|20267435|P2|STARTED|Overall Study||212
8218154|NCT02073448|20267436|P1|STARTED|Overall Study||101
8218155|NCT02073435|20267464|P2|NOT COMPLETED|Overall Study||0
8218156|NCT02073435|20267465|P1|NOT COMPLETED|Overall Study||0
8218157|NCT02073435|20267464|P2|COMPLETED|Overall Study||96
8218158|NCT02073435|20267465|P1|COMPLETED|Overall Study||81
8218159|NCT02073435|20267464|P2|STARTED|Overall Study||96
8218160|NCT02073435|20267465|P1|STARTED|Overall Study||81
8218161|NCT02073331|20267473|P1|NOT COMPLETED|Overall Study||0
8218162|NCT02073331|20267473|P1|COMPLETED|Overall Study||1420
8218163|NCT02073331|20267473|P1|STARTED|Overall Study||1420
8218176|NCT02073162|20267554|P2|NOT COMPLETED|Overall Study||11
8218177|NCT02073162|20267555|P1|NOT COMPLETED|Overall Study||6
8218178|NCT02073162|20267554|P2|COMPLETED|Overall Study||1490
8218179|NCT02073162|20267555|P1|COMPLETED|Overall Study||1493
8218180|NCT02073162|20267554|P2|STARTED|Overall Study||1501
8218181|NCT02073162|20267555|P1|STARTED|Overall Study||1499
8218182|NCT02072980|20267583|P2|NOT COMPLETED|Period 2, Second Wear||1
8218183|NCT02072980|20267584|P1|NOT COMPLETED|Period 2, Second Wear||0
8218184|NCT02072980|20267583|P2|COMPLETED|Period 2, Second Wear||7
8218185|NCT02072980|20267584|P1|COMPLETED|Period 2, Second Wear||7
8218186|NCT02072980|20267583|P2|STARTED|Period 2, Second Wear||8
8218187|NCT02072980|20267584|P1|STARTED|Period 2, Second Wear||7
8218188|NCT02072980|20267583|P2|NOT COMPLETED|Period 1, First Wear||0
8218189|NCT02072980|20267584|P1|NOT COMPLETED|Period 1, First Wear||0
8218190|NCT02072980|20267583|P2|COMPLETED|Period 1, First Wear||8
8218191|NCT02072980|20267584|P1|COMPLETED|Period 1, First Wear||7
8218192|NCT02072980|20267583|P2|STARTED|Period 1, First Wear||8
8218193|NCT02072980|20267584|P1|STARTED|Period 1, First Wear||7
8218194|NCT02072941|20267592|P2|NOT COMPLETED|Overall Study||29
8218195|NCT02072941|20267593|P1|NOT COMPLETED|Overall Study||38
8218196|NCT02072941|20267592|P2|COMPLETED|Overall Study||197
8218197|NCT02072941|20267593|P1|COMPLETED|Overall Study||181
8218198|NCT02072941|20267592|P2|STARTED|Overall Study||226
8218199|NCT02072941|20267593|P1|STARTED|Overall Study||219
8218200|NCT02072928|20267601|P1|NOT COMPLETED|Overall Study||0
8218201|NCT02072928|20267601|P1|COMPLETED|Overall Study||55
8218202|NCT02072928|20267601|P1|STARTED|Overall Study||55
8218203|NCT02072824|20267608|P3|NOT COMPLETED|Overall Study||3
8218204|NCT02072824|20267609|P2|NOT COMPLETED|Overall Study||1
8218205|NCT02072824|20267610|P1|NOT COMPLETED|Overall Study||2
8218206|NCT02072824|20267608|P3|COMPLETED|Overall Study||67
8218207|NCT02072824|20267609|P2|COMPLETED|Overall Study||33
8218208|NCT02072824|20267610|P1|COMPLETED|Overall Study||69
8218209|NCT02072824|20267608|P3|STARTED|Overall Study||70
8218210|NCT02072824|20267609|P2|STARTED|Overall Study||34
8218211|NCT02072824|20267610|P1|STARTED|Overall Study||71
8218212|NCT02072668|20267645|P2|NOT COMPLETED|Second Intervention||0
8218213|NCT02072668|20267646|P1|NOT COMPLETED|Second Intervention||1
8218214|NCT02072668|20267645|P2|COMPLETED|Second Intervention||7
8218215|NCT02072668|20267646|P1|COMPLETED|Second Intervention||6
8218216|NCT02072668|20267645|P2|STARTED|Second Intervention||7
8218217|NCT02072668|20267646|P1|STARTED|Second Intervention||7
8218218|NCT02072668|20267645|P2|NOT COMPLETED|Washout (2 Weeks)||0
8218219|NCT02072668|20267646|P1|NOT COMPLETED|Washout (2 Weeks)||0
8218220|NCT02072668|20267645|P2|COMPLETED|Washout (2 Weeks)||7
8218221|NCT02072668|20267646|P1|COMPLETED|Washout (2 Weeks)||7
8218222|NCT02072668|20267645|P2|STARTED|Washout (2 Weeks)||7
8218223|NCT02072668|20267646|P1|STARTED|Washout (2 Weeks)||7
8218224|NCT02072668|20267645|P2|NOT COMPLETED|First Intervention||0
8218226|NCT02072668|20267645|P2|COMPLETED|First Intervention||7
8218227|NCT02072668|20267646|P1|COMPLETED|First Intervention||7
8218228|NCT02072668|20267645|P2|STARTED|First Intervention||7
8218229|NCT02072668|20267646|P1|STARTED|First Intervention||7
8218230|NCT02072434|20267686|P2|NOT COMPLETED|Overall Study||90
8218231|NCT02072434|20267687|P1|NOT COMPLETED|Overall Study||54
8218232|NCT02072434|20267686|P2|COMPLETED|Overall Study||1014
8218233|NCT02072434|20267687|P1|COMPLETED|Overall Study||1041
8218234|NCT02072434|20267686|P2|Safety Analysis Set|Overall Study||1082
8218235|NCT02072434|20267687|P1|Safety Analysis Set|Overall Study||1067
8218236|NCT02072434|20267686|P2|Received Study Drug|Overall Study||1082
8218237|NCT02072434|20267687|P1|Received Study Drug|Overall Study||1067
8218238|NCT02072434|20267686|P2|Intent to Treat Analysis Set|Overall Study||1104
8218239|NCT02072434|20267687|P1|Intent to Treat Analysis Set|Overall Study||1095
8218240|NCT02072434|20267686|P2|STARTED|Overall Study||1104
8218241|NCT02072434|20267687|P1|STARTED|Overall Study||1095
8218242|NCT02072421|20267697|P1|NOT COMPLETED|Overall Study||390
8218243|NCT02072421|20267697|P1|COMPLETED|Overall Study||2489
8218244|NCT02072421|20267697|P1|STARTED|Overall Study||2879
8218245|NCT02072226|20267707|P2|NOT COMPLETED|Overall Study||10
8218246|NCT02072226|20267708|P1|NOT COMPLETED|Overall Study||15
8218247|NCT02072226|20267707|P2|COMPLETED|Overall Study||147
8218248|NCT02072226|20267708|P1|COMPLETED|Overall Study||141
8218249|NCT02072226|20267707|P2|STARTED|Overall Study||157
8218250|NCT02072226|20267708|P1|STARTED|Overall Study||156
8218251|NCT02072200|20267730|P1|NOT COMPLETED|Overall Study||2
8218252|NCT02072200|20267730|P1|COMPLETED|Overall Study||145
8218253|NCT02072200|20267730|P1|STARTED|Overall Study||147
8218254|NCT02072174|20267738|P2|NOT COMPLETED|Overall Study||39
8218255|NCT02072174|20267739|P1|NOT COMPLETED|Overall Study||32
8218256|NCT02072174|20267738|P2|COMPLETED|Overall Study||240
8218257|NCT02072174|20267739|P1|COMPLETED|Overall Study||258
8218258|NCT02072174|20267738|P2|STARTED|Overall Study||279
8218259|NCT02072174|20267739|P1|STARTED|Overall Study||290
8218260|NCT02072096|20267763|P2|NOT COMPLETED|Overall Study||78
8218261|NCT02072096|20267764|P1|NOT COMPLETED|Overall Study||85
8218262|NCT02072096|20267763|P2|COMPLETED|Overall Study||15
8218263|NCT02072096|20267764|P1|COMPLETED|Overall Study||14
8218264|NCT02072096|20267763|P2|Received at Least One Dose of Study Drug|Overall Study||93
8218265|NCT02072096|20267764|P1|Received at Least One Dose of Study Drug|Overall Study||98
8218266|NCT02072096|20267763|P2|STARTED|Overall Study||93
8218267|NCT02072096|20267764|P1|STARTED|Overall Study||99
8218268|NCT02071914|20267789|P3|NOT COMPLETED|Overall Study||0
8218269|NCT02071914|20267790|P2|NOT COMPLETED|Overall Study||0
8218270|NCT02071914|20267791|P1|NOT COMPLETED|Overall Study||0
8218271|NCT02071914|20267789|P3|COMPLETED|Overall Study||27
8218272|NCT02071914|20267790|P2|COMPLETED|Overall Study||27
8218273|NCT02071914|20267791|P1|COMPLETED|Overall Study||27
8218274|NCT02071914|20267789|P3|STARTED|Overall Study||27
8218275|NCT02071914|20267790|P2|STARTED|Overall Study||27
8218276|NCT02071914|20267791|P1|STARTED|Overall Study||27
8218277|NCT02071901|20267799|P1|NOT COMPLETED|Overall Study||0
8218278|NCT02071901|20267799|P1|COMPLETED|Overall Study||31
8218279|NCT02071901|20267799|P1|STARTED|Overall Study||31
8218280|NCT02071849|20267815|P1|NOT COMPLETED|2-year Extended Follow-up||1
8218281|NCT02071849|20267815|P1|COMPLETED|2-year Extended Follow-up||14
8218282|NCT02071849|20267815|P1|STARTED|2-year Extended Follow-up||15
8218283|NCT02071849|20267815|P1|NOT COMPLETED|6-month Primary Endpoint||5
8218284|NCT02071849|20267815|P1|COMPLETED|6-month Primary Endpoint||15
8218285|NCT02071849|20267815|P1|STARTED|6-month Primary Endpoint||20
8218286|NCT02071823|20267849|P2|NOT COMPLETED|Overall Study||0
8218287|NCT02071823|20267850|P1|NOT COMPLETED|Overall Study||1
8218288|NCT02071823|20267849|P2|COMPLETED|Overall Study||6
8218289|NCT02071823|20267850|P1|COMPLETED|Overall Study||5
8218290|NCT02071823|20267849|P2|STARTED|Overall Study||6
8218291|NCT02071823|20267850|P1|STARTED|Overall Study||6
8218292|NCT02071810|20267865|P5|NOT COMPLETED|Overall Study||1
8218293|NCT02071810|20267866|P4|NOT COMPLETED|Overall Study||1
8218294|NCT02071810|20267867|P3|NOT COMPLETED|Overall Study||0
8218295|NCT02071810|20267868|P2|NOT COMPLETED|Overall Study||0
8218296|NCT02071810|20267869|P1|NOT COMPLETED|Overall Study||0
8218297|NCT02071810|20267865|P5|COMPLETED|Overall Study||8
8218298|NCT02071810|20267866|P4|COMPLETED|Overall Study||6
8218299|NCT02071810|20267867|P3|COMPLETED|Overall Study||6
8218300|NCT02071810|20267868|P2|COMPLETED|Overall Study||6
8218301|NCT02071810|20267869|P1|COMPLETED|Overall Study||6
8218302|NCT02071810|20267865|P5|STARTED|Overall Study||9
8218303|NCT02071810|20267866|P4|STARTED|Overall Study||7
8218304|NCT02071810|20267867|P3|STARTED|Overall Study||6
8218305|NCT02071810|20267868|P2|STARTED|Overall Study||6
8218306|NCT02071810|20267869|P1|STARTED|Overall Study||6
8218307|NCT02071771|20267881|P2|NOT COMPLETED|Period 2: Second 10 Days||0
8218308|NCT02071771|20267882|P1|NOT COMPLETED|Period 2: Second 10 Days||0
8218309|NCT02071771|20267881|P2|COMPLETED|Period 2: Second 10 Days||38
8218310|NCT02071771|20267882|P1|COMPLETED|Period 2: Second 10 Days||39
8218311|NCT02071771|20267881|P2|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
8218312|NCT02071771|20267882|P1|STARTED|Period 2: Second 10 Days||39
8218313|NCT02071771|20267881|P2|NOT COMPLETED|Period 1: First 10 Days||0
8218314|NCT02071771|20267882|P1|NOT COMPLETED|Period 1: First 10 Days||2
8218315|NCT02071771|20267881|P2|COMPLETED|Period 1: First 10 Days||39
8218316|NCT02071771|20267882|P1|COMPLETED|Period 1: First 10 Days||39
8218317|NCT02071771|20267881|P2|Dispensed|Period 1: First 10 Days||39
8218318|NCT02071771|20267882|P1|Dispensed|Period 1: First 10 Days||39
8218319|NCT02071771|20267881|P2|STARTED|Period 1: First 10 Days||39
8218320|NCT02071771|20267882|P1|STARTED|Period 1: First 10 Days||41
8218321|NCT02071706|20267890|P1|NOT COMPLETED|Overall Study||3
8218322|NCT02071706|20267890|P1|COMPLETED|Overall Study||59
8218323|NCT02071706|20267890|P1|STARTED|Overall Study||62
8218324|NCT02071420|20267897|P2|NOT COMPLETED|Overall Study||3
8218325|NCT02071420|20267898|P1|NOT COMPLETED|Overall Study||3
8218326|NCT02071420|20267897|P2|COMPLETED|Overall Study||27
8218327|NCT02071420|20267898|P1|COMPLETED|Overall Study||27
8218328|NCT02071420|20267897|P2|STARTED|Overall Study||30
8218329|NCT02071420|20267898|P1|STARTED|Overall Study||30
8218330|NCT02071290|20267906|P2|NOT COMPLETED|Overall Study||7
8218331|NCT02071290|20267907|P1|NOT COMPLETED|Overall Study||4
8218332|NCT02071290|20267906|P2|COMPLETED|Overall Study||18
8218333|NCT02071290|20267907|P1|COMPLETED|Overall Study||21
8218334|NCT02071290|20267906|P2|STARTED|Overall Study||25
8218335|NCT02071290|20267907|P1|STARTED|Overall Study||25
8218336|NCT02071225|20267961|P1|NOT COMPLETED|Overall Study||30
8218337|NCT02071225|20267961|P1|COMPLETED|Overall Study||42
8218338|NCT02071225|20267961|P1|STARTED|Overall Study||72
8218339|NCT02071173|20267979|P1|NOT COMPLETED|Overall Study||1835
8218340|NCT02071173|20267979|P1|COMPLETED|Overall Study|Follow-up is ongoing. Data as of 5-Feb-2020.|409
8218341|NCT02071173|20267979|P1|ACUITY X4 Endpoint Population|Overall Study|536 with ACUITY X4 Spiral lead, 228 with ACUITY X4 Straight lead|764
8218342|NCT02071173|20267979|P1|RELIANCE 4-FRONT Endpoint Population|Overall Study|1507 with active fixation 4-FRONT lead, 37 with passive fixation 4-FRONT lead|1544
8218343|NCT02071173|20267979|P1|Implanted/Attempted With a Study Device|Overall Study||2200
8218344|NCT02071173|20267979|P1|STARTED|Overall Study||2244
8218345|NCT02071108|20267998|P1|NOT COMPLETED|Overall Study||0
8218346|NCT02071108|20267998|P1|COMPLETED|Overall Study||35
8218347|NCT02071108|20267998|P1|STARTED|Overall Study||35
8218348|NCT02071095|20268019|P2|NOT COMPLETED|Overall Study||0
8218349|NCT02071095|20268020|P1|NOT COMPLETED|Overall Study||0
8218350|NCT02071095|20268019|P2|COMPLETED|Overall Study||3
8218351|NCT02071095|20268020|P1|COMPLETED|Overall Study||12
8218352|NCT02071095|20268019|P2|STARTED|Overall Study||3
8218353|NCT02071095|20268020|P1|STARTED|Overall Study||12
8218354|NCT02071082|20268036|P2|NOT COMPLETED|Overall Study||7
8218355|NCT02071082|20268037|P1|NOT COMPLETED|Overall Study||2
8218356|NCT02071082|20268036|P2|COMPLETED|Overall Study||68
8218357|NCT02071082|20268037|P1|COMPLETED|Overall Study||2
8218358|NCT02071082|20268036|P2|STARTED|Overall Study||75
8218359|NCT02071082|20268037|P1|STARTED|Overall Study||4
8218360|NCT02070991|20268067|P2|NOT COMPLETED|Overall Study||0
8218361|NCT02070991|20268068|P1|NOT COMPLETED|Overall Study||3
8218362|NCT02070991|20268067|P2|COMPLETED|Overall Study||32
8218363|NCT02070991|20268068|P1|COMPLETED|Overall Study||28
8218364|NCT02070991|20268067|P2|STARTED|Overall Study||32
8218365|NCT02070991|20268068|P1|STARTED|Overall Study||31
8218366|NCT02070978|20268091|P3|NOT COMPLETED|Overall Study||53
8218367|NCT02070978|20268092|P2|NOT COMPLETED|Overall Study||53
8218368|NCT02070978|20268093|P1|NOT COMPLETED|Overall Study||47
8218369|NCT02070978|20268091|P3|COMPLETED|Overall Study||35
8218370|NCT02070978|20268092|P2|COMPLETED|Overall Study||29
8218371|NCT02070978|20268093|P1|COMPLETED|Overall Study||36
8218372|NCT02070978|20268091|P3|STARTED|Overall Study||88
8218373|NCT02070978|20268092|P2|STARTED|Overall Study||82
8218374|NCT02070978|20268093|P1|STARTED|Overall Study||83
8218375|NCT02070965|20268155|P3|NOT COMPLETED|Overall Study||1
8218376|NCT02070965|20268156|P2|NOT COMPLETED|Overall Study||2
8218377|NCT02070965|20268157|P1|NOT COMPLETED|Overall Study||2
8218378|NCT02070965|20268155|P3|COMPLETED|Overall Study||24
8218379|NCT02070965|20268156|P2|COMPLETED|Overall Study||21
8218380|NCT02070965|20268157|P1|COMPLETED|Overall Study||25
8218381|NCT02070965|20268155|P3|STARTED|Overall Study||25
8218382|NCT02070965|20268156|P2|STARTED|Overall Study||23
8218383|NCT02070965|20268157|P1|STARTED|Overall Study||27
8218384|NCT02070757|20268167|P2|NOT COMPLETED|Overall Study||114
8218385|NCT02070757|20268168|P1|NOT COMPLETED|Overall Study||117
8218386|NCT02070757|20268167|P2|COMPLETED|Overall Study||250
8218387|NCT02070757|20268168|P1|COMPLETED|Overall Study||245
8218388|NCT02070757|20268167|P2|Treated Participants|Overall Study||359
8218389|NCT02070757|20268168|P1|Treated Participants|Overall Study||361
8218390|NCT02070757|20268167|P2|STARTED|Overall Study||364
8218391|NCT02070757|20268168|P1|STARTED|Overall Study||362
8218392|NCT02070744|20268202|P5|NOT COMPLETED|OLE Phase (48 Weeks)||3
8218393|NCT02070744|20268203|P4|NOT COMPLETED|OLE Phase (48 Weeks)||0
8218394|NCT02070744|20268204|P3|NOT COMPLETED|OLE Phase (48 Weeks)||0
8218395|NCT02070744|20268205|P2|NOT COMPLETED|OLE Phase (48 Weeks)||0
8218396|NCT02070744|20268206|P1|NOT COMPLETED|OLE Phase (48 Weeks)||0
8218397|NCT02070744|20268202|P5|COMPLETED|OLE Phase (48 Weeks)||24
8218398|NCT02070744|20268203|P4|COMPLETED|OLE Phase (48 Weeks)||0
8218399|NCT02070744|20268204|P3|COMPLETED|OLE Phase (48 Weeks)||0
8218400|NCT02070744|20268205|P2|COMPLETED|OLE Phase (48 Weeks)||0
8218401|NCT02070744|20268206|P1|COMPLETED|OLE Phase (48 Weeks)||0
8218402|NCT02070744|20268202|P5|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
8218403|NCT02070744|20268203|P4|STARTED|OLE Phase (48 Weeks)||0
8218404|NCT02070744|20268204|P3|STARTED|OLE Phase (48 Weeks)||0
8218405|NCT02070744|20268205|P2|STARTED|OLE Phase (48 Weeks)||0
8218406|NCT02070744|20268206|P1|STARTED|OLE Phase (48 Weeks)||0
8218407|NCT02070744|20268202|P5|NOT COMPLETED|PC Phase (12 Weeks)||0
8218408|NCT02070744|20268203|P4|NOT COMPLETED|PC Phase (12 Weeks)||1
8218409|NCT02070744|20268204|P3|NOT COMPLETED|PC Phase (12 Weeks)||0
8218410|NCT02070744|20268205|P2|NOT COMPLETED|PC Phase (12 Weeks)||0
8218411|NCT02070744|20268206|P1|NOT COMPLETED|PC Phase (12 Weeks)||0
8218412|NCT02070744|20268202|P5|COMPLETED|PC Phase (12 Weeks)||0
8218413|NCT02070744|20268203|P4|COMPLETED|PC Phase (12 Weeks)||13
8218414|NCT02070744|20268204|P3|COMPLETED|PC Phase (12 Weeks)||15
8218415|NCT02070744|20268205|P2|COMPLETED|PC Phase (12 Weeks)||5
8218416|NCT02070744|20268206|P1|COMPLETED|PC Phase (12 Weeks)||6
8218417|NCT02070744|20268202|P5|Treated|PC Phase (12 Weeks)||0
8218418|NCT02070744|20268203|P4|Treated|PC Phase (12 Weeks)||13
8218419|NCT02070744|20268204|P3|Treated|PC Phase (12 Weeks)||15
8218420|NCT02070744|20268205|P2|Treated|PC Phase (12 Weeks)||5
8218421|NCT02070744|20268206|P1|Treated|PC Phase (12 Weeks)||6
8218422|NCT02070744|20268202|P5|STARTED|PC Phase (12 Weeks)||0
8218423|NCT02070744|20268203|P4|STARTED|PC Phase (12 Weeks)||14
8218424|NCT02070744|20268204|P3|STARTED|PC Phase (12 Weeks)||15
8218425|NCT02070744|20268205|P2|STARTED|PC Phase (12 Weeks)||5
8218426|NCT02070744|20268206|P1|STARTED|PC Phase (12 Weeks)||6
8218427|NCT02070692|20268258|P2|NOT COMPLETED|Overall Study||12
8218428|NCT02070692|20268259|P1|NOT COMPLETED|Overall Study||10
8218429|NCT02070692|20268258|P2|COMPLETED|Overall Study||16
8218430|NCT02070692|20268259|P1|COMPLETED|Overall Study||18
8218431|NCT02070692|20268258|P2|STARTED|Overall Study||28
8218432|NCT02070692|20268259|P1|STARTED|Overall Study||28
8218433|NCT02070640|20268275|P2|NOT COMPLETED|Overall Study||0
8218434|NCT02070640|20268276|P1|NOT COMPLETED|Overall Study||11
8218435|NCT02070640|20268275|P2|COMPLETED|Overall Study||6
8218436|NCT02070640|20268276|P1|COMPLETED|Overall Study||82
8218437|NCT02070640|20268275|P2|STARTED|Overall Study||6
8218438|NCT02070640|20268276|P1|STARTED|Overall Study||93
8218439|NCT02070588|20268289|P3|NOT COMPLETED|Overall Study||0
8218440|NCT02070588|20268290|P2|NOT COMPLETED|Overall Study||1
8218441|NCT02070588|20268291|P1|NOT COMPLETED|Overall Study||39
8218442|NCT02070588|20268289|P3|COMPLETED|Overall Study||0
8218443|NCT02070588|20268290|P2|COMPLETED|Overall Study||25
8218444|NCT02070588|20268291|P1|COMPLETED|Overall Study||47
8218445|NCT02070588|20268289|P3|STARTED|Overall Study||0
8218446|NCT02070588|20268290|P2|STARTED|Overall Study||26
8218447|NCT02070588|20268291|P1|STARTED|Overall Study||86
8218448|NCT02070484|20268307|P2|NOT COMPLETED|Overall Study||0
8218449|NCT02070484|20268308|P1|NOT COMPLETED|Overall Study||1
8218450|NCT02070484|20268307|P2|COMPLETED|Overall Study||3
8218451|NCT02070484|20268308|P1|COMPLETED|Overall Study||2
8218452|NCT02070484|20268307|P2|STARTED|Overall Study||3
8218453|NCT02070484|20268308|P1|STARTED|Overall Study||3
8218454|NCT02070380|20268330|P4|NOT COMPLETED|Second Injection||5
8218455|NCT02070380|20268331|P3|NOT COMPLETED|Second Injection||1
8218456|NCT02070380|20268332|P2|NOT COMPLETED|Second Injection||2
8218457|NCT02070380|20268333|P1|NOT COMPLETED|Second Injection||0
8218458|NCT02070380|20268330|P4|COMPLETED|Second Injection||46
8218459|NCT02070380|20268331|P3|COMPLETED|Second Injection||50
8218460|NCT02070380|20268332|P2|COMPLETED|Second Injection||32
8218461|NCT02070380|20268333|P1|COMPLETED|Second Injection||31
8218462|NCT02070380|20268330|P4|STARTED|Second Injection||51
8218463|NCT02070380|20268331|P3|STARTED|Second Injection||51
8218464|NCT02070380|20268332|P2|STARTED|Second Injection||34
8218465|NCT02070380|20268333|P1|STARTED|Second Injection||31
8218466|NCT02070380|20268330|P4|NOT COMPLETED|Washout (no Second Injection/MRI)||3
8218467|NCT02070380|20268331|P3|NOT COMPLETED|Washout (no Second Injection/MRI)||2
8218468|NCT02070380|20268332|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||5
8218469|NCT02070380|20268333|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||0
8218470|NCT02070380|20268330|P4|COMPLETED|Washout (no Second Injection/MRI)||51
8218471|NCT02070380|20268331|P3|COMPLETED|Washout (no Second Injection/MRI)||51
8218472|NCT02070380|20268332|P2|COMPLETED|Washout (no Second Injection/MRI)||34
8218473|NCT02070380|20268333|P1|COMPLETED|Washout (no Second Injection/MRI)||31
8218474|NCT02070380|20268330|P4|STARTED|Washout (no Second Injection/MRI)||54
8218475|NCT02070380|20268331|P3|STARTED|Washout (no Second Injection/MRI)||53
8218476|NCT02070380|20268332|P2|STARTED|Washout (no Second Injection/MRI)||39
8218477|NCT02070380|20268333|P1|STARTED|Washout (no Second Injection/MRI)||31
8218478|NCT02070380|20268330|P4|NOT COMPLETED|First Injection||0
8218479|NCT02070380|20268331|P3|NOT COMPLETED|First Injection||0
8218480|NCT02070380|20268332|P2|NOT COMPLETED|First Injection||0
8218481|NCT02070380|20268333|P1|NOT COMPLETED|First Injection||0
8218482|NCT02070380|20268330|P4|COMPLETED|First Injection||54
8218483|NCT02070380|20268331|P3|COMPLETED|First Injection||53
8218484|NCT02070380|20268332|P2|COMPLETED|First Injection||39
8218485|NCT02070380|20268333|P1|COMPLETED|First Injection||31
8218486|NCT02070380|20268330|P4|STARTED|First Injection||54
8218487|NCT02070380|20268331|P3|STARTED|First Injection||53
8218488|NCT02070380|20268332|P2|STARTED|First Injection||39
8218489|NCT02070380|20268333|P1|STARTED|First Injection||31
8218490|NCT02070302|20268383|P2|NOT COMPLETED|Overall Study||0
8218491|NCT02070302|20268384|P1|NOT COMPLETED|Overall Study||0
8218492|NCT02070302|20268383|P2|COMPLETED|Overall Study||5
8218493|NCT02070302|20268384|P1|COMPLETED|Overall Study||5
8218494|NCT02070302|20268383|P2|STARTED|Overall Study||5
8218495|NCT02070302|20268384|P1|STARTED|Overall Study||5
8218496|NCT02070276|20268403|P3|NOT COMPLETED|Overall Study||0
8218497|NCT02070276|20268404|P2|NOT COMPLETED|Overall Study||0
8218498|NCT02070276|20268405|P1|NOT COMPLETED|Overall Study||0
8218499|NCT02070276|20268403|P3|COMPLETED|Overall Study||148
8218500|NCT02070276|20268404|P2|COMPLETED|Overall Study||132
8218501|NCT02070276|20268405|P1|COMPLETED|Overall Study||149
8218502|NCT02070276|20268403|P3|STARTED|Overall Study||148
8218503|NCT02070276|20268404|P2|STARTED|Overall Study||132
8218504|NCT02070276|20268405|P1|STARTED|Overall Study||149
8218505|NCT02070237|20268421|P2|NOT COMPLETED|Overall Study||3
8218506|NCT02070237|20268422|P1|NOT COMPLETED|Overall Study||3
8218507|NCT02070237|20268421|P2|COMPLETED|Overall Study||42
8218508|NCT02070237|20268422|P1|COMPLETED|Overall Study||42
8218509|NCT02070237|20268421|P2|STARTED|Overall Study||45
8218510|NCT02070237|20268422|P1|STARTED|Overall Study||45
8218511|NCT02069847|20268432|P2|NOT COMPLETED|Overall Study||0
8218512|NCT02069847|20268433|P1|NOT COMPLETED|Overall Study||0
8218513|NCT02069847|20268432|P2|COMPLETED|Overall Study||68
8218514|NCT02069847|20268433|P1|COMPLETED|Overall Study||22
8218515|NCT02069847|20268432|P2|STARTED|Overall Study||68
8218516|NCT02069847|20268433|P1|STARTED|Overall Study||22
8218517|NCT02069704|20268442|P2|NOT COMPLETED|Overall Study||0
8218518|NCT02069704|20268443|P1|NOT COMPLETED|Overall Study||0
8218519|NCT02069704|20268442|P2|COMPLETED|Overall Study||71
8218520|NCT02069704|20268443|P1|COMPLETED|Overall Study||69
8218521|NCT02069704|20268442|P2|STARTED|Overall Study||71
8218522|NCT02069704|20268443|P1|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69
8218523|NCT02069392|20268475|P2|NOT COMPLETED|Overall Study||2
8218524|NCT02069392|20268476|P1|NOT COMPLETED|Overall Study||4
8218525|NCT02069392|20268475|P2|COMPLETED|Overall Study||15
8218526|NCT02069392|20268476|P1|COMPLETED|Overall Study||10
8218527|NCT02069392|20268475|P2|STARTED|Overall Study||17
8218528|NCT02069392|20268476|P1|STARTED|Overall Study||14
8218529|NCT02069379|20268500|P4|NOT COMPLETED|Second Treatment Arm||0
8218530|NCT02069379|20268501|P3|NOT COMPLETED|Second Treatment Arm||1
8218531|NCT02069379|20268502|P2|NOT COMPLETED|Second Treatment Arm||0
8218532|NCT02069379|20268503|P1|NOT COMPLETED|Second Treatment Arm||0
8218533|NCT02069379|20268500|P4|COMPLETED|Second Treatment Arm||0
8218534|NCT02069379|20268501|P3|COMPLETED|Second Treatment Arm||0
8218535|NCT02069379|20268502|P2|COMPLETED|Second Treatment Arm||1
8218536|NCT02069379|20268503|P1|COMPLETED|Second Treatment Arm||0
8218537|NCT02069379|20268500|P4|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
8218538|NCT02069379|20268501|P3|STARTED|Second Treatment Arm||1
8218539|NCT02069379|20268502|P2|STARTED|Second Treatment Arm||1
8218540|NCT02069379|20268503|P1|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
8218541|NCT02069379|20268500|P4|NOT COMPLETED|Washout Period (4 Weeks)||0
8218542|NCT02069379|20268501|P3|NOT COMPLETED|Washout Period (4 Weeks)||0
8218543|NCT02069379|20268502|P2|NOT COMPLETED|Washout Period (4 Weeks)||2
8218544|NCT02069379|20268503|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
8218545|NCT02069379|20268500|P4|COMPLETED|Washout Period (4 Weeks)||0
8218546|NCT02069379|20268501|P3|COMPLETED|Washout Period (4 Weeks)||1
8218547|NCT02069379|20268502|P2|COMPLETED|Washout Period (4 Weeks)||1
8218548|NCT02069379|20268503|P1|COMPLETED|Washout Period (4 Weeks)||0
8218549|NCT02069379|20268500|P4|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
8218550|NCT02069379|20268501|P3|STARTED|Washout Period (4 Weeks)||1
8218551|NCT02069379|20268502|P2|STARTED|Washout Period (4 Weeks)||3
8218552|NCT02069379|20268503|P1|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
8218553|NCT02069379|20268500|P4|NOT COMPLETED|First Treatment Arm||0
8218554|NCT02069379|20268501|P3|NOT COMPLETED|First Treatment Arm||1
8218555|NCT02069379|20268502|P2|NOT COMPLETED|First Treatment Arm||1
8218556|NCT02069379|20268503|P1|NOT COMPLETED|First Treatment Arm||0
8218557|NCT02069379|20268500|P4|COMPLETED|First Treatment Arm||0
8218558|NCT02069379|20268501|P3|COMPLETED|First Treatment Arm||1
8218559|NCT02069379|20268502|P2|COMPLETED|First Treatment Arm||3
8218560|NCT02069379|20268503|P1|COMPLETED|First Treatment Arm||0
8218561|NCT02069379|20268500|P4|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
8218562|NCT02069379|20268501|P3|STARTED|First Treatment Arm||2
8218563|NCT02069379|20268502|P2|STARTED|First Treatment Arm||4
8218564|NCT02069379|20268503|P1|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
8218565|NCT02069379|20268500|P4|NOT COMPLETED|Baseline Measurements||2
8218566|NCT02069379|20268501|P3|NOT COMPLETED|Baseline Measurements||0
8218567|NCT02069379|20268502|P2|NOT COMPLETED|Baseline Measurements||0
8218568|NCT02069379|20268503|P1|NOT COMPLETED|Baseline Measurements||3
8218569|NCT02069379|20268500|P4|COMPLETED|Baseline Measurements||4
8218570|NCT02069379|20268501|P3|COMPLETED|Baseline Measurements||2
8218571|NCT02069379|20268502|P2|COMPLETED|Baseline Measurements||4
8218572|NCT02069379|20268503|P1|COMPLETED|Baseline Measurements||27
8218573|NCT02069379|20268500|P4|Baseline Measurements Taken|Baseline Measurements||6
8218574|NCT02069379|20268501|P3|Baseline Measurements Taken|Baseline Measurements||2
8218575|NCT02069379|20268502|P2|Baseline Measurements Taken|Baseline Measurements||4
8218576|NCT02069379|20268503|P1|Baseline Measurements Taken|Baseline Measurements||30
8218577|NCT02069379|20268500|P4|STARTED|Baseline Measurements||6
8218578|NCT02069379|20268501|P3|STARTED|Baseline Measurements||2
8218579|NCT02069379|20268502|P2|STARTED|Baseline Measurements||4
8218580|NCT02069379|20268503|P1|STARTED|Baseline Measurements||30
8218581|NCT02069353|20268529|P1|NOT COMPLETED|Overall Study||0
8218582|NCT02069353|20268529|P1|COMPLETED|Overall Study||4
8218583|NCT02069353|20268529|P1|STARTED|Overall Study||4
8218584|NCT02069184|20268540|P2|NOT COMPLETED|Overall Study||2
8218585|NCT02069184|20268541|P1|NOT COMPLETED|Overall Study||6
8218586|NCT02069184|20268540|P2|COMPLETED|Overall Study||31
8218587|NCT02069184|20268541|P1|COMPLETED|Overall Study||27
8218588|NCT02069184|20268540|P2|STARTED|Overall Study||33
8218589|NCT02069184|20268541|P1|STARTED|Overall Study||33
8218590|NCT02069119|20268563|P4|NOT COMPLETED|Overall Study||0
8218591|NCT02069119|20268564|P3|NOT COMPLETED|Overall Study||0
8218592|NCT02069119|20268565|P2|NOT COMPLETED|Overall Study||0
8218593|NCT02069119|20268566|P1|NOT COMPLETED|Overall Study||0
8218594|NCT02069119|20268563|P4|COMPLETED|Overall Study||4
8218595|NCT02069119|20268564|P3|COMPLETED|Overall Study||20
8218596|NCT02069119|20268565|P2|COMPLETED|Overall Study||4
8218597|NCT02069119|20268566|P1|COMPLETED|Overall Study||20
8218598|NCT02069119|20268563|P4|STARTED|Overall Study||4
8218599|NCT02069119|20268564|P3|STARTED|Overall Study||20
8218600|NCT02069119|20268565|P2|STARTED|Overall Study||4
8218601|NCT02069119|20268566|P1|STARTED|Overall Study||20
8218602|NCT02069093|20268590|P1|NOT COMPLETED|Overall Study||30
8218603|NCT02069093|20268590|P1|COMPLETED|Overall Study||56
8218604|NCT02069093|20268590|P1|Pharmacokinetic Analysis Set|Overall Study||50
8218605|NCT02069093|20268590|P1|STARTED|Overall Study||86
8218606|NCT02069041|20268599|P1|NOT COMPLETED|Overall Study||0
8218607|NCT02069041|20268599|P1|COMPLETED|Overall Study||8
8218608|NCT02069041|20268599|P1|Received at Least One Dose of Study Drug|Overall Study||8
8218609|NCT02069041|20268599|P1|STARTED|Overall Study||8
8218610|NCT02069015|20268609|P2|NOT COMPLETED|Overall Study||33
8218611|NCT02069015|20268610|P1|NOT COMPLETED|Overall Study||40
8218612|NCT02069015|20268609|P2|COMPLETED|Overall Study|180 day post ED discharge at CRC|35
8218613|NCT02069015|20268610|P1|COMPLETED|Overall Study|180 post ED discharge at CRC|31
8218614|NCT02069015|20268609|P2|90 Day|Overall Study|90 day post ED discharge|35
8218615|NCT02069015|20268610|P1|90 Day|Overall Study|90 day post ED discharge at CRC|32
8218616|NCT02069015|20268609|P2|30 Day|Overall Study|30 day post-discharge at CRC|43
8218617|NCT02069015|20268610|P1|30 Day|Overall Study|30 day post-discharge at CRC|38
8218618|NCT02069015|20268609|P2|7 Day|Overall Study|7 day post ED discharge at CRC|45
8218619|NCT02069015|20268610|P1|7 Day|Overall Study|7 day post ED discharge at Clinical Research Center (CRC)|44
8218620|NCT02069015|20268609|P2|STARTED|Overall Study||68
8218621|NCT02069015|20268610|P1|STARTED|Overall Study|Baseline and enrollment at Emergency Department (ED)|71
8218640|NCT02068846|20268669|P2|NOT COMPLETED|Overall Study||1
8218641|NCT02068846|20268670|P1|NOT COMPLETED|Overall Study||1
8218642|NCT02068846|20268669|P2|COMPLETED|Overall Study||7
8218643|NCT02068846|20268670|P1|COMPLETED|Overall Study||8
8218644|NCT02068846|20268669|P2|STARTED|Overall Study||8
8218645|NCT02068846|20268670|P1|STARTED|Overall Study||9
8218646|NCT02068820|20268688|P2|NOT COMPLETED|Overall Study||0
8218647|NCT02068820|20268689|P1|NOT COMPLETED|Overall Study||0
8218648|NCT02068820|20268688|P2|COMPLETED|Overall Study||180
8218649|NCT02068820|20268689|P1|COMPLETED|Overall Study||20
8218650|NCT02068820|20268688|P2|STARTED|Overall Study||180
8218651|NCT02068820|20268689|P1|STARTED|Overall Study||20
8218652|NCT02068768|20268700|P1|NOT COMPLETED|Overall Study||7
8218653|NCT02068768|20268700|P1|COMPLETED|Overall Study||6
8218654|NCT02068768|20268700|P1|STARTED|Overall Study||13
8218655|NCT02068599|20268709|P3|NOT COMPLETED|Overall Study||13
8218656|NCT02068599|20268710|P2|NOT COMPLETED|Overall Study||10
8218657|NCT02068599|20268711|P1|NOT COMPLETED|Overall Study||11
8218658|NCT02068599|20268709|P3|COMPLETED|Overall Study||117
8218659|NCT02068599|20268710|P2|COMPLETED|Overall Study||119
8218660|NCT02068599|20268711|P1|COMPLETED|Overall Study||119
8218661|NCT02068599|20268709|P3|Full Analysis Set|Overall Study||130
8218662|NCT02068599|20268710|P2|Full Analysis Set|Overall Study||128
8218663|NCT02068599|20268711|P1|Full Analysis Set|Overall Study||129
8218664|NCT02068599|20268709|P3|Safety Analysis Set|Overall Study||130
8218665|NCT02068599|20268710|P2|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
8218666|NCT02068599|20268711|P1|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
8218667|NCT02068599|20268709|P3|STARTED|Overall Study||130
8218668|NCT02068599|20268710|P2|STARTED|Overall Study||129
8218669|NCT02068599|20268711|P1|STARTED|Overall Study||130
8218676|NCT02068508|20268762|P1|NOT COMPLETED|Overall Study||32
8218677|NCT02068508|20268762|P1|COMPLETED|Overall Study||1035
8218678|NCT02068508|20268762|P1|STARTED|Overall Study||1067
8218679|NCT02068495|20268772|P1|NOT COMPLETED|Overall Study||109
8218680|NCT02068495|20268772|P1|COMPLETED|Overall Study||3300
8218681|NCT02068495|20268772|P1|STARTED|Overall Study||3409
8218682|NCT02068443|20268784|P3|NOT COMPLETED|Overall Study||3
8218683|NCT02068443|20268785|P2|NOT COMPLETED|Overall Study||6
8218684|NCT02068443|20268786|P1|NOT COMPLETED|Overall Study||7
8218685|NCT02068443|20268784|P3|COMPLETED|Overall Study||148
8218686|NCT02068443|20268785|P2|COMPLETED|Overall Study||146
8218687|NCT02068443|20268786|P1|COMPLETED|Overall Study||64
8218688|NCT02068443|20268784|P3|STARTED|Overall Study||151
8218689|NCT02068443|20268785|P2|STARTED|Overall Study||152
8218690|NCT02068443|20268786|P1|STARTED|Overall Study||71
8218691|NCT02068222|20268821|P1|NOT COMPLETED|Overall Study||1
8218692|NCT02068222|20268821|P1|COMPLETED|Overall Study||9
8218693|NCT02068222|20268821|P1|STARTED|Overall Study||10
8218694|NCT02068157|20268828|P1|NOT COMPLETED|Overall Study||0
8218695|NCT02068157|20268828|P1|COMPLETED|Overall Study||3
8218696|NCT02068157|20268828|P1|STARTED|Overall Study||3
8218697|NCT02068027|20268835|P2|NOT COMPLETED|Overall Study||16
8218698|NCT02068027|20268836|P1|NOT COMPLETED|Overall Study||13
8218699|NCT02068027|20268835|P2|COMPLETED|Overall Study||114
8218700|NCT02068027|20268836|P1|COMPLETED|Overall Study||117
8218701|NCT02068027|20268835|P2|STARTED|Overall Study||130
8218702|NCT02068027|20268836|P1|STARTED|Overall Study||130
8218703|NCT02067858|20268844|P1|NOT COMPLETED|Overall Study||0
8218704|NCT02067858|20268844|P1|COMPLETED|Overall Study||6
8218705|NCT02067858|20268844|P1|STARTED|Overall Study||6
8218706|NCT02067728|20268852|P2|NOT COMPLETED|6 Month Measurements||97
8218707|NCT02067728|20268853|P1|NOT COMPLETED|6 Month Measurements||114
8218708|NCT02067728|20268852|P2|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
8218709|NCT02067728|20268853|P1|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
8218710|NCT02067728|20268852|P2|STARTED|6 Month Measurements||210
8218711|NCT02067728|20268853|P1|STARTED|6 Month Measurements||220
8218712|NCT02067728|20268852|P2|NOT COMPLETED|6 Month Follow up Survey||60
8218713|NCT02067728|20268853|P1|NOT COMPLETED|6 Month Follow up Survey||48
8218714|NCT02067728|20268852|P2|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
8218715|NCT02067728|20268853|P1|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
8218716|NCT02067728|20268852|P2|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
8218717|NCT02067728|20268853|P1|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
8218718|NCT02067728|20268852|P2|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
8218719|NCT02067728|20268853|P1|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
8218720|NCT02067728|20268852|P2|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
8218721|NCT02067728|20268853|P1|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
8218722|NCT02067728|20268852|P2|STARTED|Baseline - 1 Month Follow up Survey||210
8218723|NCT02067728|20268853|P1|STARTED|Baseline - 1 Month Follow up Survey||220
8218724|NCT02067676|20268887|P6|NOT COMPLETED|Overall Study||0
8218725|NCT02067676|20268888|P5|NOT COMPLETED|Overall Study||0
8218726|NCT02067676|20268889|P4|NOT COMPLETED|Overall Study||0
8218727|NCT02067676|20268890|P3|NOT COMPLETED|Overall Study||0
8218728|NCT02067676|20268891|P2|NOT COMPLETED|Overall Study||0
8218729|NCT02067676|20268892|P1|NOT COMPLETED|Overall Study||1
8218730|NCT02067676|20268887|P6|COMPLETED|Overall Study||8
8218731|NCT02067676|20268888|P5|COMPLETED|Overall Study||8
8218732|NCT02067676|20268889|P4|COMPLETED|Overall Study||8
8218733|NCT02067676|20268890|P3|COMPLETED|Overall Study||8
8218734|NCT02067676|20268891|P2|COMPLETED|Overall Study||8
8218735|NCT02067676|20268892|P1|COMPLETED|Overall Study||7
8218736|NCT02067676|20268887|P6|STARTED|Overall Study||8
8218737|NCT02067676|20268888|P5|STARTED|Overall Study||8
8218738|NCT02067676|20268889|P4|STARTED|Overall Study||8
8218739|NCT02067676|20268890|P3|STARTED|Overall Study||8
8218740|NCT02067676|20268891|P2|STARTED|Overall Study||8
8218741|NCT02067676|20268892|P1|STARTED|Overall Study||8
8218742|NCT02067663|20268932|P2|NOT COMPLETED|Overall Study||14
8218743|NCT02067663|20268933|P1|NOT COMPLETED|Overall Study||13
8218744|NCT02067663|20268932|P2|COMPLETED|Overall Study||41
8218745|NCT02067663|20268933|P1|COMPLETED|Overall Study||55
8218746|NCT02067663|20268932|P2|STARTED|Overall Study||55
8218747|NCT02067663|20268933|P1|STARTED|Overall Study||68
8218748|NCT02067611|20268953|P3|NOT COMPLETED|Overall Study||4
8218749|NCT02067611|20268954|P2|NOT COMPLETED|Overall Study||6
8218750|NCT02067611|20268955|P1|NOT COMPLETED|Overall Study||6
8218751|NCT02067611|20268953|P3|COMPLETED|Overall Study||68
8218752|NCT02067611|20268954|P2|COMPLETED|Overall Study||66
8218753|NCT02067611|20268955|P1|COMPLETED|Overall Study||66
8218754|NCT02067611|20268953|P3|STARTED|Overall Study||72
8218755|NCT02067611|20268954|P2|STARTED|Overall Study||72
8218756|NCT02067611|20268955|P1|STARTED|Overall Study||72
8218757|NCT02067585|20268993|P3|NOT COMPLETED|Overall Study||0
8218758|NCT02067585|20268994|P2|NOT COMPLETED|Overall Study||0
8218759|NCT02067585|20268995|P1|NOT COMPLETED|Overall Study||0
8218760|NCT02067585|20268993|P3|COMPLETED|Overall Study||16
8218761|NCT02067585|20268994|P2|COMPLETED|Overall Study||16
8218762|NCT02067585|20268995|P1|COMPLETED|Overall Study||16
8218763|NCT02067585|20268993|P3|STARTED|Overall Study||16
8218764|NCT02067585|20268994|P2|STARTED|Overall Study||16
8218765|NCT02067585|20268995|P1|STARTED|Overall Study||16
8218766|NCT02067533|20269032|P2|NOT COMPLETED|Overall Study||2
8218767|NCT02067533|20269033|P1|NOT COMPLETED|Overall Study||4
8218768|NCT02067533|20269032|P2|COMPLETED|Overall Study||44
8218769|NCT02067533|20269033|P1|COMPLETED|Overall Study||41
8218770|NCT02067533|20269032|P2|STARTED|Overall Study||46
8218771|NCT02067533|20269033|P1|STARTED|Overall Study||45
8218772|NCT02067468|20269042|P3|NOT COMPLETED|Overall Study||0
8218773|NCT02067468|20269043|P2|NOT COMPLETED|Overall Study||0
8218774|NCT02067468|20269044|P1|NOT COMPLETED|Overall Study||0
8218775|NCT02067468|20269042|P3|COMPLETED|Overall Study||889
8218776|NCT02067468|20269043|P2|COMPLETED|Overall Study||890
8218777|NCT02067468|20269044|P1|COMPLETED|Overall Study||882
8218778|NCT02067468|20269042|P3|Had at Least One Routine Colposcopy|Overall Study||462
8218779|NCT02067468|20269043|P2|Had at Least One Routine Colposcopy|Overall Study||372
8218780|NCT02067468|20269044|P1|Had at Least One Routine Colposcopy|Overall Study||772
8218781|NCT02067468|20269042|P3|Followed-up Through Medical Records|Overall Study||889
8218782|NCT02067468|20269043|P2|Followed-up Through Medical Records|Overall Study||890
8218783|NCT02067468|20269044|P1|Followed-up Through Medical Records|Overall Study||882
8218784|NCT02067468|20269042|P3|STARTED|Overall Study||889
8218785|NCT02067468|20269043|P2|STARTED|Overall Study||890
8218786|NCT02067468|20269044|P1|STARTED|Overall Study||882
8218787|NCT02067273|20269075|P2|NOT COMPLETED|Overall Study||3
8218788|NCT02067273|20269076|P1|NOT COMPLETED|Overall Study||0
8218789|NCT02067273|20269075|P2|COMPLETED|Overall Study||12
8218790|NCT02067273|20269076|P1|COMPLETED|Overall Study||5
8218791|NCT02067273|20269075|P2|STARTED|Overall Study||15
8218792|NCT02067273|20269076|P1|STARTED|Overall Study||5
8218793|NCT02067104|20269084|P2|NOT COMPLETED|Overall Study||5
8218794|NCT02067104|20269085|P1|NOT COMPLETED|Overall Study||4
8218795|NCT02067104|20269084|P2|COMPLETED|Overall Study||0
8218796|NCT02067104|20269085|P1|COMPLETED|Overall Study||0
8218797|NCT02067104|20269084|P2|STARTED|Overall Study||5
8218798|NCT02067104|20269085|P1|STARTED|Overall Study||4
8218799|NCT02067039|20269095|P2|NOT COMPLETED|Overall Study||508
8218800|NCT02067039|20269096|P1|NOT COMPLETED|Overall Study||573
8218801|NCT02067039|20269095|P2|COMPLETED|Overall Study||832
8218802|NCT02067039|20269096|P1|COMPLETED|Overall Study||752
8218803|NCT02067039|20269095|P2|9 Month Survey|Overall Study||838
8218804|NCT02067039|20269096|P1|9 Month Survey|Overall Study||748
8218805|NCT02067039|20269095|P2|6 Month Survey|Overall Study||756
8218806|NCT02067039|20269096|P1|6 Month Survey|Overall Study||735
8218807|NCT02067039|20269095|P2|3 Month Survey|Overall Study||766
8218808|NCT02067039|20269096|P1|3 Month Survey|Overall Study||824
8218809|NCT02067039|20269095|P2|STARTED|Overall Study||1340
8218810|NCT02067039|20269096|P1|STARTED|Overall Study||1325
8218811|NCT02067000|20269108|P1|NOT COMPLETED|Overall Study||50
8218812|NCT02067000|20269108|P1|COMPLETED|Overall Study||167
8218813|NCT02067000|20269108|P1|STARTED|Overall Study||217
8218814|NCT02066922|20269114|P1|NOT COMPLETED|Overall Study||1
8218815|NCT02066922|20269114|P1|COMPLETED|Overall Study||14
8218816|NCT02066922|20269114|P1|STARTED|Overall Study||15
8218817|NCT02066896|20269124|P2|NOT COMPLETED|Overall Study||0
8218818|NCT02066896|20269125|P1|NOT COMPLETED|Overall Study||0
8218819|NCT02066896|20269124|P2|COMPLETED|Overall Study||33
8218820|NCT02066896|20269125|P1|COMPLETED|Overall Study||33
8218821|NCT02066896|20269124|P2|STARTED|Overall Study||33
8218822|NCT02066896|20269125|P1|STARTED|Overall Study||33
8218823|NCT02066857|20269137|P2|NOT COMPLETED|Overall Study||1
8218824|NCT02066857|20269138|P1|NOT COMPLETED|Overall Study||1
8218825|NCT02066857|20269137|P2|COMPLETED|Overall Study||3
8218826|NCT02066857|20269138|P1|COMPLETED|Overall Study||0
8218827|NCT02066857|20269137|P2|STARTED|Overall Study||4
8218828|NCT02066857|20269138|P1|STARTED|Overall Study||1
8218829|NCT02066792|20269156|P4|NOT COMPLETED|Overall Study||9
8218830|NCT02066792|20269157|P3|NOT COMPLETED|Overall Study||8
8218831|NCT02066792|20269158|P2|NOT COMPLETED|Overall Study||5
8218832|NCT02066792|20269159|P1|NOT COMPLETED|Overall Study||7
8218833|NCT02066792|20269156|P4|COMPLETED|Overall Study||27
8218834|NCT02066792|20269157|P3|COMPLETED|Overall Study||30
8218835|NCT02066792|20269158|P2|COMPLETED|Overall Study||33
8218836|NCT02066792|20269159|P1|COMPLETED|Overall Study||33
8218837|NCT02066792|20269156|P4|STARTED|Overall Study||36
8218838|NCT02066792|20269157|P3|STARTED|Overall Study||38
8218839|NCT02066792|20269158|P2|STARTED|Overall Study||38
8218840|NCT02066792|20269159|P1|STARTED|Overall Study||40
8218841|NCT02066740|20269169|P1|NOT COMPLETED|Overall Study||2
8218842|NCT02066740|20269169|P1|COMPLETED|Overall Study||32
8218843|NCT02066740|20269169|P1|STARTED|Overall Study||34
8218844|NCT02066727|20269176|P2|NOT COMPLETED|Overall Study||0
8218845|NCT02066727|20269177|P1|NOT COMPLETED|Overall Study||0
8218846|NCT02066727|20269176|P2|COMPLETED|Overall Study||30
8218847|NCT02066727|20269177|P1|COMPLETED|Overall Study||30
8218848|NCT02066727|20269176|P2|STARTED|Overall Study||30
8218849|NCT02066727|20269177|P1|STARTED|Overall Study||30
8218850|NCT02066467|20269183|P1|NOT COMPLETED|Overall Study||215
8218851|NCT02066467|20269183|P1|COMPLETED|Overall Study||648
8218852|NCT02066467|20269183|P1|STARTED|Overall Study||863
8218853|NCT02066415|20269192|P3|NOT COMPLETED|Overall Study||8
8218854|NCT02066415|20269193|P2|NOT COMPLETED|Overall Study||7
8218855|NCT02066415|20269194|P1|NOT COMPLETED|Overall Study||21
8218856|NCT02066415|20269192|P3|COMPLETED|Overall Study||182
8218857|NCT02066415|20269193|P2|COMPLETED|Overall Study||184
8218858|NCT02066415|20269194|P1|COMPLETED|Overall Study||265
8218859|NCT02066415|20269192|P3|Received Study Drug|Overall Study||188
8218860|NCT02066415|20269193|P2|Received Study Drug|Overall Study||190
8218861|NCT02066415|20269194|P1|Received Study Drug|Overall Study||282
8218862|NCT02066415|20269192|P3|STARTED|Overall Study||190
8218863|NCT02066415|20269193|P2|STARTED|Overall Study||191
8218864|NCT02066415|20269194|P1|STARTED|Overall Study||286
8218865|NCT02066402|20269219|P2|NOT COMPLETED|Overall Study||23
8218866|NCT02066402|20269220|P1|NOT COMPLETED|Overall Study||26
8218867|NCT02066402|20269219|P2|COMPLETED|Overall Study||275
8218868|NCT02066402|20269220|P1|COMPLETED|Overall Study||274
8218869|NCT02066402|20269219|P2|Completed Study Treatment Period|Overall Study||256
8218870|NCT02066402|20269220|P1|Completed Study Treatment Period|Overall Study||261
8218871|NCT02066402|20269219|P2|Participants Received Treatment|Overall Study||297
8218872|NCT02066402|20269220|P1|Participants Received Treatment|Overall Study||292
8218873|NCT02066402|20269219|P2|STARTED|Overall Study||298
8218874|NCT02066402|20269220|P1|STARTED|Overall Study||300
8218899|NCT02066311|20269307|P1|NOT COMPLETED|Overall Study||5
8218900|NCT02066311|20269307|P1|COMPLETED|Overall Study|Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy.|10
8218901|NCT02066311|20269307|P1|STARTED|Overall Study||15
8218902|NCT02066298|20269317|P6|NOT COMPLETED|Overall Study||12
8218903|NCT02066298|20269318|P5|NOT COMPLETED|Overall Study||9
8218904|NCT02066298|20269319|P4|NOT COMPLETED|Overall Study||6
8218905|NCT02066298|20269320|P3|NOT COMPLETED|Overall Study||10
8218906|NCT02066298|20269321|P2|NOT COMPLETED|Overall Study||8
8218907|NCT02066298|20269322|P1|NOT COMPLETED|Overall Study||9
8218908|NCT02066298|20269317|P6|COMPLETED|Overall Study||38
8218909|NCT02066298|20269318|P5|COMPLETED|Overall Study||38
8218910|NCT02066298|20269319|P4|COMPLETED|Overall Study||45
8218911|NCT02066298|20269320|P3|COMPLETED|Overall Study||40
8218912|NCT02066298|20269321|P2|COMPLETED|Overall Study||40
8218913|NCT02066298|20269322|P1|COMPLETED|Overall Study||40
8218914|NCT02066298|20269317|P6|Completed 3rd Period|Overall Study||38
8218915|NCT02066298|20269318|P5|Completed 3rd Period|Overall Study||38
8218916|NCT02066298|20269319|P4|Completed 3rd Period|Overall Study||45
8218917|NCT02066298|20269320|P3|Completed 3rd Period|Overall Study||40
8218918|NCT02066298|20269321|P2|Completed 3rd Period|Overall Study||40
8218919|NCT02066298|20269322|P1|Completed 3rd Period|Overall Study||40
8218920|NCT02066298|20269317|P6|Completed 2nd Period|Overall Study||41
8218921|NCT02066298|20269318|P5|Completed 2nd Period|Overall Study||42
8218922|NCT02066298|20269319|P4|Completed 2nd Period|Overall Study||46
8218923|NCT02066298|20269320|P3|Completed 2nd Period|Overall Study||41
8218924|NCT02066298|20269321|P2|Completed 2nd Period|Overall Study||41
8218925|NCT02066298|20269322|P1|Completed 2nd Period|Overall Study||41
8218926|NCT02066298|20269317|P6|Completed 1st Period|Overall Study||45
8218927|NCT02066298|20269318|P5|Completed 1st Period|Overall Study||46
8218928|NCT02066298|20269319|P4|Completed 1st Period|Overall Study||48
8218929|NCT02066298|20269320|P3|Completed 1st Period|Overall Study||45
8218930|NCT02066298|20269321|P2|Completed 1st Period|Overall Study||47
8218931|NCT02066298|20269322|P1|Completed 1st Period|Overall Study||44
8218932|NCT02066298|20269317|P6|STARTED|Overall Study||50
8218933|NCT02066298|20269318|P5|STARTED|Overall Study||47
8218934|NCT02066298|20269319|P4|STARTED|Overall Study||51
8218935|NCT02066298|20269320|P3|STARTED|Overall Study||50
8218936|NCT02066298|20269321|P2|STARTED|Overall Study||48
8218937|NCT02066298|20269322|P1|STARTED|Overall Study||49
8218938|NCT02066233|20269346|P2|NOT COMPLETED|Standard Endoscopy (Day 2)||0
8218939|NCT02066233|20269347|P1|NOT COMPLETED|Standard Endoscopy (Day 2)||0
8218940|NCT02066233|20269346|P2|COMPLETED|Standard Endoscopy (Day 2)||44
8218941|NCT02066233|20269347|P1|COMPLETED|Standard Endoscopy (Day 2)||44
8218942|NCT02066233|20269346|P2|STARTED|Standard Endoscopy (Day 2)||44
8218943|NCT02066233|20269347|P1|STARTED|Standard Endoscopy (Day 2)||44
8218944|NCT02066233|20269346|P2|NOT COMPLETED|EG Scan II (Day 1)||6
8218945|NCT02066233|20269347|P1|NOT COMPLETED|EG Scan II (Day 1)||6
8218946|NCT02066233|20269346|P2|COMPLETED|EG Scan II (Day 1)||44
8218947|NCT02066233|20269347|P1|COMPLETED|EG Scan II (Day 1)||44
8218948|NCT02066233|20269346|P2|STARTED|EG Scan II (Day 1)||50
8218949|NCT02066233|20269347|P1|STARTED|EG Scan II (Day 1)||50
8218958|NCT02066129|20269380|P2|NOT COMPLETED|Overall Study||33
8218959|NCT02066129|20269381|P1|NOT COMPLETED|Overall Study||29
8218960|NCT02066129|20269380|P2|COMPLETED|Overall Study||94
8218961|NCT02066129|20269381|P1|COMPLETED|Overall Study||98
8218962|NCT02066129|20269380|P2|STARTED|Overall Study||127
8218963|NCT02066129|20269381|P1|STARTED|Overall Study||127
8218964|NCT02066051|20269395|P1|NOT COMPLETED|Overall Study||1
8218965|NCT02066051|20269395|P1|COMPLETED|Overall Study||7
8218966|NCT02066051|20269395|P1|STARTED|Overall Study||8
8218967|NCT02065895|20269400|P6|NOT COMPLETED|Overall Study||0
8218968|NCT02065895|20269401|P5|NOT COMPLETED|Overall Study||0
8218969|NCT02065895|20269402|P4|NOT COMPLETED|Overall Study||1
8218970|NCT02065895|20269403|P3|NOT COMPLETED|Overall Study||0
8218971|NCT02065895|20269404|P2|NOT COMPLETED|Overall Study||1
8218972|NCT02065895|20269405|P1|NOT COMPLETED|Overall Study||1
8218973|NCT02065895|20269400|P6|COMPLETED|Overall Study||1
8218974|NCT02065895|20269401|P5|COMPLETED|Overall Study||1
8218975|NCT02065895|20269402|P4|COMPLETED|Overall Study||0
8218976|NCT02065895|20269403|P3|COMPLETED|Overall Study||1
8218977|NCT02065895|20269404|P2|COMPLETED|Overall Study||2
8218978|NCT02065895|20269405|P1|COMPLETED|Overall Study||0
8218979|NCT02065895|20269400|P6|STARTED|Overall Study||1
8218980|NCT02065895|20269401|P5|STARTED|Overall Study||1
8218981|NCT02065895|20269402|P4|STARTED|Overall Study||1
8218982|NCT02065895|20269403|P3|STARTED|Overall Study||1
8218983|NCT02065895|20269404|P2|STARTED|Overall Study||3
8218984|NCT02065895|20269405|P1|STARTED|Overall Study||1
8218985|NCT02065791|20269424|P2|NOT COMPLETED|Overall Study||15
8218986|NCT02065791|20269425|P1|NOT COMPLETED|Overall Study||25
8218987|NCT02065791|20269424|P2|COMPLETED|Overall Study||2187
8218988|NCT02065791|20269425|P1|COMPLETED|Overall Study||2174
8218989|NCT02065791|20269424|P2|Treated|Overall Study||2200
8218990|NCT02065791|20269425|P1|Treated|Overall Study||2197
8218991|NCT02065791|20269424|P2|STARTED|Overall Study||2202
8218992|NCT02065791|20269425|P1|STARTED|Overall Study||2199
8218993|NCT02065713|20269447|P2|NOT COMPLETED|Overall Study||1
8218994|NCT02065713|20269448|P1|NOT COMPLETED|Overall Study||1
8218995|NCT02065713|20269447|P2|COMPLETED|Overall Study||20
8218996|NCT02065713|20269448|P1|COMPLETED|Overall Study||22
8218997|NCT02065713|20269447|P2|STARTED|Overall Study||21
8218998|NCT02065713|20269448|P1|STARTED|Overall Study||23
8218999|NCT02065687|20269456|P2|NOT COMPLETED|Overall Study||0
8219000|NCT02065687|20269457|P1|NOT COMPLETED|Overall Study||0
8219001|NCT02065687|20269456|P2|COMPLETED|Overall Study||235
8219002|NCT02065687|20269457|P1|COMPLETED|Overall Study||234
8219003|NCT02065687|20269456|P2|STARTED|Overall Study||235
8219004|NCT02065687|20269457|P1|STARTED|Overall Study||234
8219005|NCT02065622|20269479|P5|NOT COMPLETED|Maintenance Study||46
8219006|NCT02065622|20269480|P4|NOT COMPLETED|Maintenance Study||104
8219007|NCT02065622|20269481|P3|NOT COMPLETED|Maintenance Study||124
8219008|NCT02065622|20269482|P2|NOT COMPLETED|Maintenance Study||0
8219009|NCT02065622|20269483|P1|NOT COMPLETED|Maintenance Study||0
8219010|NCT02065622|20269479|P5|COMPLETED|Maintenance Study||105
8219011|NCT02065622|20269480|P4|COMPLETED|Maintenance Study||246
8219012|NCT02065622|20269481|P3|COMPLETED|Maintenance Study||221
8219013|NCT02065622|20269482|P2|COMPLETED|Maintenance Study||0
8219014|NCT02065622|20269483|P1|COMPLETED|Maintenance Study||0
8219015|NCT02065622|20269479|P5|STARTED|Maintenance Study||151
8219016|NCT02065622|20269480|P4|STARTED|Maintenance Study||350
8219017|NCT02065622|20269481|P3|STARTED|Maintenance Study||345
8219018|NCT02065622|20269482|P2|STARTED|Maintenance Study||0
8219019|NCT02065622|20269483|P1|STARTED|Maintenance Study||0
8219020|NCT02065622|20269479|P5|NOT COMPLETED|Induction Study||0
8219021|NCT02065622|20269480|P4|NOT COMPLETED|Induction Study||0
8219022|NCT02065622|20269481|P3|NOT COMPLETED|Induction Study||0
8219023|NCT02065622|20269482|P2|NOT COMPLETED|Induction Study||59
8219024|NCT02065622|20269483|P1|NOT COMPLETED|Induction Study||47
8219025|NCT02065622|20269479|P5|COMPLETED|Induction Study||0
8219026|NCT02065622|20269480|P4|COMPLETED|Induction Study||0
8219027|NCT02065622|20269481|P3|COMPLETED|Induction Study||0
8219028|NCT02065622|20269482|P2|COMPLETED|Induction Study||514
8219029|NCT02065622|20269483|P1|COMPLETED|Induction Study||332
8219030|NCT02065622|20269479|P5|Enrolled in Japan Sub-Study|Induction Study||0
8219031|NCT02065622|20269480|P4|Enrolled in Japan Sub-Study|Induction Study||0
8219032|NCT02065622|20269481|P3|Enrolled in Japan Sub-Study|Induction Study||0
8219033|NCT02065622|20269482|P2|Enrolled in Japan Sub-Study|Induction Study||61
8219034|NCT02065622|20269483|P1|Enrolled in Japan Sub-Study|Induction Study||39
8219035|NCT02065622|20269479|P5|Enrolled in Main Study|Induction Study||0
8219036|NCT02065622|20269480|P4|Enrolled in Main Study|Induction Study||0
8219037|NCT02065622|20269481|P3|Enrolled in Main Study|Induction Study||0
8219038|NCT02065622|20269482|P2|Enrolled in Main Study|Induction Study||512
8219039|NCT02065622|20269483|P1|Enrolled in Main Study|Induction Study||340
8219040|NCT02065622|20269479|P5|STARTED|Induction Study||0
8219041|NCT02065622|20269480|P4|STARTED|Induction Study||0
8219042|NCT02065622|20269481|P3|STARTED|Induction Study||0
8219043|NCT02065622|20269482|P2|STARTED|Induction Study||573
8219044|NCT02065622|20269483|P1|STARTED|Induction Study||379
8219045|NCT02065557|20269585|P6|NOT COMPLETED|Maintenance Period||4
8219046|NCT02065557|20269586|P5|NOT COMPLETED|Maintenance Period||8
8219047|NCT02065557|20269587|P4|NOT COMPLETED|Maintenance Period||1
8219048|NCT02065557|20269588|P3|NOT COMPLETED|Maintenance Period||0
8219049|NCT02065557|20269589|P2|NOT COMPLETED|Maintenance Period||0
8219050|NCT02065557|20269590|P1|NOT COMPLETED|Maintenance Period||0
8219051|NCT02065557|20269585|P6|COMPLETED|Maintenance Period||32
8219052|NCT02065557|20269586|P5|COMPLETED|Maintenance Period||25
8219053|NCT02065557|20269587|P4|COMPLETED|Maintenance Period||11
8219054|NCT02065557|20269588|P3|COMPLETED|Maintenance Period||0
8219055|NCT02065557|20269589|P2|COMPLETED|Maintenance Period||0
8219056|NCT02065557|20269590|P1|COMPLETED|Maintenance Period||0
8219057|NCT02065557|20269585|P6|STARTED|Maintenance Period||36
8219058|NCT02065557|20269586|P5|STARTED|Maintenance Period||33
8219059|NCT02065557|20269587|P4|STARTED|Maintenance Period||12
8219060|NCT02065557|20269588|P3|STARTED|Maintenance Period||0
8219061|NCT02065557|20269589|P2|STARTED|Maintenance Period||0
8219062|NCT02065557|20269590|P1|STARTED|Maintenance Period||0
8219063|NCT02065557|20269585|P6|NOT COMPLETED|Induction Period||0
8219064|NCT02065557|20269586|P5|NOT COMPLETED|Induction Period||0
8219065|NCT02065557|20269587|P4|NOT COMPLETED|Induction Period||0
8219066|NCT02065557|20269588|P3|NOT COMPLETED|Induction Period||2
8219067|NCT02065557|20269589|P2|NOT COMPLETED|Induction Period||8
8219068|NCT02065557|20269590|P1|NOT COMPLETED|Induction Period||10
8219069|NCT02065557|20269585|P6|COMPLETED|Induction Period||0
8219070|NCT02065557|20269586|P5|COMPLETED|Induction Period||0
8219071|NCT02065557|20269587|P4|COMPLETED|Induction Period||0
8219072|NCT02065557|20269588|P3|COMPLETED|Induction Period||16
8219073|NCT02065557|20269589|P2|COMPLETED|Induction Period||43
8219074|NCT02065557|20269590|P1|COMPLETED|Induction Period||22
8219075|NCT02065557|20269585|P6|Enrolled in Japan Sub-study|Induction Period||0
8219076|NCT02065557|20269586|P5|Enrolled in Japan Sub-study|Induction Period||0
8219077|NCT02065557|20269587|P4|Enrolled in Japan Sub-study|Induction Period||0
8219078|NCT02065557|20269588|P3|Enrolled in Japan Sub-study|Induction Period||2
8219079|NCT02065557|20269589|P2|Enrolled in Japan Sub-study|Induction Period||4
8219080|NCT02065557|20269590|P1|Enrolled in Japan Sub-study|Induction Period||2
8219081|NCT02065557|20269585|P6|Enrolled in Main Study|Induction Period||0
8219082|NCT02065557|20269586|P5|Enrolled in Main Study|Induction Period||0
8219083|NCT02065557|20269587|P4|Enrolled in Main Study|Induction Period||0
8219084|NCT02065557|20269588|P3|Enrolled in Main Study|Induction Period||16
8219085|NCT02065557|20269589|P2|Enrolled in Main Study|Induction Period||47
8219086|NCT02065557|20269590|P1|Enrolled in Main Study|Induction Period||30
8219087|NCT02065557|20269585|P6|STARTED|Induction Period||0
8219088|NCT02065557|20269586|P5|STARTED|Induction Period||0
8219089|NCT02065557|20269587|P4|STARTED|Induction Period||0
8219090|NCT02065557|20269588|P3|STARTED|Induction Period||18
8219091|NCT02065557|20269589|P2|STARTED|Induction Period||51
8219092|NCT02065557|20269590|P1|STARTED|Induction Period||32
8219093|NCT02065518|20269651|P4|NOT COMPLETED|Overall Study||5
8219094|NCT02065518|20269652|P3|NOT COMPLETED|Overall Study||9
8219095|NCT02065518|20269653|P2|NOT COMPLETED|Overall Study||8
8219096|NCT02065518|20269654|P1|NOT COMPLETED|Overall Study||6
8219097|NCT02065518|20269651|P4|COMPLETED|Overall Study||15
8219098|NCT02065518|20269652|P3|COMPLETED|Overall Study||11
8219099|NCT02065518|20269653|P2|COMPLETED|Overall Study||11
8219100|NCT02065518|20269654|P1|COMPLETED|Overall Study||13
8219101|NCT02065518|20269651|P4|STARTED|Overall Study||20
8219102|NCT02065518|20269652|P3|STARTED|Overall Study||20
8219103|NCT02065518|20269653|P2|STARTED|Overall Study||19
8219104|NCT02065518|20269654|P1|STARTED|Overall Study||19
8219105|NCT02065479|20269706|P2|NOT COMPLETED|Overall Study||0
8219106|NCT02065479|20269707|P1|NOT COMPLETED|Overall Study||0
8219107|NCT02065479|20269706|P2|COMPLETED|Overall Study||32
8219108|NCT02065479|20269707|P1|COMPLETED|Overall Study||33
8219109|NCT02065479|20269706|P2|STARTED|Overall Study||32
8219110|NCT02065479|20269707|P1|STARTED|Overall Study||33
8219111|NCT02065453|20269715|P2|NOT COMPLETED|Overall Study||4
8219112|NCT02065453|20269716|P1|NOT COMPLETED|Overall Study||3
8219113|NCT02065453|20269715|P2|COMPLETED|Overall Study||21
8219114|NCT02065453|20269716|P1|COMPLETED|Overall Study||24
8219115|NCT02065453|20269715|P2|STARTED|Overall Study||25
8219116|NCT02065453|20269716|P1|STARTED|Overall Study||27
8219117|NCT02065336|20269729|P10|NOT COMPLETED|Extension Phase||8
8219118|NCT02065336|20269730|P9|NOT COMPLETED|Extension Phase||2
8219119|NCT02065336|20269731|P8|NOT COMPLETED|Extension Phase||0
8219120|NCT02065336|20269732|P7|NOT COMPLETED|Extension Phase||0
8219121|NCT02065336|20269733|P6|NOT COMPLETED|Extension Phase||0
8219122|NCT02065336|20269734|P5|NOT COMPLETED|Extension Phase||0
8219123|NCT02065336|20269735|P4|NOT COMPLETED|Extension Phase||0
8219124|NCT02065336|20269736|P3|NOT COMPLETED|Extension Phase||0
8219125|NCT02065336|20269737|P2|NOT COMPLETED|Extension Phase||0
8219126|NCT02065336|20269738|P1|NOT COMPLETED|Extension Phase||0
8219127|NCT02065336|20269729|P10|COMPLETED|Extension Phase||0
8219128|NCT02065336|20269730|P9|COMPLETED|Extension Phase||0
8219129|NCT02065336|20269731|P8|COMPLETED|Extension Phase||0
8219130|NCT02065336|20269732|P7|COMPLETED|Extension Phase||0
8219131|NCT02065336|20269733|P6|COMPLETED|Extension Phase||0
8219132|NCT02065336|20269734|P5|COMPLETED|Extension Phase||0
8219133|NCT02065336|20269735|P4|COMPLETED|Extension Phase||0
8219134|NCT02065336|20269736|P3|COMPLETED|Extension Phase||0
8219135|NCT02065336|20269737|P2|COMPLETED|Extension Phase||0
8219136|NCT02065336|20269738|P1|COMPLETED|Extension Phase||0
8219137|NCT02065336|20269729|P10|STARTED|Extension Phase||8
8219138|NCT02065336|20269730|P9|STARTED|Extension Phase||2
8219139|NCT02065336|20269731|P8|STARTED|Extension Phase||0
8219140|NCT02065336|20269732|P7|STARTED|Extension Phase||0
8219141|NCT02065336|20269733|P6|STARTED|Extension Phase||0
8219142|NCT02065336|20269734|P5|STARTED|Extension Phase||0
8219143|NCT02065336|20269735|P4|STARTED|Extension Phase||0
8219144|NCT02065336|20269736|P3|STARTED|Extension Phase||0
8219145|NCT02065336|20269737|P2|STARTED|Extension Phase||0
8219146|NCT02065336|20269738|P1|STARTED|Extension Phase||0
8219147|NCT02065336|20269729|P10|NOT COMPLETED|Main Study||0
8219148|NCT02065336|20269730|P9|NOT COMPLETED|Main Study||0
8219149|NCT02065336|20269731|P8|NOT COMPLETED|Main Study||0
8219150|NCT02065336|20269732|P7|NOT COMPLETED|Main Study||0
8219151|NCT02065336|20269733|P6|NOT COMPLETED|Main Study||0
8219152|NCT02065336|20269734|P5|NOT COMPLETED|Main Study||0
8219153|NCT02065336|20269735|P4|NOT COMPLETED|Main Study||0
8219154|NCT02065336|20269736|P3|NOT COMPLETED|Main Study||0
8219155|NCT02065336|20269737|P2|NOT COMPLETED|Main Study||0
8219156|NCT02065336|20269738|P1|NOT COMPLETED|Main Study||0
8219157|NCT02065336|20269729|P10|COMPLETED|Main Study||0
8219158|NCT02065336|20269730|P9|COMPLETED|Main Study||0
8219159|NCT02065336|20269731|P8|COMPLETED|Main Study||10
8219160|NCT02065336|20269732|P7|COMPLETED|Main Study||12
8219161|NCT02065336|20269733|P6|COMPLETED|Main Study||6
8219162|NCT02065336|20269734|P5|COMPLETED|Main Study||6
8219163|NCT02065336|20269735|P4|COMPLETED|Main Study||6
8219164|NCT02065336|20269736|P3|COMPLETED|Main Study||6
8219165|NCT02065336|20269737|P2|COMPLETED|Main Study||6
8219166|NCT02065336|20269738|P1|COMPLETED|Main Study||6
8219167|NCT02065336|20269729|P10|STARTED|Main Study||0
8219168|NCT02065336|20269730|P9|STARTED|Main Study||0
8219169|NCT02065336|20269731|P8|STARTED|Main Study||10
8219170|NCT02065336|20269732|P7|STARTED|Main Study||12
8219171|NCT02065336|20269733|P6|STARTED|Main Study||6
8219172|NCT02065336|20269734|P5|STARTED|Main Study||6
8219173|NCT02065336|20269735|P4|STARTED|Main Study||6
8219174|NCT02065336|20269736|P3|STARTED|Main Study||6
8219175|NCT02065336|20269737|P2|STARTED|Main Study||6
8219176|NCT02065336|20269738|P1|STARTED|Main Study||6
8219177|NCT02064985|20269833|P3|NOT COMPLETED|Overall Study||0
8219178|NCT02064985|20269834|P2|NOT COMPLETED|Overall Study||0
8219179|NCT02064985|20269835|P1|NOT COMPLETED|Overall Study||0
8219180|NCT02064985|20269833|P3|COMPLETED|Overall Study||12
8219181|NCT02064985|20269834|P2|COMPLETED|Overall Study||12
8219182|NCT02064985|20269835|P1|COMPLETED|Overall Study||12
8219183|NCT02064985|20269833|P3|STARTED|Overall Study||12
8219184|NCT02064985|20269834|P2|STARTED|Overall Study||12
8219185|NCT02064985|20269835|P1|STARTED|Overall Study||12
8219186|NCT02064959|20269998|P2|NOT COMPLETED|Overall Study||0
8219187|NCT02064959|20269999|P1|NOT COMPLETED|Overall Study||0
8219188|NCT02064959|20269998|P2|COMPLETED|Overall Study||16
8219189|NCT02064959|20269999|P1|COMPLETED|Overall Study||16
8219190|NCT02064959|20269998|P2|STARTED|Overall Study||16
8219191|NCT02064959|20269999|P1|STARTED|Overall Study||16
8219192|NCT02064920|20270015|P2|NOT COMPLETED|Overall Study||9
8219193|NCT02064920|20270016|P1|NOT COMPLETED|Overall Study||1
8219194|NCT02064920|20270015|P2|COMPLETED|Overall Study||21
8219195|NCT02064920|20270016|P1|COMPLETED|Overall Study||5
8219196|NCT02064920|20270015|P2|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
8219197|NCT02064920|20270016|P1|Treated|Overall Study||6
8219198|NCT02064920|20270015|P2|STARTED|Overall Study||30
8219199|NCT02064920|20270016|P1|STARTED|Overall Study||6
8219200|NCT02064907|20270026|P2|NOT COMPLETED|Period 2||0
8219201|NCT02064907|20270027|P1|NOT COMPLETED|Period 2||0
8219202|NCT02064907|20270026|P2|COMPLETED|Period 2||26
8219203|NCT02064907|20270027|P1|COMPLETED|Period 2||26
8219204|NCT02064907|20270026|P2|STARTED|Period 2||26
8219205|NCT02064907|20270027|P1|STARTED|Period 2||26
8219206|NCT02064907|20270026|P2|NOT COMPLETED|Period 1||0
8219207|NCT02064907|20270027|P1|NOT COMPLETED|Period 1||0
8219208|NCT02064907|20270026|P2|COMPLETED|Period 1||26
8219209|NCT02064907|20270027|P1|COMPLETED|Period 1||26
8219210|NCT02064907|20270026|P2|STARTED|Period 1||26
8219211|NCT02064907|20270027|P1|STARTED|Period 1||26
8219212|NCT02064894|20270046|P3|NOT COMPLETED|Overall Study||115
8219213|NCT02064894|20270047|P2|NOT COMPLETED|Overall Study||102
8219214|NCT02064894|20270048|P1|NOT COMPLETED|Overall Study||43
8219215|NCT02064894|20270046|P3|COMPLETED|Overall Study||86
8219216|NCT02064894|20270047|P2|COMPLETED|Overall Study||99
8219217|NCT02064894|20270048|P1|COMPLETED|Overall Study||56
8219218|NCT02064894|20270046|P3|Avalaible at T-90|Overall Study||129
8219219|NCT02064894|20270047|P2|Avalaible at T-90|Overall Study||134
8219220|NCT02064894|20270048|P1|Avalaible at T-90|Overall Study||74
8219221|NCT02064894|20270046|P3|Available at T-60|Overall Study||177
8219222|NCT02064894|20270047|P2|Available at T-60|Overall Study||188
8219223|NCT02064894|20270048|P1|Available at T-60|Overall Study||91
8219224|NCT02064894|20270046|P3|STARTED|Overall Study|"Received allocated intervention (n=199)
~Did not receive allocated intervention (n=2)"|201
8219225|NCT02064894|20270047|P2|STARTED|Overall Study|"Received allocated intervention (n=198)
~Did not receive allocated intervention (n=3)"|201
8219226|NCT02064894|20270048|P1|STARTED|Overall Study|"Received allocated intervention (n=98)
~Did not receive intervention (n=1)"|99
8219227|NCT02064868|20270061|P2|NOT COMPLETED|Overall Study||13
8219228|NCT02064868|20270062|P1|NOT COMPLETED|Overall Study||34
8219229|NCT02064868|20270061|P2|COMPLETED|Overall Study||881
8219230|NCT02064868|20270062|P1|COMPLETED|Overall Study||1722
8219231|NCT02064868|20270061|P2|Per Protocol Set|Overall Study||627
8219232|NCT02064868|20270062|P1|Per Protocol Set|Overall Study||1155
8219233|NCT02064868|20270061|P2|Safety Set|Overall Study||894
8219234|NCT02064868|20270062|P1|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729
8219235|NCT02064868|20270061|P2|Full Analysis Set|Overall Study||894
8219236|NCT02064868|20270062|P1|Full Analysis Set|Overall Study||1756
8219237|NCT02064868|20270061|P2|STARTED|Overall Study||894
8219238|NCT02064868|20270062|P1|STARTED|Overall Study||1756
8219239|NCT02064816|20270082|P2|NOT COMPLETED|Overall Study||8
8219240|NCT02064816|20270083|P1|NOT COMPLETED|Overall Study||8
8219241|NCT02064816|20270082|P2|COMPLETED|Overall Study||88
8219242|NCT02064816|20270083|P1|COMPLETED|Overall Study||96
8219243|NCT02064816|20270082|P2|STARTED|Overall Study||96
8219244|NCT02064816|20270083|P1|STARTED|Overall Study||104
8219245|NCT02064582|20270121|P1|NOT COMPLETED|Overall Study||0
8219246|NCT02064582|20270121|P1|COMPLETED|Overall Study||7
8219247|NCT02064582|20270121|P1|STARTED|Overall Study||7
8219248|NCT02064439|20270129|P3|NOT COMPLETED|Overall Study||182
8219249|NCT02064439|20270130|P2|NOT COMPLETED|Overall Study||138
8219250|NCT02064439|20270131|P1|NOT COMPLETED|Overall Study||143
8219251|NCT02064439|20270129|P3|COMPLETED|Overall Study||949
8219252|NCT02064439|20270130|P2|COMPLETED|Overall Study||969
8219253|NCT02064439|20270131|P1|COMPLETED|Overall Study||984
8219254|NCT02064439|20270129|P3|STARTED|Overall Study|FAS, randomized and received study medication|1131
8219255|NCT02064439|20270130|P2|STARTED|Overall Study|FAS, randomized and received study medication|1107
8219256|NCT02064439|20270131|P1|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
8219257|NCT02064387|20270160|P12|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||3
8219258|NCT02064387|20270161|P11|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||6
8219259|NCT02064387|20270162|P10|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219260|NCT02064387|20270163|P9|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219261|NCT02064387|20270164|P8|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219262|NCT02064387|20270165|P7|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219263|NCT02064387|20270166|P6|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219264|NCT02064387|20270167|P5|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219265|NCT02064387|20270168|P4|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219266|NCT02064387|20270169|P3|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219267|NCT02064387|20270170|P2|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219268|NCT02064387|20270171|P1|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219269|NCT02064387|20270160|P12|COMPLETED|Part 2 Max 35 Months Followup Duration||3
8219270|NCT02064387|20270161|P11|COMPLETED|Part 2 Max 35 Months Followup Duration||29
8219271|NCT02064387|20270162|P10|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219272|NCT02064387|20270163|P9|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219273|NCT02064387|20270164|P8|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219274|NCT02064387|20270165|P7|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219275|NCT02064387|20270166|P6|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219276|NCT02064387|20270167|P5|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219277|NCT02064387|20270168|P4|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219278|NCT02064387|20270169|P3|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219279|NCT02064387|20270170|P2|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219280|NCT02064387|20270171|P1|COMPLETED|Part 2 Max 35 Months Followup Duration||0
8219281|NCT02064387|20270160|P12|STARTED|Part 2 Max 35 Months Followup Duration||6
8219282|NCT02064387|20270161|P11|STARTED|Part 2 Max 35 Months Followup Duration||35
8219283|NCT02064387|20270162|P10|STARTED|Part 2 Max 35 Months Followup Duration||0
8219284|NCT02064387|20270163|P9|STARTED|Part 2 Max 35 Months Followup Duration||0
8219285|NCT02064387|20270164|P8|STARTED|Part 2 Max 35 Months Followup Duration||0
8219286|NCT02064387|20270165|P7|STARTED|Part 2 Max 35 Months Followup Duration||0
8219287|NCT02064387|20270166|P6|STARTED|Part 2 Max 35 Months Followup Duration||0
8219288|NCT02064387|20270167|P5|STARTED|Part 2 Max 35 Months Followup Duration||0
8219289|NCT02064387|20270168|P4|STARTED|Part 2 Max 35 Months Followup Duration||0
8219290|NCT02064387|20270169|P3|STARTED|Part 2 Max 35 Months Followup Duration||0
8219291|NCT02064387|20270170|P2|STARTED|Part 2 Max 35 Months Followup Duration||0
8219292|NCT02064387|20270171|P1|STARTED|Part 2 Max 35 Months Followup Duration||0
8219293|NCT02064387|20270160|P12|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219294|NCT02064387|20270161|P11|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219295|NCT02064387|20270162|P10|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
8219296|NCT02064387|20270163|P9|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
8219297|NCT02064387|20270164|P8|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
8219298|NCT02064387|20270165|P7|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219299|NCT02064387|20270166|P6|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219300|NCT02064387|20270167|P5|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219301|NCT02064387|20270168|P4|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219302|NCT02064387|20270169|P3|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219303|NCT02064387|20270170|P2|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219304|NCT02064387|20270171|P1|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219305|NCT02064387|20270160|P12|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219306|NCT02064387|20270161|P11|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
8219307|NCT02064387|20270162|P10|COMPLETED|Part 1 Max 23.5 Months Followup Duration||5
8219308|NCT02064387|20270163|P9|COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
8219309|NCT02064387|20270164|P8|COMPLETED|Part 1 Max 23.5 Months Followup Duration||6
8219310|NCT02064387|20270165|P7|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
8219311|NCT02064387|20270166|P6|COMPLETED|Part 1 Max 23.5 Months Followup Duration||3
8219312|NCT02064387|20270167|P5|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
8219313|NCT02064387|20270168|P4|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
8219314|NCT02064387|20270169|P3|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
8219315|NCT02064387|20270170|P2|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
8219316|NCT02064387|20270171|P1|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
8219317|NCT02064387|20270160|P12|STARTED|Part 1 Max 23.5 Months Followup Duration||0
8219318|NCT02064387|20270161|P11|STARTED|Part 1 Max 23.5 Months Followup Duration||0
8219319|NCT02064387|20270162|P10|STARTED|Part 1 Max 23.5 Months Followup Duration||6
8219320|NCT02064387|20270163|P9|STARTED|Part 1 Max 23.5 Months Followup Duration||3
8219321|NCT02064387|20270164|P8|STARTED|Part 1 Max 23.5 Months Followup Duration||8
8219322|NCT02064387|20270165|P7|STARTED|Part 1 Max 23.5 Months Followup Duration||4
8219323|NCT02064387|20270166|P6|STARTED|Part 1 Max 23.5 Months Followup Duration||3
8219324|NCT02064387|20270167|P5|STARTED|Part 1 Max 23.5 Months Followup Duration||4
8219325|NCT02064387|20270168|P4|STARTED|Part 1 Max 23.5 Months Followup Duration||4
8219326|NCT02064387|20270169|P3|STARTED|Part 1 Max 23.5 Months Followup Duration||4
8219327|NCT02064387|20270170|P2|STARTED|Part 1 Max 23.5 Months Followup Duration||1
8219328|NCT02064387|20270171|P1|STARTED|Part 1 Max 23.5 Months Followup Duration||1
8219329|NCT02064270|20270484|P2|NOT COMPLETED|Overall Study||32
8219330|NCT02064270|20270485|P1|NOT COMPLETED|Overall Study||62
8219331|NCT02064270|20270484|P2|COMPLETED|Overall Study||231
8219332|NCT02064270|20270485|P1|COMPLETED|Overall Study||201
8219333|NCT02064270|20270484|P2|STARTED|Overall Study||263
8219334|NCT02064270|20270485|P1|STARTED|Overall Study||263
8219335|NCT02064231|20270500|P4|NOT COMPLETED|Third Test Period (Own Product)||0
8219336|NCT02064231|20270501|P3|NOT COMPLETED|Third Test Period (Own Product)||0
8219337|NCT02064231|20270502|P2|NOT COMPLETED|Third Test Period (Own Product)||0
8219338|NCT02064231|20270503|P1|NOT COMPLETED|Third Test Period (Own Product)||0
8219339|NCT02064231|20270500|P4|COMPLETED|Third Test Period (Own Product)||1
8219340|NCT02064231|20270501|P3|COMPLETED|Third Test Period (Own Product)||0
8219341|NCT02064231|20270502|P2|COMPLETED|Third Test Period (Own Product)||8
8219342|NCT02064231|20270503|P1|COMPLETED|Third Test Period (Own Product)||8
8219343|NCT02064231|20270500|P4|STARTED|Third Test Period (Own Product)||1
8219344|NCT02064231|20270501|P3|STARTED|Third Test Period (Own Product)||0
8219345|NCT02064231|20270502|P2|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
8219346|NCT02064231|20270503|P1|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
8219347|NCT02064231|20270500|P4|NOT COMPLETED|Second Test Period (Test B or Test D)||0
8219348|NCT02064231|20270501|P3|NOT COMPLETED|Second Test Period (Test B or Test D)||0
8219349|NCT02064231|20270502|P2|NOT COMPLETED|Second Test Period (Test B or Test D)||1
8219350|NCT02064231|20270503|P1|NOT COMPLETED|Second Test Period (Test B or Test D)||1
8219351|NCT02064231|20270500|P4|COMPLETED|Second Test Period (Test B or Test D)||1
8219352|NCT02064231|20270501|P3|COMPLETED|Second Test Period (Test B or Test D)||0
8219353|NCT02064231|20270502|P2|COMPLETED|Second Test Period (Test B or Test D)||7
8219354|NCT02064231|20270503|P1|COMPLETED|Second Test Period (Test B or Test D)||6
8219355|NCT02064231|20270500|P4|STARTED|Second Test Period (Test B or Test D)||1
8219356|NCT02064231|20270501|P3|STARTED|Second Test Period (Test B or Test D)||0
8219357|NCT02064231|20270502|P2|STARTED|Second Test Period (Test B or Test D)||8
8219358|NCT02064231|20270503|P1|STARTED|Second Test Period (Test B or Test D)||7
8219359|NCT02064231|20270500|P4|NOT COMPLETED|First Test Period (Test A or Test C)||0
8219360|NCT02064231|20270501|P3|NOT COMPLETED|First Test Period (Test A or Test C)||1
8219361|NCT02064231|20270502|P2|NOT COMPLETED|First Test Period (Test A or Test C)||4
8219362|NCT02064231|20270503|P1|NOT COMPLETED|First Test Period (Test A or Test C)||7
8219363|NCT02064231|20270500|P4|COMPLETED|First Test Period (Test A or Test C)||1
8219364|NCT02064231|20270501|P3|COMPLETED|First Test Period (Test A or Test C)||0
8219365|NCT02064231|20270502|P2|COMPLETED|First Test Period (Test A or Test C)||8
8219366|NCT02064231|20270503|P1|COMPLETED|First Test Period (Test A or Test C)||7
8219367|NCT02064231|20270500|P4|STARTED|First Test Period (Test A or Test C)||1
8219368|NCT02064231|20270501|P3|STARTED|First Test Period (Test A or Test C)||1
8219369|NCT02064231|20270502|P2|STARTED|First Test Period (Test A or Test C)||12
8219370|NCT02064231|20270503|P1|STARTED|First Test Period (Test A or Test C)||14
8219371|NCT02064205|20270515|P1|NOT COMPLETED|Overall Study||1
8219372|NCT02064205|20270515|P1|COMPLETED|Overall Study||31
8219373|NCT02064205|20270515|P1|Condition D|Overall Study||32
8219374|NCT02064205|20270515|P1|Condition C|Overall Study||31
8219375|NCT02064205|20270515|P1|Condition B|Overall Study||32
8219376|NCT02064205|20270515|P1|Condition A|Overall Study||32
8219377|NCT02064205|20270515|P1|STARTED|Overall Study||32
8219378|NCT02064166|20270533|P2|NOT COMPLETED|Overall Study||0
8219379|NCT02064166|20270534|P1|NOT COMPLETED|Overall Study||1
8219380|NCT02064166|20270533|P2|COMPLETED|Overall Study||6
8219381|NCT02064166|20270534|P1|COMPLETED|Overall Study||8
8219382|NCT02064166|20270533|P2|STARTED|Overall Study||6
8219383|NCT02064166|20270534|P1|STARTED|Overall Study||9
8219384|NCT02063880|20270564|P2|NOT COMPLETED|Overall Study||27
8219385|NCT02063880|20270565|P1|NOT COMPLETED|Overall Study||28
8219386|NCT02063880|20270564|P2|COMPLETED|Overall Study||66
8219387|NCT02063880|20270565|P1|COMPLETED|Overall Study||62
8219388|NCT02063880|20270564|P2|STARTED|Overall Study||93
8219389|NCT02063880|20270565|P1|STARTED|Overall Study||90
8219390|NCT02063867|20270577|P2|NOT COMPLETED|Overall Study||2965
8219391|NCT02063867|20270578|P1|NOT COMPLETED|Overall Study||4291
8219392|NCT02063867|20270577|P2|COMPLETED|Overall Study||180048
8219393|NCT02063867|20270578|P1|COMPLETED|Overall Study||152598
8219394|NCT02063867|20270577|P2|STARTED|Overall Study||183013
8219395|NCT02063867|20270578|P1|STARTED|Overall Study||156889
8219396|NCT02063854|20270603|P7|NOT COMPLETED|Overall Study||6
8219397|NCT02063854|20270604|P6|NOT COMPLETED|Overall Study||31
8219398|NCT02063854|20270605|P5|NOT COMPLETED|Overall Study||11
8219399|NCT02063854|20270606|P4|NOT COMPLETED|Overall Study||10
8219400|NCT02063854|20270607|P3|NOT COMPLETED|Overall Study||30
8219401|NCT02063854|20270608|P2|NOT COMPLETED|Overall Study||12
8219402|NCT02063854|20270609|P1|NOT COMPLETED|Overall Study||21
8219403|NCT02063854|20270603|P7|COMPLETED|Overall Study||60
8219404|NCT02063854|20270604|P6|COMPLETED|Overall Study||170
8219405|NCT02063854|20270605|P5|COMPLETED|Overall Study||54
8219406|NCT02063854|20270606|P4|COMPLETED|Overall Study||58
8219407|NCT02063854|20270607|P3|COMPLETED|Overall Study||176
8219408|NCT02063854|20270608|P2|COMPLETED|Overall Study||54
8219409|NCT02063854|20270609|P1|COMPLETED|Overall Study||178
8219410|NCT02063854|20270603|P7|Full Analysis Set: Received Study Drug|Overall Study||66
8219411|NCT02063854|20270604|P6|Full Analysis Set: Received Study Drug|Overall Study||200
8219412|NCT02063854|20270605|P5|Full Analysis Set: Received Study Drug|Overall Study||65
8219413|NCT02063854|20270606|P4|Full Analysis Set: Received Study Drug|Overall Study||68
8219414|NCT02063854|20270607|P3|Full Analysis Set: Received Study Drug|Overall Study||206
8219415|NCT02063854|20270608|P2|Full Analysis Set: Received Study Drug|Overall Study||66
8219416|NCT02063854|20270609|P1|Full Analysis Set: Received Study Drug|Overall Study||199
8219417|NCT02063854|20270603|P7|STARTED|Overall Study||66
8219418|NCT02063854|20270604|P6|STARTED|Overall Study||201
8219419|NCT02063854|20270605|P5|STARTED|Overall Study||65
8219420|NCT02063854|20270606|P4|STARTED|Overall Study||68
8219421|NCT02063854|20270607|P3|STARTED|Overall Study||206
8219422|NCT02063854|20270608|P2|STARTED|Overall Study||66
8219423|NCT02063854|20270609|P1|STARTED|Overall Study||199
8219424|NCT02063737|20270693|P2|NOT COMPLETED|Overall Study||4
8219425|NCT02063737|20270694|P1|NOT COMPLETED|Overall Study||11
8219426|NCT02063737|20270693|P2|COMPLETED|Overall Study||44
8219427|NCT02063737|20270694|P1|COMPLETED|Overall Study||41
8219428|NCT02063737|20270693|P2|STARTED|Overall Study||48
8219429|NCT02063737|20270694|P1|STARTED|Overall Study||52
8219433|NCT02063698|20270734|P2|NOT COMPLETED|Overall Study||2
8219434|NCT02063698|20270735|P1|NOT COMPLETED|Overall Study||1
8219435|NCT02063698|20270734|P2|COMPLETED|Overall Study||13
8219436|NCT02063698|20270735|P1|COMPLETED|Overall Study||14
8219437|NCT02063698|20270734|P2|STARTED|Overall Study||15
8219438|NCT02063698|20270735|P1|STARTED|Overall Study||15
8219439|NCT02063672|20270759|P2|NOT COMPLETED|Overall Study||22
8219440|NCT02063672|20270760|P1|NOT COMPLETED|Overall Study||35
8219441|NCT02063672|20270759|P2|COMPLETED|Overall Study||7
8219442|NCT02063672|20270760|P1|COMPLETED|Overall Study||18
8219443|NCT02063672|20270759|P2|STARTED|Overall Study||29
8219444|NCT02063672|20270760|P1|STARTED|Overall Study||53
8219445|NCT02063659|20270807|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||20
8219446|NCT02063659|20270808|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8219447|NCT02063659|20270809|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8219448|NCT02063659|20270810|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8219449|NCT02063659|20270807|P4|COMPLETED|Open-Label Extension Period (OLE)||47
8219450|NCT02063659|20270808|P3|COMPLETED|Open-Label Extension Period (OLE)||0
8219451|NCT02063659|20270809|P2|COMPLETED|Open-Label Extension Period (OLE)||0
8219452|NCT02063659|20270810|P1|COMPLETED|Open-Label Extension Period (OLE)||0
8219453|NCT02063659|20270807|P4|STARTED|Open-Label Extension Period (OLE)||67
8219454|NCT02063659|20270808|P3|STARTED|Open-Label Extension Period (OLE)||0
8219455|NCT02063659|20270809|P2|STARTED|Open-Label Extension Period (OLE)||0
8219456|NCT02063659|20270810|P1|STARTED|Open-Label Extension Period (OLE)||0
8219457|NCT02063659|20270807|P4|NOT COMPLETED|Double-Blind Treatment Period||0
8219458|NCT02063659|20270808|P3|NOT COMPLETED|Double-Blind Treatment Period||3
8219459|NCT02063659|20270809|P2|NOT COMPLETED|Double-Blind Treatment Period||3
8219460|NCT02063659|20270810|P1|NOT COMPLETED|Double-Blind Treatment Period||2
8219461|NCT02063659|20270807|P4|COMPLETED|Double-Blind Treatment Period||0
8219462|NCT02063659|20270808|P3|COMPLETED|Double-Blind Treatment Period||22
8219463|NCT02063659|20270809|P2|COMPLETED|Double-Blind Treatment Period||22
8219464|NCT02063659|20270810|P1|COMPLETED|Double-Blind Treatment Period||24
8219465|NCT02063659|20270807|P4|STARTED|Double-Blind Treatment Period||0
8219466|NCT02063659|20270808|P3|STARTED|Double-Blind Treatment Period||25
8219467|NCT02063659|20270809|P2|STARTED|Double-Blind Treatment Period||25
8219468|NCT02063659|20270810|P1|STARTED|Double-Blind Treatment Period||26
8219469|NCT02063516|20270842|P2|NOT COMPLETED|Overall Study||0
8219470|NCT02063516|20270843|P1|NOT COMPLETED|Overall Study||0
8219471|NCT02063516|20270842|P2|COMPLETED|Overall Study||40
8219472|NCT02063516|20270843|P1|COMPLETED|Overall Study||40
8219473|NCT02063516|20270842|P2|STARTED|Overall Study||40
8219474|NCT02063516|20270843|P1|STARTED|Overall Study||40
8219475|NCT02063230|20270857|P4|NOT COMPLETED|Overall Study||0
8219476|NCT02063230|20270858|P3|NOT COMPLETED|Overall Study||0
8219477|NCT02063230|20270859|P2|NOT COMPLETED|Overall Study||0
8219478|NCT02063230|20270860|P1|NOT COMPLETED|Overall Study||0
8219479|NCT02063230|20270857|P4|COMPLETED|Overall Study||8
8219480|NCT02063230|20270858|P3|COMPLETED|Overall Study||8
8219481|NCT02063230|20270859|P2|COMPLETED|Overall Study||8
8219482|NCT02063230|20270860|P1|COMPLETED|Overall Study||8
8219483|NCT02063230|20270857|P4|Received Treatment|Overall Study||8
8219484|NCT02063230|20270858|P3|Received Treatment|Overall Study||8
8219485|NCT02063230|20270859|P2|Received Treatment|Overall Study||8
8219486|NCT02063230|20270860|P1|Received Treatment|Overall Study||8
8219487|NCT02063230|20270857|P4|STARTED|Overall Study||8
8219488|NCT02063230|20270858|P3|STARTED|Overall Study||8
8219489|NCT02063230|20270859|P2|STARTED|Overall Study||8
8219490|NCT02063230|20270860|P1|STARTED|Overall Study||8
8219491|NCT02063217|20270893|P3|NOT COMPLETED|Overall Study||0
8219492|NCT02063217|20270894|P2|NOT COMPLETED|Overall Study||0
8219493|NCT02063217|20270895|P1|NOT COMPLETED|Overall Study||1
8219494|NCT02063217|20270893|P3|COMPLETED|Overall Study||12
8219495|NCT02063217|20270894|P2|COMPLETED|Overall Study||12
8219496|NCT02063217|20270895|P1|COMPLETED|Overall Study||11
8219497|NCT02063217|20270893|P3|STARTED|Overall Study||12
8219498|NCT02063217|20270894|P2|STARTED|Overall Study||12
8219499|NCT02063217|20270895|P1|STARTED|Overall Study||12
8219500|NCT02063178|20270905|P2|NOT COMPLETED|Overall Study||47
8219501|NCT02063178|20270906|P1|NOT COMPLETED|Overall Study||29
8219502|NCT02063178|20270905|P2|COMPLETED|Overall Study||77
8219503|NCT02063178|20270906|P1|COMPLETED|Overall Study||95
8219504|NCT02063178|20270905|P2|STARTED|Overall Study||124
8219505|NCT02063178|20270906|P1|STARTED|Overall Study||124
8219506|NCT02063087|20270920|P2|NOT COMPLETED|7 Day Follow-up||0
8219507|NCT02063087|20270921|P1|NOT COMPLETED|7 Day Follow-up||0
8219508|NCT02063087|20270920|P2|COMPLETED|7 Day Follow-up||478
8219509|NCT02063087|20270921|P1|COMPLETED|7 Day Follow-up||493
8219510|NCT02063087|20270920|P2|STARTED|7 Day Follow-up||478
8219511|NCT02063087|20270921|P1|STARTED|7 Day Follow-up||493
8219512|NCT02063087|20270920|P2|NOT COMPLETED|Emergency Department Intervention||0
8219513|NCT02063087|20270921|P1|NOT COMPLETED|Emergency Department Intervention||0
8219514|NCT02063087|20270920|P2|COMPLETED|Emergency Department Intervention||478
8219515|NCT02063087|20270921|P1|COMPLETED|Emergency Department Intervention||493
8219516|NCT02063087|20270920|P2|STARTED|Emergency Department Intervention||478
8219517|NCT02063087|20270921|P1|STARTED|Emergency Department Intervention||493
8219518|NCT02063035|20270945|P2|NOT COMPLETED|Overall Study||0
8219519|NCT02063035|20270946|P1|NOT COMPLETED|Overall Study||0
8219520|NCT02063035|20270945|P2|COMPLETED|Overall Study||17
8219521|NCT02063035|20270946|P1|COMPLETED|Overall Study||12
8219522|NCT02063035|20270945|P2|STARTED|Overall Study||17
8219523|NCT02063035|20270946|P1|STARTED|Overall Study||12
8219524|NCT02062905|20270960|P2|NOT COMPLETED|Overall Study||2
8219525|NCT02062905|20270961|P1|NOT COMPLETED|Overall Study||7
8219526|NCT02062905|20270960|P2|COMPLETED|Overall Study||31
8219527|NCT02062905|20270961|P1|COMPLETED|Overall Study||28
8219528|NCT02062905|20270960|P2|STARTED|Overall Study||33
8219529|NCT02062905|20270961|P1|STARTED|Overall Study||35
8219530|NCT02062879|20270971|P2|NOT COMPLETED|Overall Study||1
8219531|NCT02062879|20270972|P1|NOT COMPLETED|Overall Study||4
8219532|NCT02062879|20270971|P2|COMPLETED|Overall Study||9
8219533|NCT02062879|20270972|P1|COMPLETED|Overall Study||6
8219534|NCT02062879|20270971|P2|STARTED|Overall Study||10
8219535|NCT02062879|20270972|P1|STARTED|Overall Study||10
8219536|NCT02062801|20270984|P2|NOT COMPLETED|Overall Study||4
8219537|NCT02062801|20270985|P1|NOT COMPLETED|Overall Study||2
8219538|NCT02062801|20270984|P2|COMPLETED|Overall Study||297
8219539|NCT02062801|20270985|P1|COMPLETED|Overall Study||299
8219540|NCT02062801|20270984|P2|STARTED|Overall Study||301
8219541|NCT02062801|20270985|P1|STARTED|Overall Study||301
8219542|NCT02062710|20270995|P6|NOT COMPLETED|Overall Study||0
8219543|NCT02062710|20270996|P5|NOT COMPLETED|Overall Study||0
8219544|NCT02062710|20270997|P4|NOT COMPLETED|Overall Study||0
8219545|NCT02062710|20270998|P3|NOT COMPLETED|Overall Study||0
8219546|NCT02062710|20270999|P2|NOT COMPLETED|Overall Study||0
8219547|NCT02062710|20271000|P1|NOT COMPLETED|Overall Study||0
8219548|NCT02062710|20270995|P6|COMPLETED|Overall Study||4
8219549|NCT02062710|20270996|P5|COMPLETED|Overall Study||3
8219550|NCT02062710|20270997|P4|COMPLETED|Overall Study||3
8219551|NCT02062710|20270998|P3|COMPLETED|Overall Study||5
8219552|NCT02062710|20270999|P2|COMPLETED|Overall Study||4
8219553|NCT02062710|20271000|P1|COMPLETED|Overall Study||3
8219554|NCT02062710|20270995|P6|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
8219555|NCT02062710|20270996|P5|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
8219556|NCT02062710|20270997|P4|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
8219557|NCT02062710|20270998|P3|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
8219558|NCT02062710|20270999|P2|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
8219648|NCT02061748|20271196|P2|STARTED|Overall Study||30853
8219559|NCT02062710|20271000|P1|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
8219560|NCT02062658|20271008|P1|NOT COMPLETED|Overall Study||2
8219561|NCT02062658|20271008|P1|COMPLETED|Overall Study||8
8219562|NCT02062658|20271008|P1|STARTED|Overall Study||10
8219563|NCT02062645|20271012|P1|NOT COMPLETED|Overall Study||15
8219564|NCT02062645|20271012|P1|COMPLETED|Overall Study||100
8219565|NCT02062645|20271012|P1|STARTED|Overall Study||115
8219566|NCT02062632|20271020|P1|NOT COMPLETED|Overall Study||1
8219567|NCT02062632|20271020|P1|COMPLETED|Overall Study||2
8219568|NCT02062632|20271020|P1|STARTED|Overall Study||3
8219569|NCT02062580|20271029|P2|NOT COMPLETED|Overall Study||13
8219570|NCT02062580|20271030|P1|NOT COMPLETED|Overall Study||12
8219571|NCT02062580|20271029|P2|COMPLETED|Overall Study||65
8219572|NCT02062580|20271030|P1|COMPLETED|Overall Study||59
8219573|NCT02062580|20271029|P2|STARTED|Overall Study||78
8219574|NCT02062580|20271030|P1|STARTED|Overall Study||71
8219575|NCT02062502|20271040|P2|NOT COMPLETED|Overall Study||35
8219576|NCT02062502|20271041|P1|NOT COMPLETED|Overall Study||43
8219577|NCT02062502|20271040|P2|COMPLETED|Overall Study||270
8219578|NCT02062502|20271041|P1|COMPLETED|Overall Study||263
8219579|NCT02062502|20271040|P2|Vaccinated Dose 1|Overall Study||305
8219580|NCT02062502|20271041|P1|Vaccinated Dose 1|Overall Study||306
8219581|NCT02062502|20271040|P2|STARTED|Overall Study||305
8219582|NCT02062502|20271041|P1|STARTED|Overall Study||306
8219583|NCT02062450|20271061|P1|NOT COMPLETED|Overall Study||124
8219584|NCT02062450|20271061|P1|COMPLETED|Overall Study||255
8219585|NCT02062450|20271061|P1|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
8219586|NCT02062450|20271061|P1|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
8219587|NCT02062437|20271075|P1|NOT COMPLETED|Overall Study||52
8219588|NCT02062437|20271075|P1|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
8219589|NCT02062437|20271075|P1|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
8219590|NCT02062398|20271084|P1|NOT COMPLETED|Overall Study||1
8219591|NCT02062398|20271084|P1|COMPLETED|Overall Study||12
8219592|NCT02062398|20271084|P1|STARTED|Overall Study||13
8219593|NCT02062385|20271096|P4|NOT COMPLETED|Overall Study||9
8219594|NCT02062385|20271097|P3|NOT COMPLETED|Overall Study||12
8219595|NCT02062385|20271098|P2|NOT COMPLETED|Overall Study||65
8219596|NCT02062385|20271099|P1|NOT COMPLETED|Overall Study||78
8219597|NCT02062385|20271096|P4|COMPLETED|Overall Study||391
8219598|NCT02062385|20271097|P3|COMPLETED|Overall Study||388
8219599|NCT02062385|20271098|P2|COMPLETED|Overall Study||1555
8219600|NCT02062385|20271099|P1|COMPLETED|Overall Study||1542
8219601|NCT02062385|20271096|P4|Received Vaccination 3|Overall Study||392
8219602|NCT02062385|20271097|P3|Received Vaccination 3|Overall Study||389
8219603|NCT02062385|20271098|P2|Received Vaccination 3|Overall Study||1554
8219604|NCT02062385|20271099|P1|Received Vaccination 3|Overall Study||1543
8219605|NCT02062385|20271096|P4|Received Vaccination 2|Overall Study||393
8219606|NCT02062385|20271097|P3|Received Vaccination 2|Overall Study||392
8219607|NCT02062385|20271098|P2|Received Vaccination 2|Overall Study||1566
8219608|NCT02062385|20271099|P1|Received Vaccination 2|Overall Study||1554
8219609|NCT02062385|20271096|P4|Received Vaccination 1|Overall Study||400
8219610|NCT02062385|20271097|P3|Received Vaccination 1|Overall Study||400
8219611|NCT02062385|20271098|P2|Received Vaccination 1|Overall Study||1619
8219612|NCT02062385|20271099|P1|Received Vaccination 1|Overall Study||1618
8219613|NCT02062385|20271096|P4|STARTED|Overall Study||400
8219614|NCT02062385|20271097|P3|STARTED|Overall Study||400
8219615|NCT02062385|20271098|P2|STARTED|Overall Study||1620
8219616|NCT02062385|20271099|P1|STARTED|Overall Study||1620
8219617|NCT02062359|20271119|P1|NOT COMPLETED|Overall Study||0
8219618|NCT02062359|20271119|P1|COMPLETED|Overall Study||2
8219619|NCT02062359|20271119|P1|STARTED|Overall Study||2
8219620|NCT02062294|20271125|P1|NOT COMPLETED|Overall Study||0
8219621|NCT02062294|20271125|P1|COMPLETED|Overall Study||14
8219622|NCT02062294|20271125|P1|STARTED|Overall Study||14
8219623|NCT02062177|20271132|P2|NOT COMPLETED|Overall Study||0
8219624|NCT02062177|20271133|P1|NOT COMPLETED|Overall Study||0
8219625|NCT02062177|20271132|P2|COMPLETED|Overall Study||70
8219626|NCT02062177|20271133|P1|COMPLETED|Overall Study||70
8219627|NCT02062177|20271132|P2|STARTED|Overall Study||70
8219628|NCT02062177|20271133|P1|STARTED|Overall Study||70
8219629|NCT02062151|20271143|P1|NOT COMPLETED|Overall Study||1
8219630|NCT02062151|20271143|P1|COMPLETED|Overall Study||20
8219631|NCT02062151|20271143|P1|STARTED|Overall Study||21
8219632|NCT02061969|20271150|P2|NOT COMPLETED|Overall Study||0
8219633|NCT02061969|20271151|P1|NOT COMPLETED|Overall Study||0
8219634|NCT02061969|20271150|P2|COMPLETED|Overall Study||67
8219635|NCT02061969|20271151|P1|COMPLETED|Overall Study||73
8219636|NCT02061969|20271150|P2|STARTED|Overall Study||67
8219637|NCT02061969|20271151|P1|STARTED|Overall Study||73
8219638|NCT02061774|20271181|P2|NOT COMPLETED|Overall Study||0
8219639|NCT02061774|20271182|P1|NOT COMPLETED|Overall Study||0
8219640|NCT02061774|20271181|P2|COMPLETED|Overall Study||11
8219641|NCT02061774|20271182|P1|COMPLETED|Overall Study||10
8219642|NCT02061774|20271181|P2|STARTED|Overall Study||11
8219643|NCT02061774|20271182|P1|STARTED|Overall Study||10
8219644|NCT02061748|20271196|P2|NOT COMPLETED|Overall Study||0
8219645|NCT02061748|20271197|P1|NOT COMPLETED|Overall Study||0
8219646|NCT02061748|20271196|P2|COMPLETED|Overall Study||30853
8219647|NCT02061748|20271197|P1|COMPLETED|Overall Study||7646
8219649|NCT02061748|20271197|P1|STARTED|Overall Study||7646
8219650|NCT02061696|20271271|P2|NOT COMPLETED|Overall Study||0
8219651|NCT02061696|20271272|P1|NOT COMPLETED|Overall Study||0
8219652|NCT02061696|20271271|P2|COMPLETED|Overall Study||22
8219653|NCT02061696|20271272|P1|COMPLETED|Overall Study||17
8219654|NCT02061696|20271271|P2|STARTED|Overall Study||22
8219655|NCT02061696|20271272|P1|STARTED|Overall Study||17
8219656|NCT02061683|20271296|P1|NOT COMPLETED|Overall Study||60
8219657|NCT02061683|20271296|P1|COMPLETED|Overall Study||203
8219658|NCT02061683|20271296|P1|STARTED|Overall Study||263
8219659|NCT02061592|20271303|P2|NOT COMPLETED|Period 2||1
8219660|NCT02061592|20271304|P1|NOT COMPLETED|Period 2||0
8219661|NCT02061592|20271303|P2|COMPLETED|Period 2||61
8219662|NCT02061592|20271304|P1|COMPLETED|Period 2||64
8219663|NCT02061592|20271303|P2|STARTED|Period 2||62
8219664|NCT02061592|20271304|P1|STARTED|Period 2||64
8219665|NCT02061592|20271303|P2|NOT COMPLETED|Period 1||0
8219666|NCT02061592|20271304|P1|NOT COMPLETED|Period 1||2
8219667|NCT02061592|20271303|P2|COMPLETED|Period 1||62
8219668|NCT02061592|20271304|P1|COMPLETED|Period 1||64
8219669|NCT02061592|20271303|P2|STARTED|Period 1||62
8219670|NCT02061592|20271304|P1|STARTED|Period 1||66
8219671|NCT02061540|20271316|P1|NOT COMPLETED|Overall Study||4
8219672|NCT02061540|20271316|P1|COMPLETED|Overall Study||23
8219673|NCT02061540|20271316|P1|Down-Titrated on LUM001 During the Study|Overall Study||5
8219674|NCT02061540|20271316|P1|STARTED|Overall Study||27
8219675|NCT02061397|20271329|P1|NOT COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||0
8219676|NCT02061397|20271329|P1|COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||10
8219677|NCT02061397|20271329|P1|STARTED|Simvastatin 40 mg Oral Daily for 2 Month||10
8219678|NCT02061397|20271329|P1|NOT COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||0
8219679|NCT02061397|20271329|P1|COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||10
8219680|NCT02061397|20271329|P1|STARTED|Simvastatin 20 mg Oral Daily for 2 Month||10
8219681|NCT02061358|20271343|P9|NOT COMPLETED|Overall Study||0
8219682|NCT02061358|20271344|P8|NOT COMPLETED|Overall Study||0
8219683|NCT02061358|20271345|P7|NOT COMPLETED|Overall Study||0
8219684|NCT02061358|20271346|P6|NOT COMPLETED|Overall Study||0
8219685|NCT02061358|20271347|P5|NOT COMPLETED|Overall Study||0
8219686|NCT02061358|20271348|P4|NOT COMPLETED|Overall Study||0
8219687|NCT02061358|20271349|P3|NOT COMPLETED|Overall Study||0
8219688|NCT02061358|20271350|P2|NOT COMPLETED|Overall Study||0
8219689|NCT02061358|20271351|P1|NOT COMPLETED|Overall Study||0
8219690|NCT02061358|20271343|P9|COMPLETED|Overall Study||16
8219691|NCT02061358|20271344|P8|COMPLETED|Overall Study||6
8219692|NCT02061358|20271345|P7|COMPLETED|Overall Study||6
8219693|NCT02061358|20271346|P6|COMPLETED|Overall Study||6
8219694|NCT02061358|20271347|P5|COMPLETED|Overall Study||6
8219695|NCT02061358|20271348|P4|COMPLETED|Overall Study||6
8219696|NCT02061358|20271349|P3|COMPLETED|Overall Study||6
8219697|NCT02061358|20271350|P2|COMPLETED|Overall Study||6
8219698|NCT02061358|20271351|P1|COMPLETED|Overall Study||6
8219699|NCT02061358|20271343|P9|STARTED|Overall Study||16
8219700|NCT02061358|20271344|P8|STARTED|Overall Study||6
8219701|NCT02061358|20271345|P7|STARTED|Overall Study||6
8219702|NCT02061358|20271346|P6|STARTED|Overall Study||6
8219703|NCT02061358|20271347|P5|STARTED|Overall Study||6
8219704|NCT02061358|20271348|P4|STARTED|Overall Study||6
8219705|NCT02061358|20271349|P3|STARTED|Overall Study||6
8219706|NCT02061358|20271350|P2|STARTED|Overall Study||6
8219707|NCT02061358|20271351|P1|STARTED|Overall Study||6
8219708|NCT02061280|20271489|P2|NOT COMPLETED|Overall Study||12
8219709|NCT02061280|20271490|P1|NOT COMPLETED|Overall Study||18
8219710|NCT02061280|20271489|P2|COMPLETED|Overall Study||25
8219711|NCT02061280|20271490|P1|COMPLETED|Overall Study||53
8219712|NCT02061280|20271489|P2|Randomized to Treatment|Overall Study||25
8219713|NCT02061280|20271490|P1|Randomized to Treatment|Overall Study||54
8219714|NCT02061280|20271489|P2|STARTED|Overall Study||37
8219715|NCT02061280|20271490|P1|STARTED|Overall Study||71
8219716|NCT02061202|20271522|P2|NOT COMPLETED|Overall Study||1
8219717|NCT02061202|20271523|P1|NOT COMPLETED|Overall Study||1
8219718|NCT02061202|20271522|P2|COMPLETED|Overall Study||17
8219719|NCT02061202|20271523|P1|COMPLETED|Overall Study||35
8219720|NCT02061202|20271522|P2|STARTED|Overall Study||18
8219721|NCT02061202|20271523|P1|STARTED|Overall Study||36
8219722|NCT02060903|20271549|P2|NOT COMPLETED|Overall Study||7
8219723|NCT02060903|20271550|P1|NOT COMPLETED|Overall Study||4
8219724|NCT02060903|20271549|P2|COMPLETED|Overall Study||185
8219725|NCT02060903|20271550|P1|COMPLETED|Overall Study||183
8219726|NCT02060903|20271549|P2|STARTED|Overall Study||192
8219727|NCT02060903|20271550|P1|STARTED|Overall Study||187
8219728|NCT02060890|20271556|P1|NOT COMPLETED|Overall Study||4
8219729|NCT02060890|20271556|P1|COMPLETED|Overall Study||16
8219730|NCT02060890|20271556|P1|STARTED|Overall Study||20
8219731|NCT02060838|20271565|P2|NOT COMPLETED|Overall Study||0
8219732|NCT02060838|20271566|P1|NOT COMPLETED|Overall Study||0
8219733|NCT02060838|20271565|P2|COMPLETED|Overall Study||22
8219734|NCT02060838|20271566|P1|COMPLETED|Overall Study||28
8219735|NCT02060838|20271565|P2|STARTED|Overall Study||22
8219736|NCT02060838|20271566|P1|STARTED|Overall Study||28
8219737|NCT02060539|20271574|P1|NOT COMPLETED|Overall Study||0
8219738|NCT02060539|20271574|P1|COMPLETED|Overall Study||19
8219739|NCT02060539|20271574|P1|STARTED|Overall Study||19
8219749|NCT02060461|20271660|P1|NOT COMPLETED|Overall Study||0
8219750|NCT02060461|20271660|P1|COMPLETED|Overall Study||33
8219751|NCT02060461|20271660|P1|STARTED|Overall Study||33
8219752|NCT02060383|20271671|P5|NOT COMPLETED|Extension Phase||7
8219753|NCT02060383|20271672|P4|NOT COMPLETED|Extension Phase||2
8219754|NCT02060383|20271673|P3|NOT COMPLETED|Extension Phase||3
8219755|NCT02060383|20271674|P2|NOT COMPLETED|Extension Phase||3
8219756|NCT02060383|20271675|P1|NOT COMPLETED|Extension Phase||3
8219757|NCT02060383|20271671|P5|COMPLETED|Extension Phase||46
8219758|NCT02060383|20271672|P4|COMPLETED|Extension Phase||19
8219759|NCT02060383|20271673|P3|COMPLETED|Extension Phase||7
8219760|NCT02060383|20271674|P2|COMPLETED|Extension Phase||14
8219761|NCT02060383|20271675|P1|COMPLETED|Extension Phase||14
8219762|NCT02060383|20271671|P5|STARTED|Extension Phase||53
8219763|NCT02060383|20271672|P4|STARTED|Extension Phase||21
8219764|NCT02060383|20271673|P3|STARTED|Extension Phase||10
8219765|NCT02060383|20271674|P2|STARTED|Extension Phase||17
8219766|NCT02060383|20271675|P1|STARTED|Extension Phase||17
8219767|NCT02060383|20271671|P5|NOT COMPLETED|Core Phase||8
8219768|NCT02060383|20271672|P4|NOT COMPLETED|Core Phase||7
8219769|NCT02060383|20271673|P3|NOT COMPLETED|Core Phase||0
8219770|NCT02060383|20271674|P2|NOT COMPLETED|Core Phase||6
8219771|NCT02060383|20271675|P1|NOT COMPLETED|Core Phase||3
8219772|NCT02060383|20271671|P5|COMPLETED|Core Phase||95
8219773|NCT02060383|20271672|P4|COMPLETED|Core Phase||39
8219774|NCT02060383|20271673|P3|COMPLETED|Core Phase||19
8219775|NCT02060383|20271674|P2|COMPLETED|Core Phase||37
8219776|NCT02060383|20271675|P1|COMPLETED|Core Phase||35
8219777|NCT02060383|20271671|P5|Completed Core/Did Not Enter Extension|Core Phase||42
8219778|NCT02060383|20271672|P4|Completed Core/Did Not Enter Extension|Core Phase||18
8219779|NCT02060383|20271673|P3|Completed Core/Did Not Enter Extension|Core Phase||9
8219780|NCT02060383|20271674|P2|Completed Core/Did Not Enter Extension|Core Phase||20
8219781|NCT02060383|20271675|P1|Completed Core/Did Not Enter Extension|Core Phase||18
8219782|NCT02060383|20271671|P5|Completed Core/Entered Extension|Core Phase||53
8219783|NCT02060383|20271672|P4|Completed Core/Entered Extension|Core Phase||21
8219784|NCT02060383|20271673|P3|Completed Core/Entered Extension|Core Phase||10
8219785|NCT02060383|20271674|P2|Completed Core/Entered Extension|Core Phase||17
8219786|NCT02060383|20271675|P1|Completed Core/Entered Extension|Core Phase||17
8219787|NCT02060383|20271671|P5|STARTED|Core Phase||103
8219788|NCT02060383|20271672|P4|STARTED|Core Phase||46
8219789|NCT02060383|20271673|P3|STARTED|Core Phase||19
8219790|NCT02060383|20271674|P2|STARTED|Core Phase||43
8219791|NCT02060383|20271675|P1|STARTED|Core Phase||38
8219792|NCT02060370|20271701|P1|NOT COMPLETED|Overall Study||1
8219793|NCT02060370|20271701|P1|COMPLETED|Overall Study||59
8219794|NCT02060370|20271701|P1|STARTED|Overall Study||60
8219795|NCT02060058|20271713|P3|NOT COMPLETED|Overall Study||0
8219796|NCT02060058|20271714|P2|NOT COMPLETED|Overall Study||0
8219797|NCT02060058|20271715|P1|NOT COMPLETED|Overall Study||0
8219798|NCT02060058|20271713|P3|COMPLETED|Overall Study||8
8219799|NCT02060058|20271714|P2|COMPLETED|Overall Study||0
8219800|NCT02060058|20271715|P1|COMPLETED|Overall Study||4
8219801|NCT02060058|20271713|P3|STARTED|Overall Study||8
8219802|NCT02060058|20271714|P2|STARTED|Overall Study||0
8219803|NCT02060058|20271715|P1|STARTED|Overall Study||4
8219804|NCT02059993|20271731|P2|NOT COMPLETED|Overall Study||4
8219805|NCT02059993|20271732|P1|NOT COMPLETED|Overall Study||2
8219806|NCT02059993|20271731|P2|COMPLETED|Overall Study||37
8219807|NCT02059993|20271732|P1|COMPLETED|Overall Study||40
8219808|NCT02059993|20271731|P2|STARTED|Overall Study||41
8219809|NCT02059993|20271732|P1|STARTED|Overall Study||42
8219810|NCT02059980|20271742|P2|NOT COMPLETED|Overall Study||1
8219811|NCT02059980|20271743|P1|NOT COMPLETED|Overall Study||2
8219812|NCT02059980|20271742|P2|COMPLETED|Overall Study||14
8219813|NCT02059980|20271743|P1|COMPLETED|Overall Study||16
8219814|NCT02059980|20271742|P2|STARTED|Overall Study||15
8219815|NCT02059980|20271743|P1|STARTED|Overall Study||18
8219816|NCT02059928|20271755|P1|NOT COMPLETED|Overall Study||0
8219817|NCT02059928|20271755|P1|COMPLETED|Overall Study||20
8219818|NCT02059928|20271755|P1|STARTED|Overall Study||20
8219819|NCT02059902|20271761|P2|NOT COMPLETED|Overall Study||4
8219820|NCT02059902|20271762|P1|NOT COMPLETED|Overall Study||4
8219821|NCT02059902|20271761|P2|COMPLETED|Overall Study||14
8219822|NCT02059902|20271762|P1|COMPLETED|Overall Study||14
8219823|NCT02059902|20271761|P2|STARTED|Overall Study||18
8219824|NCT02059902|20271762|P1|STARTED|Overall Study||18
8219825|NCT02059642|20271770|P2|NOT COMPLETED|Overall Study||24
8219826|NCT02059642|20271771|P1|NOT COMPLETED|Overall Study||27
8219827|NCT02059642|20271770|P2|COMPLETED|Overall Study||128
8219828|NCT02059642|20271771|P1|COMPLETED|Overall Study||121
8219829|NCT02059642|20271770|P2|STARTED|Overall Study||152
8219830|NCT02059642|20271771|P1|STARTED|Overall Study||148
8219831|NCT02059434|20271788|P9|NOT COMPLETED|Period 8||0
8219832|NCT02059434|20271789|P8|NOT COMPLETED|Period 8||0
8219833|NCT02059434|20271790|P7|NOT COMPLETED|Period 8||0
8219834|NCT02059434|20271791|P6|NOT COMPLETED|Period 8||0
8219835|NCT02059434|20271792|P5|NOT COMPLETED|Period 8||0
8219836|NCT02059434|20271793|P4|NOT COMPLETED|Period 8||0
8219837|NCT02059434|20271794|P3|NOT COMPLETED|Period 8||0
8219838|NCT02059434|20271795|P2|NOT COMPLETED|Period 8||0
8219839|NCT02059434|20271796|P1|NOT COMPLETED|Period 8||0
8219840|NCT02059434|20271788|P9|COMPLETED|Period 8||34
8219841|NCT02059434|20271789|P8|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219842|NCT02059434|20271790|P7|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219843|NCT02059434|20271791|P6|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219844|NCT02059434|20271792|P5|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219845|NCT02059434|20271793|P4|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219846|NCT02059434|20271794|P3|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219847|NCT02059434|20271795|P2|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219848|NCT02059434|20271796|P1|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
8219849|NCT02059434|20271788|P9|STARTED|Period 8||34
8219850|NCT02059434|20271789|P8|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219851|NCT02059434|20271790|P7|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219852|NCT02059434|20271791|P6|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219853|NCT02059434|20271792|P5|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219854|NCT02059434|20271793|P4|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219855|NCT02059434|20271794|P3|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219856|NCT02059434|20271795|P2|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219857|NCT02059434|20271796|P1|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
8219858|NCT02059434|20271788|P9|NOT COMPLETED|Washout Between Periods 7 and 8||2
8219859|NCT02059434|20271789|P8|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219860|NCT02059434|20271790|P7|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219861|NCT02059434|20271791|P6|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219862|NCT02059434|20271792|P5|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219863|NCT02059434|20271793|P4|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219864|NCT02059434|20271794|P3|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219865|NCT02059434|20271795|P2|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219866|NCT02059434|20271796|P1|NOT COMPLETED|Washout Between Periods 7 and 8||0
8219867|NCT02059434|20271788|P9|COMPLETED|Washout Between Periods 7 and 8||34
8219868|NCT02059434|20271789|P8|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219869|NCT02059434|20271790|P7|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219870|NCT02059434|20271791|P6|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219871|NCT02059434|20271792|P5|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219872|NCT02059434|20271793|P4|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219873|NCT02059434|20271794|P3|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219874|NCT02059434|20271795|P2|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219875|NCT02059434|20271796|P1|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219876|NCT02059434|20271788|P9|STARTED|Washout Between Periods 7 and 8||36
8219877|NCT02059434|20271789|P8|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219878|NCT02059434|20271790|P7|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219879|NCT02059434|20271791|P6|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219880|NCT02059434|20271792|P5|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219881|NCT02059434|20271793|P4|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219882|NCT02059434|20271794|P3|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219883|NCT02059434|20271795|P2|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219884|NCT02059434|20271796|P1|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
8219885|NCT02059434|20271788|P9|NOT COMPLETED|Period 7||0
8219886|NCT02059434|20271789|P8|NOT COMPLETED|Period 7||0
8219887|NCT02059434|20271790|P7|NOT COMPLETED|Period 7||0
8219888|NCT02059434|20271791|P6|NOT COMPLETED|Period 7||0
8219889|NCT02059434|20271792|P5|NOT COMPLETED|Period 7||0
8219890|NCT02059434|20271793|P4|NOT COMPLETED|Period 7||0
8219891|NCT02059434|20271794|P3|NOT COMPLETED|Period 7||0
8219892|NCT02059434|20271795|P2|NOT COMPLETED|Period 7||0
8219893|NCT02059434|20271796|P1|NOT COMPLETED|Period 7||0
8219894|NCT02059434|20271788|P9|COMPLETED|Period 7||36
8219895|NCT02059434|20271789|P8|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219896|NCT02059434|20271790|P7|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219897|NCT02059434|20271791|P6|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219898|NCT02059434|20271792|P5|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219899|NCT02059434|20271793|P4|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219900|NCT02059434|20271794|P3|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219901|NCT02059434|20271795|P2|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219902|NCT02059434|20271796|P1|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
8219903|NCT02059434|20271788|P9|STARTED|Period 7||36
8219904|NCT02059434|20271789|P8|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219905|NCT02059434|20271790|P7|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219906|NCT02059434|20271791|P6|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219907|NCT02059434|20271792|P5|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219908|NCT02059434|20271793|P4|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219909|NCT02059434|20271794|P3|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219910|NCT02059434|20271795|P2|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219911|NCT02059434|20271796|P1|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
8219912|NCT02059434|20271788|P9|NOT COMPLETED|Washout Between Periods 6 and 7||1
8219913|NCT02059434|20271789|P8|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219914|NCT02059434|20271790|P7|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219915|NCT02059434|20271791|P6|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219916|NCT02059434|20271792|P5|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219917|NCT02059434|20271793|P4|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219918|NCT02059434|20271794|P3|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219919|NCT02059434|20271795|P2|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219920|NCT02059434|20271796|P1|NOT COMPLETED|Washout Between Periods 6 and 7||0
8219921|NCT02059434|20271788|P9|COMPLETED|Washout Between Periods 6 and 7||36
8219922|NCT02059434|20271789|P8|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219923|NCT02059434|20271790|P7|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219924|NCT02059434|20271791|P6|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219925|NCT02059434|20271792|P5|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219926|NCT02059434|20271793|P4|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219927|NCT02059434|20271794|P3|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219928|NCT02059434|20271795|P2|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219929|NCT02059434|20271796|P1|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219930|NCT02059434|20271788|P9|STARTED|Washout Between Periods 6 and 7||37
8219931|NCT02059434|20271789|P8|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219932|NCT02059434|20271790|P7|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219933|NCT02059434|20271791|P6|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219934|NCT02059434|20271792|P5|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219935|NCT02059434|20271793|P4|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219936|NCT02059434|20271794|P3|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219937|NCT02059434|20271795|P2|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219938|NCT02059434|20271796|P1|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
8219939|NCT02059434|20271788|P9|NOT COMPLETED|Period 6||0
8219940|NCT02059434|20271789|P8|NOT COMPLETED|Period 6||0
8219941|NCT02059434|20271790|P7|NOT COMPLETED|Period 6||0
8219942|NCT02059434|20271791|P6|NOT COMPLETED|Period 6||0
8219943|NCT02059434|20271792|P5|NOT COMPLETED|Period 6||0
8219944|NCT02059434|20271793|P4|NOT COMPLETED|Period 6||0
8219945|NCT02059434|20271794|P3|NOT COMPLETED|Period 6||0
8219946|NCT02059434|20271795|P2|NOT COMPLETED|Period 6||0
8219947|NCT02059434|20271796|P1|NOT COMPLETED|Period 6||0
8219948|NCT02059434|20271788|P9|COMPLETED|Period 6||37
8219949|NCT02059434|20271789|P8|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219950|NCT02059434|20271790|P7|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219951|NCT02059434|20271791|P6|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219952|NCT02059434|20271792|P5|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219953|NCT02059434|20271793|P4|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219954|NCT02059434|20271794|P3|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219955|NCT02059434|20271795|P2|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219956|NCT02059434|20271796|P1|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
8219957|NCT02059434|20271788|P9|STARTED|Period 6||37
8219958|NCT02059434|20271789|P8|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219959|NCT02059434|20271790|P7|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219960|NCT02059434|20271791|P6|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219961|NCT02059434|20271792|P5|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219962|NCT02059434|20271793|P4|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219963|NCT02059434|20271794|P3|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219964|NCT02059434|20271795|P2|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219965|NCT02059434|20271796|P1|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
8219966|NCT02059434|20271788|P9|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219967|NCT02059434|20271789|P8|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219968|NCT02059434|20271790|P7|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219969|NCT02059434|20271791|P6|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219970|NCT02059434|20271792|P5|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219971|NCT02059434|20271793|P4|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219972|NCT02059434|20271794|P3|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219973|NCT02059434|20271795|P2|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219974|NCT02059434|20271796|P1|NOT COMPLETED|Washout Between Periods 5 and 6||0
8219975|NCT02059434|20271788|P9|COMPLETED|Washout Between Periods 5 and 6||37
8219976|NCT02059434|20271789|P8|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219977|NCT02059434|20271790|P7|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219978|NCT02059434|20271791|P6|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219979|NCT02059434|20271792|P5|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8220123|NCT02059434|20271792|P5|STARTED|Washout Between Periods 2 and 3||2
8219980|NCT02059434|20271793|P4|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219981|NCT02059434|20271794|P3|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219982|NCT02059434|20271795|P2|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219983|NCT02059434|20271796|P1|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219984|NCT02059434|20271788|P9|STARTED|Washout Between Periods 5 and 6||37
8219985|NCT02059434|20271789|P8|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219986|NCT02059434|20271790|P7|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219987|NCT02059434|20271791|P6|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219988|NCT02059434|20271792|P5|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219989|NCT02059434|20271793|P4|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219990|NCT02059434|20271794|P3|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219991|NCT02059434|20271795|P2|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219992|NCT02059434|20271796|P1|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
8219993|NCT02059434|20271788|P9|NOT COMPLETED|Period 5||0
8219994|NCT02059434|20271789|P8|NOT COMPLETED|Period 5||0
8219995|NCT02059434|20271790|P7|NOT COMPLETED|Period 5||0
8219996|NCT02059434|20271791|P6|NOT COMPLETED|Period 5||0
8219997|NCT02059434|20271792|P5|NOT COMPLETED|Period 5||0
8219998|NCT02059434|20271793|P4|NOT COMPLETED|Period 5||0
8219999|NCT02059434|20271794|P3|NOT COMPLETED|Period 5||0
8220000|NCT02059434|20271795|P2|NOT COMPLETED|Period 5||0
8220001|NCT02059434|20271796|P1|NOT COMPLETED|Period 5||0
8220002|NCT02059434|20271788|P9|COMPLETED|Period 5||37
8220003|NCT02059434|20271789|P8|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220004|NCT02059434|20271790|P7|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220005|NCT02059434|20271791|P6|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220006|NCT02059434|20271792|P5|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220007|NCT02059434|20271793|P4|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220008|NCT02059434|20271794|P3|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220009|NCT02059434|20271795|P2|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220010|NCT02059434|20271796|P1|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
8220011|NCT02059434|20271788|P9|STARTED|Period 5||37
8220012|NCT02059434|20271789|P8|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220013|NCT02059434|20271790|P7|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220014|NCT02059434|20271791|P6|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220015|NCT02059434|20271792|P5|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220016|NCT02059434|20271793|P4|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220017|NCT02059434|20271794|P3|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220018|NCT02059434|20271795|P2|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220019|NCT02059434|20271796|P1|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
8220020|NCT02059434|20271788|P9|NOT COMPLETED|Washout Between Periods 4 and 5||1
8220021|NCT02059434|20271789|P8|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220022|NCT02059434|20271790|P7|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220023|NCT02059434|20271791|P6|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220024|NCT02059434|20271792|P5|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220025|NCT02059434|20271793|P4|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220026|NCT02059434|20271794|P3|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220027|NCT02059434|20271795|P2|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220028|NCT02059434|20271796|P1|NOT COMPLETED|Washout Between Periods 4 and 5||0
8220029|NCT02059434|20271788|P9|COMPLETED|Washout Between Periods 4 and 5||37
8220030|NCT02059434|20271789|P8|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220031|NCT02059434|20271790|P7|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220032|NCT02059434|20271791|P6|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220033|NCT02059434|20271792|P5|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220034|NCT02059434|20271793|P4|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220035|NCT02059434|20271794|P3|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220036|NCT02059434|20271795|P2|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220037|NCT02059434|20271796|P1|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220038|NCT02059434|20271788|P9|STARTED|Washout Between Periods 4 and 5||38
8220039|NCT02059434|20271789|P8|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220040|NCT02059434|20271790|P7|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220041|NCT02059434|20271791|P6|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220042|NCT02059434|20271792|P5|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220043|NCT02059434|20271793|P4|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220044|NCT02059434|20271794|P3|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220045|NCT02059434|20271795|P2|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220046|NCT02059434|20271796|P1|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
8220047|NCT02059434|20271788|P9|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220048|NCT02059434|20271789|P8|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220049|NCT02059434|20271790|P7|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220050|NCT02059434|20271791|P6|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220051|NCT02059434|20271792|P5|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220052|NCT02059434|20271793|P4|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220053|NCT02059434|20271794|P3|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220054|NCT02059434|20271795|P2|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220055|NCT02059434|20271796|P1|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
8220056|NCT02059434|20271788|P9|COMPLETED|Period 4 (After Screening/run-in Period)||38
8220057|NCT02059434|20271789|P8|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220058|NCT02059434|20271790|P7|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220059|NCT02059434|20271791|P6|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220060|NCT02059434|20271792|P5|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220061|NCT02059434|20271793|P4|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220062|NCT02059434|20271794|P3|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220063|NCT02059434|20271795|P2|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220064|NCT02059434|20271796|P1|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220065|NCT02059434|20271788|P9|STARTED|Period 4 (After Screening/run-in Period)||38
8220066|NCT02059434|20271789|P8|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220067|NCT02059434|20271790|P7|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220068|NCT02059434|20271791|P6|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220069|NCT02059434|20271792|P5|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220070|NCT02059434|20271793|P4|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220071|NCT02059434|20271794|P3|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220072|NCT02059434|20271795|P2|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220073|NCT02059434|20271796|P1|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
8220074|NCT02059434|20271788|P9|NOT COMPLETED|Period 3||0
8220075|NCT02059434|20271789|P8|NOT COMPLETED|Period 3||0
8220076|NCT02059434|20271790|P7|NOT COMPLETED|Period 3||0
8220077|NCT02059434|20271791|P6|NOT COMPLETED|Period 3||0
8220078|NCT02059434|20271792|P5|NOT COMPLETED|Period 3||0
8220079|NCT02059434|20271793|P4|NOT COMPLETED|Period 3||0
8220080|NCT02059434|20271794|P3|NOT COMPLETED|Period 3||0
8220081|NCT02059434|20271795|P2|NOT COMPLETED|Period 3||0
8220082|NCT02059434|20271796|P1|NOT COMPLETED|Period 3||0
8220083|NCT02059434|20271788|P9|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220084|NCT02059434|20271789|P8|COMPLETED|Period 3||2
8220085|NCT02059434|20271790|P7|COMPLETED|Period 3||2
8220086|NCT02059434|20271791|P6|COMPLETED|Period 3||2
8220087|NCT02059434|20271792|P5|COMPLETED|Period 3||2
8220088|NCT02059434|20271793|P4|COMPLETED|Period 3||2
8220089|NCT02059434|20271794|P3|COMPLETED|Period 3||2
8220090|NCT02059434|20271795|P2|COMPLETED|Period 3||2
8220091|NCT02059434|20271796|P1|COMPLETED|Period 3||2
8220092|NCT02059434|20271788|P9|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220093|NCT02059434|20271789|P8|STARTED|Period 3||2
8220094|NCT02059434|20271790|P7|STARTED|Period 3||2
8220095|NCT02059434|20271791|P6|STARTED|Period 3||2
8220096|NCT02059434|20271792|P5|STARTED|Period 3||2
8220097|NCT02059434|20271793|P4|STARTED|Period 3||2
8220098|NCT02059434|20271794|P3|STARTED|Period 3||2
8220099|NCT02059434|20271795|P2|STARTED|Period 3||2
8220100|NCT02059434|20271796|P1|STARTED|Period 3||2
8220101|NCT02059434|20271788|P9|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220102|NCT02059434|20271789|P8|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220103|NCT02059434|20271790|P7|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220104|NCT02059434|20271791|P6|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220105|NCT02059434|20271792|P5|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220106|NCT02059434|20271793|P4|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220107|NCT02059434|20271794|P3|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220108|NCT02059434|20271795|P2|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220109|NCT02059434|20271796|P1|NOT COMPLETED|Washout Between Periods 2 and 3||0
8220110|NCT02059434|20271788|P9|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220111|NCT02059434|20271789|P8|COMPLETED|Washout Between Periods 2 and 3||2
8220112|NCT02059434|20271790|P7|COMPLETED|Washout Between Periods 2 and 3||2
8220113|NCT02059434|20271791|P6|COMPLETED|Washout Between Periods 2 and 3||2
8220114|NCT02059434|20271792|P5|COMPLETED|Washout Between Periods 2 and 3||2
8220115|NCT02059434|20271793|P4|COMPLETED|Washout Between Periods 2 and 3||2
8220116|NCT02059434|20271794|P3|COMPLETED|Washout Between Periods 2 and 3||2
8220117|NCT02059434|20271795|P2|COMPLETED|Washout Between Periods 2 and 3||2
8220118|NCT02059434|20271796|P1|COMPLETED|Washout Between Periods 2 and 3||2
8220119|NCT02059434|20271788|P9|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220120|NCT02059434|20271789|P8|STARTED|Washout Between Periods 2 and 3||2
8220121|NCT02059434|20271790|P7|STARTED|Washout Between Periods 2 and 3||2
8220122|NCT02059434|20271791|P6|STARTED|Washout Between Periods 2 and 3||2
8220124|NCT02059434|20271793|P4|STARTED|Washout Between Periods 2 and 3||2
8220125|NCT02059434|20271794|P3|STARTED|Washout Between Periods 2 and 3||2
8220126|NCT02059434|20271795|P2|STARTED|Washout Between Periods 2 and 3||2
8220127|NCT02059434|20271796|P1|STARTED|Washout Between Periods 2 and 3||2
8220128|NCT02059434|20271788|P9|NOT COMPLETED|Period 2||0
8220129|NCT02059434|20271789|P8|NOT COMPLETED|Period 2||0
8220130|NCT02059434|20271790|P7|NOT COMPLETED|Period 2||0
8220131|NCT02059434|20271791|P6|NOT COMPLETED|Period 2||0
8220132|NCT02059434|20271792|P5|NOT COMPLETED|Period 2||0
8220133|NCT02059434|20271793|P4|NOT COMPLETED|Period 2||0
8220134|NCT02059434|20271794|P3|NOT COMPLETED|Period 2||0
8220135|NCT02059434|20271795|P2|NOT COMPLETED|Period 2||0
8220136|NCT02059434|20271796|P1|NOT COMPLETED|Period 2||0
8220137|NCT02059434|20271788|P9|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220138|NCT02059434|20271789|P8|COMPLETED|Period 2||2
8220139|NCT02059434|20271790|P7|COMPLETED|Period 2||2
8220140|NCT02059434|20271791|P6|COMPLETED|Period 2||2
8220141|NCT02059434|20271792|P5|COMPLETED|Period 2||2
8220142|NCT02059434|20271793|P4|COMPLETED|Period 2||2
8220143|NCT02059434|20271794|P3|COMPLETED|Period 2||2
8220144|NCT02059434|20271795|P2|COMPLETED|Period 2||2
8220145|NCT02059434|20271796|P1|COMPLETED|Period 2||2
8220146|NCT02059434|20271788|P9|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220147|NCT02059434|20271789|P8|STARTED|Period 2||2
8220148|NCT02059434|20271790|P7|STARTED|Period 2||2
8220149|NCT02059434|20271791|P6|STARTED|Period 2||2
8220150|NCT02059434|20271792|P5|STARTED|Period 2||2
8220151|NCT02059434|20271793|P4|STARTED|Period 2||2
8220152|NCT02059434|20271794|P3|STARTED|Period 2||2
8220153|NCT02059434|20271795|P2|STARTED|Period 2||2
8220154|NCT02059434|20271796|P1|STARTED|Period 2||2
8220155|NCT02059434|20271788|P9|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220156|NCT02059434|20271789|P8|NOT COMPLETED|Washout Between Periods 1 and 2||1
8220157|NCT02059434|20271790|P7|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220158|NCT02059434|20271791|P6|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220159|NCT02059434|20271792|P5|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220160|NCT02059434|20271793|P4|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220161|NCT02059434|20271794|P3|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220162|NCT02059434|20271795|P2|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220163|NCT02059434|20271796|P1|NOT COMPLETED|Washout Between Periods 1 and 2||0
8220164|NCT02059434|20271788|P9|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220165|NCT02059434|20271789|P8|COMPLETED|Washout Between Periods 1 and 2||2
8220166|NCT02059434|20271790|P7|COMPLETED|Washout Between Periods 1 and 2||2
8220167|NCT02059434|20271791|P6|COMPLETED|Washout Between Periods 1 and 2||2
8220168|NCT02059434|20271792|P5|COMPLETED|Washout Between Periods 1 and 2||2
8220169|NCT02059434|20271793|P4|COMPLETED|Washout Between Periods 1 and 2||2
8220170|NCT02059434|20271794|P3|COMPLETED|Washout Between Periods 1 and 2||2
8220171|NCT02059434|20271795|P2|COMPLETED|Washout Between Periods 1 and 2||2
8220172|NCT02059434|20271796|P1|COMPLETED|Washout Between Periods 1 and 2||2
8220173|NCT02059434|20271788|P9|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220174|NCT02059434|20271789|P8|STARTED|Washout Between Periods 1 and 2||3
8220175|NCT02059434|20271790|P7|STARTED|Washout Between Periods 1 and 2||2
8220176|NCT02059434|20271791|P6|STARTED|Washout Between Periods 1 and 2||2
8220177|NCT02059434|20271792|P5|STARTED|Washout Between Periods 1 and 2||2
8220178|NCT02059434|20271793|P4|STARTED|Washout Between Periods 1 and 2||2
8220179|NCT02059434|20271794|P3|STARTED|Washout Between Periods 1 and 2||2
8220180|NCT02059434|20271795|P2|STARTED|Washout Between Periods 1 and 2||2
8220181|NCT02059434|20271796|P1|STARTED|Washout Between Periods 1 and 2||2
8220182|NCT02059434|20271788|P9|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220183|NCT02059434|20271789|P8|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220184|NCT02059434|20271790|P7|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220185|NCT02059434|20271791|P6|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220186|NCT02059434|20271792|P5|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220187|NCT02059434|20271793|P4|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220188|NCT02059434|20271794|P3|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220189|NCT02059434|20271795|P2|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220190|NCT02059434|20271796|P1|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
8220191|NCT02059434|20271788|P9|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220192|NCT02059434|20271789|P8|COMPLETED|Period 1 (After Screening/run-in Period)||3
8220193|NCT02059434|20271790|P7|COMPLETED|Period 1 (After Screening/run-in Period)||2
8220194|NCT02059434|20271791|P6|COMPLETED|Period 1 (After Screening/run-in Period)||2
8220195|NCT02059434|20271792|P5|COMPLETED|Period 1 (After Screening/run-in Period)||2
8220196|NCT02059434|20271793|P4|COMPLETED|Period 1 (After Screening/run-in Period)||2
8220197|NCT02059434|20271794|P3|COMPLETED|Period 1 (After Screening/run-in Period)||2
8220198|NCT02059434|20271795|P2|COMPLETED|Period 1 (After Screening/run-in Period)||2
8220199|NCT02059434|20271796|P1|COMPLETED|Period 1 (After Screening/run-in Period)||2
8220200|NCT02059434|20271788|P9|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
8220201|NCT02059434|20271789|P8|STARTED|Period 1 (After Screening/run-in Period)||3
8220202|NCT02059434|20271790|P7|STARTED|Period 1 (After Screening/run-in Period)||2
8220203|NCT02059434|20271791|P6|STARTED|Period 1 (After Screening/run-in Period)||2
8220204|NCT02059434|20271792|P5|STARTED|Period 1 (After Screening/run-in Period)||2
8220205|NCT02059434|20271793|P4|STARTED|Period 1 (After Screening/run-in Period)||2
8220206|NCT02059434|20271794|P3|STARTED|Period 1 (After Screening/run-in Period)||2
8220207|NCT02059434|20271795|P2|STARTED|Period 1 (After Screening/run-in Period)||2
8220208|NCT02059434|20271796|P1|STARTED|Period 1 (After Screening/run-in Period)||2
8220209|NCT02059408|20271861|P3|NOT COMPLETED|Overall Study||358
8220210|NCT02059408|20271862|P2|NOT COMPLETED|Overall Study||330
8220211|NCT02059408|20271863|P1|NOT COMPLETED|Overall Study||0
8220212|NCT02059408|20271861|P3|COMPLETED|Overall Study||258
8220213|NCT02059408|20271862|P2|COMPLETED|Overall Study||269
8220214|NCT02059408|20271863|P1|COMPLETED|Overall Study||604
8220215|NCT02059408|20271861|P3|STARTED|Overall Study||616
8220216|NCT02059408|20271862|P2|STARTED|Overall Study||599
8220217|NCT02059408|20271863|P1|STARTED|Overall Study||604
8220218|NCT02059395|20271882|P2|NOT COMPLETED|Overall Study||4
8220219|NCT02059395|20271883|P1|NOT COMPLETED|Overall Study||2
8220220|NCT02059395|20271882|P2|COMPLETED|Overall Study||23
8220221|NCT02059395|20271883|P1|COMPLETED|Overall Study||20
8220222|NCT02059395|20271882|P2|STARTED|Overall Study||27
8220223|NCT02059395|20271883|P1|STARTED|Overall Study||22
8220224|NCT02059291|20271898|P25|NOT COMPLETED|Epoch 4||0
8220225|NCT02059291|20271899|P24|NOT COMPLETED|Epoch 4||1
8220226|NCT02059291|20271900|P23|NOT COMPLETED|Epoch 4||1
8220227|NCT02059291|20271901|P22|NOT COMPLETED|Epoch 4||0
8220228|NCT02059291|20271902|P21|NOT COMPLETED|Epoch 4||1
8220229|NCT02059291|20271903|P20|NOT COMPLETED|Epoch 4||0
8220230|NCT02059291|20271904|P19|NOT COMPLETED|Epoch 4||0
8220231|NCT02059291|20271905|P18|NOT COMPLETED|Epoch 4||0
8220232|NCT02059291|20271906|P17|NOT COMPLETED|Epoch 4||2
8220233|NCT02059291|20271907|P16|NOT COMPLETED|Epoch 4||0
8220234|NCT02059291|20271908|P15|NOT COMPLETED|Epoch 4||0
8220235|NCT02059291|20271909|P14|NOT COMPLETED|Epoch 4||0
8220236|NCT02059291|20271910|P13|NOT COMPLETED|Epoch 4||0
8220237|NCT02059291|20271911|P12|NOT COMPLETED|Epoch 4||0
8220238|NCT02059291|20271912|P11|NOT COMPLETED|Epoch 4||0
8220239|NCT02059291|20271913|P10|NOT COMPLETED|Epoch 4||0
8220240|NCT02059291|20271914|P9|NOT COMPLETED|Epoch 4||0
8220241|NCT02059291|20271915|P8|NOT COMPLETED|Epoch 4||0
8220242|NCT02059291|20271916|P7|NOT COMPLETED|Epoch 4||0
8220243|NCT02059291|20271917|P6|NOT COMPLETED|Epoch 4||0
8220244|NCT02059291|20271918|P5|NOT COMPLETED|Epoch 4||0
8220245|NCT02059291|20271919|P4|NOT COMPLETED|Epoch 4||0
8220246|NCT02059291|20271920|P3|NOT COMPLETED|Epoch 4||0
8220247|NCT02059291|20271921|P2|NOT COMPLETED|Epoch 4||0
8220248|NCT02059291|20271922|P1|NOT COMPLETED|Epoch 4||0
8220249|NCT02059291|20271898|P25|COMPLETED|Epoch 4||0
8220250|NCT02059291|20271899|P24|COMPLETED|Epoch 4||21
8220251|NCT02059291|20271900|P23|COMPLETED|Epoch 4||30
8220252|NCT02059291|20271901|P22|COMPLETED|Epoch 4||14
8220253|NCT02059291|20271902|P21|COMPLETED|Epoch 4||33
8220254|NCT02059291|20271903|P20|COMPLETED|Epoch 4||18
8220255|NCT02059291|20271904|P19|COMPLETED|Epoch 4||2
8220256|NCT02059291|20271905|P18|COMPLETED|Epoch 4||14
8220257|NCT02059291|20271906|P17|COMPLETED|Epoch 4||41
8220258|NCT02059291|20271907|P16|COMPLETED|Epoch 4||0
8220259|NCT02059291|20271908|P15|COMPLETED|Epoch 4||0
8220260|NCT02059291|20271909|P14|COMPLETED|Epoch 4||0
8220261|NCT02059291|20271910|P13|COMPLETED|Epoch 4||0
8220262|NCT02059291|20271911|P12|COMPLETED|Epoch 4||0
8220263|NCT02059291|20271912|P11|COMPLETED|Epoch 4||0
8220264|NCT02059291|20271913|P10|COMPLETED|Epoch 4||0
8220265|NCT02059291|20271914|P9|COMPLETED|Epoch 4||0
8220266|NCT02059291|20271915|P8|COMPLETED|Epoch 4||0
8220267|NCT02059291|20271916|P7|COMPLETED|Epoch 4||0
8220268|NCT02059291|20271917|P6|COMPLETED|Epoch 4||0
8220269|NCT02059291|20271918|P5|COMPLETED|Epoch 4||0
8220270|NCT02059291|20271919|P4|COMPLETED|Epoch 4||0
8220271|NCT02059291|20271920|P3|COMPLETED|Epoch 4||0
8220272|NCT02059291|20271921|P2|COMPLETED|Epoch 4||0
8220273|NCT02059291|20271922|P1|COMPLETED|Epoch 4||0
8220274|NCT02059291|20271898|P25|STARTED|Epoch 4||0
8220275|NCT02059291|20271899|P24|STARTED|Epoch 4||22
8220276|NCT02059291|20271900|P23|STARTED|Epoch 4||31
8220277|NCT02059291|20271901|P22|STARTED|Epoch 4||14
8220278|NCT02059291|20271902|P21|STARTED|Epoch 4||34
8220279|NCT02059291|20271903|P20|STARTED|Epoch 4||18
8220280|NCT02059291|20271904|P19|STARTED|Epoch 4||2
8220281|NCT02059291|20271905|P18|STARTED|Epoch 4||14
8220282|NCT02059291|20271906|P17|STARTED|Epoch 4||43
8220283|NCT02059291|20271907|P16|STARTED|Epoch 4||0
8220284|NCT02059291|20271908|P15|STARTED|Epoch 4||0
8220285|NCT02059291|20271909|P14|STARTED|Epoch 4||0
8220286|NCT02059291|20271910|P13|STARTED|Epoch 4||0
8220287|NCT02059291|20271911|P12|STARTED|Epoch 4||0
8220288|NCT02059291|20271912|P11|STARTED|Epoch 4||0
8220289|NCT02059291|20271913|P10|STARTED|Epoch 4||0
8220290|NCT02059291|20271914|P9|STARTED|Epoch 4||0
8220291|NCT02059291|20271915|P8|STARTED|Epoch 4||0
8220292|NCT02059291|20271916|P7|STARTED|Epoch 4||0
8220293|NCT02059291|20271917|P6|STARTED|Epoch 4||0
8220294|NCT02059291|20271918|P5|STARTED|Epoch 4||0
8220295|NCT02059291|20271919|P4|STARTED|Epoch 4||0
8220296|NCT02059291|20271920|P3|STARTED|Epoch 4||0
8220297|NCT02059291|20271921|P2|STARTED|Epoch 4||0
8220298|NCT02059291|20271922|P1|STARTED|Epoch 4||0
8220299|NCT02059291|20271898|P25|NOT COMPLETED|Epoch 3||0
8220300|NCT02059291|20271899|P24|NOT COMPLETED|Epoch 3||0
8220301|NCT02059291|20271900|P23|NOT COMPLETED|Epoch 3||0
8220302|NCT02059291|20271901|P22|NOT COMPLETED|Epoch 3||0
8220303|NCT02059291|20271902|P21|NOT COMPLETED|Epoch 3||0
8220304|NCT02059291|20271903|P20|NOT COMPLETED|Epoch 3||0
8220305|NCT02059291|20271904|P19|NOT COMPLETED|Epoch 3||0
8220306|NCT02059291|20271905|P18|NOT COMPLETED|Epoch 3||0
8220307|NCT02059291|20271906|P17|NOT COMPLETED|Epoch 3||0
8220308|NCT02059291|20271907|P16|NOT COMPLETED|Epoch 3||6
8220309|NCT02059291|20271908|P15|NOT COMPLETED|Epoch 3||0
8220310|NCT02059291|20271909|P14|NOT COMPLETED|Epoch 3||1
8220311|NCT02059291|20271910|P13|NOT COMPLETED|Epoch 3||0
8220312|NCT02059291|20271911|P12|NOT COMPLETED|Epoch 3||0
8220313|NCT02059291|20271912|P11|NOT COMPLETED|Epoch 3||0
8220314|NCT02059291|20271913|P10|NOT COMPLETED|Epoch 3||0
8220315|NCT02059291|20271914|P9|NOT COMPLETED|Epoch 3||0
8220316|NCT02059291|20271915|P8|NOT COMPLETED|Epoch 3||0
8220317|NCT02059291|20271916|P7|NOT COMPLETED|Epoch 3||0
8220318|NCT02059291|20271917|P6|NOT COMPLETED|Epoch 3||0
8220319|NCT02059291|20271918|P5|NOT COMPLETED|Epoch 3||0
8220320|NCT02059291|20271919|P4|NOT COMPLETED|Epoch 3||0
8220321|NCT02059291|20271920|P3|NOT COMPLETED|Epoch 3||0
8220322|NCT02059291|20271921|P2|NOT COMPLETED|Epoch 3||0
8220323|NCT02059291|20271922|P1|NOT COMPLETED|Epoch 3||0
8220324|NCT02059291|20271898|P25|COMPLETED|Epoch 3||0
8220325|NCT02059291|20271899|P24|COMPLETED|Epoch 3||0
8220326|NCT02059291|20271900|P23|COMPLETED|Epoch 3||0
8220327|NCT02059291|20271901|P22|COMPLETED|Epoch 3||0
8220328|NCT02059291|20271902|P21|COMPLETED|Epoch 3||0
8220329|NCT02059291|20271903|P20|COMPLETED|Epoch 3||0
8220330|NCT02059291|20271904|P19|COMPLETED|Epoch 3||0
8220331|NCT02059291|20271905|P18|COMPLETED|Epoch 3||0
8220332|NCT02059291|20271906|P17|COMPLETED|Epoch 3||0
8220333|NCT02059291|20271907|P16|COMPLETED|Epoch 3||120
8220334|NCT02059291|20271908|P15|COMPLETED|Epoch 3||5
8220335|NCT02059291|20271909|P14|COMPLETED|Epoch 3||3
8220336|NCT02059291|20271910|P13|COMPLETED|Epoch 3||7
8220337|NCT02059291|20271911|P12|COMPLETED|Epoch 3||6
8220338|NCT02059291|20271912|P11|COMPLETED|Epoch 3||10
8220339|NCT02059291|20271913|P10|COMPLETED|Epoch 3||9
8220340|NCT02059291|20271914|P9|COMPLETED|Epoch 3||0
8220341|NCT02059291|20271915|P8|COMPLETED|Epoch 3||1
8220342|NCT02059291|20271916|P7|COMPLETED|Epoch 3||2
8220343|NCT02059291|20271917|P6|COMPLETED|Epoch 3||0
8220344|NCT02059291|20271918|P5|COMPLETED|Epoch 3||0
8220345|NCT02059291|20271919|P4|COMPLETED|Epoch 3||0
8220346|NCT02059291|20271920|P3|COMPLETED|Epoch 3||0
8220347|NCT02059291|20271921|P2|COMPLETED|Epoch 3||0
8220348|NCT02059291|20271922|P1|COMPLETED|Epoch 3||0
8220349|NCT02059291|20271898|P25|STARTED|Epoch 3||0
8220350|NCT02059291|20271899|P24|STARTED|Epoch 3||0
8220351|NCT02059291|20271900|P23|STARTED|Epoch 3||0
8220352|NCT02059291|20271901|P22|STARTED|Epoch 3||0
8220353|NCT02059291|20271902|P21|STARTED|Epoch 3||0
8220354|NCT02059291|20271903|P20|STARTED|Epoch 3||0
8220355|NCT02059291|20271904|P19|STARTED|Epoch 3||0
8220356|NCT02059291|20271905|P18|STARTED|Epoch 3||0
8220357|NCT02059291|20271906|P17|STARTED|Epoch 3||0
8220358|NCT02059291|20271907|P16|STARTED|Epoch 3||126
8220359|NCT02059291|20271908|P15|STARTED|Epoch 3||5
8220360|NCT02059291|20271909|P14|STARTED|Epoch 3||4
8220361|NCT02059291|20271910|P13|STARTED|Epoch 3||7
8220362|NCT02059291|20271911|P12|STARTED|Epoch 3||6
8220363|NCT02059291|20271912|P11|STARTED|Epoch 3||10
8220364|NCT02059291|20271913|P10|STARTED|Epoch 3||9
8220365|NCT02059291|20271914|P9|STARTED|Epoch 3|Presented in Epoch 2.|0
8220366|NCT02059291|20271915|P8|STARTED|Epoch 3||1
8220367|NCT02059291|20271916|P7|STARTED|Epoch 3||2
8220368|NCT02059291|20271917|P6|STARTED|Epoch 3||0
8220369|NCT02059291|20271918|P5|STARTED|Epoch 3||0
8220370|NCT02059291|20271919|P4|STARTED|Epoch 3||0
8220371|NCT02059291|20271920|P3|STARTED|Epoch 3||0
8220372|NCT02059291|20271921|P2|STARTED|Epoch 3||0
8220373|NCT02059291|20271922|P1|STARTED|Epoch 3||0
8220374|NCT02059291|20271898|P25|NOT COMPLETED|Epoch 2||0
8220375|NCT02059291|20271899|P24|NOT COMPLETED|Epoch 2||0
8220376|NCT02059291|20271900|P23|NOT COMPLETED|Epoch 2||0
8220377|NCT02059291|20271901|P22|NOT COMPLETED|Epoch 2||0
8220378|NCT02059291|20271902|P21|NOT COMPLETED|Epoch 2||0
8220379|NCT02059291|20271903|P20|NOT COMPLETED|Epoch 2||0
8220380|NCT02059291|20271904|P19|NOT COMPLETED|Epoch 2||0
8220381|NCT02059291|20271905|P18|NOT COMPLETED|Epoch 2||0
8220382|NCT02059291|20271906|P17|NOT COMPLETED|Epoch 2||0
8220383|NCT02059291|20271907|P16|NOT COMPLETED|Epoch 2||0
8220384|NCT02059291|20271908|P15|NOT COMPLETED|Epoch 2||0
8220385|NCT02059291|20271909|P14|NOT COMPLETED|Epoch 2||0
8220386|NCT02059291|20271910|P13|NOT COMPLETED|Epoch 2||0
8220387|NCT02059291|20271911|P12|NOT COMPLETED|Epoch 2||0
8220388|NCT02059291|20271912|P11|NOT COMPLETED|Epoch 2||0
8220389|NCT02059291|20271913|P10|NOT COMPLETED|Epoch 2||0
8220390|NCT02059291|20271914|P9|NOT COMPLETED|Epoch 2||2
8220391|NCT02059291|20271915|P8|NOT COMPLETED|Epoch 2||1
8220392|NCT02059291|20271916|P7|NOT COMPLETED|Epoch 2||0
8220393|NCT02059291|20271917|P6|NOT COMPLETED|Epoch 2||2
8220394|NCT02059291|20271918|P5|NOT COMPLETED|Epoch 2||0
8220395|NCT02059291|20271919|P4|NOT COMPLETED|Epoch 2||2
8220396|NCT02059291|20271920|P3|NOT COMPLETED|Epoch 2||1
8220397|NCT02059291|20271921|P2|NOT COMPLETED|Epoch 2||1
8220398|NCT02059291|20271922|P1|NOT COMPLETED|Epoch 2||0
8220399|NCT02059291|20271898|P25|COMPLETED|Epoch 2||0
8220400|NCT02059291|20271899|P24|COMPLETED|Epoch 2||0
8220401|NCT02059291|20271900|P23|COMPLETED|Epoch 2||0
8220402|NCT02059291|20271901|P22|COMPLETED|Epoch 2||0
8220403|NCT02059291|20271902|P21|COMPLETED|Epoch 2||0
8220404|NCT02059291|20271903|P20|COMPLETED|Epoch 2||0
8220405|NCT02059291|20271904|P19|COMPLETED|Epoch 2||0
8220406|NCT02059291|20271905|P18|COMPLETED|Epoch 2||0
8220407|NCT02059291|20271906|P17|COMPLETED|Epoch 2||0
8220408|NCT02059291|20271907|P16|COMPLETED|Epoch 2||0
8220409|NCT02059291|20271908|P15|COMPLETED|Epoch 2||0
8220410|NCT02059291|20271909|P14|COMPLETED|Epoch 2||0
8220411|NCT02059291|20271910|P13|COMPLETED|Epoch 2||0
8220412|NCT02059291|20271911|P12|COMPLETED|Epoch 2||0
8220413|NCT02059291|20271912|P11|COMPLETED|Epoch 2||0
8220414|NCT02059291|20271913|P10|COMPLETED|Epoch 2||0
8220415|NCT02059291|20271914|P9|COMPLETED|Epoch 2||16
8220416|NCT02059291|20271915|P8|COMPLETED|Epoch 2||1
8220417|NCT02059291|20271916|P7|COMPLETED|Epoch 2||2
8220418|NCT02059291|20271917|P6|COMPLETED|Epoch 2||22
8220419|NCT02059291|20271918|P5|COMPLETED|Epoch 2||22
8220420|NCT02059291|20271919|P4|COMPLETED|Epoch 2||33
8220421|NCT02059291|20271920|P3|COMPLETED|Epoch 2||36
8220422|NCT02059291|20271921|P2|COMPLETED|Epoch 2||31
8220423|NCT02059291|20271922|P1|COMPLETED|Epoch 2||31
8220424|NCT02059291|20271898|P25|STARTED|Epoch 2||0
8220425|NCT02059291|20271899|P24|STARTED|Epoch 2||0
8220426|NCT02059291|20271900|P23|STARTED|Epoch 2||0
8220427|NCT02059291|20271901|P22|STARTED|Epoch 2||0
8220428|NCT02059291|20271902|P21|STARTED|Epoch 2||0
8220429|NCT02059291|20271903|P20|STARTED|Epoch 2||0
8220430|NCT02059291|20271904|P19|STARTED|Epoch 2||0
8220431|NCT02059291|20271905|P18|STARTED|Epoch 2||0
8220432|NCT02059291|20271906|P17|STARTED|Epoch 2||0
8220433|NCT02059291|20271907|P16|STARTED|Epoch 2||0
8220434|NCT02059291|20271908|P15|STARTED|Epoch 2||0
8220435|NCT02059291|20271909|P14|STARTED|Epoch 2||0
8220436|NCT02059291|20271910|P13|STARTED|Epoch 2||0
8220437|NCT02059291|20271911|P12|STARTED|Epoch 2||0
8220438|NCT02059291|20271912|P11|STARTED|Epoch 2||0
8220439|NCT02059291|20271913|P10|STARTED|Epoch 2||0
8220440|NCT02059291|20271914|P9|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
8220441|NCT02059291|20271915|P8|STARTED|Epoch 2||2
8220442|NCT02059291|20271916|P7|STARTED|Epoch 2||2
8220443|NCT02059291|20271917|P6|STARTED|Epoch 2||24
8220444|NCT02059291|20271918|P5|STARTED|Epoch 2||22
8220445|NCT02059291|20271919|P4|STARTED|Epoch 2||35
8220446|NCT02059291|20271920|P3|STARTED|Epoch 2||37
8220447|NCT02059291|20271921|P2|STARTED|Epoch 2||32
8220448|NCT02059291|20271922|P1|STARTED|Epoch 2||31
8220449|NCT02059278|20271976|P2|NOT COMPLETED|Overall Study||4
8220450|NCT02059278|20271977|P1|NOT COMPLETED|Overall Study||3
8220451|NCT02059278|20271976|P2|COMPLETED|Overall Study||166
8220452|NCT02059278|20271977|P1|COMPLETED|Overall Study||162
8220453|NCT02059278|20271976|P2|STARTED|Overall Study||170
8220454|NCT02059278|20271977|P1|STARTED|Overall Study||165
8220458|NCT02059213|20272001|P2|NOT COMPLETED|Overall Study||2
8220459|NCT02059213|20272002|P1|NOT COMPLETED|Overall Study||0
8220460|NCT02059213|20272001|P2|COMPLETED|Overall Study||40
8220461|NCT02059213|20272002|P1|COMPLETED|Overall Study||20
8220462|NCT02059213|20272001|P2|Initiated Treatment|Overall Study||40
8220463|NCT02059213|20272002|P1|Initiated Treatment|Overall Study||20
8220464|NCT02059213|20272001|P2|STARTED|Overall Study||42
8220465|NCT02059213|20272002|P1|STARTED|Overall Study||20
8220466|NCT02059187|20272023|P2|NOT COMPLETED|Overall Study||22
8220467|NCT02059187|20272024|P1|NOT COMPLETED|Overall Study||25
8220468|NCT02059187|20272023|P2|COMPLETED|Overall Study||244
8220469|NCT02059187|20272024|P1|COMPLETED|Overall Study||240
8220470|NCT02059187|20272023|P2|STARTED|Overall Study||266
8220471|NCT02059187|20272024|P1|STARTED|Overall Study||265
8220472|NCT02059174|20272050|P2|NOT COMPLETED|Period 4||0
8220473|NCT02059174|20272051|P1|NOT COMPLETED|Period 4||0
8220474|NCT02059174|20272050|P2|COMPLETED|Period 4||35
8220475|NCT02059174|20272051|P1|COMPLETED|Period 4||35
8220476|NCT02059174|20272050|P2|STARTED|Period 4||35
8220477|NCT02059174|20272051|P1|STARTED|Period 4||35
8220478|NCT02059174|20272050|P2|NOT COMPLETED|Period 3||0
8220479|NCT02059174|20272051|P1|NOT COMPLETED|Period 3||1
8220480|NCT02059174|20272050|P2|COMPLETED|Period 3||35
8220481|NCT02059174|20272051|P1|COMPLETED|Period 3||35
8220482|NCT02059174|20272050|P2|STARTED|Period 3||35
8220483|NCT02059174|20272051|P1|STARTED|Period 3||36
8220484|NCT02059174|20272050|P2|NOT COMPLETED|Period 2||2
8220485|NCT02059174|20272051|P1|NOT COMPLETED|Period 2||1
8220486|NCT02059174|20272050|P2|COMPLETED|Period 2||35
8220487|NCT02059174|20272051|P1|COMPLETED|Period 2||36
8220488|NCT02059174|20272050|P2|STARTED|Period 2||37
8220489|NCT02059174|20272051|P1|STARTED|Period 2||37
8220490|NCT02059174|20272050|P2|NOT COMPLETED|Period 1||2
8220491|NCT02059174|20272051|P1|NOT COMPLETED|Period 1||0
8220492|NCT02059174|20272050|P2|COMPLETED|Period 1||37
8220493|NCT02059174|20272051|P1|COMPLETED|Period 1||37
8220494|NCT02059174|20272050|P2|STARTED|Period 1||39
8220495|NCT02059174|20272051|P1|STARTED|Period 1||37
8220496|NCT02059161|20272075|P2|NOT COMPLETED|Overall Study||41
8220497|NCT02059161|20272076|P1|NOT COMPLETED|Overall Study||49
8220498|NCT02059161|20272075|P2|COMPLETED|Overall Study||222
8220499|NCT02059161|20272076|P1|COMPLETED|Overall Study||196
8220500|NCT02059161|20272075|P2|Treated|Overall Study||258
8220501|NCT02059161|20272076|P1|Treated|Overall Study||241
8220502|NCT02059161|20272075|P2|STARTED|Overall Study||263
8220503|NCT02059161|20272076|P1|STARTED|Overall Study||245
8220504|NCT02059148|20272136|P6|NOT COMPLETED|Treatment 3||0
8220505|NCT02059148|20272137|P5|NOT COMPLETED|Treatment 3||0
8220506|NCT02059148|20272138|P4|NOT COMPLETED|Treatment 3||0
8220507|NCT02059148|20272139|P3|NOT COMPLETED|Treatment 3||0
8220508|NCT02059148|20272140|P2|NOT COMPLETED|Treatment 3||0
8220509|NCT02059148|20272141|P1|NOT COMPLETED|Treatment 3||0
8220510|NCT02059148|20272136|P6|COMPLETED|Treatment 3||3
8220511|NCT02059148|20272137|P5|COMPLETED|Treatment 3||4
8220512|NCT02059148|20272138|P4|COMPLETED|Treatment 3||4
8220513|NCT02059148|20272139|P3|COMPLETED|Treatment 3||4
8220514|NCT02059148|20272140|P2|COMPLETED|Treatment 3||4
8220515|NCT02059148|20272141|P1|COMPLETED|Treatment 3||4
8220516|NCT02059148|20272136|P6|STARTED|Treatment 3||3
8220517|NCT02059148|20272137|P5|STARTED|Treatment 3||4
8220518|NCT02059148|20272138|P4|STARTED|Treatment 3||4
8220519|NCT02059148|20272139|P3|STARTED|Treatment 3||4
8220520|NCT02059148|20272140|P2|STARTED|Treatment 3||4
8220521|NCT02059148|20272141|P1|STARTED|Treatment 3||4
8220522|NCT02059148|20272136|P6|NOT COMPLETED|Treatment 2||0
8220523|NCT02059148|20272137|P5|NOT COMPLETED|Treatment 2||0
8220524|NCT02059148|20272138|P4|NOT COMPLETED|Treatment 2||0
8220525|NCT02059148|20272139|P3|NOT COMPLETED|Treatment 2||0
8220526|NCT02059148|20272140|P2|NOT COMPLETED|Treatment 2||0
8220527|NCT02059148|20272141|P1|NOT COMPLETED|Treatment 2||0
8220528|NCT02059148|20272136|P6|COMPLETED|Treatment 2||3
8220529|NCT02059148|20272137|P5|COMPLETED|Treatment 2||4
8220530|NCT02059148|20272138|P4|COMPLETED|Treatment 2||4
8220531|NCT02059148|20272139|P3|COMPLETED|Treatment 2||4
8220532|NCT02059148|20272140|P2|COMPLETED|Treatment 2||4
8220533|NCT02059148|20272141|P1|COMPLETED|Treatment 2||4
8220534|NCT02059148|20272136|P6|STARTED|Treatment 2||3
8220535|NCT02059148|20272137|P5|STARTED|Treatment 2||4
8220536|NCT02059148|20272138|P4|STARTED|Treatment 2||4
8220537|NCT02059148|20272139|P3|STARTED|Treatment 2||4
8220538|NCT02059148|20272140|P2|STARTED|Treatment 2||4
8220539|NCT02059148|20272141|P1|STARTED|Treatment 2||4
8220540|NCT02059148|20272136|P6|NOT COMPLETED|Treatment 1||1
8220541|NCT02059148|20272137|P5|NOT COMPLETED|Treatment 1||0
8220542|NCT02059148|20272138|P4|NOT COMPLETED|Treatment 1||0
8220543|NCT02059148|20272139|P3|NOT COMPLETED|Treatment 1||0
8220544|NCT02059148|20272140|P2|NOT COMPLETED|Treatment 1||0
8220545|NCT02059148|20272141|P1|NOT COMPLETED|Treatment 1||0
8220546|NCT02059148|20272136|P6|COMPLETED|Treatment 1||3
8220547|NCT02059148|20272137|P5|COMPLETED|Treatment 1||4
8220548|NCT02059148|20272138|P4|COMPLETED|Treatment 1||4
8220549|NCT02059148|20272139|P3|COMPLETED|Treatment 1||4
8220550|NCT02059148|20272140|P2|COMPLETED|Treatment 1||4
8220551|NCT02059148|20272141|P1|COMPLETED|Treatment 1||4
8220552|NCT02059148|20272136|P6|STARTED|Treatment 1||4
8220553|NCT02059148|20272137|P5|STARTED|Treatment 1||4
8220554|NCT02059148|20272138|P4|STARTED|Treatment 1||4
8220555|NCT02059148|20272139|P3|STARTED|Treatment 1||4
8220556|NCT02059148|20272140|P2|STARTED|Treatment 1||4
8220557|NCT02059148|20272141|P1|STARTED|Treatment 1||4
8220558|NCT02059135|20272160|P2|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
8220559|NCT02059135|20272161|P1|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
8220560|NCT02059135|20272160|P2|COMPLETED|Neonatal Follow-up (Safety Population)||50
8220561|NCT02059135|20272161|P1|COMPLETED|Neonatal Follow-up (Safety Population)||56
8220562|NCT02059135|20272160|P2|STARTED|Neonatal Follow-up (Safety Population)||54
8220563|NCT02059135|20272161|P1|STARTED|Neonatal Follow-up (Safety Population)||60
8220564|NCT02059135|20272160|P2|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
8220565|NCT02059135|20272161|P1|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
8220566|NCT02059135|20272160|P2|COMPLETED|Maternal Follow-up (ITT Population)||51
8220567|NCT02059135|20272161|P1|COMPLETED|Maternal Follow-up (ITT Population)||59
8220568|NCT02059135|20272160|P2|STARTED|Maternal Follow-up (ITT Population)||58
8220569|NCT02059135|20272161|P1|STARTED|Maternal Follow-up (ITT Population)||62
8220570|NCT02059070|20272175|P2|NOT COMPLETED|Overall Study||4
8220571|NCT02059070|20272176|P1|NOT COMPLETED|Overall Study||5
8220572|NCT02059070|20272175|P2|COMPLETED|Overall Study||16
8220573|NCT02059070|20272176|P1|COMPLETED|Overall Study||14
8220574|NCT02059070|20272175|P2|STARTED|Overall Study||20
8220575|NCT02059070|20272176|P1|STARTED|Overall Study||19
8220579|NCT02059005|20272197|P2|NOT COMPLETED|Overall Study||24
8220580|NCT02059005|20272198|P1|NOT COMPLETED|Overall Study||20
8220581|NCT02059005|20272197|P2|COMPLETED|Overall Study||24
8220582|NCT02059005|20272198|P1|COMPLETED|Overall Study||29
8220583|NCT02059005|20272197|P2|6 Month Assessment|Overall Study||24
8220584|NCT02059005|20272198|P1|6 Month Assessment|Overall Study||29
8220585|NCT02059005|20272197|P2|3 Month Assessment|Overall Study||33
8220586|NCT02059005|20272198|P1|3 Month Assessment|Overall Study||37
8220587|NCT02059005|20272197|P2|STARTED|Overall Study||48
8220588|NCT02059005|20272198|P1|STARTED|Overall Study||49
8220589|NCT02058992|20272208|P1|NOT COMPLETED|Overall Study||116
8220590|NCT02058992|20272208|P1|COMPLETED|Overall Study||3223
8220591|NCT02058992|20272208|P1|STARTED|Overall Study||3339
8220592|NCT02058966|20272217|P1|NOT COMPLETED|Fourth Intervention||0
8220593|NCT02058966|20272217|P1|COMPLETED|Fourth Intervention||12
8220594|NCT02058966|20272217|P1|Received Entacapone-Meth|Fourth Intervention||2
8220595|NCT02058966|20272217|P1|Received Entacapone-Placebo|Fourth Intervention||3
8220596|NCT02058966|20272217|P1|Received Placebo-Meth|Fourth Intervention||3
8220597|NCT02058966|20272217|P1|Received Placebo-Placebo|Fourth Intervention||4
8220598|NCT02058966|20272217|P1|STARTED|Fourth Intervention||12
8220599|NCT02058966|20272217|P1|NOT COMPLETED|Third Intervention||0
8220600|NCT02058966|20272217|P1|COMPLETED|Third Intervention||12
8220601|NCT02058966|20272217|P1|Received Entacapone-Meth|Third Intervention||3
8220602|NCT02058966|20272217|P1|Received Entacapone-Placebo|Third Intervention||1
8220603|NCT02058966|20272217|P1|Received Placebo-Meth|Third Intervention||4
8220604|NCT02058966|20272217|P1|Received Placebo-Placebo|Third Intervention||4
8220605|NCT02058966|20272217|P1|STARTED|Third Intervention||12
8220606|NCT02058966|20272217|P1|NOT COMPLETED|Second Intervention||0
8220607|NCT02058966|20272217|P1|COMPLETED|Second Intervention||13
8220608|NCT02058966|20272217|P1|Received Entacapone-Meth|Second Intervention||3
8220609|NCT02058966|20272217|P1|Received Entacapone-Placebo|Second Intervention||6
8220610|NCT02058966|20272217|P1|Received Placebo-Meth|Second Intervention||2
8220611|NCT02058966|20272217|P1|Received Placebo-Placebo|Second Intervention||2
8220612|NCT02058966|20272217|P1|STARTED|Second Intervention||13
8220613|NCT02058966|20272217|P1|NOT COMPLETED|First Intervention||1
8220614|NCT02058966|20272217|P1|COMPLETED|First Intervention||14
8220615|NCT02058966|20272217|P1|Received Entacapone-Meth|First Intervention||5
8220616|NCT02058966|20272217|P1|Received Entacapone-Placebo|First Intervention||2
8220617|NCT02058966|20272217|P1|Received Placebo-Meth|First Intervention||4
8220618|NCT02058966|20272217|P1|Received Placebo-Placebo|First Intervention||3
8220619|NCT02058966|20272217|P1|STARTED|First Intervention||15
8220620|NCT02058966|20272217|P1|NOT COMPLETED|Open-Label Methamphetamine||1
8220621|NCT02058966|20272217|P1|COMPLETED|Open-Label Methamphetamine||18
8220622|NCT02058966|20272217|P1|Received Methamphetamine|Open-Label Methamphetamine||18
8220623|NCT02058966|20272217|P1|STARTED|Open-Label Methamphetamine||19
8220624|NCT02058940|20272244|P1|NOT COMPLETED|Overall Study||1
8220625|NCT02058940|20272244|P1|COMPLETED|Overall Study||7
8220626|NCT02058940|20272244|P1|STARTED|Overall Study||8
8220627|NCT02058849|20272268|P2|NOT COMPLETED|Overall Study||1
8220628|NCT02058849|20272269|P1|NOT COMPLETED|Overall Study||7
8220629|NCT02058849|20272268|P2|COMPLETED|Overall Study||1
8220630|NCT02058849|20272269|P1|COMPLETED|Overall Study||4
8220631|NCT02058849|20272268|P2|STARTED|Overall Study||2
8220632|NCT02058849|20272269|P1|STARTED|Overall Study||11
8220633|NCT02058836|20272297|P2|NOT COMPLETED|Overall Study||1
8220634|NCT02058836|20272298|P1|NOT COMPLETED|Overall Study||1
8220635|NCT02058836|20272297|P2|COMPLETED|Overall Study||3
8220636|NCT02058836|20272298|P1|COMPLETED|Overall Study||3
8220637|NCT02058836|20272297|P2|STARTED|Overall Study||4
8220638|NCT02058836|20272298|P1|STARTED|Overall Study||4
8220639|NCT02058628|20272328|P2|NOT COMPLETED|Overall Study||8
8220640|NCT02058628|20272329|P1|NOT COMPLETED|Overall Study||7
8220641|NCT02058628|20272328|P2|COMPLETED|Overall Study||102
8220642|NCT02058628|20272329|P1|COMPLETED|Overall Study||104
8220643|NCT02058628|20272328|P2|STARTED|Overall Study||110
8220644|NCT02058628|20272329|P1|STARTED|Overall Study||111
8220645|NCT02058589|20272361|P2|NOT COMPLETED|Overall Study||2
8220646|NCT02058589|20272362|P1|NOT COMPLETED|Overall Study||2
8220647|NCT02058589|20272361|P2|COMPLETED|Overall Study||130
8220648|NCT02058589|20272362|P1|COMPLETED|Overall Study||130
8220649|NCT02058589|20272361|P2|STARTED|Overall Study||132
8220650|NCT02058589|20272362|P1|STARTED|Overall Study||132
8220651|NCT02058563|20272404|P2|NOT COMPLETED|Overall Study||24
8220652|NCT02058563|20272405|P1|NOT COMPLETED|Overall Study||28
8220653|NCT02058563|20272404|P2|COMPLETED|Overall Study||433
8220654|NCT02058563|20272405|P1|COMPLETED|Overall Study||426
8220655|NCT02058563|20272404|P2|STARTED|Overall Study||457
8220656|NCT02058563|20272405|P1|STARTED|Overall Study||454
8220657|NCT02058537|20272441|P1|NOT COMPLETED|Overall Study||1
8220658|NCT02058537|20272441|P1|COMPLETED|Overall Study||2
8220659|NCT02058537|20272441|P1|STARTED|Overall Study||3
8220660|NCT02058511|20272447|P1|NOT COMPLETED|Overall Study||0
8220661|NCT02058511|20272447|P1|COMPLETED|Overall Study||24
8220662|NCT02058511|20272447|P1|STARTED|Overall Study||24
8220663|NCT02058498|20272452|P1|NOT COMPLETED|Overall Study||4
8220664|NCT02058498|20272452|P1|COMPLETED|Overall Study||8
8220665|NCT02058498|20272452|P1|6 Weeks|Overall Study||8
8220666|NCT02058498|20272452|P1|STARTED|Overall Study||12
8220667|NCT02058368|20272460|P2|NOT COMPLETED|Overall Study||54
8220668|NCT02058368|20272461|P1|NOT COMPLETED|Overall Study||41
8220669|NCT02058368|20272460|P2|COMPLETED|Overall Study||251
8220670|NCT02058368|20272461|P1|COMPLETED|Overall Study||261
8220671|NCT02058368|20272460|P2|STARTED|Overall Study||305
8220672|NCT02058368|20272461|P1|STARTED|Overall Study||302
8220673|NCT02058290|20272513|P2|NOT COMPLETED|Overall Study||9
8220674|NCT02058290|20272514|P1|NOT COMPLETED|Overall Study||11
8220675|NCT02058290|20272513|P2|COMPLETED|Overall Study||36
8220676|NCT02058290|20272514|P1|COMPLETED|Overall Study||66
8220677|NCT02058290|20272513|P2|STARTED|Overall Study||45
8220678|NCT02058290|20272514|P1|STARTED|Overall Study||77
8220679|NCT02058251|20272530|P2|NOT COMPLETED|Overall Study||0
8220680|NCT02058251|20272531|P1|NOT COMPLETED|Overall Study||0
8220681|NCT02058251|20272530|P2|COMPLETED|Overall Study||38
8220682|NCT02058251|20272531|P1|COMPLETED|Overall Study||35
8220683|NCT02058251|20272530|P2|STARTED|Overall Study||38
8220684|NCT02058251|20272531|P1|STARTED|Overall Study||35
8220685|NCT02058160|20272541|P2|NOT COMPLETED|Overall Study||14
8220686|NCT02058160|20272542|P1|NOT COMPLETED|Overall Study||31
8220687|NCT02058160|20272541|P2|COMPLETED|Overall Study||355
8220688|NCT02058160|20272542|P1|COMPLETED|Overall Study||336
8220689|NCT02058160|20272541|P2|Treated|Overall Study||365
8220690|NCT02058160|20272542|P1|Treated|Overall Study||365
8220691|NCT02058160|20272541|P2|STARTED|Overall Study||369
8220692|NCT02058160|20272542|P1|STARTED|Overall Study||367
8220693|NCT02058147|20272579|P3|NOT COMPLETED|Overall Study||29
8220694|NCT02058147|20272580|P2|NOT COMPLETED|Overall Study||27
8220695|NCT02058147|20272581|P1|NOT COMPLETED|Overall Study||29
8220696|NCT02058147|20272579|P3|COMPLETED|Overall Study||205
8220697|NCT02058147|20272580|P2|COMPLETED|Overall Study||440
8220698|NCT02058147|20272581|P1|COMPLETED|Overall Study||440
8220699|NCT02058147|20272579|P3|Treated|Overall Study||233
8220700|NCT02058147|20272580|P2|Treated|Overall Study||467
8220701|NCT02058147|20272581|P1|Treated|Overall Study||469
8220702|NCT02058147|20272579|P3|STARTED|Overall Study||234
8220703|NCT02058147|20272580|P2|STARTED|Overall Study||467
8220704|NCT02058147|20272581|P1|STARTED|Overall Study||469
8220705|NCT02058108|20272632|P2|NOT COMPLETED|Overall Study||10
8220706|NCT02058108|20272633|P1|NOT COMPLETED|Overall Study||41
8220707|NCT02058108|20272632|P2|COMPLETED|Overall Study||0
8220708|NCT02058108|20272633|P1|COMPLETED|Overall Study||2
8220709|NCT02058108|20272632|P2|Switched to Telbivudine After Week 24|Overall Study||5
8220710|NCT02058108|20272633|P1|Switched to Telbivudine After Week 24|Overall Study||0
8220711|NCT02058108|20272632|P2|STARTED|Overall Study||10
8220712|NCT02058108|20272633|P1|STARTED|Overall Study||43
8220713|NCT02058095|20272659|P2|NOT COMPLETED|Overall Study||0
8220714|NCT02058095|20272660|P1|NOT COMPLETED|Overall Study||1
8220715|NCT02058095|20272659|P2|COMPLETED|Overall Study||7
8220716|NCT02058095|20272660|P1|COMPLETED|Overall Study||14
8220717|NCT02058095|20272659|P2|STARTED|Overall Study||7
8220718|NCT02058095|20272660|P1|STARTED|Overall Study||15
8220719|NCT02058069|20272670|P1|NOT COMPLETED|Overall Study||11
8220720|NCT02058069|20272670|P1|COMPLETED|Overall Study||89
8220721|NCT02058069|20272670|P1|STARTED|Overall Study||100
8220722|NCT02057952|20272682|P3|NOT COMPLETED|Overall Study||22
8220723|NCT02057952|20272683|P2|NOT COMPLETED|Overall Study||10
8220724|NCT02057952|20272684|P1|NOT COMPLETED|Overall Study||8
8220725|NCT02057952|20272682|P3|COMPLETED|Overall Study||28
8220726|NCT02057952|20272683|P2|COMPLETED|Overall Study||39
8220727|NCT02057952|20272684|P1|COMPLETED|Overall Study||43
8220728|NCT02057952|20272682|P3|STARTED|Overall Study||50
8220729|NCT02057952|20272683|P2|STARTED|Overall Study||49
8220730|NCT02057952|20272684|P1|STARTED|Overall Study||51
8220731|NCT02057939|20272719|P1|NOT COMPLETED|Overall Study||1
8220732|NCT02057939|20272719|P1|COMPLETED|Overall Study||37
8220733|NCT02057939|20272719|P1|STARTED|Overall Study||38
8220734|NCT02057874|20272729|P1|NOT COMPLETED|Overall Study||1
8220735|NCT02057874|20272729|P1|COMPLETED|Overall Study||1
8220736|NCT02057874|20272729|P1|STARTED|Overall Study||2
8220737|NCT02057835|20272747|P10|NOT COMPLETED|Overall Study||0
8220738|NCT02057835|20272748|P9|NOT COMPLETED|Overall Study||0
8220739|NCT02057835|20272749|P8|NOT COMPLETED|Overall Study||0
8220740|NCT02057835|20272750|P7|NOT COMPLETED|Overall Study||0
8220741|NCT02057835|20272751|P6|NOT COMPLETED|Overall Study||0
8220742|NCT02057835|20272752|P5|NOT COMPLETED|Overall Study||0
8220743|NCT02057835|20272753|P4|NOT COMPLETED|Overall Study||0
8220744|NCT02057835|20272754|P3|NOT COMPLETED|Overall Study||0
8220745|NCT02057835|20272755|P2|NOT COMPLETED|Overall Study||2
8220746|NCT02057835|20272756|P1|NOT COMPLETED|Overall Study||0
8220747|NCT02057835|20272747|P10|COMPLETED|Overall Study||6
8220748|NCT02057835|20272748|P9|COMPLETED|Overall Study||6
8220749|NCT02057835|20272749|P8|COMPLETED|Overall Study||6
8220750|NCT02057835|20272750|P7|COMPLETED|Overall Study||6
8220751|NCT02057835|20272751|P6|COMPLETED|Overall Study||8
8220752|NCT02057835|20272752|P5|COMPLETED|Overall Study||6
8220753|NCT02057835|20272753|P4|COMPLETED|Overall Study||6
8220754|NCT02057835|20272754|P3|COMPLETED|Overall Study||6
8220755|NCT02057835|20272755|P2|COMPLETED|Overall Study||4
8220756|NCT02057835|20272756|P1|COMPLETED|Overall Study||8
8220757|NCT02057835|20272747|P10|STARTED|Overall Study||6
8220758|NCT02057835|20272748|P9|STARTED|Overall Study||6
8220759|NCT02057835|20272749|P8|STARTED|Overall Study||6
8220760|NCT02057835|20272750|P7|STARTED|Overall Study||6
8220761|NCT02057835|20272751|P6|STARTED|Overall Study||8
8220762|NCT02057835|20272752|P5|STARTED|Overall Study||6
8220763|NCT02057835|20272753|P4|STARTED|Overall Study||6
8220764|NCT02057835|20272754|P3|STARTED|Overall Study||6
8220765|NCT02057835|20272755|P2|STARTED|Overall Study||6
8220766|NCT02057835|20272756|P1|STARTED|Overall Study||8
8220767|NCT02057757|20272835|P2|NOT COMPLETED|Overall Study||8
8220768|NCT02057757|20272836|P1|NOT COMPLETED|Overall Study||14
8220769|NCT02057757|20272835|P2|COMPLETED|Overall Study||121
8220770|NCT02057757|20272836|P1|COMPLETED|Overall Study||117
8220771|NCT02057757|20272835|P2|Intent to Treat|Overall Study||127
8220772|NCT02057757|20272836|P1|Intent to Treat|Overall Study||130
8220773|NCT02057757|20272835|P2|STARTED|Overall Study||129
8220774|NCT02057757|20272836|P1|STARTED|Overall Study||131
8220775|NCT02057692|20272890|P4|NOT COMPLETED|Overall Study||1
8220776|NCT02057692|20272891|P3|NOT COMPLETED|Overall Study||0
8220777|NCT02057692|20272892|P2|NOT COMPLETED|Overall Study||0
8220778|NCT02057692|20272893|P1|NOT COMPLETED|Overall Study||1
8220779|NCT02057692|20272890|P4|COMPLETED|Overall Study||11
8220780|NCT02057692|20272891|P3|COMPLETED|Overall Study||6
8220781|NCT02057692|20272892|P2|COMPLETED|Overall Study||11
8220782|NCT02057692|20272893|P1|COMPLETED|Overall Study||7
8220783|NCT02057692|20272890|P4|STARTED|Overall Study||12
8220784|NCT02057692|20272891|P3|STARTED|Overall Study||6
8220785|NCT02057692|20272892|P2|STARTED|Overall Study||11
8220786|NCT02057692|20272893|P1|STARTED|Overall Study||8
8220787|NCT02057640|20272923|P2|NOT COMPLETED|Phase II Portion of Study at DL2||0
8220788|NCT02057640|20272924|P1|NOT COMPLETED|Phase II Portion of Study at DL2||0
8220789|NCT02057640|20272923|P2|COMPLETED|Phase II Portion of Study at DL2||9
8220790|NCT02057640|20272924|P1|COMPLETED|Phase II Portion of Study at DL2||0
8220791|NCT02057640|20272923|P2|STARTED|Phase II Portion of Study at DL2||9
8220792|NCT02057640|20272924|P1|STARTED|Phase II Portion of Study at DL2||0
8220793|NCT02057640|20272923|P2|NOT COMPLETED|Weeks 1-4||0
8220794|NCT02057640|20272924|P1|NOT COMPLETED|Weeks 1-4||0
8220795|NCT02057640|20272923|P2|COMPLETED|Weeks 1-4||3
8220796|NCT02057640|20272924|P1|COMPLETED|Weeks 1-4||4
8220797|NCT02057640|20272923|P2|STARTED|Weeks 1-4||3
8220798|NCT02057640|20272924|P1|STARTED|Weeks 1-4|1 extra participant accidentally treated at DL1 (in addition to initial 3).|4
8220799|NCT02057575|20272939|P4|NOT COMPLETED|Overall Study||1
8220800|NCT02057575|20272940|P3|NOT COMPLETED|Overall Study||0
8220801|NCT02057575|20272941|P2|NOT COMPLETED|Overall Study||4
8220802|NCT02057575|20272942|P1|NOT COMPLETED|Overall Study||1
8220803|NCT02057575|20272939|P4|COMPLETED|Overall Study||72
8220804|NCT02057575|20272940|P3|COMPLETED|Overall Study||78
8220805|NCT02057575|20272941|P2|COMPLETED|Overall Study||69
8220806|NCT02057575|20272942|P1|COMPLETED|Overall Study||73
8220807|NCT02057575|20272939|P4|STARTED|Overall Study||73
8220808|NCT02057575|20272940|P3|STARTED|Overall Study||78
8220809|NCT02057575|20272941|P2|STARTED|Overall Study||73
8220810|NCT02057575|20272942|P1|STARTED|Overall Study||74
8220811|NCT02057549|20272954|P2|NOT COMPLETED|Overall Study||0
8220812|NCT02057549|20272955|P1|NOT COMPLETED|Overall Study||3
8220813|NCT02057549|20272954|P2|COMPLETED|Overall Study||18
8220814|NCT02057549|20272955|P1|COMPLETED|Overall Study||15
8220815|NCT02057549|20272954|P2|STARTED|Overall Study||18
8220816|NCT02057549|20272955|P1|STARTED|Overall Study||18
8220817|NCT02057523|20272975|P1|NOT COMPLETED|Overall Study||2
8220818|NCT02057523|20272975|P1|COMPLETED|Overall Study||0
8220819|NCT02057523|20272975|P1|STARTED|Overall Study||2
8220820|NCT02057458|20272980|P3|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
8220821|NCT02057458|20272981|P2|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
8220822|NCT02057458|20272982|P1|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||1
8220823|NCT02057458|20272980|P3|COMPLETED|Sub-Chronic Study (4 Weeks)||3
8220824|NCT02057458|20272981|P2|COMPLETED|Sub-Chronic Study (4 Weeks)||7
8220825|NCT02057458|20272982|P1|COMPLETED|Sub-Chronic Study (4 Weeks)||5
8220826|NCT02057458|20272980|P3|STARTED|Sub-Chronic Study (4 Weeks)||3
8220827|NCT02057458|20272981|P2|STARTED|Sub-Chronic Study (4 Weeks)||7
8220828|NCT02057458|20272982|P1|STARTED|Sub-Chronic Study (4 Weeks)||6
8220829|NCT02057458|20272980|P3|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
8220830|NCT02057458|20272981|P2|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
8220831|NCT02057458|20272982|P1|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
8220832|NCT02057458|20272980|P3|COMPLETED|Acute Study (1 Hour): Second Int.||0
8220833|NCT02057458|20272981|P2|COMPLETED|Acute Study (1 Hour): Second Int.||7
8220834|NCT02057458|20272982|P1|COMPLETED|Acute Study (1 Hour): Second Int.||6
8220835|NCT02057458|20272980|P3|STARTED|Acute Study (1 Hour): Second Int.||0
8220836|NCT02057458|20272981|P2|STARTED|Acute Study (1 Hour): Second Int.||7
8220837|NCT02057458|20272982|P1|STARTED|Acute Study (1 Hour): Second Int.||6
8220838|NCT02057458|20272980|P3|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
8220839|NCT02057458|20272981|P2|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
8220840|NCT02057458|20272982|P1|NOT COMPLETED|Acute Study (1 Hour): First Intervention||2
8220841|NCT02057458|20272980|P3|COMPLETED|Acute Study (1 Hour): First Intervention||0
8220842|NCT02057458|20272981|P2|COMPLETED|Acute Study (1 Hour): First Intervention||7
8220843|NCT02057458|20272982|P1|COMPLETED|Acute Study (1 Hour): First Intervention||6
8220844|NCT02057458|20272980|P3|STARTED|Acute Study (1 Hour): First Intervention||0
8220845|NCT02057458|20272981|P2|STARTED|Acute Study (1 Hour): First Intervention||7
8220846|NCT02057458|20272982|P1|STARTED|Acute Study (1 Hour): First Intervention||8
8220847|NCT02057458|20272980|P3|NOT COMPLETED|Met Inclusion Criteria||0
8220848|NCT02057458|20272981|P2|NOT COMPLETED|Met Inclusion Criteria||1
8220849|NCT02057458|20272982|P1|NOT COMPLETED|Met Inclusion Criteria||0
8220850|NCT02057458|20272980|P3|COMPLETED|Met Inclusion Criteria||3
8220851|NCT02057458|20272981|P2|COMPLETED|Met Inclusion Criteria||7
8220852|NCT02057458|20272982|P1|COMPLETED|Met Inclusion Criteria||8
8220853|NCT02057458|20272980|P3|STARTED|Met Inclusion Criteria||3
8220854|NCT02057458|20272981|P2|STARTED|Met Inclusion Criteria||8
8220855|NCT02057458|20272982|P1|STARTED|Met Inclusion Criteria||8
8220856|NCT02057458|20272980|P3|NOT COMPLETED|Recruited for Participation||0
8220857|NCT02057458|20272981|P2|NOT COMPLETED|Recruited for Participation||0
8220858|NCT02057458|20272982|P1|NOT COMPLETED|Recruited for Participation||0
8220859|NCT02057458|20272980|P3|COMPLETED|Recruited for Participation||3
8220860|NCT02057458|20272981|P2|COMPLETED|Recruited for Participation||8
8220861|NCT02057458|20272982|P1|COMPLETED|Recruited for Participation||8
8220862|NCT02057458|20272980|P3|STARTED|Recruited for Participation||3
8220863|NCT02057458|20272981|P2|STARTED|Recruited for Participation||8
8220864|NCT02057458|20272982|P1|STARTED|Recruited for Participation||8
8220865|NCT02057406|20273020|P3|NOT COMPLETED|Overall Study||4
8220866|NCT02057406|20273021|P2|NOT COMPLETED|Overall Study||3
8220867|NCT02057406|20273022|P1|NOT COMPLETED|Overall Study||1
8220868|NCT02057406|20273020|P3|COMPLETED|Overall Study||32
8220869|NCT02057406|20273021|P2|COMPLETED|Overall Study||33
8220870|NCT02057406|20273022|P1|COMPLETED|Overall Study||35
8220871|NCT02057406|20273020|P3|STARTED|Overall Study||36
8220872|NCT02057406|20273021|P2|STARTED|Overall Study||36
8220873|NCT02057406|20273022|P1|STARTED|Overall Study||36
8220874|NCT02057393|20273033|P1|NOT COMPLETED|Overall Study||2
8220875|NCT02057393|20273033|P1|COMPLETED|Overall Study||87
8220876|NCT02057393|20273033|P1|STARTED|Overall Study||89
8220877|NCT02057276|20273039|P2|NOT COMPLETED|Overall Study||0
8220878|NCT02057276|20273040|P1|NOT COMPLETED|Overall Study||0
8220879|NCT02057276|20273039|P2|COMPLETED|Overall Study||0
8220880|NCT02057276|20273040|P1|COMPLETED|Overall Study||0
8220881|NCT02057276|20273039|P2|STARTED|Overall Study||0
8220882|NCT02057276|20273040|P1|STARTED|Overall Study||0
8220883|NCT02057250|20273054|P5|NOT COMPLETED|Extension Phase||36
8220884|NCT02057250|20273055|P4|NOT COMPLETED|Extension Phase||0
8220885|NCT02057250|20273056|P3|NOT COMPLETED|Extension Phase||0
8220886|NCT02057250|20273057|P2|NOT COMPLETED|Extension Phase||0
8220887|NCT02057250|20273058|P1|NOT COMPLETED|Extension Phase||0
8220888|NCT02057250|20273054|P5|COMPLETED|Extension Phase||156
8220889|NCT02057250|20273055|P4|COMPLETED|Extension Phase||0
8220890|NCT02057250|20273056|P3|COMPLETED|Extension Phase||0
8220891|NCT02057250|20273057|P2|COMPLETED|Extension Phase||0
8220892|NCT02057250|20273058|P1|COMPLETED|Extension Phase||0
8220893|NCT02057250|20273054|P5|Treated|Extension Phase||188
8220894|NCT02057250|20273055|P4|Treated|Extension Phase||0
8220895|NCT02057250|20273056|P3|Treated|Extension Phase||0
8220896|NCT02057250|20273057|P2|Treated|Extension Phase||0
8220897|NCT02057250|20273058|P1|Treated|Extension Phase||0
8220898|NCT02057250|20273054|P5|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
8220899|NCT02057250|20273055|P4|STARTED|Extension Phase||0
8220900|NCT02057250|20273056|P3|STARTED|Extension Phase||0
8220901|NCT02057250|20273057|P2|STARTED|Extension Phase||0
8220902|NCT02057250|20273058|P1|STARTED|Extension Phase||0
8220903|NCT02057250|20273054|P5|NOT COMPLETED|AID Assessment Phase||0
8220904|NCT02057250|20273055|P4|NOT COMPLETED|AID Assessment Phase||2
8220905|NCT02057250|20273056|P3|NOT COMPLETED|AID Assessment Phase||7
8220906|NCT02057250|20273057|P2|NOT COMPLETED|AID Assessment Phase||3
8220907|NCT02057250|20273058|P1|NOT COMPLETED|AID Assessment Phase||4
8220908|NCT02057250|20273054|P5|COMPLETED|AID Assessment Phase||0
8220909|NCT02057250|20273055|P4|COMPLETED|AID Assessment Phase||54
8220910|NCT02057250|20273056|P3|COMPLETED|AID Assessment Phase||45
8220911|NCT02057250|20273057|P2|COMPLETED|AID Assessment Phase||50
8220912|NCT02057250|20273058|P1|COMPLETED|AID Assessment Phase||52
8220913|NCT02057250|20273054|P5|STARTED|AID Assessment Phase||0
8220914|NCT02057250|20273055|P4|STARTED|AID Assessment Phase||56
8220915|NCT02057250|20273056|P3|STARTED|AID Assessment Phase||52
8220916|NCT02057250|20273057|P2|STARTED|AID Assessment Phase||53
8220917|NCT02057250|20273058|P1|STARTED|AID Assessment Phase||56
8220918|NCT02057237|20273071|P1|NOT COMPLETED|Overall Study||0
8220919|NCT02057237|20273071|P1|COMPLETED|Overall Study||1
8220920|NCT02057237|20273071|P1|STARTED|Overall Study||1
8220921|NCT02057198|20273079|P3|NOT COMPLETED|Overall Study||1
8220922|NCT02057198|20273080|P2|NOT COMPLETED|Overall Study||1
8220923|NCT02057198|20273081|P1|NOT COMPLETED|Overall Study||0
8220924|NCT02057198|20273079|P3|COMPLETED|Overall Study||10
8220925|NCT02057198|20273080|P2|COMPLETED|Overall Study||10
8220926|NCT02057198|20273081|P1|COMPLETED|Overall Study||11
8220927|NCT02057198|20273079|P3|STARTED|Overall Study||11
8220928|NCT02057198|20273080|P2|STARTED|Overall Study||11
8220929|NCT02057198|20273081|P1|STARTED|Overall Study||11
8220930|NCT02057081|20273106|P2|NOT COMPLETED|Overall Study||68
8220931|NCT02057081|20273107|P1|NOT COMPLETED|Overall Study||90
8220932|NCT02057081|20273106|P2|COMPLETED|Overall Study||44
8220933|NCT02057081|20273107|P1|COMPLETED|Overall Study||46
8220934|NCT02057081|20273106|P2|Post-Treatment Assessment|Overall Study||52
8220935|NCT02057081|20273107|P1|Post-Treatment Assessment|Overall Study||58
8220936|NCT02057081|20273106|P2|Completed Baseline|Overall Study||80
8220937|NCT02057081|20273107|P1|Completed Baseline|Overall Study||88
8220938|NCT02057081|20273106|P2|STARTED|Overall Study||112
8220939|NCT02057081|20273107|P1|STARTED|Overall Study||136
8220940|NCT02057068|20273117|P2|NOT COMPLETED|Overall Study||8
8220941|NCT02057068|20273118|P1|NOT COMPLETED|Overall Study||8
8220942|NCT02057068|20273117|P2|COMPLETED|Overall Study||28
8220943|NCT02057068|20273118|P1|COMPLETED|Overall Study||52
8220944|NCT02057068|20273117|P2|STARTED|Overall Study||36
8220945|NCT02057068|20273118|P1|STARTED|Overall Study||60
8220946|NCT02057042|20273130|P2|NOT COMPLETED|Overall Study||66
8220947|NCT02057042|20273131|P1|NOT COMPLETED|Overall Study||45
8220948|NCT02057042|20273130|P2|COMPLETED|Overall Study||101
8220949|NCT02057042|20273131|P1|COMPLETED|Overall Study||118
8220950|NCT02057042|20273130|P2|STARTED|Overall Study||167
8220951|NCT02057042|20273131|P1|STARTED|Overall Study||163
8220952|NCT02056834|20273147|P1|NOT COMPLETED|Overall Study||7
8220953|NCT02056834|20273147|P1|COMPLETED|Overall Study||29
8220954|NCT02056834|20273147|P1|6 Months|Overall Study||31
8220955|NCT02056834|20273147|P1|6 Weeks|Overall Study||34
8220956|NCT02056834|20273147|P1|STARTED|Overall Study||36
8220957|NCT02056652|20273168|P2|NOT COMPLETED|Overall Study||3
8220958|NCT02056652|20273169|P1|NOT COMPLETED|Overall Study||1
8220959|NCT02056652|20273168|P2|COMPLETED|Overall Study||58
8220960|NCT02056652|20273169|P1|COMPLETED|Overall Study||60
8220961|NCT02056652|20273168|P2|STARTED|Overall Study||61
8220962|NCT02056652|20273169|P1|STARTED|Overall Study||61
8220963|NCT02056639|20273187|P2|NOT COMPLETED|Overall Study||0
8220964|NCT02056639|20273188|P1|NOT COMPLETED|Overall Study||0
8220965|NCT02056639|20273187|P2|COMPLETED|Overall Study||23
8220966|NCT02056639|20273188|P1|COMPLETED|Overall Study||23
8220967|NCT02056639|20273187|P2|STARTED|Overall Study||23
8220968|NCT02056639|20273188|P1|STARTED|Overall Study||23
8220969|NCT02056626|20273206|P4|NOT COMPLETED|Overall Study||0
8220970|NCT02056626|20273207|P3|NOT COMPLETED|Overall Study||0
8220971|NCT02056626|20273208|P2|NOT COMPLETED|Overall Study||1
8220972|NCT02056626|20273209|P1|NOT COMPLETED|Overall Study||3
8220973|NCT02056626|20273206|P4|COMPLETED|Overall Study||14
8220974|NCT02056626|20273207|P3|COMPLETED|Overall Study||4
8220975|NCT02056626|20273208|P2|COMPLETED|Overall Study||12
8220976|NCT02056626|20273209|P1|COMPLETED|Overall Study||10
8220977|NCT02056626|20273206|P4|STARTED|Overall Study||14
8220978|NCT02056626|20273207|P3|STARTED|Overall Study||4
8220979|NCT02056626|20273208|P2|STARTED|Overall Study||13
8220980|NCT02056626|20273209|P1|STARTED|Overall Study||13
8220981|NCT02056431|20273229|P2|NOT COMPLETED|Overall Study||47
8220982|NCT02056431|20273230|P1|NOT COMPLETED|Overall Study||44
8220983|NCT02056431|20273229|P2|COMPLETED|Overall Study||619
8220984|NCT02056431|20273230|P1|COMPLETED|Overall Study||560
8220985|NCT02056431|20273229|P2|STARTED|Overall Study||666
8220986|NCT02056431|20273230|P1|STARTED|Overall Study||604
8220987|NCT02056392|20273244|P6|NOT COMPLETED|Overall Study||0
8220988|NCT02056392|20273245|P5|NOT COMPLETED|Overall Study||1
8220989|NCT02056392|20273246|P4|NOT COMPLETED|Overall Study||0
8220990|NCT02056392|20273247|P3|NOT COMPLETED|Overall Study||3
8220991|NCT02056392|20273248|P2|NOT COMPLETED|Overall Study||1
8220992|NCT02056392|20273249|P1|NOT COMPLETED|Overall Study||2
8220993|NCT02056392|20273244|P6|COMPLETED|Overall Study||9
8220994|NCT02056392|20273245|P5|COMPLETED|Overall Study||7
8220995|NCT02056392|20273246|P4|COMPLETED|Overall Study||9
8220996|NCT02056392|20273247|P3|COMPLETED|Overall Study||6
8220997|NCT02056392|20273248|P2|COMPLETED|Overall Study||8
8220998|NCT02056392|20273249|P1|COMPLETED|Overall Study||8
8220999|NCT02056392|20273244|P6|STARTED|Overall Study||9
8221000|NCT02056392|20273245|P5|STARTED|Overall Study||8
8221001|NCT02056392|20273246|P4|STARTED|Overall Study||9
8221002|NCT02056392|20273247|P3|STARTED|Overall Study||9
8221003|NCT02056392|20273248|P2|STARTED|Overall Study||9
8221004|NCT02056392|20273249|P1|STARTED|Overall Study||10
8221005|NCT02056340|20273286|P2|NOT COMPLETED|Overall Study||11
8221006|NCT02056340|20273287|P1|NOT COMPLETED|Overall Study||7
8221007|NCT02056340|20273286|P2|COMPLETED|Overall Study||46
8221008|NCT02056340|20273287|P1|COMPLETED|Overall Study||52
8221009|NCT02056340|20273286|P2|STARTED|Overall Study||57
8221010|NCT02056340|20273287|P1|STARTED|Overall Study||59
8221011|NCT02056301|20273297|P2|NOT COMPLETED|Overall Study||6
8221012|NCT02056301|20273298|P1|NOT COMPLETED|Overall Study||2
8221013|NCT02056301|20273297|P2|COMPLETED|Overall Study||23
8221014|NCT02056301|20273298|P1|COMPLETED|Overall Study||31
8221015|NCT02056301|20273297|P2|STARTED|Overall Study||29
8221016|NCT02056301|20273298|P1|STARTED|Overall Study||33
8221017|NCT02056171|20273310|P2|NOT COMPLETED|Overall Study||0
8221018|NCT02056171|20273311|P1|NOT COMPLETED|Overall Study||0
8221019|NCT02056171|20273310|P2|COMPLETED|Overall Study||3
8221020|NCT02056171|20273311|P1|COMPLETED|Overall Study||3
8221021|NCT02056171|20273310|P2|STARTED|Overall Study||3
8221022|NCT02056171|20273311|P1|STARTED|Overall Study||3
8221023|NCT02055976|20273330|P9|NOT COMPLETED|Overall Study||0
8221024|NCT02055976|20273331|P8|NOT COMPLETED|Overall Study||0
8221025|NCT02055976|20273332|P7|NOT COMPLETED|Overall Study||2
8221026|NCT02055976|20273333|P6|NOT COMPLETED|Overall Study||1
8221027|NCT02055976|20273334|P5|NOT COMPLETED|Overall Study||0
8221028|NCT02055976|20273335|P4|NOT COMPLETED|Overall Study||1
8221029|NCT02055976|20273336|P3|NOT COMPLETED|Overall Study||1
8221030|NCT02055976|20273337|P2|NOT COMPLETED|Overall Study||0
8221031|NCT02055976|20273338|P1|NOT COMPLETED|Overall Study||0
8221032|NCT02055976|20273330|P9|COMPLETED|Overall Study||23
8221033|NCT02055976|20273331|P8|COMPLETED|Overall Study||24
8221034|NCT02055976|20273332|P7|COMPLETED|Overall Study||23
8221035|NCT02055976|20273333|P6|COMPLETED|Overall Study||24
8221036|NCT02055976|20273334|P5|COMPLETED|Overall Study||22
8221037|NCT02055976|20273335|P4|COMPLETED|Overall Study||25
8221038|NCT02055976|20273336|P3|COMPLETED|Overall Study||23
8221039|NCT02055976|20273337|P2|COMPLETED|Overall Study||24
8221040|NCT02055976|20273338|P1|COMPLETED|Overall Study||25
8221041|NCT02055976|20273330|P9|STARTED|Overall Study||23
8221042|NCT02055976|20273331|P8|STARTED|Overall Study||24
8221043|NCT02055976|20273332|P7|STARTED|Overall Study||25
8221044|NCT02055976|20273333|P6|STARTED|Overall Study||25
8221045|NCT02055976|20273334|P5|STARTED|Overall Study||22
8221046|NCT02055976|20273335|P4|STARTED|Overall Study||26
8221047|NCT02055976|20273336|P3|STARTED|Overall Study||24
8221048|NCT02055976|20273337|P2|STARTED|Overall Study||24
8221049|NCT02055976|20273338|P1|STARTED|Overall Study||25
8221050|NCT02055898|20273759|P2|NOT COMPLETED|Second Intervention (5 Days)||0
8221051|NCT02055898|20273760|P1|NOT COMPLETED|Second Intervention (5 Days)||0
8221052|NCT02055898|20273759|P2|COMPLETED|Second Intervention (5 Days)||5
8221053|NCT02055898|20273760|P1|COMPLETED|Second Intervention (5 Days)||5
8221054|NCT02055898|20273759|P2|STARTED|Second Intervention (5 Days)||5
8221055|NCT02055898|20273760|P1|STARTED|Second Intervention (5 Days)||5
8221056|NCT02055898|20273759|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
8221057|NCT02055898|20273760|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
8221058|NCT02055898|20273759|P2|COMPLETED|Washout (at Least 14 Days)||5
8221059|NCT02055898|20273760|P1|COMPLETED|Washout (at Least 14 Days)||5
8221060|NCT02055898|20273759|P2|STARTED|Washout (at Least 14 Days)||5
8221061|NCT02055898|20273760|P1|STARTED|Washout (at Least 14 Days)||5
8221062|NCT02055898|20273759|P2|NOT COMPLETED|First Intervention (5 Days)||1
8221063|NCT02055898|20273760|P1|NOT COMPLETED|First Intervention (5 Days)||2
8221064|NCT02055898|20273759|P2|COMPLETED|First Intervention (5 Days)||5
8221065|NCT02055898|20273760|P1|COMPLETED|First Intervention (5 Days)||5
8221066|NCT02055898|20273759|P2|STARTED|First Intervention (5 Days)||6
8221067|NCT02055898|20273760|P1|STARTED|First Intervention (5 Days)||7
8221068|NCT02055820|20273782|P10|NOT COMPLETED|Phase II: Expansion||0
8221069|NCT02055820|20273783|P9|NOT COMPLETED|Phase II: Expansion||0
8221070|NCT02055820|20273784|P8|NOT COMPLETED|Phase II: Expansion||0
8221071|NCT02055820|20273785|P7|NOT COMPLETED|Phase II: Expansion||0
8221072|NCT02055820|20273786|P6|NOT COMPLETED|Phase II: Expansion||0
8221073|NCT02055820|20273787|P5|NOT COMPLETED|Phase II: Expansion||49
8221074|NCT02055820|20273788|P4|NOT COMPLETED|Phase II: Expansion||0
8221075|NCT02055820|20273789|P3|NOT COMPLETED|Phase II: Expansion||0
8221076|NCT02055820|20273790|P2|NOT COMPLETED|Phase II: Expansion||0
8221077|NCT02055820|20273791|P1|NOT COMPLETED|Phase II: Expansion||0
8221078|NCT02055820|20273782|P10|COMPLETED|Phase II: Expansion||0
8221079|NCT02055820|20273783|P9|COMPLETED|Phase II: Expansion||0
8221080|NCT02055820|20273784|P8|COMPLETED|Phase II: Expansion||0
8221081|NCT02055820|20273785|P7|COMPLETED|Phase II: Expansion||0
8221082|NCT02055820|20273786|P6|COMPLETED|Phase II: Expansion||0
8221083|NCT02055820|20273787|P5|COMPLETED|Phase II: Expansion||159
8221084|NCT02055820|20273788|P4|COMPLETED|Phase II: Expansion||0
8221085|NCT02055820|20273789|P3|COMPLETED|Phase II: Expansion||0
8221086|NCT02055820|20273790|P2|COMPLETED|Phase II: Expansion||0
8221087|NCT02055820|20273791|P1|COMPLETED|Phase II: Expansion||0
8221088|NCT02055820|20273782|P10|STARTED|Phase II: Expansion||0
8221089|NCT02055820|20273783|P9|STARTED|Phase II: Expansion||0
8221090|NCT02055820|20273784|P8|STARTED|Phase II: Expansion||0
8221091|NCT02055820|20273785|P7|STARTED|Phase II: Expansion||0
8221092|NCT02055820|20273786|P6|STARTED|Phase II: Expansion||0
8221093|NCT02055820|20273787|P5|STARTED|Phase II: Expansion||208
8221094|NCT02055820|20273788|P4|STARTED|Phase II: Expansion||0
8221095|NCT02055820|20273789|P3|STARTED|Phase II: Expansion||0
8221096|NCT02055820|20273790|P2|STARTED|Phase II: Expansion||0
8221097|NCT02055820|20273791|P1|STARTED|Phase II: Expansion||0
8221098|NCT02055820|20273782|P10|NOT COMPLETED|Phase I: Dose-Finding||0
8221099|NCT02055820|20273783|P9|NOT COMPLETED|Phase I: Dose-Finding||0
8221100|NCT02055820|20273784|P8|NOT COMPLETED|Phase I: Dose-Finding||0
8221101|NCT02055820|20273785|P7|NOT COMPLETED|Phase I: Dose-Finding||2
8221102|NCT02055820|20273786|P6|NOT COMPLETED|Phase I: Dose-Finding||2
8221103|NCT02055820|20273787|P5|NOT COMPLETED|Phase I: Dose-Finding||0
8221104|NCT02055820|20273788|P4|NOT COMPLETED|Phase I: Dose-Finding||3
8221105|NCT02055820|20273789|P3|NOT COMPLETED|Phase I: Dose-Finding||1
8221106|NCT02055820|20273790|P2|NOT COMPLETED|Phase I: Dose-Finding||0
8221107|NCT02055820|20273791|P1|NOT COMPLETED|Phase I: Dose-Finding||1
8221108|NCT02055820|20273782|P10|COMPLETED|Phase I: Dose-Finding||6
8221109|NCT02055820|20273783|P9|COMPLETED|Phase I: Dose-Finding||6
8221110|NCT02055820|20273784|P8|COMPLETED|Phase I: Dose-Finding||6
8221111|NCT02055820|20273785|P7|COMPLETED|Phase I: Dose-Finding||5
8221112|NCT02055820|20273786|P6|COMPLETED|Phase I: Dose-Finding||5
8221113|NCT02055820|20273787|P5|COMPLETED|Phase I: Dose-Finding||0
8221114|NCT02055820|20273788|P4|COMPLETED|Phase I: Dose-Finding||3
8221115|NCT02055820|20273789|P3|COMPLETED|Phase I: Dose-Finding||7
8221116|NCT02055820|20273790|P2|COMPLETED|Phase I: Dose-Finding||3
8221117|NCT02055820|20273791|P1|COMPLETED|Phase I: Dose-Finding||6
8221118|NCT02055820|20273782|P10|STARTED|Phase I: Dose-Finding||6
8221119|NCT02055820|20273783|P9|STARTED|Phase I: Dose-Finding||6
8221120|NCT02055820|20273784|P8|STARTED|Phase I: Dose-Finding||6
8221121|NCT02055820|20273785|P7|STARTED|Phase I: Dose-Finding||7
8221122|NCT02055820|20273786|P6|STARTED|Phase I: Dose-Finding||7
8221123|NCT02055820|20273787|P5|STARTED|Phase I: Dose-Finding||0
8221124|NCT02055820|20273788|P4|STARTED|Phase I: Dose-Finding||6
8221125|NCT02055820|20273789|P3|STARTED|Phase I: Dose-Finding||8
8221126|NCT02055820|20273790|P2|STARTED|Phase I: Dose-Finding||3
8221127|NCT02055820|20273791|P1|STARTED|Phase I: Dose-Finding||7
8221128|NCT02055638|20273895|P2|NOT COMPLETED|Overall Study||8
8221129|NCT02055638|20273896|P1|NOT COMPLETED|Overall Study||10
8221130|NCT02055638|20273895|P2|COMPLETED|Overall Study||40
8221131|NCT02055638|20273896|P1|COMPLETED|Overall Study||39
8221132|NCT02055638|20273895|P2|STARTED|Overall Study||48
8221133|NCT02055638|20273896|P1|STARTED|Overall Study||49
8221134|NCT02055547|20273902|P19|NOT COMPLETED|Overall Study||0
8221135|NCT02055547|20273903|P18|NOT COMPLETED|Overall Study||0
8221136|NCT02055547|20273904|P17|NOT COMPLETED|Overall Study||0
8221137|NCT02055547|20273905|P16|NOT COMPLETED|Overall Study||1
8221138|NCT02055547|20273906|P15|NOT COMPLETED|Overall Study||0
8221139|NCT02055547|20273907|P14|NOT COMPLETED|Overall Study||1
8221140|NCT02055547|20273908|P13|NOT COMPLETED|Overall Study||0
8221141|NCT02055547|20273909|P12|NOT COMPLETED|Overall Study||0
8221142|NCT02055547|20273910|P11|NOT COMPLETED|Overall Study||1
8221143|NCT02055547|20273911|P10|NOT COMPLETED|Overall Study||1
8221144|NCT02055547|20273912|P9|NOT COMPLETED|Overall Study||2
8221145|NCT02055547|20273913|P8|NOT COMPLETED|Overall Study||0
8221146|NCT02055547|20273914|P7|NOT COMPLETED|Overall Study||2
8221147|NCT02055547|20273915|P6|NOT COMPLETED|Overall Study||1
8221148|NCT02055547|20273916|P5|NOT COMPLETED|Overall Study||1
8221149|NCT02055547|20273917|P4|NOT COMPLETED|Overall Study||0
8221150|NCT02055547|20273918|P3|NOT COMPLETED|Overall Study||3
8221151|NCT02055547|20273919|P2|NOT COMPLETED|Overall Study||1
8221152|NCT02055547|20273920|P1|NOT COMPLETED|Overall Study||0
8221153|NCT02055547|20273902|P19|COMPLETED|Overall Study||2
8221154|NCT02055547|20273903|P18|COMPLETED|Overall Study||2
8221155|NCT02055547|20273904|P17|COMPLETED|Overall Study||2
8221156|NCT02055547|20273905|P16|COMPLETED|Overall Study||1
8221157|NCT02055547|20273906|P15|COMPLETED|Overall Study||2
8221158|NCT02055547|20273907|P14|COMPLETED|Overall Study||1
8221159|NCT02055547|20273908|P13|COMPLETED|Overall Study||2
8221160|NCT02055547|20273909|P12|COMPLETED|Overall Study||6
8221161|NCT02055547|20273910|P11|COMPLETED|Overall Study||5
8221162|NCT02055547|20273911|P10|COMPLETED|Overall Study||5
8221163|NCT02055547|20273912|P9|COMPLETED|Overall Study||4
8221164|NCT02055547|20273913|P8|COMPLETED|Overall Study||6
8221165|NCT02055547|20273914|P7|COMPLETED|Overall Study||0
8221166|NCT02055547|20273915|P6|COMPLETED|Overall Study||1
8221167|NCT02055547|20273916|P5|COMPLETED|Overall Study||1
8221168|NCT02055547|20273917|P4|COMPLETED|Overall Study||2
8221169|NCT02055547|20273918|P3|COMPLETED|Overall Study||2
8221170|NCT02055547|20273919|P2|COMPLETED|Overall Study||1
8221171|NCT02055547|20273920|P1|COMPLETED|Overall Study||2
8221172|NCT02055547|20273902|P19|STARTED|Overall Study||2
8221173|NCT02055547|20273903|P18|STARTED|Overall Study||2
8221174|NCT02055547|20273904|P17|STARTED|Overall Study||2
8221175|NCT02055547|20273905|P16|STARTED|Overall Study||2
8221176|NCT02055547|20273906|P15|STARTED|Overall Study||2
8221177|NCT02055547|20273907|P14|STARTED|Overall Study||2
8221178|NCT02055547|20273908|P13|STARTED|Overall Study||2
8221179|NCT02055547|20273909|P12|STARTED|Overall Study||6
8221180|NCT02055547|20273910|P11|STARTED|Overall Study||6
8221181|NCT02055547|20273911|P10|STARTED|Overall Study||6
8221182|NCT02055547|20273912|P9|STARTED|Overall Study||6
8221183|NCT02055547|20273913|P8|STARTED|Overall Study||6
8221184|NCT02055547|20273914|P7|STARTED|Overall Study||2
8221185|NCT02055547|20273915|P6|STARTED|Overall Study||2
8221186|NCT02055547|20273916|P5|STARTED|Overall Study||2
8221187|NCT02055547|20273917|P4|STARTED|Overall Study||2
8221188|NCT02055547|20273918|P3|STARTED|Overall Study||5
8221189|NCT02055547|20273919|P2|STARTED|Overall Study||2
8221190|NCT02055547|20273920|P1|STARTED|Overall Study||2
8221191|NCT02055430|20274069|P2|NOT COMPLETED|Overall Study||0
8221192|NCT02055430|20274070|P1|NOT COMPLETED|Overall Study||0
8221193|NCT02055430|20274069|P2|COMPLETED|Overall Study||45
8221194|NCT02055430|20274070|P1|COMPLETED|Overall Study||45
8221195|NCT02055430|20274069|P2|STARTED|Overall Study||45
8221196|NCT02055430|20274070|P1|STARTED|Overall Study||45
8221197|NCT02055404|20274076|P1|NOT COMPLETED|Overall Study||0
8221198|NCT02055404|20274076|P1|COMPLETED|Overall Study||3
8221199|NCT02055404|20274076|P1|STARTED|Overall Study||3
8221200|NCT02055365|20274089|P1|NOT COMPLETED|Overall Study||1
8221201|NCT02055365|20274089|P1|COMPLETED|Overall Study||9
8221202|NCT02055365|20274089|P1|STARTED|Overall Study||10
8221203|NCT02055352|20274102|P2|NOT COMPLETED|Overall Study||17
8221204|NCT02055352|20274103|P1|NOT COMPLETED|Overall Study||6
8221205|NCT02055352|20274102|P2|COMPLETED|Overall Study||96
8221206|NCT02055352|20274103|P1|COMPLETED|Overall Study||103
8221207|NCT02055352|20274102|P2|Per-Protocol Set (PPS)|Overall Study||111
8221208|NCT02055352|20274103|P1|Per-Protocol Set (PPS)|Overall Study||108
8221209|NCT02055352|20274102|P2|STARTED|Overall Study||113
8221210|NCT02055352|20274103|P1|STARTED|Overall Study||109
8221211|NCT02055157|20274121|P4|NOT COMPLETED|18-month Extension||0
8221212|NCT02055157|20274122|P3|NOT COMPLETED|18-month Extension||0
8221213|NCT02055157|20274123|P2|NOT COMPLETED|18-month Extension||1
8221214|NCT02055157|20274124|P1|NOT COMPLETED|18-month Extension||1
8221215|NCT02055157|20274121|P4|COMPLETED|18-month Extension||8
8221216|NCT02055157|20274122|P3|COMPLETED|18-month Extension||10
8221217|NCT02055157|20274123|P2|COMPLETED|18-month Extension||6
8221218|NCT02055157|20274124|P1|COMPLETED|18-month Extension||6
8221219|NCT02055157|20274121|P4|STARTED|18-month Extension||8
8221220|NCT02055157|20274122|P3|STARTED|18-month Extension||10
8221221|NCT02055157|20274123|P2|STARTED|18-month Extension||7
8221222|NCT02055157|20274124|P1|STARTED|18-month Extension||7
8221223|NCT02055157|20274121|P4|NOT COMPLETED|Initial 6 Months||1
8221224|NCT02055157|20274122|P3|NOT COMPLETED|Initial 6 Months||0
8221225|NCT02055157|20274123|P2|NOT COMPLETED|Initial 6 Months||1
8221226|NCT02055157|20274124|P1|NOT COMPLETED|Initial 6 Months||1
8221227|NCT02055157|20274121|P4|COMPLETED|Initial 6 Months||8
8221228|NCT02055157|20274122|P3|COMPLETED|Initial 6 Months||10
8221229|NCT02055157|20274123|P2|COMPLETED|Initial 6 Months||7
8221230|NCT02055157|20274124|P1|COMPLETED|Initial 6 Months||7
8221231|NCT02055157|20274121|P4|STARTED|Initial 6 Months||9
8221232|NCT02055157|20274122|P3|STARTED|Initial 6 Months||10
8221233|NCT02055157|20274123|P2|STARTED|Initial 6 Months||8
8221234|NCT02055157|20274124|P1|STARTED|Initial 6 Months||8
8221244|NCT02055053|20274265|P2|NOT COMPLETED|Overall Study||0
8221245|NCT02055053|20274266|P1|NOT COMPLETED|Overall Study||0
8221246|NCT02055053|20274265|P2|COMPLETED|Overall Study||35
8221247|NCT02055053|20274266|P1|COMPLETED|Overall Study||35
8221248|NCT02055053|20274265|P2|STARTED|Overall Study||35
8221249|NCT02055053|20274266|P1|STARTED|Overall Study||35
8221250|NCT02054910|20274276|P2|NOT COMPLETED|Overall Study||1
8221251|NCT02054910|20274277|P1|NOT COMPLETED|Overall Study||4
8221252|NCT02054910|20274276|P2|COMPLETED|Overall Study||0
8221253|NCT02054910|20274277|P1|COMPLETED|Overall Study||0
8221254|NCT02054910|20274276|P2|STARTED|Overall Study||1
8221255|NCT02054910|20274277|P1|STARTED|Overall Study||4
8221256|NCT02054897|20274296|P3|NOT COMPLETED|Overall Study||12
8221257|NCT02054897|20274297|P2|NOT COMPLETED|Overall Study||7
8221258|NCT02054897|20274298|P1|NOT COMPLETED|Overall Study||10
8221259|NCT02054897|20274296|P3|COMPLETED|Overall Study||117
8221260|NCT02054897|20274297|P2|COMPLETED|Overall Study||123
8221261|NCT02054897|20274298|P1|COMPLETED|Overall Study||119
8221262|NCT02054897|20274296|P3|Exposed|Overall Study||129
8221263|NCT02054897|20274297|P2|Exposed|Overall Study||130
8221264|NCT02054897|20274298|P1|Exposed|Overall Study||128
8221265|NCT02054897|20274296|P3|STARTED|Overall Study||129
8221266|NCT02054897|20274297|P2|STARTED|Overall Study||130
8221267|NCT02054897|20274298|P1|STARTED|Overall Study||129
8221268|NCT02054754|20274323|P6|NOT COMPLETED|Overall Study||0
8221269|NCT02054754|20274324|P5|NOT COMPLETED|Overall Study||0
8221270|NCT02054754|20274325|P4|NOT COMPLETED|Overall Study||0
8221271|NCT02054754|20274326|P3|NOT COMPLETED|Overall Study||0
8221272|NCT02054754|20274327|P2|NOT COMPLETED|Overall Study||0
8221273|NCT02054754|20274328|P1|NOT COMPLETED|Overall Study||0
8221274|NCT02054754|20274323|P6|COMPLETED|Overall Study||10
8221275|NCT02054754|20274324|P5|COMPLETED|Overall Study||6
8221276|NCT02054754|20274325|P4|COMPLETED|Overall Study||6
8221277|NCT02054754|20274326|P3|COMPLETED|Overall Study||6
8221278|NCT02054754|20274327|P2|COMPLETED|Overall Study||6
8221279|NCT02054754|20274328|P1|COMPLETED|Overall Study||6
8221280|NCT02054754|20274323|P6|STARTED|Overall Study||10
8221281|NCT02054754|20274324|P5|STARTED|Overall Study||6
8221282|NCT02054754|20274325|P4|STARTED|Overall Study||6
8221283|NCT02054754|20274326|P3|STARTED|Overall Study||6
8221284|NCT02054754|20274327|P2|STARTED|Overall Study||6
8221285|NCT02054754|20274328|P1|STARTED|Overall Study||6
8221286|NCT02054715|20274345|P2|NOT COMPLETED|Follow-up 2||19
8221287|NCT02054715|20274346|P1|NOT COMPLETED|Follow-up 2||19
8221288|NCT02054715|20274345|P2|COMPLETED|Follow-up 2||173
8221289|NCT02054715|20274346|P1|COMPLETED|Follow-up 2||192
8221290|NCT02054715|20274345|P2|STARTED|Follow-up 2||192
8221291|NCT02054715|20274346|P1|STARTED|Follow-up 2||211
8221292|NCT02054715|20274345|P2|NOT COMPLETED|Baseline/Follow-up 1||7
8221293|NCT02054715|20274346|P1|NOT COMPLETED|Baseline/Follow-up 1||8
8221294|NCT02054715|20274345|P2|COMPLETED|Baseline/Follow-up 1||192
8221295|NCT02054715|20274346|P1|COMPLETED|Baseline/Follow-up 1||211
8221296|NCT02054715|20274345|P2|STARTED|Baseline/Follow-up 1||199
8221297|NCT02054715|20274346|P1|STARTED|Baseline/Follow-up 1||219
8221298|NCT02054702|20274360|P2|NOT COMPLETED|Overall Study||12
8221299|NCT02054702|20274361|P1|NOT COMPLETED|Overall Study||24
8221300|NCT02054702|20274360|P2|COMPLETED|Overall Study||21
8221301|NCT02054702|20274361|P1|COMPLETED|Overall Study||40
8221302|NCT02054702|20274360|P2|STARTED|Overall Study||33
8221303|NCT02054702|20274361|P1|STARTED|Overall Study||64
8221304|NCT02054572|20274389|P1|NOT COMPLETED|Overall Study||0
8221305|NCT02054572|20274389|P1|COMPLETED|Overall Study||6
8221306|NCT02054572|20274389|P1|STARTED|Overall Study||6
8221307|NCT02054520|20274418|P6|NOT COMPLETED|Overall Study||3
8221308|NCT02054520|20274419|P5|NOT COMPLETED|Overall Study||5
8221309|NCT02054520|20274420|P4|NOT COMPLETED|Overall Study||6
8221310|NCT02054520|20274421|P3|NOT COMPLETED|Overall Study||6
8221311|NCT02054520|20274422|P2|NOT COMPLETED|Overall Study||5
8221312|NCT02054520|20274423|P1|NOT COMPLETED|Overall Study||9
8221313|NCT02054520|20274418|P6|COMPLETED|Overall Study||0
8221314|NCT02054520|20274419|P5|COMPLETED|Overall Study||0
8221315|NCT02054520|20274420|P4|COMPLETED|Overall Study||0
8221316|NCT02054520|20274421|P3|COMPLETED|Overall Study||0
8221317|NCT02054520|20274422|P2|COMPLETED|Overall Study||11
8221318|NCT02054520|20274423|P1|COMPLETED|Overall Study||2
8221319|NCT02054520|20274418|P6|STARTED|Overall Study||3
8221320|NCT02054520|20274419|P5|STARTED|Overall Study||5
8221321|NCT02054520|20274420|P4|STARTED|Overall Study||6
8221322|NCT02054520|20274421|P3|STARTED|Overall Study||6
8221323|NCT02054520|20274422|P2|STARTED|Overall Study||16
8221324|NCT02054520|20274423|P1|STARTED|Overall Study||11
8221325|NCT02054481|20274447|P4|NOT COMPLETED|Overall Study||1
8221326|NCT02054481|20274448|P3|NOT COMPLETED|Overall Study||2
8221327|NCT02054481|20274449|P2|NOT COMPLETED|Overall Study||2
8221328|NCT02054481|20274450|P1|NOT COMPLETED|Overall Study||4
8221329|NCT02054481|20274447|P4|COMPLETED|Overall Study||39
8221330|NCT02054481|20274448|P3|COMPLETED|Overall Study||40
8221331|NCT02054481|20274449|P2|COMPLETED|Overall Study||39
8221332|NCT02054481|20274450|P1|COMPLETED|Overall Study||39
8221333|NCT02054481|20274447|P4|STARTED|Overall Study||40
8221334|NCT02054481|20274448|P3|STARTED|Overall Study||42
8221335|NCT02054481|20274449|P2|STARTED|Overall Study||41
8221336|NCT02054481|20274450|P1|STARTED|Overall Study||43
8221337|NCT02054338|20274498|P2|NOT COMPLETED|Overall Study||501
8221338|NCT02054338|20274499|P1|NOT COMPLETED|Overall Study||503
8221339|NCT02054338|20274498|P2|COMPLETED|Overall Study||0
8221340|NCT02054338|20274499|P1|COMPLETED|Overall Study||0
8221341|NCT02054338|20274498|P2|STARTED|Overall Study||501
8221342|NCT02054338|20274499|P1|STARTED|Overall Study||503
8221343|NCT02054325|20274511|P2|NOT COMPLETED|Overall Study||5
8221344|NCT02054325|20274512|P1|NOT COMPLETED|Overall Study||8
8221345|NCT02054325|20274511|P2|COMPLETED|Overall Study||50
8221346|NCT02054325|20274512|P1|COMPLETED|Overall Study||43
8221347|NCT02054325|20274511|P2|STARTED|Overall Study||55
8221348|NCT02054325|20274512|P1|STARTED|Overall Study||51
8221349|NCT02054156|20274522|P2|NOT COMPLETED|Overall Study||81
8221350|NCT02054156|20274523|P1|NOT COMPLETED|Overall Study||75
8221351|NCT02054156|20274522|P2|COMPLETED|Overall Study||30
8221352|NCT02054156|20274523|P1|COMPLETED|Overall Study||35
8221353|NCT02054156|20274522|P2|STARTED|Overall Study||111
8221354|NCT02054156|20274523|P1|STARTED|Overall Study||110
8221355|NCT02054130|20274539|P4|NOT COMPLETED|Overall Study||22
8221356|NCT02054130|20274540|P3|NOT COMPLETED|Overall Study||15
8221357|NCT02054130|20274541|P2|NOT COMPLETED|Overall Study||11
8221358|NCT02054130|20274542|P1|NOT COMPLETED|Overall Study||8
8221359|NCT02054130|20274539|P4|COMPLETED|Overall Study||115
8221360|NCT02054130|20274540|P3|COMPLETED|Overall Study||122
8221361|NCT02054130|20274541|P2|COMPLETED|Overall Study||127
8221362|NCT02054130|20274542|P1|COMPLETED|Overall Study||130
8221363|NCT02054130|20274539|P4|STARTED|Overall Study||137
8221364|NCT02054130|20274540|P3|STARTED|Overall Study||137
8221365|NCT02054130|20274541|P2|STARTED|Overall Study||138
8221366|NCT02054130|20274542|P1|STARTED|Overall Study||138
8221367|NCT02053753|20274636|P2|NOT COMPLETED|Overall Study||8
8221368|NCT02053753|20274637|P1|NOT COMPLETED|Overall Study||7
8221369|NCT02053753|20274636|P2|COMPLETED|Overall Study||66
8221370|NCT02053753|20274637|P1|COMPLETED|Overall Study||65
8221371|NCT02053753|20274636|P2|Received Treatment|Overall Study||71
8221372|NCT02053753|20274637|P1|Received Treatment|Overall Study||71
8221373|NCT02053753|20274636|P2|STARTED|Overall Study||74
8221374|NCT02053753|20274637|P1|STARTED|Overall Study||72
8221375|NCT02053610|20274661|P2|NOT COMPLETED|Overall Study||67
8221376|NCT02053610|20274662|P1|NOT COMPLETED|Overall Study||42
8221377|NCT02053610|20274661|P2|COMPLETED|Overall Study|Completed=Completed Treatment|266
8221378|NCT02053610|20274662|P1|COMPLETED|Overall Study|Completed=Completed Treatment|288
8221379|NCT02053610|20274661|P2|Received Study Drug|Overall Study||331
8221380|NCT02053610|20274662|P1|Received Study Drug|Overall Study||326
8221381|NCT02053610|20274661|P2|STARTED|Overall Study||333
8221382|NCT02053610|20274662|P1|STARTED|Overall Study||330
8221383|NCT02053493|20274694|P2|NOT COMPLETED|Overall Study||1
8221384|NCT02053493|20274695|P1|NOT COMPLETED|Overall Study||1
8221385|NCT02053493|20274694|P2|COMPLETED|Overall Study||58
8221386|NCT02053493|20274695|P1|COMPLETED|Overall Study||50
8221387|NCT02053493|20274694|P2|STARTED|Overall Study||59
8221388|NCT02053493|20274695|P1|STARTED|Overall Study||51
8221389|NCT02053376|20274733|P1|NOT COMPLETED|Overall Study||0
8221390|NCT02053376|20274733|P1|COMPLETED|Overall Study||43
8221391|NCT02053376|20274733|P1|STARTED|Overall Study||43
8221392|NCT02053259|20274748|P4|NOT COMPLETED|Overall Study||0
8221393|NCT02053259|20274749|P3|NOT COMPLETED|Overall Study||0
8221394|NCT02053259|20274750|P2|NOT COMPLETED|Overall Study||0
8221395|NCT02053259|20274751|P1|NOT COMPLETED|Overall Study||0
8221396|NCT02053259|20274748|P4|COMPLETED|Overall Study||23
8221397|NCT02053259|20274749|P3|COMPLETED|Overall Study||24
8221398|NCT02053259|20274750|P2|COMPLETED|Overall Study||24
8221399|NCT02053259|20274751|P1|COMPLETED|Overall Study||25
8221400|NCT02053259|20274748|P4|STARTED|Overall Study||23
8221401|NCT02053259|20274749|P3|STARTED|Overall Study||24
8221402|NCT02053259|20274750|P2|STARTED|Overall Study||24
8221403|NCT02053259|20274751|P1|STARTED|Overall Study||25
8221404|NCT02053168|20274761|P1|NOT COMPLETED|Overall Study||3
8221405|NCT02053168|20274761|P1|COMPLETED|Overall Study||22
8221406|NCT02053168|20274761|P1|STARTED|Overall Study||25
8221407|NCT02052895|20274778|P3|NOT COMPLETED|Overall Study||0
8221408|NCT02052895|20274779|P2|NOT COMPLETED|Overall Study||0
8221409|NCT02052895|20274780|P1|NOT COMPLETED|Overall Study||0
8221410|NCT02052895|20274778|P3|COMPLETED|Overall Study||15
8221411|NCT02052895|20274779|P2|COMPLETED|Overall Study||15
8221412|NCT02052895|20274780|P1|COMPLETED|Overall Study||196
8221413|NCT02052895|20274778|P3|STARTED|Overall Study||15
8221414|NCT02052895|20274779|P2|STARTED|Overall Study||15
8221415|NCT02052895|20274780|P1|STARTED|Overall Study||196
8221416|NCT02052752|20274790|P3|NOT COMPLETED|Overall Study||0
8221417|NCT02052752|20274791|P2|NOT COMPLETED|Overall Study||0
8221418|NCT02052752|20274792|P1|NOT COMPLETED|Overall Study||0
8221419|NCT02052752|20274790|P3|COMPLETED|Overall Study||30
8221420|NCT02052752|20274791|P2|COMPLETED|Overall Study||30
8221421|NCT02052752|20274792|P1|COMPLETED|Overall Study||30
8221422|NCT02052752|20274790|P3|STARTED|Overall Study||30
8221423|NCT02052752|20274791|P2|STARTED|Overall Study||30
8221424|NCT02052752|20274792|P1|STARTED|Overall Study||30
8221425|NCT02052661|20274815|P1|NOT COMPLETED|Overall Study||0
8221426|NCT02052661|20274815|P1|COMPLETED|Overall Study||300
8221427|NCT02052661|20274815|P1|STARTED|Overall Study||300
8221428|NCT02052635|20274829|P2|NOT COMPLETED|Overall Study||0
8221429|NCT02052635|20274830|P1|NOT COMPLETED|Overall Study||0
8221430|NCT02052635|20274829|P2|COMPLETED|Overall Study||6
8221431|NCT02052635|20274830|P1|COMPLETED|Overall Study||7
8221432|NCT02052635|20274829|P2|STARTED|Overall Study||6
8221433|NCT02052635|20274830|P1|STARTED|Overall Study||7
8221434|NCT02052596|20274840|P2|NOT COMPLETED|Safety Phase||35
8221435|NCT02052596|20274841|P1|NOT COMPLETED|Safety Phase||27
8221436|NCT02052596|20274840|P2|COMPLETED|Safety Phase||383
8221437|NCT02052596|20274841|P1|COMPLETED|Safety Phase||385
8221438|NCT02052596|20274840|P2|STARTED|Safety Phase||418
8221439|NCT02052596|20274841|P1|STARTED|Safety Phase||412
8221440|NCT02052596|20274840|P2|NOT COMPLETED|Active Phase||20
8221441|NCT02052596|20274841|P1|NOT COMPLETED|Active Phase||16
8221442|NCT02052596|20274840|P2|COMPLETED|Active Phase||398
8221443|NCT02052596|20274841|P1|COMPLETED|Active Phase||396
8221444|NCT02052596|20274840|P2|STARTED|Active Phase||418
8221445|NCT02052596|20274841|P1|STARTED|Active Phase||412
8221446|NCT02052557|20274868|P2|NOT COMPLETED|Overall Study||0
8221447|NCT02052557|20274869|P1|NOT COMPLETED|Overall Study||0
8221448|NCT02052557|20274868|P2|COMPLETED|Overall Study||25
8221449|NCT02052557|20274869|P1|COMPLETED|Overall Study||26
8221450|NCT02052557|20274868|P2|STARTED|Overall Study||25
8221451|NCT02052557|20274869|P1|STARTED|Overall Study||26
8221452|NCT02052544|20274901|P1|NOT COMPLETED|Overall Study||0
8221453|NCT02052544|20274901|P1|COMPLETED|Overall Study|Last Subject Out|123
8221454|NCT02052544|20274901|P1|STARTED|Overall Study|First Subject In|123
8221455|NCT02052466|20274906|P1|NOT COMPLETED|Overall Study||2
8221456|NCT02052466|20274906|P1|COMPLETED|Overall Study||30
8221457|NCT02052466|20274906|P1|STARTED|Overall Study||32
8221458|NCT02052440|20274923|P2|NOT COMPLETED|Overall Study||1
8221459|NCT02052440|20274924|P1|NOT COMPLETED|Overall Study||0
8221460|NCT02052440|20274923|P2|COMPLETED|Overall Study||51
8221461|NCT02052440|20274924|P1|COMPLETED|Overall Study||50
8221462|NCT02052440|20274923|P2|STARTED|Overall Study||52
8221463|NCT02052440|20274924|P1|STARTED|Overall Study||50
8221464|NCT02052414|20274936|P1|NOT COMPLETED|Overall Study||17
8221465|NCT02052414|20274936|P1|COMPLETED|Overall Study||17
8221466|NCT02052414|20274936|P1|STARTED|Overall Study||34
8221479|NCT02052011|20274971|P2|NOT COMPLETED|Overall Study||2
8221480|NCT02052011|20274972|P1|NOT COMPLETED|Overall Study||4
8221481|NCT02052011|20274971|P2|COMPLETED|Overall Study||8
8221482|NCT02052011|20274972|P1|COMPLETED|Overall Study||17
8221483|NCT02052011|20274971|P2|STARTED|Overall Study||10
8221484|NCT02052011|20274972|P1|STARTED|Overall Study||21
8221485|NCT02051816|20274982|P4|NOT COMPLETED|Overall Study||0
8221486|NCT02051816|20274983|P3|NOT COMPLETED|Overall Study||0
8221487|NCT02051816|20274984|P2|NOT COMPLETED|Overall Study||0
8221488|NCT02051816|20274985|P1|NOT COMPLETED|Overall Study||0
8221489|NCT02051816|20274982|P4|COMPLETED|Overall Study||36
8221490|NCT02051816|20274983|P3|COMPLETED|Overall Study||37
8221491|NCT02051816|20274984|P2|COMPLETED|Overall Study||40
8221492|NCT02051816|20274985|P1|COMPLETED|Overall Study||37
8221493|NCT02051816|20274982|P4|STARTED|Overall Study||36
8221494|NCT02051816|20274983|P3|STARTED|Overall Study||37
8221495|NCT02051816|20274984|P2|STARTED|Overall Study||40
8221496|NCT02051816|20274985|P1|STARTED|Overall Study||37
8221497|NCT02051790|20275023|P1|NOT COMPLETED|Overall Study||0
8221498|NCT02051790|20275023|P1|COMPLETED|Overall Study||241
8221499|NCT02051790|20275023|P1|STARTED|Overall Study||241
8221500|NCT02051764|20275029|P2|NOT COMPLETED|Overall Study||7
8221501|NCT02051764|20275030|P1|NOT COMPLETED|Overall Study||0
8221502|NCT02051764|20275029|P2|COMPLETED|Overall Study||21
8221503|NCT02051764|20275030|P1|COMPLETED|Overall Study||16
8221504|NCT02051764|20275029|P2|STARTED|Overall Study||28
8221505|NCT02051764|20275030|P1|STARTED|Overall Study||16
8221506|NCT02051686|20275038|P2|NOT COMPLETED|Overall Study||0
8221507|NCT02051686|20275039|P1|NOT COMPLETED|Overall Study||0
8221508|NCT02051686|20275038|P2|COMPLETED|Overall Study||46
8221509|NCT02051686|20275039|P1|COMPLETED|Overall Study||42
8221510|NCT02051686|20275038|P2|STARTED|Overall Study||46
8221511|NCT02051686|20275039|P1|STARTED|Overall Study||42
8221512|NCT02051595|20275047|P1|NOT COMPLETED|Overall Study||0
8221513|NCT02051595|20275047|P1|COMPLETED|Overall Study||25
8221514|NCT02051595|20275047|P1|STARTED|Overall Study||25
8221515|NCT02051452|20275053|P2|NOT COMPLETED|Overall Study||0
8221516|NCT02051452|20275054|P1|NOT COMPLETED|Overall Study||0
8221517|NCT02051452|20275053|P2|COMPLETED|Overall Study||16
8221518|NCT02051452|20275054|P1|COMPLETED|Overall Study||16
8221519|NCT02051452|20275053|P2|STARTED|Overall Study||16
8221520|NCT02051452|20275054|P1|STARTED|Overall Study||16
8221521|NCT02051426|20275066|P2|NOT COMPLETED|Second Intervention||0
8221522|NCT02051426|20275067|P1|NOT COMPLETED|Second Intervention||0
8221523|NCT02051426|20275066|P2|COMPLETED|Second Intervention||19
8221524|NCT02051426|20275067|P1|COMPLETED|Second Intervention||16
8221525|NCT02051426|20275066|P2|STARTED|Second Intervention||19
8221526|NCT02051426|20275067|P1|STARTED|Second Intervention||16
8221527|NCT02051426|20275066|P2|NOT COMPLETED|Washout Period of 1 Month||0
8221528|NCT02051426|20275067|P1|NOT COMPLETED|Washout Period of 1 Month||0
8221529|NCT02051426|20275066|P2|COMPLETED|Washout Period of 1 Month||19
8221530|NCT02051426|20275067|P1|COMPLETED|Washout Period of 1 Month||16
8221531|NCT02051426|20275066|P2|STARTED|Washout Period of 1 Month||19
8221532|NCT02051426|20275067|P1|STARTED|Washout Period of 1 Month||16
8221533|NCT02051426|20275066|P2|NOT COMPLETED|First Intervention||0
8221534|NCT02051426|20275067|P1|NOT COMPLETED|First Intervention||0
8221535|NCT02051426|20275066|P2|COMPLETED|First Intervention||19
8221536|NCT02051426|20275067|P1|COMPLETED|First Intervention||16
8221537|NCT02051426|20275066|P2|STARTED|First Intervention||19
8221538|NCT02051426|20275067|P1|STARTED|First Intervention||16
8221539|NCT02051335|20275081|P4|NOT COMPLETED|Period 4||0
8221540|NCT02051335|20275082|P3|NOT COMPLETED|Period 4||0
8221541|NCT02051335|20275083|P2|NOT COMPLETED|Period 4||0
8221542|NCT02051335|20275084|P1|NOT COMPLETED|Period 4||0
8221543|NCT02051335|20275081|P4|COMPLETED|Period 4||4
8221544|NCT02051335|20275082|P3|COMPLETED|Period 4||5
8221545|NCT02051335|20275083|P2|COMPLETED|Period 4||7
8221546|NCT02051335|20275084|P1|COMPLETED|Period 4||7
8221547|NCT02051335|20275081|P4|STARTED|Period 4||4
8221548|NCT02051335|20275082|P3|STARTED|Period 4||5
8221549|NCT02051335|20275083|P2|STARTED|Period 4||7
8221550|NCT02051335|20275084|P1|STARTED|Period 4||7
8221551|NCT02051335|20275081|P4|NOT COMPLETED|Period 3||0
8221552|NCT02051335|20275082|P3|NOT COMPLETED|Period 3||0
8221553|NCT02051335|20275083|P2|NOT COMPLETED|Period 3||0
8221554|NCT02051335|20275084|P1|NOT COMPLETED|Period 3||0
8221555|NCT02051335|20275081|P4|COMPLETED|Period 3||4
8221556|NCT02051335|20275082|P3|COMPLETED|Period 3||5
8221557|NCT02051335|20275083|P2|COMPLETED|Period 3||7
8221558|NCT02051335|20275084|P1|COMPLETED|Period 3||7
8221559|NCT02051335|20275081|P4|STARTED|Period 3||4
8221560|NCT02051335|20275082|P3|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
8221561|NCT02051335|20275083|P2|STARTED|Period 3||7
8221562|NCT02051335|20275084|P1|STARTED|Period 3||7
8221563|NCT02051335|20275081|P4|NOT COMPLETED|Period 2||0
8221564|NCT02051335|20275082|P3|NOT COMPLETED|Period 2||0
8221565|NCT02051335|20275083|P2|NOT COMPLETED|Period 2||0
8221566|NCT02051335|20275084|P1|NOT COMPLETED|Period 2||0
8221567|NCT02051335|20275081|P4|COMPLETED|Period 2||4
8221568|NCT02051335|20275082|P3|COMPLETED|Period 2||7
8221569|NCT02051335|20275083|P2|COMPLETED|Period 2||7
8221570|NCT02051335|20275084|P1|COMPLETED|Period 2||7
8221571|NCT02051335|20275081|P4|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
8221572|NCT02051335|20275082|P3|STARTED|Period 2||7
8221573|NCT02051335|20275083|P2|STARTED|Period 2||7
8221574|NCT02051335|20275084|P1|STARTED|Period 2||7
8221575|NCT02051335|20275081|P4|NOT COMPLETED|Period 1||0
8221576|NCT02051335|20275082|P3|NOT COMPLETED|Period 1||0
8221577|NCT02051335|20275083|P2|NOT COMPLETED|Period 1||0
8221578|NCT02051335|20275084|P1|NOT COMPLETED|Period 1||0
8221579|NCT02051335|20275081|P4|COMPLETED|Period 1||6
8221580|NCT02051335|20275082|P3|COMPLETED|Period 1||7
8221581|NCT02051335|20275083|P2|COMPLETED|Period 1||7
8221582|NCT02051335|20275084|P1|COMPLETED|Period 1||7
8221583|NCT02051335|20275081|P4|STARTED|Period 1||6
8221584|NCT02051335|20275082|P3|STARTED|Period 1||7
8221585|NCT02051335|20275083|P2|STARTED|Period 1||7
8221586|NCT02051335|20275084|P1|STARTED|Period 1||7
8221587|NCT02051296|20275136|P2|NOT COMPLETED|Overall Study||9
8221588|NCT02051296|20275137|P1|NOT COMPLETED|Overall Study||8
8221589|NCT02051296|20275136|P2|COMPLETED|Overall Study||56
8221590|NCT02051296|20275137|P1|COMPLETED|Overall Study||58
8221591|NCT02051296|20275136|P2|Received Allocated Intervention|Overall Study||58
8221592|NCT02051296|20275137|P1|Received Allocated Intervention|Overall Study||59
8221593|NCT02051296|20275136|P2|STARTED|Overall Study||65
8221594|NCT02051296|20275137|P1|STARTED|Overall Study||66
8221598|NCT02050841|20275147|P1|NOT COMPLETED|Overall Study||1
8221599|NCT02050841|20275147|P1|COMPLETED|Overall Study||49
8221600|NCT02050841|20275147|P1|STARTED|Overall Study||50
8221601|NCT02050373|20275188|P2|NOT COMPLETED|Overall Study||10
8221602|NCT02050373|20275189|P1|NOT COMPLETED|Overall Study||7
8221603|NCT02050373|20275188|P2|COMPLETED|Overall Study||24
8221604|NCT02050373|20275189|P1|COMPLETED|Overall Study||27
8221605|NCT02050373|20275188|P2|STARTED|Overall Study||34
8221606|NCT02050373|20275189|P1|STARTED|Overall Study||34
8221607|NCT02050334|20275199|P2|NOT COMPLETED|Overall Study||0
8221608|NCT02050334|20275200|P1|NOT COMPLETED|Overall Study||0
8221609|NCT02050334|20275199|P2|COMPLETED|Overall Study||9
8221610|NCT02050334|20275200|P1|COMPLETED|Overall Study||9
8221611|NCT02050334|20275199|P2|STARTED|Overall Study||9
8221612|NCT02050334|20275200|P1|STARTED|Overall Study||9
8221613|NCT02050321|20275208|P1|NOT COMPLETED|Overall Study||2
8221614|NCT02050321|20275208|P1|COMPLETED|Overall Study||0
8221615|NCT02050321|20275208|P1|STARTED|Overall Study||2
8221616|NCT02050308|20275215|P2|NOT COMPLETED|Overall Study||102
8221617|NCT02050308|20275216|P1|NOT COMPLETED|Overall Study||99
8221618|NCT02050308|20275215|P2|COMPLETED|Overall Study||22
8221619|NCT02050308|20275216|P1|COMPLETED|Overall Study||28
8221620|NCT02050308|20275215|P2|STARTED|Overall Study||124
8221621|NCT02050308|20275216|P1|STARTED|Overall Study||127
8221622|NCT02050048|20275224|P2|NOT COMPLETED|Overall Study||2
8221623|NCT02050048|20275225|P1|NOT COMPLETED|Overall Study||5
8221624|NCT02050048|20275224|P2|COMPLETED|Overall Study||10
8221625|NCT02050048|20275225|P1|COMPLETED|Overall Study||9
8221626|NCT02050048|20275224|P2|STARTED|Overall Study||12
8221627|NCT02050048|20275225|P1|STARTED|Overall Study||14
8221628|NCT02049957|20275240|P9|NOT COMPLETED|Overall Study||8
8221629|NCT02049957|20275241|P8|NOT COMPLETED|Overall Study||35
8221630|NCT02049957|20275242|P7|NOT COMPLETED|Overall Study||8
8221631|NCT02049957|20275243|P6|NOT COMPLETED|Overall Study||43
8221632|NCT02049957|20275244|P5|NOT COMPLETED|Overall Study||6
8221633|NCT02049957|20275245|P4|NOT COMPLETED|Overall Study||3
8221634|NCT02049957|20275246|P3|NOT COMPLETED|Overall Study||3
8221635|NCT02049957|20275247|P2|NOT COMPLETED|Overall Study||6
8221636|NCT02049957|20275248|P1|NOT COMPLETED|Overall Study||6
8221637|NCT02049957|20275240|P9|COMPLETED|Overall Study||0
8221638|NCT02049957|20275241|P8|COMPLETED|Overall Study||0
8221639|NCT02049957|20275242|P7|COMPLETED|Overall Study||0
8221640|NCT02049957|20275243|P6|COMPLETED|Overall Study||0
8221641|NCT02049957|20275244|P5|COMPLETED|Overall Study||0
8221642|NCT02049957|20275245|P4|COMPLETED|Overall Study||0
8221643|NCT02049957|20275246|P3|COMPLETED|Overall Study||0
8221644|NCT02049957|20275247|P2|COMPLETED|Overall Study||0
8221645|NCT02049957|20275248|P1|COMPLETED|Overall Study||0
8221646|NCT02049957|20275240|P9|STARTED|Overall Study||8
8221647|NCT02049957|20275241|P8|STARTED|Overall Study||35
8221648|NCT02049957|20275242|P7|STARTED|Overall Study||8
8221649|NCT02049957|20275243|P6|STARTED|Overall Study||43
8221650|NCT02049957|20275244|P5|STARTED|Overall Study||6
8221651|NCT02049957|20275245|P4|STARTED|Overall Study||3
8221652|NCT02049957|20275246|P3|STARTED|Overall Study||3
8221653|NCT02049957|20275247|P2|STARTED|Overall Study||6
8221654|NCT02049957|20275248|P1|STARTED|Overall Study||6
8221655|NCT02049931|20275316|P3|NOT COMPLETED|Overall Study||3
8221656|NCT02049931|20275317|P2|NOT COMPLETED|Overall Study||5
8221657|NCT02049931|20275318|P1|NOT COMPLETED|Overall Study||3
8221658|NCT02049931|20275316|P3|COMPLETED|Overall Study||17
8221659|NCT02049931|20275317|P2|COMPLETED|Overall Study||15
8221660|NCT02049931|20275318|P1|COMPLETED|Overall Study||17
8221661|NCT02049931|20275316|P3|STARTED|Overall Study||20
8221662|NCT02049931|20275317|P2|STARTED|Overall Study||20
8221663|NCT02049931|20275318|P1|STARTED|Overall Study||20
8221664|NCT02049814|20275340|P2|NOT COMPLETED|Overall Study||27
8221665|NCT02049814|20275341|P1|NOT COMPLETED|Overall Study||29
8221666|NCT02049814|20275340|P2|COMPLETED|Overall Study||219
8221667|NCT02049814|20275341|P1|COMPLETED|Overall Study||219
8221668|NCT02049814|20275340|P2|Safety Set|Overall Study||245
8221669|NCT02049814|20275341|P1|Safety Set|Overall Study||248
8221670|NCT02049814|20275340|P2|STARTED|Overall Study||246
8221671|NCT02049814|20275341|P1|STARTED|Overall Study||248
8221672|NCT02049749|20275369|P2|NOT COMPLETED|Overall Study||0
8221673|NCT02049749|20275370|P1|NOT COMPLETED|Overall Study||0
8221674|NCT02049749|20275369|P2|COMPLETED|Overall Study|80 children plus 80 caregivers|160
8221675|NCT02049749|20275370|P1|COMPLETED|Overall Study||80
8221676|NCT02049749|20275369|P2|STARTED|Overall Study|80 children plus 80 caregivers|160
8221677|NCT02049749|20275370|P1|STARTED|Overall Study|40 children plus 40 caregivers|80
8221678|NCT02049502|20275378|P1|NOT COMPLETED|Overall Study||0
8221679|NCT02049502|20275378|P1|COMPLETED|Overall Study||8
8221680|NCT02049502|20275378|P1|STARTED|Overall Study||8
8221681|NCT02049476|20275383|P1|NOT COMPLETED|Overall Study||0
8221682|NCT02049476|20275383|P1|COMPLETED|Overall Study|20th patient completed the study|20
8221683|NCT02049476|20275383|P1|STARTED|Overall Study|First patient enrolled on 1/31/2014|20
8221684|NCT02049450|20275390|P1|NOT COMPLETED|Overall Study||4
8221685|NCT02049450|20275390|P1|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
8221686|NCT02049450|20275390|P1|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
8221687|NCT02049450|20275390|P1|Discontinued Treatment Prior to Week 30|Overall Study||4
8221688|NCT02049450|20275390|P1|STARTED|Overall Study||30
8221689|NCT02049437|20275406|P2|NOT COMPLETED|Washout 2||0
8221690|NCT02049437|20275407|P1|NOT COMPLETED|Washout 2||0
8221691|NCT02049437|20275406|P2|COMPLETED|Washout 2||16
8221692|NCT02049437|20275407|P1|COMPLETED|Washout 2||15
8221693|NCT02049437|20275406|P2|STARTED|Washout 2||16
8221694|NCT02049437|20275407|P1|STARTED|Washout 2||15
8221695|NCT02049437|20275406|P2|NOT COMPLETED|Period 2||0
8221696|NCT02049437|20275407|P1|NOT COMPLETED|Period 2||0
8221697|NCT02049437|20275406|P2|COMPLETED|Period 2||16
8221698|NCT02049437|20275407|P1|COMPLETED|Period 2||15
8221699|NCT02049437|20275406|P2|STARTED|Period 2||16
8221700|NCT02049437|20275407|P1|STARTED|Period 2||15
8221701|NCT02049437|20275406|P2|NOT COMPLETED|Washout 1||0
8221702|NCT02049437|20275407|P1|NOT COMPLETED|Washout 1||0
8221703|NCT02049437|20275406|P2|COMPLETED|Washout 1||16
8221704|NCT02049437|20275407|P1|COMPLETED|Washout 1||15
8221705|NCT02049437|20275406|P2|STARTED|Washout 1||16
8221706|NCT02049437|20275407|P1|STARTED|Washout 1||15
8221707|NCT02049437|20275406|P2|NOT COMPLETED|Period 1||1
8221708|NCT02049437|20275407|P1|NOT COMPLETED|Period 1||2
8221709|NCT02049437|20275406|P2|COMPLETED|Period 1|Dropout due to low trough levels|16
8221710|NCT02049437|20275407|P1|COMPLETED|Period 1||15
8221711|NCT02049437|20275406|P2|STARTED|Period 1||17
8221712|NCT02049437|20275407|P1|STARTED|Period 1||17
8221713|NCT02049385|20275417|P2|NOT COMPLETED|Second Intervention||2
8221714|NCT02049385|20275418|P1|NOT COMPLETED|Second Intervention||0
8221715|NCT02049385|20275417|P2|COMPLETED|Second Intervention||0
8221716|NCT02049385|20275418|P1|COMPLETED|Second Intervention||1
8221717|NCT02049385|20275417|P2|STARTED|Second Intervention||2
8221718|NCT02049385|20275418|P1|STARTED|Second Intervention||1
8221719|NCT02049385|20275417|P2|NOT COMPLETED|First Intervention||0
8221720|NCT02049385|20275418|P1|NOT COMPLETED|First Intervention||3
8221721|NCT02049385|20275417|P2|COMPLETED|First Intervention||2
8221722|NCT02049385|20275418|P1|COMPLETED|First Intervention||1
8221723|NCT02049385|20275417|P2|STARTED|First Intervention||2
8221724|NCT02049385|20275418|P1|STARTED|First Intervention||4
8221725|NCT02049307|20275426|P2|NOT COMPLETED|Overall Study||1
8221726|NCT02049307|20275427|P1|NOT COMPLETED|Overall Study||2
8221727|NCT02049307|20275426|P2|COMPLETED|Overall Study||55
8221728|NCT02049307|20275427|P1|COMPLETED|Overall Study||50
8221729|NCT02049307|20275426|P2|STARTED|Overall Study||56
8221730|NCT02049307|20275427|P1|STARTED|Overall Study||52
8221731|NCT02049151|20275437|P2|NOT COMPLETED|Overall Study||0
8221732|NCT02049151|20275438|P1|NOT COMPLETED|Overall Study||0
8221733|NCT02049151|20275437|P2|COMPLETED|Overall Study||17
8221734|NCT02049151|20275438|P1|COMPLETED|Overall Study||15
8221735|NCT02049151|20275437|P2|STARTED|Overall Study|1 subject did not receive treatment|17
8221736|NCT02049151|20275438|P1|STARTED|Overall Study|2 subjects did not receive treatment|15
8221737|NCT02048904|20275452|P1|NOT COMPLETED|Overall Study||77
8221738|NCT02048904|20275452|P1|COMPLETED|Overall Study||65
8221739|NCT02048904|20275452|P1|STARTED|Overall Study||142
8221740|NCT02048891|20275458|P2|NOT COMPLETED|Overall Study||0
8221741|NCT02048891|20275459|P1|NOT COMPLETED|Overall Study||0
8221742|NCT02048891|20275458|P2|COMPLETED|Overall Study||1
8221743|NCT02048891|20275459|P1|COMPLETED|Overall Study||2
8221744|NCT02048891|20275458|P2|STARTED|Overall Study||1
8221745|NCT02048891|20275459|P1|STARTED|Overall Study||2
8221746|NCT02048878|20275467|P2|NOT COMPLETED|Overall Study||3
8221747|NCT02048878|20275468|P1|NOT COMPLETED|Overall Study||1
8221748|NCT02048878|20275467|P2|COMPLETED|Overall Study||12
8221749|NCT02048878|20275468|P1|COMPLETED|Overall Study||12
8221750|NCT02048878|20275467|P2|STARTED|Overall Study||15
8221751|NCT02048878|20275468|P1|STARTED|Overall Study||13
8221752|NCT02048722|20275484|P1|NOT COMPLETED|Follow up for 5 Years||29
8221753|NCT02048722|20275484|P1|COMPLETED|Follow up for 5 Years||0
8221754|NCT02048722|20275484|P1|STARTED|Follow up for 5 Years|2 patients remain on treatment and have not gone into follow up phase yet.|29
8221755|NCT02048722|20275484|P1|NOT COMPLETED|Reached 1st Response/Continued Treatment||10
8221756|NCT02048722|20275484|P1|COMPLETED|Reached 1st Response/Continued Treatment||13
8221757|NCT02048722|20275484|P1|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||13
8221758|NCT02048722|20275484|P1|Assessed for First Response|Reached 1st Response/Continued Treatment||23
8221759|NCT02048722|20275484|P1|STARTED|Reached 1st Response/Continued Treatment||23
8221760|NCT02048722|20275484|P1|NOT COMPLETED|2 Cycles of Treatment||8
8221761|NCT02048722|20275484|P1|COMPLETED|2 Cycles of Treatment||23
8221762|NCT02048722|20275484|P1|Attempted 2nd Cycle|2 Cycles of Treatment||23
8221763|NCT02048722|20275484|P1|Attempted 1st Cycle|2 Cycles of Treatment||31
8221764|NCT02048722|20275484|P1|STARTED|2 Cycles of Treatment||31
8221765|NCT02048670|20275496|P2|NOT COMPLETED|Overall Study||0
8221766|NCT02048670|20275497|P1|NOT COMPLETED|Overall Study||0
8221767|NCT02048670|20275496|P2|COMPLETED|Overall Study||6
8221768|NCT02048670|20275497|P1|COMPLETED|Overall Study||6
8221769|NCT02048670|20275496|P2|STARTED|Overall Study||6
8221770|NCT02048670|20275497|P1|STARTED|Overall Study||6
8221771|NCT02048241|20275507|P2|NOT COMPLETED|Overall Study||1
8221772|NCT02048241|20275508|P1|NOT COMPLETED|Overall Study||0
8221773|NCT02048241|20275507|P2|COMPLETED|Overall Study||5
8221774|NCT02048241|20275508|P1|COMPLETED|Overall Study||5
8221775|NCT02048241|20275507|P2|STARTED|Overall Study||6
8221776|NCT02048241|20275508|P1|STARTED|Overall Study||5
8221777|NCT02048072|20275514|P1|NOT COMPLETED|Overall Study||4
8221778|NCT02048072|20275514|P1|COMPLETED|Overall Study||29
8221779|NCT02048072|20275514|P1|STARTED|Overall Study||33
8221780|NCT02047981|20275520|P2|NOT COMPLETED|MORDOR Stage II Year 3||2363
8221781|NCT02047981|20275521|P1|NOT COMPLETED|MORDOR Stage II Year 3||2886
8221782|NCT02047981|20275520|P2|COMPLETED|MORDOR Stage II Year 3||30931
8221783|NCT02047981|20275521|P1|COMPLETED|MORDOR Stage II Year 3||34611
8221784|NCT02047981|20275520|P2|STARTED|MORDOR Stage II Year 3||33294
8221785|NCT02047981|20275521|P1|STARTED|MORDOR Stage II Year 3||37497
8221786|NCT02047981|20275520|P2|NOT COMPLETED|MORDOR Stage I Year 1-2||8717
8221787|NCT02047981|20275521|P1|NOT COMPLETED|MORDOR Stage I Year 1-2||9397
8221788|NCT02047981|20275520|P2|COMPLETED|MORDOR Stage I Year 1-2||84474
8221789|NCT02047981|20275521|P1|COMPLETED|MORDOR Stage I Year 1-2||87650
8221790|NCT02047981|20275520|P2|STARTED|MORDOR Stage I Year 1-2||93191
8221791|NCT02047981|20275521|P1|STARTED|MORDOR Stage I Year 1-2||97047
8221792|NCT02047929|20275538|P3|NOT COMPLETED|Overall Study||0
8221793|NCT02047929|20275539|P2|NOT COMPLETED|Overall Study||0
8221794|NCT02047929|20275540|P1|NOT COMPLETED|Overall Study||0
8221795|NCT02047929|20275538|P3|COMPLETED|Overall Study||2248
8221796|NCT02047929|20275539|P2|COMPLETED|Overall Study||2523
8221797|NCT02047929|20275540|P1|COMPLETED|Overall Study||1503
8221798|NCT02047929|20275538|P3|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0
8221799|NCT02047929|20275539|P2|Surveys Collected|Overall Study||2523
8221800|NCT02047929|20275540|P1|Surveys Collected|Overall Study||1503
8221801|NCT02047929|20275538|P3|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0
8221802|NCT02047929|20275539|P2|Practice Refresher|Overall Study||2523
8221803|NCT02047929|20275540|P1|Practice Refresher|Overall Study||1503
8221804|NCT02047929|20275538|P3|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0
8221805|NCT02047929|20275539|P2|Practice Rollout|Overall Study||2523
8221806|NCT02047929|20275540|P1|Practice Rollout|Overall Study||1503
8221807|NCT02047929|20275538|P3|STARTED|Overall Study||2248
8221808|NCT02047929|20275539|P2|STARTED|Overall Study||2523
8221809|NCT02047929|20275540|P1|STARTED|Overall Study||1503
8221810|NCT02047903|20275553|P1|NOT COMPLETED|Overall Study||59
8221811|NCT02047903|20275553|P1|COMPLETED|Overall Study||102
8221812|NCT02047903|20275553|P1|Treated|Overall Study||152
8221813|NCT02047903|20275553|P1|STARTED|Overall Study||161
8221814|NCT02047747|20275565|P1|NOT COMPLETED|Overall Study||3
8221815|NCT02047747|20275565|P1|COMPLETED|Overall Study||1
8221816|NCT02047747|20275565|P1|STARTED|Overall Study||4
8221817|NCT02047643|20275570|P2|NOT COMPLETED|Overall Study||0
8221818|NCT02047643|20275571|P1|NOT COMPLETED|Overall Study||0
8221819|NCT02047643|20275570|P2|COMPLETED|Overall Study||9
8221820|NCT02047643|20275571|P1|COMPLETED|Overall Study||9
8221821|NCT02047643|20275570|P2|STARTED|Overall Study||9
8221822|NCT02047643|20275571|P1|STARTED|Overall Study||9
8221823|NCT02047500|20275579|P1|NOT COMPLETED|Overall Study||19
8221824|NCT02047500|20275579|P1|COMPLETED|Overall Study||0
8221825|NCT02047500|20275579|P1|STARTED|Overall Study||19
8221826|NCT02047344|20275585|P2|NOT COMPLETED|Overall Study||0
8221827|NCT02047344|20275586|P1|NOT COMPLETED|Overall Study||0
8221828|NCT02047344|20275585|P2|COMPLETED|Overall Study||15
8221829|NCT02047344|20275586|P1|COMPLETED|Overall Study||16
8221830|NCT02047344|20275585|P2|STARTED|Overall Study||15
8221831|NCT02047344|20275586|P1|STARTED|Overall Study|one patient is not evaluable in process. however, evaluable to safety report.|16
8221832|NCT02047305|20275604|P1|NOT COMPLETED|Overall Study||0
8221833|NCT02047305|20275604|P1|COMPLETED|Overall Study||96
8221834|NCT02047305|20275604|P1|STARTED|Overall Study||96
8221835|NCT02047253|20275608|P1|NOT COMPLETED|Overall Study||8
8221836|NCT02047253|20275608|P1|COMPLETED|Overall Study||20
8221837|NCT02047253|20275608|P1|STARTED|Overall Study||28
8221838|NCT02047227|20275618|P2|NOT COMPLETED|Overall Study||130
8221839|NCT02047227|20275619|P1|NOT COMPLETED|Overall Study||144
8221840|NCT02047227|20275618|P2|COMPLETED|Overall Study||347
8221841|NCT02047227|20275619|P1|COMPLETED|Overall Study||318
8221842|NCT02047227|20275618|P2|Completed Ovarian Stimulation Phase|Overall Study||440
8221843|NCT02047227|20275619|P1|Completed Ovarian Stimulation Phase|Overall Study||424
8221844|NCT02047227|20275618|P2|STARTED|Overall Study||477
8221845|NCT02047227|20275619|P1|STARTED|Overall Study||462
8221846|NCT02047110|20275639|P4|NOT COMPLETED|OLE Treatment Period||0
8221847|NCT02047110|20275640|P3|NOT COMPLETED|OLE Treatment Period||1
8221848|NCT02047110|20275641|P2|NOT COMPLETED|OLE Treatment Period||0
8221849|NCT02047110|20275642|P1|NOT COMPLETED|OLE Treatment Period||0
8221850|NCT02047110|20275639|P4|COMPLETED|OLE Treatment Period||9
8221851|NCT02047110|20275640|P3|COMPLETED|OLE Treatment Period||4
8221852|NCT02047110|20275641|P2|COMPLETED|OLE Treatment Period||8
8221853|NCT02047110|20275642|P1|COMPLETED|OLE Treatment Period||4
8221854|NCT02047110|20275639|P4|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9
8221855|NCT02047110|20275640|P3|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5
8221856|NCT02047110|20275641|P2|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8
8221857|NCT02047110|20275642|P1|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4
8221858|NCT02047110|20275639|P4|NOT COMPLETED|Escape Treatment Period||2
8221859|NCT02047110|20275640|P3|NOT COMPLETED|Escape Treatment Period||3
8221860|NCT02047110|20275641|P2|NOT COMPLETED|Escape Treatment Period||6
8221861|NCT02047110|20275642|P1|NOT COMPLETED|Escape Treatment Period||3
8221862|NCT02047110|20275639|P4|COMPLETED|Escape Treatment Period||24
8221863|NCT02047110|20275640|P3|COMPLETED|Escape Treatment Period||20
8221864|NCT02047110|20275641|P2|COMPLETED|Escape Treatment Period||15
8221865|NCT02047110|20275642|P1|COMPLETED|Escape Treatment Period||23
8221866|NCT02047110|20275639|P4|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26
8221867|NCT02047110|20275640|P3|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23
8221868|NCT02047110|20275641|P2|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21
8221869|NCT02047110|20275642|P1|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26
8221870|NCT02047110|20275639|P4|NOT COMPLETED|DB (Week 12 up to Week 24)||0
8221871|NCT02047110|20275640|P3|NOT COMPLETED|DB (Week 12 up to Week 24)||1
8221872|NCT02047110|20275641|P2|NOT COMPLETED|DB (Week 12 up to Week 24)||2
8221873|NCT02047110|20275642|P1|NOT COMPLETED|DB (Week 12 up to Week 24)||0
8221874|NCT02047110|20275639|P4|COMPLETED|DB (Week 12 up to Week 24)||12
8221875|NCT02047110|20275640|P3|COMPLETED|DB (Week 12 up to Week 24)||12
8221876|NCT02047110|20275641|P2|COMPLETED|DB (Week 12 up to Week 24)||15
8221877|NCT02047110|20275642|P1|COMPLETED|DB (Week 12 up to Week 24)||9
8221878|NCT02047110|20275639|P4|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12
8221879|NCT02047110|20275640|P3|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13
8221880|NCT02047110|20275641|P2|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17
8221881|NCT02047110|20275642|P1|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9
8221882|NCT02047110|20275639|P4|NOT COMPLETED|DB Treatment Period up to Week 24||2
8221883|NCT02047110|20275640|P3|NOT COMPLETED|DB Treatment Period up to Week 24||3
8221884|NCT02047110|20275641|P2|NOT COMPLETED|DB Treatment Period up to Week 24||2
8221885|NCT02047110|20275642|P1|NOT COMPLETED|DB Treatment Period up to Week 24||5
8221886|NCT02047110|20275639|P4|COMPLETED|DB Treatment Period up to Week 24||38
8221887|NCT02047110|20275640|P3|COMPLETED|DB Treatment Period up to Week 24||36
8221888|NCT02047110|20275641|P2|COMPLETED|DB Treatment Period up to Week 24||38
8221889|NCT02047110|20275642|P1|COMPLETED|DB Treatment Period up to Week 24||35
8221982|NCT02046525|20275950|P2|STARTED|Overall Study||5
8221890|NCT02047110|20275639|P4|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
8221891|NCT02047110|20275640|P3|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39
8221892|NCT02047110|20275641|P2|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
8221893|NCT02047110|20275642|P1|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
8221912|NCT02047032|20275720|P2|NOT COMPLETED|Overall Study||15
8221913|NCT02047032|20275721|P1|NOT COMPLETED|Overall Study||5
8221914|NCT02047032|20275720|P2|COMPLETED|Overall Study||235
8221915|NCT02047032|20275721|P1|COMPLETED|Overall Study||245
8221916|NCT02047032|20275720|P2|STARTED|Overall Study||250
8221917|NCT02047032|20275721|P1|STARTED|Overall Study||250
8221918|NCT02046993|20275750|P2|NOT COMPLETED|Overall Study||11
8221919|NCT02046993|20275751|P1|NOT COMPLETED|Overall Study||3
8221920|NCT02046993|20275750|P2|COMPLETED|Overall Study||94
8221921|NCT02046993|20275751|P1|COMPLETED|Overall Study||102
8221922|NCT02046993|20275750|P2|6th Month|Overall Study||94
8221923|NCT02046993|20275751|P1|6th Month|Overall Study||102
8221924|NCT02046993|20275750|P2|3rd Month|Overall Study||97
8221925|NCT02046993|20275751|P1|3rd Month|Overall Study||104
8221926|NCT02046993|20275750|P2|STARTED|Overall Study||105
8221927|NCT02046993|20275751|P1|STARTED|Overall Study||105
8221928|NCT02046980|20275770|P3|NOT COMPLETED|Overall Study||1
8221929|NCT02046980|20275771|P2|NOT COMPLETED|Overall Study||5
8221930|NCT02046980|20275772|P1|NOT COMPLETED|Overall Study||2
8221931|NCT02046980|20275770|P3|COMPLETED|Overall Study||72
8221932|NCT02046980|20275771|P2|COMPLETED|Overall Study||67
8221933|NCT02046980|20275772|P1|COMPLETED|Overall Study||70
8221934|NCT02046980|20275770|P3|STARTED|Overall Study||73
8221935|NCT02046980|20275771|P2|STARTED|Overall Study||72
8221936|NCT02046980|20275772|P1|STARTED|Overall Study||72
8221937|NCT02046941|20275780|P1|NOT COMPLETED|Overall Study||7
8221938|NCT02046941|20275780|P1|COMPLETED|Overall Study||10
8221939|NCT02046941|20275780|P1|STARTED|Overall Study||17
8221940|NCT02046902|20275789|P3|NOT COMPLETED|Overall Study||0
8221941|NCT02046902|20275790|P2|NOT COMPLETED|Overall Study||0
8221942|NCT02046902|20275791|P1|NOT COMPLETED|Overall Study||0
8221943|NCT02046902|20275789|P3|COMPLETED|Overall Study||137
8221944|NCT02046902|20275790|P2|COMPLETED|Overall Study||113
8221945|NCT02046902|20275791|P1|COMPLETED|Overall Study||336
8221946|NCT02046902|20275789|P3|STARTED|Overall Study||137
8221947|NCT02046902|20275790|P2|STARTED|Overall Study||113
8221948|NCT02046902|20275791|P1|STARTED|Overall Study||336
8221949|NCT02046863|20275802|P1|NOT COMPLETED|Overall Study||0
8221950|NCT02046863|20275802|P1|COMPLETED|Overall Study||7
8221951|NCT02046863|20275802|P1|STARTED|Overall Study||7
8221952|NCT02046772|20275808|P2|NOT COMPLETED|Overall Study||0
8221953|NCT02046772|20275809|P1|NOT COMPLETED|Overall Study||0
8221954|NCT02046772|20275808|P2|COMPLETED|Overall Study||33
8221955|NCT02046772|20275809|P1|COMPLETED|Overall Study||30
8221956|NCT02046772|20275808|P2|STARTED|Overall Study||33
8221957|NCT02046772|20275809|P1|STARTED|Overall Study||30
8221958|NCT02046616|20275823|P1|NOT COMPLETED|8-Week FU Period||1
8221959|NCT02046616|20275823|P1|COMPLETED|8-Week FU Period||113
8221960|NCT02046616|20275823|P1|STARTED|8-Week FU Period||114
8221961|NCT02046616|20275823|P1|NOT COMPLETED|24-Week Treatment Period||19
8221962|NCT02046616|20275823|P1|COMPLETED|24-Week Treatment Period||114
8221963|NCT02046616|20275823|P1|STARTED|24-Week Treatment Period||133
8221964|NCT02046603|20275845|P2|NOT COMPLETED|Overall Study||75
8221965|NCT02046603|20275846|P1|NOT COMPLETED|Overall Study||15
8221966|NCT02046603|20275845|P2|COMPLETED|Overall Study||65
8221967|NCT02046603|20275846|P1|COMPLETED|Overall Study||7
8221968|NCT02046603|20275845|P2|Received at Least 1 Dose of Tocilizumab|Overall Study||140
8221969|NCT02046603|20275846|P1|Received at Least 1 Dose of Tocilizumab|Overall Study||21
8221970|NCT02046603|20275845|P2|STARTED|Overall Study||140
8221971|NCT02046603|20275846|P1|STARTED|Overall Study||22
8221972|NCT02046564|20275925|P2|NOT COMPLETED|Overall Study||20
8221973|NCT02046564|20275926|P1|NOT COMPLETED|Overall Study||15
8221974|NCT02046564|20275925|P2|COMPLETED|Overall Study||183
8221975|NCT02046564|20275926|P1|COMPLETED|Overall Study||194
8221976|NCT02046564|20275925|P2|STARTED|Overall Study||203
8221977|NCT02046564|20275926|P1|STARTED|Overall Study||209
8221978|NCT02046525|20275950|P2|NOT COMPLETED|Overall Study||0
8221979|NCT02046525|20275951|P1|NOT COMPLETED|Overall Study||0
8221980|NCT02046525|20275950|P2|COMPLETED|Overall Study||5
8221981|NCT02046525|20275951|P1|COMPLETED|Overall Study||5
8221983|NCT02046525|20275951|P1|STARTED|Overall Study||5
8221984|NCT02046382|20275959|P2|NOT COMPLETED|Overall Study||20
8221985|NCT02046382|20275960|P1|NOT COMPLETED|Overall Study||8
8221986|NCT02046382|20275959|P2|COMPLETED|Overall Study||47
8221987|NCT02046382|20275960|P1|COMPLETED|Overall Study||57
8221988|NCT02046382|20275959|P2|STARTED|Overall Study||67
8221989|NCT02046382|20275960|P1|STARTED|Overall Study||65
8221990|NCT02046369|20275974|P2|NOT COMPLETED|Overall Study||18
8221991|NCT02046369|20275975|P1|NOT COMPLETED|Overall Study||14
8221992|NCT02046369|20275974|P2|COMPLETED|Overall Study||156
8221993|NCT02046369|20275975|P1|COMPLETED|Overall Study||162
8221994|NCT02046369|20275974|P2|STARTED|Overall Study||174
8221995|NCT02046369|20275975|P1|STARTED|Overall Study||176
8221996|NCT02046317|20275993|P2|NOT COMPLETED|Overall Study||0
8221997|NCT02046317|20275994|P1|NOT COMPLETED|Overall Study||0
8221998|NCT02046317|20275993|P2|COMPLETED|Overall Study||8
8221999|NCT02046317|20275994|P1|COMPLETED|Overall Study||4
8222000|NCT02046317|20275993|P2|STARTED|Overall Study||8
8222001|NCT02046317|20275994|P1|STARTED|Overall Study||4
8222002|NCT02046265|20276006|P4|NOT COMPLETED|Overall Study||2
8222003|NCT02046265|20276007|P3|NOT COMPLETED|Overall Study||2
8222004|NCT02046265|20276008|P2|NOT COMPLETED|Overall Study||2
8222005|NCT02046265|20276009|P1|NOT COMPLETED|Overall Study||1
8222006|NCT02046265|20276006|P4|COMPLETED|Overall Study||12
8222007|NCT02046265|20276007|P3|COMPLETED|Overall Study||10
8222008|NCT02046265|20276008|P2|COMPLETED|Overall Study||15
8222009|NCT02046265|20276009|P1|COMPLETED|Overall Study||16
8222010|NCT02046265|20276006|P4|STARTED|Overall Study||14
8222011|NCT02046265|20276007|P3|STARTED|Overall Study||12
8222012|NCT02046265|20276008|P2|STARTED|Overall Study||17
8222013|NCT02046265|20276009|P1|STARTED|Overall Study||17
8222014|NCT02046226|20276019|P1|NOT COMPLETED|Overall Study||7
8222015|NCT02046226|20276019|P1|COMPLETED|Overall Study||0
8222016|NCT02046226|20276019|P1|STARTED|Overall Study||7
8222017|NCT02046200|20276026|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8222018|NCT02046200|20276027|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8222019|NCT02046200|20276026|P2|COMPLETED|Second Intervention (1 Day)||6
8222020|NCT02046200|20276027|P1|COMPLETED|Second Intervention (1 Day)||5
8222021|NCT02046200|20276026|P2|STARTED|Second Intervention (1 Day)||6
8222022|NCT02046200|20276027|P1|STARTED|Second Intervention (1 Day)||5
8222023|NCT02046200|20276026|P2|NOT COMPLETED|First Intervention (1 Day)||0
8222024|NCT02046200|20276027|P1|NOT COMPLETED|First Intervention (1 Day)||0
8222025|NCT02046200|20276026|P2|COMPLETED|First Intervention (1 Day)||6
8222026|NCT02046200|20276027|P1|COMPLETED|First Intervention (1 Day)||5
8222027|NCT02046200|20276026|P2|STARTED|First Intervention (1 Day)||6
8222028|NCT02046200|20276027|P1|STARTED|First Intervention (1 Day)||5
8222029|NCT02046148|20276067|P2|NOT COMPLETED|Overall Study||3
8222030|NCT02046148|20276068|P1|NOT COMPLETED|Overall Study||1
8222031|NCT02046148|20276067|P2|COMPLETED|Overall Study||23
8222032|NCT02046148|20276068|P1|COMPLETED|Overall Study||48
8222033|NCT02046148|20276067|P2|STARTED|Overall Study||26
8222034|NCT02046148|20276068|P1|STARTED|Overall Study||49
8222035|NCT02046135|20276130|P2|NOT COMPLETED|Overall Study||0
8222036|NCT02046135|20276131|P1|NOT COMPLETED|Overall Study||0
8222037|NCT02046135|20276130|P2|COMPLETED|Overall Study||25
8222038|NCT02046135|20276131|P1|COMPLETED|Overall Study||26
8222039|NCT02046135|20276130|P2|STARTED|Overall Study||25
8222040|NCT02046135|20276131|P1|STARTED|Overall Study||26
8222041|NCT02046122|20276145|P1|NOT COMPLETED|Overall Study||9
8222042|NCT02046122|20276145|P1|COMPLETED|Overall Study||8
8222043|NCT02046122|20276145|P1|STARTED|Overall Study||17
8222044|NCT02046070|20276159|P3|NOT COMPLETED|Overall Study||70
8222045|NCT02046070|20276160|P2|NOT COMPLETED|Overall Study||28
8222046|NCT02046070|20276161|P1|NOT COMPLETED|Overall Study||32
8222047|NCT02046070|20276159|P3|COMPLETED|Overall Study||8
8222048|NCT02046070|20276160|P2|COMPLETED|Overall Study||6
8222049|NCT02046070|20276161|P1|COMPLETED|Overall Study||4
8222050|NCT02046070|20276159|P3|STARTED|Overall Study||78
8222051|NCT02046070|20276160|P2|STARTED|Overall Study||34
8222052|NCT02046070|20276161|P1|STARTED|Overall Study||36
8222053|NCT02046005|20276208|P3|NOT COMPLETED|Overall Study||10
8222054|NCT02046005|20276209|P2|NOT COMPLETED|Overall Study||7
8222055|NCT02046005|20276210|P1|NOT COMPLETED|Overall Study||8
8222056|NCT02046005|20276208|P3|COMPLETED|Overall Study||70
8222057|NCT02046005|20276209|P2|COMPLETED|Overall Study||71
8222058|NCT02046005|20276210|P1|COMPLETED|Overall Study||72
8222059|NCT02046005|20276208|P3|STARTED|Overall Study||80
8222060|NCT02046005|20276209|P2|STARTED|Overall Study||78
8222061|NCT02046005|20276210|P1|STARTED|Overall Study||80
8222062|NCT02045979|20276221|P3|NOT COMPLETED|Overall Study||1
8222063|NCT02045979|20276222|P2|NOT COMPLETED|Overall Study||1
8222064|NCT02045979|20276223|P1|NOT COMPLETED|Overall Study||2
8222065|NCT02045979|20276221|P3|COMPLETED|Overall Study||107
8222066|NCT02045979|20276222|P2|COMPLETED|Overall Study||107
8222067|NCT02045979|20276223|P1|COMPLETED|Overall Study||106
8222068|NCT02045979|20276221|P3|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
8222069|NCT02045979|20276222|P2|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
8222070|NCT02045979|20276223|P1|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
8222071|NCT02045875|20276260|P2|NOT COMPLETED|Overall Study||3
8222072|NCT02045875|20276261|P1|NOT COMPLETED|Overall Study||7
8222073|NCT02045875|20276260|P2|COMPLETED|Overall Study||20
8222074|NCT02045875|20276261|P1|COMPLETED|Overall Study||20
8222075|NCT02045875|20276260|P2|STARTED|Overall Study||23
8222076|NCT02045875|20276261|P1|STARTED|Overall Study||27
8222077|NCT02045862|20276272|P3|NOT COMPLETED|Overall Study||126
8222078|NCT02045862|20276273|P2|NOT COMPLETED|Overall Study||40
8222079|NCT02045862|20276274|P1|NOT COMPLETED|Overall Study||39
8222080|NCT02045862|20276272|P3|COMPLETED|Overall Study||1092
8222081|NCT02045862|20276273|P2|COMPLETED|Overall Study||265
8222082|NCT02045862|20276274|P1|COMPLETED|Overall Study||267
8222083|NCT02045862|20276272|P3|Treated|Overall Study||1210
8222084|NCT02045862|20276273|P2|Treated|Overall Study||303
8222085|NCT02045862|20276274|P1|Treated|Overall Study||306
8222086|NCT02045862|20276272|P3|STARTED|Overall Study||1218
8222087|NCT02045862|20276273|P2|STARTED|Overall Study||305
8222088|NCT02045862|20276274|P1|STARTED|Overall Study||306
8222095|NCT02045797|20276488|P3|NOT COMPLETED|Overall Study||1
8222096|NCT02045797|20276489|P2|NOT COMPLETED|Overall Study||7
8222097|NCT02045797|20276490|P1|NOT COMPLETED|Overall Study||7
8222098|NCT02045797|20276488|P3|COMPLETED|Overall Study||24
8222099|NCT02045797|20276489|P2|COMPLETED|Overall Study||32
8222100|NCT02045797|20276490|P1|COMPLETED|Overall Study||51
8222101|NCT02045797|20276488|P3|STARTED|Overall Study||25
8222102|NCT02045797|20276489|P2|STARTED|Overall Study||39
8222103|NCT02045797|20276490|P1|STARTED|Overall Study||58
8222104|NCT02045732|20276635|P2|NOT COMPLETED|Overall Study||1
8222105|NCT02045732|20276636|P1|NOT COMPLETED|Overall Study||1
8222106|NCT02045732|20276635|P2|COMPLETED|Overall Study||2
8222107|NCT02045732|20276636|P1|COMPLETED|Overall Study||0
8222108|NCT02045732|20276635|P2|STARTED|Overall Study||3
8222109|NCT02045732|20276636|P1|STARTED|Overall Study||1
8222110|NCT02045511|20276656|P2|NOT COMPLETED|Overall Study||0
8222111|NCT02045511|20276657|P1|NOT COMPLETED|Overall Study||0
8222112|NCT02045511|20276656|P2|COMPLETED|Overall Study||7
8222113|NCT02045511|20276657|P1|COMPLETED|Overall Study||8
8222114|NCT02045511|20276656|P2|STARTED|Overall Study||7
8222115|NCT02045511|20276657|P1|STARTED|Overall Study||8
8222116|NCT02045433|20276673|P1|NOT COMPLETED|Overall Study||1
8222117|NCT02045433|20276673|P1|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15
8222118|NCT02045433|20276673|P1|STARTED|Overall Study||16
8222119|NCT02045277|20276681|P4|NOT COMPLETED|Overall Study||2
8222120|NCT02045277|20276682|P3|NOT COMPLETED|Overall Study||12
8222121|NCT02045277|20276683|P2|NOT COMPLETED|Overall Study||1
8222122|NCT02045277|20276684|P1|NOT COMPLETED|Overall Study||4
8222123|NCT02045277|20276681|P4|COMPLETED|Overall Study||29
8222124|NCT02045277|20276682|P3|COMPLETED|Overall Study||47
8222125|NCT02045277|20276683|P2|COMPLETED|Overall Study||62
8222126|NCT02045277|20276684|P1|COMPLETED|Overall Study||55
8222127|NCT02045277|20276681|P4|STARTED|Overall Study||31
8222128|NCT02045277|20276682|P3|STARTED|Overall Study||59
8222129|NCT02045277|20276683|P2|STARTED|Overall Study||63
8222130|NCT02045277|20276684|P1|STARTED|Overall Study||59
8222134|NCT02045238|20276715|P2|NOT COMPLETED|Overall Study||1
8222135|NCT02045238|20276716|P1|NOT COMPLETED|Overall Study||7
8222136|NCT02045238|20276715|P2|COMPLETED|Overall Study||14
8222137|NCT02045238|20276716|P1|COMPLETED|Overall Study||9
8222138|NCT02045238|20276715|P2|STARTED|Overall Study||15
8222139|NCT02045238|20276716|P1|STARTED|Overall Study||16
8222140|NCT02045212|20276726|P2|NOT COMPLETED|Overall Study||1
8222141|NCT02045212|20276727|P1|NOT COMPLETED|Overall Study||2
8222142|NCT02045212|20276726|P2|COMPLETED|Overall Study||8
8222143|NCT02045212|20276727|P1|COMPLETED|Overall Study||11
8222144|NCT02045212|20276726|P2|STARTED|Overall Study||9
8222145|NCT02045212|20276727|P1|STARTED|Overall Study||13
8222146|NCT02045108|20276743|P4|NOT COMPLETED|Overall Study||1
8222147|NCT02045108|20276744|P3|NOT COMPLETED|Overall Study||2
8222148|NCT02045108|20276745|P2|NOT COMPLETED|Overall Study||3
8222149|NCT02045108|20276746|P1|NOT COMPLETED|Overall Study||1
8222150|NCT02045108|20276743|P4|COMPLETED|Overall Study||19
8222151|NCT02045108|20276744|P3|COMPLETED|Overall Study||18
8222152|NCT02045108|20276745|P2|COMPLETED|Overall Study||12
8222153|NCT02045108|20276746|P1|COMPLETED|Overall Study||21
8222154|NCT02045108|20276743|P4|STARTED|Overall Study||20
8222155|NCT02045108|20276744|P3|STARTED|Overall Study||20
8222156|NCT02045108|20276745|P2|STARTED|Overall Study||15
8222157|NCT02045108|20276746|P1|STARTED|Overall Study||22
8222158|NCT02045095|20276792|P7|NOT COMPLETED|Overall Study||1
8222159|NCT02045095|20276793|P6|NOT COMPLETED|Overall Study||8
8222160|NCT02045095|20276794|P5|NOT COMPLETED|Overall Study||5
8222161|NCT02045095|20276795|P4|NOT COMPLETED|Overall Study||4
8222162|NCT02045095|20276796|P3|NOT COMPLETED|Overall Study||4
8222163|NCT02045095|20276797|P2|NOT COMPLETED|Overall Study||4
8222164|NCT02045095|20276798|P1|NOT COMPLETED|Overall Study||3
8222165|NCT02045095|20276792|P7|COMPLETED|Overall Study||0
8222166|NCT02045095|20276793|P6|COMPLETED|Overall Study||0
8222167|NCT02045095|20276794|P5|COMPLETED|Overall Study||0
8222168|NCT02045095|20276795|P4|COMPLETED|Overall Study||0
8222169|NCT02045095|20276796|P3|COMPLETED|Overall Study||0
8222170|NCT02045095|20276797|P2|COMPLETED|Overall Study||0
8222171|NCT02045095|20276798|P1|COMPLETED|Overall Study||0
8222172|NCT02045095|20276792|P7|STARTED|Overall Study||1
8222173|NCT02045095|20276793|P6|STARTED|Overall Study||8
8222174|NCT02045095|20276794|P5|STARTED|Overall Study||5
8222175|NCT02045095|20276795|P4|STARTED|Overall Study||4
8222176|NCT02045095|20276796|P3|STARTED|Overall Study||4
8222177|NCT02045095|20276797|P2|STARTED|Overall Study||4
8222178|NCT02045095|20276798|P1|STARTED|Overall Study||3
8222179|NCT02044991|20276942|P2|NOT COMPLETED|Overall Study||0
8222180|NCT02044991|20276943|P1|NOT COMPLETED|Overall Study||0
8222181|NCT02044991|20276942|P2|COMPLETED|Overall Study||0
8222182|NCT02044991|20276943|P1|COMPLETED|Overall Study||2
8222183|NCT02044991|20276942|P2|STARTED|Overall Study||0
8222184|NCT02044991|20276943|P1|STARTED|Overall Study||2
8222185|NCT02044874|20276956|P3|NOT COMPLETED|Overall Study||60
8222186|NCT02044874|20276957|P2|NOT COMPLETED|Overall Study||55
8222187|NCT02044874|20276958|P1|NOT COMPLETED|Overall Study||30
8222188|NCT02044874|20276956|P3|COMPLETED|Overall Study||140
8222189|NCT02044874|20276957|P2|COMPLETED|Overall Study||147
8222190|NCT02044874|20276958|P1|COMPLETED|Overall Study||171
8222191|NCT02044874|20276956|P3|STARTED|Overall Study||200
8222192|NCT02044874|20276957|P2|STARTED|Overall Study||202
8222193|NCT02044874|20276958|P1|STARTED|Overall Study||201
8222194|NCT02044848|20276980|P2|NOT COMPLETED|Overall Study||3
8222195|NCT02044848|20276981|P1|NOT COMPLETED|Overall Study||2
8222196|NCT02044848|20276980|P2|COMPLETED|Overall Study||0
8222197|NCT02044848|20276981|P1|COMPLETED|Overall Study||0
8222198|NCT02044848|20276980|P2|STARTED|Overall Study||3
8222199|NCT02044848|20276981|P1|STARTED|Overall Study||2
8222200|NCT02044822|20276987|P1|NOT COMPLETED|Overall Study||93
8222201|NCT02044822|20276987|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
8222202|NCT02044822|20276987|P1|STARTED|Overall Study||102
8222203|NCT02044796|20276999|P10|NOT COMPLETED|Overall Study||0
8222204|NCT02044796|20277000|P9|NOT COMPLETED|Overall Study||0
8222205|NCT02044796|20277001|P8|NOT COMPLETED|Overall Study||0
8222206|NCT02044796|20277002|P7|NOT COMPLETED|Overall Study||0
8222207|NCT02044796|20277003|P6|NOT COMPLETED|Overall Study||0
8222208|NCT02044796|20277004|P5|NOT COMPLETED|Overall Study||0
8222209|NCT02044796|20277005|P4|NOT COMPLETED|Overall Study||0
8222210|NCT02044796|20277006|P3|NOT COMPLETED|Overall Study||0
8222211|NCT02044796|20277007|P2|NOT COMPLETED|Overall Study||0
8222212|NCT02044796|20277008|P1|NOT COMPLETED|Overall Study||0
8222213|NCT02044796|20276999|P10|COMPLETED|Overall Study||34
8222214|NCT02044796|20277000|P9|COMPLETED|Overall Study||106
8222215|NCT02044796|20277001|P8|COMPLETED|Overall Study||4
8222216|NCT02044796|20277002|P7|COMPLETED|Overall Study||6
8222217|NCT02044796|20277003|P6|COMPLETED|Overall Study||6
8222218|NCT02044796|20277004|P5|COMPLETED|Overall Study||10
8222219|NCT02044796|20277005|P4|COMPLETED|Overall Study||6
8222220|NCT02044796|20277006|P3|COMPLETED|Overall Study||9
8222221|NCT02044796|20277007|P2|COMPLETED|Overall Study||9
8222222|NCT02044796|20277008|P1|COMPLETED|Overall Study||9
8222223|NCT02044796|20276999|P10|STARTED|Overall Study||34
8222224|NCT02044796|20277000|P9|STARTED|Overall Study||106
8222225|NCT02044796|20277001|P8|STARTED|Overall Study||4
8222226|NCT02044796|20277002|P7|STARTED|Overall Study||6
8222227|NCT02044796|20277003|P6|STARTED|Overall Study||6
8222228|NCT02044796|20277004|P5|STARTED|Overall Study||10
8222229|NCT02044796|20277005|P4|STARTED|Overall Study||6
8222230|NCT02044796|20277006|P3|STARTED|Overall Study||9
8222231|NCT02044796|20277007|P2|STARTED|Overall Study||9
8222232|NCT02044796|20277008|P1|STARTED|Overall Study||9
8222233|NCT02044510|20277029|P2|NOT COMPLETED|Overall Study||2
8222234|NCT02044510|20277030|P1|NOT COMPLETED|Overall Study||1
8222235|NCT02044510|20277029|P2|COMPLETED|Overall Study||14
8222236|NCT02044510|20277030|P1|COMPLETED|Overall Study||15
8222237|NCT02044510|20277029|P2|STARTED|Overall Study||16
8222238|NCT02044510|20277030|P1|STARTED|Overall Study||16
8222239|NCT02044458|20277038|P2|NOT COMPLETED|Overall Study||8
8222240|NCT02044458|20277039|P1|NOT COMPLETED|Overall Study||3
8222241|NCT02044458|20277038|P2|COMPLETED|Overall Study||61
8222242|NCT02044458|20277039|P1|COMPLETED|Overall Study||62
8222243|NCT02044458|20277038|P2|STARTED|Overall Study||69
8222244|NCT02044458|20277039|P1|STARTED|Overall Study||65
8222245|NCT02044419|20277052|P3|NOT COMPLETED|Third Intervention||0
8222246|NCT02044419|20277053|P2|NOT COMPLETED|Third Intervention||0
8222247|NCT02044419|20277054|P1|NOT COMPLETED|Third Intervention||0
8222248|NCT02044419|20277052|P3|COMPLETED|Third Intervention||10
8222249|NCT02044419|20277053|P2|COMPLETED|Third Intervention||9
8222250|NCT02044419|20277054|P1|COMPLETED|Third Intervention||11
8222251|NCT02044419|20277052|P3|STARTED|Third Intervention||10
8222252|NCT02044419|20277053|P2|STARTED|Third Intervention||9
8222253|NCT02044419|20277054|P1|STARTED|Third Intervention||11
8222254|NCT02044419|20277052|P3|NOT COMPLETED|Second Intervention||0
8222255|NCT02044419|20277053|P2|NOT COMPLETED|Second Intervention||0
8222256|NCT02044419|20277054|P1|NOT COMPLETED|Second Intervention||0
8222257|NCT02044419|20277052|P3|COMPLETED|Second Intervention||10
8222258|NCT02044419|20277053|P2|COMPLETED|Second Intervention||9
8222259|NCT02044419|20277054|P1|COMPLETED|Second Intervention||11
8222260|NCT02044419|20277052|P3|STARTED|Second Intervention||10
8222261|NCT02044419|20277053|P2|STARTED|Second Intervention||9
8222262|NCT02044419|20277054|P1|STARTED|Second Intervention||11
8222263|NCT02044419|20277052|P3|NOT COMPLETED|First Intervention||1
8222264|NCT02044419|20277053|P2|NOT COMPLETED|First Intervention||1
8222265|NCT02044419|20277054|P1|NOT COMPLETED|First Intervention||0
8222266|NCT02044419|20277052|P3|COMPLETED|First Intervention||10
8222267|NCT02044419|20277053|P2|COMPLETED|First Intervention||9
8222268|NCT02044419|20277054|P1|COMPLETED|First Intervention||11
8222269|NCT02044419|20277052|P3|STARTED|First Intervention||11
8222270|NCT02044419|20277053|P2|STARTED|First Intervention||10
8222271|NCT02044419|20277054|P1|STARTED|First Intervention||11
8222272|NCT02044393|20277079|P2|NOT COMPLETED|Period 2||0
8222273|NCT02044393|20277080|P1|NOT COMPLETED|Period 2||0
8222274|NCT02044393|20277079|P2|COMPLETED|Period 2||10
8222275|NCT02044393|20277080|P1|COMPLETED|Period 2||10
8222276|NCT02044393|20277079|P2|STARTED|Period 2||10
8222277|NCT02044393|20277080|P1|STARTED|Period 2||10
8222278|NCT02044393|20277079|P2|NOT COMPLETED|Period 1||0
8222279|NCT02044393|20277080|P1|NOT COMPLETED|Period 1||0
8222280|NCT02044393|20277079|P2|COMPLETED|Period 1||10
8222281|NCT02044393|20277080|P1|COMPLETED|Period 1||10
8222282|NCT02044393|20277079|P2|STARTED|Period 1||10
8222283|NCT02044393|20277080|P1|STARTED|Period 1||10
8222284|NCT02044380|20277093|P1|NOT COMPLETED|Overall Study||0
8222285|NCT02044380|20277093|P1|COMPLETED|Overall Study||14
8222286|NCT02044380|20277093|P1|STARTED|Overall Study|Started are the treated patients|14
8222287|NCT02044367|20277097|P6|NOT COMPLETED|Overall Study||0
8222288|NCT02044367|20277098|P5|NOT COMPLETED|Overall Study||0
8222289|NCT02044367|20277099|P4|NOT COMPLETED|Overall Study||0
8222290|NCT02044367|20277100|P3|NOT COMPLETED|Overall Study||0
8222291|NCT02044367|20277101|P2|NOT COMPLETED|Overall Study||0
8222292|NCT02044367|20277102|P1|NOT COMPLETED|Overall Study||0
8222293|NCT02044367|20277097|P6|COMPLETED|Overall Study||9
8222294|NCT02044367|20277098|P5|COMPLETED|Overall Study||9
8222295|NCT02044367|20277099|P4|COMPLETED|Overall Study||9
8222296|NCT02044367|20277100|P3|COMPLETED|Overall Study||9
8222297|NCT02044367|20277101|P2|COMPLETED|Overall Study||9
8222298|NCT02044367|20277102|P1|COMPLETED|Overall Study||9
8222299|NCT02044367|20277097|P6|STARTED|Overall Study||9
8222300|NCT02044367|20277098|P5|STARTED|Overall Study||9
8222301|NCT02044367|20277099|P4|STARTED|Overall Study||9
8222302|NCT02044367|20277100|P3|STARTED|Overall Study||9
8222303|NCT02044367|20277101|P2|STARTED|Overall Study||9
8222304|NCT02044367|20277102|P1|STARTED|Overall Study||9
8222305|NCT02044302|20277125|P2|NOT COMPLETED|Overall Study||0
8222306|NCT02044302|20277126|P1|NOT COMPLETED|Overall Study||2
8222307|NCT02044302|20277125|P2|COMPLETED|Overall Study||0
8222308|NCT02044302|20277126|P1|COMPLETED|Overall Study||0
8222309|NCT02044302|20277125|P2|STARTED|Overall Study||0
8222310|NCT02044302|20277126|P1|STARTED|Overall Study||2
8222311|NCT02044159|20277134|P2|NOT COMPLETED|Overall Study||4
8222312|NCT02044159|20277135|P1|NOT COMPLETED|Overall Study||4
8222313|NCT02044159|20277134|P2|COMPLETED|Overall Study||26
8222314|NCT02044159|20277135|P1|COMPLETED|Overall Study||23
8222315|NCT02044159|20277134|P2|STARTED|Overall Study||30
8222316|NCT02044159|20277135|P1|STARTED|Overall Study||27
8222317|NCT02044094|20277148|P1|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
8222318|NCT02044094|20277148|P1|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
8222319|NCT02044094|20277148|P1|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
8222320|NCT02044094|20277148|P1|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
8222321|NCT02044094|20277148|P1|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
8222322|NCT02044094|20277148|P1|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
8222323|NCT02044094|20277148|P1|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
8222324|NCT02044094|20277148|P1|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
8222325|NCT02043938|20277205|P1|NOT COMPLETED|Overall Study||10
8222326|NCT02043938|20277205|P1|COMPLETED|Overall Study||36
8222327|NCT02043938|20277205|P1|STARTED|Overall Study||46
8222328|NCT02043860|20277215|P1|NOT COMPLETED|Overall Study||0
8222329|NCT02043860|20277215|P1|COMPLETED|Overall Study||2
8222330|NCT02043860|20277215|P1|STARTED|Overall Study||2
8222331|NCT02043808|20277221|P2|NOT COMPLETED|Overall Study||0
8222332|NCT02043808|20277222|P1|NOT COMPLETED|Overall Study||0
8222333|NCT02043808|20277221|P2|COMPLETED|Overall Study||12793
8222334|NCT02043808|20277222|P1|COMPLETED|Overall Study||12793
8222335|NCT02043808|20277221|P2|STARTED|Overall Study||12793
8222336|NCT02043808|20277222|P1|STARTED|Overall Study||12793
8222337|NCT02043782|20277260|P6|NOT COMPLETED|Period 3||0
8222338|NCT02043782|20277261|P5|NOT COMPLETED|Period 3||0
8222339|NCT02043782|20277262|P4|NOT COMPLETED|Period 3||0
8222340|NCT02043782|20277263|P3|NOT COMPLETED|Period 3||0
8222341|NCT02043782|20277264|P2|NOT COMPLETED|Period 3||0
8222342|NCT02043782|20277265|P1|NOT COMPLETED|Period 3||0
8222343|NCT02043782|20277260|P6|COMPLETED|Period 3||6
8222344|NCT02043782|20277261|P5|COMPLETED|Period 3||6
8222345|NCT02043782|20277262|P4|COMPLETED|Period 3||6
8222346|NCT02043782|20277263|P3|COMPLETED|Period 3||6
8222347|NCT02043782|20277264|P2|COMPLETED|Period 3||6
8222348|NCT02043782|20277265|P1|COMPLETED|Period 3||7
8222349|NCT02043782|20277260|P6|STARTED|Period 3||6
8222350|NCT02043782|20277261|P5|STARTED|Period 3||6
8222351|NCT02043782|20277262|P4|STARTED|Period 3||6
8222352|NCT02043782|20277263|P3|STARTED|Period 3||6
8222353|NCT02043782|20277264|P2|STARTED|Period 3||6
8222354|NCT02043782|20277265|P1|STARTED|Period 3||7
8222355|NCT02043782|20277260|P6|NOT COMPLETED|Period 2||0
8222356|NCT02043782|20277261|P5|NOT COMPLETED|Period 2||0
8222357|NCT02043782|20277262|P4|NOT COMPLETED|Period 2||0
8222358|NCT02043782|20277263|P3|NOT COMPLETED|Period 2||0
8222359|NCT02043782|20277264|P2|NOT COMPLETED|Period 2||0
8222360|NCT02043782|20277265|P1|NOT COMPLETED|Period 2||0
8222361|NCT02043782|20277260|P6|COMPLETED|Period 2||6
8222362|NCT02043782|20277261|P5|COMPLETED|Period 2||6
8222363|NCT02043782|20277262|P4|COMPLETED|Period 2||6
8222364|NCT02043782|20277263|P3|COMPLETED|Period 2||6
8222365|NCT02043782|20277264|P2|COMPLETED|Period 2||6
8222366|NCT02043782|20277265|P1|COMPLETED|Period 2||7
8222367|NCT02043782|20277260|P6|STARTED|Period 2||6
8222368|NCT02043782|20277261|P5|STARTED|Period 2||6
8222369|NCT02043782|20277262|P4|STARTED|Period 2||6
8222370|NCT02043782|20277263|P3|STARTED|Period 2||6
8222371|NCT02043782|20277264|P2|STARTED|Period 2||6
8222372|NCT02043782|20277265|P1|STARTED|Period 2||7
8222373|NCT02043782|20277260|P6|NOT COMPLETED|Period 1||0
8222374|NCT02043782|20277261|P5|NOT COMPLETED|Period 1||0
8222375|NCT02043782|20277262|P4|NOT COMPLETED|Period 1||0
8222376|NCT02043782|20277263|P3|NOT COMPLETED|Period 1||1
8222377|NCT02043782|20277264|P2|NOT COMPLETED|Period 1||0
8222378|NCT02043782|20277265|P1|NOT COMPLETED|Period 1||0
8222379|NCT02043782|20277260|P6|COMPLETED|Period 1||6
8222380|NCT02043782|20277261|P5|COMPLETED|Period 1||6
8222381|NCT02043782|20277262|P4|COMPLETED|Period 1||6
8222382|NCT02043782|20277263|P3|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
8222383|NCT02043782|20277264|P2|COMPLETED|Period 1||6
8222384|NCT02043782|20277265|P1|COMPLETED|Period 1||7
8222385|NCT02043782|20277260|P6|STARTED|Period 1||6
8222386|NCT02043782|20277261|P5|STARTED|Period 1||6
8222387|NCT02043782|20277262|P4|STARTED|Period 1||6
8222388|NCT02043782|20277263|P3|STARTED|Period 1||7
8222389|NCT02043782|20277264|P2|STARTED|Period 1||6
8222390|NCT02043782|20277265|P1|STARTED|Period 1||7
8222391|NCT02043704|20277275|P2|NOT COMPLETED|Overall Study||7
8222392|NCT02043704|20277276|P1|NOT COMPLETED|Overall Study||3
8222393|NCT02043704|20277275|P2|COMPLETED|Overall Study||43
8222394|NCT02043704|20277276|P1|COMPLETED|Overall Study||47
8222395|NCT02043704|20277275|P2|STARTED|Overall Study||50
8222396|NCT02043704|20277276|P1|STARTED|Overall Study||50
8222405|NCT02043652|20277325|P1|NOT COMPLETED|Overall Study||26
8222406|NCT02043652|20277325|P1|COMPLETED|Overall Study||93
8222407|NCT02043652|20277325|P1|STARTED|Overall Study||119
8222408|NCT02043574|20277332|P2|NOT COMPLETED|Overall Study||6
8222409|NCT02043574|20277333|P1|NOT COMPLETED|Overall Study||6
8222410|NCT02043574|20277332|P2|COMPLETED|Overall Study||20
8222411|NCT02043574|20277333|P1|COMPLETED|Overall Study||19
8222412|NCT02043574|20277332|P2|STARTED|Overall Study||26
8222413|NCT02043574|20277333|P1|STARTED|Overall Study||25
8222414|NCT02043548|20277345|P2|NOT COMPLETED|Overall Study||1
8222415|NCT02043548|20277346|P1|NOT COMPLETED|Overall Study||1
8222416|NCT02043548|20277345|P2|COMPLETED|Overall Study||17
8222417|NCT02043548|20277346|P1|COMPLETED|Overall Study||17
8222418|NCT02043548|20277345|P2|STARTED|Overall Study||18
8222419|NCT02043548|20277346|P1|STARTED|Overall Study||18
8222420|NCT02043509|20277364|P2|NOT COMPLETED|Baseline to 2nd Follow-up||72
8222421|NCT02043509|20277365|P1|NOT COMPLETED|Baseline to 2nd Follow-up||74
8222422|NCT02043509|20277364|P2|COMPLETED|Baseline to 2nd Follow-up||132
8222423|NCT02043509|20277365|P1|COMPLETED|Baseline to 2nd Follow-up||129
8222424|NCT02043509|20277364|P2|STARTED|Baseline to 2nd Follow-up||204
8222425|NCT02043509|20277365|P1|STARTED|Baseline to 2nd Follow-up||203
8222426|NCT02043509|20277364|P2|NOT COMPLETED|Baseline to 1st Follow-up||47
8222427|NCT02043509|20277365|P1|NOT COMPLETED|Baseline to 1st Follow-up||65
8222428|NCT02043509|20277364|P2|COMPLETED|Baseline to 1st Follow-up||157
8222429|NCT02043509|20277365|P1|COMPLETED|Baseline to 1st Follow-up||138
8222430|NCT02043509|20277364|P2|STARTED|Baseline to 1st Follow-up||204
8222431|NCT02043509|20277365|P1|STARTED|Baseline to 1st Follow-up||203
8222432|NCT02043379|20277390|P2|NOT COMPLETED|Overall Study||0
8222433|NCT02043379|20277391|P1|NOT COMPLETED|Overall Study||0
8222434|NCT02043379|20277390|P2|COMPLETED|Overall Study||20
8222435|NCT02043379|20277391|P1|COMPLETED|Overall Study||30
8222436|NCT02043379|20277390|P2|STARTED|Overall Study||20
8222437|NCT02043379|20277391|P1|STARTED|Overall Study||30
8222438|NCT02043366|20277453|P6|NOT COMPLETED|Overall Study||2
8222439|NCT02043366|20277454|P5|NOT COMPLETED|Overall Study||2
8222440|NCT02043366|20277455|P4|NOT COMPLETED|Overall Study||2
8222441|NCT02043366|20277456|P3|NOT COMPLETED|Overall Study||2
8222442|NCT02043366|20277457|P2|NOT COMPLETED|Overall Study||2
8222443|NCT02043366|20277458|P1|NOT COMPLETED|Overall Study||2
8222444|NCT02043366|20277453|P6|COMPLETED|Overall Study||28
8222445|NCT02043366|20277454|P5|COMPLETED|Overall Study||28
8222446|NCT02043366|20277455|P4|COMPLETED|Overall Study||28
8222447|NCT02043366|20277456|P3|COMPLETED|Overall Study||28
8222448|NCT02043366|20277457|P2|COMPLETED|Overall Study||28
8222449|NCT02043366|20277458|P1|COMPLETED|Overall Study||28
8222450|NCT02043366|20277453|P6|STARTED|Overall Study||30
8222451|NCT02043366|20277454|P5|STARTED|Overall Study||30
8222452|NCT02043366|20277455|P4|STARTED|Overall Study||30
8222453|NCT02043366|20277456|P3|STARTED|Overall Study||30
8222454|NCT02043366|20277457|P2|STARTED|Overall Study||30
8222455|NCT02043366|20277458|P1|STARTED|Overall Study||30
8222456|NCT02043301|20277481|P3|NOT COMPLETED|Overall Study||0
8222457|NCT02043301|20277482|P2|NOT COMPLETED|Overall Study||1
8222458|NCT02043301|20277483|P1|NOT COMPLETED|Overall Study||0
8222459|NCT02043301|20277481|P3|COMPLETED|Overall Study||25
8222460|NCT02043301|20277482|P2|COMPLETED|Overall Study||24
8222461|NCT02043301|20277483|P1|COMPLETED|Overall Study||25
8222462|NCT02043301|20277481|P3|STARTED|Overall Study||25
8222463|NCT02043301|20277482|P2|STARTED|Overall Study||25
8222464|NCT02043301|20277483|P1|STARTED|Overall Study||25
8222465|NCT02043197|20277541|P1|NOT COMPLETED|Overall Study||8
8222466|NCT02043197|20277541|P1|COMPLETED|Overall Study||292
8222467|NCT02043197|20277541|P1|STARTED|Overall Study||300
8222468|NCT02043145|20277565|P3|NOT COMPLETED|Overall Study||0
8222469|NCT02043145|20277566|P2|NOT COMPLETED|Overall Study||0
8222470|NCT02043145|20277567|P1|NOT COMPLETED|Overall Study||0
8222471|NCT02043145|20277565|P3|COMPLETED|Overall Study||425
8222472|NCT02043145|20277566|P2|COMPLETED|Overall Study||247
8222473|NCT02043145|20277567|P1|COMPLETED|Overall Study||55
8222474|NCT02043145|20277565|P3|STARTED|Overall Study||425
8222475|NCT02043145|20277566|P2|STARTED|Overall Study||247
8222476|NCT02043145|20277567|P1|STARTED|Overall Study||55
8222477|NCT02043132|20277580|P2|NOT COMPLETED|Overall Study||9
8222478|NCT02043132|20277581|P1|NOT COMPLETED|Overall Study||5
8222479|NCT02043132|20277580|P2|COMPLETED|Overall Study||49
8222480|NCT02043132|20277581|P1|COMPLETED|Overall Study||53
8222481|NCT02043132|20277580|P2|STARTED|Overall Study||58
8222482|NCT02043132|20277581|P1|STARTED|Overall Study||58
8222483|NCT02043015|20277601|P1|NOT COMPLETED|Overall Study||28
8222484|NCT02043015|20277601|P1|COMPLETED|Overall Study||87
8222485|NCT02043015|20277601|P1|STARTED|Overall Study||115
8222486|NCT02042950|20277614|P1|NOT COMPLETED|Overall Study||4
8222487|NCT02042950|20277614|P1|COMPLETED|Overall Study||0
8222488|NCT02042950|20277614|P1|STARTED|Overall Study||4
8222489|NCT02042924|20277620|P1|NOT COMPLETED|Overall Study||1
8222490|NCT02042924|20277620|P1|COMPLETED|Overall Study||1
8222491|NCT02042924|20277620|P1|STARTED|Overall Study||2
8222492|NCT02042911|20277626|P1|NOT COMPLETED|Overall Study||1
8222493|NCT02042911|20277626|P1|COMPLETED|Overall Study||9
8222494|NCT02042911|20277626|P1|STARTED|Overall Study||10
8222495|NCT02042872|20277640|P2|NOT COMPLETED|Overall Study||5
8222496|NCT02042872|20277641|P1|NOT COMPLETED|Overall Study||0
8222497|NCT02042872|20277640|P2|COMPLETED|Overall Study||8
8222498|NCT02042872|20277641|P1|COMPLETED|Overall Study||8
8222499|NCT02042872|20277640|P2|STARTED|Overall Study||13
8222500|NCT02042872|20277641|P1|STARTED|Overall Study||8
8222501|NCT02042534|20277651|P2|NOT COMPLETED|Overall Study||0
8222502|NCT02042534|20277652|P1|NOT COMPLETED|Overall Study||0
8222503|NCT02042534|20277651|P2|COMPLETED|Overall Study||94
8222504|NCT02042534|20277652|P1|COMPLETED|Overall Study||101
8222505|NCT02042534|20277651|P2|STARTED|Overall Study||94
8222506|NCT02042534|20277652|P1|STARTED|Overall Study||101
8222507|NCT02042443|20277668|P2|NOT COMPLETED|Overall Study||26
8222508|NCT02042443|20277669|P1|NOT COMPLETED|Overall Study||27
8222509|NCT02042443|20277668|P2|COMPLETED|Overall Study||0
8222510|NCT02042443|20277669|P1|COMPLETED|Overall Study||0
8222511|NCT02042443|20277668|P2|Eligible and Analyzable|Overall Study||20
8222512|NCT02042443|20277669|P1|Eligible and Analyzable|Overall Study||24
8222513|NCT02042443|20277668|P2|STARTED|Overall Study||26
8222514|NCT02042443|20277669|P1|STARTED|Overall Study||27
8222515|NCT02042404|20277681|P2|NOT COMPLETED|Overall Study||0
8222516|NCT02042404|20277682|P1|NOT COMPLETED|Overall Study||5
8222517|NCT02042404|20277681|P2|COMPLETED|Overall Study||5
8222518|NCT02042404|20277682|P1|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
8222519|NCT02042404|20277681|P2|STARTED|Overall Study||5
8222520|NCT02042404|20277682|P1|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
8222521|NCT02042274|20277693|P1|NOT COMPLETED|Overall Study||0
8222522|NCT02042274|20277693|P1|COMPLETED|Overall Study||12
8222523|NCT02042274|20277693|P1|STARTED|Overall Study||12
8222524|NCT02042183|20277700|P2|NOT COMPLETED|Overall Study||36
8222525|NCT02042183|20277701|P1|NOT COMPLETED|Overall Study||65
8222526|NCT02042183|20277700|P2|COMPLETED|Overall Study||166
8222527|NCT02042183|20277701|P1|COMPLETED|Overall Study||339
8222528|NCT02042183|20277700|P2|Modified Intent-to-treat (mITT)|Overall Study||195
8222529|NCT02042183|20277701|P1|Modified Intent-to-treat (mITT)|Overall Study||399
8222530|NCT02042183|20277700|P2|Safety Population|Overall Study||195
8222531|NCT02042183|20277701|P1|Safety Population|Overall Study||400
8222532|NCT02042183|20277700|P2|STARTED|Overall Study||202
8222533|NCT02042183|20277701|P1|STARTED|Overall Study||404
8222534|NCT02042131|20277712|P3|NOT COMPLETED|Overall Study||0
8222535|NCT02042131|20277713|P2|NOT COMPLETED|Overall Study||0
8222536|NCT02042131|20277714|P1|NOT COMPLETED|Overall Study||0
8222537|NCT02042131|20277712|P3|COMPLETED|Overall Study||33
8222538|NCT02042131|20277713|P2|COMPLETED|Overall Study||32
8222539|NCT02042131|20277714|P1|COMPLETED|Overall Study||32
8222540|NCT02042131|20277712|P3|STARTED|Overall Study||33
8222541|NCT02042131|20277713|P2|STARTED|Overall Study||32
8222542|NCT02042131|20277714|P1|STARTED|Overall Study||32
8222543|NCT02042014|20277731|P1|NOT COMPLETED|Overall Study||8
8222544|NCT02042014|20277731|P1|COMPLETED|Overall Study||0
8222545|NCT02042014|20277731|P1|STARTED|Overall Study||8
8222546|NCT02041962|20277737|P2|NOT COMPLETED|Overall Study||84
8222547|NCT02041962|20277738|P1|NOT COMPLETED|Overall Study||81
8222548|NCT02041962|20277737|P2|COMPLETED|Overall Study||31
8222549|NCT02041962|20277738|P1|COMPLETED|Overall Study||42
8222550|NCT02041962|20277737|P2|Participants Completing 12 mo. f/up|Overall Study||31
8222551|NCT02041962|20277738|P1|Participants Completing 12 mo. f/up|Overall Study||42
8222552|NCT02041962|20277737|P2|Participants Completing 6 mo. f/up|Overall Study||44
8222553|NCT02041962|20277738|P1|Participants Completing 6 mo. f/up|Overall Study||69
8222554|NCT02041962|20277737|P2|STARTED|Overall Study||115
8222555|NCT02041962|20277738|P1|STARTED|Overall Study||123
8222556|NCT02041702|20277748|P2|NOT COMPLETED|Overall Study||9
8222557|NCT02041702|20277749|P1|NOT COMPLETED|Overall Study||11
8222558|NCT02041702|20277748|P2|COMPLETED|Overall Study||134
8222559|NCT02041702|20277749|P1|COMPLETED|Overall Study||129
8222560|NCT02041702|20277748|P2|Post MRI Scan/ Post Waiting|Overall Study||140
8222561|NCT02041702|20277749|P1|Post MRI Scan/ Post Waiting|Overall Study||129
8222562|NCT02041702|20277748|P2|Pre MRI Scan/ Pre Waitng|Overall Study||140
8222563|NCT02041702|20277749|P1|Pre MRI Scan/ Pre Waitng|Overall Study||129
8222564|NCT02041702|20277748|P2|STARTED|Overall Study||143
8222565|NCT02041702|20277749|P1|STARTED|Overall Study||140
8222574|NCT02041520|20277787|P2|NOT COMPLETED|Overall Study||7
8222575|NCT02041520|20277788|P1|NOT COMPLETED|Overall Study||6
8222576|NCT02041520|20277787|P2|COMPLETED|Overall Study||28
8222577|NCT02041520|20277788|P1|COMPLETED|Overall Study||29
8222578|NCT02041520|20277787|P2|STARTED|Overall Study|35 patients randomly assigned to placebo|35
8222579|NCT02041520|20277788|P1|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
8222580|NCT02041377|20277808|P1|NOT COMPLETED|Overall Study||0
8222581|NCT02041377|20277808|P1|COMPLETED|Overall Study||134
8222582|NCT02041377|20277808|P1|STARTED|Overall Study||134
8222583|NCT02041325|20277818|P2|NOT COMPLETED|Overall Study||3
8222584|NCT02041325|20277819|P1|NOT COMPLETED|Overall Study||3
8222585|NCT02041325|20277818|P2|COMPLETED|Overall Study||13
8222586|NCT02041325|20277819|P1|COMPLETED|Overall Study||19
8222587|NCT02041325|20277818|P2|STARTED|Overall Study||16
8222588|NCT02041325|20277819|P1|STARTED|Overall Study||22
8222589|NCT02041286|20277831|P1|NOT COMPLETED|Overall Study||1
8222590|NCT02041286|20277831|P1|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
8222591|NCT02041286|20277831|P1|STARTED|Overall Study||136
8222592|NCT02041221|20277845|P6|NOT COMPLETED|Part 2||0
8222593|NCT02041221|20277846|P5|NOT COMPLETED|Part 2||0
8222594|NCT02041221|20277847|P4|NOT COMPLETED|Part 2||0
8222595|NCT02041221|20277848|P3|NOT COMPLETED|Part 2||1
8222596|NCT02041221|20277849|P2|NOT COMPLETED|Part 2||0
8222597|NCT02041221|20277850|P1|NOT COMPLETED|Part 2||0
8222598|NCT02041221|20277845|P6|COMPLETED|Part 2||6
8222599|NCT02041221|20277846|P5|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
8222600|NCT02041221|20277847|P4|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
8222601|NCT02041221|20277848|P3|COMPLETED|Part 2||5
8222602|NCT02041221|20277849|P2|COMPLETED|Part 2||6
8222603|NCT02041221|20277850|P1|COMPLETED|Part 2||6
8222604|NCT02041221|20277845|P6|STARTED|Part 2||6
8222605|NCT02041221|20277846|P5|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
8222606|NCT02041221|20277847|P4|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
8222607|NCT02041221|20277848|P3|STARTED|Part 2||6
8222608|NCT02041221|20277849|P2|STARTED|Part 2||6
8222609|NCT02041221|20277850|P1|STARTED|Part 2||6
8222610|NCT02041221|20277845|P6|NOT COMPLETED|Part 1||0
8222611|NCT02041221|20277846|P5|NOT COMPLETED|Part 1||0
8222612|NCT02041221|20277847|P4|NOT COMPLETED|Part 1||0
8222613|NCT02041221|20277848|P3|NOT COMPLETED|Part 1||0
8222614|NCT02041221|20277849|P2|NOT COMPLETED|Part 1||0
8222615|NCT02041221|20277850|P1|NOT COMPLETED|Part 1||0
8222616|NCT02041221|20277845|P6|COMPLETED|Part 1||10
8222617|NCT02041221|20277846|P5|COMPLETED|Part 1||6
8222618|NCT02041221|20277847|P4|COMPLETED|Part 1||6
8222619|NCT02041221|20277848|P3|COMPLETED|Part 1||6
8222620|NCT02041221|20277849|P2|COMPLETED|Part 1||6
8222621|NCT02041221|20277850|P1|COMPLETED|Part 1||6
8222622|NCT02041221|20277845|P6|STARTED|Part 1||10
8222623|NCT02041221|20277846|P5|STARTED|Part 1||6
8222624|NCT02041221|20277847|P4|STARTED|Part 1||6
8222625|NCT02041221|20277848|P3|STARTED|Part 1||6
8222626|NCT02041221|20277849|P2|STARTED|Part 1||6
8222627|NCT02041221|20277850|P1|STARTED|Part 1||6
8222628|NCT02041104|20277866|P2|NOT COMPLETED|Overall Study||7
8222629|NCT02041104|20277867|P1|NOT COMPLETED|Overall Study||1
8222630|NCT02041104|20277866|P2|COMPLETED|Overall Study||16
8222631|NCT02041104|20277867|P1|COMPLETED|Overall Study||27
8222632|NCT02041104|20277866|P2|STARTED|Overall Study||23
8222633|NCT02041104|20277867|P1|STARTED|Overall Study||28
8222634|NCT02041091|20277907|P2|NOT COMPLETED|Optional Safety Extension Period||82
8222635|NCT02041091|20277908|P1|NOT COMPLETED|Optional Safety Extension Period||85
8222636|NCT02041091|20277907|P2|COMPLETED|Optional Safety Extension Period||0
8222637|NCT02041091|20277908|P1|COMPLETED|Optional Safety Extension Period||0
8222638|NCT02041091|20277907|P2|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
8222639|NCT02041091|20277908|P1|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
8222640|NCT02041091|20277907|P2|NOT COMPLETED|Treatment||23
8222641|NCT02041091|20277908|P1|NOT COMPLETED|Treatment||22
8222642|NCT02041091|20277907|P2|COMPLETED|Treatment||91
8222643|NCT02041091|20277908|P1|COMPLETED|Treatment||90
8222644|NCT02041091|20277907|P2|Participated in Follow Up|Treatment||96
8222645|NCT02041091|20277908|P1|Participated in Follow Up|Treatment||106
8222646|NCT02041091|20277907|P2|Received At Least One Dose of Study Drug|Treatment||114
8222647|NCT02041091|20277908|P1|Received At Least One Dose of Study Drug|Treatment||112
8222648|NCT02041091|20277907|P2|STARTED|Treatment||114
8222649|NCT02041091|20277908|P1|STARTED|Treatment||112
8222650|NCT02040870|20277930|P1|NOT COMPLETED|Overall Study||103
8222651|NCT02040870|20277930|P1|COMPLETED|Overall Study||0
8222652|NCT02040870|20277930|P1|Discontinue From Study|Overall Study||26
8222653|NCT02040870|20277930|P1|Entered Survival Follow-up|Overall Study||75
8222654|NCT02040870|20277930|P1|Entered Post-treatment Follow-up|Overall Study||2
8222655|NCT02040870|20277930|P1|STARTED|Overall Study||103
8222660|NCT02040844|20277964|P3|NOT COMPLETED|Overall Study||47
8222661|NCT02040844|20277965|P2|NOT COMPLETED|Overall Study||39
8222662|NCT02040844|20277966|P1|NOT COMPLETED|Overall Study||50
8222663|NCT02040844|20277964|P3|COMPLETED|Overall Study||97
8222664|NCT02040844|20277965|P2|COMPLETED|Overall Study||109
8222665|NCT02040844|20277966|P1|COMPLETED|Overall Study||88
8222666|NCT02040844|20277964|P3|STARTED|Overall Study||144
8222667|NCT02040844|20277965|P2|STARTED|Overall Study||148
8222668|NCT02040844|20277966|P1|STARTED|Overall Study||138
8222669|NCT02040805|20277991|P2|NOT COMPLETED|Overall Study||50
8222670|NCT02040805|20277992|P1|NOT COMPLETED|Overall Study||42
8222671|NCT02040805|20277991|P2|COMPLETED|Overall Study||113
8222672|NCT02040805|20277992|P1|COMPLETED|Overall Study||118
8222673|NCT02040805|20277991|P2|STARTED|Overall Study||163
8222674|NCT02040805|20277992|P1|STARTED|Overall Study||160
8222690|NCT02040779|20278028|P3|NOT COMPLETED|Overall Study||4
8222691|NCT02040779|20278029|P2|NOT COMPLETED|Overall Study||7
8222692|NCT02040779|20278030|P1|NOT COMPLETED|Overall Study||12
8222693|NCT02040779|20278028|P3|COMPLETED|Overall Study||88
8222694|NCT02040779|20278029|P2|COMPLETED|Overall Study||83
8222695|NCT02040779|20278030|P1|COMPLETED|Overall Study||79
8222696|NCT02040779|20278028|P3|Full Analysis Set (FAS)|Overall Study||92
8222697|NCT02040779|20278029|P2|Full Analysis Set (FAS)|Overall Study||88
8222698|NCT02040779|20278030|P1|Full Analysis Set (FAS)|Overall Study||90
8222699|NCT02040779|20278028|P3|STARTED|Overall Study||92
8222700|NCT02040779|20278029|P2|STARTED|Overall Study||90
8222701|NCT02040779|20278030|P1|STARTED|Overall Study||91
8222702|NCT02040766|20278070|P5|NOT COMPLETED|Overall Study||13
8222703|NCT02040766|20278071|P4|NOT COMPLETED|Overall Study||13
8222704|NCT02040766|20278072|P3|NOT COMPLETED|Overall Study||12
8222705|NCT02040766|20278073|P2|NOT COMPLETED|Overall Study||10
8222706|NCT02040766|20278074|P1|NOT COMPLETED|Overall Study||18
8222707|NCT02040766|20278070|P5|COMPLETED|Overall Study||112
8222708|NCT02040766|20278071|P4|COMPLETED|Overall Study||112
8222709|NCT02040766|20278072|P3|COMPLETED|Overall Study||113
8222710|NCT02040766|20278073|P2|COMPLETED|Overall Study||116
8222711|NCT02040766|20278074|P1|COMPLETED|Overall Study||109
8222712|NCT02040766|20278070|P5|STARTED|Overall Study||125
8222713|NCT02040766|20278071|P4|STARTED|Overall Study||125
8222714|NCT02040766|20278072|P3|STARTED|Overall Study||125
8222715|NCT02040766|20278073|P2|STARTED|Overall Study||126
8222716|NCT02040766|20278074|P1|STARTED|Overall Study||127
8222717|NCT02040623|20278115|P3|NOT COMPLETED|Overall Study||2
8222718|NCT02040623|20278116|P2|NOT COMPLETED|Overall Study||6
8222719|NCT02040623|20278117|P1|NOT COMPLETED|Overall Study||4
8222720|NCT02040623|20278115|P3|COMPLETED|Overall Study||10
8222721|NCT02040623|20278116|P2|COMPLETED|Overall Study||6
8222722|NCT02040623|20278117|P1|COMPLETED|Overall Study||7
8222723|NCT02040623|20278115|P3|STARTED|Overall Study||12
8222724|NCT02040623|20278116|P2|STARTED|Overall Study||12
8222725|NCT02040623|20278117|P1|STARTED|Overall Study||11
8222726|NCT02040584|20278127|P2|NOT COMPLETED|Overall Study||32
8222727|NCT02040584|20278128|P1|NOT COMPLETED|Overall Study||35
8222728|NCT02040584|20278127|P2|COMPLETED|Overall Study||74
8222729|NCT02040584|20278128|P1|COMPLETED|Overall Study||70
8222730|NCT02040584|20278127|P2|STARTED|Overall Study||106
8222731|NCT02040584|20278128|P1|STARTED|Overall Study||105
8222732|NCT02040532|20278161|P1|NOT COMPLETED|Overall Study||12
8222733|NCT02040532|20278161|P1|COMPLETED|Overall Study||20
8222734|NCT02040532|20278161|P1|Received at Least One Dose of Medication|Overall Study||26
8222735|NCT02040532|20278161|P1|STARTED|Overall Study||32
8222736|NCT02040428|20278174|P2|NOT COMPLETED|Overall Study||4
8222737|NCT02040428|20278175|P1|NOT COMPLETED|Overall Study||5
8222738|NCT02040428|20278174|P2|COMPLETED|Overall Study||77
8222739|NCT02040428|20278175|P1|COMPLETED|Overall Study||70
8222740|NCT02040428|20278174|P2|Intent to Treat (Randomized Subjects)|Overall Study||80
8222741|NCT02040428|20278175|P1|Intent to Treat (Randomized Subjects)|Overall Study||76
8222742|NCT02040428|20278174|P2|STARTED|Overall Study||81
8222743|NCT02040428|20278175|P1|STARTED|Overall Study||75
8222744|NCT02040259|20278187|P1|NOT COMPLETED|Overall Study||363
8222745|NCT02040259|20278187|P1|COMPLETED|Overall Study||1645
8222746|NCT02040259|20278187|P1|STARTED|Overall Study||2008
8222747|NCT02040116|20278195|P1|NOT COMPLETED|Overall Study||0
8222748|NCT02040116|20278195|P1|COMPLETED|Overall Study||19
8222749|NCT02040116|20278195|P1|STARTED|Overall Study||19
8222750|NCT02040077|20278206|P3|NOT COMPLETED|Overall Study||0
8222751|NCT02040077|20278207|P2|NOT COMPLETED|Overall Study||0
8222752|NCT02040077|20278208|P1|NOT COMPLETED|Overall Study||0
8222753|NCT02040077|20278206|P3|COMPLETED|Overall Study||25
8222754|NCT02040077|20278207|P2|COMPLETED|Overall Study||24
8222755|NCT02040077|20278208|P1|COMPLETED|Overall Study||27
8222756|NCT02040077|20278206|P3|STARTED|Overall Study||25
8222757|NCT02040077|20278207|P2|STARTED|Overall Study||24
8222758|NCT02040077|20278208|P1|STARTED|Overall Study||27
8222759|NCT02039947|20278223|P4|NOT COMPLETED|Overall Study||0
8222760|NCT02039947|20278224|P3|NOT COMPLETED|Overall Study||0
8222761|NCT02039947|20278225|P2|NOT COMPLETED|Overall Study||0
8222762|NCT02039947|20278226|P1|NOT COMPLETED|Overall Study||0
8222763|NCT02039947|20278223|P4|COMPLETED|Overall Study||17
8222764|NCT02039947|20278224|P3|COMPLETED|Overall Study||16
8222765|NCT02039947|20278225|P2|COMPLETED|Overall Study||16
8222766|NCT02039947|20278226|P1|COMPLETED|Overall Study||76
8222767|NCT02039947|20278223|P4|STARTED|Overall Study||17
8222768|NCT02039947|20278224|P3|STARTED|Overall Study||16
8222769|NCT02039947|20278225|P2|STARTED|Overall Study||16
8222770|NCT02039947|20278226|P1|STARTED|Overall Study||76
8222771|NCT02039908|20278261|P4|NOT COMPLETED|Phase 2-School Year||8
8222772|NCT02039908|20278262|P3|NOT COMPLETED|Phase 2-School Year||12
8222773|NCT02039908|20278263|P2|NOT COMPLETED|Phase 2-School Year||0
8222774|NCT02039908|20278264|P1|NOT COMPLETED|Phase 2-School Year||0
8222775|NCT02039908|20278261|P4|COMPLETED|Phase 2-School Year||116
8222776|NCT02039908|20278262|P3|COMPLETED|Phase 2-School Year||109
8222777|NCT02039908|20278263|P2|COMPLETED|Phase 2-School Year||0
8222778|NCT02039908|20278264|P1|COMPLETED|Phase 2-School Year||0
8222779|NCT02039908|20278261|P4|STARTED|Phase 2-School Year||124
8222780|NCT02039908|20278262|P3|STARTED|Phase 2-School Year||121
8222781|NCT02039908|20278263|P2|STARTED|Phase 2-School Year||0
8222782|NCT02039908|20278264|P1|STARTED|Phase 2-School Year||0
8222783|NCT02039908|20278261|P4|NOT COMPLETED|Phase 1-Summer||0
8222784|NCT02039908|20278262|P3|NOT COMPLETED|Phase 1-Summer||0
8222785|NCT02039908|20278263|P2|NOT COMPLETED|Phase 1-Summer||6
8222786|NCT02039908|20278264|P1|NOT COMPLETED|Phase 1-Summer||13
8222787|NCT02039908|20278261|P4|COMPLETED|Phase 1-Summer||0
8222788|NCT02039908|20278262|P3|COMPLETED|Phase 1-Summer||0
8222789|NCT02039908|20278263|P2|COMPLETED|Phase 1-Summer||132
8222790|NCT02039908|20278264|P1|COMPLETED|Phase 1-Summer||116
8222791|NCT02039908|20278261|P4|STARTED|Phase 1-Summer||0
8222792|NCT02039908|20278262|P3|STARTED|Phase 1-Summer||0
8222793|NCT02039908|20278263|P2|STARTED|Phase 1-Summer||138
8222794|NCT02039908|20278264|P1|STARTED|Phase 1-Summer||129
8222795|NCT02039856|20278278|P2|NOT COMPLETED|Overall Study||853
8222796|NCT02039856|20278279|P1|NOT COMPLETED|Overall Study||2027
8222797|NCT02039856|20278278|P2|COMPLETED|Overall Study||327
8222798|NCT02039856|20278279|P1|COMPLETED|Overall Study||693
8222799|NCT02039856|20278278|P2|Total 24-month Completed|Overall Study||327
8222800|NCT02039856|20278279|P1|Total 24-month Completed|Overall Study||693
8222801|NCT02039856|20278278|P2|24-month Completed Providers/Staff|Overall Study||105
8222802|NCT02039856|20278279|P1|24-month Completed Providers/Staff|Overall Study||174
8222803|NCT02039856|20278278|P2|24-month Started Providers/Staff|Overall Study||304
8222804|NCT02039856|20278279|P1|24-month Started Providers/Staff|Overall Study||565
8222805|NCT02039856|20278278|P2|24-month Completed - Patients|Overall Study||222
8222806|NCT02039856|20278279|P1|24-month Completed - Patients|Overall Study||519
8222807|NCT02039856|20278278|P2|24-month Started - Patients|Overall Study||442
8222808|NCT02039856|20278279|P1|24-month Started - Patients|Overall Study||953
8222809|NCT02039856|20278278|P2|24-month Started|Overall Study||746
8222810|NCT02039856|20278279|P1|24-month Started|Overall Study||1518
8222811|NCT02039856|20278278|P2|12-month Providers/Staff|Overall Study||0
8222812|NCT02039856|20278279|P1|12-month Providers/Staff|Overall Study||0
8222813|NCT02039856|20278278|P2|12-month Completed- Patients|Overall Study||241
8222814|NCT02039856|20278279|P1|12-month Completed- Patients|Overall Study||580
8222815|NCT02039856|20278278|P2|12-month Started-patients|Overall Study||442
8222816|NCT02039856|20278279|P1|12-month Started-patients|Overall Study||953
8222817|NCT02039856|20278278|P2|Total Baseline Completed|Overall Study||536
8222818|NCT02039856|20278279|P1|Total Baseline Completed|Overall Study||1147
8222819|NCT02039856|20278278|P2|Baseline Completed -Providers/Staff|Overall Study||94
8222820|NCT02039856|20278279|P1|Baseline Completed -Providers/Staff|Overall Study||194
8222821|NCT02039856|20278278|P2|Baseline Started - Providers/Staff|Overall Study||261
8222822|NCT02039856|20278279|P1|Baseline Started - Providers/Staff|Overall Study||537
8222823|NCT02039856|20278278|P2|Baseline Completed - Patients|Overall Study||442
8222824|NCT02039856|20278279|P1|Baseline Completed - Patients|Overall Study||953
8222825|NCT02039856|20278278|P2|Baseline Started - Patients|Overall Study||919
8222826|NCT02039856|20278279|P1|Baseline Started - Patients|Overall Study||2183
8222827|NCT02039856|20278278|P2|STARTED|Overall Study||1180
8222828|NCT02039856|20278279|P1|STARTED|Overall Study||2720
8222829|NCT02039817|20278301|P2|NOT COMPLETED|Overall Study||0
8222830|NCT02039817|20278302|P1|NOT COMPLETED|Overall Study||0
8222831|NCT02039817|20278301|P2|COMPLETED|Overall Study||8
8222832|NCT02039817|20278302|P1|COMPLETED|Overall Study||8
8222833|NCT02039817|20278301|P2|STARTED|Overall Study||8
8222834|NCT02039817|20278302|P1|STARTED|Overall Study||8
8222835|NCT02039778|20278311|P1|NOT COMPLETED|Overall Study||4
8222836|NCT02039778|20278311|P1|COMPLETED|Overall Study||0
8222837|NCT02039778|20278311|P1|STARTED|Overall Study||4
8222848|NCT02039687|20278334|P4|NOT COMPLETED|Overall Study||0
8222849|NCT02039687|20278335|P3|NOT COMPLETED|Overall Study||3
8222850|NCT02039687|20278336|P2|NOT COMPLETED|Overall Study||1
8222851|NCT02039687|20278337|P1|NOT COMPLETED|Overall Study||0
8222852|NCT02039687|20278334|P4|COMPLETED|Overall Study||16
8222853|NCT02039687|20278335|P3|COMPLETED|Overall Study||13
8222854|NCT02039687|20278336|P2|COMPLETED|Overall Study||15
8222855|NCT02039687|20278337|P1|COMPLETED|Overall Study||16
8222856|NCT02039687|20278334|P4|STARTED|Overall Study||16
8222857|NCT02039687|20278335|P3|STARTED|Overall Study||16
8222858|NCT02039687|20278336|P2|STARTED|Overall Study||16
8222859|NCT02039687|20278337|P1|STARTED|Overall Study||16
8222860|NCT02039674|20278377|P14|NOT COMPLETED|Overall Study||33
8222861|NCT02039674|20278378|P13|NOT COMPLETED|Overall Study||63
8222862|NCT02039674|20278379|P12|NOT COMPLETED|Overall Study||60
8222863|NCT02039674|20278380|P11|NOT COMPLETED|Overall Study||7
8222864|NCT02039674|20278381|P10|NOT COMPLETED|Overall Study||12
8222865|NCT02039674|20278382|P9|NOT COMPLETED|Overall Study||12
8222866|NCT02039674|20278383|P8|NOT COMPLETED|Overall Study||3
8222867|NCT02039674|20278384|P7|NOT COMPLETED|Overall Study||3
8222868|NCT02039674|20278385|P6|NOT COMPLETED|Overall Study||12
8222869|NCT02039674|20278386|P5|NOT COMPLETED|Overall Study||12
8222870|NCT02039674|20278387|P4|NOT COMPLETED|Overall Study||13
8222871|NCT02039674|20278388|P3|NOT COMPLETED|Overall Study||12
8222872|NCT02039674|20278389|P2|NOT COMPLETED|Overall Study||12
8222873|NCT02039674|20278390|P1|NOT COMPLETED|Overall Study||12
8222874|NCT02039674|20278377|P14|COMPLETED|Overall Study||0
8222875|NCT02039674|20278378|P13|COMPLETED|Overall Study||0
8222876|NCT02039674|20278379|P12|COMPLETED|Overall Study||0
8222877|NCT02039674|20278380|P11|COMPLETED|Overall Study||0
8222878|NCT02039674|20278381|P10|COMPLETED|Overall Study||0
8222879|NCT02039674|20278382|P9|COMPLETED|Overall Study||0
8222880|NCT02039674|20278383|P8|COMPLETED|Overall Study||0
8222881|NCT02039674|20278384|P7|COMPLETED|Overall Study||0
8222882|NCT02039674|20278385|P6|COMPLETED|Overall Study||0
8222883|NCT02039674|20278386|P5|COMPLETED|Overall Study||0
8222884|NCT02039674|20278387|P4|COMPLETED|Overall Study||0
8222885|NCT02039674|20278388|P3|COMPLETED|Overall Study||0
8222886|NCT02039674|20278389|P2|COMPLETED|Overall Study||0
8222887|NCT02039674|20278390|P1|COMPLETED|Overall Study||1
8222888|NCT02039674|20278377|P14|Treated|Overall Study||33
8222889|NCT02039674|20278378|P13|Treated|Overall Study||62
8222890|NCT02039674|20278379|P12|Treated|Overall Study||59
8222891|NCT02039674|20278380|P11|Treated|Overall Study||7
8222892|NCT02039674|20278381|P10|Treated|Overall Study||12
8222893|NCT02039674|20278382|P9|Treated|Overall Study||12
8222894|NCT02039674|20278383|P8|Treated|Overall Study||3
8222895|NCT02039674|20278384|P7|Treated|Overall Study||3
8222896|NCT02039674|20278385|P6|Treated|Overall Study||12
8222897|NCT02039674|20278386|P5|Treated|Overall Study||12
8222898|NCT02039674|20278387|P4|Treated|Overall Study||13
8222899|NCT02039674|20278388|P3|Treated|Overall Study||11
8222900|NCT02039674|20278389|P2|Treated|Overall Study||12
8222901|NCT02039674|20278390|P1|Treated|Overall Study||13
8222902|NCT02039674|20278377|P14|STARTED|Overall Study||33
8222903|NCT02039674|20278378|P13|STARTED|Overall Study||63
8222904|NCT02039674|20278379|P12|STARTED|Overall Study||60
8222905|NCT02039674|20278380|P11|STARTED|Overall Study||7
8222906|NCT02039674|20278381|P10|STARTED|Overall Study||12
8222907|NCT02039674|20278382|P9|STARTED|Overall Study||12
8222908|NCT02039674|20278383|P8|STARTED|Overall Study||3
8222909|NCT02039674|20278384|P7|STARTED|Overall Study||3
8222910|NCT02039674|20278385|P6|STARTED|Overall Study||12
8222911|NCT02039674|20278386|P5|STARTED|Overall Study||12
8222912|NCT02039674|20278387|P4|STARTED|Overall Study||13
8222913|NCT02039674|20278388|P3|STARTED|Overall Study||12
8222914|NCT02039674|20278389|P2|STARTED|Overall Study||12
8222915|NCT02039674|20278390|P1|STARTED|Overall Study||13
8222916|NCT02039505|20278432|P7|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71
8222917|NCT02039505|20278433|P6|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222918|NCT02039505|20278434|P5|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222919|NCT02039505|20278435|P4|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222920|NCT02039505|20278436|P3|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222921|NCT02039505|20278437|P2|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222922|NCT02039505|20278438|P1|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222923|NCT02039505|20278432|P7|COMPLETED|Open-Label (Week 10 up to Week 154)||188
8222924|NCT02039505|20278433|P6|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222925|NCT02039505|20278434|P5|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222926|NCT02039505|20278435|P4|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222927|NCT02039505|20278436|P3|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222928|NCT02039505|20278437|P2|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222929|NCT02039505|20278438|P1|COMPLETED|Open-Label (Week 10 up to Week 154)||0
8222930|NCT02039505|20278432|P7|STARTED|Open-Label (Week 10 up to Week 154)||259
8222931|NCT02039505|20278433|P6|STARTED|Open-Label (Week 10 up to Week 154)||0
8222932|NCT02039505|20278434|P5|STARTED|Open-Label (Week 10 up to Week 154)||0
8222933|NCT02039505|20278435|P4|STARTED|Open-Label (Week 10 up to Week 154)||0
8222934|NCT02039505|20278436|P3|STARTED|Open-Label (Week 10 up to Week 154)||0
8222935|NCT02039505|20278437|P2|STARTED|Open-Label (Week 10 up to Week 154)||0
8222936|NCT02039505|20278438|P1|STARTED|Open-Label (Week 10 up to Week 154)||0
8222937|NCT02039505|20278432|P7|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222938|NCT02039505|20278433|P6|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14
8222939|NCT02039505|20278434|P5|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11
8222940|NCT02039505|20278435|P4|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24
8222941|NCT02039505|20278436|P3|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222942|NCT02039505|20278437|P2|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222943|NCT02039505|20278438|P1|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222944|NCT02039505|20278432|P7|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222945|NCT02039505|20278433|P6|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12
8222946|NCT02039505|20278434|P5|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30
8222947|NCT02039505|20278435|P4|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18
8222948|NCT02039505|20278436|P3|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222949|NCT02039505|20278437|P2|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222950|NCT02039505|20278438|P1|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
8222951|NCT02039505|20278432|P7|STARTED|Maintenance Phase (Week 14 to Week 60)||0
8222952|NCT02039505|20278433|P6|STARTED|Maintenance Phase (Week 14 to Week 60)||26
8222953|NCT02039505|20278434|P5|STARTED|Maintenance Phase (Week 14 to Week 60)||41
8222954|NCT02039505|20278435|P4|STARTED|Maintenance Phase (Week 14 to Week 60)||42
8222955|NCT02039505|20278436|P3|STARTED|Maintenance Phase (Week 14 to Week 60)||0
8222956|NCT02039505|20278437|P2|STARTED|Maintenance Phase (Week 14 to Week 60)||0
8222957|NCT02039505|20278438|P1|STARTED|Maintenance Phase (Week 14 to Week 60)||0
8222958|NCT02039505|20278432|P7|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222959|NCT02039505|20278433|P6|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222960|NCT02039505|20278434|P5|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222961|NCT02039505|20278435|P4|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222962|NCT02039505|20278436|P3|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10
8222963|NCT02039505|20278437|P2|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9
8222964|NCT02039505|20278438|P1|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4
8222965|NCT02039505|20278432|P7|COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222966|NCT02039505|20278433|P6|COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222967|NCT02039505|20278434|P5|COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222968|NCT02039505|20278435|P4|COMPLETED|Induction Phase (Week 0 to Week 14)||0
8222969|NCT02039505|20278436|P3|COMPLETED|Induction Phase (Week 0 to Week 14)||36
8222970|NCT02039505|20278437|P2|COMPLETED|Induction Phase (Week 0 to Week 14)||155
8222971|NCT02039505|20278438|P1|COMPLETED|Induction Phase (Week 0 to Week 14)||78
8222972|NCT02039505|20278432|P7|STARTED|Induction Phase (Week 0 to Week 14)||0
8222973|NCT02039505|20278433|P6|STARTED|Induction Phase (Week 0 to Week 14)||0
8222974|NCT02039505|20278434|P5|STARTED|Induction Phase (Week 0 to Week 14)||0
8222975|NCT02039505|20278435|P4|STARTED|Induction Phase (Week 0 to Week 14)||0
8222976|NCT02039505|20278436|P3|STARTED|Induction Phase (Week 0 to Week 14)||46
8222977|NCT02039505|20278437|P2|STARTED|Induction Phase (Week 0 to Week 14)||164
8222978|NCT02039505|20278438|P1|STARTED|Induction Phase (Week 0 to Week 14)||82
8222979|NCT02039427|20278514|P4|NOT COMPLETED|Overall Study||5
8222980|NCT02039427|20278515|P3|NOT COMPLETED|Overall Study||3
8222981|NCT02039427|20278516|P2|NOT COMPLETED|Overall Study||1
8222982|NCT02039427|20278517|P1|NOT COMPLETED|Overall Study||3
8222983|NCT02039427|20278514|P4|COMPLETED|Overall Study||43
8222984|NCT02039427|20278515|P3|COMPLETED|Overall Study||45
8222985|NCT02039427|20278516|P2|COMPLETED|Overall Study||47
8222986|NCT02039427|20278517|P1|COMPLETED|Overall Study||45
8222987|NCT02039427|20278514|P4|STARTED|Overall Study||48
8222988|NCT02039427|20278515|P3|STARTED|Overall Study||48
8222989|NCT02039427|20278516|P2|STARTED|Overall Study||48
8222990|NCT02039427|20278517|P1|STARTED|Overall Study||48
8222991|NCT02039414|20278537|P2|NOT COMPLETED|Overall Study||2
8222992|NCT02039414|20278538|P1|NOT COMPLETED|Overall Study||6
8222993|NCT02039414|20278537|P2|COMPLETED|Overall Study||16
8222994|NCT02039414|20278538|P1|COMPLETED|Overall Study||16
8222995|NCT02039414|20278537|P2|STARTED|Overall Study||18
8222996|NCT02039414|20278538|P1|STARTED|Overall Study||22
8222997|NCT02039375|20278550|P1|NOT COMPLETED|Overall Study||2
8222998|NCT02039375|20278550|P1|COMPLETED|Overall Study||33
8222999|NCT02039375|20278550|P1|STARTED|Overall Study||35
8223000|NCT02039219|20278561|P2|NOT COMPLETED|Follow up||1
8223001|NCT02039219|20278562|P1|NOT COMPLETED|Follow up||0
8223002|NCT02039219|20278561|P2|COMPLETED|Follow up||5
8223003|NCT02039219|20278562|P1|COMPLETED|Follow up||7
8223004|NCT02039219|20278561|P2|STARTED|Follow up||6
8223005|NCT02039219|20278562|P1|STARTED|Follow up||7
8223006|NCT02039219|20278561|P2|NOT COMPLETED|Treatment||2
8223007|NCT02039219|20278562|P1|NOT COMPLETED|Treatment||4
8223008|NCT02039219|20278561|P2|COMPLETED|Treatment||6
8223009|NCT02039219|20278562|P1|COMPLETED|Treatment||7
8223010|NCT02039219|20278561|P2|STARTED|Treatment||8
8223011|NCT02039219|20278562|P1|STARTED|Treatment||11
8223012|NCT02039115|20278602|P2|NOT COMPLETED|Overall Study||0
8223013|NCT02039115|20278603|P1|NOT COMPLETED|Overall Study||0
8223014|NCT02039115|20278602|P2|COMPLETED|Overall Study||0
8223015|NCT02039115|20278603|P1|COMPLETED|Overall Study||1
8223016|NCT02039115|20278602|P2|STARTED|Overall Study||0
8223017|NCT02039115|20278603|P1|STARTED|Overall Study||1
8223018|NCT02038959|20278611|P2|NOT COMPLETED|Overall Study||8
8223019|NCT02038959|20278612|P1|NOT COMPLETED|Overall Study||6
8223020|NCT02038959|20278611|P2|COMPLETED|Overall Study||89
8223021|NCT02038959|20278612|P1|COMPLETED|Overall Study||92
8223022|NCT02038959|20278611|P2|STARTED|Overall Study||97
8223023|NCT02038959|20278612|P1|STARTED|Overall Study||98
8223024|NCT02038946|20278638|P1|NOT COMPLETED|Overall Study||11
8223025|NCT02038946|20278638|P1|COMPLETED|Overall Study||81
8223026|NCT02038946|20278638|P1|STARTED|Overall Study||92
8223027|NCT02038933|20278649|P1|NOT COMPLETED|Follow-up||19
8223028|NCT02038933|20278649|P1|COMPLETED|Follow-up|Includes subjects still on-treatment and subjects off-treatment continuing in the Follow-up period.|102
8223029|NCT02038933|20278649|P1|STARTED|Follow-up||121
8223030|NCT02038933|20278649|P1|NOT COMPLETED|Treatment||114
8223031|NCT02038933|20278649|P1|COMPLETED|Treatment|Subjects continuing in the treatment period|7
8223032|NCT02038933|20278649|P1|STARTED|Treatment||121
8223033|NCT02038920|20278670|P6|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77
8223034|NCT02038920|20278671|P5|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223035|NCT02038920|20278672|P4|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223036|NCT02038920|20278673|P3|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223037|NCT02038920|20278674|P2|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223038|NCT02038920|20278675|P1|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223039|NCT02038920|20278670|P6|COMPLETED|Open Label Cohort (Week 10 to 154)||57
8223040|NCT02038920|20278671|P5|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223041|NCT02038920|20278672|P4|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223042|NCT02038920|20278673|P3|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223043|NCT02038920|20278674|P2|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223044|NCT02038920|20278675|P1|COMPLETED|Open Label Cohort (Week 10 to 154)||0
8223045|NCT02038920|20278670|P6|STARTED|Open Label Cohort (Week 10 to 154)||134
8223046|NCT02038920|20278671|P5|STARTED|Open Label Cohort (Week 10 to 154)||0
8223047|NCT02038920|20278672|P4|STARTED|Open Label Cohort (Week 10 to 154)||0
8223048|NCT02038920|20278673|P3|STARTED|Open Label Cohort (Week 10 to 154)||0
8223049|NCT02038920|20278674|P2|STARTED|Open Label Cohort (Week 10 to 154)||0
8223050|NCT02038920|20278675|P1|STARTED|Open Label Cohort (Week 10 to 154)||0
8223051|NCT02038920|20278670|P6|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
8223052|NCT02038920|20278671|P5|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12
8223053|NCT02038920|20278672|P4|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8
8223054|NCT02038920|20278673|P3|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5
8223055|NCT02038920|20278674|P2|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
8223056|NCT02038920|20278675|P1|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
8223057|NCT02038920|20278670|P6|COMPLETED|Maintenance Phase (Week 14 to 60)||0
8223058|NCT02038920|20278671|P5|COMPLETED|Maintenance Phase (Week 14 to 60)||5
8223059|NCT02038920|20278672|P4|COMPLETED|Maintenance Phase (Week 14 to 60)||4
8223060|NCT02038920|20278673|P3|COMPLETED|Maintenance Phase (Week 14 to 60)||7
8223061|NCT02038920|20278674|P2|COMPLETED|Maintenance Phase (Week 14 to 60)||0
8223062|NCT02038920|20278675|P1|COMPLETED|Maintenance Phase (Week 14 to 60)||0
8223063|NCT02038920|20278670|P6|STARTED|Maintenance Phase (Week 14 to 60)||0
8223064|NCT02038920|20278671|P5|STARTED|Maintenance Phase (Week 14 to 60)||17
8223065|NCT02038920|20278672|P4|STARTED|Maintenance Phase (Week 14 to 60)||12
8223066|NCT02038920|20278673|P3|STARTED|Maintenance Phase (Week 14 to 60)||12
8223067|NCT02038920|20278674|P2|STARTED|Maintenance Phase (Week 14 to 60)||0
8223068|NCT02038920|20278675|P1|STARTED|Maintenance Phase (Week 14 to 60)||0
8223069|NCT02038920|20278670|P6|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
8223070|NCT02038920|20278671|P5|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
8223071|NCT02038920|20278672|P4|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
8223072|NCT02038920|20278673|P3|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
8223073|NCT02038920|20278674|P2|NOT COMPLETED|Induction Phase (Week 0 to 14)||12
8223074|NCT02038920|20278675|P1|NOT COMPLETED|Induction Phase (Week 0 to 14)||6
8223075|NCT02038920|20278670|P6|COMPLETED|Induction Phase (Week 0 to 14)||0
8223076|NCT02038920|20278671|P5|COMPLETED|Induction Phase (Week 0 to 14)||0
8223077|NCT02038920|20278672|P4|COMPLETED|Induction Phase (Week 0 to 14)||0
8223078|NCT02038920|20278673|P3|COMPLETED|Induction Phase (Week 0 to 14)||0
8223079|NCT02038920|20278674|P2|COMPLETED|Induction Phase (Week 0 to 14)||66
8223080|NCT02038920|20278675|P1|COMPLETED|Induction Phase (Week 0 to 14)||73
8223081|NCT02038920|20278670|P6|STARTED|Induction Phase (Week 0 to 14)||0
8223082|NCT02038920|20278671|P5|STARTED|Induction Phase (Week 0 to 14)||0
8223083|NCT02038920|20278672|P4|STARTED|Induction Phase (Week 0 to 14)||0
8223084|NCT02038920|20278673|P3|STARTED|Induction Phase (Week 0 to 14)||0
8223085|NCT02038920|20278674|P2|STARTED|Induction Phase (Week 0 to 14)||78
8223086|NCT02038920|20278675|P1|STARTED|Induction Phase (Week 0 to 14)||79
8223087|NCT02038907|20278752|P14|NOT COMPLETED|Overall Study||0
8223088|NCT02038907|20278753|P13|NOT COMPLETED|Overall Study||0
8223089|NCT02038907|20278754|P12|NOT COMPLETED|Overall Study||0
8223090|NCT02038907|20278755|P11|NOT COMPLETED|Overall Study||2
8223091|NCT02038907|20278756|P10|NOT COMPLETED|Overall Study||0
8223092|NCT02038907|20278757|P9|NOT COMPLETED|Overall Study||0
8223093|NCT02038907|20278758|P8|NOT COMPLETED|Overall Study||0
8223094|NCT02038907|20278759|P7|NOT COMPLETED|Overall Study||0
8223095|NCT02038907|20278760|P6|NOT COMPLETED|Overall Study||0
8223096|NCT02038907|20278761|P5|NOT COMPLETED|Overall Study||0
8223097|NCT02038907|20278762|P4|NOT COMPLETED|Overall Study||0
8223098|NCT02038907|20278763|P3|NOT COMPLETED|Overall Study||0
8223099|NCT02038907|20278764|P2|NOT COMPLETED|Overall Study||0
8223100|NCT02038907|20278765|P1|NOT COMPLETED|Overall Study||0
8223101|NCT02038907|20278752|P14|COMPLETED|Overall Study||31
8223102|NCT02038907|20278753|P13|COMPLETED|Overall Study||29
8223103|NCT02038907|20278754|P12|COMPLETED|Overall Study||28
8223104|NCT02038907|20278755|P11|COMPLETED|Overall Study||27
8223105|NCT02038907|20278756|P10|COMPLETED|Overall Study||30
8223106|NCT02038907|20278757|P9|COMPLETED|Overall Study||29
8223107|NCT02038907|20278758|P8|COMPLETED|Overall Study||32
8223108|NCT02038907|20278759|P7|COMPLETED|Overall Study||30
8223109|NCT02038907|20278760|P6|COMPLETED|Overall Study||31
8223110|NCT02038907|20278761|P5|COMPLETED|Overall Study||30
8223111|NCT02038907|20278762|P4|COMPLETED|Overall Study||31
8223112|NCT02038907|20278763|P3|COMPLETED|Overall Study||30
8223113|NCT02038907|20278764|P2|COMPLETED|Overall Study||30
8223114|NCT02038907|20278765|P1|COMPLETED|Overall Study||30
8223115|NCT02038907|20278752|P14|STARTED|Overall Study||31
8223116|NCT02038907|20278753|P13|STARTED|Overall Study||29
8223117|NCT02038907|20278754|P12|STARTED|Overall Study||28
8223118|NCT02038907|20278755|P11|STARTED|Overall Study||29
8223119|NCT02038907|20278756|P10|STARTED|Overall Study||30
8223120|NCT02038907|20278757|P9|STARTED|Overall Study||29
8223121|NCT02038907|20278758|P8|STARTED|Overall Study||32
8223122|NCT02038907|20278759|P7|STARTED|Overall Study||30
8223123|NCT02038907|20278760|P6|STARTED|Overall Study||31
8223124|NCT02038907|20278761|P5|STARTED|Overall Study||30
8223125|NCT02038907|20278762|P4|STARTED|Overall Study||31
8223126|NCT02038907|20278763|P3|STARTED|Overall Study||30
8223127|NCT02038907|20278764|P2|STARTED|Overall Study||30
8223128|NCT02038907|20278765|P1|STARTED|Overall Study||30
8223129|NCT02038894|20279296|P3|NOT COMPLETED|Overall Study||0
8223130|NCT02038894|20279297|P2|NOT COMPLETED|Overall Study||0
8223131|NCT02038894|20279298|P1|NOT COMPLETED|Overall Study||0
8223132|NCT02038894|20279296|P3|COMPLETED|Overall Study||61
8223133|NCT02038894|20279297|P2|COMPLETED|Overall Study||58
8223134|NCT02038894|20279298|P1|COMPLETED|Overall Study||60
8223135|NCT02038894|20279296|P3|STARTED|Overall Study||61
8223136|NCT02038894|20279297|P2|STARTED|Overall Study||58
8223137|NCT02038894|20279298|P1|STARTED|Overall Study||60
8223138|NCT02038881|20279316|P3|NOT COMPLETED|Overall Study||1
8223139|NCT02038881|20279317|P2|NOT COMPLETED|Overall Study||0
8223140|NCT02038881|20279318|P1|NOT COMPLETED|Overall Study||3
8223141|NCT02038881|20279316|P3|COMPLETED|Overall Study||30
8223142|NCT02038881|20279317|P2|COMPLETED|Overall Study||29
8223143|NCT02038881|20279318|P1|COMPLETED|Overall Study||24
8223144|NCT02038881|20279316|P3|STARTED|Overall Study||31
8223145|NCT02038881|20279317|P2|STARTED|Overall Study||29
8223146|NCT02038881|20279318|P1|STARTED|Overall Study||27
8223147|NCT02038829|20279391|P12|NOT COMPLETED|Treatment Period 6||0
8223148|NCT02038829|20279392|P11|NOT COMPLETED|Treatment Period 6||0
8223149|NCT02038829|20279393|P10|NOT COMPLETED|Treatment Period 6||0
8223150|NCT02038829|20279394|P9|NOT COMPLETED|Treatment Period 6||0
8223151|NCT02038829|20279395|P8|NOT COMPLETED|Treatment Period 6||0
8223152|NCT02038829|20279396|P7|NOT COMPLETED|Treatment Period 6||0
8223153|NCT02038829|20279397|P6|NOT COMPLETED|Treatment Period 6||0
8223154|NCT02038829|20279398|P5|NOT COMPLETED|Treatment Period 6||0
8223155|NCT02038829|20279399|P4|NOT COMPLETED|Treatment Period 6||0
8223156|NCT02038829|20279400|P3|NOT COMPLETED|Treatment Period 6||1
8223157|NCT02038829|20279401|P2|NOT COMPLETED|Treatment Period 6||0
8223158|NCT02038829|20279402|P1|NOT COMPLETED|Treatment Period 6||0
8223159|NCT02038829|20279391|P12|COMPLETED|Treatment Period 6||8
8223160|NCT02038829|20279392|P11|COMPLETED|Treatment Period 6||7
8223161|NCT02038829|20279393|P10|COMPLETED|Treatment Period 6||8
8223162|NCT02038829|20279394|P9|COMPLETED|Treatment Period 6||7
8223163|NCT02038829|20279395|P8|COMPLETED|Treatment Period 6||8
8223164|NCT02038829|20279396|P7|COMPLETED|Treatment Period 6||7
8223165|NCT02038829|20279397|P6|COMPLETED|Treatment Period 6||7
8223166|NCT02038829|20279398|P5|COMPLETED|Treatment Period 6||7
8223167|NCT02038829|20279399|P4|COMPLETED|Treatment Period 6||8
8223168|NCT02038829|20279400|P3|COMPLETED|Treatment Period 6||7
8223169|NCT02038829|20279401|P2|COMPLETED|Treatment Period 6||7
8223170|NCT02038829|20279402|P1|COMPLETED|Treatment Period 6||7
8223171|NCT02038829|20279391|P12|STARTED|Treatment Period 6||8
8223172|NCT02038829|20279392|P11|STARTED|Treatment Period 6||7
8223173|NCT02038829|20279393|P10|STARTED|Treatment Period 6||8
8223174|NCT02038829|20279394|P9|STARTED|Treatment Period 6||7
8223175|NCT02038829|20279395|P8|STARTED|Treatment Period 6||8
8223176|NCT02038829|20279396|P7|STARTED|Treatment Period 6||7
8223177|NCT02038829|20279397|P6|STARTED|Treatment Period 6||7
8223178|NCT02038829|20279398|P5|STARTED|Treatment Period 6||7
8223179|NCT02038829|20279399|P4|STARTED|Treatment Period 6||8
8223180|NCT02038829|20279400|P3|STARTED|Treatment Period 6||8
8223181|NCT02038829|20279401|P2|STARTED|Treatment Period 6||7
8223182|NCT02038829|20279402|P1|STARTED|Treatment Period 6||7
8223183|NCT02038829|20279391|P12|NOT COMPLETED|Washout Period 5||0
8223184|NCT02038829|20279392|P11|NOT COMPLETED|Washout Period 5||0
8223185|NCT02038829|20279393|P10|NOT COMPLETED|Washout Period 5||0
8223186|NCT02038829|20279394|P9|NOT COMPLETED|Washout Period 5||0
8223187|NCT02038829|20279395|P8|NOT COMPLETED|Washout Period 5||0
8223188|NCT02038829|20279396|P7|NOT COMPLETED|Washout Period 5||0
8223189|NCT02038829|20279397|P6|NOT COMPLETED|Washout Period 5||0
8223190|NCT02038829|20279398|P5|NOT COMPLETED|Washout Period 5||0
8223191|NCT02038829|20279399|P4|NOT COMPLETED|Washout Period 5||0
8223192|NCT02038829|20279400|P3|NOT COMPLETED|Washout Period 5||0
8223193|NCT02038829|20279401|P2|NOT COMPLETED|Washout Period 5||0
8223194|NCT02038829|20279402|P1|NOT COMPLETED|Washout Period 5||0
8223195|NCT02038829|20279391|P12|COMPLETED|Washout Period 5||8
8223196|NCT02038829|20279392|P11|COMPLETED|Washout Period 5||7
8223197|NCT02038829|20279393|P10|COMPLETED|Washout Period 5||8
8223198|NCT02038829|20279394|P9|COMPLETED|Washout Period 5||7
8223199|NCT02038829|20279395|P8|COMPLETED|Washout Period 5||8
8223200|NCT02038829|20279396|P7|COMPLETED|Washout Period 5||7
8223201|NCT02038829|20279397|P6|COMPLETED|Washout Period 5||7
8223202|NCT02038829|20279398|P5|COMPLETED|Washout Period 5||7
8223203|NCT02038829|20279399|P4|COMPLETED|Washout Period 5||8
8223204|NCT02038829|20279400|P3|COMPLETED|Washout Period 5||8
8223205|NCT02038829|20279401|P2|COMPLETED|Washout Period 5||7
8223206|NCT02038829|20279402|P1|COMPLETED|Washout Period 5||7
8223207|NCT02038829|20279391|P12|STARTED|Washout Period 5||8
8223208|NCT02038829|20279392|P11|STARTED|Washout Period 5||7
8223209|NCT02038829|20279393|P10|STARTED|Washout Period 5||8
8223210|NCT02038829|20279394|P9|STARTED|Washout Period 5||7
8223211|NCT02038829|20279395|P8|STARTED|Washout Period 5||8
8223212|NCT02038829|20279396|P7|STARTED|Washout Period 5||7
8223213|NCT02038829|20279397|P6|STARTED|Washout Period 5||7
8223214|NCT02038829|20279398|P5|STARTED|Washout Period 5||7
8223215|NCT02038829|20279399|P4|STARTED|Washout Period 5||8
8223216|NCT02038829|20279400|P3|STARTED|Washout Period 5||8
8223217|NCT02038829|20279401|P2|STARTED|Washout Period 5||7
8223218|NCT02038829|20279402|P1|STARTED|Washout Period 5||7
8223219|NCT02038829|20279391|P12|NOT COMPLETED|Treatment Period 5||0
8223220|NCT02038829|20279392|P11|NOT COMPLETED|Treatment Period 5||0
8223221|NCT02038829|20279393|P10|NOT COMPLETED|Treatment Period 5||0
8223222|NCT02038829|20279394|P9|NOT COMPLETED|Treatment Period 5||0
8223223|NCT02038829|20279395|P8|NOT COMPLETED|Treatment Period 5||0
8223224|NCT02038829|20279396|P7|NOT COMPLETED|Treatment Period 5||0
8223225|NCT02038829|20279397|P6|NOT COMPLETED|Treatment Period 5||0
8223226|NCT02038829|20279398|P5|NOT COMPLETED|Treatment Period 5||0
8223227|NCT02038829|20279399|P4|NOT COMPLETED|Treatment Period 5||0
8223228|NCT02038829|20279400|P3|NOT COMPLETED|Treatment Period 5||0
8223229|NCT02038829|20279401|P2|NOT COMPLETED|Treatment Period 5||0
8223230|NCT02038829|20279402|P1|NOT COMPLETED|Treatment Period 5||0
8223231|NCT02038829|20279391|P12|COMPLETED|Treatment Period 5||8
8223232|NCT02038829|20279392|P11|COMPLETED|Treatment Period 5||7
8223233|NCT02038829|20279393|P10|COMPLETED|Treatment Period 5||8
8223234|NCT02038829|20279394|P9|COMPLETED|Treatment Period 5||7
8223235|NCT02038829|20279395|P8|COMPLETED|Treatment Period 5||8
8223236|NCT02038829|20279396|P7|COMPLETED|Treatment Period 5||7
8223237|NCT02038829|20279397|P6|COMPLETED|Treatment Period 5||7
8223238|NCT02038829|20279398|P5|COMPLETED|Treatment Period 5||7
8223239|NCT02038829|20279399|P4|COMPLETED|Treatment Period 5||8
8223240|NCT02038829|20279400|P3|COMPLETED|Treatment Period 5||8
8223241|NCT02038829|20279401|P2|COMPLETED|Treatment Period 5||7
8223242|NCT02038829|20279402|P1|COMPLETED|Treatment Period 5||7
8223243|NCT02038829|20279391|P12|STARTED|Treatment Period 5||8
8223244|NCT02038829|20279392|P11|STARTED|Treatment Period 5||7
8223245|NCT02038829|20279393|P10|STARTED|Treatment Period 5||8
8223246|NCT02038829|20279394|P9|STARTED|Treatment Period 5||7
8223247|NCT02038829|20279395|P8|STARTED|Treatment Period 5||8
8223248|NCT02038829|20279396|P7|STARTED|Treatment Period 5||7
8223249|NCT02038829|20279397|P6|STARTED|Treatment Period 5||7
8223250|NCT02038829|20279398|P5|STARTED|Treatment Period 5||7
8223251|NCT02038829|20279399|P4|STARTED|Treatment Period 5||8
8223252|NCT02038829|20279400|P3|STARTED|Treatment Period 5||8
8223253|NCT02038829|20279401|P2|STARTED|Treatment Period 5||7
8223254|NCT02038829|20279402|P1|STARTED|Treatment Period 5||7
8223255|NCT02038829|20279391|P12|NOT COMPLETED|Washout Period 4||0
8223256|NCT02038829|20279392|P11|NOT COMPLETED|Washout Period 4||0
8223257|NCT02038829|20279393|P10|NOT COMPLETED|Washout Period 4||0
8223258|NCT02038829|20279394|P9|NOT COMPLETED|Washout Period 4||0
8223259|NCT02038829|20279395|P8|NOT COMPLETED|Washout Period 4||0
8223260|NCT02038829|20279396|P7|NOT COMPLETED|Washout Period 4||1
8223261|NCT02038829|20279397|P6|NOT COMPLETED|Washout Period 4||0
8223262|NCT02038829|20279398|P5|NOT COMPLETED|Washout Period 4||0
8223263|NCT02038829|20279399|P4|NOT COMPLETED|Washout Period 4||0
8223264|NCT02038829|20279400|P3|NOT COMPLETED|Washout Period 4||0
8223265|NCT02038829|20279401|P2|NOT COMPLETED|Washout Period 4||0
8223266|NCT02038829|20279402|P1|NOT COMPLETED|Washout Period 4||0
8223267|NCT02038829|20279391|P12|COMPLETED|Washout Period 4||8
8223268|NCT02038829|20279392|P11|COMPLETED|Washout Period 4||7
8223269|NCT02038829|20279393|P10|COMPLETED|Washout Period 4||8
8223270|NCT02038829|20279394|P9|COMPLETED|Washout Period 4||7
8223271|NCT02038829|20279395|P8|COMPLETED|Washout Period 4||8
8223272|NCT02038829|20279396|P7|COMPLETED|Washout Period 4||7
8223273|NCT02038829|20279397|P6|COMPLETED|Washout Period 4||7
8223274|NCT02038829|20279398|P5|COMPLETED|Washout Period 4||7
8223275|NCT02038829|20279399|P4|COMPLETED|Washout Period 4||8
8223276|NCT02038829|20279400|P3|COMPLETED|Washout Period 4||8
8223277|NCT02038829|20279401|P2|COMPLETED|Washout Period 4||7
8223278|NCT02038829|20279402|P1|COMPLETED|Washout Period 4||7
8223279|NCT02038829|20279391|P12|STARTED|Washout Period 4||8
8223280|NCT02038829|20279392|P11|STARTED|Washout Period 4||7
8223281|NCT02038829|20279393|P10|STARTED|Washout Period 4||8
8223282|NCT02038829|20279394|P9|STARTED|Washout Period 4||7
8223283|NCT02038829|20279395|P8|STARTED|Washout Period 4||8
8223284|NCT02038829|20279396|P7|STARTED|Washout Period 4||8
8223285|NCT02038829|20279397|P6|STARTED|Washout Period 4||7
8223286|NCT02038829|20279398|P5|STARTED|Washout Period 4||7
8223287|NCT02038829|20279399|P4|STARTED|Washout Period 4||8
8223288|NCT02038829|20279400|P3|STARTED|Washout Period 4||8
8223289|NCT02038829|20279401|P2|STARTED|Washout Period 4||7
8223290|NCT02038829|20279402|P1|STARTED|Washout Period 4||7
8223291|NCT02038829|20279391|P12|NOT COMPLETED|Treatment Period 4||0
8223292|NCT02038829|20279392|P11|NOT COMPLETED|Treatment Period 4||0
8223293|NCT02038829|20279393|P10|NOT COMPLETED|Treatment Period 4||0
8223294|NCT02038829|20279394|P9|NOT COMPLETED|Treatment Period 4||0
8223295|NCT02038829|20279395|P8|NOT COMPLETED|Treatment Period 4||0
8223296|NCT02038829|20279396|P7|NOT COMPLETED|Treatment Period 4||0
8223297|NCT02038829|20279397|P6|NOT COMPLETED|Treatment Period 4||0
8223298|NCT02038829|20279398|P5|NOT COMPLETED|Treatment Period 4||0
8223299|NCT02038829|20279399|P4|NOT COMPLETED|Treatment Period 4||0
8223300|NCT02038829|20279400|P3|NOT COMPLETED|Treatment Period 4||0
8223301|NCT02038829|20279401|P2|NOT COMPLETED|Treatment Period 4||1
8223302|NCT02038829|20279402|P1|NOT COMPLETED|Treatment Period 4||0
8223303|NCT02038829|20279391|P12|COMPLETED|Treatment Period 4||8
8223304|NCT02038829|20279392|P11|COMPLETED|Treatment Period 4||7
8223305|NCT02038829|20279393|P10|COMPLETED|Treatment Period 4||8
8223306|NCT02038829|20279394|P9|COMPLETED|Treatment Period 4||7
8223307|NCT02038829|20279395|P8|COMPLETED|Treatment Period 4||8
8223308|NCT02038829|20279396|P7|COMPLETED|Treatment Period 4||8
8223309|NCT02038829|20279397|P6|COMPLETED|Treatment Period 4||7
8223310|NCT02038829|20279398|P5|COMPLETED|Treatment Period 4||7
8223311|NCT02038829|20279399|P4|COMPLETED|Treatment Period 4||8
8223312|NCT02038829|20279400|P3|COMPLETED|Treatment Period 4||8
8223313|NCT02038829|20279401|P2|COMPLETED|Treatment Period 4||7
8223314|NCT02038829|20279402|P1|COMPLETED|Treatment Period 4||7
8223315|NCT02038829|20279391|P12|STARTED|Treatment Period 4||8
8223316|NCT02038829|20279392|P11|STARTED|Treatment Period 4||7
8223317|NCT02038829|20279393|P10|STARTED|Treatment Period 4||8
8223318|NCT02038829|20279394|P9|STARTED|Treatment Period 4||7
8223319|NCT02038829|20279395|P8|STARTED|Treatment Period 4||8
8223320|NCT02038829|20279396|P7|STARTED|Treatment Period 4||8
8223321|NCT02038829|20279397|P6|STARTED|Treatment Period 4||7
8223322|NCT02038829|20279398|P5|STARTED|Treatment Period 4||7
8223323|NCT02038829|20279399|P4|STARTED|Treatment Period 4||8
8223324|NCT02038829|20279400|P3|STARTED|Treatment Period 4||8
8223325|NCT02038829|20279401|P2|STARTED|Treatment Period 4||8
8223326|NCT02038829|20279402|P1|STARTED|Treatment Period 4||7
8223327|NCT02038829|20279391|P12|NOT COMPLETED|Washout Period 3||0
8223328|NCT02038829|20279392|P11|NOT COMPLETED|Washout Period 3||0
8223329|NCT02038829|20279393|P10|NOT COMPLETED|Washout Period 3||0
8223330|NCT02038829|20279394|P9|NOT COMPLETED|Washout Period 3||0
8223331|NCT02038829|20279395|P8|NOT COMPLETED|Washout Period 3||0
8223332|NCT02038829|20279396|P7|NOT COMPLETED|Washout Period 3||0
8223333|NCT02038829|20279397|P6|NOT COMPLETED|Washout Period 3||0
8223334|NCT02038829|20279398|P5|NOT COMPLETED|Washout Period 3||0
8223335|NCT02038829|20279399|P4|NOT COMPLETED|Washout Period 3||0
8223336|NCT02038829|20279400|P3|NOT COMPLETED|Washout Period 3||0
8223337|NCT02038829|20279401|P2|NOT COMPLETED|Washout Period 3||0
8223338|NCT02038829|20279402|P1|NOT COMPLETED|Washout Period 3||0
8223339|NCT02038829|20279391|P12|COMPLETED|Washout Period 3||8
8223340|NCT02038829|20279392|P11|COMPLETED|Washout Period 3||7
8223341|NCT02038829|20279393|P10|COMPLETED|Washout Period 3||8
8223342|NCT02038829|20279394|P9|COMPLETED|Washout Period 3||7
8223343|NCT02038829|20279395|P8|COMPLETED|Washout Period 3||8
8223344|NCT02038829|20279396|P7|COMPLETED|Washout Period 3||8
8223345|NCT02038829|20279397|P6|COMPLETED|Washout Period 3||7
8223346|NCT02038829|20279398|P5|COMPLETED|Washout Period 3||7
8223347|NCT02038829|20279399|P4|COMPLETED|Washout Period 3||8
8223348|NCT02038829|20279400|P3|COMPLETED|Washout Period 3||8
8223349|NCT02038829|20279401|P2|COMPLETED|Washout Period 3||8
8223350|NCT02038829|20279402|P1|COMPLETED|Washout Period 3||7
8223351|NCT02038829|20279391|P12|STARTED|Washout Period 3||8
8223352|NCT02038829|20279392|P11|STARTED|Washout Period 3||7
8223353|NCT02038829|20279393|P10|STARTED|Washout Period 3||8
8223354|NCT02038829|20279394|P9|STARTED|Washout Period 3||7
8223355|NCT02038829|20279395|P8|STARTED|Washout Period 3||8
8223356|NCT02038829|20279396|P7|STARTED|Washout Period 3||8
8223357|NCT02038829|20279397|P6|STARTED|Washout Period 3||7
8223358|NCT02038829|20279398|P5|STARTED|Washout Period 3||7
8223359|NCT02038829|20279399|P4|STARTED|Washout Period 3||8
8223360|NCT02038829|20279400|P3|STARTED|Washout Period 3||8
8223361|NCT02038829|20279401|P2|STARTED|Washout Period 3||8
8223362|NCT02038829|20279402|P1|STARTED|Washout Period 3||7
8223363|NCT02038829|20279391|P12|NOT COMPLETED|Treatment Period 3||0
8223364|NCT02038829|20279392|P11|NOT COMPLETED|Treatment Period 3||0
8223365|NCT02038829|20279393|P10|NOT COMPLETED|Treatment Period 3||0
8223366|NCT02038829|20279394|P9|NOT COMPLETED|Treatment Period 3||0
8223367|NCT02038829|20279395|P8|NOT COMPLETED|Treatment Period 3||0
8223368|NCT02038829|20279396|P7|NOT COMPLETED|Treatment Period 3||0
8223369|NCT02038829|20279397|P6|NOT COMPLETED|Treatment Period 3||0
8223370|NCT02038829|20279398|P5|NOT COMPLETED|Treatment Period 3||0
8223371|NCT02038829|20279399|P4|NOT COMPLETED|Treatment Period 3||0
8223372|NCT02038829|20279400|P3|NOT COMPLETED|Treatment Period 3||0
8223373|NCT02038829|20279401|P2|NOT COMPLETED|Treatment Period 3||0
8223374|NCT02038829|20279402|P1|NOT COMPLETED|Treatment Period 3||0
8223375|NCT02038829|20279391|P12|COMPLETED|Treatment Period 3||8
8223376|NCT02038829|20279392|P11|COMPLETED|Treatment Period 3||7
8223377|NCT02038829|20279393|P10|COMPLETED|Treatment Period 3||8
8223378|NCT02038829|20279394|P9|COMPLETED|Treatment Period 3||7
8223379|NCT02038829|20279395|P8|COMPLETED|Treatment Period 3||8
8223380|NCT02038829|20279396|P7|COMPLETED|Treatment Period 3||8
8223381|NCT02038829|20279397|P6|COMPLETED|Treatment Period 3||7
8223382|NCT02038829|20279398|P5|COMPLETED|Treatment Period 3||7
8223383|NCT02038829|20279399|P4|COMPLETED|Treatment Period 3||8
8223384|NCT02038829|20279400|P3|COMPLETED|Treatment Period 3||8
8223385|NCT02038829|20279401|P2|COMPLETED|Treatment Period 3||8
8223386|NCT02038829|20279402|P1|COMPLETED|Treatment Period 3||7
8223387|NCT02038829|20279391|P12|STARTED|Treatment Period 3||8
8223388|NCT02038829|20279392|P11|STARTED|Treatment Period 3||7
8223389|NCT02038829|20279393|P10|STARTED|Treatment Period 3||8
8223390|NCT02038829|20279394|P9|STARTED|Treatment Period 3||7
8223391|NCT02038829|20279395|P8|STARTED|Treatment Period 3||8
8223392|NCT02038829|20279396|P7|STARTED|Treatment Period 3||8
8223393|NCT02038829|20279397|P6|STARTED|Treatment Period 3||7
8223394|NCT02038829|20279398|P5|STARTED|Treatment Period 3||7
8223395|NCT02038829|20279399|P4|STARTED|Treatment Period 3||8
8223396|NCT02038829|20279400|P3|STARTED|Treatment Period 3||8
8223397|NCT02038829|20279401|P2|STARTED|Treatment Period 3||8
8223398|NCT02038829|20279402|P1|STARTED|Treatment Period 3||7
8223399|NCT02038829|20279391|P12|NOT COMPLETED|Washout Period 2||0
8223400|NCT02038829|20279392|P11|NOT COMPLETED|Washout Period 2||0
8223401|NCT02038829|20279393|P10|NOT COMPLETED|Washout Period 2||0
8223402|NCT02038829|20279394|P9|NOT COMPLETED|Washout Period 2||1
8223403|NCT02038829|20279395|P8|NOT COMPLETED|Washout Period 2||0
8223404|NCT02038829|20279396|P7|NOT COMPLETED|Washout Period 2||0
8223405|NCT02038829|20279397|P6|NOT COMPLETED|Washout Period 2||1
8223406|NCT02038829|20279398|P5|NOT COMPLETED|Washout Period 2||0
8223407|NCT02038829|20279399|P4|NOT COMPLETED|Washout Period 2||0
8223408|NCT02038829|20279400|P3|NOT COMPLETED|Washout Period 2||0
8223409|NCT02038829|20279401|P2|NOT COMPLETED|Washout Period 2||0
8223410|NCT02038829|20279402|P1|NOT COMPLETED|Washout Period 2||0
8223411|NCT02038829|20279391|P12|COMPLETED|Washout Period 2||8
8223412|NCT02038829|20279392|P11|COMPLETED|Washout Period 2||7
8223413|NCT02038829|20279393|P10|COMPLETED|Washout Period 2||8
8223414|NCT02038829|20279394|P9|COMPLETED|Washout Period 2||7
8223415|NCT02038829|20279395|P8|COMPLETED|Washout Period 2||8
8223416|NCT02038829|20279396|P7|COMPLETED|Washout Period 2||8
8223417|NCT02038829|20279397|P6|COMPLETED|Washout Period 2||7
8223418|NCT02038829|20279398|P5|COMPLETED|Washout Period 2||7
8223419|NCT02038829|20279399|P4|COMPLETED|Washout Period 2||8
8223420|NCT02038829|20279400|P3|COMPLETED|Washout Period 2||8
8223421|NCT02038829|20279401|P2|COMPLETED|Washout Period 2||8
8223422|NCT02038829|20279402|P1|COMPLETED|Washout Period 2||7
8223423|NCT02038829|20279391|P12|STARTED|Washout Period 2||8
8223424|NCT02038829|20279392|P11|STARTED|Washout Period 2||7
8223425|NCT02038829|20279393|P10|STARTED|Washout Period 2||8
8223426|NCT02038829|20279394|P9|STARTED|Washout Period 2||8
8223427|NCT02038829|20279395|P8|STARTED|Washout Period 2||8
8223428|NCT02038829|20279396|P7|STARTED|Washout Period 2||8
8223429|NCT02038829|20279397|P6|STARTED|Washout Period 2||8
8223430|NCT02038829|20279398|P5|STARTED|Washout Period 2||7
8223431|NCT02038829|20279399|P4|STARTED|Washout Period 2||8
8223432|NCT02038829|20279400|P3|STARTED|Washout Period 2||8
8223433|NCT02038829|20279401|P2|STARTED|Washout Period 2||8
8223434|NCT02038829|20279402|P1|STARTED|Washout Period 2||7
8223435|NCT02038829|20279391|P12|NOT COMPLETED|Treatment Period 2||0
8223436|NCT02038829|20279392|P11|NOT COMPLETED|Treatment Period 2||1
8223437|NCT02038829|20279393|P10|NOT COMPLETED|Treatment Period 2||0
8223438|NCT02038829|20279394|P9|NOT COMPLETED|Treatment Period 2||0
8223439|NCT02038829|20279395|P8|NOT COMPLETED|Treatment Period 2||0
8223440|NCT02038829|20279396|P7|NOT COMPLETED|Treatment Period 2||0
8223441|NCT02038829|20279397|P6|NOT COMPLETED|Treatment Period 2||0
8223442|NCT02038829|20279398|P5|NOT COMPLETED|Treatment Period 2||0
8223443|NCT02038829|20279399|P4|NOT COMPLETED|Treatment Period 2||0
8223444|NCT02038829|20279400|P3|NOT COMPLETED|Treatment Period 2||0
8223445|NCT02038829|20279401|P2|NOT COMPLETED|Treatment Period 2||0
8223446|NCT02038829|20279402|P1|NOT COMPLETED|Treatment Period 2||1
8223447|NCT02038829|20279391|P12|COMPLETED|Treatment Period 2||8
8223448|NCT02038829|20279392|P11|COMPLETED|Treatment Period 2||7
8223449|NCT02038829|20279393|P10|COMPLETED|Treatment Period 2||8
8223450|NCT02038829|20279394|P9|COMPLETED|Treatment Period 2||8
8223451|NCT02038829|20279395|P8|COMPLETED|Treatment Period 2||8
8223452|NCT02038829|20279396|P7|COMPLETED|Treatment Period 2||8
8223453|NCT02038829|20279397|P6|COMPLETED|Treatment Period 2||8
8223454|NCT02038829|20279398|P5|COMPLETED|Treatment Period 2||7
8223455|NCT02038829|20279399|P4|COMPLETED|Treatment Period 2||8
8223456|NCT02038829|20279400|P3|COMPLETED|Treatment Period 2||8
8223457|NCT02038829|20279401|P2|COMPLETED|Treatment Period 2||8
8223458|NCT02038829|20279402|P1|COMPLETED|Treatment Period 2||7
8223459|NCT02038829|20279391|P12|STARTED|Treatment Period 2||8
8223460|NCT02038829|20279392|P11|STARTED|Treatment Period 2||8
8223461|NCT02038829|20279393|P10|STARTED|Treatment Period 2||8
8223462|NCT02038829|20279394|P9|STARTED|Treatment Period 2||8
8223463|NCT02038829|20279395|P8|STARTED|Treatment Period 2||8
8223464|NCT02038829|20279396|P7|STARTED|Treatment Period 2||8
8223465|NCT02038829|20279397|P6|STARTED|Treatment Period 2||8
8223466|NCT02038829|20279398|P5|STARTED|Treatment Period 2||7
8223467|NCT02038829|20279399|P4|STARTED|Treatment Period 2||8
8223468|NCT02038829|20279400|P3|STARTED|Treatment Period 2||8
8223469|NCT02038829|20279401|P2|STARTED|Treatment Period 2||8
8223470|NCT02038829|20279402|P1|STARTED|Treatment Period 2||8
8223471|NCT02038829|20279391|P12|NOT COMPLETED|Washout Period 1||0
8223472|NCT02038829|20279392|P11|NOT COMPLETED|Washout Period 1||0
8223473|NCT02038829|20279393|P10|NOT COMPLETED|Washout Period 1||0
8223474|NCT02038829|20279394|P9|NOT COMPLETED|Washout Period 1||0
8223475|NCT02038829|20279395|P8|NOT COMPLETED|Washout Period 1||0
8223476|NCT02038829|20279396|P7|NOT COMPLETED|Washout Period 1||0
8223477|NCT02038829|20279397|P6|NOT COMPLETED|Washout Period 1||0
8223478|NCT02038829|20279398|P5|NOT COMPLETED|Washout Period 1||1
8223479|NCT02038829|20279399|P4|NOT COMPLETED|Washout Period 1||0
8223480|NCT02038829|20279400|P3|NOT COMPLETED|Washout Period 1||0
8223481|NCT02038829|20279401|P2|NOT COMPLETED|Washout Period 1||0
8223482|NCT02038829|20279402|P1|NOT COMPLETED|Washout Period 1||0
8223483|NCT02038829|20279391|P12|COMPLETED|Washout Period 1||8
8223484|NCT02038829|20279392|P11|COMPLETED|Washout Period 1||8
8223485|NCT02038829|20279393|P10|COMPLETED|Washout Period 1||8
8223486|NCT02038829|20279394|P9|COMPLETED|Washout Period 1||8
8223487|NCT02038829|20279395|P8|COMPLETED|Washout Period 1||8
8223488|NCT02038829|20279396|P7|COMPLETED|Washout Period 1||8
8223489|NCT02038829|20279397|P6|COMPLETED|Washout Period 1||8
8223490|NCT02038829|20279398|P5|COMPLETED|Washout Period 1||7
8223491|NCT02038829|20279399|P4|COMPLETED|Washout Period 1||8
8223492|NCT02038829|20279400|P3|COMPLETED|Washout Period 1||8
8223493|NCT02038829|20279401|P2|COMPLETED|Washout Period 1||8
8223494|NCT02038829|20279402|P1|COMPLETED|Washout Period 1||8
8223495|NCT02038829|20279391|P12|STARTED|Washout Period 1||8
8223496|NCT02038829|20279392|P11|STARTED|Washout Period 1||8
8223497|NCT02038829|20279393|P10|STARTED|Washout Period 1||8
8223498|NCT02038829|20279394|P9|STARTED|Washout Period 1||8
8223499|NCT02038829|20279395|P8|STARTED|Washout Period 1||8
8223500|NCT02038829|20279396|P7|STARTED|Washout Period 1||8
8223501|NCT02038829|20279397|P6|STARTED|Washout Period 1||8
8223502|NCT02038829|20279398|P5|STARTED|Washout Period 1||8
8223503|NCT02038829|20279399|P4|STARTED|Washout Period 1||8
8223504|NCT02038829|20279400|P3|STARTED|Washout Period 1||8
8223505|NCT02038829|20279401|P2|STARTED|Washout Period 1||8
8223506|NCT02038829|20279402|P1|STARTED|Washout Period 1||8
8223507|NCT02038829|20279391|P12|NOT COMPLETED|Treatment Period 1||0
8223508|NCT02038829|20279392|P11|NOT COMPLETED|Treatment Period 1||0
8223509|NCT02038829|20279393|P10|NOT COMPLETED|Treatment Period 1||0
8223510|NCT02038829|20279394|P9|NOT COMPLETED|Treatment Period 1||0
8223511|NCT02038829|20279395|P8|NOT COMPLETED|Treatment Period 1||0
8223512|NCT02038829|20279396|P7|NOT COMPLETED|Treatment Period 1||0
8223513|NCT02038829|20279397|P6|NOT COMPLETED|Treatment Period 1||0
8223514|NCT02038829|20279398|P5|NOT COMPLETED|Treatment Period 1||0
8223515|NCT02038829|20279399|P4|NOT COMPLETED|Treatment Period 1||0
8223516|NCT02038829|20279400|P3|NOT COMPLETED|Treatment Period 1||0
8223517|NCT02038829|20279401|P2|NOT COMPLETED|Treatment Period 1||0
8223518|NCT02038829|20279402|P1|NOT COMPLETED|Treatment Period 1||0
8223519|NCT02038829|20279391|P12|COMPLETED|Treatment Period 1||8
8223520|NCT02038829|20279392|P11|COMPLETED|Treatment Period 1||8
8223521|NCT02038829|20279393|P10|COMPLETED|Treatment Period 1||8
8223522|NCT02038829|20279394|P9|COMPLETED|Treatment Period 1||8
8223523|NCT02038829|20279395|P8|COMPLETED|Treatment Period 1||8
8223524|NCT02038829|20279396|P7|COMPLETED|Treatment Period 1||8
8223525|NCT02038829|20279397|P6|COMPLETED|Treatment Period 1||8
8223526|NCT02038829|20279398|P5|COMPLETED|Treatment Period 1||8
8223527|NCT02038829|20279399|P4|COMPLETED|Treatment Period 1||8
8223528|NCT02038829|20279400|P3|COMPLETED|Treatment Period 1||8
8223529|NCT02038829|20279401|P2|COMPLETED|Treatment Period 1||8
8223530|NCT02038829|20279402|P1|COMPLETED|Treatment Period 1||8
8223531|NCT02038829|20279391|P12|STARTED|Treatment Period 1||8
8223532|NCT02038829|20279392|P11|STARTED|Treatment Period 1||8
8223533|NCT02038829|20279393|P10|STARTED|Treatment Period 1||8
8223534|NCT02038829|20279394|P9|STARTED|Treatment Period 1||8
8223535|NCT02038829|20279395|P8|STARTED|Treatment Period 1||8
8223536|NCT02038829|20279396|P7|STARTED|Treatment Period 1||8
8223537|NCT02038829|20279397|P6|STARTED|Treatment Period 1||8
8223538|NCT02038829|20279398|P5|STARTED|Treatment Period 1||8
8223539|NCT02038829|20279399|P4|STARTED|Treatment Period 1||8
8223540|NCT02038829|20279400|P3|STARTED|Treatment Period 1||8
8223541|NCT02038829|20279401|P2|STARTED|Treatment Period 1||8
8223542|NCT02038829|20279402|P1|STARTED|Treatment Period 1||8
8223543|NCT02038790|20279436|P2|NOT COMPLETED|Day 1 - Second Treatment||0
8223544|NCT02038790|20279437|P1|NOT COMPLETED|Day 1 - Second Treatment||0
8223545|NCT02038790|20279436|P2|COMPLETED|Day 1 - Second Treatment||16
8223546|NCT02038790|20279437|P1|COMPLETED|Day 1 - Second Treatment||15
8223547|NCT02038790|20279436|P2|STARTED|Day 1 - Second Treatment||16
8223548|NCT02038790|20279437|P1|STARTED|Day 1 - Second Treatment||15
8223549|NCT02038790|20279436|P2|NOT COMPLETED|Day 0 - First Treatment||1
8223550|NCT02038790|20279437|P1|NOT COMPLETED|Day 0 - First Treatment||1
8223551|NCT02038790|20279436|P2|COMPLETED|Day 0 - First Treatment||16
8223552|NCT02038790|20279437|P1|COMPLETED|Day 0 - First Treatment||15
8223553|NCT02038790|20279436|P2|STARTED|Day 0 - First Treatment||17
8223554|NCT02038790|20279437|P1|STARTED|Day 0 - First Treatment||16
8223555|NCT02038764|20279473|P5|NOT COMPLETED|Overall Study||1
8223556|NCT02038764|20279474|P4|NOT COMPLETED|Overall Study||0
8223557|NCT02038764|20279475|P3|NOT COMPLETED|Overall Study||2
8223558|NCT02038764|20279476|P2|NOT COMPLETED|Overall Study||1
8223559|NCT02038764|20279477|P1|NOT COMPLETED|Overall Study||1
8223560|NCT02038764|20279473|P5|COMPLETED|Overall Study||7
8223561|NCT02038764|20279474|P4|COMPLETED|Overall Study||5
8223562|NCT02038764|20279475|P3|COMPLETED|Overall Study||7
8223563|NCT02038764|20279476|P2|COMPLETED|Overall Study||7
8223564|NCT02038764|20279477|P1|COMPLETED|Overall Study||6
8223565|NCT02038764|20279473|P5|STARTED|Overall Study||8
8223566|NCT02038764|20279474|P4|STARTED|Overall Study||5
8223567|NCT02038764|20279475|P3|STARTED|Overall Study||9
8223568|NCT02038764|20279476|P2|STARTED|Overall Study||8
8223569|NCT02038764|20279477|P1|STARTED|Overall Study||7
8223570|NCT02038647|20279579|P2|NOT COMPLETED|Overall Study||89
8223571|NCT02038647|20279580|P1|NOT COMPLETED|Overall Study||89
8223572|NCT02038647|20279579|P2|COMPLETED|Overall Study||0
8223573|NCT02038647|20279580|P1|COMPLETED|Overall Study||0
8223574|NCT02038647|20279579|P2|STARTED|Overall Study||89
8223575|NCT02038647|20279580|P1|STARTED|Overall Study||89
8223576|NCT02038569|20279612|P1|NOT COMPLETED|Overall Study||5
8223577|NCT02038569|20279612|P1|COMPLETED|Overall Study||102
8223578|NCT02038569|20279612|P1|STARTED|Overall Study||107
8223579|NCT02038543|20279643|P4|NOT COMPLETED|Overall Study||2
8223580|NCT02038543|20279644|P3|NOT COMPLETED|Overall Study||0
8223581|NCT02038543|20279645|P2|NOT COMPLETED|Overall Study||0
8223582|NCT02038543|20279646|P1|NOT COMPLETED|Overall Study||0
8223583|NCT02038543|20279643|P4|COMPLETED|Overall Study||1
8223584|NCT02038543|20279644|P3|COMPLETED|Overall Study||8
8223585|NCT02038543|20279645|P2|COMPLETED|Overall Study||4
8223586|NCT02038543|20279646|P1|COMPLETED|Overall Study||7
8223587|NCT02038543|20279643|P4|STARTED|Overall Study||3
8223588|NCT02038543|20279644|P3|STARTED|Overall Study||8
8223589|NCT02038543|20279645|P2|STARTED|Overall Study||4
8223590|NCT02038543|20279646|P1|STARTED|Overall Study||7
8223591|NCT02038218|20279662|P2|NOT COMPLETED|Overall Study||0
8223592|NCT02038218|20279663|P1|NOT COMPLETED|Overall Study||0
8223593|NCT02038218|20279662|P2|COMPLETED|Overall Study|5 patients are included in a publication in progress|7
8223594|NCT02038218|20279663|P1|COMPLETED|Overall Study|22 patients are included in a publication in progress|22
8223595|NCT02038218|20279662|P2|STARTED|Overall Study|Drug tolerated - Arm 2: liver involvement - 85.5 mg/m2. No alterations of liver functions.|7
8223596|NCT02038218|20279663|P1|STARTED|Overall Study|Drug tolerated - Arm 1: No liver disease - 98.7 mg/m2. No alterations of liver functions.|22
8223597|NCT02038179|20279671|P2|NOT COMPLETED|Phase 2 (4 Weeks)||2
8223598|NCT02038179|20279672|P1|NOT COMPLETED|Phase 2 (4 Weeks)||2
8223599|NCT02038179|20279671|P2|COMPLETED|Phase 2 (4 Weeks)||38
8223600|NCT02038179|20279672|P1|COMPLETED|Phase 2 (4 Weeks)||44
8223601|NCT02038179|20279671|P2|STARTED|Phase 2 (4 Weeks)||40
8223602|NCT02038179|20279672|P1|STARTED|Phase 2 (4 Weeks)||46
8223603|NCT02038179|20279671|P2|NOT COMPLETED|Washout (2-4 Weeks)||2
8223604|NCT02038179|20279672|P1|NOT COMPLETED|Washout (2-4 Weeks)||2
8223605|NCT02038179|20279671|P2|COMPLETED|Washout (2-4 Weeks)||40
8223606|NCT02038179|20279672|P1|COMPLETED|Washout (2-4 Weeks)||46
8223607|NCT02038179|20279671|P2|STARTED|Washout (2-4 Weeks)||42
8223608|NCT02038179|20279672|P1|STARTED|Washout (2-4 Weeks)||48
8223609|NCT02038179|20279671|P2|NOT COMPLETED|Phase 1 (4 Weeks)||5
8223610|NCT02038179|20279672|P1|NOT COMPLETED|Phase 1 (4 Weeks)||4
8223611|NCT02038179|20279671|P2|COMPLETED|Phase 1 (4 Weeks)||42
8223612|NCT02038179|20279672|P1|COMPLETED|Phase 1 (4 Weeks)||48
8223613|NCT02038179|20279671|P2|STARTED|Phase 1 (4 Weeks)||47
8223614|NCT02038179|20279672|P1|STARTED|Phase 1 (4 Weeks)||52
8223615|NCT02038153|20279682|P1|NOT COMPLETED|Overall Study||1
8223616|NCT02038153|20279682|P1|COMPLETED|Overall Study||2
8223617|NCT02038153|20279682|P1|STARTED|Overall Study||3
8223618|NCT02038075|20279689|P2|NOT COMPLETED|Overall Study||0
8223619|NCT02038075|20279690|P1|NOT COMPLETED|Overall Study||3
8223620|NCT02038075|20279689|P2|COMPLETED|Overall Study||76
8223621|NCT02038075|20279690|P1|COMPLETED|Overall Study||73
8223622|NCT02038075|20279689|P2|STARTED|Overall Study||76
8223623|NCT02038075|20279690|P1|STARTED|Overall Study||76
8223624|NCT02038049|20279698|P2|NOT COMPLETED|Overall Study||0
8223625|NCT02038049|20279699|P1|NOT COMPLETED|Overall Study||1
8223626|NCT02038049|20279698|P2|COMPLETED|Overall Study||4
8223627|NCT02038049|20279699|P1|COMPLETED|Overall Study||3
8223628|NCT02038049|20279698|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
8223629|NCT02038049|20279699|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||4
8223630|NCT02038049|20279698|P2|STARTED|Overall Study||4
8223631|NCT02038049|20279699|P1|STARTED|Overall Study||4
8223632|NCT02038023|20279721|P1|NOT COMPLETED|Overall Study||1
8223633|NCT02038023|20279721|P1|COMPLETED|Overall Study||73
8223634|NCT02038023|20279721|P1|STARTED|Overall Study||74
8223635|NCT02038010|20279728|P4|NOT COMPLETED|Follow Up||0
8223636|NCT02038010|20279729|P3|NOT COMPLETED|Follow Up||0
8223637|NCT02038010|20279730|P2|NOT COMPLETED|Follow Up||3
8223638|NCT02038010|20279731|P1|NOT COMPLETED|Follow Up||7
8223639|NCT02038010|20279728|P4|COMPLETED|Follow Up||0
8223640|NCT02038010|20279729|P3|COMPLETED|Follow Up||0
8223641|NCT02038010|20279730|P2|COMPLETED|Follow Up||3
8223642|NCT02038010|20279731|P1|COMPLETED|Follow Up||4
8223643|NCT02038010|20279728|P4|STARTED|Follow Up||0
8223644|NCT02038010|20279729|P3|STARTED|Follow Up||0
8223645|NCT02038010|20279730|P2|STARTED|Follow Up||6
8223646|NCT02038010|20279731|P1|STARTED|Follow Up||11
8223647|NCT02038010|20279728|P4|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
8223648|NCT02038010|20279729|P3|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
8223649|NCT02038010|20279730|P2|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
8223650|NCT02038010|20279731|P1|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
8223651|NCT02038010|20279728|P4|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
8223652|NCT02038010|20279729|P3|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
8223653|NCT02038010|20279730|P2|COMPLETED|Completed 3 Cycles/Reached 1st Response||3
8223654|NCT02038010|20279731|P1|COMPLETED|Completed 3 Cycles/Reached 1st Response||9
8223655|NCT02038010|20279728|P4|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
8223656|NCT02038010|20279729|P3|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
8223657|NCT02038010|20279730|P2|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||3
8223658|NCT02038010|20279731|P1|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||9
8223659|NCT02038010|20279728|P4|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
8223660|NCT02038010|20279729|P3|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
8223661|NCT02038010|20279730|P2|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||4
8223662|NCT02038010|20279731|P1|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||10
8223663|NCT02038010|20279728|P4|STARTED|Completed 3 Cycles/Reached 1st Response||0
8223664|NCT02038010|20279729|P3|STARTED|Completed 3 Cycles/Reached 1st Response||0
8223665|NCT02038010|20279730|P2|STARTED|Completed 3 Cycles/Reached 1st Response||4
8223666|NCT02038010|20279731|P1|STARTED|Completed 3 Cycles/Reached 1st Response||10
8223667|NCT02038010|20279728|P4|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
8223668|NCT02038010|20279729|P3|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
8223669|NCT02038010|20279730|P2|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||2
8223670|NCT02038010|20279731|P1|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||1
8223671|NCT02038010|20279728|P4|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
8223672|NCT02038010|20279729|P3|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
8223673|NCT02038010|20279730|P2|COMPLETED|Completed 1st Cycle and Started Cycle 2||4
8223674|NCT02038010|20279731|P1|COMPLETED|Completed 1st Cycle and Started Cycle 2||10
8223675|NCT02038010|20279728|P4|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
8223676|NCT02038010|20279729|P3|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
8223677|NCT02038010|20279730|P2|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||4
8223678|NCT02038010|20279731|P1|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||10
8223679|NCT02038010|20279728|P4|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
8223680|NCT02038010|20279729|P3|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
8223681|NCT02038010|20279730|P2|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||5
8223682|NCT02038010|20279731|P1|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||11
8223683|NCT02038010|20279728|P4|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
8223684|NCT02038010|20279729|P3|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
8223685|NCT02038010|20279730|P2|STARTED|Completed 1st Cycle and Started Cycle 2||6
8223686|NCT02038010|20279731|P1|STARTED|Completed 1st Cycle and Started Cycle 2||11
8223687|NCT02037984|20279758|P8|NOT COMPLETED|Overall Study||12
8223688|NCT02037984|20279759|P7|NOT COMPLETED|Overall Study||17
8223689|NCT02037984|20279760|P6|NOT COMPLETED|Overall Study||12
8223690|NCT02037984|20279761|P5|NOT COMPLETED|Overall Study||12
8223691|NCT02037984|20279762|P4|NOT COMPLETED|Overall Study||21
8223692|NCT02037984|20279763|P3|NOT COMPLETED|Overall Study||12
8223693|NCT02037984|20279764|P2|NOT COMPLETED|Overall Study||0
8223694|NCT02037984|20279765|P1|NOT COMPLETED|Overall Study||1
8223695|NCT02037984|20279758|P8|COMPLETED|Overall Study||39
8223696|NCT02037984|20279759|P7|COMPLETED|Overall Study||33
8223697|NCT02037984|20279760|P6|COMPLETED|Overall Study||37
8223698|NCT02037984|20279761|P5|COMPLETED|Overall Study||38
8223699|NCT02037984|20279762|P4|COMPLETED|Overall Study||30
8223700|NCT02037984|20279763|P3|COMPLETED|Overall Study||38
8223701|NCT02037984|20279764|P2|COMPLETED|Overall Study||20
8223702|NCT02037984|20279765|P1|COMPLETED|Overall Study||19
8223703|NCT02037984|20279758|P8|STARTED|Overall Study||51
8223704|NCT02037984|20279759|P7|STARTED|Overall Study||50
8223705|NCT02037984|20279760|P6|STARTED|Overall Study||49
8223706|NCT02037984|20279761|P5|STARTED|Overall Study||50
8223707|NCT02037984|20279762|P4|STARTED|Overall Study||51
8223708|NCT02037984|20279763|P3|STARTED|Overall Study||50
8223709|NCT02037984|20279764|P2|STARTED|Overall Study||20
8223710|NCT02037984|20279765|P1|STARTED|Overall Study||20
8223711|NCT02037893|20279832|P4|NOT COMPLETED|Overall Study||0
8223712|NCT02037893|20279833|P3|NOT COMPLETED|Overall Study||1
8223713|NCT02037893|20279834|P2|NOT COMPLETED|Overall Study||0
8223714|NCT02037893|20279835|P1|NOT COMPLETED|Overall Study||0
8223715|NCT02037893|20279832|P4|COMPLETED|Overall Study||28
8223716|NCT02037893|20279833|P3|COMPLETED|Overall Study||26
8223717|NCT02037893|20279834|P2|COMPLETED|Overall Study||25
8223718|NCT02037893|20279835|P1|COMPLETED|Overall Study||32
8223719|NCT02037893|20279832|P4|STARTED|Overall Study||28
8223720|NCT02037893|20279833|P3|STARTED|Overall Study||27
8223721|NCT02037893|20279834|P2|STARTED|Overall Study||25
8223722|NCT02037893|20279835|P1|STARTED|Overall Study||32
8223723|NCT02037776|20279887|P2|NOT COMPLETED|Overall Study||4
8223724|NCT02037776|20279888|P1|NOT COMPLETED|Overall Study||5
8223725|NCT02037776|20279887|P2|COMPLETED|Overall Study||60
8223726|NCT02037776|20279888|P1|COMPLETED|Overall Study||56
8223727|NCT02037776|20279887|P2|STARTED|Overall Study||64
8223728|NCT02037776|20279888|P1|STARTED|Overall Study||61
8223729|NCT02037607|20279904|P1|NOT COMPLETED|Overall Study||9
8223730|NCT02037607|20279904|P1|COMPLETED|Overall Study||91
8223731|NCT02037607|20279904|P1|STARTED|Overall Study||100
8223732|NCT02037568|20279910|P2|NOT COMPLETED|Overall Study||39
8223733|NCT02037568|20279911|P1|NOT COMPLETED|Overall Study||36
8223734|NCT02037568|20279910|P2|COMPLETED|Overall Study||37
8223735|NCT02037568|20279911|P1|COMPLETED|Overall Study||47
8223736|NCT02037568|20279910|P2|Month 6 (Post Transplantation)|Overall Study||52
8223737|NCT02037568|20279911|P1|Month 6 (Post Transplantation)|Overall Study||63
8223738|NCT02037568|20279910|P2|Month 3 (Post Transplantation)|Overall Study||62
8223739|NCT02037568|20279911|P1|Month 3 (Post Transplantation)|Overall Study||66
8223740|NCT02037568|20279910|P2|Month 1.5 (Post Transplantation)|Overall Study||76
8223741|NCT02037568|20279911|P1|Month 1.5 (Post Transplantation)|Overall Study||79
8223742|NCT02037568|20279910|P2|STARTED|Overall Study||76
8223743|NCT02037568|20279911|P1|STARTED|Overall Study||83
8223744|NCT02037555|20279935|P2|NOT COMPLETED|Overall Study||21
8223745|NCT02037555|20279936|P1|NOT COMPLETED|Overall Study||23
8223746|NCT02037555|20279935|P2|COMPLETED|Overall Study||191
8223747|NCT02037555|20279936|P1|COMPLETED|Overall Study||190
8223748|NCT02037555|20279935|P2|Dosed and Operated On|Overall Study||196
8223749|NCT02037555|20279936|P1|Dosed and Operated On|Overall Study||200
8223750|NCT02037555|20279935|P2|Dosed|Overall Study||198
8223751|NCT02037555|20279936|P1|Dosed|Overall Study||201
8223752|NCT02037555|20279935|P2|STARTED|Overall Study||212
8223753|NCT02037555|20279936|P1|STARTED|Overall Study||213
8223754|NCT02037477|20279946|P4|NOT COMPLETED|Treatment Period 2||0
8223755|NCT02037477|20279947|P3|NOT COMPLETED|Treatment Period 2||0
8223756|NCT02037477|20279948|P2|NOT COMPLETED|Treatment Period 2||0
8223757|NCT02037477|20279949|P1|NOT COMPLETED|Treatment Period 2||0
8223758|NCT02037477|20279946|P4|COMPLETED|Treatment Period 2||5
8223759|NCT02037477|20279947|P3|COMPLETED|Treatment Period 2||4
8223760|NCT02037477|20279948|P2|COMPLETED|Treatment Period 2||5
8223761|NCT02037477|20279949|P1|COMPLETED|Treatment Period 2||5
8223762|NCT02037477|20279946|P4|STARTED|Treatment Period 2||5
8223763|NCT02037477|20279947|P3|STARTED|Treatment Period 2||4
8223764|NCT02037477|20279948|P2|STARTED|Treatment Period 2||5
8223765|NCT02037477|20279949|P1|STARTED|Treatment Period 2||5
8223766|NCT02037477|20279946|P4|NOT COMPLETED|Treatment Period 1||0
8223767|NCT02037477|20279947|P3|NOT COMPLETED|Treatment Period 1||1
8223768|NCT02037477|20279948|P2|NOT COMPLETED|Treatment Period 1||0
8223769|NCT02037477|20279949|P1|NOT COMPLETED|Treatment Period 1||0
8223770|NCT02037477|20279946|P4|COMPLETED|Treatment Period 1||5
8223771|NCT02037477|20279947|P3|COMPLETED|Treatment Period 1||4
8223772|NCT02037477|20279948|P2|COMPLETED|Treatment Period 1||5
8223773|NCT02037477|20279949|P1|COMPLETED|Treatment Period 1||5
8223774|NCT02037477|20279946|P4|STARTED|Treatment Period 1||5
8223775|NCT02037477|20279947|P3|STARTED|Treatment Period 1||5
8223776|NCT02037477|20279948|P2|STARTED|Treatment Period 1||5
8223777|NCT02037477|20279949|P1|STARTED|Treatment Period 1||5
8223778|NCT02037438|20279977|P2|NOT COMPLETED|Overall Study||355
8223779|NCT02037438|20279978|P1|NOT COMPLETED|Overall Study||346
8223780|NCT02037438|20279977|P2|COMPLETED|Overall Study||561
8223781|NCT02037438|20279978|P1|COMPLETED|Overall Study||574
8223782|NCT02037438|20279977|P2|STARTED|Overall Study||916
8223783|NCT02037438|20279978|P1|STARTED|Overall Study||920
8223784|NCT02037425|20279992|P1|NOT COMPLETED|Overall Study||26
8223785|NCT02037425|20279992|P1|COMPLETED|Overall Study||18
8223786|NCT02037425|20279992|P1|Randomized to Treatment|Overall Study||32
8223787|NCT02037425|20279992|P1|STARTED|Overall Study||44
8223788|NCT02037347|20280034|P1|NOT COMPLETED|Overall Study||0
8223789|NCT02037347|20280034|P1|COMPLETED|Overall Study||1
8223790|NCT02037347|20280034|P1|STARTED|Overall Study||1
8223791|NCT02037295|20280044|P4|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
8223792|NCT02037295|20280045|P3|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
8223793|NCT02037295|20280046|P2|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
8223794|NCT02037295|20280047|P1|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
8223795|NCT02037295|20280044|P4|COMPLETED|Phase 2: Vancomycin and Placebo||6
8223796|NCT02037295|20280045|P3|COMPLETED|Phase 2: Vancomycin and Placebo||4
8223797|NCT02037295|20280046|P2|COMPLETED|Phase 2: Vancomycin and Placebo||7
8223798|NCT02037295|20280047|P1|COMPLETED|Phase 2: Vancomycin and Placebo||8
8223799|NCT02037295|20280044|P4|STARTED|Phase 2: Vancomycin and Placebo||7
8223800|NCT02037295|20280045|P3|STARTED|Phase 2: Vancomycin and Placebo||4
8223801|NCT02037295|20280046|P2|STARTED|Phase 2: Vancomycin and Placebo||7
8223802|NCT02037295|20280047|P1|STARTED|Phase 2: Vancomycin and Placebo||9
8223803|NCT02037295|20280044|P4|NOT COMPLETED|Phase 1: Crossover UF and OF||0
8223804|NCT02037295|20280045|P3|NOT COMPLETED|Phase 1: Crossover UF and OF||0
8223805|NCT02037295|20280046|P2|NOT COMPLETED|Phase 1: Crossover UF and OF||0
8223806|NCT02037295|20280047|P1|NOT COMPLETED|Phase 1: Crossover UF and OF||0
8223807|NCT02037295|20280044|P4|COMPLETED|Phase 1: Crossover UF and OF||7
8223808|NCT02037295|20280045|P3|COMPLETED|Phase 1: Crossover UF and OF||4
8223809|NCT02037295|20280046|P2|COMPLETED|Phase 1: Crossover UF and OF||7
8223810|NCT02037295|20280047|P1|COMPLETED|Phase 1: Crossover UF and OF||9
8223811|NCT02037295|20280044|P4|STARTED|Phase 1: Crossover UF and OF||7
8223812|NCT02037295|20280045|P3|STARTED|Phase 1: Crossover UF and OF||4
8223813|NCT02037295|20280046|P2|STARTED|Phase 1: Crossover UF and OF||7
8223814|NCT02037295|20280047|P1|STARTED|Phase 1: Crossover UF and OF||9
8223815|NCT02037230|20280071|P4|NOT COMPLETED|Overall Study||6
8223816|NCT02037230|20280072|P3|NOT COMPLETED|Overall Study||6
8223817|NCT02037230|20280073|P2|NOT COMPLETED|Overall Study||6
8223818|NCT02037230|20280074|P1|NOT COMPLETED|Overall Study||1
8223819|NCT02037230|20280071|P4|COMPLETED|Overall Study||5
8223820|NCT02037230|20280072|P3|COMPLETED|Overall Study||3
8223821|NCT02037230|20280073|P2|COMPLETED|Overall Study||7
8223822|NCT02037230|20280074|P1|COMPLETED|Overall Study||0
8223823|NCT02037230|20280071|P4|Completed 4 Cycles of Treatment|Overall Study||9
8223824|NCT02037230|20280072|P3|Completed 4 Cycles of Treatment|Overall Study||7
8223825|NCT02037230|20280073|P2|Completed 4 Cycles of Treatment|Overall Study||9
8223826|NCT02037230|20280074|P1|Completed 4 Cycles of Treatment|Overall Study||1
8223827|NCT02037230|20280071|P4|STARTED|Overall Study||11
8223828|NCT02037230|20280072|P3|STARTED|Overall Study||9
8223829|NCT02037230|20280073|P2|STARTED|Overall Study||13
8223830|NCT02037230|20280074|P1|STARTED|Overall Study||1
8223831|NCT02037204|20280093|P1|NOT COMPLETED|Overall Study||0
8223832|NCT02037204|20280093|P1|COMPLETED|Overall Study||35
8223833|NCT02037204|20280093|P1|STARTED|Overall Study||35
8223834|NCT02037165|20280103|P5|NOT COMPLETED|Period 5 (2 Days)||0
8223835|NCT02037165|20280104|P4|NOT COMPLETED|Period 5 (2 Days)||0
8223836|NCT02037165|20280105|P3|NOT COMPLETED|Period 5 (2 Days)||0
8223837|NCT02037165|20280106|P2|NOT COMPLETED|Period 5 (2 Days)||0
8223838|NCT02037165|20280107|P1|NOT COMPLETED|Period 5 (2 Days)||0
8223839|NCT02037165|20280103|P5|COMPLETED|Period 5 (2 Days)||4
8223840|NCT02037165|20280104|P4|COMPLETED|Period 5 (2 Days)||5
8223841|NCT02037165|20280105|P3|COMPLETED|Period 5 (2 Days)||5
8223842|NCT02037165|20280106|P2|COMPLETED|Period 5 (2 Days)||5
8223843|NCT02037165|20280107|P1|COMPLETED|Period 5 (2 Days)||5
8223844|NCT02037165|20280103|P5|STARTED|Period 5 (2 Days)||4
8223845|NCT02037165|20280104|P4|STARTED|Period 5 (2 Days)||5
8223846|NCT02037165|20280105|P3|STARTED|Period 5 (2 Days)||5
8223847|NCT02037165|20280106|P2|STARTED|Period 5 (2 Days)||5
8223848|NCT02037165|20280107|P1|STARTED|Period 5 (2 Days)||5
8223849|NCT02037165|20280103|P5|NOT COMPLETED|Washout Period 4 (6 Days)||1
8223850|NCT02037165|20280104|P4|NOT COMPLETED|Washout Period 4 (6 Days)||0
8223851|NCT02037165|20280105|P3|NOT COMPLETED|Washout Period 4 (6 Days)||0
8223852|NCT02037165|20280106|P2|NOT COMPLETED|Washout Period 4 (6 Days)||0
8223853|NCT02037165|20280107|P1|NOT COMPLETED|Washout Period 4 (6 Days)||0
8223854|NCT02037165|20280103|P5|COMPLETED|Washout Period 4 (6 Days)||4
8223855|NCT02037165|20280104|P4|COMPLETED|Washout Period 4 (6 Days)||5
8223856|NCT02037165|20280105|P3|COMPLETED|Washout Period 4 (6 Days)||5
8223857|NCT02037165|20280106|P2|COMPLETED|Washout Period 4 (6 Days)||5
8223858|NCT02037165|20280107|P1|COMPLETED|Washout Period 4 (6 Days)||5
8223859|NCT02037165|20280103|P5|STARTED|Washout Period 4 (6 Days)||5
8223860|NCT02037165|20280104|P4|STARTED|Washout Period 4 (6 Days)||5
8223861|NCT02037165|20280105|P3|STARTED|Washout Period 4 (6 Days)||5
8223862|NCT02037165|20280106|P2|STARTED|Washout Period 4 (6 Days)||5
8223863|NCT02037165|20280107|P1|STARTED|Washout Period 4 (6 Days)||5
8223864|NCT02037165|20280103|P5|NOT COMPLETED|Period 4 (2 Days)||0
8223865|NCT02037165|20280104|P4|NOT COMPLETED|Period 4 (2 Days)||0
8223866|NCT02037165|20280105|P3|NOT COMPLETED|Period 4 (2 Days)||0
8223867|NCT02037165|20280106|P2|NOT COMPLETED|Period 4 (2 Days)||0
8223868|NCT02037165|20280107|P1|NOT COMPLETED|Period 4 (2 Days)||0
8223869|NCT02037165|20280103|P5|COMPLETED|Period 4 (2 Days)||5
8223870|NCT02037165|20280104|P4|COMPLETED|Period 4 (2 Days)||5
8223871|NCT02037165|20280105|P3|COMPLETED|Period 4 (2 Days)||5
8223872|NCT02037165|20280106|P2|COMPLETED|Period 4 (2 Days)||5
8223873|NCT02037165|20280107|P1|COMPLETED|Period 4 (2 Days)||5
8223874|NCT02037165|20280103|P5|STARTED|Period 4 (2 Days)||5
8223875|NCT02037165|20280104|P4|STARTED|Period 4 (2 Days)||5
8223876|NCT02037165|20280105|P3|STARTED|Period 4 (2 Days)||5
8223877|NCT02037165|20280106|P2|STARTED|Period 4 (2 Days)||5
8223878|NCT02037165|20280107|P1|STARTED|Period 4 (2 Days)||5
8223879|NCT02037165|20280103|P5|NOT COMPLETED|Washout Period 3 (6 Days)||0
8223880|NCT02037165|20280104|P4|NOT COMPLETED|Washout Period 3 (6 Days)||0
8223881|NCT02037165|20280105|P3|NOT COMPLETED|Washout Period 3 (6 Days)||0
8223882|NCT02037165|20280106|P2|NOT COMPLETED|Washout Period 3 (6 Days)||0
8223883|NCT02037165|20280107|P1|NOT COMPLETED|Washout Period 3 (6 Days)||0
8223884|NCT02037165|20280103|P5|COMPLETED|Washout Period 3 (6 Days)||5
8223885|NCT02037165|20280104|P4|COMPLETED|Washout Period 3 (6 Days)||5
8223886|NCT02037165|20280105|P3|COMPLETED|Washout Period 3 (6 Days)||5
8223887|NCT02037165|20280106|P2|COMPLETED|Washout Period 3 (6 Days)||5
8223888|NCT02037165|20280107|P1|COMPLETED|Washout Period 3 (6 Days)||5
8223889|NCT02037165|20280103|P5|STARTED|Washout Period 3 (6 Days)||5
8223890|NCT02037165|20280104|P4|STARTED|Washout Period 3 (6 Days)||5
8223891|NCT02037165|20280105|P3|STARTED|Washout Period 3 (6 Days)||5
8223892|NCT02037165|20280106|P2|STARTED|Washout Period 3 (6 Days)||5
8223893|NCT02037165|20280107|P1|STARTED|Washout Period 3 (6 Days)||5
8223894|NCT02037165|20280103|P5|NOT COMPLETED|Period 3 (2 Days)||0
8223895|NCT02037165|20280104|P4|NOT COMPLETED|Period 3 (2 Days)||0
8223896|NCT02037165|20280105|P3|NOT COMPLETED|Period 3 (2 Days)||0
8223897|NCT02037165|20280106|P2|NOT COMPLETED|Period 3 (2 Days)||0
8223898|NCT02037165|20280107|P1|NOT COMPLETED|Period 3 (2 Days)||0
8223899|NCT02037165|20280103|P5|COMPLETED|Period 3 (2 Days)||5
8223900|NCT02037165|20280104|P4|COMPLETED|Period 3 (2 Days)||5
8223901|NCT02037165|20280105|P3|COMPLETED|Period 3 (2 Days)||5
8223902|NCT02037165|20280106|P2|COMPLETED|Period 3 (2 Days)||5
8223903|NCT02037165|20280107|P1|COMPLETED|Period 3 (2 Days)||5
8223904|NCT02037165|20280103|P5|STARTED|Period 3 (2 Days)||5
8223905|NCT02037165|20280104|P4|STARTED|Period 3 (2 Days)||5
8223906|NCT02037165|20280105|P3|STARTED|Period 3 (2 Days)||5
8223907|NCT02037165|20280106|P2|STARTED|Period 3 (2 Days)||5
8223908|NCT02037165|20280107|P1|STARTED|Period 3 (2 Days)||5
8223909|NCT02037165|20280103|P5|NOT COMPLETED|Washout Period 2 (6 Days)||0
8223910|NCT02037165|20280104|P4|NOT COMPLETED|Washout Period 2 (6 Days)||0
8223911|NCT02037165|20280105|P3|NOT COMPLETED|Washout Period 2 (6 Days)||0
8223912|NCT02037165|20280106|P2|NOT COMPLETED|Washout Period 2 (6 Days)||0
8223913|NCT02037165|20280107|P1|NOT COMPLETED|Washout Period 2 (6 Days)||0
8223914|NCT02037165|20280103|P5|COMPLETED|Washout Period 2 (6 Days)||5
8223915|NCT02037165|20280104|P4|COMPLETED|Washout Period 2 (6 Days)||5
8223916|NCT02037165|20280105|P3|COMPLETED|Washout Period 2 (6 Days)||5
8223917|NCT02037165|20280106|P2|COMPLETED|Washout Period 2 (6 Days)||5
8223918|NCT02037165|20280107|P1|COMPLETED|Washout Period 2 (6 Days)||5
8223919|NCT02037165|20280103|P5|STARTED|Washout Period 2 (6 Days)||5
8223920|NCT02037165|20280104|P4|STARTED|Washout Period 2 (6 Days)||5
8223921|NCT02037165|20280105|P3|STARTED|Washout Period 2 (6 Days)||5
8223922|NCT02037165|20280106|P2|STARTED|Washout Period 2 (6 Days)||5
8223923|NCT02037165|20280107|P1|STARTED|Washout Period 2 (6 Days)||5
8223924|NCT02037165|20280103|P5|NOT COMPLETED|Period 2 (2 Days)||0
8223925|NCT02037165|20280104|P4|NOT COMPLETED|Period 2 (2 Days)||0
8223926|NCT02037165|20280105|P3|NOT COMPLETED|Period 2 (2 Days)||0
8223927|NCT02037165|20280106|P2|NOT COMPLETED|Period 2 (2 Days)||0
8223928|NCT02037165|20280107|P1|NOT COMPLETED|Period 2 (2 Days)||0
8223929|NCT02037165|20280103|P5|COMPLETED|Period 2 (2 Days)||5
8223930|NCT02037165|20280104|P4|COMPLETED|Period 2 (2 Days)||5
8223931|NCT02037165|20280105|P3|COMPLETED|Period 2 (2 Days)||5
8223932|NCT02037165|20280106|P2|COMPLETED|Period 2 (2 Days)||5
8223933|NCT02037165|20280107|P1|COMPLETED|Period 2 (2 Days)||5
8223934|NCT02037165|20280103|P5|STARTED|Period 2 (2 Days)||5
8223935|NCT02037165|20280104|P4|STARTED|Period 2 (2 Days)||5
8223936|NCT02037165|20280105|P3|STARTED|Period 2 (2 Days)||5
8223937|NCT02037165|20280106|P2|STARTED|Period 2 (2 Days)||5
8223938|NCT02037165|20280107|P1|STARTED|Period 2 (2 Days)||5
8223939|NCT02037165|20280103|P5|NOT COMPLETED|Washout Period 1 (6 Days)||0
8223940|NCT02037165|20280104|P4|NOT COMPLETED|Washout Period 1 (6 Days)||0
8223941|NCT02037165|20280105|P3|NOT COMPLETED|Washout Period 1 (6 Days)||0
8223942|NCT02037165|20280106|P2|NOT COMPLETED|Washout Period 1 (6 Days)||0
8223943|NCT02037165|20280107|P1|NOT COMPLETED|Washout Period 1 (6 Days)||0
8223944|NCT02037165|20280103|P5|COMPLETED|Washout Period 1 (6 Days)||5
8223945|NCT02037165|20280104|P4|COMPLETED|Washout Period 1 (6 Days)||5
8223946|NCT02037165|20280105|P3|COMPLETED|Washout Period 1 (6 Days)||5
8223947|NCT02037165|20280106|P2|COMPLETED|Washout Period 1 (6 Days)||5
8223948|NCT02037165|20280107|P1|COMPLETED|Washout Period 1 (6 Days)||5
8223949|NCT02037165|20280103|P5|STARTED|Washout Period 1 (6 Days)||5
8223950|NCT02037165|20280104|P4|STARTED|Washout Period 1 (6 Days)||5
8223951|NCT02037165|20280105|P3|STARTED|Washout Period 1 (6 Days)||5
8223952|NCT02037165|20280106|P2|STARTED|Washout Period 1 (6 Days)||5
8223953|NCT02037165|20280107|P1|STARTED|Washout Period 1 (6 Days)||5
8223954|NCT02037165|20280103|P5|NOT COMPLETED|Period 1 (2 Days)||0
8223955|NCT02037165|20280104|P4|NOT COMPLETED|Period 1 (2 Days)||0
8223956|NCT02037165|20280105|P3|NOT COMPLETED|Period 1 (2 Days)||0
8223957|NCT02037165|20280106|P2|NOT COMPLETED|Period 1 (2 Days)||0
8223958|NCT02037165|20280107|P1|NOT COMPLETED|Period 1 (2 Days)||0
8223959|NCT02037165|20280103|P5|COMPLETED|Period 1 (2 Days)||5
8223960|NCT02037165|20280104|P4|COMPLETED|Period 1 (2 Days)||5
8223961|NCT02037165|20280105|P3|COMPLETED|Period 1 (2 Days)||5
8223962|NCT02037165|20280106|P2|COMPLETED|Period 1 (2 Days)||5
8223963|NCT02037165|20280107|P1|COMPLETED|Period 1 (2 Days)||5
8223964|NCT02037165|20280103|P5|STARTED|Period 1 (2 Days)|randomized subjects|5
8223965|NCT02037165|20280104|P4|STARTED|Period 1 (2 Days)|randomized subjects|5
8223966|NCT02037165|20280105|P3|STARTED|Period 1 (2 Days)|randomized subjects|5
8223967|NCT02037165|20280106|P2|STARTED|Period 1 (2 Days)|randomized subjects|5
8223968|NCT02037165|20280107|P1|STARTED|Period 1 (2 Days)|randomized subjects|5
8223969|NCT02037061|20280152|P2|NOT COMPLETED|Overall Study||0
8223970|NCT02037061|20280153|P1|NOT COMPLETED|Overall Study||0
8223971|NCT02037061|20280152|P2|COMPLETED|Overall Study||24
8223972|NCT02037061|20280153|P1|COMPLETED|Overall Study||22
8223973|NCT02037061|20280152|P2|STARTED|Overall Study||24
8223974|NCT02037061|20280153|P1|STARTED|Overall Study||22
8223975|NCT02036840|20280163|P1|NOT COMPLETED|Overall Study||0
8223976|NCT02036840|20280163|P1|COMPLETED|Overall Study||513
8223977|NCT02036840|20280163|P1|STARTED|Overall Study||513
8223978|NCT02036775|20280167|P6|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8223979|NCT02036775|20280168|P5|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8223980|NCT02036775|20280169|P4|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8223981|NCT02036775|20280170|P3|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8223982|NCT02036775|20280171|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8223983|NCT02036775|20280172|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8223984|NCT02036775|20280167|P6|COMPLETED|Treatment Period 3 (6 Days)||3
8223985|NCT02036775|20280168|P5|COMPLETED|Treatment Period 3 (6 Days)||4
8223986|NCT02036775|20280169|P4|COMPLETED|Treatment Period 3 (6 Days)||4
8223987|NCT02036775|20280170|P3|COMPLETED|Treatment Period 3 (6 Days)||4
8223988|NCT02036775|20280171|P2|COMPLETED|Treatment Period 3 (6 Days)||4
8223989|NCT02036775|20280172|P1|COMPLETED|Treatment Period 3 (6 Days)||4
8223990|NCT02036775|20280167|P6|STARTED|Treatment Period 3 (6 Days)||3
8223991|NCT02036775|20280168|P5|STARTED|Treatment Period 3 (6 Days)||4
8223992|NCT02036775|20280169|P4|STARTED|Treatment Period 3 (6 Days)||4
8223993|NCT02036775|20280170|P3|STARTED|Treatment Period 3 (6 Days)||4
8223994|NCT02036775|20280171|P2|STARTED|Treatment Period 3 (6 Days)||4
8223995|NCT02036775|20280172|P1|STARTED|Treatment Period 3 (6 Days)||4
8223996|NCT02036775|20280167|P6|NOT COMPLETED|Treatment Period 2 (6 Days)||1
8223997|NCT02036775|20280168|P5|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8223998|NCT02036775|20280169|P4|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8223999|NCT02036775|20280170|P3|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8224000|NCT02036775|20280171|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8224001|NCT02036775|20280172|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8224002|NCT02036775|20280167|P6|COMPLETED|Treatment Period 2 (6 Days)||3
8224003|NCT02036775|20280168|P5|COMPLETED|Treatment Period 2 (6 Days)||4
8224004|NCT02036775|20280169|P4|COMPLETED|Treatment Period 2 (6 Days)||4
8224005|NCT02036775|20280170|P3|COMPLETED|Treatment Period 2 (6 Days)||4
8224006|NCT02036775|20280171|P2|COMPLETED|Treatment Period 2 (6 Days)||4
8224007|NCT02036775|20280172|P1|COMPLETED|Treatment Period 2 (6 Days)||4
8224008|NCT02036775|20280167|P6|STARTED|Treatment Period 2 (6 Days)||4
8224009|NCT02036775|20280168|P5|STARTED|Treatment Period 2 (6 Days)||4
8224010|NCT02036775|20280169|P4|STARTED|Treatment Period 2 (6 Days)||4
8224011|NCT02036775|20280170|P3|STARTED|Treatment Period 2 (6 Days)||4
8224012|NCT02036775|20280171|P2|STARTED|Treatment Period 2 (6 Days)||4
8224013|NCT02036775|20280172|P1|STARTED|Treatment Period 2 (6 Days)||4
8224014|NCT02036775|20280167|P6|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8224015|NCT02036775|20280168|P5|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8224016|NCT02036775|20280169|P4|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8224017|NCT02036775|20280170|P3|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8224018|NCT02036775|20280171|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8224019|NCT02036775|20280172|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8224020|NCT02036775|20280167|P6|COMPLETED|Treatment Period 1 (6 Days)||4
8224021|NCT02036775|20280168|P5|COMPLETED|Treatment Period 1 (6 Days)||4
8224022|NCT02036775|20280169|P4|COMPLETED|Treatment Period 1 (6 Days)||4
8224023|NCT02036775|20280170|P3|COMPLETED|Treatment Period 1 (6 Days)||4
8224024|NCT02036775|20280171|P2|COMPLETED|Treatment Period 1 (6 Days)||4
8224025|NCT02036775|20280172|P1|COMPLETED|Treatment Period 1 (6 Days)||4
8224026|NCT02036775|20280167|P6|STARTED|Treatment Period 1 (6 Days)||4
8224027|NCT02036775|20280168|P5|STARTED|Treatment Period 1 (6 Days)||4
8224028|NCT02036775|20280169|P4|STARTED|Treatment Period 1 (6 Days)||4
8224029|NCT02036775|20280170|P3|STARTED|Treatment Period 1 (6 Days)||4
8224030|NCT02036775|20280171|P2|STARTED|Treatment Period 1 (6 Days)||4
8224031|NCT02036775|20280172|P1|STARTED|Treatment Period 1 (6 Days)||4
8224032|NCT02036645|20280222|P12|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224033|NCT02036645|20280223|P11|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224034|NCT02036645|20280224|P10|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224035|NCT02036645|20280225|P9|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224036|NCT02036645|20280226|P8|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224037|NCT02036645|20280227|P7|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224038|NCT02036645|20280228|P6|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224039|NCT02036645|20280229|P5|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224040|NCT02036645|20280230|P4|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224041|NCT02036645|20280231|P3|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224042|NCT02036645|20280232|P2|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224043|NCT02036645|20280233|P1|NOT COMPLETED|MAD Cohorts: Study Part 2||0
8224044|NCT02036645|20280222|P12|COMPLETED|MAD Cohorts: Study Part 2||6
8224045|NCT02036645|20280223|P11|COMPLETED|MAD Cohorts: Study Part 2||6
8224046|NCT02036645|20280224|P10|COMPLETED|MAD Cohorts: Study Part 2||6
8224047|NCT02036645|20280225|P9|COMPLETED|MAD Cohorts: Study Part 2||6
8224048|NCT02036645|20280226|P8|COMPLETED|MAD Cohorts: Study Part 2||8
8224049|NCT02036645|20280227|P7|COMPLETED|MAD Cohorts: Study Part 2||0
8224050|NCT02036645|20280228|P6|COMPLETED|MAD Cohorts: Study Part 2||0
8224051|NCT02036645|20280229|P5|COMPLETED|MAD Cohorts: Study Part 2||0
8224052|NCT02036645|20280230|P4|COMPLETED|MAD Cohorts: Study Part 2||0
8224053|NCT02036645|20280231|P3|COMPLETED|MAD Cohorts: Study Part 2||0
8224054|NCT02036645|20280232|P2|COMPLETED|MAD Cohorts: Study Part 2||0
8224055|NCT02036645|20280233|P1|COMPLETED|MAD Cohorts: Study Part 2||0
8224056|NCT02036645|20280222|P12|STARTED|MAD Cohorts: Study Part 2||6
8224057|NCT02036645|20280223|P11|STARTED|MAD Cohorts: Study Part 2||6
8224058|NCT02036645|20280224|P10|STARTED|MAD Cohorts: Study Part 2||6
8224059|NCT02036645|20280225|P9|STARTED|MAD Cohorts: Study Part 2||6
8224060|NCT02036645|20280226|P8|STARTED|MAD Cohorts: Study Part 2||8
8224061|NCT02036645|20280227|P7|STARTED|MAD Cohorts: Study Part 2||0
8224062|NCT02036645|20280228|P6|STARTED|MAD Cohorts: Study Part 2||0
8224063|NCT02036645|20280229|P5|STARTED|MAD Cohorts: Study Part 2||0
8224064|NCT02036645|20280230|P4|STARTED|MAD Cohorts: Study Part 2||0
8224065|NCT02036645|20280231|P3|STARTED|MAD Cohorts: Study Part 2||0
8224066|NCT02036645|20280232|P2|STARTED|MAD Cohorts: Study Part 2||0
8224067|NCT02036645|20280233|P1|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0
8224068|NCT02036645|20280222|P12|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224069|NCT02036645|20280223|P11|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224070|NCT02036645|20280224|P10|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224071|NCT02036645|20280225|P9|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224072|NCT02036645|20280226|P8|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224073|NCT02036645|20280227|P7|NOT COMPLETED|SAD Cohorts : Study Part 1||1
8224074|NCT02036645|20280228|P6|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224075|NCT02036645|20280229|P5|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224076|NCT02036645|20280230|P4|NOT COMPLETED|SAD Cohorts : Study Part 1||1
8224077|NCT02036645|20280231|P3|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224078|NCT02036645|20280232|P2|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224079|NCT02036645|20280233|P1|NOT COMPLETED|SAD Cohorts : Study Part 1||0
8224080|NCT02036645|20280222|P12|COMPLETED|SAD Cohorts : Study Part 1||0
8224081|NCT02036645|20280223|P11|COMPLETED|SAD Cohorts : Study Part 1||0
8224082|NCT02036645|20280224|P10|COMPLETED|SAD Cohorts : Study Part 1||0
8224083|NCT02036645|20280225|P9|COMPLETED|SAD Cohorts : Study Part 1||0
8224084|NCT02036645|20280226|P8|COMPLETED|SAD Cohorts : Study Part 1||0
8224085|NCT02036645|20280227|P7|COMPLETED|SAD Cohorts : Study Part 1||5
8224086|NCT02036645|20280228|P6|COMPLETED|SAD Cohorts : Study Part 1||6
8224087|NCT02036645|20280229|P5|COMPLETED|SAD Cohorts : Study Part 1||6
8224088|NCT02036645|20280230|P4|COMPLETED|SAD Cohorts : Study Part 1||5
8224089|NCT02036645|20280231|P3|COMPLETED|SAD Cohorts : Study Part 1||6
8224090|NCT02036645|20280232|P2|COMPLETED|SAD Cohorts : Study Part 1||3
8224091|NCT02036645|20280233|P1|COMPLETED|SAD Cohorts : Study Part 1||12
8224092|NCT02036645|20280222|P12|STARTED|SAD Cohorts : Study Part 1||0
8224093|NCT02036645|20280223|P11|STARTED|SAD Cohorts : Study Part 1||0
8224094|NCT02036645|20280224|P10|STARTED|SAD Cohorts : Study Part 1||0
8224095|NCT02036645|20280225|P9|STARTED|SAD Cohorts : Study Part 1||0
8224096|NCT02036645|20280226|P8|STARTED|SAD Cohorts : Study Part 1||0
8224097|NCT02036645|20280227|P7|STARTED|SAD Cohorts : Study Part 1||6
8224098|NCT02036645|20280228|P6|STARTED|SAD Cohorts : Study Part 1||6
8224099|NCT02036645|20280229|P5|STARTED|SAD Cohorts : Study Part 1||6
8224100|NCT02036645|20280230|P4|STARTED|SAD Cohorts : Study Part 1||6
8224101|NCT02036645|20280231|P3|STARTED|SAD Cohorts : Study Part 1||6
8224102|NCT02036645|20280232|P2|STARTED|SAD Cohorts : Study Part 1||3
8224103|NCT02036645|20280233|P1|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12
8224104|NCT02036580|20280338|P3|NOT COMPLETED|Overall Study||0
8224105|NCT02036580|20280339|P2|NOT COMPLETED|Overall Study||1
8224106|NCT02036580|20280340|P1|NOT COMPLETED|Overall Study||1
8224107|NCT02036580|20280338|P3|COMPLETED|Overall Study||4
8224108|NCT02036580|20280339|P2|COMPLETED|Overall Study||7
8224109|NCT02036580|20280340|P1|COMPLETED|Overall Study||7
8224110|NCT02036580|20280338|P3|STARTED|Overall Study||4
8224111|NCT02036580|20280339|P2|STARTED|Overall Study||8
8224112|NCT02036580|20280340|P1|STARTED|Overall Study||8
8224113|NCT02036541|20280353|P1|NOT COMPLETED|Overall Study||16
8224114|NCT02036541|20280353|P1|COMPLETED|Overall Study||49
8224115|NCT02036541|20280353|P1|Completed Endpoint Visit|Overall Study||54
8224116|NCT02036541|20280353|P1|STARTED|Overall Study||65
8224117|NCT02036515|20280361|P3|NOT COMPLETED|Overall Study||14
8224118|NCT02036515|20280362|P2|NOT COMPLETED|Overall Study||12
8224119|NCT02036515|20280363|P1|NOT COMPLETED|Overall Study||5
8224120|NCT02036515|20280361|P3|COMPLETED|Overall Study||139
8224121|NCT02036515|20280362|P2|COMPLETED|Overall Study||143
8224122|NCT02036515|20280363|P1|COMPLETED|Overall Study||151
8224123|NCT02036515|20280361|P3|Treated|Overall Study||153
8224124|NCT02036515|20280362|P2|Treated|Overall Study||153
8224125|NCT02036515|20280363|P1|Treated|Overall Study||156
8224126|NCT02036515|20280361|P3|STARTED|Overall Study||153
8224127|NCT02036515|20280362|P2|STARTED|Overall Study||155
8224128|NCT02036515|20280363|P1|STARTED|Overall Study||156
8224129|NCT02036424|20280442|P2|NOT COMPLETED|Overall Study||0
8224130|NCT02036424|20280443|P1|NOT COMPLETED|Overall Study||0
8224131|NCT02036424|20280442|P2|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
8224132|NCT02036424|20280443|P1|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
8224133|NCT02036424|20280442|P2|STARTED|Overall Study|27 study eyes, not number of subjects|27
8224134|NCT02036424|20280443|P1|STARTED|Overall Study|23 study eyes, not number of subjects|23
8224135|NCT02036320|20280451|P2|NOT COMPLETED|Period 2||0
8224136|NCT02036320|20280452|P1|NOT COMPLETED|Period 2||0
8224137|NCT02036320|20280451|P2|COMPLETED|Period 2||95
8224138|NCT02036320|20280452|P1|COMPLETED|Period 2||95
8224139|NCT02036320|20280451|P2|STARTED|Period 2||95
8224140|NCT02036320|20280452|P1|STARTED|Period 2||95
8224141|NCT02036320|20280451|P2|NOT COMPLETED|Period 1||0
8224142|NCT02036320|20280452|P1|NOT COMPLETED|Period 1||0
8224143|NCT02036320|20280451|P2|COMPLETED|Period 1||95
8224144|NCT02036320|20280452|P1|COMPLETED|Period 1||95
8224145|NCT02036320|20280451|P2|STARTED|Period 1||95
8224146|NCT02036320|20280452|P1|STARTED|Period 1||95
8224147|NCT02036294|20280464|P2|NOT COMPLETED|Overall Study||11
8224148|NCT02036294|20280465|P1|NOT COMPLETED|Overall Study||9
8224149|NCT02036294|20280464|P2|COMPLETED|Overall Study||109
8224150|NCT02036294|20280465|P1|COMPLETED|Overall Study||111
8224151|NCT02036294|20280464|P2|STARTED|Overall Study||120
8224152|NCT02036294|20280465|P1|STARTED|Overall Study||120
8224153|NCT02035748|20280481|P1|NOT COMPLETED|Overall Study||20
8224154|NCT02035748|20280481|P1|COMPLETED|Overall Study||448
8224155|NCT02035748|20280481|P1|STARTED|Overall Study||468
8224156|NCT02035696|20280495|P4|NOT COMPLETED|Overall Study||3
8224157|NCT02035696|20280496|P3|NOT COMPLETED|Overall Study||3
8224158|NCT02035696|20280497|P2|NOT COMPLETED|Overall Study||3
8224159|NCT02035696|20280498|P1|NOT COMPLETED|Overall Study||3
8224160|NCT02035696|20280495|P4|COMPLETED|Overall Study||161
8224161|NCT02035696|20280496|P3|COMPLETED|Overall Study||164
8224162|NCT02035696|20280497|P2|COMPLETED|Overall Study||163
8224163|NCT02035696|20280498|P1|COMPLETED|Overall Study||171
8224164|NCT02035696|20280495|P4|STARTED|Overall Study||164
8224165|NCT02035696|20280496|P3|STARTED|Overall Study||167
8224166|NCT02035696|20280497|P2|STARTED|Overall Study||166
8224167|NCT02035696|20280498|P1|STARTED|Overall Study||174
8224168|NCT02035553|20280554|P2|NOT COMPLETED|Overall Study||23
8224169|NCT02035553|20280555|P1|NOT COMPLETED|Overall Study||18
8224170|NCT02035553|20280554|P2|COMPLETED|Overall Study||67
8224171|NCT02035553|20280555|P1|COMPLETED|Overall Study||73
8224172|NCT02035553|20280554|P2|STARTED|Overall Study||90
8224173|NCT02035553|20280555|P1|STARTED|Overall Study||91
8224174|NCT02035475|20280561|P1|NOT COMPLETED|Overall Study||6
8224175|NCT02035475|20280561|P1|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
8224176|NCT02035475|20280561|P1|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
8224177|NCT02035345|20280567|P1|NOT COMPLETED|Overall Study||0
8224178|NCT02035345|20280567|P1|COMPLETED|Overall Study||15
8224179|NCT02035345|20280567|P1|STARTED|Overall Study||15
8224180|NCT02035332|20280572|P1|NOT COMPLETED|Overall Study||1
8224181|NCT02035332|20280572|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
8224182|NCT02035332|20280572|P1|Treated|Overall Study|Treatment Completed|20
8224183|NCT02035332|20280572|P1|STARTED|Overall Study|Treatment Attempted|21
8224184|NCT02035267|20280582|P4|NOT COMPLETED|Overall Study||1
8224185|NCT02035267|20280583|P3|NOT COMPLETED|Overall Study||2
8224186|NCT02035267|20280584|P2|NOT COMPLETED|Overall Study||1
8224187|NCT02035267|20280585|P1|NOT COMPLETED|Overall Study||0
8224188|NCT02035267|20280582|P4|COMPLETED|Overall Study||15
8224189|NCT02035267|20280583|P3|COMPLETED|Overall Study||28
8224190|NCT02035267|20280584|P2|COMPLETED|Overall Study||15
8224191|NCT02035267|20280585|P1|COMPLETED|Overall Study||31
8224192|NCT02035267|20280582|P4|STARTED|Overall Study||16
8224193|NCT02035267|20280583|P3|STARTED|Overall Study||30
8224194|NCT02035267|20280584|P2|STARTED|Overall Study||16
8224195|NCT02035267|20280585|P1|STARTED|Overall Study||31
8224196|NCT02035202|20280616|P3|NOT COMPLETED|Overall Study||2
8224197|NCT02035202|20280617|P2|NOT COMPLETED|Overall Study||16
8224198|NCT02035202|20280618|P1|NOT COMPLETED|Overall Study||8
8224199|NCT02035202|20280616|P3|COMPLETED|Overall Study||83
8224200|NCT02035202|20280617|P2|COMPLETED|Overall Study||69
8224201|NCT02035202|20280618|P1|COMPLETED|Overall Study||77
8224202|NCT02035202|20280616|P3|STARTED|Overall Study||85
8224203|NCT02035202|20280617|P2|STARTED|Overall Study||85
8224204|NCT02035202|20280618|P1|STARTED|Overall Study||85
8224205|NCT02034916|20280634|P2|NOT COMPLETED|Overall Study||35
8224206|NCT02034916|20280635|P1|NOT COMPLETED|Overall Study||49
8224207|NCT02034916|20280634|P2|COMPLETED|Overall Study||0
8224208|NCT02034916|20280635|P1|COMPLETED|Overall Study||0
8224209|NCT02034916|20280634|P2|Treated|Overall Study||35
8224210|NCT02034916|20280635|P1|Treated|Overall Study||48
8224211|NCT02034916|20280634|P2|STARTED|Overall Study||35
8224212|NCT02034916|20280635|P1|STARTED|Overall Study||49
8224213|NCT02034877|20280672|P2|NOT COMPLETED|Overall Study||6
8224214|NCT02034877|20280673|P1|NOT COMPLETED|Overall Study||0
8224215|NCT02034877|20280672|P2|COMPLETED|Overall Study||993
8224216|NCT02034877|20280673|P1|COMPLETED|Overall Study||200
8224217|NCT02034877|20280672|P2|STARTED|Overall Study||999
8224218|NCT02034877|20280673|P1|STARTED|Overall Study||200
8224219|NCT02034799|20280691|P2|NOT COMPLETED|Overall Study||4
8224220|NCT02034799|20280692|P1|NOT COMPLETED|Overall Study||2
8224221|NCT02034799|20280691|P2|COMPLETED|Overall Study||123
8224222|NCT02034799|20280692|P1|COMPLETED|Overall Study||127
8224223|NCT02034799|20280691|P2|STARTED|Overall Study||127
8224224|NCT02034799|20280692|P1|STARTED|Overall Study||129
8224225|NCT02034708|20280706|P2|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
8224226|NCT02034708|20280707|P1|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
8224227|NCT02034708|20280706|P2|COMPLETED|Second Contrast Agent Injection (1 Day)||120
8224228|NCT02034708|20280707|P1|COMPLETED|Second Contrast Agent Injection (1 Day)||129
8224229|NCT02034708|20280706|P2|STARTED|Second Contrast Agent Injection (1 Day)||120
8224230|NCT02034708|20280707|P1|STARTED|Second Contrast Agent Injection (1 Day)||129
8224231|NCT02034708|20280706|P2|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
8224232|NCT02034708|20280707|P1|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
8224233|NCT02034708|20280706|P2|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
8224234|NCT02034708|20280707|P1|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
8224235|NCT02034708|20280706|P2|STARTED|Wash-out (From 2 Days up to 14 Days)||130
8224236|NCT02034708|20280707|P1|STARTED|Wash-out (From 2 Days up to 14 Days)||138
8224237|NCT02034708|20280706|P2|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
8224238|NCT02034708|20280707|P1|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
8224239|NCT02034708|20280706|P2|COMPLETED|First Contrast Agent Injection (1 Day)||130
8224240|NCT02034708|20280707|P1|COMPLETED|First Contrast Agent Injection (1 Day)||138
8224241|NCT02034708|20280706|P2|STARTED|First Contrast Agent Injection (1 Day)||130
8224242|NCT02034708|20280707|P1|STARTED|First Contrast Agent Injection (1 Day)||138
8224243|NCT02034591|20280718|P6|NOT COMPLETED|Overall Study||0
8224244|NCT02034591|20280719|P5|NOT COMPLETED|Overall Study||1
8224245|NCT02034591|20280720|P4|NOT COMPLETED|Overall Study||0
8224246|NCT02034591|20280721|P3|NOT COMPLETED|Overall Study||0
8224247|NCT02034591|20280722|P2|NOT COMPLETED|Overall Study||0
8224248|NCT02034591|20280723|P1|NOT COMPLETED|Overall Study||0
8224249|NCT02034591|20280718|P6|COMPLETED|Overall Study||3
8224250|NCT02034591|20280719|P5|COMPLETED|Overall Study||3
8224251|NCT02034591|20280720|P4|COMPLETED|Overall Study||3
8224252|NCT02034591|20280721|P3|COMPLETED|Overall Study||4
8224253|NCT02034591|20280722|P2|COMPLETED|Overall Study||3
8224254|NCT02034591|20280723|P1|COMPLETED|Overall Study||4
8224255|NCT02034591|20280718|P6|STARTED|Overall Study||3
8224256|NCT02034591|20280719|P5|STARTED|Overall Study||4
8224257|NCT02034591|20280720|P4|STARTED|Overall Study||3
8224258|NCT02034591|20280721|P3|STARTED|Overall Study||4
8224259|NCT02034591|20280722|P2|STARTED|Overall Study||3
8224260|NCT02034591|20280723|P1|STARTED|Overall Study||4
8224261|NCT02034578|20280746|P6|NOT COMPLETED|Overall Study||0
8224262|NCT02034578|20280747|P5|NOT COMPLETED|Overall Study||0
8224263|NCT02034578|20280748|P4|NOT COMPLETED|Overall Study||0
8224264|NCT02034578|20280749|P3|NOT COMPLETED|Overall Study||0
8224265|NCT02034578|20280750|P2|NOT COMPLETED|Overall Study||0
8224266|NCT02034578|20280751|P1|NOT COMPLETED|Overall Study||0
8224267|NCT02034578|20280746|P6|COMPLETED|Overall Study||3
8224268|NCT02034578|20280747|P5|COMPLETED|Overall Study||4
8224269|NCT02034578|20280748|P4|COMPLETED|Overall Study||3
8224270|NCT02034578|20280749|P3|COMPLETED|Overall Study||4
8224271|NCT02034578|20280750|P2|COMPLETED|Overall Study||3
8224272|NCT02034578|20280751|P1|COMPLETED|Overall Study||4
8224273|NCT02034578|20280746|P6|STARTED|Overall Study||3
8224274|NCT02034578|20280747|P5|STARTED|Overall Study||4
8224275|NCT02034578|20280748|P4|STARTED|Overall Study||3
8224276|NCT02034578|20280749|P3|STARTED|Overall Study||4
8224277|NCT02034578|20280750|P2|STARTED|Overall Study||3
8224278|NCT02034578|20280751|P1|STARTED|Overall Study||4
8224279|NCT02034565|20280778|P2|NOT COMPLETED|Overall Study||0
8224280|NCT02034565|20280779|P1|NOT COMPLETED|Overall Study||1
8224281|NCT02034565|20280778|P2|COMPLETED|Overall Study||7
8224282|NCT02034565|20280779|P1|COMPLETED|Overall Study||6
8224283|NCT02034565|20280778|P2|STARTED|Overall Study||7
8224284|NCT02034565|20280779|P1|STARTED|Overall Study||7
8224285|NCT02034552|20280796|P3|NOT COMPLETED|Overall Study||17
8224286|NCT02034552|20280797|P2|NOT COMPLETED|Overall Study||20
8224287|NCT02034552|20280798|P1|NOT COMPLETED|Overall Study||14
8224288|NCT02034552|20280796|P3|COMPLETED|Overall Study||5
8224289|NCT02034552|20280797|P2|COMPLETED|Overall Study||4
8224290|NCT02034552|20280798|P1|COMPLETED|Overall Study||8
8224291|NCT02034552|20280796|P3|Received Treatment|Overall Study||22
8224292|NCT02034552|20280797|P2|Received Treatment|Overall Study||22
8224293|NCT02034552|20280798|P1|Received Treatment|Overall Study||19
8224294|NCT02034552|20280796|P3|STARTED|Overall Study||22
8224295|NCT02034552|20280797|P2|STARTED|Overall Study||24
8224296|NCT02034552|20280798|P1|STARTED|Overall Study||22
8224297|NCT02034513|20280829|P2|NOT COMPLETED|Overall Study||57
8224298|NCT02034513|20280830|P1|NOT COMPLETED|Overall Study||49
8224299|NCT02034513|20280829|P2|COMPLETED|Overall Study||195
8224300|NCT02034513|20280830|P1|COMPLETED|Overall Study||200
8224301|NCT02034513|20280829|P2|Exposed|Overall Study||251
8224302|NCT02034513|20280830|P1|Exposed|Overall Study||249
8224303|NCT02034513|20280829|P2|STARTED|Overall Study||252
8224304|NCT02034513|20280830|P1|STARTED|Overall Study||249
8224305|NCT02034474|20280848|P2|NOT COMPLETED|Overall Study||4
8224306|NCT02034474|20280849|P1|NOT COMPLETED|Overall Study||4
8224307|NCT02034474|20280848|P2|COMPLETED|Overall Study||13
8224308|NCT02034474|20280849|P1|COMPLETED|Overall Study||15
8224309|NCT02034474|20280848|P2|3 Doses|Overall Study||13
8224310|NCT02034474|20280849|P1|3 Doses|Overall Study||15
8224311|NCT02034474|20280848|P2|2 Doses|Overall Study||0
8224312|NCT02034474|20280849|P1|2 Doses|Overall Study||2
8224313|NCT02034474|20280848|P2|1 Dose|Overall Study||4
8224314|NCT02034474|20280849|P1|1 Dose|Overall Study||2
8224315|NCT02034474|20280848|P2|STARTED|Overall Study||17
8224316|NCT02034474|20280849|P1|STARTED|Overall Study||19
8224317|NCT02034435|20280861|P4|NOT COMPLETED|Overall Study||1
8224318|NCT02034435|20280862|P3|NOT COMPLETED|Overall Study||0
8224319|NCT02034435|20280863|P2|NOT COMPLETED|Overall Study||2
8224320|NCT02034435|20280864|P1|NOT COMPLETED|Overall Study||2
8224321|NCT02034435|20280861|P4|COMPLETED|Overall Study||8
8224322|NCT02034435|20280862|P3|COMPLETED|Overall Study||7
8224323|NCT02034435|20280863|P2|COMPLETED|Overall Study||13
8224324|NCT02034435|20280864|P1|COMPLETED|Overall Study||11
8224325|NCT02034435|20280861|P4|Aim 2|Overall Study||9
8224326|NCT02034435|20280862|P3|Aim 2|Overall Study||7
8224327|NCT02034435|20280863|P2|Aim 2|Overall Study||0
8224328|NCT02034435|20280864|P1|Aim 2|Overall Study||0
8224329|NCT02034435|20280861|P4|Aim 1|Overall Study||0
8224330|NCT02034435|20280862|P3|Aim 1|Overall Study||0
8224331|NCT02034435|20280863|P2|Aim 1|Overall Study||15
8224332|NCT02034435|20280864|P1|Aim 1|Overall Study||13
8224333|NCT02034435|20280861|P4|STARTED|Overall Study||9
8224334|NCT02034435|20280862|P3|STARTED|Overall Study||7
8224335|NCT02034435|20280863|P2|STARTED|Overall Study||15
8224336|NCT02034435|20280864|P1|STARTED|Overall Study||13
8224337|NCT02034175|20280878|P1|NOT COMPLETED|Overall Study||0
8224338|NCT02034175|20280878|P1|COMPLETED|Overall Study||190
8224339|NCT02034175|20280878|P1|STARTED|Overall Study||190
8224340|NCT02034162|20280884|P3|NOT COMPLETED|Open-label||0
8224341|NCT02034162|20280885|P2|NOT COMPLETED|Open-label||0
8224342|NCT02034162|20280886|P1|NOT COMPLETED|Open-label||0
8224343|NCT02034162|20280884|P3|COMPLETED|Open-label||278
8224344|NCT02034162|20280885|P2|COMPLETED|Open-label||0
8224345|NCT02034162|20280886|P1|COMPLETED|Open-label||0
8224346|NCT02034162|20280884|P3|STARTED|Open-label||278
8224347|NCT02034162|20280885|P2|STARTED|Open-label||0
8224348|NCT02034162|20280886|P1|STARTED|Open-label||0
8224349|NCT02034162|20280884|P3|NOT COMPLETED|Double-blind||0
8224350|NCT02034162|20280885|P2|NOT COMPLETED|Double-blind||8
8224351|NCT02034162|20280886|P1|NOT COMPLETED|Double-blind||9
8224352|NCT02034162|20280884|P3|COMPLETED|Double-blind||0
8224353|NCT02034162|20280885|P2|COMPLETED|Double-blind||141
8224354|NCT02034162|20280886|P1|COMPLETED|Double-blind||137
8224355|NCT02034162|20280884|P3|STARTED|Double-blind||0
8224356|NCT02034162|20280885|P2|STARTED|Double-blind||149
8224357|NCT02034162|20280886|P1|STARTED|Double-blind||146
8224358|NCT02034123|20280932|P18|NOT COMPLETED|Part2(Up to 2 Years)||0
8224359|NCT02034123|20280933|P17|NOT COMPLETED|Part2(Up to 2 Years)||0
8224360|NCT02034123|20280934|P16|NOT COMPLETED|Part2(Up to 2 Years)||0
8224361|NCT02034123|20280935|P15|NOT COMPLETED|Part2(Up to 2 Years)||0
8224362|NCT02034123|20280936|P14|NOT COMPLETED|Part2(Up to 2 Years)||0
8224363|NCT02034123|20280937|P13|NOT COMPLETED|Part2(Up to 2 Years)||0
8224364|NCT02034123|20280938|P12|NOT COMPLETED|Part2(Up to 2 Years)||0
8224365|NCT02034123|20280939|P11|NOT COMPLETED|Part2(Up to 2 Years)||0
8224366|NCT02034123|20280940|P10|NOT COMPLETED|Part2(Up to 2 Years)||0
8224367|NCT02034123|20280941|P9|NOT COMPLETED|Part2(Up to 2 Years)||0
8224368|NCT02034123|20280942|P8|NOT COMPLETED|Part2(Up to 2 Years)||0
8224369|NCT02034123|20280943|P7|NOT COMPLETED|Part2(Up to 2 Years)||0
8224370|NCT02034123|20280944|P6|NOT COMPLETED|Part2(Up to 2 Years)||0
8224371|NCT02034123|20280945|P5|NOT COMPLETED|Part2(Up to 2 Years)||0
8224372|NCT02034123|20280946|P4|NOT COMPLETED|Part2(Up to 2 Years)||0
8224373|NCT02034123|20280947|P3|NOT COMPLETED|Part2(Up to 2 Years)||0
8224374|NCT02034123|20280948|P2|NOT COMPLETED|Part2(Up to 2 Years)||0
8224375|NCT02034123|20280949|P1|NOT COMPLETED|Part2(Up to 2 Years)||0
8224376|NCT02034123|20280932|P18|COMPLETED|Part2(Up to 2 Years)||0
8224377|NCT02034123|20280933|P17|COMPLETED|Part2(Up to 2 Years)||0
8224378|NCT02034123|20280934|P16|COMPLETED|Part2(Up to 2 Years)||0
8224379|NCT02034123|20280935|P15|COMPLETED|Part2(Up to 2 Years)||0
8224380|NCT02034123|20280936|P14|COMPLETED|Part2(Up to 2 Years)||0
8224381|NCT02034123|20280937|P13|COMPLETED|Part2(Up to 2 Years)||0
8224382|NCT02034123|20280938|P12|COMPLETED|Part2(Up to 2 Years)||0
8224383|NCT02034123|20280939|P11|COMPLETED|Part2(Up to 2 Years)||0
8224384|NCT02034123|20280940|P10|COMPLETED|Part2(Up to 2 Years)||0
8224385|NCT02034123|20280941|P9|COMPLETED|Part2(Up to 2 Years)||0
8224386|NCT02034123|20280942|P8|COMPLETED|Part2(Up to 2 Years)||0
8224387|NCT02034123|20280943|P7|COMPLETED|Part2(Up to 2 Years)||0
8224388|NCT02034123|20280944|P6|COMPLETED|Part2(Up to 2 Years)||0
8224389|NCT02034123|20280945|P5|COMPLETED|Part2(Up to 2 Years)||0
8224390|NCT02034123|20280946|P4|COMPLETED|Part2(Up to 2 Years)||0
8224391|NCT02034123|20280947|P3|COMPLETED|Part2(Up to 2 Years)||0
8224392|NCT02034123|20280948|P2|COMPLETED|Part2(Up to 2 Years)||0
8224393|NCT02034123|20280949|P1|COMPLETED|Part2(Up to 2 Years)||0
8224394|NCT02034123|20280932|P18|STARTED|Part2(Up to 2 Years)||0
8224395|NCT02034123|20280933|P17|STARTED|Part2(Up to 2 Years)||0
8224396|NCT02034123|20280934|P16|STARTED|Part2(Up to 2 Years)||0
8224397|NCT02034123|20280935|P15|STARTED|Part2(Up to 2 Years)||0
8224398|NCT02034123|20280936|P14|STARTED|Part2(Up to 2 Years)||0
8224399|NCT02034123|20280937|P13|STARTED|Part2(Up to 2 Years)||0
8224400|NCT02034123|20280938|P12|STARTED|Part2(Up to 2 Years)||0
8224401|NCT02034123|20280939|P11|STARTED|Part2(Up to 2 Years)||0
8224402|NCT02034123|20280940|P10|STARTED|Part2(Up to 2 Years)||0
8224403|NCT02034123|20280941|P9|STARTED|Part2(Up to 2 Years)||0
8224404|NCT02034123|20280942|P8|STARTED|Part2(Up to 2 Years)||0
8224405|NCT02034123|20280943|P7|STARTED|Part2(Up to 2 Years)||0
8224406|NCT02034123|20280944|P6|STARTED|Part2(Up to 2 Years)||0
8224407|NCT02034123|20280945|P5|STARTED|Part2(Up to 2 Years)||0
8224408|NCT02034123|20280946|P4|STARTED|Part2(Up to 2 Years)||0
8224409|NCT02034123|20280947|P3|STARTED|Part2(Up to 2 Years)||0
8224410|NCT02034123|20280948|P2|STARTED|Part2(Up to 2 Years)||0
8224411|NCT02034123|20280949|P1|STARTED|Part2(Up to 2 Years)||0
8224412|NCT02034123|20280932|P18|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224413|NCT02034123|20280933|P17|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224414|NCT02034123|20280934|P16|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224415|NCT02034123|20280935|P15|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224416|NCT02034123|20280936|P14|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224417|NCT02034123|20280937|P13|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224418|NCT02034123|20280938|P12|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224419|NCT02034123|20280939|P11|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224420|NCT02034123|20280940|P10|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224421|NCT02034123|20280941|P9|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
8224422|NCT02034123|20280942|P8|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
8224423|NCT02034123|20280943|P7|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224424|NCT02034123|20280944|P6|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224425|NCT02034123|20280945|P5|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
8224426|NCT02034123|20280946|P4|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
8224427|NCT02034123|20280947|P3|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224428|NCT02034123|20280948|P2|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224429|NCT02034123|20280949|P1|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224430|NCT02034123|20280932|P18|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224431|NCT02034123|20280933|P17|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224432|NCT02034123|20280934|P16|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224433|NCT02034123|20280935|P15|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224434|NCT02034123|20280936|P14|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224435|NCT02034123|20280937|P13|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224436|NCT02034123|20280938|P12|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224437|NCT02034123|20280939|P11|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224438|NCT02034123|20280940|P10|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224439|NCT02034123|20280941|P9|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
8224440|NCT02034123|20280942|P8|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4
8224441|NCT02034123|20280943|P7|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
8224442|NCT02034123|20280944|P6|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3
8224443|NCT02034123|20280945|P5|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
8224444|NCT02034123|20280946|P4|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
8224445|NCT02034123|20280947|P3|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
8224446|NCT02034123|20280948|P2|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
8224447|NCT02034123|20280949|P1|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
8224448|NCT02034123|20280932|P18|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224449|NCT02034123|20280933|P17|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224450|NCT02034123|20280934|P16|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224451|NCT02034123|20280935|P15|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224452|NCT02034123|20280936|P14|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224453|NCT02034123|20280937|P13|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224454|NCT02034123|20280938|P12|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224455|NCT02034123|20280939|P11|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224456|NCT02034123|20280940|P10|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
8224457|NCT02034123|20280941|P9|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
8224458|NCT02034123|20280942|P8|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
8224459|NCT02034123|20280943|P7|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
8224460|NCT02034123|20280944|P6|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
8224461|NCT02034123|20280945|P5|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7
8224462|NCT02034123|20280946|P4|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
8224463|NCT02034123|20280947|P3|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
8224464|NCT02034123|20280948|P2|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
8224465|NCT02034123|20280949|P1|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
8224466|NCT02034058|20281268|P1|NOT COMPLETED|Overall Study||3
8224467|NCT02034058|20281268|P1|COMPLETED|Overall Study||149
8224468|NCT02034058|20281268|P1|STARTED|Overall Study|Study stopped early per pre-defined criteria for interim analysis.|152
8224469|NCT02034019|20281278|P2|NOT COMPLETED|Overall Study||2
8224470|NCT02034019|20281279|P1|NOT COMPLETED|Overall Study||1
8224471|NCT02034019|20281278|P2|COMPLETED|Overall Study||81
8224472|NCT02034019|20281279|P1|COMPLETED|Overall Study||163
8224473|NCT02034019|20281278|P2|STARTED|Overall Study||83
8224474|NCT02034019|20281279|P1|STARTED|Overall Study||164
8224475|NCT02034006|20281289|P1|NOT COMPLETED|Overall Study||14
8224476|NCT02034006|20281289|P1|COMPLETED|Overall Study||186
8224477|NCT02034006|20281289|P1|Re-treated Patients|Overall Study||130
8224478|NCT02034006|20281289|P1|Once Treated Patients|Overall Study||70
8224479|NCT02034006|20281289|P1|STARTED|Overall Study||200
8224480|NCT02033993|20281322|P2|NOT COMPLETED|Overall Study||9
8224481|NCT02033993|20281323|P1|NOT COMPLETED|Overall Study||3
8224482|NCT02033993|20281322|P2|COMPLETED|Overall Study||91
8224483|NCT02033993|20281323|P1|COMPLETED|Overall Study||96
8224484|NCT02033993|20281322|P2|STARTED|Overall Study||100
8224485|NCT02033993|20281323|P1|STARTED|Overall Study||99
8224486|NCT02033889|20281340|P3|NOT COMPLETED|Overall Study||25
8224487|NCT02033889|20281341|P2|NOT COMPLETED|Overall Study||20
8224488|NCT02033889|20281342|P1|NOT COMPLETED|Overall Study||34
8224489|NCT02033889|20281340|P3|COMPLETED|Overall Study||180
8224490|NCT02033889|20281341|P2|COMPLETED|Overall Study||187
8224491|NCT02033889|20281342|P1|COMPLETED|Overall Study||175
8224492|NCT02033889|20281340|P3|STARTED|Overall Study||205
8224493|NCT02033889|20281341|P2|STARTED|Overall Study||207
8224494|NCT02033889|20281342|P1|STARTED|Overall Study||209
8224495|NCT02033876|20281496|P2|NOT COMPLETED|Overall Study||0
8224496|NCT02033876|20281497|P1|NOT COMPLETED|Overall Study||0
8224497|NCT02033876|20281496|P2|COMPLETED|Overall Study||12
8224498|NCT02033876|20281497|P1|COMPLETED|Overall Study||12
8224499|NCT02033876|20281496|P2|STARTED|Overall Study||12
8224500|NCT02033876|20281497|P1|STARTED|Overall Study||12
8224501|NCT02033850|20281519|P2|NOT COMPLETED|Overall Study||1
8224502|NCT02033850|20281520|P1|NOT COMPLETED|Overall Study||2
8224503|NCT02033850|20281519|P2|COMPLETED|Overall Study||22
8224504|NCT02033850|20281520|P1|COMPLETED|Overall Study||21
8224505|NCT02033850|20281519|P2|STARTED|Overall Study||23
8224506|NCT02033850|20281520|P1|STARTED|Overall Study||23
8224507|NCT02033759|20281544|P2|NOT COMPLETED|Overall Study||2
8224508|NCT02033759|20281545|P1|NOT COMPLETED|Overall Study||3
8224509|NCT02033759|20281544|P2|COMPLETED|Overall Study||19
8224510|NCT02033759|20281545|P1|COMPLETED|Overall Study||19
8224511|NCT02033759|20281544|P2|STARTED|Overall Study||21
8224512|NCT02033759|20281545|P1|STARTED|Overall Study||22
8224513|NCT02033694|20281555|P1|NOT COMPLETED|Overall Study||0
8224514|NCT02033694|20281555|P1|COMPLETED|Overall Study||1271
8224515|NCT02033694|20281555|P1|STARTED|Overall Study||1271
8224516|NCT02033499|20281563|P3|NOT COMPLETED|Overall Study||9
8224517|NCT02033499|20281564|P2|NOT COMPLETED|Overall Study||8
8224518|NCT02033499|20281565|P1|NOT COMPLETED|Overall Study||5
8224519|NCT02033499|20281563|P3|COMPLETED|Overall Study||139
8224520|NCT02033499|20281564|P2|COMPLETED|Overall Study||142
8224521|NCT02033499|20281565|P1|COMPLETED|Overall Study||147
8224522|NCT02033499|20281563|P3|STARTED|Overall Study||148
8224523|NCT02033499|20281564|P2|STARTED|Overall Study||150
8224524|NCT02033499|20281565|P1|STARTED|Overall Study||152
8224525|NCT02033382|20281605|P2|NOT COMPLETED|Overall Study||46
8224526|NCT02033382|20281606|P1|NOT COMPLETED|Overall Study||51
8224527|NCT02033382|20281605|P2|COMPLETED|Overall Study||36
8224528|NCT02033382|20281606|P1|COMPLETED|Overall Study||32
8224529|NCT02033382|20281605|P2|STARTED|Overall Study||82
8224530|NCT02033382|20281606|P1|STARTED|Overall Study||83
8224531|NCT02033369|20281626|P2|NOT COMPLETED|Overall Study||5
8224532|NCT02033369|20281627|P1|NOT COMPLETED|Overall Study||5
8224533|NCT02033369|20281626|P2|COMPLETED|Overall Study||21
8224534|NCT02033369|20281627|P1|COMPLETED|Overall Study||21
8224535|NCT02033369|20281626|P2|STARTED|Overall Study||26
8224536|NCT02033369|20281627|P1|STARTED|Overall Study||26
8224540|NCT02033213|20281644|P2|NOT COMPLETED|Overall Study||0
8224541|NCT02033213|20281645|P1|NOT COMPLETED|Overall Study||0
8224542|NCT02033213|20281644|P2|COMPLETED|Overall Study||8
8224543|NCT02033213|20281645|P1|COMPLETED|Overall Study||8
8224544|NCT02033213|20281644|P2|STARTED|Overall Study||8
8224545|NCT02033213|20281645|P1|STARTED|Overall Study||8
8224546|NCT02033200|20281663|P2|NOT COMPLETED|Overall Study||0
8224547|NCT02033200|20281664|P1|NOT COMPLETED|Overall Study||0
8224548|NCT02033200|20281663|P2|COMPLETED|Overall Study||40
8224549|NCT02033200|20281664|P1|COMPLETED|Overall Study||40
8224550|NCT02033200|20281663|P2|STARTED|Overall Study||40
8224551|NCT02033200|20281664|P1|STARTED|Overall Study||40
8224552|NCT02033174|20281684|P2|NOT COMPLETED|Second Intervention||0
8224553|NCT02033174|20281685|P1|NOT COMPLETED|Second Intervention||0
8224554|NCT02033174|20281684|P2|COMPLETED|Second Intervention||8
8224555|NCT02033174|20281685|P1|COMPLETED|Second Intervention||8
8224556|NCT02033174|20281684|P2|STARTED|Second Intervention||8
8224557|NCT02033174|20281685|P1|STARTED|Second Intervention||8
8224558|NCT02033174|20281684|P2|NOT COMPLETED|Washout (1 Week)||0
8224559|NCT02033174|20281685|P1|NOT COMPLETED|Washout (1 Week)||0
8224560|NCT02033174|20281684|P2|COMPLETED|Washout (1 Week)||8
8224561|NCT02033174|20281685|P1|COMPLETED|Washout (1 Week)||8
8224562|NCT02033174|20281684|P2|STARTED|Washout (1 Week)||8
8224563|NCT02033174|20281685|P1|STARTED|Washout (1 Week)||8
8224564|NCT02033174|20281684|P2|NOT COMPLETED|First Intervention||0
8224565|NCT02033174|20281685|P1|NOT COMPLETED|First Intervention||0
8224566|NCT02033174|20281684|P2|COMPLETED|First Intervention||8
8224567|NCT02033174|20281685|P1|COMPLETED|First Intervention||8
8224568|NCT02033174|20281684|P2|STARTED|First Intervention||8
8224569|NCT02033174|20281685|P1|STARTED|First Intervention||8
8224576|NCT02033005|20281703|P3|NOT COMPLETED|Overall Study||10
8224577|NCT02033005|20281704|P2|NOT COMPLETED|Overall Study||0
8224578|NCT02033005|20281705|P1|NOT COMPLETED|Overall Study||44
8224579|NCT02033005|20281703|P3|COMPLETED|Overall Study||25
8224580|NCT02033005|20281704|P2|COMPLETED|Overall Study||9
8224581|NCT02033005|20281705|P1|COMPLETED|Overall Study||36
8224582|NCT02033005|20281703|P3|STARTED|Overall Study||35
8224583|NCT02033005|20281704|P2|STARTED|Overall Study||9
8224584|NCT02033005|20281705|P1|STARTED|Overall Study||80
8224585|NCT02032901|20281721|P2|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
8224586|NCT02032901|20281722|P1|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
8224587|NCT02032901|20281721|P2|COMPLETED|Follow-Up Period (24 Weeks)||50
8224588|NCT02032901|20281722|P1|COMPLETED|Follow-Up Period (24 Weeks)||101
8224589|NCT02032901|20281721|P2|STARTED|Follow-Up Period (24 Weeks)||51
8224590|NCT02032901|20281722|P1|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
8224591|NCT02032901|20281721|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
8224592|NCT02032901|20281722|P1|NOT COMPLETED|Treatment Period (12 Weeks)||1
8224593|NCT02032901|20281721|P2|COMPLETED|Treatment Period (12 Weeks)||51
8224594|NCT02032901|20281722|P1|COMPLETED|Treatment Period (12 Weeks)||100
8224595|NCT02032901|20281721|P2|STARTED|Treatment Period (12 Weeks)||51
8224596|NCT02032901|20281722|P1|STARTED|Treatment Period (12 Weeks)||101
8224597|NCT02032888|20281746|P3|NOT COMPLETED|Follow-up Period||0
8224598|NCT02032888|20281747|P2|NOT COMPLETED|Follow-up Period||2
8224599|NCT02032888|20281748|P1|NOT COMPLETED|Follow-up Period||3
8224600|NCT02032888|20281746|P3|COMPLETED|Follow-up Period||52
8224601|NCT02032888|20281747|P2|COMPLETED|Follow-up Period||47
8224602|NCT02032888|20281748|P1|COMPLETED|Follow-up Period||97
8224603|NCT02032888|20281746|P3|STARTED|Follow-up Period||52
8224604|NCT02032888|20281747|P2|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
8224605|NCT02032888|20281748|P1|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
8224606|NCT02032888|20281746|P3|NOT COMPLETED|Treatment Period||0
8224607|NCT02032888|20281747|P2|NOT COMPLETED|Treatment Period||2
8224608|NCT02032888|20281748|P1|NOT COMPLETED|Treatment Period||2
8224609|NCT02032888|20281746|P3|COMPLETED|Treatment Period||52
8224610|NCT02032888|20281747|P2|COMPLETED|Treatment Period||48
8224611|NCT02032888|20281748|P1|COMPLETED|Treatment Period||99
8224612|NCT02032888|20281746|P3|STARTED|Treatment Period||52
8224613|NCT02032888|20281747|P2|STARTED|Treatment Period||50
8224614|NCT02032888|20281748|P1|STARTED|Treatment Period||101
8224615|NCT02032875|20281779|P2|NOT COMPLETED|Follow-up Period||11
8224616|NCT02032875|20281780|P1|NOT COMPLETED|Follow-up Period||3
8224617|NCT02032875|20281779|P2|COMPLETED|Follow-up Period||46
8224618|NCT02032875|20281780|P1|COMPLETED|Follow-up Period||50
8224619|NCT02032875|20281779|P2|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
8224620|NCT02032875|20281780|P1|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
8224621|NCT02032875|20281779|P2|NOT COMPLETED|Treatment Period||4
8224622|NCT02032875|20281780|P1|NOT COMPLETED|Treatment Period||1
8224623|NCT02032875|20281779|P2|COMPLETED|Treatment Period||56
8224624|NCT02032875|20281780|P1|COMPLETED|Treatment Period||52
8224625|NCT02032875|20281779|P2|STARTED|Treatment Period||60
8224626|NCT02032875|20281780|P1|STARTED|Treatment Period||53
8224633|NCT02032758|20281814|P2|NOT COMPLETED|Overall Study||0
8224634|NCT02032758|20281815|P1|NOT COMPLETED|Overall Study||0
8224635|NCT02032758|20281814|P2|COMPLETED|Overall Study||11
8224636|NCT02032758|20281815|P1|COMPLETED|Overall Study||27
8224637|NCT02032758|20281814|P2|STARTED|Overall Study||11
8224638|NCT02032758|20281815|P1|STARTED|Overall Study||27
8224639|NCT02032706|20281823|P1|NOT COMPLETED|Overall Study||6
8224640|NCT02032706|20281823|P1|COMPLETED|Overall Study||30
8224641|NCT02032706|20281823|P1|STARTED|Overall Study||36
8224642|NCT02032680|20281838|P2|NOT COMPLETED|Overall Study||1
8224643|NCT02032680|20281839|P1|NOT COMPLETED|Overall Study||6
8224644|NCT02032680|20281838|P2|COMPLETED|Overall Study||7
8224645|NCT02032680|20281839|P1|COMPLETED|Overall Study||16
8224646|NCT02032680|20281838|P2|STARTED|Overall Study||8
8224647|NCT02032680|20281839|P1|STARTED|Overall Study||22
8224648|NCT02032641|20281845|P1|NOT COMPLETED|Overall Study||1
8224649|NCT02032641|20281845|P1|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
8224650|NCT02032641|20281845|P1|STARTED|Overall Study|18 Brows enrolled for evaluation|9
8224651|NCT02032550|20281857|P2|NOT COMPLETED|Overall Study||22
8224652|NCT02032550|20281858|P1|NOT COMPLETED|Overall Study||28
8224653|NCT02032550|20281857|P2|COMPLETED|Overall Study||350
8224654|NCT02032550|20281858|P1|COMPLETED|Overall Study||343
8224655|NCT02032550|20281857|P2|STARTED|Overall Study||372
8224656|NCT02032550|20281858|P1|STARTED|Overall Study||371
8224657|NCT02032433|20281870|P2|NOT COMPLETED|Overall Study||62
8224658|NCT02032433|20281871|P1|NOT COMPLETED|Overall Study||78
8224659|NCT02032433|20281870|P2|COMPLETED|Overall Study||225
8224660|NCT02032433|20281871|P1|COMPLETED|Overall Study||205
8224661|NCT02032433|20281870|P2|STARTED|Overall Study||287
8224662|NCT02032433|20281871|P1|STARTED|Overall Study||283
8224663|NCT02032420|20281993|P2|NOT COMPLETED|Overall Study||0
8224664|NCT02032420|20281994|P1|NOT COMPLETED|Overall Study||0
8224665|NCT02032420|20281993|P2|COMPLETED|Overall Study||17
8224666|NCT02032420|20281994|P1|COMPLETED|Overall Study||18
8224667|NCT02032420|20281993|P2|STARTED|Overall Study||17
8224668|NCT02032420|20281994|P1|STARTED|Overall Study||18
8224669|NCT02032407|20282006|P1|NOT COMPLETED|Overall Study||5
8224670|NCT02032407|20282006|P1|COMPLETED|Overall Study||63
8224671|NCT02032407|20282006|P1|STARTED|Overall Study||68
8224672|NCT02032238|20282019|P2|NOT COMPLETED|Overall Study||0
8224673|NCT02032238|20282020|P1|NOT COMPLETED|Overall Study||2
8224674|NCT02032238|20282019|P2|COMPLETED|Overall Study||0
8224675|NCT02032238|20282020|P1|COMPLETED|Overall Study||10
8224676|NCT02032238|20282019|P2|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
8224677|NCT02032238|20282020|P1|STARTED|Overall Study||12
8224678|NCT02032212|20282030|P4|NOT COMPLETED|Overall Study||0
8224679|NCT02032212|20282031|P3|NOT COMPLETED|Overall Study||0
8224680|NCT02032212|20282032|P2|NOT COMPLETED|Overall Study||0
8224681|NCT02032212|20282033|P1|NOT COMPLETED|Overall Study||0
8224682|NCT02032212|20282030|P4|COMPLETED|Overall Study||3
8224683|NCT02032212|20282031|P3|COMPLETED|Overall Study||3
8224684|NCT02032212|20282032|P2|COMPLETED|Overall Study||3
8224685|NCT02032212|20282033|P1|COMPLETED|Overall Study||3
8224686|NCT02032212|20282030|P4|STARTED|Overall Study||3
8224687|NCT02032212|20282031|P3|STARTED|Overall Study||3
8224688|NCT02032212|20282032|P2|STARTED|Overall Study||3
8224689|NCT02032212|20282033|P1|STARTED|Overall Study||3
8224690|NCT02032173|20282059|P1|NOT COMPLETED|Overall Study||31
8224691|NCT02032173|20282059|P1|COMPLETED|Overall Study||0
8224692|NCT02032173|20282059|P1|Rescue Group|Overall Study|1 participant moved to Rescue Group at M6 and trial discontinued before any data was collected.|1
8224693|NCT02032173|20282059|P1|Included Population - Main Group|Overall Study||31
8224694|NCT02032173|20282059|P1|STARTED|Overall Study||31
8224695|NCT02031770|20282072|P2|NOT COMPLETED|Overall Study||1
8224696|NCT02031770|20282073|P1|NOT COMPLETED|Overall Study||1
8224697|NCT02031770|20282072|P2|COMPLETED|Overall Study||9
8224698|NCT02031770|20282073|P1|COMPLETED|Overall Study||9
8224699|NCT02031770|20282072|P2|STARTED|Overall Study||10
8224700|NCT02031770|20282073|P1|STARTED|Overall Study||10
8224701|NCT02031679|20282081|P2|NOT COMPLETED|Overall Study||2
8224702|NCT02031679|20282082|P1|NOT COMPLETED|Overall Study||0
8224703|NCT02031679|20282081|P2|COMPLETED|Overall Study||12
8224704|NCT02031679|20282082|P1|COMPLETED|Overall Study||14
8224705|NCT02031679|20282081|P2|STARTED|Overall Study||14
8224706|NCT02031679|20282082|P1|STARTED|Overall Study||14
8224707|NCT02031640|20282097|P6|NOT COMPLETED|Double-blind Treatment Period||3
8224708|NCT02031640|20282098|P5|NOT COMPLETED|Double-blind Treatment Period||11
8224709|NCT02031640|20282099|P4|NOT COMPLETED|Double-blind Treatment Period||7
8224710|NCT02031640|20282100|P3|NOT COMPLETED|Double-blind Treatment Period||6
8224711|NCT02031640|20282101|P2|NOT COMPLETED|Double-blind Treatment Period||22
8224712|NCT02031640|20282102|P1|NOT COMPLETED|Double-blind Treatment Period||0
8224713|NCT02031640|20282097|P6|COMPLETED|Double-blind Treatment Period||104
8224714|NCT02031640|20282098|P5|COMPLETED|Double-blind Treatment Period||96
8224715|NCT02031640|20282099|P4|COMPLETED|Double-blind Treatment Period||99
8224716|NCT02031640|20282100|P3|COMPLETED|Double-blind Treatment Period||100
8224717|NCT02031640|20282101|P2|COMPLETED|Double-blind Treatment Period||84
8224718|NCT02031640|20282102|P1|COMPLETED|Double-blind Treatment Period||0
8224719|NCT02031640|20282097|P6|Full Analysis Set|Double-blind Treatment Period||107
8224720|NCT02031640|20282098|P5|Full Analysis Set|Double-blind Treatment Period||106
8224721|NCT02031640|20282099|P4|Full Analysis Set|Double-blind Treatment Period||106
8224722|NCT02031640|20282100|P3|Full Analysis Set|Double-blind Treatment Period||104
8224723|NCT02031640|20282101|P2|Full Analysis Set|Double-blind Treatment Period||106
8224724|NCT02031640|20282102|P1|Full Analysis Set|Double-blind Treatment Period||0
8224725|NCT02031640|20282097|P6|STARTED|Double-blind Treatment Period||107
8224726|NCT02031640|20282098|P5|STARTED|Double-blind Treatment Period||107
8224727|NCT02031640|20282099|P4|STARTED|Double-blind Treatment Period||106
8224728|NCT02031640|20282100|P3|STARTED|Double-blind Treatment Period||106
8224729|NCT02031640|20282101|P2|STARTED|Double-blind Treatment Period||106
8224730|NCT02031640|20282102|P1|STARTED|Double-blind Treatment Period||0
8224731|NCT02031640|20282097|P6|NOT COMPLETED|Run-In Period||0
8224732|NCT02031640|20282098|P5|NOT COMPLETED|Run-In Period||0
8224733|NCT02031640|20282099|P4|NOT COMPLETED|Run-In Period||0
8224734|NCT02031640|20282100|P3|NOT COMPLETED|Run-In Period||0
8224735|NCT02031640|20282101|P2|NOT COMPLETED|Run-In Period||0
8224736|NCT02031640|20282102|P1|NOT COMPLETED|Run-In Period||169
8224737|NCT02031640|20282097|P6|COMPLETED|Run-In Period||0
8224738|NCT02031640|20282098|P5|COMPLETED|Run-In Period||0
8224739|NCT02031640|20282099|P4|COMPLETED|Run-In Period||0
8224740|NCT02031640|20282100|P3|COMPLETED|Run-In Period||0
8224741|NCT02031640|20282101|P2|COMPLETED|Run-In Period||0
8224742|NCT02031640|20282102|P1|COMPLETED|Run-In Period||532
8224743|NCT02031640|20282097|P6|STARTED|Run-In Period||0
8224744|NCT02031640|20282098|P5|STARTED|Run-In Period||0
8224745|NCT02031640|20282099|P4|STARTED|Run-In Period||0
8224746|NCT02031640|20282100|P3|STARTED|Run-In Period||0
8224747|NCT02031640|20282101|P2|STARTED|Run-In Period||0
8224748|NCT02031640|20282102|P1|STARTED|Run-In Period||701
8224749|NCT02031640|20282097|P6|NOT COMPLETED|Screening Period||0
8224750|NCT02031640|20282098|P5|NOT COMPLETED|Screening Period||0
8224751|NCT02031640|20282099|P4|NOT COMPLETED|Screening Period||0
8224752|NCT02031640|20282100|P3|NOT COMPLETED|Screening Period||0
8224753|NCT02031640|20282101|P2|NOT COMPLETED|Screening Period||0
8224754|NCT02031640|20282102|P1|NOT COMPLETED|Screening Period||412
8224755|NCT02031640|20282097|P6|COMPLETED|Screening Period||0
8224756|NCT02031640|20282098|P5|COMPLETED|Screening Period||0
8224757|NCT02031640|20282099|P4|COMPLETED|Screening Period||0
8224758|NCT02031640|20282100|P3|COMPLETED|Screening Period||0
8224759|NCT02031640|20282101|P2|COMPLETED|Screening Period||0
8224760|NCT02031640|20282102|P1|COMPLETED|Screening Period||701
8224761|NCT02031640|20282097|P6|STARTED|Screening Period||0
8224762|NCT02031640|20282098|P5|STARTED|Screening Period||0
8224763|NCT02031640|20282099|P4|STARTED|Screening Period||0
8224764|NCT02031640|20282100|P3|STARTED|Screening Period||0
8224765|NCT02031640|20282101|P2|STARTED|Screening Period||0
8224766|NCT02031640|20282102|P1|STARTED|Screening Period|Consented|1113
8224767|NCT02031536|20282147|P2|NOT COMPLETED|Overall Study||0
8224768|NCT02031536|20282148|P1|NOT COMPLETED|Overall Study||1
8224769|NCT02031536|20282147|P2|COMPLETED|Overall Study||0
8224770|NCT02031536|20282148|P1|COMPLETED|Overall Study||1
8224771|NCT02031536|20282147|P2|STARTED|Overall Study||0
8224772|NCT02031536|20282148|P1|STARTED|Overall Study||2
8224773|NCT02031471|20282156|P1|NOT COMPLETED|Long Term Extension (LTE) Period||2
8224774|NCT02031471|20282156|P1|COMPLETED|Long Term Extension (LTE) Period||37
8224775|NCT02031471|20282156|P1|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
8224776|NCT02031471|20282156|P1|NOT COMPLETED|24 Week Treatment Period||11
8224777|NCT02031471|20282156|P1|COMPLETED|24 Week Treatment Period||46
8224778|NCT02031471|20282156|P1|STARTED|24 Week Treatment Period||57
8224779|NCT02031458|20282189|P3|NOT COMPLETED|Baseline to May 8, 2015||253
8224780|NCT02031458|20282190|P2|NOT COMPLETED|Baseline to May 8, 2015||267
8224781|NCT02031458|20282191|P1|NOT COMPLETED|Baseline to May 8, 2015||139
8224782|NCT02031458|20282189|P3|COMPLETED|Baseline to May 8, 2015||0
8224783|NCT02031458|20282190|P2|COMPLETED|Baseline to May 8, 2015||0
8224784|NCT02031458|20282191|P1|COMPLETED|Baseline to May 8, 2015||0
8224785|NCT02031458|20282189|P3|STARTED|Baseline to May 8, 2015||253
8224786|NCT02031458|20282190|P2|STARTED|Baseline to May 8, 2015||267
8224787|NCT02031458|20282191|P1|STARTED|Baseline to May 8, 2015||139
8224788|NCT02031458|20282189|P3|NOT COMPLETED|May 8, 2015 to January 11, 2019||252
8224789|NCT02031458|20282190|P2|NOT COMPLETED|May 8, 2015 to January 11, 2019||269
8224790|NCT02031458|20282191|P1|NOT COMPLETED|May 8, 2015 to January 11, 2019||138
8224791|NCT02031458|20282189|P3|COMPLETED|May 8, 2015 to January 11, 2019||0
8224792|NCT02031458|20282190|P2|COMPLETED|May 8, 2015 to January 11, 2019||0
8224793|NCT02031458|20282191|P1|COMPLETED|May 8, 2015 to January 11, 2019||0
8224794|NCT02031458|20282189|P3|STARTED|May 8, 2015 to January 11, 2019||252
8224795|NCT02031458|20282190|P2|STARTED|May 8, 2015 to January 11, 2019||269
8224796|NCT02031458|20282191|P1|STARTED|May 8, 2015 to January 11, 2019||138
8224808|NCT02031276|20282334|P3|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
8224809|NCT02031276|20282335|P2|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
8224810|NCT02031276|20282336|P1|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
8224811|NCT02031276|20282334|P3|COMPLETED|Period 3 Open-label Risankizumab SC||19
8224812|NCT02031276|20282335|P2|COMPLETED|Period 3 Open-label Risankizumab SC||19
8224813|NCT02031276|20282336|P1|COMPLETED|Period 3 Open-label Risankizumab SC||16
8224814|NCT02031276|20282334|P3|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
8224815|NCT02031276|20282335|P2|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
8224816|NCT02031276|20282336|P1|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
8224817|NCT02031276|20282334|P3|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
8224818|NCT02031276|20282335|P2|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
8224819|NCT02031276|20282336|P1|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
8224820|NCT02031276|20282334|P3|COMPLETED|Period 2 Open-label Risankizumab IV||38
8224821|NCT02031276|20282335|P2|COMPLETED|Period 2 Open-label Risankizumab IV||33
8224822|NCT02031276|20282336|P1|COMPLETED|Period 2 Open-label Risankizumab IV||29
8224823|NCT02031276|20282334|P3|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
8224824|NCT02031276|20282335|P2|STARTED|Period 2 Open-label Risankizumab IV||35
8224825|NCT02031276|20282336|P1|STARTED|Period 2 Open-label Risankizumab IV||33
8224826|NCT02031276|20282334|P3|NOT COMPLETED|Period 1 Double-blind IV||1
8224827|NCT02031276|20282335|P2|NOT COMPLETED|Period 1 Double-blind IV||6
8224828|NCT02031276|20282336|P1|NOT COMPLETED|Period 1 Double-blind IV||6
8224829|NCT02031276|20282334|P3|COMPLETED|Period 1 Double-blind IV||40
8224830|NCT02031276|20282335|P2|COMPLETED|Period 1 Double-blind IV||35
8224831|NCT02031276|20282336|P1|COMPLETED|Period 1 Double-blind IV||33
8224832|NCT02031276|20282334|P3|STARTED|Period 1 Double-blind IV||41
8224833|NCT02031276|20282335|P2|STARTED|Period 1 Double-blind IV||41
8224834|NCT02031276|20282336|P1|STARTED|Period 1 Double-blind IV||39
8224835|NCT02031237|20282370|P3|NOT COMPLETED|Overall Study||3
8224836|NCT02031237|20282371|P2|NOT COMPLETED|Overall Study||14
8224837|NCT02031237|20282372|P1|NOT COMPLETED|Overall Study||5
8224838|NCT02031237|20282370|P3|COMPLETED|Overall Study||0
8224839|NCT02031237|20282371|P2|COMPLETED|Overall Study||21
8224840|NCT02031237|20282372|P1|COMPLETED|Overall Study||9
8224841|NCT02031237|20282370|P3|STARTED|Overall Study||3
8224842|NCT02031237|20282371|P2|STARTED|Overall Study||35
8224843|NCT02031237|20282372|P1|STARTED|Overall Study||14
8224844|NCT02030886|20282381|P2|NOT COMPLETED|Overall Study||0
8224845|NCT02030886|20282382|P1|NOT COMPLETED|Overall Study||0
8224846|NCT02030886|20282381|P2|COMPLETED|Overall Study||6
8224847|NCT02030886|20282382|P1|COMPLETED|Overall Study||14
8224848|NCT02030886|20282381|P2|STARTED|Overall Study||6
8224849|NCT02030886|20282382|P1|STARTED|Overall Study||14
8224850|NCT02030847|20282392|P1|NOT COMPLETED|Overall Study||37
8224851|NCT02030847|20282392|P1|COMPLETED|Overall Study||5
8224852|NCT02030847|20282392|P1|STARTED|Overall Study||42
8224853|NCT02030834|20282400|P3|NOT COMPLETED|Overall Study||3
8224854|NCT02030834|20282401|P2|NOT COMPLETED|Overall Study||0
8224855|NCT02030834|20282402|P1|NOT COMPLETED|Overall Study||11
8224856|NCT02030834|20282400|P3|COMPLETED|Overall Study||7
8224857|NCT02030834|20282401|P2|COMPLETED|Overall Study||3
8224858|NCT02030834|20282402|P1|COMPLETED|Overall Study||39
8224859|NCT02030834|20282400|P3|STARTED|Overall Study||10
8224860|NCT02030834|20282401|P2|STARTED|Overall Study||3
8224861|NCT02030834|20282402|P1|STARTED|Overall Study||50
8224862|NCT02030821|20282414|P4|NOT COMPLETED|Overall Study||2
8224863|NCT02030821|20282415|P3|NOT COMPLETED|Overall Study||5
8224864|NCT02030821|20282416|P2|NOT COMPLETED|Overall Study||2
8224865|NCT02030821|20282417|P1|NOT COMPLETED|Overall Study||2
8224866|NCT02030821|20282414|P4|COMPLETED|Overall Study||72
8224867|NCT02030821|20282415|P3|COMPLETED|Overall Study||73
8224868|NCT02030821|20282416|P2|COMPLETED|Overall Study||44
8224869|NCT02030821|20282417|P1|COMPLETED|Overall Study||46
8224870|NCT02030821|20282414|P4|STARTED|Overall Study||74
8224871|NCT02030821|20282415|P3|STARTED|Overall Study||78
8224872|NCT02030821|20282416|P2|STARTED|Overall Study||46
8224873|NCT02030821|20282417|P1|STARTED|Overall Study||48
8224874|NCT02030600|20282445|P2|NOT COMPLETED|Treatment Period 2||18
8224875|NCT02030600|20282446|P1|NOT COMPLETED|Treatment Period 2||25
8224876|NCT02030600|20282445|P2|COMPLETED|Treatment Period 2||297
8224877|NCT02030600|20282446|P1|COMPLETED|Treatment Period 2||283
8224878|NCT02030600|20282445|P2|STARTED|Treatment Period 2||315
8224879|NCT02030600|20282446|P1|STARTED|Treatment Period 2||308
8224880|NCT02030600|20282445|P2|NOT COMPLETED|Treatment Period 1||45
8224881|NCT02030600|20282446|P1|NOT COMPLETED|Treatment Period 1||53
8224882|NCT02030600|20282445|P2|COMPLETED|Treatment Period 1||315
8224883|NCT02030600|20282446|P1|COMPLETED|Treatment Period 1||308
8224884|NCT02030600|20282445|P2|Exposed|Treatment Period 1||357
8224885|NCT02030600|20282446|P1|Exposed|Treatment Period 1||356
8224886|NCT02030600|20282445|P2|STARTED|Treatment Period 1||360
8224887|NCT02030600|20282446|P1|STARTED|Treatment Period 1||361
8224888|NCT02030574|20282462|P1|NOT COMPLETED|Overall Study||0
8224889|NCT02030574|20282462|P1|COMPLETED|Overall Study||2
8224890|NCT02030574|20282462|P1|STARTED|Overall Study||2
8224891|NCT02030535|20282467|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8224892|NCT02030535|20282467|P1|COMPLETED|Treatment Period 3 (1 Day)||52
8224893|NCT02030535|20282467|P1|STARTED|Treatment Period 3 (1 Day)||52
8224894|NCT02030535|20282467|P1|NOT COMPLETED|Washout Period 2 (21 Days)||0
8224895|NCT02030535|20282467|P1|COMPLETED|Washout Period 2 (21 Days)||52
8224896|NCT02030535|20282467|P1|STARTED|Washout Period 2 (21 Days)||52
8224897|NCT02030535|20282467|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8224898|NCT02030535|20282467|P1|COMPLETED|Treatment Period 2 (1 Day)||52
8224899|NCT02030535|20282467|P1|STARTED|Treatment Period 2 (1 Day)||52
8224900|NCT02030535|20282467|P1|NOT COMPLETED|Washout Period 1 (21 Days)||1
8224901|NCT02030535|20282467|P1|COMPLETED|Washout Period 1 (21 Days)||52
8224902|NCT02030535|20282467|P1|STARTED|Washout Period 1 (21 Days)||53
8224903|NCT02030535|20282467|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8224904|NCT02030535|20282467|P1|COMPLETED|Treatment Period 1 (1 Day)||53
8224905|NCT02030535|20282467|P1|STARTED|Treatment Period 1 (1 Day)||53
8224906|NCT02030405|20282535|P1|NOT COMPLETED|Overall Study||2
8224907|NCT02030405|20282535|P1|COMPLETED|Overall Study||2
8224908|NCT02030405|20282535|P1|STARTED|Overall Study||4
8224909|NCT02030288|20282544|P2|NOT COMPLETED|Overall Study||0
8224910|NCT02030288|20282545|P1|NOT COMPLETED|Overall Study||0
8224911|NCT02030288|20282544|P2|COMPLETED|Overall Study||89
8224912|NCT02030288|20282545|P1|COMPLETED|Overall Study||89
8224913|NCT02030288|20282544|P2|STARTED|Overall Study||89
8224914|NCT02030288|20282545|P1|STARTED|Overall Study||89
8224915|NCT02030119|20282561|P4|NOT COMPLETED|Overall Study||3
8224916|NCT02030119|20282562|P3|NOT COMPLETED|Overall Study||6
8224917|NCT02030119|20282563|P2|NOT COMPLETED|Overall Study||2
8224918|NCT02030119|20282564|P1|NOT COMPLETED|Overall Study||3
8224919|NCT02030119|20282561|P4|COMPLETED|Overall Study||67
8224920|NCT02030119|20282562|P3|COMPLETED|Overall Study||65
8224921|NCT02030119|20282563|P2|COMPLETED|Overall Study||68
8224922|NCT02030119|20282564|P1|COMPLETED|Overall Study||67
8224923|NCT02030119|20282561|P4|STARTED|Overall Study||70
8224924|NCT02030119|20282562|P3|STARTED|Overall Study||71
8224925|NCT02030119|20282563|P2|STARTED|Overall Study||70
8224926|NCT02030119|20282564|P1|STARTED|Overall Study||70
8224927|NCT02030080|20282582|P4|NOT COMPLETED|Overall Study||2
8224928|NCT02030080|20282583|P3|NOT COMPLETED|Overall Study||0
8224929|NCT02030080|20282584|P2|NOT COMPLETED|Overall Study||0
8224930|NCT02030080|20282585|P1|NOT COMPLETED|Overall Study||0
8224931|NCT02030080|20282582|P4|COMPLETED|Overall Study||42
8224932|NCT02030080|20282583|P3|COMPLETED|Overall Study||80
8224933|NCT02030080|20282584|P2|COMPLETED|Overall Study||64
8224934|NCT02030080|20282585|P1|COMPLETED|Overall Study||100
8224935|NCT02030080|20282582|P4|STARTED|Overall Study|11 teams|44
8224936|NCT02030080|20282583|P3|STARTED|Overall Study|20 teams|80
8224937|NCT02030080|20282584|P2|STARTED|Overall Study|16 teams|64
8224938|NCT02030080|20282585|P1|STARTED|Overall Study|25 teams|100
8224939|NCT02030041|20282602|P3|NOT COMPLETED|Overall Study||1
8224940|NCT02030041|20282603|P2|NOT COMPLETED|Overall Study||2
8224941|NCT02030041|20282604|P1|NOT COMPLETED|Overall Study||2
8224942|NCT02030041|20282602|P3|COMPLETED|Overall Study||10
8224943|NCT02030041|20282603|P2|COMPLETED|Overall Study||9
8224944|NCT02030041|20282604|P1|COMPLETED|Overall Study||9
8224945|NCT02030041|20282602|P3|STARTED|Overall Study||11
8224946|NCT02030041|20282603|P2|STARTED|Overall Study||11
8224947|NCT02030041|20282604|P1|STARTED|Overall Study||11
8224948|NCT02030002|20282615|P1|NOT COMPLETED|Follow-up||2
8224949|NCT02030002|20282615|P1|COMPLETED|Follow-up||42
8224950|NCT02030002|20282615|P1|STARTED|Follow-up||44
8224951|NCT02030002|20282615|P1|NOT COMPLETED|APC II Adhesive Coated Appliance System||0
8224952|NCT02030002|20282615|P1|COMPLETED|APC II Adhesive Coated Appliance System||44
8224953|NCT02030002|20282615|P1|STARTED|APC II Adhesive Coated Appliance System||44
8224954|NCT02030002|20282615|P1|NOT COMPLETED|APC Flash-Free Adhesive Coated Appliance||0
8224955|NCT02030002|20282615|P1|COMPLETED|APC Flash-Free Adhesive Coated Appliance||44
8224956|NCT02030002|20282615|P1|STARTED|APC Flash-Free Adhesive Coated Appliance||44
8224957|NCT02030002|20282615|P1|NOT COMPLETED|Enrollment||5
8224958|NCT02030002|20282615|P1|COMPLETED|Enrollment||44
8224959|NCT02030002|20282615|P1|STARTED|Enrollment||49
8224960|NCT02029989|20282629|P2|NOT COMPLETED|Overall Study||11
8224961|NCT02029989|20282630|P1|NOT COMPLETED|Overall Study||16
8224962|NCT02029989|20282629|P2|COMPLETED|Overall Study||49
8224963|NCT02029989|20282630|P1|COMPLETED|Overall Study||45
8224964|NCT02029989|20282629|P2|STARTED|Overall Study||60
8224965|NCT02029989|20282630|P1|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
8224966|NCT02029976|20282638|P2|NOT COMPLETED|YR-2 Follow Up vs Baseline||8
8224967|NCT02029976|20282639|P1|NOT COMPLETED|YR-2 Follow Up vs Baseline||10
8224968|NCT02029976|20282638|P2|COMPLETED|YR-2 Follow Up vs Baseline||124
8224969|NCT02029976|20282639|P1|COMPLETED|YR-2 Follow Up vs Baseline||122
8224970|NCT02029976|20282638|P2|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
8224971|NCT02029976|20282639|P1|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
8224972|NCT02029976|20282638|P2|NOT COMPLETED|YR-1 Post Intervention vs Baseline||8
8224973|NCT02029976|20282639|P1|NOT COMPLETED|YR-1 Post Intervention vs Baseline||12
8224974|NCT02029976|20282638|P2|COMPLETED|YR-1 Post Intervention vs Baseline||124
8224975|NCT02029976|20282639|P1|COMPLETED|YR-1 Post Intervention vs Baseline||120
8224976|NCT02029976|20282638|P2|STARTED|YR-1 Post Intervention vs Baseline||132
8224977|NCT02029976|20282639|P1|STARTED|YR-1 Post Intervention vs Baseline||132
8224978|NCT02029911|20282651|P1|NOT COMPLETED|Overall Study||0
8224979|NCT02029911|20282651|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
8224980|NCT02029911|20282651|P1|Treated|Overall Study|Treatment Completed|60
8224981|NCT02029911|20282651|P1|STARTED|Overall Study|Treatment Attempted|60
8224982|NCT02029872|20282659|P2|NOT COMPLETED|Overall Study||3
8224983|NCT02029872|20282660|P1|NOT COMPLETED|Overall Study||2
8224984|NCT02029872|20282659|P2|COMPLETED|Overall Study||6
8224985|NCT02029872|20282660|P1|COMPLETED|Overall Study||7
8224986|NCT02029872|20282659|P2|STARTED|Overall Study||9
8224987|NCT02029872|20282660|P1|STARTED|Overall Study||9
8224988|NCT02029846|20282668|P2|NOT COMPLETED|Overall Study||1
8224989|NCT02029846|20282669|P1|NOT COMPLETED|Overall Study||1
8224990|NCT02029846|20282668|P2|COMPLETED|Overall Study||0
8224991|NCT02029846|20282669|P1|COMPLETED|Overall Study||0
8224992|NCT02029846|20282668|P2|STARTED|Overall Study||1
8224993|NCT02029846|20282669|P1|STARTED|Overall Study||1
8224994|NCT02029755|20282682|P3|NOT COMPLETED|Overall Study||0
8224995|NCT02029755|20282683|P2|NOT COMPLETED|Overall Study||0
8224996|NCT02029755|20282684|P1|NOT COMPLETED|Overall Study||0
8224997|NCT02029755|20282682|P3|COMPLETED|Overall Study||36
8224998|NCT02029755|20282683|P2|COMPLETED|Overall Study||36
8224999|NCT02029755|20282684|P1|COMPLETED|Overall Study||36
8225000|NCT02029755|20282682|P3|STARTED|Overall Study||36
8225001|NCT02029755|20282683|P2|STARTED|Overall Study||36
8225002|NCT02029755|20282684|P1|STARTED|Overall Study||36
8225003|NCT02029703|20282697|P2|NOT COMPLETED|Overall Study||0
8225004|NCT02029703|20282698|P1|NOT COMPLETED|Overall Study||0
8225005|NCT02029703|20282697|P2|COMPLETED|Overall Study||22
8225006|NCT02029703|20282698|P1|COMPLETED|Overall Study||20
8225007|NCT02029703|20282697|P2|STARTED|Overall Study||22
8225008|NCT02029703|20282698|P1|STARTED|Overall Study||20
8225009|NCT02029638|20282707|P3|NOT COMPLETED|Overall Study||1
8225010|NCT02029638|20282708|P2|NOT COMPLETED|Overall Study||0
8225011|NCT02029638|20282709|P1|NOT COMPLETED|Overall Study||2
8225012|NCT02029638|20282707|P3|COMPLETED|Overall Study||0
8225013|NCT02029638|20282708|P2|COMPLETED|Overall Study||1
8225014|NCT02029638|20282709|P1|COMPLETED|Overall Study||0
8225015|NCT02029638|20282707|P3|STARTED|Overall Study||1
8225016|NCT02029638|20282708|P2|STARTED|Overall Study||1
8225017|NCT02029638|20282709|P1|STARTED|Overall Study||2
8225018|NCT02029521|20282738|P2|NOT COMPLETED|Overall Study||1
8225019|NCT02029521|20282739|P1|NOT COMPLETED|Overall Study||2
8225020|NCT02029521|20282738|P2|COMPLETED|Overall Study||22
8225021|NCT02029521|20282739|P1|COMPLETED|Overall Study||22
8225022|NCT02029521|20282738|P2|STARTED|Overall Study||23
8225023|NCT02029521|20282739|P1|STARTED|Overall Study||24
8225024|NCT02029495|20282824|P3|NOT COMPLETED|Overall Study||2
8225025|NCT02029495|20282825|P2|NOT COMPLETED|Overall Study||0
8225026|NCT02029495|20282826|P1|NOT COMPLETED|Overall Study||1
8225027|NCT02029495|20282824|P3|COMPLETED|Overall Study||159
8225028|NCT02029495|20282825|P2|COMPLETED|Overall Study||158
8225029|NCT02029495|20282826|P1|COMPLETED|Overall Study||158
8225030|NCT02029495|20282824|P3|STARTED|Overall Study||161
8225031|NCT02029495|20282825|P2|STARTED|Overall Study||158
8225032|NCT02029495|20282826|P1|STARTED|Overall Study||159
8225033|NCT02029417|20282837|P1|NOT COMPLETED|Overall Study||2
8225034|NCT02029417|20282837|P1|COMPLETED|Overall Study||0
8225035|NCT02029417|20282837|P1|STARTED|Overall Study||2
8225036|NCT02029274|20282846|P4|NOT COMPLETED|Overall Study||2
8225037|NCT02029274|20282847|P3|NOT COMPLETED|Overall Study||2
8225038|NCT02029274|20282848|P2|NOT COMPLETED|Overall Study||0
8225039|NCT02029274|20282849|P1|NOT COMPLETED|Overall Study||1
8225040|NCT02029274|20282846|P4|COMPLETED|Overall Study||2
8225041|NCT02029274|20282847|P3|COMPLETED|Overall Study||2
8225042|NCT02029274|20282848|P2|COMPLETED|Overall Study||4
8225043|NCT02029274|20282849|P1|COMPLETED|Overall Study||4
8225044|NCT02029274|20282846|P4|Fixed Dose Period 2|Overall Study||4
8225045|NCT02029274|20282847|P3|Fixed Dose Period 2|Overall Study||4
8225046|NCT02029274|20282848|P2|Fixed Dose Period 2|Overall Study||4
8225047|NCT02029274|20282849|P1|Fixed Dose Period 2|Overall Study||5
8225048|NCT02029274|20282846|P4|STARTED|Overall Study||4
8225049|NCT02029274|20282847|P3|STARTED|Overall Study||4
8225050|NCT02029274|20282848|P2|STARTED|Overall Study||4
8225051|NCT02029274|20282849|P1|STARTED|Overall Study||5
8225052|NCT02029235|20282881|P2|NOT COMPLETED|Overall Study||1
8225053|NCT02029235|20282882|P1|NOT COMPLETED|Overall Study||4
8225054|NCT02029235|20282881|P2|COMPLETED|Overall Study||30
8225055|NCT02029235|20282882|P1|COMPLETED|Overall Study||30
8225056|NCT02029235|20282881|P2|STARTED|Overall Study||31
8225057|NCT02029235|20282882|P1|STARTED|Overall Study||34
8225058|NCT02029196|20282892|P2|NOT COMPLETED|Overall Study||1
8225059|NCT02029196|20282893|P1|NOT COMPLETED|Overall Study||20
8225060|NCT02029196|20282892|P2|COMPLETED|Overall Study||101
8225061|NCT02029196|20282893|P1|COMPLETED|Overall Study||286
8225062|NCT02029196|20282892|P2|STARTED|Overall Study||102
8225063|NCT02029196|20282893|P1|STARTED|Overall Study||306
8225064|NCT02029040|20282903|P2|NOT COMPLETED|Overall Study||0
8225065|NCT02029040|20282904|P1|NOT COMPLETED|Overall Study||0
8225066|NCT02029040|20282903|P2|COMPLETED|Overall Study||25
8225067|NCT02029040|20282904|P1|COMPLETED|Overall Study||27
8225068|NCT02029040|20282903|P2|STARTED|Overall Study||25
8225069|NCT02029040|20282904|P1|STARTED|Overall Study||27
8225082|NCT02028871|20282985|P2|NOT COMPLETED|Overall Study||3
8225083|NCT02028871|20282986|P1|NOT COMPLETED|Overall Study||4
8225084|NCT02028871|20282985|P2|COMPLETED|Overall Study||9
8225085|NCT02028871|20282986|P1|COMPLETED|Overall Study||10
8225086|NCT02028871|20282985|P2|STARTED|Overall Study||12
8225087|NCT02028871|20282986|P1|STARTED|Overall Study||14
8225088|NCT02028780|20283007|P12|NOT COMPLETED|Follow up Phase||0
8225089|NCT02028780|20283008|P11|NOT COMPLETED|Follow up Phase||0
8225090|NCT02028780|20283009|P10|NOT COMPLETED|Follow up Phase||0
8225091|NCT02028780|20283010|P9|NOT COMPLETED|Follow up Phase||0
8225092|NCT02028780|20283011|P8|NOT COMPLETED|Follow up Phase||0
8225093|NCT02028780|20283012|P7|NOT COMPLETED|Follow up Phase||0
8225094|NCT02028780|20283013|P6|NOT COMPLETED|Follow up Phase||0
8225095|NCT02028780|20283014|P5|NOT COMPLETED|Follow up Phase||0
8225096|NCT02028780|20283015|P4|NOT COMPLETED|Follow up Phase||0
8225097|NCT02028780|20283016|P3|NOT COMPLETED|Follow up Phase||0
8225098|NCT02028780|20283017|P2|NOT COMPLETED|Follow up Phase||0
8225099|NCT02028780|20283018|P1|NOT COMPLETED|Follow up Phase||0
8225100|NCT02028780|20283007|P12|COMPLETED|Follow up Phase||9
8225101|NCT02028780|20283008|P11|COMPLETED|Follow up Phase||9
8225102|NCT02028780|20283009|P10|COMPLETED|Follow up Phase||9
8225103|NCT02028780|20283010|P9|COMPLETED|Follow up Phase||9
8225104|NCT02028780|20283011|P8|COMPLETED|Follow up Phase||3
8225105|NCT02028780|20283012|P7|COMPLETED|Follow up Phase||9
8225106|NCT02028780|20283013|P6|COMPLETED|Follow up Phase||6
8225107|NCT02028780|20283014|P5|COMPLETED|Follow up Phase||6
8225108|NCT02028780|20283015|P4|COMPLETED|Follow up Phase||6
8225109|NCT02028780|20283016|P3|COMPLETED|Follow up Phase||6
8225110|NCT02028780|20283017|P2|COMPLETED|Follow up Phase||2
8225111|NCT02028780|20283018|P1|COMPLETED|Follow up Phase||6
8225112|NCT02028780|20283007|P12|STARTED|Follow up Phase||9
8225113|NCT02028780|20283008|P11|STARTED|Follow up Phase||9
8225114|NCT02028780|20283009|P10|STARTED|Follow up Phase||9
8225115|NCT02028780|20283010|P9|STARTED|Follow up Phase||9
8225116|NCT02028780|20283011|P8|STARTED|Follow up Phase||3
8225117|NCT02028780|20283012|P7|STARTED|Follow up Phase||9
8225118|NCT02028780|20283013|P6|STARTED|Follow up Phase||6
8225119|NCT02028780|20283014|P5|STARTED|Follow up Phase||6
8225120|NCT02028780|20283015|P4|STARTED|Follow up Phase||6
8225121|NCT02028780|20283016|P3|STARTED|Follow up Phase||6
8225122|NCT02028780|20283017|P2|STARTED|Follow up Phase||2
8225123|NCT02028780|20283018|P1|STARTED|Follow up Phase||6
8225124|NCT02028780|20283007|P12|NOT COMPLETED|Observation Phase||0
8225125|NCT02028780|20283008|P11|NOT COMPLETED|Observation Phase||0
8225126|NCT02028780|20283009|P10|NOT COMPLETED|Observation Phase||0
8225127|NCT02028780|20283010|P9|NOT COMPLETED|Observation Phase||0
8225128|NCT02028780|20283011|P8|NOT COMPLETED|Observation Phase||0
8225129|NCT02028780|20283012|P7|NOT COMPLETED|Observation Phase||0
8225130|NCT02028780|20283013|P6|NOT COMPLETED|Observation Phase||0
8225131|NCT02028780|20283014|P5|NOT COMPLETED|Observation Phase||0
8225132|NCT02028780|20283015|P4|NOT COMPLETED|Observation Phase||0
8225133|NCT02028780|20283016|P3|NOT COMPLETED|Observation Phase||0
8225134|NCT02028780|20283017|P2|NOT COMPLETED|Observation Phase||0
8225135|NCT02028780|20283018|P1|NOT COMPLETED|Observation Phase||0
8225136|NCT02028780|20283007|P12|COMPLETED|Observation Phase||9
8225137|NCT02028780|20283008|P11|COMPLETED|Observation Phase||9
8225138|NCT02028780|20283009|P10|COMPLETED|Observation Phase||9
8225139|NCT02028780|20283010|P9|COMPLETED|Observation Phase||9
8225140|NCT02028780|20283011|P8|COMPLETED|Observation Phase||3
8225141|NCT02028780|20283012|P7|COMPLETED|Observation Phase||9
8225142|NCT02028780|20283013|P6|COMPLETED|Observation Phase||6
8225143|NCT02028780|20283014|P5|COMPLETED|Observation Phase||6
8225144|NCT02028780|20283015|P4|COMPLETED|Observation Phase||6
8225145|NCT02028780|20283016|P3|COMPLETED|Observation Phase||6
8225146|NCT02028780|20283017|P2|COMPLETED|Observation Phase||2
8225147|NCT02028780|20283018|P1|COMPLETED|Observation Phase||6
8225148|NCT02028780|20283007|P12|STARTED|Observation Phase||9
8225149|NCT02028780|20283008|P11|STARTED|Observation Phase||9
8225150|NCT02028780|20283009|P10|STARTED|Observation Phase||9
8225151|NCT02028780|20283010|P9|STARTED|Observation Phase||9
8225152|NCT02028780|20283011|P8|STARTED|Observation Phase||3
8225153|NCT02028780|20283012|P7|STARTED|Observation Phase||9
8225154|NCT02028780|20283013|P6|STARTED|Observation Phase||6
8225155|NCT02028780|20283014|P5|STARTED|Observation Phase||6
8225156|NCT02028780|20283015|P4|STARTED|Observation Phase||6
8225157|NCT02028780|20283016|P3|STARTED|Observation Phase||6
8225158|NCT02028780|20283017|P2|STARTED|Observation Phase||2
8225159|NCT02028780|20283018|P1|STARTED|Observation Phase||6
8225160|NCT02028767|20283083|P2|NOT COMPLETED|Treatment Period 2||0
8225161|NCT02028767|20283084|P1|NOT COMPLETED|Treatment Period 2||2
8225162|NCT02028767|20283083|P2|COMPLETED|Treatment Period 2||16
8225163|NCT02028767|20283084|P1|COMPLETED|Treatment Period 2||14
8225164|NCT02028767|20283083|P2|STARTED|Treatment Period 2||16
8225165|NCT02028767|20283084|P1|STARTED|Treatment Period 2||16
8225166|NCT02028767|20283083|P2|NOT COMPLETED|Treatment Period 1||0
8225167|NCT02028767|20283084|P1|NOT COMPLETED|Treatment Period 1||0
8225168|NCT02028767|20283083|P2|COMPLETED|Treatment Period 1||16
8225169|NCT02028767|20283084|P1|COMPLETED|Treatment Period 1||16
8225170|NCT02028767|20283083|P2|STARTED|Treatment Period 1||16
8225171|NCT02028767|20283084|P1|STARTED|Treatment Period 1||16
8225172|NCT02028754|20283096|P2|NOT COMPLETED|Overall Study||8
8225173|NCT02028754|20283097|P1|NOT COMPLETED|Overall Study||7
8225174|NCT02028754|20283096|P2|COMPLETED|Overall Study||82
8225175|NCT02028754|20283097|P1|COMPLETED|Overall Study||83
8225176|NCT02028754|20283096|P2|STARTED|Overall Study||90
8225177|NCT02028754|20283097|P1|STARTED|Overall Study||90
8225178|NCT02028715|20283117|P2|NOT COMPLETED|Overall Study||4
8225179|NCT02028715|20283118|P1|NOT COMPLETED|Overall Study||5
8225180|NCT02028715|20283117|P2|COMPLETED|Overall Study||30
8225181|NCT02028715|20283118|P1|COMPLETED|Overall Study||29
8225182|NCT02028715|20283117|P2|STARTED|Overall Study||34
8225183|NCT02028715|20283118|P1|STARTED|Overall Study||34
8225184|NCT02028676|20283145|P9|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225185|NCT02028676|20283146|P8|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225186|NCT02028676|20283147|P7|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225187|NCT02028676|20283148|P6|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225188|NCT02028676|20283149|P5|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225189|NCT02028676|20283150|P4|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225190|NCT02028676|20283151|P3|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225191|NCT02028676|20283152|P2|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225192|NCT02028676|20283153|P1|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225193|NCT02028676|20283145|P9|COMPLETED|Subsequent Cotrimoxazole Randomization||382
8225194|NCT02028676|20283146|P8|COMPLETED|Subsequent Cotrimoxazole Randomization||376
8225195|NCT02028676|20283147|P7|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225196|NCT02028676|20283148|P6|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225197|NCT02028676|20283149|P5|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225198|NCT02028676|20283150|P4|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225199|NCT02028676|20283151|P3|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225200|NCT02028676|20283152|P2|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225201|NCT02028676|20283153|P1|COMPLETED|Subsequent Cotrimoxazole Randomization||0
8225202|NCT02028676|20283145|P9|STARTED|Subsequent Cotrimoxazole Randomization||382
8225203|NCT02028676|20283146|P8|STARTED|Subsequent Cotrimoxazole Randomization||376
8225204|NCT02028676|20283147|P7|STARTED|Subsequent Cotrimoxazole Randomization||0
8225205|NCT02028676|20283148|P6|STARTED|Subsequent Cotrimoxazole Randomization||0
8225206|NCT02028676|20283149|P5|STARTED|Subsequent Cotrimoxazole Randomization||0
8225207|NCT02028676|20283150|P4|STARTED|Subsequent Cotrimoxazole Randomization||0
8225208|NCT02028676|20283151|P3|STARTED|Subsequent Cotrimoxazole Randomization||0
8225209|NCT02028676|20283152|P2|STARTED|Subsequent Cotrimoxazole Randomization||0
8225210|NCT02028676|20283153|P1|STARTED|Subsequent Cotrimoxazole Randomization||0
8225211|NCT02028676|20283145|P9|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225212|NCT02028676|20283146|P8|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225213|NCT02028676|20283147|P7|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225214|NCT02028676|20283148|P6|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225215|NCT02028676|20283149|P5|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225216|NCT02028676|20283150|P4|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225217|NCT02028676|20283151|P3|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225218|NCT02028676|20283152|P2|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225219|NCT02028676|20283153|P1|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225220|NCT02028676|20283145|P9|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225221|NCT02028676|20283146|P8|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225222|NCT02028676|20283147|P7|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
8225223|NCT02028676|20283148|P6|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
8225224|NCT02028676|20283149|P5|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225225|NCT02028676|20283150|P4|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225226|NCT02028676|20283151|P3|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225227|NCT02028676|20283152|P2|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225228|NCT02028676|20283153|P1|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
8225229|NCT02028676|20283145|P9|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8225230|NCT02028676|20283146|P8|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8225231|NCT02028676|20283147|P7|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
8225232|NCT02028676|20283148|P6|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
8225233|NCT02028676|20283149|P5|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8225234|NCT02028676|20283150|P4|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8225235|NCT02028676|20283151|P3|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8225236|NCT02028676|20283152|P2|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8225237|NCT02028676|20283153|P1|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
8225238|NCT02028676|20283145|P9|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225239|NCT02028676|20283146|P8|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225240|NCT02028676|20283147|P7|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225241|NCT02028676|20283148|P6|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225242|NCT02028676|20283149|P5|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225243|NCT02028676|20283150|P4|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225244|NCT02028676|20283151|P3|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225245|NCT02028676|20283152|P2|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225246|NCT02028676|20283153|P1|NOT COMPLETED|Initial Enrolment: Induction ART||0
8225247|NCT02028676|20283145|P9|COMPLETED|Initial Enrolment: Induction ART||0
8225248|NCT02028676|20283146|P8|COMPLETED|Initial Enrolment: Induction ART||0
8225249|NCT02028676|20283147|P7|COMPLETED|Initial Enrolment: Induction ART||0
8225250|NCT02028676|20283148|P6|COMPLETED|Initial Enrolment: Induction ART||0
8225251|NCT02028676|20283149|P5|COMPLETED|Initial Enrolment: Induction ART||405
8225252|NCT02028676|20283150|P4|COMPLETED|Initial Enrolment: Induction ART||404
8225253|NCT02028676|20283151|P3|COMPLETED|Initial Enrolment: Induction ART||397
8225254|NCT02028676|20283152|P2|COMPLETED|Initial Enrolment: Induction ART||0
8225255|NCT02028676|20283153|P1|COMPLETED|Initial Enrolment: Induction ART||0
8225256|NCT02028676|20283145|P9|STARTED|Initial Enrolment: Induction ART||0
8225257|NCT02028676|20283146|P8|STARTED|Initial Enrolment: Induction ART||0
8225258|NCT02028676|20283147|P7|STARTED|Initial Enrolment: Induction ART||0
8225259|NCT02028676|20283148|P6|STARTED|Initial Enrolment: Induction ART||0
8225260|NCT02028676|20283149|P5|STARTED|Initial Enrolment: Induction ART||405
8225261|NCT02028676|20283150|P4|STARTED|Initial Enrolment: Induction ART||404
8225262|NCT02028676|20283151|P3|STARTED|Initial Enrolment: Induction ART||397
8225263|NCT02028676|20283152|P2|STARTED|Initial Enrolment: Induction ART||0
8225264|NCT02028676|20283153|P1|STARTED|Initial Enrolment: Induction ART||0
8225265|NCT02028676|20283145|P9|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225266|NCT02028676|20283146|P8|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225267|NCT02028676|20283147|P7|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225268|NCT02028676|20283148|P6|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225269|NCT02028676|20283149|P5|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225270|NCT02028676|20283150|P4|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225271|NCT02028676|20283151|P3|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225272|NCT02028676|20283152|P2|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225273|NCT02028676|20283153|P1|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
8225274|NCT02028676|20283145|P9|COMPLETED|Initial Enrolment: CDM vs LCM||0
8225275|NCT02028676|20283146|P8|COMPLETED|Initial Enrolment: CDM vs LCM||0
8225276|NCT02028676|20283147|P7|COMPLETED|Initial Enrolment: CDM vs LCM||0
8225277|NCT02028676|20283148|P6|COMPLETED|Initial Enrolment: CDM vs LCM||0
8225278|NCT02028676|20283149|P5|COMPLETED|Initial Enrolment: CDM vs LCM||0
8225279|NCT02028676|20283150|P4|COMPLETED|Initial Enrolment: CDM vs LCM||0
8225280|NCT02028676|20283151|P3|COMPLETED|Initial Enrolment: CDM vs LCM||0
8225281|NCT02028676|20283152|P2|COMPLETED|Initial Enrolment: CDM vs LCM||600
8225282|NCT02028676|20283153|P1|COMPLETED|Initial Enrolment: CDM vs LCM||606
8225283|NCT02028676|20283145|P9|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
8225284|NCT02028676|20283146|P8|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
8225285|NCT02028676|20283147|P7|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
8225286|NCT02028676|20283148|P6|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
8225287|NCT02028676|20283149|P5|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
8225288|NCT02028676|20283150|P4|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
8225289|NCT02028676|20283151|P3|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
8225290|NCT02028676|20283152|P2|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
8225291|NCT02028676|20283153|P1|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
8225292|NCT02028325|20283326|P1|NOT COMPLETED|Overall Study||10
8225293|NCT02028325|20283326|P1|COMPLETED|Overall Study||126
8225294|NCT02028325|20283326|P1|STARTED|Overall Study||136
8225295|NCT02028208|20283333|P3|NOT COMPLETED|Overall Study||1
8225296|NCT02028208|20283334|P2|NOT COMPLETED|Overall Study||0
8225297|NCT02028208|20283335|P1|NOT COMPLETED|Overall Study||0
8225298|NCT02028208|20283333|P3|COMPLETED|Overall Study||21
8225299|NCT02028208|20283334|P2|COMPLETED|Overall Study||13
8225300|NCT02028208|20283335|P1|COMPLETED|Overall Study||21
8225301|NCT02028208|20283333|P3|STARTED|Overall Study||22
8225302|NCT02028208|20283334|P2|STARTED|Overall Study||13
8225303|NCT02028208|20283335|P1|STARTED|Overall Study||21
8225304|NCT02028182|20283346|P1|NOT COMPLETED|Overall Study||2
8225305|NCT02028182|20283346|P1|COMPLETED|Overall Study||20
8225306|NCT02028182|20283346|P1|STARTED|Overall Study||22
8225307|NCT02028169|20283352|P1|NOT COMPLETED|Overall Study||28
8225308|NCT02028169|20283352|P1|COMPLETED|Overall Study||92
8225309|NCT02028169|20283352|P1|STARTED|Overall Study||120
8225310|NCT02028065|20283378|P3|NOT COMPLETED|Treatment Through Study Completion||14
8225311|NCT02028065|20283379|P2|NOT COMPLETED|Treatment Through Study Completion||15
8225312|NCT02028065|20283380|P1|NOT COMPLETED|Treatment Through Study Completion||12
8225313|NCT02028065|20283378|P3|COMPLETED|Treatment Through Study Completion||134
8225314|NCT02028065|20283379|P2|COMPLETED|Treatment Through Study Completion||136
8225315|NCT02028065|20283380|P1|COMPLETED|Treatment Through Study Completion||64
8225316|NCT02028065|20283378|P3|Received Third Dose|Treatment Through Study Completion||134
8225317|NCT02028065|20283379|P2|Received Third Dose|Treatment Through Study Completion||136
8225318|NCT02028065|20283380|P1|Received Third Dose|Treatment Through Study Completion||64
8225319|NCT02028065|20283378|P3|Received Second Dose|Treatment Through Study Completion||138
8225320|NCT02028065|20283379|P2|Received Second Dose|Treatment Through Study Completion||140
8225321|NCT02028065|20283380|P1|Received Second Dose|Treatment Through Study Completion||69
8225322|NCT02028065|20283378|P3|Received First Dose|Treatment Through Study Completion||148
8225323|NCT02028065|20283379|P2|Received First Dose|Treatment Through Study Completion||151
8225324|NCT02028065|20283380|P1|Received First Dose|Treatment Through Study Completion||76
8225325|NCT02028065|20283378|P3|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
8225326|NCT02028065|20283379|P2|STARTED|Treatment Through Study Completion||151
8225327|NCT02028065|20283380|P1|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
8225328|NCT02028065|20283378|P3|NOT COMPLETED|Randomization Through Start Treatment||3
8225329|NCT02028065|20283379|P2|NOT COMPLETED|Randomization Through Start Treatment||3
8225330|NCT02028065|20283380|P1|NOT COMPLETED|Randomization Through Start Treatment||1
8225331|NCT02028065|20283378|P3|COMPLETED|Randomization Through Start Treatment||149
8225332|NCT02028065|20283379|P2|COMPLETED|Randomization Through Start Treatment||151
8225333|NCT02028065|20283380|P1|COMPLETED|Randomization Through Start Treatment||75
8225334|NCT02028065|20283378|P3|STARTED|Randomization Through Start Treatment|Randomized|152
8225335|NCT02028065|20283379|P2|STARTED|Randomization Through Start Treatment|Randomized|154
8225336|NCT02028065|20283380|P1|STARTED|Randomization Through Start Treatment|Randomized|76
8225337|NCT02027883|20283393|P2|NOT COMPLETED|Overall Study||0
8225338|NCT02027883|20283394|P1|NOT COMPLETED|Overall Study||0
8225339|NCT02027883|20283393|P2|COMPLETED|Overall Study||50
8225340|NCT02027883|20283394|P1|COMPLETED|Overall Study||50
8225341|NCT02027883|20283393|P2|STARTED|Overall Study||50
8225342|NCT02027883|20283394|P1|STARTED|Overall Study||50
8225343|NCT02027844|20283407|P3|NOT COMPLETED|Overall Study||2
8225344|NCT02027844|20283408|P2|NOT COMPLETED|Overall Study||6
8225345|NCT02027844|20283409|P1|NOT COMPLETED|Overall Study||5
8225346|NCT02027844|20283407|P3|COMPLETED|Overall Study||37
8225347|NCT02027844|20283408|P2|COMPLETED|Overall Study||33
8225348|NCT02027844|20283409|P1|COMPLETED|Overall Study||34
8225349|NCT02027844|20283407|P3|STARTED|Overall Study||39
8225350|NCT02027844|20283408|P2|STARTED|Overall Study||39
8225351|NCT02027844|20283409|P1|STARTED|Overall Study||39
8225352|NCT02027701|20283426|P1|NOT COMPLETED|Overall Study||16
8225353|NCT02027701|20283426|P1|COMPLETED|Overall Study||66
8225354|NCT02027701|20283426|P1|STARTED|Overall Study||82
8225355|NCT02027623|20283444|P2|NOT COMPLETED|Overall Study||12
8225356|NCT02027623|20283445|P1|NOT COMPLETED|Overall Study||9
8225357|NCT02027623|20283444|P2|COMPLETED|Overall Study||65
8225358|NCT02027623|20283445|P1|COMPLETED|Overall Study||68
8225359|NCT02027623|20283444|P2|STARTED|Overall Study||77
8225360|NCT02027623|20283445|P1|STARTED|Overall Study||77
8225361|NCT02027558|20283541|P2|NOT COMPLETED|Overall Study||2
8225362|NCT02027558|20283542|P1|NOT COMPLETED|Overall Study||9
8225363|NCT02027558|20283541|P2|COMPLETED|Overall Study||61
8225364|NCT02027558|20283542|P1|COMPLETED|Overall Study||53
8225365|NCT02027558|20283541|P2|6-month Follow-up|Overall Study||61
8225366|NCT02027558|20283542|P1|6-month Follow-up|Overall Study||53
8225367|NCT02027558|20283541|P2|3-month Follow-up|Overall Study||58
8225368|NCT02027558|20283542|P1|3-month Follow-up|Overall Study||53
8225369|NCT02027558|20283541|P2|Post-treatment|Overall Study||60
8225370|NCT02027558|20283542|P1|Post-treatment|Overall Study||49
8225371|NCT02027558|20283541|P2|STARTED|Overall Study||63
8225372|NCT02027558|20283542|P1|STARTED|Overall Study||62
8225373|NCT02027545|20283560|P2|NOT COMPLETED|Overall Study||2
8225374|NCT02027545|20283561|P1|NOT COMPLETED|Overall Study||2
8225375|NCT02027545|20283560|P2|COMPLETED|Overall Study||173
8225376|NCT02027545|20283561|P1|COMPLETED|Overall Study||259
8225377|NCT02027545|20283560|P2|STARTED|Overall Study||175
8225378|NCT02027545|20283561|P1|STARTED|Overall Study||261
8225379|NCT02027428|20283573|P3|NOT COMPLETED|Survival Follow-up||46
8225380|NCT02027428|20283574|P2|NOT COMPLETED|Survival Follow-up||79
8225381|NCT02027428|20283575|P1|NOT COMPLETED|Survival Follow-up||0
8225382|NCT02027428|20283573|P3|COMPLETED|Survival Follow-up||9
8225383|NCT02027428|20283574|P2|COMPLETED|Survival Follow-up||38
8225384|NCT02027428|20283575|P1|COMPLETED|Survival Follow-up||0
8225385|NCT02027428|20283573|P3|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|55
8225386|NCT02027428|20283574|P2|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|117
8225387|NCT02027428|20283575|P1|STARTED|Survival Follow-up||0
8225388|NCT02027428|20283573|P3|NOT COMPLETED|Maintenance||60
8225389|NCT02027428|20283574|P2|NOT COMPLETED|Maintenance||124
8225390|NCT02027428|20283575|P1|NOT COMPLETED|Maintenance||0
8225391|NCT02027428|20283573|P3|COMPLETED|Maintenance||6
8225392|NCT02027428|20283574|P2|COMPLETED|Maintenance||12
8225393|NCT02027428|20283575|P1|COMPLETED|Maintenance||0
8225394|NCT02027428|20283573|P3|STARTED|Maintenance||66
8225395|NCT02027428|20283574|P2|STARTED|Maintenance||136
8225396|NCT02027428|20283575|P1|STARTED|Maintenance||0
8225397|NCT02027428|20283573|P3|NOT COMPLETED|Induction||0
8225398|NCT02027428|20283574|P2|NOT COMPLETED|Induction||0
8225399|NCT02027428|20283575|P1|NOT COMPLETED|Induction||225
8225400|NCT02027428|20283573|P3|COMPLETED|Induction||0
8225401|NCT02027428|20283574|P2|COMPLETED|Induction||0
8225402|NCT02027428|20283575|P1|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
8225403|NCT02027428|20283573|P3|Received Study Drug|Induction||0
8225404|NCT02027428|20283574|P2|Received Study Drug|Induction||0
8225405|NCT02027428|20283575|P1|Received Study Drug|Induction||420
8225406|NCT02027428|20283573|P3|STARTED|Induction||0
8225407|NCT02027428|20283574|P2|STARTED|Induction||0
8225408|NCT02027428|20283575|P1|STARTED|Induction||427
8225409|NCT02027402|20283613|P2|NOT COMPLETED|Overall Study||1
8225410|NCT02027402|20283614|P1|NOT COMPLETED|Overall Study||4
8225411|NCT02027402|20283613|P2|COMPLETED|Overall Study||99
8225412|NCT02027402|20283614|P1|COMPLETED|Overall Study||94
8225413|NCT02027402|20283613|P2|STARTED|Overall Study||100
8225414|NCT02027402|20283614|P1|STARTED|Overall Study||98
8225415|NCT02027376|20283626|P3|NOT COMPLETED|Overall Study||0
8225416|NCT02027376|20283627|P2|NOT COMPLETED|Overall Study||0
8225417|NCT02027376|20283628|P1|NOT COMPLETED|Overall Study||1
8225418|NCT02027376|20283626|P3|COMPLETED|Overall Study||3
8225419|NCT02027376|20283627|P2|COMPLETED|Overall Study||4
8225420|NCT02027376|20283628|P1|COMPLETED|Overall Study||4
8225421|NCT02027376|20283626|P3|STARTED|Overall Study||3
8225422|NCT02027376|20283627|P2|STARTED|Overall Study||4
8225423|NCT02027376|20283628|P1|STARTED|Overall Study||5
8225424|NCT02027311|20283654|P2|NOT COMPLETED|Overall Study||2
8225425|NCT02027311|20283655|P1|NOT COMPLETED|Overall Study||3
8225426|NCT02027311|20283654|P2|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
8225427|NCT02027311|20283655|P1|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
8225428|NCT02027311|20283654|P2|STARTED|Overall Study||35
8225429|NCT02027311|20283655|P1|STARTED|Overall Study||33
8225430|NCT02027272|20283665|P2|NOT COMPLETED|Overall Study||1
8225431|NCT02027272|20283666|P1|NOT COMPLETED|Overall Study||0
8225432|NCT02027272|20283665|P2|COMPLETED|Overall Study||0
8225433|NCT02027272|20283666|P1|COMPLETED|Overall Study||0
8225434|NCT02027272|20283665|P2|STARTED|Overall Study||1
8225435|NCT02027272|20283666|P1|STARTED|Overall Study||0
8225436|NCT02027025|20283675|P3|NOT COMPLETED|Overall Study||1
8225437|NCT02027025|20283676|P2|NOT COMPLETED|Overall Study||5
8225438|NCT02027025|20283677|P1|NOT COMPLETED|Overall Study||1
8225439|NCT02027025|20283675|P3|COMPLETED|Overall Study||46
8225440|NCT02027025|20283676|P2|COMPLETED|Overall Study||42
8225441|NCT02027025|20283677|P1|COMPLETED|Overall Study||47
8225442|NCT02027025|20283675|P3|STARTED|Overall Study||47
8225443|NCT02027025|20283676|P2|STARTED|Overall Study||47
8225444|NCT02027025|20283677|P1|STARTED|Overall Study||48
8225445|NCT02026687|20283698|P2|NOT COMPLETED|Overall Study||2
8225446|NCT02026687|20283699|P1|NOT COMPLETED|Overall Study||1
8225447|NCT02026687|20283698|P2|COMPLETED|Overall Study||38
8225448|NCT02026687|20283699|P1|COMPLETED|Overall Study||39
8225449|NCT02026687|20283698|P2|STARTED|Overall Study||40
8225450|NCT02026687|20283699|P1|STARTED|Overall Study||40
8225451|NCT02026453|20283712|P3|NOT COMPLETED|Overall Study||13
8225452|NCT02026453|20283713|P2|NOT COMPLETED|Overall Study||9
8225453|NCT02026453|20283714|P1|NOT COMPLETED|Overall Study||6
8225454|NCT02026453|20283712|P3|COMPLETED|Overall Study||89
8225455|NCT02026453|20283713|P2|COMPLETED|Overall Study||94
8225456|NCT02026453|20283714|P1|COMPLETED|Overall Study||95
8225457|NCT02026453|20283712|P3|STARTED|Overall Study||102
8225458|NCT02026453|20283713|P2|STARTED|Overall Study||103
8225459|NCT02026453|20283714|P1|STARTED|Overall Study||101
8225460|NCT02026297|20283727|P2|NOT COMPLETED|Overall Study||0
8225461|NCT02026297|20283728|P1|NOT COMPLETED|Overall Study||0
8225462|NCT02026297|20283727|P2|COMPLETED|Overall Study||13
8225463|NCT02026297|20283728|P1|COMPLETED|Overall Study||7
8225464|NCT02026297|20283727|P2|STARTED|Overall Study||13
8225465|NCT02026297|20283728|P1|STARTED|Overall Study||7
8225466|NCT02026258|20283740|P2|NOT COMPLETED|Recieved Allocated Intervention||2
8225467|NCT02026258|20283741|P1|NOT COMPLETED|Recieved Allocated Intervention||1
8225468|NCT02026258|20283740|P2|COMPLETED|Recieved Allocated Intervention||17
8225469|NCT02026258|20283741|P1|COMPLETED|Recieved Allocated Intervention||15
8225470|NCT02026258|20283740|P2|STARTED|Recieved Allocated Intervention||19
8225471|NCT02026258|20283741|P1|STARTED|Recieved Allocated Intervention||16
8225472|NCT02026258|20283740|P2|NOT COMPLETED|Randomized||2
8225473|NCT02026258|20283741|P1|NOT COMPLETED|Randomized||4
8225474|NCT02026258|20283740|P2|COMPLETED|Randomized||19
8225475|NCT02026258|20283741|P1|COMPLETED|Randomized||16
8225476|NCT02026258|20283740|P2|STARTED|Randomized||21
8225477|NCT02026258|20283741|P1|STARTED|Randomized||20
8225478|NCT02026206|20283755|P2|NOT COMPLETED|Overall Study||8
8225479|NCT02026206|20283756|P1|NOT COMPLETED|Overall Study||4
8225480|NCT02026206|20283755|P2|COMPLETED|Overall Study||36
8225481|NCT02026206|20283756|P1|COMPLETED|Overall Study||40
8225482|NCT02026206|20283755|P2|STARTED|Overall Study||44
8225483|NCT02026206|20283756|P1|STARTED|Overall Study||44
8225484|NCT02026193|20283766|P2|NOT COMPLETED|Overall Study||0
8225485|NCT02026193|20283767|P1|NOT COMPLETED|Overall Study||0
8225486|NCT02026193|20283766|P2|COMPLETED|Overall Study||8
8225487|NCT02026193|20283767|P1|COMPLETED|Overall Study||3
8225488|NCT02026193|20283766|P2|STARTED|Overall Study||8
8225489|NCT02026193|20283767|P1|STARTED|Overall Study||3
8225490|NCT02026141|20283775|P2|NOT COMPLETED|Overall Study||1
8225491|NCT02026141|20283776|P1|NOT COMPLETED|Overall Study||0
8225492|NCT02026141|20283775|P2|COMPLETED|Overall Study||19
8225493|NCT02026141|20283776|P1|COMPLETED|Overall Study||20
8225494|NCT02026141|20283775|P2|STARTED|Overall Study||20
8225495|NCT02026141|20283776|P1|STARTED|Overall Study||20
8225496|NCT02026063|20283784|P2|NOT COMPLETED|Overall Study||49
8225497|NCT02026063|20283785|P1|NOT COMPLETED|Overall Study||9
8225498|NCT02026063|20283784|P2|COMPLETED|Overall Study||53
8225499|NCT02026063|20283785|P1|COMPLETED|Overall Study||13
8225500|NCT02026063|20283784|P2|STARTED|Overall Study||102
8225501|NCT02026063|20283785|P1|STARTED|Overall Study||22
8225502|NCT02026011|20283797|P2|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2
8225503|NCT02026011|20283798|P1|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1
8225504|NCT02026011|20283797|P2|COMPLETED|Allocation 2 (Second Set of Medication)||35
8225505|NCT02026011|20283798|P1|COMPLETED|Allocation 2 (Second Set of Medication)||37
8225506|NCT02026011|20283797|P2|STARTED|Allocation 2 (Second Set of Medication)||37
8225507|NCT02026011|20283798|P1|STARTED|Allocation 2 (Second Set of Medication)||38
8225508|NCT02026011|20283797|P2|NOT COMPLETED|Allocation 1 (First Set of Medication)||2
8225509|NCT02026011|20283798|P1|NOT COMPLETED|Allocation 1 (First Set of Medication)||8
8225510|NCT02026011|20283797|P2|COMPLETED|Allocation 1 (First Set of Medication)||39
8225511|NCT02026011|20283798|P1|COMPLETED|Allocation 1 (First Set of Medication)||38
8225512|NCT02026011|20283797|P2|STARTED|Allocation 1 (First Set of Medication)||41
8225513|NCT02026011|20283798|P1|STARTED|Allocation 1 (First Set of Medication)||46
8225514|NCT02025907|20283824|P2|NOT COMPLETED|Overall Study||12
8225515|NCT02025907|20283825|P1|NOT COMPLETED|Overall Study||27
8225516|NCT02025907|20283824|P2|COMPLETED|Overall Study||96
8225517|NCT02025907|20283825|P1|COMPLETED|Overall Study||81
8225518|NCT02025907|20283824|P2|STARTED|Overall Study|Participant flow is presented for safety population.|108
8225519|NCT02025907|20283825|P1|STARTED|Overall Study|Participant flow is presented for safety population.|108
8225520|NCT02025829|20283841|P2|NOT COMPLETED|Overall Study||0
8225521|NCT02025829|20283842|P1|NOT COMPLETED|Overall Study||0
8225522|NCT02025829|20283841|P2|COMPLETED|Overall Study||11
8225523|NCT02025829|20283842|P1|COMPLETED|Overall Study||3
8225524|NCT02025829|20283841|P2|STARTED|Overall Study||11
8225525|NCT02025829|20283842|P1|STARTED|Overall Study||3
8225526|NCT02025751|20283853|P2|NOT COMPLETED|Overall Study||3
8225527|NCT02025751|20283854|P1|NOT COMPLETED|Overall Study||1
8225528|NCT02025751|20283853|P2|COMPLETED|Overall Study||24
8225529|NCT02025751|20283854|P1|COMPLETED|Overall Study||25
8225530|NCT02025751|20283853|P2|STARTED|Overall Study||27
8225531|NCT02025751|20283854|P1|STARTED|Overall Study||26
8225532|NCT02025725|20283862|P2|NOT COMPLETED|Overall Study||4
8225533|NCT02025725|20283863|P1|NOT COMPLETED|Overall Study||11
8225534|NCT02025725|20283862|P2|COMPLETED|Overall Study||99
8225535|NCT02025725|20283863|P1|COMPLETED|Overall Study||91
8225536|NCT02025725|20283862|P2|STARTED|Overall Study||103
8225537|NCT02025725|20283863|P1|STARTED|Overall Study||102
8225538|NCT02025647|20283871|P1|NOT COMPLETED|Overall Study||0
8225539|NCT02025647|20283871|P1|COMPLETED|Overall Study||139
8225540|NCT02025647|20283871|P1|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS
~36 lost to follow up"|76
8225541|NCT02025647|20283871|P1|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues
~3 administered wrong session"|117
8225542|NCT02025647|20283871|P1|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS
~15 technology issues or administered wrong session"|97
8225543|NCT02025647|20283871|P1|Session 1 (Narrative Module)|Overall Study||139
8225544|NCT02025647|20283871|P1|STARTED|Overall Study||139
8225545|NCT02025634|20283902|P2|NOT COMPLETED|Overall Study||0
8225546|NCT02025634|20283903|P1|NOT COMPLETED|Overall Study||0
8225547|NCT02025634|20283902|P2|COMPLETED|Overall Study||54
8225548|NCT02025634|20283903|P1|COMPLETED|Overall Study||65
8225549|NCT02025634|20283902|P2|STARTED|Overall Study||54
8225550|NCT02025634|20283903|P1|STARTED|Overall Study||65
8225551|NCT02025621|20283915|P2|NOT COMPLETED|Overall Study||19
8225552|NCT02025621|20283916|P1|NOT COMPLETED|Overall Study||14
8225553|NCT02025621|20283915|P2|COMPLETED|Overall Study||421
8225554|NCT02025621|20283916|P1|COMPLETED|Overall Study||428
8225555|NCT02025621|20283915|P2|STARTED|Overall Study||440
8225556|NCT02025621|20283916|P1|STARTED|Overall Study||442
8225557|NCT02025530|20283936|P2|NOT COMPLETED|Overall Study||1
8225558|NCT02025530|20283937|P1|NOT COMPLETED|Overall Study||5
8225559|NCT02025530|20283936|P2|COMPLETED|Overall Study||733
8225560|NCT02025530|20283937|P1|COMPLETED|Overall Study||291
8225561|NCT02025530|20283936|P2|STARTED|Overall Study||734
8225562|NCT02025530|20283937|P1|STARTED|Overall Study||296
8225563|NCT02025439|20283949|P2|NOT COMPLETED|Overall Study||0
8225564|NCT02025439|20283950|P1|NOT COMPLETED|Overall Study||0
8225565|NCT02025439|20283949|P2|COMPLETED|Overall Study||2
8225566|NCT02025439|20283950|P1|COMPLETED|Overall Study||2
8225567|NCT02025439|20283949|P2|STARTED|Overall Study||2
8225568|NCT02025439|20283950|P1|STARTED|Overall Study||2
8225569|NCT02025426|20283960|P2|NOT COMPLETED|Overall Study||0
8225570|NCT02025426|20283961|P1|NOT COMPLETED|Overall Study||0
8225571|NCT02025426|20283960|P2|COMPLETED|Overall Study||4
8225572|NCT02025426|20283961|P1|COMPLETED|Overall Study||9
8225573|NCT02025426|20283960|P2|STARTED|Overall Study||4
8225574|NCT02025426|20283961|P1|STARTED|Overall Study||9
8225575|NCT02025205|20283983|P2|NOT COMPLETED|Overall Study||3
8225576|NCT02025205|20283984|P1|NOT COMPLETED|Overall Study||3
8225577|NCT02025205|20283983|P2|COMPLETED|Overall Study||47
8225578|NCT02025205|20283984|P1|COMPLETED|Overall Study||40
8225579|NCT02025205|20283983|P2|STARTED|Overall Study||50
8225580|NCT02025205|20283984|P1|STARTED|Overall Study||43
8225581|NCT02025179|20284028|P3|NOT COMPLETED|Overall Study||1
8225582|NCT02025179|20284029|P2|NOT COMPLETED|Overall Study||0
8225583|NCT02025179|20284030|P1|NOT COMPLETED|Overall Study||0
8225584|NCT02025179|20284028|P3|COMPLETED|Overall Study||7
8225585|NCT02025179|20284029|P2|COMPLETED|Overall Study||9
8225586|NCT02025179|20284030|P1|COMPLETED|Overall Study||8
8225587|NCT02025179|20284028|P3|STARTED|Overall Study||8
8225588|NCT02025179|20284029|P2|STARTED|Overall Study||9
8225589|NCT02025179|20284030|P1|STARTED|Overall Study||8
8225590|NCT02025075|20284055|P2|NOT COMPLETED|Overall Study||2
8225591|NCT02025075|20284056|P1|NOT COMPLETED|Overall Study||0
8225592|NCT02025075|20284055|P2|COMPLETED|Overall Study||19
8225593|NCT02025075|20284056|P1|COMPLETED|Overall Study||16
8225594|NCT02025075|20284055|P2|STARTED|Overall Study||21
8225595|NCT02025075|20284056|P1|STARTED|Overall Study||16
8225596|NCT02024971|20284080|P1|NOT COMPLETED|Overall Study||36
8225597|NCT02024971|20284080|P1|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
8225598|NCT02024971|20284080|P1|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
8225599|NCT02024971|20284080|P1|STARTED|Overall Study||1103
8225600|NCT02024932|20284093|P6|NOT COMPLETED|Overall Study||0
8225601|NCT02024932|20284094|P5|NOT COMPLETED|Overall Study||2
8225602|NCT02024932|20284095|P4|NOT COMPLETED|Overall Study||2
8225603|NCT02024932|20284096|P3|NOT COMPLETED|Overall Study||0
8225604|NCT02024932|20284097|P2|NOT COMPLETED|Overall Study||3
8225605|NCT02024932|20284098|P1|NOT COMPLETED|Overall Study||2
8225606|NCT02024932|20284093|P6|COMPLETED|Overall Study||9
8225607|NCT02024932|20284094|P5|COMPLETED|Overall Study||16
8225608|NCT02024932|20284095|P4|COMPLETED|Overall Study||0
8225609|NCT02024932|20284096|P3|COMPLETED|Overall Study||2
8225610|NCT02024932|20284097|P2|COMPLETED|Overall Study||1
8225611|NCT02024932|20284098|P1|COMPLETED|Overall Study||0
8225612|NCT02024932|20284093|P6|Pharmacodynamic (PD) Analysis Set|Overall Study||9
8225613|NCT02024932|20284094|P5|Pharmacodynamic (PD) Analysis Set|Overall Study||18
8225614|NCT02024932|20284095|P4|Pharmacodynamic (PD) Analysis Set|Overall Study||2
8225615|NCT02024932|20284096|P3|Pharmacodynamic (PD) Analysis Set|Overall Study||2
8225616|NCT02024932|20284097|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
8225617|NCT02024932|20284098|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||2
8225618|NCT02024932|20284093|P6|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8225619|NCT02024932|20284094|P5|Pharmacokinetic (PK) Analysis Set|Overall Study||18
8225620|NCT02024932|20284095|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||2
8225621|NCT02024932|20284096|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8225622|NCT02024932|20284097|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||4
8225623|NCT02024932|20284098|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||2
8225624|NCT02024932|20284093|P6|Safety Analysis Set|Overall Study||9
8225625|NCT02024932|20284094|P5|Safety Analysis Set|Overall Study||18
8225626|NCT02024932|20284095|P4|Safety Analysis Set|Overall Study||2
8225627|NCT02024932|20284096|P3|Safety Analysis Set|Overall Study||2
8225628|NCT02024932|20284097|P2|Safety Analysis Set|Overall Study||4
8225629|NCT02024932|20284098|P1|Safety Analysis Set|Overall Study||2
8225630|NCT02024932|20284093|P6|STARTED|Overall Study||9
8225631|NCT02024932|20284094|P5|STARTED|Overall Study||18
8225632|NCT02024932|20284095|P4|STARTED|Overall Study||2
8225633|NCT02024932|20284096|P3|STARTED|Overall Study||2
8225634|NCT02024932|20284097|P2|STARTED|Overall Study||4
8225635|NCT02024932|20284098|P1|STARTED|Overall Study||2
8225636|NCT02024867|20284157|P2|NOT COMPLETED|Overall Study||7
8225637|NCT02024867|20284158|P1|NOT COMPLETED|Overall Study||9
8225638|NCT02024867|20284157|P2|COMPLETED|Overall Study||124
8225639|NCT02024867|20284158|P1|COMPLETED|Overall Study||125
8225640|NCT02024867|20284157|P2|STARTED|Overall Study||131
8225641|NCT02024867|20284158|P1|STARTED|Overall Study||134
8225642|NCT02024750|20284176|P2|NOT COMPLETED|Overall Study||1
8225643|NCT02024750|20284177|P1|NOT COMPLETED|Overall Study||2
8225644|NCT02024750|20284176|P2|COMPLETED|Overall Study||107
8225645|NCT02024750|20284177|P1|COMPLETED|Overall Study||104
8225646|NCT02024750|20284176|P2|STARTED|Overall Study||108
8225647|NCT02024750|20284177|P1|STARTED|Overall Study||106
8225648|NCT02024724|20284191|P2|NOT COMPLETED|Overall Study||0
8225649|NCT02024724|20284192|P1|NOT COMPLETED|Overall Study||1
8225650|NCT02024724|20284191|P2|COMPLETED|Overall Study||30
8225651|NCT02024724|20284192|P1|COMPLETED|Overall Study||29
8225652|NCT02024724|20284191|P2|STARTED|Overall Study||30
8225653|NCT02024724|20284192|P1|STARTED|Overall Study||30
8225654|NCT02024711|20284200|P2|NOT COMPLETED|Overall Study||4
8225655|NCT02024711|20284201|P1|NOT COMPLETED|Overall Study||1
8225656|NCT02024711|20284200|P2|COMPLETED|Overall Study||128
8225657|NCT02024711|20284201|P1|COMPLETED|Overall Study||129
8225658|NCT02024711|20284200|P2|STARTED|Overall Study||132
8225659|NCT02024711|20284201|P1|STARTED|Overall Study||130
8225660|NCT02024698|20284213|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8225661|NCT02024698|20284214|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8225662|NCT02024698|20284213|P2|COMPLETED|Second Intervention (7 Days)||26
8225663|NCT02024698|20284214|P1|COMPLETED|Second Intervention (7 Days)||16
8225664|NCT02024698|20284213|P2|Received Etafilcon A Twice|Second Intervention (7 Days)||0
8225665|NCT02024698|20284214|P1|Received Etafilcon A Twice|Second Intervention (7 Days)||1
8225666|NCT02024698|20284213|P2|STARTED|Second Intervention (7 Days)||26
8225667|NCT02024698|20284214|P1|STARTED|Second Intervention (7 Days)||16
8225668|NCT02024698|20284213|P2|NOT COMPLETED|First Intervention (7 Days)||1
8225669|NCT02024698|20284214|P1|NOT COMPLETED|First Intervention (7 Days)||0
8225670|NCT02024698|20284213|P2|COMPLETED|First Intervention (7 Days)||26
8225671|NCT02024698|20284214|P1|COMPLETED|First Intervention (7 Days)||16
8225672|NCT02024698|20284213|P2|STARTED|First Intervention (7 Days)||27
8225673|NCT02024698|20284214|P1|STARTED|First Intervention (7 Days)||16
8225674|NCT02024646|20284243|P3|NOT COMPLETED|Overall Study||28
8225675|NCT02024646|20284244|P2|NOT COMPLETED|Overall Study||25
8225676|NCT02024646|20284245|P1|NOT COMPLETED|Overall Study||32
8225677|NCT02024646|20284243|P3|COMPLETED|Overall Study||133
8225678|NCT02024646|20284244|P2|COMPLETED|Overall Study||135
8225679|NCT02024646|20284245|P1|COMPLETED|Overall Study||131
8225680|NCT02024646|20284243|P3|STARTED|Overall Study||161
8225681|NCT02024646|20284244|P2|STARTED|Overall Study||160
8225682|NCT02024646|20284245|P1|STARTED|Overall Study||163
8225683|NCT02024555|20284255|P2|NOT COMPLETED|Overall Study||2
8225684|NCT02024555|20284256|P1|NOT COMPLETED|Overall Study||6
8225685|NCT02024555|20284255|P2|COMPLETED|Overall Study||46
8225686|NCT02024555|20284256|P1|COMPLETED|Overall Study||43
8225687|NCT02024555|20284255|P2|STARTED|Overall Study||48
8225688|NCT02024555|20284256|P1|STARTED|Overall Study||49
8225689|NCT02024477|20284286|P2|NOT COMPLETED|Overall Study||0
8225690|NCT02024477|20284287|P1|NOT COMPLETED|Overall Study||0
8225691|NCT02024477|20284286|P2|COMPLETED|Overall Study||21
8225692|NCT02024477|20284287|P1|COMPLETED|Overall Study||21
8225693|NCT02024477|20284286|P2|STARTED|Overall Study||21
8225694|NCT02024477|20284287|P1|STARTED|Overall Study||21
8225695|NCT02024386|20284308|P3|NOT COMPLETED|Overall Study||0
8225696|NCT02024386|20284309|P2|NOT COMPLETED|Overall Study||0
8225697|NCT02024386|20284310|P1|NOT COMPLETED|Overall Study||0
8225698|NCT02024386|20284308|P3|COMPLETED|Overall Study||5
8225699|NCT02024386|20284309|P2|COMPLETED|Overall Study||11
8225700|NCT02024386|20284310|P1|COMPLETED|Overall Study||6
8225701|NCT02024386|20284308|P3|STARTED|Overall Study||5
8225702|NCT02024386|20284309|P2|STARTED|Overall Study||11
8225703|NCT02024386|20284310|P1|STARTED|Overall Study||6
8225704|NCT02024165|20284333|P1|NOT COMPLETED|Overall Study||0
8225705|NCT02024165|20284333|P1|COMPLETED|Overall Study||71
8225706|NCT02024165|20284333|P1|STARTED|Overall Study||71
8225713|NCT02023983|20284355|P2|NOT COMPLETED|Overall Study||0
8225714|NCT02023983|20284356|P1|NOT COMPLETED|Overall Study||0
8225715|NCT02023983|20284355|P2|COMPLETED|Overall Study||75
8225716|NCT02023983|20284356|P1|COMPLETED|Overall Study||76
8225717|NCT02023983|20284355|P2|STARTED|Overall Study||75
8225718|NCT02023983|20284356|P1|STARTED|Overall Study||76
8225719|NCT02023944|20284366|P2|NOT COMPLETED|Overall Study||1
8225720|NCT02023944|20284367|P1|NOT COMPLETED|Overall Study||0
8225721|NCT02023944|20284366|P2|COMPLETED|Overall Study||24
8225722|NCT02023944|20284367|P1|COMPLETED|Overall Study||25
8225723|NCT02023944|20284366|P2|STARTED|Overall Study||25
8225724|NCT02023944|20284367|P1|STARTED|Overall Study||25
8225725|NCT02023918|20284375|P1|NOT COMPLETED|Overall Study||0
8225726|NCT02023918|20284375|P1|COMPLETED|Overall Study||6
8225727|NCT02023918|20284375|P1|STARTED|Overall Study||6
8225728|NCT02023879|20284383|P3|NOT COMPLETED|Extension Open Label Treatment||5
8225729|NCT02023879|20284384|P2|NOT COMPLETED|Extension Open Label Treatment||17
8225730|NCT02023879|20284385|P1|NOT COMPLETED|Extension Open Label Treatment||5
8225731|NCT02023879|20284383|P3|COMPLETED|Extension Open Label Treatment||43
8225732|NCT02023879|20284384|P2|COMPLETED|Extension Open Label Treatment||89
8225733|NCT02023879|20284385|P1|COMPLETED|Extension Open Label Treatment||46
8225734|NCT02023879|20284383|P3|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
8225735|NCT02023879|20284384|P2|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
8225736|NCT02023879|20284385|P1|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
8225737|NCT02023879|20284383|P3|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
8225738|NCT02023879|20284384|P2|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
8225739|NCT02023879|20284385|P1|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
8225740|NCT02023879|20284383|P3|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
8225741|NCT02023879|20284384|P2|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
8225742|NCT02023879|20284385|P1|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
8225743|NCT02023879|20284383|P3|Treated|Period 1: 24-Week Double-blind Treatment||58
8225744|NCT02023879|20284384|P2|Treated|Period 1: 24-Week Double-blind Treatment||115
8225745|NCT02023879|20284385|P1|Treated|Period 1: 24-Week Double-blind Treatment||58
8225746|NCT02023879|20284383|P3|STARTED|Period 1: 24-Week Double-blind Treatment||59
8225747|NCT02023879|20284384|P2|STARTED|Period 1: 24-Week Double-blind Treatment||116
8225748|NCT02023879|20284385|P1|STARTED|Period 1: 24-Week Double-blind Treatment||58
8225749|NCT02023866|20284474|P1|NOT COMPLETED|Overall Study||6
8225750|NCT02023866|20284474|P1|COMPLETED|Overall Study||30
8225751|NCT02023866|20284474|P1|STARTED|Overall Study||36
8225752|NCT02023801|20284487|P1|NOT COMPLETED|Overall Study||0
8225753|NCT02023801|20284487|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
8225754|NCT02023801|20284487|P1|Treated|Overall Study|Treatment Completed|24
8225755|NCT02023801|20284487|P1|STARTED|Overall Study|Treatment Attempted|24
8225756|NCT02023697|20284496|P3|NOT COMPLETED|Long-term Follow-up Period||17
8225757|NCT02023697|20284497|P2|NOT COMPLETED|Long-term Follow-up Period||21
8225758|NCT02023697|20284498|P1|NOT COMPLETED|Long-term Follow-up Period||28
8225759|NCT02023697|20284496|P3|COMPLETED|Long-term Follow-up Period||0
8225760|NCT02023697|20284497|P2|COMPLETED|Long-term Follow-up Period||0
8225761|NCT02023697|20284498|P1|COMPLETED|Long-term Follow-up Period||0
8225762|NCT02023697|20284496|P3|STARTED|Long-term Follow-up Period||17
8225763|NCT02023697|20284497|P2|STARTED|Long-term Follow-up Period||21
8225764|NCT02023697|20284498|P1|STARTED|Long-term Follow-up Period||28
8225765|NCT02023697|20284496|P3|NOT COMPLETED|Active Follow-up Period||99
8225766|NCT02023697|20284497|P2|NOT COMPLETED|Active Follow-up Period||99
8225767|NCT02023697|20284498|P1|NOT COMPLETED|Active Follow-up Period||92
8225768|NCT02023697|20284496|P3|COMPLETED|Active Follow-up Period||17
8225769|NCT02023697|20284497|P2|COMPLETED|Active Follow-up Period||21
8225770|NCT02023697|20284498|P1|COMPLETED|Active Follow-up Period||28
8225771|NCT02023697|20284496|P3|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
8225772|NCT02023697|20284497|P2|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
8225773|NCT02023697|20284498|P1|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
8225774|NCT02023697|20284496|P3|NOT COMPLETED|Treatment Period||102
8225775|NCT02023697|20284497|P2|NOT COMPLETED|Treatment Period||63
8225776|NCT02023697|20284498|P1|NOT COMPLETED|Treatment Period||46
8225777|NCT02023697|20284496|P3|COMPLETED|Treatment Period||29
8225778|NCT02023697|20284497|P2|COMPLETED|Treatment Period||67
8225779|NCT02023697|20284498|P1|COMPLETED|Treatment Period||84
8225780|NCT02023697|20284496|P3|Received Treatment|Treatment Period||121
8225781|NCT02023697|20284497|P2|Received Treatment|Treatment Period||124
8225782|NCT02023697|20284498|P1|Received Treatment|Treatment Period||125
8225783|NCT02023697|20284496|P3|STARTED|Treatment Period||131
8225784|NCT02023697|20284497|P2|STARTED|Treatment Period||130
8225785|NCT02023697|20284498|P1|STARTED|Treatment Period||130
8225786|NCT02023515|20284600|P2|NOT COMPLETED|Overall Study||3
8225787|NCT02023515|20284601|P1|NOT COMPLETED|Overall Study||1
8225788|NCT02023515|20284600|P2|COMPLETED|Overall Study||22
8225789|NCT02023515|20284601|P1|COMPLETED|Overall Study||23
8225790|NCT02023515|20284600|P2|STARTED|Overall Study||25
8225791|NCT02023515|20284601|P1|STARTED|Overall Study||24
8225798|NCT02023268|20284622|P2|NOT COMPLETED|Overall Study||4
8225799|NCT02023268|20284623|P1|NOT COMPLETED|Overall Study||0
8225800|NCT02023268|20284622|P2|COMPLETED|Overall Study||49
8225801|NCT02023268|20284623|P1|COMPLETED|Overall Study||52
8225802|NCT02023268|20284622|P2|STARTED|Overall Study||53
8225803|NCT02023268|20284623|P1|STARTED|Overall Study||52
8225804|NCT02023242|20284631|P2|NOT COMPLETED|Overall Study||2
8225805|NCT02023242|20284632|P1|NOT COMPLETED|Overall Study||3
8225806|NCT02023242|20284631|P2|COMPLETED|Overall Study||75
8225807|NCT02023242|20284632|P1|COMPLETED|Overall Study||72
8225808|NCT02023242|20284631|P2|STARTED|Overall Study||77
8225809|NCT02023242|20284632|P1|STARTED|Overall Study||75
8225810|NCT02023151|20284646|P1|NOT COMPLETED|Overall Study||4
8225811|NCT02023151|20284646|P1|COMPLETED|Overall Study||13
8225812|NCT02023151|20284646|P1|STARTED|Overall Study||17
8225813|NCT02023125|20284653|P3|NOT COMPLETED|Period 2||0
8225814|NCT02023125|20284654|P2|NOT COMPLETED|Period 2||0
8225815|NCT02023125|20284655|P1|NOT COMPLETED|Period 2||0
8225816|NCT02023125|20284653|P3|COMPLETED|Period 2||24
8225817|NCT02023125|20284654|P2|COMPLETED|Period 2||9
8225818|NCT02023125|20284655|P1|COMPLETED|Period 2||9
8225819|NCT02023125|20284653|P3|STARTED|Period 2||24
8225820|NCT02023125|20284654|P2|STARTED|Period 2||9
8225821|NCT02023125|20284655|P1|STARTED|Period 2||9
8225822|NCT02023125|20284653|P3|NOT COMPLETED|Washout Period||0
8225823|NCT02023125|20284654|P2|NOT COMPLETED|Washout Period||0
8225824|NCT02023125|20284655|P1|NOT COMPLETED|Washout Period||0
8225825|NCT02023125|20284653|P3|COMPLETED|Washout Period||24
8225826|NCT02023125|20284654|P2|COMPLETED|Washout Period||9
8225827|NCT02023125|20284655|P1|COMPLETED|Washout Period||9
8225828|NCT02023125|20284653|P3|STARTED|Washout Period||24
8225829|NCT02023125|20284654|P2|STARTED|Washout Period||9
8225830|NCT02023125|20284655|P1|STARTED|Washout Period||9
8225831|NCT02023125|20284653|P3|NOT COMPLETED|Period 1||0
8225832|NCT02023125|20284654|P2|NOT COMPLETED|Period 1||0
8225833|NCT02023125|20284655|P1|NOT COMPLETED|Period 1||0
8225834|NCT02023125|20284653|P3|COMPLETED|Period 1||24
8225835|NCT02023125|20284654|P2|COMPLETED|Period 1||9
8225836|NCT02023125|20284655|P1|COMPLETED|Period 1||9
8225837|NCT02023125|20284653|P3|STARTED|Period 1||24
8225838|NCT02023125|20284654|P2|STARTED|Period 1||9
8225839|NCT02023125|20284655|P1|STARTED|Period 1||9
8225846|NCT02023099|20284738|P3|NOT COMPLETED|Overall Study||3
8225847|NCT02023099|20284739|P2|NOT COMPLETED|Overall Study||0
8225848|NCT02023099|20284740|P1|NOT COMPLETED|Overall Study||3
8225849|NCT02023099|20284738|P3|COMPLETED|Overall Study||39
8225850|NCT02023099|20284739|P2|COMPLETED|Overall Study||106
8225851|NCT02023099|20284740|P1|COMPLETED|Overall Study||212
8225852|NCT02023099|20284738|P3|STARTED|Overall Study||42
8225853|NCT02023099|20284739|P2|STARTED|Overall Study||106
8225854|NCT02023099|20284740|P1|STARTED|Overall Study||215
8225855|NCT02022826|20284756|P1|NOT COMPLETED|Overall Study||28
8225856|NCT02022826|20284756|P1|COMPLETED|Overall Study||139
8225857|NCT02022826|20284756|P1|STARTED|Overall Study||167
8225858|NCT02022748|20284763|P3|NOT COMPLETED|Overall Study||0
8225859|NCT02022748|20284764|P2|NOT COMPLETED|Overall Study||2
8225860|NCT02022748|20284765|P1|NOT COMPLETED|Overall Study||1
8225861|NCT02022748|20284763|P3|COMPLETED|Overall Study||13
8225862|NCT02022748|20284764|P2|COMPLETED|Overall Study||4
8225863|NCT02022748|20284765|P1|COMPLETED|Overall Study||7
8225864|NCT02022748|20284763|P3|Subjects Who Completed Treatment|Overall Study||13
8225865|NCT02022748|20284764|P2|Subjects Who Completed Treatment|Overall Study||4
8225866|NCT02022748|20284765|P1|Subjects Who Completed Treatment|Overall Study||7
8225867|NCT02022748|20284763|P3|Subject Who Started Treatment|Overall Study||13
8225868|NCT02022748|20284764|P2|Subject Who Started Treatment|Overall Study||6
8225869|NCT02022748|20284765|P1|Subject Who Started Treatment|Overall Study||8
8225870|NCT02022748|20284763|P3|STARTED|Overall Study||13
8225871|NCT02022748|20284764|P2|STARTED|Overall Study||6
8225872|NCT02022748|20284765|P1|STARTED|Overall Study||8
8225873|NCT02022670|20284791|P3|NOT COMPLETED|Overall Study||1
8225874|NCT02022670|20284792|P2|NOT COMPLETED|Overall Study||0
8225875|NCT02022670|20284793|P1|NOT COMPLETED|Overall Study||1
8225876|NCT02022670|20284791|P3|COMPLETED|Overall Study||11
8225877|NCT02022670|20284792|P2|COMPLETED|Overall Study||10
8225878|NCT02022670|20284793|P1|COMPLETED|Overall Study||10
8225879|NCT02022670|20284791|P3|STARTED|Overall Study||12
8225880|NCT02022670|20284792|P2|STARTED|Overall Study||10
8225881|NCT02022670|20284793|P1|STARTED|Overall Study||11
8225882|NCT02022657|20284807|P6|NOT COMPLETED|Overall Study||1
8225883|NCT02022657|20284808|P5|NOT COMPLETED|Overall Study||0
8225884|NCT02022657|20284809|P4|NOT COMPLETED|Overall Study||0
8225885|NCT02022657|20284810|P3|NOT COMPLETED|Overall Study||1
8225886|NCT02022657|20284811|P2|NOT COMPLETED|Overall Study||0
8225887|NCT02022657|20284812|P1|NOT COMPLETED|Overall Study||2
8225888|NCT02022657|20284807|P6|COMPLETED|Overall Study||8
8225889|NCT02022657|20284808|P5|COMPLETED|Overall Study||8
8225890|NCT02022657|20284809|P4|COMPLETED|Overall Study||8
8225891|NCT02022657|20284810|P3|COMPLETED|Overall Study||8
8225892|NCT02022657|20284811|P2|COMPLETED|Overall Study||8
8225893|NCT02022657|20284812|P1|COMPLETED|Overall Study||8
8225894|NCT02022657|20284807|P6|STARTED|Overall Study||9
8225895|NCT02022657|20284808|P5|STARTED|Overall Study||8
8225896|NCT02022657|20284809|P4|STARTED|Overall Study||8
8225897|NCT02022657|20284810|P3|STARTED|Overall Study||9
8225898|NCT02022657|20284811|P2|STARTED|Overall Study||8
8225899|NCT02022657|20284812|P1|STARTED|Overall Study||10
8225906|NCT02022085|20284827|P1|NOT COMPLETED|Overall Study||1
8225907|NCT02022085|20284827|P1|COMPLETED|Overall Study||53
8225908|NCT02022085|20284827|P1|STARTED|Overall Study||54
8225909|NCT02022020|20284853|P1|NOT COMPLETED|Overall Study||0
8225910|NCT02022020|20284853|P1|COMPLETED|Overall Study||220
8225911|NCT02022020|20284853|P1|STARTED|Overall Study||220
8225912|NCT02022007|20284862|P3|NOT COMPLETED|Overall Study||2
8225913|NCT02022007|20284863|P2|NOT COMPLETED|Overall Study||1
8225914|NCT02022007|20284864|P1|NOT COMPLETED|Overall Study||1
8225915|NCT02022007|20284862|P3|COMPLETED|Overall Study||11
8225916|NCT02022007|20284863|P2|COMPLETED|Overall Study||11
8225917|NCT02022007|20284864|P1|COMPLETED|Overall Study||12
8225918|NCT02022007|20284862|P3|STARTED|Overall Study||13
8225919|NCT02022007|20284863|P2|STARTED|Overall Study||12
8225920|NCT02022007|20284864|P1|STARTED|Overall Study||13
8225921|NCT02021942|20284905|P1|NOT COMPLETED|Overall Study||0
8225922|NCT02021942|20284905|P1|COMPLETED|Overall Study||16
8225923|NCT02021942|20284905|P1|STARTED|Overall Study||16
8225924|NCT02021929|20284917|P2|NOT COMPLETED|Overall Study||1
8225925|NCT02021929|20284918|P1|NOT COMPLETED|Overall Study||2
8225926|NCT02021929|20284917|P2|COMPLETED|Overall Study||11
8225927|NCT02021929|20284918|P1|COMPLETED|Overall Study||14
8225928|NCT02021929|20284917|P2|STARTED|Overall Study||12
8225929|NCT02021929|20284918|P1|STARTED|Overall Study||16
8225930|NCT02021812|20284928|P1|NOT COMPLETED|Overall Study||21
8225931|NCT02021812|20284928|P1|COMPLETED|Overall Study||10
8225932|NCT02021812|20284928|P1|STARTED|Overall Study||31
8225933|NCT02021669|20284938|P2|NOT COMPLETED|Overall Study||3
8225934|NCT02021669|20284939|P1|NOT COMPLETED|Overall Study||7
8225935|NCT02021669|20284938|P2|COMPLETED|Overall Study||70
8225936|NCT02021669|20284939|P1|COMPLETED|Overall Study||64
8225937|NCT02021669|20284938|P2|STARTED|Overall Study||73
8225938|NCT02021669|20284939|P1|STARTED|Overall Study||71
8225939|NCT02021656|20284947|P1|NOT COMPLETED|Overall Study||6
8225940|NCT02021656|20284947|P1|COMPLETED|Overall Study||378
8225941|NCT02021656|20284947|P1|STARTED|Overall Study||384
8225942|NCT02021643|20284967|P4|NOT COMPLETED|Overall Study||12
8225943|NCT02021643|20284968|P3|NOT COMPLETED|Overall Study||0
8225944|NCT02021643|20284969|P2|NOT COMPLETED|Overall Study||10
8225945|NCT02021643|20284970|P1|NOT COMPLETED|Overall Study||9
8225946|NCT02021643|20284967|P4|COMPLETED|Overall Study||218
8225947|NCT02021643|20284968|P3|COMPLETED|Overall Study||11
8225948|NCT02021643|20284969|P2|COMPLETED|Overall Study||280
8225949|NCT02021643|20284970|P1|COMPLETED|Overall Study||147
8225950|NCT02021643|20284967|P4|STARTED|Overall Study||230
8225951|NCT02021643|20284968|P3|STARTED|Overall Study||11
8225952|NCT02021643|20284969|P2|STARTED|Overall Study||290
8225953|NCT02021643|20284970|P1|STARTED|Overall Study||156
8225954|NCT02021565|20285012|P2|NOT COMPLETED|3-month Follow-up||2
8225955|NCT02021565|20285013|P1|NOT COMPLETED|3-month Follow-up||10
8225956|NCT02021565|20285012|P2|COMPLETED|3-month Follow-up||34
8225957|NCT02021565|20285013|P1|COMPLETED|3-month Follow-up||50
8225958|NCT02021565|20285012|P2|Care Recipients|3-month Follow-up||18
8225959|NCT02021565|20285013|P1|Care Recipients|3-month Follow-up||30
8225960|NCT02021565|20285012|P2|Caregivers|3-month Follow-up||18
8225961|NCT02021565|20285013|P1|Caregivers|3-month Follow-up||30
8225962|NCT02021565|20285012|P2|STARTED|3-month Follow-up||36
8225963|NCT02021565|20285013|P1|STARTED|3-month Follow-up||60
8225964|NCT02021565|20285012|P2|NOT COMPLETED|Baseline Through Intervention||18
8225965|NCT02021565|20285013|P1|NOT COMPLETED|Baseline Through Intervention||12
8225966|NCT02021565|20285012|P2|COMPLETED|Baseline Through Intervention||36
8225967|NCT02021565|20285013|P1|COMPLETED|Baseline Through Intervention||60
8225968|NCT02021565|20285012|P2|Care Recipients|Baseline Through Intervention||27
8225969|NCT02021565|20285013|P1|Care Recipients|Baseline Through Intervention||36
8225970|NCT02021565|20285012|P2|Caregivers|Baseline Through Intervention||27
8225971|NCT02021565|20285013|P1|Caregivers|Baseline Through Intervention||36
8225972|NCT02021565|20285012|P2|STARTED|Baseline Through Intervention||54
8225973|NCT02021565|20285013|P1|STARTED|Baseline Through Intervention||72
8225974|NCT02021461|20285025|P1|NOT COMPLETED|Overall Study||0
8225975|NCT02021461|20285025|P1|COMPLETED|Overall Study||38
8225976|NCT02021461|20285025|P1|STARTED|Overall Study||38
8225977|NCT02021331|20285033|P2|NOT COMPLETED|Overall Study||2
8225978|NCT02021331|20285034|P1|NOT COMPLETED|Overall Study||0
8225979|NCT02021331|20285033|P2|COMPLETED|Overall Study||1
8225980|NCT02021331|20285034|P1|COMPLETED|Overall Study||2
8225981|NCT02021331|20285033|P2|STARTED|Overall Study||3
8225982|NCT02021331|20285034|P1|STARTED|Overall Study||2
8225983|NCT02021292|20285046|P2|NOT COMPLETED|Overall Study||3
8225984|NCT02021292|20285047|P1|NOT COMPLETED|Overall Study||0
8225985|NCT02021292|20285046|P2|COMPLETED|Overall Study||37
8225986|NCT02021292|20285047|P1|COMPLETED|Overall Study||40
8225987|NCT02021292|20285046|P2|STARTED|Overall Study||40
8225988|NCT02021292|20285047|P1|STARTED|Overall Study||40
8225989|NCT02021071|20285069|P2|NOT COMPLETED|Overall Study||0
8225990|NCT02021071|20285070|P1|NOT COMPLETED|Overall Study||0
8225991|NCT02021071|20285069|P2|COMPLETED|Overall Study||12
8225992|NCT02021071|20285070|P1|COMPLETED|Overall Study||12
8225993|NCT02021071|20285069|P2|STARTED|Overall Study||12
8225994|NCT02021071|20285070|P1|STARTED|Overall Study||12
8225995|NCT02020941|20285077|P1|NOT COMPLETED|Overall Study||8
8225996|NCT02020941|20285077|P1|COMPLETED|Overall Study||2
8225997|NCT02020941|20285077|P1|STARTED|Overall Study||10
8225998|NCT02020889|20285088|P2|NOT COMPLETED|Overall Study||3
8225999|NCT02020889|20285089|P1|NOT COMPLETED|Overall Study||7
8226000|NCT02020889|20285088|P2|COMPLETED|Overall Study||65
8226001|NCT02020889|20285089|P1|COMPLETED|Overall Study||61
8226002|NCT02020889|20285088|P2|STARTED|Overall Study||68
8226003|NCT02020889|20285089|P1|STARTED|Overall Study||68
8226004|NCT02020863|20285143|P1|NOT COMPLETED|Overall Study||5
8226005|NCT02020863|20285143|P1|COMPLETED|Overall Study||35
8226006|NCT02020863|20285143|P1|STARTED|Overall Study||40
8226007|NCT02020837|20285147|P1|NOT COMPLETED|Overall Study||0
8226008|NCT02020837|20285147|P1|COMPLETED|Overall Study||2
8226009|NCT02020837|20285147|P1|STARTED|Overall Study||2
8226010|NCT02020785|20285153|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8226011|NCT02020785|20285154|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8226012|NCT02020785|20285153|P2|COMPLETED|Second Intervention (3 Weeks)||16
8226013|NCT02020785|20285154|P1|COMPLETED|Second Intervention (3 Weeks)||15
8226014|NCT02020785|20285153|P2|STARTED|Second Intervention (3 Weeks)||16
8226015|NCT02020785|20285154|P1|STARTED|Second Intervention (3 Weeks)||15
8226016|NCT02020785|20285153|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
8226017|NCT02020785|20285154|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
8226018|NCT02020785|20285153|P2|COMPLETED|First Intervention (3 Weeks)||16
8226019|NCT02020785|20285154|P1|COMPLETED|First Intervention (3 Weeks)||15
8226020|NCT02020785|20285153|P2|STARTED|First Intervention (3 Weeks)||16
8226021|NCT02020785|20285154|P1|STARTED|First Intervention (3 Weeks)||15
8226022|NCT02020616|20285173|P7|NOT COMPLETED|Overall Study||4
8226023|NCT02020616|20285174|P6|NOT COMPLETED|Overall Study||5
8226024|NCT02020616|20285175|P5|NOT COMPLETED|Overall Study||2
8226025|NCT02020616|20285176|P4|NOT COMPLETED|Overall Study||2
8226026|NCT02020616|20285177|P3|NOT COMPLETED|Overall Study||2
8226027|NCT02020616|20285178|P2|NOT COMPLETED|Overall Study||1
8226028|NCT02020616|20285179|P1|NOT COMPLETED|Overall Study||0
8226029|NCT02020616|20285173|P7|COMPLETED|Overall Study||6
8226030|NCT02020616|20285174|P6|COMPLETED|Overall Study||3
8226031|NCT02020616|20285175|P5|COMPLETED|Overall Study||6
8226032|NCT02020616|20285176|P4|COMPLETED|Overall Study||6
8226033|NCT02020616|20285177|P3|COMPLETED|Overall Study||6
8226034|NCT02020616|20285178|P2|COMPLETED|Overall Study||7
8226035|NCT02020616|20285179|P1|COMPLETED|Overall Study||10
8226036|NCT02020616|20285173|P7|Received at Least One Dose of Study Drug|Overall Study||10
8226037|NCT02020616|20285174|P6|Received at Least One Dose of Study Drug|Overall Study||8
8226038|NCT02020616|20285175|P5|Received at Least One Dose of Study Drug|Overall Study||8
8226039|NCT02020616|20285176|P4|Received at Least One Dose of Study Drug|Overall Study||7
8226040|NCT02020616|20285177|P3|Received at Least One Dose of Study Drug|Overall Study||8
8226041|NCT02020616|20285178|P2|Received at Least One Dose of Study Drug|Overall Study||8
8226042|NCT02020616|20285179|P1|Received at Least One Dose of Study Drug|Overall Study||10
8226043|NCT02020616|20285173|P7|STARTED|Overall Study||10
8226044|NCT02020616|20285174|P6|STARTED|Overall Study||8
8226045|NCT02020616|20285175|P5|STARTED|Overall Study||8
8226046|NCT02020616|20285176|P4|STARTED|Overall Study||8
8226047|NCT02020616|20285177|P3|STARTED|Overall Study||8
8226048|NCT02020616|20285178|P2|STARTED|Overall Study||8
8226049|NCT02020616|20285179|P1|STARTED|Overall Study||10
8226050|NCT02020577|20285272|P2|NOT COMPLETED|Overall Study||55
8226051|NCT02020577|20285273|P1|NOT COMPLETED|Overall Study||3
8226052|NCT02020577|20285272|P2|COMPLETED|Overall Study||0
8226053|NCT02020577|20285273|P1|COMPLETED|Overall Study||0
8226054|NCT02020577|20285272|P2|STARTED|Overall Study||55
8226055|NCT02020577|20285273|P1|STARTED|Overall Study||3
8226056|NCT02020512|20285300|P1|NOT COMPLETED|Overall Study||8
8226057|NCT02020512|20285300|P1|COMPLETED|Overall Study||79
8226058|NCT02020512|20285300|P1|STARTED|Overall Study||87
8226059|NCT02020408|20285304|P1|NOT COMPLETED|Overall Study||3
8226060|NCT02020408|20285304|P1|COMPLETED|Overall Study||85
8226061|NCT02020408|20285304|P1|STARTED|Overall Study||88
8226062|NCT02020369|20285316|P2|NOT COMPLETED|Overall Study||2
8226063|NCT02020369|20285317|P1|NOT COMPLETED|Overall Study||3
8226064|NCT02020369|20285316|P2|COMPLETED|Overall Study||11
8226065|NCT02020369|20285317|P1|COMPLETED|Overall Study||11
8226066|NCT02020369|20285316|P2|STARTED|Overall Study||13
8226067|NCT02020369|20285317|P1|STARTED|Overall Study||14
8226068|NCT02020304|20285333|P2|NOT COMPLETED|Overall Study||2
8226069|NCT02020304|20285334|P1|NOT COMPLETED|Overall Study||3
8226070|NCT02020304|20285333|P2|COMPLETED|Overall Study||26
8226071|NCT02020304|20285334|P1|COMPLETED|Overall Study||27
8226072|NCT02020304|20285333|P2|STARTED|Overall Study||28
8226073|NCT02020304|20285334|P1|STARTED|Overall Study||30
8226074|NCT02020278|20285348|P1|NOT COMPLETED|Optional Tolvaptan Treatment Component||0
8226075|NCT02020278|20285348|P1|COMPLETED|Optional Tolvaptan Treatment Component||0
8226076|NCT02020278|20285348|P1|STARTED|Optional Tolvaptan Treatment Component||0
8226077|NCT02020278|20285348|P1|NOT COMPLETED|Core Safety Follow-up Component||0
8226078|NCT02020278|20285348|P1|COMPLETED|Core Safety Follow-up Component||3
8226079|NCT02020278|20285348|P1|STARTED|Core Safety Follow-up Component||3
8226080|NCT02020135|20285367|P1|NOT COMPLETED|Overall Study||9
8226081|NCT02020135|20285367|P1|COMPLETED|Overall Study||0
8226082|NCT02020135|20285367|P1|STARTED|Overall Study||9
8226083|NCT02020031|20285379|P2|NOT COMPLETED|Overall Study||1
8226084|NCT02020031|20285380|P1|NOT COMPLETED|Overall Study||1
8226085|NCT02020031|20285379|P2|COMPLETED|Overall Study||10
8226086|NCT02020031|20285380|P1|COMPLETED|Overall Study||10
8226087|NCT02020031|20285379|P2|STARTED|Overall Study||11
8226088|NCT02020031|20285380|P1|STARTED|Overall Study||11
8226089|NCT02020018|20285390|P2|NOT COMPLETED|Overall Study||0
8226090|NCT02020018|20285391|P1|NOT COMPLETED|Overall Study||0
8226091|NCT02020018|20285390|P2|COMPLETED|Overall Study||1597
8226092|NCT02020018|20285391|P1|COMPLETED|Overall Study||272
8226093|NCT02020018|20285390|P2|STARTED|Overall Study||1597
8226094|NCT02020018|20285391|P1|STARTED|Overall Study||272
8226095|NCT02019979|20285401|P1|NOT COMPLETED|Overall Study||14
8226096|NCT02019979|20285401|P1|COMPLETED|Overall Study||0
8226097|NCT02019979|20285401|P1|STARTED|Overall Study||14
8226098|NCT02019940|20285407|P1|NOT COMPLETED|Overall Study||10
8226099|NCT02019940|20285407|P1|COMPLETED|Overall Study||8
8226100|NCT02019940|20285407|P1|STARTED|Overall Study||18
8226101|NCT02019927|20285417|P6|NOT COMPLETED|Overall Study||1
8226102|NCT02019927|20285418|P5|NOT COMPLETED|Overall Study||3
8226103|NCT02019927|20285419|P4|NOT COMPLETED|Overall Study||2
8226104|NCT02019927|20285420|P3|NOT COMPLETED|Overall Study||1
8226105|NCT02019927|20285421|P2|NOT COMPLETED|Overall Study||4
8226106|NCT02019927|20285422|P1|NOT COMPLETED|Overall Study||2
8226107|NCT02019927|20285417|P6|COMPLETED|Overall Study||3
8226108|NCT02019927|20285418|P5|COMPLETED|Overall Study||7
8226109|NCT02019927|20285419|P4|COMPLETED|Overall Study||3
8226110|NCT02019927|20285420|P3|COMPLETED|Overall Study||8
8226111|NCT02019927|20285421|P2|COMPLETED|Overall Study||19
8226112|NCT02019927|20285422|P1|COMPLETED|Overall Study||44
8226113|NCT02019927|20285417|P6|STARTED|Overall Study||4
8226114|NCT02019927|20285418|P5|STARTED|Overall Study||10
8226115|NCT02019927|20285419|P4|STARTED|Overall Study||5
8226116|NCT02019927|20285420|P3|STARTED|Overall Study||9
8226117|NCT02019927|20285421|P2|STARTED|Overall Study||23
8226118|NCT02019927|20285422|P1|STARTED|Overall Study||46
8226119|NCT02019758|20285492|P2|NOT COMPLETED|Overall Study||9
8226120|NCT02019758|20285493|P1|NOT COMPLETED|Overall Study||9
8226121|NCT02019758|20285492|P2|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55
8226122|NCT02019758|20285493|P1|COMPLETED|Overall Study||56
8226123|NCT02019758|20285492|P2|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
8226124|NCT02019758|20285493|P1|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
8226125|NCT02019758|20285492|P2|Did Not Receive Intervention|Overall Study||1
8226126|NCT02019758|20285493|P1|Did Not Receive Intervention|Overall Study||1
8226127|NCT02019758|20285492|P2|Received Intervention|Overall Study||63
8226128|NCT02019758|20285493|P1|Received Intervention|Overall Study||64
8226129|NCT02019758|20285492|P2|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64
8226130|NCT02019758|20285493|P1|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65
8226131|NCT02019719|20285522|P5|NOT COMPLETED|Overall Study||2
8226132|NCT02019719|20285523|P4|NOT COMPLETED|Overall Study||2
8226133|NCT02019719|20285524|P3|NOT COMPLETED|Overall Study||0
8226134|NCT02019719|20285525|P2|NOT COMPLETED|Overall Study||1
8226135|NCT02019719|20285526|P1|NOT COMPLETED|Overall Study||6
8226136|NCT02019719|20285522|P5|COMPLETED|Overall Study||18
8226137|NCT02019719|20285523|P4|COMPLETED|Overall Study||17
8226138|NCT02019719|20285524|P3|COMPLETED|Overall Study||20
8226139|NCT02019719|20285525|P2|COMPLETED|Overall Study||18
8226140|NCT02019719|20285526|P1|COMPLETED|Overall Study||13
8226141|NCT02019719|20285522|P5|STARTED|Overall Study||20
8226142|NCT02019719|20285523|P4|STARTED|Overall Study||19
8226143|NCT02019719|20285524|P3|STARTED|Overall Study||20
8226144|NCT02019719|20285525|P2|STARTED|Overall Study||19
8226145|NCT02019719|20285526|P1|STARTED|Overall Study||19
8226146|NCT02019667|20285623|P2|NOT COMPLETED|Washout Period (9 Weeks)||0
8226147|NCT02019667|20285624|P1|NOT COMPLETED|Washout Period (9 Weeks)||0
8226148|NCT02019667|20285623|P2|COMPLETED|Washout Period (9 Weeks)||6
8226149|NCT02019667|20285624|P1|COMPLETED|Washout Period (9 Weeks)||10
8226150|NCT02019667|20285623|P2|STARTED|Washout Period (9 Weeks)||6
8226151|NCT02019667|20285624|P1|STARTED|Washout Period (9 Weeks)||10
8226152|NCT02019667|20285623|P2|NOT COMPLETED|2nd Intervention (6 Months)||2
8226153|NCT02019667|20285624|P1|NOT COMPLETED|2nd Intervention (6 Months)||0
8226154|NCT02019667|20285623|P2|COMPLETED|2nd Intervention (6 Months)||6
8226155|NCT02019667|20285624|P1|COMPLETED|2nd Intervention (6 Months)||10
8226156|NCT02019667|20285623|P2|STARTED|2nd Intervention (6 Months)||8
8226157|NCT02019667|20285624|P1|STARTED|2nd Intervention (6 Months)||10
8226158|NCT02019667|20285623|P2|NOT COMPLETED|Washout Period (9 Weeks)||0
8226159|NCT02019667|20285624|P1|NOT COMPLETED|Washout Period (9 Weeks)||0
8226160|NCT02019667|20285623|P2|COMPLETED|Washout Period (9 Weeks)||8
8226161|NCT02019667|20285624|P1|COMPLETED|Washout Period (9 Weeks)||10
8226162|NCT02019667|20285623|P2|STARTED|Washout Period (9 Weeks)||8
8226163|NCT02019667|20285624|P1|STARTED|Washout Period (9 Weeks)||10
8226164|NCT02019667|20285623|P2|NOT COMPLETED|First Intervention (6 Months)||1
8226165|NCT02019667|20285624|P1|NOT COMPLETED|First Intervention (6 Months)||0
8226166|NCT02019667|20285623|P2|COMPLETED|First Intervention (6 Months)||8
8226167|NCT02019667|20285624|P1|COMPLETED|First Intervention (6 Months)||10
8226168|NCT02019667|20285623|P2|STARTED|First Intervention (6 Months)||9
8226169|NCT02019667|20285624|P1|STARTED|First Intervention (6 Months)||10
8226170|NCT02019602|20285644|P2|NOT COMPLETED|Sampling Period||0
8226171|NCT02019602|20285645|P1|NOT COMPLETED|Sampling Period||0
8226172|NCT02019602|20285644|P2|COMPLETED|Sampling Period||16
8226173|NCT02019602|20285645|P1|COMPLETED|Sampling Period||16
8226174|NCT02019602|20285644|P2|STARTED|Sampling Period||16
8226175|NCT02019602|20285645|P1|STARTED|Sampling Period||16
8226176|NCT02019602|20285644|P2|NOT COMPLETED|Screening Period||0
8226177|NCT02019602|20285645|P1|NOT COMPLETED|Screening Period||5
8226178|NCT02019602|20285644|P2|COMPLETED|Screening Period||16
8226179|NCT02019602|20285645|P1|COMPLETED|Screening Period||16
8226180|NCT02019602|20285644|P2|STARTED|Screening Period||16
8226181|NCT02019602|20285645|P1|STARTED|Screening Period||21
8226182|NCT02019563|20285657|P2|NOT COMPLETED|Overall Study||0
8226183|NCT02019563|20285658|P1|NOT COMPLETED|Overall Study||0
8226184|NCT02019563|20285657|P2|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
8226185|NCT02019563|20285658|P1|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
8226186|NCT02019563|20285657|P2|STARTED|Overall Study|72 incisors were treated in the RCT group|30
8226187|NCT02019563|20285658|P1|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
8226188|NCT02019550|20285674|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8226189|NCT02019550|20285675|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8226190|NCT02019550|20285674|P2|COMPLETED|Treatment Period 2 (4 Weeks)||50
8226191|NCT02019550|20285675|P1|COMPLETED|Treatment Period 2 (4 Weeks)||46
8226192|NCT02019550|20285674|P2|STARTED|Treatment Period 2 (4 Weeks)||50
8226193|NCT02019550|20285675|P1|STARTED|Treatment Period 2 (4 Weeks)||46
8226194|NCT02019550|20285674|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
8226195|NCT02019550|20285675|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8226196|NCT02019550|20285674|P2|COMPLETED|Treatment Period 1 (4 Weeks)||50
8226197|NCT02019550|20285675|P1|COMPLETED|Treatment Period 1 (4 Weeks)||46
8226198|NCT02019550|20285674|P2|STARTED|Treatment Period 1 (4 Weeks)||51
8226199|NCT02019550|20285675|P1|STARTED|Treatment Period 1 (4 Weeks)||46
8226200|NCT02019472|20285716|P3|NOT COMPLETED|Overall Study||42
8226201|NCT02019472|20285717|P2|NOT COMPLETED|Overall Study||52
8226202|NCT02019472|20285718|P1|NOT COMPLETED|Overall Study||37
8226203|NCT02019472|20285716|P3|COMPLETED|Overall Study||145
8226204|NCT02019472|20285717|P2|COMPLETED|Overall Study||134
8226205|NCT02019472|20285718|P1|COMPLETED|Overall Study||149
8226206|NCT02019472|20285716|P3|STARTED|Overall Study||187
8226207|NCT02019472|20285717|P2|STARTED|Overall Study||186
8226208|NCT02019472|20285718|P1|STARTED|Overall Study||186
8226209|NCT02019420|20285741|P2|NOT COMPLETED|Overall Study||106
8226210|NCT02019420|20285742|P1|NOT COMPLETED|Overall Study||108
8226211|NCT02019420|20285741|P2|COMPLETED|Overall Study||254
8226212|NCT02019420|20285742|P1|COMPLETED|Overall Study||258
8226213|NCT02019420|20285741|P2|Treated|Overall Study||357
8226214|NCT02019420|20285742|P1|Treated|Overall Study||361
8226215|NCT02019420|20285741|P2|STARTED|Overall Study||360
8226216|NCT02019420|20285742|P1|STARTED|Overall Study||366
8226217|NCT02019277|20285770|P1|NOT COMPLETED|Overall Study||12
8226218|NCT02019277|20285770|P1|COMPLETED|Overall Study||38
8226219|NCT02019277|20285770|P1|STARTED|Overall Study||50
8226220|NCT02019264|20285789|P2|NOT COMPLETED|Overall Study||207
8226221|NCT02019264|20285790|P1|NOT COMPLETED|Overall Study||248
8226222|NCT02019264|20285789|P2|COMPLETED|Overall Study||5793
8226223|NCT02019264|20285790|P1|COMPLETED|Overall Study||5752
8226224|NCT02019264|20285789|P2|Safety Analysis Set|Overall Study||5995
8226225|NCT02019264|20285790|P1|Safety Analysis Set|Overall Study||5992
8226226|NCT02019264|20285789|P2|STARTED|Overall Study||6000
8226227|NCT02019264|20285790|P1|STARTED|Overall Study||6000
8226228|NCT02019108|20285826|P2|NOT COMPLETED|Overall Study||7
8226229|NCT02019108|20285827|P1|NOT COMPLETED|Overall Study||5
8226230|NCT02019108|20285826|P2|COMPLETED|Overall Study||32
8226231|NCT02019108|20285827|P1|COMPLETED|Overall Study||35
8226232|NCT02019108|20285826|P2|Retention (Week 21)|Overall Study||32
8226233|NCT02019108|20285827|P1|Retention (Week 21)|Overall Study||35
8226234|NCT02019108|20285826|P2|Follow-up (Week 17)|Overall Study||36
8226235|NCT02019108|20285827|P1|Follow-up (Week 17)|Overall Study||38
8226236|NCT02019108|20285826|P2|Baseline (Week 0)|Overall Study||39
8226237|NCT02019108|20285827|P1|Baseline (Week 0)|Overall Study||40
8226238|NCT02019108|20285826|P2|STARTED|Overall Study||39
8226239|NCT02019108|20285827|P1|STARTED|Overall Study||40
8226240|NCT02019069|20285849|P1|NOT COMPLETED|Overall Study||0
8226241|NCT02019069|20285849|P1|COMPLETED|Overall Study||11
8226242|NCT02019069|20285849|P1|STARTED|Overall Study||11
8226243|NCT02018887|20285869|P11|NOT COMPLETED|Part C: Cohort 8 Overall||1
8226244|NCT02018887|20285870|P10|NOT COMPLETED|Part C: Cohort 8 Overall||3
8226245|NCT02018887|20285871|P9|NOT COMPLETED|Part C: Cohort 8 Overall||3
8226246|NCT02018887|20285872|P8|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226247|NCT02018887|20285873|P7|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226248|NCT02018887|20285874|P6|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226249|NCT02018887|20285875|P5|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226250|NCT02018887|20285876|P4|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226251|NCT02018887|20285877|P3|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226252|NCT02018887|20285878|P2|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226253|NCT02018887|20285879|P1|NOT COMPLETED|Part C: Cohort 8 Overall||0
8226254|NCT02018887|20285869|P11|COMPLETED|Part C: Cohort 8 Overall||6
8226255|NCT02018887|20285870|P10|COMPLETED|Part C: Cohort 8 Overall||1
8226256|NCT02018887|20285871|P9|COMPLETED|Part C: Cohort 8 Overall||7
8226257|NCT02018887|20285872|P8|COMPLETED|Part C: Cohort 8 Overall||0
8226258|NCT02018887|20285873|P7|COMPLETED|Part C: Cohort 8 Overall||0
8226259|NCT02018887|20285874|P6|COMPLETED|Part C: Cohort 8 Overall||0
8226260|NCT02018887|20285875|P5|COMPLETED|Part C: Cohort 8 Overall||0
8226261|NCT02018887|20285876|P4|COMPLETED|Part C: Cohort 8 Overall||0
8226262|NCT02018887|20285877|P3|COMPLETED|Part C: Cohort 8 Overall||0
8226263|NCT02018887|20285878|P2|COMPLETED|Part C: Cohort 8 Overall||0
8226264|NCT02018887|20285879|P1|COMPLETED|Part C: Cohort 8 Overall||0
8226265|NCT02018887|20285869|P11|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7
8226266|NCT02018887|20285870|P10|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4
8226267|NCT02018887|20285871|P9|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10
8226268|NCT02018887|20285872|P8|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226269|NCT02018887|20285873|P7|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226270|NCT02018887|20285874|P6|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226271|NCT02018887|20285875|P5|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226272|NCT02018887|20285876|P4|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226273|NCT02018887|20285877|P3|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226274|NCT02018887|20285878|P2|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226275|NCT02018887|20285879|P1|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
8226276|NCT02018887|20285869|P11|STARTED|Part C: Cohort 8 Overall||7
8226277|NCT02018887|20285870|P10|STARTED|Part C: Cohort 8 Overall||4
8226278|NCT02018887|20285871|P9|STARTED|Part C: Cohort 8 Overall||10
8226279|NCT02018887|20285872|P8|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8226280|NCT02018887|20285873|P7|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8226281|NCT02018887|20285874|P6|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8226282|NCT02018887|20285875|P5|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8226283|NCT02018887|20285876|P4|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
8226284|NCT02018887|20285877|P3|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0
8226285|NCT02018887|20285878|P2|STARTED|Part C: Cohort 8 Overall||0
8226286|NCT02018887|20285879|P1|STARTED|Part C: Cohort 8 Overall||0
8226287|NCT02018887|20285869|P11|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226288|NCT02018887|20285870|P10|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226289|NCT02018887|20285871|P9|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226290|NCT02018887|20285872|P8|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4
8226291|NCT02018887|20285873|P7|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
8226292|NCT02018887|20285874|P6|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226293|NCT02018887|20285875|P5|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
8226294|NCT02018887|20285876|P4|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226295|NCT02018887|20285877|P3|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226296|NCT02018887|20285878|P2|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226297|NCT02018887|20285879|P1|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
8226298|NCT02018887|20285869|P11|COMPLETED|Part B: Cohorts 3-7 Overall||0
8226299|NCT02018887|20285870|P10|COMPLETED|Part B: Cohorts 3-7 Overall||0
8226300|NCT02018887|20285871|P9|COMPLETED|Part B: Cohorts 3-7 Overall||0
8226301|NCT02018887|20285872|P8|COMPLETED|Part B: Cohorts 3-7 Overall||5
8226302|NCT02018887|20285873|P7|COMPLETED|Part B: Cohorts 3-7 Overall||8
8226303|NCT02018887|20285874|P6|COMPLETED|Part B: Cohorts 3-7 Overall||9
8226304|NCT02018887|20285875|P5|COMPLETED|Part B: Cohorts 3-7 Overall||8
8226305|NCT02018887|20285876|P4|COMPLETED|Part B: Cohorts 3-7 Overall||9
8226306|NCT02018887|20285877|P3|COMPLETED|Part B: Cohorts 3-7 Overall||15
8226307|NCT02018887|20285878|P2|COMPLETED|Part B: Cohorts 3-7 Overall||0
8226308|NCT02018887|20285879|P1|COMPLETED|Part B: Cohorts 3-7 Overall||0
8226309|NCT02018887|20285869|P11|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
8226310|NCT02018887|20285870|P10|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
8226311|NCT02018887|20285871|P9|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
8226312|NCT02018887|20285872|P8|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8226313|NCT02018887|20285873|P7|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8226314|NCT02018887|20285874|P6|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8226315|NCT02018887|20285875|P5|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8226316|NCT02018887|20285876|P4|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
8226317|NCT02018887|20285877|P3|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15
8226318|NCT02018887|20285878|P2|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
8226319|NCT02018887|20285879|P1|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
8226320|NCT02018887|20285869|P11|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
8226321|NCT02018887|20285870|P10|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
8226322|NCT02018887|20285871|P9|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0
8226323|NCT02018887|20285872|P8|STARTED|Part B: Cohorts 3-7 Overall||9
8226324|NCT02018887|20285873|P7|STARTED|Part B: Cohorts 3-7 Overall||9
8226325|NCT02018887|20285874|P6|STARTED|Part B: Cohorts 3-7 Overall||9
8226326|NCT02018887|20285875|P5|STARTED|Part B: Cohorts 3-7 Overall||9
8226327|NCT02018887|20285876|P4|STARTED|Part B: Cohorts 3-7 Overall||9
8226328|NCT02018887|20285877|P3|STARTED|Part B: Cohorts 3-7 Overall||15
8226329|NCT02018887|20285878|P2|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
8226330|NCT02018887|20285879|P1|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
8226331|NCT02018887|20285869|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226332|NCT02018887|20285870|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226333|NCT02018887|20285871|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226334|NCT02018887|20285872|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226335|NCT02018887|20285873|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226336|NCT02018887|20285874|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226337|NCT02018887|20285875|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226338|NCT02018887|20285876|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226339|NCT02018887|20285877|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226340|NCT02018887|20285878|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226341|NCT02018887|20285879|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1
8226342|NCT02018887|20285869|P11|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226343|NCT02018887|20285870|P10|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226344|NCT02018887|20285871|P9|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226345|NCT02018887|20285872|P8|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226346|NCT02018887|20285873|P7|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226347|NCT02018887|20285874|P6|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226348|NCT02018887|20285875|P5|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226349|NCT02018887|20285876|P4|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226350|NCT02018887|20285877|P3|COMPLETED|Part A: Cohorts 1-2: Period 3||0
8226351|NCT02018887|20285878|P2|COMPLETED|Part A: Cohorts 1-2: Period 3||9
8226352|NCT02018887|20285879|P1|COMPLETED|Part A: Cohorts 1-2: Period 3||8
8226353|NCT02018887|20285869|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226354|NCT02018887|20285870|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226355|NCT02018887|20285871|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226356|NCT02018887|20285872|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226357|NCT02018887|20285873|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226358|NCT02018887|20285874|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226359|NCT02018887|20285875|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226360|NCT02018887|20285876|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226361|NCT02018887|20285877|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
8226362|NCT02018887|20285878|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9
8226363|NCT02018887|20285879|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8
8226364|NCT02018887|20285869|P11|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8226365|NCT02018887|20285870|P10|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8226366|NCT02018887|20285871|P9|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
8226367|NCT02018887|20285872|P8|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8226368|NCT02018887|20285873|P7|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8226369|NCT02018887|20285874|P6|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8226370|NCT02018887|20285875|P5|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8226371|NCT02018887|20285876|P4|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
8226372|NCT02018887|20285877|P3|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
8226373|NCT02018887|20285878|P2|STARTED|Part A: Cohorts 1-2: Period 3||9
8226374|NCT02018887|20285879|P1|STARTED|Part A: Cohorts 1-2: Period 3||9
8226375|NCT02018887|20285869|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226376|NCT02018887|20285870|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226377|NCT02018887|20285871|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226378|NCT02018887|20285872|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226379|NCT02018887|20285873|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226380|NCT02018887|20285874|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226381|NCT02018887|20285875|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226382|NCT02018887|20285876|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226383|NCT02018887|20285877|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226384|NCT02018887|20285878|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226385|NCT02018887|20285879|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226386|NCT02018887|20285869|P11|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226387|NCT02018887|20285870|P10|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226388|NCT02018887|20285871|P9|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226389|NCT02018887|20285872|P8|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226390|NCT02018887|20285873|P7|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226391|NCT02018887|20285874|P6|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226392|NCT02018887|20285875|P5|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226393|NCT02018887|20285876|P4|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226394|NCT02018887|20285877|P3|COMPLETED|Part A: Cohorts 1-2: Period 2||0
8226395|NCT02018887|20285878|P2|COMPLETED|Part A: Cohorts 1-2: Period 2||9
8226396|NCT02018887|20285879|P1|COMPLETED|Part A: Cohorts 1-2: Period 2||9
8226397|NCT02018887|20285869|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226398|NCT02018887|20285870|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226399|NCT02018887|20285871|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226400|NCT02018887|20285872|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226401|NCT02018887|20285873|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226402|NCT02018887|20285874|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226403|NCT02018887|20285875|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226404|NCT02018887|20285876|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226405|NCT02018887|20285877|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
8226406|NCT02018887|20285878|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
8226407|NCT02018887|20285879|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
8226408|NCT02018887|20285869|P11|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8226409|NCT02018887|20285870|P10|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8226410|NCT02018887|20285871|P9|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
8226411|NCT02018887|20285872|P8|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8226412|NCT02018887|20285873|P7|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8226413|NCT02018887|20285874|P6|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8226414|NCT02018887|20285875|P5|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8226415|NCT02018887|20285876|P4|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
8226496|NCT02018562|20286050|P2|NOT COMPLETED|Overall Study||0
8226416|NCT02018887|20285877|P3|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
8226417|NCT02018887|20285878|P2|STARTED|Part A: Cohorts 1-2: Period 2||9
8226418|NCT02018887|20285879|P1|STARTED|Part A: Cohorts 1-2: Period 2||9
8226419|NCT02018887|20285869|P11|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226420|NCT02018887|20285870|P10|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226421|NCT02018887|20285871|P9|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226422|NCT02018887|20285872|P8|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226423|NCT02018887|20285873|P7|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226424|NCT02018887|20285874|P6|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226425|NCT02018887|20285875|P5|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226426|NCT02018887|20285876|P4|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226427|NCT02018887|20285877|P3|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226428|NCT02018887|20285878|P2|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226429|NCT02018887|20285879|P1|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226430|NCT02018887|20285869|P11|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226431|NCT02018887|20285870|P10|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226432|NCT02018887|20285871|P9|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226433|NCT02018887|20285872|P8|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226434|NCT02018887|20285873|P7|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226435|NCT02018887|20285874|P6|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226436|NCT02018887|20285875|P5|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226437|NCT02018887|20285876|P4|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226438|NCT02018887|20285877|P3|COMPLETED|Part A: Cohorts 1-2: Period 1||0
8226439|NCT02018887|20285878|P2|COMPLETED|Part A: Cohorts 1-2: Period 1||9
8226440|NCT02018887|20285879|P1|COMPLETED|Part A: Cohorts 1-2: Period 1||9
8226441|NCT02018887|20285869|P11|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226442|NCT02018887|20285870|P10|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226443|NCT02018887|20285871|P9|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226444|NCT02018887|20285872|P8|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226445|NCT02018887|20285873|P7|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226446|NCT02018887|20285874|P6|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226447|NCT02018887|20285875|P5|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226448|NCT02018887|20285876|P4|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226449|NCT02018887|20285877|P3|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
8226450|NCT02018887|20285878|P2|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
8226451|NCT02018887|20285879|P1|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
8226452|NCT02018887|20285869|P11|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8226453|NCT02018887|20285870|P10|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8226454|NCT02018887|20285871|P9|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
8226455|NCT02018887|20285872|P8|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8226456|NCT02018887|20285873|P7|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8226457|NCT02018887|20285874|P6|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8226458|NCT02018887|20285875|P5|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8226459|NCT02018887|20285876|P4|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
8226460|NCT02018887|20285877|P3|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
8226461|NCT02018887|20285878|P2|STARTED|Part A: Cohorts 1-2: Period 1||9
8226462|NCT02018887|20285879|P1|STARTED|Part A: Cohorts 1-2: Period 1||9
8226463|NCT02018822|20285968|P3|NOT COMPLETED|Overall Study||6
8226464|NCT02018822|20285969|P2|NOT COMPLETED|Overall Study||8
8226465|NCT02018822|20285970|P1|NOT COMPLETED|Overall Study||6
8226466|NCT02018822|20285968|P3|COMPLETED|Overall Study||29
8226467|NCT02018822|20285969|P2|COMPLETED|Overall Study||42
8226468|NCT02018822|20285970|P1|COMPLETED|Overall Study||44
8226469|NCT02018822|20285968|P3|STARTED|Overall Study||35
8226470|NCT02018822|20285969|P2|STARTED|Overall Study||50
8226471|NCT02018822|20285970|P1|STARTED|Overall Study||50
8226472|NCT02018809|20285997|P4|NOT COMPLETED|Overall Study||0
8226473|NCT02018809|20285998|P3|NOT COMPLETED|Overall Study||0
8226474|NCT02018809|20285999|P2|NOT COMPLETED|Overall Study||0
8226475|NCT02018809|20286000|P1|NOT COMPLETED|Overall Study||0
8226476|NCT02018809|20285997|P4|COMPLETED|Overall Study||50
8226477|NCT02018809|20285998|P3|COMPLETED|Overall Study||50
8226478|NCT02018809|20285999|P2|COMPLETED|Overall Study||50
8226479|NCT02018809|20286000|P1|COMPLETED|Overall Study||50
8226480|NCT02018809|20285997|P4|STARTED|Overall Study||50
8226481|NCT02018809|20285998|P3|STARTED|Overall Study||50
8226482|NCT02018809|20285999|P2|STARTED|Overall Study||50
8226483|NCT02018809|20286000|P1|STARTED|Overall Study||50
8226484|NCT02018653|20286016|P2|NOT COMPLETED|Overall Study||1
8226485|NCT02018653|20286017|P1|NOT COMPLETED|Overall Study||0
8226486|NCT02018653|20286016|P2|COMPLETED|Overall Study||0
8226487|NCT02018653|20286017|P1|COMPLETED|Overall Study||1
8226488|NCT02018653|20286016|P2|STARTED|Overall Study||1
8226489|NCT02018653|20286017|P1|STARTED|Overall Study||1
8226490|NCT02018627|20286025|P2|NOT COMPLETED|Overall Study||0
8226491|NCT02018627|20286026|P1|NOT COMPLETED|Overall Study||0
8226492|NCT02018627|20286025|P2|COMPLETED|Overall Study||6
8226493|NCT02018627|20286026|P1|COMPLETED|Overall Study||7
8226494|NCT02018627|20286025|P2|STARTED|Overall Study||6
8226495|NCT02018627|20286026|P1|STARTED|Overall Study||7
8226497|NCT02018562|20286051|P1|NOT COMPLETED|Overall Study||3
8226498|NCT02018562|20286050|P2|COMPLETED|Overall Study||25
8226499|NCT02018562|20286051|P1|COMPLETED|Overall Study||22
8226500|NCT02018562|20286050|P2|STARTED|Overall Study||25
8226501|NCT02018562|20286051|P1|STARTED|Overall Study||25
8226505|NCT02018445|20286075|P1|NOT COMPLETED|Overall Study||7
8226506|NCT02018445|20286075|P1|COMPLETED|Overall Study||29
8226507|NCT02018445|20286075|P1|STARTED|Overall Study||36
8226508|NCT02018315|20286086|P1|NOT COMPLETED|Overall Study||0
8226509|NCT02018315|20286086|P1|COMPLETED|Overall Study||14
8226510|NCT02018315|20286086|P1|STARTED|Overall Study||14
8226511|NCT02018107|20286091|P1|NOT COMPLETED|Overall Study||0
8226512|NCT02018107|20286091|P1|COMPLETED|Overall Study||27
8226513|NCT02018107|20286091|P1|STARTED|Overall Study||27
8226514|NCT02018042|20286096|P1|NOT COMPLETED|Overall Study||1
8226515|NCT02018042|20286096|P1|COMPLETED|Overall Study||14
8226516|NCT02018042|20286096|P1|STARTED|Overall Study||15
8226517|NCT02017964|20286102|P1|NOT COMPLETED|Overall Study||1
8226518|NCT02017964|20286102|P1|COMPLETED|Overall Study||25
8226519|NCT02017964|20286102|P1|STARTED|Overall Study||26
8226520|NCT02017899|20286116|P6|NOT COMPLETED|Overall Study||0
8226521|NCT02017899|20286117|P5|NOT COMPLETED|Overall Study||1
8226522|NCT02017899|20286118|P4|NOT COMPLETED|Overall Study||1
8226523|NCT02017899|20286119|P3|NOT COMPLETED|Overall Study||0
8226524|NCT02017899|20286120|P2|NOT COMPLETED|Overall Study||0
8226525|NCT02017899|20286121|P1|NOT COMPLETED|Overall Study||0
8226526|NCT02017899|20286116|P6|COMPLETED|Overall Study||8
8226527|NCT02017899|20286117|P5|COMPLETED|Overall Study||8
8226528|NCT02017899|20286118|P4|COMPLETED|Overall Study||7
8226529|NCT02017899|20286119|P3|COMPLETED|Overall Study||8
8226530|NCT02017899|20286120|P2|COMPLETED|Overall Study||9
8226531|NCT02017899|20286121|P1|COMPLETED|Overall Study||8
8226532|NCT02017899|20286116|P6|STARTED|Overall Study||8
8226533|NCT02017899|20286117|P5|STARTED|Overall Study||9
8226534|NCT02017899|20286118|P4|STARTED|Overall Study||8
8226535|NCT02017899|20286119|P3|STARTED|Overall Study||8
8226536|NCT02017899|20286120|P2|STARTED|Overall Study||9
8226537|NCT02017899|20286121|P1|STARTED|Overall Study||8
8226538|NCT02017860|20286195|P1|NOT COMPLETED|Overall Study||2
8226539|NCT02017860|20286195|P1|COMPLETED|Overall Study||2
8226540|NCT02017860|20286195|P1|STARTED|Overall Study||4
8226541|NCT02017574|20286201|P2|NOT COMPLETED|Overall Study||0
8226542|NCT02017574|20286202|P1|NOT COMPLETED|Overall Study||0
8226543|NCT02017574|20286201|P2|COMPLETED|Overall Study||12
8226544|NCT02017574|20286202|P1|COMPLETED|Overall Study||12
8226545|NCT02017574|20286201|P2|STARTED|Overall Study||12
8226546|NCT02017574|20286202|P1|STARTED|Overall Study||12
8226547|NCT02017535|20286214|P4|NOT COMPLETED|Overall Study||0
8226548|NCT02017535|20286215|P3|NOT COMPLETED|Overall Study||0
8226549|NCT02017535|20286216|P2|NOT COMPLETED|Overall Study||0
8226550|NCT02017535|20286217|P1|NOT COMPLETED|Overall Study||1
8226551|NCT02017535|20286214|P4|COMPLETED|Overall Study||1
8226552|NCT02017535|20286215|P3|COMPLETED|Overall Study||2
8226553|NCT02017535|20286216|P2|COMPLETED|Overall Study||3
8226554|NCT02017535|20286217|P1|COMPLETED|Overall Study||8
8226555|NCT02017535|20286214|P4|STARTED|Overall Study||1
8226556|NCT02017535|20286215|P3|STARTED|Overall Study||2
8226557|NCT02017535|20286216|P2|STARTED|Overall Study||3
8226558|NCT02017535|20286217|P1|STARTED|Overall Study||9
8226559|NCT02017522|20286239|P1|NOT COMPLETED|Overall Study||1
8226560|NCT02017522|20286239|P1|COMPLETED|Overall Study||2
8226561|NCT02017522|20286239|P1|Scan|Overall Study||2
8226562|NCT02017522|20286239|P1|STARTED|Overall Study||3
8226563|NCT02017327|20286247|P3|NOT COMPLETED|Overall Study||15
8226564|NCT02017327|20286248|P2|NOT COMPLETED|Overall Study||12
8226565|NCT02017327|20286249|P1|NOT COMPLETED|Overall Study||16
8226566|NCT02017327|20286247|P3|COMPLETED|Overall Study||117
8226567|NCT02017327|20286248|P2|COMPLETED|Overall Study||113
8226568|NCT02017327|20286249|P1|COMPLETED|Overall Study||106
8226569|NCT02017327|20286247|P3|STARTED|Overall Study||132
8226570|NCT02017327|20286248|P2|STARTED|Overall Study||125
8226571|NCT02017327|20286249|P1|STARTED|Overall Study||122
8226572|NCT02017223|20286257|P1|NOT COMPLETED|Overall Study||2
8226573|NCT02017223|20286257|P1|COMPLETED|Overall Study||10
8226574|NCT02017223|20286257|P1|STARTED|Overall Study||12
8226575|NCT02017210|20286264|P3|NOT COMPLETED|Overall Study||0
8226576|NCT02017210|20286265|P2|NOT COMPLETED|Overall Study||0
8226577|NCT02017210|20286266|P1|NOT COMPLETED|Overall Study||0
8226578|NCT02017210|20286264|P3|COMPLETED|Overall Study||20
8226579|NCT02017210|20286265|P2|COMPLETED|Overall Study||20
8226580|NCT02017210|20286266|P1|COMPLETED|Overall Study||17
8226581|NCT02017210|20286264|P3|STARTED|Overall Study||20
8226582|NCT02017210|20286265|P2|STARTED|Overall Study||20
8226583|NCT02017210|20286266|P1|STARTED|Overall Study||17
8226584|NCT02017171|20286303|P2|NOT COMPLETED|Overall Study||46
8226585|NCT02017171|20286304|P1|NOT COMPLETED|Overall Study||62
8226586|NCT02017171|20286303|P2|COMPLETED|Overall Study||217
8226587|NCT02017171|20286304|P1|COMPLETED|Overall Study||205
8226588|NCT02017171|20286303|P2|STARTED|Overall Study||263
8226589|NCT02017171|20286304|P1|STARTED|Overall Study||267
8226590|NCT02017093|20286328|P2|NOT COMPLETED|Overall Study||0
8226591|NCT02017093|20286329|P1|NOT COMPLETED|Overall Study||0
8226592|NCT02017093|20286328|P2|COMPLETED|Overall Study||3
8226593|NCT02017093|20286329|P1|COMPLETED|Overall Study||4
8226594|NCT02017093|20286328|P2|STARTED|Overall Study||3
8226595|NCT02017093|20286329|P1|STARTED|Overall Study||4
8226596|NCT02017015|20286337|P1|NOT COMPLETED|Overall Study||69
8226597|NCT02017015|20286337|P1|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
8226598|NCT02017015|20286337|P1|Safety Population|Overall Study||83
8226599|NCT02017015|20286337|P1|STARTED|Overall Study||83
8226600|NCT02016963|20286344|P1|NOT COMPLETED|Overall Study||0
8226601|NCT02016963|20286344|P1|COMPLETED|Overall Study||20
8226602|NCT02016963|20286344|P1|STARTED|Overall Study||20
8226603|NCT02016898|20286362|P2|NOT COMPLETED|Overall Study||5
8226604|NCT02016898|20286363|P1|NOT COMPLETED|Overall Study||5
8226605|NCT02016898|20286362|P2|COMPLETED|Overall Study||40
8226606|NCT02016898|20286363|P1|COMPLETED|Overall Study||45
8226607|NCT02016898|20286362|P2|STARTED|Overall Study||45
8226608|NCT02016898|20286363|P1|STARTED|Overall Study||50
8226624|NCT02016755|20286417|P1|NOT COMPLETED|Overall Study||7
8226625|NCT02016755|20286417|P1|COMPLETED|Overall Study||3
8226626|NCT02016755|20286417|P1|Completed Month 36 LTFU Questionnaire|Overall Study||3
8226627|NCT02016755|20286417|P1|Completed Month 18 Clinic Visit|Overall Study||5
8226628|NCT02016755|20286417|P1|STARTED|Overall Study||10
8226629|NCT02016716|20286436|P3|NOT COMPLETED|Overall Study||6
8226630|NCT02016716|20286437|P2|NOT COMPLETED|Overall Study||8
8226631|NCT02016716|20286438|P1|NOT COMPLETED|Overall Study||6
8226632|NCT02016716|20286436|P3|COMPLETED|Overall Study||117
8226633|NCT02016716|20286437|P2|COMPLETED|Overall Study||110
8226634|NCT02016716|20286438|P1|COMPLETED|Overall Study||47
8226635|NCT02016716|20286436|P3|Received Study Treatment|Overall Study||123
8226636|NCT02016716|20286437|P2|Received Study Treatment|Overall Study||118
8226637|NCT02016716|20286438|P1|Received Study Treatment|Overall Study||53
8226638|NCT02016716|20286436|P3|STARTED|Overall Study||123
8226639|NCT02016716|20286437|P2|STARTED|Overall Study||118
8226640|NCT02016716|20286438|P1|STARTED|Overall Study||53
8226641|NCT02016690|20286459|P1|NOT COMPLETED|Overall Study||24
8226642|NCT02016690|20286459|P1|COMPLETED|Overall Study|(Effectiveness analysis set)|288
8226643|NCT02016690|20286459|P1|Safety Analysis Set (SAS)|Overall Study||304
8226644|NCT02016690|20286459|P1|Treated|Overall Study||312
8226645|NCT02016690|20286459|P1|STARTED|Overall Study||312
8226646|NCT02016625|20286472|P2|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
8226647|NCT02016625|20286473|P1|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
8226648|NCT02016625|20286472|P2|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
8226649|NCT02016625|20286473|P1|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
8226650|NCT02016625|20286472|P2|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
8226651|NCT02016625|20286473|P1|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
8226652|NCT02016625|20286472|P2|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
8226653|NCT02016625|20286473|P1|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
8226654|NCT02016625|20286472|P2|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
8226655|NCT02016625|20286473|P1|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
8226656|NCT02016625|20286472|P2|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
8226657|NCT02016625|20286473|P1|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
8226658|NCT02016612|20286509|P4|NOT COMPLETED|Overall Study||0
8226659|NCT02016612|20286510|P3|NOT COMPLETED|Overall Study||0
8226660|NCT02016612|20286511|P2|NOT COMPLETED|Overall Study||0
8226661|NCT02016612|20286512|P1|NOT COMPLETED|Overall Study||0
8226662|NCT02016612|20286509|P4|COMPLETED|Overall Study||61
8226663|NCT02016612|20286510|P3|COMPLETED|Overall Study||26
8226664|NCT02016612|20286511|P2|COMPLETED|Overall Study||25
8226665|NCT02016612|20286512|P1|COMPLETED|Overall Study||25
8226666|NCT02016612|20286509|P4|STARTED|Overall Study||61
8226667|NCT02016612|20286510|P3|STARTED|Overall Study||26
8226668|NCT02016612|20286511|P2|STARTED|Overall Study||25
8226669|NCT02016612|20286512|P1|STARTED|Overall Study||25
8226670|NCT02016560|20286532|P6|NOT COMPLETED|Confirmatory Phase||27
8226671|NCT02016560|20286533|P5|NOT COMPLETED|Confirmatory Phase||22
8226672|NCT02016560|20286534|P4|NOT COMPLETED|Confirmatory Phase||0
8226673|NCT02016560|20286535|P3|NOT COMPLETED|Confirmatory Phase||0
8226674|NCT02016560|20286536|P2|NOT COMPLETED|Confirmatory Phase||0
8226675|NCT02016560|20286537|P1|NOT COMPLETED|Confirmatory Phase||0
8226676|NCT02016560|20286532|P6|COMPLETED|Confirmatory Phase||35
8226677|NCT02016560|20286533|P5|COMPLETED|Confirmatory Phase||76
8226678|NCT02016560|20286534|P4|COMPLETED|Confirmatory Phase||0
8226679|NCT02016560|20286535|P3|COMPLETED|Confirmatory Phase||0
8226680|NCT02016560|20286536|P2|COMPLETED|Confirmatory Phase||0
8226681|NCT02016560|20286537|P1|COMPLETED|Confirmatory Phase||0
8226682|NCT02016560|20286532|P6|STARTED|Confirmatory Phase||62
8226683|NCT02016560|20286533|P5|STARTED|Confirmatory Phase||98
8226684|NCT02016560|20286534|P4|STARTED|Confirmatory Phase||0
8226685|NCT02016560|20286535|P3|STARTED|Confirmatory Phase||0
8226686|NCT02016560|20286536|P2|STARTED|Confirmatory Phase||0
8226687|NCT02016560|20286537|P1|STARTED|Confirmatory Phase||0
8226688|NCT02016560|20286532|P6|NOT COMPLETED|Exploratory Phase||0
8226689|NCT02016560|20286533|P5|NOT COMPLETED|Exploratory Phase||0
8226690|NCT02016560|20286534|P4|NOT COMPLETED|Exploratory Phase||16
8226691|NCT02016560|20286535|P3|NOT COMPLETED|Exploratory Phase||36
8226692|NCT02016560|20286536|P2|NOT COMPLETED|Exploratory Phase||4
8226693|NCT02016560|20286537|P1|NOT COMPLETED|Exploratory Phase||0
8226694|NCT02016560|20286532|P6|COMPLETED|Exploratory Phase||0
8226695|NCT02016560|20286533|P5|COMPLETED|Exploratory Phase||0
8226696|NCT02016560|20286534|P4|COMPLETED|Exploratory Phase||35
8226697|NCT02016560|20286535|P3|COMPLETED|Exploratory Phase||62
8226698|NCT02016560|20286536|P2|COMPLETED|Exploratory Phase||54
8226699|NCT02016560|20286537|P1|COMPLETED|Exploratory Phase||16
8226700|NCT02016560|20286532|P6|STARTED|Exploratory Phase||0
8226701|NCT02016560|20286533|P5|STARTED|Exploratory Phase||0
8226702|NCT02016560|20286534|P4|STARTED|Exploratory Phase||51
8226703|NCT02016560|20286535|P3|STARTED|Exploratory Phase||98
8226704|NCT02016560|20286536|P2|STARTED|Exploratory Phase||58
8226705|NCT02016560|20286537|P1|STARTED|Exploratory Phase||16
8226706|NCT02016482|20286561|P2|NOT COMPLETED|Period B||7
8226707|NCT02016482|20286562|P1|NOT COMPLETED|Period B||13
8226708|NCT02016482|20286561|P2|COMPLETED|Period B||87
8226709|NCT02016482|20286562|P1|COMPLETED|Period B||81
8226710|NCT02016482|20286561|P2|STARTED|Period B||94
8226711|NCT02016482|20286562|P1|STARTED|Period B||94
8226712|NCT02016482|20286561|P2|NOT COMPLETED|Period A||15
8226713|NCT02016482|20286562|P1|NOT COMPLETED|Period A||14
8226714|NCT02016482|20286561|P2|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
8226715|NCT02016482|20286562|P1|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
8226716|NCT02016482|20286561|P2|STARTED|Period A||109
8226717|NCT02016482|20286562|P1|STARTED|Period A||108
8226718|NCT02016300|20286652|P2|NOT COMPLETED|Overall Study||3
8226719|NCT02016300|20286653|P1|NOT COMPLETED|Overall Study||0
8226720|NCT02016300|20286652|P2|COMPLETED|Overall Study||9
8226721|NCT02016300|20286653|P1|COMPLETED|Overall Study||12
8226722|NCT02016300|20286652|P2|STARTED|Overall Study||12
8226723|NCT02016300|20286653|P1|STARTED|Overall Study||12
8226724|NCT02016235|20286674|P3|NOT COMPLETED|Overall Study||0
8226725|NCT02016235|20286675|P2|NOT COMPLETED|Overall Study||0
8226726|NCT02016235|20286676|P1|NOT COMPLETED|Overall Study||0
8226727|NCT02016235|20286674|P3|COMPLETED|Overall Study||10
8226728|NCT02016235|20286675|P2|COMPLETED|Overall Study||10
8226729|NCT02016235|20286676|P1|COMPLETED|Overall Study||10
8226730|NCT02016235|20286674|P3|STARTED|Overall Study||10
8226731|NCT02016235|20286675|P2|STARTED|Overall Study||10
8226732|NCT02016235|20286676|P1|STARTED|Overall Study||10
8226733|NCT02016183|20286684|P1|NOT COMPLETED|Overall Study||65
8226734|NCT02016183|20286684|P1|COMPLETED|Overall Study||3157
8226735|NCT02016183|20286684|P1|STARTED|Overall Study||3222
8226736|NCT02016170|20286694|P3|NOT COMPLETED|Overall Study||0
8226737|NCT02016170|20286695|P2|NOT COMPLETED|Overall Study||1
8226738|NCT02016170|20286696|P1|NOT COMPLETED|Overall Study||2
8226739|NCT02016170|20286694|P3|COMPLETED|Overall Study||27
8226740|NCT02016170|20286695|P2|COMPLETED|Overall Study||27
8226741|NCT02016170|20286696|P1|COMPLETED|Overall Study||25
8226742|NCT02016170|20286694|P3|STARTED|Overall Study||27
8226743|NCT02016170|20286695|P2|STARTED|Overall Study||28
8226744|NCT02016170|20286696|P1|STARTED|Overall Study||27
8226745|NCT02016105|20286707|P6|NOT COMPLETED|EXTENSION PERIOD||6
8226746|NCT02016105|20286708|P5|NOT COMPLETED|EXTENSION PERIOD||6
8226747|NCT02016105|20286709|P4|NOT COMPLETED|EXTENSION PERIOD||5
8226748|NCT02016105|20286710|P3|NOT COMPLETED|EXTENSION PERIOD||5
8226749|NCT02016105|20286711|P2|NOT COMPLETED|EXTENSION PERIOD||0
8226750|NCT02016105|20286712|P1|NOT COMPLETED|EXTENSION PERIOD||0
8226751|NCT02016105|20286707|P6|COMPLETED|EXTENSION PERIOD||100
8226752|NCT02016105|20286708|P5|COMPLETED|EXTENSION PERIOD||50
8226753|NCT02016105|20286709|P4|COMPLETED|EXTENSION PERIOD||104
8226754|NCT02016105|20286710|P3|COMPLETED|EXTENSION PERIOD||47
8226755|NCT02016105|20286711|P2|COMPLETED|EXTENSION PERIOD||0
8226756|NCT02016105|20286712|P1|COMPLETED|EXTENSION PERIOD||0
8226757|NCT02016105|20286707|P6|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
8226758|NCT02016105|20286708|P5|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
8226759|NCT02016105|20286709|P4|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
8226760|NCT02016105|20286710|P3|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
8226761|NCT02016105|20286711|P2|STARTED|EXTENSION PERIOD||0
8226762|NCT02016105|20286712|P1|STARTED|EXTENSION PERIOD||0
8226763|NCT02016105|20286707|P6|NOT COMPLETED|TREATMENT PERIOD 2||14
8226764|NCT02016105|20286708|P5|NOT COMPLETED|TREATMENT PERIOD 2||4
8226765|NCT02016105|20286709|P4|NOT COMPLETED|TREATMENT PERIOD 2||11
8226766|NCT02016105|20286710|P3|NOT COMPLETED|TREATMENT PERIOD 2||6
8226767|NCT02016105|20286711|P2|NOT COMPLETED|TREATMENT PERIOD 2||0
8226768|NCT02016105|20286712|P1|NOT COMPLETED|TREATMENT PERIOD 2||0
8226769|NCT02016105|20286707|P6|COMPLETED|TREATMENT PERIOD 2||112
8226770|NCT02016105|20286708|P5|COMPLETED|TREATMENT PERIOD 2||59
8226771|NCT02016105|20286709|P4|COMPLETED|TREATMENT PERIOD 2||116
8226772|NCT02016105|20286710|P3|COMPLETED|TREATMENT PERIOD 2||57
8226773|NCT02016105|20286711|P2|COMPLETED|TREATMENT PERIOD 2||0
8226774|NCT02016105|20286712|P1|COMPLETED|TREATMENT PERIOD 2||0
8226775|NCT02016105|20286707|P6|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
8226776|NCT02016105|20286708|P5|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
8226777|NCT02016105|20286709|P4|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
8226778|NCT02016105|20286710|P3|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
8226779|NCT02016105|20286711|P2|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
8226780|NCT02016105|20286712|P1|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
8226781|NCT02016105|20286707|P6|NOT COMPLETED|TREATMENT PERIOD 1||0
8226782|NCT02016105|20286708|P5|NOT COMPLETED|TREATMENT PERIOD 1||0
8226783|NCT02016105|20286709|P4|NOT COMPLETED|TREATMENT PERIOD 1||0
8226784|NCT02016105|20286710|P3|NOT COMPLETED|TREATMENT PERIOD 1||0
8226785|NCT02016105|20286711|P2|NOT COMPLETED|TREATMENT PERIOD 1||33
8226786|NCT02016105|20286712|P1|NOT COMPLETED|TREATMENT PERIOD 1||30
8226787|NCT02016105|20286707|P6|COMPLETED|TREATMENT PERIOD 1||0
8226788|NCT02016105|20286708|P5|COMPLETED|TREATMENT PERIOD 1||0
8226789|NCT02016105|20286709|P4|COMPLETED|TREATMENT PERIOD 1||0
8226790|NCT02016105|20286710|P3|COMPLETED|TREATMENT PERIOD 1||0
8226791|NCT02016105|20286711|P2|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
8226792|NCT02016105|20286712|P1|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
8226793|NCT02016105|20286707|P6|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8226794|NCT02016105|20286708|P5|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8226795|NCT02016105|20286709|P4|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8226796|NCT02016105|20286710|P3|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8226797|NCT02016105|20286711|P2|STARTED|TREATMENT PERIOD 1||234
8226798|NCT02016105|20286712|P1|STARTED|TREATMENT PERIOD 1||231
8226799|NCT02015910|20286762|P2|NOT COMPLETED|Overall Study||0
8226800|NCT02015910|20286763|P1|NOT COMPLETED|Overall Study||0
8226801|NCT02015910|20286762|P2|COMPLETED|Overall Study||1
8226802|NCT02015910|20286763|P1|COMPLETED|Overall Study||0
8226803|NCT02015910|20286762|P2|STARTED|Overall Study||1
8226804|NCT02015910|20286763|P1|STARTED|Overall Study||0
8226805|NCT02015793|20286771|P2|NOT COMPLETED|Overall Study||4
8226806|NCT02015793|20286772|P1|NOT COMPLETED|Overall Study||4
8226807|NCT02015793|20286771|P2|COMPLETED|Overall Study||11
8226808|NCT02015793|20286772|P1|COMPLETED|Overall Study||11
8226809|NCT02015793|20286771|P2|Entered Open-label Extension Period|Overall Study||14
8226810|NCT02015793|20286772|P1|Entered Open-label Extension Period|Overall Study||13
8226811|NCT02015793|20286771|P2|Completed Double-Blind Period|Overall Study||14
8226812|NCT02015793|20286772|P1|Completed Double-Blind Period|Overall Study||14
8226813|NCT02015793|20286771|P2|STARTED|Overall Study||15
8226814|NCT02015793|20286772|P1|STARTED|Overall Study||15
8226815|NCT02015754|20286802|P1|NOT COMPLETED|Overall Study||11
8226816|NCT02015754|20286802|P1|COMPLETED|Overall Study||3
8226817|NCT02015754|20286802|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
8226818|NCT02015754|20286802|P1|Completed First TACE|Overall Study||14
8226819|NCT02015754|20286802|P1|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
8226820|NCT02015676|20286822|P3|NOT COMPLETED|Overall Study||3
8226821|NCT02015676|20286823|P2|NOT COMPLETED|Overall Study||34
8226822|NCT02015676|20286824|P1|NOT COMPLETED|Overall Study||9
8226823|NCT02015676|20286822|P3|COMPLETED|Overall Study||3
8226824|NCT02015676|20286823|P2|COMPLETED|Overall Study||14
8226825|NCT02015676|20286824|P1|COMPLETED|Overall Study||6
8226826|NCT02015676|20286822|P3|STARTED|Overall Study||6
8226827|NCT02015676|20286823|P2|STARTED|Overall Study||48
8226828|NCT02015676|20286824|P1|STARTED|Overall Study||15
8226829|NCT02015663|20286840|P2|NOT COMPLETED|Overall Study||12
8226830|NCT02015663|20286841|P1|NOT COMPLETED|Overall Study||15
8226831|NCT02015663|20286840|P2|COMPLETED|Overall Study||4
8226832|NCT02015663|20286841|P1|COMPLETED|Overall Study||1
8226833|NCT02015663|20286840|P2|STARTED|Overall Study||16
8226834|NCT02015663|20286841|P1|STARTED|Overall Study||16
8226835|NCT02015637|20286872|P2|NOT COMPLETED|Overall Study||5
8226836|NCT02015637|20286873|P1|NOT COMPLETED|Overall Study||8
8226837|NCT02015637|20286872|P2|COMPLETED|Overall Study||149
8226838|NCT02015637|20286873|P1|COMPLETED|Overall Study||298
8226839|NCT02015637|20286872|P2|STARTED|Overall Study||154
8226840|NCT02015637|20286873|P1|STARTED|Overall Study||306
8226841|NCT02015546|20286884|P3|NOT COMPLETED|Overall Study||4
8226842|NCT02015546|20286885|P2|NOT COMPLETED|Overall Study||2
8226843|NCT02015546|20286886|P1|NOT COMPLETED|Overall Study||3
8226844|NCT02015546|20286884|P3|COMPLETED|Overall Study||22
8226845|NCT02015546|20286885|P2|COMPLETED|Overall Study||19
8226846|NCT02015546|20286886|P1|COMPLETED|Overall Study||20
8226847|NCT02015546|20286884|P3|STARTED|Overall Study||26
8226848|NCT02015546|20286885|P2|STARTED|Overall Study||21
8226849|NCT02015546|20286886|P1|STARTED|Overall Study||23
8226850|NCT02015481|20286918|P1|NOT COMPLETED|Overall Study||1
8226851|NCT02015481|20286918|P1|COMPLETED|Overall Study||24
8226852|NCT02015481|20286918|P1|STARTED|Overall Study||25
8226853|NCT02015442|20286925|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8226854|NCT02015442|20286926|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8226855|NCT02015442|20286925|P2|COMPLETED|Second Intervention (7 Days)||4
8226856|NCT02015442|20286926|P1|COMPLETED|Second Intervention (7 Days)||5
8226857|NCT02015442|20286925|P2|STARTED|Second Intervention (7 Days)||4
8226858|NCT02015442|20286926|P1|STARTED|Second Intervention (7 Days)||5
8226859|NCT02015442|20286925|P2|NOT COMPLETED|Wash-out (4 Weeks)||0
8226860|NCT02015442|20286926|P1|NOT COMPLETED|Wash-out (4 Weeks)||0
8226861|NCT02015442|20286925|P2|COMPLETED|Wash-out (4 Weeks)||4
8226862|NCT02015442|20286926|P1|COMPLETED|Wash-out (4 Weeks)||5
8226863|NCT02015442|20286925|P2|STARTED|Wash-out (4 Weeks)||4
8226864|NCT02015442|20286926|P1|STARTED|Wash-out (4 Weeks)||5
8226865|NCT02015442|20286925|P2|NOT COMPLETED|First Intervention (7 Days)||0
8226866|NCT02015442|20286926|P1|NOT COMPLETED|First Intervention (7 Days)||0
8226867|NCT02015442|20286925|P2|COMPLETED|First Intervention (7 Days)||4
8226868|NCT02015442|20286926|P1|COMPLETED|First Intervention (7 Days)||5
8226869|NCT02015442|20286925|P2|STARTED|First Intervention (7 Days)||4
8226870|NCT02015442|20286926|P1|STARTED|First Intervention (7 Days)||5
8226871|NCT02015234|20286936|P2|NOT COMPLETED|Overall Study||25
8226872|NCT02015234|20286937|P1|NOT COMPLETED|Overall Study||36
8226873|NCT02015234|20286936|P2|COMPLETED|Overall Study||54
8226874|NCT02015234|20286937|P1|COMPLETED|Overall Study||43
8226875|NCT02015234|20286936|P2|STARTED|Overall Study||79
8226876|NCT02015234|20286937|P1|STARTED|Overall Study||79
8226877|NCT02015221|20286951|P2|NOT COMPLETED|Overall Study||6
8226878|NCT02015221|20286952|P1|NOT COMPLETED|Overall Study||9
8226879|NCT02015221|20286951|P2|COMPLETED|Overall Study||34
8226880|NCT02015221|20286952|P1|COMPLETED|Overall Study||32
8226881|NCT02015221|20286951|P2|STARTED|Overall Study||40
8226882|NCT02015221|20286952|P1|STARTED|Overall Study||41
8226883|NCT02015195|20286965|P7|NOT COMPLETED|Overall Study||0
8226884|NCT02015195|20286966|P6|NOT COMPLETED|Overall Study||0
8226885|NCT02015195|20286967|P5|NOT COMPLETED|Overall Study||0
8226886|NCT02015195|20286968|P4|NOT COMPLETED|Overall Study||1
8226887|NCT02015195|20286969|P3|NOT COMPLETED|Overall Study||0
8226888|NCT02015195|20286970|P2|NOT COMPLETED|Overall Study||0
8226889|NCT02015195|20286971|P1|NOT COMPLETED|Overall Study||0
8226890|NCT02015195|20286965|P7|COMPLETED|Overall Study||16
8226891|NCT02015195|20286966|P6|COMPLETED|Overall Study||16
8226892|NCT02015195|20286967|P5|COMPLETED|Overall Study||16
8226893|NCT02015195|20286968|P4|COMPLETED|Overall Study||0
8226894|NCT02015195|20286969|P3|COMPLETED|Overall Study||16
8226895|NCT02015195|20286970|P2|COMPLETED|Overall Study||16
8226896|NCT02015195|20286971|P1|COMPLETED|Overall Study||16
8226897|NCT02015195|20286965|P7|STARTED|Overall Study||16
8226898|NCT02015195|20286966|P6|STARTED|Overall Study||16
8226899|NCT02015195|20286967|P5|STARTED|Overall Study||16
8226900|NCT02015195|20286968|P4|STARTED|Overall Study||1
8226901|NCT02015195|20286969|P3|STARTED|Overall Study||16
8226902|NCT02015195|20286970|P2|STARTED|Overall Study||16
8226903|NCT02015195|20286971|P1|STARTED|Overall Study||16
8226904|NCT02015104|20286994|P2|NOT COMPLETED|Overall Study||1
8226905|NCT02015104|20286995|P1|NOT COMPLETED|Overall Study||1
8226906|NCT02015104|20286994|P2|COMPLETED|Overall Study||15
8226907|NCT02015104|20286995|P1|COMPLETED|Overall Study||15
8226908|NCT02015104|20286994|P2|STARTED|Overall Study||16
8226909|NCT02015104|20286995|P1|STARTED|Overall Study||16
8226910|NCT02015065|20287012|P3|NOT COMPLETED|Overall Study||1
8226911|NCT02015065|20287013|P2|NOT COMPLETED|Overall Study||2
8226912|NCT02015065|20287014|P1|NOT COMPLETED|Overall Study||1
8226913|NCT02015065|20287012|P3|COMPLETED|Overall Study||1
8226914|NCT02015065|20287013|P2|COMPLETED|Overall Study||3
8226915|NCT02015065|20287014|P1|COMPLETED|Overall Study||1
8226916|NCT02015065|20287012|P3|STARTED|Overall Study||2
8226917|NCT02015065|20287013|P2|STARTED|Overall Study||5
8226918|NCT02015065|20287014|P1|STARTED|Overall Study||2
8226919|NCT02015039|20287036|P2|NOT COMPLETED|Overall Study||1
8226920|NCT02015039|20287037|P1|NOT COMPLETED|Overall Study||0
8226921|NCT02015039|20287036|P2|COMPLETED|Overall Study||6
8226922|NCT02015039|20287037|P1|COMPLETED|Overall Study||6
8226923|NCT02015039|20287036|P2|STARTED|Overall Study||7
8226924|NCT02015039|20287037|P1|STARTED|Overall Study||6
8226925|NCT02014740|20287057|P2|NOT COMPLETED|Overall Study||5
8226926|NCT02014740|20287058|P1|NOT COMPLETED|Overall Study||6
8226927|NCT02014740|20287057|P2|COMPLETED|Overall Study||40
8226928|NCT02014740|20287058|P1|COMPLETED|Overall Study||49
8226929|NCT02014740|20287057|P2|STARTED|Overall Study||45
8226930|NCT02014740|20287058|P1|STARTED|Overall Study||55
8226931|NCT02014597|20287066|P2|NOT COMPLETED|Overall Study||1
8226932|NCT02014597|20287067|P1|NOT COMPLETED|Overall Study||2
8226933|NCT02014597|20287066|P2|COMPLETED|Overall Study||10
8226934|NCT02014597|20287067|P1|COMPLETED|Overall Study||10
8226935|NCT02014597|20287066|P2|STARTED|Overall Study||11
8226936|NCT02014597|20287067|P1|STARTED|Overall Study||12
8226937|NCT02014584|20287083|P6|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226938|NCT02014584|20287084|P5|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
8226939|NCT02014584|20287085|P4|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226940|NCT02014584|20287086|P3|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226941|NCT02014584|20287087|P2|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226942|NCT02014584|20287088|P1|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226943|NCT02014584|20287083|P6|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
8226944|NCT02014584|20287084|P5|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
8226945|NCT02014584|20287085|P4|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226946|NCT02014584|20287086|P3|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226947|NCT02014584|20287087|P2|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226948|NCT02014584|20287088|P1|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
8226949|NCT02014584|20287083|P6|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
8226950|NCT02014584|20287084|P5|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
8226951|NCT02014584|20287085|P4|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
8226952|NCT02014584|20287086|P3|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
8226953|NCT02014584|20287087|P2|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
8226954|NCT02014584|20287088|P1|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
8226955|NCT02014584|20287083|P6|NOT COMPLETED|Open-Label Period (24 Weeks)||0
8226956|NCT02014584|20287084|P5|NOT COMPLETED|Open-Label Period (24 Weeks)||0
8226957|NCT02014584|20287085|P4|NOT COMPLETED|Open-Label Period (24 Weeks)||1
8226958|NCT02014584|20287086|P3|NOT COMPLETED|Open-Label Period (24 Weeks)||5
8226959|NCT02014584|20287087|P2|NOT COMPLETED|Open-Label Period (24 Weeks)||0
8226960|NCT02014584|20287088|P1|NOT COMPLETED|Open-Label Period (24 Weeks)||0
8226961|NCT02014584|20287083|P6|COMPLETED|Open-Label Period (24 Weeks)||0
8226962|NCT02014584|20287084|P5|COMPLETED|Open-Label Period (24 Weeks)||0
8226963|NCT02014584|20287085|P4|COMPLETED|Open-Label Period (24 Weeks)||47
8226964|NCT02014584|20287086|P3|COMPLETED|Open-Label Period (24 Weeks)||44
8226965|NCT02014584|20287087|P2|COMPLETED|Open-Label Period (24 Weeks)||0
8226966|NCT02014584|20287088|P1|COMPLETED|Open-Label Period (24 Weeks)||0
8226967|NCT02014584|20287083|P6|STARTED|Open-Label Period (24 Weeks)||0
8226968|NCT02014584|20287084|P5|STARTED|Open-Label Period (24 Weeks)||0
8226969|NCT02014584|20287085|P4|STARTED|Open-Label Period (24 Weeks)||48
8226970|NCT02014584|20287086|P3|STARTED|Open-Label Period (24 Weeks)||49
8226971|NCT02014584|20287087|P2|STARTED|Open-Label Period (24 Weeks)||0
8226972|NCT02014584|20287088|P1|STARTED|Open-Label Period (24 Weeks)||0
8226973|NCT02014584|20287083|P6|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
8226974|NCT02014584|20287084|P5|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
8226975|NCT02014584|20287085|P4|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
8226976|NCT02014584|20287086|P3|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
8226977|NCT02014584|20287087|P2|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
8226978|NCT02014584|20287088|P1|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
8226979|NCT02014584|20287083|P6|COMPLETED|Double-Blind Period (24 Weeks)||0
8226980|NCT02014584|20287084|P5|COMPLETED|Double-Blind Period (24 Weeks)||0
8226981|NCT02014584|20287085|P4|COMPLETED|Double-Blind Period (24 Weeks)||0
8226982|NCT02014584|20287086|P3|COMPLETED|Double-Blind Period (24 Weeks)||0
8226983|NCT02014584|20287087|P2|COMPLETED|Double-Blind Period (24 Weeks)||52
8226984|NCT02014584|20287088|P1|COMPLETED|Double-Blind Period (24 Weeks)||57
8226985|NCT02014584|20287083|P6|STARTED|Double-Blind Period (24 Weeks)||0
8226986|NCT02014584|20287084|P5|STARTED|Double-Blind Period (24 Weeks)||0
8226987|NCT02014584|20287085|P4|STARTED|Double-Blind Period (24 Weeks)||0
8226988|NCT02014584|20287086|P3|STARTED|Double-Blind Period (24 Weeks)||0
8226989|NCT02014584|20287087|P2|STARTED|Double-Blind Period (24 Weeks)||58
8226990|NCT02014584|20287088|P1|STARTED|Double-Blind Period (24 Weeks)||59
8226991|NCT02014558|20287218|P13|NOT COMPLETED|Overall Study||17
8226992|NCT02014558|20287219|P12|NOT COMPLETED|Overall Study||102
8226993|NCT02014558|20287220|P11|NOT COMPLETED|Overall Study||69
8226994|NCT02014558|20287221|P10|NOT COMPLETED|Overall Study||21
8226995|NCT02014558|20287222|P9|NOT COMPLETED|Overall Study||15
8226996|NCT02014558|20287223|P8|NOT COMPLETED|Overall Study||11
8226997|NCT02014558|20287224|P7|NOT COMPLETED|Overall Study||4
8226998|NCT02014558|20287225|P6|NOT COMPLETED|Overall Study||3
8226999|NCT02014558|20287226|P5|NOT COMPLETED|Overall Study||4
8227000|NCT02014558|20287227|P4|NOT COMPLETED|Overall Study||3
8227001|NCT02014558|20287228|P3|NOT COMPLETED|Overall Study||3
8227002|NCT02014558|20287229|P2|NOT COMPLETED|Overall Study||3
8227003|NCT02014558|20287230|P1|NOT COMPLETED|Overall Study||5
8227004|NCT02014558|20287218|P13|COMPLETED|Overall Study||0
8227005|NCT02014558|20287219|P12|COMPLETED|Overall Study||0
8227006|NCT02014558|20287220|P11|COMPLETED|Overall Study||0
8227007|NCT02014558|20287221|P10|COMPLETED|Overall Study||0
8227008|NCT02014558|20287222|P9|COMPLETED|Overall Study||0
8227009|NCT02014558|20287223|P8|COMPLETED|Overall Study||0
8227010|NCT02014558|20287224|P7|COMPLETED|Overall Study||0
8227011|NCT02014558|20287225|P6|COMPLETED|Overall Study||0
8227012|NCT02014558|20287226|P5|COMPLETED|Overall Study||0
8227013|NCT02014558|20287227|P4|COMPLETED|Overall Study||0
8227014|NCT02014558|20287228|P3|COMPLETED|Overall Study||0
8227015|NCT02014558|20287229|P2|COMPLETED|Overall Study||0
8227016|NCT02014558|20287230|P1|COMPLETED|Overall Study||0
8227017|NCT02014558|20287218|P13|Treated|Overall Study||17
8227018|NCT02014558|20287219|P12|Treated|Overall Study||100
8227019|NCT02014558|20287220|P11|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66
8227020|NCT02014558|20287221|P10|Treated|Overall Study||21
8227021|NCT02014558|20287222|P9|Treated|Overall Study||13
8227022|NCT02014558|20287223|P8|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12
8227023|NCT02014558|20287224|P7|Treated|Overall Study||3
8227024|NCT02014558|20287225|P6|Treated|Overall Study||3
8227025|NCT02014558|20287226|P5|Treated|Overall Study||3
8227026|NCT02014558|20287227|P4|Treated|Overall Study||3
8227027|NCT02014558|20287228|P3|Treated|Overall Study||3
8227028|NCT02014558|20287229|P2|Treated|Overall Study||3
8227029|NCT02014558|20287230|P1|Treated|Overall Study||5
8227030|NCT02014558|20287218|P13|STARTED|Overall Study||17
8227031|NCT02014558|20287219|P12|STARTED|Overall Study||102
8227032|NCT02014558|20287220|P11|STARTED|Overall Study||69
8227033|NCT02014558|20287221|P10|STARTED|Overall Study||21
8227034|NCT02014558|20287222|P9|STARTED|Overall Study||15
8227035|NCT02014558|20287223|P8|STARTED|Overall Study||11
8227036|NCT02014558|20287224|P7|STARTED|Overall Study||4
8227037|NCT02014558|20287225|P6|STARTED|Overall Study||3
8227038|NCT02014558|20287226|P5|STARTED|Overall Study||4
8227039|NCT02014558|20287227|P4|STARTED|Overall Study||3
8227040|NCT02014558|20287228|P3|STARTED|Overall Study||3
8227041|NCT02014558|20287229|P2|STARTED|Overall Study||3
8227042|NCT02014558|20287230|P1|STARTED|Overall Study||5
8227043|NCT02014519|20287538|P1|NOT COMPLETED|Overall Study||0
8227044|NCT02014519|20287538|P1|COMPLETED|Overall Study||2000
8227045|NCT02014519|20287538|P1|STARTED|Overall Study||2000
8227046|NCT02014480|20287595|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
8227047|NCT02014480|20287596|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8227048|NCT02014480|20287597|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8227049|NCT02014480|20287598|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8227050|NCT02014480|20287599|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8227051|NCT02014480|20287600|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8227052|NCT02014480|20287595|P6|COMPLETED|Treatment Period 3 (14 Days)||32
8227053|NCT02014480|20287596|P5|COMPLETED|Treatment Period 3 (14 Days)||34
8227054|NCT02014480|20287597|P4|COMPLETED|Treatment Period 3 (14 Days)||31
8227055|NCT02014480|20287598|P3|COMPLETED|Treatment Period 3 (14 Days)||29
8227056|NCT02014480|20287599|P2|COMPLETED|Treatment Period 3 (14 Days)||32
8227057|NCT02014480|20287600|P1|COMPLETED|Treatment Period 3 (14 Days)||34
8227058|NCT02014480|20287595|P6|STARTED|Treatment Period 3 (14 Days)||34
8227059|NCT02014480|20287596|P5|STARTED|Treatment Period 3 (14 Days)||34
8227060|NCT02014480|20287597|P4|STARTED|Treatment Period 3 (14 Days)||31
8227061|NCT02014480|20287598|P3|STARTED|Treatment Period 3 (14 Days)||30
8227062|NCT02014480|20287599|P2|STARTED|Treatment Period 3 (14 Days)||33
8227063|NCT02014480|20287600|P1|STARTED|Treatment Period 3 (14 Days)||34
8227064|NCT02014480|20287595|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8227065|NCT02014480|20287596|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8227066|NCT02014480|20287597|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8227067|NCT02014480|20287598|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8227068|NCT02014480|20287599|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8227069|NCT02014480|20287600|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8227070|NCT02014480|20287595|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||34
8227071|NCT02014480|20287596|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||34
8227072|NCT02014480|20287597|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||31
8227073|NCT02014480|20287598|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||30
8227074|NCT02014480|20287599|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||33
8227075|NCT02014480|20287600|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||34
8227076|NCT02014480|20287595|P6|STARTED|Washout Period 2 (10 to 14 Days)||34
8227077|NCT02014480|20287596|P5|STARTED|Washout Period 2 (10 to 14 Days)||34
8227078|NCT02014480|20287597|P4|STARTED|Washout Period 2 (10 to 14 Days)||31
8227079|NCT02014480|20287598|P3|STARTED|Washout Period 2 (10 to 14 Days)||30
8227080|NCT02014480|20287599|P2|STARTED|Washout Period 2 (10 to 14 Days)||33
8227081|NCT02014480|20287600|P1|STARTED|Washout Period 2 (10 to 14 Days)||34
8227082|NCT02014480|20287595|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8227083|NCT02014480|20287596|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8227084|NCT02014480|20287597|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8227085|NCT02014480|20287598|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
8227086|NCT02014480|20287599|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8227087|NCT02014480|20287600|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8227088|NCT02014480|20287595|P6|COMPLETED|Treatment Period 2 (14 Days)||34
8227089|NCT02014480|20287596|P5|COMPLETED|Treatment Period 2 (14 Days)||34
8227090|NCT02014480|20287597|P4|COMPLETED|Treatment Period 2 (14 Days)||31
8227091|NCT02014480|20287598|P3|COMPLETED|Treatment Period 2 (14 Days)||30
8227092|NCT02014480|20287599|P2|COMPLETED|Treatment Period 2 (14 Days)||33
8227093|NCT02014480|20287600|P1|COMPLETED|Treatment Period 2 (14 Days)||34
8227094|NCT02014480|20287595|P6|STARTED|Treatment Period 2 (14 Days)||34
8227095|NCT02014480|20287596|P5|STARTED|Treatment Period 2 (14 Days)||34
8227096|NCT02014480|20287597|P4|STARTED|Treatment Period 2 (14 Days)||32
8227097|NCT02014480|20287598|P3|STARTED|Treatment Period 2 (14 Days)||32
8227098|NCT02014480|20287599|P2|STARTED|Treatment Period 2 (14 Days)||34
8227099|NCT02014480|20287600|P1|STARTED|Treatment Period 2 (14 Days)||35
8227100|NCT02014480|20287595|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8227101|NCT02014480|20287596|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8227102|NCT02014480|20287597|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8227103|NCT02014480|20287598|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
8227104|NCT02014480|20287599|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8227105|NCT02014480|20287600|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8227106|NCT02014480|20287595|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||34
8227107|NCT02014480|20287596|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||34
8227108|NCT02014480|20287597|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||32
8227109|NCT02014480|20287598|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||32
8227110|NCT02014480|20287599|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||34
8227111|NCT02014480|20287600|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||35
8227112|NCT02014480|20287595|P6|STARTED|Washout Period 1 (10 to 14 Days)||34
8227113|NCT02014480|20287596|P5|STARTED|Washout Period 1 (10 to 14 Days)||34
8227114|NCT02014480|20287597|P4|STARTED|Washout Period 1 (10 to 14 Days)||32
8227115|NCT02014480|20287598|P3|STARTED|Washout Period 1 (10 to 14 Days)||33
8227116|NCT02014480|20287599|P2|STARTED|Washout Period 1 (10 to 14 Days)||34
8227117|NCT02014480|20287600|P1|STARTED|Washout Period 1 (10 to 14 Days)||35
8227118|NCT02014480|20287595|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8227119|NCT02014480|20287596|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8227120|NCT02014480|20287597|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8227121|NCT02014480|20287598|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8227122|NCT02014480|20287599|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8227123|NCT02014480|20287600|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8227124|NCT02014480|20287595|P6|COMPLETED|Treatment Period 1 (14 Days)||34
8227125|NCT02014480|20287596|P5|COMPLETED|Treatment Period 1 (14 Days)||34
8227126|NCT02014480|20287597|P4|COMPLETED|Treatment Period 1 (14 Days)||32
8227127|NCT02014480|20287598|P3|COMPLETED|Treatment Period 1 (14 Days)||33
8227128|NCT02014480|20287599|P2|COMPLETED|Treatment Period 1 (14 Days)||34
8227129|NCT02014480|20287600|P1|COMPLETED|Treatment Period 1 (14 Days)||35
8227130|NCT02014480|20287595|P6|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
8227131|NCT02014480|20287596|P5|STARTED|Treatment Period 1 (14 Days)||35
8227132|NCT02014480|20287597|P4|STARTED|Treatment Period 1 (14 Days)||34
8227133|NCT02014480|20287598|P3|STARTED|Treatment Period 1 (14 Days)||34
8227134|NCT02014480|20287599|P2|STARTED|Treatment Period 1 (14 Days)||35
8227135|NCT02014480|20287600|P1|STARTED|Treatment Period 1 (14 Days)||35
8227136|NCT02014467|20287619|P2|NOT COMPLETED|Overall Study||7
8227137|NCT02014467|20287620|P1|NOT COMPLETED|Overall Study||25
8227138|NCT02014467|20287619|P2|COMPLETED|Overall Study||112
8227139|NCT02014467|20287620|P1|COMPLETED|Overall Study||340
8227140|NCT02014467|20287619|P2|STARTED|Overall Study||119
8227141|NCT02014467|20287620|P1|STARTED|Overall Study||365
8227142|NCT02014441|20287680|P1|NOT COMPLETED|Overall Study||12
8227143|NCT02014441|20287680|P1|COMPLETED|Overall Study||49
8227144|NCT02014441|20287680|P1|Received Treatment|Overall Study||60
8227145|NCT02014441|20287680|P1|STARTED|Overall Study||61
8227146|NCT02014402|20287776|P4|NOT COMPLETED|Overall Study||3
8227147|NCT02014402|20287777|P3|NOT COMPLETED|Overall Study||3
8227148|NCT02014402|20287778|P2|NOT COMPLETED|Overall Study||3
8227149|NCT02014402|20287779|P1|NOT COMPLETED|Overall Study||2
8227150|NCT02014402|20287776|P4|COMPLETED|Overall Study||82
8227151|NCT02014402|20287777|P3|COMPLETED|Overall Study||32
8227152|NCT02014402|20287778|P2|COMPLETED|Overall Study||27
8227153|NCT02014402|20287779|P1|COMPLETED|Overall Study||29
8227154|NCT02014402|20287776|P4|Bovine Thrombin|Overall Study||28
8227155|NCT02014402|20287777|P3|Bovine Thrombin|Overall Study||12
8227156|NCT02014402|20287778|P2|Bovine Thrombin|Overall Study||10
8227157|NCT02014402|20287779|P1|Bovine Thrombin|Overall Study||11
8227158|NCT02014402|20287776|P4|Human Thrombin|Overall Study||57
8227159|NCT02014402|20287777|P3|Human Thrombin|Overall Study||23
8227160|NCT02014402|20287778|P2|Human Thrombin|Overall Study||20
8227161|NCT02014402|20287779|P1|Human Thrombin|Overall Study||20
8227162|NCT02014402|20287776|P4|STARTED|Overall Study||85
8227163|NCT02014402|20287777|P3|STARTED|Overall Study||35
8227164|NCT02014402|20287778|P2|STARTED|Overall Study||30
8227165|NCT02014402|20287779|P1|STARTED|Overall Study||31
8227166|NCT02014376|20287809|P3|NOT COMPLETED|Overall Study||0
8227167|NCT02014376|20287810|P2|NOT COMPLETED|Overall Study||1
8227168|NCT02014376|20287811|P1|NOT COMPLETED|Overall Study||3
8227169|NCT02014376|20287809|P3|COMPLETED|Overall Study||17
8227170|NCT02014376|20287810|P2|COMPLETED|Overall Study||15
8227171|NCT02014376|20287811|P1|COMPLETED|Overall Study||12
8227172|NCT02014376|20287809|P3|Received at Least 1 Dose of Study Drug|Overall Study||17
8227173|NCT02014376|20287810|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
8227174|NCT02014376|20287811|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
8227175|NCT02014376|20287809|P3|STARTED|Overall Study||17
8227176|NCT02014376|20287810|P2|STARTED|Overall Study||16
8227177|NCT02014376|20287811|P1|STARTED|Overall Study||15
8227178|NCT02014363|20287837|P3|NOT COMPLETED|Overall Study||24
8227179|NCT02014363|20287838|P2|NOT COMPLETED|Overall Study||19
8227180|NCT02014363|20287839|P1|NOT COMPLETED|Overall Study||17
8227181|NCT02014363|20287837|P3|COMPLETED|Overall Study||31
8227182|NCT02014363|20287838|P2|COMPLETED|Overall Study||35
8227183|NCT02014363|20287839|P1|COMPLETED|Overall Study||38
8227184|NCT02014363|20287837|P3|STARTED|Overall Study||55
8227185|NCT02014363|20287838|P2|STARTED|Overall Study||54
8227186|NCT02014363|20287839|P1|STARTED|Overall Study||55
8227187|NCT02014272|20287847|P2|NOT COMPLETED|Intervention Period 2||0
8227188|NCT02014272|20287848|P1|NOT COMPLETED|Intervention Period 2||0
8227189|NCT02014272|20287847|P2|COMPLETED|Intervention Period 2||13
8227190|NCT02014272|20287848|P1|COMPLETED|Intervention Period 2||13
8227191|NCT02014272|20287847|P2|STARTED|Intervention Period 2||13
8227192|NCT02014272|20287848|P1|STARTED|Intervention Period 2||13
8227193|NCT02014272|20287847|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8227194|NCT02014272|20287848|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8227195|NCT02014272|20287847|P2|COMPLETED|Washout Period 1 (7 Days)||13
8227196|NCT02014272|20287848|P1|COMPLETED|Washout Period 1 (7 Days)||13
8227197|NCT02014272|20287847|P2|STARTED|Washout Period 1 (7 Days)||13
8227198|NCT02014272|20287848|P1|STARTED|Washout Period 1 (7 Days)||13
8227199|NCT02014272|20287847|P2|NOT COMPLETED|Intervention Period 1||1
8227200|NCT02014272|20287848|P1|NOT COMPLETED|Intervention Period 1||1
8227201|NCT02014272|20287847|P2|COMPLETED|Intervention Period 1||13
8227202|NCT02014272|20287848|P1|COMPLETED|Intervention Period 1||13
8227203|NCT02014272|20287847|P2|STARTED|Intervention Period 1||14
8227204|NCT02014272|20287848|P1|STARTED|Intervention Period 1||14
8227205|NCT02014129|20287869|P3|NOT COMPLETED|Overall Study||0
8227206|NCT02014129|20287870|P2|NOT COMPLETED|Overall Study||0
8227207|NCT02014129|20287871|P1|NOT COMPLETED|Overall Study||0
8227208|NCT02014129|20287869|P3|COMPLETED|Overall Study||6
8227209|NCT02014129|20287870|P2|COMPLETED|Overall Study||3
8227210|NCT02014129|20287871|P1|COMPLETED|Overall Study||3
8227211|NCT02014129|20287869|P3|Received at Least One Dose of Study Drug|Overall Study||6
8227212|NCT02014129|20287870|P2|Received at Least One Dose of Study Drug|Overall Study||3
8227213|NCT02014129|20287871|P1|Received at Least One Dose of Study Drug|Overall Study||3
8227214|NCT02014129|20287869|P3|STARTED|Overall Study||6
8227215|NCT02014129|20287870|P2|STARTED|Overall Study||3
8227216|NCT02014129|20287871|P1|STARTED|Overall Study||3
8227217|NCT02014116|20287897|P9|NOT COMPLETED|Overall Study||10
8227218|NCT02014116|20287898|P8|NOT COMPLETED|Overall Study||5
8227219|NCT02014116|20287899|P7|NOT COMPLETED|Overall Study||1
8227220|NCT02014116|20287900|P6|NOT COMPLETED|Overall Study||16
8227221|NCT02014116|20287901|P5|NOT COMPLETED|Overall Study||2
8227222|NCT02014116|20287902|P4|NOT COMPLETED|Overall Study||7
8227223|NCT02014116|20287903|P3|NOT COMPLETED|Overall Study||3
8227224|NCT02014116|20287904|P2|NOT COMPLETED|Overall Study||4
8227225|NCT02014116|20287905|P1|NOT COMPLETED|Overall Study||3
8227226|NCT02014116|20287897|P9|COMPLETED|Overall Study||0
8227227|NCT02014116|20287898|P8|COMPLETED|Overall Study||0
8227228|NCT02014116|20287899|P7|COMPLETED|Overall Study||0
8227229|NCT02014116|20287900|P6|COMPLETED|Overall Study||0
8227230|NCT02014116|20287901|P5|COMPLETED|Overall Study||0
8227231|NCT02014116|20287902|P4|COMPLETED|Overall Study||0
8227232|NCT02014116|20287903|P3|COMPLETED|Overall Study||0
8227233|NCT02014116|20287904|P2|COMPLETED|Overall Study||0
8227234|NCT02014116|20287905|P1|COMPLETED|Overall Study||0
8227235|NCT02014116|20287897|P9|Received at Least One Dose of Study Drug|Overall Study||10
8227236|NCT02014116|20287898|P8|Received at Least One Dose of Study Drug|Overall Study||5
8227237|NCT02014116|20287899|P7|Received at Least One Dose of Study Drug|Overall Study||1
8227238|NCT02014116|20287900|P6|Received at Least One Dose of Study Drug|Overall Study||16
8227239|NCT02014116|20287901|P5|Received at Least One Dose of Study Drug|Overall Study||2
8227240|NCT02014116|20287902|P4|Received at Least One Dose of Study Drug|Overall Study||7
8227241|NCT02014116|20287903|P3|Received at Least One Dose of Study Drug|Overall Study||3
8227242|NCT02014116|20287904|P2|Received at Least One Dose of Study Drug|Overall Study||4
8227243|NCT02014116|20287905|P1|Received at Least One Dose of Study Drug|Overall Study||3
8227244|NCT02014116|20287897|P9|STARTED|Overall Study||10
8227245|NCT02014116|20287898|P8|STARTED|Overall Study||5
8227246|NCT02014116|20287899|P7|STARTED|Overall Study||1
8227247|NCT02014116|20287900|P6|STARTED|Overall Study||16
8227248|NCT02014116|20287901|P5|STARTED|Overall Study||2
8227249|NCT02014116|20287902|P4|STARTED|Overall Study||7
8227250|NCT02014116|20287903|P3|STARTED|Overall Study||3
8227251|NCT02014116|20287904|P2|STARTED|Overall Study||4
8227252|NCT02014116|20287905|P1|STARTED|Overall Study||3
8227253|NCT02014051|20287956|P2|NOT COMPLETED|Overall Study||1
8227254|NCT02014051|20287957|P1|NOT COMPLETED|Overall Study||1
8227255|NCT02014051|20287956|P2|COMPLETED|Overall Study||5
8227256|NCT02014051|20287957|P1|COMPLETED|Overall Study||2
8227257|NCT02014051|20287956|P2|STARTED|Overall Study||6
8227258|NCT02014051|20287957|P1|STARTED|Overall Study||3
8227259|NCT02013830|20287970|P1|NOT COMPLETED|Overall Study||30
8227260|NCT02013830|20287970|P1|COMPLETED|Overall Study||15
8227261|NCT02013830|20287970|P1|STARTED|Overall Study||45
8227262|NCT02013817|20287981|P1|NOT COMPLETED|Overall Study||27
8227263|NCT02013817|20287981|P1|COMPLETED|Overall Study||16
8227264|NCT02013817|20287981|P1|STARTED|Overall Study||43
8227265|NCT02013791|20287999|P9|NOT COMPLETED|Period 2||0
8227266|NCT02013791|20288000|P8|NOT COMPLETED|Period 2||0
8227267|NCT02013791|20288001|P7|NOT COMPLETED|Period 2||0
8227268|NCT02013791|20288002|P6|NOT COMPLETED|Period 2||0
8227269|NCT02013791|20288003|P5|NOT COMPLETED|Period 2||0
8227270|NCT02013791|20288004|P4|NOT COMPLETED|Period 2||0
8227271|NCT02013791|20288005|P3|NOT COMPLETED|Period 2||0
8227272|NCT02013791|20288006|P2|NOT COMPLETED|Period 2||0
8227273|NCT02013791|20288007|P1|NOT COMPLETED|Period 2||0
8227274|NCT02013791|20287999|P9|COMPLETED|Period 2||0
8227275|NCT02013791|20288000|P8|COMPLETED|Period 2||0
8227276|NCT02013791|20288001|P7|COMPLETED|Period 2||3
8227277|NCT02013791|20288002|P6|COMPLETED|Period 2||0
8227278|NCT02013791|20288003|P5|COMPLETED|Period 2||0
8227279|NCT02013791|20288004|P4|COMPLETED|Period 2||0
8227280|NCT02013791|20288005|P3|COMPLETED|Period 2||2
8227281|NCT02013791|20288006|P2|COMPLETED|Period 2||0
8227282|NCT02013791|20288007|P1|COMPLETED|Period 2||0
8227283|NCT02013791|20287999|P9|STARTED|Period 2||0
8227284|NCT02013791|20288000|P8|STARTED|Period 2||0
8227285|NCT02013791|20288001|P7|STARTED|Period 2||3
8227286|NCT02013791|20288002|P6|STARTED|Period 2||0
8227287|NCT02013791|20288003|P5|STARTED|Period 2||0
8227288|NCT02013791|20288004|P4|STARTED|Period 2||0
8227289|NCT02013791|20288005|P3|STARTED|Period 2||2
8227290|NCT02013791|20288006|P2|STARTED|Period 2||0
8227291|NCT02013791|20288007|P1|STARTED|Period 2||0
8227292|NCT02013791|20287999|P9|NOT COMPLETED|Period 1||0
8227293|NCT02013791|20288000|P8|NOT COMPLETED|Period 1||1
8227294|NCT02013791|20288001|P7|NOT COMPLETED|Period 1||1
8227295|NCT02013791|20288002|P6|NOT COMPLETED|Period 1||0
8227296|NCT02013791|20288003|P5|NOT COMPLETED|Period 1||0
8227297|NCT02013791|20288004|P4|NOT COMPLETED|Period 1||1
8227298|NCT02013791|20288005|P3|NOT COMPLETED|Period 1||0
8227299|NCT02013791|20288006|P2|NOT COMPLETED|Period 1||2
8227300|NCT02013791|20288007|P1|NOT COMPLETED|Period 1||0
8227301|NCT02013791|20287999|P9|COMPLETED|Period 1||3
8227302|NCT02013791|20288000|P8|COMPLETED|Period 1||7
8227303|NCT02013791|20288001|P7|COMPLETED|Period 1||3
8227304|NCT02013791|20288002|P6|COMPLETED|Period 1||8
8227305|NCT02013791|20288003|P5|COMPLETED|Period 1||4
8227306|NCT02013791|20288004|P4|COMPLETED|Period 1||7
8227307|NCT02013791|20288005|P3|COMPLETED|Period 1||4
8227308|NCT02013791|20288006|P2|COMPLETED|Period 1||6
8227309|NCT02013791|20288007|P1|COMPLETED|Period 1||8
8227310|NCT02013791|20287999|P9|STARTED|Period 1||3
8227311|NCT02013791|20288000|P8|STARTED|Period 1||8
8227312|NCT02013791|20288001|P7|STARTED|Period 1||4
8227313|NCT02013791|20288002|P6|STARTED|Period 1||8
8227314|NCT02013791|20288003|P5|STARTED|Period 1||4
8227315|NCT02013791|20288004|P4|STARTED|Period 1||8
8227316|NCT02013791|20288005|P3|STARTED|Period 1||4
8227317|NCT02013791|20288006|P2|STARTED|Period 1||8
8227318|NCT02013791|20288007|P1|STARTED|Period 1||8
8227319|NCT02013778|20288028|P1|NOT COMPLETED|Overall Study||7
8227320|NCT02013778|20288028|P1|COMPLETED|Overall Study||1
8227321|NCT02013778|20288028|P1|STARTED|Overall Study||8
8227322|NCT02013765|20288032|P1|NOT COMPLETED|Overall Study||1
8227323|NCT02013765|20288032|P1|COMPLETED|Overall Study||4
8227324|NCT02013765|20288032|P1|STARTED|Overall Study||5
8227325|NCT02013687|20288046|P4|NOT COMPLETED|Overall Study||2
8227326|NCT02013687|20288047|P3|NOT COMPLETED|Overall Study||2
8227327|NCT02013687|20288048|P2|NOT COMPLETED|Overall Study||0
8227328|NCT02013687|20288049|P1|NOT COMPLETED|Overall Study||0
8227329|NCT02013687|20288046|P4|COMPLETED|Overall Study||14
8227330|NCT02013687|20288047|P3|COMPLETED|Overall Study||14
8227331|NCT02013687|20288048|P2|COMPLETED|Overall Study||6
8227332|NCT02013687|20288049|P1|COMPLETED|Overall Study||6
8227333|NCT02013687|20288046|P4|STARTED|Overall Study||16
8227334|NCT02013687|20288047|P3|STARTED|Overall Study||16
8227335|NCT02013687|20288048|P2|STARTED|Overall Study||6
8227336|NCT02013687|20288049|P1|STARTED|Overall Study||6
8227337|NCT02013674|20288081|P2|NOT COMPLETED|Overall Study||1
8227338|NCT02013674|20288082|P1|NOT COMPLETED|Overall Study||1
8227339|NCT02013674|20288081|P2|COMPLETED|Overall Study||14
8227340|NCT02013674|20288082|P1|COMPLETED|Overall Study||14
8227341|NCT02013674|20288081|P2|STARTED|Overall Study||15
8227342|NCT02013674|20288082|P1|STARTED|Overall Study||15
8227343|NCT02013622|20288132|P1|NOT COMPLETED|Overall Study||24
8227344|NCT02013622|20288132|P1|COMPLETED|Overall Study||25
8227345|NCT02013622|20288132|P1|STARTED|Overall Study||49
8227346|NCT02013609|20288152|P1|NOT COMPLETED|Overall Study||18
8227347|NCT02013609|20288152|P1|COMPLETED|Overall Study||29
8227348|NCT02013609|20288152|P1|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
8227349|NCT02013544|20288177|P2|NOT COMPLETED|Overall Study||20
8227350|NCT02013544|20288178|P1|NOT COMPLETED|Overall Study||11
8227351|NCT02013544|20288177|P2|COMPLETED|Overall Study||356
8227352|NCT02013544|20288178|P1|COMPLETED|Overall Study||171
8227353|NCT02013544|20288177|P2|ITT Population|Overall Study||325
8227354|NCT02013544|20288178|P1|ITT Population|Overall Study||157
8227355|NCT02013544|20288177|P2|Safety Population|Overall Study||374
8227356|NCT02013544|20288178|P1|Safety Population|Overall Study||180
8227357|NCT02013544|20288177|P2|STARTED|Overall Study||376
8227358|NCT02013544|20288178|P1|STARTED|Overall Study||182
8227359|NCT02013531|20288200|P1|NOT COMPLETED|Overall Study||5
8227360|NCT02013531|20288200|P1|COMPLETED|Overall Study||32
8227361|NCT02013531|20288200|P1|STARTED|Overall Study||37
8227362|NCT02013414|20288222|P1|NOT COMPLETED|Overall Study||0
8227363|NCT02013414|20288222|P1|COMPLETED|Overall Study||9
8227364|NCT02013414|20288222|P1|STARTED|Overall Study||9
8227365|NCT02013388|20288236|P8|NOT COMPLETED|Overall Study||0
8227366|NCT02013388|20288237|P7|NOT COMPLETED|Overall Study||0
8227367|NCT02013388|20288238|P6|NOT COMPLETED|Overall Study||0
8227368|NCT02013388|20288239|P5|NOT COMPLETED|Overall Study||1
8227369|NCT02013388|20288240|P4|NOT COMPLETED|Overall Study||0
8227370|NCT02013388|20288241|P3|NOT COMPLETED|Overall Study||0
8227371|NCT02013388|20288242|P2|NOT COMPLETED|Overall Study||0
8227372|NCT02013388|20288243|P1|NOT COMPLETED|Overall Study||1
8227373|NCT02013388|20288236|P8|COMPLETED|Overall Study||4
8227374|NCT02013388|20288237|P7|COMPLETED|Overall Study||6
8227375|NCT02013388|20288238|P6|COMPLETED|Overall Study||6
8227376|NCT02013388|20288239|P5|COMPLETED|Overall Study||5
8227377|NCT02013388|20288240|P4|COMPLETED|Overall Study||6
8227378|NCT02013388|20288241|P3|COMPLETED|Overall Study||6
8227379|NCT02013388|20288242|P2|COMPLETED|Overall Study||6
8227380|NCT02013388|20288243|P1|COMPLETED|Overall Study||8
8227381|NCT02013388|20288236|P8|STARTED|Overall Study||4
8227382|NCT02013388|20288237|P7|STARTED|Overall Study||6
8227383|NCT02013388|20288238|P6|STARTED|Overall Study||6
8227384|NCT02013388|20288239|P5|STARTED|Overall Study||6
8227385|NCT02013388|20288240|P4|STARTED|Overall Study||6
8227386|NCT02013388|20288241|P3|STARTED|Overall Study||6
8227387|NCT02013388|20288242|P2|STARTED|Overall Study||6
8227388|NCT02013388|20288243|P1|STARTED|Overall Study||9
8227389|NCT02013375|20288277|P1|NOT COMPLETED|Overall Study||2
8227390|NCT02013375|20288277|P1|COMPLETED|Overall Study||0
8227391|NCT02013375|20288277|P1|STARTED|Overall Study||2
8227392|NCT02013245|20288288|P4|NOT COMPLETED|Overall Study||0
8227393|NCT02013245|20288289|P3|NOT COMPLETED|Overall Study||0
8227394|NCT02013245|20288290|P2|NOT COMPLETED|Overall Study||1
8227395|NCT02013245|20288291|P1|NOT COMPLETED|Overall Study||0
8227396|NCT02013245|20288288|P4|COMPLETED|Overall Study||9
8227397|NCT02013245|20288289|P3|COMPLETED|Overall Study||9
8227398|NCT02013245|20288290|P2|COMPLETED|Overall Study||8
8227399|NCT02013245|20288291|P1|COMPLETED|Overall Study||9
8227400|NCT02013245|20288288|P4|STARTED|Overall Study||9
8227401|NCT02013245|20288289|P3|STARTED|Overall Study||9
8227402|NCT02013245|20288290|P2|STARTED|Overall Study||9
8227403|NCT02013245|20288291|P1|STARTED|Overall Study||9
8227404|NCT02013206|20288307|P2|NOT COMPLETED|Overall Study||22
8227405|NCT02013206|20288308|P1|NOT COMPLETED|Overall Study||27
8227406|NCT02013206|20288307|P2|COMPLETED|Overall Study||1
8227407|NCT02013206|20288308|P1|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
8227408|NCT02013206|20288307|P2|Received Study Drug|Overall Study||23
8227409|NCT02013206|20288308|P1|Received Study Drug|Overall Study||26
8227410|NCT02013206|20288307|P2|STARTED|Overall Study||23
8227411|NCT02013206|20288308|P1|STARTED|Overall Study||29
8227412|NCT02013180|20288330|P2|NOT COMPLETED|Overall Study||0
8227413|NCT02013180|20288331|P1|NOT COMPLETED|Overall Study||0
8227414|NCT02013180|20288330|P2|COMPLETED|Overall Study||361
8227415|NCT02013180|20288331|P1|COMPLETED|Overall Study||119
8227416|NCT02013180|20288330|P2|STARTED|Overall Study||361
8227417|NCT02013180|20288331|P1|STARTED|Overall Study||119
8227418|NCT02013167|20288339|P2|NOT COMPLETED|Overall Study||178
8227419|NCT02013167|20288340|P1|NOT COMPLETED|Overall Study||101
8227420|NCT02013167|20288339|P2|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
8227421|NCT02013167|20288340|P1|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
8227422|NCT02013167|20288339|P2|Received Treatment|Overall Study||267
8227423|NCT02013167|20288340|P1|Received Treatment|Overall Study||109
8227424|NCT02013167|20288339|P2|STARTED|Overall Study||271
8227425|NCT02013167|20288340|P1|STARTED|Overall Study||134
8227426|NCT02013050|20288371|P4|NOT COMPLETED|Overall Study||4
8227427|NCT02013050|20288372|P3|NOT COMPLETED|Overall Study||0
8227428|NCT02013050|20288373|P2|NOT COMPLETED|Overall Study||5
8227429|NCT02013050|20288374|P1|NOT COMPLETED|Overall Study||4
8227430|NCT02013050|20288371|P4|COMPLETED|Overall Study||19
8227431|NCT02013050|20288372|P3|COMPLETED|Overall Study||3
8227432|NCT02013050|20288373|P2|COMPLETED|Overall Study||36
8227433|NCT02013050|20288374|P1|COMPLETED|Overall Study||38
8227434|NCT02013050|20288371|P4|STARTED|Overall Study||23
8227435|NCT02013050|20288372|P3|STARTED|Overall Study||3
8227436|NCT02013050|20288373|P2|STARTED|Overall Study||41
8227437|NCT02013050|20288374|P1|STARTED|Overall Study||42
8227438|NCT02012959|20288416|P5|NOT COMPLETED|Treatment Phase B||0
8227439|NCT02012959|20288417|P4|NOT COMPLETED|Treatment Phase B||0
8227440|NCT02012959|20288418|P3|NOT COMPLETED|Treatment Phase B||0
8227441|NCT02012959|20288419|P2|NOT COMPLETED|Treatment Phase B||0
8227442|NCT02012959|20288420|P1|NOT COMPLETED|Treatment Phase B||0
8227443|NCT02012959|20288416|P5|COMPLETED|Treatment Phase B||1
8227444|NCT02012959|20288417|P4|COMPLETED|Treatment Phase B||1
8227445|NCT02012959|20288418|P3|COMPLETED|Treatment Phase B||3
8227446|NCT02012959|20288419|P2|COMPLETED|Treatment Phase B||2
8227447|NCT02012959|20288420|P1|COMPLETED|Treatment Phase B||0
8227448|NCT02012959|20288416|P5|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
8227449|NCT02012959|20288417|P4|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
8227450|NCT02012959|20288418|P3|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
8227451|NCT02012959|20288419|P2|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
8227452|NCT02012959|20288420|P1|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
8227453|NCT02012959|20288416|P5|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
8227454|NCT02012959|20288417|P4|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator's discretion|1
8227455|NCT02012959|20288418|P3|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
8227456|NCT02012959|20288419|P2|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
8227457|NCT02012959|20288420|P1|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
8227458|NCT02012959|20288416|P5|NOT COMPLETED|Treatment Phase A||0
8227459|NCT02012959|20288417|P4|NOT COMPLETED|Treatment Phase A||0
8227460|NCT02012959|20288418|P3|NOT COMPLETED|Treatment Phase A||0
8227461|NCT02012959|20288419|P2|NOT COMPLETED|Treatment Phase A||0
8227462|NCT02012959|20288420|P1|NOT COMPLETED|Treatment Phase A||2
8227463|NCT02012959|20288416|P5|COMPLETED|Treatment Phase A||0
8227464|NCT02012959|20288417|P4|COMPLETED|Treatment Phase A||0
8227465|NCT02012959|20288418|P3|COMPLETED|Treatment Phase A||0
8227466|NCT02012959|20288419|P2|COMPLETED|Treatment Phase A||0
8227467|NCT02012959|20288420|P1|COMPLETED|Treatment Phase A||7
8227468|NCT02012959|20288416|P5|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
8227469|NCT02012959|20288417|P4|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
8227470|NCT02012959|20288418|P3|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
8227471|NCT02012959|20288419|P2|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
8227472|NCT02012959|20288420|P1|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
8227473|NCT02012959|20288416|P5|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
8227567|NCT02012192|20288578|P1|STARTED|Overall Study||90
8227474|NCT02012959|20288417|P4|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
8227475|NCT02012959|20288418|P3|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
8227476|NCT02012959|20288419|P2|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
8227477|NCT02012959|20288420|P1|STARTED|Treatment Phase A||9
8227478|NCT02012686|20288433|P2|NOT COMPLETED|Overall Study||2
8227479|NCT02012686|20288434|P1|NOT COMPLETED|Overall Study||0
8227480|NCT02012686|20288433|P2|COMPLETED|Overall Study||48
8227481|NCT02012686|20288434|P1|COMPLETED|Overall Study||50
8227482|NCT02012686|20288433|P2|STARTED|Overall Study||50
8227483|NCT02012686|20288434|P1|STARTED|Overall Study||50
8227484|NCT02012621|20288446|P1|NOT COMPLETED|Overall Study||0
8227485|NCT02012621|20288446|P1|COMPLETED|Overall Study||807
8227486|NCT02012621|20288446|P1|Visit 3 Completed|Overall Study||444
8227487|NCT02012621|20288446|P1|Visit 2 Completed|Overall Study||688
8227488|NCT02012621|20288446|P1|Visit 1 Completed|Overall Study||807
8227489|NCT02012621|20288446|P1|STARTED|Overall Study||807
8227490|NCT02012608|20288454|P2|NOT COMPLETED|Overall Study||0
8227491|NCT02012608|20288455|P1|NOT COMPLETED|Overall Study||3
8227492|NCT02012608|20288454|P2|COMPLETED|Overall Study||7
8227493|NCT02012608|20288455|P1|COMPLETED|Overall Study||4
8227494|NCT02012608|20288454|P2|STARTED|Overall Study||7
8227495|NCT02012608|20288455|P1|STARTED|Overall Study||7
8227496|NCT02012582|20288465|P4|NOT COMPLETED|Overall Study||1
8227497|NCT02012582|20288466|P3|NOT COMPLETED|Overall Study||0
8227498|NCT02012582|20288467|P2|NOT COMPLETED|Overall Study||0
8227499|NCT02012582|20288468|P1|NOT COMPLETED|Overall Study||0
8227500|NCT02012582|20288465|P4|COMPLETED|Overall Study||7
8227501|NCT02012582|20288466|P3|COMPLETED|Overall Study||8
8227502|NCT02012582|20288467|P2|COMPLETED|Overall Study||8
8227503|NCT02012582|20288468|P1|COMPLETED|Overall Study||8
8227504|NCT02012582|20288465|P4|STARTED|Overall Study||8
8227505|NCT02012582|20288466|P3|STARTED|Overall Study||8
8227506|NCT02012582|20288467|P2|STARTED|Overall Study||8
8227507|NCT02012582|20288468|P1|STARTED|Overall Study||8
8227508|NCT02012491|20288496|P2|NOT COMPLETED|Overall Study||1
8227509|NCT02012491|20288497|P1|NOT COMPLETED|Overall Study||2
8227510|NCT02012491|20288496|P2|COMPLETED|Overall Study||148
8227511|NCT02012491|20288497|P1|COMPLETED|Overall Study||149
8227512|NCT02012491|20288496|P2|STARTED|Overall Study||149
8227513|NCT02012491|20288497|P1|STARTED|Overall Study||151
8227514|NCT02012452|20288515|P2|NOT COMPLETED|Overall Study||1
8227515|NCT02012452|20288516|P1|NOT COMPLETED|Overall Study||6
8227516|NCT02012452|20288515|P2|COMPLETED|Overall Study||1
8227517|NCT02012452|20288516|P1|COMPLETED|Overall Study||1
8227518|NCT02012452|20288515|P2|STARTED|Overall Study||2
8227519|NCT02012452|20288516|P1|STARTED|Overall Study||7
8227520|NCT02012348|20288527|P3|NOT COMPLETED|Overall Study||0
8227521|NCT02012348|20288528|P2|NOT COMPLETED|Overall Study||0
8227522|NCT02012348|20288529|P1|NOT COMPLETED|Overall Study||0
8227523|NCT02012348|20288527|P3|COMPLETED|Overall Study||10
8227524|NCT02012348|20288528|P2|COMPLETED|Overall Study||10
8227525|NCT02012348|20288529|P1|COMPLETED|Overall Study||10
8227526|NCT02012348|20288527|P3|STARTED|Overall Study||10
8227527|NCT02012348|20288528|P2|STARTED|Overall Study||10
8227528|NCT02012348|20288529|P1|STARTED|Overall Study||10
8227529|NCT02012283|20288542|P2|NOT COMPLETED|Third Intervention||0
8227530|NCT02012283|20288543|P1|NOT COMPLETED|Third Intervention||0
8227531|NCT02012283|20288542|P2|COMPLETED|Third Intervention||10
8227532|NCT02012283|20288543|P1|COMPLETED|Third Intervention||10
8227533|NCT02012283|20288542|P2|STARTED|Third Intervention||10
8227534|NCT02012283|20288543|P1|STARTED|Third Intervention||10
8227535|NCT02012283|20288542|P2|NOT COMPLETED|Second Intervention||0
8227536|NCT02012283|20288543|P1|NOT COMPLETED|Second Intervention||0
8227537|NCT02012283|20288542|P2|COMPLETED|Second Intervention||10
8227538|NCT02012283|20288543|P1|COMPLETED|Second Intervention||10
8227539|NCT02012283|20288542|P2|STARTED|Second Intervention||10
8227540|NCT02012283|20288543|P1|STARTED|Second Intervention||10
8227541|NCT02012283|20288542|P2|NOT COMPLETED|First Intervention||0
8227542|NCT02012283|20288543|P1|NOT COMPLETED|First Intervention||0
8227543|NCT02012283|20288542|P2|COMPLETED|First Intervention||10
8227544|NCT02012283|20288543|P1|COMPLETED|First Intervention||10
8227545|NCT02012283|20288542|P2|STARTED|First Intervention||10
8227546|NCT02012283|20288543|P1|STARTED|First Intervention||10
8227547|NCT02012218|20288559|P5|NOT COMPLETED|Overall Study||1
8227548|NCT02012218|20288560|P4|NOT COMPLETED|Overall Study||2
8227549|NCT02012218|20288561|P3|NOT COMPLETED|Overall Study||2
8227550|NCT02012218|20288562|P2|NOT COMPLETED|Overall Study||1
8227551|NCT02012218|20288563|P1|NOT COMPLETED|Overall Study||4
8227552|NCT02012218|20288559|P5|COMPLETED|Overall Study||5
8227553|NCT02012218|20288560|P4|COMPLETED|Overall Study||17
8227554|NCT02012218|20288561|P3|COMPLETED|Overall Study||11
8227555|NCT02012218|20288562|P2|COMPLETED|Overall Study||10
8227556|NCT02012218|20288563|P1|COMPLETED|Overall Study||8
8227557|NCT02012218|20288559|P5|STARTED|Overall Study||6
8227558|NCT02012218|20288560|P4|STARTED|Overall Study||19
8227559|NCT02012218|20288561|P3|STARTED|Overall Study||13
8227560|NCT02012218|20288562|P2|STARTED|Overall Study||11
8227561|NCT02012218|20288563|P1|STARTED|Overall Study||12
8227562|NCT02012192|20288577|P2|NOT COMPLETED|Overall Study||0
8227563|NCT02012192|20288578|P1|NOT COMPLETED|Overall Study||27
8227564|NCT02012192|20288577|P2|COMPLETED|Overall Study||43
8227565|NCT02012192|20288578|P1|COMPLETED|Overall Study||63
8227566|NCT02012192|20288577|P2|STARTED|Overall Study||43
8227568|NCT02011945|20288587|P3|NOT COMPLETED|Overall Study||10
8227569|NCT02011945|20288588|P2|NOT COMPLETED|Overall Study||10
8227570|NCT02011945|20288589|P1|NOT COMPLETED|Overall Study||2
8227571|NCT02011945|20288587|P3|COMPLETED|Overall Study||6
8227572|NCT02011945|20288588|P2|COMPLETED|Overall Study||3
8227573|NCT02011945|20288589|P1|COMPLETED|Overall Study||0
8227574|NCT02011945|20288587|P3|STARTED|Overall Study||16
8227575|NCT02011945|20288588|P2|STARTED|Overall Study||13
8227576|NCT02011945|20288589|P1|STARTED|Overall Study||2
8227577|NCT02011893|20288666|P3|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
8227578|NCT02011893|20288667|P2|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
8227579|NCT02011893|20288668|P1|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
8227580|NCT02011893|20288666|P3|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
8227581|NCT02011893|20288667|P2|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
8227582|NCT02011893|20288668|P1|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
8227583|NCT02011893|20288666|P3|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
8227584|NCT02011893|20288667|P2|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
8227585|NCT02011893|20288668|P1|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
8227586|NCT02011893|20288666|P3|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
8227587|NCT02011893|20288667|P2|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
8227588|NCT02011893|20288668|P1|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
8227589|NCT02011893|20288666|P3|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
8227590|NCT02011893|20288667|P2|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
8227591|NCT02011893|20288668|P1|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
8227592|NCT02011893|20288666|P3|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
8227593|NCT02011893|20288667|P2|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
8227594|NCT02011893|20288668|P1|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
8227595|NCT02011893|20288666|P3|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
8227596|NCT02011893|20288667|P2|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
8227597|NCT02011893|20288668|P1|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
8227598|NCT02011893|20288666|P3|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
8227599|NCT02011893|20288667|P2|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
8227600|NCT02011893|20288668|P1|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
8227601|NCT02011893|20288666|P3|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
8227602|NCT02011893|20288667|P2|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
8227603|NCT02011893|20288668|P1|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
8227604|NCT02011893|20288666|P3|STARTED|Period 1 (Randomization to 12 Weeks)||55
8227605|NCT02011893|20288667|P2|STARTED|Period 1 (Randomization to 12 Weeks)||45
8227606|NCT02011893|20288668|P1|STARTED|Period 1 (Randomization to 12 Weeks)||0
8227607|NCT02011893|20288666|P3|NOT COMPLETED|Enrollment to Randomization||0
8227608|NCT02011893|20288667|P2|NOT COMPLETED|Enrollment to Randomization||0
8227609|NCT02011893|20288668|P1|NOT COMPLETED|Enrollment to Randomization||73
8227610|NCT02011893|20288666|P3|COMPLETED|Enrollment to Randomization||0
8227611|NCT02011893|20288667|P2|COMPLETED|Enrollment to Randomization||0
8227612|NCT02011893|20288668|P1|COMPLETED|Enrollment to Randomization||100
8227613|NCT02011893|20288666|P3|Randomization|Enrollment to Randomization||0
8227614|NCT02011893|20288667|P2|Randomization|Enrollment to Randomization||0
8227615|NCT02011893|20288668|P1|Randomization|Enrollment to Randomization||100
8227616|NCT02011893|20288666|P3|Permanent Stimulation Implant|Enrollment to Randomization||0
8227617|NCT02011893|20288667|P2|Permanent Stimulation Implant|Enrollment to Randomization||0
8227618|NCT02011893|20288668|P1|Permanent Stimulation Implant|Enrollment to Randomization||101
8227619|NCT02011893|20288666|P3|Trial Stimulation Implant|Enrollment to Randomization||0
8227620|NCT02011893|20288667|P2|Trial Stimulation Implant|Enrollment to Randomization||0
8227621|NCT02011893|20288668|P1|Trial Stimulation Implant|Enrollment to Randomization||121
8227622|NCT02011893|20288666|P3|Baseline|Enrollment to Randomization||0
8227623|NCT02011893|20288667|P2|Baseline|Enrollment to Randomization||0
8227624|NCT02011893|20288668|P1|Baseline|Enrollment to Randomization||141
8227625|NCT02011893|20288666|P3|STARTED|Enrollment to Randomization||0
8227626|NCT02011893|20288667|P2|STARTED|Enrollment to Randomization||0
8227627|NCT02011893|20288668|P1|STARTED|Enrollment to Randomization||173
8227628|NCT02011542|20288679|P1|NOT COMPLETED|Overall Study||1
8227629|NCT02011542|20288679|P1|COMPLETED|Overall Study||29
8227630|NCT02011542|20288679|P1|STARTED|Overall Study||30
8227631|NCT02011516|20288686|P2|NOT COMPLETED|Overall Study||2
8227632|NCT02011516|20288687|P1|NOT COMPLETED|Overall Study||4
8227633|NCT02011516|20288686|P2|COMPLETED|Overall Study||6
8227634|NCT02011516|20288687|P1|COMPLETED|Overall Study||4
8227635|NCT02011516|20288686|P2|STARTED|Overall Study||8
8227636|NCT02011516|20288687|P1|STARTED|Overall Study||8
8227637|NCT02011490|20288696|P6|NOT COMPLETED|Part 2||0
8227638|NCT02011490|20288697|P5|NOT COMPLETED|Part 2||0
8227639|NCT02011490|20288698|P4|NOT COMPLETED|Part 2||0
8227640|NCT02011490|20288699|P3|NOT COMPLETED|Part 2||0
8227641|NCT02011490|20288700|P2|NOT COMPLETED|Part 2||0
8227642|NCT02011490|20288701|P1|NOT COMPLETED|Part 2||0
8227643|NCT02011490|20288696|P6|COMPLETED|Part 2||6
8227644|NCT02011490|20288697|P5|COMPLETED|Part 2||6
8227645|NCT02011490|20288698|P4|COMPLETED|Part 2||6
8227646|NCT02011490|20288699|P3|COMPLETED|Part 2||0
8227647|NCT02011490|20288700|P2|COMPLETED|Part 2||0
8227648|NCT02011490|20288701|P1|COMPLETED|Part 2||0
8227649|NCT02011490|20288696|P6|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
8227650|NCT02011490|20288697|P5|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
8227651|NCT02011490|20288698|P4|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
8227652|NCT02011490|20288699|P3|STARTED|Part 2||0
8227653|NCT02011490|20288700|P2|STARTED|Part 2||0
8227654|NCT02011490|20288701|P1|STARTED|Part 2||0
8227655|NCT02011490|20288696|P6|NOT COMPLETED|Part 1||0
8227656|NCT02011490|20288697|P5|NOT COMPLETED|Part 1||0
8227657|NCT02011490|20288698|P4|NOT COMPLETED|Part 1||0
8227658|NCT02011490|20288699|P3|NOT COMPLETED|Part 1||0
8227659|NCT02011490|20288700|P2|NOT COMPLETED|Part 1||0
8227660|NCT02011490|20288701|P1|NOT COMPLETED|Part 1||0
8227661|NCT02011490|20288696|P6|COMPLETED|Part 1||0
8227662|NCT02011490|20288697|P5|COMPLETED|Part 1||0
8227663|NCT02011490|20288698|P4|COMPLETED|Part 1||0
8227664|NCT02011490|20288699|P3|COMPLETED|Part 1||8
8227665|NCT02011490|20288700|P2|COMPLETED|Part 1||8
8227666|NCT02011490|20288701|P1|COMPLETED|Part 1||8
8227667|NCT02011490|20288696|P6|STARTED|Part 1||0
8227668|NCT02011490|20288697|P5|STARTED|Part 1||0
8227669|NCT02011490|20288698|P4|STARTED|Part 1||0
8227670|NCT02011490|20288699|P3|STARTED|Part 1||8
8227671|NCT02011490|20288700|P2|STARTED|Part 1||8
8227672|NCT02011490|20288701|P1|STARTED|Part 1||8
8227673|NCT02011464|20288789|P2|NOT COMPLETED|Overall Study||0
8227674|NCT02011464|20288790|P1|NOT COMPLETED|Overall Study||0
8227675|NCT02011464|20288789|P2|COMPLETED|Overall Study||10
8227676|NCT02011464|20288790|P1|COMPLETED|Overall Study||10
8227677|NCT02011464|20288789|P2|STARTED|Overall Study||10
8227678|NCT02011464|20288790|P1|STARTED|Overall Study||10
8227679|NCT02011386|20288810|P1|NOT COMPLETED|Overall Study||5
8227680|NCT02011386|20288810|P1|COMPLETED|Overall Study||48
8227681|NCT02011386|20288810|P1|STARTED|Overall Study||53
8227682|NCT02011113|20288824|P1|NOT COMPLETED|Overall Study||36
8227683|NCT02011113|20288824|P1|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
8227684|NCT02011113|20288824|P1|STARTED|Overall Study||36
8227685|NCT02010996|20288840|P2|NOT COMPLETED|Overall Study||0
8227686|NCT02010996|20288841|P1|NOT COMPLETED|Overall Study||0
8227687|NCT02010996|20288840|P2|COMPLETED|Overall Study||36
8227688|NCT02010996|20288841|P1|COMPLETED|Overall Study||36
8227689|NCT02010996|20288840|P2|STARTED|Overall Study||36
8227690|NCT02010996|20288841|P1|STARTED|Overall Study||36
8227691|NCT02010775|20288856|P5|NOT COMPLETED|Overall Study||6
8227692|NCT02010775|20288857|P4|NOT COMPLETED|Overall Study||3
8227693|NCT02010775|20288858|P3|NOT COMPLETED|Overall Study||3
8227694|NCT02010775|20288859|P2|NOT COMPLETED|Overall Study||3
8227695|NCT02010775|20288860|P1|NOT COMPLETED|Overall Study||5
8227696|NCT02010775|20288856|P5|COMPLETED|Overall Study||31
8227697|NCT02010775|20288857|P4|COMPLETED|Overall Study||34
8227698|NCT02010775|20288858|P3|COMPLETED|Overall Study||34
8227699|NCT02010775|20288859|P2|COMPLETED|Overall Study||35
8227700|NCT02010775|20288860|P1|COMPLETED|Overall Study||33
8227701|NCT02010775|20288856|P5|STARTED|Overall Study||37
8227702|NCT02010775|20288857|P4|STARTED|Overall Study||37
8227703|NCT02010775|20288858|P3|STARTED|Overall Study||37
8227704|NCT02010775|20288859|P2|STARTED|Overall Study||38
8227705|NCT02010775|20288860|P1|STARTED|Overall Study||38
8227706|NCT02010697|20288880|P3|NOT COMPLETED|Overall Study||0
8227707|NCT02010697|20288881|P2|NOT COMPLETED|Overall Study||0
8227708|NCT02010697|20288882|P1|NOT COMPLETED|Overall Study||0
8227709|NCT02010697|20288880|P3|COMPLETED|Overall Study||1043
8227710|NCT02010697|20288881|P2|COMPLETED|Overall Study||1038
8227711|NCT02010697|20288882|P1|COMPLETED|Overall Study||1044
8227712|NCT02010697|20288880|P3|STARTED|Overall Study||1043
8227713|NCT02010697|20288881|P2|STARTED|Overall Study||1038
8227714|NCT02010697|20288882|P1|STARTED|Overall Study||1044
8227715|NCT02010684|20288901|P2|NOT COMPLETED|Overall Study||23
8227716|NCT02010684|20288902|P1|NOT COMPLETED|Overall Study||12
8227717|NCT02010684|20288901|P2|COMPLETED|Overall Study||59
8227718|NCT02010684|20288902|P1|COMPLETED|Overall Study||27
8227719|NCT02010684|20288901|P2|STARTED|Overall Study||82
8227720|NCT02010684|20288902|P1|STARTED|Overall Study||39
8227721|NCT02010645|20288920|P1|NOT COMPLETED|Overall Study||0
8227722|NCT02010645|20288920|P1|COMPLETED|Overall Study||6
8227723|NCT02010645|20288920|P1|STARTED|Overall Study||6
8227724|NCT02010632|20288924|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8227725|NCT02010632|20288925|P1|NOT COMPLETED|Second Intervention (7 Days)||1
8227726|NCT02010632|20288924|P2|COMPLETED|Second Intervention (7 Days)||16
8227727|NCT02010632|20288925|P1|COMPLETED|Second Intervention (7 Days)||15
8227728|NCT02010632|20288924|P2|STARTED|Second Intervention (7 Days)||16
8227729|NCT02010632|20288925|P1|STARTED|Second Intervention (7 Days)||16
8227730|NCT02010632|20288924|P2|NOT COMPLETED|Wash Out Period (14 Days)||0
8227731|NCT02010632|20288925|P1|NOT COMPLETED|Wash Out Period (14 Days)||0
8227732|NCT02010632|20288924|P2|COMPLETED|Wash Out Period (14 Days)||16
8227733|NCT02010632|20288925|P1|COMPLETED|Wash Out Period (14 Days)||16
8227734|NCT02010632|20288924|P2|STARTED|Wash Out Period (14 Days)||16
8227735|NCT02010632|20288925|P1|STARTED|Wash Out Period (14 Days)||16
8227736|NCT02010632|20288924|P2|NOT COMPLETED|First Intervention (7 Days)||0
8227737|NCT02010632|20288925|P1|NOT COMPLETED|First Intervention (7 Days)||0
8227738|NCT02010632|20288924|P2|COMPLETED|First Intervention (7 Days)||16
8227739|NCT02010632|20288925|P1|COMPLETED|First Intervention (7 Days)||16
8227740|NCT02010632|20288924|P2|STARTED|First Intervention (7 Days)||16
8227741|NCT02010632|20288925|P1|STARTED|First Intervention (7 Days)||16
8227742|NCT02010567|20288936|P5|NOT COMPLETED|Overall Study||1
8227743|NCT02010567|20288937|P4|NOT COMPLETED|Overall Study||0
8227744|NCT02010567|20288938|P3|NOT COMPLETED|Overall Study||1
8227745|NCT02010567|20288939|P2|NOT COMPLETED|Overall Study||0
8227746|NCT02010567|20288940|P1|NOT COMPLETED|Overall Study||0
8227747|NCT02010567|20288936|P5|COMPLETED|Overall Study||5
8227748|NCT02010567|20288937|P4|COMPLETED|Overall Study||3
8227749|NCT02010567|20288938|P3|COMPLETED|Overall Study||13
8227750|NCT02010567|20288939|P2|COMPLETED|Overall Study||6
8227751|NCT02010567|20288940|P1|COMPLETED|Overall Study||3
8227752|NCT02010567|20288936|P5|STARTED|Overall Study||6
8227753|NCT02010567|20288937|P4|STARTED|Overall Study||3
8227754|NCT02010567|20288938|P3|STARTED|Overall Study||14
8227755|NCT02010567|20288939|P2|STARTED|Overall Study||6
8227756|NCT02010567|20288940|P1|STARTED|Overall Study||3
8227757|NCT02010359|20288957|P2|NOT COMPLETED|Overall Study||2
8227758|NCT02010359|20288958|P1|NOT COMPLETED|Overall Study||2
8227759|NCT02010359|20288957|P2|COMPLETED|Overall Study||12
8227760|NCT02010359|20288958|P1|COMPLETED|Overall Study||13
8227761|NCT02010359|20288957|P2|STARTED|Overall Study||14
8227762|NCT02010359|20288958|P1|STARTED|Overall Study||15
8227763|NCT02010255|20288996|P14|NOT COMPLETED|Overall Study||1
8227764|NCT02010255|20288997|P13|NOT COMPLETED|Overall Study||0
8227765|NCT02010255|20288998|P12|NOT COMPLETED|Overall Study||1
8227766|NCT02010255|20288999|P11|NOT COMPLETED|Overall Study||2
8227767|NCT02010255|20289000|P10|NOT COMPLETED|Overall Study||0
8227768|NCT02010255|20289001|P9|NOT COMPLETED|Overall Study||1
8227769|NCT02010255|20289002|P8|NOT COMPLETED|Overall Study||1
8227770|NCT02010255|20289003|P7|NOT COMPLETED|Overall Study||1
8227771|NCT02010255|20289004|P6|NOT COMPLETED|Overall Study||0
8227772|NCT02010255|20289005|P5|NOT COMPLETED|Overall Study||4
8227773|NCT02010255|20289006|P4|NOT COMPLETED|Overall Study||6
8227774|NCT02010255|20289007|P3|NOT COMPLETED|Overall Study||7
8227775|NCT02010255|20289008|P2|NOT COMPLETED|Overall Study||2
8227776|NCT02010255|20289009|P1|NOT COMPLETED|Overall Study||6
8227777|NCT02010255|20288996|P14|COMPLETED|Overall Study||2
8227778|NCT02010255|20288997|P13|COMPLETED|Overall Study||3
8227779|NCT02010255|20288998|P12|COMPLETED|Overall Study||4
8227780|NCT02010255|20288999|P11|COMPLETED|Overall Study||1
8227781|NCT02010255|20289000|P10|COMPLETED|Overall Study||23
8227782|NCT02010255|20289001|P9|COMPLETED|Overall Study||21
8227783|NCT02010255|20289002|P8|COMPLETED|Overall Study||32
8227784|NCT02010255|20289003|P7|COMPLETED|Overall Study||33
8227785|NCT02010255|20289004|P6|COMPLETED|Overall Study||49
8227786|NCT02010255|20289005|P5|COMPLETED|Overall Study||48
8227787|NCT02010255|20289006|P4|COMPLETED|Overall Study||20
8227788|NCT02010255|20289007|P3|COMPLETED|Overall Study||18
8227789|NCT02010255|20289008|P2|COMPLETED|Overall Study||26
8227790|NCT02010255|20289009|P1|COMPLETED|Overall Study||22
8227791|NCT02010255|20288996|P14|STARTED|Overall Study||3
8227792|NCT02010255|20288997|P13|STARTED|Overall Study||3
8227793|NCT02010255|20288998|P12|STARTED|Overall Study||5
8227794|NCT02010255|20288999|P11|STARTED|Overall Study||3
8227795|NCT02010255|20289000|P10|STARTED|Overall Study||23
8227796|NCT02010255|20289001|P9|STARTED|Overall Study||22
8227797|NCT02010255|20289002|P8|STARTED|Overall Study||33
8227798|NCT02010255|20289003|P7|STARTED|Overall Study||34
8227799|NCT02010255|20289004|P6|STARTED|Overall Study||49
8227800|NCT02010255|20289005|P5|STARTED|Overall Study||52
8227801|NCT02010255|20289006|P4|STARTED|Overall Study||26
8227802|NCT02010255|20289007|P3|STARTED|Overall Study||25
8227803|NCT02010255|20289008|P2|STARTED|Overall Study||28
8227804|NCT02010255|20289009|P1|STARTED|Overall Study||28
8227805|NCT02010216|20289333|P1|NOT COMPLETED|Overall Study||0
8227806|NCT02010216|20289333|P1|COMPLETED|Overall Study||23
8227807|NCT02010216|20289333|P1|STARTED|Overall Study||23
8227808|NCT02010203|20289344|P5|NOT COMPLETED|Overall Study||13
8227809|NCT02010203|20289345|P4|NOT COMPLETED|Overall Study||3
8227810|NCT02010203|20289346|P3|NOT COMPLETED|Overall Study||10
8227811|NCT02010203|20289347|P2|NOT COMPLETED|Overall Study||9
8227812|NCT02010203|20289348|P1|NOT COMPLETED|Overall Study||0
8227813|NCT02010203|20289344|P5|COMPLETED|Overall Study||3
8227814|NCT02010203|20289345|P4|COMPLETED|Overall Study||23
8227815|NCT02010203|20289346|P3|COMPLETED|Overall Study||16
8227816|NCT02010203|20289347|P2|COMPLETED|Overall Study||17
8227817|NCT02010203|20289348|P1|COMPLETED|Overall Study||10
8227818|NCT02010203|20289344|P5|STARTED|Overall Study||16
8227819|NCT02010203|20289345|P4|STARTED|Overall Study||26
8227820|NCT02010203|20289346|P3|STARTED|Overall Study||26
8227821|NCT02010203|20289347|P2|STARTED|Overall Study||26
8227822|NCT02010203|20289348|P1|STARTED|Overall Study||10
8227823|NCT02010151|20289421|P2|NOT COMPLETED|Overall Study||0
8227824|NCT02010151|20289422|P1|NOT COMPLETED|Overall Study||0
8227825|NCT02010151|20289421|P2|COMPLETED|Overall Study|TM sent: 598|1696
8227826|NCT02010151|20289422|P1|COMPLETED|Overall Study|Text message (TM) sent: 0|1498
8227827|NCT02010151|20289421|P2|STARTED|Overall Study|January 2013 to December 2017|1696
8227828|NCT02010151|20289422|P1|STARTED|Overall Study|January 2013 to December 2017|1498
8227829|NCT02010021|20289434|P2|NOT COMPLETED|Overall Study||0
8227830|NCT02010021|20289435|P1|NOT COMPLETED|Overall Study||0
8227831|NCT02010021|20289434|P2|COMPLETED|Overall Study||7
8227832|NCT02010021|20289435|P1|COMPLETED|Overall Study||10
8227833|NCT02010021|20289434|P2|STARTED|Overall Study||7
8227834|NCT02010021|20289435|P1|STARTED|Overall Study||10
8227835|NCT02009982|20289445|P2|NOT COMPLETED|Overall Study||0
8227836|NCT02009982|20289446|P1|NOT COMPLETED|Overall Study||0
8227837|NCT02009982|20289445|P2|COMPLETED|Overall Study||2
8227838|NCT02009982|20289446|P1|COMPLETED|Overall Study||1
8227839|NCT02009982|20289445|P2|STARTED|Overall Study||2
8227840|NCT02009982|20289446|P1|STARTED|Overall Study||1
8227841|NCT02009930|20289454|P1|NOT COMPLETED|Overall Study||5
8227842|NCT02009930|20289454|P1|COMPLETED|Overall Study||107
8227843|NCT02009930|20289454|P1|STARTED|Overall Study|5 withdrawn|112
8227844|NCT02009878|20289479|P3|NOT COMPLETED|Overall Study||0
8227845|NCT02009878|20289480|P2|NOT COMPLETED|Overall Study||1
8227846|NCT02009878|20289481|P1|NOT COMPLETED|Overall Study||0
8227847|NCT02009878|20289479|P3|COMPLETED|Overall Study||9
8227848|NCT02009878|20289480|P2|COMPLETED|Overall Study||10
8227849|NCT02009878|20289481|P1|COMPLETED|Overall Study||10
8227850|NCT02009878|20289479|P3|STARTED|Overall Study||9
8227851|NCT02009878|20289480|P2|STARTED|Overall Study||11
8227852|NCT02009878|20289481|P1|STARTED|Overall Study||10
8227853|NCT02009865|20289515|P2|NOT COMPLETED|Overall Study||5
8227854|NCT02009865|20289516|P1|NOT COMPLETED|Overall Study||1
8227855|NCT02009865|20289515|P2|COMPLETED|Overall Study||76
8227856|NCT02009865|20289516|P1|COMPLETED|Overall Study||80
8227857|NCT02009865|20289515|P2|STARTED|Overall Study||81
8227858|NCT02009865|20289516|P1|STARTED|Overall Study||81
8227859|NCT02009722|20289532|P2|NOT COMPLETED|Overall Study||3
8227860|NCT02009722|20289533|P1|NOT COMPLETED|Overall Study||1
8227861|NCT02009722|20289532|P2|COMPLETED|Overall Study||40
8227862|NCT02009722|20289533|P1|COMPLETED|Overall Study||40
8227863|NCT02009722|20289532|P2|Received Intervention|Overall Study||42
8227864|NCT02009722|20289533|P1|Received Intervention|Overall Study||41
8227865|NCT02009722|20289532|P2|STARTED|Overall Study||43
8227866|NCT02009722|20289533|P1|STARTED|Overall Study||41
8227867|NCT02009696|20289557|P1|NOT COMPLETED|Overall Study||2
8227868|NCT02009696|20289557|P1|COMPLETED|Overall Study||219
8227869|NCT02009696|20289557|P1|STARTED|Overall Study||221
8227870|NCT02009501|20289567|P2|NOT COMPLETED|Overall Study||0
8227871|NCT02009501|20289568|P1|NOT COMPLETED|Overall Study||0
8227872|NCT02009501|20289567|P2|COMPLETED|Overall Study||11
8227873|NCT02009501|20289568|P1|COMPLETED|Overall Study||9
8227874|NCT02009501|20289567|P2|STARTED|Overall Study||11
8227875|NCT02009501|20289568|P1|STARTED|Overall Study||9
8227894|NCT02009046|20289611|P2|NOT COMPLETED|Overall Study||206
8227895|NCT02009046|20289612|P1|NOT COMPLETED|Overall Study||256
8227896|NCT02009046|20289611|P2|COMPLETED|Overall Study||678
8227897|NCT02009046|20289612|P1|COMPLETED|Overall Study||769
8227898|NCT02009046|20289611|P2|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
8227899|NCT02009046|20289612|P1|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
8227900|NCT02009046|20289611|P2|Ctrl Curriculum Only|Overall Study||456
8227901|NCT02009046|20289612|P1|Ctrl Curriculum Only|Overall Study||0
8227902|NCT02009046|20289611|P2|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
8227903|NCT02009046|20289612|P1|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
8227904|NCT02009046|20289611|P2|SEI Curriculum Only|Overall Study||0
8227905|NCT02009046|20289612|P1|SEI Curriculum Only|Overall Study||461
8227906|NCT02009046|20289611|P2|STARTED|Overall Study||884
8227907|NCT02009046|20289612|P1|STARTED|Overall Study||1025
8227908|NCT02008942|20289662|P2|NOT COMPLETED|Second Intervention||0
8227909|NCT02008942|20289663|P1|NOT COMPLETED|Second Intervention||1
8227910|NCT02008942|20289662|P2|COMPLETED|Second Intervention||30
8227911|NCT02008942|20289663|P1|COMPLETED|Second Intervention||25
8227912|NCT02008942|20289662|P2|STARTED|Second Intervention||30
8227913|NCT02008942|20289663|P1|STARTED|Second Intervention||26
8227914|NCT02008942|20289662|P2|NOT COMPLETED|First Intervention||0
8227915|NCT02008942|20289663|P1|NOT COMPLETED|First Intervention||0
8227916|NCT02008942|20289662|P2|COMPLETED|First Intervention||30
8227917|NCT02008942|20289663|P1|COMPLETED|First Intervention||27
8227918|NCT02008942|20289662|P2|STARTED|First Intervention||30
8227919|NCT02008942|20289663|P1|STARTED|First Intervention||27
8227920|NCT02008916|20289672|P3|NOT COMPLETED|Week 16 - 156||10
8227921|NCT02008916|20289673|P2|NOT COMPLETED|Week 16 - 156||13
8227922|NCT02008916|20289674|P1|NOT COMPLETED|Week 16 - 156||19
8227923|NCT02008916|20289672|P3|COMPLETED|Week 16 - 156||63
8227924|NCT02008916|20289673|P2|COMPLETED|Week 16 - 156||62
8227925|NCT02008916|20289674|P1|COMPLETED|Week 16 - 156||55
8227926|NCT02008916|20289672|P3|STARTED|Week 16 - 156||73
8227927|NCT02008916|20289673|P2|STARTED|Week 16 - 156||75
8227928|NCT02008916|20289674|P1|STARTED|Week 16 - 156||74
8227929|NCT02008916|20289672|P3|NOT COMPLETED|Primary Assessment (up to Week 16)||3
8227930|NCT02008916|20289673|P2|NOT COMPLETED|Primary Assessment (up to Week 16)||1
8227931|NCT02008916|20289674|P1|NOT COMPLETED|Primary Assessment (up to Week 16)||0
8227932|NCT02008916|20289672|P3|COMPLETED|Primary Assessment (up to Week 16)||73
8227933|NCT02008916|20289673|P2|COMPLETED|Primary Assessment (up to Week 16)||75
8227934|NCT02008916|20289674|P1|COMPLETED|Primary Assessment (up to Week 16)||74
8227935|NCT02008916|20289672|P3|Safety Set|Primary Assessment (up to Week 16)||75
8227936|NCT02008916|20289673|P2|Safety Set|Primary Assessment (up to Week 16)||76
8227937|NCT02008916|20289674|P1|Safety Set|Primary Assessment (up to Week 16)||74
8227938|NCT02008916|20289672|P3|FAS|Primary Assessment (up to Week 16)||76
8227939|NCT02008916|20289673|P2|FAS|Primary Assessment (up to Week 16)||76
8227940|NCT02008916|20289674|P1|FAS|Primary Assessment (up to Week 16)||74
8227941|NCT02008916|20289672|P3|STARTED|Primary Assessment (up to Week 16)||76
8227942|NCT02008916|20289673|P2|STARTED|Primary Assessment (up to Week 16)||76
8227943|NCT02008916|20289674|P1|STARTED|Primary Assessment (up to Week 16)||74
8227944|NCT02008890|20289710|P5|NOT COMPLETED|Extension Period||4
8227945|NCT02008890|20289711|P4|NOT COMPLETED|Extension Period||4
8227946|NCT02008890|20289712|P3|NOT COMPLETED|Extension Period||0
8227947|NCT02008890|20289713|P2|NOT COMPLETED|Extension Period||5
8227948|NCT02008890|20289714|P1|NOT COMPLETED|Extension Period||5
8227949|NCT02008890|20289710|P5|COMPLETED|Extension Period||13
8227950|NCT02008890|20289711|P4|COMPLETED|Extension Period||6
8227951|NCT02008890|20289712|P3|COMPLETED|Extension Period||0
8227952|NCT02008890|20289713|P2|COMPLETED|Extension Period||31
8227953|NCT02008890|20289714|P1|COMPLETED|Extension Period||26
8227954|NCT02008890|20289710|P5|STARTED|Extension Period||17
8227955|NCT02008890|20289711|P4|STARTED|Extension Period||10
8227956|NCT02008890|20289712|P3|STARTED|Extension Period||0
8227957|NCT02008890|20289713|P2|STARTED|Extension Period||36
8227958|NCT02008890|20289714|P1|STARTED|Extension Period||31
8227959|NCT02008890|20289710|P5|NOT COMPLETED|Period 2||8
8227960|NCT02008890|20289711|P4|NOT COMPLETED|Period 2||14
8227961|NCT02008890|20289712|P3|NOT COMPLETED|Period 2||1
8227962|NCT02008890|20289713|P2|NOT COMPLETED|Period 2||15
8227963|NCT02008890|20289714|P1|NOT COMPLETED|Period 2||27
8227964|NCT02008890|20289710|P5|COMPLETED|Period 2||20
8227965|NCT02008890|20289711|P4|COMPLETED|Period 2||13
8227966|NCT02008890|20289712|P3|COMPLETED|Period 2||9
8227967|NCT02008890|20289713|P2|COMPLETED|Period 2||49
8227968|NCT02008890|20289714|P1|COMPLETED|Period 2||38
8227969|NCT02008890|20289710|P5|STARTED|Period 2||28
8227970|NCT02008890|20289711|P4|STARTED|Period 2||27
8227971|NCT02008890|20289712|P3|STARTED|Period 2||10
8227972|NCT02008890|20289713|P2|STARTED|Period 2||64
8227973|NCT02008890|20289714|P1|STARTED|Period 2||65
8227974|NCT02008890|20289710|P5|NOT COMPLETED|Period 1||0
8227975|NCT02008890|20289711|P4|NOT COMPLETED|Period 1||0
8227976|NCT02008890|20289712|P3|NOT COMPLETED|Period 1||12
8227977|NCT02008890|20289713|P2|NOT COMPLETED|Period 1||15
8227978|NCT02008890|20289714|P1|NOT COMPLETED|Period 1||15
8227979|NCT02008890|20289710|P5|COMPLETED|Period 1||0
8227980|NCT02008890|20289711|P4|COMPLETED|Period 1||0
8227981|NCT02008890|20289712|P3|COMPLETED|Period 1||66
8227982|NCT02008890|20289713|P2|COMPLETED|Period 1||64
8227983|NCT02008890|20289714|P1|COMPLETED|Period 1||65
8227984|NCT02008890|20289710|P5|STARTED|Period 1||0
8227985|NCT02008890|20289711|P4|STARTED|Period 1||0
8227986|NCT02008890|20289712|P3|STARTED|Period 1||78
8227987|NCT02008890|20289713|P2|STARTED|Period 1||79
8227988|NCT02008890|20289714|P1|STARTED|Period 1||80
8227989|NCT02008877|20289750|P3|NOT COMPLETED|Overall Study||0
8227990|NCT02008877|20289751|P2|NOT COMPLETED|Overall Study||1
8227991|NCT02008877|20289752|P1|NOT COMPLETED|Overall Study||0
8227992|NCT02008877|20289750|P3|COMPLETED|Overall Study||10
8227993|NCT02008877|20289751|P2|COMPLETED|Overall Study||6
8227994|NCT02008877|20289752|P1|COMPLETED|Overall Study||3
8227995|NCT02008877|20289750|P3|STARTED|Overall Study||10
8227996|NCT02008877|20289751|P2|STARTED|Overall Study||7
8227997|NCT02008877|20289752|P1|STARTED|Overall Study||3
8227998|NCT02008773|20289771|P4|NOT COMPLETED|Overall Study||12
8227999|NCT02008773|20289772|P3|NOT COMPLETED|Overall Study||14
8228000|NCT02008773|20289773|P2|NOT COMPLETED|Overall Study||9
8228001|NCT02008773|20289774|P1|NOT COMPLETED|Overall Study||13
8228002|NCT02008773|20289771|P4|COMPLETED|Overall Study||38
8228003|NCT02008773|20289772|P3|COMPLETED|Overall Study||32
8228004|NCT02008773|20289773|P2|COMPLETED|Overall Study||25
8228005|NCT02008773|20289774|P1|COMPLETED|Overall Study||27
8228006|NCT02008773|20289771|P4|STARTED|Overall Study||50
8228007|NCT02008773|20289772|P3|STARTED|Overall Study||46
8228008|NCT02008773|20289773|P2|STARTED|Overall Study||34
8228009|NCT02008773|20289774|P1|STARTED|Overall Study||40
8228010|NCT02008682|20289804|P2|NOT COMPLETED|Overall Study||14
8228011|NCT02008682|20289805|P1|NOT COMPLETED|Overall Study||27
8228012|NCT02008682|20289804|P2|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
8228013|NCT02008682|20289805|P1|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
8228014|NCT02008682|20289804|P2|Exposed|Overall Study||184
8228015|NCT02008682|20289805|P1|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
8228016|NCT02008682|20289804|P2|STARTED|Overall Study||184
8228017|NCT02008682|20289805|P1|STARTED|Overall Study||184
8228018|NCT02008617|20289823|P2|NOT COMPLETED|Overall Study||0
8228019|NCT02008617|20289824|P1|NOT COMPLETED|Overall Study||0
8228020|NCT02008617|20289823|P2|COMPLETED|Overall Study||10
8228021|NCT02008617|20289824|P1|COMPLETED|Overall Study||8
8228022|NCT02008617|20289823|P2|STARTED|Overall Study||10
8228023|NCT02008617|20289824|P1|STARTED|Overall Study||8
8228024|NCT02008565|20289840|P4|NOT COMPLETED|Overall Study||0
8228025|NCT02008565|20289841|P3|NOT COMPLETED|Overall Study||2
8228026|NCT02008565|20289842|P2|NOT COMPLETED|Overall Study||1
8228027|NCT02008565|20289843|P1|NOT COMPLETED|Overall Study||1
8228028|NCT02008565|20289840|P4|COMPLETED|Overall Study||42
8228029|NCT02008565|20289841|P3|COMPLETED|Overall Study||86
8228030|NCT02008565|20289842|P2|COMPLETED|Overall Study||83
8228031|NCT02008565|20289843|P1|COMPLETED|Overall Study||85
8228032|NCT02008565|20289840|P4|STARTED|Overall Study||42
8228033|NCT02008565|20289841|P3|STARTED|Overall Study||88
8228034|NCT02008565|20289842|P2|STARTED|Overall Study||84
8228035|NCT02008565|20289843|P1|STARTED|Overall Study||86
8228036|NCT02008526|20289904|P3|NOT COMPLETED|Overall Study||9
8228037|NCT02008526|20289905|P2|NOT COMPLETED|Overall Study||14
8228038|NCT02008526|20289906|P1|NOT COMPLETED|Overall Study||8
8228039|NCT02008526|20289904|P3|COMPLETED|Overall Study||84
8228040|NCT02008526|20289905|P2|COMPLETED|Overall Study||85
8228041|NCT02008526|20289906|P1|COMPLETED|Overall Study||86
8228042|NCT02008526|20289904|P3|STARTED|Overall Study||93
8228043|NCT02008526|20289905|P2|STARTED|Overall Study||99
8228044|NCT02008526|20289906|P1|STARTED|Overall Study||94
8228051|NCT02008370|20289930|P1|NOT COMPLETED|Overall Study||7
8228052|NCT02008370|20289930|P1|COMPLETED|Overall Study||0
8228053|NCT02008370|20289930|P1|STARTED|Overall Study||7
8228054|NCT02008318|20289938|P2|NOT COMPLETED|Overall Study||1
8228055|NCT02008318|20289939|P1|NOT COMPLETED|Overall Study||12
8228056|NCT02008318|20289938|P2|COMPLETED|Overall Study||1
8228057|NCT02008318|20289939|P1|COMPLETED|Overall Study||29
8228058|NCT02008318|20289938|P2|Received At Least 1 Dose of Study Drug|Overall Study||2
8228059|NCT02008318|20289939|P1|Received At Least 1 Dose of Study Drug|Overall Study||41
8228060|NCT02008318|20289938|P2|STARTED|Overall Study||2
8228061|NCT02008318|20289939|P1|STARTED|Overall Study||41
8228062|NCT02008227|20289960|P2|NOT COMPLETED|Overall Study||613
8228063|NCT02008227|20289961|P1|NOT COMPLETED|Overall Study||612
8228064|NCT02008227|20289960|P2|COMPLETED|Overall Study||0
8228065|NCT02008227|20289961|P1|COMPLETED|Overall Study||0
8228066|NCT02008227|20289960|P2|Treated|Overall Study||608
8228067|NCT02008227|20289961|P1|Treated|Overall Study||579
8228068|NCT02008227|20289960|P2|STARTED|Overall Study||613
8228069|NCT02008227|20289961|P1|STARTED|Overall Study||612
8228070|NCT02008149|20290039|P3|NOT COMPLETED|Overall Study||0
8228071|NCT02008149|20290040|P2|NOT COMPLETED|Overall Study||1
8228072|NCT02008149|20290041|P1|NOT COMPLETED|Overall Study||3
8228073|NCT02008149|20290039|P3|COMPLETED|Overall Study||1
8228074|NCT02008149|20290040|P2|COMPLETED|Overall Study||0
8228075|NCT02008149|20290041|P1|COMPLETED|Overall Study||4
8228076|NCT02008149|20290039|P3|STARTED|Overall Study||1
8228077|NCT02008149|20290040|P2|STARTED|Overall Study||1
8228078|NCT02008149|20290041|P1|STARTED|Overall Study||7
8228079|NCT02007954|20290049|P1|NOT COMPLETED|Overall Study||7
8228080|NCT02007954|20290049|P1|COMPLETED|Overall Study||17
8228081|NCT02007954|20290049|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
8228082|NCT02007954|20290049|P1|Completed First TACE|Overall Study||24
8228083|NCT02007954|20290049|P1|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
8228084|NCT02007863|20290062|P1|NOT COMPLETED|Overall Study||0
8228085|NCT02007863|20290062|P1|COMPLETED|Overall Study||2
8228086|NCT02007863|20290062|P1|STARTED|Overall Study||2
8228087|NCT02007720|20290068|P2|NOT COMPLETED|Overall Study||72
8228088|NCT02007720|20290069|P1|NOT COMPLETED|Overall Study||82
8228089|NCT02007720|20290068|P2|COMPLETED|Overall Study||368
8228090|NCT02007720|20290069|P1|COMPLETED|Overall Study||354
8228091|NCT02007720|20290068|P2|Safety Set|Overall Study||432
8228092|NCT02007720|20290069|P1|Safety Set|Overall Study||426
8228093|NCT02007720|20290068|P2|Full Analysis Set|Overall Study||437
8228094|NCT02007720|20290069|P1|Full Analysis Set|Overall Study||433
8228095|NCT02007720|20290068|P2|STARTED|Overall Study||440
8228096|NCT02007720|20290069|P1|STARTED|Overall Study||436
8228097|NCT02007577|20290104|P2|NOT COMPLETED|Overall Study||1
8228098|NCT02007577|20290105|P1|NOT COMPLETED|Overall Study||1
8228099|NCT02007577|20290104|P2|COMPLETED|Overall Study||13
8228100|NCT02007577|20290105|P1|COMPLETED|Overall Study||26
8228101|NCT02007577|20290104|P2|STARTED|Overall Study||14
8228102|NCT02007577|20290105|P1|STARTED|Overall Study||27
8228131|NCT02007434|20290198|P8|NOT COMPLETED|Overall Study||0
8228132|NCT02007434|20290199|P7|NOT COMPLETED|Overall Study||0
8228133|NCT02007434|20290200|P6|NOT COMPLETED|Overall Study||0
8228134|NCT02007434|20290201|P5|NOT COMPLETED|Overall Study||0
8228135|NCT02007434|20290202|P4|NOT COMPLETED|Overall Study||0
8228136|NCT02007434|20290203|P3|NOT COMPLETED|Overall Study||1
8228137|NCT02007434|20290204|P2|NOT COMPLETED|Overall Study||1
8228138|NCT02007434|20290205|P1|NOT COMPLETED|Overall Study||1
8228139|NCT02007434|20290198|P8|COMPLETED|Overall Study||4
8228140|NCT02007434|20290199|P7|COMPLETED|Overall Study||18
8228141|NCT02007434|20290200|P6|COMPLETED|Overall Study||4
8228142|NCT02007434|20290201|P5|COMPLETED|Overall Study||16
8228143|NCT02007434|20290202|P4|COMPLETED|Overall Study||4
8228144|NCT02007434|20290203|P3|COMPLETED|Overall Study||16
8228145|NCT02007434|20290204|P2|COMPLETED|Overall Study||3
8228146|NCT02007434|20290205|P1|COMPLETED|Overall Study||16
8228147|NCT02007434|20290198|P8|Received Treatment|Overall Study||4
8228148|NCT02007434|20290199|P7|Received Treatment|Overall Study||18
8228149|NCT02007434|20290200|P6|Received Treatment|Overall Study||4
8228150|NCT02007434|20290201|P5|Received Treatment|Overall Study||16
8228151|NCT02007434|20290202|P4|Received Treatment|Overall Study||4
8228152|NCT02007434|20290203|P3|Received Treatment|Overall Study||17
8228153|NCT02007434|20290204|P2|Received Treatment|Overall Study||3
8228154|NCT02007434|20290205|P1|Received Treatment|Overall Study||17
8228155|NCT02007434|20290198|P8|STARTED|Overall Study||4
8228156|NCT02007434|20290199|P7|STARTED|Overall Study||18
8228157|NCT02007434|20290200|P6|STARTED|Overall Study||4
8228158|NCT02007434|20290201|P5|STARTED|Overall Study||16
8228159|NCT02007434|20290202|P4|STARTED|Overall Study||4
8228160|NCT02007434|20290203|P3|STARTED|Overall Study||17
8228161|NCT02007434|20290204|P2|STARTED|Overall Study||4
8228162|NCT02007434|20290205|P1|STARTED|Overall Study||17
8228163|NCT02007369|20290306|P3|NOT COMPLETED|Overall Study||0
8228164|NCT02007369|20290307|P2|NOT COMPLETED|Overall Study||0
8228165|NCT02007369|20290308|P1|NOT COMPLETED|Overall Study||0
8228166|NCT02007369|20290306|P3|COMPLETED|Overall Study||54
8228167|NCT02007369|20290307|P2|COMPLETED|Overall Study||40
8228168|NCT02007369|20290308|P1|COMPLETED|Overall Study||42
8228169|NCT02007369|20290306|P3|STARTED|Overall Study||54
8228170|NCT02007369|20290307|P2|STARTED|Overall Study||40
8228171|NCT02007369|20290308|P1|STARTED|Overall Study||42
8228172|NCT02007291|20290325|P2|NOT COMPLETED|Overall Study||0
8228173|NCT02007291|20290326|P1|NOT COMPLETED|Overall Study||0
8228174|NCT02007291|20290325|P2|COMPLETED|Overall Study||23
8228175|NCT02007291|20290326|P1|COMPLETED|Overall Study||48
8228176|NCT02007291|20290325|P2|STARTED|Overall Study||23
8228177|NCT02007291|20290326|P1|STARTED|Overall Study||48
8228178|NCT02007278|20290336|P2|NOT COMPLETED|Overall Study||3
8228179|NCT02007278|20290337|P1|NOT COMPLETED|Overall Study||2
8228180|NCT02007278|20290336|P2|COMPLETED|Overall Study||17
8228181|NCT02007278|20290337|P1|COMPLETED|Overall Study||18
8228182|NCT02007278|20290336|P2|STARTED|Overall Study||20
8228183|NCT02007278|20290337|P1|STARTED|Overall Study||20
8228184|NCT02007252|20290359|P2|NOT COMPLETED|Overall Study||11
8228185|NCT02007252|20290360|P1|NOT COMPLETED|Overall Study||11
8228186|NCT02007252|20290359|P2|COMPLETED|Overall Study||22
8228187|NCT02007252|20290360|P1|COMPLETED|Overall Study||20
8228188|NCT02007252|20290359|P2|Pharmacodynamic Analysis Set|Overall Study||33
8228189|NCT02007252|20290360|P1|Pharmacodynamic Analysis Set|Overall Study||31
8228190|NCT02007252|20290359|P2|Safety Analysis Set|Overall Study||33
8228191|NCT02007252|20290360|P1|Safety Analysis Set|Overall Study||31
8228192|NCT02007252|20290359|P2|STARTED|Overall Study||33
8228193|NCT02007252|20290360|P1|STARTED|Overall Study||31
8228194|NCT02007200|20290366|P1|NOT COMPLETED|Overall Study||0
8228195|NCT02007200|20290366|P1|COMPLETED|Overall Study||55
8228196|NCT02007200|20290366|P1|STARTED|Overall Study||55
8228197|NCT02007109|20290373|P1|NOT COMPLETED|Overall Study||111
8228198|NCT02007109|20290373|P1|COMPLETED|Overall Study||82
8228199|NCT02007109|20290373|P1|PACU Analysis|Overall Study||184
8228200|NCT02007109|20290373|P1|STARTED|Overall Study||193
8228201|NCT02007096|20290382|P2|NOT COMPLETED|Overall Study||16
8228202|NCT02007096|20290383|P1|NOT COMPLETED|Overall Study||11
8228203|NCT02007096|20290382|P2|COMPLETED|Overall Study||48
8228204|NCT02007096|20290383|P1|COMPLETED|Overall Study||52
8228205|NCT02007096|20290382|P2|STARTED|Overall Study||64
8228206|NCT02007096|20290383|P1|STARTED|Overall Study||63
8228207|NCT02007070|20290395|P1|NOT COMPLETED|Overall Study||33
8228208|NCT02007070|20290395|P1|COMPLETED|Overall Study|Completed 2 years of treatment.|5
8228209|NCT02007070|20290395|P1|STARTED|Overall Study||38
8228210|NCT02006979|20290416|P2|NOT COMPLETED|Overall Study||2
8228211|NCT02006979|20290417|P1|NOT COMPLETED|Overall Study||1
8228212|NCT02006979|20290416|P2|COMPLETED|Overall Study||11
8228213|NCT02006979|20290417|P1|COMPLETED|Overall Study||13
8228214|NCT02006979|20290416|P2|STARTED|Overall Study||13
8228215|NCT02006979|20290417|P1|STARTED|Overall Study||14
8228216|NCT02006927|20290429|P1|NOT COMPLETED|Overall Study||3
8228217|NCT02006927|20290429|P1|COMPLETED|Overall Study||0
8228218|NCT02006927|20290429|P1|STARTED|Overall Study||3
8228219|NCT02006888|20290437|P3|NOT COMPLETED|Overall Study||22
8228220|NCT02006888|20290438|P2|NOT COMPLETED|Overall Study||34
8228221|NCT02006888|20290439|P1|NOT COMPLETED|Overall Study||36
8228222|NCT02006888|20290437|P3|COMPLETED|Overall Study||58
8228223|NCT02006888|20290438|P2|COMPLETED|Overall Study||122
8228224|NCT02006888|20290439|P1|COMPLETED|Overall Study||122
8228225|NCT02006888|20290437|P3|STARTED|Overall Study||80
8228226|NCT02006888|20290438|P2|STARTED|Overall Study||156
8228227|NCT02006888|20290439|P1|STARTED|Overall Study||158
8228228|NCT02006836|20290450|P3|NOT COMPLETED|Self-control Period: Month 7-month 12||0
8228229|NCT02006836|20290451|P2|NOT COMPLETED|Self-control Period: Month 7-month 12||0
8228230|NCT02006836|20290452|P1|NOT COMPLETED|Self-control Period: Month 7-month 12||0
8228231|NCT02006836|20290450|P3|COMPLETED|Self-control Period: Month 7-month 12||19
8228232|NCT02006836|20290451|P2|COMPLETED|Self-control Period: Month 7-month 12||0
8228233|NCT02006836|20290452|P1|COMPLETED|Self-control Period: Month 7-month 12||0
8228234|NCT02006836|20290450|P3|STARTED|Self-control Period: Month 7-month 12||19
8228235|NCT02006836|20290451|P2|STARTED|Self-control Period: Month 7-month 12||0
8228236|NCT02006836|20290452|P1|STARTED|Self-control Period: Month 7-month 12||0
8228237|NCT02006836|20290450|P3|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
8228238|NCT02006836|20290451|P2|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
8228239|NCT02006836|20290452|P1|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
8228240|NCT02006836|20290450|P3|COMPLETED|Case-control Period: Month 1- Month 6||0
8228241|NCT02006836|20290451|P2|COMPLETED|Case-control Period: Month 1- Month 6||20
8228242|NCT02006836|20290452|P1|COMPLETED|Case-control Period: Month 1- Month 6||20
8228243|NCT02006836|20290450|P3|STARTED|Case-control Period: Month 1- Month 6||0
8228244|NCT02006836|20290451|P2|STARTED|Case-control Period: Month 1- Month 6||20
8228245|NCT02006836|20290452|P1|STARTED|Case-control Period: Month 1- Month 6||20
8228246|NCT02006758|20290468|P1|NOT COMPLETED|Overall Study||13
8228247|NCT02006758|20290468|P1|COMPLETED|Overall Study||55
8228248|NCT02006758|20290468|P1|12-month Follow up|Overall Study|12-month follow up completed|55
8228249|NCT02006758|20290468|P1|6-month Follow up|Overall Study|6-month follow up completed|60
8228250|NCT02006758|20290468|P1|1-month Follow up|Overall Study|1-month follow up completed|66
8228251|NCT02006758|20290468|P1|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67
8228252|NCT02006758|20290468|P1|STARTED|Overall Study|Total number of enrolled participants|68
8228253|NCT02006732|20290499|P4|NOT COMPLETED|Overall Study||4
8228254|NCT02006732|20290500|P3|NOT COMPLETED|Overall Study||9
8228255|NCT02006732|20290501|P2|NOT COMPLETED|Overall Study||12
8228256|NCT02006732|20290502|P1|NOT COMPLETED|Overall Study||20
8228257|NCT02006732|20290499|P4|COMPLETED|Overall Study||198
8228258|NCT02006732|20290500|P3|COMPLETED|Overall Study||193
8228259|NCT02006732|20290501|P2|COMPLETED|Overall Study||191
8228260|NCT02006732|20290502|P1|COMPLETED|Overall Study||182
8228261|NCT02006732|20290499|P4|STARTED|Overall Study||202
8228262|NCT02006732|20290500|P3|STARTED|Overall Study||202
8228263|NCT02006732|20290501|P2|STARTED|Overall Study||203
8228264|NCT02006732|20290502|P1|STARTED|Overall Study||202
8228265|NCT02006719|20290542|P2|NOT COMPLETED|Overall Study||5
8228266|NCT02006719|20290543|P1|NOT COMPLETED|Overall Study||18
8228267|NCT02006719|20290542|P2|COMPLETED|Overall Study||80
8228268|NCT02006719|20290543|P1|COMPLETED|Overall Study||219
8228269|NCT02006719|20290542|P2|STARTED|Overall Study||85
8228270|NCT02006719|20290543|P1|STARTED|Overall Study||237
8228271|NCT02006706|20290573|P1|NOT COMPLETED|Overall Study||1
8228272|NCT02006706|20290573|P1|COMPLETED|Overall Study||14
8228273|NCT02006706|20290573|P1|STARTED|Overall Study||15
8228274|NCT02006693|20290580|P2|NOT COMPLETED|Overall Study||13
8228275|NCT02006693|20290581|P1|NOT COMPLETED|Overall Study||28
8228276|NCT02006693|20290580|P2|COMPLETED|Overall Study||74
8228277|NCT02006693|20290581|P1|COMPLETED|Overall Study||84
8228278|NCT02006693|20290580|P2|STARTED|Overall Study||87
8228279|NCT02006693|20290581|P1|STARTED|Overall Study||112
8228280|NCT02006667|20290593|P1|NOT COMPLETED|Overall Study||6
8228281|NCT02006667|20290593|P1|COMPLETED|Overall Study||7
8228282|NCT02006667|20290593|P1|STARTED|Overall Study||13
8228283|NCT02006654|20290605|P2|NOT COMPLETED|Overall Study||44
8228284|NCT02006654|20290606|P1|NOT COMPLETED|Overall Study||45
8228285|NCT02006654|20290605|P2|COMPLETED|Overall Study||321
8228286|NCT02006654|20290606|P1|COMPLETED|Overall Study||324
8228287|NCT02006654|20290605|P2|Treated|Overall Study||363
8228288|NCT02006654|20290606|P1|Treated|Overall Study||365
8228289|NCT02006654|20290605|P2|STARTED|Overall Study||365
8228290|NCT02006654|20290606|P1|STARTED|Overall Study||369
8228291|NCT02006641|20290635|P3|NOT COMPLETED|Overall Study||36
8228292|NCT02006641|20290636|P2|NOT COMPLETED|Overall Study||33
8228293|NCT02006641|20290637|P1|NOT COMPLETED|Overall Study||26
8228294|NCT02006641|20290635|P3|COMPLETED|Overall Study||248
8228295|NCT02006641|20290636|P2|COMPLETED|Overall Study||257
8228296|NCT02006641|20290637|P1|COMPLETED|Overall Study||258
8228297|NCT02006641|20290635|P3|Treated|Overall Study||281
8228298|NCT02006641|20290636|P2|Treated|Overall Study||285
8228299|NCT02006641|20290637|P1|Treated|Overall Study||282
8228300|NCT02006641|20290635|P3|STARTED|Overall Study||284
8228301|NCT02006641|20290636|P2|STARTED|Overall Study||290
8228302|NCT02006641|20290637|P1|STARTED|Overall Study||284
8228303|NCT02006628|20290677|P2|NOT COMPLETED|Overall Study||2
8228304|NCT02006628|20290678|P1|NOT COMPLETED|Overall Study||3
8228305|NCT02006628|20290677|P2|COMPLETED|Overall Study||43
8228306|NCT02006628|20290678|P1|COMPLETED|Overall Study||40
8228307|NCT02006628|20290677|P2|Intention to Treat (ITT) Analysis Set|Overall Study||44
8228308|NCT02006628|20290678|P1|Intention to Treat (ITT) Analysis Set|Overall Study||42
8228309|NCT02006628|20290677|P2|Received at Least 1 Dose of Study Drug|Overall Study||45
8228310|NCT02006628|20290678|P1|Received at Least 1 Dose of Study Drug|Overall Study||43
8228311|NCT02006628|20290677|P2|STARTED|Overall Study||45
8228312|NCT02006628|20290678|P1|STARTED|Overall Study||43
8228313|NCT02006576|20290703|P3|NOT COMPLETED|Overall Study||17
8228314|NCT02006576|20290704|P2|NOT COMPLETED|Overall Study||7
8228315|NCT02006576|20290705|P1|NOT COMPLETED|Overall Study||18
8228316|NCT02006576|20290703|P3|COMPLETED|Overall Study||15
8228317|NCT02006576|20290704|P2|COMPLETED|Overall Study||44
8228318|NCT02006576|20290705|P1|COMPLETED|Overall Study||17
8228319|NCT02006576|20290703|P3|STARTED|Overall Study||32
8228320|NCT02006576|20290704|P2|STARTED|Overall Study||51
8228321|NCT02006576|20290705|P1|STARTED|Overall Study||35
8228322|NCT02006420|20290718|P2|NOT COMPLETED|Overall Study||0
8228323|NCT02006420|20290719|P1|NOT COMPLETED|Overall Study||0
8228324|NCT02006420|20290718|P2|COMPLETED|Overall Study||21
8228325|NCT02006420|20290719|P1|COMPLETED|Overall Study||24
8228326|NCT02006420|20290718|P2|STARTED|Overall Study||21
8228327|NCT02006420|20290719|P1|STARTED|Overall Study||24
8228328|NCT02006407|20290733|P1|NOT COMPLETED|Overall Study||0
8228329|NCT02006407|20290733|P1|COMPLETED|Overall Study||5
8228330|NCT02006407|20290733|P1|STARTED|Overall Study||5
8228331|NCT02006342|20290741|P2|NOT COMPLETED|Overall Study||0
8228332|NCT02006342|20290742|P1|NOT COMPLETED|Overall Study||1
8228333|NCT02006342|20290741|P2|COMPLETED|Overall Study||20
8228334|NCT02006342|20290742|P1|COMPLETED|Overall Study||19
8228335|NCT02006342|20290741|P2|STARTED|Overall Study||20
8228336|NCT02006342|20290742|P1|STARTED|Overall Study||20
8228337|NCT02006264|20290758|P2|NOT COMPLETED|Overall Study||0
8228338|NCT02006264|20290759|P1|NOT COMPLETED|Overall Study||1
8228339|NCT02006264|20290758|P2|COMPLETED|Overall Study||15
8228340|NCT02006264|20290759|P1|COMPLETED|Overall Study||14
8228341|NCT02006264|20290758|P2|STARTED|Overall Study||15
8228342|NCT02006264|20290759|P1|STARTED|Overall Study||15
8228343|NCT02006160|20290779|P2|NOT COMPLETED|Overall Study||0
8228344|NCT02006160|20290780|P1|NOT COMPLETED|Overall Study||4
8228345|NCT02006160|20290779|P2|COMPLETED|Overall Study||16
8228346|NCT02006160|20290780|P1|COMPLETED|Overall Study||41
8228347|NCT02006160|20290779|P2|STARTED|Overall Study||16
8228348|NCT02006160|20290780|P1|STARTED|Overall Study||45
8228349|NCT02006121|20290788|P2|NOT COMPLETED|Open Label Phase||0
8228350|NCT02006121|20290789|P1|NOT COMPLETED|Open Label Phase||25
8228351|NCT02006121|20290788|P2|COMPLETED|Open Label Phase||0
8228352|NCT02006121|20290789|P1|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59
8228353|NCT02006121|20290788|P2|STARTED|Open Label Phase|No patients received placebo in the open label phase|0
8228354|NCT02006121|20290789|P1|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84
8228355|NCT02006121|20290788|P2|NOT COMPLETED|Double Blind Phase||24
8228356|NCT02006121|20290789|P1|NOT COMPLETED|Double Blind Phase||12
8228357|NCT02006121|20290788|P2|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29
8228358|NCT02006121|20290789|P1|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42
8228359|NCT02006121|20290788|P2|STARTED|Double Blind Phase||53
8228360|NCT02006121|20290789|P1|STARTED|Double Blind Phase||54
8228361|NCT02006108|20290803|P1|NOT COMPLETED|Overall Study||2
8228362|NCT02006108|20290803|P1|COMPLETED|Overall Study||19
8228363|NCT02006108|20290803|P1|MR Imaging|Overall Study||19
8228364|NCT02006108|20290803|P1|STARTED|Overall Study||21
8228365|NCT02006056|20290810|P2|NOT COMPLETED|Overall Study||0
8228366|NCT02006056|20290811|P1|NOT COMPLETED|Overall Study||0
8228367|NCT02006056|20290810|P2|COMPLETED|Overall Study||4
8228368|NCT02006056|20290811|P1|COMPLETED|Overall Study||26
8228369|NCT02006056|20290810|P2|STARTED|Overall Study||4
8228370|NCT02006056|20290811|P1|STARTED|Overall Study||26
8228371|NCT02005887|20290822|P2|NOT COMPLETED|Overall Study||2
8228372|NCT02005887|20290823|P1|NOT COMPLETED|Overall Study||0
8228373|NCT02005887|20290822|P2|COMPLETED|Overall Study||23
8228374|NCT02005887|20290823|P1|COMPLETED|Overall Study||26
8228375|NCT02005887|20290822|P2|STARTED|Overall Study||25
8228376|NCT02005887|20290823|P1|STARTED|Overall Study||26
8228377|NCT02005692|20290841|P1|NOT COMPLETED|Overall Study||7
8228378|NCT02005692|20290841|P1|COMPLETED|Overall Study||63
8228379|NCT02005692|20290841|P1|STARTED|Overall Study||70
8228380|NCT02005666|20290849|P3|NOT COMPLETED|Overall Study||9
8228381|NCT02005666|20290850|P2|NOT COMPLETED|Overall Study||44
8228382|NCT02005666|20290851|P1|NOT COMPLETED|Overall Study||27
8228383|NCT02005666|20290849|P3|COMPLETED|Overall Study||160
8228384|NCT02005666|20290850|P2|COMPLETED|Overall Study||299
8228385|NCT02005666|20290851|P1|COMPLETED|Overall Study||311
8228386|NCT02005666|20290849|P3|STARTED|Overall Study||169
8228387|NCT02005666|20290850|P2|STARTED|Overall Study||343
8228388|NCT02005666|20290851|P1|STARTED|Overall Study||338
8228389|NCT02005627|20290867|P2|NOT COMPLETED|Overall Study||4
8228390|NCT02005627|20290868|P1|NOT COMPLETED|Overall Study||2
8228391|NCT02005627|20290867|P2|COMPLETED|Overall Study||19
8228392|NCT02005627|20290868|P1|COMPLETED|Overall Study||21
8228393|NCT02005627|20290867|P2|STARTED|Overall Study||23
8228394|NCT02005627|20290868|P1|STARTED|Overall Study||23
8228395|NCT02005601|20290884|P2|NOT COMPLETED|Overall Study||0
8228396|NCT02005601|20290885|P1|NOT COMPLETED|Overall Study||0
8228397|NCT02005601|20290884|P2|COMPLETED|Overall Study||53
8228398|NCT02005601|20290885|P1|COMPLETED|Overall Study||53
8228399|NCT02005601|20290884|P2|STARTED|Overall Study||53
8228400|NCT02005601|20290885|P1|STARTED|Overall Study||53
8228401|NCT02005562|20290897|P2|NOT COMPLETED|Overall Study||15
8228402|NCT02005562|20290898|P1|NOT COMPLETED|Overall Study||12
8228403|NCT02005562|20290897|P2|COMPLETED|Overall Study||110
8228404|NCT02005562|20290898|P1|COMPLETED|Overall Study||115
8228405|NCT02005562|20290897|P2|Transplanted|Overall Study||121
8228406|NCT02005562|20290898|P1|Transplanted|Overall Study||126
8228407|NCT02005562|20290897|P2|STARTED|Overall Study||125
8228408|NCT02005562|20290898|P1|STARTED|Overall Study||127
8228409|NCT02005549|20290926|P1|NOT COMPLETED|Overall Study||0
8228410|NCT02005549|20290926|P1|COMPLETED|Overall Study||18
8228411|NCT02005549|20290926|P1|STARTED|Overall Study||18
8228412|NCT02005536|20290932|P1|NOT COMPLETED|Overall Study||0
8228413|NCT02005536|20290932|P1|COMPLETED|Overall Study||60
8228414|NCT02005536|20290932|P1|STARTED|Overall Study||60
8228415|NCT02005510|20290942|P2|NOT COMPLETED|Rerandomized (Round 3)||0
8228416|NCT02005510|20290943|P1|NOT COMPLETED|Rerandomized (Round 3)||0
8228417|NCT02005510|20290942|P2|COMPLETED|Rerandomized (Round 3)||195
8228418|NCT02005510|20290943|P1|COMPLETED|Rerandomized (Round 3)||209
8228419|NCT02005510|20290942|P2|STARTED|Rerandomized (Round 3)||195
8228420|NCT02005510|20290943|P1|STARTED|Rerandomized (Round 3)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|209
8228421|NCT02005510|20290942|P2|NOT COMPLETED|Rerandomized (Round 2)||0
8228422|NCT02005510|20290943|P1|NOT COMPLETED|Rerandomized (Round 2)||0
8228423|NCT02005510|20290942|P2|COMPLETED|Rerandomized (Round 2)||1585
8228424|NCT02005510|20290943|P1|COMPLETED|Rerandomized (Round 2)||1631
8228425|NCT02005510|20290942|P2|STARTED|Rerandomized (Round 2)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|1585
8228426|NCT02005510|20290943|P1|STARTED|Rerandomized (Round 2)|Excludes 10 determined to be ineligible post-randomization due to delays in data warehouse update.|1631
8228427|NCT02005510|20290942|P2|NOT COMPLETED|Randomized (Round 1)||0
8228428|NCT02005510|20290943|P1|NOT COMPLETED|Randomized (Round 1)||0
8228429|NCT02005510|20290942|P2|COMPLETED|Randomized (Round 1)||8111
8228430|NCT02005510|20290943|P1|COMPLETED|Randomized (Round 1)||8120
8228431|NCT02005510|20290942|P2|STARTED|Randomized (Round 1)|Excludes 196 determined to be ineligible post-randomization due to delays in data warehouse update.|8111
8228432|NCT02005510|20290943|P1|STARTED|Randomized (Round 1)|Excludes 163 determined to be ineligible post-randomization due to delays in data warehouse update.|8120
8228433|NCT02005484|20290959|P1|NOT COMPLETED|Overall Study||4
8228434|NCT02005484|20290959|P1|COMPLETED|Overall Study||2
8228435|NCT02005484|20290959|P1|STARTED|Overall Study||6
8228444|NCT02005445|20291027|P2|NOT COMPLETED|Overall Study||1
8228445|NCT02005445|20291028|P1|NOT COMPLETED|Overall Study||0
8228446|NCT02005445|20291027|P2|COMPLETED|Overall Study||1
8228447|NCT02005445|20291028|P1|COMPLETED|Overall Study||2
8228448|NCT02005445|20291027|P2|STARTED|Overall Study||2
8228449|NCT02005445|20291028|P1|STARTED|Overall Study||2
8228450|NCT02005393|20291034|P1|NOT COMPLETED|Overall Study||0
8228451|NCT02005393|20291034|P1|COMPLETED|Overall Study||20
8228452|NCT02005393|20291034|P1|STARTED|Overall Study||20
8228453|NCT02005354|20291040|P2|NOT COMPLETED|Overall Study||0
8228454|NCT02005354|20291041|P1|NOT COMPLETED|Overall Study||0
8228455|NCT02005354|20291040|P2|COMPLETED|Overall Study||35
8228456|NCT02005354|20291041|P1|COMPLETED|Overall Study||35
8228457|NCT02005354|20291040|P2|STARTED|Overall Study||35
8228458|NCT02005354|20291041|P1|STARTED|Overall Study||35
8228459|NCT02005276|20291051|P4|NOT COMPLETED|Overall Study||3
8228460|NCT02005276|20291052|P3|NOT COMPLETED|Overall Study||3
8228461|NCT02005276|20291053|P2|NOT COMPLETED|Overall Study||2
8228462|NCT02005276|20291054|P1|NOT COMPLETED|Overall Study||5
8228463|NCT02005276|20291051|P4|COMPLETED|Overall Study||41
8228464|NCT02005276|20291052|P3|COMPLETED|Overall Study||56
8228465|NCT02005276|20291053|P2|COMPLETED|Overall Study||39
8228466|NCT02005276|20291054|P1|COMPLETED|Overall Study||60
8228467|NCT02005276|20291051|P4|Completed Intervention|Overall Study||42
8228468|NCT02005276|20291052|P3|Completed Intervention|Overall Study||56
8228469|NCT02005276|20291053|P2|Completed Intervention|Overall Study||39
8228470|NCT02005276|20291054|P1|Completed Intervention|Overall Study||61
8228471|NCT02005276|20291051|P4|STARTED|Overall Study||44
8228472|NCT02005276|20291052|P3|STARTED|Overall Study||59
8228473|NCT02005276|20291053|P2|STARTED|Overall Study||41
8228474|NCT02005276|20291054|P1|STARTED|Overall Study||65
8228475|NCT02005250|20291070|P2|NOT COMPLETED|Overall Study||5
8228476|NCT02005250|20291071|P1|NOT COMPLETED|Overall Study||15
8228477|NCT02005250|20291070|P2|COMPLETED|Overall Study||27
8228478|NCT02005250|20291071|P1|COMPLETED|Overall Study||46
8228479|NCT02005250|20291070|P2|STARTED|Overall Study||32
8228480|NCT02005250|20291071|P1|STARTED|Overall Study||61
8228481|NCT02005211|20291084|P7|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228482|NCT02005211|20291085|P6|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228483|NCT02005211|20291086|P5|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
8228484|NCT02005211|20291087|P4|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228485|NCT02005211|20291088|P3|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228486|NCT02005211|20291089|P2|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228487|NCT02005211|20291090|P1|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228488|NCT02005211|20291084|P7|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
8228489|NCT02005211|20291085|P6|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
8228490|NCT02005211|20291086|P5|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
8228491|NCT02005211|20291087|P4|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228492|NCT02005211|20291088|P3|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228493|NCT02005211|20291089|P2|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228494|NCT02005211|20291090|P1|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228495|NCT02005211|20291084|P7|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
8228496|NCT02005211|20291085|P6|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
8228497|NCT02005211|20291086|P5|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
8228498|NCT02005211|20291087|P4|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228499|NCT02005211|20291088|P3|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228500|NCT02005211|20291089|P2|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228501|NCT02005211|20291090|P1|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
8228502|NCT02005211|20291084|P7|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228503|NCT02005211|20291085|P6|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228504|NCT02005211|20291086|P5|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228505|NCT02005211|20291087|P4|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228506|NCT02005211|20291088|P3|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228507|NCT02005211|20291089|P2|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228508|NCT02005211|20291090|P1|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228509|NCT02005211|20291084|P7|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228510|NCT02005211|20291085|P6|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228511|NCT02005211|20291086|P5|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228512|NCT02005211|20291087|P4|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228513|NCT02005211|20291088|P3|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228514|NCT02005211|20291089|P2|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228515|NCT02005211|20291090|P1|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228516|NCT02005211|20291084|P7|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228517|NCT02005211|20291085|P6|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228518|NCT02005211|20291086|P5|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
8228519|NCT02005211|20291087|P4|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228520|NCT02005211|20291088|P3|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228521|NCT02005211|20291089|P2|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228522|NCT02005211|20291090|P1|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
8228523|NCT02005029|20291125|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8228524|NCT02005029|20291126|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8228525|NCT02005029|20291125|P2|COMPLETED|Second Intervention (1 Day)||5
8228526|NCT02005029|20291126|P1|COMPLETED|Second Intervention (1 Day)||4
8228527|NCT02005029|20291125|P2|STARTED|Second Intervention (1 Day)||5
8228528|NCT02005029|20291126|P1|STARTED|Second Intervention (1 Day)||4
8228529|NCT02005029|20291125|P2|NOT COMPLETED|Washout (2 Weeks)||0
8228530|NCT02005029|20291126|P1|NOT COMPLETED|Washout (2 Weeks)||0
8228531|NCT02005029|20291125|P2|COMPLETED|Washout (2 Weeks)||5
8228532|NCT02005029|20291126|P1|COMPLETED|Washout (2 Weeks)||4
8228533|NCT02005029|20291125|P2|STARTED|Washout (2 Weeks)||5
8228534|NCT02005029|20291126|P1|STARTED|Washout (2 Weeks)||4
8228535|NCT02005029|20291125|P2|NOT COMPLETED|First Intervention (1 Day)||0
8228536|NCT02005029|20291126|P1|NOT COMPLETED|First Intervention (1 Day)||1
8228537|NCT02005029|20291125|P2|COMPLETED|First Intervention (1 Day)||5
8228538|NCT02005029|20291126|P1|COMPLETED|First Intervention (1 Day)||4
8228539|NCT02005029|20291125|P2|STARTED|First Intervention (1 Day)||5
8228540|NCT02005029|20291126|P1|STARTED|First Intervention (1 Day)||5
8228541|NCT02005016|20291152|P1|NOT COMPLETED|Overall Study||2
8228542|NCT02005016|20291152|P1|COMPLETED|Overall Study||44
8228543|NCT02005016|20291152|P1|STARTED|Overall Study||46
8228544|NCT02004990|20291157|P1|NOT COMPLETED|Overall Study||0
8228545|NCT02004990|20291157|P1|COMPLETED|Overall Study||12
8228546|NCT02004990|20291157|P1|STARTED|Overall Study||12
8228547|NCT02004977|20291164|P2|NOT COMPLETED|Overall Study||5
8228548|NCT02004977|20291165|P1|NOT COMPLETED|Overall Study||54
8228549|NCT02004977|20291164|P2|COMPLETED|Overall Study||436
8228550|NCT02004977|20291165|P1|COMPLETED|Overall Study||409
8228551|NCT02004977|20291164|P2|STARTED|Overall Study||441
8228552|NCT02004977|20291165|P1|STARTED|Overall Study||463
8228553|NCT02004886|20291183|P4|NOT COMPLETED|Overall Study||0
8228554|NCT02004886|20291184|P3|NOT COMPLETED|Overall Study||0
8228555|NCT02004886|20291185|P2|NOT COMPLETED|Overall Study||1
8228556|NCT02004886|20291186|P1|NOT COMPLETED|Overall Study||1
8228557|NCT02004886|20291183|P4|COMPLETED|Overall Study||19
8228558|NCT02004886|20291184|P3|COMPLETED|Overall Study||18
8228559|NCT02004886|20291185|P2|COMPLETED|Overall Study||17
8228560|NCT02004886|20291186|P1|COMPLETED|Overall Study||18
8228561|NCT02004886|20291183|P4|STARTED|Overall Study||19
8228562|NCT02004886|20291184|P3|STARTED|Overall Study||18
8228563|NCT02004886|20291185|P2|STARTED|Overall Study||18
8228564|NCT02004886|20291186|P1|STARTED|Overall Study||19
8228565|NCT02004873|20291236|P1|NOT COMPLETED|Overall Study||424
8228566|NCT02004873|20291236|P1|COMPLETED|Overall Study|6-Month Follow-up|301
8228567|NCT02004873|20291236|P1|Micra Implant Success|Overall Study||719
8228568|NCT02004873|20291236|P1|STARTED|Overall Study|Micra Implant Attempt|725
8228569|NCT02004847|20291245|P2|NOT COMPLETED|Overall Study||1
8228570|NCT02004847|20291246|P1|NOT COMPLETED|Overall Study||1
8228571|NCT02004847|20291245|P2|COMPLETED|Overall Study||22
8228572|NCT02004847|20291246|P1|COMPLETED|Overall Study||23
8228573|NCT02004847|20291245|P2|STARTED|Overall Study||23
8228574|NCT02004847|20291246|P1|STARTED|Overall Study||24
8228583|NCT02004366|20291317|P5|NOT COMPLETED|On Discharge||0
8228584|NCT02004366|20291318|P4|NOT COMPLETED|On Discharge||0
8228585|NCT02004366|20291319|P3|NOT COMPLETED|On Discharge||0
8228586|NCT02004366|20291320|P2|NOT COMPLETED|On Discharge||0
8228587|NCT02004366|20291321|P1|NOT COMPLETED|On Discharge||0
8228588|NCT02004366|20291317|P5|COMPLETED|On Discharge||39
8228589|NCT02004366|20291318|P4|COMPLETED|On Discharge||93
8228590|NCT02004366|20291319|P3|COMPLETED|On Discharge||92
8228591|NCT02004366|20291320|P2|COMPLETED|On Discharge||0
8228592|NCT02004366|20291321|P1|COMPLETED|On Discharge||0
8228593|NCT02004366|20291317|P5|STARTED|On Discharge||39
8228594|NCT02004366|20291318|P4|STARTED|On Discharge||93
8228595|NCT02004366|20291319|P3|STARTED|On Discharge||92
8228596|NCT02004366|20291320|P2|STARTED|On Discharge||0
8228597|NCT02004366|20291321|P1|STARTED|On Discharge||0
8228598|NCT02004366|20291317|P5|NOT COMPLETED|In-hospital||0
8228599|NCT02004366|20291318|P4|NOT COMPLETED|In-hospital||0
8228600|NCT02004366|20291319|P3|NOT COMPLETED|In-hospital||0
8228601|NCT02004366|20291320|P2|NOT COMPLETED|In-hospital||0
8228602|NCT02004366|20291321|P1|NOT COMPLETED|In-hospital||0
8228603|NCT02004366|20291317|P5|COMPLETED|In-hospital||0
8228604|NCT02004366|20291318|P4|COMPLETED|In-hospital||0
8228605|NCT02004366|20291319|P3|COMPLETED|In-hospital||0
8228606|NCT02004366|20291320|P2|COMPLETED|In-hospital||122
8228607|NCT02004366|20291321|P1|COMPLETED|In-hospital||128
8228608|NCT02004366|20291317|P5|STARTED|In-hospital||0
8228609|NCT02004366|20291318|P4|STARTED|In-hospital||0
8228610|NCT02004366|20291319|P3|STARTED|In-hospital||0
8228611|NCT02004366|20291320|P2|STARTED|In-hospital||122
8228612|NCT02004366|20291321|P1|STARTED|In-hospital||128
8228613|NCT02004262|20291414|P6|NOT COMPLETED|Overall Study||30
8228614|NCT02004262|20291415|P5|NOT COMPLETED|Overall Study||31
8228615|NCT02004262|20291416|P4|NOT COMPLETED|Overall Study||29
8228616|NCT02004262|20291417|P3|NOT COMPLETED|Overall Study||72
8228617|NCT02004262|20291418|P2|NOT COMPLETED|Overall Study||68
8228618|NCT02004262|20291419|P1|NOT COMPLETED|Overall Study||73
8228619|NCT02004262|20291414|P6|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8228620|NCT02004262|20291415|P5|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8228621|NCT02004262|20291416|P4|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8228622|NCT02004262|20291417|P3|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8228623|NCT02004262|20291418|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8228624|NCT02004262|20291419|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
8228625|NCT02004262|20291414|P6|Treated|Overall Study||11
8228626|NCT02004262|20291415|P5|Treated|Overall Study||29
8228627|NCT02004262|20291416|P4|Treated|Overall Study||26
8228628|NCT02004262|20291417|P3|Treated|Overall Study||43
8228629|NCT02004262|20291418|P2|Treated|Overall Study||58
8228630|NCT02004262|20291419|P1|Treated|Overall Study||68
8228631|NCT02004262|20291414|P6|STARTED|Overall Study||30
8228632|NCT02004262|20291415|P5|STARTED|Overall Study||31
8228633|NCT02004262|20291416|P4|STARTED|Overall Study||29
8228634|NCT02004262|20291417|P3|STARTED|Overall Study||72
8228635|NCT02004262|20291418|P2|STARTED|Overall Study||68
8228636|NCT02004262|20291419|P1|STARTED|Overall Study||73
8228646|NCT02004158|20291485|P1|NOT COMPLETED|Overall Study||3
8228647|NCT02004158|20291485|P1|COMPLETED|Overall Study||20
8228648|NCT02004158|20291485|P1|STARTED|Overall Study||23
8228649|NCT02004132|20291493|P1|NOT COMPLETED|Overall Study||0
8228650|NCT02004132|20291493|P1|COMPLETED|Overall Study||12
8228651|NCT02004132|20291493|P1|Received Study Drug|Overall Study||12
8228652|NCT02004132|20291493|P1|STARTED|Overall Study||12
8228653|NCT02004093|20291501|P2|NOT COMPLETED|Overall Study||73
8228654|NCT02004093|20291502|P1|NOT COMPLETED|Overall Study||74
8228655|NCT02004093|20291501|P2|COMPLETED|Overall Study||1
8228656|NCT02004093|20291502|P1|COMPLETED|Overall Study||1
8228657|NCT02004093|20291501|P2|STARTED|Overall Study||74
8228658|NCT02004093|20291502|P1|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
8228659|NCT02003963|20291534|P2|NOT COMPLETED|Overall Study||1
8228660|NCT02003963|20291535|P1|NOT COMPLETED|Overall Study||2
8228661|NCT02003963|20291534|P2|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
8228662|NCT02003963|20291535|P1|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
8228663|NCT02003963|20291534|P2|STARTED|Overall Study||19
8228664|NCT02003963|20291535|P1|STARTED|Overall Study||22
8228698|NCT02003911|20291660|P2|NOT COMPLETED|Overall Study||7
8228699|NCT02003911|20291661|P1|NOT COMPLETED|Overall Study||2
8228700|NCT02003911|20291660|P2|COMPLETED|Overall Study||72
8228701|NCT02003911|20291661|P1|COMPLETED|Overall Study||78
8228702|NCT02003911|20291660|P2|STARTED|Overall Study||79
8228703|NCT02003911|20291661|P1|STARTED|Overall Study||80
8228704|NCT02003898|20291681|P1|NOT COMPLETED|Overall Study||67
8228705|NCT02003898|20291681|P1|COMPLETED|Overall Study||305
8228706|NCT02003898|20291681|P1|STARTED|Overall Study||372
8228707|NCT02003638|20291690|P2|NOT COMPLETED|Overall Study||0
8228708|NCT02003638|20291691|P1|NOT COMPLETED|Overall Study||1
8228709|NCT02003638|20291690|P2|COMPLETED|Overall Study||3
8228710|NCT02003638|20291691|P1|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
8228711|NCT02003638|20291690|P2|STARTED|Overall Study||3
8228712|NCT02003638|20291691|P1|STARTED|Overall Study||6
8228713|NCT02003625|20291699|P2|NOT COMPLETED|Overall Study||3
8228714|NCT02003625|20291700|P1|NOT COMPLETED|Overall Study||1
8228715|NCT02003625|20291699|P2|COMPLETED|Overall Study||12
8228716|NCT02003625|20291700|P1|COMPLETED|Overall Study||14
8228717|NCT02003625|20291699|P2|Received Transplant|Overall Study||12
8228718|NCT02003625|20291700|P1|Received Transplant|Overall Study||14
8228719|NCT02003625|20291699|P2|STARTED|Overall Study||15
8228720|NCT02003625|20291700|P1|STARTED|Overall Study||15
8228721|NCT02003573|20291721|P3|NOT COMPLETED|Overall Study||6
8228722|NCT02003573|20291722|P2|NOT COMPLETED|Overall Study||4
8228723|NCT02003573|20291723|P1|NOT COMPLETED|Overall Study||3
8228724|NCT02003573|20291721|P3|COMPLETED|Overall Study||0
8228725|NCT02003573|20291722|P2|COMPLETED|Overall Study||0
8228726|NCT02003573|20291723|P1|COMPLETED|Overall Study||0
8228727|NCT02003573|20291721|P3|STARTED|Overall Study|Started are treated patients|6
8228728|NCT02003573|20291722|P2|STARTED|Overall Study|Started are treated patients|4
8228729|NCT02003573|20291723|P1|STARTED|Overall Study|Started are treated patients|3
8228730|NCT02003534|20291733|P1|NOT COMPLETED|Overall Study||47
8228731|NCT02003534|20291733|P1|COMPLETED|Overall Study||329
8228732|NCT02003534|20291733|P1|STARTED|Overall Study||376
8228733|NCT02003508|20291739|P2|NOT COMPLETED|Overall Study||0
8228734|NCT02003508|20291740|P1|NOT COMPLETED|Overall Study||0
8228735|NCT02003508|20291739|P2|COMPLETED|Overall Study||166
8228736|NCT02003508|20291740|P1|COMPLETED|Overall Study||179
8228737|NCT02003508|20291739|P2|STARTED|Overall Study||166
8228738|NCT02003508|20291740|P1|STARTED|Overall Study||179
8228739|NCT02003404|20291746|P1|NOT COMPLETED|Overall Study||0
8228740|NCT02003404|20291746|P1|COMPLETED|Overall Study||17
8228741|NCT02003404|20291746|P1|STARTED|Overall Study||17
8228742|NCT02003391|20291754|P2|NOT COMPLETED|Overall Study||2
8228743|NCT02003391|20291755|P1|NOT COMPLETED|Overall Study||3
8228744|NCT02003391|20291754|P2|COMPLETED|Overall Study||73
8228745|NCT02003391|20291755|P1|COMPLETED|Overall Study||78
8228746|NCT02003391|20291754|P2|Intent to Treat Population|Overall Study||73
8228747|NCT02003391|20291755|P1|Intent to Treat Population|Overall Study||78
8228748|NCT02003391|20291754|P2|Safety Population|Overall Study||75
8228749|NCT02003391|20291755|P1|Safety Population|Overall Study||81
8228750|NCT02003391|20291754|P2|STARTED|Overall Study||75
8228751|NCT02003391|20291755|P1|STARTED|Overall Study||81
8228752|NCT02003365|20291768|P3|NOT COMPLETED|Overall Study||1
8228753|NCT02003365|20291769|P2|NOT COMPLETED|Overall Study||0
8228754|NCT02003365|20291770|P1|NOT COMPLETED|Overall Study||0
8228755|NCT02003365|20291768|P3|COMPLETED|Overall Study||9
8228756|NCT02003365|20291769|P2|COMPLETED|Overall Study||30
8228757|NCT02003365|20291770|P1|COMPLETED|Overall Study||10
8228758|NCT02003365|20291768|P3|STARTED|Overall Study||10
8228759|NCT02003365|20291769|P2|STARTED|Overall Study||30
8228760|NCT02003365|20291770|P1|STARTED|Overall Study||10
8228761|NCT02003352|20291781|P1|NOT COMPLETED|Overall Study||0
8228762|NCT02003352|20291781|P1|COMPLETED|Overall Study||98
8228763|NCT02003352|20291781|P1|STARTED|Overall Study||98
8228764|NCT02003183|20291787|P2|NOT COMPLETED|Overall Study||2
8228765|NCT02003183|20291788|P1|NOT COMPLETED|Overall Study||0
8228766|NCT02003183|20291787|P2|COMPLETED|Overall Study||15
8228767|NCT02003183|20291788|P1|COMPLETED|Overall Study||7
8228768|NCT02003183|20291787|P2|STARTED|Overall Study||17
8228769|NCT02003183|20291788|P1|STARTED|Overall Study||7
8228770|NCT02003053|20291796|P2|NOT COMPLETED|Overall Study||0
8228771|NCT02003053|20291797|P1|NOT COMPLETED|Overall Study||0
8228772|NCT02003053|20291796|P2|COMPLETED|Overall Study||3
8228773|NCT02003053|20291797|P1|COMPLETED|Overall Study||4
8228774|NCT02003053|20291796|P2|STARTED|Overall Study||3
8228775|NCT02003053|20291797|P1|STARTED|Overall Study||4
8228776|NCT02003014|20291803|P1|NOT COMPLETED|Overall Study||19
8228777|NCT02003014|20291803|P1|COMPLETED|Overall Study||880
8228778|NCT02003014|20291803|P1|STARTED|Overall Study||899
8228779|NCT02002975|20291813|P1|NOT COMPLETED|Overall Study||572
8228780|NCT02002975|20291813|P1|COMPLETED|Overall Study||17651
8228781|NCT02002975|20291813|P1|STARTED|Overall Study||18223
8228782|NCT02002936|20291829|P1|NOT COMPLETED|Overall Study||0
8228783|NCT02002936|20291829|P1|COMPLETED|Overall Study||1
8228784|NCT02002936|20291829|P1|STARTED|Overall Study||1
8228813|NCT02002871|20291903|P1|NOT COMPLETED|Overall Study||1
8228814|NCT02002871|20291903|P1|COMPLETED|Overall Study||20
8228815|NCT02002871|20291903|P1|STARTED|Overall Study||21
8228816|NCT02002832|20291931|P2|NOT COMPLETED|Overall Study||26
8228817|NCT02002832|20291932|P1|NOT COMPLETED|Overall Study||28
8228818|NCT02002832|20291931|P2|COMPLETED|Overall Study||168
8228819|NCT02002832|20291932|P1|COMPLETED|Overall Study||166
8228820|NCT02002832|20291931|P2|STARTED|Overall Study||194
8228821|NCT02002832|20291932|P1|STARTED|Overall Study||194
8228822|NCT02002767|20291942|P2|NOT COMPLETED|Overall Study||0
8228823|NCT02002767|20291943|P1|NOT COMPLETED|Overall Study||0
8228824|NCT02002767|20291942|P2|COMPLETED|Overall Study||10
8228825|NCT02002767|20291943|P1|COMPLETED|Overall Study||9
8228826|NCT02002767|20291942|P2|STARTED|Overall Study||10
8228827|NCT02002767|20291943|P1|STARTED|Overall Study||9
8228828|NCT02002702|20291962|P3|NOT COMPLETED|Overall Study||0
8228829|NCT02002702|20291963|P2|NOT COMPLETED|Overall Study||0
8228830|NCT02002702|20291964|P1|NOT COMPLETED|Overall Study||0
8228831|NCT02002702|20291962|P3|COMPLETED|Overall Study||15
8228832|NCT02002702|20291963|P2|COMPLETED|Overall Study||15
8228833|NCT02002702|20291964|P1|COMPLETED|Overall Study||16
8228834|NCT02002702|20291962|P3|STARTED|Overall Study||15
8228835|NCT02002702|20291963|P2|STARTED|Overall Study||15
8228836|NCT02002702|20291964|P1|STARTED|Overall Study||16
8228837|NCT02002689|20291996|P1|NOT COMPLETED|Overall Study||10
8228838|NCT02002689|20291996|P1|COMPLETED|Overall Study||0
8228839|NCT02002689|20291996|P1|STARTED|Overall Study||10
8228840|NCT02002650|20292004|P2|NOT COMPLETED|Overall Study||0
8228841|NCT02002650|20292005|P1|NOT COMPLETED|Overall Study||0
8228842|NCT02002650|20292004|P2|COMPLETED|Overall Study||1303
8228843|NCT02002650|20292005|P1|COMPLETED|Overall Study||1297
8228844|NCT02002650|20292004|P2|STARTED|Overall Study||1303
8228845|NCT02002650|20292005|P1|STARTED|Overall Study||1297
8228846|NCT02002533|20292015|P2|NOT COMPLETED|Overall Study||18
8228847|NCT02002533|20292016|P1|NOT COMPLETED|Overall Study||6
8228848|NCT02002533|20292015|P2|COMPLETED|Overall Study||19
8228849|NCT02002533|20292016|P1|COMPLETED|Overall Study||28
8228850|NCT02002533|20292015|P2|STARTED|Overall Study||37
8228851|NCT02002533|20292016|P1|STARTED|Overall Study||34
8228852|NCT02002494|20292039|P1|NOT COMPLETED|Overall Study||0
8228853|NCT02002494|20292039|P1|COMPLETED|Overall Study||27
8228854|NCT02002494|20292039|P1|STARTED|Overall Study||27
8228855|NCT02002221|20292056|P2|NOT COMPLETED|Overall Study||3
8228856|NCT02002221|20292057|P1|NOT COMPLETED|Overall Study||2
8228857|NCT02002221|20292056|P2|COMPLETED|Overall Study||75
8228858|NCT02002221|20292057|P1|COMPLETED|Overall Study||76
8228859|NCT02002221|20292056|P2|STARTED|Overall Study||78
8228860|NCT02002221|20292057|P1|STARTED|Overall Study||78
8228861|NCT02002208|20292073|P2|NOT COMPLETED|Overall Study||40
8228862|NCT02002208|20292074|P1|NOT COMPLETED|Overall Study||37
8228863|NCT02002208|20292073|P2|COMPLETED|Overall Study||30
8228864|NCT02002208|20292074|P1|COMPLETED|Overall Study||32
8228865|NCT02002208|20292073|P2|STARTED|Overall Study||70
8228866|NCT02002208|20292074|P1|STARTED|Overall Study||69
8228873|NCT02002091|20292097|P2|NOT COMPLETED|One Year Follow up||0
8228874|NCT02002091|20292098|P1|NOT COMPLETED|One Year Follow up||0
8228875|NCT02002091|20292097|P2|COMPLETED|One Year Follow up||191
8228876|NCT02002091|20292098|P1|COMPLETED|One Year Follow up||109
8228877|NCT02002091|20292097|P2|STARTED|One Year Follow up||191
8228878|NCT02002091|20292098|P1|STARTED|One Year Follow up||109
8228879|NCT02002091|20292097|P2|NOT COMPLETED|Screening||14
8228880|NCT02002091|20292098|P1|NOT COMPLETED|Screening||13
8228881|NCT02002091|20292097|P2|COMPLETED|Screening||191
8228882|NCT02002091|20292098|P1|COMPLETED|Screening||109
8228883|NCT02002091|20292097|P2|STARTED|Screening||205
8228884|NCT02002091|20292098|P1|STARTED|Screening||122
8228885|NCT02001987|20292133|P1|NOT COMPLETED|LTE Period (52 Weeks)||9
8228886|NCT02001987|20292133|P1|COMPLETED|LTE Period (52 Weeks)||107
8228887|NCT02001987|20292133|P1|STARTED|LTE Period (52 Weeks)||116
8228888|NCT02001987|20292133|P1|NOT COMPLETED|Core Study Period (24 Weeks)||23
8228889|NCT02001987|20292133|P1|COMPLETED|Core Study Period (24 Weeks)||116
8228890|NCT02001987|20292133|P1|STARTED|Core Study Period (24 Weeks)||139
8228891|NCT02001714|20292209|P2|NOT COMPLETED|Overall Study||12
8228892|NCT02001714|20292210|P1|NOT COMPLETED|Overall Study||22
8228893|NCT02001714|20292209|P2|COMPLETED|Overall Study||219
8228894|NCT02001714|20292210|P1|COMPLETED|Overall Study||210
8228895|NCT02001714|20292209|P2|STARTED|Overall Study||231
8228896|NCT02001714|20292210|P1|STARTED|Overall Study||232
8228897|NCT02001688|20292219|P3|NOT COMPLETED|Overall Study||1
8228898|NCT02001688|20292220|P2|NOT COMPLETED|Overall Study||1
8228899|NCT02001688|20292221|P1|NOT COMPLETED|Overall Study||0
8228900|NCT02001688|20292219|P3|COMPLETED|Overall Study||11
8228901|NCT02001688|20292220|P2|COMPLETED|Overall Study||11
8228902|NCT02001688|20292221|P1|COMPLETED|Overall Study||12
8228903|NCT02001688|20292219|P3|STARTED|Overall Study||12
8228904|NCT02001688|20292220|P2|STARTED|Overall Study||12
8228905|NCT02001688|20292221|P1|STARTED|Overall Study||12
8228906|NCT02001558|20292240|P2|NOT COMPLETED|Overall Study||14
8228907|NCT02001558|20292241|P1|NOT COMPLETED|Overall Study||8
8228908|NCT02001558|20292240|P2|COMPLETED|Overall Study||19
8228909|NCT02001558|20292241|P1|COMPLETED|Overall Study||24
8228910|NCT02001558|20292240|P2|STARTED|Overall Study||33
8228911|NCT02001558|20292241|P1|STARTED|Overall Study||32
8228912|NCT02001194|20292277|P4|NOT COMPLETED|Follow-Up Period (13 Weeks)||0
8228913|NCT02001194|20292278|P3|NOT COMPLETED|Follow-Up Period (13 Weeks)||1
8228914|NCT02001194|20292279|P2|NOT COMPLETED|Follow-Up Period (13 Weeks)||2
8228915|NCT02001194|20292280|P1|NOT COMPLETED|Follow-Up Period (13 Weeks)||3
8228916|NCT02001194|20292277|P4|COMPLETED|Follow-Up Period (13 Weeks)||78
8228917|NCT02001194|20292278|P3|COMPLETED|Follow-Up Period (13 Weeks)||73
8228918|NCT02001194|20292279|P2|COMPLETED|Follow-Up Period (13 Weeks)||78
8228919|NCT02001194|20292280|P1|COMPLETED|Follow-Up Period (13 Weeks)||64
8228920|NCT02001194|20292277|P4|STARTED|Follow-Up Period (13 Weeks)||78
8228921|NCT02001194|20292278|P3|STARTED|Follow-Up Period (13 Weeks)||74
8228922|NCT02001194|20292279|P2|STARTED|Follow-Up Period (13 Weeks)||80
8228923|NCT02001194|20292280|P1|STARTED|Follow-Up Period (13 Weeks)||67
8228924|NCT02001194|20292277|P4|NOT COMPLETED|Intervention Period (13 Weeks)||2
8228925|NCT02001194|20292278|P3|NOT COMPLETED|Intervention Period (13 Weeks)||2
8228926|NCT02001194|20292279|P2|NOT COMPLETED|Intervention Period (13 Weeks)||0
8228927|NCT02001194|20292280|P1|NOT COMPLETED|Intervention Period (13 Weeks)||1
8228928|NCT02001194|20292277|P4|COMPLETED|Intervention Period (13 Weeks)|20 teams|78
8228929|NCT02001194|20292278|P3|COMPLETED|Intervention Period (13 Weeks)|19 teams|74
8228930|NCT02001194|20292279|P2|COMPLETED|Intervention Period (13 Weeks)|20 teams|80
8228931|NCT02001194|20292280|P1|COMPLETED|Intervention Period (13 Weeks)|16 teams|67
8228932|NCT02001194|20292277|P4|STARTED|Intervention Period (13 Weeks)|20 teams|80
8228933|NCT02001194|20292278|P3|STARTED|Intervention Period (13 Weeks)|19 teams|76
8228934|NCT02001194|20292279|P2|STARTED|Intervention Period (13 Weeks)|20 teams|80
8228935|NCT02001194|20292280|P1|STARTED|Intervention Period (13 Weeks)|17 teams|68
8228936|NCT02001181|20292296|P2|NOT COMPLETED|Overall Study||3
8228937|NCT02001181|20292297|P1|NOT COMPLETED|Overall Study||1
8228938|NCT02001181|20292296|P2|COMPLETED|Overall Study||31
8228939|NCT02001181|20292297|P1|COMPLETED|Overall Study||34
8228940|NCT02001181|20292296|P2|STARTED|Overall Study||34
8228941|NCT02001181|20292297|P1|STARTED|Overall Study||35
8228942|NCT02001051|20292313|P2|NOT COMPLETED|Overall Study||1
8228943|NCT02001051|20292314|P1|NOT COMPLETED|Overall Study||0
8228944|NCT02001051|20292313|P2|COMPLETED|Overall Study||1
8228945|NCT02001051|20292314|P1|COMPLETED|Overall Study||2
8228946|NCT02001051|20292313|P2|STARTED|Overall Study||2
8228947|NCT02001051|20292314|P1|STARTED|Overall Study||2
8228948|NCT02000973|20292338|P4|NOT COMPLETED|Overall Study||0
8228949|NCT02000973|20292339|P3|NOT COMPLETED|Overall Study||0
8228950|NCT02000973|20292340|P2|NOT COMPLETED|Overall Study||0
8228951|NCT02000973|20292341|P1|NOT COMPLETED|Overall Study||0
8228952|NCT02000973|20292338|P4|COMPLETED|Overall Study||20
8228953|NCT02000973|20292339|P3|COMPLETED|Overall Study||20
8228954|NCT02000973|20292340|P2|COMPLETED|Overall Study||20
8228955|NCT02000973|20292341|P1|COMPLETED|Overall Study||20
8228956|NCT02000973|20292338|P4|STARTED|Overall Study||20
8228957|NCT02000973|20292339|P3|STARTED|Overall Study||20
8228958|NCT02000973|20292340|P2|STARTED|Overall Study||20
8228959|NCT02000973|20292341|P1|STARTED|Overall Study||20
8228960|NCT02000921|20292366|P3|NOT COMPLETED|Overall Study||10
8228961|NCT02000921|20292367|P2|NOT COMPLETED|Overall Study||16
8228962|NCT02000921|20292368|P1|NOT COMPLETED|Overall Study||5
8228963|NCT02000921|20292366|P3|COMPLETED|Overall Study||46
8228964|NCT02000921|20292367|P2|COMPLETED|Overall Study||37
8228965|NCT02000921|20292368|P1|COMPLETED|Overall Study||22
8228966|NCT02000921|20292366|P3|STARTED|Overall Study||56
8228967|NCT02000921|20292367|P2|STARTED|Overall Study||53
8228968|NCT02000921|20292368|P1|STARTED|Overall Study||27
8228969|NCT02000908|20292387|P2|NOT COMPLETED|Overall Study||4
8228970|NCT02000908|20292388|P1|NOT COMPLETED|Overall Study||2
8228971|NCT02000908|20292387|P2|COMPLETED|Overall Study||36
8228972|NCT02000908|20292388|P1|COMPLETED|Overall Study||28
8228973|NCT02000908|20292387|P2|STARTED|Overall Study||40
8228974|NCT02000908|20292388|P1|STARTED|Overall Study||30
8228975|NCT02000817|20292398|P4|NOT COMPLETED|Overall Study||0
8228976|NCT02000817|20292399|P3|NOT COMPLETED|Overall Study||1
8228977|NCT02000817|20292400|P2|NOT COMPLETED|Overall Study||1
8228978|NCT02000817|20292401|P1|NOT COMPLETED|Overall Study||2
8228979|NCT02000817|20292398|P4|COMPLETED|Overall Study||7
8228980|NCT02000817|20292399|P3|COMPLETED|Overall Study||7
8228981|NCT02000817|20292400|P2|COMPLETED|Overall Study||8
8228982|NCT02000817|20292401|P1|COMPLETED|Overall Study||4
8228983|NCT02000817|20292398|P4|STARTED|Overall Study||7
8228984|NCT02000817|20292399|P3|STARTED|Overall Study||8
8228985|NCT02000817|20292400|P2|STARTED|Overall Study||9
8228986|NCT02000817|20292401|P1|STARTED|Overall Study||6
8228987|NCT02000752|20292496|P2|NOT COMPLETED|Overall Study||13
8228988|NCT02000752|20292497|P1|NOT COMPLETED|Overall Study||31
8228989|NCT02000752|20292496|P2|COMPLETED|Overall Study||47
8228990|NCT02000752|20292497|P1|COMPLETED|Overall Study||29
8228991|NCT02000752|20292496|P2|STARTED|Overall Study||60
8228992|NCT02000752|20292497|P1|STARTED|Overall Study||60
8228999|NCT02000583|20292542|P2|NOT COMPLETED|Overall Study||5
8229000|NCT02000583|20292543|P1|NOT COMPLETED|Overall Study||3
8229001|NCT02000583|20292542|P2|COMPLETED|Overall Study||34
8229002|NCT02000583|20292543|P1|COMPLETED|Overall Study||75
8229003|NCT02000583|20292542|P2|STARTED|Overall Study||39
8229004|NCT02000583|20292543|P1|STARTED|Overall Study||78
8229005|NCT02000531|20292555|P2|NOT COMPLETED|Overall Study||8
8229006|NCT02000531|20292556|P1|NOT COMPLETED|Overall Study||4
8229007|NCT02000531|20292555|P2|COMPLETED|Overall Study||16
8229008|NCT02000531|20292556|P1|COMPLETED|Overall Study||17
8229009|NCT02000531|20292555|P2|Safety Population|Overall Study||24
8229010|NCT02000531|20292556|P1|Safety Population|Overall Study||21
8229011|NCT02000531|20292555|P2|STARTED|Overall Study||24
8229012|NCT02000531|20292556|P1|STARTED|Overall Study||21
8229013|NCT02000440|20292564|P1|NOT COMPLETED|Overall Study||4
8229014|NCT02000440|20292564|P1|COMPLETED|Overall Study||13
8229015|NCT02000440|20292564|P1|STARTED|Overall Study||17
8229016|NCT02000427|20292584|P1|NOT COMPLETED|Overall Study||22
8229017|NCT02000427|20292584|P1|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
8229018|NCT02000427|20292584|P1|STARTED|Overall Study||45
8229019|NCT02000180|20292601|P2|NOT COMPLETED|Overall Study||0
8229020|NCT02000180|20292602|P1|NOT COMPLETED|Overall Study||0
8229021|NCT02000180|20292601|P2|COMPLETED|Overall Study||19
8229022|NCT02000180|20292602|P1|COMPLETED|Overall Study||18
8229023|NCT02000180|20292601|P2|STARTED|Overall Study||19
8229024|NCT02000180|20292602|P1|STARTED|Overall Study||18
8229025|NCT02000154|20292614|P1|NOT COMPLETED|Overall Study||0
8229026|NCT02000154|20292614|P1|COMPLETED|Overall Study||1
8229027|NCT02000154|20292614|P1|STARTED|Overall Study||1
8229028|NCT02000115|20292625|P4|NOT COMPLETED|Overall Study||53
8229029|NCT02000115|20292626|P3|NOT COMPLETED|Overall Study||1
8229030|NCT02000115|20292627|P2|NOT COMPLETED|Overall Study||68
8229031|NCT02000115|20292628|P1|NOT COMPLETED|Overall Study||79
8229032|NCT02000115|20292625|P4|COMPLETED|Overall Study||0
8229033|NCT02000115|20292626|P3|COMPLETED|Overall Study|1 subject missed the 30 day follow-up visit|99
8229034|NCT02000115|20292627|P2|COMPLETED|Overall Study|8 subjects missed the One-year follow-up visit|301
8229035|NCT02000115|20292628|P1|COMPLETED|Overall Study|6 subjects missed the One-year follow-up visit|302
8229036|NCT02000115|20292625|P4|STARTED|Overall Study||53
8229037|NCT02000115|20292626|P3|STARTED|Overall Study||100
8229038|NCT02000115|20292627|P2|STARTED|Overall Study||369
8229039|NCT02000115|20292628|P1|STARTED|Overall Study||381
8229040|NCT01999985|20292646|P3|NOT COMPLETED|Overall Study||0
8229041|NCT01999985|20292647|P2|NOT COMPLETED|Overall Study||0
8229042|NCT01999985|20292648|P1|NOT COMPLETED|Overall Study||0
8229043|NCT01999985|20292646|P3|COMPLETED|Overall Study||14
8229044|NCT01999985|20292647|P2|COMPLETED|Overall Study||3
8229045|NCT01999985|20292648|P1|COMPLETED|Overall Study||8
8229046|NCT01999985|20292646|P3|STARTED|Overall Study||14
8229047|NCT01999985|20292647|P2|STARTED|Overall Study||3
8229048|NCT01999985|20292648|P1|STARTED|Overall Study||8
8229049|NCT01999972|20292662|P6|NOT COMPLETED|Dose Expansion Part||7
8229050|NCT01999972|20292663|P5|NOT COMPLETED|Dose Expansion Part||21
8229051|NCT01999972|20292664|P4|NOT COMPLETED|Dose Expansion Part||0
8229052|NCT01999972|20292665|P3|NOT COMPLETED|Dose Expansion Part||0
8229053|NCT01999972|20292666|P2|NOT COMPLETED|Dose Expansion Part||0
8229054|NCT01999972|20292667|P1|NOT COMPLETED|Dose Expansion Part||0
8229055|NCT01999972|20292662|P6|COMPLETED|Dose Expansion Part||0
8229056|NCT01999972|20292663|P5|COMPLETED|Dose Expansion Part||0
8229057|NCT01999972|20292664|P4|COMPLETED|Dose Expansion Part||0
8229058|NCT01999972|20292665|P3|COMPLETED|Dose Expansion Part||0
8229059|NCT01999972|20292666|P2|COMPLETED|Dose Expansion Part||0
8229060|NCT01999972|20292667|P1|COMPLETED|Dose Expansion Part||0
8229061|NCT01999972|20292662|P6|Treated|Dose Expansion Part||7
8229062|NCT01999972|20292663|P5|Treated|Dose Expansion Part||21
8229063|NCT01999972|20292664|P4|Treated|Dose Expansion Part||0
8229064|NCT01999972|20292665|P3|Treated|Dose Expansion Part||0
8229065|NCT01999972|20292666|P2|Treated|Dose Expansion Part||0
8229066|NCT01999972|20292667|P1|Treated|Dose Expansion Part||0
8229067|NCT01999972|20292662|P6|STARTED|Dose Expansion Part||7
8229068|NCT01999972|20292663|P5|STARTED|Dose Expansion Part||21
8229069|NCT01999972|20292664|P4|STARTED|Dose Expansion Part||0
8229070|NCT01999972|20292665|P3|STARTED|Dose Expansion Part||0
8229071|NCT01999972|20292666|P2|STARTED|Dose Expansion Part||0
8229072|NCT01999972|20292667|P1|STARTED|Dose Expansion Part||0
8229073|NCT01999972|20292662|P6|NOT COMPLETED|Dose Escalation Part||0
8229074|NCT01999972|20292663|P5|NOT COMPLETED|Dose Escalation Part||0
8229075|NCT01999972|20292664|P4|NOT COMPLETED|Dose Escalation Part||11
8229076|NCT01999972|20292665|P3|NOT COMPLETED|Dose Escalation Part||5
8229077|NCT01999972|20292666|P2|NOT COMPLETED|Dose Escalation Part||3
8229078|NCT01999972|20292667|P1|NOT COMPLETED|Dose Escalation Part||5
8229079|NCT01999972|20292662|P6|COMPLETED|Dose Escalation Part||0
8229080|NCT01999972|20292663|P5|COMPLETED|Dose Escalation Part||0
8229081|NCT01999972|20292664|P4|COMPLETED|Dose Escalation Part||0
8229082|NCT01999972|20292665|P3|COMPLETED|Dose Escalation Part||0
8229083|NCT01999972|20292666|P2|COMPLETED|Dose Escalation Part||0
8229084|NCT01999972|20292667|P1|COMPLETED|Dose Escalation Part||0
8229085|NCT01999972|20292662|P6|Treated|Dose Escalation Part||0
8229086|NCT01999972|20292663|P5|Treated|Dose Escalation Part||0
8229087|NCT01999972|20292664|P4|Treated|Dose Escalation Part||10
8229088|NCT01999972|20292665|P3|Treated|Dose Escalation Part||4
8229089|NCT01999972|20292666|P2|Treated|Dose Escalation Part||3
8229090|NCT01999972|20292667|P1|Treated|Dose Escalation Part||5
8229091|NCT01999972|20292662|P6|STARTED|Dose Escalation Part||0
8229092|NCT01999972|20292663|P5|STARTED|Dose Escalation Part||0
8229093|NCT01999972|20292664|P4|STARTED|Dose Escalation Part||11
8229094|NCT01999972|20292665|P3|STARTED|Dose Escalation Part||5
8229095|NCT01999972|20292666|P2|STARTED|Dose Escalation Part||3
8229096|NCT01999972|20292667|P1|STARTED|Dose Escalation Part||5
8229106|NCT01999920|20292793|P2|NOT COMPLETED|Overall Study||2
8229107|NCT01999920|20292794|P1|NOT COMPLETED|Overall Study||6
8229108|NCT01999920|20292793|P2|COMPLETED|Overall Study||9
8229109|NCT01999920|20292794|P1|COMPLETED|Overall Study||7
8229110|NCT01999920|20292793|P2|STARTED|Overall Study||11
8229111|NCT01999920|20292794|P1|STARTED|Overall Study||13
8229112|NCT01999894|20292810|P1|NOT COMPLETED|Overall Study||36
8229113|NCT01999894|20292810|P1|COMPLETED|Overall Study||66
8229114|NCT01999894|20292810|P1|STARTED|Overall Study||102
8229115|NCT01999868|20292818|P3|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
8229116|NCT01999868|20292819|P2|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||29
8229117|NCT01999868|20292820|P1|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||23
8229118|NCT01999868|20292818|P3|COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
8229119|NCT01999868|20292819|P2|COMPLETED|Blinded Observation Phase (Week 40 - 88)||6
8229120|NCT01999868|20292820|P1|COMPLETED|Blinded Observation Phase (Week 40 - 88)||4
8229121|NCT01999868|20292818|P3|STARTED|Blinded Observation Phase (Week 40 - 88)||0
8229122|NCT01999868|20292819|P2|STARTED|Blinded Observation Phase (Week 40 - 88)||35
8229123|NCT01999868|20292820|P1|STARTED|Blinded Observation Phase (Week 40 - 88)||27
8229124|NCT01999868|20292818|P3|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
8229125|NCT01999868|20292819|P2|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||11
8229126|NCT01999868|20292820|P1|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||18
8229127|NCT01999868|20292818|P3|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
8229128|NCT01999868|20292819|P2|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||35
8229129|NCT01999868|20292820|P1|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||27
8229130|NCT01999868|20292818|P3|STARTED|Blinded Treatment Phase (Week 12 - 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
8229131|NCT01999868|20292819|P2|STARTED|Blinded Treatment Phase (Week 12 - 40)||46
8229132|NCT01999868|20292820|P1|STARTED|Blinded Treatment Phase (Week 12 - 40)||45
8229133|NCT01999868|20292818|P3|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||5
8229134|NCT01999868|20292819|P2|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
8229135|NCT01999868|20292820|P1|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
8229136|NCT01999868|20292818|P3|COMPLETED|Lead-in Phase (Week 0 - 12)||12
8229137|NCT01999868|20292819|P2|COMPLETED|Lead-in Phase (Week 0 - 12)||46
8229138|NCT01999868|20292820|P1|COMPLETED|Lead-in Phase (Week 0 - 12)||45
8229139|NCT01999868|20292818|P3|STARTED|Lead-in Phase (Week 0 - 12)||17
8229140|NCT01999868|20292819|P2|STARTED|Lead-in Phase (Week 0 - 12)||46
8229141|NCT01999868|20292820|P1|STARTED|Lead-in Phase (Week 0 - 12)||45
8229142|NCT01999777|20292847|P2|NOT COMPLETED|Overall Study||0
8229143|NCT01999777|20292848|P1|NOT COMPLETED|Overall Study||0
8229144|NCT01999777|20292847|P2|COMPLETED|Overall Study||31
8229145|NCT01999777|20292848|P1|COMPLETED|Overall Study||31
8229146|NCT01999777|20292847|P2|STARTED|Overall Study||31
8229147|NCT01999777|20292848|P1|STARTED|Overall Study||31
8229148|NCT01999530|20292856|P1|NOT COMPLETED|Overall Study||13
8229149|NCT01999530|20292856|P1|COMPLETED|Overall Study||7
8229150|NCT01999530|20292856|P1|STARTED|Overall Study||20
8229151|NCT01999517|20292862|P2|NOT COMPLETED|Overall Study||0
8229152|NCT01999517|20292863|P1|NOT COMPLETED|Overall Study||0
8229153|NCT01999517|20292862|P2|COMPLETED|Overall Study||54
8229154|NCT01999517|20292863|P1|COMPLETED|Overall Study||68
8229155|NCT01999517|20292862|P2|STARTED|Overall Study||54
8229156|NCT01999517|20292863|P1|STARTED|Overall Study||68
8229157|NCT01999465|20292871|P2|NOT COMPLETED|Overall Study||3
8229158|NCT01999465|20292872|P1|NOT COMPLETED|Overall Study||0
8229159|NCT01999465|20292871|P2|COMPLETED|Overall Study||7
8229160|NCT01999465|20292872|P1|COMPLETED|Overall Study||10
8229161|NCT01999465|20292871|P2|STARTED|Overall Study||10
8229162|NCT01999465|20292872|P1|STARTED|Overall Study||10
8229163|NCT01999400|20292880|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
8229164|NCT01999400|20292881|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
8229165|NCT01999400|20292882|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
8229166|NCT01999400|20292883|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
8229167|NCT01999400|20292884|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
8229168|NCT01999400|20292885|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
8229169|NCT01999400|20292880|P6|COMPLETED|Fourth Intervention (1 Day)||0
8229170|NCT01999400|20292881|P5|COMPLETED|Fourth Intervention (1 Day)||0
8229171|NCT01999400|20292882|P4|COMPLETED|Fourth Intervention (1 Day)||0
8229172|NCT01999400|20292883|P3|COMPLETED|Fourth Intervention (1 Day)||1
8229173|NCT01999400|20292884|P2|COMPLETED|Fourth Intervention (1 Day)||0
8229174|NCT01999400|20292885|P1|COMPLETED|Fourth Intervention (1 Day)||1
8229175|NCT01999400|20292880|P6|STARTED|Fourth Intervention (1 Day)||0
8229176|NCT01999400|20292881|P5|STARTED|Fourth Intervention (1 Day)||0
8229177|NCT01999400|20292882|P4|STARTED|Fourth Intervention (1 Day)||0
8229178|NCT01999400|20292883|P3|STARTED|Fourth Intervention (1 Day)||1
8229179|NCT01999400|20292884|P2|STARTED|Fourth Intervention (1 Day)||0
8229180|NCT01999400|20292885|P1|STARTED|Fourth Intervention (1 Day)||1
8229181|NCT01999400|20292880|P6|NOT COMPLETED|Washout (10 Days)||0
8229182|NCT01999400|20292881|P5|NOT COMPLETED|Washout (10 Days)||0
8229183|NCT01999400|20292882|P4|NOT COMPLETED|Washout (10 Days)||0
8229184|NCT01999400|20292883|P3|NOT COMPLETED|Washout (10 Days)||0
8229185|NCT01999400|20292884|P2|NOT COMPLETED|Washout (10 Days)||0
8229186|NCT01999400|20292885|P1|NOT COMPLETED|Washout (10 Days)||0
8229187|NCT01999400|20292880|P6|COMPLETED|Washout (10 Days)||0
8229188|NCT01999400|20292881|P5|COMPLETED|Washout (10 Days)||0
8229189|NCT01999400|20292882|P4|COMPLETED|Washout (10 Days)||0
8229190|NCT01999400|20292883|P3|COMPLETED|Washout (10 Days)||1
8229191|NCT01999400|20292884|P2|COMPLETED|Washout (10 Days)||0
8229192|NCT01999400|20292885|P1|COMPLETED|Washout (10 Days)||1
8229193|NCT01999400|20292880|P6|STARTED|Washout (10 Days)||0
8229194|NCT01999400|20292881|P5|STARTED|Washout (10 Days)||0
8229195|NCT01999400|20292882|P4|STARTED|Washout (10 Days)||0
8229196|NCT01999400|20292883|P3|STARTED|Washout (10 Days)||1
8229197|NCT01999400|20292884|P2|STARTED|Washout (10 Days)||0
8229198|NCT01999400|20292885|P1|STARTED|Washout (10 Days)||1
8229199|NCT01999400|20292880|P6|NOT COMPLETED|Third Intervention (1 Day)||1
8229200|NCT01999400|20292881|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8229201|NCT01999400|20292882|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8229202|NCT01999400|20292883|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8229203|NCT01999400|20292884|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8229204|NCT01999400|20292885|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8229205|NCT01999400|20292880|P6|COMPLETED|Third Intervention (1 Day)||0
8229206|NCT01999400|20292881|P5|COMPLETED|Third Intervention (1 Day)||1
8229207|NCT01999400|20292882|P4|COMPLETED|Third Intervention (1 Day)||1
8229208|NCT01999400|20292883|P3|COMPLETED|Third Intervention (1 Day)||1
8229209|NCT01999400|20292884|P2|COMPLETED|Third Intervention (1 Day)||0
8229210|NCT01999400|20292885|P1|COMPLETED|Third Intervention (1 Day)||2
8229211|NCT01999400|20292880|P6|STARTED|Third Intervention (1 Day)||1
8229212|NCT01999400|20292881|P5|STARTED|Third Intervention (1 Day)||1
8229213|NCT01999400|20292882|P4|STARTED|Third Intervention (1 Day)||1
8229214|NCT01999400|20292883|P3|STARTED|Third Intervention (1 Day)||1
8229215|NCT01999400|20292884|P2|STARTED|Third Intervention (1 Day)||0
8229216|NCT01999400|20292885|P1|STARTED|Third Intervention (1 Day)||2
8229217|NCT01999400|20292880|P6|NOT COMPLETED|Washout (10 Days)||0
8229218|NCT01999400|20292881|P5|NOT COMPLETED|Washout (10 Days)||0
8229219|NCT01999400|20292882|P4|NOT COMPLETED|Washout (10 Days)||0
8229220|NCT01999400|20292883|P3|NOT COMPLETED|Washout (10 Days)||0
8229221|NCT01999400|20292884|P2|NOT COMPLETED|Washout (10 Days)||0
8229222|NCT01999400|20292885|P1|NOT COMPLETED|Washout (10 Days)||0
8229223|NCT01999400|20292880|P6|COMPLETED|Washout (10 Days)||1
8229224|NCT01999400|20292881|P5|COMPLETED|Washout (10 Days)||1
8229225|NCT01999400|20292882|P4|COMPLETED|Washout (10 Days)||1
8229226|NCT01999400|20292883|P3|COMPLETED|Washout (10 Days)||1
8229227|NCT01999400|20292884|P2|COMPLETED|Washout (10 Days)||0
8229228|NCT01999400|20292885|P1|COMPLETED|Washout (10 Days)||2
8229229|NCT01999400|20292880|P6|STARTED|Washout (10 Days)||1
8229230|NCT01999400|20292881|P5|STARTED|Washout (10 Days)||1
8229231|NCT01999400|20292882|P4|STARTED|Washout (10 Days)||1
8229232|NCT01999400|20292883|P3|STARTED|Washout (10 Days)||1
8229233|NCT01999400|20292884|P2|STARTED|Washout (10 Days)||0
8229234|NCT01999400|20292885|P1|STARTED|Washout (10 Days)||2
8229235|NCT01999400|20292880|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8229236|NCT01999400|20292881|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8229237|NCT01999400|20292882|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8229238|NCT01999400|20292883|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8229239|NCT01999400|20292884|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8229240|NCT01999400|20292885|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8229241|NCT01999400|20292880|P6|COMPLETED|Second Intervention (1 Day)||3
8229242|NCT01999400|20292881|P5|COMPLETED|Second Intervention (1 Day)||3
8229243|NCT01999400|20292882|P4|COMPLETED|Second Intervention (1 Day)||2
8229244|NCT01999400|20292883|P3|COMPLETED|Second Intervention (1 Day)||3
8229245|NCT01999400|20292884|P2|COMPLETED|Second Intervention (1 Day)||4
8229246|NCT01999400|20292885|P1|COMPLETED|Second Intervention (1 Day)||5
8229247|NCT01999400|20292880|P6|STARTED|Second Intervention (1 Day)||3
8229248|NCT01999400|20292881|P5|STARTED|Second Intervention (1 Day)||3
8229249|NCT01999400|20292882|P4|STARTED|Second Intervention (1 Day)||2
8229250|NCT01999400|20292883|P3|STARTED|Second Intervention (1 Day)||3
8229251|NCT01999400|20292884|P2|STARTED|Second Intervention (1 Day)||4
8229252|NCT01999400|20292885|P1|STARTED|Second Intervention (1 Day)||5
8229253|NCT01999400|20292880|P6|NOT COMPLETED|Washout (10 Days)||0
8229254|NCT01999400|20292881|P5|NOT COMPLETED|Washout (10 Days)||0
8229255|NCT01999400|20292882|P4|NOT COMPLETED|Washout (10 Days)||0
8229256|NCT01999400|20292883|P3|NOT COMPLETED|Washout (10 Days)||0
8229257|NCT01999400|20292884|P2|NOT COMPLETED|Washout (10 Days)||0
8229258|NCT01999400|20292885|P1|NOT COMPLETED|Washout (10 Days)||0
8229259|NCT01999400|20292880|P6|COMPLETED|Washout (10 Days)||3
8229260|NCT01999400|20292881|P5|COMPLETED|Washout (10 Days)||3
8229261|NCT01999400|20292882|P4|COMPLETED|Washout (10 Days)||2
8229262|NCT01999400|20292883|P3|COMPLETED|Washout (10 Days)||3
8229263|NCT01999400|20292884|P2|COMPLETED|Washout (10 Days)||4
8229264|NCT01999400|20292885|P1|COMPLETED|Washout (10 Days)||5
8229265|NCT01999400|20292880|P6|STARTED|Washout (10 Days)||3
8229266|NCT01999400|20292881|P5|STARTED|Washout (10 Days)||3
8229267|NCT01999400|20292882|P4|STARTED|Washout (10 Days)||2
8229268|NCT01999400|20292883|P3|STARTED|Washout (10 Days)||3
8229269|NCT01999400|20292884|P2|STARTED|Washout (10 Days)||4
8229270|NCT01999400|20292885|P1|STARTED|Washout (10 Days)||5
8229271|NCT01999400|20292880|P6|NOT COMPLETED|First Intervention (1 Day)||1
8229272|NCT01999400|20292881|P5|NOT COMPLETED|First Intervention (1 Day)||0
8229273|NCT01999400|20292882|P4|NOT COMPLETED|First Intervention (1 Day)||3
8229274|NCT01999400|20292883|P3|NOT COMPLETED|First Intervention (1 Day)||2
8229275|NCT01999400|20292884|P2|NOT COMPLETED|First Intervention (1 Day)||2
8229276|NCT01999400|20292885|P1|NOT COMPLETED|First Intervention (1 Day)||2
8229277|NCT01999400|20292880|P6|COMPLETED|First Intervention (1 Day)||3
8229278|NCT01999400|20292881|P5|COMPLETED|First Intervention (1 Day)||4
8229279|NCT01999400|20292882|P4|COMPLETED|First Intervention (1 Day)||2
8229280|NCT01999400|20292883|P3|COMPLETED|First Intervention (1 Day)||3
8229281|NCT01999400|20292884|P2|COMPLETED|First Intervention (1 Day)||4
8229282|NCT01999400|20292885|P1|COMPLETED|First Intervention (1 Day)||4
8229283|NCT01999400|20292880|P6|STARTED|First Intervention (1 Day)||4
8229284|NCT01999400|20292881|P5|STARTED|First Intervention (1 Day)||4
8229285|NCT01999400|20292882|P4|STARTED|First Intervention (1 Day)||5
8229286|NCT01999400|20292883|P3|STARTED|First Intervention (1 Day)||5
8229287|NCT01999400|20292884|P2|STARTED|First Intervention (1 Day)||6
8229288|NCT01999400|20292885|P1|STARTED|First Intervention (1 Day)||6
8229289|NCT01999348|20292905|P1|NOT COMPLETED|Overall Study||120
8229290|NCT01999348|20292905|P1|COMPLETED|Overall Study||1433
8229291|NCT01999348|20292905|P1|STARTED|Overall Study||1553
8229292|NCT01999322|20292917|P2|NOT COMPLETED|Overall Study||0
8229293|NCT01999322|20292918|P1|NOT COMPLETED|Overall Study||1
8229294|NCT01999322|20292917|P2|COMPLETED|Overall Study||12
8229295|NCT01999322|20292918|P1|COMPLETED|Overall Study||24
8229296|NCT01999322|20292917|P2|STARTED|Overall Study||12
8229297|NCT01999322|20292918|P1|STARTED|Overall Study||25
8229298|NCT01999231|20292934|P4|NOT COMPLETED|Overall Study||0
8229299|NCT01999231|20292935|P3|NOT COMPLETED|Overall Study||0
8229300|NCT01999231|20292936|P2|NOT COMPLETED|Overall Study||0
8229301|NCT01999231|20292937|P1|NOT COMPLETED|Overall Study||0
8229302|NCT01999231|20292934|P4|COMPLETED|Overall Study||6
8229303|NCT01999231|20292935|P3|COMPLETED|Overall Study||6
8229304|NCT01999231|20292936|P2|COMPLETED|Overall Study||6
8229305|NCT01999231|20292937|P1|COMPLETED|Overall Study||6
8229306|NCT01999231|20292934|P4|STARTED|Overall Study||6
8229307|NCT01999231|20292935|P3|STARTED|Overall Study||6
8229308|NCT01999231|20292936|P2|STARTED|Overall Study||6
8229309|NCT01999231|20292937|P1|STARTED|Overall Study||6
8229310|NCT01999218|20292970|P3|NOT COMPLETED|Overall Study||110
8229311|NCT01999218|20292971|P2|NOT COMPLETED|Overall Study||101
8229312|NCT01999218|20292972|P1|NOT COMPLETED|Overall Study||109
8229313|NCT01999218|20292970|P3|COMPLETED|Overall Study||327
8229314|NCT01999218|20292971|P2|COMPLETED|Overall Study||340
8229315|NCT01999218|20292972|P1|COMPLETED|Overall Study||339
8229316|NCT01999218|20292970|P3|Site Issue|Overall Study||435
8229317|NCT01999218|20292971|P2|Site Issue|Overall Study||435
8229318|NCT01999218|20292972|P1|Site Issue|Overall Study||445
8229319|NCT01999218|20292970|P3|Treated|Overall Study||437
8229320|NCT01999218|20292971|P2|Treated|Overall Study||440
8229321|NCT01999218|20292972|P1|Treated|Overall Study||448
8229322|NCT01999218|20292970|P3|STARTED|Overall Study||437
8229323|NCT01999218|20292971|P2|STARTED|Overall Study||441
8229324|NCT01999218|20292972|P1|STARTED|Overall Study||448
8229325|NCT01999192|20292999|P4|NOT COMPLETED|Extension Phase||0
8229326|NCT01999192|20293000|P3|NOT COMPLETED|Extension Phase||24
8229327|NCT01999192|20293001|P2|NOT COMPLETED|Extension Phase||18
8229328|NCT01999192|20293002|P1|NOT COMPLETED|Extension Phase||13
8229329|NCT01999192|20292999|P4|COMPLETED|Extension Phase||0
8229330|NCT01999192|20293000|P3|COMPLETED|Extension Phase||44
8229331|NCT01999192|20293001|P2|COMPLETED|Extension Phase||38
8229332|NCT01999192|20293002|P1|COMPLETED|Extension Phase||41
8229333|NCT01999192|20292999|P4|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
8229334|NCT01999192|20293000|P3|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
8229335|NCT01999192|20293001|P2|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
8229336|NCT01999192|20293002|P1|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
8229337|NCT01999192|20292999|P4|NOT COMPLETED|Main Phase II||1
8229338|NCT01999192|20293000|P3|NOT COMPLETED|Main Phase II||22
8229339|NCT01999192|20293001|P2|NOT COMPLETED|Main Phase II||9
8229340|NCT01999192|20293002|P1|NOT COMPLETED|Main Phase II||9
8229341|NCT01999192|20292999|P4|COMPLETED|Main Phase II||43
8229342|NCT01999192|20293000|P3|COMPLETED|Main Phase II||76
8229343|NCT01999192|20293001|P2|COMPLETED|Main Phase II||66
8229344|NCT01999192|20293002|P1|COMPLETED|Main Phase II||55
8229345|NCT01999192|20292999|P4|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
8229346|NCT01999192|20293000|P3|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
8229347|NCT01999192|20293001|P2|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
8229348|NCT01999192|20293002|P1|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
8229349|NCT01999192|20292999|P4|NOT COMPLETED|Main Phase I||8
8229350|NCT01999192|20293000|P3|NOT COMPLETED|Main Phase I||8
8229351|NCT01999192|20293001|P2|NOT COMPLETED|Main Phase I||10
8229352|NCT01999192|20293002|P1|NOT COMPLETED|Main Phase I||11
8229353|NCT01999192|20292999|P4|COMPLETED|Main Phase I||72
8229354|NCT01999192|20293000|P3|COMPLETED|Main Phase I||70
8229355|NCT01999192|20293001|P2|COMPLETED|Main Phase I||70
8229356|NCT01999192|20293002|P1|COMPLETED|Main Phase I||72
8229357|NCT01999192|20292999|P4|STARTED|Main Phase I||80
8229358|NCT01999192|20293000|P3|STARTED|Main Phase I||78
8229359|NCT01999192|20293001|P2|STARTED|Main Phase I||80
8229360|NCT01999192|20293002|P1|STARTED|Main Phase I||83
8229361|NCT01999114|20293017|P5|NOT COMPLETED|Overall Study||4
8229362|NCT01999114|20293018|P4|NOT COMPLETED|Overall Study||3
8229363|NCT01999114|20293019|P3|NOT COMPLETED|Overall Study||5
8229364|NCT01999114|20293020|P2|NOT COMPLETED|Overall Study||7
8229365|NCT01999114|20293021|P1|NOT COMPLETED|Overall Study||8
8229366|NCT01999114|20293017|P5|COMPLETED|Overall Study||61
8229367|NCT01999114|20293018|P4|COMPLETED|Overall Study||62
8229368|NCT01999114|20293019|P3|COMPLETED|Overall Study||61
8229369|NCT01999114|20293020|P2|COMPLETED|Overall Study||59
8229370|NCT01999114|20293021|P1|COMPLETED|Overall Study||58
8229371|NCT01999114|20293017|P5|STARTED|Overall Study||65
8229372|NCT01999114|20293018|P4|STARTED|Overall Study||65
8229373|NCT01999114|20293019|P3|STARTED|Overall Study||66
8229374|NCT01999114|20293020|P2|STARTED|Overall Study||66
8229375|NCT01999114|20293021|P1|STARTED|Overall Study||66
8229376|NCT01998984|20293089|P4|NOT COMPLETED|Overall Study||3
8229377|NCT01998984|20293090|P3|NOT COMPLETED|Overall Study||1
8229378|NCT01998984|20293091|P2|NOT COMPLETED|Overall Study||1
8229379|NCT01998984|20293092|P1|NOT COMPLETED|Overall Study||0
8229380|NCT01998984|20293089|P4|COMPLETED|Overall Study||58
8229381|NCT01998984|20293090|P3|COMPLETED|Overall Study||48
8229382|NCT01998984|20293091|P2|COMPLETED|Overall Study||58
8229383|NCT01998984|20293092|P1|COMPLETED|Overall Study||55
8229384|NCT01998984|20293089|P4|STARTED|Overall Study||61
8229385|NCT01998984|20293090|P3|STARTED|Overall Study||49
8229386|NCT01998984|20293091|P2|STARTED|Overall Study||59
8229387|NCT01998984|20293092|P1|STARTED|Overall Study||55
8229388|NCT01998958|20293117|P32|NOT COMPLETED|Follow-up Phase||0
8229389|NCT01998958|20293118|P31|NOT COMPLETED|Follow-up Phase||0
8229390|NCT01998958|20293119|P30|NOT COMPLETED|Follow-up Phase||0
8229391|NCT01998958|20293120|P29|NOT COMPLETED|Follow-up Phase||0
8229392|NCT01998958|20293121|P28|NOT COMPLETED|Follow-up Phase||0
8229393|NCT01998958|20293122|P27|NOT COMPLETED|Follow-up Phase||0
8229394|NCT01998958|20293123|P26|NOT COMPLETED|Follow-up Phase||0
8229395|NCT01998958|20293124|P25|NOT COMPLETED|Follow-up Phase||0
8229396|NCT01998958|20293125|P24|NOT COMPLETED|Follow-up Phase||0
8229397|NCT01998958|20293126|P23|NOT COMPLETED|Follow-up Phase||0
8229398|NCT01998958|20293127|P22|NOT COMPLETED|Follow-up Phase||0
8229399|NCT01998958|20293128|P21|NOT COMPLETED|Follow-up Phase||0
8229400|NCT01998958|20293129|P20|NOT COMPLETED|Follow-up Phase||0
8229401|NCT01998958|20293130|P19|NOT COMPLETED|Follow-up Phase||0
8229402|NCT01998958|20293131|P18|NOT COMPLETED|Follow-up Phase||0
8229403|NCT01998958|20293132|P17|NOT COMPLETED|Follow-up Phase||0
8229404|NCT01998958|20293133|P16|NOT COMPLETED|Follow-up Phase||0
8229405|NCT01998958|20293134|P15|NOT COMPLETED|Follow-up Phase||0
8229406|NCT01998958|20293135|P14|NOT COMPLETED|Follow-up Phase||0
8229407|NCT01998958|20293136|P13|NOT COMPLETED|Follow-up Phase||0
8229408|NCT01998958|20293137|P12|NOT COMPLETED|Follow-up Phase||0
8229409|NCT01998958|20293138|P11|NOT COMPLETED|Follow-up Phase||0
8229410|NCT01998958|20293139|P10|NOT COMPLETED|Follow-up Phase||0
8229411|NCT01998958|20293140|P9|NOT COMPLETED|Follow-up Phase||0
8229412|NCT01998958|20293141|P8|NOT COMPLETED|Follow-up Phase||0
8229413|NCT01998958|20293142|P7|NOT COMPLETED|Follow-up Phase||0
8229414|NCT01998958|20293143|P6|NOT COMPLETED|Follow-up Phase||0
8229415|NCT01998958|20293144|P5|NOT COMPLETED|Follow-up Phase||0
8229416|NCT01998958|20293145|P4|NOT COMPLETED|Follow-up Phase||0
8229417|NCT01998958|20293146|P3|NOT COMPLETED|Follow-up Phase||0
8229418|NCT01998958|20293147|P2|NOT COMPLETED|Follow-up Phase||0
8229419|NCT01998958|20293148|P1|NOT COMPLETED|Follow-up Phase||0
8229420|NCT01998958|20293117|P32|COMPLETED|Follow-up Phase||42
8229421|NCT01998958|20293118|P31|COMPLETED|Follow-up Phase||39
8229422|NCT01998958|20293119|P30|COMPLETED|Follow-up Phase||12
8229423|NCT01998958|20293120|P29|COMPLETED|Follow-up Phase||4
8229424|NCT01998958|20293121|P28|COMPLETED|Follow-up Phase||1
8229425|NCT01998958|20293122|P27|COMPLETED|Follow-up Phase||0
8229426|NCT01998958|20293123|P26|COMPLETED|Follow-up Phase||0
8229427|NCT01998958|20293124|P25|COMPLETED|Follow-up Phase||0
8229428|NCT01998958|20293125|P24|COMPLETED|Follow-up Phase||0
8229429|NCT01998958|20293126|P23|COMPLETED|Follow-up Phase||0
8229430|NCT01998958|20293127|P22|COMPLETED|Follow-up Phase||0
8229431|NCT01998958|20293128|P21|COMPLETED|Follow-up Phase||0
8229432|NCT01998958|20293129|P20|COMPLETED|Follow-up Phase||0
8229433|NCT01998958|20293130|P19|COMPLETED|Follow-up Phase||0
8229434|NCT01998958|20293131|P18|COMPLETED|Follow-up Phase||0
8229435|NCT01998958|20293132|P17|COMPLETED|Follow-up Phase||0
8229436|NCT01998958|20293133|P16|COMPLETED|Follow-up Phase||0
8229437|NCT01998958|20293134|P15|COMPLETED|Follow-up Phase||0
8229438|NCT01998958|20293135|P14|COMPLETED|Follow-up Phase||0
8229439|NCT01998958|20293136|P13|COMPLETED|Follow-up Phase||0
8229440|NCT01998958|20293137|P12|COMPLETED|Follow-up Phase||0
8229441|NCT01998958|20293138|P11|COMPLETED|Follow-up Phase||0
8229442|NCT01998958|20293139|P10|COMPLETED|Follow-up Phase||0
8229443|NCT01998958|20293140|P9|COMPLETED|Follow-up Phase||0
8229444|NCT01998958|20293141|P8|COMPLETED|Follow-up Phase||0
8229445|NCT01998958|20293142|P7|COMPLETED|Follow-up Phase||0
8229446|NCT01998958|20293143|P6|COMPLETED|Follow-up Phase||0
8229447|NCT01998958|20293144|P5|COMPLETED|Follow-up Phase||0
8229448|NCT01998958|20293145|P4|COMPLETED|Follow-up Phase||0
8229449|NCT01998958|20293146|P3|COMPLETED|Follow-up Phase||0
8229450|NCT01998958|20293147|P2|COMPLETED|Follow-up Phase||0
8229451|NCT01998958|20293148|P1|COMPLETED|Follow-up Phase||0
8229452|NCT01998958|20293117|P32|STARTED|Follow-up Phase||42
8229453|NCT01998958|20293118|P31|STARTED|Follow-up Phase||39
8229454|NCT01998958|20293119|P30|STARTED|Follow-up Phase||12
8229455|NCT01998958|20293120|P29|STARTED|Follow-up Phase||4
8229456|NCT01998958|20293121|P28|STARTED|Follow-up Phase||1
8229457|NCT01998958|20293122|P27|STARTED|Follow-up Phase||0
8229458|NCT01998958|20293123|P26|STARTED|Follow-up Phase||0
8229459|NCT01998958|20293124|P25|STARTED|Follow-up Phase||0
8229460|NCT01998958|20293125|P24|STARTED|Follow-up Phase||0
8229461|NCT01998958|20293126|P23|STARTED|Follow-up Phase||0
8229462|NCT01998958|20293127|P22|STARTED|Follow-up Phase||0
8229463|NCT01998958|20293128|P21|STARTED|Follow-up Phase||0
8229464|NCT01998958|20293129|P20|STARTED|Follow-up Phase||0
8229465|NCT01998958|20293130|P19|STARTED|Follow-up Phase||0
8229466|NCT01998958|20293131|P18|STARTED|Follow-up Phase||0
8229467|NCT01998958|20293132|P17|STARTED|Follow-up Phase||0
8229468|NCT01998958|20293133|P16|STARTED|Follow-up Phase||0
8229469|NCT01998958|20293134|P15|STARTED|Follow-up Phase||0
8229470|NCT01998958|20293135|P14|STARTED|Follow-up Phase||0
8229471|NCT01998958|20293136|P13|STARTED|Follow-up Phase||0
8229472|NCT01998958|20293137|P12|STARTED|Follow-up Phase||0
8229473|NCT01998958|20293138|P11|STARTED|Follow-up Phase||0
8229474|NCT01998958|20293139|P10|STARTED|Follow-up Phase||0
8229475|NCT01998958|20293140|P9|STARTED|Follow-up Phase||0
8229476|NCT01998958|20293141|P8|STARTED|Follow-up Phase||0
8229477|NCT01998958|20293142|P7|STARTED|Follow-up Phase||0
8229478|NCT01998958|20293143|P6|STARTED|Follow-up Phase||0
8229479|NCT01998958|20293144|P5|STARTED|Follow-up Phase||0
8229480|NCT01998958|20293145|P4|STARTED|Follow-up Phase||0
8229481|NCT01998958|20293146|P3|STARTED|Follow-up Phase||0
8229482|NCT01998958|20293147|P2|STARTED|Follow-up Phase||0
8229483|NCT01998958|20293148|P1|STARTED|Follow-up Phase||0
8229484|NCT01998958|20293117|P32|NOT COMPLETED|Open Label Phase (Optional)||0
8229485|NCT01998958|20293118|P31|NOT COMPLETED|Open Label Phase (Optional)||0
8229486|NCT01998958|20293119|P30|NOT COMPLETED|Open Label Phase (Optional)||0
8229487|NCT01998958|20293120|P29|NOT COMPLETED|Open Label Phase (Optional)||0
8229488|NCT01998958|20293121|P28|NOT COMPLETED|Open Label Phase (Optional)||0
8229489|NCT01998958|20293122|P27|NOT COMPLETED|Open Label Phase (Optional)||0
8229490|NCT01998958|20293123|P26|NOT COMPLETED|Open Label Phase (Optional)||0
8229491|NCT01998958|20293124|P25|NOT COMPLETED|Open Label Phase (Optional)||0
8229492|NCT01998958|20293125|P24|NOT COMPLETED|Open Label Phase (Optional)||4
8229493|NCT01998958|20293126|P23|NOT COMPLETED|Open Label Phase (Optional)||9
8229494|NCT01998958|20293127|P22|NOT COMPLETED|Open Label Phase (Optional)||3
8229495|NCT01998958|20293128|P21|NOT COMPLETED|Open Label Phase (Optional)||0
8229496|NCT01998958|20293129|P20|NOT COMPLETED|Open Label Phase (Optional)||0
8229497|NCT01998958|20293130|P19|NOT COMPLETED|Open Label Phase (Optional)||0
8229498|NCT01998958|20293131|P18|NOT COMPLETED|Open Label Phase (Optional)||0
8229499|NCT01998958|20293132|P17|NOT COMPLETED|Open Label Phase (Optional)||0
8229500|NCT01998958|20293133|P16|NOT COMPLETED|Open Label Phase (Optional)||0
8229501|NCT01998958|20293134|P15|NOT COMPLETED|Open Label Phase (Optional)||0
8229502|NCT01998958|20293135|P14|NOT COMPLETED|Open Label Phase (Optional)||0
8229503|NCT01998958|20293136|P13|NOT COMPLETED|Open Label Phase (Optional)||0
8229504|NCT01998958|20293137|P12|NOT COMPLETED|Open Label Phase (Optional)||0
8229505|NCT01998958|20293138|P11|NOT COMPLETED|Open Label Phase (Optional)||0
8229506|NCT01998958|20293139|P10|NOT COMPLETED|Open Label Phase (Optional)||0
8229507|NCT01998958|20293140|P9|NOT COMPLETED|Open Label Phase (Optional)||0
8229508|NCT01998958|20293141|P8|NOT COMPLETED|Open Label Phase (Optional)||0
8229509|NCT01998958|20293142|P7|NOT COMPLETED|Open Label Phase (Optional)||0
8229510|NCT01998958|20293143|P6|NOT COMPLETED|Open Label Phase (Optional)||0
8229511|NCT01998958|20293144|P5|NOT COMPLETED|Open Label Phase (Optional)||0
8229512|NCT01998958|20293145|P4|NOT COMPLETED|Open Label Phase (Optional)||0
8229513|NCT01998958|20293146|P3|NOT COMPLETED|Open Label Phase (Optional)||0
8229514|NCT01998958|20293147|P2|NOT COMPLETED|Open Label Phase (Optional)||0
8229515|NCT01998958|20293148|P1|NOT COMPLETED|Open Label Phase (Optional)||0
8229516|NCT01998958|20293117|P32|COMPLETED|Open Label Phase (Optional)||0
8229517|NCT01998958|20293118|P31|COMPLETED|Open Label Phase (Optional)||0
8229518|NCT01998958|20293119|P30|COMPLETED|Open Label Phase (Optional)||0
8229519|NCT01998958|20293120|P29|COMPLETED|Open Label Phase (Optional)||0
8229520|NCT01998958|20293121|P28|COMPLETED|Open Label Phase (Optional)||0
8229521|NCT01998958|20293122|P27|COMPLETED|Open Label Phase (Optional)||19
8229522|NCT01998958|20293123|P26|COMPLETED|Open Label Phase (Optional)||7
8229523|NCT01998958|20293124|P25|COMPLETED|Open Label Phase (Optional)||13
8229524|NCT01998958|20293125|P24|COMPLETED|Open Label Phase (Optional)||23
8229525|NCT01998958|20293126|P23|COMPLETED|Open Label Phase (Optional)||11
8229526|NCT01998958|20293127|P22|COMPLETED|Open Label Phase (Optional)||7
8229527|NCT01998958|20293128|P21|COMPLETED|Open Label Phase (Optional)||0
8229528|NCT01998958|20293129|P20|COMPLETED|Open Label Phase (Optional)||0
8229529|NCT01998958|20293130|P19|COMPLETED|Open Label Phase (Optional)||0
8229530|NCT01998958|20293131|P18|COMPLETED|Open Label Phase (Optional)||0
8229531|NCT01998958|20293132|P17|COMPLETED|Open Label Phase (Optional)||0
8229532|NCT01998958|20293133|P16|COMPLETED|Open Label Phase (Optional)||0
8229533|NCT01998958|20293134|P15|COMPLETED|Open Label Phase (Optional)||0
8229534|NCT01998958|20293135|P14|COMPLETED|Open Label Phase (Optional)||0
8229535|NCT01998958|20293136|P13|COMPLETED|Open Label Phase (Optional)||0
8229536|NCT01998958|20293137|P12|COMPLETED|Open Label Phase (Optional)||0
8229537|NCT01998958|20293138|P11|COMPLETED|Open Label Phase (Optional)||0
8229538|NCT01998958|20293139|P10|COMPLETED|Open Label Phase (Optional)||0
8229539|NCT01998958|20293140|P9|COMPLETED|Open Label Phase (Optional)||0
8229540|NCT01998958|20293141|P8|COMPLETED|Open Label Phase (Optional)||0
8229541|NCT01998958|20293142|P7|COMPLETED|Open Label Phase (Optional)||0
8229542|NCT01998958|20293143|P6|COMPLETED|Open Label Phase (Optional)||0
8229543|NCT01998958|20293144|P5|COMPLETED|Open Label Phase (Optional)||0
8229544|NCT01998958|20293145|P4|COMPLETED|Open Label Phase (Optional)||0
8229545|NCT01998958|20293146|P3|COMPLETED|Open Label Phase (Optional)||0
8229546|NCT01998958|20293147|P2|COMPLETED|Open Label Phase (Optional)||0
8229547|NCT01998958|20293148|P1|COMPLETED|Open Label Phase (Optional)||0
8229548|NCT01998958|20293117|P32|STARTED|Open Label Phase (Optional)||0
8229549|NCT01998958|20293118|P31|STARTED|Open Label Phase (Optional)||0
8229550|NCT01998958|20293119|P30|STARTED|Open Label Phase (Optional)||0
8229551|NCT01998958|20293120|P29|STARTED|Open Label Phase (Optional)||0
8229552|NCT01998958|20293121|P28|STARTED|Open Label Phase (Optional)||0
8229553|NCT01998958|20293122|P27|STARTED|Open Label Phase (Optional)||19
8229554|NCT01998958|20293123|P26|STARTED|Open Label Phase (Optional)||7
8229555|NCT01998958|20293124|P25|STARTED|Open Label Phase (Optional)||13
8229556|NCT01998958|20293125|P24|STARTED|Open Label Phase (Optional)||27
8229557|NCT01998958|20293126|P23|STARTED|Open Label Phase (Optional)||20
8229558|NCT01998958|20293127|P22|STARTED|Open Label Phase (Optional)||10
8229559|NCT01998958|20293128|P21|STARTED|Open Label Phase (Optional)||0
8229560|NCT01998958|20293129|P20|STARTED|Open Label Phase (Optional)||0
8229561|NCT01998958|20293130|P19|STARTED|Open Label Phase (Optional)||0
8229562|NCT01998958|20293131|P18|STARTED|Open Label Phase (Optional)||0
8229563|NCT01998958|20293132|P17|STARTED|Open Label Phase (Optional)||0
8229564|NCT01998958|20293133|P16|STARTED|Open Label Phase (Optional)||0
8229565|NCT01998958|20293134|P15|STARTED|Open Label Phase (Optional)||0
8229566|NCT01998958|20293135|P14|STARTED|Open Label Phase (Optional)||0
8229567|NCT01998958|20293136|P13|STARTED|Open Label Phase (Optional)||0
8229568|NCT01998958|20293137|P12|STARTED|Open Label Phase (Optional)||0
8229569|NCT01998958|20293138|P11|STARTED|Open Label Phase (Optional)||0
8229570|NCT01998958|20293139|P10|STARTED|Open Label Phase (Optional)||0
8229571|NCT01998958|20293140|P9|STARTED|Open Label Phase (Optional)||0
8229572|NCT01998958|20293141|P8|STARTED|Open Label Phase (Optional)||0
8229573|NCT01998958|20293142|P7|STARTED|Open Label Phase (Optional)||0
8229574|NCT01998958|20293143|P6|STARTED|Open Label Phase (Optional)||0
8229575|NCT01998958|20293144|P5|STARTED|Open Label Phase (Optional)||0
8229576|NCT01998958|20293145|P4|STARTED|Open Label Phase (Optional)||0
8229577|NCT01998958|20293146|P3|STARTED|Open Label Phase (Optional)||0
8229578|NCT01998958|20293147|P2|STARTED|Open Label Phase (Optional)||0
8229579|NCT01998958|20293148|P1|STARTED|Open Label Phase (Optional)||0
8229580|NCT01998958|20293117|P32|NOT COMPLETED|Period 2 (Panel A and B)||0
8229581|NCT01998958|20293118|P31|NOT COMPLETED|Period 2 (Panel A and B)||0
8229582|NCT01998958|20293119|P30|NOT COMPLETED|Period 2 (Panel A and B)||0
8229583|NCT01998958|20293120|P29|NOT COMPLETED|Period 2 (Panel A and B)||0
8229584|NCT01998958|20293121|P28|NOT COMPLETED|Period 2 (Panel A and B)||0
8229585|NCT01998958|20293122|P27|NOT COMPLETED|Period 2 (Panel A and B)||0
8229586|NCT01998958|20293123|P26|NOT COMPLETED|Period 2 (Panel A and B)||0
8229587|NCT01998958|20293124|P25|NOT COMPLETED|Period 2 (Panel A and B)||0
8229588|NCT01998958|20293125|P24|NOT COMPLETED|Period 2 (Panel A and B)||0
8229589|NCT01998958|20293126|P23|NOT COMPLETED|Period 2 (Panel A and B)||0
8229590|NCT01998958|20293127|P22|NOT COMPLETED|Period 2 (Panel A and B)||0
8229591|NCT01998958|20293128|P21|NOT COMPLETED|Period 2 (Panel A and B)||0
8229592|NCT01998958|20293129|P20|NOT COMPLETED|Period 2 (Panel A and B)||0
8229593|NCT01998958|20293130|P19|NOT COMPLETED|Period 2 (Panel A and B)||1
8229594|NCT01998958|20293131|P18|NOT COMPLETED|Period 2 (Panel A and B)||0
8229595|NCT01998958|20293132|P17|NOT COMPLETED|Period 2 (Panel A and B)||0
8229596|NCT01998958|20293133|P16|NOT COMPLETED|Period 2 (Panel A and B)||0
8229597|NCT01998958|20293134|P15|NOT COMPLETED|Period 2 (Panel A and B)||2
8229598|NCT01998958|20293135|P14|NOT COMPLETED|Period 2 (Panel A and B)||0
8229599|NCT01998958|20293136|P13|NOT COMPLETED|Period 2 (Panel A and B)||0
8229600|NCT01998958|20293137|P12|NOT COMPLETED|Period 2 (Panel A and B)||0
8229601|NCT01998958|20293138|P11|NOT COMPLETED|Period 2 (Panel A and B)||1
8229602|NCT01998958|20293139|P10|NOT COMPLETED|Period 2 (Panel A and B)||0
8229603|NCT01998958|20293140|P9|NOT COMPLETED|Period 2 (Panel A and B)||0
8229604|NCT01998958|20293141|P8|NOT COMPLETED|Period 2 (Panel A and B)||0
8229605|NCT01998958|20293142|P7|NOT COMPLETED|Period 2 (Panel A and B)||0
8229606|NCT01998958|20293143|P6|NOT COMPLETED|Period 2 (Panel A and B)||0
8229607|NCT01998958|20293144|P5|NOT COMPLETED|Period 2 (Panel A and B)||0
8229608|NCT01998958|20293145|P4|NOT COMPLETED|Period 2 (Panel A and B)||0
8229609|NCT01998958|20293146|P3|NOT COMPLETED|Period 2 (Panel A and B)||0
8229610|NCT01998958|20293147|P2|NOT COMPLETED|Period 2 (Panel A and B)||0
8229611|NCT01998958|20293148|P1|NOT COMPLETED|Period 2 (Panel A and B)||0
8229612|NCT01998958|20293117|P32|COMPLETED|Period 2 (Panel A and B)||0
8229613|NCT01998958|20293118|P31|COMPLETED|Period 2 (Panel A and B)||0
8229614|NCT01998958|20293119|P30|COMPLETED|Period 2 (Panel A and B)||0
8229615|NCT01998958|20293120|P29|COMPLETED|Period 2 (Panel A and B)||0
8229616|NCT01998958|20293121|P28|COMPLETED|Period 2 (Panel A and B)||0
8229617|NCT01998958|20293122|P27|COMPLETED|Period 2 (Panel A and B)||0
8229618|NCT01998958|20293123|P26|COMPLETED|Period 2 (Panel A and B)||0
8229619|NCT01998958|20293124|P25|COMPLETED|Period 2 (Panel A and B)||0
8229620|NCT01998958|20293125|P24|COMPLETED|Period 2 (Panel A and B)||0
8229621|NCT01998958|20293126|P23|COMPLETED|Period 2 (Panel A and B)||0
8229622|NCT01998958|20293127|P22|COMPLETED|Period 2 (Panel A and B)||0
8229623|NCT01998958|20293128|P21|COMPLETED|Period 2 (Panel A and B)||9
8229624|NCT01998958|20293129|P20|COMPLETED|Period 2 (Panel A and B)||11
8229625|NCT01998958|20293130|P19|COMPLETED|Period 2 (Panel A and B)||2
8229626|NCT01998958|20293131|P18|COMPLETED|Period 2 (Panel A and B)||5
8229627|NCT01998958|20293132|P17|COMPLETED|Period 2 (Panel A and B)||8
8229628|NCT01998958|20293133|P16|COMPLETED|Period 2 (Panel A and B)||5
8229629|NCT01998958|20293134|P15|COMPLETED|Period 2 (Panel A and B)||10
8229630|NCT01998958|20293135|P14|COMPLETED|Period 2 (Panel A and B)||11
8229631|NCT01998958|20293136|P13|COMPLETED|Period 2 (Panel A and B)||8
8229632|NCT01998958|20293137|P12|COMPLETED|Period 2 (Panel A and B)||5
8229633|NCT01998958|20293138|P11|COMPLETED|Period 2 (Panel A and B)||8
8229634|NCT01998958|20293139|P10|COMPLETED|Period 2 (Panel A and B)||8
8229635|NCT01998958|20293140|P9|COMPLETED|Period 2 (Panel A and B)||4
8229636|NCT01998958|20293141|P8|COMPLETED|Period 2 (Panel A and B)||6
8229637|NCT01998958|20293142|P7|COMPLETED|Period 2 (Panel A and B)||0
8229638|NCT01998958|20293143|P6|COMPLETED|Period 2 (Panel A and B)||0
8229639|NCT01998958|20293144|P5|COMPLETED|Period 2 (Panel A and B)||0
8229640|NCT01998958|20293145|P4|COMPLETED|Period 2 (Panel A and B)||0
8229641|NCT01998958|20293146|P3|COMPLETED|Period 2 (Panel A and B)||0
8229642|NCT01998958|20293147|P2|COMPLETED|Period 2 (Panel A and B)||0
8229643|NCT01998958|20293148|P1|COMPLETED|Period 2 (Panel A and B)||0
8229644|NCT01998958|20293117|P32|STARTED|Period 2 (Panel A and B)||0
8229645|NCT01998958|20293118|P31|STARTED|Period 2 (Panel A and B)||0
8229646|NCT01998958|20293119|P30|STARTED|Period 2 (Panel A and B)||0
8229647|NCT01998958|20293120|P29|STARTED|Period 2 (Panel A and B)||0
8229648|NCT01998958|20293121|P28|STARTED|Period 2 (Panel A and B)||0
8229649|NCT01998958|20293122|P27|STARTED|Period 2 (Panel A and B)||0
8229650|NCT01998958|20293123|P26|STARTED|Period 2 (Panel A and B)||0
8229651|NCT01998958|20293124|P25|STARTED|Period 2 (Panel A and B)||0
8229652|NCT01998958|20293125|P24|STARTED|Period 2 (Panel A and B)||0
8229653|NCT01998958|20293126|P23|STARTED|Period 2 (Panel A and B)||0
8229654|NCT01998958|20293127|P22|STARTED|Period 2 (Panel A and B)||0
8229655|NCT01998958|20293128|P21|STARTED|Period 2 (Panel A and B)||9
8229656|NCT01998958|20293129|P20|STARTED|Period 2 (Panel A and B)||11
8229657|NCT01998958|20293130|P19|STARTED|Period 2 (Panel A and B)||3
8229658|NCT01998958|20293131|P18|STARTED|Period 2 (Panel A and B)||5
8229659|NCT01998958|20293132|P17|STARTED|Period 2 (Panel A and B)||8
8229660|NCT01998958|20293133|P16|STARTED|Period 2 (Panel A and B)||5
8229661|NCT01998958|20293134|P15|STARTED|Period 2 (Panel A and B)||12
8229662|NCT01998958|20293135|P14|STARTED|Period 2 (Panel A and B)||11
8229663|NCT01998958|20293136|P13|STARTED|Period 2 (Panel A and B)||8
8229664|NCT01998958|20293137|P12|STARTED|Period 2 (Panel A and B)||5
8229665|NCT01998958|20293138|P11|STARTED|Period 2 (Panel A and B)||9
8229666|NCT01998958|20293139|P10|STARTED|Period 2 (Panel A and B)||8
8229667|NCT01998958|20293140|P9|STARTED|Period 2 (Panel A and B)||4
8229668|NCT01998958|20293141|P8|STARTED|Period 2 (Panel A and B)||6
8229669|NCT01998958|20293142|P7|STARTED|Period 2 (Panel A and B)||0
8229670|NCT01998958|20293143|P6|STARTED|Period 2 (Panel A and B)||0
8229671|NCT01998958|20293144|P5|STARTED|Period 2 (Panel A and B)||0
8229672|NCT01998958|20293145|P4|STARTED|Period 2 (Panel A and B)||0
8229673|NCT01998958|20293146|P3|STARTED|Period 2 (Panel A and B)||0
8229674|NCT01998958|20293147|P2|STARTED|Period 2 (Panel A and B)||0
8229675|NCT01998958|20293148|P1|STARTED|Period 2 (Panel A and B)||0
8229676|NCT01998958|20293117|P32|NOT COMPLETED|Period 1 (Panel A and B)||0
8229677|NCT01998958|20293118|P31|NOT COMPLETED|Period 1 (Panel A and B)||0
8229678|NCT01998958|20293119|P30|NOT COMPLETED|Period 1 (Panel A and B)||0
8229679|NCT01998958|20293120|P29|NOT COMPLETED|Period 1 (Panel A and B)||0
8229680|NCT01998958|20293121|P28|NOT COMPLETED|Period 1 (Panel A and B)||0
8229681|NCT01998958|20293122|P27|NOT COMPLETED|Period 1 (Panel A and B)||0
8229682|NCT01998958|20293123|P26|NOT COMPLETED|Period 1 (Panel A and B)||0
8229683|NCT01998958|20293124|P25|NOT COMPLETED|Period 1 (Panel A and B)||0
8229684|NCT01998958|20293125|P24|NOT COMPLETED|Period 1 (Panel A and B)||0
8229685|NCT01998958|20293126|P23|NOT COMPLETED|Period 1 (Panel A and B)||0
8229686|NCT01998958|20293127|P22|NOT COMPLETED|Period 1 (Panel A and B)||0
8229687|NCT01998958|20293128|P21|NOT COMPLETED|Period 1 (Panel A and B)||0
8229688|NCT01998958|20293129|P20|NOT COMPLETED|Period 1 (Panel A and B)||0
8229689|NCT01998958|20293130|P19|NOT COMPLETED|Period 1 (Panel A and B)||0
8229690|NCT01998958|20293131|P18|NOT COMPLETED|Period 1 (Panel A and B)||0
8229691|NCT01998958|20293132|P17|NOT COMPLETED|Period 1 (Panel A and B)||0
8229692|NCT01998958|20293133|P16|NOT COMPLETED|Period 1 (Panel A and B)||0
8229693|NCT01998958|20293134|P15|NOT COMPLETED|Period 1 (Panel A and B)||0
8229694|NCT01998958|20293135|P14|NOT COMPLETED|Period 1 (Panel A and B)||0
8229695|NCT01998958|20293136|P13|NOT COMPLETED|Period 1 (Panel A and B)||0
8229696|NCT01998958|20293137|P12|NOT COMPLETED|Period 1 (Panel A and B)||0
8229697|NCT01998958|20293138|P11|NOT COMPLETED|Period 1 (Panel A and B)||0
8229698|NCT01998958|20293139|P10|NOT COMPLETED|Period 1 (Panel A and B)||0
8229699|NCT01998958|20293140|P9|NOT COMPLETED|Period 1 (Panel A and B)||0
8229700|NCT01998958|20293141|P8|NOT COMPLETED|Period 1 (Panel A and B)||0
8229701|NCT01998958|20293142|P7|NOT COMPLETED|Period 1 (Panel A and B)||0
8229702|NCT01998958|20293143|P6|NOT COMPLETED|Period 1 (Panel A and B)||0
8229703|NCT01998958|20293144|P5|NOT COMPLETED|Period 1 (Panel A and B)||0
8229704|NCT01998958|20293145|P4|NOT COMPLETED|Period 1 (Panel A and B)||0
8229705|NCT01998958|20293146|P3|NOT COMPLETED|Period 1 (Panel A and B)||0
8229706|NCT01998958|20293147|P2|NOT COMPLETED|Period 1 (Panel A and B)||3
8229707|NCT01998958|20293148|P1|NOT COMPLETED|Period 1 (Panel A and B)||1
8229708|NCT01998958|20293117|P32|COMPLETED|Period 1 (Panel A and B)||0
8229709|NCT01998958|20293118|P31|COMPLETED|Period 1 (Panel A and B)||0
8229710|NCT01998958|20293119|P30|COMPLETED|Period 1 (Panel A and B)||0
8229711|NCT01998958|20293120|P29|COMPLETED|Period 1 (Panel A and B)||0
8229712|NCT01998958|20293121|P28|COMPLETED|Period 1 (Panel A and B)||0
8229713|NCT01998958|20293122|P27|COMPLETED|Period 1 (Panel A and B)||0
8229714|NCT01998958|20293123|P26|COMPLETED|Period 1 (Panel A and B)||0
8229715|NCT01998958|20293124|P25|COMPLETED|Period 1 (Panel A and B)||0
8229716|NCT01998958|20293125|P24|COMPLETED|Period 1 (Panel A and B)||0
8229717|NCT01998958|20293126|P23|COMPLETED|Period 1 (Panel A and B)||0
8229718|NCT01998958|20293127|P22|COMPLETED|Period 1 (Panel A and B)||0
8229719|NCT01998958|20293128|P21|COMPLETED|Period 1 (Panel A and B)||0
8229720|NCT01998958|20293129|P20|COMPLETED|Period 1 (Panel A and B)||0
8229721|NCT01998958|20293130|P19|COMPLETED|Period 1 (Panel A and B)||0
8229722|NCT01998958|20293131|P18|COMPLETED|Period 1 (Panel A and B)||0
8229723|NCT01998958|20293132|P17|COMPLETED|Period 1 (Panel A and B)||0
8229724|NCT01998958|20293133|P16|COMPLETED|Period 1 (Panel A and B)||0
8229725|NCT01998958|20293134|P15|COMPLETED|Period 1 (Panel A and B)||0
8229726|NCT01998958|20293135|P14|COMPLETED|Period 1 (Panel A and B)||0
8229727|NCT01998958|20293136|P13|COMPLETED|Period 1 (Panel A and B)||0
8229728|NCT01998958|20293137|P12|COMPLETED|Period 1 (Panel A and B)||0
8229729|NCT01998958|20293138|P11|COMPLETED|Period 1 (Panel A and B)||0
8229730|NCT01998958|20293139|P10|COMPLETED|Period 1 (Panel A and B)||0
8229731|NCT01998958|20293140|P9|COMPLETED|Period 1 (Panel A and B)||0
8229732|NCT01998958|20293141|P8|COMPLETED|Period 1 (Panel A and B)||0
8229733|NCT01998958|20293142|P7|COMPLETED|Period 1 (Panel A and B)||9
8229734|NCT01998958|20293143|P6|COMPLETED|Period 1 (Panel A and B)||11
8229735|NCT01998958|20293144|P5|COMPLETED|Period 1 (Panel A and B)||21
8229736|NCT01998958|20293145|P4|COMPLETED|Period 1 (Panel A and B)||12
8229737|NCT01998958|20293146|P3|COMPLETED|Period 1 (Panel A and B)||11
8229738|NCT01998958|20293147|P2|COMPLETED|Period 1 (Panel A and B)||8
8229739|NCT01998958|20293148|P1|COMPLETED|Period 1 (Panel A and B)||32
8229740|NCT01998958|20293117|P32|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229741|NCT01998958|20293118|P31|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229742|NCT01998958|20293119|P30|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229743|NCT01998958|20293120|P29|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229744|NCT01998958|20293121|P28|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229745|NCT01998958|20293122|P27|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229746|NCT01998958|20293123|P26|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229747|NCT01998958|20293124|P25|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229748|NCT01998958|20293125|P24|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229749|NCT01998958|20293126|P23|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229750|NCT01998958|20293127|P22|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229751|NCT01998958|20293128|P21|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229752|NCT01998958|20293129|P20|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229753|NCT01998958|20293130|P19|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229754|NCT01998958|20293131|P18|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229755|NCT01998958|20293132|P17|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229756|NCT01998958|20293133|P16|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229757|NCT01998958|20293134|P15|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229758|NCT01998958|20293135|P14|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229759|NCT01998958|20293136|P13|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229760|NCT01998958|20293137|P12|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229761|NCT01998958|20293138|P11|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229762|NCT01998958|20293139|P10|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229763|NCT01998958|20293140|P9|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229764|NCT01998958|20293141|P8|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229765|NCT01998958|20293142|P7|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229766|NCT01998958|20293143|P6|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229767|NCT01998958|20293144|P5|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229768|NCT01998958|20293145|P4|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229769|NCT01998958|20293146|P3|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229770|NCT01998958|20293147|P2|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
8229771|NCT01998958|20293148|P1|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5
8229772|NCT01998958|20293117|P32|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229773|NCT01998958|20293118|P31|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229774|NCT01998958|20293119|P30|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229775|NCT01998958|20293120|P29|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229776|NCT01998958|20293121|P28|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229777|NCT01998958|20293122|P27|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229778|NCT01998958|20293123|P26|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229852|NCT01998958|20293133|P16|STARTED|Period 1 (Panel A and B)||0
8229779|NCT01998958|20293124|P25|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229780|NCT01998958|20293125|P24|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229781|NCT01998958|20293126|P23|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229782|NCT01998958|20293127|P22|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229783|NCT01998958|20293128|P21|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229784|NCT01998958|20293129|P20|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229785|NCT01998958|20293130|P19|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229786|NCT01998958|20293131|P18|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229787|NCT01998958|20293132|P17|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229788|NCT01998958|20293133|P16|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229789|NCT01998958|20293134|P15|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229790|NCT01998958|20293135|P14|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229791|NCT01998958|20293136|P13|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229792|NCT01998958|20293137|P12|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229793|NCT01998958|20293138|P11|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229794|NCT01998958|20293139|P10|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229795|NCT01998958|20293140|P9|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229796|NCT01998958|20293141|P8|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229797|NCT01998958|20293142|P7|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229798|NCT01998958|20293143|P6|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229799|NCT01998958|20293144|P5|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229800|NCT01998958|20293145|P4|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229801|NCT01998958|20293146|P3|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229802|NCT01998958|20293147|P2|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
8229803|NCT01998958|20293148|P1|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8
8229804|NCT01998958|20293117|P32|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229805|NCT01998958|20293118|P31|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229806|NCT01998958|20293119|P30|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229807|NCT01998958|20293120|P29|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229808|NCT01998958|20293121|P28|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229809|NCT01998958|20293122|P27|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229810|NCT01998958|20293123|P26|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229811|NCT01998958|20293124|P25|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229812|NCT01998958|20293125|P24|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229813|NCT01998958|20293126|P23|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229814|NCT01998958|20293127|P22|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229815|NCT01998958|20293128|P21|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229816|NCT01998958|20293129|P20|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229817|NCT01998958|20293130|P19|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229818|NCT01998958|20293131|P18|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229819|NCT01998958|20293132|P17|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229820|NCT01998958|20293133|P16|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229821|NCT01998958|20293134|P15|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229822|NCT01998958|20293135|P14|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229823|NCT01998958|20293136|P13|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229824|NCT01998958|20293137|P12|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229825|NCT01998958|20293138|P11|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229826|NCT01998958|20293139|P10|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229827|NCT01998958|20293140|P9|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229828|NCT01998958|20293141|P8|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229829|NCT01998958|20293142|P7|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229830|NCT01998958|20293143|P6|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229831|NCT01998958|20293144|P5|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229832|NCT01998958|20293145|P4|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229833|NCT01998958|20293146|P3|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229834|NCT01998958|20293147|P2|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
8229835|NCT01998958|20293148|P1|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9
8229836|NCT01998958|20293117|P32|STARTED|Period 1 (Panel A and B)||0
8229837|NCT01998958|20293118|P31|STARTED|Period 1 (Panel A and B)||0
8229838|NCT01998958|20293119|P30|STARTED|Period 1 (Panel A and B)||0
8229839|NCT01998958|20293120|P29|STARTED|Period 1 (Panel A and B)||0
8229840|NCT01998958|20293121|P28|STARTED|Period 1 (Panel A and B)||0
8229841|NCT01998958|20293122|P27|STARTED|Period 1 (Panel A and B)||0
8229842|NCT01998958|20293123|P26|STARTED|Period 1 (Panel A and B)||0
8229843|NCT01998958|20293124|P25|STARTED|Period 1 (Panel A and B)||0
8229844|NCT01998958|20293125|P24|STARTED|Period 1 (Panel A and B)||0
8229845|NCT01998958|20293126|P23|STARTED|Period 1 (Panel A and B)||0
8229846|NCT01998958|20293127|P22|STARTED|Period 1 (Panel A and B)||0
8229847|NCT01998958|20293128|P21|STARTED|Period 1 (Panel A and B)||0
8229848|NCT01998958|20293129|P20|STARTED|Period 1 (Panel A and B)||0
8229849|NCT01998958|20293130|P19|STARTED|Period 1 (Panel A and B)||0
8229850|NCT01998958|20293131|P18|STARTED|Period 1 (Panel A and B)||0
8229851|NCT01998958|20293132|P17|STARTED|Period 1 (Panel A and B)||0
8229853|NCT01998958|20293134|P15|STARTED|Period 1 (Panel A and B)||0
8229854|NCT01998958|20293135|P14|STARTED|Period 1 (Panel A and B)||0
8229855|NCT01998958|20293136|P13|STARTED|Period 1 (Panel A and B)||0
8229856|NCT01998958|20293137|P12|STARTED|Period 1 (Panel A and B)||0
8229857|NCT01998958|20293138|P11|STARTED|Period 1 (Panel A and B)||0
8229858|NCT01998958|20293139|P10|STARTED|Period 1 (Panel A and B)||0
8229859|NCT01998958|20293140|P9|STARTED|Period 1 (Panel A and B)||0
8229860|NCT01998958|20293141|P8|STARTED|Period 1 (Panel A and B)||0
8229861|NCT01998958|20293142|P7|STARTED|Period 1 (Panel A and B)||9
8229862|NCT01998958|20293143|P6|STARTED|Period 1 (Panel A and B)||11
8229863|NCT01998958|20293144|P5|STARTED|Period 1 (Panel A and B)||21
8229864|NCT01998958|20293145|P4|STARTED|Period 1 (Panel A and B)||12
8229865|NCT01998958|20293146|P3|STARTED|Period 1 (Panel A and B)||11
8229866|NCT01998958|20293147|P2|STARTED|Period 1 (Panel A and B)||11
8229867|NCT01998958|20293148|P1|STARTED|Period 1 (Panel A and B)||33
8229868|NCT01998919|20293287|P2|NOT COMPLETED|Overall Study||35
8229869|NCT01998919|20293288|P1|NOT COMPLETED|Overall Study||42
8229870|NCT01998919|20293287|P2|COMPLETED|Overall Study||39
8229871|NCT01998919|20293288|P1|COMPLETED|Overall Study||37
8229872|NCT01998919|20293287|P2|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
8229873|NCT01998919|20293288|P1|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
8229874|NCT01998919|20293287|P2|STARTED|Overall Study||74
8229875|NCT01998919|20293288|P1|STARTED|Overall Study||79
8229876|NCT01998906|20293309|P3|NOT COMPLETED|Overall Study||98
8229877|NCT01998906|20293310|P2|NOT COMPLETED|Overall Study||114
8229878|NCT01998906|20293311|P1|NOT COMPLETED|Overall Study||114
8229879|NCT01998906|20293309|P3|COMPLETED|Overall Study||1
8229880|NCT01998906|20293310|P2|COMPLETED|Overall Study||2
8229881|NCT01998906|20293311|P1|COMPLETED|Overall Study||1
8229882|NCT01998906|20293309|P3|STARTED|Overall Study||99
8229883|NCT01998906|20293310|P2|STARTED|Overall Study||116
8229884|NCT01998906|20293311|P1|STARTED|Overall Study||115
8229885|NCT01998893|20293355|P1|NOT COMPLETED|Overall Study||17
8229886|NCT01998893|20293355|P1|COMPLETED|Overall Study||21
8229887|NCT01998893|20293355|P1|2nd Treatment Cycle Completed Until PD|Overall Study||3
8229888|NCT01998893|20293355|P1|2nd Treatment Cycle Started|Overall Study||5
8229889|NCT01998893|20293355|P1|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
8229890|NCT01998893|20293355|P1|STARTED|Overall Study||38
8229891|NCT01998880|20293367|P2|NOT COMPLETED|Overall Study||40
8229892|NCT01998880|20293368|P1|NOT COMPLETED|Overall Study||28
8229893|NCT01998880|20293367|P2|COMPLETED|Overall Study||78
8229894|NCT01998880|20293368|P1|COMPLETED|Overall Study|Completed=Completed treatment.|205
8229895|NCT01998880|20293367|P2|Received Study Drug|Overall Study||116
8229896|NCT01998880|20293368|P1|Received Study Drug|Overall Study||230
8229897|NCT01998880|20293367|P2|STARTED|Overall Study||118
8229898|NCT01998880|20293368|P1|STARTED|Overall Study||233
8229899|NCT01998737|20293400|P2|NOT COMPLETED|Overall Study||0
8229900|NCT01998737|20293401|P1|NOT COMPLETED|Overall Study||23
8229901|NCT01998737|20293400|P2|COMPLETED|Overall Study||100
8229902|NCT01998737|20293401|P1|COMPLETED|Overall Study||888
8229903|NCT01998737|20293400|P2|STARTED|Overall Study||100
8229904|NCT01998737|20293401|P1|STARTED|Overall Study||911
8229905|NCT01998633|20293413|P1|NOT COMPLETED|Overall Study||1
8229906|NCT01998633|20293413|P1|COMPLETED|Overall Study||46
8229907|NCT01998633|20293413|P1|STARTED|Overall Study||47
8229908|NCT01998581|20293431|P2|NOT COMPLETED|Overall Study||12
8229909|NCT01998581|20293432|P1|NOT COMPLETED|Overall Study||46
8229910|NCT01998581|20293431|P2|COMPLETED|Overall Study||44
8229911|NCT01998581|20293432|P1|COMPLETED|Overall Study||123
8229912|NCT01998581|20293431|P2|STARTED|Overall Study||56
8229913|NCT01998581|20293432|P1|STARTED|Overall Study||169
8229914|NCT01998477|20293445|P2|NOT COMPLETED|Overall Study||5
8229915|NCT01998477|20293446|P1|NOT COMPLETED|Overall Study||10
8229916|NCT01998477|20293445|P2|COMPLETED|Overall Study||143
8229917|NCT01998477|20293446|P1|COMPLETED|Overall Study||272
8229918|NCT01998477|20293445|P2|STARTED|Overall Study||148
8229919|NCT01998477|20293446|P1|STARTED|Overall Study||282
8229920|NCT01998438|20293480|P3|NOT COMPLETED|Overall Study||0
8229921|NCT01998438|20293481|P2|NOT COMPLETED|Overall Study||0
8229922|NCT01998438|20293482|P1|NOT COMPLETED|Overall Study||0
8229923|NCT01998438|20293480|P3|COMPLETED|Overall Study||318
8229924|NCT01998438|20293481|P2|COMPLETED|Overall Study||318
8229925|NCT01998438|20293482|P1|COMPLETED|Overall Study||319
8229926|NCT01998438|20293480|P3|STARTED|Overall Study||318
8229927|NCT01998438|20293481|P2|STARTED|Overall Study||318
8229928|NCT01998438|20293482|P1|STARTED|Overall Study||319
8229929|NCT01998399|20293492|P2|NOT COMPLETED|Overall Study||9
8229930|NCT01998399|20293493|P1|NOT COMPLETED|Overall Study||8
8229931|NCT01998399|20293492|P2|COMPLETED|Overall Study||4
8229932|NCT01998399|20293493|P1|COMPLETED|Overall Study||4
8229933|NCT01998399|20293492|P2|STARTED|Overall Study||13
8229934|NCT01998399|20293493|P1|STARTED|Overall Study||12
8229935|NCT01998360|20293527|P2|NOT COMPLETED|Overall Study||0
8229936|NCT01998360|20293528|P1|NOT COMPLETED|Overall Study||0
8229937|NCT01998360|20293527|P2|COMPLETED|Overall Study||50
8229938|NCT01998360|20293528|P1|COMPLETED|Overall Study||50
8229939|NCT01998360|20293527|P2|STARTED|Overall Study||50
8229940|NCT01998360|20293528|P1|STARTED|Overall Study||50
8229941|NCT01998269|20293542|P1|NOT COMPLETED|Overall Study||0
8229942|NCT01998269|20293542|P1|COMPLETED|Overall Study||193
8229943|NCT01998269|20293542|P1|STARTED|Overall Study||193
8229944|NCT01998243|20293548|P2|NOT COMPLETED|Overall Study||7
8229945|NCT01998243|20293549|P1|NOT COMPLETED|Overall Study||8
8229946|NCT01998243|20293548|P2|COMPLETED|Overall Study||32
8229947|NCT01998243|20293549|P1|COMPLETED|Overall Study||34
8229948|NCT01998243|20293548|P2|STARTED|Overall Study||39
8229949|NCT01998243|20293549|P1|STARTED|Overall Study||42
8229950|NCT01997905|20293563|P1|NOT COMPLETED|Overall Study||3
8229951|NCT01997905|20293563|P1|COMPLETED|Overall Study||10
8229952|NCT01997905|20293563|P1|Baseline Completed|Overall Study||11
8229953|NCT01997905|20293563|P1|STARTED|Overall Study||13
8229954|NCT01997892|20293572|P1|NOT COMPLETED|Overall Study||68
8229955|NCT01997892|20293572|P1|COMPLETED|Overall Study||959
8229956|NCT01997892|20293572|P1|Received Darbepoetin Alfa|Overall Study||987
8229957|NCT01997892|20293572|P1|STARTED|Overall Study||1027
8229958|NCT01997723|20293584|P1|NOT COMPLETED|Overall Study||0
8229959|NCT01997723|20293584|P1|COMPLETED|Overall Study||75
8229960|NCT01997723|20293584|P1|STARTED|Overall Study||75
8229961|NCT01997567|20293592|P2|NOT COMPLETED|Overall Study||0
8229962|NCT01997567|20293593|P1|NOT COMPLETED|Overall Study||0
8229963|NCT01997567|20293592|P2|COMPLETED|Overall Study||0
8229964|NCT01997567|20293593|P1|COMPLETED|Overall Study||0
8229965|NCT01997567|20293592|P2|STARTED|Overall Study||0
8229966|NCT01997567|20293593|P1|STARTED|Overall Study||0
8229967|NCT01997515|20293613|P2|NOT COMPLETED|Overall Study||5
8229968|NCT01997515|20293614|P1|NOT COMPLETED|Overall Study||4
8229969|NCT01997515|20293613|P2|COMPLETED|Overall Study||35
8229970|NCT01997515|20293614|P1|COMPLETED|Overall Study||36
8229971|NCT01997515|20293613|P2|STARTED|Overall Study||40
8229972|NCT01997515|20293614|P1|STARTED|Overall Study||40
8229973|NCT01997437|20293626|P1|NOT COMPLETED|Overall Study||0
8229974|NCT01997437|20293626|P1|COMPLETED|Overall Study||6
8229975|NCT01997437|20293626|P1|STARTED|Overall Study||6
8229976|NCT01997411|20293638|P8|NOT COMPLETED|Overall Study||0
8229977|NCT01997411|20293639|P7|NOT COMPLETED|Overall Study||0
8229978|NCT01997411|20293640|P6|NOT COMPLETED|Overall Study||1
8229979|NCT01997411|20293641|P5|NOT COMPLETED|Overall Study||0
8229980|NCT01997411|20293642|P4|NOT COMPLETED|Overall Study||0
8229981|NCT01997411|20293643|P3|NOT COMPLETED|Overall Study||0
8229982|NCT01997411|20293644|P2|NOT COMPLETED|Overall Study||0
8229983|NCT01997411|20293645|P1|NOT COMPLETED|Overall Study||0
8229984|NCT01997411|20293638|P8|COMPLETED|Overall Study||6
8229985|NCT01997411|20293639|P7|COMPLETED|Overall Study||6
8229986|NCT01997411|20293640|P6|COMPLETED|Overall Study||5
8229987|NCT01997411|20293641|P5|COMPLETED|Overall Study||6
8229988|NCT01997411|20293642|P4|COMPLETED|Overall Study||6
8229989|NCT01997411|20293643|P3|COMPLETED|Overall Study||6
8229990|NCT01997411|20293644|P2|COMPLETED|Overall Study||6
8229991|NCT01997411|20293645|P1|COMPLETED|Overall Study||6
8229992|NCT01997411|20293638|P8|STARTED|Overall Study||6
8229993|NCT01997411|20293639|P7|STARTED|Overall Study||6
8229994|NCT01997411|20293640|P6|STARTED|Overall Study||6
8229995|NCT01997411|20293641|P5|STARTED|Overall Study||6
8229996|NCT01997411|20293642|P4|STARTED|Overall Study||6
8229997|NCT01997411|20293643|P3|STARTED|Overall Study||6
8229998|NCT01997411|20293644|P2|STARTED|Overall Study||6
8229999|NCT01997411|20293645|P1|STARTED|Overall Study||6
8230000|NCT01997398|20293735|P1|NOT COMPLETED|Overall Study||1
8230001|NCT01997398|20293735|P1|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
8230002|NCT01997398|20293735|P1|STARTED|Overall Study||35
8230003|NCT01997333|20293746|P2|NOT COMPLETED|Survival Follow up||14
8230004|NCT01997333|20293747|P1|NOT COMPLETED|Survival Follow up||16
8230005|NCT01997333|20293746|P2|COMPLETED|Survival Follow up||199
8230006|NCT01997333|20293747|P1|COMPLETED|Survival Follow up||76
8230007|NCT01997333|20293746|P2|STARTED|Survival Follow up||213
8230008|NCT01997333|20293747|P1|STARTED|Survival Follow up||92
8230009|NCT01997333|20293746|P2|NOT COMPLETED|Randomization and Treatment||203
8230010|NCT01997333|20293747|P1|NOT COMPLETED|Randomization and Treatment||103
8230011|NCT01997333|20293746|P2|COMPLETED|Randomization and Treatment||15
8230012|NCT01997333|20293747|P1|COMPLETED|Randomization and Treatment||6
8230013|NCT01997333|20293746|P2|STARTED|Randomization and Treatment||218
8230014|NCT01997333|20293747|P1|STARTED|Randomization and Treatment||109
8230015|NCT01997281|20293764|P2|NOT COMPLETED|Overall Study||0
8230016|NCT01997281|20293765|P1|NOT COMPLETED|Overall Study||1
8230017|NCT01997281|20293764|P2|COMPLETED|Overall Study||7
8230018|NCT01997281|20293765|P1|COMPLETED|Overall Study||6
8230019|NCT01997281|20293764|P2|Withdrawal|Overall Study||0
8230020|NCT01997281|20293765|P1|Withdrawal|Overall Study||1
8230021|NCT01997281|20293764|P2|STARTED|Overall Study||7
8230022|NCT01997281|20293765|P1|STARTED|Overall Study||7
8230023|NCT01997229|20293773|P2|NOT COMPLETED|Overall Study||2
8230024|NCT01997229|20293774|P1|NOT COMPLETED|Overall Study||5
8230025|NCT01997229|20293773|P2|COMPLETED|Overall Study||61
8230026|NCT01997229|20293774|P1|COMPLETED|Overall Study||57
8230027|NCT01997229|20293773|P2|STARTED|Overall Study||63
8230028|NCT01997229|20293774|P1|STARTED|Overall Study||62
8230029|NCT01997216|20293780|P2|NOT COMPLETED|Second 9 Hours||0
8230030|NCT01997216|20293781|P1|NOT COMPLETED|Second 9 Hours||0
8230031|NCT01997216|20293780|P2|COMPLETED|Second 9 Hours||21
8230032|NCT01997216|20293781|P1|COMPLETED|Second 9 Hours||19
8230033|NCT01997216|20293780|P2|STARTED|Second 9 Hours||21
8230034|NCT01997216|20293781|P1|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
8230035|NCT01997216|20293780|P2|NOT COMPLETED|First 9 Hours||0
8230036|NCT01997216|20293781|P1|NOT COMPLETED|First 9 Hours||0
8230037|NCT01997216|20293780|P2|COMPLETED|First 9 Hours||21
8230038|NCT01997216|20293781|P1|COMPLETED|First 9 Hours||18
8230039|NCT01997216|20293780|P2|STARTED|First 9 Hours||21
8230040|NCT01997216|20293781|P1|STARTED|First 9 Hours||18
8230041|NCT01996982|20293791|P1|NOT COMPLETED|Overall Study||7
8230042|NCT01996982|20293791|P1|COMPLETED|Overall Study||0
8230043|NCT01996982|20293791|P1|STARTED|Overall Study||7
8230044|NCT01996917|20293796|P1|NOT COMPLETED|Overall Study||0
8230045|NCT01996917|20293796|P1|COMPLETED|Overall Study||21
8230046|NCT01996917|20293796|P1|STARTED|Overall Study||21
8230047|NCT01996904|20293807|P2|NOT COMPLETED|Overall Study||27
8230048|NCT01996904|20293808|P1|NOT COMPLETED|Overall Study||38
8230049|NCT01996904|20293807|P2|COMPLETED|Overall Study||90
8230050|NCT01996904|20293808|P1|COMPLETED|Overall Study||101
8230051|NCT01996904|20293807|P2|STARTED|Overall Study||117
8230052|NCT01996904|20293808|P1|STARTED|Overall Study||139
8230053|NCT01996852|20293817|P3|NOT COMPLETED|Overall Study||0
8230054|NCT01996852|20293818|P2|NOT COMPLETED|Overall Study||0
8230055|NCT01996852|20293819|P1|NOT COMPLETED|Overall Study||0
8230056|NCT01996852|20293817|P3|COMPLETED|Overall Study||0
8230057|NCT01996852|20293818|P2|COMPLETED|Overall Study||0
8230058|NCT01996852|20293819|P1|COMPLETED|Overall Study||0
8230059|NCT01996852|20293817|P3|STARTED|Overall Study||0
8230060|NCT01996852|20293818|P2|STARTED|Overall Study||0
8230061|NCT01996852|20293819|P1|STARTED|Overall Study||0
8230062|NCT01996839|20293866|P3|NOT COMPLETED|Overall Study||32
8230063|NCT01996839|20293867|P2|NOT COMPLETED|Overall Study||38
8230064|NCT01996839|20293868|P1|NOT COMPLETED|Overall Study||92
8230065|NCT01996839|20293866|P3|COMPLETED|Overall Study||139
8230066|NCT01996839|20293867|P2|COMPLETED|Overall Study||133
8230067|NCT01996839|20293868|P1|COMPLETED|Overall Study||80
8230068|NCT01996839|20293866|P3|STARTED|Overall Study||171
8230069|NCT01996839|20293867|P2|STARTED|Overall Study||171
8230070|NCT01996839|20293868|P1|STARTED|Overall Study||172
8230071|NCT01996826|20293893|P2|NOT COMPLETED|Overall Study||3
8230072|NCT01996826|20293894|P1|NOT COMPLETED|Overall Study||7
8230073|NCT01996826|20293893|P2|COMPLETED|Overall Study||33
8230074|NCT01996826|20293894|P1|COMPLETED|Overall Study||32
8230075|NCT01996826|20293893|P2|STARTED|Overall Study||36
8230076|NCT01996826|20293894|P1|STARTED|Overall Study||39
8230077|NCT01996813|20293906|P2|NOT COMPLETED|Overall Study||0
8230078|NCT01996813|20293907|P1|NOT COMPLETED|Overall Study||0
8230079|NCT01996813|20293906|P2|COMPLETED|Overall Study||24
8230080|NCT01996813|20293907|P1|COMPLETED|Overall Study||23
8230081|NCT01996813|20293906|P2|STARTED|Overall Study||24
8230082|NCT01996813|20293907|P1|STARTED|Overall Study||23
8230083|NCT01996748|20293917|P2|NOT COMPLETED|Overall Study||6
8230084|NCT01996748|20293918|P1|NOT COMPLETED|Overall Study||8
8230085|NCT01996748|20293917|P2|COMPLETED|Overall Study||63
8230086|NCT01996748|20293918|P1|COMPLETED|Overall Study||58
8230087|NCT01996748|20293917|P2|STARTED|Overall Study||69
8230088|NCT01996748|20293918|P1|STARTED|Overall Study||66
8230089|NCT01996709|20293932|P2|NOT COMPLETED|Overall Study||1
8230090|NCT01996709|20293933|P1|NOT COMPLETED|Overall Study||5
8230091|NCT01996709|20293932|P2|COMPLETED|Overall Study||67
8230092|NCT01996709|20293933|P1|COMPLETED|Overall Study||61
8230093|NCT01996709|20293932|P2|STARTED|Overall Study||68
8230094|NCT01996709|20293933|P1|STARTED|Overall Study||66
8230095|NCT01996657|20293950|P3|NOT COMPLETED|Overall Study||14
8230096|NCT01996657|20293951|P2|NOT COMPLETED|Overall Study||11
8230097|NCT01996657|20293952|P1|NOT COMPLETED|Overall Study||13
8230098|NCT01996657|20293950|P3|COMPLETED|Overall Study||234
8230099|NCT01996657|20293951|P2|COMPLETED|Overall Study||239
8230100|NCT01996657|20293952|P1|COMPLETED|Overall Study||237
8230101|NCT01996657|20293950|P3|STARTED|Overall Study||248
8230102|NCT01996657|20293951|P2|STARTED|Overall Study||250
8230103|NCT01996657|20293952|P1|STARTED|Overall Study||250
8230104|NCT01996644|20293968|P2|NOT COMPLETED|Overall Study||0
8230105|NCT01996644|20293969|P1|NOT COMPLETED|Overall Study||0
8230106|NCT01996644|20293968|P2|COMPLETED|Overall Study||16
8230107|NCT01996644|20293969|P1|COMPLETED|Overall Study||20
8230108|NCT01996644|20293968|P2|STARTED|Overall Study||16
8230109|NCT01996644|20293969|P1|STARTED|Overall Study||20
8230110|NCT01996592|20293980|P1|NOT COMPLETED|Overall Study||45
8230111|NCT01996592|20293980|P1|COMPLETED|Overall Study||530
8230112|NCT01996592|20293980|P1|STARTED|Overall Study||575
8230113|NCT01996410|20293997|P8|NOT COMPLETED|Overall Study||0
8230114|NCT01996410|20293998|P7|NOT COMPLETED|Overall Study||0
8230115|NCT01996410|20293999|P6|NOT COMPLETED|Overall Study||0
8230116|NCT01996410|20294000|P5|NOT COMPLETED|Overall Study||0
8230117|NCT01996410|20294001|P4|NOT COMPLETED|Overall Study||0
8230118|NCT01996410|20294002|P3|NOT COMPLETED|Overall Study||0
8230119|NCT01996410|20294003|P2|NOT COMPLETED|Overall Study||0
8230120|NCT01996410|20294004|P1|NOT COMPLETED|Overall Study||0
8230121|NCT01996410|20293997|P8|COMPLETED|Overall Study||0
8230122|NCT01996410|20293998|P7|COMPLETED|Overall Study||0
8230123|NCT01996410|20293999|P6|COMPLETED|Overall Study||2
8230124|NCT01996410|20294000|P5|COMPLETED|Overall Study||2
8230125|NCT01996410|20294001|P4|COMPLETED|Overall Study||0
8230126|NCT01996410|20294002|P3|COMPLETED|Overall Study||0
8230127|NCT01996410|20294003|P2|COMPLETED|Overall Study||3
8230128|NCT01996410|20294004|P1|COMPLETED|Overall Study||3
8230129|NCT01996410|20293997|P8|STARTED|Overall Study||0
8230130|NCT01996410|20293998|P7|STARTED|Overall Study||0
8230131|NCT01996410|20293999|P6|STARTED|Overall Study||2
8230132|NCT01996410|20294000|P5|STARTED|Overall Study||2
8230133|NCT01996410|20294001|P4|STARTED|Overall Study||0
8230134|NCT01996410|20294002|P3|STARTED|Overall Study||0
8230135|NCT01996410|20294003|P2|STARTED|Overall Study||3
8230136|NCT01996410|20294004|P1|STARTED|Overall Study||3
8230137|NCT01996332|20294016|P1|NOT COMPLETED|Overall Study||1805
8230138|NCT01996332|20294016|P1|COMPLETED|Overall Study||0
8230139|NCT01996332|20294016|P1|STARTED|Overall Study||1805
8230140|NCT01996319|20294024|P2|NOT COMPLETED|Overall Study||3
8230141|NCT01996319|20294025|P1|NOT COMPLETED|Overall Study||8
8230142|NCT01996319|20294024|P2|COMPLETED|Overall Study||95
8230143|NCT01996319|20294025|P1|COMPLETED|Overall Study||88
8230144|NCT01996319|20294024|P2|STARTED|Overall Study||98
8230145|NCT01996319|20294025|P1|STARTED|Overall Study||96
8230146|NCT01996254|20294047|P3|NOT COMPLETED|Overall Study||8
8230147|NCT01996254|20294048|P2|NOT COMPLETED|Overall Study||5
8230148|NCT01996254|20294049|P1|NOT COMPLETED|Overall Study||1
8230149|NCT01996254|20294047|P3|COMPLETED|Overall Study||6
8230150|NCT01996254|20294048|P2|COMPLETED|Overall Study||9
8230151|NCT01996254|20294049|P1|COMPLETED|Overall Study||4
8230152|NCT01996254|20294047|P3|Per Protocol Set|Overall Study||13
8230153|NCT01996254|20294048|P2|Per Protocol Set|Overall Study||10
8230154|NCT01996254|20294049|P1|Per Protocol Set|Overall Study||0
8230155|NCT01996254|20294047|P3|Long Term Analysis Set|Overall Study||14
8230156|NCT01996254|20294048|P2|Long Term Analysis Set|Overall Study||12
8230157|NCT01996254|20294049|P1|Long Term Analysis Set|Overall Study||0
8230158|NCT01996254|20294047|P3|Full Analysis Set|Overall Study||14
8230159|NCT01996254|20294048|P2|Full Analysis Set|Overall Study||12
8230160|NCT01996254|20294049|P1|Full Analysis Set|Overall Study||0
8230161|NCT01996254|20294047|P3|Safety Set|Overall Study||14
8230162|NCT01996254|20294048|P2|Safety Set|Overall Study||14
8230163|NCT01996254|20294049|P1|Safety Set|Overall Study||5
8230164|NCT01996254|20294047|P3|STARTED|Overall Study||14
8230165|NCT01996254|20294048|P2|STARTED|Overall Study||14
8230166|NCT01996254|20294049|P1|STARTED|Overall Study||5
8230167|NCT01996241|20294077|P2|NOT COMPLETED|Overall Study||235
8230168|NCT01996241|20294078|P1|NOT COMPLETED|Overall Study||252
8230169|NCT01996241|20294077|P2|COMPLETED|Overall Study||876
8230170|NCT01996241|20294078|P1|COMPLETED|Overall Study||912
8230171|NCT01996241|20294077|P2|STARTED|Overall Study||1111
8230172|NCT01996241|20294078|P1|STARTED|Overall Study||1164
8230173|NCT01996033|20294094|P1|NOT COMPLETED|Overall Study||9
8230174|NCT01996033|20294094|P1|COMPLETED|Overall Study||16
8230175|NCT01996033|20294094|P1|STARTED|Overall Study||25
8230176|NCT01995838|20294114|P7|NOT COMPLETED|Overall Study||5
8230177|NCT01995838|20294115|P6|NOT COMPLETED|Overall Study||2
8230178|NCT01995838|20294116|P5|NOT COMPLETED|Overall Study||2
8230179|NCT01995838|20294117|P4|NOT COMPLETED|Overall Study||2
8230180|NCT01995838|20294118|P3|NOT COMPLETED|Overall Study||0
8230181|NCT01995838|20294119|P2|NOT COMPLETED|Overall Study||2
8230182|NCT01995838|20294120|P1|NOT COMPLETED|Overall Study||5
8230183|NCT01995838|20294114|P7|COMPLETED|Overall Study||45
8230184|NCT01995838|20294115|P6|COMPLETED|Overall Study||54
8230185|NCT01995838|20294116|P5|COMPLETED|Overall Study||30
8230186|NCT01995838|20294117|P4|COMPLETED|Overall Study||36
8230187|NCT01995838|20294118|P3|COMPLETED|Overall Study||27
8230188|NCT01995838|20294119|P2|COMPLETED|Overall Study||30
8230189|NCT01995838|20294120|P1|COMPLETED|Overall Study||51
8230190|NCT01995838|20294114|P7|STARTED|Overall Study||50
8230191|NCT01995838|20294115|P6|STARTED|Overall Study||56
8230192|NCT01995838|20294116|P5|STARTED|Overall Study||32
8230193|NCT01995838|20294117|P4|STARTED|Overall Study||38
8230194|NCT01995838|20294118|P3|STARTED|Overall Study||27
8230195|NCT01995838|20294119|P2|STARTED|Overall Study||32
8230196|NCT01995838|20294120|P1|STARTED|Overall Study||56
8230197|NCT01995825|20294221|P2|NOT COMPLETED|Overall Study||0
8230198|NCT01995825|20294222|P1|NOT COMPLETED|Overall Study||1
8230199|NCT01995825|20294221|P2|COMPLETED|Overall Study||17
8230200|NCT01995825|20294222|P1|COMPLETED|Overall Study||17
8230201|NCT01995825|20294221|P2|STARTED|Overall Study||17
8230202|NCT01995825|20294222|P1|STARTED|Overall Study||18
8230203|NCT01995552|20294230|P1|NOT COMPLETED|Overall Study||17
8230204|NCT01995552|20294230|P1|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233
8230205|NCT01995552|20294230|P1|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250
8230206|NCT01995539|20294236|P1|NOT COMPLETED|Overall Study||33
8230207|NCT01995539|20294236|P1|COMPLETED|Overall Study||148
8230208|NCT01995539|20294236|P1|STARTED|Overall Study||181
8230209|NCT01995526|20294241|P1|NOT COMPLETED|Overall Study||1
8230210|NCT01995526|20294241|P1|COMPLETED|Overall Study||10
8230211|NCT01995526|20294241|P1|Received One Dose of Study Drug|Overall Study||11
8230212|NCT01995526|20294241|P1|STARTED|Overall Study||11
8230213|NCT01995513|20294249|P3|NOT COMPLETED|Double Blind Treatment Period||125
8230214|NCT01995513|20294250|P2|NOT COMPLETED|Double Blind Treatment Period||126
8230215|NCT01995513|20294251|P1|NOT COMPLETED|Double Blind Treatment Period||0
8230216|NCT01995513|20294249|P3|COMPLETED|Double Blind Treatment Period||0
8230217|NCT01995513|20294250|P2|COMPLETED|Double Blind Treatment Period||0
8230218|NCT01995513|20294251|P1|COMPLETED|Double Blind Treatment Period||0
8230219|NCT01995513|20294249|P3|Treated|Double Blind Treatment Period||124
8230220|NCT01995513|20294250|P2|Treated|Double Blind Treatment Period||125
8230221|NCT01995513|20294251|P1|Treated|Double Blind Treatment Period||0
8230222|NCT01995513|20294249|P3|STARTED|Double Blind Treatment Period||125
8230223|NCT01995513|20294250|P2|STARTED|Double Blind Treatment Period||126
8230224|NCT01995513|20294251|P1|STARTED|Double Blind Treatment Period||0
8230225|NCT01995513|20294249|P3|NOT COMPLETED|Open Label Treatment Period||0
8230226|NCT01995513|20294250|P2|NOT COMPLETED|Open Label Treatment Period||0
8230227|NCT01995513|20294251|P1|NOT COMPLETED|Open Label Treatment Period||258
8230228|NCT01995513|20294249|P3|COMPLETED|Open Label Treatment Period||0
8230229|NCT01995513|20294250|P2|COMPLETED|Open Label Treatment Period||0
8230230|NCT01995513|20294251|P1|COMPLETED|Open Label Treatment Period||251
8230231|NCT01995513|20294249|P3|STARTED|Open Label Treatment Period||0
8230232|NCT01995513|20294250|P2|STARTED|Open Label Treatment Period||0
8230233|NCT01995513|20294251|P1|STARTED|Open Label Treatment Period||509
8230234|NCT01995461|20294294|P1|NOT COMPLETED|Overall Study||5
8230235|NCT01995461|20294294|P1|COMPLETED|Overall Study||21
8230236|NCT01995461|20294294|P1|STARTED|Overall Study||26
8230237|NCT01995357|20294300|P6|NOT COMPLETED|Period 5||0
8230238|NCT01995357|20294301|P5|NOT COMPLETED|Period 5||0
8230239|NCT01995357|20294302|P4|NOT COMPLETED|Period 5||0
8230240|NCT01995357|20294303|P3|NOT COMPLETED|Period 5||1
8230241|NCT01995357|20294304|P2|NOT COMPLETED|Period 5||0
8230242|NCT01995357|20294305|P1|NOT COMPLETED|Period 5||2
8230243|NCT01995357|20294300|P6|COMPLETED|Period 5||4
8230244|NCT01995357|20294301|P5|COMPLETED|Period 5||4
8230245|NCT01995357|20294302|P4|COMPLETED|Period 5||3
8230246|NCT01995357|20294303|P3|COMPLETED|Period 5||3
8230247|NCT01995357|20294304|P2|COMPLETED|Period 5||3
8230248|NCT01995357|20294305|P1|COMPLETED|Period 5||2
8230249|NCT01995357|20294300|P6|STARTED|Period 5||4
8230250|NCT01995357|20294301|P5|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
8230251|NCT01995357|20294302|P4|STARTED|Period 5||3
8230252|NCT01995357|20294303|P3|STARTED|Period 5||4
8230253|NCT01995357|20294304|P2|STARTED|Period 5||3
8230254|NCT01995357|20294305|P1|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
8230255|NCT01995357|20294300|P6|NOT COMPLETED|Period 4||0
8230256|NCT01995357|20294301|P5|NOT COMPLETED|Period 4||0
8230257|NCT01995357|20294302|P4|NOT COMPLETED|Period 4||0
8230258|NCT01995357|20294303|P3|NOT COMPLETED|Period 4||0
8230259|NCT01995357|20294304|P2|NOT COMPLETED|Period 4||0
8230260|NCT01995357|20294305|P1|NOT COMPLETED|Period 4||0
8230261|NCT01995357|20294300|P6|COMPLETED|Period 4||4
8230262|NCT01995357|20294301|P5|COMPLETED|Period 4||4
8230263|NCT01995357|20294302|P4|COMPLETED|Period 4||3
8230264|NCT01995357|20294303|P3|COMPLETED|Period 4||4
8230265|NCT01995357|20294304|P2|COMPLETED|Period 4||3
8230266|NCT01995357|20294305|P1|COMPLETED|Period 4||4
8230267|NCT01995357|20294300|P6|STARTED|Period 4||4
8230268|NCT01995357|20294301|P5|STARTED|Period 4||4
8230269|NCT01995357|20294302|P4|STARTED|Period 4||3
8230270|NCT01995357|20294303|P3|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
8230271|NCT01995357|20294304|P2|STARTED|Period 4||3
8230272|NCT01995357|20294305|P1|STARTED|Period 4||4
8230273|NCT01995357|20294300|P6|NOT COMPLETED|Period 3||0
8230274|NCT01995357|20294301|P5|NOT COMPLETED|Period 3||0
8230275|NCT01995357|20294302|P4|NOT COMPLETED|Period 3||0
8230276|NCT01995357|20294303|P3|NOT COMPLETED|Period 3||0
8230277|NCT01995357|20294304|P2|NOT COMPLETED|Period 3||0
8230278|NCT01995357|20294305|P1|NOT COMPLETED|Period 3||0
8230279|NCT01995357|20294300|P6|COMPLETED|Period 3||4
8230280|NCT01995357|20294301|P5|COMPLETED|Period 3||4
8230281|NCT01995357|20294302|P4|COMPLETED|Period 3||3
8230282|NCT01995357|20294303|P3|COMPLETED|Period 3||4
8230283|NCT01995357|20294304|P2|COMPLETED|Period 3||3
8230284|NCT01995357|20294305|P1|COMPLETED|Period 3||4
8230285|NCT01995357|20294300|P6|STARTED|Period 3||4
8230286|NCT01995357|20294301|P5|STARTED|Period 3||4
8230287|NCT01995357|20294302|P4|STARTED|Period 3||3
8230288|NCT01995357|20294303|P3|STARTED|Period 3||4
8230289|NCT01995357|20294304|P2|STARTED|Period 3||3
8230290|NCT01995357|20294305|P1|STARTED|Period 3||4
8230291|NCT01995357|20294300|P6|NOT COMPLETED|Period 2||0
8230292|NCT01995357|20294301|P5|NOT COMPLETED|Period 2||0
8230293|NCT01995357|20294302|P4|NOT COMPLETED|Period 2||0
8230294|NCT01995357|20294303|P3|NOT COMPLETED|Period 2||0
8230295|NCT01995357|20294304|P2|NOT COMPLETED|Period 2||0
8230296|NCT01995357|20294305|P1|NOT COMPLETED|Period 2||0
8230297|NCT01995357|20294300|P6|COMPLETED|Period 2||4
8230298|NCT01995357|20294301|P5|COMPLETED|Period 2||4
8230299|NCT01995357|20294302|P4|COMPLETED|Period 2||3
8230300|NCT01995357|20294303|P3|COMPLETED|Period 2||4
8230301|NCT01995357|20294304|P2|COMPLETED|Period 2||3
8230302|NCT01995357|20294305|P1|COMPLETED|Period 2||4
8230303|NCT01995357|20294300|P6|STARTED|Period 2||4
8230304|NCT01995357|20294301|P5|STARTED|Period 2||4
8230305|NCT01995357|20294302|P4|STARTED|Period 2||3
8230306|NCT01995357|20294303|P3|STARTED|Period 2||4
8230307|NCT01995357|20294304|P2|STARTED|Period 2||3
8230308|NCT01995357|20294305|P1|STARTED|Period 2||4
8230309|NCT01995357|20294300|P6|NOT COMPLETED|Period 1||0
8230310|NCT01995357|20294301|P5|NOT COMPLETED|Period 1||0
8230311|NCT01995357|20294302|P4|NOT COMPLETED|Period 1||0
8230312|NCT01995357|20294303|P3|NOT COMPLETED|Period 1||0
8230313|NCT01995357|20294304|P2|NOT COMPLETED|Period 1||0
8230314|NCT01995357|20294305|P1|NOT COMPLETED|Period 1||0
8230315|NCT01995357|20294300|P6|COMPLETED|Period 1||4
8230316|NCT01995357|20294301|P5|COMPLETED|Period 1||4
8230317|NCT01995357|20294302|P4|COMPLETED|Period 1||3
8230318|NCT01995357|20294303|P3|COMPLETED|Period 1||4
8230319|NCT01995357|20294304|P2|COMPLETED|Period 1||3
8230320|NCT01995357|20294305|P1|COMPLETED|Period 1||4
8230321|NCT01995357|20294300|P6|STARTED|Period 1||4
8230322|NCT01995357|20294301|P5|STARTED|Period 1||4
8230323|NCT01995357|20294302|P4|STARTED|Period 1||3
8230324|NCT01995357|20294303|P3|STARTED|Period 1||4
8230325|NCT01995357|20294304|P2|STARTED|Period 1||3
8230326|NCT01995357|20294305|P1|STARTED|Period 1||4
8230327|NCT01995266|20294321|P1|NOT COMPLETED|Overall Study||9
8230328|NCT01995266|20294321|P1|COMPLETED|Overall Study||150
8230329|NCT01995266|20294321|P1|STARTED|Overall Study||159
8230330|NCT01995201|20294336|P7|NOT COMPLETED|From Week 24 Until Week 48||2
8230331|NCT01995201|20294337|P6|NOT COMPLETED|From Week 24 Until Week 48||8
8230332|NCT01995201|20294338|P5|NOT COMPLETED|From Week 24 Until Week 48||6
8230333|NCT01995201|20294339|P4|NOT COMPLETED|From Week 24 Until Week 48||1
8230334|NCT01995201|20294340|P3|NOT COMPLETED|From Week 24 Until Week 48||5
8230335|NCT01995201|20294341|P2|NOT COMPLETED|From Week 24 Until Week 48||0
8230336|NCT01995201|20294342|P1|NOT COMPLETED|From Week 24 Until Week 48||0
8230337|NCT01995201|20294336|P7|COMPLETED|From Week 24 Until Week 48||0
8230338|NCT01995201|20294337|P6|COMPLETED|From Week 24 Until Week 48||59
8230339|NCT01995201|20294338|P5|COMPLETED|From Week 24 Until Week 48||89
8230340|NCT01995201|20294339|P4|COMPLETED|From Week 24 Until Week 48||89
8230341|NCT01995201|20294340|P3|COMPLETED|From Week 24 Until Week 48||84
8230342|NCT01995201|20294341|P2|COMPLETED|From Week 24 Until Week 48||0
8230343|NCT01995201|20294342|P1|COMPLETED|From Week 24 Until Week 48||0
8230344|NCT01995201|20294336|P7|STARTED|From Week 24 Until Week 48||2
8230345|NCT01995201|20294337|P6|STARTED|From Week 24 Until Week 48||67
8230346|NCT01995201|20294338|P5|STARTED|From Week 24 Until Week 48||95
8230347|NCT01995201|20294339|P4|STARTED|From Week 24 Until Week 48||90
8230348|NCT01995201|20294340|P3|STARTED|From Week 24 Until Week 48||89
8230349|NCT01995201|20294341|P2|STARTED|From Week 24 Until Week 48||0
8230350|NCT01995201|20294342|P1|STARTED|From Week 24 Until Week 48||0
8230351|NCT01995201|20294336|P7|NOT COMPLETED|From Baseline Until Week 24||0
8230352|NCT01995201|20294337|P6|NOT COMPLETED|From Baseline Until Week 24||0
8230353|NCT01995201|20294338|P5|NOT COMPLETED|From Baseline Until Week 24||0
8230354|NCT01995201|20294339|P4|NOT COMPLETED|From Baseline Until Week 24||0
8230355|NCT01995201|20294340|P3|NOT COMPLETED|From Baseline Until Week 24||0
8230356|NCT01995201|20294341|P2|NOT COMPLETED|From Baseline Until Week 24||46
8230357|NCT01995201|20294342|P1|NOT COMPLETED|From Baseline Until Week 24||10
8230358|NCT01995201|20294336|P7|COMPLETED|From Baseline Until Week 24||0
8230359|NCT01995201|20294337|P6|COMPLETED|From Baseline Until Week 24||0
8230360|NCT01995201|20294338|P5|COMPLETED|From Baseline Until Week 24||0
8230361|NCT01995201|20294339|P4|COMPLETED|From Baseline Until Week 24||0
8230362|NCT01995201|20294340|P3|COMPLETED|From Baseline Until Week 24||0
8230363|NCT01995201|20294341|P2|COMPLETED|From Baseline Until Week 24||281
8230364|NCT01995201|20294342|P1|COMPLETED|From Baseline Until Week 24||64
8230365|NCT01995201|20294336|P7|STARTED|From Baseline Until Week 24||0
8230366|NCT01995201|20294337|P6|STARTED|From Baseline Until Week 24||0
8230367|NCT01995201|20294338|P5|STARTED|From Baseline Until Week 24||0
8230368|NCT01995201|20294339|P4|STARTED|From Baseline Until Week 24||0
8230369|NCT01995201|20294340|P3|STARTED|From Baseline Until Week 24||0
8230370|NCT01995201|20294341|P2|STARTED|From Baseline Until Week 24||327
8230371|NCT01995201|20294342|P1|STARTED|From Baseline Until Week 24||74
8230375|NCT01995136|20294466|P1|NOT COMPLETED|Overall Study||1
8230376|NCT01995136|20294466|P1|COMPLETED|Overall Study||31
8230377|NCT01995136|20294466|P1|STARTED|Overall Study||32
8230378|NCT01995123|20294472|P2|NOT COMPLETED|Overall Study||15
8230379|NCT01995123|20294473|P1|NOT COMPLETED|Overall Study||18
8230380|NCT01995123|20294472|P2|COMPLETED|Overall Study||46
8230381|NCT01995123|20294473|P1|COMPLETED|Overall Study||45
8230382|NCT01995123|20294472|P2|STARTED|Overall Study||61
8230383|NCT01995123|20294473|P1|STARTED|Overall Study||63
8230420|NCT01995045|20294567|P2|NOT COMPLETED|Overall Study||0
8230421|NCT01995045|20294568|P1|NOT COMPLETED|Overall Study||0
8230422|NCT01995045|20294567|P2|COMPLETED|Overall Study||28
8230423|NCT01995045|20294568|P1|COMPLETED|Overall Study||29
8230424|NCT01995045|20294567|P2|STARTED|Overall Study||28
8230425|NCT01995045|20294568|P1|STARTED|Overall Study||29
8230426|NCT01994993|20294585|P5|NOT COMPLETED|Overall Study||2
8230427|NCT01994993|20294586|P4|NOT COMPLETED|Overall Study||46
8230428|NCT01994993|20294587|P3|NOT COMPLETED|Overall Study||47
8230429|NCT01994993|20294588|P2|NOT COMPLETED|Overall Study||35
8230430|NCT01994993|20294589|P1|NOT COMPLETED|Overall Study||35
8230431|NCT01994993|20294585|P5|COMPLETED|Overall Study||22
8230432|NCT01994993|20294586|P4|COMPLETED|Overall Study||9
8230433|NCT01994993|20294587|P3|COMPLETED|Overall Study||23
8230434|NCT01994993|20294588|P2|COMPLETED|Overall Study||12
8230435|NCT01994993|20294589|P1|COMPLETED|Overall Study||28
8230436|NCT01994993|20294585|P5|STARTED|Overall Study||24
8230437|NCT01994993|20294586|P4|STARTED|Overall Study||55
8230438|NCT01994993|20294587|P3|STARTED|Overall Study||70
8230439|NCT01994993|20294588|P2|STARTED|Overall Study||47
8230440|NCT01994993|20294589|P1|STARTED|Overall Study||63
8230441|NCT01994954|20294643|P2|NOT COMPLETED|Overall Study||30
8230442|NCT01994954|20294644|P1|NOT COMPLETED|Overall Study||25
8230443|NCT01994954|20294643|P2|COMPLETED|Overall Study||67
8230444|NCT01994954|20294644|P1|COMPLETED|Overall Study||74
8230445|NCT01994954|20294643|P2|STARTED|Overall Study||97
8230446|NCT01994954|20294644|P1|STARTED|Overall Study||99
8230447|NCT01994902|20294662|P2|NOT COMPLETED|Test Period 2||6
8230448|NCT01994902|20294663|P1|NOT COMPLETED|Test Period 2||0
8230449|NCT01994902|20294662|P2|COMPLETED|Test Period 2||55
8230450|NCT01994902|20294663|P1|COMPLETED|Test Period 2||57
8230451|NCT01994902|20294662|P2|STARTED|Test Period 2||61
8230452|NCT01994902|20294663|P1|STARTED|Test Period 2||57
8230453|NCT01994902|20294662|P2|NOT COMPLETED|Test Period 1||3
8230454|NCT01994902|20294663|P1|NOT COMPLETED|Test Period 1||6
8230455|NCT01994902|20294662|P2|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
8230456|NCT01994902|20294663|P1|COMPLETED|Test Period 1||57
8230457|NCT01994902|20294662|P2|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
8230458|NCT01994902|20294663|P1|STARTED|Test Period 1||63
8230459|NCT01994889|20294672|P3|NOT COMPLETED|Overall Study||92
8230460|NCT01994889|20294673|P2|NOT COMPLETED|Overall Study||63
8230461|NCT01994889|20294674|P1|NOT COMPLETED|Overall Study||28
8230462|NCT01994889|20294672|P3|COMPLETED|Overall Study||85
8230463|NCT01994889|20294673|P2|COMPLETED|Overall Study||113
8230464|NCT01994889|20294674|P1|COMPLETED|Overall Study||60
8230465|NCT01994889|20294672|P3|STARTED|Overall Study||177
8230466|NCT01994889|20294673|P2|STARTED|Overall Study||176
8230467|NCT01994889|20294674|P1|STARTED|Overall Study||88
8230468|NCT01994876|20294693|P2|NOT COMPLETED|Test Period 2||1
8230469|NCT01994876|20294694|P1|NOT COMPLETED|Test Period 2||1
8230470|NCT01994876|20294693|P2|COMPLETED|Test Period 2||6
8230471|NCT01994876|20294694|P1|COMPLETED|Test Period 2||8
8230472|NCT01994876|20294693|P2|STARTED|Test Period 2||7
8230473|NCT01994876|20294694|P1|STARTED|Test Period 2||9
8230474|NCT01994876|20294693|P2|NOT COMPLETED|Test Period 1||2
8230475|NCT01994876|20294694|P1|NOT COMPLETED|Test Period 1||0
8230476|NCT01994876|20294693|P2|COMPLETED|Test Period 1||7
8230477|NCT01994876|20294694|P1|COMPLETED|Test Period 1||9
8230478|NCT01994876|20294693|P2|STARTED|Test Period 1||9
8230479|NCT01994876|20294694|P1|STARTED|Test Period 1||9
8230480|NCT01994876|20294693|P2|NOT COMPLETED|Baseline - Own Product||0
8230481|NCT01994876|20294694|P1|NOT COMPLETED|Baseline - Own Product||0
8230482|NCT01994876|20294693|P2|COMPLETED|Baseline - Own Product||9
8230483|NCT01994876|20294694|P1|COMPLETED|Baseline - Own Product||9
8230484|NCT01994876|20294693|P2|STARTED|Baseline - Own Product||9
8230485|NCT01994876|20294694|P1|STARTED|Baseline - Own Product||9
8230486|NCT01994863|20294702|P2|NOT COMPLETED|Period 2||4
8230487|NCT01994863|20294703|P1|NOT COMPLETED|Period 2||1
8230488|NCT01994863|20294702|P2|COMPLETED|Period 2||5
8230489|NCT01994863|20294703|P1|COMPLETED|Period 2||7
8230490|NCT01994863|20294702|P2|STARTED|Period 2||9
8230491|NCT01994863|20294703|P1|STARTED|Period 2||8
8230492|NCT01994863|20294702|P2|NOT COMPLETED|Period 1||3
8230493|NCT01994863|20294703|P1|NOT COMPLETED|Period 1||7
8230494|NCT01994863|20294702|P2|COMPLETED|Period 1||9
8230495|NCT01994863|20294703|P1|COMPLETED|Period 1||4
8230496|NCT01994863|20294702|P2|STARTED|Period 1||12
8230497|NCT01994863|20294703|P1|STARTED|Period 1||11
8230498|NCT01994850|20294709|P1|NOT COMPLETED|Overall Study||2
8230499|NCT01994850|20294709|P1|COMPLETED|Overall Study||30
8230500|NCT01994850|20294709|P1|STARTED|Overall Study||32
8230501|NCT01994837|20294714|P1|NOT COMPLETED|Overall Study||32
8230502|NCT01994837|20294714|P1|COMPLETED|Overall Study||0
8230503|NCT01994837|20294714|P1|Treated|Overall Study||32
8230504|NCT01994837|20294714|P1|STARTED|Overall Study||32
8230505|NCT01994785|20294731|P4|NOT COMPLETED|Overall Study||3
8230506|NCT01994785|20294732|P3|NOT COMPLETED|Overall Study||0
8230507|NCT01994785|20294733|P2|NOT COMPLETED|Overall Study||1
8230508|NCT01994785|20294734|P1|NOT COMPLETED|Overall Study||8
8230509|NCT01994785|20294731|P4|COMPLETED|Overall Study||114
8230510|NCT01994785|20294732|P3|COMPLETED|Overall Study||117
8230511|NCT01994785|20294733|P2|COMPLETED|Overall Study||108
8230512|NCT01994785|20294734|P1|COMPLETED|Overall Study||101
8230513|NCT01994785|20294731|P4|STARTED|Overall Study||117
8230514|NCT01994785|20294732|P3|STARTED|Overall Study||117
8230515|NCT01994785|20294733|P2|STARTED|Overall Study||109
8230516|NCT01994785|20294734|P1|STARTED|Overall Study||109
8230517|NCT01994746|20294744|P2|NOT COMPLETED|Second Visit||0
8230518|NCT01994746|20294745|P1|NOT COMPLETED|Second Visit||0
8230519|NCT01994746|20294744|P2|COMPLETED|Second Visit||38
8230520|NCT01994746|20294745|P1|COMPLETED|Second Visit||38
8230521|NCT01994746|20294744|P2|Completed Both Dosing Visits|Second Visit||38
8230522|NCT01994746|20294745|P1|Completed Both Dosing Visits|Second Visit||38
8230523|NCT01994746|20294744|P2|STARTED|Second Visit||38
8230524|NCT01994746|20294745|P1|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
8230525|NCT01994746|20294744|P2|NOT COMPLETED|First Visit||0
8230526|NCT01994746|20294745|P1|NOT COMPLETED|First Visit||0
8230527|NCT01994746|20294744|P2|COMPLETED|First Visit||38
8230528|NCT01994746|20294745|P1|COMPLETED|First Visit||39
8230529|NCT01994746|20294744|P2|Received At Least 1 Dose|First Visit||38
8230530|NCT01994746|20294745|P1|Received At Least 1 Dose|First Visit||39
8230531|NCT01994746|20294744|P2|STARTED|First Visit||38
8230532|NCT01994746|20294745|P1|STARTED|First Visit||39
8230533|NCT01994720|20294771|P2|NOT COMPLETED|Overall Study||56
8230534|NCT01994720|20294772|P1|NOT COMPLETED|Overall Study||46
8230535|NCT01994720|20294771|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
8230536|NCT01994720|20294772|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
8230537|NCT01994720|20294771|P2|STARTED|Overall Study||6610
8230538|NCT01994720|20294772|P1|STARTED|Overall Study||6589
8230539|NCT01994629|20294814|P2|NOT COMPLETED|Overall Study||3
8230540|NCT01994629|20294815|P1|NOT COMPLETED|Overall Study||1
8230541|NCT01994629|20294814|P2|COMPLETED|Overall Study||99
8230542|NCT01994629|20294815|P1|COMPLETED|Overall Study||99
8230543|NCT01994629|20294814|P2|STARTED|Overall Study||102
8230544|NCT01994629|20294815|P1|STARTED|Overall Study||100
8230545|NCT01994590|20294839|P1|NOT COMPLETED|Overall Study||2
8230546|NCT01994590|20294839|P1|COMPLETED|Overall Study||2
8230547|NCT01994590|20294839|P1|STARTED|Overall Study||4
8230554|NCT01994486|20294856|P1|NOT COMPLETED|Overall Study||0
8230555|NCT01994486|20294856|P1|COMPLETED|Overall Study||20
8230556|NCT01994486|20294856|P1|STARTED|Overall Study||20
8230557|NCT01994395|20294867|P2|NOT COMPLETED|Overall Study||2
8230558|NCT01994395|20294868|P1|NOT COMPLETED|Overall Study||1
8230559|NCT01994395|20294867|P2|COMPLETED|Overall Study||25
8230560|NCT01994395|20294868|P1|COMPLETED|Overall Study||25
8230561|NCT01994395|20294867|P2|STARTED|Overall Study||27
8230562|NCT01994395|20294868|P1|STARTED|Overall Study||26
8230563|NCT01994291|20294893|P3|NOT COMPLETED|Overall Study||9
8230564|NCT01994291|20294894|P2|NOT COMPLETED|Overall Study||7
8230565|NCT01994291|20294895|P1|NOT COMPLETED|Overall Study||15
8230566|NCT01994291|20294893|P3|COMPLETED|Overall Study||47
8230567|NCT01994291|20294894|P2|COMPLETED|Overall Study||36
8230568|NCT01994291|20294895|P1|COMPLETED|Overall Study||84
8230569|NCT01994291|20294893|P3|Received Treatment|Overall Study||56
8230570|NCT01994291|20294894|P2|Received Treatment|Overall Study||43
8230571|NCT01994291|20294895|P1|Received Treatment|Overall Study||99
8230572|NCT01994291|20294893|P3|STARTED|Overall Study||56
8230573|NCT01994291|20294894|P2|STARTED|Overall Study||43
8230574|NCT01994291|20294895|P1|STARTED|Overall Study||99
8230575|NCT01994226|20294951|P2|NOT COMPLETED|Overall Study||21
8230576|NCT01994226|20294952|P1|NOT COMPLETED|Overall Study||19
8230577|NCT01994226|20294951|P2|COMPLETED|Overall Study||179
8230578|NCT01994226|20294952|P1|COMPLETED|Overall Study||180
8230579|NCT01994226|20294951|P2|STARTED|Overall Study||200
8230580|NCT01994226|20294952|P1|STARTED|Overall Study||199
8230605|NCT01993940|20294978|P2|NOT COMPLETED|Overall Study||44
8230606|NCT01993940|20294979|P1|NOT COMPLETED|Overall Study||40
8230607|NCT01993940|20294978|P2|COMPLETED|Overall Study||232
8230608|NCT01993940|20294979|P1|COMPLETED|Overall Study||237
8230609|NCT01993940|20294978|P2|Received Treatment|Overall Study||276
8230610|NCT01993940|20294979|P1|Received Treatment|Overall Study||272
8230611|NCT01993940|20294978|P2|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
8230612|NCT01993940|20294979|P1|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
8230613|NCT01993927|20294993|P1|NOT COMPLETED|Overall Study||29
8230614|NCT01993927|20294993|P1|COMPLETED|Overall Study||713
8230615|NCT01993927|20294993|P1|STARTED|Overall Study||742
8230616|NCT01993888|20295001|P2|NOT COMPLETED|Overall Study||3
8230617|NCT01993888|20295002|P1|NOT COMPLETED|Overall Study||2
8230618|NCT01993888|20295001|P2|COMPLETED|Overall Study||49
8230619|NCT01993888|20295002|P1|COMPLETED|Overall Study||48
8230620|NCT01993888|20295001|P2|STARTED|Overall Study||52
8230621|NCT01993888|20295002|P1|STARTED|Overall Study||50
8230622|NCT01993875|20295020|P2|NOT COMPLETED|Overall Study||6
8230623|NCT01993875|20295021|P1|NOT COMPLETED|Overall Study||7
8230624|NCT01993875|20295020|P2|COMPLETED|Overall Study||76
8230625|NCT01993875|20295021|P1|COMPLETED|Overall Study||75
8230626|NCT01993875|20295020|P2|STARTED|Overall Study||82
8230627|NCT01993875|20295021|P1|STARTED|Overall Study||82
8230628|NCT01993849|20295039|P2|NOT COMPLETED|Overall Study||2
8230629|NCT01993849|20295040|P1|NOT COMPLETED|Overall Study||3
8230630|NCT01993849|20295039|P2|COMPLETED|Overall Study||9
8230631|NCT01993849|20295040|P1|COMPLETED|Overall Study||9
8230632|NCT01993849|20295039|P2|STARTED|Overall Study||11
8230633|NCT01993849|20295040|P1|STARTED|Overall Study||12
8230634|NCT01993836|20295051|P3|NOT COMPLETED|Overall Study||5
8230635|NCT01993836|20295052|P2|NOT COMPLETED|Overall Study||13
8230636|NCT01993836|20295053|P1|NOT COMPLETED|Overall Study||17
8230637|NCT01993836|20295051|P3|COMPLETED|Overall Study||46
8230638|NCT01993836|20295052|P2|COMPLETED|Overall Study||55
8230639|NCT01993836|20295053|P1|COMPLETED|Overall Study||55
8230640|NCT01993836|20295051|P3|STARTED|Overall Study||51
8230641|NCT01993836|20295052|P2|STARTED|Overall Study||68
8230642|NCT01993836|20295053|P1|STARTED|Overall Study|This represents the number of enrolled patients who completed baseline cognitive testing|72
8230643|NCT01993823|20295069|P2|NOT COMPLETED|Overall Study||16
8230644|NCT01993823|20295070|P1|NOT COMPLETED|Overall Study||7
8230645|NCT01993823|20295069|P2|COMPLETED|Overall Study||79
8230646|NCT01993823|20295070|P1|COMPLETED|Overall Study||88
8230647|NCT01993823|20295069|P2|STARTED|Overall Study||95
8230648|NCT01993823|20295070|P1|STARTED|Overall Study||95
8230649|NCT01993667|20295080|P2|NOT COMPLETED|Overall Study||19
8230650|NCT01993667|20295081|P1|NOT COMPLETED|Overall Study||21
8230651|NCT01993667|20295080|P2|COMPLETED|Overall Study||47
8230652|NCT01993667|20295081|P1|COMPLETED|Overall Study||43
8230653|NCT01993667|20295080|P2|STARTED|Overall Study||66
8230654|NCT01993667|20295081|P1|STARTED|Overall Study||64
8230655|NCT01993615|20295091|P2|NOT COMPLETED|Overall Study||0
8230656|NCT01993615|20295092|P1|NOT COMPLETED|Overall Study||1
8230657|NCT01993615|20295091|P2|COMPLETED|Overall Study||40
8230658|NCT01993615|20295092|P1|COMPLETED|Overall Study||39
8230659|NCT01993615|20295091|P2|STARTED|Overall Study||40
8230660|NCT01993615|20295092|P1|STARTED|Overall Study||40
8230661|NCT01993238|20295104|P1|NOT COMPLETED|Overall Study||0
8230662|NCT01993238|20295104|P1|COMPLETED|Overall Study||11
8230663|NCT01993238|20295104|P1|STARTED|Overall Study||11
8230664|NCT01993186|20295111|P2|NOT COMPLETED|Open-Label Extension Period||6
8230665|NCT01993186|20295112|P1|NOT COMPLETED|Open-Label Extension Period||7
8230666|NCT01993186|20295111|P2|COMPLETED|Open-Label Extension Period||5
8230667|NCT01993186|20295112|P1|COMPLETED|Open-Label Extension Period||16
8230668|NCT01993186|20295111|P2|STARTED|Open-Label Extension Period||11
8230669|NCT01993186|20295112|P1|STARTED|Open-Label Extension Period||23
8230670|NCT01993186|20295111|P2|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0
8230671|NCT01993186|20295112|P1|NOT COMPLETED|Double-Blind Placebo-Controlled Period||2
8230672|NCT01993186|20295111|P2|COMPLETED|Double-Blind Placebo-Controlled Period||11
8230673|NCT01993186|20295112|P1|COMPLETED|Double-Blind Placebo-Controlled Period||23
8230674|NCT01993186|20295111|P2|STARTED|Double-Blind Placebo-Controlled Period||11
8230675|NCT01993186|20295112|P1|STARTED|Double-Blind Placebo-Controlled Period||25
8230676|NCT01993108|20295157|P2|NOT COMPLETED|Overall Study||0
8230677|NCT01993108|20295158|P1|NOT COMPLETED|Overall Study||0
8230678|NCT01993108|20295157|P2|COMPLETED|Overall Study||12
8230679|NCT01993108|20295158|P1|COMPLETED|Overall Study||11
8230680|NCT01993108|20295157|P2|STARTED|Overall Study||12
8230681|NCT01993108|20295158|P1|STARTED|Overall Study||11
8230682|NCT01993030|20295189|P2|NOT COMPLETED|Overall Study||4
8230683|NCT01993030|20295190|P1|NOT COMPLETED|Overall Study||0
8230684|NCT01993030|20295189|P2|COMPLETED|Overall Study||31
8230685|NCT01993030|20295190|P1|COMPLETED|Overall Study||36
8230686|NCT01993030|20295189|P2|STARTED|Overall Study||35
8230687|NCT01993030|20295190|P1|STARTED|Overall Study||36
8230697|NCT01992874|20295220|P3|NOT COMPLETED|Part B||0
8230698|NCT01992874|20295221|P2|NOT COMPLETED|Part B||0
8230699|NCT01992874|20295222|P1|NOT COMPLETED|Part B||0
8230700|NCT01992874|20295220|P3|COMPLETED|Part B||38
8230701|NCT01992874|20295221|P2|COMPLETED|Part B||0
8230702|NCT01992874|20295222|P1|COMPLETED|Part B||0
8230703|NCT01992874|20295220|P3|STARTED|Part B||38
8230704|NCT01992874|20295221|P2|STARTED|Part B||0
8230705|NCT01992874|20295222|P1|STARTED|Part B||0
8230706|NCT01992874|20295220|P3|NOT COMPLETED|Part A||0
8230707|NCT01992874|20295221|P2|NOT COMPLETED|Part A||0
8230708|NCT01992874|20295222|P1|NOT COMPLETED|Part A||0
8230709|NCT01992874|20295220|P3|COMPLETED|Part A||0
8230710|NCT01992874|20295221|P2|COMPLETED|Part A||17
8230711|NCT01992874|20295222|P1|COMPLETED|Part A||21
8230712|NCT01992874|20295220|P3|STARTED|Part A||0
8230713|NCT01992874|20295221|P2|STARTED|Part A||17
8230714|NCT01992874|20295222|P1|STARTED|Part A||21
8230715|NCT01992757|20295250|P1|NOT COMPLETED|Overall Study||2
8230716|NCT01992757|20295250|P1|COMPLETED|Overall Study||49
8230717|NCT01992757|20295250|P1|STARTED|Overall Study||51
8230718|NCT01992653|20295263|P8|NOT COMPLETED|Overall Study||4
8230719|NCT01992653|20295264|P7|NOT COMPLETED|Overall Study||8
8230720|NCT01992653|20295265|P6|NOT COMPLETED|Overall Study||0
8230721|NCT01992653|20295266|P5|NOT COMPLETED|Overall Study||1
8230722|NCT01992653|20295267|P4|NOT COMPLETED|Overall Study||0
8230723|NCT01992653|20295268|P3|NOT COMPLETED|Overall Study||1
8230724|NCT01992653|20295269|P2|NOT COMPLETED|Overall Study||0
8230725|NCT01992653|20295270|P1|NOT COMPLETED|Overall Study||0
8230726|NCT01992653|20295263|P8|COMPLETED|Overall Study||13
8230727|NCT01992653|20295264|P7|COMPLETED|Overall Study||32
8230728|NCT01992653|20295265|P6|COMPLETED|Overall Study||6
8230729|NCT01992653|20295266|P5|COMPLETED|Overall Study||5
8230730|NCT01992653|20295267|P4|COMPLETED|Overall Study||1
8230731|NCT01992653|20295268|P3|COMPLETED|Overall Study||5
8230732|NCT01992653|20295269|P2|COMPLETED|Overall Study||3
8230733|NCT01992653|20295270|P1|COMPLETED|Overall Study||3
8230734|NCT01992653|20295263|P8|STARTED|Overall Study||17
8230735|NCT01992653|20295264|P7|STARTED|Overall Study||40
8230736|NCT01992653|20295265|P6|STARTED|Overall Study||6
8230737|NCT01992653|20295266|P5|STARTED|Overall Study||6
8230738|NCT01992653|20295267|P4|STARTED|Overall Study||1
8230739|NCT01992653|20295268|P3|STARTED|Overall Study||6
8230740|NCT01992653|20295269|P2|STARTED|Overall Study||3
8230741|NCT01992653|20295270|P1|STARTED|Overall Study||3
8230742|NCT01992549|20295496|P1|NOT COMPLETED|Overall Study||4
8230743|NCT01992549|20295496|P1|COMPLETED|Overall Study||44
8230744|NCT01992549|20295496|P1|SURG Population|Overall Study||3
8230745|NCT01992549|20295496|P1|BLEED Population|Overall Study||29
8230746|NCT01992549|20295496|P1|PROPH Population|Overall Study||47
8230747|NCT01992549|20295496|P1|ITT Population|Overall Study||47
8230748|NCT01992549|20295496|P1|SAF Population|Overall Study||48
8230749|NCT01992549|20295496|P1|STARTED|Overall Study||48
8230750|NCT01992536|20295516|P10|NOT COMPLETED|Overall Study||1
8230751|NCT01992536|20295517|P9|NOT COMPLETED|Overall Study||1
8230752|NCT01992536|20295518|P8|NOT COMPLETED|Overall Study||0
8230753|NCT01992536|20295519|P7|NOT COMPLETED|Overall Study||7
8230754|NCT01992536|20295520|P6|NOT COMPLETED|Overall Study||1
8230755|NCT01992536|20295521|P5|NOT COMPLETED|Overall Study||0
8230756|NCT01992536|20295522|P4|NOT COMPLETED|Overall Study||2
8230757|NCT01992536|20295523|P3|NOT COMPLETED|Overall Study||1
8230758|NCT01992536|20295524|P2|NOT COMPLETED|Overall Study||3
8230759|NCT01992536|20295525|P1|NOT COMPLETED|Overall Study||4
8230760|NCT01992536|20295516|P10|COMPLETED|Overall Study||18
8230761|NCT01992536|20295517|P9|COMPLETED|Overall Study||18
8230762|NCT01992536|20295518|P8|COMPLETED|Overall Study||21
8230763|NCT01992536|20295519|P7|COMPLETED|Overall Study||0
8230764|NCT01992536|20295520|P6|COMPLETED|Overall Study||20
8230765|NCT01992536|20295521|P5|COMPLETED|Overall Study||11
8230766|NCT01992536|20295522|P4|COMPLETED|Overall Study||22
8230767|NCT01992536|20295523|P3|COMPLETED|Overall Study||16
8230768|NCT01992536|20295524|P2|COMPLETED|Overall Study||22
8230769|NCT01992536|20295525|P1|COMPLETED|Overall Study||22
8230770|NCT01992536|20295516|P10|STARTED|Overall Study||19
8230771|NCT01992536|20295517|P9|STARTED|Overall Study||19
8230772|NCT01992536|20295518|P8|STARTED|Overall Study||21
8230773|NCT01992536|20295519|P7|STARTED|Overall Study||7
8230774|NCT01992536|20295520|P6|STARTED|Overall Study||21
8230775|NCT01992536|20295521|P5|STARTED|Overall Study||11
8230776|NCT01992536|20295522|P4|STARTED|Overall Study||24
8230777|NCT01992536|20295523|P3|STARTED|Overall Study||17
8230778|NCT01992536|20295524|P2|STARTED|Overall Study||25
8230779|NCT01992536|20295525|P1|STARTED|Overall Study||26
8230780|NCT01992523|20295742|P2|NOT COMPLETED|Overall Study||0
8230781|NCT01992523|20295743|P1|NOT COMPLETED|Overall Study||0
8230782|NCT01992523|20295742|P2|COMPLETED|Overall Study||41
8230783|NCT01992523|20295743|P1|COMPLETED|Overall Study||41
8230784|NCT01992523|20295742|P2|STARTED|Overall Study||41
8230785|NCT01992523|20295743|P1|STARTED|Overall Study||41
8230786|NCT01992380|20295758|P3|NOT COMPLETED|Overall Study||0
8230787|NCT01992380|20295759|P2|NOT COMPLETED|Overall Study||0
8230788|NCT01992380|20295760|P1|NOT COMPLETED|Overall Study||0
8230789|NCT01992380|20295758|P3|COMPLETED|Overall Study||10
8230790|NCT01992380|20295759|P2|COMPLETED|Overall Study||8
8230791|NCT01992380|20295760|P1|COMPLETED|Overall Study||6
8230792|NCT01992380|20295758|P3|STARTED|Overall Study||10
8230793|NCT01992380|20295759|P2|STARTED|Overall Study||8
8230794|NCT01992380|20295760|P1|STARTED|Overall Study||6
8230795|NCT01992354|20295767|P1|NOT COMPLETED|Overall Study||0
8230796|NCT01992354|20295767|P1|COMPLETED|Overall Study||4
8230797|NCT01992354|20295767|P1|STARTED|Overall Study||4
8230798|NCT01992185|20295774|P2|NOT COMPLETED|Overall Study||0
8230799|NCT01992185|20295775|P1|NOT COMPLETED|Overall Study||0
8230800|NCT01992185|20295774|P2|COMPLETED|Overall Study||8
8230801|NCT01992185|20295775|P1|COMPLETED|Overall Study||7
8230802|NCT01992185|20295774|P2|STARTED|Overall Study||8
8230803|NCT01992185|20295775|P1|STARTED|Overall Study||7
8230804|NCT01992172|20295783|P2|NOT COMPLETED|Overall Study||0
8230805|NCT01992172|20295784|P1|NOT COMPLETED|Overall Study||0
8230806|NCT01992172|20295783|P2|COMPLETED|Overall Study||0
8230807|NCT01992172|20295784|P1|COMPLETED|Overall Study||7
8230808|NCT01992172|20295783|P2|STARTED|Overall Study||0
8230809|NCT01992172|20295784|P1|STARTED|Overall Study||7
8230810|NCT01992159|20295794|P4|NOT COMPLETED|Overall Study||4
8230811|NCT01992159|20295795|P3|NOT COMPLETED|Overall Study||1
8230812|NCT01992159|20295796|P2|NOT COMPLETED|Overall Study||8
8230813|NCT01992159|20295797|P1|NOT COMPLETED|Overall Study||4
8230814|NCT01992159|20295794|P4|COMPLETED|Overall Study||59
8230815|NCT01992159|20295795|P3|COMPLETED|Overall Study||62
8230816|NCT01992159|20295796|P2|COMPLETED|Overall Study||55
8230817|NCT01992159|20295797|P1|COMPLETED|Overall Study||59
8230818|NCT01992159|20295794|P4|Completed First 12 Months of Study|Overall Study||59
8230819|NCT01992159|20295795|P3|Completed First 12 Months of Study|Overall Study||63
8230820|NCT01992159|20295796|P2|Completed First 12 Months of Study|Overall Study||56
8230821|NCT01992159|20295797|P1|Completed First 12 Months of Study|Overall Study||59
8230822|NCT01992159|20295794|P4|Received Treatment|Overall Study||63
8230823|NCT01992159|20295795|P3|Received Treatment|Overall Study||63
8230824|NCT01992159|20295796|P2|Received Treatment|Overall Study||63
8230825|NCT01992159|20295797|P1|Received Treatment|Overall Study||63
8230826|NCT01992159|20295794|P4|STARTED|Overall Study||63
8230827|NCT01992159|20295795|P3|STARTED|Overall Study||63
8230828|NCT01992159|20295796|P2|STARTED|Overall Study||63
8230829|NCT01992159|20295797|P1|STARTED|Overall Study||63
8230830|NCT01992107|20295850|P3|NOT COMPLETED|Overall Study||36
8230831|NCT01992107|20295851|P2|NOT COMPLETED|Overall Study||33
8230832|NCT01992107|20295852|P1|NOT COMPLETED|Overall Study||68
8230833|NCT01992107|20295850|P3|COMPLETED|Overall Study||545
8230834|NCT01992107|20295851|P2|COMPLETED|Overall Study||560
8230835|NCT01992107|20295852|P1|COMPLETED|Overall Study||1091
8230836|NCT01992107|20295850|P3|STARTED|Overall Study||581
8230837|NCT01992107|20295851|P2|STARTED|Overall Study||593
8230838|NCT01992107|20295852|P1|STARTED|Overall Study||1159
8230839|NCT01992094|20295908|P3|NOT COMPLETED|Overall Study||21
8230840|NCT01992094|20295909|P2|NOT COMPLETED|Overall Study||24
8230841|NCT01992094|20295910|P1|NOT COMPLETED|Overall Study||50
8230842|NCT01992094|20295908|P3|COMPLETED|Overall Study||648
8230843|NCT01992094|20295909|P2|COMPLETED|Overall Study||652
8230844|NCT01992094|20295910|P1|COMPLETED|Overall Study||1285
8230845|NCT01992094|20295908|P3|STARTED|Overall Study||669
8230846|NCT01992094|20295909|P2|STARTED|Overall Study||676
8230847|NCT01992094|20295910|P1|STARTED|Overall Study||1335
8230848|NCT01992016|20295968|P2|NOT COMPLETED|Overall Study||0
8230849|NCT01992016|20295969|P1|NOT COMPLETED|Overall Study||0
8230850|NCT01992016|20295968|P2|COMPLETED|Overall Study||7
8230851|NCT01992016|20295969|P1|COMPLETED|Overall Study||4
8230852|NCT01992016|20295968|P2|STARTED|Overall Study||7
8230853|NCT01992016|20295969|P1|STARTED|Overall Study||4
8230854|NCT01991990|20295977|P2|NOT COMPLETED|Overall Study||0
8230855|NCT01991990|20295978|P1|NOT COMPLETED|Overall Study||0
8230856|NCT01991990|20295977|P2|COMPLETED|Overall Study||12
8230857|NCT01991990|20295978|P1|COMPLETED|Overall Study||6
8230858|NCT01991990|20295977|P2|STARTED|Overall Study||12
8230859|NCT01991990|20295978|P1|STARTED|Overall Study||6
8230866|NCT01991860|20296024|P2|NOT COMPLETED|Overall Study||2
8230867|NCT01991860|20296025|P1|NOT COMPLETED|Overall Study||4
8230868|NCT01991860|20296024|P2|COMPLETED|Overall Study||164
8230869|NCT01991860|20296025|P1|COMPLETED|Overall Study||172
8230870|NCT01991860|20296024|P2|STARTED|Overall Study||166
8230871|NCT01991860|20296025|P1|STARTED|Overall Study||176
8230872|NCT01991821|20296045|P2|NOT COMPLETED|Overall Study||167
8230873|NCT01991821|20296046|P1|NOT COMPLETED|Overall Study||163
8230874|NCT01991821|20296045|P2|COMPLETED|Overall Study||11
8230875|NCT01991821|20296046|P1|COMPLETED|Overall Study||6
8230876|NCT01991821|20296045|P2|STARTED|Overall Study||178
8230877|NCT01991821|20296046|P1|STARTED|Overall Study||169
8230878|NCT01991808|20296064|P1|NOT COMPLETED|Overall Study||0
8230879|NCT01991808|20296064|P1|COMPLETED|Overall Study||16
8230880|NCT01991808|20296064|P1|STARTED|Overall Study||16
8230881|NCT01991795|20296070|P2|NOT COMPLETED|Overall Study||123
8230882|NCT01991795|20296071|P1|NOT COMPLETED|Overall Study||149
8230883|NCT01991795|20296070|P2|COMPLETED|Overall Study||9503
8230884|NCT01991795|20296071|P1|COMPLETED|Overall Study||9496
8230885|NCT01991795|20296070|P2|STARTED|Overall Study||9626
8230886|NCT01991795|20296071|P1|STARTED|Overall Study||9645
8230887|NCT01991743|20296097|P4|NOT COMPLETED|Overall Study||0
8230888|NCT01991743|20296098|P3|NOT COMPLETED|Overall Study||1
8230889|NCT01991743|20296099|P2|NOT COMPLETED|Overall Study||0
8230890|NCT01991743|20296100|P1|NOT COMPLETED|Overall Study||0
8230891|NCT01991743|20296097|P4|COMPLETED|Overall Study||60
8230892|NCT01991743|20296098|P3|COMPLETED|Overall Study||59
8230893|NCT01991743|20296099|P2|COMPLETED|Overall Study||60
8230894|NCT01991743|20296100|P1|COMPLETED|Overall Study||60
8230895|NCT01991743|20296097|P4|STARTED|Overall Study||60
8230896|NCT01991743|20296098|P3|STARTED|Overall Study||60
8230897|NCT01991743|20296099|P2|STARTED|Overall Study||60
8230898|NCT01991743|20296100|P1|STARTED|Overall Study||60
8230899|NCT01991548|20296126|P1|NOT COMPLETED|Overall Study||1
8230900|NCT01991548|20296126|P1|COMPLETED|Overall Study||39
8230901|NCT01991548|20296126|P1|STARTED|Overall Study||40
8230902|NCT01991522|20296132|P2|NOT COMPLETED|Overall Study||0
8230903|NCT01991522|20296133|P1|NOT COMPLETED|Overall Study||0
8230904|NCT01991522|20296132|P2|COMPLETED|Overall Study||17
8230905|NCT01991522|20296133|P1|COMPLETED|Overall Study||16
8230906|NCT01991522|20296132|P2|STARTED|Overall Study||17
8230907|NCT01991522|20296133|P1|STARTED|Overall Study||16
8230908|NCT01991483|20296145|P4|NOT COMPLETED|Dose Level 1000 mg||1
8230909|NCT01991483|20296146|P3|NOT COMPLETED|Dose Level 1000 mg||0
8230910|NCT01991483|20296147|P2|NOT COMPLETED|Dose Level 1000 mg||0
8230911|NCT01991483|20296148|P1|NOT COMPLETED|Dose Level 1000 mg||0
8230912|NCT01991483|20296145|P4|COMPLETED|Dose Level 1000 mg||3
8230913|NCT01991483|20296146|P3|COMPLETED|Dose Level 1000 mg||0
8230914|NCT01991483|20296147|P2|COMPLETED|Dose Level 1000 mg||0
8230915|NCT01991483|20296148|P1|COMPLETED|Dose Level 1000 mg||0
8230916|NCT01991483|20296145|P4|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4
8230917|NCT01991483|20296146|P3|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
8230918|NCT01991483|20296147|P2|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
8230919|NCT01991483|20296148|P1|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
8230920|NCT01991483|20296145|P4|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4
8230921|NCT01991483|20296146|P3|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0
8230922|NCT01991483|20296147|P2|STARTED|Dose Level 1000 mg||0
8230923|NCT01991483|20296148|P1|STARTED|Dose Level 1000 mg||0
8230924|NCT01991483|20296145|P4|NOT COMPLETED|Dose Level 600 mg||0
8230925|NCT01991483|20296146|P3|NOT COMPLETED|Dose Level 600 mg||2
8230926|NCT01991483|20296147|P2|NOT COMPLETED|Dose Level 600 mg||0
8230927|NCT01991483|20296148|P1|NOT COMPLETED|Dose Level 600 mg||0
8230928|NCT01991483|20296145|P4|COMPLETED|Dose Level 600 mg||0
8230929|NCT01991483|20296146|P3|COMPLETED|Dose Level 600 mg||9
8230930|NCT01991483|20296147|P2|COMPLETED|Dose Level 600 mg||0
8230931|NCT01991483|20296148|P1|COMPLETED|Dose Level 600 mg||0
8230932|NCT01991483|20296145|P4|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
8230933|NCT01991483|20296146|P3|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11
8230934|NCT01991483|20296147|P2|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
8230935|NCT01991483|20296148|P1|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
8230936|NCT01991483|20296145|P4|STARTED|Dose Level 600 mg||0
8230937|NCT01991483|20296146|P3|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11
8230938|NCT01991483|20296147|P2|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0
8230939|NCT01991483|20296148|P1|STARTED|Dose Level 600 mg||0
8230940|NCT01991483|20296145|P4|NOT COMPLETED|Dose Level 300 mg||0
8230941|NCT01991483|20296146|P3|NOT COMPLETED|Dose Level 300 mg||0
8230942|NCT01991483|20296147|P2|NOT COMPLETED|Dose Level 300 mg||0
8230943|NCT01991483|20296148|P1|NOT COMPLETED|Dose Level 300 mg||0
8230944|NCT01991483|20296145|P4|COMPLETED|Dose Level 300 mg||0
8230945|NCT01991483|20296146|P3|COMPLETED|Dose Level 300 mg||0
8230946|NCT01991483|20296147|P2|COMPLETED|Dose Level 300 mg||6
8230947|NCT01991483|20296148|P1|COMPLETED|Dose Level 300 mg||0
8230948|NCT01991483|20296145|P4|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
8230949|NCT01991483|20296146|P3|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
8230950|NCT01991483|20296147|P2|Received at Least One Dose of Study Drug|Dose Level 300 mg||6
8230951|NCT01991483|20296148|P1|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
8230952|NCT01991483|20296145|P4|STARTED|Dose Level 300 mg||0
8230953|NCT01991483|20296146|P3|STARTED|Dose Level 300 mg||0
8230954|NCT01991483|20296147|P2|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6
8230955|NCT01991483|20296148|P1|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0
8230956|NCT01991483|20296145|P4|NOT COMPLETED|Dose Level: Placebo||0
8230957|NCT01991483|20296146|P3|NOT COMPLETED|Dose Level: Placebo||0
8230958|NCT01991483|20296147|P2|NOT COMPLETED|Dose Level: Placebo||0
8230959|NCT01991483|20296148|P1|NOT COMPLETED|Dose Level: Placebo||0
8230960|NCT01991483|20296145|P4|COMPLETED|Dose Level: Placebo||0
8230961|NCT01991483|20296146|P3|COMPLETED|Dose Level: Placebo||0
8230962|NCT01991483|20296147|P2|COMPLETED|Dose Level: Placebo||0
8230963|NCT01991483|20296148|P1|COMPLETED|Dose Level: Placebo||7
8230964|NCT01991483|20296145|P4|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
8230965|NCT01991483|20296146|P3|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
8230966|NCT01991483|20296147|P2|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
8230967|NCT01991483|20296148|P1|Received at Least One Dose of Study Drug|Dose Level: Placebo||7
8230968|NCT01991483|20296145|P4|STARTED|Dose Level: Placebo||0
8230969|NCT01991483|20296146|P3|STARTED|Dose Level: Placebo||0
8230970|NCT01991483|20296147|P2|STARTED|Dose Level: Placebo||0
8230971|NCT01991483|20296148|P1|STARTED|Dose Level: Placebo||7
8230972|NCT01991470|20296214|P1|NOT COMPLETED|Enlite 3 Period||12
8230973|NCT01991470|20296214|P1|COMPLETED|Enlite 3 Period||146
8230974|NCT01991470|20296214|P1|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
8230975|NCT01991470|20296214|P1|NOT COMPLETED|Enlite 1 Period||20
8230976|NCT01991470|20296214|P1|COMPLETED|Enlite 1 Period||141
8230977|NCT01991470|20296214|P1|STARTED|Enlite 1 Period||161
8230978|NCT01991314|20296228|P2|NOT COMPLETED|Overall Study||11
8230979|NCT01991314|20296229|P1|NOT COMPLETED|Overall Study||11
8230980|NCT01991314|20296228|P2|COMPLETED|Overall Study||32
8230981|NCT01991314|20296229|P1|COMPLETED|Overall Study||34
8230982|NCT01991314|20296228|P2|STARTED|Overall Study||43
8230983|NCT01991314|20296229|P1|STARTED|Overall Study||45
8230984|NCT01991197|20296249|P2|NOT COMPLETED|Overall Study||3
8230985|NCT01991197|20296250|P1|NOT COMPLETED|Overall Study||3
8230986|NCT01991197|20296249|P2|COMPLETED|Overall Study||8
8230987|NCT01991197|20296250|P1|COMPLETED|Overall Study||6
8230988|NCT01991197|20296249|P2|STARTED|Overall Study||11
8230989|NCT01991197|20296250|P1|STARTED|Overall Study||9
8230990|NCT01991067|20296288|P2|NOT COMPLETED|Overall Study||5
8230991|NCT01991067|20296289|P1|NOT COMPLETED|Overall Study||6
8230992|NCT01991067|20296288|P2|COMPLETED|Overall Study||10
8230993|NCT01991067|20296289|P1|COMPLETED|Overall Study||13
8230994|NCT01991067|20296288|P2|STARTED|Overall Study||15
8230995|NCT01991067|20296289|P1|STARTED|Overall Study||19
8230996|NCT01990898|20296299|P1|NOT COMPLETED|Overall Study||4
8230997|NCT01990898|20296299|P1|COMPLETED|Overall Study||22
8230998|NCT01990898|20296299|P1|3 Months|Overall Study||22
8230999|NCT01990898|20296299|P1|STARTED|Overall Study||26
8231000|NCT01990859|20296303|P1|NOT COMPLETED|90 Day Follow Up for All Participants||0
8231001|NCT01990859|20296303|P1|COMPLETED|90 Day Follow Up for All Participants||20
8231002|NCT01990859|20296303|P1|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
8231003|NCT01990859|20296303|P1|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
8231004|NCT01990859|20296303|P1|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
8231005|NCT01990859|20296303|P1|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
8231006|NCT01990859|20296303|P1|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
8231007|NCT01990859|20296303|P1|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
8231008|NCT01990859|20296303|P1|STARTED|Treatment (4 Doses Over 12 Weeks)||20
8231009|NCT01990820|20296316|P2|NOT COMPLETED|Overall Study||0
8231010|NCT01990820|20296317|P1|NOT COMPLETED|Overall Study||0
8231011|NCT01990820|20296316|P2|COMPLETED|Overall Study||12
8231012|NCT01990820|20296317|P1|COMPLETED|Overall Study||13
8231013|NCT01990820|20296316|P2|STARTED|Overall Study||12
8231014|NCT01990820|20296317|P1|STARTED|Overall Study||13
8231015|NCT01990794|20296323|P1|NOT COMPLETED|Overall Study||3
8231016|NCT01990794|20296323|P1|COMPLETED|Overall Study||10
8231017|NCT01990794|20296323|P1|One Month Into Study|Overall Study||10
8231018|NCT01990794|20296323|P1|STARTED|Overall Study||13
8231019|NCT01990768|20296438|P3|NOT COMPLETED|6-Month Follow-up||58
8231020|NCT01990768|20296439|P2|NOT COMPLETED|6-Month Follow-up||51
8231021|NCT01990768|20296440|P1|NOT COMPLETED|6-Month Follow-up||39
8231022|NCT01990768|20296438|P3|COMPLETED|6-Month Follow-up||288
8231023|NCT01990768|20296439|P2|COMPLETED|6-Month Follow-up||261
8231024|NCT01990768|20296440|P1|COMPLETED|6-Month Follow-up||270
8231025|NCT01990768|20296438|P3|STARTED|6-Month Follow-up||346
8231026|NCT01990768|20296439|P2|STARTED|6-Month Follow-up||312
8231027|NCT01990768|20296440|P1|STARTED|6-Month Follow-up||309
8231028|NCT01990768|20296438|P3|NOT COMPLETED|In-Hospital Study Drug Infusion||80
8231029|NCT01990768|20296439|P2|NOT COMPLETED|In-Hospital Study Drug Infusion||83
8231030|NCT01990768|20296440|P1|NOT COMPLETED|In-Hospital Study Drug Infusion||95
8231031|NCT01990768|20296438|P3|COMPLETED|In-Hospital Study Drug Infusion||266
8231032|NCT01990768|20296439|P2|COMPLETED|In-Hospital Study Drug Infusion||229
8231033|NCT01990768|20296440|P1|COMPLETED|In-Hospital Study Drug Infusion||214
8231034|NCT01990768|20296438|P3|STARTED|In-Hospital Study Drug Infusion||346
8231035|NCT01990768|20296439|P2|STARTED|In-Hospital Study Drug Infusion||312
8231036|NCT01990768|20296440|P1|STARTED|In-Hospital Study Drug Infusion||309
8231037|NCT01990768|20296438|P3|NOT COMPLETED|Prehospital Study Drug Infusion||19
8231038|NCT01990768|20296439|P2|NOT COMPLETED|Prehospital Study Drug Infusion||27
8231039|NCT01990768|20296440|P1|NOT COMPLETED|Prehospital Study Drug Infusion||19
8231040|NCT01990768|20296438|P3|COMPLETED|Prehospital Study Drug Infusion||327
8231041|NCT01990768|20296439|P2|COMPLETED|Prehospital Study Drug Infusion||285
8231042|NCT01990768|20296440|P1|COMPLETED|Prehospital Study Drug Infusion||290
8231043|NCT01990768|20296438|P3|STARTED|Prehospital Study Drug Infusion||346
8231044|NCT01990768|20296439|P2|STARTED|Prehospital Study Drug Infusion||312
8231045|NCT01990768|20296440|P1|STARTED|Prehospital Study Drug Infusion||309
8231046|NCT01990768|20296438|P3|NOT COMPLETED|Intervention Started||27
8231047|NCT01990768|20296439|P2|NOT COMPLETED|Intervention Started||33
8231048|NCT01990768|20296440|P1|NOT COMPLETED|Intervention Started||36
8231049|NCT01990768|20296438|P3|COMPLETED|Intervention Started||346
8231050|NCT01990768|20296439|P2|COMPLETED|Intervention Started||312
8231051|NCT01990768|20296440|P1|COMPLETED|Intervention Started||309
8231052|NCT01990768|20296438|P3|STARTED|Intervention Started||373
8231053|NCT01990768|20296439|P2|STARTED|Intervention Started||345
8231054|NCT01990768|20296440|P1|STARTED|Intervention Started||345
8231055|NCT01990742|20296505|P2|NOT COMPLETED|Overall Study||1353
8231056|NCT01990742|20296506|P1|NOT COMPLETED|Overall Study||407
8231057|NCT01990742|20296505|P2|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
8231058|NCT01990742|20296506|P1|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
8231059|NCT01990742|20296505|P2|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
8231060|NCT01990742|20296506|P1|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
8231061|NCT01990703|20296518|P2|NOT COMPLETED|Overall Study||45
8231062|NCT01990703|20296519|P1|NOT COMPLETED|Overall Study||39
8231063|NCT01990703|20296518|P2|COMPLETED|Overall Study||93
8231064|NCT01990703|20296519|P1|COMPLETED|Overall Study||108
8231065|NCT01990703|20296518|P2|STARTED|Overall Study||138
8231066|NCT01990703|20296519|P1|STARTED|Overall Study||147
8231067|NCT01990677|20296529|P2|NOT COMPLETED|Overall Study||1
8231068|NCT01990677|20296530|P1|NOT COMPLETED|Overall Study||2
8231069|NCT01990677|20296529|P2|COMPLETED|Overall Study||5
8231070|NCT01990677|20296530|P1|COMPLETED|Overall Study||10
8231071|NCT01990677|20296529|P2|STARTED|Overall Study||6
8231072|NCT01990677|20296530|P1|STARTED|Overall Study||12
8231073|NCT01990664|20296542|P2|NOT COMPLETED|Overall Study||11
8231074|NCT01990664|20296543|P1|NOT COMPLETED|Overall Study||7
8231075|NCT01990664|20296542|P2|COMPLETED|Overall Study||79
8231076|NCT01990664|20296543|P1|COMPLETED|Overall Study||95
8231077|NCT01990664|20296542|P2|STARTED|Overall Study||90
8231078|NCT01990664|20296543|P1|STARTED|Overall Study||102
8231079|NCT01990612|20296551|P2|NOT COMPLETED|Overall Study||3
8231080|NCT01990612|20296552|P1|NOT COMPLETED|Overall Study||7
8231081|NCT01990612|20296551|P2|COMPLETED|Overall Study||3059
8231082|NCT01990612|20296552|P1|COMPLETED|Overall Study||3037
8231083|NCT01990612|20296551|P2|STARTED|Overall Study||3062
8231084|NCT01990612|20296552|P1|STARTED|Overall Study||3044
8231085|NCT01990573|20296633|P3|NOT COMPLETED|Overall Study||1
8231086|NCT01990573|20296634|P2|NOT COMPLETED|Overall Study||0
8231087|NCT01990573|20296635|P1|NOT COMPLETED|Overall Study||0
8231088|NCT01990573|20296633|P3|COMPLETED|Overall Study||16
8231089|NCT01990573|20296634|P2|COMPLETED|Overall Study||14
8231090|NCT01990573|20296635|P1|COMPLETED|Overall Study||20
8231091|NCT01990573|20296633|P3|STARTED|Overall Study||17
8231092|NCT01990573|20296634|P2|STARTED|Overall Study||14
8231093|NCT01990573|20296635|P1|STARTED|Overall Study||20
8231094|NCT01990560|20296648|P1|NOT COMPLETED|Overall Study||1
8231095|NCT01990560|20296648|P1|COMPLETED|Overall Study||7
8231096|NCT01990560|20296648|P1|STARTED|Overall Study||8
8231101|NCT01990495|20296680|P2|NOT COMPLETED|Overall Study||4
8231102|NCT01990495|20296681|P1|NOT COMPLETED|Overall Study||5
8231103|NCT01990495|20296680|P2|COMPLETED|Overall Study||15
8231104|NCT01990495|20296681|P1|COMPLETED|Overall Study||13
8231105|NCT01990495|20296680|P2|STARTED|Overall Study||19
8231106|NCT01990495|20296681|P1|STARTED|Overall Study||18
8231107|NCT01990339|20296691|P1|NOT COMPLETED|Overall Study||2312
8231108|NCT01990339|20296691|P1|COMPLETED|Overall Study||12653
8231109|NCT01990339|20296691|P1|STARTED|Overall Study||14965
8231110|NCT01990313|20296696|P1|NOT COMPLETED|Overall Study||1
8231111|NCT01990313|20296696|P1|COMPLETED|Overall Study||14
8231112|NCT01990313|20296696|P1|STARTED|Overall Study||15
8231113|NCT01990300|20296701|P1|NOT COMPLETED|Overall Study||142
8231114|NCT01990300|20296701|P1|COMPLETED|Overall Study||3139
8231115|NCT01990300|20296701|P1|STARTED|Overall Study||3281
8231116|NCT01990261|20296707|P1|NOT COMPLETED|Overall Study||25
8231117|NCT01990261|20296707|P1|COMPLETED|Overall Study||8
8231118|NCT01990261|20296707|P1|Treated|Overall Study||29
8231119|NCT01990261|20296707|P1|STARTED|Overall Study||33
8231120|NCT01989975|20296717|P1|NOT COMPLETED|Overall Study||0
8231121|NCT01989975|20296717|P1|COMPLETED|Overall Study||40
8231122|NCT01989975|20296717|P1|STARTED|Overall Study||40
8231123|NCT01989910|20296726|P2|NOT COMPLETED|Overall Study||0
8231124|NCT01989910|20296727|P1|NOT COMPLETED|Overall Study||2
8231125|NCT01989910|20296726|P2|COMPLETED|Overall Study||54
8231126|NCT01989910|20296727|P1|COMPLETED|Overall Study||51
8231127|NCT01989910|20296726|P2|STARTED|Overall Study||54
8231128|NCT01989910|20296727|P1|STARTED|Overall Study||53
8231129|NCT01989793|20296739|P2|NOT COMPLETED|Overall Study||4
8231130|NCT01989793|20296740|P1|NOT COMPLETED|Overall Study||8
8231131|NCT01989793|20296739|P2|COMPLETED|Overall Study||15
8231132|NCT01989793|20296740|P1|COMPLETED|Overall Study||10
8231133|NCT01989793|20296739|P2|STARTED|Overall Study||19
8231134|NCT01989793|20296740|P1|STARTED|Overall Study||18
8231135|NCT01989754|20296764|P2|NOT COMPLETED|Overall Study||35
8231136|NCT01989754|20296765|P1|NOT COMPLETED|Overall Study||39
8231137|NCT01989754|20296764|P2|COMPLETED|Overall Study|Participants who died are included in this category.|2872
8231138|NCT01989754|20296765|P1|COMPLETED|Overall Study|Participants who died are included in this category.|2866
8231139|NCT01989754|20296764|P2|Treated|Overall Study||2904
8231140|NCT01989754|20296765|P1|Treated|Overall Study||2903
8231141|NCT01989754|20296764|P2|STARTED|Overall Study||2907
8231142|NCT01989754|20296765|P1|STARTED|Overall Study||2905
8231143|NCT01989689|20296777|P2|NOT COMPLETED|Treatment Period ( 3 Months)||0
8231144|NCT01989689|20296778|P1|NOT COMPLETED|Treatment Period ( 3 Months)||0
8231145|NCT01989689|20296777|P2|COMPLETED|Treatment Period ( 3 Months)||10
8231146|NCT01989689|20296778|P1|COMPLETED|Treatment Period ( 3 Months)||11
8231147|NCT01989689|20296777|P2|STARTED|Treatment Period ( 3 Months)||10
8231148|NCT01989689|20296778|P1|STARTED|Treatment Period ( 3 Months)||11
8231149|NCT01989689|20296777|P2|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
8231150|NCT01989689|20296778|P1|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
8231151|NCT01989689|20296777|P2|COMPLETED|Treatment Period 1 ( 3 Months)||10
8231152|NCT01989689|20296778|P1|COMPLETED|Treatment Period 1 ( 3 Months)||11
8231153|NCT01989689|20296777|P2|STARTED|Treatment Period 1 ( 3 Months)||13
8231154|NCT01989689|20296778|P1|STARTED|Treatment Period 1 ( 3 Months)||11
8231155|NCT01989689|20296777|P2|NOT COMPLETED|Baseline||0
8231156|NCT01989689|20296778|P1|NOT COMPLETED|Baseline||0
8231157|NCT01989689|20296777|P2|COMPLETED|Baseline||13
8231158|NCT01989689|20296778|P1|COMPLETED|Baseline||11
8231159|NCT01989689|20296777|P2|STARTED|Baseline||13
8231160|NCT01989689|20296778|P1|STARTED|Baseline||11
8231167|NCT01989572|20296817|P6|NOT COMPLETED|Overall Study||110
8231168|NCT01989572|20296818|P5|NOT COMPLETED|Overall Study||98
8231169|NCT01989572|20296819|P4|NOT COMPLETED|Overall Study||51
8231170|NCT01989572|20296820|P3|NOT COMPLETED|Overall Study||62
8231171|NCT01989572|20296821|P2|NOT COMPLETED|Overall Study||58
8231172|NCT01989572|20296822|P1|NOT COMPLETED|Overall Study||55
8231173|NCT01989572|20296817|P6|COMPLETED|Overall Study||79
8231174|NCT01989572|20296818|P5|COMPLETED|Overall Study||92
8231175|NCT01989572|20296819|P4|COMPLETED|Overall Study||56
8231176|NCT01989572|20296820|P3|COMPLETED|Overall Study||47
8231177|NCT01989572|20296821|P2|COMPLETED|Overall Study||53
8231178|NCT01989572|20296822|P1|COMPLETED|Overall Study||54
8231179|NCT01989572|20296817|P6|Treated|Overall Study||171
8231180|NCT01989572|20296818|P5|Treated|Overall Study||186
8231181|NCT01989572|20296819|P4|Treated|Overall Study||104
8231182|NCT01989572|20296820|P3|Treated|Overall Study||107
8231183|NCT01989572|20296821|P2|Treated|Overall Study||110
8231184|NCT01989572|20296822|P1|Treated|Overall Study||104
8231185|NCT01989572|20296817|P6|STARTED|Overall Study||189
8231186|NCT01989572|20296818|P5|STARTED|Overall Study||190
8231187|NCT01989572|20296819|P4|STARTED|Overall Study||107
8231188|NCT01989572|20296820|P3|STARTED|Overall Study||109
8231189|NCT01989572|20296821|P2|STARTED|Overall Study||111
8231190|NCT01989572|20296822|P1|STARTED|Overall Study||109
8231194|NCT01989468|20296859|P5|NOT COMPLETED|Overall Study||8
8231195|NCT01989468|20296860|P4|NOT COMPLETED|Overall Study||16
8231196|NCT01989468|20296861|P3|NOT COMPLETED|Overall Study||19
8231197|NCT01989468|20296862|P2|NOT COMPLETED|Overall Study||37
8231198|NCT01989468|20296863|P1|NOT COMPLETED|Overall Study||47
8231199|NCT01989468|20296859|P5|COMPLETED|Overall Study||0
8231200|NCT01989468|20296860|P4|COMPLETED|Overall Study||49
8231201|NCT01989468|20296861|P3|COMPLETED|Overall Study||45
8231202|NCT01989468|20296862|P2|COMPLETED|Overall Study||102
8231203|NCT01989468|20296863|P1|COMPLETED|Overall Study||91
8231204|NCT01989468|20296859|P5|STARTED|Overall Study||8
8231205|NCT01989468|20296860|P4|STARTED|Overall Study||65
8231206|NCT01989468|20296861|P3|STARTED|Overall Study||64
8231207|NCT01989468|20296862|P2|STARTED|Overall Study||139
8231208|NCT01989468|20296863|P1|STARTED|Overall Study||138
8231209|NCT01989455|20296905|P5|NOT COMPLETED|Overall Study||1
8231210|NCT01989455|20296906|P4|NOT COMPLETED|Overall Study||0
8231211|NCT01989455|20296907|P3|NOT COMPLETED|Overall Study||1
8231212|NCT01989455|20296908|P2|NOT COMPLETED|Overall Study||2
8231213|NCT01989455|20296909|P1|NOT COMPLETED|Overall Study||0
8231214|NCT01989455|20296905|P5|COMPLETED|Overall Study||7
8231215|NCT01989455|20296906|P4|COMPLETED|Overall Study||14
8231216|NCT01989455|20296907|P3|COMPLETED|Overall Study||13
8231217|NCT01989455|20296908|P2|COMPLETED|Overall Study||12
8231218|NCT01989455|20296909|P1|COMPLETED|Overall Study||14
8231219|NCT01989455|20296905|P5|STARTED|Overall Study||8
8231220|NCT01989455|20296906|P4|STARTED|Overall Study||14
8231221|NCT01989455|20296907|P3|STARTED|Overall Study||14
8231222|NCT01989455|20296908|P2|STARTED|Overall Study||14
8231223|NCT01989455|20296909|P1|STARTED|Overall Study||14
8231224|NCT01989208|20296945|P2|NOT COMPLETED|800 mg (7 Days)||0
8231225|NCT01989208|20296946|P1|NOT COMPLETED|800 mg (7 Days)||0
8231226|NCT01989208|20296945|P2|COMPLETED|800 mg (7 Days)||11
8231227|NCT01989208|20296946|P1|COMPLETED|800 mg (7 Days)||4
8231228|NCT01989208|20296945|P2|STARTED|800 mg (7 Days)||11
8231229|NCT01989208|20296946|P1|STARTED|800 mg (7 Days)||4
8231230|NCT01989208|20296945|P2|NOT COMPLETED|400 mg (7 Days)||0
8231231|NCT01989208|20296946|P1|NOT COMPLETED|400 mg (7 Days)||0
8231232|NCT01989208|20296945|P2|COMPLETED|400 mg (7 Days)||11
8231233|NCT01989208|20296946|P1|COMPLETED|400 mg (7 Days)||4
8231234|NCT01989208|20296945|P2|STARTED|400 mg (7 Days)||11
8231235|NCT01989208|20296946|P1|STARTED|400 mg (7 Days)||4
8231236|NCT01989208|20296945|P2|NOT COMPLETED|200 mg (7 Days)||1
8231237|NCT01989208|20296946|P1|NOT COMPLETED|200 mg (7 Days)||0
8231238|NCT01989208|20296945|P2|COMPLETED|200 mg (7 Days)||11
8231239|NCT01989208|20296946|P1|COMPLETED|200 mg (7 Days)||4
8231240|NCT01989208|20296945|P2|STARTED|200 mg (7 Days)||12
8231241|NCT01989208|20296946|P1|STARTED|200 mg (7 Days)||4
8231242|NCT01989195|20296964|P1|NOT COMPLETED|Overall Study||0
8231243|NCT01989195|20296964|P1|COMPLETED|Overall Study||6
8231244|NCT01989195|20296964|P1|STARTED|Overall Study||6
8231257|NCT01989156|20296988|P3|NOT COMPLETED|End of Study (Population at Day 90)||3
8231258|NCT01989156|20296989|P2|NOT COMPLETED|End of Study (Population at Day 90)||5
8231259|NCT01989156|20296990|P1|NOT COMPLETED|End of Study (Population at Day 90)||7
8231260|NCT01989156|20296988|P3|COMPLETED|End of Study (Population at Day 90)||31
8231261|NCT01989156|20296989|P2|COMPLETED|End of Study (Population at Day 90)||35
8231262|NCT01989156|20296990|P1|COMPLETED|End of Study (Population at Day 90)||73
8231263|NCT01989156|20296988|P3|STARTED|End of Study (Population at Day 90)||34
8231264|NCT01989156|20296989|P2|STARTED|End of Study (Population at Day 90)||40
8231265|NCT01989156|20296990|P1|STARTED|End of Study (Population at Day 90)||80
8231266|NCT01989156|20296988|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||5
8231267|NCT01989156|20296989|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
8231268|NCT01989156|20296990|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||0
8231269|NCT01989156|20296988|P3|COMPLETED|Confinement Period (Population at Day 5)||34
8231270|NCT01989156|20296989|P2|COMPLETED|Confinement Period (Population at Day 5)||40
8231271|NCT01989156|20296990|P1|COMPLETED|Confinement Period (Population at Day 5)||80
8231272|NCT01989156|20296988|P3|STARTED|Confinement Period (Population at Day 5)||39
8231273|NCT01989156|20296989|P2|STARTED|Confinement Period (Population at Day 5)||41
8231274|NCT01989156|20296990|P1|STARTED|Confinement Period (Population at Day 5)||80
8231275|NCT01989130|20297012|P2|NOT COMPLETED|Overall Study||0
8231276|NCT01989130|20297013|P1|NOT COMPLETED|Overall Study||0
8231277|NCT01989130|20297012|P2|COMPLETED|Overall Study||27
8231278|NCT01989130|20297013|P1|COMPLETED|Overall Study||43
8231279|NCT01989130|20297012|P2|STARTED|Overall Study||27
8231280|NCT01989130|20297013|P1|STARTED|Overall Study||43
8231281|NCT01988922|20297028|P3|NOT COMPLETED|Overall Study||0
8231282|NCT01988922|20297029|P2|NOT COMPLETED|Overall Study||0
8231283|NCT01988922|20297030|P1|NOT COMPLETED|Overall Study||0
8231284|NCT01988922|20297028|P3|COMPLETED|Overall Study||10
8231285|NCT01988922|20297029|P2|COMPLETED|Overall Study||10
8231286|NCT01988922|20297030|P1|COMPLETED|Overall Study||10
8231287|NCT01988922|20297028|P3|STARTED|Overall Study||10
8231288|NCT01988922|20297029|P2|STARTED|Overall Study||10
8231289|NCT01988922|20297030|P1|STARTED|Overall Study||10
8231290|NCT01988857|20297041|P1|NOT COMPLETED|Overall Study||0
8231291|NCT01988857|20297041|P1|COMPLETED|Overall Study||300
8231292|NCT01988857|20297041|P1|STARTED|Overall Study||300
8231299|NCT01988662|20297067|P2|NOT COMPLETED|Overall Study||2
8231300|NCT01988662|20297068|P1|NOT COMPLETED|Overall Study||4
8231301|NCT01988662|20297067|P2|COMPLETED|Overall Study||99
8231302|NCT01988662|20297068|P1|COMPLETED|Overall Study||100
8231303|NCT01988662|20297067|P2|STARTED|Overall Study||101
8231304|NCT01988662|20297068|P1|STARTED|Overall Study||104
8231330|NCT01988415|20297163|P1|NOT COMPLETED|Overall Study||0
8231331|NCT01988415|20297163|P1|COMPLETED|Overall Study||26
8231332|NCT01988415|20297163|P1|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
8231333|NCT01988402|20297173|P2|NOT COMPLETED|Overall Study||2
8231334|NCT01988402|20297174|P1|NOT COMPLETED|Overall Study||2
8231335|NCT01988402|20297173|P2|COMPLETED|Overall Study||17
8231336|NCT01988402|20297174|P1|COMPLETED|Overall Study||14
8231337|NCT01988402|20297173|P2|STARTED|Overall Study||19
8231338|NCT01988402|20297174|P1|STARTED|Overall Study||16
8231339|NCT01988376|20297188|P2|NOT COMPLETED|Overall Study||0
8231340|NCT01988376|20297189|P1|NOT COMPLETED|Overall Study||0
8231341|NCT01988376|20297188|P2|COMPLETED|Overall Study||129
8231342|NCT01988376|20297189|P1|COMPLETED|Overall Study||129
8231343|NCT01988376|20297188|P2|STARTED|Overall Study||129
8231344|NCT01988376|20297189|P1|STARTED|Overall Study||129
8231345|NCT01988246|20297197|P2|NOT COMPLETED|Overall Study||0
8231346|NCT01988246|20297198|P1|NOT COMPLETED|Overall Study||1
8231347|NCT01988246|20297197|P2|COMPLETED|Overall Study||15
8231348|NCT01988246|20297198|P1|COMPLETED|Overall Study||14
8231349|NCT01988246|20297197|P2|STARTED|Overall Study||15
8231350|NCT01988246|20297198|P1|STARTED|Overall Study||15
8231351|NCT01988129|20297210|P2|NOT COMPLETED|Overall Study||0
8231352|NCT01988129|20297211|P1|NOT COMPLETED|Overall Study||0
8231353|NCT01988129|20297210|P2|COMPLETED|Overall Study||588
8231354|NCT01988129|20297211|P1|COMPLETED|Overall Study||601
8231355|NCT01988129|20297210|P2|Completed 1-year Follow-up Survey|Overall Study||4
8231356|NCT01988129|20297211|P1|Completed 1-year Follow-up Survey|Overall Study||100
8231357|NCT01988129|20297210|P2|Screened for Sleep Disorders|Overall Study||15
8231358|NCT01988129|20297211|P1|Screened for Sleep Disorders|Overall Study||416
8231359|NCT01988129|20297210|P2|Attended Education Session|Overall Study||18
8231360|NCT01988129|20297211|P1|Attended Education Session|Overall Study||542
8231361|NCT01988129|20297210|P2|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
8231362|NCT01988129|20297211|P1|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
8231363|NCT01988103|20297241|P5|NOT COMPLETED|Observational Follow-up Phase||0
8231364|NCT01988103|20297242|P4|NOT COMPLETED|Observational Follow-up Phase||0
8231365|NCT01988103|20297243|P3|NOT COMPLETED|Observational Follow-up Phase||1
8231366|NCT01988103|20297244|P2|NOT COMPLETED|Observational Follow-up Phase||3
8231367|NCT01988103|20297245|P1|NOT COMPLETED|Observational Follow-up Phase||0
8231368|NCT01988103|20297241|P5|COMPLETED|Observational Follow-up Phase||33
8231369|NCT01988103|20297242|P4|COMPLETED|Observational Follow-up Phase||36
8231370|NCT01988103|20297243|P3|COMPLETED|Observational Follow-up Phase||82
8231371|NCT01988103|20297244|P2|COMPLETED|Observational Follow-up Phase||79
8231372|NCT01988103|20297245|P1|COMPLETED|Observational Follow-up Phase||12
8231373|NCT01988103|20297241|P5|STARTED|Observational Follow-up Phase||33
8231374|NCT01988103|20297242|P4|STARTED|Observational Follow-up Phase||36
8231375|NCT01988103|20297243|P3|STARTED|Observational Follow-up Phase||83
8231376|NCT01988103|20297244|P2|STARTED|Observational Follow-up Phase||82
8231377|NCT01988103|20297245|P1|STARTED|Observational Follow-up Phase||12
8231378|NCT01988103|20297241|P5|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||5
8231379|NCT01988103|20297242|P4|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||3
8231380|NCT01988103|20297243|P3|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||11
8231381|NCT01988103|20297244|P2|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||13
8231382|NCT01988103|20297245|P1|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||0
8231383|NCT01988103|20297241|P5|COMPLETED|Active Treatment Phase (Weeks 16-68)||30
8231384|NCT01988103|20297242|P4|COMPLETED|Active Treatment Phase (Weeks 16-68)||33
8231385|NCT01988103|20297243|P3|COMPLETED|Active Treatment Phase (Weeks 16-68)||65
8231386|NCT01988103|20297244|P2|COMPLETED|Active Treatment Phase (Weeks 16-68)||56
8231387|NCT01988103|20297245|P1|COMPLETED|Active Treatment Phase (Weeks 16-68)||0
8231388|NCT01988103|20297241|P5|STARTED|Active Treatment Phase (Weeks 16-68)||35
8231389|NCT01988103|20297242|P4|STARTED|Active Treatment Phase (Weeks 16-68)||36
8231390|NCT01988103|20297243|P3|STARTED|Active Treatment Phase (Weeks 16-68)||76
8231391|NCT01988103|20297244|P2|STARTED|Active Treatment Phase (Weeks 16-68)||69
8231392|NCT01988103|20297245|P1|STARTED|Active Treatment Phase (Weeks 16-68)||0
8231393|NCT01988103|20297241|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
8231394|NCT01988103|20297242|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
8231395|NCT01988103|20297243|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||9
8231396|NCT01988103|20297244|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||16
8231397|NCT01988103|20297245|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||12
8231398|NCT01988103|20297241|P5|COMPLETED|Placebo-Controlled Phase Week 0-16||0
8231399|NCT01988103|20297242|P4|COMPLETED|Placebo-Controlled Phase Week 0-16||0
8231400|NCT01988103|20297243|P3|COMPLETED|Placebo-Controlled Phase Week 0-16||76
8231401|NCT01988103|20297244|P2|COMPLETED|Placebo-Controlled Phase Week 0-16||69
8231402|NCT01988103|20297245|P1|COMPLETED|Placebo-Controlled Phase Week 0-16||72
8231403|NCT01988103|20297241|P5|STARTED|Placebo-Controlled Phase Week 0-16||0
8231404|NCT01988103|20297242|P4|STARTED|Placebo-Controlled Phase Week 0-16||0
8231405|NCT01988103|20297243|P3|STARTED|Placebo-Controlled Phase Week 0-16||85
8231406|NCT01988103|20297244|P2|STARTED|Placebo-Controlled Phase Week 0-16||85
8231407|NCT01988103|20297245|P1|STARTED|Placebo-Controlled Phase Week 0-16||84
8231420|NCT01988012|20297303|P1|NOT COMPLETED|Overall Study||15
8231421|NCT01988012|20297303|P1|COMPLETED|Overall Study||85
8231422|NCT01988012|20297303|P1|STARTED|Overall Study||100
8231423|NCT01987986|20297329|P4|NOT COMPLETED|Overall Study||0
8231424|NCT01987986|20297330|P3|NOT COMPLETED|Overall Study||2
8231425|NCT01987986|20297331|P2|NOT COMPLETED|Overall Study||0
8231426|NCT01987986|20297332|P1|NOT COMPLETED|Overall Study||2
8231427|NCT01987986|20297329|P4|COMPLETED|Overall Study||24
8231428|NCT01987986|20297330|P3|COMPLETED|Overall Study||38
8231429|NCT01987986|20297331|P2|COMPLETED|Overall Study||43
8231430|NCT01987986|20297332|P1|COMPLETED|Overall Study||41
8231431|NCT01987986|20297329|P4|STARTED|Overall Study||24
8231432|NCT01987986|20297330|P3|STARTED|Overall Study||40
8231433|NCT01987986|20297331|P2|STARTED|Overall Study||43
8231434|NCT01987986|20297332|P1|STARTED|Overall Study||43
8231435|NCT01987960|20297372|P4|NOT COMPLETED|Period 3||71
8231436|NCT01987960|20297373|P3|NOT COMPLETED|Period 3||0
8231437|NCT01987960|20297374|P2|NOT COMPLETED|Period 3||0
8231438|NCT01987960|20297375|P1|NOT COMPLETED|Period 3||0
8231439|NCT01987960|20297372|P4|COMPLETED|Period 3||119
8231440|NCT01987960|20297373|P3|COMPLETED|Period 3||0
8231441|NCT01987960|20297374|P2|COMPLETED|Period 3||0
8231442|NCT01987960|20297375|P1|COMPLETED|Period 3||0
8231443|NCT01987960|20297372|P4|STARTED|Period 3||190
8231444|NCT01987960|20297373|P3|STARTED|Period 3||0
8231445|NCT01987960|20297374|P2|STARTED|Period 3||0
8231446|NCT01987960|20297375|P1|STARTED|Period 3||0
8231447|NCT01987960|20297372|P4|NOT COMPLETED|Period 2||0
8231448|NCT01987960|20297373|P3|NOT COMPLETED|Period 2||9
8231449|NCT01987960|20297374|P2|NOT COMPLETED|Period 2||5
8231450|NCT01987960|20297375|P1|NOT COMPLETED|Period 2||0
8231451|NCT01987960|20297372|P4|COMPLETED|Period 2||0
8231452|NCT01987960|20297373|P3|COMPLETED|Period 2||14
8231453|NCT01987960|20297374|P2|COMPLETED|Period 2||12
8231454|NCT01987960|20297375|P1|COMPLETED|Period 2||0
8231455|NCT01987960|20297372|P4|STARTED|Period 2||0
8231456|NCT01987960|20297373|P3|STARTED|Period 2||23
8231457|NCT01987960|20297374|P2|STARTED|Period 2||17
8231458|NCT01987960|20297375|P1|STARTED|Period 2||0
8231459|NCT01987960|20297372|P4|NOT COMPLETED|Period 1||0
8231460|NCT01987960|20297373|P3|NOT COMPLETED|Period 1||0
8231461|NCT01987960|20297374|P2|NOT COMPLETED|Period 1||0
8231462|NCT01987960|20297375|P1|NOT COMPLETED|Period 1||186
8231463|NCT01987960|20297372|P4|COMPLETED|Period 1||0
8231464|NCT01987960|20297373|P3|COMPLETED|Period 1||0
8231465|NCT01987960|20297374|P2|COMPLETED|Period 1||0
8231466|NCT01987960|20297375|P1|COMPLETED|Period 1||231
8231467|NCT01987960|20297372|P4|STARTED|Period 1||0
8231468|NCT01987960|20297373|P3|STARTED|Period 1||0
8231469|NCT01987960|20297374|P2|STARTED|Period 1||0
8231470|NCT01987960|20297375|P1|STARTED|Period 1||417
8231498|NCT01987895|20297472|P2|NOT COMPLETED|Overall Study||30
8231499|NCT01987895|20297473|P1|NOT COMPLETED|Overall Study||30
8231500|NCT01987895|20297472|P2|COMPLETED|Overall Study||296
8231501|NCT01987895|20297473|P1|COMPLETED|Overall Study||276
8231502|NCT01987895|20297472|P2|STARTED|Overall Study||326
8231503|NCT01987895|20297473|P1|STARTED|Overall Study||306
8231504|NCT01987830|20297497|P1|NOT COMPLETED|Overall Study||1
8231505|NCT01987830|20297497|P1|COMPLETED|Overall Study||12
8231506|NCT01987830|20297497|P1|STARTED|Overall Study||13
8231507|NCT01987765|20297501|P1|NOT COMPLETED|Overall Study||102
8231508|NCT01987765|20297501|P1|COMPLETED|Overall Study||745
8231509|NCT01987765|20297501|P1|STARTED|Overall Study||847
8231510|NCT01987752|20297506|P1|NOT COMPLETED|Overall Study||0
8231511|NCT01987752|20297506|P1|COMPLETED|Overall Study||732
8231512|NCT01987752|20297506|P1|STARTED|Overall Study||732
8231513|NCT01987609|20297511|P1|NOT COMPLETED|Overall Study||1
8231514|NCT01987609|20297511|P1|COMPLETED|Overall Study||6
8231515|NCT01987609|20297511|P1|Normal Saline Injected in Arm|Overall Study||6
8231516|NCT01987609|20297511|P1|Hylenex Injected in Arm|Overall Study||6
8231517|NCT01987609|20297511|P1|STARTED|Overall Study|one arm on one patient|7
8231518|NCT01987596|20297544|P2|NOT COMPLETED|Overall Study||1
8231519|NCT01987596|20297545|P1|NOT COMPLETED|Overall Study||1
8231520|NCT01987596|20297544|P2|COMPLETED|Overall Study||10
8231521|NCT01987596|20297545|P1|COMPLETED|Overall Study||11
8231522|NCT01987596|20297544|P2|STARTED|Overall Study||11
8231523|NCT01987596|20297545|P1|STARTED|Overall Study||12
8231524|NCT01987583|20297559|P2|NOT COMPLETED|Overall Study||2
8231525|NCT01987583|20297560|P1|NOT COMPLETED|Overall Study||3
8231526|NCT01987583|20297559|P2|COMPLETED|Overall Study||38
8231527|NCT01987583|20297560|P1|COMPLETED|Overall Study||37
8231528|NCT01987583|20297559|P2|STARTED|Overall Study||40
8231529|NCT01987583|20297560|P1|STARTED|Overall Study||40
8231530|NCT01987557|20297571|P3|NOT COMPLETED|Overall Study||3
8231531|NCT01987557|20297572|P2|NOT COMPLETED|Overall Study||3
8231532|NCT01987557|20297573|P1|NOT COMPLETED|Overall Study||3
8231533|NCT01987557|20297571|P3|COMPLETED|Overall Study||13
8231534|NCT01987557|20297572|P2|COMPLETED|Overall Study||13
8231535|NCT01987557|20297573|P1|COMPLETED|Overall Study||13
8231536|NCT01987557|20297571|P3|STARTED|Overall Study||16
8231537|NCT01987557|20297572|P2|STARTED|Overall Study||16
8231538|NCT01987557|20297573|P1|STARTED|Overall Study||16
8231539|NCT01987505|20297583|P1|NOT COMPLETED|Overall Study||34
8231540|NCT01987505|20297583|P1|COMPLETED|Overall Study||106
8231541|NCT01987505|20297583|P1|STARTED|Overall Study||140
8231542|NCT01987479|20297613|P1|NOT COMPLETED|Overall Study||17
8231543|NCT01987479|20297613|P1|COMPLETED|Overall Study||133
8231544|NCT01987479|20297613|P1|STARTED|Overall Study||150
8231545|NCT01987453|20297641|P3|NOT COMPLETED|Overall Study||1
8231546|NCT01987453|20297642|P2|NOT COMPLETED|Overall Study||12
8231547|NCT01987453|20297643|P1|NOT COMPLETED|Overall Study||1
8231548|NCT01987453|20297641|P3|COMPLETED|Overall Study||7
8231549|NCT01987453|20297642|P2|COMPLETED|Overall Study||29
8231550|NCT01987453|20297643|P1|COMPLETED|Overall Study||50
8231551|NCT01987453|20297641|P3|STARTED|Overall Study||8
8231552|NCT01987453|20297642|P2|STARTED|Overall Study||41
8231553|NCT01987453|20297643|P1|STARTED|Overall Study||51
8231554|NCT01987427|20297669|P3|NOT COMPLETED|Overall Study||20
8231555|NCT01987427|20297670|P2|NOT COMPLETED|Overall Study||10
8231556|NCT01987427|20297671|P1|NOT COMPLETED|Overall Study||14
8231557|NCT01987427|20297669|P3|COMPLETED|Overall Study||59
8231558|NCT01987427|20297670|P2|COMPLETED|Overall Study||68
8231559|NCT01987427|20297671|P1|COMPLETED|Overall Study||64
8231560|NCT01987427|20297669|P3|STARTED|Overall Study||79
8231561|NCT01987427|20297670|P2|STARTED|Overall Study||78
8231562|NCT01987427|20297671|P1|STARTED|Overall Study||78
8231563|NCT01987414|20297702|P2|NOT COMPLETED|Overall Study||2
8231564|NCT01987414|20297703|P1|NOT COMPLETED|Overall Study||2
8231565|NCT01987414|20297702|P2|COMPLETED|Overall Study||6
8231566|NCT01987414|20297703|P1|COMPLETED|Overall Study||8
8231567|NCT01987414|20297702|P2|STARTED|Overall Study||8
8231568|NCT01987414|20297703|P1|STARTED|Overall Study||10
8231569|NCT01987401|20297752|P3|NOT COMPLETED|Overall Study||44
8231570|NCT01987401|20297753|P2|NOT COMPLETED|Overall Study||470
8231571|NCT01987401|20297754|P1|NOT COMPLETED|Overall Study||454
8231572|NCT01987401|20297752|P3|COMPLETED|Overall Study||16
8231573|NCT01987401|20297753|P2|COMPLETED|Overall Study||121
8231574|NCT01987401|20297754|P1|COMPLETED|Overall Study||137
8231575|NCT01987401|20297752|P3|STARTED|Overall Study||60
8231576|NCT01987401|20297753|P2|STARTED|Overall Study||591
8231577|NCT01987401|20297754|P1|STARTED|Overall Study||591
8231578|NCT01987349|20297770|P8|NOT COMPLETED|Overall Study||1
8231579|NCT01987349|20297771|P7|NOT COMPLETED|Overall Study||0
8231580|NCT01987349|20297772|P6|NOT COMPLETED|Overall Study||0
8231581|NCT01987349|20297773|P5|NOT COMPLETED|Overall Study||0
8231582|NCT01987349|20297774|P4|NOT COMPLETED|Overall Study||0
8231583|NCT01987349|20297775|P3|NOT COMPLETED|Overall Study||0
8231584|NCT01987349|20297776|P2|NOT COMPLETED|Overall Study||0
8231585|NCT01987349|20297777|P1|NOT COMPLETED|Overall Study||0
8231586|NCT01987349|20297770|P8|COMPLETED|Overall Study||24
8231587|NCT01987349|20297771|P7|COMPLETED|Overall Study||10
8231588|NCT01987349|20297772|P6|COMPLETED|Overall Study||6
8231589|NCT01987349|20297773|P5|COMPLETED|Overall Study||6
8231590|NCT01987349|20297774|P4|COMPLETED|Overall Study||6
8231591|NCT01987349|20297775|P3|COMPLETED|Overall Study||8
8231592|NCT01987349|20297776|P2|COMPLETED|Overall Study||6
8231593|NCT01987349|20297777|P1|COMPLETED|Overall Study||6
8231594|NCT01987349|20297770|P8|STARTED|Overall Study||25
8231595|NCT01987349|20297771|P7|STARTED|Overall Study||10
8231596|NCT01987349|20297772|P6|STARTED|Overall Study||6
8231597|NCT01987349|20297773|P5|STARTED|Overall Study||6
8231598|NCT01987349|20297774|P4|STARTED|Overall Study||6
8231599|NCT01987349|20297775|P3|STARTED|Overall Study||8
8231600|NCT01987349|20297776|P2|STARTED|Overall Study||6
8231601|NCT01987349|20297777|P1|STARTED|Overall Study||6
8231602|NCT01987232|20297808|P5|NOT COMPLETED|Overall Study||0
8231603|NCT01987232|20297809|P4|NOT COMPLETED|Overall Study||1
8231604|NCT01987232|20297810|P3|NOT COMPLETED|Overall Study||0
8231605|NCT01987232|20297811|P2|NOT COMPLETED|Overall Study||0
8231606|NCT01987232|20297812|P1|NOT COMPLETED|Overall Study||0
8231607|NCT01987232|20297808|P5|COMPLETED|Overall Study||6
8231608|NCT01987232|20297809|P4|COMPLETED|Overall Study||14
8231609|NCT01987232|20297810|P3|COMPLETED|Overall Study||3
8231610|NCT01987232|20297811|P2|COMPLETED|Overall Study||3
8231611|NCT01987232|20297812|P1|COMPLETED|Overall Study||5
8231612|NCT01987232|20297808|P5|STARTED|Overall Study||6
8231613|NCT01987232|20297809|P4|STARTED|Overall Study||15
8231614|NCT01987232|20297810|P3|STARTED|Overall Study||3
8231615|NCT01987232|20297811|P2|STARTED|Overall Study||3
8231616|NCT01987232|20297812|P1|STARTED|Overall Study||5
8231617|NCT01987219|20297877|P6|NOT COMPLETED|Overall Study||0
8231618|NCT01987219|20297878|P5|NOT COMPLETED|Overall Study||0
8231619|NCT01987219|20297879|P4|NOT COMPLETED|Overall Study||0
8231620|NCT01987219|20297880|P3|NOT COMPLETED|Overall Study||1
8231621|NCT01987219|20297881|P2|NOT COMPLETED|Overall Study||0
8231622|NCT01987219|20297882|P1|NOT COMPLETED|Overall Study||0
8231623|NCT01987219|20297877|P6|COMPLETED|Overall Study||1
8231624|NCT01987219|20297878|P5|COMPLETED|Overall Study||1
8231625|NCT01987219|20297879|P4|COMPLETED|Overall Study||2
8231626|NCT01987219|20297880|P3|COMPLETED|Overall Study||6
8231627|NCT01987219|20297881|P2|COMPLETED|Overall Study||2
8231628|NCT01987219|20297882|P1|COMPLETED|Overall Study||2
8231629|NCT01987219|20297877|P6|STARTED|Overall Study||1
8231630|NCT01987219|20297878|P5|STARTED|Overall Study||1
8231631|NCT01987219|20297879|P4|STARTED|Overall Study||2
8231632|NCT01987219|20297880|P3|STARTED|Overall Study||7
8231633|NCT01987219|20297881|P2|STARTED|Overall Study||2
8231634|NCT01987219|20297882|P1|STARTED|Overall Study||2
8231635|NCT01987102|20297901|P2|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1
8231636|NCT01987102|20297902|P1|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0
8231637|NCT01987102|20297901|P2|COMPLETED|2 Courses of HDMTX With MOD Rescue||3
8231638|NCT01987102|20297902|P1|COMPLETED|2 Courses of HDMTX With MOD Rescue||4
8231639|NCT01987102|20297901|P2|STARTED|2 Courses of HDMTX With MOD Rescue||4
8231640|NCT01987102|20297902|P1|STARTED|2 Courses of HDMTX With MOD Rescue||4
8231641|NCT01987102|20297901|P2|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6
8231642|NCT01987102|20297902|P1|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4
8231643|NCT01987102|20297901|P2|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
8231644|NCT01987102|20297902|P1|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
8231645|NCT01987102|20297901|P2|STARTED|2 Courses of HDMTX With SOC Rescue||10
8231646|NCT01987102|20297902|P1|STARTED|2 Courses of HDMTX With SOC Rescue||8
8231647|NCT01987089|20297936|P2|NOT COMPLETED|Overall Study||4
8231648|NCT01987089|20297937|P1|NOT COMPLETED|Overall Study||1
8231649|NCT01987089|20297936|P2|COMPLETED|Overall Study||28
8231650|NCT01987089|20297937|P1|COMPLETED|Overall Study||30
8231651|NCT01987089|20297936|P2|STARTED|Overall Study||32
8231652|NCT01987089|20297937|P1|STARTED|Overall Study||31
8231653|NCT01986985|20297949|P1|NOT COMPLETED|Overall Study||7
8231654|NCT01986985|20297949|P1|COMPLETED|Overall Study||51
8231655|NCT01986985|20297949|P1|STARTED|Overall Study||58
8231656|NCT01986946|20297955|P2|NOT COMPLETED|Overall Study||0
8231657|NCT01986946|20297956|P1|NOT COMPLETED|Overall Study||0
8231658|NCT01986946|20297955|P2|COMPLETED|Overall Study||9
8231659|NCT01986946|20297956|P1|COMPLETED|Overall Study||5
8231660|NCT01986946|20297955|P2|STARTED|Overall Study||9
8231661|NCT01986946|20297956|P1|STARTED|Overall Study||5
8231662|NCT01986920|20297986|P4|NOT COMPLETED|Placebo||1
8231663|NCT01986920|20297987|P3|NOT COMPLETED|Placebo||0
8231664|NCT01986920|20297988|P2|NOT COMPLETED|Placebo||0
8231665|NCT01986920|20297989|P1|NOT COMPLETED|Placebo||0
8231666|NCT01986920|20297986|P4|COMPLETED|Placebo||34
8231667|NCT01986920|20297987|P3|COMPLETED|Placebo||0
8231668|NCT01986920|20297988|P2|COMPLETED|Placebo||0
8231669|NCT01986920|20297989|P1|COMPLETED|Placebo||0
8231670|NCT01986920|20297986|P4|STARTED|Placebo||35
8231671|NCT01986920|20297987|P3|STARTED|Placebo||0
8231672|NCT01986920|20297988|P2|STARTED|Placebo||0
8231673|NCT01986920|20297989|P1|STARTED|Placebo||0
8231674|NCT01986920|20297986|P4|NOT COMPLETED|A-101 40%||0
8231675|NCT01986920|20297987|P3|NOT COMPLETED|A-101 40%||1
8231676|NCT01986920|20297988|P2|NOT COMPLETED|A-101 40%||0
8231677|NCT01986920|20297989|P1|NOT COMPLETED|A-101 40%||0
8231678|NCT01986920|20297986|P4|COMPLETED|A-101 40%||0
8231679|NCT01986920|20297987|P3|COMPLETED|A-101 40%||34
8231680|NCT01986920|20297988|P2|COMPLETED|A-101 40%||0
8231681|NCT01986920|20297989|P1|COMPLETED|A-101 40%||0
8231682|NCT01986920|20297986|P4|STARTED|A-101 40%||0
8231683|NCT01986920|20297987|P3|STARTED|A-101 40%||35
8231684|NCT01986920|20297988|P2|STARTED|A-101 40%||0
8231685|NCT01986920|20297989|P1|STARTED|A-101 40%||0
8231686|NCT01986920|20297986|P4|NOT COMPLETED|A-101 32.5%||0
8231687|NCT01986920|20297987|P3|NOT COMPLETED|A-101 32.5%||0
8231688|NCT01986920|20297988|P2|NOT COMPLETED|A-101 32.5%||1
8231689|NCT01986920|20297989|P1|NOT COMPLETED|A-101 32.5%||0
8231690|NCT01986920|20297986|P4|COMPLETED|A-101 32.5%||0
8231691|NCT01986920|20297987|P3|COMPLETED|A-101 32.5%||0
8231692|NCT01986920|20297988|P2|COMPLETED|A-101 32.5%||34
8231693|NCT01986920|20297989|P1|COMPLETED|A-101 32.5%||0
8231694|NCT01986920|20297986|P4|STARTED|A-101 32.5%||0
8231695|NCT01986920|20297987|P3|STARTED|A-101 32.5%||0
8231696|NCT01986920|20297988|P2|STARTED|A-101 32.5%||35
8231697|NCT01986920|20297989|P1|STARTED|A-101 32.5%||0
8231698|NCT01986920|20297986|P4|NOT COMPLETED|A- 101 25%||0
8231699|NCT01986920|20297987|P3|NOT COMPLETED|A- 101 25%||0
8231700|NCT01986920|20297988|P2|NOT COMPLETED|A- 101 25%||0
8231701|NCT01986920|20297989|P1|NOT COMPLETED|A- 101 25%||1
8231702|NCT01986920|20297986|P4|COMPLETED|A- 101 25%||0
8231703|NCT01986920|20297987|P3|COMPLETED|A- 101 25%||0
8231704|NCT01986920|20297988|P2|COMPLETED|A- 101 25%||0
8231705|NCT01986920|20297989|P1|COMPLETED|A- 101 25%||34
8231706|NCT01986920|20297986|P4|STARTED|A- 101 25%||0
8231707|NCT01986920|20297987|P3|STARTED|A- 101 25%||0
8231708|NCT01986920|20297988|P2|STARTED|A- 101 25%||0
8231709|NCT01986920|20297989|P1|STARTED|A- 101 25%||35
8231710|NCT01986907|20298003|P1|NOT COMPLETED|Overall Study||162
8231711|NCT01986907|20298003|P1|COMPLETED|Overall Study||774
8231712|NCT01986907|20298003|P1|STARTED|Overall Study||936
8231713|NCT01986855|20298016|P3|NOT COMPLETED|Overall Study||11
8231714|NCT01986855|20298017|P2|NOT COMPLETED|Overall Study||14
8231715|NCT01986855|20298018|P1|NOT COMPLETED|Overall Study||13
8231716|NCT01986855|20298016|P3|COMPLETED|Overall Study||143
8231717|NCT01986855|20298017|P2|COMPLETED|Overall Study||142
8231718|NCT01986855|20298018|P1|COMPLETED|Overall Study||145
8231719|NCT01986855|20298016|P3|Treated|Overall Study||154
8231720|NCT01986855|20298017|P2|Treated|Overall Study||155
8231721|NCT01986855|20298018|P1|Treated|Overall Study||158
8231722|NCT01986855|20298016|P3|STARTED|Overall Study||154
8231723|NCT01986855|20298017|P2|STARTED|Overall Study||156
8231724|NCT01986855|20298018|P1|STARTED|Overall Study||158
8231725|NCT01986829|20298047|P1|NOT COMPLETED|Overall Study||1
8231726|NCT01986829|20298047|P1|COMPLETED|Overall Study||8
8231727|NCT01986829|20298047|P1|STARTED|Overall Study||9
8231728|NCT01986790|20298077|P3|NOT COMPLETED|Overall Study||0
8231729|NCT01986790|20298078|P2|NOT COMPLETED|Overall Study||0
8231730|NCT01986790|20298079|P1|NOT COMPLETED|Overall Study||0
8231731|NCT01986790|20298077|P3|COMPLETED|Overall Study||98
8231732|NCT01986790|20298078|P2|COMPLETED|Overall Study||154
8231733|NCT01986790|20298079|P1|COMPLETED|Overall Study||91
8231734|NCT01986790|20298077|P3|STARTED|Overall Study||98
8231735|NCT01986790|20298078|P2|STARTED|Overall Study||154
8231736|NCT01986790|20298079|P1|STARTED|Overall Study||91
8231737|NCT01986751|20298095|P2|NOT COMPLETED|Overall Study||2
8231738|NCT01986751|20298096|P1|NOT COMPLETED|Overall Study||10
8231739|NCT01986751|20298095|P2|COMPLETED|Overall Study||2
8231740|NCT01986751|20298096|P1|COMPLETED|Overall Study||0
8231741|NCT01986751|20298095|P2|STARTED|Overall Study||4
8231742|NCT01986751|20298096|P1|STARTED|Overall Study||10
8231743|NCT01986686|20298118|P2|NOT COMPLETED|Overall Study||0
8231744|NCT01986686|20298119|P1|NOT COMPLETED|Overall Study||0
8231745|NCT01986686|20298118|P2|COMPLETED|Overall Study||26
8231746|NCT01986686|20298119|P1|COMPLETED|Overall Study||81
8231747|NCT01986686|20298118|P2|STARTED|Overall Study||26
8231748|NCT01986686|20298119|P1|STARTED|Overall Study||81
8231749|NCT01986647|20298129|P4|NOT COMPLETED|Overall Study||11
8231750|NCT01986647|20298130|P3|NOT COMPLETED|Overall Study||12
8231751|NCT01986647|20298131|P2|NOT COMPLETED|Overall Study||7
8231752|NCT01986647|20298132|P1|NOT COMPLETED|Overall Study||10
8231753|NCT01986647|20298129|P4|COMPLETED|Overall Study||66
8231754|NCT01986647|20298130|P3|COMPLETED|Overall Study||37
8231755|NCT01986647|20298131|P2|COMPLETED|Overall Study||139
8231756|NCT01986647|20298132|P1|COMPLETED|Overall Study||142
8231757|NCT01986647|20298129|P4|STARTED|Overall Study||77
8231758|NCT01986647|20298130|P3|STARTED|Overall Study||49
8231759|NCT01986647|20298131|P2|STARTED|Overall Study||146
8231760|NCT01986647|20298132|P1|STARTED|Overall Study||152
8231761|NCT01986361|20298204|P2|NOT COMPLETED|Overall Study||0
8231762|NCT01986361|20298205|P1|NOT COMPLETED|Overall Study||0
8231763|NCT01986361|20298204|P2|COMPLETED|Overall Study||21
8231764|NCT01986361|20298205|P1|COMPLETED|Overall Study||101
8231765|NCT01986361|20298204|P2|STARTED|Overall Study||21
8231766|NCT01986361|20298205|P1|STARTED|Overall Study||101
8231767|NCT01986231|20298227|P1|NOT COMPLETED|Overall Study||1
8231768|NCT01986231|20298227|P1|COMPLETED|Overall Study||11
8231769|NCT01986231|20298227|P1|STARTED|Overall Study||12
8231776|NCT01986114|20298241|P1|NOT COMPLETED|Overall Study||156
8231777|NCT01986114|20298241|P1|COMPLETED|Overall Study||339
8231778|NCT01986114|20298241|P1|STARTED|Overall Study||495
8231779|NCT01986101|20298256|P3|NOT COMPLETED|Overall Study||32
8231780|NCT01986101|20298257|P2|NOT COMPLETED|Overall Study||27
8231781|NCT01986101|20298258|P1|NOT COMPLETED|Overall Study||33
8231782|NCT01986101|20298256|P3|COMPLETED|Overall Study||137
8231783|NCT01986101|20298257|P2|COMPLETED|Overall Study||157
8231784|NCT01986101|20298258|P1|COMPLETED|Overall Study||139
8231785|NCT01986101|20298256|P3|Safety Population|Overall Study||169
8231786|NCT01986101|20298257|P2|Safety Population|Overall Study||184
8231787|NCT01986101|20298258|P1|Safety Population|Overall Study||172
8231788|NCT01986101|20298256|P3|Intent-to-Treat Population|Overall Study||169
8231789|NCT01986101|20298257|P2|Intent-to-Treat Population|Overall Study||182
8231790|NCT01986101|20298258|P1|Intent-to-Treat Population|Overall Study||171
8231791|NCT01986101|20298256|P3|STARTED|Overall Study||169
8231792|NCT01986101|20298257|P2|STARTED|Overall Study||184
8231793|NCT01986101|20298258|P1|STARTED|Overall Study||172
8231794|NCT01986062|20298280|P2|NOT COMPLETED|Overall Study||1
8231795|NCT01986062|20298281|P1|NOT COMPLETED|Overall Study||1
8231796|NCT01986062|20298280|P2|COMPLETED|Overall Study||49
8231797|NCT01986062|20298281|P1|COMPLETED|Overall Study||46
8231798|NCT01986062|20298280|P2|STARTED|Overall Study||50
8231799|NCT01986062|20298281|P1|STARTED|Overall Study||47
8231800|NCT01985971|20298297|P1|NOT COMPLETED|Overall Study||1
8231801|NCT01985971|20298297|P1|COMPLETED|Overall Study||1
8231802|NCT01985971|20298297|P1|STARTED|Overall Study||2
8231803|NCT01985958|20298301|P1|NOT COMPLETED|Overall Study||1
8231804|NCT01985958|20298301|P1|COMPLETED|Overall Study||3
8231805|NCT01985958|20298301|P1|STARTED|Overall Study||4
8231806|NCT01985932|20298305|P1|NOT COMPLETED|Overall Study||0
8231807|NCT01985932|20298305|P1|COMPLETED|Overall Study||15
8231808|NCT01985932|20298305|P1|STARTED|Overall Study||15
8231809|NCT01985763|20298309|P1|NOT COMPLETED|Overall Study||0
8231810|NCT01985763|20298309|P1|COMPLETED|Overall Study||13
8231811|NCT01985763|20298309|P1|STARTED|Overall Study||13
8231812|NCT01985685|20298324|P2|NOT COMPLETED|Overall Study||0
8231813|NCT01985685|20298325|P1|NOT COMPLETED|Overall Study||0
8231814|NCT01985685|20298324|P2|COMPLETED|Overall Study||29
8231815|NCT01985685|20298325|P1|COMPLETED|Overall Study||27
8231816|NCT01985685|20298324|P2|STARTED|Overall Study||29
8231817|NCT01985685|20298325|P1|STARTED|Overall Study||27
8231818|NCT01985581|20298337|P2|NOT COMPLETED|Second Intervention||4
8231819|NCT01985581|20298338|P1|NOT COMPLETED|Second Intervention||2
8231820|NCT01985581|20298337|P2|COMPLETED|Second Intervention||19
8231821|NCT01985581|20298338|P1|COMPLETED|Second Intervention||20
8231822|NCT01985581|20298337|P2|STARTED|Second Intervention||23
8231823|NCT01985581|20298338|P1|STARTED|Second Intervention||22
8231824|NCT01985581|20298337|P2|NOT COMPLETED|First Intervention||2
8231825|NCT01985581|20298338|P1|NOT COMPLETED|First Intervention||3
8231826|NCT01985581|20298337|P2|COMPLETED|First Intervention||23
8231827|NCT01985581|20298338|P1|COMPLETED|First Intervention||22
8231828|NCT01985581|20298337|P2|STARTED|First Intervention||25
8231829|NCT01985581|20298338|P1|STARTED|First Intervention||25
8231830|NCT01985425|20298358|P2|NOT COMPLETED|Overall Study||0
8231831|NCT01985425|20298359|P1|NOT COMPLETED|Overall Study||0
8231832|NCT01985425|20298358|P2|COMPLETED|Overall Study||51
8231833|NCT01985425|20298359|P1|COMPLETED|Overall Study||49
8231834|NCT01985425|20298358|P2|STARTED|Overall Study||51
8231835|NCT01985425|20298359|P1|STARTED|Overall Study||49
8231836|NCT01985360|20298379|P2|NOT COMPLETED|Overall Study||3
8231837|NCT01985360|20298380|P1|NOT COMPLETED|Overall Study||9
8231838|NCT01985360|20298379|P2|COMPLETED|Overall Study||386
8231839|NCT01985360|20298380|P1|COMPLETED|Overall Study||379
8231840|NCT01985360|20298379|P2|STARTED|Overall Study||389
8231841|NCT01985360|20298380|P1|STARTED|Overall Study||388
8231842|NCT01985334|20298396|P8|NOT COMPLETED|Overall Study||121
8231843|NCT01985334|20298397|P7|NOT COMPLETED|Overall Study||37
8231844|NCT01985334|20298398|P6|NOT COMPLETED|Overall Study||156
8231845|NCT01985334|20298399|P5|NOT COMPLETED|Overall Study||40
8231846|NCT01985334|20298400|P4|NOT COMPLETED|Overall Study||229
8231847|NCT01985334|20298401|P3|NOT COMPLETED|Overall Study||53
8231848|NCT01985334|20298402|P2|NOT COMPLETED|Overall Study||84
8231849|NCT01985334|20298403|P1|NOT COMPLETED|Overall Study||23
8231850|NCT01985334|20298396|P8|COMPLETED|Overall Study||699
8231851|NCT01985334|20298397|P7|COMPLETED|Overall Study||237
8231852|NCT01985334|20298398|P6|COMPLETED|Overall Study||666
8231853|NCT01985334|20298399|P5|COMPLETED|Overall Study||234
8231854|NCT01985334|20298400|P4|COMPLETED|Overall Study||1033
8231855|NCT01985334|20298401|P3|COMPLETED|Overall Study||367
8231856|NCT01985334|20298402|P2|COMPLETED|Overall Study||303
8231857|NCT01985334|20298403|P1|COMPLETED|Overall Study||107
8231858|NCT01985334|20298396|P8|The Intention-to-treat (ITT) Population|Overall Study||811
8231859|NCT01985334|20298397|P7|The Intention-to-treat (ITT) Population|Overall Study||268
8231860|NCT01985334|20298398|P6|The Intention-to-treat (ITT) Population|Overall Study||811
8231861|NCT01985334|20298399|P5|The Intention-to-treat (ITT) Population|Overall Study||269
8231862|NCT01985334|20298400|P4|The Intention-to-treat (ITT) Population|Overall Study||1254
8231863|NCT01985334|20298401|P3|The Intention-to-treat (ITT) Population|Overall Study||420
8231864|NCT01985334|20298402|P2|The Intention-to-treat (ITT) Population|Overall Study||369
8231865|NCT01985334|20298403|P1|The Intention-to-treat (ITT) Population|Overall Study||122
8231866|NCT01985334|20298396|P8|STARTED|Overall Study||820
8231867|NCT01985334|20298397|P7|STARTED|Overall Study||274
8231868|NCT01985334|20298398|P6|STARTED|Overall Study||822
8231869|NCT01985334|20298399|P5|STARTED|Overall Study||274
8231870|NCT01985334|20298400|P4|STARTED|Overall Study||1262
8231871|NCT01985334|20298401|P3|STARTED|Overall Study||420
8231872|NCT01985334|20298402|P2|STARTED|Overall Study||387
8231873|NCT01985334|20298403|P1|STARTED|Overall Study||130
8231874|NCT01985321|20298471|P2|NOT COMPLETED|Overall Study||5
8231875|NCT01985321|20298472|P1|NOT COMPLETED|Overall Study||11
8231876|NCT01985321|20298471|P2|COMPLETED|Overall Study||78
8231877|NCT01985321|20298472|P1|COMPLETED|Overall Study||79
8231878|NCT01985321|20298471|P2|STARTED|Overall Study|This is treatment eligible subjects only|83
8231879|NCT01985321|20298472|P1|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
8231880|NCT01985126|20298482|P2|NOT COMPLETED|Overall Study||106
8231881|NCT01985126|20298483|P1|NOT COMPLETED|Overall Study||18
8231882|NCT01985126|20298482|P2|COMPLETED|Overall Study||0
8231883|NCT01985126|20298483|P1|COMPLETED|Overall Study||0
8231884|NCT01985126|20298482|P2|STARTED|Overall Study||106
8231885|NCT01985126|20298483|P1|STARTED|Overall Study||18
8231886|NCT01984892|20298501|P1|NOT COMPLETED|Overall Study||7
8231887|NCT01984892|20298501|P1|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
8231888|NCT01984892|20298501|P1|STARTED|Overall Study||8
8231889|NCT01984697|20298512|P5|NOT COMPLETED|Overall Study||35
8231890|NCT01984697|20298513|P4|NOT COMPLETED|Overall Study||21
8231891|NCT01984697|20298514|P3|NOT COMPLETED|Overall Study||29
8231892|NCT01984697|20298515|P2|NOT COMPLETED|Overall Study||31
8231893|NCT01984697|20298516|P1|NOT COMPLETED|Overall Study||43
8231894|NCT01984697|20298512|P5|COMPLETED|Overall Study||279
8231895|NCT01984697|20298513|P4|COMPLETED|Overall Study||280
8231896|NCT01984697|20298514|P3|COMPLETED|Overall Study||272
8231897|NCT01984697|20298515|P2|COMPLETED|Overall Study||270
8231898|NCT01984697|20298516|P1|COMPLETED|Overall Study||258
8231899|NCT01984697|20298512|P5|Month 36 Vaccination|Overall Study||31
8231900|NCT01984697|20298513|P4|Month 36 Vaccination|Overall Study||9
8231901|NCT01984697|20298514|P3|Month 36 Vaccination|Overall Study||280
8231902|NCT01984697|20298515|P2|Month 36 Vaccination|Overall Study||281
8231903|NCT01984697|20298516|P1|Month 36 Vaccination|Overall Study||270
8231904|NCT01984697|20298512|P5|Vaccination 3|Overall Study||311
8231905|NCT01984697|20298513|P4|Vaccination 3|Overall Study||293
8231906|NCT01984697|20298514|P3|Vaccination 3|Overall Study||0
8231907|NCT01984697|20298515|P2|Vaccination 3|Overall Study||0
8231908|NCT01984697|20298516|P1|Vaccination 3|Overall Study||0
8231909|NCT01984697|20298512|P5|Vaccination 2|Overall Study||313
8231910|NCT01984697|20298513|P4|Vaccination 2|Overall Study||298
8231911|NCT01984697|20298514|P3|Vaccination 2|Overall Study||291
8231912|NCT01984697|20298515|P2|Vaccination 2|Overall Study||296
8231913|NCT01984697|20298516|P1|Vaccination 2|Overall Study||293
8231914|NCT01984697|20298512|P5|Vaccination 1|Overall Study||314
8231915|NCT01984697|20298513|P4|Vaccination 1|Overall Study||300
8231916|NCT01984697|20298514|P3|Vaccination 1|Overall Study||300
8231917|NCT01984697|20298515|P2|Vaccination 1|Overall Study||301
8231918|NCT01984697|20298516|P1|Vaccination 1|Overall Study||301
8231919|NCT01984697|20298512|P5|STARTED|Overall Study||314
8231920|NCT01984697|20298513|P4|STARTED|Overall Study||301
8231921|NCT01984697|20298514|P3|STARTED|Overall Study||301
8231922|NCT01984697|20298515|P2|STARTED|Overall Study||301
8231923|NCT01984697|20298516|P1|STARTED|Overall Study||301
8231924|NCT01984684|20298635|P2|NOT COMPLETED|Overall Study||59
8231925|NCT01984684|20298636|P1|NOT COMPLETED|Overall Study||57
8231926|NCT01984684|20298635|P2|COMPLETED|Overall Study||368
8231927|NCT01984684|20298636|P1|COMPLETED|Overall Study||366
8231928|NCT01984684|20298635|P2|STARTED|Overall Study||427
8231929|NCT01984684|20298636|P1|STARTED|Overall Study||423
8231930|NCT01984515|20298646|P1|NOT COMPLETED|Overall Study||19
8231931|NCT01984515|20298646|P1|COMPLETED|Overall Study||40
8231932|NCT01984515|20298646|P1|Received CBT Session|Overall Study||40
8231933|NCT01984515|20298646|P1|STARTED|Overall Study||59
8231934|NCT01984424|20298654|P2|NOT COMPLETED|Overall Study||7
8231935|NCT01984424|20298655|P1|NOT COMPLETED|Overall Study||3
8231936|NCT01984424|20298654|P2|COMPLETED|Overall Study||138
8231937|NCT01984424|20298655|P1|COMPLETED|Overall Study||70
8231938|NCT01984424|20298654|P2|STARTED|Overall Study||145
8231939|NCT01984424|20298655|P1|STARTED|Overall Study||73
8231940|NCT01984398|20298709|P4|NOT COMPLETED|Treatment Period 2||0
8231941|NCT01984398|20298710|P3|NOT COMPLETED|Treatment Period 2||0
8231942|NCT01984398|20298711|P2|NOT COMPLETED|Treatment Period 2||0
8231943|NCT01984398|20298712|P1|NOT COMPLETED|Treatment Period 2||0
8231944|NCT01984398|20298709|P4|COMPLETED|Treatment Period 2||4
8231945|NCT01984398|20298710|P3|COMPLETED|Treatment Period 2||4
8231946|NCT01984398|20298711|P2|COMPLETED|Treatment Period 2||4
8231947|NCT01984398|20298712|P1|COMPLETED|Treatment Period 2||4
8231948|NCT01984398|20298709|P4|STARTED|Treatment Period 2||4
8231949|NCT01984398|20298710|P3|STARTED|Treatment Period 2||4
8231950|NCT01984398|20298711|P2|STARTED|Treatment Period 2||4
8231951|NCT01984398|20298712|P1|STARTED|Treatment Period 2||4
8231952|NCT01984398|20298709|P4|NOT COMPLETED|Washout Period of 5 to 7 Days||0
8231953|NCT01984398|20298710|P3|NOT COMPLETED|Washout Period of 5 to 7 Days||0
8231954|NCT01984398|20298711|P2|NOT COMPLETED|Washout Period of 5 to 7 Days||0
8231955|NCT01984398|20298712|P1|NOT COMPLETED|Washout Period of 5 to 7 Days||0
8231956|NCT01984398|20298709|P4|COMPLETED|Washout Period of 5 to 7 Days||4
8231957|NCT01984398|20298710|P3|COMPLETED|Washout Period of 5 to 7 Days||4
8231958|NCT01984398|20298711|P2|COMPLETED|Washout Period of 5 to 7 Days||4
8231959|NCT01984398|20298712|P1|COMPLETED|Washout Period of 5 to 7 Days||4
8231960|NCT01984398|20298709|P4|STARTED|Washout Period of 5 to 7 Days||4
8231961|NCT01984398|20298710|P3|STARTED|Washout Period of 5 to 7 Days||4
8231962|NCT01984398|20298711|P2|STARTED|Washout Period of 5 to 7 Days||4
8231963|NCT01984398|20298712|P1|STARTED|Washout Period of 5 to 7 Days||4
8231964|NCT01984398|20298709|P4|NOT COMPLETED|Treatment Period 1||0
8231965|NCT01984398|20298710|P3|NOT COMPLETED|Treatment Period 1||0
8231966|NCT01984398|20298711|P2|NOT COMPLETED|Treatment Period 1||0
8231967|NCT01984398|20298712|P1|NOT COMPLETED|Treatment Period 1||0
8231968|NCT01984398|20298709|P4|COMPLETED|Treatment Period 1||4
8231969|NCT01984398|20298710|P3|COMPLETED|Treatment Period 1||4
8231970|NCT01984398|20298711|P2|COMPLETED|Treatment Period 1||4
8231971|NCT01984398|20298712|P1|COMPLETED|Treatment Period 1||4
8231972|NCT01984398|20298709|P4|STARTED|Treatment Period 1||4
8231973|NCT01984398|20298710|P3|STARTED|Treatment Period 1||4
8231974|NCT01984398|20298711|P2|STARTED|Treatment Period 1||4
8231975|NCT01984398|20298712|P1|STARTED|Treatment Period 1||4
8231976|NCT01984294|20298725|P3|NOT COMPLETED|Overall Study||7
8231977|NCT01984294|20298726|P2|NOT COMPLETED|Overall Study||3
8231978|NCT01984294|20298727|P1|NOT COMPLETED|Overall Study||4
8231979|NCT01984294|20298725|P3|COMPLETED|Overall Study||27
8231980|NCT01984294|20298726|P2|COMPLETED|Overall Study||29
8231981|NCT01984294|20298727|P1|COMPLETED|Overall Study||31
8231982|NCT01984294|20298725|P3|STARTED|Overall Study||34
8231983|NCT01984294|20298726|P2|STARTED|Overall Study||32
8231984|NCT01984294|20298727|P1|STARTED|Overall Study||35
8231985|NCT01984268|20298747|P1|NOT COMPLETED|Overall Study||15
8231986|NCT01984268|20298747|P1|COMPLETED|Overall Study||0
8231987|NCT01984268|20298747|P1|STARTED|Overall Study||15
8231988|NCT01984242|20298759|P3|NOT COMPLETED|Overall Study||101
8231989|NCT01984242|20298760|P2|NOT COMPLETED|Overall Study||103
8231990|NCT01984242|20298761|P1|NOT COMPLETED|Overall Study||101
8231991|NCT01984242|20298759|P3|COMPLETED|Overall Study||0
8231992|NCT01984242|20298760|P2|COMPLETED|Overall Study||0
8231993|NCT01984242|20298761|P1|COMPLETED|Overall Study||0
8231994|NCT01984242|20298759|P3|Treated|Overall Study||100
8231995|NCT01984242|20298760|P2|Treated|Overall Study||103
8231996|NCT01984242|20298761|P1|Treated|Overall Study||101
8231997|NCT01984242|20298759|P3|STARTED|Overall Study||101
8231998|NCT01984242|20298760|P2|STARTED|Overall Study||103
8231999|NCT01984242|20298761|P1|STARTED|Overall Study||101
8232000|NCT01984229|20298911|P2|NOT COMPLETED|Safety Follow-up Period||1
8232001|NCT01984229|20298912|P1|NOT COMPLETED|Safety Follow-up Period||2
8232002|NCT01984229|20298911|P2|COMPLETED|Safety Follow-up Period||16
8232003|NCT01984229|20298912|P1|COMPLETED|Safety Follow-up Period||4
8232004|NCT01984229|20298911|P2|STARTED|Safety Follow-up Period||17
8232005|NCT01984229|20298912|P1|STARTED|Safety Follow-up Period||6
8232006|NCT01984229|20298911|P2|NOT COMPLETED|Period 3||0
8232007|NCT01984229|20298912|P1|NOT COMPLETED|Period 3||0
8232008|NCT01984229|20298911|P2|COMPLETED|Period 3||17
8232009|NCT01984229|20298912|P1|COMPLETED|Period 3||6
8232010|NCT01984229|20298911|P2|STARTED|Period 3||17
8232011|NCT01984229|20298912|P1|STARTED|Period 3||6
8232012|NCT01984229|20298911|P2|NOT COMPLETED|Period 2||0
8232013|NCT01984229|20298912|P1|NOT COMPLETED|Period 2||0
8232014|NCT01984229|20298911|P2|COMPLETED|Period 2||17
8232015|NCT01984229|20298912|P1|COMPLETED|Period 2||6
8232016|NCT01984229|20298911|P2|STARTED|Period 2||17
8232017|NCT01984229|20298912|P1|STARTED|Period 2||6
8232018|NCT01984229|20298911|P2|NOT COMPLETED|Period 1||0
8232019|NCT01984229|20298912|P1|NOT COMPLETED|Period 1||0
8232020|NCT01984229|20298911|P2|COMPLETED|Period 1||17
8232021|NCT01984229|20298912|P1|COMPLETED|Period 1||6
8232022|NCT01984229|20298911|P2|STARTED|Period 1||17
8232023|NCT01984229|20298912|P1|STARTED|Period 1||6
8232024|NCT01983969|20298965|P3|NOT COMPLETED|Overall Study||0
8232025|NCT01983969|20298966|P2|NOT COMPLETED|Overall Study||1
8232026|NCT01983969|20298967|P1|NOT COMPLETED|Overall Study||0
8232027|NCT01983969|20298965|P3|COMPLETED|Overall Study||5
8232028|NCT01983969|20298966|P2|COMPLETED|Overall Study||18
8232029|NCT01983969|20298967|P1|COMPLETED|Overall Study||37
8232030|NCT01983969|20298965|P3|STARTED|Overall Study||5
8232031|NCT01983969|20298966|P2|STARTED|Overall Study||19
8232032|NCT01983969|20298967|P1|STARTED|Overall Study||37
8232033|NCT01983930|20298981|P2|NOT COMPLETED|Overall Study||9
8232034|NCT01983930|20298982|P1|NOT COMPLETED|Overall Study||9
8232035|NCT01983930|20298981|P2|COMPLETED|Overall Study||29
8232036|NCT01983930|20298982|P1|COMPLETED|Overall Study||32
8232037|NCT01983930|20298981|P2|STARTED|Overall Study||38
8232038|NCT01983930|20298982|P1|STARTED|Overall Study||41
8232039|NCT01983878|20298994|P1|NOT COMPLETED|Overall Study||0
8232040|NCT01983878|20298994|P1|COMPLETED|Overall Study||36
8232041|NCT01983878|20298994|P1|Received At Least One Dose of Study Drug|Overall Study||36
8232042|NCT01983878|20298994|P1|STARTED|Overall Study||36
8232043|NCT01983839|20299005|P1|NOT COMPLETED|Overall Study||0
8232044|NCT01983839|20299005|P1|COMPLETED|Overall Study||18
8232045|NCT01983839|20299005|P1|STARTED|Overall Study||18
8232046|NCT01983826|20299012|P2|NOT COMPLETED|Overall Study||0
8232047|NCT01983826|20299013|P1|NOT COMPLETED|Overall Study||0
8232048|NCT01983826|20299012|P2|COMPLETED|Overall Study||8
8232049|NCT01983826|20299013|P1|COMPLETED|Overall Study||13
8232050|NCT01983826|20299012|P2|STARTED|Overall Study||8
8232051|NCT01983826|20299013|P1|STARTED|Overall Study||13
8232052|NCT01983787|20299031|P1|NOT COMPLETED|Overall Study||0
8232053|NCT01983787|20299031|P1|COMPLETED|Overall Study||10
8232054|NCT01983787|20299031|P1|STARTED|Overall Study||10
8232055|NCT01983683|20299056|P2|NOT COMPLETED|Overall Study||51
8232056|NCT01983683|20299057|P1|NOT COMPLETED|Overall Study||38
8232057|NCT01983683|20299056|P2|COMPLETED|Overall Study||260
8232058|NCT01983683|20299057|P1|COMPLETED|Overall Study||260
8232059|NCT01983683|20299056|P2|STARTED|Overall Study||311
8232060|NCT01983683|20299057|P1|STARTED|Overall Study||298
8232061|NCT01983566|20299085|P4|NOT COMPLETED|Test Period 4||0
8232062|NCT01983566|20299086|P3|NOT COMPLETED|Test Period 4||0
8232063|NCT01983566|20299087|P2|NOT COMPLETED|Test Period 4||0
8232064|NCT01983566|20299088|P1|NOT COMPLETED|Test Period 4||0
8232065|NCT01983566|20299085|P4|COMPLETED|Test Period 4||0
8232066|NCT01983566|20299086|P3|COMPLETED|Test Period 4||0
8232067|NCT01983566|20299087|P2|COMPLETED|Test Period 4||0
8232068|NCT01983566|20299088|P1|COMPLETED|Test Period 4||0
8232069|NCT01983566|20299085|P4|STARTED|Test Period 4||0
8232070|NCT01983566|20299086|P3|STARTED|Test Period 4||0
8232071|NCT01983566|20299087|P2|STARTED|Test Period 4||0
8232072|NCT01983566|20299088|P1|STARTED|Test Period 4||0
8232073|NCT01983566|20299085|P4|NOT COMPLETED|Wash-Out 3||0
8232074|NCT01983566|20299086|P3|NOT COMPLETED|Wash-Out 3||0
8232075|NCT01983566|20299087|P2|NOT COMPLETED|Wash-Out 3||0
8232076|NCT01983566|20299088|P1|NOT COMPLETED|Wash-Out 3||0
8232077|NCT01983566|20299085|P4|COMPLETED|Wash-Out 3||0
8232078|NCT01983566|20299086|P3|COMPLETED|Wash-Out 3||0
8232079|NCT01983566|20299087|P2|COMPLETED|Wash-Out 3||0
8232080|NCT01983566|20299088|P1|COMPLETED|Wash-Out 3||0
8232081|NCT01983566|20299085|P4|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
8232082|NCT01983566|20299086|P3|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
8232083|NCT01983566|20299087|P2|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
8232084|NCT01983566|20299088|P1|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
8232085|NCT01983566|20299085|P4|NOT COMPLETED|Test Period 3||0
8232086|NCT01983566|20299086|P3|NOT COMPLETED|Test Period 3||0
8232087|NCT01983566|20299087|P2|NOT COMPLETED|Test Period 3||0
8232088|NCT01983566|20299088|P1|NOT COMPLETED|Test Period 3||0
8232089|NCT01983566|20299085|P4|COMPLETED|Test Period 3||4
8232090|NCT01983566|20299086|P3|COMPLETED|Test Period 3||2
8232091|NCT01983566|20299087|P2|COMPLETED|Test Period 3||3
8232092|NCT01983566|20299088|P1|COMPLETED|Test Period 3||2
8232093|NCT01983566|20299085|P4|STARTED|Test Period 3||4
8232094|NCT01983566|20299086|P3|STARTED|Test Period 3||2
8232095|NCT01983566|20299087|P2|STARTED|Test Period 3||3
8232096|NCT01983566|20299088|P1|STARTED|Test Period 3||2
8232097|NCT01983566|20299085|P4|NOT COMPLETED|Wash-Out 2||0
8232098|NCT01983566|20299086|P3|NOT COMPLETED|Wash-Out 2||0
8232099|NCT01983566|20299087|P2|NOT COMPLETED|Wash-Out 2||0
8232100|NCT01983566|20299088|P1|NOT COMPLETED|Wash-Out 2||0
8232101|NCT01983566|20299085|P4|COMPLETED|Wash-Out 2||4
8232102|NCT01983566|20299086|P3|COMPLETED|Wash-Out 2||2
8232103|NCT01983566|20299087|P2|COMPLETED|Wash-Out 2||3
8232104|NCT01983566|20299088|P1|COMPLETED|Wash-Out 2||2
8232105|NCT01983566|20299085|P4|STARTED|Wash-Out 2||4
8232106|NCT01983566|20299086|P3|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
8232107|NCT01983566|20299087|P2|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
8232108|NCT01983566|20299088|P1|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
8232109|NCT01983566|20299085|P4|NOT COMPLETED|Test Period 2||0
8232110|NCT01983566|20299086|P3|NOT COMPLETED|Test Period 2||0
8232111|NCT01983566|20299087|P2|NOT COMPLETED|Test Period 2||0
8232112|NCT01983566|20299088|P1|NOT COMPLETED|Test Period 2||0
8232113|NCT01983566|20299085|P4|COMPLETED|Test Period 2||4
8232114|NCT01983566|20299086|P3|COMPLETED|Test Period 2||4
8232115|NCT01983566|20299087|P2|COMPLETED|Test Period 2||4
8232116|NCT01983566|20299088|P1|COMPLETED|Test Period 2||4
8232117|NCT01983566|20299085|P4|STARTED|Test Period 2||4
8232118|NCT01983566|20299086|P3|STARTED|Test Period 2||4
8232119|NCT01983566|20299087|P2|STARTED|Test Period 2||4
8232120|NCT01983566|20299088|P1|STARTED|Test Period 2||4
8232121|NCT01983566|20299085|P4|NOT COMPLETED|Wash-Out 1||0
8232122|NCT01983566|20299086|P3|NOT COMPLETED|Wash-Out 1||0
8232123|NCT01983566|20299087|P2|NOT COMPLETED|Wash-Out 1||0
8232124|NCT01983566|20299088|P1|NOT COMPLETED|Wash-Out 1||0
8232125|NCT01983566|20299085|P4|COMPLETED|Wash-Out 1||4
8232126|NCT01983566|20299086|P3|COMPLETED|Wash-Out 1||4
8232127|NCT01983566|20299087|P2|COMPLETED|Wash-Out 1||4
8232128|NCT01983566|20299088|P1|COMPLETED|Wash-Out 1||4
8232129|NCT01983566|20299085|P4|STARTED|Wash-Out 1||4
8232130|NCT01983566|20299086|P3|STARTED|Wash-Out 1||4
8232131|NCT01983566|20299087|P2|STARTED|Wash-Out 1||4
8232132|NCT01983566|20299088|P1|STARTED|Wash-Out 1||4
8232133|NCT01983566|20299085|P4|NOT COMPLETED|Test Period 1||0
8232134|NCT01983566|20299086|P3|NOT COMPLETED|Test Period 1||0
8232135|NCT01983566|20299087|P2|NOT COMPLETED|Test Period 1||0
8232136|NCT01983566|20299088|P1|NOT COMPLETED|Test Period 1||0
8232137|NCT01983566|20299085|P4|COMPLETED|Test Period 1||4
8232138|NCT01983566|20299086|P3|COMPLETED|Test Period 1||4
8232139|NCT01983566|20299087|P2|COMPLETED|Test Period 1||4
8232140|NCT01983566|20299088|P1|COMPLETED|Test Period 1||4
8232141|NCT01983566|20299085|P4|STARTED|Test Period 1||4
8232142|NCT01983566|20299086|P3|STARTED|Test Period 1||4
8232143|NCT01983566|20299087|P2|STARTED|Test Period 1||4
8232144|NCT01983566|20299088|P1|STARTED|Test Period 1||4
8232145|NCT01983553|20299109|P2|NOT COMPLETED|Overall Study||0
8232146|NCT01983553|20299110|P1|NOT COMPLETED|Overall Study||0
8232147|NCT01983553|20299109|P2|COMPLETED|Overall Study||1072
8232148|NCT01983553|20299110|P1|COMPLETED|Overall Study||2131
8232149|NCT01983553|20299109|P2|STARTED|Overall Study||1072
8232150|NCT01983553|20299110|P1|STARTED|Overall Study||2131
8232151|NCT01983293|20299144|P2|NOT COMPLETED|Overall Study||19
8232152|NCT01983293|20299145|P1|NOT COMPLETED|Overall Study||33
8232153|NCT01983293|20299144|P2|COMPLETED|Overall Study||62
8232154|NCT01983293|20299145|P1|COMPLETED|Overall Study||128
8232155|NCT01983293|20299144|P2|STARTED|Overall Study||81
8232156|NCT01983293|20299145|P1|STARTED|Overall Study||161
8232157|NCT01983254|20299153|P2|NOT COMPLETED|Overall Study||30
8232158|NCT01983254|20299154|P1|NOT COMPLETED|Overall Study||34
8232159|NCT01983254|20299153|P2|COMPLETED|Overall Study|69 patients, 37 caregivers|106
8232160|NCT01983254|20299154|P1|COMPLETED|Overall Study|62 patients, 29 caregivers|91
8232161|NCT01983254|20299153|P2|Interview 3|Overall Study|69 patients, 37 caregivers|106
8232162|NCT01983254|20299154|P1|Interview 3|Overall Study|62 patients, 29 caregivers|91
8232163|NCT01983254|20299153|P2|Interview 2|Overall Study|71 patients, 39 caregivers|110
8232164|NCT01983254|20299154|P1|Interview 2|Overall Study|65 patients, 30 caregivers|95
8232165|NCT01983254|20299153|P2|Interview 1|Overall Study|89 patients, 47 caregivers|136
8232166|NCT01983254|20299154|P1|Interview 1|Overall Study|86 patients, 39 caregivers|125
8232167|NCT01983254|20299153|P2|STARTED|Overall Study|89 patients, 47 caregivers|136
8232168|NCT01983254|20299154|P1|STARTED|Overall Study|86 patients, 39 caregivers|125
8232169|NCT01983111|20299166|P2|NOT COMPLETED|Overall Study||7
8232170|NCT01983111|20299167|P1|NOT COMPLETED|Overall Study||12
8232171|NCT01983111|20299166|P2|COMPLETED|Overall Study||59
8232172|NCT01983111|20299167|P1|COMPLETED|Overall Study||58
8232173|NCT01983111|20299166|P2|STARTED|Overall Study||66
8232174|NCT01983111|20299167|P1|STARTED|Overall Study||70
8232175|NCT01983020|20299187|P4|NOT COMPLETED|Overall Study||0
8232176|NCT01983020|20299188|P3|NOT COMPLETED|Overall Study||0
8232177|NCT01983020|20299189|P2|NOT COMPLETED|Overall Study||0
8232178|NCT01983020|20299190|P1|NOT COMPLETED|Overall Study||0
8232179|NCT01983020|20299187|P4|COMPLETED|Overall Study||11
8232180|NCT01983020|20299188|P3|COMPLETED|Overall Study||12
8232181|NCT01983020|20299189|P2|COMPLETED|Overall Study||11
8232182|NCT01983020|20299190|P1|COMPLETED|Overall Study||12
8232183|NCT01983020|20299187|P4|STARTED|Overall Study||11
8232184|NCT01983020|20299188|P3|STARTED|Overall Study||12
8232185|NCT01983020|20299189|P2|STARTED|Overall Study||11
8232186|NCT01983020|20299190|P1|STARTED|Overall Study||12
8232207|NCT01982942|20299311|P2|NOT COMPLETED|Overall Study||14
8232208|NCT01982942|20299312|P1|NOT COMPLETED|Overall Study||21
8232209|NCT01982942|20299311|P2|COMPLETED|Overall Study||112
8232210|NCT01982942|20299312|P1|COMPLETED|Overall Study||108
8232211|NCT01982942|20299311|P2|STARTED|Overall Study||126
8232212|NCT01982942|20299312|P1|STARTED|Overall Study||129
8232213|NCT01982812|20299330|P2|NOT COMPLETED|Overall Study||10
8232214|NCT01982812|20299331|P1|NOT COMPLETED|Overall Study||1
8232215|NCT01982812|20299330|P2|COMPLETED|Overall Study||11
8232216|NCT01982812|20299331|P1|COMPLETED|Overall Study||22
8232217|NCT01982812|20299330|P2|STARTED|Overall Study||21
8232218|NCT01982812|20299331|P1|STARTED|Overall Study||23
8232219|NCT01982786|20299345|P2|NOT COMPLETED|Overall Study||0
8232220|NCT01982786|20299346|P1|NOT COMPLETED|Overall Study||0
8232221|NCT01982786|20299345|P2|COMPLETED|Overall Study||28
8232222|NCT01982786|20299346|P1|COMPLETED|Overall Study||29
8232223|NCT01982786|20299345|P2|STARTED|Overall Study||28
8232224|NCT01982786|20299346|P1|STARTED|Overall Study||29
8232225|NCT01982773|20299360|P2|NOT COMPLETED|Overall Study||4
8232226|NCT01982773|20299361|P1|NOT COMPLETED|Overall Study||8
8232227|NCT01982773|20299360|P2|COMPLETED|Overall Study||56
8232228|NCT01982773|20299361|P1|COMPLETED|Overall Study||50
8232229|NCT01982773|20299360|P2|STARTED|Overall Study||60
8232230|NCT01982773|20299361|P1|STARTED|Overall Study||58
8232231|NCT01982695|20299375|P2|NOT COMPLETED|Overall Study||1
8232232|NCT01982695|20299376|P1|NOT COMPLETED|Overall Study||0
8232233|NCT01982695|20299375|P2|COMPLETED|Overall Study||10
8232234|NCT01982695|20299376|P1|COMPLETED|Overall Study||12
8232235|NCT01982695|20299375|P2|STARTED|Overall Study||11
8232236|NCT01982695|20299376|P1|STARTED|Overall Study||12
8232237|NCT01982682|20299382|P1|NOT COMPLETED|Overall Study||1
8232238|NCT01982682|20299382|P1|COMPLETED|Overall Study||40
8232239|NCT01982682|20299382|P1|STARTED|Overall Study||41
8232240|NCT01982643|20299390|P1|NOT COMPLETED|Overall Study||12
8232241|NCT01982643|20299390|P1|COMPLETED|Overall Study||37
8232242|NCT01982643|20299390|P1|STARTED|Overall Study||49
8232243|NCT01982539|20299394|P1|NOT COMPLETED|Overall Study||0
8232244|NCT01982539|20299394|P1|COMPLETED|Overall Study||25
8232245|NCT01982539|20299394|P1|STARTED|Overall Study||25
8232246|NCT01982435|20299402|P2|NOT COMPLETED|Overall Study||0
8232247|NCT01982435|20299403|P1|NOT COMPLETED|Overall Study||1
8232248|NCT01982435|20299402|P2|COMPLETED|Overall Study||12
8232249|NCT01982435|20299403|P1|COMPLETED|Overall Study||14
8232250|NCT01982435|20299402|P2|STARTED|Overall Study||12
8232251|NCT01982435|20299403|P1|STARTED|Overall Study||15
8232252|NCT01982383|20299433|P2|NOT COMPLETED|Overall Study||0
8232253|NCT01982383|20299434|P1|NOT COMPLETED|Overall Study||0
8232254|NCT01982383|20299433|P2|COMPLETED|Overall Study||0
8232255|NCT01982383|20299434|P1|COMPLETED|Overall Study||2
8232256|NCT01982383|20299433|P2|STARTED|Overall Study||0
8232257|NCT01982383|20299434|P1|STARTED|Overall Study||2
8232258|NCT01982331|20299442|P2|NOT COMPLETED|Completed Study (Day 112)||0
8232259|NCT01982331|20299443|P1|NOT COMPLETED|Completed Study (Day 112)||2
8232260|NCT01982331|20299442|P2|COMPLETED|Completed Study (Day 112)||7
8232261|NCT01982331|20299443|P1|COMPLETED|Completed Study (Day 112)||25
8232262|NCT01982331|20299442|P2|STARTED|Completed Study (Day 112)||7
8232263|NCT01982331|20299443|P1|STARTED|Completed Study (Day 112)||27
8232264|NCT01982331|20299442|P2|NOT COMPLETED|Received Vaccination 2||3
8232265|NCT01982331|20299443|P1|NOT COMPLETED|Received Vaccination 2||1
8232266|NCT01982331|20299442|P2|COMPLETED|Received Vaccination 2||7
8232267|NCT01982331|20299443|P1|COMPLETED|Received Vaccination 2||27
8232268|NCT01982331|20299442|P2|STARTED|Received Vaccination 2||10
8232269|NCT01982331|20299443|P1|STARTED|Received Vaccination 2||28
8232270|NCT01982331|20299442|P2|NOT COMPLETED|Received Vaccination 1||0
8232271|NCT01982331|20299443|P1|NOT COMPLETED|Received Vaccination 1||0
8232272|NCT01982331|20299442|P2|COMPLETED|Received Vaccination 1||10
8232273|NCT01982331|20299443|P1|COMPLETED|Received Vaccination 1||28
8232274|NCT01982331|20299442|P2|STARTED|Received Vaccination 1||10
8232275|NCT01982331|20299443|P1|STARTED|Received Vaccination 1||28
8232276|NCT01982292|20299479|P2|NOT COMPLETED|Overall Study||1
8232277|NCT01982292|20299480|P1|NOT COMPLETED|Overall Study||12
8232278|NCT01982292|20299479|P2|COMPLETED|Overall Study||107
8232279|NCT01982292|20299480|P1|COMPLETED|Overall Study||203
8232280|NCT01982292|20299479|P2|Safety Set|Overall Study||108
8232281|NCT01982292|20299480|P1|Safety Set|Overall Study||212
8232282|NCT01982292|20299479|P2|Full Analaysis Set (FAS)|Overall Study||108
8232283|NCT01982292|20299480|P1|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
8232284|NCT01982292|20299479|P2|STARTED|Overall Study||108
8232285|NCT01982292|20299480|P1|STARTED|Overall Study|"Started indicates Randomized set"|215
8232286|NCT01982253|20299501|P3|NOT COMPLETED|Overall Study||4
8232287|NCT01982253|20299502|P2|NOT COMPLETED|Overall Study||4
8232288|NCT01982253|20299503|P1|NOT COMPLETED|Overall Study||2
8232289|NCT01982253|20299501|P3|COMPLETED|Overall Study||0
8232290|NCT01982253|20299502|P2|COMPLETED|Overall Study||0
8232291|NCT01982253|20299503|P1|COMPLETED|Overall Study||0
8232292|NCT01982253|20299501|P3|STARTED|Overall Study||4
8232293|NCT01982253|20299502|P2|STARTED|Overall Study||4
8232294|NCT01982253|20299503|P1|STARTED|Overall Study||2
8232295|NCT01982240|20299517|P3|NOT COMPLETED|Overall Study||70
8232296|NCT01982240|20299518|P2|NOT COMPLETED|Overall Study||69
8232297|NCT01982240|20299519|P1|NOT COMPLETED|Overall Study||67
8232298|NCT01982240|20299517|P3|COMPLETED|Overall Study||371
8232299|NCT01982240|20299518|P2|COMPLETED|Overall Study||384
8232300|NCT01982240|20299519|P1|COMPLETED|Overall Study||385
8232301|NCT01982240|20299517|P3|STARTED|Overall Study||441
8232302|NCT01982240|20299518|P2|STARTED|Overall Study||453
8232303|NCT01982240|20299519|P1|STARTED|Overall Study||452
8232304|NCT01982123|20299539|P1|NOT COMPLETED|Overall Study||0
8232305|NCT01982123|20299539|P1|COMPLETED|Overall Study||12
8232306|NCT01982123|20299539|P1|STARTED|Overall Study||12
8232307|NCT01981967|20299546|P2|NOT COMPLETED|Overall Study||0
8232308|NCT01981967|20299547|P1|NOT COMPLETED|Overall Study||0
8232309|NCT01981967|20299546|P2|COMPLETED|Overall Study||3149
8232310|NCT01981967|20299547|P1|COMPLETED|Overall Study||6851
8232311|NCT01981967|20299546|P2|STARTED|Overall Study||3149
8232312|NCT01981967|20299547|P1|STARTED|Overall Study||6851
8232313|NCT01981954|20299557|P1|NOT COMPLETED|Fixed-Dose Assessment Period||1
8232314|NCT01981954|20299557|P1|COMPLETED|Fixed-Dose Assessment Period||21
8232315|NCT01981954|20299557|P1|Treated|Fixed-Dose Assessment Period||22
8232316|NCT01981954|20299557|P1|STARTED|Fixed-Dose Assessment Period||22
8232317|NCT01981954|20299557|P1|NOT COMPLETED|Titration Period||1
8232318|NCT01981954|20299557|P1|COMPLETED|Titration Period||22
8232319|NCT01981954|20299557|P1|Treated|Titration Period||23
8232320|NCT01981954|20299557|P1|STARTED|Titration Period||23
8232321|NCT01981863|20299604|P2|NOT COMPLETED|Overall Study||0
8232322|NCT01981863|20299605|P1|NOT COMPLETED|Overall Study||0
8232323|NCT01981863|20299604|P2|COMPLETED|Overall Study||20
8232324|NCT01981863|20299605|P1|COMPLETED|Overall Study||20
8232325|NCT01981863|20299604|P2|STARTED|Overall Study||20
8232326|NCT01981863|20299605|P1|STARTED|Overall Study||20
8232327|NCT01981772|20299617|P2|NOT COMPLETED|Overall Study||0
8232328|NCT01981772|20299618|P1|NOT COMPLETED|Overall Study||0
8232329|NCT01981772|20299617|P2|COMPLETED|Overall Study||43
8232330|NCT01981772|20299618|P1|COMPLETED|Overall Study||45
8232331|NCT01981772|20299617|P2|STARTED|Overall Study||43
8232332|NCT01981772|20299618|P1|STARTED|Overall Study||45
8232333|NCT01981759|20299628|P2|NOT COMPLETED|Overall Study||11
8232334|NCT01981759|20299629|P1|NOT COMPLETED|Overall Study||7
8232335|NCT01981759|20299628|P2|COMPLETED|Overall Study||19
8232336|NCT01981759|20299629|P1|COMPLETED|Overall Study||21
8232337|NCT01981759|20299628|P2|Completed Week 12|Overall Study||22
8232338|NCT01981759|20299629|P1|Completed Week 12|Overall Study||22
8232339|NCT01981759|20299628|P2|Randomization (Week 3)|Overall Study||30
8232340|NCT01981759|20299629|P1|Randomization (Week 3)|Overall Study||28
8232341|NCT01981759|20299628|P2|Baseline (Week 1)|Overall Study||30
8232342|NCT01981759|20299629|P1|Baseline (Week 1)|Overall Study||28
8232343|NCT01981759|20299628|P2|STARTED|Overall Study||30
8232344|NCT01981759|20299629|P1|STARTED|Overall Study||28
8232345|NCT01981616|20299641|P2|NOT COMPLETED|Overall Study||1
8232346|NCT01981616|20299642|P1|NOT COMPLETED|Overall Study||1
8232347|NCT01981616|20299641|P2|COMPLETED|Overall Study||62
8232348|NCT01981616|20299642|P1|COMPLETED|Overall Study||63
8232349|NCT01981616|20299641|P2|STARTED|Overall Study||63
8232350|NCT01981616|20299642|P1|STARTED|Overall Study||64
8232351|NCT01981590|20299654|P1|NOT COMPLETED|Overall Study||0
8232352|NCT01981590|20299654|P1|COMPLETED|Overall Study||15
8232353|NCT01981590|20299654|P1|STARTED|Overall Study||15
8232354|NCT01981564|20299663|P2|NOT COMPLETED|Overall Study||9
8232355|NCT01981564|20299664|P1|NOT COMPLETED|Overall Study||9
8232356|NCT01981564|20299663|P2|COMPLETED|Overall Study||106
8232357|NCT01981564|20299664|P1|COMPLETED|Overall Study||98
8232358|NCT01981564|20299663|P2|STARTED|Overall Study||115
8232359|NCT01981564|20299664|P1|STARTED|Overall Study||107
8232360|NCT01981551|20299672|P1|NOT COMPLETED|Overall Study||9
8232361|NCT01981551|20299672|P1|COMPLETED|Overall Study||8
8232362|NCT01981551|20299672|P1|STARTED|Overall Study||17
8232363|NCT01981473|20299682|P3|NOT COMPLETED|Overall Study||8
8232364|NCT01981473|20299683|P2|NOT COMPLETED|Overall Study||0
8232365|NCT01981473|20299684|P1|NOT COMPLETED|Overall Study||2
8232366|NCT01981473|20299682|P3|COMPLETED|Overall Study||196
8232367|NCT01981473|20299683|P2|COMPLETED|Overall Study||199
8232368|NCT01981473|20299684|P1|COMPLETED|Overall Study||200
8232369|NCT01981473|20299682|P3|STARTED|Overall Study||204
8232370|NCT01981473|20299683|P2|STARTED|Overall Study||199
8232371|NCT01981473|20299684|P1|STARTED|Overall Study||202
8232372|NCT01981356|20299725|P2|NOT COMPLETED|Overall Study||2
8232373|NCT01981356|20299726|P1|NOT COMPLETED|Overall Study||7
8232374|NCT01981356|20299725|P2|COMPLETED|Overall Study||4
8232375|NCT01981356|20299726|P1|COMPLETED|Overall Study||5
8232376|NCT01981356|20299725|P2|STARTED|Overall Study||6
8232377|NCT01981356|20299726|P1|STARTED|Overall Study||12
8232378|NCT01981122|20299753|P2|NOT COMPLETED|Overall Study||20
8232379|NCT01981122|20299754|P1|NOT COMPLETED|Overall Study||14
8232380|NCT01981122|20299753|P2|COMPLETED|Overall Study||7
8232381|NCT01981122|20299754|P1|COMPLETED|Overall Study||11
8232382|NCT01981122|20299753|P2|STARTED|Overall Study||27
8232383|NCT01981122|20299754|P1|STARTED|Overall Study||25
8232384|NCT01981109|20299760|P1|NOT COMPLETED|Overall Study||224
8232385|NCT01981109|20299760|P1|COMPLETED|Overall Study||1
8232386|NCT01981109|20299760|P1|STARTED|Overall Study||225
8232387|NCT01981096|20299767|P2|NOT COMPLETED|Overall Study||1
8232388|NCT01981096|20299768|P1|NOT COMPLETED|Overall Study||3
8232389|NCT01981096|20299767|P2|COMPLETED|Overall Study||19
8232390|NCT01981096|20299768|P1|COMPLETED|Overall Study||17
8232391|NCT01981096|20299767|P2|Post-treatment|Overall Study||19
8232392|NCT01981096|20299768|P1|Post-treatment|Overall Study||17
8232393|NCT01981096|20299767|P2|STARTED|Overall Study||20
8232394|NCT01981096|20299768|P1|STARTED|Overall Study||20
8232395|NCT01981057|20299780|P2|NOT COMPLETED|Overall Study||0
8232396|NCT01981057|20299781|P1|NOT COMPLETED|Overall Study||0
8232397|NCT01981057|20299780|P2|COMPLETED|Overall Study||50
8232398|NCT01981057|20299781|P1|COMPLETED|Overall Study||50
8232399|NCT01981057|20299780|P2|STARTED|Overall Study||50
8232400|NCT01981057|20299781|P1|STARTED|Overall Study||50
8232401|NCT01980992|20299789|P2|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
8232402|NCT01980992|20299790|P1|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
8232403|NCT01980992|20299789|P2|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
8232404|NCT01980992|20299790|P1|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
8232405|NCT01980992|20299789|P2|STARTED|52 Weeks Open Label Active Wheat OIT||19
8232406|NCT01980992|20299790|P1|STARTED|52 Weeks Open Label Active Wheat OIT||21
8232407|NCT01980992|20299789|P2|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
8232408|NCT01980992|20299790|P1|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
8232409|NCT01980992|20299789|P2|COMPLETED|52 Weeks Blinded Study Treatment||19
8232410|NCT01980992|20299790|P1|COMPLETED|52 Weeks Blinded Study Treatment||21
8232411|NCT01980992|20299789|P2|STARTED|52 Weeks Blinded Study Treatment||23
8232412|NCT01980992|20299790|P1|STARTED|52 Weeks Blinded Study Treatment||23
8232413|NCT01980940|20299815|P8|NOT COMPLETED|Overall Study||0
8232414|NCT01980940|20299816|P7|NOT COMPLETED|Overall Study||0
8232415|NCT01980940|20299817|P6|NOT COMPLETED|Overall Study||2
8232416|NCT01980940|20299818|P5|NOT COMPLETED|Overall Study||0
8232417|NCT01980940|20299819|P4|NOT COMPLETED|Overall Study||0
8232418|NCT01980940|20299820|P3|NOT COMPLETED|Overall Study||0
8232419|NCT01980940|20299821|P2|NOT COMPLETED|Overall Study||0
8232420|NCT01980940|20299822|P1|NOT COMPLETED|Overall Study||0
8232421|NCT01980940|20299815|P8|COMPLETED|Overall Study||24
8232422|NCT01980940|20299816|P7|COMPLETED|Overall Study||24
8232423|NCT01980940|20299817|P6|COMPLETED|Overall Study||0
8232424|NCT01980940|20299818|P5|COMPLETED|Overall Study||2
8232425|NCT01980940|20299819|P4|COMPLETED|Overall Study||3
8232426|NCT01980940|20299820|P3|COMPLETED|Overall Study||5
8232427|NCT01980940|20299821|P2|COMPLETED|Overall Study||5
8232428|NCT01980940|20299822|P1|COMPLETED|Overall Study||5
8232429|NCT01980940|20299815|P8|Treated|Overall Study||24
8232430|NCT01980940|20299816|P7|Treated|Overall Study||24
8232431|NCT01980940|20299817|P6|Treated|Overall Study||2
8232432|NCT01980940|20299818|P5|Treated|Overall Study||2
8232433|NCT01980940|20299819|P4|Treated|Overall Study||3
8232434|NCT01980940|20299820|P3|Treated|Overall Study||5
8232435|NCT01980940|20299821|P2|Treated|Overall Study||5
8232436|NCT01980940|20299822|P1|Treated|Overall Study||5
8232437|NCT01980940|20299815|P8|STARTED|Overall Study||24
8232438|NCT01980940|20299816|P7|STARTED|Overall Study||24
8232439|NCT01980940|20299817|P6|STARTED|Overall Study||2
8232440|NCT01980940|20299818|P5|STARTED|Overall Study||2
8232441|NCT01980940|20299819|P4|STARTED|Overall Study||3
8232442|NCT01980940|20299820|P3|STARTED|Overall Study||5
8232443|NCT01980940|20299821|P2|STARTED|Overall Study||5
8232444|NCT01980940|20299822|P1|STARTED|Overall Study||5
8232445|NCT01980914|20299874|P1|NOT COMPLETED|Overall Study||0
8232446|NCT01980914|20299874|P1|COMPLETED|Overall Study||11
8232447|NCT01980914|20299874|P1|STARTED|Overall Study||11
8232448|NCT01980888|20299881|P2|NOT COMPLETED|Overall Study||133
8232449|NCT01980888|20299882|P1|NOT COMPLETED|Overall Study||144
8232450|NCT01980888|20299881|P2|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
8232451|NCT01980888|20299882|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
8232452|NCT01980888|20299881|P2|STARTED|Overall Study||154
8232453|NCT01980888|20299882|P1|STARTED|Overall Study||157
8232454|NCT01980875|20299901|P3|NOT COMPLETED|Overall Study||24
8232455|NCT01980875|20299902|P2|NOT COMPLETED|Overall Study||25
8232456|NCT01980875|20299903|P1|NOT COMPLETED|Overall Study||8
8232457|NCT01980875|20299901|P3|COMPLETED|Overall Study||0
8232458|NCT01980875|20299902|P2|COMPLETED|Overall Study||0
8232459|NCT01980875|20299903|P1|COMPLETED|Overall Study||0
8232460|NCT01980875|20299901|P3|STARTED|Overall Study||24
8232461|NCT01980875|20299902|P2|STARTED|Overall Study||25
8232462|NCT01980875|20299903|P1|STARTED|Overall Study||8
8232463|NCT01980771|20299928|P2|NOT COMPLETED|Overall Study||119
8232464|NCT01980771|20299929|P1|NOT COMPLETED|Overall Study||84
8232465|NCT01980771|20299928|P2|COMPLETED|Overall Study||305
8232466|NCT01980771|20299929|P1|COMPLETED|Overall Study||352
8232467|NCT01980771|20299928|P2|STARTED|Overall Study||424
8232468|NCT01980771|20299929|P1|STARTED|Overall Study||436
8232469|NCT01980706|20299938|P3|NOT COMPLETED|Overall Study||13
8232470|NCT01980706|20299939|P2|NOT COMPLETED|Overall Study||17
8232471|NCT01980706|20299940|P1|NOT COMPLETED|Overall Study||17
8232472|NCT01980706|20299938|P3|COMPLETED|Overall Study||24
8232473|NCT01980706|20299939|P2|COMPLETED|Overall Study||26
8232474|NCT01980706|20299940|P1|COMPLETED|Overall Study||23
8232475|NCT01980706|20299938|P3|STARTED|Overall Study||37
8232476|NCT01980706|20299939|P2|STARTED|Overall Study||43
8232477|NCT01980706|20299940|P1|STARTED|Overall Study||40
8232478|NCT01980654|20299965|P2|NOT COMPLETED|Overall Study||0
8232479|NCT01980654|20299966|P1|NOT COMPLETED|Overall Study||0
8232480|NCT01980654|20299965|P2|COMPLETED|Overall Study||20
8232481|NCT01980654|20299966|P1|COMPLETED|Overall Study||60
8232482|NCT01980654|20299965|P2|STARTED|Overall Study||20
8232483|NCT01980654|20299966|P1|STARTED|Overall Study||60
8232484|NCT01980628|20299980|P1|NOT COMPLETED|Overall Study||63
8232485|NCT01980628|20299980|P1|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
8232486|NCT01980628|20299980|P1|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
8232487|NCT01980589|20299988|P3|NOT COMPLETED|Overall Study||0
8232488|NCT01980589|20299989|P2|NOT COMPLETED|Overall Study||0
8232489|NCT01980589|20299990|P1|NOT COMPLETED|Overall Study||0
8232490|NCT01980589|20299988|P3|COMPLETED|Overall Study||16
8232491|NCT01980589|20299989|P2|COMPLETED|Overall Study||3
8232492|NCT01980589|20299990|P1|COMPLETED|Overall Study||3
8232493|NCT01980589|20299988|P3|STARTED|Overall Study||16
8232494|NCT01980589|20299989|P2|STARTED|Overall Study||3
8232495|NCT01980589|20299990|P1|STARTED|Overall Study||3
8232496|NCT01980524|20300007|P2|NOT COMPLETED|Study Day 2||0
8232497|NCT01980524|20300008|P1|NOT COMPLETED|Study Day 2||0
8232498|NCT01980524|20300007|P2|COMPLETED|Study Day 2||4
8232499|NCT01980524|20300008|P1|COMPLETED|Study Day 2||4
8232500|NCT01980524|20300007|P2|STARTED|Study Day 2||4
8232501|NCT01980524|20300008|P1|STARTED|Study Day 2||4
8232502|NCT01980524|20300007|P2|NOT COMPLETED|Washout (at Least 2 Weeks)||0
8232503|NCT01980524|20300008|P1|NOT COMPLETED|Washout (at Least 2 Weeks)||0
8232504|NCT01980524|20300007|P2|COMPLETED|Washout (at Least 2 Weeks)||4
8232505|NCT01980524|20300008|P1|COMPLETED|Washout (at Least 2 Weeks)||4
8232506|NCT01980524|20300007|P2|STARTED|Washout (at Least 2 Weeks)||4
8232507|NCT01980524|20300008|P1|STARTED|Washout (at Least 2 Weeks)||4
8232508|NCT01980524|20300007|P2|NOT COMPLETED|Study Day 1||0
8232509|NCT01980524|20300008|P1|NOT COMPLETED|Study Day 1||0
8232510|NCT01980524|20300007|P2|COMPLETED|Study Day 1||4
8232511|NCT01980524|20300008|P1|COMPLETED|Study Day 1||4
8232512|NCT01980524|20300007|P2|STARTED|Study Day 1||4
8232513|NCT01980524|20300008|P1|STARTED|Study Day 1||4
8232514|NCT01980485|20300020|P2|NOT COMPLETED|Overall Study||25
8232515|NCT01980485|20300021|P1|NOT COMPLETED|Overall Study||36
8232516|NCT01980485|20300020|P2|COMPLETED|Overall Study||80
8232517|NCT01980485|20300021|P1|COMPLETED|Overall Study||84
8232518|NCT01980485|20300020|P2|STARTED|Overall Study||105
8232519|NCT01980485|20300021|P1|STARTED|Overall Study||120
8232520|NCT01980342|20300029|P1|NOT COMPLETED|Overall Study||1
8232521|NCT01980342|20300029|P1|COMPLETED|Overall Study||0
8232522|NCT01980342|20300029|P1|STARTED|Overall Study||1
8232523|NCT01980095|20300039|P2|NOT COMPLETED|Overall Study||11
8232524|NCT01980095|20300040|P1|NOT COMPLETED|Overall Study||15
8232525|NCT01980095|20300039|P2|COMPLETED|Overall Study||30
8232526|NCT01980095|20300040|P1|COMPLETED|Overall Study||63
8232527|NCT01980095|20300039|P2|Treated|Overall Study||41
8232528|NCT01980095|20300040|P1|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
8232529|NCT01980095|20300039|P2|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
8232530|NCT01980095|20300040|P1|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78
8232531|NCT01980056|20300051|P3|NOT COMPLETED|Overall Study||0
8232532|NCT01980056|20300052|P2|NOT COMPLETED|Overall Study||1
8232533|NCT01980056|20300053|P1|NOT COMPLETED|Overall Study||1
8232534|NCT01980056|20300051|P3|COMPLETED|Overall Study||2
8232535|NCT01980056|20300052|P2|COMPLETED|Overall Study||3
8232536|NCT01980056|20300053|P1|COMPLETED|Overall Study||3
8232537|NCT01980056|20300051|P3|STARTED|Overall Study||2
8232538|NCT01980056|20300052|P2|STARTED|Overall Study||4
8232539|NCT01980056|20300053|P1|STARTED|Overall Study||4
8232540|NCT01979952|20300067|P2|NOT COMPLETED|Overall Study||6
8232541|NCT01979952|20300068|P1|NOT COMPLETED|Overall Study||8
8232542|NCT01979952|20300067|P2|COMPLETED|Overall Study||51
8232543|NCT01979952|20300068|P1|COMPLETED|Overall Study||48
8232544|NCT01979952|20300067|P2|STARTED|Overall Study||57
8232545|NCT01979952|20300068|P1|STARTED|Overall Study||56
8232546|NCT01979835|20300096|P1|NOT COMPLETED|Follow-up||32
8232547|NCT01979835|20300096|P1|COMPLETED|Follow-up||980
8232548|NCT01979835|20300096|P1|STARTED|Follow-up||1012
8232549|NCT01979835|20300096|P1|NOT COMPLETED|Primary Outcome SA Measurment||18
8232550|NCT01979835|20300096|P1|COMPLETED|Primary Outcome SA Measurment||1012
8232551|NCT01979835|20300096|P1|STARTED|Primary Outcome SA Measurment||1030
8232552|NCT01979614|20300103|P2|NOT COMPLETED|Overall Study||1
8232553|NCT01979614|20300104|P1|NOT COMPLETED|Overall Study||1
8232554|NCT01979614|20300103|P2|COMPLETED|Overall Study||27
8232555|NCT01979614|20300104|P1|COMPLETED|Overall Study||29
8232556|NCT01979614|20300103|P2|PD Analysis Set|Overall Study||26
8232557|NCT01979614|20300104|P1|PD Analysis Set|Overall Study||25
8232558|NCT01979614|20300103|P2|PK Analysis Set|Overall Study||0
8232559|NCT01979614|20300104|P1|PK Analysis Set|Overall Study||30
8232560|NCT01979614|20300103|P2|Safety Analysis Set|Overall Study||28
8232561|NCT01979614|20300104|P1|Safety Analysis Set|Overall Study||30
8232562|NCT01979614|20300103|P2|STARTED|Overall Study||28
8232563|NCT01979614|20300104|P1|STARTED|Overall Study||30
8232564|NCT01979523|20300126|P2|NOT COMPLETED|Overall Study||0
8232565|NCT01979523|20300127|P1|NOT COMPLETED|Overall Study||1
8232566|NCT01979523|20300126|P2|COMPLETED|Overall Study||21
8232567|NCT01979523|20300127|P1|COMPLETED|Overall Study||20
8232568|NCT01979523|20300126|P2|STARTED|Overall Study||21
8232569|NCT01979523|20300127|P1|STARTED|Overall Study||21
8232570|NCT01979445|20300150|P4|NOT COMPLETED|Overall Study||0
8232571|NCT01979445|20300151|P3|NOT COMPLETED|Overall Study||0
8232572|NCT01979445|20300152|P2|NOT COMPLETED|Overall Study||0
8232573|NCT01979445|20300153|P1|NOT COMPLETED|Overall Study||0
8232574|NCT01979445|20300150|P4|COMPLETED|Overall Study||3
8232575|NCT01979445|20300151|P3|COMPLETED|Overall Study||6
8232576|NCT01979445|20300152|P2|COMPLETED|Overall Study||3
8232577|NCT01979445|20300153|P1|COMPLETED|Overall Study||3
8232578|NCT01979445|20300150|P4|ITT Population|Overall Study||3
8232579|NCT01979445|20300151|P3|ITT Population|Overall Study||6
8232580|NCT01979445|20300152|P2|ITT Population|Overall Study||3
8232581|NCT01979445|20300153|P1|ITT Population|Overall Study||3
8232582|NCT01979445|20300150|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8232583|NCT01979445|20300151|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8232584|NCT01979445|20300152|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8232585|NCT01979445|20300153|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8232586|NCT01979445|20300150|P4|STARTED|Overall Study||3
8232587|NCT01979445|20300151|P3|STARTED|Overall Study||6
8232588|NCT01979445|20300152|P2|STARTED|Overall Study||3
8232589|NCT01979445|20300153|P1|STARTED|Overall Study||3
8232590|NCT01979276|20300179|P1|NOT COMPLETED|Overall Study||0
8232591|NCT01979276|20300179|P1|COMPLETED|Overall Study||2
8232592|NCT01979276|20300179|P1|STARTED|Overall Study||2
8232605|NCT01979159|20300198|P1|NOT COMPLETED|Overall Study||0
8232606|NCT01979159|20300198|P1|COMPLETED|Overall Study||4
8232607|NCT01979159|20300198|P1|STARTED|Overall Study||4
8232608|NCT01979133|20300204|P1|NOT COMPLETED|Overall Study||3
8232609|NCT01979133|20300204|P1|COMPLETED|Overall Study||7
8232610|NCT01979133|20300204|P1|STARTED|Overall Study||10
8232611|NCT01979029|20300223|P2|NOT COMPLETED|Overall Study||0
8232612|NCT01979029|20300224|P1|NOT COMPLETED|Overall Study||0
8232613|NCT01979029|20300223|P2|COMPLETED|Overall Study||28
8232614|NCT01979029|20300224|P1|COMPLETED|Overall Study||29
8232615|NCT01979029|20300223|P2|STARTED|Overall Study||28
8232616|NCT01979029|20300224|P1|STARTED|Overall Study||29
8232617|NCT01979016|20300236|P2|NOT COMPLETED|Overall Study||1
8232618|NCT01979016|20300237|P1|NOT COMPLETED|Overall Study||2
8232619|NCT01979016|20300236|P2|COMPLETED|Overall Study||26
8232620|NCT01979016|20300237|P1|COMPLETED|Overall Study||25
8232621|NCT01979016|20300236|P2|STARTED|Overall Study||27
8232622|NCT01979016|20300237|P1|STARTED|Overall Study||27
8232623|NCT01978938|20300271|P2|NOT COMPLETED|Overall Study||14
8232624|NCT01978938|20300272|P1|NOT COMPLETED|Overall Study||23
8232625|NCT01978938|20300271|P2|COMPLETED|Overall Study||439
8232626|NCT01978938|20300272|P1|COMPLETED|Overall Study||432
8232627|NCT01978938|20300271|P2|Received at Least 1 Dose of Study Drug|Overall Study||451
8232628|NCT01978938|20300272|P1|Received at Least 1 Dose of Study Drug|Overall Study||454
8232629|NCT01978938|20300271|P2|STARTED|Overall Study||453
8232630|NCT01978938|20300272|P1|STARTED|Overall Study||455
8232631|NCT01978912|20300286|P4|NOT COMPLETED|Overall Study||3
8232632|NCT01978912|20300287|P3|NOT COMPLETED|Overall Study||3
8232633|NCT01978912|20300288|P2|NOT COMPLETED|Overall Study||3
8232634|NCT01978912|20300289|P1|NOT COMPLETED|Overall Study||3
8232635|NCT01978912|20300286|P4|COMPLETED|Overall Study||3
8232636|NCT01978912|20300287|P3|COMPLETED|Overall Study||3
8232637|NCT01978912|20300288|P2|COMPLETED|Overall Study||3
8232638|NCT01978912|20300289|P1|COMPLETED|Overall Study||3
8232639|NCT01978912|20300286|P4|STARTED|Overall Study||6
8232640|NCT01978912|20300287|P3|STARTED|Overall Study||6
8232641|NCT01978912|20300288|P2|STARTED|Overall Study||6
8232642|NCT01978912|20300289|P1|STARTED|Overall Study||6
8232643|NCT01978743|20300335|P1|NOT COMPLETED|Overall Study||0
8232644|NCT01978743|20300335|P1|COMPLETED|Overall Study||10
8232645|NCT01978743|20300335|P1|STARTED|Overall Study||10
8232646|NCT01978600|20300349|P2|NOT COMPLETED|Overall Study||0
8232647|NCT01978600|20300350|P1|NOT COMPLETED|Overall Study||0
8232648|NCT01978600|20300349|P2|COMPLETED|Overall Study||42
8232649|NCT01978600|20300350|P1|COMPLETED|Overall Study||44
8232650|NCT01978600|20300349|P2|STARTED|Overall Study||42
8232651|NCT01978600|20300350|P1|STARTED|Overall Study||44
8232652|NCT01978535|20300362|P2|NOT COMPLETED|Overall Study||0
8232653|NCT01978535|20300363|P1|NOT COMPLETED|Overall Study||0
8232654|NCT01978535|20300362|P2|COMPLETED|Overall Study||2
8232655|NCT01978535|20300363|P1|COMPLETED|Overall Study||1
8232656|NCT01978535|20300362|P2|STARTED|Overall Study||2
8232657|NCT01978535|20300363|P1|STARTED|Overall Study||1
8232658|NCT01978509|20300372|P3|NOT COMPLETED|Overall Study||0
8232659|NCT01978509|20300373|P2|NOT COMPLETED|Overall Study||5
8232660|NCT01978509|20300374|P1|NOT COMPLETED|Overall Study||2
8232661|NCT01978509|20300372|P3|COMPLETED|Overall Study||9
8232662|NCT01978509|20300373|P2|COMPLETED|Overall Study||8
8232663|NCT01978509|20300374|P1|COMPLETED|Overall Study||8
8232664|NCT01978509|20300372|P3|STARTED|Overall Study||9
8232665|NCT01978509|20300373|P2|STARTED|Overall Study||13
8232666|NCT01978509|20300374|P1|STARTED|Overall Study||10
8232667|NCT01978314|20300396|P5|NOT COMPLETED|Overall Study||0
8232668|NCT01978314|20300397|P4|NOT COMPLETED|Overall Study||0
8232669|NCT01978314|20300398|P3|NOT COMPLETED|Overall Study||0
8232670|NCT01978314|20300399|P2|NOT COMPLETED|Overall Study||0
8232671|NCT01978314|20300400|P1|NOT COMPLETED|Overall Study||0
8232672|NCT01978314|20300396|P5|COMPLETED|Overall Study||8
8232673|NCT01978314|20300397|P4|COMPLETED|Overall Study||1
8232674|NCT01978314|20300398|P3|COMPLETED|Overall Study||8
8232675|NCT01978314|20300399|P2|COMPLETED|Overall Study||8
8232676|NCT01978314|20300400|P1|COMPLETED|Overall Study||8
8232677|NCT01978314|20300396|P5|STARTED|Overall Study||8
8232678|NCT01978314|20300397|P4|STARTED|Overall Study||1
8232679|NCT01978314|20300398|P3|STARTED|Overall Study||8
8232680|NCT01978314|20300399|P2|STARTED|Overall Study||8
8232681|NCT01978314|20300400|P1|STARTED|Overall Study||8
8232682|NCT01978262|20300482|P1|NOT COMPLETED|Overall Study||11
8232683|NCT01978262|20300482|P1|COMPLETED|Overall Study||92
8232684|NCT01978262|20300482|P1|STARTED|Overall Study||103
8232685|NCT01978236|20300487|P1|NOT COMPLETED|Overall Study||2
8232686|NCT01978236|20300487|P1|COMPLETED|Overall Study||4
8232687|NCT01978236|20300487|P1|STARTED|Overall Study||6
8232688|NCT01978184|20300508|P2|NOT COMPLETED|Overall Study||20
8232689|NCT01978184|20300509|P1|NOT COMPLETED|Overall Study||13
8232690|NCT01978184|20300508|P2|COMPLETED|Overall Study||41
8232691|NCT01978184|20300509|P1|COMPLETED|Overall Study||30
8232692|NCT01978184|20300508|P2|STARTED|Overall Study||61
8232693|NCT01978184|20300509|P1|STARTED|Overall Study||43
8232694|NCT01978145|20300535|P2|NOT COMPLETED|Treatment Period 2||14
8232695|NCT01978145|20300536|P1|NOT COMPLETED|Treatment Period 2||19
8232696|NCT01978145|20300535|P2|COMPLETED|Treatment Period 2||179
8232697|NCT01978145|20300536|P1|COMPLETED|Treatment Period 2||185
8232698|NCT01978145|20300535|P2|STARTED|Treatment Period 2||193
8232699|NCT01978145|20300536|P1|STARTED|Treatment Period 2||204
8232700|NCT01978145|20300535|P2|NOT COMPLETED|Washout Period 1||3
8232701|NCT01978145|20300536|P1|NOT COMPLETED|Washout Period 1||1
8232702|NCT01978145|20300535|P2|COMPLETED|Washout Period 1||193
8232703|NCT01978145|20300536|P1|COMPLETED|Washout Period 1||204
8232704|NCT01978145|20300535|P2|STARTED|Washout Period 1||196
8232705|NCT01978145|20300536|P1|STARTED|Washout Period 1||205
8232706|NCT01978145|20300535|P2|NOT COMPLETED|Treatment Period 1||16
8232707|NCT01978145|20300536|P1|NOT COMPLETED|Treatment Period 1||9
8232708|NCT01978145|20300535|P2|COMPLETED|Treatment Period 1||196
8232709|NCT01978145|20300536|P1|COMPLETED|Treatment Period 1||205
8232710|NCT01978145|20300535|P2|STARTED|Treatment Period 1||212
8232711|NCT01978145|20300536|P1|STARTED|Treatment Period 1||214
8232712|NCT01978119|20300552|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
8232713|NCT01978119|20300553|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
8232714|NCT01978119|20300552|P2|COMPLETED|Treatment Period 2 (12 Weeks)||40
8232715|NCT01978119|20300553|P1|COMPLETED|Treatment Period 2 (12 Weeks)||38
8232716|NCT01978119|20300552|P2|STARTED|Treatment Period 2 (12 Weeks)||42
8232717|NCT01978119|20300553|P1|STARTED|Treatment Period 2 (12 Weeks)||38
8232718|NCT01978119|20300552|P2|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
8232719|NCT01978119|20300553|P1|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
8232720|NCT01978119|20300552|P2|COMPLETED|Washout Period 1 (3 Weeks)||42
8232721|NCT01978119|20300553|P1|COMPLETED|Washout Period 1 (3 Weeks)||38
8232722|NCT01978119|20300552|P2|STARTED|Washout Period 1 (3 Weeks)||42
8232723|NCT01978119|20300553|P1|STARTED|Washout Period 1 (3 Weeks)||38
8232724|NCT01978119|20300552|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
8232725|NCT01978119|20300553|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
8232726|NCT01978119|20300552|P2|COMPLETED|Treatment Period 1 (12 Weeks)||42
8232727|NCT01978119|20300553|P1|COMPLETED|Treatment Period 1 (12 Weeks)||38
8232728|NCT01978119|20300552|P2|STARTED|Treatment Period 1 (12 Weeks)||42
8232729|NCT01978119|20300553|P1|STARTED|Treatment Period 1 (12 Weeks)||40
8232730|NCT01978093|20300579|P2|NOT COMPLETED|Overall Study||73
8232731|NCT01978093|20300580|P1|NOT COMPLETED|Overall Study||65
8232732|NCT01978093|20300579|P2|COMPLETED|Overall Study||230
8232733|NCT01978093|20300580|P1|COMPLETED|Overall Study||232
8232734|NCT01978093|20300579|P2|STARTED|Overall Study||303
8232735|NCT01978093|20300580|P1|STARTED|Overall Study||297
8232736|NCT01977937|20300624|P2|NOT COMPLETED|Overall Study||2
8232737|NCT01977937|20300625|P1|NOT COMPLETED|Overall Study||3
8232738|NCT01977937|20300624|P2|COMPLETED|Overall Study||26
8232739|NCT01977937|20300625|P1|COMPLETED|Overall Study||24
8232740|NCT01977937|20300624|P2|STARTED|Overall Study||28
8232741|NCT01977937|20300625|P1|STARTED|Overall Study||27
8232742|NCT01977846|20300635|P2|NOT COMPLETED|Total Study - Prospective||29
8232743|NCT01977846|20300636|P1|NOT COMPLETED|Total Study - Prospective||0
8232744|NCT01977846|20300635|P2|COMPLETED|Total Study - Prospective||230
8232745|NCT01977846|20300636|P1|COMPLETED|Total Study - Prospective||0
8232746|NCT01977846|20300635|P2|STARTED|Total Study - Prospective||259
8232747|NCT01977846|20300636|P1|STARTED|Total Study - Prospective||0
8232748|NCT01977846|20300635|P2|NOT COMPLETED|Total Study - Retrospective||0
8232749|NCT01977846|20300636|P1|NOT COMPLETED|Total Study - Retrospective||0
8232750|NCT01977846|20300635|P2|COMPLETED|Total Study - Retrospective||0
8232751|NCT01977846|20300636|P1|COMPLETED|Total Study - Retrospective||251
8232752|NCT01977846|20300635|P2|STARTED|Total Study - Retrospective||0
8232753|NCT01977846|20300636|P1|STARTED|Total Study - Retrospective||251
8232754|NCT01977820|20300654|P2|NOT COMPLETED|Overall Study||1
8232755|NCT01977820|20300655|P1|NOT COMPLETED|Overall Study||1
8232756|NCT01977820|20300654|P2|COMPLETED|Overall Study||0
8232757|NCT01977820|20300655|P1|COMPLETED|Overall Study||0
8232758|NCT01977820|20300654|P2|STARTED|Overall Study||1
8232759|NCT01977820|20300655|P1|STARTED|Overall Study||1
8232760|NCT01977794|20300663|P2|NOT COMPLETED|Overall Study||6
8232761|NCT01977794|20300664|P1|NOT COMPLETED|Overall Study||8
8232762|NCT01977794|20300663|P2|COMPLETED|Overall Study||94
8232763|NCT01977794|20300664|P1|COMPLETED|Overall Study||92
8232764|NCT01977794|20300663|P2|STARTED|Overall Study||100
8232765|NCT01977794|20300664|P1|STARTED|Overall Study||100
8232766|NCT01977781|20300680|P2|NOT COMPLETED|Overall Study||1
8232767|NCT01977781|20300681|P1|NOT COMPLETED|Overall Study||6
8232768|NCT01977781|20300680|P2|COMPLETED|Overall Study||15
8232769|NCT01977781|20300681|P1|COMPLETED|Overall Study||18
8232770|NCT01977781|20300680|P2|STARTED|Overall Study||16
8232771|NCT01977781|20300681|P1|STARTED|Overall Study||24
8232772|NCT01977729|20300699|P1|NOT COMPLETED|Overall Study||1
8232773|NCT01977729|20300699|P1|COMPLETED|Overall Study||0
8232774|NCT01977729|20300699|P1|STARTED|Overall Study||1
8232775|NCT01977690|20300711|P2|NOT COMPLETED|Overall Study||4
8232776|NCT01977690|20300712|P1|NOT COMPLETED|Overall Study||0
8232777|NCT01977690|20300711|P2|COMPLETED|Overall Study||11
8232778|NCT01977690|20300712|P1|COMPLETED|Overall Study||15
8232779|NCT01977690|20300711|P2|STARTED|Overall Study||15
8232780|NCT01977690|20300712|P1|STARTED|Overall Study||15
8232781|NCT01977677|20300721|P3|NOT COMPLETED|Overall Study||1
8232782|NCT01977677|20300722|P2|NOT COMPLETED|Overall Study||0
8232783|NCT01977677|20300723|P1|NOT COMPLETED|Overall Study||0
8232784|NCT01977677|20300721|P3|COMPLETED|Overall Study||20
8232785|NCT01977677|20300722|P2|COMPLETED|Overall Study||6
8232786|NCT01977677|20300723|P1|COMPLETED|Overall Study||3
8232787|NCT01977677|20300721|P3|STARTED|Overall Study||21
8232788|NCT01977677|20300722|P2|STARTED|Overall Study||6
8232789|NCT01977677|20300723|P1|STARTED|Overall Study||3
8232790|NCT01977651|20300734|P1|NOT COMPLETED|Post 1 Year Extension Period||144
8232791|NCT01977651|20300734|P1|COMPLETED|Post 1 Year Extension Period||1
8232792|NCT01977651|20300734|P1|STARTED|Post 1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the post 1 year extension period|145
8232793|NCT01977651|20300734|P1|NOT COMPLETED|1 Year Extension Period||130
8232794|NCT01977651|20300734|P1|COMPLETED|1 Year Extension Period||157
8232795|NCT01977651|20300734|P1|STARTED|1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the 1 year extension period|287
8232796|NCT01977651|20300734|P1|NOT COMPLETED|4 Month Treatment Period||101
8232797|NCT01977651|20300734|P1|COMPLETED|4 Month Treatment Period||322
8232798|NCT01977651|20300734|P1|STARTED|4 Month Treatment Period||423
8232799|NCT01977625|20300738|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
8232800|NCT01977625|20300739|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
8232801|NCT01977625|20300738|P2|COMPLETED|Second Intervention (4 Weeks)||7
8232802|NCT01977625|20300739|P1|COMPLETED|Second Intervention (4 Weeks)||7
8232803|NCT01977625|20300738|P2|STARTED|Second Intervention (4 Weeks)||7
8232804|NCT01977625|20300739|P1|STARTED|Second Intervention (4 Weeks)||8
8232805|NCT01977625|20300738|P2|NOT COMPLETED|Washout (2 Weeks)||0
8232806|NCT01977625|20300739|P1|NOT COMPLETED|Washout (2 Weeks)||0
8232807|NCT01977625|20300738|P2|COMPLETED|Washout (2 Weeks)||7
8232808|NCT01977625|20300739|P1|COMPLETED|Washout (2 Weeks)||8
8232809|NCT01977625|20300738|P2|STARTED|Washout (2 Weeks)||7
8232810|NCT01977625|20300739|P1|STARTED|Washout (2 Weeks)||8
8232811|NCT01977625|20300738|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8232812|NCT01977625|20300739|P1|NOT COMPLETED|First Intervention (4 Weeks)||3
8232813|NCT01977625|20300738|P2|COMPLETED|First Intervention (4 Weeks)||7
8232814|NCT01977625|20300739|P1|COMPLETED|First Intervention (4 Weeks)||8
8232815|NCT01977625|20300738|P2|STARTED|First Intervention (4 Weeks)||7
8232816|NCT01977625|20300739|P1|STARTED|First Intervention (4 Weeks)||11
8232817|NCT01977612|20300749|P2|NOT COMPLETED|Overall Study||1
8232818|NCT01977612|20300750|P1|NOT COMPLETED|Overall Study||1
8232819|NCT01977612|20300749|P2|COMPLETED|Overall Study||79
8232820|NCT01977612|20300750|P1|COMPLETED|Overall Study||84
8232821|NCT01977612|20300749|P2|STARTED|Overall Study||80
8232822|NCT01977612|20300750|P1|STARTED|Overall Study||85
8232823|NCT01977573|20300772|P4|NOT COMPLETED|Overall Study||3
8232824|NCT01977573|20300773|P3|NOT COMPLETED|Overall Study||4
8232825|NCT01977573|20300774|P2|NOT COMPLETED|Overall Study||3
8232826|NCT01977573|20300775|P1|NOT COMPLETED|Overall Study||20
8232827|NCT01977573|20300772|P4|COMPLETED|Overall Study||33
8232828|NCT01977573|20300773|P3|COMPLETED|Overall Study||32
8232829|NCT01977573|20300774|P2|COMPLETED|Overall Study||41
8232830|NCT01977573|20300775|P1|COMPLETED|Overall Study||116
8232831|NCT01977573|20300772|P4|STARTED|Overall Study||36
8232832|NCT01977573|20300773|P3|STARTED|Overall Study||36
8232833|NCT01977573|20300774|P2|STARTED|Overall Study||44
8232834|NCT01977573|20300775|P1|STARTED|Overall Study||136
8232835|NCT01977482|20300889|P6|NOT COMPLETED|Overall Study||5
8232836|NCT01977482|20300890|P5|NOT COMPLETED|Overall Study||3
8232837|NCT01977482|20300891|P4|NOT COMPLETED|Overall Study||4
8232838|NCT01977482|20300892|P3|NOT COMPLETED|Overall Study||5
8232839|NCT01977482|20300893|P2|NOT COMPLETED|Overall Study||9
8232840|NCT01977482|20300894|P1|NOT COMPLETED|Overall Study||3
8232841|NCT01977482|20300889|P6|COMPLETED|Overall Study||14
8232842|NCT01977482|20300890|P5|COMPLETED|Overall Study||37
8232843|NCT01977482|20300891|P4|COMPLETED|Overall Study||35
8232844|NCT01977482|20300892|P3|COMPLETED|Overall Study||35
8232845|NCT01977482|20300893|P2|COMPLETED|Overall Study||30
8232846|NCT01977482|20300894|P1|COMPLETED|Overall Study||36
8232847|NCT01977482|20300889|P6|STARTED|Overall Study||19
8232848|NCT01977482|20300890|P5|STARTED|Overall Study||40
8232849|NCT01977482|20300891|P4|STARTED|Overall Study||39
8232850|NCT01977482|20300892|P3|STARTED|Overall Study||40
8232851|NCT01977482|20300893|P2|STARTED|Overall Study||39
8232852|NCT01977482|20300894|P1|STARTED|Overall Study||39
8232853|NCT01977456|20301009|P1|NOT COMPLETED|Overall Study||5
8232854|NCT01977456|20301009|P1|COMPLETED|Overall Study||22
8232855|NCT01977456|20301009|P1|STARTED|Overall Study||27
8232856|NCT01977352|20301018|P2|NOT COMPLETED|Overall Study||2
8232857|NCT01977352|20301019|P1|NOT COMPLETED|Overall Study||1
8232858|NCT01977352|20301018|P2|COMPLETED|Overall Study||19
8232859|NCT01977352|20301019|P1|COMPLETED|Overall Study||20
8232860|NCT01977352|20301018|P2|STARTED|Overall Study||21
8232861|NCT01977352|20301019|P1|STARTED|Overall Study||21
8232862|NCT01977222|20301037|P1|NOT COMPLETED|Overall Study||1
8232863|NCT01977222|20301037|P1|COMPLETED|Overall Study||11
8232864|NCT01977222|20301037|P1|STARTED|Overall Study||12
8232865|NCT01977092|20301050|P2|NOT COMPLETED|Overall Study||30
8232866|NCT01977092|20301051|P1|NOT COMPLETED|Overall Study||31
8232867|NCT01977092|20301050|P2|COMPLETED|Overall Study||151
8232868|NCT01977092|20301051|P1|COMPLETED|Overall Study||118
8232869|NCT01977092|20301050|P2|STARTED|Overall Study||181
8232870|NCT01977092|20301051|P1|STARTED|Overall Study||149
8232871|NCT01977040|20301061|P1|NOT COMPLETED|Overall Study||2
8232872|NCT01977040|20301061|P1|COMPLETED|Overall Study||66
8232873|NCT01977040|20301061|P1|STARTED|Overall Study||68
8232874|NCT01976988|20301073|P2|NOT COMPLETED|Overall Study||18
8232875|NCT01976988|20301074|P1|NOT COMPLETED|Overall Study||16
8232876|NCT01976988|20301073|P2|COMPLETED|Overall Study||184
8232877|NCT01976988|20301074|P1|COMPLETED|Overall Study||192
8232878|NCT01976988|20301073|P2|STARTED|Overall Study||202
8232879|NCT01976988|20301074|P1|STARTED|Overall Study||208
8232886|NCT01976871|20301103|P1|NOT COMPLETED|Overall Study||1
8232887|NCT01976871|20301103|P1|COMPLETED|Overall Study||20
8232888|NCT01976871|20301103|P1|STARTED|Overall Study||21
8232889|NCT01976845|20301115|P3|NOT COMPLETED|Overall Study||3
8232890|NCT01976845|20301116|P2|NOT COMPLETED|Overall Study||8
8232891|NCT01976845|20301117|P1|NOT COMPLETED|Overall Study||8
8232892|NCT01976845|20301115|P3|COMPLETED|Overall Study||40
8232893|NCT01976845|20301116|P2|COMPLETED|Overall Study||40
8232894|NCT01976845|20301117|P1|COMPLETED|Overall Study||40
8232895|NCT01976845|20301115|P3|STARTED|Overall Study||43
8232896|NCT01976845|20301116|P2|STARTED|Overall Study||48
8232897|NCT01976845|20301117|P1|STARTED|Overall Study||48
8232898|NCT01976819|20301131|P1|NOT COMPLETED|Overall Study||5
8232899|NCT01976819|20301131|P1|COMPLETED|Overall Study||11
8232900|NCT01976819|20301131|P1|STARTED|Overall Study||16
8232901|NCT01976806|20301142|P2|NOT COMPLETED|Overall Study||6
8232902|NCT01976806|20301143|P1|NOT COMPLETED|Overall Study||3
8232903|NCT01976806|20301142|P2|COMPLETED|Overall Study||22
8232904|NCT01976806|20301143|P1|COMPLETED|Overall Study||24
8232905|NCT01976806|20301142|P2|STARTED|Overall Study||28
8232906|NCT01976806|20301143|P1|STARTED|Overall Study||27
8232937|NCT01976663|20301428|P1|NOT COMPLETED|Overall Study||42
8232938|NCT01976663|20301428|P1|COMPLETED|Overall Study||84
8232939|NCT01976663|20301428|P1|Received Repeat Treatment|Overall Study||85
8232940|NCT01976663|20301428|P1|Received Asymmetry Correction|Overall Study||45
8232941|NCT01976663|20301428|P1|Received Touch-up Treatment|Overall Study||63
8232942|NCT01976663|20301428|P1|STARTED|Overall Study||126
8232943|NCT01976650|20301442|P1|NOT COMPLETED|Overall Study||6
8232944|NCT01976650|20301442|P1|COMPLETED|Overall Study||718
8232945|NCT01976650|20301442|P1|STARTED|Overall Study||724
8232946|NCT01976624|20301447|P1|NOT COMPLETED|Overall Study||14
8232947|NCT01976624|20301447|P1|COMPLETED|Overall Study||742
8232948|NCT01976624|20301447|P1|STARTED|Overall Study||756
8232949|NCT01976572|20301452|P3|NOT COMPLETED|Overall Study||0
8232950|NCT01976572|20301453|P2|NOT COMPLETED|Overall Study||0
8232951|NCT01976572|20301454|P1|NOT COMPLETED|Overall Study||0
8232952|NCT01976572|20301452|P3|COMPLETED|Overall Study||6
8232953|NCT01976572|20301453|P2|COMPLETED|Overall Study||6
8232954|NCT01976572|20301454|P1|COMPLETED|Overall Study||6
8232955|NCT01976572|20301452|P3|STARTED|Overall Study||6
8232956|NCT01976572|20301453|P2|STARTED|Overall Study||6
8232957|NCT01976572|20301454|P1|STARTED|Overall Study||6
8232958|NCT01976507|20301475|P1|NOT COMPLETED|Overall Study||7
8232959|NCT01976507|20301475|P1|COMPLETED|Overall Study||94
8232960|NCT01976507|20301475|P1|Received Initial Dose of Dabigatran|Overall Study||100
8232961|NCT01976507|20301475|P1|STARTED|Overall Study||101
8232962|NCT01976442|20301484|P2|NOT COMPLETED|Overall Study||0
8232963|NCT01976442|20301485|P1|NOT COMPLETED|Overall Study||0
8232964|NCT01976442|20301484|P2|COMPLETED|Overall Study||31
8232965|NCT01976442|20301485|P1|COMPLETED|Overall Study||69
8232966|NCT01976442|20301484|P2|STARTED|Overall Study||31
8232967|NCT01976442|20301485|P1|STARTED|Overall Study||69
8232968|NCT01976416|20301499|P2|NOT COMPLETED|Overall Study||2
8232969|NCT01976416|20301500|P1|NOT COMPLETED|Overall Study||2
8232970|NCT01976416|20301499|P2|COMPLETED|Overall Study||102
8232971|NCT01976416|20301500|P1|COMPLETED|Overall Study||102
8232972|NCT01976416|20301499|P2|STARTED|Overall Study||104
8232973|NCT01976416|20301500|P1|STARTED|Overall Study||104
8232974|NCT01976364|20301506|P3|NOT COMPLETED|Sub-study (12 Months)||5
8232975|NCT01976364|20301507|P2|NOT COMPLETED|Sub-study (12 Months)||6
8232976|NCT01976364|20301508|P1|NOT COMPLETED|Sub-study (12 Months)||0
8232977|NCT01976364|20301506|P3|COMPLETED|Sub-study (12 Months)||85
8232978|NCT01976364|20301507|P2|COMPLETED|Sub-study (12 Months)||83
8232979|NCT01976364|20301508|P1|COMPLETED|Sub-study (12 Months)||0
8232980|NCT01976364|20301506|P3|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|90
8232981|NCT01976364|20301507|P2|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|89
8232982|NCT01976364|20301508|P1|STARTED|Sub-study (12 Months)||0
8232983|NCT01976364|20301506|P3|NOT COMPLETED|Main Study (36 Months)||0
8232984|NCT01976364|20301507|P2|NOT COMPLETED|Main Study (36 Months)||0
8232985|NCT01976364|20301508|P1|NOT COMPLETED|Main Study (36 Months)||221
8232986|NCT01976364|20301506|P3|COMPLETED|Main Study (36 Months)||0
8232987|NCT01976364|20301507|P2|COMPLETED|Main Study (36 Months)||0
8232988|NCT01976364|20301508|P1|COMPLETED|Main Study (36 Months)||465
8232989|NCT01976364|20301506|P3|STARTED|Main Study (36 Months)||0
8232990|NCT01976364|20301507|P2|STARTED|Main Study (36 Months)||0
8232991|NCT01976364|20301508|P1|STARTED|Main Study (36 Months)||686
8232992|NCT01976338|20301628|P2|NOT COMPLETED|Overall Study||4
8232993|NCT01976338|20301629|P1|NOT COMPLETED|Overall Study||13
8232994|NCT01976338|20301628|P2|COMPLETED|Overall Study|12 months|89
8232995|NCT01976338|20301629|P1|COMPLETED|Overall Study|12 months|177
8232996|NCT01976338|20301628|P2|Discontinued Study Prior to 6 Months|Overall Study||2
8232997|NCT01976338|20301629|P1|Discontinued Study Prior to 6 Months|Overall Study||5
8232998|NCT01976338|20301628|P2|Completed 6 Months|Overall Study||91
8232999|NCT01976338|20301629|P1|Completed 6 Months|Overall Study||185
8233000|NCT01976338|20301628|P2|STARTED|Overall Study||93
8233001|NCT01976338|20301629|P1|STARTED|Overall Study||190
8233002|NCT01976312|20301656|P2|NOT COMPLETED|Overall Study||9
8233003|NCT01976312|20301657|P1|NOT COMPLETED|Overall Study||17
8233004|NCT01976312|20301656|P2|COMPLETED|Overall Study|Completed study at 12 months|53
8233005|NCT01976312|20301657|P1|COMPLETED|Overall Study|Completed study at 12 months|173
8233006|NCT01976312|20301656|P2|Discontinued Study Prior to 3 Months|Overall Study||2
8233007|NCT01976312|20301657|P1|Discontinued Study Prior to 3 Months|Overall Study||4
8233008|NCT01976312|20301656|P2|Completed 3 Months|Overall Study||60
8233009|NCT01976312|20301657|P1|Completed 3 Months|Overall Study||186
8233010|NCT01976312|20301656|P2|STARTED|Overall Study||62
8233011|NCT01976312|20301657|P1|STARTED|Overall Study||190
8233012|NCT01976299|20301678|P2|NOT COMPLETED|Overall Study||6
8233013|NCT01976299|20301679|P1|NOT COMPLETED|Overall Study||23
8233014|NCT01976299|20301678|P2|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
8233015|NCT01976299|20301679|P1|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
8233016|NCT01976299|20301678|P2|Completed Procedure|Overall Study||284
8233017|NCT01976299|20301679|P1|Completed Procedure|Overall Study||283
8233018|NCT01976299|20301678|P2|STARTED|Overall Study||286
8233019|NCT01976299|20301679|P1|STARTED|Overall Study||292
8233020|NCT01976273|20301695|P2|NOT COMPLETED|Overall Study||1
8233021|NCT01976273|20301696|P1|NOT COMPLETED|Overall Study||1
8233022|NCT01976273|20301695|P2|COMPLETED|Overall Study||9
8233023|NCT01976273|20301696|P1|COMPLETED|Overall Study||9
8233024|NCT01976273|20301695|P2|STARTED|Overall Study||10
8233025|NCT01976273|20301696|P1|STARTED|Overall Study||10
8233026|NCT01976104|20301706|P4|NOT COMPLETED|Overall Study||3
8233027|NCT01976104|20301707|P3|NOT COMPLETED|Overall Study||2
8233028|NCT01976104|20301708|P2|NOT COMPLETED|Overall Study||2
8233029|NCT01976104|20301709|P1|NOT COMPLETED|Overall Study||6
8233030|NCT01976104|20301706|P4|COMPLETED|Overall Study||55
8233031|NCT01976104|20301707|P3|COMPLETED|Overall Study||31
8233032|NCT01976104|20301708|P2|COMPLETED|Overall Study||68
8233033|NCT01976104|20301709|P1|COMPLETED|Overall Study||37
8233034|NCT01976104|20301706|P4|STARTED|Overall Study||58
8233035|NCT01976104|20301707|P3|STARTED|Overall Study||33
8233036|NCT01976104|20301708|P2|STARTED|Overall Study||70
8233037|NCT01976104|20301709|P1|STARTED|Overall Study||43
8233038|NCT01975974|20301735|P1|NOT COMPLETED|Overall Study||0
8233039|NCT01975974|20301735|P1|COMPLETED|Overall Study||100
8233040|NCT01975974|20301735|P1|STARTED|Overall Study||100
8233041|NCT01975948|20301743|P4|NOT COMPLETED|Overall Study||6
8233042|NCT01975948|20301744|P3|NOT COMPLETED|Overall Study||7
8233043|NCT01975948|20301745|P2|NOT COMPLETED|Overall Study||21
8233044|NCT01975948|20301746|P1|NOT COMPLETED|Overall Study||17
8233045|NCT01975948|20301743|P4|COMPLETED|Overall Study||51
8233046|NCT01975948|20301744|P3|COMPLETED|Overall Study||65
8233047|NCT01975948|20301745|P2|COMPLETED|Overall Study||34
8233048|NCT01975948|20301746|P1|COMPLETED|Overall Study||39
8233049|NCT01975948|20301743|P4|STARTED|Overall Study||57
8233050|NCT01975948|20301744|P3|STARTED|Overall Study||72
8233051|NCT01975948|20301745|P2|STARTED|Overall Study||55
8233052|NCT01975948|20301746|P1|STARTED|Overall Study||56
8233053|NCT01975935|20301772|P2|NOT COMPLETED|Overall Study||1
8233054|NCT01975935|20301773|P1|NOT COMPLETED|Overall Study||3
8233055|NCT01975935|20301772|P2|COMPLETED|Overall Study||20
8233056|NCT01975935|20301773|P1|COMPLETED|Overall Study||18
8233057|NCT01975935|20301772|P2|STARTED|Overall Study||21
8233058|NCT01975935|20301773|P1|STARTED|Overall Study||21
8233059|NCT01975922|20301785|P2|NOT COMPLETED|Overall Study||9
8233060|NCT01975922|20301786|P1|NOT COMPLETED|Overall Study||0
8233061|NCT01975922|20301785|P2|COMPLETED|Overall Study||43
8233062|NCT01975922|20301786|P1|COMPLETED|Overall Study||45
8233063|NCT01975922|20301785|P2|STARTED|Overall Study||52
8233064|NCT01975922|20301786|P1|STARTED|Overall Study||45
8233065|NCT01975909|20301796|P2|NOT COMPLETED|Overall Study||0
8233066|NCT01975909|20301797|P1|NOT COMPLETED|Overall Study||0
8233067|NCT01975909|20301796|P2|COMPLETED|Overall Study||10
8233068|NCT01975909|20301797|P1|COMPLETED|Overall Study||10
8233069|NCT01975909|20301796|P2|STARTED|Overall Study||10
8233070|NCT01975909|20301797|P1|STARTED|Overall Study||10
8233098|NCT01975701|20301895|P1|NOT COMPLETED|Overall Study||25
8233099|NCT01975701|20301895|P1|COMPLETED|Overall Study||1
8233100|NCT01975701|20301895|P1|STARTED|Overall Study||26
8233101|NCT01975675|20301906|P4|NOT COMPLETED|Overall Study||0
8233102|NCT01975675|20301907|P3|NOT COMPLETED|Overall Study||0
8233103|NCT01975675|20301908|P2|NOT COMPLETED|Overall Study||1
8233104|NCT01975675|20301909|P1|NOT COMPLETED|Overall Study||0
8233105|NCT01975675|20301906|P4|COMPLETED|Overall Study||87
8233106|NCT01975675|20301907|P3|COMPLETED|Overall Study||88
8233107|NCT01975675|20301908|P2|COMPLETED|Overall Study||82
8233108|NCT01975675|20301909|P1|COMPLETED|Overall Study||83
8233109|NCT01975675|20301906|P4|STARTED|Overall Study||87
8233110|NCT01975675|20301907|P3|STARTED|Overall Study||88
8233111|NCT01975675|20301908|P2|STARTED|Overall Study||83
8233112|NCT01975675|20301909|P1|STARTED|Overall Study||83
8233113|NCT01975519|20301931|P2|NOT COMPLETED|Overall Study||0
8233114|NCT01975519|20301932|P1|NOT COMPLETED|Overall Study||0
8233115|NCT01975519|20301931|P2|COMPLETED|Overall Study||108
8233116|NCT01975519|20301932|P1|COMPLETED|Overall Study||3
8233117|NCT01975519|20301931|P2|Phase 2a Angiosarcoma Cohort|Overall Study||22
8233118|NCT01975519|20301932|P1|Phase 2a Angiosarcoma Cohort|Overall Study||0
8233119|NCT01975519|20301931|P2|Phase 2a Soft Tissue Sarcoma|Overall Study||63
8233120|NCT01975519|20301932|P1|Phase 2a Soft Tissue Sarcoma|Overall Study||0
8233121|NCT01975519|20301931|P2|Phase 1b|Overall Study||23
8233122|NCT01975519|20301932|P1|Phase 1b|Overall Study||3
8233123|NCT01975519|20301931|P2|STARTED|Overall Study||108
8233124|NCT01975519|20301932|P1|STARTED|Overall Study||3
8233125|NCT01975467|20301949|P2|NOT COMPLETED|Overall Study||0
8233126|NCT01975467|20301950|P1|NOT COMPLETED|Overall Study||0
8233127|NCT01975467|20301949|P2|COMPLETED|Overall Study||0
8233128|NCT01975467|20301950|P1|COMPLETED|Overall Study||0
8233129|NCT01975467|20301949|P2|STARTED|Overall Study|Study terminated before enrollment|0
8233130|NCT01975467|20301950|P1|STARTED|Overall Study|Study terminated before enrollment|0
8233131|NCT01975389|20301960|P2|NOT COMPLETED|Overall Study||236
8233132|NCT01975389|20301961|P1|NOT COMPLETED|Overall Study||252
8233133|NCT01975389|20301960|P2|COMPLETED|Overall Study||5045
8233134|NCT01975389|20301961|P1|COMPLETED|Overall Study||5031
8233135|NCT01975389|20301960|P2|Treated|Overall Study||5276
8233136|NCT01975389|20301961|P1|Treated|Overall Study||5279
8233137|NCT01975389|20301960|P2|STARTED|Overall Study||5281
8233138|NCT01975389|20301961|P1|STARTED|Overall Study||5283
8233139|NCT01975376|20302021|P2|NOT COMPLETED|Overall Study||217
8233140|NCT01975376|20302022|P1|NOT COMPLETED|Overall Study||226
8233141|NCT01975376|20302021|P2|COMPLETED|Overall Study||8177
8233142|NCT01975376|20302022|P1|COMPLETED|Overall Study||8164
8233143|NCT01975376|20302021|P2|Treated|Overall Study||8386
8233144|NCT01975376|20302022|P1|Treated|Overall Study||8374
8233145|NCT01975376|20302021|P2|STARTED|Overall Study||8394
8233146|NCT01975376|20302022|P1|STARTED|Overall Study||8390
8233147|NCT01975285|20302082|P2|NOT COMPLETED|Overall Study||2
8233148|NCT01975285|20302083|P1|NOT COMPLETED|Overall Study||2
8233149|NCT01975285|20302082|P2|COMPLETED|Overall Study||28
8233150|NCT01975285|20302083|P1|COMPLETED|Overall Study||28
8233151|NCT01975285|20302082|P2|STARTED|Overall Study||30
8233152|NCT01975285|20302083|P1|STARTED|Overall Study||30
8233153|NCT01975246|20302099|P2|NOT COMPLETED|Overall Study||2
8233154|NCT01975246|20302100|P1|NOT COMPLETED|Overall Study||4
8233155|NCT01975246|20302099|P2|COMPLETED|Overall Study||158
8233156|NCT01975246|20302100|P1|COMPLETED|Overall Study||145
8233157|NCT01975246|20302099|P2|STARTED|Overall Study||160
8233158|NCT01975246|20302100|P1|STARTED|Overall Study||149
8233159|NCT01975220|20302113|P6|NOT COMPLETED|Test Period 2||0
8233160|NCT01975220|20302114|P5|NOT COMPLETED|Test Period 2||0
8233161|NCT01975220|20302115|P4|NOT COMPLETED|Test Period 2||0
8233162|NCT01975220|20302116|P3|NOT COMPLETED|Test Period 2||0
8233163|NCT01975220|20302117|P2|NOT COMPLETED|Test Period 2||0
8233164|NCT01975220|20302118|P1|NOT COMPLETED|Test Period 2||0
8233165|NCT01975220|20302113|P6|COMPLETED|Test Period 2||12
8233166|NCT01975220|20302114|P5|COMPLETED|Test Period 2||12
8233167|NCT01975220|20302115|P4|COMPLETED|Test Period 2||12
8233168|NCT01975220|20302116|P3|COMPLETED|Test Period 2||12
8233169|NCT01975220|20302117|P2|COMPLETED|Test Period 2||11
8233170|NCT01975220|20302118|P1|COMPLETED|Test Period 2||12
8233171|NCT01975220|20302113|P6|STARTED|Test Period 2||12
8233172|NCT01975220|20302114|P5|STARTED|Test Period 2||12
8233173|NCT01975220|20302115|P4|STARTED|Test Period 2||12
8233174|NCT01975220|20302116|P3|STARTED|Test Period 2||12
8233175|NCT01975220|20302117|P2|STARTED|Test Period 2||11
8233176|NCT01975220|20302118|P1|STARTED|Test Period 2||12
8233177|NCT01975220|20302113|P6|NOT COMPLETED|Test Period 1||0
8233178|NCT01975220|20302114|P5|NOT COMPLETED|Test Period 1||0
8233179|NCT01975220|20302115|P4|NOT COMPLETED|Test Period 1||0
8233180|NCT01975220|20302116|P3|NOT COMPLETED|Test Period 1||0
8233181|NCT01975220|20302117|P2|NOT COMPLETED|Test Period 1||1
8233182|NCT01975220|20302118|P1|NOT COMPLETED|Test Period 1||0
8233183|NCT01975220|20302113|P6|COMPLETED|Test Period 1||12
8233184|NCT01975220|20302114|P5|COMPLETED|Test Period 1||12
8233185|NCT01975220|20302115|P4|COMPLETED|Test Period 1||12
8233186|NCT01975220|20302116|P3|COMPLETED|Test Period 1||12
8233187|NCT01975220|20302117|P2|COMPLETED|Test Period 1||11
8233188|NCT01975220|20302118|P1|COMPLETED|Test Period 1||12
8233189|NCT01975220|20302113|P6|STARTED|Test Period 1||12
8233190|NCT01975220|20302114|P5|STARTED|Test Period 1||12
8233191|NCT01975220|20302115|P4|STARTED|Test Period 1||12
8233192|NCT01975220|20302116|P3|STARTED|Test Period 1||12
8233193|NCT01975220|20302117|P2|STARTED|Test Period 1||12
8233194|NCT01975220|20302118|P1|STARTED|Test Period 1||12
8233195|NCT01975090|20302162|P1|NOT COMPLETED|Overall Study||12
8233196|NCT01975090|20302162|P1|COMPLETED|Overall Study||117
8233197|NCT01975090|20302162|P1|6-month Follow-up|Overall Study||117
8233198|NCT01975090|20302162|P1|STARTED|Overall Study||129
8233199|NCT01974895|20302174|P2|NOT COMPLETED|Overall Study||15
8233200|NCT01974895|20302175|P1|NOT COMPLETED|Overall Study||15
8233201|NCT01974895|20302174|P2|COMPLETED|Overall Study||141
8233202|NCT01974895|20302175|P1|COMPLETED|Overall Study||143
8233203|NCT01974895|20302174|P2|STARTED|Overall Study||156
8233204|NCT01974895|20302175|P1|STARTED|Overall Study||158
8233205|NCT01974817|20302205|P1|NOT COMPLETED|Overall Study||8
8233206|NCT01974817|20302205|P1|COMPLETED|Overall Study||17
8233207|NCT01974817|20302205|P1|STARTED|Overall Study||25
8233208|NCT01974752|20302211|P2|NOT COMPLETED|Overall Study||15
8233209|NCT01974752|20302212|P1|NOT COMPLETED|Overall Study||37
8233210|NCT01974752|20302211|P2|COMPLETED|Overall Study||17
8233211|NCT01974752|20302212|P1|COMPLETED|Overall Study||60
8233212|NCT01974752|20302211|P2|STARTED|Overall Study||32
8233213|NCT01974752|20302212|P1|STARTED|Overall Study||97
8233214|NCT01974700|20302226|P2|NOT COMPLETED|Overall Study||0
8233215|NCT01974700|20302227|P1|NOT COMPLETED|Overall Study||0
8233216|NCT01974700|20302226|P2|COMPLETED|Overall Study||3
8233217|NCT01974700|20302227|P1|COMPLETED|Overall Study||5
8233218|NCT01974700|20302226|P2|STARTED|Overall Study||3
8233219|NCT01974700|20302227|P1|STARTED|Overall Study||5
8233220|NCT01974687|20302262|P25|NOT COMPLETED|Overall Study||0
8233221|NCT01974687|20302263|P24|NOT COMPLETED|Overall Study||0
8233222|NCT01974687|20302264|P23|NOT COMPLETED|Overall Study||0
8233223|NCT01974687|20302265|P22|NOT COMPLETED|Overall Study||0
8233224|NCT01974687|20302266|P21|NOT COMPLETED|Overall Study||0
8233225|NCT01974687|20302267|P20|NOT COMPLETED|Overall Study||0
8233226|NCT01974687|20302268|P19|NOT COMPLETED|Overall Study||0
8233227|NCT01974687|20302269|P18|NOT COMPLETED|Overall Study||3
8233228|NCT01974687|20302270|P17|NOT COMPLETED|Overall Study||1
8233229|NCT01974687|20302271|P16|NOT COMPLETED|Overall Study||1
8233230|NCT01974687|20302272|P15|NOT COMPLETED|Overall Study||1
8233231|NCT01974687|20302273|P14|NOT COMPLETED|Overall Study||2
8233232|NCT01974687|20302274|P13|NOT COMPLETED|Overall Study||3
8233233|NCT01974687|20302275|P12|NOT COMPLETED|Overall Study||2
8233234|NCT01974687|20302276|P11|NOT COMPLETED|Overall Study||0
8233235|NCT01974687|20302277|P10|NOT COMPLETED|Overall Study||0
8233236|NCT01974687|20302278|P9|NOT COMPLETED|Overall Study||0
8233237|NCT01974687|20302279|P8|NOT COMPLETED|Overall Study||0
8233238|NCT01974687|20302280|P7|NOT COMPLETED|Overall Study||0
8233239|NCT01974687|20302281|P6|NOT COMPLETED|Overall Study||0
8233240|NCT01974687|20302282|P5|NOT COMPLETED|Overall Study||0
8233241|NCT01974687|20302283|P4|NOT COMPLETED|Overall Study||0
8233242|NCT01974687|20302284|P3|NOT COMPLETED|Overall Study||0
8233243|NCT01974687|20302285|P2|NOT COMPLETED|Overall Study||0
8233244|NCT01974687|20302286|P1|NOT COMPLETED|Overall Study||0
8233245|NCT01974687|20302262|P25|COMPLETED|Overall Study||10
8233246|NCT01974687|20302263|P24|COMPLETED|Overall Study||6
8233247|NCT01974687|20302264|P23|COMPLETED|Overall Study||8
8233248|NCT01974687|20302265|P22|COMPLETED|Overall Study||8
8233249|NCT01974687|20302266|P21|COMPLETED|Overall Study||3
8233250|NCT01974687|20302267|P20|COMPLETED|Overall Study||3
8233251|NCT01974687|20302268|P19|COMPLETED|Overall Study||9
8233252|NCT01974687|20302269|P18|COMPLETED|Overall Study||8
8233253|NCT01974687|20302270|P17|COMPLETED|Overall Study||8
8233254|NCT01974687|20302271|P16|COMPLETED|Overall Study||8
8233255|NCT01974687|20302272|P15|COMPLETED|Overall Study||18
8233256|NCT01974687|20302273|P14|COMPLETED|Overall Study||8
8233257|NCT01974687|20302274|P13|COMPLETED|Overall Study||10
8233258|NCT01974687|20302275|P12|COMPLETED|Overall Study||11
8233259|NCT01974687|20302276|P11|COMPLETED|Overall Study||3
8233260|NCT01974687|20302277|P10|COMPLETED|Overall Study||3
8233261|NCT01974687|20302278|P9|COMPLETED|Overall Study||3
8233262|NCT01974687|20302279|P8|COMPLETED|Overall Study||3
8233263|NCT01974687|20302280|P7|COMPLETED|Overall Study||3
8233264|NCT01974687|20302281|P6|COMPLETED|Overall Study||6
8233265|NCT01974687|20302282|P5|COMPLETED|Overall Study||2
8233266|NCT01974687|20302283|P4|COMPLETED|Overall Study||6
8233267|NCT01974687|20302284|P3|COMPLETED|Overall Study||6
8233268|NCT01974687|20302285|P2|COMPLETED|Overall Study||6
8233269|NCT01974687|20302286|P1|COMPLETED|Overall Study||6
8233270|NCT01974687|20302262|P25|Treated|Overall Study||10
8233271|NCT01974687|20302263|P24|Treated|Overall Study||6
8233272|NCT01974687|20302264|P23|Treated|Overall Study||8
8233273|NCT01974687|20302265|P22|Treated|Overall Study||8
8233274|NCT01974687|20302266|P21|Treated|Overall Study||3
8233275|NCT01974687|20302267|P20|Treated|Overall Study||3
8233276|NCT01974687|20302268|P19|Treated|Overall Study||9
8233277|NCT01974687|20302269|P18|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
8233278|NCT01974687|20302270|P17|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
8233279|NCT01974687|20302271|P16|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
8233280|NCT01974687|20302272|P15|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
8233281|NCT01974687|20302273|P14|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
8233282|NCT01974687|20302274|P13|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
8233283|NCT01974687|20302275|P12|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
8233284|NCT01974687|20302276|P11|Treated|Overall Study||3
8233285|NCT01974687|20302277|P10|Treated|Overall Study||3
8233286|NCT01974687|20302278|P9|Treated|Overall Study||3
8233287|NCT01974687|20302279|P8|Treated|Overall Study||3
8233288|NCT01974687|20302280|P7|Treated|Overall Study||3
8233289|NCT01974687|20302281|P6|Treated|Overall Study||6
8233290|NCT01974687|20302282|P5|Treated|Overall Study||2
8233291|NCT01974687|20302283|P4|Treated|Overall Study||6
8233292|NCT01974687|20302284|P3|Treated|Overall Study||6
8233293|NCT01974687|20302285|P2|Treated|Overall Study||6
8233294|NCT01974687|20302286|P1|Treated|Overall Study||6
8233295|NCT01974687|20302262|P25|STARTED|Overall Study||10
8233296|NCT01974687|20302263|P24|STARTED|Overall Study||6
8233297|NCT01974687|20302264|P23|STARTED|Overall Study||8
8233298|NCT01974687|20302265|P22|STARTED|Overall Study||8
8233299|NCT01974687|20302266|P21|STARTED|Overall Study||3
8233300|NCT01974687|20302267|P20|STARTED|Overall Study||3
8233301|NCT01974687|20302268|P19|STARTED|Overall Study||9
8233302|NCT01974687|20302269|P18|STARTED|Overall Study||11
8233303|NCT01974687|20302270|P17|STARTED|Overall Study||9
8233304|NCT01974687|20302271|P16|STARTED|Overall Study||9
8233305|NCT01974687|20302272|P15|STARTED|Overall Study||19
8233306|NCT01974687|20302273|P14|STARTED|Overall Study||10
8233307|NCT01974687|20302274|P13|STARTED|Overall Study||13
8233308|NCT01974687|20302275|P12|STARTED|Overall Study||13
8233309|NCT01974687|20302276|P11|STARTED|Overall Study||3
8233310|NCT01974687|20302277|P10|STARTED|Overall Study||3
8233311|NCT01974687|20302278|P9|STARTED|Overall Study||3
8233312|NCT01974687|20302279|P8|STARTED|Overall Study||3
8233313|NCT01974687|20302280|P7|STARTED|Overall Study||3
8233314|NCT01974687|20302281|P6|STARTED|Overall Study||6
8233315|NCT01974687|20302282|P5|STARTED|Overall Study||2
8233316|NCT01974687|20302283|P4|STARTED|Overall Study||6
8233317|NCT01974687|20302284|P3|STARTED|Overall Study||6
8233318|NCT01974687|20302285|P2|STARTED|Overall Study||6
8233319|NCT01974687|20302286|P1|STARTED|Overall Study||6
8233320|NCT01974635|20302633|P1|NOT COMPLETED|Overall Study||0
8233321|NCT01974635|20302633|P1|COMPLETED|Overall Study||2
8233322|NCT01974635|20302633|P1|STARTED|Overall Study||2
8233323|NCT01974323|20302640|P2|NOT COMPLETED|Overall Study||93
8233324|NCT01974323|20302641|P1|NOT COMPLETED|Overall Study||92
8233325|NCT01974323|20302640|P2|COMPLETED|Overall Study||1027
8233326|NCT01974323|20302641|P1|COMPLETED|Overall Study||1026
8233327|NCT01974323|20302640|P2|STARTED|Overall Study||1120
8233328|NCT01974323|20302641|P1|STARTED|Overall Study||1118
8233329|NCT01974284|20302663|P1|NOT COMPLETED|Overall Study||7
8233330|NCT01974284|20302663|P1|COMPLETED|Overall Study||0
8233331|NCT01974284|20302663|P1|STARTED|Overall Study||7
8233332|NCT01974245|20302672|P2|NOT COMPLETED|Overall Study||8
8233333|NCT01974245|20302673|P1|NOT COMPLETED|Overall Study||9
8233334|NCT01974245|20302672|P2|COMPLETED|Overall Study||20
8233335|NCT01974245|20302673|P1|COMPLETED|Overall Study||18
8233336|NCT01974245|20302672|P2|STARTED|Overall Study||28
8233337|NCT01974245|20302673|P1|STARTED|Overall Study||27
8233338|NCT01974141|20302681|P2|NOT COMPLETED|Overall Study||82
8233339|NCT01974141|20302682|P1|NOT COMPLETED|Overall Study||96
8233340|NCT01974141|20302681|P2|COMPLETED|Overall Study||976
8233341|NCT01974141|20302682|P1|COMPLETED|Overall Study||948
8233342|NCT01974141|20302681|P2|STARTED|Overall Study||1058
8233343|NCT01974141|20302682|P1|STARTED|Overall Study||1044
8233344|NCT01974089|20302706|P2|NOT COMPLETED|Overall Study||0
8233345|NCT01974089|20302707|P1|NOT COMPLETED|Overall Study||0
8233346|NCT01974089|20302706|P2|COMPLETED|Overall Study||101
8233347|NCT01974089|20302707|P1|COMPLETED|Overall Study||53
8233348|NCT01974089|20302706|P2|STARTED|Overall Study||101
8233349|NCT01974089|20302707|P1|STARTED|Overall Study||53
8233350|NCT01974050|20302717|P1|NOT COMPLETED|Overall Study||25
8233351|NCT01974050|20302717|P1|COMPLETED|Overall Study||141
8233352|NCT01974050|20302717|P1|STARTED|Overall Study||166
8233353|NCT01973998|20302726|P2|NOT COMPLETED|Overall Study||2
8233354|NCT01973998|20302727|P1|NOT COMPLETED|Overall Study||2
8233355|NCT01973998|20302726|P2|COMPLETED|Overall Study||33
8233356|NCT01973998|20302727|P1|COMPLETED|Overall Study||31
8233357|NCT01973998|20302726|P2|STARTED|Overall Study||35
8233358|NCT01973998|20302727|P1|STARTED|Overall Study||33
8233359|NCT01973972|20302739|P2|NOT COMPLETED|Overall Study||19
8233360|NCT01973972|20302740|P1|NOT COMPLETED|Overall Study||18
8233361|NCT01973972|20302739|P2|COMPLETED|Overall Study||117
8233362|NCT01973972|20302740|P1|COMPLETED|Overall Study||109
8233363|NCT01973972|20302739|P2|STARTED|Overall Study||136
8233364|NCT01973972|20302740|P1|STARTED|Overall Study||127
8233365|NCT01973777|20302754|P1|NOT COMPLETED|Overall Study||7
8233366|NCT01973777|20302754|P1|COMPLETED|Overall Study||44
8233367|NCT01973777|20302754|P1|One Year Follow-up|Overall Study||44
8233368|NCT01973777|20302754|P1|STARTED|Overall Study|January 2014|51
8233369|NCT01973608|20302764|P4|NOT COMPLETED|Overall Study||0
8233370|NCT01973608|20302765|P3|NOT COMPLETED|Overall Study||0
8233371|NCT01973608|20302766|P2|NOT COMPLETED|Overall Study||0
8233372|NCT01973608|20302767|P1|NOT COMPLETED|Overall Study||0
8233373|NCT01973608|20302764|P4|COMPLETED|Overall Study||2
8233374|NCT01973608|20302765|P3|COMPLETED|Overall Study||6
8233375|NCT01973608|20302766|P2|COMPLETED|Overall Study||2
8233376|NCT01973608|20302767|P1|COMPLETED|Overall Study||2
8233377|NCT01973608|20302764|P4|STARTED|Overall Study||2
8233378|NCT01973608|20302765|P3|STARTED|Overall Study||6
8233379|NCT01973608|20302766|P2|STARTED|Overall Study||2
8233380|NCT01973608|20302767|P1|STARTED|Overall Study||2
8233381|NCT01973595|20302789|P4|NOT COMPLETED|Intervention Phase 2||0
8233382|NCT01973595|20302790|P3|NOT COMPLETED|Intervention Phase 2||0
8233383|NCT01973595|20302791|P2|NOT COMPLETED|Intervention Phase 2||0
8233384|NCT01973595|20302792|P1|NOT COMPLETED|Intervention Phase 2||0
8233385|NCT01973595|20302789|P4|COMPLETED|Intervention Phase 2||14
8233386|NCT01973595|20302790|P3|COMPLETED|Intervention Phase 2||14
8233387|NCT01973595|20302791|P2|COMPLETED|Intervention Phase 2||14
8233388|NCT01973595|20302792|P1|COMPLETED|Intervention Phase 2||14
8233389|NCT01973595|20302789|P4|STARTED|Intervention Phase 2||14
8233390|NCT01973595|20302790|P3|STARTED|Intervention Phase 2||14
8233391|NCT01973595|20302791|P2|STARTED|Intervention Phase 2||14
8233392|NCT01973595|20302792|P1|STARTED|Intervention Phase 2||14
8233393|NCT01973595|20302789|P4|NOT COMPLETED|Washout||0
8233394|NCT01973595|20302790|P3|NOT COMPLETED|Washout||1
8233395|NCT01973595|20302791|P2|NOT COMPLETED|Washout||0
8233396|NCT01973595|20302792|P1|NOT COMPLETED|Washout||1
8233397|NCT01973595|20302789|P4|COMPLETED|Washout||14
8233398|NCT01973595|20302790|P3|COMPLETED|Washout||14
8233399|NCT01973595|20302791|P2|COMPLETED|Washout||14
8233400|NCT01973595|20302792|P1|COMPLETED|Washout||14
8233401|NCT01973595|20302789|P4|STARTED|Washout||14
8233402|NCT01973595|20302790|P3|STARTED|Washout||15
8233403|NCT01973595|20302791|P2|STARTED|Washout||14
8233404|NCT01973595|20302792|P1|STARTED|Washout||15
8233405|NCT01973595|20302789|P4|NOT COMPLETED|Intervention Phase 1||0
8233406|NCT01973595|20302790|P3|NOT COMPLETED|Intervention Phase 1||0
8233407|NCT01973595|20302791|P2|NOT COMPLETED|Intervention Phase 1||0
8233408|NCT01973595|20302792|P1|NOT COMPLETED|Intervention Phase 1||0
8233409|NCT01973595|20302789|P4|COMPLETED|Intervention Phase 1||14
8233410|NCT01973595|20302790|P3|COMPLETED|Intervention Phase 1||15
8233411|NCT01973595|20302791|P2|COMPLETED|Intervention Phase 1||14
8233412|NCT01973595|20302792|P1|COMPLETED|Intervention Phase 1||15
8233413|NCT01973595|20302789|P4|STARTED|Intervention Phase 1||14
8233414|NCT01973595|20302790|P3|STARTED|Intervention Phase 1||15
8233415|NCT01973595|20302791|P2|STARTED|Intervention Phase 1||14
8233416|NCT01973595|20302792|P1|STARTED|Intervention Phase 1||15
8233417|NCT01973569|20302809|P3|NOT COMPLETED|Overall Study||18
8233418|NCT01973569|20302810|P2|NOT COMPLETED|Overall Study||25
8233419|NCT01973569|20302811|P1|NOT COMPLETED|Overall Study||29
8233420|NCT01973569|20302809|P3|COMPLETED|Overall Study||208
8233421|NCT01973569|20302810|P2|COMPLETED|Overall Study||200
8233422|NCT01973569|20302811|P1|COMPLETED|Overall Study||199
8233423|NCT01973569|20302809|P3|Discontinued Study|Overall Study||15
8233424|NCT01973569|20302810|P2|Discontinued Study|Overall Study||22
8233425|NCT01973569|20302811|P1|Discontinued Study|Overall Study||23
8233426|NCT01973569|20302809|P3|Discontinued Study Treatment|Overall Study||15
8233427|NCT01973569|20302810|P2|Discontinued Study Treatment|Overall Study||22
8233428|NCT01973569|20302811|P1|Discontinued Study Treatment|Overall Study||23
8233429|NCT01973569|20302809|P3|Did Not Receive Study Drug|Overall Study||3
8233430|NCT01973569|20302810|P2|Did Not Receive Study Drug|Overall Study||3
8233431|NCT01973569|20302811|P1|Did Not Receive Study Drug|Overall Study||6
8233432|NCT01973569|20302809|P3|Received Study Drug|Overall Study||223
8233433|NCT01973569|20302810|P2|Received Study Drug|Overall Study||222
8233434|NCT01973569|20302811|P1|Received Study Drug|Overall Study||222
8233435|NCT01973569|20302809|P3|STARTED|Overall Study||226
8233436|NCT01973569|20302810|P2|STARTED|Overall Study||225
8233437|NCT01973569|20302811|P1|STARTED|Overall Study||228
8233438|NCT01973491|20302837|P1|NOT COMPLETED|Treatment Period (16 Weeks)||1
8233439|NCT01973491|20302837|P1|COMPLETED|Treatment Period (16 Weeks)||18
8233440|NCT01973491|20302837|P1|STARTED|Treatment Period (16 Weeks)||19
8233441|NCT01973491|20302837|P1|NOT COMPLETED|Titration Period(4 Weeks)||0
8233442|NCT01973491|20302837|P1|COMPLETED|Titration Period(4 Weeks)||19
8233443|NCT01973491|20302837|P1|STARTED|Titration Period(4 Weeks)||19
8233444|NCT01973491|20302837|P1|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
8233445|NCT01973491|20302837|P1|COMPLETED|Baseline Control Period (8 Weeks)||19
8233446|NCT01973491|20302837|P1|STARTED|Baseline Control Period (8 Weeks)||37
8233447|NCT01973439|20302853|P1|NOT COMPLETED|Overall Study||5
8233448|NCT01973439|20302853|P1|COMPLETED|Overall Study||18
8233449|NCT01973439|20302853|P1|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
8233450|NCT01973439|20302853|P1|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
8233451|NCT01973439|20302853|P1|STARTED|Overall Study||23
8233452|NCT01973413|20302862|P2|NOT COMPLETED|Overall Study||0
8233453|NCT01973413|20302863|P1|NOT COMPLETED|Overall Study||1
8233454|NCT01973413|20302862|P2|COMPLETED|Overall Study||20
8233455|NCT01973413|20302863|P1|COMPLETED|Overall Study||11
8233456|NCT01973413|20302862|P2|STARTED|Overall Study||20
8233457|NCT01973413|20302863|P1|STARTED|Overall Study||12
8233458|NCT01973387|20302875|P2|NOT COMPLETED|Overall Study||18
8233459|NCT01973387|20302876|P1|NOT COMPLETED|Overall Study||106
8233460|NCT01973387|20302875|P2|COMPLETED|Overall Study||36
8233461|NCT01973387|20302876|P1|COMPLETED|Overall Study||0
8233462|NCT01973387|20302875|P2|Treated|Overall Study||52
8233463|NCT01973387|20302876|P1|Treated|Overall Study||104
8233464|NCT01973387|20302875|P2|STARTED|Overall Study||54
8233465|NCT01973387|20302876|P1|STARTED|Overall Study||106
8233466|NCT01973348|20302894|P4|NOT COMPLETED|Overall Study||0
8233467|NCT01973348|20302895|P3|NOT COMPLETED|Overall Study||0
8233468|NCT01973348|20302896|P2|NOT COMPLETED|Overall Study||3
8233469|NCT01973348|20302897|P1|NOT COMPLETED|Overall Study||8
8233470|NCT01973348|20302894|P4|COMPLETED|Overall Study||0
8233471|NCT01973348|20302895|P3|COMPLETED|Overall Study||0
8233472|NCT01973348|20302896|P2|COMPLETED|Overall Study||15
8233473|NCT01973348|20302897|P1|COMPLETED|Overall Study||19
8233474|NCT01973348|20302894|P4|STARTED|Overall Study||0
8233475|NCT01973348|20302895|P3|STARTED|Overall Study||0
8233476|NCT01973348|20302896|P2|STARTED|Overall Study||18
8233477|NCT01973348|20302897|P1|STARTED|Overall Study||27
8233478|NCT01973335|20302919|P4|NOT COMPLETED|Overall Study||0
8233479|NCT01973335|20302920|P3|NOT COMPLETED|Overall Study||0
8233480|NCT01973335|20302921|P2|NOT COMPLETED|Overall Study||0
8233481|NCT01973335|20302922|P1|NOT COMPLETED|Overall Study||0
8233482|NCT01973335|20302919|P4|COMPLETED|Overall Study||9
8233483|NCT01973335|20302920|P3|COMPLETED|Overall Study||9
8233484|NCT01973335|20302921|P2|COMPLETED|Overall Study||7
8233485|NCT01973335|20302922|P1|COMPLETED|Overall Study||9
8233486|NCT01973335|20302919|P4|STARTED|Overall Study||9
8233487|NCT01973335|20302920|P3|STARTED|Overall Study||9
8233488|NCT01973335|20302921|P2|STARTED|Overall Study||7
8233489|NCT01973335|20302922|P1|STARTED|Overall Study||9
8233490|NCT01973231|20302958|P2|NOT COMPLETED|Overall Study||12
8233491|NCT01973231|20302959|P1|NOT COMPLETED|Overall Study||11
8233492|NCT01973231|20302958|P2|COMPLETED|Overall Study||190
8233493|NCT01973231|20302959|P1|COMPLETED|Overall Study||191
8233494|NCT01973231|20302958|P2|STARTED|Overall Study||202
8233495|NCT01973231|20302959|P1|STARTED|Overall Study||202
8233496|NCT01973218|20302979|P2|NOT COMPLETED|Overall Study||0
8233497|NCT01973218|20302980|P1|NOT COMPLETED|Overall Study||2
8233498|NCT01973218|20302979|P2|COMPLETED|Overall Study||88
8233499|NCT01973218|20302980|P1|COMPLETED|Overall Study||174
8233500|NCT01973218|20302979|P2|STARTED|Overall Study||88
8233501|NCT01973218|20302980|P1|STARTED|Overall Study||176
8233502|NCT01973205|20303003|P2|NOT COMPLETED|Overall Study||22
8233503|NCT01973205|20303004|P1|NOT COMPLETED|Overall Study||30
8233504|NCT01973205|20303003|P2|COMPLETED|Overall Study||425
8233505|NCT01973205|20303004|P1|COMPLETED|Overall Study||423
8233506|NCT01973205|20303003|P2|STARTED|Overall Study||447
8233507|NCT01973205|20303004|P1|STARTED|Overall Study||453
8233508|NCT01973062|20303016|P1|NOT COMPLETED|Overall Study||0
8233509|NCT01973062|20303016|P1|COMPLETED|Overall Study||1
8233510|NCT01973062|20303016|P1|STARTED|Overall Study||1
8233511|NCT01973036|20303026|P2|NOT COMPLETED|Overall Study||0
8233512|NCT01973036|20303027|P1|NOT COMPLETED|Overall Study||0
8233513|NCT01973036|20303026|P2|COMPLETED|Overall Study||93
8233514|NCT01973036|20303027|P1|COMPLETED|Overall Study||108
8233515|NCT01973036|20303026|P2|Received Assigned Intervention|Overall Study||88
8233516|NCT01973036|20303027|P1|Received Assigned Intervention|Overall Study||113
8233517|NCT01973036|20303026|P2|STARTED|Overall Study||93
8233518|NCT01973036|20303027|P1|STARTED|Overall Study||108
8233519|NCT01972841|20303073|P6|NOT COMPLETED|Overall Study||85
8233520|NCT01972841|20303074|P5|NOT COMPLETED|Overall Study||83
8233521|NCT01972841|20303075|P4|NOT COMPLETED|Overall Study||37
8233522|NCT01972841|20303076|P3|NOT COMPLETED|Overall Study||50
8233523|NCT01972841|20303077|P2|NOT COMPLETED|Overall Study||44
8233524|NCT01972841|20303078|P1|NOT COMPLETED|Overall Study||43
8233525|NCT01972841|20303073|P6|COMPLETED|Overall Study||798
8233526|NCT01972841|20303074|P5|COMPLETED|Overall Study||802
8233527|NCT01972841|20303075|P4|COMPLETED|Overall Study||397
8233528|NCT01972841|20303076|P3|COMPLETED|Overall Study||387
8233529|NCT01972841|20303077|P2|COMPLETED|Overall Study||397
8233530|NCT01972841|20303078|P1|COMPLETED|Overall Study||404
8233531|NCT01972841|20303073|P6|STARTED|Overall Study||883
8233532|NCT01972841|20303074|P5|STARTED|Overall Study||885
8233533|NCT01972841|20303075|P4|STARTED|Overall Study||434
8233534|NCT01972841|20303076|P3|STARTED|Overall Study||437
8233535|NCT01972841|20303077|P2|STARTED|Overall Study||441
8233536|NCT01972841|20303078|P1|STARTED|Overall Study||447
8233537|NCT01972789|20303508|P2|NOT COMPLETED|Overall Study||30
8233538|NCT01972789|20303509|P1|NOT COMPLETED|Overall Study||40
8233539|NCT01972789|20303508|P2|COMPLETED|Overall Study||145
8233540|NCT01972789|20303509|P1|COMPLETED|Overall Study||134
8233541|NCT01972789|20303508|P2|STARTED|Overall Study||175
8233542|NCT01972789|20303509|P1|STARTED|Overall Study||174
8233543|NCT01972776|20303543|P6|NOT COMPLETED|Part 2||7
8233544|NCT01972776|20303544|P5|NOT COMPLETED|Part 2||13
8233545|NCT01972776|20303545|P4|NOT COMPLETED|Part 2||0
8233546|NCT01972776|20303546|P3|NOT COMPLETED|Part 2||0
8233547|NCT01972776|20303547|P2|NOT COMPLETED|Part 2||0
8233548|NCT01972776|20303548|P1|NOT COMPLETED|Part 2||0
8233549|NCT01972776|20303543|P6|COMPLETED|Part 2||0
8233550|NCT01972776|20303544|P5|COMPLETED|Part 2||1
8233551|NCT01972776|20303545|P4|COMPLETED|Part 2||0
8233552|NCT01972776|20303546|P3|COMPLETED|Part 2||0
8233553|NCT01972776|20303547|P2|COMPLETED|Part 2||0
8233554|NCT01972776|20303548|P1|COMPLETED|Part 2||0
8233555|NCT01972776|20303543|P6|STARTED|Part 2||7
8233556|NCT01972776|20303544|P5|STARTED|Part 2||14
8233557|NCT01972776|20303545|P4|STARTED|Part 2||0
8233558|NCT01972776|20303546|P3|STARTED|Part 2||0
8233559|NCT01972776|20303547|P2|STARTED|Part 2||0
8233560|NCT01972776|20303548|P1|STARTED|Part 2||0
8233561|NCT01972776|20303543|P6|NOT COMPLETED|Part 1||0
8233562|NCT01972776|20303544|P5|NOT COMPLETED|Part 1||0
8233563|NCT01972776|20303545|P4|NOT COMPLETED|Part 1||1
8233564|NCT01972776|20303546|P3|NOT COMPLETED|Part 1||2
8233565|NCT01972776|20303547|P2|NOT COMPLETED|Part 1||0
8233566|NCT01972776|20303548|P1|NOT COMPLETED|Part 1||0
8233567|NCT01972776|20303543|P6|COMPLETED|Part 1||0
8233568|NCT01972776|20303544|P5|COMPLETED|Part 1||0
8233569|NCT01972776|20303545|P4|COMPLETED|Part 1||6
8233570|NCT01972776|20303546|P3|COMPLETED|Part 1||6
8233571|NCT01972776|20303547|P2|COMPLETED|Part 1||6
8233572|NCT01972776|20303548|P1|COMPLETED|Part 1||6
8233573|NCT01972776|20303543|P6|STARTED|Part 1||0
8233574|NCT01972776|20303544|P5|STARTED|Part 1||0
8233575|NCT01972776|20303545|P4|STARTED|Part 1||7
8233576|NCT01972776|20303546|P3|STARTED|Part 1||8
8233577|NCT01972776|20303547|P2|STARTED|Part 1||6
8233578|NCT01972776|20303548|P1|STARTED|Part 1||6
8233579|NCT01972724|20303619|P3|NOT COMPLETED|Open-Label||5
8233580|NCT01972724|20303620|P2|NOT COMPLETED|Open-Label||0
8233581|NCT01972724|20303621|P1|NOT COMPLETED|Open-Label||0
8233582|NCT01972724|20303619|P3|COMPLETED|Open-Label||72
8233583|NCT01972724|20303620|P2|COMPLETED|Open-Label||0
8233584|NCT01972724|20303621|P1|COMPLETED|Open-Label||0
8233585|NCT01972724|20303619|P3|STARTED|Open-Label||77
8233586|NCT01972724|20303620|P2|STARTED|Open-Label||0
8233587|NCT01972724|20303621|P1|STARTED|Open-Label||0
8233588|NCT01972724|20303619|P3|NOT COMPLETED|Double-Blind||0
8233589|NCT01972724|20303620|P2|NOT COMPLETED|Double-Blind||9
8233590|NCT01972724|20303621|P1|NOT COMPLETED|Double-Blind||9
8233591|NCT01972724|20303619|P3|COMPLETED|Double-Blind||0
8233592|NCT01972724|20303620|P2|COMPLETED|Double-Blind||9
8233593|NCT01972724|20303621|P1|COMPLETED|Double-Blind||10
8233594|NCT01972724|20303619|P3|Intent-to-treat:Received Study Drug|Double-Blind||0
8233595|NCT01972724|20303620|P2|Intent-to-treat:Received Study Drug|Double-Blind||17
8233596|NCT01972724|20303621|P1|Intent-to-treat:Received Study Drug|Double-Blind||17
8233597|NCT01972724|20303619|P3|STARTED|Double-Blind||0
8233598|NCT01972724|20303620|P2|STARTED|Double-Blind||18
8233599|NCT01972724|20303621|P1|STARTED|Double-Blind||19
8233600|NCT01972659|20303634|P2|NOT COMPLETED|Overall Study||3
8233601|NCT01972659|20303635|P1|NOT COMPLETED|Overall Study||4
8233602|NCT01972659|20303634|P2|COMPLETED|Overall Study||37
8233603|NCT01972659|20303635|P1|COMPLETED|Overall Study||36
8233604|NCT01972659|20303634|P2|STARTED|Overall Study||40
8233605|NCT01972659|20303635|P1|STARTED|Overall Study||40
8233606|NCT01972568|20303644|P3|NOT COMPLETED|Overall Study||16
8233607|NCT01972568|20303645|P2|NOT COMPLETED|Overall Study||12
8233608|NCT01972568|20303646|P1|NOT COMPLETED|Overall Study||16
8233609|NCT01972568|20303644|P3|COMPLETED|Overall Study||84
8233610|NCT01972568|20303645|P2|COMPLETED|Overall Study||92
8233611|NCT01972568|20303646|P1|COMPLETED|Overall Study||86
8233612|NCT01972568|20303644|P3|STARTED|Overall Study||100
8233613|NCT01972568|20303645|P2|STARTED|Overall Study||104
8233614|NCT01972568|20303646|P1|STARTED|Overall Study||102
8233615|NCT01972529|20303685|P4|NOT COMPLETED|Overall Study||4
8233616|NCT01972529|20303686|P3|NOT COMPLETED|Overall Study||2
8233617|NCT01972529|20303687|P2|NOT COMPLETED|Overall Study||5
8233618|NCT01972529|20303688|P1|NOT COMPLETED|Overall Study||2
8233619|NCT01972529|20303685|P4|COMPLETED|Overall Study||55
8233620|NCT01972529|20303686|P3|COMPLETED|Overall Study||32
8233621|NCT01972529|20303687|P2|COMPLETED|Overall Study||85
8233622|NCT01972529|20303688|P1|COMPLETED|Overall Study||46
8233623|NCT01972529|20303685|P4|STARTED|Overall Study||59
8233624|NCT01972529|20303686|P3|STARTED|Overall Study||34
8233625|NCT01972529|20303687|P2|STARTED|Overall Study||90
8233626|NCT01972529|20303688|P1|STARTED|Overall Study||48
8233627|NCT01972516|20303716|P2|NOT COMPLETED|Overall Study||0
8233628|NCT01972516|20303717|P1|NOT COMPLETED|Overall Study||0
8233629|NCT01972516|20303716|P2|COMPLETED|Overall Study||1
8233630|NCT01972516|20303717|P1|COMPLETED|Overall Study||3
8233631|NCT01972516|20303716|P2|STARTED|Overall Study||1
8233632|NCT01972516|20303717|P1|STARTED|Overall Study||3
8233633|NCT01972464|20303733|P2|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
8233634|NCT01972464|20303734|P1|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
8233635|NCT01972464|20303733|P2|COMPLETED|3-Month Follow-Up (Week 20)||17
8233636|NCT01972464|20303734|P1|COMPLETED|3-Month Follow-Up (Week 20)||15
8233637|NCT01972464|20303733|P2|STARTED|3-Month Follow-Up (Week 20)||18
8233638|NCT01972464|20303734|P1|STARTED|3-Month Follow-Up (Week 20)||16
8233639|NCT01972464|20303733|P2|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
8233640|NCT01972464|20303734|P1|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
8233641|NCT01972464|20303733|P2|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
8233642|NCT01972464|20303734|P1|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
8233643|NCT01972464|20303733|P2|STARTED|Treatment Period (Week 1 Through Week 8)||22
8233644|NCT01972464|20303734|P1|STARTED|Treatment Period (Week 1 Through Week 8)||19
8233645|NCT01972438|20303750|P2|NOT COMPLETED|Post Month 12 Study Period||4
8233646|NCT01972438|20303751|P1|NOT COMPLETED|Post Month 12 Study Period||3
8233647|NCT01972438|20303750|P2|COMPLETED|Post Month 12 Study Period||0
8233648|NCT01972438|20303751|P1|COMPLETED|Post Month 12 Study Period||0
8233649|NCT01972438|20303750|P2|STARTED|Post Month 12 Study Period||4
8233650|NCT01972438|20303751|P1|STARTED|Post Month 12 Study Period||3
8233651|NCT01972438|20303750|P2|NOT COMPLETED|Months 6-12 Study Period||2
8233652|NCT01972438|20303751|P1|NOT COMPLETED|Months 6-12 Study Period||3
8233653|NCT01972438|20303750|P2|COMPLETED|Months 6-12 Study Period||4
8233654|NCT01972438|20303751|P1|COMPLETED|Months 6-12 Study Period||3
8233655|NCT01972438|20303750|P2|STARTED|Months 6-12 Study Period||6
8233656|NCT01972438|20303751|P1|STARTED|Months 6-12 Study Period||6
8233657|NCT01972438|20303750|P2|NOT COMPLETED|Months 3-6 Crossover Period||1
8233658|NCT01972438|20303751|P1|NOT COMPLETED|Months 3-6 Crossover Period||0
8233659|NCT01972438|20303750|P2|COMPLETED|Months 3-6 Crossover Period||6
8233660|NCT01972438|20303751|P1|COMPLETED|Months 3-6 Crossover Period||6
8233661|NCT01972438|20303750|P2|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
8233662|NCT01972438|20303751|P1|STARTED|Months 3-6 Crossover Period||6
8233663|NCT01972438|20303750|P2|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
8233664|NCT01972438|20303751|P1|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
8233665|NCT01972438|20303750|P2|COMPLETED|Baseline-Month 3 Crossover Period||6
8233666|NCT01972438|20303751|P1|COMPLETED|Baseline-Month 3 Crossover Period||6
8233667|NCT01972438|20303750|P2|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
8233668|NCT01972438|20303751|P1|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
8233675|NCT01972282|20303822|P1|NOT COMPLETED|Overall Study||15
8233676|NCT01972282|20303822|P1|COMPLETED|Overall Study||1005
8233677|NCT01972282|20303822|P1|STARTED|Overall Study||1020
8233710|NCT01972204|20303883|P2|NOT COMPLETED|Overall Study||4
8233711|NCT01972204|20303884|P1|NOT COMPLETED|Overall Study||4
8233712|NCT01972204|20303883|P2|COMPLETED|Overall Study||59
8233713|NCT01972204|20303884|P1|COMPLETED|Overall Study||58
8233714|NCT01972204|20303883|P2|STARTED|Overall Study||63
8233715|NCT01972204|20303884|P1|STARTED|Overall Study||62
8233716|NCT01972152|20303896|P6|NOT COMPLETED|Third Treatment Visit||0
8233717|NCT01972152|20303897|P5|NOT COMPLETED|Third Treatment Visit||0
8233718|NCT01972152|20303898|P4|NOT COMPLETED|Third Treatment Visit||0
8233719|NCT01972152|20303899|P3|NOT COMPLETED|Third Treatment Visit||0
8233720|NCT01972152|20303900|P2|NOT COMPLETED|Third Treatment Visit||0
8233721|NCT01972152|20303901|P1|NOT COMPLETED|Third Treatment Visit||0
8233722|NCT01972152|20303896|P6|COMPLETED|Third Treatment Visit||5
8233723|NCT01972152|20303897|P5|COMPLETED|Third Treatment Visit||5
8233724|NCT01972152|20303898|P4|COMPLETED|Third Treatment Visit||5
8233725|NCT01972152|20303899|P3|COMPLETED|Third Treatment Visit||5
8233726|NCT01972152|20303900|P2|COMPLETED|Third Treatment Visit||3
8233727|NCT01972152|20303901|P1|COMPLETED|Third Treatment Visit||5
8233728|NCT01972152|20303896|P6|STARTED|Third Treatment Visit||5
8233729|NCT01972152|20303897|P5|STARTED|Third Treatment Visit||5
8233730|NCT01972152|20303898|P4|STARTED|Third Treatment Visit||5
8233731|NCT01972152|20303899|P3|STARTED|Third Treatment Visit||5
8233732|NCT01972152|20303900|P2|STARTED|Third Treatment Visit||3
8233733|NCT01972152|20303901|P1|STARTED|Third Treatment Visit||5
8233734|NCT01972152|20303896|P6|NOT COMPLETED|Second Treatment Visit||0
8233735|NCT01972152|20303897|P5|NOT COMPLETED|Second Treatment Visit||0
8233736|NCT01972152|20303898|P4|NOT COMPLETED|Second Treatment Visit||0
8233737|NCT01972152|20303899|P3|NOT COMPLETED|Second Treatment Visit||0
8233738|NCT01972152|20303900|P2|NOT COMPLETED|Second Treatment Visit||1
8233739|NCT01972152|20303901|P1|NOT COMPLETED|Second Treatment Visit||0
8233740|NCT01972152|20303896|P6|COMPLETED|Second Treatment Visit||5
8233741|NCT01972152|20303897|P5|COMPLETED|Second Treatment Visit||5
8233742|NCT01972152|20303898|P4|COMPLETED|Second Treatment Visit||5
8233743|NCT01972152|20303899|P3|COMPLETED|Second Treatment Visit||5
8233744|NCT01972152|20303900|P2|COMPLETED|Second Treatment Visit||3
8233745|NCT01972152|20303901|P1|COMPLETED|Second Treatment Visit||5
8233746|NCT01972152|20303896|P6|STARTED|Second Treatment Visit||5
8233747|NCT01972152|20303897|P5|STARTED|Second Treatment Visit||5
8233748|NCT01972152|20303898|P4|STARTED|Second Treatment Visit||5
8233749|NCT01972152|20303899|P3|STARTED|Second Treatment Visit||5
8233750|NCT01972152|20303900|P2|STARTED|Second Treatment Visit||4
8233751|NCT01972152|20303901|P1|STARTED|Second Treatment Visit||5
8233752|NCT01972152|20303896|P6|NOT COMPLETED|First Treatment Visit||0
8233753|NCT01972152|20303897|P5|NOT COMPLETED|First Treatment Visit||0
8233754|NCT01972152|20303898|P4|NOT COMPLETED|First Treatment Visit||0
8233755|NCT01972152|20303899|P3|NOT COMPLETED|First Treatment Visit||0
8233756|NCT01972152|20303900|P2|NOT COMPLETED|First Treatment Visit||1
8233757|NCT01972152|20303901|P1|NOT COMPLETED|First Treatment Visit||0
8233758|NCT01972152|20303896|P6|COMPLETED|First Treatment Visit||5
8233759|NCT01972152|20303897|P5|COMPLETED|First Treatment Visit||5
8233760|NCT01972152|20303898|P4|COMPLETED|First Treatment Visit||5
8233761|NCT01972152|20303899|P3|COMPLETED|First Treatment Visit||5
8233762|NCT01972152|20303900|P2|COMPLETED|First Treatment Visit||4
8233763|NCT01972152|20303901|P1|COMPLETED|First Treatment Visit||5
8233764|NCT01972152|20303896|P6|STARTED|First Treatment Visit||5
8233765|NCT01972152|20303897|P5|STARTED|First Treatment Visit||5
8233766|NCT01972152|20303898|P4|STARTED|First Treatment Visit||5
8233767|NCT01972152|20303899|P3|STARTED|First Treatment Visit||5
8233768|NCT01972152|20303900|P2|STARTED|First Treatment Visit||5
8233769|NCT01972152|20303901|P1|STARTED|First Treatment Visit||5
8233770|NCT01972074|20303939|P3|NOT COMPLETED|Overall Study||3
8233771|NCT01972074|20303940|P2|NOT COMPLETED|Overall Study||4
8233772|NCT01972074|20303941|P1|NOT COMPLETED|Overall Study||6
8233773|NCT01972074|20303939|P3|COMPLETED|Overall Study||15
8233774|NCT01972074|20303940|P2|COMPLETED|Overall Study||17
8233775|NCT01972074|20303941|P1|COMPLETED|Overall Study||16
8233776|NCT01972074|20303939|P3|STARTED|Overall Study||18
8233777|NCT01972074|20303940|P2|STARTED|Overall Study||21
8233778|NCT01972074|20303941|P1|STARTED|Overall Study||22
8233779|NCT01972061|20303951|P3|NOT COMPLETED|Overall Study||0
8233780|NCT01972061|20303952|P2|NOT COMPLETED|Overall Study||0
8233781|NCT01972061|20303953|P1|NOT COMPLETED|Overall Study||0
8233782|NCT01972061|20303951|P3|COMPLETED|Overall Study||20
8233783|NCT01972061|20303952|P2|COMPLETED|Overall Study||23
8233784|NCT01972061|20303953|P1|COMPLETED|Overall Study||1
8233785|NCT01972061|20303951|P3|STARTED|Overall Study||20
8233786|NCT01972061|20303952|P2|STARTED|Overall Study||23
8233787|NCT01972061|20303953|P1|STARTED|Overall Study||1
8233788|NCT01971853|20303967|P2|NOT COMPLETED|Overall Study||0
8233789|NCT01971853|20303968|P1|NOT COMPLETED|Overall Study||0
8233790|NCT01971853|20303967|P2|COMPLETED|Overall Study||0
8233791|NCT01971853|20303968|P1|COMPLETED|Overall Study||0
8233792|NCT01971853|20303967|P2|STARTED|Overall Study||0
8233793|NCT01971853|20303968|P1|STARTED|Overall Study||0
8233794|NCT01971723|20303986|P2|NOT COMPLETED|Overall Study||3
8233795|NCT01971723|20303987|P1|NOT COMPLETED|Overall Study||2
8233796|NCT01971723|20303986|P2|COMPLETED|Overall Study||13
8233797|NCT01971723|20303987|P1|COMPLETED|Overall Study||14
8233798|NCT01971723|20303986|P2|STARTED|Overall Study||16
8233799|NCT01971723|20303987|P1|STARTED|Overall Study||16
8233800|NCT01971645|20304020|P3|NOT COMPLETED|Overall Study||2
8233801|NCT01971645|20304021|P2|NOT COMPLETED|Overall Study||0
8233802|NCT01971645|20304022|P1|NOT COMPLETED|Overall Study||2
8233803|NCT01971645|20304020|P3|COMPLETED|Overall Study||23
8233804|NCT01971645|20304021|P2|COMPLETED|Overall Study||27
8233805|NCT01971645|20304022|P1|COMPLETED|Overall Study||23
8233806|NCT01971645|20304020|P3|STARTED|Overall Study||25
8233807|NCT01971645|20304021|P2|STARTED|Overall Study||27
8233808|NCT01971645|20304022|P1|STARTED|Overall Study||25
8233809|NCT01971593|20304033|P2|NOT COMPLETED|Overall Study||4
8233810|NCT01971593|20304034|P1|NOT COMPLETED|Overall Study||5
8233811|NCT01971593|20304033|P2|COMPLETED|Overall Study||8
8233812|NCT01971593|20304034|P1|COMPLETED|Overall Study||9
8233813|NCT01971593|20304033|P2|STARTED|Overall Study||12
8233814|NCT01971593|20304034|P1|STARTED|Overall Study||14
8233815|NCT01971580|20304045|P2|NOT COMPLETED|Overall Study||5
8233816|NCT01971580|20304046|P1|NOT COMPLETED|Overall Study||4
8233817|NCT01971580|20304045|P2|COMPLETED|Overall Study||9
8233818|NCT01971580|20304046|P1|COMPLETED|Overall Study||10
8233819|NCT01971580|20304045|P2|STARTED|Overall Study||14
8233820|NCT01971580|20304046|P1|STARTED|Overall Study||14
8233821|NCT01971567|20304056|P2|NOT COMPLETED|Overall Study||2
8233822|NCT01971567|20304057|P1|NOT COMPLETED|Overall Study||4
8233823|NCT01971567|20304056|P2|COMPLETED|Overall Study||49
8233824|NCT01971567|20304057|P1|COMPLETED|Overall Study||52
8233825|NCT01971567|20304056|P2|STARTED|Overall Study||51
8233826|NCT01971567|20304057|P1|STARTED|Overall Study||56
8233827|NCT01971554|20304083|P4|NOT COMPLETED|Overall Study||0
8233828|NCT01971554|20304084|P3|NOT COMPLETED|Overall Study||0
8233829|NCT01971554|20304085|P2|NOT COMPLETED|Overall Study||0
8233830|NCT01971554|20304086|P1|NOT COMPLETED|Overall Study||1
8233831|NCT01971554|20304083|P4|COMPLETED|Overall Study||18
8233832|NCT01971554|20304084|P3|COMPLETED|Overall Study||18
8233833|NCT01971554|20304085|P2|COMPLETED|Overall Study||18
8233834|NCT01971554|20304086|P1|COMPLETED|Overall Study||8
8233835|NCT01971554|20304083|P4|STARTED|Overall Study||18
8233836|NCT01971554|20304084|P3|STARTED|Overall Study||18
8233837|NCT01971554|20304085|P2|STARTED|Overall Study||18
8233838|NCT01971554|20304086|P1|STARTED|Overall Study||9
8233839|NCT01971476|20304123|P3|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
8233840|NCT01971476|20304124|P2|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
8233841|NCT01971476|20304125|P1|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
8233842|NCT01971476|20304123|P3|COMPLETED|Cohort 2: 12 to <18 Years||0
8233843|NCT01971476|20304124|P2|COMPLETED|Cohort 2: 12 to <18 Years||0
8233844|NCT01971476|20304125|P1|COMPLETED|Cohort 2: 12 to <18 Years||0
8233845|NCT01971476|20304123|P3|STARTED|Cohort 2: 12 to <18 Years||0
8233846|NCT01971476|20304124|P2|STARTED|Cohort 2: 12 to <18 Years||4
8233847|NCT01971476|20304125|P1|STARTED|Cohort 2: 12 to <18 Years||6
8233848|NCT01971476|20304123|P3|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
8233849|NCT01971476|20304124|P2|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
8233850|NCT01971476|20304125|P1|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
8233851|NCT01971476|20304123|P3|COMPLETED|Cohort 1: 2 to <12 Years||0
8233852|NCT01971476|20304124|P2|COMPLETED|Cohort 1: 2 to <12 Years||0
8233853|NCT01971476|20304125|P1|COMPLETED|Cohort 1: 2 to <12 Years||0
8233854|NCT01971476|20304123|P3|STARTED|Cohort 1: 2 to <12 Years||6
8233855|NCT01971476|20304124|P2|STARTED|Cohort 1: 2 to <12 Years||3
8233856|NCT01971476|20304125|P1|STARTED|Cohort 1: 2 to <12 Years||3
8233857|NCT01971463|20304202|P1|NOT COMPLETED|Overall Study||0
8233858|NCT01971463|20304202|P1|COMPLETED|Overall Study||81
8233859|NCT01971463|20304202|P1|STARTED|Overall Study||81
8233860|NCT01971385|20304210|P3|NOT COMPLETED|Overall Study||4
8233861|NCT01971385|20304211|P2|NOT COMPLETED|Overall Study||5
8233862|NCT01971385|20304212|P1|NOT COMPLETED|Overall Study||3
8233863|NCT01971385|20304210|P3|COMPLETED|Overall Study||15
8233864|NCT01971385|20304211|P2|COMPLETED|Overall Study||13
8233865|NCT01971385|20304212|P1|COMPLETED|Overall Study||14
8233866|NCT01971385|20304210|P3|STARTED|Overall Study||19
8233867|NCT01971385|20304211|P2|STARTED|Overall Study||18
8233868|NCT01971385|20304212|P1|STARTED|Overall Study||17
8233869|NCT01971346|20304219|P1|NOT COMPLETED|Overall Study||8
8233870|NCT01971346|20304219|P1|COMPLETED|Overall Study||42
8233871|NCT01971346|20304219|P1|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50
8233872|NCT01971255|20304233|P2|NOT COMPLETED|Overall Study||2
8233873|NCT01971255|20304234|P1|NOT COMPLETED|Overall Study||1
8233874|NCT01971255|20304233|P2|COMPLETED|Overall Study||40
8233875|NCT01971255|20304234|P1|COMPLETED|Overall Study||31
8233876|NCT01971255|20304233|P2|STARTED|Overall Study||42
8233877|NCT01971255|20304234|P1|STARTED|Overall Study||32
8233878|NCT01971203|20304252|P2|NOT COMPLETED|Overall Study||8
8233879|NCT01971203|20304253|P1|NOT COMPLETED|Overall Study||9
8233880|NCT01971203|20304252|P2|COMPLETED|Overall Study||21
8233881|NCT01971203|20304253|P1|COMPLETED|Overall Study||17
8233882|NCT01971203|20304252|P2|STARTED|Overall Study||29
8233883|NCT01971203|20304253|P1|STARTED|Overall Study||26
8233884|NCT01971086|20304265|P1|NOT COMPLETED|Overall Study||0
8233885|NCT01971086|20304265|P1|COMPLETED|Overall Study||300
8233886|NCT01971086|20304265|P1|STARTED|Overall Study||300
8233887|NCT01970995|20304280|P3|NOT COMPLETED|End of Study (Population at Day 90)||1
8233888|NCT01970995|20304281|P2|NOT COMPLETED|End of Study (Population at Day 90)||0
8233889|NCT01970995|20304282|P1|NOT COMPLETED|End of Study (Population at Day 90)||1
8233890|NCT01970995|20304280|P3|COMPLETED|End of Study (Population at Day 90)||38
8233891|NCT01970995|20304281|P2|COMPLETED|End of Study (Population at Day 90)||41
8233892|NCT01970995|20304282|P1|COMPLETED|End of Study (Population at Day 90)||76
8233893|NCT01970995|20304280|P3|STARTED|End of Study (Population at Day 90)||39
8233894|NCT01970995|20304281|P2|STARTED|End of Study (Population at Day 90)||41
8233895|NCT01970995|20304282|P1|STARTED|End of Study (Population at Day 90)||77
8233896|NCT01970995|20304280|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||1
8233897|NCT01970995|20304281|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
8233898|NCT01970995|20304282|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||1
8233899|NCT01970995|20304280|P3|COMPLETED|Confinement Period (Population at Day 5)||39
8233900|NCT01970995|20304281|P2|COMPLETED|Confinement Period (Population at Day 5)||41
8233901|NCT01970995|20304282|P1|COMPLETED|Confinement Period (Population at Day 5)||77
8233902|NCT01970995|20304280|P3|STARTED|Confinement Period (Population at Day 5)||40
8233903|NCT01970995|20304281|P2|STARTED|Confinement Period (Population at Day 5)||42
8233904|NCT01970995|20304282|P1|STARTED|Confinement Period (Population at Day 5)||78
8233905|NCT01970982|20304305|P3|NOT COMPLETED|Overall Study||2
8233906|NCT01970982|20304306|P2|NOT COMPLETED|Overall Study||0
8233907|NCT01970982|20304307|P1|NOT COMPLETED|Overall Study||0
8233908|NCT01970982|20304305|P3|COMPLETED|Overall Study||38
8233909|NCT01970982|20304306|P2|COMPLETED|Overall Study||40
8233910|NCT01970982|20304307|P1|COMPLETED|Overall Study||80
8233911|NCT01970982|20304305|P3|STARTED|Overall Study||40
8233912|NCT01970982|20304306|P2|STARTED|Overall Study||40
8233913|NCT01970982|20304307|P1|STARTED|Overall Study||80
8233914|NCT01970943|20304325|P2|NOT COMPLETED|Overall Study||1
8233915|NCT01970943|20304326|P1|NOT COMPLETED|Overall Study||3
8233916|NCT01970943|20304325|P2|COMPLETED|Overall Study||11
8233917|NCT01970943|20304326|P1|COMPLETED|Overall Study||8
8233918|NCT01970943|20304325|P2|STARTED|Overall Study||12
8233919|NCT01970943|20304326|P1|STARTED|Overall Study||11
8233920|NCT01970878|20304342|P4|NOT COMPLETED|Overall Study||24
8233921|NCT01970878|20304343|P3|NOT COMPLETED|Overall Study||26
8233922|NCT01970878|20304344|P2|NOT COMPLETED|Overall Study||27
8233923|NCT01970878|20304345|P1|NOT COMPLETED|Overall Study||37
8233924|NCT01970878|20304342|P4|COMPLETED|Overall Study||147
8233925|NCT01970878|20304343|P3|COMPLETED|Overall Study||187
8233926|NCT01970878|20304344|P2|COMPLETED|Overall Study||191
8233927|NCT01970878|20304345|P1|COMPLETED|Overall Study||253
8233928|NCT01970878|20304342|P4|STARTED|Overall Study||171
8233929|NCT01970878|20304343|P3|STARTED|Overall Study||213
8233930|NCT01970878|20304344|P2|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
8233931|NCT01970878|20304345|P1|STARTED|Overall Study||290
8234000|NCT01970787|20304828|P1|NOT COMPLETED|Overall Study||1
8234001|NCT01970787|20304828|P1|COMPLETED|Overall Study||21
8234002|NCT01970787|20304828|P1|STARTED|Overall Study||22
8234003|NCT01970592|20304836|P1|NOT COMPLETED|Overall Study||6
8234004|NCT01970592|20304836|P1|COMPLETED|Overall Study||50
8234005|NCT01970592|20304836|P1|STARTED|Overall Study|Completed all training sessions|56
8234006|NCT01970540|20304844|P3|NOT COMPLETED|Overall Study||19
8234007|NCT01970540|20304845|P2|NOT COMPLETED|Overall Study||28
8234008|NCT01970540|20304846|P1|NOT COMPLETED|Overall Study||73
8234009|NCT01970540|20304844|P3|COMPLETED|Overall Study||0
8234010|NCT01970540|20304845|P2|COMPLETED|Overall Study||0
8234011|NCT01970540|20304846|P1|COMPLETED|Overall Study||0
8234012|NCT01970540|20304844|P3|STARTED|Overall Study||19
8234013|NCT01970540|20304845|P2|STARTED|Overall Study||28
8234014|NCT01970540|20304846|P1|STARTED|Overall Study||73
8234015|NCT01970527|20304877|P2|NOT COMPLETED|Follow-up Clinic Visit||3
8234016|NCT01970527|20304878|P1|NOT COMPLETED|Follow-up Clinic Visit||1
8234017|NCT01970527|20304877|P2|COMPLETED|Follow-up Clinic Visit||8
8234018|NCT01970527|20304878|P1|COMPLETED|Follow-up Clinic Visit||7
8234019|NCT01970527|20304877|P2|STARTED|Follow-up Clinic Visit||11
8234020|NCT01970527|20304878|P1|STARTED|Follow-up Clinic Visit||8
8234021|NCT01970527|20304877|P2|NOT COMPLETED|Treatment||3
8234022|NCT01970527|20304878|P1|NOT COMPLETED|Treatment||0
8234023|NCT01970527|20304877|P2|COMPLETED|Treatment||11
8234024|NCT01970527|20304878|P1|COMPLETED|Treatment||8
8234025|NCT01970527|20304877|P2|STARTED|Treatment||14
8234026|NCT01970527|20304878|P1|STARTED|Treatment||8
8234027|NCT01970527|20304877|P2|NOT COMPLETED|Pre-treatment/Baseline||0
8234028|NCT01970527|20304878|P1|NOT COMPLETED|Pre-treatment/Baseline||1
8234029|NCT01970527|20304877|P2|COMPLETED|Pre-treatment/Baseline||14
8234030|NCT01970527|20304878|P1|COMPLETED|Pre-treatment/Baseline||8
8234031|NCT01970527|20304877|P2|STARTED|Pre-treatment/Baseline||14
8234032|NCT01970527|20304878|P1|STARTED|Pre-treatment/Baseline||9
8234033|NCT01970488|20304891|P5|NOT COMPLETED|Part 2: Post Week 16||8
8234034|NCT01970488|20304892|P4|NOT COMPLETED|Part 2: Post Week 16||8
8234035|NCT01970488|20304893|P3|NOT COMPLETED|Part 2: Post Week 16||17
8234036|NCT01970488|20304894|P2|NOT COMPLETED|Part 2: Post Week 16||0
8234037|NCT01970488|20304895|P1|NOT COMPLETED|Part 2: Post Week 16||0
8234038|NCT01970488|20304891|P5|COMPLETED|Part 2: Post Week 16||69
8234039|NCT01970488|20304892|P4|COMPLETED|Part 2: Post Week 16||71
8234040|NCT01970488|20304893|P3|COMPLETED|Part 2: Post Week 16||135
8234041|NCT01970488|20304894|P2|COMPLETED|Part 2: Post Week 16||0
8234042|NCT01970488|20304895|P1|COMPLETED|Part 2: Post Week 16||0
8234043|NCT01970488|20304891|P5|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
8234044|NCT01970488|20304892|P4|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
8234045|NCT01970488|20304893|P3|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
8234046|NCT01970488|20304894|P2|STARTED|Part 2: Post Week 16||0
8234047|NCT01970488|20304895|P1|STARTED|Part 2: Post Week 16||0
8234048|NCT01970488|20304891|P5|NOT COMPLETED|Part 1: Through Week 16||0
8234049|NCT01970488|20304892|P4|NOT COMPLETED|Part 1: Through Week 16||0
8234050|NCT01970488|20304893|P3|NOT COMPLETED|Part 1: Through Week 16||0
8234051|NCT01970488|20304894|P2|NOT COMPLETED|Part 1: Through Week 16||13
8234052|NCT01970488|20304895|P1|NOT COMPLETED|Part 1: Through Week 16||11
8234053|NCT01970488|20304891|P5|COMPLETED|Part 1: Through Week 16||0
8234054|NCT01970488|20304892|P4|COMPLETED|Part 1: Through Week 16||0
8234055|NCT01970488|20304893|P3|COMPLETED|Part 1: Through Week 16||0
8234056|NCT01970488|20304894|P2|COMPLETED|Part 1: Through Week 16||162
8234057|NCT01970488|20304895|P1|COMPLETED|Part 1: Through Week 16||164
8234058|NCT01970488|20304891|P5|Received Treatment|Part 1: Through Week 16||0
8234059|NCT01970488|20304892|P4|Received Treatment|Part 1: Through Week 16||0
8234060|NCT01970488|20304893|P3|Received Treatment|Part 1: Through Week 16||0
8234061|NCT01970488|20304894|P2|Received Treatment|Part 1: Through Week 16||173
8234062|NCT01970488|20304895|P1|Received Treatment|Part 1: Through Week 16||174
8234063|NCT01970488|20304891|P5|STARTED|Part 1: Through Week 16||0
8234064|NCT01970488|20304892|P4|STARTED|Part 1: Through Week 16||0
8234065|NCT01970488|20304893|P3|STARTED|Part 1: Through Week 16||0
8234066|NCT01970488|20304894|P2|STARTED|Part 1: Through Week 16||175
8234067|NCT01970488|20304895|P1|STARTED|Part 1: Through Week 16||175
8234068|NCT01970475|20304962|P2|NOT COMPLETED|Overall Study||11
8234069|NCT01970475|20304963|P1|NOT COMPLETED|Overall Study||21
8234070|NCT01970475|20304962|P2|COMPLETED|Overall Study||251
8234071|NCT01970475|20304963|P1|COMPLETED|Overall Study||243
8234072|NCT01970475|20304962|P2|STARTED|Overall Study||262
8234073|NCT01970475|20304963|P1|STARTED|Overall Study||264
8234074|NCT01970462|20304983|P2|NOT COMPLETED|Overall Study||2
8234075|NCT01970462|20304984|P1|NOT COMPLETED|Overall Study||0
8234076|NCT01970462|20304983|P2|COMPLETED|Overall Study||2
8234077|NCT01970462|20304984|P1|COMPLETED|Overall Study||1
8234078|NCT01970462|20304983|P2|STARTED|Overall Study||4
8234079|NCT01970462|20304984|P1|STARTED|Overall Study||1
8234080|NCT01970397|20304998|P2|NOT COMPLETED|Overall Study||5
8234081|NCT01970397|20304999|P1|NOT COMPLETED|Overall Study||2
8234082|NCT01970397|20304998|P2|COMPLETED|Overall Study||64
8234083|NCT01970397|20304999|P1|COMPLETED|Overall Study||67
8234084|NCT01970397|20304998|P2|STARTED|Overall Study||69
8234085|NCT01970397|20304999|P1|STARTED|Overall Study||69
8234086|NCT01970371|20305012|P3|NOT COMPLETED|Overall Study||13
8234087|NCT01970371|20305013|P2|NOT COMPLETED|Overall Study||13
8234088|NCT01970371|20305014|P1|NOT COMPLETED|Overall Study||8
8234089|NCT01970371|20305012|P3|COMPLETED|Overall Study||17
8234090|NCT01970371|20305013|P2|COMPLETED|Overall Study||8
8234091|NCT01970371|20305014|P1|COMPLETED|Overall Study||10
8234092|NCT01970371|20305012|P3|STARTED|Overall Study||30
8234093|NCT01970371|20305013|P2|STARTED|Overall Study||21
8234094|NCT01970371|20305014|P1|STARTED|Overall Study||18
8234095|NCT01970241|20305039|P2|NOT COMPLETED|Overall Study||8
8234096|NCT01970241|20305040|P1|NOT COMPLETED|Overall Study||17
8234097|NCT01970241|20305039|P2|COMPLETED|Overall Study||31
8234098|NCT01970241|20305040|P1|COMPLETED|Overall Study||29
8234099|NCT01970241|20305039|P2|STARTED|Overall Study||39
8234100|NCT01970241|20305040|P1|STARTED|Overall Study||46
8234110|NCT01969851|20305100|P3|NOT COMPLETED|Overall Study||7
8234111|NCT01969851|20305101|P2|NOT COMPLETED|Overall Study||3
8234112|NCT01969851|20305102|P1|NOT COMPLETED|Overall Study||1
8234113|NCT01969851|20305100|P3|COMPLETED|Overall Study||14
8234114|NCT01969851|20305101|P2|COMPLETED|Overall Study||21
8234115|NCT01969851|20305102|P1|COMPLETED|Overall Study||9
8234116|NCT01969851|20305100|P3|STARTED|Overall Study||21
8234117|NCT01969851|20305101|P2|STARTED|Overall Study||24
8234118|NCT01969851|20305102|P1|STARTED|Overall Study||10
8234119|NCT01969799|20305124|P2|NOT COMPLETED|Overall Study||14
8234120|NCT01969799|20305125|P1|NOT COMPLETED|Overall Study||17
8234121|NCT01969799|20305124|P2|COMPLETED|Overall Study||58
8234122|NCT01969799|20305125|P1|COMPLETED|Overall Study||54
8234123|NCT01969799|20305124|P2|STARTED|Overall Study||72
8234124|NCT01969799|20305125|P1|STARTED|Overall Study||71
8234125|NCT01969747|20305149|P4|NOT COMPLETED|Overall Study||0
8234126|NCT01969747|20305150|P3|NOT COMPLETED|Overall Study||0
8234127|NCT01969747|20305151|P2|NOT COMPLETED|Overall Study||0
8234128|NCT01969747|20305152|P1|NOT COMPLETED|Overall Study||0
8234129|NCT01969747|20305149|P4|COMPLETED|Overall Study||18
8234130|NCT01969747|20305150|P3|COMPLETED|Overall Study||19
8234131|NCT01969747|20305151|P2|COMPLETED|Overall Study||19
8234132|NCT01969747|20305152|P1|COMPLETED|Overall Study||19
8234133|NCT01969747|20305149|P4|STARTED|Overall Study||18
8234134|NCT01969747|20305150|P3|STARTED|Overall Study||19
8234135|NCT01969747|20305151|P2|STARTED|Overall Study||19
8234136|NCT01969747|20305152|P1|STARTED|Overall Study||19
8234137|NCT01969721|20305162|P4|NOT COMPLETED|Overall Study||6
8234138|NCT01969721|20305163|P3|NOT COMPLETED|Overall Study||5
8234139|NCT01969721|20305164|P2|NOT COMPLETED|Overall Study||12
8234140|NCT01969721|20305165|P1|NOT COMPLETED|Overall Study||4
8234141|NCT01969721|20305162|P4|COMPLETED|Overall Study||46
8234142|NCT01969721|20305163|P3|COMPLETED|Overall Study||45
8234143|NCT01969721|20305164|P2|COMPLETED|Overall Study||57
8234144|NCT01969721|20305165|P1|COMPLETED|Overall Study||54
8234145|NCT01969721|20305162|P4|STARTED|Overall Study||52
8234146|NCT01969721|20305163|P3|STARTED|Overall Study||50
8234147|NCT01969721|20305164|P2|STARTED|Overall Study||69
8234148|NCT01969721|20305165|P1|STARTED|Overall Study||58
8234155|NCT01969565|20305210|P1|NOT COMPLETED|Overall Study||1
8234156|NCT01969565|20305210|P1|COMPLETED|Overall Study||0
8234157|NCT01969565|20305210|P1|STARTED|Overall Study||1
8234158|NCT01969539|20305216|P1|NOT COMPLETED|Overall Study||0
8234159|NCT01969539|20305216|P1|COMPLETED|Overall Study||11
8234160|NCT01969539|20305216|P1|STARTED|Overall Study||11
8234161|NCT01969500|20305224|P2|NOT COMPLETED|Overall Study||2
8234162|NCT01969500|20305225|P1|NOT COMPLETED|Overall Study||1
8234163|NCT01969500|20305224|P2|COMPLETED|Overall Study||24
8234164|NCT01969500|20305225|P1|COMPLETED|Overall Study||24
8234165|NCT01969500|20305224|P2|STARTED|Overall Study||26
8234166|NCT01969500|20305225|P1|STARTED|Overall Study||25
8234167|NCT01969448|20305240|P3|NOT COMPLETED|Overall Study||0
8234168|NCT01969448|20305241|P2|NOT COMPLETED|Overall Study||0
8234169|NCT01969448|20305242|P1|NOT COMPLETED|Overall Study||0
8234170|NCT01969448|20305240|P3|COMPLETED|Overall Study||0
8234171|NCT01969448|20305241|P2|COMPLETED|Overall Study||24
8234172|NCT01969448|20305242|P1|COMPLETED|Overall Study||55
8234173|NCT01969448|20305240|P3|STARTED|Overall Study||0
8234174|NCT01969448|20305241|P2|STARTED|Overall Study||24
8234175|NCT01969448|20305242|P1|STARTED|Overall Study||55
8234176|NCT01969435|20305265|P1|NOT COMPLETED|Overall Study||0
8234177|NCT01969435|20305265|P1|COMPLETED|Overall Study||50
8234178|NCT01969435|20305265|P1|STARTED|Overall Study||50
8234179|NCT01969240|20305281|P2|NOT COMPLETED|Overall Study||0
8234180|NCT01969240|20305282|P1|NOT COMPLETED|Overall Study||0
8234181|NCT01969240|20305281|P2|COMPLETED|Overall Study||447
8234182|NCT01969240|20305282|P1|COMPLETED|Overall Study||451
8234183|NCT01969240|20305281|P2|STARTED|Overall Study||447
8234184|NCT01969240|20305282|P1|STARTED|Overall Study||451
8234185|NCT01969214|20305300|P1|NOT COMPLETED|Overall Study||15
8234186|NCT01969214|20305300|P1|COMPLETED|Overall Study||86
8234187|NCT01969214|20305300|P1|STARTED|Overall Study||101
8234188|NCT01969201|20305319|P2|NOT COMPLETED|Overall Study||45
8234189|NCT01969201|20305320|P1|NOT COMPLETED|Overall Study||45
8234190|NCT01969201|20305319|P2|COMPLETED|Overall Study||313
8234191|NCT01969201|20305320|P1|COMPLETED|Overall Study||307
8234192|NCT01969201|20305319|P2|STARTED|Overall Study||358
8234193|NCT01969201|20305320|P1|STARTED|Overall Study||352
8234194|NCT01969162|20305340|P1|NOT COMPLETED|Overall Study||0
8234195|NCT01969162|20305340|P1|COMPLETED|Overall Study||35
8234196|NCT01969162|20305340|P1|STARTED|Overall Study||35
8234197|NCT01969084|20305346|P2|NOT COMPLETED|Overall Study||1
8234198|NCT01969084|20305347|P1|NOT COMPLETED|Overall Study||0
8234199|NCT01969084|20305346|P2|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
8234200|NCT01969084|20305347|P1|COMPLETED|Overall Study||19
8234201|NCT01969084|20305346|P2|STARTED|Overall Study||22
8234202|NCT01969084|20305347|P1|STARTED|Overall Study||19
8234209|NCT01968980|20305408|P2|NOT COMPLETED|Overall Study||14
8234210|NCT01968980|20305409|P1|NOT COMPLETED|Overall Study||16
8234211|NCT01968980|20305408|P2|COMPLETED|Overall Study||171
8234212|NCT01968980|20305409|P1|COMPLETED|Overall Study||169
8234213|NCT01968980|20305408|P2|STARTED|Overall Study||185
8234214|NCT01968980|20305409|P1|STARTED|Overall Study||185
8234215|NCT01968967|20305471|P5|NOT COMPLETED|Extension Period||5
8234216|NCT01968967|20305472|P4|NOT COMPLETED|Extension Period||0
8234217|NCT01968967|20305473|P3|NOT COMPLETED|Extension Period||2
8234218|NCT01968967|20305474|P2|NOT COMPLETED|Extension Period||0
8234219|NCT01968967|20305475|P1|NOT COMPLETED|Extension Period||0
8234220|NCT01968967|20305471|P5|COMPLETED|Extension Period||34
8234221|NCT01968967|20305472|P4|COMPLETED|Extension Period||19
8234222|NCT01968967|20305473|P3|COMPLETED|Extension Period||45
8234223|NCT01968967|20305474|P2|COMPLETED|Extension Period||0
8234224|NCT01968967|20305475|P1|COMPLETED|Extension Period||0
8234225|NCT01968967|20305471|P5|STARTED|Extension Period||39
8234226|NCT01968967|20305472|P4|STARTED|Extension Period||19
8234227|NCT01968967|20305473|P3|STARTED|Extension Period||47
8234228|NCT01968967|20305474|P2|STARTED|Extension Period||0
8234229|NCT01968967|20305475|P1|STARTED|Extension Period||0
8234230|NCT01968967|20305471|P5|NOT COMPLETED|Treatment Period||0
8234231|NCT01968967|20305472|P4|NOT COMPLETED|Treatment Period||0
8234232|NCT01968967|20305473|P3|NOT COMPLETED|Treatment Period||0
8234233|NCT01968967|20305474|P2|NOT COMPLETED|Treatment Period||134
8234234|NCT01968967|20305475|P1|NOT COMPLETED|Treatment Period||146
8234235|NCT01968967|20305471|P5|COMPLETED|Treatment Period||0
8234236|NCT01968967|20305472|P4|COMPLETED|Treatment Period||0
8234237|NCT01968967|20305473|P3|COMPLETED|Treatment Period||0
8234238|NCT01968967|20305474|P2|COMPLETED|Treatment Period||934
8234239|NCT01968967|20305475|P1|COMPLETED|Treatment Period||925
8234240|NCT01968967|20305471|P5|Treated|Treatment Period||0
8234241|NCT01968967|20305472|P4|Treated|Treatment Period||0
8234242|NCT01968967|20305473|P3|Treated|Treatment Period||0
8234243|NCT01968967|20305474|P2|Treated|Treatment Period||1063
8234244|NCT01968967|20305475|P1|Treated|Treatment Period||1065
8234245|NCT01968967|20305471|P5|STARTED|Treatment Period||0
8234246|NCT01968967|20305472|P4|STARTED|Treatment Period||0
8234247|NCT01968967|20305473|P3|STARTED|Treatment Period||0
8234248|NCT01968967|20305474|P2|STARTED|Treatment Period||1068
8234249|NCT01968967|20305475|P1|STARTED|Treatment Period||1071
8234250|NCT01968954|20305544|P2|NOT COMPLETED|Overall Study||43
8234251|NCT01968954|20305545|P1|NOT COMPLETED|Overall Study||40
8234252|NCT01968954|20305544|P2|COMPLETED|Overall Study||314
8234253|NCT01968954|20305545|P1|COMPLETED|Overall Study||314
8234254|NCT01968954|20305544|P2|Treated|Overall Study||356
8234255|NCT01968954|20305545|P1|Treated|Overall Study||353
8234256|NCT01968954|20305544|P2|STARTED|Overall Study||357
8234257|NCT01968954|20305545|P1|STARTED|Overall Study||354
8234258|NCT01968811|20305609|P1|NOT COMPLETED|Overall Study||5
8234259|NCT01968811|20305609|P1|COMPLETED|Overall Study||5
8234260|NCT01968811|20305609|P1|STARTED|Overall Study||10
8234261|NCT01968694|20305616|P2|NOT COMPLETED|Visit 2 (1 Day)||0
8234262|NCT01968694|20305617|P1|NOT COMPLETED|Visit 2 (1 Day)||0
8234263|NCT01968694|20305616|P2|COMPLETED|Visit 2 (1 Day)||8
8234264|NCT01968694|20305617|P1|COMPLETED|Visit 2 (1 Day)||10
8234265|NCT01968694|20305616|P2|STARTED|Visit 2 (1 Day)||8
8234266|NCT01968694|20305617|P1|STARTED|Visit 2 (1 Day)||10
8234267|NCT01968694|20305616|P2|NOT COMPLETED|Washout (1 Month)||1
8234268|NCT01968694|20305617|P1|NOT COMPLETED|Washout (1 Month)||0
8234269|NCT01968694|20305616|P2|COMPLETED|Washout (1 Month)||8
8234270|NCT01968694|20305617|P1|COMPLETED|Washout (1 Month)||10
8234271|NCT01968694|20305616|P2|STARTED|Washout (1 Month)||9
8234272|NCT01968694|20305617|P1|STARTED|Washout (1 Month)||10
8234273|NCT01968694|20305616|P2|NOT COMPLETED|Visit 1 (1 Day)||0
8234274|NCT01968694|20305617|P1|NOT COMPLETED|Visit 1 (1 Day)||0
8234275|NCT01968694|20305616|P2|COMPLETED|Visit 1 (1 Day)||9
8234276|NCT01968694|20305617|P1|COMPLETED|Visit 1 (1 Day)||10
8234277|NCT01968694|20305616|P2|STARTED|Visit 1 (1 Day)||9
8234278|NCT01968694|20305617|P1|STARTED|Visit 1 (1 Day)||10
8234279|NCT01968551|20305634|P3|NOT COMPLETED|Extension Phase||4
8234280|NCT01968551|20305635|P2|NOT COMPLETED|Extension Phase||1
8234281|NCT01968551|20305636|P1|NOT COMPLETED|Extension Phase||1
8234282|NCT01968551|20305634|P3|COMPLETED|Extension Phase||30
8234283|NCT01968551|20305635|P2|COMPLETED|Extension Phase||86
8234284|NCT01968551|20305636|P1|COMPLETED|Extension Phase||19
8234285|NCT01968551|20305634|P3|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
8234286|NCT01968551|20305635|P2|STARTED|Extension Phase||87
8234287|NCT01968551|20305636|P1|STARTED|Extension Phase||20
8234288|NCT01968551|20305634|P3|NOT COMPLETED|Open Label Phase (48 Weeks)||5
8234289|NCT01968551|20305635|P2|NOT COMPLETED|Open Label Phase (48 Weeks)||3
8234290|NCT01968551|20305636|P1|NOT COMPLETED|Open Label Phase (48 Weeks)||2
8234291|NCT01968551|20305634|P3|COMPLETED|Open Label Phase (48 Weeks)||41
8234292|NCT01968551|20305635|P2|COMPLETED|Open Label Phase (48 Weeks)||87
8234293|NCT01968551|20305636|P1|COMPLETED|Open Label Phase (48 Weeks)||20
8234294|NCT01968551|20305634|P3|STARTED|Open Label Phase (48 Weeks)||46
8234295|NCT01968551|20305635|P2|STARTED|Open Label Phase (48 Weeks)||90
8234296|NCT01968551|20305636|P1|STARTED|Open Label Phase (48 Weeks)||22
8234297|NCT01968447|20305652|P2|NOT COMPLETED|Overall Study||0
8234298|NCT01968447|20305653|P1|NOT COMPLETED|Overall Study||0
8234299|NCT01968447|20305652|P2|COMPLETED|Overall Study||20
8234300|NCT01968447|20305653|P1|COMPLETED|Overall Study||20
8234301|NCT01968447|20305652|P2|STARTED|Overall Study||20
8234302|NCT01968447|20305653|P1|STARTED|Overall Study||20
8234303|NCT01968434|20305673|P2|NOT COMPLETED|Overall Study||6
8234304|NCT01968434|20305674|P1|NOT COMPLETED|Overall Study||3
8234305|NCT01968434|20305673|P2|COMPLETED|Overall Study||66
8234306|NCT01968434|20305674|P1|COMPLETED|Overall Study||75
8234307|NCT01968434|20305673|P2|STARTED|Overall Study||72
8234308|NCT01968434|20305674|P1|STARTED|Overall Study||78
8234309|NCT01968421|20305686|P2|NOT COMPLETED|Overall Study||0
8234310|NCT01968421|20305687|P1|NOT COMPLETED|Overall Study||0
8234311|NCT01968421|20305686|P2|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|97
8234312|NCT01968421|20305687|P1|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|99
8234313|NCT01968421|20305686|P2|Starting Trial|Overall Study||97
8234314|NCT01968421|20305687|P1|Starting Trial|Overall Study||99
8234315|NCT01968421|20305686|P2|STARTED|Overall Study|March 1, 2015 was the date for recruiting controls|97
8234316|NCT01968421|20305687|P1|STARTED|Overall Study|March 1, 2015 was the date for recruiting patients|99
8234317|NCT01968382|20305696|P3|NOT COMPLETED|Overall Study||0
8234318|NCT01968382|20305697|P2|NOT COMPLETED|Overall Study||0
8234319|NCT01968382|20305698|P1|NOT COMPLETED|Overall Study||0
8234320|NCT01968382|20305696|P3|COMPLETED|Overall Study||20
8234321|NCT01968382|20305697|P2|COMPLETED|Overall Study||19
8234322|NCT01968382|20305698|P1|COMPLETED|Overall Study||18
8234323|NCT01968382|20305696|P3|STARTED|Overall Study||20
8234324|NCT01968382|20305697|P2|STARTED|Overall Study||19
8234325|NCT01968382|20305698|P1|STARTED|Overall Study||18
8234326|NCT01968226|20305742|P1|NOT COMPLETED|Overall Study||2
8234327|NCT01968226|20305742|P1|COMPLETED|Overall Study||1
8234328|NCT01968226|20305742|P1|STARTED|Overall Study||3
8234335|NCT01968135|20305760|P2|NOT COMPLETED|Overall Study||0
8234336|NCT01968135|20305761|P1|NOT COMPLETED|Overall Study||0
8234337|NCT01968135|20305760|P2|COMPLETED|Overall Study||16
8234338|NCT01968135|20305761|P1|COMPLETED|Overall Study||16
8234339|NCT01968135|20305760|P2|STARTED|Overall Study||16
8234340|NCT01968135|20305761|P1|STARTED|Overall Study||16
8234341|NCT01968070|20305791|P18|NOT COMPLETED|Period 3||0
8234342|NCT01968070|20305792|P17|NOT COMPLETED|Period 3||0
8234343|NCT01968070|20305793|P16|NOT COMPLETED|Period 3||0
8234344|NCT01968070|20305794|P15|NOT COMPLETED|Period 3||0
8234345|NCT01968070|20305795|P14|NOT COMPLETED|Period 3||0
8234346|NCT01968070|20305796|P13|NOT COMPLETED|Period 3||0
8234347|NCT01968070|20305797|P12|NOT COMPLETED|Period 3||0
8234348|NCT01968070|20305798|P11|NOT COMPLETED|Period 3||0
8234349|NCT01968070|20305799|P10|NOT COMPLETED|Period 3||0
8234350|NCT01968070|20305800|P9|NOT COMPLETED|Period 3||0
8234351|NCT01968070|20305801|P8|NOT COMPLETED|Period 3||0
8234352|NCT01968070|20305802|P7|NOT COMPLETED|Period 3||0
8234353|NCT01968070|20305803|P6|NOT COMPLETED|Period 3||0
8234354|NCT01968070|20305804|P5|NOT COMPLETED|Period 3||0
8234355|NCT01968070|20305805|P4|NOT COMPLETED|Period 3||0
8234356|NCT01968070|20305806|P3|NOT COMPLETED|Period 3||0
8234357|NCT01968070|20305807|P2|NOT COMPLETED|Period 3||0
8234358|NCT01968070|20305808|P1|NOT COMPLETED|Period 3||0
8234359|NCT01968070|20305791|P18|COMPLETED|Period 3||0
8234360|NCT01968070|20305792|P17|COMPLETED|Period 3||0
8234361|NCT01968070|20305793|P16|COMPLETED|Period 3||0
8234362|NCT01968070|20305794|P15|COMPLETED|Period 3||0
8234363|NCT01968070|20305795|P14|COMPLETED|Period 3||0
8234364|NCT01968070|20305796|P13|COMPLETED|Period 3||0
8234365|NCT01968070|20305797|P12|COMPLETED|Period 3||0
8234366|NCT01968070|20305798|P11|COMPLETED|Period 3||0
8234367|NCT01968070|20305799|P10|COMPLETED|Period 3||0
8234368|NCT01968070|20305800|P9|COMPLETED|Period 3||0
8234369|NCT01968070|20305801|P8|COMPLETED|Period 3||0
8234370|NCT01968070|20305802|P7|COMPLETED|Period 3||0
8234371|NCT01968070|20305803|P6|COMPLETED|Period 3||4
8234372|NCT01968070|20305804|P5|COMPLETED|Period 3||3
8234373|NCT01968070|20305805|P4|COMPLETED|Period 3||4
8234374|NCT01968070|20305806|P3|COMPLETED|Period 3||4
8234375|NCT01968070|20305807|P2|COMPLETED|Period 3||4
8234376|NCT01968070|20305808|P1|COMPLETED|Period 3||4
8234377|NCT01968070|20305791|P18|STARTED|Period 3||0
8234378|NCT01968070|20305792|P17|STARTED|Period 3||0
8234379|NCT01968070|20305793|P16|STARTED|Period 3||0
8234380|NCT01968070|20305794|P15|STARTED|Period 3||0
8234381|NCT01968070|20305795|P14|STARTED|Period 3||0
8234382|NCT01968070|20305796|P13|STARTED|Period 3||0
8234383|NCT01968070|20305797|P12|STARTED|Period 3||0
8234384|NCT01968070|20305798|P11|STARTED|Period 3||0
8234385|NCT01968070|20305799|P10|STARTED|Period 3||0
8234386|NCT01968070|20305800|P9|STARTED|Period 3||0
8234387|NCT01968070|20305801|P8|STARTED|Period 3||0
8234388|NCT01968070|20305802|P7|STARTED|Period 3||0
8234389|NCT01968070|20305803|P6|STARTED|Period 3||4
8234390|NCT01968070|20305804|P5|STARTED|Period 3||3
8234391|NCT01968070|20305805|P4|STARTED|Period 3||4
8234392|NCT01968070|20305806|P3|STARTED|Period 3||4
8234393|NCT01968070|20305807|P2|STARTED|Period 3||4
8234394|NCT01968070|20305808|P1|STARTED|Period 3||4
8234395|NCT01968070|20305791|P18|NOT COMPLETED|Period 2||0
8234396|NCT01968070|20305792|P17|NOT COMPLETED|Period 2||0
8234397|NCT01968070|20305793|P16|NOT COMPLETED|Period 2||0
8234398|NCT01968070|20305794|P15|NOT COMPLETED|Period 2||0
8234399|NCT01968070|20305795|P14|NOT COMPLETED|Period 2||0
8234400|NCT01968070|20305796|P13|NOT COMPLETED|Period 2||0
8234401|NCT01968070|20305797|P12|NOT COMPLETED|Period 2||0
8234402|NCT01968070|20305798|P11|NOT COMPLETED|Period 2||0
8234403|NCT01968070|20305799|P10|NOT COMPLETED|Period 2||0
8234404|NCT01968070|20305800|P9|NOT COMPLETED|Period 2||0
8234405|NCT01968070|20305801|P8|NOT COMPLETED|Period 2||0
8234406|NCT01968070|20305802|P7|NOT COMPLETED|Period 2||0
8234407|NCT01968070|20305803|P6|NOT COMPLETED|Period 2||0
8234408|NCT01968070|20305804|P5|NOT COMPLETED|Period 2||1
8234409|NCT01968070|20305805|P4|NOT COMPLETED|Period 2||0
8234410|NCT01968070|20305806|P3|NOT COMPLETED|Period 2||0
8234411|NCT01968070|20305807|P2|NOT COMPLETED|Period 2||0
8234412|NCT01968070|20305808|P1|NOT COMPLETED|Period 2||0
8234413|NCT01968070|20305791|P18|COMPLETED|Period 2||0
8234414|NCT01968070|20305792|P17|COMPLETED|Period 2||0
8234415|NCT01968070|20305793|P16|COMPLETED|Period 2||0
8234416|NCT01968070|20305794|P15|COMPLETED|Period 2||0
8234417|NCT01968070|20305795|P14|COMPLETED|Period 2||0
8234418|NCT01968070|20305796|P13|COMPLETED|Period 2||0
8234419|NCT01968070|20305797|P12|COMPLETED|Period 2||0
8234420|NCT01968070|20305798|P11|COMPLETED|Period 2||0
8234421|NCT01968070|20305799|P10|COMPLETED|Period 2||0
8234422|NCT01968070|20305800|P9|COMPLETED|Period 2||0
8234423|NCT01968070|20305801|P8|COMPLETED|Period 2||0
8234424|NCT01968070|20305802|P7|COMPLETED|Period 2||0
8234425|NCT01968070|20305803|P6|COMPLETED|Period 2||4
8234426|NCT01968070|20305804|P5|COMPLETED|Period 2||2
8234427|NCT01968070|20305805|P4|COMPLETED|Period 2||4
8234428|NCT01968070|20305806|P3|COMPLETED|Period 2||4
8234429|NCT01968070|20305807|P2|COMPLETED|Period 2||4
8234430|NCT01968070|20305808|P1|COMPLETED|Period 2||4
8234431|NCT01968070|20305791|P18|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234432|NCT01968070|20305792|P17|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234433|NCT01968070|20305793|P16|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234434|NCT01968070|20305794|P15|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234435|NCT01968070|20305795|P14|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234436|NCT01968070|20305796|P13|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234437|NCT01968070|20305797|P12|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234438|NCT01968070|20305798|P11|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234439|NCT01968070|20305799|P10|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234440|NCT01968070|20305800|P9|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234441|NCT01968070|20305801|P8|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234442|NCT01968070|20305802|P7|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
8234443|NCT01968070|20305803|P6|STARTED|Period 2||4
8234444|NCT01968070|20305804|P5|STARTED|Period 2||3
8234445|NCT01968070|20305805|P4|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4
8234446|NCT01968070|20305806|P3|STARTED|Period 2||4
8234447|NCT01968070|20305807|P2|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4
8234448|NCT01968070|20305808|P1|STARTED|Period 2||4
8234449|NCT01968070|20305791|P18|NOT COMPLETED|Period 1||0
8234450|NCT01968070|20305792|P17|NOT COMPLETED|Period 1||0
8234451|NCT01968070|20305793|P16|NOT COMPLETED|Period 1||1
8234452|NCT01968070|20305794|P15|NOT COMPLETED|Period 1||0
8234453|NCT01968070|20305795|P14|NOT COMPLETED|Period 1||0
8234454|NCT01968070|20305796|P13|NOT COMPLETED|Period 1||0
8234455|NCT01968070|20305797|P12|NOT COMPLETED|Period 1||1
8234456|NCT01968070|20305798|P11|NOT COMPLETED|Period 1||0
8234457|NCT01968070|20305799|P10|NOT COMPLETED|Period 1||0
8234458|NCT01968070|20305800|P9|NOT COMPLETED|Period 1||0
8234459|NCT01968070|20305801|P8|NOT COMPLETED|Period 1||0
8234460|NCT01968070|20305802|P7|NOT COMPLETED|Period 1||2
8234461|NCT01968070|20305803|P6|NOT COMPLETED|Period 1||0
8234462|NCT01968070|20305804|P5|NOT COMPLETED|Period 1||1
8234463|NCT01968070|20305805|P4|NOT COMPLETED|Period 1||2
8234464|NCT01968070|20305806|P3|NOT COMPLETED|Period 1||0
8234465|NCT01968070|20305807|P2|NOT COMPLETED|Period 1||1
8234466|NCT01968070|20305808|P1|NOT COMPLETED|Period 1||0
8234467|NCT01968070|20305791|P18|COMPLETED|Period 1||2
8234468|NCT01968070|20305792|P17|COMPLETED|Period 1||2
8234469|NCT01968070|20305793|P16|COMPLETED|Period 1||8
8234470|NCT01968070|20305794|P15|COMPLETED|Period 1||2
8234471|NCT01968070|20305795|P14|COMPLETED|Period 1||2
8234472|NCT01968070|20305796|P13|COMPLETED|Period 1||9
8234473|NCT01968070|20305797|P12|COMPLETED|Period 1||1
8234474|NCT01968070|20305798|P11|COMPLETED|Period 1||2
8234475|NCT01968070|20305799|P10|COMPLETED|Period 1||9
8234476|NCT01968070|20305800|P9|COMPLETED|Period 1||2
8234477|NCT01968070|20305801|P8|COMPLETED|Period 1||2
8234478|NCT01968070|20305802|P7|COMPLETED|Period 1||8
8234479|NCT01968070|20305803|P6|COMPLETED|Period 1||4
8234480|NCT01968070|20305804|P5|COMPLETED|Period 1||3
8234481|NCT01968070|20305805|P4|COMPLETED|Period 1||2
8234482|NCT01968070|20305806|P3|COMPLETED|Period 1||4
8234483|NCT01968070|20305807|P2|COMPLETED|Period 1||3
8234484|NCT01968070|20305808|P1|COMPLETED|Period 1||4
8234485|NCT01968070|20305791|P18|STARTED|Period 1||2
8234486|NCT01968070|20305792|P17|STARTED|Period 1||2
8234487|NCT01968070|20305793|P16|STARTED|Period 1||9
8234488|NCT01968070|20305794|P15|STARTED|Period 1||2
8234489|NCT01968070|20305795|P14|STARTED|Period 1||2
8234490|NCT01968070|20305796|P13|STARTED|Period 1||9
8234491|NCT01968070|20305797|P12|STARTED|Period 1||2
8234492|NCT01968070|20305798|P11|STARTED|Period 1||2
8234493|NCT01968070|20305799|P10|STARTED|Period 1||9
8234494|NCT01968070|20305800|P9|STARTED|Period 1||2
8234495|NCT01968070|20305801|P8|STARTED|Period 1||2
8234496|NCT01968070|20305802|P7|STARTED|Period 1||10
8234497|NCT01968070|20305803|P6|STARTED|Period 1||4
8234498|NCT01968070|20305804|P5|STARTED|Period 1||4
8234499|NCT01968070|20305805|P4|STARTED|Period 1||4
8234500|NCT01968070|20305806|P3|STARTED|Period 1||4
8234501|NCT01968070|20305807|P2|STARTED|Period 1||4
8234502|NCT01968070|20305808|P1|STARTED|Period 1||4
8234503|NCT01968057|20305866|P1|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
8234504|NCT01968057|20305866|P1|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
8234505|NCT01968057|20305866|P1|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
8234506|NCT01968057|20305866|P1|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
8234507|NCT01968057|20305866|P1|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
8234508|NCT01968057|20305866|P1|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
8234509|NCT01968057|20305866|P1|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
8234510|NCT01968057|20305866|P1|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
8234511|NCT01968031|20305879|P3|NOT COMPLETED|Overall Study||29
8234512|NCT01968031|20305880|P2|NOT COMPLETED|Overall Study||20
8234513|NCT01968031|20305881|P1|NOT COMPLETED|Overall Study||18
8234514|NCT01968031|20305879|P3|COMPLETED|Overall Study||178
8234515|NCT01968031|20305880|P2|COMPLETED|Overall Study||182
8234516|NCT01968031|20305881|P1|COMPLETED|Overall Study||186
8234517|NCT01968031|20305879|P3|Completed Week 10|Overall Study||181
8234518|NCT01968031|20305880|P2|Completed Week 10|Overall Study||181
8234519|NCT01968031|20305881|P1|Completed Week 10|Overall Study||187
8234520|NCT01968031|20305879|P3|Completed Week 6|Overall Study||187
8234521|NCT01968031|20305880|P2|Completed Week 6|Overall Study||183
8234522|NCT01968031|20305881|P1|Completed Week 6|Overall Study||191
8234523|NCT01968031|20305879|P3|Completed Week 2|Overall Study||199
8234524|NCT01968031|20305880|P2|Completed Week 2|Overall Study||190
8234525|NCT01968031|20305881|P1|Completed Week 2|Overall Study||197
8234526|NCT01968031|20305879|P3|STARTED|Overall Study||207
8234527|NCT01968031|20305880|P2|STARTED|Overall Study||202
8234528|NCT01968031|20305881|P1|STARTED|Overall Study||204
8234529|NCT01967940|20305925|P4|NOT COMPLETED|Part 2||3
8234530|NCT01967940|20305926|P3|NOT COMPLETED|Part 2||0
8234531|NCT01967940|20305927|P2|NOT COMPLETED|Part 2||0
8234532|NCT01967940|20305928|P1|NOT COMPLETED|Part 2||0
8234533|NCT01967940|20305925|P4|COMPLETED|Part 2||35
8234534|NCT01967940|20305926|P3|COMPLETED|Part 2||0
8234535|NCT01967940|20305927|P2|COMPLETED|Part 2||0
8234536|NCT01967940|20305928|P1|COMPLETED|Part 2||0
8234537|NCT01967940|20305925|P4|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
8234538|NCT01967940|20305926|P3|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
8234539|NCT01967940|20305927|P2|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
8234540|NCT01967940|20305928|P1|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
8234541|NCT01967940|20305925|P4|NOT COMPLETED|Part 1||0
8234542|NCT01967940|20305926|P3|NOT COMPLETED|Part 1||0
8234543|NCT01967940|20305927|P2|NOT COMPLETED|Part 1||0
8234544|NCT01967940|20305928|P1|NOT COMPLETED|Part 1||0
8234545|NCT01967940|20305925|P4|COMPLETED|Part 1||0
8234546|NCT01967940|20305926|P3|COMPLETED|Part 1||15
8234547|NCT01967940|20305927|P2|COMPLETED|Part 1||28
8234548|NCT01967940|20305928|P1|COMPLETED|Part 1||12
8234549|NCT01967940|20305925|P4|STARTED|Part 1||0
8234550|NCT01967940|20305926|P3|STARTED|Part 1||15
8234551|NCT01967940|20305927|P2|STARTED|Part 1||28
8234552|NCT01967940|20305928|P1|STARTED|Part 1||12
8234553|NCT01967888|20305956|P2|NOT COMPLETED|Overall Study||7
8234554|NCT01967888|20305957|P1|NOT COMPLETED|Overall Study||10
8234555|NCT01967888|20305956|P2|COMPLETED|Overall Study||45
8234556|NCT01967888|20305957|P1|COMPLETED|Overall Study||42
8234557|NCT01967888|20305956|P2|STARTED|Overall Study||52
8234558|NCT01967888|20305957|P1|STARTED|Overall Study||52
8234559|NCT01967862|20306025|P1|NOT COMPLETED|Overall Study||0
8234560|NCT01967862|20306025|P1|COMPLETED|Overall Study||54
8234561|NCT01967862|20306025|P1|STARTED|Overall Study||54
8234562|NCT01967836|20306029|P1|NOT COMPLETED|Overall Study||9
8234563|NCT01967836|20306029|P1|COMPLETED|Overall Study||11
8234564|NCT01967836|20306029|P1|STARTED|Overall Study||20
8234565|NCT01967784|20306035|P1|NOT COMPLETED|Overall Study||0
8234566|NCT01967784|20306035|P1|COMPLETED|Overall Study||100
8234567|NCT01967784|20306035|P1|STARTED|Overall Study||100
8234568|NCT01967732|20306045|P4|NOT COMPLETED|Second Intervention (Day 3)||0
8234569|NCT01967732|20306046|P3|NOT COMPLETED|Second Intervention (Day 3)||0
8234570|NCT01967732|20306047|P2|NOT COMPLETED|Second Intervention (Day 3)||0
8234571|NCT01967732|20306048|P1|NOT COMPLETED|Second Intervention (Day 3)||0
8234572|NCT01967732|20306045|P4|COMPLETED|Second Intervention (Day 3)||9
8234573|NCT01967732|20306046|P3|COMPLETED|Second Intervention (Day 3)||9
8234574|NCT01967732|20306047|P2|COMPLETED|Second Intervention (Day 3)||20
8234575|NCT01967732|20306048|P1|COMPLETED|Second Intervention (Day 3)||22
8234576|NCT01967732|20306045|P4|STARTED|Second Intervention (Day 3)||9
8234577|NCT01967732|20306046|P3|STARTED|Second Intervention (Day 3)||9
8234578|NCT01967732|20306047|P2|STARTED|Second Intervention (Day 3)||20
8234579|NCT01967732|20306048|P1|STARTED|Second Intervention (Day 3)||22
8234580|NCT01967732|20306045|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234581|NCT01967732|20306046|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234582|NCT01967732|20306047|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234583|NCT01967732|20306048|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234584|NCT01967732|20306045|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
8234585|NCT01967732|20306046|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
8234586|NCT01967732|20306047|P2|COMPLETED|Washout Period of 1 Day (Day 2)||20
8234587|NCT01967732|20306048|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
8234588|NCT01967732|20306045|P4|STARTED|Washout Period of 1 Day (Day 2)||9
8234589|NCT01967732|20306046|P3|STARTED|Washout Period of 1 Day (Day 2)||9
8234590|NCT01967732|20306047|P2|STARTED|Washout Period of 1 Day (Day 2)||20
8234591|NCT01967732|20306048|P1|STARTED|Washout Period of 1 Day (Day 2)||22
8234592|NCT01967732|20306045|P4|NOT COMPLETED|First Intervention (Day 1)||0
8234593|NCT01967732|20306046|P3|NOT COMPLETED|First Intervention (Day 1)||0
8234594|NCT01967732|20306047|P2|NOT COMPLETED|First Intervention (Day 1)||1
8234595|NCT01967732|20306048|P1|NOT COMPLETED|First Intervention (Day 1)||0
8234596|NCT01967732|20306045|P4|COMPLETED|First Intervention (Day 1)||9
8234597|NCT01967732|20306046|P3|COMPLETED|First Intervention (Day 1)||9
8234598|NCT01967732|20306047|P2|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
8234599|NCT01967732|20306048|P1|COMPLETED|First Intervention (Day 1)||22
8234600|NCT01967732|20306045|P4|STARTED|First Intervention (Day 1)||9
8234601|NCT01967732|20306046|P3|STARTED|First Intervention (Day 1)||9
8234602|NCT01967732|20306047|P2|STARTED|First Intervention (Day 1)||21
8234603|NCT01967732|20306048|P1|STARTED|First Intervention (Day 1)||22
8234604|NCT01967732|20306045|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234605|NCT01967732|20306046|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234606|NCT01967732|20306047|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
8234607|NCT01967732|20306048|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234608|NCT01967732|20306045|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
8234609|NCT01967732|20306046|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
8234610|NCT01967732|20306047|P2|COMPLETED|Washout Period of 1 Day (Day 0)||21
8234611|NCT01967732|20306048|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
8234612|NCT01967732|20306045|P4|STARTED|Washout Period of 1 Day (Day 0)||9
8234613|NCT01967732|20306046|P3|STARTED|Washout Period of 1 Day (Day 0)||9
8234614|NCT01967732|20306047|P2|STARTED|Washout Period of 1 Day (Day 0)||22
8234615|NCT01967732|20306048|P1|STARTED|Washout Period of 1 Day (Day 0)||22
8234616|NCT01967719|20306062|P4|NOT COMPLETED|Second Intervention (Day 3)||0
8234617|NCT01967719|20306063|P3|NOT COMPLETED|Second Intervention (Day 3)||0
8234618|NCT01967719|20306064|P2|NOT COMPLETED|Second Intervention (Day 3)||1
8234619|NCT01967719|20306065|P1|NOT COMPLETED|Second Intervention (Day 3)||0
8234620|NCT01967719|20306062|P4|COMPLETED|Second Intervention (Day 3)||8
8234621|NCT01967719|20306063|P3|COMPLETED|Second Intervention (Day 3)||9
8234622|NCT01967719|20306064|P2|COMPLETED|Second Intervention (Day 3)||20
8234623|NCT01967719|20306065|P1|COMPLETED|Second Intervention (Day 3)||22
8234624|NCT01967719|20306062|P4|STARTED|Second Intervention (Day 3)||8
8234625|NCT01967719|20306063|P3|STARTED|Second Intervention (Day 3)||9
8234626|NCT01967719|20306064|P2|STARTED|Second Intervention (Day 3)||21
8234627|NCT01967719|20306065|P1|STARTED|Second Intervention (Day 3)||22
8234628|NCT01967719|20306062|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234629|NCT01967719|20306063|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234630|NCT01967719|20306064|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234631|NCT01967719|20306065|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234632|NCT01967719|20306062|P4|COMPLETED|Washout Period of 1 Day (Day 2)||8
8234633|NCT01967719|20306063|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
8234634|NCT01967719|20306064|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
8234635|NCT01967719|20306065|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
8234636|NCT01967719|20306062|P4|STARTED|Washout Period of 1 Day (Day 2)||8
8234637|NCT01967719|20306063|P3|STARTED|Washout Period of 1 Day (Day 2)||9
8234638|NCT01967719|20306064|P2|STARTED|Washout Period of 1 Day (Day 2)||21
8234639|NCT01967719|20306065|P1|STARTED|Washout Period of 1 Day (Day 2)||22
8234640|NCT01967719|20306062|P4|NOT COMPLETED|First Intervention (Day 1)||1
8234641|NCT01967719|20306063|P3|NOT COMPLETED|First Intervention (Day 1)||0
8234642|NCT01967719|20306064|P2|NOT COMPLETED|First Intervention (Day 1)||1
8234643|NCT01967719|20306065|P1|NOT COMPLETED|First Intervention (Day 1)||0
8234644|NCT01967719|20306062|P4|COMPLETED|First Intervention (Day 1)||8
8234645|NCT01967719|20306063|P3|COMPLETED|First Intervention (Day 1)||9
8234646|NCT01967719|20306064|P2|COMPLETED|First Intervention (Day 1)||21
8234647|NCT01967719|20306065|P1|COMPLETED|First Intervention (Day 1)||22
8234648|NCT01967719|20306062|P4|STARTED|First Intervention (Day 1)||9
8234649|NCT01967719|20306063|P3|STARTED|First Intervention (Day 1)||9
8234650|NCT01967719|20306064|P2|STARTED|First Intervention (Day 1)||22
8234651|NCT01967719|20306065|P1|STARTED|First Intervention (Day 1)||22
8234652|NCT01967719|20306062|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234653|NCT01967719|20306063|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234654|NCT01967719|20306064|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234655|NCT01967719|20306065|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234656|NCT01967719|20306062|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
8234657|NCT01967719|20306063|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
8234658|NCT01967719|20306064|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
8234659|NCT01967719|20306065|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
8234660|NCT01967719|20306062|P4|STARTED|Washout Period of 1 Day (Day 0)||9
8234661|NCT01967719|20306063|P3|STARTED|Washout Period of 1 Day (Day 0)||9
8234662|NCT01967719|20306064|P2|STARTED|Washout Period of 1 Day (Day 0)||22
8234663|NCT01967719|20306065|P1|STARTED|Washout Period of 1 Day (Day 0)||22
8234664|NCT01967706|20306080|P4|NOT COMPLETED|Second Intervention (Day 3)||0
8234665|NCT01967706|20306081|P3|NOT COMPLETED|Second Intervention (Day 3)||0
8234666|NCT01967706|20306082|P2|NOT COMPLETED|Second Intervention (Day 3)||0
8234667|NCT01967706|20306083|P1|NOT COMPLETED|Second Intervention (Day 3)||0
8234668|NCT01967706|20306080|P4|COMPLETED|Second Intervention (Day 3)||9
8234669|NCT01967706|20306081|P3|COMPLETED|Second Intervention (Day 3)||9
8234670|NCT01967706|20306082|P2|COMPLETED|Second Intervention (Day 3)||22
8234671|NCT01967706|20306083|P1|COMPLETED|Second Intervention (Day 3)||21
8234672|NCT01967706|20306080|P4|STARTED|Second Intervention (Day 3)||9
8234673|NCT01967706|20306081|P3|STARTED|Second Intervention (Day 3)||9
8234674|NCT01967706|20306082|P2|STARTED|Second Intervention (Day 3)||22
8234675|NCT01967706|20306083|P1|STARTED|Second Intervention (Day 3)||21
8234676|NCT01967706|20306080|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234677|NCT01967706|20306081|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234678|NCT01967706|20306082|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234679|NCT01967706|20306083|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8234680|NCT01967706|20306080|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
8234681|NCT01967706|20306081|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
8234682|NCT01967706|20306082|P2|COMPLETED|Washout Period of 1 Day (Day 2)||22
8234683|NCT01967706|20306083|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
8234684|NCT01967706|20306080|P4|STARTED|Washout Period of 1 Day (Day 2)||9
8234685|NCT01967706|20306081|P3|STARTED|Washout Period of 1 Day (Day 2)||9
8234686|NCT01967706|20306082|P2|STARTED|Washout Period of 1 Day (Day 2)||22
8234687|NCT01967706|20306083|P1|STARTED|Washout Period of 1 Day (Day 2)||21
8234688|NCT01967706|20306080|P4|NOT COMPLETED|First Intervention (Day 1)||0
8234689|NCT01967706|20306081|P3|NOT COMPLETED|First Intervention (Day 1)||0
8234690|NCT01967706|20306082|P2|NOT COMPLETED|First Intervention (Day 1)||0
8234691|NCT01967706|20306083|P1|NOT COMPLETED|First Intervention (Day 1)||1
8234692|NCT01967706|20306080|P4|COMPLETED|First Intervention (Day 1)||9
8234693|NCT01967706|20306081|P3|COMPLETED|First Intervention (Day 1)||9
8234694|NCT01967706|20306082|P2|COMPLETED|First Intervention (Day 1)||22
8234695|NCT01967706|20306083|P1|COMPLETED|First Intervention (Day 1)||21
8234696|NCT01967706|20306080|P4|STARTED|First Intervention (Day 1)||9
8234697|NCT01967706|20306081|P3|STARTED|First Intervention (Day 1)||9
8234698|NCT01967706|20306082|P2|STARTED|First Intervention (Day 1)||22
8234699|NCT01967706|20306083|P1|STARTED|First Intervention (Day 1)||22
8234700|NCT01967706|20306080|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234701|NCT01967706|20306081|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234702|NCT01967706|20306082|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234703|NCT01967706|20306083|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8234704|NCT01967706|20306080|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
8234705|NCT01967706|20306081|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
8234706|NCT01967706|20306082|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
8234707|NCT01967706|20306083|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
8234708|NCT01967706|20306080|P4|STARTED|Washout Period of 1 Day (Day 0)||9
8234709|NCT01967706|20306081|P3|STARTED|Washout Period of 1 Day (Day 0)||9
8234710|NCT01967706|20306082|P2|STARTED|Washout Period of 1 Day (Day 0)||22
8234711|NCT01967706|20306083|P1|STARTED|Washout Period of 1 Day (Day 0)||22
8234712|NCT01967641|20306096|P1|NOT COMPLETED|12-week Outpatient Phase||13
8234713|NCT01967641|20306096|P1|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
8234714|NCT01967641|20306096|P1|STARTED|12-week Outpatient Phase||31
8234715|NCT01967641|20306096|P1|NOT COMPLETED|Admission to Inpatient Phase||12
8234716|NCT01967641|20306096|P1|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
8234717|NCT01967641|20306096|P1|STARTED|Admission to Inpatient Phase||43
8234718|NCT01967641|20306096|P1|NOT COMPLETED|Randomized||8
8234719|NCT01967641|20306096|P1|COMPLETED|Randomized|Completed week 12|43
8234720|NCT01967641|20306096|P1|STARTED|Randomized||51
8234721|NCT01967628|20306104|P2|NOT COMPLETED|Overall Study||31
8234722|NCT01967628|20306105|P1|NOT COMPLETED|Overall Study||27
8234723|NCT01967628|20306104|P2|COMPLETED|Overall Study||19
8234724|NCT01967628|20306105|P1|COMPLETED|Overall Study||21
8234725|NCT01967628|20306104|P2|STARTED|Overall Study||50
8234726|NCT01967628|20306105|P1|STARTED|Overall Study||48
8234727|NCT01967576|20306111|P1|NOT COMPLETED|Overall Study||7
8234728|NCT01967576|20306111|P1|COMPLETED|Overall Study||7
8234729|NCT01967576|20306111|P1|STARTED|Overall Study||14
8234730|NCT01967550|20306122|P2|NOT COMPLETED|Overall Study||2
8234731|NCT01967550|20306123|P1|NOT COMPLETED|Overall Study||5
8234732|NCT01967550|20306122|P2|COMPLETED|Overall Study||149
8234733|NCT01967550|20306123|P1|COMPLETED|Overall Study||148
8234734|NCT01967550|20306122|P2|STARTED|Overall Study||151
8234735|NCT01967550|20306123|P1|STARTED|Overall Study||153
8234736|NCT01967537|20306129|P1|NOT COMPLETED|Overall Study||60
8234737|NCT01967537|20306129|P1|COMPLETED|Overall Study||281
8234738|NCT01967537|20306129|P1|STARTED|Overall Study||341
8234739|NCT01967433|20306140|P2|NOT COMPLETED|Overall Study||1
8234740|NCT01967433|20306141|P1|NOT COMPLETED|Overall Study||0
8234741|NCT01967433|20306140|P2|COMPLETED|Overall Study||58
8234742|NCT01967433|20306141|P1|COMPLETED|Overall Study||61
8234743|NCT01967433|20306140|P2|STARTED|Overall Study||59
8234744|NCT01967433|20306141|P1|STARTED|Overall Study||61
8234745|NCT01967342|20306162|P3|NOT COMPLETED|Overall Study||29
8234746|NCT01967342|20306163|P2|NOT COMPLETED|Overall Study||25
8234747|NCT01967342|20306164|P1|NOT COMPLETED|Overall Study||27
8234748|NCT01967342|20306162|P3|COMPLETED|Overall Study||68
8234749|NCT01967342|20306163|P2|COMPLETED|Overall Study||70
8234750|NCT01967342|20306164|P1|COMPLETED|Overall Study||71
8234751|NCT01967342|20306162|P3|10-week Follow-up|Overall Study||80
8234752|NCT01967342|20306163|P2|10-week Follow-up|Overall Study||83
8234753|NCT01967342|20306164|P1|10-week Follow-up|Overall Study||78
8234754|NCT01967342|20306162|P3|5-week Follow-up|Overall Study||76
8234755|NCT01967342|20306163|P2|5-week Follow-up|Overall Study||78
8234756|NCT01967342|20306164|P1|5-week Follow-up|Overall Study||83
8234757|NCT01967342|20306162|P3|STARTED|Overall Study||97
8234758|NCT01967342|20306163|P2|STARTED|Overall Study||95
8234759|NCT01967342|20306164|P1|STARTED|Overall Study||98
8234760|NCT01967277|20306183|P2|NOT COMPLETED|Overall Study||3
8234761|NCT01967277|20306184|P1|NOT COMPLETED|Overall Study||1
8234762|NCT01967277|20306183|P2|COMPLETED|Overall Study||19
8234763|NCT01967277|20306184|P1|COMPLETED|Overall Study||21
8234764|NCT01967277|20306183|P2|STARTED|Overall Study||22
8234765|NCT01967277|20306184|P1|STARTED|Overall Study||22
8234766|NCT01967225|20306196|P2|NOT COMPLETED|Overall Study||3
8234767|NCT01967225|20306197|P1|NOT COMPLETED|Overall Study||12
8234768|NCT01967225|20306196|P2|COMPLETED|Overall Study||38
8234769|NCT01967225|20306197|P1|COMPLETED|Overall Study||72
8234770|NCT01967225|20306196|P2|Participants Received Treatment|Overall Study||41
8234771|NCT01967225|20306197|P1|Participants Received Treatment|Overall Study||83
8234772|NCT01967225|20306196|P2|STARTED|Overall Study||41
8234773|NCT01967225|20306197|P1|STARTED|Overall Study||84
8234774|NCT01967173|20306229|P8|NOT COMPLETED|Overall Study||24
8234775|NCT01967173|20306230|P7|NOT COMPLETED|Overall Study||18
8234776|NCT01967173|20306231|P6|NOT COMPLETED|Overall Study||23
8234777|NCT01967173|20306232|P5|NOT COMPLETED|Overall Study||17
8234778|NCT01967173|20306233|P4|NOT COMPLETED|Overall Study||14
8234779|NCT01967173|20306234|P3|NOT COMPLETED|Overall Study||16
8234780|NCT01967173|20306235|P2|NOT COMPLETED|Overall Study||17
8234781|NCT01967173|20306236|P1|NOT COMPLETED|Overall Study||24
8234782|NCT01967173|20306229|P8|COMPLETED|Overall Study||50
8234783|NCT01967173|20306230|P7|COMPLETED|Overall Study||57
8234784|NCT01967173|20306231|P6|COMPLETED|Overall Study||49
8234785|NCT01967173|20306232|P5|COMPLETED|Overall Study||56
8234786|NCT01967173|20306233|P4|COMPLETED|Overall Study||57
8234787|NCT01967173|20306234|P3|COMPLETED|Overall Study||55
8234788|NCT01967173|20306235|P2|COMPLETED|Overall Study||52
8234789|NCT01967173|20306236|P1|COMPLETED|Overall Study||45
8234790|NCT01967173|20306229|P8|Completed 4th Period|Overall Study||50
8234791|NCT01967173|20306230|P7|Completed 4th Period|Overall Study||57
8234792|NCT01967173|20306231|P6|Completed 4th Period|Overall Study||49
8234793|NCT01967173|20306232|P5|Completed 4th Period|Overall Study||56
8234794|NCT01967173|20306233|P4|Completed 4th Period|Overall Study||57
8234795|NCT01967173|20306234|P3|Completed 4th Period|Overall Study||55
8234796|NCT01967173|20306235|P2|Completed 4th Period|Overall Study||52
8234797|NCT01967173|20306236|P1|Completed 4th Period|Overall Study||45
8234798|NCT01967173|20306229|P8|Completed 3rd Period|Overall Study||56
8234799|NCT01967173|20306230|P7|Completed 3rd Period|Overall Study||59
8234800|NCT01967173|20306231|P6|Completed 3rd Period|Overall Study||56
8234801|NCT01967173|20306232|P5|Completed 3rd Period|Overall Study||59
8234802|NCT01967173|20306233|P4|Completed 3rd Period|Overall Study||61
8234803|NCT01967173|20306234|P3|Completed 3rd Period|Overall Study||60
8234804|NCT01967173|20306235|P2|Completed 3rd Period|Overall Study||54
8234805|NCT01967173|20306236|P1|Completed 3rd Period|Overall Study||48
8234806|NCT01967173|20306229|P8|Completed 2nd Period|Overall Study||61
8234807|NCT01967173|20306230|P7|Completed 2nd Period|Overall Study||63
8234808|NCT01967173|20306231|P6|Completed 2nd Period|Overall Study||57
8234809|NCT01967173|20306232|P5|Completed 2nd Period|Overall Study||63
8234810|NCT01967173|20306233|P4|Completed 2nd Period|Overall Study||62
8234811|NCT01967173|20306234|P3|Completed 2nd Period|Overall Study||63
8234812|NCT01967173|20306235|P2|Completed 2nd Period|Overall Study||58
8234813|NCT01967173|20306236|P1|Completed 2nd Period|Overall Study||52
8234814|NCT01967173|20306229|P8|Completed 1st Period|Overall Study||69
8234815|NCT01967173|20306230|P7|Completed 1st Period|Overall Study||67
8234816|NCT01967173|20306231|P6|Completed 1st Period|Overall Study||62
8234817|NCT01967173|20306232|P5|Completed 1st Period|Overall Study||64
8234818|NCT01967173|20306233|P4|Completed 1st Period|Overall Study||65
8234819|NCT01967173|20306234|P3|Completed 1st Period|Overall Study||67
8234820|NCT01967173|20306235|P2|Completed 1st Period|Overall Study||60
8234821|NCT01967173|20306236|P1|Completed 1st Period|Overall Study||58
8234822|NCT01967173|20306229|P8|STARTED|Overall Study||74
8234823|NCT01967173|20306230|P7|STARTED|Overall Study||75
8234824|NCT01967173|20306231|P6|STARTED|Overall Study||72
8234825|NCT01967173|20306232|P5|STARTED|Overall Study||73
8234826|NCT01967173|20306233|P4|STARTED|Overall Study||71
8234827|NCT01967173|20306234|P3|STARTED|Overall Study||71
8234828|NCT01967173|20306235|P2|STARTED|Overall Study||69
8234829|NCT01967173|20306236|P1|STARTED|Overall Study||69
8234830|NCT01967147|20306250|P2|NOT COMPLETED|Overall Study||20
8234831|NCT01967147|20306251|P1|NOT COMPLETED|Overall Study||13
8234832|NCT01967147|20306250|P2|COMPLETED|Overall Study||82
8234833|NCT01967147|20306251|P1|COMPLETED|Overall Study||99
8234834|NCT01967147|20306250|P2|STARTED|Overall Study||102
8234835|NCT01967147|20306251|P1|STARTED|Overall Study||112
8234836|NCT01967134|20306269|P3|NOT COMPLETED|Overall Study||0
8234837|NCT01967134|20306270|P2|NOT COMPLETED|Overall Study||1
8234838|NCT01967134|20306271|P1|NOT COMPLETED|Overall Study||0
8234839|NCT01967134|20306269|P3|COMPLETED|Overall Study||9
8234840|NCT01967134|20306270|P2|COMPLETED|Overall Study||7
8234841|NCT01967134|20306271|P1|COMPLETED|Overall Study||8
8234842|NCT01967134|20306269|P3|STARTED|Overall Study||9
8234843|NCT01967134|20306270|P2|STARTED|Overall Study||8
8234844|NCT01967134|20306271|P1|STARTED|Overall Study||8
8234845|NCT01967121|20306294|P3|NOT COMPLETED|Overall Study||0
8234846|NCT01967121|20306295|P2|NOT COMPLETED|Overall Study||0
8234847|NCT01967121|20306296|P1|NOT COMPLETED|Overall Study||0
8234848|NCT01967121|20306294|P3|COMPLETED|Overall Study||25
8234849|NCT01967121|20306295|P2|COMPLETED|Overall Study||25
8234850|NCT01967121|20306296|P1|COMPLETED|Overall Study||25
8234851|NCT01967121|20306294|P3|STARTED|Overall Study||25
8234852|NCT01967121|20306295|P2|STARTED|Overall Study||25
8234853|NCT01967121|20306296|P1|STARTED|Overall Study||25
8234854|NCT01967069|20306306|P2|NOT COMPLETED|Overall Study||8
8234855|NCT01967069|20306307|P1|NOT COMPLETED|Overall Study||8
8234856|NCT01967069|20306306|P2|COMPLETED|Overall Study||87
8234857|NCT01967069|20306307|P1|COMPLETED|Overall Study||174
8234858|NCT01967069|20306306|P2|STARTED|Overall Study||95
8234859|NCT01967069|20306307|P1|STARTED|Overall Study||182
8234860|NCT01966978|20306315|P2|NOT COMPLETED|Overall Study||13
8234861|NCT01966978|20306316|P1|NOT COMPLETED|Overall Study||17
8234862|NCT01966978|20306315|P2|COMPLETED|Overall Study||46
8234863|NCT01966978|20306316|P1|COMPLETED|Overall Study||44
8234864|NCT01966978|20306315|P2|STARTED|Overall Study||59
8234865|NCT01966978|20306316|P1|STARTED|Overall Study||61
8234866|NCT01966926|20306338|P2|NOT COMPLETED|Overall Study||0
8234867|NCT01966926|20306339|P1|NOT COMPLETED|Overall Study||0
8234868|NCT01966926|20306338|P2|COMPLETED|Overall Study||15
8234869|NCT01966926|20306339|P1|COMPLETED|Overall Study||15
8234870|NCT01966926|20306338|P2|STARTED|Overall Study||15
8234871|NCT01966926|20306339|P1|STARTED|Overall Study||15
8234872|NCT01966900|20306357|P2|NOT COMPLETED|Overall Study||0
8234873|NCT01966900|20306358|P1|NOT COMPLETED|Overall Study||2
8234874|NCT01966900|20306357|P2|COMPLETED|Overall Study||6
8234875|NCT01966900|20306358|P1|COMPLETED|Overall Study||6
8234876|NCT01966900|20306357|P2|STARTED|Overall Study||6
8234877|NCT01966900|20306358|P1|STARTED|Overall Study||8
8234878|NCT01966809|20306368|P1|NOT COMPLETED|Overall Study||0
8234879|NCT01966809|20306368|P1|COMPLETED|Overall Study||1
8234880|NCT01966809|20306368|P1|STARTED|Overall Study||1
8234881|NCT01966796|20306379|P4|NOT COMPLETED|Overall Study||0
8234882|NCT01966796|20306380|P3|NOT COMPLETED|Overall Study||0
8234883|NCT01966796|20306381|P2|NOT COMPLETED|Overall Study||0
8234884|NCT01966796|20306382|P1|NOT COMPLETED|Overall Study||0
8234885|NCT01966796|20306379|P4|COMPLETED|Overall Study||269
8234886|NCT01966796|20306380|P3|COMPLETED|Overall Study||195
8234887|NCT01966796|20306381|P2|COMPLETED|Overall Study||51
8234888|NCT01966796|20306382|P1|COMPLETED|Overall Study||15
8234889|NCT01966796|20306379|P4|STARTED|Overall Study||269
8234890|NCT01966796|20306380|P3|STARTED|Overall Study||195
8234891|NCT01966796|20306381|P2|STARTED|Overall Study||51
8234892|NCT01966796|20306382|P1|STARTED|Overall Study||15
8234893|NCT01966770|20306396|P1|NOT COMPLETED|Overall Study||0
8234894|NCT01966770|20306396|P1|COMPLETED|Overall Study||20
8234895|NCT01966770|20306396|P1|STARTED|Overall Study||20
8234896|NCT01966731|20306505|P1|NOT COMPLETED|Overall Study||635
8234897|NCT01966731|20306505|P1|COMPLETED|Overall Study||0
8234898|NCT01966731|20306505|P1|Completed Study|Overall Study||0
8234899|NCT01966731|20306505|P1|Completed 3 Months of Treatment|Overall Study||600
8234900|NCT01966731|20306505|P1|Initiated Hydroxyurea|Overall Study||606
8234901|NCT01966731|20306505|P1|STARTED|Overall Study||635
8234902|NCT01966718|20306509|P1|NOT COMPLETED|Overall Study||0
8234903|NCT01966718|20306509|P1|COMPLETED|Overall Study||8
8234904|NCT01966718|20306509|P1|STARTED|Overall Study||8
8234911|NCT01966458|20306538|P2|NOT COMPLETED|Overall Study||2
8234912|NCT01966458|20306539|P1|NOT COMPLETED|Overall Study||4
8234913|NCT01966458|20306538|P2|COMPLETED|Overall Study||155
8234914|NCT01966458|20306539|P1|COMPLETED|Overall Study||304
8234915|NCT01966458|20306538|P2|STARTED|Overall Study||157
8234916|NCT01966458|20306539|P1|STARTED|Overall Study||308
8234917|NCT01966445|20306554|P7|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5
8234918|NCT01966445|20306555|P6|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234919|NCT01966445|20306556|P5|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234920|NCT01966445|20306557|P4|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234921|NCT01966445|20306558|P3|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234922|NCT01966445|20306559|P2|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234923|NCT01966445|20306560|P1|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234924|NCT01966445|20306554|P7|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4
8234925|NCT01966445|20306555|P6|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234926|NCT01966445|20306556|P5|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234927|NCT01966445|20306557|P4|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234928|NCT01966445|20306558|P3|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234929|NCT01966445|20306559|P2|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234930|NCT01966445|20306560|P1|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
8234931|NCT01966445|20306554|P7|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9
8234932|NCT01966445|20306555|P6|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8234933|NCT01966445|20306556|P5|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8234934|NCT01966445|20306557|P4|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8234935|NCT01966445|20306558|P3|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8234936|NCT01966445|20306559|P2|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8234937|NCT01966445|20306560|P1|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
8234938|NCT01966445|20306554|P7|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
8234939|NCT01966445|20306555|P6|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8234940|NCT01966445|20306556|P5|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
8234941|NCT01966445|20306557|P4|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
8234942|NCT01966445|20306558|P3|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8234943|NCT01966445|20306559|P2|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
8234944|NCT01966445|20306560|P1|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
8234945|NCT01966445|20306554|P7|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
8234946|NCT01966445|20306555|P6|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4
8234947|NCT01966445|20306556|P5|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8234948|NCT01966445|20306557|P4|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
8234949|NCT01966445|20306558|P3|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8234950|NCT01966445|20306559|P2|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8234951|NCT01966445|20306560|P1|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
8234952|NCT01966445|20306554|P7|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0
8234953|NCT01966445|20306555|P6|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
8234954|NCT01966445|20306556|P5|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4
8234955|NCT01966445|20306557|P4|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
8234956|NCT01966445|20306558|P3|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2
8234957|NCT01966445|20306559|P2|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3
8234958|NCT01966445|20306560|P1|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1
8234959|NCT01966432|20306670|P3|NOT COMPLETED|Overall Study||26
8234960|NCT01966432|20306671|P2|NOT COMPLETED|Overall Study||13
8234961|NCT01966432|20306672|P1|NOT COMPLETED|Overall Study||5
8234962|NCT01966432|20306670|P3|COMPLETED|Overall Study||28
8234963|NCT01966432|20306671|P2|COMPLETED|Overall Study||21
8234964|NCT01966432|20306672|P1|COMPLETED|Overall Study||5
8234965|NCT01966432|20306670|P3|STARTED|Overall Study||54
8234966|NCT01966432|20306671|P2|STARTED|Overall Study||34
8234967|NCT01966432|20306672|P1|STARTED|Overall Study||10
8234968|NCT01966380|20306692|P2|NOT COMPLETED|Overall Study||1
8234969|NCT01966380|20306693|P1|NOT COMPLETED|Overall Study||0
8234970|NCT01966380|20306692|P2|COMPLETED|Overall Study||2
8234971|NCT01966380|20306693|P1|COMPLETED|Overall Study||3
8234972|NCT01966380|20306692|P2|STARTED|Overall Study||3
8234973|NCT01966380|20306693|P1|STARTED|Overall Study||3
8234974|NCT01966354|20306702|P3|NOT COMPLETED|Overall Study||0
8234975|NCT01966354|20306703|P2|NOT COMPLETED|Overall Study||0
8234976|NCT01966354|20306704|P1|NOT COMPLETED|Overall Study||0
8234977|NCT01966354|20306702|P3|COMPLETED|Overall Study||72
8234978|NCT01966354|20306703|P2|COMPLETED|Overall Study||73
8234979|NCT01966354|20306704|P1|COMPLETED|Overall Study||75
8234980|NCT01966354|20306702|P3|STARTED|Overall Study||72
8234981|NCT01966354|20306703|P2|STARTED|Overall Study||73
8234982|NCT01966354|20306704|P1|STARTED|Overall Study||75
8234983|NCT01966159|20306729|P2|NOT COMPLETED|Overall Study||0
8234984|NCT01966159|20306730|P1|NOT COMPLETED|Overall Study||0
8234985|NCT01966159|20306729|P2|COMPLETED|Overall Study||207
8234986|NCT01966159|20306730|P1|COMPLETED|Overall Study||205
8234987|NCT01966159|20306729|P2|STARTED|Overall Study||207
8234988|NCT01966159|20306730|P1|STARTED|Overall Study||205
8234989|NCT01966120|20306742|P2|NOT COMPLETED|Overall Study||6
8234990|NCT01966120|20306743|P1|NOT COMPLETED|Overall Study||1
8234991|NCT01966120|20306742|P2|COMPLETED|Overall Study||26
8234992|NCT01966120|20306743|P1|COMPLETED|Overall Study||54
8234993|NCT01966120|20306742|P2|STARTED|Overall Study||32
8234994|NCT01966120|20306743|P1|STARTED|Overall Study||55
8234995|NCT01966107|20306767|P2|NOT COMPLETED|Overall Study||881
8234996|NCT01966107|20306768|P1|NOT COMPLETED|Overall Study||802
8234997|NCT01966107|20306767|P2|COMPLETED|Overall Study||937
8234998|NCT01966107|20306768|P1|COMPLETED|Overall Study||1010
8234999|NCT01966107|20306767|P2|Full Analysis Set|Overall Study||1798
8235000|NCT01966107|20306768|P1|Full Analysis Set|Overall Study||1791
8235001|NCT01966107|20306767|P2|STARTED|Overall Study||1818
8235002|NCT01966107|20306768|P1|STARTED|Overall Study||1812
8235003|NCT01966068|20306782|P1|NOT COMPLETED|Overall Study||138
8235004|NCT01966068|20306782|P1|COMPLETED|Overall Study||156
8235005|NCT01966068|20306782|P1|Use the MyAsthma Portal More Than Once|Overall Study||156
8235006|NCT01966068|20306782|P1|Used the MyAsthma Portal at Least Once|Overall Study||237
8235007|NCT01966068|20306782|P1|STARTED|Overall Study||294
8235008|NCT01966042|20306787|P1|NOT COMPLETED|Overall Study||2
8235009|NCT01966042|20306787|P1|COMPLETED|Overall Study||11
8235010|NCT01966042|20306787|P1|STARTED|Overall Study||13
8235011|NCT01966003|20306796|P2|NOT COMPLETED|Overall Study||270
8235012|NCT01966003|20306797|P1|NOT COMPLETED|Overall Study||270
8235013|NCT01966003|20306796|P2|COMPLETED|Overall Study||44
8235014|NCT01966003|20306797|P1|COMPLETED|Overall Study||58
8235015|NCT01966003|20306796|P2|Received Study Drug|Overall Study||309
8235016|NCT01966003|20306797|P1|Received Study Drug|Overall Study||324
8235017|NCT01966003|20306796|P2|STARTED|Overall Study||314
8235018|NCT01966003|20306797|P1|STARTED|Overall Study||328
8235019|NCT01965938|20306815|P2|NOT COMPLETED|Overall Study||0
8235020|NCT01965938|20306816|P1|NOT COMPLETED|Overall Study||1
8235021|NCT01965938|20306815|P2|COMPLETED|Overall Study||20
8235022|NCT01965938|20306816|P1|COMPLETED|Overall Study||20
8235023|NCT01965938|20306815|P2|STARTED|Overall Study||20
8235024|NCT01965938|20306816|P1|STARTED|Overall Study||21
8235025|NCT01965899|20306836|P1|NOT COMPLETED|Overall Study||6
8235026|NCT01965899|20306836|P1|COMPLETED|Overall Study||145
8235027|NCT01965899|20306836|P1|STARTED|Overall Study||151
8235028|NCT01965834|20306847|P1|NOT COMPLETED|Overall Study||4
8235029|NCT01965834|20306847|P1|COMPLETED|Overall Study||2
8235030|NCT01965834|20306847|P1|STARTED|Overall Study||6
8235031|NCT01965782|20306853|P1|NOT COMPLETED|Overall Study||0
8235032|NCT01965782|20306853|P1|COMPLETED|Overall Study||0
8235033|NCT01965782|20306853|P1|STARTED|Overall Study||0
8235034|NCT01965756|20306865|P2|NOT COMPLETED|Overall Study||0
8235035|NCT01965756|20306866|P1|NOT COMPLETED|Overall Study||0
8235036|NCT01965756|20306865|P2|COMPLETED|Overall Study||10
8235037|NCT01965756|20306866|P1|COMPLETED|Overall Study||10
8235038|NCT01965756|20306865|P2|STARTED|Overall Study||10
8235039|NCT01965756|20306866|P1|STARTED|Overall Study||10
8235040|NCT01965665|20306880|P1|NOT COMPLETED|Overall Study||1
8235041|NCT01965665|20306880|P1|COMPLETED|Overall Study||19
8235042|NCT01965665|20306880|P1|STARTED|Overall Study||20
8235043|NCT01965652|20306888|P2|NOT COMPLETED|Overall Study||210
8235044|NCT01965652|20306889|P1|NOT COMPLETED|Overall Study||210
8235045|NCT01965652|20306888|P2|COMPLETED|Overall Study||413
8235046|NCT01965652|20306889|P1|COMPLETED|Overall Study||413
8235047|NCT01965652|20306888|P2|Received Treatment|Overall Study||623
8235048|NCT01965652|20306889|P1|Received Treatment|Overall Study||622
8235049|NCT01965652|20306888|P2|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
8235050|NCT01965652|20306889|P1|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
8235051|NCT01965600|20306919|P4|NOT COMPLETED|Second Intervention||2
8235052|NCT01965600|20306920|P3|NOT COMPLETED|Second Intervention||2
8235053|NCT01965600|20306921|P2|NOT COMPLETED|Second Intervention||0
8235054|NCT01965600|20306922|P1|NOT COMPLETED|Second Intervention||0
8235055|NCT01965600|20306919|P4|COMPLETED|Second Intervention||0
8235056|NCT01965600|20306920|P3|COMPLETED|Second Intervention||1
8235057|NCT01965600|20306921|P2|COMPLETED|Second Intervention||4
8235058|NCT01965600|20306922|P1|COMPLETED|Second Intervention||4
8235059|NCT01965600|20306919|P4|STARTED|Second Intervention||2
8235060|NCT01965600|20306920|P3|STARTED|Second Intervention||3
8235061|NCT01965600|20306921|P2|STARTED|Second Intervention||4
8235062|NCT01965600|20306922|P1|STARTED|Second Intervention||4
8235063|NCT01965600|20306919|P4|NOT COMPLETED|Washout Period of Approximately 15 Days||2
8235064|NCT01965600|20306920|P3|NOT COMPLETED|Washout Period of Approximately 15 Days||2
8235065|NCT01965600|20306921|P2|NOT COMPLETED|Washout Period of Approximately 15 Days||4
8235066|NCT01965600|20306922|P1|NOT COMPLETED|Washout Period of Approximately 15 Days||2
8235067|NCT01965600|20306919|P4|COMPLETED|Washout Period of Approximately 15 Days||2
8235068|NCT01965600|20306920|P3|COMPLETED|Washout Period of Approximately 15 Days||3
8235069|NCT01965600|20306921|P2|COMPLETED|Washout Period of Approximately 15 Days||4
8235070|NCT01965600|20306922|P1|COMPLETED|Washout Period of Approximately 15 Days||4
8235071|NCT01965600|20306919|P4|STARTED|Washout Period of Approximately 15 Days||4
8235072|NCT01965600|20306920|P3|STARTED|Washout Period of Approximately 15 Days||5
8235073|NCT01965600|20306921|P2|STARTED|Washout Period of Approximately 15 Days||8
8235074|NCT01965600|20306922|P1|STARTED|Washout Period of Approximately 15 Days||6
8235075|NCT01965600|20306919|P4|NOT COMPLETED|First Intervention||0
8235076|NCT01965600|20306920|P3|NOT COMPLETED|First Intervention||0
8235077|NCT01965600|20306921|P2|NOT COMPLETED|First Intervention||0
8235078|NCT01965600|20306922|P1|NOT COMPLETED|First Intervention||0
8235079|NCT01965600|20306919|P4|COMPLETED|First Intervention||4
8235080|NCT01965600|20306920|P3|COMPLETED|First Intervention||5
8235081|NCT01965600|20306921|P2|COMPLETED|First Intervention||8
8235082|NCT01965600|20306922|P1|COMPLETED|First Intervention||6
8235083|NCT01965600|20306919|P4|Received at Least One Dose of Drug|First Intervention||4
8235084|NCT01965600|20306920|P3|Received at Least One Dose of Drug|First Intervention||5
8235085|NCT01965600|20306921|P2|Received at Least One Dose of Drug|First Intervention||8
8235086|NCT01965600|20306922|P1|Received at Least One Dose of Drug|First Intervention||6
8235087|NCT01965600|20306919|P4|STARTED|First Intervention||4
8235088|NCT01965600|20306920|P3|STARTED|First Intervention||5
8235089|NCT01965600|20306921|P2|STARTED|First Intervention||8
8235090|NCT01965600|20306922|P1|STARTED|First Intervention||6
8235091|NCT01965561|20306966|P1|NOT COMPLETED|Overall Study||0
8235092|NCT01965561|20306966|P1|COMPLETED|Overall Study||10
8235093|NCT01965561|20306966|P1|STARTED|Overall Study||10
8235094|NCT01965535|20306979|P2|NOT COMPLETED|Overall Study||1
8235095|NCT01965535|20306980|P1|NOT COMPLETED|Overall Study||2
8235096|NCT01965535|20306979|P2|COMPLETED|Overall Study||76
8235097|NCT01965535|20306980|P1|COMPLETED|Overall Study||76
8235098|NCT01965535|20306979|P2|STARTED|Overall Study||77
8235099|NCT01965535|20306980|P1|STARTED|Overall Study||78
8235100|NCT01965431|20306994|P6|NOT COMPLETED|Overall Study||6
8235101|NCT01965431|20306995|P5|NOT COMPLETED|Overall Study||6
8235102|NCT01965431|20306996|P4|NOT COMPLETED|Overall Study||6
8235103|NCT01965431|20306997|P3|NOT COMPLETED|Overall Study||6
8235104|NCT01965431|20306998|P2|NOT COMPLETED|Overall Study||6
8235105|NCT01965431|20306999|P1|NOT COMPLETED|Overall Study||6
8235106|NCT01965431|20306994|P6|COMPLETED|Overall Study||2
8235107|NCT01965431|20306995|P5|COMPLETED|Overall Study||2
8235108|NCT01965431|20306996|P4|COMPLETED|Overall Study||2
8235109|NCT01965431|20306997|P3|COMPLETED|Overall Study||2
8235110|NCT01965431|20306998|P2|COMPLETED|Overall Study||2
8235111|NCT01965431|20306999|P1|COMPLETED|Overall Study||2
8235112|NCT01965431|20306994|P6|STARTED|Overall Study||8
8235113|NCT01965431|20306995|P5|STARTED|Overall Study||8
8235114|NCT01965431|20306996|P4|STARTED|Overall Study||8
8235115|NCT01965431|20306997|P3|STARTED|Overall Study||8
8235116|NCT01965431|20306998|P2|STARTED|Overall Study||8
8235117|NCT01965431|20306999|P1|STARTED|Overall Study|Started are actually Treated subjects|8
8235118|NCT01965366|20307014|P2|NOT COMPLETED|Overall Study||5
8235119|NCT01965366|20307015|P1|NOT COMPLETED|Overall Study||10
8235120|NCT01965366|20307014|P2|COMPLETED|Overall Study||9
8235121|NCT01965366|20307015|P1|COMPLETED|Overall Study||3
8235122|NCT01965366|20307014|P2|STARTED|Overall Study||14
8235123|NCT01965366|20307015|P1|STARTED|Overall Study||13
8235127|NCT01965288|20307030|P2|NOT COMPLETED|Overall Study||0
8235128|NCT01965288|20307031|P1|NOT COMPLETED|Overall Study||0
8235129|NCT01965288|20307030|P2|COMPLETED|Overall Study||30
8235130|NCT01965288|20307031|P1|COMPLETED|Overall Study||30
8235131|NCT01965288|20307030|P2|STARTED|Overall Study||30
8235132|NCT01965288|20307031|P1|STARTED|Overall Study||30
8235133|NCT01965262|20307237|P2|NOT COMPLETED|Second Intervention (7 Days)||10
8235134|NCT01965262|20307238|P1|NOT COMPLETED|Second Intervention (7 Days)||1
8235135|NCT01965262|20307237|P2|COMPLETED|Second Intervention (7 Days)||5
8235136|NCT01965262|20307238|P1|COMPLETED|Second Intervention (7 Days)||14
8235137|NCT01965262|20307237|P2|STARTED|Second Intervention (7 Days)||15
8235138|NCT01965262|20307238|P1|STARTED|Second Intervention (7 Days)||15
8235139|NCT01965262|20307237|P2|NOT COMPLETED|First Intervention (7 Days)||0
8235140|NCT01965262|20307238|P1|NOT COMPLETED|First Intervention (7 Days)||0
8235141|NCT01965262|20307237|P2|COMPLETED|First Intervention (7 Days)||15
8235142|NCT01965262|20307238|P1|COMPLETED|First Intervention (7 Days)||15
8235143|NCT01965262|20307237|P2|STARTED|First Intervention (7 Days)||15
8235144|NCT01965262|20307238|P1|STARTED|First Intervention (7 Days)||15
8235145|NCT01965158|20307302|P2|NOT COMPLETED|Overall Study||35
8235146|NCT01965158|20307303|P1|NOT COMPLETED|Overall Study||41
8235147|NCT01965158|20307302|P2|COMPLETED|Overall Study||238
8235148|NCT01965158|20307303|P1|COMPLETED|Overall Study||233
8235149|NCT01965158|20307302|P2|Received Treatment|Overall Study||273
8235150|NCT01965158|20307303|P1|Received Treatment|Overall Study||272
8235151|NCT01965158|20307302|P2|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
8235152|NCT01965158|20307303|P1|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
8235153|NCT01965067|20307319|P2|NOT COMPLETED|Overall Study||0
8235154|NCT01965067|20307320|P1|NOT COMPLETED|Overall Study||0
8235155|NCT01965067|20307319|P2|COMPLETED|Overall Study||30
8235156|NCT01965067|20307320|P1|COMPLETED|Overall Study||30
8235157|NCT01965067|20307319|P2|STARTED|Overall Study||30
8235158|NCT01965067|20307320|P1|STARTED|Overall Study||30
8235159|NCT01965002|20307336|P1|NOT COMPLETED|Overall Study||0
8235160|NCT01965002|20307336|P1|COMPLETED|Overall Study||5
8235161|NCT01965002|20307336|P1|STARTED|Overall Study||5
8235162|NCT01964976|20307344|P1|NOT COMPLETED|Overall Study||31
8235163|NCT01964976|20307344|P1|COMPLETED|Overall Study||1065
8235164|NCT01964976|20307344|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
8235165|NCT01964963|20307356|P1|NOT COMPLETED|Overall Study||943
8235166|NCT01964963|20307356|P1|COMPLETED|Overall Study||18249
8235167|NCT01964963|20307356|P1|STARTED|Overall Study||19192
8235168|NCT01964950|20307364|P1|NOT COMPLETED|Overall Study||25
8235169|NCT01964950|20307364|P1|COMPLETED|Overall Study||1076
8235170|NCT01964950|20307364|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
8235171|NCT01964924|20307376|P2|NOT COMPLETED|Trametinib + GSK2141||0
8235172|NCT01964924|20307377|P1|NOT COMPLETED|Trametinib + GSK2141||0
8235173|NCT01964924|20307376|P2|COMPLETED|Trametinib + GSK2141||19
8235174|NCT01964924|20307377|P1|COMPLETED|Trametinib + GSK2141||0
8235175|NCT01964924|20307376|P2|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19
8235176|NCT01964924|20307377|P1|STARTED|Trametinib + GSK2141||0
8235177|NCT01964924|20307376|P2|NOT COMPLETED|Trametinib Monotherapy||0
8235178|NCT01964924|20307377|P1|NOT COMPLETED|Trametinib Monotherapy||19
8235179|NCT01964924|20307376|P2|COMPLETED|Trametinib Monotherapy||0
8235180|NCT01964924|20307377|P1|COMPLETED|Trametinib Monotherapy||18
8235181|NCT01964924|20307376|P2|STARTED|Trametinib Monotherapy||0
8235182|NCT01964924|20307377|P1|STARTED|Trametinib Monotherapy||37
8235183|NCT01964898|20307401|P2|NOT COMPLETED|Overall Study||7
8235184|NCT01964898|20307402|P1|NOT COMPLETED|Overall Study||7
8235185|NCT01964898|20307401|P2|COMPLETED|Overall Study||26
8235186|NCT01964898|20307402|P1|COMPLETED|Overall Study||24
8235187|NCT01964898|20307401|P2|12 Week Assessment|Overall Study||30
8235188|NCT01964898|20307402|P1|12 Week Assessment|Overall Study||25
8235189|NCT01964898|20307401|P2|STARTED|Overall Study||33
8235190|NCT01964898|20307402|P1|STARTED|Overall Study||31
8235191|NCT01964755|20307422|P1|NOT COMPLETED|Overall Study||2
8235192|NCT01964755|20307422|P1|COMPLETED|Overall Study||4
8235193|NCT01964755|20307422|P1|Cycle 5|Overall Study||4
8235194|NCT01964755|20307422|P1|Cycle 4|Overall Study||4
8235195|NCT01964755|20307422|P1|Cycle 3|Overall Study||4
8235196|NCT01964755|20307422|P1|Cycle 2|Overall Study||5
8235197|NCT01964755|20307422|P1|STARTED|Overall Study||6
8235198|NCT01964716|20307437|P2|NOT COMPLETED|Overall Study||6
8235199|NCT01964716|20307438|P1|NOT COMPLETED|Overall Study||5
8235200|NCT01964716|20307437|P2|COMPLETED|Overall Study||244
8235201|NCT01964716|20307438|P1|COMPLETED|Overall Study||245
8235202|NCT01964716|20307437|P2|Vaccinated Dose 3|Overall Study||244
8235203|NCT01964716|20307438|P1|Vaccinated Dose 3|Overall Study||247
8235204|NCT01964716|20307437|P2|Vaccinated Dose 2|Overall Study||248
8235205|NCT01964716|20307438|P1|Vaccinated Dose 2|Overall Study||249
8235206|NCT01964716|20307437|P2|Vaccinated Dose 1|Overall Study||250
8235207|NCT01964716|20307438|P1|Vaccinated Dose 1|Overall Study||250
8235208|NCT01964716|20307437|P2|STARTED|Overall Study||250
8235209|NCT01964716|20307438|P1|STARTED|Overall Study||250
8235210|NCT01964547|20307476|P2|NOT COMPLETED|Overall Study||11
8235211|NCT01964547|20307477|P1|NOT COMPLETED|Overall Study||12
8235212|NCT01964547|20307476|P2|COMPLETED|Overall Study||48
8235213|NCT01964547|20307477|P1|COMPLETED|Overall Study||50
8235214|NCT01964547|20307476|P2|STARTED|Overall Study||59
8235215|NCT01964547|20307477|P1|STARTED|Overall Study||62
8235216|NCT01964521|20307501|P1|NOT COMPLETED|Overall Study||4
8235217|NCT01964521|20307501|P1|COMPLETED|Overall Study||20
8235218|NCT01964521|20307501|P1|STARTED|Overall Study||24
8235219|NCT01964430|20307508|P2|NOT COMPLETED|Overall Study||124
8235220|NCT01964430|20307509|P1|NOT COMPLETED|Overall Study||145
8235221|NCT01964430|20307508|P2|COMPLETED|Overall Study||310
8235222|NCT01964430|20307509|P1|COMPLETED|Overall Study||287
8235223|NCT01964430|20307508|P2|Treated Population|Overall Study||423
8235224|NCT01964430|20307509|P1|Treated Population|Overall Study||429
8235225|NCT01964430|20307508|P2|STARTED|Overall Study||434
8235226|NCT01964430|20307509|P1|STARTED|Overall Study||432
8235235|NCT01964352|20307558|P4|NOT COMPLETED|Overall Study||8
8235236|NCT01964352|20307559|P3|NOT COMPLETED|Overall Study||6
8235237|NCT01964352|20307560|P2|NOT COMPLETED|Overall Study||11
8235238|NCT01964352|20307561|P1|NOT COMPLETED|Overall Study||26
8235239|NCT01964352|20307558|P4|COMPLETED|Overall Study||195
8235240|NCT01964352|20307559|P3|COMPLETED|Overall Study||196
8235241|NCT01964352|20307560|P2|COMPLETED|Overall Study||192
8235242|NCT01964352|20307561|P1|COMPLETED|Overall Study||178
8235243|NCT01964352|20307558|P4|STARTED|Overall Study||203
8235244|NCT01964352|20307559|P3|STARTED|Overall Study||202
8235245|NCT01964352|20307560|P2|STARTED|Overall Study||203
8235246|NCT01964352|20307561|P1|STARTED|Overall Study||204
8235250|NCT01964300|20307600|P2|NOT COMPLETED|Overall Study||11
8235251|NCT01964300|20307601|P1|NOT COMPLETED|Overall Study||6
8235252|NCT01964300|20307600|P2|COMPLETED|Overall Study||1
8235253|NCT01964300|20307601|P1|COMPLETED|Overall Study||1
8235254|NCT01964300|20307600|P2|STARTED|Overall Study||12
8235255|NCT01964300|20307601|P1|STARTED|Overall Study||7
8235256|NCT01964222|20307615|P2|NOT COMPLETED|Overall Study||11
8235257|NCT01964222|20307616|P1|NOT COMPLETED|Overall Study||15
8235258|NCT01964222|20307615|P2|COMPLETED|Overall Study||89
8235259|NCT01964222|20307616|P1|COMPLETED|Overall Study||86
8235260|NCT01964222|20307615|P2|STARTED|Overall Study||100
8235261|NCT01964222|20307616|P1|STARTED|Overall Study||101
8235262|NCT01964105|20307633|P3|NOT COMPLETED|Overall Study||0
8235263|NCT01964105|20307634|P2|NOT COMPLETED|Overall Study||13
8235264|NCT01964105|20307635|P1|NOT COMPLETED|Overall Study||2
8235265|NCT01964105|20307633|P3|COMPLETED|Overall Study||10
8235266|NCT01964105|20307634|P2|COMPLETED|Overall Study||62
8235267|NCT01964105|20307635|P1|COMPLETED|Overall Study||13
8235268|NCT01964105|20307633|P3|STARTED|Overall Study||10
8235269|NCT01964105|20307634|P2|STARTED|Overall Study||75
8235270|NCT01964105|20307635|P1|STARTED|Overall Study||15
8235271|NCT01964092|20307645|P2|NOT COMPLETED|Overall Study||0
8235272|NCT01964092|20307646|P1|NOT COMPLETED|Overall Study||2
8235273|NCT01964092|20307645|P2|COMPLETED|Overall Study||181
8235274|NCT01964092|20307646|P1|COMPLETED|Overall Study||227
8235275|NCT01964092|20307645|P2|STARTED|Overall Study||181
8235276|NCT01964092|20307646|P1|STARTED|Overall Study||229
8235277|NCT01963923|20307654|P2|NOT COMPLETED|3 Months Post-surgery||1
8235278|NCT01963923|20307655|P1|NOT COMPLETED|3 Months Post-surgery||2
8235279|NCT01963923|20307654|P2|COMPLETED|3 Months Post-surgery||9
8235280|NCT01963923|20307655|P1|COMPLETED|3 Months Post-surgery||10
8235281|NCT01963923|20307654|P2|STARTED|3 Months Post-surgery||10
8235282|NCT01963923|20307655|P1|STARTED|3 Months Post-surgery||12
8235283|NCT01963923|20307654|P2|NOT COMPLETED|3 Weeks Post-surgery||10
8235284|NCT01963923|20307655|P1|NOT COMPLETED|3 Weeks Post-surgery||8
8235285|NCT01963923|20307654|P2|COMPLETED|3 Weeks Post-surgery||10
8235286|NCT01963923|20307655|P1|COMPLETED|3 Weeks Post-surgery||12
8235287|NCT01963923|20307654|P2|STARTED|3 Weeks Post-surgery||20
8235288|NCT01963923|20307655|P1|STARTED|3 Weeks Post-surgery||20
8235289|NCT01963845|20307677|P2|NOT COMPLETED|Overall Study||0
8235290|NCT01963845|20307678|P1|NOT COMPLETED|Overall Study||0
8235291|NCT01963845|20307677|P2|COMPLETED|Overall Study||25
8235292|NCT01963845|20307678|P1|COMPLETED|Overall Study||25
8235293|NCT01963845|20307677|P2|STARTED|Overall Study||25
8235294|NCT01963845|20307678|P1|STARTED|Overall Study||25
8235295|NCT01963767|20307694|P2|NOT COMPLETED|Overall Study||2
8235296|NCT01963767|20307695|P1|NOT COMPLETED|Overall Study||6
8235297|NCT01963767|20307694|P2|COMPLETED|Overall Study||53
8235298|NCT01963767|20307695|P1|COMPLETED|Overall Study||52
8235299|NCT01963767|20307694|P2|STARTED|Overall Study||55
8235300|NCT01963767|20307695|P1|STARTED|Overall Study||58
8235301|NCT01963676|20307705|P2|NOT COMPLETED|Overall Study||0
8235302|NCT01963676|20307706|P1|NOT COMPLETED|Overall Study||1
8235303|NCT01963676|20307705|P2|COMPLETED|Overall Study||13
8235304|NCT01963676|20307706|P1|COMPLETED|Overall Study||13
8235305|NCT01963676|20307705|P2|STARTED|Overall Study||13
8235306|NCT01963676|20307706|P1|STARTED|Overall Study||14
8235307|NCT01963611|20307719|P5|NOT COMPLETED|Overall Study||51
8235308|NCT01963611|20307720|P4|NOT COMPLETED|Overall Study||52
8235309|NCT01963611|20307721|P3|NOT COMPLETED|Overall Study||52
8235310|NCT01963611|20307722|P2|NOT COMPLETED|Overall Study||49
8235311|NCT01963611|20307723|P1|NOT COMPLETED|Overall Study||51
8235312|NCT01963611|20307719|P5|COMPLETED|Overall Study||0
8235313|NCT01963611|20307720|P4|COMPLETED|Overall Study||0
8235314|NCT01963611|20307721|P3|COMPLETED|Overall Study||0
8235315|NCT01963611|20307722|P2|COMPLETED|Overall Study||0
8235316|NCT01963611|20307723|P1|COMPLETED|Overall Study||0
8235317|NCT01963611|20307719|P5|Safety Analysis Set|Overall Study||50
8235318|NCT01963611|20307720|P4|Safety Analysis Set|Overall Study||52
8235319|NCT01963611|20307721|P3|Safety Analysis Set|Overall Study||52
8235320|NCT01963611|20307722|P2|Safety Analysis Set|Overall Study||49
8235321|NCT01963611|20307723|P1|Safety Analysis Set|Overall Study||51
8235322|NCT01963611|20307719|P5|STARTED|Overall Study||51
8235323|NCT01963611|20307720|P4|STARTED|Overall Study||52
8235324|NCT01963611|20307721|P3|STARTED|Overall Study||52
8235325|NCT01963611|20307722|P2|STARTED|Overall Study||49
8235326|NCT01963611|20307723|P1|STARTED|Overall Study||51
8235327|NCT01963481|20307780|P1|NOT COMPLETED|Overall Study||0
8235328|NCT01963481|20307780|P1|COMPLETED|Overall Study||23
8235329|NCT01963481|20307780|P1|STARTED|Overall Study||23
8235330|NCT01963403|20307788|P2|NOT COMPLETED|Overall Study||4
8235331|NCT01963403|20307789|P1|NOT COMPLETED|Overall Study||2
8235332|NCT01963403|20307788|P2|COMPLETED|Overall Study|Follow-up over three months|9
8235333|NCT01963403|20307789|P1|COMPLETED|Overall Study|Follow-up over three months|11
8235334|NCT01963403|20307788|P2|STARTED|Overall Study||13
8235335|NCT01963403|20307789|P1|STARTED|Overall Study||13
8235336|NCT01963260|20307811|P10|NOT COMPLETED|Overall Study||0
8235337|NCT01963260|20307812|P9|NOT COMPLETED|Overall Study||0
8235338|NCT01963260|20307813|P8|NOT COMPLETED|Overall Study||0
8235339|NCT01963260|20307814|P7|NOT COMPLETED|Overall Study||0
8235340|NCT01963260|20307815|P6|NOT COMPLETED|Overall Study||0
8235341|NCT01963260|20307816|P5|NOT COMPLETED|Overall Study||2
8235342|NCT01963260|20307817|P4|NOT COMPLETED|Overall Study||1
8235343|NCT01963260|20307818|P3|NOT COMPLETED|Overall Study||0
8235344|NCT01963260|20307819|P2|NOT COMPLETED|Overall Study||0
8235345|NCT01963260|20307820|P1|NOT COMPLETED|Overall Study||2
8235346|NCT01963260|20307811|P10|COMPLETED|Overall Study||4
8235347|NCT01963260|20307812|P9|COMPLETED|Overall Study||1
8235348|NCT01963260|20307813|P8|COMPLETED|Overall Study||2
8235349|NCT01963260|20307814|P7|COMPLETED|Overall Study||3
8235350|NCT01963260|20307815|P6|COMPLETED|Overall Study||10
8235351|NCT01963260|20307816|P5|COMPLETED|Overall Study||4
8235352|NCT01963260|20307817|P4|COMPLETED|Overall Study||5
8235353|NCT01963260|20307818|P3|COMPLETED|Overall Study||6
8235354|NCT01963260|20307819|P2|COMPLETED|Overall Study||6
8235355|NCT01963260|20307820|P1|COMPLETED|Overall Study||4
8235356|NCT01963260|20307811|P10|Treated|Overall Study||4
8235357|NCT01963260|20307812|P9|Treated|Overall Study||1
8235358|NCT01963260|20307813|P8|Treated|Overall Study||2
8235359|NCT01963260|20307814|P7|Treated|Overall Study||3
8235360|NCT01963260|20307815|P6|Treated|Overall Study||10
8235361|NCT01963260|20307816|P5|Treated|Overall Study||6
8235362|NCT01963260|20307817|P4|Treated|Overall Study||6
8235363|NCT01963260|20307818|P3|Treated|Overall Study||6
8235364|NCT01963260|20307819|P2|Treated|Overall Study||6
8235365|NCT01963260|20307820|P1|Treated|Overall Study||6
8235366|NCT01963260|20307811|P10|STARTED|Overall Study||4
8235367|NCT01963260|20307812|P9|STARTED|Overall Study||1
8235368|NCT01963260|20307813|P8|STARTED|Overall Study||2
8235369|NCT01963260|20307814|P7|STARTED|Overall Study||3
8235370|NCT01963260|20307815|P6|STARTED|Overall Study||10
8235371|NCT01963260|20307816|P5|STARTED|Overall Study||6
8235372|NCT01963260|20307817|P4|STARTED|Overall Study||6
8235373|NCT01963260|20307818|P3|STARTED|Overall Study||6
8235374|NCT01963260|20307819|P2|STARTED|Overall Study||6
8235375|NCT01963260|20307820|P1|STARTED|Overall Study||6
8235376|NCT01963234|20307875|P2|NOT COMPLETED|Overall Study||0
8235377|NCT01963234|20307876|P1|NOT COMPLETED|Overall Study||61
8235378|NCT01963234|20307875|P2|COMPLETED|Overall Study||171
8235379|NCT01963234|20307876|P1|COMPLETED|Overall Study||207
8235380|NCT01963234|20307875|P2|STARTED|Overall Study||171
8235381|NCT01963234|20307876|P1|STARTED|Overall Study||268
8235382|NCT01963169|20307903|P3|NOT COMPLETED|Overall Study||26
8235383|NCT01963169|20307904|P2|NOT COMPLETED|Overall Study||82
8235384|NCT01963169|20307905|P1|NOT COMPLETED|Overall Study||59
8235385|NCT01963169|20307903|P3|COMPLETED|Overall Study||237
8235386|NCT01963169|20307904|P2|COMPLETED|Overall Study||220
8235387|NCT01963169|20307905|P1|COMPLETED|Overall Study||242
8235388|NCT01963169|20307903|P3|STARTED|Overall Study||263
8235389|NCT01963169|20307904|P2|STARTED|Overall Study||302
8235390|NCT01963169|20307905|P1|STARTED|Overall Study||301
8235391|NCT01963143|20307922|P3|NOT COMPLETED|Overall Study||1
8235392|NCT01963143|20307923|P2|NOT COMPLETED|Overall Study||1
8235393|NCT01963143|20307924|P1|NOT COMPLETED|Overall Study||0
8235394|NCT01963143|20307922|P3|COMPLETED|Overall Study||14
8235395|NCT01963143|20307923|P2|COMPLETED|Overall Study||18
8235396|NCT01963143|20307924|P1|COMPLETED|Overall Study||14
8235397|NCT01963143|20307922|P3|STARTED|Overall Study||15
8235398|NCT01963143|20307923|P2|STARTED|Overall Study||19
8235399|NCT01963143|20307924|P1|STARTED|Overall Study||14
8235400|NCT01963117|20307934|P1|NOT COMPLETED|Overall Study||1
8235401|NCT01963117|20307934|P1|COMPLETED|Overall Study||10
8235402|NCT01963117|20307934|P1|STARTED|Overall Study||11
8235403|NCT01963091|20307945|P2|NOT COMPLETED|Overall Study||0
8235404|NCT01963091|20307946|P1|NOT COMPLETED|Overall Study||0
8235405|NCT01963091|20307945|P2|COMPLETED|Overall Study||16
8235406|NCT01963091|20307946|P1|COMPLETED|Overall Study||17
8235407|NCT01963091|20307945|P2|STARTED|Overall Study||16
8235408|NCT01963091|20307946|P1|STARTED|Overall Study||17
8235409|NCT01963078|20307960|P4|NOT COMPLETED|Overall Study||2
8235410|NCT01963078|20307961|P3|NOT COMPLETED|Overall Study||1
8235411|NCT01963078|20307962|P2|NOT COMPLETED|Overall Study||1
8235412|NCT01963078|20307963|P1|NOT COMPLETED|Overall Study||1
8235413|NCT01963078|20307960|P4|COMPLETED|Overall Study||7
8235414|NCT01963078|20307961|P3|COMPLETED|Overall Study||9
8235415|NCT01963078|20307962|P2|COMPLETED|Overall Study||9
8235416|NCT01963078|20307963|P1|COMPLETED|Overall Study||8
8235417|NCT01963078|20307960|P4|STARTED|Overall Study||9
8235418|NCT01963078|20307961|P3|STARTED|Overall Study||10
8235419|NCT01963078|20307962|P2|STARTED|Overall Study||10
8235420|NCT01963078|20307963|P1|STARTED|Overall Study||9
8235421|NCT01962987|20307976|P3|NOT COMPLETED|Overall Study||12
8235422|NCT01962987|20307977|P2|NOT COMPLETED|Overall Study||28
8235423|NCT01962987|20307978|P1|NOT COMPLETED|Overall Study||30
8235424|NCT01962987|20307976|P3|COMPLETED|Overall Study||83
8235425|NCT01962987|20307977|P2|COMPLETED|Overall Study||163
8235426|NCT01962987|20307978|P1|COMPLETED|Overall Study||160
8235427|NCT01962987|20307976|P3|STARTED|Overall Study||95
8235428|NCT01962987|20307977|P2|STARTED|Overall Study||191
8235429|NCT01962987|20307978|P1|STARTED|Overall Study||190
8235430|NCT01962974|20307986|P1|NOT COMPLETED|Overall Study||7
8235431|NCT01962974|20307986|P1|COMPLETED|Overall Study||0
8235432|NCT01962974|20307986|P1|STARTED|Overall Study||7
8235433|NCT01962961|20307995|P3|NOT COMPLETED|Overall Study||1
8235434|NCT01962961|20307996|P2|NOT COMPLETED|Overall Study||1
8235435|NCT01962961|20307997|P1|NOT COMPLETED|Overall Study||0
8235436|NCT01962961|20307995|P3|COMPLETED|Overall Study||6
8235437|NCT01962961|20307996|P2|COMPLETED|Overall Study||7
8235438|NCT01962961|20307997|P1|COMPLETED|Overall Study||9
8235439|NCT01962961|20307995|P3|STARTED|Overall Study||7
8235440|NCT01962961|20307996|P2|STARTED|Overall Study||8
8235441|NCT01962961|20307997|P1|STARTED|Overall Study||9
8235442|NCT01962922|20308013|P2|NOT COMPLETED|Extendion Portion (up to Month 6)||3
8235443|NCT01962922|20308014|P1|NOT COMPLETED|Extendion Portion (up to Month 6)||5
8235444|NCT01962922|20308013|P2|COMPLETED|Extendion Portion (up to Month 6)||20
8235445|NCT01962922|20308014|P1|COMPLETED|Extendion Portion (up to Month 6)||18
8235446|NCT01962922|20308013|P2|STARTED|Extendion Portion (up to Month 6)||23
8235447|NCT01962922|20308014|P1|STARTED|Extendion Portion (up to Month 6)||23
8235448|NCT01962922|20308013|P2|NOT COMPLETED|PK Portion Day 21||0
8235449|NCT01962922|20308014|P1|NOT COMPLETED|PK Portion Day 21||0
8235450|NCT01962922|20308013|P2|COMPLETED|PK Portion Day 21||23
8235451|NCT01962922|20308014|P1|COMPLETED|PK Portion Day 21||23
8235452|NCT01962922|20308013|P2|STARTED|PK Portion Day 21||23
8235453|NCT01962922|20308014|P1|STARTED|PK Portion Day 21||23
8235454|NCT01962922|20308013|P2|NOT COMPLETED|PK Portion Day 14||0
8235455|NCT01962922|20308014|P1|NOT COMPLETED|PK Portion Day 14||0
8235456|NCT01962922|20308013|P2|COMPLETED|PK Portion Day 14||23
8235457|NCT01962922|20308014|P1|COMPLETED|PK Portion Day 14||23
8235458|NCT01962922|20308013|P2|STARTED|PK Portion Day 14||23
8235459|NCT01962922|20308014|P1|STARTED|PK Portion Day 14||23
8235460|NCT01962922|20308013|P2|NOT COMPLETED|PK Portion Day 7||0
8235461|NCT01962922|20308014|P1|NOT COMPLETED|PK Portion Day 7||4
8235462|NCT01962922|20308013|P2|COMPLETED|PK Portion Day 7||23
8235463|NCT01962922|20308014|P1|COMPLETED|PK Portion Day 7||23
8235464|NCT01962922|20308013|P2|STARTED|PK Portion Day 7||23
8235465|NCT01962922|20308014|P1|STARTED|PK Portion Day 7||27
8235466|NCT01962896|20308036|P1|NOT COMPLETED|Overall Study||4
8235467|NCT01962896|20308036|P1|COMPLETED|Overall Study||0
8235468|NCT01962896|20308036|P1|STARTED|Overall Study||4
8235469|NCT01962870|20308045|P2|NOT COMPLETED|Overall Study||0
8235470|NCT01962870|20308046|P1|NOT COMPLETED|Overall Study||0
8235471|NCT01962870|20308045|P2|COMPLETED|Overall Study||17
8235472|NCT01962870|20308046|P1|COMPLETED|Overall Study||13
8235473|NCT01962870|20308045|P2|STARTED|Overall Study||17
8235474|NCT01962870|20308046|P1|STARTED|Overall Study||13
8235475|NCT01962714|20308094|P2|NOT COMPLETED|Overall Study||33
8235476|NCT01962714|20308095|P1|NOT COMPLETED|Overall Study||30
8235477|NCT01962714|20308094|P2|COMPLETED|Overall Study||60
8235478|NCT01962714|20308095|P1|COMPLETED|Overall Study||61
8235479|NCT01962714|20308094|P2|3-month Follow-up|Overall Study||56
8235480|NCT01962714|20308095|P1|3-month Follow-up|Overall Study||58
8235481|NCT01962714|20308094|P2|Immediate Post-treatment Assessment|Overall Study||57
8235482|NCT01962714|20308095|P1|Immediate Post-treatment Assessment|Overall Study||63
8235483|NCT01962714|20308094|P2|STARTED|Overall Study||93
8235484|NCT01962714|20308095|P1|STARTED|Overall Study||91
8235485|NCT01962688|20308105|P2|NOT COMPLETED|Overall Study||0
8235486|NCT01962688|20308106|P1|NOT COMPLETED|Overall Study||0
8235487|NCT01962688|20308105|P2|COMPLETED|Overall Study||18
8235488|NCT01962688|20308106|P1|COMPLETED|Overall Study||19
8235489|NCT01962688|20308105|P2|STARTED|Overall Study||18
8235490|NCT01962688|20308106|P1|STARTED|Overall Study||19
8235491|NCT01962675|20308124|P2|NOT COMPLETED|Overall Study||0
8235492|NCT01962675|20308125|P1|NOT COMPLETED|Overall Study||0
8235493|NCT01962675|20308124|P2|COMPLETED|Overall Study||7
8235494|NCT01962675|20308125|P1|COMPLETED|Overall Study||7
8235495|NCT01962675|20308124|P2|STARTED|Overall Study||7
8235496|NCT01962675|20308125|P1|STARTED|Overall Study||7
8235497|NCT01962558|20308139|P2|NOT COMPLETED|Overall Study||0
8235498|NCT01962558|20308140|P1|NOT COMPLETED|Overall Study||0
8235499|NCT01962558|20308139|P2|COMPLETED|Overall Study||14
8235500|NCT01962558|20308140|P1|COMPLETED|Overall Study||16
8235501|NCT01962558|20308139|P2|12-Weeks|Overall Study||14
8235502|NCT01962558|20308140|P1|12-Weeks|Overall Study||16
8235503|NCT01962558|20308139|P2|Acute Study|Overall Study||14
8235504|NCT01962558|20308140|P1|Acute Study|Overall Study||16
8235505|NCT01962558|20308139|P2|STARTED|Overall Study||14
8235506|NCT01962558|20308140|P1|STARTED|Overall Study||16
8235507|NCT01962493|20308158|P2|NOT COMPLETED|Overall Study||5
8235508|NCT01962493|20308159|P1|NOT COMPLETED|Overall Study||5
8235509|NCT01962493|20308158|P2|COMPLETED|Overall Study||77
8235510|NCT01962493|20308159|P1|COMPLETED|Overall Study||73
8235511|NCT01962493|20308158|P2|STARTED|Overall Study||82
8235512|NCT01962493|20308159|P1|STARTED|Overall Study||78
8235513|NCT01962441|20308182|P3|NOT COMPLETED|Retreatment Substudy||0
8235514|NCT01962441|20308183|P2|NOT COMPLETED|Retreatment Substudy||0
8235515|NCT01962441|20308184|P1|NOT COMPLETED|Retreatment Substudy||2
8235516|NCT01962441|20308182|P3|COMPLETED|Retreatment Substudy||0
8235517|NCT01962441|20308183|P2|COMPLETED|Retreatment Substudy||10
8235518|NCT01962441|20308184|P1|COMPLETED|Retreatment Substudy||18
8235519|NCT01962441|20308182|P3|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
8235520|NCT01962441|20308183|P2|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
8235521|NCT01962441|20308184|P1|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
8235522|NCT01962441|20308182|P3|NOT COMPLETED|Randomized Period||11
8235523|NCT01962441|20308183|P2|NOT COMPLETED|Randomized Period||11
8235524|NCT01962441|20308184|P1|NOT COMPLETED|Randomized Period||10
8235525|NCT01962441|20308182|P3|COMPLETED|Randomized Period||189
8235526|NCT01962441|20308183|P2|COMPLETED|Randomized Period||190
8235527|NCT01962441|20308184|P1|COMPLETED|Randomized Period||190
8235528|NCT01962441|20308182|P3|STARTED|Randomized Period||200
8235529|NCT01962441|20308183|P2|STARTED|Randomized Period||201
8235530|NCT01962441|20308184|P1|STARTED|Randomized Period||200
8235531|NCT01962428|20308216|P2|NOT COMPLETED|Overall Study||6
8235532|NCT01962428|20308217|P1|NOT COMPLETED|Overall Study||10
8235533|NCT01962428|20308216|P2|COMPLETED|Overall Study||133
8235534|NCT01962428|20308217|P1|COMPLETED|Overall Study||129
8235535|NCT01962428|20308216|P2|STARTED|Overall Study||139
8235536|NCT01962428|20308217|P1|STARTED|Overall Study||139
8235537|NCT01962298|20308228|P5|NOT COMPLETED|Overall Study||6
8235538|NCT01962298|20308229|P4|NOT COMPLETED|Overall Study||2
8235539|NCT01962298|20308230|P3|NOT COMPLETED|Overall Study||5
8235540|NCT01962298|20308231|P2|NOT COMPLETED|Overall Study||4
8235541|NCT01962298|20308232|P1|NOT COMPLETED|Overall Study||3
8235542|NCT01962298|20308228|P5|COMPLETED|Overall Study||9
8235543|NCT01962298|20308229|P4|COMPLETED|Overall Study||13
8235544|NCT01962298|20308230|P3|COMPLETED|Overall Study||10
8235545|NCT01962298|20308231|P2|COMPLETED|Overall Study||11
8235546|NCT01962298|20308232|P1|COMPLETED|Overall Study||12
8235547|NCT01962298|20308228|P5|Received Intervention|Overall Study||15
8235548|NCT01962298|20308229|P4|Received Intervention|Overall Study||15
8235549|NCT01962298|20308230|P3|Received Intervention|Overall Study||15
8235550|NCT01962298|20308231|P2|Received Intervention|Overall Study||15
8235551|NCT01962298|20308232|P1|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
8235552|NCT01962298|20308228|P5|STARTED|Overall Study||15
8235553|NCT01962298|20308229|P4|STARTED|Overall Study||15
8235554|NCT01962298|20308230|P3|STARTED|Overall Study||15
8235555|NCT01962298|20308231|P2|STARTED|Overall Study||15
8235556|NCT01962298|20308232|P1|STARTED|Overall Study||15
8235557|NCT01962207|20308253|P4|NOT COMPLETED|Booster Phase (6 Months)||0
8235558|NCT01962207|20308254|P3|NOT COMPLETED|Booster Phase (6 Months)||0
8235559|NCT01962207|20308255|P2|NOT COMPLETED|Booster Phase (6 Months)||0
8235560|NCT01962207|20308256|P1|NOT COMPLETED|Booster Phase (6 Months)||0
8235561|NCT01962207|20308253|P4|COMPLETED|Booster Phase (6 Months)||21
8235562|NCT01962207|20308254|P3|COMPLETED|Booster Phase (6 Months)||77
8235563|NCT01962207|20308255|P2|COMPLETED|Booster Phase (6 Months)||16
8235564|NCT01962207|20308256|P1|COMPLETED|Booster Phase (6 Months)||67
8235565|NCT01962207|20308253|P4|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21
8235566|NCT01962207|20308254|P3|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77
8235567|NCT01962207|20308255|P2|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16
8235568|NCT01962207|20308256|P1|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67
8235569|NCT01962207|20308253|P4|NOT COMPLETED|Persistence Phase (5 Years)||12
8235570|NCT01962207|20308254|P3|NOT COMPLETED|Persistence Phase (5 Years)||44
8235571|NCT01962207|20308255|P2|NOT COMPLETED|Persistence Phase (5 Years)||13
8235572|NCT01962207|20308256|P1|NOT COMPLETED|Persistence Phase (5 Years)||29
8235573|NCT01962207|20308253|P4|COMPLETED|Persistence Phase (5 Years)||17
8235574|NCT01962207|20308254|P3|COMPLETED|Persistence Phase (5 Years)||71
8235575|NCT01962207|20308255|P2|COMPLETED|Persistence Phase (5 Years)||10
8235576|NCT01962207|20308256|P1|COMPLETED|Persistence Phase (5 Years)||47
8235577|NCT01962207|20308253|P4|STARTED|Persistence Phase (5 Years)||29
8235578|NCT01962207|20308254|P3|STARTED|Persistence Phase (5 Years)||115
8235579|NCT01962207|20308255|P2|STARTED|Persistence Phase (5 Years)||23
8235580|NCT01962207|20308256|P1|STARTED|Persistence Phase (5 Years)||76
8235581|NCT01962103|20308367|P9|NOT COMPLETED|Phase 2||14
8235582|NCT01962103|20308368|P8|NOT COMPLETED|Phase 2||14
8235583|NCT01962103|20308369|P7|NOT COMPLETED|Phase 2||14
8235584|NCT01962103|20308370|P6|NOT COMPLETED|Phase 2||0
8235585|NCT01962103|20308371|P5|NOT COMPLETED|Phase 2||0
8235586|NCT01962103|20308372|P4|NOT COMPLETED|Phase 2||0
8235587|NCT01962103|20308373|P3|NOT COMPLETED|Phase 2||0
8235588|NCT01962103|20308374|P2|NOT COMPLETED|Phase 2||0
8235589|NCT01962103|20308375|P1|NOT COMPLETED|Phase 2||0
8235590|NCT01962103|20308367|P9|COMPLETED|Phase 2|completed treatment|0
8235591|NCT01962103|20308368|P8|COMPLETED|Phase 2|completed treatment|0
8235592|NCT01962103|20308369|P7|COMPLETED|Phase 2|completed treatment|0
8235593|NCT01962103|20308370|P6|COMPLETED|Phase 2||0
8235594|NCT01962103|20308371|P5|COMPLETED|Phase 2||0
8235595|NCT01962103|20308372|P4|COMPLETED|Phase 2||0
8235596|NCT01962103|20308373|P3|COMPLETED|Phase 2||0
8235597|NCT01962103|20308374|P2|COMPLETED|Phase 2||0
8235598|NCT01962103|20308375|P1|COMPLETED|Phase 2||0
8235599|NCT01962103|20308367|P9|STARTED|Phase 2||14
8235600|NCT01962103|20308368|P8|STARTED|Phase 2||14
8235601|NCT01962103|20308369|P7|STARTED|Phase 2||14
8235602|NCT01962103|20308370|P6|STARTED|Phase 2||0
8235603|NCT01962103|20308371|P5|STARTED|Phase 2||0
8235604|NCT01962103|20308372|P4|STARTED|Phase 2||0
8235605|NCT01962103|20308373|P3|STARTED|Phase 2||0
8235606|NCT01962103|20308374|P2|STARTED|Phase 2||0
8235607|NCT01962103|20308375|P1|STARTED|Phase 2||0
8235608|NCT01962103|20308367|P9|NOT COMPLETED|Phase 1||0
8235609|NCT01962103|20308368|P8|NOT COMPLETED|Phase 1||0
8235610|NCT01962103|20308369|P7|NOT COMPLETED|Phase 1||0
8235611|NCT01962103|20308370|P6|NOT COMPLETED|Phase 1||7
8235612|NCT01962103|20308371|P5|NOT COMPLETED|Phase 1||8
8235613|NCT01962103|20308372|P4|NOT COMPLETED|Phase 1||11
8235614|NCT01962103|20308373|P3|NOT COMPLETED|Phase 1||14
8235615|NCT01962103|20308374|P2|NOT COMPLETED|Phase 1||8
8235616|NCT01962103|20308375|P1|NOT COMPLETED|Phase 1||16
8235617|NCT01962103|20308367|P9|COMPLETED|Phase 1||0
8235618|NCT01962103|20308368|P8|COMPLETED|Phase 1||0
8235619|NCT01962103|20308369|P7|COMPLETED|Phase 1||0
8235620|NCT01962103|20308370|P6|COMPLETED|Phase 1||0
8235621|NCT01962103|20308371|P5|COMPLETED|Phase 1||0
8235622|NCT01962103|20308372|P4|COMPLETED|Phase 1||0
8235623|NCT01962103|20308373|P3|COMPLETED|Phase 1||0
8235624|NCT01962103|20308374|P2|COMPLETED|Phase 1||0
8235625|NCT01962103|20308375|P1|COMPLETED|Phase 1||0
8235626|NCT01962103|20308367|P9|STARTED|Phase 1||0
8235627|NCT01962103|20308368|P8|STARTED|Phase 1||0
8235628|NCT01962103|20308369|P7|STARTED|Phase 1||0
8235629|NCT01962103|20308370|P6|STARTED|Phase 1||7
8235630|NCT01962103|20308371|P5|STARTED|Phase 1||8
8235631|NCT01962103|20308372|P4|STARTED|Phase 1||11
8235632|NCT01962103|20308373|P3|STARTED|Phase 1||14
8235633|NCT01962103|20308374|P2|STARTED|Phase 1||8
8235634|NCT01962103|20308375|P1|STARTED|Phase 1||16
8235635|NCT01962025|20308477|P2|NOT COMPLETED|Overall Study||0
8235636|NCT01962025|20308478|P1|NOT COMPLETED|Overall Study||0
8235637|NCT01962025|20308477|P2|COMPLETED|Overall Study||6
8235638|NCT01962025|20308478|P1|COMPLETED|Overall Study||8
8235639|NCT01962025|20308477|P2|STARTED|Overall Study||6
8235640|NCT01962025|20308478|P1|STARTED|Overall Study||8
8235641|NCT01961921|20308492|P1|NOT COMPLETED|Overall Study||2
8235642|NCT01961921|20308492|P1|COMPLETED|Overall Study||25
8235643|NCT01961921|20308492|P1|STARTED|Overall Study||27
8235644|NCT01961687|20308502|P1|NOT COMPLETED|Overall Study||61
8235645|NCT01961687|20308502|P1|COMPLETED|Overall Study||60
8235646|NCT01961687|20308502|P1|STARTED|Overall Study||121
8235647|NCT01961609|20308516|P4|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7
8235648|NCT01961609|20308517|P3|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4
8235649|NCT01961609|20308518|P2|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6
8235650|NCT01961609|20308519|P1|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
8235651|NCT01961609|20308516|P4|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17
8235652|NCT01961609|20308517|P3|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
8235653|NCT01961609|20308518|P2|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25
8235654|NCT01961609|20308519|P1|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71
8235655|NCT01961609|20308516|P4|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24
8235656|NCT01961609|20308517|P3|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16
8235657|NCT01961609|20308518|P2|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31
8235658|NCT01961609|20308519|P1|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83
8235659|NCT01961609|20308516|P4|Safety Set|Maintanence 2 (Weeks 49 - 72)||24
8235660|NCT01961609|20308517|P3|Safety Set|Maintanence 2 (Weeks 49 - 72)||16
8235661|NCT01961609|20308518|P2|Safety Set|Maintanence 2 (Weeks 49 - 72)||31
8235662|NCT01961609|20308519|P1|Safety Set|Maintanence 2 (Weeks 49 - 72)||83
8235663|NCT01961609|20308516|P4|STARTED|Maintanence 2 (Weeks 49 - 72)||24
8235664|NCT01961609|20308517|P3|STARTED|Maintanence 2 (Weeks 49 - 72)||16
8235665|NCT01961609|20308518|P2|STARTED|Maintanence 2 (Weeks 49 - 72)||31
8235666|NCT01961609|20308519|P1|STARTED|Maintanence 2 (Weeks 49 - 72)||83
8235667|NCT01961609|20308516|P4|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
8235668|NCT01961609|20308517|P3|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19
8235669|NCT01961609|20308518|P2|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11
8235670|NCT01961609|20308519|P1|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23
8235671|NCT01961609|20308516|P4|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
8235672|NCT01961609|20308517|P3|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18
8235673|NCT01961609|20308518|P2|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55
8235674|NCT01961609|20308519|P1|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84
8235675|NCT01961609|20308516|P4|Safety Set|Maintenance 1 (Weeks 17 - 48)||0
8235676|NCT01961609|20308517|P3|Safety Set|Maintenance 1 (Weeks 17 - 48)||37
8235677|NCT01961609|20308518|P2|Safety Set|Maintenance 1 (Weeks 17 - 48)||66
8235678|NCT01961609|20308519|P1|Safety Set|Maintenance 1 (Weeks 17 - 48)||107
8235679|NCT01961609|20308516|P4|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0
8235680|NCT01961609|20308517|P3|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37
8235681|NCT01961609|20308518|P2|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66
8235682|NCT01961609|20308519|P1|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107
8235683|NCT01961609|20308516|P4|STARTED|Maintenance 1 (Weeks 17 - 48)||0
8235684|NCT01961609|20308517|P3|STARTED|Maintenance 1 (Weeks 17 - 48)||37
8235685|NCT01961609|20308518|P2|STARTED|Maintenance 1 (Weeks 17 - 48)||66
8235686|NCT01961609|20308519|P1|STARTED|Maintenance 1 (Weeks 17 - 48)||107
8235687|NCT01961609|20308516|P4|NOT COMPLETED|Initiation||0
8235688|NCT01961609|20308517|P3|NOT COMPLETED|Initiation||0
8235689|NCT01961609|20308518|P2|NOT COMPLETED|Initiation||13
8235690|NCT01961609|20308519|P1|NOT COMPLETED|Initiation||12
8235691|NCT01961609|20308516|P4|COMPLETED|Initiation||0
8235692|NCT01961609|20308517|P3|COMPLETED|Initiation||0
8235693|NCT01961609|20308518|P2|COMPLETED|Initiation||103
8235694|NCT01961609|20308519|P1|COMPLETED|Initiation||107
8235695|NCT01961609|20308516|P4|Full Analysis Set|Initiation||0
8235696|NCT01961609|20308517|P3|Full Analysis Set|Initiation||0
8235697|NCT01961609|20308518|P2|Full Analysis Set|Initiation||115
8235698|NCT01961609|20308519|P1|Full Analysis Set|Initiation||118
8235699|NCT01961609|20308516|P4|Safety Set|Initiation||0
8235700|NCT01961609|20308517|P3|Safety Set|Initiation||0
8235701|NCT01961609|20308518|P2|Safety Set|Initiation||115
8235702|NCT01961609|20308519|P1|Safety Set|Initiation||118
8235703|NCT01961609|20308516|P4|STARTED|Initiation||0
8235704|NCT01961609|20308517|P3|STARTED|Initiation||0
8235705|NCT01961609|20308518|P2|STARTED|Initiation||116
8235706|NCT01961609|20308519|P1|STARTED|Initiation||119
8235707|NCT01961544|20308571|P1|NOT COMPLETED|Overall Study||13
8235708|NCT01961544|20308571|P1|COMPLETED|Overall Study||88
8235709|NCT01961544|20308571|P1|STARTED|Overall Study||101
8235710|NCT01961531|20308576|P1|NOT COMPLETED|Overall Study||0
8235711|NCT01961531|20308576|P1|COMPLETED|Overall Study||40
8235712|NCT01961531|20308576|P1|STARTED|Overall Study||40
8235713|NCT01961362|20308581|P1|NOT COMPLETED|Overall Study||0
8235714|NCT01961362|20308581|P1|COMPLETED|Overall Study||19
8235715|NCT01961362|20308581|P1|STARTED|Overall Study||19
8235716|NCT01961349|20308590|P3|NOT COMPLETED|Overall Study||2
8235717|NCT01961349|20308591|P2|NOT COMPLETED|Overall Study||6
8235718|NCT01961349|20308592|P1|NOT COMPLETED|Overall Study||3
8235719|NCT01961349|20308590|P3|COMPLETED|Overall Study||109
8235720|NCT01961349|20308591|P2|COMPLETED|Overall Study||101
8235721|NCT01961349|20308592|P1|COMPLETED|Overall Study||51
8235722|NCT01961349|20308590|P3|STARTED|Overall Study||111
8235723|NCT01961349|20308591|P2|STARTED|Overall Study||107
8235724|NCT01961349|20308592|P1|STARTED|Overall Study||54
8235725|NCT01961323|20308603|P1|NOT COMPLETED|Overall Study||49
8235726|NCT01961323|20308603|P1|COMPLETED|Overall Study||21
8235727|NCT01961323|20308603|P1|STARTED|Overall Study||70
8235728|NCT01961297|20308611|P2|NOT COMPLETED|Overall Study||1
8235729|NCT01961297|20308612|P1|NOT COMPLETED|Overall Study||2
8235730|NCT01961297|20308611|P2|COMPLETED|Overall Study||22
8235731|NCT01961297|20308612|P1|COMPLETED|Overall Study||28
8235732|NCT01961297|20308611|P2|STARTED|Overall Study||23
8235733|NCT01961297|20308612|P1|STARTED|Overall Study||30
8235734|NCT01961271|20308626|P1|NOT COMPLETED|Overall Study||50
8235735|NCT01961271|20308626|P1|COMPLETED|Overall Study||64
8235736|NCT01961271|20308626|P1|STARTED|Overall Study||114
8235737|NCT01961167|20308635|P1|NOT COMPLETED|Overall Study||0
8235738|NCT01961167|20308635|P1|COMPLETED|Overall Study||27
8235739|NCT01961167|20308635|P1|STARTED|Overall Study||27
8235740|NCT01961115|20308676|P3|NOT COMPLETED|Overall Study||4
8235741|NCT01961115|20308677|P2|NOT COMPLETED|Overall Study||0
8235742|NCT01961115|20308678|P1|NOT COMPLETED|Overall Study||2
8235743|NCT01961115|20308676|P3|COMPLETED|Overall Study||5
8235744|NCT01961115|20308677|P2|COMPLETED|Overall Study||0
8235745|NCT01961115|20308678|P1|COMPLETED|Overall Study||0
8235746|NCT01961115|20308676|P3|STARTED|Overall Study||9
8235747|NCT01961115|20308677|P2|STARTED|Overall Study||0
8235748|NCT01961115|20308678|P1|STARTED|Overall Study||2
8235749|NCT01961089|20308713|P1|NOT COMPLETED|Overall Study||0
8235750|NCT01961089|20308713|P1|COMPLETED|Overall Study||40
8235751|NCT01961089|20308713|P1|STARTED|Overall Study||40
8235752|NCT01960907|20308721|P2|NOT COMPLETED|Overall Study||45
8235753|NCT01960907|20308722|P1|NOT COMPLETED|Overall Study||36
8235754|NCT01960907|20308721|P2|COMPLETED|Overall Study||109
8235755|NCT01960907|20308722|P1|COMPLETED|Overall Study||122
8235756|NCT01960907|20308721|P2|STARTED|Overall Study||154
8235757|NCT01960907|20308722|P1|STARTED|Overall Study||158
8235773|NCT01960842|20308773|P1|NOT COMPLETED|Overall Study||3
8235774|NCT01960842|20308773|P1|COMPLETED|Overall Study||28
8235775|NCT01960842|20308773|P1|STARTED|Overall Study||31
8235776|NCT01960816|20308796|P1|NOT COMPLETED|Overall Study||1
8235777|NCT01960816|20308796|P1|COMPLETED|Overall Study||32
8235778|NCT01960816|20308796|P1|STARTED|Overall Study||33
8235779|NCT01960790|20308802|P1|NOT COMPLETED|Overall Study||11
8235780|NCT01960790|20308802|P1|COMPLETED|Overall Study||462
8235781|NCT01960790|20308802|P1|STARTED|Overall Study||473
8235782|NCT01960725|20308814|P2|NOT COMPLETED|Overall Study||5
8235783|NCT01960725|20308815|P1|NOT COMPLETED|Overall Study||6
8235784|NCT01960725|20308814|P2|COMPLETED|Overall Study||28
8235785|NCT01960725|20308815|P1|COMPLETED|Overall Study||27
8235786|NCT01960725|20308814|P2|Received Third Vaccine|Overall Study||32
8235787|NCT01960725|20308815|P1|Received Third Vaccine|Overall Study||32
8235788|NCT01960725|20308814|P2|Recieved Second Vaccine|Overall Study||33
8235789|NCT01960725|20308815|P1|Recieved Second Vaccine|Overall Study||33
8235790|NCT01960725|20308814|P2|Received First Vaccine|Overall Study||33
8235791|NCT01960725|20308815|P1|Received First Vaccine|Overall Study||33
8235792|NCT01960725|20308814|P2|STARTED|Overall Study||33
8235793|NCT01960725|20308815|P1|STARTED|Overall Study||33
8235794|NCT01960530|20308837|P1|NOT COMPLETED|Overall Study||0
8235795|NCT01960530|20308837|P1|COMPLETED|Overall Study||14
8235796|NCT01960530|20308837|P1|STARTED|Overall Study||14
8235797|NCT01960465|20308872|P2|NOT COMPLETED|Overall Study||9
8235798|NCT01960465|20308873|P1|NOT COMPLETED|Overall Study||20
8235799|NCT01960465|20308872|P2|COMPLETED|Overall Study||73
8235800|NCT01960465|20308873|P1|COMPLETED|Overall Study||118
8235801|NCT01960465|20308872|P2|STARTED|Overall Study||82
8235802|NCT01960465|20308873|P1|STARTED|Overall Study||138
8235803|NCT01960413|20308885|P2|NOT COMPLETED|Overall Study||1
8235804|NCT01960413|20308886|P1|NOT COMPLETED|Overall Study||4
8235805|NCT01960413|20308885|P2|COMPLETED|Overall Study||21
8235806|NCT01960413|20308886|P1|COMPLETED|Overall Study||20
8235807|NCT01960413|20308885|P2|STARTED|Overall Study||22
8235808|NCT01960413|20308886|P1|STARTED|Overall Study||24
8235809|NCT01960400|20308894|P2|NOT COMPLETED|Overall Study||0
8235810|NCT01960400|20308895|P1|NOT COMPLETED|Overall Study||0
8235811|NCT01960400|20308894|P2|COMPLETED|Overall Study||11
8235812|NCT01960400|20308895|P1|COMPLETED|Overall Study||11
8235813|NCT01960400|20308894|P2|STARTED|Overall Study||11
8235814|NCT01960400|20308895|P1|STARTED|Overall Study||11
8235815|NCT01960387|20308907|P1|NOT COMPLETED|Overall Study||0
8235816|NCT01960387|20308907|P1|COMPLETED|Overall Study||2
8235817|NCT01960387|20308907|P1|STARTED|Overall Study||2
8235818|NCT01960348|20308916|P2|NOT COMPLETED|Overall Study||22
8235819|NCT01960348|20308917|P1|NOT COMPLETED|Overall Study||10
8235820|NCT01960348|20308916|P2|COMPLETED|Overall Study||55
8235821|NCT01960348|20308917|P1|COMPLETED|Overall Study||138
8235822|NCT01960348|20308916|P2|STARTED|Overall Study||77
8235823|NCT01960348|20308917|P1|STARTED|Overall Study||148
8235824|NCT01960296|20308937|P2|NOT COMPLETED|Overall Study||3
8235825|NCT01960296|20308938|P1|NOT COMPLETED|Overall Study||2
8235826|NCT01960296|20308937|P2|COMPLETED|Overall Study||22
8235827|NCT01960296|20308938|P1|COMPLETED|Overall Study||21
8235828|NCT01960296|20308937|P2|STARTED|Overall Study||25
8235829|NCT01960296|20308938|P1|STARTED|Overall Study||23
8235830|NCT01960140|20308958|P1|NOT COMPLETED|Period 2 (Days 3-18)||2
8235831|NCT01960140|20308958|P1|COMPLETED|Period 2 (Days 3-18)||38
8235832|NCT01960140|20308958|P1|Received Simvastatin|Period 2 (Days 3-18)||38
8235833|NCT01960140|20308958|P1|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
8235834|NCT01960140|20308958|P1|STARTED|Period 2 (Days 3-18)||40
8235835|NCT01960140|20308958|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
8235836|NCT01960140|20308958|P1|COMPLETED|Period 1 (Days 1-2)||40
8235837|NCT01960140|20308958|P1|Received Simvastatin|Period 1 (Days 1-2)||40
8235838|NCT01960140|20308958|P1|STARTED|Period 1 (Days 1-2)||40
8235839|NCT01960114|20308969|P2|NOT COMPLETED|Overall Study||1
8235840|NCT01960114|20308970|P1|NOT COMPLETED|Overall Study||1
8235841|NCT01960114|20308969|P2|COMPLETED|Overall Study||268
8235842|NCT01960114|20308970|P1|COMPLETED|Overall Study||133
8235843|NCT01960114|20308969|P2|STARTED|Overall Study||269
8235844|NCT01960114|20308970|P1|STARTED|Overall Study||134
8235854|NCT01959945|20309049|P4|NOT COMPLETED|Overall Study||16
8235855|NCT01959945|20309050|P3|NOT COMPLETED|Overall Study||19
8235856|NCT01959945|20309051|P2|NOT COMPLETED|Overall Study||3
8235857|NCT01959945|20309052|P1|NOT COMPLETED|Overall Study||4
8235858|NCT01959945|20309049|P4|COMPLETED|Overall Study||15
8235859|NCT01959945|20309050|P3|COMPLETED|Overall Study||9
8235860|NCT01959945|20309051|P2|COMPLETED|Overall Study||75
8235861|NCT01959945|20309052|P1|COMPLETED|Overall Study||76
8235862|NCT01959945|20309049|P4|STARTED|Overall Study||31
8235863|NCT01959945|20309050|P3|STARTED|Overall Study||28
8235864|NCT01959945|20309051|P2|STARTED|Overall Study||78
8235865|NCT01959945|20309052|P1|STARTED|Overall Study||80
8235866|NCT01959932|20309077|P3|NOT COMPLETED|Overall Study||0
8235867|NCT01959932|20309078|P2|NOT COMPLETED|Overall Study||0
8235868|NCT01959932|20309079|P1|NOT COMPLETED|Overall Study||1
8235869|NCT01959932|20309077|P3|COMPLETED|Overall Study||39
8235870|NCT01959932|20309078|P2|COMPLETED|Overall Study||41
8235871|NCT01959932|20309079|P1|COMPLETED|Overall Study||79
8235872|NCT01959932|20309077|P3|STARTED|Overall Study||39
8235873|NCT01959932|20309078|P2|STARTED|Overall Study||41
8235874|NCT01959932|20309079|P1|STARTED|Overall Study||80
8235875|NCT01959919|20309097|P1|NOT COMPLETED|Overall Study||2
8235876|NCT01959919|20309097|P1|COMPLETED|Overall Study||84
8235877|NCT01959919|20309097|P1|STARTED|Overall Study||86
8235878|NCT01959880|20309111|P4|NOT COMPLETED|Overall Study||181
8235879|NCT01959880|20309112|P3|NOT COMPLETED|Overall Study||208
8235880|NCT01959880|20309113|P2|NOT COMPLETED|Overall Study||369
8235881|NCT01959880|20309114|P1|NOT COMPLETED|Overall Study||1132
8235882|NCT01959880|20309111|P4|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
8235883|NCT01959880|20309112|P3|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
8235884|NCT01959880|20309113|P2|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
8235885|NCT01959880|20309114|P1|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
8235886|NCT01959880|20309111|P4|STARTED|Overall Study||181
8235887|NCT01959880|20309112|P3|STARTED|Overall Study||209
8235888|NCT01959880|20309113|P2|STARTED|Overall Study||369
8235889|NCT01959880|20309114|P1|STARTED|Overall Study||1132
8235890|NCT01959841|20309139|P3|NOT COMPLETED|Overall Study||43
8235891|NCT01959841|20309140|P2|NOT COMPLETED|Overall Study||57
8235892|NCT01959841|20309141|P1|NOT COMPLETED|Overall Study||43
8235893|NCT01959841|20309139|P3|COMPLETED|Overall Study||206
8235894|NCT01959841|20309140|P2|COMPLETED|Overall Study||193
8235895|NCT01959841|20309141|P1|COMPLETED|Overall Study||209
8235896|NCT01959841|20309139|P3|Reason FAS Excluding 3|Overall Study||0
8235897|NCT01959841|20309140|P2|Reason FAS Excluding 3|Overall Study||1
8235898|NCT01959841|20309141|P1|Reason FAS Excluding 3|Overall Study||0
8235899|NCT01959841|20309139|P3|Reason FAS Excluding 2|Overall Study||0
8235900|NCT01959841|20309140|P2|Reason FAS Excluding 2|Overall Study||1
8235901|NCT01959841|20309141|P1|Reason FAS Excluding 2|Overall Study||0
8235902|NCT01959841|20309139|P3|Reason FAS Excluding 1|Overall Study||4
8235903|NCT01959841|20309140|P2|Reason FAS Excluding 1|Overall Study||5
8235904|NCT01959841|20309141|P1|Reason FAS Excluding 1|Overall Study||5
8235905|NCT01959841|20309139|P3|Full Analysis Set Excluded|Overall Study||4
8235906|NCT01959841|20309140|P2|Full Analysis Set Excluded|Overall Study||7
8235907|NCT01959841|20309141|P1|Full Analysis Set Excluded|Overall Study||5
8235908|NCT01959841|20309139|P3|Full Analysis Set Included|Overall Study||245
8235909|NCT01959841|20309140|P2|Full Analysis Set Included|Overall Study||243
8235910|NCT01959841|20309141|P1|Full Analysis Set Included|Overall Study||247
8235911|NCT01959841|20309139|P3|STARTED|Overall Study||249
8235912|NCT01959841|20309140|P2|STARTED|Overall Study||250
8235913|NCT01959841|20309141|P1|STARTED|Overall Study||252
8235914|NCT01959685|20309164|P1|NOT COMPLETED|Overall Study||0
8235915|NCT01959685|20309164|P1|COMPLETED|Overall Study||9
8235916|NCT01959685|20309164|P1|STARTED|Overall Study||9
8235917|NCT01959672|20309169|P1|NOT COMPLETED|Overall Study||1
8235918|NCT01959672|20309169|P1|COMPLETED|Overall Study||10
8235919|NCT01959672|20309169|P1|STARTED|Overall Study||11
8235920|NCT01959607|20309180|P4|NOT COMPLETED|Second Intervention (Day 3)||0
8235921|NCT01959607|20309181|P3|NOT COMPLETED|Second Intervention (Day 3)||0
8235922|NCT01959607|20309182|P2|NOT COMPLETED|Second Intervention (Day 3)||0
8235923|NCT01959607|20309183|P1|NOT COMPLETED|Second Intervention (Day 3)||0
8235924|NCT01959607|20309180|P4|COMPLETED|Second Intervention (Day 3)||9
8235925|NCT01959607|20309181|P3|COMPLETED|Second Intervention (Day 3)||9
8235926|NCT01959607|20309182|P2|COMPLETED|Second Intervention (Day 3)||21
8235927|NCT01959607|20309183|P1|COMPLETED|Second Intervention (Day 3)||21
8235928|NCT01959607|20309180|P4|STARTED|Second Intervention (Day 3)||9
8235929|NCT01959607|20309181|P3|STARTED|Second Intervention (Day 3)||9
8235930|NCT01959607|20309182|P2|STARTED|Second Intervention (Day 3)||21
8235931|NCT01959607|20309183|P1|STARTED|Second Intervention (Day 3)||21
8235932|NCT01959607|20309180|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8235933|NCT01959607|20309181|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8235934|NCT01959607|20309182|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8235935|NCT01959607|20309183|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
8235936|NCT01959607|20309180|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
8235937|NCT01959607|20309181|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
8235938|NCT01959607|20309182|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
8235939|NCT01959607|20309183|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
8235940|NCT01959607|20309180|P4|STARTED|Washout Period of 1 Day (Day 2)||9
8235941|NCT01959607|20309181|P3|STARTED|Washout Period of 1 Day (Day 2)||9
8235942|NCT01959607|20309182|P2|STARTED|Washout Period of 1 Day (Day 2)||21
8235943|NCT01959607|20309183|P1|STARTED|Washout Period of 1 Day (Day 2)||21
8235944|NCT01959607|20309180|P4|NOT COMPLETED|First Intervention (Day 1)||0
8235945|NCT01959607|20309181|P3|NOT COMPLETED|First Intervention (Day 1)||0
8235946|NCT01959607|20309182|P2|NOT COMPLETED|First Intervention (Day 1)||1
8235947|NCT01959607|20309183|P1|NOT COMPLETED|First Intervention (Day 1)||1
8235948|NCT01959607|20309180|P4|COMPLETED|First Intervention (Day 1)||9
8235949|NCT01959607|20309181|P3|COMPLETED|First Intervention (Day 1)||9
8235950|NCT01959607|20309182|P2|COMPLETED|First Intervention (Day 1)||21
8235951|NCT01959607|20309183|P1|COMPLETED|First Intervention (Day 1)||21
8235952|NCT01959607|20309180|P4|STARTED|First Intervention (Day 1)||9
8235953|NCT01959607|20309181|P3|STARTED|First Intervention (Day 1)||9
8235954|NCT01959607|20309182|P2|STARTED|First Intervention (Day 1)||22
8235955|NCT01959607|20309183|P1|STARTED|First Intervention (Day 1)||22
8235956|NCT01959607|20309180|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8235957|NCT01959607|20309181|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8235958|NCT01959607|20309182|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8235959|NCT01959607|20309183|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
8235960|NCT01959607|20309180|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
8235961|NCT01959607|20309181|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
8235962|NCT01959607|20309182|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
8235963|NCT01959607|20309183|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
8235964|NCT01959607|20309180|P4|STARTED|Washout Period of 1 Day (Day 0)||9
8235965|NCT01959607|20309181|P3|STARTED|Washout Period of 1 Day (Day 0)||9
8235966|NCT01959607|20309182|P2|STARTED|Washout Period of 1 Day (Day 0)||22
8235967|NCT01959607|20309183|P1|STARTED|Washout Period of 1 Day (Day 0)||22
8235968|NCT01959581|20309196|P1|NOT COMPLETED|Overall Study||5
8235969|NCT01959581|20309196|P1|COMPLETED|Overall Study||25
8235970|NCT01959581|20309196|P1|STARTED|Overall Study||30
8235971|NCT01959542|20309200|P1|NOT COMPLETED|Overall Study||3
8235972|NCT01959542|20309200|P1|COMPLETED|Overall Study||12
8235973|NCT01959542|20309200|P1|Evaluable at Visit 2|Overall Study||12
8235974|NCT01959542|20309200|P1|Evaluable at Visit 1|Overall Study||12
8235975|NCT01959542|20309200|P1|STARTED|Overall Study||15
8235976|NCT01959529|20309207|P2|NOT COMPLETED|Overall Study||72
8235977|NCT01959529|20309208|P1|NOT COMPLETED|Overall Study||76
8235978|NCT01959529|20309207|P2|COMPLETED|Overall Study||3747
8235979|NCT01959529|20309208|P1|COMPLETED|Overall Study||3742
8235980|NCT01959529|20309207|P2|Exposed|Overall Study||3806
8235981|NCT01959529|20309208|P1|Exposed|Overall Study||3809
8235982|NCT01959529|20309207|P2|STARTED|Overall Study||3819
8235983|NCT01959529|20309208|P1|STARTED|Overall Study||3818
8235984|NCT01959516|20309220|P2|NOT COMPLETED|Epoch 2||1
8235985|NCT01959516|20309221|P1|NOT COMPLETED|Epoch 2||2
8235986|NCT01959516|20309220|P2|COMPLETED|Epoch 2||62
8235987|NCT01959516|20309221|P1|COMPLETED|Epoch 2||61
8235988|NCT01959516|20309220|P2|STARTED|Epoch 2||63
8235989|NCT01959516|20309221|P1|STARTED|Epoch 2||63
8235990|NCT01959516|20309220|P2|NOT COMPLETED|Epoch 1||5
8235991|NCT01959516|20309221|P1|NOT COMPLETED|Epoch 1||10
8235992|NCT01959516|20309220|P2|COMPLETED|Epoch 1||58
8235993|NCT01959516|20309221|P1|COMPLETED|Epoch 1||53
8235994|NCT01959516|20309220|P2|ITT Population|Epoch 1||62
8235995|NCT01959516|20309221|P1|ITT Population|Epoch 1||62
8235996|NCT01959516|20309220|P2|Safety Population|Epoch 1||62
8235997|NCT01959516|20309221|P1|Safety Population|Epoch 1||62
8235998|NCT01959516|20309220|P2|STARTED|Epoch 1||63
8235999|NCT01959516|20309221|P1|STARTED|Epoch 1||63
8236000|NCT01959503|20309231|P2|NOT COMPLETED|Overall Study||2
8236001|NCT01959503|20309232|P1|NOT COMPLETED|Overall Study||3
8236002|NCT01959503|20309231|P2|COMPLETED|Overall Study||49
8236003|NCT01959503|20309232|P1|COMPLETED|Overall Study||104
8236004|NCT01959503|20309231|P2|STARTED|Overall Study||51
8236005|NCT01959503|20309232|P1|STARTED|Overall Study||107
8236006|NCT01959490|20309255|P3|NOT COMPLETED|Overall Study||0
8236007|NCT01959490|20309256|P2|NOT COMPLETED|Overall Study||0
8236008|NCT01959490|20309257|P1|NOT COMPLETED|Overall Study||0
8236009|NCT01959490|20309255|P3|COMPLETED|Overall Study||5
8236010|NCT01959490|20309256|P2|COMPLETED|Overall Study||6
8236011|NCT01959490|20309257|P1|COMPLETED|Overall Study||5
8236012|NCT01959490|20309255|P3|STARTED|Overall Study||5
8236013|NCT01959490|20309256|P2|STARTED|Overall Study||6
8236014|NCT01959490|20309257|P1|STARTED|Overall Study||5
8236015|NCT01959425|20309285|P2|NOT COMPLETED|Overall Study||8
8236016|NCT01959425|20309286|P1|NOT COMPLETED|Overall Study||12
8236017|NCT01959425|20309285|P2|COMPLETED|Overall Study||23
8236018|NCT01959425|20309286|P1|COMPLETED|Overall Study||20
8236019|NCT01959425|20309285|P2|STARTED|Overall Study||31
8236020|NCT01959425|20309286|P1|STARTED|Overall Study||32
8236021|NCT01959412|20309306|P6|NOT COMPLETED|Overall Study||0
8236022|NCT01959412|20309307|P5|NOT COMPLETED|Overall Study||3
8236023|NCT01959412|20309308|P4|NOT COMPLETED|Overall Study||2
8236024|NCT01959412|20309309|P3|NOT COMPLETED|Overall Study||0
8236025|NCT01959412|20309310|P2|NOT COMPLETED|Overall Study||1
8236026|NCT01959412|20309311|P1|NOT COMPLETED|Overall Study||1
8236027|NCT01959412|20309306|P6|COMPLETED|Overall Study||15
8236028|NCT01959412|20309307|P5|COMPLETED|Overall Study||13
8236029|NCT01959412|20309308|P4|COMPLETED|Overall Study||13
8236030|NCT01959412|20309309|P3|COMPLETED|Overall Study||15
8236031|NCT01959412|20309310|P2|COMPLETED|Overall Study||14
8236032|NCT01959412|20309311|P1|COMPLETED|Overall Study||14
8236033|NCT01959412|20309306|P6|STARTED|Overall Study||15
8236034|NCT01959412|20309307|P5|STARTED|Overall Study||16
8236035|NCT01959412|20309308|P4|STARTED|Overall Study||15
8236036|NCT01959412|20309309|P3|STARTED|Overall Study||15
8236037|NCT01959412|20309310|P2|STARTED|Overall Study||15
8236038|NCT01959412|20309311|P1|STARTED|Overall Study||15
8236039|NCT01959347|20309351|P2|NOT COMPLETED|Overall Study||7
8236040|NCT01959347|20309352|P1|NOT COMPLETED|Overall Study||9
8236041|NCT01959347|20309351|P2|COMPLETED|Overall Study||235
8236042|NCT01959347|20309352|P1|COMPLETED|Overall Study||229
8236043|NCT01959347|20309351|P2|STARTED|Overall Study||242
8236044|NCT01959347|20309352|P1|STARTED|Overall Study||238
8236045|NCT01959334|20309458|P2|NOT COMPLETED|Third Dose||1
8236046|NCT01959334|20309459|P1|NOT COMPLETED|Third Dose||0
8236047|NCT01959334|20309458|P2|COMPLETED|Third Dose||48
8236048|NCT01959334|20309459|P1|COMPLETED|Third Dose||25
8236049|NCT01959334|20309458|P2|STARTED|Third Dose||49
8236050|NCT01959334|20309459|P1|STARTED|Third Dose||25
8236051|NCT01959334|20309458|P2|NOT COMPLETED|Second Dose||0
8236052|NCT01959334|20309459|P1|NOT COMPLETED|Second Dose||1
8236053|NCT01959334|20309458|P2|COMPLETED|Second Dose||49
8236054|NCT01959334|20309459|P1|COMPLETED|Second Dose||25
8236055|NCT01959334|20309458|P2|STARTED|Second Dose||49
8236056|NCT01959334|20309459|P1|STARTED|Second Dose||26
8236057|NCT01959334|20309458|P2|NOT COMPLETED|First Dose||0
8236058|NCT01959334|20309459|P1|NOT COMPLETED|First Dose||0
8236059|NCT01959334|20309458|P2|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49
8236060|NCT01959334|20309459|P1|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26
8236061|NCT01959334|20309458|P2|STARTED|First Dose||49
8236062|NCT01959334|20309459|P1|STARTED|First Dose||26
8236063|NCT01959243|20309471|P2|NOT COMPLETED|Overall Study||4
8236064|NCT01959243|20309472|P1|NOT COMPLETED|Overall Study||13
8236065|NCT01959243|20309471|P2|COMPLETED|Overall Study||166
8236066|NCT01959243|20309472|P1|COMPLETED|Overall Study||324
8236067|NCT01959243|20309471|P2|Received at Least 1 Dose of Study Drug|Overall Study||170
8236068|NCT01959243|20309472|P1|Received at Least 1 Dose of Study Drug|Overall Study||337
8236069|NCT01959243|20309471|P2|STARTED|Overall Study||170
8236070|NCT01959243|20309472|P1|STARTED|Overall Study||337
8236071|NCT01959230|20309484|P2|NOT COMPLETED|Overall Study||1
8236072|NCT01959230|20309485|P1|NOT COMPLETED|Overall Study||4
8236073|NCT01959230|20309484|P2|COMPLETED|Overall Study||19
8236074|NCT01959230|20309485|P1|COMPLETED|Overall Study||36
8236075|NCT01959230|20309484|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
8236076|NCT01959230|20309485|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
8236077|NCT01959230|20309484|P2|STARTED|Overall Study||20
8236078|NCT01959230|20309485|P1|STARTED|Overall Study||40
8236079|NCT01959178|20309495|P2|NOT COMPLETED|Overall Study||2
8236080|NCT01959178|20309496|P1|NOT COMPLETED|Overall Study||2
8236081|NCT01959178|20309495|P2|COMPLETED|Overall Study||71
8236082|NCT01959178|20309496|P1|COMPLETED|Overall Study||71
8236083|NCT01959178|20309495|P2|STARTED|Overall Study||73
8236084|NCT01959178|20309496|P1|STARTED|Overall Study||73
8236085|NCT01959165|20309508|P4|NOT COMPLETED|Overall Study||2
8236086|NCT01959165|20309509|P3|NOT COMPLETED|Overall Study||0
8236087|NCT01959165|20309510|P2|NOT COMPLETED|Overall Study||1
8236088|NCT01959165|20309511|P1|NOT COMPLETED|Overall Study||1
8236089|NCT01959165|20309508|P4|COMPLETED|Overall Study||7
8236090|NCT01959165|20309509|P3|COMPLETED|Overall Study||12
8236091|NCT01959165|20309510|P2|COMPLETED|Overall Study||10
8236092|NCT01959165|20309511|P1|COMPLETED|Overall Study||12
8236093|NCT01959165|20309508|P4|STARTED|Overall Study||9
8236094|NCT01959165|20309509|P3|STARTED|Overall Study||12
8236095|NCT01959165|20309510|P2|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11
8236096|NCT01959165|20309511|P1|STARTED|Overall Study||13
8236097|NCT01959139|20309537|P4|NOT COMPLETED|Phase II||55
8236098|NCT01959139|20309538|P3|NOT COMPLETED|Phase II||56
8236099|NCT01959139|20309539|P2|NOT COMPLETED|Phase II||0
8236100|NCT01959139|20309540|P1|NOT COMPLETED|Phase II||0
8236101|NCT01959139|20309537|P4|COMPLETED|Phase II||0
8236102|NCT01959139|20309538|P3|COMPLETED|Phase II||0
8236103|NCT01959139|20309539|P2|COMPLETED|Phase II||0
8236104|NCT01959139|20309540|P1|COMPLETED|Phase II||0
8236105|NCT01959139|20309537|P4|Assessed for AEs|Phase II||51
8236106|NCT01959139|20309538|P3|Assessed for AEs|Phase II||54
8236107|NCT01959139|20309539|P2|Assessed for AEs|Phase II||0
8236108|NCT01959139|20309540|P1|Assessed for AEs|Phase II||0
8236109|NCT01959139|20309537|P4|STARTED|Phase II||55
8236110|NCT01959139|20309538|P3|STARTED|Phase II||56
8236111|NCT01959139|20309539|P2|STARTED|Phase II||0
8236112|NCT01959139|20309540|P1|STARTED|Phase II||0
8236113|NCT01959139|20309537|P4|NOT COMPLETED|Phase I: Cohort 2||0
8236114|NCT01959139|20309538|P3|NOT COMPLETED|Phase I: Cohort 2||0
8236115|NCT01959139|20309539|P2|NOT COMPLETED|Phase I: Cohort 2||0
8236116|NCT01959139|20309540|P1|NOT COMPLETED|Phase I: Cohort 2||0
8236117|NCT01959139|20309537|P4|COMPLETED|Phase I: Cohort 2||0
8236118|NCT01959139|20309538|P3|COMPLETED|Phase I: Cohort 2||0
8236119|NCT01959139|20309539|P2|COMPLETED|Phase I: Cohort 2||6
8236120|NCT01959139|20309540|P1|COMPLETED|Phase I: Cohort 2||0
8236121|NCT01959139|20309537|P4|STARTED|Phase I: Cohort 2||0
8236122|NCT01959139|20309538|P3|STARTED|Phase I: Cohort 2||0
8236123|NCT01959139|20309539|P2|STARTED|Phase I: Cohort 2||6
8236124|NCT01959139|20309540|P1|STARTED|Phase I: Cohort 2||0
8236125|NCT01959139|20309537|P4|NOT COMPLETED|Phase I: Cohort 1||0
8236126|NCT01959139|20309538|P3|NOT COMPLETED|Phase I: Cohort 1||0
8236127|NCT01959139|20309539|P2|NOT COMPLETED|Phase I: Cohort 1||0
8236128|NCT01959139|20309540|P1|NOT COMPLETED|Phase I: Cohort 1||0
8236129|NCT01959139|20309537|P4|COMPLETED|Phase I: Cohort 1||0
8236130|NCT01959139|20309538|P3|COMPLETED|Phase I: Cohort 1||0
8236131|NCT01959139|20309539|P2|COMPLETED|Phase I: Cohort 1||0
8236132|NCT01959139|20309540|P1|COMPLETED|Phase I: Cohort 1||5
8236133|NCT01959139|20309537|P4|STARTED|Phase I: Cohort 1||0
8236134|NCT01959139|20309538|P3|STARTED|Phase I: Cohort 1||0
8236135|NCT01959139|20309539|P2|STARTED|Phase I: Cohort 1||0
8236136|NCT01959139|20309540|P1|STARTED|Phase I: Cohort 1||5
8236137|NCT01959113|20309559|P1|NOT COMPLETED|Overall Study||0
8236138|NCT01959113|20309559|P1|COMPLETED|Overall Study||5
8236139|NCT01959113|20309559|P1|STARTED|Overall Study||5
8236140|NCT01959048|20309565|P1|NOT COMPLETED|Overall Study||0
8236141|NCT01959048|20309565|P1|COMPLETED|Overall Study||3
8236142|NCT01959048|20309565|P1|STARTED|Overall Study||3
8236143|NCT01959035|20309573|P1|NOT COMPLETED|Overall Study||11
8236144|NCT01959035|20309573|P1|COMPLETED|Overall Study||77
8236145|NCT01959035|20309573|P1|STARTED|Overall Study||88
8236146|NCT01958918|20309601|P2|NOT COMPLETED|Overall Study||42
8236147|NCT01958918|20309602|P1|NOT COMPLETED|Overall Study||43
8236148|NCT01958918|20309601|P2|COMPLETED|Overall Study||314
8236149|NCT01958918|20309602|P1|COMPLETED|Overall Study||313
8236150|NCT01958918|20309601|P2|Full Analysis Set|Overall Study||354
8236151|NCT01958918|20309602|P1|Full Analysis Set|Overall Study||353
8236152|NCT01958918|20309601|P2|STARTED|Overall Study||356
8236153|NCT01958918|20309602|P1|STARTED|Overall Study||356
8236154|NCT01958827|20309616|P1|NOT COMPLETED|Overall Study||10
8236155|NCT01958827|20309616|P1|COMPLETED|Overall Study||18
8236156|NCT01958827|20309616|P1|STARTED|Overall Study||28
8236157|NCT01958788|20309634|P1|NOT COMPLETED|Overall Study||0
8236158|NCT01958788|20309634|P1|COMPLETED|Overall Study||7
8236159|NCT01958788|20309634|P1|STARTED|Overall Study||7
8236160|NCT01958671|20309647|P3|NOT COMPLETED|Overall Study||32
8236161|NCT01958671|20309648|P2|NOT COMPLETED|Overall Study||24
8236162|NCT01958671|20309649|P1|NOT COMPLETED|Overall Study||19
8236163|NCT01958671|20309647|P3|COMPLETED|Overall Study||121
8236164|NCT01958671|20309648|P2|COMPLETED|Overall Study||128
8236165|NCT01958671|20309649|P1|COMPLETED|Overall Study||137
8236166|NCT01958671|20309647|P3|STARTED|Overall Study||153
8236167|NCT01958671|20309648|P2|STARTED|Overall Study||152
8236168|NCT01958671|20309649|P1|STARTED|Overall Study||156
8236169|NCT01958645|20309693|P3|NOT COMPLETED|Overall Study||0
8236170|NCT01958645|20309694|P2|NOT COMPLETED|Overall Study||0
8236171|NCT01958645|20309695|P1|NOT COMPLETED|Overall Study||0
8236172|NCT01958645|20309693|P3|COMPLETED|Overall Study||4
8236173|NCT01958645|20309694|P2|COMPLETED|Overall Study||4
8236174|NCT01958645|20309695|P1|COMPLETED|Overall Study||4
8236175|NCT01958645|20309693|P3|STARTED|Overall Study||4
8236176|NCT01958645|20309694|P2|STARTED|Overall Study||4
8236177|NCT01958645|20309695|P1|STARTED|Overall Study||4
8236178|NCT01958619|20309723|P4|NOT COMPLETED|Overall Study||0
8236179|NCT01958619|20309724|P3|NOT COMPLETED|Overall Study||1
8236180|NCT01958619|20309725|P2|NOT COMPLETED|Overall Study||0
8236181|NCT01958619|20309726|P1|NOT COMPLETED|Overall Study||2
8236182|NCT01958619|20309723|P4|COMPLETED|Overall Study||12
8236183|NCT01958619|20309724|P3|COMPLETED|Overall Study||13
8236184|NCT01958619|20309725|P2|COMPLETED|Overall Study||14
8236185|NCT01958619|20309726|P1|COMPLETED|Overall Study||13
8236186|NCT01958619|20309723|P4|STARTED|Overall Study||12
8236187|NCT01958619|20309724|P3|STARTED|Overall Study||14
8236188|NCT01958619|20309725|P2|STARTED|Overall Study||14
8236189|NCT01958619|20309726|P1|STARTED|Overall Study||15
8236190|NCT01958606|20309748|P2|NOT COMPLETED|Overall Study||0
8236191|NCT01958606|20309749|P1|NOT COMPLETED|Overall Study||2
8236192|NCT01958606|20309748|P2|COMPLETED|Overall Study||5
8236193|NCT01958606|20309749|P1|COMPLETED|Overall Study||11
8236194|NCT01958606|20309748|P2|STARTED|Overall Study||5
8236195|NCT01958606|20309749|P1|STARTED|Overall Study||13
8236196|NCT01958489|20309787|P2|NOT COMPLETED|Period 2||1
8236197|NCT01958489|20309788|P1|NOT COMPLETED|Period 2||0
8236198|NCT01958489|20309787|P2|COMPLETED|Period 2||23
8236199|NCT01958489|20309788|P1|COMPLETED|Period 2||0
8236200|NCT01958489|20309787|P2|Received at Least 1 Dose of Study Drug|Period 2||24
8236201|NCT01958489|20309788|P1|Received at Least 1 Dose of Study Drug|Period 2||0
8236202|NCT01958489|20309787|P2|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
8236203|NCT01958489|20309788|P1|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
8236204|NCT01958489|20309787|P2|NOT COMPLETED|Period 1||0
8236205|NCT01958489|20309788|P1|NOT COMPLETED|Period 1||0
8236206|NCT01958489|20309787|P2|COMPLETED|Period 1||0
8236207|NCT01958489|20309788|P1|COMPLETED|Period 1||24
8236208|NCT01958489|20309787|P2|Received at Least 1 Dose of Study Drug|Period 1||0
8236209|NCT01958489|20309788|P1|Received at Least 1 Dose of Study Drug|Period 1||24
8236210|NCT01958489|20309787|P2|STARTED|Period 1||0
8236211|NCT01958489|20309788|P1|STARTED|Period 1||24
8236212|NCT01958476|20309804|P2|NOT COMPLETED|Overall Study||0
8236213|NCT01958476|20309805|P1|NOT COMPLETED|Overall Study||1
8236214|NCT01958476|20309804|P2|COMPLETED|Overall Study||58
8236215|NCT01958476|20309805|P1|COMPLETED|Overall Study||58
8236216|NCT01958476|20309804|P2|STARTED|Overall Study||58
8236217|NCT01958476|20309805|P1|STARTED|Overall Study||59
8236218|NCT01958437|20309835|P4|NOT COMPLETED|Overall Study||1
8236219|NCT01958437|20309836|P3|NOT COMPLETED|Overall Study||1
8236220|NCT01958437|20309837|P2|NOT COMPLETED|Overall Study||0
8236221|NCT01958437|20309838|P1|NOT COMPLETED|Overall Study||0
8236222|NCT01958437|20309835|P4|COMPLETED|Overall Study||10
8236223|NCT01958437|20309836|P3|COMPLETED|Overall Study||10
8236224|NCT01958437|20309837|P2|COMPLETED|Overall Study||11
8236225|NCT01958437|20309838|P1|COMPLETED|Overall Study||11
8236226|NCT01958437|20309835|P4|STARTED|Overall Study||11
8236227|NCT01958437|20309836|P3|STARTED|Overall Study||11
8236228|NCT01958437|20309837|P2|STARTED|Overall Study||11
8236229|NCT01958437|20309838|P1|STARTED|Overall Study||11
8236230|NCT01958346|20309862|P2|NOT COMPLETED|Overall Study||0
8236231|NCT01958346|20309863|P1|NOT COMPLETED|Overall Study||0
8236232|NCT01958346|20309862|P2|COMPLETED|Overall Study||39
8236233|NCT01958346|20309863|P1|COMPLETED|Overall Study||39
8236234|NCT01958346|20309862|P2|STARTED|Overall Study||39
8236235|NCT01958346|20309863|P1|STARTED|Overall Study||39
8236236|NCT01958320|20309873|P2|NOT COMPLETED|Overall Study||0
8236237|NCT01958320|20309874|P1|NOT COMPLETED|Overall Study||0
8236238|NCT01958320|20309873|P2|COMPLETED|Overall Study||98
8236239|NCT01958320|20309874|P1|COMPLETED|Overall Study||104
8236240|NCT01958320|20309873|P2|STARTED|Overall Study||98
8236241|NCT01958320|20309874|P1|STARTED|Overall Study||104
8236242|NCT01958294|20309902|P1|NOT COMPLETED|Overall Study||2
8236243|NCT01958294|20309902|P1|COMPLETED|Overall Study||10
8236244|NCT01958294|20309902|P1|STARTED|Overall Study||12
8236245|NCT01958281|20309911|P3|NOT COMPLETED|Overall Study||0
8236246|NCT01958281|20309912|P2|NOT COMPLETED|Overall Study||4
8236247|NCT01958281|20309913|P1|NOT COMPLETED|Overall Study||6
8236248|NCT01958281|20309911|P3|COMPLETED|Overall Study||18
8236249|NCT01958281|20309912|P2|COMPLETED|Overall Study||6
8236250|NCT01958281|20309913|P1|COMPLETED|Overall Study||4
8236251|NCT01958281|20309911|P3|STARTED|Overall Study||18
8236252|NCT01958281|20309912|P2|STARTED|Overall Study||10
8236253|NCT01958281|20309913|P1|STARTED|Overall Study||10
8236254|NCT01958164|20309989|P2|NOT COMPLETED|Overall Study||5
8236255|NCT01958164|20309990|P1|NOT COMPLETED|Overall Study||2
8236256|NCT01958164|20309989|P2|COMPLETED|Overall Study||5
8236257|NCT01958164|20309990|P1|COMPLETED|Overall Study||4
8236258|NCT01958164|20309989|P2|STARTED|Overall Study|Randomised and treated|10
8236259|NCT01958164|20309990|P1|STARTED|Overall Study|Randomised and treated|6
8236260|NCT01958125|20310005|P2|NOT COMPLETED|Overall Study||8
8236261|NCT01958125|20310006|P1|NOT COMPLETED|Overall Study||2
8236262|NCT01958125|20310005|P2|COMPLETED|Overall Study||44
8236263|NCT01958125|20310006|P1|COMPLETED|Overall Study||48
8236264|NCT01958125|20310005|P2|STARTED|Overall Study||52
8236265|NCT01958125|20310006|P1|STARTED|Overall Study||50
8236266|NCT01958112|20310020|P1|NOT COMPLETED|Overall Study||0
8236267|NCT01958112|20310020|P1|COMPLETED|Overall Study||14
8236268|NCT01958112|20310020|P1|STARTED|Overall Study||14
8236269|NCT01958073|20310030|P5|NOT COMPLETED|Open Label Period||0
8236270|NCT01958073|20310031|P4|NOT COMPLETED|Open Label Period||0
8236271|NCT01958073|20310032|P3|NOT COMPLETED|Open Label Period||0
8236272|NCT01958073|20310033|P2|NOT COMPLETED|Open Label Period||0
8236273|NCT01958073|20310034|P1|NOT COMPLETED|Open Label Period||0
8236274|NCT01958073|20310030|P5|COMPLETED|Open Label Period||17
8236275|NCT01958073|20310031|P4|COMPLETED|Open Label Period||5
8236276|NCT01958073|20310032|P3|COMPLETED|Open Label Period||0
8236277|NCT01958073|20310033|P2|COMPLETED|Open Label Period||0
8236278|NCT01958073|20310034|P1|COMPLETED|Open Label Period||0
8236279|NCT01958073|20310030|P5|STARTED|Open Label Period||17
8236280|NCT01958073|20310031|P4|STARTED|Open Label Period||5
8236281|NCT01958073|20310032|P3|STARTED|Open Label Period||0
8236282|NCT01958073|20310033|P2|STARTED|Open Label Period||0
8236283|NCT01958073|20310034|P1|STARTED|Open Label Period||0
8236284|NCT01958073|20310030|P5|NOT COMPLETED|Randomized Period||0
8236285|NCT01958073|20310031|P4|NOT COMPLETED|Randomized Period||0
8236286|NCT01958073|20310032|P3|NOT COMPLETED|Randomized Period||6
8236287|NCT01958073|20310033|P2|NOT COMPLETED|Randomized Period||1
8236288|NCT01958073|20310034|P1|NOT COMPLETED|Randomized Period||2
8236289|NCT01958073|20310030|P5|COMPLETED|Randomized Period||0
8236290|NCT01958073|20310031|P4|COMPLETED|Randomized Period||0
8236291|NCT01958073|20310032|P3|COMPLETED|Randomized Period||11
8236292|NCT01958073|20310033|P2|COMPLETED|Randomized Period||8
8236293|NCT01958073|20310034|P1|COMPLETED|Randomized Period||7
8236294|NCT01958073|20310030|P5|STARTED|Randomized Period||0
8236295|NCT01958073|20310031|P4|STARTED|Randomized Period||0
8236296|NCT01958073|20310032|P3|STARTED|Randomized Period||17
8236297|NCT01958073|20310033|P2|STARTED|Randomized Period||9
8236298|NCT01958073|20310034|P1|STARTED|Randomized Period||9
8236299|NCT01958060|20310069|P6|NOT COMPLETED|Overall Study||0
8236300|NCT01958060|20310070|P5|NOT COMPLETED|Overall Study||1
8236301|NCT01958060|20310071|P4|NOT COMPLETED|Overall Study||0
8236302|NCT01958060|20310072|P3|NOT COMPLETED|Overall Study||0
8236303|NCT01958060|20310073|P2|NOT COMPLETED|Overall Study||0
8236304|NCT01958060|20310074|P1|NOT COMPLETED|Overall Study||2
8236305|NCT01958060|20310069|P6|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
8236306|NCT01958060|20310070|P5|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
8236307|NCT01958060|20310071|P4|COMPLETED|Overall Study||5
8236308|NCT01958060|20310072|P3|COMPLETED|Overall Study||6
8236309|NCT01958060|20310073|P2|COMPLETED|Overall Study||6
8236310|NCT01958060|20310074|P1|COMPLETED|Overall Study||8
8236311|NCT01958060|20310069|P6|STARTED|Overall Study||1
8236312|NCT01958060|20310070|P5|STARTED|Overall Study||7
8236313|NCT01958060|20310071|P4|STARTED|Overall Study||5
8236314|NCT01958060|20310072|P3|STARTED|Overall Study||6
8236315|NCT01958060|20310073|P2|STARTED|Overall Study||6
8236316|NCT01958060|20310074|P1|STARTED|Overall Study||10
8236327|NCT01958008|20310112|P4|NOT COMPLETED|Overall Study||0
8236328|NCT01958008|20310113|P3|NOT COMPLETED|Overall Study||1
8236329|NCT01958008|20310114|P2|NOT COMPLETED|Overall Study||0
8236330|NCT01958008|20310115|P1|NOT COMPLETED|Overall Study||1
8236331|NCT01958008|20310112|P4|COMPLETED|Overall Study||21
8236332|NCT01958008|20310113|P3|COMPLETED|Overall Study||20
8236333|NCT01958008|20310114|P2|COMPLETED|Overall Study||21
8236334|NCT01958008|20310115|P1|COMPLETED|Overall Study||20
8236335|NCT01958008|20310112|P4|STARTED|Overall Study||21
8236336|NCT01958008|20310113|P3|STARTED|Overall Study||21
8236337|NCT01958008|20310114|P2|STARTED|Overall Study||21
8236338|NCT01958008|20310115|P1|STARTED|Overall Study||21
8236339|NCT01957930|20310146|P3|NOT COMPLETED|Overall Study||0
8236340|NCT01957930|20310147|P2|NOT COMPLETED|Overall Study||0
8236341|NCT01957930|20310148|P1|NOT COMPLETED|Overall Study||0
8236342|NCT01957930|20310146|P3|COMPLETED|Overall Study||19
8236343|NCT01957930|20310147|P2|COMPLETED|Overall Study||37
8236344|NCT01957930|20310148|P1|COMPLETED|Overall Study||35
8236345|NCT01957930|20310146|P3|STARTED|Overall Study||19
8236346|NCT01957930|20310147|P2|STARTED|Overall Study||37
8236347|NCT01957930|20310148|P1|STARTED|Overall Study||35
8236348|NCT01957865|20310158|P3|NOT COMPLETED|Overall Study||3
8236349|NCT01957865|20310159|P2|NOT COMPLETED|Overall Study||2
8236350|NCT01957865|20310160|P1|NOT COMPLETED|Overall Study||0
8236351|NCT01957865|20310158|P3|COMPLETED|Overall Study||19
8236352|NCT01957865|20310159|P2|COMPLETED|Overall Study||18
8236353|NCT01957865|20310160|P1|COMPLETED|Overall Study||21
8236354|NCT01957865|20310158|P3|STARTED|Overall Study||22
8236355|NCT01957865|20310159|P2|STARTED|Overall Study||20
8236356|NCT01957865|20310160|P1|STARTED|Overall Study||21
8236362|NCT01957761|20310186|P1|NOT COMPLETED|Overall Study||0
8236363|NCT01957761|20310186|P1|COMPLETED|Overall Study||189
8236364|NCT01957761|20310186|P1|STARTED|Overall Study||189
8236365|NCT01957709|20310190|P1|NOT COMPLETED|Overall Study||1
8236366|NCT01957709|20310190|P1|COMPLETED|Overall Study||7
8236367|NCT01957709|20310190|P1|STARTED|Overall Study||8
8236368|NCT01957657|20310196|P1|NOT COMPLETED|Overall Study||0
8236369|NCT01957657|20310196|P1|COMPLETED|Overall Study||4
8236370|NCT01957657|20310196|P1|STARTED|Overall Study||4
8236371|NCT01957644|20310215|P5|NOT COMPLETED|Overall Study||1
8236372|NCT01957644|20310216|P4|NOT COMPLETED|Overall Study||2
8236373|NCT01957644|20310217|P3|NOT COMPLETED|Overall Study||1
8236374|NCT01957644|20310218|P2|NOT COMPLETED|Overall Study||6
8236375|NCT01957644|20310219|P1|NOT COMPLETED|Overall Study||6
8236376|NCT01957644|20310215|P5|COMPLETED|Overall Study||0
8236377|NCT01957644|20310216|P4|COMPLETED|Overall Study||0
8236378|NCT01957644|20310217|P3|COMPLETED|Overall Study||0
8236379|NCT01957644|20310218|P2|COMPLETED|Overall Study||0
8236380|NCT01957644|20310219|P1|COMPLETED|Overall Study||0
8236381|NCT01957644|20310215|P5|STARTED|Overall Study||1
8236382|NCT01957644|20310216|P4|STARTED|Overall Study||2
8236383|NCT01957644|20310217|P3|STARTED|Overall Study||1
8236384|NCT01957644|20310218|P2|STARTED|Overall Study||6
8236385|NCT01957644|20310219|P1|STARTED|Overall Study||6
8236386|NCT01957579|20310243|P4|NOT COMPLETED|Overall Study||0
8236387|NCT01957579|20310244|P3|NOT COMPLETED|Overall Study||2
8236388|NCT01957579|20310245|P2|NOT COMPLETED|Overall Study||1
8236389|NCT01957579|20310246|P1|NOT COMPLETED|Overall Study||0
8236390|NCT01957579|20310243|P4|COMPLETED|Overall Study||6
8236391|NCT01957579|20310244|P3|COMPLETED|Overall Study||2
8236392|NCT01957579|20310245|P2|COMPLETED|Overall Study||6
8236393|NCT01957579|20310246|P1|COMPLETED|Overall Study||3
8236394|NCT01957579|20310243|P4|STARTED|Overall Study||6
8236395|NCT01957579|20310244|P3|STARTED|Overall Study||4
8236396|NCT01957579|20310245|P2|STARTED|Overall Study||7
8236397|NCT01957579|20310246|P1|STARTED|Overall Study||3
8236398|NCT01957553|20310313|P2|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
8236399|NCT01957553|20310314|P1|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
8236400|NCT01957553|20310313|P2|COMPLETED|Test Period 2 (21 +- 1 Days)||56
8236401|NCT01957553|20310314|P1|COMPLETED|Test Period 2 (21 +- 1 Days)||51
8236402|NCT01957553|20310313|P2|STARTED|Test Period 2 (21 +- 1 Days)||63
8236403|NCT01957553|20310314|P1|STARTED|Test Period 2 (21 +- 1 Days)||54
8236404|NCT01957553|20310313|P2|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
8236405|NCT01957553|20310314|P1|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
8236406|NCT01957553|20310313|P2|COMPLETED|Test Period 1 (21 +- 1 Days)||63
8236407|NCT01957553|20310314|P1|COMPLETED|Test Period 1 (21 +- 1 Days)||54
8236408|NCT01957553|20310313|P2|STARTED|Test Period 1 (21 +- 1 Days)||66
8236409|NCT01957553|20310314|P1|STARTED|Test Period 1 (21 +- 1 Days)||61
8236410|NCT01957488|20310320|P6|NOT COMPLETED|Test Period 3 (2 Weeks)||0
8236411|NCT01957488|20310321|P5|NOT COMPLETED|Test Period 3 (2 Weeks)||0
8236412|NCT01957488|20310322|P4|NOT COMPLETED|Test Period 3 (2 Weeks)||0
8236413|NCT01957488|20310323|P3|NOT COMPLETED|Test Period 3 (2 Weeks)||0
8236414|NCT01957488|20310324|P2|NOT COMPLETED|Test Period 3 (2 Weeks)||1
8236415|NCT01957488|20310325|P1|NOT COMPLETED|Test Period 3 (2 Weeks)||1
8236416|NCT01957488|20310320|P6|COMPLETED|Test Period 3 (2 Weeks)||23
8236417|NCT01957488|20310321|P5|COMPLETED|Test Period 3 (2 Weeks)||25
8236418|NCT01957488|20310322|P4|COMPLETED|Test Period 3 (2 Weeks)||28
8236419|NCT01957488|20310323|P3|COMPLETED|Test Period 3 (2 Weeks)||25
8236420|NCT01957488|20310324|P2|COMPLETED|Test Period 3 (2 Weeks)||26
8236421|NCT01957488|20310325|P1|COMPLETED|Test Period 3 (2 Weeks)||23
8236422|NCT01957488|20310320|P6|STARTED|Test Period 3 (2 Weeks)||23
8236423|NCT01957488|20310321|P5|STARTED|Test Period 3 (2 Weeks)||25
8236424|NCT01957488|20310322|P4|STARTED|Test Period 3 (2 Weeks)||28
8236425|NCT01957488|20310323|P3|STARTED|Test Period 3 (2 Weeks)||25
8236426|NCT01957488|20310324|P2|STARTED|Test Period 3 (2 Weeks)||27
8236427|NCT01957488|20310325|P1|STARTED|Test Period 3 (2 Weeks)||24
8236428|NCT01957488|20310320|P6|NOT COMPLETED|Test Period 2 (2 Weeks)||1
8236429|NCT01957488|20310321|P5|NOT COMPLETED|Test Period 2 (2 Weeks)||2
8236430|NCT01957488|20310322|P4|NOT COMPLETED|Test Period 2 (2 Weeks)||1
8236431|NCT01957488|20310323|P3|NOT COMPLETED|Test Period 2 (2 Weeks)||1
8236432|NCT01957488|20310324|P2|NOT COMPLETED|Test Period 2 (2 Weeks)||1
8236433|NCT01957488|20310325|P1|NOT COMPLETED|Test Period 2 (2 Weeks)||3
8236434|NCT01957488|20310320|P6|COMPLETED|Test Period 2 (2 Weeks)||23
8236435|NCT01957488|20310321|P5|COMPLETED|Test Period 2 (2 Weeks)||25
8236436|NCT01957488|20310322|P4|COMPLETED|Test Period 2 (2 Weeks)||28
8236437|NCT01957488|20310323|P3|COMPLETED|Test Period 2 (2 Weeks)||25
8236438|NCT01957488|20310324|P2|COMPLETED|Test Period 2 (2 Weeks)||27
8236439|NCT01957488|20310325|P1|COMPLETED|Test Period 2 (2 Weeks)||24
8236440|NCT01957488|20310320|P6|STARTED|Test Period 2 (2 Weeks)||24
8236441|NCT01957488|20310321|P5|STARTED|Test Period 2 (2 Weeks)||27
8236442|NCT01957488|20310322|P4|STARTED|Test Period 2 (2 Weeks)||29
8236443|NCT01957488|20310323|P3|STARTED|Test Period 2 (2 Weeks)||26
8236444|NCT01957488|20310324|P2|STARTED|Test Period 2 (2 Weeks)||28
8236445|NCT01957488|20310325|P1|STARTED|Test Period 2 (2 Weeks)||27
8236446|NCT01957488|20310320|P6|NOT COMPLETED|Test Period 1 (2 Weeks)||6
8236447|NCT01957488|20310321|P5|NOT COMPLETED|Test Period 1 (2 Weeks)||3
8236448|NCT01957488|20310322|P4|NOT COMPLETED|Test Period 1 (2 Weeks)||3
8236449|NCT01957488|20310323|P3|NOT COMPLETED|Test Period 1 (2 Weeks)||4
8236450|NCT01957488|20310324|P2|NOT COMPLETED|Test Period 1 (2 Weeks)||3
8236451|NCT01957488|20310325|P1|NOT COMPLETED|Test Period 1 (2 Weeks)||3
8236452|NCT01957488|20310320|P6|COMPLETED|Test Period 1 (2 Weeks)||24
8236453|NCT01957488|20310321|P5|COMPLETED|Test Period 1 (2 Weeks)||27
8236454|NCT01957488|20310322|P4|COMPLETED|Test Period 1 (2 Weeks)||29
8236455|NCT01957488|20310323|P3|COMPLETED|Test Period 1 (2 Weeks)||26
8236456|NCT01957488|20310324|P2|COMPLETED|Test Period 1 (2 Weeks)||28
8236457|NCT01957488|20310325|P1|COMPLETED|Test Period 1 (2 Weeks)||27
8236458|NCT01957488|20310320|P6|STARTED|Test Period 1 (2 Weeks)||30
8236459|NCT01957488|20310321|P5|STARTED|Test Period 1 (2 Weeks)||30
8236460|NCT01957488|20310322|P4|STARTED|Test Period 1 (2 Weeks)||32
8236461|NCT01957488|20310323|P3|STARTED|Test Period 1 (2 Weeks)||30
8236462|NCT01957488|20310324|P2|STARTED|Test Period 1 (2 Weeks)||31
8236463|NCT01957488|20310325|P1|STARTED|Test Period 1 (2 Weeks)||30
8236464|NCT01957475|20310333|P2|NOT COMPLETED|Test Period 2||0
8236465|NCT01957475|20310334|P1|NOT COMPLETED|Test Period 2||1
8236466|NCT01957475|20310333|P2|COMPLETED|Test Period 2||8
8236467|NCT01957475|20310334|P1|COMPLETED|Test Period 2||8
8236468|NCT01957475|20310333|P2|STARTED|Test Period 2||8
8236469|NCT01957475|20310334|P1|STARTED|Test Period 2||9
8236470|NCT01957475|20310333|P2|NOT COMPLETED|Test Period 1||1
8236471|NCT01957475|20310334|P1|NOT COMPLETED|Test Period 1||2
8236472|NCT01957475|20310333|P2|COMPLETED|Test Period 1||9
8236473|NCT01957475|20310334|P1|COMPLETED|Test Period 1||8
8236474|NCT01957475|20310333|P2|STARTED|Test Period 1||10
8236475|NCT01957475|20310334|P1|STARTED|Test Period 1||10
8236476|NCT01957462|20310340|P2|NOT COMPLETED|Test Period 2||0
8236477|NCT01957462|20310341|P1|NOT COMPLETED|Test Period 2||0
8236478|NCT01957462|20310340|P2|COMPLETED|Test Period 2||15
8236479|NCT01957462|20310341|P1|COMPLETED|Test Period 2||14
8236480|NCT01957462|20310340|P2|STARTED|Test Period 2||15
8236481|NCT01957462|20310341|P1|STARTED|Test Period 2||14
8236482|NCT01957462|20310340|P2|NOT COMPLETED|Test Period 1||0
8236483|NCT01957462|20310341|P1|NOT COMPLETED|Test Period 1||2
8236484|NCT01957462|20310340|P2|COMPLETED|Test Period 1||15
8236485|NCT01957462|20310341|P1|COMPLETED|Test Period 1||14
8236486|NCT01957462|20310340|P2|STARTED|Test Period 1||15
8236487|NCT01957462|20310341|P1|STARTED|Test Period 1||16
8236488|NCT01957410|20310347|P1|NOT COMPLETED|Optional Open Label||0
8236489|NCT01957410|20310347|P1|COMPLETED|Optional Open Label||13
8236490|NCT01957410|20310347|P1|STARTED|Optional Open Label||13
8236491|NCT01957410|20310347|P1|NOT COMPLETED|Open Label||0
8236492|NCT01957410|20310347|P1|COMPLETED|Open Label||13
8236493|NCT01957410|20310347|P1|STARTED|Open Label||13
8236494|NCT01957397|20310352|P2|NOT COMPLETED|Test Period 3||2
8236495|NCT01957397|20310353|P1|NOT COMPLETED|Test Period 3||2
8236496|NCT01957397|20310352|P2|COMPLETED|Test Period 3||9
8236497|NCT01957397|20310353|P1|COMPLETED|Test Period 3||9
8236498|NCT01957397|20310352|P2|STARTED|Test Period 3||11
8236499|NCT01957397|20310353|P1|STARTED|Test Period 3||11
8236500|NCT01957397|20310352|P2|NOT COMPLETED|Test Period 2||1
8236501|NCT01957397|20310353|P1|NOT COMPLETED|Test Period 2||0
8236502|NCT01957397|20310352|P2|COMPLETED|Test Period 2||11
8236503|NCT01957397|20310353|P1|COMPLETED|Test Period 2||11
8236504|NCT01957397|20310352|P2|STARTED|Test Period 2||12
8236505|NCT01957397|20310353|P1|STARTED|Test Period 2||11
8236506|NCT01957397|20310352|P2|NOT COMPLETED|Test Period 1||1
8236507|NCT01957397|20310353|P1|NOT COMPLETED|Test Period 1||2
8236508|NCT01957397|20310352|P2|COMPLETED|Test Period 1||12
8236509|NCT01957397|20310353|P1|COMPLETED|Test Period 1||11
8236510|NCT01957397|20310352|P2|STARTED|Test Period 1||13
8236511|NCT01957397|20310353|P1|STARTED|Test Period 1||13
8236512|NCT01957397|20310352|P2|NOT COMPLETED|Baseline Own Product||0
8236513|NCT01957397|20310353|P1|NOT COMPLETED|Baseline Own Product||0
8236514|NCT01957397|20310352|P2|COMPLETED|Baseline Own Product||13
8236515|NCT01957397|20310353|P1|COMPLETED|Baseline Own Product||13
8236516|NCT01957397|20310352|P2|STARTED|Baseline Own Product||13
8236517|NCT01957397|20310353|P1|STARTED|Baseline Own Product||13
8236518|NCT01957384|20310363|P6|NOT COMPLETED|Test Period 3 (14 Days)||0
8236519|NCT01957384|20310364|P5|NOT COMPLETED|Test Period 3 (14 Days)||0
8236520|NCT01957384|20310365|P4|NOT COMPLETED|Test Period 3 (14 Days)||0
8236521|NCT01957384|20310366|P3|NOT COMPLETED|Test Period 3 (14 Days)||0
8236522|NCT01957384|20310367|P2|NOT COMPLETED|Test Period 3 (14 Days)||0
8236523|NCT01957384|20310368|P1|NOT COMPLETED|Test Period 3 (14 Days)||0
8236524|NCT01957384|20310363|P6|COMPLETED|Test Period 3 (14 Days)||3
8236525|NCT01957384|20310364|P5|COMPLETED|Test Period 3 (14 Days)||3
8236526|NCT01957384|20310365|P4|COMPLETED|Test Period 3 (14 Days)||4
8236527|NCT01957384|20310366|P3|COMPLETED|Test Period 3 (14 Days)||4
8236528|NCT01957384|20310367|P2|COMPLETED|Test Period 3 (14 Days)||4
8236529|NCT01957384|20310368|P1|COMPLETED|Test Period 3 (14 Days)||4
8236530|NCT01957384|20310363|P6|STARTED|Test Period 3 (14 Days)||3
8236531|NCT01957384|20310364|P5|STARTED|Test Period 3 (14 Days)||3
8236532|NCT01957384|20310365|P4|STARTED|Test Period 3 (14 Days)||4
8236533|NCT01957384|20310366|P3|STARTED|Test Period 3 (14 Days)||4
8236534|NCT01957384|20310367|P2|STARTED|Test Period 3 (14 Days)||4
8236535|NCT01957384|20310368|P1|STARTED|Test Period 3 (14 Days)||4
8236536|NCT01957384|20310363|P6|NOT COMPLETED|Test Period 2 (14 Days)||0
8236537|NCT01957384|20310364|P5|NOT COMPLETED|Test Period 2 (14 Days)||0
8236538|NCT01957384|20310365|P4|NOT COMPLETED|Test Period 2 (14 Days)||0
8236539|NCT01957384|20310366|P3|NOT COMPLETED|Test Period 2 (14 Days)||0
8236540|NCT01957384|20310367|P2|NOT COMPLETED|Test Period 2 (14 Days)||0
8236541|NCT01957384|20310368|P1|NOT COMPLETED|Test Period 2 (14 Days)||0
8236542|NCT01957384|20310363|P6|COMPLETED|Test Period 2 (14 Days)||3
8236543|NCT01957384|20310364|P5|COMPLETED|Test Period 2 (14 Days)||3
8236544|NCT01957384|20310365|P4|COMPLETED|Test Period 2 (14 Days)||4
8236545|NCT01957384|20310366|P3|COMPLETED|Test Period 2 (14 Days)||4
8236546|NCT01957384|20310367|P2|COMPLETED|Test Period 2 (14 Days)||4
8236547|NCT01957384|20310368|P1|COMPLETED|Test Period 2 (14 Days)||4
8236548|NCT01957384|20310363|P6|STARTED|Test Period 2 (14 Days)||3
8236549|NCT01957384|20310364|P5|STARTED|Test Period 2 (14 Days)||3
8236550|NCT01957384|20310365|P4|STARTED|Test Period 2 (14 Days)||4
8236551|NCT01957384|20310366|P3|STARTED|Test Period 2 (14 Days)||4
8236552|NCT01957384|20310367|P2|STARTED|Test Period 2 (14 Days)||4
8236553|NCT01957384|20310368|P1|STARTED|Test Period 2 (14 Days)||4
8236554|NCT01957384|20310363|P6|NOT COMPLETED|Test Period 1 (14 Days)||0
8236555|NCT01957384|20310364|P5|NOT COMPLETED|Test Period 1 (14 Days)||0
8236556|NCT01957384|20310365|P4|NOT COMPLETED|Test Period 1 (14 Days)||0
8236557|NCT01957384|20310366|P3|NOT COMPLETED|Test Period 1 (14 Days)||0
8236558|NCT01957384|20310367|P2|NOT COMPLETED|Test Period 1 (14 Days)||0
8236559|NCT01957384|20310368|P1|NOT COMPLETED|Test Period 1 (14 Days)||0
8236560|NCT01957384|20310363|P6|COMPLETED|Test Period 1 (14 Days)||3
8236561|NCT01957384|20310364|P5|COMPLETED|Test Period 1 (14 Days)||3
8236562|NCT01957384|20310365|P4|COMPLETED|Test Period 1 (14 Days)||4
8236563|NCT01957384|20310366|P3|COMPLETED|Test Period 1 (14 Days)||4
8236564|NCT01957384|20310367|P2|COMPLETED|Test Period 1 (14 Days)||4
8236565|NCT01957384|20310368|P1|COMPLETED|Test Period 1 (14 Days)||4
8236566|NCT01957384|20310363|P6|STARTED|Test Period 1 (14 Days)||3
8236567|NCT01957384|20310364|P5|STARTED|Test Period 1 (14 Days)||3
8236568|NCT01957384|20310365|P4|STARTED|Test Period 1 (14 Days)||4
8236569|NCT01957384|20310366|P3|STARTED|Test Period 1 (14 Days)||4
8236570|NCT01957384|20310367|P2|STARTED|Test Period 1 (14 Days)||4
8236571|NCT01957384|20310368|P1|STARTED|Test Period 1 (14 Days)||4
8236572|NCT01957215|20310378|P2|NOT COMPLETED|Overall Study||12
8236573|NCT01957215|20310379|P1|NOT COMPLETED|Overall Study||13
8236574|NCT01957215|20310378|P2|COMPLETED|Overall Study||123
8236575|NCT01957215|20310379|P1|COMPLETED|Overall Study||122
8236576|NCT01957215|20310378|P2|STARTED|Overall Study||135
8236577|NCT01957215|20310379|P1|STARTED|Overall Study||135
8236578|NCT01957202|20310407|P18|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236579|NCT01957202|20310408|P17|NOT COMPLETED|Treatment Period 3 (8 Days)||1
8236580|NCT01957202|20310409|P16|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236581|NCT01957202|20310410|P15|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236582|NCT01957202|20310411|P14|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236583|NCT01957202|20310412|P13|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236584|NCT01957202|20310413|P12|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236585|NCT01957202|20310414|P11|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236586|NCT01957202|20310415|P10|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236587|NCT01957202|20310416|P9|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236588|NCT01957202|20310417|P8|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236589|NCT01957202|20310418|P7|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236590|NCT01957202|20310419|P6|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236591|NCT01957202|20310420|P5|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236592|NCT01957202|20310421|P4|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236593|NCT01957202|20310422|P3|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236594|NCT01957202|20310423|P2|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236595|NCT01957202|20310424|P1|NOT COMPLETED|Treatment Period 3 (8 Days)||0
8236596|NCT01957202|20310407|P18|COMPLETED|Treatment Period 3 (8 Days)||3
8236597|NCT01957202|20310408|P17|COMPLETED|Treatment Period 3 (8 Days)||4
8236598|NCT01957202|20310409|P16|COMPLETED|Treatment Period 3 (8 Days)||3
8236599|NCT01957202|20310410|P15|COMPLETED|Treatment Period 3 (8 Days)||6
8236600|NCT01957202|20310411|P14|COMPLETED|Treatment Period 3 (8 Days)||3
8236601|NCT01957202|20310412|P13|COMPLETED|Treatment Period 3 (8 Days)||3
8236602|NCT01957202|20310413|P12|COMPLETED|Treatment Period 3 (8 Days)||6
8236603|NCT01957202|20310414|P11|COMPLETED|Treatment Period 3 (8 Days)||3
8236604|NCT01957202|20310415|P10|COMPLETED|Treatment Period 3 (8 Days)||6
8236605|NCT01957202|20310416|P9|COMPLETED|Treatment Period 3 (8 Days)||3
8236606|NCT01957202|20310417|P8|COMPLETED|Treatment Period 3 (8 Days)||3
8236607|NCT01957202|20310418|P7|COMPLETED|Treatment Period 3 (8 Days)||3
8236608|NCT01957202|20310419|P6|COMPLETED|Treatment Period 3 (8 Days)||2
8236609|NCT01957202|20310420|P5|COMPLETED|Treatment Period 3 (8 Days)||3
8236610|NCT01957202|20310421|P4|COMPLETED|Treatment Period 3 (8 Days)||3
8236611|NCT01957202|20310422|P3|COMPLETED|Treatment Period 3 (8 Days)||6
8236612|NCT01957202|20310423|P2|COMPLETED|Treatment Period 3 (8 Days)||5
8236613|NCT01957202|20310424|P1|COMPLETED|Treatment Period 3 (8 Days)||3
8236614|NCT01957202|20310407|P18|STARTED|Treatment Period 3 (8 Days)||3
8236615|NCT01957202|20310408|P17|STARTED|Treatment Period 3 (8 Days)||5
8236616|NCT01957202|20310409|P16|STARTED|Treatment Period 3 (8 Days)||3
8236617|NCT01957202|20310410|P15|STARTED|Treatment Period 3 (8 Days)||6
8236618|NCT01957202|20310411|P14|STARTED|Treatment Period 3 (8 Days)||3
8236619|NCT01957202|20310412|P13|STARTED|Treatment Period 3 (8 Days)||3
8236620|NCT01957202|20310413|P12|STARTED|Treatment Period 3 (8 Days)||6
8236621|NCT01957202|20310414|P11|STARTED|Treatment Period 3 (8 Days)||3
8236622|NCT01957202|20310415|P10|STARTED|Treatment Period 3 (8 Days)||6
8236623|NCT01957202|20310416|P9|STARTED|Treatment Period 3 (8 Days)||3
8236624|NCT01957202|20310417|P8|STARTED|Treatment Period 3 (8 Days)||3
8236625|NCT01957202|20310418|P7|STARTED|Treatment Period 3 (8 Days)||3
8236626|NCT01957202|20310419|P6|STARTED|Treatment Period 3 (8 Days)||2
8236627|NCT01957202|20310420|P5|STARTED|Treatment Period 3 (8 Days)||3
8236628|NCT01957202|20310421|P4|STARTED|Treatment Period 3 (8 Days)||3
8236629|NCT01957202|20310422|P3|STARTED|Treatment Period 3 (8 Days)||6
8236630|NCT01957202|20310423|P2|STARTED|Treatment Period 3 (8 Days)||5
8236631|NCT01957202|20310424|P1|STARTED|Treatment Period 3 (8 Days)||3
8236632|NCT01957202|20310407|P18|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236633|NCT01957202|20310408|P17|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236634|NCT01957202|20310409|P16|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236635|NCT01957202|20310410|P15|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236636|NCT01957202|20310411|P14|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236637|NCT01957202|20310412|P13|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236638|NCT01957202|20310413|P12|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236639|NCT01957202|20310414|P11|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236640|NCT01957202|20310415|P10|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236641|NCT01957202|20310416|P9|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236642|NCT01957202|20310417|P8|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236643|NCT01957202|20310418|P7|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236644|NCT01957202|20310419|P6|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236645|NCT01957202|20310420|P5|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236646|NCT01957202|20310421|P4|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236647|NCT01957202|20310422|P3|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236648|NCT01957202|20310423|P2|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236649|NCT01957202|20310424|P1|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
8236650|NCT01957202|20310407|P18|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236651|NCT01957202|20310408|P17|COMPLETED|Washout Period 2 (14 to 28 Days)||5
8236652|NCT01957202|20310409|P16|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236653|NCT01957202|20310410|P15|COMPLETED|Washout Period 2 (14 to 28 Days)||6
8236654|NCT01957202|20310411|P14|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236655|NCT01957202|20310412|P13|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236656|NCT01957202|20310413|P12|COMPLETED|Washout Period 2 (14 to 28 Days)||6
8236657|NCT01957202|20310414|P11|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236658|NCT01957202|20310415|P10|COMPLETED|Washout Period 2 (14 to 28 Days)||6
8236659|NCT01957202|20310416|P9|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236660|NCT01957202|20310417|P8|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236661|NCT01957202|20310418|P7|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236662|NCT01957202|20310419|P6|COMPLETED|Washout Period 2 (14 to 28 Days)||2
8236663|NCT01957202|20310420|P5|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236664|NCT01957202|20310421|P4|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236665|NCT01957202|20310422|P3|COMPLETED|Washout Period 2 (14 to 28 Days)||6
8236666|NCT01957202|20310423|P2|COMPLETED|Washout Period 2 (14 to 28 Days)||5
8236667|NCT01957202|20310424|P1|COMPLETED|Washout Period 2 (14 to 28 Days)||3
8236668|NCT01957202|20310407|P18|STARTED|Washout Period 2 (14 to 28 Days)||3
8236669|NCT01957202|20310408|P17|STARTED|Washout Period 2 (14 to 28 Days)||5
8236670|NCT01957202|20310409|P16|STARTED|Washout Period 2 (14 to 28 Days)||3
8236671|NCT01957202|20310410|P15|STARTED|Washout Period 2 (14 to 28 Days)||6
8236672|NCT01957202|20310411|P14|STARTED|Washout Period 2 (14 to 28 Days)||3
8236673|NCT01957202|20310412|P13|STARTED|Washout Period 2 (14 to 28 Days)||3
8236674|NCT01957202|20310413|P12|STARTED|Washout Period 2 (14 to 28 Days)||6
8236675|NCT01957202|20310414|P11|STARTED|Washout Period 2 (14 to 28 Days)||3
8236676|NCT01957202|20310415|P10|STARTED|Washout Period 2 (14 to 28 Days)||6
8236677|NCT01957202|20310416|P9|STARTED|Washout Period 2 (14 to 28 Days)||3
8236678|NCT01957202|20310417|P8|STARTED|Washout Period 2 (14 to 28 Days)||3
8236679|NCT01957202|20310418|P7|STARTED|Washout Period 2 (14 to 28 Days)||3
8236680|NCT01957202|20310419|P6|STARTED|Washout Period 2 (14 to 28 Days)||2
8236681|NCT01957202|20310420|P5|STARTED|Washout Period 2 (14 to 28 Days)||3
8236682|NCT01957202|20310421|P4|STARTED|Washout Period 2 (14 to 28 Days)||3
8236683|NCT01957202|20310422|P3|STARTED|Washout Period 2 (14 to 28 Days)||6
8236684|NCT01957202|20310423|P2|STARTED|Washout Period 2 (14 to 28 Days)||5
8236685|NCT01957202|20310424|P1|STARTED|Washout Period 2 (14 to 28 Days)||3
8236686|NCT01957202|20310407|P18|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236687|NCT01957202|20310408|P17|NOT COMPLETED|Treatment Period 2 (8 Days)||1
8236688|NCT01957202|20310409|P16|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236689|NCT01957202|20310410|P15|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236690|NCT01957202|20310411|P14|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236691|NCT01957202|20310412|P13|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236692|NCT01957202|20310413|P12|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236693|NCT01957202|20310414|P11|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236694|NCT01957202|20310415|P10|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236695|NCT01957202|20310416|P9|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236696|NCT01957202|20310417|P8|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236697|NCT01957202|20310418|P7|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236698|NCT01957202|20310419|P6|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236699|NCT01957202|20310420|P5|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236700|NCT01957202|20310421|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236701|NCT01957202|20310422|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236702|NCT01957202|20310423|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||1
8236703|NCT01957202|20310424|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
8236704|NCT01957202|20310407|P18|COMPLETED|Treatment Period 2 (8 Days)||3
8236705|NCT01957202|20310408|P17|COMPLETED|Treatment Period 2 (8 Days)||5
8236706|NCT01957202|20310409|P16|COMPLETED|Treatment Period 2 (8 Days)||3
8236707|NCT01957202|20310410|P15|COMPLETED|Treatment Period 2 (8 Days)||6
8236708|NCT01957202|20310411|P14|COMPLETED|Treatment Period 2 (8 Days)||3
8236709|NCT01957202|20310412|P13|COMPLETED|Treatment Period 2 (8 Days)||3
8236710|NCT01957202|20310413|P12|COMPLETED|Treatment Period 2 (8 Days)||6
8236711|NCT01957202|20310414|P11|COMPLETED|Treatment Period 2 (8 Days)||3
8236712|NCT01957202|20310415|P10|COMPLETED|Treatment Period 2 (8 Days)||6
8236713|NCT01957202|20310416|P9|COMPLETED|Treatment Period 2 (8 Days)||3
8236714|NCT01957202|20310417|P8|COMPLETED|Treatment Period 2 (8 Days)||3
8236715|NCT01957202|20310418|P7|COMPLETED|Treatment Period 2 (8 Days)||3
8236716|NCT01957202|20310419|P6|COMPLETED|Treatment Period 2 (8 Days)||2
8236717|NCT01957202|20310420|P5|COMPLETED|Treatment Period 2 (8 Days)||3
8236718|NCT01957202|20310421|P4|COMPLETED|Treatment Period 2 (8 Days)||3
8236719|NCT01957202|20310422|P3|COMPLETED|Treatment Period 2 (8 Days)||6
8236720|NCT01957202|20310423|P2|COMPLETED|Treatment Period 2 (8 Days)||5
8236721|NCT01957202|20310424|P1|COMPLETED|Treatment Period 2 (8 Days)||3
8236722|NCT01957202|20310407|P18|STARTED|Treatment Period 2 (8 Days)||3
8236723|NCT01957202|20310408|P17|STARTED|Treatment Period 2 (8 Days)||6
8236724|NCT01957202|20310409|P16|STARTED|Treatment Period 2 (8 Days)||3
8236725|NCT01957202|20310410|P15|STARTED|Treatment Period 2 (8 Days)||6
8236726|NCT01957202|20310411|P14|STARTED|Treatment Period 2 (8 Days)||3
8236727|NCT01957202|20310412|P13|STARTED|Treatment Period 2 (8 Days)||3
8236728|NCT01957202|20310413|P12|STARTED|Treatment Period 2 (8 Days)||6
8236729|NCT01957202|20310414|P11|STARTED|Treatment Period 2 (8 Days)||3
8236730|NCT01957202|20310415|P10|STARTED|Treatment Period 2 (8 Days)||6
8236731|NCT01957202|20310416|P9|STARTED|Treatment Period 2 (8 Days)||3
8236732|NCT01957202|20310417|P8|STARTED|Treatment Period 2 (8 Days)||3
8236733|NCT01957202|20310418|P7|STARTED|Treatment Period 2 (8 Days)||3
8236734|NCT01957202|20310419|P6|STARTED|Treatment Period 2 (8 Days)||2
8236735|NCT01957202|20310420|P5|STARTED|Treatment Period 2 (8 Days)||3
8236736|NCT01957202|20310421|P4|STARTED|Treatment Period 2 (8 Days)||3
8236737|NCT01957202|20310422|P3|STARTED|Treatment Period 2 (8 Days)||6
8236738|NCT01957202|20310423|P2|STARTED|Treatment Period 2 (8 Days)||6
8236739|NCT01957202|20310424|P1|STARTED|Treatment Period 2 (8 Days)||3
8236740|NCT01957202|20310407|P18|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236741|NCT01957202|20310408|P17|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236742|NCT01957202|20310409|P16|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236743|NCT01957202|20310410|P15|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236744|NCT01957202|20310411|P14|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236745|NCT01957202|20310412|P13|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236746|NCT01957202|20310413|P12|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236747|NCT01957202|20310414|P11|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236748|NCT01957202|20310415|P10|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236749|NCT01957202|20310416|P9|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236750|NCT01957202|20310417|P8|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236751|NCT01957202|20310418|P7|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236752|NCT01957202|20310419|P6|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236753|NCT01957202|20310420|P5|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236754|NCT01957202|20310421|P4|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236755|NCT01957202|20310422|P3|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236756|NCT01957202|20310423|P2|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236757|NCT01957202|20310424|P1|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
8236758|NCT01957202|20310407|P18|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236759|NCT01957202|20310408|P17|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8236760|NCT01957202|20310409|P16|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236761|NCT01957202|20310410|P15|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8236762|NCT01957202|20310411|P14|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236763|NCT01957202|20310412|P13|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236764|NCT01957202|20310413|P12|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8236765|NCT01957202|20310414|P11|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236766|NCT01957202|20310415|P10|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8236767|NCT01957202|20310416|P9|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236768|NCT01957202|20310417|P8|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236769|NCT01957202|20310418|P7|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236770|NCT01957202|20310419|P6|COMPLETED|Washout Period 1 (14 to 28 Days)||2
8236771|NCT01957202|20310420|P5|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236772|NCT01957202|20310421|P4|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236773|NCT01957202|20310422|P3|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8236774|NCT01957202|20310423|P2|COMPLETED|Washout Period 1 (14 to 28 Days)||6
8236775|NCT01957202|20310424|P1|COMPLETED|Washout Period 1 (14 to 28 Days)||3
8236776|NCT01957202|20310407|P18|STARTED|Washout Period 1 (14 to 28 Days)||3
8236777|NCT01957202|20310408|P17|STARTED|Washout Period 1 (14 to 28 Days)||6
8236778|NCT01957202|20310409|P16|STARTED|Washout Period 1 (14 to 28 Days)||3
8236779|NCT01957202|20310410|P15|STARTED|Washout Period 1 (14 to 28 Days)||6
8236780|NCT01957202|20310411|P14|STARTED|Washout Period 1 (14 to 28 Days)||3
8236781|NCT01957202|20310412|P13|STARTED|Washout Period 1 (14 to 28 Days)||3
8236782|NCT01957202|20310413|P12|STARTED|Washout Period 1 (14 to 28 Days)||6
8236783|NCT01957202|20310414|P11|STARTED|Washout Period 1 (14 to 28 Days)||3
8236784|NCT01957202|20310415|P10|STARTED|Washout Period 1 (14 to 28 Days)||6
8236785|NCT01957202|20310416|P9|STARTED|Washout Period 1 (14 to 28 Days)||3
8236786|NCT01957202|20310417|P8|STARTED|Washout Period 1 (14 to 28 Days)||3
8236787|NCT01957202|20310418|P7|STARTED|Washout Period 1 (14 to 28 Days)||3
8236788|NCT01957202|20310419|P6|STARTED|Washout Period 1 (14 to 28 Days)||2
8236789|NCT01957202|20310420|P5|STARTED|Washout Period 1 (14 to 28 Days)||3
8236790|NCT01957202|20310421|P4|STARTED|Washout Period 1 (14 to 28 Days)||3
8236791|NCT01957202|20310422|P3|STARTED|Washout Period 1 (14 to 28 Days)||6
8236792|NCT01957202|20310423|P2|STARTED|Washout Period 1 (14 to 28 Days)||6
8236793|NCT01957202|20310424|P1|STARTED|Washout Period 1 (14 to 28 Days)||3
8236794|NCT01957202|20310407|P18|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236795|NCT01957202|20310408|P17|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236796|NCT01957202|20310409|P16|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236797|NCT01957202|20310410|P15|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236798|NCT01957202|20310411|P14|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236799|NCT01957202|20310412|P13|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236800|NCT01957202|20310413|P12|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236801|NCT01957202|20310414|P11|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236802|NCT01957202|20310415|P10|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236803|NCT01957202|20310416|P9|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236804|NCT01957202|20310417|P8|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236805|NCT01957202|20310418|P7|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236806|NCT01957202|20310419|P6|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236807|NCT01957202|20310420|P5|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236808|NCT01957202|20310421|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236809|NCT01957202|20310422|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236810|NCT01957202|20310423|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236811|NCT01957202|20310424|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
8236812|NCT01957202|20310407|P18|COMPLETED|Treatment Period 1 (8 Days)||3
8236813|NCT01957202|20310408|P17|COMPLETED|Treatment Period 1 (8 Days)||6
8236814|NCT01957202|20310409|P16|COMPLETED|Treatment Period 1 (8 Days)||3
8236815|NCT01957202|20310410|P15|COMPLETED|Treatment Period 1 (8 Days)||6
8236816|NCT01957202|20310411|P14|COMPLETED|Treatment Period 1 (8 Days)||3
8236817|NCT01957202|20310412|P13|COMPLETED|Treatment Period 1 (8 Days)||3
8236818|NCT01957202|20310413|P12|COMPLETED|Treatment Period 1 (8 Days)||6
8236819|NCT01957202|20310414|P11|COMPLETED|Treatment Period 1 (8 Days)||3
8236820|NCT01957202|20310415|P10|COMPLETED|Treatment Period 1 (8 Days)||6
8236821|NCT01957202|20310416|P9|COMPLETED|Treatment Period 1 (8 Days)||3
8236822|NCT01957202|20310417|P8|COMPLETED|Treatment Period 1 (8 Days)||3
8236823|NCT01957202|20310418|P7|COMPLETED|Treatment Period 1 (8 Days)||3
8236824|NCT01957202|20310419|P6|COMPLETED|Treatment Period 1 (8 Days)||2
8236825|NCT01957202|20310420|P5|COMPLETED|Treatment Period 1 (8 Days)||3
8236826|NCT01957202|20310421|P4|COMPLETED|Treatment Period 1 (8 Days)||3
8236827|NCT01957202|20310422|P3|COMPLETED|Treatment Period 1 (8 Days)||6
8236828|NCT01957202|20310423|P2|COMPLETED|Treatment Period 1 (8 Days)||6
8236829|NCT01957202|20310424|P1|COMPLETED|Treatment Period 1 (8 Days)||3
8236830|NCT01957202|20310407|P18|STARTED|Treatment Period 1 (8 Days)||3
8236831|NCT01957202|20310408|P17|STARTED|Treatment Period 1 (8 Days)||6
8236832|NCT01957202|20310409|P16|STARTED|Treatment Period 1 (8 Days)||3
8236833|NCT01957202|20310410|P15|STARTED|Treatment Period 1 (8 Days)||6
8236834|NCT01957202|20310411|P14|STARTED|Treatment Period 1 (8 Days)||3
8236835|NCT01957202|20310412|P13|STARTED|Treatment Period 1 (8 Days)||3
8236836|NCT01957202|20310413|P12|STARTED|Treatment Period 1 (8 Days)||6
8236837|NCT01957202|20310414|P11|STARTED|Treatment Period 1 (8 Days)||3
8236838|NCT01957202|20310415|P10|STARTED|Treatment Period 1 (8 Days)||6
8236839|NCT01957202|20310416|P9|STARTED|Treatment Period 1 (8 Days)||3
8236840|NCT01957202|20310417|P8|STARTED|Treatment Period 1 (8 Days)||3
8236841|NCT01957202|20310418|P7|STARTED|Treatment Period 1 (8 Days)||3
8236842|NCT01957202|20310419|P6|STARTED|Treatment Period 1 (8 Days)||2
8236843|NCT01957202|20310420|P5|STARTED|Treatment Period 1 (8 Days)||3
8236844|NCT01957202|20310421|P4|STARTED|Treatment Period 1 (8 Days)||3
8236845|NCT01957202|20310422|P3|STARTED|Treatment Period 1 (8 Days)||6
8236846|NCT01957202|20310423|P2|STARTED|Treatment Period 1 (8 Days)||6
8236847|NCT01957202|20310424|P1|STARTED|Treatment Period 1 (8 Days)||3
8236848|NCT01957163|20310449|P3|NOT COMPLETED|Overall Study||18
8236849|NCT01957163|20310450|P2|NOT COMPLETED|Overall Study||11
8236850|NCT01957163|20310451|P1|NOT COMPLETED|Overall Study||15
8236851|NCT01957163|20310449|P3|COMPLETED|Overall Study||189
8236852|NCT01957163|20310450|P2|COMPLETED|Overall Study||195
8236853|NCT01957163|20310451|P1|COMPLETED|Overall Study||191
8236854|NCT01957163|20310449|P3|STARTED|Overall Study||207
8236855|NCT01957163|20310450|P2|STARTED|Overall Study||206
8236856|NCT01957163|20310451|P1|STARTED|Overall Study||206
8236857|NCT01957150|20310464|P2|NOT COMPLETED|Overall Study||58
8236858|NCT01957150|20310465|P1|NOT COMPLETED|Overall Study||55
8236859|NCT01957150|20310464|P2|COMPLETED|Overall Study||83
8236860|NCT01957150|20310465|P1|COMPLETED|Overall Study||87
8236861|NCT01957150|20310464|P2|STARTED|Overall Study||141
8236862|NCT01957150|20310465|P1|STARTED|Overall Study||142
8236863|NCT01957137|20310481|P1|NOT COMPLETED|No Stimulation||0
8236864|NCT01957137|20310481|P1|COMPLETED|No Stimulation||28
8236865|NCT01957137|20310481|P1|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
8236866|NCT01957137|20310481|P1|NOT COMPLETED|Randomized Portion||2
8236867|NCT01957137|20310481|P1|COMPLETED|Randomized Portion||28
8236868|NCT01957137|20310481|P1|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
8236869|NCT01957137|20310481|P1|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
8236870|NCT01957137|20310481|P1|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
8236871|NCT01957137|20310481|P1|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
8236872|NCT01957137|20310481|P1|STARTED|Randomized Portion||30
8236873|NCT01957111|20310511|P2|NOT COMPLETED|Overall Study||1
8236874|NCT01957111|20310512|P1|NOT COMPLETED|Overall Study||1
8236875|NCT01957111|20310511|P2|COMPLETED|Overall Study||15
8236876|NCT01957111|20310512|P1|COMPLETED|Overall Study||15
8236877|NCT01957111|20310511|P2|STARTED|Overall Study||16
8236878|NCT01957111|20310512|P1|STARTED|Overall Study||16
8236879|NCT01957085|20310520|P1|NOT COMPLETED|Overall Study||0
8236880|NCT01957085|20310520|P1|COMPLETED|Overall Study|Per Institutional Review Board, exact dates are not to be reported|366
8236881|NCT01957085|20310520|P1|STARTED|Overall Study|Per Institutional Review Board requirements, exact dates are not to be reported|366
8236882|NCT01956773|20310531|P2|NOT COMPLETED|Overall Study||1
8236883|NCT01956773|20310532|P1|NOT COMPLETED|Overall Study||628
8236884|NCT01956773|20310531|P2|COMPLETED|Overall Study||99
8236885|NCT01956773|20310532|P1|COMPLETED|Overall Study||1892
8236886|NCT01956773|20310531|P2|STARTED|Overall Study||100
8236887|NCT01956773|20310532|P1|STARTED|Overall Study||2520
8236888|NCT01956669|20310550|P7|NOT COMPLETED|Overall Study||6
8236889|NCT01956669|20310551|P6|NOT COMPLETED|Overall Study||4
8236890|NCT01956669|20310552|P5|NOT COMPLETED|Overall Study||4
8236891|NCT01956669|20310553|P4|NOT COMPLETED|Overall Study||10
8236892|NCT01956669|20310554|P3|NOT COMPLETED|Overall Study||10
8236893|NCT01956669|20310555|P2|NOT COMPLETED|Overall Study||11
8236894|NCT01956669|20310556|P1|NOT COMPLETED|Overall Study||12
8236895|NCT01956669|20310550|P7|COMPLETED|Overall Study||0
8236896|NCT01956669|20310551|P6|COMPLETED|Overall Study||0
8236897|NCT01956669|20310552|P5|COMPLETED|Overall Study||0
8236898|NCT01956669|20310553|P4|COMPLETED|Overall Study||0
8236899|NCT01956669|20310554|P3|COMPLETED|Overall Study||0
8236900|NCT01956669|20310555|P2|COMPLETED|Overall Study||0
8236901|NCT01956669|20310556|P1|COMPLETED|Overall Study||0
8236902|NCT01956669|20310550|P7|Per Protocol Set (PP Set)|Overall Study||5
8236903|NCT01956669|20310551|P6|Per Protocol Set (PP Set)|Overall Study||4
8236904|NCT01956669|20310552|P5|Per Protocol Set (PP Set)|Overall Study||4
8236905|NCT01956669|20310553|P4|Per Protocol Set (PP Set)|Overall Study||9
8236906|NCT01956669|20310554|P3|Per Protocol Set (PP Set)|Overall Study||6
8236907|NCT01956669|20310555|P2|Per Protocol Set (PP Set)|Overall Study||10
8236908|NCT01956669|20310556|P1|Per Protocol Set (PP Set)|Overall Study||9
8236909|NCT01956669|20310550|P7|Biomarker Set|Overall Study||3
8236910|NCT01956669|20310551|P6|Biomarker Set|Overall Study||4
8236911|NCT01956669|20310552|P5|Biomarker Set|Overall Study||3
8236912|NCT01956669|20310553|P4|Biomarker Set|Overall Study||9
8236913|NCT01956669|20310554|P3|Biomarker Set|Overall Study||9
8236914|NCT01956669|20310555|P2|Biomarker Set|Overall Study||11
8236915|NCT01956669|20310556|P1|Biomarker Set|Overall Study||12
8236916|NCT01956669|20310550|P7|PKES Set|Overall Study||5
8236917|NCT01956669|20310551|P6|PKES Set|Overall Study||1
8236918|NCT01956669|20310552|P5|PKES Set|Overall Study||1
8236919|NCT01956669|20310553|P4|PKES Set|Overall Study||0
8236920|NCT01956669|20310554|P3|PKES Set|Overall Study||3
8236921|NCT01956669|20310555|P2|PKES Set|Overall Study||0
8236922|NCT01956669|20310556|P1|PKES Set|Overall Study||4
8236923|NCT01956669|20310550|P7|PK Set|Overall Study||6
8236924|NCT01956669|20310551|P6|PK Set|Overall Study||4
8236925|NCT01956669|20310552|P5|PK Set|Overall Study||4
8236926|NCT01956669|20310553|P4|PK Set|Overall Study||10
8236927|NCT01956669|20310554|P3|PK Set|Overall Study||10
8236928|NCT01956669|20310555|P2|PK Set|Overall Study||11
8236929|NCT01956669|20310556|P1|PK Set|Overall Study||11
8236930|NCT01956669|20310550|P7|STARTED|Overall Study||6
8236931|NCT01956669|20310551|P6|STARTED|Overall Study||4
8236932|NCT01956669|20310552|P5|STARTED|Overall Study||4
8236933|NCT01956669|20310553|P4|STARTED|Overall Study||10
8236934|NCT01956669|20310554|P3|STARTED|Overall Study||10
8236935|NCT01956669|20310555|P2|STARTED|Overall Study||11
8236936|NCT01956669|20310556|P1|STARTED|Overall Study||12
8236937|NCT01956435|20310651|P2|NOT COMPLETED|Overall Study||0
8236938|NCT01956435|20310652|P1|NOT COMPLETED|Overall Study||0
8236939|NCT01956435|20310651|P2|COMPLETED|Overall Study||3
8236940|NCT01956435|20310652|P1|COMPLETED|Overall Study||3
8236941|NCT01956435|20310651|P2|STARTED|Overall Study||3
8236942|NCT01956435|20310652|P1|STARTED|Overall Study||3
8236943|NCT01956279|20310661|P2|NOT COMPLETED|Overall Study||14
8236944|NCT01956279|20310662|P1|NOT COMPLETED|Overall Study||14
8236945|NCT01956279|20310661|P2|COMPLETED|Overall Study||74
8236946|NCT01956279|20310662|P1|COMPLETED|Overall Study||68
8236947|NCT01956279|20310661|P2|STARTED|Overall Study||88
8236948|NCT01956279|20310662|P1|STARTED|Overall Study||82
8236949|NCT01956240|20310678|P2|NOT COMPLETED|Overall Study||24
8236950|NCT01956240|20310679|P1|NOT COMPLETED|Overall Study||23
8236951|NCT01956240|20310678|P2|COMPLETED|Overall Study||25
8236952|NCT01956240|20310679|P1|COMPLETED|Overall Study||25
8236953|NCT01956240|20310678|P2|STARTED|Overall Study||49
8236954|NCT01956240|20310679|P1|STARTED|Overall Study||48
8236985|NCT01956097|20310798|P3|NOT COMPLETED|Overall Study||0
8236986|NCT01956097|20310799|P2|NOT COMPLETED|Overall Study||2
8236987|NCT01956097|20310800|P1|NOT COMPLETED|Overall Study||6
8236988|NCT01956097|20310798|P3|COMPLETED|Overall Study||15
8236989|NCT01956097|20310799|P2|COMPLETED|Overall Study||28
8236990|NCT01956097|20310800|P1|COMPLETED|Overall Study||24
8236991|NCT01956097|20310798|P3|STARTED|Overall Study||15
8236992|NCT01956097|20310799|P2|STARTED|Overall Study||30
8236993|NCT01956097|20310800|P1|STARTED|Overall Study||30
8236994|NCT01956071|20310817|P1|NOT COMPLETED|Overall Study||0
8236995|NCT01956071|20310817|P1|COMPLETED|Overall Study||44
8236996|NCT01956071|20310817|P1|STARTED|Overall Study||44
8236997|NCT01956032|20310821|P1|NOT COMPLETED|Overall Study||0
8236998|NCT01956032|20310821|P1|COMPLETED|Overall Study||15
8236999|NCT01956032|20310821|P1|STARTED|Overall Study||15
8237000|NCT01955954|20310868|P1|NOT COMPLETED|Overall Study||36
8237001|NCT01955954|20310868|P1|COMPLETED|Overall Study|12-months|33
8237002|NCT01955954|20310868|P1|Completed 6-month Assessement|Overall Study||42
8237003|NCT01955954|20310868|P1|Completed 2-month Assessment|Overall Study|Primary endpoint|46
8237004|NCT01955954|20310868|P1|Completed Post-treatment Assessement|Overall Study||48
8237005|NCT01955954|20310868|P1|Completed Treatment|Overall Study||53
8237006|NCT01955954|20310868|P1|Received Treatment|Overall Study||66
8237007|NCT01955954|20310868|P1|STARTED|Overall Study||69
8237008|NCT01955837|20310879|P2|NOT COMPLETED|Overall Study||0
8237009|NCT01955837|20310880|P1|NOT COMPLETED|Overall Study||0
8237010|NCT01955837|20310879|P2|COMPLETED|Overall Study||135
8237011|NCT01955837|20310880|P1|COMPLETED|Overall Study||271
8237012|NCT01955837|20310879|P2|STARTED|Overall Study||135
8237013|NCT01955837|20310880|P1|STARTED|Overall Study||271
8237014|NCT01955733|20310911|P3|NOT COMPLETED|Period 2||21
8237015|NCT01955733|20310912|P2|NOT COMPLETED|Period 2||19
8237016|NCT01955733|20310913|P1|NOT COMPLETED|Period 2||12
8237017|NCT01955733|20310911|P3|COMPLETED|Period 2||8
8237018|NCT01955733|20310912|P2|COMPLETED|Period 2||10
8237019|NCT01955733|20310913|P1|COMPLETED|Period 2||20
8237020|NCT01955733|20310911|P3|STARTED|Period 2||29
8237021|NCT01955733|20310912|P2|STARTED|Period 2||29
8237022|NCT01955733|20310913|P1|STARTED|Period 2||32
8237023|NCT01955733|20310911|P3|NOT COMPLETED|Period 1||0
8237024|NCT01955733|20310912|P2|NOT COMPLETED|Period 1||0
8237025|NCT01955733|20310913|P1|NOT COMPLETED|Period 1||1
8237026|NCT01955733|20310911|P3|COMPLETED|Period 1||29
8237027|NCT01955733|20310912|P2|COMPLETED|Period 1||29
8237028|NCT01955733|20310913|P1|COMPLETED|Period 1||32
8237029|NCT01955733|20310911|P3|STARTED|Period 1||29
8237030|NCT01955733|20310912|P2|STARTED|Period 1||29
8237031|NCT01955733|20310913|P1|STARTED|Period 1||33
8237032|NCT01955720|20310933|P6|NOT COMPLETED|Overall Study||0
8237033|NCT01955720|20310934|P5|NOT COMPLETED|Overall Study||0
8237034|NCT01955720|20310935|P4|NOT COMPLETED|Overall Study||0
8237035|NCT01955720|20310936|P3|NOT COMPLETED|Overall Study||0
8237036|NCT01955720|20310937|P2|NOT COMPLETED|Overall Study||0
8237037|NCT01955720|20310938|P1|NOT COMPLETED|Overall Study||0
8237038|NCT01955720|20310933|P6|COMPLETED|Overall Study||7
8237039|NCT01955720|20310934|P5|COMPLETED|Overall Study||7
8237040|NCT01955720|20310935|P4|COMPLETED|Overall Study||3
8237041|NCT01955720|20310936|P3|COMPLETED|Overall Study||3
8237042|NCT01955720|20310937|P2|COMPLETED|Overall Study||13
8237043|NCT01955720|20310938|P1|COMPLETED|Overall Study||13
8237044|NCT01955720|20310933|P6|Subjects With Moderate Renal Impairment|Overall Study||0
8237045|NCT01955720|20310934|P5|Subjects With Moderate Renal Impairment|Overall Study||0
8237046|NCT01955720|20310935|P4|Subjects With Moderate Renal Impairment|Overall Study||0
8237047|NCT01955720|20310936|P3|Subjects With Moderate Renal Impairment|Overall Study||0
8237048|NCT01955720|20310937|P2|Subjects With Moderate Renal Impairment|Overall Study||3
8237049|NCT01955720|20310938|P1|Subjects With Moderate Renal Impairment|Overall Study||3
8237050|NCT01955720|20310933|P6|Subjects With Mild Renal Impairment|Overall Study||3
8237051|NCT01955720|20310934|P5|Subjects With Mild Renal Impairment|Overall Study||3
8237052|NCT01955720|20310935|P4|Subjects With Mild Renal Impairment|Overall Study||0
8237053|NCT01955720|20310936|P3|Subjects With Mild Renal Impairment|Overall Study||0
8237054|NCT01955720|20310937|P2|Subjects With Mild Renal Impairment|Overall Study||3
8237055|NCT01955720|20310938|P1|Subjects With Mild Renal Impairment|Overall Study||3
8237056|NCT01955720|20310933|P6|Healthy Subjects Aged 65-80|Overall Study||4
8237057|NCT01955720|20310934|P5|Healthy Subjects Aged 65-80|Overall Study||4
8237058|NCT01955720|20310935|P4|Healthy Subjects Aged 65-80|Overall Study||0
8237059|NCT01955720|20310936|P3|Healthy Subjects Aged 65-80|Overall Study||0
8237060|NCT01955720|20310937|P2|Healthy Subjects Aged 65-80|Overall Study||4
8237061|NCT01955720|20310938|P1|Healthy Subjects Aged 65-80|Overall Study||4
8237062|NCT01955720|20310933|P6|Healthy Subjects Aged 45-64|Overall Study||0
8237063|NCT01955720|20310934|P5|Healthy Subjects Aged 45-64|Overall Study||0
8237064|NCT01955720|20310935|P4|Healthy Subjects Aged 45-64|Overall Study||3
8237065|NCT01955720|20310936|P3|Healthy Subjects Aged 45-64|Overall Study||3
8237066|NCT01955720|20310937|P2|Healthy Subjects Aged 45-64|Overall Study||3
8237067|NCT01955720|20310938|P1|Healthy Subjects Aged 45-64|Overall Study||3
8237068|NCT01955720|20310933|P6|STARTED|Overall Study||7
8237069|NCT01955720|20310934|P5|STARTED|Overall Study||7
8237070|NCT01955720|20310935|P4|STARTED|Overall Study||3
8237071|NCT01955720|20310936|P3|STARTED|Overall Study||3
8237072|NCT01955720|20310937|P2|STARTED|Overall Study||13
8237073|NCT01955720|20310938|P1|STARTED|Overall Study||13
8237074|NCT01955707|20311006|P2|NOT COMPLETED|Overall Study||22
8237075|NCT01955707|20311007|P1|NOT COMPLETED|Overall Study||20
8237076|NCT01955707|20311006|P2|COMPLETED|Overall Study||57
8237077|NCT01955707|20311007|P1|COMPLETED|Overall Study||62
8237078|NCT01955707|20311006|P2|Received Total Volume of Study Drug|Overall Study||77
8237079|NCT01955707|20311007|P1|Received Total Volume of Study Drug|Overall Study||82
8237080|NCT01955707|20311006|P2|Dosed|Overall Study||78
8237081|NCT01955707|20311007|P1|Dosed|Overall Study||82
8237082|NCT01955707|20311006|P2|Withdrew Prior to Dosing|Overall Study||1
8237083|NCT01955707|20311007|P1|Withdrew Prior to Dosing|Overall Study||0
8237084|NCT01955707|20311006|P2|STARTED|Overall Study||79
8237085|NCT01955707|20311007|P1|STARTED|Overall Study||82
8237086|NCT01955629|20311031|P1|NOT COMPLETED|Overall Study||0
8237087|NCT01955629|20311031|P1|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
8237088|NCT01955629|20311031|P1|STARTED|Overall Study||4
8237089|NCT01955564|20311050|P7|NOT COMPLETED|Overall Study||0
8237090|NCT01955564|20311051|P6|NOT COMPLETED|Overall Study||0
8237091|NCT01955564|20311052|P5|NOT COMPLETED|Overall Study||0
8237092|NCT01955564|20311053|P4|NOT COMPLETED|Overall Study||0
8237093|NCT01955564|20311054|P3|NOT COMPLETED|Overall Study||0
8237094|NCT01955564|20311055|P2|NOT COMPLETED|Overall Study||0
8237095|NCT01955564|20311056|P1|NOT COMPLETED|Overall Study||0
8237096|NCT01955564|20311050|P7|COMPLETED|Overall Study||6
8237097|NCT01955564|20311051|P6|COMPLETED|Overall Study||6
8237098|NCT01955564|20311052|P5|COMPLETED|Overall Study||6
8237099|NCT01955564|20311053|P4|COMPLETED|Overall Study||6
8237100|NCT01955564|20311054|P3|COMPLETED|Overall Study||6
8237101|NCT01955564|20311055|P2|COMPLETED|Overall Study||6
8237102|NCT01955564|20311056|P1|COMPLETED|Overall Study||18
8237103|NCT01955564|20311050|P7|STARTED|Overall Study||6
8237104|NCT01955564|20311051|P6|STARTED|Overall Study||6
8237105|NCT01955564|20311052|P5|STARTED|Overall Study||6
8237106|NCT01955564|20311053|P4|STARTED|Overall Study||6
8237107|NCT01955564|20311054|P3|STARTED|Overall Study||6
8237108|NCT01955564|20311055|P2|STARTED|Overall Study||6
8237109|NCT01955564|20311056|P1|STARTED|Overall Study||18
8237110|NCT01955473|20311089|P5|NOT COMPLETED|Overall Study||0
8237111|NCT01955473|20311090|P4|NOT COMPLETED|Overall Study||0
8237112|NCT01955473|20311091|P3|NOT COMPLETED|Overall Study||0
8237113|NCT01955473|20311092|P2|NOT COMPLETED|Overall Study||0
8237114|NCT01955473|20311093|P1|NOT COMPLETED|Overall Study||0
8237115|NCT01955473|20311089|P5|COMPLETED|Overall Study||30
8237116|NCT01955473|20311090|P4|COMPLETED|Overall Study||6
8237117|NCT01955473|20311091|P3|COMPLETED|Overall Study||6
8237118|NCT01955473|20311092|P2|COMPLETED|Overall Study||6
8237119|NCT01955473|20311093|P1|COMPLETED|Overall Study||3
8237120|NCT01955473|20311089|P5|STARTED|Overall Study||30
8237121|NCT01955473|20311090|P4|STARTED|Overall Study||6
8237122|NCT01955473|20311091|P3|STARTED|Overall Study||6
8237123|NCT01955473|20311092|P2|STARTED|Overall Study||6
8237124|NCT01955473|20311093|P1|STARTED|Overall Study||3
8237125|NCT01955434|20311247|P1|NOT COMPLETED|Overall Study||0
8237126|NCT01955434|20311247|P1|COMPLETED|Overall Study||25
8237127|NCT01955434|20311247|P1|STARTED|Overall Study||25
8237128|NCT01955382|20311257|P2|NOT COMPLETED|Overall Study||0
8237129|NCT01955382|20311258|P1|NOT COMPLETED|Overall Study||0
8237130|NCT01955382|20311257|P2|COMPLETED|Overall Study||35
8237131|NCT01955382|20311258|P1|COMPLETED|Overall Study||35
8237132|NCT01955382|20311257|P2|STARTED|Overall Study||35
8237133|NCT01955382|20311258|P1|STARTED|Overall Study||35
8237134|NCT01955369|20311266|P1|NOT COMPLETED|Overall Study||0
8237135|NCT01955369|20311266|P1|COMPLETED|Overall Study||200
8237136|NCT01955369|20311266|P1|STARTED|Overall Study||200
8237137|NCT01955161|20311275|P3|NOT COMPLETED|Overall Study||35
8237138|NCT01955161|20311276|P2|NOT COMPLETED|Overall Study||25
8237139|NCT01955161|20311277|P1|NOT COMPLETED|Overall Study||27
8237140|NCT01955161|20311275|P3|COMPLETED|Overall Study||275
8237141|NCT01955161|20311276|P2|COMPLETED|Overall Study||288
8237142|NCT01955161|20311277|P1|COMPLETED|Overall Study||283
8237143|NCT01955161|20311275|P3|Treated|Overall Study||309
8237144|NCT01955161|20311276|P2|Treated|Overall Study||313
8237145|NCT01955161|20311277|P1|Treated|Overall Study||308
8237146|NCT01955161|20311275|P3|STARTED|Overall Study||310
8237147|NCT01955161|20311276|P2|STARTED|Overall Study||313
8237148|NCT01955161|20311277|P1|STARTED|Overall Study||310
8237149|NCT01955122|20311317|P2|NOT COMPLETED|Overall Study||5
8237150|NCT01955122|20311318|P1|NOT COMPLETED|Overall Study||5
8237151|NCT01955122|20311317|P2|COMPLETED|Overall Study||57
8237152|NCT01955122|20311318|P1|COMPLETED|Overall Study||59
8237153|NCT01955122|20311317|P2|No. Patients Completed Double Procedure|Overall Study||57
8237154|NCT01955122|20311318|P1|No. Patients Completed Double Procedure|Overall Study||59
8237155|NCT01955122|20311317|P2|No.Patients Enrolled|Overall Study||62
8237156|NCT01955122|20311318|P1|No.Patients Enrolled|Overall Study||64
8237157|NCT01955122|20311317|P2|STARTED|Overall Study|"Excluded (n = 5)
~Included in analysis (n = 57)"|62
8237158|NCT01955122|20311318|P1|STARTED|Overall Study|"Excluded (n = 5)
~Included in analysis (n = 59)"|64
8237159|NCT01955083|20311338|P2|NOT COMPLETED|Overall Study||1
8237160|NCT01955083|20311339|P1|NOT COMPLETED|Overall Study||1
8237161|NCT01955083|20311338|P2|COMPLETED|Overall Study||14
8237162|NCT01955083|20311339|P1|COMPLETED|Overall Study||14
8237163|NCT01955083|20311338|P2|STARTED|Overall Study||15
8237164|NCT01955083|20311339|P1|STARTED|Overall Study||15
8237165|NCT01955044|20311372|P3|NOT COMPLETED|Overall Study||0
8237166|NCT01955044|20311373|P2|NOT COMPLETED|Overall Study||1
8237167|NCT01955044|20311374|P1|NOT COMPLETED|Overall Study||1
8237168|NCT01955044|20311372|P3|COMPLETED|Overall Study||10
8237169|NCT01955044|20311373|P2|COMPLETED|Overall Study||9
8237170|NCT01955044|20311374|P1|COMPLETED|Overall Study||9
8237171|NCT01955044|20311372|P3|STARTED|Overall Study||10
8237172|NCT01955044|20311373|P2|STARTED|Overall Study||10
8237173|NCT01955044|20311374|P1|STARTED|Overall Study||10
8237174|NCT01955005|20311387|P2|NOT COMPLETED|Overall Study||5
8237175|NCT01955005|20311388|P1|NOT COMPLETED|Overall Study||3
8237176|NCT01955005|20311387|P2|COMPLETED|Overall Study||25
8237177|NCT01955005|20311388|P1|COMPLETED|Overall Study||27
8237178|NCT01955005|20311387|P2|STARTED|Overall Study||30
8237179|NCT01955005|20311388|P1|STARTED|Overall Study||30
8237180|NCT01954927|20311400|P2|NOT COMPLETED|Overall Study||1
8237181|NCT01954927|20311401|P1|NOT COMPLETED|Overall Study||3
8237182|NCT01954927|20311400|P2|COMPLETED|Overall Study||44
8237183|NCT01954927|20311401|P1|COMPLETED|Overall Study||42
8237184|NCT01954927|20311400|P2|STARTED|Overall Study||45
8237185|NCT01954927|20311401|P1|STARTED|Overall Study||45
8237186|NCT01954771|20311422|P3|NOT COMPLETED|Overall Study||3
8237187|NCT01954771|20311423|P2|NOT COMPLETED|Overall Study||3
8237188|NCT01954771|20311424|P1|NOT COMPLETED|Overall Study||7
8237189|NCT01954771|20311422|P3|COMPLETED|Overall Study||25
8237190|NCT01954771|20311423|P2|COMPLETED|Overall Study||29
8237191|NCT01954771|20311424|P1|COMPLETED|Overall Study||22
8237192|NCT01954771|20311422|P3|STARTED|Overall Study||28
8237193|NCT01954771|20311423|P2|STARTED|Overall Study||32
8237194|NCT01954771|20311424|P1|STARTED|Overall Study||29
8237195|NCT01954745|20311441|P1|NOT COMPLETED|Overall Study||19
8237196|NCT01954745|20311441|P1|COMPLETED|Overall Study||0
8237197|NCT01954745|20311441|P1|STARTED|Overall Study||19
8237198|NCT01954628|20311450|P2|NOT COMPLETED|Overall Study||27
8237199|NCT01954628|20311451|P1|NOT COMPLETED|Overall Study||31
8237200|NCT01954628|20311450|P2|COMPLETED|Overall Study||173
8237201|NCT01954628|20311451|P1|COMPLETED|Overall Study||169
8237202|NCT01954628|20311450|P2|US 6 Month Ophthalmology Safety Visit|Overall Study||32
8237203|NCT01954628|20311451|P1|US 6 Month Ophthalmology Safety Visit|Overall Study||37
8237204|NCT01954628|20311450|P2|Pharmacokinetic Population|Overall Study||0
8237205|NCT01954628|20311451|P1|Pharmacokinetic Population|Overall Study||181
8237206|NCT01954628|20311450|P2|Safety Set|Overall Study||200
8237207|NCT01954628|20311451|P1|Safety Set|Overall Study||200
8237208|NCT01954628|20311450|P2|Full Analysis Set (FAS)|Overall Study||198
8237209|NCT01954628|20311451|P1|Full Analysis Set (FAS)|Overall Study||200
8237210|NCT01954628|20311450|P2|STARTED|Overall Study||200
8237211|NCT01954628|20311451|P1|STARTED|Overall Study||200
8237212|NCT01954394|20311472|P2|NOT COMPLETED|Overall Study||57
8237213|NCT01954394|20311473|P1|NOT COMPLETED|Overall Study||30
8237214|NCT01954394|20311472|P2|COMPLETED|Overall Study||598
8237215|NCT01954394|20311473|P1|COMPLETED|Overall Study||301
8237216|NCT01954394|20311472|P2|Treated|Overall Study|Safety population|655
8237217|NCT01954394|20311473|P1|Treated|Overall Study|Safety population|330
8237218|NCT01954394|20311472|P2|STARTED|Overall Study|Enrolled|655
8237219|NCT01954394|20311473|P1|STARTED|Overall Study|Enrolled|331
8237220|NCT01954342|20311527|P4|NOT COMPLETED|Overall Study||18
8237221|NCT01954342|20311528|P3|NOT COMPLETED|Overall Study||0
8237222|NCT01954342|20311529|P2|NOT COMPLETED|Overall Study||0
8237223|NCT01954342|20311530|P1|NOT COMPLETED|Overall Study||0
8237224|NCT01954342|20311527|P4|COMPLETED|Overall Study||0
8237225|NCT01954342|20311528|P3|COMPLETED|Overall Study||10
8237226|NCT01954342|20311529|P2|COMPLETED|Overall Study||8
8237227|NCT01954342|20311530|P1|COMPLETED|Overall Study||36
8237228|NCT01954342|20311527|P4|STARTED|Overall Study||18
8237229|NCT01954342|20311528|P3|STARTED|Overall Study||10
8237230|NCT01954342|20311529|P2|STARTED|Overall Study||8
8237231|NCT01954342|20311530|P1|STARTED|Overall Study||36
8237232|NCT01954264|20311580|P1|NOT COMPLETED|Overall Study||0
8237233|NCT01954264|20311580|P1|COMPLETED|Overall Study||2421
8237234|NCT01954264|20311580|P1|STARTED|Overall Study||2421
8237235|NCT01954251|20311632|P2|NOT COMPLETED|Overall Study||19
8237236|NCT01954251|20311633|P1|NOT COMPLETED|Overall Study||13
8237237|NCT01954251|20311632|P2|COMPLETED|Overall Study||396
8237238|NCT01954251|20311633|P1|COMPLETED|Overall Study||400
8237239|NCT01954251|20311632|P2|STARTED|Overall Study||415
8237240|NCT01954251|20311633|P1|STARTED|Overall Study||413
8237241|NCT01954160|20311669|P2|NOT COMPLETED|Overall Study||0
8237242|NCT01954160|20311670|P1|NOT COMPLETED|Overall Study||5
8237243|NCT01954160|20311669|P2|COMPLETED|Overall Study||0
8237244|NCT01954160|20311670|P1|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
8237245|NCT01954160|20311669|P2|STARTED|Overall Study|Not started|0
8237246|NCT01954160|20311670|P1|STARTED|Overall Study||5
8237247|NCT01954121|20311730|P2|NOT COMPLETED|Overall Study||91
8237248|NCT01954121|20311731|P1|NOT COMPLETED|Overall Study||127
8237249|NCT01954121|20311730|P2|COMPLETED|Overall Study||125
8237250|NCT01954121|20311731|P1|COMPLETED|Overall Study||93
8237251|NCT01954121|20311730|P2|STARTED|Overall Study||216
8237252|NCT01954121|20311731|P1|STARTED|Overall Study||220
8237253|NCT01954082|20311747|P2|NOT COMPLETED|Overall Study||57
8237254|NCT01954082|20311748|P1|NOT COMPLETED|Overall Study||68
8237255|NCT01954082|20311747|P2|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
8237256|NCT01954082|20311748|P1|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
8237257|NCT01954082|20311747|P2|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
8237258|NCT01954082|20311748|P1|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
8237259|NCT01954082|20311747|P2|STARTED|Overall Study||321
8237260|NCT01954082|20311748|P1|STARTED|Overall Study||317
8237273|NCT01954017|20311814|P3|NOT COMPLETED|Overall Study||13
8237274|NCT01954017|20311815|P2|NOT COMPLETED|Overall Study||8
8237275|NCT01954017|20311816|P1|NOT COMPLETED|Overall Study||5
8237276|NCT01954017|20311814|P3|COMPLETED|Overall Study||21
8237277|NCT01954017|20311815|P2|COMPLETED|Overall Study||25
8237278|NCT01954017|20311816|P1|COMPLETED|Overall Study||31
8237279|NCT01954017|20311814|P3|STARTED|Overall Study||34
8237280|NCT01954017|20311815|P2|STARTED|Overall Study||33
8237281|NCT01954017|20311816|P1|STARTED|Overall Study||36
8237282|NCT01953913|20312042|P1|NOT COMPLETED|Overall Study||542
8237283|NCT01953913|20312042|P1|COMPLETED|Overall Study||0
8237284|NCT01953913|20312042|P1|Treated|Overall Study||541
8237285|NCT01953913|20312042|P1|STARTED|Overall Study||542
8237286|NCT01953874|20312050|P2|NOT COMPLETED|Overall Study||0
8237287|NCT01953874|20312051|P1|NOT COMPLETED|Overall Study||0
8237288|NCT01953874|20312050|P2|COMPLETED|Overall Study||61
8237289|NCT01953874|20312051|P1|COMPLETED|Overall Study||65
8237290|NCT01953874|20312050|P2|STARTED|Overall Study||61
8237291|NCT01953874|20312051|P1|STARTED|Overall Study||65
8237292|NCT01953783|20312094|P1|NOT COMPLETED|Overall Study||2
8237293|NCT01953783|20312094|P1|COMPLETED|Overall Study||5
8237294|NCT01953783|20312094|P1|STARTED|Overall Study||7
8237295|NCT01953601|20312119|P3|NOT COMPLETED|Part 2 (Extension Study)||204
8237296|NCT01953601|20312120|P2|NOT COMPLETED|Part 2 (Extension Study)||191
8237297|NCT01953601|20312121|P1|NOT COMPLETED|Part 2 (Extension Study)||198
8237298|NCT01953601|20312119|P3|COMPLETED|Part 2 (Extension Study)||0
8237299|NCT01953601|20312120|P2|COMPLETED|Part 2 (Extension Study)||0
8237300|NCT01953601|20312121|P1|COMPLETED|Part 2 (Extension Study)||0
8237301|NCT01953601|20312119|P3|Treated|Part 2 (Extension Study)||204
8237302|NCT01953601|20312120|P2|Treated|Part 2 (Extension Study)||191
8237303|NCT01953601|20312121|P1|Treated|Part 2 (Extension Study)||197
8237304|NCT01953601|20312119|P3|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204
8237305|NCT01953601|20312120|P2|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191
8237306|NCT01953601|20312121|P1|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198
8237307|NCT01953601|20312119|P3|NOT COMPLETED|Part 1 (Base Study)||246
8237308|NCT01953601|20312120|P2|NOT COMPLETED|Part 1 (Base Study)||253
8237309|NCT01953601|20312121|P1|NOT COMPLETED|Part 1 (Base Study)||251
8237310|NCT01953601|20312119|P3|COMPLETED|Part 1 (Base Study)||239
8237311|NCT01953601|20312120|P2|COMPLETED|Part 1 (Base Study)||231
8237312|NCT01953601|20312121|P1|COMPLETED|Part 1 (Base Study)||234
8237313|NCT01953601|20312119|P3|Treated|Part 1 (Base Study)||484
8237314|NCT01953601|20312120|P2|Treated|Part 1 (Base Study)||484
8237315|NCT01953601|20312121|P1|Treated|Part 1 (Base Study)||483
8237316|NCT01953601|20312119|P3|STARTED|Part 1 (Base Study)||485
8237317|NCT01953601|20312120|P2|STARTED|Part 1 (Base Study)||484
8237318|NCT01953601|20312121|P1|STARTED|Part 1 (Base Study)||485
8237319|NCT01953575|20312171|P3|NOT COMPLETED|Overall Study||0
8237320|NCT01953575|20312172|P2|NOT COMPLETED|Overall Study||0
8237321|NCT01953575|20312173|P1|NOT COMPLETED|Overall Study||0
8237322|NCT01953575|20312171|P3|COMPLETED|Overall Study||10
8237323|NCT01953575|20312172|P2|COMPLETED|Overall Study||10
8237324|NCT01953575|20312173|P1|COMPLETED|Overall Study||10
8237325|NCT01953575|20312171|P3|STARTED|Overall Study||10
8237326|NCT01953575|20312172|P2|STARTED|Overall Study||10
8237327|NCT01953575|20312173|P1|STARTED|Overall Study||10
8237328|NCT01953432|20312183|P2|NOT COMPLETED|Overall Study||15
8237329|NCT01953432|20312184|P1|NOT COMPLETED|Overall Study||14
8237330|NCT01953432|20312183|P2|COMPLETED|Overall Study||6
8237331|NCT01953432|20312184|P1|COMPLETED|Overall Study||8
8237332|NCT01953432|20312183|P2|STARTED|Overall Study||21
8237333|NCT01953432|20312184|P1|STARTED|Overall Study||22
8237334|NCT01953354|20312192|P2|NOT COMPLETED|Overall Study||2
8237335|NCT01953354|20312193|P1|NOT COMPLETED|Overall Study||1
8237336|NCT01953354|20312192|P2|COMPLETED|Overall Study||5
8237337|NCT01953354|20312193|P1|COMPLETED|Overall Study||8
8237338|NCT01953354|20312192|P2|STARTED|Overall Study||7
8237339|NCT01953354|20312193|P1|STARTED|Overall Study||9
8237340|NCT01953328|20312221|P8|NOT COMPLETED|Overall Study||0
8237341|NCT01953328|20312222|P7|NOT COMPLETED|Overall Study||0
8237342|NCT01953328|20312223|P6|NOT COMPLETED|Overall Study||0
8237343|NCT01953328|20312224|P5|NOT COMPLETED|Overall Study||2
8237344|NCT01953328|20312225|P4|NOT COMPLETED|Overall Study||0
8237345|NCT01953328|20312226|P3|NOT COMPLETED|Overall Study||0
8237346|NCT01953328|20312227|P2|NOT COMPLETED|Overall Study||0
8237347|NCT01953328|20312228|P1|NOT COMPLETED|Overall Study||0
8237348|NCT01953328|20312221|P8|COMPLETED|Overall Study||51
8237349|NCT01953328|20312222|P7|COMPLETED|Overall Study||51
8237350|NCT01953328|20312223|P6|COMPLETED|Overall Study||51
8237351|NCT01953328|20312224|P5|COMPLETED|Overall Study||50
8237352|NCT01953328|20312225|P4|COMPLETED|Overall Study||50
8237353|NCT01953328|20312226|P3|COMPLETED|Overall Study||50
8237354|NCT01953328|20312227|P2|COMPLETED|Overall Study||50
8237355|NCT01953328|20312228|P1|COMPLETED|Overall Study||49
8237356|NCT01953328|20312221|P8|Received Treatment|Overall Study||51
8237357|NCT01953328|20312222|P7|Received Treatment|Overall Study||51
8237358|NCT01953328|20312223|P6|Received Treatment|Overall Study||51
8237359|NCT01953328|20312224|P5|Received Treatment|Overall Study||52
8237360|NCT01953328|20312225|P4|Received Treatment|Overall Study||50
8237361|NCT01953328|20312226|P3|Received Treatment|Overall Study||50
8237362|NCT01953328|20312227|P2|Received Treatment|Overall Study||50
8237363|NCT01953328|20312228|P1|Received Treatment|Overall Study||49
8237364|NCT01953328|20312221|P8|STARTED|Overall Study||51
8237365|NCT01953328|20312222|P7|STARTED|Overall Study||51
8237366|NCT01953328|20312223|P6|STARTED|Overall Study||51
8237367|NCT01953328|20312224|P5|STARTED|Overall Study||52
8237368|NCT01953328|20312225|P4|STARTED|Overall Study||50
8237369|NCT01953328|20312226|P3|STARTED|Overall Study||50
8237370|NCT01953328|20312227|P2|STARTED|Overall Study||50
8237371|NCT01953328|20312228|P1|STARTED|Overall Study||49
8237372|NCT01953237|20312432|P2|NOT COMPLETED|Overall Study||0
8237373|NCT01953237|20312433|P1|NOT COMPLETED|Overall Study||0
8237374|NCT01953237|20312432|P2|COMPLETED|Overall Study||21
8237375|NCT01953237|20312433|P1|COMPLETED|Overall Study||10
8237376|NCT01953237|20312432|P2|STARTED|Overall Study||21
8237377|NCT01953237|20312433|P1|STARTED|Overall Study||10
8237378|NCT01953224|20312441|P2|NOT COMPLETED|Overall Study||3
8237379|NCT01953224|20312442|P1|NOT COMPLETED|Overall Study||2
8237380|NCT01953224|20312441|P2|COMPLETED|Overall Study||17
8237381|NCT01953224|20312442|P1|COMPLETED|Overall Study||18
8237382|NCT01953224|20312441|P2|STARTED|Overall Study||20
8237383|NCT01953224|20312442|P1|STARTED|Overall Study||20
8237384|NCT01953211|20312458|P1|NOT COMPLETED|Overall Study||0
8237385|NCT01953211|20312458|P1|COMPLETED|Overall Study|completed prior to clinical trials submission|64
8237386|NCT01953211|20312458|P1|STARTED|Overall Study|completed prior to clinical trials submission|64
8237387|NCT01953081|20312466|P2|NOT COMPLETED|Overall Study||3
8237388|NCT01953081|20312467|P1|NOT COMPLETED|Overall Study||2
8237389|NCT01953081|20312466|P2|COMPLETED|Overall Study||3
8237390|NCT01953081|20312467|P1|COMPLETED|Overall Study||5
8237391|NCT01953081|20312466|P2|STARTED|Overall Study||6
8237392|NCT01953081|20312467|P1|STARTED|Overall Study||7
8237393|NCT01953003|20312491|P2|NOT COMPLETED|Overall Study||55
8237394|NCT01953003|20312492|P1|NOT COMPLETED|Overall Study||56
8237395|NCT01953003|20312491|P2|COMPLETED|Overall Study||1
8237396|NCT01953003|20312492|P1|COMPLETED|Overall Study||0
8237397|NCT01953003|20312491|P2|STARTED|Overall Study||56
8237398|NCT01953003|20312492|P1|STARTED|Overall Study||56
8237399|NCT01952834|20312498|P1|NOT COMPLETED|Overall Study||1
8237400|NCT01952834|20312498|P1|COMPLETED|Overall Study||20
8237401|NCT01952834|20312498|P1|STARTED|Overall Study||21
8237402|NCT01952691|20312505|P1|NOT COMPLETED|Overall Study||2
8237403|NCT01952691|20312505|P1|COMPLETED|Overall Study||20
8237404|NCT01952691|20312505|P1|STARTED|Overall Study||22
8237405|NCT01952678|20312513|P2|NOT COMPLETED|Overall Study||0
8237406|NCT01952678|20312514|P1|NOT COMPLETED|Overall Study||0
8237407|NCT01952678|20312513|P2|COMPLETED|Overall Study||102
8237408|NCT01952678|20312514|P1|COMPLETED|Overall Study||102
8237409|NCT01952678|20312513|P2|STARTED|Overall Study||102
8237410|NCT01952678|20312514|P1|STARTED|Overall Study||102
8237411|NCT01952665|20312532|P2|NOT COMPLETED|Overall Study||6
8237412|NCT01952665|20312533|P1|NOT COMPLETED|Overall Study||6
8237413|NCT01952665|20312532|P2|COMPLETED|Overall Study||20
8237414|NCT01952665|20312533|P1|COMPLETED|Overall Study||31
8237415|NCT01952665|20312532|P2|STARTED|Overall Study||26
8237416|NCT01952665|20312533|P1|STARTED|Overall Study||37
8237417|NCT01952600|20312674|P3|NOT COMPLETED|Overall Study||7
8237418|NCT01952600|20312675|P2|NOT COMPLETED|Overall Study||13
8237419|NCT01952600|20312676|P1|NOT COMPLETED|Overall Study||15
8237420|NCT01952600|20312674|P3|COMPLETED|Overall Study||38
8237421|NCT01952600|20312675|P2|COMPLETED|Overall Study||77
8237422|NCT01952600|20312676|P1|COMPLETED|Overall Study||65
8237423|NCT01952600|20312674|P3|STARTED|Overall Study||45
8237424|NCT01952600|20312675|P2|STARTED|Overall Study||90
8237425|NCT01952600|20312676|P1|STARTED|Overall Study||80
8237426|NCT01952574|20312688|P7|NOT COMPLETED|Clinical Home Use Substudy||1
8237427|NCT01952574|20312689|P6|NOT COMPLETED|Clinical Home Use Substudy||3
8237428|NCT01952574|20312690|P5|NOT COMPLETED|Clinical Home Use Substudy||0
8237429|NCT01952574|20312691|P4|NOT COMPLETED|Clinical Home Use Substudy||0
8237430|NCT01952574|20312692|P3|NOT COMPLETED|Clinical Home Use Substudy||0
8237431|NCT01952574|20312693|P2|NOT COMPLETED|Clinical Home Use Substudy||0
8237432|NCT01952574|20312694|P1|NOT COMPLETED|Clinical Home Use Substudy||0
8237433|NCT01952574|20312688|P7|COMPLETED|Clinical Home Use Substudy||40
8237434|NCT01952574|20312689|P6|COMPLETED|Clinical Home Use Substudy||39
8237435|NCT01952574|20312690|P5|COMPLETED|Clinical Home Use Substudy||0
8237436|NCT01952574|20312691|P4|COMPLETED|Clinical Home Use Substudy||0
8237437|NCT01952574|20312692|P3|COMPLETED|Clinical Home Use Substudy||0
8237438|NCT01952574|20312693|P2|COMPLETED|Clinical Home Use Substudy||0
8237439|NCT01952574|20312694|P1|COMPLETED|Clinical Home Use Substudy||0
8237440|NCT01952574|20312688|P7|STARTED|Clinical Home Use Substudy||41
8237441|NCT01952574|20312689|P6|STARTED|Clinical Home Use Substudy||42
8237442|NCT01952574|20312690|P5|STARTED|Clinical Home Use Substudy||0
8237443|NCT01952574|20312691|P4|STARTED|Clinical Home Use Substudy||0
8237444|NCT01952574|20312692|P3|STARTED|Clinical Home Use Substudy||0
8237445|NCT01952574|20312693|P2|STARTED|Clinical Home Use Substudy||0
8237446|NCT01952574|20312694|P1|STARTED|Clinical Home Use Substudy||0
8237447|NCT01952574|20312688|P7|NOT COMPLETED|Open-label Treatment Phase||0
8237448|NCT01952574|20312689|P6|NOT COMPLETED|Open-label Treatment Phase||0
8237449|NCT01952574|20312690|P5|NOT COMPLETED|Open-label Treatment Phase||162
8237450|NCT01952574|20312691|P4|NOT COMPLETED|Open-label Treatment Phase||0
8237451|NCT01952574|20312692|P3|NOT COMPLETED|Open-label Treatment Phase||0
8237452|NCT01952574|20312693|P2|NOT COMPLETED|Open-label Treatment Phase||0
8237453|NCT01952574|20312694|P1|NOT COMPLETED|Open-label Treatment Phase||0
8237454|NCT01952574|20312688|P7|COMPLETED|Open-label Treatment Phase||0
8237455|NCT01952574|20312689|P6|COMPLETED|Open-label Treatment Phase||0
8237456|NCT01952574|20312690|P5|COMPLETED|Open-label Treatment Phase||221
8237457|NCT01952574|20312691|P4|COMPLETED|Open-label Treatment Phase||0
8237458|NCT01952574|20312692|P3|COMPLETED|Open-label Treatment Phase||0
8237459|NCT01952574|20312693|P2|COMPLETED|Open-label Treatment Phase||0
8237460|NCT01952574|20312694|P1|COMPLETED|Open-label Treatment Phase||0
8237461|NCT01952574|20312688|P7|Received 140 mg Erenumab|Open-label Treatment Phase||0
8237462|NCT01952574|20312689|P6|Received 140 mg Erenumab|Open-label Treatment Phase||0
8237463|NCT01952574|20312690|P5|Received 140 mg Erenumab|Open-label Treatment Phase||250
8237464|NCT01952574|20312691|P4|Received 140 mg Erenumab|Open-label Treatment Phase||0
8237465|NCT01952574|20312692|P3|Received 140 mg Erenumab|Open-label Treatment Phase||0
8237466|NCT01952574|20312693|P2|Received 140 mg Erenumab|Open-label Treatment Phase||0
8237467|NCT01952574|20312694|P1|Received 140 mg Erenumab|Open-label Treatment Phase||0
8237468|NCT01952574|20312688|P7|Received 70 mg Erenumab|Open-label Treatment Phase||0
8237469|NCT01952574|20312689|P6|Received 70 mg Erenumab|Open-label Treatment Phase||0
8237470|NCT01952574|20312690|P5|Received 70 mg Erenumab|Open-label Treatment Phase||383
8237471|NCT01952574|20312691|P4|Received 70 mg Erenumab|Open-label Treatment Phase||0
8237472|NCT01952574|20312692|P3|Received 70 mg Erenumab|Open-label Treatment Phase||0
8237473|NCT01952574|20312693|P2|Received 70 mg Erenumab|Open-label Treatment Phase||0
8237474|NCT01952574|20312694|P1|Received 70 mg Erenumab|Open-label Treatment Phase||0
8237475|NCT01952574|20312688|P7|STARTED|Open-label Treatment Phase||0
8237476|NCT01952574|20312689|P6|STARTED|Open-label Treatment Phase||0
8237477|NCT01952574|20312690|P5|STARTED|Open-label Treatment Phase||383
8237478|NCT01952574|20312691|P4|STARTED|Open-label Treatment Phase||0
8237479|NCT01952574|20312692|P3|STARTED|Open-label Treatment Phase||0
8237480|NCT01952574|20312693|P2|STARTED|Open-label Treatment Phase||0
8237481|NCT01952574|20312694|P1|STARTED|Open-label Treatment Phase||0
8237482|NCT01952574|20312688|P7|NOT COMPLETED|Double-blind Treatment Phase||0
8237483|NCT01952574|20312689|P6|NOT COMPLETED|Double-blind Treatment Phase||0
8237484|NCT01952574|20312690|P5|NOT COMPLETED|Double-blind Treatment Phase||0
8237485|NCT01952574|20312691|P4|NOT COMPLETED|Double-blind Treatment Phase||6
8237486|NCT01952574|20312692|P3|NOT COMPLETED|Double-blind Treatment Phase||9
8237487|NCT01952574|20312693|P2|NOT COMPLETED|Double-blind Treatment Phase||3
8237488|NCT01952574|20312694|P1|NOT COMPLETED|Double-blind Treatment Phase||17
8237489|NCT01952574|20312688|P7|COMPLETED|Double-blind Treatment Phase||0
8237490|NCT01952574|20312689|P6|COMPLETED|Double-blind Treatment Phase||0
8237491|NCT01952574|20312690|P5|COMPLETED|Double-blind Treatment Phase||0
8237492|NCT01952574|20312691|P4|COMPLETED|Double-blind Treatment Phase||101
8237493|NCT01952574|20312692|P3|COMPLETED|Double-blind Treatment Phase||99
8237494|NCT01952574|20312693|P2|COMPLETED|Double-blind Treatment Phase||105
8237495|NCT01952574|20312694|P1|COMPLETED|Double-blind Treatment Phase||143
8237496|NCT01952574|20312688|P7|Received Study Drug|Double-blind Treatment Phase||0
8237497|NCT01952574|20312689|P6|Received Study Drug|Double-blind Treatment Phase||0
8237498|NCT01952574|20312690|P5|Received Study Drug|Double-blind Treatment Phase||0
8237499|NCT01952574|20312691|P4|Received Study Drug|Double-blind Treatment Phase||106
8237500|NCT01952574|20312692|P3|Received Study Drug|Double-blind Treatment Phase||105
8237501|NCT01952574|20312693|P2|Received Study Drug|Double-blind Treatment Phase||108
8237502|NCT01952574|20312694|P1|Received Study Drug|Double-blind Treatment Phase||153
8237503|NCT01952574|20312688|P7|STARTED|Double-blind Treatment Phase||0
8237504|NCT01952574|20312689|P6|STARTED|Double-blind Treatment Phase||0
8237505|NCT01952574|20312690|P5|STARTED|Double-blind Treatment Phase||0
8237506|NCT01952574|20312691|P4|STARTED|Double-blind Treatment Phase||107
8237507|NCT01952574|20312692|P3|STARTED|Double-blind Treatment Phase||108
8237508|NCT01952574|20312693|P2|STARTED|Double-blind Treatment Phase||108
8237509|NCT01952574|20312694|P1|STARTED|Double-blind Treatment Phase||160
8237510|NCT01952470|20312739|P2|NOT COMPLETED|Overall Study||3
8237511|NCT01952470|20312740|P1|NOT COMPLETED|Overall Study||3
8237512|NCT01952470|20312739|P2|COMPLETED|Overall Study||13
8237513|NCT01952470|20312740|P1|COMPLETED|Overall Study||13
8237514|NCT01952470|20312739|P2|Missing 3 Month LCI 2% Data.|Overall Study||0
8237515|NCT01952470|20312740|P1|Missing 3 Month LCI 2% Data.|Overall Study||1
8237516|NCT01952470|20312739|P2|Missing 1+3 Month LCI 2% Data.|Overall Study||1
8237517|NCT01952470|20312740|P1|Missing 1+3 Month LCI 2% Data.|Overall Study||2
8237518|NCT01952470|20312739|P2|Missing Baseline LCI 2% Data.|Overall Study||2
8237519|NCT01952470|20312740|P1|Missing Baseline LCI 2% Data.|Overall Study||0
8237520|NCT01952470|20312739|P2|Death|Overall Study||1
8237521|NCT01952470|20312740|P1|Death|Overall Study||1
8237522|NCT01952470|20312739|P2|Discontinued Intervention|Overall Study||1
8237523|NCT01952470|20312740|P1|Discontinued Intervention|Overall Study||2
8237524|NCT01952470|20312739|P2|ITT Analysis|Overall Study||16
8237525|NCT01952470|20312740|P1|ITT Analysis|Overall Study||16
8237526|NCT01952470|20312739|P2|STARTED|Overall Study||16
8237527|NCT01952470|20312740|P1|STARTED|Overall Study||16
8237528|NCT01952444|20312778|P2|NOT COMPLETED|Overall Study||1
8237529|NCT01952444|20312779|P1|NOT COMPLETED|Overall Study||0
8237530|NCT01952444|20312778|P2|COMPLETED|Overall Study||19
8237531|NCT01952444|20312779|P1|COMPLETED|Overall Study||20
8237532|NCT01952444|20312778|P2|STARTED|Overall Study||20
8237533|NCT01952444|20312779|P1|STARTED|Overall Study||20
8237534|NCT01952418|20312805|P2|NOT COMPLETED|Overall Study||0
8237535|NCT01952418|20312806|P1|NOT COMPLETED|Overall Study||0
8237536|NCT01952418|20312805|P2|COMPLETED|Overall Study||895
8237537|NCT01952418|20312806|P1|COMPLETED|Overall Study||910
8237538|NCT01952418|20312805|P2|STARTED|Overall Study||895
8237539|NCT01952418|20312806|P1|STARTED|Overall Study||910
8237540|NCT01952366|20312818|P1|NOT COMPLETED|Overall Study||31
8237541|NCT01952366|20312818|P1|COMPLETED|Overall Study||138
8237542|NCT01952366|20312818|P1|STARTED|Overall Study||169
8237543|NCT01952301|20312825|P1|NOT COMPLETED|Overall Study||0
8237544|NCT01952301|20312825|P1|COMPLETED|Overall Study||30
8237545|NCT01952301|20312825|P1|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
8237546|NCT01952145|20312833|P2|NOT COMPLETED|Overall Study||14
8237547|NCT01952145|20312834|P1|NOT COMPLETED|Overall Study||28
8237548|NCT01952145|20312833|P2|COMPLETED|Overall Study||265
8237549|NCT01952145|20312834|P1|COMPLETED|Overall Study||250
8237550|NCT01952145|20312833|P2|STARTED|Overall Study||279
8237551|NCT01952145|20312834|P1|STARTED|Overall Study||278
8237568|NCT01952054|20312897|P1|NOT COMPLETED|Overall Study||1
8237569|NCT01952054|20312897|P1|COMPLETED|Overall Study||5
8237570|NCT01952054|20312897|P1|STARTED|Overall Study||6
8237571|NCT01952041|20312905|P2|NOT COMPLETED|Overall Study||21
8237572|NCT01952041|20312906|P1|NOT COMPLETED|Overall Study||17
8237573|NCT01952041|20312905|P2|COMPLETED|Overall Study||43
8237574|NCT01952041|20312906|P1|COMPLETED|Overall Study||45
8237575|NCT01952041|20312905|P2|STARTED|Overall Study||64
8237576|NCT01952041|20312906|P1|STARTED|Overall Study||62
8237577|NCT01952015|20312920|P1|NOT COMPLETED|Treatment Period 3||9
8237578|NCT01952015|20312920|P1|COMPLETED|Treatment Period 3||0
8237579|NCT01952015|20312920|P1|STARTED|Treatment Period 3||9
8237580|NCT01952015|20312920|P1|NOT COMPLETED|Maintenance||2
8237581|NCT01952015|20312920|P1|COMPLETED|Maintenance||9
8237582|NCT01952015|20312920|P1|STARTED|Maintenance||11
8237583|NCT01952015|20312920|P1|NOT COMPLETED|Induction||1
8237584|NCT01952015|20312920|P1|COMPLETED|Induction||11
8237585|NCT01952015|20312920|P1|STARTED|Induction||12
8237586|NCT01951963|20312943|P2|NOT COMPLETED|Overall Study||0
8237587|NCT01951963|20312944|P1|NOT COMPLETED|Overall Study||0
8237588|NCT01951963|20312943|P2|COMPLETED|Overall Study||32
8237589|NCT01951963|20312944|P1|COMPLETED|Overall Study||31
8237590|NCT01951963|20312943|P2|STARTED|Overall Study||32
8237591|NCT01951963|20312944|P1|STARTED|Overall Study||31
8237592|NCT01951950|20312956|P2|NOT COMPLETED|Overall Study||6
8237593|NCT01951950|20312957|P1|NOT COMPLETED|Overall Study||6
8237594|NCT01951950|20312956|P2|COMPLETED|Overall Study||20
8237595|NCT01951950|20312957|P1|COMPLETED|Overall Study||20
8237596|NCT01951950|20312956|P2|STARTED|Overall Study||26
8237597|NCT01951950|20312957|P1|STARTED|Overall Study||26
8237598|NCT01951820|20312965|P2|NOT COMPLETED|Overall Study||0
8237599|NCT01951820|20312966|P1|NOT COMPLETED|Overall Study||0
8237600|NCT01951820|20312965|P2|COMPLETED|Overall Study||30
8237601|NCT01951820|20312966|P1|COMPLETED|Overall Study||34
8237602|NCT01951820|20312965|P2|STARTED|Overall Study||30
8237603|NCT01951820|20312966|P1|STARTED|Overall Study||34
8237604|NCT01951768|20312974|P2|NOT COMPLETED|Overall Study||0
8237605|NCT01951768|20312975|P1|NOT COMPLETED|Overall Study||0
8237606|NCT01951768|20312974|P2|COMPLETED|Overall Study|45 patients|45
8237607|NCT01951768|20312975|P1|COMPLETED|Overall Study|43 patients|43
8237608|NCT01951768|20312974|P2|STARTED|Overall Study||45
8237609|NCT01951768|20312975|P1|STARTED|Overall Study||43
8237610|NCT01951703|20312987|P2|NOT COMPLETED|Second Intervention||2
8237611|NCT01951703|20312988|P1|NOT COMPLETED|Second Intervention||0
8237612|NCT01951703|20312987|P2|COMPLETED|Second Intervention||60
8237613|NCT01951703|20312988|P1|COMPLETED|Second Intervention||61
8237614|NCT01951703|20312987|P2|STARTED|Second Intervention||62
8237615|NCT01951703|20312988|P1|STARTED|Second Intervention||61
8237616|NCT01951703|20312987|P2|NOT COMPLETED|First Intervention||1
8237617|NCT01951703|20312988|P1|NOT COMPLETED|First Intervention||3
8237618|NCT01951703|20312987|P2|COMPLETED|First Intervention||62
8237619|NCT01951703|20312988|P1|COMPLETED|First Intervention||61
8237620|NCT01951703|20312987|P2|STARTED|First Intervention||63
8237621|NCT01951703|20312988|P1|STARTED|First Intervention||64
8237622|NCT01951651|20312998|P2|NOT COMPLETED|Overall Study||2
8237623|NCT01951651|20312999|P1|NOT COMPLETED|Overall Study||4
8237624|NCT01951651|20312998|P2|COMPLETED|Overall Study||10
8237625|NCT01951651|20312999|P1|COMPLETED|Overall Study||8
8237626|NCT01951651|20312998|P2|STARTED|Overall Study||12
8237627|NCT01951651|20312999|P1|STARTED|Overall Study||12
8237628|NCT01951586|20313013|P2|NOT COMPLETED|Overall Study||148
8237629|NCT01951586|20313014|P1|NOT COMPLETED|Overall Study||78
8237630|NCT01951586|20313013|P2|COMPLETED|Overall Study||0
8237631|NCT01951586|20313014|P1|COMPLETED|Overall Study||0
8237632|NCT01951586|20313013|P2|Received Study Drug|Overall Study||145
8237633|NCT01951586|20313014|P1|Received Study Drug|Overall Study||76
8237634|NCT01951586|20313013|P2|STARTED|Overall Study||148
8237635|NCT01951586|20313014|P1|STARTED|Overall Study||78
8237636|NCT01951573|20313038|P2|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
8237637|NCT01951573|20313039|P1|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
8237638|NCT01951573|20313038|P2|COMPLETED|Period 2, Second 9 Hours of Wear||16
8237639|NCT01951573|20313039|P1|COMPLETED|Period 2, Second 9 Hours of Wear||17
8237640|NCT01951573|20313038|P2|STARTED|Period 2, Second 9 Hours of Wear||16
8237641|NCT01951573|20313039|P1|STARTED|Period 2, Second 9 Hours of Wear||17
8237642|NCT01951573|20313038|P2|NOT COMPLETED|Washout Period||1
8237643|NCT01951573|20313039|P1|NOT COMPLETED|Washout Period||0
8237644|NCT01951573|20313038|P2|COMPLETED|Washout Period||16
8237645|NCT01951573|20313039|P1|COMPLETED|Washout Period||17
8237646|NCT01951573|20313038|P2|STARTED|Washout Period||17
8237647|NCT01951573|20313039|P1|STARTED|Washout Period||17
8237648|NCT01951573|20313038|P2|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
8237649|NCT01951573|20313039|P1|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
8237650|NCT01951573|20313038|P2|COMPLETED|Period 1, First 9 Hours of Wear||17
8237651|NCT01951573|20313039|P1|COMPLETED|Period 1, First 9 Hours of Wear||17
8237652|NCT01951573|20313038|P2|STARTED|Period 1, First 9 Hours of Wear||17
8237653|NCT01951573|20313039|P1|STARTED|Period 1, First 9 Hours of Wear||17
8237654|NCT01951417|20313049|P1|NOT COMPLETED|Overall Study||9
8237655|NCT01951417|20313049|P1|COMPLETED|Overall Study||72
8237656|NCT01951417|20313049|P1|STARTED|Overall Study||81
8237657|NCT01951391|20313074|P2|NOT COMPLETED|Overall Study||0
8237658|NCT01951391|20313075|P1|NOT COMPLETED|Overall Study||0
8237659|NCT01951391|20313074|P2|COMPLETED|Overall Study||5
8237660|NCT01951391|20313075|P1|COMPLETED|Overall Study||5
8237661|NCT01951391|20313074|P2|STARTED|Overall Study||5
8237662|NCT01951391|20313075|P1|STARTED|Overall Study||5
8237669|NCT01951352|20313094|P1|NOT COMPLETED|Overall Study||0
8237670|NCT01951352|20313094|P1|COMPLETED|Overall Study||10
8237671|NCT01951352|20313094|P1|STARTED|Overall Study||10
8237672|NCT01951339|20313103|P2|NOT COMPLETED|Overall Study||1
8237673|NCT01951339|20313104|P1|NOT COMPLETED|Overall Study||2
8237674|NCT01951339|20313103|P2|COMPLETED|Overall Study||14
8237675|NCT01951339|20313104|P1|COMPLETED|Overall Study||13
8237676|NCT01951339|20313103|P2|STARTED|Overall Study||15
8237677|NCT01951339|20313104|P1|STARTED|Overall Study||15
8237678|NCT01951326|20313128|P2|NOT COMPLETED|Overall Study||78
8237679|NCT01951326|20313129|P1|NOT COMPLETED|Overall Study||79
8237680|NCT01951326|20313128|P2|COMPLETED|Overall Study||87
8237681|NCT01951326|20313129|P1|COMPLETED|Overall Study||87
8237682|NCT01951326|20313128|P2|STARTED|Overall Study||165
8237683|NCT01951326|20313129|P1|STARTED|Overall Study||166
8237684|NCT01951261|20313163|P2|NOT COMPLETED|Overall Study||6
8237685|NCT01951261|20313164|P1|NOT COMPLETED|Overall Study||9
8237686|NCT01951261|20313163|P2|COMPLETED|Overall Study||52
8237687|NCT01951261|20313164|P1|COMPLETED|Overall Study||49
8237688|NCT01951261|20313163|P2|Discontinued|Overall Study|"2-readmission when was at home
~1-new home hospitalitation 3-missing"|6
8237689|NCT01951261|20313164|P1|Discontinued|Overall Study|"2-readmission when was at home
~1-monitor failure
~1-new home hospitalitation 4-missing
~1-death"|9
8237690|NCT01951261|20313163|P2|STARTED|Overall Study||58
8237691|NCT01951261|20313164|P1|STARTED|Overall Study||58
8237692|NCT01951170|20313182|P1|NOT COMPLETED|Overall Study||1
8237693|NCT01951170|20313182|P1|COMPLETED|Overall Study||51
8237694|NCT01951170|20313182|P1|STARTED|Overall Study||52
8237695|NCT01951157|20313208|P3|NOT COMPLETED|Overall Study||25
8237696|NCT01951157|20313209|P2|NOT COMPLETED|Overall Study||22
8237697|NCT01951157|20313210|P1|NOT COMPLETED|Overall Study||22
8237698|NCT01951157|20313208|P3|COMPLETED|Overall Study||0
8237699|NCT01951157|20313209|P2|COMPLETED|Overall Study||0
8237700|NCT01951157|20313210|P1|COMPLETED|Overall Study||0
8237701|NCT01951157|20313208|P3|STARTED|Overall Study||25
8237702|NCT01951157|20313209|P2|STARTED|Overall Study||22
8237703|NCT01951157|20313210|P1|STARTED|Overall Study||22
8237704|NCT01951118|20313239|P1|NOT COMPLETED|Overall Study||27
8237705|NCT01951118|20313239|P1|COMPLETED|Overall Study||94
8237706|NCT01951118|20313239|P1|STARTED|Overall Study||121
8237719|NCT01951092|20313277|P1|NOT COMPLETED|Overall Study||12
8237720|NCT01951092|20313277|P1|COMPLETED|Overall Study||20
8237721|NCT01951092|20313277|P1|STARTED|Overall Study||32
8237722|NCT01951066|20313282|P2|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
8237723|NCT01951066|20313283|P1|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
8237724|NCT01951066|20313282|P2|COMPLETED|Second Intervention (Week 16 to Week 32)||10
8237725|NCT01951066|20313283|P1|COMPLETED|Second Intervention (Week 16 to Week 32)||10
8237726|NCT01951066|20313282|P2|STARTED|Second Intervention (Week 16 to Week 32)||10
8237727|NCT01951066|20313283|P1|STARTED|Second Intervention (Week 16 to Week 32)||10
8237728|NCT01951066|20313282|P2|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
8237729|NCT01951066|20313283|P1|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
8237730|NCT01951066|20313282|P2|COMPLETED|First Intervention (Baseline to Week 16)||10
8237731|NCT01951066|20313283|P1|COMPLETED|First Intervention (Baseline to Week 16)||10
8237732|NCT01951066|20313282|P2|STARTED|First Intervention (Baseline to Week 16)||10
8237733|NCT01951066|20313283|P1|STARTED|First Intervention (Baseline to Week 16)||10
8237734|NCT01950819|20313290|P2|NOT COMPLETED|Overall Study||134
8237735|NCT01950819|20313291|P1|NOT COMPLETED|Overall Study||129
8237736|NCT01950819|20313290|P2|COMPLETED|Overall Study||881
8237737|NCT01950819|20313291|P1|COMPLETED|Overall Study||893
8237738|NCT01950819|20313290|P2|STARTED|Overall Study||1015
8237739|NCT01950819|20313291|P1|STARTED|Overall Study||1022
8237740|NCT01950780|20313339|P1|NOT COMPLETED|Overall Study||0
8237741|NCT01950780|20313339|P1|COMPLETED|Overall Study||12
8237742|NCT01950780|20313339|P1|STARTED|Overall Study||12
8237743|NCT01950741|20313344|P1|NOT COMPLETED|Overall Study||3
8237744|NCT01950741|20313344|P1|COMPLETED|Overall Study||45
8237745|NCT01950741|20313344|P1|STARTED|Overall Study||48
8237746|NCT01950663|20313353|P1|NOT COMPLETED|Overall Study||1
8237747|NCT01950663|20313353|P1|COMPLETED|Overall Study||467
8237748|NCT01950663|20313353|P1|STARTED|Overall Study||468
8237749|NCT01950364|20313359|P2|NOT COMPLETED|Overall Study||10
8237750|NCT01950364|20313360|P1|NOT COMPLETED|Overall Study||10
8237751|NCT01950364|20313359|P2|COMPLETED|Overall Study||0
8237752|NCT01950364|20313360|P1|COMPLETED|Overall Study||0
8237753|NCT01950364|20313359|P2|STARTED|Overall Study||10
8237754|NCT01950364|20313360|P1|STARTED|Overall Study||10
8237755|NCT01950299|20313461|P3|NOT COMPLETED|Overall Study||7
8237756|NCT01950299|20313462|P2|NOT COMPLETED|Overall Study||4
8237757|NCT01950299|20313463|P1|NOT COMPLETED|Overall Study||11
8237758|NCT01950299|20313461|P3|COMPLETED|Overall Study||28
8237759|NCT01950299|20313462|P2|COMPLETED|Overall Study||27
8237760|NCT01950299|20313463|P1|COMPLETED|Overall Study||22
8237761|NCT01950299|20313461|P3|STARTED|Overall Study||35
8237762|NCT01950299|20313462|P2|STARTED|Overall Study||31
8237763|NCT01950299|20313463|P1|STARTED|Overall Study||33
8237764|NCT01950273|20313482|P2|NOT COMPLETED|Overall Study||0
8237765|NCT01950273|20313483|P1|NOT COMPLETED|Overall Study||4
8237766|NCT01950273|20313482|P2|COMPLETED|Overall Study||46
8237767|NCT01950273|20313483|P1|COMPLETED|Overall Study||45
8237768|NCT01950273|20313482|P2|STARTED|Overall Study||46
8237769|NCT01950273|20313483|P1|STARTED|Overall Study||49
8237770|NCT01950260|20313505|P2|NOT COMPLETED|Overall Study||0
8237771|NCT01950260|20313506|P1|NOT COMPLETED|Overall Study||0
8237772|NCT01950260|20313505|P2|COMPLETED|Overall Study||31
8237773|NCT01950260|20313506|P1|COMPLETED|Overall Study||30
8237774|NCT01950260|20313505|P2|STARTED|Overall Study||31
8237775|NCT01950260|20313506|P1|STARTED|Overall Study||30
8237776|NCT01950078|20313518|P2|NOT COMPLETED|Overall Study||12
8237777|NCT01950078|20313519|P1|NOT COMPLETED|Overall Study||20
8237778|NCT01950078|20313518|P2|COMPLETED|Overall Study||496
8237779|NCT01950078|20313519|P1|COMPLETED|Overall Study||1005
8237780|NCT01950078|20313518|P2|STARTED|Overall Study||508
8237781|NCT01950078|20313519|P1|STARTED|Overall Study||1025
8237782|NCT01950013|20313530|P3|NOT COMPLETED|Overall Study||0
8237783|NCT01950013|20313531|P2|NOT COMPLETED|Overall Study||2
8237784|NCT01950013|20313532|P1|NOT COMPLETED|Overall Study||0
8237785|NCT01950013|20313530|P3|COMPLETED|Overall Study||15
8237786|NCT01950013|20313531|P2|COMPLETED|Overall Study||13
8237787|NCT01950013|20313532|P1|COMPLETED|Overall Study||15
8237788|NCT01950013|20313530|P3|STARTED|Overall Study||15
8237789|NCT01950013|20313531|P2|STARTED|Overall Study||15
8237790|NCT01950013|20313532|P1|STARTED|Overall Study||15
8237791|NCT01949870|20313543|P1|NOT COMPLETED|Overall Study||6
8237792|NCT01949870|20313543|P1|COMPLETED|Overall Study||0
8237793|NCT01949870|20313543|P1|Received Treatment|Overall Study||4
8237794|NCT01949870|20313543|P1|STARTED|Overall Study||6
8237795|NCT01949844|20313547|P1|NOT COMPLETED|Overall Study||0
8237796|NCT01949844|20313547|P1|COMPLETED|Overall Study||44
8237797|NCT01949844|20313547|P1|STARTED|Overall Study||44
8237798|NCT01949779|20313551|P1|NOT COMPLETED|Overall Study||2
8237799|NCT01949779|20313551|P1|COMPLETED|Overall Study||79
8237800|NCT01949779|20313551|P1|STARTED|Overall Study||81
8237801|NCT01949662|20313559|P2|NOT COMPLETED|Overall Study||14
8237802|NCT01949662|20313560|P1|NOT COMPLETED|Overall Study||18
8237803|NCT01949662|20313559|P2|COMPLETED|Overall Study||29
8237804|NCT01949662|20313560|P1|COMPLETED|Overall Study||29
8237805|NCT01949662|20313559|P2|STARTED|Overall Study||43
8237806|NCT01949662|20313560|P1|STARTED|Overall Study||47
8237807|NCT01949545|20313576|P4|NOT COMPLETED|Overall Study||0
8237808|NCT01949545|20313577|P3|NOT COMPLETED|Overall Study||0
8237809|NCT01949545|20313578|P2|NOT COMPLETED|Overall Study||0
8237810|NCT01949545|20313579|P1|NOT COMPLETED|Overall Study||0
8237811|NCT01949545|20313576|P4|COMPLETED|Overall Study||4
8237812|NCT01949545|20313577|P3|COMPLETED|Overall Study||14
8237813|NCT01949545|20313578|P2|COMPLETED|Overall Study||17
8237814|NCT01949545|20313579|P1|COMPLETED|Overall Study||11
8237815|NCT01949545|20313576|P4|STARTED|Overall Study||4
8237816|NCT01949545|20313577|P3|STARTED|Overall Study||14
8237817|NCT01949545|20313578|P2|STARTED|Overall Study||17
8237818|NCT01949545|20313579|P1|STARTED|Overall Study||11
8237819|NCT01949532|20313727|P2|NOT COMPLETED|Overall Study||3
8237820|NCT01949532|20313728|P1|NOT COMPLETED|Overall Study||3
8237821|NCT01949532|20313727|P2|COMPLETED|Overall Study||8
8237822|NCT01949532|20313728|P1|COMPLETED|Overall Study||12
8237823|NCT01949532|20313727|P2|STARTED|Overall Study||11
8237824|NCT01949532|20313728|P1|STARTED|Overall Study||15
8237825|NCT01949480|20313798|P2|NOT COMPLETED|Overall Study||8
8237826|NCT01949480|20313799|P1|NOT COMPLETED|Overall Study||5
8237827|NCT01949480|20313798|P2|COMPLETED|Overall Study||14
8237828|NCT01949480|20313799|P1|COMPLETED|Overall Study||15
8237829|NCT01949480|20313798|P2|STARTED|Overall Study||22
8237830|NCT01949480|20313799|P1|STARTED|Overall Study||20
8237831|NCT01949389|20313827|P1|NOT COMPLETED|Overall Study||0
8237832|NCT01949389|20313827|P1|COMPLETED|Overall Study||51
8237833|NCT01949389|20313827|P1|STARTED|Overall Study||51
8237840|NCT01949155|20313845|P2|NOT COMPLETED|Overall Study||0
8237841|NCT01949155|20313846|P1|NOT COMPLETED|Overall Study||2
8237842|NCT01949155|20313845|P2|COMPLETED|Overall Study||88
8237843|NCT01949155|20313846|P1|COMPLETED|Overall Study||176
8237844|NCT01949155|20313845|P2|STARTED|Overall Study||88
8237845|NCT01949155|20313846|P1|STARTED|Overall Study||178
8237846|NCT01949142|20313858|P2|NOT COMPLETED|Overall Study||1
8237847|NCT01949142|20313859|P1|NOT COMPLETED|Overall Study||3
8237848|NCT01949142|20313858|P2|COMPLETED|Overall Study||86
8237849|NCT01949142|20313859|P1|COMPLETED|Overall Study||176
8237850|NCT01949142|20313858|P2|STARTED|Overall Study||87
8237851|NCT01949142|20313859|P1|STARTED|Overall Study||179
8237852|NCT01949116|20313871|P2|NOT COMPLETED|Overall Study||6
8237853|NCT01949116|20313872|P1|NOT COMPLETED|Overall Study||8
8237854|NCT01949116|20313871|P2|COMPLETED|Overall Study||84
8237855|NCT01949116|20313872|P1|COMPLETED|Overall Study||78
8237856|NCT01949116|20313871|P2|STARTED|Overall Study||90
8237857|NCT01949116|20313872|P1|STARTED|Overall Study||86
8237858|NCT01949090|20313909|P5|NOT COMPLETED|Overall Study||4
8237859|NCT01949090|20313910|P4|NOT COMPLETED|Overall Study||1
8237860|NCT01949090|20313911|P3|NOT COMPLETED|Overall Study||2
8237861|NCT01949090|20313912|P2|NOT COMPLETED|Overall Study||2
8237862|NCT01949090|20313913|P1|NOT COMPLETED|Overall Study||4
8237863|NCT01949090|20313909|P5|COMPLETED|Overall Study||116
8237864|NCT01949090|20313910|P4|COMPLETED|Overall Study||59
8237865|NCT01949090|20313911|P3|COMPLETED|Overall Study||58
8237866|NCT01949090|20313912|P2|COMPLETED|Overall Study||58
8237867|NCT01949090|20313913|P1|COMPLETED|Overall Study||56
8237868|NCT01949090|20313909|P5|STARTED|Overall Study||120
8237869|NCT01949090|20313910|P4|STARTED|Overall Study||60
8237870|NCT01949090|20313911|P3|STARTED|Overall Study||60
8237871|NCT01949090|20313912|P2|STARTED|Overall Study||60
8237872|NCT01949090|20313913|P1|STARTED|Overall Study||60
8237873|NCT01949051|20314090|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8237874|NCT01949051|20314091|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8237875|NCT01949051|20314092|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8237876|NCT01949051|20314093|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8237877|NCT01949051|20314094|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8237878|NCT01949051|20314095|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8237879|NCT01949051|20314090|P6|COMPLETED|Treatment Period 3 (7 Days)||12
8237880|NCT01949051|20314091|P5|COMPLETED|Treatment Period 3 (7 Days)||13
8237881|NCT01949051|20314092|P4|COMPLETED|Treatment Period 3 (7 Days)||12
8237882|NCT01949051|20314093|P3|COMPLETED|Treatment Period 3 (7 Days)||12
8237883|NCT01949051|20314094|P2|COMPLETED|Treatment Period 3 (7 Days)||12
8237884|NCT01949051|20314095|P1|COMPLETED|Treatment Period 3 (7 Days)||11
8237885|NCT01949051|20314090|P6|STARTED|Treatment Period 3 (7 Days)||12
8237886|NCT01949051|20314091|P5|STARTED|Treatment Period 3 (7 Days)||13
8237887|NCT01949051|20314092|P4|STARTED|Treatment Period 3 (7 Days)||12
8237888|NCT01949051|20314093|P3|STARTED|Treatment Period 3 (7 Days)||12
8237889|NCT01949051|20314094|P2|STARTED|Treatment Period 3 (7 Days)||12
8237890|NCT01949051|20314095|P1|STARTED|Treatment Period 3 (7 Days)||11
8237891|NCT01949051|20314090|P6|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8237892|NCT01949051|20314091|P5|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8237893|NCT01949051|20314092|P4|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8237894|NCT01949051|20314093|P3|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8237895|NCT01949051|20314094|P2|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8237896|NCT01949051|20314095|P1|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
8237897|NCT01949051|20314090|P6|COMPLETED|Washout Period 2 (14 to 20 Days)||12
8237898|NCT01949051|20314091|P5|COMPLETED|Washout Period 2 (14 to 20 Days)||13
8237899|NCT01949051|20314092|P4|COMPLETED|Washout Period 2 (14 to 20 Days)||12
8237900|NCT01949051|20314093|P3|COMPLETED|Washout Period 2 (14 to 20 Days)||12
8237901|NCT01949051|20314094|P2|COMPLETED|Washout Period 2 (14 to 20 Days)||12
8237902|NCT01949051|20314095|P1|COMPLETED|Washout Period 2 (14 to 20 Days)||11
8237903|NCT01949051|20314090|P6|STARTED|Washout Period 2 (14 to 20 Days)||12
8237904|NCT01949051|20314091|P5|STARTED|Washout Period 2 (14 to 20 Days)||13
8237905|NCT01949051|20314092|P4|STARTED|Washout Period 2 (14 to 20 Days)||12
8237906|NCT01949051|20314093|P3|STARTED|Washout Period 2 (14 to 20 Days)||12
8237907|NCT01949051|20314094|P2|STARTED|Washout Period 2 (14 to 20 Days)||12
8237908|NCT01949051|20314095|P1|STARTED|Washout Period 2 (14 to 20 Days)||11
8237909|NCT01949051|20314090|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||1
8237910|NCT01949051|20314091|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8237911|NCT01949051|20314092|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8237912|NCT01949051|20314093|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||1
8237913|NCT01949051|20314094|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||1
8237914|NCT01949051|20314095|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8237915|NCT01949051|20314090|P6|COMPLETED|Treatment Period 2 (7 Days)||12
8237916|NCT01949051|20314091|P5|COMPLETED|Treatment Period 2 (7 Days)||13
8237917|NCT01949051|20314092|P4|COMPLETED|Treatment Period 2 (7 Days)||12
8237918|NCT01949051|20314093|P3|COMPLETED|Treatment Period 2 (7 Days)||12
8237919|NCT01949051|20314094|P2|COMPLETED|Treatment Period 2 (7 Days)||12
8237920|NCT01949051|20314095|P1|COMPLETED|Treatment Period 2 (7 Days)||11
8237921|NCT01949051|20314090|P6|STARTED|Treatment Period 2 (7 Days)||13
8237922|NCT01949051|20314091|P5|STARTED|Treatment Period 2 (7 Days)||13
8237923|NCT01949051|20314092|P4|STARTED|Treatment Period 2 (7 Days)||12
8237924|NCT01949051|20314093|P3|STARTED|Treatment Period 2 (7 Days)||13
8237925|NCT01949051|20314094|P2|STARTED|Treatment Period 2 (7 Days)||13
8237926|NCT01949051|20314095|P1|STARTED|Treatment Period 2 (7 Days)||11
8237927|NCT01949051|20314090|P6|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8237928|NCT01949051|20314091|P5|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8237929|NCT01949051|20314092|P4|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8237930|NCT01949051|20314093|P3|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8237931|NCT01949051|20314094|P2|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8237932|NCT01949051|20314095|P1|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
8237933|NCT01949051|20314090|P6|COMPLETED|Washout Period 1 (14 to 20 Days)||13
8237934|NCT01949051|20314091|P5|COMPLETED|Washout Period 1 (14 to 20 Days)||13
8237935|NCT01949051|20314092|P4|COMPLETED|Washout Period 1 (14 to 20 Days)||12
8237936|NCT01949051|20314093|P3|COMPLETED|Washout Period 1 (14 to 20 Days)||13
8237937|NCT01949051|20314094|P2|COMPLETED|Washout Period 1 (14 to 20 Days)||13
8237938|NCT01949051|20314095|P1|COMPLETED|Washout Period 1 (14 to 20 Days)||11
8237939|NCT01949051|20314090|P6|STARTED|Washout Period 1 (14 to 20 Days)||13
8237940|NCT01949051|20314091|P5|STARTED|Washout Period 1 (14 to 20 Days)||13
8237941|NCT01949051|20314092|P4|STARTED|Washout Period 1 (14 to 20 Days)||12
8237942|NCT01949051|20314093|P3|STARTED|Washout Period 1 (14 to 20 Days)||13
8237943|NCT01949051|20314094|P2|STARTED|Washout Period 1 (14 to 20 Days)||13
8237944|NCT01949051|20314095|P1|STARTED|Washout Period 1 (14 to 20 Days)||11
8237945|NCT01949051|20314090|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8237946|NCT01949051|20314091|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8237947|NCT01949051|20314092|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||1
8237948|NCT01949051|20314093|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8237949|NCT01949051|20314094|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8237950|NCT01949051|20314095|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||2
8237951|NCT01949051|20314090|P6|COMPLETED|Treatment Period 1 (7 Days)||13
8237952|NCT01949051|20314091|P5|COMPLETED|Treatment Period 1 (7 Days)||13
8237953|NCT01949051|20314092|P4|COMPLETED|Treatment Period 1 (7 Days)||12
8237954|NCT01949051|20314093|P3|COMPLETED|Treatment Period 1 (7 Days)||13
8237955|NCT01949051|20314094|P2|COMPLETED|Treatment Period 1 (7 Days)||13
8237956|NCT01949051|20314095|P1|COMPLETED|Treatment Period 1 (7 Days)||11
8237957|NCT01949051|20314090|P6|STARTED|Treatment Period 1 (7 Days)||13
8237958|NCT01949051|20314091|P5|STARTED|Treatment Period 1 (7 Days)||13
8237959|NCT01949051|20314092|P4|STARTED|Treatment Period 1 (7 Days)||13
8237960|NCT01949051|20314093|P3|STARTED|Treatment Period 1 (7 Days)||13
8237961|NCT01949051|20314094|P2|STARTED|Treatment Period 1 (7 Days)||13
8237962|NCT01949051|20314095|P1|STARTED|Treatment Period 1 (7 Days)||13
8237963|NCT01948986|20314111|P5|NOT COMPLETED|Overall Study||0
8237964|NCT01948986|20314112|P4|NOT COMPLETED|Overall Study||0
8237965|NCT01948986|20314113|P3|NOT COMPLETED|Overall Study||0
8237966|NCT01948986|20314114|P2|NOT COMPLETED|Overall Study||0
8237967|NCT01948986|20314115|P1|NOT COMPLETED|Overall Study||0
8237968|NCT01948986|20314111|P5|COMPLETED|Overall Study||8
8237969|NCT01948986|20314112|P4|COMPLETED|Overall Study||6
8237970|NCT01948986|20314113|P3|COMPLETED|Overall Study||8
8237971|NCT01948986|20314114|P2|COMPLETED|Overall Study||8
8237972|NCT01948986|20314115|P1|COMPLETED|Overall Study||6
8237973|NCT01948986|20314111|P5|STARTED|Overall Study||8
8237974|NCT01948986|20314112|P4|STARTED|Overall Study||6
8237975|NCT01948986|20314113|P3|STARTED|Overall Study||8
8237976|NCT01948986|20314114|P2|STARTED|Overall Study||8
8237977|NCT01948986|20314115|P1|STARTED|Overall Study||6
8237978|NCT01948947|20314274|P2|NOT COMPLETED|Overall Study||0
8237979|NCT01948947|20314275|P1|NOT COMPLETED|Overall Study||0
8237980|NCT01948947|20314274|P2|COMPLETED|Overall Study||15
8237981|NCT01948947|20314275|P1|COMPLETED|Overall Study||14
8237982|NCT01948947|20314274|P2|STARTED|Overall Study||15
8237983|NCT01948947|20314275|P1|STARTED|Overall Study||14
8237984|NCT01948908|20314290|P3|NOT COMPLETED|Overall Study||2
8237985|NCT01948908|20314291|P2|NOT COMPLETED|Overall Study||0
8237986|NCT01948908|20314292|P1|NOT COMPLETED|Overall Study||1
8237987|NCT01948908|20314290|P3|COMPLETED|Overall Study||31
8237988|NCT01948908|20314291|P2|COMPLETED|Overall Study||33
8237989|NCT01948908|20314292|P1|COMPLETED|Overall Study||32
8237990|NCT01948908|20314290|P3|STARTED|Overall Study||33
8237991|NCT01948908|20314291|P2|STARTED|Overall Study||33
8237992|NCT01948908|20314292|P1|STARTED|Overall Study||33
8237993|NCT01948830|20314308|P2|NOT COMPLETED|Overall Study||32
8237994|NCT01948830|20314309|P1|NOT COMPLETED|Overall Study||33
8237995|NCT01948830|20314308|P2|COMPLETED|Overall Study||295
8237996|NCT01948830|20314309|P1|COMPLETED|Overall Study||290
8237997|NCT01948830|20314308|P2|Safety Set|Overall Study||326
8237998|NCT01948830|20314309|P1|Safety Set|Overall Study||323
8237999|NCT01948830|20314308|P2|STARTED|Overall Study||327
8238000|NCT01948830|20314309|P1|STARTED|Overall Study||323
8238001|NCT01948791|20314341|P1|NOT COMPLETED|Overall Study||71
8238002|NCT01948791|20314341|P1|COMPLETED|Overall Study||151
8238003|NCT01948791|20314341|P1|STARTED|Overall Study||222
8238004|NCT01948518|20314349|P1|NOT COMPLETED|Overall Study||0
8238005|NCT01948518|20314349|P1|COMPLETED|Overall Study||15
8238006|NCT01948518|20314349|P1|STARTED|Overall Study||15
8238007|NCT01948388|20314356|P2|NOT COMPLETED|Overall Study||1
8238008|NCT01948388|20314357|P1|NOT COMPLETED|Overall Study||2
8238009|NCT01948388|20314356|P2|COMPLETED|Overall Study||9
8238010|NCT01948388|20314357|P1|COMPLETED|Overall Study||8
8238011|NCT01948388|20314356|P2|STARTED|Overall Study||10
8238012|NCT01948388|20314357|P1|STARTED|Overall Study||10
8238013|NCT01948375|20314373|P2|NOT COMPLETED|Overall Study||0
8238014|NCT01948375|20314374|P1|NOT COMPLETED|Overall Study||0
8238015|NCT01948375|20314373|P2|COMPLETED|Overall Study||30
8238016|NCT01948375|20314374|P1|COMPLETED|Overall Study||30
8238017|NCT01948375|20314373|P2|STARTED|Overall Study||30
8238018|NCT01948375|20314374|P1|STARTED|Overall Study||30
8238019|NCT01948310|20314390|P2|NOT COMPLETED|Overall Study||5
8238020|NCT01948310|20314391|P1|NOT COMPLETED|Overall Study||3
8238021|NCT01948310|20314390|P2|COMPLETED|Overall Study||13
8238022|NCT01948310|20314391|P1|COMPLETED|Overall Study||16
8238023|NCT01948310|20314390|P2|STARTED|Overall Study||18
8238024|NCT01948310|20314391|P1|STARTED|Overall Study||19
8238025|NCT01948258|20314401|P1|NOT COMPLETED|Overall Study||162
8238026|NCT01948258|20314401|P1|COMPLETED|Overall Study||233
8238027|NCT01948258|20314401|P1|STARTED|Overall Study||395
8238028|NCT01948193|20314407|P1|NOT COMPLETED|Overall Study||9
8238029|NCT01948193|20314407|P1|COMPLETED|Overall Study||168
8238030|NCT01948193|20314407|P1|STARTED|Overall Study||177
8238031|NCT01948141|20314416|P1|NOT COMPLETED|Overall Study||0
8238032|NCT01948141|20314416|P1|COMPLETED|Overall Study||6
8238033|NCT01948141|20314416|P1|STARTED|Overall Study||6
8238034|NCT01948076|20314429|P2|NOT COMPLETED|Overall Study||1
8238035|NCT01948076|20314430|P1|NOT COMPLETED|Overall Study||0
8238036|NCT01948076|20314429|P2|COMPLETED|Overall Study||19
8238037|NCT01948076|20314430|P1|COMPLETED|Overall Study||20
8238038|NCT01948076|20314429|P2|STARTED|Overall Study||20
8238039|NCT01948076|20314430|P1|STARTED|Overall Study||20
8238040|NCT01948063|20314440|P2|NOT COMPLETED|Overall Study||2
8238041|NCT01948063|20314441|P1|NOT COMPLETED|Overall Study||1
8238042|NCT01948063|20314440|P2|COMPLETED|Overall Study||19
8238043|NCT01948063|20314441|P1|COMPLETED|Overall Study||19
8238044|NCT01948063|20314440|P2|STARTED|Overall Study||21
8238045|NCT01948063|20314441|P1|STARTED|Overall Study||20
8238046|NCT01948050|20314449|P2|NOT COMPLETED|Overall Study||1
8238047|NCT01948050|20314450|P1|NOT COMPLETED|Overall Study||0
8238048|NCT01948050|20314449|P2|COMPLETED|Overall Study||7
8238049|NCT01948050|20314450|P1|COMPLETED|Overall Study||16
8238050|NCT01948050|20314449|P2|STARTED|Overall Study||8
8238051|NCT01948050|20314450|P1|STARTED|Overall Study||16
8238052|NCT01947946|20314459|P3|NOT COMPLETED|Overall Study||5
8238053|NCT01947946|20314460|P2|NOT COMPLETED|Overall Study||5
8238054|NCT01947946|20314461|P1|NOT COMPLETED|Overall Study||3
8238055|NCT01947946|20314459|P3|COMPLETED|Overall Study||0
8238056|NCT01947946|20314460|P2|COMPLETED|Overall Study||0
8238057|NCT01947946|20314461|P1|COMPLETED|Overall Study|Study Stopped|0
8238058|NCT01947946|20314459|P3|STARTED|Overall Study||5
8238059|NCT01947946|20314460|P2|STARTED|Overall Study||5
8238060|NCT01947946|20314461|P1|STARTED|Overall Study||3
8238061|NCT01947907|20314473|P4|NOT COMPLETED|Overall Study||0
8238062|NCT01947907|20314474|P3|NOT COMPLETED|Overall Study||0
8238063|NCT01947907|20314475|P2|NOT COMPLETED|Overall Study||0
8238064|NCT01947907|20314476|P1|NOT COMPLETED|Overall Study||0
8238065|NCT01947907|20314473|P4|COMPLETED|Overall Study||13
8238066|NCT01947907|20314474|P3|COMPLETED|Overall Study||14
8238067|NCT01947907|20314475|P2|COMPLETED|Overall Study||14
8238068|NCT01947907|20314476|P1|COMPLETED|Overall Study||12
8238069|NCT01947907|20314473|P4|STARTED|Overall Study||13
8238070|NCT01947907|20314474|P3|STARTED|Overall Study||14
8238071|NCT01947907|20314475|P2|STARTED|Overall Study||14
8238072|NCT01947907|20314476|P1|STARTED|Overall Study||12
8238073|NCT01947894|20314518|P3|NOT COMPLETED|Overall Study||27
8238074|NCT01947894|20314519|P2|NOT COMPLETED|Overall Study||18
8238075|NCT01947894|20314520|P1|NOT COMPLETED|Overall Study||87
8238076|NCT01947894|20314518|P3|COMPLETED|Overall Study||61
8238077|NCT01947894|20314519|P2|COMPLETED|Overall Study||24
8238078|NCT01947894|20314520|P1|COMPLETED|Overall Study||160
8238079|NCT01947894|20314518|P3|Treated|Overall Study||87
8238080|NCT01947894|20314519|P2|Treated|Overall Study||41
8238081|NCT01947894|20314520|P1|Treated|Overall Study||246
8238082|NCT01947894|20314518|P3|STARTED|Overall Study||88
8238083|NCT01947894|20314519|P2|STARTED|Overall Study||42
8238084|NCT01947894|20314520|P1|STARTED|Overall Study||247
8238085|NCT01947855|20314585|P3|NOT COMPLETED|Overall Study||0
8238086|NCT01947855|20314586|P2|NOT COMPLETED|Overall Study||0
8238087|NCT01947855|20314587|P1|NOT COMPLETED|Overall Study||1
8238088|NCT01947855|20314585|P3|COMPLETED|Overall Study||19
8238089|NCT01947855|20314586|P2|COMPLETED|Overall Study||20
8238090|NCT01947855|20314587|P1|COMPLETED|Overall Study||20
8238091|NCT01947855|20314585|P3|STARTED|Overall Study||19
8238092|NCT01947855|20314586|P2|STARTED|Overall Study||20
8238093|NCT01947855|20314587|P1|STARTED|Overall Study||21
8238094|NCT01947816|20314595|P1|NOT COMPLETED|Overall Study||70
8238095|NCT01947816|20314595|P1|COMPLETED|Overall Study||1523
8238096|NCT01947816|20314595|P1|STARTED|Overall Study||1593
8238097|NCT01947647|20314605|P2|NOT COMPLETED|6-month Followup Phase||8
8238098|NCT01947647|20314606|P1|NOT COMPLETED|6-month Followup Phase||9
8238099|NCT01947647|20314605|P2|COMPLETED|6-month Followup Phase||13
8238100|NCT01947647|20314606|P1|COMPLETED|6-month Followup Phase||20
8238101|NCT01947647|20314605|P2|STARTED|6-month Followup Phase||21
8238102|NCT01947647|20314606|P1|STARTED|6-month Followup Phase||29
8238103|NCT01947647|20314605|P2|NOT COMPLETED|Treatment Phase||26
8238104|NCT01947647|20314606|P1|NOT COMPLETED|Treatment Phase||17
8238105|NCT01947647|20314605|P2|COMPLETED|Treatment Phase||21
8238106|NCT01947647|20314606|P1|COMPLETED|Treatment Phase||29
8238107|NCT01947647|20314605|P2|STARTED|Treatment Phase||47
8238108|NCT01947647|20314606|P1|STARTED|Treatment Phase||46
8238109|NCT01947582|20314622|P1|NOT COMPLETED|Overall Study||1
8238110|NCT01947582|20314622|P1|COMPLETED|Overall Study||1
8238111|NCT01947582|20314622|P1|STARTED|Overall Study||2
8238112|NCT01947517|20314631|P2|NOT COMPLETED|Overall Study||1
8238113|NCT01947517|20314632|P1|NOT COMPLETED|Overall Study||1
8238114|NCT01947517|20314631|P2|COMPLETED|Overall Study||25
8238115|NCT01947517|20314632|P1|COMPLETED|Overall Study||25
8238116|NCT01947517|20314631|P2|STARTED|Overall Study||26
8238117|NCT01947517|20314632|P1|STARTED|Overall Study||26
8238118|NCT01947491|20314650|P4|NOT COMPLETED|Overall Study||5
8238119|NCT01947491|20314651|P3|NOT COMPLETED|Overall Study||2
8238120|NCT01947491|20314652|P2|NOT COMPLETED|Overall Study||6
8238121|NCT01947491|20314653|P1|NOT COMPLETED|Overall Study||8
8238122|NCT01947491|20314650|P4|COMPLETED|Overall Study||38
8238123|NCT01947491|20314651|P3|COMPLETED|Overall Study||88
8238124|NCT01947491|20314652|P2|COMPLETED|Overall Study||81
8238125|NCT01947491|20314653|P1|COMPLETED|Overall Study||166
8238126|NCT01947491|20314650|P4|STARTED|Overall Study||43
8238127|NCT01947491|20314651|P3|STARTED|Overall Study||90
8238128|NCT01947491|20314652|P2|STARTED|Overall Study||87
8238129|NCT01947491|20314653|P1|STARTED|Overall Study||174
8238130|NCT01947335|20314665|P2|NOT COMPLETED|Overall Study||0
8238131|NCT01947335|20314666|P1|NOT COMPLETED|Overall Study||0
8238132|NCT01947335|20314665|P2|COMPLETED|Overall Study||41
8238133|NCT01947335|20314666|P1|COMPLETED|Overall Study||42
8238134|NCT01947335|20314665|P2|STARTED|Overall Study||41
8238135|NCT01947335|20314666|P1|STARTED|Overall Study||42
8238136|NCT01947283|20314683|P7|NOT COMPLETED|Overall Study||8
8238137|NCT01947283|20314684|P6|NOT COMPLETED|Overall Study||7
8238138|NCT01947283|20314685|P5|NOT COMPLETED|Overall Study||0
8238139|NCT01947283|20314686|P4|NOT COMPLETED|Overall Study||17
8238140|NCT01947283|20314687|P3|NOT COMPLETED|Overall Study||21
8238141|NCT01947283|20314688|P2|NOT COMPLETED|Overall Study||23
8238142|NCT01947283|20314689|P1|NOT COMPLETED|Overall Study||29
8238143|NCT01947283|20314683|P7|COMPLETED|Overall Study||32
8238144|NCT01947283|20314684|P6|COMPLETED|Overall Study||27
8238145|NCT01947283|20314685|P5|COMPLETED|Overall Study||95
8238146|NCT01947283|20314686|P4|COMPLETED|Overall Study||55
8238147|NCT01947283|20314687|P3|COMPLETED|Overall Study||62
8238148|NCT01947283|20314688|P2|COMPLETED|Overall Study||45
8238149|NCT01947283|20314689|P1|COMPLETED|Overall Study||60
8238150|NCT01947283|20314683|P7|Completed NRCT Baseline Assessment|Overall Study||0
8238151|NCT01947283|20314684|P6|Completed NRCT Baseline Assessment|Overall Study||0
8238152|NCT01947283|20314685|P5|Completed NRCT Baseline Assessment|Overall Study||95
8238153|NCT01947283|20314686|P4|Completed NRCT Baseline Assessment|Overall Study||0
8238154|NCT01947283|20314687|P3|Completed NRCT Baseline Assessment|Overall Study||0
8238155|NCT01947283|20314688|P2|Completed NRCT Baseline Assessment|Overall Study||0
8238156|NCT01947283|20314689|P1|Completed NRCT Baseline Assessment|Overall Study||0
8238157|NCT01947283|20314683|P7|In Analysis|Overall Study||38
8238158|NCT01947283|20314684|P6|In Analysis|Overall Study||30
8238159|NCT01947283|20314685|P5|In Analysis|Overall Study||95
8238160|NCT01947283|20314686|P4|In Analysis|Overall Study||72
8238161|NCT01947283|20314687|P3|In Analysis|Overall Study||83
8238162|NCT01947283|20314688|P2|In Analysis|Overall Study||68
8238163|NCT01947283|20314689|P1|In Analysis|Overall Study||89
8238164|NCT01947283|20314683|P7|End-of-Intervention Assessment|Overall Study||33
8238165|NCT01947283|20314684|P6|End-of-Intervention Assessment|Overall Study||32
8238166|NCT01947283|20314685|P5|End-of-Intervention Assessment|Overall Study||0
8238167|NCT01947283|20314686|P4|End-of-Intervention Assessment|Overall Study||66
8238168|NCT01947283|20314687|P3|End-of-Intervention Assessment|Overall Study||73
8238169|NCT01947283|20314688|P2|End-of-Intervention Assessment|Overall Study||53
8238170|NCT01947283|20314689|P1|End-of-Intervention Assessment|Overall Study||74
8238171|NCT01947283|20314683|P7|Clinical Recording|Overall Study||0
8238172|NCT01947283|20314684|P6|Clinical Recording|Overall Study||0
8238173|NCT01947283|20314685|P5|Clinical Recording|Overall Study||0
8238174|NCT01947283|20314686|P4|Clinical Recording|Overall Study||57
8238175|NCT01947283|20314687|P3|Clinical Recording|Overall Study||68
8238176|NCT01947283|20314688|P2|Clinical Recording|Overall Study||54
8238177|NCT01947283|20314689|P1|Clinical Recording|Overall Study||65
8238178|NCT01947283|20314683|P7|Follow-up Assessment|Overall Study||36
8238179|NCT01947283|20314684|P6|Follow-up Assessment|Overall Study||27
8238180|NCT01947283|20314685|P5|Follow-up Assessment|Overall Study||0
8238181|NCT01947283|20314686|P4|Follow-up Assessment|Overall Study||59
8238182|NCT01947283|20314687|P3|Follow-up Assessment|Overall Study||65
8238183|NCT01947283|20314688|P2|Follow-up Assessment|Overall Study||51
8238184|NCT01947283|20314689|P1|Follow-up Assessment|Overall Study||64
8238185|NCT01947283|20314683|P7|Baseline Assessment|Overall Study||40
8238186|NCT01947283|20314684|P6|Baseline Assessment|Overall Study||34
8238187|NCT01947283|20314685|P5|Baseline Assessment|Overall Study||0
8238188|NCT01947283|20314686|P4|Baseline Assessment|Overall Study||72
8238189|NCT01947283|20314687|P3|Baseline Assessment|Overall Study||83
8238190|NCT01947283|20314688|P2|Baseline Assessment|Overall Study||68
8238191|NCT01947283|20314689|P1|Baseline Assessment|Overall Study||89
8238192|NCT01947283|20314683|P7|STARTED|Overall Study||40
8238193|NCT01947283|20314684|P6|STARTED|Overall Study||34
8238194|NCT01947283|20314685|P5|STARTED|Overall Study||95
8238195|NCT01947283|20314686|P4|STARTED|Overall Study||72
8238196|NCT01947283|20314687|P3|STARTED|Overall Study||83
8238197|NCT01947283|20314688|P2|STARTED|Overall Study||68
8238198|NCT01947283|20314689|P1|STARTED|Overall Study||89
8238199|NCT01947153|20314740|P2|NOT COMPLETED|Test Period 2||0
8238200|NCT01947153|20314741|P1|NOT COMPLETED|Test Period 2||0
8238201|NCT01947153|20314740|P2|COMPLETED|Test Period 2||18
8238202|NCT01947153|20314741|P1|COMPLETED|Test Period 2||18
8238203|NCT01947153|20314740|P2|STARTED|Test Period 2||18
8238204|NCT01947153|20314741|P1|STARTED|Test Period 2||18
8238205|NCT01947153|20314740|P2|NOT COMPLETED|Test Period 1||0
8238206|NCT01947153|20314741|P1|NOT COMPLETED|Test Period 1||0
8238207|NCT01947153|20314740|P2|COMPLETED|Test Period 1||18
8238208|NCT01947153|20314741|P1|COMPLETED|Test Period 1||18
8238209|NCT01947153|20314740|P2|STARTED|Test Period 1||18
8238210|NCT01947153|20314741|P1|STARTED|Test Period 1||18
8238211|NCT01947127|20314761|P2|NOT COMPLETED|Overall Study||43
8238212|NCT01947127|20314762|P1|NOT COMPLETED|Overall Study||23
8238213|NCT01947127|20314761|P2|COMPLETED|Overall Study||249
8238214|NCT01947127|20314762|P1|COMPLETED|Overall Study||143
8238215|NCT01947127|20314761|P2|STARTED|Overall Study||292
8238216|NCT01947127|20314762|P1|STARTED|Overall Study||166
8238217|NCT01946880|20314774|P2|NOT COMPLETED|Overall Study||3
8238218|NCT01946880|20314775|P1|NOT COMPLETED|Overall Study||7
8238219|NCT01946880|20314774|P2|COMPLETED|Overall Study||49
8238220|NCT01946880|20314775|P1|COMPLETED|Overall Study||43
8238221|NCT01946880|20314774|P2|STARTED|Overall Study||52
8238222|NCT01946880|20314775|P1|STARTED|Overall Study||50
8238223|NCT01946542|20314853|P2|NOT COMPLETED|Testing Visit 2||0
8238224|NCT01946542|20314854|P1|NOT COMPLETED|Testing Visit 2||0
8238225|NCT01946542|20314853|P2|COMPLETED|Testing Visit 2||1
8238226|NCT01946542|20314854|P1|COMPLETED|Testing Visit 2||1
8238227|NCT01946542|20314853|P2|STARTED|Testing Visit 2||1
8238228|NCT01946542|20314854|P1|STARTED|Testing Visit 2||1
8238229|NCT01946542|20314853|P2|NOT COMPLETED|Testing Visit 1||0
8238230|NCT01946542|20314854|P1|NOT COMPLETED|Testing Visit 1||0
8238231|NCT01946542|20314853|P2|COMPLETED|Testing Visit 1||1
8238232|NCT01946542|20314854|P1|COMPLETED|Testing Visit 1||1
8238233|NCT01946542|20314853|P2|STARTED|Testing Visit 1||1
8238234|NCT01946542|20314854|P1|STARTED|Testing Visit 1||1
8238253|NCT01946438|20314878|P4|NOT COMPLETED|Overall Study||1
8238254|NCT01946438|20314879|P3|NOT COMPLETED|Overall Study||1
8238255|NCT01946438|20314880|P2|NOT COMPLETED|Overall Study||0
8238256|NCT01946438|20314881|P1|NOT COMPLETED|Overall Study||2
8238257|NCT01946438|20314878|P4|COMPLETED|Overall Study||51
8238258|NCT01946438|20314879|P3|COMPLETED|Overall Study||51
8238259|NCT01946438|20314880|P2|COMPLETED|Overall Study||52
8238260|NCT01946438|20314881|P1|COMPLETED|Overall Study||50
8238261|NCT01946438|20314878|P4|STARTED|Overall Study||52
8238262|NCT01946438|20314879|P3|STARTED|Overall Study||52
8238263|NCT01946438|20314880|P2|STARTED|Overall Study||52
8238264|NCT01946438|20314881|P1|STARTED|Overall Study||52
8238265|NCT01946425|20314909|P2|NOT COMPLETED|Overall Study||0
8238266|NCT01946425|20314910|P1|NOT COMPLETED|Overall Study||2
8238267|NCT01946425|20314909|P2|COMPLETED|Overall Study||30
8238268|NCT01946425|20314910|P1|COMPLETED|Overall Study||28
8238269|NCT01946425|20314909|P2|STARTED|Overall Study||30
8238270|NCT01946425|20314910|P1|STARTED|Overall Study||30
8238271|NCT01946412|20314924|P1|NOT COMPLETED|Overall Study||5
8238272|NCT01946412|20314924|P1|COMPLETED|Overall Study||28
8238273|NCT01946412|20314924|P1|STARTED|Overall Study||33
8238274|NCT01946282|20314949|P3|NOT COMPLETED|Year 3||30
8238275|NCT01946282|20314950|P2|NOT COMPLETED|Year 3||43
8238276|NCT01946282|20314951|P1|NOT COMPLETED|Year 3||288
8238277|NCT01946282|20314949|P3|COMPLETED|Year 3||140
8238278|NCT01946282|20314950|P2|COMPLETED|Year 3||141
8238279|NCT01946282|20314951|P1|COMPLETED|Year 3||856
8238280|NCT01946282|20314949|P3|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|170
8238281|NCT01946282|20314950|P2|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|184
8238282|NCT01946282|20314951|P1|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|1144
8238283|NCT01946282|20314949|P3|NOT COMPLETED|Year 2||115
8238284|NCT01946282|20314950|P2|NOT COMPLETED|Year 2||131
8238285|NCT01946282|20314951|P1|NOT COMPLETED|Year 2||803
8238286|NCT01946282|20314949|P3|COMPLETED|Year 2||184
8238287|NCT01946282|20314950|P2|COMPLETED|Year 2||210
8238288|NCT01946282|20314951|P1|COMPLETED|Year 2||1248
8238289|NCT01946282|20314949|P3|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|299
8238290|NCT01946282|20314950|P2|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|341
8238291|NCT01946282|20314951|P1|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|2051
8238292|NCT01946282|20314949|P3|NOT COMPLETED|Year 1||654
8238293|NCT01946282|20314950|P2|NOT COMPLETED|Year 1||608
8238294|NCT01946282|20314951|P1|NOT COMPLETED|Year 1||4186
8238295|NCT01946282|20314949|P3|COMPLETED|Year 1||346
8238296|NCT01946282|20314950|P2|COMPLETED|Year 1||392
8238297|NCT01946282|20314951|P1|COMPLETED|Year 1||2379
8238298|NCT01946282|20314949|P3|STARTED|Year 1||1000
8238299|NCT01946282|20314950|P2|STARTED|Year 1||1000
8238300|NCT01946282|20314951|P1|STARTED|Year 1||6565
8238301|NCT01946243|20314961|P1|NOT COMPLETED|Overall Study||0
8238302|NCT01946243|20314961|P1|COMPLETED|Overall Study||96
8238303|NCT01946243|20314961|P1|STARTED|Overall Study||96
8238312|NCT01946191|20315003|P2|NOT COMPLETED|Primary Outcome Analysis||18
8238313|NCT01946191|20315004|P1|NOT COMPLETED|Primary Outcome Analysis||18
8238314|NCT01946191|20315003|P2|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|77
8238315|NCT01946191|20315004|P1|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|80
8238316|NCT01946191|20315003|P2|STARTED|Primary Outcome Analysis||95
8238317|NCT01946191|20315004|P1|STARTED|Primary Outcome Analysis||98
8238318|NCT01946191|20315003|P2|NOT COMPLETED|Follow-Up, 24-mo Endpoint||18
8238319|NCT01946191|20315004|P1|NOT COMPLETED|Follow-Up, 24-mo Endpoint||17
8238320|NCT01946191|20315003|P2|COMPLETED|Follow-Up, 24-mo Endpoint||77
8238321|NCT01946191|20315004|P1|COMPLETED|Follow-Up, 24-mo Endpoint||80
8238322|NCT01946191|20315003|P2|STARTED|Follow-Up, 24-mo Endpoint||95
8238323|NCT01946191|20315004|P1|STARTED|Follow-Up, 24-mo Endpoint||97
8238324|NCT01946191|20315003|P2|NOT COMPLETED|Allocation||1
8238325|NCT01946191|20315004|P1|NOT COMPLETED|Allocation||1
8238326|NCT01946191|20315003|P2|COMPLETED|Allocation||95
8238327|NCT01946191|20315004|P1|COMPLETED|Allocation||97
8238328|NCT01946191|20315003|P2|STARTED|Allocation||96
8238329|NCT01946191|20315004|P1|STARTED|Allocation||98
8238330|NCT01946178|20315030|P1|NOT COMPLETED|Overall Study||2
8238331|NCT01946178|20315030|P1|COMPLETED|Overall Study||71
8238332|NCT01946178|20315030|P1|STARTED|Overall Study||73
8238333|NCT01946165|20315040|P2|NOT COMPLETED|Overall Study||2
8238334|NCT01946165|20315041|P1|NOT COMPLETED|Overall Study||2
8238335|NCT01946165|20315040|P2|COMPLETED|Overall Study||21
8238336|NCT01946165|20315041|P1|COMPLETED|Overall Study||43
8238337|NCT01946165|20315040|P2|STARTED|Overall Study||23
8238338|NCT01946165|20315041|P1|STARTED|Overall Study||45
8238339|NCT01946126|20315051|P2|NOT COMPLETED|Overall Study||0
8238340|NCT01946126|20315052|P1|NOT COMPLETED|Overall Study||0
8238341|NCT01946126|20315051|P2|COMPLETED|Overall Study||275
8238342|NCT01946126|20315052|P1|COMPLETED|Overall Study||184
8238343|NCT01946126|20315051|P2|STARTED|Overall Study||275
8238344|NCT01946126|20315052|P1|STARTED|Overall Study||184
8238345|NCT01945996|20315068|P2|NOT COMPLETED|Overall Study||5
8238346|NCT01945996|20315069|P1|NOT COMPLETED|Overall Study||3
8238347|NCT01945996|20315068|P2|COMPLETED|Overall Study||17
8238348|NCT01945996|20315069|P1|COMPLETED|Overall Study||19
8238349|NCT01945996|20315068|P2|STARTED|Overall Study||22
8238350|NCT01945996|20315069|P1|STARTED|Overall Study||22
8238351|NCT01945970|20315101|P6|NOT COMPLETED|Overall Study||0
8238352|NCT01945970|20315102|P5|NOT COMPLETED|Overall Study||0
8238353|NCT01945970|20315103|P4|NOT COMPLETED|Overall Study||0
8238354|NCT01945970|20315104|P3|NOT COMPLETED|Overall Study||0
8238355|NCT01945970|20315105|P2|NOT COMPLETED|Overall Study||0
8238356|NCT01945970|20315106|P1|NOT COMPLETED|Overall Study||0
8238357|NCT01945970|20315101|P6|COMPLETED|Overall Study||5
8238358|NCT01945970|20315102|P5|COMPLETED|Overall Study||5
8238359|NCT01945970|20315103|P4|COMPLETED|Overall Study||5
8238360|NCT01945970|20315104|P3|COMPLETED|Overall Study||5
8238361|NCT01945970|20315105|P2|COMPLETED|Overall Study||5
8238362|NCT01945970|20315106|P1|COMPLETED|Overall Study||5
8238363|NCT01945970|20315101|P6|STARTED|Overall Study||5
8238364|NCT01945970|20315102|P5|STARTED|Overall Study||5
8238365|NCT01945970|20315103|P4|STARTED|Overall Study||5
8238366|NCT01945970|20315104|P3|STARTED|Overall Study||5
8238367|NCT01945970|20315105|P2|STARTED|Overall Study||5
8238368|NCT01945970|20315106|P1|STARTED|Overall Study||5
8238369|NCT01945944|20315145|P2|NOT COMPLETED|Overall Study||3
8238370|NCT01945944|20315146|P1|NOT COMPLETED|Overall Study||1
8238371|NCT01945944|20315145|P2|COMPLETED|Overall Study||6
8238372|NCT01945944|20315146|P1|COMPLETED|Overall Study||8
8238373|NCT01945944|20315145|P2|STARTED|Overall Study||9
8238374|NCT01945944|20315146|P1|STARTED|Overall Study||9
8238375|NCT01945866|20315170|P2|NOT COMPLETED|Overall Study||0
8238376|NCT01945866|20315171|P1|NOT COMPLETED|Overall Study||2
8238377|NCT01945866|20315170|P2|COMPLETED|Overall Study||64
8238378|NCT01945866|20315171|P1|COMPLETED|Overall Study||63
8238379|NCT01945866|20315170|P2|STARTED|Overall Study||64
8238380|NCT01945866|20315171|P1|STARTED|Overall Study||65
8238389|NCT01945710|20315229|P7|NOT COMPLETED|Overall Study||23
8238390|NCT01945710|20315230|P6|NOT COMPLETED|Overall Study||3
8238391|NCT01945710|20315231|P5|NOT COMPLETED|Overall Study||9
8238392|NCT01945710|20315232|P4|NOT COMPLETED|Overall Study||3
8238393|NCT01945710|20315233|P3|NOT COMPLETED|Overall Study||7
8238394|NCT01945710|20315234|P2|NOT COMPLETED|Overall Study||6
8238395|NCT01945710|20315235|P1|NOT COMPLETED|Overall Study||7
8238396|NCT01945710|20315229|P7|COMPLETED|Overall Study||0
8238397|NCT01945710|20315230|P6|COMPLETED|Overall Study||0
8238398|NCT01945710|20315231|P5|COMPLETED|Overall Study||0
8238399|NCT01945710|20315232|P4|COMPLETED|Overall Study||0
8238400|NCT01945710|20315233|P3|COMPLETED|Overall Study||0
8238401|NCT01945710|20315234|P2|COMPLETED|Overall Study||0
8238402|NCT01945710|20315235|P1|COMPLETED|Overall Study||0
8238403|NCT01945710|20315229|P7|STARTED|Overall Study||23
8238404|NCT01945710|20315230|P6|STARTED|Overall Study||3
8238405|NCT01945710|20315231|P5|STARTED|Overall Study||9
8238406|NCT01945710|20315232|P4|STARTED|Overall Study||3
8238407|NCT01945710|20315233|P3|STARTED|Overall Study||7
8238408|NCT01945710|20315234|P2|STARTED|Overall Study||6
8238409|NCT01945710|20315235|P1|STARTED|Overall Study||7
8238422|NCT01945489|20315439|P2|NOT COMPLETED|Cycle 2||1
8238423|NCT01945489|20315440|P1|NOT COMPLETED|Cycle 2||1
8238424|NCT01945489|20315439|P2|COMPLETED|Cycle 2||106
8238425|NCT01945489|20315440|P1|COMPLETED|Cycle 2||87
8238426|NCT01945489|20315439|P2|STARTED|Cycle 2||107
8238427|NCT01945489|20315440|P1|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
8238428|NCT01945489|20315439|P2|NOT COMPLETED|Cycle 1||4
8238429|NCT01945489|20315440|P1|NOT COMPLETED|Cycle 1||13
8238430|NCT01945489|20315439|P2|COMPLETED|Cycle 1||121
8238431|NCT01945489|20315440|P1|COMPLETED|Cycle 1||116
8238432|NCT01945489|20315439|P2|STARTED|Cycle 1||125
8238433|NCT01945489|20315440|P1|STARTED|Cycle 1||129
8238434|NCT01945294|20315460|P4|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
8238435|NCT01945294|20315461|P3|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
8238436|NCT01945294|20315462|P2|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
8238437|NCT01945294|20315463|P1|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
8238438|NCT01945294|20315460|P4|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
8238439|NCT01945294|20315461|P3|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
8238440|NCT01945294|20315462|P2|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
8238441|NCT01945294|20315463|P1|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
8238442|NCT01945294|20315460|P4|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
8238443|NCT01945294|20315461|P3|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
8238444|NCT01945294|20315462|P2|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
8238445|NCT01945294|20315463|P1|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
8238446|NCT01945294|20315460|P4|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8238447|NCT01945294|20315461|P3|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8238448|NCT01945294|20315462|P2|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8238449|NCT01945294|20315463|P1|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
8238450|NCT01945294|20315460|P4|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8238451|NCT01945294|20315461|P3|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8238452|NCT01945294|20315462|P2|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
8238453|NCT01945294|20315463|P1|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
8238454|NCT01945294|20315460|P4|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
8238455|NCT01945294|20315461|P3|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
8238456|NCT01945294|20315462|P2|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
8238457|NCT01945294|20315463|P1|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
8238458|NCT01945281|20315494|P2|NOT COMPLETED|Overall Study||4
8238459|NCT01945281|20315495|P1|NOT COMPLETED|Overall Study||6
8238460|NCT01945281|20315494|P2|COMPLETED|Overall Study||13
8238461|NCT01945281|20315495|P1|COMPLETED|Overall Study||28
8238462|NCT01945281|20315494|P2|Treated|Overall Study||16
8238463|NCT01945281|20315495|P1|Treated|Overall Study||33
8238464|NCT01945281|20315494|P2|STARTED|Overall Study||17
8238465|NCT01945281|20315495|P1|STARTED|Overall Study||34
8238466|NCT01945242|20315507|P2|NOT COMPLETED|Overall Study||3
8238467|NCT01945242|20315508|P1|NOT COMPLETED|Overall Study||3
8238468|NCT01945242|20315507|P2|COMPLETED|Overall Study||120
8238469|NCT01945242|20315508|P1|COMPLETED|Overall Study||1248
8238470|NCT01945242|20315507|P2|STARTED|Overall Study||123
8238471|NCT01945242|20315508|P1|STARTED|Overall Study||1251
8238472|NCT01945216|20315523|P1|NOT COMPLETED|Overall Study||99
8238473|NCT01945216|20315523|P1|COMPLETED|Overall Study||3218
8238474|NCT01945216|20315523|P1|STARTED|Overall Study||3317
8238475|NCT01945138|20315537|P2|NOT COMPLETED|Overall Study||0
8238476|NCT01945138|20315538|P1|NOT COMPLETED|Overall Study||0
8238477|NCT01945138|20315537|P2|COMPLETED|Overall Study||7
8238478|NCT01945138|20315538|P1|COMPLETED|Overall Study||7
8238479|NCT01945138|20315537|P2|STARTED|Overall Study||7
8238480|NCT01945138|20315538|P1|STARTED|Overall Study||7
8238481|NCT01945112|20315572|P2|NOT COMPLETED|Overall Study||0
8238482|NCT01945112|20315573|P1|NOT COMPLETED|Overall Study||0
8238483|NCT01945112|20315572|P2|COMPLETED|Overall Study||51
8238484|NCT01945112|20315573|P1|COMPLETED|Overall Study||77
8238485|NCT01945112|20315572|P2|STARTED|Overall Study|total number of sites where tape was applied|51
8238486|NCT01945112|20315573|P1|STARTED|Overall Study|total number of sites where tape was applied|77
8238487|NCT01945086|20315581|P3|NOT COMPLETED|Overall Study||2
8238488|NCT01945086|20315582|P2|NOT COMPLETED|Overall Study||0
8238489|NCT01945086|20315583|P1|NOT COMPLETED|Overall Study||1
8238490|NCT01945086|20315581|P3|COMPLETED|Overall Study||26
8238491|NCT01945086|20315582|P2|COMPLETED|Overall Study||24
8238492|NCT01945086|20315583|P1|COMPLETED|Overall Study||26
8238493|NCT01945086|20315581|P3|STARTED|Overall Study||28
8238494|NCT01945086|20315582|P2|STARTED|Overall Study||24
8238495|NCT01945086|20315583|P1|STARTED|Overall Study||27
8238496|NCT01945034|20315627|P3|NOT COMPLETED|Overall Study||7
8238497|NCT01945034|20315628|P2|NOT COMPLETED|Overall Study||5
8238498|NCT01945034|20315629|P1|NOT COMPLETED|Overall Study||1
8238499|NCT01945034|20315627|P3|COMPLETED|Overall Study||145
8238500|NCT01945034|20315628|P2|COMPLETED|Overall Study||80
8238501|NCT01945034|20315629|P1|COMPLETED|Overall Study||66
8238502|NCT01945034|20315627|P3|STARTED|Overall Study||152
8238503|NCT01945034|20315628|P2|STARTED|Overall Study||85
8238504|NCT01945034|20315629|P1|STARTED|Overall Study||67
8238511|NCT01944969|20315693|P1|NOT COMPLETED|Overall Study||26
8238512|NCT01944969|20315693|P1|COMPLETED|Overall Study||0
8238513|NCT01944969|20315693|P1|STARTED|Overall Study||26
8238514|NCT01944930|20315706|P2|NOT COMPLETED|Overall Study||1
8238515|NCT01944930|20315707|P1|NOT COMPLETED|Overall Study||2
8238516|NCT01944930|20315706|P2|COMPLETED|Overall Study||10
8238517|NCT01944930|20315707|P1|COMPLETED|Overall Study||10
8238518|NCT01944930|20315706|P2|STARTED|Overall Study||11
8238519|NCT01944930|20315707|P1|STARTED|Overall Study||12
8238520|NCT01944878|20315715|P2|NOT COMPLETED|Overall Study||0
8238521|NCT01944878|20315716|P1|NOT COMPLETED|Overall Study||0
8238522|NCT01944878|20315715|P2|COMPLETED|Overall Study||328
8238523|NCT01944878|20315716|P1|COMPLETED|Overall Study||127
8238524|NCT01944878|20315715|P2|STARTED|Overall Study||328
8238525|NCT01944878|20315716|P1|STARTED|Overall Study||127
8238526|NCT01944839|20315726|P2|NOT COMPLETED|Overall Study||28
8238527|NCT01944839|20315727|P1|NOT COMPLETED|Overall Study||22
8238528|NCT01944839|20315726|P2|COMPLETED|Overall Study||282
8238529|NCT01944839|20315727|P1|COMPLETED|Overall Study||287
8238530|NCT01944839|20315726|P2|STARTED|Overall Study||310
8238531|NCT01944839|20315727|P1|STARTED|Overall Study||309
8238532|NCT01944774|20315736|P3|NOT COMPLETED|Overall Study||8
8238533|NCT01944774|20315737|P2|NOT COMPLETED|Overall Study||8
8238534|NCT01944774|20315738|P1|NOT COMPLETED|Overall Study||6
8238535|NCT01944774|20315736|P3|COMPLETED|Overall Study||62
8238536|NCT01944774|20315737|P2|COMPLETED|Overall Study||60
8238537|NCT01944774|20315738|P1|COMPLETED|Overall Study||63
8238538|NCT01944774|20315736|P3|Received Treatment|Overall Study||70
8238539|NCT01944774|20315737|P2|Received Treatment|Overall Study||67
8238540|NCT01944774|20315738|P1|Received Treatment|Overall Study||68
8238541|NCT01944774|20315736|P3|STARTED|Overall Study||70
8238542|NCT01944774|20315737|P2|STARTED|Overall Study||68
8238543|NCT01944774|20315738|P1|STARTED|Overall Study||69
8238544|NCT01944722|20315781|P1|NOT COMPLETED|Overall Study||9515
8238545|NCT01944722|20315781|P1|COMPLETED|Overall Study||24343
8238546|NCT01944722|20315781|P1|STARTED|Overall Study||33858
8238547|NCT01944670|20315815|P1|NOT COMPLETED|Overall Study||2
8238548|NCT01944670|20315815|P1|COMPLETED|Overall Study||24
8238549|NCT01944670|20315815|P1|STARTED|Overall Study||26
8238550|NCT01944644|20315822|P2|NOT COMPLETED|Overall Study||0
8238551|NCT01944644|20315823|P1|NOT COMPLETED|Overall Study||0
8238552|NCT01944644|20315822|P2|COMPLETED|Overall Study||32
8238553|NCT01944644|20315823|P1|COMPLETED|Overall Study||34
8238554|NCT01944644|20315822|P2|STARTED|Overall Study||32
8238555|NCT01944644|20315823|P1|STARTED|Overall Study||34
8238556|NCT01944631|20315837|P2|NOT COMPLETED|Overall Study||2
8238557|NCT01944631|20315838|P1|NOT COMPLETED|Overall Study||4
8238558|NCT01944631|20315837|P2|COMPLETED|Overall Study||98
8238559|NCT01944631|20315838|P1|COMPLETED|Overall Study||96
8238560|NCT01944631|20315837|P2|STARTED|Overall Study||100
8238561|NCT01944631|20315838|P1|STARTED|Overall Study||100
8238562|NCT01944462|20315854|P1|NOT COMPLETED|Optional Vaccination||0
8238563|NCT01944462|20315854|P1|COMPLETED|Optional Vaccination||20
8238564|NCT01944462|20315854|P1|STARTED|Optional Vaccination||20
8238565|NCT01944462|20315854|P1|NOT COMPLETED|PPPP Educational Program||60
8238566|NCT01944462|20315854|P1|COMPLETED|PPPP Educational Program||143
8238567|NCT01944462|20315854|P1|3 Month Follow-Up|PPPP Educational Program||143
8238568|NCT01944462|20315854|P1|Post-Test|PPPP Educational Program||187
8238569|NCT01944462|20315854|P1|Baseline|PPPP Educational Program||203
8238570|NCT01944462|20315854|P1|STARTED|PPPP Educational Program||203
8238571|NCT01944371|20315866|P3|NOT COMPLETED|Overall Study||0
8238572|NCT01944371|20315867|P2|NOT COMPLETED|Overall Study||0
8238573|NCT01944371|20315868|P1|NOT COMPLETED|Overall Study||0
8238574|NCT01944371|20315866|P3|COMPLETED|Overall Study||10
8238575|NCT01944371|20315867|P2|COMPLETED|Overall Study||10
8238576|NCT01944371|20315868|P1|COMPLETED|Overall Study||10
8238577|NCT01944371|20315866|P3|STARTED|Overall Study||10
8238578|NCT01944371|20315867|P2|STARTED|Overall Study||10
8238579|NCT01944371|20315868|P1|STARTED|Overall Study||10
8238580|NCT01944345|20315885|P1|NOT COMPLETED|Overall Study||0
8238581|NCT01944345|20315885|P1|COMPLETED|Overall Study||69
8238582|NCT01944345|20315885|P1|STARTED|Overall Study||69
8238583|NCT01944319|20315893|P2|NOT COMPLETED|Overall Study||0
8238584|NCT01944319|20315894|P1|NOT COMPLETED|Overall Study||0
8238585|NCT01944319|20315893|P2|COMPLETED|Overall Study||39
8238586|NCT01944319|20315894|P1|COMPLETED|Overall Study||40
8238587|NCT01944319|20315893|P2|STARTED|Overall Study||39
8238588|NCT01944319|20315894|P1|STARTED|Overall Study||40
8238589|NCT01944293|20315906|P2|NOT COMPLETED|Overall Study||0
8238590|NCT01944293|20315907|P1|NOT COMPLETED|Overall Study||0
8238591|NCT01944293|20315906|P2|COMPLETED|Overall Study||9
8238592|NCT01944293|20315907|P1|COMPLETED|Overall Study||7
8238593|NCT01944293|20315906|P2|STARTED|Overall Study||9
8238594|NCT01944293|20315907|P1|STARTED|Overall Study||7
8238595|NCT01944098|20315917|P2|NOT COMPLETED|Overall Study||0
8238596|NCT01944098|20315918|P1|NOT COMPLETED|Overall Study||1
8238597|NCT01944098|20315917|P2|COMPLETED|Overall Study||10
8238598|NCT01944098|20315918|P1|COMPLETED|Overall Study||9
8238599|NCT01944098|20315917|P2|STARTED|Overall Study||10
8238600|NCT01944098|20315918|P1|STARTED|Overall Study||10
8238601|NCT01944059|20315930|P1|NOT COMPLETED|Overall Study||7
8238602|NCT01944059|20315930|P1|COMPLETED|Overall Study||24
8238603|NCT01944059|20315930|P1|STARTED|Overall Study||31
8238616|NCT01943864|20315980|P1|NOT COMPLETED|Overall Study||0
8238617|NCT01943864|20315980|P1|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
8238618|NCT01943864|20315980|P1|STARTED|Overall Study||20
8238619|NCT01943825|20316012|P4|NOT COMPLETED|Overall Study||11
8238620|NCT01943825|20316013|P3|NOT COMPLETED|Overall Study||15
8238621|NCT01943825|20316014|P2|NOT COMPLETED|Overall Study||4
8238622|NCT01943825|20316015|P1|NOT COMPLETED|Overall Study||10
8238623|NCT01943825|20316012|P4|COMPLETED|Overall Study||14
8238624|NCT01943825|20316013|P3|COMPLETED|Overall Study||10
8238625|NCT01943825|20316014|P2|COMPLETED|Overall Study||11
8238626|NCT01943825|20316015|P1|COMPLETED|Overall Study||15
8238627|NCT01943825|20316012|P4|STARTED|Overall Study||25
8238628|NCT01943825|20316013|P3|STARTED|Overall Study||25
8238629|NCT01943825|20316014|P2|STARTED|Overall Study||15
8238630|NCT01943825|20316015|P1|STARTED|Overall Study||25
8238631|NCT01943799|20316057|P4|NOT COMPLETED|Overall Study||0
8238632|NCT01943799|20316058|P3|NOT COMPLETED|Overall Study||2
8238633|NCT01943799|20316059|P2|NOT COMPLETED|Overall Study||3
8238634|NCT01943799|20316060|P1|NOT COMPLETED|Overall Study||5
8238635|NCT01943799|20316057|P4|COMPLETED|Overall Study||50
8238636|NCT01943799|20316058|P3|COMPLETED|Overall Study||49
8238637|NCT01943799|20316059|P2|COMPLETED|Overall Study||47
8238638|NCT01943799|20316060|P1|COMPLETED|Overall Study||22
8238639|NCT01943799|20316057|P4|STARTED|Overall Study||50
8238640|NCT01943799|20316058|P3|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51
8238641|NCT01943799|20316059|P2|STARTED|Overall Study||50
8238642|NCT01943799|20316060|P1|STARTED|Overall Study||27
8238643|NCT01943591|20316100|P2|NOT COMPLETED|Overall Study||11
8238644|NCT01943591|20316101|P1|NOT COMPLETED|Overall Study||5
8238645|NCT01943591|20316100|P2|COMPLETED|Overall Study||95
8238646|NCT01943591|20316101|P1|COMPLETED|Overall Study||99
8238647|NCT01943591|20316100|P2|STARTED|Overall Study||106
8238648|NCT01943591|20316101|P1|STARTED|Overall Study||104
8238649|NCT01943565|20316126|P3|NOT COMPLETED|Overall Study||0
8238650|NCT01943565|20316127|P2|NOT COMPLETED|Overall Study||0
8238651|NCT01943565|20316128|P1|NOT COMPLETED|Overall Study||0
8238652|NCT01943565|20316126|P3|COMPLETED|Overall Study||9
8238653|NCT01943565|20316127|P2|COMPLETED|Overall Study||9
8238654|NCT01943565|20316128|P1|COMPLETED|Overall Study||11
8238655|NCT01943565|20316126|P3|STARTED|Overall Study||9
8238656|NCT01943565|20316127|P2|STARTED|Overall Study||9
8238657|NCT01943565|20316128|P1|STARTED|Overall Study||11
8238658|NCT01943552|20316159|P2|NOT COMPLETED|Overall Study||25
8238659|NCT01943552|20316160|P1|NOT COMPLETED|Overall Study||25
8238660|NCT01943552|20316159|P2|COMPLETED|Overall Study||69
8238661|NCT01943552|20316160|P1|COMPLETED|Overall Study||71
8238662|NCT01943552|20316159|P2|STARTED|Overall Study||94
8238663|NCT01943552|20316160|P1|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
8238664|NCT01943539|20316176|P2|NOT COMPLETED|Overall Study||0
8238665|NCT01943539|20316177|P1|NOT COMPLETED|Overall Study||4
8238666|NCT01943539|20316176|P2|COMPLETED|Overall Study||40
8238667|NCT01943539|20316177|P1|COMPLETED|Overall Study||40
8238668|NCT01943539|20316176|P2|STARTED|Overall Study||40
8238669|NCT01943539|20316177|P1|STARTED|Overall Study||44
8238670|NCT01943474|20316188|P2|NOT COMPLETED|Overall Study||0
8238671|NCT01943474|20316189|P1|NOT COMPLETED|Overall Study||0
8238672|NCT01943474|20316188|P2|COMPLETED|Overall Study||125
8238673|NCT01943474|20316189|P1|COMPLETED|Overall Study||123
8238674|NCT01943474|20316188|P2|STARTED|Overall Study||125
8238675|NCT01943474|20316189|P1|STARTED|Overall Study||123
8238676|NCT01943461|20316214|P4|NOT COMPLETED|Overall Study||0
8238677|NCT01943461|20316215|P3|NOT COMPLETED|Overall Study||0
8238678|NCT01943461|20316216|P2|NOT COMPLETED|Overall Study||0
8238679|NCT01943461|20316217|P1|NOT COMPLETED|Overall Study||0
8238680|NCT01943461|20316214|P4|COMPLETED|Overall Study||40
8238681|NCT01943461|20316215|P3|COMPLETED|Overall Study||6
8238682|NCT01943461|20316216|P2|COMPLETED|Overall Study||6
8238683|NCT01943461|20316217|P1|COMPLETED|Overall Study||5
8238684|NCT01943461|20316214|P4|STARTED|Overall Study||40
8238685|NCT01943461|20316215|P3|STARTED|Overall Study||6
8238686|NCT01943461|20316216|P2|STARTED|Overall Study||6
8238687|NCT01943461|20316217|P1|STARTED|Overall Study||5
8238688|NCT01943435|20316274|P3|NOT COMPLETED|6 Month Follow up||15
8238689|NCT01943435|20316275|P2|NOT COMPLETED|6 Month Follow up||7
8238690|NCT01943435|20316276|P1|NOT COMPLETED|6 Month Follow up||12
8238691|NCT01943435|20316274|P3|COMPLETED|6 Month Follow up||65
8238692|NCT01943435|20316275|P2|COMPLETED|6 Month Follow up||59
8238693|NCT01943435|20316276|P1|COMPLETED|6 Month Follow up||67
8238694|NCT01943435|20316274|P3|STARTED|6 Month Follow up||80
8238695|NCT01943435|20316275|P2|STARTED|6 Month Follow up||66
8238696|NCT01943435|20316276|P1|STARTED|6 Month Follow up||79
8238697|NCT01943435|20316274|P3|NOT COMPLETED|2 Month Follow up||0
8238698|NCT01943435|20316275|P2|NOT COMPLETED|2 Month Follow up||3
8238699|NCT01943435|20316276|P1|NOT COMPLETED|2 Month Follow up||2
8238700|NCT01943435|20316274|P3|COMPLETED|2 Month Follow up||80
8238701|NCT01943435|20316275|P2|COMPLETED|2 Month Follow up||66
8238702|NCT01943435|20316276|P1|COMPLETED|2 Month Follow up||79
8238703|NCT01943435|20316274|P3|STARTED|2 Month Follow up||80
8238704|NCT01943435|20316275|P2|STARTED|2 Month Follow up||69
8238705|NCT01943435|20316276|P1|STARTED|2 Month Follow up||81
8238706|NCT01943435|20316274|P3|NOT COMPLETED|Intervention Period||4
8238707|NCT01943435|20316275|P2|NOT COMPLETED|Intervention Period||3
8238708|NCT01943435|20316276|P1|NOT COMPLETED|Intervention Period||3
8238709|NCT01943435|20316274|P3|COMPLETED|Intervention Period||80
8238710|NCT01943435|20316275|P2|COMPLETED|Intervention Period||69
8238711|NCT01943435|20316276|P1|COMPLETED|Intervention Period||81
8238712|NCT01943435|20316274|P3|STARTED|Intervention Period||84
8238713|NCT01943435|20316275|P2|STARTED|Intervention Period||72
8238714|NCT01943435|20316276|P1|STARTED|Intervention Period||84
8238715|NCT01943435|20316274|P3|NOT COMPLETED|Baseline Eligibility and Randomization||3
8238716|NCT01943435|20316275|P2|NOT COMPLETED|Baseline Eligibility and Randomization||12
8238717|NCT01943435|20316276|P1|NOT COMPLETED|Baseline Eligibility and Randomization||4
8238718|NCT01943435|20316274|P3|COMPLETED|Baseline Eligibility and Randomization||84
8238719|NCT01943435|20316275|P2|COMPLETED|Baseline Eligibility and Randomization||72
8238720|NCT01943435|20316276|P1|COMPLETED|Baseline Eligibility and Randomization||84
8238721|NCT01943435|20316274|P3|STARTED|Baseline Eligibility and Randomization||87
8238722|NCT01943435|20316275|P2|STARTED|Baseline Eligibility and Randomization||84
8238723|NCT01943435|20316276|P1|STARTED|Baseline Eligibility and Randomization||88
8238724|NCT01943344|20316290|P1|NOT COMPLETED|Overall Study||3
8238725|NCT01943344|20316290|P1|COMPLETED|Overall Study||9
8238726|NCT01943344|20316290|P1|STARTED|Overall Study||12
8238727|NCT01943292|20316299|P3|NOT COMPLETED|Overall Study||0
8238728|NCT01943292|20316300|P2|NOT COMPLETED|Overall Study||0
8238729|NCT01943292|20316301|P1|NOT COMPLETED|Overall Study||1
8238730|NCT01943292|20316299|P3|COMPLETED|Overall Study||3
8238731|NCT01943292|20316300|P2|COMPLETED|Overall Study||3
8238732|NCT01943292|20316301|P1|COMPLETED|Overall Study||2
8238733|NCT01943292|20316299|P3|Completed Follow-Up|Overall Study||3
8238734|NCT01943292|20316300|P2|Completed Follow-Up|Overall Study||3
8238735|NCT01943292|20316301|P1|Completed Follow-Up|Overall Study||2
8238736|NCT01943292|20316299|P3|Completed Treatment|Overall Study||3
8238737|NCT01943292|20316300|P2|Completed Treatment|Overall Study||3
8238738|NCT01943292|20316301|P1|Completed Treatment|Overall Study||3
8238739|NCT01943292|20316299|P3|Completed Cycle 1|Overall Study||3
8238740|NCT01943292|20316300|P2|Completed Cycle 1|Overall Study||3
8238741|NCT01943292|20316301|P1|Completed Cycle 1|Overall Study||3
8238742|NCT01943292|20316299|P3|STARTED|Overall Study||3
8238743|NCT01943292|20316300|P2|STARTED|Overall Study||3
8238744|NCT01943292|20316301|P1|STARTED|Overall Study||3
8238745|NCT01943227|20316314|P2|NOT COMPLETED|Overall Study||0
8238746|NCT01943227|20316315|P1|NOT COMPLETED|Overall Study||0
8238747|NCT01943227|20316314|P2|COMPLETED|Overall Study||10
8238748|NCT01943227|20316315|P1|COMPLETED|Overall Study||10
8238749|NCT01943227|20316314|P2|STARTED|Overall Study||10
8238750|NCT01943227|20316315|P1|STARTED|Overall Study||10
8238751|NCT01943110|20316321|P1|NOT COMPLETED|Overall Study||0
8238752|NCT01943110|20316321|P1|COMPLETED|Overall Study||30
8238753|NCT01943110|20316321|P1|STARTED|Overall Study||30
8238754|NCT01942993|20316337|P1|NOT COMPLETED|Overall Study||2
8238755|NCT01942993|20316337|P1|COMPLETED|Overall Study||1
8238756|NCT01942993|20316337|P1|STARTED|Overall Study||3
8238757|NCT01942785|20316354|P1|NOT COMPLETED|Overall Study||4
8238758|NCT01942785|20316354|P1|COMPLETED|Overall Study||50
8238759|NCT01942785|20316354|P1|STARTED|Overall Study||54
8238760|NCT01942733|20316383|P1|NOT COMPLETED|Overall Study||3
8238761|NCT01942733|20316383|P1|COMPLETED|Overall Study||41
8238762|NCT01942733|20316383|P1|STARTED|Overall Study||44
8238763|NCT01942720|20316412|P1|NOT COMPLETED|Overall Study||21
8238764|NCT01942720|20316412|P1|COMPLETED|Overall Study||53
8238765|NCT01942720|20316412|P1|STARTED|Overall Study||74
8238766|NCT01942707|20316422|P2|NOT COMPLETED|Overall Study||0
8238767|NCT01942707|20316423|P1|NOT COMPLETED|Overall Study||0
8238768|NCT01942707|20316422|P2|COMPLETED|Overall Study||23
8238769|NCT01942707|20316423|P1|COMPLETED|Overall Study||23
8238770|NCT01942707|20316422|P2|STARTED|Overall Study||23
8238771|NCT01942707|20316423|P1|STARTED|Overall Study||23
8238772|NCT01942694|20316435|P2|NOT COMPLETED|Overall Study||0
8238773|NCT01942694|20316436|P1|NOT COMPLETED|Overall Study||1
8238774|NCT01942694|20316435|P2|COMPLETED|Overall Study||1211
8238775|NCT01942694|20316436|P1|COMPLETED|Overall Study||1211
8238776|NCT01942694|20316435|P2|STARTED|Overall Study||1211
8238777|NCT01942694|20316436|P1|STARTED|Overall Study||1212
8238778|NCT01942668|20316461|P5|NOT COMPLETED|Overall Study||59
8238779|NCT01942668|20316462|P4|NOT COMPLETED|Overall Study||146
8238780|NCT01942668|20316463|P3|NOT COMPLETED|Overall Study||110
8238781|NCT01942668|20316464|P2|NOT COMPLETED|Overall Study||121
8238782|NCT01942668|20316465|P1|NOT COMPLETED|Overall Study||134
8238783|NCT01942668|20316461|P5|COMPLETED|Overall Study||93
8238784|NCT01942668|20316462|P4|COMPLETED|Overall Study||281
8238785|NCT01942668|20316463|P3|COMPLETED|Overall Study||312
8238786|NCT01942668|20316464|P2|COMPLETED|Overall Study||305
8238787|NCT01942668|20316465|P1|COMPLETED|Overall Study||284
8238788|NCT01942668|20316461|P5|STARTED|Overall Study||152
8238789|NCT01942668|20316462|P4|STARTED|Overall Study||427
8238790|NCT01942668|20316463|P3|STARTED|Overall Study||422
8238791|NCT01942668|20316464|P2|STARTED|Overall Study||426
8238792|NCT01942668|20316465|P1|STARTED|Overall Study||418
8238793|NCT01942590|20317524|P2|NOT COMPLETED|Overall Study||1
8238794|NCT01942590|20317525|P1|NOT COMPLETED|Overall Study||1
8238795|NCT01942590|20317524|P2|COMPLETED|Overall Study||4
8238796|NCT01942590|20317525|P1|COMPLETED|Overall Study||7
8238797|NCT01942590|20317524|P2|STARTED|Overall Study||5
8238798|NCT01942590|20317525|P1|STARTED|Overall Study||8
8238799|NCT01942486|20317555|P1|NOT COMPLETED|Overall Study||27
8238800|NCT01942486|20317555|P1|COMPLETED|Overall Study||8
8238801|NCT01942486|20317555|P1|STARTED|Overall Study||35
8238802|NCT01942161|20317562|P3|NOT COMPLETED|Overall Study||6
8238803|NCT01942161|20317563|P2|NOT COMPLETED|Overall Study||6
8238804|NCT01942161|20317564|P1|NOT COMPLETED|Overall Study||8
8238805|NCT01942161|20317562|P3|COMPLETED|Overall Study||35
8238806|NCT01942161|20317563|P2|COMPLETED|Overall Study||24
8238807|NCT01942161|20317564|P1|COMPLETED|Overall Study||27
8238808|NCT01942161|20317562|P3|STARTED|Overall Study||41
8238809|NCT01942161|20317563|P2|STARTED|Overall Study||30
8238810|NCT01942161|20317564|P1|STARTED|Overall Study||35
8238811|NCT01942148|20317584|P1|NOT COMPLETED|Overall Study||27
8238812|NCT01942148|20317584|P1|COMPLETED|Overall Study||41
8238813|NCT01942148|20317584|P1|STARTED|Overall Study||68
8238820|NCT01941940|20317630|P1|NOT COMPLETED|Overall Study||33
8238821|NCT01941940|20317630|P1|COMPLETED|Overall Study||194
8238822|NCT01941940|20317630|P1|STARTED|Overall Study||227
8238823|NCT01941927|20317672|P2|NOT COMPLETED|Overall Study||0
8238824|NCT01941927|20317673|P1|NOT COMPLETED|Overall Study||0
8238825|NCT01941927|20317672|P2|COMPLETED|Overall Study||10
8238826|NCT01941927|20317673|P1|COMPLETED|Overall Study||10
8238827|NCT01941927|20317672|P2|STARTED|Overall Study||10
8238828|NCT01941927|20317673|P1|STARTED|Overall Study||10
8238829|NCT01941745|20317689|P4|NOT COMPLETED|Overall Study||0
8238830|NCT01941745|20317690|P3|NOT COMPLETED|Overall Study||0
8238831|NCT01941745|20317691|P2|NOT COMPLETED|Overall Study||0
8238832|NCT01941745|20317692|P1|NOT COMPLETED|Overall Study||0
8238833|NCT01941745|20317689|P4|COMPLETED|Overall Study||23
8238834|NCT01941745|20317690|P3|COMPLETED|Overall Study||21
8238835|NCT01941745|20317691|P2|COMPLETED|Overall Study||22
8238836|NCT01941745|20317692|P1|COMPLETED|Overall Study||22
8238837|NCT01941745|20317689|P4|STARTED|Overall Study||23
8238838|NCT01941745|20317690|P3|STARTED|Overall Study||21
8238839|NCT01941745|20317691|P2|STARTED|Overall Study||22
8238840|NCT01941745|20317692|P1|STARTED|Overall Study||22
8238841|NCT01941628|20317716|P2|NOT COMPLETED|Overall Study||0
8238842|NCT01941628|20317717|P1|NOT COMPLETED|Overall Study||1
8238843|NCT01941628|20317716|P2|COMPLETED|Overall Study||45
8238844|NCT01941628|20317717|P1|COMPLETED|Overall Study||45
8238845|NCT01941628|20317716|P2|STARTED|Overall Study||45
8238846|NCT01941628|20317717|P1|STARTED|Overall Study||46
8238847|NCT01941615|20317727|P1|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
8238848|NCT01941615|20317727|P1|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
8238849|NCT01941615|20317727|P1|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
8238850|NCT01941615|20317727|P1|NOT COMPLETED|Reference Treatment: Microgynon®||0
8238851|NCT01941615|20317727|P1|COMPLETED|Reference Treatment: Microgynon®||0
8238852|NCT01941615|20317727|P1|STARTED|Reference Treatment: Microgynon®||0
8238853|NCT01941615|20317727|P1|NOT COMPLETED|Run in Treatment: Microgynon®||0
8238854|NCT01941615|20317727|P1|COMPLETED|Run in Treatment: Microgynon®||16
8238855|NCT01941615|20317727|P1|STARTED|Run in Treatment: Microgynon®||16
8238856|NCT01941537|20317738|P2|NOT COMPLETED|Overall Study||3
8238857|NCT01941537|20317739|P1|NOT COMPLETED|Overall Study||4
8238858|NCT01941537|20317738|P2|COMPLETED|Overall Study||17
8238859|NCT01941537|20317739|P1|COMPLETED|Overall Study||36
8238860|NCT01941537|20317738|P2|STARTED|Overall Study||20
8238861|NCT01941537|20317739|P1|STARTED|Overall Study||40
8238862|NCT01941498|20317751|P1|NOT COMPLETED|Overall Study||1
8238863|NCT01941498|20317751|P1|COMPLETED|Overall Study||96
8238864|NCT01941498|20317751|P1|STARTED|Overall Study||97
8238865|NCT01941485|20317797|P1|NOT COMPLETED|Overall Study||0
8238866|NCT01941485|20317797|P1|COMPLETED|Overall Study||59
8238867|NCT01941485|20317797|P1|STARTED|Overall Study||59
8238868|NCT01941472|20317863|P1|NOT COMPLETED|Overall Study||0
8238869|NCT01941472|20317863|P1|COMPLETED|Overall Study||40
8238870|NCT01941472|20317863|P1|STARTED|Overall Study||40
8238871|NCT01941186|20317869|P2|NOT COMPLETED|Follow-up||0
8238872|NCT01941186|20317870|P1|NOT COMPLETED|Follow-up||1
8238873|NCT01941186|20317869|P2|COMPLETED|Follow-up||33
8238874|NCT01941186|20317870|P1|COMPLETED|Follow-up||30
8238875|NCT01941186|20317869|P2|STARTED|Follow-up||33
8238876|NCT01941186|20317870|P1|STARTED|Follow-up||31
8238877|NCT01941186|20317869|P2|NOT COMPLETED|Randomization/Allocation to Study Group||0
8238878|NCT01941186|20317870|P1|NOT COMPLETED|Randomization/Allocation to Study Group||0
8238879|NCT01941186|20317869|P2|COMPLETED|Randomization/Allocation to Study Group||33
8238880|NCT01941186|20317870|P1|COMPLETED|Randomization/Allocation to Study Group||31
8238881|NCT01941186|20317869|P2|STARTED|Randomization/Allocation to Study Group||33
8238882|NCT01941186|20317870|P1|STARTED|Randomization/Allocation to Study Group||31
8238883|NCT01941095|20317896|P1|NOT COMPLETED|Overall Study||56
8238884|NCT01941095|20317896|P1|COMPLETED|Overall Study||41
8238885|NCT01941095|20317896|P1|STARTED|Overall Study||97
8238886|NCT01941030|20317921|P2|NOT COMPLETED|Overall Study||13
8238887|NCT01941030|20317922|P1|NOT COMPLETED|Overall Study||13
8238888|NCT01941030|20317921|P2|COMPLETED|Overall Study||13
8238889|NCT01941030|20317922|P1|COMPLETED|Overall Study||12
8238890|NCT01941030|20317921|P2|STARTED|Overall Study||26
8238891|NCT01941030|20317922|P1|STARTED|Overall Study||25
8238892|NCT01940939|20317944|P2|NOT COMPLETED|Overall Study||8
8238893|NCT01940939|20317945|P1|NOT COMPLETED|Overall Study||2
8238894|NCT01940939|20317944|P2|COMPLETED|Overall Study||27
8238895|NCT01940939|20317945|P1|COMPLETED|Overall Study||33
8238896|NCT01940939|20317944|P2|STARTED|Overall Study||35
8238897|NCT01940939|20317945|P1|STARTED|Overall Study||35
8238898|NCT01940900|20317957|P2|NOT COMPLETED|Overall Study||31
8238899|NCT01940900|20317958|P1|NOT COMPLETED|Overall Study||29
8238900|NCT01940900|20317957|P2|COMPLETED|Overall Study||284
8238901|NCT01940900|20317958|P1|COMPLETED|Overall Study||282
8238902|NCT01940900|20317957|P2|STARTED|Overall Study||315
8238903|NCT01940900|20317958|P1|STARTED|Overall Study||311
8238904|NCT01940887|20317966|P2|NOT COMPLETED|Year 2||222
8238905|NCT01940887|20317967|P1|NOT COMPLETED|Year 2||217
8238906|NCT01940887|20317966|P2|COMPLETED|Year 2||75
8238907|NCT01940887|20317967|P1|COMPLETED|Year 2||66
8238908|NCT01940887|20317966|P2|STARTED|Year 2||297
8238909|NCT01940887|20317967|P1|STARTED|Year 2||283
8238910|NCT01940887|20317966|P2|NOT COMPLETED|Year 1||23
8238911|NCT01940887|20317967|P1|NOT COMPLETED|Year 1||39
8238912|NCT01940887|20317966|P2|COMPLETED|Year 1||297
8238913|NCT01940887|20317967|P1|COMPLETED|Year 1||283
8238914|NCT01940887|20317966|P2|STARTED|Year 1||320
8238915|NCT01940887|20317967|P1|STARTED|Year 1||322
8238916|NCT01940705|20317977|P4|NOT COMPLETED|Overall Study||4
8238917|NCT01940705|20317978|P3|NOT COMPLETED|Overall Study||8
8238918|NCT01940705|20317979|P2|NOT COMPLETED|Overall Study||8
8238919|NCT01940705|20317980|P1|NOT COMPLETED|Overall Study||4
8238920|NCT01940705|20317977|P4|COMPLETED|Overall Study||63
8238921|NCT01940705|20317978|P3|COMPLETED|Overall Study||61
8238922|NCT01940705|20317979|P2|COMPLETED|Overall Study||59
8238923|NCT01940705|20317980|P1|COMPLETED|Overall Study||62
8238924|NCT01940705|20317977|P4|STARTED|Overall Study||67
8238925|NCT01940705|20317978|P3|STARTED|Overall Study||69
8238926|NCT01940705|20317979|P2|STARTED|Overall Study||67
8238927|NCT01940705|20317980|P1|STARTED|Overall Study||66
8238928|NCT01940523|20318000|P2|NOT COMPLETED|Overall Study||0
8238929|NCT01940523|20318001|P1|NOT COMPLETED|Overall Study||0
8238930|NCT01940523|20318000|P2|COMPLETED|Overall Study||320
8238931|NCT01940523|20318001|P1|COMPLETED|Overall Study||320
8238932|NCT01940523|20318000|P2|STARTED|Overall Study||320
8238933|NCT01940523|20318001|P1|STARTED|Overall Study||320
8238934|NCT01940510|20318011|P1|NOT COMPLETED|Overall Study||0
8238935|NCT01940510|20318011|P1|COMPLETED|Overall Study||24
8238936|NCT01940510|20318011|P1|STARTED|Overall Study||24
8238937|NCT01940497|20318044|P2|NOT COMPLETED|Overall Study||18
8238938|NCT01940497|20318045|P1|NOT COMPLETED|Overall Study||21
8238939|NCT01940497|20318044|P2|COMPLETED|Overall Study||101
8238940|NCT01940497|20318045|P1|COMPLETED|Overall Study||100
8238941|NCT01940497|20318044|P2|Treated: Neoadjuvant|Overall Study||21
8238942|NCT01940497|20318045|P1|Treated: Neoadjuvant|Overall Study||20
8238943|NCT01940497|20318044|P2|Treated: Adjuvant|Overall Study||92
8238944|NCT01940497|20318045|P1|Treated: Adjuvant|Overall Study||95
8238945|NCT01940497|20318044|P2|Treated|Overall Study||113
8238946|NCT01940497|20318045|P1|Treated|Overall Study||115
8238947|NCT01940497|20318044|P2|STARTED|Overall Study||119
8238948|NCT01940497|20318045|P1|STARTED|Overall Study||121
8238949|NCT01940484|20318086|P1|NOT COMPLETED|Overall Study||10
8238950|NCT01940484|20318086|P1|COMPLETED|Overall Study||88
8238951|NCT01940484|20318086|P1|STARTED|Overall Study||98
8238964|NCT01940354|20318125|P2|NOT COMPLETED|Overall Study||2
8238965|NCT01940354|20318126|P1|NOT COMPLETED|Overall Study||4
8238966|NCT01940354|20318125|P2|COMPLETED|Overall Study||108
8238967|NCT01940354|20318126|P1|COMPLETED|Overall Study||106
8238968|NCT01940354|20318125|P2|STARTED|Overall Study||110
8238969|NCT01940354|20318126|P1|STARTED|Overall Study||110
8238982|NCT01940276|20318155|P2|NOT COMPLETED|Overall Study||0
8238983|NCT01940276|20318156|P1|NOT COMPLETED|Overall Study||0
8238984|NCT01940276|20318155|P2|COMPLETED|Overall Study||50
8238985|NCT01940276|20318156|P1|COMPLETED|Overall Study||50
8238986|NCT01940276|20318155|P2|STARTED|Overall Study||50
8238987|NCT01940276|20318156|P1|STARTED|Overall Study||50
8238988|NCT01940146|20318176|P4|NOT COMPLETED|Overall Study||2
8238989|NCT01940146|20318177|P3|NOT COMPLETED|Overall Study||1
8238990|NCT01940146|20318178|P2|NOT COMPLETED|Overall Study||0
8238991|NCT01940146|20318179|P1|NOT COMPLETED|Overall Study||1
8238992|NCT01940146|20318176|P4|COMPLETED|Overall Study||53
8238993|NCT01940146|20318177|P3|COMPLETED|Overall Study||55
8238994|NCT01940146|20318178|P2|COMPLETED|Overall Study||55
8238995|NCT01940146|20318179|P1|COMPLETED|Overall Study||55
8238996|NCT01940146|20318176|P4|STARTED|Overall Study||55
8238997|NCT01940146|20318177|P3|STARTED|Overall Study||56
8238998|NCT01940146|20318178|P2|STARTED|Overall Study||55
8238999|NCT01940146|20318179|P1|STARTED|Overall Study||56
8239000|NCT01940120|20318189|P1|NOT COMPLETED|Overall Study||48
8239001|NCT01940120|20318189|P1|COMPLETED|Overall Study||30
8239002|NCT01940120|20318189|P1|STARTED|Overall Study||78
8239003|NCT01939977|20318345|P2|NOT COMPLETED|Overall Study||7
8239004|NCT01939977|20318346|P1|NOT COMPLETED|Overall Study||9
8239005|NCT01939977|20318345|P2|COMPLETED|Overall Study||41
8239006|NCT01939977|20318346|P1|COMPLETED|Overall Study||37
8239007|NCT01939977|20318345|P2|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
8239008|NCT01939977|20318346|P1|STARTED|Overall Study||46
8239009|NCT01939938|20318382|P1|NOT COMPLETED|Overall Study||0
8239010|NCT01939938|20318382|P1|COMPLETED|Overall Study||10
8239011|NCT01939938|20318382|P1|STARTED|Overall Study||10
8239012|NCT01939899|20318393|P5|NOT COMPLETED|Phase 2||1
8239013|NCT01939899|20318394|P4|NOT COMPLETED|Phase 2||11
8239014|NCT01939899|20318395|P3|NOT COMPLETED|Phase 2||0
8239015|NCT01939899|20318396|P2|NOT COMPLETED|Phase 2||0
8239016|NCT01939899|20318397|P1|NOT COMPLETED|Phase 2||0
8239017|NCT01939899|20318393|P5|COMPLETED|Phase 2||0
8239018|NCT01939899|20318394|P4|COMPLETED|Phase 2||1
8239019|NCT01939899|20318395|P3|COMPLETED|Phase 2||0
8239020|NCT01939899|20318396|P2|COMPLETED|Phase 2||0
8239021|NCT01939899|20318397|P1|COMPLETED|Phase 2||0
8239022|NCT01939899|20318393|P5|STARTED|Phase 2||1
8239023|NCT01939899|20318394|P4|STARTED|Phase 2||12
8239024|NCT01939899|20318395|P3|STARTED|Phase 2||0
8239025|NCT01939899|20318396|P2|STARTED|Phase 2||0
8239026|NCT01939899|20318397|P1|STARTED|Phase 2||0
8239027|NCT01939899|20318393|P5|NOT COMPLETED|Lead-in Dose Finding Phase||0
8239028|NCT01939899|20318394|P4|NOT COMPLETED|Lead-in Dose Finding Phase||0
8239029|NCT01939899|20318395|P3|NOT COMPLETED|Lead-in Dose Finding Phase||5
8239030|NCT01939899|20318396|P2|NOT COMPLETED|Lead-in Dose Finding Phase||7
8239031|NCT01939899|20318397|P1|NOT COMPLETED|Lead-in Dose Finding Phase||2
8239032|NCT01939899|20318393|P5|COMPLETED|Lead-in Dose Finding Phase||0
8239033|NCT01939899|20318394|P4|COMPLETED|Lead-in Dose Finding Phase||0
8239034|NCT01939899|20318395|P3|COMPLETED|Lead-in Dose Finding Phase||1
8239035|NCT01939899|20318396|P2|COMPLETED|Lead-in Dose Finding Phase||0
8239036|NCT01939899|20318397|P1|COMPLETED|Lead-in Dose Finding Phase||1
8239037|NCT01939899|20318393|P5|STARTED|Lead-in Dose Finding Phase||0
8239038|NCT01939899|20318394|P4|STARTED|Lead-in Dose Finding Phase||0
8239039|NCT01939899|20318395|P3|STARTED|Lead-in Dose Finding Phase||6
8239040|NCT01939899|20318396|P2|STARTED|Lead-in Dose Finding Phase||7
8239041|NCT01939899|20318397|P1|STARTED|Lead-in Dose Finding Phase||3
8239042|NCT01939548|20318444|P3|NOT COMPLETED|Overall Study||30
8239043|NCT01939548|20318445|P2|NOT COMPLETED|Overall Study||49
8239044|NCT01939548|20318446|P1|NOT COMPLETED|Overall Study||37
8239045|NCT01939548|20318444|P3|COMPLETED|Overall Study||50
8239046|NCT01939548|20318445|P2|COMPLETED|Overall Study||33
8239047|NCT01939548|20318446|P1|COMPLETED|Overall Study||41
8239048|NCT01939548|20318444|P3|STARTED|Overall Study||80
8239049|NCT01939548|20318445|P2|STARTED|Overall Study||82
8239050|NCT01939548|20318446|P1|STARTED|Overall Study||78
8239051|NCT01939496|20318520|P3|NOT COMPLETED|Overall Study||2
8239052|NCT01939496|20318521|P2|NOT COMPLETED|Overall Study||3
8239053|NCT01939496|20318522|P1|NOT COMPLETED|Overall Study||9
8239054|NCT01939496|20318520|P3|COMPLETED|Overall Study||54
8239055|NCT01939496|20318521|P2|COMPLETED|Overall Study||54
8239056|NCT01939496|20318522|P1|COMPLETED|Overall Study||47
8239057|NCT01939496|20318520|P3|STARTED|Overall Study||56
8239058|NCT01939496|20318521|P2|STARTED|Overall Study||57
8239059|NCT01939496|20318522|P1|STARTED|Overall Study||56
8239060|NCT01939405|20318574|P2|NOT COMPLETED|Overall Study||2
8239061|NCT01939405|20318575|P1|NOT COMPLETED|Overall Study||3
8239062|NCT01939405|20318574|P2|COMPLETED|Overall Study||28
8239063|NCT01939405|20318575|P1|COMPLETED|Overall Study||27
8239064|NCT01939405|20318574|P2|STARTED|Overall Study||30
8239065|NCT01939405|20318575|P1|STARTED|Overall Study||30
8239101|NCT01939314|20318610|P2|NOT COMPLETED|Overall Study||8
8239102|NCT01939314|20318611|P1|NOT COMPLETED|Overall Study||9
8239103|NCT01939314|20318610|P2|COMPLETED|Overall Study||40
8239104|NCT01939314|20318611|P1|COMPLETED|Overall Study||36
8239105|NCT01939314|20318610|P2|24 Hour Endpoint|Overall Study||40
8239106|NCT01939314|20318611|P1|24 Hour Endpoint|Overall Study||36
8239107|NCT01939314|20318610|P2|15 Minute Endpoint|Overall Study||46
8239108|NCT01939314|20318611|P1|15 Minute Endpoint|Overall Study||41
8239109|NCT01939314|20318610|P2|STARTED|Overall Study||48
8239110|NCT01939314|20318611|P1|STARTED|Overall Study||45
8239111|NCT01939301|20318623|P2|NOT COMPLETED|Overall Study||1
8239112|NCT01939301|20318624|P1|NOT COMPLETED|Overall Study||1
8239113|NCT01939301|20318623|P2|COMPLETED|Overall Study||38
8239114|NCT01939301|20318624|P1|COMPLETED|Overall Study||38
8239115|NCT01939301|20318623|P2|STARTED|Overall Study||39
8239116|NCT01939301|20318624|P1|STARTED|Overall Study||39
8239117|NCT01939288|20318632|P2|NOT COMPLETED|Overall Study||0
8239118|NCT01939288|20318633|P1|NOT COMPLETED|Overall Study||0
8239119|NCT01939288|20318632|P2|COMPLETED|Overall Study||5
8239120|NCT01939288|20318633|P1|COMPLETED|Overall Study||5
8239121|NCT01939288|20318632|P2|STARTED|Overall Study||5
8239122|NCT01939288|20318633|P1|STARTED|Overall Study||5
8239126|NCT01939223|20318645|P2|NOT COMPLETED|Overall Study||11
8239127|NCT01939223|20318646|P1|NOT COMPLETED|Overall Study||13
8239128|NCT01939223|20318645|P2|COMPLETED|Overall Study||0
8239129|NCT01939223|20318646|P1|COMPLETED|Overall Study||1
8239130|NCT01939223|20318645|P2|Participants Received Treatment|Overall Study||11
8239131|NCT01939223|20318646|P1|Participants Received Treatment|Overall Study||14
8239132|NCT01939223|20318645|P2|STARTED|Overall Study||11
8239133|NCT01939223|20318646|P1|STARTED|Overall Study||14
8239155|NCT01939145|20318727|P2|NOT COMPLETED|Overall Study||7
8239156|NCT01939145|20318728|P1|NOT COMPLETED|Overall Study||2
8239157|NCT01939145|20318727|P2|COMPLETED|Overall Study||44
8239158|NCT01939145|20318728|P1|COMPLETED|Overall Study||47
8239159|NCT01939145|20318727|P2|STARTED|Overall Study||51
8239160|NCT01939145|20318728|P1|STARTED|Overall Study||49
8239161|NCT01939028|20318736|P1|NOT COMPLETED|Overall Study||12
8239162|NCT01939028|20318736|P1|COMPLETED|Overall Study||46
8239163|NCT01939028|20318736|P1|STARTED|Overall Study||58
8239164|NCT01939002|20318749|P2|NOT COMPLETED|Overall Study||18
8239165|NCT01939002|20318750|P1|NOT COMPLETED|Overall Study||19
8239166|NCT01939002|20318749|P2|COMPLETED|Overall Study||80
8239167|NCT01939002|20318750|P1|COMPLETED|Overall Study||84
8239168|NCT01939002|20318749|P2|STARTED|Overall Study||98
8239169|NCT01939002|20318750|P1|STARTED|Overall Study||103
8239170|NCT01938989|20318816|P2|NOT COMPLETED|Overall Study||0
8239171|NCT01938989|20318817|P1|NOT COMPLETED|Overall Study||0
8239172|NCT01938989|20318816|P2|COMPLETED|Overall Study||77
8239173|NCT01938989|20318817|P1|COMPLETED|Overall Study||77
8239174|NCT01938989|20318816|P2|STARTED|Overall Study||77
8239175|NCT01938989|20318817|P1|STARTED|Overall Study||77
8239176|NCT01938846|20318826|P3|NOT COMPLETED|Overall Study||24
8239177|NCT01938846|20318827|P2|NOT COMPLETED|Overall Study||25
8239178|NCT01938846|20318828|P1|NOT COMPLETED|Overall Study||41
8239179|NCT01938846|20318826|P3|COMPLETED|Overall Study||0
8239180|NCT01938846|20318827|P2|COMPLETED|Overall Study||0
8239181|NCT01938846|20318828|P1|COMPLETED|Overall Study||0
8239182|NCT01938846|20318826|P3|STARTED|Overall Study||24
8239183|NCT01938846|20318827|P2|STARTED|Overall Study||25
8239184|NCT01938846|20318828|P1|STARTED|Overall Study||41
8239185|NCT01938833|20319020|P1|NOT COMPLETED|Overall Study||0
8239186|NCT01938833|20319020|P1|COMPLETED|Overall Study||9
8239187|NCT01938833|20319020|P1|STARTED|Overall Study||9
8239188|NCT01938716|20319028|P1|NOT COMPLETED|Overall Study||4
8239189|NCT01938716|20319028|P1|COMPLETED|Overall Study||8
8239190|NCT01938716|20319028|P1|STARTED|Overall Study||12
8239191|NCT01938664|20319038|P2|NOT COMPLETED|Overall Study||10
8239192|NCT01938664|20319039|P1|NOT COMPLETED|Overall Study||15
8239193|NCT01938664|20319038|P2|COMPLETED|Overall Study||0
8239194|NCT01938664|20319039|P1|COMPLETED|Overall Study||5
8239195|NCT01938664|20319038|P2|STARTED|Overall Study||10
8239196|NCT01938664|20319039|P1|STARTED|Overall Study||20
8239197|NCT01938625|20319051|P2|NOT COMPLETED|Overall Study||2
8239198|NCT01938625|20319052|P1|NOT COMPLETED|Overall Study||0
8239199|NCT01938625|20319051|P2|COMPLETED|Overall Study||23
8239200|NCT01938625|20319052|P1|COMPLETED|Overall Study||10
8239201|NCT01938625|20319051|P2|STARTED|Overall Study||25
8239202|NCT01938625|20319052|P1|STARTED|Overall Study||10
8239203|NCT01938573|20319072|P2|NOT COMPLETED|Overall Study||0
8239204|NCT01938573|20319073|P1|NOT COMPLETED|Overall Study||2
8239205|NCT01938573|20319072|P2|COMPLETED|Overall Study||6
8239206|NCT01938573|20319073|P1|COMPLETED|Overall Study||13
8239207|NCT01938573|20319072|P2|STARTED|Overall Study||6
8239208|NCT01938573|20319073|P1|STARTED|Overall Study||15
8239209|NCT01938430|20319093|P14|NOT COMPLETED|Overall Study||1
8239210|NCT01938430|20319094|P13|NOT COMPLETED|Overall Study||0
8239211|NCT01938430|20319095|P12|NOT COMPLETED|Overall Study||1
8239212|NCT01938430|20319096|P11|NOT COMPLETED|Overall Study||3
8239213|NCT01938430|20319097|P10|NOT COMPLETED|Overall Study||3
8239214|NCT01938430|20319098|P9|NOT COMPLETED|Overall Study||4
8239215|NCT01938430|20319099|P8|NOT COMPLETED|Overall Study||1
8239216|NCT01938430|20319100|P7|NOT COMPLETED|Overall Study||2
8239217|NCT01938430|20319101|P6|NOT COMPLETED|Overall Study||1
8239218|NCT01938430|20319102|P5|NOT COMPLETED|Overall Study||0
8239219|NCT01938430|20319103|P4|NOT COMPLETED|Overall Study||2
8239220|NCT01938430|20319104|P3|NOT COMPLETED|Overall Study||5
8239221|NCT01938430|20319105|P2|NOT COMPLETED|Overall Study||3
8239222|NCT01938430|20319106|P1|NOT COMPLETED|Overall Study||4
8239223|NCT01938430|20319093|P14|COMPLETED|Overall Study||2
8239224|NCT01938430|20319094|P13|COMPLETED|Overall Study||4
8239225|NCT01938430|20319095|P12|COMPLETED|Overall Study||3
8239226|NCT01938430|20319096|P11|COMPLETED|Overall Study||3
8239227|NCT01938430|20319097|P10|COMPLETED|Overall Study||23
8239228|NCT01938430|20319098|P9|COMPLETED|Overall Study||22
8239229|NCT01938430|20319099|P8|COMPLETED|Overall Study||24
8239230|NCT01938430|20319100|P7|COMPLETED|Overall Study||24
8239231|NCT01938430|20319101|P6|COMPLETED|Overall Study||55
8239232|NCT01938430|20319102|P5|COMPLETED|Overall Study||55
8239233|NCT01938430|20319103|P4|COMPLETED|Overall Study||24
8239234|NCT01938430|20319104|P3|COMPLETED|Overall Study||18
8239235|NCT01938430|20319105|P2|COMPLETED|Overall Study||26
8239236|NCT01938430|20319106|P1|COMPLETED|Overall Study||26
8239237|NCT01938430|20319093|P14|STARTED|Overall Study||3
8239238|NCT01938430|20319094|P13|STARTED|Overall Study||4
8239239|NCT01938430|20319095|P12|STARTED|Overall Study||4
8239240|NCT01938430|20319096|P11|STARTED|Overall Study||6
8239241|NCT01938430|20319097|P10|STARTED|Overall Study||26
8239242|NCT01938430|20319098|P9|STARTED|Overall Study||26
8239243|NCT01938430|20319099|P8|STARTED|Overall Study||25
8239244|NCT01938430|20319100|P7|STARTED|Overall Study||26
8239245|NCT01938430|20319101|P6|STARTED|Overall Study||56
8239246|NCT01938430|20319102|P5|STARTED|Overall Study||55
8239247|NCT01938430|20319103|P4|STARTED|Overall Study||26
8239248|NCT01938430|20319104|P3|STARTED|Overall Study||23
8239249|NCT01938430|20319105|P2|STARTED|Overall Study||29
8239250|NCT01938430|20319106|P1|STARTED|Overall Study||30
8239251|NCT01938391|20319431|P1|NOT COMPLETED|12 Month Follow up||2
8239252|NCT01938391|20319431|P1|COMPLETED|12 Month Follow up||22
8239253|NCT01938391|20319431|P1|STARTED|12 Month Follow up||24
8239254|NCT01938391|20319431|P1|NOT COMPLETED|6 Month Follow up||1
8239255|NCT01938391|20319431|P1|COMPLETED|6 Month Follow up||24
8239256|NCT01938391|20319431|P1|STARTED|6 Month Follow up||25
8239257|NCT01938391|20319431|P1|NOT COMPLETED|2 Week Follow up||0
8239258|NCT01938391|20319431|P1|COMPLETED|2 Week Follow up||25
8239259|NCT01938391|20319431|P1|STARTED|2 Week Follow up||25
8239260|NCT01938391|20319431|P1|NOT COMPLETED|Baseline||0
8239261|NCT01938391|20319431|P1|COMPLETED|Baseline||25
8239262|NCT01938391|20319431|P1|STARTED|Baseline||25
8239263|NCT01938378|20319444|P1|NOT COMPLETED|Overall Study||0
8239264|NCT01938378|20319444|P1|COMPLETED|Overall Study||41
8239265|NCT01938378|20319444|P1|STARTED|Overall Study||41
8239266|NCT01938170|20319509|P1|NOT COMPLETED|Overall Study||0
8239267|NCT01938170|20319509|P1|COMPLETED|Overall Study||41
8239268|NCT01938170|20319509|P1|STARTED|Overall Study||41
8239269|NCT01938079|20319516|P2|NOT COMPLETED|Overall Study||0
8239270|NCT01938079|20319517|P1|NOT COMPLETED|Overall Study||0
8239271|NCT01938079|20319516|P2|COMPLETED|Overall Study||10
8239272|NCT01938079|20319517|P1|COMPLETED|Overall Study||10
8239273|NCT01938079|20319516|P2|STARTED|Overall Study||10
8239274|NCT01938079|20319517|P1|STARTED|Overall Study||10
8239275|NCT01938066|20319525|P2|NOT COMPLETED|Overall Study||2
8239276|NCT01938066|20319526|P1|NOT COMPLETED|Overall Study||1
8239277|NCT01938066|20319525|P2|COMPLETED|Overall Study||13
8239278|NCT01938066|20319526|P1|COMPLETED|Overall Study||14
8239279|NCT01938066|20319525|P2|STARTED|Overall Study||15
8239280|NCT01938066|20319526|P1|STARTED|Overall Study||15
8239281|NCT01938040|20319536|P2|NOT COMPLETED|Overall Study||0
8239282|NCT01938040|20319537|P1|NOT COMPLETED|Overall Study||0
8239283|NCT01938040|20319536|P2|COMPLETED|Overall Study||27
8239284|NCT01938040|20319537|P1|COMPLETED|Overall Study||28
8239285|NCT01938040|20319536|P2|Behavior Metrics|Overall Study||27
8239286|NCT01938040|20319537|P1|Behavior Metrics|Overall Study||28
8239287|NCT01938040|20319536|P2|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
8239288|NCT01938040|20319537|P1|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
8239289|NCT01938040|20319536|P2|STARTED|Overall Study||27
8239290|NCT01938040|20319537|P1|STARTED|Overall Study||28
8239301|NCT01937975|20319593|P3|NOT COMPLETED|Overall Study||0
8239302|NCT01937975|20319594|P2|NOT COMPLETED|Overall Study||0
8239303|NCT01937975|20319595|P1|NOT COMPLETED|Overall Study||0
8239304|NCT01937975|20319593|P3|COMPLETED|Overall Study||8
8239305|NCT01937975|20319594|P2|COMPLETED|Overall Study||8
8239306|NCT01937975|20319595|P1|COMPLETED|Overall Study||8
8239307|NCT01937975|20319593|P3|STARTED|Overall Study||8
8239308|NCT01937975|20319594|P2|STARTED|Overall Study||8
8239309|NCT01937975|20319595|P1|STARTED|Overall Study||8
8239310|NCT01937871|20319645|P3|NOT COMPLETED|Overall Study||11
8239311|NCT01937871|20319646|P2|NOT COMPLETED|Overall Study||17
8239312|NCT01937871|20319647|P1|NOT COMPLETED|Overall Study||24
8239313|NCT01937871|20319645|P3|COMPLETED|Overall Study||174
8239314|NCT01937871|20319646|P2|COMPLETED|Overall Study||346
8239315|NCT01937871|20319647|P1|COMPLETED|Overall Study||337
8239316|NCT01937871|20319645|P3|Received at Least One Dose of Study Drug|Overall Study||185
8239317|NCT01937871|20319646|P2|Received at Least One Dose of Study Drug|Overall Study||362
8239318|NCT01937871|20319647|P1|Received at Least One Dose of Study Drug|Overall Study||361
8239319|NCT01937871|20319645|P3|STARTED|Overall Study||185
8239320|NCT01937871|20319646|P2|STARTED|Overall Study||363
8239321|NCT01937871|20319647|P1|STARTED|Overall Study||361
8239322|NCT01937715|20319723|P5|NOT COMPLETED|Overall Study||2
8239323|NCT01937715|20319724|P4|NOT COMPLETED|Overall Study||4
8239324|NCT01937715|20319725|P3|NOT COMPLETED|Overall Study||0
8239325|NCT01937715|20319726|P2|NOT COMPLETED|Overall Study||1
8239326|NCT01937715|20319727|P1|NOT COMPLETED|Overall Study||0
8239327|NCT01937715|20319723|P5|COMPLETED|Overall Study||1
8239328|NCT01937715|20319724|P4|COMPLETED|Overall Study||1
8239329|NCT01937715|20319725|P3|COMPLETED|Overall Study||3
8239330|NCT01937715|20319726|P2|COMPLETED|Overall Study||3
8239331|NCT01937715|20319727|P1|COMPLETED|Overall Study||3
8239332|NCT01937715|20319723|P5|STARTED|Overall Study||3
8239333|NCT01937715|20319724|P4|STARTED|Overall Study||5
8239334|NCT01937715|20319725|P3|STARTED|Overall Study||3
8239335|NCT01937715|20319726|P2|STARTED|Overall Study||4
8239336|NCT01937715|20319727|P1|STARTED|Overall Study||3
8239337|NCT01937624|20319849|P1|NOT COMPLETED|Overall Study||0
8239338|NCT01937624|20319849|P1|COMPLETED|Overall Study||51
8239339|NCT01937624|20319849|P1|STARTED|Overall Study||51
8239340|NCT01937598|20319853|P2|NOT COMPLETED|Overall Study||0
8239341|NCT01937598|20319854|P1|NOT COMPLETED|Overall Study||0
8239342|NCT01937598|20319853|P2|COMPLETED|Overall Study||8
8239343|NCT01937598|20319854|P1|COMPLETED|Overall Study||8
8239344|NCT01937598|20319853|P2|STARTED|Overall Study||8
8239345|NCT01937598|20319854|P1|STARTED|Overall Study||8
8239346|NCT01937559|20319879|P3|NOT COMPLETED|Overall Study||0
8239347|NCT01937559|20319880|P2|NOT COMPLETED|Overall Study||11
8239348|NCT01937559|20319881|P1|NOT COMPLETED|Overall Study||11
8239349|NCT01937559|20319879|P3|COMPLETED|Overall Study||66
8239350|NCT01937559|20319880|P2|COMPLETED|Overall Study||50
8239351|NCT01937559|20319881|P1|COMPLETED|Overall Study||50
8239352|NCT01937559|20319879|P3|STARTED|Overall Study||66
8239353|NCT01937559|20319880|P2|STARTED|Overall Study||61
8239354|NCT01937559|20319881|P1|STARTED|Overall Study||61
8239355|NCT01937520|20319907|P2|NOT COMPLETED|Overall Study||0
8239356|NCT01937520|20319908|P1|NOT COMPLETED|Overall Study||0
8239357|NCT01937520|20319907|P2|COMPLETED|Overall Study||9
8239358|NCT01937520|20319908|P1|COMPLETED|Overall Study||11
8239359|NCT01937520|20319907|P2|STARTED|Overall Study||9
8239360|NCT01937520|20319908|P1|STARTED|Overall Study||11
8239361|NCT01937507|20319944|P1|NOT COMPLETED|Overall Study||2
8239362|NCT01937507|20319944|P1|COMPLETED|Overall Study||0
8239363|NCT01937507|20319944|P1|STARTED|Overall Study||2
8239364|NCT01937390|20319951|P1|NOT COMPLETED|Overall Study||35
8239365|NCT01937390|20319951|P1|COMPLETED|Overall Study||550
8239366|NCT01937390|20319951|P1|STARTED|Overall Study||585
8239367|NCT01937364|20319961|P2|NOT COMPLETED|Overall Study||1
8239368|NCT01937364|20319962|P1|NOT COMPLETED|Overall Study||2
8239369|NCT01937364|20319961|P2|COMPLETED|Overall Study||7
8239370|NCT01937364|20319962|P1|COMPLETED|Overall Study||7
8239371|NCT01937364|20319961|P2|STARTED|Overall Study||8
8239372|NCT01937364|20319962|P1|STARTED|Overall Study||9
8239385|NCT01937312|20319983|P2|NOT COMPLETED|Overall Study||3
8239386|NCT01937312|20319984|P1|NOT COMPLETED|Overall Study||11
8239387|NCT01937312|20319983|P2|COMPLETED|Overall Study||92
8239388|NCT01937312|20319984|P1|COMPLETED|Overall Study||83
8239389|NCT01937312|20319983|P2|Treated|Overall Study||95
8239390|NCT01937312|20319984|P1|Treated|Overall Study||93
8239391|NCT01937312|20319983|P2|STARTED|Overall Study||95
8239392|NCT01937312|20319984|P1|STARTED|Overall Study||94
8239393|NCT01937299|20319999|P2|NOT COMPLETED|Overall Study||4
8239394|NCT01937299|20320000|P1|NOT COMPLETED|Overall Study||14
8239395|NCT01937299|20319999|P2|COMPLETED|Overall Study||112
8239396|NCT01937299|20320000|P1|COMPLETED|Overall Study||103
8239397|NCT01937299|20319999|P2|STARTED|Overall Study||116
8239398|NCT01937299|20320000|P1|STARTED|Overall Study||117
8239399|NCT01937260|20320013|P2|NOT COMPLETED|Overall Study||0
8239400|NCT01937260|20320014|P1|NOT COMPLETED|Overall Study||1
8239401|NCT01937260|20320013|P2|COMPLETED|Overall Study||10
8239402|NCT01937260|20320014|P1|COMPLETED|Overall Study||20
8239403|NCT01937260|20320013|P2|STARTED|Overall Study||10
8239404|NCT01937260|20320014|P1|STARTED|Overall Study||21
8239405|NCT01937195|20320021|P1|NOT COMPLETED|Overall Study||0
8239406|NCT01937195|20320021|P1|COMPLETED|Overall Study||95
8239407|NCT01937195|20320021|P1|STARTED|Overall Study||95
8239408|NCT01937130|20320035|P4|NOT COMPLETED|Overall Study||2
8239409|NCT01937130|20320036|P3|NOT COMPLETED|Overall Study||3
8239410|NCT01937130|20320037|P2|NOT COMPLETED|Overall Study||4
8239411|NCT01937130|20320038|P1|NOT COMPLETED|Overall Study||5
8239412|NCT01937130|20320035|P4|COMPLETED|Overall Study||2
8239413|NCT01937130|20320036|P3|COMPLETED|Overall Study||2
8239414|NCT01937130|20320037|P2|COMPLETED|Overall Study||3
8239415|NCT01937130|20320038|P1|COMPLETED|Overall Study||0
8239416|NCT01937130|20320035|P4|STARTED|Overall Study||4
8239417|NCT01937130|20320036|P3|STARTED|Overall Study||5
8239418|NCT01937130|20320037|P2|STARTED|Overall Study||7
8239419|NCT01937130|20320038|P1|STARTED|Overall Study||5
8239420|NCT01937117|20320065|P1|NOT COMPLETED|Overall Study||13
8239421|NCT01937117|20320065|P1|COMPLETED|Overall Study||75
8239422|NCT01937117|20320065|P1|STARTED|Overall Study||88
8239423|NCT01937026|20320069|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
8239424|NCT01937026|20320069|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
8239425|NCT01937026|20320069|P1|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
8239426|NCT01937026|20320069|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
8239427|NCT01937026|20320069|P1|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
8239428|NCT01937026|20320069|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
8239429|NCT01937026|20320069|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
8239430|NCT01937026|20320069|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
8239431|NCT01937026|20320069|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
8239432|NCT01936974|20320080|P2|NOT COMPLETED|Overall Study||5
8239433|NCT01936974|20320081|P1|NOT COMPLETED|Overall Study||2
8239434|NCT01936974|20320080|P2|COMPLETED|Overall Study||0
8239435|NCT01936974|20320081|P1|COMPLETED|Overall Study||0
8239436|NCT01936974|20320080|P2|STARTED|Overall Study||5
8239437|NCT01936974|20320081|P1|STARTED|Overall Study||2
8239438|NCT01936909|20320090|P3|NOT COMPLETED|Overall Study||6
8239439|NCT01936909|20320091|P2|NOT COMPLETED|Overall Study||8
8239440|NCT01936909|20320092|P1|NOT COMPLETED|Overall Study||10
8239441|NCT01936909|20320090|P3|COMPLETED|Overall Study||14
8239442|NCT01936909|20320091|P2|COMPLETED|Overall Study||12
8239443|NCT01936909|20320092|P1|COMPLETED|Overall Study||10
8239444|NCT01936909|20320090|P3|STARTED|Overall Study||20
8239445|NCT01936909|20320091|P2|STARTED|Overall Study||20
8239446|NCT01936909|20320092|P1|STARTED|Overall Study||20
8239447|NCT01936896|20320106|P1|NOT COMPLETED|Overall Study||0
8239448|NCT01936896|20320106|P1|COMPLETED|Overall Study||10
8239449|NCT01936896|20320106|P1|STARTED|Overall Study||10
8239459|NCT01936844|20320135|P2|NOT COMPLETED|Overall Study||7
8239460|NCT01936844|20320136|P1|NOT COMPLETED|Overall Study||6
8239461|NCT01936844|20320135|P2|COMPLETED|Overall Study||8
8239462|NCT01936844|20320136|P1|COMPLETED|Overall Study||9
8239463|NCT01936844|20320135|P2|STARTED|Overall Study||15
8239464|NCT01936844|20320136|P1|STARTED|Overall Study||15
8239465|NCT01936662|20320148|P2|NOT COMPLETED|Overall Study||0
8239466|NCT01936662|20320149|P1|NOT COMPLETED|Overall Study||0
8239467|NCT01936662|20320148|P2|COMPLETED|Overall Study||42
8239468|NCT01936662|20320149|P1|COMPLETED|Overall Study||42
8239469|NCT01936662|20320148|P2|STARTED|Overall Study||42
8239470|NCT01936662|20320149|P1|STARTED|Overall Study||42
8239471|NCT01936649|20320157|P1|NOT COMPLETED|Overall Study||13
8239472|NCT01936649|20320157|P1|COMPLETED|Overall Study||50
8239473|NCT01936649|20320157|P1|Treated|Overall Study||51
8239474|NCT01936649|20320157|P1|STARTED|Overall Study||63
8239475|NCT01936623|20320164|P2|NOT COMPLETED|Overall Study||5
8239476|NCT01936623|20320165|P1|NOT COMPLETED|Overall Study||0
8239477|NCT01936623|20320164|P2|COMPLETED|Overall Study||35
8239478|NCT01936623|20320165|P1|COMPLETED|Overall Study||40
8239479|NCT01936623|20320164|P2|STARTED|Overall Study||40
8239480|NCT01936623|20320165|P1|STARTED|Overall Study||40
8239481|NCT01936467|20320179|P2|NOT COMPLETED|Overall Study||0
8239482|NCT01936467|20320180|P1|NOT COMPLETED|Overall Study||0
8239483|NCT01936467|20320179|P2|COMPLETED|Overall Study||61
8239484|NCT01936467|20320180|P1|COMPLETED|Overall Study||60
8239485|NCT01936467|20320179|P2|STARTED|Overall Study||61
8239486|NCT01936467|20320180|P1|STARTED|Overall Study||60
8239487|NCT01936389|20320200|P2|NOT COMPLETED|Overall Study||0
8239488|NCT01936389|20320201|P1|NOT COMPLETED|Overall Study||1
8239489|NCT01936389|20320200|P2|COMPLETED|Overall Study||5
8239490|NCT01936389|20320201|P1|COMPLETED|Overall Study||4
8239491|NCT01936389|20320200|P2|STARTED|Overall Study||5
8239492|NCT01936389|20320201|P1|STARTED|Overall Study||5
8239493|NCT01936363|20320209|P2|NOT COMPLETED|Overall Study||0
8239494|NCT01936363|20320210|P1|NOT COMPLETED|Overall Study||0
8239495|NCT01936363|20320209|P2|COMPLETED|Overall Study||33
8239496|NCT01936363|20320210|P1|COMPLETED|Overall Study||32
8239497|NCT01936363|20320209|P2|STARTED|Overall Study||33
8239498|NCT01936363|20320210|P1|STARTED|Overall Study||32
8239508|NCT01936259|20320252|P2|NOT COMPLETED|Overall Study||20
8239509|NCT01936259|20320253|P1|NOT COMPLETED|Overall Study||12
8239510|NCT01936259|20320252|P2|COMPLETED|Overall Study||111
8239511|NCT01936259|20320253|P1|COMPLETED|Overall Study||118
8239512|NCT01936259|20320252|P2|STARTED|Overall Study||131
8239513|NCT01936259|20320253|P1|STARTED|Overall Study||130
8239514|NCT01936181|20320273|P4|NOT COMPLETED|Transition-extension||5
8239515|NCT01936181|20320274|P3|NOT COMPLETED|Transition-extension||6
8239516|NCT01936181|20320275|P2|NOT COMPLETED|Transition-extension||0
8239517|NCT01936181|20320276|P1|NOT COMPLETED|Transition-extension||15
8239518|NCT01936181|20320273|P4|COMPLETED|Transition-extension||96
8239519|NCT01936181|20320274|P3|COMPLETED|Transition-extension||88
8239520|NCT01936181|20320275|P2|COMPLETED|Transition-extension||0
8239521|NCT01936181|20320276|P1|COMPLETED|Transition-extension||186
8239522|NCT01936181|20320273|P4|STARTED|Transition-extension||101
8239523|NCT01936181|20320274|P3|STARTED|Transition-extension||94
8239524|NCT01936181|20320275|P2|STARTED|Transition-extension||0
8239525|NCT01936181|20320276|P1|STARTED|Transition-extension||201
8239526|NCT01936181|20320273|P4|NOT COMPLETED|Randomised, Double-blind||0
8239527|NCT01936181|20320274|P3|NOT COMPLETED|Randomised, Double-blind||0
8239528|NCT01936181|20320275|P2|NOT COMPLETED|Randomised, Double-blind||68
8239529|NCT01936181|20320276|P1|NOT COMPLETED|Randomised, Double-blind||64
8239530|NCT01936181|20320273|P4|COMPLETED|Randomised, Double-blind||0
8239531|NCT01936181|20320274|P3|COMPLETED|Randomised, Double-blind||0
8239532|NCT01936181|20320275|P2|COMPLETED|Randomised, Double-blind||225
8239533|NCT01936181|20320276|P1|COMPLETED|Randomised, Double-blind||227
8239534|NCT01936181|20320273|P4|STARTED|Randomised, Double-blind||0
8239535|NCT01936181|20320274|P3|STARTED|Randomised, Double-blind||0
8239536|NCT01936181|20320275|P2|STARTED|Randomised, Double-blind||293
8239537|NCT01936181|20320276|P1|STARTED|Randomised, Double-blind||291
8239538|NCT01935947|20320290|P3|NOT COMPLETED|Overall Study||2
8239539|NCT01935947|20320291|P2|NOT COMPLETED|Overall Study||4
8239540|NCT01935947|20320292|P1|NOT COMPLETED|Overall Study||3
8239541|NCT01935947|20320290|P3|COMPLETED|Overall Study||0
8239542|NCT01935947|20320291|P2|COMPLETED|Overall Study||0
8239543|NCT01935947|20320292|P1|COMPLETED|Overall Study||1
8239544|NCT01935947|20320290|P3|Cytotoxic Therapy|Overall Study||2
8239545|NCT01935947|20320291|P2|Cytotoxic Therapy|Overall Study||3
8239546|NCT01935947|20320292|P1|Cytotoxic Therapy|Overall Study||3
8239547|NCT01935947|20320290|P3|Epigenetic Therapy|Overall Study||0
8239548|NCT01935947|20320291|P2|Epigenetic Therapy|Overall Study||4
8239549|NCT01935947|20320292|P1|Epigenetic Therapy|Overall Study||4
8239550|NCT01935947|20320290|P3|STARTED|Overall Study||2
8239551|NCT01935947|20320291|P2|STARTED|Overall Study||4
8239552|NCT01935947|20320292|P1|STARTED|Overall Study||4
8239553|NCT01935934|20320317|P2|NOT COMPLETED|Overall Study||0
8239554|NCT01935934|20320318|P1|NOT COMPLETED|Overall Study||0
8239555|NCT01935934|20320317|P2|COMPLETED|Overall Study||32
8239556|NCT01935934|20320318|P1|COMPLETED|Overall Study||70
8239557|NCT01935934|20320317|P2|STARTED|Overall Study||32
8239558|NCT01935934|20320318|P1|STARTED|Overall Study||70
8239559|NCT01935700|20320327|P2|NOT COMPLETED|Overall Study||0
8239560|NCT01935700|20320328|P1|NOT COMPLETED|Overall Study||5
8239561|NCT01935700|20320327|P2|COMPLETED|Overall Study||86
8239562|NCT01935700|20320328|P1|COMPLETED|Overall Study||9
8239563|NCT01935700|20320327|P2|STARTED|Overall Study||86
8239564|NCT01935700|20320328|P1|STARTED|Overall Study||14
8239565|NCT01935622|20320339|P3|NOT COMPLETED|Overall Study||0
8239566|NCT01935622|20320340|P2|NOT COMPLETED|Overall Study||2
8239567|NCT01935622|20320341|P1|NOT COMPLETED|Overall Study||2
8239568|NCT01935622|20320339|P3|COMPLETED|Overall Study||4
8239569|NCT01935622|20320340|P2|COMPLETED|Overall Study||1
8239570|NCT01935622|20320341|P1|COMPLETED|Overall Study||1
8239571|NCT01935622|20320339|P3|STARTED|Overall Study||4
8239572|NCT01935622|20320340|P2|STARTED|Overall Study||3
8239573|NCT01935622|20320341|P1|STARTED|Overall Study||3
8239574|NCT01935180|20320351|P2|NOT COMPLETED|Overall Study||14
8239575|NCT01935180|20320352|P1|NOT COMPLETED|Overall Study||21
8239576|NCT01935180|20320351|P2|COMPLETED|Overall Study||561
8239577|NCT01935180|20320352|P1|COMPLETED|Overall Study||552
8239578|NCT01935180|20320351|P2|STARTED|Overall Study||575
8239579|NCT01935180|20320352|P1|STARTED|Overall Study||573
8239580|NCT01934972|20320372|P2|NOT COMPLETED|Overall Study||6
8239581|NCT01934972|20320373|P1|NOT COMPLETED|Overall Study||9
8239582|NCT01934972|20320372|P2|COMPLETED|Overall Study||5
8239583|NCT01934972|20320373|P1|COMPLETED|Overall Study||4
8239584|NCT01934972|20320372|P2|STARTED|Overall Study||11
8239585|NCT01934972|20320373|P1|STARTED|Overall Study||13
8239586|NCT01934894|20320403|P2|NOT COMPLETED|Overall Study||5
8239587|NCT01934894|20320404|P1|NOT COMPLETED|Overall Study||6
8239588|NCT01934894|20320403|P2|COMPLETED|Overall Study||0
8239589|NCT01934894|20320404|P1|COMPLETED|Overall Study||0
8239590|NCT01934894|20320403|P2|STARTED|Overall Study||5
8239591|NCT01934894|20320404|P1|STARTED|Overall Study||6
8239592|NCT01934790|20320419|P1|NOT COMPLETED|Long Term Follow up||0
8239593|NCT01934790|20320419|P1|COMPLETED|Long Term Follow up||12
8239594|NCT01934790|20320419|P1|STARTED|Long Term Follow up||12
8239595|NCT01934790|20320419|P1|NOT COMPLETED|Active Follow up||24
8239596|NCT01934790|20320419|P1|COMPLETED|Active Follow up||10
8239597|NCT01934790|20320419|P1|STARTED|Active Follow up||34
8239598|NCT01934790|20320419|P1|NOT COMPLETED|Treatment||16
8239599|NCT01934790|20320419|P1|COMPLETED|Treatment||29
8239600|NCT01934790|20320419|P1|Participants Received Study Treatment|Treatment||44
8239601|NCT01934790|20320419|P1|STARTED|Treatment|Eligible for treatment|45
8239602|NCT01934647|20320450|P3|NOT COMPLETED|Overall Study||0
8239603|NCT01934647|20320451|P2|NOT COMPLETED|Overall Study||0
8239604|NCT01934647|20320452|P1|NOT COMPLETED|Overall Study||0
8239605|NCT01934647|20320450|P3|COMPLETED|Overall Study||3
8239606|NCT01934647|20320451|P2|COMPLETED|Overall Study||2
8239607|NCT01934647|20320452|P1|COMPLETED|Overall Study||2
8239608|NCT01934647|20320450|P3|STARTED|Overall Study||3
8239609|NCT01934647|20320451|P2|STARTED|Overall Study||2
8239610|NCT01934647|20320452|P1|STARTED|Overall Study||2
8239611|NCT01934582|20320460|P1|NOT COMPLETED|Overall Study||0
8239612|NCT01934582|20320460|P1|COMPLETED|Overall Study||13
8239613|NCT01934582|20320460|P1|STARTED|Overall Study||13
8239614|NCT01934556|20320477|P3|NOT COMPLETED|Overall Study||10
8239615|NCT01934556|20320478|P2|NOT COMPLETED|Overall Study||16
8239616|NCT01934556|20320479|P1|NOT COMPLETED|Overall Study||5
8239617|NCT01934556|20320477|P3|COMPLETED|Overall Study||50
8239618|NCT01934556|20320478|P2|COMPLETED|Overall Study||44
8239619|NCT01934556|20320479|P1|COMPLETED|Overall Study||25
8239620|NCT01934556|20320477|P3|STARTED|Overall Study||60
8239621|NCT01934556|20320478|P2|STARTED|Overall Study||60
8239622|NCT01934556|20320479|P1|STARTED|Overall Study||30
8239623|NCT01934517|20320511|P1|NOT COMPLETED|Overall Study||0
8239624|NCT01934517|20320511|P1|COMPLETED|Overall Study||25
8239625|NCT01934517|20320511|P1|STARTED|Overall Study||25
8239626|NCT01934504|20320523|P4|NOT COMPLETED|Overall Study||7
8239627|NCT01934504|20320524|P3|NOT COMPLETED|Overall Study||5
8239628|NCT01934504|20320525|P2|NOT COMPLETED|Overall Study||0
8239629|NCT01934504|20320526|P1|NOT COMPLETED|Overall Study||1
8239630|NCT01934504|20320523|P4|COMPLETED|Overall Study||1
8239631|NCT01934504|20320524|P3|COMPLETED|Overall Study||11
8239632|NCT01934504|20320525|P2|COMPLETED|Overall Study||3
8239633|NCT01934504|20320526|P1|COMPLETED|Overall Study||5
8239634|NCT01934504|20320523|P4|STARTED|Overall Study||8
8239635|NCT01934504|20320524|P3|STARTED|Overall Study||16
8239636|NCT01934504|20320525|P2|STARTED|Overall Study||3
8239637|NCT01934504|20320526|P1|STARTED|Overall Study||6
8239638|NCT01934231|20320548|P1|NOT COMPLETED|Overall Study||0
8239639|NCT01934231|20320548|P1|COMPLETED|Overall Study||27
8239640|NCT01934231|20320548|P1|STARTED|Overall Study||27
8239641|NCT01934218|20320559|P2|NOT COMPLETED|Open-Label Phase||24
8239642|NCT01934218|20320560|P1|NOT COMPLETED|Open-Label Phase||26
8239643|NCT01934218|20320559|P2|COMPLETED|Open-Label Phase||304
8239644|NCT01934218|20320560|P1|COMPLETED|Open-Label Phase||290
8239645|NCT01934218|20320559|P2|STARTED|Open-Label Phase||328
8239646|NCT01934218|20320560|P1|STARTED|Open-Label Phase||316
8239647|NCT01934218|20320559|P2|NOT COMPLETED|Double-blind Phase||54
8239648|NCT01934218|20320560|P1|NOT COMPLETED|Double-blind Phase||48
8239649|NCT01934218|20320559|P2|COMPLETED|Double-blind Phase||356
8239650|NCT01934218|20320560|P1|COMPLETED|Double-blind Phase||356
8239651|NCT01934218|20320559|P2|Analyzed Participants|Double-blind Phase||407
8239652|NCT01934218|20320560|P1|Analyzed Participants|Double-blind Phase||402
8239653|NCT01934218|20320559|P2|STARTED|Double-blind Phase||410
8239654|NCT01934218|20320560|P1|STARTED|Double-blind Phase||404
8239655|NCT01934192|20320571|P4|NOT COMPLETED|Overall Study||1
8239656|NCT01934192|20320572|P3|NOT COMPLETED|Overall Study||1
8239657|NCT01934192|20320573|P2|NOT COMPLETED|Overall Study||7
8239658|NCT01934192|20320574|P1|NOT COMPLETED|Overall Study||9
8239659|NCT01934192|20320571|P4|COMPLETED|Overall Study||3
8239660|NCT01934192|20320572|P3|COMPLETED|Overall Study||3
8239661|NCT01934192|20320573|P2|COMPLETED|Overall Study||37
8239662|NCT01934192|20320574|P1|COMPLETED|Overall Study||31
8239663|NCT01934192|20320571|P4|STARTED|Overall Study||4
8239664|NCT01934192|20320572|P3|STARTED|Overall Study||4
8239665|NCT01934192|20320573|P2|STARTED|Overall Study||44
8239666|NCT01934192|20320574|P1|STARTED|Overall Study||40
8239667|NCT01934140|20320710|P2|NOT COMPLETED|Booster Phase (6 Months)||3
8239668|NCT01934140|20320711|P1|NOT COMPLETED|Booster Phase (6 Months)||5
8239669|NCT01934140|20320710|P2|COMPLETED|Booster Phase (6 Months)||53
8239670|NCT01934140|20320711|P1|COMPLETED|Booster Phase (6 Months)||159
8239671|NCT01934140|20320710|P2|Vaccinated|Booster Phase (6 Months)||56
8239672|NCT01934140|20320711|P1|Vaccinated|Booster Phase (6 Months)||164
8239673|NCT01934140|20320710|P2|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56
8239674|NCT01934140|20320711|P1|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164
8239675|NCT01934140|20320710|P2|NOT COMPLETED|Persistence Phase (Year 6-10)||25
8239676|NCT01934140|20320711|P1|NOT COMPLETED|Persistence Phase (Year 6-10)||83
8239677|NCT01934140|20320710|P2|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51
8239678|NCT01934140|20320711|P1|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152
8239679|NCT01934140|20320710|P2|STARTED|Persistence Phase (Year 6-10)||76
8239680|NCT01934140|20320711|P1|STARTED|Persistence Phase (Year 6-10)||235
8239681|NCT01934010|20320762|P3|NOT COMPLETED|Overall Study||2
8239682|NCT01934010|20320763|P2|NOT COMPLETED|Overall Study||11
8239683|NCT01934010|20320764|P1|NOT COMPLETED|Overall Study||23
8239684|NCT01934010|20320762|P3|COMPLETED|Overall Study||74
8239685|NCT01934010|20320763|P2|COMPLETED|Overall Study||56
8239686|NCT01934010|20320764|P1|COMPLETED|Overall Study||91
8239687|NCT01934010|20320762|P3|STARTED|Overall Study||76
8239688|NCT01934010|20320763|P2|STARTED|Overall Study||67
8239689|NCT01934010|20320764|P1|STARTED|Overall Study||114
8239690|NCT01933984|20320783|P2|NOT COMPLETED|Overall Study||0
8239691|NCT01933984|20320784|P1|NOT COMPLETED|Overall Study||0
8239692|NCT01933984|20320783|P2|COMPLETED|Overall Study||25
8239693|NCT01933984|20320784|P1|COMPLETED|Overall Study||26
8239694|NCT01933984|20320783|P2|STARTED|Overall Study||25
8239695|NCT01933984|20320784|P1|STARTED|Overall Study||26
8239702|NCT01933919|20320825|P2|NOT COMPLETED|Open-label Long-term Phase||6
8239703|NCT01933919|20320826|P1|NOT COMPLETED|Open-label Long-term Phase||7
8239704|NCT01933919|20320825|P2|COMPLETED|Open-label Long-term Phase||9
8239705|NCT01933919|20320826|P1|COMPLETED|Open-label Long-term Phase||12
8239706|NCT01933919|20320825|P2|STARTED|Open-label Long-term Phase||15
8239707|NCT01933919|20320826|P1|STARTED|Open-label Long-term Phase||19
8239708|NCT01933919|20320825|P2|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
8239709|NCT01933919|20320826|P1|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
8239710|NCT01933919|20320825|P2|COMPLETED|Double-blind Placebo-controlled Phase||15
8239711|NCT01933919|20320826|P1|COMPLETED|Double-blind Placebo-controlled Phase||19
8239712|NCT01933919|20320825|P2|Received Study Drug|Double-blind Placebo-controlled Phase||19
8239713|NCT01933919|20320826|P1|Received Study Drug|Double-blind Placebo-controlled Phase||19
8239714|NCT01933919|20320825|P2|STARTED|Double-blind Placebo-controlled Phase||19
8239715|NCT01933919|20320826|P1|STARTED|Double-blind Placebo-controlled Phase||19
8239716|NCT01933880|20320862|P2|NOT COMPLETED|Overall Study||1
8239717|NCT01933880|20320863|P1|NOT COMPLETED|Overall Study||30
8239718|NCT01933880|20320862|P2|COMPLETED|Overall Study||40
8239719|NCT01933880|20320863|P1|COMPLETED|Overall Study||123
8239720|NCT01933880|20320862|P2|STARTED|Overall Study||41
8239721|NCT01933880|20320863|P1|STARTED|Overall Study||153
8239722|NCT01933789|20320937|P9|NOT COMPLETED|Overall Study||0
8239723|NCT01933789|20320938|P8|NOT COMPLETED|Overall Study||14
8239724|NCT01933789|20320939|P7|NOT COMPLETED|Overall Study||15
8239725|NCT01933789|20320940|P6|NOT COMPLETED|Overall Study||67
8239726|NCT01933789|20320941|P5|NOT COMPLETED|Overall Study||59
8239727|NCT01933789|20320942|P4|NOT COMPLETED|Overall Study||1
8239728|NCT01933789|20320943|P3|NOT COMPLETED|Overall Study||0
8239729|NCT01933789|20320944|P2|NOT COMPLETED|Overall Study||1
8239730|NCT01933789|20320945|P1|NOT COMPLETED|Overall Study||6
8239731|NCT01933789|20320937|P9|COMPLETED|Overall Study||25
8239732|NCT01933789|20320938|P8|COMPLETED|Overall Study||47
8239733|NCT01933789|20320939|P7|COMPLETED|Overall Study||43
8239734|NCT01933789|20320940|P6|COMPLETED|Overall Study||221
8239735|NCT01933789|20320941|P5|COMPLETED|Overall Study||190
8239736|NCT01933789|20320942|P4|COMPLETED|Overall Study||1
8239737|NCT01933789|20320943|P3|COMPLETED|Overall Study||2
8239738|NCT01933789|20320944|P2|COMPLETED|Overall Study||66
8239739|NCT01933789|20320945|P1|COMPLETED|Overall Study||59
8239740|NCT01933789|20320937|P9|Qualitative Interviews|Overall Study||25
8239741|NCT01933789|20320938|P8|Qualitative Interviews|Overall Study||0
8239742|NCT01933789|20320939|P7|Qualitative Interviews|Overall Study||0
8239743|NCT01933789|20320940|P6|Qualitative Interviews|Overall Study||0
8239744|NCT01933789|20320941|P5|Qualitative Interviews|Overall Study||0
8239745|NCT01933789|20320942|P4|Qualitative Interviews|Overall Study||0
8239746|NCT01933789|20320943|P3|Qualitative Interviews|Overall Study||0
8239747|NCT01933789|20320944|P2|Qualitative Interviews|Overall Study||0
8239748|NCT01933789|20320945|P1|Qualitative Interviews|Overall Study||0
8239749|NCT01933789|20320937|P9|Completed 6-Month Survey|Overall Study||0
8239750|NCT01933789|20320938|P8|Completed 6-Month Survey|Overall Study||40
8239751|NCT01933789|20320939|P7|Completed 6-Month Survey|Overall Study||35
8239752|NCT01933789|20320940|P6|Completed 6-Month Survey|Overall Study||188
8239753|NCT01933789|20320941|P5|Completed 6-Month Survey|Overall Study||160
8239754|NCT01933789|20320942|P4|Completed 6-Month Survey|Overall Study||0
8239755|NCT01933789|20320943|P3|Completed 6-Month Survey|Overall Study||0
8239756|NCT01933789|20320944|P2|Completed 6-Month Survey|Overall Study||0
8239757|NCT01933789|20320945|P1|Completed 6-Month Survey|Overall Study||0
8239758|NCT01933789|20320937|P9|Completed 3-Month Survey|Overall Study||0
8239759|NCT01933789|20320938|P8|Completed 3-Month Survey|Overall Study||43
8239760|NCT01933789|20320939|P7|Completed 3-Month Survey|Overall Study||37
8239761|NCT01933789|20320940|P6|Completed 3-Month Survey|Overall Study||211
8239762|NCT01933789|20320941|P5|Completed 3-Month Survey|Overall Study||176
8239763|NCT01933789|20320942|P4|Completed 3-Month Survey|Overall Study||0
8239764|NCT01933789|20320943|P3|Completed 3-Month Survey|Overall Study||0
8239765|NCT01933789|20320944|P2|Completed 3-Month Survey|Overall Study||0
8239766|NCT01933789|20320945|P1|Completed 3-Month Survey|Overall Study||0
8239767|NCT01933789|20320937|P9|Completed 2-Week Survey|Overall Study||0
8239768|NCT01933789|20320938|P8|Completed 2-Week Survey|Overall Study||0
8239769|NCT01933789|20320939|P7|Completed 2-Week Survey|Overall Study||0
8239770|NCT01933789|20320940|P6|Completed 2-Week Survey|Overall Study||215
8239771|NCT01933789|20320941|P5|Completed 2-Week Survey|Overall Study||184
8239772|NCT01933789|20320942|P4|Completed 2-Week Survey|Overall Study||0
8239773|NCT01933789|20320943|P3|Completed 2-Week Survey|Overall Study||0
8239774|NCT01933789|20320944|P2|Completed 2-Week Survey|Overall Study||0
8239775|NCT01933789|20320945|P1|Completed 2-Week Survey|Overall Study||0
8239776|NCT01933789|20320937|P9|Completed After-visit Survey|Overall Study||0
8239777|NCT01933789|20320938|P8|Completed After-visit Survey|Overall Study||0
8239778|NCT01933789|20320939|P7|Completed After-visit Survey|Overall Study||0
8239779|NCT01933789|20320940|P6|Completed After-visit Survey|Overall Study||0
8239780|NCT01933789|20320941|P5|Completed After-visit Survey|Overall Study||0
8239781|NCT01933789|20320942|P4|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1
8239782|NCT01933789|20320943|P3|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2
8239783|NCT01933789|20320944|P2|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64
8239784|NCT01933789|20320945|P1|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57
8239785|NCT01933789|20320937|P9|Had Target Visit|Overall Study||0
8239786|NCT01933789|20320938|P8|Had Target Visit|Overall Study||0
8239787|NCT01933789|20320939|P7|Had Target Visit|Overall Study||0
8239788|NCT01933789|20320940|P6|Had Target Visit|Overall Study||266
8239789|NCT01933789|20320941|P5|Had Target Visit|Overall Study||228
8239790|NCT01933789|20320942|P4|Had Target Visit|Overall Study||2
8239791|NCT01933789|20320943|P3|Had Target Visit|Overall Study||2
8239792|NCT01933789|20320944|P2|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65
8239793|NCT01933789|20320945|P1|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61
8239794|NCT01933789|20320937|P9|STARTED|Overall Study||25
8239795|NCT01933789|20320938|P8|STARTED|Overall Study||61
8239796|NCT01933789|20320939|P7|STARTED|Overall Study||58
8239797|NCT01933789|20320940|P6|STARTED|Overall Study||288
8239798|NCT01933789|20320941|P5|STARTED|Overall Study||249
8239799|NCT01933789|20320942|P4|STARTED|Overall Study||2
8239800|NCT01933789|20320943|P3|STARTED|Overall Study||2
8239801|NCT01933789|20320944|P2|STARTED|Overall Study||67
8239802|NCT01933789|20320945|P1|STARTED|Overall Study||65
8239803|NCT01933776|20321246|P2|NOT COMPLETED|Overall Study||0
8239804|NCT01933776|20321247|P1|NOT COMPLETED|Overall Study||0
8239805|NCT01933776|20321246|P2|COMPLETED|Overall Study||20
8239806|NCT01933776|20321247|P1|COMPLETED|Overall Study||20
8239807|NCT01933776|20321246|P2|STARTED|Overall Study||20
8239808|NCT01933776|20321247|P1|STARTED|Overall Study||20
8239809|NCT01933672|20321255|P7|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8239810|NCT01933672|20321256|P6|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8239811|NCT01933672|20321257|P5|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8239812|NCT01933672|20321258|P4|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
8239813|NCT01933672|20321259|P3|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8239814|NCT01933672|20321260|P2|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
8239815|NCT01933672|20321261|P1|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
8239816|NCT01933672|20321255|P7|COMPLETED|Third Intervention Period (12-16 Days)||6
8239817|NCT01933672|20321256|P6|COMPLETED|Third Intervention Period (12-16 Days)||4
8239818|NCT01933672|20321257|P5|COMPLETED|Third Intervention Period (12-16 Days)||6
8239819|NCT01933672|20321258|P4|COMPLETED|Third Intervention Period (12-16 Days)||4
8239820|NCT01933672|20321259|P3|COMPLETED|Third Intervention Period (12-16 Days)||1
8239821|NCT01933672|20321260|P2|COMPLETED|Third Intervention Period (12-16 Days)||5
8239822|NCT01933672|20321261|P1|COMPLETED|Third Intervention Period (12-16 Days)||0
8239823|NCT01933672|20321255|P7|STARTED|Third Intervention Period (12-16 Days)||6
8239824|NCT01933672|20321256|P6|STARTED|Third Intervention Period (12-16 Days)||4
8239825|NCT01933672|20321257|P5|STARTED|Third Intervention Period (12-16 Days)||6
8239826|NCT01933672|20321258|P4|STARTED|Third Intervention Period (12-16 Days)||5
8239827|NCT01933672|20321259|P3|STARTED|Third Intervention Period (12-16 Days)||1
8239828|NCT01933672|20321260|P2|STARTED|Third Intervention Period (12-16 Days)||6
8239829|NCT01933672|20321261|P1|STARTED|Third Intervention Period (12-16 Days)||0
8239830|NCT01933672|20321255|P7|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8239831|NCT01933672|20321256|P6|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8239832|NCT01933672|20321257|P5|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8239833|NCT01933672|20321258|P4|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8239834|NCT01933672|20321259|P3|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8239835|NCT01933672|20321260|P2|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8239836|NCT01933672|20321261|P1|NOT COMPLETED|Second Washout Period (7-14 Days)||0
8239837|NCT01933672|20321255|P7|COMPLETED|Second Washout Period (7-14 Days)||6
8239838|NCT01933672|20321256|P6|COMPLETED|Second Washout Period (7-14 Days)||4
8239839|NCT01933672|20321257|P5|COMPLETED|Second Washout Period (7-14 Days)||6
8239840|NCT01933672|20321258|P4|COMPLETED|Second Washout Period (7-14 Days)||5
8239841|NCT01933672|20321259|P3|COMPLETED|Second Washout Period (7-14 Days)||1
8239842|NCT01933672|20321260|P2|COMPLETED|Second Washout Period (7-14 Days)||6
8239843|NCT01933672|20321261|P1|COMPLETED|Second Washout Period (7-14 Days)||0
8239844|NCT01933672|20321255|P7|STARTED|Second Washout Period (7-14 Days)||6
8239845|NCT01933672|20321256|P6|STARTED|Second Washout Period (7-14 Days)||4
8239846|NCT01933672|20321257|P5|STARTED|Second Washout Period (7-14 Days)||6
8239847|NCT01933672|20321258|P4|STARTED|Second Washout Period (7-14 Days)||5
8239848|NCT01933672|20321259|P3|STARTED|Second Washout Period (7-14 Days)||1
8239849|NCT01933672|20321260|P2|STARTED|Second Washout Period (7-14 Days)||6
8239850|NCT01933672|20321261|P1|STARTED|Second Washout Period (7-14 Days)||0
8239851|NCT01933672|20321255|P7|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8239852|NCT01933672|20321256|P6|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8239853|NCT01933672|20321257|P5|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8239854|NCT01933672|20321258|P4|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8239855|NCT01933672|20321259|P3|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
8239856|NCT01933672|20321260|P2|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
8239857|NCT01933672|20321261|P1|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
8239858|NCT01933672|20321255|P7|COMPLETED|Second Intervention Period (12-16 Days)||6
8239859|NCT01933672|20321256|P6|COMPLETED|Second Intervention Period (12-16 Days)||4
8239860|NCT01933672|20321257|P5|COMPLETED|Second Intervention Period (12-16 Days)||6
8239861|NCT01933672|20321258|P4|COMPLETED|Second Intervention Period (12-16 Days)||5
8239862|NCT01933672|20321259|P3|COMPLETED|Second Intervention Period (12-16 Days)||1
8239863|NCT01933672|20321260|P2|COMPLETED|Second Intervention Period (12-16 Days)||6
8239864|NCT01933672|20321261|P1|COMPLETED|Second Intervention Period (12-16 Days)||0
8239865|NCT01933672|20321255|P7|STARTED|Second Intervention Period (12-16 Days)||6
8239866|NCT01933672|20321256|P6|STARTED|Second Intervention Period (12-16 Days)||4
8239867|NCT01933672|20321257|P5|STARTED|Second Intervention Period (12-16 Days)||6
8239868|NCT01933672|20321258|P4|STARTED|Second Intervention Period (12-16 Days)||5
8239869|NCT01933672|20321259|P3|STARTED|Second Intervention Period (12-16 Days)||2
8239870|NCT01933672|20321260|P2|STARTED|Second Intervention Period (12-16 Days)||7
8239871|NCT01933672|20321261|P1|STARTED|Second Intervention Period (12-16 Days)||0
8239872|NCT01933672|20321255|P7|NOT COMPLETED|First Washout Period (7-14 Days)||0
8239873|NCT01933672|20321256|P6|NOT COMPLETED|First Washout Period (7-14 Days)||0
8239874|NCT01933672|20321257|P5|NOT COMPLETED|First Washout Period (7-14 Days)||0
8239875|NCT01933672|20321258|P4|NOT COMPLETED|First Washout Period (7-14 Days)||0
8239876|NCT01933672|20321259|P3|NOT COMPLETED|First Washout Period (7-14 Days)||0
8239877|NCT01933672|20321260|P2|NOT COMPLETED|First Washout Period (7-14 Days)||0
8239878|NCT01933672|20321261|P1|NOT COMPLETED|First Washout Period (7-14 Days)||0
8239879|NCT01933672|20321255|P7|COMPLETED|First Washout Period (7-14 Days)||6
8239880|NCT01933672|20321256|P6|COMPLETED|First Washout Period (7-14 Days)||4
8239881|NCT01933672|20321257|P5|COMPLETED|First Washout Period (7-14 Days)||6
8239882|NCT01933672|20321258|P4|COMPLETED|First Washout Period (7-14 Days)||5
8239883|NCT01933672|20321259|P3|COMPLETED|First Washout Period (7-14 Days)||2
8239884|NCT01933672|20321260|P2|COMPLETED|First Washout Period (7-14 Days)||7
8239885|NCT01933672|20321261|P1|COMPLETED|First Washout Period (7-14 Days)||0
8239886|NCT01933672|20321255|P7|STARTED|First Washout Period (7-14 Days)||6
8239887|NCT01933672|20321256|P6|STARTED|First Washout Period (7-14 Days)||4
8239888|NCT01933672|20321257|P5|STARTED|First Washout Period (7-14 Days)||6
8239889|NCT01933672|20321258|P4|STARTED|First Washout Period (7-14 Days)||5
8239890|NCT01933672|20321259|P3|STARTED|First Washout Period (7-14 Days)||2
8239891|NCT01933672|20321260|P2|STARTED|First Washout Period (7-14 Days)||7
8239892|NCT01933672|20321261|P1|STARTED|First Washout Period (7-14 Days)||0
8239893|NCT01933672|20321255|P7|NOT COMPLETED|First Intervention Period (12-16 Days)||0
8239894|NCT01933672|20321256|P6|NOT COMPLETED|First Intervention Period (12-16 Days)||1
8239895|NCT01933672|20321257|P5|NOT COMPLETED|First Intervention Period (12-16 Days)||1
8239896|NCT01933672|20321258|P4|NOT COMPLETED|First Intervention Period (12-16 Days)||0
8239897|NCT01933672|20321259|P3|NOT COMPLETED|First Intervention Period (12-16 Days)||1
8239898|NCT01933672|20321260|P2|NOT COMPLETED|First Intervention Period (12-16 Days)||0
8239899|NCT01933672|20321261|P1|NOT COMPLETED|First Intervention Period (12-16 Days)||0
8239900|NCT01933672|20321255|P7|COMPLETED|First Intervention Period (12-16 Days)||6
8239901|NCT01933672|20321256|P6|COMPLETED|First Intervention Period (12-16 Days)||4
8239902|NCT01933672|20321257|P5|COMPLETED|First Intervention Period (12-16 Days)||6
8239903|NCT01933672|20321258|P4|COMPLETED|First Intervention Period (12-16 Days)||5
8239904|NCT01933672|20321259|P3|COMPLETED|First Intervention Period (12-16 Days)||2
8239905|NCT01933672|20321260|P2|COMPLETED|First Intervention Period (12-16 Days)||7
8239906|NCT01933672|20321261|P1|COMPLETED|First Intervention Period (12-16 Days)||0
8239907|NCT01933672|20321255|P7|STARTED|First Intervention Period (12-16 Days)||6
8239908|NCT01933672|20321256|P6|STARTED|First Intervention Period (12-16 Days)||5
8239909|NCT01933672|20321257|P5|STARTED|First Intervention Period (12-16 Days)||7
8239910|NCT01933672|20321258|P4|STARTED|First Intervention Period (12-16 Days)||5
8239911|NCT01933672|20321259|P3|STARTED|First Intervention Period (12-16 Days)||3
8239912|NCT01933672|20321260|P2|STARTED|First Intervention Period (12-16 Days)||7
8239913|NCT01933672|20321261|P1|STARTED|First Intervention Period (12-16 Days)||0
8239914|NCT01933672|20321255|P7|NOT COMPLETED|Metformin Run-in Period||0
8239915|NCT01933672|20321256|P6|NOT COMPLETED|Metformin Run-in Period||0
8239916|NCT01933672|20321257|P5|NOT COMPLETED|Metformin Run-in Period||0
8239917|NCT01933672|20321258|P4|NOT COMPLETED|Metformin Run-in Period||0
8239918|NCT01933672|20321259|P3|NOT COMPLETED|Metformin Run-in Period||0
8239919|NCT01933672|20321260|P2|NOT COMPLETED|Metformin Run-in Period||0
8239920|NCT01933672|20321261|P1|NOT COMPLETED|Metformin Run-in Period||10
8239921|NCT01933672|20321255|P7|COMPLETED|Metformin Run-in Period||0
8239922|NCT01933672|20321256|P6|COMPLETED|Metformin Run-in Period||0
8239923|NCT01933672|20321257|P5|COMPLETED|Metformin Run-in Period||0
8239924|NCT01933672|20321258|P4|COMPLETED|Metformin Run-in Period||0
8239925|NCT01933672|20321259|P3|COMPLETED|Metformin Run-in Period||0
8239926|NCT01933672|20321260|P2|COMPLETED|Metformin Run-in Period||0
8239927|NCT01933672|20321261|P1|COMPLETED|Metformin Run-in Period||33
8239928|NCT01933672|20321255|P7|Received Treatment|Metformin Run-in Period||0
8239929|NCT01933672|20321256|P6|Received Treatment|Metformin Run-in Period||0
8239930|NCT01933672|20321257|P5|Received Treatment|Metformin Run-in Period||0
8239931|NCT01933672|20321258|P4|Received Treatment|Metformin Run-in Period||0
8239932|NCT01933672|20321259|P3|Received Treatment|Metformin Run-in Period||0
8239933|NCT01933672|20321260|P2|Received Treatment|Metformin Run-in Period||0
8239934|NCT01933672|20321261|P1|Received Treatment|Metformin Run-in Period||43
8239935|NCT01933672|20321255|P7|STARTED|Metformin Run-in Period||0
8239936|NCT01933672|20321256|P6|STARTED|Metformin Run-in Period||0
8239937|NCT01933672|20321257|P5|STARTED|Metformin Run-in Period||0
8239938|NCT01933672|20321258|P4|STARTED|Metformin Run-in Period||0
8239939|NCT01933672|20321259|P3|STARTED|Metformin Run-in Period||0
8239940|NCT01933672|20321260|P2|STARTED|Metformin Run-in Period||0
8239941|NCT01933672|20321261|P1|STARTED|Metformin Run-in Period||43
8239942|NCT01933594|20321313|P6|NOT COMPLETED|Overall Study||0
8239943|NCT01933594|20321314|P5|NOT COMPLETED|Overall Study||2
8239944|NCT01933594|20321315|P4|NOT COMPLETED|Overall Study||0
8239945|NCT01933594|20321316|P3|NOT COMPLETED|Overall Study||0
8239946|NCT01933594|20321317|P2|NOT COMPLETED|Overall Study||0
8239947|NCT01933594|20321318|P1|NOT COMPLETED|Overall Study||1
8239948|NCT01933594|20321313|P6|COMPLETED|Overall Study||3
8239949|NCT01933594|20321314|P5|COMPLETED|Overall Study||11
8239950|NCT01933594|20321315|P4|COMPLETED|Overall Study||7
8239951|NCT01933594|20321316|P3|COMPLETED|Overall Study||12
8239952|NCT01933594|20321317|P2|COMPLETED|Overall Study||12
8239953|NCT01933594|20321318|P1|COMPLETED|Overall Study||11
8239954|NCT01933594|20321313|P6|STARTED|Overall Study||3
8239955|NCT01933594|20321314|P5|STARTED|Overall Study||13
8239956|NCT01933594|20321315|P4|STARTED|Overall Study||7
8239957|NCT01933594|20321316|P3|STARTED|Overall Study||12
8239958|NCT01933594|20321317|P2|STARTED|Overall Study||12
8239959|NCT01933594|20321318|P1|STARTED|Overall Study||12
8239960|NCT01933464|20321410|P2|NOT COMPLETED|Overall Study||0
8239961|NCT01933464|20321411|P1|NOT COMPLETED|Overall Study||0
8239962|NCT01933464|20321410|P2|COMPLETED|Overall Study||5
8239963|NCT01933464|20321411|P1|COMPLETED|Overall Study||5
8239964|NCT01933464|20321410|P2|STARTED|Overall Study||5
8239965|NCT01933464|20321411|P1|STARTED|Overall Study||5
8239966|NCT01933425|20321423|P2|NOT COMPLETED|Overall Study||0
8239967|NCT01933425|20321424|P1|NOT COMPLETED|Overall Study||0
8239968|NCT01933425|20321423|P2|COMPLETED|Overall Study||7
8239969|NCT01933425|20321424|P1|COMPLETED|Overall Study||7
8239970|NCT01933425|20321423|P2|STARTED|Overall Study||7
8239971|NCT01933425|20321424|P1|STARTED|Overall Study||7
8239972|NCT01933399|20321437|P3|NOT COMPLETED|Overall Study||0
8239973|NCT01933399|20321438|P2|NOT COMPLETED|Overall Study||0
8239974|NCT01933399|20321439|P1|NOT COMPLETED|Overall Study||0
8239975|NCT01933399|20321437|P3|COMPLETED|Overall Study||37
8239976|NCT01933399|20321438|P2|COMPLETED|Overall Study||32
8239977|NCT01933399|20321439|P1|COMPLETED|Overall Study||29
8239978|NCT01933399|20321437|P3|STARTED|Overall Study||37
8239979|NCT01933399|20321438|P2|STARTED|Overall Study||32
8239980|NCT01933399|20321439|P1|STARTED|Overall Study||29
8239981|NCT01933334|20321452|P2|NOT COMPLETED|Overall Study||2
8239982|NCT01933334|20321453|P1|NOT COMPLETED|Overall Study||5
8239983|NCT01933334|20321452|P2|COMPLETED|Overall Study||29
8239984|NCT01933334|20321453|P1|COMPLETED|Overall Study||27
8239985|NCT01933334|20321452|P2|STARTED|Overall Study||31
8239986|NCT01933334|20321453|P1|STARTED|Overall Study||32
8239987|NCT01933243|20321465|P2|NOT COMPLETED|Overall Study||4
8239988|NCT01933243|20321466|P1|NOT COMPLETED|Overall Study||2
8239989|NCT01933243|20321465|P2|COMPLETED|Overall Study||8
8239990|NCT01933243|20321466|P1|COMPLETED|Overall Study||10
8239991|NCT01933243|20321465|P2|STARTED|Overall Study||12
8239992|NCT01933243|20321466|P1|STARTED|Overall Study||12
8239993|NCT01933230|20321476|P1|NOT COMPLETED|Overall Study||0
8239994|NCT01933230|20321476|P1|COMPLETED|Overall Study||2
8239995|NCT01933230|20321476|P1|STARTED|Overall Study||2
8239996|NCT01933217|20321482|P2|NOT COMPLETED|Crossover (4 Weeks)||0
8239997|NCT01933217|20321483|P1|NOT COMPLETED|Crossover (4 Weeks)||0
8239998|NCT01933217|20321482|P2|COMPLETED|Crossover (4 Weeks)||10
8239999|NCT01933217|20321483|P1|COMPLETED|Crossover (4 Weeks)||10
8240000|NCT01933217|20321482|P2|STARTED|Crossover (4 Weeks)||10
8240001|NCT01933217|20321483|P1|STARTED|Crossover (4 Weeks)||10
8240002|NCT01933217|20321482|P2|NOT COMPLETED|Randomization (4 Weeks)||4
8240003|NCT01933217|20321483|P1|NOT COMPLETED|Randomization (4 Weeks)||2
8240004|NCT01933217|20321482|P2|COMPLETED|Randomization (4 Weeks)||10
8240005|NCT01933217|20321483|P1|COMPLETED|Randomization (4 Weeks)||10
8240006|NCT01933217|20321482|P2|STARTED|Randomization (4 Weeks)||14
8240007|NCT01933217|20321483|P1|STARTED|Randomization (4 Weeks)||12
8240008|NCT01933113|20321495|P1|NOT COMPLETED|Overall Study||1
8240009|NCT01933113|20321495|P1|COMPLETED|Overall Study||2
8240010|NCT01933113|20321495|P1|STARTED|Overall Study||3
8240011|NCT01933048|20321501|P2|NOT COMPLETED|Overall Study||28
8240012|NCT01933048|20321502|P1|NOT COMPLETED|Overall Study||25
8240013|NCT01933048|20321501|P2|COMPLETED|Overall Study||501
8240014|NCT01933048|20321502|P1|COMPLETED|Overall Study||523
8240015|NCT01933048|20321501|P2|STARTED|Overall Study||529
8240016|NCT01933048|20321502|P1|STARTED|Overall Study||548
8240017|NCT01932996|20321517|P2|NOT COMPLETED|Overall Study||0
8240018|NCT01932996|20321518|P1|NOT COMPLETED|Overall Study||2
8240019|NCT01932996|20321517|P2|COMPLETED|Overall Study||180
8240020|NCT01932996|20321518|P1|COMPLETED|Overall Study||170
8240021|NCT01932996|20321517|P2|STARTED|Overall Study||180
8240022|NCT01932996|20321518|P1|STARTED|Overall Study||172
8240023|NCT01932970|20321528|P1|NOT COMPLETED|Overall Study||18
8240024|NCT01932970|20321528|P1|COMPLETED|Overall Study||140
8240025|NCT01932970|20321528|P1|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
8240026|NCT01932970|20321528|P1|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
8240027|NCT01932788|20321538|P2|NOT COMPLETED|Overall Study||51
8240028|NCT01932788|20321539|P1|NOT COMPLETED|Overall Study||38
8240029|NCT01932788|20321538|P2|COMPLETED|Overall Study||118
8240030|NCT01932788|20321539|P1|COMPLETED|Overall Study||135
8240031|NCT01932788|20321538|P2|STARTED|Overall Study||169
8240032|NCT01932788|20321539|P1|STARTED|Overall Study||173
8240045|NCT01932697|20321588|P2|NOT COMPLETED|Overall Study||0
8240046|NCT01932697|20321589|P1|NOT COMPLETED|Overall Study||2
8240047|NCT01932697|20321588|P2|COMPLETED|Overall Study||43
8240048|NCT01932697|20321589|P1|COMPLETED|Overall Study||36
8240049|NCT01932697|20321588|P2|STARTED|Overall Study||43
8240050|NCT01932697|20321589|P1|STARTED|Overall Study||38
8240051|NCT01932606|20321603|P2|NOT COMPLETED|Overall Study||0
8240052|NCT01932606|20321604|P1|NOT COMPLETED|Overall Study||0
8240053|NCT01932606|20321603|P2|COMPLETED|Overall Study||14
8240054|NCT01932606|20321604|P1|COMPLETED|Overall Study||14
8240055|NCT01932606|20321603|P2|STARTED|Overall Study||14
8240056|NCT01932606|20321604|P1|STARTED|Overall Study||14
8240057|NCT01932437|20321656|P6|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1
8240058|NCT01932437|20321657|P5|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240059|NCT01932437|20321658|P4|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240060|NCT01932437|20321659|P3|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240061|NCT01932437|20321660|P2|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240062|NCT01932437|20321661|P1|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240063|NCT01932437|20321656|P6|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5
8240064|NCT01932437|20321657|P5|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240065|NCT01932437|20321658|P4|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240066|NCT01932437|20321659|P3|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240067|NCT01932437|20321660|P2|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240068|NCT01932437|20321661|P1|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
8240069|NCT01932437|20321656|P6|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6
8240070|NCT01932437|20321657|P5|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240071|NCT01932437|20321658|P4|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240072|NCT01932437|20321659|P3|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240073|NCT01932437|20321660|P2|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
8240074|NCT01932437|20321661|P1|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
8240075|NCT01932437|20321656|P6|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240076|NCT01932437|20321657|P5|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240077|NCT01932437|20321658|P4|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240078|NCT01932437|20321659|P3|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240079|NCT01932437|20321660|P2|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240080|NCT01932437|20321661|P1|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240081|NCT01932437|20321656|P6|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240082|NCT01932437|20321657|P5|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
8240083|NCT01932437|20321658|P4|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240084|NCT01932437|20321659|P3|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240085|NCT01932437|20321660|P2|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240086|NCT01932437|20321661|P1|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
8240087|NCT01932437|20321656|P6|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240088|NCT01932437|20321657|P5|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
8240089|NCT01932437|20321658|P4|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240090|NCT01932437|20321659|P3|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240091|NCT01932437|20321660|P2|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
8240092|NCT01932437|20321661|P1|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
8240093|NCT01932437|20321656|P6|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240094|NCT01932437|20321657|P5|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240095|NCT01932437|20321658|P4|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240096|NCT01932437|20321659|P3|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240097|NCT01932437|20321660|P2|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240098|NCT01932437|20321661|P1|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240099|NCT01932437|20321656|P6|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240100|NCT01932437|20321657|P5|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240101|NCT01932437|20321658|P4|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
8240102|NCT01932437|20321659|P3|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240103|NCT01932437|20321660|P2|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240104|NCT01932437|20321661|P1|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
8240105|NCT01932437|20321656|P6|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240106|NCT01932437|20321657|P5|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240107|NCT01932437|20321658|P4|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
8240108|NCT01932437|20321659|P3|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240109|NCT01932437|20321660|P2|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
8240110|NCT01932437|20321661|P1|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
8240111|NCT01932437|20321656|P6|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240112|NCT01932437|20321657|P5|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240113|NCT01932437|20321658|P4|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240114|NCT01932437|20321659|P3|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240115|NCT01932437|20321660|P2|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240116|NCT01932437|20321661|P1|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240117|NCT01932437|20321656|P6|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240118|NCT01932437|20321657|P5|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240119|NCT01932437|20321658|P4|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240120|NCT01932437|20321659|P3|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
8240121|NCT01932437|20321660|P2|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240122|NCT01932437|20321661|P1|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
8240123|NCT01932437|20321656|P6|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240124|NCT01932437|20321657|P5|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240125|NCT01932437|20321658|P4|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240126|NCT01932437|20321659|P3|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
8240127|NCT01932437|20321660|P2|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
8240128|NCT01932437|20321661|P1|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
8240129|NCT01932437|20321656|P6|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240130|NCT01932437|20321657|P5|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240131|NCT01932437|20321658|P4|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240132|NCT01932437|20321659|P3|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240133|NCT01932437|20321660|P2|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240134|NCT01932437|20321661|P1|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240135|NCT01932437|20321656|P6|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240136|NCT01932437|20321657|P5|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240137|NCT01932437|20321658|P4|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240138|NCT01932437|20321659|P3|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240139|NCT01932437|20321660|P2|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
8240140|NCT01932437|20321661|P1|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
8240141|NCT01932437|20321656|P6|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240142|NCT01932437|20321657|P5|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240143|NCT01932437|20321658|P4|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240144|NCT01932437|20321659|P3|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
8240145|NCT01932437|20321660|P2|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
8240146|NCT01932437|20321661|P1|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
8240147|NCT01932294|20321711|P1|NOT COMPLETED|Overall Study||99
8240148|NCT01932294|20321711|P1|COMPLETED|Overall Study||72
8240149|NCT01932294|20321711|P1|STARTED|Overall Study||171
8240150|NCT01932242|20321719|P2|NOT COMPLETED|Overall Study||5
8240151|NCT01932242|20321720|P1|NOT COMPLETED|Overall Study||5
8240152|NCT01932242|20321719|P2|COMPLETED|Overall Study||30
8240153|NCT01932242|20321720|P1|COMPLETED|Overall Study||30
8240154|NCT01932242|20321719|P2|STARTED|Overall Study||35
8240155|NCT01932242|20321720|P1|STARTED|Overall Study||35
8240156|NCT01932164|20321764|P1|NOT COMPLETED|Overall Study||0
8240157|NCT01932164|20321764|P1|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
8240158|NCT01932164|20321764|P1|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
8240159|NCT01932164|20321764|P1|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
8240160|NCT01932164|20321764|P1|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
8240161|NCT01932164|20321764|P1|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
8240162|NCT01932164|20321764|P1|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
8240163|NCT01932164|20321764|P1|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
8240164|NCT01932112|20321769|P1|NOT COMPLETED|Overall Study||0
8240165|NCT01932112|20321769|P1|COMPLETED|Overall Study||378
8240166|NCT01932112|20321769|P1|STARTED|Overall Study||378
8240167|NCT01932060|20321775|P2|NOT COMPLETED|Overall Study||0
8240168|NCT01932060|20321776|P1|NOT COMPLETED|Overall Study||0
8240169|NCT01932060|20321775|P2|COMPLETED|Overall Study||24
8240170|NCT01932060|20321776|P1|COMPLETED|Overall Study||27
8240171|NCT01932060|20321775|P2|STARTED|Overall Study||24
8240172|NCT01932060|20321776|P1|STARTED|Overall Study||27
8240173|NCT01931956|20321788|P4|NOT COMPLETED|Overall Study||133
8240174|NCT01931956|20321789|P3|NOT COMPLETED|Overall Study||487
8240175|NCT01931956|20321790|P2|NOT COMPLETED|Overall Study||7
8240176|NCT01931956|20321791|P1|NOT COMPLETED|Overall Study||51
8240177|NCT01931956|20321788|P4|COMPLETED|Overall Study||138
8240178|NCT01931956|20321789|P3|COMPLETED|Overall Study||141
8240179|NCT01931956|20321790|P2|COMPLETED|Overall Study||0
8240180|NCT01931956|20321791|P1|COMPLETED|Overall Study||8
8240181|NCT01931956|20321788|P4|STARTED|Overall Study||271
8240182|NCT01931956|20321789|P3|STARTED|Overall Study||628
8240183|NCT01931956|20321790|P2|STARTED|Overall Study||7
8240184|NCT01931956|20321791|P1|STARTED|Overall Study||59
8240185|NCT01931878|20322147|P2|NOT COMPLETED|Second Intervention (After 3 Months)||2
8240186|NCT01931878|20322148|P1|NOT COMPLETED|Second Intervention (After 3 Months)||0
8240187|NCT01931878|20322147|P2|COMPLETED|Second Intervention (After 3 Months)||12
8240188|NCT01931878|20322148|P1|COMPLETED|Second Intervention (After 3 Months)||9
8240189|NCT01931878|20322147|P2|STARTED|Second Intervention (After 3 Months)||14
8240190|NCT01931878|20322148|P1|STARTED|Second Intervention (After 3 Months)||9
8240191|NCT01931878|20322147|P2|NOT COMPLETED|First Intervention||0
8240192|NCT01931878|20322148|P1|NOT COMPLETED|First Intervention||1
8240193|NCT01931878|20322147|P2|COMPLETED|First Intervention||14
8240194|NCT01931878|20322148|P1|COMPLETED|First Intervention||9
8240195|NCT01931878|20322147|P2|STARTED|First Intervention||14
8240196|NCT01931878|20322148|P1|STARTED|First Intervention||10
8240197|NCT01931865|20322158|P1|NOT COMPLETED|Overall Study||4
8240198|NCT01931865|20322158|P1|COMPLETED|Overall Study||8
8240199|NCT01931865|20322158|P1|STARTED|Overall Study||12
8240200|NCT01931839|20322171|P7|NOT COMPLETED|Overall Study||4
8240201|NCT01931839|20322172|P6|NOT COMPLETED|Overall Study||5
8240202|NCT01931839|20322173|P5|NOT COMPLETED|Overall Study||1
8240203|NCT01931839|20322174|P4|NOT COMPLETED|Overall Study||14
8240204|NCT01931839|20322175|P3|NOT COMPLETED|Overall Study||39
8240205|NCT01931839|20322176|P2|NOT COMPLETED|Overall Study||26
8240206|NCT01931839|20322177|P1|NOT COMPLETED|Overall Study||41
8240207|NCT01931839|20322171|P7|COMPLETED|Overall Study||56
8240208|NCT01931839|20322172|P6|COMPLETED|Overall Study||50
8240209|NCT01931839|20322173|P5|COMPLETED|Overall Study||18
8240210|NCT01931839|20322174|P4|COMPLETED|Overall Study||162
8240211|NCT01931839|20322175|P3|COMPLETED|Overall Study||301
8240212|NCT01931839|20322176|P2|COMPLETED|Overall Study||152
8240213|NCT01931839|20322177|P1|COMPLETED|Overall Study||294
8240214|NCT01931839|20322171|P7|Safety Analysis Set (As Dosed)|Overall Study||60
8240215|NCT01931839|20322172|P6|Safety Analysis Set (As Dosed)|Overall Study||55
8240216|NCT01931839|20322173|P5|Safety Analysis Set (As Dosed)|Overall Study||19
8240217|NCT01931839|20322174|P4|Safety Analysis Set (As Dosed)|Overall Study||176
8240218|NCT01931839|20322175|P3|Safety Analysis Set (As Dosed)|Overall Study||340
8240219|NCT01931839|20322176|P2|Safety Analysis Set (As Dosed)|Overall Study||178
8240220|NCT01931839|20322177|P1|Safety Analysis Set (As Dosed)|Overall Study||335
8240221|NCT01931839|20322171|P7|Full Analysis Set (As Randomized)|Overall Study||60
8240222|NCT01931839|20322172|P6|Full Analysis Set (As Randomized)|Overall Study||55
8240223|NCT01931839|20322173|P5|Full Analysis Set (As Randomized)|Overall Study||19
8240224|NCT01931839|20322174|P4|Full Analysis Set (As Randomized)|Overall Study||176
8240225|NCT01931839|20322175|P3|Full Analysis Set (As Randomized)|Overall Study||340
8240226|NCT01931839|20322176|P2|Full Analysis Set (As Randomized)|Overall Study||179
8240227|NCT01931839|20322177|P1|Full Analysis Set (As Randomized)|Overall Study||334
8240228|NCT01931839|20322171|P7|STARTED|Overall Study||60
8240229|NCT01931839|20322172|P6|STARTED|Overall Study||55
8240230|NCT01931839|20322173|P5|STARTED|Overall Study||19
8240231|NCT01931839|20322174|P4|STARTED|Overall Study||176
8240232|NCT01931839|20322175|P3|STARTED|Overall Study||340
8240233|NCT01931839|20322176|P2|STARTED|Overall Study||178
8240234|NCT01931839|20322177|P1|STARTED|Overall Study||335
8240235|NCT01931735|20322249|P4|NOT COMPLETED|Observational Non-Randomized Phase||2
8240236|NCT01931735|20322250|P3|NOT COMPLETED|Observational Non-Randomized Phase||0
8240237|NCT01931735|20322251|P2|NOT COMPLETED|Observational Non-Randomized Phase||0
8240238|NCT01931735|20322252|P1|NOT COMPLETED|Observational Non-Randomized Phase||0
8240239|NCT01931735|20322249|P4|COMPLETED|Observational Non-Randomized Phase||9
8240240|NCT01931735|20322250|P3|COMPLETED|Observational Non-Randomized Phase||0
8240241|NCT01931735|20322251|P2|COMPLETED|Observational Non-Randomized Phase||1
8240242|NCT01931735|20322252|P1|COMPLETED|Observational Non-Randomized Phase||2
8240243|NCT01931735|20322249|P4|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
8240244|NCT01931735|20322250|P3|STARTED|Observational Non-Randomized Phase||0
8240245|NCT01931735|20322251|P2|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
8240246|NCT01931735|20322252|P1|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
8240247|NCT01931735|20322249|P4|NOT COMPLETED|Randomized Phase||0
8240248|NCT01931735|20322250|P3|NOT COMPLETED|Randomized Phase||5
8240249|NCT01931735|20322251|P2|NOT COMPLETED|Randomized Phase||2
8240250|NCT01931735|20322252|P1|NOT COMPLETED|Randomized Phase||2
8240251|NCT01931735|20322249|P4|COMPLETED|Randomized Phase||0
8240252|NCT01931735|20322250|P3|COMPLETED|Randomized Phase||4
8240253|NCT01931735|20322251|P2|COMPLETED|Randomized Phase||1
8240254|NCT01931735|20322252|P1|COMPLETED|Randomized Phase||2
8240255|NCT01931735|20322249|P4|STARTED|Randomized Phase||0
8240256|NCT01931735|20322250|P3|STARTED|Randomized Phase||9
8240257|NCT01931735|20322251|P2|STARTED|Randomized Phase||3
8240258|NCT01931735|20322252|P1|STARTED|Randomized Phase||4
8240262|NCT01931670|20322299|P3|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
8240263|NCT01931670|20322300|P2|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
8240264|NCT01931670|20322301|P1|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
8240265|NCT01931670|20322299|P3|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
8240266|NCT01931670|20322300|P2|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
8240267|NCT01931670|20322301|P1|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
8240268|NCT01931670|20322299|P3|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
8240269|NCT01931670|20322300|P2|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
8240270|NCT01931670|20322301|P1|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
8240271|NCT01931670|20322299|P3|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
8240272|NCT01931670|20322300|P2|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
8240273|NCT01931670|20322301|P1|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
8240274|NCT01931670|20322299|P3|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
8240275|NCT01931670|20322300|P2|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
8240276|NCT01931670|20322301|P1|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
8240277|NCT01931670|20322299|P3|NOT COMPLETED|Treatment Period||45
8240278|NCT01931670|20322300|P2|NOT COMPLETED|Treatment Period||48
8240279|NCT01931670|20322301|P1|NOT COMPLETED|Treatment Period||90
8240280|NCT01931670|20322299|P3|COMPLETED|Treatment Period||184
8240281|NCT01931670|20322300|P2|COMPLETED|Treatment Period||178
8240282|NCT01931670|20322301|P1|COMPLETED|Treatment Period||270
8240283|NCT01931670|20322299|P3|STARTED|Treatment Period||229
8240284|NCT01931670|20322300|P2|STARTED|Treatment Period||226
8240285|NCT01931670|20322301|P1|STARTED|Treatment Period||360
8240286|NCT01931566|20322402|P3|NOT COMPLETED|Overall Study||1506
8240287|NCT01931566|20322403|P2|NOT COMPLETED|Overall Study||1476
8240288|NCT01931566|20322404|P1|NOT COMPLETED|Overall Study||429
8240289|NCT01931566|20322402|P3|COMPLETED|Overall Study||39
8240290|NCT01931566|20322403|P2|COMPLETED|Overall Study||40
8240291|NCT01931566|20322404|P1|COMPLETED|Overall Study||4
8240292|NCT01931566|20322402|P3|Treated|Overall Study||1531
8240293|NCT01931566|20322403|P2|Treated|Overall Study||1507
8240294|NCT01931566|20322404|P1|Treated|Overall Study||427
8240295|NCT01931566|20322402|P3|STARTED|Overall Study||1545
8240296|NCT01931566|20322403|P2|STARTED|Overall Study||1516
8240297|NCT01931566|20322404|P1|STARTED|Overall Study||433
8240298|NCT01931527|20322419|P2|NOT COMPLETED|Overall Study||0
8240299|NCT01931527|20322420|P1|NOT COMPLETED|Overall Study||0
8240300|NCT01931527|20322419|P2|COMPLETED|Overall Study||15
8240301|NCT01931527|20322420|P1|COMPLETED|Overall Study||16
8240302|NCT01931527|20322419|P2|STARTED|Overall Study||15
8240303|NCT01931527|20322420|P1|STARTED|Overall Study||16
8240304|NCT01931475|20322442|P2|NOT COMPLETED|Period 2: Extension Treatment Phase||19
8240305|NCT01931475|20322443|P1|NOT COMPLETED|Period 2: Extension Treatment Phase||4
8240306|NCT01931475|20322442|P2|COMPLETED|Period 2: Extension Treatment Phase||157
8240307|NCT01931475|20322443|P1|COMPLETED|Period 2: Extension Treatment Phase||162
8240308|NCT01931475|20322442|P2|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
8240309|NCT01931475|20322443|P1|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
8240310|NCT01931475|20322442|P2|STARTED|Period 2: Extension Treatment Phase||176
8240311|NCT01931475|20322443|P1|STARTED|Period 2: Extension Treatment Phase||166
8240312|NCT01931475|20322442|P2|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
8240313|NCT01931475|20322443|P1|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
8240314|NCT01931475|20322442|P2|COMPLETED|Period 1: Double-Blind Treatment Phase||176
8240315|NCT01931475|20322443|P1|COMPLETED|Period 1: Double-Blind Treatment Phase||166
8240316|NCT01931475|20322442|P2|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
8240317|NCT01931475|20322443|P1|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
8240318|NCT01931475|20322442|P2|STARTED|Period 1: Double-Blind Treatment Phase||202
8240319|NCT01931475|20322443|P1|STARTED|Period 1: Double-Blind Treatment Phase||205
8240320|NCT01931462|20322470|P1|NOT COMPLETED|Overall Study||1
8240321|NCT01931462|20322470|P1|COMPLETED|Overall Study||1
8240322|NCT01931462|20322470|P1|STARTED|Overall Study||2
8240323|NCT01931397|20322481|P1|NOT COMPLETED|Overall Study||11
8240324|NCT01931397|20322481|P1|COMPLETED|Overall Study||19
8240325|NCT01931397|20322481|P1|STARTED|Overall Study||30
8240326|NCT01931202|20322493|P3|NOT COMPLETED|Overall Study||4
8240327|NCT01931202|20322494|P2|NOT COMPLETED|Overall Study||5
8240328|NCT01931202|20322495|P1|NOT COMPLETED|Overall Study||0
8240329|NCT01931202|20322493|P3|COMPLETED|Overall Study||45
8240330|NCT01931202|20322494|P2|COMPLETED|Overall Study||46
8240331|NCT01931202|20322495|P1|COMPLETED|Overall Study||8
8240332|NCT01931202|20322493|P3|STARTED|Overall Study||49
8240333|NCT01931202|20322494|P2|STARTED|Overall Study||51
8240334|NCT01931202|20322495|P1|STARTED|Overall Study||8
8240335|NCT01931150|20322541|P2|NOT COMPLETED|Overall Study||2
8240336|NCT01931150|20322542|P1|NOT COMPLETED|Overall Study||1
8240337|NCT01931150|20322541|P2|COMPLETED|Overall Study||4
8240338|NCT01931150|20322542|P1|COMPLETED|Overall Study||4
8240339|NCT01931150|20322541|P2|STARTED|Overall Study||6
8240340|NCT01931150|20322542|P1|STARTED|Overall Study||5
8240341|NCT01931098|20322550|P2|NOT COMPLETED|Overall Study||4
8240342|NCT01931098|20322551|P1|NOT COMPLETED|Overall Study||0
8240343|NCT01931098|20322550|P2|COMPLETED|Overall Study||22
8240344|NCT01931098|20322551|P1|COMPLETED|Overall Study||9
8240345|NCT01931098|20322550|P2|STARTED|Overall Study||26
8240346|NCT01931098|20322551|P1|STARTED|Overall Study||9
8240347|NCT01931059|20322567|P2|NOT COMPLETED|Day3||0
8240348|NCT01931059|20322568|P1|NOT COMPLETED|Day3||1
8240349|NCT01931059|20322567|P2|COMPLETED|Day3||4
8240350|NCT01931059|20322568|P1|COMPLETED|Day3||5
8240351|NCT01931059|20322567|P2|STARTED|Day3||4
8240352|NCT01931059|20322568|P1|STARTED|Day3||6
8240353|NCT01931059|20322567|P2|NOT COMPLETED|Day2||0
8240354|NCT01931059|20322568|P1|NOT COMPLETED|Day2||0
8240355|NCT01931059|20322567|P2|COMPLETED|Day2||4
8240356|NCT01931059|20322568|P1|COMPLETED|Day2||6
8240357|NCT01931059|20322567|P2|STARTED|Day2||4
8240358|NCT01931059|20322568|P1|STARTED|Day2||6
8240359|NCT01931059|20322567|P2|NOT COMPLETED|Day 1||1
8240360|NCT01931059|20322568|P1|NOT COMPLETED|Day 1||0
8240361|NCT01931059|20322567|P2|COMPLETED|Day 1||4
8240362|NCT01931059|20322568|P1|COMPLETED|Day 1||6
8240363|NCT01931059|20322567|P2|STARTED|Day 1||5
8240364|NCT01931059|20322568|P1|STARTED|Day 1||6
8240365|NCT01930890|20322584|P4|NOT COMPLETED|Overall Study||27
8240366|NCT01930890|20322585|P3|NOT COMPLETED|Overall Study||13
8240367|NCT01930890|20322586|P2|NOT COMPLETED|Overall Study||33
8240368|NCT01930890|20322587|P1|NOT COMPLETED|Overall Study||14
8240369|NCT01930890|20322584|P4|COMPLETED|Overall Study||0
8240370|NCT01930890|20322585|P3|COMPLETED|Overall Study||0
8240371|NCT01930890|20322586|P2|COMPLETED|Overall Study||0
8240372|NCT01930890|20322587|P1|COMPLETED|Overall Study||0
8240373|NCT01930890|20322584|P4|STARTED|Overall Study||27
8240374|NCT01930890|20322585|P3|STARTED|Overall Study||13
8240375|NCT01930890|20322586|P2|STARTED|Overall Study||33
8240376|NCT01930890|20322587|P1|STARTED|Overall Study||14
8240377|NCT01930799|20322601|P1|NOT COMPLETED|Overall Study||8
8240378|NCT01930799|20322601|P1|COMPLETED|Overall Study||112
8240379|NCT01930799|20322601|P1|STARTED|Overall Study||120
8240380|NCT01930747|20322609|P3|NOT COMPLETED|Overall Study||0
8240381|NCT01930747|20322610|P2|NOT COMPLETED|Overall Study||0
8240382|NCT01930747|20322611|P1|NOT COMPLETED|Overall Study||0
8240383|NCT01930747|20322609|P3|COMPLETED|Overall Study||12
8240384|NCT01930747|20322610|P2|COMPLETED|Overall Study||14
8240385|NCT01930747|20322611|P1|COMPLETED|Overall Study||16
8240386|NCT01930747|20322609|P3|STARTED|Overall Study||12
8240387|NCT01930747|20322610|P2|STARTED|Overall Study||14
8240388|NCT01930747|20322611|P1|STARTED|Overall Study||16
8240389|NCT01930643|20322627|P2|NOT COMPLETED|Overall Study||0
8240390|NCT01930643|20322628|P1|NOT COMPLETED|Overall Study||0
8240391|NCT01930643|20322627|P2|COMPLETED|Overall Study||6
8240392|NCT01930643|20322628|P1|COMPLETED|Overall Study||7
8240393|NCT01930643|20322627|P2|STARTED|Overall Study||6
8240394|NCT01930643|20322628|P1|STARTED|Overall Study||7
8240395|NCT01930487|20322634|P2|NOT COMPLETED|Second Intervention (30 Days)||0
8240396|NCT01930487|20322635|P1|NOT COMPLETED|Second Intervention (30 Days)||0
8240397|NCT01930487|20322634|P2|COMPLETED|Second Intervention (30 Days)||23
8240398|NCT01930487|20322635|P1|COMPLETED|Second Intervention (30 Days)||19
8240399|NCT01930487|20322634|P2|STARTED|Second Intervention (30 Days)||23
8240400|NCT01930487|20322635|P1|STARTED|Second Intervention (30 Days)||19
8240401|NCT01930487|20322634|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
8240402|NCT01930487|20322635|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
8240403|NCT01930487|20322634|P2|COMPLETED|Washout Period (3 Weeks)||23
8240404|NCT01930487|20322635|P1|COMPLETED|Washout Period (3 Weeks)||19
8240405|NCT01930487|20322634|P2|STARTED|Washout Period (3 Weeks)||23
8240406|NCT01930487|20322635|P1|STARTED|Washout Period (3 Weeks)||19
8240407|NCT01930487|20322634|P2|NOT COMPLETED|First Intervention (30 Days)||2
8240408|NCT01930487|20322635|P1|NOT COMPLETED|First Intervention (30 Days)||2
8240409|NCT01930487|20322634|P2|COMPLETED|First Intervention (30 Days)||23
8240410|NCT01930487|20322635|P1|COMPLETED|First Intervention (30 Days)||19
8240411|NCT01930487|20322634|P2|STARTED|First Intervention (30 Days)||25
8240412|NCT01930487|20322635|P1|STARTED|First Intervention (30 Days)||21
8240413|NCT01930435|20322729|P1|NOT COMPLETED|Overall Study||0
8240414|NCT01930435|20322729|P1|COMPLETED|Overall Study||20
8240415|NCT01930435|20322729|P1|STARTED|Overall Study||20
8240416|NCT01930214|20322740|P3|NOT COMPLETED|Overall Study||25
8240417|NCT01930214|20322741|P2|NOT COMPLETED|Overall Study||21
8240418|NCT01930214|20322742|P1|NOT COMPLETED|Overall Study||20
8240419|NCT01930214|20322740|P3|COMPLETED|Overall Study||108
8240420|NCT01930214|20322741|P2|COMPLETED|Overall Study||96
8240421|NCT01930214|20322742|P1|COMPLETED|Overall Study||80
8240422|NCT01930214|20322740|P3|STARTED|Overall Study||133
8240423|NCT01930214|20322741|P2|STARTED|Overall Study||117
8240424|NCT01930214|20322742|P1|STARTED|Overall Study||100
8240425|NCT01930188|20322762|P3|NOT COMPLETED|Overall Study||19
8240426|NCT01930188|20322763|P2|NOT COMPLETED|Overall Study||21
8240427|NCT01930188|20322764|P1|NOT COMPLETED|Overall Study||22
8240428|NCT01930188|20322762|P3|COMPLETED|Overall Study||388
8240429|NCT01930188|20322763|P2|COMPLETED|Overall Study||388
8240430|NCT01930188|20322764|P1|COMPLETED|Overall Study||387
8240431|NCT01930188|20322762|P3|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32
8240432|NCT01930188|20322763|P2|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61
8240433|NCT01930188|20322764|P1|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53
8240434|NCT01930188|20322762|P3|STARTED|Overall Study||407
8240435|NCT01930188|20322763|P2|STARTED|Overall Study||409
8240436|NCT01930188|20322764|P1|STARTED|Overall Study||409
8240437|NCT01930175|20322791|P3|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8240438|NCT01930175|20322792|P2|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8240439|NCT01930175|20322793|P1|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8240440|NCT01930175|20322791|P3|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||3
8240441|NCT01930175|20322792|P2|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8240442|NCT01930175|20322793|P1|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
8240443|NCT01930175|20322791|P3|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|3
8240444|NCT01930175|20322792|P2|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
8240445|NCT01930175|20322793|P1|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
8240446|NCT01930175|20322791|P3|NOT COMPLETED|Core Study||1
8240447|NCT01930175|20322792|P2|NOT COMPLETED|Core Study||1
8240448|NCT01930175|20322793|P1|NOT COMPLETED|Core Study||0
8240449|NCT01930175|20322791|P3|COMPLETED|Core Study||3
8240450|NCT01930175|20322792|P2|COMPLETED|Core Study||1
8240451|NCT01930175|20322793|P1|COMPLETED|Core Study||7
8240452|NCT01930175|20322791|P3|Pharmacokinetics (PK) Analysis Set|Core Study|Placebo patients were excluded from the PK analyses|0
8240453|NCT01930175|20322792|P2|Pharmacokinetics (PK) Analysis Set|Core Study||2
8240454|NCT01930175|20322793|P1|Pharmacokinetics (PK) Analysis Set|Core Study||7
8240455|NCT01930175|20322791|P3|Safety Analysis Set|Core Study||4
8240456|NCT01930175|20322792|P2|Safety Analysis Set|Core Study||2
8240457|NCT01930175|20322793|P1|Safety Analysis Set|Core Study||7
8240458|NCT01930175|20322791|P3|STARTED|Core Study||4
8240459|NCT01930175|20322792|P2|STARTED|Core Study||2
8240460|NCT01930175|20322793|P1|STARTED|Core Study||7
8240461|NCT01930162|20322823|P1|NOT COMPLETED|Overall Study||5
8240462|NCT01930162|20322823|P1|COMPLETED|Overall Study||4
8240463|NCT01930162|20322823|P1|STARTED|Overall Study||9
8240464|NCT01930058|20322835|P3|NOT COMPLETED|Overall Study||0
8240465|NCT01930058|20322836|P2|NOT COMPLETED|Overall Study||0
8240466|NCT01930058|20322837|P1|NOT COMPLETED|Overall Study||0
8240467|NCT01930058|20322835|P3|COMPLETED|Overall Study||3
8240468|NCT01930058|20322836|P2|COMPLETED|Overall Study||3
8240469|NCT01930058|20322837|P1|COMPLETED|Overall Study||3
8240470|NCT01930058|20322835|P3|STARTED|Overall Study||3
8240471|NCT01930058|20322836|P2|STARTED|Overall Study||3
8240472|NCT01930058|20322837|P1|STARTED|Overall Study||3
8240473|NCT01930045|20322859|P6|NOT COMPLETED|Part 2 - Period 5||0
8240474|NCT01930045|20322860|P5|NOT COMPLETED|Part 2 - Period 5||0
8240475|NCT01930045|20322861|P4|NOT COMPLETED|Part 2 - Period 5||0
8240476|NCT01930045|20322862|P3|NOT COMPLETED|Part 2 - Period 5||0
8240477|NCT01930045|20322863|P2|NOT COMPLETED|Part 2 - Period 5||0
8240478|NCT01930045|20322864|P1|NOT COMPLETED|Part 2 - Period 5||0
8240479|NCT01930045|20322859|P6|COMPLETED|Part 2 - Period 5||1
8240480|NCT01930045|20322860|P5|COMPLETED|Part 2 - Period 5||3
8240481|NCT01930045|20322861|P4|COMPLETED|Part 2 - Period 5||3
8240482|NCT01930045|20322862|P3|COMPLETED|Part 2 - Period 5||3
8240483|NCT01930045|20322863|P2|COMPLETED|Part 2 - Period 5||3
8240484|NCT01930045|20322864|P1|COMPLETED|Part 2 - Period 5||3
8240485|NCT01930045|20322859|P6|STARTED|Part 2 - Period 5||1
8240486|NCT01930045|20322860|P5|STARTED|Part 2 - Period 5||3
8240487|NCT01930045|20322861|P4|STARTED|Part 2 - Period 5||3
8240488|NCT01930045|20322862|P3|STARTED|Part 2 - Period 5||3
8240489|NCT01930045|20322863|P2|STARTED|Part 2 - Period 5||3
8240490|NCT01930045|20322864|P1|STARTED|Part 2 - Period 5||3
8240491|NCT01930045|20322859|P6|NOT COMPLETED|Part 2 - Period 4||0
8240492|NCT01930045|20322860|P5|NOT COMPLETED|Part 2 - Period 4||0
8240493|NCT01930045|20322861|P4|NOT COMPLETED|Part 2 - Period 4||0
8240494|NCT01930045|20322862|P3|NOT COMPLETED|Part 2 - Period 4||0
8240495|NCT01930045|20322863|P2|NOT COMPLETED|Part 2 - Period 4||0
8240496|NCT01930045|20322864|P1|NOT COMPLETED|Part 2 - Period 4||0
8240497|NCT01930045|20322859|P6|COMPLETED|Part 2 - Period 4||1
8240498|NCT01930045|20322860|P5|COMPLETED|Part 2 - Period 4||3
8240499|NCT01930045|20322861|P4|COMPLETED|Part 2 - Period 4||3
8240500|NCT01930045|20322862|P3|COMPLETED|Part 2 - Period 4||3
8240501|NCT01930045|20322863|P2|COMPLETED|Part 2 - Period 4||3
8240502|NCT01930045|20322864|P1|COMPLETED|Part 2 - Period 4||3
8240503|NCT01930045|20322859|P6|STARTED|Part 2 - Period 4||1
8240504|NCT01930045|20322860|P5|STARTED|Part 2 - Period 4||3
8240505|NCT01930045|20322861|P4|STARTED|Part 2 - Period 4||3
8240506|NCT01930045|20322862|P3|STARTED|Part 2 - Period 4||3
8240507|NCT01930045|20322863|P2|STARTED|Part 2 - Period 4||3
8240508|NCT01930045|20322864|P1|STARTED|Part 2 - Period 4||3
8240509|NCT01930045|20322859|P6|NOT COMPLETED|Pause (up to 37 Days)||2
8240510|NCT01930045|20322860|P5|NOT COMPLETED|Pause (up to 37 Days)||0
8240511|NCT01930045|20322861|P4|NOT COMPLETED|Pause (up to 37 Days)||0
8240512|NCT01930045|20322862|P3|NOT COMPLETED|Pause (up to 37 Days)||0
8240513|NCT01930045|20322863|P2|NOT COMPLETED|Pause (up to 37 Days)||0
8240514|NCT01930045|20322864|P1|NOT COMPLETED|Pause (up to 37 Days)||0
8240515|NCT01930045|20322859|P6|COMPLETED|Pause (up to 37 Days)||1
8240516|NCT01930045|20322860|P5|COMPLETED|Pause (up to 37 Days)||3
8240517|NCT01930045|20322861|P4|COMPLETED|Pause (up to 37 Days)||3
8240518|NCT01930045|20322862|P3|COMPLETED|Pause (up to 37 Days)||3
8240519|NCT01930045|20322863|P2|COMPLETED|Pause (up to 37 Days)||3
8240520|NCT01930045|20322864|P1|COMPLETED|Pause (up to 37 Days)||3
8240521|NCT01930045|20322859|P6|STARTED|Pause (up to 37 Days)||3
8240522|NCT01930045|20322860|P5|STARTED|Pause (up to 37 Days)||3
8240523|NCT01930045|20322861|P4|STARTED|Pause (up to 37 Days)||3
8240524|NCT01930045|20322862|P3|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
8240525|NCT01930045|20322863|P2|STARTED|Pause (up to 37 Days)||3
8240526|NCT01930045|20322864|P1|STARTED|Pause (up to 37 Days)||3
8240527|NCT01930045|20322859|P6|NOT COMPLETED|Part 1 - Period 3||0
8240528|NCT01930045|20322860|P5|NOT COMPLETED|Part 1 - Period 3||0
8240529|NCT01930045|20322861|P4|NOT COMPLETED|Part 1 - Period 3||0
8240530|NCT01930045|20322862|P3|NOT COMPLETED|Part 1 - Period 3||0
8240531|NCT01930045|20322863|P2|NOT COMPLETED|Part 1 - Period 3||0
8240532|NCT01930045|20322864|P1|NOT COMPLETED|Part 1 - Period 3||0
8240533|NCT01930045|20322859|P6|COMPLETED|Part 1 - Period 3||3
8240534|NCT01930045|20322860|P5|COMPLETED|Part 1 - Period 3||3
8240535|NCT01930045|20322861|P4|COMPLETED|Part 1 - Period 3||3
8240536|NCT01930045|20322862|P3|COMPLETED|Part 1 - Period 3||2
8240537|NCT01930045|20322863|P2|COMPLETED|Part 1 - Period 3||3
8240538|NCT01930045|20322864|P1|COMPLETED|Part 1 - Period 3||3
8240539|NCT01930045|20322859|P6|STARTED|Part 1 - Period 3||3
8240540|NCT01930045|20322860|P5|STARTED|Part 1 - Period 3||3
8240541|NCT01930045|20322861|P4|STARTED|Part 1 - Period 3||3
8240542|NCT01930045|20322862|P3|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
8240543|NCT01930045|20322863|P2|STARTED|Part 1 - Period 3||3
8240544|NCT01930045|20322864|P1|STARTED|Part 1 - Period 3||3
8240545|NCT01930045|20322859|P6|NOT COMPLETED|Part 1 - Period 2||0
8240546|NCT01930045|20322860|P5|NOT COMPLETED|Part 1 - Period 2||0
8240547|NCT01930045|20322861|P4|NOT COMPLETED|Part 1 - Period 2||0
8240548|NCT01930045|20322862|P3|NOT COMPLETED|Part 1 - Period 2||0
8240549|NCT01930045|20322863|P2|NOT COMPLETED|Part 1 - Period 2||0
8240550|NCT01930045|20322864|P1|NOT COMPLETED|Part 1 - Period 2||0
8240551|NCT01930045|20322859|P6|COMPLETED|Part 1 - Period 2||3
8240552|NCT01930045|20322860|P5|COMPLETED|Part 1 - Period 2||3
8240553|NCT01930045|20322861|P4|COMPLETED|Part 1 - Period 2||3
8240554|NCT01930045|20322862|P3|COMPLETED|Part 1 - Period 2||3
8240555|NCT01930045|20322863|P2|COMPLETED|Part 1 - Period 2||3
8240556|NCT01930045|20322864|P1|COMPLETED|Part 1 - Period 2||3
8240557|NCT01930045|20322859|P6|STARTED|Part 1 - Period 2||3
8240558|NCT01930045|20322860|P5|STARTED|Part 1 - Period 2||3
8240559|NCT01930045|20322861|P4|STARTED|Part 1 - Period 2||3
8240560|NCT01930045|20322862|P3|STARTED|Part 1 - Period 2||3
8240561|NCT01930045|20322863|P2|STARTED|Part 1 - Period 2||3
8240562|NCT01930045|20322864|P1|STARTED|Part 1 - Period 2||3
8240563|NCT01930045|20322859|P6|NOT COMPLETED|Part 1 - Period 1||0
8240564|NCT01930045|20322860|P5|NOT COMPLETED|Part 1 - Period 1||0
8240565|NCT01930045|20322861|P4|NOT COMPLETED|Part 1 - Period 1||0
8240566|NCT01930045|20322862|P3|NOT COMPLETED|Part 1 - Period 1||0
8240567|NCT01930045|20322863|P2|NOT COMPLETED|Part 1 - Period 1||0
8240568|NCT01930045|20322864|P1|NOT COMPLETED|Part 1 - Period 1||0
8240569|NCT01930045|20322859|P6|COMPLETED|Part 1 - Period 1||3
8240570|NCT01930045|20322860|P5|COMPLETED|Part 1 - Period 1||3
8240571|NCT01930045|20322861|P4|COMPLETED|Part 1 - Period 1||3
8240572|NCT01930045|20322862|P3|COMPLETED|Part 1 - Period 1||3
8240573|NCT01930045|20322863|P2|COMPLETED|Part 1 - Period 1||3
8240574|NCT01930045|20322864|P1|COMPLETED|Part 1 - Period 1||3
8240575|NCT01930045|20322859|P6|STARTED|Part 1 - Period 1||3
8240576|NCT01930045|20322860|P5|STARTED|Part 1 - Period 1||3
8240577|NCT01930045|20322861|P4|STARTED|Part 1 - Period 1||3
8240578|NCT01930045|20322862|P3|STARTED|Part 1 - Period 1||3
8240579|NCT01930045|20322863|P2|STARTED|Part 1 - Period 1||3
8240580|NCT01930045|20322864|P1|STARTED|Part 1 - Period 1||3
8240581|NCT01929993|20322891|P2|NOT COMPLETED|Overall Study||28
8240582|NCT01929993|20322892|P1|NOT COMPLETED|Overall Study||30
8240583|NCT01929993|20322891|P2|COMPLETED|Overall Study||54
8240584|NCT01929993|20322892|P1|COMPLETED|Overall Study||52
8240585|NCT01929993|20322891|P2|STARTED|Overall Study||82
8240586|NCT01929993|20322892|P1|STARTED|Overall Study||82
8240587|NCT01929980|20322898|P1|NOT COMPLETED|Overall Study||1
8240588|NCT01929980|20322898|P1|COMPLETED|Overall Study||3
8240589|NCT01929980|20322898|P1|STARTED|Overall Study||4
8240590|NCT01929889|20322902|P1|NOT COMPLETED|Overall Study||5
8240591|NCT01929889|20322902|P1|COMPLETED|Overall Study|3 subjects completed the study.|3
8240592|NCT01929889|20322902|P1|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
8240593|NCT01929876|20322906|P1|NOT COMPLETED|Period 2||1
8240594|NCT01929876|20322906|P1|COMPLETED|Period 2||15
8240595|NCT01929876|20322906|P1|STARTED|Period 2||16
8240596|NCT01929876|20322906|P1|NOT COMPLETED|Period 1||0
8240597|NCT01929876|20322906|P1|COMPLETED|Period 1||16
8240598|NCT01929876|20322906|P1|STARTED|Period 1||16
8240599|NCT01929863|20322919|P2|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
8240600|NCT01929863|20322920|P1|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
8240601|NCT01929863|20322919|P2|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
8240602|NCT01929863|20322920|P1|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
8240603|NCT01929863|20322919|P2|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
8240604|NCT01929863|20322920|P1|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
8240605|NCT01929863|20322919|P2|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
8240606|NCT01929863|20322920|P1|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
8240607|NCT01929863|20322919|P2|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
8240608|NCT01929863|20322920|P1|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
8240609|NCT01929863|20322919|P2|STARTED|Period 3:Intervention Period 2 (7 Days)||7
8240610|NCT01929863|20322920|P1|STARTED|Period 3:Intervention Period 2 (7 Days)||6
8240611|NCT01929863|20322919|P2|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
8240612|NCT01929863|20322920|P1|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
8240613|NCT01929863|20322919|P2|COMPLETED|Period 2:Washout Period (13-15 Days)||7
8240614|NCT01929863|20322920|P1|COMPLETED|Period 2:Washout Period (13-15 Days)||6
8240615|NCT01929863|20322919|P2|STARTED|Period 2:Washout Period (13-15 Days)||7
8240616|NCT01929863|20322920|P1|STARTED|Period 2:Washout Period (13-15 Days)||6
8240617|NCT01929863|20322919|P2|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
8240618|NCT01929863|20322920|P1|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
8240619|NCT01929863|20322919|P2|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
8240620|NCT01929863|20322920|P1|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
8240621|NCT01929863|20322919|P2|STARTED|Period 1:Intervention Period 1 (7 Days)||8
8240622|NCT01929863|20322920|P1|STARTED|Period 1:Intervention Period 1 (7 Days)||7
8240623|NCT01929759|20322963|P1|NOT COMPLETED|Overall Study||0
8240624|NCT01929759|20322963|P1|COMPLETED|Overall Study||10
8240625|NCT01929759|20322963|P1|STARTED|Overall Study||10
8240626|NCT01929707|20322975|P8|NOT COMPLETED|Intervention Period 2||0
8240627|NCT01929707|20322976|P7|NOT COMPLETED|Intervention Period 2||0
8240628|NCT01929707|20322977|P6|NOT COMPLETED|Intervention Period 2||2
8240629|NCT01929707|20322978|P5|NOT COMPLETED|Intervention Period 2||0
8240630|NCT01929707|20322979|P4|NOT COMPLETED|Intervention Period 2||0
8240631|NCT01929707|20322980|P3|NOT COMPLETED|Intervention Period 2||0
8240632|NCT01929707|20322981|P2|NOT COMPLETED|Intervention Period 2||0
8240633|NCT01929707|20322982|P1|NOT COMPLETED|Intervention Period 2||0
8240634|NCT01929707|20322975|P8|COMPLETED|Intervention Period 2||4
8240635|NCT01929707|20322976|P7|COMPLETED|Intervention Period 2||12
8240636|NCT01929707|20322977|P6|COMPLETED|Intervention Period 2||6
8240637|NCT01929707|20322978|P5|COMPLETED|Intervention Period 2||6
8240638|NCT01929707|20322979|P4|COMPLETED|Intervention Period 2||5
8240639|NCT01929707|20322980|P3|COMPLETED|Intervention Period 2||0
8240640|NCT01929707|20322981|P2|COMPLETED|Intervention Period 2||0
8240641|NCT01929707|20322982|P1|COMPLETED|Intervention Period 2||0
8240642|NCT01929707|20322975|P8|STARTED|Intervention Period 2|Incomplete-crossover design|4
8240643|NCT01929707|20322976|P7|STARTED|Intervention Period 2|Incomplete-crossover design|12
8240644|NCT01929707|20322977|P6|STARTED|Intervention Period 2|Incomplete-crossover design|8
8240645|NCT01929707|20322978|P5|STARTED|Intervention Period 2|Incomplete-crossover design|6
8240646|NCT01929707|20322979|P4|STARTED|Intervention Period 2|Incomplete-crossover design|5
8240647|NCT01929707|20322980|P3|STARTED|Intervention Period 2|Incomplete-crossover design|0
8240648|NCT01929707|20322981|P2|STARTED|Intervention Period 2|Incomplete-crossover design|0
8240649|NCT01929707|20322982|P1|STARTED|Intervention Period 2|Incomplete-crossover design|0
8240650|NCT01929707|20322975|P8|NOT COMPLETED|Washout Period ≥7 Days||0
8240651|NCT01929707|20322976|P7|NOT COMPLETED|Washout Period ≥7 Days||0
8240652|NCT01929707|20322977|P6|NOT COMPLETED|Washout Period ≥7 Days||0
8240653|NCT01929707|20322978|P5|NOT COMPLETED|Washout Period ≥7 Days||0
8240654|NCT01929707|20322979|P4|NOT COMPLETED|Washout Period ≥7 Days||0
8240655|NCT01929707|20322980|P3|NOT COMPLETED|Washout Period ≥7 Days||0
8240656|NCT01929707|20322981|P2|NOT COMPLETED|Washout Period ≥7 Days||0
8240657|NCT01929707|20322982|P1|NOT COMPLETED|Washout Period ≥7 Days||0
8240658|NCT01929707|20322975|P8|COMPLETED|Washout Period ≥7 Days||0
8240659|NCT01929707|20322976|P7|COMPLETED|Washout Period ≥7 Days||0
8240660|NCT01929707|20322977|P6|COMPLETED|Washout Period ≥7 Days||0
8240661|NCT01929707|20322978|P5|COMPLETED|Washout Period ≥7 Days||0
8240662|NCT01929707|20322979|P4|COMPLETED|Washout Period ≥7 Days||7
8240663|NCT01929707|20322980|P3|COMPLETED|Washout Period ≥7 Days||12
8240664|NCT01929707|20322981|P2|COMPLETED|Washout Period ≥7 Days||8
8240665|NCT01929707|20322982|P1|COMPLETED|Washout Period ≥7 Days||6
8240666|NCT01929707|20322975|P8|STARTED|Washout Period ≥7 Days||0
8240667|NCT01929707|20322976|P7|STARTED|Washout Period ≥7 Days||0
8240668|NCT01929707|20322977|P6|STARTED|Washout Period ≥7 Days||0
8240669|NCT01929707|20322978|P5|STARTED|Washout Period ≥7 Days||0
8240670|NCT01929707|20322979|P4|STARTED|Washout Period ≥7 Days||7
8240671|NCT01929707|20322980|P3|STARTED|Washout Period ≥7 Days||12
8240672|NCT01929707|20322981|P2|STARTED|Washout Period ≥7 Days||8
8240673|NCT01929707|20322982|P1|STARTED|Washout Period ≥7 Days||6
8240674|NCT01929707|20322975|P8|NOT COMPLETED|Intervention Period 1||0
8240675|NCT01929707|20322976|P7|NOT COMPLETED|Intervention Period 1||0
8240676|NCT01929707|20322977|P6|NOT COMPLETED|Intervention Period 1||0
8240677|NCT01929707|20322978|P5|NOT COMPLETED|Intervention Period 1||0
8240678|NCT01929707|20322979|P4|NOT COMPLETED|Intervention Period 1||3
8240679|NCT01929707|20322980|P3|NOT COMPLETED|Intervention Period 1||0
8240680|NCT01929707|20322981|P2|NOT COMPLETED|Intervention Period 1||0
8240681|NCT01929707|20322982|P1|NOT COMPLETED|Intervention Period 1||0
8240682|NCT01929707|20322975|P8|COMPLETED|Intervention Period 1||0
8240683|NCT01929707|20322976|P7|COMPLETED|Intervention Period 1||0
8240684|NCT01929707|20322977|P6|COMPLETED|Intervention Period 1||0
8240685|NCT01929707|20322978|P5|COMPLETED|Intervention Period 1||0
8240686|NCT01929707|20322979|P4|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
8240687|NCT01929707|20322980|P3|COMPLETED|Intervention Period 1||12
8240688|NCT01929707|20322981|P2|COMPLETED|Intervention Period 1||8
8240689|NCT01929707|20322982|P1|COMPLETED|Intervention Period 1||6
8240690|NCT01929707|20322975|P8|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
8240691|NCT01929707|20322976|P7|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
8240692|NCT01929707|20322977|P6|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
8240693|NCT01929707|20322978|P5|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
8240694|NCT01929707|20322979|P4|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
8240695|NCT01929707|20322980|P3|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
8240696|NCT01929707|20322981|P2|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
8240697|NCT01929707|20322982|P1|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
8240698|NCT01929707|20322975|P8|STARTED|Intervention Period 1||0
8240699|NCT01929707|20322976|P7|STARTED|Intervention Period 1||0
8240700|NCT01929707|20322977|P6|STARTED|Intervention Period 1||0
8240701|NCT01929707|20322978|P5|STARTED|Intervention Period 1||0
8240702|NCT01929707|20322979|P4|STARTED|Intervention Period 1||10
8240703|NCT01929707|20322980|P3|STARTED|Intervention Period 1||12
8240704|NCT01929707|20322981|P2|STARTED|Intervention Period 1||8
8240705|NCT01929707|20322982|P1|STARTED|Intervention Period 1||6
8240706|NCT01929681|20323014|P2|NOT COMPLETED|Overall Study||1
8240707|NCT01929681|20323015|P1|NOT COMPLETED|Overall Study||2
8240708|NCT01929681|20323014|P2|COMPLETED|Overall Study||24
8240709|NCT01929681|20323015|P1|COMPLETED|Overall Study||26
8240710|NCT01929681|20323014|P2|STARTED|Overall Study||25
8240711|NCT01929681|20323015|P1|STARTED|Overall Study||28
8240712|NCT01929473|20323029|P1|NOT COMPLETED|Overall Study||587
8240713|NCT01929473|20323029|P1|COMPLETED|Overall Study||3243
8240714|NCT01929473|20323029|P1|365 Day|Overall Study||3589
8240715|NCT01929473|20323029|P1|STARTED|Overall Study|0 day|3830
8240716|NCT01929460|20323035|P2|NOT COMPLETED|Overall Study||0
8240717|NCT01929460|20323036|P1|NOT COMPLETED|Overall Study||0
8240718|NCT01929460|20323035|P2|COMPLETED|Overall Study||13
8240719|NCT01929460|20323036|P1|COMPLETED|Overall Study||13
8240720|NCT01929460|20323035|P2|STARTED|Overall Study||13
8240721|NCT01929460|20323036|P1|STARTED|Overall Study||13
8240722|NCT01929408|20323058|P1|NOT COMPLETED|Overall Study||8
8240723|NCT01929408|20323058|P1|COMPLETED|Overall Study||695
8240724|NCT01929408|20323058|P1|STARTED|Overall Study||703
8240725|NCT01929395|20323066|P3|NOT COMPLETED|Overall Study||1
8240726|NCT01929395|20323067|P2|NOT COMPLETED|Overall Study||1
8240727|NCT01929395|20323068|P1|NOT COMPLETED|Overall Study||1
8240728|NCT01929395|20323066|P3|COMPLETED|Overall Study||69
8240729|NCT01929395|20323067|P2|COMPLETED|Overall Study||69
8240730|NCT01929395|20323068|P1|COMPLETED|Overall Study||18
8240731|NCT01929395|20323066|P3|STARTED|Overall Study||70
8240732|NCT01929395|20323067|P2|STARTED|Overall Study||70
8240733|NCT01929395|20323068|P1|STARTED|Overall Study||19
8240734|NCT01929343|20323081|P3|NOT COMPLETED|Overall Study||0
8240735|NCT01929343|20323082|P2|NOT COMPLETED|Overall Study||2
8240736|NCT01929343|20323083|P1|NOT COMPLETED|Overall Study||1
8240737|NCT01929343|20323081|P3|COMPLETED|Overall Study||12
8240738|NCT01929343|20323082|P2|COMPLETED|Overall Study||7
8240739|NCT01929343|20323083|P1|COMPLETED|Overall Study||11
8240740|NCT01929343|20323081|P3|STARTED|Overall Study||12
8240741|NCT01929343|20323082|P2|STARTED|Overall Study||9
8240742|NCT01929343|20323083|P1|STARTED|Overall Study||12
8240743|NCT01929317|20323111|P2|NOT COMPLETED|Long-term Phase||4
8240744|NCT01929317|20323112|P1|NOT COMPLETED|Long-term Phase||19
8240745|NCT01929317|20323111|P2|COMPLETED|Long-term Phase||14
8240746|NCT01929317|20323112|P1|COMPLETED|Long-term Phase||25
8240747|NCT01929317|20323111|P2|STARTED|Long-term Phase||18
8240748|NCT01929317|20323112|P1|STARTED|Long-term Phase||44
8240749|NCT01929317|20323111|P2|NOT COMPLETED|Dose Increase Effect Verification Phase||1
8240750|NCT01929317|20323112|P1|NOT COMPLETED|Dose Increase Effect Verification Phase||9
8240751|NCT01929317|20323111|P2|COMPLETED|Dose Increase Effect Verification Phase||19
8240752|NCT01929317|20323112|P1|COMPLETED|Dose Increase Effect Verification Phase||52
8240753|NCT01929317|20323111|P2|STARTED|Dose Increase Effect Verification Phase||20
8240754|NCT01929317|20323112|P1|STARTED|Dose Increase Effect Verification Phase||61
8240755|NCT01929291|20323179|P1|NOT COMPLETED|Overall Study||0
8240756|NCT01929291|20323179|P1|COMPLETED|Overall Study||672
8240757|NCT01929291|20323179|P1|STARTED|Overall Study||672
8240758|NCT01929226|20323187|P2|NOT COMPLETED|Overall Study||1
8240759|NCT01929226|20323188|P1|NOT COMPLETED|Overall Study||5
8240760|NCT01929226|20323187|P2|COMPLETED|Overall Study||69
8240761|NCT01929226|20323188|P1|COMPLETED|Overall Study||205
8240762|NCT01929226|20323187|P2|STARTED|Overall Study||70
8240763|NCT01929226|20323188|P1|STARTED|Overall Study||210
8240764|NCT01929135|20323214|P2|NOT COMPLETED|Overall Study||1
8240765|NCT01929135|20323215|P1|NOT COMPLETED|Overall Study||1
8240766|NCT01929135|20323214|P2|COMPLETED|Overall Study||18
8240767|NCT01929135|20323215|P1|COMPLETED|Overall Study||18
8240768|NCT01929135|20323214|P2|STARTED|Overall Study||19
8240769|NCT01929135|20323215|P1|STARTED|Overall Study||19
8240770|NCT01929109|20323234|P5|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240771|NCT01929109|20323235|P4|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240772|NCT01929109|20323236|P3|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240773|NCT01929109|20323237|P2|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240774|NCT01929109|20323238|P1|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240775|NCT01929109|20323234|P5|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
8240776|NCT01929109|20323235|P4|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240777|NCT01929109|20323236|P3|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240778|NCT01929109|20323237|P2|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240779|NCT01929109|20323238|P1|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
8240780|NCT01929109|20323234|P5|STARTED|Period 2 (End Stage Renal Disease Only)||8
8240781|NCT01929109|20323235|P4|STARTED|Period 2 (End Stage Renal Disease Only)||0
8240782|NCT01929109|20323236|P3|STARTED|Period 2 (End Stage Renal Disease Only)||0
8240783|NCT01929109|20323237|P2|STARTED|Period 2 (End Stage Renal Disease Only)||0
8240784|NCT01929109|20323238|P1|STARTED|Period 2 (End Stage Renal Disease Only)||0
8240785|NCT01929109|20323234|P5|NOT COMPLETED|Period 1 (All Groups)||0
8240786|NCT01929109|20323235|P4|NOT COMPLETED|Period 1 (All Groups)||0
8240787|NCT01929109|20323236|P3|NOT COMPLETED|Period 1 (All Groups)||1
8240788|NCT01929109|20323237|P2|NOT COMPLETED|Period 1 (All Groups)||0
8240789|NCT01929109|20323238|P1|NOT COMPLETED|Period 1 (All Groups)||0
8240790|NCT01929109|20323234|P5|COMPLETED|Period 1 (All Groups)||8
8240791|NCT01929109|20323235|P4|COMPLETED|Period 1 (All Groups)||8
8240792|NCT01929109|20323236|P3|COMPLETED|Period 1 (All Groups)||8
8240793|NCT01929109|20323237|P2|COMPLETED|Period 1 (All Groups)||8
8240794|NCT01929109|20323238|P1|COMPLETED|Period 1 (All Groups)||14
8240795|NCT01929109|20323234|P5|STARTED|Period 1 (All Groups)||8
8240796|NCT01929109|20323235|P4|STARTED|Period 1 (All Groups)||8
8240797|NCT01929109|20323236|P3|STARTED|Period 1 (All Groups)||9
8240798|NCT01929109|20323237|P2|STARTED|Period 1 (All Groups)||8
8240799|NCT01929109|20323238|P1|STARTED|Period 1 (All Groups)||14
8240800|NCT01929083|20323257|P2|NOT COMPLETED|Intervention 2||1
8240801|NCT01929083|20323258|P1|NOT COMPLETED|Intervention 2||0
8240802|NCT01929083|20323257|P2|COMPLETED|Intervention 2||8
8240803|NCT01929083|20323258|P1|COMPLETED|Intervention 2||7
8240804|NCT01929083|20323257|P2|Returned for 2nd Ibutilide Administratio|Intervention 2||8
8240805|NCT01929083|20323258|P1|Returned for 2nd Ibutilide Administratio|Intervention 2||7
8240806|NCT01929083|20323257|P2|STARTED|Intervention 2||9
8240807|NCT01929083|20323258|P1|STARTED|Intervention 2||7
8240808|NCT01929083|20323257|P2|NOT COMPLETED|Intervention 1||0
8240809|NCT01929083|20323258|P1|NOT COMPLETED|Intervention 1||3
8240810|NCT01929083|20323257|P2|COMPLETED|Intervention 1||9
8240811|NCT01929083|20323258|P1|COMPLETED|Intervention 1||7
8240812|NCT01929083|20323257|P2|Returned for 1st Ibutilide Administratio|Intervention 1||9
8240813|NCT01929083|20323258|P1|Returned for 1st Ibutilide Administratio|Intervention 1||7
8240814|NCT01929083|20323257|P2|STARTED|Intervention 1||9
8240815|NCT01929083|20323258|P1|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
8240816|NCT01929057|20323284|P2|NOT COMPLETED|Overall Study||0
8240817|NCT01929057|20323285|P1|NOT COMPLETED|Overall Study||0
8240818|NCT01929057|20323284|P2|COMPLETED|Overall Study||3
8240819|NCT01929057|20323285|P1|COMPLETED|Overall Study||31
8240820|NCT01929057|20323284|P2|STARTED|Overall Study||3
8240821|NCT01929057|20323285|P1|STARTED|Overall Study||31
8240822|NCT01929044|20323295|P2|NOT COMPLETED|Overall Study||17
8240823|NCT01929044|20323296|P1|NOT COMPLETED|Overall Study||11
8240824|NCT01929044|20323295|P2|COMPLETED|Overall Study||129
8240825|NCT01929044|20323296|P1|COMPLETED|Overall Study||142
8240826|NCT01929044|20323295|P2|STARTED|Overall Study||146
8240827|NCT01929044|20323296|P1|STARTED|Overall Study||153
8240828|NCT01929031|20323318|P6|NOT COMPLETED|Overall Study||1
8240829|NCT01929031|20323319|P5|NOT COMPLETED|Overall Study||1
8240830|NCT01929031|20323320|P4|NOT COMPLETED|Overall Study||0
8240831|NCT01929031|20323321|P3|NOT COMPLETED|Overall Study||1
8240832|NCT01929031|20323322|P2|NOT COMPLETED|Overall Study||2
8240833|NCT01929031|20323323|P1|NOT COMPLETED|Overall Study||4
8240834|NCT01929031|20323318|P6|COMPLETED|Overall Study||35
8240835|NCT01929031|20323319|P5|COMPLETED|Overall Study||33
8240836|NCT01929031|20323320|P4|COMPLETED|Overall Study||35
8240837|NCT01929031|20323321|P3|COMPLETED|Overall Study||34
8240838|NCT01929031|20323322|P2|COMPLETED|Overall Study||207
8240839|NCT01929031|20323323|P1|COMPLETED|Overall Study||209
8240840|NCT01929031|20323318|P6|STARTED|Overall Study||36
8240841|NCT01929031|20323319|P5|STARTED|Overall Study||34
8240842|NCT01929031|20323320|P4|STARTED|Overall Study||35
8240843|NCT01929031|20323321|P3|STARTED|Overall Study||35
8240844|NCT01929031|20323322|P2|STARTED|Overall Study||209
8240845|NCT01929031|20323323|P1|STARTED|Overall Study||213
8240846|NCT01929018|20323347|P2|NOT COMPLETED|Overall Study||1
8240847|NCT01929018|20323348|P1|NOT COMPLETED|Overall Study||1
8240848|NCT01929018|20323347|P2|COMPLETED|Overall Study||18
8240849|NCT01929018|20323348|P1|COMPLETED|Overall Study||18
8240850|NCT01929018|20323347|P2|STARTED|Overall Study||19
8240851|NCT01929018|20323348|P1|STARTED|Overall Study||19
8240852|NCT01928940|20323372|P2|NOT COMPLETED|Overall Study||1
8240853|NCT01928940|20323373|P1|NOT COMPLETED|Overall Study||0
8240854|NCT01928940|20323372|P2|COMPLETED|Overall Study||5
8240855|NCT01928940|20323373|P1|COMPLETED|Overall Study||6
8240856|NCT01928940|20323372|P2|STARTED|Overall Study||6
8240857|NCT01928940|20323373|P1|STARTED|Overall Study||6
8240864|NCT01928862|20323558|P5|NOT COMPLETED|Overall Study||1
8240865|NCT01928862|20323559|P4|NOT COMPLETED|Overall Study||0
8240866|NCT01928862|20323560|P3|NOT COMPLETED|Overall Study||0
8240867|NCT01928862|20323561|P2|NOT COMPLETED|Overall Study||0
8240868|NCT01928862|20323562|P1|NOT COMPLETED|Overall Study||1
8240869|NCT01928862|20323558|P5|COMPLETED|Overall Study||13
8240870|NCT01928862|20323559|P4|COMPLETED|Overall Study||16
8240871|NCT01928862|20323560|P3|COMPLETED|Overall Study||16
8240872|NCT01928862|20323561|P2|COMPLETED|Overall Study||16
8240873|NCT01928862|20323562|P1|COMPLETED|Overall Study||15
8240874|NCT01928862|20323558|P5|STARTED|Overall Study||14
8240875|NCT01928862|20323559|P4|STARTED|Overall Study||16
8240876|NCT01928862|20323560|P3|STARTED|Overall Study||16
8240877|NCT01928862|20323561|P2|STARTED|Overall Study||16
8240878|NCT01928862|20323562|P1|STARTED|Overall Study||16
8240879|NCT01928849|20323601|P2|NOT COMPLETED|Overall Study||7
8240880|NCT01928849|20323602|P1|NOT COMPLETED|Overall Study||14
8240881|NCT01928849|20323601|P2|COMPLETED|Overall Study||55
8240882|NCT01928849|20323602|P1|COMPLETED|Overall Study||52
8240883|NCT01928849|20323601|P2|STARTED|Overall Study||62
8240884|NCT01928849|20323602|P1|STARTED|Overall Study||66
8240885|NCT01928797|20323622|P2|NOT COMPLETED|Overall Study||0
8240886|NCT01928797|20323623|P1|NOT COMPLETED|Overall Study||0
8240887|NCT01928797|20323622|P2|COMPLETED|Overall Study||30
8240888|NCT01928797|20323623|P1|COMPLETED|Overall Study||30
8240889|NCT01928797|20323622|P2|STARTED|Overall Study||30
8240890|NCT01928797|20323623|P1|STARTED|Overall Study||30
8240891|NCT01928771|20323636|P3|NOT COMPLETED|Overall Study||40
8240892|NCT01928771|20323637|P2|NOT COMPLETED|Overall Study||40
8240893|NCT01928771|20323638|P1|NOT COMPLETED|Overall Study||46
8240894|NCT01928771|20323636|P3|COMPLETED|Overall Study||367
8240895|NCT01928771|20323637|P2|COMPLETED|Overall Study||358
8240896|NCT01928771|20323638|P1|COMPLETED|Overall Study||354
8240897|NCT01928771|20323636|P3|Received Treatment|Overall Study||407
8240898|NCT01928771|20323637|P2|Received Treatment|Overall Study||398
8240899|NCT01928771|20323638|P1|Received Treatment|Overall Study||399
8240900|NCT01928771|20323636|P3|STARTED|Overall Study||407
8240901|NCT01928771|20323637|P2|STARTED|Overall Study||398
8240902|NCT01928771|20323638|P1|STARTED|Overall Study||400
8240903|NCT01928758|20323717|P2|NOT COMPLETED|Overall Study||20
8240904|NCT01928758|20323718|P1|NOT COMPLETED|Overall Study||25
8240905|NCT01928758|20323717|P2|COMPLETED|Overall Study||74
8240906|NCT01928758|20323718|P1|COMPLETED|Overall Study||69
8240907|NCT01928758|20323717|P2|STARTED|Overall Study||94
8240908|NCT01928758|20323718|P1|STARTED|Overall Study||94
8240909|NCT01928719|20323736|P2|NOT COMPLETED|Overall Study||19
8240910|NCT01928719|20323737|P1|NOT COMPLETED|Overall Study||52
8240911|NCT01928719|20323736|P2|COMPLETED|Overall Study||104
8240912|NCT01928719|20323737|P1|COMPLETED|Overall Study||70
8240913|NCT01928719|20323736|P2|STARTED|Overall Study||123
8240914|NCT01928719|20323737|P1|STARTED|Overall Study||122
8240915|NCT01928693|20323757|P3|NOT COMPLETED|Overall Study||0
8240916|NCT01928693|20323758|P2|NOT COMPLETED|Overall Study||0
8240917|NCT01928693|20323759|P1|NOT COMPLETED|Overall Study||0
8240918|NCT01928693|20323757|P3|COMPLETED|Overall Study||1
8240919|NCT01928693|20323758|P2|COMPLETED|Overall Study||1
8240920|NCT01928693|20323759|P1|COMPLETED|Overall Study||0
8240921|NCT01928693|20323757|P3|STARTED|Overall Study||1
8240922|NCT01928693|20323758|P2|STARTED|Overall Study||1
8240923|NCT01928693|20323759|P1|STARTED|Overall Study||0
8240924|NCT01928680|20323785|P1|NOT COMPLETED|Overall Study||0
8240925|NCT01928680|20323785|P1|COMPLETED|Overall Study||33
8240926|NCT01928680|20323785|P1|STARTED|Overall Study||33
8240927|NCT01928615|20323789|P1|NOT COMPLETED|Overall Study||2
8240928|NCT01928615|20323789|P1|COMPLETED|Overall Study||0
8240929|NCT01928615|20323789|P1|STARTED|Overall Study||2
8240930|NCT01928485|20323806|P2|NOT COMPLETED|Overall Study||1
8240931|NCT01928485|20323807|P1|NOT COMPLETED|Overall Study||0
8240932|NCT01928485|20323806|P2|COMPLETED|Overall Study||1
8240933|NCT01928485|20323807|P1|COMPLETED|Overall Study||4
8240934|NCT01928485|20323806|P2|STARTED|Overall Study||2
8240935|NCT01928485|20323807|P1|STARTED|Overall Study||4
8240936|NCT01928472|20323859|P4|NOT COMPLETED|Overall Study||2
8240937|NCT01928472|20323860|P3|NOT COMPLETED|Overall Study||7
8240938|NCT01928472|20323861|P2|NOT COMPLETED|Overall Study||8
8240939|NCT01928472|20323862|P1|NOT COMPLETED|Overall Study||8
8240940|NCT01928472|20323859|P4|COMPLETED|Overall Study||100
8240941|NCT01928472|20323860|P3|COMPLETED|Overall Study||91
8240942|NCT01928472|20323861|P2|COMPLETED|Overall Study||96
8240943|NCT01928472|20323862|P1|COMPLETED|Overall Study||90
8240944|NCT01928472|20323859|P4|STARTED|Overall Study||102
8240945|NCT01928472|20323860|P3|STARTED|Overall Study||98
8240946|NCT01928472|20323861|P2|STARTED|Overall Study||104
8240947|NCT01928472|20323862|P1|STARTED|Overall Study||98
8240948|NCT01928433|20323932|P3|NOT COMPLETED|Overall Study||28
8240949|NCT01928433|20323933|P2|NOT COMPLETED|Overall Study||21
8240950|NCT01928433|20323934|P1|NOT COMPLETED|Overall Study||20
8240951|NCT01928433|20323932|P3|COMPLETED|Overall Study||46
8240952|NCT01928433|20323933|P2|COMPLETED|Overall Study||54
8240953|NCT01928433|20323934|P1|COMPLETED|Overall Study||56
8240954|NCT01928433|20323932|P3|STARTED|Overall Study||74
8240955|NCT01928433|20323933|P2|STARTED|Overall Study||75
8240956|NCT01928433|20323934|P1|STARTED|Overall Study||76
8240957|NCT01928394|20323980|P23|NOT COMPLETED|Follow-up Period||6
8240958|NCT01928394|20323981|P22|NOT COMPLETED|Follow-up Period||9
8240959|NCT01928394|20323982|P21|NOT COMPLETED|Follow-up Period||9
8240960|NCT01928394|20323983|P20|NOT COMPLETED|Follow-up Period||21
8240961|NCT01928394|20323984|P19|NOT COMPLETED|Follow-up Period||16
8240962|NCT01928394|20323985|P18|NOT COMPLETED|Follow-up Period||8
8240963|NCT01928394|20323986|P17|NOT COMPLETED|Follow-up Period||14
8240964|NCT01928394|20323987|P16|NOT COMPLETED|Follow-up Period||0
8240965|NCT01928394|20323988|P15|NOT COMPLETED|Follow-up Period||30
8240966|NCT01928394|20323989|P14|NOT COMPLETED|Follow-up Period||38
8240967|NCT01928394|20323990|P13|NOT COMPLETED|Follow-up Period||14
8240968|NCT01928394|20323991|P12|NOT COMPLETED|Follow-up Period||22
8240969|NCT01928394|20323992|P11|NOT COMPLETED|Follow-up Period||11
8240970|NCT01928394|20323993|P10|NOT COMPLETED|Follow-up Period||2
8240971|NCT01928394|20323994|P9|NOT COMPLETED|Follow-up Period||1
8240972|NCT01928394|20323995|P8|NOT COMPLETED|Follow-up Period||6
8240973|NCT01928394|20323996|P7|NOT COMPLETED|Follow-up Period||12
8240974|NCT01928394|20323997|P6|NOT COMPLETED|Follow-up Period||8
8240975|NCT01928394|20323998|P5|NOT COMPLETED|Follow-up Period||0
8240976|NCT01928394|20323999|P4|NOT COMPLETED|Follow-up Period||10
8240977|NCT01928394|20324000|P3|NOT COMPLETED|Follow-up Period||3
8240978|NCT01928394|20324001|P2|NOT COMPLETED|Follow-up Period||0
8240979|NCT01928394|20324002|P1|NOT COMPLETED|Follow-up Period||3
8240980|NCT01928394|20323980|P23|COMPLETED|Follow-up Period||36
8240981|NCT01928394|20323981|P22|COMPLETED|Follow-up Period||34
8240982|NCT01928394|20323982|P21|COMPLETED|Follow-up Period||32
8240983|NCT01928394|20323983|P20|COMPLETED|Follow-up Period||83
8240984|NCT01928394|20323984|P19|COMPLETED|Follow-up Period||76
8240985|NCT01928394|20323985|P18|COMPLETED|Follow-up Period||50
8240986|NCT01928394|20323986|P17|COMPLETED|Follow-up Period||41
8240987|NCT01928394|20323987|P16|COMPLETED|Follow-up Period||3
8240988|NCT01928394|20323988|P15|COMPLETED|Follow-up Period||66
8240989|NCT01928394|20323989|P14|COMPLETED|Follow-up Period||107
8240990|NCT01928394|20323990|P13|COMPLETED|Follow-up Period||47
8240991|NCT01928394|20323991|P12|COMPLETED|Follow-up Period||59
8240992|NCT01928394|20323992|P11|COMPLETED|Follow-up Period||19
8240993|NCT01928394|20323993|P10|COMPLETED|Follow-up Period||16
8240994|NCT01928394|20323994|P9|COMPLETED|Follow-up Period||2
8240995|NCT01928394|20323995|P8|COMPLETED|Follow-up Period||10
8240996|NCT01928394|20323996|P7|COMPLETED|Follow-up Period||40
8240997|NCT01928394|20323997|P6|COMPLETED|Follow-up Period||41
8240998|NCT01928394|20323998|P5|COMPLETED|Follow-up Period||3
8240999|NCT01928394|20323999|P4|COMPLETED|Follow-up Period||40
8241000|NCT01928394|20324000|P3|COMPLETED|Follow-up Period||15
8241001|NCT01928394|20324001|P2|COMPLETED|Follow-up Period||3
8241002|NCT01928394|20324002|P1|COMPLETED|Follow-up Period||12
8241003|NCT01928394|20323980|P23|STARTED|Follow-up Period||42
8241004|NCT01928394|20323981|P22|STARTED|Follow-up Period||43
8241005|NCT01928394|20323982|P21|STARTED|Follow-up Period||41
8241006|NCT01928394|20323983|P20|STARTED|Follow-up Period||104
8241007|NCT01928394|20323984|P19|STARTED|Follow-up Period||92
8241008|NCT01928394|20323985|P18|STARTED|Follow-up Period||58
8241009|NCT01928394|20323986|P17|STARTED|Follow-up Period||55
8241010|NCT01928394|20323987|P16|STARTED|Follow-up Period||3
8241011|NCT01928394|20323988|P15|STARTED|Follow-up Period||96
8241012|NCT01928394|20323989|P14|STARTED|Follow-up Period||145
8241013|NCT01928394|20323990|P13|STARTED|Follow-up Period||61
8241014|NCT01928394|20323991|P12|STARTED|Follow-up Period||81
8241015|NCT01928394|20323992|P11|STARTED|Follow-up Period||30
8241016|NCT01928394|20323993|P10|STARTED|Follow-up Period||18
8241017|NCT01928394|20323994|P9|STARTED|Follow-up Period||3
8241018|NCT01928394|20323995|P8|STARTED|Follow-up Period||16
8241019|NCT01928394|20323996|P7|STARTED|Follow-up Period||52
8241020|NCT01928394|20323997|P6|STARTED|Follow-up Period||49
8241021|NCT01928394|20323998|P5|STARTED|Follow-up Period||3
8241022|NCT01928394|20323999|P4|STARTED|Follow-up Period||50
8241023|NCT01928394|20324000|P3|STARTED|Follow-up Period||18
8241024|NCT01928394|20324001|P2|STARTED|Follow-up Period||3
8241025|NCT01928394|20324002|P1|STARTED|Follow-up Period||15
8241026|NCT01928394|20323980|P23|NOT COMPLETED|Treatment Period||39
8241027|NCT01928394|20323981|P22|NOT COMPLETED|Treatment Period||42
8241028|NCT01928394|20323982|P21|NOT COMPLETED|Treatment Period||40
8241029|NCT01928394|20323983|P20|NOT COMPLETED|Treatment Period||96
8241030|NCT01928394|20323984|P19|NOT COMPLETED|Treatment Period||70
8241031|NCT01928394|20323985|P18|NOT COMPLETED|Treatment Period||71
8241032|NCT01928394|20323986|P17|NOT COMPLETED|Treatment Period||50
8241033|NCT01928394|20323987|P16|NOT COMPLETED|Treatment Period||2
8241034|NCT01928394|20323988|P15|NOT COMPLETED|Treatment Period||88
8241035|NCT01928394|20323989|P14|NOT COMPLETED|Treatment Period||139
8241036|NCT01928394|20323990|P13|NOT COMPLETED|Treatment Period||55
8241037|NCT01928394|20323991|P12|NOT COMPLETED|Treatment Period||93
8241038|NCT01928394|20323992|P11|NOT COMPLETED|Treatment Period||30
8241039|NCT01928394|20323993|P10|NOT COMPLETED|Treatment Period||18
8241040|NCT01928394|20323994|P9|NOT COMPLETED|Treatment Period||3
8241041|NCT01928394|20323995|P8|NOT COMPLETED|Treatment Period||18
8241042|NCT01928394|20323996|P7|NOT COMPLETED|Treatment Period||49
8241043|NCT01928394|20323997|P6|NOT COMPLETED|Treatment Period||43
8241044|NCT01928394|20323998|P5|NOT COMPLETED|Treatment Period||3
8241045|NCT01928394|20323999|P4|NOT COMPLETED|Treatment Period||56
8241046|NCT01928394|20324000|P3|NOT COMPLETED|Treatment Period||18
8241047|NCT01928394|20324001|P2|NOT COMPLETED|Treatment Period||3
8241048|NCT01928394|20324002|P1|NOT COMPLETED|Treatment Period||18
8241049|NCT01928394|20323980|P23|COMPLETED|Treatment Period||3
8241050|NCT01928394|20323981|P22|COMPLETED|Treatment Period||1
8241051|NCT01928394|20323982|P21|COMPLETED|Treatment Period||1
8241052|NCT01928394|20323983|P20|COMPLETED|Treatment Period||8
8241053|NCT01928394|20323984|P19|COMPLETED|Treatment Period||22
8241054|NCT01928394|20323985|P18|COMPLETED|Treatment Period||7
8241055|NCT01928394|20323986|P17|COMPLETED|Treatment Period||5
8241056|NCT01928394|20323987|P16|COMPLETED|Treatment Period||1
8241057|NCT01928394|20323988|P15|COMPLETED|Treatment Period||8
8241058|NCT01928394|20323989|P14|COMPLETED|Treatment Period||8
8241059|NCT01928394|20323990|P13|COMPLETED|Treatment Period||6
8241060|NCT01928394|20323991|P12|COMPLETED|Treatment Period||5
8241061|NCT01928394|20323992|P11|COMPLETED|Treatment Period||0
8241062|NCT01928394|20323993|P10|COMPLETED|Treatment Period||0
8241063|NCT01928394|20323994|P9|COMPLETED|Treatment Period||0
8241064|NCT01928394|20323995|P8|COMPLETED|Treatment Period||0
8241065|NCT01928394|20323996|P7|COMPLETED|Treatment Period||3
8241066|NCT01928394|20323997|P6|COMPLETED|Treatment Period||6
8241067|NCT01928394|20323998|P5|COMPLETED|Treatment Period||0
8241068|NCT01928394|20323999|P4|COMPLETED|Treatment Period||3
8241069|NCT01928394|20324000|P3|COMPLETED|Treatment Period||0
8241070|NCT01928394|20324001|P2|COMPLETED|Treatment Period||0
8241071|NCT01928394|20324002|P1|COMPLETED|Treatment Period||0
8241072|NCT01928394|20323980|P23|Transition- Continued|Treatment Period||0
8241073|NCT01928394|20323981|P22|Transition- Continued|Treatment Period||0
8241074|NCT01928394|20323982|P21|Transition- Continued|Treatment Period||0
8241075|NCT01928394|20323983|P20|Transition- Continued|Treatment Period||19
8241076|NCT01928394|20323984|P19|Transition- Continued|Treatment Period||1
8241077|NCT01928394|20323985|P18|Transition- Continued|Treatment Period||0
8241078|NCT01928394|20323986|P17|Transition- Continued|Treatment Period||0
8241079|NCT01928394|20323987|P16|Transition- Continued|Treatment Period||0
8241080|NCT01928394|20323988|P15|Transition- Continued|Treatment Period||2
8241081|NCT01928394|20323989|P14|Transition- Continued|Treatment Period||0
8241082|NCT01928394|20323990|P13|Transition- Continued|Treatment Period||17
8241083|NCT01928394|20323991|P12|Transition- Continued|Treatment Period||0
8241084|NCT01928394|20323992|P11|Transition- Continued|Treatment Period||0
8241085|NCT01928394|20323993|P10|Transition- Continued|Treatment Period||1
8241086|NCT01928394|20323994|P9|Transition- Continued|Treatment Period||1
8241087|NCT01928394|20323995|P8|Transition- Continued|Treatment Period||0
8241088|NCT01928394|20323996|P7|Transition- Continued|Treatment Period||6
8241089|NCT01928394|20323997|P6|Transition- Continued|Treatment Period||3
8241090|NCT01928394|20323998|P5|Transition- Continued|Treatment Period||0
8241091|NCT01928394|20323999|P4|Transition- Continued|Treatment Period||0
8241092|NCT01928394|20324000|P3|Transition- Continued|Treatment Period||3
8241093|NCT01928394|20324001|P2|Transition- Continued|Treatment Period||0
8241094|NCT01928394|20324002|P1|Transition- Continued|Treatment Period||0
8241095|NCT01928394|20323980|P23|Transition|Treatment Period||0
8241096|NCT01928394|20323981|P22|Transition|Treatment Period||0
8241097|NCT01928394|20323982|P21|Transition|Treatment Period||0
8241098|NCT01928394|20323983|P20|Transition|Treatment Period||0
8241099|NCT01928394|20323984|P19|Transition|Treatment Period||0
8241100|NCT01928394|20323985|P18|Transition|Treatment Period||20
8241101|NCT01928394|20323986|P17|Transition|Treatment Period||0
8241102|NCT01928394|20323987|P16|Transition|Treatment Period||0
8241103|NCT01928394|20323988|P15|Transition|Treatment Period||0
8241104|NCT01928394|20323989|P14|Transition|Treatment Period||2
8241105|NCT01928394|20323990|P13|Transition|Treatment Period||0
8241106|NCT01928394|20323991|P12|Transition|Treatment Period||17
8241107|NCT01928394|20323992|P11|Transition|Treatment Period||0
8241108|NCT01928394|20323993|P10|Transition|Treatment Period||0
8241109|NCT01928394|20323994|P9|Transition|Treatment Period||0
8241110|NCT01928394|20323995|P8|Transition|Treatment Period||2
8241111|NCT01928394|20323996|P7|Transition|Treatment Period||0
8241112|NCT01928394|20323997|P6|Transition|Treatment Period||0
8241113|NCT01928394|20323998|P5|Transition|Treatment Period||0
8241114|NCT01928394|20323999|P4|Transition|Treatment Period||9
8241115|NCT01928394|20324000|P3|Transition|Treatment Period||0
8241116|NCT01928394|20324001|P2|Transition|Treatment Period||0
8241117|NCT01928394|20324002|P1|Transition|Treatment Period||3
8241118|NCT01928394|20323980|P23|STARTED|Treatment Period||42
8241119|NCT01928394|20323981|P22|STARTED|Treatment Period||43
8241120|NCT01928394|20323982|P21|STARTED|Treatment Period||41
8241121|NCT01928394|20323983|P20|STARTED|Treatment Period||104
8241122|NCT01928394|20323984|P19|STARTED|Treatment Period||92
8241123|NCT01928394|20323985|P18|STARTED|Treatment Period||78
8241124|NCT01928394|20323986|P17|STARTED|Treatment Period||55
8241125|NCT01928394|20323987|P16|STARTED|Treatment Period||3
8241126|NCT01928394|20323988|P15|STARTED|Treatment Period||96
8241127|NCT01928394|20323989|P14|STARTED|Treatment Period||147
8241128|NCT01928394|20323990|P13|STARTED|Treatment Period||61
8241129|NCT01928394|20323991|P12|STARTED|Treatment Period||98
8241130|NCT01928394|20323992|P11|STARTED|Treatment Period||30
8241131|NCT01928394|20323993|P10|STARTED|Treatment Period||18
8241132|NCT01928394|20323994|P9|STARTED|Treatment Period||3
8241133|NCT01928394|20323995|P8|STARTED|Treatment Period||18
8241134|NCT01928394|20323996|P7|STARTED|Treatment Period||52
8241135|NCT01928394|20323997|P6|STARTED|Treatment Period||49
8241136|NCT01928394|20323998|P5|STARTED|Treatment Period||3
8241137|NCT01928394|20323999|P4|STARTED|Treatment Period||59
8241138|NCT01928394|20324000|P3|STARTED|Treatment Period||18
8241139|NCT01928394|20324001|P2|STARTED|Treatment Period||3
8241140|NCT01928394|20324002|P1|STARTED|Treatment Period||18
8241141|NCT01928381|20324050|P7|NOT COMPLETED|Part 2 - Post Third Intervention||0
8241142|NCT01928381|20324051|P6|NOT COMPLETED|Part 2 - Post Third Intervention||0
8241143|NCT01928381|20324052|P5|NOT COMPLETED|Part 2 - Post Third Intervention||0
8241144|NCT01928381|20324053|P4|NOT COMPLETED|Part 2 - Post Third Intervention||0
8241145|NCT01928381|20324054|P3|NOT COMPLETED|Part 2 - Post Third Intervention||1
8241146|NCT01928381|20324055|P2|NOT COMPLETED|Part 2 - Post Third Intervention||0
8241147|NCT01928381|20324056|P1|NOT COMPLETED|Part 2 - Post Third Intervention||0
8241148|NCT01928381|20324050|P7|COMPLETED|Part 2 - Post Third Intervention||5
8241149|NCT01928381|20324051|P6|COMPLETED|Part 2 - Post Third Intervention||5
8241150|NCT01928381|20324052|P5|COMPLETED|Part 2 - Post Third Intervention||3
8241151|NCT01928381|20324053|P4|COMPLETED|Part 2 - Post Third Intervention||4
8241152|NCT01928381|20324054|P3|COMPLETED|Part 2 - Post Third Intervention||3
8241153|NCT01928381|20324055|P2|COMPLETED|Part 2 - Post Third Intervention||5
8241154|NCT01928381|20324056|P1|COMPLETED|Part 2 - Post Third Intervention||0
8241155|NCT01928381|20324050|P7|STARTED|Part 2 - Post Third Intervention||5
8241156|NCT01928381|20324051|P6|STARTED|Part 2 - Post Third Intervention||5
8241157|NCT01928381|20324052|P5|STARTED|Part 2 - Post Third Intervention||3
8241158|NCT01928381|20324053|P4|STARTED|Part 2 - Post Third Intervention||4
8241159|NCT01928381|20324054|P3|STARTED|Part 2 - Post Third Intervention||4
8241160|NCT01928381|20324055|P2|STARTED|Part 2 - Post Third Intervention||5
8241161|NCT01928381|20324056|P1|STARTED|Part 2 - Post Third Intervention||0
8241162|NCT01928381|20324050|P7|NOT COMPLETED|Part 2 - Third Intervention||0
8241163|NCT01928381|20324051|P6|NOT COMPLETED|Part 2 - Third Intervention||0
8241164|NCT01928381|20324052|P5|NOT COMPLETED|Part 2 - Third Intervention||0
8241165|NCT01928381|20324053|P4|NOT COMPLETED|Part 2 - Third Intervention||0
8241166|NCT01928381|20324054|P3|NOT COMPLETED|Part 2 - Third Intervention||0
8241167|NCT01928381|20324055|P2|NOT COMPLETED|Part 2 - Third Intervention||0
8241168|NCT01928381|20324056|P1|NOT COMPLETED|Part 2 - Third Intervention||0
8241169|NCT01928381|20324050|P7|COMPLETED|Part 2 - Third Intervention||5
8241170|NCT01928381|20324051|P6|COMPLETED|Part 2 - Third Intervention||5
8241171|NCT01928381|20324052|P5|COMPLETED|Part 2 - Third Intervention||3
8241172|NCT01928381|20324053|P4|COMPLETED|Part 2 - Third Intervention||4
8241173|NCT01928381|20324054|P3|COMPLETED|Part 2 - Third Intervention||4
8241174|NCT01928381|20324055|P2|COMPLETED|Part 2 - Third Intervention||5
8241175|NCT01928381|20324056|P1|COMPLETED|Part 2 - Third Intervention||0
8241176|NCT01928381|20324050|P7|STARTED|Part 2 - Third Intervention||5
8241177|NCT01928381|20324051|P6|STARTED|Part 2 - Third Intervention||5
8241178|NCT01928381|20324052|P5|STARTED|Part 2 - Third Intervention||3
8241179|NCT01928381|20324053|P4|STARTED|Part 2 - Third Intervention||4
8241180|NCT01928381|20324054|P3|STARTED|Part 2 - Third Intervention||4
8241181|NCT01928381|20324055|P2|STARTED|Part 2 - Third Intervention||5
8241182|NCT01928381|20324056|P1|STARTED|Part 2 - Third Intervention||0
8241183|NCT01928381|20324050|P7|NOT COMPLETED|Washout Second Intervention||0
8241184|NCT01928381|20324051|P6|NOT COMPLETED|Washout Second Intervention||0
8241185|NCT01928381|20324052|P5|NOT COMPLETED|Washout Second Intervention||0
8241186|NCT01928381|20324053|P4|NOT COMPLETED|Washout Second Intervention||0
8241187|NCT01928381|20324054|P3|NOT COMPLETED|Washout Second Intervention||0
8241188|NCT01928381|20324055|P2|NOT COMPLETED|Washout Second Intervention||0
8241189|NCT01928381|20324056|P1|NOT COMPLETED|Washout Second Intervention||0
8241190|NCT01928381|20324050|P7|COMPLETED|Washout Second Intervention||5
8241191|NCT01928381|20324051|P6|COMPLETED|Washout Second Intervention||5
8241192|NCT01928381|20324052|P5|COMPLETED|Washout Second Intervention||3
8241193|NCT01928381|20324053|P4|COMPLETED|Washout Second Intervention||4
8241194|NCT01928381|20324054|P3|COMPLETED|Washout Second Intervention||4
8241195|NCT01928381|20324055|P2|COMPLETED|Washout Second Intervention||5
8241196|NCT01928381|20324056|P1|COMPLETED|Washout Second Intervention||0
8241197|NCT01928381|20324050|P7|STARTED|Washout Second Intervention||5
8241198|NCT01928381|20324051|P6|STARTED|Washout Second Intervention||5
8241199|NCT01928381|20324052|P5|STARTED|Washout Second Intervention||3
8241200|NCT01928381|20324053|P4|STARTED|Washout Second Intervention||4
8241201|NCT01928381|20324054|P3|STARTED|Washout Second Intervention||4
8241202|NCT01928381|20324055|P2|STARTED|Washout Second Intervention||5
8241203|NCT01928381|20324056|P1|STARTED|Washout Second Intervention||0
8241204|NCT01928381|20324050|P7|NOT COMPLETED|Part 2 - Second Intervention||0
8241205|NCT01928381|20324051|P6|NOT COMPLETED|Part 2 - Second Intervention||0
8241206|NCT01928381|20324052|P5|NOT COMPLETED|Part 2 - Second Intervention||0
8241207|NCT01928381|20324053|P4|NOT COMPLETED|Part 2 - Second Intervention||1
8241208|NCT01928381|20324054|P3|NOT COMPLETED|Part 2 - Second Intervention||0
8241209|NCT01928381|20324055|P2|NOT COMPLETED|Part 2 - Second Intervention||1
8241210|NCT01928381|20324056|P1|NOT COMPLETED|Part 2 - Second Intervention||0
8241211|NCT01928381|20324050|P7|COMPLETED|Part 2 - Second Intervention||5
8241212|NCT01928381|20324051|P6|COMPLETED|Part 2 - Second Intervention||5
8241213|NCT01928381|20324052|P5|COMPLETED|Part 2 - Second Intervention||3
8241214|NCT01928381|20324053|P4|COMPLETED|Part 2 - Second Intervention||4
8241215|NCT01928381|20324054|P3|COMPLETED|Part 2 - Second Intervention||4
8241216|NCT01928381|20324055|P2|COMPLETED|Part 2 - Second Intervention||5
8241217|NCT01928381|20324056|P1|COMPLETED|Part 2 - Second Intervention||0
8241218|NCT01928381|20324050|P7|STARTED|Part 2 - Second Intervention||5
8241219|NCT01928381|20324051|P6|STARTED|Part 2 - Second Intervention||5
8241220|NCT01928381|20324052|P5|STARTED|Part 2 - Second Intervention||3
8241221|NCT01928381|20324053|P4|STARTED|Part 2 - Second Intervention||5
8241222|NCT01928381|20324054|P3|STARTED|Part 2 - Second Intervention||4
8241223|NCT01928381|20324055|P2|STARTED|Part 2 - Second Intervention||6
8241224|NCT01928381|20324056|P1|STARTED|Part 2 - Second Intervention||0
8241225|NCT01928381|20324050|P7|NOT COMPLETED|Washout First Intervention||0
8241226|NCT01928381|20324051|P6|NOT COMPLETED|Washout First Intervention||0
8241227|NCT01928381|20324052|P5|NOT COMPLETED|Washout First Intervention||1
8241228|NCT01928381|20324053|P4|NOT COMPLETED|Washout First Intervention||0
8241229|NCT01928381|20324054|P3|NOT COMPLETED|Washout First Intervention||0
8241230|NCT01928381|20324055|P2|NOT COMPLETED|Washout First Intervention||0
8241231|NCT01928381|20324056|P1|NOT COMPLETED|Washout First Intervention||0
8241232|NCT01928381|20324050|P7|COMPLETED|Washout First Intervention||5
8241233|NCT01928381|20324051|P6|COMPLETED|Washout First Intervention||5
8241234|NCT01928381|20324052|P5|COMPLETED|Washout First Intervention||3
8241235|NCT01928381|20324053|P4|COMPLETED|Washout First Intervention||5
8241236|NCT01928381|20324054|P3|COMPLETED|Washout First Intervention||4
8241237|NCT01928381|20324055|P2|COMPLETED|Washout First Intervention||6
8241238|NCT01928381|20324056|P1|COMPLETED|Washout First Intervention||0
8241239|NCT01928381|20324050|P7|STARTED|Washout First Intervention||5
8241240|NCT01928381|20324051|P6|STARTED|Washout First Intervention||5
8241241|NCT01928381|20324052|P5|STARTED|Washout First Intervention||4
8241242|NCT01928381|20324053|P4|STARTED|Washout First Intervention||5
8241243|NCT01928381|20324054|P3|STARTED|Washout First Intervention||4
8241244|NCT01928381|20324055|P2|STARTED|Washout First Intervention||6
8241245|NCT01928381|20324056|P1|STARTED|Washout First Intervention||0
8241246|NCT01928381|20324050|P7|NOT COMPLETED|Part 2 - First Intervention||1
8241247|NCT01928381|20324051|P6|NOT COMPLETED|Part 2 - First Intervention||1
8241248|NCT01928381|20324052|P5|NOT COMPLETED|Part 2 - First Intervention||0
8241249|NCT01928381|20324053|P4|NOT COMPLETED|Part 2 - First Intervention||1
8241250|NCT01928381|20324054|P3|NOT COMPLETED|Part 2 - First Intervention||2
8241251|NCT01928381|20324055|P2|NOT COMPLETED|Part 2 - First Intervention||0
8241252|NCT01928381|20324056|P1|NOT COMPLETED|Part 2 - First Intervention||0
8241253|NCT01928381|20324050|P7|COMPLETED|Part 2 - First Intervention||5
8241254|NCT01928381|20324051|P6|COMPLETED|Part 2 - First Intervention||5
8241255|NCT01928381|20324052|P5|COMPLETED|Part 2 - First Intervention||4
8241256|NCT01928381|20324053|P4|COMPLETED|Part 2 - First Intervention||5
8241257|NCT01928381|20324054|P3|COMPLETED|Part 2 - First Intervention||4
8241258|NCT01928381|20324055|P2|COMPLETED|Part 2 - First Intervention||6
8241259|NCT01928381|20324056|P1|COMPLETED|Part 2 - First Intervention||0
8241260|NCT01928381|20324050|P7|STARTED|Part 2 - First Intervention||6
8241261|NCT01928381|20324051|P6|STARTED|Part 2 - First Intervention||6
8241262|NCT01928381|20324052|P5|STARTED|Part 2 - First Intervention||4
8241263|NCT01928381|20324053|P4|STARTED|Part 2 - First Intervention||6
8241264|NCT01928381|20324054|P3|STARTED|Part 2 - First Intervention||6
8241265|NCT01928381|20324055|P2|STARTED|Part 2 - First Intervention||6
8241266|NCT01928381|20324056|P1|STARTED|Part 2 - First Intervention||0
8241267|NCT01928381|20324050|P7|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241268|NCT01928381|20324051|P6|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241269|NCT01928381|20324052|P5|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241270|NCT01928381|20324053|P4|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241271|NCT01928381|20324054|P3|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241272|NCT01928381|20324055|P2|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241273|NCT01928381|20324056|P1|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
8241274|NCT01928381|20324050|P7|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241275|NCT01928381|20324051|P6|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241276|NCT01928381|20324052|P5|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241277|NCT01928381|20324053|P4|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241278|NCT01928381|20324054|P3|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241279|NCT01928381|20324055|P2|COMPLETED|Placebo run-in & Part 2 Eligibility||0
8241280|NCT01928381|20324056|P1|COMPLETED|Placebo run-in & Part 2 Eligibility||34
8241281|NCT01928381|20324050|P7|STARTED|Placebo run-in & Part 2 Eligibility||0
8241282|NCT01928381|20324051|P6|STARTED|Placebo run-in & Part 2 Eligibility||0
8241283|NCT01928381|20324052|P5|STARTED|Placebo run-in & Part 2 Eligibility||0
8241284|NCT01928381|20324053|P4|STARTED|Placebo run-in & Part 2 Eligibility||0
8241285|NCT01928381|20324054|P3|STARTED|Placebo run-in & Part 2 Eligibility||0
8241286|NCT01928381|20324055|P2|STARTED|Placebo run-in & Part 2 Eligibility||0
8241287|NCT01928381|20324056|P1|STARTED|Placebo run-in & Part 2 Eligibility||48
8241288|NCT01928381|20324050|P7|NOT COMPLETED|Part 1 - Pain Training||0
8241289|NCT01928381|20324051|P6|NOT COMPLETED|Part 1 - Pain Training||0
8241290|NCT01928381|20324052|P5|NOT COMPLETED|Part 1 - Pain Training||0
8241291|NCT01928381|20324053|P4|NOT COMPLETED|Part 1 - Pain Training||0
8241292|NCT01928381|20324054|P3|NOT COMPLETED|Part 1 - Pain Training||0
8241293|NCT01928381|20324055|P2|NOT COMPLETED|Part 1 - Pain Training||0
8241294|NCT01928381|20324056|P1|NOT COMPLETED|Part 1 - Pain Training||35
8241295|NCT01928381|20324050|P7|COMPLETED|Part 1 - Pain Training||0
8241296|NCT01928381|20324051|P6|COMPLETED|Part 1 - Pain Training||0
8241297|NCT01928381|20324052|P5|COMPLETED|Part 1 - Pain Training||0
8241298|NCT01928381|20324053|P4|COMPLETED|Part 1 - Pain Training||0
8241299|NCT01928381|20324054|P3|COMPLETED|Part 1 - Pain Training||0
8241300|NCT01928381|20324055|P2|COMPLETED|Part 1 - Pain Training||0
8241301|NCT01928381|20324056|P1|COMPLETED|Part 1 - Pain Training||48
8241302|NCT01928381|20324050|P7|STARTED|Part 1 - Pain Training||0
8241303|NCT01928381|20324051|P6|STARTED|Part 1 - Pain Training||0
8241304|NCT01928381|20324052|P5|STARTED|Part 1 - Pain Training||0
8241305|NCT01928381|20324053|P4|STARTED|Part 1 - Pain Training||0
8241306|NCT01928381|20324054|P3|STARTED|Part 1 - Pain Training||0
8241307|NCT01928381|20324055|P2|STARTED|Part 1 - Pain Training||0
8241308|NCT01928381|20324056|P1|STARTED|Part 1 - Pain Training||83
8241309|NCT01928381|20324050|P7|NOT COMPLETED|Screening for Pain Training||0
8241310|NCT01928381|20324051|P6|NOT COMPLETED|Screening for Pain Training||0
8241311|NCT01928381|20324052|P5|NOT COMPLETED|Screening for Pain Training||0
8241312|NCT01928381|20324053|P4|NOT COMPLETED|Screening for Pain Training||0
8241313|NCT01928381|20324054|P3|NOT COMPLETED|Screening for Pain Training||0
8241314|NCT01928381|20324055|P2|NOT COMPLETED|Screening for Pain Training||0
8241315|NCT01928381|20324056|P1|NOT COMPLETED|Screening for Pain Training||60
8241316|NCT01928381|20324050|P7|COMPLETED|Screening for Pain Training||0
8241317|NCT01928381|20324051|P6|COMPLETED|Screening for Pain Training||0
8241318|NCT01928381|20324052|P5|COMPLETED|Screening for Pain Training||0
8241319|NCT01928381|20324053|P4|COMPLETED|Screening for Pain Training||0
8241320|NCT01928381|20324054|P3|COMPLETED|Screening for Pain Training||0
8241321|NCT01928381|20324055|P2|COMPLETED|Screening for Pain Training||0
8241322|NCT01928381|20324056|P1|COMPLETED|Screening for Pain Training||83
8241323|NCT01928381|20324050|P7|STARTED|Screening for Pain Training||0
8241324|NCT01928381|20324051|P6|STARTED|Screening for Pain Training||0
8241325|NCT01928381|20324052|P5|STARTED|Screening for Pain Training||0
8241326|NCT01928381|20324053|P4|STARTED|Screening for Pain Training||0
8241327|NCT01928381|20324054|P3|STARTED|Screening for Pain Training||0
8241328|NCT01928381|20324055|P2|STARTED|Screening for Pain Training||0
8241329|NCT01928381|20324056|P1|STARTED|Screening for Pain Training||143
8241330|NCT01928329|20324071|P2|NOT COMPLETED|Overall Study||14
8241331|NCT01928329|20324072|P1|NOT COMPLETED|Overall Study||12
8241332|NCT01928329|20324071|P2|COMPLETED|Overall Study||25
8241333|NCT01928329|20324072|P1|COMPLETED|Overall Study||28
8241334|NCT01928329|20324071|P2|STARTED|Overall Study||39
8241335|NCT01928329|20324072|P1|STARTED|Overall Study||40
8241336|NCT01928290|20324086|P2|NOT COMPLETED|Overall Study||0
8241337|NCT01928290|20324087|P1|NOT COMPLETED|Overall Study||0
8241338|NCT01928290|20324086|P2|COMPLETED|Overall Study||26
8241339|NCT01928290|20324087|P1|COMPLETED|Overall Study||41
8241340|NCT01928290|20324086|P2|STARTED|Overall Study||26
8241341|NCT01928290|20324087|P1|STARTED|Overall Study||41
8241342|NCT01928225|20324107|P2|NOT COMPLETED|Overall Study||3
8241343|NCT01928225|20324108|P1|NOT COMPLETED|Overall Study||3
8241344|NCT01928225|20324107|P2|COMPLETED|Overall Study||87
8241345|NCT01928225|20324108|P1|COMPLETED|Overall Study||87
8241346|NCT01928225|20324107|P2|STARTED|Overall Study||90
8241347|NCT01928225|20324108|P1|STARTED|Overall Study||90
8241348|NCT01928186|20324116|P1|NOT COMPLETED|Overall Study||0
8241349|NCT01928186|20324116|P1|COMPLETED|Overall Study||28
8241350|NCT01928186|20324116|P1|STARTED|Overall Study||28
8241351|NCT01928082|20324130|P1|NOT COMPLETED|Overall Study||1
8241352|NCT01928082|20324130|P1|COMPLETED|Overall Study||0
8241353|NCT01928082|20324130|P1|STARTED|Overall Study||1
8241354|NCT01928030|20324148|P3|NOT COMPLETED|Overall Study||0
8241355|NCT01928030|20324149|P2|NOT COMPLETED|Overall Study||0
8241356|NCT01928030|20324150|P1|NOT COMPLETED|Overall Study||0
8241357|NCT01928030|20324148|P3|COMPLETED|Overall Study||0
8241358|NCT01928030|20324149|P2|COMPLETED|Overall Study||0
8241359|NCT01928030|20324150|P1|COMPLETED|Overall Study||3
8241360|NCT01928030|20324148|P3|STARTED|Overall Study||0
8241361|NCT01928030|20324149|P2|STARTED|Overall Study||0
8241362|NCT01928030|20324150|P1|STARTED|Overall Study||3
8241363|NCT01927887|20324157|P1|NOT COMPLETED|Overall Study||0
8241364|NCT01927887|20324157|P1|COMPLETED|Overall Study||12
8241365|NCT01927887|20324157|P1|STARTED|Overall Study||12
8241366|NCT01927861|20324164|P2|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
8241367|NCT01927861|20324165|P1|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
8241368|NCT01927861|20324164|P2|COMPLETED|Extended Treatment Phase (26 Weeks)||14
8241369|NCT01927861|20324165|P1|COMPLETED|Extended Treatment Phase (26 Weeks)||15
8241370|NCT01927861|20324164|P2|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14
8241371|NCT01927861|20324165|P1|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15
8241372|NCT01927861|20324164|P2|NOT COMPLETED|Extension Phase (104 Weeks)||3
8241373|NCT01927861|20324165|P1|NOT COMPLETED|Extension Phase (104 Weeks)||0
8241374|NCT01927861|20324164|P2|COMPLETED|Extension Phase (104 Weeks)||23
8241375|NCT01927861|20324165|P1|COMPLETED|Extension Phase (104 Weeks)||25
8241376|NCT01927861|20324164|P2|STARTED|Extension Phase (104 Weeks)||26
8241377|NCT01927861|20324165|P1|STARTED|Extension Phase (104 Weeks)||25
8241378|NCT01927861|20324164|P2|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
8241379|NCT01927861|20324165|P1|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
8241380|NCT01927861|20324164|P2|COMPLETED|Pivotal Phase (104 Weeks)||26
8241381|NCT01927861|20324165|P1|COMPLETED|Pivotal Phase (104 Weeks)||25
8241382|NCT01927861|20324164|P2|STARTED|Pivotal Phase (104 Weeks)||26
8241383|NCT01927861|20324165|P1|STARTED|Pivotal Phase (104 Weeks)||25
8241384|NCT01927757|20324303|P1|NOT COMPLETED|Overall Study||23
8241385|NCT01927757|20324303|P1|COMPLETED|Overall Study||67
8241386|NCT01927757|20324303|P1|Received Etanercept|Overall Study||88
8241387|NCT01927757|20324303|P1|STARTED|Overall Study||90
8241388|NCT01927718|20324321|P1|NOT COMPLETED|Overall Study||0
8241389|NCT01927718|20324321|P1|COMPLETED|Overall Study||10
8241390|NCT01927718|20324321|P1|STARTED|Overall Study||10
8241391|NCT01927627|20324325|P1|NOT COMPLETED|Overall Study||5
8241392|NCT01927627|20324325|P1|COMPLETED|Overall Study||37
8241393|NCT01927627|20324325|P1|STARTED|Overall Study||42
8241394|NCT01927575|20324330|P1|NOT COMPLETED|Overall Study||0
8241395|NCT01927575|20324330|P1|COMPLETED|Overall Study||1
8241396|NCT01927575|20324330|P1|STARTED|Overall Study||1
8241397|NCT01927562|20324338|P1|NOT COMPLETED|Overall Study||38
8241398|NCT01927562|20324338|P1|COMPLETED|Overall Study|5 at M24, 2 at M30,12 at M36 due to two protocol changes moving followups from M24 to M30 to M36|19
8241399|NCT01927562|20324338|P1|STARTED|Overall Study||57
8241400|NCT01927419|20324344|P2|NOT COMPLETED|Overall Study||28
8241401|NCT01927419|20324345|P1|NOT COMPLETED|Overall Study||70
8241402|NCT01927419|20324344|P2|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
8241403|NCT01927419|20324345|P1|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
8241404|NCT01927419|20324344|P2|Received Treatment|Overall Study||46
8241405|NCT01927419|20324345|P1|Received Treatment|Overall Study||94
8241406|NCT01927419|20324344|P2|STARTED|Overall Study||47
8241407|NCT01927419|20324345|P1|STARTED|Overall Study||95
8241414|NCT01927120|20324378|P1|NOT COMPLETED|Overall Study||10
8241415|NCT01927120|20324378|P1|COMPLETED|Overall Study||10
8241416|NCT01927120|20324378|P1|STARTED|Overall Study||20
8241417|NCT01927055|20324396|P3|NOT COMPLETED|Double-Blind||13
8241418|NCT01927055|20324397|P2|NOT COMPLETED|Double-Blind||11
8241419|NCT01927055|20324398|P1|NOT COMPLETED|Double-Blind||0
8241420|NCT01927055|20324396|P3|COMPLETED|Double-Blind||10
8241421|NCT01927055|20324397|P2|COMPLETED|Double-Blind||11
8241422|NCT01927055|20324398|P1|COMPLETED|Double-Blind||0
8241423|NCT01927055|20324396|P3|STARTED|Double-Blind||23
8241424|NCT01927055|20324397|P2|STARTED|Double-Blind||22
8241425|NCT01927055|20324398|P1|STARTED|Double-Blind||0
8241426|NCT01927055|20324396|P3|NOT COMPLETED|Open-label||0
8241427|NCT01927055|20324397|P2|NOT COMPLETED|Open-label||0
8241428|NCT01927055|20324398|P1|NOT COMPLETED|Open-label||16
8241429|NCT01927055|20324396|P3|COMPLETED|Open-label||0
8241430|NCT01927055|20324397|P2|COMPLETED|Open-label||0
8241431|NCT01927055|20324398|P1|COMPLETED|Open-label||45
8241432|NCT01927055|20324396|P3|STARTED|Open-label||0
8241433|NCT01927055|20324397|P2|STARTED|Open-label||0
8241434|NCT01927055|20324398|P1|STARTED|Open-label||61
8241435|NCT01926977|20324407|P2|NOT COMPLETED|Overall Study||0
8241436|NCT01926977|20324408|P1|NOT COMPLETED|Overall Study||0
8241437|NCT01926977|20324407|P2|COMPLETED|Overall Study||53
8241438|NCT01926977|20324408|P1|COMPLETED|Overall Study||47
8241439|NCT01926977|20324407|P2|STARTED|Overall Study||53
8241440|NCT01926977|20324408|P1|STARTED|Overall Study||47
8241441|NCT01926886|20324416|P2|NOT COMPLETED|Overall Study||0
8241442|NCT01926886|20324417|P1|NOT COMPLETED|Overall Study||32
8241443|NCT01926886|20324416|P2|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21
8241444|NCT01926886|20324417|P1|COMPLETED|Overall Study||70
8241445|NCT01926886|20324416|P2|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0
8241446|NCT01926886|20324417|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
8241447|NCT01926886|20324416|P2|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21
8241448|NCT01926886|20324417|P1|STARTED|Overall Study||102
8241449|NCT01926782|20324436|P6|NOT COMPLETED|Overall Study||41
8241450|NCT01926782|20324437|P5|NOT COMPLETED|Overall Study||8
8241451|NCT01926782|20324438|P4|NOT COMPLETED|Overall Study||20
8241452|NCT01926782|20324439|P3|NOT COMPLETED|Overall Study||40
8241453|NCT01926782|20324440|P2|NOT COMPLETED|Overall Study||13
8241454|NCT01926782|20324441|P1|NOT COMPLETED|Overall Study||28
8241455|NCT01926782|20324436|P6|COMPLETED|Overall Study||105
8241456|NCT01926782|20324437|P5|COMPLETED|Overall Study||29
8241457|NCT01926782|20324438|P4|COMPLETED|Overall Study||53
8241458|NCT01926782|20324439|P3|COMPLETED|Overall Study||272
8241459|NCT01926782|20324440|P2|COMPLETED|Overall Study||65
8241460|NCT01926782|20324441|P1|COMPLETED|Overall Study||129
8241461|NCT01926782|20324436|P6|Completed 24 Weeks Treatment Period|Overall Study||120
8241462|NCT01926782|20324437|P5|Completed 24 Weeks Treatment Period|Overall Study||31
8241463|NCT01926782|20324438|P4|Completed 24 Weeks Treatment Period|Overall Study||58
8241464|NCT01926782|20324439|P3|Completed 24 Weeks Treatment Period|Overall Study||285
8241465|NCT01926782|20324440|P2|Completed 24 Weeks Treatment Period|Overall Study||68
8241466|NCT01926782|20324441|P1|Completed 24 Weeks Treatment Period|Overall Study||137
8241467|NCT01926782|20324436|P6|Treated|Overall Study||146
8241468|NCT01926782|20324437|P5|Treated|Overall Study||37
8241469|NCT01926782|20324438|P4|Treated|Overall Study||72
8241470|NCT01926782|20324439|P3|Treated|Overall Study||312
8241471|NCT01926782|20324440|P2|Treated|Overall Study||78
8241472|NCT01926782|20324441|P1|Treated|Overall Study||157
8241473|NCT01926782|20324436|P6|STARTED|Overall Study||146
8241474|NCT01926782|20324437|P5|STARTED|Overall Study||37
8241475|NCT01926782|20324438|P4|STARTED|Overall Study||73
8241476|NCT01926782|20324439|P3|STARTED|Overall Study||312
8241477|NCT01926782|20324440|P2|STARTED|Overall Study||78
8241478|NCT01926782|20324441|P1|STARTED|Overall Study||157
8241479|NCT01926626|20324590|P1|NOT COMPLETED|Overall Study||22
8241480|NCT01926626|20324590|P1|COMPLETED|Overall Study||16
8241481|NCT01926626|20324590|P1|Received Moclobemide|Overall Study||37
8241482|NCT01926626|20324590|P1|STARTED|Overall Study||38
8241483|NCT01926509|20324604|P4|NOT COMPLETED|Overall Study||0
8241484|NCT01926509|20324605|P3|NOT COMPLETED|Overall Study||0
8241485|NCT01926509|20324606|P2|NOT COMPLETED|Overall Study||0
8241486|NCT01926509|20324607|P1|NOT COMPLETED|Overall Study||1
8241487|NCT01926509|20324604|P4|COMPLETED|Overall Study||6
8241488|NCT01926509|20324605|P3|COMPLETED|Overall Study||5
8241489|NCT01926509|20324606|P2|COMPLETED|Overall Study||6
8241490|NCT01926509|20324607|P1|COMPLETED|Overall Study||5
8241491|NCT01926509|20324604|P4|STARTED|Overall Study||6
8241492|NCT01926509|20324605|P3|STARTED|Overall Study||5
8241493|NCT01926509|20324606|P2|STARTED|Overall Study||6
8241494|NCT01926509|20324607|P1|STARTED|Overall Study||6
8241495|NCT01926496|20324626|P2|NOT COMPLETED|Overall Study||48
8241496|NCT01926496|20324627|P1|NOT COMPLETED|Overall Study||37
8241497|NCT01926496|20324626|P2|COMPLETED|Overall Study||197
8241498|NCT01926496|20324627|P1|COMPLETED|Overall Study||203
8241499|NCT01926496|20324626|P2|STARTED|Overall Study||245
8241500|NCT01926496|20324627|P1|STARTED|Overall Study||240
8241501|NCT01926444|20324647|P4|NOT COMPLETED|Overall Study||2
8241502|NCT01926444|20324648|P3|NOT COMPLETED|Overall Study||4
8241503|NCT01926444|20324649|P2|NOT COMPLETED|Overall Study||0
8241504|NCT01926444|20324650|P1|NOT COMPLETED|Overall Study||0
8241505|NCT01926444|20324647|P4|COMPLETED|Overall Study||101
8241506|NCT01926444|20324648|P3|COMPLETED|Overall Study||53
8241507|NCT01926444|20324649|P2|COMPLETED|Overall Study||52
8241508|NCT01926444|20324650|P1|COMPLETED|Overall Study||56
8241509|NCT01926444|20324647|P4|STARTED|Overall Study||103
8241510|NCT01926444|20324648|P3|STARTED|Overall Study||57
8241511|NCT01926444|20324649|P2|STARTED|Overall Study||52
8241512|NCT01926444|20324650|P1|STARTED|Overall Study||56
8241513|NCT01926119|20324692|P1|NOT COMPLETED|Overall Study||1
8241514|NCT01926119|20324692|P1|COMPLETED|Overall Study||3
8241515|NCT01926119|20324692|P1|STARTED|Overall Study||4
8241516|NCT01926028|20324705|P3|NOT COMPLETED|Overall Study||2
8241517|NCT01926028|20324706|P2|NOT COMPLETED|Overall Study||22
8241518|NCT01926028|20324707|P1|NOT COMPLETED|Overall Study||21
8241519|NCT01926028|20324705|P3|COMPLETED|Overall Study||12
8241520|NCT01926028|20324706|P2|COMPLETED|Overall Study||67
8241521|NCT01926028|20324707|P1|COMPLETED|Overall Study||64
8241522|NCT01926028|20324705|P3|STARTED|Overall Study||14
8241523|NCT01926028|20324706|P2|STARTED|Overall Study||89
8241524|NCT01926028|20324707|P1|STARTED|Overall Study||85
8241525|NCT01926015|20324743|P2|NOT COMPLETED|Overall Study||1
8241526|NCT01926015|20324744|P1|NOT COMPLETED|Overall Study||2
8241527|NCT01926015|20324743|P2|COMPLETED|Overall Study||95
8241528|NCT01926015|20324744|P1|COMPLETED|Overall Study||94
8241529|NCT01926015|20324743|P2|Received >=1 Vaccination|Overall Study||96
8241530|NCT01926015|20324744|P1|Received >=1 Vaccination|Overall Study||94
8241531|NCT01926015|20324743|P2|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
8241532|NCT01926015|20324744|P1|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
8241533|NCT01925989|20324776|P3|NOT COMPLETED|Period 2||0
8241534|NCT01925989|20324777|P2|NOT COMPLETED|Period 2||0
8241535|NCT01925989|20324778|P1|NOT COMPLETED|Period 2||0
8241536|NCT01925989|20324776|P3|COMPLETED|Period 2||12
8241537|NCT01925989|20324777|P2|COMPLETED|Period 2||6
8241538|NCT01925989|20324778|P1|COMPLETED|Period 2||6
8241539|NCT01925989|20324776|P3|STARTED|Period 2||12
8241540|NCT01925989|20324777|P2|STARTED|Period 2||6
8241541|NCT01925989|20324778|P1|STARTED|Period 2||6
8241542|NCT01925989|20324776|P3|NOT COMPLETED|Period 1||0
8241543|NCT01925989|20324777|P2|NOT COMPLETED|Period 1||2
8241544|NCT01925989|20324778|P1|NOT COMPLETED|Period 1||1
8241545|NCT01925989|20324776|P3|COMPLETED|Period 1||12
8241546|NCT01925989|20324777|P2|COMPLETED|Period 1||6
8241547|NCT01925989|20324778|P1|COMPLETED|Period 1||6
8241548|NCT01925989|20324776|P3|Received at Least 1 Dose of Study Drug|Period 1||0
8241549|NCT01925989|20324777|P2|Received at Least 1 Dose of Study Drug|Period 1||8
8241550|NCT01925989|20324778|P1|Received at Least 1 Dose of Study Drug|Period 1||7
8241551|NCT01925989|20324776|P3|STARTED|Period 1||12
8241552|NCT01925989|20324777|P2|STARTED|Period 1||8
8241553|NCT01925989|20324778|P1|STARTED|Period 1||7
8241554|NCT01925950|20324798|P2|NOT COMPLETED|Part 2||0
8241555|NCT01925950|20324799|P1|NOT COMPLETED|Part 2||1
8241556|NCT01925950|20324798|P2|COMPLETED|Part 2||0
8241557|NCT01925950|20324799|P1|COMPLETED|Part 2||0
8241558|NCT01925950|20324798|P2|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
8241559|NCT01925950|20324799|P1|STARTED|Part 2||1
8241560|NCT01925950|20324798|P2|NOT COMPLETED|Part 1||0
8241561|NCT01925950|20324799|P1|NOT COMPLETED|Part 1||0
8241562|NCT01925950|20324798|P2|COMPLETED|Part 1||1
8241563|NCT01925950|20324799|P1|COMPLETED|Part 1||1
8241564|NCT01925950|20324798|P2|STARTED|Part 1||1
8241565|NCT01925950|20324799|P1|STARTED|Part 1||1
8241566|NCT01925781|20324807|P2|NOT COMPLETED|Overall Study||4
8241567|NCT01925781|20324808|P1|NOT COMPLETED|Overall Study||2
8241568|NCT01925781|20324807|P2|COMPLETED|Overall Study||1
8241569|NCT01925781|20324808|P1|COMPLETED|Overall Study||3
8241570|NCT01925781|20324807|P2|STARTED|Overall Study||5
8241571|NCT01925781|20324808|P1|STARTED|Overall Study||5
8241572|NCT01925768|20324818|P2|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18
8241573|NCT01925768|20324819|P1|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20
8241574|NCT01925768|20324818|P2|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67
8241575|NCT01925768|20324819|P1|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75
8241576|NCT01925768|20324818|P2|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85
8241577|NCT01925768|20324819|P1|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95
8241578|NCT01925768|20324818|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
8241579|NCT01925768|20324819|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11
8241580|NCT01925768|20324818|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87
8241581|NCT01925768|20324819|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98
8241582|NCT01925768|20324818|P2|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13
8241583|NCT01925768|20324819|P1|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35
8241584|NCT01925768|20324818|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91
8241585|NCT01925768|20324819|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101
8241586|NCT01925768|20324818|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
8241587|NCT01925768|20324819|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
8241588|NCT01925768|20324818|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||110
8241589|NCT01925768|20324819|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||109
8241590|NCT01925703|20324867|P1|NOT COMPLETED|Overall Study||4
8241591|NCT01925703|20324867|P1|COMPLETED|Overall Study||9
8241592|NCT01925703|20324867|P1|Follow-up Completed|Overall Study||9
8241593|NCT01925703|20324867|P1|Full Iron Repletion Achieved|Overall Study||11
8241594|NCT01925703|20324867|P1|Dosing Regimen Completed|Overall Study||12
8241595|NCT01925703|20324867|P1|STARTED|Overall Study||13
8241596|NCT01925677|20324873|P1|NOT COMPLETED|Overall Study||0
8241597|NCT01925677|20324873|P1|COMPLETED|Overall Study||3
8241598|NCT01925677|20324873|P1|STARTED|Overall Study||3
8241599|NCT01925612|20324885|P5|NOT COMPLETED|Overall Study||2
8241600|NCT01925612|20324886|P4|NOT COMPLETED|Overall Study||1
8241601|NCT01925612|20324887|P3|NOT COMPLETED|Overall Study||1
8241602|NCT01925612|20324888|P2|NOT COMPLETED|Overall Study||4
8241603|NCT01925612|20324889|P1|NOT COMPLETED|Overall Study||4
8241604|NCT01925612|20324885|P5|COMPLETED|Overall Study||10
8241605|NCT01925612|20324886|P4|COMPLETED|Overall Study||10
8241606|NCT01925612|20324887|P3|COMPLETED|Overall Study||10
8241607|NCT01925612|20324888|P2|COMPLETED|Overall Study||18
8241608|NCT01925612|20324889|P1|COMPLETED|Overall Study||25
8241609|NCT01925612|20324885|P5|STARTED|Overall Study||12
8241610|NCT01925612|20324886|P4|STARTED|Overall Study||11
8241611|NCT01925612|20324887|P3|STARTED|Overall Study||11
8241612|NCT01925612|20324888|P2|STARTED|Overall Study||22
8241613|NCT01925612|20324889|P1|STARTED|Overall Study||29
8241614|NCT01925469|20324928|P2|NOT COMPLETED|Overall Study||0
8241615|NCT01925469|20324929|P1|NOT COMPLETED|Overall Study||1
8241616|NCT01925469|20324928|P2|COMPLETED|Overall Study||15
8241617|NCT01925469|20324929|P1|COMPLETED|Overall Study||14
8241618|NCT01925469|20324928|P2|STARTED|Overall Study||15
8241619|NCT01925469|20324929|P1|STARTED|Overall Study||15
8241620|NCT01925417|20324939|P1|NOT COMPLETED|Overall Study||3
8241621|NCT01925417|20324939|P1|COMPLETED|Overall Study||31
8241622|NCT01925417|20324939|P1|STARTED|Overall Study||34
8241623|NCT01925404|20324951|P4|NOT COMPLETED|Overall Study||0
8241624|NCT01925404|20324952|P3|NOT COMPLETED|Overall Study||0
8241625|NCT01925404|20324953|P2|NOT COMPLETED|Overall Study||0
8241626|NCT01925404|20324954|P1|NOT COMPLETED|Overall Study||0
8241627|NCT01925404|20324951|P4|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
8241628|NCT01925404|20324952|P3|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
8241629|NCT01925404|20324953|P2|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
8241630|NCT01925404|20324954|P1|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|0
8241631|NCT01925404|20324951|P4|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
8241632|NCT01925404|20324952|P3|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
8241633|NCT01925404|20324953|P2|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|0
8241634|NCT01925404|20324954|P1|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.
~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|0
8241635|NCT01925339|20324970|P2|NOT COMPLETED|Overall Study||0
8241636|NCT01925339|20324971|P1|NOT COMPLETED|Overall Study||2
8241637|NCT01925339|20324970|P2|COMPLETED|Overall Study||20
8241638|NCT01925339|20324971|P1|COMPLETED|Overall Study||18
8241639|NCT01925339|20324970|P2|STARTED|Overall Study||20
8241640|NCT01925339|20324971|P1|STARTED|Overall Study||20
8241641|NCT01925274|20324982|P3|NOT COMPLETED|Overall Study||6
8241642|NCT01925274|20324983|P2|NOT COMPLETED|Overall Study||6
8241643|NCT01925274|20324984|P1|NOT COMPLETED|Overall Study||7
8241644|NCT01925274|20324982|P3|COMPLETED|Overall Study||0
8241645|NCT01925274|20324983|P2|COMPLETED|Overall Study||0
8241646|NCT01925274|20324984|P1|COMPLETED|Overall Study||0
8241647|NCT01925274|20324982|P3|STARTED|Overall Study||6
8241648|NCT01925274|20324983|P2|STARTED|Overall Study||6
8241649|NCT01925274|20324984|P1|STARTED|Overall Study||7
8241650|NCT01925209|20325065|P4|NOT COMPLETED|Follow-up||4
8241651|NCT01925209|20325066|P3|NOT COMPLETED|Follow-up||1
8241652|NCT01925209|20325067|P2|NOT COMPLETED|Follow-up||6
8241653|NCT01925209|20325068|P1|NOT COMPLETED|Follow-up||1
8241654|NCT01925209|20325065|P4|COMPLETED|Follow-up||54
8241655|NCT01925209|20325066|P3|COMPLETED|Follow-up||55
8241656|NCT01925209|20325067|P2|COMPLETED|Follow-up||55
8241657|NCT01925209|20325068|P1|COMPLETED|Follow-up||56
8241658|NCT01925209|20325065|P4|STARTED|Follow-up||58
8241659|NCT01925209|20325066|P3|STARTED|Follow-up||56
8241660|NCT01925209|20325067|P2|STARTED|Follow-up||61
8241661|NCT01925209|20325068|P1|STARTED|Follow-up||57
8241662|NCT01925209|20325065|P4|NOT COMPLETED|Maintenance Treatment Epoch||2
8241663|NCT01925209|20325066|P3|NOT COMPLETED|Maintenance Treatment Epoch||2
8241664|NCT01925209|20325067|P2|NOT COMPLETED|Maintenance Treatment Epoch||1
8241665|NCT01925209|20325068|P1|NOT COMPLETED|Maintenance Treatment Epoch||0
8241666|NCT01925209|20325065|P4|COMPLETED|Maintenance Treatment Epoch||48
8241667|NCT01925209|20325066|P3|COMPLETED|Maintenance Treatment Epoch||50
8241668|NCT01925209|20325067|P2|COMPLETED|Maintenance Treatment Epoch||45
8241669|NCT01925209|20325068|P1|COMPLETED|Maintenance Treatment Epoch||49
8241670|NCT01925209|20325065|P4|STARTED|Maintenance Treatment Epoch||50
8241671|NCT01925209|20325066|P3|STARTED|Maintenance Treatment Epoch||52
8241672|NCT01925209|20325067|P2|STARTED|Maintenance Treatment Epoch||46
8241673|NCT01925209|20325068|P1|STARTED|Maintenance Treatment Epoch||49
8241674|NCT01925209|20325065|P4|NOT COMPLETED|Treatment Epoch||5
8241675|NCT01925209|20325066|P3|NOT COMPLETED|Treatment Epoch||7
8241676|NCT01925209|20325067|P2|NOT COMPLETED|Treatment Epoch||8
8241677|NCT01925209|20325068|P1|NOT COMPLETED|Treatment Epoch||9
8241678|NCT01925209|20325065|P4|COMPLETED|Treatment Epoch||57
8241679|NCT01925209|20325066|P3|COMPLETED|Treatment Epoch||56
8241680|NCT01925209|20325067|P2|COMPLETED|Treatment Epoch||55
8241681|NCT01925209|20325068|P1|COMPLETED|Treatment Epoch||54
8241682|NCT01925209|20325065|P4|Full Analysis Set|Treatment Epoch||62
8241683|NCT01925209|20325066|P3|Full Analysis Set|Treatment Epoch||63
8241684|NCT01925209|20325067|P2|Full Analysis Set|Treatment Epoch||63
8241685|NCT01925209|20325068|P1|Full Analysis Set|Treatment Epoch||63
8241686|NCT01925209|20325065|P4|STARTED|Treatment Epoch||62
8241687|NCT01925209|20325066|P3|STARTED|Treatment Epoch||63
8241688|NCT01925209|20325067|P2|STARTED|Treatment Epoch||63
8241689|NCT01925209|20325068|P1|STARTED|Treatment Epoch||63
8241690|NCT01925183|20325100|P2|NOT COMPLETED|Overall Study||0
8241691|NCT01925183|20325101|P1|NOT COMPLETED|Overall Study||1
8241692|NCT01925183|20325100|P2|COMPLETED|Overall Study||3
8241693|NCT01925183|20325101|P1|COMPLETED|Overall Study||2
8241694|NCT01925183|20325100|P2|STARTED|Overall Study||3
8241695|NCT01925183|20325101|P1|STARTED|Overall Study||3
8241696|NCT01925170|20325109|P1|NOT COMPLETED|Overall Study||53
8241697|NCT01925170|20325109|P1|COMPLETED|Overall Study||1585
8241698|NCT01925170|20325109|P1|STARTED|Overall Study||1638
8241699|NCT01925144|20325127|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
8241700|NCT01925144|20325127|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
8241701|NCT01925144|20325127|P1|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
8241702|NCT01925144|20325127|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
8241703|NCT01925144|20325127|P1|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
8241704|NCT01925144|20325127|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
8241705|NCT01925144|20325127|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
8241706|NCT01925144|20325127|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
8241707|NCT01925144|20325127|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
8241708|NCT01925014|20325140|P2|NOT COMPLETED|Overall Study||19
8241709|NCT01925014|20325141|P1|NOT COMPLETED|Overall Study||9
8241710|NCT01925014|20325140|P2|COMPLETED|Overall Study||1520
8241711|NCT01925014|20325141|P1|COMPLETED|Overall Study||1526
8241712|NCT01925014|20325140|P2|STARTED|Overall Study||1539
8241713|NCT01925014|20325141|P1|STARTED|Overall Study||1535
8241714|NCT01924988|20325175|P1|NOT COMPLETED|Overall Study||0
8241715|NCT01924988|20325175|P1|COMPLETED|Overall Study||15
8241716|NCT01924988|20325175|P1|STARTED|Overall Study||15
8241717|NCT01924975|20325187|P2|NOT COMPLETED|Overall Study||0
8241718|NCT01924975|20325188|P1|NOT COMPLETED|Overall Study||0
8241719|NCT01924975|20325187|P2|COMPLETED|Overall Study||51
8241720|NCT01924975|20325188|P1|COMPLETED|Overall Study||51
8241721|NCT01924975|20325187|P2|STARTED|Overall Study||51
8241722|NCT01924975|20325188|P1|STARTED|Overall Study||51
8241723|NCT01924949|20325198|P1|NOT COMPLETED|Overall Study||0
8241724|NCT01924949|20325198|P1|COMPLETED|Overall Study||5
8241725|NCT01924949|20325198|P1|STARTED|Overall Study||5
8241726|NCT01924871|20325209|P2|NOT COMPLETED|Overall Study||2
8241727|NCT01924871|20325210|P1|NOT COMPLETED|Overall Study||6
8241728|NCT01924871|20325209|P2|COMPLETED|Overall Study||29
8241729|NCT01924871|20325210|P1|COMPLETED|Overall Study||25
8241730|NCT01924871|20325209|P2|STARTED|Overall Study||31
8241731|NCT01924871|20325210|P1|STARTED|Overall Study||31
8241732|NCT01924845|20325216|P1|NOT COMPLETED|Overall Study||6
8241733|NCT01924845|20325216|P1|COMPLETED|Overall Study||18
8241734|NCT01924845|20325216|P1|STARTED|Overall Study||24
8241735|NCT01924806|20325226|P2|NOT COMPLETED|Overall Study||1
8241736|NCT01924806|20325227|P1|NOT COMPLETED|Overall Study||2
8241737|NCT01924806|20325226|P2|COMPLETED|Overall Study||3
8241738|NCT01924806|20325227|P1|COMPLETED|Overall Study||3
8241739|NCT01924806|20325226|P2|STARTED|Overall Study||4
8241740|NCT01924806|20325227|P1|STARTED|Overall Study||5
8241741|NCT01924767|20325244|P5|NOT COMPLETED|Overall Study||0
8241742|NCT01924767|20325245|P4|NOT COMPLETED|Overall Study||0
8241743|NCT01924767|20325246|P3|NOT COMPLETED|Overall Study||1
8241744|NCT01924767|20325247|P2|NOT COMPLETED|Overall Study||0
8241745|NCT01924767|20325248|P1|NOT COMPLETED|Overall Study||1
8241746|NCT01924767|20325244|P5|COMPLETED|Overall Study||9
8241747|NCT01924767|20325245|P4|COMPLETED|Overall Study||9
8241748|NCT01924767|20325246|P3|COMPLETED|Overall Study||8
8241749|NCT01924767|20325247|P2|COMPLETED|Overall Study||9
8241750|NCT01924767|20325248|P1|COMPLETED|Overall Study||11
8241751|NCT01924767|20325244|P5|STARTED|Overall Study||9
8241752|NCT01924767|20325245|P4|STARTED|Overall Study||9
8241753|NCT01924767|20325246|P3|STARTED|Overall Study||9
8241754|NCT01924767|20325247|P2|STARTED|Overall Study||9
8241755|NCT01924767|20325248|P1|STARTED|Overall Study||12
8241756|NCT01924689|20325354|P6|NOT COMPLETED|Overall Study||2
8241757|NCT01924689|20325355|P5|NOT COMPLETED|Overall Study||6
8241758|NCT01924689|20325356|P4|NOT COMPLETED|Overall Study||6
8241759|NCT01924689|20325357|P3|NOT COMPLETED|Overall Study||4
8241760|NCT01924689|20325358|P2|NOT COMPLETED|Overall Study||3
8241761|NCT01924689|20325359|P1|NOT COMPLETED|Overall Study||3
8241762|NCT01924689|20325354|P6|COMPLETED|Overall Study||0
8241763|NCT01924689|20325355|P5|COMPLETED|Overall Study||0
8241764|NCT01924689|20325356|P4|COMPLETED|Overall Study||0
8241765|NCT01924689|20325357|P3|COMPLETED|Overall Study||0
8241766|NCT01924689|20325358|P2|COMPLETED|Overall Study||0
8241767|NCT01924689|20325359|P1|COMPLETED|Overall Study||0
8241768|NCT01924689|20325354|P6|STARTED|Overall Study||2
8241769|NCT01924689|20325355|P5|STARTED|Overall Study||6
8241770|NCT01924689|20325356|P4|STARTED|Overall Study||6
8241771|NCT01924689|20325357|P3|STARTED|Overall Study||4
8241772|NCT01924689|20325358|P2|STARTED|Overall Study||3
8241773|NCT01924689|20325359|P1|STARTED|Overall Study||3
8241774|NCT01924559|20325417|P1|NOT COMPLETED|Overall Study||0
8241775|NCT01924559|20325417|P1|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
8241776|NCT01924559|20325417|P1|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
8241783|NCT01924442|20325464|P2|NOT COMPLETED|Overall Study||137
8241784|NCT01924442|20325465|P1|NOT COMPLETED|Overall Study||40
8241785|NCT01924442|20325464|P2|COMPLETED|Overall Study||967
8241786|NCT01924442|20325465|P1|COMPLETED|Overall Study||1059
8241787|NCT01924442|20325464|P2|STARTED|Overall Study||1104
8241788|NCT01924442|20325465|P1|STARTED|Overall Study||1099
8241789|NCT01924429|20325475|P2|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
8241790|NCT01924429|20325476|P1|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
8241791|NCT01924429|20325475|P2|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
8241792|NCT01924429|20325476|P1|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
8241793|NCT01924429|20325475|P2|STARTED|Period 2 - Second Intervention (4 Weeks)||11
8241794|NCT01924429|20325476|P1|STARTED|Period 2 - Second Intervention (4 Weeks)||14
8241795|NCT01924429|20325475|P2|NOT COMPLETED|Washout Period (2 Weeks)||2
8241796|NCT01924429|20325476|P1|NOT COMPLETED|Washout Period (2 Weeks)||3
8241797|NCT01924429|20325475|P2|COMPLETED|Washout Period (2 Weeks)||11
8241798|NCT01924429|20325476|P1|COMPLETED|Washout Period (2 Weeks)||14
8241799|NCT01924429|20325475|P2|STARTED|Washout Period (2 Weeks)||13
8241800|NCT01924429|20325476|P1|STARTED|Washout Period (2 Weeks)||17
8241801|NCT01924429|20325475|P2|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
8241802|NCT01924429|20325476|P1|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
8241803|NCT01924429|20325475|P2|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
8241804|NCT01924429|20325476|P1|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
8241805|NCT01924429|20325475|P2|STARTED|Period 1 - First Intervention (4 Weeks)||13
8241806|NCT01924429|20325476|P1|STARTED|Period 1 - First Intervention (4 Weeks)||17
8241807|NCT01924390|20325508|P2|NOT COMPLETED|Overall Study||1
8241808|NCT01924390|20325509|P1|NOT COMPLETED|Overall Study||1
8241809|NCT01924390|20325508|P2|COMPLETED|Overall Study||21
8241810|NCT01924390|20325509|P1|COMPLETED|Overall Study||21
8241811|NCT01924390|20325508|P2|STARTED|Overall Study||22
8241812|NCT01924390|20325509|P1|STARTED|Overall Study||22
8241813|NCT01924364|20325519|P1|NOT COMPLETED|Overall Study||3
8241814|NCT01924364|20325519|P1|COMPLETED|Overall Study||4
8241815|NCT01924364|20325519|P1|STARTED|Overall Study||7
8241816|NCT01924299|20325536|P2|NOT COMPLETED|Period 2||1
8241817|NCT01924299|20325537|P1|NOT COMPLETED|Period 2||1
8241818|NCT01924299|20325536|P2|COMPLETED|Period 2||17
8241819|NCT01924299|20325537|P1|COMPLETED|Period 2||17
8241820|NCT01924299|20325536|P2|Received Baricitinib|Period 2||17
8241821|NCT01924299|20325537|P1|Received Baricitinib|Period 2||17
8241822|NCT01924299|20325536|P2|Received at Least 1 Dose of Study Drug|Period 2||18
8241823|NCT01924299|20325537|P1|Received at Least 1 Dose of Study Drug|Period 2||18
8241824|NCT01924299|20325536|P2|STARTED|Period 2||18
8241825|NCT01924299|20325537|P1|STARTED|Period 2||18
8241826|NCT01924299|20325536|P2|NOT COMPLETED|Period 1||0
8241827|NCT01924299|20325537|P1|NOT COMPLETED|Period 1||0
8241828|NCT01924299|20325536|P2|COMPLETED|Period 1||18
8241829|NCT01924299|20325537|P1|COMPLETED|Period 1||18
8241830|NCT01924299|20325536|P2|Received Baricitinib|Period 1||18
8241831|NCT01924299|20325537|P1|Received Baricitinib|Period 1||18
8241832|NCT01924299|20325536|P2|STARTED|Period 1||18
8241833|NCT01924299|20325537|P1|STARTED|Period 1||18
8241834|NCT01924182|20325559|P2|NOT COMPLETED|Overall Study||0
8241835|NCT01924182|20325560|P1|NOT COMPLETED|Overall Study||1
8241836|NCT01924182|20325559|P2|COMPLETED|Overall Study||0
8241837|NCT01924182|20325560|P1|COMPLETED|Overall Study||2
8241838|NCT01924182|20325559|P2|STARTED|Overall Study||0
8241839|NCT01924182|20325560|P1|STARTED|Overall Study||3
8241840|NCT01924169|20325572|P1|NOT COMPLETED|Overall Study||0
8241841|NCT01924169|20325572|P1|COMPLETED|Overall Study||3
8241842|NCT01924169|20325572|P1|STARTED|Overall Study||3
8241843|NCT01923961|20325580|P3|NOT COMPLETED|Third Intervention||0
8241844|NCT01923961|20325581|P2|NOT COMPLETED|Third Intervention||0
8241845|NCT01923961|20325582|P1|NOT COMPLETED|Third Intervention||0
8241846|NCT01923961|20325580|P3|COMPLETED|Third Intervention||2
8241847|NCT01923961|20325581|P2|COMPLETED|Third Intervention||3
8241848|NCT01923961|20325582|P1|COMPLETED|Third Intervention||3
8241849|NCT01923961|20325580|P3|STARTED|Third Intervention||2
8241850|NCT01923961|20325581|P2|STARTED|Third Intervention||3
8241851|NCT01923961|20325582|P1|STARTED|Third Intervention||3
8241852|NCT01923961|20325580|P3|NOT COMPLETED|Washout (1 Week)||0
8241853|NCT01923961|20325581|P2|NOT COMPLETED|Washout (1 Week)||0
8241854|NCT01923961|20325582|P1|NOT COMPLETED|Washout (1 Week)||0
8241855|NCT01923961|20325580|P3|COMPLETED|Washout (1 Week)||2
8241856|NCT01923961|20325581|P2|COMPLETED|Washout (1 Week)||3
8241857|NCT01923961|20325582|P1|COMPLETED|Washout (1 Week)||3
8241858|NCT01923961|20325580|P3|STARTED|Washout (1 Week)||2
8241859|NCT01923961|20325581|P2|STARTED|Washout (1 Week)||3
8241860|NCT01923961|20325582|P1|STARTED|Washout (1 Week)||3
8241861|NCT01923961|20325580|P3|NOT COMPLETED|Second Intervention||0
8241862|NCT01923961|20325581|P2|NOT COMPLETED|Second Intervention||0
8241863|NCT01923961|20325582|P1|NOT COMPLETED|Second Intervention||0
8241864|NCT01923961|20325580|P3|COMPLETED|Second Intervention||2
8241865|NCT01923961|20325581|P2|COMPLETED|Second Intervention||3
8241866|NCT01923961|20325582|P1|COMPLETED|Second Intervention||3
8241867|NCT01923961|20325580|P3|STARTED|Second Intervention||2
8241868|NCT01923961|20325581|P2|STARTED|Second Intervention||3
8241869|NCT01923961|20325582|P1|STARTED|Second Intervention||3
8241870|NCT01923961|20325580|P3|NOT COMPLETED|Washout (1 Week)||0
8241871|NCT01923961|20325581|P2|NOT COMPLETED|Washout (1 Week)||0
8241872|NCT01923961|20325582|P1|NOT COMPLETED|Washout (1 Week)||0
8241873|NCT01923961|20325580|P3|COMPLETED|Washout (1 Week)||2
8241874|NCT01923961|20325581|P2|COMPLETED|Washout (1 Week)||3
8241875|NCT01923961|20325582|P1|COMPLETED|Washout (1 Week)||3
8241876|NCT01923961|20325580|P3|STARTED|Washout (1 Week)||2
8241877|NCT01923961|20325581|P2|STARTED|Washout (1 Week)||3
8241878|NCT01923961|20325582|P1|STARTED|Washout (1 Week)||3
8241879|NCT01923961|20325580|P3|NOT COMPLETED|First Intervention||0
8241880|NCT01923961|20325581|P2|NOT COMPLETED|First Intervention||0
8241881|NCT01923961|20325582|P1|NOT COMPLETED|First Intervention||0
8241882|NCT01923961|20325580|P3|COMPLETED|First Intervention||2
8241883|NCT01923961|20325581|P2|COMPLETED|First Intervention||3
8241884|NCT01923961|20325582|P1|COMPLETED|First Intervention||3
8241885|NCT01923961|20325580|P3|STARTED|First Intervention||2
8241886|NCT01923961|20325581|P2|STARTED|First Intervention||3
8241887|NCT01923961|20325582|P1|STARTED|First Intervention||3
8241888|NCT01923896|20325601|P2|NOT COMPLETED|Overall Study||0
8241889|NCT01923896|20325602|P1|NOT COMPLETED|Overall Study||1
8241890|NCT01923896|20325601|P2|COMPLETED|Overall Study||8
8241891|NCT01923896|20325602|P1|COMPLETED|Overall Study||7
8241892|NCT01923896|20325601|P2|STARTED|Overall Study||8
8241893|NCT01923896|20325602|P1|STARTED|Overall Study||8
8241894|NCT01923805|20325616|P2|NOT COMPLETED|Overall Study||5
8241895|NCT01923805|20325617|P1|NOT COMPLETED|Overall Study||3
8241896|NCT01923805|20325616|P2|COMPLETED|Overall Study||0
8241897|NCT01923805|20325617|P1|COMPLETED|Overall Study||0
8241898|NCT01923805|20325616|P2|STARTED|Overall Study|early termination|5
8241899|NCT01923805|20325617|P1|STARTED|Overall Study|early termination|3
8241900|NCT01923740|20325625|P2|NOT COMPLETED|Overall Study||9
8241901|NCT01923740|20325626|P1|NOT COMPLETED|Overall Study||6
8241902|NCT01923740|20325625|P2|COMPLETED|Overall Study||223
8241903|NCT01923740|20325626|P1|COMPLETED|Overall Study||221
8241904|NCT01923740|20325625|P2|STARTED|Overall Study||232
8241905|NCT01923740|20325626|P1|STARTED|Overall Study||227
8241906|NCT01923480|20325891|P6|NOT COMPLETED|Period 2 (Hours 1-7)||0
8241907|NCT01923480|20325892|P5|NOT COMPLETED|Period 2 (Hours 1-7)||0
8241908|NCT01923480|20325893|P4|NOT COMPLETED|Period 2 (Hours 1-7)||0
8241909|NCT01923480|20325894|P3|NOT COMPLETED|Period 2 (Hours 1-7)||0
8241910|NCT01923480|20325895|P2|NOT COMPLETED|Period 2 (Hours 1-7)||0
8241911|NCT01923480|20325896|P1|NOT COMPLETED|Period 2 (Hours 1-7)||0
8241912|NCT01923480|20325891|P6|COMPLETED|Period 2 (Hours 1-7)||2
8241913|NCT01923480|20325892|P5|COMPLETED|Period 2 (Hours 1-7)||2
8241914|NCT01923480|20325893|P4|COMPLETED|Period 2 (Hours 1-7)||2
8241915|NCT01923480|20325894|P3|COMPLETED|Period 2 (Hours 1-7)||2
8241916|NCT01923480|20325895|P2|COMPLETED|Period 2 (Hours 1-7)||1
8241917|NCT01923480|20325896|P1|COMPLETED|Period 2 (Hours 1-7)||1
8241918|NCT01923480|20325891|P6|STARTED|Period 2 (Hours 1-7)||2
8241919|NCT01923480|20325892|P5|STARTED|Period 2 (Hours 1-7)||2
8241920|NCT01923480|20325893|P4|STARTED|Period 2 (Hours 1-7)||2
8241921|NCT01923480|20325894|P3|STARTED|Period 2 (Hours 1-7)||2
8241922|NCT01923480|20325895|P2|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
8241923|NCT01923480|20325896|P1|STARTED|Period 2 (Hours 1-7)||1
8241924|NCT01923480|20325891|P6|NOT COMPLETED|Period 1 (Hours 1-7)||0
8241925|NCT01923480|20325892|P5|NOT COMPLETED|Period 1 (Hours 1-7)||0
8241926|NCT01923480|20325893|P4|NOT COMPLETED|Period 1 (Hours 1-7)||0
8241927|NCT01923480|20325894|P3|NOT COMPLETED|Period 1 (Hours 1-7)||0
8241928|NCT01923480|20325895|P2|NOT COMPLETED|Period 1 (Hours 1-7)||0
8241929|NCT01923480|20325896|P1|NOT COMPLETED|Period 1 (Hours 1-7)||0
8241930|NCT01923480|20325891|P6|COMPLETED|Period 1 (Hours 1-7)||2
8241931|NCT01923480|20325892|P5|COMPLETED|Period 1 (Hours 1-7)||2
8241932|NCT01923480|20325893|P4|COMPLETED|Period 1 (Hours 1-7)||2
8241933|NCT01923480|20325894|P3|COMPLETED|Period 1 (Hours 1-7)||2
8241934|NCT01923480|20325895|P2|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
8241935|NCT01923480|20325896|P1|COMPLETED|Period 1 (Hours 1-7)||1
8241936|NCT01923480|20325891|P6|STARTED|Period 1 (Hours 1-7)||2
8241937|NCT01923480|20325892|P5|STARTED|Period 1 (Hours 1-7)||2
8241938|NCT01923480|20325893|P4|STARTED|Period 1 (Hours 1-7)||2
8241939|NCT01923480|20325894|P3|STARTED|Period 1 (Hours 1-7)||2
8241940|NCT01923480|20325895|P2|STARTED|Period 1 (Hours 1-7)||2
8241941|NCT01923480|20325896|P1|STARTED|Period 1 (Hours 1-7)||1
8241942|NCT01923467|20326051|P1|NOT COMPLETED|Overall Study||541
8241943|NCT01923467|20326051|P1|COMPLETED|Overall Study|Completed 3-month follow up survey|226
8241944|NCT01923467|20326051|P1|Baseline Completed, Enrolled|Overall Study||288
8241945|NCT01923467|20326051|P1|STARTED|Overall Study|Offered stop smoking program|767
8241946|NCT01923428|20326059|P4|NOT COMPLETED|Overall Study||10
8241947|NCT01923428|20326060|P3|NOT COMPLETED|Overall Study||11
8241948|NCT01923428|20326061|P2|NOT COMPLETED|Overall Study||12
8241949|NCT01923428|20326062|P1|NOT COMPLETED|Overall Study||19
8241950|NCT01923428|20326059|P4|COMPLETED|Overall Study||80
8241951|NCT01923428|20326060|P3|COMPLETED|Overall Study||78
8241952|NCT01923428|20326061|P2|COMPLETED|Overall Study||77
8241953|NCT01923428|20326062|P1|COMPLETED|Overall Study||69
8241954|NCT01923428|20326059|P4|STARTED|Overall Study||90
8241955|NCT01923428|20326060|P3|STARTED|Overall Study||89
8241956|NCT01923428|20326061|P2|STARTED|Overall Study||89
8241957|NCT01923428|20326062|P1|STARTED|Overall Study||88
8241958|NCT01923389|20326074|P2|NOT COMPLETED|Overall Study||0
8241959|NCT01923389|20326075|P1|NOT COMPLETED|Overall Study||1
8241960|NCT01923389|20326074|P2|COMPLETED|Overall Study||2
8241961|NCT01923389|20326075|P1|COMPLETED|Overall Study||1
8241962|NCT01923389|20326074|P2|STARTED|Overall Study||2
8241963|NCT01923389|20326075|P1|STARTED|Overall Study||2
8241964|NCT01923363|20326097|P1|NOT COMPLETED|Overall Study||1
8241965|NCT01923363|20326097|P1|COMPLETED|Overall Study||28
8241966|NCT01923363|20326097|P1|STARTED|Overall Study||29
8241967|NCT01923311|20326106|P2|NOT COMPLETED|Overall Study||1
8241968|NCT01923311|20326107|P1|NOT COMPLETED|Overall Study||17
8241969|NCT01923311|20326106|P2|COMPLETED|Overall Study||13
8241970|NCT01923311|20326107|P1|COMPLETED|Overall Study||0
8241971|NCT01923311|20326106|P2|STARTED|Overall Study||14
8241972|NCT01923311|20326107|P1|STARTED|Overall Study||17
8241973|NCT01923285|20326152|P2|NOT COMPLETED|Overall Study||6
8241974|NCT01923285|20326153|P1|NOT COMPLETED|Overall Study||7
8241975|NCT01923285|20326152|P2|COMPLETED|Overall Study||70
8241976|NCT01923285|20326153|P1|COMPLETED|Overall Study||69
8241977|NCT01923285|20326152|P2|Modified Intent-to-treat|Overall Study||73
8241978|NCT01923285|20326153|P1|Modified Intent-to-treat|Overall Study||73
8241979|NCT01923285|20326152|P2|STARTED|Overall Study||76
8241980|NCT01923285|20326153|P1|STARTED|Overall Study||76
8241981|NCT01923181|20326174|P9|NOT COMPLETED|Overall Study||3
8241982|NCT01923181|20326175|P8|NOT COMPLETED|Overall Study||8
8241983|NCT01923181|20326176|P7|NOT COMPLETED|Overall Study||8
8241984|NCT01923181|20326177|P6|NOT COMPLETED|Overall Study||4
8241985|NCT01923181|20326178|P5|NOT COMPLETED|Overall Study||8
8241986|NCT01923181|20326179|P4|NOT COMPLETED|Overall Study||5
8241987|NCT01923181|20326180|P3|NOT COMPLETED|Overall Study||2
8241988|NCT01923181|20326181|P2|NOT COMPLETED|Overall Study||6
8241989|NCT01923181|20326182|P1|NOT COMPLETED|Overall Study||3
8241990|NCT01923181|20326174|P9|COMPLETED|Overall Study||68
8241991|NCT01923181|20326175|P8|COMPLETED|Overall Study||61
8241992|NCT01923181|20326176|P7|COMPLETED|Overall Study||62
8241993|NCT01923181|20326177|P6|COMPLETED|Overall Study||66
8241994|NCT01923181|20326178|P5|COMPLETED|Overall Study||63
8241995|NCT01923181|20326179|P4|COMPLETED|Overall Study||65
8241996|NCT01923181|20326180|P3|COMPLETED|Overall Study||67
8241997|NCT01923181|20326181|P2|COMPLETED|Overall Study||64
8241998|NCT01923181|20326182|P1|COMPLETED|Overall Study||67
8241999|NCT01923181|20326174|P9|Safety Analysis Set (SAS)|Overall Study||71
8242000|NCT01923181|20326175|P8|Safety Analysis Set (SAS)|Overall Study||69
8242001|NCT01923181|20326176|P7|Safety Analysis Set (SAS)|Overall Study||70
8242002|NCT01923181|20326177|P6|Safety Analysis Set (SAS)|Overall Study||70
8242003|NCT01923181|20326178|P5|Safety Analysis Set (SAS)|Overall Study||71
8242004|NCT01923181|20326179|P4|Safety Analysis Set (SAS)|Overall Study||70
8242005|NCT01923181|20326180|P3|Safety Analysis Set (SAS)|Overall Study||69
8242006|NCT01923181|20326181|P2|Safety Analysis Set (SAS)|Overall Study||70
8242007|NCT01923181|20326182|P1|Safety Analysis Set (SAS)|Overall Study||70
8242008|NCT01923181|20326174|P9|Full Analysis Set (FAS)|Overall Study||71
8242009|NCT01923181|20326175|P8|Full Analysis Set (FAS)|Overall Study||69
8242010|NCT01923181|20326176|P7|Full Analysis Set (FAS)|Overall Study||70
8242011|NCT01923181|20326177|P6|Full Analysis Set (FAS)|Overall Study||70
8242012|NCT01923181|20326178|P5|Full Analysis Set (FAS)|Overall Study||71
8242013|NCT01923181|20326179|P4|Full Analysis Set (FAS)|Overall Study||70
8242014|NCT01923181|20326180|P3|Full Analysis Set (FAS)|Overall Study||69
8242015|NCT01923181|20326181|P2|Full Analysis Set (FAS)|Overall Study||70
8242016|NCT01923181|20326182|P1|Full Analysis Set (FAS)|Overall Study||70
8242017|NCT01923181|20326174|P9|STARTED|Overall Study||71
8242018|NCT01923181|20326175|P8|STARTED|Overall Study||69
8242019|NCT01923181|20326176|P7|STARTED|Overall Study||70
8242020|NCT01923181|20326177|P6|STARTED|Overall Study||70
8242021|NCT01923181|20326178|P5|STARTED|Overall Study||71
8242022|NCT01923181|20326179|P4|STARTED|Overall Study||70
8242023|NCT01923181|20326180|P3|STARTED|Overall Study||69
8242024|NCT01923181|20326181|P2|STARTED|Overall Study||70
8242025|NCT01923181|20326182|P1|STARTED|Overall Study||70
8242026|NCT01923168|20326260|P3|NOT COMPLETED|Overall Study||17
8242027|NCT01923168|20326261|P2|NOT COMPLETED|Overall Study||39
8242028|NCT01923168|20326262|P1|NOT COMPLETED|Overall Study||37
8242029|NCT01923168|20326260|P3|COMPLETED|Overall Study||109
8242030|NCT01923168|20326261|P2|COMPLETED|Overall Study||44
8242031|NCT01923168|20326262|P1|COMPLETED|Overall Study||94
8242032|NCT01923168|20326260|P3|STARTED|Overall Study||126
8242033|NCT01923168|20326261|P2|STARTED|Overall Study||83
8242034|NCT01923168|20326262|P1|STARTED|Overall Study||131
8242035|NCT01923129|20326321|P2|NOT COMPLETED|Overall Study||0
8242036|NCT01923129|20326322|P1|NOT COMPLETED|Overall Study||0
8242037|NCT01923129|20326321|P2|COMPLETED|Overall Study||71
8242038|NCT01923129|20326322|P1|COMPLETED|Overall Study||71
8242039|NCT01923129|20326321|P2|STARTED|Overall Study||71
8242040|NCT01923129|20326322|P1|STARTED|Overall Study||71
8242041|NCT01922986|20326332|P2|NOT COMPLETED|Overall Study||0
8242042|NCT01922986|20326333|P1|NOT COMPLETED|Overall Study||0
8242043|NCT01922986|20326332|P2|COMPLETED|Overall Study||2
8242044|NCT01922986|20326333|P1|COMPLETED|Overall Study||2
8242045|NCT01922986|20326332|P2|STARTED|Overall Study||2
8242046|NCT01922986|20326333|P1|STARTED|Overall Study||2
8242047|NCT01922934|20326345|P2|NOT COMPLETED|Visit 12 / Final Visits||290
8242048|NCT01922934|20326346|P1|NOT COMPLETED|Visit 12 / Final Visits||6
8242049|NCT01922934|20326345|P2|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
8242050|NCT01922934|20326346|P1|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
8242051|NCT01922934|20326345|P2|STARTED|Visit 12 / Final Visits||2930
8242052|NCT01922934|20326346|P1|STARTED|Visit 12 / Final Visits||119
8242053|NCT01922934|20326345|P2|NOT COMPLETED|Visit 1- Weight Measured||1284
8242054|NCT01922934|20326346|P1|NOT COMPLETED|Visit 1- Weight Measured||21
8242055|NCT01922934|20326345|P2|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
8242056|NCT01922934|20326346|P1|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
8242057|NCT01922934|20326345|P2|STARTED|Visit 1- Weight Measured||4214
8242058|NCT01922934|20326346|P1|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
8242059|NCT01922934|20326345|P2|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
8242060|NCT01922934|20326346|P1|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
8242061|NCT01922934|20326345|P2|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
8242062|NCT01922934|20326346|P1|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
8242063|NCT01922934|20326345|P2|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
8242064|NCT01922934|20326346|P1|STARTED|Visit 0 - Patient Contacted & Consented||375
8242065|NCT01922934|20326345|P2|NOT COMPLETED|Eligible Patients||88
8242066|NCT01922934|20326346|P1|NOT COMPLETED|Eligible Patients||53
8242067|NCT01922934|20326345|P2|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
8242068|NCT01922934|20326346|P1|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
8242069|NCT01922934|20326345|P2|STARTED|Eligible Patients||4302
8242070|NCT01922934|20326346|P1|STARTED|Eligible Patients||428
8242071|NCT01922739|20326358|P1|NOT COMPLETED|Open-label Treatment Period||34
8242072|NCT01922739|20326358|P1|COMPLETED|Open-label Treatment Period||136
8242073|NCT01922739|20326358|P1|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
8242074|NCT01922739|20326358|P1|STARTED|Open-label Treatment Period||170
8242075|NCT01922739|20326358|P1|NOT COMPLETED|Titration/Adjustment Period||12
8242076|NCT01922739|20326358|P1|COMPLETED|Titration/Adjustment Period||170
8242077|NCT01922739|20326358|P1|Safety Analysis Set|Titration/Adjustment Period||182
8242078|NCT01922739|20326358|P1|STARTED|Titration/Adjustment Period||182
8242079|NCT01922349|20326387|P4|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
8242080|NCT01922349|20326388|P3|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
8242081|NCT01922349|20326389|P2|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
8242082|NCT01922349|20326390|P1|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
8242083|NCT01922349|20326387|P4|COMPLETED|Multiple Rising Dose (MRD) Period||26
8242084|NCT01922349|20326388|P3|COMPLETED|Multiple Rising Dose (MRD) Period||18
8242085|NCT01922349|20326389|P2|COMPLETED|Multiple Rising Dose (MRD) Period||27
8242086|NCT01922349|20326390|P1|COMPLETED|Multiple Rising Dose (MRD) Period||24
8242087|NCT01922349|20326387|P4|STARTED|Multiple Rising Dose (MRD) Period||27
8242088|NCT01922349|20326388|P3|STARTED|Multiple Rising Dose (MRD) Period||18
8242089|NCT01922349|20326389|P2|STARTED|Multiple Rising Dose (MRD) Period||27
8242090|NCT01922349|20326390|P1|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
8242091|NCT01922349|20326387|P4|NOT COMPLETED|Single Rising Dose (SRD) Period||0
8242092|NCT01922349|20326388|P3|NOT COMPLETED|Single Rising Dose (SRD) Period||0
8242093|NCT01922349|20326389|P2|NOT COMPLETED|Single Rising Dose (SRD) Period||0
8242094|NCT01922349|20326390|P1|NOT COMPLETED|Single Rising Dose (SRD) Period||0
8242095|NCT01922349|20326387|P4|COMPLETED|Single Rising Dose (SRD) Period||27
8242096|NCT01922349|20326388|P3|COMPLETED|Single Rising Dose (SRD) Period||18
8242097|NCT01922349|20326389|P2|COMPLETED|Single Rising Dose (SRD) Period||27
8242098|NCT01922349|20326390|P1|COMPLETED|Single Rising Dose (SRD) Period||25
8242099|NCT01922349|20326387|P4|STARTED|Single Rising Dose (SRD) Period||27
8242100|NCT01922349|20326388|P3|STARTED|Single Rising Dose (SRD) Period||18
8242101|NCT01922349|20326389|P2|STARTED|Single Rising Dose (SRD) Period||27
8242102|NCT01922349|20326390|P1|STARTED|Single Rising Dose (SRD) Period||25
8242103|NCT01922336|20326498|P3|NOT COMPLETED|Overall Study||0
8242104|NCT01922336|20326499|P2|NOT COMPLETED|Overall Study||0
8242105|NCT01922336|20326500|P1|NOT COMPLETED|Overall Study||0
8242106|NCT01922336|20326498|P3|COMPLETED|Overall Study||53
8242107|NCT01922336|20326499|P2|COMPLETED|Overall Study||53
8242108|NCT01922336|20326500|P1|COMPLETED|Overall Study||53
8242109|NCT01922336|20326498|P3|STARTED|Overall Study||53
8242110|NCT01922336|20326499|P2|STARTED|Overall Study||53
8242111|NCT01922336|20326500|P1|STARTED|Overall Study||53
8242112|NCT01922271|20326519|P2|NOT COMPLETED|PERIOD 2||0
8242113|NCT01922271|20326520|P1|NOT COMPLETED|PERIOD 2||0
8242114|NCT01922271|20326519|P2|COMPLETED|PERIOD 2||76
8242115|NCT01922271|20326520|P1|COMPLETED|PERIOD 2||75
8242116|NCT01922271|20326519|P2|STARTED|PERIOD 2||76
8242117|NCT01922271|20326520|P1|STARTED|PERIOD 2||75
8242118|NCT01922271|20326519|P2|NOT COMPLETED|WASHOUT Period||0
8242119|NCT01922271|20326520|P1|NOT COMPLETED|WASHOUT Period||1
8242120|NCT01922271|20326519|P2|COMPLETED|WASHOUT Period||76
8242121|NCT01922271|20326520|P1|COMPLETED|WASHOUT Period||75
8242122|NCT01922271|20326519|P2|STARTED|WASHOUT Period||76
8242123|NCT01922271|20326520|P1|STARTED|WASHOUT Period||76
8242124|NCT01922271|20326519|P2|NOT COMPLETED|PERIOD 1||0
8242125|NCT01922271|20326520|P1|NOT COMPLETED|PERIOD 1||0
8242126|NCT01922271|20326519|P2|COMPLETED|PERIOD 1||76
8242127|NCT01922271|20326520|P1|COMPLETED|PERIOD 1||76
8242128|NCT01922271|20326519|P2|STARTED|PERIOD 1||76
8242129|NCT01922271|20326520|P1|STARTED|PERIOD 1||76
8242130|NCT01922258|20326540|P2|NOT COMPLETED|Overall Study||16
8242131|NCT01922258|20326541|P1|NOT COMPLETED|Overall Study||16
8242132|NCT01922258|20326540|P2|COMPLETED|Overall Study||121
8242133|NCT01922258|20326541|P1|COMPLETED|Overall Study||117
8242134|NCT01922258|20326540|P2|STARTED|Overall Study||137
8242135|NCT01922258|20326541|P1|STARTED|Overall Study||133
8242136|NCT01922219|20326549|P1|NOT COMPLETED|Overall Study||9
8242137|NCT01922219|20326549|P1|COMPLETED|Overall Study||28
8242138|NCT01922219|20326549|P1|STARTED|Overall Study||37
8242139|NCT01922115|20326557|P2|NOT COMPLETED|Overall Study||7
8242140|NCT01922115|20326558|P1|NOT COMPLETED|Overall Study||7
8242141|NCT01922115|20326557|P2|COMPLETED|Overall Study||24
8242142|NCT01922115|20326558|P1|COMPLETED|Overall Study||21
8242143|NCT01922115|20326557|P2|STARTED|Overall Study||31
8242144|NCT01922115|20326558|P1|STARTED|Overall Study||28
8242145|NCT01922102|20326573|P3|NOT COMPLETED|Overall Study||8
8242146|NCT01922102|20326574|P2|NOT COMPLETED|Overall Study||9
8242147|NCT01922102|20326575|P1|NOT COMPLETED|Overall Study||9
8242148|NCT01922102|20326573|P3|COMPLETED|Overall Study||83
8242149|NCT01922102|20326574|P2|COMPLETED|Overall Study||175
8242150|NCT01922102|20326575|P1|COMPLETED|Overall Study||173
8242151|NCT01922102|20326573|P3|STARTED|Overall Study||91
8242152|NCT01922102|20326574|P2|STARTED|Overall Study||184
8242153|NCT01922102|20326575|P1|STARTED|Overall Study||182
8242154|NCT01922089|20326611|P2|NOT COMPLETED|Overall Study||30
8242155|NCT01922089|20326612|P1|NOT COMPLETED|Overall Study||39
8242156|NCT01922089|20326611|P2|COMPLETED|Overall Study||221
8242157|NCT01922089|20326612|P1|COMPLETED|Overall Study||208
8242158|NCT01922089|20326611|P2|Safety Set|Overall Study||251
8242159|NCT01922089|20326612|P1|Safety Set|Overall Study||246
8242160|NCT01922089|20326611|P2|STARTED|Overall Study||251
8242161|NCT01922089|20326612|P1|STARTED|Overall Study||247
8242162|NCT01922050|20326636|P14|NOT COMPLETED|Part 2 Double-blind Phase||3
8242163|NCT01922050|20326637|P13|NOT COMPLETED|Part 2 Double-blind Phase||0
8242164|NCT01922050|20326638|P12|NOT COMPLETED|Part 2 Double-blind Phase||2
8242165|NCT01922050|20326639|P11|NOT COMPLETED|Part 2 Double-blind Phase||1
8242166|NCT01922050|20326640|P10|NOT COMPLETED|Part 2 Double-blind Phase||0
8242167|NCT01922050|20326641|P9|NOT COMPLETED|Part 2 Double-blind Phase||0
8242168|NCT01922050|20326642|P8|NOT COMPLETED|Part 2 Double-blind Phase||0
8242169|NCT01922050|20326643|P7|NOT COMPLETED|Part 2 Double-blind Phase||0
8242170|NCT01922050|20326644|P6|NOT COMPLETED|Part 2 Double-blind Phase||0
8242171|NCT01922050|20326645|P5|NOT COMPLETED|Part 2 Double-blind Phase||0
8242172|NCT01922050|20326646|P4|NOT COMPLETED|Part 2 Double-blind Phase||0
8242173|NCT01922050|20326647|P3|NOT COMPLETED|Part 2 Double-blind Phase||0
8242174|NCT01922050|20326648|P2|NOT COMPLETED|Part 2 Double-blind Phase||0
8242175|NCT01922050|20326649|P1|NOT COMPLETED|Part 2 Double-blind Phase||0
8242176|NCT01922050|20326636|P14|COMPLETED|Part 2 Double-blind Phase||56
8242177|NCT01922050|20326637|P13|COMPLETED|Part 2 Double-blind Phase||62
8242178|NCT01922050|20326638|P12|COMPLETED|Part 2 Double-blind Phase||58
8242179|NCT01922050|20326639|P11|COMPLETED|Part 2 Double-blind Phase||61
8242180|NCT01922050|20326640|P10|COMPLETED|Part 2 Double-blind Phase||0
8242181|NCT01922050|20326641|P9|COMPLETED|Part 2 Double-blind Phase||0
8242182|NCT01922050|20326642|P8|COMPLETED|Part 2 Double-blind Phase||0
8242183|NCT01922050|20326643|P7|COMPLETED|Part 2 Double-blind Phase||0
8242184|NCT01922050|20326644|P6|COMPLETED|Part 2 Double-blind Phase||0
8242185|NCT01922050|20326645|P5|COMPLETED|Part 2 Double-blind Phase||0
8242186|NCT01922050|20326646|P4|COMPLETED|Part 2 Double-blind Phase||0
8242187|NCT01922050|20326647|P3|COMPLETED|Part 2 Double-blind Phase||0
8242188|NCT01922050|20326648|P2|COMPLETED|Part 2 Double-blind Phase||0
8242189|NCT01922050|20326649|P1|COMPLETED|Part 2 Double-blind Phase||0
8242190|NCT01922050|20326636|P14|STARTED|Part 2 Double-blind Phase||59
8242191|NCT01922050|20326637|P13|STARTED|Part 2 Double-blind Phase||62
8242192|NCT01922050|20326638|P12|STARTED|Part 2 Double-blind Phase||60
8242193|NCT01922050|20326639|P11|STARTED|Part 2 Double-blind Phase||62
8242194|NCT01922050|20326640|P10|STARTED|Part 2 Double-blind Phase||0
8242195|NCT01922050|20326641|P9|STARTED|Part 2 Double-blind Phase||0
8242196|NCT01922050|20326642|P8|STARTED|Part 2 Double-blind Phase||0
8242197|NCT01922050|20326643|P7|STARTED|Part 2 Double-blind Phase||0
8242198|NCT01922050|20326644|P6|STARTED|Part 2 Double-blind Phase||0
8242199|NCT01922050|20326645|P5|STARTED|Part 2 Double-blind Phase||0
8242200|NCT01922050|20326646|P4|STARTED|Part 2 Double-blind Phase||0
8242201|NCT01922050|20326647|P3|STARTED|Part 2 Double-blind Phase||0
8242202|NCT01922050|20326648|P2|STARTED|Part 2 Double-blind Phase||0
8242203|NCT01922050|20326649|P1|STARTED|Part 2 Double-blind Phase||0
8242204|NCT01922050|20326636|P14|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242205|NCT01922050|20326637|P13|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242206|NCT01922050|20326638|P12|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242207|NCT01922050|20326639|P11|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242208|NCT01922050|20326640|P10|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242209|NCT01922050|20326641|P9|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242210|NCT01922050|20326642|P8|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242211|NCT01922050|20326643|P7|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242212|NCT01922050|20326644|P6|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242213|NCT01922050|20326645|P5|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242214|NCT01922050|20326646|P4|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242215|NCT01922050|20326647|P3|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242216|NCT01922050|20326648|P2|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242217|NCT01922050|20326649|P1|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242218|NCT01922050|20326636|P14|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242219|NCT01922050|20326637|P13|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242220|NCT01922050|20326638|P12|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242221|NCT01922050|20326639|P11|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
8242222|NCT01922050|20326640|P10|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
8242223|NCT01922050|20326641|P9|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
8242224|NCT01922050|20326642|P8|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
8242225|NCT01922050|20326643|P7|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
8242226|NCT01922050|20326644|P6|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18
8242227|NCT01922050|20326645|P5|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17
8242228|NCT01922050|20326646|P4|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
8242229|NCT01922050|20326647|P3|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
8242230|NCT01922050|20326648|P2|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
8242231|NCT01922050|20326649|P1|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
8242232|NCT01922050|20326636|P14|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8242233|NCT01922050|20326637|P13|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8242234|NCT01922050|20326638|P12|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8242235|NCT01922050|20326639|P11|STARTED|Part 1 Open-label, Dose-escalation Phase||0
8242236|NCT01922050|20326640|P10|STARTED|Part 1 Open-label, Dose-escalation Phase||12
8242237|NCT01922050|20326641|P9|STARTED|Part 1 Open-label, Dose-escalation Phase||6
8242238|NCT01922050|20326642|P8|STARTED|Part 1 Open-label, Dose-escalation Phase||3
8242239|NCT01922050|20326643|P7|STARTED|Part 1 Open-label, Dose-escalation Phase||3
8242240|NCT01922050|20326644|P6|STARTED|Part 1 Open-label, Dose-escalation Phase||18
8242241|NCT01922050|20326645|P5|STARTED|Part 1 Open-label, Dose-escalation Phase||17
8242242|NCT01922050|20326646|P4|STARTED|Part 1 Open-label, Dose-escalation Phase||6
8242243|NCT01922050|20326647|P3|STARTED|Part 1 Open-label, Dose-escalation Phase||6
8242244|NCT01922050|20326648|P2|STARTED|Part 1 Open-label, Dose-escalation Phase||3
8242245|NCT01922050|20326649|P1|STARTED|Part 1 Open-label, Dose-escalation Phase||3
8242246|NCT01922037|20326689|P2|NOT COMPLETED|Overall Study||174
8242247|NCT01922037|20326690|P1|NOT COMPLETED|Overall Study||10
8242248|NCT01922037|20326689|P2|COMPLETED|Overall Study||563
8242249|NCT01922037|20326690|P1|COMPLETED|Overall Study||59
8242250|NCT01922037|20326689|P2|Treated|Overall Study||732
8242251|NCT01922037|20326690|P1|Treated|Overall Study||69
8242252|NCT01922037|20326689|P2|STARTED|Overall Study||737
8242253|NCT01922037|20326690|P1|STARTED|Overall Study||69
8242254|NCT01922024|20326784|P2|NOT COMPLETED|Overall Study||0
8242255|NCT01922024|20326785|P1|NOT COMPLETED|Overall Study||0
8242256|NCT01922024|20326784|P2|COMPLETED|Overall Study||471
8242257|NCT01922024|20326785|P1|COMPLETED|Overall Study||1653
8242258|NCT01922024|20326784|P2|STARTED|Overall Study||471
8242259|NCT01922024|20326785|P1|STARTED|Overall Study||1653
8242260|NCT01922011|20326793|P2|NOT COMPLETED|Overall Study||5
8242261|NCT01922011|20326794|P1|NOT COMPLETED|Overall Study||6
8242262|NCT01922011|20326793|P2|COMPLETED|Overall Study||69
8242263|NCT01922011|20326794|P1|COMPLETED|Overall Study||69
8242264|NCT01922011|20326793|P2|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
8242265|NCT01922011|20326794|P1|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
8242266|NCT01922011|20326793|P2|Treated|Overall Study|Treated Participants|73
8242267|NCT01922011|20326794|P1|Treated|Overall Study|Treated Participants|73
8242268|NCT01922011|20326793|P2|STARTED|Overall Study|Randomized participants|74
8242269|NCT01922011|20326794|P1|STARTED|Overall Study|Randomized participants|75
8242270|NCT01921894|20326837|P3|NOT COMPLETED|Overall Study||0
8242271|NCT01921894|20326838|P2|NOT COMPLETED|Overall Study||0
8242272|NCT01921894|20326839|P1|NOT COMPLETED|Overall Study||0
8242273|NCT01921894|20326837|P3|COMPLETED|Overall Study||8
8242274|NCT01921894|20326838|P2|COMPLETED|Overall Study||8
8242275|NCT01921894|20326839|P1|COMPLETED|Overall Study||8
8242276|NCT01921894|20326837|P3|STARTED|Overall Study||8
8242277|NCT01921894|20326838|P2|STARTED|Overall Study||8
8242278|NCT01921894|20326839|P1|STARTED|Overall Study||8
8242279|NCT01921829|20326861|P2|NOT COMPLETED|Overall Study||1
8242280|NCT01921829|20326862|P1|NOT COMPLETED|Overall Study||0
8242281|NCT01921829|20326861|P2|COMPLETED|Overall Study||8
8242282|NCT01921829|20326862|P1|COMPLETED|Overall Study||10
8242283|NCT01921829|20326861|P2|STARTED|Overall Study||9
8242284|NCT01921829|20326862|P1|STARTED|Overall Study||10
8242285|NCT01921751|20326911|P3|NOT COMPLETED|Overall Study||0
8242286|NCT01921751|20326912|P2|NOT COMPLETED|Overall Study||0
8242287|NCT01921751|20326913|P1|NOT COMPLETED|Overall Study||0
8242288|NCT01921751|20326911|P3|COMPLETED|Overall Study|All randomized patients are reported here.|5
8242289|NCT01921751|20326912|P2|COMPLETED|Overall Study|All randomized patients are reported here.|4
8242290|NCT01921751|20326913|P1|COMPLETED|Overall Study|All randomized patients are reported here.|4
8242291|NCT01921751|20326911|P3|STARTED|Overall Study||5
8242292|NCT01921751|20326912|P2|STARTED|Overall Study||4
8242293|NCT01921751|20326913|P1|STARTED|Overall Study||4
8242294|NCT01921634|20326931|P1|NOT COMPLETED|Overall Study||0
8242295|NCT01921634|20326931|P1|COMPLETED|Overall Study||300
8242296|NCT01921634|20326931|P1|STARTED|Overall Study||300
8242297|NCT01921517|20326938|P2|NOT COMPLETED|Overall Study||9
8242298|NCT01921517|20326939|P1|NOT COMPLETED|Overall Study||15
8242299|NCT01921517|20326938|P2|COMPLETED|Overall Study||29
8242300|NCT01921517|20326939|P1|COMPLETED|Overall Study||27
8242301|NCT01921517|20326938|P2|STARTED|Overall Study||38
8242302|NCT01921517|20326939|P1|STARTED|Overall Study||42
8242303|NCT01921452|20326945|P1|NOT COMPLETED|Overall Study||0
8242304|NCT01921452|20326945|P1|COMPLETED|Overall Study||283
8242305|NCT01921452|20326945|P1|STARTED|Overall Study||283
8242306|NCT01921387|20326950|P1|NOT COMPLETED|Overall Study||1
8242307|NCT01921387|20326950|P1|COMPLETED|Overall Study||19
8242308|NCT01921387|20326950|P1|STARTED|Overall Study||20
8242309|NCT01921348|20326959|P2|NOT COMPLETED|Overall Study||2
8242310|NCT01921348|20326960|P1|NOT COMPLETED|Overall Study||1
8242311|NCT01921348|20326959|P2|COMPLETED|Overall Study||7
8242312|NCT01921348|20326960|P1|COMPLETED|Overall Study||8
8242313|NCT01921348|20326959|P2|STARTED|Overall Study||9
8242314|NCT01921348|20326960|P1|STARTED|Overall Study||9
8242315|NCT01921322|20326972|P2|NOT COMPLETED|Overall Study||17
8242316|NCT01921322|20326973|P1|NOT COMPLETED|Overall Study||15
8242317|NCT01921322|20326972|P2|COMPLETED|Overall Study||44
8242318|NCT01921322|20326973|P1|COMPLETED|Overall Study||42
8242319|NCT01921322|20326972|P2|STARTED|Overall Study||61
8242320|NCT01921322|20326973|P1|STARTED|Overall Study||57
8242321|NCT01921296|20326981|P1|NOT COMPLETED|Overall Study||0
8242322|NCT01921296|20326981|P1|COMPLETED|Overall Study||2
8242323|NCT01921296|20326981|P1|STARTED|Overall Study||2
8242324|NCT01921270|20326989|P1|NOT COMPLETED|Overall Study||1
8242325|NCT01921270|20326989|P1|COMPLETED|Overall Study||17
8242326|NCT01921270|20326989|P1|STARTED|Overall Study||18
8242327|NCT01921257|20327005|P1|NOT COMPLETED|Overall Study||3
8242328|NCT01921257|20327005|P1|COMPLETED|Overall Study||13
8242329|NCT01921257|20327005|P1|Active Treatment|Overall Study||13
8242330|NCT01921257|20327005|P1|Placebo run-in|Overall Study||16
8242331|NCT01921257|20327005|P1|STARTED|Overall Study||16
8242332|NCT01921218|20327012|P2|NOT COMPLETED|Overall Study||4
8242333|NCT01921218|20327013|P1|NOT COMPLETED|Overall Study||3
8242334|NCT01921218|20327012|P2|COMPLETED|Overall Study||3
8242335|NCT01921218|20327013|P1|COMPLETED|Overall Study||3
8242336|NCT01921218|20327012|P2|STARTED|Overall Study||7
8242337|NCT01921218|20327013|P1|STARTED|Overall Study||6
8242338|NCT01921205|20327029|P2|NOT COMPLETED|Overall Study||20
8242339|NCT01921205|20327030|P1|NOT COMPLETED|Overall Study||21
8242340|NCT01921205|20327029|P2|COMPLETED|Overall Study||151
8242341|NCT01921205|20327030|P1|COMPLETED|Overall Study||151
8242342|NCT01921205|20327029|P2|STARTED|Overall Study||171
8242343|NCT01921205|20327030|P1|STARTED|Overall Study||172
8242344|NCT01921179|20327060|P2|NOT COMPLETED|Long Term Follow-up After GOALS Training||0
8242345|NCT01921179|20327061|P1|NOT COMPLETED|Long Term Follow-up After GOALS Training||2
8242346|NCT01921179|20327060|P2|COMPLETED|Long Term Follow-up After GOALS Training||0
8242347|NCT01921179|20327061|P1|COMPLETED|Long Term Follow-up After GOALS Training||32
8242348|NCT01921179|20327060|P2|STARTED|Long Term Follow-up After GOALS Training|13 out of 19 participants who completed EDU, also completed GOALS training|0
8242349|NCT01921179|20327061|P1|STARTED|Long Term Follow-up After GOALS Training||34
8242350|NCT01921179|20327060|P2|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
8242351|NCT01921179|20327061|P1|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
8242352|NCT01921179|20327060|P2|COMPLETED|5 Week Randomized GOALS vs EDU Training||19
8242353|NCT01921179|20327061|P1|COMPLETED|5 Week Randomized GOALS vs EDU Training||21
8242354|NCT01921179|20327060|P2|STARTED|5 Week Randomized GOALS vs EDU Training||22
8242355|NCT01921179|20327061|P1|STARTED|5 Week Randomized GOALS vs EDU Training||24
8242362|NCT01921114|20327087|P2|NOT COMPLETED|Overall Study||0
8242363|NCT01921114|20327088|P1|NOT COMPLETED|Overall Study||0
8242364|NCT01921114|20327087|P2|COMPLETED|Overall Study||0
8242365|NCT01921114|20327088|P1|COMPLETED|Overall Study||0
8242366|NCT01921114|20327087|P2|STARTED|Overall Study||0
8242367|NCT01921114|20327088|P1|STARTED|Overall Study||0
8242368|NCT01921101|20327098|P2|NOT COMPLETED|Overall Study||6
8242369|NCT01921101|20327099|P1|NOT COMPLETED|Overall Study||16
8242370|NCT01921101|20327098|P2|COMPLETED|Overall Study||32
8242371|NCT01921101|20327099|P1|COMPLETED|Overall Study||24
8242372|NCT01921101|20327098|P2|STARTED|Overall Study||38
8242373|NCT01921101|20327099|P1|STARTED|Overall Study||40
8242374|NCT01920958|20327107|P1|NOT COMPLETED|Overall Study||5
8242375|NCT01920958|20327107|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
8242376|NCT01920958|20327107|P1|STARTED|Overall Study||233
8242377|NCT01920893|20327125|P2|NOT COMPLETED|Overall Study||2
8242378|NCT01920893|20327126|P1|NOT COMPLETED|Overall Study||7
8242379|NCT01920893|20327125|P2|COMPLETED|Overall Study||28
8242380|NCT01920893|20327126|P1|COMPLETED|Overall Study||23
8242381|NCT01920893|20327125|P2|Treated (Safety Population)|Overall Study||30
8242382|NCT01920893|20327126|P1|Treated (Safety Population)|Overall Study||30
8242383|NCT01920893|20327125|P2|STARTED|Overall Study||30
8242384|NCT01920893|20327126|P1|STARTED|Overall Study||30
8242385|NCT01920854|20327159|P7|NOT COMPLETED|Overall Study||1
8242386|NCT01920854|20327160|P6|NOT COMPLETED|Overall Study||0
8242387|NCT01920854|20327161|P5|NOT COMPLETED|Overall Study||1
8242388|NCT01920854|20327162|P4|NOT COMPLETED|Overall Study||0
8242389|NCT01920854|20327163|P3|NOT COMPLETED|Overall Study||0
8242390|NCT01920854|20327164|P2|NOT COMPLETED|Overall Study||0
8242391|NCT01920854|20327165|P1|NOT COMPLETED|Overall Study||1
8242392|NCT01920854|20327159|P7|COMPLETED|Overall Study||5
8242393|NCT01920854|20327160|P6|COMPLETED|Overall Study||6
8242394|NCT01920854|20327161|P5|COMPLETED|Overall Study||5
8242395|NCT01920854|20327162|P4|COMPLETED|Overall Study||6
8242396|NCT01920854|20327163|P3|COMPLETED|Overall Study||6
8242397|NCT01920854|20327164|P2|COMPLETED|Overall Study||6
8242398|NCT01920854|20327165|P1|COMPLETED|Overall Study||11
8242399|NCT01920854|20327159|P7|STARTED|Overall Study||6
8242400|NCT01920854|20327160|P6|STARTED|Overall Study||6
8242401|NCT01920854|20327161|P5|STARTED|Overall Study||6
8242402|NCT01920854|20327162|P4|STARTED|Overall Study||6
8242403|NCT01920854|20327163|P3|STARTED|Overall Study||6
8242404|NCT01920854|20327164|P2|STARTED|Overall Study||6
8242405|NCT01920854|20327165|P1|STARTED|Overall Study||12
8242406|NCT01920802|20327292|P3|NOT COMPLETED|Overall Study||1
8242407|NCT01920802|20327293|P2|NOT COMPLETED|Overall Study||2
8242408|NCT01920802|20327294|P1|NOT COMPLETED|Overall Study||4
8242409|NCT01920802|20327292|P3|COMPLETED|Overall Study||10
8242410|NCT01920802|20327293|P2|COMPLETED|Overall Study||7
8242411|NCT01920802|20327294|P1|COMPLETED|Overall Study||7
8242412|NCT01920802|20327292|P3|STARTED|Overall Study||11
8242413|NCT01920802|20327293|P2|STARTED|Overall Study||9
8242414|NCT01920802|20327294|P1|STARTED|Overall Study||11
8242415|NCT01920711|20327325|P2|NOT COMPLETED|Overall Study||373
8242416|NCT01920711|20327326|P1|NOT COMPLETED|Overall Study||364
8242417|NCT01920711|20327325|P2|COMPLETED|Overall Study||2030
8242418|NCT01920711|20327326|P1|COMPLETED|Overall Study||2055
8242419|NCT01920711|20327325|P2|STARTED|Overall Study||2403
8242420|NCT01920711|20327326|P1|STARTED|Overall Study||2419
8242421|NCT01920594|20327343|P2|NOT COMPLETED|Overall Study||3
8242422|NCT01920594|20327344|P1|NOT COMPLETED|Overall Study||7
8242423|NCT01920594|20327343|P2|COMPLETED|Overall Study||25
8242424|NCT01920594|20327344|P1|COMPLETED|Overall Study||20
8242425|NCT01920594|20327343|P2|STARTED|Overall Study||28
8242426|NCT01920594|20327344|P1|STARTED|Overall Study||27
8242427|NCT01920568|20327394|P2|NOT COMPLETED|Overall Study||84
8242428|NCT01920568|20327395|P1|NOT COMPLETED|Overall Study||151
8242429|NCT01920568|20327394|P2|COMPLETED|Overall Study||75
8242430|NCT01920568|20327395|P1|COMPLETED|Overall Study||175
8242431|NCT01920568|20327394|P2|STARTED|Overall Study||159
8242432|NCT01920568|20327395|P1|STARTED|Overall Study||326
8242433|NCT01920555|20327421|P5|NOT COMPLETED|Overall Study||1
8242434|NCT01920555|20327422|P4|NOT COMPLETED|Overall Study||3
8242435|NCT01920555|20327423|P3|NOT COMPLETED|Overall Study||1
8242436|NCT01920555|20327424|P2|NOT COMPLETED|Overall Study||4
8242437|NCT01920555|20327425|P1|NOT COMPLETED|Overall Study||4
8242438|NCT01920555|20327421|P5|COMPLETED|Overall Study||18
8242439|NCT01920555|20327422|P4|COMPLETED|Overall Study||17
8242440|NCT01920555|20327423|P3|COMPLETED|Overall Study||21
8242441|NCT01920555|20327424|P2|COMPLETED|Overall Study||16
8242442|NCT01920555|20327425|P1|COMPLETED|Overall Study||14
8242443|NCT01920555|20327421|P5|STARTED|Overall Study||19
8242444|NCT01920555|20327422|P4|STARTED|Overall Study||20
8242445|NCT01920555|20327423|P3|STARTED|Overall Study||22
8242446|NCT01920555|20327424|P2|STARTED|Overall Study||20
8242447|NCT01920555|20327425|P1|STARTED|Overall Study||18
8242448|NCT01920477|20327484|P2|NOT COMPLETED|Overall Study||17
8242449|NCT01920477|20327485|P1|NOT COMPLETED|Overall Study||15
8242450|NCT01920477|20327484|P2|COMPLETED|Overall Study||1
8242451|NCT01920477|20327485|P1|COMPLETED|Overall Study||2
8242452|NCT01920477|20327484|P2|Requiried Individualized Follow-up|Overall Study||0
8242453|NCT01920477|20327485|P1|Requiried Individualized Follow-up|Overall Study||1
8242454|NCT01920477|20327484|P2|STARTED|Overall Study||18
8242455|NCT01920477|20327485|P1|STARTED|Overall Study||17
8242456|NCT01920282|20327519|P3|NOT COMPLETED|Overall Study||0
8242457|NCT01920282|20327520|P2|NOT COMPLETED|Overall Study||0
8242458|NCT01920282|20327521|P1|NOT COMPLETED|Overall Study||0
8242459|NCT01920282|20327519|P3|COMPLETED|Overall Study||15
8242460|NCT01920282|20327520|P2|COMPLETED|Overall Study||15
8242461|NCT01920282|20327521|P1|COMPLETED|Overall Study||15
8242462|NCT01920282|20327519|P3|STARTED|Overall Study||15
8242463|NCT01920282|20327520|P2|STARTED|Overall Study||15
8242464|NCT01920282|20327521|P1|STARTED|Overall Study||15
8242465|NCT01920178|20327534|P2|NOT COMPLETED|Overall Study||1
8242466|NCT01920178|20327535|P1|NOT COMPLETED|Overall Study||2
8242467|NCT01920178|20327534|P2|COMPLETED|Overall Study||1
8242468|NCT01920178|20327535|P1|COMPLETED|Overall Study||3
8242469|NCT01920178|20327534|P2|STARTED|Overall Study||2
8242470|NCT01920178|20327535|P1|STARTED|Overall Study||5
8242477|NCT01919996|20327584|P1|NOT COMPLETED|Overall Study||0
8242478|NCT01919996|20327584|P1|COMPLETED|Overall Study||8
8242479|NCT01919996|20327584|P1|STARTED|Overall Study||8
8242480|NCT01919970|20327592|P2|NOT COMPLETED|Overall Study||0
8242481|NCT01919970|20327593|P1|NOT COMPLETED|Overall Study||3
8242482|NCT01919970|20327592|P2|COMPLETED|Overall Study||18
8242483|NCT01919970|20327593|P1|COMPLETED|Overall Study||11
8242484|NCT01919970|20327592|P2|STARTED|Overall Study||18
8242485|NCT01919970|20327593|P1|STARTED|Overall Study||14
8242486|NCT01919814|20327601|P2|NOT COMPLETED|Overall Study||0
8242487|NCT01919814|20327602|P1|NOT COMPLETED|Overall Study||3
8242488|NCT01919814|20327601|P2|COMPLETED|Overall Study||30
8242489|NCT01919814|20327602|P1|COMPLETED|Overall Study||27
8242490|NCT01919814|20327601|P2|STARTED|Overall Study||30
8242491|NCT01919814|20327602|P1|STARTED|Overall Study||30
8242498|NCT01919723|20327640|P2|NOT COMPLETED|Overall Study||2
8242499|NCT01919723|20327641|P1|NOT COMPLETED|Overall Study||2
8242500|NCT01919723|20327640|P2|COMPLETED|Overall Study||33
8242501|NCT01919723|20327641|P1|COMPLETED|Overall Study||33
8242502|NCT01919723|20327640|P2|STARTED|Overall Study||35
8242503|NCT01919723|20327641|P1|STARTED|Overall Study||35
8242504|NCT01919697|20327655|P2|NOT COMPLETED|Overall Study||385
8242505|NCT01919697|20327656|P1|NOT COMPLETED|Overall Study||53
8242506|NCT01919697|20327655|P2|COMPLETED|Overall Study||1761
8242507|NCT01919697|20327656|P1|COMPLETED|Overall Study||171
8242508|NCT01919697|20327655|P2|STARTED|Overall Study||2146
8242509|NCT01919697|20327656|P1|STARTED|Overall Study||224
8242516|NCT01919450|20327699|P4|NOT COMPLETED|Overall Study||1
8242517|NCT01919450|20327700|P3|NOT COMPLETED|Overall Study||0
8242518|NCT01919450|20327701|P2|NOT COMPLETED|Overall Study||0
8242519|NCT01919450|20327702|P1|NOT COMPLETED|Overall Study||0
8242520|NCT01919450|20327699|P4|COMPLETED|Overall Study||19
8242521|NCT01919450|20327700|P3|COMPLETED|Overall Study||20
8242522|NCT01919450|20327701|P2|COMPLETED|Overall Study||20
8242523|NCT01919450|20327702|P1|COMPLETED|Overall Study||20
8242524|NCT01919450|20327699|P4|STARTED|Overall Study||20
8242525|NCT01919450|20327700|P3|STARTED|Overall Study||20
8242526|NCT01919450|20327701|P2|STARTED|Overall Study||20
8242527|NCT01919450|20327702|P1|STARTED|Overall Study||20
8242528|NCT01919411|20327714|P2|NOT COMPLETED|Overall Study||5
8242529|NCT01919411|20327715|P1|NOT COMPLETED|Overall Study||5
8242530|NCT01919411|20327714|P2|COMPLETED|Overall Study||41
8242531|NCT01919411|20327715|P1|COMPLETED|Overall Study||38
8242532|NCT01919411|20327714|P2|STARTED|Overall Study||46
8242533|NCT01919411|20327715|P1|STARTED|Overall Study||43
8242534|NCT01919398|20327734|P3|NOT COMPLETED|Overall Study||4
8242535|NCT01919398|20327735|P2|NOT COMPLETED|Overall Study||0
8242536|NCT01919398|20327736|P1|NOT COMPLETED|Overall Study||0
8242537|NCT01919398|20327734|P3|COMPLETED|Overall Study||9
8242538|NCT01919398|20327735|P2|COMPLETED|Overall Study||3
8242539|NCT01919398|20327736|P1|COMPLETED|Overall Study||3
8242540|NCT01919398|20327734|P3|Received at Least One Dose of Study Drug|Overall Study||13
8242541|NCT01919398|20327735|P2|Received at Least One Dose of Study Drug|Overall Study||3
8242542|NCT01919398|20327736|P1|Received at Least One Dose of Study Drug|Overall Study||3
8242543|NCT01919398|20327734|P3|STARTED|Overall Study||13
8242544|NCT01919398|20327735|P2|STARTED|Overall Study||3
8242545|NCT01919398|20327736|P1|STARTED|Overall Study||3
8242546|NCT01919307|20327756|P1|NOT COMPLETED|Overall Study||9
8242547|NCT01919307|20327756|P1|COMPLETED|Overall Study||20
8242548|NCT01919307|20327756|P1|STARTED|Overall Study||29
8242549|NCT01919229|20327766|P3|NOT COMPLETED|Overall Study||1
8242550|NCT01919229|20327767|P2|NOT COMPLETED|Overall Study||0
8242551|NCT01919229|20327768|P1|NOT COMPLETED|Overall Study||0
8242552|NCT01919229|20327766|P3|COMPLETED|Overall Study||3
8242553|NCT01919229|20327767|P2|COMPLETED|Overall Study||6
8242554|NCT01919229|20327768|P1|COMPLETED|Overall Study||4
8242555|NCT01919229|20327766|P3|STARTED|Overall Study||4
8242556|NCT01919229|20327767|P2|STARTED|Overall Study||6
8242557|NCT01919229|20327768|P1|STARTED|Overall Study||4
8242558|NCT01919216|20327800|P3|NOT COMPLETED|Overall Study||1
8242559|NCT01919216|20327801|P2|NOT COMPLETED|Overall Study||1
8242560|NCT01919216|20327802|P1|NOT COMPLETED|Overall Study||2
8242561|NCT01919216|20327800|P3|COMPLETED|Overall Study||4
8242562|NCT01919216|20327801|P2|COMPLETED|Overall Study||20
8242563|NCT01919216|20327802|P1|COMPLETED|Overall Study||26
8242564|NCT01919216|20327800|P3|STARTED|Overall Study||5
8242565|NCT01919216|20327801|P2|STARTED|Overall Study||21
8242566|NCT01919216|20327802|P1|STARTED|Overall Study||28
8242567|NCT01919164|20327815|P5|NOT COMPLETED|Overall Study||33
8242568|NCT01919164|20327816|P4|NOT COMPLETED|Overall Study||28
8242569|NCT01919164|20327817|P3|NOT COMPLETED|Overall Study||37
8242570|NCT01919164|20327818|P2|NOT COMPLETED|Overall Study||30
8242571|NCT01919164|20327819|P1|NOT COMPLETED|Overall Study||43
8242572|NCT01919164|20327815|P5|COMPLETED|Overall Study||77
8242573|NCT01919164|20327816|P4|COMPLETED|Overall Study||82
8242574|NCT01919164|20327817|P3|COMPLETED|Overall Study||74
8242575|NCT01919164|20327818|P2|COMPLETED|Overall Study||80
8242576|NCT01919164|20327819|P1|COMPLETED|Overall Study||65
8242577|NCT01919164|20327815|P5|Safety Analysis Set|Overall Study||109
8242578|NCT01919164|20327816|P4|Safety Analysis Set|Overall Study|1 participant in Sprifermin2 Cycles arm who inadvertently received 100 mcg was included in this arm.|111
8242579|NCT01919164|20327817|P3|Safety Analysis Set|Overall Study||111
8242580|NCT01919164|20327818|P2|Safety Analysis Set|Overall Study|1 participant assigned to Placebo arm who inadvertently received 30 mcg was included in this arm.|109
8242581|NCT01919164|20327819|P1|Safety Analysis Set|Overall Study||107
8242582|NCT01919164|20327815|P5|STARTED|Overall Study||110
8242583|NCT01919164|20327816|P4|STARTED|Overall Study||110
8242584|NCT01919164|20327817|P3|STARTED|Overall Study||111
8242585|NCT01919164|20327818|P2|STARTED|Overall Study||110
8242586|NCT01919164|20327819|P1|STARTED|Overall Study||108
8242587|NCT01919112|20327874|P3|NOT COMPLETED|Secondary Analysis-day 30||1
8242588|NCT01919112|20327875|P2|NOT COMPLETED|Secondary Analysis-day 30||1
8242589|NCT01919112|20327876|P1|NOT COMPLETED|Secondary Analysis-day 30||2
8242590|NCT01919112|20327874|P3|COMPLETED|Secondary Analysis-day 30||14
8242591|NCT01919112|20327875|P2|COMPLETED|Secondary Analysis-day 30||12
8242592|NCT01919112|20327876|P1|COMPLETED|Secondary Analysis-day 30||12
8242593|NCT01919112|20327874|P3|STARTED|Secondary Analysis-day 30||15
8242594|NCT01919112|20327875|P2|STARTED|Secondary Analysis-day 30||13
8242595|NCT01919112|20327876|P1|STARTED|Secondary Analysis-day 30||14
8242596|NCT01919112|20327874|P3|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
8242597|NCT01919112|20327875|P2|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
8242598|NCT01919112|20327876|P1|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
8242599|NCT01919112|20327874|P3|COMPLETED|Primary Analysis-day 5 of Intervention||15
8242600|NCT01919112|20327875|P2|COMPLETED|Primary Analysis-day 5 of Intervention||13
8242601|NCT01919112|20327876|P1|COMPLETED|Primary Analysis-day 5 of Intervention||14
8242602|NCT01919112|20327874|P3|STARTED|Primary Analysis-day 5 of Intervention||15
8242603|NCT01919112|20327875|P2|STARTED|Primary Analysis-day 5 of Intervention||13
8242604|NCT01919112|20327876|P1|STARTED|Primary Analysis-day 5 of Intervention||14
8242605|NCT01918800|20327916|P2|NOT COMPLETED|Overall Study||5
8242606|NCT01918800|20327917|P1|NOT COMPLETED|Overall Study||9
8242607|NCT01918800|20327916|P2|COMPLETED|Overall Study||104
8242608|NCT01918800|20327917|P1|COMPLETED|Overall Study||100
8242609|NCT01918800|20327916|P2|STARTED|Overall Study||109
8242610|NCT01918800|20327917|P1|STARTED|Overall Study||109
8242611|NCT01918774|20327935|P1|NOT COMPLETED|Overall Study||5
8242612|NCT01918774|20327935|P1|COMPLETED|Overall Study||52
8242613|NCT01918774|20327935|P1|STARTED|Overall Study||57
8242614|NCT01918761|20327950|P1|NOT COMPLETED|Overall Study||0
8242615|NCT01918761|20327950|P1|COMPLETED|Overall Study||5
8242616|NCT01918761|20327950|P1|STARTED|Overall Study||5
8242617|NCT01918371|20327959|P2|NOT COMPLETED|Overall Study||1
8242618|NCT01918371|20327960|P1|NOT COMPLETED|Overall Study||1
8242619|NCT01918371|20327959|P2|COMPLETED|Overall Study||156
8242620|NCT01918371|20327960|P1|COMPLETED|Overall Study||165
8242621|NCT01918371|20327959|P2|Participants With Complete Data|Overall Study||156
8242622|NCT01918371|20327960|P1|Participants With Complete Data|Overall Study||165
8242623|NCT01918371|20327959|P2|STARTED|Overall Study||157
8242624|NCT01918371|20327960|P1|STARTED|Overall Study||166
8242625|NCT01918332|20328038|P4|NOT COMPLETED|Overall Study||7
8242626|NCT01918332|20328039|P3|NOT COMPLETED|Overall Study||9
8242627|NCT01918332|20328040|P2|NOT COMPLETED|Overall Study||5
8242628|NCT01918332|20328041|P1|NOT COMPLETED|Overall Study||8
8242629|NCT01918332|20328038|P4|COMPLETED|Overall Study||38
8242630|NCT01918332|20328039|P3|COMPLETED|Overall Study||30
8242631|NCT01918332|20328040|P2|COMPLETED|Overall Study||36
8242632|NCT01918332|20328041|P1|COMPLETED|Overall Study||35
8242633|NCT01918332|20328038|P4|STARTED|Overall Study||45
8242634|NCT01918332|20328039|P3|STARTED|Overall Study||39
8242635|NCT01918332|20328040|P2|STARTED|Overall Study||41
8242636|NCT01918332|20328041|P1|STARTED|Overall Study||43
8242637|NCT01918306|20328053|P4|NOT COMPLETED|Overall Study||3
8242638|NCT01918306|20328054|P3|NOT COMPLETED|Overall Study||2
8242639|NCT01918306|20328055|P2|NOT COMPLETED|Overall Study||0
8242640|NCT01918306|20328056|P1|NOT COMPLETED|Overall Study||6
8242641|NCT01918306|20328053|P4|COMPLETED|Overall Study||0
8242642|NCT01918306|20328054|P3|COMPLETED|Overall Study||0
8242643|NCT01918306|20328055|P2|COMPLETED|Overall Study||0
8242644|NCT01918306|20328056|P1|COMPLETED|Overall Study||0
8242645|NCT01918306|20328053|P4|STARTED|Overall Study||3
8242646|NCT01918306|20328054|P3|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
8242647|NCT01918306|20328055|P2|STARTED|Overall Study|No patients enrolled|0
8242648|NCT01918306|20328056|P1|STARTED|Overall Study||6
8242649|NCT01918189|20328076|P1|NOT COMPLETED|Overall Study||18
8242650|NCT01918189|20328076|P1|COMPLETED|Overall Study||41
8242651|NCT01918189|20328076|P1|Completed Follow-up Assessment|Overall Study||41
8242652|NCT01918189|20328076|P1|Completed Baseline Assessment|Overall Study||58
8242653|NCT01918189|20328076|P1|STARTED|Overall Study||59
8242654|NCT01918085|20328087|P2|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
8242655|NCT01918085|20328088|P1|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
8242656|NCT01918085|20328087|P2|COMPLETED|Test Period 2: Hydrocolloid Strip||11
8242657|NCT01918085|20328088|P1|COMPLETED|Test Period 2: Hydrocolloid Strip||10
8242658|NCT01918085|20328087|P2|STARTED|Test Period 2: Hydrocolloid Strip||11
8242659|NCT01918085|20328088|P1|STARTED|Test Period 2: Hydrocolloid Strip||10
8242660|NCT01918085|20328087|P2|NOT COMPLETED|Test Period 2: Strata Strip||0
8242661|NCT01918085|20328088|P1|NOT COMPLETED|Test Period 2: Strata Strip||0
8242662|NCT01918085|20328087|P2|COMPLETED|Test Period 2: Strata Strip||11
8242663|NCT01918085|20328088|P1|COMPLETED|Test Period 2: Strata Strip||10
8242664|NCT01918085|20328087|P2|STARTED|Test Period 2: Strata Strip||11
8242665|NCT01918085|20328088|P1|STARTED|Test Period 2: Strata Strip||10
8242666|NCT01918085|20328087|P2|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
8242667|NCT01918085|20328088|P1|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
8242668|NCT01918085|20328087|P2|COMPLETED|Test Period 1: Hydrocolloid Strip||11
8242669|NCT01918085|20328088|P1|COMPLETED|Test Period 1: Hydrocolloid Strip||10
8242670|NCT01918085|20328087|P2|STARTED|Test Period 1: Hydrocolloid Strip||11
8242671|NCT01918085|20328088|P1|STARTED|Test Period 1: Hydrocolloid Strip||10
8242672|NCT01918085|20328087|P2|NOT COMPLETED|Test Period 1: Strata Strip||1
8242673|NCT01918085|20328088|P1|NOT COMPLETED|Test Period 1: Strata Strip||0
8242674|NCT01918085|20328087|P2|COMPLETED|Test Period 1: Strata Strip||11
8242675|NCT01918085|20328088|P1|COMPLETED|Test Period 1: Strata Strip||10
8242676|NCT01918085|20328087|P2|STARTED|Test Period 1: Strata Strip||12
8242677|NCT01918085|20328088|P1|STARTED|Test Period 1: Strata Strip||10
8242678|NCT01918072|20328096|P3|NOT COMPLETED|Quality Assessment Period||0
8242679|NCT01918072|20328097|P2|NOT COMPLETED|Quality Assessment Period||0
8242680|NCT01918072|20328098|P1|NOT COMPLETED|Quality Assessment Period||0
8242681|NCT01918072|20328096|P3|COMPLETED|Quality Assessment Period||202
8242682|NCT01918072|20328097|P2|COMPLETED|Quality Assessment Period||0
8242683|NCT01918072|20328098|P1|COMPLETED|Quality Assessment Period||0
8242684|NCT01918072|20328096|P3|STARTED|Quality Assessment Period||202
8242685|NCT01918072|20328097|P2|STARTED|Quality Assessment Period||0
8242686|NCT01918072|20328098|P1|STARTED|Quality Assessment Period||0
8242687|NCT01918072|20328096|P3|NOT COMPLETED|E-consult Assessment Period||0
8242688|NCT01918072|20328097|P2|NOT COMPLETED|E-consult Assessment Period||0
8242689|NCT01918072|20328098|P1|NOT COMPLETED|E-consult Assessment Period||0
8242690|NCT01918072|20328096|P3|COMPLETED|E-consult Assessment Period||0
8242691|NCT01918072|20328097|P2|COMPLETED|E-consult Assessment Period||42
8242692|NCT01918072|20328098|P1|COMPLETED|E-consult Assessment Period||0
8242693|NCT01918072|20328096|P3|STARTED|E-consult Assessment Period||0
8242694|NCT01918072|20328097|P2|STARTED|E-consult Assessment Period||42
8242695|NCT01918072|20328098|P1|STARTED|E-consult Assessment Period||0
8242696|NCT01918072|20328096|P3|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
8242697|NCT01918072|20328097|P2|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
8242698|NCT01918072|20328098|P1|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
8242699|NCT01918072|20328096|P3|COMPLETED|Controlled Trial Step Five - Four Months||0
8242700|NCT01918072|20328097|P2|COMPLETED|Controlled Trial Step Five - Four Months||0
8242701|NCT01918072|20328098|P1|COMPLETED|Controlled Trial Step Five - Four Months||11
8242702|NCT01918072|20328096|P3|Control|Controlled Trial Step Five - Four Months||0
8242703|NCT01918072|20328097|P2|Control|Controlled Trial Step Five - Four Months||0
8242704|NCT01918072|20328098|P1|Control|Controlled Trial Step Five - Four Months||0
8242705|NCT01918072|20328096|P3|Intervention|Controlled Trial Step Five - Four Months||0
8242706|NCT01918072|20328097|P2|Intervention|Controlled Trial Step Five - Four Months||0
8242707|NCT01918072|20328098|P1|Intervention|Controlled Trial Step Five - Four Months||11
8242708|NCT01918072|20328096|P3|STARTED|Controlled Trial Step Five - Four Months||0
8242709|NCT01918072|20328097|P2|STARTED|Controlled Trial Step Five - Four Months||0
8242710|NCT01918072|20328098|P1|STARTED|Controlled Trial Step Five - Four Months||11
8242711|NCT01918072|20328096|P3|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
8242712|NCT01918072|20328097|P2|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
8242713|NCT01918072|20328098|P1|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
8242714|NCT01918072|20328096|P3|COMPLETED|Controlled Trial Step Four - Six Months||0
8242715|NCT01918072|20328097|P2|COMPLETED|Controlled Trial Step Four - Six Months||0
8242716|NCT01918072|20328098|P1|COMPLETED|Controlled Trial Step Four - Six Months||11
8242717|NCT01918072|20328096|P3|Control|Controlled Trial Step Four - Six Months||0
8242718|NCT01918072|20328097|P2|Control|Controlled Trial Step Four - Six Months||0
8242719|NCT01918072|20328098|P1|Control|Controlled Trial Step Four - Six Months||0
8242720|NCT01918072|20328096|P3|Intervention|Controlled Trial Step Four - Six Months||0
8242721|NCT01918072|20328097|P2|Intervention|Controlled Trial Step Four - Six Months||0
8242722|NCT01918072|20328098|P1|Intervention|Controlled Trial Step Four - Six Months||11
8242723|NCT01918072|20328096|P3|STARTED|Controlled Trial Step Four - Six Months||0
8242724|NCT01918072|20328097|P2|STARTED|Controlled Trial Step Four - Six Months||0
8242725|NCT01918072|20328098|P1|STARTED|Controlled Trial Step Four - Six Months||11
8242726|NCT01918072|20328096|P3|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
8242727|NCT01918072|20328097|P2|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
8242728|NCT01918072|20328098|P1|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
8242729|NCT01918072|20328096|P3|COMPLETED|Controlled Trial Step Three - Six Months||0
8242730|NCT01918072|20328097|P2|COMPLETED|Controlled Trial Step Three - Six Months||0
8242731|NCT01918072|20328098|P1|COMPLETED|Controlled Trial Step Three - Six Months||11
8242732|NCT01918072|20328096|P3|Control|Controlled Trial Step Three - Six Months||0
8242733|NCT01918072|20328097|P2|Control|Controlled Trial Step Three - Six Months||0
8242734|NCT01918072|20328098|P1|Control|Controlled Trial Step Three - Six Months||2
8242735|NCT01918072|20328096|P3|Intervention|Controlled Trial Step Three - Six Months||0
8242736|NCT01918072|20328097|P2|Intervention|Controlled Trial Step Three - Six Months||0
8242737|NCT01918072|20328098|P1|Intervention|Controlled Trial Step Three - Six Months||9
8242738|NCT01918072|20328096|P3|STARTED|Controlled Trial Step Three - Six Months||0
8242739|NCT01918072|20328097|P2|STARTED|Controlled Trial Step Three - Six Months||0
8242740|NCT01918072|20328098|P1|STARTED|Controlled Trial Step Three - Six Months||11
8242741|NCT01918072|20328096|P3|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
8242742|NCT01918072|20328097|P2|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
8242743|NCT01918072|20328098|P1|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
8242744|NCT01918072|20328096|P3|COMPLETED|Controlled Trial Step Two - Six Months||0
8242745|NCT01918072|20328097|P2|COMPLETED|Controlled Trial Step Two - Six Months||0
8242746|NCT01918072|20328098|P1|COMPLETED|Controlled Trial Step Two - Six Months||11
8242747|NCT01918072|20328096|P3|Control|Controlled Trial Step Two - Six Months||0
8242748|NCT01918072|20328097|P2|Control|Controlled Trial Step Two - Six Months||0
8242749|NCT01918072|20328098|P1|Control|Controlled Trial Step Two - Six Months||4
8242750|NCT01918072|20328096|P3|Intervention|Controlled Trial Step Two - Six Months||0
8242751|NCT01918072|20328097|P2|Intervention|Controlled Trial Step Two - Six Months||0
8242752|NCT01918072|20328098|P1|Intervention|Controlled Trial Step Two - Six Months||7
8242753|NCT01918072|20328096|P3|STARTED|Controlled Trial Step Two - Six Months||0
8242754|NCT01918072|20328097|P2|STARTED|Controlled Trial Step Two - Six Months||0
8242755|NCT01918072|20328098|P1|STARTED|Controlled Trial Step Two - Six Months||11
8242756|NCT01918072|20328096|P3|NOT COMPLETED|Controlled Trial Step One - Six Months||0
8242757|NCT01918072|20328097|P2|NOT COMPLETED|Controlled Trial Step One - Six Months||0
8242758|NCT01918072|20328098|P1|NOT COMPLETED|Controlled Trial Step One - Six Months||0
8242759|NCT01918072|20328096|P3|COMPLETED|Controlled Trial Step One - Six Months||0
8242760|NCT01918072|20328097|P2|COMPLETED|Controlled Trial Step One - Six Months||0
8242761|NCT01918072|20328098|P1|COMPLETED|Controlled Trial Step One - Six Months||11
8242762|NCT01918072|20328096|P3|Control|Controlled Trial Step One - Six Months||0
8242763|NCT01918072|20328097|P2|Control|Controlled Trial Step One - Six Months||0
8242764|NCT01918072|20328098|P1|Control|Controlled Trial Step One - Six Months||10
8242765|NCT01918072|20328096|P3|Intervention|Controlled Trial Step One - Six Months||0
8242766|NCT01918072|20328097|P2|Intervention|Controlled Trial Step One - Six Months||0
8242767|NCT01918072|20328098|P1|Intervention|Controlled Trial Step One - Six Months||1
8242768|NCT01918072|20328096|P3|STARTED|Controlled Trial Step One - Six Months||0
8242769|NCT01918072|20328097|P2|STARTED|Controlled Trial Step One - Six Months||0
8242770|NCT01918072|20328098|P1|STARTED|Controlled Trial Step One - Six Months||11
8242771|NCT01918033|20328112|P3|NOT COMPLETED|Overall Study||3
8242772|NCT01918033|20328113|P2|NOT COMPLETED|Overall Study||2
8242773|NCT01918033|20328114|P1|NOT COMPLETED|Overall Study||5
8242774|NCT01918033|20328112|P3|COMPLETED|Overall Study||199
8242775|NCT01918033|20328113|P2|COMPLETED|Overall Study||201
8242776|NCT01918033|20328114|P1|COMPLETED|Overall Study||198
8242777|NCT01918033|20328112|P3|Treated|Overall Study|One randomized participant did not receive study drug.|201
8242778|NCT01918033|20328113|P2|Treated|Overall Study||203
8242779|NCT01918033|20328114|P1|Treated|Overall Study|One randomized participant did not receive study drug.|202
8242780|NCT01918033|20328112|P3|STARTED|Overall Study||202
8242781|NCT01918033|20328113|P2|STARTED|Overall Study||203
8242782|NCT01918033|20328114|P1|STARTED|Overall Study||203
8242783|NCT01917812|20328155|P3|NOT COMPLETED|Overall Study||0
8242784|NCT01917812|20328156|P2|NOT COMPLETED|Overall Study||0
8242785|NCT01917812|20328157|P1|NOT COMPLETED|Overall Study||1
8242786|NCT01917812|20328155|P3|COMPLETED|Overall Study||16
8242787|NCT01917812|20328156|P2|COMPLETED|Overall Study||16
8242788|NCT01917812|20328157|P1|COMPLETED|Overall Study||15
8242789|NCT01917812|20328155|P3|STARTED|Overall Study||16
8242790|NCT01917812|20328156|P2|STARTED|Overall Study||16
8242791|NCT01917812|20328157|P1|STARTED|Overall Study||16
8242792|NCT01917773|20328177|P1|NOT COMPLETED|Overall Study||0
8242793|NCT01917773|20328177|P1|COMPLETED|Overall Study||13
8242794|NCT01917773|20328177|P1|STARTED|Overall Study||13
8242795|NCT01917747|20328185|P2|NOT COMPLETED|Overall Study||11
8242796|NCT01917747|20328186|P1|NOT COMPLETED|Overall Study||19
8242797|NCT01917747|20328185|P2|COMPLETED|Overall Study||35
8242798|NCT01917747|20328186|P1|COMPLETED|Overall Study||41
8242799|NCT01917747|20328185|P2|STARTED|Overall Study||46
8242800|NCT01917747|20328186|P1|STARTED|Overall Study||60
8242801|NCT01917682|20328198|P1|NOT COMPLETED|Overall Study||0
8242802|NCT01917682|20328198|P1|COMPLETED|Overall Study||754
8242803|NCT01917682|20328198|P1|STARTED|Overall Study||754
8242804|NCT01917656|20328215|P2|NOT COMPLETED|Overall Study||24
8242805|NCT01917656|20328216|P1|NOT COMPLETED|Overall Study||26
8242806|NCT01917656|20328215|P2|COMPLETED|Overall Study||147
8242807|NCT01917656|20328216|P1|COMPLETED|Overall Study||146
8242808|NCT01917656|20328215|P2|Exposed During Ramadan (Fasting)|Overall Study||163
8242809|NCT01917656|20328216|P1|Exposed During Ramadan (Fasting)|Overall Study||152
8242810|NCT01917656|20328215|P2|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
8242811|NCT01917656|20328216|P1|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
8242812|NCT01917656|20328215|P2|STARTED|Overall Study||171
8242813|NCT01917656|20328216|P1|STARTED|Overall Study||172
8242814|NCT01917526|20328242|P2|NOT COMPLETED|Overall Study||1
8242815|NCT01917526|20328243|P1|NOT COMPLETED|Overall Study||1
8242816|NCT01917526|20328242|P2|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
8242817|NCT01917526|20328243|P1|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
8242818|NCT01917526|20328242|P2|STARTED|Overall Study||250
8242819|NCT01917526|20328243|P1|STARTED|Overall Study||250
8242820|NCT01917513|20328253|P2|NOT COMPLETED|Overall Study||102
8242821|NCT01917513|20328254|P1|NOT COMPLETED|Overall Study||95
8242822|NCT01917513|20328253|P2|COMPLETED|Overall Study||396
8242823|NCT01917513|20328254|P1|COMPLETED|Overall Study||407
8242824|NCT01917513|20328253|P2|STARTED|Overall Study||498
8242825|NCT01917513|20328254|P1|STARTED|Overall Study||502
8242826|NCT01917344|20328260|P1|NOT COMPLETED|Overall Study||1
8242827|NCT01917344|20328260|P1|COMPLETED|Overall Study||9
8242828|NCT01917344|20328260|P1|STARTED|Overall Study||10
8242829|NCT01917318|20328266|P2|NOT COMPLETED|Second Treatment||0
8242830|NCT01917318|20328267|P1|NOT COMPLETED|Second Treatment||0
8242831|NCT01917318|20328266|P2|COMPLETED|Second Treatment||0
8242832|NCT01917318|20328267|P1|COMPLETED|Second Treatment||0
8242833|NCT01917318|20328266|P2|STARTED|Second Treatment||0
8242834|NCT01917318|20328267|P1|STARTED|Second Treatment||0
8242835|NCT01917318|20328266|P2|NOT COMPLETED|First Treatment||1
8242836|NCT01917318|20328267|P1|NOT COMPLETED|First Treatment||0
8242837|NCT01917318|20328266|P2|COMPLETED|First Treatment||0
8242838|NCT01917318|20328267|P1|COMPLETED|First Treatment||0
8242839|NCT01917318|20328266|P2|STARTED|First Treatment||1
8242840|NCT01917318|20328267|P1|STARTED|First Treatment||0
8242841|NCT01917214|20328287|P1|NOT COMPLETED|Overall Study||0
8242842|NCT01917214|20328287|P1|COMPLETED|Overall Study||212
8242843|NCT01917214|20328287|P1|STARTED|Overall Study||212
8242844|NCT01917188|20328299|P3|NOT COMPLETED|Overall Study||9
8242845|NCT01917188|20328300|P2|NOT COMPLETED|Overall Study||6
8242846|NCT01917188|20328301|P1|NOT COMPLETED|Overall Study||12
8242847|NCT01917188|20328299|P3|COMPLETED|Overall Study||11
8242848|NCT01917188|20328300|P2|COMPLETED|Overall Study||17
8242849|NCT01917188|20328301|P1|COMPLETED|Overall Study||17
8242850|NCT01917188|20328299|P3|STARTED|Overall Study||20
8242851|NCT01917188|20328300|P2|STARTED|Overall Study||23
8242852|NCT01917188|20328301|P1|STARTED|Overall Study||29
8242853|NCT01917136|20328309|P1|NOT COMPLETED|Overall Study||0
8242854|NCT01917136|20328309|P1|COMPLETED|Overall Study||21
8242855|NCT01917136|20328309|P1|STARTED|Overall Study||21
8242856|NCT01917084|20328313|P1|NOT COMPLETED|Overall Study||1
8242857|NCT01917084|20328313|P1|COMPLETED|Overall Study||19
8242858|NCT01917084|20328313|P1|STARTED|Overall Study||20
8242859|NCT01917006|20328326|P8|NOT COMPLETED|Open-label Period||2
8242860|NCT01917006|20328327|P7|NOT COMPLETED|Open-label Period||0
8242861|NCT01917006|20328328|P6|NOT COMPLETED|Open-label Period||0
8242862|NCT01917006|20328329|P5|NOT COMPLETED|Open-label Period||0
8242863|NCT01917006|20328330|P4|NOT COMPLETED|Open-label Period||0
8242864|NCT01917006|20328331|P3|NOT COMPLETED|Open-label Period||0
8242865|NCT01917006|20328332|P2|NOT COMPLETED|Open-label Period||0
8242866|NCT01917006|20328333|P1|NOT COMPLETED|Open-label Period||0
8242867|NCT01917006|20328326|P8|COMPLETED|Open-label Period||6
8242868|NCT01917006|20328327|P7|COMPLETED|Open-label Period||0
8242869|NCT01917006|20328328|P6|COMPLETED|Open-label Period||0
8242870|NCT01917006|20328329|P5|COMPLETED|Open-label Period||0
8242871|NCT01917006|20328330|P4|COMPLETED|Open-label Period||0
8242872|NCT01917006|20328331|P3|COMPLETED|Open-label Period||0
8242873|NCT01917006|20328332|P2|COMPLETED|Open-label Period||0
8242874|NCT01917006|20328333|P1|COMPLETED|Open-label Period||0
8242875|NCT01917006|20328326|P8|STARTED|Open-label Period||8
8242876|NCT01917006|20328327|P7|STARTED|Open-label Period||0
8242877|NCT01917006|20328328|P6|STARTED|Open-label Period||0
8242878|NCT01917006|20328329|P5|STARTED|Open-label Period||0
8242879|NCT01917006|20328330|P4|STARTED|Open-label Period||0
8242880|NCT01917006|20328331|P3|STARTED|Open-label Period||0
8242881|NCT01917006|20328332|P2|STARTED|Open-label Period||0
8242882|NCT01917006|20328333|P1|STARTED|Open-label Period||0
8242883|NCT01917006|20328326|P8|NOT COMPLETED|Randomized-treatment Period||0
8242884|NCT01917006|20328327|P7|NOT COMPLETED|Randomized-treatment Period||1
8242885|NCT01917006|20328328|P6|NOT COMPLETED|Randomized-treatment Period||1
8242886|NCT01917006|20328329|P5|NOT COMPLETED|Randomized-treatment Period||0
8242887|NCT01917006|20328330|P4|NOT COMPLETED|Randomized-treatment Period||1
8242888|NCT01917006|20328331|P3|NOT COMPLETED|Randomized-treatment Period||0
8242889|NCT01917006|20328332|P2|NOT COMPLETED|Randomized-treatment Period||0
8242890|NCT01917006|20328333|P1|NOT COMPLETED|Randomized-treatment Period||2
8242891|NCT01917006|20328326|P8|COMPLETED|Randomized-treatment Period||0
8242892|NCT01917006|20328327|P7|COMPLETED|Randomized-treatment Period||14
8242893|NCT01917006|20328328|P6|COMPLETED|Randomized-treatment Period||7
8242894|NCT01917006|20328329|P5|COMPLETED|Randomized-treatment Period||8
8242895|NCT01917006|20328330|P4|COMPLETED|Randomized-treatment Period||7
8242896|NCT01917006|20328331|P3|COMPLETED|Randomized-treatment Period||8
8242897|NCT01917006|20328332|P2|COMPLETED|Randomized-treatment Period||7
8242898|NCT01917006|20328333|P1|COMPLETED|Randomized-treatment Period||3
8242899|NCT01917006|20328326|P8|STARTED|Randomized-treatment Period||0
8242900|NCT01917006|20328327|P7|STARTED|Randomized-treatment Period||15
8242901|NCT01917006|20328328|P6|STARTED|Randomized-treatment Period||8
8242902|NCT01917006|20328329|P5|STARTED|Randomized-treatment Period||8
8242903|NCT01917006|20328330|P4|STARTED|Randomized-treatment Period||8
8242904|NCT01917006|20328331|P3|STARTED|Randomized-treatment Period||8
8242905|NCT01917006|20328332|P2|STARTED|Randomized-treatment Period||7
8242906|NCT01917006|20328333|P1|STARTED|Randomized-treatment Period||5
8242907|NCT01916980|20328366|P2|NOT COMPLETED|Overall Study||4
8242908|NCT01916980|20328367|P1|NOT COMPLETED|Overall Study||7
8242909|NCT01916980|20328366|P2|COMPLETED|Overall Study||25
8242910|NCT01916980|20328367|P1|COMPLETED|Overall Study||58
8242911|NCT01916980|20328366|P2|STARTED|Overall Study||29
8242912|NCT01916980|20328367|P1|STARTED|Overall Study||65
8242913|NCT01916967|20328386|P3|NOT COMPLETED|Overall Study||9
8242914|NCT01916967|20328387|P2|NOT COMPLETED|Overall Study||1
8242915|NCT01916967|20328388|P1|NOT COMPLETED|Overall Study||0
8242916|NCT01916967|20328386|P3|COMPLETED|Overall Study||71
8242917|NCT01916967|20328387|P2|COMPLETED|Overall Study||78
8242918|NCT01916967|20328388|P1|COMPLETED|Overall Study||80
8242919|NCT01916967|20328386|P3|STARTED|Overall Study||80
8242920|NCT01916967|20328387|P2|STARTED|Overall Study||79
8242921|NCT01916967|20328388|P1|STARTED|Overall Study||80
8242922|NCT01916941|20328431|P2|NOT COMPLETED|Overall Study||4
8242923|NCT01916941|20328432|P1|NOT COMPLETED|Overall Study||5
8242924|NCT01916941|20328431|P2|COMPLETED|Overall Study||14
8242925|NCT01916941|20328432|P1|COMPLETED|Overall Study||13
8242926|NCT01916941|20328431|P2|STARTED|Overall Study||18
8242927|NCT01916941|20328432|P1|STARTED|Overall Study||18
8242928|NCT01916928|20328438|P1|NOT COMPLETED|Overall Study||0
8242929|NCT01916928|20328438|P1|COMPLETED|Overall Study||50
8242930|NCT01916928|20328438|P1|STARTED|Overall Study||50
8242931|NCT01916824|20328444|P2|NOT COMPLETED|Overall Study||9
8242932|NCT01916824|20328445|P1|NOT COMPLETED|Overall Study||7
8242933|NCT01916824|20328444|P2|COMPLETED|Overall Study||20
8242934|NCT01916824|20328445|P1|COMPLETED|Overall Study||17
8242935|NCT01916824|20328444|P2|STARTED|Overall Study||29
8242936|NCT01916824|20328445|P1|STARTED|Overall Study||24
8242937|NCT01916681|20328455|P4|NOT COMPLETED|Overall Study||0
8242938|NCT01916681|20328456|P3|NOT COMPLETED|Overall Study||0
8242939|NCT01916681|20328457|P2|NOT COMPLETED|Overall Study||0
8242940|NCT01916681|20328458|P1|NOT COMPLETED|Overall Study||0
8242941|NCT01916681|20328455|P4|COMPLETED|Overall Study||125
8242942|NCT01916681|20328456|P3|COMPLETED|Overall Study||123
8242943|NCT01916681|20328457|P2|COMPLETED|Overall Study||120
8242944|NCT01916681|20328458|P1|COMPLETED|Overall Study||123
8242945|NCT01916681|20328455|P4|STARTED|Overall Study||125
8242946|NCT01916681|20328456|P3|STARTED|Overall Study||123
8242947|NCT01916681|20328457|P2|STARTED|Overall Study||120
8242948|NCT01916681|20328458|P1|STARTED|Overall Study||123
8242949|NCT01916655|20328499|P3|NOT COMPLETED|Overall Study||29
8242950|NCT01916655|20328500|P2|NOT COMPLETED|Overall Study||20
8242951|NCT01916655|20328501|P1|NOT COMPLETED|Overall Study||15
8242952|NCT01916655|20328499|P3|COMPLETED|Overall Study||91
8242953|NCT01916655|20328500|P2|COMPLETED|Overall Study||89
8242954|NCT01916655|20328501|P1|COMPLETED|Overall Study||116
8242955|NCT01916655|20328499|P3|STARTED|Overall Study||120
8242956|NCT01916655|20328500|P2|STARTED|Overall Study||109
8242957|NCT01916655|20328501|P1|STARTED|Overall Study||131
8242958|NCT01916629|20328511|P2|NOT COMPLETED|Overall Study||0
8242959|NCT01916629|20328512|P1|NOT COMPLETED|Overall Study||0
8242960|NCT01916629|20328511|P2|COMPLETED|Overall Study||5
8242961|NCT01916629|20328512|P1|COMPLETED|Overall Study||7
8242962|NCT01916629|20328511|P2|STARTED|Overall Study||5
8242963|NCT01916629|20328512|P1|STARTED|Overall Study||7
8242964|NCT01916590|20328520|P2|NOT COMPLETED|Overall Study||0
8242965|NCT01916590|20328521|P1|NOT COMPLETED|Overall Study||0
8242966|NCT01916590|20328520|P2|COMPLETED|Overall Study||3
8242967|NCT01916590|20328521|P1|COMPLETED|Overall Study||4
8242968|NCT01916590|20328520|P2|STARTED|Overall Study||3
8242969|NCT01916590|20328521|P1|STARTED|Overall Study||4
8242970|NCT01916304|20328527|P1|NOT COMPLETED|Overall Study||17
8242971|NCT01916304|20328527|P1|COMPLETED|Overall Study||84
8242972|NCT01916304|20328527|P1|Intent-to-Treat Set|Overall Study||84
8242973|NCT01916304|20328527|P1|Safety Set|Overall Study||101
8242974|NCT01916304|20328527|P1|STARTED|Overall Study||101
8242975|NCT01916226|20328539|P4|NOT COMPLETED|Overall Study||4
8242976|NCT01916226|20328540|P3|NOT COMPLETED|Overall Study||3
8242977|NCT01916226|20328541|P2|NOT COMPLETED|Overall Study||1
8242978|NCT01916226|20328542|P1|NOT COMPLETED|Overall Study||1
8242979|NCT01916226|20328539|P4|COMPLETED|Overall Study||167
8242980|NCT01916226|20328540|P3|COMPLETED|Overall Study||168
8242981|NCT01916226|20328541|P2|COMPLETED|Overall Study||169
8242982|NCT01916226|20328542|P1|COMPLETED|Overall Study||169
8242983|NCT01916226|20328539|P4|STARTED|Overall Study||171
8242984|NCT01916226|20328540|P3|STARTED|Overall Study||171
8242985|NCT01916226|20328541|P2|STARTED|Overall Study||170
8242986|NCT01916226|20328542|P1|STARTED|Overall Study||170
8242987|NCT01916109|20328576|P1|NOT COMPLETED|Overall Study||1
8242988|NCT01916109|20328576|P1|COMPLETED|Overall Study||3
8242989|NCT01916109|20328576|P1|STARTED|Overall Study||4
8242990|NCT01915940|20328582|P3|NOT COMPLETED|Treatment Period||4
8242991|NCT01915940|20328583|P2|NOT COMPLETED|Treatment Period||11
8242992|NCT01915940|20328584|P1|NOT COMPLETED|Treatment Period||0
8242993|NCT01915940|20328582|P3|COMPLETED|Treatment Period||62
8242994|NCT01915940|20328583|P2|COMPLETED|Treatment Period||53
8242995|NCT01915940|20328584|P1|COMPLETED|Treatment Period||0
8242996|NCT01915940|20328582|P3|STARTED|Treatment Period||66
8242997|NCT01915940|20328583|P2|STARTED|Treatment Period||64
8242998|NCT01915940|20328584|P1|STARTED|Treatment Period||0
8242999|NCT01915940|20328582|P3|NOT COMPLETED|Pre-randomization Washout Period||0
8243000|NCT01915940|20328583|P2|NOT COMPLETED|Pre-randomization Washout Period||0
8243001|NCT01915940|20328584|P1|NOT COMPLETED|Pre-randomization Washout Period||39
8243002|NCT01915940|20328582|P3|COMPLETED|Pre-randomization Washout Period||0
8243003|NCT01915940|20328583|P2|COMPLETED|Pre-randomization Washout Period||0
8243004|NCT01915940|20328584|P1|COMPLETED|Pre-randomization Washout Period||130
8243005|NCT01915940|20328582|P3|STARTED|Pre-randomization Washout Period||0
8243006|NCT01915940|20328583|P2|STARTED|Pre-randomization Washout Period||0
8243007|NCT01915940|20328584|P1|STARTED|Pre-randomization Washout Period||169
8243008|NCT01915914|20328600|P4|NOT COMPLETED|Follow-up Phase||2
8243009|NCT01915914|20328601|P3|NOT COMPLETED|Follow-up Phase||0
8243010|NCT01915914|20328602|P2|NOT COMPLETED|Follow-up Phase||0
8243011|NCT01915914|20328603|P1|NOT COMPLETED|Follow-up Phase||0
8243012|NCT01915914|20328600|P4|COMPLETED|Follow-up Phase||64
8243013|NCT01915914|20328601|P3|COMPLETED|Follow-up Phase||0
8243014|NCT01915914|20328602|P2|COMPLETED|Follow-up Phase||0
8243015|NCT01915914|20328603|P1|COMPLETED|Follow-up Phase||0
8243016|NCT01915914|20328600|P4|STARTED|Follow-up Phase||66
8243017|NCT01915914|20328601|P3|STARTED|Follow-up Phase||0
8243018|NCT01915914|20328602|P2|STARTED|Follow-up Phase||0
8243019|NCT01915914|20328603|P1|STARTED|Follow-up Phase||0
8243020|NCT01915914|20328600|P4|NOT COMPLETED|Maintenance Phase||0
8243021|NCT01915914|20328601|P3|NOT COMPLETED|Maintenance Phase||2
8243022|NCT01915914|20328602|P2|NOT COMPLETED|Maintenance Phase||6
8243023|NCT01915914|20328603|P1|NOT COMPLETED|Maintenance Phase||0
8243024|NCT01915914|20328600|P4|COMPLETED|Maintenance Phase||0
8243025|NCT01915914|20328601|P3|COMPLETED|Maintenance Phase||51
8243026|NCT01915914|20328602|P2|COMPLETED|Maintenance Phase||48
8243027|NCT01915914|20328603|P1|COMPLETED|Maintenance Phase||0
8243028|NCT01915914|20328600|P4|STARTED|Maintenance Phase||0
8243029|NCT01915914|20328601|P3|STARTED|Maintenance Phase||53
8243030|NCT01915914|20328602|P2|STARTED|Maintenance Phase||54
8243031|NCT01915914|20328603|P1|STARTED|Maintenance Phase||0
8243032|NCT01915914|20328600|P4|NOT COMPLETED|Acute Phase||0
8243033|NCT01915914|20328601|P3|NOT COMPLETED|Acute Phase||0
8243034|NCT01915914|20328602|P2|NOT COMPLETED|Acute Phase||0
8243035|NCT01915914|20328603|P1|NOT COMPLETED|Acute Phase||12
8243036|NCT01915914|20328600|P4|COMPLETED|Acute Phase||0
8243037|NCT01915914|20328601|P3|COMPLETED|Acute Phase||0
8243038|NCT01915914|20328602|P2|COMPLETED|Acute Phase||0
8243039|NCT01915914|20328603|P1|COMPLETED|Acute Phase||111
8243040|NCT01915914|20328600|P4|Completed-Not Entered Maintenance Phase|Acute Phase||0
8243041|NCT01915914|20328601|P3|Completed-Not Entered Maintenance Phase|Acute Phase||0
8243042|NCT01915914|20328602|P2|Completed-Not Entered Maintenance Phase|Acute Phase||0
8243043|NCT01915914|20328603|P1|Completed-Not Entered Maintenance Phase|Acute Phase||4
8243044|NCT01915914|20328600|P4|STARTED|Acute Phase||0
8243045|NCT01915914|20328601|P3|STARTED|Acute Phase||0
8243046|NCT01915914|20328602|P2|STARTED|Acute Phase||0
8243047|NCT01915914|20328603|P1|STARTED|Acute Phase||123
8243048|NCT01915849|20328635|P4|NOT COMPLETED|Treatment Period 4 (4 Days)||0
8243049|NCT01915849|20328636|P3|NOT COMPLETED|Treatment Period 4 (4 Days)||0
8243050|NCT01915849|20328637|P2|NOT COMPLETED|Treatment Period 4 (4 Days)||0
8243051|NCT01915849|20328638|P1|NOT COMPLETED|Treatment Period 4 (4 Days)||0
8243052|NCT01915849|20328635|P4|COMPLETED|Treatment Period 4 (4 Days)||3
8243053|NCT01915849|20328636|P3|COMPLETED|Treatment Period 4 (4 Days)||3
8243054|NCT01915849|20328637|P2|COMPLETED|Treatment Period 4 (4 Days)||3
8243055|NCT01915849|20328638|P1|COMPLETED|Treatment Period 4 (4 Days)||3
8243056|NCT01915849|20328635|P4|STARTED|Treatment Period 4 (4 Days)||3
8243057|NCT01915849|20328636|P3|STARTED|Treatment Period 4 (4 Days)||3
8243058|NCT01915849|20328637|P2|STARTED|Treatment Period 4 (4 Days)||3
8243059|NCT01915849|20328638|P1|STARTED|Treatment Period 4 (4 Days)||3
8243060|NCT01915849|20328635|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8243061|NCT01915849|20328636|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8243062|NCT01915849|20328637|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8243063|NCT01915849|20328638|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
8243064|NCT01915849|20328635|P4|COMPLETED|Treatment Period 3 (4 Days)||3
8243065|NCT01915849|20328636|P3|COMPLETED|Treatment Period 3 (4 Days)||3
8243066|NCT01915849|20328637|P2|COMPLETED|Treatment Period 3 (4 Days)||3
8243067|NCT01915849|20328638|P1|COMPLETED|Treatment Period 3 (4 Days)||3
8243068|NCT01915849|20328635|P4|STARTED|Treatment Period 3 (4 Days)||3
8243069|NCT01915849|20328636|P3|STARTED|Treatment Period 3 (4 Days)||3
8243070|NCT01915849|20328637|P2|STARTED|Treatment Period 3 (4 Days)||3
8243071|NCT01915849|20328638|P1|STARTED|Treatment Period 3 (4 Days)||3
8243072|NCT01915849|20328635|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8243073|NCT01915849|20328636|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8243074|NCT01915849|20328637|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8243075|NCT01915849|20328638|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
8243076|NCT01915849|20328635|P4|COMPLETED|Treatment Period 2 (4 Days)||3
8243077|NCT01915849|20328636|P3|COMPLETED|Treatment Period 2 (4 Days)||3
8243078|NCT01915849|20328637|P2|COMPLETED|Treatment Period 2 (4 Days)||3
8243079|NCT01915849|20328638|P1|COMPLETED|Treatment Period 2 (4 Days)||3
8243080|NCT01915849|20328635|P4|STARTED|Treatment Period 2 (4 Days)||3
8243081|NCT01915849|20328636|P3|STARTED|Treatment Period 2 (4 Days)||3
8243082|NCT01915849|20328637|P2|STARTED|Treatment Period 2 (4 Days)||3
8243083|NCT01915849|20328638|P1|STARTED|Treatment Period 2 (4 Days)||3
8243084|NCT01915849|20328635|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8243085|NCT01915849|20328636|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8243086|NCT01915849|20328637|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
8243087|NCT01915849|20328638|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||2
8243088|NCT01915849|20328635|P4|COMPLETED|Treatment Period 1 (4 Days)||3
8243089|NCT01915849|20328636|P3|COMPLETED|Treatment Period 1 (4 Days)||3
8243090|NCT01915849|20328637|P2|COMPLETED|Treatment Period 1 (4 Days)||3
8243091|NCT01915849|20328638|P1|COMPLETED|Treatment Period 1 (4 Days)||3
8243092|NCT01915849|20328635|P4|STARTED|Treatment Period 1 (4 Days)||3
8243093|NCT01915849|20328636|P3|STARTED|Treatment Period 1 (4 Days)||3
8243094|NCT01915849|20328637|P2|STARTED|Treatment Period 1 (4 Days)||3
8243095|NCT01915849|20328638|P1|STARTED|Treatment Period 1 (4 Days)||5
8243096|NCT01915823|20328650|P2|NOT COMPLETED|Overall Study||2
8243097|NCT01915823|20328651|P1|NOT COMPLETED|Overall Study||2
8243098|NCT01915823|20328650|P2|COMPLETED|Overall Study||173
8243099|NCT01915823|20328651|P1|COMPLETED|Overall Study||171
8243100|NCT01915823|20328650|P2|STARTED|Overall Study||175
8243101|NCT01915823|20328651|P1|STARTED|Overall Study||173
8243102|NCT01915771|20328661|P1|NOT COMPLETED|Day 15||1
8243103|NCT01915771|20328661|P1|COMPLETED|Day 15||13
8243104|NCT01915771|20328661|P1|STARTED|Day 15||14
8243105|NCT01915771|20328661|P1|NOT COMPLETED|Day 1||1
8243106|NCT01915771|20328661|P1|COMPLETED|Day 1||14
8243107|NCT01915771|20328661|P1|STARTED|Day 1||15
8243108|NCT01915732|20328685|P2|NOT COMPLETED|Overall Study||71
8243109|NCT01915732|20328686|P1|NOT COMPLETED|Overall Study||70
8243110|NCT01915732|20328685|P2|COMPLETED|Overall Study||445
8243111|NCT01915732|20328686|P1|COMPLETED|Overall Study||430
8243112|NCT01915732|20328685|P2|STARTED|Overall Study||516
8243113|NCT01915732|20328686|P1|STARTED|Overall Study||500
8243114|NCT01915563|20328712|P2|NOT COMPLETED|Overall Study||0
8243115|NCT01915563|20328713|P1|NOT COMPLETED|Overall Study||0
8243116|NCT01915563|20328712|P2|COMPLETED|Overall Study||227
8243117|NCT01915563|20328713|P1|COMPLETED|Overall Study||243
8243118|NCT01915563|20328712|P2|STARTED|Overall Study||227
8243119|NCT01915563|20328713|P1|STARTED|Overall Study||243
8243120|NCT01915498|20328739|P19|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||2
8243121|NCT01915498|20328740|P18|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243122|NCT01915498|20328741|P17|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243123|NCT01915498|20328742|P16|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243124|NCT01915498|20328743|P15|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243125|NCT01915498|20328744|P14|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243126|NCT01915498|20328745|P13|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243127|NCT01915498|20328746|P12|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243128|NCT01915498|20328747|P11|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243129|NCT01915498|20328748|P10|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243130|NCT01915498|20328749|P9|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243131|NCT01915498|20328750|P8|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243132|NCT01915498|20328751|P7|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243133|NCT01915498|20328752|P6|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243134|NCT01915498|20328753|P5|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243135|NCT01915498|20328754|P4|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243136|NCT01915498|20328755|P3|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243137|NCT01915498|20328756|P2|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243138|NCT01915498|20328757|P1|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243139|NCT01915498|20328739|P19|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||14
8243140|NCT01915498|20328740|P18|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243141|NCT01915498|20328741|P17|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243142|NCT01915498|20328742|P16|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243143|NCT01915498|20328743|P15|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243144|NCT01915498|20328744|P14|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243145|NCT01915498|20328745|P13|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243146|NCT01915498|20328746|P12|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243147|NCT01915498|20328747|P11|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243148|NCT01915498|20328748|P10|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243149|NCT01915498|20328749|P9|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243150|NCT01915498|20328750|P8|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243151|NCT01915498|20328751|P7|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243152|NCT01915498|20328752|P6|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243153|NCT01915498|20328753|P5|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243154|NCT01915498|20328754|P4|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243155|NCT01915498|20328755|P3|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243156|NCT01915498|20328756|P2|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243157|NCT01915498|20328757|P1|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
8243158|NCT01915498|20328739|P19|STARTED|Safety Follow-up (Sept 2017 to July 2019||16
8243159|NCT01915498|20328740|P18|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243160|NCT01915498|20328741|P17|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243161|NCT01915498|20328742|P16|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243162|NCT01915498|20328743|P15|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243163|NCT01915498|20328744|P14|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243164|NCT01915498|20328745|P13|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243165|NCT01915498|20328746|P12|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243166|NCT01915498|20328747|P11|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243167|NCT01915498|20328748|P10|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243168|NCT01915498|20328749|P9|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243169|NCT01915498|20328750|P8|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243170|NCT01915498|20328751|P7|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243171|NCT01915498|20328752|P6|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243172|NCT01915498|20328753|P5|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243173|NCT01915498|20328754|P4|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243174|NCT01915498|20328755|P3|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243254|NCT01915108|20329337|P2|NOT COMPLETED|Overall Study||3
8243175|NCT01915498|20328756|P2|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243176|NCT01915498|20328757|P1|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
8243177|NCT01915498|20328739|P19|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243178|NCT01915498|20328740|P18|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||100
8243179|NCT01915498|20328741|P17|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||24
8243180|NCT01915498|20328742|P16|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||23
8243181|NCT01915498|20328743|P15|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||25
8243182|NCT01915498|20328744|P14|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||46
8243183|NCT01915498|20328745|P13|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8243184|NCT01915498|20328746|P12|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||4
8243185|NCT01915498|20328747|P11|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
8243186|NCT01915498|20328748|P10|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||14
8243187|NCT01915498|20328749|P9|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
8243188|NCT01915498|20328750|P8|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||21
8243189|NCT01915498|20328751|P7|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8243190|NCT01915498|20328752|P6|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
8243191|NCT01915498|20328753|P5|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||5
8243192|NCT01915498|20328754|P4|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||8
8243193|NCT01915498|20328755|P3|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8243194|NCT01915498|20328756|P2|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8243195|NCT01915498|20328757|P1|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
8243196|NCT01915498|20328739|P19|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243197|NCT01915498|20328740|P18|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
8243198|NCT01915498|20328741|P17|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
8243199|NCT01915498|20328742|P16|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||2
8243200|NCT01915498|20328743|P15|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243201|NCT01915498|20328744|P14|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
8243202|NCT01915498|20328745|P13|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243203|NCT01915498|20328746|P12|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
8243204|NCT01915498|20328747|P11|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243205|NCT01915498|20328748|P10|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243206|NCT01915498|20328749|P9|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243207|NCT01915498|20328750|P8|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
8243208|NCT01915498|20328751|P7|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243209|NCT01915498|20328752|P6|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243210|NCT01915498|20328753|P5|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243211|NCT01915498|20328754|P4|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243212|NCT01915498|20328755|P3|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243213|NCT01915498|20328756|P2|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243214|NCT01915498|20328757|P1|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
8243215|NCT01915498|20328739|P19|STARTED|Main Analysis (Sept 2013 - Sept 2017)||0
8243216|NCT01915498|20328740|P18|STARTED|Main Analysis (Sept 2013 - Sept 2017)||106
8243217|NCT01915498|20328741|P17|STARTED|Main Analysis (Sept 2013 - Sept 2017)||27
8243218|NCT01915498|20328742|P16|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
8243219|NCT01915498|20328743|P15|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
8243220|NCT01915498|20328744|P14|STARTED|Main Analysis (Sept 2013 - Sept 2017)||49
8243221|NCT01915498|20328745|P13|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8243222|NCT01915498|20328746|P12|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
8243223|NCT01915498|20328747|P11|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
8243224|NCT01915498|20328748|P10|STARTED|Main Analysis (Sept 2013 - Sept 2017)||14
8243225|NCT01915498|20328749|P9|STARTED|Main Analysis (Sept 2013 - Sept 2017)||6
8243226|NCT01915498|20328750|P8|STARTED|Main Analysis (Sept 2013 - Sept 2017)||22
8243227|NCT01915498|20328751|P7|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8243228|NCT01915498|20328752|P6|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
8243229|NCT01915498|20328753|P5|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
8243230|NCT01915498|20328754|P4|STARTED|Main Analysis (Sept 2013 - Sept 2017)||8
8243231|NCT01915498|20328755|P3|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8243232|NCT01915498|20328756|P2|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8243233|NCT01915498|20328757|P1|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
8243234|NCT01915303|20329281|P1|NOT COMPLETED|Extension Phase||17
8243235|NCT01915303|20329281|P1|COMPLETED|Extension Phase||12
8243236|NCT01915303|20329281|P1|STARTED|Extension Phase||29
8243237|NCT01915303|20329281|P1|NOT COMPLETED|Core Phase||16
8243238|NCT01915303|20329281|P1|COMPLETED|Core Phase||52
8243239|NCT01915303|20329281|P1|STARTED|Core Phase||68
8243240|NCT01915173|20329310|P4|NOT COMPLETED|Overall Study||0
8243241|NCT01915173|20329311|P3|NOT COMPLETED|Overall Study||0
8243242|NCT01915173|20329312|P2|NOT COMPLETED|Overall Study||0
8243243|NCT01915173|20329313|P1|NOT COMPLETED|Overall Study||0
8243244|NCT01915173|20329310|P4|COMPLETED|Overall Study||6
8243245|NCT01915173|20329311|P3|COMPLETED|Overall Study||6
8243246|NCT01915173|20329312|P2|COMPLETED|Overall Study||6
8243247|NCT01915173|20329313|P1|COMPLETED|Overall Study||6
8243248|NCT01915173|20329310|P4|STARTED|Overall Study||6
8243249|NCT01915173|20329311|P3|STARTED|Overall Study||6
8243250|NCT01915173|20329312|P2|STARTED|Overall Study||6
8243251|NCT01915173|20329313|P1|STARTED|Overall Study||6
8243252|NCT01915108|20329335|P4|NOT COMPLETED|Overall Study||2
8243253|NCT01915108|20329336|P3|NOT COMPLETED|Overall Study||1
8243255|NCT01915108|20329338|P1|NOT COMPLETED|Overall Study||2
8243256|NCT01915108|20329335|P4|COMPLETED|Overall Study|two patients were excluded from the study|30
8243257|NCT01915108|20329336|P3|COMPLETED|Overall Study|one patients were excluded from the study|31
8243258|NCT01915108|20329337|P2|COMPLETED|Overall Study|three patients were excluded from the study|29
8243259|NCT01915108|20329338|P1|COMPLETED|Overall Study|two patients were excluded from the study|30
8243260|NCT01915108|20329335|P4|STARTED|Overall Study||32
8243261|NCT01915108|20329336|P3|STARTED|Overall Study||32
8243262|NCT01915108|20329337|P2|STARTED|Overall Study||32
8243263|NCT01915108|20329338|P1|STARTED|Overall Study||32
8243289|NCT01914926|20329382|P2|NOT COMPLETED|Overall Study||1
8243290|NCT01914926|20329383|P1|NOT COMPLETED|Overall Study||1
8243291|NCT01914926|20329382|P2|COMPLETED|Overall Study||24
8243292|NCT01914926|20329383|P1|COMPLETED|Overall Study||28
8243293|NCT01914926|20329382|P2|STARTED|Overall Study||25
8243294|NCT01914926|20329383|P1|STARTED|Overall Study||29
8243295|NCT01914757|20329392|P3|NOT COMPLETED|Overall Study||38
8243296|NCT01914757|20329393|P2|NOT COMPLETED|Overall Study||51
8243297|NCT01914757|20329394|P1|NOT COMPLETED|Overall Study||36
8243298|NCT01914757|20329392|P3|COMPLETED|Overall Study||402
8243299|NCT01914757|20329393|P2|COMPLETED|Overall Study||390
8243300|NCT01914757|20329394|P1|COMPLETED|Overall Study||389
8243301|NCT01914757|20329392|P3|STARTED|Overall Study||440
8243302|NCT01914757|20329393|P2|STARTED|Overall Study||441
8243303|NCT01914757|20329394|P1|STARTED|Overall Study||425
8243304|NCT01914679|20329468|P1|NOT COMPLETED|Overall Study||5
8243305|NCT01914679|20329468|P1|COMPLETED|Overall Study||12
8243306|NCT01914679|20329468|P1|Began 12 Week Actual RINCE Treatment|Overall Study||17
8243307|NCT01914679|20329468|P1|STARTED|Overall Study||17
8243308|NCT01914666|20329475|P3|NOT COMPLETED|Tapering Period||0
8243309|NCT01914666|20329476|P2|NOT COMPLETED|Tapering Period||0
8243310|NCT01914666|20329477|P1|NOT COMPLETED|Tapering Period||0
8243311|NCT01914666|20329475|P3|COMPLETED|Tapering Period||40
8243312|NCT01914666|20329476|P2|COMPLETED|Tapering Period||39
8243313|NCT01914666|20329477|P1|COMPLETED|Tapering Period||59
8243314|NCT01914666|20329475|P3|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
8243315|NCT01914666|20329476|P2|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
8243316|NCT01914666|20329477|P1|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
8243317|NCT01914666|20329475|P3|NOT COMPLETED|Treatment Period||8
8243318|NCT01914666|20329476|P2|NOT COMPLETED|Treatment Period||6
8243319|NCT01914666|20329477|P1|NOT COMPLETED|Treatment Period||13
8243320|NCT01914666|20329475|P3|COMPLETED|Treatment Period||33
8243321|NCT01914666|20329476|P2|COMPLETED|Treatment Period||36
8243322|NCT01914666|20329477|P1|COMPLETED|Treatment Period||55
8243323|NCT01914666|20329475|P3|Received at Least 1 Dose of Study Drug|Treatment Period||41
8243324|NCT01914666|20329476|P2|Received at Least 1 Dose of Study Drug|Treatment Period||42
8243325|NCT01914666|20329477|P1|Received at Least 1 Dose of Study Drug|Treatment Period||68
8243326|NCT01914666|20329475|P3|STARTED|Treatment Period||41
8243327|NCT01914666|20329476|P2|STARTED|Treatment Period||42
8243328|NCT01914666|20329477|P1|STARTED|Treatment Period||68
8243329|NCT01914510|20329510|P1|NOT COMPLETED|Overall Study||2
8243330|NCT01914510|20329510|P1|COMPLETED|Overall Study||38
8243331|NCT01914510|20329510|P1|STARTED|Overall Study||40
8243332|NCT01914393|20329520|P3|NOT COMPLETED|Overall Study||138
8243333|NCT01914393|20329521|P2|NOT COMPLETED|Overall Study||71
8243334|NCT01914393|20329522|P1|NOT COMPLETED|Overall Study||115
8243335|NCT01914393|20329520|P3|COMPLETED|Overall Study||168
8243336|NCT01914393|20329521|P2|COMPLETED|Overall Study||54
8243337|NCT01914393|20329522|P1|COMPLETED|Overall Study||156
8243338|NCT01914393|20329520|P3|STARTED|Overall Study||306
8243339|NCT01914393|20329521|P2|STARTED|Overall Study||125
8243340|NCT01914393|20329522|P1|STARTED|Overall Study||271
8243341|NCT01914159|20329554|P1|NOT COMPLETED|Overall Study||3
8243342|NCT01914159|20329554|P1|COMPLETED|Overall Study||21
8243343|NCT01914159|20329554|P1|STARTED|Overall Study||24
8243344|NCT01914003|20329562|P2|NOT COMPLETED|Overall Study||12
8243345|NCT01914003|20329563|P1|NOT COMPLETED|Overall Study||8
8243346|NCT01914003|20329562|P2|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
8243347|NCT01914003|20329563|P1|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
8243348|NCT01914003|20329562|P2|STARTED|Overall Study||26
8243349|NCT01914003|20329563|P1|STARTED|Overall Study||27
8243350|NCT01913795|20329573|P4|NOT COMPLETED|Overall Study||1
8243351|NCT01913795|20329574|P3|NOT COMPLETED|Overall Study||0
8243352|NCT01913795|20329575|P2|NOT COMPLETED|Overall Study||3
8243353|NCT01913795|20329576|P1|NOT COMPLETED|Overall Study||0
8243354|NCT01913795|20329573|P4|COMPLETED|Overall Study||5
8243355|NCT01913795|20329574|P3|COMPLETED|Overall Study||9
8243356|NCT01913795|20329575|P2|COMPLETED|Overall Study||7
8243357|NCT01913795|20329576|P1|COMPLETED|Overall Study||4
8243358|NCT01913795|20329573|P4|STARTED|Overall Study||6
8243359|NCT01913795|20329574|P3|STARTED|Overall Study||9
8243360|NCT01913795|20329575|P2|STARTED|Overall Study||10
8243361|NCT01913795|20329576|P1|STARTED|Overall Study||4
8243362|NCT01913639|20329590|P1|NOT COMPLETED|Overall Study||3
8243363|NCT01913639|20329590|P1|COMPLETED|Overall Study||36
8243364|NCT01913639|20329590|P1|STARTED|Overall Study||39
8243365|NCT01913600|20329597|P1|NOT COMPLETED|Overall Study||1
8243366|NCT01913600|20329597|P1|COMPLETED|Overall Study||55
8243367|NCT01913600|20329597|P1|STARTED|Overall Study||56
8243368|NCT01913535|20329619|P5|NOT COMPLETED|Phase 2 (Days 3-5)||0
8243369|NCT01913535|20329620|P4|NOT COMPLETED|Phase 2 (Days 3-5)||0
8243370|NCT01913535|20329621|P3|NOT COMPLETED|Phase 2 (Days 3-5)||0
8243371|NCT01913535|20329622|P2|NOT COMPLETED|Phase 2 (Days 3-5)||0
8243372|NCT01913535|20329623|P1|NOT COMPLETED|Phase 2 (Days 3-5)||0
8243373|NCT01913535|20329619|P5|COMPLETED|Phase 2 (Days 3-5)||1
8243374|NCT01913535|20329620|P4|COMPLETED|Phase 2 (Days 3-5)||2
8243375|NCT01913535|20329621|P3|COMPLETED|Phase 2 (Days 3-5)||1
8243376|NCT01913535|20329622|P2|COMPLETED|Phase 2 (Days 3-5)||2
8243377|NCT01913535|20329623|P1|COMPLETED|Phase 2 (Days 3-5)||2
8243378|NCT01913535|20329619|P5|STARTED|Phase 2 (Days 3-5)||1
8243379|NCT01913535|20329620|P4|STARTED|Phase 2 (Days 3-5)||2
8243380|NCT01913535|20329621|P3|STARTED|Phase 2 (Days 3-5)||1
8243381|NCT01913535|20329622|P2|STARTED|Phase 2 (Days 3-5)||2
8243382|NCT01913535|20329623|P1|STARTED|Phase 2 (Days 3-5)||2
8243383|NCT01913535|20329619|P5|NOT COMPLETED|Phase 1 (Days 0-2)||0
8243384|NCT01913535|20329620|P4|NOT COMPLETED|Phase 1 (Days 0-2)||0
8243385|NCT01913535|20329621|P3|NOT COMPLETED|Phase 1 (Days 0-2)||0
8243386|NCT01913535|20329622|P2|NOT COMPLETED|Phase 1 (Days 0-2)||0
8243387|NCT01913535|20329623|P1|NOT COMPLETED|Phase 1 (Days 0-2)||0
8243388|NCT01913535|20329619|P5|COMPLETED|Phase 1 (Days 0-2)||1
8243389|NCT01913535|20329620|P4|COMPLETED|Phase 1 (Days 0-2)||2
8243390|NCT01913535|20329621|P3|COMPLETED|Phase 1 (Days 0-2)||1
8243391|NCT01913535|20329622|P2|COMPLETED|Phase 1 (Days 0-2)||2
8243392|NCT01913535|20329623|P1|COMPLETED|Phase 1 (Days 0-2)||2
8243393|NCT01913535|20329619|P5|STARTED|Phase 1 (Days 0-2)||1
8243394|NCT01913535|20329620|P4|STARTED|Phase 1 (Days 0-2)||2
8243395|NCT01913535|20329621|P3|STARTED|Phase 1 (Days 0-2)||1
8243396|NCT01913535|20329622|P2|STARTED|Phase 1 (Days 0-2)||2
8243397|NCT01913535|20329623|P1|STARTED|Phase 1 (Days 0-2)||2
8243398|NCT01913483|20329656|P2|NOT COMPLETED|Overall Study||22
8243399|NCT01913483|20329657|P1|NOT COMPLETED|Overall Study||21
8243400|NCT01913483|20329656|P2|COMPLETED|Overall Study||343
8243401|NCT01913483|20329657|P1|COMPLETED|Overall Study||346
8243402|NCT01913483|20329656|P2|Received at Least 1 Dose of Study Drug|Overall Study||321
8243403|NCT01913483|20329657|P1|Received at Least 1 Dose of Study Drug|Overall Study||335
8243404|NCT01913483|20329656|P2|STARTED|Overall Study||365
8243405|NCT01913483|20329657|P1|STARTED|Overall Study||367
8243406|NCT01913470|20329669|P2|NOT COMPLETED|Overall Study||3
8243407|NCT01913470|20329670|P1|NOT COMPLETED|Overall Study||0
8243408|NCT01913470|20329669|P2|COMPLETED|Overall Study||4
8243409|NCT01913470|20329670|P1|COMPLETED|Overall Study||5
8243410|NCT01913470|20329669|P2|STARTED|Overall Study||7
8243411|NCT01913470|20329670|P1|STARTED|Overall Study||5
8243415|NCT01913353|20329744|P2|NOT COMPLETED|Overall Study||15
8243416|NCT01913353|20329745|P1|NOT COMPLETED|Overall Study||32
8243417|NCT01913353|20329744|P2|COMPLETED|Overall Study||204
8243418|NCT01913353|20329745|P1|COMPLETED|Overall Study||189
8243419|NCT01913353|20329744|P2|STARTED|Overall Study||219
8243420|NCT01913353|20329745|P1|STARTED|Overall Study||221
8243421|NCT01913340|20329815|P2|NOT COMPLETED|Overall Study||6
8243422|NCT01913340|20329816|P1|NOT COMPLETED|Overall Study||3
8243423|NCT01913340|20329815|P2|COMPLETED|Overall Study||20
8243424|NCT01913340|20329816|P1|COMPLETED|Overall Study||21
8243425|NCT01913340|20329815|P2|STARTED|Overall Study||26
8243426|NCT01913340|20329816|P1|STARTED|Overall Study|22 (92%) received all 5 doses, 1 (4%) received 4 doses, and 1 (4%) only received 1 dose.|24
8243427|NCT01913327|20329840|P2|NOT COMPLETED|Overall Study||1
8243428|NCT01913327|20329841|P1|NOT COMPLETED|Overall Study||0
8243429|NCT01913327|20329840|P2|COMPLETED|Overall Study||1
8243430|NCT01913327|20329841|P1|COMPLETED|Overall Study||1
8243431|NCT01913327|20329840|P2|STARTED|Overall Study||2
8243432|NCT01913327|20329841|P1|STARTED|Overall Study||1
8243433|NCT01913314|20329853|P1|NOT COMPLETED|Overall Study||0
8243434|NCT01913314|20329853|P1|COMPLETED|Overall Study||6
8243435|NCT01913314|20329853|P1|Received Study Drug|Overall Study||6
8243436|NCT01913314|20329853|P1|STARTED|Overall Study||6
8243437|NCT01913041|20329866|P1|NOT COMPLETED|Overall Study||39
8243438|NCT01913041|20329866|P1|COMPLETED|Overall Study||830
8243439|NCT01913041|20329866|P1|STARTED|Overall Study||869
8243440|NCT01912963|20329873|P3|NOT COMPLETED|Overall Study||7
8243441|NCT01912963|20329874|P2|NOT COMPLETED|Overall Study||19
8243442|NCT01912963|20329875|P1|NOT COMPLETED|Overall Study||6
8243443|NCT01912963|20329873|P3|COMPLETED|Overall Study||0
8243444|NCT01912963|20329874|P2|COMPLETED|Overall Study||0
8243445|NCT01912963|20329875|P1|COMPLETED|Overall Study||0
8243446|NCT01912963|20329873|P3|STARTED|Overall Study||7
8243447|NCT01912963|20329874|P2|STARTED|Overall Study||19
8243448|NCT01912963|20329875|P1|STARTED|Overall Study||6
8243449|NCT01912872|20329898|P4|NOT COMPLETED|Overall Study||12
8243450|NCT01912872|20329899|P3|NOT COMPLETED|Overall Study||10
8243451|NCT01912872|20329900|P2|NOT COMPLETED|Overall Study||4
8243452|NCT01912872|20329901|P1|NOT COMPLETED|Overall Study||5
8243453|NCT01912872|20329898|P4|COMPLETED|Overall Study||27
8243454|NCT01912872|20329899|P3|COMPLETED|Overall Study||30
8243455|NCT01912872|20329900|P2|COMPLETED|Overall Study||13
8243456|NCT01912872|20329901|P1|COMPLETED|Overall Study||11
8243457|NCT01912872|20329898|P4|Discontinued Treatment Prior to Month 12|Overall Study||11
8243458|NCT01912872|20329899|P3|Discontinued Treatment Prior to Month 12|Overall Study||10
8243459|NCT01912872|20329900|P2|Discontinued Treatment Prior to Month 12|Overall Study||4
8243460|NCT01912872|20329901|P1|Discontinued Treatment Prior to Month 12|Overall Study||5
8243461|NCT01912872|20329898|P4|Completed Study Treatment at Month 12|Overall Study||27
8243462|NCT01912872|20329899|P3|Completed Study Treatment at Month 12|Overall Study||30
8243463|NCT01912872|20329900|P2|Completed Study Treatment at Month 12|Overall Study||13
8243464|NCT01912872|20329901|P1|Completed Study Treatment at Month 12|Overall Study||11
8243465|NCT01912872|20329898|P4|STARTED|Overall Study||39
8243466|NCT01912872|20329899|P3|STARTED|Overall Study||40
8243467|NCT01912872|20329900|P2|STARTED|Overall Study||17
8243468|NCT01912872|20329901|P1|STARTED|Overall Study||16
8243469|NCT01912781|20329945|P2|NOT COMPLETED|Overall Study||0
8243470|NCT01912781|20329946|P1|NOT COMPLETED|Overall Study||2
8243471|NCT01912781|20329945|P2|COMPLETED|Overall Study||35
8243472|NCT01912781|20329946|P1|COMPLETED|Overall Study||69
8243473|NCT01912781|20329945|P2|STARTED|Overall Study||35
8243474|NCT01912781|20329946|P1|STARTED|Overall Study||71
8243475|NCT01912768|20329977|P2|NOT COMPLETED|Overall Study||4
8243476|NCT01912768|20329978|P1|NOT COMPLETED|Overall Study||10
8243477|NCT01912768|20329977|P2|COMPLETED|Overall Study||109
8243478|NCT01912768|20329978|P1|COMPLETED|Overall Study||229
8243479|NCT01912768|20329977|P2|STARTED|Overall Study||113
8243480|NCT01912768|20329978|P1|STARTED|Overall Study||239
8243481|NCT01912729|20330009|P2|NOT COMPLETED|Overall Study||1
8243482|NCT01912729|20330010|P1|NOT COMPLETED|Overall Study||0
8243483|NCT01912729|20330009|P2|COMPLETED|Overall Study||19
8243484|NCT01912729|20330010|P1|COMPLETED|Overall Study||20
8243485|NCT01912729|20330009|P2|STARTED|Overall Study||20
8243486|NCT01912729|20330010|P1|STARTED|Overall Study||20
8243487|NCT01912716|20330022|P2|NOT COMPLETED|Overall Study||0
8243488|NCT01912716|20330023|P1|NOT COMPLETED|Overall Study||0
8243489|NCT01912716|20330022|P2|COMPLETED|Overall Study||515
8243490|NCT01912716|20330023|P1|COMPLETED|Overall Study||522
8243491|NCT01912716|20330022|P2|3-day Follow-up|Overall Study||513
8243492|NCT01912716|20330023|P1|3-day Follow-up|Overall Study||521
8243493|NCT01912716|20330022|P2|5-day Follow-up|Overall Study||515
8243494|NCT01912716|20330023|P1|5-day Follow-up|Overall Study||522
8243495|NCT01912716|20330022|P2|Receipt of 2nd Dose|Overall Study||503
8243496|NCT01912716|20330023|P1|Receipt of 2nd Dose|Overall Study||511
8243497|NCT01912716|20330022|P2|STARTED|Overall Study||515
8243498|NCT01912716|20330023|P1|STARTED|Overall Study|receipt of 1st dose of indomethacin|522
8243499|NCT01912612|20330033|P3|NOT COMPLETED|Overall Study||3
8243500|NCT01912612|20330034|P2|NOT COMPLETED|Overall Study||0
8243501|NCT01912612|20330035|P1|NOT COMPLETED|Overall Study||5
8243502|NCT01912612|20330033|P3|COMPLETED|Overall Study||0
8243503|NCT01912612|20330034|P2|COMPLETED|Overall Study||40
8243504|NCT01912612|20330035|P1|COMPLETED|Overall Study||31
8243505|NCT01912612|20330033|P3|STARTED|Overall Study||3
8243506|NCT01912612|20330034|P2|STARTED|Overall Study||40
8243507|NCT01912612|20330035|P1|STARTED|Overall Study||36
8243508|NCT01912599|20330079|P2|NOT COMPLETED|Overall Study||1
8243509|NCT01912599|20330080|P1|NOT COMPLETED|Overall Study||0
8243510|NCT01912599|20330079|P2|COMPLETED|Overall Study||15
8243511|NCT01912599|20330080|P1|COMPLETED|Overall Study||20
8243512|NCT01912599|20330079|P2|STARTED|Overall Study||16
8243513|NCT01912599|20330080|P1|STARTED|Overall Study||20
8243514|NCT01912495|20330094|P1|NOT COMPLETED|Overall Study||0
8243515|NCT01912495|20330094|P1|COMPLETED|Overall Study||57
8243516|NCT01912495|20330094|P1|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
8243517|NCT01912404|20330105|P2|NOT COMPLETED|Overall Study||0
8243518|NCT01912404|20330106|P1|NOT COMPLETED|Overall Study||1
8243519|NCT01912404|20330105|P2|COMPLETED|Overall Study||2
8243520|NCT01912404|20330106|P1|COMPLETED|Overall Study||2
8243521|NCT01912404|20330105|P2|STARTED|Overall Study||2
8243522|NCT01912404|20330106|P1|STARTED|Overall Study||3
8243523|NCT01912352|20330112|P1|NOT COMPLETED|Overall Study||5
8243524|NCT01912352|20330112|P1|COMPLETED|Overall Study||78
8243525|NCT01912352|20330112|P1|STARTED|Overall Study||83
8243526|NCT01912339|20330119|P3|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
8243527|NCT01912339|20330120|P2|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
8243528|NCT01912339|20330121|P1|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
8243529|NCT01912339|20330119|P3|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
8243530|NCT01912339|20330120|P2|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
8243531|NCT01912339|20330121|P1|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
8243532|NCT01912339|20330119|P3|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
8243533|NCT01912339|20330120|P2|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
8243534|NCT01912339|20330121|P1|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
8243535|NCT01912339|20330119|P3|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
8243536|NCT01912339|20330120|P2|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
8243537|NCT01912339|20330121|P1|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
8243538|NCT01912339|20330119|P3|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
8243539|NCT01912339|20330120|P2|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
8243540|NCT01912339|20330121|P1|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
8243541|NCT01912339|20330119|P3|STARTED|Unblinded (3 to 6 Months/Crossover)||0
8243542|NCT01912339|20330120|P2|STARTED|Unblinded (3 to 6 Months/Crossover)||61
8243543|NCT01912339|20330121|P1|STARTED|Unblinded (3 to 6 Months/Crossover)||134
8243544|NCT01912339|20330119|P3|NOT COMPLETED|Blinded (0 to 3 Months)||0
8243545|NCT01912339|20330120|P2|NOT COMPLETED|Blinded (0 to 3 Months)||0
8243546|NCT01912339|20330121|P1|NOT COMPLETED|Blinded (0 to 3 Months)||2
8243547|NCT01912339|20330119|P3|COMPLETED|Blinded (0 to 3 Months)||0
8243548|NCT01912339|20330120|P2|COMPLETED|Blinded (0 to 3 Months)||61
8243549|NCT01912339|20330121|P1|COMPLETED|Blinded (0 to 3 Months)||134
8243550|NCT01912339|20330119|P3|STARTED|Blinded (0 to 3 Months)||0
8243551|NCT01912339|20330120|P2|STARTED|Blinded (0 to 3 Months)||61
8243552|NCT01912339|20330121|P1|STARTED|Blinded (0 to 3 Months)||136
8243553|NCT01912287|20330138|P3|NOT COMPLETED|Overall Study||15
8243554|NCT01912287|20330139|P2|NOT COMPLETED|Overall Study||23
8243555|NCT01912287|20330140|P1|NOT COMPLETED|Overall Study||33
8243556|NCT01912287|20330138|P3|COMPLETED|Overall Study||28
8243557|NCT01912287|20330139|P2|COMPLETED|Overall Study||67
8243558|NCT01912287|20330140|P1|COMPLETED|Overall Study||60
8243559|NCT01912287|20330138|P3|STARTED|Overall Study||43
8243560|NCT01912287|20330139|P2|STARTED|Overall Study||90
8243561|NCT01912287|20330140|P1|STARTED|Overall Study||93
8243562|NCT01912222|20330151|P3|NOT COMPLETED|Part B: Treatment Period||20
8243563|NCT01912222|20330152|P2|NOT COMPLETED|Part B: Treatment Period||15
8243564|NCT01912222|20330153|P1|NOT COMPLETED|Part B: Treatment Period||13
8243565|NCT01912222|20330151|P3|COMPLETED|Part B: Treatment Period||0
8243566|NCT01912222|20330152|P2|COMPLETED|Part B: Treatment Period||0
8243567|NCT01912222|20330153|P1|COMPLETED|Part B: Treatment Period||0
8243568|NCT01912222|20330151|P3|STARTED|Part B: Treatment Period||20
8243569|NCT01912222|20330152|P2|STARTED|Part B: Treatment Period||15
8243570|NCT01912222|20330153|P1|STARTED|Part B: Treatment Period||13
8243571|NCT01912222|20330151|P3|NOT COMPLETED|Part A: Pharmacokinetic Period||2
8243572|NCT01912222|20330152|P2|NOT COMPLETED|Part A: Pharmacokinetic Period||2
8243573|NCT01912222|20330153|P1|NOT COMPLETED|Part A: Pharmacokinetic Period||1
8243574|NCT01912222|20330151|P3|COMPLETED|Part A: Pharmacokinetic Period||18
8243575|NCT01912222|20330152|P2|COMPLETED|Part A: Pharmacokinetic Period||13
8243576|NCT01912222|20330153|P1|COMPLETED|Part A: Pharmacokinetic Period||12
8243577|NCT01912222|20330151|P3|STARTED|Part A: Pharmacokinetic Period||20
8243578|NCT01912222|20330152|P2|STARTED|Part A: Pharmacokinetic Period||15
8243579|NCT01912222|20330153|P1|STARTED|Part A: Pharmacokinetic Period||13
8243580|NCT01911910|20330178|P2|NOT COMPLETED|Overall Study||11
8243581|NCT01911910|20330179|P1|NOT COMPLETED|Overall Study||13
8243582|NCT01911910|20330178|P2|COMPLETED|Overall Study||194
8243583|NCT01911910|20330179|P1|COMPLETED|Overall Study||184
8243584|NCT01911910|20330178|P2|STARTED|Overall Study||205
8243585|NCT01911910|20330179|P1|STARTED|Overall Study||197
8243586|NCT01911845|20330211|P1|NOT COMPLETED|Overall Study||6
8243587|NCT01911845|20330211|P1|COMPLETED|Overall Study||32
8243588|NCT01911845|20330211|P1|Completed Study Drug|Overall Study||37
8243589|NCT01911845|20330211|P1|STARTED|Overall Study||38
8243590|NCT01911819|20330228|P3|NOT COMPLETED|Overall Study||0
8243591|NCT01911819|20330229|P2|NOT COMPLETED|Overall Study||2
8243592|NCT01911819|20330230|P1|NOT COMPLETED|Overall Study||1
8243593|NCT01911819|20330228|P3|COMPLETED|Overall Study||10
8243594|NCT01911819|20330229|P2|COMPLETED|Overall Study||9
8243595|NCT01911819|20330230|P1|COMPLETED|Overall Study||9
8243596|NCT01911819|20330228|P3|STARTED|Overall Study||10
8243597|NCT01911819|20330229|P2|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
8243598|NCT01911819|20330230|P1|STARTED|Overall Study||10
8243599|NCT01911793|20330243|P2|NOT COMPLETED|Overall Study||5
8243600|NCT01911793|20330244|P1|NOT COMPLETED|Overall Study||1
8243601|NCT01911793|20330243|P2|COMPLETED|Overall Study||0
8243602|NCT01911793|20330244|P1|COMPLETED|Overall Study||0
8243603|NCT01911793|20330243|P2|STARTED|Overall Study||5
8243604|NCT01911793|20330244|P1|STARTED|Overall Study||1
8243605|NCT01911780|20330268|P2|NOT COMPLETED|Extension Period (52 Weeks)||3
8243606|NCT01911780|20330269|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
8243607|NCT01911780|20330268|P2|COMPLETED|Extension Period (52 Weeks)||58
8243608|NCT01911780|20330269|P1|COMPLETED|Extension Period (52 Weeks)||61
8243609|NCT01911780|20330268|P2|STARTED|Extension Period (52 Weeks)||61
8243610|NCT01911780|20330269|P1|STARTED|Extension Period (52 Weeks)||65
8243611|NCT01911780|20330268|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||3
8243612|NCT01911780|20330269|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||3
8243613|NCT01911780|20330268|P2|COMPLETED|Double-blind Period (8 Weeks)||61
8243614|NCT01911780|20330269|P1|COMPLETED|Double-blind Period (8 Weeks)||65
8243615|NCT01911780|20330268|P2|STARTED|Double-blind Period (8 Weeks)||64
8243616|NCT01911780|20330269|P1|STARTED|Double-blind Period (8 Weeks)||68
8243617|NCT01911689|20330289|P2|NOT COMPLETED|Overall Study||0
8243618|NCT01911689|20330290|P1|NOT COMPLETED|Overall Study||0
8243619|NCT01911689|20330289|P2|COMPLETED|Overall Study||51
8243620|NCT01911689|20330290|P1|COMPLETED|Overall Study||117
8243621|NCT01911689|20330289|P2|STARTED|Overall Study||51
8243622|NCT01911689|20330290|P1|STARTED|Overall Study||117
8243623|NCT01911546|20330303|P1|NOT COMPLETED|Overall Study||6
8243624|NCT01911546|20330303|P1|COMPLETED|Overall Study||14
8243625|NCT01911546|20330303|P1|STARTED|Overall Study||20
8243626|NCT01911442|20330313|P3|NOT COMPLETED|Overall Study||12
8243627|NCT01911442|20330314|P2|NOT COMPLETED|Overall Study||4
8243628|NCT01911442|20330315|P1|NOT COMPLETED|Overall Study||6
8243629|NCT01911442|20330313|P3|COMPLETED|Overall Study||38
8243630|NCT01911442|20330314|P2|COMPLETED|Overall Study||47
8243631|NCT01911442|20330315|P1|COMPLETED|Overall Study||43
8243632|NCT01911442|20330313|P3|STARTED|Overall Study||50
8243633|NCT01911442|20330314|P2|STARTED|Overall Study||51
8243634|NCT01911442|20330315|P1|STARTED|Overall Study||49
8243635|NCT01911429|20330344|P3|NOT COMPLETED|Overall Study||20
8243636|NCT01911429|20330345|P2|NOT COMPLETED|Overall Study||10
8243637|NCT01911429|20330346|P1|NOT COMPLETED|Overall Study||12
8243638|NCT01911429|20330344|P3|COMPLETED|Overall Study||93
8243639|NCT01911429|20330345|P2|COMPLETED|Overall Study||96
8243640|NCT01911429|20330346|P1|COMPLETED|Overall Study||96
8243641|NCT01911429|20330344|P3|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
8243642|NCT01911429|20330345|P2|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
8243643|NCT01911429|20330346|P1|STARTED|Overall Study||108
8243644|NCT01911403|20330380|P2|NOT COMPLETED|Overall Study||3
8243645|NCT01911403|20330381|P1|NOT COMPLETED|Overall Study||9
8243646|NCT01911403|20330380|P2|COMPLETED|Overall Study||59
8243647|NCT01911403|20330381|P1|COMPLETED|Overall Study||52
8243648|NCT01911403|20330380|P2|STARTED|Overall Study||62
8243649|NCT01911403|20330381|P1|STARTED|Overall Study||61
8243650|NCT01911390|20330402|P4|NOT COMPLETED|Overall Study||1
8243651|NCT01911390|20330403|P3|NOT COMPLETED|Overall Study||1
8243652|NCT01911390|20330404|P2|NOT COMPLETED|Overall Study||0
8243653|NCT01911390|20330405|P1|NOT COMPLETED|Overall Study||1
8243654|NCT01911390|20330402|P4|COMPLETED|Overall Study||10
8243655|NCT01911390|20330403|P3|COMPLETED|Overall Study||9
8243656|NCT01911390|20330404|P2|COMPLETED|Overall Study||10
8243657|NCT01911390|20330405|P1|COMPLETED|Overall Study||9
8243658|NCT01911390|20330402|P4|STARTED|Overall Study||11
8243659|NCT01911390|20330403|P3|STARTED|Overall Study||10
8243660|NCT01911390|20330404|P2|STARTED|Overall Study||10
8243661|NCT01911390|20330405|P1|STARTED|Overall Study||10
8243662|NCT01911351|20330421|P2|NOT COMPLETED|Overall Study||0
8243663|NCT01911351|20330422|P1|NOT COMPLETED|Overall Study||0
8243664|NCT01911351|20330421|P2|COMPLETED|Overall Study||43
8243665|NCT01911351|20330422|P1|COMPLETED|Overall Study||39
8243666|NCT01911351|20330421|P2|STARTED|Overall Study||43
8243667|NCT01911351|20330422|P1|STARTED|Overall Study||39
8243668|NCT01911273|20330438|P2|NOT COMPLETED|Overall Study||2
8243669|NCT01911273|20330439|P1|NOT COMPLETED|Overall Study||1
8243670|NCT01911273|20330438|P2|COMPLETED|Overall Study||0
8243671|NCT01911273|20330439|P1|COMPLETED|Overall Study||0
8243672|NCT01911273|20330438|P2|STARTED|Overall Study||2
8243673|NCT01911273|20330439|P1|STARTED|Overall Study||1
8243674|NCT01911260|20330473|P4|NOT COMPLETED|Follow-up Period||12
8243675|NCT01911260|20330474|P3|NOT COMPLETED|Follow-up Period||15
8243676|NCT01911260|20330475|P2|NOT COMPLETED|Follow-up Period||20
8243677|NCT01911260|20330476|P1|NOT COMPLETED|Follow-up Period||13
8243678|NCT01911260|20330473|P4|COMPLETED|Follow-up Period||30
8243679|NCT01911260|20330474|P3|COMPLETED|Follow-up Period||24
8243680|NCT01911260|20330475|P2|COMPLETED|Follow-up Period||18
8243681|NCT01911260|20330476|P1|COMPLETED|Follow-up Period||27
8243682|NCT01911260|20330473|P4|STARTED|Follow-up Period||42
8243683|NCT01911260|20330474|P3|STARTED|Follow-up Period||39
8243684|NCT01911260|20330475|P2|STARTED|Follow-up Period||38
8243685|NCT01911260|20330476|P1|STARTED|Follow-up Period||40
8243686|NCT01911260|20330473|P4|NOT COMPLETED|Supplementation Period||8
8243687|NCT01911260|20330474|P3|NOT COMPLETED|Supplementation Period||10
8243688|NCT01911260|20330475|P2|NOT COMPLETED|Supplementation Period||12
8243689|NCT01911260|20330476|P1|NOT COMPLETED|Supplementation Period||10
8243690|NCT01911260|20330473|P4|COMPLETED|Supplementation Period||42
8243691|NCT01911260|20330474|P3|COMPLETED|Supplementation Period||39
8243692|NCT01911260|20330475|P2|COMPLETED|Supplementation Period||38
8243693|NCT01911260|20330476|P1|COMPLETED|Supplementation Period||40
8243694|NCT01911260|20330473|P4|STARTED|Supplementation Period||50
8243695|NCT01911260|20330474|P3|STARTED|Supplementation Period||49
8243696|NCT01911260|20330475|P2|STARTED|Supplementation Period||50
8243697|NCT01911260|20330476|P1|STARTED|Supplementation Period||50
8243698|NCT01911221|20330486|P1|NOT COMPLETED|Overall Study||0
8243699|NCT01911221|20330486|P1|COMPLETED|Overall Study||13
8243700|NCT01911221|20330486|P1|STARTED|Overall Study||13
8243701|NCT01911169|20330502|P2|NOT COMPLETED|Overall Study||0
8243702|NCT01911169|20330503|P1|NOT COMPLETED|Overall Study||0
8243703|NCT01911169|20330502|P2|COMPLETED|Overall Study||3
8243704|NCT01911169|20330503|P1|COMPLETED|Overall Study||6
8243705|NCT01911169|20330502|P2|STARTED|Overall Study||3
8243706|NCT01911169|20330503|P1|STARTED|Overall Study||6
8243707|NCT01911065|20330513|P2|NOT COMPLETED|Overall Study||0
8243708|NCT01911065|20330514|P1|NOT COMPLETED|Overall Study||0
8243709|NCT01911065|20330513|P2|COMPLETED|Overall Study||9
8243710|NCT01911065|20330514|P1|COMPLETED|Overall Study||45
8243711|NCT01911065|20330513|P2|STARTED|Overall Study||9
8243712|NCT01911065|20330514|P1|STARTED|Overall Study||45
8243713|NCT01910831|20330522|P1|NOT COMPLETED|Overall Study||1
8243714|NCT01910831|20330522|P1|COMPLETED|Overall Study||19
8243715|NCT01910831|20330522|P1|STARTED|Overall Study||20
8243716|NCT01910792|20330531|P2|NOT COMPLETED|Overall Study||0
8243717|NCT01910792|20330532|P1|NOT COMPLETED|Overall Study||0
8243718|NCT01910792|20330531|P2|COMPLETED|Overall Study||10
8243719|NCT01910792|20330532|P1|COMPLETED|Overall Study||9
8243720|NCT01910792|20330531|P2|STARTED|Overall Study||10
8243721|NCT01910792|20330532|P1|STARTED|Overall Study||9
8243722|NCT01910688|20330538|P1|NOT COMPLETED|Overall Study||5
8243723|NCT01910688|20330538|P1|COMPLETED|Overall Study||20
8243724|NCT01910688|20330538|P1|12months|Overall Study||22
8243725|NCT01910688|20330538|P1|3rd RFA Treatment|Overall Study||18
8243726|NCT01910688|20330538|P1|7.5months|Overall Study||24
8243727|NCT01910688|20330538|P1|2nd RFA Treatment|Overall Study||22
8243728|NCT01910688|20330538|P1|3.5month|Overall Study||25
8243729|NCT01910688|20330538|P1|STARTED|Overall Study||25
8243730|NCT01910636|20330547|P2|NOT COMPLETED|Overall Study||0
8243731|NCT01910636|20330548|P1|NOT COMPLETED|Overall Study||0
8243732|NCT01910636|20330547|P2|COMPLETED|Overall Study||63
8243733|NCT01910636|20330548|P1|COMPLETED|Overall Study||90
8243734|NCT01910636|20330547|P2|STARTED|Overall Study||63
8243735|NCT01910636|20330548|P1|STARTED|Overall Study||90
8243736|NCT01910519|20330562|P2|NOT COMPLETED|Overall Study||0
8243737|NCT01910519|20330563|P1|NOT COMPLETED|Overall Study||4
8243738|NCT01910519|20330562|P2|COMPLETED|Overall Study||15
8243739|NCT01910519|20330563|P1|COMPLETED|Overall Study||31
8243740|NCT01910519|20330562|P2|STARTED|Overall Study||15
8243741|NCT01910519|20330563|P1|STARTED|Overall Study||35
8243742|NCT01910441|20330589|P2|NOT COMPLETED|Overall Study||10
8243743|NCT01910441|20330590|P1|NOT COMPLETED|Overall Study||7
8243744|NCT01910441|20330589|P2|COMPLETED|Overall Study||37
8243745|NCT01910441|20330590|P1|COMPLETED|Overall Study||41
8243746|NCT01910441|20330589|P2|STARTED|Overall Study||47
8243747|NCT01910441|20330590|P1|STARTED|Overall Study||48
8243760|NCT01910389|20330669|P2|NOT COMPLETED|Overall Study||8
8243761|NCT01910389|20330670|P1|NOT COMPLETED|Overall Study||15
8243762|NCT01910389|20330669|P2|COMPLETED|Overall Study||0
8243763|NCT01910389|20330670|P1|COMPLETED|Overall Study||0
8243764|NCT01910389|20330669|P2|STARTED|Overall Study||8
8243765|NCT01910389|20330670|P1|STARTED|Overall Study||15
8243766|NCT01910311|20330700|P1|NOT COMPLETED|Period 2 (Days 3-32)||0
8243767|NCT01910311|20330700|P1|COMPLETED|Period 2 (Days 3-32)||18
8243768|NCT01910311|20330700|P1|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
8243769|NCT01910311|20330700|P1|Received Baricitinib|Period 2 (Days 3-32)||18
8243770|NCT01910311|20330700|P1|STARTED|Period 2 (Days 3-32)||18
8243771|NCT01910311|20330700|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
8243772|NCT01910311|20330700|P1|COMPLETED|Period 1 (Days 1-2)||18
8243773|NCT01910311|20330700|P1|Received Baricitinib|Period 1 (Days 1-2)||18
8243774|NCT01910311|20330700|P1|STARTED|Period 1 (Days 1-2)||18
8243775|NCT01910298|20330713|P2|NOT COMPLETED|Overall Study||32
8243776|NCT01910298|20330714|P1|NOT COMPLETED|Overall Study||5
8243777|NCT01910298|20330713|P2|COMPLETED|Overall Study||23
8243778|NCT01910298|20330714|P1|COMPLETED|Overall Study||71
8243779|NCT01910298|20330713|P2|Safety Set|Overall Study|4 participants did not have first surgery date and were not included in Safety Set.|51
8243780|NCT01910298|20330714|P1|Safety Set|Overall Study||76
8243781|NCT01910298|20330713|P2|STARTED|Overall Study||55
8243782|NCT01910298|20330714|P1|STARTED|Overall Study||76
8243783|NCT01910181|20330732|P1|NOT COMPLETED|Overall Study||46
8243784|NCT01910181|20330732|P1|COMPLETED|Overall Study||0
8243785|NCT01910181|20330732|P1|Expansion Cohort|Overall Study||26
8243786|NCT01910181|20330732|P1|PK Cohort|Overall Study||20
8243787|NCT01910181|20330732|P1|STARTED|Overall Study||46
8243788|NCT01910129|20330759|P3|NOT COMPLETED|Randomized Phase 3||0
8243789|NCT01910129|20330760|P2|NOT COMPLETED|Randomized Phase 3||1
8243790|NCT01910129|20330761|P1|NOT COMPLETED|Randomized Phase 3||0
8243791|NCT01910129|20330759|P3|COMPLETED|Randomized Phase 3||0
8243792|NCT01910129|20330760|P2|COMPLETED|Randomized Phase 3||4
8243793|NCT01910129|20330761|P1|COMPLETED|Randomized Phase 3||5
8243794|NCT01910129|20330759|P3|STARTED|Randomized Phase 3||0
8243795|NCT01910129|20330760|P2|STARTED|Randomized Phase 3||5
8243796|NCT01910129|20330761|P1|STARTED|Randomized Phase 3||5
8243797|NCT01910129|20330759|P3|NOT COMPLETED|Randomized Phase 2||0
8243798|NCT01910129|20330760|P2|NOT COMPLETED|Randomized Phase 2||1
8243799|NCT01910129|20330761|P1|NOT COMPLETED|Randomized Phase 2||2
8243800|NCT01910129|20330759|P3|COMPLETED|Randomized Phase 2||0
8243801|NCT01910129|20330760|P2|COMPLETED|Randomized Phase 2||5
8243802|NCT01910129|20330761|P1|COMPLETED|Randomized Phase 2||5
8243803|NCT01910129|20330759|P3|STARTED|Randomized Phase 2||0
8243804|NCT01910129|20330760|P2|STARTED|Randomized Phase 2||6
8243805|NCT01910129|20330761|P1|STARTED|Randomized Phase 2||7
8243806|NCT01910129|20330759|P3|NOT COMPLETED|Run-in Period Phase 1||0
8243807|NCT01910129|20330760|P2|NOT COMPLETED|Run-in Period Phase 1||0
8243808|NCT01910129|20330761|P1|NOT COMPLETED|Run-in Period Phase 1||0
8243809|NCT01910129|20330759|P3|COMPLETED|Run-in Period Phase 1||13
8243810|NCT01910129|20330760|P2|COMPLETED|Run-in Period Phase 1||0
8243811|NCT01910129|20330761|P1|COMPLETED|Run-in Period Phase 1||0
8243812|NCT01910129|20330759|P3|STARTED|Run-in Period Phase 1||13
8243813|NCT01910129|20330760|P2|STARTED|Run-in Period Phase 1||0
8243814|NCT01910129|20330761|P1|STARTED|Run-in Period Phase 1||0
8243815|NCT01910116|20330785|P2|NOT COMPLETED|Overall Study||16
8243816|NCT01910116|20330786|P1|NOT COMPLETED|Overall Study||14
8243817|NCT01910116|20330785|P2|COMPLETED|Overall Study||94
8243818|NCT01910116|20330786|P1|COMPLETED|Overall Study||96
8243819|NCT01910116|20330785|P2|Week 16|Overall Study||94
8243820|NCT01910116|20330786|P1|Week 16|Overall Study||96
8243821|NCT01910116|20330785|P2|Week 12|Overall Study||96
8243822|NCT01910116|20330786|P1|Week 12|Overall Study||97
8243823|NCT01910116|20330785|P2|Week 8|Overall Study||99
8243824|NCT01910116|20330786|P1|Week 8|Overall Study||98
8243825|NCT01910116|20330785|P2|Week 4|Overall Study||102
8243826|NCT01910116|20330786|P1|Week 4|Overall Study||106
8243827|NCT01910116|20330785|P2|STARTED|Overall Study||110
8243828|NCT01910116|20330786|P1|STARTED|Overall Study||110
8243829|NCT01910064|20330862|P1|NOT COMPLETED|Overall Study||45
8243830|NCT01910064|20330862|P1|COMPLETED|Overall Study||391
8243831|NCT01910064|20330862|P1|STARTED|Overall Study||436
8243832|NCT01909973|20330873|P2|NOT COMPLETED|Overall Study||0
8243833|NCT01909973|20330874|P1|NOT COMPLETED|Overall Study||1
8243834|NCT01909973|20330873|P2|COMPLETED|Overall Study||7
8243835|NCT01909973|20330874|P1|COMPLETED|Overall Study||7
8243836|NCT01909973|20330873|P2|STARTED|Overall Study||7
8243837|NCT01909973|20330874|P1|STARTED|Overall Study||8
8243838|NCT01909804|20330894|P12|NOT COMPLETED|Overall Study||3
8243839|NCT01909804|20330895|P11|NOT COMPLETED|Overall Study||1
8243840|NCT01909804|20330896|P10|NOT COMPLETED|Overall Study||1
8243841|NCT01909804|20330897|P9|NOT COMPLETED|Overall Study||0
8243842|NCT01909804|20330898|P8|NOT COMPLETED|Overall Study||1
8243843|NCT01909804|20330899|P7|NOT COMPLETED|Overall Study||2
8243844|NCT01909804|20330900|P6|NOT COMPLETED|Overall Study||4
8243845|NCT01909804|20330901|P5|NOT COMPLETED|Overall Study||8
8243846|NCT01909804|20330902|P4|NOT COMPLETED|Overall Study||0
8243847|NCT01909804|20330903|P3|NOT COMPLETED|Overall Study||0
8243848|NCT01909804|20330904|P2|NOT COMPLETED|Overall Study||1
8243849|NCT01909804|20330905|P1|NOT COMPLETED|Overall Study||4
8243850|NCT01909804|20330894|P12|COMPLETED|Overall Study||26
8243851|NCT01909804|20330895|P11|COMPLETED|Overall Study||26
8243852|NCT01909804|20330896|P10|COMPLETED|Overall Study||28
8243853|NCT01909804|20330897|P9|COMPLETED|Overall Study||27
8243854|NCT01909804|20330898|P8|COMPLETED|Overall Study||25
8243855|NCT01909804|20330899|P7|COMPLETED|Overall Study||25
8243856|NCT01909804|20330900|P6|COMPLETED|Overall Study||21
8243857|NCT01909804|20330901|P5|COMPLETED|Overall Study||18
8243858|NCT01909804|20330902|P4|COMPLETED|Overall Study||26
8243859|NCT01909804|20330903|P3|COMPLETED|Overall Study||27
8243860|NCT01909804|20330904|P2|COMPLETED|Overall Study||27
8243861|NCT01909804|20330905|P1|COMPLETED|Overall Study||22
8243862|NCT01909804|20330894|P12|STARTED|Overall Study||29
8243863|NCT01909804|20330895|P11|STARTED|Overall Study||27
8243864|NCT01909804|20330896|P10|STARTED|Overall Study||29
8243865|NCT01909804|20330897|P9|STARTED|Overall Study||27
8243866|NCT01909804|20330898|P8|STARTED|Overall Study||26
8243867|NCT01909804|20330899|P7|STARTED|Overall Study||27
8243868|NCT01909804|20330900|P6|STARTED|Overall Study||25
8243869|NCT01909804|20330901|P5|STARTED|Overall Study||26
8243870|NCT01909804|20330902|P4|STARTED|Overall Study||26
8243871|NCT01909804|20330903|P3|STARTED|Overall Study||27
8243872|NCT01909804|20330904|P2|STARTED|Overall Study||28
8243873|NCT01909804|20330905|P1|STARTED|Overall Study||26
8243874|NCT01909791|20330954|P3|NOT COMPLETED|Overall Study||28
8243875|NCT01909791|20330955|P2|NOT COMPLETED|Overall Study||28
8243876|NCT01909791|20330956|P1|NOT COMPLETED|Overall Study||21
8243877|NCT01909791|20330954|P3|COMPLETED|Overall Study||208
8243878|NCT01909791|20330955|P2|COMPLETED|Overall Study||212
8243879|NCT01909791|20330956|P1|COMPLETED|Overall Study||205
8243880|NCT01909791|20330954|P3|STARTED|Overall Study||236
8243881|NCT01909791|20330955|P2|STARTED|Overall Study||240
8243882|NCT01909791|20330956|P1|STARTED|Overall Study||226
8243883|NCT01909778|20331014|P1|NOT COMPLETED|Overall Study||1
8243884|NCT01909778|20331014|P1|COMPLETED|Overall Study||1
8243885|NCT01909778|20331014|P1|STARTED|Overall Study||2
8243886|NCT01909713|20331038|P1|NOT COMPLETED|Overall Study||0
8243887|NCT01909713|20331038|P1|COMPLETED|Overall Study||35
8243888|NCT01909713|20331038|P1|STARTED|Overall Study||35
8243889|NCT01909674|20331093|P2|NOT COMPLETED|Overall Study||2
8243890|NCT01909674|20331094|P1|NOT COMPLETED|Overall Study||5
8243891|NCT01909674|20331093|P2|COMPLETED|Overall Study||7
8243892|NCT01909674|20331094|P1|COMPLETED|Overall Study||7
8243893|NCT01909674|20331093|P2|STARTED|Overall Study||9
8243894|NCT01909674|20331094|P1|STARTED|Overall Study||12
8243895|NCT01909570|20331102|P2|NOT COMPLETED|Overall Study||27
8243896|NCT01909570|20331103|P1|NOT COMPLETED|Overall Study||27
8243897|NCT01909570|20331102|P2|COMPLETED|Overall Study||64
8243898|NCT01909570|20331103|P1|COMPLETED|Overall Study||57
8243899|NCT01909570|20331102|P2|STARTED|Overall Study||91
8243900|NCT01909570|20331103|P1|STARTED|Overall Study||84
8243901|NCT01909466|20331113|P2|NOT COMPLETED|Overall Study||23
8243902|NCT01909466|20331114|P1|NOT COMPLETED|Overall Study||22
8243903|NCT01909466|20331113|P2|COMPLETED|Overall Study||50
8243904|NCT01909466|20331114|P1|COMPLETED|Overall Study||46
8243905|NCT01909466|20331113|P2|STARTED|Overall Study||73
8243906|NCT01909466|20331114|P1|STARTED|Overall Study||68
8243907|NCT01909336|20331137|P3|NOT COMPLETED|Overall Study||3
8243908|NCT01909336|20331138|P2|NOT COMPLETED|Overall Study||3
8243909|NCT01909336|20331139|P1|NOT COMPLETED|Overall Study||4
8243910|NCT01909336|20331137|P3|COMPLETED|Overall Study||52
8243911|NCT01909336|20331138|P2|COMPLETED|Overall Study||50
8243912|NCT01909336|20331139|P1|COMPLETED|Overall Study||49
8243913|NCT01909336|20331137|P3|STARTED|Overall Study||55
8243914|NCT01909336|20331138|P2|STARTED|Overall Study||53
8243915|NCT01909336|20331139|P1|STARTED|Overall Study||53
8243916|NCT01909180|20331153|P1|NOT COMPLETED|Overall Study||0
8243917|NCT01909180|20331153|P1|COMPLETED|Overall Study||49
8243918|NCT01909180|20331153|P1|STARTED|Overall Study||49
8243919|NCT01909154|20331159|P1|NOT COMPLETED|Overall Study||0
8243920|NCT01909154|20331159|P1|COMPLETED|Overall Study||12
8243921|NCT01909154|20331159|P1|STARTED|Overall Study||12
8243922|NCT01909141|20331170|P2|NOT COMPLETED|Overall Study||0
8243923|NCT01909141|20331171|P1|NOT COMPLETED|Overall Study||0
8243924|NCT01909141|20331170|P2|COMPLETED|Overall Study||50
8243925|NCT01909141|20331171|P1|COMPLETED|Overall Study||50
8243926|NCT01909141|20331170|P2|STARTED|Overall Study||50
8243927|NCT01909141|20331171|P1|STARTED|Overall Study||50
8243928|NCT01909011|20331187|P2|NOT COMPLETED|Overall Study||0
8243929|NCT01909011|20331188|P1|NOT COMPLETED|Overall Study||0
8243930|NCT01909011|20331187|P2|COMPLETED|Overall Study||9
8243931|NCT01909011|20331188|P1|COMPLETED|Overall Study||7
8243932|NCT01909011|20331187|P2|STARTED|Overall Study||9
8243933|NCT01909011|20331188|P1|STARTED|Overall Study||7
8243934|NCT01908972|20331200|P2|NOT COMPLETED|Overall Study||0
8243935|NCT01908972|20331201|P1|NOT COMPLETED|Overall Study||2
8243936|NCT01908972|20331200|P2|COMPLETED|Overall Study||17
8243937|NCT01908972|20331201|P1|COMPLETED|Overall Study||15
8243938|NCT01908972|20331200|P2|STARTED|Overall Study||17
8243939|NCT01908972|20331201|P1|STARTED|Overall Study||17
8243940|NCT01908907|20331237|P2|NOT COMPLETED|Overall Study||0
8243941|NCT01908907|20331238|P1|NOT COMPLETED|Overall Study||2
8243942|NCT01908907|20331237|P2|COMPLETED|Overall Study||29
8243943|NCT01908907|20331238|P1|COMPLETED|Overall Study||29
8243944|NCT01908907|20331237|P2|STARTED|Overall Study||29
8243945|NCT01908907|20331238|P1|STARTED|Overall Study||31
8243946|NCT01908842|20331260|P2|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
8243947|NCT01908842|20331261|P1|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
8243948|NCT01908842|20331260|P2|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
8243949|NCT01908842|20331261|P1|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
8243950|NCT01908842|20331260|P2|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
8243951|NCT01908842|20331261|P1|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
8243952|NCT01908842|20331260|P2|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
8243953|NCT01908842|20331261|P1|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
8243954|NCT01908842|20331260|P2|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
8243955|NCT01908842|20331261|P1|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
8243956|NCT01908842|20331260|P2|STARTED|Switch to Other BNX Formulation (Day 15)||344
8243957|NCT01908842|20331261|P1|STARTED|Switch to Other BNX Formulation (Day 15)||357
8243958|NCT01908842|20331260|P2|NOT COMPLETED|Induction||31
8243959|NCT01908842|20331261|P1|NOT COMPLETED|Induction||26
8243960|NCT01908842|20331260|P2|COMPLETED|Induction||344
8243961|NCT01908842|20331261|P1|COMPLETED|Induction||357
8243962|NCT01908842|20331260|P2|STARTED|Induction||375
8243963|NCT01908842|20331261|P1|STARTED|Induction||383
8243964|NCT01908829|20331282|P3|NOT COMPLETED|Overall Study||39
8243965|NCT01908829|20331283|P2|NOT COMPLETED|Overall Study||49
8243966|NCT01908829|20331284|P1|NOT COMPLETED|Overall Study||49
8243967|NCT01908829|20331282|P3|COMPLETED|Overall Study||680
8243968|NCT01908829|20331283|P2|COMPLETED|Overall Study||679
8243969|NCT01908829|20331284|P1|COMPLETED|Overall Study||678
8243970|NCT01908829|20331282|P3|Treated With Double-blind Drug|Overall Study||719
8243971|NCT01908829|20331283|P2|Treated With Double-blind Drug|Overall Study||728
8243972|NCT01908829|20331284|P1|Treated With Double-blind Drug|Overall Study||725
8243973|NCT01908829|20331282|P3|STARTED|Overall Study||719
8243974|NCT01908829|20331283|P2|STARTED|Overall Study||728
8243975|NCT01908829|20331284|P1|STARTED|Overall Study||727
8243976|NCT01908816|20331401|P4|NOT COMPLETED|Overall Study||35
8243977|NCT01908816|20331402|P3|NOT COMPLETED|Overall Study||58
8243978|NCT01908816|20331403|P2|NOT COMPLETED|Overall Study||84
8243979|NCT01908816|20331404|P1|NOT COMPLETED|Overall Study||93
8243980|NCT01908816|20331401|P4|COMPLETED|Overall Study||0
8243981|NCT01908816|20331402|P3|COMPLETED|Overall Study||0
8243982|NCT01908816|20331403|P2|COMPLETED|Overall Study||0
8243983|NCT01908816|20331404|P1|COMPLETED|Overall Study||0
8243984|NCT01908816|20331401|P4|STARTED|Overall Study||35
8243985|NCT01908816|20331402|P3|STARTED|Overall Study||58
8243986|NCT01908816|20331403|P2|STARTED|Overall Study||84
8243987|NCT01908816|20331404|P1|STARTED|Overall Study||93
8243988|NCT01908803|20331429|P2|NOT COMPLETED|Overall Study||1
8243989|NCT01908803|20331430|P1|NOT COMPLETED|Overall Study||4
8243990|NCT01908803|20331429|P2|COMPLETED|Overall Study||23
8243991|NCT01908803|20331430|P1|COMPLETED|Overall Study||42
8243992|NCT01908803|20331429|P2|Treated|Overall Study||24
8243993|NCT01908803|20331430|P1|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
8243994|NCT01908803|20331429|P2|STARTED|Overall Study||24
8243995|NCT01908803|20331430|P1|STARTED|Overall Study||46
8243996|NCT01908751|20331445|P4|NOT COMPLETED|Overall Study||4
8243997|NCT01908751|20331446|P3|NOT COMPLETED|Overall Study||5
8243998|NCT01908751|20331447|P2|NOT COMPLETED|Overall Study||5
8243999|NCT01908751|20331448|P1|NOT COMPLETED|Overall Study||5
8244000|NCT01908751|20331445|P4|COMPLETED|Overall Study||16
8244001|NCT01908751|20331446|P3|COMPLETED|Overall Study||16
8244002|NCT01908751|20331447|P2|COMPLETED|Overall Study||18
8244003|NCT01908751|20331448|P1|COMPLETED|Overall Study||17
8244004|NCT01908751|20331445|P4|STARTED|Overall Study||20
8244005|NCT01908751|20331446|P3|STARTED|Overall Study||21
8244006|NCT01908751|20331447|P2|STARTED|Overall Study||23
8244007|NCT01908751|20331448|P1|STARTED|Overall Study||22
8244008|NCT01908699|20331484|P2|NOT COMPLETED|Overall Study||78
8244009|NCT01908699|20331485|P1|NOT COMPLETED|Overall Study||75
8244010|NCT01908699|20331484|P2|COMPLETED|Overall Study||58
8244011|NCT01908699|20331485|P1|COMPLETED|Overall Study||62
8244012|NCT01908699|20331484|P2|Received at Least 1 Dose of Study Drug|Overall Study||135
8244013|NCT01908699|20331485|P1|Received at Least 1 Dose of Study Drug|Overall Study||136
8244014|NCT01908699|20331484|P2|STARTED|Overall Study||136
8244015|NCT01908699|20331485|P1|STARTED|Overall Study||137
8244016|NCT01908582|20331501|P1|NOT COMPLETED|Period 2||2
8244017|NCT01908582|20331501|P1|COMPLETED|Period 2||24
8244018|NCT01908582|20331501|P1|STARTED|Period 2||26
8244019|NCT01908582|20331501|P1|NOT COMPLETED|Period 1||0
8244020|NCT01908582|20331501|P1|COMPLETED|Period 1||26
8244021|NCT01908582|20331501|P1|Received at Least One Dose of Study Drug|Period 1||26
8244022|NCT01908582|20331501|P1|STARTED|Period 1||26
8244023|NCT01908530|20331515|P3|NOT COMPLETED|Overall Study||0
8244024|NCT01908530|20331516|P2|NOT COMPLETED|Overall Study||0
8244025|NCT01908530|20331517|P1|NOT COMPLETED|Overall Study||0
8244026|NCT01908530|20331515|P3|COMPLETED|Overall Study||10
8244027|NCT01908530|20331516|P2|COMPLETED|Overall Study||8
8244028|NCT01908530|20331517|P1|COMPLETED|Overall Study||8
8244029|NCT01908530|20331515|P3|STARTED|Overall Study||10
8244030|NCT01908530|20331516|P2|STARTED|Overall Study||8
8244031|NCT01908530|20331517|P1|STARTED|Overall Study||8
8244038|NCT01908205|20331558|P2|NOT COMPLETED|Overall Study||1
8244039|NCT01908205|20331559|P1|NOT COMPLETED|Overall Study||5
8244040|NCT01908205|20331558|P2|COMPLETED|Overall Study||29
8244041|NCT01908205|20331559|P1|COMPLETED|Overall Study||25
8244042|NCT01908205|20331558|P2|STARTED|Overall Study||30
8244043|NCT01908205|20331559|P1|STARTED|Overall Study||30
8244044|NCT01908140|20331587|P2|NOT COMPLETED|Overall Study||79
8244045|NCT01908140|20331588|P1|NOT COMPLETED|Overall Study||66
8244046|NCT01908140|20331587|P2|COMPLETED|Overall Study||386
8244047|NCT01908140|20331588|P1|COMPLETED|Overall Study||402
8244048|NCT01908140|20331587|P2|STARTED|Overall Study||465
8244049|NCT01908140|20331588|P1|STARTED|Overall Study||468
8244050|NCT01908127|20331598|P2|NOT COMPLETED|Overall Study||0
8244051|NCT01908127|20331599|P1|NOT COMPLETED|Overall Study||1
8244052|NCT01908127|20331598|P2|COMPLETED|Overall Study||23
8244053|NCT01908127|20331599|P1|COMPLETED|Overall Study||22
8244054|NCT01908127|20331598|P2|STARTED|Overall Study||23
8244055|NCT01908127|20331599|P1|STARTED|Overall Study||23
8244056|NCT01908101|20331607|P1|NOT COMPLETED|Overall Study||9
8244057|NCT01908101|20331607|P1|COMPLETED|Overall Study||59
8244058|NCT01908101|20331607|P1|STARTED|Overall Study||68
8244059|NCT01908062|20331613|P2|NOT COMPLETED|Overall Study||3
8244060|NCT01908062|20331614|P1|NOT COMPLETED|Overall Study||2
8244061|NCT01908062|20331613|P2|COMPLETED|Overall Study||22
8244062|NCT01908062|20331614|P1|COMPLETED|Overall Study||24
8244063|NCT01908062|20331613|P2|STARTED|Overall Study||25
8244064|NCT01908062|20331614|P1|STARTED|Overall Study||26
8244065|NCT01907906|20331641|P2|NOT COMPLETED|Overall Study||1
8244066|NCT01907906|20331642|P1|NOT COMPLETED|Overall Study||4
8244067|NCT01907906|20331641|P2|COMPLETED|Overall Study||12
8244068|NCT01907906|20331642|P1|COMPLETED|Overall Study||12
8244069|NCT01907906|20331641|P2|STARTED|Overall Study||13
8244070|NCT01907906|20331642|P1|STARTED|Overall Study||16
8244071|NCT01907854|20331722|P2|NOT COMPLETED|Overall Study||13
8244072|NCT01907854|20331723|P1|NOT COMPLETED|Overall Study||16
8244073|NCT01907854|20331722|P2|COMPLETED|Overall Study||191
8244074|NCT01907854|20331723|P1|COMPLETED|Overall Study||187
8244075|NCT01907854|20331722|P2|Exposed|Overall Study||204
8244076|NCT01907854|20331723|P1|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
8244077|NCT01907854|20331722|P2|STARTED|Overall Study||204
8244078|NCT01907854|20331723|P1|STARTED|Overall Study||203
8244079|NCT01907828|20331743|P2|NOT COMPLETED|Overall Study||6
8244080|NCT01907828|20331744|P1|NOT COMPLETED|Overall Study||7
8244081|NCT01907828|20331743|P2|COMPLETED|Overall Study||16
8244082|NCT01907828|20331744|P1|COMPLETED|Overall Study||32
8244083|NCT01907828|20331743|P2|24-month Follow-up|Overall Study||16
8244084|NCT01907828|20331744|P1|24-month Follow-up|Overall Study|2 participants terminated early|32
8244085|NCT01907828|20331743|P2|12-month Follow-up|Overall Study||16
8244086|NCT01907828|20331744|P1|12-month Follow-up|Overall Study|1 participant terminated early|34
8244087|NCT01907828|20331743|P2|6-month Follow-up|Overall Study||16
8244088|NCT01907828|20331744|P1|6-month Follow-up|Overall Study|1 participant terminated early|35
8244089|NCT01907828|20331743|P2|3-month Follow-up|Overall Study|1 participant terminated early|16
8244090|NCT01907828|20331744|P1|3-month Follow-up|Overall Study|1 participant terminated early|36
8244091|NCT01907828|20331743|P2|1-month Follow-up|Overall Study|3 participants terminated early|17
8244092|NCT01907828|20331744|P1|1-month Follow-up|Overall Study|2 participants terminated early|37
8244093|NCT01907828|20331743|P2|Underwent Procedure|Overall Study|2 participants terminated early|20
8244094|NCT01907828|20331744|P1|Underwent Procedure|Overall Study||39
8244095|NCT01907828|20331743|P2|STARTED|Overall Study||22
8244096|NCT01907828|20331744|P1|STARTED|Overall Study||39
8244097|NCT01907815|20331772|P2|NOT COMPLETED|Overall Study||0
8244098|NCT01907815|20331773|P1|NOT COMPLETED|Overall Study||1
8244099|NCT01907815|20331772|P2|COMPLETED|Overall Study||7
8244100|NCT01907815|20331773|P1|COMPLETED|Overall Study||16
8244101|NCT01907815|20331772|P2|STARTED|Overall Study||7
8244102|NCT01907815|20331773|P1|STARTED|Overall Study||17
8244103|NCT01907737|20331787|P1|NOT COMPLETED|Overall Study||1
8244104|NCT01907737|20331787|P1|COMPLETED|Overall Study||21
8244105|NCT01907737|20331787|P1|STARTED|Overall Study||22
8244106|NCT01907607|20331797|P1|NOT COMPLETED|Overall Study||0
8244107|NCT01907607|20331797|P1|COMPLETED|Overall Study||29
8244108|NCT01907607|20331797|P1|STARTED|Overall Study||29
8244109|NCT01907516|20331806|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8244110|NCT01907516|20331807|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8244111|NCT01907516|20331806|P2|COMPLETED|Second Intervention (3 Weeks)||34
8244112|NCT01907516|20331807|P1|COMPLETED|Second Intervention (3 Weeks)||40
8244113|NCT01907516|20331806|P2|STARTED|Second Intervention (3 Weeks)||34
8244114|NCT01907516|20331807|P1|STARTED|Second Intervention (3 Weeks)||40
8244115|NCT01907516|20331806|P2|NOT COMPLETED|First Intervention (3 Weeks)||16
8244116|NCT01907516|20331807|P1|NOT COMPLETED|First Intervention (3 Weeks)||10
8244117|NCT01907516|20331806|P2|COMPLETED|First Intervention (3 Weeks)||34
8244118|NCT01907516|20331807|P1|COMPLETED|First Intervention (3 Weeks)||40
8244119|NCT01907516|20331806|P2|STARTED|First Intervention (3 Weeks)||50
8244120|NCT01907516|20331807|P1|STARTED|First Intervention (3 Weeks)||50
8244121|NCT01907490|20331814|P1|NOT COMPLETED|Overall Study||0
8244122|NCT01907490|20331814|P1|COMPLETED|Overall Study||38
8244123|NCT01907490|20331814|P1|STARTED|Overall Study||38
8244124|NCT01907334|20331821|P2|NOT COMPLETED|Overall Study||0
8244125|NCT01907334|20331822|P1|NOT COMPLETED|Overall Study||0
8244126|NCT01907334|20331821|P2|COMPLETED|Overall Study||4
8244127|NCT01907334|20331822|P1|COMPLETED|Overall Study||6
8244128|NCT01907334|20331821|P2|STARTED|Overall Study||4
8244129|NCT01907334|20331822|P1|STARTED|Overall Study||6
8244130|NCT01907321|20331827|P1|NOT COMPLETED|Overall Study||2
8244131|NCT01907321|20331827|P1|COMPLETED|Overall Study||12
8244132|NCT01907321|20331827|P1|STARTED|Overall Study||14
8244133|NCT01907269|20331834|P2|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
8244134|NCT01907269|20331835|P1|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
8244135|NCT01907269|20331834|P2|COMPLETED|18 Month Outcome Measures Post-intervent||970
8244136|NCT01907269|20331835|P1|COMPLETED|18 Month Outcome Measures Post-intervent||859
8244137|NCT01907269|20331834|P2|STARTED|18 Month Outcome Measures Post-intervent||1250
8244138|NCT01907269|20331835|P1|STARTED|18 Month Outcome Measures Post-intervent||1178
8244139|NCT01907269|20331834|P2|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
8244140|NCT01907269|20331835|P1|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
8244141|NCT01907269|20331834|P2|COMPLETED|6 Month Outcome Measures Post-interventi||1053
8244142|NCT01907269|20331835|P1|COMPLETED|6 Month Outcome Measures Post-interventi||953
8244143|NCT01907269|20331834|P2|STARTED|6 Month Outcome Measures Post-interventi||1342
8244144|NCT01907269|20331835|P1|STARTED|6 Month Outcome Measures Post-interventi||1342
8244145|NCT01907217|20331851|P2|NOT COMPLETED|Overall Study||2
8244146|NCT01907217|20331852|P1|NOT COMPLETED|Overall Study||0
8244147|NCT01907217|20331851|P2|COMPLETED|Overall Study||67
8244148|NCT01907217|20331852|P1|COMPLETED|Overall Study||69
8244149|NCT01907217|20331851|P2|STARTED|Overall Study||69
8244150|NCT01907217|20331852|P1|STARTED|Overall Study||69
8244151|NCT01907113|20331869|P5|NOT COMPLETED|Overall Study||0
8244152|NCT01907113|20331870|P4|NOT COMPLETED|Overall Study||0
8244153|NCT01907113|20331871|P3|NOT COMPLETED|Overall Study||0
8244154|NCT01907113|20331872|P2|NOT COMPLETED|Overall Study||0
8244155|NCT01907113|20331873|P1|NOT COMPLETED|Overall Study||0
8244156|NCT01907113|20331869|P5|COMPLETED|Overall Study||8
8244157|NCT01907113|20331870|P4|COMPLETED|Overall Study||8
8244158|NCT01907113|20331871|P3|COMPLETED|Overall Study||7
8244159|NCT01907113|20331872|P2|COMPLETED|Overall Study||9
8244160|NCT01907113|20331873|P1|COMPLETED|Overall Study||8
8244161|NCT01907113|20331869|P5|STARTED|Overall Study||8
8244162|NCT01907113|20331870|P4|STARTED|Overall Study||8
8244163|NCT01907113|20331871|P3|STARTED|Overall Study||7
8244164|NCT01907113|20331872|P2|STARTED|Overall Study||9
8244165|NCT01907113|20331873|P1|STARTED|Overall Study||8
8244166|NCT01907100|20331964|P4|NOT COMPLETED|Overall Study||146
8244167|NCT01907100|20331965|P3|NOT COMPLETED|Overall Study||147
8244168|NCT01907100|20331966|P2|NOT COMPLETED|Overall Study||40
8244169|NCT01907100|20331967|P1|NOT COMPLETED|Overall Study||42
8244170|NCT01907100|20331964|P4|COMPLETED|Overall Study||83
8244171|NCT01907100|20331965|P3|COMPLETED|Overall Study||82
8244172|NCT01907100|20331966|P2|COMPLETED|Overall Study||4
8244173|NCT01907100|20331967|P1|COMPLETED|Overall Study||1
8244174|NCT01907100|20331964|P4|Treated Patients|Overall Study||227
8244175|NCT01907100|20331965|P3|Treated Patients|Overall Study||228
8244176|NCT01907100|20331966|P2|Treated Patients|Overall Study||44
8244177|NCT01907100|20331967|P1|Treated Patients|Overall Study||41
8244178|NCT01907100|20331964|P4|STARTED|Overall Study||229
8244179|NCT01907100|20331965|P3|STARTED|Overall Study||229
8244180|NCT01907100|20331966|P2|STARTED|Overall Study||44
8244181|NCT01907100|20331967|P1|STARTED|Overall Study||43
8244182|NCT01907087|20331981|P1|NOT COMPLETED|Overall Study||1
8244183|NCT01907087|20331981|P1|COMPLETED|Overall Study||23
8244184|NCT01907087|20331981|P1|STARTED|Overall Study||24
8244185|NCT01906866|20331992|P2|NOT COMPLETED|Overall Study||21
8244186|NCT01906866|20331993|P1|NOT COMPLETED|Overall Study||9
8244187|NCT01906866|20331992|P2|COMPLETED|Overall Study||44
8244188|NCT01906866|20331993|P1|COMPLETED|Overall Study||51
8244189|NCT01906866|20331992|P2|STARTED|Overall Study||65
8244190|NCT01906866|20331993|P1|STARTED|Overall Study||60
8244191|NCT01906658|20332006|P4|NOT COMPLETED|Overall Study||0
8244192|NCT01906658|20332007|P3|NOT COMPLETED|Overall Study||3
8244193|NCT01906658|20332008|P2|NOT COMPLETED|Overall Study||1
8244194|NCT01906658|20332009|P1|NOT COMPLETED|Overall Study||2
8244195|NCT01906658|20332006|P4|COMPLETED|Overall Study||11
8244196|NCT01906658|20332007|P3|COMPLETED|Overall Study||7
8244197|NCT01906658|20332008|P2|COMPLETED|Overall Study||10
8244198|NCT01906658|20332009|P1|COMPLETED|Overall Study||9
8244199|NCT01906658|20332006|P4|STARTED|Overall Study||11
8244200|NCT01906658|20332007|P3|STARTED|Overall Study||10
8244201|NCT01906658|20332008|P2|STARTED|Overall Study||11
8244202|NCT01906658|20332009|P1|STARTED|Overall Study||11
8244203|NCT01906515|20332033|P2|NOT COMPLETED|Overall Study||0
8244204|NCT01906515|20332034|P1|NOT COMPLETED|Overall Study||0
8244205|NCT01906515|20332033|P2|COMPLETED|Overall Study||61
8244206|NCT01906515|20332034|P1|COMPLETED|Overall Study||45
8244207|NCT01906515|20332033|P2|STARTED|Overall Study||61
8244208|NCT01906515|20332034|P1|STARTED|Overall Study||45
8244209|NCT01906476|20332044|P2|NOT COMPLETED|Overall Study||16
8244210|NCT01906476|20332045|P1|NOT COMPLETED|Overall Study||17
8244211|NCT01906476|20332044|P2|COMPLETED|Overall Study||139
8244212|NCT01906476|20332045|P1|COMPLETED|Overall Study||140
8244213|NCT01906476|20332044|P2|STARTED|Overall Study||155
8244214|NCT01906476|20332045|P1|STARTED|Overall Study||157
8244215|NCT01906372|20332053|P1|NOT COMPLETED|Overall Study||2
8244216|NCT01906372|20332053|P1|COMPLETED|Overall Study||10
8244217|NCT01906372|20332053|P1|Visit 10: Follow up Phase Completed|Overall Study||8
8244218|NCT01906372|20332053|P1|Visit 7: Treatment Phase Completed|Overall Study||10
8244219|NCT01906372|20332053|P1|STARTED|Overall Study||12
8244220|NCT01906346|20332058|P1|NOT COMPLETED|Overall Study||1
8244221|NCT01906346|20332058|P1|COMPLETED|Overall Study||8
8244222|NCT01906346|20332058|P1|STARTED|Overall Study||9
8244223|NCT01906008|20332066|P2|NOT COMPLETED|Overall Study||27
8244224|NCT01906008|20332067|P1|NOT COMPLETED|Overall Study||27
8244225|NCT01906008|20332066|P2|COMPLETED|Overall Study||34
8244226|NCT01906008|20332067|P1|COMPLETED|Overall Study||32
8244227|NCT01906008|20332066|P2|STARTED|Overall Study||61
8244228|NCT01906008|20332067|P1|STARTED|Overall Study||59
8244229|NCT01905956|20332077|P2|NOT COMPLETED|Overall Study||11
8244230|NCT01905956|20332078|P1|NOT COMPLETED|Overall Study||6
8244231|NCT01905956|20332077|P2|COMPLETED|Overall Study|Per-protocol population|48
8244232|NCT01905956|20332078|P1|COMPLETED|Overall Study|Per-protocol population|54
8244233|NCT01905956|20332077|P2|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
8244234|NCT01905956|20332078|P1|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
8244235|NCT01905956|20332077|P2|STARTED|Overall Study|Randomized|59
8244236|NCT01905956|20332078|P1|STARTED|Overall Study|Randomized|60
8244237|NCT01905943|20332100|P1|NOT COMPLETED|Overall Study||314
8244238|NCT01905943|20332100|P1|COMPLETED|Overall Study|All patients provide reason at final analysis|658
8244239|NCT01905943|20332100|P1|STARTED|Overall Study||972
8244240|NCT01905683|20332217|P1|NOT COMPLETED|Overall Study||51
8244241|NCT01905683|20332217|P1|COMPLETED|Overall Study||319
8244242|NCT01905683|20332217|P1|STARTED|Overall Study||370
8244255|NCT01905592|20332260|P2|NOT COMPLETED|Overall Study||135
8244256|NCT01905592|20332261|P1|NOT COMPLETED|Overall Study||71
8244257|NCT01905592|20332260|P2|COMPLETED|Overall Study||0
8244258|NCT01905592|20332261|P1|COMPLETED|Overall Study||0
8244259|NCT01905592|20332260|P2|STARTED|Overall Study||135
8244260|NCT01905592|20332261|P1|STARTED|Overall Study||71
8244309|NCT01905423|20332316|P5|NOT COMPLETED|Overall Study||0
8244310|NCT01905423|20332317|P4|NOT COMPLETED|Overall Study||0
8244311|NCT01905423|20332318|P3|NOT COMPLETED|Overall Study||0
8244312|NCT01905423|20332319|P2|NOT COMPLETED|Overall Study||0
8244313|NCT01905423|20332320|P1|NOT COMPLETED|Overall Study||0
8244314|NCT01905423|20332316|P5|COMPLETED|Overall Study||2487
8244315|NCT01905423|20332317|P4|COMPLETED|Overall Study||2757
8244316|NCT01905423|20332318|P3|COMPLETED|Overall Study||4111
8244317|NCT01905423|20332319|P2|COMPLETED|Overall Study||3297
8244318|NCT01905423|20332320|P1|COMPLETED|Overall Study||4456
8244319|NCT01905423|20332316|P5|Year 3 Follow-up|Overall Study||0
8244320|NCT01905423|20332317|P4|Year 3 Follow-up|Overall Study||0
8244321|NCT01905423|20332318|P3|Year 3 Follow-up|Overall Study||1028
8244322|NCT01905423|20332319|P2|Year 3 Follow-up|Overall Study||871
8244323|NCT01905423|20332320|P1|Year 3 Follow-up|Overall Study||905
8244324|NCT01905423|20332316|P5|Year 2 Follow-up|Overall Study||0
8244325|NCT01905423|20332317|P4|Year 2 Follow-up|Overall Study||0
8244326|NCT01905423|20332318|P3|Year 2 Follow-up|Overall Study||1043
8244327|NCT01905423|20332319|P2|Year 2 Follow-up|Overall Study||858
8244328|NCT01905423|20332320|P1|Year 2 Follow-up|Overall Study||1114
8244329|NCT01905423|20332316|P5|Year 1 Follow-up|Overall Study||1161
8244330|NCT01905423|20332317|P4|Year 1 Follow-up|Overall Study||1275
8244331|NCT01905423|20332318|P3|Year 1 Follow-up|Overall Study||1007
8244332|NCT01905423|20332319|P2|Year 1 Follow-up|Overall Study||846
8244333|NCT01905423|20332320|P1|Year 1 Follow-up|Overall Study||994
8244334|NCT01905423|20332316|P5|Baseline|Overall Study||1326
8244335|NCT01905423|20332317|P4|Baseline|Overall Study||1482
8244336|NCT01905423|20332318|P3|Baseline|Overall Study||1033
8244337|NCT01905423|20332319|P2|Baseline|Overall Study||722
8244338|NCT01905423|20332320|P1|Baseline|Overall Study||1443
8244339|NCT01905423|20332316|P5|STARTED|Overall Study||2487
8244340|NCT01905423|20332317|P4|STARTED|Overall Study||2757
8244341|NCT01905423|20332318|P3|STARTED|Overall Study||4111
8244342|NCT01905423|20332319|P2|STARTED|Overall Study||3297
8244343|NCT01905423|20332320|P1|STARTED|Overall Study||4456
8244344|NCT01905267|20332359|P2|NOT COMPLETED|Overall Study||2
8244345|NCT01905267|20332360|P1|NOT COMPLETED|Overall Study||2
8244346|NCT01905267|20332359|P2|COMPLETED|Overall Study||14
8244347|NCT01905267|20332360|P1|COMPLETED|Overall Study||15
8244348|NCT01905267|20332359|P2|STARTED|Overall Study||16
8244349|NCT01905267|20332360|P1|STARTED|Overall Study||17
8244350|NCT01905254|20332368|P1|NOT COMPLETED|Overall Study||0
8244351|NCT01905254|20332368|P1|COMPLETED|Overall Study||34
8244352|NCT01905254|20332368|P1|STARTED|Overall Study||34
8244353|NCT01904864|20332374|P2|NOT COMPLETED|Overall Study||12
8244354|NCT01904864|20332375|P1|NOT COMPLETED|Overall Study||9
8244355|NCT01904864|20332374|P2|COMPLETED|Overall Study||28
8244356|NCT01904864|20332375|P1|COMPLETED|Overall Study||31
8244357|NCT01904864|20332374|P2|STARTED|Overall Study||40
8244358|NCT01904864|20332375|P1|STARTED|Overall Study||40
8244359|NCT01904773|20332381|P9|NOT COMPLETED|Sixth Intervention||0
8244360|NCT01904773|20332382|P8|NOT COMPLETED|Sixth Intervention||0
8244361|NCT01904773|20332383|P7|NOT COMPLETED|Sixth Intervention||0
8244362|NCT01904773|20332384|P6|NOT COMPLETED|Sixth Intervention||0
8244363|NCT01904773|20332385|P5|NOT COMPLETED|Sixth Intervention||0
8244364|NCT01904773|20332386|P4|NOT COMPLETED|Sixth Intervention||0
8244365|NCT01904773|20332387|P3|NOT COMPLETED|Sixth Intervention||0
8244366|NCT01904773|20332388|P2|NOT COMPLETED|Sixth Intervention||0
8244367|NCT01904773|20332389|P1|NOT COMPLETED|Sixth Intervention||0
8244368|NCT01904773|20332381|P9|COMPLETED|Sixth Intervention||4
8244369|NCT01904773|20332382|P8|COMPLETED|Sixth Intervention||2
8244370|NCT01904773|20332383|P7|COMPLETED|Sixth Intervention||3
8244371|NCT01904773|20332384|P6|COMPLETED|Sixth Intervention||4
8244372|NCT01904773|20332385|P5|COMPLETED|Sixth Intervention||3
8244373|NCT01904773|20332386|P4|COMPLETED|Sixth Intervention||2
8244374|NCT01904773|20332387|P3|COMPLETED|Sixth Intervention||1
8244375|NCT01904773|20332388|P2|COMPLETED|Sixth Intervention||0
8244376|NCT01904773|20332389|P1|COMPLETED|Sixth Intervention||0
8244377|NCT01904773|20332381|P9|STARTED|Sixth Intervention||4
8244378|NCT01904773|20332382|P8|STARTED|Sixth Intervention||2
8244379|NCT01904773|20332383|P7|STARTED|Sixth Intervention||3
8244380|NCT01904773|20332384|P6|STARTED|Sixth Intervention||4
8244381|NCT01904773|20332385|P5|STARTED|Sixth Intervention||3
8244382|NCT01904773|20332386|P4|STARTED|Sixth Intervention||2
8244383|NCT01904773|20332387|P3|STARTED|Sixth Intervention||1
8244384|NCT01904773|20332388|P2|STARTED|Sixth Intervention||0
8244385|NCT01904773|20332389|P1|STARTED|Sixth Intervention||0
8244386|NCT01904773|20332381|P9|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244387|NCT01904773|20332382|P8|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244388|NCT01904773|20332383|P7|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244389|NCT01904773|20332384|P6|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244390|NCT01904773|20332385|P5|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244391|NCT01904773|20332386|P4|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244392|NCT01904773|20332387|P3|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244393|NCT01904773|20332388|P2|NOT COMPLETED|Placebo Washout Fifth Intervention||1
8244394|NCT01904773|20332389|P1|NOT COMPLETED|Placebo Washout Fifth Intervention||0
8244395|NCT01904773|20332381|P9|COMPLETED|Placebo Washout Fifth Intervention||4
8244396|NCT01904773|20332382|P8|COMPLETED|Placebo Washout Fifth Intervention||2
8244397|NCT01904773|20332383|P7|COMPLETED|Placebo Washout Fifth Intervention||3
8244398|NCT01904773|20332384|P6|COMPLETED|Placebo Washout Fifth Intervention||4
8244399|NCT01904773|20332385|P5|COMPLETED|Placebo Washout Fifth Intervention||3
8244400|NCT01904773|20332386|P4|COMPLETED|Placebo Washout Fifth Intervention||2
8244401|NCT01904773|20332387|P3|COMPLETED|Placebo Washout Fifth Intervention||1
8244402|NCT01904773|20332388|P2|COMPLETED|Placebo Washout Fifth Intervention||0
8244403|NCT01904773|20332389|P1|COMPLETED|Placebo Washout Fifth Intervention||0
8244404|NCT01904773|20332381|P9|STARTED|Placebo Washout Fifth Intervention||4
8244405|NCT01904773|20332382|P8|STARTED|Placebo Washout Fifth Intervention||2
8244406|NCT01904773|20332383|P7|STARTED|Placebo Washout Fifth Intervention||3
8244407|NCT01904773|20332384|P6|STARTED|Placebo Washout Fifth Intervention||4
8244408|NCT01904773|20332385|P5|STARTED|Placebo Washout Fifth Intervention||3
8244409|NCT01904773|20332386|P4|STARTED|Placebo Washout Fifth Intervention||2
8244410|NCT01904773|20332387|P3|STARTED|Placebo Washout Fifth Intervention||1
8244411|NCT01904773|20332388|P2|STARTED|Placebo Washout Fifth Intervention||1
8244412|NCT01904773|20332389|P1|STARTED|Placebo Washout Fifth Intervention||0
8244413|NCT01904773|20332381|P9|NOT COMPLETED|Fifth Intervention||0
8244414|NCT01904773|20332382|P8|NOT COMPLETED|Fifth Intervention||1
8244415|NCT01904773|20332383|P7|NOT COMPLETED|Fifth Intervention||0
8244416|NCT01904773|20332384|P6|NOT COMPLETED|Fifth Intervention||0
8244417|NCT01904773|20332385|P5|NOT COMPLETED|Fifth Intervention||0
8244418|NCT01904773|20332386|P4|NOT COMPLETED|Fifth Intervention||0
8244419|NCT01904773|20332387|P3|NOT COMPLETED|Fifth Intervention||0
8244420|NCT01904773|20332388|P2|NOT COMPLETED|Fifth Intervention||0
8244421|NCT01904773|20332389|P1|NOT COMPLETED|Fifth Intervention||0
8244422|NCT01904773|20332381|P9|COMPLETED|Fifth Intervention||4
8244423|NCT01904773|20332382|P8|COMPLETED|Fifth Intervention||2
8244424|NCT01904773|20332383|P7|COMPLETED|Fifth Intervention||3
8244425|NCT01904773|20332384|P6|COMPLETED|Fifth Intervention||4
8244426|NCT01904773|20332385|P5|COMPLETED|Fifth Intervention||3
8244427|NCT01904773|20332386|P4|COMPLETED|Fifth Intervention||2
8244428|NCT01904773|20332387|P3|COMPLETED|Fifth Intervention||1
8244429|NCT01904773|20332388|P2|COMPLETED|Fifth Intervention||1
8244430|NCT01904773|20332389|P1|COMPLETED|Fifth Intervention||0
8244431|NCT01904773|20332381|P9|STARTED|Fifth Intervention||4
8244432|NCT01904773|20332382|P8|STARTED|Fifth Intervention||3
8244433|NCT01904773|20332383|P7|STARTED|Fifth Intervention||3
8244434|NCT01904773|20332384|P6|STARTED|Fifth Intervention||4
8244435|NCT01904773|20332385|P5|STARTED|Fifth Intervention||3
8244436|NCT01904773|20332386|P4|STARTED|Fifth Intervention||2
8244437|NCT01904773|20332387|P3|STARTED|Fifth Intervention||1
8244438|NCT01904773|20332388|P2|STARTED|Fifth Intervention||1
8244439|NCT01904773|20332389|P1|STARTED|Fifth Intervention||0
8244440|NCT01904773|20332381|P9|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244441|NCT01904773|20332382|P8|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244442|NCT01904773|20332383|P7|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244443|NCT01904773|20332384|P6|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244444|NCT01904773|20332385|P5|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244445|NCT01904773|20332386|P4|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244446|NCT01904773|20332387|P3|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244447|NCT01904773|20332388|P2|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244448|NCT01904773|20332389|P1|NOT COMPLETED|Placebo Washout Fourth Intervention||0
8244449|NCT01904773|20332381|P9|COMPLETED|Placebo Washout Fourth Intervention||4
8244450|NCT01904773|20332382|P8|COMPLETED|Placebo Washout Fourth Intervention||3
8244451|NCT01904773|20332383|P7|COMPLETED|Placebo Washout Fourth Intervention||3
8244452|NCT01904773|20332384|P6|COMPLETED|Placebo Washout Fourth Intervention||4
8244453|NCT01904773|20332385|P5|COMPLETED|Placebo Washout Fourth Intervention||3
8244454|NCT01904773|20332386|P4|COMPLETED|Placebo Washout Fourth Intervention||2
8244455|NCT01904773|20332387|P3|COMPLETED|Placebo Washout Fourth Intervention||1
8244456|NCT01904773|20332388|P2|COMPLETED|Placebo Washout Fourth Intervention||1
8244457|NCT01904773|20332389|P1|COMPLETED|Placebo Washout Fourth Intervention||0
8244458|NCT01904773|20332381|P9|STARTED|Placebo Washout Fourth Intervention||4
8244459|NCT01904773|20332382|P8|STARTED|Placebo Washout Fourth Intervention||3
8244460|NCT01904773|20332383|P7|STARTED|Placebo Washout Fourth Intervention||3
8244461|NCT01904773|20332384|P6|STARTED|Placebo Washout Fourth Intervention||4
8244462|NCT01904773|20332385|P5|STARTED|Placebo Washout Fourth Intervention||3
8244463|NCT01904773|20332386|P4|STARTED|Placebo Washout Fourth Intervention||2
8244464|NCT01904773|20332387|P3|STARTED|Placebo Washout Fourth Intervention||1
8244465|NCT01904773|20332388|P2|STARTED|Placebo Washout Fourth Intervention||1
8244466|NCT01904773|20332389|P1|STARTED|Placebo Washout Fourth Intervention||0
8244467|NCT01904773|20332381|P9|NOT COMPLETED|Fourth Intervention||0
8244468|NCT01904773|20332382|P8|NOT COMPLETED|Fourth Intervention||0
8244469|NCT01904773|20332383|P7|NOT COMPLETED|Fourth Intervention||0
8244470|NCT01904773|20332384|P6|NOT COMPLETED|Fourth Intervention||0
8244471|NCT01904773|20332385|P5|NOT COMPLETED|Fourth Intervention||0
8244472|NCT01904773|20332386|P4|NOT COMPLETED|Fourth Intervention||0
8244473|NCT01904773|20332387|P3|NOT COMPLETED|Fourth Intervention||0
8244474|NCT01904773|20332388|P2|NOT COMPLETED|Fourth Intervention||0
8244475|NCT01904773|20332389|P1|NOT COMPLETED|Fourth Intervention||0
8244476|NCT01904773|20332381|P9|COMPLETED|Fourth Intervention||4
8244477|NCT01904773|20332382|P8|COMPLETED|Fourth Intervention||3
8244478|NCT01904773|20332383|P7|COMPLETED|Fourth Intervention||3
8244479|NCT01904773|20332384|P6|COMPLETED|Fourth Intervention||4
8244480|NCT01904773|20332385|P5|COMPLETED|Fourth Intervention||3
8244481|NCT01904773|20332386|P4|COMPLETED|Fourth Intervention||2
8244482|NCT01904773|20332387|P3|COMPLETED|Fourth Intervention||1
8244483|NCT01904773|20332388|P2|COMPLETED|Fourth Intervention||1
8244484|NCT01904773|20332389|P1|COMPLETED|Fourth Intervention||0
8244485|NCT01904773|20332381|P9|STARTED|Fourth Intervention||4
8244486|NCT01904773|20332382|P8|STARTED|Fourth Intervention||3
8244487|NCT01904773|20332383|P7|STARTED|Fourth Intervention||3
8244488|NCT01904773|20332384|P6|STARTED|Fourth Intervention||4
8244489|NCT01904773|20332385|P5|STARTED|Fourth Intervention||3
8244490|NCT01904773|20332386|P4|STARTED|Fourth Intervention||2
8244491|NCT01904773|20332387|P3|STARTED|Fourth Intervention||1
8244492|NCT01904773|20332388|P2|STARTED|Fourth Intervention||1
8244493|NCT01904773|20332389|P1|STARTED|Fourth Intervention||0
8244494|NCT01904773|20332381|P9|NOT COMPLETED|Placebo Washout Third Intervention||0
8244495|NCT01904773|20332382|P8|NOT COMPLETED|Placebo Washout Third Intervention||0
8244496|NCT01904773|20332383|P7|NOT COMPLETED|Placebo Washout Third Intervention||0
8244497|NCT01904773|20332384|P6|NOT COMPLETED|Placebo Washout Third Intervention||0
8244498|NCT01904773|20332385|P5|NOT COMPLETED|Placebo Washout Third Intervention||0
8244499|NCT01904773|20332386|P4|NOT COMPLETED|Placebo Washout Third Intervention||0
8244500|NCT01904773|20332387|P3|NOT COMPLETED|Placebo Washout Third Intervention||0
8244501|NCT01904773|20332388|P2|NOT COMPLETED|Placebo Washout Third Intervention||0
8244502|NCT01904773|20332389|P1|NOT COMPLETED|Placebo Washout Third Intervention||0
8244503|NCT01904773|20332381|P9|COMPLETED|Placebo Washout Third Intervention||4
8244504|NCT01904773|20332382|P8|COMPLETED|Placebo Washout Third Intervention||3
8244505|NCT01904773|20332383|P7|COMPLETED|Placebo Washout Third Intervention||3
8244506|NCT01904773|20332384|P6|COMPLETED|Placebo Washout Third Intervention||4
8244507|NCT01904773|20332385|P5|COMPLETED|Placebo Washout Third Intervention||3
8244508|NCT01904773|20332386|P4|COMPLETED|Placebo Washout Third Intervention||2
8244509|NCT01904773|20332387|P3|COMPLETED|Placebo Washout Third Intervention||1
8244510|NCT01904773|20332388|P2|COMPLETED|Placebo Washout Third Intervention||1
8244511|NCT01904773|20332389|P1|COMPLETED|Placebo Washout Third Intervention||0
8244512|NCT01904773|20332381|P9|STARTED|Placebo Washout Third Intervention||4
8244513|NCT01904773|20332382|P8|STARTED|Placebo Washout Third Intervention||3
8244514|NCT01904773|20332383|P7|STARTED|Placebo Washout Third Intervention||3
8244515|NCT01904773|20332384|P6|STARTED|Placebo Washout Third Intervention||4
8244516|NCT01904773|20332385|P5|STARTED|Placebo Washout Third Intervention||3
8244517|NCT01904773|20332386|P4|STARTED|Placebo Washout Third Intervention||2
8244518|NCT01904773|20332387|P3|STARTED|Placebo Washout Third Intervention||1
8244519|NCT01904773|20332388|P2|STARTED|Placebo Washout Third Intervention||1
8244520|NCT01904773|20332389|P1|STARTED|Placebo Washout Third Intervention||0
8244521|NCT01904773|20332381|P9|NOT COMPLETED|Third Intervention||0
8244522|NCT01904773|20332382|P8|NOT COMPLETED|Third Intervention||0
8244523|NCT01904773|20332383|P7|NOT COMPLETED|Third Intervention||0
8244524|NCT01904773|20332384|P6|NOT COMPLETED|Third Intervention||0
8244525|NCT01904773|20332385|P5|NOT COMPLETED|Third Intervention||0
8244526|NCT01904773|20332386|P4|NOT COMPLETED|Third Intervention||0
8244527|NCT01904773|20332387|P3|NOT COMPLETED|Third Intervention||0
8244528|NCT01904773|20332388|P2|NOT COMPLETED|Third Intervention||0
8244529|NCT01904773|20332389|P1|NOT COMPLETED|Third Intervention||0
8244530|NCT01904773|20332381|P9|COMPLETED|Third Intervention||4
8244531|NCT01904773|20332382|P8|COMPLETED|Third Intervention||3
8244532|NCT01904773|20332383|P7|COMPLETED|Third Intervention||3
8244533|NCT01904773|20332384|P6|COMPLETED|Third Intervention||4
8244534|NCT01904773|20332385|P5|COMPLETED|Third Intervention||3
8244535|NCT01904773|20332386|P4|COMPLETED|Third Intervention||2
8244536|NCT01904773|20332387|P3|COMPLETED|Third Intervention||1
8244537|NCT01904773|20332388|P2|COMPLETED|Third Intervention||1
8244538|NCT01904773|20332389|P1|COMPLETED|Third Intervention||0
8244539|NCT01904773|20332381|P9|STARTED|Third Intervention||4
8244540|NCT01904773|20332382|P8|STARTED|Third Intervention||3
8244541|NCT01904773|20332383|P7|STARTED|Third Intervention||3
8244542|NCT01904773|20332384|P6|STARTED|Third Intervention||4
8244543|NCT01904773|20332385|P5|STARTED|Third Intervention||3
8244544|NCT01904773|20332386|P4|STARTED|Third Intervention||2
8244545|NCT01904773|20332387|P3|STARTED|Third Intervention||1
8244546|NCT01904773|20332388|P2|STARTED|Third Intervention||1
8244547|NCT01904773|20332389|P1|STARTED|Third Intervention||0
8244548|NCT01904773|20332381|P9|NOT COMPLETED|Placebo Washout Second Intervention||0
8244549|NCT01904773|20332382|P8|NOT COMPLETED|Placebo Washout Second Intervention||0
8244550|NCT01904773|20332383|P7|NOT COMPLETED|Placebo Washout Second Intervention||0
8244551|NCT01904773|20332384|P6|NOT COMPLETED|Placebo Washout Second Intervention||0
8244552|NCT01904773|20332385|P5|NOT COMPLETED|Placebo Washout Second Intervention||0
8244553|NCT01904773|20332386|P4|NOT COMPLETED|Placebo Washout Second Intervention||0
8244554|NCT01904773|20332387|P3|NOT COMPLETED|Placebo Washout Second Intervention||0
8244555|NCT01904773|20332388|P2|NOT COMPLETED|Placebo Washout Second Intervention||0
8244556|NCT01904773|20332389|P1|NOT COMPLETED|Placebo Washout Second Intervention||0
8244557|NCT01904773|20332381|P9|COMPLETED|Placebo Washout Second Intervention||4
8244558|NCT01904773|20332382|P8|COMPLETED|Placebo Washout Second Intervention||3
8244559|NCT01904773|20332383|P7|COMPLETED|Placebo Washout Second Intervention||3
8244560|NCT01904773|20332384|P6|COMPLETED|Placebo Washout Second Intervention||4
8244561|NCT01904773|20332385|P5|COMPLETED|Placebo Washout Second Intervention||3
8244562|NCT01904773|20332386|P4|COMPLETED|Placebo Washout Second Intervention||2
8244563|NCT01904773|20332387|P3|COMPLETED|Placebo Washout Second Intervention||1
8244564|NCT01904773|20332388|P2|COMPLETED|Placebo Washout Second Intervention||1
8244565|NCT01904773|20332389|P1|COMPLETED|Placebo Washout Second Intervention||0
8244566|NCT01904773|20332381|P9|STARTED|Placebo Washout Second Intervention||4
8244567|NCT01904773|20332382|P8|STARTED|Placebo Washout Second Intervention||3
8244568|NCT01904773|20332383|P7|STARTED|Placebo Washout Second Intervention||3
8244569|NCT01904773|20332384|P6|STARTED|Placebo Washout Second Intervention||4
8244570|NCT01904773|20332385|P5|STARTED|Placebo Washout Second Intervention||3
8244571|NCT01904773|20332386|P4|STARTED|Placebo Washout Second Intervention||2
8244572|NCT01904773|20332387|P3|STARTED|Placebo Washout Second Intervention||1
8244573|NCT01904773|20332388|P2|STARTED|Placebo Washout Second Intervention||1
8244574|NCT01904773|20332389|P1|STARTED|Placebo Washout Second Intervention||0
8244575|NCT01904773|20332381|P9|NOT COMPLETED|Second Intervention||0
8244576|NCT01904773|20332382|P8|NOT COMPLETED|Second Intervention||0
8244577|NCT01904773|20332383|P7|NOT COMPLETED|Second Intervention||0
8244578|NCT01904773|20332384|P6|NOT COMPLETED|Second Intervention||0
8244579|NCT01904773|20332385|P5|NOT COMPLETED|Second Intervention||0
8244580|NCT01904773|20332386|P4|NOT COMPLETED|Second Intervention||0
8244581|NCT01904773|20332387|P3|NOT COMPLETED|Second Intervention||0
8244582|NCT01904773|20332388|P2|NOT COMPLETED|Second Intervention||0
8244583|NCT01904773|20332389|P1|NOT COMPLETED|Second Intervention||0
8244584|NCT01904773|20332381|P9|COMPLETED|Second Intervention||4
8244585|NCT01904773|20332382|P8|COMPLETED|Second Intervention||3
8244586|NCT01904773|20332383|P7|COMPLETED|Second Intervention||3
8244587|NCT01904773|20332384|P6|COMPLETED|Second Intervention||4
8244588|NCT01904773|20332385|P5|COMPLETED|Second Intervention||3
8244589|NCT01904773|20332386|P4|COMPLETED|Second Intervention||2
8244590|NCT01904773|20332387|P3|COMPLETED|Second Intervention||1
8244591|NCT01904773|20332388|P2|COMPLETED|Second Intervention||1
8244592|NCT01904773|20332389|P1|COMPLETED|Second Intervention||0
8244593|NCT01904773|20332381|P9|STARTED|Second Intervention||4
8244594|NCT01904773|20332382|P8|STARTED|Second Intervention||3
8244595|NCT01904773|20332383|P7|STARTED|Second Intervention||3
8244596|NCT01904773|20332384|P6|STARTED|Second Intervention||4
8244597|NCT01904773|20332385|P5|STARTED|Second Intervention||3
8244598|NCT01904773|20332386|P4|STARTED|Second Intervention||2
8244599|NCT01904773|20332387|P3|STARTED|Second Intervention||1
8244600|NCT01904773|20332388|P2|STARTED|Second Intervention||1
8244601|NCT01904773|20332389|P1|STARTED|Second Intervention||0
8244602|NCT01904773|20332381|P9|NOT COMPLETED|Placebo Washout First Intervention||0
8244603|NCT01904773|20332382|P8|NOT COMPLETED|Placebo Washout First Intervention||0
8244604|NCT01904773|20332383|P7|NOT COMPLETED|Placebo Washout First Intervention||0
8244605|NCT01904773|20332384|P6|NOT COMPLETED|Placebo Washout First Intervention||0
8244606|NCT01904773|20332385|P5|NOT COMPLETED|Placebo Washout First Intervention||0
8244607|NCT01904773|20332386|P4|NOT COMPLETED|Placebo Washout First Intervention||0
8244608|NCT01904773|20332387|P3|NOT COMPLETED|Placebo Washout First Intervention||0
8244609|NCT01904773|20332388|P2|NOT COMPLETED|Placebo Washout First Intervention||1
8244610|NCT01904773|20332389|P1|NOT COMPLETED|Placebo Washout First Intervention||0
8244611|NCT01904773|20332381|P9|COMPLETED|Placebo Washout First Intervention||4
8244612|NCT01904773|20332382|P8|COMPLETED|Placebo Washout First Intervention||3
8244613|NCT01904773|20332383|P7|COMPLETED|Placebo Washout First Intervention||3
8244614|NCT01904773|20332384|P6|COMPLETED|Placebo Washout First Intervention||4
8244615|NCT01904773|20332385|P5|COMPLETED|Placebo Washout First Intervention||3
8244616|NCT01904773|20332386|P4|COMPLETED|Placebo Washout First Intervention||2
8244617|NCT01904773|20332387|P3|COMPLETED|Placebo Washout First Intervention||1
8244618|NCT01904773|20332388|P2|COMPLETED|Placebo Washout First Intervention||1
8244619|NCT01904773|20332389|P1|COMPLETED|Placebo Washout First Intervention||0
8244620|NCT01904773|20332381|P9|STARTED|Placebo Washout First Intervention||4
8244621|NCT01904773|20332382|P8|STARTED|Placebo Washout First Intervention||3
8244622|NCT01904773|20332383|P7|STARTED|Placebo Washout First Intervention||3
8244623|NCT01904773|20332384|P6|STARTED|Placebo Washout First Intervention||4
8244624|NCT01904773|20332385|P5|STARTED|Placebo Washout First Intervention||3
8244625|NCT01904773|20332386|P4|STARTED|Placebo Washout First Intervention||2
8244626|NCT01904773|20332387|P3|STARTED|Placebo Washout First Intervention||1
8244627|NCT01904773|20332388|P2|STARTED|Placebo Washout First Intervention||2
8244628|NCT01904773|20332389|P1|STARTED|Placebo Washout First Intervention||0
8244629|NCT01904773|20332381|P9|NOT COMPLETED|First Intervention||0
8244630|NCT01904773|20332382|P8|NOT COMPLETED|First Intervention||0
8244631|NCT01904773|20332383|P7|NOT COMPLETED|First Intervention||1
8244632|NCT01904773|20332384|P6|NOT COMPLETED|First Intervention||0
8244633|NCT01904773|20332385|P5|NOT COMPLETED|First Intervention||0
8244634|NCT01904773|20332386|P4|NOT COMPLETED|First Intervention||0
8244635|NCT01904773|20332387|P3|NOT COMPLETED|First Intervention||0
8244636|NCT01904773|20332388|P2|NOT COMPLETED|First Intervention||0
8244637|NCT01904773|20332389|P1|NOT COMPLETED|First Intervention||0
8244638|NCT01904773|20332381|P9|COMPLETED|First Intervention||4
8244639|NCT01904773|20332382|P8|COMPLETED|First Intervention||3
8244640|NCT01904773|20332383|P7|COMPLETED|First Intervention||3
8244641|NCT01904773|20332384|P6|COMPLETED|First Intervention||4
8244642|NCT01904773|20332385|P5|COMPLETED|First Intervention||3
8244643|NCT01904773|20332386|P4|COMPLETED|First Intervention||2
8244644|NCT01904773|20332387|P3|COMPLETED|First Intervention||1
8244645|NCT01904773|20332388|P2|COMPLETED|First Intervention||2
8244646|NCT01904773|20332389|P1|COMPLETED|First Intervention||0
8244647|NCT01904773|20332381|P9|STARTED|First Intervention||4
8244648|NCT01904773|20332382|P8|STARTED|First Intervention||3
8244649|NCT01904773|20332383|P7|STARTED|First Intervention||4
8244650|NCT01904773|20332384|P6|STARTED|First Intervention||4
8244651|NCT01904773|20332385|P5|STARTED|First Intervention||3
8244652|NCT01904773|20332386|P4|STARTED|First Intervention||2
8244653|NCT01904773|20332387|P3|STARTED|First Intervention||1
8244654|NCT01904773|20332388|P2|STARTED|First Intervention||2
8244655|NCT01904773|20332389|P1|STARTED|First Intervention||0
8244656|NCT01904773|20332381|P9|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244657|NCT01904773|20332382|P8|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244658|NCT01904773|20332383|P7|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244659|NCT01904773|20332384|P6|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244660|NCT01904773|20332385|P5|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244661|NCT01904773|20332386|P4|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244662|NCT01904773|20332387|P3|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244663|NCT01904773|20332388|P2|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244664|NCT01904773|20332389|P1|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
8244665|NCT01904773|20332381|P9|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244666|NCT01904773|20332382|P8|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244667|NCT01904773|20332383|P7|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244668|NCT01904773|20332384|P6|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244669|NCT01904773|20332385|P5|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244670|NCT01904773|20332386|P4|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244671|NCT01904773|20332387|P3|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244672|NCT01904773|20332388|P2|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244673|NCT01904773|20332389|P1|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
8244674|NCT01904773|20332381|P9|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244675|NCT01904773|20332382|P8|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244676|NCT01904773|20332383|P7|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244677|NCT01904773|20332384|P6|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244678|NCT01904773|20332385|P5|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244679|NCT01904773|20332386|P4|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244680|NCT01904773|20332387|P3|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244681|NCT01904773|20332388|P2|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244682|NCT01904773|20332389|P1|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
8244683|NCT01904773|20332381|P9|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244684|NCT01904773|20332382|P8|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244685|NCT01904773|20332383|P7|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244686|NCT01904773|20332384|P6|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244687|NCT01904773|20332385|P5|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244688|NCT01904773|20332386|P4|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244689|NCT01904773|20332387|P3|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244690|NCT01904773|20332388|P2|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244691|NCT01904773|20332389|P1|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
8244692|NCT01904773|20332381|P9|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244693|NCT01904773|20332382|P8|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244694|NCT01904773|20332383|P7|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244695|NCT01904773|20332384|P6|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244696|NCT01904773|20332385|P5|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244697|NCT01904773|20332386|P4|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244698|NCT01904773|20332387|P3|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244699|NCT01904773|20332388|P2|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
8244700|NCT01904773|20332389|P1|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
8244701|NCT01904773|20332381|P9|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244702|NCT01904773|20332382|P8|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244703|NCT01904773|20332383|P7|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244704|NCT01904773|20332384|P6|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244705|NCT01904773|20332385|P5|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244706|NCT01904773|20332386|P4|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244707|NCT01904773|20332387|P3|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244708|NCT01904773|20332388|P2|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244709|NCT01904773|20332389|P1|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244710|NCT01904773|20332381|P9|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244711|NCT01904773|20332382|P8|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244712|NCT01904773|20332383|P7|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244713|NCT01904773|20332384|P6|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244714|NCT01904773|20332385|P5|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244715|NCT01904773|20332386|P4|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244716|NCT01904773|20332387|P3|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244717|NCT01904773|20332388|P2|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244718|NCT01904773|20332389|P1|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
8244719|NCT01904773|20332381|P9|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244720|NCT01904773|20332382|P8|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244721|NCT01904773|20332383|P7|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244722|NCT01904773|20332384|P6|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244723|NCT01904773|20332385|P5|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244724|NCT01904773|20332386|P4|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244725|NCT01904773|20332387|P3|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244726|NCT01904773|20332388|P2|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
8244727|NCT01904773|20332389|P1|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
8244728|NCT01904773|20332381|P9|NOT COMPLETED|Screen||0
8244729|NCT01904773|20332382|P8|NOT COMPLETED|Screen||0
8244730|NCT01904773|20332383|P7|NOT COMPLETED|Screen||0
8244731|NCT01904773|20332384|P6|NOT COMPLETED|Screen||0
8244732|NCT01904773|20332385|P5|NOT COMPLETED|Screen||0
8244733|NCT01904773|20332386|P4|NOT COMPLETED|Screen||0
8244734|NCT01904773|20332387|P3|NOT COMPLETED|Screen||0
8244735|NCT01904773|20332388|P2|NOT COMPLETED|Screen||0
8244736|NCT01904773|20332389|P1|NOT COMPLETED|Screen||4
8244737|NCT01904773|20332381|P9|COMPLETED|Screen||0
8244738|NCT01904773|20332382|P8|COMPLETED|Screen||0
8244739|NCT01904773|20332383|P7|COMPLETED|Screen||0
8244740|NCT01904773|20332384|P6|COMPLETED|Screen||0
8244741|NCT01904773|20332385|P5|COMPLETED|Screen||0
8244742|NCT01904773|20332386|P4|COMPLETED|Screen||0
8244743|NCT01904773|20332387|P3|COMPLETED|Screen||0
8244744|NCT01904773|20332388|P2|COMPLETED|Screen||0
8244745|NCT01904773|20332389|P1|COMPLETED|Screen||24
8244746|NCT01904773|20332381|P9|STARTED|Screen||0
8244747|NCT01904773|20332382|P8|STARTED|Screen||0
8244748|NCT01904773|20332383|P7|STARTED|Screen||0
8244749|NCT01904773|20332384|P6|STARTED|Screen||0
8244750|NCT01904773|20332385|P5|STARTED|Screen||0
8244751|NCT01904773|20332386|P4|STARTED|Screen||0
8244752|NCT01904773|20332387|P3|STARTED|Screen||0
8244753|NCT01904773|20332388|P2|STARTED|Screen||0
8244754|NCT01904773|20332389|P1|STARTED|Screen||28
8244755|NCT01904760|20332406|P2|NOT COMPLETED|Overall Study||0
8244756|NCT01904760|20332407|P1|NOT COMPLETED|Overall Study||1
8244757|NCT01904760|20332406|P2|COMPLETED|Overall Study||40
8244758|NCT01904760|20332407|P1|COMPLETED|Overall Study||39
8244759|NCT01904760|20332406|P2|STARTED|Overall Study||40
8244760|NCT01904760|20332407|P1|STARTED|Overall Study||40
8244761|NCT01904721|20332422|P7|NOT COMPLETED|Overall Study||7
8244762|NCT01904721|20332423|P6|NOT COMPLETED|Overall Study||9
8244763|NCT01904721|20332424|P5|NOT COMPLETED|Overall Study||8
8244764|NCT01904721|20332425|P4|NOT COMPLETED|Overall Study||1
8244765|NCT01904721|20332426|P3|NOT COMPLETED|Overall Study||1
8244766|NCT01904721|20332427|P2|NOT COMPLETED|Overall Study||0
8244767|NCT01904721|20332428|P1|NOT COMPLETED|Overall Study||0
8244768|NCT01904721|20332422|P7|COMPLETED|Overall Study||57
8244769|NCT01904721|20332423|P6|COMPLETED|Overall Study||56
8244770|NCT01904721|20332424|P5|COMPLETED|Overall Study||57
8244771|NCT01904721|20332425|P4|COMPLETED|Overall Study||11
8244772|NCT01904721|20332426|P3|COMPLETED|Overall Study||11
8244773|NCT01904721|20332427|P2|COMPLETED|Overall Study||13
8244774|NCT01904721|20332428|P1|COMPLETED|Overall Study||13
8244775|NCT01904721|20332422|P7|STARTED|Overall Study||64
8244776|NCT01904721|20332423|P6|STARTED|Overall Study||65
8244777|NCT01904721|20332424|P5|STARTED|Overall Study||65
8244778|NCT01904721|20332425|P4|STARTED|Overall Study||12
8244779|NCT01904721|20332426|P3|STARTED|Overall Study||12
8244780|NCT01904721|20332427|P2|STARTED|Overall Study||13
8244781|NCT01904721|20332428|P1|STARTED|Overall Study||13
8244782|NCT01904604|20332458|P3|NOT COMPLETED|Overall Study||2
8244783|NCT01904604|20332459|P2|NOT COMPLETED|Overall Study||7
8244784|NCT01904604|20332460|P1|NOT COMPLETED|Overall Study||7
8244785|NCT01904604|20332458|P3|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23
8244786|NCT01904604|20332459|P2|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
8244787|NCT01904604|20332460|P1|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
8244788|NCT01904604|20332458|P3|Completed Week 130 OFC|Overall Study||23
8244789|NCT01904604|20332459|P2|Completed Week 130 OFC|Overall Study||18
8244790|NCT01904604|20332460|P1|Completed Week 130 OFC|Overall Study||18
8244791|NCT01904604|20332458|P3|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0
8244792|NCT01904604|20332459|P2|Began Crossover Treatment|Overall Study||21
8244793|NCT01904604|20332460|P1|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20
8244794|NCT01904604|20332458|P3|Completed Week 52 OFC|Overall Study||25
8244795|NCT01904604|20332459|P2|Completed Week 52 OFC|Overall Study||21
8244796|NCT01904604|20332460|P1|Completed Week 52 OFC|Overall Study||22
8244797|NCT01904604|20332458|P3|STARTED|Overall Study||25
8244798|NCT01904604|20332459|P2|STARTED|Overall Study||25
8244799|NCT01904604|20332460|P1|STARTED|Overall Study||25
8244800|NCT01904526|20332489|P1|NOT COMPLETED|Overall Study||0
8244801|NCT01904526|20332489|P1|COMPLETED|Overall Study||5
8244802|NCT01904526|20332489|P1|STARTED|Overall Study||5
8244803|NCT01904448|20332503|P1|NOT COMPLETED|Overall Study||0
8244804|NCT01904448|20332503|P1|COMPLETED|Overall Study||5
8244805|NCT01904448|20332503|P1|STARTED|Overall Study||5
8244806|NCT01904383|20332525|P1|NOT COMPLETED|Overall Study||1774
8244807|NCT01904383|20332525|P1|COMPLETED|Overall Study||2283
8244808|NCT01904383|20332525|P1|Treated|Overall Study||3940
8244809|NCT01904383|20332525|P1|STARTED|Overall Study||4057
8244810|NCT01904279|20332532|P2|NOT COMPLETED|Overall Study||3
8244811|NCT01904279|20332533|P1|NOT COMPLETED|Overall Study||3
8244812|NCT01904279|20332532|P2|COMPLETED|Overall Study||22
8244813|NCT01904279|20332533|P1|COMPLETED|Overall Study||24
8244814|NCT01904279|20332532|P2|STARTED|Overall Study||25
8244815|NCT01904279|20332533|P1|STARTED|Overall Study||27
8244816|NCT01904149|20332559|P6|NOT COMPLETED|Overall Study||3
8244817|NCT01904149|20332560|P5|NOT COMPLETED|Overall Study||5
8244818|NCT01904149|20332561|P4|NOT COMPLETED|Overall Study||4
8244819|NCT01904149|20332562|P3|NOT COMPLETED|Overall Study||2
8244820|NCT01904149|20332563|P2|NOT COMPLETED|Overall Study||11
8244821|NCT01904149|20332564|P1|NOT COMPLETED|Overall Study||5
8244822|NCT01904149|20332559|P6|COMPLETED|Overall Study||48
8244823|NCT01904149|20332560|P5|COMPLETED|Overall Study||46
8244824|NCT01904149|20332561|P4|COMPLETED|Overall Study||47
8244825|NCT01904149|20332562|P3|COMPLETED|Overall Study||148
8244826|NCT01904149|20332563|P2|COMPLETED|Overall Study||140
8244827|NCT01904149|20332564|P1|COMPLETED|Overall Study||147
8244828|NCT01904149|20332559|P6|Multiple-dose Phase|Overall Study||49
8244829|NCT01904149|20332560|P5|Multiple-dose Phase|Overall Study||48
8244830|NCT01904149|20332561|P4|Multiple-dose Phase|Overall Study||48
8244831|NCT01904149|20332562|P3|Multiple-dose Phase|Overall Study||149
8244832|NCT01904149|20332563|P2|Multiple-dose Phase|Overall Study||146
8244833|NCT01904149|20332564|P1|Multiple-dose Phase|Overall Study||150
8244834|NCT01904149|20332559|P6|Single-dose Phase|Overall Study||51
8244835|NCT01904149|20332560|P5|Single-dose Phase|Overall Study||51
8244836|NCT01904149|20332561|P4|Single-dose Phase|Overall Study||51
8244837|NCT01904149|20332562|P3|Single-dose Phase|Overall Study||150
8244838|NCT01904149|20332563|P2|Single-dose Phase|Overall Study||151
8244839|NCT01904149|20332564|P1|Single-dose Phase|Overall Study||152
8244840|NCT01904149|20332559|P6|STARTED|Overall Study||51
8244841|NCT01904149|20332560|P5|STARTED|Overall Study||51
8244842|NCT01904149|20332561|P4|STARTED|Overall Study||51
8244843|NCT01904149|20332562|P3|STARTED|Overall Study||150
8244844|NCT01904149|20332563|P2|STARTED|Overall Study||151
8244845|NCT01904149|20332564|P1|STARTED|Overall Study||152
8244846|NCT01904071|20332589|P3|NOT COMPLETED|Overall Study||0
8244847|NCT01904071|20332590|P2|NOT COMPLETED|Overall Study||0
8244848|NCT01904071|20332591|P1|NOT COMPLETED|Overall Study||0
8244849|NCT01904071|20332589|P3|COMPLETED|Overall Study||20
8244850|NCT01904071|20332590|P2|COMPLETED|Overall Study||20
8244851|NCT01904071|20332591|P1|COMPLETED|Overall Study||24
8244852|NCT01904071|20332589|P3|STARTED|Overall Study||20
8244853|NCT01904071|20332590|P2|STARTED|Overall Study||20
8244854|NCT01904071|20332591|P1|STARTED|Overall Study||24
8244855|NCT01904058|20332615|P4|NOT COMPLETED|Overall Study||1
8244856|NCT01904058|20332616|P3|NOT COMPLETED|Overall Study||1
8244857|NCT01904058|20332617|P2|NOT COMPLETED|Overall Study||0
8244858|NCT01904058|20332618|P1|NOT COMPLETED|Overall Study||3
8244859|NCT01904058|20332615|P4|COMPLETED|Overall Study||12
8244860|NCT01904058|20332616|P3|COMPLETED|Overall Study||10
8244861|NCT01904058|20332617|P2|COMPLETED|Overall Study||21
8244862|NCT01904058|20332618|P1|COMPLETED|Overall Study||18
8244863|NCT01904058|20332615|P4|STARTED|Overall Study||13
8244864|NCT01904058|20332616|P3|STARTED|Overall Study||11
8244865|NCT01904058|20332617|P2|STARTED|Overall Study||21
8244866|NCT01904058|20332618|P1|STARTED|Overall Study||21
8244867|NCT01903993|20332658|P2|NOT COMPLETED|Overall Study||144
8244868|NCT01903993|20332659|P1|NOT COMPLETED|Overall Study||143
8244869|NCT01903993|20332658|P2|COMPLETED|Overall Study||0
8244870|NCT01903993|20332659|P1|COMPLETED|Overall Study||0
8244871|NCT01903993|20332658|P2|Received Treatment|Overall Study||142
8244872|NCT01903993|20332659|P1|Received Treatment|Overall Study||135
8244873|NCT01903993|20332658|P2|STARTED|Overall Study||144
8244874|NCT01903993|20332659|P1|STARTED|Overall Study||143
8244875|NCT01903876|20332676|P2|NOT COMPLETED|Six-Month Follow-up Period||145
8244876|NCT01903876|20332677|P1|NOT COMPLETED|Six-Month Follow-up Period||91
8244877|NCT01903876|20332676|P2|COMPLETED|Six-Month Follow-up Period||123
8244878|NCT01903876|20332677|P1|COMPLETED|Six-Month Follow-up Period||92
8244879|NCT01903876|20332676|P2|STARTED|Six-Month Follow-up Period||268
8244880|NCT01903876|20332677|P1|STARTED|Six-Month Follow-up Period||183
8244881|NCT01903876|20332676|P2|NOT COMPLETED|Baseline to Post-Intervention Period||108
8244882|NCT01903876|20332677|P1|NOT COMPLETED|Baseline to Post-Intervention Period||184
8244883|NCT01903876|20332676|P2|COMPLETED|Baseline to Post-Intervention Period||268
8244884|NCT01903876|20332677|P1|COMPLETED|Baseline to Post-Intervention Period||183
8244885|NCT01903876|20332676|P2|STARTED|Baseline to Post-Intervention Period||376
8244886|NCT01903876|20332677|P1|STARTED|Baseline to Post-Intervention Period||367
8244887|NCT01903863|20332687|P2|NOT COMPLETED|Overall Study||0
8244888|NCT01903863|20332688|P1|NOT COMPLETED|Overall Study||2
8244889|NCT01903863|20332687|P2|COMPLETED|Overall Study||16
8244890|NCT01903863|20332688|P1|COMPLETED|Overall Study||13
8244891|NCT01903863|20332687|P2|STARTED|Overall Study||16
8244892|NCT01903863|20332688|P1|STARTED|Overall Study||15
8244893|NCT01903811|20332710|P2|NOT COMPLETED|Overall Study||14
8244894|NCT01903811|20332711|P1|NOT COMPLETED|Overall Study||8
8244895|NCT01903811|20332710|P2|COMPLETED|Overall Study||57
8244896|NCT01903811|20332711|P1|COMPLETED|Overall Study||64
8244897|NCT01903811|20332710|P2|Crossover to Arm II|Overall Study||0
8244898|NCT01903811|20332711|P1|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16
8244899|NCT01903811|20332710|P2|STARTED|Overall Study||71
8244900|NCT01903811|20332711|P1|STARTED|Overall Study||72
8244901|NCT01903798|20332728|P4|NOT COMPLETED|Overall Study||0
8244902|NCT01903798|20332729|P3|NOT COMPLETED|Overall Study||0
8244903|NCT01903798|20332730|P2|NOT COMPLETED|Overall Study||0
8244904|NCT01903798|20332731|P1|NOT COMPLETED|Overall Study||0
8244905|NCT01903798|20332728|P4|COMPLETED|Overall Study||1
8244906|NCT01903798|20332729|P3|COMPLETED|Overall Study||1
8244907|NCT01903798|20332730|P2|COMPLETED|Overall Study||0
8244908|NCT01903798|20332731|P1|COMPLETED|Overall Study||2
8244909|NCT01903798|20332728|P4|STARTED|Overall Study||1
8244910|NCT01903798|20332729|P3|STARTED|Overall Study||1
8244911|NCT01903798|20332730|P2|STARTED|Overall Study||0
8244912|NCT01903798|20332731|P1|STARTED|Overall Study||2
8244913|NCT01903720|20332745|P1|NOT COMPLETED|Overall Study||12
8244914|NCT01903720|20332745|P1|COMPLETED|Overall Study||59
8244915|NCT01903720|20332745|P1|STARTED|Overall Study||71
8244916|NCT01903564|20332762|P2|NOT COMPLETED|Overall Study||0
8244917|NCT01903564|20332763|P1|NOT COMPLETED|Overall Study||0
8244918|NCT01903564|20332762|P2|COMPLETED|Overall Study||29
8244919|NCT01903564|20332763|P1|COMPLETED|Overall Study||10
8244920|NCT01903564|20332762|P2|STARTED|Overall Study||29
8244921|NCT01903564|20332763|P1|STARTED|Overall Study||10
8244922|NCT01903525|20332781|P2|NOT COMPLETED|Overall Study||10
8244923|NCT01903525|20332782|P1|NOT COMPLETED|Overall Study||5
8244924|NCT01903525|20332781|P2|COMPLETED|Overall Study||10
8244925|NCT01903525|20332782|P1|COMPLETED|Overall Study||15
8244926|NCT01903525|20332781|P2|STARTED|Overall Study||20
8244927|NCT01903525|20332782|P1|STARTED|Overall Study||20
8244928|NCT01903460|20332798|P4|NOT COMPLETED|Overall Study||1
8244929|NCT01903460|20332799|P3|NOT COMPLETED|Overall Study||0
8244930|NCT01903460|20332800|P2|NOT COMPLETED|Overall Study||0
8244931|NCT01903460|20332801|P1|NOT COMPLETED|Overall Study||0
8244932|NCT01903460|20332798|P4|COMPLETED|Overall Study||2
8244933|NCT01903460|20332799|P3|COMPLETED|Overall Study||3
8244934|NCT01903460|20332800|P2|COMPLETED|Overall Study||8
8244935|NCT01903460|20332801|P1|COMPLETED|Overall Study||6
8244936|NCT01903460|20332798|P4|STARTED|Overall Study||3
8244937|NCT01903460|20332799|P3|STARTED|Overall Study||3
8244938|NCT01903460|20332800|P2|STARTED|Overall Study||8
8244939|NCT01903460|20332801|P1|STARTED|Overall Study||6
8244940|NCT01903434|20332818|P2|NOT COMPLETED|Treatment Period 3||0
8244941|NCT01903434|20332819|P1|NOT COMPLETED|Treatment Period 3||0
8244942|NCT01903434|20332818|P2|COMPLETED|Treatment Period 3||28
8244943|NCT01903434|20332819|P1|COMPLETED|Treatment Period 3||29
8244944|NCT01903434|20332818|P2|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
8244945|NCT01903434|20332819|P1|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
8244946|NCT01903434|20332818|P2|STARTED|Treatment Period 3||28
8244947|NCT01903434|20332819|P1|STARTED|Treatment Period 3||29
8244948|NCT01903434|20332818|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8244949|NCT01903434|20332819|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8244950|NCT01903434|20332818|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
8244951|NCT01903434|20332819|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
8244952|NCT01903434|20332818|P2|STARTED|Washout Period 1 (at Least 14 Days)||28
8244953|NCT01903434|20332819|P1|STARTED|Washout Period 1 (at Least 14 Days)||29
8244954|NCT01903434|20332818|P2|NOT COMPLETED|Treatment Period 2||0
8244955|NCT01903434|20332819|P1|NOT COMPLETED|Treatment Period 2||0
8244956|NCT01903434|20332818|P2|COMPLETED|Treatment Period 2||28
8244957|NCT01903434|20332819|P1|COMPLETED|Treatment Period 2||29
8244958|NCT01903434|20332818|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
8244959|NCT01903434|20332819|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
8244960|NCT01903434|20332818|P2|STARTED|Treatment Period 2||28
8244961|NCT01903434|20332819|P1|STARTED|Treatment Period 2||29
8244962|NCT01903434|20332818|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
8244963|NCT01903434|20332819|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
8244964|NCT01903434|20332818|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||28
8244965|NCT01903434|20332819|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||29
8244966|NCT01903434|20332818|P2|STARTED|Washout Period 1 (at Least 14 Days)||30
8244967|NCT01903434|20332819|P1|STARTED|Washout Period 1 (at Least 14 Days)||30
8244968|NCT01903434|20332818|P2|NOT COMPLETED|Treatment Period 1||0
8244969|NCT01903434|20332819|P1|NOT COMPLETED|Treatment Period 1||0
8244970|NCT01903434|20332818|P2|COMPLETED|Treatment Period 1||30
8244971|NCT01903434|20332819|P1|COMPLETED|Treatment Period 1||30
8244972|NCT01903434|20332818|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
8244973|NCT01903434|20332819|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
8244974|NCT01903434|20332818|P2|STARTED|Treatment Period 1||30
8244975|NCT01903434|20332819|P1|STARTED|Treatment Period 1||30
8244976|NCT01903356|20332827|P1|NOT COMPLETED|Overall Study||15
8244977|NCT01903356|20332827|P1|COMPLETED|Overall Study||709
8244978|NCT01903356|20332827|P1|STARTED|Overall Study||724
8244979|NCT01903265|20332837|P2|NOT COMPLETED|Overall Study||17
8244980|NCT01903265|20332838|P1|NOT COMPLETED|Overall Study||14
8244981|NCT01903265|20332837|P2|COMPLETED|Overall Study||85
8244982|NCT01903265|20332838|P1|COMPLETED|Overall Study||89
8244983|NCT01903265|20332837|P2|STARTED|Overall Study||102
8244984|NCT01903265|20332838|P1|STARTED|Overall Study||103
8244985|NCT01903252|20332854|P6|NOT COMPLETED|Maintenance, Open-Label||18
8244986|NCT01903252|20332855|P5|NOT COMPLETED|Maintenance, Open-Label||21
8244987|NCT01903252|20332856|P4|NOT COMPLETED|Maintenance, Open-Label||6
8244988|NCT01903252|20332857|P3|NOT COMPLETED|Maintenance, Open-Label||0
8244989|NCT01903252|20332858|P2|NOT COMPLETED|Maintenance, Open-Label||0
8244990|NCT01903252|20332859|P1|NOT COMPLETED|Maintenance, Open-Label||0
8244991|NCT01903252|20332854|P6|COMPLETED|Maintenance, Open-Label||181
8244992|NCT01903252|20332855|P5|COMPLETED|Maintenance, Open-Label||253
8244993|NCT01903252|20332856|P4|COMPLETED|Maintenance, Open-Label||196
8244994|NCT01903252|20332857|P3|COMPLETED|Maintenance, Open-Label||0
8244995|NCT01903252|20332858|P2|COMPLETED|Maintenance, Open-Label||0
8244996|NCT01903252|20332859|P1|COMPLETED|Maintenance, Open-Label||0
8244997|NCT01903252|20332854|P6|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
8244998|NCT01903252|20332855|P5|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
8244999|NCT01903252|20332856|P4|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
8245000|NCT01903252|20332857|P3|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
8245001|NCT01903252|20332858|P2|STARTED|Maintenance, Open-Label||0
8245002|NCT01903252|20332859|P1|STARTED|Maintenance, Open-Label||0
8245003|NCT01903252|20332854|P6|NOT COMPLETED|Extended Induction, Open-Label||0
8245004|NCT01903252|20332855|P5|NOT COMPLETED|Extended Induction, Open-Label||0
8245005|NCT01903252|20332856|P4|NOT COMPLETED|Extended Induction, Open-Label||0
8245006|NCT01903252|20332857|P3|NOT COMPLETED|Extended Induction, Open-Label||23
8245007|NCT01903252|20332858|P2|NOT COMPLETED|Extended Induction, Open-Label||0
8245008|NCT01903252|20332859|P1|NOT COMPLETED|Extended Induction, Open-Label||0
8245009|NCT01903252|20332854|P6|COMPLETED|Extended Induction, Open-Label||0
8245010|NCT01903252|20332855|P5|COMPLETED|Extended Induction, Open-Label||0
8245011|NCT01903252|20332856|P4|COMPLETED|Extended Induction, Open-Label||0
8245012|NCT01903252|20332857|P3|COMPLETED|Extended Induction, Open-Label||220
8245013|NCT01903252|20332858|P2|COMPLETED|Extended Induction, Open-Label||0
8245014|NCT01903252|20332859|P1|COMPLETED|Extended Induction, Open-Label||0
8245015|NCT01903252|20332854|P6|STARTED|Extended Induction, Open-Label||0
8245016|NCT01903252|20332855|P5|STARTED|Extended Induction, Open-Label||0
8245017|NCT01903252|20332856|P4|STARTED|Extended Induction, Open-Label||0
8245018|NCT01903252|20332857|P3|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
8245019|NCT01903252|20332858|P2|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
8245020|NCT01903252|20332859|P1|STARTED|Extended Induction, Open-Label||0
8245021|NCT01903252|20332854|P6|NOT COMPLETED|Double-Blind Induction||0
8245022|NCT01903252|20332855|P5|NOT COMPLETED|Double-Blind Induction||0
8245023|NCT01903252|20332856|P4|NOT COMPLETED|Double-Blind Induction||0
8245024|NCT01903252|20332857|P3|NOT COMPLETED|Double-Blind Induction||0
8245025|NCT01903252|20332858|P2|NOT COMPLETED|Double-Blind Induction||41
8245026|NCT01903252|20332859|P1|NOT COMPLETED|Double-Blind Induction||39
8245027|NCT01903252|20332854|P6|COMPLETED|Double-Blind Induction||0
8245028|NCT01903252|20332855|P5|COMPLETED|Double-Blind Induction||0
8245029|NCT01903252|20332856|P4|COMPLETED|Double-Blind Induction||0
8245030|NCT01903252|20332857|P3|COMPLETED|Double-Blind Induction||0
8245031|NCT01903252|20332858|P2|COMPLETED|Double-Blind Induction||367
8245032|NCT01903252|20332859|P1|COMPLETED|Double-Blind Induction||370
8245033|NCT01903252|20332854|P6|STARTED|Double-Blind Induction||0
8245034|NCT01903252|20332855|P5|STARTED|Double-Blind Induction||0
8245035|NCT01903252|20332856|P4|STARTED|Double-Blind Induction||0
8245036|NCT01903252|20332857|P3|STARTED|Double-Blind Induction||0
8245037|NCT01903252|20332858|P2|STARTED|Double-Blind Induction||408
8245038|NCT01903252|20332859|P1|STARTED|Double-Blind Induction||409
8245039|NCT01903187|20332938|P2|NOT COMPLETED|12 Month||0
8245040|NCT01903187|20332939|P1|NOT COMPLETED|12 Month||0
8245041|NCT01903187|20332938|P2|COMPLETED|12 Month||0
8245042|NCT01903187|20332939|P1|COMPLETED|12 Month||2
8245043|NCT01903187|20332938|P2|STARTED|12 Month||0
8245044|NCT01903187|20332939|P1|STARTED|12 Month||2
8245045|NCT01903187|20332938|P2|NOT COMPLETED|6 Month||0
8245046|NCT01903187|20332939|P1|NOT COMPLETED|6 Month||0
8245047|NCT01903187|20332938|P2|COMPLETED|6 Month||0
8245048|NCT01903187|20332939|P1|COMPLETED|6 Month||2
8245049|NCT01903187|20332938|P2|STARTED|6 Month||0
8245050|NCT01903187|20332939|P1|STARTED|6 Month||2
8245051|NCT01903187|20332938|P2|NOT COMPLETED|3 Month||0
8245052|NCT01903187|20332939|P1|NOT COMPLETED|3 Month||0
8245053|NCT01903187|20332938|P2|COMPLETED|3 Month||0
8245054|NCT01903187|20332939|P1|COMPLETED|3 Month||2
8245055|NCT01903187|20332938|P2|STARTED|3 Month||0
8245056|NCT01903187|20332939|P1|STARTED|3 Month||2
8245057|NCT01903187|20332938|P2|NOT COMPLETED|1 Month||0
8245058|NCT01903187|20332939|P1|NOT COMPLETED|1 Month||0
8245059|NCT01903187|20332938|P2|COMPLETED|1 Month||2
8245060|NCT01903187|20332939|P1|COMPLETED|1 Month||2
8245061|NCT01903187|20332938|P2|STARTED|1 Month||2
8245062|NCT01903187|20332939|P1|STARTED|1 Month||2
8245063|NCT01903187|20332938|P2|NOT COMPLETED|Procedure||0
8245064|NCT01903187|20332939|P1|NOT COMPLETED|Procedure||0
8245065|NCT01903187|20332938|P2|COMPLETED|Procedure||2
8245066|NCT01903187|20332939|P1|COMPLETED|Procedure||2
8245067|NCT01903187|20332938|P2|STARTED|Procedure||2
8245068|NCT01903187|20332939|P1|STARTED|Procedure||2
8245069|NCT01903148|20332953|P1|NOT COMPLETED|Overall Study||0
8245070|NCT01903148|20332953|P1|COMPLETED|Overall Study||441
8245071|NCT01903148|20332953|P1|STARTED|Overall Study||441
8245072|NCT01903031|20332972|P3|NOT COMPLETED|Overall Study||5
8245073|NCT01903031|20332973|P2|NOT COMPLETED|Overall Study||3
8245074|NCT01903031|20332974|P1|NOT COMPLETED|Overall Study||2
8245075|NCT01903031|20332972|P3|COMPLETED|Overall Study||24
8245076|NCT01903031|20332973|P2|COMPLETED|Overall Study||25
8245077|NCT01903031|20332974|P1|COMPLETED|Overall Study||25
8245078|NCT01903031|20332972|P3|STARTED|Overall Study||29
8245079|NCT01903031|20332973|P2|STARTED|Overall Study||28
8245080|NCT01903031|20332974|P1|STARTED|Overall Study||27
8245081|NCT01903005|20333016|P1|NOT COMPLETED|Overall Study||373
8245082|NCT01903005|20333016|P1|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
8245083|NCT01903005|20333016|P1|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
8245087|NCT01902901|20333037|P2|NOT COMPLETED|Overall Study||2
8245088|NCT01902901|20333038|P1|NOT COMPLETED|Overall Study||0
8245089|NCT01902901|20333037|P2|COMPLETED|Overall Study||201
8245090|NCT01902901|20333038|P1|COMPLETED|Overall Study||180
8245091|NCT01902901|20333037|P2|STARTED|Overall Study||203
8245092|NCT01902901|20333038|P1|STARTED|Overall Study||180
8245093|NCT01902888|20333048|P1|NOT COMPLETED|Overall Study||3
8245094|NCT01902888|20333048|P1|COMPLETED|Overall Study||0
8245095|NCT01902888|20333048|P1|STARTED|Overall Study||3
8245096|NCT01902758|20333055|P2|NOT COMPLETED|Overall Study||0
8245097|NCT01902758|20333056|P1|NOT COMPLETED|Overall Study||0
8245098|NCT01902758|20333055|P2|COMPLETED|Overall Study||14
8245099|NCT01902758|20333056|P1|COMPLETED|Overall Study||14
8245100|NCT01902758|20333055|P2|STARTED|Overall Study||14
8245101|NCT01902758|20333056|P1|STARTED|Overall Study||14
8245102|NCT01902628|20333062|P1|NOT COMPLETED|Overall Study||83
8245103|NCT01902628|20333062|P1|COMPLETED|Overall Study||354
8245104|NCT01902628|20333062|P1|STARTED|Overall Study||437
8245105|NCT01902459|20333071|P2|NOT COMPLETED|Overall Study||0
8245106|NCT01902459|20333072|P1|NOT COMPLETED|Overall Study||0
8245107|NCT01902459|20333071|P2|COMPLETED|Overall Study||75
8245108|NCT01902459|20333072|P1|COMPLETED|Overall Study||75
8245109|NCT01902459|20333071|P2|STARTED|Overall Study||75
8245110|NCT01902459|20333072|P1|STARTED|Overall Study||75
8245111|NCT01902303|20333090|P2|NOT COMPLETED|Overall Study||24
8245112|NCT01902303|20333091|P1|NOT COMPLETED|Overall Study||23
8245113|NCT01902303|20333090|P2|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
8245114|NCT01902303|20333091|P1|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
8245115|NCT01902303|20333090|P2|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
8245116|NCT01902303|20333091|P1|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
8245117|NCT01902303|20333090|P2|STARTED|Overall Study|Allocated to active treatment|81
8245118|NCT01902303|20333091|P1|STARTED|Overall Study|Allocated to placebo|77
8245245|NCT01902134|20333133|P6|NOT COMPLETED|Overall Study||9
8245246|NCT01902134|20333134|P5|NOT COMPLETED|Overall Study||7
8245247|NCT01902134|20333135|P4|NOT COMPLETED|Overall Study||2
8245248|NCT01902134|20333136|P3|NOT COMPLETED|Overall Study||15
8245249|NCT01902134|20333137|P2|NOT COMPLETED|Overall Study||11
8245250|NCT01902134|20333138|P1|NOT COMPLETED|Overall Study||8
8245251|NCT01902134|20333133|P6|COMPLETED|Overall Study||45
8245252|NCT01902134|20333134|P5|COMPLETED|Overall Study||46
8245253|NCT01902134|20333135|P4|COMPLETED|Overall Study||52
8245254|NCT01902134|20333136|P3|COMPLETED|Overall Study||145
8245255|NCT01902134|20333137|P2|COMPLETED|Overall Study||150
8245256|NCT01902134|20333138|P1|COMPLETED|Overall Study||151
8245257|NCT01902134|20333133|P6|Multiple-dose Phase|Overall Study||52
8245258|NCT01902134|20333134|P5|Multiple-dose Phase|Overall Study||53
8245259|NCT01902134|20333135|P4|Multiple-dose Phase|Overall Study||54
8245260|NCT01902134|20333136|P3|Multiple-dose Phase|Overall Study||160
8245261|NCT01902134|20333137|P2|Multiple-dose Phase|Overall Study||160
8245262|NCT01902134|20333138|P1|Multiple-dose Phase|Overall Study||159
8245263|NCT01902134|20333133|P6|Single-dose Phase|Overall Study||54
8245264|NCT01902134|20333134|P5|Single-dose Phase|Overall Study||53
8245265|NCT01902134|20333135|P4|Single-dose Phase|Overall Study||54
8245266|NCT01902134|20333136|P3|Single-dose Phase|Overall Study||160
8245267|NCT01902134|20333137|P2|Single-dose Phase|Overall Study||161
8245268|NCT01902134|20333138|P1|Single-dose Phase|Overall Study||159
8245269|NCT01902134|20333133|P6|STARTED|Overall Study||54
8245270|NCT01902134|20333134|P5|STARTED|Overall Study||53
8245271|NCT01902134|20333135|P4|STARTED|Overall Study||54
8245272|NCT01902134|20333136|P3|STARTED|Overall Study||160
8245273|NCT01902134|20333137|P2|STARTED|Overall Study||161
8245274|NCT01902134|20333138|P1|STARTED|Overall Study||159
8245275|NCT01902004|20333162|P2|NOT COMPLETED|Overall Study||18
8245276|NCT01902004|20333163|P1|NOT COMPLETED|Overall Study||15
8245277|NCT01902004|20333162|P2|COMPLETED|Overall Study||29
8245278|NCT01902004|20333163|P1|COMPLETED|Overall Study||33
8245279|NCT01902004|20333162|P2|STARTED|Overall Study||47
8245280|NCT01902004|20333163|P1|STARTED|Overall Study||48
8245281|NCT01901874|20333175|P1|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20
8245282|NCT01901874|20333175|P1|COMPLETED|1-Year (365-Day) MAE Evaluation||244
8245283|NCT01901874|20333175|P1|STARTED|1-Year (365-Day) MAE Evaluation||264
8245284|NCT01901874|20333175|P1|NOT COMPLETED|30-Day MAE Evaluation||1
8245285|NCT01901874|20333175|P1|COMPLETED|30-Day MAE Evaluation||264
8245286|NCT01901874|20333175|P1|STARTED|30-Day MAE Evaluation||265
8245287|NCT01901874|20333175|P1|NOT COMPLETED|Screening Committee Retrospective Review||47
8245288|NCT01901874|20333175|P1|COMPLETED|Screening Committee Retrospective Review||265
8245289|NCT01901874|20333175|P1|STARTED|Screening Committee Retrospective Review||312
8245290|NCT01901874|20333175|P1|NOT COMPLETED|Procedure||0
8245291|NCT01901874|20333175|P1|COMPLETED|Procedure||312
8245292|NCT01901874|20333175|P1|STARTED|Procedure||312
8245293|NCT01901848|20333190|P2|NOT COMPLETED|Removed From Analyses||0
8245294|NCT01901848|20333191|P1|NOT COMPLETED|Removed From Analyses||10
8245295|NCT01901848|20333190|P2|COMPLETED|Removed From Analyses||19
8245296|NCT01901848|20333191|P1|COMPLETED|Removed From Analyses||12
8245297|NCT01901848|20333190|P2|STARTED|Removed From Analyses||19
8245298|NCT01901848|20333191|P1|STARTED|Removed From Analyses||22
8245299|NCT01901848|20333190|P2|NOT COMPLETED|Randomized and Treated||6
8245300|NCT01901848|20333191|P1|NOT COMPLETED|Randomized and Treated||3
8245301|NCT01901848|20333190|P2|COMPLETED|Randomized and Treated||19
8245302|NCT01901848|20333191|P1|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
8245303|NCT01901848|20333190|P2|STARTED|Randomized and Treated||25
8245304|NCT01901848|20333191|P1|STARTED|Randomized and Treated||25
8245305|NCT01901809|20333203|P4|NOT COMPLETED|Overall Study||2
8245306|NCT01901809|20333204|P3|NOT COMPLETED|Overall Study||3
8245307|NCT01901809|20333205|P2|NOT COMPLETED|Overall Study||0
8245308|NCT01901809|20333206|P1|NOT COMPLETED|Overall Study||0
8245309|NCT01901809|20333203|P4|COMPLETED|Overall Study||22
8245310|NCT01901809|20333204|P3|COMPLETED|Overall Study||21
8245311|NCT01901809|20333205|P2|COMPLETED|Overall Study||23
8245312|NCT01901809|20333206|P1|COMPLETED|Overall Study||19
8245313|NCT01901809|20333203|P4|STARTED|Overall Study||24
8245314|NCT01901809|20333204|P3|STARTED|Overall Study||24
8245315|NCT01901809|20333205|P2|STARTED|Overall Study||23
8245316|NCT01901809|20333206|P1|STARTED|Overall Study||19
8245317|NCT01901653|20333233|P13|NOT COMPLETED|Overall Study||5
8245318|NCT01901653|20333234|P12|NOT COMPLETED|Overall Study||16
8245319|NCT01901653|20333235|P11|NOT COMPLETED|Overall Study||2
8245320|NCT01901653|20333236|P10|NOT COMPLETED|Overall Study||18
8245321|NCT01901653|20333237|P9|NOT COMPLETED|Overall Study||1
8245322|NCT01901653|20333238|P8|NOT COMPLETED|Overall Study||10
8245323|NCT01901653|20333239|P7|NOT COMPLETED|Overall Study||7
8245324|NCT01901653|20333240|P6|NOT COMPLETED|Overall Study||3
8245325|NCT01901653|20333241|P5|NOT COMPLETED|Overall Study||2
8245326|NCT01901653|20333242|P4|NOT COMPLETED|Overall Study||3
8245327|NCT01901653|20333243|P3|NOT COMPLETED|Overall Study||11
8245328|NCT01901653|20333244|P2|NOT COMPLETED|Overall Study||1
8245329|NCT01901653|20333245|P1|NOT COMPLETED|Overall Study||3
8245330|NCT01901653|20333233|P13|COMPLETED|Overall Study||0
8245331|NCT01901653|20333234|P12|COMPLETED|Overall Study||0
8245332|NCT01901653|20333235|P11|COMPLETED|Overall Study||0
8245333|NCT01901653|20333236|P10|COMPLETED|Overall Study||0
8245334|NCT01901653|20333237|P9|COMPLETED|Overall Study||0
8245335|NCT01901653|20333238|P8|COMPLETED|Overall Study||0
8245336|NCT01901653|20333239|P7|COMPLETED|Overall Study||0
8245337|NCT01901653|20333240|P6|COMPLETED|Overall Study||0
8245338|NCT01901653|20333241|P5|COMPLETED|Overall Study||0
8245339|NCT01901653|20333242|P4|COMPLETED|Overall Study||0
8245340|NCT01901653|20333243|P3|COMPLETED|Overall Study||0
8245341|NCT01901653|20333244|P2|COMPLETED|Overall Study||0
8245342|NCT01901653|20333245|P1|COMPLETED|Overall Study||0
8245343|NCT01901653|20333233|P13|STARTED|Overall Study||5
8245344|NCT01901653|20333234|P12|STARTED|Overall Study||16
8245345|NCT01901653|20333235|P11|STARTED|Overall Study||2
8245346|NCT01901653|20333236|P10|STARTED|Overall Study||18
8245347|NCT01901653|20333237|P9|STARTED|Overall Study||1
8245348|NCT01901653|20333238|P8|STARTED|Overall Study||10
8245349|NCT01901653|20333239|P7|STARTED|Overall Study||7
8245350|NCT01901653|20333240|P6|STARTED|Overall Study||3
8245351|NCT01901653|20333241|P5|STARTED|Overall Study||2
8245352|NCT01901653|20333242|P4|STARTED|Overall Study||3
8245353|NCT01901653|20333243|P3|STARTED|Overall Study||11
8245354|NCT01901653|20333244|P2|STARTED|Overall Study||1
8245355|NCT01901653|20333245|P1|STARTED|Overall Study||3
8245356|NCT01901614|20333289|P2|NOT COMPLETED|Overall Study||1
8245357|NCT01901614|20333290|P1|NOT COMPLETED|Overall Study||2
8245358|NCT01901614|20333289|P2|COMPLETED|Overall Study||1
8245359|NCT01901614|20333290|P1|COMPLETED|Overall Study||1
8245360|NCT01901614|20333289|P2|STARTED|Overall Study||2
8245361|NCT01901614|20333290|P1|STARTED|Overall Study||3
8245362|NCT01901588|20333298|P2|NOT COMPLETED|Overall Study||0
8245363|NCT01901588|20333299|P1|NOT COMPLETED|Overall Study||0
8245364|NCT01901588|20333298|P2|COMPLETED|Overall Study||31
8245365|NCT01901588|20333299|P1|COMPLETED|Overall Study||32
8245366|NCT01901588|20333298|P2|STARTED|Overall Study||31
8245367|NCT01901588|20333299|P1|STARTED|Overall Study||32
8245368|NCT01901575|20333315|P1|NOT COMPLETED|Overall Study||0
8245369|NCT01901575|20333315|P1|COMPLETED|Overall Study||16
8245370|NCT01901575|20333315|P1|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
8245371|NCT01901432|20333325|P5|NOT COMPLETED|Overall Study||9
8245372|NCT01901432|20333326|P4|NOT COMPLETED|Overall Study||0
8245373|NCT01901432|20333327|P3|NOT COMPLETED|Overall Study||2
8245374|NCT01901432|20333328|P2|NOT COMPLETED|Overall Study||1
8245375|NCT01901432|20333329|P1|NOT COMPLETED|Overall Study||0
8245376|NCT01901432|20333325|P5|COMPLETED|Overall Study||27
8245377|NCT01901432|20333326|P4|COMPLETED|Overall Study||3
8245378|NCT01901432|20333327|P3|COMPLETED|Overall Study||1
8245379|NCT01901432|20333328|P2|COMPLETED|Overall Study||2
8245380|NCT01901432|20333329|P1|COMPLETED|Overall Study||3
8245381|NCT01901432|20333325|P5|Received Study Drug|Overall Study||35
8245382|NCT01901432|20333326|P4|Received Study Drug|Overall Study||3
8245383|NCT01901432|20333327|P3|Received Study Drug|Overall Study||3
8245384|NCT01901432|20333328|P2|Received Study Drug|Overall Study||3
8245385|NCT01901432|20333329|P1|Received Study Drug|Overall Study||3
8245386|NCT01901432|20333325|P5|STARTED|Overall Study||36
8245387|NCT01901432|20333326|P4|STARTED|Overall Study||3
8245388|NCT01901432|20333327|P3|STARTED|Overall Study||3
8245389|NCT01901432|20333328|P2|STARTED|Overall Study||3
8245390|NCT01901432|20333329|P1|STARTED|Overall Study||3
8245391|NCT01901419|20333381|P2|NOT COMPLETED|Overall Study||9
8245392|NCT01901419|20333382|P1|NOT COMPLETED|Overall Study||8
8245393|NCT01901419|20333381|P2|COMPLETED|Overall Study||31
8245394|NCT01901419|20333382|P1|COMPLETED|Overall Study||32
8245395|NCT01901419|20333381|P2|STARTED|Overall Study||40
8245396|NCT01901419|20333382|P1|STARTED|Overall Study||40
8245397|NCT01901393|20333448|P2|NOT COMPLETED|Overall Study||0
8245398|NCT01901393|20333449|P1|NOT COMPLETED|Overall Study||1
8245399|NCT01901393|20333448|P2|COMPLETED|Overall Study||49
8245400|NCT01901393|20333449|P1|COMPLETED|Overall Study||50
8245401|NCT01901393|20333448|P2|STARTED|Overall Study||49
8245402|NCT01901393|20333449|P1|STARTED|Overall Study||51
8245403|NCT01901341|20333467|P2|NOT COMPLETED|Overall Study||21
8245404|NCT01901341|20333468|P1|NOT COMPLETED|Overall Study||20
8245405|NCT01901341|20333467|P2|COMPLETED|Overall Study||1
8245406|NCT01901341|20333468|P1|COMPLETED|Overall Study||2
8245407|NCT01901341|20333467|P2|Received at Least 1 Dose of Study Drug|Overall Study||22
8245408|NCT01901341|20333468|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
8245409|NCT01901341|20333467|P2|STARTED|Overall Study||22
8245410|NCT01901341|20333468|P1|STARTED|Overall Study||22
8245411|NCT01901328|20333482|P2|NOT COMPLETED|Overall Study||21
8245412|NCT01901328|20333483|P1|NOT COMPLETED|Overall Study||22
8245413|NCT01901328|20333482|P2|COMPLETED|Overall Study||2
8245414|NCT01901328|20333483|P1|COMPLETED|Overall Study||4
8245415|NCT01901328|20333482|P2|Received at Least 1 Dose of Study Drug|Overall Study||23
8245416|NCT01901328|20333483|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
8245417|NCT01901328|20333482|P2|STARTED|Overall Study||23
8245418|NCT01901328|20333483|P1|STARTED|Overall Study||26
8245419|NCT01901302|20333497|P2|NOT COMPLETED|Overall Study||23
8245420|NCT01901302|20333498|P1|NOT COMPLETED|Overall Study||27
8245421|NCT01901302|20333497|P2|COMPLETED|Overall Study||7
8245422|NCT01901302|20333498|P1|COMPLETED|Overall Study||4
8245423|NCT01901302|20333497|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
8245424|NCT01901302|20333498|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
8245425|NCT01901302|20333497|P2|STARTED|Overall Study||30
8245426|NCT01901302|20333498|P1|STARTED|Overall Study||31
8245431|NCT01901250|20333516|P2|NOT COMPLETED|Overall Study||126
8245432|NCT01901250|20333517|P1|NOT COMPLETED|Overall Study||138
8245433|NCT01901250|20333516|P2|COMPLETED|Overall Study||139
8245434|NCT01901250|20333517|P1|COMPLETED|Overall Study||122
8245435|NCT01901250|20333516|P2|End of 1st Grade|Overall Study||151
8245436|NCT01901250|20333517|P1|End of 1st Grade|Overall Study||143
8245437|NCT01901250|20333516|P2|Start of 1st Grade|Overall Study||176
8245438|NCT01901250|20333517|P1|Start of 1st Grade|Overall Study||173
8245439|NCT01901250|20333516|P2|End of Kidergarten|Overall Study||212
8245440|NCT01901250|20333517|P1|End of Kidergarten|Overall Study||215
8245441|NCT01901250|20333516|P2|STARTED|Overall Study||265
8245442|NCT01901250|20333517|P1|STARTED|Overall Study||260
8245443|NCT01901224|20333523|P1|NOT COMPLETED|Overall Study||2
8245444|NCT01901224|20333523|P1|COMPLETED|Overall Study||0
8245445|NCT01901224|20333523|P1|STARTED|Overall Study||2
8245446|NCT01901211|20333534|P2|NOT COMPLETED|Second Ten-week Period||0
8245447|NCT01901211|20333535|P1|NOT COMPLETED|Second Ten-week Period||0
8245448|NCT01901211|20333534|P2|COMPLETED|Second Ten-week Period||5
8245449|NCT01901211|20333535|P1|COMPLETED|Second Ten-week Period||6
8245450|NCT01901211|20333534|P2|STARTED|Second Ten-week Period||5
8245451|NCT01901211|20333535|P1|STARTED|Second Ten-week Period||6
8245452|NCT01901211|20333534|P2|NOT COMPLETED|Washout (6 Weeks)||0
8245453|NCT01901211|20333535|P1|NOT COMPLETED|Washout (6 Weeks)||0
8245454|NCT01901211|20333534|P2|COMPLETED|Washout (6 Weeks)||5
8245455|NCT01901211|20333535|P1|COMPLETED|Washout (6 Weeks)||6
8245456|NCT01901211|20333534|P2|STARTED|Washout (6 Weeks)||5
8245457|NCT01901211|20333535|P1|STARTED|Washout (6 Weeks)||6
8245458|NCT01901211|20333534|P2|NOT COMPLETED|First Ten-week Period||0
8245459|NCT01901211|20333535|P1|NOT COMPLETED|First Ten-week Period||0
8245460|NCT01901211|20333534|P2|COMPLETED|First Ten-week Period||5
8245461|NCT01901211|20333535|P1|COMPLETED|First Ten-week Period||6
8245462|NCT01901211|20333534|P2|STARTED|First Ten-week Period||5
8245463|NCT01901211|20333535|P1|STARTED|First Ten-week Period||6
8245464|NCT01901185|20333558|P1|NOT COMPLETED|Overall Study||2
8245465|NCT01901185|20333558|P1|COMPLETED|Overall Study||75
8245466|NCT01901185|20333558|P1|Received Etanercept With Autoinjector A|Overall Study||75
8245467|NCT01901185|20333558|P1|STARTED|Overall Study||77
8245468|NCT01901146|20333567|P5|NOT COMPLETED|Adjuvant Phase||14
8245469|NCT01901146|20333568|P4|NOT COMPLETED|Adjuvant Phase||7
8245470|NCT01901146|20333569|P3|NOT COMPLETED|Adjuvant Phase||26
8245471|NCT01901146|20333570|P2|NOT COMPLETED|Adjuvant Phase||0
8245472|NCT01901146|20333571|P1|NOT COMPLETED|Adjuvant Phase||0
8245473|NCT01901146|20333567|P5|COMPLETED|Adjuvant Phase||157
8245474|NCT01901146|20333568|P4|COMPLETED|Adjuvant Phase||164
8245475|NCT01901146|20333569|P3|COMPLETED|Adjuvant Phase||323
8245476|NCT01901146|20333570|P2|COMPLETED|Adjuvant Phase||0
8245477|NCT01901146|20333571|P1|COMPLETED|Adjuvant Phase||0
8245478|NCT01901146|20333567|P5|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171
8245479|NCT01901146|20333568|P4|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171
8245480|NCT01901146|20333569|P3|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349
8245481|NCT01901146|20333570|P2|STARTED|Adjuvant Phase||0
8245482|NCT01901146|20333571|P1|STARTED|Adjuvant Phase||0
8245483|NCT01901146|20333567|P5|NOT COMPLETED|Neoadjuvant Phase||0
8245484|NCT01901146|20333568|P4|NOT COMPLETED|Neoadjuvant Phase||0
8245485|NCT01901146|20333569|P3|NOT COMPLETED|Neoadjuvant Phase||0
8245486|NCT01901146|20333570|P2|NOT COMPLETED|Neoadjuvant Phase||14
8245487|NCT01901146|20333571|P1|NOT COMPLETED|Neoadjuvant Phase||6
8245488|NCT01901146|20333567|P5|COMPLETED|Neoadjuvant Phase||0
8245489|NCT01901146|20333568|P4|COMPLETED|Neoadjuvant Phase||0
8245490|NCT01901146|20333569|P3|COMPLETED|Neoadjuvant Phase||0
8245491|NCT01901146|20333570|P2|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347
8245492|NCT01901146|20333571|P1|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358
8245493|NCT01901146|20333567|P5|STARTED|Neoadjuvant Phase||0
8245494|NCT01901146|20333568|P4|STARTED|Neoadjuvant Phase||0
8245495|NCT01901146|20333569|P3|STARTED|Neoadjuvant Phase||0
8245496|NCT01901146|20333570|P2|STARTED|Neoadjuvant Phase||361
8245497|NCT01901146|20333571|P1|STARTED|Neoadjuvant Phase||364
8245498|NCT01900899|20333586|P2|NOT COMPLETED|Overall Study||1
8245499|NCT01900899|20333587|P1|NOT COMPLETED|Overall Study||9
8245500|NCT01900899|20333586|P2|COMPLETED|Overall Study||24
8245501|NCT01900899|20333587|P1|COMPLETED|Overall Study||150
8245502|NCT01900899|20333586|P2|STARTED|Overall Study||25
8245503|NCT01900899|20333587|P1|STARTED|Overall Study||159
8245504|NCT01900730|20333613|P2|NOT COMPLETED|Overall Study||0
8245505|NCT01900730|20333614|P1|NOT COMPLETED|Overall Study||2
8245506|NCT01900730|20333613|P2|COMPLETED|Overall Study||0
8245507|NCT01900730|20333614|P1|COMPLETED|Overall Study||1
8245508|NCT01900730|20333613|P2|STARTED|Overall Study||0
8245509|NCT01900730|20333614|P1|STARTED|Overall Study||3
8245510|NCT01900704|20333623|P3|NOT COMPLETED|Overall Study||33
8245511|NCT01900704|20333624|P2|NOT COMPLETED|Overall Study||35
8245512|NCT01900704|20333625|P1|NOT COMPLETED|Overall Study||41
8245513|NCT01900704|20333623|P3|COMPLETED|Overall Study||237
8245514|NCT01900704|20333624|P2|COMPLETED|Overall Study||235
8245515|NCT01900704|20333625|P1|COMPLETED|Overall Study||229
8245516|NCT01900704|20333623|P3|STARTED|Overall Study||270
8245517|NCT01900704|20333624|P2|STARTED|Overall Study||270
8245518|NCT01900704|20333625|P1|STARTED|Overall Study||270
8245519|NCT01900665|20333638|P2|NOT COMPLETED|Open Label Period||859
8245520|NCT01900665|20333639|P1|NOT COMPLETED|Open Label Period||881
8245521|NCT01900665|20333638|P2|COMPLETED|Open Label Period||0
8245522|NCT01900665|20333639|P1|COMPLETED|Open Label Period||0
8245523|NCT01900665|20333638|P2|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
8245524|NCT01900665|20333639|P1|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
8245525|NCT01900665|20333638|P2|NOT COMPLETED|Placebo Controlled Period||164
8245526|NCT01900665|20333639|P1|NOT COMPLETED|Placebo Controlled Period||143
8245527|NCT01900665|20333638|P2|COMPLETED|Placebo Controlled Period||908
8245528|NCT01900665|20333639|P1|COMPLETED|Placebo Controlled Period||914
8245529|NCT01900665|20333638|P2|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
8245530|NCT01900665|20333639|P1|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
8245531|NCT01900665|20333638|P2|STARTED|Placebo Controlled Period||1072
8245532|NCT01900665|20333639|P1|STARTED|Placebo Controlled Period||1057
8245533|NCT01900652|20333682|P2|NOT COMPLETED|Overall Study||3
8245534|NCT01900652|20333683|P1|NOT COMPLETED|Overall Study||8
8245535|NCT01900652|20333682|P2|COMPLETED|Overall Study||25
8245536|NCT01900652|20333683|P1|COMPLETED|Overall Study||75
8245537|NCT01900652|20333682|P2|Post-Erlotinib Progression Tumor Sample|Overall Study||23
8245538|NCT01900652|20333683|P1|Post-Erlotinib Progression Tumor Sample|Overall Study||66
8245539|NCT01900652|20333682|P2|STARTED|Overall Study||28
8245540|NCT01900652|20333683|P1|STARTED|Overall Study||83
8245541|NCT01900626|20333719|P2|NOT COMPLETED|Overall Study||1
8245542|NCT01900626|20333720|P1|NOT COMPLETED|Overall Study||1
8245543|NCT01900626|20333719|P2|COMPLETED|Overall Study||0
8245544|NCT01900626|20333720|P1|COMPLETED|Overall Study||0
8245545|NCT01900626|20333719|P2|STARTED|Overall Study||1
8245546|NCT01900626|20333720|P1|STARTED|Overall Study||1
8245547|NCT01900561|20333738|P2|NOT COMPLETED|Overall Study||9
8245548|NCT01900561|20333739|P1|NOT COMPLETED|Overall Study||17
8245549|NCT01900561|20333738|P2|COMPLETED|Overall Study||269
8245550|NCT01900561|20333739|P1|COMPLETED|Overall Study||261
8245551|NCT01900561|20333738|P2|STARTED|Overall Study||278
8245552|NCT01900561|20333739|P1|STARTED|Overall Study||278
8245553|NCT01900444|20333799|P1|NOT COMPLETED|Overall Study||3
8245554|NCT01900444|20333799|P1|COMPLETED|Overall Study||116
8245555|NCT01900444|20333799|P1|STARTED|Overall Study||119
8245556|NCT01900431|20333812|P3|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
8245557|NCT01900431|20333813|P2|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
8245558|NCT01900431|20333814|P1|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
8245559|NCT01900431|20333812|P3|COMPLETED|Open-Label Treatment Period (Part C)||13
8245560|NCT01900431|20333813|P2|COMPLETED|Open-Label Treatment Period (Part C)||0
8245561|NCT01900431|20333814|P1|COMPLETED|Open-Label Treatment Period (Part C)||0
8245562|NCT01900431|20333812|P3|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
8245563|NCT01900431|20333813|P2|STARTED|Open-Label Treatment Period (Part C)||0
8245564|NCT01900431|20333814|P1|STARTED|Open-Label Treatment Period (Part C)||0
8245565|NCT01900431|20333812|P3|NOT COMPLETED|Extended Treatment Period (Part B)||0
8245566|NCT01900431|20333813|P2|NOT COMPLETED|Extended Treatment Period (Part B)||10
8245567|NCT01900431|20333814|P1|NOT COMPLETED|Extended Treatment Period (Part B)||1
8245568|NCT01900431|20333812|P3|COMPLETED|Extended Treatment Period (Part B)||0
8245569|NCT01900431|20333813|P2|COMPLETED|Extended Treatment Period (Part B)||12
8245570|NCT01900431|20333814|P1|COMPLETED|Extended Treatment Period (Part B)||7
8245571|NCT01900431|20333812|P3|STARTED|Extended Treatment Period (Part B)||0
8245572|NCT01900431|20333813|P2|STARTED|Extended Treatment Period (Part B)||22
8245573|NCT01900431|20333814|P1|STARTED|Extended Treatment Period (Part B)||8
8245574|NCT01900431|20333812|P3|NOT COMPLETED|Principal Treatment Period (Part A)||0
8245575|NCT01900431|20333813|P2|NOT COMPLETED|Principal Treatment Period (Part A)||10
8245576|NCT01900431|20333814|P1|NOT COMPLETED|Principal Treatment Period (Part A)||7
8245577|NCT01900431|20333812|P3|COMPLETED|Principal Treatment Period (Part A)||0
8245578|NCT01900431|20333813|P2|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
8245579|NCT01900431|20333814|P1|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
8245580|NCT01900431|20333812|P3|STARTED|Principal Treatment Period (Part A)||0
8245581|NCT01900431|20333813|P2|STARTED|Principal Treatment Period (Part A)||38
8245582|NCT01900431|20333814|P1|STARTED|Principal Treatment Period (Part A)||20
8245583|NCT01900392|20333841|P3|NOT COMPLETED|Overall Study||0
8245584|NCT01900392|20333842|P2|NOT COMPLETED|Overall Study||1
8245585|NCT01900392|20333843|P1|NOT COMPLETED|Overall Study||1
8245586|NCT01900392|20333841|P3|COMPLETED|Overall Study||77
8245587|NCT01900392|20333842|P2|COMPLETED|Overall Study||74
8245588|NCT01900392|20333843|P1|COMPLETED|Overall Study||38
8245589|NCT01900392|20333841|P3|STARTED|Overall Study||77
8245590|NCT01900392|20333842|P2|STARTED|Overall Study||75
8245591|NCT01900392|20333843|P1|STARTED|Overall Study||39
8245592|NCT01900314|20333856|P2|NOT COMPLETED|Overall Study||4
8245593|NCT01900314|20333857|P1|NOT COMPLETED|Overall Study||4
8245594|NCT01900314|20333856|P2|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
8245595|NCT01900314|20333857|P1|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
8245596|NCT01900314|20333856|P2|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
8245597|NCT01900314|20333857|P1|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
8245598|NCT01900314|20333856|P2|STARTED|Overall Study||20
8245599|NCT01900314|20333857|P1|STARTED|Overall Study||20
8245600|NCT01900249|20333868|P3|NOT COMPLETED|Overall Study||4
8245601|NCT01900249|20333869|P2|NOT COMPLETED|Overall Study||5
8245602|NCT01900249|20333870|P1|NOT COMPLETED|Overall Study||3
8245603|NCT01900249|20333868|P3|COMPLETED|Overall Study||65
8245604|NCT01900249|20333869|P2|COMPLETED|Overall Study||63
8245605|NCT01900249|20333870|P1|COMPLETED|Overall Study||64
8245606|NCT01900249|20333868|P3|STARTED|Overall Study||69
8245607|NCT01900249|20333869|P2|STARTED|Overall Study||68
8245608|NCT01900249|20333870|P1|STARTED|Overall Study||67
8245609|NCT01900067|20333880|P2|NOT COMPLETED|Overall Study||13
8245610|NCT01900067|20333881|P1|NOT COMPLETED|Overall Study||12
8245611|NCT01900067|20333880|P2|COMPLETED|Overall Study||124
8245612|NCT01900067|20333881|P1|COMPLETED|Overall Study||122
8245613|NCT01900067|20333880|P2|STARTED|Overall Study||137
8245614|NCT01900067|20333881|P1|STARTED|Overall Study||134
8245615|NCT01900054|20333887|P1|NOT COMPLETED|Overall Study||2
8245616|NCT01900054|20333887|P1|COMPLETED|Overall Study||56
8245617|NCT01900054|20333887|P1|STARTED|Overall Study||58
8245618|NCT01899911|20333892|P1|NOT COMPLETED|Overall Study||0
8245619|NCT01899911|20333892|P1|COMPLETED|Overall Study||12
8245620|NCT01899911|20333892|P1|STARTED|Overall Study||12
8245621|NCT01899768|20333896|P1|NOT COMPLETED|Part C||0
8245622|NCT01899768|20333896|P1|COMPLETED|Part C||11
8245623|NCT01899768|20333896|P1|STARTED|Part C||11
8245624|NCT01899768|20333896|P1|NOT COMPLETED|Part B||2
8245625|NCT01899768|20333896|P1|COMPLETED|Part B||11
8245626|NCT01899768|20333896|P1|STARTED|Part B||13
8245627|NCT01899768|20333896|P1|NOT COMPLETED|Part A||3
8245628|NCT01899768|20333896|P1|COMPLETED|Part A||13
8245629|NCT01899768|20333896|P1|STARTED|Part A||16
8245630|NCT01899742|20333970|P2|NOT COMPLETED|Overall Study||16
8245631|NCT01899742|20333971|P1|NOT COMPLETED|Overall Study||17
8245632|NCT01899742|20333970|P2|COMPLETED|Overall Study||231
8245633|NCT01899742|20333971|P1|COMPLETED|Overall Study||230
8245634|NCT01899742|20333970|P2|STARTED|Overall Study||247
8245635|NCT01899742|20333971|P1|STARTED|Overall Study||247
8245636|NCT01899729|20333984|P5|NOT COMPLETED|Overall Study||2
8245637|NCT01899729|20333985|P4|NOT COMPLETED|Overall Study||0
8245638|NCT01899729|20333986|P3|NOT COMPLETED|Overall Study||2
8245639|NCT01899729|20333987|P2|NOT COMPLETED|Overall Study||2
8245640|NCT01899729|20333988|P1|NOT COMPLETED|Overall Study||2
8245641|NCT01899729|20333984|P5|COMPLETED|Overall Study||9
8245642|NCT01899729|20333985|P4|COMPLETED|Overall Study||9
8245643|NCT01899729|20333986|P3|COMPLETED|Overall Study||6
8245644|NCT01899729|20333987|P2|COMPLETED|Overall Study||7
8245645|NCT01899729|20333988|P1|COMPLETED|Overall Study||7
8245646|NCT01899729|20333984|P5|STARTED|Overall Study||11
8245647|NCT01899729|20333985|P4|STARTED|Overall Study||9
8245648|NCT01899729|20333986|P3|STARTED|Overall Study||8
8245649|NCT01899729|20333987|P2|STARTED|Overall Study||9
8245650|NCT01899729|20333988|P1|STARTED|Overall Study||9
8245651|NCT01899677|20334002|P2|NOT COMPLETED|Overall Study||7
8245652|NCT01899677|20334003|P1|NOT COMPLETED|Overall Study||10
8245653|NCT01899677|20334002|P2|COMPLETED|Overall Study||28
8245654|NCT01899677|20334003|P1|COMPLETED|Overall Study||25
8245655|NCT01899677|20334002|P2|STARTED|Overall Study||35
8245656|NCT01899677|20334003|P1|STARTED|Overall Study||35
8245660|NCT01899144|20334035|P1|NOT COMPLETED|Treatment Period 5||1
8245661|NCT01899144|20334035|P1|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
8245662|NCT01899144|20334035|P1|STARTED|Treatment Period 5||58
8245663|NCT01899144|20334035|P1|NOT COMPLETED|Treatment Period 4||0
8245664|NCT01899144|20334035|P1|COMPLETED|Treatment Period 4||58
8245665|NCT01899144|20334035|P1|STARTED|Treatment Period 4||58
8245666|NCT01899144|20334035|P1|NOT COMPLETED|Treatment Period 3||2
8245667|NCT01899144|20334035|P1|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
8245668|NCT01899144|20334035|P1|STARTED|Treatment Period 3||60
8245669|NCT01899144|20334035|P1|NOT COMPLETED|Treatment Period 2||1
8245670|NCT01899144|20334035|P1|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
8245671|NCT01899144|20334035|P1|STARTED|Treatment Period 2||61
8245672|NCT01899144|20334035|P1|NOT COMPLETED|Treatment Period 1||0
8245673|NCT01899144|20334035|P1|COMPLETED|Treatment Period 1||61
8245674|NCT01899144|20334035|P1|STARTED|Treatment Period 1||61
8245675|NCT01899053|20334071|P14|NOT COMPLETED|Overall Study||20
8245676|NCT01899053|20334072|P13|NOT COMPLETED|Overall Study||14
8245677|NCT01899053|20334073|P12|NOT COMPLETED|Overall Study||7
8245678|NCT01899053|20334074|P11|NOT COMPLETED|Overall Study||16
8245679|NCT01899053|20334075|P10|NOT COMPLETED|Overall Study||3
8245680|NCT01899053|20334076|P9|NOT COMPLETED|Overall Study||6
8245681|NCT01899053|20334077|P8|NOT COMPLETED|Overall Study||3
8245682|NCT01899053|20334078|P7|NOT COMPLETED|Overall Study||3
8245683|NCT01899053|20334079|P6|NOT COMPLETED|Overall Study||3
8245684|NCT01899053|20334080|P5|NOT COMPLETED|Overall Study||6
8245685|NCT01899053|20334081|P4|NOT COMPLETED|Overall Study||3
8245686|NCT01899053|20334082|P3|NOT COMPLETED|Overall Study||7
8245687|NCT01899053|20334083|P2|NOT COMPLETED|Overall Study||3
8245688|NCT01899053|20334084|P1|NOT COMPLETED|Overall Study||7
8245689|NCT01899053|20334071|P14|COMPLETED|Overall Study||0
8245690|NCT01899053|20334072|P13|COMPLETED|Overall Study||0
8245691|NCT01899053|20334073|P12|COMPLETED|Overall Study||0
8245692|NCT01899053|20334074|P11|COMPLETED|Overall Study||0
8245693|NCT01899053|20334075|P10|COMPLETED|Overall Study||0
8245694|NCT01899053|20334076|P9|COMPLETED|Overall Study||0
8245695|NCT01899053|20334077|P8|COMPLETED|Overall Study||0
8245696|NCT01899053|20334078|P7|COMPLETED|Overall Study||0
8245697|NCT01899053|20334079|P6|COMPLETED|Overall Study||0
8245698|NCT01899053|20334080|P5|COMPLETED|Overall Study||0
8245699|NCT01899053|20334081|P4|COMPLETED|Overall Study||0
8245700|NCT01899053|20334082|P3|COMPLETED|Overall Study||0
8245701|NCT01899053|20334083|P2|COMPLETED|Overall Study||0
8245702|NCT01899053|20334084|P1|COMPLETED|Overall Study||0
8245703|NCT01899053|20334071|P14|STARTED|Overall Study||20
8245704|NCT01899053|20334072|P13|STARTED|Overall Study||14
8245705|NCT01899053|20334073|P12|STARTED|Overall Study||7
8245706|NCT01899053|20334074|P11|STARTED|Overall Study||16
8245707|NCT01899053|20334075|P10|STARTED|Overall Study||3
8245708|NCT01899053|20334076|P9|STARTED|Overall Study||6
8245709|NCT01899053|20334077|P8|STARTED|Overall Study||3
8245710|NCT01899053|20334078|P7|STARTED|Overall Study||3
8245711|NCT01899053|20334079|P6|STARTED|Overall Study||3
8245712|NCT01899053|20334080|P5|STARTED|Overall Study||6
8245713|NCT01899053|20334081|P4|STARTED|Overall Study||3
8245714|NCT01899053|20334082|P3|STARTED|Overall Study||7
8245715|NCT01899053|20334083|P2|STARTED|Overall Study||3
8245716|NCT01899053|20334084|P1|STARTED|Overall Study||7
8245780|NCT01898806|20334499|P1|NOT COMPLETED|Overall Study||3
8245781|NCT01898806|20334499|P1|COMPLETED|Overall Study||8
8245782|NCT01898806|20334499|P1|STARTED|Overall Study||11
8245783|NCT01898611|20334506|P2|NOT COMPLETED|Overall Study||1
8245784|NCT01898611|20334507|P1|NOT COMPLETED|Overall Study||0
8245785|NCT01898611|20334506|P2|COMPLETED|Overall Study||10
8245786|NCT01898611|20334507|P1|COMPLETED|Overall Study||5
8245787|NCT01898611|20334506|P2|STARTED|Overall Study||11
8245788|NCT01898611|20334507|P1|STARTED|Overall Study||5
8245789|NCT01898598|20334529|P2|NOT COMPLETED|Overall Study||2
8245790|NCT01898598|20334530|P1|NOT COMPLETED|Overall Study||4
8245791|NCT01898598|20334529|P2|COMPLETED|Overall Study||4
8245792|NCT01898598|20334530|P1|COMPLETED|Overall Study||8
8245793|NCT01898598|20334529|P2|Treated|Overall Study||5
8245794|NCT01898598|20334530|P1|Treated|Overall Study||11
8245795|NCT01898598|20334529|P2|STARTED|Overall Study||6
8245796|NCT01898598|20334530|P1|STARTED|Overall Study||12
8245797|NCT01898442|20334549|P3|NOT COMPLETED|Overall Study||3
8245798|NCT01898442|20334550|P2|NOT COMPLETED|Overall Study||2
8245799|NCT01898442|20334551|P1|NOT COMPLETED|Overall Study||1
8245800|NCT01898442|20334549|P3|COMPLETED|Overall Study||15
8245801|NCT01898442|20334550|P2|COMPLETED|Overall Study||15
8245802|NCT01898442|20334551|P1|COMPLETED|Overall Study||16
8245803|NCT01898442|20334549|P3|STARTED|Overall Study||18
8245804|NCT01898442|20334550|P2|STARTED|Overall Study||17
8245805|NCT01898442|20334551|P1|STARTED|Overall Study||17
8245806|NCT01898429|20334574|P3|NOT COMPLETED|Phase 3||0
8245807|NCT01898429|20334575|P2|NOT COMPLETED|Phase 3||0
8245808|NCT01898429|20334576|P1|NOT COMPLETED|Phase 3||0
8245809|NCT01898429|20334574|P3|COMPLETED|Phase 3||5
8245810|NCT01898429|20334575|P2|COMPLETED|Phase 3||0
8245811|NCT01898429|20334576|P1|COMPLETED|Phase 3||0
8245812|NCT01898429|20334574|P3|STARTED|Phase 3||5
8245813|NCT01898429|20334575|P2|STARTED|Phase 3||0
8245814|NCT01898429|20334576|P1|STARTED|Phase 3||0
8245815|NCT01898429|20334574|P3|NOT COMPLETED|Phase 2||0
8245816|NCT01898429|20334575|P2|NOT COMPLETED|Phase 2||0
8245817|NCT01898429|20334576|P1|NOT COMPLETED|Phase 2||0
8245818|NCT01898429|20334574|P3|COMPLETED|Phase 2||0
8245819|NCT01898429|20334575|P2|COMPLETED|Phase 2||5
8245820|NCT01898429|20334576|P1|COMPLETED|Phase 2||0
8245821|NCT01898429|20334574|P3|STARTED|Phase 2||0
8245822|NCT01898429|20334575|P2|STARTED|Phase 2||5
8245823|NCT01898429|20334576|P1|STARTED|Phase 2||0
8245824|NCT01898429|20334574|P3|NOT COMPLETED|Phase 1||0
8245825|NCT01898429|20334575|P2|NOT COMPLETED|Phase 1||0
8245826|NCT01898429|20334576|P1|NOT COMPLETED|Phase 1||0
8245827|NCT01898429|20334574|P3|COMPLETED|Phase 1||0
8245828|NCT01898429|20334575|P2|COMPLETED|Phase 1||0
8245829|NCT01898429|20334576|P1|COMPLETED|Phase 1||5
8245830|NCT01898429|20334574|P3|STARTED|Phase 1||0
8245831|NCT01898429|20334575|P2|STARTED|Phase 1||0
8245832|NCT01898429|20334576|P1|STARTED|Phase 1||5
8245833|NCT01898403|20334580|P1|NOT COMPLETED|Overall Study||0
8245834|NCT01898403|20334580|P1|COMPLETED|Overall Study||50
8245835|NCT01898403|20334580|P1|STARTED|Overall Study||50
8245836|NCT01898299|20334588|P2|NOT COMPLETED|Post Treatment (One Month)||4
8245837|NCT01898299|20334589|P1|NOT COMPLETED|Post Treatment (One Month)||3
8245838|NCT01898299|20334588|P2|COMPLETED|Post Treatment (One Month)||38
8245839|NCT01898299|20334589|P1|COMPLETED|Post Treatment (One Month)||44
8245840|NCT01898299|20334588|P2|STARTED|Post Treatment (One Month)||42
8245841|NCT01898299|20334589|P1|STARTED|Post Treatment (One Month)||47
8245842|NCT01898299|20334588|P2|NOT COMPLETED|Post Treatment (One Week)||0
8245843|NCT01898299|20334589|P1|NOT COMPLETED|Post Treatment (One Week)||0
8245844|NCT01898299|20334588|P2|COMPLETED|Post Treatment (One Week)||42
8245845|NCT01898299|20334589|P1|COMPLETED|Post Treatment (One Week)||47
8245846|NCT01898299|20334588|P2|STARTED|Post Treatment (One Week)||42
8245847|NCT01898299|20334589|P1|STARTED|Post Treatment (One Week)||47
8245848|NCT01898286|20334595|P1|NOT COMPLETED|Overall Study||3
8245849|NCT01898286|20334595|P1|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
8245850|NCT01898286|20334595|P1|STARTED|Overall Study||38
8245851|NCT01898208|20334605|P3|NOT COMPLETED|Overall Study||37
8245852|NCT01898208|20334606|P2|NOT COMPLETED|Overall Study||49
8245853|NCT01898208|20334607|P1|NOT COMPLETED|Overall Study||40
8245854|NCT01898208|20334605|P3|COMPLETED|Overall Study||212
8245855|NCT01898208|20334606|P2|COMPLETED|Overall Study||198
8245856|NCT01898208|20334607|P1|COMPLETED|Overall Study||207
8245857|NCT01898208|20334605|P3|STARTED|Overall Study||249
8245858|NCT01898208|20334606|P2|STARTED|Overall Study||247
8245859|NCT01898208|20334607|P1|STARTED|Overall Study||247
8245860|NCT01898195|20334654|P3|NOT COMPLETED|Smoking Abstinence||36
8245861|NCT01898195|20334655|P2|NOT COMPLETED|Smoking Abstinence||38
8245862|NCT01898195|20334656|P1|NOT COMPLETED|Smoking Abstinence||35
8245863|NCT01898195|20334654|P3|COMPLETED|Smoking Abstinence||15
8245864|NCT01898195|20334655|P2|COMPLETED|Smoking Abstinence||16
8245865|NCT01898195|20334656|P1|COMPLETED|Smoking Abstinence||18
8245866|NCT01898195|20334654|P3|STARTED|Smoking Abstinence||51
8245867|NCT01898195|20334655|P2|STARTED|Smoking Abstinence||54
8245868|NCT01898195|20334656|P1|STARTED|Smoking Abstinence||53
8245869|NCT01898195|20334654|P3|NOT COMPLETED|Varenicline Adherence||36
8245870|NCT01898195|20334655|P2|NOT COMPLETED|Varenicline Adherence||38
8245871|NCT01898195|20334656|P1|NOT COMPLETED|Varenicline Adherence||35
8245872|NCT01898195|20334654|P3|COMPLETED|Varenicline Adherence||15
8245873|NCT01898195|20334655|P2|COMPLETED|Varenicline Adherence||16
8245874|NCT01898195|20334656|P1|COMPLETED|Varenicline Adherence||18
8245875|NCT01898195|20334654|P3|STARTED|Varenicline Adherence||51
8245876|NCT01898195|20334655|P2|STARTED|Varenicline Adherence||54
8245877|NCT01898195|20334656|P1|STARTED|Varenicline Adherence||53
8245878|NCT01898130|20334667|P1|NOT COMPLETED|Follow up Until PD or Death||1
8245879|NCT01898130|20334667|P1|COMPLETED|Follow up Until PD or Death||26
8245880|NCT01898130|20334667|P1|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27
8245881|NCT01898130|20334667|P1|NOT COMPLETED|Treatment||6
8245882|NCT01898130|20334667|P1|COMPLETED|Treatment||21
8245883|NCT01898130|20334667|P1|Went on to Start Cycle 3|Treatment||21
8245884|NCT01898130|20334667|P1|Reached 1st Response/2 Cycles|Treatment||24
8245885|NCT01898130|20334667|P1|STARTED|Treatment||27
8245886|NCT01898091|20334682|P2|NOT COMPLETED|Overall Study||6
8245887|NCT01898091|20334683|P1|NOT COMPLETED|Overall Study||2
8245888|NCT01898091|20334682|P2|COMPLETED|Overall Study||19
8245889|NCT01898091|20334683|P1|COMPLETED|Overall Study||23
8245890|NCT01898091|20334682|P2|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
8245891|NCT01898091|20334683|P1|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
8245892|NCT01898078|20334691|P2|NOT COMPLETED|Overall Study||8
8245893|NCT01898078|20334692|P1|NOT COMPLETED|Overall Study||6
8245894|NCT01898078|20334691|P2|COMPLETED|Overall Study|Completed treatment|5
8245895|NCT01898078|20334692|P1|COMPLETED|Overall Study|Completed treatment|7
8245896|NCT01898078|20334691|P2|STARTED|Overall Study||13
8245897|NCT01898078|20334692|P1|STARTED|Overall Study||13
8245898|NCT01898013|20334710|P2|NOT COMPLETED|Visit 6||5
8245899|NCT01898013|20334711|P1|NOT COMPLETED|Visit 6||3
8245900|NCT01898013|20334710|P2|COMPLETED|Visit 6||42
8245901|NCT01898013|20334711|P1|COMPLETED|Visit 6||41
8245902|NCT01898013|20334710|P2|STARTED|Visit 6||47
8245903|NCT01898013|20334711|P1|STARTED|Visit 6||44
8245904|NCT01898013|20334710|P2|NOT COMPLETED|Visit 5||1
8245905|NCT01898013|20334711|P1|NOT COMPLETED|Visit 5||1
8245906|NCT01898013|20334710|P2|COMPLETED|Visit 5||47
8245907|NCT01898013|20334711|P1|COMPLETED|Visit 5||44
8245908|NCT01898013|20334710|P2|STARTED|Visit 5||48
8245909|NCT01898013|20334711|P1|STARTED|Visit 5||45
8245910|NCT01898013|20334710|P2|NOT COMPLETED|Visit 4||1
8245911|NCT01898013|20334711|P1|NOT COMPLETED|Visit 4||0
8245912|NCT01898013|20334710|P2|COMPLETED|Visit 4||48
8245913|NCT01898013|20334711|P1|COMPLETED|Visit 4||45
8245914|NCT01898013|20334710|P2|STARTED|Visit 4||49
8245915|NCT01898013|20334711|P1|STARTED|Visit 4||45
8245916|NCT01898013|20334710|P2|NOT COMPLETED|Visit 3 (Randomization Visit)||0
8245917|NCT01898013|20334711|P1|NOT COMPLETED|Visit 3 (Randomization Visit)||0
8245918|NCT01898013|20334710|P2|COMPLETED|Visit 3 (Randomization Visit)||49
8245919|NCT01898013|20334711|P1|COMPLETED|Visit 3 (Randomization Visit)||45
8245920|NCT01898013|20334710|P2|STARTED|Visit 3 (Randomization Visit)||49
8245921|NCT01898013|20334711|P1|STARTED|Visit 3 (Randomization Visit)||45
8245922|NCT01897896|20334729|P2|NOT COMPLETED|Overall Study||12
8245923|NCT01897896|20334730|P1|NOT COMPLETED|Overall Study||26
8245924|NCT01897896|20334729|P2|COMPLETED|Overall Study||25
8245925|NCT01897896|20334730|P1|COMPLETED|Overall Study||56
8245926|NCT01897896|20334729|P2|STARTED|Overall Study||37
8245927|NCT01897896|20334730|P1|STARTED|Overall Study||82
8245928|NCT01897792|20334812|P2|NOT COMPLETED|Overall Study||0
8245929|NCT01897792|20334813|P1|NOT COMPLETED|Overall Study||0
8245930|NCT01897792|20334812|P2|COMPLETED|Overall Study||5
8245931|NCT01897792|20334813|P1|COMPLETED|Overall Study||6
8245932|NCT01897792|20334812|P2|STARTED|Overall Study||5
8245933|NCT01897792|20334813|P1|STARTED|Overall Study||6
8245934|NCT01897766|20334837|P1|NOT COMPLETED|Overall Study||0
8245935|NCT01897766|20334837|P1|COMPLETED|Overall Study||482
8245936|NCT01897766|20334837|P1|STARTED|Overall Study||482
8245937|NCT01897727|20334862|P2|NOT COMPLETED|Overall Study||1
8245938|NCT01897727|20334863|P1|NOT COMPLETED|Overall Study||0
8245939|NCT01897727|20334862|P2|COMPLETED|Overall Study||8
8245940|NCT01897727|20334863|P1|COMPLETED|Overall Study||8
8245941|NCT01897727|20334862|P2|STARTED|Overall Study||9
8245942|NCT01897727|20334863|P1|STARTED|Overall Study||8
8245943|NCT01897714|20334875|P6|NOT COMPLETED|Phase II (MTD)||11
8245944|NCT01897714|20334876|P5|NOT COMPLETED|Phase II (MTD)||30
8245945|NCT01897714|20334877|P4|NOT COMPLETED|Phase II (MTD)||0
8245946|NCT01897714|20334878|P3|NOT COMPLETED|Phase II (MTD)||0
8245947|NCT01897714|20334879|P2|NOT COMPLETED|Phase II (MTD)||0
8245948|NCT01897714|20334880|P1|NOT COMPLETED|Phase II (MTD)||0
8245949|NCT01897714|20334875|P6|COMPLETED|Phase II (MTD)||2
8245950|NCT01897714|20334876|P5|COMPLETED|Phase II (MTD)||15
8245951|NCT01897714|20334877|P4|COMPLETED|Phase II (MTD)||0
8245952|NCT01897714|20334878|P3|COMPLETED|Phase II (MTD)||0
8245953|NCT01897714|20334879|P2|COMPLETED|Phase II (MTD)||0
8245954|NCT01897714|20334880|P1|COMPLETED|Phase II (MTD)||0
8245955|NCT01897714|20334875|P6|STARTED|Phase II (MTD)||13
8245956|NCT01897714|20334876|P5|STARTED|Phase II (MTD)|6 patients were entered from the Phase I: Melflufen 40 mg + Dexamethasone arm.|45
8245957|NCT01897714|20334877|P4|STARTED|Phase II (MTD)||0
8245958|NCT01897714|20334878|P3|STARTED|Phase II (MTD)||0
8245959|NCT01897714|20334879|P2|STARTED|Phase II (MTD)||0
8245960|NCT01897714|20334880|P1|STARTED|Phase II (MTD)||0
8245961|NCT01897714|20334875|P6|NOT COMPLETED|Phase I (Dose Escalation)||0
8245962|NCT01897714|20334876|P5|NOT COMPLETED|Phase I (Dose Escalation)||0
8245963|NCT01897714|20334877|P4|NOT COMPLETED|Phase I (Dose Escalation)||6
8245964|NCT01897714|20334878|P3|NOT COMPLETED|Phase I (Dose Escalation)||5
8245965|NCT01897714|20334879|P2|NOT COMPLETED|Phase I (Dose Escalation)||7
8245966|NCT01897714|20334880|P1|NOT COMPLETED|Phase I (Dose Escalation)||3
8245967|NCT01897714|20334875|P6|COMPLETED|Phase I (Dose Escalation)||0
8245968|NCT01897714|20334876|P5|COMPLETED|Phase I (Dose Escalation)||0
8245969|NCT01897714|20334877|P4|COMPLETED|Phase I (Dose Escalation)||0
8245970|NCT01897714|20334878|P3|COMPLETED|Phase I (Dose Escalation)||1
8245971|NCT01897714|20334879|P2|COMPLETED|Phase I (Dose Escalation)||0
8245972|NCT01897714|20334880|P1|COMPLETED|Phase I (Dose Escalation)||1
8245973|NCT01897714|20334875|P6|STARTED|Phase I (Dose Escalation)||0
8245974|NCT01897714|20334876|P5|STARTED|Phase I (Dose Escalation)||0
8245975|NCT01897714|20334877|P4|STARTED|Phase I (Dose Escalation)||6
8245976|NCT01897714|20334878|P3|STARTED|Phase I (Dose Escalation)||6
8245977|NCT01897714|20334879|P2|STARTED|Phase I (Dose Escalation)||7
8245978|NCT01897714|20334880|P1|STARTED|Phase I (Dose Escalation)||4
8245979|NCT01897532|20334926|P2|NOT COMPLETED|Discontinuation From Trial||41
8245980|NCT01897532|20334927|P1|NOT COMPLETED|Discontinuation From Trial||62
8245981|NCT01897532|20334926|P2|COMPLETED|Discontinuation From Trial||3458
8245982|NCT01897532|20334927|P1|COMPLETED|Discontinuation From Trial||3430
8245983|NCT01897532|20334926|P2|Treated|Discontinuation From Trial||3494
8245984|NCT01897532|20334927|P1|Treated|Discontinuation From Trial||3485
8245985|NCT01897532|20334926|P2|STARTED|Discontinuation From Trial||3499
8245986|NCT01897532|20334927|P1|STARTED|Discontinuation From Trial||3492
8245987|NCT01897532|20334926|P2|NOT COMPLETED|Discontinuation From Treatment||839
8245988|NCT01897532|20334927|P1|NOT COMPLETED|Discontinuation From Treatment||962
8245989|NCT01897532|20334926|P2|COMPLETED|Discontinuation From Treatment||2660
8245990|NCT01897532|20334927|P1|COMPLETED|Discontinuation From Treatment||2530
8245991|NCT01897532|20334926|P2|Treated|Discontinuation From Treatment||3494
8245992|NCT01897532|20334927|P1|Treated|Discontinuation From Treatment||3485
8245993|NCT01897532|20334926|P2|STARTED|Discontinuation From Treatment||3499
8245994|NCT01897532|20334927|P1|STARTED|Discontinuation From Treatment||3492
8245995|NCT01897493|20334935|P1|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
8245996|NCT01897493|20334935|P1|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
8245997|NCT01897493|20334935|P1|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
8245998|NCT01897493|20334935|P1|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
8245999|NCT01897493|20334935|P1|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
8246000|NCT01897493|20334935|P1|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
8246093|NCT01896726|20335113|P1|COMPLETED|Treatment Period 2 (Days 23-31)||18
8246001|NCT01897493|20334935|P1|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
8246002|NCT01897493|20334935|P1|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
8246003|NCT01897402|20334950|P2|NOT COMPLETED|Overall Study||16
8246004|NCT01897402|20334951|P1|NOT COMPLETED|Overall Study||19
8246005|NCT01897402|20334950|P2|COMPLETED|Overall Study||244
8246006|NCT01897402|20334951|P1|COMPLETED|Overall Study||246
8246007|NCT01897402|20334950|P2|STARTED|Overall Study||260
8246008|NCT01897402|20334951|P1|STARTED|Overall Study||265
8246009|NCT01897285|20334963|P1|NOT COMPLETED|Overall Study||0
8246010|NCT01897285|20334963|P1|COMPLETED|Overall Study||20
8246011|NCT01897285|20334963|P1|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
8246012|NCT01897233|20334971|P1|NOT COMPLETED|Part B (24 Weeks)||4
8246013|NCT01897233|20334971|P1|COMPLETED|Part B (24 Weeks)||54
8246014|NCT01897233|20334971|P1|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
8246015|NCT01897233|20334971|P1|NOT COMPLETED|Part A (14 Days)||0
8246016|NCT01897233|20334971|P1|COMPLETED|Part A (14 Days)||10
8246017|NCT01897233|20334971|P1|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
8246018|NCT01897233|20334971|P1|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
8246019|NCT01897233|20334971|P1|STARTED|Part A (14 Days)||10
8246020|NCT01897077|20334995|P2|NOT COMPLETED|Overall Study||0
8246021|NCT01897077|20334996|P1|NOT COMPLETED|Overall Study||0
8246022|NCT01897077|20334995|P2|COMPLETED|Overall Study||5
8246023|NCT01897077|20334996|P1|COMPLETED|Overall Study||0
8246024|NCT01897077|20334995|P2|STARTED|Overall Study||5
8246025|NCT01897077|20334996|P1|STARTED|Overall Study||0
8246026|NCT01897025|20335014|P2|NOT COMPLETED|Overall Study||0
8246027|NCT01897025|20335015|P1|NOT COMPLETED|Overall Study||0
8246028|NCT01897025|20335014|P2|COMPLETED|Overall Study||9
8246029|NCT01897025|20335015|P1|COMPLETED|Overall Study||10
8246030|NCT01897025|20335014|P2|STARTED|Overall Study||9
8246031|NCT01897025|20335015|P1|STARTED|Overall Study||10
8246032|NCT01896986|20335023|P2|NOT COMPLETED|Overall Study||23
8246033|NCT01896986|20335024|P1|NOT COMPLETED|Overall Study||14
8246034|NCT01896986|20335023|P2|COMPLETED|Overall Study||0
8246035|NCT01896986|20335024|P1|COMPLETED|Overall Study||0
8246036|NCT01896986|20335023|P2|STARTED|Overall Study||23
8246037|NCT01896986|20335024|P1|STARTED|Overall Study||14
8246038|NCT01896934|20335030|P1|NOT COMPLETED|Overall Study||2
8246039|NCT01896934|20335030|P1|COMPLETED|Overall Study||19
8246040|NCT01896934|20335030|P1|STARTED|Overall Study||21
8246041|NCT01896921|20335036|P1|NOT COMPLETED|Overall Study||2
8246042|NCT01896921|20335036|P1|COMPLETED|Overall Study||5
8246043|NCT01896921|20335036|P1|STARTED|Overall Study||7
8246044|NCT01896895|20335043|P4|NOT COMPLETED|OLEX Period||0
8246045|NCT01896895|20335044|P3|NOT COMPLETED|OLEX Period||0
8246046|NCT01896895|20335045|P2|NOT COMPLETED|OLEX Period||0
8246047|NCT01896895|20335046|P1|NOT COMPLETED|OLEX Period||0
8246048|NCT01896895|20335043|P4|COMPLETED|OLEX Period||39
8246049|NCT01896895|20335044|P3|COMPLETED|OLEX Period||0
8246050|NCT01896895|20335045|P2|COMPLETED|OLEX Period||0
8246051|NCT01896895|20335046|P1|COMPLETED|OLEX Period||0
8246052|NCT01896895|20335043|P4|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
8246053|NCT01896895|20335044|P3|STARTED|OLEX Period||0
8246054|NCT01896895|20335045|P2|STARTED|OLEX Period||0
8246055|NCT01896895|20335046|P1|STARTED|OLEX Period||0
8246056|NCT01896895|20335043|P4|NOT COMPLETED|Double-blind MP||0
8246057|NCT01896895|20335044|P3|NOT COMPLETED|Double-blind MP||3
8246058|NCT01896895|20335045|P2|NOT COMPLETED|Double-blind MP||2
8246059|NCT01896895|20335046|P1|NOT COMPLETED|Double-blind MP||1
8246060|NCT01896895|20335043|P4|COMPLETED|Double-blind MP||0
8246061|NCT01896895|20335044|P3|COMPLETED|Double-blind MP||16
8246062|NCT01896895|20335045|P2|COMPLETED|Double-blind MP||20
8246063|NCT01896895|20335046|P1|COMPLETED|Double-blind MP||19
8246064|NCT01896895|20335043|P4|STARTED|Double-blind MP||0
8246065|NCT01896895|20335044|P3|STARTED|Double-blind MP||19
8246066|NCT01896895|20335045|P2|STARTED|Double-blind MP||22
8246067|NCT01896895|20335046|P1|STARTED|Double-blind MP||20
8246068|NCT01896869|20335063|P2|NOT COMPLETED|Overall Study||6
8246069|NCT01896869|20335064|P1|NOT COMPLETED|Overall Study||1
8246070|NCT01896869|20335063|P2|COMPLETED|Overall Study||36
8246071|NCT01896869|20335064|P1|COMPLETED|Overall Study||40
8246072|NCT01896869|20335063|P2|STARTED|Overall Study||42
8246073|NCT01896869|20335064|P1|STARTED|Overall Study||41
8246074|NCT01896856|20335089|P6|NOT COMPLETED|Overall Study||0
8246075|NCT01896856|20335090|P5|NOT COMPLETED|Overall Study||0
8246076|NCT01896856|20335091|P4|NOT COMPLETED|Overall Study||0
8246077|NCT01896856|20335092|P3|NOT COMPLETED|Overall Study||1
8246078|NCT01896856|20335093|P2|NOT COMPLETED|Overall Study||0
8246079|NCT01896856|20335094|P1|NOT COMPLETED|Overall Study||0
8246080|NCT01896856|20335089|P6|COMPLETED|Overall Study||34
8246081|NCT01896856|20335090|P5|COMPLETED|Overall Study||62
8246082|NCT01896856|20335091|P4|COMPLETED|Overall Study||6
8246083|NCT01896856|20335092|P3|COMPLETED|Overall Study||6
8246084|NCT01896856|20335093|P2|COMPLETED|Overall Study||3
8246085|NCT01896856|20335094|P1|COMPLETED|Overall Study||6
8246086|NCT01896856|20335089|P6|STARTED|Overall Study||34
8246087|NCT01896856|20335090|P5|STARTED|Overall Study||62
8246088|NCT01896856|20335091|P4|STARTED|Overall Study||6
8246089|NCT01896856|20335092|P3|STARTED|Overall Study||7
8246090|NCT01896856|20335093|P2|STARTED|Overall Study||3
8246091|NCT01896856|20335094|P1|STARTED|Overall Study||6
8246092|NCT01896726|20335113|P1|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
8246094|NCT01896726|20335113|P1|Received Microgynon|Treatment Period 2 (Days 23-31)||18
8246095|NCT01896726|20335113|P1|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
8246096|NCT01896726|20335113|P1|STARTED|Treatment Period 2 (Days 23-31)||20
8246097|NCT01896726|20335113|P1|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
8246098|NCT01896726|20335113|P1|COMPLETED|Treatment Period 1 (Days 1-22)||20
8246099|NCT01896726|20335113|P1|Received Microgynon|Treatment Period 1 (Days 1-22)||20
8246100|NCT01896726|20335113|P1|STARTED|Treatment Period 1 (Days 1-22)||20
8246101|NCT01896700|20335128|P2|NOT COMPLETED|Overall Study||6
8246102|NCT01896700|20335129|P1|NOT COMPLETED|Overall Study||4
8246103|NCT01896700|20335128|P2|COMPLETED|Overall Study||6
8246104|NCT01896700|20335129|P1|COMPLETED|Overall Study||8
8246105|NCT01896700|20335128|P2|STARTED|Overall Study||12
8246106|NCT01896700|20335129|P1|STARTED|Overall Study||12
8246107|NCT01896687|20335151|P2|NOT COMPLETED|Overall Study||0
8246108|NCT01896687|20335152|P1|NOT COMPLETED|Overall Study||0
8246109|NCT01896687|20335151|P2|COMPLETED|Overall Study||15
8246110|NCT01896687|20335152|P1|COMPLETED|Overall Study||15
8246111|NCT01896687|20335151|P2|STARTED|Overall Study||15
8246112|NCT01896687|20335152|P1|STARTED|Overall Study||15
8246113|NCT01896557|20335160|P2|NOT COMPLETED|Clopidogrel + GI Protector||4
8246114|NCT01896557|20335161|P1|NOT COMPLETED|Clopidogrel + GI Protector||2
8246115|NCT01896557|20335160|P2|COMPLETED|Clopidogrel + GI Protector||44
8246116|NCT01896557|20335161|P1|COMPLETED|Clopidogrel + GI Protector||41
8246117|NCT01896557|20335160|P2|STARTED|Clopidogrel + GI Protector||48
8246118|NCT01896557|20335161|P1|STARTED|Clopidogrel + GI Protector||43
8246119|NCT01896557|20335160|P2|NOT COMPLETED|Clopidogrel Alone||0
8246120|NCT01896557|20335161|P1|NOT COMPLETED|Clopidogrel Alone||1
8246121|NCT01896557|20335160|P2|COMPLETED|Clopidogrel Alone||48
8246122|NCT01896557|20335161|P1|COMPLETED|Clopidogrel Alone||43
8246123|NCT01896557|20335160|P2|STARTED|Clopidogrel Alone||48
8246124|NCT01896557|20335161|P1|STARTED|Clopidogrel Alone||44
8246125|NCT01896544|20335176|P3|NOT COMPLETED|Overall Study||0
8246126|NCT01896544|20335177|P2|NOT COMPLETED|Overall Study||0
8246127|NCT01896544|20335178|P1|NOT COMPLETED|Overall Study||0
8246128|NCT01896544|20335176|P3|COMPLETED|Overall Study||10
8246129|NCT01896544|20335177|P2|COMPLETED|Overall Study||10
8246130|NCT01896544|20335178|P1|COMPLETED|Overall Study||10
8246131|NCT01896544|20335176|P3|STARTED|Overall Study||10
8246132|NCT01896544|20335177|P2|STARTED|Overall Study||10
8246133|NCT01896544|20335178|P1|STARTED|Overall Study||10
8246134|NCT01896297|20335198|P1|NOT COMPLETED|Overall Study||1
8246135|NCT01896297|20335198|P1|COMPLETED|Overall Study||59
8246136|NCT01896297|20335198|P1|STARTED|Overall Study||60
8246137|NCT01896232|20335205|P2|NOT COMPLETED|Overall Study||53
8246138|NCT01896232|20335206|P1|NOT COMPLETED|Overall Study||49
8246139|NCT01896232|20335205|P2|COMPLETED|Overall Study||287
8246140|NCT01896232|20335206|P1|COMPLETED|Overall Study||294
8246141|NCT01896232|20335205|P2|Received Treatment|Overall Study||338
8246142|NCT01896232|20335206|P1|Received Treatment|Overall Study||341
8246143|NCT01896232|20335205|P2|STARTED|Overall Study||340
8246144|NCT01896232|20335206|P1|STARTED|Overall Study||343
8246145|NCT01896206|20335226|P1|NOT COMPLETED|Overall Study||0
8246146|NCT01896206|20335226|P1|COMPLETED|Overall Study||21
8246147|NCT01896206|20335226|P1|STARTED|Overall Study||21
8246148|NCT01896193|20335234|P2|NOT COMPLETED|Overall Study||12
8246149|NCT01896193|20335235|P1|NOT COMPLETED|Overall Study||21
8246150|NCT01896193|20335234|P2|COMPLETED|Overall Study||53
8246151|NCT01896193|20335235|P1|COMPLETED|Overall Study||41
8246152|NCT01896193|20335234|P2|STARTED|Overall Study||65
8246153|NCT01896193|20335235|P1|STARTED|Overall Study||62
8246154|NCT01896128|20335261|P2|NOT COMPLETED|Overall Study||3
8246155|NCT01896128|20335262|P1|NOT COMPLETED|Overall Study||3
8246156|NCT01896128|20335261|P2|COMPLETED|Overall Study||8
8246157|NCT01896128|20335262|P1|COMPLETED|Overall Study||5
8246158|NCT01896128|20335261|P2|STARTED|Overall Study||11
8246159|NCT01896128|20335262|P1|STARTED|Overall Study||8
8246160|NCT01896115|20335278|P2|NOT COMPLETED|Overall Study||0
8246161|NCT01896115|20335279|P1|NOT COMPLETED|Overall Study||1
8246162|NCT01896115|20335278|P2|COMPLETED|Overall Study||24
8246163|NCT01896115|20335279|P1|COMPLETED|Overall Study||15
8246164|NCT01896115|20335278|P2|Phase 2 Steering|Overall Study||24
8246165|NCT01896115|20335279|P1|Phase 2 Steering|Overall Study||0
8246166|NCT01896115|20335278|P2|Phase 2 Single Contact|Overall Study||24
8246167|NCT01896115|20335279|P1|Phase 2 Single Contact|Overall Study||0
8246168|NCT01896115|20335278|P2|Phase 1 Ventral Steering|Overall Study||0
8246169|NCT01896115|20335279|P1|Phase 1 Ventral Steering|Overall Study||15
8246170|NCT01896115|20335278|P2|Phase 1 Dorsal Steering|Overall Study||0
8246171|NCT01896115|20335279|P1|Phase 1 Dorsal Steering|Overall Study||15
8246172|NCT01896115|20335278|P2|Phase 1 Conventional PW|Overall Study||0
8246173|NCT01896115|20335279|P1|Phase 1 Conventional PW|Overall Study||15
8246174|NCT01896115|20335278|P2|Phase 1 Short PW|Overall Study||0
8246175|NCT01896115|20335279|P1|Phase 1 Short PW|Overall Study||15
8246176|NCT01896115|20335278|P2|STARTED|Overall Study||24
8246177|NCT01896115|20335279|P1|STARTED|Overall Study||16
8246178|NCT01896050|20335304|P2|NOT COMPLETED|Overall Study||2
8246179|NCT01896050|20335305|P1|NOT COMPLETED|Overall Study||38
8246180|NCT01896050|20335304|P2|COMPLETED|Overall Study||20
8246181|NCT01896050|20335305|P1|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
8246182|NCT01896050|20335304|P2|STARTED|Overall Study||22
8246183|NCT01896050|20335305|P1|STARTED|Overall Study||93
8246184|NCT01895972|20335315|P1|NOT COMPLETED|Overall Study||9
8246185|NCT01895972|20335315|P1|COMPLETED|Overall Study||121
8246186|NCT01895972|20335315|P1|STARTED|Overall Study||130
8246187|NCT01895959|20335320|P1|NOT COMPLETED|Overall Study||2
8246188|NCT01895959|20335320|P1|COMPLETED|Overall Study||10
8246189|NCT01895959|20335320|P1|STARTED|Overall Study||12
8246190|NCT01895946|20335328|P2|NOT COMPLETED|Overall Study||0
8246191|NCT01895946|20335329|P1|NOT COMPLETED|Overall Study||0
8246192|NCT01895946|20335328|P2|COMPLETED|Overall Study||12
8246193|NCT01895946|20335329|P1|COMPLETED|Overall Study||18
8246194|NCT01895946|20335328|P2|STARTED|Overall Study||12
8246195|NCT01895946|20335329|P1|STARTED|Overall Study||18
8246196|NCT01895777|20335349|P2|NOT COMPLETED|Overall Study||5
8246197|NCT01895777|20335350|P1|NOT COMPLETED|Overall Study||9
8246198|NCT01895777|20335349|P2|COMPLETED|Overall Study||85
8246199|NCT01895777|20335350|P1|COMPLETED|Overall Study||168
8246200|NCT01895777|20335349|P2|Treated|Overall Study||90
8246201|NCT01895777|20335350|P1|Treated|Overall Study||176
8246202|NCT01895777|20335349|P2|STARTED|Overall Study||90
8246203|NCT01895777|20335350|P1|STARTED|Overall Study||177
8246204|NCT01895647|20335378|P3|NOT COMPLETED|Overall Study||0
8246205|NCT01895647|20335379|P2|NOT COMPLETED|Overall Study||0
8246206|NCT01895647|20335380|P1|NOT COMPLETED|Overall Study||0
8246207|NCT01895647|20335378|P3|COMPLETED|Overall Study||7
8246208|NCT01895647|20335379|P2|COMPLETED|Overall Study||10
8246209|NCT01895647|20335380|P1|COMPLETED|Overall Study||8
8246210|NCT01895647|20335378|P3|STARTED|Overall Study||7
8246211|NCT01895647|20335379|P2|STARTED|Overall Study||10
8246212|NCT01895647|20335380|P1|STARTED|Overall Study||8
8246213|NCT01895634|20335394|P1|NOT COMPLETED|Overall Study||3
8246214|NCT01895634|20335394|P1|COMPLETED|Overall Study||46
8246215|NCT01895634|20335394|P1|STARTED|Overall Study||49
8246216|NCT01895608|20335406|P4|NOT COMPLETED|Overall Study||0
8246217|NCT01895608|20335407|P3|NOT COMPLETED|Overall Study||3
8246218|NCT01895608|20335408|P2|NOT COMPLETED|Overall Study||1
8246219|NCT01895608|20335409|P1|NOT COMPLETED|Overall Study||0
8246220|NCT01895608|20335406|P4|COMPLETED|Overall Study||6
8246221|NCT01895608|20335407|P3|COMPLETED|Overall Study||8
8246222|NCT01895608|20335408|P2|COMPLETED|Overall Study||6
8246223|NCT01895608|20335409|P1|COMPLETED|Overall Study||10
8246224|NCT01895608|20335406|P4|STARTED|Overall Study||6
8246225|NCT01895608|20335407|P3|STARTED|Overall Study||11
8246226|NCT01895608|20335408|P2|STARTED|Overall Study||7
8246227|NCT01895608|20335409|P1|STARTED|Overall Study||10
8246228|NCT01895543|20335439|P1|NOT COMPLETED|Overall Study||129
8246229|NCT01895543|20335439|P1|COMPLETED|Overall Study||282
8246230|NCT01895543|20335439|P1|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
8246231|NCT01895543|20335439|P1|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
8246232|NCT01895543|20335439|P1|STARTED|Overall Study||411
8246233|NCT01895452|20335455|P2|NOT COMPLETED|Overall Study||28
8246234|NCT01895452|20335456|P1|NOT COMPLETED|Overall Study||4
8246235|NCT01895452|20335455|P2|COMPLETED|Overall Study||198
8246236|NCT01895452|20335456|P1|COMPLETED|Overall Study||61
8246237|NCT01895452|20335455|P2|STARTED|Overall Study||226
8246238|NCT01895452|20335456|P1|STARTED|Overall Study||65
8246239|NCT01895361|20335469|P3|NOT COMPLETED|Overall Study||24
8246240|NCT01895361|20335470|P2|NOT COMPLETED|Overall Study||21
8246241|NCT01895361|20335471|P1|NOT COMPLETED|Overall Study||24
8246242|NCT01895361|20335469|P3|COMPLETED|Overall Study||41
8246243|NCT01895361|20335470|P2|COMPLETED|Overall Study||45
8246244|NCT01895361|20335471|P1|COMPLETED|Overall Study||43
8246245|NCT01895361|20335469|P3|STARTED|Overall Study||65
8246246|NCT01895361|20335470|P2|STARTED|Overall Study||66
8246247|NCT01895361|20335471|P1|STARTED|Overall Study||67
8246248|NCT01895335|20335500|P1|NOT COMPLETED|Overall Study||215
8246249|NCT01895335|20335500|P1|COMPLETED|Overall Study||786
8246250|NCT01895335|20335500|P1|Treated|Overall Study||1000
8246251|NCT01895335|20335500|P1|STARTED|Overall Study||1001
8246252|NCT01895322|20335517|P1|NOT COMPLETED|Overall Study||13
8246253|NCT01895322|20335517|P1|COMPLETED|Overall Study||7
8246254|NCT01895322|20335517|P1|STARTED|Overall Study||20
8246255|NCT01895309|20335526|P2|NOT COMPLETED|Overall Study||51
8246256|NCT01895309|20335527|P1|NOT COMPLETED|Overall Study||40
8246257|NCT01895309|20335526|P2|COMPLETED|Overall Study||246
8246258|NCT01895309|20335527|P1|COMPLETED|Overall Study||259
8246259|NCT01895309|20335526|P2|STARTED|Overall Study||297
8246260|NCT01895309|20335527|P1|STARTED|Overall Study||299
8246261|NCT01895270|20335541|P2|NOT COMPLETED|Isradipine Taper (W7-8)||2
8246262|NCT01895270|20335542|P1|NOT COMPLETED|Isradipine Taper (W7-8)||0
8246263|NCT01895270|20335541|P2|COMPLETED|Isradipine Taper (W7-8)||0
8246264|NCT01895270|20335542|P1|COMPLETED|Isradipine Taper (W7-8)||2
8246265|NCT01895270|20335541|P2|STARTED|Isradipine Taper (W7-8)||2
8246266|NCT01895270|20335542|P1|STARTED|Isradipine Taper (W7-8)||2
8246267|NCT01895270|20335541|P2|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
8246268|NCT01895270|20335542|P1|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
8246269|NCT01895270|20335541|P2|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
8246270|NCT01895270|20335542|P1|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
8246271|NCT01895270|20335541|P2|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
8246272|NCT01895270|20335542|P1|STARTED|Buprenorphine Taper (W5 to W6D3)||5
8246273|NCT01895270|20335541|P2|NOT COMPLETED|Study Medications Induction (W1-4)||6
8246274|NCT01895270|20335542|P1|NOT COMPLETED|Study Medications Induction (W1-4)||6
8246275|NCT01895270|20335541|P2|COMPLETED|Study Medications Induction (W1-4)||8
8246276|NCT01895270|20335542|P1|COMPLETED|Study Medications Induction (W1-4)||5
8246277|NCT01895270|20335541|P2|STARTED|Study Medications Induction (W1-4)||14
8246278|NCT01895270|20335542|P1|STARTED|Study Medications Induction (W1-4)||11
8246279|NCT01895127|20335550|P2|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
8246280|NCT01895127|20335551|P1|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
8246281|NCT01895127|20335550|P2|COMPLETED|Long Term Follow-up (Month 3-12)||4
8246282|NCT01895127|20335551|P1|COMPLETED|Long Term Follow-up (Month 3-12)||1
8246283|NCT01895127|20335550|P2|STARTED|Long Term Follow-up (Month 3-12)||7
8246284|NCT01895127|20335551|P1|STARTED|Long Term Follow-up (Month 3-12)||3
8246285|NCT01895127|20335550|P2|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
8246286|NCT01895127|20335551|P1|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
8246287|NCT01895127|20335550|P2|COMPLETED|Month 3 Follow-up & Biopsy||7
8246288|NCT01895127|20335551|P1|COMPLETED|Month 3 Follow-up & Biopsy||3
8246289|NCT01895127|20335550|P2|STARTED|Month 3 Follow-up & Biopsy||7
8246290|NCT01895127|20335551|P1|STARTED|Month 3 Follow-up & Biopsy||3
8246291|NCT01895127|20335550|P2|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
8246292|NCT01895127|20335551|P1|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
8246293|NCT01895127|20335550|P2|COMPLETED|Treatment Period (Week 0-Month 3)||7
8246294|NCT01895127|20335551|P1|COMPLETED|Treatment Period (Week 0-Month 3)||3
8246295|NCT01895127|20335550|P2|STARTED|Treatment Period (Week 0-Month 3)||7
8246296|NCT01895127|20335551|P1|STARTED|Treatment Period (Week 0-Month 3)||3
8246297|NCT01895127|20335550|P2|NOT COMPLETED|Screening||0
8246298|NCT01895127|20335551|P1|NOT COMPLETED|Screening||0
8246299|NCT01895127|20335550|P2|COMPLETED|Screening||7
8246300|NCT01895127|20335551|P1|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
8246301|NCT01895127|20335550|P2|STARTED|Screening||7
8246302|NCT01895127|20335551|P1|STARTED|Screening||4
8246303|NCT01895101|20335561|P3|NOT COMPLETED|Overall Study||5
8246304|NCT01895101|20335562|P2|NOT COMPLETED|Overall Study||5
8246305|NCT01895101|20335563|P1|NOT COMPLETED|Overall Study||1
8246306|NCT01895101|20335561|P3|COMPLETED|Overall Study||245
8246307|NCT01895101|20335562|P2|COMPLETED|Overall Study||245
8246308|NCT01895101|20335563|P1|COMPLETED|Overall Study||249
8246309|NCT01895101|20335561|P3|STARTED|Overall Study||250
8246310|NCT01895101|20335562|P2|STARTED|Overall Study||250
8246311|NCT01895101|20335563|P1|STARTED|Overall Study||250
8246312|NCT01895088|20335577|P1|NOT COMPLETED|Overall Study||18
8246313|NCT01895088|20335577|P1|COMPLETED|Overall Study||253
8246314|NCT01895088|20335577|P1|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
8246315|NCT01895062|20335583|P2|NOT COMPLETED|Overall Study||0
8246316|NCT01895062|20335584|P1|NOT COMPLETED|Overall Study||0
8246317|NCT01895062|20335583|P2|COMPLETED|Overall Study||24
8246318|NCT01895062|20335584|P1|COMPLETED|Overall Study||30
8246319|NCT01895062|20335583|P2|STARTED|Overall Study||24
8246320|NCT01895062|20335584|P1|STARTED|Overall Study||30
8246321|NCT01895036|20335592|P1|NOT COMPLETED|Overall Study||0
8246322|NCT01895036|20335592|P1|COMPLETED|Overall Study||6
8246323|NCT01895036|20335592|P1|STARTED|Overall Study||6
8246324|NCT01894984|20335598|P2|NOT COMPLETED|Overall Study||175
8246325|NCT01894984|20335599|P1|NOT COMPLETED|Overall Study||314
8246326|NCT01894984|20335598|P2|COMPLETED|Overall Study||69
8246327|NCT01894984|20335599|P1|COMPLETED|Overall Study||82
8246328|NCT01894984|20335598|P2|STARTED|Overall Study||244
8246329|NCT01894984|20335599|P1|STARTED|Overall Study||396
8246330|NCT01894919|20335628|P13|NOT COMPLETED|Overall Study||0
8246331|NCT01894919|20335629|P12|NOT COMPLETED|Overall Study||0
8246332|NCT01894919|20335630|P11|NOT COMPLETED|Overall Study||2
8246333|NCT01894919|20335631|P10|NOT COMPLETED|Overall Study||1
8246334|NCT01894919|20335632|P9|NOT COMPLETED|Overall Study||0
8246335|NCT01894919|20335633|P8|NOT COMPLETED|Overall Study||0
8246336|NCT01894919|20335634|P7|NOT COMPLETED|Overall Study||0
8246337|NCT01894919|20335635|P6|NOT COMPLETED|Overall Study||0
8246338|NCT01894919|20335636|P5|NOT COMPLETED|Overall Study||3
8246339|NCT01894919|20335637|P4|NOT COMPLETED|Overall Study||0
8246340|NCT01894919|20335638|P3|NOT COMPLETED|Overall Study||0
8246341|NCT01894919|20335639|P2|NOT COMPLETED|Overall Study||0
8246342|NCT01894919|20335640|P1|NOT COMPLETED|Overall Study||2
8246343|NCT01894919|20335628|P13|COMPLETED|Overall Study||50
8246344|NCT01894919|20335629|P12|COMPLETED|Overall Study||55
8246345|NCT01894919|20335630|P11|COMPLETED|Overall Study||98
8246346|NCT01894919|20335631|P10|COMPLETED|Overall Study||89
8246347|NCT01894919|20335632|P9|COMPLETED|Overall Study||91
8246348|NCT01894919|20335633|P8|COMPLETED|Overall Study||36
8246349|NCT01894919|20335634|P7|COMPLETED|Overall Study||32
8246350|NCT01894919|20335635|P6|COMPLETED|Overall Study||39
8246351|NCT01894919|20335636|P5|COMPLETED|Overall Study||78
8246352|NCT01894919|20335637|P4|COMPLETED|Overall Study||43
8246353|NCT01894919|20335638|P3|COMPLETED|Overall Study||89
8246354|NCT01894919|20335639|P2|COMPLETED|Overall Study||47
8246355|NCT01894919|20335640|P1|COMPLETED|Overall Study||96
8246356|NCT01894919|20335628|P13|STARTED|Overall Study||50
8246357|NCT01894919|20335629|P12|STARTED|Overall Study||55
8246358|NCT01894919|20335630|P11|STARTED|Overall Study||100
8246359|NCT01894919|20335631|P10|STARTED|Overall Study||90
8246360|NCT01894919|20335632|P9|STARTED|Overall Study||91
8246361|NCT01894919|20335633|P8|STARTED|Overall Study||36
8246362|NCT01894919|20335634|P7|STARTED|Overall Study||32
8246363|NCT01894919|20335635|P6|STARTED|Overall Study||39
8246364|NCT01894919|20335636|P5|STARTED|Overall Study||81
8246365|NCT01894919|20335637|P4|STARTED|Overall Study||43
8246366|NCT01894919|20335638|P3|STARTED|Overall Study||89
8246367|NCT01894919|20335639|P2|STARTED|Overall Study||47
8246368|NCT01894919|20335640|P1|STARTED|Overall Study||98
8246369|NCT01894906|20335762|P2|NOT COMPLETED|Overall Study||0
8246370|NCT01894906|20335763|P1|NOT COMPLETED|Overall Study||0
8246371|NCT01894906|20335762|P2|COMPLETED|Overall Study||6
8246372|NCT01894906|20335763|P1|COMPLETED|Overall Study||6
8246373|NCT01894906|20335762|P2|Treatment F|Overall Study||6
8246374|NCT01894906|20335763|P1|Treatment F|Overall Study||6
8246375|NCT01894906|20335762|P2|Treatment E|Overall Study||6
8246376|NCT01894906|20335763|P1|Treatment E|Overall Study||6
8246377|NCT01894906|20335762|P2|Treatment D|Overall Study||6
8246378|NCT01894906|20335763|P1|Treatment D|Overall Study||6
8246379|NCT01894906|20335762|P2|Treatment C|Overall Study||6
8246380|NCT01894906|20335763|P1|Treatment C|Overall Study||6
8246381|NCT01894906|20335762|P2|Treatment B|Overall Study||6
8246382|NCT01894906|20335763|P1|Treatment B|Overall Study||6
8246383|NCT01894906|20335762|P2|Treatment A|Overall Study||6
8246384|NCT01894906|20335763|P1|Treatment A|Overall Study||6
8246385|NCT01894906|20335762|P2|STARTED|Overall Study||6
8246386|NCT01894906|20335763|P1|STARTED|Overall Study||6
8246387|NCT01894841|20335795|P2|NOT COMPLETED|Overall Study||9
8246388|NCT01894841|20335796|P1|NOT COMPLETED|Overall Study||18
8246389|NCT01894841|20335795|P2|COMPLETED|Overall Study||44
8246390|NCT01894841|20335796|P1|COMPLETED|Overall Study||34
8246391|NCT01894841|20335795|P2|STARTED|Overall Study||53
8246392|NCT01894841|20335796|P1|STARTED|Overall Study||52
8246393|NCT01894776|20335812|P1|NOT COMPLETED|Overall Study||1
8246394|NCT01894776|20335812|P1|COMPLETED|Overall Study||14
8246395|NCT01894776|20335812|P1|STARTED|Overall Study||15
8246405|NCT01894607|20335835|P1|NOT COMPLETED|Overall Study||1
8246406|NCT01894607|20335835|P1|COMPLETED|Overall Study||10
8246407|NCT01894607|20335835|P1|STARTED|Overall Study||11
8246408|NCT01894581|20335842|P2|NOT COMPLETED|Overall Study||7
8246409|NCT01894581|20335843|P1|NOT COMPLETED|Overall Study||5
8246410|NCT01894581|20335842|P2|COMPLETED|Overall Study||12
8246411|NCT01894581|20335843|P1|COMPLETED|Overall Study||15
8246412|NCT01894581|20335842|P2|STARTED|Overall Study||19
8246413|NCT01894581|20335843|P1|STARTED|Overall Study||20
8246414|NCT01894568|20335851|P2|NOT COMPLETED|Overall Study||10
8246415|NCT01894568|20335852|P1|NOT COMPLETED|Overall Study||10
8246416|NCT01894568|20335851|P2|COMPLETED|Overall Study||186
8246417|NCT01894568|20335852|P1|COMPLETED|Overall Study||182
8246418|NCT01894568|20335851|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
8246419|NCT01894568|20335852|P1|Received at Least 1 Dose of Study Drug|Overall Study||192
8246420|NCT01894568|20335851|P2|STARTED|Overall Study||196
8246421|NCT01894568|20335852|P1|STARTED|Overall Study||192
8246422|NCT01894555|20335892|P1|NOT COMPLETED|Overall Study||0
8246423|NCT01894555|20335892|P1|COMPLETED|Overall Study||33
8246424|NCT01894555|20335892|P1|STARTED|Overall Study||33
8246425|NCT01894516|20335900|P4|NOT COMPLETED|Period 2 (Week 13 to Week 24)||1
8246426|NCT01894516|20335901|P3|NOT COMPLETED|Period 2 (Week 13 to Week 24)||5
8246427|NCT01894516|20335902|P2|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
8246428|NCT01894516|20335903|P1|NOT COMPLETED|Period 2 (Week 13 to Week 24)||0
8246429|NCT01894516|20335900|P4|COMPLETED|Period 2 (Week 13 to Week 24)||65
8246430|NCT01894516|20335901|P3|COMPLETED|Period 2 (Week 13 to Week 24)||142
8246431|NCT01894516|20335902|P2|COMPLETED|Period 2 (Week 13 to Week 24)||50
8246432|NCT01894516|20335903|P1|COMPLETED|Period 2 (Week 13 to Week 24)||0
8246433|NCT01894516|20335900|P4|STARTED|Period 2 (Week 13 to Week 24)||66
8246434|NCT01894516|20335901|P3|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(65 participants) and 50 mg QD (15 participants) moved to 100 mg QD group.|147
8246435|NCT01894516|20335902|P2|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (15 participants).|52
8246436|NCT01894516|20335903|P1|STARTED|Period 2 (Week 13 to Week 24)|All participants from Placebo moved to 100 mg QD (65 participants) group.|0
8246437|NCT01894516|20335900|P4|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
8246438|NCT01894516|20335901|P3|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
8246439|NCT01894516|20335902|P2|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
8246440|NCT01894516|20335903|P1|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
8246441|NCT01894516|20335900|P4|COMPLETED|Period 1 (Baseline up to Week 12)||66
8246442|NCT01894516|20335901|P3|COMPLETED|Period 1 (Baseline up to Week 12)||67
8246443|NCT01894516|20335902|P2|COMPLETED|Period 1 (Baseline up to Week 12)||67
8246444|NCT01894516|20335903|P1|COMPLETED|Period 1 (Baseline up to Week 12)||65
8246445|NCT01894516|20335900|P4|STARTED|Period 1 (Baseline up to Week 12)||69
8246446|NCT01894516|20335901|P3|STARTED|Period 1 (Baseline up to Week 12)||70
8246447|NCT01894516|20335902|P2|STARTED|Period 1 (Baseline up to Week 12)||72
8246448|NCT01894516|20335903|P1|STARTED|Period 1 (Baseline up to Week 12)||72
8246449|NCT01894503|20335952|P1|NOT COMPLETED|Overall Study||0
8246450|NCT01894503|20335952|P1|COMPLETED|Overall Study||5
8246451|NCT01894503|20335952|P1|STARTED|Overall Study||5
8246458|NCT01894256|20335971|P3|NOT COMPLETED|Part B||14
8246459|NCT01894256|20335972|P2|NOT COMPLETED|Part B||14
8246460|NCT01894256|20335973|P1|NOT COMPLETED|Part B||15
8246461|NCT01894256|20335971|P3|COMPLETED|Part B||0
8246462|NCT01894256|20335972|P2|COMPLETED|Part B||0
8246463|NCT01894256|20335973|P1|COMPLETED|Part B||0
8246464|NCT01894256|20335971|P3|STARTED|Part B||14
8246465|NCT01894256|20335972|P2|STARTED|Part B||14
8246466|NCT01894256|20335973|P1|STARTED|Part B||15
8246467|NCT01894256|20335971|P3|NOT COMPLETED|Part A||0
8246468|NCT01894256|20335972|P2|NOT COMPLETED|Part A||1
8246469|NCT01894256|20335973|P1|NOT COMPLETED|Part A||0
8246470|NCT01894256|20335971|P3|COMPLETED|Part A||14
8246471|NCT01894256|20335972|P2|COMPLETED|Part A||14
8246472|NCT01894256|20335973|P1|COMPLETED|Part A||15
8246473|NCT01894256|20335971|P3|STARTED|Part A||14
8246474|NCT01894256|20335972|P2|STARTED|Part A||15
8246475|NCT01894256|20335973|P1|STARTED|Part A||15
8246476|NCT01894243|20336020|P3|NOT COMPLETED|Overall Study||8
8246477|NCT01894243|20336021|P2|NOT COMPLETED|Overall Study||10
8246478|NCT01894243|20336022|P1|NOT COMPLETED|Overall Study||13
8246479|NCT01894243|20336020|P3|COMPLETED|Overall Study||0
8246480|NCT01894243|20336021|P2|COMPLETED|Overall Study||0
8246481|NCT01894243|20336022|P1|COMPLETED|Overall Study||0
8246482|NCT01894243|20336020|P3|Ongoing Into Part B|Overall Study||8
8246483|NCT01894243|20336021|P2|Ongoing Into Part B|Overall Study||10
8246484|NCT01894243|20336022|P1|Ongoing Into Part B|Overall Study||13
8246485|NCT01894243|20336020|P3|Completed Treatment in Part A|Overall Study||8
8246486|NCT01894243|20336021|P2|Completed Treatment in Part A|Overall Study||10
8246487|NCT01894243|20336022|P1|Completed Treatment in Part A|Overall Study||13
8246488|NCT01894243|20336020|P3|STARTED|Overall Study||8
8246489|NCT01894243|20336021|P2|STARTED|Overall Study||10
8246490|NCT01894243|20336022|P1|STARTED|Overall Study||13
8246491|NCT01894230|20336061|P2|NOT COMPLETED|Overall Study||7
8246492|NCT01894230|20336062|P1|NOT COMPLETED|Overall Study||7
8246493|NCT01894230|20336061|P2|COMPLETED|Overall Study||69
8246494|NCT01894230|20336062|P1|COMPLETED|Overall Study||76
8246495|NCT01894230|20336061|P2|STARTED|Overall Study||76
8246496|NCT01894230|20336062|P1|STARTED|Overall Study||83
8246497|NCT01894178|20336088|P2|NOT COMPLETED|Overall Study||0
8246498|NCT01894178|20336089|P1|NOT COMPLETED|Overall Study||0
8246499|NCT01894178|20336088|P2|COMPLETED|Overall Study||30
8246500|NCT01894178|20336089|P1|COMPLETED|Overall Study||30
8246501|NCT01894178|20336088|P2|STARTED|Overall Study||30
8246502|NCT01894178|20336089|P1|STARTED|Overall Study||30
8246503|NCT01894152|20336097|P1|NOT COMPLETED|Overall Study||151
8246504|NCT01894152|20336097|P1|COMPLETED|Overall Study||1851
8246505|NCT01894152|20336097|P1|STARTED|Overall Study||2002
8246506|NCT01894100|20336140|P2|NOT COMPLETED|Overall Study||1
8246507|NCT01894100|20336141|P1|NOT COMPLETED|Overall Study||3
8246508|NCT01894100|20336140|P2|COMPLETED|Overall Study||14
8246509|NCT01894100|20336141|P1|COMPLETED|Overall Study||12
8246510|NCT01894100|20336140|P2|STARTED|Overall Study||15
8246511|NCT01894100|20336141|P1|STARTED|Overall Study||15
8246512|NCT01894087|20336151|P2|NOT COMPLETED|Overall Study||0
8246513|NCT01894087|20336152|P1|NOT COMPLETED|Overall Study||6
8246514|NCT01894087|20336151|P2|COMPLETED|Overall Study||102
8246515|NCT01894087|20336152|P1|COMPLETED|Overall Study||96
8246516|NCT01894087|20336151|P2|STARTED|Overall Study||102
8246517|NCT01894087|20336152|P1|STARTED|Overall Study||102
8246518|NCT01894022|20336166|P2|NOT COMPLETED|Overall Study||10
8246519|NCT01894022|20336167|P1|NOT COMPLETED|Overall Study||9
8246520|NCT01894022|20336166|P2|COMPLETED|Overall Study||0
8246521|NCT01894022|20336167|P1|COMPLETED|Overall Study||0
8246522|NCT01894022|20336166|P2|STARTED|Overall Study||10
8246523|NCT01894022|20336167|P1|STARTED|Overall Study||9
8246524|NCT01893983|20336221|P2|NOT COMPLETED|Overall Study||6
8246525|NCT01893983|20336222|P1|NOT COMPLETED|Overall Study||10
8246526|NCT01893983|20336221|P2|COMPLETED|Overall Study||134
8246527|NCT01893983|20336222|P1|COMPLETED|Overall Study||130
8246528|NCT01893983|20336221|P2|STARTED|Overall Study||140
8246529|NCT01893983|20336222|P1|STARTED|Overall Study||140
8246530|NCT01893905|20336236|P2|NOT COMPLETED|Overall Study||14
8246531|NCT01893905|20336237|P1|NOT COMPLETED|Overall Study||25
8246532|NCT01893905|20336236|P2|COMPLETED|Overall Study||64
8246533|NCT01893905|20336237|P1|COMPLETED|Overall Study||55
8246534|NCT01893905|20336236|P2|STARTED|Overall Study||78
8246535|NCT01893905|20336237|P1|STARTED|Overall Study||80
8246536|NCT01893879|20336245|P2|NOT COMPLETED|Overall Study||3
8246537|NCT01893879|20336246|P1|NOT COMPLETED|Overall Study||2
8246538|NCT01893879|20336245|P2|COMPLETED|Overall Study||4
8246539|NCT01893879|20336246|P1|COMPLETED|Overall Study||5
8246540|NCT01893879|20336245|P2|STARTED|Overall Study||7
8246541|NCT01893879|20336246|P1|STARTED|Overall Study||7
8246542|NCT01893827|20336254|P2|NOT COMPLETED|Overall Study||26
8246543|NCT01893827|20336255|P1|NOT COMPLETED|Overall Study||19
8246544|NCT01893827|20336254|P2|COMPLETED|Overall Study||94
8246545|NCT01893827|20336255|P1|COMPLETED|Overall Study||98
8246546|NCT01893827|20336254|P2|STARTED|Overall Study||120
8246547|NCT01893827|20336255|P1|STARTED|Overall Study||117
8246548|NCT01893801|20336261|P1|NOT COMPLETED|Overall Study||0
8246549|NCT01893801|20336261|P1|COMPLETED|Overall Study||25
8246550|NCT01893801|20336261|P1|STARTED|Overall Study||25
8246551|NCT01893632|20336271|P2|NOT COMPLETED|Overall Study||0
8246552|NCT01893632|20336272|P1|NOT COMPLETED|Overall Study||0
8246553|NCT01893632|20336271|P2|COMPLETED|Overall Study||1
8246554|NCT01893632|20336272|P1|COMPLETED|Overall Study||1
8246555|NCT01893632|20336271|P2|STARTED|Overall Study||1
8246556|NCT01893632|20336272|P1|STARTED|Overall Study||1
8246557|NCT01893567|20336278|P1|NOT COMPLETED|Overall Study||0
8246558|NCT01893567|20336278|P1|COMPLETED|Overall Study||28
8246559|NCT01893567|20336278|P1|STARTED|Overall Study||28
8246569|NCT01893372|20336351|P2|NOT COMPLETED|Overall Study||0
8246570|NCT01893372|20336352|P1|NOT COMPLETED|Overall Study||0
8246571|NCT01893372|20336351|P2|COMPLETED|Overall Study||22
8246572|NCT01893372|20336352|P1|COMPLETED|Overall Study||7
8246573|NCT01893372|20336351|P2|STARTED|Overall Study||22
8246574|NCT01893372|20336352|P1|STARTED|Overall Study||7
8246584|NCT01893346|20336384|P4|NOT COMPLETED|Overall Study||0
8246585|NCT01893346|20336385|P3|NOT COMPLETED|Overall Study||0
8246586|NCT01893346|20336386|P2|NOT COMPLETED|Overall Study||1
8246587|NCT01893346|20336387|P1|NOT COMPLETED|Overall Study||3
8246588|NCT01893346|20336384|P4|COMPLETED|Overall Study||8
8246589|NCT01893346|20336385|P3|COMPLETED|Overall Study||8
8246590|NCT01893346|20336386|P2|COMPLETED|Overall Study||7
8246591|NCT01893346|20336387|P1|COMPLETED|Overall Study||8
8246592|NCT01893346|20336384|P4|Patients Who Received Full Infusion|Overall Study||8
8246593|NCT01893346|20336385|P3|Patients Who Received Full Infusion|Overall Study||8
8246594|NCT01893346|20336386|P2|Patients Who Received Full Infusion|Overall Study||8
8246595|NCT01893346|20336387|P1|Patients Who Received Full Infusion|Overall Study||8
8246596|NCT01893346|20336384|P4|STARTED|Overall Study||8
8246597|NCT01893346|20336385|P3|STARTED|Overall Study||8
8246598|NCT01893346|20336386|P2|STARTED|Overall Study||8
8246599|NCT01893346|20336387|P1|STARTED|Overall Study||11
8246600|NCT01893281|20336401|P1|NOT COMPLETED|Overall Study||3
8246601|NCT01893281|20336401|P1|COMPLETED|Overall Study||75
8246602|NCT01893281|20336401|P1|Received at Least 1 Dose of Study Drug|Overall Study||78
8246603|NCT01893281|20336401|P1|STARTED|Overall Study||78
8246604|NCT01893203|20336408|P1|NOT COMPLETED|Overall Study||1
8246605|NCT01893203|20336408|P1|COMPLETED|Overall Study||13
8246606|NCT01893203|20336408|P1|STARTED|Overall Study||14
8246607|NCT01892865|20336417|P2|NOT COMPLETED|Overall Study||0
8246608|NCT01892865|20336418|P1|NOT COMPLETED|Overall Study||0
8246609|NCT01892865|20336417|P2|COMPLETED|Overall Study||379
8246610|NCT01892865|20336418|P1|COMPLETED|Overall Study||356
8246611|NCT01892865|20336417|P2|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
8246612|NCT01892865|20336418|P1|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
8246621|NCT01892709|20336439|P1|NOT COMPLETED|Overall Study||0
8246622|NCT01892709|20336439|P1|COMPLETED|Overall Study||215
8246623|NCT01892709|20336439|P1|STARTED|Overall Study||215
8246624|NCT01892657|20336449|P1|NOT COMPLETED|Overall Study||18
8246625|NCT01892657|20336449|P1|COMPLETED|Overall Study||110
8246626|NCT01892657|20336449|P1|STARTED|Overall Study||128
8246627|NCT01892540|20336468|P3|NOT COMPLETED|Overall Study||3
8246628|NCT01892540|20336469|P2|NOT COMPLETED|Overall Study||0
8246629|NCT01892540|20336470|P1|NOT COMPLETED|Overall Study||0
8246630|NCT01892540|20336468|P3|COMPLETED|Overall Study||25
8246631|NCT01892540|20336469|P2|COMPLETED|Overall Study||0
8246632|NCT01892540|20336470|P1|COMPLETED|Overall Study||15
8246633|NCT01892540|20336468|P3|STARTED|Overall Study||28
8246634|NCT01892540|20336469|P2|STARTED|Overall Study||0
8246635|NCT01892540|20336470|P1|STARTED|Overall Study||15
8246636|NCT01892436|20336491|P4|NOT COMPLETED|Overall Study||14
8246637|NCT01892436|20336492|P3|NOT COMPLETED|Overall Study||11
8246638|NCT01892436|20336493|P2|NOT COMPLETED|Overall Study||29
8246639|NCT01892436|20336494|P1|NOT COMPLETED|Overall Study||23
8246640|NCT01892436|20336491|P4|COMPLETED|Overall Study||61
8246641|NCT01892436|20336492|P3|COMPLETED|Overall Study||63
8246642|NCT01892436|20336493|P2|COMPLETED|Overall Study||132
8246643|NCT01892436|20336494|P1|COMPLETED|Overall Study||124
8246644|NCT01892436|20336491|P4|STARTED|Overall Study||75
8246645|NCT01892436|20336492|P3|STARTED|Overall Study||74
8246646|NCT01892436|20336493|P2|STARTED|Overall Study||161
8246647|NCT01892436|20336494|P1|STARTED|Overall Study||147
8246648|NCT01892345|20336534|P2|NOT COMPLETED|Overall Study||3
8246649|NCT01892345|20336535|P1|NOT COMPLETED|Overall Study||16
8246650|NCT01892345|20336534|P2|COMPLETED|Overall Study||44
8246651|NCT01892345|20336535|P1|COMPLETED|Overall Study||80
8246652|NCT01892345|20336534|P2|Received At Least 1 Dose Of Study Drug|Overall Study||47
8246653|NCT01892345|20336535|P1|Received At Least 1 Dose Of Study Drug|Overall Study||96
8246654|NCT01892345|20336534|P2|STARTED|Overall Study||47
8246655|NCT01892345|20336535|P1|STARTED|Overall Study||96
8246656|NCT01892306|20336555|P2|NOT COMPLETED|Overall Study||6
8246657|NCT01892306|20336556|P1|NOT COMPLETED|Overall Study||5
8246658|NCT01892306|20336555|P2|COMPLETED|Overall Study||10
8246659|NCT01892306|20336556|P1|COMPLETED|Overall Study||8
8246660|NCT01892306|20336555|P2|STARTED|Overall Study||16
8246661|NCT01892306|20336556|P1|STARTED|Overall Study||13
8246662|NCT01892293|20336576|P1|NOT COMPLETED|Overall Study||4
8246663|NCT01892293|20336576|P1|COMPLETED|Overall Study||2
8246664|NCT01892293|20336576|P1|Received T-cell|Overall Study||2
8246665|NCT01892293|20336576|P1|STARTED|Overall Study||6
8246666|NCT01892267|20336584|P2|NOT COMPLETED|Overall Study||0
8246667|NCT01892267|20336585|P1|NOT COMPLETED|Overall Study||0
8246668|NCT01892267|20336584|P2|COMPLETED|Overall Study||10
8246669|NCT01892267|20336585|P1|COMPLETED|Overall Study||9
8246670|NCT01892267|20336584|P2|STARTED|Overall Study||10
8246671|NCT01892267|20336585|P1|STARTED|Overall Study||9
8246672|NCT01892189|20336620|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246673|NCT01892189|20336621|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246674|NCT01892189|20336622|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246675|NCT01892189|20336623|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246676|NCT01892189|20336624|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246677|NCT01892189|20336625|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246678|NCT01892189|20336626|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246679|NCT01892189|20336627|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246680|NCT01892189|20336628|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
8246681|NCT01892189|20336620|P9|COMPLETED|Third Intervention Period (1 Day)||1
8246682|NCT01892189|20336621|P8|COMPLETED|Third Intervention Period (1 Day)||3
8246683|NCT01892189|20336622|P7|COMPLETED|Third Intervention Period (1 Day)||2
8246684|NCT01892189|20336623|P6|COMPLETED|Third Intervention Period (1 Day)||2
8246685|NCT01892189|20336624|P5|COMPLETED|Third Intervention Period (1 Day)||3
8246686|NCT01892189|20336625|P4|COMPLETED|Third Intervention Period (1 Day)||2
8246687|NCT01892189|20336626|P3|COMPLETED|Third Intervention Period (1 Day)||1
8246688|NCT01892189|20336627|P2|COMPLETED|Third Intervention Period (1 Day)||3
8246689|NCT01892189|20336628|P1|COMPLETED|Third Intervention Period (1 Day)||3
8246690|NCT01892189|20336620|P9|STARTED|Third Intervention Period (1 Day)||1
8246691|NCT01892189|20336621|P8|STARTED|Third Intervention Period (1 Day)||3
8246692|NCT01892189|20336622|P7|STARTED|Third Intervention Period (1 Day)||2
8246693|NCT01892189|20336623|P6|STARTED|Third Intervention Period (1 Day)||2
8246694|NCT01892189|20336624|P5|STARTED|Third Intervention Period (1 Day)||3
8246695|NCT01892189|20336625|P4|STARTED|Third Intervention Period (1 Day)||2
8246696|NCT01892189|20336626|P3|STARTED|Third Intervention Period (1 Day)||1
8246697|NCT01892189|20336627|P2|STARTED|Third Intervention Period (1 Day)||3
8246698|NCT01892189|20336628|P1|STARTED|Third Intervention Period (1 Day)||3
8246699|NCT01892189|20336620|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246700|NCT01892189|20336621|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246701|NCT01892189|20336622|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246702|NCT01892189|20336623|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246703|NCT01892189|20336624|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246704|NCT01892189|20336625|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246705|NCT01892189|20336626|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246706|NCT01892189|20336627|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246707|NCT01892189|20336628|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8246708|NCT01892189|20336620|P9|COMPLETED|Washout Period 2 (7 Days)||1
8246709|NCT01892189|20336621|P8|COMPLETED|Washout Period 2 (7 Days)||3
8246710|NCT01892189|20336622|P7|COMPLETED|Washout Period 2 (7 Days)||2
8246711|NCT01892189|20336623|P6|COMPLETED|Washout Period 2 (7 Days)||2
8246712|NCT01892189|20336624|P5|COMPLETED|Washout Period 2 (7 Days)||3
8246713|NCT01892189|20336625|P4|COMPLETED|Washout Period 2 (7 Days)||2
8246714|NCT01892189|20336626|P3|COMPLETED|Washout Period 2 (7 Days)||1
8246715|NCT01892189|20336627|P2|COMPLETED|Washout Period 2 (7 Days)||3
8246716|NCT01892189|20336628|P1|COMPLETED|Washout Period 2 (7 Days)||3
8246717|NCT01892189|20336620|P9|STARTED|Washout Period 2 (7 Days)||1
8246718|NCT01892189|20336621|P8|STARTED|Washout Period 2 (7 Days)||3
8246719|NCT01892189|20336622|P7|STARTED|Washout Period 2 (7 Days)||2
8246720|NCT01892189|20336623|P6|STARTED|Washout Period 2 (7 Days)||2
8246721|NCT01892189|20336624|P5|STARTED|Washout Period 2 (7 Days)||3
8246722|NCT01892189|20336625|P4|STARTED|Washout Period 2 (7 Days)||2
8246723|NCT01892189|20336626|P3|STARTED|Washout Period 2 (7 Days)||1
8246724|NCT01892189|20336627|P2|STARTED|Washout Period 2 (7 Days)||3
8246725|NCT01892189|20336628|P1|STARTED|Washout Period 2 (7 Days)||3
8246726|NCT01892189|20336620|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246727|NCT01892189|20336621|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246728|NCT01892189|20336622|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246729|NCT01892189|20336623|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246730|NCT01892189|20336624|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246731|NCT01892189|20336625|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246732|NCT01892189|20336626|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246733|NCT01892189|20336627|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246734|NCT01892189|20336628|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
8246735|NCT01892189|20336620|P9|COMPLETED|Second Intervention Period (1 Day)||1
8246736|NCT01892189|20336621|P8|COMPLETED|Second Intervention Period (1 Day)||3
8246737|NCT01892189|20336622|P7|COMPLETED|Second Intervention Period (1 Day)||2
8246738|NCT01892189|20336623|P6|COMPLETED|Second Intervention Period (1 Day)||2
8246739|NCT01892189|20336624|P5|COMPLETED|Second Intervention Period (1 Day)||3
8246740|NCT01892189|20336625|P4|COMPLETED|Second Intervention Period (1 Day)||2
8246741|NCT01892189|20336626|P3|COMPLETED|Second Intervention Period (1 Day)||1
8246742|NCT01892189|20336627|P2|COMPLETED|Second Intervention Period (1 Day)||3
8246743|NCT01892189|20336628|P1|COMPLETED|Second Intervention Period (1 Day)||3
8246744|NCT01892189|20336620|P9|STARTED|Second Intervention Period (1 Day)||1
8246745|NCT01892189|20336621|P8|STARTED|Second Intervention Period (1 Day)||3
8246746|NCT01892189|20336622|P7|STARTED|Second Intervention Period (1 Day)||2
8246747|NCT01892189|20336623|P6|STARTED|Second Intervention Period (1 Day)||2
8246748|NCT01892189|20336624|P5|STARTED|Second Intervention Period (1 Day)||3
8246749|NCT01892189|20336625|P4|STARTED|Second Intervention Period (1 Day)||2
8246750|NCT01892189|20336626|P3|STARTED|Second Intervention Period (1 Day)||1
8246751|NCT01892189|20336627|P2|STARTED|Second Intervention Period (1 Day)||3
8246752|NCT01892189|20336628|P1|STARTED|Second Intervention Period (1 Day)||3
8246753|NCT01892189|20336620|P9|NOT COMPLETED|Washout Period 1 (7 Days)||2
8246754|NCT01892189|20336621|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
8246755|NCT01892189|20336622|P7|NOT COMPLETED|Washout Period 1 (7 Days)||1
8246756|NCT01892189|20336623|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
8246757|NCT01892189|20336624|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8246758|NCT01892189|20336625|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
8246759|NCT01892189|20336626|P3|NOT COMPLETED|Washout Period 1 (7 Days)||2
8246760|NCT01892189|20336627|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8246761|NCT01892189|20336628|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8246762|NCT01892189|20336620|P9|COMPLETED|Washout Period 1 (7 Days)||1
8246763|NCT01892189|20336621|P8|COMPLETED|Washout Period 1 (7 Days)||3
8246764|NCT01892189|20336622|P7|COMPLETED|Washout Period 1 (7 Days)||2
8246765|NCT01892189|20336623|P6|COMPLETED|Washout Period 1 (7 Days)||2
8246766|NCT01892189|20336624|P5|COMPLETED|Washout Period 1 (7 Days)||3
8246767|NCT01892189|20336625|P4|COMPLETED|Washout Period 1 (7 Days)||2
8246768|NCT01892189|20336626|P3|COMPLETED|Washout Period 1 (7 Days)||1
8246769|NCT01892189|20336627|P2|COMPLETED|Washout Period 1 (7 Days)||3
8246770|NCT01892189|20336628|P1|COMPLETED|Washout Period 1 (7 Days)||3
8246771|NCT01892189|20336620|P9|STARTED|Washout Period 1 (7 Days)||3
8246772|NCT01892189|20336621|P8|STARTED|Washout Period 1 (7 Days)||3
8246773|NCT01892189|20336622|P7|STARTED|Washout Period 1 (7 Days)||3
8246774|NCT01892189|20336623|P6|STARTED|Washout Period 1 (7 Days)||3
8246775|NCT01892189|20336624|P5|STARTED|Washout Period 1 (7 Days)||3
8246776|NCT01892189|20336625|P4|STARTED|Washout Period 1 (7 Days)||3
8246777|NCT01892189|20336626|P3|STARTED|Washout Period 1 (7 Days)||3
8246778|NCT01892189|20336627|P2|STARTED|Washout Period 1 (7 Days)||3
8246779|NCT01892189|20336628|P1|STARTED|Washout Period 1 (7 Days)||3
8246780|NCT01892189|20336620|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
8246781|NCT01892189|20336621|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
8246782|NCT01892189|20336622|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
8246783|NCT01892189|20336623|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
8246784|NCT01892189|20336624|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
8246785|NCT01892189|20336625|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
8246786|NCT01892189|20336626|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
8246787|NCT01892189|20336627|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
8246788|NCT01892189|20336628|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
8246789|NCT01892189|20336620|P9|COMPLETED|First Intervention Period (1 Day)||3
8246790|NCT01892189|20336621|P8|COMPLETED|First Intervention Period (1 Day)||3
8246791|NCT01892189|20336622|P7|COMPLETED|First Intervention Period (1 Day)||3
8246792|NCT01892189|20336623|P6|COMPLETED|First Intervention Period (1 Day)||3
8246793|NCT01892189|20336624|P5|COMPLETED|First Intervention Period (1 Day)||3
8246794|NCT01892189|20336625|P4|COMPLETED|First Intervention Period (1 Day)||3
8246795|NCT01892189|20336626|P3|COMPLETED|First Intervention Period (1 Day)||3
8246796|NCT01892189|20336627|P2|COMPLETED|First Intervention Period (1 Day)||3
8246797|NCT01892189|20336628|P1|COMPLETED|First Intervention Period (1 Day)||3
8246798|NCT01892189|20336620|P9|STARTED|First Intervention Period (1 Day)||3
8246799|NCT01892189|20336621|P8|STARTED|First Intervention Period (1 Day)||3
8246800|NCT01892189|20336622|P7|STARTED|First Intervention Period (1 Day)||3
8246801|NCT01892189|20336623|P6|STARTED|First Intervention Period (1 Day)||3
8246802|NCT01892189|20336624|P5|STARTED|First Intervention Period (1 Day)||3
8246803|NCT01892189|20336625|P4|STARTED|First Intervention Period (1 Day)||3
8246804|NCT01892189|20336626|P3|STARTED|First Intervention Period (1 Day)||3
8246805|NCT01892189|20336627|P2|STARTED|First Intervention Period (1 Day)||3
8246806|NCT01892189|20336628|P1|STARTED|First Intervention Period (1 Day)||3
8246807|NCT01892163|20336670|P2|NOT COMPLETED|Overall Study||1
8246808|NCT01892163|20336671|P1|NOT COMPLETED|Overall Study||2
8246809|NCT01892163|20336670|P2|COMPLETED|Overall Study||49
8246810|NCT01892163|20336671|P1|COMPLETED|Overall Study||48
8246811|NCT01892163|20336670|P2|STARTED|Overall Study||50
8246812|NCT01892163|20336671|P1|STARTED|Overall Study||50
8246813|NCT01892020|20336683|P2|NOT COMPLETED|Period 2||0
8246814|NCT01892020|20336684|P1|NOT COMPLETED|Period 2||1
8246815|NCT01892020|20336683|P2|COMPLETED|Period 2||74
8246816|NCT01892020|20336684|P1|COMPLETED|Period 2||77
8246817|NCT01892020|20336683|P2|STARTED|Period 2||74
8246818|NCT01892020|20336684|P1|STARTED|Period 2||78
8246819|NCT01892020|20336683|P2|NOT COMPLETED|Period 1||6
8246820|NCT01892020|20336684|P1|NOT COMPLETED|Period 1||3
8246821|NCT01892020|20336683|P2|COMPLETED|Period 1||74
8246822|NCT01892020|20336684|P1|COMPLETED|Period 1||78
8246823|NCT01892020|20336683|P2|STARTED|Period 1||80
8246824|NCT01892020|20336684|P1|STARTED|Period 1||81
8246825|NCT01892007|20336704|P2|NOT COMPLETED|Overall Study||0
8246826|NCT01892007|20336705|P1|NOT COMPLETED|Overall Study||0
8246827|NCT01892007|20336704|P2|COMPLETED|Overall Study||30
8246828|NCT01892007|20336705|P1|COMPLETED|Overall Study||27
8246829|NCT01892007|20336704|P2|STARTED|Overall Study||30
8246830|NCT01892007|20336705|P1|STARTED|Overall Study||27
8246834|NCT01891968|20336735|P1|NOT COMPLETED|Overall Study||0
8246835|NCT01891968|20336735|P1|COMPLETED|Overall Study||15
8246836|NCT01891968|20336735|P1|STARTED|Overall Study||15
8246837|NCT01891890|20336742|P3|NOT COMPLETED|Overall Study||7
8246838|NCT01891890|20336743|P2|NOT COMPLETED|Overall Study||3
8246839|NCT01891890|20336744|P1|NOT COMPLETED|Overall Study||7
8246840|NCT01891890|20336742|P3|COMPLETED|Overall Study||14
8246841|NCT01891890|20336743|P2|COMPLETED|Overall Study||24
8246842|NCT01891890|20336744|P1|COMPLETED|Overall Study||17
8246843|NCT01891890|20336742|P3|STARTED|Overall Study||21
8246844|NCT01891890|20336743|P2|STARTED|Overall Study||27
8246845|NCT01891890|20336744|P1|STARTED|Overall Study||24
8246846|NCT01891864|20336787|P6|NOT COMPLETED|Extension Period||0
8246847|NCT01891864|20336788|P5|NOT COMPLETED|Extension Period||7
8246848|NCT01891864|20336789|P4|NOT COMPLETED|Extension Period||5
8246849|NCT01891864|20336790|P3|NOT COMPLETED|Extension Period||8
8246850|NCT01891864|20336791|P2|NOT COMPLETED|Extension Period||0
8246851|NCT01891864|20336792|P1|NOT COMPLETED|Extension Period||0
8246852|NCT01891864|20336787|P6|COMPLETED|Extension Period||90
8246853|NCT01891864|20336788|P5|COMPLETED|Extension Period||88
8246854|NCT01891864|20336789|P4|COMPLETED|Extension Period||137
8246855|NCT01891864|20336790|P3|COMPLETED|Extension Period||132
8246856|NCT01891864|20336791|P2|COMPLETED|Extension Period||0
8246857|NCT01891864|20336792|P1|COMPLETED|Extension Period||0
8246858|NCT01891864|20336787|P6|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
8246859|NCT01891864|20336788|P5|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
8246860|NCT01891864|20336789|P4|STARTED|Extension Period||142
8246861|NCT01891864|20336790|P3|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
8246862|NCT01891864|20336791|P2|STARTED|Extension Period||0
8246863|NCT01891864|20336792|P1|STARTED|Extension Period||0
8246864|NCT01891864|20336787|P6|NOT COMPLETED|Treatment Period 2||5
8246865|NCT01891864|20336788|P5|NOT COMPLETED|Treatment Period 2||4
8246866|NCT01891864|20336789|P4|NOT COMPLETED|Treatment Period 2||9
8246867|NCT01891864|20336790|P3|NOT COMPLETED|Treatment Period 2||7
8246868|NCT01891864|20336791|P2|NOT COMPLETED|Treatment Period 2||0
8246869|NCT01891864|20336792|P1|NOT COMPLETED|Treatment Period 2||0
8246870|NCT01891864|20336787|P6|COMPLETED|Treatment Period 2||91
8246871|NCT01891864|20336788|P5|COMPLETED|Treatment Period 2||96
8246872|NCT01891864|20336789|P4|COMPLETED|Treatment Period 2||142
8246873|NCT01891864|20336790|P3|COMPLETED|Treatment Period 2||143
8246874|NCT01891864|20336791|P2|COMPLETED|Treatment Period 2||0
8246875|NCT01891864|20336792|P1|COMPLETED|Treatment Period 2||0
8246876|NCT01891864|20336787|P6|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
8246877|NCT01891864|20336788|P5|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
8246878|NCT01891864|20336789|P4|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
8246879|NCT01891864|20336790|P3|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
8246880|NCT01891864|20336791|P2|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
8246881|NCT01891864|20336792|P1|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
8246882|NCT01891864|20336787|P6|NOT COMPLETED|Treatment Period 1||0
8246883|NCT01891864|20336788|P5|NOT COMPLETED|Treatment Period 1||0
8246884|NCT01891864|20336789|P4|NOT COMPLETED|Treatment Period 1||0
8246885|NCT01891864|20336790|P3|NOT COMPLETED|Treatment Period 1||0
8246886|NCT01891864|20336791|P2|NOT COMPLETED|Treatment Period 1||12
8246887|NCT01891864|20336792|P1|NOT COMPLETED|Treatment Period 1||8
8246888|NCT01891864|20336787|P6|COMPLETED|Treatment Period 1||0
8246889|NCT01891864|20336788|P5|COMPLETED|Treatment Period 1||0
8246890|NCT01891864|20336789|P4|COMPLETED|Treatment Period 1||0
8246891|NCT01891864|20336790|P3|COMPLETED|Treatment Period 1||0
8246892|NCT01891864|20336791|P2|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
8246893|NCT01891864|20336792|P1|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
8246894|NCT01891864|20336787|P6|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8246895|NCT01891864|20336788|P5|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8246896|NCT01891864|20336789|P4|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8246897|NCT01891864|20336790|P3|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
8246898|NCT01891864|20336791|P2|STARTED|Treatment Period 1||267
8246899|NCT01891864|20336792|P1|STARTED|Treatment Period 1||264
8246900|NCT01891734|20336814|P2|NOT COMPLETED|Overall Study||3
8246901|NCT01891734|20336815|P1|NOT COMPLETED|Overall Study||3
8246902|NCT01891734|20336814|P2|COMPLETED|Overall Study||13
8246903|NCT01891734|20336815|P1|COMPLETED|Overall Study||14
8246904|NCT01891734|20336814|P2|STARTED|Overall Study||16
8246905|NCT01891734|20336815|P1|STARTED|Overall Study||17
8246906|NCT01891721|20336828|P3|NOT COMPLETED|Overall Study||1
8246907|NCT01891721|20336829|P2|NOT COMPLETED|Overall Study||5
8246908|NCT01891721|20336830|P1|NOT COMPLETED|Overall Study||10
8246909|NCT01891721|20336828|P3|COMPLETED|Overall Study||19
8246910|NCT01891721|20336829|P2|COMPLETED|Overall Study||35
8246911|NCT01891721|20336830|P1|COMPLETED|Overall Study||29
8246912|NCT01891721|20336828|P3|STARTED|Overall Study||20
8246913|NCT01891721|20336829|P2|STARTED|Overall Study||40
8246914|NCT01891721|20336830|P1|STARTED|Overall Study||39
8246915|NCT01891669|20336854|P10|NOT COMPLETED|Overall Study||2
8246916|NCT01891669|20336855|P9|NOT COMPLETED|Overall Study||1
8246917|NCT01891669|20336856|P8|NOT COMPLETED|Overall Study||4
8246918|NCT01891669|20336857|P7|NOT COMPLETED|Overall Study||1
8246919|NCT01891669|20336858|P6|NOT COMPLETED|Overall Study||0
8246920|NCT01891669|20336859|P5|NOT COMPLETED|Overall Study||0
8246921|NCT01891669|20336860|P4|NOT COMPLETED|Overall Study||0
8246922|NCT01891669|20336861|P3|NOT COMPLETED|Overall Study||0
8246923|NCT01891669|20336862|P2|NOT COMPLETED|Overall Study||1
8246924|NCT01891669|20336863|P1|NOT COMPLETED|Overall Study||2
8246925|NCT01891669|20336854|P10|COMPLETED|Overall Study||1
8246926|NCT01891669|20336855|P9|COMPLETED|Overall Study||2
8246927|NCT01891669|20336856|P8|COMPLETED|Overall Study||2
8246928|NCT01891669|20336857|P7|COMPLETED|Overall Study||1
8246929|NCT01891669|20336858|P6|COMPLETED|Overall Study||2
8246930|NCT01891669|20336859|P5|COMPLETED|Overall Study||2
8246931|NCT01891669|20336860|P4|COMPLETED|Overall Study||2
8246932|NCT01891669|20336861|P3|COMPLETED|Overall Study||2
8246933|NCT01891669|20336862|P2|COMPLETED|Overall Study||1
8246934|NCT01891669|20336863|P1|COMPLETED|Overall Study||0
8246935|NCT01891669|20336854|P10|STARTED|Overall Study||3
8246936|NCT01891669|20336855|P9|STARTED|Overall Study||3
8246937|NCT01891669|20336856|P8|STARTED|Overall Study||6
8246938|NCT01891669|20336857|P7|STARTED|Overall Study||2
8246939|NCT01891669|20336858|P6|STARTED|Overall Study||2
8246940|NCT01891669|20336859|P5|STARTED|Overall Study||2
8246941|NCT01891669|20336860|P4|STARTED|Overall Study||2
8246942|NCT01891669|20336861|P3|STARTED|Overall Study||2
8246943|NCT01891669|20336862|P2|STARTED|Overall Study||2
8246944|NCT01891669|20336863|P1|STARTED|Overall Study||2
8246945|NCT01891357|20337014|P1|NOT COMPLETED|Overall Study||3
8246946|NCT01891357|20337014|P1|COMPLETED|Overall Study||61
8246947|NCT01891357|20337014|P1|STARTED|Overall Study||64
8246948|NCT01891331|20337025|P4|NOT COMPLETED|Overall Study||2
8246949|NCT01891331|20337026|P3|NOT COMPLETED|Overall Study||1
8246950|NCT01891331|20337027|P2|NOT COMPLETED|Overall Study||2
8246951|NCT01891331|20337028|P1|NOT COMPLETED|Overall Study||2
8246952|NCT01891331|20337025|P4|COMPLETED|Overall Study||13
8246953|NCT01891331|20337026|P3|COMPLETED|Overall Study||13
8246954|NCT01891331|20337027|P2|COMPLETED|Overall Study||10
8246955|NCT01891331|20337028|P1|COMPLETED|Overall Study||12
8246956|NCT01891331|20337025|P4|STARTED|Overall Study||15
8246957|NCT01891331|20337026|P3|STARTED|Overall Study||14
8246958|NCT01891331|20337027|P2|STARTED|Overall Study||12
8246959|NCT01891331|20337028|P1|STARTED|Overall Study||14
8246960|NCT01891305|20337042|P4|NOT COMPLETED|Overall Study||0
8246961|NCT01891305|20337043|P3|NOT COMPLETED|Overall Study||3
8246962|NCT01891305|20337044|P2|NOT COMPLETED|Overall Study||1
8246963|NCT01891305|20337045|P1|NOT COMPLETED|Overall Study||3
8246964|NCT01891305|20337042|P4|COMPLETED|Overall Study||12
8246965|NCT01891305|20337043|P3|COMPLETED|Overall Study||11
8246966|NCT01891305|20337044|P2|COMPLETED|Overall Study||11
8246967|NCT01891305|20337045|P1|COMPLETED|Overall Study||9
8246968|NCT01891305|20337042|P4|STARTED|Overall Study||12
8246969|NCT01891305|20337043|P3|STARTED|Overall Study||14
8246970|NCT01891305|20337044|P2|STARTED|Overall Study||12
8246971|NCT01891305|20337045|P1|STARTED|Overall Study||12
8246972|NCT01890967|20337061|P6|NOT COMPLETED|Overall Study||13
8246973|NCT01890967|20337062|P5|NOT COMPLETED|Overall Study||10
8246974|NCT01890967|20337063|P4|NOT COMPLETED|Overall Study||11
8246975|NCT01890967|20337064|P3|NOT COMPLETED|Overall Study||10
8246976|NCT01890967|20337065|P2|NOT COMPLETED|Overall Study||11
8246977|NCT01890967|20337066|P1|NOT COMPLETED|Overall Study||10
8246978|NCT01890967|20337061|P6|COMPLETED|Overall Study||75
8246979|NCT01890967|20337062|P5|COMPLETED|Overall Study||77
8246980|NCT01890967|20337063|P4|COMPLETED|Overall Study||77
8246981|NCT01890967|20337064|P3|COMPLETED|Overall Study||78
8246982|NCT01890967|20337065|P2|COMPLETED|Overall Study||77
8246983|NCT01890967|20337066|P1|COMPLETED|Overall Study||78
8246984|NCT01890967|20337061|P6|Received at Least One Dose of Study Drug|Overall Study||87
8246985|NCT01890967|20337062|P5|Received at Least One Dose of Study Drug|Overall Study||86
8246986|NCT01890967|20337063|P4|Received at Least One Dose of Study Drug|Overall Study||86
8246987|NCT01890967|20337064|P3|Received at Least One Dose of Study Drug|Overall Study||86
8246988|NCT01890967|20337065|P2|Received at Least One Dose of Study Drug|Overall Study||87
8246989|NCT01890967|20337066|P1|Received at Least One Dose of Study Drug|Overall Study||87
8246990|NCT01890967|20337061|P6|STARTED|Overall Study||88
8246991|NCT01890967|20337062|P5|STARTED|Overall Study||87
8246992|NCT01890967|20337063|P4|STARTED|Overall Study||88
8246993|NCT01890967|20337064|P3|STARTED|Overall Study||88
8246994|NCT01890967|20337065|P2|STARTED|Overall Study||88
8246995|NCT01890967|20337066|P1|STARTED|Overall Study||88
8246996|NCT01890954|20337135|P2|NOT COMPLETED|Overall Study||0
8246997|NCT01890954|20337136|P1|NOT COMPLETED|Overall Study||1
8246998|NCT01890954|20337135|P2|COMPLETED|Overall Study||8
8246999|NCT01890954|20337136|P1|COMPLETED|Overall Study||8
8247000|NCT01890954|20337135|P2|STARTED|Overall Study||8
8247001|NCT01890954|20337136|P1|STARTED|Overall Study||9
8247002|NCT01890915|20337144|P2|NOT COMPLETED|Overall Study||1
8247003|NCT01890915|20337145|P1|NOT COMPLETED|Overall Study||3
8247004|NCT01890915|20337144|P2|COMPLETED|Overall Study||9
8247005|NCT01890915|20337145|P1|COMPLETED|Overall Study||8
8247006|NCT01890915|20337144|P2|STARTED|Overall Study||10
8247007|NCT01890915|20337145|P1|STARTED|Overall Study||11
8247062|NCT01890759|20337185|P2|NOT COMPLETED|Overall Study||12
8247063|NCT01890759|20337186|P1|NOT COMPLETED|Overall Study||2
8247064|NCT01890759|20337185|P2|COMPLETED|Overall Study||188
8247065|NCT01890759|20337186|P1|COMPLETED|Overall Study||98
8247066|NCT01890759|20337185|P2|STARTED|Overall Study||200
8247067|NCT01890759|20337186|P1|STARTED|Overall Study||100
8247068|NCT01890746|20337220|P2|NOT COMPLETED|Overall Study||41
8247069|NCT01890746|20337221|P1|NOT COMPLETED|Overall Study||52
8247070|NCT01890746|20337220|P2|COMPLETED|Overall Study||33
8247071|NCT01890746|20337221|P1|COMPLETED|Overall Study||22
8247072|NCT01890746|20337220|P2|STARTED|Overall Study||74
8247073|NCT01890746|20337221|P1|STARTED|Overall Study||74
8247074|NCT01890707|20337307|P2|NOT COMPLETED|Overall Study||1
8247075|NCT01890707|20337308|P1|NOT COMPLETED|Overall Study||1
8247076|NCT01890707|20337307|P2|COMPLETED|Overall Study||7
8247077|NCT01890707|20337308|P1|COMPLETED|Overall Study||10
8247078|NCT01890707|20337307|P2|STARTED|Overall Study||8
8247079|NCT01890707|20337308|P1|STARTED|Overall Study||11
8247080|NCT01890694|20337316|P2|NOT COMPLETED|Overall Study||1
8247081|NCT01890694|20337317|P1|NOT COMPLETED|Overall Study||1
8247082|NCT01890694|20337316|P2|COMPLETED|Overall Study||0
8247083|NCT01890694|20337317|P1|COMPLETED|Overall Study||0
8247084|NCT01890694|20337316|P2|STARTED|Overall Study||1
8247085|NCT01890694|20337317|P1|STARTED|Overall Study||1
8247086|NCT01890642|20337352|P3|NOT COMPLETED|Overall Study||0
8247087|NCT01890642|20337353|P2|NOT COMPLETED|Overall Study||0
8247088|NCT01890642|20337354|P1|NOT COMPLETED|Overall Study||0
8247089|NCT01890642|20337352|P3|COMPLETED|Overall Study||96
8247090|NCT01890642|20337353|P2|COMPLETED|Overall Study||53
8247091|NCT01890642|20337354|P1|COMPLETED|Overall Study||56
8247092|NCT01890642|20337352|P3|STARTED|Overall Study||96
8247093|NCT01890642|20337353|P2|STARTED|Overall Study||53
8247094|NCT01890642|20337354|P1|STARTED|Overall Study||56
8247095|NCT01890577|20337374|P1|NOT COMPLETED|Overall Study||28
8247096|NCT01890577|20337374|P1|COMPLETED|Overall Study||0
8247097|NCT01890577|20337374|P1|STARTED|Overall Study||28
8247098|NCT01890512|20337387|P1|NOT COMPLETED|Overall Study||3
8247099|NCT01890512|20337387|P1|COMPLETED|Overall Study||17
8247100|NCT01890512|20337387|P1|STARTED|Overall Study||20
8247101|NCT01890473|20337393|P2|NOT COMPLETED|Overall Study||0
8247102|NCT01890473|20337394|P1|NOT COMPLETED|Overall Study||2
8247103|NCT01890473|20337393|P2|COMPLETED|Overall Study||113
8247104|NCT01890473|20337394|P1|COMPLETED|Overall Study||109
8247105|NCT01890473|20337393|P2|STARTED|Overall Study||113
8247106|NCT01890473|20337394|P1|STARTED|Overall Study||111
8247107|NCT01890434|20337420|P1|NOT COMPLETED|Overall Study||20
8247108|NCT01890434|20337420|P1|COMPLETED|Overall Study||458
8247109|NCT01890434|20337420|P1|Evaluated for Efficacy|Overall Study||389
8247110|NCT01890434|20337420|P1|STARTED|Overall Study||478
8247111|NCT01890421|20337450|P1|NOT COMPLETED|Overall Study||11
8247112|NCT01890421|20337450|P1|COMPLETED|Overall Study||415
8247113|NCT01890421|20337450|P1|STARTED|Overall Study||426
8247114|NCT01890343|20337476|P3|NOT COMPLETED|Overall Study||0
8247115|NCT01890343|20337477|P2|NOT COMPLETED|Overall Study||0
8247116|NCT01890343|20337478|P1|NOT COMPLETED|Overall Study||0
8247117|NCT01890343|20337476|P3|COMPLETED|Overall Study||10
8247118|NCT01890343|20337477|P2|COMPLETED|Overall Study||10
8247119|NCT01890343|20337478|P1|COMPLETED|Overall Study||8
8247120|NCT01890343|20337476|P3|STARTED|Overall Study||10
8247121|NCT01890343|20337477|P2|STARTED|Overall Study||10
8247122|NCT01890343|20337478|P1|STARTED|Overall Study||8
8247123|NCT01890265|20337495|P6|NOT COMPLETED|Overall Study||0
8247124|NCT01890265|20337496|P5|NOT COMPLETED|Overall Study||2
8247125|NCT01890265|20337497|P4|NOT COMPLETED|Overall Study||0
8247126|NCT01890265|20337498|P3|NOT COMPLETED|Overall Study||4
8247127|NCT01890265|20337499|P2|NOT COMPLETED|Overall Study||13
8247128|NCT01890265|20337500|P1|NOT COMPLETED|Overall Study||10
8247129|NCT01890265|20337495|P6|COMPLETED|Overall Study||6
8247130|NCT01890265|20337496|P5|COMPLETED|Overall Study||13
8247131|NCT01890265|20337497|P4|COMPLETED|Overall Study||12
8247132|NCT01890265|20337498|P3|COMPLETED|Overall Study||20
8247133|NCT01890265|20337499|P2|COMPLETED|Overall Study||40
8247134|NCT01890265|20337500|P1|COMPLETED|Overall Study||40
8247135|NCT01890265|20337495|P6|Intent-to-Treat (ITT) Population|Overall Study||6
8247136|NCT01890265|20337496|P5|Intent-to-Treat (ITT) Population|Overall Study||15
8247137|NCT01890265|20337497|P4|Intent-to-Treat (ITT) Population|Overall Study||12
8247138|NCT01890265|20337498|P3|Intent-to-Treat (ITT) Population|Overall Study||24
8247139|NCT01890265|20337499|P2|Intent-to-Treat (ITT) Population|Overall Study||51
8247140|NCT01890265|20337500|P1|Intent-to-Treat (ITT) Population|Overall Study||50
8247141|NCT01890265|20337495|P6|Safety Population|Overall Study||6
8247142|NCT01890265|20337496|P5|Safety Population|Overall Study||15
8247143|NCT01890265|20337497|P4|Safety Population|Overall Study||12
8247144|NCT01890265|20337498|P3|Safety Population|Overall Study||24
8247145|NCT01890265|20337499|P2|Safety Population|Overall Study||53
8247146|NCT01890265|20337500|P1|Safety Population|Overall Study||50
8247147|NCT01890265|20337495|P6|STARTED|Overall Study||6
8247148|NCT01890265|20337496|P5|STARTED|Overall Study||15
8247149|NCT01890265|20337497|P4|STARTED|Overall Study||12
8247150|NCT01890265|20337498|P3|STARTED|Overall Study||24
8247151|NCT01890265|20337499|P2|STARTED|Overall Study||53
8247152|NCT01890265|20337500|P1|STARTED|Overall Study||50
8247153|NCT01890226|20337524|P2|NOT COMPLETED|Overall Study||0
8247154|NCT01890226|20337525|P1|NOT COMPLETED|Overall Study||0
8247155|NCT01890226|20337524|P2|COMPLETED|Overall Study||156
8247156|NCT01890226|20337525|P1|COMPLETED|Overall Study||155
8247157|NCT01890226|20337524|P2|STARTED|Overall Study||156
8247158|NCT01890226|20337525|P1|STARTED|Overall Study||155
8247159|NCT01890148|20337537|P1|NOT COMPLETED|Overall Study||1
8247160|NCT01890148|20337537|P1|COMPLETED|Overall Study||4
8247161|NCT01890148|20337537|P1|STARTED|Overall Study||5
8247162|NCT01890122|20337557|P4|NOT COMPLETED|Overall Study||59
8247163|NCT01890122|20337558|P3|NOT COMPLETED|Overall Study||13
8247164|NCT01890122|20337559|P2|NOT COMPLETED|Overall Study||37
8247165|NCT01890122|20337560|P1|NOT COMPLETED|Overall Study||27
8247166|NCT01890122|20337557|P4|COMPLETED|Overall Study||104
8247167|NCT01890122|20337558|P3|COMPLETED|Overall Study||146
8247168|NCT01890122|20337559|P2|COMPLETED|Overall Study||126
8247169|NCT01890122|20337560|P1|COMPLETED|Overall Study||135
8247170|NCT01890122|20337557|P4|Treated|Overall Study||163
8247171|NCT01890122|20337558|P3|Treated|Overall Study||159
8247172|NCT01890122|20337559|P2|Treated|Overall Study||162
8247173|NCT01890122|20337560|P1|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
8247174|NCT01890122|20337557|P4|STARTED|Overall Study||163
8247175|NCT01890122|20337558|P3|STARTED|Overall Study||159
8247176|NCT01890122|20337559|P2|STARTED|Overall Study||163
8247177|NCT01890122|20337560|P1|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
8247178|NCT01890109|20337624|P2|NOT COMPLETED|Overall Study||5
8247179|NCT01890109|20337625|P1|NOT COMPLETED|Overall Study||1
8247180|NCT01890109|20337624|P2|COMPLETED|Overall Study||46
8247181|NCT01890109|20337625|P1|COMPLETED|Overall Study||51
8247182|NCT01890109|20337624|P2|Received Study Treatment|Overall Study||50
8247183|NCT01890109|20337625|P1|Received Study Treatment|Overall Study||52
8247184|NCT01890109|20337624|P2|STARTED|Overall Study||51
8247185|NCT01890109|20337625|P1|STARTED|Overall Study||52
8247186|NCT01890031|20337649|P5|NOT COMPLETED|Overall Study||0
8247187|NCT01890031|20337650|P4|NOT COMPLETED|Overall Study||0
8247188|NCT01890031|20337651|P3|NOT COMPLETED|Overall Study||0
8247189|NCT01890031|20337652|P2|NOT COMPLETED|Overall Study||0
8247190|NCT01890031|20337653|P1|NOT COMPLETED|Overall Study||0
8247191|NCT01890031|20337649|P5|COMPLETED|Overall Study||8
8247192|NCT01890031|20337650|P4|COMPLETED|Overall Study||11
8247193|NCT01890031|20337651|P3|COMPLETED|Overall Study||12
8247194|NCT01890031|20337652|P2|COMPLETED|Overall Study||50
8247195|NCT01890031|20337653|P1|COMPLETED|Overall Study||50
8247196|NCT01890031|20337649|P5|STARTED|Overall Study||8
8247197|NCT01890031|20337650|P4|STARTED|Overall Study||11
8247198|NCT01890031|20337651|P3|STARTED|Overall Study||12
8247199|NCT01890031|20337652|P2|STARTED|Overall Study||50
8247200|NCT01890031|20337653|P1|STARTED|Overall Study||50
8247213|NCT01889797|20337689|P2|NOT COMPLETED|Overall Study||0
8247214|NCT01889797|20337690|P1|NOT COMPLETED|Overall Study||0
8247215|NCT01889797|20337689|P2|COMPLETED|Overall Study||16
8247216|NCT01889797|20337690|P1|COMPLETED|Overall Study||16
8247217|NCT01889797|20337689|P2|STARTED|Overall Study||16
8247218|NCT01889797|20337690|P1|STARTED|Overall Study||16
8247219|NCT01889667|20337705|P3|NOT COMPLETED|Overall Study||0
8247220|NCT01889667|20337706|P2|NOT COMPLETED|Overall Study||0
8247221|NCT01889667|20337707|P1|NOT COMPLETED|Overall Study||0
8247222|NCT01889667|20337705|P3|COMPLETED|Overall Study||10
8247223|NCT01889667|20337706|P2|COMPLETED|Overall Study||10
8247224|NCT01889667|20337707|P1|COMPLETED|Overall Study||10
8247225|NCT01889667|20337705|P3|STARTED|Overall Study||10
8247226|NCT01889667|20337706|P2|STARTED|Overall Study||10
8247227|NCT01889667|20337707|P1|STARTED|Overall Study||10
8247228|NCT01889602|20337730|P3|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
8247229|NCT01889602|20337731|P2|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
8247230|NCT01889602|20337732|P1|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
8247231|NCT01889602|20337730|P3|COMPLETED|Third Washout Period of at Least 2 Weeks||16
8247232|NCT01889602|20337731|P2|COMPLETED|Third Washout Period of at Least 2 Weeks||15
8247233|NCT01889602|20337732|P1|COMPLETED|Third Washout Period of at Least 2 Weeks||15
8247234|NCT01889602|20337730|P3|STARTED|Third Washout Period of at Least 2 Weeks||16
8247235|NCT01889602|20337731|P2|STARTED|Third Washout Period of at Least 2 Weeks||15
8247236|NCT01889602|20337732|P1|STARTED|Third Washout Period of at Least 2 Weeks||15
8247237|NCT01889602|20337730|P3|NOT COMPLETED|Third Intervention||0
8247238|NCT01889602|20337731|P2|NOT COMPLETED|Third Intervention||2
8247239|NCT01889602|20337732|P1|NOT COMPLETED|Third Intervention||3
8247240|NCT01889602|20337730|P3|COMPLETED|Third Intervention||16
8247241|NCT01889602|20337731|P2|COMPLETED|Third Intervention||15
8247242|NCT01889602|20337732|P1|COMPLETED|Third Intervention||15
8247243|NCT01889602|20337730|P3|STARTED|Third Intervention||16
8247244|NCT01889602|20337731|P2|STARTED|Third Intervention||17
8247245|NCT01889602|20337732|P1|STARTED|Third Intervention||18
8247246|NCT01889602|20337730|P3|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
8247247|NCT01889602|20337731|P2|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
8247248|NCT01889602|20337732|P1|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
8247249|NCT01889602|20337730|P3|COMPLETED|Second Washout Period of at Least 2 Week||16
8247250|NCT01889602|20337731|P2|COMPLETED|Second Washout Period of at Least 2 Week||17
8247251|NCT01889602|20337732|P1|COMPLETED|Second Washout Period of at Least 2 Week||18
8247252|NCT01889602|20337730|P3|STARTED|Second Washout Period of at Least 2 Week||16
8247253|NCT01889602|20337731|P2|STARTED|Second Washout Period of at Least 2 Week||17
8247254|NCT01889602|20337732|P1|STARTED|Second Washout Period of at Least 2 Week||18
8247255|NCT01889602|20337730|P3|NOT COMPLETED|Second Intervention||2
8247256|NCT01889602|20337731|P2|NOT COMPLETED|Second Intervention||0
8247257|NCT01889602|20337732|P1|NOT COMPLETED|Second Intervention||1
8247258|NCT01889602|20337730|P3|COMPLETED|Second Intervention||16
8247259|NCT01889602|20337731|P2|COMPLETED|Second Intervention||17
8247260|NCT01889602|20337732|P1|COMPLETED|Second Intervention||18
8247261|NCT01889602|20337730|P3|STARTED|Second Intervention||18
8247262|NCT01889602|20337731|P2|STARTED|Second Intervention||17
8247263|NCT01889602|20337732|P1|STARTED|Second Intervention||19
8247264|NCT01889602|20337730|P3|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
8247265|NCT01889602|20337731|P2|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
8247266|NCT01889602|20337732|P1|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
8247267|NCT01889602|20337730|P3|COMPLETED|First Washout Period of at Least 2 Weeks||18
8247268|NCT01889602|20337731|P2|COMPLETED|First Washout Period of at Least 2 Weeks||17
8247269|NCT01889602|20337732|P1|COMPLETED|First Washout Period of at Least 2 Weeks||19
8247270|NCT01889602|20337730|P3|STARTED|First Washout Period of at Least 2 Weeks||18
8247271|NCT01889602|20337731|P2|STARTED|First Washout Period of at Least 2 Weeks||17
8247272|NCT01889602|20337732|P1|STARTED|First Washout Period of at Least 2 Weeks||19
8247273|NCT01889602|20337730|P3|NOT COMPLETED|First Intervention||2
8247274|NCT01889602|20337731|P2|NOT COMPLETED|First Intervention||3
8247275|NCT01889602|20337732|P1|NOT COMPLETED|First Intervention||1
8247276|NCT01889602|20337730|P3|COMPLETED|First Intervention||18
8247277|NCT01889602|20337731|P2|COMPLETED|First Intervention||17
8247278|NCT01889602|20337732|P1|COMPLETED|First Intervention||19
8247279|NCT01889602|20337730|P3|STARTED|First Intervention||20
8247280|NCT01889602|20337731|P2|STARTED|First Intervention||20
8247281|NCT01889602|20337732|P1|STARTED|First Intervention||20
8247282|NCT01889563|20337759|P2|NOT COMPLETED|Overall Study||5
8247283|NCT01889563|20337760|P1|NOT COMPLETED|Overall Study||7
8247284|NCT01889563|20337759|P2|COMPLETED|Overall Study||10
8247285|NCT01889563|20337760|P1|COMPLETED|Overall Study||10
8247286|NCT01889563|20337759|P2|STARTED|Overall Study||15
8247287|NCT01889563|20337760|P1|STARTED|Overall Study||17
8247288|NCT01889420|20337768|P1|NOT COMPLETED|Overall Study||0
8247289|NCT01889420|20337768|P1|COMPLETED|Overall Study||1
8247290|NCT01889420|20337768|P1|STARTED|Overall Study||1
8247291|NCT01889355|20337774|P1|NOT COMPLETED|Overall Study||2
8247292|NCT01889355|20337774|P1|COMPLETED|Overall Study||113
8247293|NCT01889355|20337774|P1|STARTED|Overall Study||115
8247294|NCT01889251|20337780|P2|NOT COMPLETED|Overall Study||0
8247295|NCT01889251|20337781|P1|NOT COMPLETED|Overall Study||1
8247296|NCT01889251|20337780|P2|COMPLETED|Overall Study||57
8247297|NCT01889251|20337781|P1|COMPLETED|Overall Study||114
8247298|NCT01889251|20337780|P2|STARTED|Overall Study||57
8247299|NCT01889251|20337781|P1|STARTED|Overall Study||115
8247300|NCT01889238|20337787|P1|NOT COMPLETED|Overall Study||9
8247301|NCT01889238|20337787|P1|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
8247302|NCT01889238|20337787|P1|STARTED|Overall Study||118
8247303|NCT01889069|20337806|P1|NOT COMPLETED|Overall Study||45
8247304|NCT01889069|20337806|P1|COMPLETED|Overall Study||113
8247305|NCT01889069|20337806|P1|STARTED|Overall Study||158
8247306|NCT01888965|20337851|P1|NOT COMPLETED|Overall Study||9
8247307|NCT01888965|20337851|P1|COMPLETED|Overall Study||0
8247308|NCT01888965|20337851|P1|STARTED|Overall Study||9
8247309|NCT01888952|20337857|P1|NOT COMPLETED|Overall Study||0
8247310|NCT01888952|20337857|P1|COMPLETED|Overall Study||10
8247311|NCT01888952|20337857|P1|STARTED|Overall Study||10
8247312|NCT01888900|20337863|P2|NOT COMPLETED|Overall Study||2
8247313|NCT01888900|20337864|P1|NOT COMPLETED|Overall Study||0
8247314|NCT01888900|20337863|P2|COMPLETED|Overall Study||11
8247315|NCT01888900|20337864|P1|COMPLETED|Overall Study||22
8247316|NCT01888900|20337863|P2|STARTED|Overall Study||13
8247317|NCT01888900|20337864|P1|STARTED|Overall Study||22
8247318|NCT01888874|20337891|P7|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
8247319|NCT01888874|20337892|P6|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
8247320|NCT01888874|20337893|P5|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
8247321|NCT01888874|20337894|P4|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
8247322|NCT01888874|20337895|P3|NOT COMPLETED|Period 2 (Week 13 to Week 24)||8
8247323|NCT01888874|20337896|P2|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
8247324|NCT01888874|20337897|P1|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
8247325|NCT01888874|20337891|P7|COMPLETED|Period 2 (Week 13 to Week 24)||80
8247326|NCT01888874|20337892|P6|COMPLETED|Period 2 (Week 13 to Week 24)||109
8247327|NCT01888874|20337893|P5|COMPLETED|Period 2 (Week 13 to Week 24)||57
8247328|NCT01888874|20337894|P4|COMPLETED|Period 2 (Week 13 to Week 24)||78
8247329|NCT01888874|20337895|P3|COMPLETED|Period 2 (Week 13 to Week 24)||104
8247330|NCT01888874|20337896|P2|COMPLETED|Period 2 (Week 13 to Week 24)||55
8247331|NCT01888874|20337897|P1|COMPLETED|Period 2 (Week 13 to Week 24)||50
8247332|NCT01888874|20337891|P7|STARTED|Period 2 (Week 13 to Week 24)||83
8247333|NCT01888874|20337892|P6|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 25 mg BID(17 participants) moved to 50 mg BID group.|112
8247334|NCT01888874|20337893|P5|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 25 mg BID group moved to 50 mg BID group (17 participants).|60
8247335|NCT01888874|20337894|P4|STARTED|Period 2 (Week 13 to Week 24)||80
8247336|NCT01888874|20337895|P3|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 50 mg QD (19 participants) moved to 100 mg QD group.|112
8247337|NCT01888874|20337896|P2|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (19 participants).|57
8247338|NCT01888874|20337897|P1|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo group moved to 100 mg QD(15 participants) and 50 mg BID(15 participants).|53
8247339|NCT01888874|20337891|P7|NOT COMPLETED|Period 1 (Baseline up to Week 12)||1
8247340|NCT01888874|20337892|P6|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
8247341|NCT01888874|20337893|P5|NOT COMPLETED|Period 1 (Baseline up to Week 12)||9
8247342|NCT01888874|20337894|P4|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
8247343|NCT01888874|20337895|P3|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
8247344|NCT01888874|20337896|P2|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
8247345|NCT01888874|20337897|P1|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
8247346|NCT01888874|20337891|P7|COMPLETED|Period 1 (Baseline up to Week 12)||83
8247347|NCT01888874|20337892|P6|COMPLETED|Period 1 (Baseline up to Week 12)||80
8247348|NCT01888874|20337893|P5|COMPLETED|Period 1 (Baseline up to Week 12)||77
8247349|NCT01888874|20337894|P4|COMPLETED|Period 1 (Baseline up to Week 12)||80
8247350|NCT01888874|20337895|P3|COMPLETED|Period 1 (Baseline up to Week 12)||78
8247351|NCT01888874|20337896|P2|COMPLETED|Period 1 (Baseline up to Week 12)||76
8247352|NCT01888874|20337897|P1|COMPLETED|Period 1 (Baseline up to Week 12)||83
8247353|NCT01888874|20337891|P7|STARTED|Period 1 (Baseline up to Week 12)||84
8247354|NCT01888874|20337892|P6|STARTED|Period 1 (Baseline up to Week 12)||85
8247355|NCT01888874|20337893|P5|STARTED|Period 1 (Baseline up to Week 12)||86
8247356|NCT01888874|20337894|P4|STARTED|Period 1 (Baseline up to Week 12)||86
8247357|NCT01888874|20337895|P3|STARTED|Period 1 (Baseline up to Week 12)||85
8247358|NCT01888874|20337896|P2|STARTED|Period 1 (Baseline up to Week 12)||82
8247359|NCT01888874|20337897|P1|STARTED|Period 1 (Baseline up to Week 12)||86
8247360|NCT01888640|20337986|P3|NOT COMPLETED|Overall Study||5
8247361|NCT01888640|20337987|P2|NOT COMPLETED|Overall Study||31
8247362|NCT01888640|20337988|P1|NOT COMPLETED|Overall Study||27
8247363|NCT01888640|20337986|P3|COMPLETED|Overall Study||94
8247364|NCT01888640|20337987|P2|COMPLETED|Overall Study||68
8247365|NCT01888640|20337988|P1|COMPLETED|Overall Study||76
8247366|NCT01888640|20337986|P3|STARTED|Overall Study||99
8247367|NCT01888640|20337987|P2|STARTED|Overall Study||99
8247368|NCT01888640|20337988|P1|STARTED|Overall Study||103
8247369|NCT01888432|20338044|P2|NOT COMPLETED|36-month Analysis (Extension)||0
8247370|NCT01888432|20338045|P1|NOT COMPLETED|36-month Analysis (Extension)||1
8247371|NCT01888432|20338044|P2|COMPLETED|36-month Analysis (Extension)||5
8247372|NCT01888432|20338045|P1|COMPLETED|36-month Analysis (Extension)||12
8247373|NCT01888432|20338044|P2|STARTED|36-month Analysis (Extension)||5
8247374|NCT01888432|20338045|P1|STARTED|36-month Analysis (Extension)||13
8247375|NCT01888432|20338044|P2|NOT COMPLETED|24-month Analysis (FAS)||17
8247376|NCT01888432|20338045|P1|NOT COMPLETED|24-month Analysis (FAS)||17
8247377|NCT01888432|20338044|P2|COMPLETED|24-month Analysis (FAS)||125
8247378|NCT01888432|20338045|P1|COMPLETED|24-month Analysis (FAS)||125
8247379|NCT01888432|20338044|P2|STARTED|24-month Analysis (FAS)||142
8247380|NCT01888432|20338045|P1|STARTED|24-month Analysis (FAS)||142
8247381|NCT01888432|20338044|P2|NOT COMPLETED|12-month Analysis (FAS)||9
8247382|NCT01888432|20338045|P1|NOT COMPLETED|12-month Analysis (FAS)||11
8247383|NCT01888432|20338044|P2|COMPLETED|12-month Analysis (FAS)||133
8247384|NCT01888432|20338045|P1|COMPLETED|12-month Analysis (FAS)||131
8247385|NCT01888432|20338044|P2|STARTED|12-month Analysis (FAS)||142
8247386|NCT01888432|20338045|P1|STARTED|12-month Analysis (FAS)||142
8247387|NCT01888367|20338086|P3|NOT COMPLETED|Overall Study||5
8247388|NCT01888367|20338087|P2|NOT COMPLETED|Overall Study||5
8247389|NCT01888367|20338088|P1|NOT COMPLETED|Overall Study||8
8247390|NCT01888367|20338086|P3|COMPLETED|Overall Study||73
8247391|NCT01888367|20338087|P2|COMPLETED|Overall Study||66
8247392|NCT01888367|20338088|P1|COMPLETED|Overall Study||288
8247393|NCT01888367|20338086|P3|STARTED|Overall Study||78
8247394|NCT01888367|20338087|P2|STARTED|Overall Study||71
8247395|NCT01888367|20338088|P1|STARTED|Overall Study||296
8247396|NCT01888003|20338108|P3|NOT COMPLETED|Overall Study||40
8247397|NCT01888003|20338109|P2|NOT COMPLETED|Overall Study||6
8247398|NCT01888003|20338110|P1|NOT COMPLETED|Overall Study||5
8247399|NCT01888003|20338108|P3|COMPLETED|Overall Study||0
8247400|NCT01888003|20338109|P2|COMPLETED|Overall Study||0
8247401|NCT01888003|20338110|P1|COMPLETED|Overall Study||0
8247402|NCT01888003|20338108|P3|STARTED|Overall Study||40
8247403|NCT01888003|20338109|P2|STARTED|Overall Study||6
8247404|NCT01888003|20338110|P1|STARTED|Overall Study||5
8247405|NCT01887990|20338131|P4|NOT COMPLETED|Overall Study||0
8247406|NCT01887990|20338132|P3|NOT COMPLETED|Overall Study||0
8247407|NCT01887990|20338133|P2|NOT COMPLETED|Overall Study||0
8247408|NCT01887990|20338134|P1|NOT COMPLETED|Overall Study||0
8247409|NCT01887990|20338131|P4|COMPLETED|Overall Study||2
8247410|NCT01887990|20338132|P3|COMPLETED|Overall Study||2
8247411|NCT01887990|20338133|P2|COMPLETED|Overall Study||7
8247412|NCT01887990|20338134|P1|COMPLETED|Overall Study||7
8247413|NCT01887990|20338131|P4|STARTED|Overall Study||2
8247414|NCT01887990|20338132|P3|STARTED|Overall Study||2
8247415|NCT01887990|20338133|P2|STARTED|Overall Study||7
8247416|NCT01887990|20338134|P1|STARTED|Overall Study||7
8247417|NCT01887912|20338150|P2|NOT COMPLETED|Overall Study||731
8247418|NCT01887912|20338151|P1|NOT COMPLETED|Overall Study||1392
8247419|NCT01887912|20338150|P2|COMPLETED|Overall Study||2370
8247420|NCT01887912|20338151|P1|COMPLETED|Overall Study||4809
8247421|NCT01887912|20338150|P2|Safety Population|Overall Study||3057
8247422|NCT01887912|20338151|P1|Safety Population|Overall Study||6113
8247423|NCT01887912|20338150|P2|STARTED|Overall Study||3101
8247424|NCT01887912|20338151|P1|STARTED|Overall Study||6201
8247433|NCT01887678|20338202|P2|NOT COMPLETED|Overall Study||28
8247434|NCT01887678|20338203|P1|NOT COMPLETED|Overall Study||17
8247435|NCT01887678|20338202|P2|COMPLETED|Overall Study||85
8247436|NCT01887678|20338203|P1|COMPLETED|Overall Study||102
8247437|NCT01887678|20338202|P2|STARTED|Overall Study||113
8247438|NCT01887678|20338203|P1|STARTED|Overall Study||119
8247447|NCT01887587|20338358|P1|NOT COMPLETED|Overall Study||0
8247448|NCT01887587|20338358|P1|COMPLETED|Overall Study||5
8247449|NCT01887587|20338358|P1|STARTED|Overall Study||5
8247450|NCT01887470|20338367|P4|NOT COMPLETED|Overall Study||0
8247451|NCT01887470|20338368|P3|NOT COMPLETED|Overall Study||0
8247452|NCT01887470|20338369|P2|NOT COMPLETED|Overall Study||0
8247453|NCT01887470|20338370|P1|NOT COMPLETED|Overall Study||0
8247454|NCT01887470|20338367|P4|COMPLETED|Overall Study||10
8247455|NCT01887470|20338368|P3|COMPLETED|Overall Study||10
8247456|NCT01887470|20338369|P2|COMPLETED|Overall Study||10
8247457|NCT01887470|20338370|P1|COMPLETED|Overall Study||10
8247458|NCT01887470|20338367|P4|STARTED|Overall Study||10
8247459|NCT01887470|20338368|P3|STARTED|Overall Study||10
8247460|NCT01887470|20338369|P2|STARTED|Overall Study||10
8247461|NCT01887470|20338370|P1|STARTED|Overall Study||10
8247462|NCT01887418|20338389|P3|NOT COMPLETED|Overall Study||1
8247463|NCT01887418|20338390|P2|NOT COMPLETED|Overall Study||0
8247464|NCT01887418|20338391|P1|NOT COMPLETED|Overall Study||0
8247465|NCT01887418|20338389|P3|COMPLETED|Overall Study||9
8247466|NCT01887418|20338390|P2|COMPLETED|Overall Study||14
8247467|NCT01887418|20338391|P1|COMPLETED|Overall Study||15
8247468|NCT01887418|20338389|P3|STARTED|Overall Study||10
8247469|NCT01887418|20338390|P2|STARTED|Overall Study||14
8247470|NCT01887418|20338391|P1|STARTED|Overall Study||15
8247471|NCT01887353|20338410|P2|NOT COMPLETED|Overall Study||3
8247472|NCT01887353|20338411|P1|NOT COMPLETED|Overall Study||4
8247473|NCT01887353|20338410|P2|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
8247474|NCT01887353|20338411|P1|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
8247475|NCT01887353|20338410|P2|STARTED|Overall Study||4
8247476|NCT01887353|20338411|P1|STARTED|Overall Study||4
8247477|NCT01887327|20338420|P3|NOT COMPLETED|Overall Study||3
8247478|NCT01887327|20338421|P2|NOT COMPLETED|Overall Study||4
8247479|NCT01887327|20338422|P1|NOT COMPLETED|Overall Study||1
8247480|NCT01887327|20338420|P3|COMPLETED|Overall Study||27
8247481|NCT01887327|20338421|P2|COMPLETED|Overall Study||27
8247482|NCT01887327|20338422|P1|COMPLETED|Overall Study||29
8247483|NCT01887327|20338420|P3|STARTED|Overall Study||30
8247484|NCT01887327|20338421|P2|STARTED|Overall Study||31
8247485|NCT01887327|20338422|P1|STARTED|Overall Study||30
8247486|NCT01887288|20338439|P1|NOT COMPLETED|Overall Study||16
8247487|NCT01887288|20338439|P1|COMPLETED|Overall Study||0
8247488|NCT01887288|20338439|P1|STARTED|Overall Study||16
8247489|NCT01887210|20338446|P2|NOT COMPLETED|Overall Study||4
8247490|NCT01887210|20338447|P1|NOT COMPLETED|Overall Study||1
8247491|NCT01887210|20338446|P2|COMPLETED|Overall Study||29
8247492|NCT01887210|20338447|P1|COMPLETED|Overall Study||32
8247493|NCT01887210|20338446|P2|STARTED|Overall Study||33
8247494|NCT01887210|20338447|P1|STARTED|Overall Study||33
8247495|NCT01887171|20338461|P2|NOT COMPLETED|Overall Study||0
8247496|NCT01887171|20338462|P1|NOT COMPLETED|Overall Study||0
8247497|NCT01887171|20338461|P2|COMPLETED|Overall Study||43
8247498|NCT01887171|20338462|P1|COMPLETED|Overall Study||43
8247499|NCT01887171|20338461|P2|STARTED|Overall Study||43
8247500|NCT01887171|20338462|P1|STARTED|Overall Study||43
8247501|NCT01887132|20338468|P1|NOT COMPLETED|Overall Study||0
8247502|NCT01887132|20338468|P1|COMPLETED|Overall Study||4
8247503|NCT01887132|20338468|P1|STARTED|Overall Study||4
8247504|NCT01886963|20338475|P2|NOT COMPLETED|Overall Study||4
8247505|NCT01886963|20338476|P1|NOT COMPLETED|Overall Study||5
8247506|NCT01886963|20338475|P2|COMPLETED|Overall Study||49
8247507|NCT01886963|20338476|P1|COMPLETED|Overall Study||46
8247508|NCT01886963|20338475|P2|12 Week Follow Up|Overall Study||22
8247509|NCT01886963|20338476|P1|12 Week Follow Up|Overall Study||24
8247510|NCT01886963|20338475|P2|4 Week Follow Up|Overall Study||26
8247511|NCT01886963|20338476|P1|4 Week Follow Up|Overall Study||24
8247512|NCT01886963|20338475|P2|2 Week Follow Up|Overall Study||35
8247513|NCT01886963|20338476|P1|2 Week Follow Up|Overall Study||38
8247514|NCT01886963|20338475|P2|STARTED|Overall Study||53
8247515|NCT01886963|20338476|P1|STARTED|Overall Study||51
8247516|NCT01886937|20338484|P2|NOT COMPLETED|Overall Study||0
8247517|NCT01886937|20338485|P1|NOT COMPLETED|Overall Study||0
8247518|NCT01886937|20338484|P2|COMPLETED|Overall Study||6
8247519|NCT01886937|20338485|P1|COMPLETED|Overall Study||7
8247520|NCT01886937|20338484|P2|STARTED|Overall Study||6
8247521|NCT01886937|20338485|P1|STARTED|Overall Study||7
8247540|NCT01886833|20338529|P1|NOT COMPLETED|Overall Study||204
8247541|NCT01886833|20338529|P1|COMPLETED|Overall Study||216
8247542|NCT01886833|20338529|P1|STARTED|Overall Study||420
8247543|NCT01886807|20338540|P3|NOT COMPLETED|Overall Study||10
8247544|NCT01886807|20338541|P2|NOT COMPLETED|Overall Study||10
8247545|NCT01886807|20338542|P1|NOT COMPLETED|Overall Study||5
8247546|NCT01886807|20338540|P3|COMPLETED|Overall Study||153
8247547|NCT01886807|20338541|P2|COMPLETED|Overall Study||145
8247548|NCT01886807|20338542|P1|COMPLETED|Overall Study||159
8247549|NCT01886807|20338540|P3|STARTED|Overall Study||163
8247550|NCT01886807|20338541|P2|STARTED|Overall Study||155
8247551|NCT01886807|20338542|P1|STARTED|Overall Study||164
8247552|NCT01886781|20338561|P2|NOT COMPLETED|Overall Study||2
8247553|NCT01886781|20338562|P1|NOT COMPLETED|Overall Study||14
8247554|NCT01886781|20338561|P2|COMPLETED|Overall Study||25
8247555|NCT01886781|20338562|P1|COMPLETED|Overall Study||40
8247556|NCT01886781|20338561|P2|STARTED|Overall Study||27
8247557|NCT01886781|20338562|P1|STARTED|Overall Study||54
8247558|NCT01886716|20338572|P4|NOT COMPLETED|1-Month Post Follow-Up||0
8247559|NCT01886716|20338573|P3|NOT COMPLETED|1-Month Post Follow-Up||0
8247560|NCT01886716|20338574|P2|NOT COMPLETED|1-Month Post Follow-Up||0
8247561|NCT01886716|20338575|P1|NOT COMPLETED|1-Month Post Follow-Up||0
8247562|NCT01886716|20338572|P4|COMPLETED|1-Month Post Follow-Up||14
8247563|NCT01886716|20338573|P3|COMPLETED|1-Month Post Follow-Up||19
8247564|NCT01886716|20338574|P2|COMPLETED|1-Month Post Follow-Up||17
8247565|NCT01886716|20338575|P1|COMPLETED|1-Month Post Follow-Up||20
8247566|NCT01886716|20338572|P4|STARTED|1-Month Post Follow-Up||14
8247567|NCT01886716|20338573|P3|STARTED|1-Month Post Follow-Up||19
8247568|NCT01886716|20338574|P2|STARTED|1-Month Post Follow-Up||17
8247569|NCT01886716|20338575|P1|STARTED|1-Month Post Follow-Up||20
8247570|NCT01886716|20338572|P4|NOT COMPLETED|1-Week Post Follow-Up||0
8247571|NCT01886716|20338573|P3|NOT COMPLETED|1-Week Post Follow-Up||0
8247572|NCT01886716|20338574|P2|NOT COMPLETED|1-Week Post Follow-Up||0
8247573|NCT01886716|20338575|P1|NOT COMPLETED|1-Week Post Follow-Up||0
8247574|NCT01886716|20338572|P4|COMPLETED|1-Week Post Follow-Up||14
8247575|NCT01886716|20338573|P3|COMPLETED|1-Week Post Follow-Up||19
8247576|NCT01886716|20338574|P2|COMPLETED|1-Week Post Follow-Up||17
8247577|NCT01886716|20338575|P1|COMPLETED|1-Week Post Follow-Up||20
8247578|NCT01886716|20338572|P4|STARTED|1-Week Post Follow-Up||14
8247579|NCT01886716|20338573|P3|STARTED|1-Week Post Follow-Up||19
8247580|NCT01886716|20338574|P2|STARTED|1-Week Post Follow-Up||17
8247581|NCT01886716|20338575|P1|STARTED|1-Week Post Follow-Up||20
8247582|NCT01886716|20338572|P4|NOT COMPLETED|Week 4||0
8247583|NCT01886716|20338573|P3|NOT COMPLETED|Week 4||0
8247584|NCT01886716|20338574|P2|NOT COMPLETED|Week 4||0
8247585|NCT01886716|20338575|P1|NOT COMPLETED|Week 4||0
8247586|NCT01886716|20338572|P4|COMPLETED|Week 4||14
8247587|NCT01886716|20338573|P3|COMPLETED|Week 4||19
8247588|NCT01886716|20338574|P2|COMPLETED|Week 4||17
8247589|NCT01886716|20338575|P1|COMPLETED|Week 4||20
8247590|NCT01886716|20338572|P4|STARTED|Week 4||14
8247591|NCT01886716|20338573|P3|STARTED|Week 4||19
8247592|NCT01886716|20338574|P2|STARTED|Week 4||17
8247593|NCT01886716|20338575|P1|STARTED|Week 4||20
8247594|NCT01886716|20338572|P4|NOT COMPLETED|Week 3||1
8247595|NCT01886716|20338573|P3|NOT COMPLETED|Week 3||0
8247596|NCT01886716|20338574|P2|NOT COMPLETED|Week 3||1
8247597|NCT01886716|20338575|P1|NOT COMPLETED|Week 3||1
8247598|NCT01886716|20338572|P4|COMPLETED|Week 3||14
8247599|NCT01886716|20338573|P3|COMPLETED|Week 3||19
8247600|NCT01886716|20338574|P2|COMPLETED|Week 3||17
8247601|NCT01886716|20338575|P1|COMPLETED|Week 3||20
8247602|NCT01886716|20338572|P4|STARTED|Week 3||15
8247603|NCT01886716|20338573|P3|STARTED|Week 3||19
8247604|NCT01886716|20338574|P2|STARTED|Week 3||18
8247605|NCT01886716|20338575|P1|STARTED|Week 3||21
8247606|NCT01886716|20338572|P4|NOT COMPLETED|Week 2||3
8247607|NCT01886716|20338573|P3|NOT COMPLETED|Week 2||1
8247608|NCT01886716|20338574|P2|NOT COMPLETED|Week 2||2
8247609|NCT01886716|20338575|P1|NOT COMPLETED|Week 2||3
8247610|NCT01886716|20338572|P4|COMPLETED|Week 2||15
8247611|NCT01886716|20338573|P3|COMPLETED|Week 2||19
8247612|NCT01886716|20338574|P2|COMPLETED|Week 2||18
8247613|NCT01886716|20338575|P1|COMPLETED|Week 2||21
8247614|NCT01886716|20338572|P4|STARTED|Week 2||18
8247615|NCT01886716|20338573|P3|STARTED|Week 2||20
8247616|NCT01886716|20338574|P2|STARTED|Week 2||20
8247617|NCT01886716|20338575|P1|STARTED|Week 2||24
8247618|NCT01886716|20338572|P4|NOT COMPLETED|Week 1||2
8247619|NCT01886716|20338573|P3|NOT COMPLETED|Week 1||2
8247620|NCT01886716|20338574|P2|NOT COMPLETED|Week 1||0
8247621|NCT01886716|20338575|P1|NOT COMPLETED|Week 1||0
8247622|NCT01886716|20338572|P4|COMPLETED|Week 1||18
8247623|NCT01886716|20338573|P3|COMPLETED|Week 1||20
8247624|NCT01886716|20338574|P2|COMPLETED|Week 1||20
8247625|NCT01886716|20338575|P1|COMPLETED|Week 1||24
8247626|NCT01886716|20338572|P4|STARTED|Week 1||20
8247627|NCT01886716|20338573|P3|STARTED|Week 1||22
8247628|NCT01886716|20338574|P2|STARTED|Week 1||20
8247629|NCT01886716|20338575|P1|STARTED|Week 1||24
8247630|NCT01886690|20338591|P2|NOT COMPLETED|Overall Study||2
8247631|NCT01886690|20338592|P1|NOT COMPLETED|Overall Study||0
8247632|NCT01886690|20338591|P2|COMPLETED|Overall Study||71
8247633|NCT01886690|20338592|P1|COMPLETED|Overall Study||75
8247634|NCT01886690|20338591|P2|STARTED|Overall Study||73
8247635|NCT01886690|20338592|P1|STARTED|Overall Study||75
8247636|NCT01886313|20338608|P2|NOT COMPLETED|Overall Study||1
8247637|NCT01886313|20338609|P1|NOT COMPLETED|Overall Study||1
8247638|NCT01886313|20338608|P2|COMPLETED|Overall Study||4
8247639|NCT01886313|20338609|P1|COMPLETED|Overall Study||5
8247640|NCT01886313|20338608|P2|STARTED|Overall Study||5
8247641|NCT01886313|20338609|P1|STARTED|Overall Study||6
8247642|NCT01886300|20338615|P1|NOT COMPLETED|Overall Study||16
8247643|NCT01886300|20338615|P1|COMPLETED|Overall Study||0
8247644|NCT01886300|20338615|P1|STARTED|Overall Study||16
8247645|NCT01886287|20338626|P1|NOT COMPLETED|Overall Study||2
8247646|NCT01886287|20338626|P1|COMPLETED|Overall Study||0
8247647|NCT01886287|20338626|P1|STARTED|Overall Study||2
8247648|NCT01886235|20338631|P1|NOT COMPLETED|Overall Study||0
8247649|NCT01886235|20338631|P1|COMPLETED|Overall Study||10
8247650|NCT01886235|20338631|P1|STARTED|Overall Study||10
8247651|NCT01886105|20338642|P1|NOT COMPLETED|Overall Study||3
8247652|NCT01886105|20338642|P1|COMPLETED|Overall Study||1
8247653|NCT01886105|20338642|P1|STARTED|Overall Study||4
8247654|NCT01885936|20338649|P2|NOT COMPLETED|Overall Study||0
8247655|NCT01885936|20338650|P1|NOT COMPLETED|Overall Study||1
8247656|NCT01885936|20338649|P2|COMPLETED|Overall Study||5
8247657|NCT01885936|20338650|P1|COMPLETED|Overall Study||7
8247658|NCT01885936|20338649|P2|STARTED|Overall Study||5
8247659|NCT01885936|20338650|P1|STARTED|Overall Study||8
8247660|NCT01885910|20338660|P1|NOT COMPLETED|Overall Study||8
8247661|NCT01885910|20338660|P1|COMPLETED|Overall Study||24
8247662|NCT01885910|20338660|P1|STARTED|Overall Study||32
8247663|NCT01885897|20338680|P6|NOT COMPLETED|Overall Study||0
8247664|NCT01885897|20338681|P5|NOT COMPLETED|Overall Study||0
8247665|NCT01885897|20338682|P4|NOT COMPLETED|Overall Study||0
8247666|NCT01885897|20338683|P3|NOT COMPLETED|Overall Study||0
8247667|NCT01885897|20338684|P2|NOT COMPLETED|Overall Study||0
8247668|NCT01885897|20338685|P1|NOT COMPLETED|Overall Study||0
8247669|NCT01885897|20338680|P6|COMPLETED|Overall Study||9
8247670|NCT01885897|20338681|P5|COMPLETED|Overall Study||8
8247671|NCT01885897|20338682|P4|COMPLETED|Overall Study||3
8247672|NCT01885897|20338683|P3|COMPLETED|Overall Study||4
8247673|NCT01885897|20338684|P2|COMPLETED|Overall Study||3
8247674|NCT01885897|20338685|P1|COMPLETED|Overall Study||6
8247675|NCT01885897|20338680|P6|STARTED|Overall Study||9
8247676|NCT01885897|20338681|P5|STARTED|Overall Study||8
8247677|NCT01885897|20338682|P4|STARTED|Overall Study||3
8247678|NCT01885897|20338683|P3|STARTED|Overall Study||4
8247679|NCT01885897|20338684|P2|STARTED|Overall Study||3
8247680|NCT01885897|20338685|P1|STARTED|Overall Study||6
8247681|NCT01885871|20338723|P1|NOT COMPLETED|Overall Study||0
8247682|NCT01885871|20338723|P1|COMPLETED|Overall Study||20
8247683|NCT01885871|20338723|P1|STARTED|Overall Study||20
8247684|NCT01885559|20338733|P2|NOT COMPLETED|Overall Study||36
8247685|NCT01885559|20338734|P1|NOT COMPLETED|Overall Study||24
8247686|NCT01885559|20338733|P2|COMPLETED|Overall Study||208
8247687|NCT01885559|20338734|P1|COMPLETED|Overall Study||218
8247688|NCT01885559|20338733|P2|STARTED|Overall Study||244
8247689|NCT01885559|20338734|P1|STARTED|Overall Study||242
8247690|NCT01885208|20338756|P2|NOT COMPLETED|Overall Study||38
8247691|NCT01885208|20338757|P1|NOT COMPLETED|Overall Study||32
8247692|NCT01885208|20338756|P2|COMPLETED|Overall Study||369
8247693|NCT01885208|20338757|P1|COMPLETED|Overall Study||374
8247694|NCT01885208|20338756|P2|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
8247695|NCT01885208|20338757|P1|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
8247696|NCT01885208|20338756|P2|Exposed|Overall Study||405
8247697|NCT01885208|20338757|P1|Exposed|Overall Study||404
8247698|NCT01885208|20338756|P2|STARTED|Overall Study||407
8247699|NCT01885208|20338757|P1|STARTED|Overall Study||406
8247700|NCT01885182|20338775|P2|NOT COMPLETED|Overall Study||22
8247701|NCT01885182|20338776|P1|NOT COMPLETED|Overall Study||34
8247702|NCT01885182|20338775|P2|COMPLETED|Overall Study||93
8247703|NCT01885182|20338776|P1|COMPLETED|Overall Study||83
8247704|NCT01885182|20338775|P2|FAP Population|Overall Study||106
8247705|NCT01885182|20338776|P1|FAP Population|Overall Study||107
8247706|NCT01885182|20338775|P2|Safety Population|Overall Study||111
8247707|NCT01885182|20338776|P1|Safety Population|Overall Study||114
8247708|NCT01885182|20338775|P2|STARTED|Overall Study||115
8247709|NCT01885182|20338776|P1|STARTED|Overall Study||117
8247710|NCT01885117|20338800|P2|NOT COMPLETED|Overall Study||0
8247711|NCT01885117|20338801|P1|NOT COMPLETED|Overall Study||0
8247712|NCT01885117|20338800|P2|COMPLETED|Overall Study||64
8247713|NCT01885117|20338801|P1|COMPLETED|Overall Study||61
8247714|NCT01885117|20338800|P2|STARTED|Overall Study||64
8247715|NCT01885117|20338801|P1|STARTED|Overall Study||61
8247716|NCT01885104|20338823|P2|NOT COMPLETED|Overall Study||1
8247717|NCT01885104|20338824|P1|NOT COMPLETED|Overall Study||2
8247718|NCT01885104|20338823|P2|COMPLETED|Overall Study||33
8247719|NCT01885104|20338824|P1|COMPLETED|Overall Study||29
8247720|NCT01885104|20338823|P2|STARTED|Overall Study||34
8247721|NCT01885104|20338824|P1|STARTED|Overall Study||31
8247728|NCT01884844|20338849|P2|NOT COMPLETED|Overall Study||5
8247729|NCT01884844|20338850|P1|NOT COMPLETED|Overall Study||3
8247730|NCT01884844|20338849|P2|COMPLETED|Overall Study||12
8247731|NCT01884844|20338850|P1|COMPLETED|Overall Study||13
8247732|NCT01884844|20338849|P2|STARTED|Overall Study||17
8247733|NCT01884844|20338850|P1|STARTED|Overall Study||16
8247734|NCT01884688|20338856|P1|NOT COMPLETED|Overall Study||2
8247735|NCT01884688|20338856|P1|COMPLETED|Overall Study||1
8247736|NCT01884688|20338856|P1|STARTED|Overall Study||3
8247737|NCT01884675|20338862|P2|NOT COMPLETED|Overall Study||2
8247738|NCT01884675|20338863|P1|NOT COMPLETED|Overall Study||3
8247739|NCT01884675|20338862|P2|COMPLETED|Overall Study||15
8247740|NCT01884675|20338863|P1|COMPLETED|Overall Study||13
8247741|NCT01884675|20338862|P2|STARTED|Overall Study||17
8247742|NCT01884675|20338863|P1|STARTED|Overall Study||16
8247743|NCT01884597|20338906|P3|NOT COMPLETED|Overall Study||1
8247744|NCT01884597|20338907|P2|NOT COMPLETED|Overall Study||1
8247745|NCT01884597|20338908|P1|NOT COMPLETED|Overall Study||1
8247746|NCT01884597|20338906|P3|COMPLETED|Overall Study||15
8247747|NCT01884597|20338907|P2|COMPLETED|Overall Study||2
8247748|NCT01884597|20338908|P1|COMPLETED|Overall Study||4
8247749|NCT01884597|20338906|P3|STARTED|Overall Study||16
8247750|NCT01884597|20338907|P2|STARTED|Overall Study||3
8247751|NCT01884597|20338908|P1|STARTED|Overall Study||5
8247752|NCT01884571|20338937|P1|NOT COMPLETED|Overall Study||8
8247753|NCT01884571|20338937|P1|COMPLETED|Overall Study||23
8247754|NCT01884571|20338937|P1|STARTED|Overall Study||31
8247755|NCT01884545|20338952|P4|NOT COMPLETED|Overall Study||9
8247756|NCT01884545|20338953|P3|NOT COMPLETED|Overall Study||14
8247757|NCT01884545|20338954|P2|NOT COMPLETED|Overall Study||18
8247758|NCT01884545|20338955|P1|NOT COMPLETED|Overall Study||13
8247759|NCT01884545|20338952|P4|COMPLETED|Overall Study||43
8247760|NCT01884545|20338953|P3|COMPLETED|Overall Study||35
8247761|NCT01884545|20338954|P2|COMPLETED|Overall Study||31
8247762|NCT01884545|20338955|P1|COMPLETED|Overall Study||37
8247763|NCT01884545|20338952|P4|STARTED|Overall Study||52
8247764|NCT01884545|20338953|P3|STARTED|Overall Study||49
8247765|NCT01884545|20338954|P2|STARTED|Overall Study||49
8247766|NCT01884545|20338955|P1|STARTED|Overall Study||50
8247767|NCT01884519|20339063|P2|NOT COMPLETED|Overall Study||0
8247768|NCT01884519|20339064|P1|NOT COMPLETED|Overall Study||0
8247769|NCT01884519|20339063|P2|COMPLETED|Overall Study||60
8247770|NCT01884519|20339064|P1|COMPLETED|Overall Study||60
8247771|NCT01884519|20339063|P2|STARTED|Overall Study||60
8247772|NCT01884519|20339064|P1|STARTED|Overall Study||60
8247773|NCT01884350|20339108|P3|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11
8247774|NCT01884350|20339109|P2|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13
8247775|NCT01884350|20339110|P1|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80
8247776|NCT01884350|20339108|P3|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
8247777|NCT01884350|20339109|P2|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
8247778|NCT01884350|20339110|P1|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503
8247779|NCT01884350|20339108|P3|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223
8247780|NCT01884350|20339109|P2|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308
8247781|NCT01884350|20339110|P1|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604
8247782|NCT01884350|20339108|P3|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261
8247783|NCT01884350|20339109|P2|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263
8247784|NCT01884350|20339110|P1|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583
8247785|NCT01884350|20339108|P3|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
8247786|NCT01884350|20339109|P2|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
8247787|NCT01884350|20339110|P1|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
8247788|NCT01884350|20339108|P3|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
8247789|NCT01884350|20339109|P2|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525
8247790|NCT01884350|20339110|P1|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529
8247791|NCT01884350|20339108|P3|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0
8247792|NCT01884350|20339109|P2|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558
8247793|NCT01884350|20339110|P1|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604
8247794|NCT01884350|20339108|P3|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0
8247795|NCT01884350|20339109|P2|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579
8247796|NCT01884350|20339110|P1|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583
8247797|NCT01884337|20339133|P2|NOT COMPLETED|Follow-up Period||1
8247798|NCT01884337|20339134|P1|NOT COMPLETED|Follow-up Period||1
8247799|NCT01884337|20339133|P2|COMPLETED|Follow-up Period||170
8247800|NCT01884337|20339134|P1|COMPLETED|Follow-up Period||323
8247801|NCT01884337|20339133|P2|STARTED|Follow-up Period||171
8247802|NCT01884337|20339134|P1|STARTED|Follow-up Period||324
8247803|NCT01884337|20339133|P2|NOT COMPLETED|Treatment||2
8247804|NCT01884337|20339134|P1|NOT COMPLETED|Treatment||4
8247805|NCT01884337|20339133|P2|COMPLETED|Treatment||170
8247806|NCT01884337|20339134|P1|COMPLETED|Treatment||322
8247807|NCT01884337|20339133|P2|Continuing Into Follow-up Period|Treatment||171
8247808|NCT01884337|20339134|P1|Continuing Into Follow-up Period|Treatment||324
8247809|NCT01884337|20339133|P2|STARTED|Treatment||172
8247810|NCT01884337|20339134|P1|STARTED|Treatment||326
8247811|NCT01884311|20339142|P1|NOT COMPLETED|Overall Study||5
8247812|NCT01884311|20339142|P1|COMPLETED|Overall Study||33
8247813|NCT01884311|20339142|P1|STARTED|Overall Study||38
8247814|NCT01884077|20339152|P2|NOT COMPLETED|Overall Study||10
8247815|NCT01884077|20339153|P1|NOT COMPLETED|Overall Study||8
8247816|NCT01884077|20339152|P2|COMPLETED|Overall Study||1
8247817|NCT01884077|20339153|P1|COMPLETED|Overall Study||0
8247818|NCT01884077|20339152|P2|STARTED|Overall Study||11
8247819|NCT01884077|20339153|P1|STARTED|Overall Study||8
8247820|NCT01884064|20339165|P2|NOT COMPLETED|Overall Study||0
8247821|NCT01884064|20339166|P1|NOT COMPLETED|Overall Study||0
8247822|NCT01884064|20339165|P2|COMPLETED|Overall Study||5
8247823|NCT01884064|20339166|P1|COMPLETED|Overall Study||12
8247824|NCT01884064|20339165|P2|STARTED|Overall Study||5
8247825|NCT01884064|20339166|P1|STARTED|Overall Study||12
8247826|NCT01884025|20339174|P2|NOT COMPLETED|Overall Study||4
8247827|NCT01884025|20339175|P1|NOT COMPLETED|Overall Study||3
8247828|NCT01884025|20339174|P2|COMPLETED|Overall Study||10
8247829|NCT01884025|20339175|P1|COMPLETED|Overall Study||10
8247830|NCT01884025|20339174|P2|STARTED|Overall Study||14
8247831|NCT01884025|20339175|P1|STARTED|Overall Study||13
8247832|NCT01883999|20339203|P1|NOT COMPLETED|Overall Study||3
8247833|NCT01883999|20339203|P1|COMPLETED|Overall Study||61
8247834|NCT01883999|20339203|P1|STARTED|Overall Study||64
8247835|NCT01883986|20339211|P2|NOT COMPLETED|Overall Study||1
8247836|NCT01883986|20339212|P1|NOT COMPLETED|Overall Study||3
8247837|NCT01883986|20339211|P2|COMPLETED|Overall Study|Completed study|19
8247838|NCT01883986|20339212|P1|COMPLETED|Overall Study|Received allocated intervention|17
8247839|NCT01883986|20339211|P2|Did Not Complete Study|Overall Study|Did not completed study|1
8247840|NCT01883986|20339212|P1|Did Not Complete Study|Overall Study||3
8247841|NCT01883986|20339211|P2|STARTED|Overall Study|Allocated to usual care arm|20
8247842|NCT01883986|20339212|P1|STARTED|Overall Study|Allocated to intervention arm|20
8247843|NCT01883908|20339226|P2|NOT COMPLETED|Overall Study||0
8247844|NCT01883908|20339227|P1|NOT COMPLETED|Overall Study||0
8247845|NCT01883908|20339226|P2|COMPLETED|Overall Study||1
8247846|NCT01883908|20339227|P1|COMPLETED|Overall Study||3
8247847|NCT01883908|20339226|P2|STARTED|Overall Study||1
8247848|NCT01883908|20339227|P1|STARTED|Overall Study||3
8247849|NCT01883895|20339235|P1|NOT COMPLETED|Overall Study||2
8247850|NCT01883895|20339235|P1|COMPLETED|Overall Study||32
8247851|NCT01883895|20339235|P1|STARTED|Overall Study||34
8247852|NCT01883856|20339242|P2|NOT COMPLETED|Overall Study||0
8247853|NCT01883856|20339243|P1|NOT COMPLETED|Overall Study||0
8247854|NCT01883856|20339242|P2|COMPLETED|Overall Study||26
8247855|NCT01883856|20339243|P1|COMPLETED|Overall Study||26
8247856|NCT01883856|20339242|P2|STARTED|Overall Study||26
8247857|NCT01883856|20339243|P1|STARTED|Overall Study||26
8247858|NCT01883804|20339253|P1|NOT COMPLETED|Overall Study||5
8247859|NCT01883804|20339253|P1|COMPLETED|Overall Study||20
8247860|NCT01883804|20339253|P1|STARTED|Overall Study||25
8247861|NCT01883635|20339262|P2|NOT COMPLETED|Overall Study||0
8247862|NCT01883635|20339263|P1|NOT COMPLETED|Overall Study||4
8247863|NCT01883635|20339262|P2|COMPLETED|Overall Study||20
8247864|NCT01883635|20339263|P1|COMPLETED|Overall Study||20
8247865|NCT01883635|20339262|P2|STARTED|Overall Study||20
8247866|NCT01883635|20339263|P1|STARTED|Overall Study||24
8247867|NCT01883492|20339277|P2|NOT COMPLETED|Overall Study||11
8247868|NCT01883492|20339278|P1|NOT COMPLETED|Overall Study||13
8247869|NCT01883492|20339277|P2|COMPLETED|Overall Study||67
8247870|NCT01883492|20339278|P1|COMPLETED|Overall Study||62
8247871|NCT01883492|20339277|P2|STARTED|Overall Study||78
8247872|NCT01883492|20339278|P1|STARTED|Overall Study||75
8247873|NCT01883453|20339310|P2|NOT COMPLETED|Overall Study||23
8247874|NCT01883453|20339311|P1|NOT COMPLETED|Overall Study||25
8247875|NCT01883453|20339310|P2|COMPLETED|Overall Study||50
8247876|NCT01883453|20339311|P1|COMPLETED|Overall Study||48
8247877|NCT01883453|20339310|P2|STARTED|Overall Study||73
8247878|NCT01883453|20339311|P1|STARTED|Overall Study||73
8247879|NCT01883440|20339319|P2|NOT COMPLETED|Overall Study||0
8247880|NCT01883440|20339320|P1|NOT COMPLETED|Overall Study||3
8247881|NCT01883440|20339319|P2|COMPLETED|Overall Study||45
8247882|NCT01883440|20339320|P1|COMPLETED|Overall Study||42
8247883|NCT01883440|20339319|P2|STARTED|Overall Study||45
8247884|NCT01883440|20339320|P1|STARTED|Overall Study||45
8247885|NCT01883427|20339330|P2|NOT COMPLETED|Overall Study||0
8247886|NCT01883427|20339331|P1|NOT COMPLETED|Overall Study||0
8247887|NCT01883427|20339330|P2|COMPLETED|Overall Study||20
8247888|NCT01883427|20339331|P1|COMPLETED|Overall Study||20
8247889|NCT01883427|20339330|P2|STARTED|Overall Study||20
8247890|NCT01883427|20339331|P1|STARTED|Overall Study||20
8247891|NCT01883141|20339337|P1|NOT COMPLETED|Overall Study||0
8247892|NCT01883141|20339337|P1|COMPLETED|Overall Study|Exit form with exit reason available|31
8247893|NCT01883141|20339337|P1|Multivein|Overall Study||23
8247894|NCT01883141|20339337|P1|Biv Pacing-Posterior|Overall Study||22
8247895|NCT01883141|20339337|P1|BiV Pacing-Anterior|Overall Study||23
8247896|NCT01883141|20339337|P1|Multispot-pacing|Overall Study||24
8247897|NCT01883141|20339337|P1|BiV Pacing-Standard Therapy|Overall Study||26
8247898|NCT01883141|20339337|P1|BiV Pacing-Mid|Overall Study||25
8247899|NCT01883141|20339337|P1|BiV Pacing-Distal|Overall Study||24
8247900|NCT01883141|20339337|P1|Usable EP Data|Overall Study||26
8247901|NCT01883141|20339337|P1|EP Study Performed|Overall Study||30
8247902|NCT01883141|20339337|P1|Passing Eligibility|Overall Study||30
8247903|NCT01883141|20339337|P1|STARTED|Overall Study||31
8247904|NCT01882985|20339346|P1|NOT COMPLETED|Overall Study||2
8247905|NCT01882985|20339346|P1|COMPLETED|Overall Study||12
8247906|NCT01882985|20339346|P1|STARTED|Overall Study||14
8247907|NCT01882907|20339355|P2|NOT COMPLETED|Overall Study||28
8247908|NCT01882907|20339356|P1|NOT COMPLETED|Overall Study||14
8247909|NCT01882907|20339355|P2|COMPLETED|Overall Study||83
8247910|NCT01882907|20339356|P1|COMPLETED|Overall Study||103
8247911|NCT01882907|20339355|P2|STARTED|Overall Study||111
8247912|NCT01882907|20339356|P1|STARTED|Overall Study||117
8247913|NCT01882868|20339372|P1|NOT COMPLETED|Overall Study||0
8247914|NCT01882868|20339372|P1|COMPLETED|Overall Study||62
8247915|NCT01882868|20339372|P1|STARTED|Overall Study||62
8247916|NCT01882829|20339402|P1|NOT COMPLETED|Overall Study||6
8247917|NCT01882829|20339402|P1|COMPLETED|Overall Study||14
8247918|NCT01882829|20339402|P1|STARTED|Overall Study||20
8247922|NCT01882764|20339429|P2|NOT COMPLETED|Overall Study||18
8247923|NCT01882764|20339430|P1|NOT COMPLETED|Overall Study||47
8247924|NCT01882764|20339429|P2|COMPLETED|Overall Study||1
8247925|NCT01882764|20339430|P1|COMPLETED|Overall Study||0
8247926|NCT01882764|20339429|P2|STARTED|Overall Study||19
8247927|NCT01882764|20339430|P1|STARTED|Overall Study||47
8247928|NCT01882725|20339436|P1|NOT COMPLETED|Overall Study||0
8247929|NCT01882725|20339436|P1|COMPLETED|Overall Study||14
8247930|NCT01882725|20339436|P1|STARTED|Overall Study||14
8247931|NCT01882647|20339443|P2|NOT COMPLETED|Overall Study||6
8247932|NCT01882647|20339444|P1|NOT COMPLETED|Overall Study||2
8247933|NCT01882647|20339443|P2|COMPLETED|Overall Study||106
8247934|NCT01882647|20339444|P1|COMPLETED|Overall Study||108
8247935|NCT01882647|20339443|P2|STARTED|Overall Study||112
8247936|NCT01882647|20339444|P1|STARTED|Overall Study||110
8247937|NCT01882543|20339462|P2|NOT COMPLETED|Overall Study||3
8247938|NCT01882543|20339463|P1|NOT COMPLETED|Overall Study||4
8247939|NCT01882543|20339462|P2|COMPLETED|Overall Study||29
8247940|NCT01882543|20339463|P1|COMPLETED|Overall Study||33
8247941|NCT01882543|20339462|P2|STARTED|Overall Study||32
8247942|NCT01882543|20339463|P1|STARTED|Overall Study||37
8247943|NCT01882465|20339484|P7|NOT COMPLETED|Period 3||0
8247944|NCT01882465|20339485|P6|NOT COMPLETED|Period 3||0
8247945|NCT01882465|20339486|P5|NOT COMPLETED|Period 3||0
8247946|NCT01882465|20339487|P4|NOT COMPLETED|Period 3||0
8247947|NCT01882465|20339488|P3|NOT COMPLETED|Period 3||0
8247948|NCT01882465|20339489|P2|NOT COMPLETED|Period 3||0
8247949|NCT01882465|20339490|P1|NOT COMPLETED|Period 3||0
8247950|NCT01882465|20339484|P7|COMPLETED|Period 3||0
8247951|NCT01882465|20339485|P6|COMPLETED|Period 3||5
8247952|NCT01882465|20339486|P5|COMPLETED|Period 3||4
8247953|NCT01882465|20339487|P4|COMPLETED|Period 3||5
8247954|NCT01882465|20339488|P3|COMPLETED|Period 3||5
8247955|NCT01882465|20339489|P2|COMPLETED|Period 3||6
8247956|NCT01882465|20339490|P1|COMPLETED|Period 3||6
8247957|NCT01882465|20339484|P7|STARTED|Period 3||0
8247958|NCT01882465|20339485|P6|STARTED|Period 3||5
8247959|NCT01882465|20339486|P5|STARTED|Period 3||4
8247960|NCT01882465|20339487|P4|STARTED|Period 3||5
8247961|NCT01882465|20339488|P3|STARTED|Period 3||5
8247962|NCT01882465|20339489|P2|STARTED|Period 3||6
8247963|NCT01882465|20339490|P1|STARTED|Period 3||6
8247964|NCT01882465|20339484|P7|NOT COMPLETED|Period 2||0
8247965|NCT01882465|20339485|P6|NOT COMPLETED|Period 2||0
8247966|NCT01882465|20339486|P5|NOT COMPLETED|Period 2||1
8247967|NCT01882465|20339487|P4|NOT COMPLETED|Period 2||0
8247968|NCT01882465|20339488|P3|NOT COMPLETED|Period 2||0
8247969|NCT01882465|20339489|P2|NOT COMPLETED|Period 2||0
8247970|NCT01882465|20339490|P1|NOT COMPLETED|Period 2||0
8247971|NCT01882465|20339484|P7|COMPLETED|Period 2||0
8247972|NCT01882465|20339485|P6|COMPLETED|Period 2||5
8247973|NCT01882465|20339486|P5|COMPLETED|Period 2||4
8247974|NCT01882465|20339487|P4|COMPLETED|Period 2||5
8247975|NCT01882465|20339488|P3|COMPLETED|Period 2||5
8247976|NCT01882465|20339489|P2|COMPLETED|Period 2||6
8247977|NCT01882465|20339490|P1|COMPLETED|Period 2||6
8247978|NCT01882465|20339484|P7|STARTED|Period 2||0
8247979|NCT01882465|20339485|P6|STARTED|Period 2||5
8247980|NCT01882465|20339486|P5|STARTED|Period 2||5
8247981|NCT01882465|20339487|P4|STARTED|Period 2||5
8247982|NCT01882465|20339488|P3|STARTED|Period 2||5
8247983|NCT01882465|20339489|P2|STARTED|Period 2||6
8247984|NCT01882465|20339490|P1|STARTED|Period 2||6
8247985|NCT01882465|20339484|P7|NOT COMPLETED|Period 1||1
8247986|NCT01882465|20339485|P6|NOT COMPLETED|Period 1||0
8247987|NCT01882465|20339486|P5|NOT COMPLETED|Period 1||0
8247988|NCT01882465|20339487|P4|NOT COMPLETED|Period 1||1
8247989|NCT01882465|20339488|P3|NOT COMPLETED|Period 1||0
8247990|NCT01882465|20339489|P2|NOT COMPLETED|Period 1||0
8247991|NCT01882465|20339490|P1|NOT COMPLETED|Period 1||0
8247992|NCT01882465|20339484|P7|COMPLETED|Period 1||0
8247993|NCT01882465|20339485|P6|COMPLETED|Period 1||5
8247994|NCT01882465|20339486|P5|COMPLETED|Period 1||5
8247995|NCT01882465|20339487|P4|COMPLETED|Period 1||5
8247996|NCT01882465|20339488|P3|COMPLETED|Period 1||5
8247997|NCT01882465|20339489|P2|COMPLETED|Period 1||6
8247998|NCT01882465|20339490|P1|COMPLETED|Period 1||6
8247999|NCT01882465|20339484|P7|STARTED|Period 1||1
8248000|NCT01882465|20339485|P6|STARTED|Period 1||5
8248001|NCT01882465|20339486|P5|STARTED|Period 1||5
8248002|NCT01882465|20339487|P4|STARTED|Period 1||6
8248003|NCT01882465|20339488|P3|STARTED|Period 1||5
8248004|NCT01882465|20339489|P2|STARTED|Period 1||6
8248005|NCT01882465|20339490|P1|STARTED|Period 1||6
8248006|NCT01882439|20339502|P4|NOT COMPLETED|Overall Study||9
8248007|NCT01882439|20339503|P3|NOT COMPLETED|Overall Study||10
8248008|NCT01882439|20339504|P2|NOT COMPLETED|Overall Study||21
8248009|NCT01882439|20339505|P1|NOT COMPLETED|Overall Study||9
8248010|NCT01882439|20339502|P4|COMPLETED|Overall Study||56
8248011|NCT01882439|20339503|P3|COMPLETED|Overall Study||56
8248012|NCT01882439|20339504|P2|COMPLETED|Overall Study||111
8248013|NCT01882439|20339505|P1|COMPLETED|Overall Study||122
8248014|NCT01882439|20339502|P4|STARTED|Overall Study|Received treatment|65
8248015|NCT01882439|20339503|P3|STARTED|Overall Study|Received treatment|66
8248016|NCT01882439|20339504|P2|STARTED|Overall Study|Received treatment|132
8248017|NCT01882439|20339505|P1|STARTED|Overall Study|Received treatment|131
8248018|NCT01882413|20339685|P1|NOT COMPLETED|Overall Study||0
8248019|NCT01882413|20339685|P1|COMPLETED|Overall Study||204
8248020|NCT01882413|20339685|P1|STARTED|Overall Study||204
8248021|NCT01882257|20339702|P3|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
8248022|NCT01882257|20339703|P2|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
8248023|NCT01882257|20339704|P1|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
8248024|NCT01882257|20339702|P3|COMPLETED|Therapy Portion of Study (12 Months)||18
8248025|NCT01882257|20339703|P2|COMPLETED|Therapy Portion of Study (12 Months)||27
8248026|NCT01882257|20339704|P1|COMPLETED|Therapy Portion of Study (12 Months)||11
8248027|NCT01882257|20339702|P3|STARTED|Therapy Portion of Study (12 Months)||22
8248028|NCT01882257|20339703|P2|STARTED|Therapy Portion of Study (12 Months)||38
8248029|NCT01882257|20339704|P1|STARTED|Therapy Portion of Study (12 Months)||11
8248030|NCT01882257|20339702|P3|NOT COMPLETED|Study Origination to Beginning Therapy||1
8248031|NCT01882257|20339703|P2|NOT COMPLETED|Study Origination to Beginning Therapy||2
8248032|NCT01882257|20339704|P1|NOT COMPLETED|Study Origination to Beginning Therapy||0
8248033|NCT01882257|20339702|P3|COMPLETED|Study Origination to Beginning Therapy||22
8248034|NCT01882257|20339703|P2|COMPLETED|Study Origination to Beginning Therapy||38
8248035|NCT01882257|20339704|P1|COMPLETED|Study Origination to Beginning Therapy||11
8248036|NCT01882257|20339702|P3|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
8248037|NCT01882257|20339703|P2|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
8248038|NCT01882257|20339704|P1|Started Therapy Using Device|Study Origination to Beginning Therapy||11
8248039|NCT01882257|20339702|P3|STARTED|Study Origination to Beginning Therapy||23
8248040|NCT01882257|20339703|P2|STARTED|Study Origination to Beginning Therapy||40
8248041|NCT01882257|20339704|P1|STARTED|Study Origination to Beginning Therapy||11
8248042|NCT01882088|20339711|P1|NOT COMPLETED|Overall Study||5
8248043|NCT01882088|20339711|P1|COMPLETED|Overall Study||30
8248044|NCT01882088|20339711|P1|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35
8248045|NCT01882062|20339724|P1|NOT COMPLETED|Overall Study||0
8248046|NCT01882062|20339724|P1|COMPLETED|Overall Study|18th of july 2013|10
8248047|NCT01882062|20339724|P1|STARTED|Overall Study|16th of may 2013|10
8248048|NCT01881984|20339728|P1|NOT COMPLETED|Overall Study||0
8248049|NCT01881984|20339728|P1|COMPLETED|Overall Study||4
8248050|NCT01881984|20339728|P1|STARTED|Overall Study||4
8248051|NCT01881932|20339736|P3|NOT COMPLETED|Overall Study||0
8248052|NCT01881932|20339737|P2|NOT COMPLETED|Overall Study||0
8248053|NCT01881932|20339738|P1|NOT COMPLETED|Overall Study||0
8248054|NCT01881932|20339736|P3|COMPLETED|Overall Study||13
8248055|NCT01881932|20339737|P2|COMPLETED|Overall Study||4
8248056|NCT01881932|20339738|P1|COMPLETED|Overall Study||2
8248057|NCT01881932|20339736|P3|STARTED|Overall Study||13
8248058|NCT01881932|20339737|P2|STARTED|Overall Study||4
8248059|NCT01881932|20339738|P1|STARTED|Overall Study||2
8248060|NCT01881867|20339748|P2|NOT COMPLETED|Overall Study||13
8248061|NCT01881867|20339749|P1|NOT COMPLETED|Overall Study||12
8248062|NCT01881867|20339748|P2|COMPLETED|Overall Study||15
8248063|NCT01881867|20339749|P1|COMPLETED|Overall Study||14
8248064|NCT01881867|20339748|P2|STARTED|Overall Study||28
8248065|NCT01881867|20339749|P1|STARTED|Overall Study||26
8248066|NCT01881828|20339769|P2|NOT COMPLETED|Overall Study||0
8248067|NCT01881828|20339770|P1|NOT COMPLETED|Overall Study||0
8248068|NCT01881828|20339769|P2|COMPLETED|Overall Study||69
8248069|NCT01881828|20339770|P1|COMPLETED|Overall Study||71
8248070|NCT01881828|20339769|P2|STARTED|Overall Study|23 excluded from randomization from enrollment|69
8248071|NCT01881828|20339770|P1|STARTED|Overall Study|23 excluded at randomization from enrollment|71
8248072|NCT01881776|20339793|P3|NOT COMPLETED|Overall Study||2
8248073|NCT01881776|20339794|P2|NOT COMPLETED|Overall Study||4
8248074|NCT01881776|20339795|P1|NOT COMPLETED|Overall Study||1
8248075|NCT01881776|20339793|P3|COMPLETED|Overall Study||20
8248076|NCT01881776|20339794|P2|COMPLETED|Overall Study||20
8248077|NCT01881776|20339795|P1|COMPLETED|Overall Study||23
8248078|NCT01881776|20339793|P3|STARTED|Overall Study||22
8248079|NCT01881776|20339794|P2|STARTED|Overall Study||24
8248080|NCT01881776|20339795|P1|STARTED|Overall Study||24
8248081|NCT01881750|20339823|P2|NOT COMPLETED|Overall Study||4
8248082|NCT01881750|20339824|P1|NOT COMPLETED|Overall Study||2
8248083|NCT01881750|20339823|P2|COMPLETED|Overall Study||22
8248084|NCT01881750|20339824|P1|COMPLETED|Overall Study||25
8248085|NCT01881750|20339823|P2|STARTED|Overall Study||26
8248086|NCT01881750|20339824|P1|STARTED|Overall Study||27
8248087|NCT01881737|20339842|P1|NOT COMPLETED|Overall Study||5
8248088|NCT01881737|20339842|P1|COMPLETED|Overall Study||10
8248089|NCT01881737|20339842|P1|Number Screened|Overall Study||15
8248090|NCT01881737|20339842|P1|STARTED|Overall Study|This is a pilot study|15
8248091|NCT01881620|20339851|P1|NOT COMPLETED|Overall Study||4
8248092|NCT01881620|20339851|P1|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105
8248093|NCT01881620|20339851|P1|STARTED|Overall Study||109
8248094|NCT01881412|20339862|P2|NOT COMPLETED|Overall Study||2
8248095|NCT01881412|20339863|P1|NOT COMPLETED|Overall Study||10
8248096|NCT01881412|20339862|P2|COMPLETED|Overall Study||57
8248097|NCT01881412|20339863|P1|COMPLETED|Overall Study||49
8248098|NCT01881412|20339862|P2|STARTED|Overall Study||59
8248099|NCT01881412|20339863|P1|STARTED|Overall Study||59
8248100|NCT01881373|20339882|P3|NOT COMPLETED|24 Months||0
8248101|NCT01881373|20339883|P2|NOT COMPLETED|24 Months||0
8248102|NCT01881373|20339884|P1|NOT COMPLETED|24 Months||0
8248103|NCT01881373|20339882|P3|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
8248104|NCT01881373|20339883|P2|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
8248105|NCT01881373|20339884|P1|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
8248106|NCT01881373|20339882|P3|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
8248107|NCT01881373|20339883|P2|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
8248108|NCT01881373|20339884|P1|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
8248109|NCT01881373|20339882|P3|NOT COMPLETED|Baseline||0
8248110|NCT01881373|20339883|P2|NOT COMPLETED|Baseline||0
8248111|NCT01881373|20339884|P1|NOT COMPLETED|Baseline||0
8248112|NCT01881373|20339882|P3|COMPLETED|Baseline|Cross-sectional sample|1321
8248113|NCT01881373|20339883|P2|COMPLETED|Baseline|Cross-sectional sample|1491
8248114|NCT01881373|20339884|P1|COMPLETED|Baseline|Cross-sectional sample|1517
8248115|NCT01881373|20339882|P3|STARTED|Baseline|Cross-sectional sample|1321
8248116|NCT01881373|20339883|P2|STARTED|Baseline|Cross-sectional sample|1491
8248117|NCT01881373|20339884|P1|STARTED|Baseline|Cross-sectional sample|1517
8248118|NCT01881230|20339931|P3|NOT COMPLETED|Overall Study||66
8248119|NCT01881230|20339932|P2|NOT COMPLETED|Overall Study||64
8248120|NCT01881230|20339933|P1|NOT COMPLETED|Overall Study||61
8248121|NCT01881230|20339931|P3|COMPLETED|Overall Study|Not applicable according to the study design|0
8248122|NCT01881230|20339932|P2|COMPLETED|Overall Study|Not applicable according to the study design|0
8248123|NCT01881230|20339933|P1|COMPLETED|Overall Study|Not applicable according to the study design|0
8248124|NCT01881230|20339931|P3|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
8248125|NCT01881230|20339932|P2|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
8248126|NCT01881230|20339933|P1|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
8248127|NCT01881230|20339931|P3|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
8248128|NCT01881230|20339932|P2|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
8248129|NCT01881230|20339933|P1|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
8248130|NCT01881230|20339931|P3|STARTED|Overall Study||66
8248131|NCT01881230|20339932|P2|STARTED|Overall Study||64
8248132|NCT01881230|20339933|P1|STARTED|Overall Study||61
8248133|NCT01881126|20339961|P2|NOT COMPLETED|Overall Study||2
8248134|NCT01881126|20339962|P1|NOT COMPLETED|Overall Study||1
8248135|NCT01881126|20339961|P2|COMPLETED|Overall Study||44
8248136|NCT01881126|20339962|P1|COMPLETED|Overall Study||46
8248137|NCT01881126|20339961|P2|STARTED|Overall Study||46
8248138|NCT01881126|20339962|P1|STARTED|Overall Study||47
8248139|NCT01881113|20339970|P2|NOT COMPLETED|Overall Study||6
8248140|NCT01881113|20339971|P1|NOT COMPLETED|Overall Study||8
8248141|NCT01881113|20339970|P2|COMPLETED|Overall Study||44
8248142|NCT01881113|20339971|P1|COMPLETED|Overall Study||43
8248143|NCT01881113|20339970|P2|STARTED|Overall Study||50
8248144|NCT01881113|20339971|P1|STARTED|Overall Study||51
8248145|NCT01881087|20340028|P3|NOT COMPLETED|Overall Study||2
8248146|NCT01881087|20340029|P2|NOT COMPLETED|Overall Study||0
8248147|NCT01881087|20340030|P1|NOT COMPLETED|Overall Study||1
8248148|NCT01881087|20340028|P3|COMPLETED|Overall Study||60
8248149|NCT01881087|20340029|P2|COMPLETED|Overall Study||61
8248150|NCT01881087|20340030|P1|COMPLETED|Overall Study||59
8248151|NCT01881087|20340028|P3|STARTED|Overall Study||62
8248152|NCT01881087|20340029|P2|STARTED|Overall Study||61
8248153|NCT01881087|20340030|P1|STARTED|Overall Study||60
8248154|NCT01881009|20340043|P2|NOT COMPLETED|Summer Camp Session (6 Days)||1
8248155|NCT01881009|20340044|P1|NOT COMPLETED|Summer Camp Session (6 Days)||0
8248156|NCT01881009|20340043|P2|COMPLETED|Summer Camp Session (6 Days)||21
8248157|NCT01881009|20340044|P1|COMPLETED|Summer Camp Session (6 Days)||0
8248158|NCT01881009|20340043|P2|STARTED|Summer Camp Session (6 Days)||22
8248159|NCT01881009|20340044|P1|STARTED|Summer Camp Session (6 Days)||0
8248160|NCT01881009|20340043|P2|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
8248161|NCT01881009|20340044|P1|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
8248162|NCT01881009|20340043|P2|COMPLETED|Inpatient Safety Testing (22 Hours)||0
8248163|NCT01881009|20340044|P1|COMPLETED|Inpatient Safety Testing (22 Hours)||16
8248164|NCT01881009|20340043|P2|STARTED|Inpatient Safety Testing (22 Hours)||0
8248165|NCT01881009|20340044|P1|STARTED|Inpatient Safety Testing (22 Hours)||16
8248166|NCT01880840|20340055|P2|NOT COMPLETED|Overall Study||5
8248167|NCT01880840|20340056|P1|NOT COMPLETED|Overall Study||8
8248168|NCT01880840|20340055|P2|COMPLETED|Overall Study||91
8248169|NCT01880840|20340056|P1|COMPLETED|Overall Study||87
8248170|NCT01880840|20340055|P2|STARTED|Overall Study||96
8248171|NCT01880840|20340056|P1|STARTED|Overall Study||95
8248172|NCT01880736|20340066|P4|NOT COMPLETED|Overall Study||6
8248173|NCT01880736|20340067|P3|NOT COMPLETED|Overall Study||1
8248174|NCT01880736|20340068|P2|NOT COMPLETED|Overall Study||2
8248175|NCT01880736|20340069|P1|NOT COMPLETED|Overall Study||1
8248176|NCT01880736|20340066|P4|COMPLETED|Overall Study||108
8248177|NCT01880736|20340067|P3|COMPLETED|Overall Study||114
8248178|NCT01880736|20340068|P2|COMPLETED|Overall Study||113
8248179|NCT01880736|20340069|P1|COMPLETED|Overall Study||113
8248180|NCT01880736|20340066|P4|STARTED|Overall Study||114
8248181|NCT01880736|20340067|P3|STARTED|Overall Study||115
8248182|NCT01880736|20340068|P2|STARTED|Overall Study||115
8248183|NCT01880736|20340069|P1|STARTED|Overall Study||114
8248184|NCT01880723|20340113|P2|NOT COMPLETED|Overall Study||0
8248185|NCT01880723|20340114|P1|NOT COMPLETED|Overall Study||0
8248186|NCT01880723|20340113|P2|COMPLETED|Overall Study||16
8248187|NCT01880723|20340114|P1|COMPLETED|Overall Study||16
8248188|NCT01880723|20340113|P2|STARTED|Overall Study||16
8248189|NCT01880723|20340114|P1|STARTED|Overall Study||16
8248190|NCT01880697|20340130|P2|NOT COMPLETED|Overall Study||1
8248191|NCT01880697|20340131|P1|NOT COMPLETED|Overall Study||0
8248192|NCT01880697|20340130|P2|COMPLETED|Overall Study||62
8248193|NCT01880697|20340131|P1|COMPLETED|Overall Study||63
8248194|NCT01880697|20340130|P2|STARTED|Overall Study||63
8248195|NCT01880697|20340131|P1|STARTED|Overall Study||63
8248196|NCT01880593|20340153|P2|NOT COMPLETED|Overall Study||6
8248197|NCT01880593|20340154|P1|NOT COMPLETED|Overall Study||8
8248198|NCT01880593|20340153|P2|COMPLETED|Overall Study||10
8248199|NCT01880593|20340154|P1|COMPLETED|Overall Study||10
8248200|NCT01880593|20340153|P2|STARTED|Overall Study||16
8248201|NCT01880593|20340154|P1|STARTED|Overall Study||18
8248202|NCT01880528|20340174|P2|NOT COMPLETED|Overall Study||1
8248203|NCT01880528|20340175|P1|NOT COMPLETED|Overall Study||1
8248204|NCT01880528|20340174|P2|COMPLETED|Overall Study||10
8248205|NCT01880528|20340175|P1|COMPLETED|Overall Study||11
8248206|NCT01880528|20340174|P2|STARTED|Overall Study||11
8248207|NCT01880528|20340175|P1|STARTED|Overall Study||12
8248208|NCT01880515|20340191|P2|NOT COMPLETED|Overall Study||9
8248209|NCT01880515|20340192|P1|NOT COMPLETED|Overall Study||8
8248210|NCT01880515|20340191|P2|COMPLETED|Overall Study||45
8248211|NCT01880515|20340192|P1|COMPLETED|Overall Study||45
8248212|NCT01880515|20340191|P2|STARTED|Overall Study||54
8248213|NCT01880515|20340192|P1|STARTED|Overall Study||53
8248214|NCT01880437|20340203|P3|NOT COMPLETED|Overall Study||19
8248215|NCT01880437|20340204|P2|NOT COMPLETED|Overall Study||4
8248216|NCT01880437|20340205|P1|NOT COMPLETED|Overall Study||15
8248217|NCT01880437|20340203|P3|COMPLETED|Overall Study||0
8248218|NCT01880437|20340204|P2|COMPLETED|Overall Study||0
8248219|NCT01880437|20340205|P1|COMPLETED|Overall Study||0
8248220|NCT01880437|20340203|P3|STARTED|Overall Study||19
8248221|NCT01880437|20340204|P2|STARTED|Overall Study||4
8248222|NCT01880437|20340205|P1|STARTED|Overall Study||15
8248223|NCT01880424|20340231|P2|NOT COMPLETED|Overall Study||55
8248224|NCT01880424|20340232|P1|NOT COMPLETED|Overall Study||33
8248225|NCT01880424|20340231|P2|COMPLETED|Overall Study||367
8248226|NCT01880424|20340232|P1|COMPLETED|Overall Study||384
8248227|NCT01880424|20340231|P2|STARTED|Overall Study||422
8248228|NCT01880424|20340232|P1|STARTED|Overall Study||417
8248229|NCT01880320|20340257|P3|NOT COMPLETED|Overall Study||8
8248230|NCT01880320|20340258|P2|NOT COMPLETED|Overall Study||25
8248231|NCT01880320|20340259|P1|NOT COMPLETED|Overall Study||20
8248232|NCT01880320|20340257|P3|COMPLETED|Overall Study||61
8248233|NCT01880320|20340258|P2|COMPLETED|Overall Study||192
8248234|NCT01880320|20340259|P1|COMPLETED|Overall Study||197
8248235|NCT01880320|20340257|P3|STARTED|Overall Study||69
8248236|NCT01880320|20340258|P2|STARTED|Overall Study||217
8248237|NCT01880320|20340259|P1|STARTED|Overall Study||217
8248238|NCT01880099|20340276|P3|NOT COMPLETED|Overall Study||7
8248239|NCT01880099|20340277|P2|NOT COMPLETED|Overall Study||10
8248240|NCT01880099|20340278|P1|NOT COMPLETED|Overall Study||8
8248241|NCT01880099|20340276|P3|COMPLETED|Overall Study||15
8248242|NCT01880099|20340277|P2|COMPLETED|Overall Study||11
8248243|NCT01880099|20340278|P1|COMPLETED|Overall Study||9
8248244|NCT01880099|20340276|P3|STARTED|Overall Study||22
8248245|NCT01880099|20340277|P2|STARTED|Overall Study||21
8248246|NCT01880099|20340278|P1|STARTED|Overall Study||17
8248247|NCT01880086|20340288|P2|NOT COMPLETED|Overall Study||1
8248248|NCT01880086|20340289|P1|NOT COMPLETED|Overall Study||1
8248249|NCT01880086|20340288|P2|COMPLETED|Overall Study||6
8248250|NCT01880086|20340289|P1|COMPLETED|Overall Study||5
8248251|NCT01880086|20340288|P2|STARTED|Overall Study||7
8248252|NCT01880086|20340289|P1|STARTED|Overall Study||6
8248253|NCT01880073|20340307|P1|NOT COMPLETED|Overall Study||0
8248254|NCT01880073|20340307|P1|COMPLETED|Overall Study||24
8248255|NCT01880073|20340307|P1|STARTED|Overall Study||24
8248256|NCT01880047|20340318|P4|NOT COMPLETED|Extension Phase - 18 Months||2
8248257|NCT01880047|20340319|P3|NOT COMPLETED|Extension Phase - 18 Months||1
8248258|NCT01880047|20340320|P2|NOT COMPLETED|Extension Phase - 18 Months||3
8248259|NCT01880047|20340321|P1|NOT COMPLETED|Extension Phase - 18 Months||9
8248260|NCT01880047|20340318|P4|COMPLETED|Extension Phase - 18 Months||0
8248261|NCT01880047|20340319|P3|COMPLETED|Extension Phase - 18 Months||3
8248262|NCT01880047|20340320|P2|COMPLETED|Extension Phase - 18 Months||3
8248263|NCT01880047|20340321|P1|COMPLETED|Extension Phase - 18 Months||6
8248264|NCT01880047|20340318|P4|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2
8248265|NCT01880047|20340319|P3|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4
8248266|NCT01880047|20340320|P2|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6
8248267|NCT01880047|20340321|P1|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15
8248268|NCT01880047|20340318|P4|NOT COMPLETED|Weeks 5-8||0
8248269|NCT01880047|20340319|P3|NOT COMPLETED|Weeks 5-8||0
8248270|NCT01880047|20340320|P2|NOT COMPLETED|Weeks 5-8||1
8248271|NCT01880047|20340321|P1|NOT COMPLETED|Weeks 5-8||2
8248272|NCT01880047|20340318|P4|COMPLETED|Weeks 5-8||2
8248273|NCT01880047|20340319|P3|COMPLETED|Weeks 5-8||4
8248274|NCT01880047|20340320|P2|COMPLETED|Weeks 5-8||6
8248275|NCT01880047|20340321|P1|COMPLETED|Weeks 5-8||15
8248276|NCT01880047|20340318|P4|STARTED|Weeks 5-8||2
8248277|NCT01880047|20340319|P3|STARTED|Weeks 5-8||4
8248278|NCT01880047|20340320|P2|STARTED|Weeks 5-8||7
8248279|NCT01880047|20340321|P1|STARTED|Weeks 5-8||17
8248280|NCT01880047|20340318|P4|NOT COMPLETED|Weeks 3-4||0
8248281|NCT01880047|20340319|P3|NOT COMPLETED|Weeks 3-4||0
8248282|NCT01880047|20340320|P2|NOT COMPLETED|Weeks 3-4||1
8248283|NCT01880047|20340321|P1|NOT COMPLETED|Weeks 3-4||0
8248284|NCT01880047|20340318|P4|COMPLETED|Weeks 3-4||2
8248285|NCT01880047|20340319|P3|COMPLETED|Weeks 3-4||4
8248286|NCT01880047|20340320|P2|COMPLETED|Weeks 3-4||7
8248287|NCT01880047|20340321|P1|COMPLETED|Weeks 3-4||17
8248288|NCT01880047|20340318|P4|STARTED|Weeks 3-4||2
8248289|NCT01880047|20340319|P3|STARTED|Weeks 3-4||4
8248290|NCT01880047|20340320|P2|STARTED|Weeks 3-4||8
8248291|NCT01880047|20340321|P1|STARTED|Weeks 3-4||17
8248292|NCT01880047|20340318|P4|NOT COMPLETED|Weeks 0-2||1
8248293|NCT01880047|20340319|P3|NOT COMPLETED|Weeks 0-2||1
8248294|NCT01880047|20340320|P2|NOT COMPLETED|Weeks 0-2||1
8248295|NCT01880047|20340321|P1|NOT COMPLETED|Weeks 0-2||0
8248296|NCT01880047|20340318|P4|COMPLETED|Weeks 0-2||2
8248297|NCT01880047|20340319|P3|COMPLETED|Weeks 0-2||4
8248298|NCT01880047|20340320|P2|COMPLETED|Weeks 0-2||8
8248299|NCT01880047|20340321|P1|COMPLETED|Weeks 0-2||17
8248300|NCT01880047|20340318|P4|STARTED|Weeks 0-2||3
8248301|NCT01880047|20340319|P3|STARTED|Weeks 0-2||5
8248302|NCT01880047|20340320|P2|STARTED|Weeks 0-2||9
8248303|NCT01880047|20340321|P1|STARTED|Weeks 0-2||17
8248304|NCT01879852|20340344|P2|NOT COMPLETED|Overall Study||0
8248305|NCT01879852|20340345|P1|NOT COMPLETED|Overall Study||2
8248306|NCT01879852|20340344|P2|COMPLETED|Overall Study||13
8248307|NCT01879852|20340345|P1|COMPLETED|Overall Study||12
8248308|NCT01879852|20340344|P2|STARTED|Overall Study||13
8248309|NCT01879852|20340345|P1|STARTED|Overall Study||14
8248310|NCT01879826|20340359|P2|NOT COMPLETED|Overall Study||0
8248311|NCT01879826|20340360|P1|NOT COMPLETED|Overall Study||0
8248312|NCT01879826|20340359|P2|COMPLETED|Overall Study||40
8248313|NCT01879826|20340360|P1|COMPLETED|Overall Study||41
8248314|NCT01879826|20340359|P2|STARTED|Overall Study||40
8248315|NCT01879826|20340360|P1|STARTED|Overall Study||41
8248316|NCT01879800|20340370|P2|NOT COMPLETED|Overall Study||4
8248317|NCT01879800|20340371|P1|NOT COMPLETED|Overall Study||0
8248318|NCT01879800|20340370|P2|COMPLETED|Overall Study||26
8248319|NCT01879800|20340371|P1|COMPLETED|Overall Study||14
8248320|NCT01879800|20340370|P2|STARTED|Overall Study||30
8248321|NCT01879800|20340371|P1|STARTED|Overall Study||14
8248322|NCT01879735|20340383|P2|NOT COMPLETED|Overall Study||0
8248323|NCT01879735|20340384|P1|NOT COMPLETED|Overall Study||0
8248324|NCT01879735|20340383|P2|COMPLETED|Overall Study||16
8248325|NCT01879735|20340384|P1|COMPLETED|Overall Study||6
8248326|NCT01879735|20340383|P2|STARTED|Overall Study||16
8248327|NCT01879735|20340384|P1|STARTED|Overall Study||6
8248328|NCT01879722|20340400|P10|NOT COMPLETED|Overall Study||0
8248329|NCT01879722|20340401|P9|NOT COMPLETED|Overall Study||2
8248330|NCT01879722|20340402|P8|NOT COMPLETED|Overall Study||1
8248331|NCT01879722|20340403|P7|NOT COMPLETED|Overall Study||0
8248332|NCT01879722|20340404|P6|NOT COMPLETED|Overall Study||0
8248333|NCT01879722|20340405|P5|NOT COMPLETED|Overall Study||1
8248334|NCT01879722|20340406|P4|NOT COMPLETED|Overall Study||1
8248335|NCT01879722|20340407|P3|NOT COMPLETED|Overall Study||0
8248336|NCT01879722|20340408|P2|NOT COMPLETED|Overall Study||1
8248337|NCT01879722|20340409|P1|NOT COMPLETED|Overall Study||0
8248338|NCT01879722|20340400|P10|COMPLETED|Overall Study||6
8248339|NCT01879722|20340401|P9|COMPLETED|Overall Study||6
8248340|NCT01879722|20340402|P8|COMPLETED|Overall Study||7
8248341|NCT01879722|20340403|P7|COMPLETED|Overall Study||8
8248342|NCT01879722|20340404|P6|COMPLETED|Overall Study||9
8248343|NCT01879722|20340405|P5|COMPLETED|Overall Study||7
8248344|NCT01879722|20340406|P4|COMPLETED|Overall Study||7
8248345|NCT01879722|20340407|P3|COMPLETED|Overall Study||7
8248346|NCT01879722|20340408|P2|COMPLETED|Overall Study||7
8248347|NCT01879722|20340409|P1|COMPLETED|Overall Study||7
8248348|NCT01879722|20340400|P10|STARTED|Overall Study||6
8248349|NCT01879722|20340401|P9|STARTED|Overall Study||8
8248350|NCT01879722|20340402|P8|STARTED|Overall Study||8
8248351|NCT01879722|20340403|P7|STARTED|Overall Study||8
8248352|NCT01879722|20340404|P6|STARTED|Overall Study||9
8248353|NCT01879722|20340405|P5|STARTED|Overall Study||8
8248354|NCT01879722|20340406|P4|STARTED|Overall Study||8
8248355|NCT01879722|20340407|P3|STARTED|Overall Study||7
8248356|NCT01879722|20340408|P2|STARTED|Overall Study||8
8248357|NCT01879722|20340409|P1|STARTED|Overall Study||7
8248358|NCT01879683|20340557|P1|NOT COMPLETED|Overall Study||1
8248359|NCT01879683|20340557|P1|COMPLETED|Overall Study||9
8248360|NCT01879683|20340557|P1|STARTED|Overall Study||10
8248361|NCT01879618|20340564|P1|NOT COMPLETED|Overall Study||21
8248362|NCT01879618|20340564|P1|COMPLETED|Overall Study||131
8248363|NCT01879618|20340564|P1|STARTED|Overall Study||152
8248364|NCT01879579|20340571|P2|NOT COMPLETED|Overall Study||2
8248365|NCT01879579|20340572|P1|NOT COMPLETED|Overall Study||5
8248366|NCT01879579|20340571|P2|COMPLETED|Overall Study||26
8248367|NCT01879579|20340572|P1|COMPLETED|Overall Study||28
8248368|NCT01879579|20340571|P2|STARTED|Overall Study||28
8248369|NCT01879579|20340572|P1|STARTED|Overall Study||33
8248370|NCT01879553|20340602|P2|NOT COMPLETED|Overall Study||0
8248371|NCT01879553|20340603|P1|NOT COMPLETED|Overall Study||1
8248372|NCT01879553|20340602|P2|COMPLETED|Overall Study||63
8248373|NCT01879553|20340603|P1|COMPLETED|Overall Study||62
8248374|NCT01879553|20340602|P2|STARTED|Overall Study||63
8248375|NCT01879553|20340603|P1|STARTED|Overall Study||63
8248376|NCT01879540|20340624|P1|NOT COMPLETED|Overall Study||0
8248377|NCT01879540|20340624|P1|COMPLETED|Overall Study||63
8248378|NCT01879540|20340624|P1|STARTED|Overall Study||63
8248379|NCT01879410|20340637|P2|NOT COMPLETED|Overall Study||38
8248380|NCT01879410|20340638|P1|NOT COMPLETED|Overall Study||24
8248381|NCT01879410|20340637|P2|COMPLETED|Overall Study||312
8248382|NCT01879410|20340638|P1|COMPLETED|Overall Study||326
8248383|NCT01879410|20340637|P2|Intent-to-Treat Population|Overall Study||348
8248384|NCT01879410|20340638|P1|Intent-to-Treat Population|Overall Study||349
8248385|NCT01879410|20340637|P2|STARTED|Overall Study||350
8248386|NCT01879410|20340638|P1|STARTED|Overall Study||350
8248387|NCT01879371|20340652|P6|NOT COMPLETED|Overall Study||0
8248388|NCT01879371|20340653|P5|NOT COMPLETED|Overall Study||0
8248389|NCT01879371|20340654|P4|NOT COMPLETED|Overall Study||0
8248390|NCT01879371|20340655|P3|NOT COMPLETED|Overall Study||0
8248391|NCT01879371|20340656|P2|NOT COMPLETED|Overall Study||0
8248392|NCT01879371|20340657|P1|NOT COMPLETED|Overall Study||0
8248393|NCT01879371|20340652|P6|COMPLETED|Overall Study||6
8248394|NCT01879371|20340653|P5|COMPLETED|Overall Study||6
8248395|NCT01879371|20340654|P4|COMPLETED|Overall Study||6
8248396|NCT01879371|20340655|P3|COMPLETED|Overall Study||6
8248397|NCT01879371|20340656|P2|COMPLETED|Overall Study||6
8248398|NCT01879371|20340657|P1|COMPLETED|Overall Study||6
8248399|NCT01879371|20340652|P6|STARTED|Overall Study||6
8248400|NCT01879371|20340653|P5|STARTED|Overall Study||6
8248401|NCT01879371|20340654|P4|STARTED|Overall Study||6
8248402|NCT01879371|20340655|P3|STARTED|Overall Study||6
8248403|NCT01879371|20340656|P2|STARTED|Overall Study||6
8248404|NCT01879371|20340657|P1|STARTED|Overall Study||6
8248405|NCT01879345|20340674|P3|NOT COMPLETED|7-day Multiple-dose Period||0
8248406|NCT01879345|20340675|P2|NOT COMPLETED|7-day Multiple-dose Period||0
8248407|NCT01879345|20340676|P1|NOT COMPLETED|7-day Multiple-dose Period||0
8248408|NCT01879345|20340674|P3|COMPLETED|7-day Multiple-dose Period||6
8248409|NCT01879345|20340675|P2|COMPLETED|7-day Multiple-dose Period||6
8248410|NCT01879345|20340676|P1|COMPLETED|7-day Multiple-dose Period||6
8248411|NCT01879345|20340674|P3|STARTED|7-day Multiple-dose Period||6
8248412|NCT01879345|20340675|P2|STARTED|7-day Multiple-dose Period||6
8248413|NCT01879345|20340676|P1|STARTED|7-day Multiple-dose Period||6
8248414|NCT01879345|20340674|P3|NOT COMPLETED|Single-dose Period||0
8248415|NCT01879345|20340675|P2|NOT COMPLETED|Single-dose Period||0
8248416|NCT01879345|20340676|P1|NOT COMPLETED|Single-dose Period||0
8248417|NCT01879345|20340674|P3|COMPLETED|Single-dose Period||6
8248418|NCT01879345|20340675|P2|COMPLETED|Single-dose Period||6
8248419|NCT01879345|20340676|P1|COMPLETED|Single-dose Period||6
8248420|NCT01879345|20340674|P3|STARTED|Single-dose Period||6
8248421|NCT01879345|20340675|P2|STARTED|Single-dose Period||6
8248422|NCT01879345|20340676|P1|STARTED|Single-dose Period||6
8248423|NCT01879332|20340693|P3|NOT COMPLETED|Overall Study||4
8248424|NCT01879332|20340694|P2|NOT COMPLETED|Overall Study||6
8248425|NCT01879332|20340695|P1|NOT COMPLETED|Overall Study||6
8248426|NCT01879332|20340693|P3|COMPLETED|Overall Study||0
8248427|NCT01879332|20340694|P2|COMPLETED|Overall Study||0
8248428|NCT01879332|20340695|P1|COMPLETED|Overall Study||0
8248429|NCT01879332|20340693|P3|STARTED|Overall Study||4
8248430|NCT01879332|20340694|P2|STARTED|Overall Study||6
8248431|NCT01879332|20340695|P1|STARTED|Overall Study||6
8248432|NCT01879319|20340705|P2|NOT COMPLETED|Overall Study||5
8248433|NCT01879319|20340706|P1|NOT COMPLETED|Overall Study||2
8248434|NCT01879319|20340705|P2|COMPLETED|Overall Study||77
8248435|NCT01879319|20340706|P1|COMPLETED|Overall Study||80
8248436|NCT01879319|20340705|P2|Received Treatment|Overall Study||82
8248437|NCT01879319|20340706|P1|Received Treatment|Overall Study||82
8248438|NCT01879319|20340705|P2|STARTED|Overall Study||82
8248439|NCT01879319|20340706|P1|STARTED|Overall Study||82
8248440|NCT01879176|20340716|P2|NOT COMPLETED|Overall Study||6
8248441|NCT01879176|20340717|P1|NOT COMPLETED|Overall Study||8
8248442|NCT01879176|20340716|P2|COMPLETED|Overall Study||16
8248443|NCT01879176|20340717|P1|COMPLETED|Overall Study||16
8248444|NCT01879176|20340716|P2|STARTED|Overall Study||22
8248445|NCT01879176|20340717|P1|STARTED|Overall Study||24
8248446|NCT01879072|20340723|P1|NOT COMPLETED|Overall Study||151
8248447|NCT01879072|20340723|P1|COMPLETED|Overall Study||1709
8248448|NCT01879072|20340723|P1|STARTED|Overall Study||1860
8248449|NCT01879059|20340727|P1|NOT COMPLETED|Overall Study||0
8248450|NCT01879059|20340727|P1|COMPLETED|Overall Study||13
8248451|NCT01879059|20340727|P1|STARTED|Overall Study||13
8248452|NCT01878890|20340735|P4|NOT COMPLETED|Overall Study||0
8248453|NCT01878890|20340736|P3|NOT COMPLETED|Overall Study||0
8248454|NCT01878890|20340737|P2|NOT COMPLETED|Overall Study||1
8248455|NCT01878890|20340738|P1|NOT COMPLETED|Overall Study||0
8248456|NCT01878890|20340735|P4|COMPLETED|Overall Study||5
8248457|NCT01878890|20340736|P3|COMPLETED|Overall Study||4
8248458|NCT01878890|20340737|P2|COMPLETED|Overall Study||10
8248459|NCT01878890|20340738|P1|COMPLETED|Overall Study||5
8248460|NCT01878890|20340735|P4|STARTED|Overall Study||5
8248461|NCT01878890|20340736|P3|STARTED|Overall Study||4
8248462|NCT01878890|20340737|P2|STARTED|Overall Study||11
8248463|NCT01878890|20340738|P1|STARTED|Overall Study||5
8248464|NCT01878825|20340753|P2|NOT COMPLETED|Overall Study||0
8248465|NCT01878825|20340754|P1|NOT COMPLETED|Overall Study||0
8248466|NCT01878825|20340753|P2|COMPLETED|Overall Study||60
8248467|NCT01878825|20340754|P1|COMPLETED|Overall Study||60
8248468|NCT01878825|20340753|P2|STARTED|Overall Study||60
8248469|NCT01878825|20340754|P1|STARTED|Overall Study||60
8248470|NCT01878812|20340792|P2|NOT COMPLETED|Overall Study||0
8248471|NCT01878812|20340793|P1|NOT COMPLETED|Overall Study||0
8248472|NCT01878812|20340792|P2|COMPLETED|Overall Study||57
8248473|NCT01878812|20340793|P1|COMPLETED|Overall Study||60
8248474|NCT01878812|20340792|P2|STARTED|Overall Study||57
8248475|NCT01878812|20340793|P1|STARTED|Overall Study||60
8248476|NCT01878799|20340829|P2|NOT COMPLETED|Overall Study||0
8248477|NCT01878799|20340830|P1|NOT COMPLETED|Overall Study||1
8248478|NCT01878799|20340829|P2|COMPLETED|Overall Study||13
8248479|NCT01878799|20340830|P1|COMPLETED|Overall Study||36
8248480|NCT01878799|20340829|P2|STARTED|Overall Study||13
8248481|NCT01878799|20340830|P1|STARTED|Overall Study||37
8248482|NCT01878786|20340839|P3|NOT COMPLETED|Overall Study||7
8248483|NCT01878786|20340840|P2|NOT COMPLETED|Overall Study||9
8248484|NCT01878786|20340841|P1|NOT COMPLETED|Overall Study||9
8248485|NCT01878786|20340839|P3|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0
8248486|NCT01878786|20340840|P2|COMPLETED|Overall Study|Study closed prematurely|0
8248487|NCT01878786|20340841|P1|COMPLETED|Overall Study|Study closed prematurely|0
8248488|NCT01878786|20340839|P3|STARTED|Overall Study||7
8248489|NCT01878786|20340840|P2|STARTED|Overall Study||9
8248490|NCT01878786|20340841|P1|STARTED|Overall Study||9
8248491|NCT01878656|20340857|P2|NOT COMPLETED|Overall Study||0
8248492|NCT01878656|20340858|P1|NOT COMPLETED|Overall Study||0
8248493|NCT01878656|20340857|P2|COMPLETED|Overall Study||72
8248494|NCT01878656|20340858|P1|COMPLETED|Overall Study||72
8248495|NCT01878656|20340857|P2|STARTED|Overall Study||72
8248496|NCT01878656|20340858|P1|STARTED|Overall Study||72
8248497|NCT01878604|20340864|P1|NOT COMPLETED|Overall Study||0
8248498|NCT01878604|20340864|P1|COMPLETED|Overall Study||5
8248499|NCT01878604|20340864|P1|STARTED|Overall Study||5
8248500|NCT01878526|20340871|P2|NOT COMPLETED|Overall Study||2
8248501|NCT01878526|20340872|P1|NOT COMPLETED|Overall Study||3
8248502|NCT01878526|20340871|P2|COMPLETED|Overall Study||38
8248503|NCT01878526|20340872|P1|COMPLETED|Overall Study||37
8248504|NCT01878526|20340871|P2|STARTED|Overall Study||40
8248505|NCT01878526|20340872|P1|STARTED|Overall Study||40
8248506|NCT01878383|20340887|P2|NOT COMPLETED|Overall Study||1499
8248507|NCT01878383|20340888|P1|NOT COMPLETED|Overall Study||0
8248508|NCT01878383|20340887|P2|COMPLETED|Overall Study||11001
8248509|NCT01878383|20340888|P1|COMPLETED|Overall Study||50
8248510|NCT01878383|20340887|P2|STARTED|Overall Study||12500
8248511|NCT01878383|20340888|P1|STARTED|Overall Study||50
8248512|NCT01878292|20340898|P3|NOT COMPLETED|Double-blind Down-Taper Period||4
8248513|NCT01878292|20340899|P2|NOT COMPLETED|Double-blind Down-Taper Period||8
8248514|NCT01878292|20340900|P1|NOT COMPLETED|Double-blind Down-Taper Period||5
8248515|NCT01878292|20340898|P3|COMPLETED|Double-blind Down-Taper Period||142
8248516|NCT01878292|20340899|P2|COMPLETED|Double-blind Down-Taper Period||132
8248517|NCT01878292|20340900|P1|COMPLETED|Double-blind Down-Taper Period||122
8248518|NCT01878292|20340898|P3|STARTED|Double-blind Down-Taper Period||146
8248519|NCT01878292|20340899|P2|STARTED|Double-blind Down-Taper Period||140
8248520|NCT01878292|20340900|P1|STARTED|Double-blind Down-Taper Period||127
8248521|NCT01878292|20340898|P3|NOT COMPLETED|Double-blind Treatment Period||19
8248522|NCT01878292|20340899|P2|NOT COMPLETED|Double-blind Treatment Period||26
8248523|NCT01878292|20340900|P1|NOT COMPLETED|Double-blind Treatment Period||29
8248524|NCT01878292|20340898|P3|COMPLETED|Double-blind Treatment Period||161
8248525|NCT01878292|20340899|P2|COMPLETED|Double-blind Treatment Period||149
8248526|NCT01878292|20340900|P1|COMPLETED|Double-blind Treatment Period||142
8248527|NCT01878292|20340898|P3|STARTED|Double-blind Treatment Period||180
8248528|NCT01878292|20340899|P2|STARTED|Double-blind Treatment Period||175
8248529|NCT01878292|20340900|P1|STARTED|Double-blind Treatment Period||171
8248530|NCT01878292|20340898|P3|NOT COMPLETED|Randomized||0
8248531|NCT01878292|20340899|P2|NOT COMPLETED|Randomized||0
8248532|NCT01878292|20340900|P1|NOT COMPLETED|Randomized||3
8248533|NCT01878292|20340898|P3|COMPLETED|Randomized||180
8248534|NCT01878292|20340899|P2|COMPLETED|Randomized||175
8248535|NCT01878292|20340900|P1|COMPLETED|Randomized||171
8248536|NCT01878292|20340898|P3|STARTED|Randomized||180
8248537|NCT01878292|20340899|P2|STARTED|Randomized||175
8248538|NCT01878292|20340900|P1|STARTED|Randomized||174
8248539|NCT01878253|20340911|P1|NOT COMPLETED|Overall Study||9
8248540|NCT01878253|20340911|P1|COMPLETED|Overall Study||86
8248541|NCT01878253|20340911|P1|2 Year|Overall Study||86
8248542|NCT01878253|20340911|P1|1 Year|Overall Study||88
8248543|NCT01878253|20340911|P1|6 Months|Overall Study||90
8248544|NCT01878253|20340911|P1|6 Weeks|Overall Study||95
8248545|NCT01878253|20340911|P1|Pre-Operative|Overall Study||95
8248546|NCT01878253|20340911|P1|STARTED|Overall Study||95
8248547|NCT01878214|20340922|P2|NOT COMPLETED|Overall Study||44
8248548|NCT01878214|20340923|P1|NOT COMPLETED|Overall Study||53
8248549|NCT01878214|20340922|P2|COMPLETED|Overall Study||175
8248550|NCT01878214|20340923|P1|COMPLETED|Overall Study||170
8248551|NCT01878214|20340922|P2|STARTED|Overall Study||219
8248552|NCT01878214|20340923|P1|STARTED|Overall Study||223
8248553|NCT01878175|20340937|P1|NOT COMPLETED|Overall Study||2
8248554|NCT01878175|20340937|P1|COMPLETED|Overall Study||13
8248555|NCT01878175|20340937|P1|STARTED|Overall Study||15
8248556|NCT01878149|20340956|P2|NOT COMPLETED|Overall Study||2
8248557|NCT01878149|20340957|P1|NOT COMPLETED|Overall Study||2
8248558|NCT01878149|20340956|P2|COMPLETED|Overall Study||15
8248559|NCT01878149|20340957|P1|COMPLETED|Overall Study||19
8248560|NCT01878149|20340956|P2|STARTED|Overall Study||17
8248561|NCT01878149|20340957|P1|STARTED|Overall Study||21
8248562|NCT01878097|20340965|P2|NOT COMPLETED|Implementation Year 4||3007
8248563|NCT01878097|20340966|P1|NOT COMPLETED|Implementation Year 4||3604
8248564|NCT01878097|20340965|P2|COMPLETED|Implementation Year 4||6607
8248565|NCT01878097|20340966|P1|COMPLETED|Implementation Year 4||6981
8248566|NCT01878097|20340965|P2|STARTED|Implementation Year 4||9614
8248567|NCT01878097|20340966|P1|STARTED|Implementation Year 4||10585
8248568|NCT01878097|20340965|P2|NOT COMPLETED|Implementation Year 3||2980
8248569|NCT01878097|20340966|P1|NOT COMPLETED|Implementation Year 3||3494
8248570|NCT01878097|20340965|P2|COMPLETED|Implementation Year 3||6770
8248571|NCT01878097|20340966|P1|COMPLETED|Implementation Year 3||7046
8248572|NCT01878097|20340965|P2|STARTED|Implementation Year 3||9750
8248573|NCT01878097|20340966|P1|STARTED|Implementation Year 3||10540
8248574|NCT01878097|20340965|P2|NOT COMPLETED|Implementation Year 2||2841
8248575|NCT01878097|20340966|P1|NOT COMPLETED|Implementation Year 2||3281
8248576|NCT01878097|20340965|P2|COMPLETED|Implementation Year 2||6770
8248577|NCT01878097|20340966|P1|COMPLETED|Implementation Year 2||8286
8248578|NCT01878097|20340965|P2|STARTED|Implementation Year 2||9611
8248579|NCT01878097|20340966|P1|STARTED|Implementation Year 2||11567
8248580|NCT01878097|20340965|P2|NOT COMPLETED|Implementation Year 1||2549
8248581|NCT01878097|20340966|P1|NOT COMPLETED|Implementation Year 1||3202
8248582|NCT01878097|20340965|P2|COMPLETED|Implementation Year 1||7317
8248583|NCT01878097|20340966|P1|COMPLETED|Implementation Year 1||8540
8248584|NCT01878097|20340965|P2|STARTED|Implementation Year 1||9866
8248585|NCT01878097|20340966|P1|STARTED|Implementation Year 1||11742
8248586|NCT01878097|20340965|P2|NOT COMPLETED|Baseline||1800
8248587|NCT01878097|20340966|P1|NOT COMPLETED|Baseline||2497
8248588|NCT01878097|20340965|P2|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
8248589|NCT01878097|20340966|P1|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
8248590|NCT01878097|20340965|P2|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
8248591|NCT01878097|20340966|P1|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
8248592|NCT01878084|20340974|P1|NOT COMPLETED|Overall Study||2
8248593|NCT01878084|20340974|P1|COMPLETED|Overall Study||7
8248594|NCT01878084|20340974|P1|Control (Sockets Were Left Empty)|Overall Study||7
8248595|NCT01878084|20340974|P1|Test(Received TAMP Bioglass) s|Overall Study||7
8248596|NCT01878084|20340974|P1|STARTED|Overall Study||9
8248609|NCT01877941|20341000|P1|NOT COMPLETED|Overall Study||0
8248610|NCT01877941|20341000|P1|COMPLETED|Overall Study||39
8248611|NCT01877941|20341000|P1|STARTED|Overall Study||39
8248612|NCT01877915|20341008|P2|NOT COMPLETED|Overall Study||68
8248613|NCT01877915|20341009|P1|NOT COMPLETED|Overall Study||54
8248614|NCT01877915|20341008|P2|COMPLETED|Overall Study||2447
8248615|NCT01877915|20341009|P1|COMPLETED|Overall Study||2453
8248616|NCT01877915|20341008|P2|STARTED|Overall Study||2515
8248617|NCT01877915|20341009|P1|STARTED|Overall Study||2507
8248618|NCT01877720|20341031|P2|NOT COMPLETED|Overall Study||0
8248619|NCT01877720|20341032|P1|NOT COMPLETED|Overall Study||1
8248620|NCT01877720|20341031|P2|COMPLETED|Overall Study||8
8248621|NCT01877720|20341032|P1|COMPLETED|Overall Study||7
8248622|NCT01877720|20341031|P2|2nd Intervention|Overall Study||8
8248623|NCT01877720|20341032|P1|2nd Intervention|Overall Study||7
8248624|NCT01877720|20341031|P2|1st Intervention|Overall Study||8
8248625|NCT01877720|20341032|P1|1st Intervention|Overall Study||7
8248626|NCT01877720|20341031|P2|STARTED|Overall Study||8
8248627|NCT01877720|20341032|P1|STARTED|Overall Study||8
8248628|NCT01877668|20341061|P5|NOT COMPLETED|Overall Study||10
8248629|NCT01877668|20341062|P4|NOT COMPLETED|Overall Study||8
8248630|NCT01877668|20341063|P3|NOT COMPLETED|Overall Study||12
8248631|NCT01877668|20341064|P2|NOT COMPLETED|Overall Study||8
8248632|NCT01877668|20341065|P1|NOT COMPLETED|Overall Study||11
8248633|NCT01877668|20341061|P5|COMPLETED|Overall Study||43
8248634|NCT01877668|20341062|P4|COMPLETED|Overall Study||44
8248635|NCT01877668|20341063|P3|COMPLETED|Overall Study||94
8248636|NCT01877668|20341064|P2|COMPLETED|Overall Study||96
8248637|NCT01877668|20341065|P1|COMPLETED|Overall Study||96
8248638|NCT01877668|20341061|P5|STARTED|Overall Study|Received treatment|53
8248639|NCT01877668|20341062|P4|STARTED|Overall Study|Received treatment|52
8248640|NCT01877668|20341063|P3|STARTED|Overall Study|Received treatment|106
8248641|NCT01877668|20341064|P2|STARTED|Overall Study|Received treatment|104
8248642|NCT01877668|20341065|P1|STARTED|Overall Study|Received treatment|107
8248651|NCT01877642|20341315|P7|NOT COMPLETED|Overall Study||0
8248652|NCT01877642|20341316|P6|NOT COMPLETED|Overall Study||0
8248653|NCT01877642|20341317|P5|NOT COMPLETED|Overall Study||0
8248654|NCT01877642|20341318|P4|NOT COMPLETED|Overall Study||0
8248655|NCT01877642|20341319|P3|NOT COMPLETED|Overall Study||0
8248656|NCT01877642|20341320|P2|NOT COMPLETED|Overall Study||0
8248657|NCT01877642|20341321|P1|NOT COMPLETED|Overall Study||0
8248658|NCT01877642|20341315|P7|COMPLETED|Overall Study||3
8248659|NCT01877642|20341316|P6|COMPLETED|Overall Study||3
8248660|NCT01877642|20341317|P5|COMPLETED|Overall Study||3
8248661|NCT01877642|20341318|P4|COMPLETED|Overall Study||3
8248662|NCT01877642|20341319|P3|COMPLETED|Overall Study||3
8248663|NCT01877642|20341320|P2|COMPLETED|Overall Study||3
8248664|NCT01877642|20341321|P1|COMPLETED|Overall Study||4
8248665|NCT01877642|20341315|P7|STARTED|Overall Study||3
8248666|NCT01877642|20341316|P6|STARTED|Overall Study||3
8248667|NCT01877642|20341317|P5|STARTED|Overall Study||3
8248668|NCT01877642|20341318|P4|STARTED|Overall Study||3
8248669|NCT01877642|20341319|P3|STARTED|Overall Study||3
8248670|NCT01877642|20341320|P2|STARTED|Overall Study||3
8248671|NCT01877642|20341321|P1|STARTED|Overall Study||4
8248672|NCT01877564|20341344|P2|NOT COMPLETED|Overall Study||0
8248673|NCT01877564|20341345|P1|NOT COMPLETED|Overall Study||0
8248674|NCT01877564|20341344|P2|COMPLETED|Overall Study||4
8248675|NCT01877564|20341345|P1|COMPLETED|Overall Study||6
8248676|NCT01877564|20341344|P2|STARTED|Overall Study||4
8248677|NCT01877564|20341345|P1|STARTED|Overall Study||6
8248678|NCT01877551|20341353|P2|NOT COMPLETED|Overall Study||1
8248679|NCT01877551|20341354|P1|NOT COMPLETED|Overall Study||0
8248680|NCT01877551|20341353|P2|COMPLETED|Overall Study||13
8248681|NCT01877551|20341354|P1|COMPLETED|Overall Study||13
8248682|NCT01877551|20341353|P2|STARTED|Overall Study||14
8248683|NCT01877551|20341354|P1|STARTED|Overall Study||13
8248684|NCT01877538|20341366|P1|NOT COMPLETED|Overall Study||0
8248685|NCT01877538|20341366|P1|COMPLETED|Overall Study||7
8248686|NCT01877538|20341366|P1|STARTED|Overall Study||7
8248687|NCT01877421|20341403|P18|NOT COMPLETED|Phase 2||0
8248688|NCT01877421|20341404|P17|NOT COMPLETED|Phase 2||0
8248689|NCT01877421|20341405|P16|NOT COMPLETED|Phase 2||1
8248690|NCT01877421|20341406|P15|NOT COMPLETED|Phase 2||0
8248691|NCT01877421|20341407|P14|NOT COMPLETED|Phase 2||0
8248692|NCT01877421|20341408|P13|NOT COMPLETED|Phase 2||1
8248693|NCT01877421|20341409|P12|NOT COMPLETED|Phase 2||0
8248694|NCT01877421|20341410|P11|NOT COMPLETED|Phase 2||2
8248695|NCT01877421|20341411|P10|NOT COMPLETED|Phase 2||0
8248696|NCT01877421|20341412|P9|NOT COMPLETED|Phase 2||1
8248697|NCT01877421|20341413|P8|NOT COMPLETED|Phase 2||0
8248698|NCT01877421|20341414|P7|NOT COMPLETED|Phase 2||1
8248699|NCT01877421|20341415|P6|NOT COMPLETED|Phase 2||0
8248700|NCT01877421|20341416|P5|NOT COMPLETED|Phase 2||0
8248701|NCT01877421|20341417|P4|NOT COMPLETED|Phase 2||0
8248702|NCT01877421|20341418|P3|NOT COMPLETED|Phase 2||0
8248703|NCT01877421|20341419|P2|NOT COMPLETED|Phase 2||0
8248704|NCT01877421|20341420|P1|NOT COMPLETED|Phase 2||0
8248705|NCT01877421|20341403|P18|COMPLETED|Phase 2||0
8248706|NCT01877421|20341404|P17|COMPLETED|Phase 2||0
8248707|NCT01877421|20341405|P16|COMPLETED|Phase 2||2
8248708|NCT01877421|20341406|P15|COMPLETED|Phase 2||7
8248709|NCT01877421|20341407|P14|COMPLETED|Phase 2||3
8248710|NCT01877421|20341408|P13|COMPLETED|Phase 2||6
8248711|NCT01877421|20341409|P12|COMPLETED|Phase 2||3
8248712|NCT01877421|20341410|P11|COMPLETED|Phase 2||5
8248713|NCT01877421|20341411|P10|COMPLETED|Phase 2||3
8248714|NCT01877421|20341412|P9|COMPLETED|Phase 2||5
8248715|NCT01877421|20341413|P8|COMPLETED|Phase 2||2
8248716|NCT01877421|20341414|P7|COMPLETED|Phase 2||6
8248717|NCT01877421|20341415|P6|COMPLETED|Phase 2||3
8248718|NCT01877421|20341416|P5|COMPLETED|Phase 2||7
8248719|NCT01877421|20341417|P4|COMPLETED|Phase 2||2
8248720|NCT01877421|20341418|P3|COMPLETED|Phase 2||4
8248721|NCT01877421|20341419|P2|COMPLETED|Phase 2||0
8248722|NCT01877421|20341420|P1|COMPLETED|Phase 2||0
8248723|NCT01877421|20341403|P18|STARTED|Phase 2||0
8248724|NCT01877421|20341404|P17|STARTED|Phase 2||0
8248725|NCT01877421|20341405|P16|STARTED|Phase 2||3
8248726|NCT01877421|20341406|P15|STARTED|Phase 2||7
8248727|NCT01877421|20341407|P14|STARTED|Phase 2||3
8248728|NCT01877421|20341408|P13|STARTED|Phase 2||7
8248729|NCT01877421|20341409|P12|STARTED|Phase 2||3
8248730|NCT01877421|20341410|P11|STARTED|Phase 2||7
8248731|NCT01877421|20341411|P10|STARTED|Phase 2||3
8248732|NCT01877421|20341412|P9|STARTED|Phase 2||6
8248733|NCT01877421|20341413|P8|STARTED|Phase 2||2
8248734|NCT01877421|20341414|P7|STARTED|Phase 2||7
8248735|NCT01877421|20341415|P6|STARTED|Phase 2||3
8248736|NCT01877421|20341416|P5|STARTED|Phase 2||7
8248737|NCT01877421|20341417|P4|STARTED|Phase 2||2
8248738|NCT01877421|20341418|P3|STARTED|Phase 2||4
8248739|NCT01877421|20341419|P2|STARTED|Phase 2||0
8248740|NCT01877421|20341420|P1|STARTED|Phase 2||0
8248741|NCT01877421|20341403|P18|NOT COMPLETED|Phase 1||0
8248742|NCT01877421|20341404|P17|NOT COMPLETED|Phase 1||0
8248743|NCT01877421|20341405|P16|NOT COMPLETED|Phase 1||0
8248744|NCT01877421|20341406|P15|NOT COMPLETED|Phase 1||0
8248745|NCT01877421|20341407|P14|NOT COMPLETED|Phase 1||0
8248746|NCT01877421|20341408|P13|NOT COMPLETED|Phase 1||0
8248747|NCT01877421|20341409|P12|NOT COMPLETED|Phase 1||0
8248748|NCT01877421|20341410|P11|NOT COMPLETED|Phase 1||0
8248749|NCT01877421|20341411|P10|NOT COMPLETED|Phase 1||0
8248750|NCT01877421|20341412|P9|NOT COMPLETED|Phase 1||0
8248751|NCT01877421|20341413|P8|NOT COMPLETED|Phase 1||0
8248752|NCT01877421|20341414|P7|NOT COMPLETED|Phase 1||0
8248753|NCT01877421|20341415|P6|NOT COMPLETED|Phase 1||0
8248754|NCT01877421|20341416|P5|NOT COMPLETED|Phase 1||0
8248755|NCT01877421|20341417|P4|NOT COMPLETED|Phase 1||0
8248756|NCT01877421|20341418|P3|NOT COMPLETED|Phase 1||0
8248757|NCT01877421|20341419|P2|NOT COMPLETED|Phase 1||0
8248758|NCT01877421|20341420|P1|NOT COMPLETED|Phase 1||0
8248759|NCT01877421|20341403|P18|COMPLETED|Phase 1||3
8248760|NCT01877421|20341404|P17|COMPLETED|Phase 1||7
8248761|NCT01877421|20341405|P16|COMPLETED|Phase 1||3
8248762|NCT01877421|20341406|P15|COMPLETED|Phase 1||7
8248763|NCT01877421|20341407|P14|COMPLETED|Phase 1||3
8248764|NCT01877421|20341408|P13|COMPLETED|Phase 1||7
8248765|NCT01877421|20341409|P12|COMPLETED|Phase 1||3
8248766|NCT01877421|20341410|P11|COMPLETED|Phase 1||7
8248767|NCT01877421|20341411|P10|COMPLETED|Phase 1||3
8248768|NCT01877421|20341412|P9|COMPLETED|Phase 1||7
8248769|NCT01877421|20341413|P8|COMPLETED|Phase 1||2
8248770|NCT01877421|20341414|P7|COMPLETED|Phase 1||4
8248771|NCT01877421|20341415|P6|COMPLETED|Phase 1||2
8248772|NCT01877421|20341416|P5|COMPLETED|Phase 1||4
8248773|NCT01877421|20341417|P4|COMPLETED|Phase 1||2
8248774|NCT01877421|20341418|P3|COMPLETED|Phase 1||4
8248775|NCT01877421|20341419|P2|COMPLETED|Phase 1||1
8248776|NCT01877421|20341420|P1|COMPLETED|Phase 1||2
8248777|NCT01877421|20341403|P18|STARTED|Phase 1||3
8248778|NCT01877421|20341404|P17|STARTED|Phase 1||7
8248779|NCT01877421|20341405|P16|STARTED|Phase 1||3
8248780|NCT01877421|20341406|P15|STARTED|Phase 1||7
8248781|NCT01877421|20341407|P14|STARTED|Phase 1||3
8248782|NCT01877421|20341408|P13|STARTED|Phase 1||7
8248783|NCT01877421|20341409|P12|STARTED|Phase 1||3
8248784|NCT01877421|20341410|P11|STARTED|Phase 1||7
8248785|NCT01877421|20341411|P10|STARTED|Phase 1||3
8248786|NCT01877421|20341412|P9|STARTED|Phase 1||7
8248787|NCT01877421|20341413|P8|STARTED|Phase 1||2
8248788|NCT01877421|20341414|P7|STARTED|Phase 1||4
8248789|NCT01877421|20341415|P6|STARTED|Phase 1||2
8248790|NCT01877421|20341416|P5|STARTED|Phase 1||4
8248791|NCT01877421|20341417|P4|STARTED|Phase 1||2
8248792|NCT01877421|20341418|P3|STARTED|Phase 1||4
8248793|NCT01877421|20341419|P2|STARTED|Phase 1||1
8248794|NCT01877421|20341420|P1|STARTED|Phase 1||2
8248795|NCT01877408|20341530|P2|NOT COMPLETED|Overall Study||2
8248796|NCT01877408|20341531|P1|NOT COMPLETED|Overall Study||0
8248797|NCT01877408|20341530|P2|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
8248798|NCT01877408|20341531|P1|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
8248799|NCT01877408|20341530|P2|STARTED|Overall Study||100
8248800|NCT01877408|20341531|P1|STARTED|Overall Study||50
8248801|NCT01877343|20341551|P7|NOT COMPLETED|Overall Study||0
8248802|NCT01877343|20341552|P6|NOT COMPLETED|Overall Study||0
8248803|NCT01877343|20341553|P5|NOT COMPLETED|Overall Study||0
8248804|NCT01877343|20341554|P4|NOT COMPLETED|Overall Study||0
8248805|NCT01877343|20341555|P3|NOT COMPLETED|Overall Study||0
8248806|NCT01877343|20341556|P2|NOT COMPLETED|Overall Study||0
8248807|NCT01877343|20341557|P1|NOT COMPLETED|Overall Study||0
8248808|NCT01877343|20341551|P7|COMPLETED|Overall Study||0
8248809|NCT01877343|20341552|P6|COMPLETED|Overall Study||5
8248810|NCT01877343|20341553|P5|COMPLETED|Overall Study||0
8248811|NCT01877343|20341554|P4|COMPLETED|Overall Study||0
8248812|NCT01877343|20341555|P3|COMPLETED|Overall Study||0
8248813|NCT01877343|20341556|P2|COMPLETED|Overall Study||3
8248814|NCT01877343|20341557|P1|COMPLETED|Overall Study||2
8248815|NCT01877343|20341551|P7|STARTED|Overall Study||0
8248816|NCT01877343|20341552|P6|STARTED|Overall Study||5
8248817|NCT01877343|20341553|P5|STARTED|Overall Study||0
8248818|NCT01877343|20341554|P4|STARTED|Overall Study||0
8248819|NCT01877343|20341555|P3|STARTED|Overall Study||0
8248820|NCT01877343|20341556|P2|STARTED|Overall Study||3
8248821|NCT01877343|20341557|P1|STARTED|Overall Study||2
8248822|NCT01877278|20341564|P2|NOT COMPLETED|Overall Study||3
8248823|NCT01877278|20341565|P1|NOT COMPLETED|Overall Study||3
8248824|NCT01877278|20341564|P2|COMPLETED|Overall Study||30
8248825|NCT01877278|20341565|P1|COMPLETED|Overall Study||30
8248826|NCT01877278|20341564|P2|STARTED|Overall Study||33
8248827|NCT01877278|20341565|P1|STARTED|Overall Study||33
8248828|NCT01877265|20341573|P6|NOT COMPLETED|Treatment Period 3||0
8248829|NCT01877265|20341574|P5|NOT COMPLETED|Treatment Period 3||0
8248830|NCT01877265|20341575|P4|NOT COMPLETED|Treatment Period 3||0
8248831|NCT01877265|20341576|P3|NOT COMPLETED|Treatment Period 3||0
8248832|NCT01877265|20341577|P2|NOT COMPLETED|Treatment Period 3||0
8248833|NCT01877265|20341578|P1|NOT COMPLETED|Treatment Period 3||1
8248834|NCT01877265|20341573|P6|COMPLETED|Treatment Period 3||2
8248835|NCT01877265|20341574|P5|COMPLETED|Treatment Period 3||3
8248836|NCT01877265|20341575|P4|COMPLETED|Treatment Period 3||3
8248837|NCT01877265|20341576|P3|COMPLETED|Treatment Period 3||2
8248838|NCT01877265|20341577|P2|COMPLETED|Treatment Period 3||3
8248839|NCT01877265|20341578|P1|COMPLETED|Treatment Period 3||2
8248840|NCT01877265|20341573|P6|Received at Least One Dose of Study Drug|Treatment Period 3||2
8248841|NCT01877265|20341574|P5|Received at Least One Dose of Study Drug|Treatment Period 3||3
8248842|NCT01877265|20341575|P4|Received at Least One Dose of Study Drug|Treatment Period 3||3
8248843|NCT01877265|20341576|P3|Received at Least One Dose of Study Drug|Treatment Period 3||2
8248844|NCT01877265|20341577|P2|Received at Least One Dose of Study Drug|Treatment Period 3||3
8248845|NCT01877265|20341578|P1|Received at Least One Dose of Study Drug|Treatment Period 3||3
8248846|NCT01877265|20341573|P6|STARTED|Treatment Period 3||2
8248847|NCT01877265|20341574|P5|STARTED|Treatment Period 3||3
8248848|NCT01877265|20341575|P4|STARTED|Treatment Period 3||3
8248849|NCT01877265|20341576|P3|STARTED|Treatment Period 3||2
8248850|NCT01877265|20341577|P2|STARTED|Treatment Period 3||3
8248851|NCT01877265|20341578|P1|STARTED|Treatment Period 3||3
8248852|NCT01877265|20341573|P6|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
8248853|NCT01877265|20341574|P5|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8248854|NCT01877265|20341575|P4|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8248855|NCT01877265|20341576|P3|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8248856|NCT01877265|20341577|P2|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8248857|NCT01877265|20341578|P1|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
8248858|NCT01877265|20341573|P6|COMPLETED|Washout Period 2 (at Least 14 Days)||2
8248859|NCT01877265|20341574|P5|COMPLETED|Washout Period 2 (at Least 14 Days)||3
8248860|NCT01877265|20341575|P4|COMPLETED|Washout Period 2 (at Least 14 Days)||3
8248861|NCT01877265|20341576|P3|COMPLETED|Washout Period 2 (at Least 14 Days)||2
8248862|NCT01877265|20341577|P2|COMPLETED|Washout Period 2 (at Least 14 Days)||3
8248863|NCT01877265|20341578|P1|COMPLETED|Washout Period 2 (at Least 14 Days)||3
8248864|NCT01877265|20341573|P6|STARTED|Washout Period 2 (at Least 14 Days)||3
8248865|NCT01877265|20341574|P5|STARTED|Washout Period 2 (at Least 14 Days)||3
8248866|NCT01877265|20341575|P4|STARTED|Washout Period 2 (at Least 14 Days)||3
8248867|NCT01877265|20341576|P3|STARTED|Washout Period 2 (at Least 14 Days)||2
8248868|NCT01877265|20341577|P2|STARTED|Washout Period 2 (at Least 14 Days)||3
8248869|NCT01877265|20341578|P1|STARTED|Washout Period 2 (at Least 14 Days)||3
8248870|NCT01877265|20341573|P6|NOT COMPLETED|Treatment Period 2||0
8248871|NCT01877265|20341574|P5|NOT COMPLETED|Treatment Period 2||0
8248872|NCT01877265|20341575|P4|NOT COMPLETED|Treatment Period 2||0
8248873|NCT01877265|20341576|P3|NOT COMPLETED|Treatment Period 2||0
8248874|NCT01877265|20341577|P2|NOT COMPLETED|Treatment Period 2||0
8248875|NCT01877265|20341578|P1|NOT COMPLETED|Treatment Period 2||0
8248876|NCT01877265|20341573|P6|COMPLETED|Treatment Period 2||3
8248877|NCT01877265|20341574|P5|COMPLETED|Treatment Period 2||3
8248878|NCT01877265|20341575|P4|COMPLETED|Treatment Period 2||3
8248879|NCT01877265|20341576|P3|COMPLETED|Treatment Period 2||2
8248880|NCT01877265|20341577|P2|COMPLETED|Treatment Period 2||3
8248881|NCT01877265|20341578|P1|COMPLETED|Treatment Period 2||3
8248882|NCT01877265|20341573|P6|Received at Least One Dose of Study Drug|Treatment Period 2||3
8248883|NCT01877265|20341574|P5|Received at Least One Dose of Study Drug|Treatment Period 2||3
8248884|NCT01877265|20341575|P4|Received at Least One Dose of Study Drug|Treatment Period 2||3
8248885|NCT01877265|20341576|P3|Received at Least One Dose of Study Drug|Treatment Period 2||2
8248886|NCT01877265|20341577|P2|Received at Least One Dose of Study Drug|Treatment Period 2||3
8248887|NCT01877265|20341578|P1|Received at Least One Dose of Study Drug|Treatment Period 2||3
8248888|NCT01877265|20341573|P6|STARTED|Treatment Period 2||3
8248889|NCT01877265|20341574|P5|STARTED|Treatment Period 2||3
8248890|NCT01877265|20341575|P4|STARTED|Treatment Period 2||3
8248891|NCT01877265|20341576|P3|STARTED|Treatment Period 2||2
8248892|NCT01877265|20341577|P2|STARTED|Treatment Period 2||3
8248893|NCT01877265|20341578|P1|STARTED|Treatment Period 2||3
8248894|NCT01877265|20341573|P6|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8248895|NCT01877265|20341574|P5|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8248896|NCT01877265|20341575|P4|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8248897|NCT01877265|20341576|P3|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8248898|NCT01877265|20341577|P2|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8248899|NCT01877265|20341578|P1|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
8248900|NCT01877265|20341573|P6|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8248901|NCT01877265|20341574|P5|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8248902|NCT01877265|20341575|P4|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8248903|NCT01877265|20341576|P3|COMPLETED|Washout Period 1 (at Least 14 Days)||2
8248904|NCT01877265|20341577|P2|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8248905|NCT01877265|20341578|P1|COMPLETED|Washout Period 1 (at Least 14 Days)||3
8248906|NCT01877265|20341573|P6|STARTED|Washout Period 1 (at Least 14 Days)||3
8248907|NCT01877265|20341574|P5|STARTED|Washout Period 1 (at Least 14 Days)||3
8248908|NCT01877265|20341575|P4|STARTED|Washout Period 1 (at Least 14 Days)||3
8248909|NCT01877265|20341576|P3|STARTED|Washout Period 1 (at Least 14 Days)||2
8248910|NCT01877265|20341577|P2|STARTED|Washout Period 1 (at Least 14 Days)||3
8248911|NCT01877265|20341578|P1|STARTED|Washout Period 1 (at Least 14 Days)||3
8248912|NCT01877265|20341573|P6|NOT COMPLETED|Treatment Period 1||0
8248913|NCT01877265|20341574|P5|NOT COMPLETED|Treatment Period 1||0
8248914|NCT01877265|20341575|P4|NOT COMPLETED|Treatment Period 1||0
8248915|NCT01877265|20341576|P3|NOT COMPLETED|Treatment Period 1||1
8248916|NCT01877265|20341577|P2|NOT COMPLETED|Treatment Period 1||0
8248917|NCT01877265|20341578|P1|NOT COMPLETED|Treatment Period 1||0
8248918|NCT01877265|20341573|P6|COMPLETED|Treatment Period 1||3
8248919|NCT01877265|20341574|P5|COMPLETED|Treatment Period 1||3
8248920|NCT01877265|20341575|P4|COMPLETED|Treatment Period 1||3
8248921|NCT01877265|20341576|P3|COMPLETED|Treatment Period 1||2
8248922|NCT01877265|20341577|P2|COMPLETED|Treatment Period 1||3
8248923|NCT01877265|20341578|P1|COMPLETED|Treatment Period 1||3
8248924|NCT01877265|20341573|P6|Received at Least One Dose of Study Drug|Treatment Period 1||3
8248925|NCT01877265|20341574|P5|Received at Least One Dose of Study Drug|Treatment Period 1||3
8248926|NCT01877265|20341575|P4|Received at Least One Dose of Study Drug|Treatment Period 1||3
8248927|NCT01877265|20341576|P3|Received at Least One Dose of Study Drug|Treatment Period 1||3
8248928|NCT01877265|20341577|P2|Received at Least One Dose of Study Drug|Treatment Period 1||3
8248929|NCT01877265|20341578|P1|Received at Least One Dose of Study Drug|Treatment Period 1||3
8248930|NCT01877265|20341573|P6|STARTED|Treatment Period 1||3
8248931|NCT01877265|20341574|P5|STARTED|Treatment Period 1||3
8248932|NCT01877265|20341575|P4|STARTED|Treatment Period 1||3
8248933|NCT01877265|20341576|P3|STARTED|Treatment Period 1||3
8248934|NCT01877265|20341577|P2|STARTED|Treatment Period 1||3
8248935|NCT01877265|20341578|P1|STARTED|Treatment Period 1||3
8248936|NCT01877239|20341595|P1|NOT COMPLETED|Overall Study||50
8248937|NCT01877239|20341595|P1|COMPLETED|Overall Study||61
8248938|NCT01877239|20341595|P1|Treated|Overall Study||76
8248939|NCT01877239|20341595|P1|STARTED|Overall Study||111
8248940|NCT01877187|20341601|P1|NOT COMPLETED|Overall Study||22
8248941|NCT01877187|20341601|P1|COMPLETED|Overall Study|10 HCC, 7 non-HCC|17
8248942|NCT01877187|20341601|P1|Completed 90 Day f/u|Overall Study|11 HCC, 9 non-HCC|20
8248943|NCT01877187|20341601|P1|Completed 30 Day f/u|Overall Study|18 HCC, 17 non-HCC|35
8248944|NCT01877187|20341601|P1|STARTED|Overall Study|21 HCC, 18 non-HCC|39
8248945|NCT01877161|20341630|P1|NOT COMPLETED|Third Session of Stimulation||0
8248946|NCT01877161|20341630|P1|COMPLETED|Third Session of Stimulation||12
8248947|NCT01877161|20341630|P1|STARTED|Third Session of Stimulation||12
8248948|NCT01877161|20341630|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
8248949|NCT01877161|20341630|P1|COMPLETED|Washout (at Least 3 Days)||12
8248950|NCT01877161|20341630|P1|STARTED|Washout (at Least 3 Days)||12
8248951|NCT01877161|20341630|P1|NOT COMPLETED|Second Session of Stimulation||0
8248952|NCT01877161|20341630|P1|COMPLETED|Second Session of Stimulation||12
8248953|NCT01877161|20341630|P1|STARTED|Second Session of Stimulation||12
8248954|NCT01877161|20341630|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
8248955|NCT01877161|20341630|P1|COMPLETED|Washout (at Least 3 Days)||12
8248956|NCT01877161|20341630|P1|STARTED|Washout (at Least 3 Days)||12
8248957|NCT01877161|20341630|P1|NOT COMPLETED|First Session of Stimulation||0
8248958|NCT01877161|20341630|P1|COMPLETED|First Session of Stimulation||12
8248959|NCT01877161|20341630|P1|STARTED|First Session of Stimulation||12
8248960|NCT01877148|20341640|P2|NOT COMPLETED|Overall Study||1
8248961|NCT01877148|20341641|P1|NOT COMPLETED|Overall Study||1
8248962|NCT01877148|20341640|P2|COMPLETED|Overall Study||5
8248963|NCT01877148|20341641|P1|COMPLETED|Overall Study||5
8248964|NCT01877148|20341640|P2|STARTED|Overall Study||6
8248965|NCT01877148|20341641|P1|STARTED|Overall Study||6
8248966|NCT01877083|20341653|P1|NOT COMPLETED|Extension Phase||5
8248967|NCT01877083|20341653|P1|COMPLETED|Extension Phase||0
8248968|NCT01877083|20341653|P1|STARTED|Extension Phase||5
8248969|NCT01877083|20341653|P1|NOT COMPLETED|Treatment Phase||20
8248970|NCT01877083|20341653|P1|COMPLETED|Treatment Phase||5
8248971|NCT01877083|20341653|P1|STARTED|Treatment Phase||25
8248972|NCT01876992|20341662|P2|NOT COMPLETED|Overall Study||0
8248973|NCT01876992|20341663|P1|NOT COMPLETED|Overall Study||0
8248974|NCT01876992|20341662|P2|COMPLETED|Overall Study||5
8248975|NCT01876992|20341663|P1|COMPLETED|Overall Study||5
8248976|NCT01876992|20341662|P2|STARTED|Overall Study||5
8248977|NCT01876992|20341663|P1|STARTED|Overall Study||5
8248978|NCT01876979|20341677|P2|NOT COMPLETED|Overall Study||3
8248979|NCT01876979|20341678|P1|NOT COMPLETED|Overall Study||2
8248980|NCT01876979|20341677|P2|COMPLETED|Overall Study||0
8248981|NCT01876979|20341678|P1|COMPLETED|Overall Study||0
8248982|NCT01876979|20341677|P2|STARTED|Overall Study||3
8248983|NCT01876979|20341678|P1|STARTED|Overall Study||2
8248984|NCT01876823|20341684|P1|NOT COMPLETED|Overall Study||9
8248985|NCT01876823|20341684|P1|COMPLETED|Overall Study||26
8248986|NCT01876823|20341684|P1|STARTED|Overall Study||35
8248987|NCT01876810|20341697|P2|NOT COMPLETED|Overall Study||1
8248988|NCT01876810|20341698|P1|NOT COMPLETED|Overall Study||0
8248989|NCT01876810|20341697|P2|COMPLETED|Overall Study||13
8248990|NCT01876810|20341698|P1|COMPLETED|Overall Study||14
8248991|NCT01876810|20341697|P2|STARTED|Overall Study||14
8248992|NCT01876810|20341698|P1|STARTED|Overall Study||14
8249001|NCT01876732|20341717|P1|NOT COMPLETED|Overall Study||75
8249002|NCT01876732|20341717|P1|COMPLETED|Overall Study||57
8249003|NCT01876732|20341717|P1|STARTED|Overall Study||132
8249004|NCT01876706|20341722|P1|NOT COMPLETED|Overall Study||25
8249005|NCT01876706|20341722|P1|COMPLETED|Overall Study||26
8249006|NCT01876706|20341722|P1|60 Months|Overall Study||26
8249007|NCT01876706|20341722|P1|48 Months|Overall Study||31
8249008|NCT01876706|20341722|P1|36 Months|Overall Study||32
8249009|NCT01876706|20341722|P1|24 Months|Overall Study||35
8249010|NCT01876706|20341722|P1|12 Months|Overall Study||42
8249011|NCT01876706|20341722|P1|6 Months|Overall Study||46
8249012|NCT01876706|20341722|P1|3 Months|Overall Study||51
8249013|NCT01876706|20341722|P1|1 Month|Overall Study||51
8249014|NCT01876706|20341722|P1|STARTED|Overall Study||51
8249015|NCT01876511|20341742|P3|NOT COMPLETED|Overall Study||31
8249016|NCT01876511|20341743|P2|NOT COMPLETED|Overall Study||25
8249017|NCT01876511|20341744|P1|NOT COMPLETED|Overall Study||23
8249018|NCT01876511|20341742|P3|COMPLETED|Overall Study||16
8249019|NCT01876511|20341743|P2|COMPLETED|Overall Study||0
8249020|NCT01876511|20341744|P1|COMPLETED|Overall Study||18
8249021|NCT01876511|20341742|P3|Stages 1 and 2|Overall Study||21
8249022|NCT01876511|20341743|P2|Stages 1 and 2|Overall Study||25
8249023|NCT01876511|20341744|P1|Stages 1 and 2|Overall Study||24
8249024|NCT01876511|20341742|P3|STARTED|Overall Study||47
8249025|NCT01876511|20341743|P2|STARTED|Overall Study||25
8249026|NCT01876511|20341744|P1|STARTED|Overall Study||41
8249027|NCT01876485|20341781|P2|NOT COMPLETED|Overall Study||26
8249028|NCT01876485|20341782|P1|NOT COMPLETED|Overall Study||24
8249029|NCT01876485|20341781|P2|COMPLETED|Overall Study||114
8249030|NCT01876485|20341782|P1|COMPLETED|Overall Study||116
8249031|NCT01876485|20341781|P2|Maintenance|Overall Study||114
8249032|NCT01876485|20341782|P1|Maintenance|Overall Study||116
8249033|NCT01876485|20341781|P2|Post-Intervention|Overall Study||129
8249034|NCT01876485|20341782|P1|Post-Intervention|Overall Study||125
8249035|NCT01876485|20341781|P2|STARTED|Overall Study||140
8249036|NCT01876485|20341782|P1|STARTED|Overall Study||140
8249037|NCT01876446|20341792|P2|NOT COMPLETED|Overall Study||6
8249038|NCT01876446|20341793|P1|NOT COMPLETED|Overall Study||2
8249039|NCT01876446|20341792|P2|COMPLETED|Overall Study||12
8249040|NCT01876446|20341793|P1|COMPLETED|Overall Study||18
8249041|NCT01876446|20341792|P2|STARTED|Overall Study||18
8249042|NCT01876446|20341793|P1|STARTED|Overall Study||20
8249043|NCT01876420|20341809|P1|NOT COMPLETED|Overall Study||1
8249044|NCT01876420|20341809|P1|COMPLETED|Overall Study||59
8249045|NCT01876420|20341809|P1|STARTED|Overall Study||60
8249046|NCT01876381|20341821|P1|NOT COMPLETED|Overall Study||7
8249047|NCT01876381|20341821|P1|COMPLETED|Overall Study||16
8249048|NCT01876381|20341821|P1|STARTED|Overall Study||23
8249049|NCT01876368|20341828|P2|NOT COMPLETED|Overall Study||13
8249050|NCT01876368|20341829|P1|NOT COMPLETED|Overall Study||9
8249051|NCT01876368|20341828|P2|COMPLETED|Overall Study||175
8249052|NCT01876368|20341829|P1|COMPLETED|Overall Study||179
8249053|NCT01876368|20341828|P2|Safety Set (SAF)|Overall Study||187
8249054|NCT01876368|20341829|P1|Safety Set (SAF)|Overall Study||188
8249055|NCT01876368|20341828|P2|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
8249056|NCT01876368|20341829|P1|Full Analysis Set (FAS)|Overall Study||188
8249057|NCT01876368|20341828|P2|STARTED|Overall Study||188
8249058|NCT01876368|20341829|P1|STARTED|Overall Study||188
8249059|NCT01876329|20341858|P3|NOT COMPLETED|Overall Study||0
8249060|NCT01876329|20341859|P2|NOT COMPLETED|Overall Study||0
8249061|NCT01876329|20341860|P1|NOT COMPLETED|Overall Study||0
8249062|NCT01876329|20341858|P3|COMPLETED|Overall Study||44
8249063|NCT01876329|20341859|P2|COMPLETED|Overall Study||36
8249064|NCT01876329|20341860|P1|COMPLETED|Overall Study||45
8249065|NCT01876329|20341858|P3|STARTED|Overall Study||44
8249066|NCT01876329|20341859|P2|STARTED|Overall Study||36
8249067|NCT01876329|20341860|P1|STARTED|Overall Study||45
8249068|NCT01876251|20341874|P3|NOT COMPLETED|Overall Study||11
8249069|NCT01876251|20341875|P2|NOT COMPLETED|Overall Study||3
8249070|NCT01876251|20341876|P1|NOT COMPLETED|Overall Study||15
8249071|NCT01876251|20341874|P3|COMPLETED|Overall Study||0
8249072|NCT01876251|20341875|P2|COMPLETED|Overall Study||0
8249073|NCT01876251|20341876|P1|COMPLETED|Overall Study||0
8249074|NCT01876251|20341874|P3|STARTED|Overall Study||11
8249075|NCT01876251|20341875|P2|STARTED|Overall Study||3
8249076|NCT01876251|20341876|P1|STARTED|Overall Study||15
8249077|NCT01876212|20341935|P2|NOT COMPLETED|Overall Study||0
8249078|NCT01876212|20341936|P1|NOT COMPLETED|Overall Study||0
8249079|NCT01876212|20341935|P2|COMPLETED|Overall Study||6
8249080|NCT01876212|20341936|P1|COMPLETED|Overall Study||9
8249081|NCT01876212|20341935|P2|STARTED|Overall Study||6
8249082|NCT01876212|20341936|P1|STARTED|Overall Study||9
8249083|NCT01876043|20341980|P1|NOT COMPLETED|Overall Study||2
8249084|NCT01876043|20341980|P1|COMPLETED|Overall Study||22
8249085|NCT01876043|20341980|P1|Interim Analysis Population|Overall Study||17
8249086|NCT01876043|20341980|P1|STARTED|Overall Study||24
8249087|NCT01875991|20341992|P2|NOT COMPLETED|Overall Study||6
8249088|NCT01875991|20341993|P1|NOT COMPLETED|Overall Study||7
8249089|NCT01875991|20341992|P2|COMPLETED|Overall Study||103
8249090|NCT01875991|20341993|P1|COMPLETED|Overall Study||101
8249091|NCT01875991|20341992|P2|Received Etanercept in Period 2|Overall Study||103
8249092|NCT01875991|20341993|P1|Received Etanercept in Period 2|Overall Study||102
8249093|NCT01875991|20341992|P2|Received Etanercept in Period 1|Overall Study||108
8249094|NCT01875991|20341993|P1|Received Etanercept in Period 1|Overall Study||108
8249095|NCT01875991|20341992|P2|STARTED|Overall Study||109
8249096|NCT01875991|20341993|P1|STARTED|Overall Study||108
8249097|NCT01875978|20342016|P2|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
8249098|NCT01875978|20342017|P1|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
8249099|NCT01875978|20342016|P2|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
8249100|NCT01875978|20342017|P1|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
8249101|NCT01875978|20342016|P2|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
8249102|NCT01875978|20342017|P1|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
8249103|NCT01875978|20342016|P2|NOT COMPLETED|Study 4weeks||0
8249104|NCT01875978|20342017|P1|NOT COMPLETED|Study 4weeks||0
8249105|NCT01875978|20342016|P2|COMPLETED|Study 4weeks||20
8249106|NCT01875978|20342017|P1|COMPLETED|Study 4weeks||20
8249107|NCT01875978|20342016|P2|STARTED|Study 4weeks||20
8249108|NCT01875978|20342017|P1|STARTED|Study 4weeks||20
8249109|NCT01875874|20342029|P1|NOT COMPLETED|Overall Study||3
8249110|NCT01875874|20342029|P1|COMPLETED|Overall Study||5
8249111|NCT01875874|20342029|P1|STARTED|Overall Study||8
8249112|NCT01875861|20342036|P2|NOT COMPLETED|Sustainability||0
8249113|NCT01875861|20342037|P1|NOT COMPLETED|Sustainability||0
8249114|NCT01875861|20342036|P2|COMPLETED|Sustainability||3444
8249115|NCT01875861|20342037|P1|COMPLETED|Sustainability||4306
8249116|NCT01875861|20342036|P2|STARTED|Sustainability||3444
8249117|NCT01875861|20342037|P1|STARTED|Sustainability||4306
8249118|NCT01875861|20342036|P2|NOT COMPLETED|Implementation||0
8249119|NCT01875861|20342037|P1|NOT COMPLETED|Implementation||0
8249120|NCT01875861|20342036|P2|COMPLETED|Implementation||3444
8249121|NCT01875861|20342037|P1|COMPLETED|Implementation||4546
8249122|NCT01875861|20342036|P2|STARTED|Implementation||3444
8249123|NCT01875861|20342037|P1|STARTED|Implementation||4546
8249124|NCT01875861|20342036|P2|NOT COMPLETED|Pre-implementation||0
8249125|NCT01875861|20342037|P1|NOT COMPLETED|Pre-implementation||0
8249126|NCT01875861|20342036|P2|COMPLETED|Pre-implementation||3714
8249127|NCT01875861|20342037|P1|COMPLETED|Pre-implementation||4779
8249128|NCT01875861|20342036|P2|STARTED|Pre-implementation||3714
8249129|NCT01875861|20342037|P1|STARTED|Pre-implementation||4779
8249130|NCT01875848|20342049|P2|NOT COMPLETED|Overall Study||0
8249131|NCT01875848|20342050|P1|NOT COMPLETED|Overall Study||2
8249132|NCT01875848|20342049|P2|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
8249133|NCT01875848|20342050|P1|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
8249134|NCT01875848|20342049|P2|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
8249135|NCT01875848|20342050|P1|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
8249136|NCT01875783|20342058|P1|NOT COMPLETED|Overall Study||0
8249137|NCT01875783|20342058|P1|COMPLETED|Overall Study||385
8249138|NCT01875783|20342058|P1|STARTED|Overall Study||385
8249139|NCT01875731|20342067|P2|NOT COMPLETED|Overall Study||0
8249140|NCT01875731|20342068|P1|NOT COMPLETED|Overall Study||1
8249141|NCT01875731|20342067|P2|COMPLETED|Overall Study||32
8249142|NCT01875731|20342068|P1|COMPLETED|Overall Study||33
8249143|NCT01875731|20342067|P2|STARTED|Overall Study||32
8249144|NCT01875731|20342068|P1|STARTED|Overall Study||34
8249145|NCT01875510|20342078|P2|NOT COMPLETED|Overall Study||0
8249146|NCT01875510|20342079|P1|NOT COMPLETED|Overall Study||0
8249147|NCT01875510|20342078|P2|COMPLETED|Overall Study||40
8249148|NCT01875510|20342079|P1|COMPLETED|Overall Study||40
8249149|NCT01875510|20342078|P2|STARTED|Overall Study||40
8249150|NCT01875510|20342079|P1|STARTED|Overall Study||40
8249151|NCT01875471|20342087|P2|NOT COMPLETED|Overall Study||1
8249152|NCT01875471|20342088|P1|NOT COMPLETED|Overall Study||1
8249153|NCT01875471|20342087|P2|COMPLETED|Overall Study||137
8249154|NCT01875471|20342088|P1|COMPLETED|Overall Study||136
8249155|NCT01875471|20342087|P2|Completed Per Protocol|Overall Study||123
8249156|NCT01875471|20342088|P1|Completed Per Protocol|Overall Study||127
8249157|NCT01875471|20342087|P2|STARTED|Overall Study||138
8249158|NCT01875471|20342088|P1|STARTED|Overall Study||137
8249159|NCT01875445|20342096|P2|NOT COMPLETED|Overall Study||0
8249160|NCT01875445|20342097|P1|NOT COMPLETED|Overall Study||7
8249161|NCT01875445|20342096|P2|COMPLETED|Overall Study||19
8249162|NCT01875445|20342097|P1|COMPLETED|Overall Study||12
8249163|NCT01875445|20342096|P2|STARTED|Overall Study||19
8249164|NCT01875445|20342097|P1|STARTED|Overall Study||19
8249165|NCT01875250|20342107|P2|NOT COMPLETED|Overall Study||0
8249166|NCT01875250|20342108|P1|NOT COMPLETED|Overall Study||2
8249167|NCT01875250|20342107|P2|COMPLETED|Overall Study||19
8249168|NCT01875250|20342108|P1|COMPLETED|Overall Study||17
8249169|NCT01875250|20342107|P2|STARTED|Overall Study||19
8249170|NCT01875250|20342108|P1|STARTED|Overall Study||19
8249171|NCT01875237|20342123|P2|NOT COMPLETED|Overall Study||0
8249172|NCT01875237|20342124|P1|NOT COMPLETED|Overall Study||2
8249173|NCT01875237|20342123|P2|COMPLETED|Overall Study||1
8249174|NCT01875237|20342124|P1|COMPLETED|Overall Study||0
8249175|NCT01875237|20342123|P2|STARTED|Overall Study||1
8249176|NCT01875237|20342124|P1|STARTED|Overall Study||2
8249177|NCT01875185|20342150|P2|NOT COMPLETED|Overall Study||48
8249178|NCT01875185|20342151|P1|NOT COMPLETED|Overall Study||52
8249179|NCT01875185|20342150|P2|COMPLETED|Overall Study||0
8249180|NCT01875185|20342151|P1|COMPLETED|Overall Study||0
8249181|NCT01875185|20342150|P2|STARTED|Overall Study||48
8249182|NCT01875185|20342151|P1|STARTED|Overall Study||52
8249183|NCT01875159|20342165|P2|NOT COMPLETED|Overall Study||0
8249184|NCT01875159|20342166|P1|NOT COMPLETED|Overall Study||3
8249185|NCT01875159|20342165|P2|COMPLETED|Overall Study||53
8249186|NCT01875159|20342166|P1|COMPLETED|Overall Study||42
8249187|NCT01875159|20342165|P2|STARTED|Overall Study||53
8249188|NCT01875159|20342166|P1|STARTED|Overall Study||45
8249189|NCT01874951|20342176|P2|NOT COMPLETED|Overall Study||0
8249190|NCT01874951|20342177|P1|NOT COMPLETED|Overall Study||0
8249191|NCT01874951|20342176|P2|COMPLETED|Overall Study||6
8249192|NCT01874951|20342177|P1|COMPLETED|Overall Study||6
8249193|NCT01874951|20342176|P2|STARTED|Overall Study||6
8249194|NCT01874951|20342177|P1|STARTED|Overall Study||6
8249195|NCT01874756|20342201|P4|NOT COMPLETED|Overall Study||6
8249196|NCT01874756|20342202|P3|NOT COMPLETED|Overall Study||2
8249197|NCT01874756|20342203|P2|NOT COMPLETED|Overall Study||0
8249198|NCT01874756|20342204|P1|NOT COMPLETED|Overall Study||1
8249199|NCT01874756|20342201|P4|COMPLETED|Overall Study||21
8249200|NCT01874756|20342202|P3|COMPLETED|Overall Study||27
8249201|NCT01874756|20342203|P2|COMPLETED|Overall Study||10
8249202|NCT01874756|20342204|P1|COMPLETED|Overall Study||28
8249203|NCT01874756|20342201|P4|STARTED|Overall Study||27
8249204|NCT01874756|20342202|P3|STARTED|Overall Study||29
8249205|NCT01874756|20342203|P2|STARTED|Overall Study||10
8249206|NCT01874756|20342204|P1|STARTED|Overall Study||29
8249207|NCT01874665|20342236|P2|NOT COMPLETED|Overall Study||15
8249208|NCT01874665|20342237|P1|NOT COMPLETED|Overall Study||30
8249209|NCT01874665|20342236|P2|COMPLETED|Overall Study||0
8249210|NCT01874665|20342237|P1|COMPLETED|Overall Study||0
8249211|NCT01874665|20342236|P2|STARTED|Overall Study||15
8249212|NCT01874665|20342237|P1|STARTED|Overall Study||30
8249213|NCT01874535|20342265|P2|NOT COMPLETED|Overall Study||44
8249214|NCT01874535|20342266|P1|NOT COMPLETED|Overall Study||55
8249215|NCT01874535|20342265|P2|COMPLETED|Overall Study||157
8249216|NCT01874535|20342266|P1|COMPLETED|Overall Study||152
8249217|NCT01874535|20342265|P2|STARTED|Overall Study||201
8249218|NCT01874535|20342266|P1|STARTED|Overall Study||207
8249225|NCT01874340|20342302|P4|NOT COMPLETED|Overall Study||5
8249226|NCT01874340|20342303|P3|NOT COMPLETED|Overall Study||8
8249227|NCT01874340|20342304|P2|NOT COMPLETED|Overall Study||8
8249228|NCT01874340|20342305|P1|NOT COMPLETED|Overall Study||6
8249229|NCT01874340|20342302|P4|COMPLETED|Overall Study||1
8249230|NCT01874340|20342303|P3|COMPLETED|Overall Study||0
8249231|NCT01874340|20342304|P2|COMPLETED|Overall Study||0
8249232|NCT01874340|20342305|P1|COMPLETED|Overall Study||0
8249233|NCT01874340|20342302|P4|STARTED|Overall Study||6
8249234|NCT01874340|20342303|P3|STARTED|Overall Study||8
8249235|NCT01874340|20342304|P2|STARTED|Overall Study||8
8249236|NCT01874340|20342305|P1|STARTED|Overall Study||6
8249237|NCT01874288|20342336|P5|NOT COMPLETED|Overall Study||2
8249238|NCT01874288|20342337|P4|NOT COMPLETED|Overall Study||7
8249239|NCT01874288|20342338|P3|NOT COMPLETED|Overall Study||5
8249240|NCT01874288|20342339|P2|NOT COMPLETED|Overall Study||0
8249241|NCT01874288|20342340|P1|NOT COMPLETED|Overall Study||3
8249242|NCT01874288|20342336|P5|COMPLETED|Overall Study||0
8249243|NCT01874288|20342337|P4|COMPLETED|Overall Study||0
8249244|NCT01874288|20342338|P3|COMPLETED|Overall Study||4
8249245|NCT01874288|20342339|P2|COMPLETED|Overall Study||3
8249246|NCT01874288|20342340|P1|COMPLETED|Overall Study||0
8249247|NCT01874288|20342336|P5|Received at Least 1 Dose of Study Drug|Overall Study||2
8249248|NCT01874288|20342337|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
8249249|NCT01874288|20342338|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
8249250|NCT01874288|20342339|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8249251|NCT01874288|20342340|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8249252|NCT01874288|20342336|P5|STARTED|Overall Study||2
8249253|NCT01874288|20342337|P4|STARTED|Overall Study||7
8249254|NCT01874288|20342338|P3|STARTED|Overall Study||9
8249255|NCT01874288|20342339|P2|STARTED|Overall Study||3
8249256|NCT01874288|20342340|P1|STARTED|Overall Study||3
8249257|NCT01874275|20342375|P2|NOT COMPLETED|Overall Study||0
8249258|NCT01874275|20342376|P1|NOT COMPLETED|Overall Study||1
8249259|NCT01874275|20342375|P2|COMPLETED|Overall Study||2
8249260|NCT01874275|20342376|P1|COMPLETED|Overall Study||3
8249261|NCT01874275|20342375|P2|STARTED|Overall Study||2
8249262|NCT01874275|20342376|P1|STARTED|Overall Study||4
8249263|NCT01874262|20342390|P2|NOT COMPLETED|Overall Study||3
8249264|NCT01874262|20342391|P1|NOT COMPLETED|Overall Study||5
8249265|NCT01874262|20342390|P2|COMPLETED|Overall Study||80
8249266|NCT01874262|20342391|P1|COMPLETED|Overall Study||86
8249267|NCT01874262|20342390|P2|Not Included Due to Tehnical Issues|Overall Study||3
8249268|NCT01874262|20342391|P1|Not Included Due to Tehnical Issues|Overall Study||3
8249269|NCT01874262|20342390|P2|Not Correctly Randomised|Overall Study||0
8249270|NCT01874262|20342391|P1|Not Correctly Randomised|Overall Study||2
8249271|NCT01874262|20342390|P2|STARTED|Overall Study||83
8249272|NCT01874262|20342391|P1|STARTED|Overall Study||91
8249273|NCT01874145|20342399|P2|NOT COMPLETED|Extension Period||4
8249274|NCT01874145|20342400|P1|NOT COMPLETED|Extension Period||6
8249275|NCT01874145|20342399|P2|COMPLETED|Extension Period||97
8249276|NCT01874145|20342400|P1|COMPLETED|Extension Period||91
8249277|NCT01874145|20342399|P2|Full Analysis Set|Extension Period||101
8249278|NCT01874145|20342400|P1|Full Analysis Set|Extension Period||95
8249279|NCT01874145|20342399|P2|STARTED|Extension Period|Non-Switchers|101
8249280|NCT01874145|20342400|P1|STARTED|Extension Period|Switchers|97
8249281|NCT01874145|20342399|P2|NOT COMPLETED|Core Period||7
8249282|NCT01874145|20342400|P1|NOT COMPLETED|Core Period||3
8249283|NCT01874145|20342399|P2|COMPLETED|Core Period||101
8249284|NCT01874145|20342400|P1|COMPLETED|Core Period||98
8249285|NCT01874145|20342399|P2|Full Analysis Set|Core Period||108
8249286|NCT01874145|20342400|P1|Full Analysis Set|Core Period||100
8249287|NCT01874145|20342399|P2|STARTED|Core Period||108
8249288|NCT01874145|20342400|P1|STARTED|Core Period||101
8249289|NCT01874132|20342439|P3|NOT COMPLETED|Overall Study||3
8249290|NCT01874132|20342440|P2|NOT COMPLETED|Overall Study||4
8249291|NCT01874132|20342441|P1|NOT COMPLETED|Overall Study||4
8249292|NCT01874132|20342439|P3|COMPLETED|Overall Study||19
8249293|NCT01874132|20342440|P2|COMPLETED|Overall Study||18
8249294|NCT01874132|20342441|P1|COMPLETED|Overall Study||18
8249295|NCT01874132|20342439|P3|STARTED|Overall Study||22
8249296|NCT01874132|20342440|P2|STARTED|Overall Study||22
8249297|NCT01874132|20342441|P1|STARTED|Overall Study||22
8249298|NCT01874119|20342452|P2|NOT COMPLETED|Second Intervention (6 Days)||0
8249299|NCT01874119|20342453|P1|NOT COMPLETED|Second Intervention (6 Days)||0
8249300|NCT01874119|20342452|P2|COMPLETED|Second Intervention (6 Days)||3
8249301|NCT01874119|20342453|P1|COMPLETED|Second Intervention (6 Days)||4
8249302|NCT01874119|20342452|P2|STARTED|Second Intervention (6 Days)||3
8249303|NCT01874119|20342453|P1|STARTED|Second Intervention (6 Days)||4
8249304|NCT01874119|20342452|P2|NOT COMPLETED|Washout (7 Days)||2
8249305|NCT01874119|20342453|P1|NOT COMPLETED|Washout (7 Days)||3
8249306|NCT01874119|20342452|P2|COMPLETED|Washout (7 Days)||3
8249307|NCT01874119|20342453|P1|COMPLETED|Washout (7 Days)||4
8249308|NCT01874119|20342452|P2|STARTED|Washout (7 Days)||5
8249309|NCT01874119|20342453|P1|STARTED|Washout (7 Days)||7
8249310|NCT01874119|20342452|P2|NOT COMPLETED|First Intervention (6 Days)||0
8249311|NCT01874119|20342453|P1|NOT COMPLETED|First Intervention (6 Days)||1
8249312|NCT01874119|20342452|P2|COMPLETED|First Intervention (6 Days)||5
8249313|NCT01874119|20342453|P1|COMPLETED|First Intervention (6 Days)||7
8249314|NCT01874119|20342452|P2|STARTED|First Intervention (6 Days)||5
8249315|NCT01874119|20342453|P1|STARTED|First Intervention (6 Days)||8
8249316|NCT01874054|20342459|P1|NOT COMPLETED|Overall Study||55
8249317|NCT01874054|20342459|P1|COMPLETED|Overall Study||0
8249318|NCT01874054|20342459|P1|Completed 16 Cycles of BV Treatment|Overall Study||17
8249319|NCT01874054|20342459|P1|Completed ≥2 Cycles of Combo Treatment|Overall Study||53
8249320|NCT01874054|20342459|P1|STARTED|Overall Study||55
8249321|NCT01873989|20342470|P2|NOT COMPLETED|Overall Study||1
8249322|NCT01873989|20342471|P1|NOT COMPLETED|Overall Study||1
8249323|NCT01873989|20342470|P2|COMPLETED|Overall Study||6
8249324|NCT01873989|20342471|P1|COMPLETED|Overall Study||7
8249325|NCT01873989|20342470|P2|STARTED|Overall Study||7
8249326|NCT01873989|20342471|P1|STARTED|Overall Study||8
8249327|NCT01873950|20342481|P5|NOT COMPLETED|Period 5||0
8249328|NCT01873950|20342482|P4|NOT COMPLETED|Period 5||1
8249329|NCT01873950|20342483|P3|NOT COMPLETED|Period 5||0
8249330|NCT01873950|20342484|P2|NOT COMPLETED|Period 5||0
8249331|NCT01873950|20342485|P1|NOT COMPLETED|Period 5||0
8249332|NCT01873950|20342481|P5|COMPLETED|Period 5||4
8249333|NCT01873950|20342482|P4|COMPLETED|Period 5||3
8249334|NCT01873950|20342483|P3|COMPLETED|Period 5||4
8249335|NCT01873950|20342484|P2|COMPLETED|Period 5||5
8249336|NCT01873950|20342485|P1|COMPLETED|Period 5||4
8249337|NCT01873950|20342481|P5|STARTED|Period 5||4
8249338|NCT01873950|20342482|P4|STARTED|Period 5||4
8249339|NCT01873950|20342483|P3|STARTED|Period 5||4
8249340|NCT01873950|20342484|P2|STARTED|Period 5||5
8249341|NCT01873950|20342485|P1|STARTED|Period 5||4
8249342|NCT01873950|20342481|P5|NOT COMPLETED|Period 4||0
8249343|NCT01873950|20342482|P4|NOT COMPLETED|Period 4||0
8249344|NCT01873950|20342483|P3|NOT COMPLETED|Period 4||0
8249345|NCT01873950|20342484|P2|NOT COMPLETED|Period 4||0
8249346|NCT01873950|20342485|P1|NOT COMPLETED|Period 4||0
8249347|NCT01873950|20342481|P5|COMPLETED|Period 4||5
8249348|NCT01873950|20342482|P4|COMPLETED|Period 4||4
8249349|NCT01873950|20342483|P3|COMPLETED|Period 4||4
8249350|NCT01873950|20342484|P2|COMPLETED|Period 4||5
8249351|NCT01873950|20342485|P1|COMPLETED|Period 4||4
8249352|NCT01873950|20342481|P5|STARTED|Period 4||5
8249353|NCT01873950|20342482|P4|STARTED|Period 4||4
8249354|NCT01873950|20342483|P3|STARTED|Period 4||4
8249355|NCT01873950|20342484|P2|STARTED|Period 4||5
8249356|NCT01873950|20342485|P1|STARTED|Period 4||4
8249357|NCT01873950|20342481|P5|NOT COMPLETED|Period 3||0
8249358|NCT01873950|20342482|P4|NOT COMPLETED|Period 3||0
8249359|NCT01873950|20342483|P3|NOT COMPLETED|Period 3||0
8249360|NCT01873950|20342484|P2|NOT COMPLETED|Period 3||0
8249361|NCT01873950|20342485|P1|NOT COMPLETED|Period 3||0
8249362|NCT01873950|20342481|P5|COMPLETED|Period 3||4
8249363|NCT01873950|20342482|P4|COMPLETED|Period 3||5
8249364|NCT01873950|20342483|P3|COMPLETED|Period 3||5
8249365|NCT01873950|20342484|P2|COMPLETED|Period 3||4
8249366|NCT01873950|20342485|P1|COMPLETED|Period 3||4
8249367|NCT01873950|20342481|P5|STARTED|Period 3||4
8249368|NCT01873950|20342482|P4|STARTED|Period 3||5
8249369|NCT01873950|20342483|P3|STARTED|Period 3||5
8249370|NCT01873950|20342484|P2|STARTED|Period 3||4
8249371|NCT01873950|20342485|P1|STARTED|Period 3||4
8249372|NCT01873950|20342481|P5|NOT COMPLETED|Period 2||0
8249373|NCT01873950|20342482|P4|NOT COMPLETED|Period 2||0
8249374|NCT01873950|20342483|P3|NOT COMPLETED|Period 2||0
8249375|NCT01873950|20342484|P2|NOT COMPLETED|Period 2||0
8249376|NCT01873950|20342485|P1|NOT COMPLETED|Period 2||0
8249377|NCT01873950|20342481|P5|COMPLETED|Period 2||5
8249378|NCT01873950|20342482|P4|COMPLETED|Period 2||4
8249379|NCT01873950|20342483|P3|COMPLETED|Period 2||4
8249380|NCT01873950|20342484|P2|COMPLETED|Period 2||4
8249381|NCT01873950|20342485|P1|COMPLETED|Period 2||5
8249382|NCT01873950|20342481|P5|STARTED|Period 2||5
8249383|NCT01873950|20342482|P4|STARTED|Period 2||4
8249384|NCT01873950|20342483|P3|STARTED|Period 2||4
8249385|NCT01873950|20342484|P2|STARTED|Period 2||4
8249386|NCT01873950|20342485|P1|STARTED|Period 2||5
8249387|NCT01873950|20342481|P5|NOT COMPLETED|Period 1||0
8249388|NCT01873950|20342482|P4|NOT COMPLETED|Period 1||0
8249389|NCT01873950|20342483|P3|NOT COMPLETED|Period 1||0
8249390|NCT01873950|20342484|P2|NOT COMPLETED|Period 1||0
8249391|NCT01873950|20342485|P1|NOT COMPLETED|Period 1||0
8249392|NCT01873950|20342481|P5|COMPLETED|Period 1||4
8249393|NCT01873950|20342482|P4|COMPLETED|Period 1||4
8249394|NCT01873950|20342483|P3|COMPLETED|Period 1||5
8249395|NCT01873950|20342484|P2|COMPLETED|Period 1||4
8249396|NCT01873950|20342485|P1|COMPLETED|Period 1||5
8249397|NCT01873950|20342481|P5|STARTED|Period 1||4
8249398|NCT01873950|20342482|P4|STARTED|Period 1||4
8249399|NCT01873950|20342483|P3|STARTED|Period 1||5
8249400|NCT01873950|20342484|P2|STARTED|Period 1||4
8249401|NCT01873950|20342485|P1|STARTED|Period 1||5
8249402|NCT01873859|20342522|P2|NOT COMPLETED|Overall Study||4
8249403|NCT01873859|20342523|P1|NOT COMPLETED|Overall Study||0
8249404|NCT01873859|20342522|P2|COMPLETED|Overall Study||79
8249405|NCT01873859|20342523|P1|COMPLETED|Overall Study||83
8249406|NCT01873859|20342522|P2|STARTED|Overall Study||83
8249407|NCT01873859|20342523|P1|STARTED|Overall Study||83
8249408|NCT01873846|20342531|P1|NOT COMPLETED|Overall Study||12
8249409|NCT01873846|20342531|P1|COMPLETED|Overall Study||388
8249410|NCT01873846|20342531|P1|Eligble Participants Dispensed Lenses|Overall Study||396
8249411|NCT01873846|20342531|P1|STARTED|Overall Study||400
8249412|NCT01873742|20342541|P2|NOT COMPLETED|Overall Study||76
8249413|NCT01873742|20342542|P1|NOT COMPLETED|Overall Study||68
8249414|NCT01873742|20342541|P2|COMPLETED|Overall Study||87
8249415|NCT01873742|20342542|P1|COMPLETED|Overall Study||97
8249416|NCT01873742|20342541|P2|STARTED|Overall Study||163
8249417|NCT01873742|20342542|P1|STARTED|Overall Study||165
8249418|NCT01873729|20342548|P1|NOT COMPLETED|Overall Study||1
8249419|NCT01873729|20342548|P1|COMPLETED|Overall Study||2
8249420|NCT01873729|20342548|P1|STARTED|Overall Study||3
8249421|NCT01873586|20342553|P1|NOT COMPLETED|Overall Study||3
8249422|NCT01873586|20342553|P1|COMPLETED|Overall Study||26
8249423|NCT01873586|20342553|P1|STARTED|Overall Study||29
8249424|NCT01873495|20342566|P1|NOT COMPLETED|Overall Study||7
8249425|NCT01873495|20342566|P1|COMPLETED|Overall Study||0
8249426|NCT01873495|20342566|P1|STARTED|Overall Study||7
8249427|NCT01873417|20342574|P1|NOT COMPLETED|Overall Study||35
8249428|NCT01873417|20342574|P1|COMPLETED|Overall Study||202
8249429|NCT01873417|20342574|P1|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
8249430|NCT01873417|20342574|P1|STARTED|Overall Study||237
8249431|NCT01873287|20342587|P2|NOT COMPLETED|Overall Study||174
8249432|NCT01873287|20342588|P1|NOT COMPLETED|Overall Study||305
8249433|NCT01873287|20342587|P2|COMPLETED|Overall Study||883
8249434|NCT01873287|20342588|P1|COMPLETED|Overall Study||1701
8249435|NCT01873287|20342587|P2|STARTED|Overall Study||1057
8249436|NCT01873287|20342588|P1|STARTED|Overall Study||2006
8249437|NCT01872910|20342602|P6|NOT COMPLETED|Overall Study||0
8249438|NCT01872910|20342603|P5|NOT COMPLETED|Overall Study||0
8249439|NCT01872910|20342604|P4|NOT COMPLETED|Overall Study||0
8249440|NCT01872910|20342605|P3|NOT COMPLETED|Overall Study||2
8249441|NCT01872910|20342606|P2|NOT COMPLETED|Overall Study||0
8249442|NCT01872910|20342607|P1|NOT COMPLETED|Overall Study||2
8249443|NCT01872910|20342602|P6|COMPLETED|Overall Study||3
8249444|NCT01872910|20342603|P5|COMPLETED|Overall Study||15
8249445|NCT01872910|20342604|P4|COMPLETED|Overall Study||15
8249446|NCT01872910|20342605|P3|COMPLETED|Overall Study||28
8249447|NCT01872910|20342606|P2|COMPLETED|Overall Study||31
8249448|NCT01872910|20342607|P1|COMPLETED|Overall Study||28
8249449|NCT01872910|20342602|P6|Received Any Study Drug|Overall Study||3
8249450|NCT01872910|20342603|P5|Received Any Study Drug|Overall Study||15
8249451|NCT01872910|20342604|P4|Received Any Study Drug|Overall Study||15
8249452|NCT01872910|20342605|P3|Received Any Study Drug|Overall Study||30
8249453|NCT01872910|20342606|P2|Received Any Study Drug|Overall Study||31
8249454|NCT01872910|20342607|P1|Received Any Study Drug|Overall Study||30
8249455|NCT01872910|20342602|P6|STARTED|Overall Study||3
8249456|NCT01872910|20342603|P5|STARTED|Overall Study||15
8249457|NCT01872910|20342604|P4|STARTED|Overall Study||15
8249458|NCT01872910|20342605|P3|STARTED|Overall Study||30
8249459|NCT01872910|20342606|P2|STARTED|Overall Study||31
8249460|NCT01872910|20342607|P1|STARTED|Overall Study||30
8249461|NCT01872819|20342647|P1|NOT COMPLETED|Overall Study||0
8249462|NCT01872819|20342647|P1|COMPLETED|Overall Study||14
8249463|NCT01872819|20342647|P1|STARTED|Overall Study||14
8249464|NCT01872715|20342652|P1|NOT COMPLETED|Overall Study||4
8249465|NCT01872715|20342652|P1|COMPLETED|Overall Study||20
8249466|NCT01872715|20342652|P1|STARTED|Overall Study||24
8249467|NCT01872689|20342671|P4|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
8249468|NCT01872689|20342672|P3|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
8249469|NCT01872689|20342673|P2|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
8249470|NCT01872689|20342674|P1|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
8249471|NCT01872689|20342671|P4|COMPLETED|Open-Label Period (Only For Monotherapy)||0
8249472|NCT01872689|20342672|P3|COMPLETED|Open-Label Period (Only For Monotherapy)||0
8249473|NCT01872689|20342673|P2|COMPLETED|Open-Label Period (Only For Monotherapy)||33
8249474|NCT01872689|20342674|P1|COMPLETED|Open-Label Period (Only For Monotherapy)||31
8249475|NCT01872689|20342671|P4|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
8249476|NCT01872689|20342672|P3|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
8249477|NCT01872689|20342673|P2|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
8249478|NCT01872689|20342674|P1|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
8249479|NCT01872689|20342671|P4|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
8249480|NCT01872689|20342672|P3|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
8249481|NCT01872689|20342673|P2|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
8249482|NCT01872689|20342674|P1|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
8249483|NCT01872689|20342671|P4|COMPLETED|Double-Blind/Placebo-Controlled Period||136
8249484|NCT01872689|20342672|P3|COMPLETED|Double-Blind/Placebo-Controlled Period||129
8249485|NCT01872689|20342673|P2|COMPLETED|Double-Blind/Placebo-Controlled Period||58
8249486|NCT01872689|20342674|P1|COMPLETED|Double-Blind/Placebo-Controlled Period||56
8249487|NCT01872689|20342671|P4|STARTED|Double-Blind/Placebo-Controlled Period||174
8249488|NCT01872689|20342672|P3|STARTED|Double-Blind/Placebo-Controlled Period||177
8249489|NCT01872689|20342673|P2|STARTED|Double-Blind/Placebo-Controlled Period||78
8249490|NCT01872689|20342674|P1|STARTED|Double-Blind/Placebo-Controlled Period||76
8249491|NCT01872611|20342750|P2|NOT COMPLETED|Overall Study||12
8249492|NCT01872611|20342751|P1|NOT COMPLETED|Overall Study||24
8249493|NCT01872611|20342750|P2|COMPLETED|Overall Study||292
8249494|NCT01872611|20342751|P1|COMPLETED|Overall Study||277
8249495|NCT01872611|20342750|P2|Full Analysis Set|Overall Study||293
8249496|NCT01872611|20342751|P1|Full Analysis Set|Overall Study||289
8249497|NCT01872611|20342750|P2|Treated (Safety Analysis Set)|Overall Study||295
8249498|NCT01872611|20342751|P1|Treated (Safety Analysis Set)|Overall Study||293
8249499|NCT01872611|20342750|P2|Randomized|Overall Study||304
8249500|NCT01872611|20342751|P1|Randomized|Overall Study||301
8249501|NCT01872611|20342750|P2|STARTED|Overall Study||304
8249502|NCT01872611|20342751|P1|STARTED|Overall Study||301
8249503|NCT01872338|20342771|P2|NOT COMPLETED|Overall Study||0
8249504|NCT01872338|20342772|P1|NOT COMPLETED|Overall Study||20
8249505|NCT01872338|20342771|P2|COMPLETED|Overall Study||69
8249506|NCT01872338|20342772|P1|COMPLETED|Overall Study||46
8249507|NCT01872338|20342771|P2|STARTED|Overall Study||69
8249508|NCT01872338|20342772|P1|STARTED|Overall Study||66
8249515|NCT01872078|20342803|P4|NOT COMPLETED|Overall Study||2
8249516|NCT01872078|20342804|P3|NOT COMPLETED|Overall Study||3
8249517|NCT01872078|20342805|P2|NOT COMPLETED|Overall Study||0
8249518|NCT01872078|20342806|P1|NOT COMPLETED|Overall Study||0
8249519|NCT01872078|20342803|P4|COMPLETED|Overall Study||15
8249520|NCT01872078|20342804|P3|COMPLETED|Overall Study||14
8249521|NCT01872078|20342805|P2|COMPLETED|Overall Study||15
8249522|NCT01872078|20342806|P1|COMPLETED|Overall Study||16
8249523|NCT01872078|20342803|P4|STARTED|Overall Study||17
8249524|NCT01872078|20342804|P3|STARTED|Overall Study||17
8249525|NCT01872078|20342805|P2|STARTED|Overall Study||15
8249526|NCT01872078|20342806|P1|STARTED|Overall Study||16
8249527|NCT01871870|20342816|P1|NOT COMPLETED|Overall Study||9
8249528|NCT01871870|20342816|P1|COMPLETED|Overall Study||11
8249529|NCT01871870|20342816|P1|STARTED|Overall Study||20
8249530|NCT01871805|20342827|P6|NOT COMPLETED|Phase II||87
8249531|NCT01871805|20342828|P5|NOT COMPLETED|Phase II||0
8249532|NCT01871805|20342829|P4|NOT COMPLETED|Phase II||0
8249533|NCT01871805|20342830|P3|NOT COMPLETED|Phase II||0
8249534|NCT01871805|20342831|P2|NOT COMPLETED|Phase II||0
8249535|NCT01871805|20342832|P1|NOT COMPLETED|Phase II||0
8249536|NCT01871805|20342827|P6|COMPLETED|Phase II||0
8249537|NCT01871805|20342828|P5|COMPLETED|Phase II||0
8249538|NCT01871805|20342829|P4|COMPLETED|Phase II||0
8249539|NCT01871805|20342830|P3|COMPLETED|Phase II||0
8249540|NCT01871805|20342831|P2|COMPLETED|Phase II||0
8249541|NCT01871805|20342832|P1|COMPLETED|Phase II||0
8249542|NCT01871805|20342827|P6|STARTED|Phase II||87
8249543|NCT01871805|20342828|P5|STARTED|Phase II||0
8249544|NCT01871805|20342829|P4|STARTED|Phase II||0
8249545|NCT01871805|20342830|P3|STARTED|Phase II||0
8249546|NCT01871805|20342831|P2|STARTED|Phase II||0
8249547|NCT01871805|20342832|P1|STARTED|Phase II||0
8249548|NCT01871805|20342827|P6|NOT COMPLETED|Phase I||0
8249549|NCT01871805|20342828|P5|NOT COMPLETED|Phase I||13
8249550|NCT01871805|20342829|P4|NOT COMPLETED|Phase I||7
8249551|NCT01871805|20342830|P3|NOT COMPLETED|Phase I||13
8249552|NCT01871805|20342831|P2|NOT COMPLETED|Phase I||7
8249553|NCT01871805|20342832|P1|NOT COMPLETED|Phase I||7
8249554|NCT01871805|20342827|P6|COMPLETED|Phase I||0
8249555|NCT01871805|20342828|P5|COMPLETED|Phase I||0
8249556|NCT01871805|20342829|P4|COMPLETED|Phase I||0
8249557|NCT01871805|20342830|P3|COMPLETED|Phase I||0
8249558|NCT01871805|20342831|P2|COMPLETED|Phase I||0
8249559|NCT01871805|20342832|P1|COMPLETED|Phase I||0
8249560|NCT01871805|20342827|P6|STARTED|Phase I||0
8249561|NCT01871805|20342828|P5|STARTED|Phase I||13
8249562|NCT01871805|20342829|P4|STARTED|Phase I||7
8249563|NCT01871805|20342830|P3|STARTED|Phase I||13
8249564|NCT01871805|20342831|P2|STARTED|Phase I||7
8249565|NCT01871805|20342832|P1|STARTED|Phase I||7
8249566|NCT01871558|20342904|P2|NOT COMPLETED|Overall Study||2
8249567|NCT01871558|20342905|P1|NOT COMPLETED|Overall Study||3
8249568|NCT01871558|20342904|P2|COMPLETED|Overall Study||19
8249569|NCT01871558|20342905|P1|COMPLETED|Overall Study||18
8249570|NCT01871558|20342904|P2|STARTED|Overall Study||21
8249571|NCT01871558|20342905|P1|STARTED|Overall Study||21
8249572|NCT01871545|20342925|P2|NOT COMPLETED|Overall Study||3
8249573|NCT01871545|20342926|P1|NOT COMPLETED|Overall Study||17
8249574|NCT01871545|20342925|P2|COMPLETED|Overall Study||8
8249575|NCT01871545|20342926|P1|COMPLETED|Overall Study||56
8249576|NCT01871545|20342925|P2|STARTED|Overall Study||11
8249577|NCT01871545|20342926|P1|STARTED|Overall Study||73
8249578|NCT01871532|20342967|P2|NOT COMPLETED|Overall Study||2
8249579|NCT01871532|20342968|P1|NOT COMPLETED|Overall Study||1
8249580|NCT01871532|20342967|P2|COMPLETED|Overall Study||10
8249581|NCT01871532|20342968|P1|COMPLETED|Overall Study||11
8249582|NCT01871532|20342967|P2|Subjects Received hCG Treatment|Overall Study||9
8249583|NCT01871532|20342968|P1|Subjects Received hCG Treatment|Overall Study||11
8249584|NCT01871532|20342967|P2|STARTED|Overall Study||12
8249585|NCT01871532|20342968|P1|STARTED|Overall Study||12
8249586|NCT01871519|20343002|P1|NOT COMPLETED|Overall Study||90
8249587|NCT01871519|20343002|P1|COMPLETED|Overall Study||260
8249588|NCT01871519|20343002|P1|STARTED|Overall Study||350
8249589|NCT01871506|20343025|P2|NOT COMPLETED|Overall Study||0
8249590|NCT01871506|20343026|P1|NOT COMPLETED|Overall Study||0
8249591|NCT01871506|20343025|P2|COMPLETED|Overall Study||153
8249592|NCT01871506|20343026|P1|COMPLETED|Overall Study||150
8249593|NCT01871506|20343025|P2|STARTED|Overall Study||153
8249594|NCT01871506|20343026|P1|STARTED|Overall Study||150
8249595|NCT01871441|20343050|P1|NOT COMPLETED|Overall Study||0
8249596|NCT01871441|20343050|P1|COMPLETED|Overall Study||4
8249597|NCT01871441|20343050|P1|STARTED|Overall Study||4
8249598|NCT01871402|20343059|P2|NOT COMPLETED|Overall Study||3
8249599|NCT01871402|20343060|P1|NOT COMPLETED|Overall Study||1
8249600|NCT01871402|20343059|P2|COMPLETED|Overall Study||108
8249601|NCT01871402|20343060|P1|COMPLETED|Overall Study||109
8249602|NCT01871402|20343059|P2|STARTED|Overall Study||111
8249603|NCT01871402|20343060|P1|STARTED|Overall Study||110
8249604|NCT01871285|20343078|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8249605|NCT01871285|20343079|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8249606|NCT01871285|20343080|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8249607|NCT01871285|20343081|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8249608|NCT01871285|20343078|P4|COMPLETED|Second Intervention (1 Day)||2
8249609|NCT01871285|20343079|P3|COMPLETED|Second Intervention (1 Day)||3
8249610|NCT01871285|20343080|P2|COMPLETED|Second Intervention (1 Day)||14
8249611|NCT01871285|20343081|P1|COMPLETED|Second Intervention (1 Day)||17
8249612|NCT01871285|20343078|P4|STARTED|Second Intervention (1 Day)||2
8249613|NCT01871285|20343079|P3|STARTED|Second Intervention (1 Day)||3
8249614|NCT01871285|20343080|P2|STARTED|Second Intervention (1 Day)||14
8249615|NCT01871285|20343081|P1|STARTED|Second Intervention (1 Day)||17
8249616|NCT01871285|20343078|P4|NOT COMPLETED|First Intervention (1 Day)||0
8249617|NCT01871285|20343079|P3|NOT COMPLETED|First Intervention (1 Day)||1
8249618|NCT01871285|20343080|P2|NOT COMPLETED|First Intervention (1 Day)||1
8249619|NCT01871285|20343081|P1|NOT COMPLETED|First Intervention (1 Day)||1
8249620|NCT01871285|20343078|P4|COMPLETED|First Intervention (1 Day)||2
8249621|NCT01871285|20343079|P3|COMPLETED|First Intervention (1 Day)||3
8249622|NCT01871285|20343080|P2|COMPLETED|First Intervention (1 Day)||14
8249623|NCT01871285|20343081|P1|COMPLETED|First Intervention (1 Day)||17
8249624|NCT01871285|20343078|P4|STARTED|First Intervention (1 Day)||2
8249625|NCT01871285|20343079|P3|STARTED|First Intervention (1 Day)||4
8249626|NCT01871285|20343080|P2|STARTED|First Intervention (1 Day)||15
8249627|NCT01871285|20343081|P1|STARTED|First Intervention (1 Day)||18
8249628|NCT01871142|20343107|P1|NOT COMPLETED|Overall Study||1
8249629|NCT01871142|20343107|P1|COMPLETED|Overall Study||11
8249630|NCT01871142|20343107|P1|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
8249631|NCT01871142|20343107|P1|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
8249632|NCT01871142|20343107|P1|Received Placebo + Hypoxia|Overall Study||12
8249633|NCT01871142|20343107|P1|Received Placebo + Normoixa|Overall Study||11
8249634|NCT01871142|20343107|P1|STARTED|Overall Study||12
8249635|NCT01871090|20343123|P2|NOT COMPLETED|Overall Study||23
8249636|NCT01871090|20343124|P1|NOT COMPLETED|Overall Study||2
8249637|NCT01871090|20343123|P2|COMPLETED|Overall Study||25
8249638|NCT01871090|20343124|P1|COMPLETED|Overall Study||33
8249639|NCT01871090|20343123|P2|STARTED|Overall Study||48
8249640|NCT01871090|20343124|P1|STARTED|Overall Study||35
8249641|NCT01871077|20343134|P1|NOT COMPLETED|Overall Study||0
8249642|NCT01871077|20343134|P1|COMPLETED|Overall Study||30
8249643|NCT01871077|20343134|P1|STARTED|Overall Study||30
8249644|NCT01870999|20343144|P3|NOT COMPLETED|Overall Study||7
8249645|NCT01870999|20343145|P2|NOT COMPLETED|Overall Study||8
8249646|NCT01870999|20343146|P1|NOT COMPLETED|Overall Study||4
8249647|NCT01870999|20343144|P3|COMPLETED|Overall Study||4
8249648|NCT01870999|20343145|P2|COMPLETED|Overall Study||8
8249649|NCT01870999|20343146|P1|COMPLETED|Overall Study||10
8249650|NCT01870999|20343144|P3|Safety Population; Received Study Drug|Overall Study||10
8249651|NCT01870999|20343145|P2|Safety Population; Received Study Drug|Overall Study||15
8249652|NCT01870999|20343146|P1|Safety Population; Received Study Drug|Overall Study||14
8249653|NCT01870999|20343144|P3|STARTED|Overall Study||11
8249654|NCT01870999|20343145|P2|STARTED|Overall Study||16
8249655|NCT01870999|20343146|P1|STARTED|Overall Study||14
8249656|NCT01870973|20343204|P2|NOT COMPLETED|Overall Study||3
8249657|NCT01870973|20343205|P1|NOT COMPLETED|Overall Study||10
8249658|NCT01870973|20343204|P2|COMPLETED|Overall Study||49
8249659|NCT01870973|20343205|P1|COMPLETED|Overall Study||46
8249660|NCT01870973|20343204|P2|STARTED|Overall Study||52
8249661|NCT01870973|20343205|P1|STARTED|Overall Study||56
8249662|NCT01870921|20343211|P1|NOT COMPLETED|Overall Study||90
8249663|NCT01870921|20343211|P1|COMPLETED|Overall Study||1914
8249664|NCT01870921|20343211|P1|STARTED|Overall Study||2004
8249665|NCT01870869|20343221|P4|NOT COMPLETED|Overall Study||30
8249666|NCT01870869|20343222|P3|NOT COMPLETED|Overall Study||130
8249667|NCT01870869|20343223|P2|NOT COMPLETED|Overall Study||14
8249668|NCT01870869|20343224|P1|NOT COMPLETED|Overall Study||28
8249669|NCT01870869|20343221|P4|COMPLETED|Overall Study||205
8249670|NCT01870869|20343222|P3|COMPLETED|Overall Study||1092
8249671|NCT01870869|20343223|P2|COMPLETED|Overall Study||192
8249672|NCT01870869|20343224|P1|COMPLETED|Overall Study||260
8249673|NCT01870869|20343221|P4|STARTED|Overall Study||235
8249674|NCT01870869|20343222|P3|STARTED|Overall Study||1222
8249675|NCT01870869|20343223|P2|STARTED|Overall Study||206
8249676|NCT01870869|20343224|P1|STARTED|Overall Study||288
8249677|NCT01870856|20343252|P2|NOT COMPLETED|Overall Study||0
8249678|NCT01870856|20343253|P1|NOT COMPLETED|Overall Study||0
8249679|NCT01870856|20343252|P2|COMPLETED|Overall Study||27
8249680|NCT01870856|20343253|P1|COMPLETED|Overall Study||25
8249681|NCT01870856|20343252|P2|STARTED|Overall Study||27
8249682|NCT01870856|20343253|P1|STARTED|Overall Study||25
8249683|NCT01870843|20343263|P1|NOT COMPLETED|Overall Study||53
8249684|NCT01870843|20343263|P1|COMPLETED|Overall Study||208
8249685|NCT01870843|20343263|P1|STARTED|Overall Study||261
8249686|NCT01870778|20343278|P2|NOT COMPLETED|Overall Study||9
8249687|NCT01870778|20343279|P1|NOT COMPLETED|Overall Study||8
8249688|NCT01870778|20343278|P2|COMPLETED|Overall Study||3262
8249689|NCT01870778|20343279|P1|COMPLETED|Overall Study||3266
8249690|NCT01870778|20343278|P2|Biomarker Analysis Set|Overall Study||510
8249691|NCT01870778|20343279|P1|Biomarker Analysis Set|Overall Study||521
8249692|NCT01870778|20343278|P2|Full Analysis Set|Overall Study||3271
8249693|NCT01870778|20343279|P1|Full Analysis Set|Overall Study||3274
8249694|NCT01870778|20343278|P2|Safety Set|Overall Study||3248
8249695|NCT01870778|20343279|P1|Safety Set|Overall Study||3257
8249696|NCT01870778|20343278|P2|STARTED|Overall Study||3271
8249697|NCT01870778|20343279|P1|STARTED|Overall Study||3274
8249698|NCT01870739|20343305|P2|NOT COMPLETED|Add-on Period (40 Weeks)||2
8249699|NCT01870739|20343306|P1|NOT COMPLETED|Add-on Period (40 Weeks)||3
8249700|NCT01870739|20343305|P2|COMPLETED|Add-on Period (40 Weeks)||51
8249701|NCT01870739|20343306|P1|COMPLETED|Add-on Period (40 Weeks)||51
8249702|NCT01870739|20343305|P2|STARTED|Add-on Period (40 Weeks)||53
8249703|NCT01870739|20343306|P1|STARTED|Add-on Period (40 Weeks)||54
8249704|NCT01870739|20343305|P2|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
8249705|NCT01870739|20343306|P1|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
8249706|NCT01870739|20343305|P2|COMPLETED|Single Drug Treatment (12 Weeks)||53
8249707|NCT01870739|20343306|P1|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
8249708|NCT01870739|20343305|P2|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
8249709|NCT01870739|20343306|P1|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
8249710|NCT01870739|20343305|P2|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
8249711|NCT01870739|20343306|P1|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
8249712|NCT01870739|20343305|P2|STARTED|Single Drug Treatment (12 Weeks)||57
8249713|NCT01870739|20343306|P1|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
8249714|NCT01870726|20343345|P7|NOT COMPLETED|Overall Study||10
8249715|NCT01870726|20343346|P6|NOT COMPLETED|Overall Study||5
8249716|NCT01870726|20343347|P5|NOT COMPLETED|Overall Study||7
8249717|NCT01870726|20343348|P4|NOT COMPLETED|Overall Study||6
8249718|NCT01870726|20343349|P3|NOT COMPLETED|Overall Study||4
8249719|NCT01870726|20343350|P2|NOT COMPLETED|Overall Study||6
8249720|NCT01870726|20343351|P1|NOT COMPLETED|Overall Study||5
8249721|NCT01870726|20343345|P7|COMPLETED|Overall Study||0
8249722|NCT01870726|20343346|P6|COMPLETED|Overall Study||0
8249723|NCT01870726|20343347|P5|COMPLETED|Overall Study||0
8249724|NCT01870726|20343348|P4|COMPLETED|Overall Study||0
8249725|NCT01870726|20343349|P3|COMPLETED|Overall Study||0
8249726|NCT01870726|20343350|P2|COMPLETED|Overall Study||0
8249727|NCT01870726|20343351|P1|COMPLETED|Overall Study||0
8249728|NCT01870726|20343345|P7|STARTED|Overall Study||10
8249729|NCT01870726|20343346|P6|STARTED|Overall Study||5
8249730|NCT01870726|20343347|P5|STARTED|Overall Study||7
8249731|NCT01870726|20343348|P4|STARTED|Overall Study||6
8249732|NCT01870726|20343349|P3|STARTED|Overall Study||4
8249733|NCT01870726|20343350|P2|STARTED|Overall Study||6
8249734|NCT01870726|20343351|P1|STARTED|Overall Study||5
8249735|NCT01870596|20343436|P2|NOT COMPLETED|Overall Study||0
8249736|NCT01870596|20343437|P1|NOT COMPLETED|Overall Study||0
8249737|NCT01870596|20343436|P2|COMPLETED|Overall Study||18
8249738|NCT01870596|20343437|P1|COMPLETED|Overall Study||14
8249739|NCT01870596|20343436|P2|STARTED|Overall Study||18
8249740|NCT01870596|20343437|P1|STARTED|Overall Study||14
8249741|NCT01870583|20343446|P3|NOT COMPLETED|Overall Study||8
8249742|NCT01870583|20343447|P2|NOT COMPLETED|Overall Study||18
8249743|NCT01870583|20343448|P1|NOT COMPLETED|Overall Study||11
8249744|NCT01870583|20343446|P3|COMPLETED|Overall Study||455
8249745|NCT01870583|20343447|P2|COMPLETED|Overall Study||456
8249746|NCT01870583|20343448|P1|COMPLETED|Overall Study||456
8249747|NCT01870583|20343446|P3|STARTED|Overall Study||463
8249748|NCT01870583|20343447|P2|STARTED|Overall Study||474
8249749|NCT01870583|20343448|P1|STARTED|Overall Study||467
8249756|NCT01870388|20343519|P2|NOT COMPLETED|Overall Study||0
8249757|NCT01870388|20343520|P1|NOT COMPLETED|Overall Study||0
8249758|NCT01870388|20343519|P2|COMPLETED|Overall Study||8
8249759|NCT01870388|20343520|P1|COMPLETED|Overall Study||8
8249760|NCT01870388|20343519|P2|Received 1 Dose of Study Drug|Overall Study||8
8249761|NCT01870388|20343520|P1|Received 1 Dose of Study Drug|Overall Study||8
8249762|NCT01870388|20343519|P2|STARTED|Overall Study||8
8249763|NCT01870388|20343520|P1|STARTED|Overall Study||8
8249764|NCT01870297|20343535|P7|NOT COMPLETED|Overall Study||2
8249765|NCT01870297|20343536|P6|NOT COMPLETED|Overall Study||1
8249766|NCT01870297|20343537|P5|NOT COMPLETED|Overall Study||3
8249767|NCT01870297|20343538|P4|NOT COMPLETED|Overall Study||0
8249768|NCT01870297|20343539|P3|NOT COMPLETED|Overall Study||1
8249769|NCT01870297|20343540|P2|NOT COMPLETED|Overall Study||7
8249770|NCT01870297|20343541|P1|NOT COMPLETED|Overall Study||0
8249771|NCT01870297|20343535|P7|COMPLETED|Overall Study||8
8249772|NCT01870297|20343536|P6|COMPLETED|Overall Study||8
8249773|NCT01870297|20343537|P5|COMPLETED|Overall Study||7
8249774|NCT01870297|20343538|P4|COMPLETED|Overall Study||9
8249775|NCT01870297|20343539|P3|COMPLETED|Overall Study||7
8249776|NCT01870297|20343540|P2|COMPLETED|Overall Study||8
8249777|NCT01870297|20343541|P1|COMPLETED|Overall Study||11
8249778|NCT01870297|20343535|P7|STARTED|Overall Study||10
8249779|NCT01870297|20343536|P6|STARTED|Overall Study||9
8249780|NCT01870297|20343537|P5|STARTED|Overall Study||10
8249781|NCT01870297|20343538|P4|STARTED|Overall Study||9
8249782|NCT01870297|20343539|P3|STARTED|Overall Study||8
8249783|NCT01870297|20343540|P2|STARTED|Overall Study||15
8249784|NCT01870297|20343541|P1|STARTED|Overall Study||11
8249785|NCT01870076|20343585|P4|NOT COMPLETED|Overall Study||0
8249786|NCT01870076|20343586|P3|NOT COMPLETED|Overall Study||1
8249787|NCT01870076|20343587|P2|NOT COMPLETED|Overall Study||0
8249788|NCT01870076|20343588|P1|NOT COMPLETED|Overall Study||1
8249789|NCT01870076|20343585|P4|COMPLETED|Overall Study||11
8249790|NCT01870076|20343586|P3|COMPLETED|Overall Study||7
8249791|NCT01870076|20343587|P2|COMPLETED|Overall Study||12
8249792|NCT01870076|20343588|P1|COMPLETED|Overall Study||9
8249793|NCT01870076|20343585|P4|STARTED|Overall Study||11
8249794|NCT01870076|20343586|P3|STARTED|Overall Study||8
8249795|NCT01870076|20343587|P2|STARTED|Overall Study||12
8249796|NCT01870076|20343588|P1|STARTED|Overall Study||10
8249797|NCT01869959|20343606|P5|NOT COMPLETED|Treatment Period||0
8249798|NCT01869959|20343607|P4|NOT COMPLETED|Treatment Period||2
8249799|NCT01869959|20343608|P3|NOT COMPLETED|Treatment Period||3
8249800|NCT01869959|20343609|P2|NOT COMPLETED|Treatment Period||2
8249801|NCT01869959|20343610|P1|NOT COMPLETED|Treatment Period||1
8249802|NCT01869959|20343606|P5|COMPLETED|Treatment Period||0
8249803|NCT01869959|20343607|P4|COMPLETED|Treatment Period||8
8249804|NCT01869959|20343608|P3|COMPLETED|Treatment Period||12
8249805|NCT01869959|20343609|P2|COMPLETED|Treatment Period||8
8249806|NCT01869959|20343610|P1|COMPLETED|Treatment Period||10
8249807|NCT01869959|20343606|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
8249808|NCT01869959|20343607|P4|Received at Least 1 Dose of Study Drug|Treatment Period||10
8249809|NCT01869959|20343608|P3|Received at Least 1 Dose of Study Drug|Treatment Period||15
8249810|NCT01869959|20343609|P2|Received at Least 1 Dose of Study Drug|Treatment Period||10
8249811|NCT01869959|20343610|P1|Received at Least 1 Dose of Study Drug|Treatment Period||11
8249812|NCT01869959|20343606|P5|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
8249813|NCT01869959|20343607|P4|STARTED|Treatment Period||10
8249814|NCT01869959|20343608|P3|STARTED|Treatment Period||15
8249815|NCT01869959|20343609|P2|STARTED|Treatment Period||10
8249816|NCT01869959|20343610|P1|STARTED|Treatment Period||11
8249817|NCT01869959|20343606|P5|NOT COMPLETED|Randomization Period||1
8249818|NCT01869959|20343607|P4|NOT COMPLETED|Randomization Period||0
8249819|NCT01869959|20343608|P3|NOT COMPLETED|Randomization Period||0
8249820|NCT01869959|20343609|P2|NOT COMPLETED|Randomization Period||0
8249821|NCT01869959|20343610|P1|NOT COMPLETED|Randomization Period||0
8249822|NCT01869959|20343606|P5|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
8249823|NCT01869959|20343607|P4|COMPLETED|Randomization Period||0
8249824|NCT01869959|20343608|P3|COMPLETED|Randomization Period||0
8249825|NCT01869959|20343609|P2|COMPLETED|Randomization Period||0
8249826|NCT01869959|20343610|P1|COMPLETED|Randomization Period||0
8249827|NCT01869959|20343606|P5|STARTED|Randomization Period||47
8249828|NCT01869959|20343607|P4|STARTED|Randomization Period||0
8249829|NCT01869959|20343608|P3|STARTED|Randomization Period||0
8249830|NCT01869959|20343609|P2|STARTED|Randomization Period||0
8249831|NCT01869959|20343610|P1|STARTED|Randomization Period||0
8249832|NCT01869777|20343678|P1|NOT COMPLETED|Overall Study||1
8249833|NCT01869777|20343678|P1|COMPLETED|Overall Study||101
8249834|NCT01869777|20343678|P1|STARTED|Overall Study||102
8249835|NCT01869764|20343691|P2|NOT COMPLETED|Overall Study||2
8249836|NCT01869764|20343692|P1|NOT COMPLETED|Overall Study||0
8249837|NCT01869764|20343691|P2|COMPLETED|Overall Study||27
8249838|NCT01869764|20343692|P1|COMPLETED|Overall Study||28
8249839|NCT01869764|20343691|P2|STARTED|Overall Study||29
8249840|NCT01869764|20343692|P1|STARTED|Overall Study||28
8249841|NCT01869699|20343710|P2|NOT COMPLETED|Overall Study||0
8249842|NCT01869699|20343711|P1|NOT COMPLETED|Overall Study||1
8249843|NCT01869699|20343710|P2|COMPLETED|Overall Study||20
8249844|NCT01869699|20343711|P1|COMPLETED|Overall Study||20
8249845|NCT01869699|20343710|P2|STARTED|Overall Study||20
8249846|NCT01869699|20343711|P1|STARTED|Overall Study||21
8249847|NCT01869686|20343729|P1|NOT COMPLETED|Overall Study||0
8249848|NCT01869686|20343729|P1|COMPLETED|Overall Study||12
8249849|NCT01869686|20343729|P1|STARTED|Overall Study||12
8249850|NCT01869647|20343744|P3|NOT COMPLETED|Overall Study||0
8249851|NCT01869647|20343745|P2|NOT COMPLETED|Overall Study||6
8249852|NCT01869647|20343746|P1|NOT COMPLETED|Overall Study||1
8249853|NCT01869647|20343744|P3|COMPLETED|Overall Study||62
8249854|NCT01869647|20343745|P2|COMPLETED|Overall Study||130
8249855|NCT01869647|20343746|P1|COMPLETED|Overall Study||65
8249856|NCT01869647|20343744|P3|STARTED|Overall Study||62
8249857|NCT01869647|20343745|P2|STARTED|Overall Study||136
8249858|NCT01869647|20343746|P1|STARTED|Overall Study||66
8249859|NCT01869634|20343759|P2|NOT COMPLETED|Overall Study||0
8249860|NCT01869634|20343760|P1|NOT COMPLETED|Overall Study||2
8249861|NCT01869634|20343759|P2|COMPLETED|Overall Study||17
8249862|NCT01869634|20343760|P1|COMPLETED|Overall Study||18
8249863|NCT01869634|20343759|P2|STARTED|Overall Study||17
8249864|NCT01869634|20343760|P1|STARTED|Overall Study||20
8249865|NCT01869478|20343772|P2|NOT COMPLETED|Overall Study||0
8249866|NCT01869478|20343773|P1|NOT COMPLETED|Overall Study||0
8249867|NCT01869478|20343772|P2|COMPLETED|Overall Study||1
8249868|NCT01869478|20343773|P1|COMPLETED|Overall Study||0
8249869|NCT01869478|20343772|P2|STARTED|Overall Study||1
8249870|NCT01869478|20343773|P1|STARTED|Overall Study||0
8249871|NCT01869439|20343781|P1|NOT COMPLETED|Overall Study||0
8249872|NCT01869439|20343781|P1|COMPLETED|Overall Study||40
8249873|NCT01869439|20343781|P1|STARTED|Overall Study||40
8249874|NCT01869374|20343787|P2|NOT COMPLETED|Overall Study||1
8249875|NCT01869374|20343788|P1|NOT COMPLETED|Overall Study||0
8249876|NCT01869374|20343787|P2|COMPLETED|Overall Study||8
8249877|NCT01869374|20343788|P1|COMPLETED|Overall Study||9
8249878|NCT01869374|20343787|P2|STARTED|Overall Study||9
8249879|NCT01869374|20343788|P1|STARTED|Overall Study||9
8249880|NCT01869348|20343796|P2|NOT COMPLETED|Overall Study||1
8249881|NCT01869348|20343797|P1|NOT COMPLETED|Overall Study||1
8249882|NCT01869348|20343796|P2|COMPLETED|Overall Study||19
8249883|NCT01869348|20343797|P1|COMPLETED|Overall Study||19
8249884|NCT01869348|20343796|P2|STARTED|Overall Study||20
8249885|NCT01869348|20343797|P1|STARTED|Overall Study||20
8249886|NCT01869192|20343805|P2|NOT COMPLETED|Postoperative Chemotherapy||2
8249887|NCT01869192|20343806|P1|NOT COMPLETED|Postoperative Chemotherapy||0
8249888|NCT01869192|20343805|P2|COMPLETED|Postoperative Chemotherapy||31
8249889|NCT01869192|20343806|P1|COMPLETED|Postoperative Chemotherapy||32
8249890|NCT01869192|20343805|P2|STARTED|Postoperative Chemotherapy||33
8249891|NCT01869192|20343806|P1|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
8249892|NCT01869192|20343805|P2|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
8249893|NCT01869192|20343806|P1|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
8249894|NCT01869192|20343805|P2|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
8249895|NCT01869192|20343806|P1|COMPLETED|Preoperative Chemotherapy to Surgery||35
8249896|NCT01869192|20343805|P2|STARTED|Preoperative Chemotherapy to Surgery||35
8249897|NCT01869192|20343806|P1|STARTED|Preoperative Chemotherapy to Surgery||37
8249898|NCT01869075|20343820|P6|NOT COMPLETED|Phase 2||0
8249899|NCT01869075|20343821|P5|NOT COMPLETED|Phase 2||0
8249900|NCT01869075|20343822|P4|NOT COMPLETED|Phase 2||0
8249901|NCT01869075|20343823|P3|NOT COMPLETED|Phase 2||0
8249902|NCT01869075|20343824|P2|NOT COMPLETED|Phase 2||0
8249903|NCT01869075|20343825|P1|NOT COMPLETED|Phase 2||0
8249904|NCT01869075|20343820|P6|COMPLETED|Phase 2||45
8249905|NCT01869075|20343821|P5|COMPLETED|Phase 2||75
8249906|NCT01869075|20343822|P4|COMPLETED|Phase 2||45
8249907|NCT01869075|20343823|P3|COMPLETED|Phase 2||75
8249908|NCT01869075|20343824|P2|COMPLETED|Phase 2||30
8249909|NCT01869075|20343825|P1|COMPLETED|Phase 2||90
8249910|NCT01869075|20343820|P6|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
8249911|NCT01869075|20343821|P5|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
8249912|NCT01869075|20343822|P4|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
8249913|NCT01869075|20343823|P3|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
8249914|NCT01869075|20343824|P2|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
8249915|NCT01869075|20343825|P1|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
8249916|NCT01869075|20343820|P6|NOT COMPLETED|Phase 1||0
8249917|NCT01869075|20343821|P5|NOT COMPLETED|Phase 1||0
8249918|NCT01869075|20343822|P4|NOT COMPLETED|Phase 1||0
8249919|NCT01869075|20343823|P3|NOT COMPLETED|Phase 1||0
8249920|NCT01869075|20343824|P2|NOT COMPLETED|Phase 1||0
8249921|NCT01869075|20343825|P1|NOT COMPLETED|Phase 1||0
8249922|NCT01869075|20343820|P6|COMPLETED|Phase 1||90
8249923|NCT01869075|20343821|P5|COMPLETED|Phase 1||30
8249924|NCT01869075|20343822|P4|COMPLETED|Phase 1||75
8249925|NCT01869075|20343823|P3|COMPLETED|Phase 1||45
8249926|NCT01869075|20343824|P2|COMPLETED|Phase 1||75
8249927|NCT01869075|20343825|P1|COMPLETED|Phase 1||45
8249928|NCT01869075|20343820|P6|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
8249929|NCT01869075|20343821|P5|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
8249930|NCT01869075|20343822|P4|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
8249931|NCT01869075|20343823|P3|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
8249932|NCT01869075|20343824|P2|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
8249933|NCT01869075|20343825|P1|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
8249934|NCT01869075|20343820|P6|NOT COMPLETED|Phase 0 (Baseline)||0
8249935|NCT01869075|20343821|P5|NOT COMPLETED|Phase 0 (Baseline)||0
8249936|NCT01869075|20343822|P4|NOT COMPLETED|Phase 0 (Baseline)||0
8249937|NCT01869075|20343823|P3|NOT COMPLETED|Phase 0 (Baseline)||0
8249938|NCT01869075|20343824|P2|NOT COMPLETED|Phase 0 (Baseline)||0
8249939|NCT01869075|20343825|P1|NOT COMPLETED|Phase 0 (Baseline)||0
8249940|NCT01869075|20343820|P6|COMPLETED|Phase 0 (Baseline)||341
8249941|NCT01869075|20343821|P5|COMPLETED|Phase 0 (Baseline)||0
8249942|NCT01869075|20343822|P4|COMPLETED|Phase 0 (Baseline)||416
8249943|NCT01869075|20343823|P3|COMPLETED|Phase 0 (Baseline)||0
8249944|NCT01869075|20343824|P2|COMPLETED|Phase 0 (Baseline)||418
8249945|NCT01869075|20343825|P1|COMPLETED|Phase 0 (Baseline)||0
8249946|NCT01869075|20343820|P6|STARTED|Phase 0 (Baseline)||341
8249947|NCT01869075|20343821|P5|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
8249948|NCT01869075|20343822|P4|STARTED|Phase 0 (Baseline)||416
8249949|NCT01869075|20343823|P3|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
8249950|NCT01869075|20343824|P2|STARTED|Phase 0 (Baseline)||418
8249951|NCT01869075|20343825|P1|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
8249952|NCT01868997|20343841|P2|NOT COMPLETED|Overall Study||6
8249953|NCT01868997|20343842|P1|NOT COMPLETED|Overall Study||7
8249954|NCT01868997|20343841|P2|COMPLETED|Overall Study||36
8249955|NCT01868997|20343842|P1|COMPLETED|Overall Study||38
8249956|NCT01868997|20343841|P2|STARTED|Overall Study|randomized and treated|42
8249957|NCT01868997|20343842|P1|STARTED|Overall Study|randomized and treated|45
8249958|NCT01868893|20343858|P1|NOT COMPLETED|Overall Study||20
8249959|NCT01868893|20343858|P1|COMPLETED|Overall Study||0
8249960|NCT01868893|20343858|P1|STARTED|Overall Study||20
8249961|NCT01868789|20343867|P2|NOT COMPLETED|Overall Study||2
8249962|NCT01868789|20343868|P1|NOT COMPLETED|Overall Study||2
8249963|NCT01868789|20343867|P2|COMPLETED|Overall Study||12
8249964|NCT01868789|20343868|P1|COMPLETED|Overall Study||7
8249965|NCT01868789|20343867|P2|STARTED|Overall Study||14
8249966|NCT01868789|20343868|P1|STARTED|Overall Study||9
8249967|NCT01868776|20343878|P2|NOT COMPLETED|Overall Study||0
8249968|NCT01868776|20343879|P1|NOT COMPLETED|Overall Study||0
8249969|NCT01868776|20343878|P2|COMPLETED|Overall Study||50
8249970|NCT01868776|20343879|P1|COMPLETED|Overall Study||50
8249971|NCT01868776|20343878|P2|STARTED|Overall Study||50
8249972|NCT01868776|20343879|P1|STARTED|Overall Study||50
8249973|NCT01868646|20343889|P2|NOT COMPLETED|Overall Study||5
8249974|NCT01868646|20343890|P1|NOT COMPLETED|Overall Study||3
8249975|NCT01868646|20343889|P2|COMPLETED|Overall Study||67
8249976|NCT01868646|20343890|P1|COMPLETED|Overall Study||73
8249977|NCT01868646|20343889|P2|STARTED|Overall Study||72
8249978|NCT01868646|20343890|P1|STARTED|Overall Study||76
8249979|NCT01868633|20343918|P2|NOT COMPLETED|Overall Study||0
8249980|NCT01868633|20343919|P1|NOT COMPLETED|Overall Study||0
8249981|NCT01868633|20343918|P2|COMPLETED|Overall Study||26
8249982|NCT01868633|20343919|P1|COMPLETED|Overall Study||26
8249983|NCT01868633|20343918|P2|STARTED|Overall Study||26
8249984|NCT01868633|20343919|P1|STARTED|Overall Study||26
8249985|NCT01868594|20343935|P2|NOT COMPLETED|Overall Study||3
8249986|NCT01868594|20343936|P1|NOT COMPLETED|Overall Study||4
8249987|NCT01868594|20343935|P2|COMPLETED|Overall Study||72
8249988|NCT01868594|20343936|P1|COMPLETED|Overall Study||72
8249989|NCT01868594|20343935|P2|STARTED|Overall Study||75
8249990|NCT01868594|20343936|P1|STARTED|Overall Study||76
8249991|NCT01868542|20343956|P2|NOT COMPLETED|Overall Study||2
8249992|NCT01868542|20343957|P1|NOT COMPLETED|Overall Study||0
8249993|NCT01868542|20343956|P2|COMPLETED|Overall Study||21
8249994|NCT01868542|20343957|P1|COMPLETED|Overall Study||23
8249995|NCT01868542|20343956|P2|STARTED|Overall Study||23
8249996|NCT01868542|20343957|P1|STARTED|Overall Study||23
8249997|NCT01868503|20343975|P1|NOT COMPLETED|Overall Study||2
8249998|NCT01868503|20343975|P1|COMPLETED|Overall Study||5
8249999|NCT01868503|20343975|P1|STARTED|Overall Study||7
8250000|NCT01868477|20343985|P2|NOT COMPLETED|Overall Study||5
8250001|NCT01868477|20343986|P1|NOT COMPLETED|Overall Study||4
8250002|NCT01868477|20343985|P2|COMPLETED|Overall Study||6
8250003|NCT01868477|20343986|P1|COMPLETED|Overall Study||8
8250004|NCT01868477|20343985|P2|Not Switched to EPO+DFX|Overall Study||0
8250005|NCT01868477|20343986|P1|Not Switched to EPO+DFX|Overall Study||7
8250006|NCT01868477|20343985|P2|Switched to EPO+DFX|Overall Study||0
8250007|NCT01868477|20343986|P1|Switched to EPO+DFX|Overall Study||5
8250008|NCT01868477|20343985|P2|STARTED|Overall Study||11
8250009|NCT01868477|20343986|P1|STARTED|Overall Study||12
8250010|NCT01868425|20344012|P2|NOT COMPLETED|Overall Study||0
8250011|NCT01868425|20344013|P1|NOT COMPLETED|Overall Study||0
8250012|NCT01868425|20344012|P2|COMPLETED|Overall Study||57
8250013|NCT01868425|20344013|P1|COMPLETED|Overall Study||55
8250014|NCT01868425|20344012|P2|STARTED|Overall Study||57
8250015|NCT01868425|20344013|P1|STARTED|Overall Study||55
8250016|NCT01868334|20344047|P4|NOT COMPLETED|Year 2 Pre-post Study||0
8250017|NCT01868334|20344048|P3|NOT COMPLETED|Year 2 Pre-post Study||0
8250018|NCT01868334|20344049|P2|NOT COMPLETED|Year 2 Pre-post Study||0
8250019|NCT01868334|20344050|P1|NOT COMPLETED|Year 2 Pre-post Study||0
8250020|NCT01868334|20344047|P4|COMPLETED|Year 2 Pre-post Study||19274
8250021|NCT01868334|20344048|P3|COMPLETED|Year 2 Pre-post Study||20904
8250022|NCT01868334|20344049|P2|COMPLETED|Year 2 Pre-post Study||8047
8250023|NCT01868334|20344050|P1|COMPLETED|Year 2 Pre-post Study||22324
8250024|NCT01868334|20344047|P4|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
8250025|NCT01868334|20344048|P3|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
8250026|NCT01868334|20344049|P2|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
8250027|NCT01868334|20344050|P1|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
8250028|NCT01868334|20344047|P4|NOT COMPLETED|Year 1 RCCT Study||0
8250029|NCT01868334|20344048|P3|NOT COMPLETED|Year 1 RCCT Study||0
8250030|NCT01868334|20344049|P2|NOT COMPLETED|Year 1 RCCT Study||0
8250031|NCT01868334|20344050|P1|NOT COMPLETED|Year 1 RCCT Study||0
8250032|NCT01868334|20344047|P4|COMPLETED|Year 1 RCCT Study||20904
8250033|NCT01868334|20344048|P3|COMPLETED|Year 1 RCCT Study||19274
8250034|NCT01868334|20344049|P2|COMPLETED|Year 1 RCCT Study||17185
8250035|NCT01868334|20344050|P1|COMPLETED|Year 1 RCCT Study||13186
8250036|NCT01868334|20344047|P4|STARTED|Year 1 RCCT Study||20904
8250037|NCT01868334|20344048|P3|STARTED|Year 1 RCCT Study||19274
8250038|NCT01868334|20344049|P2|STARTED|Year 1 RCCT Study||17185
8250039|NCT01868334|20344050|P1|STARTED|Year 1 RCCT Study||13186
8250040|NCT01868243|20344090|P2|NOT COMPLETED|Overall Study||1
8250041|NCT01868243|20344091|P1|NOT COMPLETED|Overall Study||0
8250042|NCT01868243|20344090|P2|COMPLETED|Overall Study||11
8250043|NCT01868243|20344091|P1|COMPLETED|Overall Study||15
8250044|NCT01868243|20344090|P2|STARTED|Overall Study||12
8250045|NCT01868243|20344091|P1|STARTED|Overall Study||15
8250046|NCT01868165|20344099|P1|NOT COMPLETED|Overall Study||45
8250047|NCT01868165|20344099|P1|COMPLETED|Overall Study||292
8250048|NCT01868165|20344099|P1|STARTED|Overall Study||337
8250049|NCT01868139|20344103|P1|NOT COMPLETED|Overall Study||1
8250050|NCT01868139|20344103|P1|COMPLETED|Overall Study||0
8250051|NCT01868139|20344103|P1|STARTED|Overall Study||1
8250052|NCT01868074|20344115|P2|NOT COMPLETED|Overall Study||4
8250053|NCT01868074|20344116|P1|NOT COMPLETED|Overall Study||7
8250054|NCT01868074|20344115|P2|COMPLETED|Overall Study||32
8250055|NCT01868074|20344116|P1|COMPLETED|Overall Study||29
8250056|NCT01868074|20344115|P2|STARTED|Overall Study||36
8250057|NCT01868074|20344116|P1|STARTED|Overall Study||36
8250058|NCT01868035|20344126|P1|NOT COMPLETED|Overall Study||7
8250059|NCT01868035|20344126|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
8250060|NCT01868035|20344126|P1|STARTED|Overall Study||15
8250061|NCT01868022|20344151|P9|NOT COMPLETED|Overall Study||2
8250062|NCT01868022|20344152|P8|NOT COMPLETED|Overall Study||9
8250063|NCT01868022|20344153|P7|NOT COMPLETED|Overall Study||0
8250064|NCT01868022|20344154|P6|NOT COMPLETED|Overall Study||1
8250065|NCT01868022|20344155|P5|NOT COMPLETED|Overall Study||2
8250066|NCT01868022|20344156|P4|NOT COMPLETED|Overall Study||1
8250067|NCT01868022|20344157|P3|NOT COMPLETED|Overall Study||1
8250068|NCT01868022|20344158|P2|NOT COMPLETED|Overall Study||0
8250069|NCT01868022|20344159|P1|NOT COMPLETED|Overall Study||0
8250070|NCT01868022|20344151|P9|COMPLETED|Overall Study||6
8250071|NCT01868022|20344152|P8|COMPLETED|Overall Study||16
8250072|NCT01868022|20344153|P7|COMPLETED|Overall Study||3
8250073|NCT01868022|20344154|P6|COMPLETED|Overall Study||2
8250074|NCT01868022|20344155|P5|COMPLETED|Overall Study||1
8250075|NCT01868022|20344156|P4|COMPLETED|Overall Study||2
8250076|NCT01868022|20344157|P3|COMPLETED|Overall Study||13
8250077|NCT01868022|20344158|P2|COMPLETED|Overall Study||3
8250078|NCT01868022|20344159|P1|COMPLETED|Overall Study||3
8250079|NCT01868022|20344151|P9|STARTED|Overall Study||8
8250080|NCT01868022|20344152|P8|STARTED|Overall Study||25
8250081|NCT01868022|20344153|P7|STARTED|Overall Study||3
8250082|NCT01868022|20344154|P6|STARTED|Overall Study||3
8250083|NCT01868022|20344155|P5|STARTED|Overall Study||3
8250084|NCT01868022|20344156|P4|STARTED|Overall Study||3
8250085|NCT01868022|20344157|P3|STARTED|Overall Study||14
8250086|NCT01868022|20344158|P2|STARTED|Overall Study||3
8250087|NCT01868022|20344159|P1|STARTED|Overall Study||3
8250088|NCT01868009|20344365|P2|NOT COMPLETED|Period 2 (5-9 Days)||0
8250089|NCT01868009|20344366|P1|NOT COMPLETED|Period 2 (5-9 Days)||2
8250090|NCT01868009|20344365|P2|COMPLETED|Period 2 (5-9 Days)||142
8250091|NCT01868009|20344366|P1|COMPLETED|Period 2 (5-9 Days)||141
8250092|NCT01868009|20344365|P2|STARTED|Period 2 (5-9 Days)||142
8250093|NCT01868009|20344366|P1|STARTED|Period 2 (5-9 Days)||143
8250094|NCT01868009|20344365|P2|NOT COMPLETED|Period 1 (5-9 Days)||2
8250095|NCT01868009|20344366|P1|NOT COMPLETED|Period 1 (5-9 Days)||0
8250096|NCT01868009|20344365|P2|COMPLETED|Period 1 (5-9 Days)||142
8250097|NCT01868009|20344366|P1|COMPLETED|Period 1 (5-9 Days)||143
8250098|NCT01868009|20344365|P2|STARTED|Period 1 (5-9 Days)||144
8250099|NCT01868009|20344366|P1|STARTED|Period 1 (5-9 Days)||143
8250100|NCT01867710|20344380|P4|NOT COMPLETED|Overall Study||42
8250101|NCT01867710|20344381|P3|NOT COMPLETED|Overall Study||40
8250102|NCT01867710|20344382|P2|NOT COMPLETED|Overall Study||41
8250103|NCT01867710|20344383|P1|NOT COMPLETED|Overall Study||41
8250104|NCT01867710|20344380|P4|COMPLETED|Overall Study||0
8250105|NCT01867710|20344381|P3|COMPLETED|Overall Study||0
8250106|NCT01867710|20344382|P2|COMPLETED|Overall Study||0
8250107|NCT01867710|20344383|P1|COMPLETED|Overall Study||0
8250108|NCT01867710|20344380|P4|Treated|Overall Study||42
8250109|NCT01867710|20344381|P3|Treated|Overall Study||39
8250110|NCT01867710|20344382|P2|Treated|Overall Study||41
8250111|NCT01867710|20344383|P1|Treated|Overall Study||41
8250112|NCT01867710|20344380|P4|STARTED|Overall Study||42
8250113|NCT01867710|20344381|P3|STARTED|Overall Study||40
8250114|NCT01867710|20344382|P2|STARTED|Overall Study||41
8250115|NCT01867710|20344383|P1|STARTED|Overall Study||41
8250116|NCT01867671|20344451|P2|NOT COMPLETED|Overall Study||28
8250117|NCT01867671|20344452|P1|NOT COMPLETED|Overall Study||29
8250118|NCT01867671|20344451|P2|COMPLETED|Overall Study||22
8250119|NCT01867671|20344452|P1|COMPLETED|Overall Study||67
8250120|NCT01867671|20344451|P2|STARTED|Overall Study||50
8250121|NCT01867671|20344452|P1|STARTED|Overall Study||96
8250122|NCT01867658|20344465|P1|NOT COMPLETED|Overall Study||9
8250123|NCT01867658|20344465|P1|COMPLETED|Overall Study||103
8250124|NCT01867658|20344465|P1|STARTED|Overall Study||112
8250125|NCT01867632|20344478|P2|NOT COMPLETED|Overall Study||0
8250126|NCT01867632|20344479|P1|NOT COMPLETED|Overall Study||0
8250127|NCT01867632|20344478|P2|COMPLETED|Overall Study||66
8250128|NCT01867632|20344479|P1|COMPLETED|Overall Study||65
8250129|NCT01867632|20344478|P2|STARTED|Overall Study||66
8250130|NCT01867632|20344479|P1|STARTED|Overall Study||65
8250131|NCT01867606|20344489|P2|NOT COMPLETED|Overall Study||15
8250132|NCT01867606|20344490|P1|NOT COMPLETED|Overall Study||10
8250133|NCT01867606|20344489|P2|COMPLETED|Overall Study||17
8250134|NCT01867606|20344490|P1|COMPLETED|Overall Study||16
8250135|NCT01867606|20344489|P2|STARTED|Overall Study||32
8250136|NCT01867606|20344490|P1|STARTED|Overall Study||26
8250137|NCT01867580|20344508|P2|NOT COMPLETED|Overall Study||24
8250138|NCT01867580|20344509|P1|NOT COMPLETED|Overall Study||28
8250139|NCT01867580|20344508|P2|COMPLETED|Overall Study||64
8250140|NCT01867580|20344509|P1|COMPLETED|Overall Study||65
8250141|NCT01867580|20344508|P2|STARTED|Overall Study||88
8250142|NCT01867580|20344509|P1|STARTED|Overall Study||93
8250143|NCT01867515|20344522|P3|NOT COMPLETED|Overall Study||11
8250144|NCT01867515|20344523|P2|NOT COMPLETED|Overall Study||1
8250145|NCT01867515|20344524|P1|NOT COMPLETED|Overall Study||0
8250146|NCT01867515|20344522|P3|COMPLETED|Overall Study||14
8250147|NCT01867515|20344523|P2|COMPLETED|Overall Study||11
8250148|NCT01867515|20344524|P1|COMPLETED|Overall Study||13
8250149|NCT01867515|20344522|P3|STARTED|Overall Study||25
8250150|NCT01867515|20344523|P2|STARTED|Overall Study||12
8250151|NCT01867515|20344524|P1|STARTED|Overall Study||13
8250152|NCT01867424|20344534|P2|NOT COMPLETED|Overall Study||1
8250153|NCT01867424|20344535|P1|NOT COMPLETED|Overall Study||2
8250154|NCT01867424|20344534|P2|COMPLETED|Overall Study||11
8250155|NCT01867424|20344535|P1|COMPLETED|Overall Study||10
8250156|NCT01867424|20344534|P2|STARTED|Overall Study||12
8250157|NCT01867424|20344535|P1|STARTED|Overall Study||12
8250158|NCT01867307|20344549|P2|NOT COMPLETED|Overall Study||3
8250159|NCT01867307|20344550|P1|NOT COMPLETED|Overall Study||3
8250160|NCT01867307|20344549|P2|COMPLETED|Overall Study||16
8250161|NCT01867307|20344550|P1|COMPLETED|Overall Study||15
8250162|NCT01867307|20344549|P2|STARTED|Overall Study|Started are the treated patients|19
8250163|NCT01867307|20344550|P1|STARTED|Overall Study|Started are the treated patients|18
8250164|NCT01867294|20344560|P4|NOT COMPLETED|Overall Study||0
8250165|NCT01867294|20344561|P3|NOT COMPLETED|Overall Study||0
8250166|NCT01867294|20344562|P2|NOT COMPLETED|Overall Study||1
8250167|NCT01867294|20344563|P1|NOT COMPLETED|Overall Study||1
8250168|NCT01867294|20344560|P4|COMPLETED|Overall Study||0
8250169|NCT01867294|20344561|P3|COMPLETED|Overall Study||0
8250170|NCT01867294|20344562|P2|COMPLETED|Overall Study||9
8250171|NCT01867294|20344563|P1|COMPLETED|Overall Study||8
8250172|NCT01867294|20344560|P4|STARTED|Overall Study||0
8250173|NCT01867294|20344561|P3|STARTED|Overall Study||0
8250174|NCT01867294|20344562|P2|STARTED|Overall Study||10
8250175|NCT01867294|20344563|P1|STARTED|Overall Study||9
8250176|NCT01867216|20344610|P7|NOT COMPLETED|Overall Study||1
8250177|NCT01867216|20344611|P6|NOT COMPLETED|Overall Study||0
8250178|NCT01867216|20344612|P5|NOT COMPLETED|Overall Study||1
8250179|NCT01867216|20344613|P4|NOT COMPLETED|Overall Study||0
8250180|NCT01867216|20344614|P3|NOT COMPLETED|Overall Study||0
8250181|NCT01867216|20344615|P2|NOT COMPLETED|Overall Study||0
8250182|NCT01867216|20344616|P1|NOT COMPLETED|Overall Study||4
8250183|NCT01867216|20344610|P7|COMPLETED|Overall Study||8
8250184|NCT01867216|20344611|P6|COMPLETED|Overall Study||8
8250185|NCT01867216|20344612|P5|COMPLETED|Overall Study||8
8250186|NCT01867216|20344613|P4|COMPLETED|Overall Study||8
8250187|NCT01867216|20344614|P3|COMPLETED|Overall Study||8
8250188|NCT01867216|20344615|P2|COMPLETED|Overall Study||8
8250189|NCT01867216|20344616|P1|COMPLETED|Overall Study||12
8250190|NCT01867216|20344610|P7|Received Study Drug|Overall Study||9
8250191|NCT01867216|20344611|P6|Received Study Drug|Overall Study||8
8250192|NCT01867216|20344612|P5|Received Study Drug|Overall Study||9
8250193|NCT01867216|20344613|P4|Received Study Drug|Overall Study||8
8250194|NCT01867216|20344614|P3|Received Study Drug|Overall Study||8
8250195|NCT01867216|20344615|P2|Received Study Drug|Overall Study||8
8250196|NCT01867216|20344616|P1|Received Study Drug|Overall Study||14
8250197|NCT01867216|20344610|P7|STARTED|Overall Study||9
8250198|NCT01867216|20344611|P6|STARTED|Overall Study||8
8250199|NCT01867216|20344612|P5|STARTED|Overall Study||9
8250200|NCT01867216|20344613|P4|STARTED|Overall Study||8
8250201|NCT01867216|20344614|P3|STARTED|Overall Study||8
8250202|NCT01867216|20344615|P2|STARTED|Overall Study||8
8250203|NCT01867216|20344616|P1|STARTED|Overall Study||16
8250204|NCT01867164|20344673|P2|NOT COMPLETED|Overall Study||0
8250205|NCT01867164|20344674|P1|NOT COMPLETED|Overall Study||0
8250206|NCT01867164|20344673|P2|COMPLETED|Overall Study||79
8250207|NCT01867164|20344674|P1|COMPLETED|Overall Study||81
8250208|NCT01867164|20344673|P2|STARTED|Overall Study||79
8250209|NCT01867164|20344674|P1|STARTED|Overall Study||81
8250210|NCT01867086|20344688|P1|NOT COMPLETED|Overall Study||1
8250211|NCT01867086|20344688|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
8250212|NCT01867086|20344688|P1|STARTED|Overall Study||1
8250213|NCT01867047|20344697|P2|NOT COMPLETED|Overall Study||5
8250214|NCT01867047|20344698|P1|NOT COMPLETED|Overall Study||8
8250215|NCT01867047|20344697|P2|COMPLETED|Overall Study||23
8250216|NCT01867047|20344698|P1|COMPLETED|Overall Study||23
8250217|NCT01867047|20344697|P2|STARTED|Overall Study||28
8250218|NCT01867047|20344698|P1|STARTED|Overall Study||31
8250219|NCT01867021|20344718|P2|NOT COMPLETED|Overall Study||10
8250220|NCT01867021|20344719|P1|NOT COMPLETED|Overall Study||2
8250221|NCT01867021|20344718|P2|COMPLETED|Overall Study||1440
8250222|NCT01867021|20344719|P1|COMPLETED|Overall Study||1450
8250223|NCT01867021|20344718|P2|STARTED|Overall Study||1450
8250224|NCT01867021|20344719|P1|STARTED|Overall Study||1452
8250225|NCT01867008|20344738|P1|NOT COMPLETED|Overall Study||1
8250226|NCT01867008|20344738|P1|COMPLETED|Overall Study||54
8250227|NCT01867008|20344738|P1|STARTED|Overall Study||55
8250228|NCT01866943|20344742|P2|NOT COMPLETED|Overall Study||22
8250229|NCT01866943|20344743|P1|NOT COMPLETED|Overall Study||19
8250230|NCT01866943|20344742|P2|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
8250231|NCT01866943|20344743|P1|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
8250232|NCT01866943|20344742|P2|STARTED|Overall Study||22
8250233|NCT01866943|20344743|P1|STARTED|Overall Study||19
8250234|NCT01866917|20344754|P2|NOT COMPLETED|Overall Study||6
8250235|NCT01866917|20344755|P1|NOT COMPLETED|Overall Study||4
8250236|NCT01866917|20344754|P2|COMPLETED|Overall Study||12
8250237|NCT01866917|20344755|P1|COMPLETED|Overall Study||13
8250238|NCT01866917|20344754|P2|STARTED|Overall Study||18
8250239|NCT01866917|20344755|P1|STARTED|Overall Study||17
8250240|NCT01866839|20344763|P1|NOT COMPLETED|Overall Study||10
8250241|NCT01866839|20344763|P1|COMPLETED|Overall Study||30
8250242|NCT01866839|20344763|P1|STARTED|Overall Study||40
8250243|NCT01866826|20344779|P2|NOT COMPLETED|Second Intervention - 4 Weeks||0
8250244|NCT01866826|20344780|P1|NOT COMPLETED|Second Intervention - 4 Weeks||0
8250245|NCT01866826|20344779|P2|COMPLETED|Second Intervention - 4 Weeks||20
8250246|NCT01866826|20344780|P1|COMPLETED|Second Intervention - 4 Weeks||22
8250247|NCT01866826|20344779|P2|STARTED|Second Intervention - 4 Weeks||20
8250248|NCT01866826|20344780|P1|STARTED|Second Intervention - 4 Weeks||22
8250249|NCT01866826|20344779|P2|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3
8250250|NCT01866826|20344780|P1|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0
8250251|NCT01866826|20344779|P2|COMPLETED|Wash-Out Period - 4 -6 Weeks||20
8250252|NCT01866826|20344780|P1|COMPLETED|Wash-Out Period - 4 -6 Weeks||22
8250253|NCT01866826|20344779|P2|STARTED|Wash-Out Period - 4 -6 Weeks||23
8250254|NCT01866826|20344780|P1|STARTED|Wash-Out Period - 4 -6 Weeks||22
8250255|NCT01866826|20344779|P2|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0
8250256|NCT01866826|20344780|P1|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1
8250257|NCT01866826|20344779|P2|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23
8250258|NCT01866826|20344780|P1|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22
8250259|NCT01866826|20344779|P2|STARTED|Phase I -Initial Randomization - 4 Weeks||23
8250260|NCT01866826|20344780|P1|STARTED|Phase I -Initial Randomization - 4 Weeks||23
8250261|NCT01866709|20344796|P2|NOT COMPLETED|Overall Study||0
8250262|NCT01866709|20344797|P1|NOT COMPLETED|Overall Study||1
8250263|NCT01866709|20344796|P2|COMPLETED|Overall Study||17
8250264|NCT01866709|20344797|P1|COMPLETED|Overall Study||14
8250265|NCT01866709|20344796|P2|STARTED|Overall Study||17
8250266|NCT01866709|20344797|P1|STARTED|Overall Study||15
8250267|NCT01866592|20344805|P1|NOT COMPLETED|Overall Study||23
8250268|NCT01866592|20344805|P1|COMPLETED|Overall Study||58
8250269|NCT01866592|20344805|P1|STARTED|Overall Study||81
8250270|NCT01866423|20344838|P1|NOT COMPLETED|Overall Study||4
8250271|NCT01866423|20344838|P1|COMPLETED|Overall Study||0
8250272|NCT01866423|20344838|P1|STARTED|Overall Study||4
8250273|NCT01866410|20344848|P1|NOT COMPLETED|Overall Study||0
8250274|NCT01866410|20344848|P1|COMPLETED|Overall Study||37
8250275|NCT01866410|20344848|P1|STARTED|Overall Study||37
8250276|NCT01866319|20344866|P3|NOT COMPLETED|Overall Study||180
8250277|NCT01866319|20344867|P2|NOT COMPLETED|Overall Study||178
8250278|NCT01866319|20344868|P1|NOT COMPLETED|Overall Study||207
8250279|NCT01866319|20344866|P3|COMPLETED|Overall Study||97
8250280|NCT01866319|20344867|P2|COMPLETED|Overall Study||101
8250281|NCT01866319|20344868|P1|COMPLETED|Overall Study||71
8250282|NCT01866319|20344866|P3|Treated|Overall Study||277
8250283|NCT01866319|20344867|P2|Treated|Overall Study||278
8250284|NCT01866319|20344868|P1|Treated|Overall Study||256
8250285|NCT01866319|20344866|P3|STARTED|Overall Study||277
8250286|NCT01866319|20344867|P2|STARTED|Overall Study||279
8250287|NCT01866319|20344868|P1|STARTED|Overall Study||278
8250288|NCT01866306|20344889|P7|NOT COMPLETED|Overall Study||0
8250289|NCT01866306|20344890|P6|NOT COMPLETED|Overall Study||0
8250290|NCT01866306|20344891|P5|NOT COMPLETED|Overall Study||0
8250291|NCT01866306|20344892|P4|NOT COMPLETED|Overall Study||0
8250292|NCT01866306|20344893|P3|NOT COMPLETED|Overall Study||0
8250293|NCT01866306|20344894|P2|NOT COMPLETED|Overall Study||0
8250294|NCT01866306|20344895|P1|NOT COMPLETED|Overall Study||0
8250295|NCT01866306|20344889|P7|COMPLETED|Overall Study||23
8250296|NCT01866306|20344890|P6|COMPLETED|Overall Study||6
8250297|NCT01866306|20344891|P5|COMPLETED|Overall Study||6
8250298|NCT01866306|20344892|P4|COMPLETED|Overall Study||6
8250299|NCT01866306|20344893|P3|COMPLETED|Overall Study||6
8250300|NCT01866306|20344894|P2|COMPLETED|Overall Study||6
8250301|NCT01866306|20344895|P1|COMPLETED|Overall Study||6
8250302|NCT01866306|20344889|P7|STARTED|Overall Study||23
8250303|NCT01866306|20344890|P6|STARTED|Overall Study||6
8250304|NCT01866306|20344891|P5|STARTED|Overall Study||6
8250305|NCT01866306|20344892|P4|STARTED|Overall Study||6
8250306|NCT01866306|20344893|P3|STARTED|Overall Study||6
8250307|NCT01866306|20344894|P2|STARTED|Overall Study||6
8250308|NCT01866306|20344895|P1|STARTED|Overall Study||6
8250309|NCT01866293|20344967|P1|NOT COMPLETED|Overall Study||2
8250310|NCT01866293|20344967|P1|COMPLETED|Overall Study||9
8250311|NCT01866293|20344967|P1|STARTED|Overall Study||11
8250312|NCT01866163|20344977|P2|NOT COMPLETED|Overall Study||4
8250313|NCT01866163|20344978|P1|NOT COMPLETED|Overall Study||10
8250314|NCT01866163|20344977|P2|COMPLETED|Overall Study||99
8250315|NCT01866163|20344978|P1|COMPLETED|Overall Study||313
8250316|NCT01866163|20344977|P2|STARTED|Overall Study||103
8250317|NCT01866163|20344978|P1|STARTED|Overall Study||323
8250318|NCT01866150|20344988|P1|NOT COMPLETED|Overall Study||0
8250319|NCT01866150|20344988|P1|COMPLETED|Overall Study||450
8250320|NCT01866150|20344988|P1|STARTED|Overall Study||450
8250321|NCT01866098|20345012|P3|NOT COMPLETED|Overall Study||21
8250322|NCT01866098|20345013|P2|NOT COMPLETED|Overall Study||27
8250323|NCT01866098|20345014|P1|NOT COMPLETED|Overall Study||19
8250324|NCT01866098|20345012|P3|COMPLETED|Overall Study||25
8250325|NCT01866098|20345013|P2|COMPLETED|Overall Study||20
8250326|NCT01866098|20345014|P1|COMPLETED|Overall Study||32
8250327|NCT01866098|20345012|P3|STARTED|Overall Study||46
8250328|NCT01866098|20345013|P2|STARTED|Overall Study||47
8250329|NCT01866098|20345014|P1|STARTED|Overall Study||51
8250330|NCT01865812|20345043|P1|NOT COMPLETED|Overall Study||2
8250331|NCT01865812|20345043|P1|COMPLETED|Overall Study||24
8250332|NCT01865812|20345043|P1|STARTED|Overall Study||26
8250345|NCT01865708|20345062|P1|NOT COMPLETED|Overall Study||0
8250346|NCT01865708|20345062|P1|COMPLETED|Overall Study||10
8250347|NCT01865708|20345062|P1|STARTED|Overall Study||10
8250348|NCT01865552|20345073|P6|NOT COMPLETED|Period 2||0
8250349|NCT01865552|20345074|P5|NOT COMPLETED|Period 2||0
8250350|NCT01865552|20345075|P4|NOT COMPLETED|Period 2||0
8250351|NCT01865552|20345076|P3|NOT COMPLETED|Period 2||0
8250352|NCT01865552|20345077|P2|NOT COMPLETED|Period 2||0
8250353|NCT01865552|20345078|P1|NOT COMPLETED|Period 2||0
8250354|NCT01865552|20345073|P6|COMPLETED|Period 2||22
8250355|NCT01865552|20345074|P5|COMPLETED|Period 2||20
8250356|NCT01865552|20345075|P4|COMPLETED|Period 2||22
8250357|NCT01865552|20345076|P3|COMPLETED|Period 2||23
8250358|NCT01865552|20345077|P2|COMPLETED|Period 2||23
8250359|NCT01865552|20345078|P1|COMPLETED|Period 2||22
8250360|NCT01865552|20345073|P6|STARTED|Period 2||22
8250361|NCT01865552|20345074|P5|STARTED|Period 2||20
8250362|NCT01865552|20345075|P4|STARTED|Period 2||22
8250363|NCT01865552|20345076|P3|STARTED|Period 2||23
8250364|NCT01865552|20345077|P2|STARTED|Period 2||23
8250365|NCT01865552|20345078|P1|STARTED|Period 2||22
8250366|NCT01865552|20345073|P6|NOT COMPLETED|Period 1||1
8250367|NCT01865552|20345074|P5|NOT COMPLETED|Period 1||3
8250368|NCT01865552|20345075|P4|NOT COMPLETED|Period 1||1
8250369|NCT01865552|20345076|P3|NOT COMPLETED|Period 1||0
8250370|NCT01865552|20345077|P2|NOT COMPLETED|Period 1||0
8250371|NCT01865552|20345078|P1|NOT COMPLETED|Period 1||1
8250372|NCT01865552|20345073|P6|COMPLETED|Period 1||22
8250373|NCT01865552|20345074|P5|COMPLETED|Period 1||20
8250374|NCT01865552|20345075|P4|COMPLETED|Period 1||22
8250375|NCT01865552|20345076|P3|COMPLETED|Period 1||23
8250376|NCT01865552|20345077|P2|COMPLETED|Period 1||23
8250377|NCT01865552|20345078|P1|COMPLETED|Period 1||22
8250378|NCT01865552|20345073|P6|Discontinued From Period 1|Period 1||1
8250379|NCT01865552|20345074|P5|Discontinued From Period 1|Period 1||3
8250380|NCT01865552|20345075|P4|Discontinued From Period 1|Period 1||1
8250381|NCT01865552|20345076|P3|Discontinued From Period 1|Period 1||0
8250382|NCT01865552|20345077|P2|Discontinued From Period 1|Period 1||0
8250383|NCT01865552|20345078|P1|Discontinued From Period 1|Period 1||1
8250384|NCT01865552|20345073|P6|STARTED|Period 1||23
8250385|NCT01865552|20345074|P5|STARTED|Period 1||23
8250386|NCT01865552|20345075|P4|STARTED|Period 1||23
8250387|NCT01865552|20345076|P3|STARTED|Period 1||23
8250388|NCT01865552|20345077|P2|STARTED|Period 1||23
8250389|NCT01865552|20345078|P1|STARTED|Period 1||23
8250390|NCT01865487|20345116|P10|NOT COMPLETED|Overall Study||0
8250391|NCT01865487|20345117|P9|NOT COMPLETED|Overall Study||0
8250392|NCT01865487|20345118|P8|NOT COMPLETED|Overall Study||0
8250393|NCT01865487|20345119|P7|NOT COMPLETED|Overall Study||1
8250394|NCT01865487|20345120|P6|NOT COMPLETED|Overall Study||0
8250395|NCT01865487|20345121|P5|NOT COMPLETED|Overall Study||1
8250396|NCT01865487|20345122|P4|NOT COMPLETED|Overall Study||1
8250397|NCT01865487|20345123|P3|NOT COMPLETED|Overall Study||0
8250398|NCT01865487|20345124|P2|NOT COMPLETED|Overall Study||0
8250399|NCT01865487|20345125|P1|NOT COMPLETED|Overall Study||0
8250400|NCT01865487|20345116|P10|COMPLETED|Overall Study||4
8250401|NCT01865487|20345117|P9|COMPLETED|Overall Study||12
8250402|NCT01865487|20345118|P8|COMPLETED|Overall Study||4
8250403|NCT01865487|20345119|P7|COMPLETED|Overall Study||11
8250404|NCT01865487|20345120|P6|COMPLETED|Overall Study||4
8250405|NCT01865487|20345121|P5|COMPLETED|Overall Study||11
8250406|NCT01865487|20345122|P4|COMPLETED|Overall Study||4
8250407|NCT01865487|20345123|P3|COMPLETED|Overall Study||15
8250408|NCT01865487|20345124|P2|COMPLETED|Overall Study||15
8250409|NCT01865487|20345125|P1|COMPLETED|Overall Study||15
8250410|NCT01865487|20345116|P10|STARTED|Overall Study||4
8250411|NCT01865487|20345117|P9|STARTED|Overall Study||12
8250412|NCT01865487|20345118|P8|STARTED|Overall Study||4
8250413|NCT01865487|20345119|P7|STARTED|Overall Study||12
8250414|NCT01865487|20345120|P6|STARTED|Overall Study||4
8250415|NCT01865487|20345121|P5|STARTED|Overall Study||12
8250416|NCT01865487|20345122|P4|STARTED|Overall Study||5
8250417|NCT01865487|20345123|P3|STARTED|Overall Study||15
8250418|NCT01865487|20345124|P2|STARTED|Overall Study||15
8250419|NCT01865487|20345125|P1|STARTED|Overall Study||15
8250420|NCT01865448|20345164|P2|NOT COMPLETED|Overall Study||3
8250421|NCT01865448|20345165|P1|NOT COMPLETED|Overall Study||2
8250422|NCT01865448|20345164|P2|COMPLETED|Overall Study||14
8250423|NCT01865448|20345165|P1|COMPLETED|Overall Study||15
8250424|NCT01865448|20345164|P2|STARTED|Overall Study||17
8250425|NCT01865448|20345165|P1|STARTED|Overall Study||17
8250426|NCT01865084|20345276|P3|NOT COMPLETED|Open Label Extension (OLE) Period||7
8250427|NCT01865084|20345277|P2|NOT COMPLETED|Open Label Extension (OLE) Period||11
8250428|NCT01865084|20345278|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
8250429|NCT01865084|20345276|P3|COMPLETED|Open Label Extension (OLE) Period||158
8250430|NCT01865084|20345277|P2|COMPLETED|Open Label Extension (OLE) Period||139
8250431|NCT01865084|20345278|P1|COMPLETED|Open Label Extension (OLE) Period||0
8250432|NCT01865084|20345276|P3|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
8250433|NCT01865084|20345277|P2|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
8250434|NCT01865084|20345278|P1|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
8250435|NCT01865084|20345276|P3|NOT COMPLETED|Double Blind Period (DB)||6
8250436|NCT01865084|20345277|P2|NOT COMPLETED|Double Blind Period (DB)||4
8250437|NCT01865084|20345278|P1|NOT COMPLETED|Double Blind Period (DB)||5
8250438|NCT01865084|20345276|P3|COMPLETED|Double Blind Period (DB)||107
8250439|NCT01865084|20345277|P2|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
8250440|NCT01865084|20345278|P1|COMPLETED|Double Blind Period (DB)||111
8250441|NCT01865084|20345276|P3|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
8250442|NCT01865084|20345277|P2|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
8250443|NCT01865084|20345278|P1|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
8250444|NCT01865084|20345276|P3|STARTED|Double Blind Period (DB)||113
8250445|NCT01865084|20345277|P2|STARTED|Double Blind Period (DB)||102
8250446|NCT01865084|20345278|P1|STARTED|Double Blind Period (DB)||116
8250447|NCT01864564|20345306|P2|NOT COMPLETED|Overall Study||95
8250448|NCT01864564|20345307|P1|NOT COMPLETED|Overall Study||37
8250449|NCT01864564|20345306|P2|COMPLETED|Overall Study||387
8250450|NCT01864564|20345307|P1|COMPLETED|Overall Study||443
8250451|NCT01864564|20345306|P2|STARTED|Overall Study||482
8250452|NCT01864564|20345307|P1|STARTED|Overall Study||480
8250456|NCT01864525|20345339|P2|NOT COMPLETED|Overall Study||0
8250457|NCT01864525|20345340|P1|NOT COMPLETED|Overall Study||1
8250458|NCT01864525|20345339|P2|COMPLETED|Overall Study||7
8250459|NCT01864525|20345340|P1|COMPLETED|Overall Study||9
8250460|NCT01864525|20345339|P2|STARTED|Overall Study||7
8250461|NCT01864525|20345340|P1|STARTED|Overall Study||10
8250462|NCT01864434|20345350|P2|NOT COMPLETED|Overall Study||0
8250463|NCT01864434|20345351|P1|NOT COMPLETED|Overall Study||0
8250464|NCT01864434|20345350|P2|COMPLETED|Overall Study||25
8250465|NCT01864434|20345351|P1|COMPLETED|Overall Study||25
8250466|NCT01864434|20345350|P2|STARTED|Overall Study||25
8250467|NCT01864434|20345351|P1|STARTED|Overall Study||25
8250468|NCT01864291|20345361|P1|NOT COMPLETED|Overall Study||2
8250469|NCT01864291|20345361|P1|COMPLETED|Overall Study|7/9 subjects had a minimum of one year followup since enrollment.|7
8250470|NCT01864291|20345361|P1|STARTED|Overall Study||9
8250471|NCT01864200|20345369|P2|NOT COMPLETED|Overall Study||3
8250472|NCT01864200|20345370|P1|NOT COMPLETED|Overall Study||2
8250473|NCT01864200|20345369|P2|COMPLETED|Overall Study||26
8250474|NCT01864200|20345370|P1|COMPLETED|Overall Study||43
8250475|NCT01864200|20345369|P2|STARTED|Overall Study||29
8250476|NCT01864200|20345370|P1|STARTED|Overall Study||45
8250477|NCT01864174|20345378|P2|NOT COMPLETED|Off Treatment Follow-Up||0
8250478|NCT01864174|20345379|P1|NOT COMPLETED|Off Treatment Follow-Up||3
8250479|NCT01864174|20345378|P2|COMPLETED|Off Treatment Follow-Up||1
8250480|NCT01864174|20345379|P1|COMPLETED|Off Treatment Follow-Up||6
8250481|NCT01864174|20345378|P2|STARTED|Off Treatment Follow-Up||1
8250482|NCT01864174|20345379|P1|STARTED|Off Treatment Follow-Up||9
8250483|NCT01864174|20345378|P2|NOT COMPLETED|Double Blind - Compliant Randomized||26
8250484|NCT01864174|20345379|P1|NOT COMPLETED|Double Blind - Compliant Randomized||23
8250485|NCT01864174|20345378|P2|COMPLETED|Double Blind - Compliant Randomized||245
8250486|NCT01864174|20345379|P1|COMPLETED|Double Blind - Compliant Randomized||245
8250487|NCT01864174|20345378|P2|STARTED|Double Blind - Compliant Randomized||271
8250488|NCT01864174|20345379|P1|STARTED|Double Blind - Compliant Randomized||268
8250489|NCT01864174|20345378|P2|NOT COMPLETED|Double Blind Treatment - All Treated||14
8250490|NCT01864174|20345379|P1|NOT COMPLETED|Double Blind Treatment - All Treated||15
8250491|NCT01864174|20345378|P2|COMPLETED|Double Blind Treatment - All Treated||271
8250492|NCT01864174|20345379|P1|COMPLETED|Double Blind Treatment - All Treated||268
8250493|NCT01864174|20345378|P2|STARTED|Double Blind Treatment - All Treated||285
8250494|NCT01864174|20345379|P1|STARTED|Double Blind Treatment - All Treated||283
8250495|NCT01864148|20345398|P5|NOT COMPLETED|Overall Study||23
8250496|NCT01864148|20345399|P4|NOT COMPLETED|Overall Study||26
8250497|NCT01864148|20345400|P3|NOT COMPLETED|Overall Study||11
8250498|NCT01864148|20345401|P2|NOT COMPLETED|Overall Study||5
8250499|NCT01864148|20345402|P1|NOT COMPLETED|Overall Study||20
8250500|NCT01864148|20345398|P5|COMPLETED|Overall Study||69
8250501|NCT01864148|20345399|P4|COMPLETED|Overall Study||68
8250502|NCT01864148|20345400|P3|COMPLETED|Overall Study||84
8250503|NCT01864148|20345401|P2|COMPLETED|Overall Study||40
8250504|NCT01864148|20345402|P1|COMPLETED|Overall Study||73
8250505|NCT01864148|20345398|P5|Randomized and Dosed|Overall Study||92
8250506|NCT01864148|20345399|P4|Randomized and Dosed|Overall Study||93
8250507|NCT01864148|20345400|P3|Randomized and Dosed|Overall Study||95
8250508|NCT01864148|20345401|P2|Randomized and Dosed|Overall Study||45
8250509|NCT01864148|20345402|P1|Randomized and Dosed|Overall Study||93
8250510|NCT01864148|20345398|P5|STARTED|Overall Study||92
8250511|NCT01864148|20345399|P4|STARTED|Overall Study||94
8250512|NCT01864148|20345400|P3|STARTED|Overall Study||95
8250513|NCT01864148|20345401|P2|STARTED|Overall Study||45
8250514|NCT01864148|20345402|P1|STARTED|Overall Study||93
8250515|NCT01864005|20345431|P2|NOT COMPLETED|Overall Study||6
8250516|NCT01864005|20345432|P1|NOT COMPLETED|Overall Study||3
8250517|NCT01864005|20345431|P2|COMPLETED|Overall Study||25
8250518|NCT01864005|20345432|P1|COMPLETED|Overall Study||26
8250519|NCT01864005|20345431|P2|STARTED|Overall Study||31
8250520|NCT01864005|20345432|P1|STARTED|Overall Study||29
8250521|NCT01863953|20345449|P3|NOT COMPLETED|Overall Study||1
8250522|NCT01863953|20345450|P2|NOT COMPLETED|Overall Study||0
8250523|NCT01863953|20345451|P1|NOT COMPLETED|Overall Study||0
8250524|NCT01863953|20345449|P3|COMPLETED|Overall Study||37
8250525|NCT01863953|20345450|P2|COMPLETED|Overall Study||36
8250526|NCT01863953|20345451|P1|COMPLETED|Overall Study||38
8250527|NCT01863953|20345449|P3|STARTED|Overall Study||38
8250528|NCT01863953|20345450|P2|STARTED|Overall Study||36
8250529|NCT01863953|20345451|P1|STARTED|Overall Study||38
8250530|NCT01863771|20345465|P4|NOT COMPLETED|Maintenance Phase||43
8250531|NCT01863771|20345466|P3|NOT COMPLETED|Maintenance Phase||12
8250532|NCT01863771|20345467|P2|NOT COMPLETED|Maintenance Phase||5
8250533|NCT01863771|20345468|P1|NOT COMPLETED|Maintenance Phase||0
8250534|NCT01863771|20345465|P4|COMPLETED|Maintenance Phase||17
8250535|NCT01863771|20345466|P3|COMPLETED|Maintenance Phase||19
8250536|NCT01863771|20345467|P2|COMPLETED|Maintenance Phase||27
8250537|NCT01863771|20345468|P1|COMPLETED|Maintenance Phase||0
8250538|NCT01863771|20345465|P4|STARTED|Maintenance Phase||60
8250539|NCT01863771|20345466|P3|STARTED|Maintenance Phase||31
8250540|NCT01863771|20345467|P2|STARTED|Maintenance Phase||32
8250541|NCT01863771|20345468|P1|STARTED|Maintenance Phase||0
8250542|NCT01863771|20345465|P4|NOT COMPLETED|Induction Phase||0
8250543|NCT01863771|20345466|P3|NOT COMPLETED|Induction Phase||0
8250544|NCT01863771|20345467|P2|NOT COMPLETED|Induction Phase||0
8250545|NCT01863771|20345468|P1|NOT COMPLETED|Induction Phase||21
8250546|NCT01863771|20345465|P4|COMPLETED|Induction Phase||0
8250547|NCT01863771|20345466|P3|COMPLETED|Induction Phase||0
8250548|NCT01863771|20345467|P2|COMPLETED|Induction Phase||0
8250549|NCT01863771|20345468|P1|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
8250550|NCT01863771|20345465|P4|STARTED|Induction Phase||0
8250551|NCT01863771|20345466|P3|STARTED|Induction Phase||0
8250552|NCT01863771|20345467|P2|STARTED|Induction Phase||0
8250553|NCT01863771|20345468|P1|STARTED|Induction Phase||144
8250554|NCT01863758|20345480|P1|NOT COMPLETED|Prophylactic Treatment-Phase II||2
8250555|NCT01863758|20345480|P1|COMPLETED|Prophylactic Treatment-Phase II||64
8250556|NCT01863758|20345480|P1|STARTED|Prophylactic Treatment-Phase II||66
8250557|NCT01863758|20345480|P1|NOT COMPLETED|Prophylactic Treatment-Phase I||0
8250558|NCT01863758|20345480|P1|COMPLETED|Prophylactic Treatment-Phase I||66
8250559|NCT01863758|20345480|P1|STARTED|Prophylactic Treatment-Phase I||66
8250560|NCT01863758|20345480|P1|NOT COMPLETED|Pharmacokinetic Assessment||0
8250561|NCT01863758|20345480|P1|COMPLETED|Pharmacokinetic Assessment||66
8250562|NCT01863758|20345480|P1|STARTED|Pharmacokinetic Assessment||66
8250563|NCT01863732|20345492|P4|NOT COMPLETED|Overall Study||8
8250564|NCT01863732|20345493|P3|NOT COMPLETED|Overall Study||11
8250565|NCT01863732|20345494|P2|NOT COMPLETED|Overall Study||12
8250566|NCT01863732|20345495|P1|NOT COMPLETED|Overall Study||13
8250567|NCT01863732|20345492|P4|COMPLETED|Overall Study||33
8250568|NCT01863732|20345493|P3|COMPLETED|Overall Study||35
8250569|NCT01863732|20345494|P2|COMPLETED|Overall Study||75
8250570|NCT01863732|20345495|P1|COMPLETED|Overall Study||87
8250571|NCT01863732|20345492|P4|STARTED|Overall Study||41
8250572|NCT01863732|20345493|P3|STARTED|Overall Study||46
8250573|NCT01863732|20345494|P2|STARTED|Overall Study||87
8250574|NCT01863732|20345495|P1|STARTED|Overall Study||100
8250575|NCT01863680|20345508|P1|NOT COMPLETED|Overall Study||57
8250576|NCT01863680|20345508|P1|COMPLETED|Overall Study||121
8250577|NCT01863680|20345508|P1|Subjects Who Have Undergone IVF/ET|Overall Study||123
8250578|NCT01863680|20345508|P1|Subjects Received Study Drug|Overall Study||149
8250579|NCT01863680|20345508|P1|Subjects Received hCG Injection|Overall Study||162
8250580|NCT01863680|20345508|P1|Subjects Started COS Treatment|Overall Study||169
8250581|NCT01863680|20345508|P1|STARTED|Overall Study||178
8250582|NCT01863667|20345516|P2|NOT COMPLETED|Overall Study||32
8250583|NCT01863667|20345517|P1|NOT COMPLETED|Overall Study||33
8250584|NCT01863667|20345516|P2|COMPLETED|Overall Study||0
8250585|NCT01863667|20345517|P1|COMPLETED|Overall Study||0
8250586|NCT01863667|20345516|P2|STARTED|Overall Study||32
8250587|NCT01863667|20345517|P1|STARTED|Overall Study||33
8250588|NCT01863563|20345537|P1|NOT COMPLETED|Overall Study||0
8250589|NCT01863563|20345537|P1|COMPLETED|Overall Study||100
8250590|NCT01863563|20345537|P1|STARTED|Overall Study||100
8250591|NCT01863498|20345543|P2|NOT COMPLETED|Overall Study||0
8250592|NCT01863498|20345544|P1|NOT COMPLETED|Overall Study||0
8250593|NCT01863498|20345543|P2|COMPLETED|Overall Study||32
8250594|NCT01863498|20345544|P1|COMPLETED|Overall Study||33
8250595|NCT01863498|20345543|P2|STARTED|Overall Study||32
8250596|NCT01863498|20345544|P1|STARTED|Overall Study||33
8250597|NCT01863433|20345554|P1|NOT COMPLETED|Overall Study||1
8250598|NCT01863433|20345554|P1|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
8250599|NCT01863433|20345554|P1|STARTED|Overall Study||120
8250600|NCT01863368|20345564|P2|NOT COMPLETED|Phase II, Day 35 to Day 90||0
8250601|NCT01863368|20345565|P1|NOT COMPLETED|Phase II, Day 35 to Day 90||2
8250602|NCT01863368|20345564|P2|COMPLETED|Phase II, Day 35 to Day 90||41
8250603|NCT01863368|20345565|P1|COMPLETED|Phase II, Day 35 to Day 90||41
8250604|NCT01863368|20345564|P2|STARTED|Phase II, Day 35 to Day 90||41
8250605|NCT01863368|20345565|P1|STARTED|Phase II, Day 35 to Day 90||43
8250606|NCT01863368|20345564|P2|NOT COMPLETED|Phase I, Day 0 to Day 35||7
8250607|NCT01863368|20345565|P1|NOT COMPLETED|Phase I, Day 0 to Day 35||3
8250608|NCT01863368|20345564|P2|COMPLETED|Phase I, Day 0 to Day 35||41
8250609|NCT01863368|20345565|P1|COMPLETED|Phase I, Day 0 to Day 35||43
8250610|NCT01863368|20345564|P2|Treated|Phase I, Day 0 to Day 35||47
8250611|NCT01863368|20345565|P1|Treated|Phase I, Day 0 to Day 35||46
8250612|NCT01863368|20345564|P2|STARTED|Phase I, Day 0 to Day 35||48
8250613|NCT01863368|20345565|P1|STARTED|Phase I, Day 0 to Day 35||46
8250614|NCT01863134|20345580|P2|NOT COMPLETED|Overall Study||0
8250615|NCT01863134|20345581|P1|NOT COMPLETED|Overall Study||0
8250616|NCT01863134|20345580|P2|COMPLETED|Overall Study||68
8250617|NCT01863134|20345581|P1|COMPLETED|Overall Study||72
8250618|NCT01863134|20345580|P2|STARTED|Overall Study||68
8250619|NCT01863134|20345581|P1|STARTED|Overall Study||72
8250620|NCT01863030|20345587|P1|NOT COMPLETED|Follow up||18
8250621|NCT01863030|20345587|P1|COMPLETED|Follow up||13
8250622|NCT01863030|20345587|P1|24 Months|Follow up||13
8250623|NCT01863030|20345587|P1|12 Months|Follow up||26
8250624|NCT01863030|20345587|P1|6 Months|Follow up||29
8250625|NCT01863030|20345587|P1|3 Months|Follow up||28
8250626|NCT01863030|20345587|P1|2 Weeks|Follow up||31
8250627|NCT01863030|20345587|P1|STARTED|Follow up||31
8250628|NCT01863030|20345587|P1|NOT COMPLETED|Baseline||0
8250629|NCT01863030|20345587|P1|COMPLETED|Baseline||31
8250630|NCT01863030|20345587|P1|STARTED|Baseline||31
8250631|NCT01863017|20345605|P2|NOT COMPLETED|Overall Study||0
8250632|NCT01863017|20345606|P1|NOT COMPLETED|Overall Study||0
8250633|NCT01863017|20345605|P2|COMPLETED|Overall Study||19
8250634|NCT01863017|20345606|P1|COMPLETED|Overall Study||12
8250635|NCT01863017|20345605|P2|Participants With PWS|Overall Study||7
8250636|NCT01863017|20345606|P1|Participants With PWS|Overall Study||3
8250637|NCT01863017|20345605|P2|Obese Participants|Overall Study||7
8250638|NCT01863017|20345606|P1|Obese Participants|Overall Study||4
8250639|NCT01863017|20345605|P2|Normal Weight Participants|Overall Study||5
8250640|NCT01863017|20345606|P1|Normal Weight Participants|Overall Study||5
8250641|NCT01863017|20345605|P2|STARTED|Overall Study||19
8250642|NCT01863017|20345606|P1|STARTED|Overall Study||12
8250643|NCT01862991|20345619|P3|NOT COMPLETED|Overall Study||1
8250644|NCT01862991|20345620|P2|NOT COMPLETED|Overall Study||1
8250645|NCT01862991|20345621|P1|NOT COMPLETED|Overall Study||3
8250646|NCT01862991|20345619|P3|COMPLETED|Overall Study||27
8250647|NCT01862991|20345620|P2|COMPLETED|Overall Study||27
8250648|NCT01862991|20345621|P1|COMPLETED|Overall Study||21
8250649|NCT01862991|20345619|P3|STARTED|Overall Study||28
8250650|NCT01862991|20345620|P2|STARTED|Overall Study||28
8250651|NCT01862991|20345621|P1|STARTED|Overall Study||24
8250652|NCT01862874|20345634|P2|NOT COMPLETED|Overall Study||77
8250653|NCT01862874|20345635|P1|NOT COMPLETED|Overall Study||79
8250654|NCT01862874|20345634|P2|COMPLETED|Overall Study||485
8250655|NCT01862874|20345635|P1|COMPLETED|Overall Study||483
8250656|NCT01862874|20345634|P2|Vaccination 3|Overall Study||532
8250657|NCT01862874|20345635|P1|Vaccination 3|Overall Study||530
8250658|NCT01862874|20345634|P2|Vaccination 2|Overall Study||542
8250659|NCT01862874|20345635|P1|Vaccination 2|Overall Study||539
8250660|NCT01862874|20345634|P2|Vaccination 1|Overall Study||562
8250661|NCT01862874|20345635|P1|Vaccination 1|Overall Study||561
8250662|NCT01862874|20345634|P2|STARTED|Overall Study|Randomized participants|562
8250663|NCT01862874|20345635|P1|STARTED|Overall Study|Randomized participants|562
8250664|NCT01862796|20345654|P3|NOT COMPLETED|Overall Study||1
8250665|NCT01862796|20345655|P2|NOT COMPLETED|Overall Study||0
8250666|NCT01862796|20345656|P1|NOT COMPLETED|Overall Study||0
8250667|NCT01862796|20345654|P3|COMPLETED|Overall Study||23
8250668|NCT01862796|20345655|P2|COMPLETED|Overall Study||18
8250669|NCT01862796|20345656|P1|COMPLETED|Overall Study||19
8250670|NCT01862796|20345654|P3|STARTED|Overall Study||24
8250671|NCT01862796|20345655|P2|STARTED|Overall Study||18
8250672|NCT01862796|20345656|P1|STARTED|Overall Study||19
8250673|NCT01862640|20345671|P4|NOT COMPLETED|Overall Study||15
8250674|NCT01862640|20345672|P3|NOT COMPLETED|Overall Study||18
8250675|NCT01862640|20345673|P2|NOT COMPLETED|Overall Study||16
8250676|NCT01862640|20345674|P1|NOT COMPLETED|Overall Study||7
8250677|NCT01862640|20345671|P4|COMPLETED|Overall Study||121
8250678|NCT01862640|20345672|P3|COMPLETED|Overall Study||122
8250679|NCT01862640|20345673|P2|COMPLETED|Overall Study||121
8250680|NCT01862640|20345674|P1|COMPLETED|Overall Study||13
8250681|NCT01862640|20345671|P4|STARTED|Overall Study||136
8250682|NCT01862640|20345672|P3|STARTED|Overall Study||140
8250683|NCT01862640|20345673|P2|STARTED|Overall Study||137
8250684|NCT01862640|20345674|P1|STARTED|Overall Study||20
8250703|NCT01862484|20345695|P2|NOT COMPLETED|Overall Study||8
8250704|NCT01862484|20345696|P1|NOT COMPLETED|Overall Study||2
8250705|NCT01862484|20345695|P2|COMPLETED|Overall Study||6
8250706|NCT01862484|20345696|P1|COMPLETED|Overall Study||13
8250707|NCT01862484|20345695|P2|STARTED|Overall Study||14
8250708|NCT01862484|20345696|P1|STARTED|Overall Study||15
8250709|NCT01862419|20345704|P2|NOT COMPLETED|Overall Study||0
8250710|NCT01862419|20345705|P1|NOT COMPLETED|Overall Study||0
8250711|NCT01862419|20345704|P2|COMPLETED|Overall Study||1192
8250712|NCT01862419|20345705|P1|COMPLETED|Overall Study||1201
8250713|NCT01862419|20345704|P2|STARTED|Overall Study||1192
8250714|NCT01862419|20345705|P1|STARTED|Overall Study||1201
8250715|NCT01862328|20345722|P7|NOT COMPLETED|Overall Study||10
8250716|NCT01862328|20345723|P6|NOT COMPLETED|Overall Study||7
8250717|NCT01862328|20345724|P5|NOT COMPLETED|Overall Study||12
8250718|NCT01862328|20345725|P4|NOT COMPLETED|Overall Study||7
8250719|NCT01862328|20345726|P3|NOT COMPLETED|Overall Study||6
8250720|NCT01862328|20345727|P2|NOT COMPLETED|Overall Study||18
8250721|NCT01862328|20345728|P1|NOT COMPLETED|Overall Study||4
8250722|NCT01862328|20345722|P7|COMPLETED|Overall Study||0
8250723|NCT01862328|20345723|P6|COMPLETED|Overall Study||0
8250724|NCT01862328|20345724|P5|COMPLETED|Overall Study||0
8250725|NCT01862328|20345725|P4|COMPLETED|Overall Study||0
8250726|NCT01862328|20345726|P3|COMPLETED|Overall Study||0
8250727|NCT01862328|20345727|P2|COMPLETED|Overall Study||0
8250728|NCT01862328|20345728|P1|COMPLETED|Overall Study||0
8250729|NCT01862328|20345722|P7|STARTED|Overall Study||10
8250730|NCT01862328|20345723|P6|STARTED|Overall Study||7
8250731|NCT01862328|20345724|P5|STARTED|Overall Study||12
8250732|NCT01862328|20345725|P4|STARTED|Overall Study||7
8250733|NCT01862328|20345726|P3|STARTED|Overall Study||6
8250734|NCT01862328|20345727|P2|STARTED|Overall Study||18
8250735|NCT01862328|20345728|P1|STARTED|Overall Study||4
8250736|NCT01862250|20345780|P1|NOT COMPLETED|Overall Study||4
8250737|NCT01862250|20345780|P1|COMPLETED|Overall Study||8
8250738|NCT01862250|20345780|P1|STARTED|Overall Study||12
8250739|NCT01862159|20345787|P1|NOT COMPLETED|Overall Study||0
8250740|NCT01862159|20345787|P1|COMPLETED|Overall Study||25038
8250741|NCT01862159|20345787|P1|STARTED|Overall Study||25038
8250742|NCT01862133|20345794|P2|NOT COMPLETED|Overall Study||0
8250743|NCT01862133|20345795|P1|NOT COMPLETED|Overall Study||0
8250744|NCT01862133|20345794|P2|COMPLETED|Overall Study||31
8250745|NCT01862133|20345795|P1|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
8250746|NCT01862133|20345794|P2|Returned During 6 mo Study|Overall Study||31
8250747|NCT01862133|20345795|P1|Returned During 6 mo Study|Overall Study||92
8250748|NCT01862133|20345794|P2|STARTED|Overall Study||31
8250749|NCT01862133|20345795|P1|STARTED|Overall Study||105
8250750|NCT01862029|20345801|P1|NOT COMPLETED|Overall Study||1
8250751|NCT01862029|20345801|P1|COMPLETED|Overall Study||8
8250752|NCT01862029|20345801|P1|STARTED|Overall Study||9
8250753|NCT01861925|20345809|P3|NOT COMPLETED|Overall Study||0
8250754|NCT01861925|20345810|P2|NOT COMPLETED|Overall Study||0
8250755|NCT01861925|20345811|P1|NOT COMPLETED|Overall Study||0
8250756|NCT01861925|20345809|P3|COMPLETED|Overall Study||8
8250757|NCT01861925|20345810|P2|COMPLETED|Overall Study||8
8250758|NCT01861925|20345811|P1|COMPLETED|Overall Study||34
8250759|NCT01861925|20345809|P3|STARTED|Overall Study||8
8250760|NCT01861925|20345810|P2|STARTED|Overall Study||8
8250761|NCT01861925|20345811|P1|STARTED|Overall Study||34
8250762|NCT01861756|20345834|P2|NOT COMPLETED|Overall Study||18
8250763|NCT01861756|20345835|P1|NOT COMPLETED|Overall Study||13
8250764|NCT01861756|20345834|P2|COMPLETED|Overall Study||85
8250765|NCT01861756|20345835|P1|COMPLETED|Overall Study||88
8250766|NCT01861756|20345834|P2|STARTED|Overall Study||103
8250767|NCT01861756|20345835|P1|STARTED|Overall Study||101
8250768|NCT01861704|20345843|P2|NOT COMPLETED|Overall Study||3
8250769|NCT01861704|20345844|P1|NOT COMPLETED|Overall Study||3
8250770|NCT01861704|20345843|P2|COMPLETED|Overall Study||104
8250771|NCT01861704|20345844|P1|COMPLETED|Overall Study||67
8250772|NCT01861704|20345843|P2|STARTED|Overall Study||107
8250773|NCT01861704|20345844|P1|STARTED|Overall Study||70
8250774|NCT01861665|20345852|P2|NOT COMPLETED|Overall Study||0
8250775|NCT01861665|20345853|P1|NOT COMPLETED|Overall Study||0
8250776|NCT01861665|20345852|P2|COMPLETED|Overall Study||17
8250777|NCT01861665|20345853|P1|COMPLETED|Overall Study||10
8250778|NCT01861665|20345852|P2|STARTED|Overall Study||17
8250779|NCT01861665|20345853|P1|STARTED|Overall Study||10
8250780|NCT01861587|20345861|P2|NOT COMPLETED|Overall Study||0
8250781|NCT01861587|20345862|P1|NOT COMPLETED|Overall Study||0
8250782|NCT01861587|20345861|P2|COMPLETED|Overall Study||13
8250783|NCT01861587|20345862|P1|COMPLETED|Overall Study||14
8250784|NCT01861587|20345861|P2|STARTED|Overall Study||13
8250785|NCT01861587|20345862|P1|STARTED|Overall Study||14
8250786|NCT01861574|20345878|P4|NOT COMPLETED|Overall Study||0
8250787|NCT01861574|20345879|P3|NOT COMPLETED|Overall Study||0
8250788|NCT01861574|20345880|P2|NOT COMPLETED|Overall Study||0
8250789|NCT01861574|20345881|P1|NOT COMPLETED|Overall Study||0
8250790|NCT01861574|20345878|P4|COMPLETED|Overall Study||28
8250791|NCT01861574|20345879|P3|COMPLETED|Overall Study||27
8250792|NCT01861574|20345880|P2|COMPLETED|Overall Study||25
8250793|NCT01861574|20345881|P1|COMPLETED|Overall Study||28
8250794|NCT01861574|20345878|P4|STARTED|Overall Study||28
8250795|NCT01861574|20345879|P3|STARTED|Overall Study||27
8250796|NCT01861574|20345880|P2|STARTED|Overall Study||25
8250797|NCT01861574|20345881|P1|STARTED|Overall Study||28
8250798|NCT01861522|20345904|P2|NOT COMPLETED|Overall Study||0
8250799|NCT01861522|20345905|P1|NOT COMPLETED|Overall Study||3
8250800|NCT01861522|20345904|P2|COMPLETED|Overall Study||232
8250801|NCT01861522|20345905|P1|COMPLETED|Overall Study||237
8250802|NCT01861522|20345904|P2|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
8250803|NCT01861522|20345905|P1|STARTED|Overall Study||240
8250804|NCT01861457|20345913|P2|NOT COMPLETED|Overall Study||0
8250805|NCT01861457|20345914|P1|NOT COMPLETED|Overall Study||0
8250806|NCT01861457|20345913|P2|COMPLETED|Overall Study||19
8250807|NCT01861457|20345914|P1|COMPLETED|Overall Study||20
8250808|NCT01861457|20345913|P2|STARTED|Overall Study||19
8250809|NCT01861457|20345914|P1|STARTED|Overall Study||20
8250810|NCT01861301|20345922|P1|NOT COMPLETED|Overall Study||0
8250811|NCT01861301|20345922|P1|COMPLETED|Overall Study||18
8250812|NCT01861301|20345922|P1|STARTED|Overall Study||18
8250813|NCT01861028|20345929|P1|NOT COMPLETED|Overall Study||0
8250814|NCT01861028|20345929|P1|COMPLETED|Overall Study||44
8250815|NCT01861028|20345929|P1|STARTED|Overall Study||44
8250816|NCT01860989|20345934|P1|NOT COMPLETED|Overall Study||5
8250817|NCT01860989|20345934|P1|COMPLETED|Overall Study||6
8250818|NCT01860989|20345934|P1|STARTED|Overall Study||11
8250837|NCT01860950|20345969|P6|NOT COMPLETED|Overall Study||0
8250838|NCT01860950|20345970|P5|NOT COMPLETED|Overall Study||0
8250839|NCT01860950|20345971|P4|NOT COMPLETED|Overall Study||0
8250840|NCT01860950|20345972|P3|NOT COMPLETED|Overall Study||0
8250841|NCT01860950|20345973|P2|NOT COMPLETED|Overall Study||0
8250842|NCT01860950|20345974|P1|NOT COMPLETED|Overall Study||0
8250843|NCT01860950|20345969|P6|COMPLETED|Overall Study||13
8250844|NCT01860950|20345970|P5|COMPLETED|Overall Study||14
8250845|NCT01860950|20345971|P4|COMPLETED|Overall Study||13
8250846|NCT01860950|20345972|P3|COMPLETED|Overall Study||10
8250847|NCT01860950|20345973|P2|COMPLETED|Overall Study||15
8250848|NCT01860950|20345974|P1|COMPLETED|Overall Study||14
8250849|NCT01860950|20345969|P6|STARTED|Overall Study||13
8250850|NCT01860950|20345970|P5|STARTED|Overall Study||14
8250851|NCT01860950|20345971|P4|STARTED|Overall Study||13
8250852|NCT01860950|20345972|P3|STARTED|Overall Study||10
8250853|NCT01860950|20345973|P2|STARTED|Overall Study||15
8250854|NCT01860950|20345974|P1|STARTED|Overall Study||14
8250855|NCT01860846|20345995|P1|NOT COMPLETED|Overall Study||33
8250856|NCT01860846|20345995|P1|COMPLETED|Overall Study||73
8250857|NCT01860846|20345995|P1|Month 12|Overall Study||73
8250858|NCT01860846|20345995|P1|Month 6|Overall Study||85
8250859|NCT01860846|20345995|P1|Month 4|Overall Study||82
8250860|NCT01860846|20345995|P1|Month 2|Overall Study||83
8250861|NCT01860846|20345995|P1|Month 1|Overall Study||97
8250862|NCT01860846|20345995|P1|STARTED|Overall Study||106
8250863|NCT01860807|20346008|P2|NOT COMPLETED|Overall Study||29
8250864|NCT01860807|20346009|P1|NOT COMPLETED|Overall Study||30
8250865|NCT01860807|20346008|P2|COMPLETED|Overall Study||32
8250866|NCT01860807|20346009|P1|COMPLETED|Overall Study||34
8250867|NCT01860807|20346008|P2|STARTED|Overall Study||61
8250868|NCT01860807|20346009|P1|STARTED|Overall Study||64
8250869|NCT01860703|20346015|P4|NOT COMPLETED|Overall Study||2
8250870|NCT01860703|20346016|P3|NOT COMPLETED|Overall Study||1
8250871|NCT01860703|20346017|P2|NOT COMPLETED|Overall Study||5
8250872|NCT01860703|20346018|P1|NOT COMPLETED|Overall Study||2
8250873|NCT01860703|20346015|P4|COMPLETED|Overall Study||10
8250874|NCT01860703|20346016|P3|COMPLETED|Overall Study||11
8250875|NCT01860703|20346017|P2|COMPLETED|Overall Study||8
8250876|NCT01860703|20346018|P1|COMPLETED|Overall Study||11
8250877|NCT01860703|20346015|P4|STARTED|Overall Study||12
8250878|NCT01860703|20346016|P3|STARTED|Overall Study||12
8250879|NCT01860703|20346017|P2|STARTED|Overall Study||13
8250880|NCT01860703|20346018|P1|STARTED|Overall Study||13
8250881|NCT01860677|20346050|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8250882|NCT01860677|20346051|P1|NOT COMPLETED|Second Intervention (1 Day)||7
8250883|NCT01860677|20346050|P2|COMPLETED|Second Intervention (1 Day)||0
8250884|NCT01860677|20346051|P1|COMPLETED|Second Intervention (1 Day)||1
8250885|NCT01860677|20346050|P2|STARTED|Second Intervention (1 Day)||0
8250886|NCT01860677|20346051|P1|STARTED|Second Intervention (1 Day)||8
8250887|NCT01860677|20346050|P2|NOT COMPLETED|First Intervention (1 Day)||0
8250888|NCT01860677|20346051|P1|NOT COMPLETED|First Intervention (1 Day)||0
8250889|NCT01860677|20346050|P2|COMPLETED|First Intervention (1 Day)||0
8250890|NCT01860677|20346051|P1|COMPLETED|First Intervention (1 Day)||8
8250891|NCT01860677|20346050|P2|STARTED|First Intervention (1 Day)||0
8250892|NCT01860677|20346051|P1|STARTED|First Intervention (1 Day)||8
8250893|NCT01860651|20346062|P2|NOT COMPLETED|Overall Study||8
8250894|NCT01860651|20346063|P1|NOT COMPLETED|Overall Study||25
8250895|NCT01860651|20346062|P2|COMPLETED|Overall Study||39
8250896|NCT01860651|20346063|P1|COMPLETED|Overall Study||31
8250897|NCT01860651|20346062|P2|STARTED|Overall Study||47
8250898|NCT01860651|20346063|P1|STARTED|Overall Study||56
8250899|NCT01860586|20346079|P1|NOT COMPLETED|Overall Study||0
8250900|NCT01860586|20346079|P1|COMPLETED|Overall Study||20
8250901|NCT01860586|20346079|P1|STARTED|Overall Study||20
8250902|NCT01860573|20346087|P2|NOT COMPLETED|Overall Study||0
8250903|NCT01860573|20346088|P1|NOT COMPLETED|Overall Study||0
8250904|NCT01860573|20346087|P2|COMPLETED|Overall Study||85
8250905|NCT01860573|20346088|P1|COMPLETED|Overall Study||83
8250906|NCT01860573|20346087|P2|STARTED|Overall Study||85
8250907|NCT01860573|20346088|P1|STARTED|Overall Study||83
8250908|NCT01860534|20346108|P2|NOT COMPLETED|ROP #2||0
8250909|NCT01860534|20346109|P1|NOT COMPLETED|ROP #2||1
8250910|NCT01860534|20346108|P2|COMPLETED|ROP #2||13
8250911|NCT01860534|20346109|P1|COMPLETED|ROP #2||13
8250912|NCT01860534|20346108|P2|STARTED|ROP #2||13
8250913|NCT01860534|20346109|P1|STARTED|ROP #2||14
8250914|NCT01860534|20346108|P2|NOT COMPLETED|ROP #1||1
8250915|NCT01860534|20346109|P1|NOT COMPLETED|ROP #1||0
8250916|NCT01860534|20346108|P2|COMPLETED|ROP #1||13
8250917|NCT01860534|20346109|P1|COMPLETED|ROP #1||14
8250918|NCT01860534|20346108|P2|STARTED|ROP #1||14
8250919|NCT01860534|20346109|P1|STARTED|ROP #1||14
8250920|NCT01860521|20346123|P2|NOT COMPLETED|Overall Study||0
8250921|NCT01860521|20346124|P1|NOT COMPLETED|Overall Study||0
8250922|NCT01860521|20346123|P2|COMPLETED|Overall Study|June 2013|52
8250923|NCT01860521|20346124|P1|COMPLETED|Overall Study|June 2013|52
8250924|NCT01860521|20346123|P2|STARTED|Overall Study|September 2011|52
8250925|NCT01860521|20346124|P1|STARTED|Overall Study|September 2011|52
8250926|NCT01860287|20346139|P3|NOT COMPLETED|Overall Study||0
8250927|NCT01860287|20346140|P2|NOT COMPLETED|Overall Study||0
8250928|NCT01860287|20346141|P1|NOT COMPLETED|Overall Study||0
8250929|NCT01860287|20346139|P3|COMPLETED|Overall Study||15
8250930|NCT01860287|20346140|P2|COMPLETED|Overall Study||15
8250931|NCT01860287|20346141|P1|COMPLETED|Overall Study||18
8250932|NCT01860287|20346139|P3|STARTED|Overall Study||15
8250933|NCT01860287|20346140|P2|STARTED|Overall Study||15
8250934|NCT01860287|20346141|P1|STARTED|Overall Study||18
8250935|NCT01860170|20346152|P3|NOT COMPLETED|Overall Study||0
8250936|NCT01860170|20346153|P2|NOT COMPLETED|Overall Study||0
8250937|NCT01860170|20346154|P1|NOT COMPLETED|Overall Study||0
8250938|NCT01860170|20346152|P3|COMPLETED|Overall Study||22
8250939|NCT01860170|20346153|P2|COMPLETED|Overall Study||3
8250940|NCT01860170|20346154|P1|COMPLETED|Overall Study||3
8250941|NCT01860170|20346152|P3|STARTED|Overall Study||22
8250942|NCT01860170|20346153|P2|STARTED|Overall Study||3
8250943|NCT01860170|20346154|P1|STARTED|Overall Study||3
8250944|NCT01860079|20346170|P2|NOT COMPLETED|Overall Study||22
8250945|NCT01860079|20346171|P1|NOT COMPLETED|Overall Study||14
8250946|NCT01860079|20346170|P2|COMPLETED|Overall Study||363
8250947|NCT01860079|20346171|P1|COMPLETED|Overall Study||370
8250948|NCT01860079|20346170|P2|STARTED|Overall Study||385
8250949|NCT01860079|20346171|P1|STARTED|Overall Study||384
8250950|NCT01860040|20346179|P2|NOT COMPLETED|Overall Study||0
8250951|NCT01860040|20346180|P1|NOT COMPLETED|Overall Study||1
8250952|NCT01860040|20346179|P2|COMPLETED|Overall Study|did not meet recruitment goal|0
8250953|NCT01860040|20346180|P1|COMPLETED|Overall Study|did not meet recruitment goal|0
8250954|NCT01860040|20346179|P2|STARTED|Overall Study|did not meet recruitment goal|0
8250955|NCT01860040|20346180|P1|STARTED|Overall Study|did not meet recruitment goal|1
8250956|NCT01859988|20346191|P6|NOT COMPLETED|Overall Study||19
8250957|NCT01859988|20346192|P5|NOT COMPLETED|Overall Study||23
8250958|NCT01859988|20346193|P4|NOT COMPLETED|Overall Study||10
8250959|NCT01859988|20346194|P3|NOT COMPLETED|Overall Study||28
8250960|NCT01859988|20346195|P2|NOT COMPLETED|Overall Study||12
8250961|NCT01859988|20346196|P1|NOT COMPLETED|Overall Study||11
8250962|NCT01859988|20346191|P6|COMPLETED|Overall Study||42
8250963|NCT01859988|20346192|P5|COMPLETED|Overall Study||42
8250964|NCT01859988|20346193|P4|COMPLETED|Overall Study||55
8250965|NCT01859988|20346194|P3|COMPLETED|Overall Study||34
8250966|NCT01859988|20346195|P2|COMPLETED|Overall Study||52
8250967|NCT01859988|20346196|P1|COMPLETED|Overall Study||52
8250968|NCT01859988|20346191|P6|Treated|Overall Study||61
8250969|NCT01859988|20346192|P5|Treated|Overall Study||65
8250970|NCT01859988|20346193|P4|Treated|Overall Study||65
8250971|NCT01859988|20346194|P3|Treated|Overall Study||61
8250972|NCT01859988|20346195|P2|Treated|Overall Study||64
8250973|NCT01859988|20346196|P1|Treated|Overall Study||63
8250974|NCT01859988|20346191|P6|STARTED|Overall Study||61
8250975|NCT01859988|20346192|P5|STARTED|Overall Study||65
8250976|NCT01859988|20346193|P4|STARTED|Overall Study||65
8250977|NCT01859988|20346194|P3|STARTED|Overall Study||62
8250978|NCT01859988|20346195|P2|STARTED|Overall Study||64
8250979|NCT01859988|20346196|P1|STARTED|Overall Study||63
8250980|NCT01859949|20346290|P2|NOT COMPLETED|Overall Study||17
8250981|NCT01859949|20346291|P1|NOT COMPLETED|Overall Study||14
8250982|NCT01859949|20346290|P2|COMPLETED|Overall Study||15
8250983|NCT01859949|20346291|P1|COMPLETED|Overall Study||15
8250984|NCT01859949|20346290|P2|STARTED|Overall Study|Treated participants|32
8250985|NCT01859949|20346291|P1|STARTED|Overall Study|Treated participants|29
8250986|NCT01859923|20346311|P4|NOT COMPLETED|Overall Study||1
8250987|NCT01859923|20346312|P3|NOT COMPLETED|Overall Study||1
8250988|NCT01859923|20346313|P2|NOT COMPLETED|Overall Study||0
8250989|NCT01859923|20346314|P1|NOT COMPLETED|Overall Study||0
8250990|NCT01859923|20346311|P4|COMPLETED|Overall Study||11
8250991|NCT01859923|20346312|P3|COMPLETED|Overall Study||11
8250992|NCT01859923|20346313|P2|COMPLETED|Overall Study||6
8250993|NCT01859923|20346314|P1|COMPLETED|Overall Study||7
8250994|NCT01859923|20346311|P4|STARTED|Overall Study||12
8250995|NCT01859923|20346312|P3|STARTED|Overall Study||12
8250996|NCT01859923|20346313|P2|STARTED|Overall Study||6
8250997|NCT01859923|20346314|P1|STARTED|Overall Study||7
8250998|NCT01859793|20346368|P2|NOT COMPLETED|2nd Intervention Period||0
8250999|NCT01859793|20346369|P1|NOT COMPLETED|2nd Intervention Period||0
8251000|NCT01859793|20346368|P2|COMPLETED|2nd Intervention Period||16
8251001|NCT01859793|20346369|P1|COMPLETED|2nd Intervention Period||14
8251002|NCT01859793|20346368|P2|STARTED|2nd Intervention Period||16
8251003|NCT01859793|20346369|P1|STARTED|2nd Intervention Period||14
8251004|NCT01859793|20346368|P2|NOT COMPLETED|Washout Period (4 Weeks)||1
8251005|NCT01859793|20346369|P1|NOT COMPLETED|Washout Period (4 Weeks)||1
8251006|NCT01859793|20346368|P2|COMPLETED|Washout Period (4 Weeks)||16
8251007|NCT01859793|20346369|P1|COMPLETED|Washout Period (4 Weeks)||14
8251008|NCT01859793|20346368|P2|STARTED|Washout Period (4 Weeks)||17
8251009|NCT01859793|20346369|P1|STARTED|Washout Period (4 Weeks)||15
8251010|NCT01859793|20346368|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
8251011|NCT01859793|20346369|P1|NOT COMPLETED|First Intervention (8 Weeks)||5
8251012|NCT01859793|20346368|P2|COMPLETED|First Intervention (8 Weeks)||17
8251013|NCT01859793|20346369|P1|COMPLETED|First Intervention (8 Weeks)||15
8251014|NCT01859793|20346368|P2|STARTED|First Intervention (8 Weeks)||18
8251015|NCT01859793|20346369|P1|STARTED|First Intervention (8 Weeks)||20
8251016|NCT01859741|20346387|P8|NOT COMPLETED|Overall Study||70
8251017|NCT01859741|20346388|P7|NOT COMPLETED|Overall Study||70
8251018|NCT01859741|20346389|P6|NOT COMPLETED|Overall Study||6
8251019|NCT01859741|20346390|P5|NOT COMPLETED|Overall Study||6
8251020|NCT01859741|20346391|P4|NOT COMPLETED|Overall Study||3
8251021|NCT01859741|20346392|P3|NOT COMPLETED|Overall Study||6
8251022|NCT01859741|20346393|P2|NOT COMPLETED|Overall Study||3
8251023|NCT01859741|20346394|P1|NOT COMPLETED|Overall Study||3
8251024|NCT01859741|20346387|P8|COMPLETED|Overall Study||3
8251025|NCT01859741|20346388|P7|COMPLETED|Overall Study||2
8251026|NCT01859741|20346389|P6|COMPLETED|Overall Study||0
8251027|NCT01859741|20346390|P5|COMPLETED|Overall Study||0
8251028|NCT01859741|20346391|P4|COMPLETED|Overall Study||0
8251029|NCT01859741|20346392|P3|COMPLETED|Overall Study||0
8251030|NCT01859741|20346393|P2|COMPLETED|Overall Study||0
8251031|NCT01859741|20346394|P1|COMPLETED|Overall Study||0
8251032|NCT01859741|20346387|P8|STARTED|Overall Study||73
8251033|NCT01859741|20346388|P7|STARTED|Overall Study||72
8251034|NCT01859741|20346389|P6|STARTED|Overall Study||6
8251035|NCT01859741|20346390|P5|STARTED|Overall Study||6
8251036|NCT01859741|20346391|P4|STARTED|Overall Study||3
8251037|NCT01859741|20346392|P3|STARTED|Overall Study||6
8251038|NCT01859741|20346393|P2|STARTED|Overall Study||3
8251039|NCT01859741|20346394|P1|STARTED|Overall Study||3
8251040|NCT01859715|20346423|P3|NOT COMPLETED|Overall Study||23
8251041|NCT01859715|20346424|P2|NOT COMPLETED|Overall Study||8
8251042|NCT01859715|20346425|P1|NOT COMPLETED|Overall Study||16
8251043|NCT01859715|20346423|P3|COMPLETED|Overall Study||93
8251044|NCT01859715|20346424|P2|COMPLETED|Overall Study||83
8251045|NCT01859715|20346425|P1|COMPLETED|Overall Study||125
8251046|NCT01859715|20346423|P3|STARTED|Overall Study||116
8251047|NCT01859715|20346424|P2|STARTED|Overall Study||91
8251048|NCT01859715|20346425|P1|STARTED|Overall Study||141
8251049|NCT01859702|20346436|P1|NOT COMPLETED|Overall Study||5
8251050|NCT01859702|20346436|P1|COMPLETED|Overall Study||31
8251051|NCT01859702|20346436|P1|STARTED|Overall Study||36
8251052|NCT01859637|20346440|P1|NOT COMPLETED|Overall Study||0
8251053|NCT01859637|20346440|P1|COMPLETED|Overall Study||6
8251054|NCT01859637|20346440|P1|STARTED|Overall Study||6
8251055|NCT01859611|20346446|P1|NOT COMPLETED|Overall Study||8
8251056|NCT01859611|20346446|P1|COMPLETED|Overall Study||43
8251057|NCT01859611|20346446|P1|STARTED|Overall Study||51
8251058|NCT01859598|20346450|P1|NOT COMPLETED|Visit 3 at 6 Months||912
8251059|NCT01859598|20346450|P1|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
8251060|NCT01859598|20346450|P1|STARTED|Visit 3 at 6 Months||17253
8251061|NCT01859598|20346450|P1|NOT COMPLETED|Visit 2 at 3 Months||1742
8251062|NCT01859598|20346450|P1|COMPLETED|Visit 2 at 3 Months||17253
8251063|NCT01859598|20346450|P1|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
8251064|NCT01859507|20346458|P1|NOT COMPLETED|Overall Study||4
8251065|NCT01859507|20346458|P1|COMPLETED|Overall Study||28
8251066|NCT01859507|20346458|P1|STARTED|Overall Study||32
8251067|NCT01859494|20346463|P1|NOT COMPLETED|Overall Study||1
8251068|NCT01859494|20346463|P1|COMPLETED|Overall Study||218
8251069|NCT01859494|20346463|P1|STARTED|Overall Study||219
8251070|NCT01859390|20346474|P2|NOT COMPLETED|Overall Study||7
8251071|NCT01859390|20346475|P1|NOT COMPLETED|Overall Study||1
8251072|NCT01859390|20346474|P2|COMPLETED|Overall Study||30
8251073|NCT01859390|20346475|P1|COMPLETED|Overall Study||35
8251074|NCT01859390|20346474|P2|Withdrawals|Overall Study||2
8251075|NCT01859390|20346475|P1|Withdrawals|Overall Study||2
8251076|NCT01859390|20346474|P2|STARTED|Overall Study||37
8251077|NCT01859390|20346475|P1|STARTED|Overall Study||36
8251078|NCT01859325|20346499|P3|NOT COMPLETED|Overall Study||0
8251079|NCT01859325|20346500|P2|NOT COMPLETED|Overall Study||4
8251080|NCT01859325|20346501|P1|NOT COMPLETED|Overall Study||3
8251081|NCT01859325|20346499|P3|COMPLETED|Overall Study||2
8251082|NCT01859325|20346500|P2|COMPLETED|Overall Study||12
8251083|NCT01859325|20346501|P1|COMPLETED|Overall Study||12
8251084|NCT01859325|20346499|P3|STARTED|Overall Study||2
8251085|NCT01859325|20346500|P2|STARTED|Overall Study||16
8251086|NCT01859325|20346501|P1|STARTED|Overall Study||15
8251087|NCT01859312|20346509|P1|NOT COMPLETED|Overall Study||0
8251088|NCT01859312|20346509|P1|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
8251089|NCT01859312|20346509|P1|STARTED|Overall Study||8
8251090|NCT01859247|20346564|P8|NOT COMPLETED|Overall Study||0
8251091|NCT01859247|20346565|P7|NOT COMPLETED|Overall Study||0
8251092|NCT01859247|20346566|P6|NOT COMPLETED|Overall Study||0
8251093|NCT01859247|20346567|P5|NOT COMPLETED|Overall Study||0
8251094|NCT01859247|20346568|P4|NOT COMPLETED|Overall Study||0
8251095|NCT01859247|20346569|P3|NOT COMPLETED|Overall Study||0
8251096|NCT01859247|20346570|P2|NOT COMPLETED|Overall Study||0
8251097|NCT01859247|20346571|P1|NOT COMPLETED|Overall Study||0
8251098|NCT01859247|20346564|P8|COMPLETED|Overall Study||1
8251099|NCT01859247|20346565|P7|COMPLETED|Overall Study||1
8251100|NCT01859247|20346566|P6|COMPLETED|Overall Study||1
8251101|NCT01859247|20346567|P5|COMPLETED|Overall Study||1
8251102|NCT01859247|20346568|P4|COMPLETED|Overall Study||1
8251103|NCT01859247|20346569|P3|COMPLETED|Overall Study||1
8251104|NCT01859247|20346570|P2|COMPLETED|Overall Study||1
8251105|NCT01859247|20346571|P1|COMPLETED|Overall Study||1
8251106|NCT01859247|20346564|P8|STARTED|Overall Study||1
8251107|NCT01859247|20346565|P7|STARTED|Overall Study||1
8251108|NCT01859247|20346566|P6|STARTED|Overall Study||1
8251109|NCT01859247|20346567|P5|STARTED|Overall Study||1
8251110|NCT01859247|20346568|P4|STARTED|Overall Study||1
8251111|NCT01859247|20346569|P3|STARTED|Overall Study||1
8251112|NCT01859247|20346570|P2|STARTED|Overall Study||1
8251113|NCT01859247|20346571|P1|STARTED|Overall Study||1
8251114|NCT01859195|20346598|P2|NOT COMPLETED|Overall Study||0
8251115|NCT01859195|20346599|P1|NOT COMPLETED|Overall Study||0
8251116|NCT01859195|20346598|P2|COMPLETED|Overall Study||12
8251117|NCT01859195|20346599|P1|COMPLETED|Overall Study||24
8251118|NCT01859195|20346598|P2|STARTED|Overall Study||12
8251119|NCT01859195|20346599|P1|STARTED|Overall Study||24
8251120|NCT01859143|20346609|P2|NOT COMPLETED|Overall Study||0
8251121|NCT01859143|20346610|P1|NOT COMPLETED|Overall Study||2
8251122|NCT01859143|20346609|P2|COMPLETED|Overall Study||60
8251123|NCT01859143|20346610|P1|COMPLETED|Overall Study||238
8251124|NCT01859143|20346609|P2|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
8251125|NCT01859143|20346610|P1|STARTED|Overall Study||240
8251126|NCT01859078|20346624|P1|NOT COMPLETED|Overall Study||0
8251127|NCT01859078|20346624|P1|COMPLETED|Overall Study||28
8251128|NCT01859078|20346624|P1|STARTED|Overall Study||28
8251129|NCT01859013|20346640|P2|NOT COMPLETED|Overall Study||5
8251130|NCT01859013|20346641|P1|NOT COMPLETED|Overall Study||4
8251131|NCT01859013|20346640|P2|COMPLETED|Overall Study||9
8251132|NCT01859013|20346641|P1|COMPLETED|Overall Study||12
8251133|NCT01859013|20346640|P2|STARTED|Overall Study||14
8251134|NCT01859013|20346641|P1|STARTED|Overall Study||16
8251135|NCT01858766|20346666|P19|NOT COMPLETED|Overall Study||4
8251136|NCT01858766|20346667|P18|NOT COMPLETED|Overall Study||4
8251137|NCT01858766|20346668|P17|NOT COMPLETED|Overall Study||3
8251138|NCT01858766|20346669|P16|NOT COMPLETED|Overall Study||6
8251139|NCT01858766|20346670|P15|NOT COMPLETED|Overall Study||8
8251140|NCT01858766|20346671|P14|NOT COMPLETED|Overall Study||3
8251141|NCT01858766|20346672|P13|NOT COMPLETED|Overall Study||5
8251142|NCT01858766|20346673|P12|NOT COMPLETED|Overall Study||5
8251143|NCT01858766|20346674|P11|NOT COMPLETED|Overall Study||0
8251144|NCT01858766|20346675|P10|NOT COMPLETED|Overall Study||0
8251145|NCT01858766|20346676|P9|NOT COMPLETED|Overall Study||0
8251146|NCT01858766|20346677|P8|NOT COMPLETED|Overall Study||2
8251147|NCT01858766|20346678|P7|NOT COMPLETED|Overall Study||0
8251148|NCT01858766|20346679|P6|NOT COMPLETED|Overall Study||4
8251149|NCT01858766|20346680|P5|NOT COMPLETED|Overall Study||1
8251150|NCT01858766|20346681|P4|NOT COMPLETED|Overall Study||0
8251151|NCT01858766|20346682|P3|NOT COMPLETED|Overall Study||1
8251152|NCT01858766|20346683|P2|NOT COMPLETED|Overall Study||0
8251153|NCT01858766|20346684|P1|NOT COMPLETED|Overall Study||1
8251154|NCT01858766|20346666|P19|COMPLETED|Overall Study||22
8251155|NCT01858766|20346667|P18|COMPLETED|Overall Study||23
8251156|NCT01858766|20346668|P17|COMPLETED|Overall Study||22
8251157|NCT01858766|20346669|P16|COMPLETED|Overall Study||20
8251158|NCT01858766|20346670|P15|COMPLETED|Overall Study||23
8251159|NCT01858766|20346671|P14|COMPLETED|Overall Study||26
8251160|NCT01858766|20346672|P13|COMPLETED|Overall Study||25
8251161|NCT01858766|20346673|P12|COMPLETED|Overall Study||25
8251162|NCT01858766|20346674|P11|COMPLETED|Overall Study||5
8251163|NCT01858766|20346675|P10|COMPLETED|Overall Study||4
8251164|NCT01858766|20346676|P9|COMPLETED|Overall Study||1
8251165|NCT01858766|20346677|P8|COMPLETED|Overall Study||5
8251166|NCT01858766|20346678|P7|COMPLETED|Overall Study||7
8251167|NCT01858766|20346679|P6|COMPLETED|Overall Study||24
8251168|NCT01858766|20346680|P5|COMPLETED|Overall Study||26
8251169|NCT01858766|20346681|P4|COMPLETED|Overall Study||10
8251170|NCT01858766|20346682|P3|COMPLETED|Overall Study||10
8251171|NCT01858766|20346683|P2|COMPLETED|Overall Study||28
8251172|NCT01858766|20346684|P1|COMPLETED|Overall Study||26
8251173|NCT01858766|20346666|P19|STARTED|Overall Study||26
8251174|NCT01858766|20346667|P18|STARTED|Overall Study||27
8251175|NCT01858766|20346668|P17|STARTED|Overall Study||25
8251176|NCT01858766|20346669|P16|STARTED|Overall Study||26
8251177|NCT01858766|20346670|P15|STARTED|Overall Study||31
8251178|NCT01858766|20346671|P14|STARTED|Overall Study||29
8251179|NCT01858766|20346672|P13|STARTED|Overall Study||30
8251180|NCT01858766|20346673|P12|STARTED|Overall Study||30
8251181|NCT01858766|20346674|P11|STARTED|Overall Study||5
8251182|NCT01858766|20346675|P10|STARTED|Overall Study||4
8251183|NCT01858766|20346676|P9|STARTED|Overall Study||1
8251184|NCT01858766|20346677|P8|STARTED|Overall Study||7
8251185|NCT01858766|20346678|P7|STARTED|Overall Study||7
8251186|NCT01858766|20346679|P6|STARTED|Overall Study||28
8251187|NCT01858766|20346680|P5|STARTED|Overall Study||27
8251188|NCT01858766|20346681|P4|STARTED|Overall Study||10
8251189|NCT01858766|20346682|P3|STARTED|Overall Study||11
8251190|NCT01858766|20346683|P2|STARTED|Overall Study||28
8251191|NCT01858766|20346684|P1|STARTED|Overall Study||27
8251192|NCT01858701|20346755|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
8251193|NCT01858701|20346756|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
8251194|NCT01858701|20346755|P2|COMPLETED|Period 2, Second 30 Days of Wear||16
8251195|NCT01858701|20346756|P1|COMPLETED|Period 2, Second 30 Days of Wear||18
8251196|NCT01858701|20346755|P2|STARTED|Period 2, Second 30 Days of Wear||17
8251197|NCT01858701|20346756|P1|STARTED|Period 2, Second 30 Days of Wear||18
8251198|NCT01858701|20346755|P2|NOT COMPLETED|Washout Period, 1-13 Days||2
8251199|NCT01858701|20346756|P1|NOT COMPLETED|Washout Period, 1-13 Days||2
8251200|NCT01858701|20346755|P2|COMPLETED|Washout Period, 1-13 Days||17
8251201|NCT01858701|20346756|P1|COMPLETED|Washout Period, 1-13 Days||18
8251202|NCT01858701|20346755|P2|STARTED|Washout Period, 1-13 Days||19
8251203|NCT01858701|20346756|P1|STARTED|Washout Period, 1-13 Days||20
8251204|NCT01858701|20346755|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
8251205|NCT01858701|20346756|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
8251206|NCT01858701|20346755|P2|COMPLETED|Period 1, First 30 Days of Wear||19
8251207|NCT01858701|20346756|P1|COMPLETED|Period 1, First 30 Days of Wear||20
8251208|NCT01858701|20346755|P2|STARTED|Period 1, First 30 Days of Wear||20
8251209|NCT01858701|20346756|P1|STARTED|Period 1, First 30 Days of Wear||20
8251210|NCT01858636|20346762|P1|NOT COMPLETED|Overall Study||28
8251211|NCT01858636|20346762|P1|COMPLETED|Overall Study||207
8251212|NCT01858636|20346762|P1|Device Deployment|Overall Study||211
8251213|NCT01858636|20346762|P1|STARTED|Overall Study|Subjects consented|235
8251214|NCT01858558|20346769|P2|NOT COMPLETED|Overall Study||2
8251215|NCT01858558|20346770|P1|NOT COMPLETED|Overall Study||9
8251216|NCT01858558|20346769|P2|COMPLETED|Overall Study||29
8251217|NCT01858558|20346770|P1|COMPLETED|Overall Study||61
8251218|NCT01858558|20346769|P2|STARTED|Overall Study||31
8251219|NCT01858558|20346770|P1|STARTED|Overall Study||70
8251226|NCT01858532|20346792|P4|NOT COMPLETED|Overall Study||93
8251227|NCT01858532|20346793|P3|NOT COMPLETED|Overall Study||98
8251228|NCT01858532|20346794|P2|NOT COMPLETED|Overall Study||192
8251229|NCT01858532|20346795|P1|NOT COMPLETED|Overall Study||181
8251230|NCT01858532|20346792|P4|COMPLETED|Overall Study||418
8251231|NCT01858532|20346793|P3|COMPLETED|Overall Study||411
8251232|NCT01858532|20346794|P2|COMPLETED|Overall Study||1131
8251233|NCT01858532|20346795|P1|COMPLETED|Overall Study||1144
8251234|NCT01858532|20346792|P4|STARTED|Overall Study||511
8251235|NCT01858532|20346793|P3|STARTED|Overall Study||509
8251236|NCT01858532|20346794|P2|STARTED|Overall Study||1323
8251237|NCT01858532|20346795|P1|STARTED|Overall Study||1325
8251238|NCT01858428|20346812|P2|NOT COMPLETED|Overall Study||10
8251239|NCT01858428|20346813|P1|NOT COMPLETED|Overall Study||1
8251240|NCT01858428|20346812|P2|COMPLETED|Overall Study||190
8251241|NCT01858428|20346813|P1|COMPLETED|Overall Study||99
8251242|NCT01858428|20346812|P2|STARTED|Overall Study||200
8251243|NCT01858428|20346813|P1|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
8251244|NCT01858389|20346849|P2|NOT COMPLETED|Overall Study||25
8251245|NCT01858389|20346850|P1|NOT COMPLETED|Overall Study||16
8251246|NCT01858389|20346849|P2|COMPLETED|Overall Study||0
8251247|NCT01858389|20346850|P1|COMPLETED|Overall Study||0
8251248|NCT01858389|20346849|P2|Received Treatment|Overall Study||22
8251249|NCT01858389|20346850|P1|Received Treatment|Overall Study||16
8251250|NCT01858389|20346849|P2|STARTED|Overall Study|Enrolled|25
8251251|NCT01858389|20346850|P1|STARTED|Overall Study|Enrolled|16
8251252|NCT01858376|20346865|P1|NOT COMPLETED|Overall Study||4
8251253|NCT01858376|20346865|P1|COMPLETED|Overall Study||20
8251254|NCT01858376|20346865|P1|STARTED|Overall Study||24
8251255|NCT01858194|20346874|P2|NOT COMPLETED|Overall Study||2
8251256|NCT01858194|20346875|P1|NOT COMPLETED|Overall Study||0
8251257|NCT01858194|20346874|P2|COMPLETED|Overall Study||7
8251258|NCT01858194|20346875|P1|COMPLETED|Overall Study|All patients in Control arm completed.|8
8251259|NCT01858194|20346874|P2|STARTED|Overall Study||9
8251260|NCT01858194|20346875|P1|STARTED|Overall Study||8
8251261|NCT01857986|20346917|P2|NOT COMPLETED|Overall Study||7
8251262|NCT01857986|20346918|P1|NOT COMPLETED|Overall Study||5
8251263|NCT01857986|20346917|P2|COMPLETED|Overall Study||30
8251264|NCT01857986|20346918|P1|COMPLETED|Overall Study||34
8251265|NCT01857986|20346917|P2|STARTED|Overall Study||37
8251266|NCT01857986|20346918|P1|STARTED|Overall Study||39
8251267|NCT01857973|20346928|P1|NOT COMPLETED|Overall Study||5
8251268|NCT01857973|20346928|P1|COMPLETED|Overall Study||73
8251269|NCT01857973|20346928|P1|Phase 7|Overall Study||4
8251270|NCT01857973|20346928|P1|Phase 6|Overall Study||4
8251271|NCT01857973|20346928|P1|Phase 4|Overall Study||10
8251272|NCT01857973|20346928|P1|Phase 3|Overall Study||10
8251273|NCT01857973|20346928|P1|Phase 2|Overall Study||14
8251274|NCT01857973|20346928|P1|Phase 1|Overall Study||17
8251275|NCT01857973|20346928|P1|Xploratory B Phase|Overall Study||9
8251276|NCT01857973|20346928|P1|Exploratory A Phase|Overall Study||9
8251277|NCT01857973|20346928|P1|STARTED|Overall Study||78
8251278|NCT01857882|20346941|P2|NOT COMPLETED|Overall Study||0
8251279|NCT01857882|20346942|P1|NOT COMPLETED|Overall Study||0
8251280|NCT01857882|20346941|P2|COMPLETED|Overall Study||20
8251281|NCT01857882|20346942|P1|COMPLETED|Overall Study||21
8251282|NCT01857882|20346941|P2|STARTED|Overall Study||20
8251283|NCT01857882|20346942|P1|STARTED|Overall Study||21
8251284|NCT01857869|20346958|P10|NOT COMPLETED|Booster/Rechallenge Phase||0
8251285|NCT01857869|20346959|P9|NOT COMPLETED|Booster/Rechallenge Phase||0
8251286|NCT01857869|20346960|P8|NOT COMPLETED|Booster/Rechallenge Phase||0
8251287|NCT01857869|20346961|P7|NOT COMPLETED|Booster/Rechallenge Phase||0
8251288|NCT01857869|20346962|P6|NOT COMPLETED|Booster/Rechallenge Phase||0
8251289|NCT01857869|20346963|P5|NOT COMPLETED|Booster/Rechallenge Phase||0
8251290|NCT01857869|20346964|P4|NOT COMPLETED|Booster/Rechallenge Phase||2
8251291|NCT01857869|20346965|P3|NOT COMPLETED|Booster/Rechallenge Phase||0
8251292|NCT01857869|20346966|P2|NOT COMPLETED|Booster/Rechallenge Phase||0
8251293|NCT01857869|20346967|P1|NOT COMPLETED|Booster/Rechallenge Phase||0
8251294|NCT01857869|20346958|P10|COMPLETED|Booster/Rechallenge Phase||6
8251295|NCT01857869|20346959|P9|COMPLETED|Booster/Rechallenge Phase||3
8251296|NCT01857869|20346960|P8|COMPLETED|Booster/Rechallenge Phase||4
8251297|NCT01857869|20346961|P7|COMPLETED|Booster/Rechallenge Phase||5
8251298|NCT01857869|20346962|P6|COMPLETED|Booster/Rechallenge Phase||2
8251299|NCT01857869|20346963|P5|COMPLETED|Booster/Rechallenge Phase||10
8251300|NCT01857869|20346964|P4|COMPLETED|Booster/Rechallenge Phase||7
8251301|NCT01857869|20346965|P3|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8251302|NCT01857869|20346966|P2|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8251303|NCT01857869|20346967|P1|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8251304|NCT01857869|20346958|P10|STARTED|Booster/Rechallenge Phase||6
8251305|NCT01857869|20346959|P9|STARTED|Booster/Rechallenge Phase||3
8251306|NCT01857869|20346960|P8|STARTED|Booster/Rechallenge Phase||4
8251307|NCT01857869|20346961|P7|STARTED|Booster/Rechallenge Phase||5
8251308|NCT01857869|20346962|P6|STARTED|Booster/Rechallenge Phase||2
8251309|NCT01857869|20346963|P5|STARTED|Booster/Rechallenge Phase||10
8251310|NCT01857869|20346964|P4|STARTED|Booster/Rechallenge Phase||9
8251311|NCT01857869|20346965|P3|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8251312|NCT01857869|20346966|P2|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8251313|NCT01857869|20346967|P1|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
8251314|NCT01857869|20346958|P10|NOT COMPLETED|Primary/Challenge Phase||0
8251315|NCT01857869|20346959|P9|NOT COMPLETED|Primary/Challenge Phase||0
8251316|NCT01857869|20346960|P8|NOT COMPLETED|Primary/Challenge Phase||0
8251317|NCT01857869|20346961|P7|NOT COMPLETED|Primary/Challenge Phase||0
8251318|NCT01857869|20346962|P6|NOT COMPLETED|Primary/Challenge Phase||0
8251319|NCT01857869|20346963|P5|NOT COMPLETED|Primary/Challenge Phase||0
8251320|NCT01857869|20346964|P4|NOT COMPLETED|Primary/Challenge Phase||0
8251321|NCT01857869|20346965|P3|NOT COMPLETED|Primary/Challenge Phase||0
8251322|NCT01857869|20346966|P2|NOT COMPLETED|Primary/Challenge Phase||1
8251323|NCT01857869|20346967|P1|NOT COMPLETED|Primary/Challenge Phase||5
8251324|NCT01857869|20346958|P10|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251325|NCT01857869|20346959|P9|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251326|NCT01857869|20346960|P8|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251327|NCT01857869|20346961|P7|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251328|NCT01857869|20346962|P6|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251329|NCT01857869|20346963|P5|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251330|NCT01857869|20346964|P4|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251331|NCT01857869|20346965|P3|COMPLETED|Primary/Challenge Phase||12
8251332|NCT01857869|20346966|P2|COMPLETED|Primary/Challenge Phase||16
8251333|NCT01857869|20346967|P1|COMPLETED|Primary/Challenge Phase||29
8251334|NCT01857869|20346958|P10|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251335|NCT01857869|20346959|P9|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251336|NCT01857869|20346960|P8|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251337|NCT01857869|20346961|P7|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251338|NCT01857869|20346962|P6|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251339|NCT01857869|20346963|P5|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251340|NCT01857869|20346964|P4|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
8251341|NCT01857869|20346965|P3|STARTED|Primary/Challenge Phase||12
8251342|NCT01857869|20346966|P2|STARTED|Primary/Challenge Phase||17
8251343|NCT01857869|20346967|P1|STARTED|Primary/Challenge Phase||34
8251344|NCT01857713|20347047|P1|NOT COMPLETED|Overall Study||6
8251345|NCT01857713|20347047|P1|COMPLETED|Overall Study||89
8251346|NCT01857713|20347047|P1|STARTED|Overall Study||95
8251347|NCT01857622|20347057|P3|NOT COMPLETED|Overall Study||2
8251348|NCT01857622|20347058|P2|NOT COMPLETED|Overall Study||1
8251349|NCT01857622|20347059|P1|NOT COMPLETED|Overall Study||11
8251350|NCT01857622|20347057|P3|COMPLETED|Overall Study||19
8251351|NCT01857622|20347058|P2|COMPLETED|Overall Study||21
8251352|NCT01857622|20347059|P1|COMPLETED|Overall Study||39
8251353|NCT01857622|20347057|P3|STARTED|Overall Study||21
8251354|NCT01857622|20347058|P2|STARTED|Overall Study||22
8251355|NCT01857622|20347059|P1|STARTED|Overall Study||50
8251356|NCT01857583|20347071|P4|NOT COMPLETED|Overall Study||4
8251357|NCT01857583|20347072|P3|NOT COMPLETED|Overall Study||3
8251358|NCT01857583|20347073|P2|NOT COMPLETED|Overall Study||1
8251359|NCT01857583|20347074|P1|NOT COMPLETED|Overall Study||1
8251360|NCT01857583|20347071|P4|COMPLETED|Overall Study||17
8251361|NCT01857583|20347072|P3|COMPLETED|Overall Study||19
8251362|NCT01857583|20347073|P2|COMPLETED|Overall Study||6
8251363|NCT01857583|20347074|P1|COMPLETED|Overall Study||29
8251364|NCT01857583|20347071|P4|Safety Analysis Population|Overall Study||20
8251365|NCT01857583|20347072|P3|Safety Analysis Population|Overall Study||22
8251366|NCT01857583|20347073|P2|Safety Analysis Population|Overall Study||7
8251367|NCT01857583|20347074|P1|Safety Analysis Population|Overall Study||30
8251368|NCT01857583|20347071|P4|STARTED|Overall Study||21
8251369|NCT01857583|20347072|P3|STARTED|Overall Study||22
8251370|NCT01857583|20347073|P2|STARTED|Overall Study||7
8251371|NCT01857583|20347074|P1|STARTED|Overall Study||30
8251372|NCT01857531|20347084|P1|NOT COMPLETED|Overall Study||4
8251373|NCT01857531|20347084|P1|COMPLETED|Overall Study||12
8251374|NCT01857531|20347084|P1|STARTED|Overall Study||16
8251375|NCT01857362|20347093|P2|NOT COMPLETED|Overall Study||0
8251376|NCT01857362|20347094|P1|NOT COMPLETED|Overall Study||0
8251377|NCT01857362|20347093|P2|COMPLETED|Overall Study||6
8251378|NCT01857362|20347094|P1|COMPLETED|Overall Study||6
8251379|NCT01857362|20347093|P2|STARTED|Overall Study||6
8251380|NCT01857362|20347094|P1|STARTED|Overall Study||6
8251381|NCT01857323|20347102|P1|NOT COMPLETED|Overall Study||64
8251382|NCT01857323|20347102|P1|COMPLETED|Overall Study||253
8251383|NCT01857323|20347102|P1|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
8251384|NCT01857323|20347102|P1|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
8251385|NCT01857310|20347113|P2|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||282
8251386|NCT01857310|20347114|P1|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||315
8251387|NCT01857310|20347113|P2|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|903
8251388|NCT01857310|20347114|P1|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|870
8251389|NCT01857310|20347113|P2|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
8251390|NCT01857310|20347114|P1|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
8251391|NCT01857310|20347113|P2|NOT COMPLETED|Primary Analysis: Live Birth||0
8251392|NCT01857310|20347114|P1|NOT COMPLETED|Primary Analysis: Live Birth||0
8251393|NCT01857310|20347113|P2|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
8251394|NCT01857310|20347114|P1|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
8251395|NCT01857310|20347113|P2|STARTED|Primary Analysis: Live Birth|Male partner|1185
8251396|NCT01857310|20347114|P1|STARTED|Primary Analysis: Live Birth|Male partner|1185
8251397|NCT01857297|20347194|P2|NOT COMPLETED|Overall Study||0
8251398|NCT01857297|20347195|P1|NOT COMPLETED|Overall Study||0
8251399|NCT01857297|20347194|P2|COMPLETED|Overall Study||60
8251400|NCT01857297|20347195|P1|COMPLETED|Overall Study||60
8251401|NCT01857297|20347194|P2|STARTED|Overall Study||60
8251402|NCT01857297|20347195|P1|STARTED|Overall Study||60
8251403|NCT01857271|20347209|P1|NOT COMPLETED|Overall Study||1
8251404|NCT01857271|20347209|P1|COMPLETED|Overall Study||2
8251405|NCT01857271|20347209|P1|STARTED|Overall Study||3
8251406|NCT01857258|20347213|P2|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
8251407|NCT01857258|20347214|P1|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
8251408|NCT01857258|20347213|P2|COMPLETED|Second Intervention (3 h Postprandially)||7
8251409|NCT01857258|20347214|P1|COMPLETED|Second Intervention (3 h Postprandially)||8
8251410|NCT01857258|20347213|P2|STARTED|Second Intervention (3 h Postprandially)||7
8251411|NCT01857258|20347214|P1|STARTED|Second Intervention (3 h Postprandially)||8
8251412|NCT01857258|20347213|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
8251413|NCT01857258|20347214|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
8251414|NCT01857258|20347213|P2|COMPLETED|Wash-out Period (7 Days)||7
8251415|NCT01857258|20347214|P1|COMPLETED|Wash-out Period (7 Days)||8
8251416|NCT01857258|20347213|P2|STARTED|Wash-out Period (7 Days)||7
8251417|NCT01857258|20347214|P1|STARTED|Wash-out Period (7 Days)||8
8251418|NCT01857258|20347213|P2|NOT COMPLETED|First Intervention (3 h Postprandially)||0
8251419|NCT01857258|20347214|P1|NOT COMPLETED|First Intervention (3 h Postprandially)||0
8251420|NCT01857258|20347213|P2|COMPLETED|First Intervention (3 h Postprandially)||7
8251421|NCT01857258|20347214|P1|COMPLETED|First Intervention (3 h Postprandially)||8
8251422|NCT01857258|20347213|P2|STARTED|First Intervention (3 h Postprandially)||7
8251423|NCT01857258|20347214|P1|STARTED|First Intervention (3 h Postprandially)||8
8251424|NCT01857232|20347239|P5|NOT COMPLETED|Overall Study||6
8251425|NCT01857232|20347240|P4|NOT COMPLETED|Overall Study||2
8251426|NCT01857232|20347241|P3|NOT COMPLETED|Overall Study||4
8251427|NCT01857232|20347242|P2|NOT COMPLETED|Overall Study||2
8251428|NCT01857232|20347243|P1|NOT COMPLETED|Overall Study||8
8251429|NCT01857232|20347239|P5|COMPLETED|Overall Study||63
8251430|NCT01857232|20347240|P4|COMPLETED|Overall Study||68
8251431|NCT01857232|20347241|P3|COMPLETED|Overall Study||63
8251432|NCT01857232|20347242|P2|COMPLETED|Overall Study||65
8251433|NCT01857232|20347243|P1|COMPLETED|Overall Study||61
8251434|NCT01857232|20347239|P5|Evaluable ITT|Overall Study||65
8251435|NCT01857232|20347240|P4|Evaluable ITT|Overall Study||68
8251436|NCT01857232|20347241|P3|Evaluable ITT|Overall Study||63
8251437|NCT01857232|20347242|P2|Evaluable ITT|Overall Study||66
8251438|NCT01857232|20347243|P1|Evaluable ITT|Overall Study||66
8251439|NCT01857232|20347239|P5|STARTED|Overall Study||69
8251440|NCT01857232|20347240|P4|STARTED|Overall Study||70
8251441|NCT01857232|20347241|P3|STARTED|Overall Study||67
8251442|NCT01857232|20347242|P2|STARTED|Overall Study||67
8251443|NCT01857232|20347243|P1|STARTED|Overall Study||69
8251444|NCT01857206|20347262|P2|NOT COMPLETED|Overall Study||10
8251445|NCT01857206|20347263|P1|NOT COMPLETED|Overall Study||13
8251446|NCT01857206|20347262|P2|COMPLETED|Overall Study||673
8251447|NCT01857206|20347263|P1|COMPLETED|Overall Study||1359
8251448|NCT01857206|20347262|P2|STARTED|Overall Study||683
8251449|NCT01857206|20347263|P1|STARTED|Overall Study||1372
8251450|NCT01857102|20347281|P2|NOT COMPLETED|Period 2||0
8251451|NCT01857102|20347282|P1|NOT COMPLETED|Period 2||2
8251452|NCT01857102|20347281|P2|COMPLETED|Period 2||51
8251453|NCT01857102|20347282|P1|COMPLETED|Period 2||53
8251454|NCT01857102|20347281|P2|Neophytes|Period 2||4
8251455|NCT01857102|20347282|P1|Neophytes|Period 2||7
8251456|NCT01857102|20347281|P2|Habitual Users|Period 2||47
8251457|NCT01857102|20347282|P1|Habitual Users|Period 2||48
8251458|NCT01857102|20347281|P2|STARTED|Period 2||51
8251459|NCT01857102|20347282|P1|STARTED|Period 2||55
8251460|NCT01857102|20347281|P2|NOT COMPLETED|Period 1||5
8251461|NCT01857102|20347282|P1|NOT COMPLETED|Period 1||3
8251462|NCT01857102|20347281|P2|COMPLETED|Period 1||51
8251463|NCT01857102|20347282|P1|COMPLETED|Period 1||55
8251464|NCT01857102|20347281|P2|Neophtyes|Period 1||4
8251465|NCT01857102|20347282|P1|Neophtyes|Period 1||7
8251466|NCT01857102|20347281|P2|Habitual Users|Period 1||52
8251467|NCT01857102|20347282|P1|Habitual Users|Period 1||51
8251468|NCT01857102|20347281|P2|STARTED|Period 1||56
8251469|NCT01857102|20347282|P1|STARTED|Period 1||58
8251470|NCT01857063|20347292|P2|NOT COMPLETED|Period 2 (7 Days)||2
8251471|NCT01857063|20347293|P1|NOT COMPLETED|Period 2 (7 Days)||4
8251472|NCT01857063|20347292|P2|COMPLETED|Period 2 (7 Days)||104
8251473|NCT01857063|20347293|P1|COMPLETED|Period 2 (7 Days)||104
8251474|NCT01857063|20347292|P2|STARTED|Period 2 (7 Days)||106
8251475|NCT01857063|20347293|P1|STARTED|Period 2 (7 Days)||108
8251476|NCT01857063|20347292|P2|NOT COMPLETED|Period 1 (7 Days)||4
8251477|NCT01857063|20347293|P1|NOT COMPLETED|Period 1 (7 Days)||2
8251478|NCT01857063|20347292|P2|COMPLETED|Period 1 (7 Days)||106
8251479|NCT01857063|20347293|P1|COMPLETED|Period 1 (7 Days)||108
8251480|NCT01857063|20347292|P2|STARTED|Period 1 (7 Days)||110
8251481|NCT01857063|20347293|P1|STARTED|Period 1 (7 Days)||110
8251482|NCT01856933|20347319|P1|NOT COMPLETED|Overall Study||0
8251483|NCT01856933|20347319|P1|COMPLETED|Overall Study||6
8251484|NCT01856933|20347319|P1|STARTED|Overall Study||6
8251485|NCT01856907|20347327|P3|NOT COMPLETED|Overall Study||0
8251486|NCT01856907|20347328|P2|NOT COMPLETED|Overall Study||3
8251487|NCT01856907|20347329|P1|NOT COMPLETED|Overall Study||0
8251488|NCT01856907|20347327|P3|COMPLETED|Overall Study||12
8251489|NCT01856907|20347328|P2|COMPLETED|Overall Study||9
8251490|NCT01856907|20347329|P1|COMPLETED|Overall Study||12
8251491|NCT01856907|20347327|P3|STARTED|Overall Study||12
8251492|NCT01856907|20347328|P2|STARTED|Overall Study||12
8251493|NCT01856907|20347329|P1|STARTED|Overall Study||12
8251494|NCT01856790|20347367|P1|NOT COMPLETED|Closed Loop Control + Liraglutide||2
8251495|NCT01856790|20347367|P1|COMPLETED|Closed Loop Control + Liraglutide||11
8251496|NCT01856790|20347367|P1|STARTED|Closed Loop Control + Liraglutide||13
8251497|NCT01856790|20347367|P1|NOT COMPLETED|Closed Loop Control||2
8251498|NCT01856790|20347367|P1|COMPLETED|Closed Loop Control||13
8251499|NCT01856790|20347367|P1|STARTED|Closed Loop Control||15
8251500|NCT01856764|20347393|P2|NOT COMPLETED|Overall Study||0
8251501|NCT01856764|20347394|P1|NOT COMPLETED|Overall Study||0
8251502|NCT01856764|20347393|P2|COMPLETED|Overall Study||20
8251503|NCT01856764|20347394|P1|COMPLETED|Overall Study||20
8251504|NCT01856764|20347393|P2|STARTED|Overall Study||20
8251505|NCT01856764|20347394|P1|STARTED|Overall Study||20
8251506|NCT01856712|20347406|P2|NOT COMPLETED|Overall Study||3
8251507|NCT01856712|20347407|P1|NOT COMPLETED|Overall Study||7
8251508|NCT01856712|20347406|P2|COMPLETED|Overall Study||19
8251509|NCT01856712|20347407|P1|COMPLETED|Overall Study||16
8251510|NCT01856712|20347406|P2|Lost to 45 Day Follow up|Overall Study||1
8251511|NCT01856712|20347407|P1|Lost to 45 Day Follow up|Overall Study||1
8251512|NCT01856712|20347406|P2|Lost to 14 Day Follow up|Overall Study||2
8251513|NCT01856712|20347407|P1|Lost to 14 Day Follow up|Overall Study||6
8251514|NCT01856712|20347406|P2|STARTED|Overall Study|1 received oral in error thus randomized.|22
8251515|NCT01856712|20347407|P1|STARTED|Overall Study||23
8251516|NCT01856686|20347421|P2|NOT COMPLETED|Overall Study||11
8251517|NCT01856686|20347422|P1|NOT COMPLETED|Overall Study||5
8251518|NCT01856686|20347421|P2|COMPLETED|Overall Study||22
8251519|NCT01856686|20347422|P1|COMPLETED|Overall Study||26
8251520|NCT01856686|20347421|P2|STARTED|Overall Study||33
8251521|NCT01856686|20347422|P1|STARTED|Overall Study||31
8251537|NCT01856595|20347487|P9|NOT COMPLETED|Overall Study||0
8251538|NCT01856595|20347488|P8|NOT COMPLETED|Overall Study||0
8251539|NCT01856595|20347489|P7|NOT COMPLETED|Overall Study||1
8251540|NCT01856595|20347490|P6|NOT COMPLETED|Overall Study||0
8251541|NCT01856595|20347491|P5|NOT COMPLETED|Overall Study||0
8251542|NCT01856595|20347492|P4|NOT COMPLETED|Overall Study||0
8251543|NCT01856595|20347493|P3|NOT COMPLETED|Overall Study||0
8251544|NCT01856595|20347494|P2|NOT COMPLETED|Overall Study||1
8251545|NCT01856595|20347495|P1|NOT COMPLETED|Overall Study||0
8251546|NCT01856595|20347487|P9|COMPLETED|Overall Study||14
8251547|NCT01856595|20347488|P8|COMPLETED|Overall Study||10
8251548|NCT01856595|20347489|P7|COMPLETED|Overall Study||12
8251549|NCT01856595|20347490|P6|COMPLETED|Overall Study||12
8251550|NCT01856595|20347491|P5|COMPLETED|Overall Study||14
8251551|NCT01856595|20347492|P4|COMPLETED|Overall Study||12
8251552|NCT01856595|20347493|P3|COMPLETED|Overall Study||12
8251553|NCT01856595|20347494|P2|COMPLETED|Overall Study||11
8251554|NCT01856595|20347495|P1|COMPLETED|Overall Study||18
8251555|NCT01856595|20347487|P9|STARTED|Overall Study||14
8251556|NCT01856595|20347488|P8|STARTED|Overall Study||10
8251557|NCT01856595|20347489|P7|STARTED|Overall Study||13
8251558|NCT01856595|20347490|P6|STARTED|Overall Study||12
8251559|NCT01856595|20347491|P5|STARTED|Overall Study||14
8251560|NCT01856595|20347492|P4|STARTED|Overall Study||12
8251561|NCT01856595|20347493|P3|STARTED|Overall Study||12
8251562|NCT01856595|20347494|P2|STARTED|Overall Study||12
8251563|NCT01856595|20347495|P1|STARTED|Overall Study||18
8251564|NCT01856582|20347728|P1|NOT COMPLETED|Overall Study||1
8251565|NCT01856582|20347728|P1|COMPLETED|Overall Study||22
8251566|NCT01856582|20347728|P1|STARTED|Overall Study||23
8251567|NCT01856569|20347732|P1|NOT COMPLETED|Overall Study||13
8251568|NCT01856569|20347732|P1|COMPLETED|Overall Study||139
8251569|NCT01856569|20347732|P1|Full Analysis Set|Overall Study||144
8251570|NCT01856569|20347732|P1|STARTED|Overall Study||152
8251571|NCT01856543|20347743|P2|NOT COMPLETED|Overall Study||6
8251572|NCT01856543|20347744|P1|NOT COMPLETED|Overall Study||13
8251573|NCT01856543|20347743|P2|COMPLETED|Overall Study||64
8251574|NCT01856543|20347744|P1|COMPLETED|Overall Study||60
8251575|NCT01856543|20347743|P2|STARTED|Overall Study||70
8251576|NCT01856543|20347744|P1|STARTED|Overall Study||73
8251577|NCT01856530|20347756|P2|NOT COMPLETED|Overall Study||0
8251578|NCT01856530|20347757|P1|NOT COMPLETED|Overall Study||0
8251579|NCT01856530|20347756|P2|COMPLETED|Overall Study||27
8251580|NCT01856530|20347757|P1|COMPLETED|Overall Study||27
8251581|NCT01856530|20347756|P2|STARTED|Overall Study||27
8251582|NCT01856530|20347757|P1|STARTED|Overall Study||27
8251583|NCT01856491|20347773|P1|NOT COMPLETED|Overall Study||15
8251584|NCT01856491|20347773|P1|COMPLETED|Overall Study||152
8251585|NCT01856491|20347773|P1|STARTED|Overall Study||167
8251586|NCT01856361|20347784|P2|NOT COMPLETED|Overall Study||0
8251587|NCT01856361|20347785|P1|NOT COMPLETED|Overall Study||0
8251588|NCT01856361|20347784|P2|COMPLETED|Overall Study||1
8251589|NCT01856361|20347785|P1|COMPLETED|Overall Study||1
8251590|NCT01856361|20347784|P2|STARTED|Overall Study||1
8251591|NCT01856361|20347785|P1|STARTED|Overall Study||1
8251592|NCT01856322|20347802|P3|NOT COMPLETED|Overall Study||3
8251593|NCT01856322|20347803|P2|NOT COMPLETED|Overall Study||0
8251594|NCT01856322|20347804|P1|NOT COMPLETED|Overall Study||0
8251595|NCT01856322|20347802|P3|COMPLETED|Overall Study||0
8251596|NCT01856322|20347803|P2|COMPLETED|Overall Study||0
8251597|NCT01856322|20347804|P1|COMPLETED|Overall Study||0
8251598|NCT01856322|20347802|P3|STARTED|Overall Study||3
8251599|NCT01856322|20347803|P2|STARTED|Overall Study||0
8251600|NCT01856322|20347804|P1|STARTED|Overall Study||0
8251601|NCT01856309|20347815|P4|NOT COMPLETED|Overall Study||609
8251602|NCT01856309|20347816|P3|NOT COMPLETED|Overall Study||595
8251603|NCT01856309|20347817|P2|NOT COMPLETED|Overall Study||288
8251604|NCT01856309|20347818|P1|NOT COMPLETED|Overall Study||299
8251605|NCT01856309|20347815|P4|COMPLETED|Overall Study||9
8251606|NCT01856309|20347816|P3|COMPLETED|Overall Study||11
8251607|NCT01856309|20347817|P2|COMPLETED|Overall Study||3
8251608|NCT01856309|20347818|P1|COMPLETED|Overall Study||6
8251609|NCT01856309|20347815|P4|Treated Partcipants|Overall Study||618
8251610|NCT01856309|20347816|P3|Treated Partcipants|Overall Study||605
8251611|NCT01856309|20347817|P2|Treated Partcipants|Overall Study||290
8251612|NCT01856309|20347818|P1|Treated Partcipants|Overall Study||305
8251613|NCT01856309|20347815|P4|Participants From Study CNTO136ARA3003|Overall Study||206
8251614|NCT01856309|20347816|P3|Participants From Study CNTO136ARA3003|Overall Study||201
8251615|NCT01856309|20347817|P2|Participants From Study CNTO136ARA3003|Overall Study||104
8251616|NCT01856309|20347818|P1|Participants From Study CNTO136ARA3003|Overall Study||108
8251617|NCT01856309|20347815|P4|Participants From Study CNTO136ARA3002|Overall Study||412
8251618|NCT01856309|20347816|P3|Participants From Study CNTO136ARA3002|Overall Study||405
8251619|NCT01856309|20347817|P2|Participants From Study CNTO136ARA3002|Overall Study||187
8251620|NCT01856309|20347818|P1|Participants From Study CNTO136ARA3002|Overall Study||197
8251621|NCT01856309|20347815|P4|STARTED|Overall Study||618
8251622|NCT01856309|20347816|P3|STARTED|Overall Study||606
8251623|NCT01856309|20347817|P2|STARTED|Overall Study||291
8251624|NCT01856309|20347818|P1|STARTED|Overall Study||305
8251625|NCT01856270|20347918|P2|NOT COMPLETED|Overall Study||12
8251626|NCT01856270|20347919|P1|NOT COMPLETED|Overall Study||11
8251627|NCT01856270|20347918|P2|COMPLETED|Overall Study||14
8251628|NCT01856270|20347919|P1|COMPLETED|Overall Study||13
8251629|NCT01856270|20347918|P2|STARTED|Overall Study||26
8251630|NCT01856270|20347919|P1|STARTED|Overall Study||24
8251631|NCT01856257|20347942|P4|NOT COMPLETED|Overall Study||2
8251632|NCT01856257|20347943|P3|NOT COMPLETED|Overall Study||0
8251633|NCT01856257|20347944|P2|NOT COMPLETED|Overall Study||1
8251634|NCT01856257|20347945|P1|NOT COMPLETED|Overall Study||3
8251635|NCT01856257|20347942|P4|COMPLETED|Overall Study||0
8251636|NCT01856257|20347943|P3|COMPLETED|Overall Study||11
8251637|NCT01856257|20347944|P2|COMPLETED|Overall Study||28
8251638|NCT01856257|20347945|P1|COMPLETED|Overall Study||26
8251639|NCT01856257|20347942|P4|STARTED|Overall Study||2
8251640|NCT01856257|20347943|P3|STARTED|Overall Study||11
8251641|NCT01856257|20347944|P2|STARTED|Overall Study||29
8251642|NCT01856257|20347945|P1|STARTED|Overall Study||29
8251643|NCT01856218|20348044|P1|NOT COMPLETED|Long-Term Extension Phase||0
8251644|NCT01856218|20348044|P1|COMPLETED|Long-Term Extension Phase||3
8251645|NCT01856218|20348044|P1|STARTED|Long-Term Extension Phase||3
8251646|NCT01856218|20348044|P1|NOT COMPLETED|First Phase||0
8251647|NCT01856218|20348044|P1|COMPLETED|First Phase||3
8251648|NCT01856218|20348044|P1|STARTED|First Phase||3
8251649|NCT01856114|20348060|P2|NOT COMPLETED|Overall Study||0
8251650|NCT01856114|20348061|P1|NOT COMPLETED|Overall Study||2
8251651|NCT01856114|20348060|P2|COMPLETED|Overall Study||11
8251652|NCT01856114|20348061|P1|COMPLETED|Overall Study||9
8251653|NCT01856114|20348060|P2|STARTED|Overall Study||11
8251654|NCT01856114|20348061|P1|STARTED|Overall Study||11
8251655|NCT01855997|20348071|P1|NOT COMPLETED|Overall Study||0
8251656|NCT01855997|20348071|P1|COMPLETED|Overall Study||1669
8251657|NCT01855997|20348071|P1|STARTED|Overall Study||1669
8251658|NCT01855958|20348126|P2|NOT COMPLETED|Overall Study||0
8251659|NCT01855958|20348127|P1|NOT COMPLETED|Overall Study||1
8251660|NCT01855958|20348126|P2|COMPLETED|Overall Study||13
8251661|NCT01855958|20348127|P1|COMPLETED|Overall Study||12
8251662|NCT01855958|20348126|P2|STARTED|Overall Study||13
8251663|NCT01855958|20348127|P1|STARTED|Overall Study||13
8251664|NCT01855945|20348157|P12|NOT COMPLETED|Overall Study||3
8251665|NCT01855945|20348158|P11|NOT COMPLETED|Overall Study||5
8251666|NCT01855945|20348159|P10|NOT COMPLETED|Overall Study||2
8251667|NCT01855945|20348160|P9|NOT COMPLETED|Overall Study||2
8251668|NCT01855945|20348161|P8|NOT COMPLETED|Overall Study||8
8251669|NCT01855945|20348162|P7|NOT COMPLETED|Overall Study||10
8251670|NCT01855945|20348163|P6|NOT COMPLETED|Overall Study||3
8251671|NCT01855945|20348164|P5|NOT COMPLETED|Overall Study||1
8251672|NCT01855945|20348165|P4|NOT COMPLETED|Overall Study||4
8251673|NCT01855945|20348166|P3|NOT COMPLETED|Overall Study||12
8251674|NCT01855945|20348167|P2|NOT COMPLETED|Overall Study||11
8251675|NCT01855945|20348168|P1|NOT COMPLETED|Overall Study||16
8251676|NCT01855945|20348157|P12|COMPLETED|Overall Study||49
8251677|NCT01855945|20348158|P11|COMPLETED|Overall Study||46
8251678|NCT01855945|20348159|P10|COMPLETED|Overall Study||49
8251679|NCT01855945|20348160|P9|COMPLETED|Overall Study||46
8251680|NCT01855945|20348161|P8|COMPLETED|Overall Study||47
8251681|NCT01855945|20348162|P7|COMPLETED|Overall Study||43
8251682|NCT01855945|20348163|P6|COMPLETED|Overall Study||50
8251683|NCT01855945|20348164|P5|COMPLETED|Overall Study||50
8251684|NCT01855945|20348165|P4|COMPLETED|Overall Study||49
8251685|NCT01855945|20348166|P3|COMPLETED|Overall Study||39
8251686|NCT01855945|20348167|P2|COMPLETED|Overall Study||44
8251687|NCT01855945|20348168|P1|COMPLETED|Overall Study||38
8251688|NCT01855945|20348157|P12|STARTED|Overall Study||52
8251689|NCT01855945|20348158|P11|STARTED|Overall Study||51
8251690|NCT01855945|20348159|P10|STARTED|Overall Study||51
8251691|NCT01855945|20348160|P9|STARTED|Overall Study||48
8251692|NCT01855945|20348161|P8|STARTED|Overall Study||55
8251693|NCT01855945|20348162|P7|STARTED|Overall Study||53
8251694|NCT01855945|20348163|P6|STARTED|Overall Study||53
8251695|NCT01855945|20348164|P5|STARTED|Overall Study||51
8251696|NCT01855945|20348165|P4|STARTED|Overall Study||53
8251697|NCT01855945|20348166|P3|STARTED|Overall Study||51
8251698|NCT01855945|20348167|P2|STARTED|Overall Study||55
8251699|NCT01855945|20348168|P1|STARTED|Overall Study||54
8251700|NCT01855919|20348304|P2|NOT COMPLETED|Overall Study||26
8251701|NCT01855919|20348305|P1|NOT COMPLETED|Overall Study||23
8251702|NCT01855919|20348304|P2|COMPLETED|Overall Study||200
8251703|NCT01855919|20348305|P1|COMPLETED|Overall Study||209
8251704|NCT01855919|20348304|P2|Received at Least 1 Dose of Study Drug|Overall Study||226
8251705|NCT01855919|20348305|P1|Received at Least 1 Dose of Study Drug|Overall Study||232
8251706|NCT01855919|20348304|P2|STARTED|Overall Study||226
8251707|NCT01855919|20348305|P1|STARTED|Overall Study||232
8251708|NCT01855828|20348337|P1|NOT COMPLETED|Overall Study||2
8251709|NCT01855828|20348337|P1|COMPLETED|Overall Study||48
8251710|NCT01855828|20348337|P1|STARTED|Overall Study||50
8251711|NCT01855789|20348347|P4|NOT COMPLETED|2) Week 24 up to End of Study||58
8251712|NCT01855789|20348348|P3|NOT COMPLETED|2) Week 24 up to End of Study||18
8251713|NCT01855789|20348349|P2|NOT COMPLETED|2) Week 24 up to End of Study||15
8251714|NCT01855789|20348350|P1|NOT COMPLETED|2) Week 24 up to End of Study||0
8251715|NCT01855789|20348347|P4|COMPLETED|2) Week 24 up to End of Study||250
8251716|NCT01855789|20348348|P3|COMPLETED|2) Week 24 up to End of Study||129
8251717|NCT01855789|20348349|P2|COMPLETED|2) Week 24 up to End of Study||132
8251718|NCT01855789|20348350|P1|COMPLETED|2) Week 24 up to End of Study||0
8251719|NCT01855789|20348347|P4|STARTED|2) Week 24 up to End of Study||308
8251720|NCT01855789|20348348|P3|STARTED|2) Week 24 up to End of Study||147
8251721|NCT01855789|20348349|P2|STARTED|2) Week 24 up to End of Study||147
8251722|NCT01855789|20348350|P1|STARTED|2) Week 24 up to End of Study||0
8251723|NCT01855789|20348347|P4|NOT COMPLETED|1) Baseline up to Week 24||0
8251724|NCT01855789|20348348|P3|NOT COMPLETED|1) Baseline up to Week 24||0
8251725|NCT01855789|20348349|P2|NOT COMPLETED|1) Baseline up to Week 24||0
8251726|NCT01855789|20348350|P1|NOT COMPLETED|1) Baseline up to Week 24||116
8251727|NCT01855789|20348347|P4|COMPLETED|1) Baseline up to Week 24||0
8251728|NCT01855789|20348348|P3|COMPLETED|1) Baseline up to Week 24||0
8251729|NCT01855789|20348349|P2|COMPLETED|1) Baseline up to Week 24||0
8251730|NCT01855789|20348350|P1|COMPLETED|1) Baseline up to Week 24||602
8251731|NCT01855789|20348347|P4|STARTED|1) Baseline up to Week 24||0
8251732|NCT01855789|20348348|P3|STARTED|1) Baseline up to Week 24||0
8251733|NCT01855789|20348349|P2|STARTED|1) Baseline up to Week 24||0
8251734|NCT01855789|20348350|P1|STARTED|1) Baseline up to Week 24||718
8251735|NCT01855750|20348374|P2|NOT COMPLETED|Overall Study||419
8251736|NCT01855750|20348375|P1|NOT COMPLETED|Overall Study||419
8251737|NCT01855750|20348374|P2|COMPLETED|Overall Study||0
8251738|NCT01855750|20348375|P1|COMPLETED|Overall Study||0
8251739|NCT01855750|20348374|P2|Treated|Overall Study|1 participant not treated: withdrew consent.|418
8251740|NCT01855750|20348375|P1|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416
8251741|NCT01855750|20348374|P2|STARTED|Overall Study||419
8251742|NCT01855750|20348375|P1|STARTED|Overall Study||419
8251743|NCT01855425|20348391|P1|NOT COMPLETED|Overall Study||20
8251744|NCT01855425|20348391|P1|COMPLETED|Overall Study||76
8251745|NCT01855425|20348391|P1|STARTED|Overall Study||96
8251746|NCT01855399|20348397|P2|NOT COMPLETED|12 Month||11
8251747|NCT01855399|20348398|P1|NOT COMPLETED|12 Month||7
8251748|NCT01855399|20348397|P2|COMPLETED|12 Month||118
8251749|NCT01855399|20348398|P1|COMPLETED|12 Month||119
8251750|NCT01855399|20348397|P2|STARTED|12 Month||129
8251751|NCT01855399|20348398|P1|STARTED|12 Month||126
8251752|NCT01855399|20348397|P2|NOT COMPLETED|6 Month||15
8251753|NCT01855399|20348398|P1|NOT COMPLETED|6 Month||20
8251754|NCT01855399|20348397|P2|COMPLETED|6 Month||129
8251755|NCT01855399|20348398|P1|COMPLETED|6 Month||126
8251756|NCT01855399|20348397|P2|STARTED|6 Month||144
8251757|NCT01855399|20348398|P1|STARTED|6 Month||146
8251758|NCT01855360|20348404|P1|NOT COMPLETED|Overall Study||10
8251759|NCT01855360|20348404|P1|COMPLETED|Overall Study||30
8251760|NCT01855360|20348404|P1|STARTED|Overall Study||40
8251761|NCT01855243|20348412|P3|NOT COMPLETED|Overall Study||0
8251762|NCT01855243|20348413|P2|NOT COMPLETED|Overall Study||0
8251763|NCT01855243|20348414|P1|NOT COMPLETED|Overall Study||1
8251764|NCT01855243|20348412|P3|COMPLETED|Overall Study||22
8251765|NCT01855243|20348413|P2|COMPLETED|Overall Study||21
8251766|NCT01855243|20348414|P1|COMPLETED|Overall Study||19
8251767|NCT01855243|20348412|P3|STARTED|Overall Study||22
8251768|NCT01855243|20348413|P2|STARTED|Overall Study||21
8251769|NCT01855243|20348414|P1|STARTED|Overall Study||20
8251770|NCT01855126|20348436|P2|NOT COMPLETED|Second Intervention (8 Weeks)||2
8251771|NCT01855126|20348437|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
8251772|NCT01855126|20348436|P2|COMPLETED|Second Intervention (8 Weeks)||14
8251773|NCT01855126|20348437|P1|COMPLETED|Second Intervention (8 Weeks)||18
8251774|NCT01855126|20348436|P2|STARTED|Second Intervention (8 Weeks)||16
8251775|NCT01855126|20348437|P1|STARTED|Second Intervention (8 Weeks)||20
8251776|NCT01855126|20348436|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
8251777|NCT01855126|20348437|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
8251778|NCT01855126|20348436|P2|COMPLETED|Washout Period (2 Weeks)||16
8251779|NCT01855126|20348437|P1|COMPLETED|Washout Period (2 Weeks)||20
8251780|NCT01855126|20348436|P2|STARTED|Washout Period (2 Weeks)||16
8251781|NCT01855126|20348437|P1|STARTED|Washout Period (2 Weeks)||20
8251782|NCT01855126|20348436|P2|NOT COMPLETED|First Intervention (8 Weeks)||6
8251783|NCT01855126|20348437|P1|NOT COMPLETED|First Intervention (8 Weeks)||4
8251784|NCT01855126|20348436|P2|COMPLETED|First Intervention (8 Weeks)||16
8251785|NCT01855126|20348437|P1|COMPLETED|First Intervention (8 Weeks)||20
8251786|NCT01855126|20348436|P2|STARTED|First Intervention (8 Weeks)||22
8251787|NCT01855126|20348437|P1|STARTED|First Intervention (8 Weeks)||24
8251788|NCT01855074|20348449|P1|NOT COMPLETED|Overall Study||14
8251789|NCT01855074|20348449|P1|COMPLETED|Overall Study||66
8251790|NCT01855074|20348449|P1|Treated|Overall Study||79
8251791|NCT01855074|20348449|P1|STARTED|Overall Study||80
8251792|NCT01854944|20348461|P3|NOT COMPLETED|Overall Study||1
8251793|NCT01854944|20348462|P2|NOT COMPLETED|Overall Study||0
8251794|NCT01854944|20348463|P1|NOT COMPLETED|Overall Study||0
8251795|NCT01854944|20348461|P3|COMPLETED|Overall Study||3
8251796|NCT01854944|20348462|P2|COMPLETED|Overall Study||4
8251797|NCT01854944|20348463|P1|COMPLETED|Overall Study||4
8251798|NCT01854944|20348461|P3|STARTED|Overall Study||4
8251799|NCT01854944|20348462|P2|STARTED|Overall Study||4
8251800|NCT01854944|20348463|P1|STARTED|Overall Study||4
8251801|NCT01854918|20348515|P2|NOT COMPLETED|All-IP Period (Years 2 and 3)||195
8251802|NCT01854918|20348516|P1|NOT COMPLETED|All-IP Period (Years 2 and 3)||118
8251803|NCT01854918|20348515|P2|COMPLETED|All-IP Period (Years 2 and 3)||2196
8251804|NCT01854918|20348516|P1|COMPLETED|All-IP Period (Years 2 and 3)||1079
8251805|NCT01854918|20348515|P2|Received Evolocumab|All-IP Period (Years 2 and 3)||2291
8251806|NCT01854918|20348516|P1|Received Evolocumab|All-IP Period (Years 2 and 3)||1152
8251807|NCT01854918|20348515|P2|STARTED|All-IP Period (Years 2 and 3)||2391
8251808|NCT01854918|20348516|P1|STARTED|All-IP Period (Years 2 and 3)||1197
8251809|NCT01854918|20348515|P2|NOT COMPLETED|SOC-controlled Period (Year 1)||63
8251810|NCT01854918|20348516|P1|NOT COMPLETED|SOC-controlled Period (Year 1)||30
8251811|NCT01854918|20348515|P2|COMPLETED|SOC-controlled Period (Year 1)||2391
8251812|NCT01854918|20348516|P1|COMPLETED|SOC-controlled Period (Year 1)||1197
8251813|NCT01854918|20348515|P2|Received Evolocumab|SOC-controlled Period (Year 1)||2452
8251814|NCT01854918|20348516|P1|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5
8251815|NCT01854918|20348515|P2|STARTED|SOC-controlled Period (Year 1)||2454
8251816|NCT01854918|20348516|P1|STARTED|SOC-controlled Period (Year 1)||1227
8251817|NCT01854905|20348531|P1|NOT COMPLETED|Overall Study||0
8251818|NCT01854905|20348531|P1|COMPLETED|Overall Study||400
8251819|NCT01854905|20348531|P1|STARTED|Overall Study||400
8251820|NCT01854879|20348535|P1|NOT COMPLETED|Overall Study||5
8251821|NCT01854879|20348535|P1|COMPLETED|Overall Study|92 had matched endpoint data|92
8251822|NCT01854879|20348535|P1|STARTED|Overall Study|97 consented|97
8251823|NCT01854827|20348539|P1|NOT COMPLETED|Overall Study||1
8251824|NCT01854827|20348539|P1|COMPLETED|Overall Study||29
8251825|NCT01854827|20348539|P1|STARTED|Overall Study||30
8251826|NCT01854710|20348551|P6|NOT COMPLETED|Overall Study||2
8251827|NCT01854710|20348552|P5|NOT COMPLETED|Overall Study||2
8251828|NCT01854710|20348553|P4|NOT COMPLETED|Overall Study||2
8251829|NCT01854710|20348554|P3|NOT COMPLETED|Overall Study||2
8251830|NCT01854710|20348555|P2|NOT COMPLETED|Overall Study||3
8251831|NCT01854710|20348556|P1|NOT COMPLETED|Overall Study||4
8251832|NCT01854710|20348551|P6|COMPLETED|Overall Study||8
8251833|NCT01854710|20348552|P5|COMPLETED|Overall Study||8
8251834|NCT01854710|20348553|P4|COMPLETED|Overall Study||8
8251835|NCT01854710|20348554|P3|COMPLETED|Overall Study||8
8251836|NCT01854710|20348555|P2|COMPLETED|Overall Study||7
8251837|NCT01854710|20348556|P1|COMPLETED|Overall Study||6
8251838|NCT01854710|20348551|P6|STARTED|Overall Study||10
8251839|NCT01854710|20348552|P5|STARTED|Overall Study||10
8251840|NCT01854710|20348553|P4|STARTED|Overall Study||10
8251841|NCT01854710|20348554|P3|STARTED|Overall Study||10
8251842|NCT01854710|20348555|P2|STARTED|Overall Study||10
8251843|NCT01854710|20348556|P1|STARTED|Overall Study||10
8251844|NCT01854697|20348577|P5|NOT COMPLETED|Overall Study||2
8251845|NCT01854697|20348578|P4|NOT COMPLETED|Overall Study||3
8251846|NCT01854697|20348579|P3|NOT COMPLETED|Overall Study||2
8251847|NCT01854697|20348580|P2|NOT COMPLETED|Overall Study||3
8251848|NCT01854697|20348581|P1|NOT COMPLETED|Overall Study||6
8251849|NCT01854697|20348577|P5|COMPLETED|Overall Study||39
8251850|NCT01854697|20348578|P4|COMPLETED|Overall Study||80
8251851|NCT01854697|20348579|P3|COMPLETED|Overall Study||82
8251852|NCT01854697|20348580|P2|COMPLETED|Overall Study||31
8251853|NCT01854697|20348581|P1|COMPLETED|Overall Study||63
8251854|NCT01854697|20348577|P5|STARTED|Overall Study||41
8251855|NCT01854697|20348578|P4|STARTED|Overall Study||83
8251856|NCT01854697|20348579|P3|STARTED|Overall Study||84
8251857|NCT01854697|20348580|P2|STARTED|Overall Study||34
8251858|NCT01854697|20348581|P1|STARTED|Overall Study||69
8251859|NCT01854658|20348625|P4|NOT COMPLETED|Overall Study||59
8251860|NCT01854658|20348626|P3|NOT COMPLETED|Overall Study||80
8251861|NCT01854658|20348627|P2|NOT COMPLETED|Overall Study||75
8251862|NCT01854658|20348628|P1|NOT COMPLETED|Overall Study||93
8251863|NCT01854658|20348625|P4|COMPLETED|Overall Study||165
8251864|NCT01854658|20348626|P3|COMPLETED|Overall Study||432
8251865|NCT01854658|20348627|P2|COMPLETED|Overall Study||365
8251866|NCT01854658|20348628|P1|COMPLETED|Overall Study||346
8251867|NCT01854658|20348625|P4|STARTED|Overall Study||224
8251868|NCT01854658|20348626|P3|STARTED|Overall Study||512
8251869|NCT01854658|20348627|P2|STARTED|Overall Study||440
8251870|NCT01854658|20348628|P1|STARTED|Overall Study||439
8251871|NCT01854645|20348663|P5|NOT COMPLETED|Overall Study||60
8251872|NCT01854645|20348664|P4|NOT COMPLETED|Overall Study||62
8251873|NCT01854645|20348665|P3|NOT COMPLETED|Overall Study||82
8251874|NCT01854645|20348666|P2|NOT COMPLETED|Overall Study||106
8251875|NCT01854645|20348667|P1|NOT COMPLETED|Overall Study||98
8251876|NCT01854645|20348663|P5|COMPLETED|Overall Study||160
8251877|NCT01854645|20348664|P4|COMPLETED|Overall Study||391
8251878|NCT01854645|20348665|P3|COMPLETED|Overall Study||370
8251879|NCT01854645|20348666|P2|COMPLETED|Overall Study||345
8251880|NCT01854645|20348667|P1|COMPLETED|Overall Study||429
8251881|NCT01854645|20348663|P5|STARTED|Overall Study||220
8251882|NCT01854645|20348664|P4|STARTED|Overall Study||453
8251883|NCT01854645|20348665|P3|STARTED|Overall Study||452
8251884|NCT01854645|20348666|P2|STARTED|Overall Study||451
8251885|NCT01854645|20348667|P1|STARTED|Overall Study||527
8251886|NCT01854632|20348706|P2|NOT COMPLETED|Overall Study||13
8251887|NCT01854632|20348707|P1|NOT COMPLETED|Overall Study||26
8251888|NCT01854632|20348706|P2|COMPLETED|Overall Study||574
8251889|NCT01854632|20348707|P1|COMPLETED|Overall Study||1148
8251890|NCT01854632|20348706|P2|STARTED|Overall Study||587
8251891|NCT01854632|20348707|P1|STARTED|Overall Study||1174
8251892|NCT01854593|20348715|P2|NOT COMPLETED|Overall Study||1
8251893|NCT01854593|20348716|P1|NOT COMPLETED|Overall Study||2
8251894|NCT01854593|20348715|P2|COMPLETED|Overall Study||34
8251895|NCT01854593|20348716|P1|COMPLETED|Overall Study||32
8251896|NCT01854593|20348715|P2|STARTED|Overall Study||35
8251897|NCT01854593|20348716|P1|STARTED|Overall Study||34
8251898|NCT01854528|20348748|P2|NOT COMPLETED|Overall Study||15
8251899|NCT01854528|20348749|P1|NOT COMPLETED|Overall Study||0
8251900|NCT01854528|20348748|P2|COMPLETED|Overall Study||32
8251901|NCT01854528|20348749|P1|COMPLETED|Overall Study||101
8251902|NCT01854528|20348748|P2|STARTED|Overall Study||47
8251903|NCT01854528|20348749|P1|STARTED|Overall Study||101
8251904|NCT01854281|20348769|P4|NOT COMPLETED|Overall Study||0
8251905|NCT01854281|20348770|P3|NOT COMPLETED|Overall Study||0
8251906|NCT01854281|20348771|P2|NOT COMPLETED|Overall Study||0
8251907|NCT01854281|20348772|P1|NOT COMPLETED|Overall Study||0
8251908|NCT01854281|20348769|P4|COMPLETED|Overall Study||8
8251909|NCT01854281|20348770|P3|COMPLETED|Overall Study||5
8251910|NCT01854281|20348771|P2|COMPLETED|Overall Study||19
8251911|NCT01854281|20348772|P1|COMPLETED|Overall Study||15
8251912|NCT01854281|20348769|P4|STARTED|Overall Study||8
8251913|NCT01854281|20348770|P3|STARTED|Overall Study||5
8251914|NCT01854281|20348771|P2|STARTED|Overall Study||19
8251915|NCT01854281|20348772|P1|STARTED|Overall Study||15
8251916|NCT01854268|20348782|P1|NOT COMPLETED|Overall Study||0
8251917|NCT01854268|20348782|P1|COMPLETED|Overall Study||25
8251918|NCT01854268|20348782|P1|STARTED|Overall Study||25
8251919|NCT01854242|20348788|P1|NOT COMPLETED|Overall Study||0
8251920|NCT01854242|20348788|P1|COMPLETED|Overall Study||50
8251921|NCT01854242|20348788|P1|STARTED|Overall Study||50
8251922|NCT01854177|20348792|P1|NOT COMPLETED|Overall Study||0
8251923|NCT01854177|20348792|P1|COMPLETED|Overall Study||10
8251924|NCT01854177|20348792|P1|STARTED|Overall Study||10
8251925|NCT01854138|20348802|P2|NOT COMPLETED|Overall Study||52
8251926|NCT01854138|20348803|P1|NOT COMPLETED|Overall Study||0
8251927|NCT01854138|20348802|P2|COMPLETED|Overall Study||196
8251928|NCT01854138|20348803|P1|COMPLETED|Overall Study||400
8251929|NCT01854138|20348802|P2|STARTED|Overall Study||248
8251930|NCT01854138|20348803|P1|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
8251931|NCT01854047|20348820|P5|NOT COMPLETED|Overall Study||19
8251932|NCT01854047|20348821|P4|NOT COMPLETED|Overall Study||15
8251933|NCT01854047|20348822|P3|NOT COMPLETED|Overall Study||13
8251934|NCT01854047|20348823|P2|NOT COMPLETED|Overall Study||8
8251935|NCT01854047|20348824|P1|NOT COMPLETED|Overall Study||12
8251936|NCT01854047|20348820|P5|COMPLETED|Overall Study||135
8251937|NCT01854047|20348821|P4|COMPLETED|Overall Study||142
8251938|NCT01854047|20348822|P3|COMPLETED|Overall Study||137
8251939|NCT01854047|20348823|P2|COMPLETED|Overall Study||149
8251940|NCT01854047|20348824|P1|COMPLETED|Overall Study||146
8251941|NCT01854047|20348820|P5|Completed 12-week Study Treatment|Overall Study||143
8251942|NCT01854047|20348821|P4|Completed 12-week Study Treatment|Overall Study||146
8251943|NCT01854047|20348822|P3|Completed 12-week Study Treatment|Overall Study||141
8251944|NCT01854047|20348823|P2|Completed 12-week Study Treatment|Overall Study||149
8251945|NCT01854047|20348824|P1|Completed 12-week Study Treatment|Overall Study||153
8251946|NCT01854047|20348820|P5|Treated|Overall Study||150
8251947|NCT01854047|20348821|P4|Treated|Overall Study||157
8251948|NCT01854047|20348822|P3|Treated|Overall Study||148
8251949|NCT01854047|20348823|P2|Treated|Overall Study||156
8251950|NCT01854047|20348824|P1|Treated|Overall Study||158
8251951|NCT01854047|20348820|P5|STARTED|Overall Study||154
8251952|NCT01854047|20348821|P4|STARTED|Overall Study||157
8251953|NCT01854047|20348822|P3|STARTED|Overall Study||150
8251954|NCT01854047|20348823|P2|STARTED|Overall Study||157
8251955|NCT01854047|20348824|P1|STARTED|Overall Study||158
8251956|NCT01854034|20348946|P1|NOT COMPLETED|Overall Study||0
8251957|NCT01854034|20348946|P1|COMPLETED|Overall Study||29
8251958|NCT01854034|20348946|P1|STARTED|Overall Study||29
8251959|NCT01853982|20348955|P2|NOT COMPLETED|Overall Study||1
8251960|NCT01853982|20348956|P1|NOT COMPLETED|Overall Study||2
8251961|NCT01853982|20348955|P2|COMPLETED|Overall Study||1
8251962|NCT01853982|20348956|P1|COMPLETED|Overall Study||0
8251963|NCT01853982|20348955|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
8251964|NCT01853982|20348956|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
8251965|NCT01853982|20348955|P2|STARTED|Overall Study||2
8251966|NCT01853982|20348956|P1|STARTED|Overall Study||2
8251967|NCT01853930|20348964|P2|NOT COMPLETED|Overall Study||0
8251968|NCT01853930|20348965|P1|NOT COMPLETED|Overall Study||0
8251969|NCT01853930|20348964|P2|COMPLETED|Overall Study||8
8251970|NCT01853930|20348965|P1|COMPLETED|Overall Study||25
8251971|NCT01853930|20348964|P2|STARTED|Overall Study||8
8251972|NCT01853930|20348965|P1|STARTED|Overall Study||25
8251973|NCT01853878|20348973|P2|NOT COMPLETED|Overall Study||44
8251974|NCT01853878|20348974|P1|NOT COMPLETED|Overall Study||63
8251975|NCT01853878|20348973|P2|COMPLETED|Overall Study||3
8251976|NCT01853878|20348974|P1|COMPLETED|Overall Study||23
8251977|NCT01853878|20348973|P2|STARTED|Overall Study||47
8251978|NCT01853878|20348974|P1|STARTED|Overall Study||86
8251979|NCT01853839|20348998|P1|NOT COMPLETED|Overall Study||429
8251980|NCT01853839|20348998|P1|COMPLETED|Overall Study||1663
8251981|NCT01853839|20348998|P1|STARTED|Overall Study||2092
8251988|NCT01853696|20349031|P2|NOT COMPLETED|Overall Study||5
8251989|NCT01853696|20349032|P1|NOT COMPLETED|Overall Study||6
8251990|NCT01853696|20349031|P2|COMPLETED|Overall Study||78
8251991|NCT01853696|20349032|P1|COMPLETED|Overall Study||78
8251992|NCT01853696|20349031|P2|STARTED|Overall Study||83
8251993|NCT01853696|20349032|P1|STARTED|Overall Study||84
8251994|NCT01853644|20349040|P1|NOT COMPLETED|Follow up for 3 Years or Until Death||3
8251995|NCT01853644|20349040|P1|COMPLETED|Follow up for 3 Years or Until Death||26
8251996|NCT01853644|20349040|P1|STARTED|Follow up for 3 Years or Until Death|All patients that are treated on the study go into the follow up period|29
8251997|NCT01853644|20349040|P1|NOT COMPLETED|Continued Treatment After First Response||12
8251998|NCT01853644|20349040|P1|COMPLETED|Continued Treatment After First Response||12
8251999|NCT01853644|20349040|P1|STARTED|Continued Treatment After First Response||24
8252000|NCT01853644|20349040|P1|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6
8252001|NCT01853644|20349040|P1|COMPLETED|Reached First Response/Complete 2 Cycles||24
8252002|NCT01853644|20349040|P1|STARTED|Reached First Response/Complete 2 Cycles||30
8252003|NCT01853644|20349040|P1|NOT COMPLETED|Registration and Treatment Start||1
8252004|NCT01853644|20349040|P1|COMPLETED|Registration and Treatment Start||30
8252005|NCT01853644|20349040|P1|Started Treatment|Registration and Treatment Start||30
8252006|NCT01853644|20349040|P1|Registered|Registration and Treatment Start||31
8252007|NCT01853644|20349040|P1|STARTED|Registration and Treatment Start||31
8252008|NCT01853618|20349054|P5|NOT COMPLETED|Overall Study||3
8252009|NCT01853618|20349055|P4|NOT COMPLETED|Overall Study||1
8252010|NCT01853618|20349056|P3|NOT COMPLETED|Overall Study||2
8252011|NCT01853618|20349057|P2|NOT COMPLETED|Overall Study||2
8252012|NCT01853618|20349058|P1|NOT COMPLETED|Overall Study||2
8252013|NCT01853618|20349054|P5|COMPLETED|Overall Study||17
8252014|NCT01853618|20349055|P4|COMPLETED|Overall Study||8
8252015|NCT01853618|20349056|P3|COMPLETED|Overall Study||10
8252016|NCT01853618|20349057|P2|COMPLETED|Overall Study||10
8252017|NCT01853618|20349058|P1|COMPLETED|Overall Study||6
8252018|NCT01853618|20349054|P5|STARTED|Overall Study||20
8252019|NCT01853618|20349055|P4|STARTED|Overall Study||9
8252020|NCT01853618|20349056|P3|STARTED|Overall Study||12
8252021|NCT01853618|20349057|P2|STARTED|Overall Study||12
8252022|NCT01853618|20349058|P1|STARTED|Overall Study||8
8252023|NCT01853605|20349089|P4|NOT COMPLETED|Overall Study||0
8252024|NCT01853605|20349090|P3|NOT COMPLETED|Overall Study||0
8252025|NCT01853605|20349091|P2|NOT COMPLETED|Overall Study||0
8252026|NCT01853605|20349092|P1|NOT COMPLETED|Overall Study||0
8252027|NCT01853605|20349089|P4|COMPLETED|Overall Study||428
8252028|NCT01853605|20349090|P3|COMPLETED|Overall Study||751
8252029|NCT01853605|20349091|P2|COMPLETED|Overall Study||693
8252030|NCT01853605|20349092|P1|COMPLETED|Overall Study||1939
8252031|NCT01853605|20349089|P4|STARTED|Overall Study||428
8252032|NCT01853605|20349090|P3|STARTED|Overall Study||751
8252033|NCT01853605|20349091|P2|STARTED|Overall Study||693
8252034|NCT01853605|20349092|P1|STARTED|Overall Study||1939
8252035|NCT01853553|20349112|P2|NOT COMPLETED|Overall Study||0
8252036|NCT01853553|20349113|P1|NOT COMPLETED|Overall Study||1
8252037|NCT01853553|20349112|P2|COMPLETED|Overall Study||32
8252038|NCT01853553|20349113|P1|COMPLETED|Overall Study||28
8252039|NCT01853553|20349112|P2|STARTED|Overall Study||32
8252040|NCT01853553|20349113|P1|STARTED|Overall Study||29
8252041|NCT01853475|20349124|P3|NOT COMPLETED|Overall Study||0
8252042|NCT01853475|20349125|P2|NOT COMPLETED|Overall Study||1
8252043|NCT01853475|20349126|P1|NOT COMPLETED|Overall Study||0
8252044|NCT01853475|20349124|P3|COMPLETED|Overall Study||8
8252045|NCT01853475|20349125|P2|COMPLETED|Overall Study||7
8252046|NCT01853475|20349126|P1|COMPLETED|Overall Study||8
8252047|NCT01853475|20349124|P3|STARTED|Overall Study||8
8252048|NCT01853475|20349125|P2|STARTED|Overall Study||8
8252049|NCT01853475|20349126|P1|STARTED|Overall Study||8
8252050|NCT01853462|20349145|P2|NOT COMPLETED|Overall Study||1
8252051|NCT01853462|20349146|P1|NOT COMPLETED|Overall Study||1
8252052|NCT01853462|20349145|P2|COMPLETED|Overall Study||10
8252053|NCT01853462|20349146|P1|COMPLETED|Overall Study||10
8252054|NCT01853462|20349145|P2|STARTED|Overall Study||11
8252055|NCT01853462|20349146|P1|STARTED|Overall Study||11
8252056|NCT01853397|20349216|P4|NOT COMPLETED|Overall Study||2
8252057|NCT01853397|20349217|P3|NOT COMPLETED|Overall Study||0
8252058|NCT01853397|20349218|P2|NOT COMPLETED|Overall Study||0
8252059|NCT01853397|20349219|P1|NOT COMPLETED|Overall Study||0
8252060|NCT01853397|20349216|P4|COMPLETED|Overall Study||15
8252061|NCT01853397|20349217|P3|COMPLETED|Overall Study||17
8252062|NCT01853397|20349218|P2|COMPLETED|Overall Study||20
8252063|NCT01853397|20349219|P1|COMPLETED|Overall Study||18
8252064|NCT01853397|20349216|P4|STARTED|Overall Study||17
8252065|NCT01853397|20349217|P3|STARTED|Overall Study||17
8252066|NCT01853397|20349218|P2|STARTED|Overall Study||20
8252067|NCT01853397|20349219|P1|STARTED|Overall Study||18
8252068|NCT01853384|20349247|P2|NOT COMPLETED|Completed Follow up Visit 2||3
8252069|NCT01853384|20349248|P1|NOT COMPLETED|Completed Follow up Visit 2||3
8252070|NCT01853384|20349247|P2|COMPLETED|Completed Follow up Visit 2||91
8252071|NCT01853384|20349248|P1|COMPLETED|Completed Follow up Visit 2||93
8252072|NCT01853384|20349247|P2|STARTED|Completed Follow up Visit 2||94
8252073|NCT01853384|20349248|P1|STARTED|Completed Follow up Visit 2||96
8252074|NCT01853384|20349247|P2|NOT COMPLETED|Completed Follow up Visit 1||9
8252075|NCT01853384|20349248|P1|NOT COMPLETED|Completed Follow up Visit 1||14
8252076|NCT01853384|20349247|P2|COMPLETED|Completed Follow up Visit 1||85
8252077|NCT01853384|20349248|P1|COMPLETED|Completed Follow up Visit 1||82
8252078|NCT01853384|20349247|P2|STARTED|Completed Follow up Visit 1||94
8252079|NCT01853384|20349248|P1|STARTED|Completed Follow up Visit 1||96
8252080|NCT01853384|20349247|P2|NOT COMPLETED|Enrolled in Follow up Period||0
8252081|NCT01853384|20349248|P1|NOT COMPLETED|Enrolled in Follow up Period||0
8252082|NCT01853384|20349247|P2|COMPLETED|Enrolled in Follow up Period||94
8252083|NCT01853384|20349248|P1|COMPLETED|Enrolled in Follow up Period||96
8252178|NCT01852825|20349547|P2|COMPLETED|Overall Study||7
8252084|NCT01853384|20349247|P2|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
8252085|NCT01853384|20349248|P1|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
8252086|NCT01853384|20349247|P2|STARTED|Enrolled in Follow up Period||94
8252087|NCT01853384|20349248|P1|STARTED|Enrolled in Follow up Period||96
8252088|NCT01853384|20349247|P2|NOT COMPLETED|Randomized||46
8252089|NCT01853384|20349248|P1|NOT COMPLETED|Randomized||62
8252090|NCT01853384|20349247|P2|COMPLETED|Randomized||75
8252091|NCT01853384|20349248|P1|COMPLETED|Randomized||69
8252092|NCT01853384|20349247|P2|STARTED|Randomized||121
8252093|NCT01853384|20349248|P1|STARTED|Randomized||131
8252094|NCT01853371|20349268|P2|NOT COMPLETED|Overall Study||2
8252095|NCT01853371|20349269|P1|NOT COMPLETED|Overall Study||0
8252096|NCT01853371|20349268|P2|COMPLETED|Overall Study||8
8252097|NCT01853371|20349269|P1|COMPLETED|Overall Study||10
8252098|NCT01853371|20349268|P2|STARTED|Overall Study||10
8252099|NCT01853371|20349269|P1|STARTED|Overall Study||10
8252100|NCT01853332|20349277|P1|NOT COMPLETED|Overall Study||59
8252101|NCT01853332|20349277|P1|COMPLETED|Overall Study||151
8252102|NCT01853332|20349277|P1|STARTED|Overall Study||210
8252103|NCT01853280|20349288|P2|NOT COMPLETED|Overall Study||6
8252104|NCT01853280|20349289|P1|NOT COMPLETED|Overall Study||2
8252105|NCT01853280|20349288|P2|COMPLETED|Overall Study||16
8252106|NCT01853280|20349289|P1|COMPLETED|Overall Study||20
8252107|NCT01853280|20349288|P2|STARTED|Overall Study||22
8252108|NCT01853280|20349289|P1|STARTED|Overall Study||22
8252109|NCT01853254|20349295|P1|NOT COMPLETED|Overall Study||104
8252110|NCT01853254|20349295|P1|COMPLETED|Overall Study||168
8252111|NCT01853254|20349295|P1|STARTED|Overall Study||272
8252112|NCT01853228|20349299|P2|NOT COMPLETED|Phase 2||8
8252113|NCT01853228|20349300|P1|NOT COMPLETED|Phase 2||0
8252114|NCT01853228|20349299|P2|COMPLETED|Phase 2||0
8252115|NCT01853228|20349300|P1|COMPLETED|Phase 2||0
8252116|NCT01853228|20349299|P2|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8
8252117|NCT01853228|20349300|P1|STARTED|Phase 2||0
8252118|NCT01853228|20349299|P2|NOT COMPLETED|Phase 1||0
8252119|NCT01853228|20349300|P1|NOT COMPLETED|Phase 1||9
8252120|NCT01853228|20349299|P2|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7
8252121|NCT01853228|20349300|P1|COMPLETED|Phase 1||0
8252122|NCT01853228|20349299|P2|STARTED|Phase 1||7
8252123|NCT01853228|20349300|P1|STARTED|Phase 1||9
8252124|NCT01853215|20349317|P1|NOT COMPLETED|Overall Study||0
8252125|NCT01853215|20349317|P1|COMPLETED|Overall Study||24
8252126|NCT01853215|20349317|P1|STARTED|Overall Study||24
8252127|NCT01853176|20349330|P2|NOT COMPLETED|Overall Study||0
8252128|NCT01853176|20349331|P1|NOT COMPLETED|Overall Study||4
8252129|NCT01853176|20349330|P2|COMPLETED|Overall Study||0
8252130|NCT01853176|20349331|P1|COMPLETED|Overall Study||0
8252131|NCT01853176|20349330|P2|STARTED|Overall Study||0
8252132|NCT01853176|20349331|P1|STARTED|Overall Study||4
8252133|NCT01853137|20349339|P2|NOT COMPLETED|Overall Study||1
8252134|NCT01853137|20349340|P1|NOT COMPLETED|Overall Study||4
8252135|NCT01853137|20349339|P2|COMPLETED|Overall Study||17
8252136|NCT01853137|20349340|P1|COMPLETED|Overall Study||21
8252137|NCT01853137|20349339|P2|STARTED|Overall Study||18
8252138|NCT01853137|20349340|P1|STARTED|Overall Study||25
8252139|NCT01853085|20349348|P1|NOT COMPLETED|Overall Study||235
8252140|NCT01853085|20349348|P1|COMPLETED|Overall Study||1595
8252141|NCT01853085|20349348|P1|STARTED|Overall Study||1830
8252142|NCT01853072|20349361|P2|NOT COMPLETED|Overall Study||21
8252143|NCT01853072|20349362|P1|NOT COMPLETED|Overall Study||12
8252144|NCT01853072|20349361|P2|COMPLETED|Overall Study||286
8252145|NCT01853072|20349362|P1|COMPLETED|Overall Study||296
8252146|NCT01853072|20349361|P2|Full Analysis Set|Overall Study||300
8252147|NCT01853072|20349362|P1|Full Analysis Set|Overall Study||298
8252148|NCT01853072|20349361|P2|Treated (Safety Analysis Set)|Overall Study||302
8252149|NCT01853072|20349362|P1|Treated (Safety Analysis Set)|Overall Study||301
8252150|NCT01853072|20349361|P2|Randomized|Overall Study||307
8252151|NCT01853072|20349362|P1|Randomized|Overall Study||308
8252152|NCT01853072|20349361|P2|STARTED|Overall Study||307
8252153|NCT01853072|20349362|P1|STARTED|Overall Study||308
8252154|NCT01853046|20349382|P2|NOT COMPLETED|Overall Study||6
8252155|NCT01853046|20349383|P1|NOT COMPLETED|Overall Study||18
8252156|NCT01853046|20349382|P2|COMPLETED|Overall Study||0
8252157|NCT01853046|20349383|P1|COMPLETED|Overall Study||0
8252158|NCT01853046|20349382|P2|Received Treatment|Overall Study||6
8252159|NCT01853046|20349383|P1|Received Treatment|Overall Study||18
8252160|NCT01853046|20349382|P2|STARTED|Overall Study||6
8252161|NCT01853046|20349383|P1|STARTED|Overall Study||18
8252162|NCT01852955|20349437|P2|NOT COMPLETED|Overall Study||3
8252163|NCT01852955|20349438|P1|NOT COMPLETED|Overall Study||2
8252164|NCT01852955|20349437|P2|COMPLETED|Overall Study||32
8252165|NCT01852955|20349438|P1|COMPLETED|Overall Study||33
8252166|NCT01852955|20349437|P2|STARTED|Overall Study||35
8252167|NCT01852955|20349438|P1|STARTED|Overall Study||35
8252168|NCT01852942|20349450|P2|NOT COMPLETED|Overall Study||6
8252169|NCT01852942|20349451|P1|NOT COMPLETED|Overall Study||5
8252170|NCT01852942|20349450|P2|COMPLETED|Overall Study||21
8252171|NCT01852942|20349451|P1|COMPLETED|Overall Study||20
8252172|NCT01852942|20349450|P2|STARTED|Overall Study||27
8252173|NCT01852942|20349451|P1|STARTED|Overall Study||25
8252174|NCT01852825|20349546|P3|NOT COMPLETED|Overall Study||0
8252175|NCT01852825|20349547|P2|NOT COMPLETED|Overall Study||0
8252176|NCT01852825|20349548|P1|NOT COMPLETED|Overall Study||2
8252177|NCT01852825|20349546|P3|COMPLETED|Overall Study||3
8252179|NCT01852825|20349548|P1|COMPLETED|Overall Study||14
8252180|NCT01852825|20349546|P3|STARTED|Overall Study||3
8252181|NCT01852825|20349547|P2|STARTED|Overall Study||7
8252182|NCT01852825|20349548|P1|STARTED|Overall Study||16
8252183|NCT01852812|20349574|P3|NOT COMPLETED|Overall Study||1
8252184|NCT01852812|20349575|P2|NOT COMPLETED|Overall Study||1
8252185|NCT01852812|20349576|P1|NOT COMPLETED|Overall Study||0
8252186|NCT01852812|20349574|P3|COMPLETED|Overall Study||17
8252187|NCT01852812|20349575|P2|COMPLETED|Overall Study||17
8252188|NCT01852812|20349576|P1|COMPLETED|Overall Study||51
8252189|NCT01852812|20349574|P3|STARTED|Overall Study||18
8252190|NCT01852812|20349575|P2|STARTED|Overall Study||18
8252191|NCT01852812|20349576|P1|STARTED|Overall Study||51
8252192|NCT01852799|20349596|P1|NOT COMPLETED|Overall Study||18
8252193|NCT01852799|20349596|P1|COMPLETED|Overall Study||0
8252194|NCT01852799|20349596|P1|STARTED|Overall Study||18
8252195|NCT01852669|20349607|P2|NOT COMPLETED|Overall Study||1
8252196|NCT01852669|20349608|P1|NOT COMPLETED|Overall Study||0
8252197|NCT01852669|20349607|P2|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
8252198|NCT01852669|20349608|P1|COMPLETED|Overall Study||71
8252199|NCT01852669|20349607|P2|STARTED|Overall Study||69
8252200|NCT01852669|20349608|P1|STARTED|Overall Study||71
8252201|NCT01852591|20349614|P1|NOT COMPLETED|Overall Study||3
8252202|NCT01852591|20349614|P1|COMPLETED|Overall Study||5
8252203|NCT01852591|20349614|P1|STARTED|Overall Study||8
8252204|NCT01852513|20349623|P2|NOT COMPLETED|Overall Study||0
8252205|NCT01852513|20349624|P1|NOT COMPLETED|Overall Study||0
8252206|NCT01852513|20349623|P2|COMPLETED|Overall Study||19
8252207|NCT01852513|20349624|P1|COMPLETED|Overall Study||20
8252208|NCT01852513|20349623|P2|STARTED|Overall Study||19
8252209|NCT01852513|20349624|P1|STARTED|Overall Study||20
8252210|NCT01852383|20349634|P1|NOT COMPLETED|Overall Study||11
8252211|NCT01852383|20349634|P1|COMPLETED|Overall Study||19
8252212|NCT01852383|20349634|P1|STARTED|Overall Study||30
8252213|NCT01852344|20349645|P4|NOT COMPLETED|Overall Study||0
8252214|NCT01852344|20349646|P3|NOT COMPLETED|Overall Study||0
8252215|NCT01852344|20349647|P2|NOT COMPLETED|Overall Study||0
8252216|NCT01852344|20349648|P1|NOT COMPLETED|Overall Study||0
8252217|NCT01852344|20349645|P4|COMPLETED|Overall Study||27
8252218|NCT01852344|20349646|P3|COMPLETED|Overall Study||27
8252219|NCT01852344|20349647|P2|COMPLETED|Overall Study||27
8252220|NCT01852344|20349648|P1|COMPLETED|Overall Study||27
8252221|NCT01852344|20349645|P4|Actual Participation in First Assignment|Overall Study||27
8252222|NCT01852344|20349646|P3|Actual Participation in First Assignment|Overall Study||27
8252223|NCT01852344|20349647|P2|Actual Participation in First Assignment|Overall Study||27
8252224|NCT01852344|20349648|P1|Actual Participation in First Assignment|Overall Study||27
8252225|NCT01852344|20349645|P4|STARTED|Overall Study||27
8252226|NCT01852344|20349646|P3|STARTED|Overall Study||27
8252227|NCT01852344|20349647|P2|STARTED|Overall Study||27
8252228|NCT01852344|20349648|P1|STARTED|Overall Study||27
8252229|NCT01852292|20349668|P2|NOT COMPLETED|Overall Study||79
8252230|NCT01852292|20349669|P1|NOT COMPLETED|Overall Study||79
8252231|NCT01852292|20349668|P2|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
8252232|NCT01852292|20349669|P1|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
8252233|NCT01852292|20349668|P2|STARTED|Overall Study||79
8252234|NCT01852292|20349669|P1|STARTED|Overall Study||79
8252235|NCT01852214|20349693|P2|NOT COMPLETED|Period 2||0
8252236|NCT01852214|20349694|P1|NOT COMPLETED|Period 2||0
8252237|NCT01852214|20349693|P2|COMPLETED|Period 2||20
8252238|NCT01852214|20349694|P1|COMPLETED|Period 2||25
8252239|NCT01852214|20349693|P2|STARTED|Period 2||20
8252240|NCT01852214|20349694|P1|STARTED|Period 2||25
8252241|NCT01852214|20349693|P2|NOT COMPLETED|Washout Period||1
8252242|NCT01852214|20349694|P1|NOT COMPLETED|Washout Period||0
8252243|NCT01852214|20349693|P2|COMPLETED|Washout Period||20
8252244|NCT01852214|20349694|P1|COMPLETED|Washout Period||25
8252245|NCT01852214|20349693|P2|STARTED|Washout Period||21
8252246|NCT01852214|20349694|P1|STARTED|Washout Period||25
8252247|NCT01852214|20349693|P2|NOT COMPLETED|Period 1||3
8252248|NCT01852214|20349694|P1|NOT COMPLETED|Period 1||1
8252249|NCT01852214|20349693|P2|COMPLETED|Period 1||21
8252250|NCT01852214|20349694|P1|COMPLETED|Period 1||25
8252251|NCT01852214|20349693|P2|STARTED|Period 1||24
8252252|NCT01852214|20349694|P1|STARTED|Period 1||26
8252253|NCT01852201|20349708|P2|NOT COMPLETED|Overall Study||0
8252254|NCT01852201|20349709|P1|NOT COMPLETED|Overall Study||0
8252255|NCT01852201|20349708|P2|COMPLETED|Overall Study||12
8252256|NCT01852201|20349709|P1|COMPLETED|Overall Study||21
8252257|NCT01852201|20349708|P2|STARTED|Overall Study||12
8252258|NCT01852201|20349709|P1|STARTED|Overall Study||21
8252259|NCT01852175|20349733|P2|NOT COMPLETED|Overall Study||0
8252260|NCT01852175|20349734|P1|NOT COMPLETED|Overall Study||0
8252261|NCT01852175|20349733|P2|COMPLETED|Overall Study||55
8252262|NCT01852175|20349734|P1|COMPLETED|Overall Study||55
8252263|NCT01852175|20349733|P2|STARTED|Overall Study||55
8252264|NCT01852175|20349734|P1|STARTED|Overall Study||55
8252265|NCT01852162|20349746|P2|NOT COMPLETED|Overall Study||1
8252266|NCT01852162|20349747|P1|NOT COMPLETED|Overall Study||4
8252267|NCT01852162|20349746|P2|COMPLETED|Overall Study||16
8252268|NCT01852162|20349747|P1|COMPLETED|Overall Study||14
8252269|NCT01852162|20349746|P2|STARTED|Overall Study||17
8252270|NCT01852162|20349747|P1|STARTED|Overall Study||18
8252271|NCT01852110|20349763|P6|NOT COMPLETED|Overall Study||0
8252272|NCT01852110|20349764|P5|NOT COMPLETED|Overall Study||0
8252273|NCT01852110|20349765|P4|NOT COMPLETED|Overall Study||0
8252274|NCT01852110|20349766|P3|NOT COMPLETED|Overall Study||0
8252275|NCT01852110|20349767|P2|NOT COMPLETED|Overall Study||46
8252276|NCT01852110|20349768|P1|NOT COMPLETED|Overall Study||50
8252277|NCT01852110|20349763|P6|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252278|NCT01852110|20349764|P5|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252279|NCT01852110|20349765|P4|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252280|NCT01852110|20349766|P3|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252281|NCT01852110|20349767|P2|COMPLETED|Overall Study||74
8252282|NCT01852110|20349768|P1|COMPLETED|Overall Study||70
8252283|NCT01852110|20349763|P6|Treated|Overall Study||0
8252284|NCT01852110|20349764|P5|Treated|Overall Study||0
8252285|NCT01852110|20349765|P4|Treated|Overall Study||0
8252286|NCT01852110|20349766|P3|Treated|Overall Study||0
8252287|NCT01852110|20349767|P2|Treated|Overall Study||120
8252288|NCT01852110|20349768|P1|Treated|Overall Study||119
8252289|NCT01852110|20349763|P6|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252290|NCT01852110|20349764|P5|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252291|NCT01852110|20349765|P4|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252292|NCT01852110|20349766|P3|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
8252293|NCT01852110|20349767|P2|STARTED|Overall Study||120
8252294|NCT01852110|20349768|P1|STARTED|Overall Study||120
8252295|NCT01852084|20349800|P4|NOT COMPLETED|Overall Study||0
8252296|NCT01852084|20349801|P3|NOT COMPLETED|Overall Study||2
8252297|NCT01852084|20349802|P2|NOT COMPLETED|Overall Study||0
8252298|NCT01852084|20349803|P1|NOT COMPLETED|Overall Study||0
8252299|NCT01852084|20349800|P4|COMPLETED|Overall Study||12
8252300|NCT01852084|20349801|P3|COMPLETED|Overall Study||18
8252301|NCT01852084|20349802|P2|COMPLETED|Overall Study||80
8252302|NCT01852084|20349803|P1|COMPLETED|Overall Study||79
8252303|NCT01852084|20349800|P4|STARTED|Overall Study||12
8252304|NCT01852084|20349801|P3|STARTED|Overall Study||20
8252305|NCT01852084|20349802|P2|STARTED|Overall Study||80
8252306|NCT01852084|20349803|P1|STARTED|Overall Study||79
8252307|NCT01852058|20349832|P12|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252308|NCT01852058|20349833|P11|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252309|NCT01852058|20349834|P10|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252310|NCT01852058|20349835|P9|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252311|NCT01852058|20349836|P8|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252312|NCT01852058|20349837|P7|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252313|NCT01852058|20349838|P6|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252314|NCT01852058|20349839|P5|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252315|NCT01852058|20349840|P4|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252316|NCT01852058|20349841|P3|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252317|NCT01852058|20349842|P2|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252318|NCT01852058|20349843|P1|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252319|NCT01852058|20349832|P12|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
8252320|NCT01852058|20349833|P11|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
8252321|NCT01852058|20349834|P10|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||3
8252322|NCT01852058|20349835|P9|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252323|NCT01852058|20349836|P8|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252324|NCT01852058|20349837|P7|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252325|NCT01852058|20349838|P6|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252326|NCT01852058|20349839|P5|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252327|NCT01852058|20349840|P4|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252328|NCT01852058|20349841|P3|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252329|NCT01852058|20349842|P2|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252330|NCT01852058|20349843|P1|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
8252331|NCT01852058|20349832|P12|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
8252332|NCT01852058|20349833|P11|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
8252333|NCT01852058|20349834|P10|STARTED|Treatment Cycle4:Retreatment 3,Study 121||3
8252334|NCT01852058|20349835|P9|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252335|NCT01852058|20349836|P8|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252336|NCT01852058|20349837|P7|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252337|NCT01852058|20349838|P6|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252338|NCT01852058|20349839|P5|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252339|NCT01852058|20349840|P4|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252340|NCT01852058|20349841|P3|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252341|NCT01852058|20349842|P2|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252342|NCT01852058|20349843|P1|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
8252343|NCT01852058|20349832|P12|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252344|NCT01852058|20349833|P11|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252345|NCT01852058|20349834|P10|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252346|NCT01852058|20349835|P9|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
8252347|NCT01852058|20349836|P8|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
8252511|NCT01851863|20350011|P2|COMPLETED|Overall Study||57
8252348|NCT01852058|20349837|P7|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252349|NCT01852058|20349838|P6|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252350|NCT01852058|20349839|P5|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252351|NCT01852058|20349840|P4|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252352|NCT01852058|20349841|P3|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252353|NCT01852058|20349842|P2|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252354|NCT01852058|20349843|P1|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252355|NCT01852058|20349832|P12|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252356|NCT01852058|20349833|P11|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252357|NCT01852058|20349834|P10|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252358|NCT01852058|20349835|P9|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||33
8252359|NCT01852058|20349836|P8|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||15
8252360|NCT01852058|20349837|P7|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||5
8252361|NCT01852058|20349838|P6|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252362|NCT01852058|20349839|P5|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252363|NCT01852058|20349840|P4|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252364|NCT01852058|20349841|P3|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252365|NCT01852058|20349842|P2|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252366|NCT01852058|20349843|P1|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
8252367|NCT01852058|20349832|P12|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252368|NCT01852058|20349833|P11|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252369|NCT01852058|20349834|P10|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252370|NCT01852058|20349835|P9|STARTED|Treatment Cycle3:Retreatment 2,Study 121||34
8252371|NCT01852058|20349836|P8|STARTED|Treatment Cycle3:Retreatment 2,Study 121||16
8252372|NCT01852058|20349837|P7|STARTED|Treatment Cycle3:Retreatment 2,Study 121||5
8252373|NCT01852058|20349838|P6|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252374|NCT01852058|20349839|P5|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252375|NCT01852058|20349840|P4|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252376|NCT01852058|20349841|P3|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252377|NCT01852058|20349842|P2|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252378|NCT01852058|20349843|P1|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
8252379|NCT01852058|20349832|P12|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252380|NCT01852058|20349833|P11|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252381|NCT01852058|20349834|P10|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252382|NCT01852058|20349835|P9|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252383|NCT01852058|20349836|P8|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252384|NCT01852058|20349837|P7|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252385|NCT01852058|20349838|P6|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||9
8252386|NCT01852058|20349839|P5|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||7
8252387|NCT01852058|20349840|P4|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||1
8252388|NCT01852058|20349841|P3|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252389|NCT01852058|20349842|P2|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252390|NCT01852058|20349843|P1|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252391|NCT01852058|20349832|P12|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252392|NCT01852058|20349833|P11|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252393|NCT01852058|20349834|P10|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252394|NCT01852058|20349835|P9|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252395|NCT01852058|20349836|P8|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252396|NCT01852058|20349837|P7|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252397|NCT01852058|20349838|P6|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||27
8252398|NCT01852058|20349839|P5|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||38
8252399|NCT01852058|20349840|P4|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||8
8252400|NCT01852058|20349841|P3|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252401|NCT01852058|20349842|P2|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252402|NCT01852058|20349843|P1|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
8252403|NCT01852058|20349832|P12|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252404|NCT01852058|20349833|P11|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252405|NCT01852058|20349834|P10|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252406|NCT01852058|20349835|P9|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252407|NCT01852058|20349836|P8|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252408|NCT01852058|20349837|P7|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252409|NCT01852058|20349838|P6|STARTED|Treatment Cycle2:Retreatment 1,Study 121||36
8252410|NCT01852058|20349839|P5|STARTED|Treatment Cycle2:Retreatment 1,Study 121||45
8252411|NCT01852058|20349840|P4|STARTED|Treatment Cycle2:Retreatment 1,Study 121||9
8252412|NCT01852058|20349841|P3|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252413|NCT01852058|20349842|P2|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252414|NCT01852058|20349843|P1|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
8252415|NCT01852058|20349832|P12|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252416|NCT01852058|20349833|P11|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252417|NCT01852058|20349834|P10|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252418|NCT01852058|20349835|P9|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252419|NCT01852058|20349836|P8|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252420|NCT01852058|20349837|P7|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252421|NCT01852058|20349838|P6|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252422|NCT01852058|20349839|P5|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252423|NCT01852058|20349840|P4|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252424|NCT01852058|20349841|P3|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252425|NCT01852058|20349842|P2|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252426|NCT01852058|20349843|P1|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||1
8252427|NCT01852058|20349832|P12|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252428|NCT01852058|20349833|P11|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252429|NCT01852058|20349834|P10|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252430|NCT01852058|20349835|P9|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252431|NCT01852058|20349836|P8|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252432|NCT01852058|20349837|P7|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252433|NCT01852058|20349838|P6|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252434|NCT01852058|20349839|P5|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252435|NCT01852058|20349840|P4|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
8252436|NCT01852058|20349841|P3|COMPLETED|Treatment Cycle 1, Occurred in Study 120||25
8252437|NCT01852058|20349842|P2|COMPLETED|Treatment Cycle 1, Occurred in Study 120||39
8252438|NCT01852058|20349843|P1|COMPLETED|Treatment Cycle 1, Occurred in Study 120||30
8252439|NCT01852058|20349832|P12|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252440|NCT01852058|20349833|P11|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252441|NCT01852058|20349834|P10|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252442|NCT01852058|20349835|P9|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252443|NCT01852058|20349836|P8|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252444|NCT01852058|20349837|P7|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252445|NCT01852058|20349838|P6|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252446|NCT01852058|20349839|P5|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252447|NCT01852058|20349840|P4|STARTED|Treatment Cycle 1, Occurred in Study 120||0
8252448|NCT01852058|20349841|P3|STARTED|Treatment Cycle 1, Occurred in Study 120||25
8252449|NCT01852058|20349842|P2|STARTED|Treatment Cycle 1, Occurred in Study 120||39
8252450|NCT01852058|20349843|P1|STARTED|Treatment Cycle 1, Occurred in Study 120||31
8252451|NCT01852045|20349923|P3|NOT COMPLETED|Overall Study||4
8252452|NCT01852045|20349924|P2|NOT COMPLETED|Overall Study||4
8252453|NCT01852045|20349925|P1|NOT COMPLETED|Overall Study||6
8252454|NCT01852045|20349923|P3|COMPLETED|Overall Study||26
8252455|NCT01852045|20349924|P2|COMPLETED|Overall Study||41
8252456|NCT01852045|20349925|P1|COMPLETED|Overall Study||33
8252457|NCT01852045|20349923|P3|Safety Population|Overall Study||30
8252458|NCT01852045|20349924|P2|Safety Population|Overall Study||45
8252459|NCT01852045|20349925|P1|Safety Population|Overall Study||38
8252460|NCT01852045|20349923|P3|mITT Population|Overall Study||30
8252461|NCT01852045|20349924|P2|mITT Population|Overall Study||45
8252462|NCT01852045|20349925|P1|mITT Population|Overall Study||38
8252463|NCT01852045|20349923|P3|STARTED|Overall Study||30
8252464|NCT01852045|20349924|P2|STARTED|Overall Study||45
8252465|NCT01852045|20349925|P1|STARTED|Overall Study||39
8252466|NCT01852032|20349963|P1|NOT COMPLETED|Overall Study||0
8252467|NCT01852032|20349963|P1|COMPLETED|Overall Study||23
8252468|NCT01852032|20349963|P1|STARTED|Overall Study||23
8252469|NCT01852019|20349973|P5|NOT COMPLETED|Day 8||0
8252470|NCT01852019|20349974|P4|NOT COMPLETED|Day 8||0
8252471|NCT01852019|20349975|P3|NOT COMPLETED|Day 8||0
8252472|NCT01852019|20349976|P2|NOT COMPLETED|Day 8||0
8252473|NCT01852019|20349977|P1|NOT COMPLETED|Day 8||0
8252474|NCT01852019|20349973|P5|COMPLETED|Day 8||6
8252475|NCT01852019|20349974|P4|COMPLETED|Day 8||6
8252476|NCT01852019|20349975|P3|COMPLETED|Day 8||0
8252477|NCT01852019|20349976|P2|COMPLETED|Day 8||0
8252478|NCT01852019|20349977|P1|COMPLETED|Day 8||0
8252479|NCT01852019|20349973|P5|STARTED|Day 8||6
8252480|NCT01852019|20349974|P4|STARTED|Day 8||6
8252481|NCT01852019|20349975|P3|STARTED|Day 8||0
8252482|NCT01852019|20349976|P2|STARTED|Day 8||0
8252483|NCT01852019|20349977|P1|STARTED|Day 8||0
8252484|NCT01852019|20349973|P5|NOT COMPLETED|Day 1||0
8252485|NCT01852019|20349974|P4|NOT COMPLETED|Day 1||0
8252486|NCT01852019|20349975|P3|NOT COMPLETED|Day 1||0
8252487|NCT01852019|20349976|P2|NOT COMPLETED|Day 1||0
8252488|NCT01852019|20349977|P1|NOT COMPLETED|Day 1||0
8252489|NCT01852019|20349973|P5|COMPLETED|Day 1||0
8252490|NCT01852019|20349974|P4|COMPLETED|Day 1||0
8252491|NCT01852019|20349975|P3|COMPLETED|Day 1||6
8252492|NCT01852019|20349976|P2|COMPLETED|Day 1||3
8252493|NCT01852019|20349977|P1|COMPLETED|Day 1||3
8252494|NCT01852019|20349973|P5|STARTED|Day 1||0
8252495|NCT01852019|20349974|P4|STARTED|Day 1||0
8252496|NCT01852019|20349975|P3|STARTED|Day 1||6
8252497|NCT01852019|20349976|P2|STARTED|Day 1||3
8252498|NCT01852019|20349977|P1|STARTED|Day 1||3
8252499|NCT01851876|20349998|P2|NOT COMPLETED|Overall Study||0
8252500|NCT01851876|20349999|P1|NOT COMPLETED|Overall Study||0
8252501|NCT01851876|20349998|P2|COMPLETED|Overall Study||62
8252502|NCT01851876|20349999|P1|COMPLETED|Overall Study||56
8252503|NCT01851876|20349998|P2|STARTED|Overall Study||62
8252504|NCT01851876|20349999|P1|STARTED|Overall Study||56
8252505|NCT01851863|20350009|P4|NOT COMPLETED|Overall Study||3
8252506|NCT01851863|20350010|P3|NOT COMPLETED|Overall Study||5
8252507|NCT01851863|20350011|P2|NOT COMPLETED|Overall Study||9
8252508|NCT01851863|20350012|P1|NOT COMPLETED|Overall Study||5
8252509|NCT01851863|20350009|P4|COMPLETED|Overall Study||63
8252510|NCT01851863|20350010|P3|COMPLETED|Overall Study||60
8252512|NCT01851863|20350012|P1|COMPLETED|Overall Study||60
8252513|NCT01851863|20350009|P4|STARTED|Overall Study||66
8252514|NCT01851863|20350010|P3|STARTED|Overall Study||65
8252515|NCT01851863|20350011|P2|STARTED|Overall Study||66
8252516|NCT01851863|20350012|P1|STARTED|Overall Study||65
8252517|NCT01851772|20350033|P1|NOT COMPLETED|Overall Study||0
8252518|NCT01851772|20350033|P1|COMPLETED|Overall Study||3
8252519|NCT01851772|20350033|P1|STARTED|Overall Study||3
8252520|NCT01851720|20350041|P2|NOT COMPLETED|Overall Study||1
8252521|NCT01851720|20350042|P1|NOT COMPLETED|Overall Study||0
8252522|NCT01851720|20350041|P2|COMPLETED|Overall Study||0
8252523|NCT01851720|20350042|P1|COMPLETED|Overall Study||0
8252524|NCT01851720|20350041|P2|STARTED|Overall Study||1
8252525|NCT01851720|20350042|P1|STARTED|Overall Study||0
8252526|NCT01851655|20350050|P2|NOT COMPLETED|Overall Study||0
8252527|NCT01851655|20350051|P1|NOT COMPLETED|Overall Study||0
8252528|NCT01851655|20350050|P2|COMPLETED|Overall Study||12
8252529|NCT01851655|20350051|P1|COMPLETED|Overall Study||12
8252530|NCT01851655|20350050|P2|STARTED|Overall Study||12
8252531|NCT01851655|20350051|P1|STARTED|Overall Study||12
8252532|NCT01851590|20350072|P3|NOT COMPLETED|Overall Study||3
8252533|NCT01851590|20350073|P2|NOT COMPLETED|Overall Study||1
8252534|NCT01851590|20350074|P1|NOT COMPLETED|Overall Study||0
8252535|NCT01851590|20350072|P3|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
8252536|NCT01851590|20350073|P2|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
8252537|NCT01851590|20350074|P1|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
8252538|NCT01851590|20350072|P3|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
8252539|NCT01851590|20350073|P2|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
8252540|NCT01851590|20350074|P1|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
8252541|NCT01851590|20350072|P3|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
8252542|NCT01851590|20350073|P2|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
8252543|NCT01851590|20350074|P1|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
8252544|NCT01851590|20350072|P3|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
8252545|NCT01851590|20350073|P2|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
8252546|NCT01851590|20350074|P1|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
8252547|NCT01851590|20350072|P3|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
8252548|NCT01851590|20350073|P2|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
8252549|NCT01851590|20350074|P1|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
8252550|NCT01851590|20350072|P3|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
8252551|NCT01851590|20350073|P2|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
8252552|NCT01851590|20350074|P1|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
8252553|NCT01851330|20350097|P3|NOT COMPLETED|Overall Study||12
8252554|NCT01851330|20350098|P2|NOT COMPLETED|Overall Study||16
8252555|NCT01851330|20350099|P1|NOT COMPLETED|Overall Study||13
8252556|NCT01851330|20350097|P3|COMPLETED|Overall Study||204
8252557|NCT01851330|20350098|P2|COMPLETED|Overall Study||200
8252558|NCT01851330|20350099|P1|COMPLETED|Overall Study||202
8252559|NCT01851330|20350097|P3|STARTED|Overall Study||216
8252560|NCT01851330|20350098|P2|STARTED|Overall Study||216
8252561|NCT01851330|20350099|P1|STARTED|Overall Study||215
8252562|NCT01851174|20350134|P1|NOT COMPLETED|Overall Study||0
8252563|NCT01851174|20350134|P1|COMPLETED|Overall Study||15
8252564|NCT01851174|20350134|P1|STARTED|Overall Study||15
8252565|NCT01850823|20350142|P3|NOT COMPLETED|Overall Study||10
8252566|NCT01850823|20350143|P2|NOT COMPLETED|Overall Study||3
8252567|NCT01850823|20350144|P1|NOT COMPLETED|Overall Study||3
8252568|NCT01850823|20350142|P3|COMPLETED|Overall Study||345
8252569|NCT01850823|20350143|P2|COMPLETED|Overall Study||347
8252570|NCT01850823|20350144|P1|COMPLETED|Overall Study||172
8252571|NCT01850823|20350142|P3|STARTED|Overall Study||355
8252572|NCT01850823|20350143|P2|STARTED|Overall Study||350
8252573|NCT01850823|20350144|P1|STARTED|Overall Study||175
8252574|NCT01850745|20350157|P3|NOT COMPLETED|Overall Study||0
8252575|NCT01850745|20350158|P2|NOT COMPLETED|Overall Study||0
8252576|NCT01850745|20350159|P1|NOT COMPLETED|Overall Study||0
8252577|NCT01850745|20350157|P3|COMPLETED|Overall Study||131
8252578|NCT01850745|20350158|P2|COMPLETED|Overall Study||169
8252579|NCT01850745|20350159|P1|COMPLETED|Overall Study||147
8252580|NCT01850745|20350157|P3|STARTED|Overall Study||131
8252581|NCT01850745|20350158|P2|STARTED|Overall Study||169
8252582|NCT01850745|20350159|P1|STARTED|Overall Study||147
8252583|NCT01850641|20350167|P1|NOT COMPLETED|Overall Study||5
8252584|NCT01850641|20350167|P1|COMPLETED|Overall Study||30
8252585|NCT01850641|20350167|P1|STARTED|Overall Study||35
8252586|NCT01850615|20350181|P2|NOT COMPLETED|Overall Study||5
8252587|NCT01850615|20350182|P1|NOT COMPLETED|Overall Study||9
8252588|NCT01850615|20350181|P2|COMPLETED|Overall Study||115
8252589|NCT01850615|20350182|P1|COMPLETED|Overall Study||107
8252590|NCT01850615|20350181|P2|Exposed|Overall Study||120
8252591|NCT01850615|20350182|P1|Exposed|Overall Study||115
8252592|NCT01850615|20350181|P2|STARTED|Overall Study||120
8252593|NCT01850615|20350182|P1|STARTED|Overall Study||116
8252594|NCT01850602|20350200|P2|NOT COMPLETED|Overall Study||18
8252595|NCT01850602|20350201|P1|NOT COMPLETED|Overall Study||14
8252596|NCT01850602|20350200|P2|COMPLETED|Overall Study||87
8252597|NCT01850602|20350201|P1|COMPLETED|Overall Study||94
8252598|NCT01850602|20350200|P2|STARTED|Overall Study||105
8252599|NCT01850602|20350201|P1|STARTED|Overall Study||108
8252600|NCT01850589|20350215|P2|NOT COMPLETED|Overall Study||0
8252601|NCT01850589|20350216|P1|NOT COMPLETED|Overall Study||8
8252602|NCT01850589|20350215|P2|COMPLETED|Overall Study||22
8252603|NCT01850589|20350216|P1|COMPLETED|Overall Study||14
8252604|NCT01850589|20350215|P2|STARTED|Overall Study||22
8252605|NCT01850589|20350216|P1|STARTED|Overall Study||22
8252606|NCT01850550|20350224|P2|NOT COMPLETED|Overall Study||3
8252607|NCT01850550|20350225|P1|NOT COMPLETED|Overall Study||0
8252608|NCT01850550|20350224|P2|COMPLETED|Overall Study||37
8252609|NCT01850550|20350225|P1|COMPLETED|Overall Study||40
8252610|NCT01850550|20350224|P2|STARTED|Overall Study||40
8252611|NCT01850550|20350225|P1|STARTED|Overall Study||40
8252612|NCT01850485|20350235|P2|NOT COMPLETED|Overall Study||0
8252613|NCT01850485|20350236|P1|NOT COMPLETED|Overall Study||0
8252614|NCT01850485|20350235|P2|COMPLETED|Overall Study||13
8252615|NCT01850485|20350236|P1|COMPLETED|Overall Study||9
8252616|NCT01850485|20350235|P2|STARTED|Overall Study||13
8252617|NCT01850485|20350236|P1|STARTED|Overall Study||9
8252618|NCT01850446|20350256|P2|NOT COMPLETED|Overall Study||2
8252619|NCT01850446|20350257|P1|NOT COMPLETED|Overall Study||5
8252620|NCT01850446|20350256|P2|COMPLETED|Overall Study||90
8252621|NCT01850446|20350257|P1|COMPLETED|Overall Study||87
8252622|NCT01850446|20350256|P2|STARTED|Overall Study||92
8252623|NCT01850446|20350257|P1|STARTED|Overall Study||92
8252624|NCT01850394|20350292|P3|NOT COMPLETED|Overall Study||0
8252625|NCT01850394|20350293|P2|NOT COMPLETED|Overall Study||0
8252626|NCT01850394|20350294|P1|NOT COMPLETED|Overall Study||0
8252627|NCT01850394|20350292|P3|COMPLETED|Overall Study||45
8252628|NCT01850394|20350293|P2|COMPLETED|Overall Study||45
8252629|NCT01850394|20350294|P1|COMPLETED|Overall Study||45
8252630|NCT01850394|20350292|P3|STARTED|Overall Study||45
8252631|NCT01850394|20350293|P2|STARTED|Overall Study||45
8252632|NCT01850394|20350294|P1|STARTED|Overall Study||45
8252633|NCT01850030|20350316|P2|NOT COMPLETED|Overall Study||369
8252634|NCT01850030|20350317|P1|NOT COMPLETED|Overall Study||347
8252635|NCT01850030|20350316|P2|COMPLETED|Overall Study||142
8252636|NCT01850030|20350317|P1|COMPLETED|Overall Study||173
8252637|NCT01850030|20350316|P2|STARTED|Overall Study||511
8252638|NCT01850030|20350317|P1|STARTED|Overall Study||520
8252639|NCT01850004|20350329|P1|NOT COMPLETED|Overall Study||8
8252640|NCT01850004|20350329|P1|COMPLETED|Overall Study||76
8252641|NCT01850004|20350329|P1|STARTED|Overall Study||84
8252642|NCT01849848|20350336|P1|NOT COMPLETED|Overall Study||4
8252643|NCT01849848|20350336|P1|COMPLETED|Overall Study||13
8252644|NCT01849848|20350336|P1|STARTED|Overall Study||17
8252654|NCT01849692|20350398|P8|NOT COMPLETED|Overall Study||0
8252655|NCT01849692|20350399|P7|NOT COMPLETED|Overall Study||0
8252656|NCT01849692|20350400|P6|NOT COMPLETED|Overall Study||0
8252657|NCT01849692|20350401|P5|NOT COMPLETED|Overall Study||0
8252658|NCT01849692|20350402|P4|NOT COMPLETED|Overall Study||0
8252659|NCT01849692|20350403|P3|NOT COMPLETED|Overall Study||0
8252660|NCT01849692|20350404|P2|NOT COMPLETED|Overall Study||0
8252661|NCT01849692|20350405|P1|NOT COMPLETED|Overall Study||0
8252662|NCT01849692|20350398|P8|COMPLETED|Overall Study||3
8252663|NCT01849692|20350399|P7|COMPLETED|Overall Study||10
8252664|NCT01849692|20350400|P6|COMPLETED|Overall Study||3
8252665|NCT01849692|20350401|P5|COMPLETED|Overall Study||10
8252666|NCT01849692|20350402|P4|COMPLETED|Overall Study||3
8252667|NCT01849692|20350403|P3|COMPLETED|Overall Study||10
8252668|NCT01849692|20350404|P2|COMPLETED|Overall Study||3
8252669|NCT01849692|20350405|P1|COMPLETED|Overall Study||10
8252670|NCT01849692|20350398|P8|STARTED|Overall Study||3
8252671|NCT01849692|20350399|P7|STARTED|Overall Study||10
8252672|NCT01849692|20350400|P6|STARTED|Overall Study||3
8252673|NCT01849692|20350401|P5|STARTED|Overall Study||10
8252674|NCT01849692|20350402|P4|STARTED|Overall Study||3
8252675|NCT01849692|20350403|P3|STARTED|Overall Study||10
8252676|NCT01849692|20350404|P2|STARTED|Overall Study||3
8252677|NCT01849692|20350405|P1|STARTED|Overall Study||10
8252678|NCT01849588|20350434|P1|NOT COMPLETED|Overall Study||3
8252679|NCT01849588|20350434|P1|COMPLETED|Overall Study||0
8252680|NCT01849588|20350434|P1|STARTED|Overall Study||3
8252681|NCT01849575|20350443|P2|NOT COMPLETED|Overall Study||207
8252682|NCT01849575|20350444|P1|NOT COMPLETED|Overall Study||150
8252683|NCT01849575|20350443|P2|COMPLETED|Overall Study||1576
8252684|NCT01849575|20350444|P1|COMPLETED|Overall Study||1599
8252685|NCT01849575|20350443|P2|STARTED|Overall Study||1783
8252686|NCT01849575|20350444|P1|STARTED|Overall Study||1749
8252687|NCT01849562|20350453|P3|NOT COMPLETED|Overall Study||0
8252688|NCT01849562|20350454|P2|NOT COMPLETED|Overall Study||0
8252689|NCT01849562|20350455|P1|NOT COMPLETED|Overall Study||2
8252690|NCT01849562|20350453|P3|COMPLETED|Overall Study||10
8252691|NCT01849562|20350454|P2|COMPLETED|Overall Study||10
8252692|NCT01849562|20350455|P1|COMPLETED|Overall Study||8
8252693|NCT01849562|20350453|P3|STARTED|Overall Study||10
8252694|NCT01849562|20350454|P2|STARTED|Overall Study||10
8252695|NCT01849562|20350455|P1|STARTED|Overall Study||10
8252696|NCT01849497|20350468|P2|NOT COMPLETED|Overall Study||4
8252697|NCT01849497|20350469|P1|NOT COMPLETED|Overall Study||1
8252698|NCT01849497|20350468|P2|COMPLETED|Overall Study||70
8252699|NCT01849497|20350469|P1|COMPLETED|Overall Study||74
8252700|NCT01849497|20350468|P2|Received Treatment|Overall Study||74
8252701|NCT01849497|20350469|P1|Received Treatment|Overall Study||75
8252702|NCT01849497|20350468|P2|STARTED|Overall Study||74
8252703|NCT01849497|20350469|P1|STARTED|Overall Study||75
8252704|NCT01849458|20350477|P1|NOT COMPLETED|Overall Study||4
8252705|NCT01849458|20350477|P1|COMPLETED|Overall Study||46
8252706|NCT01849458|20350477|P1|6 Months Follow-up|Overall Study||50
8252707|NCT01849458|20350477|P1|STARTED|Overall Study||50
8252708|NCT01849419|20350487|P1|NOT COMPLETED|Overall Study||0
8252709|NCT01849419|20350487|P1|COMPLETED|Overall Study||65
8252710|NCT01849419|20350487|P1|STARTED|Overall Study||65
8252711|NCT01849289|20350516|P2|NOT COMPLETED|Overall Study||24
8252712|NCT01849289|20350517|P1|NOT COMPLETED|Overall Study||32
8252713|NCT01849289|20350516|P2|COMPLETED|Overall Study||254
8252714|NCT01849289|20350517|P1|COMPLETED|Overall Study||523
8252715|NCT01849289|20350516|P2|Exposed|Overall Study||278
8252716|NCT01849289|20350517|P1|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
8252717|NCT01849289|20350516|P2|STARTED|Overall Study||278
8252718|NCT01849289|20350517|P1|STARTED|Overall Study||555
8252719|NCT01849276|20350533|P1|NOT COMPLETED|Followed for Survival for 5 Years||2
8252720|NCT01849276|20350533|P1|COMPLETED|Followed for Survival for 5 Years||0
8252721|NCT01849276|20350533|P1|STARTED|Followed for Survival for 5 Years||2
8252722|NCT01849276|20350533|P1|NOT COMPLETED|Completed Treatment||0
8252723|NCT01849276|20350533|P1|COMPLETED|Completed Treatment||2
8252724|NCT01849276|20350533|P1|STARTED|Completed Treatment||2
8252725|NCT01849276|20350533|P1|NOT COMPLETED|Registered to the Study||0
8252726|NCT01849276|20350533|P1|COMPLETED|Registered to the Study||2
8252727|NCT01849276|20350533|P1|STARTED|Registered to the Study||2
8252731|NCT01849172|20350557|P2|NOT COMPLETED|Overall Study||6
8252732|NCT01849172|20350558|P1|NOT COMPLETED|Overall Study||7
8252733|NCT01849172|20350557|P2|COMPLETED|Overall Study||174
8252734|NCT01849172|20350558|P1|COMPLETED|Overall Study||173
8252735|NCT01849172|20350557|P2|STARTED|Overall Study||180
8252736|NCT01849172|20350558|P1|STARTED|Overall Study||180
8252737|NCT01849068|20350596|P2|NOT COMPLETED|Overall Study||0
8252738|NCT01849068|20350597|P1|NOT COMPLETED|Overall Study||0
8252739|NCT01849068|20350596|P2|COMPLETED|Overall Study||10
8252740|NCT01849068|20350597|P1|COMPLETED|Overall Study||10
8252741|NCT01849068|20350596|P2|STARTED|Overall Study||10
8252742|NCT01849068|20350597|P1|STARTED|Overall Study||10
8252743|NCT01849055|20350615|P6|NOT COMPLETED|Overall Study||0
8252744|NCT01849055|20350616|P5|NOT COMPLETED|Overall Study||0
8252745|NCT01849055|20350617|P4|NOT COMPLETED|Overall Study||0
8252746|NCT01849055|20350618|P3|NOT COMPLETED|Overall Study||1
8252747|NCT01849055|20350619|P2|NOT COMPLETED|Overall Study||0
8252748|NCT01849055|20350620|P1|NOT COMPLETED|Overall Study||0
8252749|NCT01849055|20350615|P6|COMPLETED|Overall Study||8
8252750|NCT01849055|20350616|P5|COMPLETED|Overall Study||8
8252751|NCT01849055|20350617|P4|COMPLETED|Overall Study||8
8252752|NCT01849055|20350618|P3|COMPLETED|Overall Study||7
8252753|NCT01849055|20350619|P2|COMPLETED|Overall Study||8
8252754|NCT01849055|20350620|P1|COMPLETED|Overall Study||8
8252755|NCT01849055|20350615|P6|STARTED|Overall Study||8
8252756|NCT01849055|20350616|P5|STARTED|Overall Study||8
8252757|NCT01849055|20350617|P4|STARTED|Overall Study||8
8252758|NCT01849055|20350618|P3|STARTED|Overall Study||8
8252759|NCT01849055|20350619|P2|STARTED|Overall Study||8
8252760|NCT01849055|20350620|P1|STARTED|Overall Study||8
8252761|NCT01848990|20350655|P3|NOT COMPLETED|Overall Study||16
8252762|NCT01848990|20350656|P2|NOT COMPLETED|Overall Study||20
8252763|NCT01848990|20350657|P1|NOT COMPLETED|Overall Study||46
8252764|NCT01848990|20350655|P3|COMPLETED|Overall Study||98
8252765|NCT01848990|20350656|P2|COMPLETED|Overall Study||95
8252766|NCT01848990|20350657|P1|COMPLETED|Overall Study||181
8252767|NCT01848990|20350655|P3|Completed Month 6|Overall Study||103
8252768|NCT01848990|20350656|P2|Completed Month 6|Overall Study||106
8252769|NCT01848990|20350657|P1|Completed Month 6|Overall Study||194
8252770|NCT01848990|20350655|P3|Received at Least 1 Dose of Study Drug|Overall Study||113
8252771|NCT01848990|20350656|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
8252772|NCT01848990|20350657|P1|Received at Least 1 Dose of Study Drug|Overall Study||227
8252773|NCT01848990|20350655|P3|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
8252774|NCT01848990|20350656|P2|STARTED|Overall Study||115
8252775|NCT01848990|20350657|P1|STARTED|Overall Study||227
8252776|NCT01848977|20350716|P1|NOT COMPLETED|Overall Study||0
8252777|NCT01848977|20350716|P1|COMPLETED|Overall Study||20
8252778|NCT01848977|20350716|P1|STARTED|Overall Study||20
8252779|NCT01848938|20350727|P2|NOT COMPLETED|Overall Study||1
8252780|NCT01848938|20350728|P1|NOT COMPLETED|Overall Study||1
8252781|NCT01848938|20350727|P2|COMPLETED|Overall Study||60
8252782|NCT01848938|20350728|P1|COMPLETED|Overall Study||61
8252783|NCT01848938|20350727|P2|STARTED|Overall Study||61
8252784|NCT01848938|20350728|P1|STARTED|Overall Study||62
8252785|NCT01848899|20350746|P2|NOT COMPLETED|Overall Study||0
8252786|NCT01848899|20350747|P1|NOT COMPLETED|Overall Study||0
8252787|NCT01848899|20350746|P2|COMPLETED|Overall Study||50
8252788|NCT01848899|20350747|P1|COMPLETED|Overall Study||50
8252789|NCT01848899|20350746|P2|STARTED|Overall Study||50
8252790|NCT01848899|20350747|P1|STARTED|Overall Study||50
8252791|NCT01848847|20350763|P2|NOT COMPLETED|Overall Study||3
8252792|NCT01848847|20350764|P1|NOT COMPLETED|Overall Study||2
8252793|NCT01848847|20350763|P2|COMPLETED|Overall Study||48
8252794|NCT01848847|20350764|P1|COMPLETED|Overall Study||49
8252795|NCT01848847|20350763|P2|STARTED|Overall Study||51
8252796|NCT01848847|20350764|P1|STARTED|Overall Study||51
8252817|NCT01848821|20350818|P2|NOT COMPLETED|Overall Study||0
8252818|NCT01848821|20350819|P1|NOT COMPLETED|Overall Study||0
8252819|NCT01848821|20350818|P2|COMPLETED|Overall Study||7
8252820|NCT01848821|20350819|P1|COMPLETED|Overall Study||7
8252821|NCT01848821|20350818|P2|STARTED|Overall Study||7
8252822|NCT01848821|20350819|P1|STARTED|Overall Study||7
8252823|NCT01848756|20350829|P1|NOT COMPLETED|Overall Study||3
8252824|NCT01848756|20350829|P1|COMPLETED|Overall Study|Cycle 1|12
8252825|NCT01848756|20350829|P1|STARTED|Overall Study||15
8252826|NCT01848483|20350841|P2|NOT COMPLETED|Overall Study||11
8252827|NCT01848483|20350842|P1|NOT COMPLETED|Overall Study||11
8252828|NCT01848483|20350841|P2|COMPLETED|Overall Study||49
8252829|NCT01848483|20350842|P1|COMPLETED|Overall Study||50
8252830|NCT01848483|20350841|P2|STARTED|Overall Study||60
8252831|NCT01848483|20350842|P1|STARTED|Overall Study||61
8252832|NCT01848457|20350860|P4|NOT COMPLETED|Overall Study||0
8252833|NCT01848457|20350861|P3|NOT COMPLETED|Overall Study||0
8252834|NCT01848457|20350862|P2|NOT COMPLETED|Overall Study||0
8252835|NCT01848457|20350863|P1|NOT COMPLETED|Overall Study||1
8252836|NCT01848457|20350860|P4|COMPLETED|Overall Study||3
8252837|NCT01848457|20350861|P3|COMPLETED|Overall Study||3
8252838|NCT01848457|20350862|P2|COMPLETED|Overall Study||3
8252839|NCT01848457|20350863|P1|COMPLETED|Overall Study||3
8252840|NCT01848457|20350860|P4|Cycle 4|Overall Study||3
8252841|NCT01848457|20350861|P3|Cycle 4|Overall Study||3
8252842|NCT01848457|20350862|P2|Cycle 4|Overall Study||3
8252843|NCT01848457|20350863|P1|Cycle 4|Overall Study||3
8252844|NCT01848457|20350860|P4|Cycle 3|Overall Study||3
8252845|NCT01848457|20350861|P3|Cycle 3|Overall Study||3
8252846|NCT01848457|20350862|P2|Cycle 3|Overall Study||3
8252847|NCT01848457|20350863|P1|Cycle 3|Overall Study||3
8252848|NCT01848457|20350860|P4|Cycle 2|Overall Study||3
8252849|NCT01848457|20350861|P3|Cycle 2|Overall Study||3
8252850|NCT01848457|20350862|P2|Cycle 2|Overall Study||3
8252851|NCT01848457|20350863|P1|Cycle 2|Overall Study||3
8252852|NCT01848457|20350860|P4|Cycle 1|Overall Study||3
8252853|NCT01848457|20350861|P3|Cycle 1|Overall Study||3
8252854|NCT01848457|20350862|P2|Cycle 1|Overall Study||3
8252855|NCT01848457|20350863|P1|Cycle 1|Overall Study||4
8252856|NCT01848457|20350860|P4|Baseline|Overall Study||3
8252857|NCT01848457|20350861|P3|Baseline|Overall Study||3
8252858|NCT01848457|20350862|P2|Baseline|Overall Study||3
8252859|NCT01848457|20350863|P1|Baseline|Overall Study||4
8252860|NCT01848457|20350860|P4|STARTED|Overall Study||3
8252861|NCT01848457|20350861|P3|STARTED|Overall Study||3
8252862|NCT01848457|20350862|P2|STARTED|Overall Study||3
8252863|NCT01848457|20350863|P1|STARTED|Overall Study||4
8252864|NCT01848366|20350887|P1|NOT COMPLETED|Overall Study||0
8252865|NCT01848366|20350887|P1|COMPLETED|Overall Study||8
8252866|NCT01848366|20350887|P1|STARTED|Overall Study||8
8252867|NCT01848353|20350895|P4|NOT COMPLETED|Phase 3||0
8252868|NCT01848353|20350896|P3|NOT COMPLETED|Phase 3||0
8252869|NCT01848353|20350897|P2|NOT COMPLETED|Phase 3||1
8252870|NCT01848353|20350898|P1|NOT COMPLETED|Phase 3||1
8252871|NCT01848353|20350895|P4|COMPLETED|Phase 3||0
8252872|NCT01848353|20350896|P3|COMPLETED|Phase 3||0
8252873|NCT01848353|20350897|P2|COMPLETED|Phase 3||9
8252874|NCT01848353|20350898|P1|COMPLETED|Phase 3||4
8252875|NCT01848353|20350895|P4|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
8252876|NCT01848353|20350896|P3|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
8252877|NCT01848353|20350897|P2|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10
8252878|NCT01848353|20350898|P1|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5
8252879|NCT01848353|20350895|P4|NOT COMPLETED|Phase 2||0
8252880|NCT01848353|20350896|P3|NOT COMPLETED|Phase 2||0
8252881|NCT01848353|20350897|P2|NOT COMPLETED|Phase 2||2
8252882|NCT01848353|20350898|P1|NOT COMPLETED|Phase 2||3
8252883|NCT01848353|20350895|P4|COMPLETED|Phase 2||0
8252884|NCT01848353|20350896|P3|COMPLETED|Phase 2||0
8252885|NCT01848353|20350897|P2|COMPLETED|Phase 2||26
8252886|NCT01848353|20350898|P1|COMPLETED|Phase 2||20
8252887|NCT01848353|20350895|P4|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
8252888|NCT01848353|20350896|P3|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
8252889|NCT01848353|20350897|P2|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28
8252890|NCT01848353|20350898|P1|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23
8252891|NCT01848353|20350895|P4|NOT COMPLETED|Phase 1||0
8252892|NCT01848353|20350896|P3|NOT COMPLETED|Phase 1||0
8252893|NCT01848353|20350897|P2|NOT COMPLETED|Phase 1||1
8252894|NCT01848353|20350898|P1|NOT COMPLETED|Phase 1||3
8252895|NCT01848353|20350895|P4|COMPLETED|Phase 1||19
8252896|NCT01848353|20350896|P3|COMPLETED|Phase 1||20
8252897|NCT01848353|20350897|P2|COMPLETED|Phase 1||42
8252898|NCT01848353|20350898|P1|COMPLETED|Phase 1||35
8252899|NCT01848353|20350895|P4|STARTED|Phase 1||19
8252900|NCT01848353|20350896|P3|STARTED|Phase 1||20
8252901|NCT01848353|20350897|P2|STARTED|Phase 1||43
8252902|NCT01848353|20350898|P1|STARTED|Phase 1||38
8252903|NCT01848288|20350954|P1|NOT COMPLETED|Overall Study||3
8252904|NCT01848288|20350954|P1|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
8252905|NCT01848288|20350954|P1|STARTED|Overall Study||100
8252906|NCT01848210|20350965|P2|NOT COMPLETED|Overall Study||78
8252907|NCT01848210|20350966|P1|NOT COMPLETED|Overall Study||88
8252908|NCT01848210|20350965|P2|COMPLETED|Overall Study||340
8252909|NCT01848210|20350966|P1|COMPLETED|Overall Study||323
8252910|NCT01848210|20350965|P2|Per Protocol Population|Overall Study||245
8252911|NCT01848210|20350966|P1|Per Protocol Population|Overall Study||222
8252912|NCT01848210|20350965|P2|Intent-to-Treat (ITT) Population|Overall Study||388
8252913|NCT01848210|20350966|P1|Intent-to-Treat (ITT) Population|Overall Study||383
8252914|NCT01848210|20350965|P2|Safety Population-Received Study Drug|Overall Study||398
8252915|NCT01848210|20350966|P1|Safety Population-Received Study Drug|Overall Study||394
8252916|NCT01848210|20350965|P2|STARTED|Overall Study||418
8252917|NCT01848210|20350966|P1|STARTED|Overall Study||411
8252918|NCT01848184|20350978|P1|NOT COMPLETED|Overall Study||26
8252919|NCT01848184|20350978|P1|COMPLETED|Overall Study||100
8252920|NCT01848184|20350978|P1|STARTED|Overall Study||126
8252921|NCT01848158|20350990|P2|NOT COMPLETED|Overall Study||0
8252922|NCT01848158|20350991|P1|NOT COMPLETED|Overall Study||0
8252923|NCT01848158|20350990|P2|COMPLETED|Overall Study||7
8252924|NCT01848158|20350991|P1|COMPLETED|Overall Study||10
8252925|NCT01848158|20350990|P2|STARTED|Overall Study||7
8252926|NCT01848158|20350991|P1|STARTED|Overall Study||10
8252927|NCT01848145|20351015|P1|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
8252928|NCT01848145|20351015|P1|COMPLETED|Subsequent Infusions: Weeks 3-8||20
8252929|NCT01848145|20351015|P1|STARTED|Subsequent Infusions: Weeks 3-8||30
8252930|NCT01848145|20351015|P1|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
8252931|NCT01848145|20351015|P1|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
8252932|NCT01848145|20351015|P1|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
8252933|NCT01848145|20351015|P1|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
8252934|NCT01848145|20351015|P1|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
8252935|NCT01848145|20351015|P1|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
8252936|NCT01848145|20351015|P1|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
8252937|NCT01848145|20351015|P1|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
8252938|NCT01848145|20351015|P1|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
8252939|NCT01848145|20351015|P1|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
8252940|NCT01848145|20351015|P1|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
8252941|NCT01848145|20351015|P1|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
8252942|NCT01848067|20351024|P1|NOT COMPLETED|Overall Study||0
8252943|NCT01848067|20351024|P1|COMPLETED|Overall Study||9
8252944|NCT01848067|20351024|P1|STARTED|Overall Study||9
8252945|NCT01848054|20351032|P2|NOT COMPLETED|Stabilization/Maintenance||40
8252946|NCT01848054|20351033|P1|NOT COMPLETED|Stabilization/Maintenance||40
8252947|NCT01848054|20351032|P2|COMPLETED|Stabilization/Maintenance||107
8252948|NCT01848054|20351033|P1|COMPLETED|Stabilization/Maintenance||92
8252949|NCT01848054|20351032|P2|STARTED|Stabilization/Maintenance||147
8252950|NCT01848054|20351033|P1|STARTED|Stabilization/Maintenance||132
8252951|NCT01848054|20351032|P2|NOT COMPLETED|Induction Phase||8
8252952|NCT01848054|20351033|P1|NOT COMPLETED|Induction Phase||23
8252953|NCT01848054|20351032|P2|COMPLETED|Induction Phase||147
8252954|NCT01848054|20351033|P1|COMPLETED|Induction Phase||132
8252955|NCT01848054|20351032|P2|STARTED|Induction Phase||155
8252956|NCT01848054|20351033|P1|STARTED|Induction Phase||155
8252957|NCT01847885|20351055|P3|NOT COMPLETED|Randomization||2
8252958|NCT01847885|20351056|P2|NOT COMPLETED|Randomization||4
8252959|NCT01847885|20351057|P1|NOT COMPLETED|Randomization||0
8252960|NCT01847885|20351055|P3|COMPLETED|Randomization||13
8252961|NCT01847885|20351056|P2|COMPLETED|Randomization||27
8252962|NCT01847885|20351057|P1|COMPLETED|Randomization||0
8252963|NCT01847885|20351055|P3|Per Protocol Set|Randomization||13
8252964|NCT01847885|20351056|P2|Per Protocol Set|Randomization||27
8252965|NCT01847885|20351057|P1|Per Protocol Set|Randomization||0
8252966|NCT01847885|20351055|P3|Safety Set|Randomization||13
8252967|NCT01847885|20351056|P2|Safety Set|Randomization||28
8252968|NCT01847885|20351057|P1|Safety Set|Randomization||0
8252969|NCT01847885|20351055|P3|Full Analysis Set|Randomization||15
8252970|NCT01847885|20351056|P2|Full Analysis Set|Randomization||28
8252971|NCT01847885|20351057|P1|Full Analysis Set|Randomization||0
8252972|NCT01847885|20351055|P3|STARTED|Randomization||15
8252973|NCT01847885|20351056|P2|STARTED|Randomization||31
8252974|NCT01847885|20351057|P1|STARTED|Randomization||0
8252975|NCT01847885|20351055|P3|NOT COMPLETED|Initial Enrollment (Consented)||0
8252976|NCT01847885|20351056|P2|NOT COMPLETED|Initial Enrollment (Consented)||0
8252977|NCT01847885|20351057|P1|NOT COMPLETED|Initial Enrollment (Consented)||48
8252978|NCT01847885|20351055|P3|COMPLETED|Initial Enrollment (Consented)||0
8252979|NCT01847885|20351056|P2|COMPLETED|Initial Enrollment (Consented)||0
8252980|NCT01847885|20351057|P1|COMPLETED|Initial Enrollment (Consented)||40
8252981|NCT01847885|20351055|P3|Per Protocol Set|Initial Enrollment (Consented)||0
8252982|NCT01847885|20351056|P2|Per Protocol Set|Initial Enrollment (Consented)||0
8252983|NCT01847885|20351057|P1|Per Protocol Set|Initial Enrollment (Consented)||40
8252984|NCT01847885|20351055|P3|Safety Set|Initial Enrollment (Consented)||0
8252985|NCT01847885|20351056|P2|Safety Set|Initial Enrollment (Consented)||0
8252986|NCT01847885|20351057|P1|Safety Set|Initial Enrollment (Consented)||41
8252987|NCT01847885|20351055|P3|Full Analysis Set|Initial Enrollment (Consented)||0
8252988|NCT01847885|20351056|P2|Full Analysis Set|Initial Enrollment (Consented)||0
8252989|NCT01847885|20351057|P1|Full Analysis Set|Initial Enrollment (Consented)||43
8252990|NCT01847885|20351055|P3|Randomized|Initial Enrollment (Consented)||0
8252991|NCT01847885|20351056|P2|Randomized|Initial Enrollment (Consented)||0
8252992|NCT01847885|20351057|P1|Randomized|Initial Enrollment (Consented)||46
8252993|NCT01847885|20351055|P3|STARTED|Initial Enrollment (Consented)||0
8252994|NCT01847885|20351056|P2|STARTED|Initial Enrollment (Consented)||0
8252995|NCT01847885|20351057|P1|STARTED|Initial Enrollment (Consented)||88
8252996|NCT01847638|20351091|P2|NOT COMPLETED|Overall Study||0
8252997|NCT01847638|20351092|P1|NOT COMPLETED|Overall Study||0
8252998|NCT01847638|20351091|P2|COMPLETED|Overall Study||25
8252999|NCT01847638|20351092|P1|COMPLETED|Overall Study||25
8253000|NCT01847638|20351091|P2|STARTED|Overall Study||25
8253001|NCT01847638|20351092|P1|STARTED|Overall Study||25
8253002|NCT01847560|20351112|P10|NOT COMPLETED|Overall Study||0
8253003|NCT01847560|20351113|P9|NOT COMPLETED|Overall Study||0
8253004|NCT01847560|20351114|P8|NOT COMPLETED|Overall Study||0
8253005|NCT01847560|20351115|P7|NOT COMPLETED|Overall Study||0
8253006|NCT01847560|20351116|P6|NOT COMPLETED|Overall Study||0
8253007|NCT01847560|20351117|P5|NOT COMPLETED|Overall Study||0
8253008|NCT01847560|20351118|P4|NOT COMPLETED|Overall Study||0
8253009|NCT01847560|20351119|P3|NOT COMPLETED|Overall Study||0
8253010|NCT01847560|20351120|P2|NOT COMPLETED|Overall Study||0
8253011|NCT01847560|20351121|P1|NOT COMPLETED|Overall Study||0
8253012|NCT01847560|20351112|P10|COMPLETED|Overall Study||39438
8253013|NCT01847560|20351113|P9|COMPLETED|Overall Study||77547
8253014|NCT01847560|20351114|P8|COMPLETED|Overall Study||19829
8253015|NCT01847560|20351115|P7|COMPLETED|Overall Study||40971
8253016|NCT01847560|20351116|P6|COMPLETED|Overall Study||28343
8253017|NCT01847560|20351117|P5|COMPLETED|Overall Study||27731
8253018|NCT01847560|20351118|P4|COMPLETED|Overall Study||56655
8253019|NCT01847560|20351119|P3|COMPLETED|Overall Study||9731
8253020|NCT01847560|20351120|P2|COMPLETED|Overall Study||19955
8253021|NCT01847560|20351121|P1|COMPLETED|Overall Study||13464
8253022|NCT01847560|20351112|P10|STARTED|Overall Study||39438
8253023|NCT01847560|20351113|P9|STARTED|Overall Study||77547
8253024|NCT01847560|20351114|P8|STARTED|Overall Study||19829
8253025|NCT01847560|20351115|P7|STARTED|Overall Study||40971
8253026|NCT01847560|20351116|P6|STARTED|Overall Study||28343
8253027|NCT01847560|20351117|P5|STARTED|Overall Study||27731
8253028|NCT01847560|20351118|P4|STARTED|Overall Study||56655
8253029|NCT01847560|20351119|P3|STARTED|Overall Study||9731
8253030|NCT01847560|20351120|P2|STARTED|Overall Study||19955
8253031|NCT01847560|20351121|P1|STARTED|Overall Study||13464
8253032|NCT01847547|20351165|P2|NOT COMPLETED|Overall Study||0
8253033|NCT01847547|20351166|P1|NOT COMPLETED|Overall Study||0
8253034|NCT01847547|20351165|P2|COMPLETED|Overall Study||2991
8253035|NCT01847547|20351166|P1|COMPLETED|Overall Study||2991
8253036|NCT01847547|20351165|P2|STARTED|Overall Study||2991
8253037|NCT01847547|20351166|P1|STARTED|Overall Study||2991
8253038|NCT01847469|20351210|P2|NOT COMPLETED|Overall Study||3
8253039|NCT01847469|20351211|P1|NOT COMPLETED|Overall Study||9
8253040|NCT01847469|20351210|P2|COMPLETED|Overall Study||3
8253041|NCT01847469|20351211|P1|COMPLETED|Overall Study||9
8253042|NCT01847469|20351210|P2|STARTED|Overall Study||6
8253043|NCT01847469|20351211|P1|STARTED|Overall Study||18
8253044|NCT01847443|20351221|P4|NOT COMPLETED|Study Period 4||0
8253045|NCT01847443|20351222|P3|NOT COMPLETED|Study Period 4||0
8253046|NCT01847443|20351223|P2|NOT COMPLETED|Study Period 4||0
8253047|NCT01847443|20351224|P1|NOT COMPLETED|Study Period 4||0
8253048|NCT01847443|20351221|P4|COMPLETED|Study Period 4||21
8253049|NCT01847443|20351222|P3|COMPLETED|Study Period 4||21
8253050|NCT01847443|20351223|P2|COMPLETED|Study Period 4||19
8253051|NCT01847443|20351224|P1|COMPLETED|Study Period 4||16
8253052|NCT01847443|20351221|P4|STARTED|Study Period 4||21
8253053|NCT01847443|20351222|P3|STARTED|Study Period 4||21
8253054|NCT01847443|20351223|P2|STARTED|Study Period 4||19
8253055|NCT01847443|20351224|P1|STARTED|Study Period 4||16
8253056|NCT01847443|20351221|P4|NOT COMPLETED|Washout Period Before Study Period 4||0
8253057|NCT01847443|20351222|P3|NOT COMPLETED|Washout Period Before Study Period 4||0
8253058|NCT01847443|20351223|P2|NOT COMPLETED|Washout Period Before Study Period 4||0
8253059|NCT01847443|20351224|P1|NOT COMPLETED|Washout Period Before Study Period 4||2
8253060|NCT01847443|20351221|P4|COMPLETED|Washout Period Before Study Period 4||21
8253061|NCT01847443|20351222|P3|COMPLETED|Washout Period Before Study Period 4||21
8253062|NCT01847443|20351223|P2|COMPLETED|Washout Period Before Study Period 4||19
8253063|NCT01847443|20351224|P1|COMPLETED|Washout Period Before Study Period 4||16
8253064|NCT01847443|20351221|P4|STARTED|Washout Period Before Study Period 4||21
8253065|NCT01847443|20351222|P3|STARTED|Washout Period Before Study Period 4||21
8253066|NCT01847443|20351223|P2|STARTED|Washout Period Before Study Period 4||19
8253067|NCT01847443|20351224|P1|STARTED|Washout Period Before Study Period 4||18
8253068|NCT01847443|20351221|P4|NOT COMPLETED|Study Period 3||0
8253069|NCT01847443|20351222|P3|NOT COMPLETED|Study Period 3||0
8253070|NCT01847443|20351223|P2|NOT COMPLETED|Study Period 3||0
8253071|NCT01847443|20351224|P1|NOT COMPLETED|Study Period 3||0
8253072|NCT01847443|20351221|P4|COMPLETED|Study Period 3||21
8253073|NCT01847443|20351222|P3|COMPLETED|Study Period 3||21
8253074|NCT01847443|20351223|P2|COMPLETED|Study Period 3||19
8253075|NCT01847443|20351224|P1|COMPLETED|Study Period 3||18
8253076|NCT01847443|20351221|P4|STARTED|Study Period 3||21
8253077|NCT01847443|20351222|P3|STARTED|Study Period 3||21
8253078|NCT01847443|20351223|P2|STARTED|Study Period 3||19
8253079|NCT01847443|20351224|P1|STARTED|Study Period 3||18
8253080|NCT01847443|20351221|P4|NOT COMPLETED|Washout Period Before Study Period 3||0
8253081|NCT01847443|20351222|P3|NOT COMPLETED|Washout Period Before Study Period 3||0
8253082|NCT01847443|20351223|P2|NOT COMPLETED|Washout Period Before Study Period 3||0
8253083|NCT01847443|20351224|P1|NOT COMPLETED|Washout Period Before Study Period 3||1
8253084|NCT01847443|20351221|P4|COMPLETED|Washout Period Before Study Period 3||21
8253085|NCT01847443|20351222|P3|COMPLETED|Washout Period Before Study Period 3||21
8253086|NCT01847443|20351223|P2|COMPLETED|Washout Period Before Study Period 3||19
8253087|NCT01847443|20351224|P1|COMPLETED|Washout Period Before Study Period 3||18
8253088|NCT01847443|20351221|P4|STARTED|Washout Period Before Study Period 3||21
8253089|NCT01847443|20351222|P3|STARTED|Washout Period Before Study Period 3||21
8253090|NCT01847443|20351223|P2|STARTED|Washout Period Before Study Period 3||19
8253091|NCT01847443|20351224|P1|STARTED|Washout Period Before Study Period 3||19
8253092|NCT01847443|20351221|P4|NOT COMPLETED|Study Period 2||0
8253093|NCT01847443|20351222|P3|NOT COMPLETED|Study Period 2||0
8253094|NCT01847443|20351223|P2|NOT COMPLETED|Study Period 2||0
8253095|NCT01847443|20351224|P1|NOT COMPLETED|Study Period 2||0
8253096|NCT01847443|20351221|P4|COMPLETED|Study Period 2||21
8253097|NCT01847443|20351222|P3|COMPLETED|Study Period 2||21
8253098|NCT01847443|20351223|P2|COMPLETED|Study Period 2||19
8253099|NCT01847443|20351224|P1|COMPLETED|Study Period 2||19
8253100|NCT01847443|20351221|P4|STARTED|Study Period 2||21
8253101|NCT01847443|20351222|P3|STARTED|Study Period 2||21
8253102|NCT01847443|20351223|P2|STARTED|Study Period 2||19
8253103|NCT01847443|20351224|P1|STARTED|Study Period 2||19
8253104|NCT01847443|20351221|P4|NOT COMPLETED|Washout Period Before Study Period 2||0
8253105|NCT01847443|20351222|P3|NOT COMPLETED|Washout Period Before Study Period 2||0
8253106|NCT01847443|20351223|P2|NOT COMPLETED|Washout Period Before Study Period 2||1
8253107|NCT01847443|20351224|P1|NOT COMPLETED|Washout Period Before Study Period 2||2
8253108|NCT01847443|20351221|P4|COMPLETED|Washout Period Before Study Period 2||21
8253109|NCT01847443|20351222|P3|COMPLETED|Washout Period Before Study Period 2||21
8253110|NCT01847443|20351223|P2|COMPLETED|Washout Period Before Study Period 2||19
8253111|NCT01847443|20351224|P1|COMPLETED|Washout Period Before Study Period 2||19
8253112|NCT01847443|20351221|P4|STARTED|Washout Period Before Study Period 2||21
8253113|NCT01847443|20351222|P3|STARTED|Washout Period Before Study Period 2||21
8253114|NCT01847443|20351223|P2|STARTED|Washout Period Before Study Period 2||20
8253115|NCT01847443|20351224|P1|STARTED|Washout Period Before Study Period 2||21
8253116|NCT01847443|20351221|P4|NOT COMPLETED|Study Period 1||0
8253117|NCT01847443|20351222|P3|NOT COMPLETED|Study Period 1||0
8253118|NCT01847443|20351223|P2|NOT COMPLETED|Study Period 1||1
8253119|NCT01847443|20351224|P1|NOT COMPLETED|Study Period 1||0
8253120|NCT01847443|20351221|P4|COMPLETED|Study Period 1||21
8253121|NCT01847443|20351222|P3|COMPLETED|Study Period 1||21
8253122|NCT01847443|20351223|P2|COMPLETED|Study Period 1||20
8253123|NCT01847443|20351224|P1|COMPLETED|Study Period 1||21
8253124|NCT01847443|20351221|P4|STARTED|Study Period 1||21
8253125|NCT01847443|20351222|P3|STARTED|Study Period 1||21
8253126|NCT01847443|20351223|P2|STARTED|Study Period 1||21
8253127|NCT01847443|20351224|P1|STARTED|Study Period 1||21
8253128|NCT01847430|20351254|P1|NOT COMPLETED|Overall Study||0
8253129|NCT01847430|20351254|P1|COMPLETED|Overall Study||302
8253130|NCT01847430|20351254|P1|STARTED|Overall Study||302
8253131|NCT01847313|20351267|P2|NOT COMPLETED|Overall Study||2
8253132|NCT01847313|20351268|P1|NOT COMPLETED|Overall Study||0
8253133|NCT01847313|20351267|P2|COMPLETED|Overall Study||8
8253134|NCT01847313|20351268|P1|COMPLETED|Overall Study||10
8253135|NCT01847313|20351267|P2|STARTED|Overall Study||10
8253136|NCT01847313|20351268|P1|STARTED|Overall Study||10
8253149|NCT01847209|20351341|P1|NOT COMPLETED|Overall Study||2
8253150|NCT01847209|20351341|P1|COMPLETED|Overall Study||23
8253151|NCT01847209|20351341|P1|STARTED|Overall Study||25
8253152|NCT01847196|20351346|P1|NOT COMPLETED|Overall Study||0
8253153|NCT01847196|20351346|P1|COMPLETED|Overall Study||5
8253154|NCT01847196|20351346|P1|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
8253155|NCT01847131|20351353|P2|NOT COMPLETED|Overall Study||0
8253156|NCT01847131|20351354|P1|NOT COMPLETED|Overall Study||0
8253157|NCT01847131|20351353|P2|COMPLETED|Overall Study||25
8253158|NCT01847131|20351354|P1|COMPLETED|Overall Study||25
8253159|NCT01847131|20351353|P2|STARTED|Overall Study||25
8253160|NCT01847131|20351354|P1|STARTED|Overall Study||25
8253161|NCT01847092|20351364|P2|NOT COMPLETED|Overall Study||11
8253162|NCT01847092|20351365|P1|NOT COMPLETED|Overall Study||26
8253163|NCT01847092|20351364|P2|COMPLETED|Overall Study||66
8253164|NCT01847092|20351365|P1|COMPLETED|Overall Study||51
8253165|NCT01847092|20351364|P2|STARTED|Overall Study||77
8253166|NCT01847092|20351365|P1|STARTED|Overall Study||77
8253167|NCT01847027|20351375|P2|NOT COMPLETED|Overall Study||2
8253168|NCT01847027|20351376|P1|NOT COMPLETED|Overall Study||1
8253169|NCT01847027|20351375|P2|COMPLETED|Overall Study||10
8253170|NCT01847027|20351376|P1|COMPLETED|Overall Study||10
8253171|NCT01847027|20351375|P2|STARTED|Overall Study||12
8253172|NCT01847027|20351376|P1|STARTED|Overall Study||11
8253173|NCT01847014|20351386|P1|NOT COMPLETED|Completion of Extension Study||4
8253174|NCT01847014|20351386|P1|COMPLETED|Completion of Extension Study||0
8253175|NCT01847014|20351386|P1|STARTED|Completion of Extension Study||4
8253176|NCT01847014|20351386|P1|NOT COMPLETED|Baseline Extension Visit||0
8253177|NCT01847014|20351386|P1|COMPLETED|Baseline Extension Visit||4
8253178|NCT01847014|20351386|P1|STARTED|Baseline Extension Visit||4
8253179|NCT01847001|20351390|P1|NOT COMPLETED|Overall Study||0
8253180|NCT01847001|20351390|P1|COMPLETED|Overall Study||10
8253181|NCT01847001|20351390|P1|STARTED|Overall Study||10
8253182|NCT01846871|20351394|P1|NOT COMPLETED|Overall Study||0
8253183|NCT01846871|20351394|P1|COMPLETED|Overall Study||10
8253184|NCT01846871|20351394|P1|STARTED|Overall Study||10
8253185|NCT01846741|20351419|P1|NOT COMPLETED|Implantation to 18-Month/End of Study||0
8253186|NCT01846741|20351419|P1|COMPLETED|Implantation to 18-Month/End of Study||20
8253187|NCT01846741|20351419|P1|STARTED|Implantation to 18-Month/End of Study||20
8253188|NCT01846741|20351419|P1|NOT COMPLETED|Baseline Visit||2
8253189|NCT01846741|20351419|P1|COMPLETED|Baseline Visit||20
8253190|NCT01846741|20351419|P1|STARTED|Baseline Visit||22
8253191|NCT01846728|20351475|P1|NOT COMPLETED|Overall Study||0
8253192|NCT01846728|20351475|P1|COMPLETED|Overall Study||6
8253193|NCT01846728|20351475|P1|STARTED|Overall Study||6
8253194|NCT01846702|20351490|P7|NOT COMPLETED|Overall Study||0
8253195|NCT01846702|20351491|P6|NOT COMPLETED|Overall Study||0
8253196|NCT01846702|20351492|P5|NOT COMPLETED|Overall Study||0
8253197|NCT01846702|20351493|P4|NOT COMPLETED|Overall Study||0
8253198|NCT01846702|20351494|P3|NOT COMPLETED|Overall Study||1
8253199|NCT01846702|20351495|P2|NOT COMPLETED|Overall Study||0
8253200|NCT01846702|20351496|P1|NOT COMPLETED|Overall Study||0
8253201|NCT01846702|20351490|P7|COMPLETED|Overall Study||6
8253202|NCT01846702|20351491|P6|COMPLETED|Overall Study||6
8253203|NCT01846702|20351492|P5|COMPLETED|Overall Study||6
8253204|NCT01846702|20351493|P4|COMPLETED|Overall Study||6
8253205|NCT01846702|20351494|P3|COMPLETED|Overall Study||6
8253206|NCT01846702|20351495|P2|COMPLETED|Overall Study||6
8253207|NCT01846702|20351496|P1|COMPLETED|Overall Study||6
8253208|NCT01846702|20351490|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
8253209|NCT01846702|20351491|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
8253210|NCT01846702|20351492|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8253211|NCT01846702|20351493|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8253212|NCT01846702|20351494|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8253213|NCT01846702|20351495|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8253214|NCT01846702|20351496|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8253215|NCT01846702|20351490|P7|STARTED|Overall Study||6
8253216|NCT01846702|20351491|P6|STARTED|Overall Study||6
8253217|NCT01846702|20351492|P5|STARTED|Overall Study||6
8253218|NCT01846702|20351493|P4|STARTED|Overall Study||6
8253219|NCT01846702|20351494|P3|STARTED|Overall Study||7
8253220|NCT01846702|20351495|P2|STARTED|Overall Study||6
8253221|NCT01846702|20351496|P1|STARTED|Overall Study||6
8253222|NCT01846624|20351575|P1|NOT COMPLETED|Overall Study||1
8253223|NCT01846624|20351575|P1|COMPLETED|Overall Study||12
8253224|NCT01846624|20351575|P1|STARTED|Overall Study||13
8253225|NCT01846611|20351585|P2|NOT COMPLETED|Overall Study||43
8253226|NCT01846611|20351586|P1|NOT COMPLETED|Overall Study||38
8253227|NCT01846611|20351585|P2|COMPLETED|Overall Study||244
8253228|NCT01846611|20351586|P1|COMPLETED|Overall Study||251
8253229|NCT01846611|20351585|P2|Treated|Overall Study||282
8253230|NCT01846611|20351586|P1|Treated|Overall Study||286
8253231|NCT01846611|20351585|P2|STARTED|Overall Study||287
8253232|NCT01846611|20351586|P1|STARTED|Overall Study||289
8253233|NCT01846507|20351596|P1|NOT COMPLETED|Overall Study||7
8253234|NCT01846507|20351596|P1|COMPLETED|Overall Study||25
8253235|NCT01846507|20351596|P1|STARTED|Overall Study||32
8253236|NCT01846494|20351615|P2|NOT COMPLETED|Overall Study||38
8253237|NCT01846494|20351616|P1|NOT COMPLETED|Overall Study||30
8253238|NCT01846494|20351615|P2|COMPLETED|Overall Study||25
8253239|NCT01846494|20351616|P1|COMPLETED|Overall Study||20
8253240|NCT01846494|20351615|P2|STARTED|Overall Study||63
8253241|NCT01846494|20351616|P1|STARTED|Overall Study||50
8253242|NCT01846455|20351629|P5|NOT COMPLETED|Overall Study||0
8253243|NCT01846455|20351630|P4|NOT COMPLETED|Overall Study||0
8253244|NCT01846455|20351631|P3|NOT COMPLETED|Overall Study||0
8253245|NCT01846455|20351632|P2|NOT COMPLETED|Overall Study||0
8253246|NCT01846455|20351633|P1|NOT COMPLETED|Overall Study||0
8253247|NCT01846455|20351629|P5|COMPLETED|Overall Study||8
8253248|NCT01846455|20351630|P4|COMPLETED|Overall Study||10
8253249|NCT01846455|20351631|P3|COMPLETED|Overall Study||8
8253250|NCT01846455|20351632|P2|COMPLETED|Overall Study||8
8253251|NCT01846455|20351633|P1|COMPLETED|Overall Study||9
8253252|NCT01846455|20351629|P5|PK Population|Overall Study||8
8253253|NCT01846455|20351630|P4|PK Population|Overall Study||6
8253254|NCT01846455|20351631|P3|PK Population|Overall Study||6
8253255|NCT01846455|20351632|P2|PK Population|Overall Study||7
8253256|NCT01846455|20351633|P1|PK Population|Overall Study||6
8253257|NCT01846455|20351629|P5|STARTED|Overall Study||8
8253258|NCT01846455|20351630|P4|STARTED|Overall Study||10
8253259|NCT01846455|20351631|P3|STARTED|Overall Study||8
8253260|NCT01846455|20351632|P2|STARTED|Overall Study||8
8253261|NCT01846455|20351633|P1|STARTED|Overall Study||9
8253262|NCT01846442|20351694|P4|NOT COMPLETED|Overall Study||3
8253263|NCT01846442|20351695|P3|NOT COMPLETED|Overall Study||4
8253264|NCT01846442|20351696|P2|NOT COMPLETED|Overall Study||6
8253265|NCT01846442|20351697|P1|NOT COMPLETED|Overall Study||6
8253266|NCT01846442|20351694|P4|COMPLETED|Overall Study||51
8253267|NCT01846442|20351695|P3|COMPLETED|Overall Study||52
8253268|NCT01846442|20351696|P2|COMPLETED|Overall Study||48
8253269|NCT01846442|20351697|P1|COMPLETED|Overall Study||48
8253270|NCT01846442|20351694|P4|ITT Population|Overall Study||54
8253271|NCT01846442|20351695|P3|ITT Population|Overall Study||56
8253272|NCT01846442|20351696|P2|ITT Population|Overall Study||53
8253273|NCT01846442|20351697|P1|ITT Population|Overall Study||53
8253274|NCT01846442|20351694|P4|Safety Population|Overall Study||54
8253275|NCT01846442|20351695|P3|Safety Population|Overall Study||56
8253276|NCT01846442|20351696|P2|Safety Population|Overall Study||53
8253277|NCT01846442|20351697|P1|Safety Population|Overall Study||54
8253278|NCT01846442|20351694|P4|STARTED|Overall Study||54
8253279|NCT01846442|20351695|P3|STARTED|Overall Study||56
8253280|NCT01846442|20351696|P2|STARTED|Overall Study||54
8253281|NCT01846442|20351697|P1|STARTED|Overall Study||54
8253282|NCT01846416|20351738|P3|NOT COMPLETED|Survival Follow-up||12
8253283|NCT01846416|20351739|P2|NOT COMPLETED|Survival Follow-up||80
8253284|NCT01846416|20351740|P1|NOT COMPLETED|Survival Follow-up||28
8253285|NCT01846416|20351738|P3|COMPLETED|Survival Follow-up||0
8253286|NCT01846416|20351739|P2|COMPLETED|Survival Follow-up||0
8253287|NCT01846416|20351740|P1|COMPLETED|Survival Follow-up||0
8253288|NCT01846416|20351738|P3|STARTED|Survival Follow-up||12
8253289|NCT01846416|20351739|P2|STARTED|Survival Follow-up||80
8253290|NCT01846416|20351740|P1|STARTED|Survival Follow-up||28
8253291|NCT01846416|20351738|P3|NOT COMPLETED|Treatment Phase||13
8253292|NCT01846416|20351739|P2|NOT COMPLETED|Treatment Phase||93
8253293|NCT01846416|20351740|P1|NOT COMPLETED|Treatment Phase||31
8253294|NCT01846416|20351738|P3|COMPLETED|Treatment Phase||0
8253295|NCT01846416|20351739|P2|COMPLETED|Treatment Phase||0
8253296|NCT01846416|20351740|P1|COMPLETED|Treatment Phase||0
8253297|NCT01846416|20351738|P3|STARTED|Treatment Phase||13
8253298|NCT01846416|20351739|P2|STARTED|Treatment Phase||93
8253299|NCT01846416|20351740|P1|STARTED|Treatment Phase||31
8253300|NCT01846299|20351785|P2|NOT COMPLETED|Overall Study||10
8253301|NCT01846299|20351786|P1|NOT COMPLETED|Overall Study||12
8253302|NCT01846299|20351785|P2|COMPLETED|Overall Study||50
8253303|NCT01846299|20351786|P1|COMPLETED|Overall Study||106
8253304|NCT01846299|20351785|P2|Safety Set|Overall Study||58
8253305|NCT01846299|20351786|P1|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
8253306|NCT01846299|20351785|P2|Full Analysis Set|Overall Study||60
8253307|NCT01846299|20351786|P1|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
8253308|NCT01846299|20351785|P2|STARTED|Overall Study||60
8253309|NCT01846299|20351786|P1|STARTED|Overall Study||118
8253310|NCT01846273|20351825|P3|NOT COMPLETED|Overall Study||0
8253311|NCT01846273|20351826|P2|NOT COMPLETED|Overall Study||26
8253312|NCT01846273|20351827|P1|NOT COMPLETED|Overall Study||22
8253313|NCT01846273|20351825|P3|COMPLETED|Overall Study||41
8253314|NCT01846273|20351826|P2|COMPLETED|Overall Study||87
8253315|NCT01846273|20351827|P1|COMPLETED|Overall Study||146
8253316|NCT01846273|20351825|P3|Safety Analysis Set|Overall Study||14
8253317|NCT01846273|20351826|P2|Safety Analysis Set|Overall Study||135
8253318|NCT01846273|20351827|P1|Safety Analysis Set|Overall Study||172
8253319|NCT01846273|20351825|P3|STARTED|Overall Study||41
8253320|NCT01846273|20351826|P2|STARTED|Overall Study||113
8253321|NCT01846273|20351827|P1|STARTED|Overall Study||168
8253322|NCT01846221|20351883|P2|NOT COMPLETED|Overall Study||0
8253323|NCT01846221|20351884|P1|NOT COMPLETED|Overall Study||3
8253324|NCT01846221|20351883|P2|COMPLETED|Overall Study||51
8253325|NCT01846221|20351884|P1|COMPLETED|Overall Study||47
8253326|NCT01846221|20351883|P2|STARTED|Overall Study||51
8253327|NCT01846221|20351884|P1|STARTED|Overall Study||50
8253328|NCT01846208|20351901|P3|NOT COMPLETED|Overall Study||8
8253329|NCT01846208|20351902|P2|NOT COMPLETED|Overall Study||4
8253330|NCT01846208|20351903|P1|NOT COMPLETED|Overall Study||9
8253331|NCT01846208|20351901|P3|COMPLETED|Overall Study||32
8253332|NCT01846208|20351902|P2|COMPLETED|Overall Study||20
8253333|NCT01846208|20351903|P1|COMPLETED|Overall Study||19
8253334|NCT01846208|20351901|P3|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
8253335|NCT01846208|20351902|P2|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
8253336|NCT01846208|20351903|P1|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
8253337|NCT01846208|20351901|P3|Year 2 Desensitization OFC|Overall Study||33
8253338|NCT01846208|20351902|P2|Year 2 Desensitization OFC|Overall Study||20
8253339|NCT01846208|20351903|P1|Year 2 Desensitization OFC|Overall Study||19
8253340|NCT01846208|20351901|P3|Year 1 Desensitization OFC|Overall Study||34
8253341|NCT01846208|20351902|P2|Year 1 Desensitization OFC|Overall Study||20
8253342|NCT01846208|20351903|P1|Year 1 Desensitization OFC|Overall Study||23
8253343|NCT01846208|20351901|P3|Initiatiated Treatment|Overall Study||39
8253344|NCT01846208|20351902|P2|Initiatiated Treatment|Overall Study||23
8253345|NCT01846208|20351903|P1|Initiatiated Treatment|Overall Study||27
8253346|NCT01846208|20351901|P3|STARTED|Overall Study||40
8253347|NCT01846208|20351902|P2|STARTED|Overall Study||24
8253348|NCT01846208|20351903|P1|STARTED|Overall Study||28
8253349|NCT01846104|20351923|P1|NOT COMPLETED|Overall Study||1
8253350|NCT01846104|20351923|P1|COMPLETED|Overall Study||3
8253351|NCT01846104|20351923|P1|STARTED|Overall Study||4
8253352|NCT01846039|20351929|P1|NOT COMPLETED|Overall Study||2
8253353|NCT01846039|20351929|P1|COMPLETED|Overall Study||27
8253354|NCT01846039|20351929|P1|STARTED|Overall Study||29
8253355|NCT01845974|20351941|P2|NOT COMPLETED|Overall Study||0
8253356|NCT01845974|20351942|P1|NOT COMPLETED|Overall Study||1
8253357|NCT01845974|20351941|P2|COMPLETED|Overall Study||9
8253358|NCT01845974|20351942|P1|COMPLETED|Overall Study||3
8253359|NCT01845974|20351941|P2|STARTED|Overall Study||9
8253360|NCT01845974|20351942|P1|STARTED|Overall Study||4
8253361|NCT01845831|20351950|P5|NOT COMPLETED|Outpatient Phase||0
8253362|NCT01845831|20351951|P4|NOT COMPLETED|Outpatient Phase||0
8253363|NCT01845831|20351952|P3|NOT COMPLETED|Outpatient Phase||0
8253364|NCT01845831|20351953|P2|NOT COMPLETED|Outpatient Phase||0
8253365|NCT01845831|20351954|P1|NOT COMPLETED|Outpatient Phase||0
8253366|NCT01845831|20351950|P5|COMPLETED|Outpatient Phase||87
8253367|NCT01845831|20351951|P4|COMPLETED|Outpatient Phase||98
8253368|NCT01845831|20351952|P3|COMPLETED|Outpatient Phase||68
8253369|NCT01845831|20351953|P2|COMPLETED|Outpatient Phase||0
8253370|NCT01845831|20351954|P1|COMPLETED|Outpatient Phase||0
8253371|NCT01845831|20351950|P5|STARTED|Outpatient Phase||87
8253372|NCT01845831|20351951|P4|STARTED|Outpatient Phase||98
8253373|NCT01845831|20351952|P3|STARTED|Outpatient Phase||68
8253374|NCT01845831|20351953|P2|STARTED|Outpatient Phase||0
8253375|NCT01845831|20351954|P1|STARTED|Outpatient Phase||0
8253376|NCT01845831|20351950|P5|NOT COMPLETED|Inpatient Phase||0
8253377|NCT01845831|20351951|P4|NOT COMPLETED|Inpatient Phase||0
8253378|NCT01845831|20351952|P3|NOT COMPLETED|Inpatient Phase||0
8253379|NCT01845831|20351953|P2|NOT COMPLETED|Inpatient Phase||1
8253380|NCT01845831|20351954|P1|NOT COMPLETED|Inpatient Phase||1
8253381|NCT01845831|20351950|P5|COMPLETED|Inpatient Phase||0
8253382|NCT01845831|20351951|P4|COMPLETED|Inpatient Phase||0
8253383|NCT01845831|20351952|P3|COMPLETED|Inpatient Phase||0
8253384|NCT01845831|20351953|P2|COMPLETED|Inpatient Phase||138
8253385|NCT01845831|20351954|P1|COMPLETED|Inpatient Phase||139
8253386|NCT01845831|20351950|P5|STARTED|Inpatient Phase||0
8253387|NCT01845831|20351951|P4|STARTED|Inpatient Phase||0
8253388|NCT01845831|20351952|P3|STARTED|Inpatient Phase||0
8253389|NCT01845831|20351953|P2|STARTED|Inpatient Phase||139
8253390|NCT01845831|20351954|P1|STARTED|Inpatient Phase||140
8253391|NCT01845818|20351983|P2|NOT COMPLETED|Overall Study||17
8253392|NCT01845818|20351984|P1|NOT COMPLETED|Overall Study||45
8253393|NCT01845818|20351983|P2|COMPLETED|Overall Study||40
8253394|NCT01845818|20351984|P1|COMPLETED|Overall Study||81
8253395|NCT01845818|20351983|P2|STARTED|Overall Study||57
8253396|NCT01845818|20351984|P1|STARTED|Overall Study||126
8253397|NCT01845792|20352025|P2|NOT COMPLETED|Overall Study||0
8253398|NCT01845792|20352026|P1|NOT COMPLETED|Overall Study||0
8253399|NCT01845792|20352025|P2|COMPLETED|Overall Study||2
8253400|NCT01845792|20352026|P1|COMPLETED|Overall Study||5
8253401|NCT01845792|20352025|P2|STARTED|Overall Study||2
8253402|NCT01845792|20352026|P1|STARTED|Overall Study||5
8253403|NCT01845636|20352034|P1|NOT COMPLETED|Overall Study||4
8253404|NCT01845636|20352034|P1|COMPLETED|Overall Study||37
8253405|NCT01845636|20352034|P1|STARTED|Overall Study||41
8253406|NCT01845220|20352042|P2|NOT COMPLETED|Overall Study||0
8253407|NCT01845220|20352043|P1|NOT COMPLETED|Overall Study||0
8253408|NCT01845220|20352042|P2|COMPLETED|Overall Study||30
8253409|NCT01845220|20352043|P1|COMPLETED|Overall Study||30
8253410|NCT01845220|20352042|P2|STARTED|Overall Study||30
8253411|NCT01845220|20352043|P1|STARTED|Overall Study||30
8253412|NCT01845155|20352051|P2|NOT COMPLETED|Overall Study||0
8253413|NCT01845155|20352052|P1|NOT COMPLETED|Overall Study||1
8253414|NCT01845155|20352051|P2|COMPLETED|Overall Study||144
8253415|NCT01845155|20352052|P1|COMPLETED|Overall Study||145
8253416|NCT01845155|20352051|P2|STARTED|Overall Study||144
8253417|NCT01845155|20352052|P1|STARTED|Overall Study||146
8253418|NCT01845103|20352060|P1|NOT COMPLETED|Overall Study||0
8253419|NCT01845103|20352060|P1|COMPLETED|Overall Study||1
8253420|NCT01845103|20352060|P1|STARTED|Overall Study||1
8253421|NCT01845077|20352068|P6|NOT COMPLETED|Treatment Period 2||0
8253422|NCT01845077|20352069|P5|NOT COMPLETED|Treatment Period 2||0
8253423|NCT01845077|20352070|P4|NOT COMPLETED|Treatment Period 2||0
8253424|NCT01845077|20352071|P3|NOT COMPLETED|Treatment Period 2||0
8253425|NCT01845077|20352072|P2|NOT COMPLETED|Treatment Period 2||0
8253426|NCT01845077|20352073|P1|NOT COMPLETED|Treatment Period 2||0
8253427|NCT01845077|20352068|P6|COMPLETED|Treatment Period 2||11
8253428|NCT01845077|20352069|P5|COMPLETED|Treatment Period 2||11
8253429|NCT01845077|20352070|P4|COMPLETED|Treatment Period 2||10
8253430|NCT01845077|20352071|P3|COMPLETED|Treatment Period 2||11
8253431|NCT01845077|20352072|P2|COMPLETED|Treatment Period 2||11
8253432|NCT01845077|20352073|P1|COMPLETED|Treatment Period 2||11
8253433|NCT01845077|20352068|P6|STARTED|Treatment Period 2||11
8253434|NCT01845077|20352069|P5|STARTED|Treatment Period 2||11
8253435|NCT01845077|20352070|P4|STARTED|Treatment Period 2||10
8253436|NCT01845077|20352071|P3|STARTED|Treatment Period 2||11
8253437|NCT01845077|20352072|P2|STARTED|Treatment Period 2||11
8253438|NCT01845077|20352073|P1|STARTED|Treatment Period 2||11
8253439|NCT01845077|20352068|P6|NOT COMPLETED|Washout Period||1
8253440|NCT01845077|20352069|P5|NOT COMPLETED|Washout Period||1
8253441|NCT01845077|20352070|P4|NOT COMPLETED|Washout Period||2
8253442|NCT01845077|20352071|P3|NOT COMPLETED|Washout Period||1
8253443|NCT01845077|20352072|P2|NOT COMPLETED|Washout Period||1
8253444|NCT01845077|20352073|P1|NOT COMPLETED|Washout Period||1
8253445|NCT01845077|20352068|P6|COMPLETED|Washout Period||11
8253446|NCT01845077|20352069|P5|COMPLETED|Washout Period||11
8253447|NCT01845077|20352070|P4|COMPLETED|Washout Period||10
8253448|NCT01845077|20352071|P3|COMPLETED|Washout Period||11
8253449|NCT01845077|20352072|P2|COMPLETED|Washout Period||11
8253450|NCT01845077|20352073|P1|COMPLETED|Washout Period||11
8253451|NCT01845077|20352068|P6|STARTED|Washout Period||12
8253452|NCT01845077|20352069|P5|STARTED|Washout Period||12
8253453|NCT01845077|20352070|P4|STARTED|Washout Period||12
8253454|NCT01845077|20352071|P3|STARTED|Washout Period||12
8253455|NCT01845077|20352072|P2|STARTED|Washout Period||12
8253456|NCT01845077|20352073|P1|STARTED|Washout Period||12
8253457|NCT01845077|20352068|P6|NOT COMPLETED|Treatment Period 1||0
8253458|NCT01845077|20352069|P5|NOT COMPLETED|Treatment Period 1||0
8253459|NCT01845077|20352070|P4|NOT COMPLETED|Treatment Period 1||0
8253460|NCT01845077|20352071|P3|NOT COMPLETED|Treatment Period 1||0
8253461|NCT01845077|20352072|P2|NOT COMPLETED|Treatment Period 1||0
8253462|NCT01845077|20352073|P1|NOT COMPLETED|Treatment Period 1||0
8253463|NCT01845077|20352068|P6|COMPLETED|Treatment Period 1||12
8253464|NCT01845077|20352069|P5|COMPLETED|Treatment Period 1||12
8253465|NCT01845077|20352070|P4|COMPLETED|Treatment Period 1||12
8253466|NCT01845077|20352071|P3|COMPLETED|Treatment Period 1||12
8253467|NCT01845077|20352072|P2|COMPLETED|Treatment Period 1||12
8253468|NCT01845077|20352073|P1|COMPLETED|Treatment Period 1||12
8253469|NCT01845077|20352068|P6|STARTED|Treatment Period 1||12
8253470|NCT01845077|20352069|P5|STARTED|Treatment Period 1||12
8253471|NCT01845077|20352070|P4|STARTED|Treatment Period 1||12
8253472|NCT01845077|20352071|P3|STARTED|Treatment Period 1||12
8253473|NCT01845077|20352072|P2|STARTED|Treatment Period 1||12
8253474|NCT01845077|20352073|P1|STARTED|Treatment Period 1||12
8253475|NCT01845025|20352119|P2|NOT COMPLETED|Overall Study||77
8253476|NCT01845025|20352120|P1|NOT COMPLETED|Overall Study||85
8253477|NCT01845025|20352119|P2|COMPLETED|Overall Study||332
8253478|NCT01845025|20352120|P1|COMPLETED|Overall Study||326
8253479|NCT01845025|20352119|P2|STARTED|Overall Study||409
8253480|NCT01845025|20352120|P1|STARTED|Overall Study||411
8253487|NCT01844895|20352167|P1|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
8253488|NCT01844895|20352167|P1|COMPLETED|Day 29 - Day113 - Autoinjector||111
8253489|NCT01844895|20352167|P1|STARTED|Day 29 - Day113 - Autoinjector||117
8253490|NCT01844895|20352167|P1|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
8253491|NCT01844895|20352167|P1|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
8253492|NCT01844895|20352167|P1|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
8253493|NCT01844856|20352185|P2|NOT COMPLETED|Overall Study||16
8253494|NCT01844856|20352186|P1|NOT COMPLETED|Overall Study||24
8253495|NCT01844856|20352185|P2|COMPLETED|Overall Study||255
8253496|NCT01844856|20352186|P1|COMPLETED|Overall Study||246
8253497|NCT01844856|20352185|P2|Received at Least 1 Dose of Study Drug|Overall Study||268
8253498|NCT01844856|20352186|P1|Received at Least 1 Dose of Study Drug|Overall Study||270
8253499|NCT01844856|20352185|P2|STARTED|Overall Study||271
8253500|NCT01844856|20352186|P1|STARTED|Overall Study||270
8253501|NCT01844830|20352198|P2|NOT COMPLETED|Overall Study||0
8253502|NCT01844830|20352199|P1|NOT COMPLETED|Overall Study||1
8253503|NCT01844830|20352198|P2|COMPLETED|Overall Study||30
8253504|NCT01844830|20352199|P1|COMPLETED|Overall Study||59
8253505|NCT01844830|20352198|P2|400 µL Dose|Overall Study||10
8253506|NCT01844830|20352199|P1|400 µL Dose|Overall Study||20
8253507|NCT01844830|20352198|P2|200 µL Dose|Overall Study||12
8253508|NCT01844830|20352199|P1|200 µL Dose|Overall Study||24
8253509|NCT01844830|20352198|P2|100 µL Dose|Overall Study||8
8253510|NCT01844830|20352199|P1|100 µL Dose|Overall Study||16
8253511|NCT01844830|20352198|P2|STARTED|Overall Study||30
8253512|NCT01844830|20352199|P1|STARTED|Overall Study||60
8253513|NCT01844817|20352229|P2|NOT COMPLETED|Treatment||63
8253514|NCT01844817|20352230|P1|NOT COMPLETED|Treatment||64
8253515|NCT01844817|20352229|P2|COMPLETED|Treatment||0
8253516|NCT01844817|20352230|P1|COMPLETED|Treatment||0
8253517|NCT01844817|20352229|P2|STARTED|Treatment||63
8253518|NCT01844817|20352230|P1|STARTED|Treatment||64
8253519|NCT01844817|20352229|P2|NOT COMPLETED|Enrolled and Randomized||3
8253520|NCT01844817|20352230|P1|NOT COMPLETED|Enrolled and Randomized||2
8253521|NCT01844817|20352229|P2|COMPLETED|Enrolled and Randomized||63
8253522|NCT01844817|20352230|P1|COMPLETED|Enrolled and Randomized||64
8253523|NCT01844817|20352229|P2|STARTED|Enrolled and Randomized||66
8253524|NCT01844817|20352230|P1|STARTED|Enrolled and Randomized||66
8253525|NCT01844778|20352243|P3|NOT COMPLETED|Overall Study||4
8253526|NCT01844778|20352244|P2|NOT COMPLETED|Overall Study||3
8253527|NCT01844778|20352245|P1|NOT COMPLETED|Overall Study||2
8253528|NCT01844778|20352243|P3|COMPLETED|Overall Study||14
8253529|NCT01844778|20352244|P2|COMPLETED|Overall Study||25
8253530|NCT01844778|20352245|P1|COMPLETED|Overall Study||12
8253531|NCT01844778|20352243|P3|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
8253532|NCT01844778|20352244|P2|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
8253533|NCT01844778|20352245|P1|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
8253534|NCT01844778|20352243|P3|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
8253535|NCT01844778|20352244|P2|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
8253536|NCT01844778|20352245|P1|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
8253537|NCT01844778|20352243|P3|STARTED|Overall Study||18
8253538|NCT01844778|20352244|P2|STARTED|Overall Study||28
8253539|NCT01844778|20352245|P1|STARTED|Overall Study||14
8253550|NCT01844700|20352292|P2|NOT COMPLETED|Overall Study||1
8253551|NCT01844700|20352293|P1|NOT COMPLETED|Overall Study||3
8253552|NCT01844700|20352292|P2|COMPLETED|Overall Study||2
8253553|NCT01844700|20352293|P1|COMPLETED|Overall Study||1
8253554|NCT01844700|20352292|P2|STARTED|Overall Study||3
8253555|NCT01844700|20352293|P1|STARTED|Overall Study||4
8253556|NCT01844687|20352305|P1|NOT COMPLETED|Visit 8||0
8253557|NCT01844687|20352305|P1|COMPLETED|Visit 8||31
8253558|NCT01844687|20352305|P1|STARTED|Visit 8||31
8253559|NCT01844687|20352305|P1|NOT COMPLETED|Visit 7||0
8253560|NCT01844687|20352305|P1|COMPLETED|Visit 7||31
8253561|NCT01844687|20352305|P1|STARTED|Visit 7||31
8253562|NCT01844687|20352305|P1|NOT COMPLETED|Visit 6||0
8253563|NCT01844687|20352305|P1|COMPLETED|Visit 6||31
8253564|NCT01844687|20352305|P1|STARTED|Visit 6||31
8253565|NCT01844687|20352305|P1|NOT COMPLETED|Visit 5||0
8253566|NCT01844687|20352305|P1|COMPLETED|Visit 5||31
8253567|NCT01844687|20352305|P1|STARTED|Visit 5||31
8253568|NCT01844687|20352305|P1|NOT COMPLETED|Visit 4||4
8253569|NCT01844687|20352305|P1|COMPLETED|Visit 4||31
8253570|NCT01844687|20352305|P1|STARTED|Visit 4||35
8253571|NCT01844687|20352305|P1|NOT COMPLETED|Visit 3||5
8253572|NCT01844687|20352305|P1|COMPLETED|Visit 3||35
8253573|NCT01844687|20352305|P1|STARTED|Visit 3||40
8253574|NCT01844687|20352305|P1|NOT COMPLETED|Visit 2||2
8253575|NCT01844687|20352305|P1|COMPLETED|Visit 2||40
8253576|NCT01844687|20352305|P1|STARTED|Visit 2||42
8253577|NCT01844687|20352305|P1|NOT COMPLETED|Visit 1||8
8253578|NCT01844687|20352305|P1|COMPLETED|Visit 1||42
8253579|NCT01844687|20352305|P1|STARTED|Visit 1||50
8253580|NCT01844583|20352366|P2|NOT COMPLETED|Overall Study||10
8253581|NCT01844583|20352367|P1|NOT COMPLETED|Overall Study||8
8253582|NCT01844583|20352366|P2|COMPLETED|Overall Study||19
8253583|NCT01844583|20352367|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18
8253584|NCT01844583|20352366|P2|STARTED|Overall Study||29
8253585|NCT01844583|20352367|P1|STARTED|Overall Study||26
8253586|NCT01844531|20352399|P4|NOT COMPLETED|Overall Study||0
8253587|NCT01844531|20352400|P3|NOT COMPLETED|Overall Study||0
8253588|NCT01844531|20352401|P2|NOT COMPLETED|Overall Study||1
8253589|NCT01844531|20352402|P1|NOT COMPLETED|Overall Study||0
8253590|NCT01844531|20352399|P4|COMPLETED|Overall Study||6
8253591|NCT01844531|20352400|P3|COMPLETED|Overall Study||6
8253592|NCT01844531|20352401|P2|COMPLETED|Overall Study||5
8253593|NCT01844531|20352402|P1|COMPLETED|Overall Study||6
8253594|NCT01844531|20352399|P4|STARTED|Overall Study||6
8253595|NCT01844531|20352400|P3|STARTED|Overall Study||6
8253596|NCT01844531|20352401|P2|STARTED|Overall Study||6
8253597|NCT01844531|20352402|P1|STARTED|Overall Study||6
8253598|NCT01844518|20352432|P1|NOT COMPLETED|Long-Term Extension||157
8253599|NCT01844518|20352432|P1|COMPLETED|Long-Term Extension|Study is on-going|0
8253600|NCT01844518|20352432|P1|STARTED|Long-Term Extension|7 participants completed ST but did not continue in study.|157
8253601|NCT01844518|20352432|P1|NOT COMPLETED|Short-Term (ST) Period||9
8253602|NCT01844518|20352432|P1|COMPLETED|Short-Term (ST) Period||164
8253603|NCT01844518|20352432|P1|STARTED|Short-Term (ST) Period||173
8253604|NCT01844505|20352449|P3|NOT COMPLETED|Overall Study||295
8253605|NCT01844505|20352450|P2|NOT COMPLETED|Overall Study||269
8253606|NCT01844505|20352451|P1|NOT COMPLETED|Overall Study||249
8253607|NCT01844505|20352449|P3|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
8253608|NCT01844505|20352450|P2|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
8253609|NCT01844505|20352451|P1|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
8253610|NCT01844505|20352449|P3|STARTED|Overall Study||311
8253611|NCT01844505|20352450|P2|STARTED|Overall Study||313
8253612|NCT01844505|20352451|P1|STARTED|Overall Study||313
8253613|NCT01844479|20352501|P2|NOT COMPLETED|Second Intervention up to 30 Minutes||0
8253614|NCT01844479|20352502|P1|NOT COMPLETED|Second Intervention up to 30 Minutes||0
8253615|NCT01844479|20352501|P2|COMPLETED|Second Intervention up to 30 Minutes||13
8253616|NCT01844479|20352502|P1|COMPLETED|Second Intervention up to 30 Minutes||14
8253617|NCT01844479|20352501|P2|STARTED|Second Intervention up to 30 Minutes||13
8253618|NCT01844479|20352502|P1|STARTED|Second Intervention up to 30 Minutes||14
8253619|NCT01844479|20352501|P2|NOT COMPLETED|First Intervention up to 30 Minutes||0
8253620|NCT01844479|20352502|P1|NOT COMPLETED|First Intervention up to 30 Minutes||0
8253621|NCT01844479|20352501|P2|COMPLETED|First Intervention up to 30 Minutes||13
8253622|NCT01844479|20352502|P1|COMPLETED|First Intervention up to 30 Minutes||14
8253623|NCT01844479|20352501|P2|STARTED|First Intervention up to 30 Minutes||13
8253624|NCT01844479|20352502|P1|STARTED|First Intervention up to 30 Minutes||14
8253625|NCT01844388|20352532|P2|NOT COMPLETED|Overall Study||7
8253626|NCT01844388|20352533|P1|NOT COMPLETED|Overall Study||8
8253627|NCT01844388|20352532|P2|COMPLETED|Overall Study||114
8253628|NCT01844388|20352533|P1|COMPLETED|Overall Study||236
8253629|NCT01844388|20352532|P2|STARTED|Overall Study||121
8253630|NCT01844388|20352533|P1|STARTED|Overall Study||244
8253631|NCT01844375|20352545|P2|NOT COMPLETED|Overall Study||1
8253632|NCT01844375|20352546|P1|NOT COMPLETED|Overall Study||1
8253633|NCT01844375|20352545|P2|COMPLETED|Overall Study||34
8253634|NCT01844375|20352546|P1|COMPLETED|Overall Study||34
8253635|NCT01844375|20352545|P2|STARTED|Overall Study||35
8253636|NCT01844375|20352546|P1|STARTED|Overall Study||35
8253637|NCT01844284|20352558|P2|NOT COMPLETED|Overall Study||7
8253638|NCT01844284|20352559|P1|NOT COMPLETED|Overall Study||12
8253639|NCT01844284|20352558|P2|COMPLETED|Overall Study||127
8253640|NCT01844284|20352559|P1|COMPLETED|Overall Study||254
8253641|NCT01844284|20352558|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|134
8253642|NCT01844284|20352559|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|266
8253643|NCT01844206|20352769|P2|NOT COMPLETED|Overall Study||1
8253644|NCT01844206|20352770|P1|NOT COMPLETED|Overall Study||0
8253645|NCT01844206|20352769|P2|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
8253646|NCT01844206|20352770|P1|COMPLETED|Overall Study||2
8253647|NCT01844206|20352769|P2|STARTED|Overall Study||3
8253648|NCT01844206|20352770|P1|STARTED|Overall Study||2
8253649|NCT01844115|20352778|P2|NOT COMPLETED|Overall Study||58
8253650|NCT01844115|20352779|P1|NOT COMPLETED|Overall Study||39
8253651|NCT01844115|20352778|P2|COMPLETED|Overall Study||144
8253652|NCT01844115|20352779|P1|COMPLETED|Overall Study||163
8253653|NCT01844115|20352778|P2|STARTED|Overall Study||202
8253654|NCT01844115|20352779|P1|STARTED|Overall Study||202
8253655|NCT01843972|20352797|P10|NOT COMPLETED|Overall Study||0
8253656|NCT01843972|20352798|P9|NOT COMPLETED|Overall Study||0
8253657|NCT01843972|20352799|P8|NOT COMPLETED|Overall Study||0
8253658|NCT01843972|20352800|P7|NOT COMPLETED|Overall Study||0
8253659|NCT01843972|20352801|P6|NOT COMPLETED|Overall Study||0
8253660|NCT01843972|20352802|P5|NOT COMPLETED|Overall Study||1
8253661|NCT01843972|20352803|P4|NOT COMPLETED|Overall Study||0
8253662|NCT01843972|20352804|P3|NOT COMPLETED|Overall Study||0
8253663|NCT01843972|20352805|P2|NOT COMPLETED|Overall Study||0
8253664|NCT01843972|20352806|P1|NOT COMPLETED|Overall Study||0
8253665|NCT01843972|20352797|P10|COMPLETED|Overall Study||12
8253666|NCT01843972|20352798|P9|COMPLETED|Overall Study||17
8253667|NCT01843972|20352799|P8|COMPLETED|Overall Study||5
8253668|NCT01843972|20352800|P7|COMPLETED|Overall Study||5
8253669|NCT01843972|20352801|P6|COMPLETED|Overall Study||6
8253670|NCT01843972|20352802|P5|COMPLETED|Overall Study||5
8253671|NCT01843972|20352803|P4|COMPLETED|Overall Study||6
8253672|NCT01843972|20352804|P3|COMPLETED|Overall Study||5
8253673|NCT01843972|20352805|P2|COMPLETED|Overall Study||6
8253674|NCT01843972|20352806|P1|COMPLETED|Overall Study||13
8253675|NCT01843972|20352797|P10|STARTED|Overall Study||12
8253676|NCT01843972|20352798|P9|STARTED|Overall Study||17
8253677|NCT01843972|20352799|P8|STARTED|Overall Study||5
8253678|NCT01843972|20352800|P7|STARTED|Overall Study||5
8253679|NCT01843972|20352801|P6|STARTED|Overall Study||6
8253680|NCT01843972|20352802|P5|STARTED|Overall Study||6
8253681|NCT01843972|20352803|P4|STARTED|Overall Study||6
8253682|NCT01843972|20352804|P3|STARTED|Overall Study||5
8253683|NCT01843972|20352805|P2|STARTED|Overall Study||6
8253684|NCT01843972|20352806|P1|STARTED|Overall Study||13
8253685|NCT01843933|20352876|P2|NOT COMPLETED|Overall Study||4
8253686|NCT01843933|20352877|P1|NOT COMPLETED|Overall Study||6
8253687|NCT01843933|20352876|P2|COMPLETED|Overall Study||103
8253688|NCT01843933|20352877|P1|COMPLETED|Overall Study||98
8253689|NCT01843933|20352876|P2|STARTED|Overall Study||107
8253690|NCT01843933|20352877|P1|STARTED|Overall Study||104
8253691|NCT01843920|20352885|P2|NOT COMPLETED|Overall Study||0
8253692|NCT01843920|20352886|P1|NOT COMPLETED|Overall Study||0
8253693|NCT01843920|20352885|P2|COMPLETED|Overall Study||9
8253694|NCT01843920|20352886|P1|COMPLETED|Overall Study||12
8253695|NCT01843920|20352885|P2|STARTED|Overall Study||9
8253696|NCT01843920|20352886|P1|STARTED|Overall Study||12
8253697|NCT01843842|20352896|P2|NOT COMPLETED|Overall Study||1
8253698|NCT01843842|20352897|P1|NOT COMPLETED|Overall Study||1
8253699|NCT01843842|20352896|P2|COMPLETED|Overall Study||151
8253700|NCT01843842|20352897|P1|COMPLETED|Overall Study||153
8253701|NCT01843842|20352896|P2|STARTED|Overall Study||152
8253702|NCT01843842|20352897|P1|STARTED|Overall Study||154
8253703|NCT01843803|20352919|P2|NOT COMPLETED|Overall Study||3
8253704|NCT01843803|20352920|P1|NOT COMPLETED|Overall Study||1
8253705|NCT01843803|20352919|P2|COMPLETED|Overall Study||136
8253706|NCT01843803|20352920|P1|COMPLETED|Overall Study||136
8253707|NCT01843803|20352919|P2|STARTED|Overall Study||139
8253708|NCT01843803|20352920|P1|STARTED|Overall Study||137
8253709|NCT01843777|20352934|P2|NOT COMPLETED|Overall Study||0
8253710|NCT01843777|20352935|P1|NOT COMPLETED|Overall Study||1
8253711|NCT01843777|20352934|P2|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
8253712|NCT01843777|20352935|P1|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
8253713|NCT01843777|20352934|P2|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
8253714|NCT01843777|20352935|P1|Per Protocol Population|Overall Study||11
8253715|NCT01843777|20352934|P2|STARTED|Overall Study|Number of participants randomized to treatment.|10
8253716|NCT01843777|20352935|P1|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
8253717|NCT01843751|20352945|P2|NOT COMPLETED|Overall Study||7
8253718|NCT01843751|20352946|P1|NOT COMPLETED|Overall Study||11
8253719|NCT01843751|20352945|P2|COMPLETED|Overall Study||3
8253720|NCT01843751|20352946|P1|COMPLETED|Overall Study||0
8253721|NCT01843751|20352945|P2|STARTED|Overall Study||10
8253722|NCT01843751|20352946|P1|STARTED|Overall Study||11
8253723|NCT01843673|20352960|P1|NOT COMPLETED|Overall Study||6
8253724|NCT01843673|20352960|P1|COMPLETED|Overall Study||10
8253725|NCT01843673|20352960|P1|STARTED|Overall Study||16
8253726|NCT01843660|20352972|P1|NOT COMPLETED|Overall Study||30
8253727|NCT01843660|20352972|P1|COMPLETED|Overall Study||1029
8253728|NCT01843660|20352972|P1|STARTED|Overall Study||1059
8253729|NCT01843621|20352990|P1|NOT COMPLETED|Overall Study||0
8253730|NCT01843621|20352990|P1|COMPLETED|Overall Study||7
8253731|NCT01843621|20352990|P1|STARTED|Overall Study||7
8253732|NCT01843465|20353007|P1|NOT COMPLETED|Overall Study||0
8253733|NCT01843465|20353007|P1|COMPLETED|Overall Study||34
8253734|NCT01843465|20353007|P1|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
8253743|NCT01843348|20353041|P3|NOT COMPLETED|Overall Study||41
8253744|NCT01843348|20353042|P2|NOT COMPLETED|Overall Study||40
8253745|NCT01843348|20353043|P1|NOT COMPLETED|Overall Study||23
8253746|NCT01843348|20353041|P3|COMPLETED|Overall Study||158
8253747|NCT01843348|20353042|P2|COMPLETED|Overall Study||168
8253748|NCT01843348|20353043|P1|COMPLETED|Overall Study||182
8253749|NCT01843348|20353041|P3|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
8253750|NCT01843348|20353042|P2|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
8253751|NCT01843348|20353043|P1|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
8253752|NCT01843348|20353041|P3|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
8253753|NCT01843348|20353042|P2|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
8253754|NCT01843348|20353043|P1|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
8253755|NCT01843348|20353041|P3|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
8253756|NCT01843348|20353042|P2|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
8253846|NCT01842620|20353327|P2|NOT COMPLETED|Period 1||0
8253847|NCT01842620|20353328|P1|NOT COMPLETED|Period 1||1
8253757|NCT01843348|20353043|P1|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
8253758|NCT01843348|20353041|P3|STARTED|Overall Study||199
8253759|NCT01843348|20353042|P2|STARTED|Overall Study||208
8253760|NCT01843348|20353043|P1|STARTED|Overall Study||205
8253761|NCT01843205|20353083|P2|NOT COMPLETED|Second Treatment (11 Days)||0
8253762|NCT01843205|20353084|P1|NOT COMPLETED|Second Treatment (11 Days)||0
8253763|NCT01843205|20353083|P2|COMPLETED|Second Treatment (11 Days)||4
8253764|NCT01843205|20353084|P1|COMPLETED|Second Treatment (11 Days)||4
8253765|NCT01843205|20353083|P2|STARTED|Second Treatment (11 Days)||4
8253766|NCT01843205|20353084|P1|STARTED|Second Treatment (11 Days)||4
8253767|NCT01843205|20353083|P2|NOT COMPLETED|First Treatment (11 Days)||0
8253768|NCT01843205|20353084|P1|NOT COMPLETED|First Treatment (11 Days)||1
8253769|NCT01843205|20353083|P2|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
8253770|NCT01843205|20353084|P1|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
8253771|NCT01843205|20353083|P2|STARTED|First Treatment (11 Days)||4
8253772|NCT01843205|20353084|P1|STARTED|First Treatment (11 Days)||5
8253773|NCT01843192|20353145|P3|NOT COMPLETED|Overall Study||2
8253774|NCT01843192|20353146|P2|NOT COMPLETED|Overall Study||6
8253775|NCT01843192|20353147|P1|NOT COMPLETED|Overall Study||2
8253776|NCT01843192|20353145|P3|COMPLETED|Overall Study||9
8253777|NCT01843192|20353146|P2|COMPLETED|Overall Study||28
8253778|NCT01843192|20353147|P1|COMPLETED|Overall Study||24
8253779|NCT01843192|20353145|P3|STARTED|Overall Study||11
8253780|NCT01843192|20353146|P2|STARTED|Overall Study||34
8253781|NCT01843192|20353147|P1|STARTED|Overall Study||26
8253782|NCT01843062|20353178|P2|NOT COMPLETED|Overall Study||9
8253783|NCT01843062|20353179|P1|NOT COMPLETED|Overall Study||22
8253784|NCT01843062|20353178|P2|COMPLETED|Overall Study||69
8253785|NCT01843062|20353179|P1|COMPLETED|Overall Study||133
8253786|NCT01843062|20353178|P2|Ongoing at Primary Analysis Data Cut-off|Overall Study||71
8253787|NCT01843062|20353179|P1|Ongoing at Primary Analysis Data Cut-off|Overall Study||134
8253788|NCT01843062|20353178|P2|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51
8253789|NCT01843062|20353179|P1|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91
8253790|NCT01843062|20353178|P2|Safety Analysis Set|Overall Study||77
8253791|NCT01843062|20353179|P1|Safety Analysis Set|Overall Study||154
8253792|NCT01843062|20353178|P2|Intention to Treat (ITT) Analysis Set|Overall Study||78
8253793|NCT01843062|20353179|P1|Intention to Treat (ITT) Analysis Set|Overall Study||155
8253794|NCT01843062|20353178|P2|STARTED|Overall Study||78
8253795|NCT01843062|20353179|P1|STARTED|Overall Study||155
8253796|NCT01842958|20353193|P2|NOT COMPLETED|Overall Study||1
8253797|NCT01842958|20353194|P1|NOT COMPLETED|Overall Study||1
8253798|NCT01842958|20353193|P2|COMPLETED|Overall Study||24
8253799|NCT01842958|20353194|P1|COMPLETED|Overall Study||24
8253800|NCT01842958|20353193|P2|Randomized|Overall Study||25
8253801|NCT01842958|20353194|P1|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
8253802|NCT01842958|20353193|P2|STARTED|Overall Study||25
8253803|NCT01842958|20353194|P1|STARTED|Overall Study||25
8253804|NCT01842906|20353214|P2|NOT COMPLETED|Overall Study||0
8253805|NCT01842906|20353215|P1|NOT COMPLETED|Overall Study||0
8253806|NCT01842906|20353214|P2|COMPLETED|Overall Study||104
8253807|NCT01842906|20353215|P1|COMPLETED|Overall Study||115
8253808|NCT01842906|20353214|P2|STARTED|Overall Study||104
8253809|NCT01842906|20353215|P1|STARTED|Overall Study||115
8253813|NCT01842815|20353246|P1|NOT COMPLETED|Overall Study||4
8253814|NCT01842815|20353246|P1|COMPLETED|Overall Study||16
8253815|NCT01842815|20353246|P1|STARTED|Overall Study||20
8253816|NCT01842789|20353257|P2|NOT COMPLETED|Overall Study||0
8253817|NCT01842789|20353258|P1|NOT COMPLETED|Overall Study||0
8253818|NCT01842789|20353257|P2|COMPLETED|Overall Study||8
8253819|NCT01842789|20353258|P1|COMPLETED|Overall Study||10
8253820|NCT01842789|20353257|P2|STARTED|Overall Study||8
8253821|NCT01842789|20353258|P1|STARTED|Overall Study||10
8253825|NCT01842633|20353278|P3|NOT COMPLETED|Overall Study||0
8253826|NCT01842633|20353279|P2|NOT COMPLETED|Overall Study||2
8253827|NCT01842633|20353280|P1|NOT COMPLETED|Overall Study||3
8253828|NCT01842633|20353278|P3|COMPLETED|Overall Study||34
8253829|NCT01842633|20353279|P2|COMPLETED|Overall Study||64
8253830|NCT01842633|20353280|P1|COMPLETED|Overall Study||62
8253831|NCT01842633|20353278|P3|STARTED|Overall Study||34
8253832|NCT01842633|20353279|P2|STARTED|Overall Study||66
8253833|NCT01842633|20353280|P1|STARTED|Overall Study||65
8253834|NCT01842620|20353327|P2|NOT COMPLETED|Period 2||0
8253835|NCT01842620|20353328|P1|NOT COMPLETED|Period 2||0
8253836|NCT01842620|20353327|P2|COMPLETED|Period 2||12
8253837|NCT01842620|20353328|P1|COMPLETED|Period 2||12
8253838|NCT01842620|20353327|P2|STARTED|Period 2||12
8253839|NCT01842620|20353328|P1|STARTED|Period 2||12
8253840|NCT01842620|20353327|P2|NOT COMPLETED|Washout Period||0
8253841|NCT01842620|20353328|P1|NOT COMPLETED|Washout Period||0
8253842|NCT01842620|20353327|P2|COMPLETED|Washout Period||12
8253843|NCT01842620|20353328|P1|COMPLETED|Washout Period||12
8253844|NCT01842620|20353327|P2|STARTED|Washout Period||12
8253845|NCT01842620|20353328|P1|STARTED|Washout Period||12
8253848|NCT01842620|20353327|P2|COMPLETED|Period 1||12
8253849|NCT01842620|20353328|P1|COMPLETED|Period 1||12
8253850|NCT01842620|20353327|P2|STARTED|Period 1||12
8253851|NCT01842620|20353328|P1|STARTED|Period 1||13
8253852|NCT01842607|20353344|P1|NOT COMPLETED|Overall Study||66
8253853|NCT01842607|20353344|P1|COMPLETED|Overall Study||585
8253854|NCT01842607|20353344|P1|STARTED|Overall Study||651
8253855|NCT01842594|20353363|P1|NOT COMPLETED|Overall Study||3
8253856|NCT01842594|20353363|P1|COMPLETED|Overall Study||10
8253857|NCT01842594|20353363|P1|STARTED|Overall Study||13
8253858|NCT01842581|20353370|P2|NOT COMPLETED|Overall Study||30
8253859|NCT01842581|20353371|P1|NOT COMPLETED|Overall Study||44
8253860|NCT01842581|20353370|P2|COMPLETED|Overall Study||79
8253861|NCT01842581|20353371|P1|COMPLETED|Overall Study||69
8253862|NCT01842581|20353370|P2|Received at Least 1 Dose of Study Drug|Overall Study||108
8253863|NCT01842581|20353371|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
8253864|NCT01842581|20353370|P2|STARTED|Overall Study||109
8253865|NCT01842581|20353371|P1|STARTED|Overall Study||113
8253866|NCT01842464|20353387|P1|NOT COMPLETED|Overall Study||0
8253867|NCT01842464|20353387|P1|COMPLETED|Overall Study||44
8253868|NCT01842464|20353387|P1|STARTED|Overall Study||44
8253869|NCT01842438|20353395|P2|NOT COMPLETED|T2: 6month Follow-up||4
8253870|NCT01842438|20353396|P1|NOT COMPLETED|T2: 6month Follow-up||4
8253871|NCT01842438|20353395|P2|COMPLETED|T2: 6month Follow-up||32
8253872|NCT01842438|20353396|P1|COMPLETED|T2: 6month Follow-up||32
8253873|NCT01842438|20353395|P2|STARTED|T2: 6month Follow-up||36
8253874|NCT01842438|20353396|P1|STARTED|T2: 6month Follow-up||36
8253875|NCT01842438|20353395|P2|NOT COMPLETED|T1: Immediately After the Intervention||8
8253876|NCT01842438|20353396|P1|NOT COMPLETED|T1: Immediately After the Intervention||6
8253877|NCT01842438|20353395|P2|COMPLETED|T1: Immediately After the Intervention||36
8253878|NCT01842438|20353396|P1|COMPLETED|T1: Immediately After the Intervention||36
8253879|NCT01842438|20353395|P2|STARTED|T1: Immediately After the Intervention||44
8253880|NCT01842438|20353396|P1|STARTED|T1: Immediately After the Intervention||42
8253881|NCT01842334|20353410|P2|NOT COMPLETED|Overall Study||4
8253882|NCT01842334|20353411|P1|NOT COMPLETED|Overall Study||3
8253883|NCT01842334|20353410|P2|COMPLETED|Overall Study||3
8253884|NCT01842334|20353411|P1|COMPLETED|Overall Study||2
8253885|NCT01842334|20353410|P2|STARTED|Overall Study||7
8253886|NCT01842334|20353411|P1|STARTED|Overall Study||5
8253887|NCT01842308|20353422|P5|NOT COMPLETED|Overall Study||1
8253888|NCT01842308|20353423|P4|NOT COMPLETED|Overall Study||0
8253889|NCT01842308|20353424|P3|NOT COMPLETED|Overall Study||0
8253890|NCT01842308|20353425|P2|NOT COMPLETED|Overall Study||0
8253891|NCT01842308|20353426|P1|NOT COMPLETED|Overall Study||0
8253892|NCT01842308|20353422|P5|COMPLETED|Overall Study||35
8253893|NCT01842308|20353423|P4|COMPLETED|Overall Study||2
8253894|NCT01842308|20353424|P3|COMPLETED|Overall Study||3
8253895|NCT01842308|20353425|P2|COMPLETED|Overall Study||3
8253896|NCT01842308|20353426|P1|COMPLETED|Overall Study||6
8253897|NCT01842308|20353422|P5|STARTED|Overall Study||36
8253898|NCT01842308|20353423|P4|STARTED|Overall Study||2
8253899|NCT01842308|20353424|P3|STARTED|Overall Study||3
8253900|NCT01842308|20353425|P2|STARTED|Overall Study||3
8253901|NCT01842308|20353426|P1|STARTED|Overall Study||6
8253902|NCT01841970|20353445|P1|NOT COMPLETED|Overall Study||11
8253903|NCT01841970|20353445|P1|COMPLETED|Overall Study||9
8253904|NCT01841970|20353445|P1|STARTED|Overall Study||20
8253905|NCT01841931|20353461|P1|NOT COMPLETED|Overall Study||4
8253906|NCT01841931|20353461|P1|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
8253907|NCT01841931|20353461|P1|STARTED|Overall Study||4
8253908|NCT01841762|20353469|P1|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
8253909|NCT01841762|20353469|P1|COMPLETED|Post-Treatment Safety Follow-Up Period||269
8253910|NCT01841762|20353469|P1|STARTED|Post-Treatment Safety Follow-Up Period||284
8253911|NCT01841762|20353469|P1|NOT COMPLETED|Treatment Period||32
8253912|NCT01841762|20353469|P1|COMPLETED|Treatment Period||252
8253913|NCT01841762|20353469|P1|STARTED|Treatment Period||284
8253914|NCT01841762|20353469|P1|NOT COMPLETED|Screening Period||51
8253915|NCT01841762|20353469|P1|COMPLETED|Screening Period||284
8253916|NCT01841762|20353469|P1|STARTED|Screening Period||335
8253925|NCT01841697|20353493|P2|NOT COMPLETED|Overall Study||18
8253926|NCT01841697|20353494|P1|NOT COMPLETED|Overall Study||20
8253927|NCT01841697|20353493|P2|COMPLETED|Overall Study||302
8253928|NCT01841697|20353494|P1|COMPLETED|Overall Study||302
8253929|NCT01841697|20353493|P2|STARTED|Overall Study||320
8253930|NCT01841697|20353494|P1|STARTED|Overall Study||322
8253931|NCT01841632|20353510|P1|NOT COMPLETED|Overall Study||0
8253932|NCT01841632|20353510|P1|COMPLETED|Overall Study||3
8253933|NCT01841632|20353510|P1|STARTED|Overall Study||3
8253934|NCT01841619|20353515|P1|NOT COMPLETED|Overall Study||0
8253935|NCT01841619|20353515|P1|COMPLETED|Overall Study||16
8253936|NCT01841619|20353515|P1|STARTED|Overall Study||16
8253937|NCT01841606|20353525|P2|NOT COMPLETED|Overall Study||0
8253938|NCT01841606|20353526|P1|NOT COMPLETED|Overall Study||0
8253939|NCT01841606|20353525|P2|COMPLETED|Overall Study||27
8253940|NCT01841606|20353526|P1|COMPLETED|Overall Study||25
8253941|NCT01841606|20353525|P2|STARTED|Overall Study||27
8253942|NCT01841606|20353526|P1|STARTED|Overall Study||25
8253943|NCT01841593|20353534|P2|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
8253944|NCT01841593|20353535|P1|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
8253945|NCT01841593|20353534|P2|COMPLETED|Third Intervention (Days 15 to 21)||6
8253946|NCT01841593|20353535|P1|COMPLETED|Third Intervention (Days 15 to 21)||11
8253947|NCT01841593|20353534|P2|STARTED|Third Intervention (Days 15 to 21)||6
8253948|NCT01841593|20353535|P1|STARTED|Third Intervention (Days 15 to 21)||11
8253949|NCT01841593|20353534|P2|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
8253950|NCT01841593|20353535|P1|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
8253951|NCT01841593|20353534|P2|COMPLETED|Second Intervention (Days 8 to 14)||6
8253952|NCT01841593|20353535|P1|COMPLETED|Second Intervention (Days 8 to 14)||11
8253953|NCT01841593|20353534|P2|STARTED|Second Intervention (Days 8 to 14)||6
8253954|NCT01841593|20353535|P1|STARTED|Second Intervention (Days 8 to 14)||12
8253955|NCT01841593|20353534|P2|NOT COMPLETED|First Intervention (Days 1 to 7)||1
8253956|NCT01841593|20353535|P1|NOT COMPLETED|First Intervention (Days 1 to 7)||0
8253957|NCT01841593|20353534|P2|COMPLETED|First Intervention (Days 1 to 7)||6
8253958|NCT01841593|20353535|P1|COMPLETED|First Intervention (Days 1 to 7)||12
8253959|NCT01841593|20353534|P2|STARTED|First Intervention (Days 1 to 7)||7
8253960|NCT01841593|20353535|P1|STARTED|First Intervention (Days 1 to 7)||12
8253961|NCT01841567|20353551|P1|NOT COMPLETED|Overall Study||3
8253962|NCT01841567|20353551|P1|COMPLETED|Overall Study||57
8253963|NCT01841567|20353551|P1|STARTED|Overall Study||60
8253964|NCT01841554|20353556|P1|NOT COMPLETED|Overall Study||19
8253965|NCT01841554|20353556|P1|COMPLETED|Overall Study||42
8253966|NCT01841554|20353556|P1|1 Year Follow Up|Overall Study||42
8253967|NCT01841554|20353556|P1|Implanted|Overall Study||60
8253968|NCT01841554|20353556|P1|STARTED|Overall Study||61
8253969|NCT01841281|20353569|P4|NOT COMPLETED|Second Intervention (12 Weeks)||0
8253970|NCT01841281|20353570|P3|NOT COMPLETED|Second Intervention (12 Weeks)||0
8253971|NCT01841281|20353571|P2|NOT COMPLETED|Second Intervention (12 Weeks)||3
8253972|NCT01841281|20353572|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
8253973|NCT01841281|20353569|P4|COMPLETED|Second Intervention (12 Weeks)||13
8253974|NCT01841281|20353570|P3|COMPLETED|Second Intervention (12 Weeks)||10
8253975|NCT01841281|20353571|P2|COMPLETED|Second Intervention (12 Weeks)||6
8253976|NCT01841281|20353572|P1|COMPLETED|Second Intervention (12 Weeks)||9
8253977|NCT01841281|20353569|P4|STARTED|Second Intervention (12 Weeks)||13
8253978|NCT01841281|20353570|P3|STARTED|Second Intervention (12 Weeks)||10
8253979|NCT01841281|20353571|P2|STARTED|Second Intervention (12 Weeks)||9
8253980|NCT01841281|20353572|P1|STARTED|Second Intervention (12 Weeks)||9
8253981|NCT01841281|20353569|P4|NOT COMPLETED|Washout (6 Weeks)||1
8253982|NCT01841281|20353570|P3|NOT COMPLETED|Washout (6 Weeks)||3
8253983|NCT01841281|20353571|P2|NOT COMPLETED|Washout (6 Weeks)||3
8253984|NCT01841281|20353572|P1|NOT COMPLETED|Washout (6 Weeks)||2
8253985|NCT01841281|20353569|P4|COMPLETED|Washout (6 Weeks)||13
8253986|NCT01841281|20353570|P3|COMPLETED|Washout (6 Weeks)||10
8253987|NCT01841281|20353571|P2|COMPLETED|Washout (6 Weeks)||9
8253988|NCT01841281|20353572|P1|COMPLETED|Washout (6 Weeks)||9
8253989|NCT01841281|20353569|P4|STARTED|Washout (6 Weeks)||14
8253990|NCT01841281|20353570|P3|STARTED|Washout (6 Weeks)||13
8253991|NCT01841281|20353571|P2|STARTED|Washout (6 Weeks)||12
8253992|NCT01841281|20353572|P1|STARTED|Washout (6 Weeks)||11
8253993|NCT01841281|20353569|P4|NOT COMPLETED|First Intervention (12 Weeks)||0
8253994|NCT01841281|20353570|P3|NOT COMPLETED|First Intervention (12 Weeks)||0
8253995|NCT01841281|20353571|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
8253996|NCT01841281|20353572|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
8253997|NCT01841281|20353569|P4|COMPLETED|First Intervention (12 Weeks)||14
8253998|NCT01841281|20353570|P3|COMPLETED|First Intervention (12 Weeks)||13
8253999|NCT01841281|20353571|P2|COMPLETED|First Intervention (12 Weeks)||12
8254000|NCT01841281|20353572|P1|COMPLETED|First Intervention (12 Weeks)||11
8254001|NCT01841281|20353569|P4|STARTED|First Intervention (12 Weeks)||14
8254002|NCT01841281|20353570|P3|STARTED|First Intervention (12 Weeks)||13
8254003|NCT01841281|20353571|P2|STARTED|First Intervention (12 Weeks)||12
8254004|NCT01841281|20353572|P1|STARTED|First Intervention (12 Weeks)||11
8254005|NCT01841216|20353594|P2|NOT COMPLETED|Overall Study||0
8254006|NCT01841216|20353595|P1|NOT COMPLETED|Overall Study||0
8254007|NCT01841216|20353594|P2|COMPLETED|Overall Study||15
8254008|NCT01841216|20353595|P1|COMPLETED|Overall Study||15
8254009|NCT01841216|20353594|P2|STARTED|Overall Study||15
8254010|NCT01841216|20353595|P1|STARTED|Overall Study||15
8254011|NCT01841073|20353605|P2|NOT COMPLETED|Overall Study||3
8254012|NCT01841073|20353606|P1|NOT COMPLETED|Overall Study||2
8254013|NCT01841073|20353605|P2|COMPLETED|Overall Study||19
8254014|NCT01841073|20353606|P1|COMPLETED|Overall Study||20
8254015|NCT01841073|20353605|P2|STARTED|Overall Study||22
8254016|NCT01841073|20353606|P1|STARTED|Overall Study||22
8254017|NCT01841060|20353616|P1|NOT COMPLETED|Overall Study||10
8254018|NCT01841060|20353616|P1|COMPLETED|Overall Study||32
8254019|NCT01841060|20353616|P1|STARTED|Overall Study||42
8254020|NCT01841021|20353623|P1|NOT COMPLETED|Overall Study||0
8254021|NCT01841021|20353623|P1|COMPLETED|Overall Study||1
8254022|NCT01841021|20353623|P1|STARTED|Overall Study||1
8254023|NCT01840943|20353635|P2|NOT COMPLETED|Overall Study||12
8254024|NCT01840943|20353636|P1|NOT COMPLETED|Overall Study||13
8254025|NCT01840943|20353635|P2|COMPLETED|Overall Study||0
8254026|NCT01840943|20353636|P1|COMPLETED|Overall Study||1
8254027|NCT01840943|20353635|P2|STARTED|Overall Study||12
8254028|NCT01840943|20353636|P1|STARTED|Overall Study||14
8254029|NCT01840722|20353672|P2|NOT COMPLETED|Overall Study||69
8254030|NCT01840722|20353673|P1|NOT COMPLETED|Overall Study||0
8254031|NCT01840722|20353672|P2|COMPLETED|Overall Study||130
8254032|NCT01840722|20353673|P1|COMPLETED|Overall Study||201
8254033|NCT01840722|20353672|P2|STARTED|Overall Study||199
8254034|NCT01840722|20353673|P1|STARTED|Overall Study||201
8254035|NCT01840605|20353685|P2|NOT COMPLETED|Overall Study||2
8254036|NCT01840605|20353686|P1|NOT COMPLETED|Overall Study||2
8254037|NCT01840605|20353685|P2|COMPLETED|Overall Study||150
8254038|NCT01840605|20353686|P1|COMPLETED|Overall Study||149
8254039|NCT01840605|20353685|P2|STARTED|Overall Study||152
8254040|NCT01840605|20353686|P1|STARTED|Overall Study||151
8254041|NCT01840410|20353700|P2|NOT COMPLETED|Overall Study||4
8254042|NCT01840410|20353701|P1|NOT COMPLETED|Overall Study||7
8254043|NCT01840410|20353700|P2|COMPLETED|Overall Study||55
8254044|NCT01840410|20353701|P1|COMPLETED|Overall Study||112
8254045|NCT01840410|20353700|P2|Full Analysis Set|Overall Study||59
8254046|NCT01840410|20353701|P1|Full Analysis Set|Overall Study||119
8254047|NCT01840410|20353700|P2|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
8254048|NCT01840410|20353701|P1|Safety Set|Overall Study||119
8254049|NCT01840410|20353700|P2|STARTED|Overall Study||59
8254050|NCT01840410|20353701|P1|STARTED|Overall Study||119
8254051|NCT01840345|20353737|P1|NOT COMPLETED|Overall Study||1
8254052|NCT01840345|20353737|P1|COMPLETED|Overall Study||10
8254053|NCT01840345|20353737|P1|STARTED|Overall Study||11
8254054|NCT01840319|20353744|P1|NOT COMPLETED|Overall Study||0
8254055|NCT01840319|20353744|P1|COMPLETED|Overall Study||156
8254056|NCT01840319|20353744|P1|STARTED|Overall Study||156
8254057|NCT01840228|20353750|P2|NOT COMPLETED|Overall Study||1
8254058|NCT01840228|20353751|P1|NOT COMPLETED|Overall Study||1
8254059|NCT01840228|20353750|P2|COMPLETED|Overall Study||18
8254060|NCT01840228|20353751|P1|COMPLETED|Overall Study||18
8254061|NCT01840228|20353750|P2|STARTED|Overall Study||19
8254062|NCT01840228|20353751|P1|STARTED|Overall Study||19
8254063|NCT01840163|20353779|P2|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
8254064|NCT01840163|20353780|P1|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
8254065|NCT01840163|20353779|P2|COMPLETED|Systemic Follow Up-secondary Outcome||191
8254066|NCT01840163|20353780|P1|COMPLETED|Systemic Follow Up-secondary Outcome||174
8254067|NCT01840163|20353779|P2|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
8254068|NCT01840163|20353780|P1|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
8254069|NCT01840163|20353779|P2|NOT COMPLETED|First Follow up -Primary Outcome||16
8254070|NCT01840163|20353780|P1|NOT COMPLETED|First Follow up -Primary Outcome||19
8254071|NCT01840163|20353779|P2|COMPLETED|First Follow up -Primary Outcome||254
8254072|NCT01840163|20353780|P1|COMPLETED|First Follow up -Primary Outcome||248
8254073|NCT01840163|20353779|P2|STARTED|First Follow up -Primary Outcome||270
8254074|NCT01840163|20353780|P1|STARTED|First Follow up -Primary Outcome||267
8254075|NCT01840072|20353802|P2|NOT COMPLETED|Overall Study||47
8254076|NCT01840072|20353803|P1|NOT COMPLETED|Overall Study||7
8254077|NCT01840072|20353802|P2|COMPLETED|Overall Study||1986
8254078|NCT01840072|20353803|P1|COMPLETED|Overall Study||2031
8254079|NCT01840072|20353802|P2|STARTED|Overall Study||2033
8254080|NCT01840072|20353803|P1|STARTED|Overall Study||2038
8254081|NCT01839916|20353825|P1|NOT COMPLETED|Overall Study||41
8254082|NCT01839916|20353825|P1|COMPLETED|Overall Study||36
8254083|NCT01839916|20353825|P1|STARTED|Overall Study||77
8254084|NCT01839708|20353836|P2|NOT COMPLETED|Overall Study||67
8254085|NCT01839708|20353837|P1|NOT COMPLETED|Overall Study||76
8254086|NCT01839708|20353836|P2|COMPLETED|Overall Study||115
8254087|NCT01839708|20353837|P1|COMPLETED|Overall Study||311
8254088|NCT01839708|20353836|P2|STARTED|Overall Study||182
8254089|NCT01839708|20353837|P1|STARTED|Overall Study||387
8254090|NCT01839695|20353869|P1|NOT COMPLETED|Overall Study||0
8254091|NCT01839695|20353869|P1|COMPLETED|Overall Study||9
8254092|NCT01839695|20353869|P1|STARTED|Overall Study||9
8254101|NCT01839604|20353904|P5|NOT COMPLETED|Overall Study||0
8254102|NCT01839604|20353905|P4|NOT COMPLETED|Overall Study||0
8254103|NCT01839604|20353906|P3|NOT COMPLETED|Overall Study||0
8254104|NCT01839604|20353907|P2|NOT COMPLETED|Overall Study||0
8254105|NCT01839604|20353908|P1|NOT COMPLETED|Overall Study||0
8254106|NCT01839604|20353904|P5|COMPLETED|Overall Study||15
8254107|NCT01839604|20353905|P4|COMPLETED|Overall Study||5
8254108|NCT01839604|20353906|P3|COMPLETED|Overall Study||7
8254109|NCT01839604|20353907|P2|COMPLETED|Overall Study||6
8254110|NCT01839604|20353908|P1|COMPLETED|Overall Study||6
8254111|NCT01839604|20353904|P5|STARTED|Overall Study||15
8254112|NCT01839604|20353905|P4|STARTED|Overall Study||5
8254113|NCT01839604|20353906|P3|STARTED|Overall Study||7
8254114|NCT01839604|20353907|P2|STARTED|Overall Study||6
8254115|NCT01839604|20353908|P1|STARTED|Overall Study||6
8254116|NCT01839487|20353937|P6|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||44
8254117|NCT01839487|20353938|P5|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||88
8254118|NCT01839487|20353939|P4|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||62
8254119|NCT01839487|20353940|P3|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||61
8254120|NCT01839487|20353941|P2|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8254121|NCT01839487|20353942|P1|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8254122|NCT01839487|20353937|P6|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8254123|NCT01839487|20353938|P5|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||1
8254124|NCT01839487|20353939|P4|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8254125|NCT01839487|20353940|P3|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8254126|NCT01839487|20353941|P2|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8254127|NCT01839487|20353942|P1|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
8254128|NCT01839487|20353937|P6|STARTED|Phase 2 (Maximum Exposure:935 Days)||44
8254129|NCT01839487|20353938|P5|STARTED|Phase 2 (Maximum Exposure:935 Days)||89
8254130|NCT01839487|20353939|P4|STARTED|Phase 2 (Maximum Exposure:935 Days)||62
8254131|NCT01839487|20353940|P3|STARTED|Phase 2 (Maximum Exposure:935 Days)||61
8254132|NCT01839487|20353941|P2|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
8254133|NCT01839487|20353942|P1|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
8254134|NCT01839487|20353937|P6|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254135|NCT01839487|20353938|P5|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254136|NCT01839487|20353939|P4|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254137|NCT01839487|20353940|P3|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254138|NCT01839487|20353941|P2|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||7
8254139|NCT01839487|20353942|P1|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||16
8254140|NCT01839487|20353937|P6|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254141|NCT01839487|20353938|P5|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254142|NCT01839487|20353939|P4|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254143|NCT01839487|20353940|P3|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254144|NCT01839487|20353941|P2|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254145|NCT01839487|20353942|P1|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
8254146|NCT01839487|20353937|P6|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
8254147|NCT01839487|20353938|P5|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
8254148|NCT01839487|20353939|P4|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
8254149|NCT01839487|20353940|P3|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
8254150|NCT01839487|20353941|P2|STARTED|Run-in Phase (Maximum Exposure:295 Days)||7
8254151|NCT01839487|20353942|P1|STARTED|Run-in Phase (Maximum Exposure:295 Days)||16
8254152|NCT01839396|20353965|P2|NOT COMPLETED|Overall Study||0
8254153|NCT01839396|20353966|P1|NOT COMPLETED|Overall Study||0
8254154|NCT01839396|20353965|P2|COMPLETED|Overall Study||39
8254155|NCT01839396|20353966|P1|COMPLETED|Overall Study||121
8254156|NCT01839396|20353965|P2|STARTED|Overall Study||39
8254157|NCT01839396|20353966|P1|STARTED|Overall Study||121
8254158|NCT01839318|20353974|P6|NOT COMPLETED|Period 3, Third Day of Wear||0
8254159|NCT01839318|20353975|P5|NOT COMPLETED|Period 3, Third Day of Wear||0
8254160|NCT01839318|20353976|P4|NOT COMPLETED|Period 3, Third Day of Wear||0
8254161|NCT01839318|20353977|P3|NOT COMPLETED|Period 3, Third Day of Wear||0
8254162|NCT01839318|20353978|P2|NOT COMPLETED|Period 3, Third Day of Wear||0
8254163|NCT01839318|20353979|P1|NOT COMPLETED|Period 3, Third Day of Wear||0
8254164|NCT01839318|20353974|P6|COMPLETED|Period 3, Third Day of Wear||2
8254165|NCT01839318|20353975|P5|COMPLETED|Period 3, Third Day of Wear||7
8254166|NCT01839318|20353976|P4|COMPLETED|Period 3, Third Day of Wear||6
8254167|NCT01839318|20353977|P3|COMPLETED|Period 3, Third Day of Wear||5
8254168|NCT01839318|20353978|P2|COMPLETED|Period 3, Third Day of Wear||4
8254169|NCT01839318|20353979|P1|COMPLETED|Period 3, Third Day of Wear||4
8254170|NCT01839318|20353974|P6|STARTED|Period 3, Third Day of Wear||2
8254171|NCT01839318|20353975|P5|STARTED|Period 3, Third Day of Wear||7
8254172|NCT01839318|20353976|P4|STARTED|Period 3, Third Day of Wear||6
8254173|NCT01839318|20353977|P3|STARTED|Period 3, Third Day of Wear||5
8254174|NCT01839318|20353978|P2|STARTED|Period 3, Third Day of Wear||4
8254175|NCT01839318|20353979|P1|STARTED|Period 3, Third Day of Wear||4
8254176|NCT01839318|20353974|P6|NOT COMPLETED|Period 2, Second Day of Wear||0
8254177|NCT01839318|20353975|P5|NOT COMPLETED|Period 2, Second Day of Wear||0
8254178|NCT01839318|20353976|P4|NOT COMPLETED|Period 2, Second Day of Wear||0
8254179|NCT01839318|20353977|P3|NOT COMPLETED|Period 2, Second Day of Wear||0
8254180|NCT01839318|20353978|P2|NOT COMPLETED|Period 2, Second Day of Wear||0
8254181|NCT01839318|20353979|P1|NOT COMPLETED|Period 2, Second Day of Wear||0
8254182|NCT01839318|20353974|P6|COMPLETED|Period 2, Second Day of Wear||2
8254183|NCT01839318|20353975|P5|COMPLETED|Period 2, Second Day of Wear||7
8254184|NCT01839318|20353976|P4|COMPLETED|Period 2, Second Day of Wear||6
8254185|NCT01839318|20353977|P3|COMPLETED|Period 2, Second Day of Wear||5
8254186|NCT01839318|20353978|P2|COMPLETED|Period 2, Second Day of Wear||4
8254187|NCT01839318|20353979|P1|COMPLETED|Period 2, Second Day of Wear||4
8254188|NCT01839318|20353974|P6|STARTED|Period 2, Second Day of Wear||2
8254189|NCT01839318|20353975|P5|STARTED|Period 2, Second Day of Wear||7
8254190|NCT01839318|20353976|P4|STARTED|Period 2, Second Day of Wear||6
8254191|NCT01839318|20353977|P3|STARTED|Period 2, Second Day of Wear||5
8254192|NCT01839318|20353978|P2|STARTED|Period 2, Second Day of Wear||4
8254193|NCT01839318|20353979|P1|STARTED|Period 2, Second Day of Wear||4
8254194|NCT01839318|20353974|P6|NOT COMPLETED|Period 1, First Day of Wear||0
8254195|NCT01839318|20353975|P5|NOT COMPLETED|Period 1, First Day of Wear||0
8254196|NCT01839318|20353976|P4|NOT COMPLETED|Period 1, First Day of Wear||0
8254197|NCT01839318|20353977|P3|NOT COMPLETED|Period 1, First Day of Wear||0
8254198|NCT01839318|20353978|P2|NOT COMPLETED|Period 1, First Day of Wear||0
8254199|NCT01839318|20353979|P1|NOT COMPLETED|Period 1, First Day of Wear||0
8254200|NCT01839318|20353974|P6|COMPLETED|Period 1, First Day of Wear||2
8254201|NCT01839318|20353975|P5|COMPLETED|Period 1, First Day of Wear||7
8254202|NCT01839318|20353976|P4|COMPLETED|Period 1, First Day of Wear||6
8254203|NCT01839318|20353977|P3|COMPLETED|Period 1, First Day of Wear||5
8254204|NCT01839318|20353978|P2|COMPLETED|Period 1, First Day of Wear||4
8254205|NCT01839318|20353979|P1|COMPLETED|Period 1, First Day of Wear||4
8254206|NCT01839318|20353974|P6|STARTED|Period 1, First Day of Wear||2
8254207|NCT01839318|20353975|P5|STARTED|Period 1, First Day of Wear||7
8254208|NCT01839318|20353976|P4|STARTED|Period 1, First Day of Wear||6
8254209|NCT01839318|20353977|P3|STARTED|Period 1, First Day of Wear||5
8254210|NCT01839318|20353978|P2|STARTED|Period 1, First Day of Wear||4
8254211|NCT01839318|20353979|P1|STARTED|Period 1, First Day of Wear||4
8254233|NCT01839188|20354014|P1|NOT COMPLETED|Overall Study||1
8254234|NCT01839188|20354014|P1|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384
8254235|NCT01839188|20354014|P1|Treated|Overall Study||385
8254236|NCT01839188|20354014|P1|STARTED|Overall Study||385
8254237|NCT01839110|20354057|P3|NOT COMPLETED|Overall Study||3
8254238|NCT01839110|20354058|P2|NOT COMPLETED|Overall Study||2
8254239|NCT01839110|20354059|P1|NOT COMPLETED|Overall Study||3
8254240|NCT01839110|20354057|P3|COMPLETED|Overall Study||6
8254241|NCT01839110|20354058|P2|COMPLETED|Overall Study||4
8254242|NCT01839110|20354059|P1|COMPLETED|Overall Study||4
8254243|NCT01839110|20354057|P3|STARTED|Overall Study||9
8254244|NCT01839110|20354058|P2|STARTED|Overall Study||6
8254245|NCT01839110|20354059|P1|STARTED|Overall Study||7
8254246|NCT01839058|20354069|P2|NOT COMPLETED|Overall Study||3
8254247|NCT01839058|20354070|P1|NOT COMPLETED|Overall Study||4
8254248|NCT01839058|20354069|P2|COMPLETED|Overall Study||16
8254249|NCT01839058|20354070|P1|COMPLETED|Overall Study||17
8254250|NCT01839058|20354069|P2|STARTED|Overall Study||19
8254251|NCT01839058|20354070|P1|STARTED|Overall Study||21
8254252|NCT01838980|20354082|P1|NOT COMPLETED|Overall Study||0
8254253|NCT01838980|20354082|P1|COMPLETED|Overall Study||15
8254254|NCT01838980|20354082|P1|STARTED|Overall Study||15
8254255|NCT01838941|20354086|P1|NOT COMPLETED|Overall Study||2
8254256|NCT01838941|20354086|P1|COMPLETED|Overall Study||10
8254257|NCT01838941|20354086|P1|STARTED|Overall Study||12
8254258|NCT01838876|20354091|P1|NOT COMPLETED|Overall Study||233
8254259|NCT01838876|20354091|P1|COMPLETED|Overall Study||209
8254260|NCT01838876|20354091|P1|Entered Safety Follow-up Period|Overall Study||287
8254261|NCT01838876|20354091|P1|Safety Population; Received Study Drug|Overall Study||345
8254262|NCT01838876|20354091|P1|STARTED|Overall Study||442
8254263|NCT01838863|20354106|P2|NOT COMPLETED|Overall Study||9
8254264|NCT01838863|20354107|P1|NOT COMPLETED|Overall Study||10
8254265|NCT01838863|20354106|P2|COMPLETED|Overall Study||60
8254266|NCT01838863|20354107|P1|COMPLETED|Overall Study||65
8254267|NCT01838863|20354106|P2|STARTED|Overall Study||69
8254268|NCT01838863|20354107|P1|STARTED|Overall Study||75
8254269|NCT01838785|20354193|P1|NOT COMPLETED|Overall Study||0
8254270|NCT01838785|20354193|P1|COMPLETED|Overall Study||25
8254271|NCT01838785|20354193|P1|STARTED|Overall Study||25
8254272|NCT01838694|20354200|P2|NOT COMPLETED|Overall Study||1
8254273|NCT01838694|20354201|P1|NOT COMPLETED|Overall Study||0
8254274|NCT01838694|20354200|P2|COMPLETED|Overall Study||21
8254275|NCT01838694|20354201|P1|COMPLETED|Overall Study||8
8254276|NCT01838694|20354200|P2|STARTED|Overall Study||22
8254277|NCT01838694|20354201|P1|STARTED|Overall Study||8
8254278|NCT01838681|20354210|P4|NOT COMPLETED|Period B/A+||117
8254279|NCT01838681|20354211|P3|NOT COMPLETED|Period B/A+||95
8254280|NCT01838681|20354212|P2|NOT COMPLETED|Period B/A+||62
8254281|NCT01838681|20354213|P1|NOT COMPLETED|Period B/A+||0
8254282|NCT01838681|20354210|P4|COMPLETED|Period B/A+||653
8254283|NCT01838681|20354211|P3|COMPLETED|Period B/A+||349
8254284|NCT01838681|20354212|P2|COMPLETED|Period B/A+||380
8254285|NCT01838681|20354213|P1|COMPLETED|Period B/A+||0
8254286|NCT01838681|20354210|P4|STARTED|Period B/A+||770
8254287|NCT01838681|20354211|P3|STARTED|Period B/A+||444
8254288|NCT01838681|20354212|P2|STARTED|Period B/A+||442
8254289|NCT01838681|20354213|P1|STARTED|Period B/A+||0
8254290|NCT01838681|20354210|P4|NOT COMPLETED|Period A||0
8254291|NCT01838681|20354211|P3|NOT COMPLETED|Period A||0
8254292|NCT01838681|20354212|P2|NOT COMPLETED|Period A||0
8254293|NCT01838681|20354213|P1|NOT COMPLETED|Period A||325
8254294|NCT01838681|20354210|P4|COMPLETED|Period A||0
8254295|NCT01838681|20354211|P3|COMPLETED|Period A||0
8254296|NCT01838681|20354212|P2|COMPLETED|Period A||0
8254297|NCT01838681|20354213|P1|COMPLETED|Period A||1661
8254298|NCT01838681|20354210|P4|STARTED|Period A||0
8254299|NCT01838681|20354211|P3|STARTED|Period A||0
8254300|NCT01838681|20354212|P2|STARTED|Period A||0
8254301|NCT01838681|20354213|P1|STARTED|Period A||1986
8254302|NCT01838655|20354253|P1|NOT COMPLETED|Overall Study||0
8254303|NCT01838655|20354253|P1|COMPLETED|Overall Study||5
8254304|NCT01838655|20354253|P1|STARTED|Overall Study||5
8254305|NCT01838642|20354321|P1|NOT COMPLETED|Overall Study||1
8254306|NCT01838642|20354321|P1|COMPLETED|Overall Study||2
8254307|NCT01838642|20354321|P1|STARTED|Overall Study||3
8254308|NCT01838616|20354334|P2|NOT COMPLETED|Pick-up Arm||0
8254309|NCT01838616|20354335|P1|NOT COMPLETED|Pick-up Arm||15
8254310|NCT01838616|20354334|P2|COMPLETED|Pick-up Arm||0
8254311|NCT01838616|20354335|P1|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
8254312|NCT01838616|20354334|P2|Full Analysis Set|Pick-up Arm||0
8254313|NCT01838616|20354335|P1|Full Analysis Set|Pick-up Arm||49
8254314|NCT01838616|20354334|P2|STARTED|Pick-up Arm||0
8254315|NCT01838616|20354335|P1|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
8254316|NCT01838616|20354334|P2|NOT COMPLETED|Continuation Period||14
8254317|NCT01838616|20354335|P1|NOT COMPLETED|Continuation Period||14
8254318|NCT01838616|20354334|P2|COMPLETED|Continuation Period||48
8254319|NCT01838616|20354335|P1|COMPLETED|Continuation Period||86
8254320|NCT01838616|20354334|P2|Switched to Pick-up Arm|Continuation Period||7
8254321|NCT01838616|20354335|P1|Switched to Pick-up Arm|Continuation Period||0
8254322|NCT01838616|20354334|P2|STARTED|Continuation Period||62
8254323|NCT01838616|20354335|P1|STARTED|Continuation Period||100
8254324|NCT01838616|20354334|P2|NOT COMPLETED|Titration Period||66
8254325|NCT01838616|20354335|P1|NOT COMPLETED|Titration Period||30
8254326|NCT01838616|20354334|P2|COMPLETED|Titration Period||62
8254327|NCT01838616|20354335|P1|COMPLETED|Titration Period||100
8254328|NCT01838616|20354334|P2|Per Protocol Set|Titration Period||112
8254329|NCT01838616|20354335|P1|Per Protocol Set|Titration Period||117
8254330|NCT01838616|20354334|P2|Full Analysis Set|Titration Period||128
8254331|NCT01838616|20354335|P1|Full Analysis Set|Titration Period||130
8254332|NCT01838616|20354334|P2|Switched to Pick-up Arm|Titration Period||43
8254333|NCT01838616|20354335|P1|Switched to Pick-up Arm|Titration Period||0
8254334|NCT01838616|20354334|P2|Major Protocol Deviations|Titration Period||16
8254335|NCT01838616|20354335|P1|Major Protocol Deviations|Titration Period||13
8254336|NCT01838616|20354334|P2|No Post Baseline Pain Intensity Values|Titration Period||2
8254337|NCT01838616|20354335|P1|No Post Baseline Pain Intensity Values|Titration Period||0
8254338|NCT01838616|20354334|P2|STARTED|Titration Period||128
8254339|NCT01838616|20354335|P1|STARTED|Titration Period||130
8254340|NCT01838590|20354406|P2|NOT COMPLETED|Overall Study||5
8254341|NCT01838590|20354407|P1|NOT COMPLETED|Overall Study||12
8254342|NCT01838590|20354406|P2|COMPLETED|Overall Study||46
8254343|NCT01838590|20354407|P1|COMPLETED|Overall Study||40
8254344|NCT01838590|20354406|P2|STARTED|Overall Study||51
8254345|NCT01838590|20354407|P1|STARTED|Overall Study||52
8254346|NCT01838499|20354431|P2|NOT COMPLETED|Overall Study||17
8254347|NCT01838499|20354432|P1|NOT COMPLETED|Overall Study||24
8254348|NCT01838499|20354431|P2|COMPLETED|Overall Study||37
8254349|NCT01838499|20354432|P1|COMPLETED|Overall Study||31
8254350|NCT01838499|20354431|P2|STARTED|Overall Study||54
8254351|NCT01838499|20354432|P1|STARTED|Overall Study||55
8254352|NCT01838447|20354444|P2|NOT COMPLETED|Overall Study||3
8254353|NCT01838447|20354445|P1|NOT COMPLETED|Overall Study||2
8254354|NCT01838447|20354444|P2|COMPLETED|Overall Study||21
8254355|NCT01838447|20354445|P1|COMPLETED|Overall Study||20
8254356|NCT01838447|20354444|P2|STARTED|Overall Study||24
8254357|NCT01838447|20354445|P1|STARTED|Overall Study||22
8254358|NCT01838304|20354465|P2|NOT COMPLETED|Overall Study||0
8254359|NCT01838304|20354466|P1|NOT COMPLETED|Overall Study||1
8254360|NCT01838304|20354465|P2|COMPLETED|Overall Study||20
8254361|NCT01838304|20354466|P1|COMPLETED|Overall Study||19
8254362|NCT01838304|20354465|P2|STARTED|Overall Study||20
8254363|NCT01838304|20354466|P1|STARTED|Overall Study||20
8254364|NCT01838226|20354480|P2|NOT COMPLETED|Overall Study||71
8254365|NCT01838226|20354481|P1|NOT COMPLETED|Overall Study||76
8254366|NCT01838226|20354480|P2|COMPLETED|Overall Study||128
8254367|NCT01838226|20354481|P1|COMPLETED|Overall Study||126
8254368|NCT01838226|20354480|P2|STARTED|Overall Study||199
8254369|NCT01838226|20354481|P1|STARTED|Overall Study||202
8254370|NCT01838213|20354493|P2|NOT COMPLETED|Overall Study||191
8254371|NCT01838213|20354494|P1|NOT COMPLETED|Overall Study||166
8254372|NCT01838213|20354493|P2|COMPLETED|Overall Study||262
8254373|NCT01838213|20354494|P1|COMPLETED|Overall Study||81
8254374|NCT01838213|20354493|P2|STARTED|Overall Study||453
8254375|NCT01838213|20354494|P1|STARTED|Overall Study||247
8254376|NCT01838200|20354502|P2|NOT COMPLETED|Overall Study||2
8254377|NCT01838200|20354503|P1|NOT COMPLETED|Overall Study||3
8254378|NCT01838200|20354502|P2|COMPLETED|Overall Study||0
8254379|NCT01838200|20354503|P1|COMPLETED|Overall Study||0
8254380|NCT01838200|20354502|P2|STARTED|Overall Study||2
8254381|NCT01838200|20354503|P1|STARTED|Overall Study||3
8254382|NCT01837966|20354515|P2|NOT COMPLETED|Overall Study||1
8254383|NCT01837966|20354516|P1|NOT COMPLETED|Overall Study||2
8254384|NCT01837966|20354515|P2|COMPLETED|Overall Study||45
8254385|NCT01837966|20354516|P1|COMPLETED|Overall Study||45
8254386|NCT01837966|20354515|P2|STARTED|Overall Study||46
8254387|NCT01837966|20354516|P1|STARTED|Overall Study||47
8254388|NCT01837823|20354522|P1|NOT COMPLETED|Overall Study||6
8254389|NCT01837823|20354522|P1|COMPLETED|Overall Study||85
8254390|NCT01837823|20354522|P1|STARTED|Overall Study||91
8254391|NCT01837797|20354553|P5|NOT COMPLETED|Period 3||23
8254392|NCT01837797|20354554|P4|NOT COMPLETED|Period 3||0
8254393|NCT01837797|20354555|P3|NOT COMPLETED|Period 3||0
8254394|NCT01837797|20354556|P2|NOT COMPLETED|Period 3||0
8254395|NCT01837797|20354557|P1|NOT COMPLETED|Period 3||0
8254396|NCT01837797|20354553|P5|COMPLETED|Period 3||24
8254397|NCT01837797|20354554|P4|COMPLETED|Period 3||0
8254398|NCT01837797|20354555|P3|COMPLETED|Period 3||0
8254399|NCT01837797|20354556|P2|COMPLETED|Period 3||0
8254400|NCT01837797|20354557|P1|COMPLETED|Period 3||0
8254401|NCT01837797|20354553|P5|STARTED|Period 3||47
8254402|NCT01837797|20354554|P4|STARTED|Period 3||0
8254403|NCT01837797|20354555|P3|STARTED|Period 3||0
8254404|NCT01837797|20354556|P2|STARTED|Period 3||0
8254405|NCT01837797|20354557|P1|STARTED|Period 3||0
8254406|NCT01837797|20354553|P5|NOT COMPLETED|Period 2||0
8254407|NCT01837797|20354554|P4|NOT COMPLETED|Period 2||5
8254408|NCT01837797|20354555|P3|NOT COMPLETED|Period 2||2
8254409|NCT01837797|20354556|P2|NOT COMPLETED|Period 2||5
8254410|NCT01837797|20354557|P1|NOT COMPLETED|Period 2||0
8254411|NCT01837797|20354553|P5|COMPLETED|Period 2||0
8254412|NCT01837797|20354554|P4|COMPLETED|Period 2||1
8254413|NCT01837797|20354555|P3|COMPLETED|Period 2||1
8254414|NCT01837797|20354556|P2|COMPLETED|Period 2||1
8254415|NCT01837797|20354557|P1|COMPLETED|Period 2||0
8254416|NCT01837797|20354553|P5|STARTED|Period 2||0
8254417|NCT01837797|20354554|P4|STARTED|Period 2||6
8254418|NCT01837797|20354555|P3|STARTED|Period 2||3
8254419|NCT01837797|20354556|P2|STARTED|Period 2||6
8254420|NCT01837797|20354557|P1|STARTED|Period 2||0
8254421|NCT01837797|20354553|P5|NOT COMPLETED|Period 1||0
8254422|NCT01837797|20354554|P4|NOT COMPLETED|Period 1||0
8254423|NCT01837797|20354555|P3|NOT COMPLETED|Period 1||0
8254424|NCT01837797|20354556|P2|NOT COMPLETED|Period 1||0
8254425|NCT01837797|20354557|P1|NOT COMPLETED|Period 1||102
8254426|NCT01837797|20354553|P5|COMPLETED|Period 1||0
8254427|NCT01837797|20354554|P4|COMPLETED|Period 1||0
8254428|NCT01837797|20354555|P3|COMPLETED|Period 1||0
8254429|NCT01837797|20354556|P2|COMPLETED|Period 1||0
8254430|NCT01837797|20354557|P1|COMPLETED|Period 1||27
8254431|NCT01837797|20354553|P5|STARTED|Period 1||0
8254432|NCT01837797|20354554|P4|STARTED|Period 1||0
8254433|NCT01837797|20354555|P3|STARTED|Period 1||0
8254434|NCT01837797|20354556|P2|STARTED|Period 1||0
8254435|NCT01837797|20354557|P1|STARTED|Period 1||129
8254436|NCT01837719|20354592|P1|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
8254437|NCT01837719|20354592|P1|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
8254438|NCT01837719|20354592|P1|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
8254439|NCT01837719|20354592|P1|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
8254440|NCT01837719|20354592|P1|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
8254441|NCT01837719|20354592|P1|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
8254442|NCT01837719|20354592|P1|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
8254443|NCT01837719|20354592|P1|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
8254444|NCT01837719|20354592|P1|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
8254445|NCT01837719|20354592|P1|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
8254446|NCT01837719|20354592|P1|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
8254447|NCT01837719|20354592|P1|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
8254448|NCT01837719|20354592|P1|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
8254449|NCT01837719|20354592|P1|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
8254450|NCT01837719|20354592|P1|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
8254451|NCT01837680|20354661|P2|NOT COMPLETED|Overall Study||8
8254452|NCT01837680|20354662|P1|NOT COMPLETED|Overall Study||10
8254453|NCT01837680|20354661|P2|COMPLETED|Overall Study||45
8254454|NCT01837680|20354662|P1|COMPLETED|Overall Study||42
8254455|NCT01837680|20354661|P2|STARTED|Overall Study||53
8254456|NCT01837680|20354662|P1|STARTED|Overall Study||52
8254457|NCT01837654|20354700|P2|NOT COMPLETED|Overall Study||0
8254458|NCT01837654|20354701|P1|NOT COMPLETED|Overall Study||0
8254459|NCT01837654|20354700|P2|COMPLETED|Overall Study||11
8254460|NCT01837654|20354701|P1|COMPLETED|Overall Study||11
8254461|NCT01837654|20354700|P2|STARTED|Overall Study||11
8254462|NCT01837654|20354701|P1|STARTED|Overall Study||11
8254463|NCT01837550|20354711|P2|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
8254464|NCT01837550|20354712|P1|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
8254465|NCT01837550|20354711|P2|COMPLETED|T0-T2, 6 Months Follow-up||37
8254466|NCT01837550|20354712|P1|COMPLETED|T0-T2, 6 Months Follow-up||37
8254467|NCT01837550|20354711|P2|STARTED|T0-T2, 6 Months Follow-up||37
8254468|NCT01837550|20354712|P1|STARTED|T0-T2, 6 Months Follow-up||37
8254469|NCT01837550|20354711|P2|NOT COMPLETED|T0-T1, 5 Weeks||0
8254470|NCT01837550|20354712|P1|NOT COMPLETED|T0-T1, 5 Weeks||0
8254471|NCT01837550|20354711|P2|COMPLETED|T0-T1, 5 Weeks||37
8254472|NCT01837550|20354712|P1|COMPLETED|T0-T1, 5 Weeks||37
8254473|NCT01837550|20354711|P2|STARTED|T0-T1, 5 Weeks||37
8254474|NCT01837550|20354712|P1|STARTED|T0-T1, 5 Weeks||37
8254475|NCT01837537|20354724|P1|NOT COMPLETED|Overall Study||0
8254476|NCT01837537|20354724|P1|COMPLETED|Overall Study||90
8254477|NCT01837537|20354724|P1|STARTED|Overall Study||90
8254478|NCT01837524|20354731|P2|NOT COMPLETED|Overall Study||2
8254479|NCT01837524|20354732|P1|NOT COMPLETED|Overall Study||3
8254480|NCT01837524|20354731|P2|COMPLETED|Overall Study||25
8254481|NCT01837524|20354732|P1|COMPLETED|Overall Study||25
8254482|NCT01837524|20354731|P2|STARTED|Overall Study||27
8254483|NCT01837524|20354732|P1|STARTED|Overall Study||28
8254484|NCT01837069|20354740|P2|NOT COMPLETED|Overall Study||0
8254485|NCT01837069|20354741|P1|NOT COMPLETED|Overall Study||0
8254486|NCT01837069|20354740|P2|COMPLETED|Overall Study||95
8254487|NCT01837069|20354741|P1|COMPLETED|Overall Study||103
8254488|NCT01837069|20354740|P2|STARTED|Overall Study||95
8254489|NCT01837069|20354741|P1|STARTED|Overall Study||103
8254490|NCT01836809|20354757|P4|NOT COMPLETED|Overall Study||2
8254491|NCT01836809|20354758|P3|NOT COMPLETED|Overall Study||0
8254492|NCT01836809|20354759|P2|NOT COMPLETED|Overall Study||0
8254493|NCT01836809|20354760|P1|NOT COMPLETED|Overall Study||0
8254494|NCT01836809|20354757|P4|COMPLETED|Overall Study||0
8254495|NCT01836809|20354758|P3|COMPLETED|Overall Study||0
8254496|NCT01836809|20354759|P2|COMPLETED|Overall Study||0
8254497|NCT01836809|20354760|P1|COMPLETED|Overall Study||0
8254498|NCT01836809|20354757|P4|STARTED|Overall Study||2
8254499|NCT01836809|20354758|P3|STARTED|Overall Study||0
8254500|NCT01836809|20354759|P2|STARTED|Overall Study||0
8254501|NCT01836809|20354760|P1|STARTED|Overall Study||0
8254502|NCT01836549|20354796|P7|NOT COMPLETED|Overall Study||1
8254503|NCT01836549|20354797|P6|NOT COMPLETED|Overall Study||0
8254504|NCT01836549|20354798|P5|NOT COMPLETED|Overall Study||0
8254505|NCT01836549|20354799|P4|NOT COMPLETED|Overall Study||1
8254506|NCT01836549|20354800|P3|NOT COMPLETED|Overall Study||1
8254507|NCT01836549|20354801|P2|NOT COMPLETED|Overall Study||0
8254508|NCT01836549|20354802|P1|NOT COMPLETED|Overall Study||0
8254509|NCT01836549|20354796|P7|COMPLETED|Overall Study||8
8254510|NCT01836549|20354797|P6|COMPLETED|Overall Study||4
8254511|NCT01836549|20354798|P5|COMPLETED|Overall Study||18
8254512|NCT01836549|20354799|P4|COMPLETED|Overall Study||8
8254513|NCT01836549|20354800|P3|COMPLETED|Overall Study||0
8254514|NCT01836549|20354801|P2|COMPLETED|Overall Study||1
8254515|NCT01836549|20354802|P1|COMPLETED|Overall Study||1
8254516|NCT01836549|20354796|P7|STARTED|Overall Study||9
8254517|NCT01836549|20354797|P6|STARTED|Overall Study||4
8254518|NCT01836549|20354798|P5|STARTED|Overall Study||18
8254519|NCT01836549|20354799|P4|STARTED|Overall Study||9
8254520|NCT01836549|20354800|P3|STARTED|Overall Study||1
8254521|NCT01836549|20354801|P2|STARTED|Overall Study||1
8254522|NCT01836549|20354802|P1|STARTED|Overall Study||1
8254523|NCT01836523|20354826|P4|NOT COMPLETED|Overall Study||74
8254524|NCT01836523|20354827|P3|NOT COMPLETED|Overall Study||91
8254525|NCT01836523|20354828|P2|NOT COMPLETED|Overall Study||85
8254526|NCT01836523|20354829|P1|NOT COMPLETED|Overall Study||51
8254527|NCT01836523|20354826|P4|COMPLETED|Overall Study||274
8254528|NCT01836523|20354827|P3|COMPLETED|Overall Study||258
8254529|NCT01836523|20354828|P2|COMPLETED|Overall Study||265
8254530|NCT01836523|20354829|P1|COMPLETED|Overall Study||300
8254531|NCT01836523|20354826|P4|Exposed|Overall Study||348
8254532|NCT01836523|20354827|P3|Exposed|Overall Study||347
8254533|NCT01836523|20354828|P2|Exposed|Overall Study||348
8254534|NCT01836523|20354829|P1|Exposed|Overall Study||350
8254535|NCT01836523|20354826|P4|STARTED|Overall Study||348
8254536|NCT01836523|20354827|P3|STARTED|Overall Study||349
8254537|NCT01836523|20354828|P2|STARTED|Overall Study||350
8254538|NCT01836523|20354829|P1|STARTED|Overall Study||351
8254539|NCT01836471|20354856|P5|NOT COMPLETED|Overall Study||5
8254540|NCT01836471|20354857|P4|NOT COMPLETED|Overall Study||2
8254541|NCT01836471|20354858|P3|NOT COMPLETED|Overall Study||2
8254542|NCT01836471|20354859|P2|NOT COMPLETED|Overall Study||9
8254543|NCT01836471|20354860|P1|NOT COMPLETED|Overall Study||11
8254544|NCT01836471|20354856|P5|COMPLETED|Overall Study||49
8254545|NCT01836471|20354857|P4|COMPLETED|Overall Study||40
8254546|NCT01836471|20354858|P3|COMPLETED|Overall Study||49
8254547|NCT01836471|20354859|P2|COMPLETED|Overall Study||85
8254548|NCT01836471|20354860|P1|COMPLETED|Overall Study||82
8254549|NCT01836471|20354856|P5|STARTED|Overall Study||54
8254550|NCT01836471|20354857|P4|STARTED|Overall Study||42
8254551|NCT01836471|20354858|P3|STARTED|Overall Study||51
8254552|NCT01836471|20354859|P2|STARTED|Overall Study||94
8254553|NCT01836471|20354860|P1|STARTED|Overall Study||93
8254554|NCT01836458|20354889|P4|NOT COMPLETED|Overall Study||6
8254555|NCT01836458|20354890|P3|NOT COMPLETED|Overall Study||5
8254556|NCT01836458|20354891|P2|NOT COMPLETED|Overall Study||2
8254557|NCT01836458|20354892|P1|NOT COMPLETED|Overall Study||3
8254558|NCT01836458|20354889|P4|COMPLETED|Overall Study||1
8254559|NCT01836458|20354890|P3|COMPLETED|Overall Study||2
8254560|NCT01836458|20354891|P2|COMPLETED|Overall Study||2
8254561|NCT01836458|20354892|P1|COMPLETED|Overall Study||4
8254562|NCT01836458|20354889|P4|STARTED|Overall Study||7
8254563|NCT01836458|20354890|P3|STARTED|Overall Study||7
8254564|NCT01836458|20354891|P2|STARTED|Overall Study||4
8254565|NCT01836458|20354892|P1|STARTED|Overall Study||7
8254566|NCT01836445|20354916|P2|NOT COMPLETED|12 Month STI Testing||77
8254567|NCT01836445|20354917|P1|NOT COMPLETED|12 Month STI Testing||80
8254568|NCT01836445|20354916|P2|COMPLETED|12 Month STI Testing||378
8254569|NCT01836445|20354917|P1|COMPLETED|12 Month STI Testing||365
8254570|NCT01836445|20354916|P2|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
8254571|NCT01836445|20354917|P1|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
8254572|NCT01836445|20354916|P2|NOT COMPLETED|12 Month Follow-up Assessment||64
8254573|NCT01836445|20354917|P1|NOT COMPLETED|12 Month Follow-up Assessment||75
8254574|NCT01836445|20354916|P2|COMPLETED|12 Month Follow-up Assessment||391
8254575|NCT01836445|20354917|P1|COMPLETED|12 Month Follow-up Assessment||370
8254576|NCT01836445|20354916|P2|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
8254577|NCT01836445|20354917|P1|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
8254578|NCT01836445|20354916|P2|NOT COMPLETED|6 Month Follow-up Assessment||75
8254579|NCT01836445|20354917|P1|NOT COMPLETED|6 Month Follow-up Assessment||103
8254580|NCT01836445|20354916|P2|COMPLETED|6 Month Follow-up Assessment||380
8254581|NCT01836445|20354917|P1|COMPLETED|6 Month Follow-up Assessment||342
8254582|NCT01836445|20354916|P2|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
8254583|NCT01836445|20354917|P1|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
8254584|NCT01836445|20354916|P2|NOT COMPLETED|3 Month Follow-up Assessment||47
8254585|NCT01836445|20354917|P1|NOT COMPLETED|3 Month Follow-up Assessment||97
8254586|NCT01836445|20354916|P2|COMPLETED|3 Month Follow-up Assessment||409
8254587|NCT01836445|20354917|P1|COMPLETED|3 Month Follow-up Assessment||348
8254588|NCT01836445|20354916|P2|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
8254589|NCT01836445|20354917|P1|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
8254590|NCT01836445|20354916|P2|NOT COMPLETED|Intervention Modules||22
8254591|NCT01836445|20354917|P1|NOT COMPLETED|Intervention Modules||70
8254592|NCT01836445|20354916|P2|COMPLETED|Intervention Modules||434
8254593|NCT01836445|20354917|P1|COMPLETED|Intervention Modules||375
8254594|NCT01836445|20354916|P2|STARTED|Intervention Modules||456
8254595|NCT01836445|20354917|P1|STARTED|Intervention Modules||445
8254596|NCT01836276|20354977|P2|NOT COMPLETED|Overall Study||51
8254597|NCT01836276|20354978|P1|NOT COMPLETED|Overall Study||28
8254598|NCT01836276|20354977|P2|COMPLETED|Overall Study||174
8254599|NCT01836276|20354978|P1|COMPLETED|Overall Study||196
8254600|NCT01836276|20354977|P2|Week 12|Overall Study||165
8254601|NCT01836276|20354978|P1|Week 12|Overall Study||183
8254602|NCT01836276|20354977|P2|Week 4|Overall Study||186
8254603|NCT01836276|20354978|P1|Week 4|Overall Study||198
8254604|NCT01836276|20354977|P2|STARTED|Overall Study||225
8254605|NCT01836276|20354978|P1|STARTED|Overall Study||224
8254606|NCT01836198|20354986|P3|NOT COMPLETED|Part B||0
8254607|NCT01836198|20354987|P2|NOT COMPLETED|Part B||0
8254608|NCT01836198|20354988|P1|NOT COMPLETED|Part B||0
8254609|NCT01836198|20354986|P3|COMPLETED|Part B||12
8254610|NCT01836198|20354987|P2|COMPLETED|Part B||0
8254611|NCT01836198|20354988|P1|COMPLETED|Part B||0
8254612|NCT01836198|20354986|P3|Received at Least 1 Dose of Study Drug|Part B||12
8254613|NCT01836198|20354987|P2|Received at Least 1 Dose of Study Drug|Part B||0
8254614|NCT01836198|20354988|P1|Received at Least 1 Dose of Study Drug|Part B||0
8254615|NCT01836198|20354986|P3|STARTED|Part B||12
8254616|NCT01836198|20354987|P2|STARTED|Part B||0
8254617|NCT01836198|20354988|P1|STARTED|Part B||0
8254618|NCT01836198|20354986|P3|NOT COMPLETED|Part A, Period 2||0
8254619|NCT01836198|20354987|P2|NOT COMPLETED|Part A, Period 2||1
8254620|NCT01836198|20354988|P1|NOT COMPLETED|Part A, Period 2||0
8254621|NCT01836198|20354986|P3|COMPLETED|Part A, Period 2||0
8254622|NCT01836198|20354987|P2|COMPLETED|Part A, Period 2||14
8254623|NCT01836198|20354988|P1|COMPLETED|Part A, Period 2||15
8254624|NCT01836198|20354986|P3|Completed Part A, Entered Part B|Part A, Period 2||0
8254625|NCT01836198|20354987|P2|Completed Part A, Entered Part B|Part A, Period 2||6
8254626|NCT01836198|20354988|P1|Completed Part A, Entered Part B|Part A, Period 2||6
8254627|NCT01836198|20354986|P3|STARTED|Part A, Period 2||0
8254628|NCT01836198|20354987|P2|STARTED|Part A, Period 2||15
8254629|NCT01836198|20354988|P1|STARTED|Part A, Period 2||15
8254630|NCT01836198|20354986|P3|NOT COMPLETED|Part A, Period 1||0
8254631|NCT01836198|20354987|P2|NOT COMPLETED|Part A, Period 1||0
8254632|NCT01836198|20354988|P1|NOT COMPLETED|Part A, Period 1||0
8254633|NCT01836198|20354986|P3|COMPLETED|Part A, Period 1||0
8254634|NCT01836198|20354987|P2|COMPLETED|Part A, Period 1||15
8254635|NCT01836198|20354988|P1|COMPLETED|Part A, Period 1||15
8254636|NCT01836198|20354986|P3|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
8254637|NCT01836198|20354987|P2|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
8254638|NCT01836198|20354988|P1|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
8254639|NCT01836198|20354986|P3|STARTED|Part A, Period 1||0
8254640|NCT01836198|20354987|P2|STARTED|Part A, Period 1||15
8254641|NCT01836198|20354988|P1|STARTED|Part A, Period 1||15
8254642|NCT01836185|20355014|P4|NOT COMPLETED|Overall Study||0
8254643|NCT01836185|20355015|P3|NOT COMPLETED|Overall Study||0
8254644|NCT01836185|20355016|P2|NOT COMPLETED|Overall Study||0
8254645|NCT01836185|20355017|P1|NOT COMPLETED|Overall Study||0
8254646|NCT01836185|20355014|P4|COMPLETED|Overall Study||6
8254647|NCT01836185|20355015|P3|COMPLETED|Overall Study||8
8254648|NCT01836185|20355016|P2|COMPLETED|Overall Study||8
8254649|NCT01836185|20355017|P1|COMPLETED|Overall Study||10
8254650|NCT01836185|20355014|P4|Received Single Dose of Study Treatment|Overall Study||6
8254651|NCT01836185|20355015|P3|Received Single Dose of Study Treatment|Overall Study||8
8254652|NCT01836185|20355016|P2|Received Single Dose of Study Treatment|Overall Study||8
8254653|NCT01836185|20355017|P1|Received Single Dose of Study Treatment|Overall Study||10
8254654|NCT01836185|20355014|P4|STARTED|Overall Study||6
8254655|NCT01836185|20355015|P3|STARTED|Overall Study||8
8254656|NCT01836185|20355016|P2|STARTED|Overall Study||8
8254657|NCT01836185|20355017|P1|STARTED|Overall Study||10
8254658|NCT01836133|20355035|P1|NOT COMPLETED|Overall Study||0
8254659|NCT01836133|20355035|P1|COMPLETED|Overall Study||70
8254660|NCT01836133|20355035|P1|STARTED|Overall Study||70
8254661|NCT01836042|20355044|P3|NOT COMPLETED|Overall Study||0
8254662|NCT01836042|20355045|P2|NOT COMPLETED|Overall Study||0
8254663|NCT01836042|20355046|P1|NOT COMPLETED|Overall Study||0
8254664|NCT01836042|20355044|P3|COMPLETED|Overall Study||22
8254665|NCT01836042|20355045|P2|COMPLETED|Overall Study||35
8254666|NCT01836042|20355046|P1|COMPLETED|Overall Study||51
8254667|NCT01836042|20355044|P3|STARTED|Overall Study||22
8254668|NCT01836042|20355045|P2|STARTED|Overall Study||35
8254669|NCT01836042|20355046|P1|STARTED|Overall Study||51
8254670|NCT01836029|20355056|P2|NOT COMPLETED|Overall Study||0
8254671|NCT01836029|20355057|P1|NOT COMPLETED|Overall Study||0
8254672|NCT01836029|20355056|P2|COMPLETED|Overall Study||95
8254673|NCT01836029|20355057|P1|COMPLETED|Overall Study||100
8254674|NCT01836029|20355056|P2|STARTED|Overall Study||95
8254675|NCT01836029|20355057|P1|STARTED|Overall Study||100
8254676|NCT01835912|20355069|P1|NOT COMPLETED|Overall Study||0
8254677|NCT01835912|20355069|P1|COMPLETED|Overall Study||10
8254678|NCT01835912|20355069|P1|Chronic Placebo|Overall Study||10
8254679|NCT01835912|20355069|P1|Chronic|Overall Study||10
8254680|NCT01835912|20355069|P1|Acute Placebo|Overall Study||10
8254681|NCT01835912|20355069|P1|Acute|Overall Study||10
8254682|NCT01835912|20355069|P1|STARTED|Overall Study||10
8254683|NCT01835899|20355090|P3|NOT COMPLETED|Overall Study||1
8254684|NCT01835899|20355091|P2|NOT COMPLETED|Overall Study||1
8254685|NCT01835899|20355092|P1|NOT COMPLETED|Overall Study||0
8254686|NCT01835899|20355090|P3|COMPLETED|Overall Study||8
8254687|NCT01835899|20355091|P2|COMPLETED|Overall Study||8
8254688|NCT01835899|20355092|P1|COMPLETED|Overall Study||6
8254689|NCT01835899|20355090|P3|STARTED|Overall Study||9
8254690|NCT01835899|20355091|P2|STARTED|Overall Study||9
8254691|NCT01835899|20355092|P1|STARTED|Overall Study||6
8254692|NCT01835756|20355112|P2|NOT COMPLETED|Overall Study||0
8254693|NCT01835756|20355113|P1|NOT COMPLETED|Overall Study||0
8254694|NCT01835756|20355112|P2|COMPLETED|Overall Study||31
8254695|NCT01835756|20355113|P1|COMPLETED|Overall Study||31
8254696|NCT01835756|20355112|P2|STARTED|Overall Study||31
8254697|NCT01835756|20355113|P1|STARTED|Overall Study||31
8254698|NCT01835743|20355125|P2|NOT COMPLETED|Overall Study||0
8254699|NCT01835743|20355126|P1|NOT COMPLETED|Overall Study||0
8254700|NCT01835743|20355125|P2|COMPLETED|Overall Study||32
8254701|NCT01835743|20355126|P1|COMPLETED|Overall Study||37
8254702|NCT01835743|20355125|P2|STARTED|Overall Study||32
8254703|NCT01835743|20355126|P1|STARTED|Overall Study||37
8254707|NCT01835587|20355149|P4|NOT COMPLETED|Overall Study||9
8254708|NCT01835587|20355150|P3|NOT COMPLETED|Overall Study||2
8254709|NCT01835587|20355151|P2|NOT COMPLETED|Overall Study||4
8254710|NCT01835587|20355152|P1|NOT COMPLETED|Overall Study||2
8254711|NCT01835587|20355149|P4|COMPLETED|Overall Study||10
8254712|NCT01835587|20355150|P3|COMPLETED|Overall Study||2
8254713|NCT01835587|20355151|P2|COMPLETED|Overall Study||0
8254714|NCT01835587|20355152|P1|COMPLETED|Overall Study||1
8254715|NCT01835587|20355149|P4|STARTED|Overall Study||19
8254716|NCT01835587|20355150|P3|STARTED|Overall Study||4
8254717|NCT01835587|20355151|P2|STARTED|Overall Study||4
8254718|NCT01835587|20355152|P1|STARTED|Overall Study||3
8254719|NCT01835548|20355213|P3|NOT COMPLETED|Double-Blind Treatment Period||0
8254720|NCT01835548|20355214|P2|NOT COMPLETED|Double-Blind Treatment Period||2
8254721|NCT01835548|20355215|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8254722|NCT01835548|20355213|P3|COMPLETED|Double-Blind Treatment Period||0
8254723|NCT01835548|20355214|P2|COMPLETED|Double-Blind Treatment Period||39
8254724|NCT01835548|20355215|P1|COMPLETED|Double-Blind Treatment Period||44
8254725|NCT01835548|20355213|P3|STARTED|Double-Blind Treatment Period||0
8254726|NCT01835548|20355214|P2|STARTED|Double-Blind Treatment Period||41
8254727|NCT01835548|20355215|P1|STARTED|Double-Blind Treatment Period||44
8254728|NCT01835548|20355213|P3|NOT COMPLETED|Dose Stabilization Period||0
8254729|NCT01835548|20355214|P2|NOT COMPLETED|Dose Stabilization Period||0
8254730|NCT01835548|20355215|P1|NOT COMPLETED|Dose Stabilization Period||0
8254731|NCT01835548|20355213|P3|COMPLETED|Dose Stabilization Period||85
8254732|NCT01835548|20355214|P2|COMPLETED|Dose Stabilization Period||0
8254733|NCT01835548|20355215|P1|COMPLETED|Dose Stabilization Period||0
8254734|NCT01835548|20355213|P3|STARTED|Dose Stabilization Period||85
8254735|NCT01835548|20355214|P2|STARTED|Dose Stabilization Period||0
8254736|NCT01835548|20355215|P1|STARTED|Dose Stabilization Period||0
8254737|NCT01835548|20355213|P3|NOT COMPLETED|Dose Optimization Period||2
8254738|NCT01835548|20355214|P2|NOT COMPLETED|Dose Optimization Period||0
8254739|NCT01835548|20355215|P1|NOT COMPLETED|Dose Optimization Period||0
8254740|NCT01835548|20355213|P3|COMPLETED|Dose Optimization Period||85
8254741|NCT01835548|20355214|P2|COMPLETED|Dose Optimization Period||0
8254742|NCT01835548|20355215|P1|COMPLETED|Dose Optimization Period||0
8254743|NCT01835548|20355213|P3|STARTED|Dose Optimization Period||87
8254744|NCT01835548|20355214|P2|STARTED|Dose Optimization Period||0
8254745|NCT01835548|20355215|P1|STARTED|Dose Optimization Period||0
8254746|NCT01835548|20355213|P3|NOT COMPLETED|Screening/Washout Period||0
8254747|NCT01835548|20355214|P2|NOT COMPLETED|Screening/Washout Period||0
8254748|NCT01835548|20355215|P1|NOT COMPLETED|Screening/Washout Period||0
8254749|NCT01835548|20355213|P3|COMPLETED|Screening/Washout Period||87
8254750|NCT01835548|20355214|P2|COMPLETED|Screening/Washout Period||0
8254751|NCT01835548|20355215|P1|COMPLETED|Screening/Washout Period||0
8254752|NCT01835548|20355213|P3|STARTED|Screening/Washout Period||87
8254753|NCT01835548|20355214|P2|STARTED|Screening/Washout Period||0
8254754|NCT01835548|20355215|P1|STARTED|Screening/Washout Period||0
8254755|NCT01835496|20355235|P1|NOT COMPLETED|Overall Study||0
8254756|NCT01835496|20355235|P1|COMPLETED|Overall Study||8
8254757|NCT01835496|20355235|P1|STARTED|Overall Study||8
8254764|NCT01835431|20355256|P2|NOT COMPLETED|Overall Study||12
8254765|NCT01835431|20355257|P1|NOT COMPLETED|Overall Study||8
8254766|NCT01835431|20355256|P2|COMPLETED|Overall Study||168
8254767|NCT01835431|20355257|P1|COMPLETED|Overall Study||174
8254768|NCT01835431|20355256|P2|Exposed|Overall Study|One subject was withdrawn before exposure|179
8254769|NCT01835431|20355257|P1|Exposed|Overall Study|One subject was withdrawn before exposure.|181
8254770|NCT01835431|20355256|P2|STARTED|Overall Study||180
8254771|NCT01835431|20355257|P1|STARTED|Overall Study||182
8254772|NCT01835379|20355277|P2|NOT COMPLETED|Overall Study||0
8254773|NCT01835379|20355278|P1|NOT COMPLETED|Overall Study||0
8254774|NCT01835379|20355277|P2|COMPLETED|Overall Study||41
8254775|NCT01835379|20355278|P1|COMPLETED|Overall Study||41
8254776|NCT01835379|20355277|P2|STARTED|Overall Study||41
8254777|NCT01835379|20355278|P1|STARTED|Overall Study||41
8254778|NCT01835262|20355288|P2|NOT COMPLETED|Overall Study||0
8254779|NCT01835262|20355289|P1|NOT COMPLETED|Overall Study||0
8254780|NCT01835262|20355288|P2|COMPLETED|Overall Study||45
8254781|NCT01835262|20355289|P1|COMPLETED|Overall Study||45
8254782|NCT01835262|20355288|P2|STARTED|Overall Study||45
8254783|NCT01835262|20355289|P1|STARTED|Overall Study||45
8254784|NCT01835223|20355297|P2|NOT COMPLETED|Overall Study||1
8254785|NCT01835223|20355298|P1|NOT COMPLETED|Overall Study||9
8254786|NCT01835223|20355297|P2|COMPLETED|Overall Study||2
8254787|NCT01835223|20355298|P1|COMPLETED|Overall Study||21
8254788|NCT01835223|20355297|P2|STARTED|Overall Study||3
8254789|NCT01835223|20355298|P1|STARTED|Overall Study||30
8254802|NCT01835132|20355347|P1|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
8254803|NCT01835132|20355347|P1|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
8254804|NCT01835132|20355347|P1|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
8254805|NCT01835132|20355347|P1|NOT COMPLETED|1st Extension Phase||0
8254806|NCT01835132|20355347|P1|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
8254807|NCT01835132|20355347|P1|STARTED|1st Extension Phase||6
8254808|NCT01835132|20355347|P1|NOT COMPLETED|Initial Phase||2
8254809|NCT01835132|20355347|P1|COMPLETED|Initial Phase||6
8254810|NCT01835132|20355347|P1|STARTED|Initial Phase||8
8254811|NCT01835015|20355392|P5|NOT COMPLETED|Overall Study||0
8254812|NCT01835015|20355393|P4|NOT COMPLETED|Overall Study||0
8254813|NCT01835015|20355394|P3|NOT COMPLETED|Overall Study||1
8254814|NCT01835015|20355395|P2|NOT COMPLETED|Overall Study||0
8254815|NCT01835015|20355396|P1|NOT COMPLETED|Overall Study||0
8254816|NCT01835015|20355392|P5|COMPLETED|Overall Study||6
8254817|NCT01835015|20355393|P4|COMPLETED|Overall Study||6
8254818|NCT01835015|20355394|P3|COMPLETED|Overall Study||6
8254819|NCT01835015|20355395|P2|COMPLETED|Overall Study||6
8254820|NCT01835015|20355396|P1|COMPLETED|Overall Study||6
8254821|NCT01835015|20355392|P5|STARTED|Overall Study||6
8254822|NCT01835015|20355393|P4|STARTED|Overall Study||6
8254823|NCT01835015|20355394|P3|STARTED|Overall Study||7
8254824|NCT01835015|20355395|P2|STARTED|Overall Study||6
8254825|NCT01835015|20355396|P1|STARTED|Overall Study||6
8254826|NCT01834729|20355473|P4|NOT COMPLETED|Overall Study||2
8254827|NCT01834729|20355474|P3|NOT COMPLETED|Overall Study||3
8254828|NCT01834729|20355475|P2|NOT COMPLETED|Overall Study||1
8254829|NCT01834729|20355476|P1|NOT COMPLETED|Overall Study||1
8254830|NCT01834729|20355473|P4|COMPLETED|Overall Study||16
8254831|NCT01834729|20355474|P3|COMPLETED|Overall Study||15
8254832|NCT01834729|20355475|P2|COMPLETED|Overall Study||19
8254833|NCT01834729|20355476|P1|COMPLETED|Overall Study||17
8254834|NCT01834729|20355473|P4|STARTED|Overall Study||18
8254835|NCT01834729|20355474|P3|STARTED|Overall Study||18
8254836|NCT01834729|20355475|P2|STARTED|Overall Study||20
8254837|NCT01834729|20355476|P1|STARTED|Overall Study||18
8254838|NCT01834716|20355492|P2|NOT COMPLETED|Overall Study||1
8254839|NCT01834716|20355493|P1|NOT COMPLETED|Overall Study||0
8254840|NCT01834716|20355492|P2|COMPLETED|Overall Study||11
8254841|NCT01834716|20355493|P1|COMPLETED|Overall Study||4
8254842|NCT01834716|20355492|P2|STARTED|Overall Study||12
8254843|NCT01834716|20355493|P1|STARTED|Overall Study||4
8254844|NCT01834651|20355499|P1|NOT COMPLETED|Overall Study||1
8254845|NCT01834651|20355499|P1|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
8254846|NCT01834651|20355499|P1|STARTED|Overall Study||17
8254847|NCT01834586|20355509|P1|NOT COMPLETED|Overall Study||1
8254848|NCT01834586|20355509|P1|COMPLETED|Overall Study||29
8254849|NCT01834586|20355509|P1|STARTED|Overall Study||30
8254850|NCT01834404|20355516|P2|NOT COMPLETED|Overall Study||0
8254851|NCT01834404|20355517|P1|NOT COMPLETED|Overall Study||0
8254852|NCT01834404|20355516|P2|COMPLETED|Overall Study||12
8254853|NCT01834404|20355517|P1|COMPLETED|Overall Study||12
8254854|NCT01834404|20355516|P2|STARTED|Overall Study||12
8254855|NCT01834404|20355517|P1|STARTED|Overall Study||12
8254856|NCT01834274|20355549|P2|NOT COMPLETED|Overall Study||41
8254857|NCT01834274|20355550|P1|NOT COMPLETED|Overall Study||47
8254858|NCT01834274|20355549|P2|COMPLETED|Overall Study||5
8254859|NCT01834274|20355550|P1|COMPLETED|Overall Study||3
8254860|NCT01834274|20355549|P2|STARTED|Overall Study||46
8254861|NCT01834274|20355550|P1|STARTED|Overall Study||50
8254862|NCT01834261|20355562|P2|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
8254863|NCT01834261|20355563|P1|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
8254864|NCT01834261|20355562|P2|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
8254865|NCT01834261|20355563|P1|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
8254866|NCT01834261|20355562|P2|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
8254867|NCT01834261|20355563|P1|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
8254868|NCT01834261|20355562|P2|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
8254869|NCT01834261|20355563|P1|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
8254870|NCT01834261|20355562|P2|COMPLETED|MIT fMRI and MEG Resting State Study||9
8254871|NCT01834261|20355563|P1|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
8254872|NCT01834261|20355562|P2|STARTED|MIT fMRI and MEG Resting State Study||10
8254873|NCT01834261|20355563|P1|STARTED|MIT fMRI and MEG Resting State Study||11
8254874|NCT01834222|20355573|P1|NOT COMPLETED|Overall Study||1
8254875|NCT01834222|20355573|P1|COMPLETED|Overall Study||658
8254876|NCT01834222|20355573|P1|Treated|Overall Study||658
8254877|NCT01834222|20355573|P1|STARTED|Overall Study||659
8254878|NCT01834144|20355584|P2|NOT COMPLETED|Overall Study||1
8254879|NCT01834144|20355585|P1|NOT COMPLETED|Overall Study||0
8254880|NCT01834144|20355584|P2|COMPLETED|Overall Study||2
8254881|NCT01834144|20355585|P1|COMPLETED|Overall Study||1
8254882|NCT01834144|20355584|P2|STARTED|Overall Study||3
8254883|NCT01834144|20355585|P1|STARTED|Overall Study||1
8254884|NCT01834027|20355593|P2|NOT COMPLETED|Overall Study||0
8254885|NCT01834027|20355594|P1|NOT COMPLETED|Overall Study||0
8254886|NCT01834027|20355593|P2|COMPLETED|Overall Study||28
8254887|NCT01834027|20355594|P1|COMPLETED|Overall Study||28
8254888|NCT01834027|20355593|P2|STARTED|Overall Study||28
8254889|NCT01834027|20355594|P1|STARTED|Overall Study||28
8254890|NCT01833988|20355604|P2|NOT COMPLETED|Overall Study||0
8254891|NCT01833988|20355605|P1|NOT COMPLETED|Overall Study||0
8254892|NCT01833988|20355604|P2|COMPLETED|Overall Study||16
8254893|NCT01833988|20355605|P1|COMPLETED|Overall Study||16
8254894|NCT01833988|20355604|P2|STARTED|Overall Study||16
8254895|NCT01833988|20355605|P1|STARTED|Overall Study||16
8254896|NCT01833936|20355661|P2|NOT COMPLETED|Overall Study||2
8254897|NCT01833936|20355662|P1|NOT COMPLETED|Overall Study||4
8254898|NCT01833936|20355661|P2|COMPLETED|Overall Study||18
8254899|NCT01833936|20355662|P1|COMPLETED|Overall Study||16
8254900|NCT01833936|20355661|P2|STARTED|Overall Study||20
8254901|NCT01833936|20355662|P1|STARTED|Overall Study||20
8254902|NCT01833897|20355668|P1|NOT COMPLETED|Overall Study||1
8254903|NCT01833897|20355668|P1|COMPLETED|Overall Study||7
8254904|NCT01833897|20355668|P1|STARTED|Overall Study||8
8254905|NCT01833845|20355676|P1|NOT COMPLETED|Overall Study||0
8254906|NCT01833845|20355676|P1|COMPLETED|Overall Study||4
8254907|NCT01833845|20355676|P1|STARTED|Overall Study||4
8254908|NCT01833832|20355680|P1|NOT COMPLETED|Overall Study||1
8254909|NCT01833832|20355680|P1|COMPLETED|Overall Study||10
8254910|NCT01833832|20355680|P1|STARTED|Overall Study||11
8254911|NCT01833754|20355691|P3|NOT COMPLETED|Overall Study||0
8254912|NCT01833754|20355692|P2|NOT COMPLETED|Overall Study||0
8254913|NCT01833754|20355693|P1|NOT COMPLETED|Overall Study||0
8254914|NCT01833754|20355691|P3|COMPLETED|Overall Study||8
8254915|NCT01833754|20355692|P2|COMPLETED|Overall Study||8
8254916|NCT01833754|20355693|P1|COMPLETED|Overall Study||8
8254917|NCT01833754|20355691|P3|STARTED|Overall Study||8
8254918|NCT01833754|20355692|P2|STARTED|Overall Study||8
8254919|NCT01833754|20355693|P1|STARTED|Overall Study||8
8254920|NCT01833741|20355722|P1|NOT COMPLETED|Overall Study||140
8254921|NCT01833741|20355722|P1|COMPLETED|Overall Study||997
8254922|NCT01833741|20355722|P1|STARTED|Overall Study||1137
8254923|NCT01833546|20355739|P4|NOT COMPLETED|Overall Study||0
8254924|NCT01833546|20355740|P3|NOT COMPLETED|Overall Study||0
8254925|NCT01833546|20355741|P2|NOT COMPLETED|Overall Study||0
8254926|NCT01833546|20355742|P1|NOT COMPLETED|Overall Study||0
8254927|NCT01833546|20355739|P4|COMPLETED|Overall Study||6
8254928|NCT01833546|20355740|P3|COMPLETED|Overall Study||8
8254929|NCT01833546|20355741|P2|COMPLETED|Overall Study||3
8254930|NCT01833546|20355742|P1|COMPLETED|Overall Study||3
8254931|NCT01833546|20355739|P4|STARTED|Overall Study||6
8254932|NCT01833546|20355740|P3|STARTED|Overall Study||8
8254933|NCT01833546|20355741|P2|STARTED|Overall Study||3
8254934|NCT01833546|20355742|P1|STARTED|Overall Study||3
8254941|NCT01833494|20355850|P1|NOT COMPLETED|Overall Study||45
8254942|NCT01833494|20355850|P1|COMPLETED|Overall Study||116
8254943|NCT01833494|20355850|P1|STARTED|Overall Study||161
8254944|NCT01833481|20355860|P3|NOT COMPLETED|Overall Study||0
8254945|NCT01833481|20355861|P2|NOT COMPLETED|Overall Study||0
8254946|NCT01833481|20355862|P1|NOT COMPLETED|Overall Study||0
8254947|NCT01833481|20355860|P3|COMPLETED|Overall Study||10
8254948|NCT01833481|20355861|P2|COMPLETED|Overall Study||10
8254949|NCT01833481|20355862|P1|COMPLETED|Overall Study||10
8254950|NCT01833481|20355860|P3|STARTED|Overall Study||10
8254951|NCT01833481|20355861|P2|STARTED|Overall Study||10
8254952|NCT01833481|20355862|P1|STARTED|Overall Study||10
8254953|NCT01833455|20355878|P2|NOT COMPLETED|Overall Study||0
8254954|NCT01833455|20355879|P1|NOT COMPLETED|Overall Study||1
8254955|NCT01833455|20355878|P2|COMPLETED|Overall Study||4
8254956|NCT01833455|20355879|P1|COMPLETED|Overall Study||3
8254957|NCT01833455|20355878|P2|Completed 2nd Baseline (Washout)|Overall Study||4
8254958|NCT01833455|20355879|P1|Completed 2nd Baseline (Washout)|Overall Study||3
8254959|NCT01833455|20355878|P2|Completed 1st Intervention|Overall Study||4
8254960|NCT01833455|20355879|P1|Completed 1st Intervention|Overall Study||3
8254961|NCT01833455|20355878|P2|Completed 1st Baseline|Overall Study||4
8254962|NCT01833455|20355879|P1|Completed 1st Baseline|Overall Study||4
8254963|NCT01833455|20355878|P2|STARTED|Overall Study||4
8254964|NCT01833455|20355879|P1|STARTED|Overall Study||4
8254965|NCT01833403|20355897|P1|NOT COMPLETED|Overall Study||0
8254966|NCT01833403|20355897|P1|COMPLETED|Overall Study||4
8254967|NCT01833403|20355897|P1|STARTED|Overall Study||4
8254968|NCT01833247|20355902|P1|NOT COMPLETED|Overall Study||0
8254969|NCT01833247|20355902|P1|COMPLETED|Overall Study||12
8254970|NCT01833247|20355902|P1|STARTED|Overall Study||12
8254971|NCT01833169|20355908|P1|NOT COMPLETED|Overall Study||146
8254972|NCT01833169|20355908|P1|COMPLETED|Overall Study||0
8254973|NCT01833169|20355908|P1|Consented to be Followed for Survival|Overall Study||128
8254974|NCT01833169|20355908|P1|STARTED|Overall Study||146
8254975|NCT01833143|20355919|P1|NOT COMPLETED|Overall Study||1
8254976|NCT01833143|20355919|P1|COMPLETED|Overall Study||16
8254977|NCT01833143|20355919|P1|STARTED|Overall Study||17
8254978|NCT01833130|20355928|P2|NOT COMPLETED|Overall Study||19
8254979|NCT01833130|20355929|P1|NOT COMPLETED|Overall Study||10
8254980|NCT01833130|20355928|P2|COMPLETED|Overall Study||8
8254981|NCT01833130|20355929|P1|COMPLETED|Overall Study||15
8254982|NCT01833130|20355928|P2|STARTED|Overall Study||27
8254983|NCT01833130|20355929|P1|STARTED|Overall Study||25
8254984|NCT01833117|20355967|P2|NOT COMPLETED|Overall Study||0
8254985|NCT01833117|20355968|P1|NOT COMPLETED|Overall Study||0
8254986|NCT01833117|20355967|P2|COMPLETED|Overall Study||19
8254987|NCT01833117|20355968|P1|COMPLETED|Overall Study||43
8254988|NCT01833117|20355967|P2|STARTED|Overall Study||19
8254989|NCT01833117|20355968|P1|STARTED|Overall Study||43
8254990|NCT01833078|20355976|P1|NOT COMPLETED|Overall Study||0
8254991|NCT01833078|20355976|P1|COMPLETED|Overall Study||5
8254992|NCT01833078|20355976|P1|STARTED|Overall Study||5
8254993|NCT01833065|20355984|P5|NOT COMPLETED|Overall Study||36
8254994|NCT01833065|20355985|P4|NOT COMPLETED|Overall Study||9
8254995|NCT01833065|20355986|P3|NOT COMPLETED|Overall Study||12
8254996|NCT01833065|20355987|P2|NOT COMPLETED|Overall Study||13
8254997|NCT01833065|20355988|P1|NOT COMPLETED|Overall Study||24
8254998|NCT01833065|20355984|P5|COMPLETED|Overall Study||74
8254999|NCT01833065|20355985|P4|COMPLETED|Overall Study||41
8255000|NCT01833065|20355986|P3|COMPLETED|Overall Study||23
8255001|NCT01833065|20355987|P2|COMPLETED|Overall Study||40
8255002|NCT01833065|20355988|P1|COMPLETED|Overall Study||41
8255003|NCT01833065|20355984|P5|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
8255004|NCT01833065|20355985|P4|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
8255005|NCT01833065|20355986|P3|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
8255006|NCT01833065|20355987|P2|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
8255007|NCT01833065|20355988|P1|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
8255008|NCT01833065|20355984|P5|STARTED|Overall Study|Randomized patients - As treated|110
8255009|NCT01833065|20355985|P4|STARTED|Overall Study|Randomized patients - As treated|50
8255010|NCT01833065|20355986|P3|STARTED|Overall Study|Randomized patients - As treated|35
8255011|NCT01833065|20355987|P2|STARTED|Overall Study|Randomized patients - As treated|53
8255012|NCT01833065|20355988|P1|STARTED|Overall Study|Randomized patients - As treated|65
8255013|NCT01833026|20356021|P2|NOT COMPLETED|Overall Study||0
8255014|NCT01833026|20356022|P1|NOT COMPLETED|Overall Study||0
8255015|NCT01833026|20356021|P2|COMPLETED|Overall Study||34
8255016|NCT01833026|20356022|P1|COMPLETED|Overall Study||22
8255017|NCT01833026|20356021|P2|STARTED|Overall Study||34
8255018|NCT01833026|20356022|P1|STARTED|Overall Study||22
8255019|NCT01832961|20356028|P2|NOT COMPLETED|Third Intervention||0
8255020|NCT01832961|20356029|P1|NOT COMPLETED|Third Intervention||0
8255021|NCT01832961|20356028|P2|COMPLETED|Third Intervention||7
8255022|NCT01832961|20356029|P1|COMPLETED|Third Intervention||8
8255023|NCT01832961|20356028|P2|STARTED|Third Intervention||7
8255024|NCT01832961|20356029|P1|STARTED|Third Intervention||8
8255025|NCT01832961|20356028|P2|NOT COMPLETED|Second Intervention||0
8255026|NCT01832961|20356029|P1|NOT COMPLETED|Second Intervention||0
8255027|NCT01832961|20356028|P2|COMPLETED|Second Intervention||7
8255028|NCT01832961|20356029|P1|COMPLETED|Second Intervention||8
8255029|NCT01832961|20356028|P2|STARTED|Second Intervention||7
8255030|NCT01832961|20356029|P1|STARTED|Second Intervention||8
8255031|NCT01832961|20356028|P2|NOT COMPLETED|Washout||0
8255032|NCT01832961|20356029|P1|NOT COMPLETED|Washout||0
8255033|NCT01832961|20356028|P2|COMPLETED|Washout||7
8255034|NCT01832961|20356029|P1|COMPLETED|Washout||8
8255035|NCT01832961|20356028|P2|STARTED|Washout||7
8255036|NCT01832961|20356029|P1|STARTED|Washout||8
8255037|NCT01832961|20356028|P2|NOT COMPLETED|First Intervention||0
8255038|NCT01832961|20356029|P1|NOT COMPLETED|First Intervention||0
8255039|NCT01832961|20356028|P2|COMPLETED|First Intervention||7
8255040|NCT01832961|20356029|P1|COMPLETED|First Intervention||8
8255041|NCT01832961|20356028|P2|STARTED|First Intervention||7
8255042|NCT01832961|20356029|P1|STARTED|First Intervention||8
8255043|NCT01832818|20356057|P1|NOT COMPLETED|Overall Study||6
8255044|NCT01832818|20356057|P1|COMPLETED|Overall Study||8
8255045|NCT01832818|20356057|P1|STARTED|Overall Study||14
8255046|NCT01832766|20356066|P2|NOT COMPLETED|Second Intervention||0
8255047|NCT01832766|20356067|P1|NOT COMPLETED|Second Intervention||0
8255048|NCT01832766|20356066|P2|COMPLETED|Second Intervention||5
8255049|NCT01832766|20356067|P1|COMPLETED|Second Intervention||7
8255050|NCT01832766|20356066|P2|STARTED|Second Intervention||5
8255051|NCT01832766|20356067|P1|STARTED|Second Intervention||7
8255052|NCT01832766|20356066|P2|NOT COMPLETED|Washout||1
8255053|NCT01832766|20356067|P1|NOT COMPLETED|Washout||0
8255054|NCT01832766|20356066|P2|COMPLETED|Washout||5
8255055|NCT01832766|20356067|P1|COMPLETED|Washout||7
8255056|NCT01832766|20356066|P2|STARTED|Washout||6
8255057|NCT01832766|20356067|P1|STARTED|Washout||7
8255058|NCT01832766|20356066|P2|NOT COMPLETED|First Intervention||0
8255059|NCT01832766|20356067|P1|NOT COMPLETED|First Intervention||0
8255060|NCT01832766|20356066|P2|COMPLETED|First Intervention|one participant did not return for cross over visit|6
8255061|NCT01832766|20356067|P1|COMPLETED|First Intervention||7
8255062|NCT01832766|20356066|P2|STARTED|First Intervention||6
8255063|NCT01832766|20356067|P1|STARTED|First Intervention||7
8255064|NCT01832753|20356080|P3|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
8255065|NCT01832753|20356081|P2|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
8255066|NCT01832753|20356082|P1|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
8255067|NCT01832753|20356080|P3|COMPLETED|Open Label Dose Phase (Months 12-18)||0
8255068|NCT01832753|20356081|P2|COMPLETED|Open Label Dose Phase (Months 12-18)||3
8255069|NCT01832753|20356082|P1|COMPLETED|Open Label Dose Phase (Months 12-18)||3
8255070|NCT01832753|20356080|P3|STARTED|Open Label Dose Phase (Months 12-18)||0
8255071|NCT01832753|20356081|P2|STARTED|Open Label Dose Phase (Months 12-18)||3
8255072|NCT01832753|20356082|P1|STARTED|Open Label Dose Phase (Months 12-18)||3
8255073|NCT01832753|20356080|P3|NOT COMPLETED|Randomization Phase (Months 6-12)||0
8255074|NCT01832753|20356081|P2|NOT COMPLETED|Randomization Phase (Months 6-12)||1
8255075|NCT01832753|20356082|P1|NOT COMPLETED|Randomization Phase (Months 6-12)||1
8255076|NCT01832753|20356080|P3|COMPLETED|Randomization Phase (Months 6-12)||0
8255077|NCT01832753|20356081|P2|COMPLETED|Randomization Phase (Months 6-12)||3
8255078|NCT01832753|20356082|P1|COMPLETED|Randomization Phase (Months 6-12)||4
8255079|NCT01832753|20356080|P3|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0
8255080|NCT01832753|20356081|P2|STARTED|Randomization Phase (Months 6-12)||4
8255081|NCT01832753|20356082|P1|STARTED|Randomization Phase (Months 6-12)||5
8255082|NCT01832753|20356080|P3|NOT COMPLETED|Observation Phase (Months 0-6)||2
8255083|NCT01832753|20356081|P2|NOT COMPLETED|Observation Phase (Months 0-6)||0
8255084|NCT01832753|20356082|P1|NOT COMPLETED|Observation Phase (Months 0-6)||0
8255085|NCT01832753|20356080|P3|COMPLETED|Observation Phase (Months 0-6)||1
8255086|NCT01832753|20356081|P2|COMPLETED|Observation Phase (Months 0-6)||4
8255087|NCT01832753|20356082|P1|COMPLETED|Observation Phase (Months 0-6)||5
8255088|NCT01832753|20356080|P3|STARTED|Observation Phase (Months 0-6)||3
8255089|NCT01832753|20356081|P2|STARTED|Observation Phase (Months 0-6)||4
8255090|NCT01832753|20356082|P1|STARTED|Observation Phase (Months 0-6)||5
8255091|NCT01832727|20356103|P9|NOT COMPLETED|Overall Study||18
8255092|NCT01832727|20356104|P8|NOT COMPLETED|Overall Study||6
8255093|NCT01832727|20356105|P7|NOT COMPLETED|Overall Study||8
8255094|NCT01832727|20356106|P6|NOT COMPLETED|Overall Study||6
8255095|NCT01832727|20356107|P5|NOT COMPLETED|Overall Study||4
8255096|NCT01832727|20356108|P4|NOT COMPLETED|Overall Study||4
8255097|NCT01832727|20356109|P3|NOT COMPLETED|Overall Study||3
8255098|NCT01832727|20356110|P2|NOT COMPLETED|Overall Study||7
8255099|NCT01832727|20356111|P1|NOT COMPLETED|Overall Study||9
8255100|NCT01832727|20356103|P9|COMPLETED|Overall Study||0
8255101|NCT01832727|20356104|P8|COMPLETED|Overall Study||0
8255102|NCT01832727|20356105|P7|COMPLETED|Overall Study||0
8255103|NCT01832727|20356106|P6|COMPLETED|Overall Study||0
8255104|NCT01832727|20356107|P5|COMPLETED|Overall Study||0
8255105|NCT01832727|20356108|P4|COMPLETED|Overall Study||0
8255106|NCT01832727|20356109|P3|COMPLETED|Overall Study||0
8255107|NCT01832727|20356110|P2|COMPLETED|Overall Study||0
8255108|NCT01832727|20356111|P1|COMPLETED|Overall Study||0
8255109|NCT01832727|20356103|P9|STARTED|Overall Study||18
8255110|NCT01832727|20356104|P8|STARTED|Overall Study||6
8255111|NCT01832727|20356105|P7|STARTED|Overall Study||8
8255112|NCT01832727|20356106|P6|STARTED|Overall Study||6
8255113|NCT01832727|20356107|P5|STARTED|Overall Study||4
8255114|NCT01832727|20356108|P4|STARTED|Overall Study||4
8255115|NCT01832727|20356109|P3|STARTED|Overall Study||3
8255116|NCT01832727|20356110|P2|STARTED|Overall Study||7
8255117|NCT01832727|20356111|P1|STARTED|Overall Study||9
8255118|NCT01832610|20356211|P1|NOT COMPLETED|Overall Study||4
8255119|NCT01832610|20356211|P1|COMPLETED|Overall Study||97
8255120|NCT01832610|20356211|P1|STARTED|Overall Study||101
8255121|NCT01832532|20356224|P2|NOT COMPLETED|Overall Study||2
8255122|NCT01832532|20356225|P1|NOT COMPLETED|Overall Study||5
8255123|NCT01832532|20356224|P2|COMPLETED|Overall Study||9
8255124|NCT01832532|20356225|P1|COMPLETED|Overall Study||18
8255125|NCT01832532|20356224|P2|STARTED|Overall Study||11
8255126|NCT01832532|20356225|P1|STARTED|Overall Study||23
8255127|NCT01832506|20356234|P3|NOT COMPLETED|Overall Study||0
8255128|NCT01832506|20356235|P2|NOT COMPLETED|Overall Study||0
8255129|NCT01832506|20356236|P1|NOT COMPLETED|Overall Study||0
8255130|NCT01832506|20356234|P3|COMPLETED|Overall Study||6
8255131|NCT01832506|20356235|P2|COMPLETED|Overall Study||3
8255132|NCT01832506|20356236|P1|COMPLETED|Overall Study||3
8255133|NCT01832506|20356234|P3|STARTED|Overall Study||6
8255134|NCT01832506|20356235|P2|STARTED|Overall Study||3
8255135|NCT01832506|20356236|P1|STARTED|Overall Study||3
8255136|NCT01832493|20356287|P1|NOT COMPLETED|Overall Study||8
8255137|NCT01832493|20356287|P1|COMPLETED|Overall Study||42
8255138|NCT01832493|20356287|P1|STARTED|Overall Study||50
8255139|NCT01832480|20356296|P2|NOT COMPLETED|Overall Study||42
8255140|NCT01832480|20356297|P1|NOT COMPLETED|Overall Study||41
8255141|NCT01832480|20356296|P2|COMPLETED|Overall Study||270
8255142|NCT01832480|20356297|P1|COMPLETED|Overall Study||270
8255143|NCT01832480|20356296|P2|STARTED|Overall Study||312
8255144|NCT01832480|20356297|P1|STARTED|Overall Study||311
8255145|NCT01832402|20356305|P2|NOT COMPLETED|Overall Study||4
8255146|NCT01832402|20356306|P1|NOT COMPLETED|Overall Study||7
8255147|NCT01832402|20356305|P2|COMPLETED|Overall Study||12
8255148|NCT01832402|20356306|P1|COMPLETED|Overall Study||12
8255149|NCT01832402|20356305|P2|Completed Study With Incorrect Dose|Overall Study||3
8255150|NCT01832402|20356306|P1|Completed Study With Incorrect Dose|Overall Study||2
8255151|NCT01832402|20356305|P2|Completed Study With Correct Dose|Overall Study||9
8255152|NCT01832402|20356306|P1|Completed Study With Correct Dose|Overall Study||10
8255153|NCT01832402|20356305|P2|Received Allocated Medication|Overall Study||12
8255154|NCT01832402|20356306|P1|Received Allocated Medication|Overall Study||12
8255155|NCT01832402|20356305|P2|STARTED|Overall Study||16
8255156|NCT01832402|20356306|P1|STARTED|Overall Study||19
8255157|NCT01832259|20356320|P2|NOT COMPLETED|Overall Study||0
8255158|NCT01832259|20356321|P1|NOT COMPLETED|Overall Study||0
8255159|NCT01832259|20356320|P2|COMPLETED|Overall Study||15
8255160|NCT01832259|20356321|P1|COMPLETED|Overall Study||15
8255161|NCT01832259|20356320|P2|STARTED|Overall Study||15
8255162|NCT01832259|20356321|P1|STARTED|Overall Study||15
8255163|NCT01832155|20356333|P2|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
8255164|NCT01832155|20356334|P1|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
8255165|NCT01832155|20356333|P2|COMPLETED|End of Study: 4 - 8 Weeks||18
8255166|NCT01832155|20356334|P1|COMPLETED|End of Study: 4 - 8 Weeks||16
8255167|NCT01832155|20356333|P2|STARTED|End of Study: 4 - 8 Weeks||18
8255168|NCT01832155|20356334|P1|STARTED|End of Study: 4 - 8 Weeks||16
8255169|NCT01832155|20356333|P2|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
8255170|NCT01832155|20356334|P1|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
8255171|NCT01832155|20356333|P2|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
8255172|NCT01832155|20356334|P1|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
8255173|NCT01832155|20356333|P2|STARTED|Mid-point of Study: 0 - 4 Weeks||18
8255174|NCT01832155|20356334|P1|STARTED|Mid-point of Study: 0 - 4 Weeks||17
8255175|NCT01832155|20356333|P2|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
8255176|NCT01832155|20356334|P1|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
8255177|NCT01832155|20356333|P2|COMPLETED|Beginning of Study: Baseline at 0 Week||18
8255178|NCT01832155|20356334|P1|COMPLETED|Beginning of Study: Baseline at 0 Week||17
8255179|NCT01832155|20356333|P2|STARTED|Beginning of Study: Baseline at 0 Week||18
8255180|NCT01832155|20356334|P1|STARTED|Beginning of Study: Baseline at 0 Week||18
8255181|NCT01832090|20356357|P2|NOT COMPLETED|Overall Study||1
8255182|NCT01832090|20356358|P1|NOT COMPLETED|Overall Study||6
8255183|NCT01832090|20356357|P2|COMPLETED|Overall Study||28
8255184|NCT01832090|20356358|P1|COMPLETED|Overall Study||83
8255185|NCT01832090|20356357|P2|STARTED|Overall Study||29
8255186|NCT01832090|20356358|P1|STARTED|Overall Study||89
8255190|NCT01831960|20356410|P2|NOT COMPLETED|Overall Study||0
8255191|NCT01831960|20356411|P1|NOT COMPLETED|Overall Study||0
8255192|NCT01831960|20356410|P2|COMPLETED|Overall Study||22
8255193|NCT01831960|20356411|P1|COMPLETED|Overall Study||20
8255194|NCT01831960|20356410|P2|STARTED|Overall Study||22
8255195|NCT01831960|20356411|P1|STARTED|Overall Study||20
8255196|NCT01831934|20356425|P2|NOT COMPLETED|Overall Study||0
8255197|NCT01831934|20356426|P1|NOT COMPLETED|Overall Study||1
8255198|NCT01831934|20356425|P2|COMPLETED|Overall Study||10
8255199|NCT01831934|20356426|P1|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
8255200|NCT01831934|20356425|P2|STARTED|Overall Study||10
8255201|NCT01831934|20356426|P1|STARTED|Overall Study||12
8255202|NCT01831921|20356434|P2|NOT COMPLETED|Overall Study||39
8255203|NCT01831921|20356435|P1|NOT COMPLETED|Overall Study||84
8255204|NCT01831921|20356434|P2|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
8255205|NCT01831921|20356435|P1|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
8255206|NCT01831921|20356434|P2|18 Months|Overall Study|Of 59 eligible for this visit.|49
8255207|NCT01831921|20356435|P1|18 Months|Overall Study|Of 118 eligible for this visit.|90
8255208|NCT01831921|20356434|P2|12 Months|Overall Study||62
8255209|NCT01831921|20356435|P1|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
8255210|NCT01831921|20356434|P2|6 Months|Overall Study||63
8255211|NCT01831921|20356435|P1|6 Months|Overall Study||122
8255212|NCT01831921|20356434|P2|STARTED|Overall Study||75
8255213|NCT01831921|20356435|P1|STARTED|Overall Study||150
8255214|NCT01831856|20356459|P2|NOT COMPLETED|Overall Study||37
8255215|NCT01831856|20356460|P1|NOT COMPLETED|Overall Study||34
8255216|NCT01831856|20356459|P2|COMPLETED|Overall Study||30
8255217|NCT01831856|20356460|P1|COMPLETED|Overall Study||33
8255218|NCT01831856|20356459|P2|STARTED|Overall Study||67
8255219|NCT01831856|20356460|P1|STARTED|Overall Study||67
8255220|NCT01831817|20356470|P4|NOT COMPLETED|Overall Study||0
8255221|NCT01831817|20356471|P3|NOT COMPLETED|Overall Study||0
8255222|NCT01831817|20356472|P2|NOT COMPLETED|Overall Study||0
8255223|NCT01831817|20356473|P1|NOT COMPLETED|Overall Study||4
8255224|NCT01831817|20356470|P4|COMPLETED|Overall Study||36
8255225|NCT01831817|20356471|P3|COMPLETED|Overall Study||35
8255226|NCT01831817|20356472|P2|COMPLETED|Overall Study||34
8255227|NCT01831817|20356473|P1|COMPLETED|Overall Study||31
8255228|NCT01831817|20356470|P4|STARTED|Overall Study||36
8255229|NCT01831817|20356471|P3|STARTED|Overall Study||35
8255230|NCT01831817|20356472|P2|STARTED|Overall Study||34
8255231|NCT01831817|20356473|P1|STARTED|Overall Study||35
8255232|NCT01831804|20356520|P9|NOT COMPLETED|Overall Study||2
8255233|NCT01831804|20356521|P8|NOT COMPLETED|Overall Study||3
8255234|NCT01831804|20356522|P7|NOT COMPLETED|Overall Study||1
8255235|NCT01831804|20356523|P6|NOT COMPLETED|Overall Study||0
8255236|NCT01831804|20356524|P5|NOT COMPLETED|Overall Study||2
8255237|NCT01831804|20356525|P4|NOT COMPLETED|Overall Study||0
8255238|NCT01831804|20356526|P3|NOT COMPLETED|Overall Study||6
8255239|NCT01831804|20356527|P2|NOT COMPLETED|Overall Study||2
8255240|NCT01831804|20356528|P1|NOT COMPLETED|Overall Study||1
8255241|NCT01831804|20356520|P9|COMPLETED|Overall Study||2
8255242|NCT01831804|20356521|P8|COMPLETED|Overall Study||23
8255243|NCT01831804|20356522|P7|COMPLETED|Overall Study||3
8255244|NCT01831804|20356523|P6|COMPLETED|Overall Study||3
8255245|NCT01831804|20356524|P5|COMPLETED|Overall Study||3
8255246|NCT01831804|20356525|P4|COMPLETED|Overall Study||5
8255247|NCT01831804|20356526|P3|COMPLETED|Overall Study||3
8255248|NCT01831804|20356527|P2|COMPLETED|Overall Study||1
8255249|NCT01831804|20356528|P1|COMPLETED|Overall Study||3
8255250|NCT01831804|20356520|P9|STARTED|Overall Study||4
8255251|NCT01831804|20356521|P8|STARTED|Overall Study||26
8255252|NCT01831804|20356522|P7|STARTED|Overall Study||4
8255253|NCT01831804|20356523|P6|STARTED|Overall Study||3
8255254|NCT01831804|20356524|P5|STARTED|Overall Study||5
8255255|NCT01831804|20356525|P4|STARTED|Overall Study||5
8255256|NCT01831804|20356526|P3|STARTED|Overall Study||9
8255257|NCT01831804|20356527|P2|STARTED|Overall Study||3
8255258|NCT01831804|20356528|P1|STARTED|Overall Study||4
8255259|NCT01831791|20356623|P1|NOT COMPLETED|Overall Study||10
8255260|NCT01831791|20356623|P1|COMPLETED|Overall Study||110
8255261|NCT01831791|20356623|P1|STARTED|Overall Study||120
8255262|NCT01831765|20356652|P3|NOT COMPLETED|Overall Study||42
8255263|NCT01831765|20356653|P2|NOT COMPLETED|Overall Study||27
8255264|NCT01831765|20356654|P1|NOT COMPLETED|Overall Study||44
8255265|NCT01831765|20356652|P3|COMPLETED|Overall Study||338
8255266|NCT01831765|20356653|P2|COMPLETED|Overall Study||355
8255267|NCT01831765|20356654|P1|COMPLETED|Overall Study||337
8255268|NCT01831765|20356652|P3|Completed 52 Weeks|Overall Study||338
8255269|NCT01831765|20356653|P2|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
8255270|NCT01831765|20356654|P1|Completed 52 Weeks|Overall Study||337
8255271|NCT01831765|20356652|P3|Completed 26 Weeks|Overall Study||356
8255272|NCT01831765|20356653|P2|Completed 26 Weeks|Overall Study||355
8255273|NCT01831765|20356654|P1|Completed 26 Weeks|Overall Study||351
8255274|NCT01831765|20356652|P3|STARTED|Overall Study||380
8255275|NCT01831765|20356653|P2|STARTED|Overall Study||382
8255276|NCT01831765|20356654|P1|STARTED|Overall Study||381
8255277|NCT01831726|20356680|P1|NOT COMPLETED|Overall Study||80
8255278|NCT01831726|20356680|P1|COMPLETED|Overall Study||0
8255279|NCT01831726|20356680|P1|STARTED|Overall Study||80
8255280|NCT01831596|20356687|P1|NOT COMPLETED|Overall Study||8
8255281|NCT01831596|20356687|P1|COMPLETED|Overall Study||51
8255282|NCT01831596|20356687|P1|STARTED|Overall Study||59
8255286|NCT01831466|20356720|P12|NOT COMPLETED|Overall Study||4
8255287|NCT01831466|20356721|P11|NOT COMPLETED|Overall Study||2
8255288|NCT01831466|20356722|P10|NOT COMPLETED|Overall Study||5
8255289|NCT01831466|20356723|P9|NOT COMPLETED|Overall Study||3
8255290|NCT01831466|20356724|P8|NOT COMPLETED|Overall Study||2
8255291|NCT01831466|20356725|P7|NOT COMPLETED|Overall Study||1
8255292|NCT01831466|20356726|P6|NOT COMPLETED|Overall Study||26
8255293|NCT01831466|20356727|P5|NOT COMPLETED|Overall Study||17
8255294|NCT01831466|20356728|P4|NOT COMPLETED|Overall Study||19
8255295|NCT01831466|20356729|P3|NOT COMPLETED|Overall Study||23
8255296|NCT01831466|20356730|P2|NOT COMPLETED|Overall Study||18
8255297|NCT01831466|20356731|P1|NOT COMPLETED|Overall Study||16
8255298|NCT01831466|20356720|P12|COMPLETED|Overall Study||3
8255299|NCT01831466|20356721|P11|COMPLETED|Overall Study||4
8255300|NCT01831466|20356722|P10|COMPLETED|Overall Study||2
8255301|NCT01831466|20356723|P9|COMPLETED|Overall Study||4
8255302|NCT01831466|20356724|P8|COMPLETED|Overall Study||5
8255303|NCT01831466|20356725|P7|COMPLETED|Overall Study||6
8255304|NCT01831466|20356726|P6|COMPLETED|Overall Study||48
8255305|NCT01831466|20356727|P5|COMPLETED|Overall Study||57
8255306|NCT01831466|20356728|P4|COMPLETED|Overall Study||51
8255307|NCT01831466|20356729|P3|COMPLETED|Overall Study||48
8255308|NCT01831466|20356730|P2|COMPLETED|Overall Study||52
8255309|NCT01831466|20356731|P1|COMPLETED|Overall Study||55
8255310|NCT01831466|20356720|P12|STARTED|Overall Study|Treated|7
8255311|NCT01831466|20356721|P11|STARTED|Overall Study|Treated|6
8255312|NCT01831466|20356722|P10|STARTED|Overall Study|Treated|7
8255313|NCT01831466|20356723|P9|STARTED|Overall Study|Treated|7
8255314|NCT01831466|20356724|P8|STARTED|Overall Study|Treated|7
8255315|NCT01831466|20356725|P7|STARTED|Overall Study|Treated|7
8255316|NCT01831466|20356726|P6|STARTED|Overall Study|Treated|74
8255317|NCT01831466|20356727|P5|STARTED|Overall Study|Treated|74
8255318|NCT01831466|20356728|P4|STARTED|Overall Study|Treated|70
8255319|NCT01831466|20356729|P3|STARTED|Overall Study|Treated|71
8255320|NCT01831466|20356730|P2|STARTED|Overall Study|Treated|70
8255321|NCT01831466|20356731|P1|STARTED|Overall Study|Treated|71
8255322|NCT01831258|20356853|P2|NOT COMPLETED|Overall Study||3
8255323|NCT01831258|20356854|P1|NOT COMPLETED|Overall Study||5
8255324|NCT01831258|20356853|P2|COMPLETED|Overall Study||32
8255325|NCT01831258|20356854|P1|COMPLETED|Overall Study||30
8255326|NCT01831258|20356853|P2|STARTED|Overall Study||35
8255327|NCT01831258|20356854|P1|STARTED|Overall Study||35
8255328|NCT01831232|20356880|P1|NOT COMPLETED|Overall Study||0
8255329|NCT01831232|20356880|P1|COMPLETED|Overall Study||24
8255330|NCT01831232|20356880|P1|STARTED|Overall Study||24
8255331|NCT01831219|20356891|P2|NOT COMPLETED|Overall Study||24
8255332|NCT01831219|20356892|P1|NOT COMPLETED|Overall Study||33
8255333|NCT01831219|20356891|P2|COMPLETED|Overall Study||21
8255334|NCT01831219|20356892|P1|COMPLETED|Overall Study||40
8255335|NCT01831219|20356891|P2|STARTED|Overall Study||45
8255336|NCT01831219|20356892|P1|STARTED|Overall Study||73
8255337|NCT01831154|20356913|P3|NOT COMPLETED|Overall Study||0
8255338|NCT01831154|20356914|P2|NOT COMPLETED|Overall Study||0
8255339|NCT01831154|20356915|P1|NOT COMPLETED|Overall Study||0
8255340|NCT01831154|20356913|P3|COMPLETED|Overall Study||11
8255341|NCT01831154|20356914|P2|COMPLETED|Overall Study||11
8255342|NCT01831154|20356915|P1|COMPLETED|Overall Study||15
8255343|NCT01831154|20356913|P3|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
8255344|NCT01831154|20356914|P2|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
8255345|NCT01831154|20356915|P1|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
8255346|NCT01831089|20356944|P6|NOT COMPLETED|Cohort B: Arm B||14
8255347|NCT01831089|20356945|P5|NOT COMPLETED|Cohort B: Arm B||0
8255348|NCT01831089|20356946|P4|NOT COMPLETED|Cohort B: Arm B||0
8255349|NCT01831089|20356947|P3|NOT COMPLETED|Cohort B: Arm B||0
8255350|NCT01831089|20356948|P2|NOT COMPLETED|Cohort B: Arm B||0
8255351|NCT01831089|20356949|P1|NOT COMPLETED|Cohort B: Arm B||0
8255352|NCT01831089|20356944|P6|COMPLETED|Cohort B: Arm B||0
8255353|NCT01831089|20356945|P5|COMPLETED|Cohort B: Arm B||0
8255354|NCT01831089|20356946|P4|COMPLETED|Cohort B: Arm B||0
8255355|NCT01831089|20356947|P3|COMPLETED|Cohort B: Arm B||0
8255356|NCT01831089|20356948|P2|COMPLETED|Cohort B: Arm B||0
8255357|NCT01831089|20356949|P1|COMPLETED|Cohort B: Arm B||0
8255358|NCT01831089|20356944|P6|STARTED|Cohort B: Arm B||14
8255359|NCT01831089|20356945|P5|STARTED|Cohort B: Arm B||0
8255360|NCT01831089|20356946|P4|STARTED|Cohort B: Arm B||0
8255361|NCT01831089|20356947|P3|STARTED|Cohort B: Arm B||0
8255362|NCT01831089|20356948|P2|STARTED|Cohort B: Arm B||0
8255363|NCT01831089|20356949|P1|STARTED|Cohort B: Arm B||0
8255364|NCT01831089|20356944|P6|NOT COMPLETED|Cohort V: Dose Level 5||0
8255365|NCT01831089|20356945|P5|NOT COMPLETED|Cohort V: Dose Level 5||37
8255366|NCT01831089|20356946|P4|NOT COMPLETED|Cohort V: Dose Level 5||0
8255367|NCT01831089|20356947|P3|NOT COMPLETED|Cohort V: Dose Level 5||0
8255368|NCT01831089|20356948|P2|NOT COMPLETED|Cohort V: Dose Level 5||0
8255369|NCT01831089|20356949|P1|NOT COMPLETED|Cohort V: Dose Level 5||0
8255370|NCT01831089|20356944|P6|COMPLETED|Cohort V: Dose Level 5||0
8255371|NCT01831089|20356945|P5|COMPLETED|Cohort V: Dose Level 5||0
8255372|NCT01831089|20356946|P4|COMPLETED|Cohort V: Dose Level 5||0
8255373|NCT01831089|20356947|P3|COMPLETED|Cohort V: Dose Level 5||0
8255374|NCT01831089|20356948|P2|COMPLETED|Cohort V: Dose Level 5||0
8255375|NCT01831089|20356949|P1|COMPLETED|Cohort V: Dose Level 5||0
8255376|NCT01831089|20356944|P6|STARTED|Cohort V: Dose Level 5||0
8255377|NCT01831089|20356945|P5|STARTED|Cohort V: Dose Level 5||37
8255378|NCT01831089|20356946|P4|STARTED|Cohort V: Dose Level 5||0
8255379|NCT01831089|20356947|P3|STARTED|Cohort V: Dose Level 5||0
8255380|NCT01831089|20356948|P2|STARTED|Cohort V: Dose Level 5||0
8255381|NCT01831089|20356949|P1|STARTED|Cohort V: Dose Level 5||0
8255382|NCT01831089|20356944|P6|NOT COMPLETED|Cohort IV: Dose Level 4||0
8255383|NCT01831089|20356945|P5|NOT COMPLETED|Cohort IV: Dose Level 4||0
8255384|NCT01831089|20356946|P4|NOT COMPLETED|Cohort IV: Dose Level 4||6
8255385|NCT01831089|20356947|P3|NOT COMPLETED|Cohort IV: Dose Level 4||0
8255386|NCT01831089|20356948|P2|NOT COMPLETED|Cohort IV: Dose Level 4||0
8255387|NCT01831089|20356949|P1|NOT COMPLETED|Cohort IV: Dose Level 4||0
8255388|NCT01831089|20356944|P6|COMPLETED|Cohort IV: Dose Level 4||0
8255389|NCT01831089|20356945|P5|COMPLETED|Cohort IV: Dose Level 4||0
8255390|NCT01831089|20356946|P4|COMPLETED|Cohort IV: Dose Level 4||0
8255391|NCT01831089|20356947|P3|COMPLETED|Cohort IV: Dose Level 4||0
8255392|NCT01831089|20356948|P2|COMPLETED|Cohort IV: Dose Level 4||0
8255393|NCT01831089|20356949|P1|COMPLETED|Cohort IV: Dose Level 4||0
8255394|NCT01831089|20356944|P6|STARTED|Cohort IV: Dose Level 4||0
8255395|NCT01831089|20356945|P5|STARTED|Cohort IV: Dose Level 4||0
8255396|NCT01831089|20356946|P4|STARTED|Cohort IV: Dose Level 4||6
8255397|NCT01831089|20356947|P3|STARTED|Cohort IV: Dose Level 4||0
8255398|NCT01831089|20356948|P2|STARTED|Cohort IV: Dose Level 4||0
8255399|NCT01831089|20356949|P1|STARTED|Cohort IV: Dose Level 4||0
8255400|NCT01831089|20356944|P6|NOT COMPLETED|Cohort III: Dose Level 3||0
8255401|NCT01831089|20356945|P5|NOT COMPLETED|Cohort III: Dose Level 3||0
8255402|NCT01831089|20356946|P4|NOT COMPLETED|Cohort III: Dose Level 3||0
8255403|NCT01831089|20356947|P3|NOT COMPLETED|Cohort III: Dose Level 3||6
8255404|NCT01831089|20356948|P2|NOT COMPLETED|Cohort III: Dose Level 3||0
8255405|NCT01831089|20356949|P1|NOT COMPLETED|Cohort III: Dose Level 3||0
8255406|NCT01831089|20356944|P6|COMPLETED|Cohort III: Dose Level 3||0
8255407|NCT01831089|20356945|P5|COMPLETED|Cohort III: Dose Level 3||0
8255408|NCT01831089|20356946|P4|COMPLETED|Cohort III: Dose Level 3||0
8255409|NCT01831089|20356947|P3|COMPLETED|Cohort III: Dose Level 3||0
8255410|NCT01831089|20356948|P2|COMPLETED|Cohort III: Dose Level 3||0
8255411|NCT01831089|20356949|P1|COMPLETED|Cohort III: Dose Level 3||0
8255412|NCT01831089|20356944|P6|STARTED|Cohort III: Dose Level 3||0
8255413|NCT01831089|20356945|P5|STARTED|Cohort III: Dose Level 3||0
8255414|NCT01831089|20356946|P4|STARTED|Cohort III: Dose Level 3||0
8255415|NCT01831089|20356947|P3|STARTED|Cohort III: Dose Level 3||6
8255416|NCT01831089|20356948|P2|STARTED|Cohort III: Dose Level 3||0
8255417|NCT01831089|20356949|P1|STARTED|Cohort III: Dose Level 3||0
8255418|NCT01831089|20356944|P6|NOT COMPLETED|Cohort II: Dose Level 2||0
8255419|NCT01831089|20356945|P5|NOT COMPLETED|Cohort II: Dose Level 2||0
8255420|NCT01831089|20356946|P4|NOT COMPLETED|Cohort II: Dose Level 2||0
8255421|NCT01831089|20356947|P3|NOT COMPLETED|Cohort II: Dose Level 2||0
8255422|NCT01831089|20356948|P2|NOT COMPLETED|Cohort II: Dose Level 2||3
8255423|NCT01831089|20356949|P1|NOT COMPLETED|Cohort II: Dose Level 2||0
8255424|NCT01831089|20356944|P6|COMPLETED|Cohort II: Dose Level 2||0
8255425|NCT01831089|20356945|P5|COMPLETED|Cohort II: Dose Level 2||0
8255426|NCT01831089|20356946|P4|COMPLETED|Cohort II: Dose Level 2||0
8255427|NCT01831089|20356947|P3|COMPLETED|Cohort II: Dose Level 2||0
8255428|NCT01831089|20356948|P2|COMPLETED|Cohort II: Dose Level 2||0
8255429|NCT01831089|20356949|P1|COMPLETED|Cohort II: Dose Level 2||0
8255430|NCT01831089|20356944|P6|STARTED|Cohort II: Dose Level 2||0
8255431|NCT01831089|20356945|P5|STARTED|Cohort II: Dose Level 2||0
8255432|NCT01831089|20356946|P4|STARTED|Cohort II: Dose Level 2||0
8255433|NCT01831089|20356947|P3|STARTED|Cohort II: Dose Level 2||0
8255434|NCT01831089|20356948|P2|STARTED|Cohort II: Dose Level 2||3
8255435|NCT01831089|20356949|P1|STARTED|Cohort II: Dose Level 2||0
8255436|NCT01831089|20356944|P6|NOT COMPLETED|Cohort I: Dose Level 1||0
8255437|NCT01831089|20356945|P5|NOT COMPLETED|Cohort I: Dose Level 1||0
8255438|NCT01831089|20356946|P4|NOT COMPLETED|Cohort I: Dose Level 1||0
8255439|NCT01831089|20356947|P3|NOT COMPLETED|Cohort I: Dose Level 1||0
8255440|NCT01831089|20356948|P2|NOT COMPLETED|Cohort I: Dose Level 1||0
8255441|NCT01831089|20356949|P1|NOT COMPLETED|Cohort I: Dose Level 1||3
8255442|NCT01831089|20356944|P6|COMPLETED|Cohort I: Dose Level 1||0
8255443|NCT01831089|20356945|P5|COMPLETED|Cohort I: Dose Level 1||0
8255444|NCT01831089|20356946|P4|COMPLETED|Cohort I: Dose Level 1||0
8255445|NCT01831089|20356947|P3|COMPLETED|Cohort I: Dose Level 1||0
8255446|NCT01831089|20356948|P2|COMPLETED|Cohort I: Dose Level 1||0
8255447|NCT01831089|20356949|P1|COMPLETED|Cohort I: Dose Level 1||0
8255448|NCT01831089|20356944|P6|STARTED|Cohort I: Dose Level 1||0
8255449|NCT01831089|20356945|P5|STARTED|Cohort I: Dose Level 1||0
8255450|NCT01831089|20356946|P4|STARTED|Cohort I: Dose Level 1||0
8255451|NCT01831089|20356947|P3|STARTED|Cohort I: Dose Level 1||0
8255452|NCT01831089|20356948|P2|STARTED|Cohort I: Dose Level 1||0
8255453|NCT01831089|20356949|P1|STARTED|Cohort I: Dose Level 1||3
8255460|NCT01830972|20357000|P2|NOT COMPLETED|Part IV||1
8255461|NCT01830972|20357001|P1|NOT COMPLETED|Part IV||3
8255462|NCT01830972|20357000|P2|COMPLETED|Part IV||10
8255463|NCT01830972|20357001|P1|COMPLETED|Part IV||39
8255464|NCT01830972|20357000|P2|STARTED|Part IV||11
8255465|NCT01830972|20357001|P1|STARTED|Part IV||42
8255466|NCT01830972|20357000|P2|NOT COMPLETED|Part III||0
8255467|NCT01830972|20357001|P1|NOT COMPLETED|Part III||2
8255468|NCT01830972|20357000|P2|COMPLETED|Part III||11
8255469|NCT01830972|20357001|P1|COMPLETED|Part III||42
8255470|NCT01830972|20357000|P2|STARTED|Part III||11
8255471|NCT01830972|20357001|P1|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
8255472|NCT01830972|20357000|P2|NOT COMPLETED|Part II||2
8255473|NCT01830972|20357001|P1|NOT COMPLETED|Part II||2
8255474|NCT01830972|20357000|P2|COMPLETED|Part II||11
8255475|NCT01830972|20357001|P1|COMPLETED|Part II||44
8255476|NCT01830972|20357000|P2|STARTED|Part II|Entered study at Part 2|13
8255477|NCT01830972|20357001|P1|STARTED|Part II||46
8255478|NCT01830972|20357000|P2|NOT COMPLETED|Part I||0
8255479|NCT01830972|20357001|P1|NOT COMPLETED|Part I||0
8255480|NCT01830972|20357000|P2|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
8255481|NCT01830972|20357001|P1|COMPLETED|Part I||46
8255482|NCT01830972|20357000|P2|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
8255483|NCT01830972|20357001|P1|STARTED|Part I||46
8255484|NCT01830933|20357027|P2|NOT COMPLETED|Overall Study||232
8255485|NCT01830933|20357028|P1|NOT COMPLETED|Overall Study||168
8255486|NCT01830933|20357027|P2|COMPLETED|Overall Study||580
8255487|NCT01830933|20357028|P1|COMPLETED|Overall Study||655
8255488|NCT01830933|20357027|P2|Completed Meet-up|Overall Study||603
8255489|NCT01830933|20357028|P1|Completed Meet-up|Overall Study||675
8255490|NCT01830933|20357027|P2|STARTED|Overall Study||812
8255491|NCT01830933|20357028|P1|STARTED|Overall Study||823
8255492|NCT01830920|20357045|P5|NOT COMPLETED|Overall Study||8
8255493|NCT01830920|20357046|P4|NOT COMPLETED|Overall Study||16
8255494|NCT01830920|20357047|P3|NOT COMPLETED|Overall Study||8
8255495|NCT01830920|20357048|P2|NOT COMPLETED|Overall Study||6
8255496|NCT01830920|20357049|P1|NOT COMPLETED|Overall Study||21
8255497|NCT01830920|20357045|P5|COMPLETED|Overall Study||99
8255498|NCT01830920|20357046|P4|COMPLETED|Overall Study||109
8255499|NCT01830920|20357047|P3|COMPLETED|Overall Study||40
8255500|NCT01830920|20357048|P2|COMPLETED|Overall Study||40
8255501|NCT01830920|20357049|P1|COMPLETED|Overall Study||105
8255502|NCT01830920|20357045|P5|Received Allocated Drug|Overall Study||105
8255503|NCT01830920|20357046|P4|Received Allocated Drug|Overall Study||119
8255504|NCT01830920|20357047|P3|Received Allocated Drug|Overall Study||47
8255505|NCT01830920|20357048|P2|Received Allocated Drug|Overall Study||45
8255506|NCT01830920|20357049|P1|Received Allocated Drug|Overall Study||115
8255507|NCT01830920|20357045|P5|STARTED|Overall Study||107
8255508|NCT01830920|20357046|P4|STARTED|Overall Study||125
8255509|NCT01830920|20357047|P3|STARTED|Overall Study||48
8255510|NCT01830920|20357048|P2|STARTED|Overall Study||46
8255511|NCT01830920|20357049|P1|STARTED|Overall Study||126
8255512|NCT01830881|20357088|P2|NOT COMPLETED|Overall Study||1
8255513|NCT01830881|20357089|P1|NOT COMPLETED|Overall Study||0
8255514|NCT01830881|20357088|P2|COMPLETED|Overall Study||61
8255515|NCT01830881|20357089|P1|COMPLETED|Overall Study||62
8255516|NCT01830881|20357088|P2|STARTED|Overall Study||62
8255517|NCT01830881|20357089|P1|STARTED|Overall Study||62
8255518|NCT01830855|20357137|P4|NOT COMPLETED|Overall Study||82
8255519|NCT01830855|20357138|P3|NOT COMPLETED|Overall Study||66
8255520|NCT01830855|20357139|P2|NOT COMPLETED|Overall Study||61
8255521|NCT01830855|20357140|P1|NOT COMPLETED|Overall Study||155
8255522|NCT01830855|20357137|P4|COMPLETED|Overall Study||815
8255523|NCT01830855|20357138|P3|COMPLETED|Overall Study||521
8255524|NCT01830855|20357139|P2|COMPLETED|Overall Study||537
8255525|NCT01830855|20357140|P1|COMPLETED|Overall Study||1353
8255526|NCT01830855|20357137|P4|STARTED|Overall Study||897
8255527|NCT01830855|20357138|P3|STARTED|Overall Study||587
8255528|NCT01830855|20357139|P2|STARTED|Overall Study||598
8255529|NCT01830855|20357140|P1|STARTED|Overall Study||1508
8255530|NCT01830842|20357246|P2|NOT COMPLETED|Overall Study||2
8255531|NCT01830842|20357247|P1|NOT COMPLETED|Overall Study||5
8255532|NCT01830842|20357246|P2|COMPLETED|Overall Study||22
8255533|NCT01830842|20357247|P1|COMPLETED|Overall Study||25
8255534|NCT01830842|20357246|P2|STARTED|Overall Study||24
8255535|NCT01830842|20357247|P1|STARTED|Overall Study||30
8255536|NCT01830816|20357256|P3|NOT COMPLETED|Overall Study||7
8255537|NCT01830816|20357257|P2|NOT COMPLETED|Overall Study||14
8255538|NCT01830816|20357258|P1|NOT COMPLETED|Overall Study||20
8255539|NCT01830816|20357256|P3|COMPLETED|Overall Study||0
8255540|NCT01830816|20357257|P2|COMPLETED|Overall Study||0
8255541|NCT01830816|20357258|P1|COMPLETED|Overall Study||0
8255542|NCT01830816|20357256|P3|Pharmacokinetic-Evaluable Population|Overall Study||6
8255543|NCT01830816|20357257|P2|Pharmacokinetic-Evaluable Population|Overall Study||14
8255544|NCT01830816|20357258|P1|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18
8255545|NCT01830816|20357256|P3|STARTED|Overall Study||7
8255546|NCT01830816|20357257|P2|STARTED|Overall Study||14
8255547|NCT01830816|20357258|P1|STARTED|Overall Study||20
8255548|NCT01830790|20357283|P2|NOT COMPLETED|Overall Study||0
8255549|NCT01830790|20357284|P1|NOT COMPLETED|Overall Study||0
8255550|NCT01830790|20357283|P2|COMPLETED|Overall Study||10
8255551|NCT01830790|20357284|P1|COMPLETED|Overall Study||0
8255552|NCT01830790|20357283|P2|STARTED|Overall Study||10
8255553|NCT01830790|20357284|P1|STARTED|Overall Study||0
8255554|NCT01830699|20357294|P2|NOT COMPLETED|Overall Study||0
8255555|NCT01830699|20357295|P1|NOT COMPLETED|Overall Study||0
8255556|NCT01830699|20357294|P2|COMPLETED|Overall Study||20
8255557|NCT01830699|20357295|P1|COMPLETED|Overall Study||13
8255558|NCT01830699|20357294|P2|STARTED|Overall Study||20
8255559|NCT01830699|20357295|P1|STARTED|Overall Study||13
8255560|NCT01830621|20357307|P2|NOT COMPLETED|Overall Study||0
8255561|NCT01830621|20357308|P1|NOT COMPLETED|Overall Study||0
8255562|NCT01830621|20357307|P2|COMPLETED|Overall Study||144
8255563|NCT01830621|20357308|P1|COMPLETED|Overall Study||138
8255564|NCT01830621|20357307|P2|STARTED|Overall Study||144
8255565|NCT01830621|20357308|P1|STARTED|Overall Study||138
8255566|NCT01830595|20357322|P2|NOT COMPLETED|Second Period||0
8255567|NCT01830595|20357323|P1|NOT COMPLETED|Second Period||0
8255568|NCT01830595|20357322|P2|COMPLETED|Second Period||23
8255569|NCT01830595|20357323|P1|COMPLETED|Second Period||23
8255570|NCT01830595|20357322|P2|STARTED|Second Period||23
8255571|NCT01830595|20357323|P1|STARTED|Second Period||23
8255572|NCT01830595|20357322|P2|NOT COMPLETED|Washout||2
8255573|NCT01830595|20357323|P1|NOT COMPLETED|Washout||2
8255574|NCT01830595|20357322|P2|COMPLETED|Washout||23
8255575|NCT01830595|20357323|P1|COMPLETED|Washout||23
8255576|NCT01830595|20357322|P2|STARTED|Washout||25
8255577|NCT01830595|20357323|P1|STARTED|Washout||25
8255578|NCT01830595|20357322|P2|NOT COMPLETED|First Period||3
8255579|NCT01830595|20357323|P1|NOT COMPLETED|First Period||1
8255580|NCT01830595|20357322|P2|COMPLETED|First Period||25
8255581|NCT01830595|20357323|P1|COMPLETED|First Period||25
8255582|NCT01830595|20357322|P2|Received at Least One Dose|First Period||28
8255583|NCT01830595|20357323|P1|Received at Least One Dose|First Period||26
8255584|NCT01830595|20357322|P2|STARTED|First Period||28
8255585|NCT01830595|20357323|P1|STARTED|First Period||26
8255586|NCT01830543|20357340|P3|NOT COMPLETED|Overall Study||214
8255587|NCT01830543|20357341|P2|NOT COMPLETED|Overall Study||152
8255588|NCT01830543|20357342|P1|NOT COMPLETED|Overall Study||159
8255589|NCT01830543|20357340|P3|COMPLETED|Overall Study||492
8255590|NCT01830543|20357341|P2|COMPLETED|Overall Study||557
8255591|NCT01830543|20357342|P1|COMPLETED|Overall Study||550
8255592|NCT01830543|20357340|P3|Treated|Overall Study||697
8255593|NCT01830543|20357341|P2|Treated|Overall Study||706
8255594|NCT01830543|20357342|P1|Treated|Overall Study||696
8255595|NCT01830543|20357340|P3|STARTED|Overall Study||706
8255596|NCT01830543|20357341|P2|STARTED|Overall Study||709
8255597|NCT01830543|20357342|P1|STARTED|Overall Study||709
8255598|NCT01830205|20357378|P4|NOT COMPLETED|Overall Study||0
8255599|NCT01830205|20357379|P3|NOT COMPLETED|Overall Study||0
8255600|NCT01830205|20357380|P2|NOT COMPLETED|Overall Study||0
8255601|NCT01830205|20357381|P1|NOT COMPLETED|Overall Study||0
8255602|NCT01830205|20357378|P4|COMPLETED|Overall Study||12
8255603|NCT01830205|20357379|P3|COMPLETED|Overall Study||6
8255604|NCT01830205|20357380|P2|COMPLETED|Overall Study||6
8255605|NCT01830205|20357381|P1|COMPLETED|Overall Study||12
8255606|NCT01830205|20357378|P4|STARTED|Overall Study||12
8255607|NCT01830205|20357379|P3|STARTED|Overall Study||6
8255608|NCT01830205|20357380|P2|STARTED|Overall Study||6
8255609|NCT01830205|20357381|P1|STARTED|Overall Study||12
8255610|NCT01830140|20357465|P2|NOT COMPLETED|Overall Study||4
8255611|NCT01830140|20357466|P1|NOT COMPLETED|Overall Study||7
8255612|NCT01830140|20357465|P2|COMPLETED|Overall Study||229
8255613|NCT01830140|20357466|P1|COMPLETED|Overall Study||226
8255614|NCT01830140|20357465|P2|STARTED|Overall Study||233
8255615|NCT01830140|20357466|P1|STARTED|Overall Study||233
8255616|NCT01830127|20357474|P2|NOT COMPLETED|Overall Study||9
8255617|NCT01830127|20357475|P1|NOT COMPLETED|Overall Study||5
8255618|NCT01830127|20357474|P2|COMPLETED|Overall Study||8
8255619|NCT01830127|20357475|P1|COMPLETED|Overall Study||13
8255620|NCT01830127|20357474|P2|STARTED|Overall Study||17
8255621|NCT01830127|20357475|P1|STARTED|Overall Study||18
8255622|NCT01829997|20357483|P1|NOT COMPLETED|Overall Study||6
8255623|NCT01829997|20357483|P1|COMPLETED|Overall Study||16
8255624|NCT01829997|20357483|P1|STARTED|Overall Study||22
8255625|NCT01829919|20357492|P1|NOT COMPLETED|Overall Study||0
8255626|NCT01829919|20357492|P1|COMPLETED|Overall Study||24
8255627|NCT01829919|20357492|P1|STARTED|Overall Study||24
8255628|NCT01829711|20357508|P1|NOT COMPLETED|Overall Study||43
8255629|NCT01829711|20357508|P1|COMPLETED|Overall Study||37
8255630|NCT01829711|20357508|P1|STARTED|Overall Study||80
8255631|NCT01829516|20357539|P2|NOT COMPLETED|2nd Intervention||0
8255632|NCT01829516|20357540|P1|NOT COMPLETED|2nd Intervention||0
8255633|NCT01829516|20357539|P2|COMPLETED|2nd Intervention||14
8255634|NCT01829516|20357540|P1|COMPLETED|2nd Intervention||18
8255635|NCT01829516|20357539|P2|STARTED|2nd Intervention||14
8255636|NCT01829516|20357540|P1|STARTED|2nd Intervention||18
8255637|NCT01829516|20357539|P2|NOT COMPLETED|Washout Period - 1 Week||0
8255638|NCT01829516|20357540|P1|NOT COMPLETED|Washout Period - 1 Week||0
8255639|NCT01829516|20357539|P2|COMPLETED|Washout Period - 1 Week||14
8255640|NCT01829516|20357540|P1|COMPLETED|Washout Period - 1 Week||18
8255641|NCT01829516|20357539|P2|STARTED|Washout Period - 1 Week||14
8255642|NCT01829516|20357540|P1|STARTED|Washout Period - 1 Week||18
8255643|NCT01829516|20357539|P2|NOT COMPLETED|First Intervention||0
8255644|NCT01829516|20357540|P1|NOT COMPLETED|First Intervention||0
8255645|NCT01829516|20357539|P2|COMPLETED|First Intervention||14
8255646|NCT01829516|20357540|P1|COMPLETED|First Intervention||18
8255647|NCT01829516|20357539|P2|STARTED|First Intervention||14
8255648|NCT01829516|20357540|P1|STARTED|First Intervention||18
8255649|NCT01829503|20357548|P1|NOT COMPLETED|Overall Study||0
8255650|NCT01829503|20357548|P1|COMPLETED|Overall Study||44
8255651|NCT01829503|20357548|P1|STARTED|Overall Study||44
8255652|NCT01829477|20357565|P2|NOT COMPLETED|Overall Study||15
8255653|NCT01829477|20357566|P1|NOT COMPLETED|Overall Study||16
8255654|NCT01829477|20357565|P2|COMPLETED|Overall Study||1
8255655|NCT01829477|20357566|P1|COMPLETED|Overall Study||1
8255656|NCT01829477|20357565|P2|STARTED|Overall Study||16
8255657|NCT01829477|20357566|P1|STARTED|Overall Study||17
8255658|NCT01829464|20357579|P3|NOT COMPLETED|Overall Study||26
8255659|NCT01829464|20357580|P2|NOT COMPLETED|Overall Study||29
8255660|NCT01829464|20357581|P1|NOT COMPLETED|Overall Study||28
8255661|NCT01829464|20357579|P3|COMPLETED|Overall Study||3
8255662|NCT01829464|20357580|P2|COMPLETED|Overall Study||2
8255663|NCT01829464|20357581|P1|COMPLETED|Overall Study||2
8255664|NCT01829464|20357579|P3|STARTED|Overall Study||29
8255665|NCT01829464|20357580|P2|STARTED|Overall Study||31
8255666|NCT01829464|20357581|P1|STARTED|Overall Study||30
8255667|NCT01829425|20357597|P2|NOT COMPLETED|Overall Study||4
8255668|NCT01829425|20357598|P1|NOT COMPLETED|Overall Study||6
8255669|NCT01829425|20357597|P2|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70
8255670|NCT01829425|20357598|P1|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72
8255671|NCT01829425|20357597|P2|STARTED|Overall Study||74
8255672|NCT01829425|20357598|P1|STARTED|Overall Study||78
8255673|NCT01829399|20357628|P2|NOT COMPLETED|Visit 2 (One Month Later)||0
8255674|NCT01829399|20357629|P1|NOT COMPLETED|Visit 2 (One Month Later)||0
8255675|NCT01829399|20357628|P2|COMPLETED|Visit 2 (One Month Later)||12
8255676|NCT01829399|20357629|P1|COMPLETED|Visit 2 (One Month Later)||12
8255677|NCT01829399|20357628|P2|STARTED|Visit 2 (One Month Later)||12
8255678|NCT01829399|20357629|P1|STARTED|Visit 2 (One Month Later)||12
8255679|NCT01829399|20357628|P2|NOT COMPLETED|Visit 1||0
8255680|NCT01829399|20357629|P1|NOT COMPLETED|Visit 1||0
8255681|NCT01829399|20357628|P2|COMPLETED|Visit 1||12
8255682|NCT01829399|20357629|P1|COMPLETED|Visit 1||12
8255683|NCT01829399|20357628|P2|STARTED|Visit 1||12
8255684|NCT01829399|20357629|P1|STARTED|Visit 1||12
8255685|NCT01829360|20357641|P4|NOT COMPLETED|Overall Study||0
8255686|NCT01829360|20357642|P3|NOT COMPLETED|Overall Study||1
8255687|NCT01829360|20357643|P2|NOT COMPLETED|Overall Study||0
8255688|NCT01829360|20357644|P1|NOT COMPLETED|Overall Study||0
8255689|NCT01829360|20357641|P4|COMPLETED|Overall Study||8
8255690|NCT01829360|20357642|P3|COMPLETED|Overall Study||9
8255691|NCT01829360|20357643|P2|COMPLETED|Overall Study||9
8255692|NCT01829360|20357644|P1|COMPLETED|Overall Study||8
8255693|NCT01829360|20357641|P4|STARTED|Overall Study||8
8255694|NCT01829360|20357642|P3|STARTED|Overall Study||10
8255695|NCT01829360|20357643|P2|STARTED|Overall Study||9
8255696|NCT01829360|20357644|P1|STARTED|Overall Study||8
8255697|NCT01829347|20357664|P2|NOT COMPLETED|VTI-210E||6
8255698|NCT01829347|20357665|P1|NOT COMPLETED|VTI-210E||3
8255699|NCT01829347|20357664|P2|COMPLETED|VTI-210E||0
8255700|NCT01829347|20357665|P1|COMPLETED|VTI-210E||0
8255701|NCT01829347|20357664|P2|STARTED|VTI-210E||6
8255702|NCT01829347|20357665|P1|STARTED|VTI-210E||3
8255703|NCT01829347|20357664|P2|NOT COMPLETED|VTI-210||3
8255704|NCT01829347|20357665|P1|NOT COMPLETED|VTI-210||6
8255705|NCT01829347|20357664|P2|COMPLETED|VTI-210||6
8255706|NCT01829347|20357665|P1|COMPLETED|VTI-210||3
8255707|NCT01829347|20357664|P2|STARTED|VTI-210||9
8255708|NCT01829347|20357665|P1|STARTED|VTI-210||9
8255709|NCT01829295|20357675|P4|NOT COMPLETED|6-12 Months||13
8255710|NCT01829295|20357676|P3|NOT COMPLETED|6-12 Months||12
8255711|NCT01829295|20357677|P2|NOT COMPLETED|6-12 Months||2
8255712|NCT01829295|20357678|P1|NOT COMPLETED|6-12 Months||4
8255713|NCT01829295|20357675|P4|COMPLETED|6-12 Months||29
8255714|NCT01829295|20357676|P3|COMPLETED|6-12 Months||20
8255715|NCT01829295|20357677|P2|COMPLETED|6-12 Months||54
8255716|NCT01829295|20357678|P1|COMPLETED|6-12 Months||60
8255717|NCT01829295|20357675|P4|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42
8255718|NCT01829295|20357676|P3|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32
8255719|NCT01829295|20357677|P2|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56
8255720|NCT01829295|20357678|P1|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64
8255721|NCT01829295|20357675|P4|NOT COMPLETED|0-6 Months||0
8255722|NCT01829295|20357676|P3|NOT COMPLETED|0-6 Months||0
8255723|NCT01829295|20357677|P2|NOT COMPLETED|0-6 Months||11
8255724|NCT01829295|20357678|P1|NOT COMPLETED|0-6 Months||11
8255725|NCT01829295|20357675|P4|COMPLETED|0-6 Months||0
8255726|NCT01829295|20357676|P3|COMPLETED|0-6 Months||0
8255727|NCT01829295|20357677|P2|COMPLETED|0-6 Months||98
8255728|NCT01829295|20357678|P1|COMPLETED|0-6 Months||96
8255729|NCT01829295|20357675|P4|STARTED|0-6 Months||0
8255730|NCT01829295|20357676|P3|STARTED|0-6 Months||0
8255731|NCT01829295|20357677|P2|STARTED|0-6 Months||109
8255732|NCT01829295|20357678|P1|STARTED|0-6 Months||107
8255733|NCT01829243|20357688|P2|NOT COMPLETED|Second Intervention||0
8255734|NCT01829243|20357689|P1|NOT COMPLETED|Second Intervention||0
8255735|NCT01829243|20357688|P2|COMPLETED|Second Intervention||13
8255736|NCT01829243|20357689|P1|COMPLETED|Second Intervention||7
8255737|NCT01829243|20357688|P2|STARTED|Second Intervention||13
8255738|NCT01829243|20357689|P1|STARTED|Second Intervention||7
8255739|NCT01829243|20357688|P2|NOT COMPLETED|Washout Period of 1 Week||0
8255740|NCT01829243|20357689|P1|NOT COMPLETED|Washout Period of 1 Week||0
8255741|NCT01829243|20357688|P2|COMPLETED|Washout Period of 1 Week||13
8255742|NCT01829243|20357689|P1|COMPLETED|Washout Period of 1 Week||7
8255743|NCT01829243|20357688|P2|STARTED|Washout Period of 1 Week||13
8255744|NCT01829243|20357689|P1|STARTED|Washout Period of 1 Week||7
8255745|NCT01829243|20357688|P2|NOT COMPLETED|First Intervention||2
8255746|NCT01829243|20357689|P1|NOT COMPLETED|First Intervention||4
8255747|NCT01829243|20357688|P2|COMPLETED|First Intervention||13
8255748|NCT01829243|20357689|P1|COMPLETED|First Intervention||7
8255749|NCT01829243|20357688|P2|STARTED|First Intervention||15
8255750|NCT01829243|20357689|P1|STARTED|First Intervention||11
8255751|NCT01829230|20357703|P2|NOT COMPLETED|Overall Study||4
8255752|NCT01829230|20357704|P1|NOT COMPLETED|Overall Study||1
8255753|NCT01829230|20357703|P2|COMPLETED|Overall Study||38
8255754|NCT01829230|20357704|P1|COMPLETED|Overall Study||39
8255755|NCT01829230|20357703|P2|STARTED|Overall Study||42
8255756|NCT01829230|20357704|P1|STARTED|Overall Study||40
8255757|NCT01829217|20357712|P1|NOT COMPLETED|Overall Study||0
8255758|NCT01829217|20357712|P1|COMPLETED|Overall Study||13
8255759|NCT01829217|20357712|P1|STARTED|Overall Study||13
8255760|NCT01829191|20357718|P2|NOT COMPLETED|Overall Study||14
8255761|NCT01829191|20357719|P1|NOT COMPLETED|Overall Study||7
8255762|NCT01829191|20357718|P2|COMPLETED|Overall Study||50
8255763|NCT01829191|20357719|P1|COMPLETED|Overall Study||56
8255764|NCT01829191|20357718|P2|STARTED|Overall Study||64
8255765|NCT01829191|20357719|P1|STARTED|Overall Study||63
8255766|NCT01829165|20357728|P2|NOT COMPLETED|Overall Study||0
8255767|NCT01829165|20357729|P1|NOT COMPLETED|Overall Study||2
8255768|NCT01829165|20357728|P2|COMPLETED|Overall Study||13
8255769|NCT01829165|20357729|P1|COMPLETED|Overall Study||18
8255770|NCT01829165|20357728|P2|STARTED|Overall Study||13
8255771|NCT01829165|20357729|P1|STARTED|Overall Study||20
8255772|NCT01829113|20357737|P2|NOT COMPLETED|Overall Study||78
8255773|NCT01829113|20357738|P1|NOT COMPLETED|Overall Study||77
8255774|NCT01829113|20357737|P2|COMPLETED|Overall Study||0
8255775|NCT01829113|20357738|P1|COMPLETED|Overall Study||0
8255776|NCT01829113|20357737|P2|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
8255777|NCT01829113|20357738|P1|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
8255778|NCT01829048|20357755|P5|NOT COMPLETED|Overall Study||0
8255779|NCT01829048|20357756|P4|NOT COMPLETED|Overall Study||2
8255780|NCT01829048|20357757|P3|NOT COMPLETED|Overall Study||0
8255781|NCT01829048|20357758|P2|NOT COMPLETED|Overall Study||0
8255782|NCT01829048|20357759|P1|NOT COMPLETED|Overall Study||0
8255783|NCT01829048|20357755|P5|COMPLETED|Overall Study||2
8255784|NCT01829048|20357756|P4|COMPLETED|Overall Study||12
8255785|NCT01829048|20357757|P3|COMPLETED|Overall Study||7
8255786|NCT01829048|20357758|P2|COMPLETED|Overall Study||8
8255787|NCT01829048|20357759|P1|COMPLETED|Overall Study||6
8255788|NCT01829048|20357755|P5|STARTED|Overall Study||2
8255789|NCT01829048|20357756|P4|STARTED|Overall Study||14
8255790|NCT01829048|20357757|P3|STARTED|Overall Study||7
8255791|NCT01829048|20357758|P2|STARTED|Overall Study||8
8255792|NCT01829048|20357759|P1|STARTED|Overall Study||6
8255793|NCT01828983|20357833|P2|NOT COMPLETED|Overall Study||0
8255794|NCT01828983|20357834|P1|NOT COMPLETED|Overall Study||0
8255795|NCT01828983|20357833|P2|COMPLETED|Overall Study||81
8255796|NCT01828983|20357834|P1|COMPLETED|Overall Study||80
8255797|NCT01828983|20357833|P2|STARTED|Overall Study||81
8255798|NCT01828983|20357834|P1|STARTED|Overall Study||80
8255799|NCT01828593|20357847|P3|NOT COMPLETED|Placebo-Free Phase||6
8255800|NCT01828593|20357848|P2|NOT COMPLETED|Placebo-Free Phase||6
8255801|NCT01828593|20357849|P1|NOT COMPLETED|Placebo-Free Phase||0
8255802|NCT01828593|20357847|P3|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
8255803|NCT01828593|20357848|P2|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
8255804|NCT01828593|20357849|P1|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
8255805|NCT01828593|20357847|P3|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
8255806|NCT01828593|20357848|P2|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
8255807|NCT01828593|20357849|P1|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
8255808|NCT01828593|20357847|P3|NOT COMPLETED|Placebo-Controlled Phase||1
8255809|NCT01828593|20357848|P2|NOT COMPLETED|Placebo-Controlled Phase||0
8255810|NCT01828593|20357849|P1|NOT COMPLETED|Placebo-Controlled Phase||0
8255811|NCT01828593|20357847|P3|COMPLETED|Placebo-Controlled Phase||32
8255812|NCT01828593|20357848|P2|COMPLETED|Placebo-Controlled Phase||34
8255813|NCT01828593|20357849|P1|COMPLETED|Placebo-Controlled Phase||36
8255814|NCT01828593|20357847|P3|STARTED|Placebo-Controlled Phase||33
8255815|NCT01828593|20357848|P2|STARTED|Placebo-Controlled Phase||34
8255816|NCT01828593|20357849|P1|STARTED|Placebo-Controlled Phase||36
8255817|NCT01828567|20357872|P2|NOT COMPLETED|Overall Study||10
8255818|NCT01828567|20357873|P1|NOT COMPLETED|Overall Study||31
8255819|NCT01828567|20357872|P2|COMPLETED|Overall Study||199
8255820|NCT01828567|20357873|P1|COMPLETED|Overall Study||177
8255821|NCT01828567|20357872|P2|1 Month|Overall Study||192
8255822|NCT01828567|20357873|P1|1 Month|Overall Study||172
8255823|NCT01828567|20357872|P2|STARTED|Overall Study||209
8255824|NCT01828567|20357873|P1|STARTED|Overall Study||208
8255825|NCT01828554|20357889|P1|NOT COMPLETED|Overall Study||0
8255826|NCT01828554|20357889|P1|COMPLETED|Overall Study||8
8255827|NCT01828554|20357889|P1|STARTED|Overall Study||8
8255828|NCT01828515|20357896|P2|NOT COMPLETED|Second Intervention (19 Days)||3
8255829|NCT01828515|20357897|P1|NOT COMPLETED|Second Intervention (19 Days)||0
8255830|NCT01828515|20357896|P2|COMPLETED|Second Intervention (19 Days)||5
8255831|NCT01828515|20357897|P1|COMPLETED|Second Intervention (19 Days)||6
8255832|NCT01828515|20357896|P2|STARTED|Second Intervention (19 Days)||8
8255833|NCT01828515|20357897|P1|STARTED|Second Intervention (19 Days)||6
8255834|NCT01828515|20357896|P2|NOT COMPLETED|Washout (23 Days)||1
8255835|NCT01828515|20357897|P1|NOT COMPLETED|Washout (23 Days)||5
8255836|NCT01828515|20357896|P2|COMPLETED|Washout (23 Days)||8
8255837|NCT01828515|20357897|P1|COMPLETED|Washout (23 Days)||6
8255838|NCT01828515|20357896|P2|STARTED|Washout (23 Days)||9
8255839|NCT01828515|20357897|P1|STARTED|Washout (23 Days)||11
8255840|NCT01828515|20357896|P2|NOT COMPLETED|First Intervention (19 Days)||2
8255841|NCT01828515|20357897|P1|NOT COMPLETED|First Intervention (19 Days)||2
8255842|NCT01828515|20357896|P2|COMPLETED|First Intervention (19 Days)||9
8255843|NCT01828515|20357897|P1|COMPLETED|First Intervention (19 Days)||11
8255844|NCT01828515|20357896|P2|STARTED|First Intervention (19 Days)||11
8255845|NCT01828515|20357897|P1|STARTED|First Intervention (19 Days)||13
8255846|NCT01828476|20357905|P2|NOT COMPLETED|Overall Study||0
8255847|NCT01828476|20357906|P1|NOT COMPLETED|Overall Study||0
8255848|NCT01828476|20357905|P2|COMPLETED|Overall Study||0
8255849|NCT01828476|20357906|P1|COMPLETED|Overall Study||13
8255850|NCT01828476|20357905|P2|STARTED|Overall Study||0
8255851|NCT01828476|20357906|P1|STARTED|Overall Study||13
8255852|NCT01828281|20357928|P2|NOT COMPLETED|Overall Study||0
8255853|NCT01828281|20357929|P1|NOT COMPLETED|Overall Study||1
8255854|NCT01828281|20357928|P2|COMPLETED|Overall Study||45
8255855|NCT01828281|20357929|P1|COMPLETED|Overall Study||44
8255856|NCT01828281|20357928|P2|STARTED|Overall Study||45
8255857|NCT01828281|20357929|P1|STARTED|Overall Study||45
8255858|NCT01828255|20357941|P2|NOT COMPLETED|Overall Study||0
8255859|NCT01828255|20357942|P1|NOT COMPLETED|Overall Study||0
8255860|NCT01828255|20357941|P2|COMPLETED|Overall Study||20
8255861|NCT01828255|20357942|P1|COMPLETED|Overall Study||20
8255862|NCT01828255|20357941|P2|STARTED|Overall Study||20
8255863|NCT01828255|20357942|P1|STARTED|Overall Study||20
8255864|NCT01828216|20357958|P2|NOT COMPLETED|Overall Study||0
8255865|NCT01828216|20357959|P1|NOT COMPLETED|Overall Study||0
8255866|NCT01828216|20357958|P2|COMPLETED|Overall Study||157
8255867|NCT01828216|20357959|P1|COMPLETED|Overall Study||159
8255868|NCT01828216|20357958|P2|STARTED|Overall Study||157
8255869|NCT01828216|20357959|P1|STARTED|Overall Study||159
8255870|NCT01828164|20357967|P1|NOT COMPLETED|Overall Study||17
8255871|NCT01828164|20357967|P1|COMPLETED|Overall Study||32
8255872|NCT01828164|20357967|P1|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
8255919|NCT01828034|20358022|P4|NOT COMPLETED|Overall Study||1
8255920|NCT01828034|20358023|P3|NOT COMPLETED|Overall Study||0
8255921|NCT01828034|20358024|P2|NOT COMPLETED|Overall Study||0
8255922|NCT01828034|20358025|P1|NOT COMPLETED|Overall Study||0
8255923|NCT01828034|20358022|P4|COMPLETED|Overall Study||29
8255924|NCT01828034|20358023|P3|COMPLETED|Overall Study||3
8255925|NCT01828034|20358024|P2|COMPLETED|Overall Study||6
8255926|NCT01828034|20358025|P1|COMPLETED|Overall Study||3
8255927|NCT01828034|20358022|P4|STARTED|Overall Study||30
8255928|NCT01828034|20358023|P3|STARTED|Overall Study||3
8255929|NCT01828034|20358024|P2|STARTED|Overall Study||6
8255930|NCT01828034|20358025|P1|STARTED|Overall Study||3
8255931|NCT01828021|20358037|P1|NOT COMPLETED|Overall Study||25
8255932|NCT01828021|20358037|P1|COMPLETED|Overall Study||0
8255933|NCT01828021|20358037|P1|STARTED|Overall Study||25
8255934|NCT01827930|20358045|P3|NOT COMPLETED|Overall Study||0
8255935|NCT01827930|20358046|P2|NOT COMPLETED|Overall Study||0
8255936|NCT01827930|20358047|P1|NOT COMPLETED|Overall Study||0
8255937|NCT01827930|20358045|P3|COMPLETED|Overall Study||19
8255938|NCT01827930|20358046|P2|COMPLETED|Overall Study||25
8255939|NCT01827930|20358047|P1|COMPLETED|Overall Study||24
8255940|NCT01827930|20358045|P3|STARTED|Overall Study||19
8255941|NCT01827930|20358046|P2|STARTED|Overall Study||25
8255942|NCT01827930|20358047|P1|STARTED|Overall Study||24
8255943|NCT01827839|20358076|P1|NOT COMPLETED|Overall Study||3
8255944|NCT01827839|20358076|P1|COMPLETED|Overall Study||93
8255945|NCT01827839|20358076|P1|STARTED|Overall Study||96
8255946|NCT01827787|20358100|P2|NOT COMPLETED|Overall Study||0
8255947|NCT01827787|20358101|P1|NOT COMPLETED|Overall Study||0
8255948|NCT01827787|20358100|P2|COMPLETED|Overall Study||38
8255949|NCT01827787|20358101|P1|COMPLETED|Overall Study||45
8255950|NCT01827787|20358100|P2|STARTED|Overall Study||38
8255951|NCT01827787|20358101|P1|STARTED|Overall Study||45
8255952|NCT01827670|20358121|P2|NOT COMPLETED|Overall Study||3
8255953|NCT01827670|20358122|P1|NOT COMPLETED|Overall Study||3
8255954|NCT01827670|20358121|P2|COMPLETED|Overall Study||56
8255955|NCT01827670|20358122|P1|COMPLETED|Overall Study||57
8255956|NCT01827670|20358121|P2|STARTED|Overall Study||59
8255957|NCT01827670|20358122|P1|STARTED|Overall Study||60
8255958|NCT01827592|20358141|P3|NOT COMPLETED|Overall Study||76
8255959|NCT01827592|20358142|P2|NOT COMPLETED|Overall Study||80
8255960|NCT01827592|20358143|P1|NOT COMPLETED|Overall Study||74
8255961|NCT01827592|20358141|P3|COMPLETED|Overall Study||48
8255962|NCT01827592|20358142|P2|COMPLETED|Overall Study||46
8255963|NCT01827592|20358143|P1|COMPLETED|Overall Study||52
8255964|NCT01827592|20358141|P3|Safety Analysis Set|Overall Study||124
8255965|NCT01827592|20358142|P2|Safety Analysis Set|Overall Study||126
8255966|NCT01827592|20358143|P1|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
8255967|NCT01827592|20358141|P3|STARTED|Overall Study|Randomized patients.|124
8255968|NCT01827592|20358142|P2|STARTED|Overall Study|Randomized patients.|126
8255969|NCT01827592|20358143|P1|STARTED|Overall Study|Randomized patients.|126
8255970|NCT01827475|20358175|P3|NOT COMPLETED|Overall Study||0
8255971|NCT01827475|20358176|P2|NOT COMPLETED|Overall Study||0
8255972|NCT01827475|20358177|P1|NOT COMPLETED|Overall Study||0
8255973|NCT01827475|20358175|P3|COMPLETED|Overall Study||30
8255974|NCT01827475|20358176|P2|COMPLETED|Overall Study||30
8255975|NCT01827475|20358177|P1|COMPLETED|Overall Study||30
8255976|NCT01827475|20358175|P3|STARTED|Overall Study||30
8255977|NCT01827475|20358176|P2|STARTED|Overall Study||30
8255978|NCT01827475|20358177|P1|STARTED|Overall Study||30
8255979|NCT01827462|20358191|P3|NOT COMPLETED|Overall Study||28
8255980|NCT01827462|20358192|P2|NOT COMPLETED|Overall Study||18
8255981|NCT01827462|20358193|P1|NOT COMPLETED|Overall Study||41
8255982|NCT01827462|20358191|P3|COMPLETED|Overall Study||12
8255983|NCT01827462|20358192|P2|COMPLETED|Overall Study||19
8255984|NCT01827462|20358193|P1|COMPLETED|Overall Study||18
8255985|NCT01827462|20358191|P3|STARTED|Overall Study||40
8255986|NCT01827462|20358192|P2|STARTED|Overall Study||37
8255987|NCT01827462|20358193|P1|STARTED|Overall Study||59
8255988|NCT01827371|20358208|P4|NOT COMPLETED|Overall Study||23
8255989|NCT01827371|20358209|P3|NOT COMPLETED|Overall Study||11
8255990|NCT01827371|20358210|P2|NOT COMPLETED|Overall Study||7
8255991|NCT01827371|20358211|P1|NOT COMPLETED|Overall Study||13
8255992|NCT01827371|20358208|P4|COMPLETED|Overall Study||97
8255993|NCT01827371|20358209|P3|COMPLETED|Overall Study||93
8255994|NCT01827371|20358210|P2|COMPLETED|Overall Study||89
8255995|NCT01827371|20358211|P1|COMPLETED|Overall Study||102
8255996|NCT01827371|20358208|P4|STARTED|Overall Study||120
8255997|NCT01827371|20358209|P3|STARTED|Overall Study||104
8255998|NCT01827371|20358210|P2|STARTED|Overall Study||96
8255999|NCT01827371|20358211|P1|STARTED|Overall Study||115
8256000|NCT01827358|20358235|P2|NOT COMPLETED|Overall Study||31
8256001|NCT01827358|20358236|P1|NOT COMPLETED|Overall Study||35
8256002|NCT01827358|20358235|P2|COMPLETED|Overall Study||44
8256003|NCT01827358|20358236|P1|COMPLETED|Overall Study||45
8256004|NCT01827358|20358235|P2|STARTED|Overall Study||75
8256005|NCT01827358|20358236|P1|STARTED|Overall Study||80
8256006|NCT01827332|20358270|P2|NOT COMPLETED|Overall Study||1
8256007|NCT01827332|20358271|P1|NOT COMPLETED|Overall Study||2
8256008|NCT01827332|20358270|P2|COMPLETED|Overall Study||7
8256009|NCT01827332|20358271|P1|COMPLETED|Overall Study||6
8256010|NCT01827332|20358270|P2|STARTED|Overall Study||8
8256011|NCT01827332|20358271|P1|STARTED|Overall Study||8
8256012|NCT01827319|20358279|P1|NOT COMPLETED|Overall Study||3
8256013|NCT01827319|20358279|P1|COMPLETED|Overall Study||200
8256014|NCT01827319|20358279|P1|STARTED|Overall Study||203
8256015|NCT01827306|20358287|P2|NOT COMPLETED|Overall Study||5
8256016|NCT01827306|20358288|P1|NOT COMPLETED|Overall Study||11
8256017|NCT01827306|20358287|P2|COMPLETED|Overall Study||8
8256018|NCT01827306|20358288|P1|COMPLETED|Overall Study||10
8256019|NCT01827306|20358287|P2|STARTED|Overall Study||13
8256020|NCT01827306|20358288|P1|STARTED|Overall Study||21
8256021|NCT01827267|20358302|P2|NOT COMPLETED|Overall Study||12
8256022|NCT01827267|20358303|P1|NOT COMPLETED|Overall Study||5
8256023|NCT01827267|20358302|P2|COMPLETED|Overall Study||32
8256024|NCT01827267|20358303|P1|COMPLETED|Overall Study||13
8256025|NCT01827267|20358302|P2|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
8256026|NCT01827267|20358303|P1|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
8256027|NCT01827267|20358302|P2|Received Study Drug|Overall Study||43
8256028|NCT01827267|20358303|P1|Received Study Drug|Overall Study||17
8256029|NCT01827267|20358302|P2|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
8256030|NCT01827267|20358303|P1|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
8256031|NCT01827254|20358318|P1|NOT COMPLETED|Overall Study||59
8256032|NCT01827254|20358318|P1|COMPLETED|Overall Study||2
8256033|NCT01827254|20358318|P1|Evaluable Population|Overall Study||52
8256034|NCT01827254|20358318|P1|STARTED|Overall Study||61
8256035|NCT01827163|20358328|P1|NOT COMPLETED|Overall Study||11
8256036|NCT01827163|20358328|P1|COMPLETED|Overall Study||9
8256037|NCT01827163|20358328|P1|STARTED|Overall Study||20
8256038|NCT01827046|20358335|P2|NOT COMPLETED|Overall Study||9
8256039|NCT01827046|20358336|P1|NOT COMPLETED|Overall Study||1
8256040|NCT01827046|20358335|P2|COMPLETED|Overall Study||240
8256041|NCT01827046|20358336|P1|COMPLETED|Overall Study||249
8256042|NCT01827046|20358335|P2|STARTED|Overall Study||249
8256043|NCT01827046|20358336|P1|STARTED|Overall Study||250
8256044|NCT01826981|20358391|P15|NOT COMPLETED|Overall Study||0
8256045|NCT01826981|20358392|P14|NOT COMPLETED|Overall Study||5
8256046|NCT01826981|20358393|P13|NOT COMPLETED|Overall Study||1
8256047|NCT01826981|20358394|P12|NOT COMPLETED|Overall Study||2
8256048|NCT01826981|20358395|P11|NOT COMPLETED|Overall Study||2
8256049|NCT01826981|20358396|P10|NOT COMPLETED|Overall Study||1
8256050|NCT01826981|20358397|P9|NOT COMPLETED|Overall Study||7
8256051|NCT01826981|20358398|P8|NOT COMPLETED|Overall Study||11
8256052|NCT01826981|20358399|P7|NOT COMPLETED|Overall Study||1
8256053|NCT01826981|20358400|P6|NOT COMPLETED|Overall Study||1
8256054|NCT01826981|20358401|P5|NOT COMPLETED|Overall Study||7
8256055|NCT01826981|20358402|P4|NOT COMPLETED|Overall Study||0
8256056|NCT01826981|20358403|P3|NOT COMPLETED|Overall Study||0
8256057|NCT01826981|20358404|P2|NOT COMPLETED|Overall Study||1
8256058|NCT01826981|20358405|P1|NOT COMPLETED|Overall Study||0
8256059|NCT01826981|20358391|P15|COMPLETED|Overall Study||8
8256060|NCT01826981|20358392|P14|COMPLETED|Overall Study||15
8256061|NCT01826981|20358393|P13|COMPLETED|Overall Study||25
8256062|NCT01826981|20358394|P12|COMPLETED|Overall Study||25
8256063|NCT01826981|20358395|P11|COMPLETED|Overall Study||22
8256064|NCT01826981|20358396|P10|COMPLETED|Overall Study||26
8256065|NCT01826981|20358397|P9|COMPLETED|Overall Study||13
8256066|NCT01826981|20358398|P8|COMPLETED|Overall Study||40
8256067|NCT01826981|20358399|P7|COMPLETED|Overall Study||24
8256068|NCT01826981|20358400|P6|COMPLETED|Overall Study||25
8256069|NCT01826981|20358401|P5|COMPLETED|Overall Study||18
8256070|NCT01826981|20358402|P4|COMPLETED|Overall Study||26
8256071|NCT01826981|20358403|P3|COMPLETED|Overall Study||25
8256072|NCT01826981|20358404|P2|COMPLETED|Overall Study||9
8256073|NCT01826981|20358405|P1|COMPLETED|Overall Study||19
8256074|NCT01826981|20358391|P15|STARTED|Overall Study||8
8256075|NCT01826981|20358392|P14|STARTED|Overall Study||20
8256076|NCT01826981|20358393|P13|STARTED|Overall Study||26
8256077|NCT01826981|20358394|P12|STARTED|Overall Study||27
8256078|NCT01826981|20358395|P11|STARTED|Overall Study||24
8256079|NCT01826981|20358396|P10|STARTED|Overall Study||27
8256080|NCT01826981|20358397|P9|STARTED|Overall Study||20
8256081|NCT01826981|20358398|P8|STARTED|Overall Study||51
8256082|NCT01826981|20358399|P7|STARTED|Overall Study||25
8256083|NCT01826981|20358400|P6|STARTED|Overall Study||26
8256084|NCT01826981|20358401|P5|STARTED|Overall Study||25
8256085|NCT01826981|20358402|P4|STARTED|Overall Study||26
8256086|NCT01826981|20358403|P3|STARTED|Overall Study||25
8256087|NCT01826981|20358404|P2|STARTED|Overall Study||10
8256088|NCT01826981|20358405|P1|STARTED|Overall Study||19
8256089|NCT01826851|20358553|P2|NOT COMPLETED|Overall Study||0
8256090|NCT01826851|20358554|P1|NOT COMPLETED|Overall Study||0
8256091|NCT01826851|20358553|P2|COMPLETED|Overall Study||41
8256092|NCT01826851|20358554|P1|COMPLETED|Overall Study||38
8256093|NCT01826851|20358553|P2|STARTED|Overall Study||41
8256094|NCT01826851|20358554|P1|STARTED|Overall Study||38
8256095|NCT01826812|20358574|P2|NOT COMPLETED|Overall Study||1
8256096|NCT01826812|20358575|P1|NOT COMPLETED|Overall Study||0
8256097|NCT01826812|20358574|P2|COMPLETED|Overall Study||32
8256098|NCT01826812|20358575|P1|COMPLETED|Overall Study||167
8256099|NCT01826812|20358574|P2|STARTED|Overall Study||33
8256100|NCT01826812|20358575|P1|STARTED|Overall Study||167
8256101|NCT01826604|20358591|P2|NOT COMPLETED|Overall Study||9
8256102|NCT01826604|20358592|P1|NOT COMPLETED|Overall Study||8
8256103|NCT01826604|20358591|P2|COMPLETED|Overall Study||148
8256104|NCT01826604|20358592|P1|COMPLETED|Overall Study||136
8256105|NCT01826604|20358591|P2|STARTED|Overall Study||157
8256106|NCT01826604|20358592|P1|STARTED|Overall Study||144
8256107|NCT01826513|20358603|P3|NOT COMPLETED|Overall Study||0
8256108|NCT01826513|20358604|P2|NOT COMPLETED|Overall Study||0
8256109|NCT01826513|20358605|P1|NOT COMPLETED|Overall Study||0
8256110|NCT01826513|20358603|P3|COMPLETED|Overall Study||10
8256111|NCT01826513|20358604|P2|COMPLETED|Overall Study||10
8256112|NCT01826513|20358605|P1|COMPLETED|Overall Study||5
8256113|NCT01826513|20358603|P3|STARTED|Overall Study||10
8256114|NCT01826513|20358604|P2|STARTED|Overall Study||10
8256115|NCT01826513|20358605|P1|STARTED|Overall Study||5
8256116|NCT01826487|20358636|P2|NOT COMPLETED|Overall Study||5
8256117|NCT01826487|20358637|P1|NOT COMPLETED|Overall Study||4
8256118|NCT01826487|20358636|P2|COMPLETED|Overall Study||110
8256119|NCT01826487|20358637|P1|COMPLETED|Overall Study||111
8256120|NCT01826487|20358636|P2|ITT Population|Overall Study||114
8256121|NCT01826487|20358637|P1|ITT Population|Overall Study||114
8256122|NCT01826487|20358636|P2|As-treated Population|Overall Study||115
8256123|NCT01826487|20358637|P1|As-treated Population|Overall Study||115
8256124|NCT01826487|20358636|P2|STARTED|Overall Study||115
8256125|NCT01826487|20358637|P1|STARTED|Overall Study||115
8256126|NCT01826448|20358664|P2|NOT COMPLETED|Overall Study||9
8256127|NCT01826448|20358665|P1|NOT COMPLETED|Overall Study||4
8256128|NCT01826448|20358664|P2|COMPLETED|Overall Study||0
8256129|NCT01826448|20358665|P1|COMPLETED|Overall Study||0
8256130|NCT01826448|20358664|P2|STARTED|Overall Study||9
8256131|NCT01826448|20358665|P1|STARTED|Overall Study||4
8256132|NCT01826422|20358673|P2|NOT COMPLETED|Overall Study||3
8256133|NCT01826422|20358674|P1|NOT COMPLETED|Overall Study||1
8256134|NCT01826422|20358673|P2|COMPLETED|Overall Study||19
8256135|NCT01826422|20358674|P1|COMPLETED|Overall Study||17
8256136|NCT01826422|20358673|P2|STARTED|Overall Study||22
8256137|NCT01826422|20358674|P1|STARTED|Overall Study||18
8256138|NCT01826370|20358718|P1|NOT COMPLETED|Overall Study||20
8256139|NCT01826370|20358718|P1|COMPLETED|Overall Study||658
8256140|NCT01826370|20358718|P1|STARTED|Overall Study||678
8256141|NCT01826227|20358724|P1|NOT COMPLETED|Overall Study||0
8256142|NCT01826227|20358724|P1|COMPLETED|Overall Study||5
8256143|NCT01826227|20358724|P1|STARTED|Overall Study||5
8256144|NCT01826214|20358730|P2|NOT COMPLETED|Overall Study||34
8256145|NCT01826214|20358731|P1|NOT COMPLETED|Overall Study||35
8256146|NCT01826214|20358730|P2|COMPLETED|Overall Study||0
8256147|NCT01826214|20358731|P1|COMPLETED|Overall Study||0
8256148|NCT01826214|20358730|P2|Treated|Overall Study|Treated = received at least one dose of study drug|34
8256149|NCT01826214|20358731|P1|Treated|Overall Study|Treated = received at least one dose of study drug|35
8256150|NCT01826214|20358730|P2|Untreated|Overall Study|Untreated = did not receive study drug|1
8256151|NCT01826214|20358731|P1|Untreated|Overall Study|Untreated = did not receive study drug|0
8256152|NCT01826214|20358730|P2|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
8256153|NCT01826214|20358731|P1|STARTED|Overall Study||35
8256154|NCT01826201|20358749|P1|NOT COMPLETED|Overall Study||4
8256155|NCT01826201|20358749|P1|COMPLETED|Overall Study||17
8256156|NCT01826201|20358749|P1|STARTED|Overall Study|Subjects in each arm are same|21
8256157|NCT01825941|20358757|P2|NOT COMPLETED|Overall Study||1
8256158|NCT01825941|20358758|P1|NOT COMPLETED|Overall Study||4
8256159|NCT01825941|20358757|P2|COMPLETED|Overall Study||103
8256160|NCT01825941|20358758|P1|COMPLETED|Overall Study||100
8256161|NCT01825941|20358757|P2|STARTED|Overall Study||104
8256162|NCT01825941|20358758|P1|STARTED|Overall Study||104
8256163|NCT01825889|20358766|P2|NOT COMPLETED|Overall Study||0
8256164|NCT01825889|20358767|P1|NOT COMPLETED|Overall Study||0
8256165|NCT01825889|20358766|P2|COMPLETED|Overall Study||10
8256166|NCT01825889|20358767|P1|COMPLETED|Overall Study||10
8256167|NCT01825889|20358766|P2|Received One Dose of Study Drug|Overall Study||10
8256168|NCT01825889|20358767|P1|Received One Dose of Study Drug|Overall Study||10
8256169|NCT01825889|20358766|P2|STARTED|Overall Study||10
8256170|NCT01825889|20358767|P1|STARTED|Overall Study||10
8256171|NCT01825876|20358777|P2|NOT COMPLETED|Period 2||1
8256172|NCT01825876|20358778|P1|NOT COMPLETED|Period 2||0
8256173|NCT01825876|20358777|P2|COMPLETED|Period 2||16
8256174|NCT01825876|20358778|P1|COMPLETED|Period 2||0
8256175|NCT01825876|20358777|P2|Received 1 Dose of Study Drug|Period 2||17
8256176|NCT01825876|20358778|P1|Received 1 Dose of Study Drug|Period 2||0
8256177|NCT01825876|20358777|P2|STARTED|Period 2|Participants received a different treatment in Period 1.|17
8256178|NCT01825876|20358778|P1|STARTED|Period 2|Participants received a different treatment in Period 2.|0
8256179|NCT01825876|20358777|P2|NOT COMPLETED|Period 1||0
8256180|NCT01825876|20358778|P1|NOT COMPLETED|Period 1||0
8256181|NCT01825876|20358777|P2|COMPLETED|Period 1||0
8256182|NCT01825876|20358778|P1|COMPLETED|Period 1||17
8256183|NCT01825876|20358777|P2|Received 1 Dose of Study Drug|Period 1||0
8256184|NCT01825876|20358778|P1|Received 1 Dose of Study Drug|Period 1||17
8256185|NCT01825876|20358777|P2|STARTED|Period 1||0
8256186|NCT01825876|20358778|P1|STARTED|Period 1||17
8256187|NCT01825837|20358799|P4|NOT COMPLETED|PART II||0
8256188|NCT01825837|20358800|P3|NOT COMPLETED|PART II||19
8256189|NCT01825837|20358801|P2|NOT COMPLETED|PART II||14
8256190|NCT01825837|20358802|P1|NOT COMPLETED|PART II||19
8256191|NCT01825837|20358799|P4|COMPLETED|PART II||0
8256192|NCT01825837|20358800|P3|COMPLETED|PART II||7
8256193|NCT01825837|20358801|P2|COMPLETED|PART II||12
8256194|NCT01825837|20358802|P1|COMPLETED|PART II||16
8256195|NCT01825837|20358799|P4|Per-Protocol Population|PART II||0
8256196|NCT01825837|20358800|P3|Per-Protocol Population|PART II||24
8256197|NCT01825837|20358801|P2|Per-Protocol Population|PART II||23
8256198|NCT01825837|20358802|P1|Per-Protocol Population|PART II||32
8256199|NCT01825837|20358799|P4|Intent-to-Treat Population|PART II||0
8256200|NCT01825837|20358800|P3|Intent-to-Treat Population|PART II||26
8256201|NCT01825837|20358801|P2|Intent-to-Treat Population|PART II||25
8256202|NCT01825837|20358802|P1|Intent-to-Treat Population|PART II||34
8256203|NCT01825837|20358799|P4|Safety Population (Double-Blind)|PART II||0
8256204|NCT01825837|20358800|P3|Safety Population (Double-Blind)|PART II||26
8256205|NCT01825837|20358801|P2|Safety Population (Double-Blind)|PART II||26
8256206|NCT01825837|20358802|P1|Safety Population (Double-Blind)|PART II||35
8256207|NCT01825837|20358799|P4|Randomized Patients|PART II||0
8256208|NCT01825837|20358800|P3|Randomized Patients|PART II||26
8256209|NCT01825837|20358801|P2|Randomized Patients|PART II||26
8256210|NCT01825837|20358802|P1|Randomized Patients|PART II||35
8256211|NCT01825837|20358799|P4|STARTED|PART II||0
8256212|NCT01825837|20358800|P3|STARTED|PART II||26
8256213|NCT01825837|20358801|P2|STARTED|PART II||26
8256214|NCT01825837|20358802|P1|STARTED|PART II||35
8256215|NCT01825837|20358799|P4|NOT COMPLETED|PART I||17
8256216|NCT01825837|20358800|P3|NOT COMPLETED|PART I||0
8256217|NCT01825837|20358801|P2|NOT COMPLETED|PART I||0
8256218|NCT01825837|20358802|P1|NOT COMPLETED|PART I||0
8256219|NCT01825837|20358799|P4|COMPLETED|PART I||87
8256220|NCT01825837|20358800|P3|COMPLETED|PART I||0
8256221|NCT01825837|20358801|P2|COMPLETED|PART I||0
8256222|NCT01825837|20358802|P1|COMPLETED|PART I||0
8256223|NCT01825837|20358799|P4|Safety Population (Open-Label)|PART I||104
8256224|NCT01825837|20358800|P3|Safety Population (Open-Label)|PART I||0
8256225|NCT01825837|20358801|P2|Safety Population (Open-Label)|PART I||0
8256226|NCT01825837|20358802|P1|Safety Population (Open-Label)|PART I||0
8256227|NCT01825837|20358799|P4|Enrolled|PART I||104
8256228|NCT01825837|20358800|P3|Enrolled|PART I||0
8256229|NCT01825837|20358801|P2|Enrolled|PART I||0
8256230|NCT01825837|20358802|P1|Enrolled|PART I||0
8256231|NCT01825837|20358799|P4|STARTED|PART I||104
8256232|NCT01825837|20358800|P3|STARTED|PART I||0
8256233|NCT01825837|20358801|P2|STARTED|PART I||0
8256234|NCT01825837|20358802|P1|STARTED|PART I||0
8256235|NCT01825798|20358812|P2|NOT COMPLETED|Overall Study||5
8256236|NCT01825798|20358813|P1|NOT COMPLETED|Overall Study||2
8256237|NCT01825798|20358812|P2|COMPLETED|Overall Study||23
8256238|NCT01825798|20358813|P1|COMPLETED|Overall Study||30
8256239|NCT01825798|20358812|P2|STARTED|Overall Study||28
8256240|NCT01825798|20358813|P1|STARTED|Overall Study||32
8256241|NCT01825785|20358848|P7|NOT COMPLETED|Overall Study||0
8256242|NCT01825785|20358849|P6|NOT COMPLETED|Overall Study||1
8256243|NCT01825785|20358850|P5|NOT COMPLETED|Overall Study||2
8256244|NCT01825785|20358851|P4|NOT COMPLETED|Overall Study||0
8256245|NCT01825785|20358852|P3|NOT COMPLETED|Overall Study||0
8256246|NCT01825785|20358853|P2|NOT COMPLETED|Overall Study||0
8256247|NCT01825785|20358854|P1|NOT COMPLETED|Overall Study||0
8256248|NCT01825785|20358848|P7|COMPLETED|Overall Study||6
8256249|NCT01825785|20358849|P6|COMPLETED|Overall Study||5
8256250|NCT01825785|20358850|P5|COMPLETED|Overall Study||4
8256251|NCT01825785|20358851|P4|COMPLETED|Overall Study||6
8256252|NCT01825785|20358852|P3|COMPLETED|Overall Study||6
8256253|NCT01825785|20358853|P2|COMPLETED|Overall Study||6
8256254|NCT01825785|20358854|P1|COMPLETED|Overall Study||12
8256255|NCT01825785|20358848|P7|STARTED|Overall Study||6
8256256|NCT01825785|20358849|P6|STARTED|Overall Study||6
8256257|NCT01825785|20358850|P5|STARTED|Overall Study||6
8256258|NCT01825785|20358851|P4|STARTED|Overall Study||6
8256259|NCT01825785|20358852|P3|STARTED|Overall Study||6
8256260|NCT01825785|20358853|P2|STARTED|Overall Study||6
8256261|NCT01825785|20358854|P1|STARTED|Overall Study||12
8256262|NCT01825655|20359000|P2|NOT COMPLETED|Overall Study||0
8256263|NCT01825655|20359001|P1|NOT COMPLETED|Overall Study||0
8256264|NCT01825655|20359000|P2|COMPLETED|Overall Study||2
8256265|NCT01825655|20359001|P1|COMPLETED|Overall Study||0
8256266|NCT01825655|20359000|P2|STARTED|Overall Study||2
8256267|NCT01825655|20359001|P1|STARTED|Overall Study||0
8256268|NCT01825577|20359007|P1|NOT COMPLETED|Overall Study||8
8256269|NCT01825577|20359007|P1|COMPLETED|Overall Study||6
8256270|NCT01825577|20359007|P1|STARTED|Overall Study||14
8256271|NCT01825408|20359016|P4|NOT COMPLETED|Overall Study||0
8256272|NCT01825408|20359017|P3|NOT COMPLETED|Overall Study||0
8256273|NCT01825408|20359018|P2|NOT COMPLETED|Overall Study||0
8256274|NCT01825408|20359019|P1|NOT COMPLETED|Overall Study||0
8256275|NCT01825408|20359016|P4|COMPLETED|Overall Study||12
8256276|NCT01825408|20359017|P3|COMPLETED|Overall Study||14
8256277|NCT01825408|20359018|P2|COMPLETED|Overall Study||7
8256278|NCT01825408|20359019|P1|COMPLETED|Overall Study||7
8256279|NCT01825408|20359016|P4|STARTED|Overall Study||12
8256280|NCT01825408|20359017|P3|STARTED|Overall Study||14
8256281|NCT01825408|20359018|P2|STARTED|Overall Study||7
8256282|NCT01825408|20359019|P1|STARTED|Overall Study||7
8256283|NCT01825200|20359031|P2|NOT COMPLETED|Overall Study||7
8256284|NCT01825200|20359032|P1|NOT COMPLETED|Overall Study||5
8256285|NCT01825200|20359031|P2|COMPLETED|Overall Study||1314
8256286|NCT01825200|20359032|P1|COMPLETED|Overall Study||1314
8256287|NCT01825200|20359031|P2|STARTED|Overall Study||1321
8256288|NCT01825200|20359032|P1|STARTED|Overall Study||1319
8256289|NCT01825122|20359046|P2|NOT COMPLETED|Overall Study||19
8256290|NCT01825122|20359047|P1|NOT COMPLETED|Overall Study||10
8256291|NCT01825122|20359046|P2|COMPLETED|Overall Study||59
8256292|NCT01825122|20359047|P1|COMPLETED|Overall Study||67
8256293|NCT01825122|20359046|P2|STARTED|Overall Study||78
8256294|NCT01825122|20359047|P1|STARTED|Overall Study||77
8256295|NCT01824979|20359055|P2|NOT COMPLETED|Overall Study||13
8256296|NCT01824979|20359056|P1|NOT COMPLETED|Overall Study||13
8256297|NCT01824979|20359055|P2|COMPLETED|Overall Study||37
8256298|NCT01824979|20359056|P1|COMPLETED|Overall Study||37
8256299|NCT01824979|20359055|P2|STARTED|Overall Study||50
8256300|NCT01824979|20359056|P1|STARTED|Overall Study||50
8256301|NCT01824901|20359064|P4|NOT COMPLETED|Overall Study||0
8256302|NCT01824901|20359065|P3|NOT COMPLETED|Overall Study||0
8256303|NCT01824901|20359066|P2|NOT COMPLETED|Overall Study||0
8256304|NCT01824901|20359067|P1|NOT COMPLETED|Overall Study||0
8256305|NCT01824901|20359064|P4|COMPLETED|Overall Study||0
8256306|NCT01824901|20359065|P3|COMPLETED|Overall Study||0
8256307|NCT01824901|20359066|P2|COMPLETED|Overall Study||0
8256308|NCT01824901|20359067|P1|COMPLETED|Overall Study||2
8256309|NCT01824901|20359064|P4|STARTED|Overall Study||0
8256310|NCT01824901|20359065|P3|STARTED|Overall Study||0
8256311|NCT01824901|20359066|P2|STARTED|Overall Study||0
8256312|NCT01824901|20359067|P1|STARTED|Overall Study||2
8256313|NCT01824823|20359073|P2|NOT COMPLETED|Overall Study||1
8256314|NCT01824823|20359074|P1|NOT COMPLETED|Overall Study||2
8256315|NCT01824823|20359073|P2|COMPLETED|Overall Study||0
8256316|NCT01824823|20359074|P1|COMPLETED|Overall Study||0
8256317|NCT01824823|20359073|P2|STARTED|Overall Study||1
8256318|NCT01824823|20359074|P1|STARTED|Overall Study||2
8256319|NCT01824693|20359083|P3|NOT COMPLETED|Overall Study||15
8256320|NCT01824693|20359084|P2|NOT COMPLETED|Overall Study||7
8256321|NCT01824693|20359085|P1|NOT COMPLETED|Overall Study||1
8256322|NCT01824693|20359083|P3|COMPLETED|Overall Study||0
8256323|NCT01824693|20359084|P2|COMPLETED|Overall Study||2
8256324|NCT01824693|20359085|P1|COMPLETED|Overall Study||5
8256325|NCT01824693|20359083|P3|STARTED|Overall Study||15
8256326|NCT01824693|20359084|P2|STARTED|Overall Study||9
8256327|NCT01824693|20359085|P1|STARTED|Overall Study||6
8256328|NCT01824602|20359102|P4|NOT COMPLETED|Overall Study||5
8256329|NCT01824602|20359103|P3|NOT COMPLETED|Overall Study||4
8256330|NCT01824602|20359104|P2|NOT COMPLETED|Overall Study||0
8256331|NCT01824602|20359105|P1|NOT COMPLETED|Overall Study||1
8256332|NCT01824602|20359102|P4|COMPLETED|Overall Study||5
8256333|NCT01824602|20359103|P3|COMPLETED|Overall Study||5
8256334|NCT01824602|20359104|P2|COMPLETED|Overall Study||8
8256335|NCT01824602|20359105|P1|COMPLETED|Overall Study||10
8256336|NCT01824602|20359102|P4|Intent-to-treat Population|Overall Study||9
8256337|NCT01824602|20359103|P3|Intent-to-treat Population|Overall Study||9
8256338|NCT01824602|20359104|P2|Intent-to-treat Population|Overall Study||8
8256339|NCT01824602|20359105|P1|Intent-to-treat Population|Overall Study||11
8256340|NCT01824602|20359102|P4|Safety Population|Overall Study||10
8256341|NCT01824602|20359103|P3|Safety Population|Overall Study||9
8256342|NCT01824602|20359104|P2|Safety Population|Overall Study||8
8256343|NCT01824602|20359105|P1|Safety Population|Overall Study||11
8256344|NCT01824602|20359102|P4|STARTED|Overall Study||10
8256345|NCT01824602|20359103|P3|STARTED|Overall Study||9
8256346|NCT01824602|20359104|P2|STARTED|Overall Study||8
8256347|NCT01824602|20359105|P1|STARTED|Overall Study||11
8256348|NCT01824589|20359119|P4|NOT COMPLETED|Overall Study||0
8256349|NCT01824589|20359120|P3|NOT COMPLETED|Overall Study||0
8256350|NCT01824589|20359121|P2|NOT COMPLETED|Overall Study||0
8256351|NCT01824589|20359122|P1|NOT COMPLETED|Overall Study||0
8256352|NCT01824589|20359119|P4|COMPLETED|Overall Study||0
8256353|NCT01824589|20359120|P3|COMPLETED|Overall Study||0
8256354|NCT01824589|20359121|P2|COMPLETED|Overall Study||0
8256355|NCT01824589|20359122|P1|COMPLETED|Overall Study||1
8256356|NCT01824589|20359119|P4|STARTED|Overall Study||0
8256357|NCT01824589|20359120|P3|STARTED|Overall Study||0
8256358|NCT01824589|20359121|P2|STARTED|Overall Study||0
8256359|NCT01824589|20359122|P1|STARTED|Overall Study||1
8256360|NCT01824576|20359144|P1|NOT COMPLETED|Overall Study||2
8256361|NCT01824576|20359144|P1|COMPLETED|Overall Study||7
8256362|NCT01824576|20359144|P1|STARTED|Overall Study||9
8256363|NCT01824498|20359162|P6|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8256364|NCT01824498|20359163|P5|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8256365|NCT01824498|20359164|P4|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8256366|NCT01824498|20359165|P3|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8256367|NCT01824498|20359166|P2|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8256368|NCT01824498|20359167|P1|NOT COMPLETED|3rd Intervention (8 Weeks)||0
8256369|NCT01824498|20359162|P6|COMPLETED|3rd Intervention (8 Weeks)||4
8256370|NCT01824498|20359163|P5|COMPLETED|3rd Intervention (8 Weeks)||3
8256371|NCT01824498|20359164|P4|COMPLETED|3rd Intervention (8 Weeks)||2
8256372|NCT01824498|20359165|P3|COMPLETED|3rd Intervention (8 Weeks)||4
8256373|NCT01824498|20359166|P2|COMPLETED|3rd Intervention (8 Weeks)||2
8256374|NCT01824498|20359167|P1|COMPLETED|3rd Intervention (8 Weeks)||3
8256375|NCT01824498|20359162|P6|STARTED|3rd Intervention (8 Weeks)||4
8256376|NCT01824498|20359163|P5|STARTED|3rd Intervention (8 Weeks)||3
8256377|NCT01824498|20359164|P4|STARTED|3rd Intervention (8 Weeks)||2
8256378|NCT01824498|20359165|P3|STARTED|3rd Intervention (8 Weeks)||4
8256379|NCT01824498|20359166|P2|STARTED|3rd Intervention (8 Weeks)||2
8256380|NCT01824498|20359167|P1|STARTED|3rd Intervention (8 Weeks)||3
8256381|NCT01824498|20359162|P6|NOT COMPLETED|Washout (8 Weeks)||0
8256382|NCT01824498|20359163|P5|NOT COMPLETED|Washout (8 Weeks)||0
8256383|NCT01824498|20359164|P4|NOT COMPLETED|Washout (8 Weeks)||0
8256384|NCT01824498|20359165|P3|NOT COMPLETED|Washout (8 Weeks)||0
8256385|NCT01824498|20359166|P2|NOT COMPLETED|Washout (8 Weeks)||0
8256386|NCT01824498|20359167|P1|NOT COMPLETED|Washout (8 Weeks)||0
8256387|NCT01824498|20359162|P6|COMPLETED|Washout (8 Weeks)||4
8256388|NCT01824498|20359163|P5|COMPLETED|Washout (8 Weeks)||3
8256389|NCT01824498|20359164|P4|COMPLETED|Washout (8 Weeks)||2
8256390|NCT01824498|20359165|P3|COMPLETED|Washout (8 Weeks)||4
8256391|NCT01824498|20359166|P2|COMPLETED|Washout (8 Weeks)||2
8256392|NCT01824498|20359167|P1|COMPLETED|Washout (8 Weeks)||3
8256393|NCT01824498|20359162|P6|STARTED|Washout (8 Weeks)||4
8256394|NCT01824498|20359163|P5|STARTED|Washout (8 Weeks)||3
8256395|NCT01824498|20359164|P4|STARTED|Washout (8 Weeks)||2
8256396|NCT01824498|20359165|P3|STARTED|Washout (8 Weeks)||4
8256397|NCT01824498|20359166|P2|STARTED|Washout (8 Weeks)||2
8256398|NCT01824498|20359167|P1|STARTED|Washout (8 Weeks)||3
8256399|NCT01824498|20359162|P6|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8256400|NCT01824498|20359163|P5|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8256401|NCT01824498|20359164|P4|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8256402|NCT01824498|20359165|P3|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8256403|NCT01824498|20359166|P2|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8256404|NCT01824498|20359167|P1|NOT COMPLETED|2nd Intervention (8 Weeks)||0
8256405|NCT01824498|20359162|P6|COMPLETED|2nd Intervention (8 Weeks)||4
8256406|NCT01824498|20359163|P5|COMPLETED|2nd Intervention (8 Weeks)||3
8256407|NCT01824498|20359164|P4|COMPLETED|2nd Intervention (8 Weeks)||2
8256408|NCT01824498|20359165|P3|COMPLETED|2nd Intervention (8 Weeks)||4
8256409|NCT01824498|20359166|P2|COMPLETED|2nd Intervention (8 Weeks)||2
8256410|NCT01824498|20359167|P1|COMPLETED|2nd Intervention (8 Weeks)||3
8256411|NCT01824498|20359162|P6|STARTED|2nd Intervention (8 Weeks)||4
8256412|NCT01824498|20359163|P5|STARTED|2nd Intervention (8 Weeks)||3
8256413|NCT01824498|20359164|P4|STARTED|2nd Intervention (8 Weeks)||2
8256414|NCT01824498|20359165|P3|STARTED|2nd Intervention (8 Weeks)||4
8256415|NCT01824498|20359166|P2|STARTED|2nd Intervention (8 Weeks)||2
8256416|NCT01824498|20359167|P1|STARTED|2nd Intervention (8 Weeks)||3
8256417|NCT01824498|20359162|P6|NOT COMPLETED|Washout (8 Weeks)||0
8256418|NCT01824498|20359163|P5|NOT COMPLETED|Washout (8 Weeks)||1
8256419|NCT01824498|20359164|P4|NOT COMPLETED|Washout (8 Weeks)||1
8256420|NCT01824498|20359165|P3|NOT COMPLETED|Washout (8 Weeks)||2
8256421|NCT01824498|20359166|P2|NOT COMPLETED|Washout (8 Weeks)||0
8256422|NCT01824498|20359167|P1|NOT COMPLETED|Washout (8 Weeks)||2
8256423|NCT01824498|20359162|P6|COMPLETED|Washout (8 Weeks)||4
8256424|NCT01824498|20359163|P5|COMPLETED|Washout (8 Weeks)||3
8256425|NCT01824498|20359164|P4|COMPLETED|Washout (8 Weeks)||2
8256426|NCT01824498|20359165|P3|COMPLETED|Washout (8 Weeks)||4
8256427|NCT01824498|20359166|P2|COMPLETED|Washout (8 Weeks)||2
8256428|NCT01824498|20359167|P1|COMPLETED|Washout (8 Weeks)||3
8256429|NCT01824498|20359162|P6|STARTED|Washout (8 Weeks)||4
8256430|NCT01824498|20359163|P5|STARTED|Washout (8 Weeks)|1 dropped out|4
8256431|NCT01824498|20359164|P4|STARTED|Washout (8 Weeks)|1 dropped out|3
8256432|NCT01824498|20359165|P3|STARTED|Washout (8 Weeks)|2 dropped out|6
8256433|NCT01824498|20359166|P2|STARTED|Washout (8 Weeks)||2
8256434|NCT01824498|20359167|P1|STARTED|Washout (8 Weeks)|2 dropped out|5
8256435|NCT01824498|20359162|P6|NOT COMPLETED|1st Intervention (8 Weeks)||0
8256436|NCT01824498|20359163|P5|NOT COMPLETED|1st Intervention (8 Weeks)||0
8256437|NCT01824498|20359164|P4|NOT COMPLETED|1st Intervention (8 Weeks)||0
8256438|NCT01824498|20359165|P3|NOT COMPLETED|1st Intervention (8 Weeks)||0
8256439|NCT01824498|20359166|P2|NOT COMPLETED|1st Intervention (8 Weeks)||0
8256440|NCT01824498|20359167|P1|NOT COMPLETED|1st Intervention (8 Weeks)||0
8256441|NCT01824498|20359162|P6|COMPLETED|1st Intervention (8 Weeks)||4
8256442|NCT01824498|20359163|P5|COMPLETED|1st Intervention (8 Weeks)||4
8256443|NCT01824498|20359164|P4|COMPLETED|1st Intervention (8 Weeks)||3
8256444|NCT01824498|20359165|P3|COMPLETED|1st Intervention (8 Weeks)||6
8256445|NCT01824498|20359166|P2|COMPLETED|1st Intervention (8 Weeks)||2
8256446|NCT01824498|20359167|P1|COMPLETED|1st Intervention (8 Weeks)||5
8256447|NCT01824498|20359162|P6|STARTED|1st Intervention (8 Weeks)||4
8256448|NCT01824498|20359163|P5|STARTED|1st Intervention (8 Weeks)||4
8256449|NCT01824498|20359164|P4|STARTED|1st Intervention (8 Weeks)||3
8256450|NCT01824498|20359165|P3|STARTED|1st Intervention (8 Weeks)||6
8256451|NCT01824498|20359166|P2|STARTED|1st Intervention (8 Weeks)||2
8256452|NCT01824498|20359167|P1|STARTED|1st Intervention (8 Weeks)||5
8256453|NCT01824472|20359178|P3|NOT COMPLETED|Overall Study||4
8256454|NCT01824472|20359179|P2|NOT COMPLETED|Overall Study||7
8256455|NCT01824472|20359180|P1|NOT COMPLETED|Overall Study||1
8256456|NCT01824472|20359178|P3|COMPLETED|Overall Study||11
8256457|NCT01824472|20359179|P2|COMPLETED|Overall Study||6
8256458|NCT01824472|20359180|P1|COMPLETED|Overall Study||16
8256459|NCT01824472|20359178|P3|STARTED|Overall Study||15
8256460|NCT01824472|20359179|P2|STARTED|Overall Study||13
8256461|NCT01824472|20359180|P1|STARTED|Overall Study||17
8256465|NCT01824394|20359214|P3|NOT COMPLETED|Overall Study||74
8256466|NCT01824394|20359215|P2|NOT COMPLETED|Overall Study||116
8256467|NCT01824394|20359216|P1|NOT COMPLETED|Overall Study||119
8256468|NCT01824394|20359214|P3|COMPLETED|Overall Study||51
8256469|NCT01824394|20359215|P2|COMPLETED|Overall Study||53
8256470|NCT01824394|20359216|P1|COMPLETED|Overall Study||55
8256471|NCT01824394|20359214|P3|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
8256472|NCT01824394|20359215|P2|Per-Protocol Population|Overall Study||148
8256473|NCT01824394|20359216|P1|Per-Protocol Population|Overall Study||150
8256474|NCT01824394|20359214|P3|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
8256475|NCT01824394|20359215|P2|Safety Population|Overall Study||149
8256476|NCT01824394|20359216|P1|Safety Population|Overall Study||151
8256477|NCT01824394|20359214|P3|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
8256478|NCT01824394|20359215|P2|Intent to Treat Population|Overall Study||149
8256479|NCT01824394|20359216|P1|Intent to Treat Population|Overall Study||151
8256480|NCT01824394|20359214|P3|STARTED|Overall Study||125
8256481|NCT01824394|20359215|P2|STARTED|Overall Study||169
8256482|NCT01824394|20359216|P1|STARTED|Overall Study||174
8256483|NCT01824355|20359226|P1|NOT COMPLETED|Overall Study||3
8256484|NCT01824355|20359226|P1|COMPLETED|Overall Study||110
8256485|NCT01824355|20359226|P1|STARTED|Overall Study||113
8256486|NCT01824342|20359237|P2|NOT COMPLETED|Overall Study||5
8256487|NCT01824342|20359238|P1|NOT COMPLETED|Overall Study||9
8256488|NCT01824342|20359237|P2|COMPLETED|Overall Study||2
8256489|NCT01824342|20359238|P1|COMPLETED|Overall Study||2
8256490|NCT01824342|20359237|P2|STARTED|Overall Study||7
8256491|NCT01824342|20359238|P1|STARTED|Overall Study||11
8256492|NCT01824303|20359252|P2|NOT COMPLETED|Open Label Extension||0
8256493|NCT01824303|20359253|P1|NOT COMPLETED|Open Label Extension||0
8256494|NCT01824303|20359252|P2|COMPLETED|Open Label Extension||11
8256495|NCT01824303|20359253|P1|COMPLETED|Open Label Extension||12
8256496|NCT01824303|20359252|P2|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
8256497|NCT01824303|20359253|P1|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
8256498|NCT01824303|20359252|P2|NOT COMPLETED|Randomized Study||1
8256499|NCT01824303|20359253|P1|NOT COMPLETED|Randomized Study||2
8256500|NCT01824303|20359252|P2|COMPLETED|Randomized Study||13
8256501|NCT01824303|20359253|P1|COMPLETED|Randomized Study||14
8256502|NCT01824303|20359252|P2|STARTED|Randomized Study||14
8256503|NCT01824303|20359253|P1|STARTED|Randomized Study||16
8256516|NCT01824160|20359292|P1|NOT COMPLETED|Overall Study||0
8256517|NCT01824160|20359292|P1|COMPLETED|Overall Study||50
8256518|NCT01824160|20359292|P1|STARTED|Overall Study||50
8256519|NCT01823991|20359298|P2|NOT COMPLETED|Overall Study||5
8256520|NCT01823991|20359299|P1|NOT COMPLETED|Overall Study||8
8256521|NCT01823991|20359298|P2|COMPLETED|Overall Study||13
8256522|NCT01823991|20359299|P1|COMPLETED|Overall Study||10
8256523|NCT01823991|20359298|P2|STARTED|Overall Study||18
8256524|NCT01823991|20359299|P1|STARTED|Overall Study||18
8256525|NCT01823861|20359333|P2|NOT COMPLETED|12 Month Follow up||61
8256526|NCT01823861|20359334|P1|NOT COMPLETED|12 Month Follow up||42
8256527|NCT01823861|20359333|P2|COMPLETED|12 Month Follow up||159
8256528|NCT01823861|20359334|P1|COMPLETED|12 Month Follow up||169
8256529|NCT01823861|20359333|P2|STARTED|12 Month Follow up||220
8256530|NCT01823861|20359334|P1|STARTED|12 Month Follow up||211
8256531|NCT01823861|20359333|P2|NOT COMPLETED|4 Month Follow up||31
8256532|NCT01823861|20359334|P1|NOT COMPLETED|4 Month Follow up||38
8256533|NCT01823861|20359333|P2|COMPLETED|4 Month Follow up||220
8256534|NCT01823861|20359334|P1|COMPLETED|4 Month Follow up||211
8256535|NCT01823861|20359333|P2|STARTED|4 Month Follow up||251
8256536|NCT01823861|20359334|P1|STARTED|4 Month Follow up||249
8256537|NCT01823679|20359340|P1|NOT COMPLETED|Overall Study||1
8256538|NCT01823679|20359340|P1|COMPLETED|Overall Study||1
8256539|NCT01823679|20359340|P1|STARTED|Overall Study||2
8256540|NCT01823653|20359348|P1|NOT COMPLETED|Overall Study||0
8256541|NCT01823653|20359348|P1|COMPLETED|Overall Study||60
8256542|NCT01823653|20359348|P1|STARTED|Overall Study||60
8256543|NCT01823614|20359362|P6|NOT COMPLETED|Overall Study||0
8256544|NCT01823614|20359363|P5|NOT COMPLETED|Overall Study||0
8256545|NCT01823614|20359364|P4|NOT COMPLETED|Overall Study||0
8256546|NCT01823614|20359365|P3|NOT COMPLETED|Overall Study||0
8256547|NCT01823614|20359366|P2|NOT COMPLETED|Overall Study||0
8256548|NCT01823614|20359367|P1|NOT COMPLETED|Overall Study||0
8256549|NCT01823614|20359362|P6|COMPLETED|Overall Study||154
8256550|NCT01823614|20359363|P5|COMPLETED|Overall Study||172
8256551|NCT01823614|20359364|P4|COMPLETED|Overall Study||122
8256552|NCT01823614|20359365|P3|COMPLETED|Overall Study||176
8256553|NCT01823614|20359366|P2|COMPLETED|Overall Study||140
8256554|NCT01823614|20359367|P1|COMPLETED|Overall Study||179
8256555|NCT01823614|20359362|P6|STARTED|Overall Study||154
8256556|NCT01823614|20359363|P5|STARTED|Overall Study||172
8256557|NCT01823614|20359364|P4|STARTED|Overall Study||122
8256558|NCT01823614|20359365|P3|STARTED|Overall Study||176
8256559|NCT01823614|20359366|P2|STARTED|Overall Study||140
8256560|NCT01823614|20359367|P1|STARTED|Overall Study||179
8256561|NCT01823536|20359393|P6|NOT COMPLETED|Overall Study||0
8256562|NCT01823536|20359394|P5|NOT COMPLETED|Overall Study||2
8256563|NCT01823536|20359395|P4|NOT COMPLETED|Overall Study||2
8256564|NCT01823536|20359396|P3|NOT COMPLETED|Overall Study||1
8256565|NCT01823536|20359397|P2|NOT COMPLETED|Overall Study||2
8256566|NCT01823536|20359398|P1|NOT COMPLETED|Overall Study||2
8256567|NCT01823536|20359393|P6|COMPLETED|Overall Study||2
8256568|NCT01823536|20359394|P5|COMPLETED|Overall Study||99
8256569|NCT01823536|20359395|P4|COMPLETED|Overall Study||64
8256570|NCT01823536|20359396|P3|COMPLETED|Overall Study||119
8256571|NCT01823536|20359397|P2|COMPLETED|Overall Study||101
8256572|NCT01823536|20359398|P1|COMPLETED|Overall Study||71
8256573|NCT01823536|20359393|P6|STARTED|Overall Study||2
8256574|NCT01823536|20359394|P5|STARTED|Overall Study||101
8256575|NCT01823536|20359395|P4|STARTED|Overall Study||66
8256576|NCT01823536|20359396|P3|STARTED|Overall Study||120
8256577|NCT01823536|20359397|P2|STARTED|Overall Study||103
8256578|NCT01823536|20359398|P1|STARTED|Overall Study||73
8256579|NCT01823510|20359436|P2|NOT COMPLETED|Days 22-28||0
8256580|NCT01823510|20359437|P1|NOT COMPLETED|Days 22-28||0
8256581|NCT01823510|20359436|P2|COMPLETED|Days 22-28||10
8256582|NCT01823510|20359437|P1|COMPLETED|Days 22-28||10
8256583|NCT01823510|20359436|P2|STARTED|Days 22-28||10
8256584|NCT01823510|20359437|P1|STARTED|Days 22-28||10
8256585|NCT01823510|20359436|P2|NOT COMPLETED|Days 8-21||0
8256586|NCT01823510|20359437|P1|NOT COMPLETED|Days 8-21||0
8256587|NCT01823510|20359436|P2|COMPLETED|Days 8-21||10
8256588|NCT01823510|20359437|P1|COMPLETED|Days 8-21||10
8256589|NCT01823510|20359436|P2|STARTED|Days 8-21||10
8256590|NCT01823510|20359437|P1|STARTED|Days 8-21||10
8256591|NCT01823510|20359436|P2|NOT COMPLETED|Days 1-7||0
8256592|NCT01823510|20359437|P1|NOT COMPLETED|Days 1-7||0
8256593|NCT01823510|20359436|P2|COMPLETED|Days 1-7||10
8256594|NCT01823510|20359437|P1|COMPLETED|Days 1-7||10
8256595|NCT01823510|20359436|P2|STARTED|Days 1-7||10
8256596|NCT01823510|20359437|P1|STARTED|Days 1-7||10
8256597|NCT01823497|20359451|P2|NOT COMPLETED|Overall Study||8
8256598|NCT01823497|20359452|P1|NOT COMPLETED|Overall Study||3
8256599|NCT01823497|20359451|P2|COMPLETED|Overall Study||9
8256600|NCT01823497|20359452|P1|COMPLETED|Overall Study||16
8256601|NCT01823497|20359451|P2|STARTED|Overall Study||17
8256602|NCT01823497|20359452|P1|STARTED|Overall Study||19
8256603|NCT01823341|20359460|P1|NOT COMPLETED|Overall Study||15
8256604|NCT01823341|20359460|P1|COMPLETED|Overall Study||82
8256605|NCT01823341|20359460|P1|STARTED|Overall Study||97
8256606|NCT01823328|20359505|P2|NOT COMPLETED|Overall Study||6
8256607|NCT01823328|20359506|P1|NOT COMPLETED|Overall Study||8
8256608|NCT01823328|20359505|P2|COMPLETED|Overall Study||67
8256609|NCT01823328|20359506|P1|COMPLETED|Overall Study||62
8256610|NCT01823328|20359505|P2|STARTED|Overall Study||73
8256611|NCT01823328|20359506|P1|STARTED|Overall Study||70
8256612|NCT01823289|20359526|P1|NOT COMPLETED|Overall Study||24
8256613|NCT01823289|20359526|P1|COMPLETED|Overall Study||47
8256614|NCT01823289|20359526|P1|STARTED|Overall Study||71
8256615|NCT01823224|20359534|P2|NOT COMPLETED|Overall Study||11
8256616|NCT01823224|20359535|P1|NOT COMPLETED|Overall Study||6
8256617|NCT01823224|20359534|P2|COMPLETED|Overall Study||22
8256618|NCT01823224|20359535|P1|COMPLETED|Overall Study||28
8256619|NCT01823224|20359534|P2|STARTED|Overall Study||33
8256620|NCT01823224|20359535|P1|STARTED|Overall Study||34
8256621|NCT01823146|20359545|P2|NOT COMPLETED|Overall Study||2
8256622|NCT01823146|20359546|P1|NOT COMPLETED|Overall Study||2
8256623|NCT01823146|20359545|P2|COMPLETED|Overall Study||49
8256624|NCT01823146|20359546|P1|COMPLETED|Overall Study||53
8256625|NCT01823146|20359545|P2|STARTED|Overall Study||51
8256626|NCT01823146|20359546|P1|STARTED|Overall Study||55
8256627|NCT01823107|20359556|P1|NOT COMPLETED|Overall Study||1
8256628|NCT01823107|20359556|P1|COMPLETED|Overall Study||24
8256629|NCT01823107|20359556|P1|STARTED|Overall Study||25
8256630|NCT01822925|20359566|P4|NOT COMPLETED|Overall Study||5
8256631|NCT01822925|20359567|P3|NOT COMPLETED|Overall Study||3
8256632|NCT01822925|20359568|P2|NOT COMPLETED|Overall Study||2
8256633|NCT01822925|20359569|P1|NOT COMPLETED|Overall Study||6
8256634|NCT01822925|20359566|P4|COMPLETED|Overall Study||27
8256635|NCT01822925|20359567|P3|COMPLETED|Overall Study||29
8256636|NCT01822925|20359568|P2|COMPLETED|Overall Study||30
8256637|NCT01822925|20359569|P1|COMPLETED|Overall Study||26
8256638|NCT01822925|20359566|P4|STARTED|Overall Study||32
8256639|NCT01822925|20359567|P3|STARTED|Overall Study||32
8256640|NCT01822925|20359568|P2|STARTED|Overall Study||32
8256641|NCT01822925|20359569|P1|STARTED|Overall Study||32
8256642|NCT01822899|20359621|P2|NOT COMPLETED|Overall Study||18
8256643|NCT01822899|20359622|P1|NOT COMPLETED|Overall Study||24
8256644|NCT01822899|20359621|P2|COMPLETED|Overall Study||340
8256645|NCT01822899|20359622|P1|COMPLETED|Overall Study||334
8256646|NCT01822899|20359621|P2|STARTED|Overall Study||358
8256647|NCT01822899|20359622|P1|STARTED|Overall Study||358
8256648|NCT01822886|20359630|P1|NOT COMPLETED|Overall Study||15
8256649|NCT01822886|20359630|P1|COMPLETED|Overall Study||5
8256650|NCT01822886|20359630|P1|STARTED|Overall Study||20
8256651|NCT01822821|20359640|P2|NOT COMPLETED|Overall Study||1
8256652|NCT01822821|20359641|P1|NOT COMPLETED|Overall Study||2
8256653|NCT01822821|20359640|P2|COMPLETED|Overall Study||74
8256654|NCT01822821|20359641|P1|COMPLETED|Overall Study||73
8256655|NCT01822821|20359640|P2|STARTED|Overall Study||75
8256656|NCT01822821|20359641|P1|STARTED|Overall Study||75
8256657|NCT01822756|20359670|P5|NOT COMPLETED|Overall Study||7
8256658|NCT01822756|20359671|P4|NOT COMPLETED|Overall Study||4
8256659|NCT01822756|20359672|P3|NOT COMPLETED|Overall Study||10
8256660|NCT01822756|20359673|P2|NOT COMPLETED|Overall Study||4
8256661|NCT01822756|20359674|P1|NOT COMPLETED|Overall Study||16
8256662|NCT01822756|20359670|P5|COMPLETED|Overall Study||1
8256663|NCT01822756|20359671|P4|COMPLETED|Overall Study||0
8256664|NCT01822756|20359672|P3|COMPLETED|Overall Study||0
8256665|NCT01822756|20359673|P2|COMPLETED|Overall Study||0
8256666|NCT01822756|20359674|P1|COMPLETED|Overall Study||0
8256667|NCT01822756|20359670|P5|Discontinued From the Study|Overall Study||7
8256668|NCT01822756|20359671|P4|Discontinued From the Study|Overall Study||4
8256669|NCT01822756|20359672|P3|Discontinued From the Study|Overall Study||10
8256670|NCT01822756|20359673|P2|Discontinued From the Study|Overall Study||4
8256671|NCT01822756|20359674|P1|Discontinued From the Study|Overall Study||16
8256672|NCT01822756|20359670|P5|STARTED|Overall Study||8
8256673|NCT01822756|20359671|P4|STARTED|Overall Study||4
8256674|NCT01822756|20359672|P3|STARTED|Overall Study||10
8256675|NCT01822756|20359673|P2|STARTED|Overall Study||4
8256676|NCT01822756|20359674|P1|STARTED|Overall Study||16
8256677|NCT01822691|20359716|P1|NOT COMPLETED|Overall Study||2
8256678|NCT01822691|20359716|P1|COMPLETED|Overall Study||13
8256679|NCT01822691|20359716|P1|STARTED|Overall Study||15
8256680|NCT01822678|20359727|P3|NOT COMPLETED|Overall Study||11
8256681|NCT01822678|20359728|P2|NOT COMPLETED|Overall Study||15
8256682|NCT01822678|20359729|P1|NOT COMPLETED|Overall Study||12
8256683|NCT01822678|20359727|P3|COMPLETED|Overall Study||29
8256684|NCT01822678|20359728|P2|COMPLETED|Overall Study||49
8256685|NCT01822678|20359729|P1|COMPLETED|Overall Study||45
8256686|NCT01822678|20359727|P3|Per Protocol Population|Overall Study||34
8256687|NCT01822678|20359728|P2|Per Protocol Population|Overall Study||52
8256688|NCT01822678|20359729|P1|Per Protocol Population|Overall Study||45
8256689|NCT01822678|20359727|P3|Intention-to-Treat Population (ITT)|Overall Study||40
8256690|NCT01822678|20359728|P2|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
8256691|NCT01822678|20359729|P1|Intention-to-Treat Population (ITT)|Overall Study||57
8256692|NCT01822678|20359727|P3|Safety Population|Overall Study||40
8256693|NCT01822678|20359728|P2|Safety Population|Overall Study||64
8256694|NCT01822678|20359729|P1|Safety Population|Overall Study||57
8256695|NCT01822678|20359727|P3|Treated|Overall Study||40
8256696|NCT01822678|20359728|P2|Treated|Overall Study||64
8256697|NCT01822678|20359729|P1|Treated|Overall Study||57
8256698|NCT01822678|20359727|P3|STARTED|Overall Study||40
8256699|NCT01822678|20359728|P2|STARTED|Overall Study||64
8256700|NCT01822678|20359729|P1|STARTED|Overall Study||57
8256701|NCT01822665|20359737|P1|NOT COMPLETED|Overall Study||8
8256702|NCT01822665|20359737|P1|COMPLETED|Overall Study||20
8256703|NCT01822665|20359737|P1|Received Paracetamol Tablet (1000 mg)|Overall Study||28
8256704|NCT01822665|20359737|P1|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
8256705|NCT01822665|20359737|P1|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
8256706|NCT01822665|20359737|P1|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
8256707|NCT01822665|20359737|P1|STARTED|Overall Study||28
8256708|NCT01822587|20359764|P3|NOT COMPLETED|Overall Study||18
8256709|NCT01822587|20359765|P2|NOT COMPLETED|Overall Study||15
8256710|NCT01822587|20359766|P1|NOT COMPLETED|Overall Study||16
8256711|NCT01822587|20359764|P3|COMPLETED|Overall Study||44
8256712|NCT01822587|20359765|P2|COMPLETED|Overall Study||45
8256713|NCT01822587|20359766|P1|COMPLETED|Overall Study||43
8256714|NCT01822587|20359764|P3|STARTED|Overall Study||62
8256715|NCT01822587|20359765|P2|STARTED|Overall Study||60
8256716|NCT01822587|20359766|P1|STARTED|Overall Study||59
8256717|NCT01822574|20359789|P3|NOT COMPLETED|Overall Study||0
8256718|NCT01822574|20359790|P2|NOT COMPLETED|Overall Study||0
8256719|NCT01822574|20359791|P1|NOT COMPLETED|Overall Study||0
8256720|NCT01822574|20359789|P3|COMPLETED|Overall Study||30
8256721|NCT01822574|20359790|P2|COMPLETED|Overall Study||30
8256722|NCT01822574|20359791|P1|COMPLETED|Overall Study||30
8256723|NCT01822574|20359789|P3|STARTED|Overall Study||30
8256724|NCT01822574|20359790|P2|STARTED|Overall Study||30
8256725|NCT01822574|20359791|P1|STARTED|Overall Study||30
8256726|NCT01822561|20359805|P1|NOT COMPLETED|Overall Study||2
8256727|NCT01822561|20359805|P1|COMPLETED|Overall Study||13
8256728|NCT01822561|20359805|P1|STARTED|Overall Study||15
8256729|NCT01822548|20359815|P2|NOT COMPLETED|Overall Study||0
8256730|NCT01822548|20359816|P1|NOT COMPLETED|Overall Study||0
8256731|NCT01822548|20359815|P2|COMPLETED|Overall Study||24
8256732|NCT01822548|20359816|P1|COMPLETED|Overall Study||40
8256733|NCT01822548|20359815|P2|Discontinued Intervention|Overall Study||5
8256734|NCT01822548|20359816|P1|Discontinued Intervention|Overall Study||0
8256735|NCT01822548|20359815|P2|STARTED|Overall Study||24
8256736|NCT01822548|20359816|P1|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
8256737|NCT01822535|20359826|P2|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
8256738|NCT01822535|20359827|P1|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
8256739|NCT01822535|20359826|P2|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
8256740|NCT01822535|20359827|P1|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
8256741|NCT01822535|20359826|P2|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
8256742|NCT01822535|20359827|P1|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
8256743|NCT01822535|20359826|P2|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
8256744|NCT01822535|20359827|P1|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
8256745|NCT01822535|20359826|P2|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
8256746|NCT01822535|20359827|P1|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
8256747|NCT01822535|20359826|P2|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
8256748|NCT01822535|20359827|P1|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
8256749|NCT01822496|20359843|P4|NOT COMPLETED|Overall Study||4
8256750|NCT01822496|20359844|P3|NOT COMPLETED|Overall Study||0
8256751|NCT01822496|20359845|P2|NOT COMPLETED|Overall Study||2
8256752|NCT01822496|20359846|P1|NOT COMPLETED|Overall Study||2
8256753|NCT01822496|20359843|P4|COMPLETED|Overall Study||7
8256754|NCT01822496|20359844|P3|COMPLETED|Overall Study||9
8256755|NCT01822496|20359845|P2|COMPLETED|Overall Study||21
8256756|NCT01822496|20359846|P1|COMPLETED|Overall Study||14
8256757|NCT01822496|20359843|P4|Eligible and Started Study Treatment|Overall Study||7
8256758|NCT01822496|20359844|P3|Eligible and Started Study Treatment|Overall Study||9
8256759|NCT01822496|20359845|P2|Eligible and Started Study Treatment|Overall Study||20
8256760|NCT01822496|20359846|P1|Eligible and Started Study Treatment|Overall Study||14
8256761|NCT01822496|20359843|P4|Eligible With Disease Assessment|Overall Study||4
8256762|NCT01822496|20359844|P3|Eligible With Disease Assessment|Overall Study||6
8256763|NCT01822496|20359845|P2|Eligible With Disease Assessment|Overall Study||15
8256764|NCT01822496|20359846|P1|Eligible With Disease Assessment|Overall Study||10
8256765|NCT01822496|20359843|P4|Eligible|Overall Study||7
8256766|NCT01822496|20359844|P3|Eligible|Overall Study||9
8256767|NCT01822496|20359845|P2|Eligible|Overall Study||21
8256768|NCT01822496|20359846|P1|Eligible|Overall Study||14
8256769|NCT01822496|20359843|P4|STARTED|Overall Study||11
8256770|NCT01822496|20359844|P3|STARTED|Overall Study||9
8256771|NCT01822496|20359845|P2|STARTED|Overall Study||23
8256772|NCT01822496|20359846|P1|STARTED|Overall Study||16
8256773|NCT01822457|20359882|P2|NOT COMPLETED|Overall Study||5
8256774|NCT01822457|20359883|P1|NOT COMPLETED|Overall Study||4
8256775|NCT01822457|20359882|P2|COMPLETED|Overall Study||12
8256776|NCT01822457|20359883|P1|COMPLETED|Overall Study||16
8256777|NCT01822457|20359882|P2|STARTED|Overall Study||17
8256778|NCT01822457|20359883|P1|STARTED|Overall Study||20
8256800|NCT01822301|20359943|P1|NOT COMPLETED|Overall Study||0
8256801|NCT01822301|20359943|P1|COMPLETED|Overall Study||5
8256802|NCT01822301|20359943|P1|STARTED|Overall Study||5
8256803|NCT01822223|20359955|P2|NOT COMPLETED|Overall Study||1
8256804|NCT01822223|20359956|P1|NOT COMPLETED|Overall Study||0
8256805|NCT01822223|20359955|P2|COMPLETED|Overall Study||9
8256806|NCT01822223|20359956|P1|COMPLETED|Overall Study||10
8256807|NCT01822223|20359955|P2|STARTED|Overall Study||10
8256808|NCT01822223|20359956|P1|STARTED|Overall Study||10
8256809|NCT01822197|20359972|P1|NOT COMPLETED|Overall Study||0
8256810|NCT01822197|20359972|P1|COMPLETED|Overall Study||30
8256811|NCT01822197|20359972|P1|STARTED|Overall Study||30
8256812|NCT01822132|20359980|P2|NOT COMPLETED|Overall Study||2
8256813|NCT01822132|20359981|P1|NOT COMPLETED|Overall Study||4
8256814|NCT01822132|20359980|P2|COMPLETED|Overall Study||25
8256815|NCT01822132|20359981|P1|COMPLETED|Overall Study||21
8256816|NCT01822132|20359980|P2|STARTED|Overall Study||27
8256817|NCT01822132|20359981|P1|STARTED|Overall Study||25
8256818|NCT01822119|20359995|P1|NOT COMPLETED|Overall Study||0
8256819|NCT01822119|20359995|P1|COMPLETED|Overall Study||27
8256820|NCT01822119|20359995|P1|STARTED|Overall Study||27
8256821|NCT01821963|20360018|P1|NOT COMPLETED|Overall Study||1
8256822|NCT01821963|20360018|P1|COMPLETED|Overall Study||0
8256823|NCT01821963|20360018|P1|STARTED|Overall Study||1
8256824|NCT01821937|20360024|P2|NOT COMPLETED|Overall Study||3
8256825|NCT01821937|20360025|P1|NOT COMPLETED|Overall Study||0
8256826|NCT01821937|20360024|P2|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
8256827|NCT01821937|20360025|P1|COMPLETED|Overall Study||10
8256828|NCT01821937|20360024|P2|STARTED|Overall Study||15
8256829|NCT01821937|20360025|P1|STARTED|Overall Study||10
8256830|NCT01821898|20360045|P2|NOT COMPLETED|Overall Study||1
8256831|NCT01821898|20360046|P1|NOT COMPLETED|Overall Study||2
8256832|NCT01821898|20360045|P2|COMPLETED|Overall Study||0
8256833|NCT01821898|20360046|P1|COMPLETED|Overall Study||0
8256834|NCT01821898|20360045|P2|STARTED|Overall Study||1
8256835|NCT01821898|20360046|P1|STARTED|Overall Study||2
8256836|NCT01821859|20360058|P1|NOT COMPLETED|Overall Study||5
8256837|NCT01821859|20360058|P1|COMPLETED|Overall Study||0
8256838|NCT01821859|20360058|P1|STARTED|Overall Study||5
8256839|NCT01821807|20360064|P2|NOT COMPLETED|Overall Study||1
8256840|NCT01821807|20360065|P1|NOT COMPLETED|Overall Study||3
8256841|NCT01821807|20360064|P2|COMPLETED|Overall Study||109
8256842|NCT01821807|20360065|P1|COMPLETED|Overall Study||147
8256843|NCT01821807|20360064|P2|STARTED|Overall Study||110
8256844|NCT01821807|20360065|P1|STARTED|Overall Study||150
8256845|NCT01821729|20360073|P1|NOT COMPLETED|Overall Study||1
8256846|NCT01821729|20360073|P1|COMPLETED|Overall Study||49
8256847|NCT01821729|20360073|P1|Underwent Attempted Surgery|Overall Study||42
8256848|NCT01821729|20360073|P1|Received Chemoradiotherapy|Overall Study||45
8256849|NCT01821729|20360073|P1|STARTED|Overall Study||50
8256850|NCT01821625|20360078|P1|NOT COMPLETED|Overall Study||6
8256851|NCT01821625|20360078|P1|COMPLETED|Overall Study||1
8256852|NCT01821625|20360078|P1|STARTED|Overall Study||7
8256853|NCT01821560|20360084|P2|NOT COMPLETED|Overall Study||7
8256854|NCT01821560|20360085|P1|NOT COMPLETED|Overall Study||6
8256855|NCT01821560|20360084|P2|COMPLETED|Overall Study||15
8256856|NCT01821560|20360085|P1|COMPLETED|Overall Study||16
8256857|NCT01821560|20360084|P2|STARTED|Overall Study||22
8256858|NCT01821560|20360085|P1|STARTED|Overall Study||22
8256859|NCT01821534|20360091|P1|NOT COMPLETED|Overall Study||0
8256860|NCT01821534|20360091|P1|COMPLETED|Overall Study||201
8256861|NCT01821534|20360091|P1|STARTED|Overall Study||201
8256862|NCT01821417|20360100|P2|NOT COMPLETED|Overall Study||0
8256863|NCT01821417|20360101|P1|NOT COMPLETED|Overall Study||0
8256864|NCT01821417|20360100|P2|COMPLETED|Overall Study||31
8256865|NCT01821417|20360101|P1|COMPLETED|Overall Study||37
8256866|NCT01821417|20360100|P2|STARTED|Overall Study||31
8256867|NCT01821417|20360101|P1|STARTED|Overall Study||37
8256874|NCT01821378|20360125|P3|NOT COMPLETED|Overall Study||42
8256875|NCT01821378|20360126|P2|NOT COMPLETED|Overall Study||54
8256876|NCT01821378|20360127|P1|NOT COMPLETED|Overall Study||27
8256877|NCT01821378|20360125|P3|COMPLETED|Overall Study||70
8256878|NCT01821378|20360126|P2|COMPLETED|Overall Study||145
8256879|NCT01821378|20360127|P1|COMPLETED|Overall Study||74
8256880|NCT01821378|20360125|P3|STARTED|Overall Study||112
8256881|NCT01821378|20360126|P2|STARTED|Overall Study||199
8256882|NCT01821378|20360127|P1|STARTED|Overall Study||101
8256883|NCT01821352|20360165|P2|NOT COMPLETED|Overall Study||0
8256884|NCT01821352|20360166|P1|NOT COMPLETED|Overall Study||0
8256885|NCT01821352|20360165|P2|COMPLETED|Overall Study||25
8256886|NCT01821352|20360166|P1|COMPLETED|Overall Study||28
8256887|NCT01821352|20360165|P2|STARTED|Overall Study||25
8256888|NCT01821352|20360166|P1|STARTED|Overall Study||28
8256889|NCT01821326|20360176|P1|NOT COMPLETED|Overall Study||0
8256890|NCT01821326|20360176|P1|COMPLETED|Overall Study||339
8256891|NCT01821326|20360176|P1|STARTED|Overall Study||339
8256892|NCT01821300|20360182|P2|NOT COMPLETED|Overall Study||0
8256893|NCT01821300|20360183|P1|NOT COMPLETED|Overall Study||0
8256894|NCT01821300|20360182|P2|COMPLETED|Overall Study||103
8256895|NCT01821300|20360183|P1|COMPLETED|Overall Study||154
8256896|NCT01821300|20360182|P2|STARTED|Overall Study||103
8256897|NCT01821300|20360183|P1|STARTED|Overall Study||154
8256898|NCT01821118|20360217|P2|NOT COMPLETED|Overall Study||1
8256899|NCT01821118|20360218|P1|NOT COMPLETED|Overall Study||0
8256900|NCT01821118|20360217|P2|COMPLETED|Overall Study||11
8256901|NCT01821118|20360218|P1|COMPLETED|Overall Study||24
8256902|NCT01821118|20360217|P2|STARTED|Overall Study||12
8256903|NCT01821118|20360218|P1|STARTED|Overall Study||24
8256904|NCT01821105|20360251|P1|NOT COMPLETED|Overall Study||0
8256905|NCT01821105|20360251|P1|COMPLETED|Overall Study||21
8256906|NCT01821105|20360251|P1|STARTED|Overall Study||21
8256910|NCT01820637|20360265|P1|NOT COMPLETED|Overall Study||3
8256911|NCT01820637|20360265|P1|COMPLETED|Overall Study||54
8256912|NCT01820637|20360265|P1|STARTED|Overall Study||57
8256913|NCT01820585|20360274|P4|NOT COMPLETED|Overall Study||49
8256914|NCT01820585|20360275|P3|NOT COMPLETED|Overall Study||34
8256915|NCT01820585|20360276|P2|NOT COMPLETED|Overall Study||32
8256916|NCT01820585|20360277|P1|NOT COMPLETED|Overall Study||27
8256917|NCT01820585|20360274|P4|COMPLETED|Overall Study||83
8256918|NCT01820585|20360275|P3|COMPLETED|Overall Study||101
8256919|NCT01820585|20360276|P2|COMPLETED|Overall Study||98
8256920|NCT01820585|20360277|P1|COMPLETED|Overall Study||104
8256921|NCT01820585|20360274|P4|Completed Maintenance Period|Overall Study||84
8256922|NCT01820585|20360275|P3|Completed Maintenance Period|Overall Study||101
8256923|NCT01820585|20360276|P2|Completed Maintenance Period|Overall Study||98
8256924|NCT01820585|20360277|P1|Completed Maintenance Period|Overall Study||105
8256925|NCT01820585|20360274|P4|Entered Maintenance Period|Overall Study||123
8256926|NCT01820585|20360275|P3|Entered Maintenance Period|Overall Study||131
8256927|NCT01820585|20360276|P2|Entered Maintenance Period|Overall Study||124
8256928|NCT01820585|20360277|P1|Entered Maintenance Period|Overall Study||128
8256929|NCT01820585|20360274|P4|Completed Titration Period|Overall Study||126
8256930|NCT01820585|20360275|P3|Completed Titration Period|Overall Study||131
8256931|NCT01820585|20360276|P2|Completed Titration Period|Overall Study||125
8256932|NCT01820585|20360277|P1|Completed Titration Period|Overall Study||128
8256933|NCT01820585|20360274|P4|Full Analysis Set|Overall Study||129
8256934|NCT01820585|20360275|P3|Full Analysis Set|Overall Study||135
8256935|NCT01820585|20360276|P2|Full Analysis Set|Overall Study||130
8256936|NCT01820585|20360277|P1|Full Analysis Set|Overall Study||131
8256937|NCT01820585|20360274|P4|Randomized and Treated|Overall Study||132
8256938|NCT01820585|20360275|P3|Randomized and Treated|Overall Study||135
8256939|NCT01820585|20360276|P2|Randomized and Treated|Overall Study||130
8256940|NCT01820585|20360277|P1|Randomized and Treated|Overall Study||131
8256941|NCT01820585|20360274|P4|STARTED|Overall Study||132
8256942|NCT01820585|20360275|P3|STARTED|Overall Study||135
8256943|NCT01820585|20360276|P2|STARTED|Overall Study||130
8256944|NCT01820585|20360277|P1|STARTED|Overall Study||131
8256945|NCT01820572|20360289|P2|NOT COMPLETED|Treatment Period||36
8256946|NCT01820572|20360290|P1|NOT COMPLETED|Treatment Period||26
8256947|NCT01820572|20360289|P2|COMPLETED|Treatment Period||186
8256948|NCT01820572|20360290|P1|COMPLETED|Treatment Period||195
8256949|NCT01820572|20360289|P2|STARTED|Treatment Period||222
8256950|NCT01820572|20360290|P1|STARTED|Treatment Period||221
8256951|NCT01820572|20360289|P2|NOT COMPLETED|Randomization||1
8256952|NCT01820572|20360290|P1|NOT COMPLETED|Randomization||2
8256953|NCT01820572|20360289|P2|COMPLETED|Randomization||222
8256954|NCT01820572|20360290|P1|COMPLETED|Randomization||221
8256955|NCT01820572|20360289|P2|STARTED|Randomization||223
8256956|NCT01820572|20360290|P1|STARTED|Randomization||223
8256957|NCT01820559|20360333|P3|NOT COMPLETED|Overall Study||29
8256958|NCT01820559|20360334|P2|NOT COMPLETED|Overall Study||13
8256959|NCT01820559|20360335|P1|NOT COMPLETED|Overall Study||14
8256960|NCT01820559|20360333|P3|COMPLETED|Overall Study||110
8256961|NCT01820559|20360334|P2|COMPLETED|Overall Study||122
8256962|NCT01820559|20360335|P1|COMPLETED|Overall Study||122
8256963|NCT01820559|20360333|P3|Completed Maintenance Period|Overall Study||110
8256964|NCT01820559|20360334|P2|Completed Maintenance Period|Overall Study||123
8256965|NCT01820559|20360335|P1|Completed Maintenance Period|Overall Study||122
8256966|NCT01820559|20360333|P3|Entered Maintenance Period|Overall Study||129
8256967|NCT01820559|20360334|P2|Entered Maintenance Period|Overall Study||133
8256968|NCT01820559|20360335|P1|Entered Maintenance Period|Overall Study||129
8256969|NCT01820559|20360333|P3|Completed Tutration Period|Overall Study||131
8256970|NCT01820559|20360334|P2|Completed Tutration Period|Overall Study||134
8256971|NCT01820559|20360335|P1|Completed Tutration Period|Overall Study||130
8256972|NCT01820559|20360333|P3|Randomized and Treated|Overall Study||139
8256973|NCT01820559|20360334|P2|Randomized and Treated|Overall Study||135
8256974|NCT01820559|20360335|P1|Randomized and Treated|Overall Study||136
8256975|NCT01820559|20360333|P3|STARTED|Overall Study||139
8256976|NCT01820559|20360334|P2|STARTED|Overall Study||135
8256977|NCT01820559|20360335|P1|STARTED|Overall Study||136
8256978|NCT01820416|20360346|P3|NOT COMPLETED|Overall Study||0
8256979|NCT01820416|20360347|P2|NOT COMPLETED|Overall Study||2
8256980|NCT01820416|20360348|P1|NOT COMPLETED|Overall Study||3
8256981|NCT01820416|20360346|P3|COMPLETED|Overall Study||11
8256982|NCT01820416|20360347|P2|COMPLETED|Overall Study||10
8256983|NCT01820416|20360348|P1|COMPLETED|Overall Study||9
8256984|NCT01820416|20360346|P3|STARTED|Overall Study||11
8256985|NCT01820416|20360347|P2|STARTED|Overall Study||12
8256986|NCT01820416|20360348|P1|STARTED|Overall Study||12
8256987|NCT01820364|20360356|P2|NOT COMPLETED|Part II: LGX818 + MEK162||1
8256988|NCT01820364|20360357|P1|NOT COMPLETED|Part II: LGX818 + MEK162||0
8256989|NCT01820364|20360356|P2|COMPLETED|Part II: LGX818 + MEK162||0
8256990|NCT01820364|20360357|P1|COMPLETED|Part II: LGX818 + MEK162||0
8256991|NCT01820364|20360356|P2|STARTED|Part II: LGX818 + MEK162||1
8256992|NCT01820364|20360357|P1|STARTED|Part II: LGX818 + MEK162||0
8256993|NCT01820364|20360356|P2|NOT COMPLETED|Part I: LGX818||0
8256994|NCT01820364|20360357|P1|NOT COMPLETED|Part I: LGX818||14
8256995|NCT01820364|20360356|P2|COMPLETED|Part I: LGX818||0
8256996|NCT01820364|20360357|P1|COMPLETED|Part I: LGX818||1
8256997|NCT01820364|20360356|P2|STARTED|Part I: LGX818||0
8256998|NCT01820364|20360357|P1|STARTED|Part I: LGX818||15
8256999|NCT01819935|20360371|P2|NOT COMPLETED|Overall Study||0
8257000|NCT01819935|20360372|P1|NOT COMPLETED|Overall Study||0
8257001|NCT01819935|20360371|P2|COMPLETED|Overall Study||4943
8257002|NCT01819935|20360372|P1|COMPLETED|Overall Study||328
8257003|NCT01819935|20360371|P2|STARTED|Overall Study||4943
8257004|NCT01819935|20360372|P1|STARTED|Overall Study||328
8257005|NCT01819922|20360392|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
8257006|NCT01819922|20360393|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
8257007|NCT01819922|20360392|P2|COMPLETED|Second Intervention Period (1 Day)||6
8257008|NCT01819922|20360393|P1|COMPLETED|Second Intervention Period (1 Day)||6
8257009|NCT01819922|20360392|P2|STARTED|Second Intervention Period (1 Day)||6
8257010|NCT01819922|20360393|P1|STARTED|Second Intervention Period (1 Day)||6
8257011|NCT01819922|20360392|P2|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
8257012|NCT01819922|20360393|P1|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
8257013|NCT01819922|20360392|P2|COMPLETED|Washout Period (at Least 7-10 Days)||6
8257014|NCT01819922|20360393|P1|COMPLETED|Washout Period (at Least 7-10 Days)||6
8257015|NCT01819922|20360392|P2|STARTED|Washout Period (at Least 7-10 Days)||6
8257016|NCT01819922|20360393|P1|STARTED|Washout Period (at Least 7-10 Days)||6
8257017|NCT01819922|20360392|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
8257018|NCT01819922|20360393|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
8257019|NCT01819922|20360392|P2|COMPLETED|First Intervention Period (1 Day)||6
8257020|NCT01819922|20360393|P1|COMPLETED|First Intervention Period (1 Day)||6
8257021|NCT01819922|20360392|P2|STARTED|First Intervention Period (1 Day)||6
8257022|NCT01819922|20360393|P1|STARTED|First Intervention Period (1 Day)||6
8257023|NCT01819883|20360479|P2|NOT COMPLETED|Overall Study||0
8257024|NCT01819883|20360480|P1|NOT COMPLETED|Overall Study||4
8257025|NCT01819883|20360479|P2|COMPLETED|Overall Study||20
8257026|NCT01819883|20360480|P1|COMPLETED|Overall Study||16
8257027|NCT01819883|20360479|P2|STARTED|Overall Study||20
8257028|NCT01819883|20360480|P1|STARTED|Overall Study||20
8257029|NCT01819844|20360486|P1|NOT COMPLETED|Overall Study||0
8257030|NCT01819844|20360486|P1|COMPLETED|Overall Study||12
8257031|NCT01819844|20360486|P1|STARTED|Overall Study||12
8257032|NCT01819727|20360501|P2|NOT COMPLETED|Overall Study||28
8257033|NCT01819727|20360502|P1|NOT COMPLETED|Overall Study||20
8257034|NCT01819727|20360501|P2|COMPLETED|Overall Study||102
8257035|NCT01819727|20360502|P1|COMPLETED|Overall Study||111
8257036|NCT01819727|20360501|P2|STARTED|Overall Study||130
8257037|NCT01819727|20360502|P1|STARTED|Overall Study||131
8257038|NCT01819597|20360512|P1|NOT COMPLETED|Overall Study||0
8257039|NCT01819597|20360512|P1|COMPLETED|Overall Study||52
8257040|NCT01819597|20360512|P1|STARTED|Overall Study||52
8257041|NCT01819506|20360524|P2|NOT COMPLETED|Overall Study||5
8257042|NCT01819506|20360525|P1|NOT COMPLETED|Overall Study||8
8257043|NCT01819506|20360524|P2|COMPLETED|Overall Study||47
8257044|NCT01819506|20360525|P1|COMPLETED|Overall Study||43
8257045|NCT01819506|20360524|P2|STARTED|Overall Study||52
8257046|NCT01819506|20360525|P1|STARTED|Overall Study||51
8257047|NCT01819415|20360539|P4|NOT COMPLETED|Overall Study||2
8257048|NCT01819415|20360540|P3|NOT COMPLETED|Overall Study||1
8257049|NCT01819415|20360541|P2|NOT COMPLETED|Overall Study||4
8257050|NCT01819415|20360542|P1|NOT COMPLETED|Overall Study||3
8257051|NCT01819415|20360539|P4|COMPLETED|Overall Study||8
8257052|NCT01819415|20360540|P3|COMPLETED|Overall Study||9
8257053|NCT01819415|20360541|P2|COMPLETED|Overall Study||6
8257054|NCT01819415|20360542|P1|COMPLETED|Overall Study||7
8257055|NCT01819415|20360539|P4|STARTED|Overall Study||10
8257056|NCT01819415|20360540|P3|STARTED|Overall Study||10
8257057|NCT01819415|20360541|P2|STARTED|Overall Study||10
8257058|NCT01819415|20360542|P1|STARTED|Overall Study||10
8257059|NCT01819311|20360554|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
8257060|NCT01819311|20360555|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
8257061|NCT01819311|20360554|P2|COMPLETED|Follow-up Phase (8 Weeks)||23
8257062|NCT01819311|20360555|P1|COMPLETED|Follow-up Phase (8 Weeks)||24
8257063|NCT01819311|20360554|P2|STARTED|Follow-up Phase (8 Weeks)||30
8257064|NCT01819311|20360555|P1|STARTED|Follow-up Phase (8 Weeks)||31
8257065|NCT01819311|20360554|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||1
8257066|NCT01819311|20360555|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||2
8257067|NCT01819311|20360554|P2|COMPLETED|Treatment Phase (4 Weeks)||30
8257068|NCT01819311|20360555|P1|COMPLETED|Treatment Phase (4 Weeks)||31
8257069|NCT01819311|20360554|P2|STARTED|Treatment Phase (4 Weeks)||31
8257070|NCT01819311|20360555|P1|STARTED|Treatment Phase (4 Weeks)||33
8257071|NCT01819272|20360577|P6|NOT COMPLETED|Overall Study||7
8257072|NCT01819272|20360578|P5|NOT COMPLETED|Overall Study||4
8257073|NCT01819272|20360579|P4|NOT COMPLETED|Overall Study||5
8257074|NCT01819272|20360580|P3|NOT COMPLETED|Overall Study||3
8257075|NCT01819272|20360581|P2|NOT COMPLETED|Overall Study||3
8257076|NCT01819272|20360582|P1|NOT COMPLETED|Overall Study||6
8257077|NCT01819272|20360577|P6|COMPLETED|Overall Study||33
8257078|NCT01819272|20360578|P5|COMPLETED|Overall Study||36
8257079|NCT01819272|20360579|P4|COMPLETED|Overall Study||35
8257080|NCT01819272|20360580|P3|COMPLETED|Overall Study||37
8257081|NCT01819272|20360581|P2|COMPLETED|Overall Study||36
8257082|NCT01819272|20360582|P1|COMPLETED|Overall Study||35
8257083|NCT01819272|20360577|P6|STARTED|Overall Study||40
8257084|NCT01819272|20360578|P5|STARTED|Overall Study||40
8257085|NCT01819272|20360579|P4|STARTED|Overall Study||40
8257086|NCT01819272|20360580|P3|STARTED|Overall Study||40
8257087|NCT01819272|20360581|P2|STARTED|Overall Study||39
8257088|NCT01819272|20360582|P1|STARTED|Overall Study||41
8257089|NCT01819233|20360608|P1|NOT COMPLETED|Overall Study||6
8257090|NCT01819233|20360608|P1|COMPLETED|Overall Study||32
8257091|NCT01819233|20360608|P1|STARTED|Overall Study||38
8257092|NCT01819194|20360620|P1|NOT COMPLETED|Overall Study||2
8257093|NCT01819194|20360620|P1|COMPLETED|Overall Study||60
8257094|NCT01819194|20360620|P1|STARTED|Overall Study||62
8257095|NCT01819129|20360627|P2|NOT COMPLETED|Overall Study||39
8257096|NCT01819129|20360628|P1|NOT COMPLETED|Overall Study||44
8257097|NCT01819129|20360627|P2|COMPLETED|Overall Study||305
8257098|NCT01819129|20360628|P1|COMPLETED|Overall Study||301
8257099|NCT01819129|20360627|P2|Exposed|Overall Study||341
8257100|NCT01819129|20360628|P1|Exposed|Overall Study||341
8257101|NCT01819129|20360627|P2|STARTED|Overall Study||344
8257102|NCT01819129|20360628|P1|STARTED|Overall Study||345
8257103|NCT01818804|20360642|P2|NOT COMPLETED|Overall Study||7
8257104|NCT01818804|20360643|P1|NOT COMPLETED|Overall Study||5
8257105|NCT01818804|20360642|P2|COMPLETED|Overall Study||65
8257106|NCT01818804|20360643|P1|COMPLETED|Overall Study||68
8257107|NCT01818804|20360642|P2|STARTED|Overall Study||72
8257108|NCT01818804|20360643|P1|STARTED|Overall Study||73
8257109|NCT01818765|20360653|P1|NOT COMPLETED|Overall Study||2
8257110|NCT01818765|20360653|P1|COMPLETED|Overall Study||18
8257111|NCT01818765|20360653|P1|STARTED|Overall Study||20
8257112|NCT01818752|20360666|P2|NOT COMPLETED|Overall Study||198
8257113|NCT01818752|20360667|P1|NOT COMPLETED|Overall Study||187
8257114|NCT01818752|20360666|P2|COMPLETED|Overall Study|Completed treatment|280
8257115|NCT01818752|20360667|P1|COMPLETED|Overall Study|Completed treatment|290
8257116|NCT01818752|20360666|P2|Received Treatment|Overall Study||474
8257117|NCT01818752|20360667|P1|Received Treatment|Overall Study||470
8257118|NCT01818752|20360666|P2|STARTED|Overall Study||478
8257119|NCT01818752|20360667|P1|STARTED|Overall Study||477
8257120|NCT01818726|20360687|P2|NOT COMPLETED|Overall Study||2
8257121|NCT01818726|20360688|P1|NOT COMPLETED|Overall Study||6
8257122|NCT01818726|20360687|P2|COMPLETED|Overall Study||3
8257123|NCT01818726|20360688|P1|COMPLETED|Overall Study||4
8257124|NCT01818726|20360687|P2|STARTED|Overall Study||5
8257125|NCT01818726|20360688|P1|STARTED|Overall Study||10
8257126|NCT01818700|20360698|P1|NOT COMPLETED|Overall Study||104
8257127|NCT01818700|20360698|P1|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
8257128|NCT01818700|20360698|P1|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
8257129|NCT01818700|20360698|P1|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
8257130|NCT01818700|20360698|P1|Safety Set|Overall Study|4 subjects were not study drug administered.|241
8257131|NCT01818700|20360698|P1|STARTED|Overall Study|The No. of enrolled patients|245
8257132|NCT01818596|20360709|P2|NOT COMPLETED|Overall Study||0
8257133|NCT01818596|20360710|P1|NOT COMPLETED|Overall Study||31
8257134|NCT01818596|20360709|P2|COMPLETED|Overall Study||6
8257135|NCT01818596|20360710|P1|COMPLETED|Overall Study||215
8257136|NCT01818596|20360709|P2|STARTED|Overall Study||6
8257137|NCT01818596|20360710|P1|STARTED|Overall Study||246
8257138|NCT01818531|20360749|P2|NOT COMPLETED|Overall Study||2
8257139|NCT01818531|20360750|P1|NOT COMPLETED|Overall Study||1
8257140|NCT01818531|20360749|P2|COMPLETED|Overall Study||73
8257141|NCT01818531|20360750|P1|COMPLETED|Overall Study||74
8257142|NCT01818531|20360749|P2|STARTED|Overall Study||75
8257143|NCT01818531|20360750|P1|STARTED|Overall Study||75
8257144|NCT01818518|20360770|P6|NOT COMPLETED|Overall Study||0
8257145|NCT01818518|20360771|P5|NOT COMPLETED|Overall Study||0
8257146|NCT01818518|20360772|P4|NOT COMPLETED|Overall Study||0
8257147|NCT01818518|20360773|P3|NOT COMPLETED|Overall Study||0
8257148|NCT01818518|20360774|P2|NOT COMPLETED|Overall Study||0
8257149|NCT01818518|20360775|P1|NOT COMPLETED|Overall Study||0
8257150|NCT01818518|20360770|P6|COMPLETED|Overall Study||37
8257151|NCT01818518|20360771|P5|COMPLETED|Overall Study||38
8257152|NCT01818518|20360772|P4|COMPLETED|Overall Study||59
8257153|NCT01818518|20360773|P3|COMPLETED|Overall Study||288
8257154|NCT01818518|20360774|P2|COMPLETED|Overall Study||263
8257155|NCT01818518|20360775|P1|COMPLETED|Overall Study||310
8257156|NCT01818518|20360770|P6|STARTED|Overall Study||37
8257157|NCT01818518|20360771|P5|STARTED|Overall Study||38
8257158|NCT01818518|20360772|P4|STARTED|Overall Study||59
8257159|NCT01818518|20360773|P3|STARTED|Overall Study||288
8257160|NCT01818518|20360774|P2|STARTED|Overall Study||263
8257161|NCT01818518|20360775|P1|STARTED|Overall Study||310
8257171|NCT01818414|20360823|P2|NOT COMPLETED|Overall Study||0
8257172|NCT01818414|20360824|P1|NOT COMPLETED|Overall Study||0
8257173|NCT01818414|20360823|P2|COMPLETED|Overall Study||15
8257174|NCT01818414|20360824|P1|COMPLETED|Overall Study||14
8257175|NCT01818414|20360823|P2|STARTED|Overall Study||15
8257176|NCT01818414|20360824|P1|STARTED|Overall Study||14
8257177|NCT01818336|20360838|P2|NOT COMPLETED|Overall Study||12
8257178|NCT01818336|20360839|P1|NOT COMPLETED|Overall Study||0
8257179|NCT01818336|20360838|P2|COMPLETED|Overall Study||47
8257180|NCT01818336|20360839|P1|COMPLETED|Overall Study||391
8257181|NCT01818336|20360838|P2|STARTED|Overall Study||59
8257182|NCT01818336|20360839|P1|STARTED|Overall Study||391
8257183|NCT01818297|20360847|P2|NOT COMPLETED|Open Label Phase (3-12 Months)||10
8257184|NCT01818297|20360848|P1|NOT COMPLETED|Open Label Phase (3-12 Months)||18
8257185|NCT01818297|20360847|P2|COMPLETED|Open Label Phase (3-12 Months)||19
8257186|NCT01818297|20360848|P1|COMPLETED|Open Label Phase (3-12 Months)||14
8257187|NCT01818297|20360847|P2|STARTED|Open Label Phase (3-12 Months)||29
8257188|NCT01818297|20360848|P1|STARTED|Open Label Phase (3-12 Months)||32
8257189|NCT01818297|20360847|P2|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
8257190|NCT01818297|20360848|P1|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
8257191|NCT01818297|20360847|P2|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
8257192|NCT01818297|20360848|P1|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
8257193|NCT01818297|20360847|P2|Week 6|Blinded Phase (Randomization - 3 Months)||29
8257194|NCT01818297|20360848|P1|Week 6|Blinded Phase (Randomization - 3 Months)||32
8257195|NCT01818297|20360847|P2|Week 1|Blinded Phase (Randomization - 3 Months)||30
8257196|NCT01818297|20360848|P1|Week 1|Blinded Phase (Randomization - 3 Months)||32
8257197|NCT01818297|20360847|P2|STARTED|Blinded Phase (Randomization - 3 Months)||30
8257198|NCT01818297|20360848|P1|STARTED|Blinded Phase (Randomization - 3 Months)||32
8257199|NCT01818284|20360866|P2|NOT COMPLETED|Overall Study||6
8257200|NCT01818284|20360867|P1|NOT COMPLETED|Overall Study||4
8257201|NCT01818284|20360866|P2|COMPLETED|Overall Study||5
8257202|NCT01818284|20360867|P1|COMPLETED|Overall Study||7
8257203|NCT01818284|20360866|P2|STARTED|Overall Study||11
8257204|NCT01818284|20360867|P1|STARTED|Overall Study||11
8257205|NCT01818245|20360875|P2|NOT COMPLETED|Intervention C||0
8257206|NCT01818245|20360876|P1|NOT COMPLETED|Intervention C||0
8257207|NCT01818245|20360875|P2|COMPLETED|Intervention C||0
8257208|NCT01818245|20360876|P1|COMPLETED|Intervention C||30
8257209|NCT01818245|20360875|P2|STARTED|Intervention C||0
8257210|NCT01818245|20360876|P1|STARTED|Intervention C||30
8257211|NCT01818245|20360875|P2|NOT COMPLETED|Washout (16-28 Days)||0
8257212|NCT01818245|20360876|P1|NOT COMPLETED|Washout (16-28 Days)||0
8257213|NCT01818245|20360875|P2|COMPLETED|Washout (16-28 Days)||0
8257214|NCT01818245|20360876|P1|COMPLETED|Washout (16-28 Days)||30
8257215|NCT01818245|20360875|P2|STARTED|Washout (16-28 Days)||0
8257216|NCT01818245|20360876|P1|STARTED|Washout (16-28 Days)||30
8257217|NCT01818245|20360875|P2|NOT COMPLETED|Intervention B||0
8257218|NCT01818245|20360876|P1|NOT COMPLETED|Intervention B||0
8257219|NCT01818245|20360875|P2|COMPLETED|Intervention B||0
8257220|NCT01818245|20360876|P1|COMPLETED|Intervention B||30
8257221|NCT01818245|20360875|P2|STARTED|Intervention B||0
8257222|NCT01818245|20360876|P1|STARTED|Intervention B||30
8257223|NCT01818245|20360875|P2|NOT COMPLETED|Washout (16-28 Days)||0
8257224|NCT01818245|20360876|P1|NOT COMPLETED|Washout (16-28 Days)||0
8257225|NCT01818245|20360875|P2|COMPLETED|Washout (16-28 Days)||0
8257226|NCT01818245|20360876|P1|COMPLETED|Washout (16-28 Days)||30
8257227|NCT01818245|20360875|P2|STARTED|Washout (16-28 Days)||0
8257228|NCT01818245|20360876|P1|STARTED|Washout (16-28 Days)||30
8257229|NCT01818245|20360875|P2|NOT COMPLETED|Intervention A||0
8257230|NCT01818245|20360876|P1|NOT COMPLETED|Intervention A||0
8257231|NCT01818245|20360875|P2|COMPLETED|Intervention A||22
8257232|NCT01818245|20360876|P1|COMPLETED|Intervention A||30
8257233|NCT01818245|20360875|P2|Received One Dose of Study Drug|Intervention A||22
8257234|NCT01818245|20360876|P1|Received One Dose of Study Drug|Intervention A||30
8257235|NCT01818245|20360875|P2|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
8257236|NCT01818245|20360876|P1|STARTED|Intervention A||30
8257237|NCT01818141|20360900|P2|NOT COMPLETED|Overall Study||3
8257238|NCT01818141|20360901|P1|NOT COMPLETED|Overall Study||3
8257239|NCT01818141|20360900|P2|COMPLETED|Overall Study||13
8257240|NCT01818141|20360901|P1|COMPLETED|Overall Study||15
8257241|NCT01818141|20360900|P2|STARTED|Overall Study||16
8257242|NCT01818141|20360901|P1|STARTED|Overall Study||18
8257243|NCT01818063|20360911|P2|NOT COMPLETED|Overall Study||0
8257244|NCT01818063|20360912|P1|NOT COMPLETED|Overall Study||0
8257245|NCT01818063|20360911|P2|COMPLETED|Overall Study||4
8257246|NCT01818063|20360912|P1|COMPLETED|Overall Study||5
8257247|NCT01818063|20360911|P2|STARTED|Overall Study||4
8257248|NCT01818063|20360912|P1|STARTED|Overall Study||5
8257255|NCT01817907|20360971|P2|NOT COMPLETED|Second Intervention||0
8257256|NCT01817907|20360972|P1|NOT COMPLETED|Second Intervention||0
8257257|NCT01817907|20360971|P2|COMPLETED|Second Intervention||7
8257258|NCT01817907|20360972|P1|COMPLETED|Second Intervention||8
8257259|NCT01817907|20360971|P2|STARTED|Second Intervention||7
8257260|NCT01817907|20360972|P1|STARTED|Second Intervention||8
8257261|NCT01817907|20360971|P2|NOT COMPLETED|Washout Period||0
8257262|NCT01817907|20360972|P1|NOT COMPLETED|Washout Period||0
8257263|NCT01817907|20360971|P2|COMPLETED|Washout Period||7
8257264|NCT01817907|20360972|P1|COMPLETED|Washout Period||8
8257265|NCT01817907|20360971|P2|STARTED|Washout Period||7
8257266|NCT01817907|20360972|P1|STARTED|Washout Period||8
8257267|NCT01817907|20360971|P2|NOT COMPLETED|First Intervention||0
8257268|NCT01817907|20360972|P1|NOT COMPLETED|First Intervention||0
8257269|NCT01817907|20360971|P2|COMPLETED|First Intervention||7
8257270|NCT01817907|20360972|P1|COMPLETED|First Intervention||8
8257271|NCT01817907|20360971|P2|STARTED|First Intervention||7
8257272|NCT01817907|20360972|P1|STARTED|First Intervention||8
8257273|NCT01817855|20360984|P4|NOT COMPLETED|Overall Study||0
8257274|NCT01817855|20360985|P3|NOT COMPLETED|Overall Study||2
8257275|NCT01817855|20360986|P2|NOT COMPLETED|Overall Study||2
8257276|NCT01817855|20360987|P1|NOT COMPLETED|Overall Study||0
8257277|NCT01817855|20360984|P4|COMPLETED|Overall Study||5
8257278|NCT01817855|20360985|P3|COMPLETED|Overall Study||9
8257279|NCT01817855|20360986|P2|COMPLETED|Overall Study||6
8257280|NCT01817855|20360987|P1|COMPLETED|Overall Study||23
8257281|NCT01817855|20360984|P4|STARTED|Overall Study||5
8257282|NCT01817855|20360985|P3|STARTED|Overall Study||11
8257283|NCT01817855|20360986|P2|STARTED|Overall Study||8
8257284|NCT01817855|20360987|P1|STARTED|Overall Study||23
8257285|NCT01817790|20361017|P2|NOT COMPLETED|Overall Study||8
8257286|NCT01817790|20361018|P1|NOT COMPLETED|Overall Study||4
8257287|NCT01817790|20361017|P2|COMPLETED|Overall Study||304
8257288|NCT01817790|20361018|P1|COMPLETED|Overall Study||310
8257289|NCT01817790|20361017|P2|STARTED|Overall Study||312
8257290|NCT01817790|20361018|P1|STARTED|Overall Study||314
8257291|NCT01817777|20361062|P3|NOT COMPLETED|Interventional Phase (20 Weeks)||5
8257292|NCT01817777|20361063|P2|NOT COMPLETED|Interventional Phase (20 Weeks)||5
8257293|NCT01817777|20361064|P1|NOT COMPLETED|Interventional Phase (20 Weeks)||0
8257294|NCT01817777|20361062|P3|COMPLETED|Interventional Phase (20 Weeks)||10
8257295|NCT01817777|20361063|P2|COMPLETED|Interventional Phase (20 Weeks)||11
8257296|NCT01817777|20361064|P1|COMPLETED|Interventional Phase (20 Weeks)||0
8257297|NCT01817777|20361062|P3|STARTED|Interventional Phase (20 Weeks)||15
8257298|NCT01817777|20361063|P2|STARTED|Interventional Phase (20 Weeks)||16
8257299|NCT01817777|20361064|P1|STARTED|Interventional Phase (20 Weeks)||0
8257300|NCT01817777|20361062|P3|NOT COMPLETED|Observational Phase (8 Weeks)||0
8257301|NCT01817777|20361063|P2|NOT COMPLETED|Observational Phase (8 Weeks)||0
8257302|NCT01817777|20361064|P1|NOT COMPLETED|Observational Phase (8 Weeks)||5
8257303|NCT01817777|20361062|P3|COMPLETED|Observational Phase (8 Weeks)||0
8257304|NCT01817777|20361063|P2|COMPLETED|Observational Phase (8 Weeks)||0
8257305|NCT01817777|20361064|P1|COMPLETED|Observational Phase (8 Weeks)||31
8257306|NCT01817777|20361062|P3|STARTED|Observational Phase (8 Weeks)||0
8257307|NCT01817777|20361063|P2|STARTED|Observational Phase (8 Weeks)||0
8257308|NCT01817777|20361064|P1|STARTED|Observational Phase (8 Weeks)||36
8257309|NCT01817764|20361088|P2|NOT COMPLETED|Overall Study||38
8257310|NCT01817764|20361089|P1|NOT COMPLETED|Overall Study||34
8257311|NCT01817764|20361088|P2|COMPLETED|Overall Study||315
8257312|NCT01817764|20361089|P1|COMPLETED|Overall Study||319
8257313|NCT01817764|20361088|P2|STARTED|Overall Study||353
8257314|NCT01817764|20361089|P1|STARTED|Overall Study||353
8257315|NCT01817725|20361097|P1|NOT COMPLETED|Overall Study||1
8257316|NCT01817725|20361097|P1|COMPLETED|Overall Study||19
8257317|NCT01817725|20361097|P1|STARTED|Overall Study||20
8257318|NCT01817712|20361104|P2|NOT COMPLETED|Overall Study||30
8257319|NCT01817712|20361105|P1|NOT COMPLETED|Overall Study||21
8257320|NCT01817712|20361104|P2|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240
8257321|NCT01817712|20361105|P1|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250
8257322|NCT01817712|20361104|P2|STARTED|Overall Study||270
8257323|NCT01817712|20361105|P1|STARTED|Overall Study||271
8257324|NCT01817582|20361118|P3|NOT COMPLETED|Overall Study||0
8257325|NCT01817582|20361119|P2|NOT COMPLETED|Overall Study||1
8257326|NCT01817582|20361120|P1|NOT COMPLETED|Overall Study||2
8257327|NCT01817582|20361118|P3|COMPLETED|Overall Study||33
8257328|NCT01817582|20361119|P2|COMPLETED|Overall Study||35
8257329|NCT01817582|20361120|P1|COMPLETED|Overall Study||31
8257330|NCT01817582|20361118|P3|Received at Least 1 Dose of Study Drug|Overall Study||33
8257331|NCT01817582|20361119|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
8257332|NCT01817582|20361120|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
8257333|NCT01817582|20361118|P3|STARTED|Overall Study||33
8257334|NCT01817582|20361119|P2|STARTED|Overall Study||36
8257335|NCT01817582|20361120|P1|STARTED|Overall Study||33
8257336|NCT01817530|20361190|P8|NOT COMPLETED|Overall Study||24
8257337|NCT01817530|20361191|P7|NOT COMPLETED|Overall Study||23
8257338|NCT01817530|20361192|P6|NOT COMPLETED|Overall Study||19
8257339|NCT01817530|20361193|P5|NOT COMPLETED|Overall Study||11
8257340|NCT01817530|20361194|P4|NOT COMPLETED|Overall Study||13
8257341|NCT01817530|20361195|P3|NOT COMPLETED|Overall Study||11
8257342|NCT01817530|20361196|P2|NOT COMPLETED|Overall Study||13
8257343|NCT01817530|20361197|P1|NOT COMPLETED|Overall Study||15
8257344|NCT01817530|20361190|P8|COMPLETED|Overall Study||53
8257345|NCT01817530|20361191|P7|COMPLETED|Overall Study||53
8257346|NCT01817530|20361192|P6|COMPLETED|Overall Study||58
8257347|NCT01817530|20361193|P5|COMPLETED|Overall Study||67
8257348|NCT01817530|20361194|P4|COMPLETED|Overall Study||52
8257349|NCT01817530|20361195|P3|COMPLETED|Overall Study||53
8257350|NCT01817530|20361196|P2|COMPLETED|Overall Study||52
8257351|NCT01817530|20361197|P1|COMPLETED|Overall Study||50
8257352|NCT01817530|20361190|P8|STARTED|Overall Study||77
8257353|NCT01817530|20361191|P7|STARTED|Overall Study||76
8257354|NCT01817530|20361192|P6|STARTED|Overall Study||77
8257355|NCT01817530|20361193|P5|STARTED|Overall Study||78
8257356|NCT01817530|20361194|P4|STARTED|Overall Study||65
8257357|NCT01817530|20361195|P3|STARTED|Overall Study||64
8257358|NCT01817530|20361196|P2|STARTED|Overall Study||65
8257359|NCT01817530|20361197|P1|STARTED|Overall Study||65
8257360|NCT01817491|20361361|P2|NOT COMPLETED|Overall Study||0
8257361|NCT01817491|20361362|P1|NOT COMPLETED|Overall Study||4
8257362|NCT01817491|20361361|P2|COMPLETED|Overall Study||28
8257363|NCT01817491|20361362|P1|COMPLETED|Overall Study||28
8257364|NCT01817491|20361361|P2|STARTED|Overall Study||28
8257365|NCT01817491|20361362|P1|STARTED|Overall Study||32
8257366|NCT01817374|20361408|P1|NOT COMPLETED|Overall Study||0
8257367|NCT01817374|20361408|P1|COMPLETED|Overall Study||6
8257368|NCT01817374|20361408|P1|STARTED|Overall Study||6
8257375|NCT01816984|20361435|P1|NOT COMPLETED|Overall Study||1
8257376|NCT01816984|20361435|P1|COMPLETED|Overall Study||11
8257377|NCT01816984|20361435|P1|STARTED|Overall Study||12
8257378|NCT01816906|20361448|P2|NOT COMPLETED|12 Months||5
8257379|NCT01816906|20361449|P1|NOT COMPLETED|12 Months||4
8257380|NCT01816906|20361448|P2|COMPLETED|12 Months||14
8257381|NCT01816906|20361449|P1|COMPLETED|12 Months||16
8257382|NCT01816906|20361448|P2|STARTED|12 Months||19
8257383|NCT01816906|20361449|P1|STARTED|12 Months||20
8257384|NCT01816906|20361448|P2|NOT COMPLETED|Six Months||22
8257385|NCT01816906|20361449|P1|NOT COMPLETED|Six Months||21
8257386|NCT01816906|20361448|P2|COMPLETED|Six Months||19
8257387|NCT01816906|20361449|P1|COMPLETED|Six Months||20
8257388|NCT01816906|20361448|P2|STARTED|Six Months||41
8257389|NCT01816906|20361449|P1|STARTED|Six Months||41
8257390|NCT01816893|20361467|P2|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
8257391|NCT01816893|20361468|P1|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
8257392|NCT01816893|20361467|P2|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
8257393|NCT01816893|20361468|P1|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
8257394|NCT01816893|20361467|P2|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
8257395|NCT01816893|20361468|P1|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
8257396|NCT01816893|20361467|P2|NOT COMPLETED|Washout Period||0
8257397|NCT01816893|20361468|P1|NOT COMPLETED|Washout Period||2
8257398|NCT01816893|20361467|P2|COMPLETED|Washout Period||11
8257399|NCT01816893|20361468|P1|COMPLETED|Washout Period||9
8257400|NCT01816893|20361467|P2|STARTED|Washout Period||11
8257401|NCT01816893|20361468|P1|STARTED|Washout Period||11
8257402|NCT01816893|20361467|P2|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
8257403|NCT01816893|20361468|P1|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
8257404|NCT01816893|20361467|P2|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
8257405|NCT01816893|20361468|P1|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
8257406|NCT01816893|20361467|P2|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
8257407|NCT01816893|20361468|P1|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
8257408|NCT01816776|20361480|P2|NOT COMPLETED|Overall Study||8
8257409|NCT01816776|20361481|P1|NOT COMPLETED|Overall Study||13
8257410|NCT01816776|20361480|P2|COMPLETED|Overall Study||70
8257411|NCT01816776|20361481|P1|COMPLETED|Overall Study||60
8257412|NCT01816776|20361480|P2|6 Month Primary Effectiveness Assessed|Overall Study||73
8257413|NCT01816776|20361481|P1|6 Month Primary Effectiveness Assessed|Overall Study||68
8257414|NCT01816776|20361480|P2|STARTED|Overall Study||78
8257415|NCT01816776|20361481|P1|STARTED|Overall Study||73
8257416|NCT01816763|20361504|P3|NOT COMPLETED|Overall Study||11
8257417|NCT01816763|20361505|P2|NOT COMPLETED|Overall Study||15
8257418|NCT01816763|20361506|P1|NOT COMPLETED|Overall Study||4
8257419|NCT01816763|20361504|P3|COMPLETED|Overall Study||169
8257420|NCT01816763|20361505|P2|COMPLETED|Overall Study||179
8257421|NCT01816763|20361506|P1|COMPLETED|Overall Study||191
8257422|NCT01816763|20361504|P3|STARTED|Overall Study||180
8257423|NCT01816763|20361505|P2|STARTED|Overall Study||194
8257424|NCT01816763|20361506|P1|STARTED|Overall Study||195
8257425|NCT01816711|20361522|P2|NOT COMPLETED|Overall Study||0
8257426|NCT01816711|20361523|P1|NOT COMPLETED|Overall Study||0
8257427|NCT01816711|20361522|P2|COMPLETED|Overall Study||83
8257428|NCT01816711|20361523|P1|COMPLETED|Overall Study||121
8257429|NCT01816711|20361522|P2|STARTED|Overall Study||83
8257430|NCT01816711|20361523|P1|STARTED|Overall Study||121
8257431|NCT01816685|20361531|P2|NOT COMPLETED|Overall Study||11
8257432|NCT01816685|20361532|P1|NOT COMPLETED|Overall Study||10
8257433|NCT01816685|20361531|P2|COMPLETED|Overall Study||56
8257434|NCT01816685|20361532|P1|COMPLETED|Overall Study||58
8257435|NCT01816685|20361531|P2|STARTED|Overall Study||67
8257436|NCT01816685|20361532|P1|STARTED|Overall Study||68
8257437|NCT01816594|20361542|P2|NOT COMPLETED|Overall Study||2
8257438|NCT01816594|20361543|P1|NOT COMPLETED|Overall Study||11
8257439|NCT01816594|20361542|P2|COMPLETED|Overall Study||23
8257440|NCT01816594|20361543|P1|COMPLETED|Overall Study||14
8257441|NCT01816594|20361542|P2|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
8257442|NCT01816594|20361543|P1|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
8257443|NCT01816594|20361542|P2|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
8257444|NCT01816594|20361543|P1|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
8257445|NCT01816594|20361542|P2|STARTED|Overall Study||25
8257446|NCT01816594|20361543|P1|STARTED|Overall Study||25
8257447|NCT01816477|20361581|P2|NOT COMPLETED|Overall Study||1
8257448|NCT01816477|20361582|P1|NOT COMPLETED|Overall Study||16
8257449|NCT01816477|20361581|P2|COMPLETED|Overall Study||41
8257450|NCT01816477|20361582|P1|COMPLETED|Overall Study||27
8257451|NCT01816477|20361581|P2|STARTED|Overall Study||42
8257452|NCT01816477|20361582|P1|STARTED|Overall Study||43
8257453|NCT01816451|20361595|P3|NOT COMPLETED|Overall Study||0
8257454|NCT01816451|20361596|P2|NOT COMPLETED|Overall Study||0
8257455|NCT01816451|20361597|P1|NOT COMPLETED|Overall Study||0
8257456|NCT01816451|20361595|P3|COMPLETED|Overall Study||8
8257457|NCT01816451|20361596|P2|COMPLETED|Overall Study||11
8257458|NCT01816451|20361597|P1|COMPLETED|Overall Study||13
8257459|NCT01816451|20361595|P3|STARTED|Overall Study||8
8257460|NCT01816451|20361596|P2|STARTED|Overall Study||11
8257461|NCT01816451|20361597|P1|STARTED|Overall Study||13
8257462|NCT01816295|20361636|P2|NOT COMPLETED|OLE Phase||56
8257463|NCT01816295|20361637|P1|NOT COMPLETED|OLE Phase||53
8257464|NCT01816295|20361636|P2|COMPLETED|OLE Phase||227
8257465|NCT01816295|20361637|P1|COMPLETED|OLE Phase||222
8257466|NCT01816295|20361636|P2|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
8257467|NCT01816295|20361637|P1|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
8257468|NCT01816295|20361636|P2|NOT COMPLETED|Double Blind Phase||56
8257469|NCT01816295|20361637|P1|NOT COMPLETED|Double Blind Phase||63
8257470|NCT01816295|20361636|P2|COMPLETED|Double Blind Phase||302
8257471|NCT01816295|20361637|P1|COMPLETED|Double Blind Phase||294
8257472|NCT01816295|20361636|P2|Received Study Drug|Double Blind Phase||354
8257473|NCT01816295|20361637|P1|Received Study Drug|Double Blind Phase||356
8257474|NCT01816295|20361636|P2|STARTED|Double Blind Phase||358
8257475|NCT01816295|20361637|P1|STARTED|Double Blind Phase||357
8257476|NCT01816243|20361652|P1|NOT COMPLETED|Overall Study||12
8257477|NCT01816243|20361652|P1|COMPLETED|Overall Study||27
8257478|NCT01816243|20361652|P1|STARTED|Overall Study||39
8257479|NCT01816230|20361659|P1|NOT COMPLETED|Overall Study||0
8257480|NCT01816230|20361659|P1|COMPLETED|Overall Study||36
8257481|NCT01816230|20361659|P1|STARTED|Overall Study||36
8257482|NCT01816074|20361667|P4|NOT COMPLETED|Phase 2||1
8257483|NCT01816074|20361668|P3|NOT COMPLETED|Phase 2||0
8257484|NCT01816074|20361669|P2|NOT COMPLETED|Phase 2||2
8257485|NCT01816074|20361670|P1|NOT COMPLETED|Phase 2||2
8257486|NCT01816074|20361667|P4|COMPLETED|Phase 2||9
8257487|NCT01816074|20361668|P3|COMPLETED|Phase 2||10
8257488|NCT01816074|20361669|P2|COMPLETED|Phase 2||7
8257489|NCT01816074|20361670|P1|COMPLETED|Phase 2||9
8257490|NCT01816074|20361667|P4|STARTED|Phase 2||10
8257491|NCT01816074|20361668|P3|STARTED|Phase 2||10
8257492|NCT01816074|20361669|P2|STARTED|Phase 2||9
8257493|NCT01816074|20361670|P1|STARTED|Phase 2||11
8257494|NCT01816074|20361667|P4|NOT COMPLETED|Phase 1||0
8257495|NCT01816074|20361668|P3|NOT COMPLETED|Phase 1||1
8257496|NCT01816074|20361669|P2|NOT COMPLETED|Phase 1||0
8257497|NCT01816074|20361670|P1|NOT COMPLETED|Phase 1||0
8257498|NCT01816074|20361667|P4|COMPLETED|Phase 1||10
8257499|NCT01816074|20361668|P3|COMPLETED|Phase 1||10
8257500|NCT01816074|20361669|P2|COMPLETED|Phase 1||9
8257501|NCT01816074|20361670|P1|COMPLETED|Phase 1||11
8257502|NCT01816074|20361667|P4|STARTED|Phase 1||10
8257503|NCT01816074|20361668|P3|STARTED|Phase 1||11
8257504|NCT01816074|20361669|P2|STARTED|Phase 1||9
8257505|NCT01816074|20361670|P1|STARTED|Phase 1||11
8257506|NCT01816061|20361700|P2|NOT COMPLETED|Overall Study||24
8257507|NCT01816061|20361701|P1|NOT COMPLETED|Overall Study||13
8257508|NCT01816061|20361700|P2|COMPLETED|Overall Study||27
8257509|NCT01816061|20361701|P1|COMPLETED|Overall Study||27
8257510|NCT01816061|20361700|P2|STARTED|Overall Study||51
8257511|NCT01816061|20361701|P1|STARTED|Overall Study||40
8257512|NCT01816048|20361709|P1|NOT COMPLETED|Overall Study||6
8257513|NCT01816048|20361709|P1|COMPLETED|Overall Study||2
8257514|NCT01816048|20361709|P1|STARTED|Overall Study||8
8257515|NCT01815918|20361724|P2|NOT COMPLETED|Overall Study||19
8257516|NCT01815918|20361725|P1|NOT COMPLETED|Overall Study||18
8257517|NCT01815918|20361724|P2|COMPLETED|Overall Study||11
8257518|NCT01815918|20361725|P1|COMPLETED|Overall Study||12
8257519|NCT01815918|20361724|P2|STARTED|Overall Study||30
8257520|NCT01815918|20361725|P1|STARTED|Overall Study||30
8257521|NCT01815840|20361741|P2|NOT COMPLETED|Overall Study||63
8257522|NCT01815840|20361742|P1|NOT COMPLETED|Overall Study||59
8257523|NCT01815840|20361741|P2|COMPLETED|Overall Study||50
8257524|NCT01815840|20361742|P1|COMPLETED|Overall Study||57
8257525|NCT01815840|20361741|P2|STARTED|Overall Study||113
8257526|NCT01815840|20361742|P1|STARTED|Overall Study||116
8257533|NCT01815671|20361789|P2|NOT COMPLETED|Overall Study||0
8257534|NCT01815671|20361790|P1|NOT COMPLETED|Overall Study||0
8257535|NCT01815671|20361789|P2|COMPLETED|Overall Study||85
8257536|NCT01815671|20361790|P1|COMPLETED|Overall Study||88
8257537|NCT01815671|20361789|P2|STARTED|Overall Study||85
8257538|NCT01815671|20361790|P1|STARTED|Overall Study||88
8257539|NCT01815645|20361802|P2|NOT COMPLETED|Overall Study||0
8257540|NCT01815645|20361803|P1|NOT COMPLETED|Overall Study||0
8257541|NCT01815645|20361802|P2|COMPLETED|Overall Study||33
8257542|NCT01815645|20361803|P1|COMPLETED|Overall Study||32
8257543|NCT01815645|20361802|P2|STARTED|Overall Study||33
8257544|NCT01815645|20361803|P1|STARTED|Overall Study||32
8257545|NCT01815515|20361819|P1|NOT COMPLETED|Overall Study||0
8257546|NCT01815515|20361819|P1|COMPLETED|Overall Study||17
8257547|NCT01815515|20361819|P1|STARTED|Overall Study||17
8257548|NCT01815502|20361826|P2|NOT COMPLETED|Overall Study||0
8257549|NCT01815502|20361827|P1|NOT COMPLETED|Overall Study||0
8257550|NCT01815502|20361826|P2|COMPLETED|Overall Study||10
8257551|NCT01815502|20361827|P1|COMPLETED|Overall Study||10
8257552|NCT01815502|20361826|P2|STARTED|Overall Study||10
8257553|NCT01815502|20361827|P1|STARTED|Overall Study||10
8257554|NCT01815424|20361842|P5|NOT COMPLETED|Week 16 to 52||3
8257555|NCT01815424|20361843|P4|NOT COMPLETED|Week 16 to 52||3
8257556|NCT01815424|20361844|P3|NOT COMPLETED|Week 16 to 52||0
8257557|NCT01815424|20361845|P2|NOT COMPLETED|Week 16 to 52||5
8257558|NCT01815424|20361846|P1|NOT COMPLETED|Week 16 to 52||2
8257559|NCT01815424|20361842|P5|COMPLETED|Week 16 to 52||36
8257560|NCT01815424|20361843|P4|COMPLETED|Week 16 to 52||35
8257561|NCT01815424|20361844|P3|COMPLETED|Week 16 to 52||0
8257562|NCT01815424|20361845|P2|COMPLETED|Week 16 to 52||79
8257563|NCT01815424|20361846|P1|COMPLETED|Week 16 to 52||81
8257564|NCT01815424|20361842|P5|STARTED|Week 16 to 52||39
8257565|NCT01815424|20361843|P4|STARTED|Week 16 to 52||38
8257566|NCT01815424|20361844|P3|STARTED|Week 16 to 52||0
8257567|NCT01815424|20361845|P2|STARTED|Week 16 to 52||84
8257568|NCT01815424|20361846|P1|STARTED|Week 16 to 52||83
8257569|NCT01815424|20361842|P5|NOT COMPLETED|Week 0 to 16||0
8257570|NCT01815424|20361843|P4|NOT COMPLETED|Week 0 to 16||0
8257571|NCT01815424|20361844|P3|NOT COMPLETED|Week 0 to 16||11
8257572|NCT01815424|20361845|P2|NOT COMPLETED|Week 0 to 16||4
8257573|NCT01815424|20361846|P1|NOT COMPLETED|Week 0 to 16||7
8257574|NCT01815424|20361842|P5|COMPLETED|Week 0 to 16||0
8257575|NCT01815424|20361843|P4|COMPLETED|Week 0 to 16||0
8257576|NCT01815424|20361844|P3|COMPLETED|Week 0 to 16||77
8257577|NCT01815424|20361845|P2|COMPLETED|Week 0 to 16||84
8257578|NCT01815424|20361846|P1|COMPLETED|Week 0 to 16||83
8257579|NCT01815424|20361842|P5|STARTED|Week 0 to 16||0
8257580|NCT01815424|20361843|P4|STARTED|Week 0 to 16||0
8257581|NCT01815424|20361844|P3|STARTED|Week 0 to 16||88
8257582|NCT01815424|20361845|P2|STARTED|Week 0 to 16||88
8257583|NCT01815424|20361846|P1|STARTED|Week 0 to 16||90
8257584|NCT01815333|20362042|P1|NOT COMPLETED|Overall Study||0
8257585|NCT01815333|20362042|P1|COMPLETED|Overall Study||10
8257586|NCT01815333|20362042|P1|STARTED|Overall Study||10
8257587|NCT01815229|20362049|P3|NOT COMPLETED|Overall Study||51
8257588|NCT01815229|20362050|P2|NOT COMPLETED|Overall Study||0
8257589|NCT01815229|20362051|P1|NOT COMPLETED|Overall Study||0
8257590|NCT01815229|20362049|P3|COMPLETED|Overall Study||0
8257591|NCT01815229|20362050|P2|COMPLETED|Overall Study||18
8257592|NCT01815229|20362051|P1|COMPLETED|Overall Study||13
8257593|NCT01815229|20362049|P3|STARTED|Overall Study||51
8257594|NCT01815229|20362050|P2|STARTED|Overall Study||18
8257595|NCT01815229|20362051|P1|STARTED|Overall Study||13
8257596|NCT01815138|20362062|P2|NOT COMPLETED|Overall Study||6
8257597|NCT01815138|20362063|P1|NOT COMPLETED|Overall Study||8
8257598|NCT01815138|20362062|P2|COMPLETED|Overall Study||31
8257599|NCT01815138|20362063|P1|COMPLETED|Overall Study||26
8257600|NCT01815138|20362062|P2|STARTED|Overall Study||37
8257601|NCT01815138|20362063|P1|STARTED|Overall Study||34
8257602|NCT01815099|20362075|P1|NOT COMPLETED|Overall Study||2
8257603|NCT01815099|20362075|P1|COMPLETED|Overall Study||2
8257604|NCT01815099|20362075|P1|Began rTMS Treatment|Overall Study||3
8257605|NCT01815099|20362075|P1|STARTED|Overall Study||4
8257606|NCT01815008|20362080|P1|NOT COMPLETED|Overall Study||4
8257607|NCT01815008|20362080|P1|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
8257608|NCT01815008|20362080|P1|STARTED|Overall Study|Had difficulty in completing enrollment|19
8257609|NCT01814878|20362089|P2|NOT COMPLETED|Overall Study||30
8257610|NCT01814878|20362090|P1|NOT COMPLETED|Overall Study||46
8257611|NCT01814878|20362089|P2|COMPLETED|Overall Study||128
8257612|NCT01814878|20362090|P1|COMPLETED|Overall Study||116
8257613|NCT01814878|20362089|P2|STARTED|Overall Study||158
8257614|NCT01814878|20362090|P1|STARTED|Overall Study||162
8257615|NCT01814826|20362113|P3|NOT COMPLETED|Overall Study||3
8257616|NCT01814826|20362114|P2|NOT COMPLETED|Overall Study||29
8257617|NCT01814826|20362115|P1|NOT COMPLETED|Overall Study||32
8257618|NCT01814826|20362113|P3|COMPLETED|Overall Study||0
8257619|NCT01814826|20362114|P2|COMPLETED|Overall Study||0
8257620|NCT01814826|20362115|P1|COMPLETED|Overall Study||0
8257621|NCT01814826|20362113|P3|STARTED|Overall Study|3 participants were enrolled into the dose escalation phase.|3
8257622|NCT01814826|20362114|P2|STARTED|Overall Study|29 participants were enrolled into the MTD expansion phase.|29
8257623|NCT01814826|20362115|P1|STARTED|Overall Study|6 participants were enrolled into the dose escalation phase and 26 in the MTD expansion phase.|32
8257633|NCT01814800|20362207|P1|NOT COMPLETED|Overall Study||5
8257634|NCT01814800|20362207|P1|COMPLETED|Overall Study||54
8257635|NCT01814800|20362207|P1|STARTED|Overall Study||59
8257636|NCT01814787|20362246|P2|NOT COMPLETED|Overall Study||0
8257637|NCT01814787|20362247|P1|NOT COMPLETED|Overall Study||0
8257638|NCT01814787|20362246|P2|COMPLETED|Overall Study||684
8257639|NCT01814787|20362247|P1|COMPLETED|Overall Study||685
8257640|NCT01814787|20362246|P2|STARTED|Overall Study||684
8257641|NCT01814787|20362247|P1|STARTED|Overall Study||685
8257642|NCT01814774|20362253|P1|NOT COMPLETED|Overall Study||0
8257643|NCT01814774|20362253|P1|COMPLETED|Overall Study||48
8257644|NCT01814774|20362253|P1|STARTED|Overall Study||48
8257645|NCT01814761|20362267|P2|NOT COMPLETED|Overall Study||30
8257646|NCT01814761|20362268|P1|NOT COMPLETED|Overall Study||8
8257647|NCT01814761|20362267|P2|COMPLETED|Overall Study||240
8257648|NCT01814761|20362268|P1|COMPLETED|Overall Study||34
8257649|NCT01814761|20362267|P2|STARTED|Overall Study||270
8257650|NCT01814761|20362268|P1|STARTED|Overall Study||42
8257651|NCT01814748|20362282|P2|NOT COMPLETED|Overall Study||7
8257652|NCT01814748|20362283|P1|NOT COMPLETED|Overall Study||8
8257653|NCT01814748|20362282|P2|COMPLETED|Overall Study||94
8257654|NCT01814748|20362283|P1|COMPLETED|Overall Study||94
8257655|NCT01814748|20362282|P2|STARTED|Overall Study||101
8257656|NCT01814748|20362283|P1|STARTED|Overall Study||102
8257657|NCT01814722|20362306|P3|NOT COMPLETED|Overall Study||0
8257658|NCT01814722|20362307|P2|NOT COMPLETED|Overall Study||0
8257659|NCT01814722|20362308|P1|NOT COMPLETED|Overall Study||0
8257660|NCT01814722|20362306|P3|COMPLETED|Overall Study||6
8257661|NCT01814722|20362307|P2|COMPLETED|Overall Study||21
8257662|NCT01814722|20362308|P1|COMPLETED|Overall Study||36
8257663|NCT01814722|20362306|P3|STARTED|Overall Study||6
8257664|NCT01814722|20362307|P2|STARTED|Overall Study||21
8257665|NCT01814722|20362308|P1|STARTED|Overall Study||36
8257666|NCT01814696|20362327|P2|NOT COMPLETED|Overall Study||0
8257667|NCT01814696|20362328|P1|NOT COMPLETED|Overall Study||2
8257668|NCT01814696|20362327|P2|COMPLETED|Overall Study||11
8257669|NCT01814696|20362328|P1|COMPLETED|Overall Study||13
8257670|NCT01814696|20362327|P2|STARTED|Overall Study||11
8257671|NCT01814696|20362328|P1|STARTED|Overall Study||15
8257672|NCT01814670|20362346|P1|NOT COMPLETED|Overall Study||12
8257673|NCT01814670|20362346|P1|COMPLETED|Overall Study||173
8257674|NCT01814670|20362346|P1|STARTED|Overall Study||185
8257675|NCT01814553|20362356|P2|NOT COMPLETED|Overall Study||22
8257676|NCT01814553|20362357|P1|NOT COMPLETED|Overall Study||18
8257677|NCT01814553|20362356|P2|COMPLETED|Overall Study||0
8257678|NCT01814553|20362357|P1|COMPLETED|Overall Study||0
8257679|NCT01814553|20362356|P2|STARTED|Overall Study||22
8257680|NCT01814553|20362357|P1|STARTED|Overall Study||18
8257681|NCT01814397|20362371|P1|NOT COMPLETED|Overall Study||14
8257682|NCT01814397|20362371|P1|COMPLETED|Overall Study||36
8257683|NCT01814397|20362371|P1|3 Month Evaluation|Overall Study||43
8257684|NCT01814397|20362371|P1|STARTED|Overall Study||50
8257685|NCT01814371|20362380|P2|NOT COMPLETED|Overall Study||27
8257686|NCT01814371|20362381|P1|NOT COMPLETED|Overall Study||30
8257687|NCT01814371|20362380|P2|COMPLETED|Overall Study||199
8257688|NCT01814371|20362381|P1|COMPLETED|Overall Study||218
8257689|NCT01814371|20362380|P2|STARTED|Overall Study||226
8257690|NCT01814371|20362381|P1|STARTED|Overall Study||248
8257697|NCT01814241|20362429|P1|NOT COMPLETED|Overall Study||4
8257698|NCT01814241|20362429|P1|COMPLETED|Overall Study||16
8257699|NCT01814241|20362429|P1|STARTED|Overall Study||20
8257700|NCT01814137|20362439|P2|NOT COMPLETED|Overall Study||5
8257701|NCT01814137|20362440|P1|NOT COMPLETED|Overall Study||5
8257702|NCT01814137|20362439|P2|COMPLETED|Overall Study||15
8257703|NCT01814137|20362440|P1|COMPLETED|Overall Study||15
8257704|NCT01814137|20362439|P2|STARTED|Overall Study||20
8257705|NCT01814137|20362440|P1|STARTED|Overall Study||20
8257706|NCT01814072|20362486|P32|NOT COMPLETED|Overall Study||0
8257707|NCT01814072|20362487|P31|NOT COMPLETED|Overall Study||2
8257708|NCT01814072|20362488|P30|NOT COMPLETED|Overall Study||3
8257709|NCT01814072|20362489|P29|NOT COMPLETED|Overall Study||4
8257710|NCT01814072|20362490|P28|NOT COMPLETED|Overall Study||4
8257711|NCT01814072|20362491|P27|NOT COMPLETED|Overall Study||2
8257712|NCT01814072|20362492|P26|NOT COMPLETED|Overall Study||2
8257713|NCT01814072|20362493|P25|NOT COMPLETED|Overall Study||6
8257714|NCT01814072|20362494|P24|NOT COMPLETED|Overall Study||1
8257715|NCT01814072|20362495|P23|NOT COMPLETED|Overall Study||4
8257716|NCT01814072|20362496|P22|NOT COMPLETED|Overall Study||1
8257717|NCT01814072|20362497|P21|NOT COMPLETED|Overall Study||2
8257718|NCT01814072|20362498|P20|NOT COMPLETED|Overall Study||5
8257719|NCT01814072|20362499|P19|NOT COMPLETED|Overall Study||3
8257720|NCT01814072|20362500|P18|NOT COMPLETED|Overall Study||1
8257721|NCT01814072|20362501|P17|NOT COMPLETED|Overall Study||3
8257722|NCT01814072|20362502|P16|NOT COMPLETED|Overall Study||2
8257723|NCT01814072|20362503|P15|NOT COMPLETED|Overall Study||3
8257724|NCT01814072|20362504|P14|NOT COMPLETED|Overall Study||2
8257725|NCT01814072|20362505|P13|NOT COMPLETED|Overall Study||3
8257726|NCT01814072|20362506|P12|NOT COMPLETED|Overall Study||2
8257727|NCT01814072|20362507|P11|NOT COMPLETED|Overall Study||1
8257728|NCT01814072|20362508|P10|NOT COMPLETED|Overall Study||5
8257729|NCT01814072|20362509|P9|NOT COMPLETED|Overall Study||3
8257730|NCT01814072|20362510|P8|NOT COMPLETED|Overall Study||1
8257731|NCT01814072|20362511|P7|NOT COMPLETED|Overall Study||4
8257732|NCT01814072|20362512|P6|NOT COMPLETED|Overall Study||6
8257733|NCT01814072|20362513|P5|NOT COMPLETED|Overall Study||4
8257734|NCT01814072|20362514|P4|NOT COMPLETED|Overall Study||0
8257735|NCT01814072|20362515|P3|NOT COMPLETED|Overall Study||3
8257736|NCT01814072|20362516|P2|NOT COMPLETED|Overall Study||2
8257737|NCT01814072|20362517|P1|NOT COMPLETED|Overall Study||4
8257738|NCT01814072|20362486|P32|COMPLETED|Overall Study||17
8257739|NCT01814072|20362487|P31|COMPLETED|Overall Study||15
8257740|NCT01814072|20362488|P30|COMPLETED|Overall Study||14
8257741|NCT01814072|20362489|P29|COMPLETED|Overall Study||14
8257742|NCT01814072|20362490|P28|COMPLETED|Overall Study||13
8257743|NCT01814072|20362491|P27|COMPLETED|Overall Study||16
8257744|NCT01814072|20362492|P26|COMPLETED|Overall Study||14
8257745|NCT01814072|20362493|P25|COMPLETED|Overall Study||11
8257746|NCT01814072|20362494|P24|COMPLETED|Overall Study||17
8257747|NCT01814072|20362495|P23|COMPLETED|Overall Study||13
8257748|NCT01814072|20362496|P22|COMPLETED|Overall Study||16
8257749|NCT01814072|20362497|P21|COMPLETED|Overall Study||14
8257750|NCT01814072|20362498|P20|COMPLETED|Overall Study||11
8257751|NCT01814072|20362499|P19|COMPLETED|Overall Study||14
8257752|NCT01814072|20362500|P18|COMPLETED|Overall Study||17
8257753|NCT01814072|20362501|P17|COMPLETED|Overall Study||14
8257754|NCT01814072|20362502|P16|COMPLETED|Overall Study||16
8257755|NCT01814072|20362503|P15|COMPLETED|Overall Study||15
8257756|NCT01814072|20362504|P14|COMPLETED|Overall Study||16
8257757|NCT01814072|20362505|P13|COMPLETED|Overall Study||15
8257758|NCT01814072|20362506|P12|COMPLETED|Overall Study||16
8257759|NCT01814072|20362507|P11|COMPLETED|Overall Study||17
8257760|NCT01814072|20362508|P10|COMPLETED|Overall Study||13
8257761|NCT01814072|20362509|P9|COMPLETED|Overall Study||16
8257762|NCT01814072|20362510|P8|COMPLETED|Overall Study||17
8257763|NCT01814072|20362511|P7|COMPLETED|Overall Study||14
8257764|NCT01814072|20362512|P6|COMPLETED|Overall Study||12
8257765|NCT01814072|20362513|P5|COMPLETED|Overall Study||14
8257766|NCT01814072|20362514|P4|COMPLETED|Overall Study||18
8257767|NCT01814072|20362515|P3|COMPLETED|Overall Study||15
8257768|NCT01814072|20362516|P2|COMPLETED|Overall Study||16
8257769|NCT01814072|20362517|P1|COMPLETED|Overall Study||14
8257770|NCT01814072|20362486|P32|Intent to Treat|Overall Study||0
8257771|NCT01814072|20362487|P31|Intent to Treat|Overall Study||2
8257772|NCT01814072|20362488|P30|Intent to Treat|Overall Study||3
8257773|NCT01814072|20362489|P29|Intent to Treat|Overall Study||4
8257774|NCT01814072|20362490|P28|Intent to Treat|Overall Study||4
8257775|NCT01814072|20362491|P27|Intent to Treat|Overall Study||2
8257776|NCT01814072|20362492|P26|Intent to Treat|Overall Study||2
8257777|NCT01814072|20362493|P25|Intent to Treat|Overall Study||6
8257778|NCT01814072|20362494|P24|Intent to Treat|Overall Study||1
8257779|NCT01814072|20362495|P23|Intent to Treat|Overall Study||4
8257780|NCT01814072|20362496|P22|Intent to Treat|Overall Study||1
8257781|NCT01814072|20362497|P21|Intent to Treat|Overall Study||2
8257782|NCT01814072|20362498|P20|Intent to Treat|Overall Study||5
8257783|NCT01814072|20362499|P19|Intent to Treat|Overall Study||3
8257784|NCT01814072|20362500|P18|Intent to Treat|Overall Study||1
8257785|NCT01814072|20362501|P17|Intent to Treat|Overall Study||3
8257786|NCT01814072|20362502|P16|Intent to Treat|Overall Study||2
8257787|NCT01814072|20362503|P15|Intent to Treat|Overall Study||3
8257788|NCT01814072|20362504|P14|Intent to Treat|Overall Study||2
8257789|NCT01814072|20362505|P13|Intent to Treat|Overall Study||3
8257790|NCT01814072|20362506|P12|Intent to Treat|Overall Study||2
8257791|NCT01814072|20362507|P11|Intent to Treat|Overall Study||1
8257792|NCT01814072|20362508|P10|Intent to Treat|Overall Study||5
8257793|NCT01814072|20362509|P9|Intent to Treat|Overall Study||3
8257794|NCT01814072|20362510|P8|Intent to Treat|Overall Study||1
8257795|NCT01814072|20362511|P7|Intent to Treat|Overall Study||4
8257796|NCT01814072|20362512|P6|Intent to Treat|Overall Study||6
8257797|NCT01814072|20362513|P5|Intent to Treat|Overall Study||4
8257798|NCT01814072|20362514|P4|Intent to Treat|Overall Study||0
8257799|NCT01814072|20362515|P3|Intent to Treat|Overall Study||3
8257800|NCT01814072|20362516|P2|Intent to Treat|Overall Study||2
8257801|NCT01814072|20362517|P1|Intent to Treat|Overall Study||4
8257802|NCT01814072|20362486|P32|3-mo Visit|Overall Study||17
8257803|NCT01814072|20362487|P31|3-mo Visit|Overall Study||16
8257804|NCT01814072|20362488|P30|3-mo Visit|Overall Study||16
8257805|NCT01814072|20362489|P29|3-mo Visit|Overall Study||15
8257806|NCT01814072|20362490|P28|3-mo Visit|Overall Study||14
8257807|NCT01814072|20362491|P27|3-mo Visit|Overall Study||17
8257808|NCT01814072|20362492|P26|3-mo Visit|Overall Study||14
8257809|NCT01814072|20362493|P25|3-mo Visit|Overall Study||13
8257810|NCT01814072|20362494|P24|3-mo Visit|Overall Study||18
8257811|NCT01814072|20362495|P23|3-mo Visit|Overall Study||15
8257812|NCT01814072|20362496|P22|3-mo Visit|Overall Study||17
8257813|NCT01814072|20362497|P21|3-mo Visit|Overall Study||15
8257814|NCT01814072|20362498|P20|3-mo Visit|Overall Study||13
8257815|NCT01814072|20362499|P19|3-mo Visit|Overall Study||14
8257816|NCT01814072|20362500|P18|3-mo Visit|Overall Study||16
8257817|NCT01814072|20362501|P17|3-mo Visit|Overall Study||16
8257818|NCT01814072|20362502|P16|3-mo Visit|Overall Study||16
8257819|NCT01814072|20362503|P15|3-mo Visit|Overall Study||16
8257820|NCT01814072|20362504|P14|3-mo Visit|Overall Study||16
8257821|NCT01814072|20362505|P13|3-mo Visit|Overall Study||16
8257822|NCT01814072|20362506|P12|3-mo Visit|Overall Study||17
8257823|NCT01814072|20362507|P11|3-mo Visit|Overall Study||18
8257824|NCT01814072|20362508|P10|3-mo Visit|Overall Study||15
8257825|NCT01814072|20362509|P9|3-mo Visit|Overall Study||18
8257826|NCT01814072|20362510|P8|3-mo Visit|Overall Study||18
8257827|NCT01814072|20362511|P7|3-mo Visit|Overall Study||16
8257828|NCT01814072|20362512|P6|3-mo Visit|Overall Study||15
8257829|NCT01814072|20362513|P5|3-mo Visit|Overall Study||15
8257830|NCT01814072|20362514|P4|3-mo Visit|Overall Study||18
8257831|NCT01814072|20362515|P3|3-mo Visit|Overall Study||16
8257832|NCT01814072|20362516|P2|3-mo Visit|Overall Study||18
8257833|NCT01814072|20362517|P1|3-mo Visit|Overall Study||15
8257834|NCT01814072|20362486|P32|STARTED|Overall Study||17
8257835|NCT01814072|20362487|P31|STARTED|Overall Study||17
8257836|NCT01814072|20362488|P30|STARTED|Overall Study||17
8257837|NCT01814072|20362489|P29|STARTED|Overall Study||18
8257838|NCT01814072|20362490|P28|STARTED|Overall Study||17
8257839|NCT01814072|20362491|P27|STARTED|Overall Study||18
8257840|NCT01814072|20362492|P26|STARTED|Overall Study||16
8257841|NCT01814072|20362493|P25|STARTED|Overall Study||17
8257842|NCT01814072|20362494|P24|STARTED|Overall Study||18
8257843|NCT01814072|20362495|P23|STARTED|Overall Study||17
8257844|NCT01814072|20362496|P22|STARTED|Overall Study||17
8257845|NCT01814072|20362497|P21|STARTED|Overall Study||16
8257846|NCT01814072|20362498|P20|STARTED|Overall Study||16
8257847|NCT01814072|20362499|P19|STARTED|Overall Study||17
8257848|NCT01814072|20362500|P18|STARTED|Overall Study||18
8257849|NCT01814072|20362501|P17|STARTED|Overall Study||17
8257850|NCT01814072|20362502|P16|STARTED|Overall Study||18
8257851|NCT01814072|20362503|P15|STARTED|Overall Study||18
8257852|NCT01814072|20362504|P14|STARTED|Overall Study||18
8257853|NCT01814072|20362505|P13|STARTED|Overall Study||18
8257854|NCT01814072|20362506|P12|STARTED|Overall Study||18
8257855|NCT01814072|20362507|P11|STARTED|Overall Study||18
8257856|NCT01814072|20362508|P10|STARTED|Overall Study||18
8257857|NCT01814072|20362509|P9|STARTED|Overall Study||19
8257858|NCT01814072|20362510|P8|STARTED|Overall Study||18
8257859|NCT01814072|20362511|P7|STARTED|Overall Study||18
8257860|NCT01814072|20362512|P6|STARTED|Overall Study||18
8257861|NCT01814072|20362513|P5|STARTED|Overall Study||18
8257862|NCT01814072|20362514|P4|STARTED|Overall Study||18
8257863|NCT01814072|20362515|P3|STARTED|Overall Study||18
8257864|NCT01814072|20362516|P2|STARTED|Overall Study||18
8257865|NCT01814072|20362517|P1|STARTED|Overall Study||18
8257866|NCT01814046|20362559|P3|NOT COMPLETED|Retreatment||0
8257867|NCT01814046|20362560|P2|NOT COMPLETED|Retreatment||0
8257868|NCT01814046|20362561|P1|NOT COMPLETED|Retreatment||0
8257869|NCT01814046|20362559|P3|COMPLETED|Retreatment||3
8257870|NCT01814046|20362560|P2|COMPLETED|Retreatment||0
8257871|NCT01814046|20362561|P1|COMPLETED|Retreatment||0
8257872|NCT01814046|20362559|P3|STARTED|Retreatment||3
8257873|NCT01814046|20362560|P2|STARTED|Retreatment||0
8257874|NCT01814046|20362561|P1|STARTED|Retreatment||0
8257875|NCT01814046|20362559|P3|NOT COMPLETED|Drug Administration||0
8257876|NCT01814046|20362560|P2|NOT COMPLETED|Drug Administration||0
8257877|NCT01814046|20362561|P1|NOT COMPLETED|Drug Administration||1
8257878|NCT01814046|20362559|P3|COMPLETED|Drug Administration||0
8257879|NCT01814046|20362560|P2|COMPLETED|Drug Administration||2
8257880|NCT01814046|20362561|P1|COMPLETED|Drug Administration||21
8257881|NCT01814046|20362559|P3|STARTED|Drug Administration||0
8257882|NCT01814046|20362560|P2|STARTED|Drug Administration||2
8257883|NCT01814046|20362561|P1|STARTED|Drug Administration||22
8257887|NCT01813890|20362585|P3|NOT COMPLETED|Overall Study||6
8257888|NCT01813890|20362586|P2|NOT COMPLETED|Overall Study||4
8257889|NCT01813890|20362587|P1|NOT COMPLETED|Overall Study||9
8257890|NCT01813890|20362585|P3|COMPLETED|Overall Study||13
8257891|NCT01813890|20362586|P2|COMPLETED|Overall Study||17
8257892|NCT01813890|20362587|P1|COMPLETED|Overall Study||11
8257893|NCT01813890|20362585|P3|STARTED|Overall Study||19
8257894|NCT01813890|20362586|P2|STARTED|Overall Study||21
8257895|NCT01813890|20362587|P1|STARTED|Overall Study||20
8257896|NCT01813734|20362616|P1|NOT COMPLETED|Overall Study||0
8257897|NCT01813734|20362616|P1|COMPLETED|Overall Study||9
8257898|NCT01813734|20362616|P1|STARTED|Overall Study||9
8257899|NCT01813721|20362624|P1|NOT COMPLETED|Overall Study||64
8257900|NCT01813721|20362624|P1|COMPLETED|Overall Study||943
8257901|NCT01813721|20362624|P1|STARTED|Overall Study|Indicates number of participants enrolled|1007
8257902|NCT01813474|20362679|P3|NOT COMPLETED|Overall Study||11
8257903|NCT01813474|20362680|P2|NOT COMPLETED|Overall Study||7
8257904|NCT01813474|20362681|P1|NOT COMPLETED|Overall Study||3
8257905|NCT01813474|20362679|P3|COMPLETED|Overall Study|ongoing study at final data cut off|1
8257906|NCT01813474|20362680|P2|COMPLETED|Overall Study||0
8257907|NCT01813474|20362681|P1|COMPLETED|Overall Study|ongoing study at final data cut off|1
8257908|NCT01813474|20362679|P3|STARTED|Overall Study||12
8257909|NCT01813474|20362680|P2|STARTED|Overall Study||7
8257910|NCT01813474|20362681|P1|STARTED|Overall Study||4
8257911|NCT01813435|20362705|P2|NOT COMPLETED|Overall Study||1007
8257912|NCT01813435|20362706|P1|NOT COMPLETED|Overall Study||2170
8257913|NCT01813435|20362705|P2|COMPLETED|Overall Study||6981
8257914|NCT01813435|20362706|P1|COMPLETED|Overall Study||5810
8257915|NCT01813435|20362705|P2|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988
8257916|NCT01813435|20362706|P1|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980
8257917|NCT01813422|20362730|P2|NOT COMPLETED|Overall Study||16
8257918|NCT01813422|20362731|P1|NOT COMPLETED|Overall Study||20
8257919|NCT01813422|20362730|P2|COMPLETED|Overall Study||468
8257920|NCT01813422|20362731|P1|COMPLETED|Overall Study||466
8257921|NCT01813422|20362730|P2|Received Treatment|Overall Study||484
8257922|NCT01813422|20362731|P1|Received Treatment|Overall Study||484
8257923|NCT01813422|20362730|P2|STARTED|Overall Study||484
8257924|NCT01813422|20362731|P1|STARTED|Overall Study||486
8257925|NCT01813357|20362745|P2|NOT COMPLETED|Overall Study||6
8257926|NCT01813357|20362746|P1|NOT COMPLETED|Overall Study||5
8257927|NCT01813357|20362745|P2|COMPLETED|Overall Study||38
8257928|NCT01813357|20362746|P1|COMPLETED|Overall Study||35
8257929|NCT01813357|20362745|P2|STARTED|Overall Study||44
8257930|NCT01813357|20362746|P1|STARTED|Overall Study||40
8257931|NCT01813214|20362756|P2|NOT COMPLETED|Overall Study||0
8257932|NCT01813214|20362757|P1|NOT COMPLETED|Overall Study||0
8257933|NCT01813214|20362756|P2|COMPLETED|Overall Study||2
8257934|NCT01813214|20362757|P1|COMPLETED|Overall Study||3
8257935|NCT01813214|20362756|P2|STARTED|Overall Study||2
8257936|NCT01813214|20362757|P1|STARTED|Overall Study||3
8257937|NCT01813149|20362770|P2|NOT COMPLETED|Overall Study||0
8257938|NCT01813149|20362771|P1|NOT COMPLETED|Overall Study||0
8257939|NCT01813149|20362770|P2|COMPLETED|Overall Study||38
8257940|NCT01813149|20362771|P1|COMPLETED|Overall Study||90
8257941|NCT01813149|20362770|P2|STARTED|Overall Study||38
8257942|NCT01813149|20362771|P1|STARTED|Overall Study||90
8257943|NCT01813110|20362782|P2|NOT COMPLETED|Overall Study||1
8257944|NCT01813110|20362783|P1|NOT COMPLETED|Overall Study||0
8257945|NCT01813110|20362782|P2|COMPLETED|Overall Study||10
8257946|NCT01813110|20362783|P1|COMPLETED|Overall Study||10
8257947|NCT01813110|20362782|P2|STARTED|Overall Study||11
8257948|NCT01813110|20362783|P1|STARTED|Overall Study||10
8257949|NCT01813071|20362802|P9|NOT COMPLETED|Overall Study||3
8257950|NCT01813071|20362803|P8|NOT COMPLETED|Overall Study||5
8257951|NCT01813071|20362804|P7|NOT COMPLETED|Overall Study||3
8257952|NCT01813071|20362805|P6|NOT COMPLETED|Overall Study||7
8257953|NCT01813071|20362806|P5|NOT COMPLETED|Overall Study||1
8257954|NCT01813071|20362807|P4|NOT COMPLETED|Overall Study||0
8257955|NCT01813071|20362808|P3|NOT COMPLETED|Overall Study||0
8257956|NCT01813071|20362809|P2|NOT COMPLETED|Overall Study||0
8257957|NCT01813071|20362810|P1|NOT COMPLETED|Overall Study||0
8257958|NCT01813071|20362802|P9|COMPLETED|Overall Study||13
8257959|NCT01813071|20362803|P8|COMPLETED|Overall Study||7
8257960|NCT01813071|20362804|P7|COMPLETED|Overall Study||9
8257961|NCT01813071|20362805|P6|COMPLETED|Overall Study||5
8257962|NCT01813071|20362806|P5|COMPLETED|Overall Study||11
8257963|NCT01813071|20362807|P4|COMPLETED|Overall Study||9
8257964|NCT01813071|20362808|P3|COMPLETED|Overall Study||10
8257965|NCT01813071|20362809|P2|COMPLETED|Overall Study||10
8257966|NCT01813071|20362810|P1|COMPLETED|Overall Study||10
8257967|NCT01813071|20362802|P9|STARTED|Overall Study||16
8257968|NCT01813071|20362803|P8|STARTED|Overall Study||12
8257969|NCT01813071|20362804|P7|STARTED|Overall Study||12
8257970|NCT01813071|20362805|P6|STARTED|Overall Study||12
8257971|NCT01813071|20362806|P5|STARTED|Overall Study||12
8257972|NCT01813071|20362807|P4|STARTED|Overall Study||9
8257973|NCT01813071|20362808|P3|STARTED|Overall Study||10
8257974|NCT01813071|20362809|P2|STARTED|Overall Study||10
8257975|NCT01813071|20362810|P1|STARTED|Overall Study||10
8257976|NCT01813058|20363277|P2|NOT COMPLETED|Overall Study||4
8257977|NCT01813058|20363278|P1|NOT COMPLETED|Overall Study||5
8257978|NCT01813058|20363277|P2|COMPLETED|Overall Study||56
8257979|NCT01813058|20363278|P1|COMPLETED|Overall Study||55
8257980|NCT01813058|20363277|P2|STARTED|Overall Study||60
8257981|NCT01813058|20363278|P1|STARTED|Overall Study||60
8257982|NCT01813019|20363286|P2|NOT COMPLETED|Overall Study||6
8257983|NCT01813019|20363287|P1|NOT COMPLETED|Overall Study||7
8257984|NCT01813019|20363286|P2|COMPLETED|Overall Study||20
8257985|NCT01813019|20363287|P1|COMPLETED|Overall Study||17
8257986|NCT01813019|20363286|P2|STARTED|Overall Study||26
8257987|NCT01813019|20363287|P1|STARTED|Overall Study||24
8257988|NCT01812837|20363298|P3|NOT COMPLETED|Overall Study||0
8257989|NCT01812837|20363299|P2|NOT COMPLETED|Overall Study||1
8257990|NCT01812837|20363300|P1|NOT COMPLETED|Overall Study||2
8257991|NCT01812837|20363298|P3|COMPLETED|Overall Study||17
8257992|NCT01812837|20363299|P2|COMPLETED|Overall Study||16
8257993|NCT01812837|20363300|P1|COMPLETED|Overall Study||15
8257994|NCT01812837|20363298|P3|STARTED|Overall Study||17
8257995|NCT01812837|20363299|P2|STARTED|Overall Study||17
8257996|NCT01812837|20363300|P1|STARTED|Overall Study||17
8258006|NCT01812707|20363325|P4|NOT COMPLETED|Overall Study||2
8258007|NCT01812707|20363326|P3|NOT COMPLETED|Overall Study||0
8258008|NCT01812707|20363327|P2|NOT COMPLETED|Overall Study||0
8258009|NCT01812707|20363328|P1|NOT COMPLETED|Overall Study||2
8258010|NCT01812707|20363325|P4|COMPLETED|Overall Study||23
8258011|NCT01812707|20363326|P3|COMPLETED|Overall Study||25
8258012|NCT01812707|20363327|P2|COMPLETED|Overall Study||25
8258013|NCT01812707|20363328|P1|COMPLETED|Overall Study||23
8258014|NCT01812707|20363325|P4|Treated|Overall Study||25
8258015|NCT01812707|20363326|P3|Treated|Overall Study||25
8258016|NCT01812707|20363327|P2|Treated|Overall Study||25
8258017|NCT01812707|20363328|P1|Treated|Overall Study||25
8258018|NCT01812707|20363325|P4|STARTED|Overall Study||25
8258019|NCT01812707|20363326|P3|STARTED|Overall Study||25
8258020|NCT01812707|20363327|P2|STARTED|Overall Study||25
8258021|NCT01812707|20363328|P1|STARTED|Overall Study||25
8258022|NCT01812681|20363364|P2|NOT COMPLETED|Overall Study||0
8258023|NCT01812681|20363365|P1|NOT COMPLETED|Overall Study||3
8258024|NCT01812681|20363364|P2|COMPLETED|Overall Study||24
8258025|NCT01812681|20363365|P1|COMPLETED|Overall Study||57
8258026|NCT01812681|20363364|P2|STARTED|Overall Study||24
8258027|NCT01812681|20363365|P1|STARTED|Overall Study||60
8258028|NCT01812655|20363376|P3|NOT COMPLETED|Overall Study||0
8258029|NCT01812655|20363377|P2|NOT COMPLETED|Overall Study||1
8258030|NCT01812655|20363378|P1|NOT COMPLETED|Overall Study||1
8258031|NCT01812655|20363376|P3|COMPLETED|Overall Study||10
8258032|NCT01812655|20363377|P2|COMPLETED|Overall Study||10
8258033|NCT01812655|20363378|P1|COMPLETED|Overall Study||8
8258034|NCT01812655|20363376|P3|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
8258035|NCT01812655|20363377|P2|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
8258129|NCT01811654|20363611|P1|STARTED|Overall Study||14
8258036|NCT01812655|20363378|P1|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
8258037|NCT01812473|20363394|P2|NOT COMPLETED|Overall Study||0
8258038|NCT01812473|20363395|P1|NOT COMPLETED|Overall Study||0
8258039|NCT01812473|20363394|P2|COMPLETED|Overall Study||13
8258040|NCT01812473|20363395|P1|COMPLETED|Overall Study||22
8258041|NCT01812473|20363394|P2|STARTED|Overall Study||13
8258042|NCT01812473|20363395|P1|STARTED|Overall Study||22
8258043|NCT01812057|20363403|P2|NOT COMPLETED|Overall Study||0
8258044|NCT01812057|20363404|P1|NOT COMPLETED|Overall Study||2
8258045|NCT01812057|20363403|P2|COMPLETED|Overall Study||24
8258046|NCT01812057|20363404|P1|COMPLETED|Overall Study||23
8258047|NCT01812057|20363403|P2|STARTED|Overall Study||24
8258048|NCT01812057|20363404|P1|STARTED|Overall Study||25
8258049|NCT01812044|20363445|P3|NOT COMPLETED|Overall Study||0
8258050|NCT01812044|20363446|P2|NOT COMPLETED|Overall Study||0
8258051|NCT01812044|20363447|P1|NOT COMPLETED|Overall Study||0
8258052|NCT01812044|20363445|P3|COMPLETED|Overall Study||16
8258053|NCT01812044|20363446|P2|COMPLETED|Overall Study||17
8258054|NCT01812044|20363447|P1|COMPLETED|Overall Study||17
8258055|NCT01812044|20363445|P3|STARTED|Overall Study||16
8258056|NCT01812044|20363446|P2|STARTED|Overall Study||17
8258057|NCT01812044|20363447|P1|STARTED|Overall Study||17
8258058|NCT01812005|20363478|P2|NOT COMPLETED|Overall Study||0
8258059|NCT01812005|20363479|P1|NOT COMPLETED|Overall Study||0
8258060|NCT01812005|20363478|P2|COMPLETED|Overall Study||13
8258061|NCT01812005|20363479|P1|COMPLETED|Overall Study||1
8258062|NCT01812005|20363478|P2|STARTED|Overall Study||13
8258063|NCT01812005|20363479|P1|STARTED|Overall Study||1
8258064|NCT01811953|20363507|P6|NOT COMPLETED|Overall Study||1
8258065|NCT01811953|20363508|P5|NOT COMPLETED|Overall Study||1
8258066|NCT01811953|20363509|P4|NOT COMPLETED|Overall Study||1
8258067|NCT01811953|20363510|P3|NOT COMPLETED|Overall Study||0
8258068|NCT01811953|20363511|P2|NOT COMPLETED|Overall Study||0
8258069|NCT01811953|20363512|P1|NOT COMPLETED|Overall Study||0
8258070|NCT01811953|20363507|P6|COMPLETED|Overall Study||11
8258071|NCT01811953|20363508|P5|COMPLETED|Overall Study||11
8258072|NCT01811953|20363509|P4|COMPLETED|Overall Study||5
8258073|NCT01811953|20363510|P3|COMPLETED|Overall Study||6
8258074|NCT01811953|20363511|P2|COMPLETED|Overall Study||6
8258075|NCT01811953|20363512|P1|COMPLETED|Overall Study||6
8258076|NCT01811953|20363507|P6|STARTED|Overall Study||12
8258077|NCT01811953|20363508|P5|STARTED|Overall Study||12
8258078|NCT01811953|20363509|P4|STARTED|Overall Study||6
8258079|NCT01811953|20363510|P3|STARTED|Overall Study||6
8258080|NCT01811953|20363511|P2|STARTED|Overall Study||6
8258081|NCT01811953|20363512|P1|STARTED|Overall Study||6
8258082|NCT01811940|20363558|P2|NOT COMPLETED|Overall Study||26
8258083|NCT01811940|20363559|P1|NOT COMPLETED|Overall Study||22
8258084|NCT01811940|20363558|P2|COMPLETED|Overall Study||37
8258085|NCT01811940|20363559|P1|COMPLETED|Overall Study||42
8258086|NCT01811940|20363558|P2|STARTED|Overall Study||63
8258087|NCT01811940|20363559|P1|STARTED|Overall Study||64
8258088|NCT01811732|20363569|P2|NOT COMPLETED|Overall Study||58
8258089|NCT01811732|20363570|P1|NOT COMPLETED|Overall Study||55
8258090|NCT01811732|20363569|P2|COMPLETED|Overall Study||271
8258091|NCT01811732|20363570|P1|COMPLETED|Overall Study||276
8258092|NCT01811732|20363569|P2|STARTED|Overall Study||329
8258093|NCT01811732|20363570|P1|STARTED|Overall Study||331
8258094|NCT01811706|20363580|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
8258095|NCT01811706|20363581|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8258096|NCT01811706|20363580|P2|COMPLETED|Second Intervention (4 Weeks)||10
8258097|NCT01811706|20363581|P1|COMPLETED|Second Intervention (4 Weeks)||9
8258098|NCT01811706|20363580|P2|STARTED|Second Intervention (4 Weeks)||10
8258099|NCT01811706|20363581|P1|STARTED|Second Intervention (4 Weeks)||9
8258100|NCT01811706|20363580|P2|NOT COMPLETED|Washout ( 2 Weeks)||0
8258101|NCT01811706|20363581|P1|NOT COMPLETED|Washout ( 2 Weeks)||0
8258102|NCT01811706|20363580|P2|COMPLETED|Washout ( 2 Weeks)||10
8258103|NCT01811706|20363581|P1|COMPLETED|Washout ( 2 Weeks)||9
8258104|NCT01811706|20363580|P2|STARTED|Washout ( 2 Weeks)||10
8258105|NCT01811706|20363581|P1|STARTED|Washout ( 2 Weeks)||9
8258106|NCT01811706|20363580|P2|NOT COMPLETED|First Intervention ( 4 Weeks)||0
8258107|NCT01811706|20363581|P1|NOT COMPLETED|First Intervention ( 4 Weeks)||1
8258108|NCT01811706|20363580|P2|COMPLETED|First Intervention ( 4 Weeks)||10
8258109|NCT01811706|20363581|P1|COMPLETED|First Intervention ( 4 Weeks)||9
8258110|NCT01811706|20363580|P2|STARTED|First Intervention ( 4 Weeks)||10
8258111|NCT01811706|20363581|P1|STARTED|First Intervention ( 4 Weeks)||10
8258112|NCT01811693|20363594|P3|NOT COMPLETED|Overall Study||0
8258113|NCT01811693|20363595|P2|NOT COMPLETED|Overall Study||0
8258114|NCT01811693|20363596|P1|NOT COMPLETED|Overall Study||0
8258115|NCT01811693|20363594|P3|COMPLETED|Overall Study||0
8258116|NCT01811693|20363595|P2|COMPLETED|Overall Study||0
8258117|NCT01811693|20363596|P1|COMPLETED|Overall Study||4
8258118|NCT01811693|20363594|P3|STARTED|Overall Study||0
8258119|NCT01811693|20363595|P2|STARTED|Overall Study||0
8258120|NCT01811693|20363596|P1|STARTED|Overall Study||4
8258121|NCT01811680|20363603|P1|NOT COMPLETED|Overall Study||0
8258122|NCT01811680|20363603|P1|COMPLETED|Overall Study||10
8258123|NCT01811680|20363603|P1|STARTED|Overall Study||10
8258124|NCT01811654|20363610|P2|NOT COMPLETED|Overall Study||0
8258125|NCT01811654|20363611|P1|NOT COMPLETED|Overall Study||0
8258126|NCT01811654|20363610|P2|COMPLETED|Overall Study||16
8258127|NCT01811654|20363611|P1|COMPLETED|Overall Study||14
8258128|NCT01811654|20363610|P2|STARTED|Overall Study||16
8258130|NCT01811563|20363621|P2|NOT COMPLETED|Overall Study||3
8258131|NCT01811563|20363622|P1|NOT COMPLETED|Overall Study||5
8258132|NCT01811563|20363621|P2|COMPLETED|Overall Study||20
8258133|NCT01811563|20363622|P1|COMPLETED|Overall Study||20
8258134|NCT01811563|20363621|P2|STARTED|Overall Study||23
8258135|NCT01811563|20363622|P1|STARTED|Overall Study||25
8258136|NCT01811485|20363651|P3|NOT COMPLETED|Overall Study||5
8258137|NCT01811485|20363652|P2|NOT COMPLETED|Overall Study||4
8258138|NCT01811485|20363653|P1|NOT COMPLETED|Overall Study||2
8258139|NCT01811485|20363651|P3|COMPLETED|Overall Study||51
8258140|NCT01811485|20363652|P2|COMPLETED|Overall Study||55
8258141|NCT01811485|20363653|P1|COMPLETED|Overall Study||54
8258142|NCT01811485|20363651|P3|STARTED|Overall Study||56
8258143|NCT01811485|20363652|P2|STARTED|Overall Study||59
8258144|NCT01811485|20363653|P1|STARTED|Overall Study|"Started indicates randomized patients"|56
8258145|NCT01811472|20363673|P3|NOT COMPLETED|Overall Study||5
8258146|NCT01811472|20363674|P2|NOT COMPLETED|Overall Study||0
8258147|NCT01811472|20363675|P1|NOT COMPLETED|Overall Study||2
8258148|NCT01811472|20363673|P3|COMPLETED|Overall Study||16
8258149|NCT01811472|20363674|P2|COMPLETED|Overall Study||11
8258150|NCT01811472|20363675|P1|COMPLETED|Overall Study||18
8258151|NCT01811472|20363673|P3|STARTED|Overall Study||21
8258152|NCT01811472|20363674|P2|STARTED|Overall Study||11
8258153|NCT01811472|20363675|P1|STARTED|Overall Study||20
8258154|NCT01811355|20363720|P2|NOT COMPLETED|Second Dose||0
8258155|NCT01811355|20363721|P1|NOT COMPLETED|Second Dose||0
8258156|NCT01811355|20363720|P2|COMPLETED|Second Dose||12
8258157|NCT01811355|20363721|P1|COMPLETED|Second Dose||9
8258158|NCT01811355|20363720|P2|STARTED|Second Dose||12
8258159|NCT01811355|20363721|P1|STARTED|Second Dose||9
8258160|NCT01811355|20363720|P2|NOT COMPLETED|Washout||0
8258161|NCT01811355|20363721|P1|NOT COMPLETED|Washout||0
8258162|NCT01811355|20363720|P2|COMPLETED|Washout||12
8258163|NCT01811355|20363721|P1|COMPLETED|Washout||9
8258164|NCT01811355|20363720|P2|STARTED|Washout||12
8258165|NCT01811355|20363721|P1|STARTED|Washout||9
8258166|NCT01811355|20363720|P2|NOT COMPLETED|First Dose||0
8258167|NCT01811355|20363721|P1|NOT COMPLETED|First Dose||2
8258168|NCT01811355|20363720|P2|COMPLETED|First Dose||12
8258169|NCT01811355|20363721|P1|COMPLETED|First Dose||9
8258170|NCT01811355|20363720|P2|STARTED|First Dose||12
8258171|NCT01811355|20363721|P1|STARTED|First Dose||11
8258172|NCT01811316|20363732|P3|NOT COMPLETED|Overall Study||0
8258173|NCT01811316|20363733|P2|NOT COMPLETED|Overall Study||0
8258174|NCT01811316|20363734|P1|NOT COMPLETED|Overall Study||3
8258175|NCT01811316|20363732|P3|COMPLETED|Overall Study||19
8258176|NCT01811316|20363733|P2|COMPLETED|Overall Study||22
8258177|NCT01811316|20363734|P1|COMPLETED|Overall Study||18
8258178|NCT01811316|20363732|P3|Visit 12 Weeks|Overall Study||19
8258179|NCT01811316|20363733|P2|Visit 12 Weeks|Overall Study||22
8258180|NCT01811316|20363734|P1|Visit 12 Weeks|Overall Study||18
8258181|NCT01811316|20363732|P3|Visit 4 Weeks|Overall Study||19
8258182|NCT01811316|20363733|P2|Visit 4 Weeks|Overall Study||22
8258183|NCT01811316|20363734|P1|Visit 4 Weeks|Overall Study||19
8258184|NCT01811316|20363732|P3|STARTED|Overall Study||19
8258185|NCT01811316|20363733|P2|STARTED|Overall Study||22
8258186|NCT01811316|20363734|P1|STARTED|Overall Study||21
8258187|NCT01811303|20363751|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
8258188|NCT01811303|20363752|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
8258189|NCT01811303|20363753|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
8258190|NCT01811303|20363754|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
8258191|NCT01811303|20363751|P4|COMPLETED|Fourth Intervention (1 Day)||2
8258192|NCT01811303|20363752|P3|COMPLETED|Fourth Intervention (1 Day)||4
8258193|NCT01811303|20363753|P2|COMPLETED|Fourth Intervention (1 Day)||4
8258194|NCT01811303|20363754|P1|COMPLETED|Fourth Intervention (1 Day)||4
8258195|NCT01811303|20363751|P4|STARTED|Fourth Intervention (1 Day)||2
8258196|NCT01811303|20363752|P3|STARTED|Fourth Intervention (1 Day)||4
8258197|NCT01811303|20363753|P2|STARTED|Fourth Intervention (1 Day)||4
8258198|NCT01811303|20363754|P1|STARTED|Fourth Intervention (1 Day)||4
8258199|NCT01811303|20363751|P4|NOT COMPLETED|Washout (2 Days or More)||0
8258200|NCT01811303|20363752|P3|NOT COMPLETED|Washout (2 Days or More)||0
8258201|NCT01811303|20363753|P2|NOT COMPLETED|Washout (2 Days or More)||0
8258202|NCT01811303|20363754|P1|NOT COMPLETED|Washout (2 Days or More)||0
8258203|NCT01811303|20363751|P4|COMPLETED|Washout (2 Days or More)||2
8258204|NCT01811303|20363752|P3|COMPLETED|Washout (2 Days or More)||4
8258205|NCT01811303|20363753|P2|COMPLETED|Washout (2 Days or More)||4
8258206|NCT01811303|20363754|P1|COMPLETED|Washout (2 Days or More)||4
8258207|NCT01811303|20363751|P4|STARTED|Washout (2 Days or More)||2
8258208|NCT01811303|20363752|P3|STARTED|Washout (2 Days or More)||4
8258209|NCT01811303|20363753|P2|STARTED|Washout (2 Days or More)||4
8258210|NCT01811303|20363754|P1|STARTED|Washout (2 Days or More)||4
8258211|NCT01811303|20363751|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8258212|NCT01811303|20363752|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8258213|NCT01811303|20363753|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8258214|NCT01811303|20363754|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8258215|NCT01811303|20363751|P4|COMPLETED|Third Intervention (1 Day)||2
8258216|NCT01811303|20363752|P3|COMPLETED|Third Intervention (1 Day)||4
8258217|NCT01811303|20363753|P2|COMPLETED|Third Intervention (1 Day)||4
8258218|NCT01811303|20363754|P1|COMPLETED|Third Intervention (1 Day)||4
8258219|NCT01811303|20363751|P4|STARTED|Third Intervention (1 Day)||2
8258220|NCT01811303|20363752|P3|STARTED|Third Intervention (1 Day)||4
8258221|NCT01811303|20363753|P2|STARTED|Third Intervention (1 Day)||4
8258222|NCT01811303|20363754|P1|STARTED|Third Intervention (1 Day)||4
8258223|NCT01811303|20363751|P4|NOT COMPLETED|Washout (2 Days or More)||0
8258224|NCT01811303|20363752|P3|NOT COMPLETED|Washout (2 Days or More)||0
8258225|NCT01811303|20363753|P2|NOT COMPLETED|Washout (2 Days or More)||0
8258226|NCT01811303|20363754|P1|NOT COMPLETED|Washout (2 Days or More)||0
8258227|NCT01811303|20363751|P4|COMPLETED|Washout (2 Days or More)||2
8258228|NCT01811303|20363752|P3|COMPLETED|Washout (2 Days or More)||4
8258229|NCT01811303|20363753|P2|COMPLETED|Washout (2 Days or More)||4
8258230|NCT01811303|20363754|P1|COMPLETED|Washout (2 Days or More)||4
8258231|NCT01811303|20363751|P4|STARTED|Washout (2 Days or More)||2
8258232|NCT01811303|20363752|P3|STARTED|Washout (2 Days or More)||4
8258233|NCT01811303|20363753|P2|STARTED|Washout (2 Days or More)||4
8258234|NCT01811303|20363754|P1|STARTED|Washout (2 Days or More)||4
8258235|NCT01811303|20363751|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8258236|NCT01811303|20363752|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8258237|NCT01811303|20363753|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8258238|NCT01811303|20363754|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8258239|NCT01811303|20363751|P4|COMPLETED|Second Intervention (1 Day)||2
8258240|NCT01811303|20363752|P3|COMPLETED|Second Intervention (1 Day)||4
8258241|NCT01811303|20363753|P2|COMPLETED|Second Intervention (1 Day)||4
8258242|NCT01811303|20363754|P1|COMPLETED|Second Intervention (1 Day)||4
8258243|NCT01811303|20363751|P4|STARTED|Second Intervention (1 Day)||2
8258244|NCT01811303|20363752|P3|STARTED|Second Intervention (1 Day)||4
8258245|NCT01811303|20363753|P2|STARTED|Second Intervention (1 Day)||4
8258246|NCT01811303|20363754|P1|STARTED|Second Intervention (1 Day)||4
8258247|NCT01811303|20363751|P4|NOT COMPLETED|Washout (2 Days or More)||0
8258248|NCT01811303|20363752|P3|NOT COMPLETED|Washout (2 Days or More)||0
8258249|NCT01811303|20363753|P2|NOT COMPLETED|Washout (2 Days or More)||0
8258250|NCT01811303|20363754|P1|NOT COMPLETED|Washout (2 Days or More)||0
8258251|NCT01811303|20363751|P4|COMPLETED|Washout (2 Days or More)||2
8258252|NCT01811303|20363752|P3|COMPLETED|Washout (2 Days or More)||4
8258253|NCT01811303|20363753|P2|COMPLETED|Washout (2 Days or More)||4
8258254|NCT01811303|20363754|P1|COMPLETED|Washout (2 Days or More)||4
8258255|NCT01811303|20363751|P4|STARTED|Washout (2 Days or More)||2
8258256|NCT01811303|20363752|P3|STARTED|Washout (2 Days or More)||4
8258257|NCT01811303|20363753|P2|STARTED|Washout (2 Days or More)||4
8258258|NCT01811303|20363754|P1|STARTED|Washout (2 Days or More)||4
8258259|NCT01811303|20363751|P4|NOT COMPLETED|First Intervention (1 Day)||0
8258260|NCT01811303|20363752|P3|NOT COMPLETED|First Intervention (1 Day)||0
8258261|NCT01811303|20363753|P2|NOT COMPLETED|First Intervention (1 Day)||0
8258262|NCT01811303|20363754|P1|NOT COMPLETED|First Intervention (1 Day)||0
8258263|NCT01811303|20363751|P4|COMPLETED|First Intervention (1 Day)||2
8258264|NCT01811303|20363752|P3|COMPLETED|First Intervention (1 Day)||4
8258265|NCT01811303|20363753|P2|COMPLETED|First Intervention (1 Day)||4
8258266|NCT01811303|20363754|P1|COMPLETED|First Intervention (1 Day)||4
8258267|NCT01811303|20363751|P4|STARTED|First Intervention (1 Day)||2
8258268|NCT01811303|20363752|P3|STARTED|First Intervention (1 Day)||4
8258269|NCT01811303|20363753|P2|STARTED|First Intervention (1 Day)||4
8258270|NCT01811303|20363754|P1|STARTED|First Intervention (1 Day)||4
8258271|NCT01811238|20363762|P1|NOT COMPLETED|Overall Study||81
8258272|NCT01811238|20363762|P1|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
8258273|NCT01811238|20363762|P1|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
8258274|NCT01811238|20363762|P1|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
8258275|NCT01811238|20363762|P1|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
8258276|NCT01811238|20363762|P1|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
8258277|NCT01811225|20363771|P2|NOT COMPLETED|Treatment Period 2||6
8258278|NCT01811225|20363772|P1|NOT COMPLETED|Treatment Period 2||4
8258279|NCT01811225|20363771|P2|COMPLETED|Treatment Period 2||23
8258280|NCT01811225|20363772|P1|COMPLETED|Treatment Period 2||20
8258281|NCT01811225|20363771|P2|STARTED|Treatment Period 2||29
8258282|NCT01811225|20363772|P1|STARTED|Treatment Period 2||24
8258283|NCT01811225|20363771|P2|NOT COMPLETED|Treatment Period 1||17
8258284|NCT01811225|20363772|P1|NOT COMPLETED|Treatment Period 1||25
8258285|NCT01811225|20363771|P2|COMPLETED|Treatment Period 1||29
8258286|NCT01811225|20363772|P1|COMPLETED|Treatment Period 1|53 completed one arm of the cross-over and 43 completed two arms of the cross-over|24
8258287|NCT01811225|20363771|P2|STARTED|Treatment Period 1||46
8258288|NCT01811225|20363772|P1|STARTED|Treatment Period 1||49
8258289|NCT01811212|20363782|P1|NOT COMPLETED|Overall Study||0
8258290|NCT01811212|20363782|P1|COMPLETED|Overall Study||25
8258291|NCT01811212|20363782|P1|STARTED|Overall Study||25
8258292|NCT01811186|20363797|P2|NOT COMPLETED|Overall Study||62
8258293|NCT01811186|20363798|P1|NOT COMPLETED|Overall Study||71
8258294|NCT01811186|20363797|P2|COMPLETED|Overall Study||64
8258295|NCT01811186|20363798|P1|COMPLETED|Overall Study||61
8258296|NCT01811186|20363797|P2|STARTED|Overall Study||126
8258297|NCT01811186|20363798|P1|STARTED|Overall Study||132
8258298|NCT01811147|20363818|P4|NOT COMPLETED|Overall Study||29
8258299|NCT01811147|20363819|P3|NOT COMPLETED|Overall Study||43
8258300|NCT01811147|20363820|P2|NOT COMPLETED|Overall Study||45
8258301|NCT01811147|20363821|P1|NOT COMPLETED|Overall Study||36
8258302|NCT01811147|20363818|P4|COMPLETED|Overall Study||4
8258303|NCT01811147|20363819|P3|COMPLETED|Overall Study||6
8258304|NCT01811147|20363820|P2|COMPLETED|Overall Study||11
8258305|NCT01811147|20363821|P1|COMPLETED|Overall Study||15
8258306|NCT01811147|20363818|P4|STARTED|Overall Study||33
8258307|NCT01811147|20363819|P3|STARTED|Overall Study||49
8258308|NCT01811147|20363820|P2|STARTED|Overall Study||56
8258309|NCT01811147|20363821|P1|STARTED|Overall Study||51
8258310|NCT01811030|20363835|P1|NOT COMPLETED|Overall Study||13
8258311|NCT01811030|20363835|P1|COMPLETED|Overall Study||20
8258312|NCT01811030|20363835|P1|STARTED|Overall Study||33
8258313|NCT01811004|20363842|P2|NOT COMPLETED|Overall Study||3
8258314|NCT01811004|20363843|P1|NOT COMPLETED|Overall Study||1
8258315|NCT01811004|20363842|P2|COMPLETED|Overall Study||5
8258316|NCT01811004|20363843|P1|COMPLETED|Overall Study||8
8258317|NCT01811004|20363842|P2|STARTED|Overall Study||8
8258318|NCT01811004|20363843|P1|STARTED|Overall Study||9
8258322|NCT01810952|20363867|P2|NOT COMPLETED|Overall Study||0
8258323|NCT01810952|20363868|P1|NOT COMPLETED|Overall Study||0
8258324|NCT01810952|20363867|P2|COMPLETED|Overall Study||17
8258325|NCT01810952|20363868|P1|COMPLETED|Overall Study||20
8258326|NCT01810952|20363867|P2|STARTED|Overall Study||17
8258327|NCT01810952|20363868|P1|STARTED|Overall Study||20
8258346|NCT01810783|20363897|P1|NOT COMPLETED|Overall Study||109
8258347|NCT01810783|20363897|P1|COMPLETED|Overall Study||101
8258348|NCT01810783|20363897|P1|STARTED|Overall Study||210
8258349|NCT01810692|20363903|P2|NOT COMPLETED|Overall Study||0
8258350|NCT01810692|20363904|P1|NOT COMPLETED|Overall Study||0
8258351|NCT01810692|20363903|P2|COMPLETED|Overall Study||77
8258352|NCT01810692|20363904|P1|COMPLETED|Overall Study||77
8258353|NCT01810692|20363903|P2|STARTED|Overall Study||77
8258354|NCT01810692|20363904|P1|STARTED|Overall Study||77
8258355|NCT01810666|20363916|P1|NOT COMPLETED|Overall Study||0
8258356|NCT01810666|20363916|P1|COMPLETED|Overall Study||30
8258357|NCT01810666|20363916|P1|STARTED|Overall Study||30
8258358|NCT01810432|20363922|P2|NOT COMPLETED|Period 2||2
8258359|NCT01810432|20363923|P1|NOT COMPLETED|Period 2||4
8258360|NCT01810432|20363922|P2|COMPLETED|Period 2||17
8258361|NCT01810432|20363923|P1|COMPLETED|Period 2||15
8258362|NCT01810432|20363922|P2|Received at Least 1 Dose of Study Drug|Period 2||19
8258363|NCT01810432|20363923|P1|Received at Least 1 Dose of Study Drug|Period 2||19
8258364|NCT01810432|20363922|P2|STARTED|Period 2||19
8258365|NCT01810432|20363923|P1|STARTED|Period 2||19
8258366|NCT01810432|20363922|P2|NOT COMPLETED|Washout||1
8258367|NCT01810432|20363923|P1|NOT COMPLETED|Washout||1
8258368|NCT01810432|20363922|P2|COMPLETED|Washout||19
8258369|NCT01810432|20363923|P1|COMPLETED|Washout||19
8258370|NCT01810432|20363922|P2|STARTED|Washout||20
8258371|NCT01810432|20363923|P1|STARTED|Washout||20
8258372|NCT01810432|20363922|P2|NOT COMPLETED|Period 1||0
8258373|NCT01810432|20363923|P1|NOT COMPLETED|Period 1||0
8258374|NCT01810432|20363922|P2|COMPLETED|Period 1||20
8258375|NCT01810432|20363923|P1|COMPLETED|Period 1||20
8258376|NCT01810432|20363922|P2|Received at Least 1 Dose of Study Drug|Period 1||20
8258377|NCT01810432|20363923|P1|Received at Least 1 Dose of Study Drug|Period 1||20
8258378|NCT01810432|20363922|P2|STARTED|Period 1||20
8258379|NCT01810432|20363923|P1|STARTED|Period 1||20
8258380|NCT01810380|20363936|P3|NOT COMPLETED|Overall Study||32
8258381|NCT01810380|20363937|P2|NOT COMPLETED|Overall Study||38
8258382|NCT01810380|20363938|P1|NOT COMPLETED|Overall Study||55
8258383|NCT01810380|20363936|P3|COMPLETED|Overall Study||122
8258384|NCT01810380|20363937|P2|COMPLETED|Overall Study||113
8258385|NCT01810380|20363938|P1|COMPLETED|Overall Study||108
8258386|NCT01810380|20363936|P3|Treated|Overall Study||153
8258387|NCT01810380|20363937|P2|Treated|Overall Study||150
8258388|NCT01810380|20363938|P1|Treated|Overall Study||161
8258389|NCT01810380|20363936|P3|STARTED|Overall Study||154
8258390|NCT01810380|20363937|P2|STARTED|Overall Study||151
8258391|NCT01810380|20363938|P1|STARTED|Overall Study||163
8258392|NCT01810302|20363999|P2|NOT COMPLETED|Overall Study||1
8258393|NCT01810302|20364000|P1|NOT COMPLETED|Overall Study||1
8258394|NCT01810302|20363999|P2|COMPLETED|Overall Study||0
8258395|NCT01810302|20364000|P1|COMPLETED|Overall Study||0
8258396|NCT01810302|20363999|P2|STARTED|Overall Study||1
8258397|NCT01810302|20364000|P1|STARTED|Overall Study||1
8258398|NCT01810289|20364010|P2|NOT COMPLETED|Overall Study||0
8258399|NCT01810289|20364011|P1|NOT COMPLETED|Overall Study||0
8258400|NCT01810289|20364010|P2|COMPLETED|Overall Study||4747
8258401|NCT01810289|20364011|P1|COMPLETED|Overall Study||7277
8258402|NCT01810289|20364010|P2|STARTED|Overall Study||4747
8258403|NCT01810289|20364011|P1|STARTED|Overall Study||7277
8258404|NCT01810263|20364027|P2|NOT COMPLETED|Overall Study||7
8258405|NCT01810263|20364028|P1|NOT COMPLETED|Overall Study||8
8258406|NCT01810263|20364027|P2|COMPLETED|Overall Study||11
8258407|NCT01810263|20364028|P1|COMPLETED|Overall Study|2014 July|8
8258408|NCT01810263|20364027|P2|STARTED|Overall Study||18
8258409|NCT01810263|20364028|P1|STARTED|Overall Study||16
8258410|NCT01810042|20364034|P1|NOT COMPLETED|Overall Study||10
8258411|NCT01810042|20364034|P1|COMPLETED|Overall Study||39
8258412|NCT01810042|20364034|P1|STARTED|Overall Study||49
8258413|NCT01810016|20364044|P3|NOT COMPLETED|Overall Study||1
8258414|NCT01810016|20364045|P2|NOT COMPLETED|Overall Study||1
8258415|NCT01810016|20364046|P1|NOT COMPLETED|Overall Study||1
8258416|NCT01810016|20364044|P3|COMPLETED|Overall Study||0
8258417|NCT01810016|20364045|P2|COMPLETED|Overall Study||1
8258418|NCT01810016|20364046|P1|COMPLETED|Overall Study||4
8258419|NCT01810016|20364044|P3|STARTED|Overall Study||1
8258420|NCT01810016|20364045|P2|STARTED|Overall Study||2
8258421|NCT01810016|20364046|P1|STARTED|Overall Study||5
8258422|NCT01809938|20364057|P2|NOT COMPLETED|Second Intervention (170 Minutes)||0
8258423|NCT01809938|20364058|P1|NOT COMPLETED|Second Intervention (170 Minutes)||0
8258424|NCT01809938|20364057|P2|COMPLETED|Second Intervention (170 Minutes)||5
8258425|NCT01809938|20364058|P1|COMPLETED|Second Intervention (170 Minutes)||5
8258426|NCT01809938|20364057|P2|STARTED|Second Intervention (170 Minutes)||5
8258427|NCT01809938|20364058|P1|STARTED|Second Intervention (170 Minutes)||5
8258428|NCT01809938|20364057|P2|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
8258429|NCT01809938|20364058|P1|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
8258430|NCT01809938|20364057|P2|COMPLETED|Washout (Not Less Than 24 Hours)||5
8258431|NCT01809938|20364058|P1|COMPLETED|Washout (Not Less Than 24 Hours)||5
8258432|NCT01809938|20364057|P2|STARTED|Washout (Not Less Than 24 Hours)||5
8258433|NCT01809938|20364058|P1|STARTED|Washout (Not Less Than 24 Hours)||5
8258434|NCT01809938|20364057|P2|NOT COMPLETED|First Intervention (170 Minutes)||0
8258435|NCT01809938|20364058|P1|NOT COMPLETED|First Intervention (170 Minutes)||0
8258436|NCT01809938|20364057|P2|COMPLETED|First Intervention (170 Minutes)||5
8258437|NCT01809938|20364058|P1|COMPLETED|First Intervention (170 Minutes)||5
8258438|NCT01809938|20364057|P2|STARTED|First Intervention (170 Minutes)||5
8258439|NCT01809938|20364058|P1|STARTED|First Intervention (170 Minutes)||5
8258440|NCT01809899|20364067|P2|NOT COMPLETED|Overall Study||0
8258441|NCT01809899|20364068|P1|NOT COMPLETED|Overall Study||0
8258442|NCT01809899|20364067|P2|COMPLETED|Overall Study||4
8258443|NCT01809899|20364068|P1|COMPLETED|Overall Study||8
8258444|NCT01809899|20364067|P2|STARTED|Overall Study||4
8258445|NCT01809899|20364068|P1|STARTED|Overall Study||8
8258446|NCT01809834|20364076|P1|NOT COMPLETED|Overall Study||0
8258447|NCT01809834|20364076|P1|COMPLETED|Overall Study||44
8258448|NCT01809834|20364076|P1|STARTED|Overall Study||44
8258449|NCT01809639|20364104|P2|NOT COMPLETED|Overall Study||0
8258450|NCT01809639|20364105|P1|NOT COMPLETED|Overall Study||0
8258451|NCT01809639|20364104|P2|COMPLETED|Overall Study||7
8258452|NCT01809639|20364105|P1|COMPLETED|Overall Study||18
8258453|NCT01809639|20364104|P2|STARTED|Overall Study||7
8258454|NCT01809639|20364105|P1|STARTED|Overall Study||18
8258455|NCT01809327|20364116|P5|NOT COMPLETED|Overall Study||25
8258456|NCT01809327|20364117|P4|NOT COMPLETED|Overall Study||12
8258457|NCT01809327|20364118|P3|NOT COMPLETED|Overall Study||22
8258458|NCT01809327|20364119|P2|NOT COMPLETED|Overall Study||26
8258459|NCT01809327|20364120|P1|NOT COMPLETED|Overall Study||32
8258460|NCT01809327|20364116|P5|COMPLETED|Overall Study||212
8258461|NCT01809327|20364117|P4|COMPLETED|Overall Study||225
8258462|NCT01809327|20364118|P3|COMPLETED|Overall Study||216
8258463|NCT01809327|20364119|P2|COMPLETED|Overall Study||211
8258464|NCT01809327|20364120|P1|COMPLETED|Overall Study||205
8258465|NCT01809327|20364116|P5|STARTED|Overall Study||237
8258466|NCT01809327|20364117|P4|STARTED|Overall Study||237
8258467|NCT01809327|20364118|P3|STARTED|Overall Study||238
8258468|NCT01809327|20364119|P2|STARTED|Overall Study||237
8258469|NCT01809327|20364120|P1|STARTED|Overall Study||237
8258470|NCT01809314|20364162|P1|NOT COMPLETED|Overall Study||745
8258471|NCT01809314|20364162|P1|COMPLETED|Overall Study||422
8258472|NCT01809314|20364162|P1|STARTED|Overall Study||1167
8258473|NCT01809262|20364168|P10|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258474|NCT01809262|20364169|P9|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258475|NCT01809262|20364170|P8|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258476|NCT01809262|20364171|P7|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258477|NCT01809262|20364172|P6|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258478|NCT01809262|20364173|P5|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258479|NCT01809262|20364174|P4|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258480|NCT01809262|20364175|P3|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258481|NCT01809262|20364176|P2|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258482|NCT01809262|20364177|P1|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
8258483|NCT01809262|20364168|P10|COMPLETED|Period 5 (Fifth Dose + Washout)||4
8258484|NCT01809262|20364169|P9|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8258485|NCT01809262|20364170|P8|COMPLETED|Period 5 (Fifth Dose + Washout)||4
8258486|NCT01809262|20364171|P7|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8258487|NCT01809262|20364172|P6|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8258488|NCT01809262|20364173|P5|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8258489|NCT01809262|20364174|P4|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8258490|NCT01809262|20364175|P3|COMPLETED|Period 5 (Fifth Dose + Washout)||4
8258491|NCT01809262|20364176|P2|COMPLETED|Period 5 (Fifth Dose + Washout)||3
8258492|NCT01809262|20364177|P1|COMPLETED|Period 5 (Fifth Dose + Washout)||4
8258493|NCT01809262|20364168|P10|STARTED|Period 5 (Fifth Dose + Washout)||4
8258494|NCT01809262|20364169|P9|STARTED|Period 5 (Fifth Dose + Washout)||3
8258495|NCT01809262|20364170|P8|STARTED|Period 5 (Fifth Dose + Washout)||4
8258496|NCT01809262|20364171|P7|STARTED|Period 5 (Fifth Dose + Washout)||3
8258497|NCT01809262|20364172|P6|STARTED|Period 5 (Fifth Dose + Washout)||3
8258498|NCT01809262|20364173|P5|STARTED|Period 5 (Fifth Dose + Washout)||3
8258499|NCT01809262|20364174|P4|STARTED|Period 5 (Fifth Dose + Washout)||3
8258500|NCT01809262|20364175|P3|STARTED|Period 5 (Fifth Dose + Washout)||4
8258501|NCT01809262|20364176|P2|STARTED|Period 5 (Fifth Dose + Washout)||3
8258502|NCT01809262|20364177|P1|STARTED|Period 5 (Fifth Dose + Washout)||4
8258503|NCT01809262|20364168|P10|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258504|NCT01809262|20364169|P9|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258505|NCT01809262|20364170|P8|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258506|NCT01809262|20364171|P7|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258507|NCT01809262|20364172|P6|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258508|NCT01809262|20364173|P5|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258509|NCT01809262|20364174|P4|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258510|NCT01809262|20364175|P3|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258511|NCT01809262|20364176|P2|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258512|NCT01809262|20364177|P1|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
8258513|NCT01809262|20364168|P10|COMPLETED|Period 4 (Fourth Dose + Washout)||4
8258514|NCT01809262|20364169|P9|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8258515|NCT01809262|20364170|P8|COMPLETED|Period 4 (Fourth Dose + Washout)||4
8258516|NCT01809262|20364171|P7|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8258517|NCT01809262|20364172|P6|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8258518|NCT01809262|20364173|P5|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8258519|NCT01809262|20364174|P4|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8258520|NCT01809262|20364175|P3|COMPLETED|Period 4 (Fourth Dose + Washout)||4
8258521|NCT01809262|20364176|P2|COMPLETED|Period 4 (Fourth Dose + Washout)||3
8258522|NCT01809262|20364177|P1|COMPLETED|Period 4 (Fourth Dose + Washout)||4
8258523|NCT01809262|20364168|P10|STARTED|Period 4 (Fourth Dose + Washout)||4
8258524|NCT01809262|20364169|P9|STARTED|Period 4 (Fourth Dose + Washout)||3
8258525|NCT01809262|20364170|P8|STARTED|Period 4 (Fourth Dose + Washout)||4
8258526|NCT01809262|20364171|P7|STARTED|Period 4 (Fourth Dose + Washout)||3
8258527|NCT01809262|20364172|P6|STARTED|Period 4 (Fourth Dose + Washout)||3
8258528|NCT01809262|20364173|P5|STARTED|Period 4 (Fourth Dose + Washout)||3
8258529|NCT01809262|20364174|P4|STARTED|Period 4 (Fourth Dose + Washout)||3
8258530|NCT01809262|20364175|P3|STARTED|Period 4 (Fourth Dose + Washout)||4
8258531|NCT01809262|20364176|P2|STARTED|Period 4 (Fourth Dose + Washout)||3
8258532|NCT01809262|20364177|P1|STARTED|Period 4 (Fourth Dose + Washout)||4
8258533|NCT01809262|20364168|P10|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258534|NCT01809262|20364169|P9|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258535|NCT01809262|20364170|P8|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258536|NCT01809262|20364171|P7|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258537|NCT01809262|20364172|P6|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258538|NCT01809262|20364173|P5|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258539|NCT01809262|20364174|P4|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258540|NCT01809262|20364175|P3|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258541|NCT01809262|20364176|P2|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
8258542|NCT01809262|20364177|P1|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
8258543|NCT01809262|20364168|P10|COMPLETED|Period 3 (Third Dose + Washout)||4
8258544|NCT01809262|20364169|P9|COMPLETED|Period 3 (Third Dose + Washout)||3
8258545|NCT01809262|20364170|P8|COMPLETED|Period 3 (Third Dose + Washout)||4
8258546|NCT01809262|20364171|P7|COMPLETED|Period 3 (Third Dose + Washout)||3
8258547|NCT01809262|20364172|P6|COMPLETED|Period 3 (Third Dose + Washout)||3
8258548|NCT01809262|20364173|P5|COMPLETED|Period 3 (Third Dose + Washout)||3
8258549|NCT01809262|20364174|P4|COMPLETED|Period 3 (Third Dose + Washout)||3
8258550|NCT01809262|20364175|P3|COMPLETED|Period 3 (Third Dose + Washout)||4
8258551|NCT01809262|20364176|P2|COMPLETED|Period 3 (Third Dose + Washout)||3
8258552|NCT01809262|20364177|P1|COMPLETED|Period 3 (Third Dose + Washout)||4
8258553|NCT01809262|20364168|P10|STARTED|Period 3 (Third Dose + Washout)||4
8258554|NCT01809262|20364169|P9|STARTED|Period 3 (Third Dose + Washout)||3
8258555|NCT01809262|20364170|P8|STARTED|Period 3 (Third Dose + Washout)||4
8258556|NCT01809262|20364171|P7|STARTED|Period 3 (Third Dose + Washout)||3
8258557|NCT01809262|20364172|P6|STARTED|Period 3 (Third Dose + Washout)||3
8258558|NCT01809262|20364173|P5|STARTED|Period 3 (Third Dose + Washout)||3
8258559|NCT01809262|20364174|P4|STARTED|Period 3 (Third Dose + Washout)||3
8258560|NCT01809262|20364175|P3|STARTED|Period 3 (Third Dose + Washout)||4
8258561|NCT01809262|20364176|P2|STARTED|Period 3 (Third Dose + Washout)||4
8258562|NCT01809262|20364177|P1|STARTED|Period 3 (Third Dose + Washout)||4
8258563|NCT01809262|20364168|P10|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258564|NCT01809262|20364169|P9|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258565|NCT01809262|20364170|P8|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258566|NCT01809262|20364171|P7|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258567|NCT01809262|20364172|P6|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258568|NCT01809262|20364173|P5|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258569|NCT01809262|20364174|P4|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258570|NCT01809262|20364175|P3|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258571|NCT01809262|20364176|P2|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258572|NCT01809262|20364177|P1|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
8258573|NCT01809262|20364168|P10|COMPLETED|Period 2 (Second Dose + Washout)||4
8258574|NCT01809262|20364169|P9|COMPLETED|Period 2 (Second Dose + Washout)||3
8258575|NCT01809262|20364170|P8|COMPLETED|Period 2 (Second Dose + Washout)||4
8258576|NCT01809262|20364171|P7|COMPLETED|Period 2 (Second Dose + Washout)||3
8258577|NCT01809262|20364172|P6|COMPLETED|Period 2 (Second Dose + Washout)||3
8258578|NCT01809262|20364173|P5|COMPLETED|Period 2 (Second Dose + Washout)||3
8258579|NCT01809262|20364174|P4|COMPLETED|Period 2 (Second Dose + Washout)||3
8258580|NCT01809262|20364175|P3|COMPLETED|Period 2 (Second Dose + Washout)||4
8258581|NCT01809262|20364176|P2|COMPLETED|Period 2 (Second Dose + Washout)||4
8258582|NCT01809262|20364177|P1|COMPLETED|Period 2 (Second Dose + Washout)||4
8258583|NCT01809262|20364168|P10|STARTED|Period 2 (Second Dose + Washout)||4
8258584|NCT01809262|20364169|P9|STARTED|Period 2 (Second Dose + Washout)||3
8258585|NCT01809262|20364170|P8|STARTED|Period 2 (Second Dose + Washout)||4
8258586|NCT01809262|20364171|P7|STARTED|Period 2 (Second Dose + Washout)||3
8258587|NCT01809262|20364172|P6|STARTED|Period 2 (Second Dose + Washout)||3
8258588|NCT01809262|20364173|P5|STARTED|Period 2 (Second Dose + Washout)||3
8258589|NCT01809262|20364174|P4|STARTED|Period 2 (Second Dose + Washout)||3
8258590|NCT01809262|20364175|P3|STARTED|Period 2 (Second Dose + Washout)||4
8258591|NCT01809262|20364176|P2|STARTED|Period 2 (Second Dose + Washout)||4
8258592|NCT01809262|20364177|P1|STARTED|Period 2 (Second Dose + Washout)||4
8258593|NCT01809262|20364168|P10|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258594|NCT01809262|20364169|P9|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258595|NCT01809262|20364170|P8|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258596|NCT01809262|20364171|P7|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258597|NCT01809262|20364172|P6|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258598|NCT01809262|20364173|P5|NOT COMPLETED|Period 1 (First Dose + Washout)||1
8258599|NCT01809262|20364174|P4|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258600|NCT01809262|20364175|P3|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258601|NCT01809262|20364176|P2|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258602|NCT01809262|20364177|P1|NOT COMPLETED|Period 1 (First Dose + Washout)||0
8258603|NCT01809262|20364168|P10|COMPLETED|Period 1 (First Dose + Washout)||4
8258604|NCT01809262|20364169|P9|COMPLETED|Period 1 (First Dose + Washout)||3
8258605|NCT01809262|20364170|P8|COMPLETED|Period 1 (First Dose + Washout)||4
8258606|NCT01809262|20364171|P7|COMPLETED|Period 1 (First Dose + Washout)||3
8258607|NCT01809262|20364172|P6|COMPLETED|Period 1 (First Dose + Washout)||3
8258608|NCT01809262|20364173|P5|COMPLETED|Period 1 (First Dose + Washout)||3
8258609|NCT01809262|20364174|P4|COMPLETED|Period 1 (First Dose + Washout)||3
8258610|NCT01809262|20364175|P3|COMPLETED|Period 1 (First Dose + Washout)||4
8258611|NCT01809262|20364176|P2|COMPLETED|Period 1 (First Dose + Washout)||4
8258612|NCT01809262|20364177|P1|COMPLETED|Period 1 (First Dose + Washout)||4
8258613|NCT01809262|20364168|P10|STARTED|Period 1 (First Dose + Washout)||4
8258614|NCT01809262|20364169|P9|STARTED|Period 1 (First Dose + Washout)||3
8258615|NCT01809262|20364170|P8|STARTED|Period 1 (First Dose + Washout)||4
8258616|NCT01809262|20364171|P7|STARTED|Period 1 (First Dose + Washout)||3
8258617|NCT01809262|20364172|P6|STARTED|Period 1 (First Dose + Washout)||3
8258618|NCT01809262|20364173|P5|STARTED|Period 1 (First Dose + Washout)||4
8258619|NCT01809262|20364174|P4|STARTED|Period 1 (First Dose + Washout)||3
8258620|NCT01809262|20364175|P3|STARTED|Period 1 (First Dose + Washout)||4
8258621|NCT01809262|20364176|P2|STARTED|Period 1 (First Dose + Washout)||4
8258622|NCT01809262|20364177|P1|STARTED|Period 1 (First Dose + Washout)||4
8258623|NCT01809210|20364251|P7|NOT COMPLETED|Overall Study||5
8258624|NCT01809210|20364252|P6|NOT COMPLETED|Overall Study||3
8258625|NCT01809210|20364253|P5|NOT COMPLETED|Overall Study||2
8258626|NCT01809210|20364254|P4|NOT COMPLETED|Overall Study||1
8258627|NCT01809210|20364255|P3|NOT COMPLETED|Overall Study||3
8258628|NCT01809210|20364256|P2|NOT COMPLETED|Overall Study||1
8258629|NCT01809210|20364257|P1|NOT COMPLETED|Overall Study||1
8258630|NCT01809210|20364251|P7|COMPLETED|Overall Study||7
8258631|NCT01809210|20364252|P6|COMPLETED|Overall Study||12
8258632|NCT01809210|20364253|P5|COMPLETED|Overall Study||4
8258633|NCT01809210|20364254|P4|COMPLETED|Overall Study||2
8258634|NCT01809210|20364255|P3|COMPLETED|Overall Study||4
8258635|NCT01809210|20364256|P2|COMPLETED|Overall Study||8
8258636|NCT01809210|20364257|P1|COMPLETED|Overall Study||2
8258637|NCT01809210|20364251|P7|STARTED|Overall Study||12
8258638|NCT01809210|20364252|P6|STARTED|Overall Study||15
8258639|NCT01809210|20364253|P5|STARTED|Overall Study||6
8258640|NCT01809210|20364254|P4|STARTED|Overall Study||3
8258641|NCT01809210|20364255|P3|STARTED|Overall Study||7
8258642|NCT01809210|20364256|P2|STARTED|Overall Study||9
8258643|NCT01809210|20364257|P1|STARTED|Overall Study||3
8258644|NCT01809197|20364331|P2|NOT COMPLETED|Overall Study||8
8258645|NCT01809197|20364332|P1|NOT COMPLETED|Overall Study||10
8258646|NCT01809197|20364331|P2|COMPLETED|Overall Study||177
8258647|NCT01809197|20364332|P1|COMPLETED|Overall Study||177
8258648|NCT01809197|20364331|P2|STARTED|Overall Study||185
8258649|NCT01809197|20364332|P1|STARTED|Overall Study||187
8258650|NCT01809132|20364341|P3|NOT COMPLETED|Overall Study||1
8258651|NCT01809132|20364342|P2|NOT COMPLETED|Overall Study||0
8258652|NCT01809132|20364343|P1|NOT COMPLETED|Overall Study||0
8258653|NCT01809132|20364341|P3|COMPLETED|Overall Study||0
8258654|NCT01809132|20364342|P2|COMPLETED|Overall Study||50
8258655|NCT01809132|20364343|P1|COMPLETED|Overall Study||53
8258656|NCT01809132|20364341|P3|STARTED|Overall Study|Subject was consented but withdrew prior to randomization and initiation of treatment.|1
8258657|NCT01809132|20364342|P2|STARTED|Overall Study||50
8258658|NCT01809132|20364343|P1|STARTED|Overall Study||53
8258659|NCT01809106|20364364|P4|NOT COMPLETED|Overall Study||4
8258660|NCT01809106|20364365|P3|NOT COMPLETED|Overall Study||3
8258661|NCT01809106|20364366|P2|NOT COMPLETED|Overall Study||5
8258662|NCT01809106|20364367|P1|NOT COMPLETED|Overall Study||8
8258663|NCT01809106|20364364|P4|COMPLETED|Overall Study||124
8258664|NCT01809106|20364365|P3|COMPLETED|Overall Study||127
8258665|NCT01809106|20364366|P2|COMPLETED|Overall Study||125
8258666|NCT01809106|20364367|P1|COMPLETED|Overall Study||122
8258667|NCT01809106|20364364|P4|STARTED|Overall Study||128
8258668|NCT01809106|20364365|P3|STARTED|Overall Study||130
8258669|NCT01809106|20364366|P2|STARTED|Overall Study||130
8258670|NCT01809106|20364367|P1|STARTED|Overall Study||130
8258671|NCT01809054|20364387|P2|NOT COMPLETED|Overall Study||0
8258672|NCT01809054|20364388|P1|NOT COMPLETED|Overall Study||0
8258673|NCT01809054|20364387|P2|COMPLETED|Overall Study||22
8258674|NCT01809054|20364388|P1|COMPLETED|Overall Study||27
8258675|NCT01809054|20364387|P2|STARTED|Overall Study||22
8258676|NCT01809054|20364388|P1|STARTED|Overall Study||27
8258677|NCT01808963|20364396|P1|NOT COMPLETED|Overall Study||0
8258678|NCT01808963|20364396|P1|COMPLETED|Overall Study||13
8258679|NCT01808963|20364396|P1|STARTED|Overall Study||13
8258680|NCT01808950|20364403|P3|NOT COMPLETED|Overall Study||0
8258681|NCT01808950|20364404|P2|NOT COMPLETED|Overall Study||0
8258682|NCT01808950|20364405|P1|NOT COMPLETED|Overall Study||0
8258683|NCT01808950|20364403|P3|COMPLETED|Overall Study||0
8258684|NCT01808950|20364404|P2|COMPLETED|Overall Study||3
8258685|NCT01808950|20364405|P1|COMPLETED|Overall Study||1
8258686|NCT01808950|20364403|P3|STARTED|Overall Study||0
8258687|NCT01808950|20364404|P2|STARTED|Overall Study||3
8258688|NCT01808950|20364405|P1|STARTED|Overall Study||1
8258689|NCT01808794|20364418|P2|NOT COMPLETED|Overall Study||0
8258690|NCT01808794|20364419|P1|NOT COMPLETED|Overall Study||0
8258691|NCT01808794|20364418|P2|COMPLETED|Overall Study||0
8258692|NCT01808794|20364419|P1|COMPLETED|Overall Study||0
8258693|NCT01808794|20364418|P2|STARTED|Overall Study||0
8258694|NCT01808794|20364419|P1|STARTED|Overall Study||0
8258695|NCT01808755|20364427|P2|NOT COMPLETED|Overall Study||0
8258696|NCT01808755|20364428|P1|NOT COMPLETED|Overall Study||0
8258697|NCT01808755|20364427|P2|COMPLETED|Overall Study||30
8258698|NCT01808755|20364428|P1|COMPLETED|Overall Study||30
8258699|NCT01808755|20364427|P2|STARTED|Overall Study||30
8258700|NCT01808755|20364428|P1|STARTED|Overall Study||30
8258701|NCT01808690|20364435|P2|NOT COMPLETED|Overall Study||2
8258702|NCT01808690|20364436|P1|NOT COMPLETED|Overall Study||1
8258703|NCT01808690|20364435|P2|COMPLETED|Overall Study||21
8258704|NCT01808690|20364436|P1|COMPLETED|Overall Study||24
8258705|NCT01808690|20364435|P2|STARTED|Overall Study||23
8258706|NCT01808690|20364436|P1|STARTED|Overall Study||25
8258707|NCT01808651|20364455|P3|NOT COMPLETED|Study Period 2||0
8258708|NCT01808651|20364456|P2|NOT COMPLETED|Study Period 2||0
8258709|NCT01808651|20364457|P1|NOT COMPLETED|Study Period 2||0
8258710|NCT01808651|20364455|P3|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
8258711|NCT01808651|20364456|P2|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
8258712|NCT01808651|20364457|P1|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
8258713|NCT01808651|20364455|P3|STARTED|Study Period 2||33
8258714|NCT01808651|20364456|P2|STARTED|Study Period 2||52
8258715|NCT01808651|20364457|P1|STARTED|Study Period 2||77
8258716|NCT01808651|20364455|P3|NOT COMPLETED|Study Period 1||5
8258717|NCT01808651|20364456|P2|NOT COMPLETED|Study Period 1||17
8258718|NCT01808651|20364457|P1|NOT COMPLETED|Study Period 1||26
8258719|NCT01808651|20364455|P3|COMPLETED|Study Period 1||31
8258720|NCT01808651|20364456|P2|COMPLETED|Study Period 1||48
8258721|NCT01808651|20364457|P1|COMPLETED|Study Period 1||73
8258722|NCT01808651|20364455|P3|Received at Least One Dose of Study Drug|Study Period 1||36
8258723|NCT01808651|20364456|P2|Received at Least One Dose of Study Drug|Study Period 1||65
8258724|NCT01808651|20364457|P1|Received at Least One Dose of Study Drug|Study Period 1||98
8258725|NCT01808651|20364455|P3|STARTED|Study Period 1||36
8258726|NCT01808651|20364456|P2|STARTED|Study Period 1||65
8258727|NCT01808651|20364457|P1|STARTED|Study Period 1||99
8258728|NCT01808612|20364492|P3|NOT COMPLETED|Discontinuation Period||0
8258729|NCT01808612|20364493|P2|NOT COMPLETED|Discontinuation Period||1
8258730|NCT01808612|20364494|P1|NOT COMPLETED|Discontinuation Period||2
8258731|NCT01808612|20364492|P3|COMPLETED|Discontinuation Period||145
8258732|NCT01808612|20364493|P2|COMPLETED|Discontinuation Period||37
8258733|NCT01808612|20364494|P1|COMPLETED|Discontinuation Period||85
8258734|NCT01808612|20364492|P3|STARTED|Discontinuation Period||145
8258735|NCT01808612|20364493|P2|STARTED|Discontinuation Period||38
8258736|NCT01808612|20364494|P1|STARTED|Discontinuation Period||87
8258737|NCT01808612|20364492|P3|NOT COMPLETED|Treatment Period||14
8258738|NCT01808612|20364493|P2|NOT COMPLETED|Treatment Period||7
8258739|NCT01808612|20364494|P1|NOT COMPLETED|Treatment Period||15
8258740|NCT01808612|20364492|P3|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
8258741|NCT01808612|20364493|P2|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
8258742|NCT01808612|20364494|P1|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
8258743|NCT01808612|20364492|P3|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
8258744|NCT01808612|20364493|P2|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
8258745|NCT01808612|20364494|P1|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
8258746|NCT01808612|20364492|P3|STARTED|Treatment Period||260
8258747|NCT01808612|20364493|P2|STARTED|Treatment Period||84
8258748|NCT01808612|20364494|P1|STARTED|Treatment Period||169
8258757|NCT01808560|20364547|P3|NOT COMPLETED|4-Month After Cataract Surgery||0
8258758|NCT01808560|20364548|P2|NOT COMPLETED|4-Month After Cataract Surgery||0
8258759|NCT01808560|20364549|P1|NOT COMPLETED|4-Month After Cataract Surgery||0
8258760|NCT01808560|20364547|P3|COMPLETED|4-Month After Cataract Surgery||13
8258761|NCT01808560|20364548|P2|COMPLETED|4-Month After Cataract Surgery||0
8258762|NCT01808560|20364549|P1|COMPLETED|4-Month After Cataract Surgery||0
8258763|NCT01808560|20364547|P3|STARTED|4-Month After Cataract Surgery||13
8258764|NCT01808560|20364548|P2|STARTED|4-Month After Cataract Surgery||0
8258765|NCT01808560|20364549|P1|STARTED|4-Month After Cataract Surgery||0
8258766|NCT01808560|20364547|P3|NOT COMPLETED|Crossover Treatment||0
8258767|NCT01808560|20364548|P2|NOT COMPLETED|Crossover Treatment||0
8258768|NCT01808560|20364549|P1|NOT COMPLETED|Crossover Treatment||0
8258769|NCT01808560|20364547|P3|COMPLETED|Crossover Treatment||13
8258770|NCT01808560|20364548|P2|COMPLETED|Crossover Treatment||0
8258771|NCT01808560|20364549|P1|COMPLETED|Crossover Treatment||0
8258772|NCT01808560|20364547|P3|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
8258773|NCT01808560|20364548|P2|STARTED|Crossover Treatment||0
8258774|NCT01808560|20364549|P1|STARTED|Crossover Treatment||0
8258775|NCT01808560|20364547|P3|NOT COMPLETED|3-Month After Cataract Surgery||0
8258776|NCT01808560|20364548|P2|NOT COMPLETED|3-Month After Cataract Surgery||0
8258777|NCT01808560|20364549|P1|NOT COMPLETED|3-Month After Cataract Surgery||0
8258778|NCT01808560|20364547|P3|COMPLETED|3-Month After Cataract Surgery||0
8258779|NCT01808560|20364548|P2|COMPLETED|3-Month After Cataract Surgery||13
8258780|NCT01808560|20364549|P1|COMPLETED|3-Month After Cataract Surgery||17
8258781|NCT01808560|20364547|P3|STARTED|3-Month After Cataract Surgery||0
8258782|NCT01808560|20364548|P2|STARTED|3-Month After Cataract Surgery||13
8258783|NCT01808560|20364549|P1|STARTED|3-Month After Cataract Surgery||17
8258784|NCT01808560|20364547|P3|NOT COMPLETED|1-Month After Cataract Surgery||0
8258785|NCT01808560|20364548|P2|NOT COMPLETED|1-Month After Cataract Surgery||0
8258786|NCT01808560|20364549|P1|NOT COMPLETED|1-Month After Cataract Surgery||0
8258787|NCT01808560|20364547|P3|COMPLETED|1-Month After Cataract Surgery||0
8258788|NCT01808560|20364548|P2|COMPLETED|1-Month After Cataract Surgery||13
8258789|NCT01808560|20364549|P1|COMPLETED|1-Month After Cataract Surgery||16
8258790|NCT01808560|20364547|P3|STARTED|1-Month After Cataract Surgery||0
8258791|NCT01808560|20364548|P2|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
8258792|NCT01808560|20364549|P1|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
8258793|NCT01808560|20364547|P3|NOT COMPLETED|Randomization and Treatment Allocation||0
8258794|NCT01808560|20364548|P2|NOT COMPLETED|Randomization and Treatment Allocation||0
8258795|NCT01808560|20364549|P1|NOT COMPLETED|Randomization and Treatment Allocation||0
8258796|NCT01808560|20364547|P3|COMPLETED|Randomization and Treatment Allocation||0
8258797|NCT01808560|20364548|P2|COMPLETED|Randomization and Treatment Allocation||16
8258798|NCT01808560|20364549|P1|COMPLETED|Randomization and Treatment Allocation||18
8258799|NCT01808560|20364547|P3|STARTED|Randomization and Treatment Allocation||0
8258800|NCT01808560|20364548|P2|STARTED|Randomization and Treatment Allocation||16
8258801|NCT01808560|20364549|P1|STARTED|Randomization and Treatment Allocation||18
8258812|NCT01808534|20364581|P1|NOT COMPLETED|Overall Study||4
8258813|NCT01808534|20364581|P1|COMPLETED|Overall Study||1
8258814|NCT01808534|20364581|P1|STARTED|Overall Study||5
8258815|NCT01808508|20364592|P3|NOT COMPLETED|Overall Study||0
8258816|NCT01808508|20364593|P2|NOT COMPLETED|Overall Study||0
8258817|NCT01808508|20364594|P1|NOT COMPLETED|Overall Study||1
8258818|NCT01808508|20364592|P3|COMPLETED|Overall Study||3
8258819|NCT01808508|20364593|P2|COMPLETED|Overall Study||9
8258820|NCT01808508|20364594|P1|COMPLETED|Overall Study||10
8258821|NCT01808508|20364592|P3|STARTED|Overall Study||3
8258822|NCT01808508|20364593|P2|STARTED|Overall Study||9
8258823|NCT01808508|20364594|P1|STARTED|Overall Study||11
8258824|NCT01808339|20364611|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8258825|NCT01808339|20364612|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8258826|NCT01808339|20364613|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8258827|NCT01808339|20364614|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8258828|NCT01808339|20364615|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8258829|NCT01808339|20364616|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8258830|NCT01808339|20364611|P6|COMPLETED|Treatment Period 3 (14 Days)||5
8258831|NCT01808339|20364612|P5|COMPLETED|Treatment Period 3 (14 Days)||4
8258832|NCT01808339|20364613|P4|COMPLETED|Treatment Period 3 (14 Days)||2
8258833|NCT01808339|20364614|P3|COMPLETED|Treatment Period 3 (14 Days)||3
8258834|NCT01808339|20364615|P2|COMPLETED|Treatment Period 3 (14 Days)||3
8258835|NCT01808339|20364616|P1|COMPLETED|Treatment Period 3 (14 Days)||4
8258836|NCT01808339|20364611|P6|STARTED|Treatment Period 3 (14 Days)||5
8258837|NCT01808339|20364612|P5|STARTED|Treatment Period 3 (14 Days)||4
8258838|NCT01808339|20364613|P4|STARTED|Treatment Period 3 (14 Days)||2
8258839|NCT01808339|20364614|P3|STARTED|Treatment Period 3 (14 Days)||4
8258840|NCT01808339|20364615|P2|STARTED|Treatment Period 3 (14 Days)||3
8258841|NCT01808339|20364616|P1|STARTED|Treatment Period 3 (14 Days)||4
8258842|NCT01808339|20364611|P6|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8258843|NCT01808339|20364612|P5|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8258844|NCT01808339|20364613|P4|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8258845|NCT01808339|20364614|P3|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8258846|NCT01808339|20364615|P2|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8258847|NCT01808339|20364616|P1|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
8258848|NCT01808339|20364611|P6|COMPLETED|Washout Period 2 (14-21 Days)||5
8258849|NCT01808339|20364612|P5|COMPLETED|Washout Period 2 (14-21 Days)||4
8258850|NCT01808339|20364613|P4|COMPLETED|Washout Period 2 (14-21 Days)||2
8258851|NCT01808339|20364614|P3|COMPLETED|Washout Period 2 (14-21 Days)||4
8258852|NCT01808339|20364615|P2|COMPLETED|Washout Period 2 (14-21 Days)||3
8258853|NCT01808339|20364616|P1|COMPLETED|Washout Period 2 (14-21 Days)||4
8258854|NCT01808339|20364611|P6|STARTED|Washout Period 2 (14-21 Days)||5
8258855|NCT01808339|20364612|P5|STARTED|Washout Period 2 (14-21 Days)||4
8258856|NCT01808339|20364613|P4|STARTED|Washout Period 2 (14-21 Days)||2
8258857|NCT01808339|20364614|P3|STARTED|Washout Period 2 (14-21 Days)||4
8258858|NCT01808339|20364615|P2|STARTED|Washout Period 2 (14-21 Days)||3
8258859|NCT01808339|20364616|P1|STARTED|Washout Period 2 (14-21 Days)||4
8258860|NCT01808339|20364611|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8258861|NCT01808339|20364612|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8258862|NCT01808339|20364613|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8258863|NCT01808339|20364614|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8258864|NCT01808339|20364615|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8258865|NCT01808339|20364616|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8258866|NCT01808339|20364611|P6|COMPLETED|Treatment Period 2 (14 Days)||5
8258867|NCT01808339|20364612|P5|COMPLETED|Treatment Period 2 (14 Days)||4
8258868|NCT01808339|20364613|P4|COMPLETED|Treatment Period 2 (14 Days)||2
8258869|NCT01808339|20364614|P3|COMPLETED|Treatment Period 2 (14 Days)||4
8258870|NCT01808339|20364615|P2|COMPLETED|Treatment Period 2 (14 Days)||3
8258871|NCT01808339|20364616|P1|COMPLETED|Treatment Period 2 (14 Days)||4
8258872|NCT01808339|20364611|P6|STARTED|Treatment Period 2 (14 Days)||5
8258873|NCT01808339|20364612|P5|STARTED|Treatment Period 2 (14 Days)||4
8258874|NCT01808339|20364613|P4|STARTED|Treatment Period 2 (14 Days)||2
8258875|NCT01808339|20364614|P3|STARTED|Treatment Period 2 (14 Days)||4
8258876|NCT01808339|20364615|P2|STARTED|Treatment Period 2 (14 Days)||3
8258877|NCT01808339|20364616|P1|STARTED|Treatment Period 2 (14 Days)||4
8258878|NCT01808339|20364611|P6|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8258879|NCT01808339|20364612|P5|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8258880|NCT01808339|20364613|P4|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8258881|NCT01808339|20364614|P3|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8258882|NCT01808339|20364615|P2|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8258883|NCT01808339|20364616|P1|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
8258884|NCT01808339|20364611|P6|COMPLETED|Washout Period 1 (14-21 Days)||5
8258885|NCT01808339|20364612|P5|COMPLETED|Washout Period 1 (14-21 Days)||4
8258886|NCT01808339|20364613|P4|COMPLETED|Washout Period 1 (14-21 Days)||2
8258887|NCT01808339|20364614|P3|COMPLETED|Washout Period 1 (14-21 Days)||4
8258888|NCT01808339|20364615|P2|COMPLETED|Washout Period 1 (14-21 Days)||3
8258889|NCT01808339|20364616|P1|COMPLETED|Washout Period 1 (14-21 Days)||4
8258890|NCT01808339|20364611|P6|STARTED|Washout Period 1 (14-21 Days)||5
8258891|NCT01808339|20364612|P5|STARTED|Washout Period 1 (14-21 Days)||4
8258892|NCT01808339|20364613|P4|STARTED|Washout Period 1 (14-21 Days)||2
8258893|NCT01808339|20364614|P3|STARTED|Washout Period 1 (14-21 Days)||4
8258894|NCT01808339|20364615|P2|STARTED|Washout Period 1 (14-21 Days)||3
8258895|NCT01808339|20364616|P1|STARTED|Washout Period 1 (14-21 Days)||4
8258896|NCT01808339|20364611|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8258897|NCT01808339|20364612|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8258898|NCT01808339|20364613|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8258899|NCT01808339|20364614|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8258900|NCT01808339|20364615|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8258901|NCT01808339|20364616|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8258902|NCT01808339|20364611|P6|COMPLETED|Treatment Period 1 (14 Days)||5
8258903|NCT01808339|20364612|P5|COMPLETED|Treatment Period 1 (14 Days)||4
8258904|NCT01808339|20364613|P4|COMPLETED|Treatment Period 1 (14 Days)||2
8258905|NCT01808339|20364614|P3|COMPLETED|Treatment Period 1 (14 Days)||4
8258906|NCT01808339|20364615|P2|COMPLETED|Treatment Period 1 (14 Days)||3
8258907|NCT01808339|20364616|P1|COMPLETED|Treatment Period 1 (14 Days)||4
8258908|NCT01808339|20364611|P6|STARTED|Treatment Period 1 (14 Days)||6
8258909|NCT01808339|20364612|P5|STARTED|Treatment Period 1 (14 Days)||6
8258910|NCT01808339|20364613|P4|STARTED|Treatment Period 1 (14 Days)||4
8258911|NCT01808339|20364614|P3|STARTED|Treatment Period 1 (14 Days)||4
8258912|NCT01808339|20364615|P2|STARTED|Treatment Period 1 (14 Days)||4
8258913|NCT01808339|20364616|P1|STARTED|Treatment Period 1 (14 Days)||4
8258914|NCT01808326|20364633|P1|NOT COMPLETED|Overall Study||0
8258915|NCT01808326|20364633|P1|COMPLETED|Overall Study||5
8258916|NCT01808326|20364633|P1|STARTED|Overall Study||5
8258917|NCT01808313|20364660|P1|NOT COMPLETED|Overall Study||10
8258918|NCT01808313|20364660|P1|COMPLETED|Overall Study||123
8258919|NCT01808313|20364660|P1|STARTED|Overall Study||133
8258920|NCT01808261|20364690|P2|NOT COMPLETED|Overall Study||33
8258921|NCT01808261|20364691|P1|NOT COMPLETED|Overall Study||36
8258922|NCT01808261|20364690|P2|COMPLETED|Overall Study||32
8258923|NCT01808261|20364691|P1|COMPLETED|Overall Study||32
8258924|NCT01808261|20364690|P2|STARTED|Overall Study||65
8258925|NCT01808261|20364691|P1|STARTED|Overall Study||68
8258926|NCT01808248|20364747|P1|NOT COMPLETED|Overall Study||5
8258927|NCT01808248|20364747|P1|COMPLETED|Overall Study||42
8258928|NCT01808248|20364747|P1|Completed Posttreatment Week 12 Visit|Overall Study||45
8258929|NCT01808248|20364747|P1|STARTED|Overall Study||47
8258930|NCT01808222|20364759|P1|NOT COMPLETED|Overall Study||1
8258931|NCT01808222|20364759|P1|COMPLETED|Overall Study||24
8258932|NCT01808222|20364759|P1|Completed mpMR Scan|Overall Study||24
8258933|NCT01808222|20364759|P1|Completed Fluciclovine PET-CT Scan|Overall Study||25
8258934|NCT01808222|20364759|P1|STARTED|Overall Study||25
8258935|NCT01808209|20364766|P2|NOT COMPLETED|Overall Study||1
8258936|NCT01808209|20364767|P1|NOT COMPLETED|Overall Study||0
8258937|NCT01808209|20364766|P2|COMPLETED|Overall Study||26
8258938|NCT01808209|20364767|P1|COMPLETED|Overall Study||33
8258939|NCT01808209|20364766|P2|STARTED|Overall Study||27
8258940|NCT01808209|20364767|P1|STARTED|Overall Study||33
8258941|NCT01808196|20364809|P1|NOT COMPLETED|Overall Study||1
8258942|NCT01808196|20364809|P1|COMPLETED|Overall Study||5
8258943|NCT01808196|20364809|P1|STARTED|Overall Study||6
8258944|NCT01808144|20364817|P2|NOT COMPLETED|Overall Study||48
8258945|NCT01808144|20364818|P1|NOT COMPLETED|Overall Study||40
8258946|NCT01808144|20364817|P2|COMPLETED|Overall Study||51
8258947|NCT01808144|20364818|P1|COMPLETED|Overall Study||57
8258948|NCT01808144|20364817|P2|STARTED|Overall Study||99
8258949|NCT01808144|20364818|P1|STARTED|Overall Study||97
8258950|NCT01808118|20364826|P3|NOT COMPLETED|Period 2||8
8258951|NCT01808118|20364827|P2|NOT COMPLETED|Period 2||13
8258952|NCT01808118|20364828|P1|NOT COMPLETED|Period 2||0
8258953|NCT01808118|20364826|P3|COMPLETED|Period 2||144
8258954|NCT01808118|20364827|P2|COMPLETED|Period 2||140
8258955|NCT01808118|20364828|P1|COMPLETED|Period 2||0
8258956|NCT01808118|20364826|P3|STARTED|Period 2||152
8258957|NCT01808118|20364827|P2|STARTED|Period 2||153
8258958|NCT01808118|20364828|P1|STARTED|Period 2||0
8258959|NCT01808118|20364826|P3|NOT COMPLETED|Period 1||0
8258960|NCT01808118|20364827|P2|NOT COMPLETED|Period 1||0
8258961|NCT01808118|20364828|P1|NOT COMPLETED|Period 1||368
8258962|NCT01808118|20364826|P3|COMPLETED|Period 1||0
8258963|NCT01808118|20364827|P2|COMPLETED|Period 1||0
8258964|NCT01808118|20364828|P1|COMPLETED|Period 1||305
8258965|NCT01808118|20364826|P3|STARTED|Period 1||0
8258966|NCT01808118|20364827|P2|STARTED|Period 1||0
8258967|NCT01808118|20364828|P1|STARTED|Period 1||673
8258968|NCT01808092|20364891|P2|NOT COMPLETED|Overall Study||45
8258969|NCT01808092|20364892|P1|NOT COMPLETED|Overall Study||54
8258970|NCT01808092|20364891|P2|COMPLETED|Overall Study||363
8258971|NCT01808092|20364892|P1|COMPLETED|Overall Study||355
8258972|NCT01808092|20364891|P2|STARTED|Overall Study||408
8258973|NCT01808092|20364892|P1|STARTED|Overall Study||409
8258974|NCT01808066|20364994|P1|NOT COMPLETED|Overall Study||15
8258975|NCT01808066|20364994|P1|COMPLETED|Overall Study||6
8258976|NCT01808066|20364994|P1|STARTED|Overall Study||21
8258977|NCT01807949|20365005|P3|NOT COMPLETED|Overall Study||9
8258978|NCT01807949|20365006|P2|NOT COMPLETED|Overall Study||7
8258979|NCT01807949|20365007|P1|NOT COMPLETED|Overall Study||2
8258980|NCT01807949|20365005|P3|COMPLETED|Overall Study||180
8258981|NCT01807949|20365006|P2|COMPLETED|Overall Study||180
8258982|NCT01807949|20365007|P1|COMPLETED|Overall Study||185
8258983|NCT01807949|20365005|P3|STARTED|Overall Study||189
8258984|NCT01807949|20365006|P2|STARTED|Overall Study||187
8258985|NCT01807949|20365007|P1|STARTED|Overall Study||187
8258986|NCT01807923|20365059|P3|NOT COMPLETED|Overall Study||11
8258987|NCT01807923|20365060|P2|NOT COMPLETED|Overall Study||6
8258988|NCT01807923|20365061|P1|NOT COMPLETED|Overall Study||5
8258989|NCT01807923|20365059|P3|COMPLETED|Overall Study||176
8258990|NCT01807923|20365060|P2|COMPLETED|Overall Study||179
8258991|NCT01807923|20365061|P1|COMPLETED|Overall Study||182
8258992|NCT01807923|20365059|P3|STARTED|Overall Study||187
8258993|NCT01807923|20365060|P2|STARTED|Overall Study||185
8258994|NCT01807923|20365061|P1|STARTED|Overall Study||187
8258995|NCT01807871|20365112|P2|NOT COMPLETED|Overall Study||218
8258996|NCT01807871|20365113|P1|NOT COMPLETED|Overall Study||178
8258997|NCT01807871|20365112|P2|COMPLETED|Overall Study||127
8258998|NCT01807871|20365113|P1|COMPLETED|Overall Study||178
8258999|NCT01807871|20365112|P2|STARTED|Overall Study||345
8259000|NCT01807871|20365113|P1|STARTED|Overall Study||356
8259001|NCT01807650|20365123|P1|NOT COMPLETED|Overall Study||20
8259002|NCT01807650|20365123|P1|COMPLETED|Overall Study||92
8259003|NCT01807650|20365123|P1|STARTED|Overall Study||112
8259004|NCT01807637|20365176|P2|NOT COMPLETED|One Month||0
8259005|NCT01807637|20365177|P1|NOT COMPLETED|One Month||0
8259006|NCT01807637|20365176|P2|COMPLETED|One Month||2
8259007|NCT01807637|20365177|P1|COMPLETED|One Month||4
8259008|NCT01807637|20365176|P2|STARTED|One Month||2
8259009|NCT01807637|20365177|P1|STARTED|One Month||4
8259010|NCT01807637|20365176|P2|NOT COMPLETED|One Week||0
8259011|NCT01807637|20365177|P1|NOT COMPLETED|One Week||0
8259012|NCT01807637|20365176|P2|COMPLETED|One Week||2
8259013|NCT01807637|20365177|P1|COMPLETED|One Week||4
8259014|NCT01807637|20365176|P2|STARTED|One Week||2
8259015|NCT01807637|20365177|P1|STARTED|One Week||4
8259016|NCT01807637|20365176|P2|NOT COMPLETED|Baseline||0
8259017|NCT01807637|20365177|P1|NOT COMPLETED|Baseline||0
8259018|NCT01807637|20365176|P2|COMPLETED|Baseline||2
8259019|NCT01807637|20365177|P1|COMPLETED|Baseline||4
8259020|NCT01807637|20365176|P2|STARTED|Baseline||2
8259021|NCT01807637|20365177|P1|STARTED|Baseline||4
8259022|NCT01807624|20365193|P1|NOT COMPLETED|Overall Study||0
8259023|NCT01807624|20365193|P1|COMPLETED|Overall Study||24
8259024|NCT01807624|20365193|P1|STARTED|Overall Study||24
8259025|NCT01807598|20365209|P1|NOT COMPLETED|Overall Study||6
8259026|NCT01807598|20365209|P1|COMPLETED|Overall Study||4
8259027|NCT01807598|20365209|P1|STARTED|Overall Study||10
8259028|NCT01807585|20365223|P3|NOT COMPLETED|Overall Study||6
8259029|NCT01807585|20365224|P2|NOT COMPLETED|Overall Study||4
8259030|NCT01807585|20365225|P1|NOT COMPLETED|Overall Study||1
8259031|NCT01807585|20365223|P3|COMPLETED|Overall Study||108
8259032|NCT01807585|20365224|P2|COMPLETED|Overall Study||104
8259033|NCT01807585|20365225|P1|COMPLETED|Overall Study||19
8259034|NCT01807585|20365223|P3|3 Mos|Overall Study||113
8259035|NCT01807585|20365224|P2|3 Mos|Overall Study||108
8259036|NCT01807585|20365225|P1|3 Mos|Overall Study||20
8259037|NCT01807585|20365223|P3|STARTED|Overall Study||114
8259038|NCT01807585|20365224|P2|STARTED|Overall Study||108
8259039|NCT01807585|20365225|P1|STARTED|Overall Study||20
8259040|NCT01807520|20365241|P7|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
8259041|NCT01807520|20365242|P6|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
8259042|NCT01807520|20365243|P5|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8259043|NCT01807520|20365244|P4|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8259044|NCT01807520|20365245|P3|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8259045|NCT01807520|20365246|P2|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8259046|NCT01807520|20365247|P1|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
8259047|NCT01807520|20365241|P7|COMPLETED|Follow-up Period (132-140 Weeks)||75
8259048|NCT01807520|20365242|P6|COMPLETED|Follow-up Period (132-140 Weeks)||77
8259049|NCT01807520|20365243|P5|COMPLETED|Follow-up Period (132-140 Weeks)||0
8259050|NCT01807520|20365244|P4|COMPLETED|Follow-up Period (132-140 Weeks)||0
8259051|NCT01807520|20365245|P3|COMPLETED|Follow-up Period (132-140 Weeks)||2
8259052|NCT01807520|20365246|P2|COMPLETED|Follow-up Period (132-140 Weeks)||0
8259053|NCT01807520|20365247|P1|COMPLETED|Follow-up Period (132-140 Weeks)||0
8259054|NCT01807520|20365241|P7|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
8259055|NCT01807520|20365242|P6|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
8259056|NCT01807520|20365243|P5|STARTED|Follow-up Period (132-140 Weeks)||0
8259057|NCT01807520|20365244|P4|STARTED|Follow-up Period (132-140 Weeks)||0
8259058|NCT01807520|20365245|P3|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
8259059|NCT01807520|20365246|P2|STARTED|Follow-up Period (132-140 Weeks)||0
8259060|NCT01807520|20365247|P1|STARTED|Follow-up Period (132-140 Weeks)||0
8259061|NCT01807520|20365241|P7|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8259062|NCT01807520|20365242|P6|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8259063|NCT01807520|20365243|P5|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
8259064|NCT01807520|20365244|P4|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
8259065|NCT01807520|20365245|P3|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8259066|NCT01807520|20365246|P2|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
8259067|NCT01807520|20365247|P1|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
8259068|NCT01807520|20365241|P7|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8259069|NCT01807520|20365242|P6|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8259070|NCT01807520|20365243|P5|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
8259071|NCT01807520|20365244|P4|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
8259072|NCT01807520|20365245|P3|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
8259073|NCT01807520|20365246|P2|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
8259074|NCT01807520|20365247|P1|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
8259075|NCT01807520|20365241|P7|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
8259076|NCT01807520|20365242|P6|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
8259077|NCT01807520|20365243|P5|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
8259078|NCT01807520|20365244|P4|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
8259079|NCT01807520|20365245|P3|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
8259080|NCT01807520|20365246|P2|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
8259081|NCT01807520|20365247|P1|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
8259082|NCT01807520|20365241|P7|Safety Set|Treatment Period 2 (16-132 Weeks)||0
8259083|NCT01807520|20365242|P6|Safety Set|Treatment Period 2 (16-132 Weeks)||0
8259084|NCT01807520|20365243|P5|Safety Set|Treatment Period 2 (16-132 Weeks)||29
8259085|NCT01807520|20365244|P4|Safety Set|Treatment Period 2 (16-132 Weeks)||29
8259086|NCT01807520|20365245|P3|Safety Set|Treatment Period 2 (16-132 Weeks)||0
8259087|NCT01807520|20365246|P2|Safety Set|Treatment Period 2 (16-132 Weeks)||65
8259088|NCT01807520|20365247|P1|Safety Set|Treatment Period 2 (16-132 Weeks)||63
8259089|NCT01807520|20365241|P7|STARTED|Treatment Period 2 (16-132 Weeks)||0
8259090|NCT01807520|20365242|P6|STARTED|Treatment Period 2 (16-132 Weeks)||0
8259091|NCT01807520|20365243|P5|STARTED|Treatment Period 2 (16-132 Weeks)||29
8259092|NCT01807520|20365244|P4|STARTED|Treatment Period 2 (16-132 Weeks)||29
8259093|NCT01807520|20365245|P3|STARTED|Treatment Period 2 (16-132 Weeks)||0
8259094|NCT01807520|20365246|P2|STARTED|Treatment Period 2 (16-132 Weeks)||65
8259095|NCT01807520|20365247|P1|STARTED|Treatment Period 2 (16-132 Weeks)||63
8259096|NCT01807520|20365241|P7|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259097|NCT01807520|20365242|P6|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259098|NCT01807520|20365243|P5|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259099|NCT01807520|20365244|P4|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259100|NCT01807520|20365245|P3|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
8259101|NCT01807520|20365246|P2|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
8259102|NCT01807520|20365247|P1|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
8259103|NCT01807520|20365241|P7|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259104|NCT01807520|20365242|P6|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259105|NCT01807520|20365243|P5|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259106|NCT01807520|20365244|P4|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
8259107|NCT01807520|20365245|P3|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
8259108|NCT01807520|20365246|P2|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
8259109|NCT01807520|20365247|P1|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
8259110|NCT01807520|20365241|P7|Safety Set|Treatment Period 1 (0-16 Weeks)||0
8259111|NCT01807520|20365242|P6|Safety Set|Treatment Period 1 (0-16 Weeks)||0
8259112|NCT01807520|20365243|P5|Safety Set|Treatment Period 1 (0-16 Weeks)||0
8259113|NCT01807520|20365244|P4|Safety Set|Treatment Period 1 (0-16 Weeks)||0
8259114|NCT01807520|20365245|P3|Safety Set|Treatment Period 1 (0-16 Weeks)||65
8259115|NCT01807520|20365246|P2|Safety Set|Treatment Period 1 (0-16 Weeks)||65
8259116|NCT01807520|20365247|P1|Safety Set|Treatment Period 1 (0-16 Weeks)||67
8259117|NCT01807520|20365241|P7|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
8259118|NCT01807520|20365242|P6|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
8259119|NCT01807520|20365243|P5|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
8259120|NCT01807520|20365244|P4|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
8259121|NCT01807520|20365245|P3|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
8259122|NCT01807520|20365246|P2|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
8259123|NCT01807520|20365247|P1|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
8259124|NCT01807520|20365241|P7|STARTED|Treatment Period 1 (0-16 Weeks)||0
8259125|NCT01807520|20365242|P6|STARTED|Treatment Period 1 (0-16 Weeks)||0
8259126|NCT01807520|20365243|P5|STARTED|Treatment Period 1 (0-16 Weeks)||0
8259127|NCT01807520|20365244|P4|STARTED|Treatment Period 1 (0-16 Weeks)||0
8259128|NCT01807520|20365245|P3|STARTED|Treatment Period 1 (0-16 Weeks)||65
8259129|NCT01807520|20365246|P2|STARTED|Treatment Period 1 (0-16 Weeks)||66
8259130|NCT01807520|20365247|P1|STARTED|Treatment Period 1 (0-16 Weeks)||67
8259131|NCT01807455|20365266|P1|NOT COMPLETED|Overall Study||0
8259132|NCT01807455|20365266|P1|COMPLETED|Overall Study||12
8259133|NCT01807455|20365266|P1|STARTED|Overall Study||12
8259134|NCT01807299|20365278|P4|NOT COMPLETED|Overall Study||2
8259135|NCT01807299|20365279|P3|NOT COMPLETED|Overall Study||0
8259136|NCT01807299|20365280|P2|NOT COMPLETED|Overall Study||1
8259137|NCT01807299|20365281|P1|NOT COMPLETED|Overall Study||3
8259138|NCT01807299|20365278|P4|COMPLETED|Overall Study||11
8259139|NCT01807299|20365279|P3|COMPLETED|Overall Study||12
8259140|NCT01807299|20365280|P2|COMPLETED|Overall Study||13
8259141|NCT01807299|20365281|P1|COMPLETED|Overall Study||11
8259142|NCT01807299|20365278|P4|STARTED|Overall Study||13
8259143|NCT01807299|20365279|P3|STARTED|Overall Study||12
8259144|NCT01807299|20365280|P2|STARTED|Overall Study||14
8259145|NCT01807299|20365281|P1|STARTED|Overall Study||14
8259146|NCT01807234|20365297|P6|NOT COMPLETED|Overall Study||4
8259147|NCT01807234|20365298|P5|NOT COMPLETED|Overall Study||4
8259148|NCT01807234|20365299|P4|NOT COMPLETED|Overall Study||2
8259149|NCT01807234|20365300|P3|NOT COMPLETED|Overall Study||2
8259150|NCT01807234|20365301|P2|NOT COMPLETED|Overall Study||6
8259151|NCT01807234|20365302|P1|NOT COMPLETED|Overall Study||5
8259152|NCT01807234|20365297|P6|COMPLETED|Overall Study||8
8259153|NCT01807234|20365298|P5|COMPLETED|Overall Study||8
8259154|NCT01807234|20365299|P4|COMPLETED|Overall Study||10
8259155|NCT01807234|20365300|P3|COMPLETED|Overall Study||10
8259156|NCT01807234|20365301|P2|COMPLETED|Overall Study||6
8259157|NCT01807234|20365302|P1|COMPLETED|Overall Study||7
8259158|NCT01807234|20365297|P6|Completed Only 1 Attack|Overall Study||1
8259159|NCT01807234|20365298|P5|Completed Only 1 Attack|Overall Study||0
8259160|NCT01807234|20365299|P4|Completed Only 1 Attack|Overall Study||1
8259161|NCT01807234|20365300|P3|Completed Only 1 Attack|Overall Study||0
8259162|NCT01807234|20365301|P2|Completed Only 1 Attack|Overall Study||1
8259163|NCT01807234|20365302|P1|Completed Only 1 Attack|Overall Study||2
8259164|NCT01807234|20365297|P6|Randomized, But Did Not Take Drug|Overall Study||3
8259165|NCT01807234|20365298|P5|Randomized, But Did Not Take Drug|Overall Study||4
8259166|NCT01807234|20365299|P4|Randomized, But Did Not Take Drug|Overall Study||1
8259167|NCT01807234|20365300|P3|Randomized, But Did Not Take Drug|Overall Study||2
8259168|NCT01807234|20365301|P2|Randomized, But Did Not Take Drug|Overall Study||5
8259169|NCT01807234|20365302|P1|Randomized, But Did Not Take Drug|Overall Study||3
8259170|NCT01807234|20365297|P6|STARTED|Overall Study||12
8259171|NCT01807234|20365298|P5|STARTED|Overall Study||12
8259172|NCT01807234|20365299|P4|STARTED|Overall Study||12
8259173|NCT01807234|20365300|P3|STARTED|Overall Study||12
8259174|NCT01807234|20365301|P2|STARTED|Overall Study||12
8259175|NCT01807234|20365302|P1|STARTED|Overall Study||12
8259176|NCT01807156|20365337|P1|NOT COMPLETED|Overall Study||1
8259177|NCT01807156|20365337|P1|COMPLETED|Overall Study||6
8259178|NCT01807156|20365337|P1|STARTED|Overall Study||7
8259179|NCT01807104|20365344|P2|NOT COMPLETED|Overall Study||4
8259180|NCT01807104|20365345|P1|NOT COMPLETED|Overall Study||4
8259181|NCT01807104|20365344|P2|COMPLETED|Overall Study||40
8259182|NCT01807104|20365345|P1|COMPLETED|Overall Study||39
8259183|NCT01807104|20365344|P2|STARTED|Overall Study||44
8259184|NCT01807104|20365345|P1|STARTED|Overall Study||43
8259185|NCT01807065|20365353|P2|NOT COMPLETED|Overall Study||1
8259186|NCT01807065|20365354|P1|NOT COMPLETED|Overall Study||1
8259187|NCT01807065|20365353|P2|COMPLETED|Overall Study||25
8259188|NCT01807065|20365354|P1|COMPLETED|Overall Study||24
8259189|NCT01807065|20365353|P2|STARTED|Overall Study||26
8259190|NCT01807065|20365354|P1|STARTED|Overall Study||25
8259191|NCT01807026|20365368|P6|NOT COMPLETED|Overall Study||0
8259192|NCT01807026|20365369|P5|NOT COMPLETED|Overall Study||0
8259193|NCT01807026|20365370|P4|NOT COMPLETED|Overall Study||0
8259194|NCT01807026|20365371|P3|NOT COMPLETED|Overall Study||0
8259195|NCT01807026|20365372|P2|NOT COMPLETED|Overall Study||0
8259196|NCT01807026|20365373|P1|NOT COMPLETED|Overall Study||0
8259197|NCT01807026|20365368|P6|COMPLETED|Overall Study||3
8259198|NCT01807026|20365369|P5|COMPLETED|Overall Study||9
8259199|NCT01807026|20365370|P4|COMPLETED|Overall Study||2
8259200|NCT01807026|20365371|P3|COMPLETED|Overall Study||10
8259201|NCT01807026|20365372|P2|COMPLETED|Overall Study||2
8259202|NCT01807026|20365373|P1|COMPLETED|Overall Study||10
8259203|NCT01807026|20365368|P6|Received at Least One Dose of Study Drug|Overall Study||3
8259204|NCT01807026|20365369|P5|Received at Least One Dose of Study Drug|Overall Study||9
8259205|NCT01807026|20365370|P4|Received at Least One Dose of Study Drug|Overall Study||2
8259206|NCT01807026|20365371|P3|Received at Least One Dose of Study Drug|Overall Study||10
8259207|NCT01807026|20365372|P2|Received at Least One Dose of Study Drug|Overall Study||2
8259208|NCT01807026|20365373|P1|Received at Least One Dose of Study Drug|Overall Study||10
8259209|NCT01807026|20365368|P6|STARTED|Overall Study||3
8259210|NCT01807026|20365369|P5|STARTED|Overall Study||9
8259211|NCT01807026|20365370|P4|STARTED|Overall Study||2
8259212|NCT01807026|20365371|P3|STARTED|Overall Study||10
8259213|NCT01807026|20365372|P2|STARTED|Overall Study||2
8259214|NCT01807026|20365373|P1|STARTED|Overall Study||10
8259218|NCT01806961|20365420|P1|NOT COMPLETED|Overall Study||16
8259219|NCT01806961|20365420|P1|COMPLETED|Overall Study||0
8259220|NCT01806961|20365420|P1|STARTED|Overall Study||16
8259221|NCT01806896|20365426|P2|NOT COMPLETED|Overall Study||0
8259222|NCT01806896|20365427|P1|NOT COMPLETED|Overall Study||3
8259223|NCT01806896|20365426|P2|COMPLETED|Overall Study||17
8259224|NCT01806896|20365427|P1|COMPLETED|Overall Study||17
8259225|NCT01806896|20365426|P2|Received Treatment|Overall Study||17
8259226|NCT01806896|20365427|P1|Received Treatment|Overall Study||19
8259227|NCT01806896|20365426|P2|STARTED|Overall Study||17
8259228|NCT01806896|20365427|P1|STARTED|Overall Study||20
8259229|NCT01806857|20365455|P2|NOT COMPLETED|Overall Study||0
8259230|NCT01806857|20365456|P1|NOT COMPLETED|Overall Study||1
8259231|NCT01806857|20365455|P2|COMPLETED|Overall Study||29
8259232|NCT01806857|20365456|P1|COMPLETED|Overall Study||30
8259233|NCT01806857|20365455|P2|STARTED|Overall Study||29
8259234|NCT01806857|20365456|P1|STARTED|Overall Study||31
8259235|NCT01806779|20365494|P3|NOT COMPLETED|Overall Study||23
8259236|NCT01806779|20365495|P2|NOT COMPLETED|Overall Study||44
8259237|NCT01806779|20365496|P1|NOT COMPLETED|Overall Study||42
8259238|NCT01806779|20365494|P3|COMPLETED|Overall Study||0
8259239|NCT01806779|20365495|P2|COMPLETED|Overall Study||40
8259240|NCT01806779|20365496|P1|COMPLETED|Overall Study||48
8259241|NCT01806779|20365494|P3|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
8259242|NCT01806779|20365495|P2|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
8259243|NCT01806779|20365496|P1|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
8259244|NCT01806779|20365494|P3|Randomized at Visit 2|Overall Study||0
8259245|NCT01806779|20365495|P2|Randomized at Visit 2|Overall Study||84
8259246|NCT01806779|20365496|P1|Randomized at Visit 2|Overall Study||90
8259247|NCT01806779|20365494|P3|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
8259248|NCT01806779|20365495|P2|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
8259249|NCT01806779|20365496|P1|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
8259250|NCT01806779|20365494|P3|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
8259251|NCT01806779|20365495|P2|STARTED|Overall Study||84
8259252|NCT01806779|20365496|P1|STARTED|Overall Study||90
8259253|NCT01806740|20365509|P1|NOT COMPLETED|Overall Study||6
8259254|NCT01806740|20365509|P1|COMPLETED|Overall Study||31
8259255|NCT01806740|20365509|P1|STARTED|Overall Study||37
8259256|NCT01806714|20365520|P2|NOT COMPLETED|Overall Study||170
8259257|NCT01806714|20365521|P1|NOT COMPLETED|Overall Study||200
8259258|NCT01806714|20365520|P2|COMPLETED|Overall Study||1919
8259259|NCT01806714|20365521|P1|COMPLETED|Overall Study||1893
8259260|NCT01806714|20365520|P2|STARTED|Overall Study||2089
8259261|NCT01806714|20365521|P1|STARTED|Overall Study||2093
8259262|NCT01806675|20365534|P3|NOT COMPLETED|Overall Study||0
8259263|NCT01806675|20365535|P2|NOT COMPLETED|Overall Study||0
8259264|NCT01806675|20365536|P1|NOT COMPLETED|Overall Study||0
8259265|NCT01806675|20365534|P3|COMPLETED|Overall Study||8
8259266|NCT01806675|20365535|P2|COMPLETED|Overall Study||6
8259267|NCT01806675|20365536|P1|COMPLETED|Overall Study||11
8259268|NCT01806675|20365534|P3|STARTED|Overall Study||8
8259269|NCT01806675|20365535|P2|STARTED|Overall Study||6
8259270|NCT01806675|20365536|P1|STARTED|Overall Study||11
8259271|NCT01806662|20365556|P2|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
8259272|NCT01806662|20365557|P1|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
8259273|NCT01806662|20365556|P2|COMPLETED|Second Intervention (Weeks 16-32)||11
8259274|NCT01806662|20365557|P1|COMPLETED|Second Intervention (Weeks 16-32)||10
8259275|NCT01806662|20365556|P2|STARTED|Second Intervention (Weeks 16-32)||15
8259276|NCT01806662|20365557|P1|STARTED|Second Intervention (Weeks 16-32)||12
8259277|NCT01806662|20365556|P2|NOT COMPLETED|First Intervention (Weeks 0-16)||1
8259278|NCT01806662|20365557|P1|NOT COMPLETED|First Intervention (Weeks 0-16)||4
8259279|NCT01806662|20365556|P2|COMPLETED|First Intervention (Weeks 0-16)||15
8259280|NCT01806662|20365557|P1|COMPLETED|First Intervention (Weeks 0-16)||12
8259281|NCT01806662|20365556|P2|Received Intervention|First Intervention (Weeks 0-16)||15
8259282|NCT01806662|20365557|P1|Received Intervention|First Intervention (Weeks 0-16)||12
8259283|NCT01806662|20365556|P2|STARTED|First Intervention (Weeks 0-16)||16
8259284|NCT01806662|20365557|P1|STARTED|First Intervention (Weeks 0-16)||16
8259285|NCT01806597|20365566|P6|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
8259286|NCT01806597|20365567|P5|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259287|NCT01806597|20365568|P4|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259288|NCT01806597|20365569|P3|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259289|NCT01806597|20365570|P2|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259290|NCT01806597|20365571|P1|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259291|NCT01806597|20365566|P6|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
8259292|NCT01806597|20365567|P5|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
8259293|NCT01806597|20365568|P4|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259294|NCT01806597|20365569|P3|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259295|NCT01806597|20365570|P2|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259296|NCT01806597|20365571|P1|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
8259297|NCT01806597|20365566|P6|STARTED|Follow-up Period (Week 132 to Week 140)||161
8259298|NCT01806597|20365567|P5|STARTED|Follow-up Period (Week 132 to Week 140)||3
8259299|NCT01806597|20365568|P4|STARTED|Follow-up Period (Week 132 to Week 140)||0
8259300|NCT01806597|20365569|P3|STARTED|Follow-up Period (Week 132 to Week 140)||0
8259301|NCT01806597|20365570|P2|STARTED|Follow-up Period (Week 132 to Week 140)||0
8259302|NCT01806597|20365571|P1|STARTED|Follow-up Period (Week 132 to Week 140)||0
8259303|NCT01806597|20365566|P6|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
8259304|NCT01806597|20365567|P5|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
8259305|NCT01806597|20365568|P4|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
8259306|NCT01806597|20365569|P3|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
8259307|NCT01806597|20365570|P2|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
8259308|NCT01806597|20365571|P1|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
8259309|NCT01806597|20365566|P6|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
8259310|NCT01806597|20365567|P5|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
8259311|NCT01806597|20365568|P4|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
8259312|NCT01806597|20365569|P3|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
8259313|NCT01806597|20365570|P2|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
8259314|NCT01806597|20365571|P1|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
8259315|NCT01806597|20365566|P6|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
8259316|NCT01806597|20365567|P5|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
8259317|NCT01806597|20365568|P4|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
8259318|NCT01806597|20365569|P3|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
8259319|NCT01806597|20365570|P2|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
8259320|NCT01806597|20365571|P1|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
8259321|NCT01806597|20365566|P6|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
8259322|NCT01806597|20365567|P5|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
8259323|NCT01806597|20365568|P4|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
8259324|NCT01806597|20365569|P3|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
8259325|NCT01806597|20365570|P2|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
8259326|NCT01806597|20365571|P1|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
8259327|NCT01806597|20365566|P6|COMPLETED|Period 1 (Baseline to Week 16)||0
8259328|NCT01806597|20365567|P5|COMPLETED|Period 1 (Baseline to Week 16)||63
8259329|NCT01806597|20365568|P4|COMPLETED|Period 1 (Baseline to Week 16)||0
8259330|NCT01806597|20365569|P3|COMPLETED|Period 1 (Baseline to Week 16)||0
8259331|NCT01806597|20365570|P2|COMPLETED|Period 1 (Baseline to Week 16)||64
8259332|NCT01806597|20365571|P1|COMPLETED|Period 1 (Baseline to Week 16)||63
8259333|NCT01806597|20365566|P6|STARTED|Period 1 (Baseline to Week 16)||0
8259334|NCT01806597|20365567|P5|STARTED|Period 1 (Baseline to Week 16)||68
8259335|NCT01806597|20365568|P4|STARTED|Period 1 (Baseline to Week 16)||0
8259336|NCT01806597|20365569|P3|STARTED|Period 1 (Baseline to Week 16)||0
8259337|NCT01806597|20365570|P2|STARTED|Period 1 (Baseline to Week 16)||69
8259338|NCT01806597|20365571|P1|STARTED|Period 1 (Baseline to Week 16)||68
8259345|NCT01806571|20365620|P1|NOT COMPLETED|Overall Study||0
8259346|NCT01806571|20365620|P1|COMPLETED|Overall Study||34
8259347|NCT01806571|20365620|P1|STARTED|Overall Study||34
8259354|NCT01806506|20365655|P2|NOT COMPLETED|Overall Study||1
8259355|NCT01806506|20365656|P1|NOT COMPLETED|Overall Study||2
8259356|NCT01806506|20365655|P2|COMPLETED|Overall Study||35
8259357|NCT01806506|20365656|P1|COMPLETED|Overall Study||34
8259358|NCT01806506|20365655|P2|9 Months|Overall Study|1 patient (reason - lost contact)|35
8259359|NCT01806506|20365656|P1|9 Months|Overall Study||34
8259360|NCT01806506|20365655|P2|6 Months|Overall Study||36
8259361|NCT01806506|20365656|P1|6 Months|Overall Study|1 patient (reason - lost contact)|34
8259362|NCT01806506|20365655|P2|3 Months|Overall Study||36
8259363|NCT01806506|20365656|P1|3 Months|Overall Study|1 patient (reason - lost contact)|35
8259364|NCT01806506|20365655|P2|1 Month|Overall Study||36
8259365|NCT01806506|20365656|P1|1 Month|Overall Study||36
8259366|NCT01806506|20365655|P2|STARTED|Overall Study||36
8259367|NCT01806506|20365656|P1|STARTED|Overall Study||36
8259368|NCT01806389|20365662|P1|NOT COMPLETED|Overall Study||4
8259369|NCT01806389|20365662|P1|COMPLETED|Overall Study||10
8259370|NCT01806389|20365662|P1|STARTED|Overall Study||14
8259371|NCT01806298|20365676|P1|NOT COMPLETED|Overall Study||10
8259372|NCT01806298|20365676|P1|COMPLETED|Overall Study||68
8259373|NCT01806298|20365676|P1|STARTED|Overall Study||78
8259374|NCT01806259|20365688|P2|NOT COMPLETED|Overall Study||0
8259375|NCT01806259|20365689|P1|NOT COMPLETED|Overall Study||0
8259376|NCT01806259|20365688|P2|COMPLETED|Overall Study||107
8259377|NCT01806259|20365689|P1|COMPLETED|Overall Study||96
8259378|NCT01806259|20365688|P2|STARTED|Overall Study||107
8259379|NCT01806259|20365689|P1|STARTED|Overall Study||96
8259380|NCT01806064|20365702|P5|NOT COMPLETED|Overall Study||2
8259381|NCT01806064|20365703|P4|NOT COMPLETED|Overall Study||1
8259382|NCT01806064|20365704|P3|NOT COMPLETED|Overall Study||0
8259383|NCT01806064|20365705|P2|NOT COMPLETED|Overall Study||0
8259384|NCT01806064|20365706|P1|NOT COMPLETED|Overall Study||0
8259385|NCT01806064|20365702|P5|COMPLETED|Overall Study||73
8259386|NCT01806064|20365703|P4|COMPLETED|Overall Study||74
8259387|NCT01806064|20365704|P3|COMPLETED|Overall Study||5
8259388|NCT01806064|20365705|P2|COMPLETED|Overall Study||15
8259389|NCT01806064|20365706|P1|COMPLETED|Overall Study||3
8259390|NCT01806064|20365702|P5|STARTED|Overall Study||75
8259391|NCT01806064|20365703|P4|STARTED|Overall Study||75
8259392|NCT01806064|20365704|P3|STARTED|Overall Study||5
8259393|NCT01806064|20365705|P2|STARTED|Overall Study||15
8259394|NCT01806064|20365706|P1|STARTED|Overall Study||3
8259395|NCT01806051|20365731|P1|NOT COMPLETED|Overall Study||6
8259396|NCT01806051|20365731|P1|COMPLETED|Overall Study||0
8259397|NCT01806051|20365731|P1|STARTED|Overall Study||6
8259398|NCT01805895|20365739|P2|NOT COMPLETED|Overall Study||0
8259399|NCT01805895|20365740|P1|NOT COMPLETED|Overall Study||0
8259400|NCT01805895|20365739|P2|COMPLETED|Overall Study||8
8259401|NCT01805895|20365740|P1|COMPLETED|Overall Study||8
8259402|NCT01805895|20365739|P2|STARTED|Overall Study||8
8259403|NCT01805895|20365740|P1|STARTED|Overall Study||8
8259404|NCT01805882|20365757|P9|NOT COMPLETED|Overall Study||1
8259405|NCT01805882|20365758|P8|NOT COMPLETED|Overall Study||0
8259406|NCT01805882|20365759|P7|NOT COMPLETED|Overall Study||2
8259407|NCT01805882|20365760|P6|NOT COMPLETED|Overall Study||1
8259408|NCT01805882|20365761|P5|NOT COMPLETED|Overall Study||0
8259409|NCT01805882|20365762|P4|NOT COMPLETED|Overall Study||2
8259410|NCT01805882|20365763|P3|NOT COMPLETED|Overall Study||1
8259411|NCT01805882|20365764|P2|NOT COMPLETED|Overall Study||0
8259412|NCT01805882|20365765|P1|NOT COMPLETED|Overall Study||0
8259413|NCT01805882|20365757|P9|COMPLETED|Overall Study||24
8259414|NCT01805882|20365758|P8|COMPLETED|Overall Study||25
8259415|NCT01805882|20365759|P7|COMPLETED|Overall Study||48
8259416|NCT01805882|20365760|P6|COMPLETED|Overall Study||20
8259417|NCT01805882|20365761|P5|COMPLETED|Overall Study||14
8259418|NCT01805882|20365762|P4|COMPLETED|Overall Study||32
8259419|NCT01805882|20365763|P3|COMPLETED|Overall Study||19
8259420|NCT01805882|20365764|P2|COMPLETED|Overall Study||20
8259421|NCT01805882|20365765|P1|COMPLETED|Overall Study||20
8259422|NCT01805882|20365757|P9|STARTED|Overall Study||25
8259423|NCT01805882|20365758|P8|STARTED|Overall Study||25
8259424|NCT01805882|20365759|P7|STARTED|Overall Study||50
8259425|NCT01805882|20365760|P6|STARTED|Overall Study||21
8259426|NCT01805882|20365761|P5|STARTED|Overall Study||14
8259427|NCT01805882|20365762|P4|STARTED|Overall Study||34
8259428|NCT01805882|20365763|P3|STARTED|Overall Study||20
8259429|NCT01805882|20365764|P2|STARTED|Overall Study||20
8259430|NCT01805882|20365765|P1|STARTED|Overall Study||20
8259431|NCT01805791|20365788|P3|NOT COMPLETED|Overall Study||20
8259432|NCT01805791|20365789|P2|NOT COMPLETED|Overall Study||17
8259433|NCT01805791|20365790|P1|NOT COMPLETED|Overall Study||22
8259434|NCT01805791|20365788|P3|COMPLETED|Overall Study||48
8259435|NCT01805791|20365789|P2|COMPLETED|Overall Study||50
8259436|NCT01805791|20365790|P1|COMPLETED|Overall Study||44
8259437|NCT01805791|20365788|P3|STARTED|Overall Study||68
8259438|NCT01805791|20365789|P2|STARTED|Overall Study||67
8259439|NCT01805791|20365790|P1|STARTED|Overall Study||66
8259440|NCT01805687|20365804|P1|NOT COMPLETED|Overall Study||0
8259441|NCT01805687|20365804|P1|COMPLETED|Overall Study||25
8259442|NCT01805687|20365804|P1|STARTED|Overall Study||25
8259443|NCT01805440|20365811|P3|NOT COMPLETED|Overall Study||0
8259444|NCT01805440|20365812|P2|NOT COMPLETED|Overall Study||0
8259445|NCT01805440|20365813|P1|NOT COMPLETED|Overall Study||1
8259446|NCT01805440|20365811|P3|COMPLETED|Overall Study||26
8259447|NCT01805440|20365812|P2|COMPLETED|Overall Study||17
8259448|NCT01805440|20365813|P1|COMPLETED|Overall Study||18
8259449|NCT01805440|20365811|P3|STARTED|Overall Study||26
8259450|NCT01805440|20365812|P2|STARTED|Overall Study||17
8259451|NCT01805440|20365813|P1|STARTED|Overall Study||19
8259452|NCT01805323|20365826|P1|NOT COMPLETED|Overall Study||0
8259453|NCT01805323|20365826|P1|COMPLETED|Overall Study||101
8259454|NCT01805323|20365826|P1|STARTED|Overall Study||101
8259455|NCT01805297|20365833|P2|NOT COMPLETED|Overall Study||3
8259456|NCT01805297|20365834|P1|NOT COMPLETED|Overall Study||2
8259457|NCT01805297|20365833|P2|COMPLETED|Overall Study||3
8259458|NCT01805297|20365834|P1|COMPLETED|Overall Study||4
8259459|NCT01805297|20365833|P2|STARTED|Overall Study||6
8259460|NCT01805297|20365834|P1|STARTED|Overall Study||6
8259461|NCT01805180|20365848|P3|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
8259462|NCT01805180|20365849|P2|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
8259463|NCT01805180|20365850|P1|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
8259464|NCT01805180|20365848|P3|COMPLETED|Pivotal Randomization Through Study Exit||15
8259465|NCT01805180|20365849|P2|COMPLETED|Pivotal Randomization Through Study Exit||17
8259466|NCT01805180|20365850|P1|COMPLETED|Pivotal Randomization Through Study Exit||0
8259467|NCT01805180|20365848|P3|STARTED|Pivotal Randomization Through Study Exit||20
8259468|NCT01805180|20365849|P2|STARTED|Pivotal Randomization Through Study Exit||22
8259469|NCT01805180|20365850|P1|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
8259470|NCT01805180|20365848|P3|NOT COMPLETED|Lead-in Donor Phase||0
8259471|NCT01805180|20365849|P2|NOT COMPLETED|Lead-in Donor Phase||0
8259472|NCT01805180|20365850|P1|NOT COMPLETED|Lead-in Donor Phase||1
8259473|NCT01805180|20365848|P3|COMPLETED|Lead-in Donor Phase||0
8259474|NCT01805180|20365849|P2|COMPLETED|Lead-in Donor Phase||0
8259475|NCT01805180|20365850|P1|COMPLETED|Lead-in Donor Phase||6
8259476|NCT01805180|20365848|P3|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
8259477|NCT01805180|20365849|P2|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
8259478|NCT01805180|20365850|P1|STARTED|Lead-in Donor Phase||7
8259479|NCT01805154|20365873|P1|NOT COMPLETED|Overall Study||354
8259480|NCT01805154|20365873|P1|COMPLETED|Overall Study||1175
8259481|NCT01805154|20365873|P1|STARTED|Overall Study||1529
8259482|NCT01805089|20365883|P2|NOT COMPLETED|Overall Study||4
8259483|NCT01805089|20365884|P1|NOT COMPLETED|Overall Study||5
8259484|NCT01805089|20365883|P2|COMPLETED|Overall Study||43
8259485|NCT01805089|20365884|P1|COMPLETED|Overall Study||43
8259486|NCT01805089|20365883|P2|STARTED|Overall Study||47
8259487|NCT01805089|20365884|P1|STARTED|Overall Study||48
8259488|NCT01805037|20365894|P2|NOT COMPLETED|Follow Up (up to 3 Years)||6
8259489|NCT01805037|20365895|P1|NOT COMPLETED|Follow Up (up to 3 Years)||0
8259490|NCT01805037|20365894|P2|COMPLETED|Follow Up (up to 3 Years)||14
8259491|NCT01805037|20365895|P1|COMPLETED|Follow Up (up to 3 Years)||0
8259492|NCT01805037|20365894|P2|STARTED|Follow Up (up to 3 Years)|Patients who received at least one dose of study treatment go into follow-up.|20
8259493|NCT01805037|20365895|P1|STARTED|Follow Up (up to 3 Years)||0
8259494|NCT01805037|20365894|P2|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||12
8259495|NCT01805037|20365895|P1|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||0
8259496|NCT01805037|20365894|P2|COMPLETED|2nd Cycle of Maintenance and Beyond||2
8259497|NCT01805037|20365895|P1|COMPLETED|2nd Cycle of Maintenance and Beyond||0
8259498|NCT01805037|20365894|P2|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||14
8259499|NCT01805037|20365895|P1|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||0
8259500|NCT01805037|20365894|P2|STARTED|2nd Cycle of Maintenance and Beyond||14
8259501|NCT01805037|20365895|P1|STARTED|2nd Cycle of Maintenance and Beyond||0
8259502|NCT01805037|20365894|P2|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||6
8259503|NCT01805037|20365895|P1|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
8259504|NCT01805037|20365894|P2|COMPLETED|1st Cycle of Maintenance (3 Weeks)||14
8259505|NCT01805037|20365895|P1|COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
8259506|NCT01805037|20365894|P2|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||14
8259507|NCT01805037|20365895|P1|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||0
8259508|NCT01805037|20365894|P2|STARTED|1st Cycle of Maintenance (3 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction|20
8259509|NCT01805037|20365895|P1|STARTED|1st Cycle of Maintenance (3 Weeks)||0
8259510|NCT01805037|20365894|P2|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
8259511|NCT01805037|20365895|P1|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
8259512|NCT01805037|20365894|P2|COMPLETED|Consolidation (Optional, 4 Weeks)||6
8259513|NCT01805037|20365895|P1|COMPLETED|Consolidation (Optional, 4 Weeks)||0
8259514|NCT01805037|20365894|P2|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||6
8259515|NCT01805037|20365895|P1|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||0
8259516|NCT01805037|20365894|P2|STARTED|Consolidation (Optional, 4 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction.|6
8259517|NCT01805037|20365895|P1|STARTED|Consolidation (Optional, 4 Weeks)||0
8259518|NCT01805037|20365894|P2|NOT COMPLETED|Induction (4 Weeks)||0
8259519|NCT01805037|20365895|P1|NOT COMPLETED|Induction (4 Weeks)||0
8259520|NCT01805037|20365894|P2|COMPLETED|Induction (4 Weeks)||20
8259521|NCT01805037|20365895|P1|COMPLETED|Induction (4 Weeks)||0
8259522|NCT01805037|20365894|P2|Received Dose of Study Drug|Induction (4 Weeks)||20
8259523|NCT01805037|20365895|P1|Received Dose of Study Drug|Induction (4 Weeks)||0
8259524|NCT01805037|20365894|P2|STARTED|Induction (4 Weeks)||20
8259525|NCT01805037|20365895|P1|STARTED|Induction (4 Weeks)||0
8259526|NCT01805024|20365913|P4|NOT COMPLETED|Overall Study||0
8259527|NCT01805024|20365914|P3|NOT COMPLETED|Overall Study||0
8259528|NCT01805024|20365915|P2|NOT COMPLETED|Overall Study||0
8259529|NCT01805024|20365916|P1|NOT COMPLETED|Overall Study||0
8259530|NCT01805024|20365913|P4|COMPLETED|Overall Study||8
8259531|NCT01805024|20365914|P3|COMPLETED|Overall Study||4
8259532|NCT01805024|20365915|P2|COMPLETED|Overall Study||4
8259533|NCT01805024|20365916|P1|COMPLETED|Overall Study||4
8259534|NCT01805024|20365913|P4|STARTED|Overall Study||8
8259535|NCT01805024|20365914|P3|STARTED|Overall Study||4
8259536|NCT01805024|20365915|P2|STARTED|Overall Study||4
8259537|NCT01805024|20365916|P1|STARTED|Overall Study||4
8259538|NCT01804946|20365940|P2|NOT COMPLETED|Overall Study||4
8259539|NCT01804946|20365941|P1|NOT COMPLETED|Overall Study||2
8259540|NCT01804946|20365940|P2|COMPLETED|Overall Study||76
8259541|NCT01804946|20365941|P1|COMPLETED|Overall Study||79
8259542|NCT01804946|20365940|P2|STARTED|Overall Study||80
8259543|NCT01804946|20365941|P1|STARTED|Overall Study||81
8259544|NCT01804881|20365965|P2|NOT COMPLETED|Overall Study||4
8259545|NCT01804881|20365966|P1|NOT COMPLETED|Overall Study||5
8259546|NCT01804881|20365965|P2|COMPLETED|Overall Study||10
8259547|NCT01804881|20365966|P1|COMPLETED|Overall Study||11
8259548|NCT01804881|20365965|P2|STARTED|Overall Study||14
8259549|NCT01804881|20365966|P1|STARTED|Overall Study||16
8259550|NCT01804842|20365979|P3|NOT COMPLETED|Overall Study||1
8259551|NCT01804842|20365980|P2|NOT COMPLETED|Overall Study||2
8259552|NCT01804842|20365981|P1|NOT COMPLETED|Overall Study||3
8259553|NCT01804842|20365979|P3|COMPLETED|Overall Study||8
8259554|NCT01804842|20365980|P2|COMPLETED|Overall Study||6
8259555|NCT01804842|20365981|P1|COMPLETED|Overall Study||6
8259556|NCT01804842|20365979|P3|Completed Treatment C|Overall Study||9
8259557|NCT01804842|20365980|P2|Completed Treatment C|Overall Study||7
8259558|NCT01804842|20365981|P1|Completed Treatment C|Overall Study||7
8259559|NCT01804842|20365979|P3|Completed Treatment B|Overall Study||8
8259560|NCT01804842|20365980|P2|Completed Treatment B|Overall Study||8
8259561|NCT01804842|20365981|P1|Completed Treatment B|Overall Study||8
8259562|NCT01804842|20365979|P3|Completed Treatment A|Overall Study||8
8259563|NCT01804842|20365980|P2|Completed Treatment A|Overall Study||6
8259564|NCT01804842|20365981|P1|Completed Treatment A|Overall Study||9
8259565|NCT01804842|20365979|P3|STARTED|Overall Study||9
8259566|NCT01804842|20365980|P2|STARTED|Overall Study||8
8259567|NCT01804842|20365981|P1|STARTED|Overall Study||9
8259574|NCT01804673|20366010|P1|NOT COMPLETED|Overall Study||140
8259575|NCT01804673|20366010|P1|COMPLETED|Overall Study||34
8259576|NCT01804673|20366010|P1|Completed Hour 72|Overall Study||36
8259577|NCT01804673|20366010|P1|Completed Hour 48|Overall Study||79
8259578|NCT01804673|20366010|P1|Completed Hour 24|Overall Study||170
8259579|NCT01804673|20366010|P1|STARTED|Overall Study||174
8259580|NCT01804582|20366028|P2|NOT COMPLETED|Overall Study||56
8259581|NCT01804582|20366029|P1|NOT COMPLETED|Overall Study||49
8259582|NCT01804582|20366028|P2|COMPLETED|Overall Study||117
8259583|NCT01804582|20366029|P1|COMPLETED|Overall Study||128
8259584|NCT01804582|20366028|P2|STARTED|Overall Study||173
8259585|NCT01804582|20366029|P1|STARTED|Overall Study||177
8259592|NCT01804257|20366056|P1|NOT COMPLETED|Overall Study||1
8259593|NCT01804257|20366056|P1|COMPLETED|Overall Study||27
8259594|NCT01804257|20366056|P1|STARTED|Overall Study||28
8259595|NCT01804140|20366060|P1|NOT COMPLETED|Overall Study||114
8259596|NCT01804140|20366060|P1|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
8259597|NCT01804140|20366060|P1|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
8259598|NCT01804101|20366067|P2|NOT COMPLETED|Overall Study||0
8259599|NCT01804101|20366068|P1|NOT COMPLETED|Overall Study||0
8259600|NCT01804101|20366067|P2|COMPLETED|Overall Study||10
8259601|NCT01804101|20366068|P1|COMPLETED|Overall Study||38
8259602|NCT01804101|20366067|P2|STARTED|Overall Study||10
8259603|NCT01804101|20366068|P1|STARTED|Overall Study||38
8259604|NCT01804075|20366078|P2|NOT COMPLETED|Overall Study||0
8259605|NCT01804075|20366079|P1|NOT COMPLETED|Overall Study||0
8259606|NCT01804075|20366078|P2|COMPLETED|Overall Study||16
8259607|NCT01804075|20366079|P1|COMPLETED|Overall Study||15
8259608|NCT01804075|20366078|P2|STARTED|Overall Study||16
8259609|NCT01804075|20366079|P1|STARTED|Overall Study||15
8259610|NCT01804062|20366087|P1|NOT COMPLETED|Overall Study||0
8259611|NCT01804062|20366087|P1|COMPLETED|Overall Study||30
8259612|NCT01804062|20366087|P1|STARTED|Overall Study||30
8259613|NCT01804049|20366094|P2|NOT COMPLETED|Overall Study||32
8259614|NCT01804049|20366095|P1|NOT COMPLETED|Overall Study||11
8259615|NCT01804049|20366094|P2|COMPLETED|Overall Study||45
8259616|NCT01804049|20366095|P1|COMPLETED|Overall Study||32
8259617|NCT01804049|20366094|P2|STARTED|Overall Study||77
8259618|NCT01804049|20366095|P1|STARTED|Overall Study||43
8259619|NCT01804036|20366107|P2|NOT COMPLETED|Overall Study||20
8259620|NCT01804036|20366108|P1|NOT COMPLETED|Overall Study||13
8259621|NCT01804036|20366107|P2|COMPLETED|Overall Study||21
8259622|NCT01804036|20366108|P1|COMPLETED|Overall Study||18
8259623|NCT01804036|20366107|P2|STARTED|Overall Study||41
8259624|NCT01804036|20366108|P1|STARTED|Overall Study||31
8259625|NCT01803880|20366143|P3|NOT COMPLETED|Overall Study||15
8259626|NCT01803880|20366144|P2|NOT COMPLETED|Overall Study||10
8259627|NCT01803880|20366145|P1|NOT COMPLETED|Overall Study||6
8259628|NCT01803880|20366143|P3|COMPLETED|Overall Study||14
8259629|NCT01803880|20366144|P2|COMPLETED|Overall Study||18
8259630|NCT01803880|20366145|P1|COMPLETED|Overall Study||13
8259631|NCT01803880|20366143|P3|STARTED|Overall Study||29
8259632|NCT01803880|20366144|P2|STARTED|Overall Study||28
8259633|NCT01803880|20366145|P1|STARTED|Overall Study||19
8259634|NCT01803737|20366181|P2|NOT COMPLETED|Overall Study||3
8259635|NCT01803737|20366182|P1|NOT COMPLETED|Overall Study||1
8259636|NCT01803737|20366181|P2|COMPLETED|Overall Study||10
8259637|NCT01803737|20366182|P1|COMPLETED|Overall Study||12
8259638|NCT01803737|20366181|P2|STARTED|Overall Study||13
8259639|NCT01803737|20366182|P1|STARTED|Overall Study||13
8259640|NCT01803711|20366206|P2|NOT COMPLETED|Overall Study||1
8259641|NCT01803711|20366207|P1|NOT COMPLETED|Overall Study||1
8259642|NCT01803711|20366206|P2|COMPLETED|Overall Study||2
8259643|NCT01803711|20366207|P1|COMPLETED|Overall Study||1
8259644|NCT01803711|20366206|P2|STARTED|Overall Study||3
8259645|NCT01803711|20366207|P1|STARTED|Overall Study||2
8259646|NCT01803646|20366225|P2|NOT COMPLETED|Overall Study||10
8259647|NCT01803646|20366226|P1|NOT COMPLETED|Overall Study||17
8259648|NCT01803646|20366225|P2|COMPLETED|Overall Study||129
8259649|NCT01803646|20366226|P1|COMPLETED|Overall Study||187
8259650|NCT01803646|20366225|P2|STARTED|Overall Study||139
8259651|NCT01803646|20366226|P1|STARTED|Overall Study||204
8259652|NCT01803607|20366238|P2|NOT COMPLETED|Overall Study||67
8259653|NCT01803607|20366239|P1|NOT COMPLETED|Overall Study||68
8259654|NCT01803607|20366238|P2|COMPLETED|Overall Study||0
8259655|NCT01803607|20366239|P1|COMPLETED|Overall Study||0
8259656|NCT01803607|20366238|P2|STARTED|Overall Study||67
8259657|NCT01803607|20366239|P1|STARTED|Overall Study||68
8259658|NCT01803464|20366263|P4|NOT COMPLETED|Overall Study||0
8259659|NCT01803464|20366264|P3|NOT COMPLETED|Overall Study||4
8259660|NCT01803464|20366265|P2|NOT COMPLETED|Overall Study||0
8259661|NCT01803464|20366266|P1|NOT COMPLETED|Overall Study||1
8259662|NCT01803464|20366263|P4|COMPLETED|Overall Study||10
8259663|NCT01803464|20366264|P3|COMPLETED|Overall Study||6
8259664|NCT01803464|20366265|P2|COMPLETED|Overall Study||4
8259665|NCT01803464|20366266|P1|COMPLETED|Overall Study||4
8259666|NCT01803464|20366263|P4|STARTED|Overall Study||10
8259667|NCT01803464|20366264|P3|STARTED|Overall Study||10
8259668|NCT01803464|20366265|P2|STARTED|Overall Study||4
8259669|NCT01803464|20366266|P1|STARTED|Overall Study||5
8259670|NCT01803282|20366296|P12|NOT COMPLETED|Overall Study||15
8259671|NCT01803282|20366297|P11|NOT COMPLETED|Overall Study||8
8259672|NCT01803282|20366298|P10|NOT COMPLETED|Overall Study||45
8259673|NCT01803282|20366299|P9|NOT COMPLETED|Overall Study||11
8259674|NCT01803282|20366300|P8|NOT COMPLETED|Overall Study||46
8259675|NCT01803282|20366301|P7|NOT COMPLETED|Overall Study||41
8259676|NCT01803282|20366302|P6|NOT COMPLETED|Overall Study||10
8259677|NCT01803282|20366303|P5|NOT COMPLETED|Overall Study||11
8259678|NCT01803282|20366304|P4|NOT COMPLETED|Overall Study||36
8259679|NCT01803282|20366305|P3|NOT COMPLETED|Overall Study||6
8259680|NCT01803282|20366306|P2|NOT COMPLETED|Overall Study||3
8259681|NCT01803282|20366307|P1|NOT COMPLETED|Overall Study||4
8259682|NCT01803282|20366296|P12|COMPLETED|Overall Study||0
8259683|NCT01803282|20366297|P11|COMPLETED|Overall Study||0
8259684|NCT01803282|20366298|P10|COMPLETED|Overall Study||0
8259685|NCT01803282|20366299|P9|COMPLETED|Overall Study||0
8259686|NCT01803282|20366300|P8|COMPLETED|Overall Study||0
8259687|NCT01803282|20366301|P7|COMPLETED|Overall Study||0
8259688|NCT01803282|20366302|P6|COMPLETED|Overall Study||0
8259689|NCT01803282|20366303|P5|COMPLETED|Overall Study||0
8259690|NCT01803282|20366304|P4|COMPLETED|Overall Study||0
8259691|NCT01803282|20366305|P3|COMPLETED|Overall Study||0
8259692|NCT01803282|20366306|P2|COMPLETED|Overall Study||0
8259693|NCT01803282|20366307|P1|COMPLETED|Overall Study||0
8259694|NCT01803282|20366296|P12|STARTED|Overall Study||15
8259695|NCT01803282|20366297|P11|STARTED|Overall Study||8
8259696|NCT01803282|20366298|P10|STARTED|Overall Study||45
8259697|NCT01803282|20366299|P9|STARTED|Overall Study||11
8259698|NCT01803282|20366300|P8|STARTED|Overall Study||46
8259699|NCT01803282|20366301|P7|STARTED|Overall Study||41
8259700|NCT01803282|20366302|P6|STARTED|Overall Study||10
8259701|NCT01803282|20366303|P5|STARTED|Overall Study||11
8259702|NCT01803282|20366304|P4|STARTED|Overall Study||36
8259703|NCT01803282|20366305|P3|STARTED|Overall Study||6
8259704|NCT01803282|20366306|P2|STARTED|Overall Study||3
8259705|NCT01803282|20366307|P1|STARTED|Overall Study||4
8259706|NCT01803269|20366348|P3|NOT COMPLETED|Overall Study||0
8259707|NCT01803269|20366349|P2|NOT COMPLETED|Overall Study||0
8259708|NCT01803269|20366350|P1|NOT COMPLETED|Overall Study||3
8259709|NCT01803269|20366348|P3|COMPLETED|Overall Study||14
8259710|NCT01803269|20366349|P2|COMPLETED|Overall Study||8
8259711|NCT01803269|20366350|P1|COMPLETED|Overall Study||4
8259712|NCT01803269|20366348|P3|STARTED|Overall Study||14
8259713|NCT01803269|20366349|P2|STARTED|Overall Study||8
8259714|NCT01803269|20366350|P1|STARTED|Overall Study||7
8259715|NCT01803204|20366372|P2|NOT COMPLETED|Overall Study||0
8259716|NCT01803204|20366373|P1|NOT COMPLETED|Overall Study||0
8259717|NCT01803204|20366372|P2|COMPLETED|Overall Study||20
8259718|NCT01803204|20366373|P1|COMPLETED|Overall Study||20
8259719|NCT01803204|20366372|P2|STARTED|Overall Study||20
8259720|NCT01803204|20366373|P1|STARTED|Overall Study||20
8259721|NCT01803074|20366397|P14|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259722|NCT01803074|20366398|P13|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259723|NCT01803074|20366399|P12|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259724|NCT01803074|20366400|P11|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259725|NCT01803074|20366401|P10|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259726|NCT01803074|20366402|P9|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259727|NCT01803074|20366403|P8|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259728|NCT01803074|20366404|P7|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259729|NCT01803074|20366405|P6|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259730|NCT01803074|20366406|P5|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259731|NCT01803074|20366407|P4|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259732|NCT01803074|20366408|P3|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259733|NCT01803074|20366409|P2|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259734|NCT01803074|20366410|P1|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259735|NCT01803074|20366397|P14|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4
8259736|NCT01803074|20366398|P13|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7
8259737|NCT01803074|20366399|P12|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8
8259738|NCT01803074|20366400|P11|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259739|NCT01803074|20366401|P10|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259740|NCT01803074|20366402|P9|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259741|NCT01803074|20366403|P8|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259742|NCT01803074|20366404|P7|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259743|NCT01803074|20366405|P6|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259744|NCT01803074|20366406|P5|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259745|NCT01803074|20366407|P4|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259746|NCT01803074|20366408|P3|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259747|NCT01803074|20366409|P2|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259748|NCT01803074|20366410|P1|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
8259749|NCT01803074|20366397|P14|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4
8259750|NCT01803074|20366398|P13|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7
8259751|NCT01803074|20366399|P12|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8
8259752|NCT01803074|20366400|P11|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259753|NCT01803074|20366401|P10|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259754|NCT01803074|20366402|P9|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259755|NCT01803074|20366403|P8|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259756|NCT01803074|20366404|P7|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259757|NCT01803074|20366405|P6|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259758|NCT01803074|20366406|P5|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259759|NCT01803074|20366407|P4|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259760|NCT01803074|20366408|P3|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259761|NCT01803074|20366409|P2|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259762|NCT01803074|20366410|P1|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
8259763|NCT01803074|20366397|P14|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259764|NCT01803074|20366398|P13|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259765|NCT01803074|20366399|P12|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259766|NCT01803074|20366400|P11|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259767|NCT01803074|20366401|P10|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259768|NCT01803074|20366402|P9|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259769|NCT01803074|20366403|P8|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259770|NCT01803074|20366404|P7|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259771|NCT01803074|20366405|P6|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259772|NCT01803074|20366406|P5|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259773|NCT01803074|20366407|P4|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259774|NCT01803074|20366408|P3|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259775|NCT01803074|20366409|P2|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259776|NCT01803074|20366410|P1|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259777|NCT01803074|20366397|P14|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259778|NCT01803074|20366398|P13|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259779|NCT01803074|20366399|P12|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259780|NCT01803074|20366400|P11|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
8259781|NCT01803074|20366401|P10|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4
8259782|NCT01803074|20366402|P9|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
8259783|NCT01803074|20366403|P8|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
8259784|NCT01803074|20366404|P7|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259785|NCT01803074|20366405|P6|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259786|NCT01803074|20366406|P5|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259787|NCT01803074|20366407|P4|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259788|NCT01803074|20366408|P3|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259789|NCT01803074|20366409|P2|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259790|NCT01803074|20366410|P1|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
8259791|NCT01803074|20366397|P14|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259792|NCT01803074|20366398|P13|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259793|NCT01803074|20366399|P12|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259794|NCT01803074|20366400|P11|STARTED|Period 2: Part B (HIV-1 Clade B)||8
8259795|NCT01803074|20366401|P10|STARTED|Period 2: Part B (HIV-1 Clade B)||4
8259796|NCT01803074|20366402|P9|STARTED|Period 2: Part B (HIV-1 Clade B)||8
8259797|NCT01803074|20366403|P8|STARTED|Period 2: Part B (HIV-1 Clade B)||8
8259798|NCT01803074|20366404|P7|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259799|NCT01803074|20366405|P6|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259800|NCT01803074|20366406|P5|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259801|NCT01803074|20366407|P4|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259802|NCT01803074|20366408|P3|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259803|NCT01803074|20366409|P2|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259804|NCT01803074|20366410|P1|STARTED|Period 2: Part B (HIV-1 Clade B)||0
8259805|NCT01803074|20366397|P14|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259806|NCT01803074|20366398|P13|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259807|NCT01803074|20366399|P12|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259808|NCT01803074|20366400|P11|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259809|NCT01803074|20366401|P10|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259810|NCT01803074|20366402|P9|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259811|NCT01803074|20366403|P8|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259812|NCT01803074|20366404|P7|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259813|NCT01803074|20366405|P6|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259814|NCT01803074|20366406|P5|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259815|NCT01803074|20366407|P4|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259816|NCT01803074|20366408|P3|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259817|NCT01803074|20366409|P2|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259818|NCT01803074|20366410|P1|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259819|NCT01803074|20366397|P14|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259820|NCT01803074|20366398|P13|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259821|NCT01803074|20366399|P12|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259822|NCT01803074|20366400|P11|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259823|NCT01803074|20366401|P10|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259824|NCT01803074|20366402|P9|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259825|NCT01803074|20366403|P8|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
8259826|NCT01803074|20366404|P7|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12
8259827|NCT01803074|20366405|P6|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8259828|NCT01803074|20366406|P5|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8259829|NCT01803074|20366407|P4|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8259830|NCT01803074|20366408|P3|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8259831|NCT01803074|20366409|P2|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8259832|NCT01803074|20366410|P1|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
8259833|NCT01803074|20366397|P14|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8259834|NCT01803074|20366398|P13|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8259835|NCT01803074|20366399|P12|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8259836|NCT01803074|20366400|P11|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8259837|NCT01803074|20366401|P10|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8259838|NCT01803074|20366402|P9|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8259839|NCT01803074|20366403|P8|STARTED|Period 1: Part A (HIV-1 Clade B)||0
8259840|NCT01803074|20366404|P7|STARTED|Period 1: Part A (HIV-1 Clade B)||12
8259841|NCT01803074|20366405|P6|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8259842|NCT01803074|20366406|P5|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8259843|NCT01803074|20366407|P4|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8259844|NCT01803074|20366408|P3|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8259845|NCT01803074|20366409|P2|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8259846|NCT01803074|20366410|P1|STARTED|Period 1: Part A (HIV-1 Clade B)||8
8259847|NCT01802879|20366664|P1|NOT COMPLETED|Overall Study||8
8259848|NCT01802879|20366664|P1|COMPLETED|Overall Study||0
8259849|NCT01802879|20366664|P1|STARTED|Overall Study||8
8259850|NCT01802775|20366671|P2|NOT COMPLETED|Overall Study||12
8259851|NCT01802775|20366672|P1|NOT COMPLETED|Overall Study||6
8259852|NCT01802775|20366671|P2|COMPLETED|Overall Study||89
8259853|NCT01802775|20366672|P1|COMPLETED|Overall Study||96
8259854|NCT01802775|20366671|P2|Received Drug (Safety Analysis Set)|Overall Study||100
8259855|NCT01802775|20366672|P1|Received Drug (Safety Analysis Set)|Overall Study||101
8259856|NCT01802775|20366671|P2|STARTED|Overall Study||101
8259857|NCT01802775|20366672|P1|STARTED|Overall Study||102
8259858|NCT01802710|20366690|P2|NOT COMPLETED|From T1 to T2||2
8259859|NCT01802710|20366691|P1|NOT COMPLETED|From T1 to T2||2
8259860|NCT01802710|20366690|P2|COMPLETED|From T1 to T2||70
8259861|NCT01802710|20366691|P1|COMPLETED|From T1 to T2||58
8259862|NCT01802710|20366690|P2|STARTED|From T1 to T2||72
8259863|NCT01802710|20366691|P1|STARTED|From T1 to T2||60
8259864|NCT01802710|20366690|P2|NOT COMPLETED|From T0 to T1||10
8259865|NCT01802710|20366691|P1|NOT COMPLETED|From T0 to T1||16
8259866|NCT01802710|20366690|P2|COMPLETED|From T0 to T1||72
8259867|NCT01802710|20366691|P1|COMPLETED|From T0 to T1||60
8259868|NCT01802710|20366690|P2|STARTED|From T0 to T1||82
8259869|NCT01802710|20366691|P1|STARTED|From T0 to T1||76
8259888|NCT01802580|20366728|P2|NOT COMPLETED|Overall Study||11
8259889|NCT01802580|20366729|P1|NOT COMPLETED|Overall Study||9
8259890|NCT01802580|20366728|P2|COMPLETED|Overall Study||9
8259891|NCT01802580|20366729|P1|COMPLETED|Overall Study||11
8259892|NCT01802580|20366728|P2|STARTED|Overall Study||20
8259893|NCT01802580|20366729|P1|STARTED|Overall Study||20
8259894|NCT01802554|20366742|P2|NOT COMPLETED|Overall Study||6
8259895|NCT01802554|20366743|P1|NOT COMPLETED|Overall Study||8
8259896|NCT01802554|20366742|P2|COMPLETED|Overall Study||43
8259897|NCT01802554|20366743|P1|COMPLETED|Overall Study||43
8259898|NCT01802554|20366742|P2|STARTED|Overall Study||49
8259899|NCT01802554|20366743|P1|STARTED|Overall Study||51
8259900|NCT01802515|20366760|P3|NOT COMPLETED|Overall Study||0
8259901|NCT01802515|20366761|P2|NOT COMPLETED|Overall Study||0
8259902|NCT01802515|20366762|P1|NOT COMPLETED|Overall Study||3
8259903|NCT01802515|20366760|P3|COMPLETED|Overall Study||4
8259904|NCT01802515|20366761|P2|COMPLETED|Overall Study||5
8259905|NCT01802515|20366762|P1|COMPLETED|Overall Study||2
8259906|NCT01802515|20366760|P3|STARTED|Overall Study||4
8259907|NCT01802515|20366761|P2|STARTED|Overall Study||5
8259908|NCT01802515|20366762|P1|STARTED|Overall Study||5
8259909|NCT01802437|20366775|P2|NOT COMPLETED|Overall Study||4
8259910|NCT01802437|20366776|P1|NOT COMPLETED|Overall Study||4
8259911|NCT01802437|20366775|P2|COMPLETED|Overall Study||16
8259912|NCT01802437|20366776|P1|COMPLETED|Overall Study||16
8259913|NCT01802437|20366775|P2|STARTED|Overall Study||20
8259914|NCT01802437|20366776|P1|STARTED|Overall Study||20
8259921|NCT01802385|20366801|P2|NOT COMPLETED|Overall Study||120
8259922|NCT01802385|20366802|P1|NOT COMPLETED|Overall Study||106
8259923|NCT01802385|20366801|P2|COMPLETED|Overall Study||109
8259924|NCT01802385|20366802|P1|COMPLETED|Overall Study||125
8259925|NCT01802385|20366801|P2|STARTED|Overall Study||229
8259926|NCT01802385|20366802|P1|STARTED|Overall Study||231
8259927|NCT01802333|20366825|P3|NOT COMPLETED|Overall Study||63
8259928|NCT01802333|20366826|P2|NOT COMPLETED|Overall Study||61
8259929|NCT01802333|20366827|P1|NOT COMPLETED|Overall Study||49
8259930|NCT01802333|20366825|P3|COMPLETED|Overall Study||161
8259931|NCT01802333|20366826|P2|COMPLETED|Overall Study||206
8259932|NCT01802333|20366827|P1|COMPLETED|Overall Study||214
8259933|NCT01802333|20366825|P3|Known Cytogenetic Risk at Baseline|Overall Study||210
8259934|NCT01802333|20366826|P2|Known Cytogenetic Risk at Baseline|Overall Study||250
8259935|NCT01802333|20366827|P1|Known Cytogenetic Risk at Baseline|Overall Study||252
8259936|NCT01802333|20366825|P3|Known NPM1 Status at Baseline|Overall Study||142
8259937|NCT01802333|20366826|P2|Known NPM1 Status at Baseline|Overall Study||156
8259938|NCT01802333|20366827|P1|Known NPM1 Status at Baseline|Overall Study||169
8259939|NCT01802333|20366825|P3|High Risk Patients Achieved CR/CRi|Overall Study||29
8259940|NCT01802333|20366826|P2|High Risk Patients Achieved CR/CRi|Overall Study||40
8259941|NCT01802333|20366827|P1|High Risk Patients Achieved CR/CRi|Overall Study||38
8259942|NCT01802333|20366825|P3|High Risk Patients|Overall Study||38
8259943|NCT01802333|20366826|P2|High Risk Patients|Overall Study||61
8259944|NCT01802333|20366827|P1|High Risk Patients|Overall Study||60
8259945|NCT01802333|20366825|P3|STARTED|Overall Study||224
8259946|NCT01802333|20366826|P2|STARTED|Overall Study||267
8259947|NCT01802333|20366827|P1|STARTED|Overall Study||263
8259948|NCT01802320|20366854|P1|NOT COMPLETED|Overall Study||2
8259949|NCT01802320|20366854|P1|COMPLETED|Overall Study||16
8259950|NCT01802320|20366854|P1|STARTED|Overall Study||18
8259951|NCT01802216|20366864|P2|NOT COMPLETED|12 Month Visit||4
8259952|NCT01802216|20366865|P1|NOT COMPLETED|12 Month Visit||3
8259953|NCT01802216|20366864|P2|COMPLETED|12 Month Visit||30
8259954|NCT01802216|20366865|P1|COMPLETED|12 Month Visit||14
8259955|NCT01802216|20366864|P2|STARTED|12 Month Visit||34
8259956|NCT01802216|20366865|P1|STARTED|12 Month Visit||17
8259957|NCT01802216|20366864|P2|NOT COMPLETED|8 Month Visit||5
8259958|NCT01802216|20366865|P1|NOT COMPLETED|8 Month Visit||3
8259959|NCT01802216|20366864|P2|COMPLETED|8 Month Visit||29
8259960|NCT01802216|20366865|P1|COMPLETED|8 Month Visit||14
8259961|NCT01802216|20366864|P2|STARTED|8 Month Visit||34
8259962|NCT01802216|20366865|P1|STARTED|8 Month Visit||17
8259963|NCT01802216|20366864|P2|NOT COMPLETED|4 Month Visit||4
8259964|NCT01802216|20366865|P1|NOT COMPLETED|4 Month Visit||3
8259965|NCT01802216|20366864|P2|COMPLETED|4 Month Visit||30
8259966|NCT01802216|20366865|P1|COMPLETED|4 Month Visit||14
8259967|NCT01802216|20366864|P2|STARTED|4 Month Visit||34
8259968|NCT01802216|20366865|P1|STARTED|4 Month Visit||17
8259969|NCT01802216|20366864|P2|NOT COMPLETED|Baseline||0
8259970|NCT01802216|20366865|P1|NOT COMPLETED|Baseline||0
8259971|NCT01802216|20366864|P2|COMPLETED|Baseline||34
8259972|NCT01802216|20366865|P1|COMPLETED|Baseline||17
8259973|NCT01802216|20366864|P2|STARTED|Baseline||34
8259974|NCT01802216|20366865|P1|STARTED|Baseline||17
8259975|NCT01802151|20366877|P4|NOT COMPLETED|Overall Study||0
8259976|NCT01802151|20366878|P3|NOT COMPLETED|Overall Study||2
8259977|NCT01802151|20366879|P2|NOT COMPLETED|Overall Study||0
8259978|NCT01802151|20366880|P1|NOT COMPLETED|Overall Study||0
8259979|NCT01802151|20366877|P4|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
8259980|NCT01802151|20366878|P3|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
8259981|NCT01802151|20366879|P2|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
8259982|NCT01802151|20366880|P1|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
8259983|NCT01802151|20366877|P4|STARTED|Overall Study||20
8259984|NCT01802151|20366878|P3|STARTED|Overall Study||22
8259985|NCT01802151|20366879|P2|STARTED|Overall Study||21
8259986|NCT01802151|20366880|P1|STARTED|Overall Study||20
8259987|NCT01802073|20366944|P2|NOT COMPLETED|Overall Study||11
8259988|NCT01802073|20366945|P1|NOT COMPLETED|Overall Study||5
8259989|NCT01802073|20366944|P2|COMPLETED|Overall Study||9
8259990|NCT01802073|20366945|P1|COMPLETED|Overall Study||9
8259991|NCT01802073|20366944|P2|STARTED|Overall Study||20
8259992|NCT01802073|20366945|P1|STARTED|Overall Study||14
8259996|NCT01801917|20366975|P4|NOT COMPLETED|Extension - All Active||0
8259997|NCT01801917|20366976|P3|NOT COMPLETED|Extension - All Active||0
8259998|NCT01801917|20366977|P2|NOT COMPLETED|Extension - All Active||0
8259999|NCT01801917|20366978|P1|NOT COMPLETED|Extension - All Active||0
8260000|NCT01801917|20366975|P4|COMPLETED|Extension - All Active||0
8260001|NCT01801917|20366976|P3|COMPLETED|Extension - All Active||3
8260002|NCT01801917|20366977|P2|COMPLETED|Extension - All Active||0
8260003|NCT01801917|20366978|P1|COMPLETED|Extension - All Active||6
8260004|NCT01801917|20366975|P4|STARTED|Extension - All Active||0
8260005|NCT01801917|20366976|P3|STARTED|Extension - All Active||3
8260006|NCT01801917|20366977|P2|STARTED|Extension - All Active||0
8260007|NCT01801917|20366978|P1|STARTED|Extension - All Active||6
8260008|NCT01801917|20366975|P4|NOT COMPLETED|Period 1 - Randomized||0
8260009|NCT01801917|20366976|P3|NOT COMPLETED|Period 1 - Randomized||1
8260010|NCT01801917|20366977|P2|NOT COMPLETED|Period 1 - Randomized||0
8260011|NCT01801917|20366978|P1|NOT COMPLETED|Period 1 - Randomized||1
8260012|NCT01801917|20366975|P4|COMPLETED|Period 1 - Randomized||1
8260013|NCT01801917|20366976|P3|COMPLETED|Period 1 - Randomized||3
8260014|NCT01801917|20366977|P2|COMPLETED|Period 1 - Randomized||2
8260015|NCT01801917|20366978|P1|COMPLETED|Period 1 - Randomized||6
8260016|NCT01801917|20366975|P4|STARTED|Period 1 - Randomized||1
8260017|NCT01801917|20366976|P3|STARTED|Period 1 - Randomized||4
8260018|NCT01801917|20366977|P2|STARTED|Period 1 - Randomized||2
8260019|NCT01801917|20366978|P1|STARTED|Period 1 - Randomized||7
8260020|NCT01801865|20366998|P1|NOT COMPLETED|Overall Study||42
8260021|NCT01801865|20366998|P1|COMPLETED|Overall Study||615
8260022|NCT01801865|20366998|P1|STARTED|Overall Study||657
8260023|NCT01801735|20367003|P1|NOT COMPLETED|Overall Study||210
8260024|NCT01801735|20367003|P1|COMPLETED|Overall Study||390
8260025|NCT01801735|20367003|P1|STARTED|Overall Study||600
8260026|NCT01801475|20367010|P5|NOT COMPLETED|Overall Study||1
8260027|NCT01801475|20367011|P4|NOT COMPLETED|Overall Study||0
8260028|NCT01801475|20367012|P3|NOT COMPLETED|Overall Study||0
8260029|NCT01801475|20367013|P2|NOT COMPLETED|Overall Study||0
8260030|NCT01801475|20367014|P1|NOT COMPLETED|Overall Study||0
8260031|NCT01801475|20367010|P5|COMPLETED|Overall Study||39
8260032|NCT01801475|20367011|P4|COMPLETED|Overall Study||10
8260033|NCT01801475|20367012|P3|COMPLETED|Overall Study||10
8260034|NCT01801475|20367013|P2|COMPLETED|Overall Study||30
8260035|NCT01801475|20367014|P1|COMPLETED|Overall Study||10
8260036|NCT01801475|20367010|P5|STARTED|Overall Study||40
8260037|NCT01801475|20367011|P4|STARTED|Overall Study||10
8260038|NCT01801475|20367012|P3|STARTED|Overall Study||10
8260039|NCT01801475|20367013|P2|STARTED|Overall Study||30
8260040|NCT01801475|20367014|P1|STARTED|Overall Study||10
8260041|NCT01801449|20367025|P1|NOT COMPLETED|Overall Study||0
8260042|NCT01801449|20367025|P1|COMPLETED|Overall Study||6
8260043|NCT01801449|20367025|P1|STARTED|Overall Study||6
8260044|NCT01801436|20367039|P1|NOT COMPLETED|Overall Study||9
8260045|NCT01801436|20367039|P1|COMPLETED|Overall Study||5
8260046|NCT01801436|20367039|P1|STARTED|Overall Study||14
8260047|NCT01801358|20367077|P6|NOT COMPLETED|Overall Study||8
8260048|NCT01801358|20367078|P5|NOT COMPLETED|Overall Study||6
8260049|NCT01801358|20367079|P4|NOT COMPLETED|Overall Study||6
8260050|NCT01801358|20367080|P3|NOT COMPLETED|Overall Study||6
8260051|NCT01801358|20367081|P2|NOT COMPLETED|Overall Study||6
8260052|NCT01801358|20367082|P1|NOT COMPLETED|Overall Study||6
8260053|NCT01801358|20367077|P6|COMPLETED|Overall Study||0
8260054|NCT01801358|20367078|P5|COMPLETED|Overall Study||0
8260055|NCT01801358|20367079|P4|COMPLETED|Overall Study||0
8260056|NCT01801358|20367080|P3|COMPLETED|Overall Study||0
8260057|NCT01801358|20367081|P2|COMPLETED|Overall Study||0
8260058|NCT01801358|20367082|P1|COMPLETED|Overall Study||0
8260059|NCT01801358|20367077|P6|STARTED|Overall Study||8
8260060|NCT01801358|20367078|P5|STARTED|Overall Study||6
8260061|NCT01801358|20367079|P4|STARTED|Overall Study||6
8260062|NCT01801358|20367080|P3|STARTED|Overall Study||6
8260063|NCT01801358|20367081|P2|STARTED|Overall Study||6
8260064|NCT01801358|20367082|P1|STARTED|Overall Study||6
8260065|NCT01801280|20367204|P4|NOT COMPLETED|Period 4||0
8260066|NCT01801280|20367205|P3|NOT COMPLETED|Period 4||1
8260067|NCT01801280|20367206|P2|NOT COMPLETED|Period 4||0
8260068|NCT01801280|20367207|P1|NOT COMPLETED|Period 4||0
8260069|NCT01801280|20367204|P4|COMPLETED|Period 4||5
8260070|NCT01801280|20367205|P3|COMPLETED|Period 4||4
8260071|NCT01801280|20367206|P2|COMPLETED|Period 4||4
8260072|NCT01801280|20367207|P1|COMPLETED|Period 4||4
8260073|NCT01801280|20367204|P4|STARTED|Period 4||5
8260074|NCT01801280|20367205|P3|STARTED|Period 4||5
8260075|NCT01801280|20367206|P2|STARTED|Period 4||4
8260076|NCT01801280|20367207|P1|STARTED|Period 4||4
8260077|NCT01801280|20367204|P4|NOT COMPLETED|Period 3||0
8260078|NCT01801280|20367205|P3|NOT COMPLETED|Period 3||0
8260079|NCT01801280|20367206|P2|NOT COMPLETED|Period 3||0
8260080|NCT01801280|20367207|P1|NOT COMPLETED|Period 3||0
8260081|NCT01801280|20367204|P4|COMPLETED|Period 3||5
8260082|NCT01801280|20367205|P3|COMPLETED|Period 3||5
8260083|NCT01801280|20367206|P2|COMPLETED|Period 3||4
8260084|NCT01801280|20367207|P1|COMPLETED|Period 3||4
8260085|NCT01801280|20367204|P4|STARTED|Period 3||5
8260086|NCT01801280|20367205|P3|STARTED|Period 3||5
8260087|NCT01801280|20367206|P2|STARTED|Period 3||4
8260088|NCT01801280|20367207|P1|STARTED|Period 3||4
8260089|NCT01801280|20367204|P4|NOT COMPLETED|Period 2||0
8260090|NCT01801280|20367205|P3|NOT COMPLETED|Period 2||0
8260091|NCT01801280|20367206|P2|NOT COMPLETED|Period 2||0
8260092|NCT01801280|20367207|P1|NOT COMPLETED|Period 2||1
8260093|NCT01801280|20367204|P4|COMPLETED|Period 2||5
8260094|NCT01801280|20367205|P3|COMPLETED|Period 2||5
8260095|NCT01801280|20367206|P2|COMPLETED|Period 2||4
8260096|NCT01801280|20367207|P1|COMPLETED|Period 2||4
8260097|NCT01801280|20367204|P4|STARTED|Period 2||5
8260098|NCT01801280|20367205|P3|STARTED|Period 2||5
8260099|NCT01801280|20367206|P2|STARTED|Period 2||4
8260100|NCT01801280|20367207|P1|STARTED|Period 2||5
8260101|NCT01801280|20367204|P4|NOT COMPLETED|Period 1||0
8260102|NCT01801280|20367205|P3|NOT COMPLETED|Period 1||0
8260103|NCT01801280|20367206|P2|NOT COMPLETED|Period 1||1
8260104|NCT01801280|20367207|P1|NOT COMPLETED|Period 1||0
8260105|NCT01801280|20367204|P4|COMPLETED|Period 1||5
8260106|NCT01801280|20367205|P3|COMPLETED|Period 1||5
8260107|NCT01801280|20367206|P2|COMPLETED|Period 1||4
8260108|NCT01801280|20367207|P1|COMPLETED|Period 1||5
8260109|NCT01801280|20367204|P4|STARTED|Period 1||5
8260110|NCT01801280|20367205|P3|STARTED|Period 1||5
8260111|NCT01801280|20367206|P2|STARTED|Period 1||5
8260112|NCT01801280|20367207|P1|STARTED|Period 1|Each period lasted 10-14 weeks|5
8260116|NCT01801111|20367222|P1|NOT COMPLETED|Overall Study||138
8260117|NCT01801111|20367222|P1|COMPLETED|Overall Study||0
8260118|NCT01801111|20367222|P1|STARTED|Overall Study||138
8260122|NCT01800968|20367274|P2|NOT COMPLETED|Overall Study||32
8260123|NCT01800968|20367275|P1|NOT COMPLETED|Overall Study||36
8260124|NCT01800968|20367274|P2|COMPLETED|Overall Study||114
8260125|NCT01800968|20367275|P1|COMPLETED|Overall Study||118
8260126|NCT01800968|20367274|P2|STARTED|Overall Study||146
8260127|NCT01800968|20367275|P1|STARTED|Overall Study||154
8260128|NCT01800916|20367317|P9|NOT COMPLETED|Test Period 3 (1 Week)||0
8260129|NCT01800916|20367318|P8|NOT COMPLETED|Test Period 3 (1 Week)||0
8260130|NCT01800916|20367319|P7|NOT COMPLETED|Test Period 3 (1 Week)||0
8260131|NCT01800916|20367320|P6|NOT COMPLETED|Test Period 3 (1 Week)||0
8260132|NCT01800916|20367321|P5|NOT COMPLETED|Test Period 3 (1 Week)||0
8260133|NCT01800916|20367322|P4|NOT COMPLETED|Test Period 3 (1 Week)||0
8260134|NCT01800916|20367323|P3|NOT COMPLETED|Test Period 3 (1 Week)||0
8260135|NCT01800916|20367324|P2|NOT COMPLETED|Test Period 3 (1 Week)||0
8260136|NCT01800916|20367325|P1|NOT COMPLETED|Test Period 3 (1 Week)||0
8260137|NCT01800916|20367317|P9|COMPLETED|Test Period 3 (1 Week)||7
8260138|NCT01800916|20367318|P8|COMPLETED|Test Period 3 (1 Week)||7
8260139|NCT01800916|20367319|P7|COMPLETED|Test Period 3 (1 Week)||7
8260140|NCT01800916|20367320|P6|COMPLETED|Test Period 3 (1 Week)||7
8260141|NCT01800916|20367321|P5|COMPLETED|Test Period 3 (1 Week)||7
8260142|NCT01800916|20367322|P4|COMPLETED|Test Period 3 (1 Week)||6
8260143|NCT01800916|20367323|P3|COMPLETED|Test Period 3 (1 Week)||7
8260144|NCT01800916|20367324|P2|COMPLETED|Test Period 3 (1 Week)||7
8260145|NCT01800916|20367325|P1|COMPLETED|Test Period 3 (1 Week)||7
8260146|NCT01800916|20367317|P9|STARTED|Test Period 3 (1 Week)||7
8260147|NCT01800916|20367318|P8|STARTED|Test Period 3 (1 Week)||7
8260148|NCT01800916|20367319|P7|STARTED|Test Period 3 (1 Week)||7
8260149|NCT01800916|20367320|P6|STARTED|Test Period 3 (1 Week)||7
8260150|NCT01800916|20367321|P5|STARTED|Test Period 3 (1 Week)||7
8260151|NCT01800916|20367322|P4|STARTED|Test Period 3 (1 Week)||6
8260152|NCT01800916|20367323|P3|STARTED|Test Period 3 (1 Week)||7
8260153|NCT01800916|20367324|P2|STARTED|Test Period 3 (1 Week)||7
8260154|NCT01800916|20367325|P1|STARTED|Test Period 3 (1 Week)||7
8260155|NCT01800916|20367317|P9|NOT COMPLETED|Test Period 2 (1 Week)||0
8260156|NCT01800916|20367318|P8|NOT COMPLETED|Test Period 2 (1 Week)||0
8260157|NCT01800916|20367319|P7|NOT COMPLETED|Test Period 2 (1 Week)||0
8260158|NCT01800916|20367320|P6|NOT COMPLETED|Test Period 2 (1 Week)||0
8260159|NCT01800916|20367321|P5|NOT COMPLETED|Test Period 2 (1 Week)||0
8260160|NCT01800916|20367322|P4|NOT COMPLETED|Test Period 2 (1 Week)||0
8260161|NCT01800916|20367323|P3|NOT COMPLETED|Test Period 2 (1 Week)||0
8260162|NCT01800916|20367324|P2|NOT COMPLETED|Test Period 2 (1 Week)||0
8260163|NCT01800916|20367325|P1|NOT COMPLETED|Test Period 2 (1 Week)||0
8260164|NCT01800916|20367317|P9|COMPLETED|Test Period 2 (1 Week)||7
8260165|NCT01800916|20367318|P8|COMPLETED|Test Period 2 (1 Week)||7
8260166|NCT01800916|20367319|P7|COMPLETED|Test Period 2 (1 Week)||7
8260167|NCT01800916|20367320|P6|COMPLETED|Test Period 2 (1 Week)||7
8260168|NCT01800916|20367321|P5|COMPLETED|Test Period 2 (1 Week)||7
8260169|NCT01800916|20367322|P4|COMPLETED|Test Period 2 (1 Week)||6
8260170|NCT01800916|20367323|P3|COMPLETED|Test Period 2 (1 Week)||7
8260171|NCT01800916|20367324|P2|COMPLETED|Test Period 2 (1 Week)||7
8260172|NCT01800916|20367325|P1|COMPLETED|Test Period 2 (1 Week)||7
8260173|NCT01800916|20367317|P9|STARTED|Test Period 2 (1 Week)||7
8260174|NCT01800916|20367318|P8|STARTED|Test Period 2 (1 Week)||7
8260175|NCT01800916|20367319|P7|STARTED|Test Period 2 (1 Week)||7
8260176|NCT01800916|20367320|P6|STARTED|Test Period 2 (1 Week)||7
8260177|NCT01800916|20367321|P5|STARTED|Test Period 2 (1 Week)||7
8260178|NCT01800916|20367322|P4|STARTED|Test Period 2 (1 Week)||6
8260179|NCT01800916|20367323|P3|STARTED|Test Period 2 (1 Week)||7
8260180|NCT01800916|20367324|P2|STARTED|Test Period 2 (1 Week)||7
8260181|NCT01800916|20367325|P1|STARTED|Test Period 2 (1 Week)||7
8260182|NCT01800916|20367317|P9|NOT COMPLETED|Test Period 1 (1 Week)||0
8260183|NCT01800916|20367318|P8|NOT COMPLETED|Test Period 1 (1 Week)||0
8260184|NCT01800916|20367319|P7|NOT COMPLETED|Test Period 1 (1 Week)||0
8260185|NCT01800916|20367320|P6|NOT COMPLETED|Test Period 1 (1 Week)||0
8260186|NCT01800916|20367321|P5|NOT COMPLETED|Test Period 1 (1 Week)||1
8260187|NCT01800916|20367322|P4|NOT COMPLETED|Test Period 1 (1 Week)||1
8260188|NCT01800916|20367323|P3|NOT COMPLETED|Test Period 1 (1 Week)||0
8260189|NCT01800916|20367324|P2|NOT COMPLETED|Test Period 1 (1 Week)||0
8260190|NCT01800916|20367325|P1|NOT COMPLETED|Test Period 1 (1 Week)||0
8260191|NCT01800916|20367317|P9|COMPLETED|Test Period 1 (1 Week)||7
8260192|NCT01800916|20367318|P8|COMPLETED|Test Period 1 (1 Week)||7
8260193|NCT01800916|20367319|P7|COMPLETED|Test Period 1 (1 Week)||7
8260194|NCT01800916|20367320|P6|COMPLETED|Test Period 1 (1 Week)||7
8260195|NCT01800916|20367321|P5|COMPLETED|Test Period 1 (1 Week)||7
8260196|NCT01800916|20367322|P4|COMPLETED|Test Period 1 (1 Week)||6
8260197|NCT01800916|20367323|P3|COMPLETED|Test Period 1 (1 Week)||7
8260198|NCT01800916|20367324|P2|COMPLETED|Test Period 1 (1 Week)||7
8260199|NCT01800916|20367325|P1|COMPLETED|Test Period 1 (1 Week)||7
8260200|NCT01800916|20367317|P9|STARTED|Test Period 1 (1 Week)||7
8260201|NCT01800916|20367318|P8|STARTED|Test Period 1 (1 Week)||7
8260202|NCT01800916|20367319|P7|STARTED|Test Period 1 (1 Week)||7
8260203|NCT01800916|20367320|P6|STARTED|Test Period 1 (1 Week)||7
8260204|NCT01800916|20367321|P5|STARTED|Test Period 1 (1 Week)||8
8260205|NCT01800916|20367322|P4|STARTED|Test Period 1 (1 Week)||7
8260206|NCT01800916|20367323|P3|STARTED|Test Period 1 (1 Week)||7
8260207|NCT01800916|20367324|P2|STARTED|Test Period 1 (1 Week)||7
8260208|NCT01800916|20367325|P1|STARTED|Test Period 1 (1 Week)||7
8260209|NCT01800903|20367335|P6|NOT COMPLETED|Third Test Period||0
8260210|NCT01800903|20367336|P5|NOT COMPLETED|Third Test Period||0
8260211|NCT01800903|20367337|P4|NOT COMPLETED|Third Test Period||0
8260212|NCT01800903|20367338|P3|NOT COMPLETED|Third Test Period||0
8260213|NCT01800903|20367339|P2|NOT COMPLETED|Third Test Period||0
8260214|NCT01800903|20367340|P1|NOT COMPLETED|Third Test Period||0
8260215|NCT01800903|20367335|P6|COMPLETED|Third Test Period||6
8260216|NCT01800903|20367336|P5|COMPLETED|Third Test Period||6
8260217|NCT01800903|20367337|P4|COMPLETED|Third Test Period||7
8260218|NCT01800903|20367338|P3|COMPLETED|Third Test Period||4
8260219|NCT01800903|20367339|P2|COMPLETED|Third Test Period||6
8260220|NCT01800903|20367340|P1|COMPLETED|Third Test Period||6
8260221|NCT01800903|20367335|P6|STARTED|Third Test Period||6
8260222|NCT01800903|20367336|P5|STARTED|Third Test Period||6
8260223|NCT01800903|20367337|P4|STARTED|Third Test Period||7
8260224|NCT01800903|20367338|P3|STARTED|Third Test Period||4
8260225|NCT01800903|20367339|P2|STARTED|Third Test Period||6
8260226|NCT01800903|20367340|P1|STARTED|Third Test Period||6
8260227|NCT01800903|20367335|P6|NOT COMPLETED|Second Test Period||0
8260228|NCT01800903|20367336|P5|NOT COMPLETED|Second Test Period||0
8260229|NCT01800903|20367337|P4|NOT COMPLETED|Second Test Period||0
8260230|NCT01800903|20367338|P3|NOT COMPLETED|Second Test Period||0
8260231|NCT01800903|20367339|P2|NOT COMPLETED|Second Test Period||0
8260232|NCT01800903|20367340|P1|NOT COMPLETED|Second Test Period||1
8260233|NCT01800903|20367335|P6|COMPLETED|Second Test Period||6
8260234|NCT01800903|20367336|P5|COMPLETED|Second Test Period||6
8260235|NCT01800903|20367337|P4|COMPLETED|Second Test Period||7
8260236|NCT01800903|20367338|P3|COMPLETED|Second Test Period||4
8260237|NCT01800903|20367339|P2|COMPLETED|Second Test Period||6
8260238|NCT01800903|20367340|P1|COMPLETED|Second Test Period||6
8260239|NCT01800903|20367335|P6|STARTED|Second Test Period||6
8260240|NCT01800903|20367336|P5|STARTED|Second Test Period||6
8260241|NCT01800903|20367337|P4|STARTED|Second Test Period||7
8260242|NCT01800903|20367338|P3|STARTED|Second Test Period||4
8260243|NCT01800903|20367339|P2|STARTED|Second Test Period||6
8260244|NCT01800903|20367340|P1|STARTED|Second Test Period||7
8260245|NCT01800903|20367335|P6|NOT COMPLETED|First Test Period||0
8260246|NCT01800903|20367336|P5|NOT COMPLETED|First Test Period||0
8260247|NCT01800903|20367337|P4|NOT COMPLETED|First Test Period||0
8260248|NCT01800903|20367338|P3|NOT COMPLETED|First Test Period||0
8260249|NCT01800903|20367339|P2|NOT COMPLETED|First Test Period||0
8260250|NCT01800903|20367340|P1|NOT COMPLETED|First Test Period||0
8260251|NCT01800903|20367335|P6|COMPLETED|First Test Period||6
8260252|NCT01800903|20367336|P5|COMPLETED|First Test Period||6
8260253|NCT01800903|20367337|P4|COMPLETED|First Test Period||7
8260254|NCT01800903|20367338|P3|COMPLETED|First Test Period||4
8260255|NCT01800903|20367339|P2|COMPLETED|First Test Period||6
8260256|NCT01800903|20367340|P1|COMPLETED|First Test Period||7
8260257|NCT01800903|20367335|P6|STARTED|First Test Period||6
8260258|NCT01800903|20367336|P5|STARTED|First Test Period||6
8260259|NCT01800903|20367337|P4|STARTED|First Test Period||7
8260260|NCT01800903|20367338|P3|STARTED|First Test Period||4
8260261|NCT01800903|20367339|P2|STARTED|First Test Period||6
8260262|NCT01800903|20367340|P1|STARTED|First Test Period||7
8260263|NCT01800890|20367346|P9|NOT COMPLETED|Test Period 3||0
8260264|NCT01800890|20367347|P8|NOT COMPLETED|Test Period 3||0
8260265|NCT01800890|20367348|P7|NOT COMPLETED|Test Period 3||0
8260266|NCT01800890|20367349|P6|NOT COMPLETED|Test Period 3||0
8260267|NCT01800890|20367350|P5|NOT COMPLETED|Test Period 3||0
8260268|NCT01800890|20367351|P4|NOT COMPLETED|Test Period 3||0
8260269|NCT01800890|20367352|P3|NOT COMPLETED|Test Period 3||0
8260270|NCT01800890|20367353|P2|NOT COMPLETED|Test Period 3||0
8260271|NCT01800890|20367354|P1|NOT COMPLETED|Test Period 3||0
8260272|NCT01800890|20367346|P9|COMPLETED|Test Period 3||3
8260273|NCT01800890|20367347|P8|COMPLETED|Test Period 3||3
8260274|NCT01800890|20367348|P7|COMPLETED|Test Period 3||3
8260275|NCT01800890|20367349|P6|COMPLETED|Test Period 3||4
8260276|NCT01800890|20367350|P5|COMPLETED|Test Period 3||4
8260277|NCT01800890|20367351|P4|COMPLETED|Test Period 3||2
8260278|NCT01800890|20367352|P3|COMPLETED|Test Period 3||3
8260279|NCT01800890|20367353|P2|COMPLETED|Test Period 3||3
8260280|NCT01800890|20367354|P1|COMPLETED|Test Period 3||3
8260281|NCT01800890|20367346|P9|STARTED|Test Period 3||3
8260282|NCT01800890|20367347|P8|STARTED|Test Period 3||3
8260283|NCT01800890|20367348|P7|STARTED|Test Period 3||3
8260284|NCT01800890|20367349|P6|STARTED|Test Period 3||4
8260285|NCT01800890|20367350|P5|STARTED|Test Period 3||4
8260286|NCT01800890|20367351|P4|STARTED|Test Period 3||2
8260287|NCT01800890|20367352|P3|STARTED|Test Period 3||3
8260288|NCT01800890|20367353|P2|STARTED|Test Period 3||3
8260289|NCT01800890|20367354|P1|STARTED|Test Period 3||3
8260290|NCT01800890|20367346|P9|NOT COMPLETED|Test Period 2||0
8260291|NCT01800890|20367347|P8|NOT COMPLETED|Test Period 2||0
8260292|NCT01800890|20367348|P7|NOT COMPLETED|Test Period 2||0
8260293|NCT01800890|20367349|P6|NOT COMPLETED|Test Period 2||0
8260294|NCT01800890|20367350|P5|NOT COMPLETED|Test Period 2||0
8260295|NCT01800890|20367351|P4|NOT COMPLETED|Test Period 2||0
8260296|NCT01800890|20367352|P3|NOT COMPLETED|Test Period 2||0
8260297|NCT01800890|20367353|P2|NOT COMPLETED|Test Period 2||0
8260298|NCT01800890|20367354|P1|NOT COMPLETED|Test Period 2||0
8260299|NCT01800890|20367346|P9|COMPLETED|Test Period 2||3
8260300|NCT01800890|20367347|P8|COMPLETED|Test Period 2||3
8260301|NCT01800890|20367348|P7|COMPLETED|Test Period 2||3
8260302|NCT01800890|20367349|P6|COMPLETED|Test Period 2||4
8260303|NCT01800890|20367350|P5|COMPLETED|Test Period 2||4
8260304|NCT01800890|20367351|P4|COMPLETED|Test Period 2||2
8260305|NCT01800890|20367352|P3|COMPLETED|Test Period 2||3
8260306|NCT01800890|20367353|P2|COMPLETED|Test Period 2||3
8260307|NCT01800890|20367354|P1|COMPLETED|Test Period 2||3
8260308|NCT01800890|20367346|P9|STARTED|Test Period 2||3
8260309|NCT01800890|20367347|P8|STARTED|Test Period 2||3
8260310|NCT01800890|20367348|P7|STARTED|Test Period 2||3
8260311|NCT01800890|20367349|P6|STARTED|Test Period 2||4
8260312|NCT01800890|20367350|P5|STARTED|Test Period 2||4
8260313|NCT01800890|20367351|P4|STARTED|Test Period 2||2
8260314|NCT01800890|20367352|P3|STARTED|Test Period 2||3
8260315|NCT01800890|20367353|P2|STARTED|Test Period 2||3
8260316|NCT01800890|20367354|P1|STARTED|Test Period 2||3
8260317|NCT01800890|20367346|P9|NOT COMPLETED|Test Period 1||0
8260318|NCT01800890|20367347|P8|NOT COMPLETED|Test Period 1||0
8260319|NCT01800890|20367348|P7|NOT COMPLETED|Test Period 1||0
8260320|NCT01800890|20367349|P6|NOT COMPLETED|Test Period 1||0
8260321|NCT01800890|20367350|P5|NOT COMPLETED|Test Period 1||0
8260322|NCT01800890|20367351|P4|NOT COMPLETED|Test Period 1||1
8260323|NCT01800890|20367352|P3|NOT COMPLETED|Test Period 1||0
8260324|NCT01800890|20367353|P2|NOT COMPLETED|Test Period 1||0
8260325|NCT01800890|20367354|P1|NOT COMPLETED|Test Period 1||0
8260326|NCT01800890|20367346|P9|COMPLETED|Test Period 1||3
8260327|NCT01800890|20367347|P8|COMPLETED|Test Period 1||3
8260328|NCT01800890|20367348|P7|COMPLETED|Test Period 1||3
8260329|NCT01800890|20367349|P6|COMPLETED|Test Period 1||4
8260330|NCT01800890|20367350|P5|COMPLETED|Test Period 1||4
8260331|NCT01800890|20367351|P4|COMPLETED|Test Period 1||2
8260332|NCT01800890|20367352|P3|COMPLETED|Test Period 1||3
8260333|NCT01800890|20367353|P2|COMPLETED|Test Period 1||3
8260334|NCT01800890|20367354|P1|COMPLETED|Test Period 1||3
8260335|NCT01800890|20367346|P9|STARTED|Test Period 1||3
8260336|NCT01800890|20367347|P8|STARTED|Test Period 1||3
8260337|NCT01800890|20367348|P7|STARTED|Test Period 1||3
8260338|NCT01800890|20367349|P6|STARTED|Test Period 1||4
8260339|NCT01800890|20367350|P5|STARTED|Test Period 1||4
8260340|NCT01800890|20367351|P4|STARTED|Test Period 1||3
8260341|NCT01800890|20367352|P3|STARTED|Test Period 1||3
8260342|NCT01800890|20367353|P2|STARTED|Test Period 1||3
8260343|NCT01800890|20367354|P1|STARTED|Test Period 1||3
8260344|NCT01800877|20367366|P2|NOT COMPLETED|Overall Study||0
8260345|NCT01800877|20367367|P1|NOT COMPLETED|Overall Study||2
8260346|NCT01800877|20367366|P2|COMPLETED|Overall Study||60
8260347|NCT01800877|20367367|P1|COMPLETED|Overall Study||58
8260348|NCT01800877|20367366|P2|STARTED|Overall Study||60
8260349|NCT01800877|20367367|P1|STARTED|Overall Study||60
8260350|NCT01800838|20367377|P4|NOT COMPLETED|Overall Study||0
8260351|NCT01800838|20367378|P3|NOT COMPLETED|Overall Study||0
8260352|NCT01800838|20367379|P2|NOT COMPLETED|Overall Study||0
8260353|NCT01800838|20367380|P1|NOT COMPLETED|Overall Study||0
8260354|NCT01800838|20367377|P4|COMPLETED|Overall Study||2
8260355|NCT01800838|20367378|P3|COMPLETED|Overall Study||7
8260356|NCT01800838|20367379|P2|COMPLETED|Overall Study||1
8260357|NCT01800838|20367380|P1|COMPLETED|Overall Study||1
8260358|NCT01800838|20367377|P4|STARTED|Overall Study||2
8260359|NCT01800838|20367378|P3|STARTED|Overall Study||7
8260360|NCT01800838|20367379|P2|STARTED|Overall Study||1
8260361|NCT01800838|20367380|P1|STARTED|Overall Study||1
8260362|NCT01800786|20367387|P2|NOT COMPLETED|Overall Study||1
8260363|NCT01800786|20367388|P1|NOT COMPLETED|Overall Study||2
8260364|NCT01800786|20367387|P2|COMPLETED|Overall Study||15
8260365|NCT01800786|20367388|P1|COMPLETED|Overall Study||15
8260366|NCT01800786|20367387|P2|STARTED|Overall Study||16
8260367|NCT01800786|20367388|P1|STARTED|Overall Study||17
8260368|NCT01800318|20367398|P4|NOT COMPLETED|Overall Study||1
8260369|NCT01800318|20367399|P3|NOT COMPLETED|Overall Study||1
8260370|NCT01800318|20367400|P2|NOT COMPLETED|Overall Study||5
8260371|NCT01800318|20367401|P1|NOT COMPLETED|Overall Study||2
8260372|NCT01800318|20367398|P4|COMPLETED|Overall Study||39
8260373|NCT01800318|20367399|P3|COMPLETED|Overall Study||40
8260374|NCT01800318|20367400|P2|COMPLETED|Overall Study||37
8260375|NCT01800318|20367401|P1|COMPLETED|Overall Study||37
8260376|NCT01800318|20367398|P4|STARTED|Overall Study||40
8260377|NCT01800318|20367399|P3|STARTED|Overall Study||41
8260378|NCT01800318|20367400|P2|STARTED|Overall Study||42
8260379|NCT01800318|20367401|P1|STARTED|Overall Study||39
8260380|NCT01800201|20367429|P2|NOT COMPLETED|Overall Study||3
8260381|NCT01800201|20367430|P1|NOT COMPLETED|Overall Study||3
8260382|NCT01800201|20367429|P2|COMPLETED|Overall Study||1000
8260383|NCT01800201|20367430|P1|COMPLETED|Overall Study||503
8260384|NCT01800201|20367429|P2|STARTED|Overall Study||1003
8260385|NCT01800201|20367430|P1|STARTED|Overall Study||506
8260386|NCT01800162|20367445|P3|NOT COMPLETED|Overall Study||0
8260387|NCT01800162|20367446|P2|NOT COMPLETED|Overall Study||0
8260388|NCT01800162|20367447|P1|NOT COMPLETED|Overall Study||0
8260389|NCT01800162|20367445|P3|COMPLETED|Overall Study||1
8260390|NCT01800162|20367446|P2|COMPLETED|Overall Study||0
8260391|NCT01800162|20367447|P1|COMPLETED|Overall Study||1
8260392|NCT01800162|20367445|P3|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
8260393|NCT01800162|20367446|P2|STARTED|Overall Study||0
8260394|NCT01800162|20367447|P1|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
8260395|NCT01800058|20367471|P1|NOT COMPLETED|Overall Study||1
8260396|NCT01800058|20367471|P1|COMPLETED|Overall Study||65
8260397|NCT01800058|20367471|P1|STARTED|Overall Study||66
8260398|NCT01799993|20367484|P2|NOT COMPLETED|Overall Study||128
8260399|NCT01799993|20367485|P1|NOT COMPLETED|Overall Study||133
8260400|NCT01799993|20367484|P2|COMPLETED|Overall Study||235
8260401|NCT01799993|20367485|P1|COMPLETED|Overall Study||229
8260402|NCT01799993|20367484|P2|mITT Population|Overall Study||253
8260403|NCT01799993|20367485|P1|mITT Population|Overall Study||255
8260404|NCT01799993|20367484|P2|ITT Population|Overall Study||358
8260405|NCT01799993|20367485|P1|ITT Population|Overall Study||354
8260406|NCT01799993|20367484|P2|STARTED|Overall Study||363
8260407|NCT01799993|20367485|P1|STARTED|Overall Study||362
8260408|NCT01799941|20367517|P1|NOT COMPLETED|Overall Study||96
8260409|NCT01799941|20367517|P1|COMPLETED|Overall Study||271
8260410|NCT01799941|20367517|P1|STARTED|Overall Study||367
8260411|NCT01799889|20367583|P12|NOT COMPLETED|Overall Study||3
8260412|NCT01799889|20367584|P11|NOT COMPLETED|Overall Study||7
8260413|NCT01799889|20367585|P10|NOT COMPLETED|Overall Study||8
8260414|NCT01799889|20367586|P9|NOT COMPLETED|Overall Study||33
8260415|NCT01799889|20367587|P8|NOT COMPLETED|Overall Study||20
8260416|NCT01799889|20367588|P7|NOT COMPLETED|Overall Study||21
8260417|NCT01799889|20367589|P6|NOT COMPLETED|Overall Study||20
8260418|NCT01799889|20367590|P5|NOT COMPLETED|Overall Study||49
8260419|NCT01799889|20367591|P4|NOT COMPLETED|Overall Study||39
8260420|NCT01799889|20367592|P3|NOT COMPLETED|Overall Study||44
8260421|NCT01799889|20367593|P2|NOT COMPLETED|Overall Study||41
8260422|NCT01799889|20367594|P1|NOT COMPLETED|Overall Study||41
8260423|NCT01799889|20367583|P12|COMPLETED|Overall Study||0
8260424|NCT01799889|20367584|P11|COMPLETED|Overall Study||0
8260425|NCT01799889|20367585|P10|COMPLETED|Overall Study||0
8260426|NCT01799889|20367586|P9|COMPLETED|Overall Study||0
8260427|NCT01799889|20367587|P8|COMPLETED|Overall Study||0
8260428|NCT01799889|20367588|P7|COMPLETED|Overall Study||0
8260429|NCT01799889|20367589|P6|COMPLETED|Overall Study||0
8260430|NCT01799889|20367590|P5|COMPLETED|Overall Study||0
8260431|NCT01799889|20367591|P4|COMPLETED|Overall Study||0
8260432|NCT01799889|20367592|P3|COMPLETED|Overall Study||0
8260433|NCT01799889|20367593|P2|COMPLETED|Overall Study||0
8260434|NCT01799889|20367594|P1|COMPLETED|Overall Study||0
8260435|NCT01799889|20367583|P12|STARTED|Overall Study||3
8260436|NCT01799889|20367584|P11|STARTED|Overall Study||7
8260437|NCT01799889|20367585|P10|STARTED|Overall Study||8
8260438|NCT01799889|20367586|P9|STARTED|Overall Study||33
8260439|NCT01799889|20367587|P8|STARTED|Overall Study||20
8260440|NCT01799889|20367588|P7|STARTED|Overall Study||21
8260441|NCT01799889|20367589|P6|STARTED|Overall Study||20
8260442|NCT01799889|20367590|P5|STARTED|Overall Study||49
8260443|NCT01799889|20367591|P4|STARTED|Overall Study||39
8260444|NCT01799889|20367592|P3|STARTED|Overall Study||44
8260445|NCT01799889|20367593|P2|STARTED|Overall Study||41
8260446|NCT01799889|20367594|P1|STARTED|Overall Study||41
8260447|NCT01799720|20367695|P3|NOT COMPLETED|Overall Study||1
8260448|NCT01799720|20367696|P2|NOT COMPLETED|Overall Study||1
8260449|NCT01799720|20367697|P1|NOT COMPLETED|Overall Study||3
8260450|NCT01799720|20367695|P3|COMPLETED|Overall Study||18
8260451|NCT01799720|20367696|P2|COMPLETED|Overall Study||17
8260452|NCT01799720|20367697|P1|COMPLETED|Overall Study||17
8260453|NCT01799720|20367695|P3|Began the Treatment and Finished it|Overall Study||18
8260454|NCT01799720|20367696|P2|Began the Treatment and Finished it|Overall Study||17
8260455|NCT01799720|20367697|P1|Began the Treatment and Finished it|Overall Study||17
8260456|NCT01799720|20367695|P3|Began the Treatment|Overall Study||19
8260457|NCT01799720|20367696|P2|Began the Treatment|Overall Study||18
8260458|NCT01799720|20367697|P1|Began the Treatment|Overall Study||20
8260459|NCT01799720|20367695|P3|STARTED|Overall Study||19
8260460|NCT01799720|20367696|P2|STARTED|Overall Study||18
8260461|NCT01799720|20367697|P1|STARTED|Overall Study||20
8260462|NCT01799590|20367735|P3|NOT COMPLETED|Overall Study||14
8260463|NCT01799590|20367736|P2|NOT COMPLETED|Overall Study||16
8260464|NCT01799590|20367737|P1|NOT COMPLETED|Overall Study||26
8260465|NCT01799590|20367735|P3|COMPLETED|Overall Study||77
8260466|NCT01799590|20367736|P2|COMPLETED|Overall Study||78
8260467|NCT01799590|20367737|P1|COMPLETED|Overall Study||85
8260468|NCT01799590|20367735|P3|STARTED|Overall Study||91
8260469|NCT01799590|20367736|P2|STARTED|Overall Study||94
8260470|NCT01799590|20367737|P1|STARTED|Overall Study||111
8260471|NCT01799278|20367772|P1|NOT COMPLETED|Overall Study||0
8260472|NCT01799278|20367772|P1|COMPLETED|Overall Study||60
8260473|NCT01799278|20367772|P1|STARTED|Overall Study||60
8260474|NCT01799239|20367780|P2|NOT COMPLETED|Period 2 (7 Days)||1
8260475|NCT01799239|20367781|P1|NOT COMPLETED|Period 2 (7 Days)||2
8260476|NCT01799239|20367780|P2|COMPLETED|Period 2 (7 Days)||14
8260477|NCT01799239|20367781|P1|COMPLETED|Period 2 (7 Days)||11
8260478|NCT01799239|20367780|P2|STARTED|Period 2 (7 Days)||15
8260479|NCT01799239|20367781|P1|STARTED|Period 2 (7 Days)||13
8260480|NCT01799239|20367780|P2|NOT COMPLETED|Period 1 (7 Days)||1
8260481|NCT01799239|20367781|P1|NOT COMPLETED|Period 1 (7 Days)||3
8260482|NCT01799239|20367780|P2|COMPLETED|Period 1 (7 Days)||15
8260483|NCT01799239|20367781|P1|COMPLETED|Period 1 (7 Days)||12
8260484|NCT01799239|20367780|P2|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
8260485|NCT01799239|20367781|P1|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
8260486|NCT01799226|20367789|P2|NOT COMPLETED|Overall Study||0
8260487|NCT01799226|20367790|P1|NOT COMPLETED|Overall Study||2
8260488|NCT01799226|20367789|P2|COMPLETED|Overall Study||16
8260489|NCT01799226|20367790|P1|COMPLETED|Overall Study||14
8260490|NCT01799226|20367789|P2|Left Stent Side|Overall Study||8
8260491|NCT01799226|20367790|P1|Left Stent Side|Overall Study||8
8260492|NCT01799226|20367789|P2|Right Stent Side|Overall Study||8
8260493|NCT01799226|20367790|P1|Right Stent Side|Overall Study||8
8260494|NCT01799226|20367789|P2|STARTED|Overall Study||16
8260495|NCT01799226|20367790|P1|STARTED|Overall Study||16
8260496|NCT01799213|20367800|P2|NOT COMPLETED|Overall Study||6
8260497|NCT01799213|20367801|P1|NOT COMPLETED|Overall Study||7
8260498|NCT01799213|20367800|P2|COMPLETED|Overall Study||178
8260499|NCT01799213|20367801|P1|COMPLETED|Overall Study||173
8260500|NCT01799213|20367800|P2|STARTED|Overall Study||184
8260501|NCT01799213|20367801|P1|STARTED|Overall Study||180
8260502|NCT01798992|20367821|P4|NOT COMPLETED|Overall Study||1
8260503|NCT01798992|20367822|P3|NOT COMPLETED|Overall Study||2
8260504|NCT01798992|20367823|P2|NOT COMPLETED|Overall Study||2
8260505|NCT01798992|20367824|P1|NOT COMPLETED|Overall Study||0
8260506|NCT01798992|20367821|P4|COMPLETED|Overall Study||16
8260507|NCT01798992|20367822|P3|COMPLETED|Overall Study||14
8260508|NCT01798992|20367823|P2|COMPLETED|Overall Study||17
8260509|NCT01798992|20367824|P1|COMPLETED|Overall Study||4
8260510|NCT01798992|20367821|P4|STARTED|Overall Study||17
8260511|NCT01798992|20367822|P3|STARTED|Overall Study||16
8260512|NCT01798992|20367823|P2|STARTED|Overall Study||19
8260513|NCT01798992|20367824|P1|STARTED|Overall Study||4
8260514|NCT01798966|20367838|P1|NOT COMPLETED|Overall Study||0
8260515|NCT01798966|20367838|P1|COMPLETED|Overall Study||10
8260516|NCT01798966|20367838|P1|STARTED|Overall Study||10
8260517|NCT01798927|20367844|P1|NOT COMPLETED|Overall Study||1
8260518|NCT01798927|20367844|P1|COMPLETED|Overall Study||3
8260519|NCT01798927|20367844|P1|STARTED|Overall Study||4
8260520|NCT01798849|20367853|P3|NOT COMPLETED|Overall Study||1
8260521|NCT01798849|20367854|P2|NOT COMPLETED|Overall Study||0
8260522|NCT01798849|20367855|P1|NOT COMPLETED|Overall Study||0
8260523|NCT01798849|20367853|P3|COMPLETED|Overall Study||8
8260524|NCT01798849|20367854|P2|COMPLETED|Overall Study||8
8260525|NCT01798849|20367855|P1|COMPLETED|Overall Study||8
8260526|NCT01798849|20367853|P3|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9
8260527|NCT01798849|20367854|P2|STARTED|Overall Study||8
8260528|NCT01798849|20367855|P1|STARTED|Overall Study||8
8260529|NCT01798706|20368045|P2|NOT COMPLETED|Overall Study||21
8260530|NCT01798706|20368046|P1|NOT COMPLETED|Overall Study||21
8260531|NCT01798706|20368045|P2|COMPLETED|Overall Study||153
8260532|NCT01798706|20368046|P1|COMPLETED|Overall Study||155
8260533|NCT01798706|20368045|P2|STARTED|Overall Study||174
8260534|NCT01798706|20368046|P1|STARTED|Overall Study||176
8260535|NCT01798641|20368074|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8260536|NCT01798641|20368075|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8260537|NCT01798641|20368074|P2|COMPLETED|Second Intervention (6 Weeks)||19
8260538|NCT01798641|20368075|P1|COMPLETED|Second Intervention (6 Weeks)||19
8260539|NCT01798641|20368074|P2|STARTED|Second Intervention (6 Weeks)||19
8260540|NCT01798641|20368075|P1|STARTED|Second Intervention (6 Weeks)||19
8260541|NCT01798641|20368074|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
8260542|NCT01798641|20368075|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
8260543|NCT01798641|20368074|P2|COMPLETED|First Intervention (6 Weeks)||19
8260544|NCT01798641|20368075|P1|COMPLETED|First Intervention (6 Weeks)||19
8260545|NCT01798641|20368074|P2|STARTED|First Intervention (6 Weeks)||19
8260546|NCT01798641|20368075|P1|STARTED|First Intervention (6 Weeks)||19
8260547|NCT01798589|20368089|P1|NOT COMPLETED|Overall Study||0
8260548|NCT01798589|20368089|P1|COMPLETED|Overall Study||16
8260549|NCT01798589|20368089|P1|STARTED|Overall Study||16
8260550|NCT01798550|20368100|P2|NOT COMPLETED|Overall Study||6
8260551|NCT01798550|20368101|P1|NOT COMPLETED|Overall Study||2
8260552|NCT01798550|20368100|P2|COMPLETED|Overall Study||26
8260553|NCT01798550|20368101|P1|COMPLETED|Overall Study||28
8260554|NCT01798550|20368100|P2|STARTED|Overall Study||32
8260555|NCT01798550|20368101|P1|STARTED|Overall Study||30
8260556|NCT01798485|20368117|P2|NOT COMPLETED|Overall Study||290
8260557|NCT01798485|20368118|P1|NOT COMPLETED|Overall Study||346
8260558|NCT01798485|20368117|P2|COMPLETED|Overall Study||59
8260559|NCT01798485|20368118|P1|COMPLETED|Overall Study||1
8260560|NCT01798485|20368117|P2|Randomized as of 19 October 2015|Overall Study||337
8260561|NCT01798485|20368118|P1|Randomized as of 19 October 2015|Overall Study||335
8260562|NCT01798485|20368117|P2|Safety Population as of 23 Dec 2015|Overall Study||342
8260563|NCT01798485|20368118|P1|Safety Population as of 23 Dec 2015|Overall Study||338
8260564|NCT01798485|20368117|P2|STARTED|Overall Study||349
8260565|NCT01798485|20368118|P1|STARTED|Overall Study||347
8260566|NCT01798394|20368154|P2|NOT COMPLETED|Overall Study||3
8260567|NCT01798394|20368155|P1|NOT COMPLETED|Overall Study||3
8260568|NCT01798394|20368154|P2|COMPLETED|Overall Study||19
8260569|NCT01798394|20368155|P1|COMPLETED|Overall Study||21
8260570|NCT01798394|20368154|P2|STARTED|Overall Study||22
8260571|NCT01798394|20368155|P1|STARTED|Overall Study||24
8260572|NCT01798316|20368175|P2|NOT COMPLETED|Overall Study||0
8260573|NCT01798316|20368176|P1|NOT COMPLETED|Overall Study||0
8260574|NCT01798316|20368175|P2|COMPLETED|Overall Study||53
8260575|NCT01798316|20368176|P1|COMPLETED|Overall Study||52
8260576|NCT01798316|20368175|P2|STARTED|Overall Study||53
8260577|NCT01798316|20368176|P1|STARTED|Overall Study||52
8260578|NCT01798264|20368198|P4|NOT COMPLETED|Overall Study||4
8260579|NCT01798264|20368199|P3|NOT COMPLETED|Overall Study||0
8260580|NCT01798264|20368200|P2|NOT COMPLETED|Overall Study||0
8260581|NCT01798264|20368201|P1|NOT COMPLETED|Overall Study||1
8260582|NCT01798264|20368198|P4|COMPLETED|Overall Study||7
8260583|NCT01798264|20368199|P3|COMPLETED|Overall Study||10
8260584|NCT01798264|20368200|P2|COMPLETED|Overall Study||11
8260585|NCT01798264|20368201|P1|COMPLETED|Overall Study||11
8260586|NCT01798264|20368198|P4|STARTED|Overall Study||11
8260587|NCT01798264|20368199|P3|STARTED|Overall Study||10
8260588|NCT01798264|20368200|P2|STARTED|Overall Study||11
8260589|NCT01798264|20368201|P1|STARTED|Overall Study||12
8260590|NCT01798225|20368225|P2|NOT COMPLETED|Overall Study||3
8260591|NCT01798225|20368226|P1|NOT COMPLETED|Overall Study||0
8260592|NCT01798225|20368225|P2|COMPLETED|Overall Study||53
8260593|NCT01798225|20368226|P1|COMPLETED|Overall Study||57
8260594|NCT01798225|20368225|P2|STARTED|Overall Study||56
8260595|NCT01798225|20368226|P1|STARTED|Overall Study||57
8260596|NCT01798186|20368238|P4|NOT COMPLETED|Overall Study||0
8260597|NCT01798186|20368239|P3|NOT COMPLETED|Overall Study||0
8260598|NCT01798186|20368240|P2|NOT COMPLETED|Overall Study||0
8260599|NCT01798186|20368241|P1|NOT COMPLETED|Overall Study||0
8260600|NCT01798186|20368238|P4|COMPLETED|Overall Study||8
8260601|NCT01798186|20368239|P3|COMPLETED|Overall Study||6
8260602|NCT01798186|20368240|P2|COMPLETED|Overall Study||6
8260603|NCT01798186|20368241|P1|COMPLETED|Overall Study||6
8260604|NCT01798186|20368238|P4|STARTED|Overall Study||8
8260605|NCT01798186|20368239|P3|STARTED|Overall Study||6
8260606|NCT01798186|20368240|P2|STARTED|Overall Study||6
8260607|NCT01798186|20368241|P1|STARTED|Overall Study||6
8260608|NCT01798134|20368255|P1|NOT COMPLETED|Overall Study||16
8260609|NCT01798134|20368255|P1|COMPLETED|Overall Study||9
8260610|NCT01798134|20368255|P1|STARTED|Overall Study||25
8260620|NCT01797965|20368307|P4|NOT COMPLETED|Overall Study||73
8260621|NCT01797965|20368308|P3|NOT COMPLETED|Overall Study||8
8260622|NCT01797965|20368309|P2|NOT COMPLETED|Overall Study||569
8260623|NCT01797965|20368310|P1|NOT COMPLETED|Overall Study||549
8260624|NCT01797965|20368307|P4|COMPLETED|Overall Study||154
8260625|NCT01797965|20368308|P3|COMPLETED|Overall Study||62
8260626|NCT01797965|20368309|P2|COMPLETED|Overall Study||38
8260627|NCT01797965|20368310|P1|COMPLETED|Overall Study||48
8260628|NCT01797965|20368307|P4|STARTED|Overall Study||227
8260629|NCT01797965|20368308|P3|STARTED|Overall Study||70
8260630|NCT01797965|20368309|P2|STARTED|Overall Study||607
8260631|NCT01797965|20368310|P1|STARTED|Overall Study||597
8260632|NCT01797835|20368444|P2|NOT COMPLETED|Overall Study||27
8260633|NCT01797835|20368445|P1|NOT COMPLETED|Overall Study||31
8260634|NCT01797835|20368444|P2|COMPLETED|Overall Study||114
8260635|NCT01797835|20368445|P1|COMPLETED|Overall Study||122
8260636|NCT01797835|20368444|P2|STARTED|Overall Study||141
8260637|NCT01797835|20368445|P1|STARTED|Overall Study||153
8260638|NCT01797822|20368453|P1|NOT COMPLETED|Overall Study||0
8260639|NCT01797822|20368453|P1|COMPLETED|Overall Study|The protocol is now closed.|20
8260640|NCT01797822|20368453|P1|STARTED|Overall Study||20
8260641|NCT01797783|20368461|P2|NOT COMPLETED|Overall Study||1
8260642|NCT01797783|20368462|P1|NOT COMPLETED|Overall Study||2
8260643|NCT01797783|20368461|P2|COMPLETED|Overall Study||26
8260644|NCT01797783|20368462|P1|COMPLETED|Overall Study||50
8260645|NCT01797783|20368461|P2|STARTED|Overall Study||27
8260646|NCT01797783|20368462|P1|STARTED|Overall Study||52
8260647|NCT01797731|20368486|P2|NOT COMPLETED|Overall Study||3
8260648|NCT01797731|20368487|P1|NOT COMPLETED|Overall Study||3
8260649|NCT01797731|20368486|P2|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
8260650|NCT01797731|20368487|P1|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
8260651|NCT01797731|20368486|P2|STARTED|Overall Study||50
8260652|NCT01797731|20368487|P1|STARTED|Overall Study||50
8260653|NCT01797705|20368495|P1|NOT COMPLETED|Overall Study||5
8260654|NCT01797705|20368495|P1|COMPLETED|Overall Study||28
8260655|NCT01797705|20368495|P1|STARTED|Overall Study||33
8260656|NCT01797575|20368503|P4|NOT COMPLETED|Week 8 Re-Randomization||3
8260657|NCT01797575|20368504|P3|NOT COMPLETED|Week 8 Re-Randomization||1
8260658|NCT01797575|20368505|P2|NOT COMPLETED|Week 8 Re-Randomization||0
8260659|NCT01797575|20368506|P1|NOT COMPLETED|Week 8 Re-Randomization||0
8260660|NCT01797575|20368503|P4|COMPLETED|Week 8 Re-Randomization||7
8260661|NCT01797575|20368504|P3|COMPLETED|Week 8 Re-Randomization||4
8260662|NCT01797575|20368505|P2|COMPLETED|Week 8 Re-Randomization||5
8260663|NCT01797575|20368506|P1|COMPLETED|Week 8 Re-Randomization||4
8260664|NCT01797575|20368503|P4|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
8260665|NCT01797575|20368504|P3|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
8260666|NCT01797575|20368505|P2|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
8260667|NCT01797575|20368506|P1|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
8260668|NCT01797575|20368503|P4|NOT COMPLETED|Baseline Allocation||7
8260669|NCT01797575|20368504|P3|NOT COMPLETED|Baseline Allocation||5
8260670|NCT01797575|20368505|P2|NOT COMPLETED|Baseline Allocation||1
8260671|NCT01797575|20368506|P1|NOT COMPLETED|Baseline Allocation||1
8260672|NCT01797575|20368503|P4|COMPLETED|Baseline Allocation||8
8260673|NCT01797575|20368504|P3|COMPLETED|Baseline Allocation||4
8260674|NCT01797575|20368505|P2|COMPLETED|Baseline Allocation||8
8260675|NCT01797575|20368506|P1|COMPLETED|Baseline Allocation||4
8260676|NCT01797575|20368503|P4|STARTED|Baseline Allocation||15
8260677|NCT01797575|20368504|P3|STARTED|Baseline Allocation||9
8260678|NCT01797575|20368505|P2|STARTED|Baseline Allocation||9
8260679|NCT01797575|20368506|P1|STARTED|Baseline Allocation||5
8260680|NCT01797562|20368556|P1|NOT COMPLETED|Overall Study||5
8260681|NCT01797562|20368556|P1|COMPLETED|Overall Study||111
8260682|NCT01797562|20368556|P1|STARTED|Overall Study||116
8260683|NCT01797536|20368565|P4|NOT COMPLETED|Overall Study||0
8260684|NCT01797536|20368566|P3|NOT COMPLETED|Overall Study||0
8260685|NCT01797536|20368567|P2|NOT COMPLETED|Overall Study||1
8260686|NCT01797536|20368568|P1|NOT COMPLETED|Overall Study||0
8260687|NCT01797536|20368565|P4|COMPLETED|Overall Study||8
8260688|NCT01797536|20368566|P3|COMPLETED|Overall Study||7
8260689|NCT01797536|20368567|P2|COMPLETED|Overall Study||10
8260690|NCT01797536|20368568|P1|COMPLETED|Overall Study||8
8260691|NCT01797536|20368565|P4|STARTED|Overall Study||8
8260692|NCT01797536|20368566|P3|STARTED|Overall Study||7
8260693|NCT01797536|20368567|P2|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
8260694|NCT01797536|20368568|P1|STARTED|Overall Study||8
8260695|NCT01797484|20368600|P2|NOT COMPLETED|Overall Study||0
8260696|NCT01797484|20368601|P1|NOT COMPLETED|Overall Study||0
8260697|NCT01797484|20368600|P2|COMPLETED|Overall Study||10
8260698|NCT01797484|20368601|P1|COMPLETED|Overall Study||10
8260699|NCT01797484|20368600|P2|STARTED|Overall Study||10
8260700|NCT01797484|20368601|P1|STARTED|Overall Study||10
8260701|NCT01797471|20368607|P1|NOT COMPLETED|Overall Study||0
8260702|NCT01797471|20368607|P1|COMPLETED|Overall Study||1
8260703|NCT01797471|20368607|P1|STARTED|Overall Study||1
8260704|NCT01797458|20368619|P3|NOT COMPLETED|Overall Study||7
8260705|NCT01797458|20368620|P2|NOT COMPLETED|Overall Study||9
8260706|NCT01797458|20368621|P1|NOT COMPLETED|Overall Study||12
8260707|NCT01797458|20368619|P3|COMPLETED|Overall Study||58
8260708|NCT01797458|20368620|P2|COMPLETED|Overall Study||43
8260709|NCT01797458|20368621|P1|COMPLETED|Overall Study||40
8260710|NCT01797458|20368619|P3|STARTED|Overall Study||65
8260711|NCT01797458|20368620|P2|STARTED|Overall Study||52
8260712|NCT01797458|20368621|P1|STARTED|Overall Study||52
8260713|NCT01797445|20368640|P2|NOT COMPLETED|Open-Label Extension Phase||0
8260714|NCT01797445|20368641|P1|NOT COMPLETED|Open-Label Extension Phase||1
8260715|NCT01797445|20368640|P2|COMPLETED|Open-Label Extension Phase||119
8260716|NCT01797445|20368641|P1|COMPLETED|Open-Label Extension Phase||140
8260717|NCT01797445|20368640|P2|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119
8260718|NCT01797445|20368641|P1|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141
8260719|NCT01797445|20368640|P2|NOT COMPLETED|Double-Blind Phase||89
8260720|NCT01797445|20368641|P1|NOT COMPLETED|Double-Blind Phase||87
8260721|NCT01797445|20368640|P2|COMPLETED|Double-Blind Phase||348
8260722|NCT01797445|20368641|P1|COMPLETED|Double-Blind Phase||348
8260723|NCT01797445|20368640|P2|STARTED|Double-Blind Phase||437
8260724|NCT01797445|20368641|P1|STARTED|Double-Blind Phase||435
8260725|NCT01797432|20368681|P1|NOT COMPLETED|Overall Study||4
8260726|NCT01797432|20368681|P1|COMPLETED|Overall Study||10
8260727|NCT01797432|20368681|P1|STARTED|Overall Study||14
8260728|NCT01797380|20368688|P2|NOT COMPLETED|Overall Study||2
8260729|NCT01797380|20368689|P1|NOT COMPLETED|Overall Study||3
8260730|NCT01797380|20368688|P2|COMPLETED|Overall Study||0
8260731|NCT01797380|20368689|P1|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
8260732|NCT01797380|20368688|P2|STARTED|Overall Study||2
8260733|NCT01797380|20368689|P1|STARTED|Overall Study|Terminated due to lack of enrollment|3
8260734|NCT01797328|20368697|P2|NOT COMPLETED|Overall Study||0
8260735|NCT01797328|20368698|P1|NOT COMPLETED|Overall Study||2
8260736|NCT01797328|20368697|P2|COMPLETED|Overall Study||12
8260737|NCT01797328|20368698|P1|COMPLETED|Overall Study||14
8260738|NCT01797328|20368697|P2|STARTED|Overall Study||12
8260739|NCT01797328|20368698|P1|STARTED|Overall Study||16
8260740|NCT01797302|20368707|P3|NOT COMPLETED|Overall Study||26
8260741|NCT01797302|20368708|P2|NOT COMPLETED|Overall Study||26
8260742|NCT01797302|20368709|P1|NOT COMPLETED|Overall Study||17
8260743|NCT01797302|20368707|P3|COMPLETED|Overall Study||50
8260744|NCT01797302|20368708|P2|COMPLETED|Overall Study||48
8260745|NCT01797302|20368709|P1|COMPLETED|Overall Study||58
8260746|NCT01797302|20368707|P3|3 Month Visit|Overall Study||57
8260747|NCT01797302|20368708|P2|3 Month Visit|Overall Study||57
8260748|NCT01797302|20368709|P1|3 Month Visit|Overall Study||60
8260749|NCT01797302|20368707|P3|STARTED|Overall Study||76
8260750|NCT01797302|20368708|P2|STARTED|Overall Study||74
8260751|NCT01797302|20368709|P1|STARTED|Overall Study||75
8260752|NCT01797263|20368746|P2|NOT COMPLETED|Overall Study||40
8260753|NCT01797263|20368747|P1|NOT COMPLETED|Overall Study||37
8260754|NCT01797263|20368746|P2|COMPLETED|Overall Study||87
8260755|NCT01797263|20368747|P1|COMPLETED|Overall Study||92
8260756|NCT01797263|20368746|P2|9 Month|Overall Study||87
8260757|NCT01797263|20368747|P1|9 Month|Overall Study||92
8260758|NCT01797263|20368746|P2|6 Month|Overall Study||85
8260759|NCT01797263|20368747|P1|6 Month|Overall Study||90
8260760|NCT01797263|20368746|P2|3 Month|Overall Study||84
8260761|NCT01797263|20368747|P1|3 Month|Overall Study||87
8260762|NCT01797263|20368746|P2|1 Month|Overall Study||87
8260763|NCT01797263|20368747|P1|1 Month|Overall Study||96
8260764|NCT01797263|20368746|P2|STARTED|Overall Study||127
8260765|NCT01797263|20368747|P1|STARTED|Overall Study||129
8260766|NCT01797185|20368782|P3|NOT COMPLETED|Overall Study||12
8260767|NCT01797185|20368783|P2|NOT COMPLETED|Overall Study||38
8260768|NCT01797185|20368784|P1|NOT COMPLETED|Overall Study||28
8260769|NCT01797185|20368782|P3|COMPLETED|Overall Study||38
8260770|NCT01797185|20368783|P2|COMPLETED|Overall Study||125
8260771|NCT01797185|20368784|P1|COMPLETED|Overall Study||134
8260772|NCT01797185|20368782|P3|STARTED|Overall Study||50
8260773|NCT01797185|20368783|P2|STARTED|Overall Study||163
8260774|NCT01797185|20368784|P1|STARTED|Overall Study||162
8260775|NCT01797159|20368792|P1|NOT COMPLETED|Overall Study||0
8260776|NCT01797159|20368792|P1|COMPLETED|Overall Study||20
8260777|NCT01797159|20368792|P1|STARTED|Overall Study||20
8260778|NCT01797120|20368808|P2|NOT COMPLETED|Overall Study||65
8260779|NCT01797120|20368809|P1|NOT COMPLETED|Overall Study||66
8260780|NCT01797120|20368808|P2|COMPLETED|Overall Study||0
8260781|NCT01797120|20368809|P1|COMPLETED|Overall Study||0
8260782|NCT01797120|20368808|P2|STARTED|Overall Study||65
8260783|NCT01797120|20368809|P1|STARTED|Overall Study||66
8260784|NCT01797094|20368823|P2|NOT COMPLETED|Overall Study||2
8260785|NCT01797094|20368824|P1|NOT COMPLETED|Overall Study||6
8260786|NCT01797094|20368823|P2|COMPLETED|Overall Study||51
8260787|NCT01797094|20368824|P1|COMPLETED|Overall Study||42
8260788|NCT01797094|20368823|P2|STARTED|Overall Study||53
8260789|NCT01797094|20368824|P1|STARTED|Overall Study||48
8260790|NCT01797081|20368846|P4|NOT COMPLETED|Overall Study||9
8260791|NCT01797081|20368847|P3|NOT COMPLETED|Overall Study||5
8260792|NCT01797081|20368848|P2|NOT COMPLETED|Overall Study||4
8260793|NCT01797081|20368849|P1|NOT COMPLETED|Overall Study||14
8260794|NCT01797081|20368846|P4|COMPLETED|Overall Study||40
8260795|NCT01797081|20368847|P3|COMPLETED|Overall Study||43
8260796|NCT01797081|20368848|P2|COMPLETED|Overall Study||95
8260797|NCT01797081|20368849|P1|COMPLETED|Overall Study||90
8260798|NCT01797081|20368846|P4|STARTED|Overall Study||49
8260799|NCT01797081|20368847|P3|STARTED|Overall Study||48
8260800|NCT01797081|20368848|P2|STARTED|Overall Study||99
8260801|NCT01797081|20368849|P1|STARTED|Overall Study||104
8260802|NCT01797029|20368868|P2|NOT COMPLETED|Overall Study||61
8260803|NCT01797029|20368869|P1|NOT COMPLETED|Overall Study||159
8260804|NCT01797029|20368868|P2|COMPLETED|Overall Study||526
8260805|NCT01797029|20368869|P1|COMPLETED|Overall Study||1015
8260806|NCT01797029|20368868|P2|STARTED|Overall Study||587
8260807|NCT01797029|20368869|P1|STARTED|Overall Study||1174
8260808|NCT01796977|20368877|P1|NOT COMPLETED|Overall Study||0
8260809|NCT01796977|20368877|P1|COMPLETED|Overall Study||27
8260810|NCT01796977|20368877|P1|STARTED|Overall Study||27
8260811|NCT01796964|20368890|P2|NOT COMPLETED|Overall Study||3
8260812|NCT01796964|20368891|P1|NOT COMPLETED|Overall Study||3
8260813|NCT01796964|20368890|P2|COMPLETED|Overall Study||42
8260814|NCT01796964|20368891|P1|COMPLETED|Overall Study||41
8260815|NCT01796964|20368890|P2|STARTED|Overall Study||45
8260816|NCT01796964|20368891|P1|STARTED|Overall Study||44
8260817|NCT01796912|20368913|P2|NOT COMPLETED|Second Intervention||0
8260818|NCT01796912|20368914|P1|NOT COMPLETED|Second Intervention||0
8260819|NCT01796912|20368913|P2|COMPLETED|Second Intervention||10
8260820|NCT01796912|20368914|P1|COMPLETED|Second Intervention||10
8260821|NCT01796912|20368913|P2|STARTED|Second Intervention||10
8260822|NCT01796912|20368914|P1|STARTED|Second Intervention||10
8260823|NCT01796912|20368913|P2|NOT COMPLETED|Washout||0
8260824|NCT01796912|20368914|P1|NOT COMPLETED|Washout||0
8260825|NCT01796912|20368913|P2|COMPLETED|Washout||10
8260826|NCT01796912|20368914|P1|COMPLETED|Washout||10
8260827|NCT01796912|20368913|P2|STARTED|Washout||10
8260828|NCT01796912|20368914|P1|STARTED|Washout||10
8260829|NCT01796912|20368913|P2|NOT COMPLETED|First Intervention||0
8260830|NCT01796912|20368914|P1|NOT COMPLETED|First Intervention||0
8260831|NCT01796912|20368913|P2|COMPLETED|First Intervention||10
8260832|NCT01796912|20368914|P1|COMPLETED|First Intervention||10
8260833|NCT01796912|20368913|P2|STARTED|First Intervention||10
8260834|NCT01796912|20368914|P1|STARTED|First Intervention||10
8260835|NCT01796860|20368932|P1|NOT COMPLETED|Overall Study||3
8260836|NCT01796860|20368932|P1|COMPLETED|Overall Study||7
8260837|NCT01796860|20368932|P1|STARTED|Overall Study||10
8260838|NCT01796665|20368941|P3|NOT COMPLETED|Overall Study||42
8260839|NCT01796665|20368942|P2|NOT COMPLETED|Overall Study||73
8260840|NCT01796665|20368943|P1|NOT COMPLETED|Overall Study||58
8260841|NCT01796665|20368941|P3|COMPLETED|Overall Study||195
8260842|NCT01796665|20368942|P2|COMPLETED|Overall Study||396
8260843|NCT01796665|20368943|P1|COMPLETED|Overall Study||416
8260844|NCT01796665|20368941|P3|STARTED|Overall Study||237
8260845|NCT01796665|20368942|P2|STARTED|Overall Study||469
8260846|NCT01796665|20368943|P1|STARTED|Overall Study||474
8260847|NCT01796548|20368957|P1|NOT COMPLETED|Overall Study||3
8260848|NCT01796548|20368957|P1|COMPLETED|Overall Study||14
8260849|NCT01796548|20368957|P1|Treated|Overall Study||15
8260850|NCT01796548|20368957|P1|STARTED|Overall Study||17
8260851|NCT01796470|20368974|P5|NOT COMPLETED|Overall Study||8
8260852|NCT01796470|20368975|P4|NOT COMPLETED|Overall Study||3
8260853|NCT01796470|20368976|P3|NOT COMPLETED|Overall Study||6
8260854|NCT01796470|20368977|P2|NOT COMPLETED|Overall Study||14
8260855|NCT01796470|20368978|P1|NOT COMPLETED|Overall Study||35
8260856|NCT01796470|20368974|P5|COMPLETED|Overall Study||0
8260857|NCT01796470|20368975|P4|COMPLETED|Overall Study||0
8260858|NCT01796470|20368976|P3|COMPLETED|Overall Study||0
8260859|NCT01796470|20368977|P2|COMPLETED|Overall Study||0
8260860|NCT01796470|20368978|P1|COMPLETED|Overall Study||0
8260861|NCT01796470|20368974|P5|Entospletinib Monotherapy|Overall Study||0
8260862|NCT01796470|20368975|P4|Entospletinib Monotherapy|Overall Study||0
8260863|NCT01796470|20368976|P3|Entospletinib Monotherapy|Overall Study||0
8260864|NCT01796470|20368977|P2|Entospletinib Monotherapy|Overall Study||4
8260865|NCT01796470|20368978|P1|Entospletinib Monotherapy|Overall Study||4
8260866|NCT01796470|20368974|P5|STARTED|Overall Study||8
8260867|NCT01796470|20368975|P4|STARTED|Overall Study||3
8260868|NCT01796470|20368976|P3|STARTED|Overall Study||6
8260869|NCT01796470|20368977|P2|STARTED|Overall Study||14
8260870|NCT01796470|20368978|P1|STARTED|Overall Study||35
8260871|NCT01796392|20369022|P2|NOT COMPLETED|Overall Study||3
8260872|NCT01796392|20369023|P1|NOT COMPLETED|Overall Study||9
8260873|NCT01796392|20369022|P2|COMPLETED|Overall Study|59 active subjects at 12-months|59
8260874|NCT01796392|20369023|P1|COMPLETED|Overall Study|119 active subjects at 12-months|119
8260875|NCT01796392|20369022|P2|STARTED|Overall Study||62
8260876|NCT01796392|20369023|P1|STARTED|Overall Study||128
8260877|NCT01796301|20369037|P2|NOT COMPLETED|Overall Study||20
8260878|NCT01796301|20369038|P1|NOT COMPLETED|Overall Study||18
8260879|NCT01796301|20369037|P2|COMPLETED|Overall Study||198
8260880|NCT01796301|20369038|P1|COMPLETED|Overall Study||200
8260881|NCT01796301|20369037|P2|Received Treatment|Overall Study||218
8260882|NCT01796301|20369038|P1|Received Treatment|Overall Study||214
8260883|NCT01796301|20369037|P2|STARTED|Overall Study||218
8260884|NCT01796301|20369038|P1|STARTED|Overall Study||218
8260885|NCT01796236|20369074|P2|NOT COMPLETED|Overall Study||2
8260886|NCT01796236|20369075|P1|NOT COMPLETED|Overall Study||2
8260887|NCT01796236|20369074|P2|COMPLETED|Overall Study||50
8260888|NCT01796236|20369075|P1|COMPLETED|Overall Study||49
8260889|NCT01796236|20369074|P2|STARTED|Overall Study||52
8260890|NCT01796236|20369075|P1|STARTED|Overall Study||51
8260891|NCT01795937|20369124|P3|NOT COMPLETED|Overall Study||0
8260892|NCT01795937|20369125|P2|NOT COMPLETED|Overall Study||1
8260893|NCT01795937|20369126|P1|NOT COMPLETED|Overall Study||1
8260894|NCT01795937|20369124|P3|COMPLETED|Overall Study||17
8260895|NCT01795937|20369125|P2|COMPLETED|Overall Study||15
8260896|NCT01795937|20369126|P1|COMPLETED|Overall Study||17
8260897|NCT01795937|20369124|P3|STARTED|Overall Study||17
8260898|NCT01795937|20369125|P2|STARTED|Overall Study||16
8260899|NCT01795937|20369126|P1|STARTED|Overall Study||18
8260900|NCT01795898|20369155|P1|NOT COMPLETED|Overall Study||60
8260901|NCT01795898|20369155|P1|COMPLETED|Overall Study||177
8260902|NCT01795898|20369155|P1|STARTED|Overall Study||237
8260903|NCT01795859|20369165|P2|NOT COMPLETED|Overall Study||2
8260904|NCT01795859|20369166|P1|NOT COMPLETED|Overall Study||1
8260905|NCT01795859|20369165|P2|COMPLETED|Overall Study||43
8260906|NCT01795859|20369166|P1|COMPLETED|Overall Study||44
8260907|NCT01795859|20369165|P2|STARTED|Overall Study||45
8260908|NCT01795859|20369166|P1|STARTED|Overall Study||45
8260909|NCT01795833|20369184|P2|NOT COMPLETED|Overall Study||149
8260910|NCT01795833|20369185|P1|NOT COMPLETED|Overall Study||150
8260911|NCT01795833|20369184|P2|COMPLETED|Overall Study||882
8260912|NCT01795833|20369185|P1|COMPLETED|Overall Study||881
8260913|NCT01795833|20369184|P2|STARTED|Overall Study||1031
8260914|NCT01795833|20369185|P1|STARTED|Overall Study||1031
8260915|NCT01795716|20369205|P2|NOT COMPLETED|Second Intervention (13 Days)||0
8260916|NCT01795716|20369206|P1|NOT COMPLETED|Second Intervention (13 Days)||0
8260917|NCT01795716|20369205|P2|COMPLETED|Second Intervention (13 Days)||11
8260918|NCT01795716|20369206|P1|COMPLETED|Second Intervention (13 Days)||10
8260919|NCT01795716|20369205|P2|STARTED|Second Intervention (13 Days)||11
8260920|NCT01795716|20369206|P1|STARTED|Second Intervention (13 Days)||10
8260921|NCT01795716|20369205|P2|NOT COMPLETED|Washout (10 Days)||0
8260922|NCT01795716|20369206|P1|NOT COMPLETED|Washout (10 Days)||0
8260923|NCT01795716|20369205|P2|COMPLETED|Washout (10 Days)||11
8260924|NCT01795716|20369206|P1|COMPLETED|Washout (10 Days)||10
8260925|NCT01795716|20369205|P2|STARTED|Washout (10 Days)||11
8260926|NCT01795716|20369206|P1|STARTED|Washout (10 Days)||10
8260927|NCT01795716|20369205|P2|NOT COMPLETED|First Intervention (13 Days)||0
8260928|NCT01795716|20369206|P1|NOT COMPLETED|First Intervention (13 Days)||0
8260929|NCT01795716|20369205|P2|COMPLETED|First Intervention (13 Days)||11
8260930|NCT01795716|20369206|P1|COMPLETED|First Intervention (13 Days)||10
8260931|NCT01795716|20369205|P2|STARTED|First Intervention (13 Days)||11
8260932|NCT01795716|20369206|P1|STARTED|First Intervention (13 Days)||10
8260933|NCT01795638|20369214|P2|NOT COMPLETED|Overall Study||11
8260934|NCT01795638|20369215|P1|NOT COMPLETED|Overall Study||13
8260935|NCT01795638|20369214|P2|COMPLETED|Overall Study||15
8260936|NCT01795638|20369215|P1|COMPLETED|Overall Study||14
8260937|NCT01795638|20369214|P2|STARTED|Overall Study||26
8260938|NCT01795638|20369215|P1|STARTED|Overall Study||27
8260939|NCT01795547|20369241|P2|NOT COMPLETED|Overall Study||64
8260940|NCT01795547|20369242|P1|NOT COMPLETED|Overall Study||48
8260941|NCT01795547|20369241|P2|COMPLETED|Overall Study||83
8260942|NCT01795547|20369242|P1|COMPLETED|Overall Study||100
8260943|NCT01795547|20369241|P2|STARTED|Overall Study||147
8260944|NCT01795547|20369242|P1|STARTED|Overall Study||148
8260945|NCT01795534|20369264|P2|NOT COMPLETED|Second Intervention (Second Shot)||0
8260946|NCT01795534|20369265|P1|NOT COMPLETED|Second Intervention (Second Shot)||0
8260947|NCT01795534|20369264|P2|COMPLETED|Second Intervention (Second Shot)||5
8260948|NCT01795534|20369265|P1|COMPLETED|Second Intervention (Second Shot)||5
8260949|NCT01795534|20369264|P2|STARTED|Second Intervention (Second Shot)||5
8260950|NCT01795534|20369265|P1|STARTED|Second Intervention (Second Shot)||5
8260951|NCT01795534|20369264|P2|NOT COMPLETED|Wash Out Period (4 Days)||0
8260952|NCT01795534|20369265|P1|NOT COMPLETED|Wash Out Period (4 Days)||0
8260953|NCT01795534|20369264|P2|COMPLETED|Wash Out Period (4 Days)||5
8260954|NCT01795534|20369265|P1|COMPLETED|Wash Out Period (4 Days)||5
8260955|NCT01795534|20369264|P2|STARTED|Wash Out Period (4 Days)||5
8260956|NCT01795534|20369265|P1|STARTED|Wash Out Period (4 Days)||5
8260957|NCT01795534|20369264|P2|NOT COMPLETED|First Intervention (First Shot)||0
8260958|NCT01795534|20369265|P1|NOT COMPLETED|First Intervention (First Shot)||0
8260959|NCT01795534|20369264|P2|COMPLETED|First Intervention (First Shot)||5
8260960|NCT01795534|20369265|P1|COMPLETED|First Intervention (First Shot)||5
8260961|NCT01795534|20369264|P2|STARTED|First Intervention (First Shot)||5
8260962|NCT01795534|20369265|P1|STARTED|First Intervention (First Shot)||5
8260963|NCT01795495|20369274|P3|NOT COMPLETED|Overall Study||2
8260964|NCT01795495|20369275|P2|NOT COMPLETED|Overall Study||0
8260965|NCT01795495|20369276|P1|NOT COMPLETED|Overall Study||1
8260966|NCT01795495|20369274|P3|COMPLETED|Overall Study||19
8260967|NCT01795495|20369275|P2|COMPLETED|Overall Study||22
8260968|NCT01795495|20369276|P1|COMPLETED|Overall Study||19
8260969|NCT01795495|20369274|P3|STARTED|Overall Study||21
8260970|NCT01795495|20369275|P2|STARTED|Overall Study||22
8260971|NCT01795495|20369276|P1|STARTED|Overall Study||20
8260972|NCT01795105|20369287|P1|NOT COMPLETED|Overall Study||44
8260973|NCT01795105|20369287|P1|COMPLETED|Overall Study||648
8260974|NCT01795105|20369287|P1|STARTED|Overall Study||692
8260975|NCT01794949|20369296|P2|NOT COMPLETED|Overall Study||0
8260976|NCT01794949|20369297|P1|NOT COMPLETED|Overall Study||1
8260977|NCT01794949|20369296|P2|COMPLETED|Overall Study||1
8260978|NCT01794949|20369297|P1|COMPLETED|Overall Study||6
8260979|NCT01794949|20369296|P2|6 Month Follow-up|Overall Study||1
8260980|NCT01794949|20369297|P1|6 Month Follow-up|Overall Study||6
8260981|NCT01794949|20369296|P2|STARTED|Overall Study||1
8260982|NCT01794949|20369297|P1|STARTED|Overall Study||7
8260983|NCT01794936|20369303|P1|NOT COMPLETED|Overall Study||0
8260984|NCT01794936|20369303|P1|COMPLETED|Overall Study||9
8260985|NCT01794936|20369303|P1|STARTED|Overall Study||9
8260986|NCT01794845|20369308|P1|NOT COMPLETED|Overall Study||1
8260987|NCT01794845|20369308|P1|COMPLETED|Overall Study||4
8260988|NCT01794845|20369308|P1|STARTED|Overall Study||5
8260989|NCT01794806|20369317|P2|NOT COMPLETED|Overall Study||1
8260990|NCT01794806|20369318|P1|NOT COMPLETED|Overall Study||5
8260991|NCT01794806|20369317|P2|COMPLETED|Overall Study||27
8260992|NCT01794806|20369318|P1|COMPLETED|Overall Study||26
8260993|NCT01794806|20369317|P2|4 Weeks|Overall Study||27
8260994|NCT01794806|20369318|P1|4 Weeks|Overall Study||26
8260995|NCT01794806|20369317|P2|1 Week|Overall Study||28
8260996|NCT01794806|20369318|P1|1 Week|Overall Study||28
8260997|NCT01794806|20369317|P2|STARTED|Overall Study||28
8260998|NCT01794806|20369318|P1|STARTED|Overall Study||31
8260999|NCT01794780|20369336|P8|NOT COMPLETED|Overall Study||9
8261000|NCT01794780|20369337|P7|NOT COMPLETED|Overall Study||42
8261001|NCT01794780|20369338|P6|NOT COMPLETED|Overall Study||180
8261002|NCT01794780|20369339|P5|NOT COMPLETED|Overall Study||3
8261003|NCT01794780|20369340|P4|NOT COMPLETED|Overall Study||83
8261004|NCT01794780|20369341|P3|NOT COMPLETED|Overall Study||242
8261005|NCT01794780|20369342|P2|NOT COMPLETED|Overall Study||96
8261006|NCT01794780|20369343|P1|NOT COMPLETED|Overall Study||17
8261007|NCT01794780|20369336|P8|COMPLETED|Overall Study||21
8261008|NCT01794780|20369337|P7|COMPLETED|Overall Study||112
8261009|NCT01794780|20369338|P6|COMPLETED|Overall Study||452
8261010|NCT01794780|20369339|P5|COMPLETED|Overall Study||6
8261011|NCT01794780|20369340|P4|COMPLETED|Overall Study||200
8261012|NCT01794780|20369341|P3|COMPLETED|Overall Study||571
8261013|NCT01794780|20369342|P2|COMPLETED|Overall Study||180
8261014|NCT01794780|20369343|P1|COMPLETED|Overall Study||15
8261015|NCT01794780|20369336|P8|STARTED|Overall Study||30
8261016|NCT01794780|20369337|P7|STARTED|Overall Study||154
8261017|NCT01794780|20369338|P6|STARTED|Overall Study||632
8261018|NCT01794780|20369339|P5|STARTED|Overall Study||9
8261019|NCT01794780|20369340|P4|STARTED|Overall Study||283
8261020|NCT01794780|20369341|P3|STARTED|Overall Study||813
8261021|NCT01794780|20369342|P2|STARTED|Overall Study||276
8261022|NCT01794780|20369343|P1|STARTED|Overall Study||32
8261023|NCT01794741|20369393|P2|NOT COMPLETED|Overall Study||9
8261024|NCT01794741|20369394|P1|NOT COMPLETED|Overall Study||19
8261025|NCT01794741|20369393|P2|COMPLETED|Overall Study||92
8261026|NCT01794741|20369394|P1|COMPLETED|Overall Study||285
8261027|NCT01794741|20369393|P2|STARTED|Overall Study||101
8261028|NCT01794741|20369394|P1|STARTED|Overall Study||304
8261029|NCT01794702|20369403|P3|NOT COMPLETED|Overall Study||0
8261030|NCT01794702|20369404|P2|NOT COMPLETED|Overall Study||0
8261031|NCT01794702|20369405|P1|NOT COMPLETED|Overall Study||0
8261032|NCT01794702|20369403|P3|COMPLETED|Overall Study||47
8261033|NCT01794702|20369404|P2|COMPLETED|Overall Study||0
8261034|NCT01794702|20369405|P1|COMPLETED|Overall Study||18
8261035|NCT01794702|20369403|P3|STARTED|Overall Study||47
8261036|NCT01794702|20369404|P2|STARTED|Overall Study||0
8261037|NCT01794702|20369405|P1|STARTED|Overall Study||18
8261038|NCT01794689|20369419|P4|NOT COMPLETED|Intervention 2 (2 Nights)||0
8261039|NCT01794689|20369420|P3|NOT COMPLETED|Intervention 2 (2 Nights)||0
8261040|NCT01794689|20369421|P2|NOT COMPLETED|Intervention 2 (2 Nights)||0
8261041|NCT01794689|20369422|P1|NOT COMPLETED|Intervention 2 (2 Nights)||0
8261042|NCT01794689|20369419|P4|COMPLETED|Intervention 2 (2 Nights)||18
8261043|NCT01794689|20369420|P3|COMPLETED|Intervention 2 (2 Nights)||21
8261044|NCT01794689|20369421|P2|COMPLETED|Intervention 2 (2 Nights)||27
8261045|NCT01794689|20369422|P1|COMPLETED|Intervention 2 (2 Nights)||20
8261046|NCT01794689|20369419|P4|STARTED|Intervention 2 (2 Nights)||18
8261047|NCT01794689|20369420|P3|STARTED|Intervention 2 (2 Nights)||21
8261048|NCT01794689|20369421|P2|STARTED|Intervention 2 (2 Nights)||27
8261049|NCT01794689|20369422|P1|STARTED|Intervention 2 (2 Nights)||20
8261050|NCT01794689|20369419|P4|NOT COMPLETED|Washout (2 Weeks)||0
8261051|NCT01794689|20369420|P3|NOT COMPLETED|Washout (2 Weeks)||0
8261052|NCT01794689|20369421|P2|NOT COMPLETED|Washout (2 Weeks)||0
8261053|NCT01794689|20369422|P1|NOT COMPLETED|Washout (2 Weeks)||0
8261054|NCT01794689|20369419|P4|COMPLETED|Washout (2 Weeks)||18
8261055|NCT01794689|20369420|P3|COMPLETED|Washout (2 Weeks)||21
8261056|NCT01794689|20369421|P2|COMPLETED|Washout (2 Weeks)||27
8261057|NCT01794689|20369422|P1|COMPLETED|Washout (2 Weeks)||20
8261058|NCT01794689|20369419|P4|STARTED|Washout (2 Weeks)||18
8261059|NCT01794689|20369420|P3|STARTED|Washout (2 Weeks)||21
8261060|NCT01794689|20369421|P2|STARTED|Washout (2 Weeks)||27
8261061|NCT01794689|20369422|P1|STARTED|Washout (2 Weeks)||20
8261062|NCT01794689|20369419|P4|NOT COMPLETED|Intervention 1 (2 Nights)||4
8261063|NCT01794689|20369420|P3|NOT COMPLETED|Intervention 1 (2 Nights)||3
8261064|NCT01794689|20369421|P2|NOT COMPLETED|Intervention 1 (2 Nights)||2
8261065|NCT01794689|20369422|P1|NOT COMPLETED|Intervention 1 (2 Nights)||5
8261066|NCT01794689|20369419|P4|COMPLETED|Intervention 1 (2 Nights)||18
8261067|NCT01794689|20369420|P3|COMPLETED|Intervention 1 (2 Nights)||21
8261068|NCT01794689|20369421|P2|COMPLETED|Intervention 1 (2 Nights)||27
8261069|NCT01794689|20369422|P1|COMPLETED|Intervention 1 (2 Nights)||20
8261070|NCT01794689|20369419|P4|STARTED|Intervention 1 (2 Nights)||22
8261071|NCT01794689|20369420|P3|STARTED|Intervention 1 (2 Nights)||24
8261072|NCT01794689|20369421|P2|STARTED|Intervention 1 (2 Nights)||29
8261073|NCT01794689|20369422|P1|STARTED|Intervention 1 (2 Nights)||25
8261074|NCT01794455|20369446|P2|NOT COMPLETED|Overall Study||0
8261075|NCT01794455|20369447|P1|NOT COMPLETED|Overall Study||0
8261076|NCT01794455|20369446|P2|COMPLETED|Overall Study||1
8261077|NCT01794455|20369447|P1|COMPLETED|Overall Study||0
8261078|NCT01794455|20369446|P2|STARTED|Overall Study||1
8261079|NCT01794455|20369447|P1|STARTED|Overall Study||0
8261080|NCT01794312|20369465|P2|NOT COMPLETED|Overall Study||11
8261081|NCT01794312|20369466|P1|NOT COMPLETED|Overall Study||6
8261082|NCT01794312|20369465|P2|COMPLETED|Overall Study||67
8261083|NCT01794312|20369466|P1|COMPLETED|Overall Study||68
8261084|NCT01794312|20369465|P2|STARTED|Overall Study||78
8261085|NCT01794312|20369466|P1|STARTED|Overall Study||74
8261089|NCT01794039|20369482|P2|NOT COMPLETED|Overall Study||0
8261090|NCT01794039|20369483|P1|NOT COMPLETED|Overall Study||0
8261091|NCT01794039|20369482|P2|COMPLETED|Overall Study||4
8261092|NCT01794039|20369483|P1|COMPLETED|Overall Study||5
8261093|NCT01794039|20369482|P2|STARTED|Overall Study||4
8261094|NCT01794039|20369483|P1|STARTED|Overall Study||5
8261095|NCT01794000|20369495|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
8261096|NCT01794000|20369496|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
8261097|NCT01794000|20369495|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
8261098|NCT01794000|20369496|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
8261099|NCT01794000|20369495|P2|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
8261100|NCT01794000|20369496|P1|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
8261101|NCT01794000|20369495|P2|NOT COMPLETED|Double-Blind Phase (DBP)||166
8261102|NCT01794000|20369496|P1|NOT COMPLETED|Double-Blind Phase (DBP)||169
8261103|NCT01794000|20369495|P2|COMPLETED|Double-Blind Phase (DBP)||4
8261104|NCT01794000|20369496|P1|COMPLETED|Double-Blind Phase (DBP)||2
8261105|NCT01794000|20369495|P2|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
8261106|NCT01794000|20369496|P1|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
8261107|NCT01794000|20369495|P2|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
8261108|NCT01794000|20369496|P1|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
8261109|NCT01794000|20369495|P2|STARTED|Double-Blind Phase (DBP)||170
8261110|NCT01794000|20369496|P1|STARTED|Double-Blind Phase (DBP)||171
8261111|NCT01793935|20369529|P2|NOT COMPLETED|Overall Study||3
8261112|NCT01793935|20369530|P1|NOT COMPLETED|Overall Study||6
8261113|NCT01793935|20369529|P2|COMPLETED|Overall Study||31
8261114|NCT01793935|20369530|P1|COMPLETED|Overall Study||28
8261115|NCT01793935|20369529|P2|STARTED|Overall Study||34
8261116|NCT01793935|20369530|P1|STARTED|Overall Study||34
8261117|NCT01793909|20369566|P2|NOT COMPLETED|Overall Study||5
8261118|NCT01793909|20369567|P1|NOT COMPLETED|Overall Study||10
8261119|NCT01793909|20369566|P2|COMPLETED|Overall Study||20
8261120|NCT01793909|20369567|P1|COMPLETED|Overall Study||20
8261121|NCT01793909|20369566|P2|STARTED|Overall Study||25
8261122|NCT01793909|20369567|P1|STARTED|Overall Study||30
8261123|NCT01793883|20369576|P3|NOT COMPLETED|Overall Study||8
8261124|NCT01793883|20369577|P2|NOT COMPLETED|Overall Study||10
8261125|NCT01793883|20369578|P1|NOT COMPLETED|Overall Study||12
8261126|NCT01793883|20369576|P3|COMPLETED|Overall Study||204
8261127|NCT01793883|20369577|P2|COMPLETED|Overall Study||204
8261128|NCT01793883|20369578|P1|COMPLETED|Overall Study||201
8261129|NCT01793883|20369576|P3|STARTED|Overall Study||212
8261130|NCT01793883|20369577|P2|STARTED|Overall Study||214
8261131|NCT01793883|20369578|P1|STARTED|Overall Study||213
8261132|NCT01793792|20369586|P1|NOT COMPLETED|Overall Study||12
8261133|NCT01793792|20369586|P1|COMPLETED|Overall Study||141
8261134|NCT01793792|20369586|P1|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153
8261135|NCT01793792|20369586|P1|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153
8261136|NCT01793688|20369591|P1|NOT COMPLETED|Overall Study||2
8261137|NCT01793688|20369591|P1|COMPLETED|Overall Study||980
8261138|NCT01793688|20369591|P1|STARTED|Overall Study||982
8261148|NCT01793285|20369629|P1|NOT COMPLETED|Overall Study||0
8261149|NCT01793285|20369629|P1|COMPLETED|Overall Study||85
8261150|NCT01793285|20369629|P1|STARTED|Overall Study||85
8261151|NCT01793142|20369649|P1|NOT COMPLETED|Overall Study||7
8261152|NCT01793142|20369649|P1|COMPLETED|Overall Study||3423
8261153|NCT01793142|20369649|P1|Treated|Overall Study||3423
8261154|NCT01793142|20369649|P1|STARTED|Overall Study||3430
8261155|NCT01792986|20369660|P1|NOT COMPLETED|Overall Study||0
8261156|NCT01792986|20369660|P1|COMPLETED|Overall Study||12
8261157|NCT01792986|20369660|P1|STARTED|Overall Study||12
8261158|NCT01792830|20369679|P11|NOT COMPLETED|Overall Study||3
8261159|NCT01792830|20369680|P10|NOT COMPLETED|Overall Study||0
8261160|NCT01792830|20369681|P9|NOT COMPLETED|Overall Study||9
8261161|NCT01792830|20369682|P8|NOT COMPLETED|Overall Study||1
8261162|NCT01792830|20369683|P7|NOT COMPLETED|Overall Study||2
8261163|NCT01792830|20369684|P6|NOT COMPLETED|Overall Study||1
8261164|NCT01792830|20369685|P5|NOT COMPLETED|Overall Study||1
8261165|NCT01792830|20369686|P4|NOT COMPLETED|Overall Study||3
8261166|NCT01792830|20369687|P3|NOT COMPLETED|Overall Study||0
8261167|NCT01792830|20369688|P2|NOT COMPLETED|Overall Study||0
8261168|NCT01792830|20369689|P1|NOT COMPLETED|Overall Study||25
8261169|NCT01792830|20369679|P11|COMPLETED|Overall Study||9
8261170|NCT01792830|20369680|P10|COMPLETED|Overall Study||4
8261171|NCT01792830|20369681|P9|COMPLETED|Overall Study||11
8261172|NCT01792830|20369682|P8|COMPLETED|Overall Study||6
8261173|NCT01792830|20369683|P7|COMPLETED|Overall Study||12
8261174|NCT01792830|20369684|P6|COMPLETED|Overall Study||3
8261175|NCT01792830|20369685|P5|COMPLETED|Overall Study||1
8261176|NCT01792830|20369686|P4|COMPLETED|Overall Study||18
8261177|NCT01792830|20369687|P3|COMPLETED|Overall Study||4
8261178|NCT01792830|20369688|P2|COMPLETED|Overall Study||3
8261179|NCT01792830|20369689|P1|COMPLETED|Overall Study||59
8261180|NCT01792830|20369679|P11|STARTED|Overall Study||12
8261181|NCT01792830|20369680|P10|STARTED|Overall Study||4
8261182|NCT01792830|20369681|P9|STARTED|Overall Study||20
8261183|NCT01792830|20369682|P8|STARTED|Overall Study||7
8261184|NCT01792830|20369683|P7|STARTED|Overall Study||14
8261185|NCT01792830|20369684|P6|STARTED|Overall Study||4
8261186|NCT01792830|20369685|P5|STARTED|Overall Study||2
8261187|NCT01792830|20369686|P4|STARTED|Overall Study||21
8261188|NCT01792830|20369687|P3|STARTED|Overall Study||4
8261189|NCT01792830|20369688|P2|STARTED|Overall Study||3
8261190|NCT01792830|20369689|P1|STARTED|Overall Study||84
8261191|NCT01792817|20369758|P3|NOT COMPLETED|Phase 2 Open Label||26
8261192|NCT01792817|20369759|P2|NOT COMPLETED|Phase 2 Open Label||0
8261193|NCT01792817|20369760|P1|NOT COMPLETED|Phase 2 Open Label||0
8261194|NCT01792817|20369758|P3|COMPLETED|Phase 2 Open Label||74
8261195|NCT01792817|20369759|P2|COMPLETED|Phase 2 Open Label||0
8261196|NCT01792817|20369760|P1|COMPLETED|Phase 2 Open Label||0
8261197|NCT01792817|20369758|P3|STARTED|Phase 2 Open Label||100
8261198|NCT01792817|20369759|P2|STARTED|Phase 2 Open Label||0
8261199|NCT01792817|20369760|P1|STARTED|Phase 2 Open Label||0
8261200|NCT01792817|20369758|P3|NOT COMPLETED|Phase 1 Double Blind Period||0
8261201|NCT01792817|20369759|P2|NOT COMPLETED|Phase 1 Double Blind Period||31
8261202|NCT01792817|20369760|P1|NOT COMPLETED|Phase 1 Double Blind Period||19
8261203|NCT01792817|20369758|P3|COMPLETED|Phase 1 Double Blind Period||0
8261204|NCT01792817|20369759|P2|COMPLETED|Phase 1 Double Blind Period||42
8261205|NCT01792817|20369760|P1|COMPLETED|Phase 1 Double Blind Period||58
8261206|NCT01792817|20369758|P3|STARTED|Phase 1 Double Blind Period||0
8261207|NCT01792817|20369759|P2|STARTED|Phase 1 Double Blind Period||73
8261208|NCT01792817|20369760|P1|STARTED|Phase 1 Double Blind Period||77
8261209|NCT01792635|20369776|P3|NOT COMPLETED|Part B||4
8261210|NCT01792635|20369777|P2|NOT COMPLETED|Part B||4
8261211|NCT01792635|20369778|P1|NOT COMPLETED|Part B||0
8261212|NCT01792635|20369776|P3|COMPLETED|Part B||3
8261213|NCT01792635|20369777|P2|COMPLETED|Part B||2
8261214|NCT01792635|20369778|P1|COMPLETED|Part B||0
8261215|NCT01792635|20369776|P3|STARTED|Part B||7
8261216|NCT01792635|20369777|P2|STARTED|Part B||6
8261217|NCT01792635|20369778|P1|STARTED|Part B||0
8261218|NCT01792635|20369776|P3|NOT COMPLETED|Part A||0
8261219|NCT01792635|20369777|P2|NOT COMPLETED|Part A||0
8261220|NCT01792635|20369778|P1|NOT COMPLETED|Part A||0
8261221|NCT01792635|20369776|P3|COMPLETED|Part A||0
8261222|NCT01792635|20369777|P2|COMPLETED|Part A||0
8261223|NCT01792635|20369778|P1|COMPLETED|Part A||6
8261224|NCT01792635|20369776|P3|STARTED|Part A||0
8261225|NCT01792635|20369777|P2|STARTED|Part A||0
8261226|NCT01792635|20369778|P1|STARTED|Part A||6
8261227|NCT01792518|20369806|P2|NOT COMPLETED|Overall Study||7
8261228|NCT01792518|20369807|P1|NOT COMPLETED|Overall Study||8
8261229|NCT01792518|20369806|P2|COMPLETED|Overall Study||175
8261230|NCT01792518|20369807|P1|COMPLETED|Overall Study||170
8261231|NCT01792518|20369806|P2|STARTED|Overall Study||182
8261232|NCT01792518|20369807|P1|STARTED|Overall Study||178
8261233|NCT01792284|20369817|P3|NOT COMPLETED|Randomization Period 2||0
8261234|NCT01792284|20369818|P2|NOT COMPLETED|Randomization Period 2||3
8261235|NCT01792284|20369819|P1|NOT COMPLETED|Randomization Period 2||0
8261236|NCT01792284|20369817|P3|COMPLETED|Randomization Period 2||85
8261237|NCT01792284|20369818|P2|COMPLETED|Randomization Period 2||87
8261238|NCT01792284|20369819|P1|COMPLETED|Randomization Period 2||0
8261239|NCT01792284|20369817|P3|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
8261240|NCT01792284|20369818|P2|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
8261241|NCT01792284|20369819|P1|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
8261242|NCT01792284|20369817|P3|STARTED|Randomization Period 2||85
8261243|NCT01792284|20369818|P2|STARTED|Randomization Period 2||90
8261244|NCT01792284|20369819|P1|STARTED|Randomization Period 2||0
8261245|NCT01792284|20369817|P3|NOT COMPLETED|Randomization Period 1||5
8261246|NCT01792284|20369818|P2|NOT COMPLETED|Randomization Period 1||2
8261247|NCT01792284|20369819|P1|NOT COMPLETED|Randomization Period 1||0
8261248|NCT01792284|20369817|P3|COMPLETED|Randomization Period 1||85
8261249|NCT01792284|20369818|P2|COMPLETED|Randomization Period 1||90
8261250|NCT01792284|20369819|P1|COMPLETED|Randomization Period 1||0
8261251|NCT01792284|20369817|P3|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
8261252|NCT01792284|20369818|P2|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
8261253|NCT01792284|20369819|P1|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
8261254|NCT01792284|20369817|P3|STARTED|Randomization Period 1||90
8261255|NCT01792284|20369818|P2|STARTED|Randomization Period 1||92
8261256|NCT01792284|20369819|P1|STARTED|Randomization Period 1||0
8261257|NCT01792284|20369817|P3|NOT COMPLETED|Lead-in Period||0
8261258|NCT01792284|20369818|P2|NOT COMPLETED|Lead-in Period||0
8261259|NCT01792284|20369819|P1|NOT COMPLETED|Lead-in Period||30
8261260|NCT01792284|20369817|P3|COMPLETED|Lead-in Period||0
8261261|NCT01792284|20369818|P2|COMPLETED|Lead-in Period||0
8261262|NCT01792284|20369819|P1|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
8261263|NCT01792284|20369817|P3|STARTED|Lead-in Period||0
8261264|NCT01792284|20369818|P2|STARTED|Lead-in Period||0
8261265|NCT01792284|20369819|P1|STARTED|Lead-in Period||212
8261266|NCT01792115|20369860|P3|NOT COMPLETED|Overall Study||0
8261267|NCT01792115|20369861|P2|NOT COMPLETED|Overall Study||1
8261268|NCT01792115|20369862|P1|NOT COMPLETED|Overall Study||0
8261269|NCT01792115|20369860|P3|COMPLETED|Overall Study||8
8261270|NCT01792115|20369861|P2|COMPLETED|Overall Study||6
8261271|NCT01792115|20369862|P1|COMPLETED|Overall Study||7
8261272|NCT01792115|20369860|P3|STARTED|Overall Study||8
8261273|NCT01792115|20369861|P2|STARTED|Overall Study||7
8261274|NCT01792115|20369862|P1|STARTED|Overall Study||7
8261275|NCT01792024|20369891|P1|NOT COMPLETED|Overall Study||0
8261276|NCT01792024|20369891|P1|COMPLETED|Overall Study||27
8261277|NCT01792024|20369891|P1|STARTED|Overall Study||27
8261278|NCT01791972|20369901|P2|NOT COMPLETED|Overall Study||0
8261279|NCT01791972|20369902|P1|NOT COMPLETED|Overall Study||0
8261280|NCT01791972|20369901|P2|COMPLETED|Overall Study||19
8261281|NCT01791972|20369902|P1|COMPLETED|Overall Study||19
8261282|NCT01791972|20369901|P2|STARTED|Overall Study||19
8261283|NCT01791972|20369902|P1|STARTED|Overall Study||19
8261284|NCT01791894|20369912|P1|NOT COMPLETED|Overall Study||1
8261285|NCT01791894|20369912|P1|COMPLETED|Overall Study||4
8261286|NCT01791894|20369912|P1|STARTED|Overall Study||5
8261287|NCT01791803|20369923|P4|NOT COMPLETED|Overall Study||5
8261288|NCT01791803|20369924|P3|NOT COMPLETED|Overall Study||2
8261289|NCT01791803|20369925|P2|NOT COMPLETED|Overall Study||2
8261290|NCT01791803|20369926|P1|NOT COMPLETED|Overall Study||0
8261291|NCT01791803|20369923|P4|COMPLETED|Overall Study||37
8261292|NCT01791803|20369924|P3|COMPLETED|Overall Study||38
8261293|NCT01791803|20369925|P2|COMPLETED|Overall Study||39
8261294|NCT01791803|20369926|P1|COMPLETED|Overall Study||41
8261295|NCT01791803|20369923|P4|STARTED|Overall Study||42
8261296|NCT01791803|20369924|P3|STARTED|Overall Study||40
8261297|NCT01791803|20369925|P2|STARTED|Overall Study||41
8261298|NCT01791803|20369926|P1|STARTED|Overall Study||41
8261299|NCT01791725|20369944|P3|NOT COMPLETED|Overall Study||0
8261300|NCT01791725|20369945|P2|NOT COMPLETED|Overall Study||1
8261301|NCT01791725|20369946|P1|NOT COMPLETED|Overall Study||0
8261302|NCT01791725|20369944|P3|COMPLETED|Overall Study||6
8261303|NCT01791725|20369945|P2|COMPLETED|Overall Study||4
8261304|NCT01791725|20369946|P1|COMPLETED|Overall Study||12
8261305|NCT01791725|20369944|P3|STARTED|Overall Study||6
8261306|NCT01791725|20369945|P2|STARTED|Overall Study||5
8261307|NCT01791725|20369946|P1|STARTED|Overall Study||12
8261308|NCT01791517|20369969|P12|NOT COMPLETED|Phase II||1
8261309|NCT01791517|20369970|P11|NOT COMPLETED|Phase II||1
8261310|NCT01791517|20369971|P10|NOT COMPLETED|Phase II||3
8261311|NCT01791517|20369972|P9|NOT COMPLETED|Phase II||2
8261312|NCT01791517|20369973|P8|NOT COMPLETED|Phase II||3
8261313|NCT01791517|20369974|P7|NOT COMPLETED|Phase II||2
8261314|NCT01791517|20369975|P6|NOT COMPLETED|Phase II||4
8261315|NCT01791517|20369976|P5|NOT COMPLETED|Phase II||2
8261316|NCT01791517|20369977|P4|NOT COMPLETED|Phase II||0
8261317|NCT01791517|20369978|P3|NOT COMPLETED|Phase II||1
8261318|NCT01791517|20369979|P2|NOT COMPLETED|Phase II||0
8261319|NCT01791517|20369980|P1|NOT COMPLETED|Phase II||2
8261320|NCT01791517|20369969|P12|COMPLETED|Phase II||17
8261321|NCT01791517|20369970|P11|COMPLETED|Phase II||15
8261322|NCT01791517|20369971|P10|COMPLETED|Phase II||15
8261323|NCT01791517|20369972|P9|COMPLETED|Phase II||17
8261324|NCT01791517|20369973|P8|COMPLETED|Phase II||17
8261325|NCT01791517|20369974|P7|COMPLETED|Phase II||17
8261326|NCT01791517|20369975|P6|COMPLETED|Phase II||14
8261327|NCT01791517|20369976|P5|COMPLETED|Phase II||16
8261328|NCT01791517|20369977|P4|COMPLETED|Phase II||15
8261329|NCT01791517|20369978|P3|COMPLETED|Phase II||15
8261330|NCT01791517|20369979|P2|COMPLETED|Phase II||14
8261331|NCT01791517|20369980|P1|COMPLETED|Phase II||15
8261332|NCT01791517|20369969|P12|STARTED|Phase II||18
8261333|NCT01791517|20369970|P11|STARTED|Phase II||16
8261334|NCT01791517|20369971|P10|STARTED|Phase II||18
8261335|NCT01791517|20369972|P9|STARTED|Phase II||19
8261336|NCT01791517|20369973|P8|STARTED|Phase II||20
8261337|NCT01791517|20369974|P7|STARTED|Phase II||19
8261338|NCT01791517|20369975|P6|STARTED|Phase II||18
8261339|NCT01791517|20369976|P5|STARTED|Phase II||18
8261340|NCT01791517|20369977|P4|STARTED|Phase II||15
8261341|NCT01791517|20369978|P3|STARTED|Phase II||16
8261342|NCT01791517|20369979|P2|STARTED|Phase II||14
8261343|NCT01791517|20369980|P1|STARTED|Phase II||17
8261344|NCT01791517|20369969|P12|NOT COMPLETED|Phase I: Period 4||0
8261345|NCT01791517|20369970|P11|NOT COMPLETED|Phase I: Period 4||0
8261346|NCT01791517|20369971|P10|NOT COMPLETED|Phase I: Period 4||0
8261347|NCT01791517|20369972|P9|NOT COMPLETED|Phase I: Period 4||0
8261348|NCT01791517|20369973|P8|NOT COMPLETED|Phase I: Period 4||0
8261349|NCT01791517|20369974|P7|NOT COMPLETED|Phase I: Period 4||0
8261350|NCT01791517|20369975|P6|NOT COMPLETED|Phase I: Period 4||0
8261351|NCT01791517|20369976|P5|NOT COMPLETED|Phase I: Period 4||0
8261352|NCT01791517|20369977|P4|NOT COMPLETED|Phase I: Period 4||0
8261353|NCT01791517|20369978|P3|NOT COMPLETED|Phase I: Period 4||0
8261354|NCT01791517|20369979|P2|NOT COMPLETED|Phase I: Period 4||0
8261355|NCT01791517|20369980|P1|NOT COMPLETED|Phase I: Period 4||0
8261356|NCT01791517|20369969|P12|COMPLETED|Phase I: Period 4||18
8261357|NCT01791517|20369970|P11|COMPLETED|Phase I: Period 4||16
8261358|NCT01791517|20369971|P10|COMPLETED|Phase I: Period 4||18
8261359|NCT01791517|20369972|P9|COMPLETED|Phase I: Period 4||19
8261360|NCT01791517|20369973|P8|COMPLETED|Phase I: Period 4||20
8261361|NCT01791517|20369974|P7|COMPLETED|Phase I: Period 4||19
8261362|NCT01791517|20369975|P6|COMPLETED|Phase I: Period 4||18
8261363|NCT01791517|20369976|P5|COMPLETED|Phase I: Period 4||18
8261364|NCT01791517|20369977|P4|COMPLETED|Phase I: Period 4||15
8261365|NCT01791517|20369978|P3|COMPLETED|Phase I: Period 4||16
8261366|NCT01791517|20369979|P2|COMPLETED|Phase I: Period 4||14
8261367|NCT01791517|20369980|P1|COMPLETED|Phase I: Period 4||17
8261368|NCT01791517|20369969|P12|STARTED|Phase I: Period 4||18
8261369|NCT01791517|20369970|P11|STARTED|Phase I: Period 4||16
8261370|NCT01791517|20369971|P10|STARTED|Phase I: Period 4||18
8261371|NCT01791517|20369972|P9|STARTED|Phase I: Period 4||19
8261372|NCT01791517|20369973|P8|STARTED|Phase I: Period 4||20
8261373|NCT01791517|20369974|P7|STARTED|Phase I: Period 4||19
8261374|NCT01791517|20369975|P6|STARTED|Phase I: Period 4||18
8261375|NCT01791517|20369976|P5|STARTED|Phase I: Period 4||18
8261376|NCT01791517|20369977|P4|STARTED|Phase I: Period 4||15
8261377|NCT01791517|20369978|P3|STARTED|Phase I: Period 4||16
8261378|NCT01791517|20369979|P2|STARTED|Phase I: Period 4||14
8261379|NCT01791517|20369980|P1|STARTED|Phase I: Period 4||17
8261380|NCT01791517|20369969|P12|NOT COMPLETED|Phase I: Period 3||1
8261381|NCT01791517|20369970|P11|NOT COMPLETED|Phase I: Period 3||0
8261382|NCT01791517|20369971|P10|NOT COMPLETED|Phase I: Period 3||0
8261383|NCT01791517|20369972|P9|NOT COMPLETED|Phase I: Period 3||0
8261384|NCT01791517|20369973|P8|NOT COMPLETED|Phase I: Period 3||0
8261385|NCT01791517|20369974|P7|NOT COMPLETED|Phase I: Period 3||0
8261386|NCT01791517|20369975|P6|NOT COMPLETED|Phase I: Period 3||0
8261387|NCT01791517|20369976|P5|NOT COMPLETED|Phase I: Period 3||1
8261388|NCT01791517|20369977|P4|NOT COMPLETED|Phase I: Period 3||1
8261389|NCT01791517|20369978|P3|NOT COMPLETED|Phase I: Period 3||0
8261390|NCT01791517|20369979|P2|NOT COMPLETED|Phase I: Period 3||1
8261391|NCT01791517|20369980|P1|NOT COMPLETED|Phase I: Period 3||0
8261392|NCT01791517|20369969|P12|COMPLETED|Phase I: Period 3||18
8261393|NCT01791517|20369970|P11|COMPLETED|Phase I: Period 3||16
8261394|NCT01791517|20369971|P10|COMPLETED|Phase I: Period 3||18
8261395|NCT01791517|20369972|P9|COMPLETED|Phase I: Period 3||19
8261396|NCT01791517|20369973|P8|COMPLETED|Phase I: Period 3||20
8261397|NCT01791517|20369974|P7|COMPLETED|Phase I: Period 3||19
8261398|NCT01791517|20369975|P6|COMPLETED|Phase I: Period 3||18
8261399|NCT01791517|20369976|P5|COMPLETED|Phase I: Period 3||18
8261400|NCT01791517|20369977|P4|COMPLETED|Phase I: Period 3||15
8261401|NCT01791517|20369978|P3|COMPLETED|Phase I: Period 3||16
8261402|NCT01791517|20369979|P2|COMPLETED|Phase I: Period 3||14
8261403|NCT01791517|20369980|P1|COMPLETED|Phase I: Period 3||17
8261404|NCT01791517|20369969|P12|STARTED|Phase I: Period 3||19
8261405|NCT01791517|20369970|P11|STARTED|Phase I: Period 3||16
8261406|NCT01791517|20369971|P10|STARTED|Phase I: Period 3||18
8261407|NCT01791517|20369972|P9|STARTED|Phase I: Period 3||19
8261408|NCT01791517|20369973|P8|STARTED|Phase I: Period 3||20
8261409|NCT01791517|20369974|P7|STARTED|Phase I: Period 3||19
8261410|NCT01791517|20369975|P6|STARTED|Phase I: Period 3||18
8261411|NCT01791517|20369976|P5|STARTED|Phase I: Period 3||19
8261412|NCT01791517|20369977|P4|STARTED|Phase I: Period 3||16
8261413|NCT01791517|20369978|P3|STARTED|Phase I: Period 3||16
8261414|NCT01791517|20369979|P2|STARTED|Phase I: Period 3||15
8261415|NCT01791517|20369980|P1|STARTED|Phase I: Period 3||17
8261416|NCT01791517|20369969|P12|NOT COMPLETED|Phase I: Period 2||0
8261417|NCT01791517|20369970|P11|NOT COMPLETED|Phase I: Period 2||2
8261418|NCT01791517|20369971|P10|NOT COMPLETED|Phase I: Period 2||1
8261419|NCT01791517|20369972|P9|NOT COMPLETED|Phase I: Period 2||0
8261420|NCT01791517|20369973|P8|NOT COMPLETED|Phase I: Period 2||0
8261421|NCT01791517|20369974|P7|NOT COMPLETED|Phase I: Period 2||0
8261422|NCT01791517|20369975|P6|NOT COMPLETED|Phase I: Period 2||1
8261423|NCT01791517|20369976|P5|NOT COMPLETED|Phase I: Period 2||0
8261424|NCT01791517|20369977|P4|NOT COMPLETED|Phase I: Period 2||1
8261425|NCT01791517|20369978|P3|NOT COMPLETED|Phase I: Period 2||2
8261426|NCT01791517|20369979|P2|NOT COMPLETED|Phase I: Period 2||3
8261427|NCT01791517|20369980|P1|NOT COMPLETED|Phase I: Period 2||1
8261428|NCT01791517|20369969|P12|COMPLETED|Phase I: Period 2||19
8261429|NCT01791517|20369970|P11|COMPLETED|Phase I: Period 2||16
8261430|NCT01791517|20369971|P10|COMPLETED|Phase I: Period 2||18
8261431|NCT01791517|20369972|P9|COMPLETED|Phase I: Period 2||19
8261432|NCT01791517|20369973|P8|COMPLETED|Phase I: Period 2||20
8261433|NCT01791517|20369974|P7|COMPLETED|Phase I: Period 2||19
8261434|NCT01791517|20369975|P6|COMPLETED|Phase I: Period 2||18
8261435|NCT01791517|20369976|P5|COMPLETED|Phase I: Period 2||19
8261436|NCT01791517|20369977|P4|COMPLETED|Phase I: Period 2||16
8261437|NCT01791517|20369978|P3|COMPLETED|Phase I: Period 2||16
8261438|NCT01791517|20369979|P2|COMPLETED|Phase I: Period 2||15
8261439|NCT01791517|20369980|P1|COMPLETED|Phase I: Period 2||17
8261440|NCT01791517|20369969|P12|STARTED|Phase I: Period 2||19
8261441|NCT01791517|20369970|P11|STARTED|Phase I: Period 2||18
8261442|NCT01791517|20369971|P10|STARTED|Phase I: Period 2||19
8261443|NCT01791517|20369972|P9|STARTED|Phase I: Period 2||19
8261444|NCT01791517|20369973|P8|STARTED|Phase I: Period 2||20
8261445|NCT01791517|20369974|P7|STARTED|Phase I: Period 2||19
8261446|NCT01791517|20369975|P6|STARTED|Phase I: Period 2||19
8261447|NCT01791517|20369976|P5|STARTED|Phase I: Period 2||19
8261448|NCT01791517|20369977|P4|STARTED|Phase I: Period 2||17
8261449|NCT01791517|20369978|P3|STARTED|Phase I: Period 2||18
8261450|NCT01791517|20369979|P2|STARTED|Phase I: Period 2||18
8261451|NCT01791517|20369980|P1|STARTED|Phase I: Period 2||18
8261452|NCT01791517|20369969|P12|NOT COMPLETED|Phase I: Period 1||1
8261453|NCT01791517|20369970|P11|NOT COMPLETED|Phase I: Period 1||0
8261454|NCT01791517|20369971|P10|NOT COMPLETED|Phase I: Period 1||1
8261455|NCT01791517|20369972|P9|NOT COMPLETED|Phase I: Period 1||1
8261456|NCT01791517|20369973|P8|NOT COMPLETED|Phase I: Period 1||0
8261457|NCT01791517|20369974|P7|NOT COMPLETED|Phase I: Period 1||1
8261458|NCT01791517|20369975|P6|NOT COMPLETED|Phase I: Period 1||1
8261459|NCT01791517|20369976|P5|NOT COMPLETED|Phase I: Period 1||1
8261460|NCT01791517|20369977|P4|NOT COMPLETED|Phase I: Period 1||2
8261461|NCT01791517|20369978|P3|NOT COMPLETED|Phase I: Period 1||2
8261462|NCT01791517|20369979|P2|NOT COMPLETED|Phase I: Period 1||2
8261463|NCT01791517|20369980|P1|NOT COMPLETED|Phase I: Period 1||1
8261464|NCT01791517|20369969|P12|COMPLETED|Phase I: Period 1||19
8261465|NCT01791517|20369970|P11|COMPLETED|Phase I: Period 1||18
8261466|NCT01791517|20369971|P10|COMPLETED|Phase I: Period 1||19
8261467|NCT01791517|20369972|P9|COMPLETED|Phase I: Period 1||19
8261468|NCT01791517|20369973|P8|COMPLETED|Phase I: Period 1||20
8261469|NCT01791517|20369974|P7|COMPLETED|Phase I: Period 1||19
8261470|NCT01791517|20369975|P6|COMPLETED|Phase I: Period 1||19
8261471|NCT01791517|20369976|P5|COMPLETED|Phase I: Period 1||19
8261472|NCT01791517|20369977|P4|COMPLETED|Phase I: Period 1||17
8261473|NCT01791517|20369978|P3|COMPLETED|Phase I: Period 1||18
8261474|NCT01791517|20369979|P2|COMPLETED|Phase I: Period 1||18
8261475|NCT01791517|20369980|P1|COMPLETED|Phase I: Period 1||18
8261476|NCT01791517|20369969|P12|STARTED|Phase I: Period 1||20
8261477|NCT01791517|20369970|P11|STARTED|Phase I: Period 1||18
8261478|NCT01791517|20369971|P10|STARTED|Phase I: Period 1||20
8261479|NCT01791517|20369972|P9|STARTED|Phase I: Period 1||20
8261480|NCT01791517|20369973|P8|STARTED|Phase I: Period 1||20
8261481|NCT01791517|20369974|P7|STARTED|Phase I: Period 1||20
8261482|NCT01791517|20369975|P6|STARTED|Phase I: Period 1||20
8261483|NCT01791517|20369976|P5|STARTED|Phase I: Period 1||20
8261484|NCT01791517|20369977|P4|STARTED|Phase I: Period 1||19
8261485|NCT01791517|20369978|P3|STARTED|Phase I: Period 1||20
8261486|NCT01791517|20369979|P2|STARTED|Phase I: Period 1||20
8261487|NCT01791517|20369980|P1|STARTED|Phase I: Period 1||19
8261488|NCT01791491|20370006|P1|NOT COMPLETED|Overall Study||0
8261489|NCT01791491|20370006|P1|COMPLETED|Overall Study||9
8261490|NCT01791491|20370006|P1|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
8261491|NCT01791465|20370018|P1|NOT COMPLETED|Overall Study||0
8261492|NCT01791465|20370018|P1|COMPLETED|Overall Study||6
8261493|NCT01791465|20370018|P1|STARTED|Overall Study||6
8261494|NCT01791413|20370044|P2|NOT COMPLETED|Overall Study||1
8261495|NCT01791413|20370045|P1|NOT COMPLETED|Overall Study||5
8261496|NCT01791413|20370044|P2|COMPLETED|Overall Study||19
8261497|NCT01791413|20370045|P1|COMPLETED|Overall Study||15
8261498|NCT01791413|20370044|P2|STARTED|Overall Study||20
8261499|NCT01791413|20370045|P1|STARTED|Overall Study||20
8261500|NCT01791244|20370054|P2|NOT COMPLETED|Overall Study||18
8261501|NCT01791244|20370055|P1|NOT COMPLETED|Overall Study||15
8261502|NCT01791244|20370054|P2|COMPLETED|Overall Study||29
8261503|NCT01791244|20370055|P1|COMPLETED|Overall Study||31
8261504|NCT01791244|20370054|P2|Intent to Treat (ITT)|Overall Study||39
8261505|NCT01791244|20370055|P1|Intent to Treat (ITT)|Overall Study||38
8261506|NCT01791244|20370054|P2|STARTED|Overall Study||47
8261507|NCT01791244|20370055|P1|STARTED|Overall Study||46
8261508|NCT01791205|20370091|P2|NOT COMPLETED|Phase II||0
8261509|NCT01791205|20370092|P1|NOT COMPLETED|Phase II||12
8261510|NCT01791205|20370091|P2|COMPLETED|Phase II||0
8261511|NCT01791205|20370092|P1|COMPLETED|Phase II||92
8261512|NCT01791205|20370091|P2|STARTED|Phase II||0
8261513|NCT01791205|20370092|P1|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
8261514|NCT01791205|20370091|P2|NOT COMPLETED|Phase I||0
8261515|NCT01791205|20370092|P1|NOT COMPLETED|Phase I||0
8261516|NCT01791205|20370091|P2|COMPLETED|Phase I||152
8261517|NCT01791205|20370092|P1|COMPLETED|Phase I||152
8261518|NCT01791205|20370091|P2|STARTED|Phase I||152
8261519|NCT01791205|20370092|P1|STARTED|Phase I||152
8261520|NCT01791153|20370176|P8|NOT COMPLETED|Part 2: Open-label Period||6
8261521|NCT01791153|20370177|P7|NOT COMPLETED|Part 2: Open-label Period||6
8261522|NCT01791153|20370178|P6|NOT COMPLETED|Part 2: Open-label Period||4
8261523|NCT01791153|20370179|P5|NOT COMPLETED|Part 2: Open-label Period||2
8261524|NCT01791153|20370180|P4|NOT COMPLETED|Part 2: Open-label Period||0
8261525|NCT01791153|20370181|P3|NOT COMPLETED|Part 2: Open-label Period||0
8261526|NCT01791153|20370182|P2|NOT COMPLETED|Part 2: Open-label Period||0
8261527|NCT01791153|20370183|P1|NOT COMPLETED|Part 2: Open-label Period||0
8261528|NCT01791153|20370176|P8|COMPLETED|Part 2: Open-label Period||61
8261529|NCT01791153|20370177|P7|COMPLETED|Part 2: Open-label Period||44
8261530|NCT01791153|20370178|P6|COMPLETED|Part 2: Open-label Period||54
8261531|NCT01791153|20370179|P5|COMPLETED|Part 2: Open-label Period||38
8261532|NCT01791153|20370180|P4|COMPLETED|Part 2: Open-label Period||0
8261533|NCT01791153|20370181|P3|COMPLETED|Part 2: Open-label Period||0
8261534|NCT01791153|20370182|P2|COMPLETED|Part 2: Open-label Period||0
8261535|NCT01791153|20370183|P1|COMPLETED|Part 2: Open-label Period||0
8261536|NCT01791153|20370176|P8|STARTED|Part 2: Open-label Period||67
8261537|NCT01791153|20370177|P7|STARTED|Part 2: Open-label Period||50
8261538|NCT01791153|20370178|P6|STARTED|Part 2: Open-label Period||58
8261539|NCT01791153|20370179|P5|STARTED|Part 2: Open-label Period||40
8261540|NCT01791153|20370180|P4|STARTED|Part 2: Open-label Period||0
8261541|NCT01791153|20370181|P3|STARTED|Part 2: Open-label Period||0
8261542|NCT01791153|20370182|P2|STARTED|Part 2: Open-label Period||0
8261543|NCT01791153|20370183|P1|STARTED|Part 2: Open-label Period||0
8261544|NCT01791153|20370176|P8|NOT COMPLETED|Part 1: Blinded Period||0
8261545|NCT01791153|20370177|P7|NOT COMPLETED|Part 1: Blinded Period||0
8261546|NCT01791153|20370178|P6|NOT COMPLETED|Part 1: Blinded Period||0
8261547|NCT01791153|20370179|P5|NOT COMPLETED|Part 1: Blinded Period||0
8261548|NCT01791153|20370180|P4|NOT COMPLETED|Part 1: Blinded Period||5
8261549|NCT01791153|20370181|P3|NOT COMPLETED|Part 1: Blinded Period||6
8261550|NCT01791153|20370182|P2|NOT COMPLETED|Part 1: Blinded Period||8
8261551|NCT01791153|20370183|P1|NOT COMPLETED|Part 1: Blinded Period||15
8261552|NCT01791153|20370176|P8|COMPLETED|Part 1: Blinded Period||0
8261553|NCT01791153|20370177|P7|COMPLETED|Part 1: Blinded Period||0
8261554|NCT01791153|20370178|P6|COMPLETED|Part 1: Blinded Period||0
8261555|NCT01791153|20370179|P5|COMPLETED|Part 1: Blinded Period||0
8261556|NCT01791153|20370180|P4|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46
8261557|NCT01791153|20370181|P3|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44
8261558|NCT01791153|20370182|P2|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41
8261559|NCT01791153|20370183|P1|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85
8261560|NCT01791153|20370176|P8|STARTED|Part 1: Blinded Period||0
8261561|NCT01791153|20370177|P7|STARTED|Part 1: Blinded Period||0
8261562|NCT01791153|20370178|P6|STARTED|Part 1: Blinded Period||0
8261563|NCT01791153|20370179|P5|STARTED|Part 1: Blinded Period||0
8261564|NCT01791153|20370180|P4|STARTED|Part 1: Blinded Period||51
8261565|NCT01791153|20370181|P3|STARTED|Part 1: Blinded Period||50
8261566|NCT01791153|20370182|P2|STARTED|Part 1: Blinded Period||49
8261567|NCT01791153|20370183|P1|STARTED|Part 1: Blinded Period||100
8261568|NCT01791127|20370243|P1|NOT COMPLETED|Overall Study||1472
8261569|NCT01791127|20370243|P1|COMPLETED|Overall Study||286
8261570|NCT01791127|20370243|P1|STARTED|Overall Study||1758
8261571|NCT01790932|20370267|P1|NOT COMPLETED|Overall Study||50
8261572|NCT01790932|20370267|P1|COMPLETED|Overall Study||0
8261573|NCT01790932|20370267|P1|STARTED|Overall Study||50
8261574|NCT01790828|20370273|P1|NOT COMPLETED|Overall Study||34
8261575|NCT01790828|20370273|P1|COMPLETED|Overall Study||8
8261576|NCT01790828|20370273|P1|STARTED|Overall Study||42
8261577|NCT01790750|20370296|P1|NOT COMPLETED|Overall Study||0
8261578|NCT01790750|20370296|P1|COMPLETED|Overall Study||50
8261579|NCT01790750|20370296|P1|STARTED|Overall Study||50
8261580|NCT01790685|20370303|P2|NOT COMPLETED|Overall Study||0
8261581|NCT01790685|20370304|P1|NOT COMPLETED|Overall Study||0
8261582|NCT01790685|20370303|P2|COMPLETED|Overall Study||17
8261583|NCT01790685|20370304|P1|COMPLETED|Overall Study||23
8261584|NCT01790685|20370303|P2|STARTED|Overall Study||17
8261585|NCT01790685|20370304|P1|STARTED|Overall Study||23
8261586|NCT01790659|20370312|P2|NOT COMPLETED|Overall Study||6
8261587|NCT01790659|20370313|P1|NOT COMPLETED|Overall Study||6
8261588|NCT01790659|20370312|P2|COMPLETED|Overall Study||192
8261589|NCT01790659|20370313|P1|COMPLETED|Overall Study||195
8261590|NCT01790659|20370312|P2|STARTED|Overall Study||198
8261591|NCT01790659|20370313|P1|STARTED|Overall Study||201
8261592|NCT01790633|20370331|P2|NOT COMPLETED|Overall Study||5
8261593|NCT01790633|20370332|P1|NOT COMPLETED|Overall Study||48
8261594|NCT01790633|20370331|P2|COMPLETED|Overall Study||159
8261595|NCT01790633|20370332|P1|COMPLETED|Overall Study||115
8261596|NCT01790633|20370331|P2|STARTED|Overall Study||164
8261597|NCT01790633|20370332|P1|STARTED|Overall Study||163
8261607|NCT01790581|20370415|P2|NOT COMPLETED|Overall Study||0
8261608|NCT01790581|20370416|P1|NOT COMPLETED|Overall Study||0
8261609|NCT01790581|20370415|P2|COMPLETED|Overall Study||12
8261610|NCT01790581|20370416|P1|COMPLETED|Overall Study||12
8261611|NCT01790581|20370415|P2|STARTED|Overall Study||12
8261612|NCT01790581|20370416|P1|STARTED|Overall Study||12
8261613|NCT01790568|20370424|P2|NOT COMPLETED|Overall Study||1
8261614|NCT01790568|20370425|P1|NOT COMPLETED|Overall Study||0
8261615|NCT01790568|20370424|P2|COMPLETED|Overall Study||25
8261616|NCT01790568|20370425|P1|COMPLETED|Overall Study||12
8261617|NCT01790568|20370424|P2|STARTED|Overall Study||26
8261618|NCT01790568|20370425|P1|STARTED|Overall Study||12
8261619|NCT01790516|20370433|P2|NOT COMPLETED|Overall Study||0
8261620|NCT01790516|20370434|P1|NOT COMPLETED|Overall Study||1
8261621|NCT01790516|20370433|P2|COMPLETED|Overall Study||1
8261622|NCT01790516|20370434|P1|COMPLETED|Overall Study||0
8261623|NCT01790516|20370433|P2|STARTED|Overall Study||1
8261624|NCT01790516|20370434|P1|STARTED|Overall Study||1
8261625|NCT01790503|20370451|P11|NOT COMPLETED|Overall Study||16
8261626|NCT01790503|20370452|P10|NOT COMPLETED|Overall Study||26
8261627|NCT01790503|20370453|P9|NOT COMPLETED|Overall Study||3
8261628|NCT01790503|20370454|P8|NOT COMPLETED|Overall Study||1
8261629|NCT01790503|20370455|P7|NOT COMPLETED|Overall Study||1
8261630|NCT01790503|20370456|P6|NOT COMPLETED|Overall Study||5
8261631|NCT01790503|20370457|P5|NOT COMPLETED|Overall Study||5
8261632|NCT01790503|20370458|P4|NOT COMPLETED|Overall Study||2
8261633|NCT01790503|20370459|P3|NOT COMPLETED|Overall Study||1
8261634|NCT01790503|20370460|P2|NOT COMPLETED|Overall Study||1
8261635|NCT01790503|20370461|P1|NOT COMPLETED|Overall Study||3
8261636|NCT01790503|20370451|P11|COMPLETED|Overall Study||0
8261637|NCT01790503|20370452|P10|COMPLETED|Overall Study||1
8261638|NCT01790503|20370453|P9|COMPLETED|Overall Study||0
8261639|NCT01790503|20370454|P8|COMPLETED|Overall Study||0
8261640|NCT01790503|20370455|P7|COMPLETED|Overall Study||0
8261641|NCT01790503|20370456|P6|COMPLETED|Overall Study||0
8261642|NCT01790503|20370457|P5|COMPLETED|Overall Study||0
8261643|NCT01790503|20370458|P4|COMPLETED|Overall Study||0
8261644|NCT01790503|20370459|P3|COMPLETED|Overall Study||0
8261645|NCT01790503|20370460|P2|COMPLETED|Overall Study||0
8261646|NCT01790503|20370461|P1|COMPLETED|Overall Study||0
8261647|NCT01790503|20370451|P11|STARTED|Overall Study||16
8261648|NCT01790503|20370452|P10|STARTED|Overall Study||27
8261649|NCT01790503|20370453|P9|STARTED|Overall Study||3
8261650|NCT01790503|20370454|P8|STARTED|Overall Study||1
8261651|NCT01790503|20370455|P7|STARTED|Overall Study||1
8261652|NCT01790503|20370456|P6|STARTED|Overall Study||5
8261653|NCT01790503|20370457|P5|STARTED|Overall Study||5
8261654|NCT01790503|20370458|P4|STARTED|Overall Study||2
8261655|NCT01790503|20370459|P3|STARTED|Overall Study||1
8261656|NCT01790503|20370460|P2|STARTED|Overall Study||1
8261657|NCT01790503|20370461|P1|STARTED|Overall Study||3
8261658|NCT01790490|20370516|P3|NOT COMPLETED|Overall Study||0
8261659|NCT01790490|20370517|P2|NOT COMPLETED|Overall Study||0
8261660|NCT01790490|20370518|P1|NOT COMPLETED|Overall Study||0
8261661|NCT01790490|20370516|P3|COMPLETED|Overall Study||2
8261662|NCT01790490|20370517|P2|COMPLETED|Overall Study||3
8261663|NCT01790490|20370518|P1|COMPLETED|Overall Study||3
8261664|NCT01790490|20370516|P3|STARTED|Overall Study||2
8261665|NCT01790490|20370517|P2|STARTED|Overall Study||3
8261666|NCT01790490|20370518|P1|STARTED|Overall Study||3
8261667|NCT01790438|20370531|P2|NOT COMPLETED|Overall Study||11
8261668|NCT01790438|20370532|P1|NOT COMPLETED|Overall Study||35
8261669|NCT01790438|20370531|P2|COMPLETED|Overall Study||202
8261670|NCT01790438|20370532|P1|COMPLETED|Overall Study||393
8261671|NCT01790438|20370531|P2|Received at Least One Dose of Study Drug|Overall Study||212
8261672|NCT01790438|20370532|P1|Received at Least One Dose of Study Drug|Overall Study||427
8261673|NCT01790438|20370531|P2|STARTED|Overall Study||213
8261674|NCT01790438|20370532|P1|STARTED|Overall Study||428
8261675|NCT01790295|20370582|P1|NOT COMPLETED|Overall Study||11
8261676|NCT01790295|20370582|P1|COMPLETED|Overall Study||10
8261677|NCT01790295|20370582|P1|STARTED|Overall Study||21
8261678|NCT01790243|20370607|P2|NOT COMPLETED|Overall Study||43
8261679|NCT01790243|20370608|P1|NOT COMPLETED|Overall Study||290
8261680|NCT01790243|20370607|P2|COMPLETED|Overall Study||117
8261681|NCT01790243|20370608|P1|COMPLETED|Overall Study||739
8261682|NCT01790243|20370607|P2|STARTED|Overall Study||160
8261683|NCT01790243|20370608|P1|STARTED|Overall Study||1029
8261684|NCT01790178|20370634|P2|NOT COMPLETED|Overall Study||0
8261685|NCT01790178|20370635|P1|NOT COMPLETED|Overall Study||0
8261686|NCT01790178|20370634|P2|COMPLETED|Overall Study||24
8261687|NCT01790178|20370635|P1|COMPLETED|Overall Study||16
8261688|NCT01790178|20370634|P2|STARTED|Overall Study||24
8261689|NCT01790178|20370635|P1|STARTED|Overall Study||16
8261690|NCT01790126|20370652|P3|NOT COMPLETED|Overall Study||31
8261691|NCT01790126|20370653|P2|NOT COMPLETED|Overall Study||29
8261692|NCT01790126|20370654|P1|NOT COMPLETED|Overall Study||30
8261693|NCT01790126|20370652|P3|COMPLETED|Overall Study||0
8261694|NCT01790126|20370653|P2|COMPLETED|Overall Study||0
8261695|NCT01790126|20370654|P1|COMPLETED|Overall Study||0
8261696|NCT01790126|20370652|P3|Treated|Overall Study||31
8261697|NCT01790126|20370653|P2|Treated|Overall Study||29
8261698|NCT01790126|20370654|P1|Treated|Overall Study||29
8261699|NCT01790126|20370652|P3|STARTED|Overall Study||31
8261700|NCT01790126|20370653|P2|STARTED|Overall Study||29
8261701|NCT01790126|20370654|P1|STARTED|Overall Study||30
8261702|NCT01790048|20370711|P2|NOT COMPLETED|Overall Study||17
8261703|NCT01790048|20370712|P1|NOT COMPLETED|Overall Study||12
8261704|NCT01790048|20370711|P2|COMPLETED|Overall Study||1086
8261705|NCT01790048|20370712|P1|COMPLETED|Overall Study||1144
8261706|NCT01790048|20370711|P2|STARTED|Overall Study||1103
8261707|NCT01790048|20370712|P1|STARTED|Overall Study||1156
8261708|NCT01789970|20370730|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
8261709|NCT01789970|20370731|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
8261710|NCT01789970|20370732|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
8261711|NCT01789970|20370730|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
8261712|NCT01789970|20370731|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
8261713|NCT01789970|20370732|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
8261714|NCT01789970|20370730|P3|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
8261715|NCT01789970|20370731|P2|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
8261716|NCT01789970|20370732|P1|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
8261717|NCT01789970|20370730|P3|STARTED|Double-blind Treatment Period (12 Weeks)||191
8261718|NCT01789970|20370731|P2|STARTED|Double-blind Treatment Period (12 Weeks)||180
8261719|NCT01789970|20370732|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
8261720|NCT01789970|20370730|P3|NOT COMPLETED|Open-label Titration Period||0
8261721|NCT01789970|20370731|P2|NOT COMPLETED|Open-label Titration Period||0
8261722|NCT01789970|20370732|P1|NOT COMPLETED|Open-label Titration Period||254
8261723|NCT01789970|20370730|P3|COMPLETED|Open-label Titration Period||0
8261724|NCT01789970|20370731|P2|COMPLETED|Open-label Titration Period||0
8261725|NCT01789970|20370732|P1|COMPLETED|Open-label Titration Period||371
8261726|NCT01789970|20370730|P3|Safety Analysis Set|Open-label Titration Period||0
8261727|NCT01789970|20370731|P2|Safety Analysis Set|Open-label Titration Period||0
8261728|NCT01789970|20370732|P1|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
8261729|NCT01789970|20370730|P3|STARTED|Open-label Titration Period||0
8261730|NCT01789970|20370731|P2|STARTED|Open-label Titration Period||0
8261731|NCT01789970|20370732|P1|STARTED|Open-label Titration Period||625
8261732|NCT01789905|20370764|P1|NOT COMPLETED|Overall Study||0
8261733|NCT01789905|20370764|P1|COMPLETED|Overall Study||116
8261734|NCT01789905|20370764|P1|STARTED|Overall Study||116
8261735|NCT01789814|20370772|P2|NOT COMPLETED|Overall Study||0
8261736|NCT01789814|20370773|P1|NOT COMPLETED|Overall Study||0
8261737|NCT01789814|20370772|P2|COMPLETED|Overall Study||12
8261738|NCT01789814|20370773|P1|COMPLETED|Overall Study||12
8261739|NCT01789814|20370772|P2|STARTED|Overall Study||12
8261740|NCT01789814|20370773|P1|STARTED|Overall Study||12
8261741|NCT01789775|20370781|P2|NOT COMPLETED|Overall Study||7
8261742|NCT01789775|20370782|P1|NOT COMPLETED|Overall Study||2
8261743|NCT01789775|20370781|P2|COMPLETED|Overall Study||50
8261744|NCT01789775|20370782|P1|COMPLETED|Overall Study||53
8261745|NCT01789775|20370781|P2|STARTED|Overall Study||57
8261746|NCT01789775|20370782|P1|STARTED|Overall Study||55
8261747|NCT01789606|20370790|P2|NOT COMPLETED|Overall Study||450
8261748|NCT01789606|20370791|P1|NOT COMPLETED|Overall Study||23
8261749|NCT01789606|20370790|P2|COMPLETED|Overall Study||382
8261750|NCT01789606|20370791|P1|COMPLETED|Overall Study||228
8261751|NCT01789606|20370790|P2|STARTED|Overall Study||832
8261752|NCT01789606|20370791|P1|STARTED|Overall Study||251
8261753|NCT01789567|20370809|P1|NOT COMPLETED|Overall Study||6
8261754|NCT01789567|20370809|P1|COMPLETED|Overall Study||14
8261755|NCT01789567|20370809|P1|STARTED|Overall Study||20
8261756|NCT01789476|20370818|P2|NOT COMPLETED|Overall Study||2
8261757|NCT01789476|20370819|P1|NOT COMPLETED|Overall Study||8
8261758|NCT01789476|20370818|P2|COMPLETED|Overall Study||15
8261759|NCT01789476|20370819|P1|COMPLETED|Overall Study||26
8261760|NCT01789476|20370818|P2|STARTED|Overall Study||17
8261761|NCT01789476|20370819|P1|STARTED|Overall Study||34
8261762|NCT01789255|20370829|P1|NOT COMPLETED|Overall Study||0
8261763|NCT01789255|20370829|P1|COMPLETED|Overall Study||12
8261764|NCT01789255|20370829|P1|STARTED|Overall Study||12
8261765|NCT01789203|20370841|P2|NOT COMPLETED|Overall Study||4
8261766|NCT01789203|20370842|P1|NOT COMPLETED|Overall Study||9
8261767|NCT01789203|20370841|P2|COMPLETED|Overall Study||63
8261768|NCT01789203|20370842|P1|COMPLETED|Overall Study||124
8261769|NCT01789203|20370841|P2|STARTED|Overall Study||67
8261770|NCT01789203|20370842|P1|STARTED|Overall Study||133
8261771|NCT01789138|20370872|P2|NOT COMPLETED|Overall Study||52
8261772|NCT01789138|20370873|P1|NOT COMPLETED|Overall Study||41
8261773|NCT01789138|20370872|P2|COMPLETED|Overall Study||206
8261774|NCT01789138|20370873|P1|COMPLETED|Overall Study||213
8261775|NCT01789138|20370872|P2|STARTED|Overall Study||258
8261776|NCT01789138|20370873|P1|STARTED|Overall Study||254
8261777|NCT01789047|20370883|P2|NOT COMPLETED|Overall Study||4
8261778|NCT01789047|20370884|P1|NOT COMPLETED|Overall Study||4
8261779|NCT01789047|20370883|P2|COMPLETED|Overall Study||17
8261780|NCT01789047|20370884|P1|COMPLETED|Overall Study||17
8261781|NCT01789047|20370883|P2|STARTED|Overall Study||21
8261782|NCT01789047|20370884|P1|STARTED|Overall Study||21
8261783|NCT01788943|20370892|P2|NOT COMPLETED|Overall Study||0
8261784|NCT01788943|20370893|P1|NOT COMPLETED|Overall Study||1
8261785|NCT01788943|20370892|P2|COMPLETED|Overall Study||12
8261786|NCT01788943|20370893|P1|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
8261787|NCT01788943|20370892|P2|STARTED|Overall Study||12
8261788|NCT01788943|20370893|P1|STARTED|Overall Study|Recruitment for study began.|13
8261789|NCT01788631|20370903|P2|NOT COMPLETED|Overall Study||1
8261790|NCT01788631|20370904|P1|NOT COMPLETED|Overall Study||3
8261791|NCT01788631|20370903|P2|COMPLETED|Overall Study||43
8261792|NCT01788631|20370904|P1|COMPLETED|Overall Study||49
8261793|NCT01788631|20370903|P2|Randomized|Overall Study||47
8261794|NCT01788631|20370904|P1|Randomized|Overall Study||53
8261795|NCT01788631|20370903|P2|STARTED|Overall Study||44
8261796|NCT01788631|20370904|P1|STARTED|Overall Study||52
8261797|NCT01788566|20370922|P1|NOT COMPLETED|Overall Study||8
8261798|NCT01788566|20370922|P1|COMPLETED|Overall Study||53
8261799|NCT01788566|20370922|P1|STARTED|Overall Study||61
8261800|NCT01788475|20370935|P3|NOT COMPLETED|Overall Study||0
8261801|NCT01788475|20370936|P2|NOT COMPLETED|Overall Study||0
8261802|NCT01788475|20370937|P1|NOT COMPLETED|Overall Study||3
8261803|NCT01788475|20370935|P3|COMPLETED|Overall Study||0
8261804|NCT01788475|20370936|P2|COMPLETED|Overall Study||0
8261805|NCT01788475|20370937|P1|COMPLETED|Overall Study||0
8261806|NCT01788475|20370935|P3|STARTED|Overall Study||0
8261807|NCT01788475|20370936|P2|STARTED|Overall Study||0
8261808|NCT01788475|20370937|P1|STARTED|Overall Study||3
8261809|NCT01788423|20370960|P3|NOT COMPLETED|Overall Study||5
8261810|NCT01788423|20370961|P2|NOT COMPLETED|Overall Study||4
8261811|NCT01788423|20370962|P1|NOT COMPLETED|Overall Study||0
8261812|NCT01788423|20370960|P3|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50
8261813|NCT01788423|20370961|P2|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51
8261814|NCT01788423|20370962|P1|COMPLETED|Overall Study||53
8261815|NCT01788423|20370960|P3|STARTED|Overall Study||55
8261816|NCT01788423|20370961|P2|STARTED|Overall Study||55
8261817|NCT01788423|20370962|P1|STARTED|Overall Study||53
8261818|NCT01788358|20370973|P1|NOT COMPLETED|Overall Study||98
8261819|NCT01788358|20370973|P1|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
8261820|NCT01788358|20370973|P1|Completed Week 52|Overall Study||193
8261821|NCT01788358|20370973|P1|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
8261822|NCT01788358|20370973|P1|Completed Week 28|Overall Study||417
8261823|NCT01788358|20370973|P1|Treated|Overall Study||508
8261824|NCT01788358|20370973|P1|STARTED|Overall Study||508
8261825|NCT01788228|20370987|P2|NOT COMPLETED|Overall Study||0
8261826|NCT01788228|20370988|P1|NOT COMPLETED|Overall Study||1
8261827|NCT01788228|20370987|P2|COMPLETED|Overall Study||1
8261828|NCT01788228|20370988|P1|COMPLETED|Overall Study||48
8261829|NCT01788228|20370987|P2|STARTED|Overall Study||1
8261830|NCT01788228|20370988|P1|STARTED|Overall Study||49
8261831|NCT01788215|20371021|P2|NOT COMPLETED|Overall Study||1
8261832|NCT01788215|20371022|P1|NOT COMPLETED|Overall Study||2
8261833|NCT01788215|20371021|P2|COMPLETED|Overall Study||4
8261834|NCT01788215|20371022|P1|COMPLETED|Overall Study||3
8261835|NCT01788215|20371021|P2|12 Weeks of Doxycycline or Placebo|Overall Study||5
8261836|NCT01788215|20371022|P1|12 Weeks of Doxycycline or Placebo|Overall Study||5
8261837|NCT01788215|20371021|P2|STARTED|Overall Study||5
8261838|NCT01788215|20371022|P1|STARTED|Overall Study||5
8261839|NCT01788163|20371051|P9|NOT COMPLETED|Overall Study||16
8261840|NCT01788163|20371052|P8|NOT COMPLETED|Overall Study||48
8261841|NCT01788163|20371053|P7|NOT COMPLETED|Overall Study||1
8261842|NCT01788163|20371054|P6|NOT COMPLETED|Overall Study||7
8261843|NCT01788163|20371055|P5|NOT COMPLETED|Overall Study||0
8261844|NCT01788163|20371056|P4|NOT COMPLETED|Overall Study||0
8261845|NCT01788163|20371057|P3|NOT COMPLETED|Overall Study||0
8261846|NCT01788163|20371058|P2|NOT COMPLETED|Overall Study||0
8261847|NCT01788163|20371059|P1|NOT COMPLETED|Overall Study||55
8261848|NCT01788163|20371051|P9|COMPLETED|Overall Study||956
8261849|NCT01788163|20371052|P8|COMPLETED|Overall Study||254
8261850|NCT01788163|20371053|P7|COMPLETED|Overall Study||49
8261851|NCT01788163|20371054|P6|COMPLETED|Overall Study||95
8261852|NCT01788163|20371055|P5|COMPLETED|Overall Study||94
8261853|NCT01788163|20371056|P4|COMPLETED|Overall Study||71
8261854|NCT01788163|20371057|P3|COMPLETED|Overall Study||62
8261855|NCT01788163|20371058|P2|COMPLETED|Overall Study||271
8261856|NCT01788163|20371059|P1|COMPLETED|Overall Study||1403
8261857|NCT01788163|20371051|P9|STARTED|Overall Study||972
8261858|NCT01788163|20371052|P8|STARTED|Overall Study||302
8261859|NCT01788163|20371053|P7|STARTED|Overall Study||50
8261860|NCT01788163|20371054|P6|STARTED|Overall Study||102
8261861|NCT01788163|20371055|P5|STARTED|Overall Study||94
8261862|NCT01788163|20371056|P4|STARTED|Overall Study||71
8261863|NCT01788163|20371057|P3|STARTED|Overall Study||62
8261864|NCT01788163|20371058|P2|STARTED|Overall Study||271
8261865|NCT01788163|20371059|P1|STARTED|Overall Study||1458
8261866|NCT01788046|20371222|P2|NOT COMPLETED|Overall Study||37
8261867|NCT01788046|20371223|P1|NOT COMPLETED|Overall Study||56
8261868|NCT01788046|20371222|P2|COMPLETED|Overall Study||218
8261869|NCT01788046|20371223|P1|COMPLETED|Overall Study||204
8261870|NCT01788046|20371222|P2|Received Treatment|Overall Study||252
8261871|NCT01788046|20371223|P1|Received Treatment|Overall Study||259
8261872|NCT01788046|20371222|P2|STARTED|Overall Study||255
8261873|NCT01788046|20371223|P1|STARTED|Overall Study||260
8261874|NCT01787916|20371239|P2|NOT COMPLETED|Second Intervention (24 Weeks)||0
8261875|NCT01787916|20371240|P1|NOT COMPLETED|Second Intervention (24 Weeks)||0
8261876|NCT01787916|20371239|P2|COMPLETED|Second Intervention (24 Weeks)||7
8261877|NCT01787916|20371240|P1|COMPLETED|Second Intervention (24 Weeks)||8
8261878|NCT01787916|20371239|P2|STARTED|Second Intervention (24 Weeks)||7
8261879|NCT01787916|20371240|P1|STARTED|Second Intervention (24 Weeks)||8
8261880|NCT01787916|20371239|P2|NOT COMPLETED|Washout (4 Weeks)||0
8261881|NCT01787916|20371240|P1|NOT COMPLETED|Washout (4 Weeks)||0
8261882|NCT01787916|20371239|P2|COMPLETED|Washout (4 Weeks)||7
8261883|NCT01787916|20371240|P1|COMPLETED|Washout (4 Weeks)||8
8261884|NCT01787916|20371239|P2|STARTED|Washout (4 Weeks)||7
8261885|NCT01787916|20371240|P1|STARTED|Washout (4 Weeks)||8
8261886|NCT01787916|20371239|P2|NOT COMPLETED|First Intervention (24 Weeks)||0
8261887|NCT01787916|20371240|P1|NOT COMPLETED|First Intervention (24 Weeks)||0
8261888|NCT01787916|20371239|P2|COMPLETED|First Intervention (24 Weeks)||7
8261889|NCT01787916|20371240|P1|COMPLETED|First Intervention (24 Weeks)||8
8261890|NCT01787916|20371239|P2|STARTED|First Intervention (24 Weeks)||7
8261891|NCT01787916|20371240|P1|STARTED|First Intervention (24 Weeks)||8
8261892|NCT01787838|20371246|P1|NOT COMPLETED|Overall Study||1413
8261893|NCT01787838|20371246|P1|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
8261894|NCT01787838|20371246|P1|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
8261895|NCT01787825|20371250|P2|NOT COMPLETED|Overall Study||1
8261896|NCT01787825|20371251|P1|NOT COMPLETED|Overall Study||6
8261897|NCT01787825|20371250|P2|COMPLETED|Overall Study||60
8261898|NCT01787825|20371251|P1|COMPLETED|Overall Study||54
8261899|NCT01787825|20371250|P2|STARTED|Overall Study||61
8261900|NCT01787825|20371251|P1|STARTED|Overall Study||60
8261901|NCT01787799|20371262|P1|NOT COMPLETED|Overall Study||0
8261902|NCT01787799|20371262|P1|COMPLETED|Overall Study||100
8261903|NCT01787799|20371262|P1|STARTED|Overall Study||100
8261904|NCT01787760|20371269|P3|NOT COMPLETED|Overall Study||5
8261905|NCT01787760|20371270|P2|NOT COMPLETED|Overall Study||16
8261906|NCT01787760|20371271|P1|NOT COMPLETED|Overall Study||26
8261907|NCT01787760|20371269|P3|COMPLETED|Overall Study||46
8261908|NCT01787760|20371270|P2|COMPLETED|Overall Study||34
8261909|NCT01787760|20371271|P1|COMPLETED|Overall Study||25
8261910|NCT01787760|20371269|P3|STARTED|Overall Study||51
8261911|NCT01787760|20371270|P2|STARTED|Overall Study||50
8261912|NCT01787760|20371271|P1|STARTED|Overall Study||51
8261913|NCT01787604|20371285|P2|NOT COMPLETED|Overall Study||4
8261914|NCT01787604|20371286|P1|NOT COMPLETED|Overall Study||4
8261915|NCT01787604|20371285|P2|COMPLETED|Overall Study||28
8261916|NCT01787604|20371286|P1|COMPLETED|Overall Study||28
8261917|NCT01787604|20371285|P2|STARTED|Overall Study||32
8261918|NCT01787604|20371286|P1|STARTED|Overall Study||32
8261919|NCT01787591|20371296|P4|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
8261920|NCT01787591|20371297|P3|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
8261921|NCT01787591|20371298|P2|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
8261922|NCT01787591|20371299|P1|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
8261923|NCT01787591|20371296|P4|COMPLETED|Period 4 (Cross-over Arm 4)||5
8261924|NCT01787591|20371297|P3|COMPLETED|Period 4 (Cross-over Arm 4)||5
8261925|NCT01787591|20371298|P2|COMPLETED|Period 4 (Cross-over Arm 4)||5
8261926|NCT01787591|20371299|P1|COMPLETED|Period 4 (Cross-over Arm 4)||5
8261927|NCT01787591|20371296|P4|STARTED|Period 4 (Cross-over Arm 4)||5
8261928|NCT01787591|20371297|P3|STARTED|Period 4 (Cross-over Arm 4)||5
8261929|NCT01787591|20371298|P2|STARTED|Period 4 (Cross-over Arm 4)||5
8261930|NCT01787591|20371299|P1|STARTED|Period 4 (Cross-over Arm 4)||5
8261931|NCT01787591|20371296|P4|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
8261932|NCT01787591|20371297|P3|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
8261933|NCT01787591|20371298|P2|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
8261934|NCT01787591|20371299|P1|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
8261935|NCT01787591|20371296|P4|COMPLETED|Period 3 (Cross-over Arm 3)||5
8261936|NCT01787591|20371297|P3|COMPLETED|Period 3 (Cross-over Arm 3)||5
8261937|NCT01787591|20371298|P2|COMPLETED|Period 3 (Cross-over Arm 3)||5
8261938|NCT01787591|20371299|P1|COMPLETED|Period 3 (Cross-over Arm 3)||5
8261939|NCT01787591|20371296|P4|STARTED|Period 3 (Cross-over Arm 3)||5
8261940|NCT01787591|20371297|P3|STARTED|Period 3 (Cross-over Arm 3)||5
8261941|NCT01787591|20371298|P2|STARTED|Period 3 (Cross-over Arm 3)||5
8261942|NCT01787591|20371299|P1|STARTED|Period 3 (Cross-over Arm 3)||5
8261943|NCT01787591|20371296|P4|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
8261944|NCT01787591|20371297|P3|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
8261945|NCT01787591|20371298|P2|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
8261946|NCT01787591|20371299|P1|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
8261947|NCT01787591|20371296|P4|COMPLETED|Period 2 (Cross-over Arm 2)||5
8261948|NCT01787591|20371297|P3|COMPLETED|Period 2 (Cross-over Arm 2)||5
8261949|NCT01787591|20371298|P2|COMPLETED|Period 2 (Cross-over Arm 2)||5
8261950|NCT01787591|20371299|P1|COMPLETED|Period 2 (Cross-over Arm 2)||5
8261951|NCT01787591|20371296|P4|STARTED|Period 2 (Cross-over Arm 2)||5
8261952|NCT01787591|20371297|P3|STARTED|Period 2 (Cross-over Arm 2)||5
8261953|NCT01787591|20371298|P2|STARTED|Period 2 (Cross-over Arm 2)||5
8261954|NCT01787591|20371299|P1|STARTED|Period 2 (Cross-over Arm 2)||5
8261955|NCT01787591|20371296|P4|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
8261956|NCT01787591|20371297|P3|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
8261957|NCT01787591|20371298|P2|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
8261958|NCT01787591|20371299|P1|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
8261959|NCT01787591|20371296|P4|COMPLETED|Period 1 (Cross-over Arm 1)||5
8261960|NCT01787591|20371297|P3|COMPLETED|Period 1 (Cross-over Arm 1)||5
8261961|NCT01787591|20371298|P2|COMPLETED|Period 1 (Cross-over Arm 1)||5
8261962|NCT01787591|20371299|P1|COMPLETED|Period 1 (Cross-over Arm 1)||5
8261963|NCT01787591|20371296|P4|STARTED|Period 1 (Cross-over Arm 1)||6
8261964|NCT01787591|20371297|P3|STARTED|Period 1 (Cross-over Arm 1)||5
8261965|NCT01787591|20371298|P2|STARTED|Period 1 (Cross-over Arm 1)||5
8261966|NCT01787591|20371299|P1|STARTED|Period 1 (Cross-over Arm 1)||5
8261967|NCT01787552|20371329|P4|NOT COMPLETED|Overall Study||27
8261968|NCT01787552|20371330|P3|NOT COMPLETED|Overall Study||5
8261969|NCT01787552|20371331|P2|NOT COMPLETED|Overall Study||9
8261970|NCT01787552|20371332|P1|NOT COMPLETED|Overall Study||8
8261971|NCT01787552|20371329|P4|COMPLETED|Overall Study||0
8261972|NCT01787552|20371330|P3|COMPLETED|Overall Study||0
8261973|NCT01787552|20371331|P2|COMPLETED|Overall Study||1
8261974|NCT01787552|20371332|P1|COMPLETED|Overall Study||0
8261975|NCT01787552|20371329|P4|STARTED|Overall Study||27
8261976|NCT01787552|20371330|P3|STARTED|Overall Study||5
8261977|NCT01787552|20371331|P2|STARTED|Overall Study||10
8261978|NCT01787552|20371332|P1|STARTED|Overall Study||8
8261979|NCT01787461|20371402|P2|NOT COMPLETED|Overall Study||9
8261980|NCT01787461|20371403|P1|NOT COMPLETED|Overall Study||14
8261981|NCT01787461|20371402|P2|COMPLETED|Overall Study||89
8261982|NCT01787461|20371403|P1|COMPLETED|Overall Study||82
8261983|NCT01787461|20371402|P2|STARTED|Overall Study||98
8261984|NCT01787461|20371403|P1|STARTED|Overall Study||96
8261991|NCT01787331|20371452|P1|NOT COMPLETED|Overall Study||2
8261992|NCT01787331|20371452|P1|COMPLETED|Overall Study||19
8261993|NCT01787331|20371452|P1|STARTED|Overall Study||21
8261994|NCT01787292|20371464|P2|NOT COMPLETED|Home Based Exercise Program||1
8261995|NCT01787292|20371465|P1|NOT COMPLETED|Home Based Exercise Program||3
8261996|NCT01787292|20371464|P2|COMPLETED|Home Based Exercise Program||13
8261997|NCT01787292|20371465|P1|COMPLETED|Home Based Exercise Program||12
8261998|NCT01787292|20371464|P2|STARTED|Home Based Exercise Program||14
8261999|NCT01787292|20371465|P1|STARTED|Home Based Exercise Program||15
8262000|NCT01787292|20371464|P2|NOT COMPLETED|Crossover Exercise Interventions||2
8262001|NCT01787292|20371465|P1|NOT COMPLETED|Crossover Exercise Interventions||2
8262002|NCT01787292|20371464|P2|COMPLETED|Crossover Exercise Interventions|These participants completed the 12-week in-house program and cross-over into the balance program.|14
8262003|NCT01787292|20371465|P1|COMPLETED|Crossover Exercise Interventions|Participants completed the 12-week in-house program and cross-over into the balance program.|15
8262004|NCT01787292|20371464|P2|STARTED|Crossover Exercise Interventions|Participants in this group performed balance training prior to cross-over to aerobic training.|16
8262005|NCT01787292|20371465|P1|STARTED|Crossover Exercise Interventions|Participants in this group performed aerobic training prior to cross-over to balance training.|17
8262006|NCT01787279|20371482|P1|NOT COMPLETED|Overall Study||3
8262007|NCT01787279|20371482|P1|COMPLETED|Overall Study||56
8262008|NCT01787279|20371482|P1|STARTED|Overall Study||59
8262009|NCT01787240|20371493|P2|NOT COMPLETED|Overall Study||1
8262010|NCT01787240|20371494|P1|NOT COMPLETED|Overall Study||5
8262011|NCT01787240|20371493|P2|COMPLETED|Overall Study||4
8262012|NCT01787240|20371494|P1|COMPLETED|Overall Study||10
8262013|NCT01787240|20371493|P2|STARTED|Overall Study||5
8262014|NCT01787240|20371494|P1|STARTED|Overall Study||15
8262015|NCT01787188|20371508|P3|NOT COMPLETED|Overall Study||18
8262016|NCT01787188|20371509|P2|NOT COMPLETED|Overall Study||18
8262017|NCT01787188|20371510|P1|NOT COMPLETED|Overall Study||17
8262018|NCT01787188|20371508|P3|COMPLETED|Overall Study||116
8262019|NCT01787188|20371509|P2|COMPLETED|Overall Study||112
8262020|NCT01787188|20371510|P1|COMPLETED|Overall Study||122
8262021|NCT01787188|20371508|P3|STARTED|Overall Study||134
8262022|NCT01787188|20371509|P2|STARTED|Overall Study||130
8262023|NCT01787188|20371510|P1|STARTED|Overall Study||139
8262024|NCT01787175|20371565|P2|NOT COMPLETED|Overall Study||0
8262025|NCT01787175|20371566|P1|NOT COMPLETED|Overall Study||0
8262026|NCT01787175|20371565|P2|COMPLETED|Overall Study||28
8262027|NCT01787175|20371566|P1|COMPLETED|Overall Study||30
8262028|NCT01787175|20371565|P2|STARTED|Overall Study||28
8262029|NCT01787175|20371566|P1|STARTED|Overall Study||30
8262030|NCT01787097|20371576|P4|NOT COMPLETED|Overall Study||0
8262031|NCT01787097|20371577|P3|NOT COMPLETED|Overall Study||0
8262032|NCT01787097|20371578|P2|NOT COMPLETED|Overall Study||0
8262033|NCT01787097|20371579|P1|NOT COMPLETED|Overall Study||1
8262034|NCT01787097|20371576|P4|COMPLETED|Overall Study||9
8262035|NCT01787097|20371577|P3|COMPLETED|Overall Study||7
8262036|NCT01787097|20371578|P2|COMPLETED|Overall Study||7
8262037|NCT01787097|20371579|P1|COMPLETED|Overall Study|Study completed|7
8262038|NCT01787097|20371576|P4|STARTED|Overall Study||9
8262039|NCT01787097|20371577|P3|STARTED|Overall Study||7
8262040|NCT01787097|20371578|P2|STARTED|Overall Study||7
8262041|NCT01787097|20371579|P1|STARTED|Overall Study|Study started in 2012/2013|8
8262042|NCT01787032|20371611|P6|NOT COMPLETED|Overall Study||1
8262043|NCT01787032|20371612|P5|NOT COMPLETED|Overall Study||1
8262044|NCT01787032|20371613|P4|NOT COMPLETED|Overall Study||0
8262045|NCT01787032|20371614|P3|NOT COMPLETED|Overall Study||0
8262046|NCT01787032|20371615|P2|NOT COMPLETED|Overall Study||0
8262047|NCT01787032|20371616|P1|NOT COMPLETED|Overall Study||0
8262048|NCT01787032|20371611|P6|COMPLETED|Overall Study||3
8262049|NCT01787032|20371612|P5|COMPLETED|Overall Study||3
8262050|NCT01787032|20371613|P4|COMPLETED|Overall Study||3
8262051|NCT01787032|20371614|P3|COMPLETED|Overall Study||3
8262052|NCT01787032|20371615|P2|COMPLETED|Overall Study||3
8262053|NCT01787032|20371616|P1|COMPLETED|Overall Study||3
8262054|NCT01787032|20371611|P6|Received T2|Overall Study||4
8262055|NCT01787032|20371612|P5|Received T2|Overall Study||4
8262056|NCT01787032|20371613|P4|Received T2|Overall Study||3
8262057|NCT01787032|20371614|P3|Received T2|Overall Study||3
8262058|NCT01787032|20371615|P2|Received T2|Overall Study||3
8262059|NCT01787032|20371616|P1|Received T2|Overall Study||3
8262060|NCT01787032|20371611|P6|Received T1|Overall Study||4
8262061|NCT01787032|20371612|P5|Received T1|Overall Study||3
8262062|NCT01787032|20371613|P4|Received T1|Overall Study||3
8262063|NCT01787032|20371614|P3|Received T1|Overall Study||3
8262064|NCT01787032|20371615|P2|Received T1|Overall Study||3
8262065|NCT01787032|20371616|P1|Received T1|Overall Study||3
8262066|NCT01787032|20371611|P6|Received R|Overall Study||3
8262067|NCT01787032|20371612|P5|Received R|Overall Study||4
8262068|NCT01787032|20371613|P4|Received R|Overall Study||3
8262069|NCT01787032|20371614|P3|Received R|Overall Study||3
8262070|NCT01787032|20371615|P2|Received R|Overall Study||3
8262071|NCT01787032|20371616|P1|Received R|Overall Study||3
8262072|NCT01787032|20371611|P6|STARTED|Overall Study||4
8262073|NCT01787032|20371612|P5|STARTED|Overall Study||4
8262074|NCT01787032|20371613|P4|STARTED|Overall Study||3
8262075|NCT01787032|20371614|P3|STARTED|Overall Study||3
8262076|NCT01787032|20371615|P2|STARTED|Overall Study||3
8262077|NCT01787032|20371616|P1|STARTED|Overall Study||3
8262078|NCT01787006|20371640|P2|NOT COMPLETED|Overall Study||3
8262079|NCT01787006|20371641|P1|NOT COMPLETED|Overall Study||3
8262080|NCT01787006|20371640|P2|COMPLETED|Overall Study||36
8262081|NCT01787006|20371641|P1|COMPLETED|Overall Study||32
8262082|NCT01787006|20371640|P2|STARTED|Overall Study||39
8262083|NCT01787006|20371641|P1|STARTED|Overall Study||35
8262084|NCT01786993|20371669|P2|NOT COMPLETED|Overall Study||10
8262085|NCT01786993|20371670|P1|NOT COMPLETED|Overall Study||12
8262086|NCT01786993|20371669|P2|COMPLETED|Overall Study||170
8262087|NCT01786993|20371670|P1|COMPLETED|Overall Study||189
8262088|NCT01786993|20371669|P2|Per Protocol Population at 9 Months|Overall Study||170
8262089|NCT01786993|20371670|P1|Per Protocol Population at 9 Months|Overall Study||189
8262090|NCT01786993|20371669|P2|STARTED|Overall Study||180
8262091|NCT01786993|20371670|P1|STARTED|Overall Study||201
8262092|NCT01786967|20371677|P1|NOT COMPLETED|Overall Study||0
8262093|NCT01786967|20371677|P1|COMPLETED|Overall Study||61
8262094|NCT01786967|20371677|P1|Metabolizer Status Undetermined|Overall Study||3
8262095|NCT01786967|20371677|P1|Poor Metabolizers|Overall Study||4
8262096|NCT01786967|20371677|P1|Extensive Metabolizers|Overall Study||54
8262097|NCT01786967|20371677|P1|STARTED|Overall Study||61
8262098|NCT01786954|20371686|P2|NOT COMPLETED|Overall Study||0
8262099|NCT01786954|20371687|P1|NOT COMPLETED|Overall Study||0
8262100|NCT01786954|20371686|P2|COMPLETED|Overall Study||34
8262101|NCT01786954|20371687|P1|COMPLETED|Overall Study||34
8262102|NCT01786954|20371686|P2|STARTED|Overall Study||34
8262103|NCT01786954|20371687|P1|STARTED|Overall Study||34
8262104|NCT01786902|20371699|P2|NOT COMPLETED|Overall Study||3
8262105|NCT01786902|20371700|P1|NOT COMPLETED|Overall Study||4
8262106|NCT01786902|20371699|P2|COMPLETED|Overall Study||31
8262107|NCT01786902|20371700|P1|COMPLETED|Overall Study||32
8262108|NCT01786902|20371699|P2|STARTED|Overall Study||34
8262109|NCT01786902|20371700|P1|STARTED|Overall Study||36
8262113|NCT01786707|20371729|P2|NOT COMPLETED|Overall Study||1
8262114|NCT01786707|20371730|P1|NOT COMPLETED|Overall Study||1
8262115|NCT01786707|20371729|P2|COMPLETED|Overall Study||0
8262116|NCT01786707|20371730|P1|COMPLETED|Overall Study||0
8262117|NCT01786707|20371729|P2|STARTED|Overall Study||1
8262118|NCT01786707|20371730|P1|STARTED|Overall Study||1
8262119|NCT01786668|20371742|P4|NOT COMPLETED|Overall Study||4
8262120|NCT01786668|20371743|P3|NOT COMPLETED|Overall Study||5
8262121|NCT01786668|20371744|P2|NOT COMPLETED|Overall Study||1
8262122|NCT01786668|20371745|P1|NOT COMPLETED|Overall Study||1
8262123|NCT01786668|20371742|P4|COMPLETED|Overall Study||47
8262124|NCT01786668|20371743|P3|COMPLETED|Overall Study||47
8262125|NCT01786668|20371744|P2|COMPLETED|Overall Study||51
8262126|NCT01786668|20371745|P1|COMPLETED|Overall Study||51
8262127|NCT01786668|20371742|P4|STARTED|Overall Study||51
8262128|NCT01786668|20371743|P3|STARTED|Overall Study||52
8262129|NCT01786668|20371744|P2|STARTED|Overall Study||52
8262130|NCT01786668|20371745|P1|STARTED|Overall Study||52
8262131|NCT01786629|20371845|P2|NOT COMPLETED|Overall Study||5
8262132|NCT01786629|20371846|P1|NOT COMPLETED|Overall Study||0
8262133|NCT01786629|20371845|P2|COMPLETED|Overall Study||164
8262134|NCT01786629|20371846|P1|COMPLETED|Overall Study||169
8262135|NCT01786629|20371845|P2|STARTED|Overall Study||169
8262136|NCT01786629|20371846|P1|STARTED|Overall Study||169
8262137|NCT01786603|20371854|P2|NOT COMPLETED|Overall Study||12
8262138|NCT01786603|20371855|P1|NOT COMPLETED|Overall Study||18
8262139|NCT01786603|20371854|P2|COMPLETED|Overall Study||8
8262140|NCT01786603|20371855|P1|COMPLETED|Overall Study||42
8262141|NCT01786603|20371854|P2|STARTED|Overall Study||20
8262142|NCT01786603|20371855|P1|STARTED|Overall Study||60
8262143|NCT01786564|20371873|P1|NOT COMPLETED|Overall Study||64
8262144|NCT01786564|20371873|P1|COMPLETED|Overall Study||56
8262145|NCT01786564|20371873|P1|STARTED|Overall Study||120
8262146|NCT01786551|20371877|P1|NOT COMPLETED|Overall Study||2
8262147|NCT01786551|20371877|P1|COMPLETED|Overall Study||14
8262148|NCT01786551|20371877|P1|STARTED|Overall Study||16
8262149|NCT01786343|20371885|P2|NOT COMPLETED|Overall Study||0
8262150|NCT01786343|20371886|P1|NOT COMPLETED|Overall Study||0
8262151|NCT01786343|20371885|P2|COMPLETED|Overall Study||46
8262152|NCT01786343|20371886|P1|COMPLETED|Overall Study||28
8262153|NCT01786343|20371885|P2|STARTED|Overall Study||46
8262154|NCT01786343|20371886|P1|STARTED|Overall Study||28
8262155|NCT01786330|20371898|P2|NOT COMPLETED|Overall Study||3
8262156|NCT01786330|20371899|P1|NOT COMPLETED|Overall Study||1
8262157|NCT01786330|20371898|P2|COMPLETED|Overall Study||27
8262158|NCT01786330|20371899|P1|COMPLETED|Overall Study||29
8262159|NCT01786330|20371898|P2|STARTED|Overall Study||30
8262160|NCT01786330|20371899|P1|STARTED|Overall Study||30
8262161|NCT01786252|20371913|P2|NOT COMPLETED|Overall Study||0
8262162|NCT01786252|20371914|P1|NOT COMPLETED|Overall Study||0
8262163|NCT01786252|20371913|P2|COMPLETED|Overall Study||8
8262164|NCT01786252|20371914|P1|COMPLETED|Overall Study||7
8262165|NCT01786252|20371913|P2|STARTED|Overall Study||8
8262166|NCT01786252|20371914|P1|STARTED|Overall Study||7
8262167|NCT01786239|20371928|P2|NOT COMPLETED|Overall Study||11
8262168|NCT01786239|20371929|P1|NOT COMPLETED|Overall Study||11
8262169|NCT01786239|20371928|P2|COMPLETED|Overall Study||14
8262170|NCT01786239|20371929|P1|COMPLETED|Overall Study||14
8262171|NCT01786239|20371928|P2|STARTED|Overall Study||25
8262172|NCT01786239|20371929|P1|STARTED|Overall Study||25
8262173|NCT01786187|20371937|P2|NOT COMPLETED|Overall Study||10
8262174|NCT01786187|20371938|P1|NOT COMPLETED|Overall Study||5
8262175|NCT01786187|20371937|P2|COMPLETED|Overall Study||37
8262176|NCT01786187|20371938|P1|COMPLETED|Overall Study||35
8262177|NCT01786187|20371937|P2|STARTED|Overall Study||47
8262178|NCT01786187|20371938|P1|STARTED|Overall Study||40
8262179|NCT01786174|20371951|P2|NOT COMPLETED|Overall Study||0
8262180|NCT01786174|20371952|P1|NOT COMPLETED|Overall Study||2
8262181|NCT01786174|20371951|P2|COMPLETED|Overall Study||10
8262182|NCT01786174|20371952|P1|COMPLETED|Overall Study||16
8262183|NCT01786174|20371951|P2|Randomized|Overall Study||11
8262184|NCT01786174|20371952|P1|Randomized|Overall Study||19
8262185|NCT01786174|20371951|P2|STARTED|Overall Study||10
8262186|NCT01786174|20371952|P1|STARTED|Overall Study||18
8262187|NCT01786161|20371968|P2|NOT COMPLETED|Overall Study||0
8262188|NCT01786161|20371969|P1|NOT COMPLETED|Overall Study||0
8262189|NCT01786161|20371968|P2|COMPLETED|Overall Study||22
8262190|NCT01786161|20371969|P1|COMPLETED|Overall Study||22
8262191|NCT01786161|20371968|P2|STARTED|Overall Study||22
8262192|NCT01786161|20371969|P1|STARTED|Overall Study||22
8262193|NCT01786148|20371981|P2|NOT COMPLETED|Overall Study||22
8262194|NCT01786148|20371982|P1|NOT COMPLETED|Overall Study||22
8262195|NCT01786148|20371981|P2|COMPLETED|Overall Study||50
8262196|NCT01786148|20371982|P1|COMPLETED|Overall Study||55
8262197|NCT01786148|20371981|P2|STARTED|Overall Study||72
8262198|NCT01786148|20371982|P1|STARTED|Overall Study||77
8262199|NCT01786109|20371997|P3|NOT COMPLETED|Overall Study||2
8262200|NCT01786109|20371998|P2|NOT COMPLETED|Overall Study||0
8262201|NCT01786109|20371999|P1|NOT COMPLETED|Overall Study||1
8262202|NCT01786109|20371997|P3|COMPLETED|Overall Study||25
8262203|NCT01786109|20371998|P2|COMPLETED|Overall Study||24
8262204|NCT01786109|20371999|P1|COMPLETED|Overall Study||23
8262205|NCT01786109|20371997|P3|STARTED|Overall Study||27
8262206|NCT01786109|20371998|P2|STARTED|Overall Study||24
8262207|NCT01786109|20371999|P1|STARTED|Overall Study||24
8262208|NCT01785875|20372028|P3|NOT COMPLETED|Overall Study||107
8262209|NCT01785875|20372029|P2|NOT COMPLETED|Overall Study||289
8262210|NCT01785875|20372030|P1|NOT COMPLETED|Overall Study||294
8262211|NCT01785875|20372028|P3|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
8262212|NCT01785875|20372029|P2|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
8262213|NCT01785875|20372030|P1|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
8262214|NCT01785875|20372028|P3|Received Etelcalcetide|Overall Study||123
8262215|NCT01785875|20372029|P2|Received Etelcalcetide|Overall Study||384
8262216|NCT01785875|20372030|P1|Received Etelcalcetide|Overall Study||383
8262217|NCT01785875|20372028|P3|STARTED|Overall Study||123
8262218|NCT01785875|20372029|P2|STARTED|Overall Study||384
8262219|NCT01785875|20372030|P1|STARTED|Overall Study||384
8262220|NCT01785849|20372099|P2|NOT COMPLETED|Overall Study||34
8262221|NCT01785849|20372100|P1|NOT COMPLETED|Overall Study||61
8262222|NCT01785849|20372099|P2|COMPLETED|Overall Study||220
8262223|NCT01785849|20372100|P1|COMPLETED|Overall Study||193
8262224|NCT01785849|20372099|P2|Received Treatment|Overall Study||251
8262225|NCT01785849|20372100|P1|Received Treatment|Overall Study||254
8262226|NCT01785849|20372099|P2|STARTED|Overall Study||254
8262227|NCT01785849|20372100|P1|STARTED|Overall Study||254
8262228|NCT01785810|20372116|P1|NOT COMPLETED|Overall Study||8
8262229|NCT01785810|20372116|P1|COMPLETED|Overall Study||29
8262230|NCT01785810|20372116|P1|STARTED|Overall Study||37
8262231|NCT01785680|20372122|P2|NOT COMPLETED|Overall Study||0
8262232|NCT01785680|20372123|P1|NOT COMPLETED|Overall Study||0
8262233|NCT01785680|20372122|P2|COMPLETED|Overall Study||857
8262234|NCT01785680|20372123|P1|COMPLETED|Overall Study||1100
8262235|NCT01785680|20372122|P2|STARTED|Overall Study||857
8262236|NCT01785680|20372123|P1|STARTED|Overall Study||1100
8262237|NCT01785628|20372137|P2|NOT COMPLETED|Overall Study||3
8262238|NCT01785628|20372138|P1|NOT COMPLETED|Overall Study||2
8262239|NCT01785628|20372137|P2|COMPLETED|Overall Study||12
8262240|NCT01785628|20372138|P1|COMPLETED|Overall Study||13
8262241|NCT01785628|20372137|P2|STARTED|Overall Study||15
8262242|NCT01785628|20372138|P1|STARTED|Overall Study||15
8262243|NCT01785615|20372161|P4|NOT COMPLETED|Atorvastatin Phase||0
8262244|NCT01785615|20372162|P3|NOT COMPLETED|Atorvastatin Phase||0
8262245|NCT01785615|20372163|P2|NOT COMPLETED|Atorvastatin Phase||0
8262246|NCT01785615|20372164|P1|NOT COMPLETED|Atorvastatin Phase||0
8262247|NCT01785615|20372161|P4|COMPLETED|Atorvastatin Phase||0
8262248|NCT01785615|20372162|P3|COMPLETED|Atorvastatin Phase||0
8262249|NCT01785615|20372163|P2|COMPLETED|Atorvastatin Phase||44
8262250|NCT01785615|20372164|P1|COMPLETED|Atorvastatin Phase||44
8262251|NCT01785615|20372161|P4|STARTED|Atorvastatin Phase||0
8262252|NCT01785615|20372162|P3|STARTED|Atorvastatin Phase||0
8262253|NCT01785615|20372163|P2|STARTED|Atorvastatin Phase||44
8262254|NCT01785615|20372164|P1|STARTED|Atorvastatin Phase||44
8262255|NCT01785615|20372161|P4|NOT COMPLETED|Dietary Phase||24
8262256|NCT01785615|20372162|P3|NOT COMPLETED|Dietary Phase||0
8262257|NCT01785615|20372163|P2|NOT COMPLETED|Dietary Phase||0
8262258|NCT01785615|20372164|P1|NOT COMPLETED|Dietary Phase||0
8262259|NCT01785615|20372161|P4|COMPLETED|Dietary Phase||116
8262260|NCT01785615|20372162|P3|COMPLETED|Dietary Phase||35
8262261|NCT01785615|20372163|P2|COMPLETED|Dietary Phase||0
8262262|NCT01785615|20372164|P1|COMPLETED|Dietary Phase||0
8262263|NCT01785615|20372161|P4|STARTED|Dietary Phase||140
8262264|NCT01785615|20372162|P3|STARTED|Dietary Phase||35
8262265|NCT01785615|20372163|P2|STARTED|Dietary Phase||0
8262266|NCT01785615|20372164|P1|STARTED|Dietary Phase||0
8262267|NCT01785602|20372236|P2|NOT COMPLETED|Overall Study||9
8262268|NCT01785602|20372237|P1|NOT COMPLETED|Overall Study||13
8262269|NCT01785602|20372236|P2|COMPLETED|Overall Study||18
8262270|NCT01785602|20372237|P1|COMPLETED|Overall Study||63
8262271|NCT01785602|20372236|P2|STARTED|Overall Study||27
8262272|NCT01785602|20372237|P1|STARTED|Overall Study||76
8262273|NCT01785524|20372247|P2|NOT COMPLETED|Overall Study||2
8262274|NCT01785524|20372248|P1|NOT COMPLETED|Overall Study||2
8262275|NCT01785524|20372247|P2|COMPLETED|Overall Study||2
8262276|NCT01785524|20372248|P1|COMPLETED|Overall Study||5
8262277|NCT01785524|20372247|P2|STARTED|Overall Study||4
8262278|NCT01785524|20372248|P1|STARTED|Overall Study||7
8262279|NCT01785472|20372267|P3|NOT COMPLETED|Overall Study||22
8262280|NCT01785472|20372268|P2|NOT COMPLETED|Overall Study||19
8262281|NCT01785472|20372269|P1|NOT COMPLETED|Overall Study||24
8262282|NCT01785472|20372267|P3|COMPLETED|Overall Study||464
8262283|NCT01785472|20372268|P2|COMPLETED|Overall Study||454
8262284|NCT01785472|20372269|P1|COMPLETED|Overall Study||455
8262285|NCT01785472|20372267|P3|Safety Set (SAF)|Overall Study||484
8262286|NCT01785472|20372268|P2|Safety Set (SAF)|Overall Study||472
8262287|NCT01785472|20372269|P1|Safety Set (SAF)|Overall Study||478
8262288|NCT01785472|20372267|P3|Full Analysis Set (FAS)|Overall Study||484
8262289|NCT01785472|20372268|P2|Full Analysis Set (FAS)|Overall Study||472
8262290|NCT01785472|20372269|P1|Full Analysis Set (FAS)|Overall Study||479
8262291|NCT01785472|20372267|P3|STARTED|Overall Study||486
8262292|NCT01785472|20372268|P2|STARTED|Overall Study||473
8262293|NCT01785472|20372269|P1|STARTED|Overall Study||479
8262294|NCT01785459|20372313|P2|NOT COMPLETED|Overall Study||0
8262295|NCT01785459|20372314|P1|NOT COMPLETED|Overall Study||0
8262296|NCT01785459|20372313|P2|COMPLETED|Overall Study||12
8262297|NCT01785459|20372314|P1|COMPLETED|Overall Study||11
8262298|NCT01785459|20372313|P2|STARTED|Overall Study||12
8262299|NCT01785459|20372314|P1|STARTED|Overall Study||11
8262300|NCT01785186|20372329|P5|NOT COMPLETED|Overall Study||6
8262301|NCT01785186|20372330|P4|NOT COMPLETED|Overall Study||5
8262302|NCT01785186|20372331|P3|NOT COMPLETED|Overall Study||5
8262303|NCT01785186|20372332|P2|NOT COMPLETED|Overall Study||6
8262304|NCT01785186|20372333|P1|NOT COMPLETED|Overall Study||6
8262305|NCT01785186|20372329|P5|COMPLETED|Overall Study||117
8262306|NCT01785186|20372330|P4|COMPLETED|Overall Study||58
8262307|NCT01785186|20372331|P3|COMPLETED|Overall Study||52
8262308|NCT01785186|20372332|P2|COMPLETED|Overall Study||57
8262309|NCT01785186|20372333|P1|COMPLETED|Overall Study||53
8262310|NCT01785186|20372329|P5|STARTED|Overall Study||123
8262311|NCT01785186|20372330|P4|STARTED|Overall Study||63
8262312|NCT01785186|20372331|P3|STARTED|Overall Study||57
8262313|NCT01785186|20372332|P2|STARTED|Overall Study||63
8262314|NCT01785186|20372333|P1|STARTED|Overall Study||59
8262315|NCT01785160|20372355|P1|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
8262316|NCT01785160|20372355|P1|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
8262317|NCT01785160|20372355|P1|STARTED|Treatment Period 2: Raltegravir + Faldap||23
8262318|NCT01785160|20372355|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
8262319|NCT01785160|20372355|P1|COMPLETED|Washout Period of at Least 7 Days||23
8262320|NCT01785160|20372355|P1|STARTED|Washout Period of at Least 7 Days||24
8262321|NCT01785160|20372355|P1|NOT COMPLETED|Treatment Period 1: Raltegravir||1
8262322|NCT01785160|20372355|P1|COMPLETED|Treatment Period 1: Raltegravir||24
8262323|NCT01785160|20372355|P1|STARTED|Treatment Period 1: Raltegravir||25
8262324|NCT01785134|20372365|P2|NOT COMPLETED|Overall Study||7
8262325|NCT01785134|20372366|P1|NOT COMPLETED|Overall Study||12
8262326|NCT01785134|20372365|P2|COMPLETED|Overall Study||33
8262327|NCT01785134|20372366|P1|COMPLETED|Overall Study||29
8262328|NCT01785134|20372365|P2|STARTED|Overall Study||40
8262329|NCT01785134|20372366|P1|STARTED|Overall Study||41
8262330|NCT01785095|20372380|P1|NOT COMPLETED|Overall Study||3
8262331|NCT01785095|20372380|P1|COMPLETED|Overall Study||24
8262332|NCT01785095|20372380|P1|STARTED|Overall Study||27
8262333|NCT01785069|20372392|P4|NOT COMPLETED|Overall Study||14
8262334|NCT01785069|20372393|P3|NOT COMPLETED|Overall Study||13
8262335|NCT01785069|20372394|P2|NOT COMPLETED|Overall Study||12
8262336|NCT01785069|20372395|P1|NOT COMPLETED|Overall Study||12
8262337|NCT01785069|20372392|P4|COMPLETED|Overall Study||54
8262338|NCT01785069|20372393|P3|COMPLETED|Overall Study||91
8262339|NCT01785069|20372394|P2|COMPLETED|Overall Study||64
8262340|NCT01785069|20372395|P1|COMPLETED|Overall Study||95
8262341|NCT01785069|20372392|P4|STARTED|Overall Study||68
8262342|NCT01785069|20372393|P3|STARTED|Overall Study||104
8262343|NCT01785069|20372394|P2|STARTED|Overall Study||76
8262344|NCT01785069|20372395|P1|STARTED|Overall Study||107
8262345|NCT01784991|20372423|P2|NOT COMPLETED|Overall Study||0
8262346|NCT01784991|20372424|P1|NOT COMPLETED|Overall Study||0
8262347|NCT01784991|20372423|P2|COMPLETED|Overall Study||0
8262348|NCT01784991|20372424|P1|COMPLETED|Overall Study||0
8262349|NCT01784991|20372423|P2|STARTED|Overall Study||0
8262350|NCT01784991|20372424|P1|STARTED|Overall Study||0
8262351|NCT01784965|20372444|P2|NOT COMPLETED|Overall Study||11
8262352|NCT01784965|20372445|P1|NOT COMPLETED|Overall Study||6
8262353|NCT01784965|20372444|P2|COMPLETED|Overall Study||24
8262354|NCT01784965|20372445|P1|COMPLETED|Overall Study||27
8262355|NCT01784965|20372444|P2|STARTED|Overall Study||35
8262356|NCT01784965|20372445|P1|STARTED|Overall Study||33
8262357|NCT01784926|20372457|P2|NOT COMPLETED|Overall Study||8
8262358|NCT01784926|20372458|P1|NOT COMPLETED|Overall Study||11
8262359|NCT01784926|20372457|P2|COMPLETED|Overall Study||42
8262360|NCT01784926|20372458|P1|COMPLETED|Overall Study||43
8262361|NCT01784926|20372457|P2|STARTED|Overall Study||50
8262362|NCT01784926|20372458|P1|STARTED|Overall Study||54
8262363|NCT01784848|20372476|P2|NOT COMPLETED|Overall Study||3
8262364|NCT01784848|20372477|P1|NOT COMPLETED|Overall Study||1
8262365|NCT01784848|20372476|P2|COMPLETED|Overall Study||47
8262366|NCT01784848|20372477|P1|COMPLETED|Overall Study||49
8262367|NCT01784848|20372476|P2|STARTED|Overall Study||50
8262368|NCT01784848|20372477|P1|STARTED|Overall Study||50
8262381|NCT01784770|20372498|P1|NOT COMPLETED|Overall Study||0
8262382|NCT01784770|20372498|P1|COMPLETED|Overall Study||21
8262383|NCT01784770|20372498|P1|STARTED|Overall Study||21
8262384|NCT01784666|20372506|P3|NOT COMPLETED|Overall Study||0
8262385|NCT01784666|20372507|P2|NOT COMPLETED|Overall Study||0
8262386|NCT01784666|20372508|P1|NOT COMPLETED|Overall Study||0
8262387|NCT01784666|20372506|P3|COMPLETED|Overall Study||1
8262388|NCT01784666|20372507|P2|COMPLETED|Overall Study||0
8262389|NCT01784666|20372508|P1|COMPLETED|Overall Study||1
8262390|NCT01784666|20372506|P3|STARTED|Overall Study||1
8262391|NCT01784666|20372507|P2|STARTED|Overall Study||0
8262392|NCT01784666|20372508|P1|STARTED|Overall Study||1
8262393|NCT01784614|20372516|P8|NOT COMPLETED|Period 4||0
8262394|NCT01784614|20372517|P7|NOT COMPLETED|Period 4||0
8262395|NCT01784614|20372518|P6|NOT COMPLETED|Period 4||0
8262396|NCT01784614|20372519|P5|NOT COMPLETED|Period 4||0
8262397|NCT01784614|20372520|P4|NOT COMPLETED|Period 4||0
8262398|NCT01784614|20372521|P3|NOT COMPLETED|Period 4||0
8262399|NCT01784614|20372522|P2|NOT COMPLETED|Period 4||0
8262400|NCT01784614|20372523|P1|NOT COMPLETED|Period 4||0
8262401|NCT01784614|20372516|P8|COMPLETED|Period 4||2
8262402|NCT01784614|20372517|P7|COMPLETED|Period 4||3
8262403|NCT01784614|20372518|P6|COMPLETED|Period 4||3
8262404|NCT01784614|20372519|P5|COMPLETED|Period 4||3
8262405|NCT01784614|20372520|P4|COMPLETED|Period 4||3
8262406|NCT01784614|20372521|P3|COMPLETED|Period 4||3
8262407|NCT01784614|20372522|P2|COMPLETED|Period 4||2
8262408|NCT01784614|20372523|P1|COMPLETED|Period 4||3
8262409|NCT01784614|20372516|P8|STARTED|Period 4||2
8262410|NCT01784614|20372517|P7|STARTED|Period 4||3
8262411|NCT01784614|20372518|P6|STARTED|Period 4||3
8262412|NCT01784614|20372519|P5|STARTED|Period 4||3
8262413|NCT01784614|20372520|P4|STARTED|Period 4||3
8262414|NCT01784614|20372521|P3|STARTED|Period 4||3
8262415|NCT01784614|20372522|P2|STARTED|Period 4||2
8262416|NCT01784614|20372523|P1|STARTED|Period 4||3
8262417|NCT01784614|20372516|P8|NOT COMPLETED|Period 3||0
8262418|NCT01784614|20372517|P7|NOT COMPLETED|Period 3||0
8262419|NCT01784614|20372518|P6|NOT COMPLETED|Period 3||0
8262420|NCT01784614|20372519|P5|NOT COMPLETED|Period 3||0
8262421|NCT01784614|20372520|P4|NOT COMPLETED|Period 3||0
8262422|NCT01784614|20372521|P3|NOT COMPLETED|Period 3||0
8262423|NCT01784614|20372522|P2|NOT COMPLETED|Period 3||0
8262424|NCT01784614|20372523|P1|NOT COMPLETED|Period 3||0
8262425|NCT01784614|20372516|P8|COMPLETED|Period 3||2
8262426|NCT01784614|20372517|P7|COMPLETED|Period 3||3
8262427|NCT01784614|20372518|P6|COMPLETED|Period 3||3
8262428|NCT01784614|20372519|P5|COMPLETED|Period 3||3
8262429|NCT01784614|20372520|P4|COMPLETED|Period 3||3
8262430|NCT01784614|20372521|P3|COMPLETED|Period 3||3
8262431|NCT01784614|20372522|P2|COMPLETED|Period 3||2
8262432|NCT01784614|20372523|P1|COMPLETED|Period 3||3
8262433|NCT01784614|20372516|P8|STARTED|Period 3||2
8262434|NCT01784614|20372517|P7|STARTED|Period 3||3
8262435|NCT01784614|20372518|P6|STARTED|Period 3||3
8262436|NCT01784614|20372519|P5|STARTED|Period 3||3
8262437|NCT01784614|20372520|P4|STARTED|Period 3||3
8262438|NCT01784614|20372521|P3|STARTED|Period 3||3
8262439|NCT01784614|20372522|P2|STARTED|Period 3||2
8262440|NCT01784614|20372523|P1|STARTED|Period 3||3
8262441|NCT01784614|20372516|P8|NOT COMPLETED|Period 2||0
8262442|NCT01784614|20372517|P7|NOT COMPLETED|Period 2||0
8262443|NCT01784614|20372518|P6|NOT COMPLETED|Period 2||0
8262444|NCT01784614|20372519|P5|NOT COMPLETED|Period 2||0
8262445|NCT01784614|20372520|P4|NOT COMPLETED|Period 2||0
8262446|NCT01784614|20372521|P3|NOT COMPLETED|Period 2||0
8262447|NCT01784614|20372522|P2|NOT COMPLETED|Period 2||0
8262448|NCT01784614|20372523|P1|NOT COMPLETED|Period 2||0
8262449|NCT01784614|20372516|P8|COMPLETED|Period 2||2
8262450|NCT01784614|20372517|P7|COMPLETED|Period 2||3
8262451|NCT01784614|20372518|P6|COMPLETED|Period 2||3
8262452|NCT01784614|20372519|P5|COMPLETED|Period 2||3
8262453|NCT01784614|20372520|P4|COMPLETED|Period 2||3
8262454|NCT01784614|20372521|P3|COMPLETED|Period 2||3
8262455|NCT01784614|20372522|P2|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
8262456|NCT01784614|20372523|P1|COMPLETED|Period 2||3
8262457|NCT01784614|20372516|P8|STARTED|Period 2||2
8262458|NCT01784614|20372517|P7|STARTED|Period 2||3
8262459|NCT01784614|20372518|P6|STARTED|Period 2||3
8262460|NCT01784614|20372519|P5|STARTED|Period 2||3
8262461|NCT01784614|20372520|P4|STARTED|Period 2||3
8262462|NCT01784614|20372521|P3|STARTED|Period 2||3
8262463|NCT01784614|20372522|P2|STARTED|Period 2||3
8262464|NCT01784614|20372523|P1|STARTED|Period 2||3
8262465|NCT01784614|20372516|P8|NOT COMPLETED|Period 1||0
8262466|NCT01784614|20372517|P7|NOT COMPLETED|Period 1||0
8262467|NCT01784614|20372518|P6|NOT COMPLETED|Period 1||0
8262468|NCT01784614|20372519|P5|NOT COMPLETED|Period 1||0
8262469|NCT01784614|20372520|P4|NOT COMPLETED|Period 1||0
8262470|NCT01784614|20372521|P3|NOT COMPLETED|Period 1||0
8262471|NCT01784614|20372522|P2|NOT COMPLETED|Period 1||0
8262472|NCT01784614|20372523|P1|NOT COMPLETED|Period 1||0
8262473|NCT01784614|20372516|P8|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
8262474|NCT01784614|20372517|P7|COMPLETED|Period 1||3
8262475|NCT01784614|20372518|P6|COMPLETED|Period 1||3
8262476|NCT01784614|20372519|P5|COMPLETED|Period 1||3
8262477|NCT01784614|20372520|P4|COMPLETED|Period 1||3
8262478|NCT01784614|20372521|P3|COMPLETED|Period 1||3
8262479|NCT01784614|20372522|P2|COMPLETED|Period 1||3
8262480|NCT01784614|20372523|P1|COMPLETED|Period 1||3
8262481|NCT01784614|20372516|P8|Received at Least 1 Dose of Study Drug|Period 1||3
8262482|NCT01784614|20372517|P7|Received at Least 1 Dose of Study Drug|Period 1||3
8262483|NCT01784614|20372518|P6|Received at Least 1 Dose of Study Drug|Period 1||3
8262484|NCT01784614|20372519|P5|Received at Least 1 Dose of Study Drug|Period 1||3
8262485|NCT01784614|20372520|P4|Received at Least 1 Dose of Study Drug|Period 1||3
8262486|NCT01784614|20372521|P3|Received at Least 1 Dose of Study Drug|Period 1||3
8262487|NCT01784614|20372522|P2|Received at Least 1 Dose of Study Drug|Period 1||3
8262488|NCT01784614|20372523|P1|Received at Least 1 Dose of Study Drug|Period 1||3
8262489|NCT01784614|20372516|P8|STARTED|Period 1||3
8262490|NCT01784614|20372517|P7|STARTED|Period 1||3
8262491|NCT01784614|20372518|P6|STARTED|Period 1||3
8262492|NCT01784614|20372519|P5|STARTED|Period 1||3
8262493|NCT01784614|20372520|P4|STARTED|Period 1||3
8262494|NCT01784614|20372521|P3|STARTED|Period 1||3
8262495|NCT01784614|20372522|P2|STARTED|Period 1||3
8262496|NCT01784614|20372523|P1|STARTED|Period 1||3
8262503|NCT01784419|20372566|P1|NOT COMPLETED|Overall Study||3
8262504|NCT01784419|20372566|P1|COMPLETED|Overall Study||7
8262505|NCT01784419|20372566|P1|STARTED|Overall Study||10
8262506|NCT01784211|20372574|P6|NOT COMPLETED|Part B (Days 16-21)||0
8262507|NCT01784211|20372575|P5|NOT COMPLETED|Part B (Days 16-21)||0
8262508|NCT01784211|20372576|P4|NOT COMPLETED|Part B (Days 16-21)||0
8262509|NCT01784211|20372577|P3|NOT COMPLETED|Part B (Days 16-21)||0
8262510|NCT01784211|20372578|P2|NOT COMPLETED|Part B (Days 16-21)||0
8262511|NCT01784211|20372579|P1|NOT COMPLETED|Part B (Days 16-21)||0
8262512|NCT01784211|20372574|P6|COMPLETED|Part B (Days 16-21)||10
8262513|NCT01784211|20372575|P5|COMPLETED|Part B (Days 16-21)||11
8262514|NCT01784211|20372576|P4|COMPLETED|Part B (Days 16-21)||9
8262515|NCT01784211|20372577|P3|COMPLETED|Part B (Days 16-21)||10
8262516|NCT01784211|20372578|P2|COMPLETED|Part B (Days 16-21)||0
8262517|NCT01784211|20372579|P1|COMPLETED|Part B (Days 16-21)||0
8262518|NCT01784211|20372574|P6|STARTED|Part B (Days 16-21)||10
8262519|NCT01784211|20372575|P5|STARTED|Part B (Days 16-21)||11
8262520|NCT01784211|20372576|P4|STARTED|Part B (Days 16-21)||9
8262521|NCT01784211|20372577|P3|STARTED|Part B (Days 16-21)||10
8262522|NCT01784211|20372578|P2|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
8262523|NCT01784211|20372579|P1|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
8262524|NCT01784211|20372574|P6|NOT COMPLETED|Part A (Days 1-15)||0
8262525|NCT01784211|20372575|P5|NOT COMPLETED|Part A (Days 1-15)||0
8262526|NCT01784211|20372576|P4|NOT COMPLETED|Part A (Days 1-15)||0
8262527|NCT01784211|20372577|P3|NOT COMPLETED|Part A (Days 1-15)||0
8262528|NCT01784211|20372578|P2|NOT COMPLETED|Part A (Days 1-15)||2
8262529|NCT01784211|20372579|P1|NOT COMPLETED|Part A (Days 1-15)||3
8262530|NCT01784211|20372574|P6|COMPLETED|Part A (Days 1-15)||0
8262531|NCT01784211|20372575|P5|COMPLETED|Part A (Days 1-15)||0
8262532|NCT01784211|20372576|P4|COMPLETED|Part A (Days 1-15)||0
8262533|NCT01784211|20372577|P3|COMPLETED|Part A (Days 1-15)||0
8262534|NCT01784211|20372578|P2|COMPLETED|Part A (Days 1-15)||36
8262535|NCT01784211|20372579|P1|COMPLETED|Part A (Days 1-15)||35
8262536|NCT01784211|20372574|P6|Entered Part B|Part A (Days 1-15)||0
8262537|NCT01784211|20372575|P5|Entered Part B|Part A (Days 1-15)||0
8262538|NCT01784211|20372576|P4|Entered Part B|Part A (Days 1-15)||0
8262539|NCT01784211|20372577|P3|Entered Part B|Part A (Days 1-15)||0
8262540|NCT01784211|20372578|P2|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21
8262541|NCT01784211|20372579|P1|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19
8262542|NCT01784211|20372574|P6|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
8262543|NCT01784211|20372575|P5|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
8262544|NCT01784211|20372576|P4|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
8262545|NCT01784211|20372577|P3|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
8262546|NCT01784211|20372578|P2|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38
8262547|NCT01784211|20372579|P1|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37
8262548|NCT01784211|20372574|P6|STARTED|Part A (Days 1-15)||0
8262549|NCT01784211|20372575|P5|STARTED|Part A (Days 1-15)||0
8262550|NCT01784211|20372576|P4|STARTED|Part A (Days 1-15)||0
8262551|NCT01784211|20372577|P3|STARTED|Part A (Days 1-15)||0
8262552|NCT01784211|20372578|P2|STARTED|Part A (Days 1-15)||38
8262553|NCT01784211|20372579|P1|STARTED|Part A (Days 1-15)||38
8262566|NCT01784055|20372609|P1|NOT COMPLETED|Overall Study||26
8262567|NCT01784055|20372609|P1|COMPLETED|Overall Study||100
8262568|NCT01784055|20372609|P1|STARTED|Overall Study||126
8262569|NCT01784029|20372616|P3|NOT COMPLETED|Overall Study||22
8262570|NCT01784029|20372617|P2|NOT COMPLETED|Overall Study||20
8262571|NCT01784029|20372618|P1|NOT COMPLETED|Overall Study||19
8262572|NCT01784029|20372616|P3|COMPLETED|Overall Study||41
8262573|NCT01784029|20372617|P2|COMPLETED|Overall Study||39
8262574|NCT01784029|20372618|P1|COMPLETED|Overall Study||42
8262575|NCT01784029|20372616|P3|STARTED|Overall Study||63
8262576|NCT01784029|20372617|P2|STARTED|Overall Study||59
8262577|NCT01784029|20372618|P1|STARTED|Overall Study||61
8262578|NCT01783990|20372628|P2|NOT COMPLETED|Overall Study||2
8262579|NCT01783990|20372629|P1|NOT COMPLETED|Overall Study||5
8262580|NCT01783990|20372628|P2|COMPLETED|Overall Study||18
8262581|NCT01783990|20372629|P1|COMPLETED|Overall Study||125
8262582|NCT01783990|20372628|P2|STARTED|Overall Study||20
8262583|NCT01783990|20372629|P1|STARTED|Overall Study||130
8262590|NCT01783912|20372663|P3|NOT COMPLETED|Overall Study||23
8262591|NCT01783912|20372664|P2|NOT COMPLETED|Overall Study||46
8262592|NCT01783912|20372665|P1|NOT COMPLETED|Overall Study||30
8262593|NCT01783912|20372663|P3|COMPLETED|Overall Study||25
8262594|NCT01783912|20372664|P2|COMPLETED|Overall Study||58
8262595|NCT01783912|20372665|P1|COMPLETED|Overall Study||88
8262596|NCT01783912|20372663|P3|STARTED|Overall Study||48
8262597|NCT01783912|20372664|P2|STARTED|Overall Study||104
8262598|NCT01783912|20372665|P1|STARTED|Overall Study||118
8262599|NCT01783886|20372676|P3|NOT COMPLETED|Overall Study||10
8262600|NCT01783886|20372677|P2|NOT COMPLETED|Overall Study||11
8262601|NCT01783886|20372678|P1|NOT COMPLETED|Overall Study||5
8262602|NCT01783886|20372676|P3|COMPLETED|Overall Study||117
8262603|NCT01783886|20372677|P2|COMPLETED|Overall Study||116
8262604|NCT01783886|20372678|P1|COMPLETED|Overall Study||122
8262605|NCT01783886|20372676|P3|Participants Received Treatment|Overall Study||124
8262606|NCT01783886|20372677|P2|Participants Received Treatment|Overall Study||127
8262607|NCT01783886|20372678|P1|Participants Received Treatment|Overall Study||127
8262608|NCT01783886|20372676|P3|STARTED|Overall Study||127
8262609|NCT01783886|20372677|P2|STARTED|Overall Study||127
8262610|NCT01783886|20372678|P1|STARTED|Overall Study||127
8262611|NCT01783860|20372706|P2|NOT COMPLETED|Overall Study||0
8262612|NCT01783860|20372707|P1|NOT COMPLETED|Overall Study||0
8262613|NCT01783860|20372706|P2|COMPLETED|Overall Study||50
8262614|NCT01783860|20372707|P1|COMPLETED|Overall Study||50
8262615|NCT01783860|20372706|P2|STARTED|Overall Study||50
8262616|NCT01783860|20372707|P1|STARTED|Overall Study||50
8262617|NCT01783847|20372726|P3|NOT COMPLETED|Overall Study||0
8262618|NCT01783847|20372727|P2|NOT COMPLETED|Overall Study||1
8262619|NCT01783847|20372728|P1|NOT COMPLETED|Overall Study||16
8262620|NCT01783847|20372726|P3|COMPLETED|Overall Study||16
8262621|NCT01783847|20372727|P2|COMPLETED|Overall Study||15
8262622|NCT01783847|20372728|P1|COMPLETED|Overall Study||69
8262623|NCT01783847|20372726|P3|STARTED|Overall Study||16
8262624|NCT01783847|20372727|P2|STARTED|Overall Study||16
8262625|NCT01783847|20372728|P1|STARTED|Overall Study||85
8262626|NCT01783821|20372741|P2|NOT COMPLETED|Overall Study||1
8262627|NCT01783821|20372742|P1|NOT COMPLETED|Overall Study||1
8262628|NCT01783821|20372741|P2|COMPLETED|Overall Study||30
8262629|NCT01783821|20372742|P1|COMPLETED|Overall Study||29
8262630|NCT01783821|20372741|P2|STARTED|Overall Study||31
8262631|NCT01783821|20372742|P1|STARTED|Overall Study||30
8262632|NCT01783743|20372760|P2|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
8262633|NCT01783743|20372761|P1|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
8262634|NCT01783743|20372760|P2|COMPLETED|Rescreening of Subjects by Senior Grader||3044
8262635|NCT01783743|20372761|P1|COMPLETED|Rescreening of Subjects by Senior Grader||2613
8262636|NCT01783743|20372760|P2|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
8262637|NCT01783743|20372761|P1|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
8262638|NCT01783743|20372760|P2|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
8262639|NCT01783743|20372761|P1|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
8262640|NCT01783743|20372760|P2|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
8262641|NCT01783743|20372761|P1|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
8262642|NCT01783743|20372760|P2|STARTED|Rescreening of Subjects by Senior Grader||13964
8262643|NCT01783743|20372761|P1|STARTED|Rescreening of Subjects by Senior Grader||13509
8262644|NCT01783743|20372760|P2|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
8262645|NCT01783743|20372761|P1|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
8262646|NCT01783743|20372760|P2|COMPLETED|Screening of Subjects by CTA During MDA||9525
8262647|NCT01783743|20372761|P1|COMPLETED|Screening of Subjects by CTA During MDA||10082
8262648|NCT01783743|20372760|P2|STARTED|Screening of Subjects by CTA During MDA||13964
8262649|NCT01783743|20372761|P1|STARTED|Screening of Subjects by CTA During MDA||13509
8262650|NCT01783730|20372775|P1|NOT COMPLETED|Overall Study||6
8262651|NCT01783730|20372775|P1|COMPLETED|Overall Study||157
8262652|NCT01783730|20372775|P1|STARTED|Overall Study||163
8262653|NCT01783678|20372800|P6|NOT COMPLETED|Overall Study||5
8262654|NCT01783678|20372801|P5|NOT COMPLETED|Overall Study||7
8262655|NCT01783678|20372802|P4|NOT COMPLETED|Overall Study||8
8262656|NCT01783678|20372803|P3|NOT COMPLETED|Overall Study||1
8262657|NCT01783678|20372804|P2|NOT COMPLETED|Overall Study||18
8262658|NCT01783678|20372805|P1|NOT COMPLETED|Overall Study||2
8262659|NCT01783678|20372800|P6|COMPLETED|Overall Study||26
8262660|NCT01783678|20372801|P5|COMPLETED|Overall Study||42
8262661|NCT01783678|20372802|P4|COMPLETED|Overall Study||50
8262662|NCT01783678|20372803|P3|COMPLETED|Overall Study||5
8262663|NCT01783678|20372804|P2|COMPLETED|Overall Study||94
8262664|NCT01783678|20372805|P1|COMPLETED|Overall Study||17
8262665|NCT01783678|20372800|P6|STARTED|Overall Study||31
8262666|NCT01783678|20372801|P5|STARTED|Overall Study||49
8262667|NCT01783678|20372802|P4|STARTED|Overall Study||58
8262668|NCT01783678|20372803|P3|STARTED|Overall Study||6
8262669|NCT01783678|20372804|P2|STARTED|Overall Study||112
8262670|NCT01783678|20372805|P1|STARTED|Overall Study||19
8262671|NCT01783639|20372877|P1|NOT COMPLETED|Overall Study||0
8262672|NCT01783639|20372877|P1|COMPLETED|Overall Study||120
8262673|NCT01783639|20372877|P1|STARTED|Overall Study||120
8262674|NCT01783574|20372883|P2|NOT COMPLETED|Overall Study||9
8262675|NCT01783574|20372884|P1|NOT COMPLETED|Overall Study||5
8262676|NCT01783574|20372883|P2|COMPLETED|Overall Study||41
8262677|NCT01783574|20372884|P1|COMPLETED|Overall Study||46
8262678|NCT01783574|20372883|P2|STARTED|Overall Study||50
8262679|NCT01783574|20372884|P1|STARTED|Overall Study||51
8262680|NCT01783561|20372896|P2|NOT COMPLETED|Overall Study||0
8262681|NCT01783561|20372897|P1|NOT COMPLETED|Overall Study||0
8262682|NCT01783561|20372896|P2|COMPLETED|Overall Study||10
8262683|NCT01783561|20372897|P1|COMPLETED|Overall Study||11
8262684|NCT01783561|20372896|P2|STARTED|Overall Study||10
8262685|NCT01783561|20372897|P1|STARTED|Overall Study||11
8262686|NCT01783548|20372909|P2|NOT COMPLETED|Overall Study||18
8262687|NCT01783548|20372910|P1|NOT COMPLETED|Overall Study||34
8262688|NCT01783548|20372909|P2|COMPLETED|Overall Study||167
8262689|NCT01783548|20372910|P1|COMPLETED|Overall Study||328
8262690|NCT01783548|20372909|P2|Full Analysis Set (FAS)|Overall Study||184
8262691|NCT01783548|20372910|P1|Full Analysis Set (FAS)|Overall Study||358
8262692|NCT01783548|20372909|P2|STARTED|Overall Study|Randomized|185
8262693|NCT01783548|20372910|P1|STARTED|Overall Study|Randomized|362
8262694|NCT01783522|20372924|P2|NOT COMPLETED|Overall Study||0
8262695|NCT01783522|20372925|P1|NOT COMPLETED|Overall Study||0
8262696|NCT01783522|20372924|P2|COMPLETED|Overall Study||5
8262697|NCT01783522|20372925|P1|COMPLETED|Overall Study||4
8262698|NCT01783522|20372924|P2|STARTED|Overall Study||5
8262699|NCT01783522|20372925|P1|STARTED|Overall Study||4
8262700|NCT01783496|20372943|P6|NOT COMPLETED|Overall Study||1
8262701|NCT01783496|20372944|P5|NOT COMPLETED|Overall Study||0
8262702|NCT01783496|20372945|P4|NOT COMPLETED|Overall Study||2
8262703|NCT01783496|20372946|P3|NOT COMPLETED|Overall Study||0
8262704|NCT01783496|20372947|P2|NOT COMPLETED|Overall Study||0
8262705|NCT01783496|20372948|P1|NOT COMPLETED|Overall Study||1
8262706|NCT01783496|20372943|P6|COMPLETED|Overall Study||4
8262707|NCT01783496|20372944|P5|COMPLETED|Overall Study||5
8262708|NCT01783496|20372945|P4|COMPLETED|Overall Study||8
8262709|NCT01783496|20372946|P3|COMPLETED|Overall Study||10
8262710|NCT01783496|20372947|P2|COMPLETED|Overall Study||10
8262711|NCT01783496|20372948|P1|COMPLETED|Overall Study||9
8262712|NCT01783496|20372943|P6|STARTED|Overall Study||5
8262713|NCT01783496|20372944|P5|STARTED|Overall Study||5
8262714|NCT01783496|20372945|P4|STARTED|Overall Study||10
8262715|NCT01783496|20372946|P3|STARTED|Overall Study||10
8262716|NCT01783496|20372947|P2|STARTED|Overall Study||10
8262717|NCT01783496|20372948|P1|STARTED|Overall Study||10
8262718|NCT01783483|20372976|P2|NOT COMPLETED|Overall Study||15
8262719|NCT01783483|20372977|P1|NOT COMPLETED|Overall Study||20
8262720|NCT01783483|20372976|P2|COMPLETED|Overall Study||101
8262721|NCT01783483|20372977|P1|COMPLETED|Overall Study||100
8262722|NCT01783483|20372976|P2|STARTED|Overall Study||116
8262723|NCT01783483|20372977|P1|STARTED|Overall Study||120
8262724|NCT01783470|20373005|P2|NOT COMPLETED|Overall Study||0
8262725|NCT01783470|20373006|P1|NOT COMPLETED|Overall Study||0
8262726|NCT01783470|20373005|P2|COMPLETED|Overall Study||6
8262727|NCT01783470|20373006|P1|COMPLETED|Overall Study||6
8262728|NCT01783470|20373005|P2|STARTED|Overall Study|Single-dose|6
8262729|NCT01783470|20373006|P1|STARTED|Overall Study||6
8262730|NCT01783418|20373015|P2|NOT COMPLETED|Overall Study||0
8262731|NCT01783418|20373016|P1|NOT COMPLETED|Overall Study||1
8262732|NCT01783418|20373015|P2|COMPLETED|Overall Study||6
8262733|NCT01783418|20373016|P1|COMPLETED|Overall Study||7
8262734|NCT01783418|20373015|P2|STARTED|Overall Study||6
8262735|NCT01783418|20373016|P1|STARTED|Overall Study||8
8262736|NCT01783236|20373036|P2|NOT COMPLETED|Overall Study||0
8262737|NCT01783236|20373037|P1|NOT COMPLETED|Overall Study||2
8262738|NCT01783236|20373036|P2|COMPLETED|Overall Study||8
8262739|NCT01783236|20373037|P1|COMPLETED|Overall Study||6
8262740|NCT01783236|20373036|P2|STARTED|Overall Study||8
8262741|NCT01783236|20373037|P1|STARTED|Overall Study||8
8262742|NCT01783080|20373051|P1|NOT COMPLETED|Overall Study||0
8262743|NCT01783080|20373051|P1|COMPLETED|Overall Study||16
8262744|NCT01783080|20373051|P1|STARTED|Overall Study||16
8262745|NCT01783054|20373058|P1|NOT COMPLETED|Overall Study||0
8262746|NCT01783054|20373058|P1|COMPLETED|Overall Study||2
8262747|NCT01783054|20373058|P1|STARTED|Overall Study||2
8262748|NCT01783015|20373069|P3|NOT COMPLETED|Open Label Treatment||6
8262749|NCT01783015|20373070|P2|NOT COMPLETED|Open Label Treatment||0
8262750|NCT01783015|20373071|P1|NOT COMPLETED|Open Label Treatment||0
8262751|NCT01783015|20373069|P3|COMPLETED|Open Label Treatment||5
8262752|NCT01783015|20373070|P2|COMPLETED|Open Label Treatment||0
8262753|NCT01783015|20373071|P1|COMPLETED|Open Label Treatment||0
8262754|NCT01783015|20373069|P3|STARTED|Open Label Treatment||11
8262755|NCT01783015|20373070|P2|STARTED|Open Label Treatment||0
8262756|NCT01783015|20373071|P1|STARTED|Open Label Treatment||0
8262757|NCT01783015|20373069|P3|NOT COMPLETED|Blinded Treatment||0
8262758|NCT01783015|20373070|P2|NOT COMPLETED|Blinded Treatment||3
8262759|NCT01783015|20373071|P1|NOT COMPLETED|Blinded Treatment||2
8262760|NCT01783015|20373069|P3|COMPLETED|Blinded Treatment||0
8262761|NCT01783015|20373070|P2|COMPLETED|Blinded Treatment||2
8262762|NCT01783015|20373071|P1|COMPLETED|Blinded Treatment||9
8262763|NCT01783015|20373069|P3|Treated|Blinded Treatment||0
8262764|NCT01783015|20373070|P2|Treated|Blinded Treatment||5
8262765|NCT01783015|20373071|P1|Treated|Blinded Treatment||11
8262766|NCT01783015|20373069|P3|STARTED|Blinded Treatment||0
8262767|NCT01783015|20373070|P2|STARTED|Blinded Treatment||5
8262768|NCT01783015|20373071|P1|STARTED|Blinded Treatment||11
8262769|NCT01782963|20373156|P1|NOT COMPLETED|Overall Study||0
8262770|NCT01782963|20373156|P1|COMPLETED|Overall Study||50
8262771|NCT01782963|20373156|P1|STARTED|Overall Study||50
8262772|NCT01782898|20373171|P2|NOT COMPLETED|Overall Study||6
8262773|NCT01782898|20373172|P1|NOT COMPLETED|Overall Study||6
8262774|NCT01782898|20373171|P2|COMPLETED|Overall Study||29
8262775|NCT01782898|20373172|P1|COMPLETED|Overall Study||29
8262776|NCT01782898|20373171|P2|STARTED|Overall Study||35
8262777|NCT01782898|20373172|P1|STARTED|Overall Study||35
8262778|NCT01782885|20373184|P2|NOT COMPLETED|Overall Study||6
8262779|NCT01782885|20373185|P1|NOT COMPLETED|Overall Study||4
8262780|NCT01782885|20373184|P2|COMPLETED|Overall Study||33
8262781|NCT01782885|20373185|P1|COMPLETED|Overall Study||32
8262782|NCT01782885|20373184|P2|STARTED|Overall Study||39
8262783|NCT01782885|20373185|P1|STARTED|Overall Study||36
8262784|NCT01782872|20373211|P4|NOT COMPLETED|Overall Study||1
8262785|NCT01782872|20373212|P3|NOT COMPLETED|Overall Study||0
8262786|NCT01782872|20373213|P2|NOT COMPLETED|Overall Study||1
8262787|NCT01782872|20373214|P1|NOT COMPLETED|Overall Study||0
8262788|NCT01782872|20373211|P4|COMPLETED|Overall Study||19
8262789|NCT01782872|20373212|P3|COMPLETED|Overall Study||20
8262790|NCT01782872|20373213|P2|COMPLETED|Overall Study||19
8262791|NCT01782872|20373214|P1|COMPLETED|Overall Study||20
8262792|NCT01782872|20373211|P4|STARTED|Overall Study||20
8262793|NCT01782872|20373212|P3|STARTED|Overall Study||20
8262794|NCT01782872|20373213|P2|STARTED|Overall Study||20
8262795|NCT01782872|20373214|P1|STARTED|Overall Study||20
8262796|NCT01782859|20373238|P2|NOT COMPLETED|Overall Study||7
8262797|NCT01782859|20373239|P1|NOT COMPLETED|Overall Study||6
8262798|NCT01782859|20373238|P2|COMPLETED|Overall Study||13
8262799|NCT01782859|20373239|P1|COMPLETED|Overall Study||14
8262800|NCT01782859|20373238|P2|STARTED|Overall Study||20
8262801|NCT01782859|20373239|P1|STARTED|Overall Study||20
8262802|NCT01782833|20373253|P1|NOT COMPLETED|Overall Study||270
8262803|NCT01782833|20373253|P1|COMPLETED|Overall Study||3365
8262804|NCT01782833|20373253|P1|STARTED|Overall Study||3635
8262805|NCT01782742|20373261|P2|NOT COMPLETED|Open Label Phase||0
8262806|NCT01782742|20373262|P1|NOT COMPLETED|Open Label Phase||0
8262807|NCT01782742|20373261|P2|COMPLETED|Open Label Phase||0
8262808|NCT01782742|20373262|P1|COMPLETED|Open Label Phase||19
8262809|NCT01782742|20373261|P2|STARTED|Open Label Phase||0
8262810|NCT01782742|20373262|P1|STARTED|Open Label Phase||19
8262811|NCT01782742|20373261|P2|NOT COMPLETED|Double-blind Treatment Phase||0
8262812|NCT01782742|20373262|P1|NOT COMPLETED|Double-blind Treatment Phase||1
8262813|NCT01782742|20373261|P2|COMPLETED|Double-blind Treatment Phase||4
8262814|NCT01782742|20373262|P1|COMPLETED|Double-blind Treatment Phase||15
8262815|NCT01782742|20373261|P2|STARTED|Double-blind Treatment Phase||4
8262816|NCT01782742|20373262|P1|STARTED|Double-blind Treatment Phase||16
8262817|NCT01782690|20373295|P1|NOT COMPLETED|Overall Study||299
8262818|NCT01782690|20373295|P1|COMPLETED|Overall Study||39
8262819|NCT01782690|20373295|P1|STARTED|Overall Study||338
8262820|NCT01782664|20373317|P6|NOT COMPLETED|Overall Study||0
8262821|NCT01782664|20373318|P5|NOT COMPLETED|Overall Study||0
8262822|NCT01782664|20373319|P4|NOT COMPLETED|Overall Study||5
8262823|NCT01782664|20373320|P3|NOT COMPLETED|Overall Study||4
8262824|NCT01782664|20373321|P2|NOT COMPLETED|Overall Study||5
8262825|NCT01782664|20373322|P1|NOT COMPLETED|Overall Study||6
8262826|NCT01782664|20373317|P6|COMPLETED|Overall Study||2
8262827|NCT01782664|20373318|P5|COMPLETED|Overall Study||6
8262828|NCT01782664|20373319|P4|COMPLETED|Overall Study||9
8262829|NCT01782664|20373320|P3|COMPLETED|Overall Study||12
8262830|NCT01782664|20373321|P2|COMPLETED|Overall Study||10
8262831|NCT01782664|20373322|P1|COMPLETED|Overall Study||8
8262832|NCT01782664|20373317|P6|STARTED|Overall Study||2
8262833|NCT01782664|20373318|P5|STARTED|Overall Study||6
8262834|NCT01782664|20373319|P4|STARTED|Overall Study||14
8262835|NCT01782664|20373320|P3|STARTED|Overall Study||16
8262836|NCT01782664|20373321|P2|STARTED|Overall Study||15
8262837|NCT01782664|20373322|P1|STARTED|Overall Study||14
8262838|NCT01782495|20373479|P11|NOT COMPLETED|Overall Study||0
8262839|NCT01782495|20373480|P10|NOT COMPLETED|Overall Study||0
8262840|NCT01782495|20373481|P9|NOT COMPLETED|Overall Study||0
8262841|NCT01782495|20373482|P8|NOT COMPLETED|Overall Study||3
8262842|NCT01782495|20373483|P7|NOT COMPLETED|Overall Study||0
8262843|NCT01782495|20373484|P6|NOT COMPLETED|Overall Study||0
8262844|NCT01782495|20373485|P5|NOT COMPLETED|Overall Study||0
8262845|NCT01782495|20373486|P4|NOT COMPLETED|Overall Study||0
8262846|NCT01782495|20373487|P3|NOT COMPLETED|Overall Study||0
8262847|NCT01782495|20373488|P2|NOT COMPLETED|Overall Study||1
8262848|NCT01782495|20373489|P1|NOT COMPLETED|Overall Study||0
8262849|NCT01782495|20373479|P11|COMPLETED|Overall Study||1
8262850|NCT01782495|20373480|P10|COMPLETED|Overall Study||2
8262851|NCT01782495|20373481|P9|COMPLETED|Overall Study||3
8262852|NCT01782495|20373482|P8|COMPLETED|Overall Study||6
8262853|NCT01782495|20373483|P7|COMPLETED|Overall Study||12
8262854|NCT01782495|20373484|P6|COMPLETED|Overall Study||22
8262855|NCT01782495|20373485|P5|COMPLETED|Overall Study||2
8262856|NCT01782495|20373486|P4|COMPLETED|Overall Study||4
8262857|NCT01782495|20373487|P3|COMPLETED|Overall Study||13
8262858|NCT01782495|20373488|P2|COMPLETED|Overall Study||26
8262859|NCT01782495|20373489|P1|COMPLETED|Overall Study||34
8262860|NCT01782495|20373479|P11|STARTED|Overall Study||1
8262861|NCT01782495|20373480|P10|STARTED|Overall Study||2
8262862|NCT01782495|20373481|P9|STARTED|Overall Study||3
8262863|NCT01782495|20373482|P8|STARTED|Overall Study||9
8262864|NCT01782495|20373483|P7|STARTED|Overall Study||12
8262865|NCT01782495|20373484|P6|STARTED|Overall Study||22
8262866|NCT01782495|20373485|P5|STARTED|Overall Study||2
8262867|NCT01782495|20373486|P4|STARTED|Overall Study||4
8262868|NCT01782495|20373487|P3|STARTED|Overall Study||13
8262869|NCT01782495|20373488|P2|STARTED|Overall Study||27
8262870|NCT01782495|20373489|P1|STARTED|Overall Study||34
8262871|NCT01782482|20373548|P2|NOT COMPLETED|Overall Study||10
8262872|NCT01782482|20373549|P1|NOT COMPLETED|Overall Study||10
8262873|NCT01782482|20373548|P2|COMPLETED|Overall Study||270
8262874|NCT01782482|20373549|P1|COMPLETED|Overall Study||271
8262875|NCT01782482|20373548|P2|STARTED|Overall Study||280
8262876|NCT01782482|20373549|P1|STARTED|Overall Study||281
8262877|NCT01782469|20373557|P1|NOT COMPLETED|Overall Study||1
8262878|NCT01782469|20373557|P1|COMPLETED|Overall Study||15
8262879|NCT01782469|20373557|P1|STARTED|Overall Study||16
8262880|NCT01782378|20373567|P2|NOT COMPLETED|Second Series||32
8262881|NCT01782378|20373568|P1|NOT COMPLETED|Second Series||26
8262882|NCT01782378|20373567|P2|COMPLETED|Second Series||0
8262883|NCT01782378|20373568|P1|COMPLETED|Second Series||5
8262884|NCT01782378|20373567|P2|STARTED|Second Series||32
8262885|NCT01782378|20373568|P1|STARTED|Second Series||31
8262886|NCT01782378|20373567|P2|NOT COMPLETED|First Series||8
8262887|NCT01782378|20373568|P1|NOT COMPLETED|First Series||7
8262888|NCT01782378|20373567|P2|COMPLETED|First Series||23
8262889|NCT01782378|20373568|P1|COMPLETED|First Series||25
8262890|NCT01782378|20373567|P2|STARTED|First Series||31
8262891|NCT01782378|20373568|P1|STARTED|First Series||32
8262892|NCT01782326|20373634|P2|NOT COMPLETED|Double-blind Treatment||320
8262893|NCT01782326|20373635|P1|NOT COMPLETED|Double-blind Treatment||278
8262894|NCT01782326|20373634|P2|COMPLETED|Double-blind Treatment||1360
8262895|NCT01782326|20373635|P1|COMPLETED|Double-blind Treatment||1400
8262896|NCT01782326|20373634|P2|STARTED|Double-blind Treatment||1680
8262897|NCT01782326|20373635|P1|STARTED|Double-blind Treatment||1678
8262898|NCT01782326|20373634|P2|NOT COMPLETED|Planned Treatment Epoch||208
8262899|NCT01782326|20373635|P1|NOT COMPLETED|Planned Treatment Epoch||202
8262900|NCT01782326|20373634|P2|COMPLETED|Planned Treatment Epoch||1474
8262901|NCT01782326|20373635|P1|COMPLETED|Planned Treatment Epoch||1478
8262902|NCT01782326|20373634|P2|Urine Cortisol Set|Planned Treatment Epoch||269
8262903|NCT01782326|20373635|P1|Urine Cortisol Set|Planned Treatment Epoch||266
8262904|NCT01782326|20373634|P2|Safety Set (SAF)|Planned Treatment Epoch||1680
8262905|NCT01782326|20373635|P1|Safety Set (SAF)|Planned Treatment Epoch||1678
8262906|NCT01782326|20373634|P2|Serial Spirometry Set|Planned Treatment Epoch||279
8262907|NCT01782326|20373635|P1|Serial Spirometry Set|Planned Treatment Epoch||280
8262908|NCT01782326|20373634|P2|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
8262909|NCT01782326|20373635|P1|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
8262910|NCT01782326|20373634|P2|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
8262911|NCT01782326|20373635|P1|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
8262912|NCT01782326|20373634|P2|STARTED|Planned Treatment Epoch||1682
8262913|NCT01782326|20373635|P1|STARTED|Planned Treatment Epoch||1680
8262914|NCT01782313|20373695|P1|NOT COMPLETED|Survival Follow up||1
8262915|NCT01782313|20373695|P1|COMPLETED|Survival Follow up||57
8262916|NCT01782313|20373695|P1|STARTED|Survival Follow up||58
8262917|NCT01782313|20373695|P1|NOT COMPLETED|Continued Treatment After 16 Weeks||7
8262918|NCT01782313|20373695|P1|COMPLETED|Continued Treatment After 16 Weeks||18
8262919|NCT01782313|20373695|P1|STARTED|Continued Treatment After 16 Weeks||25
8262920|NCT01782313|20373695|P1|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
8262921|NCT01782313|20373695|P1|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
8262922|NCT01782313|20373695|P1|STARTED|Treated Cycle 4/Reached 16 Week Response||31
8262923|NCT01782313|20373695|P1|NOT COMPLETED|Treated Cycle 3||21
8262924|NCT01782313|20373695|P1|COMPLETED|Treated Cycle 3||31
8262925|NCT01782313|20373695|P1|STARTED|Treated Cycle 3||52
8262926|NCT01782313|20373695|P1|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
8262927|NCT01782313|20373695|P1|COMPLETED|Reached First Response/Completed 2 Cycle||52
8262928|NCT01782313|20373695|P1|STARTED|Reached First Response/Completed 2 Cycle||58
8262929|NCT01782222|20373709|P3|NOT COMPLETED|Overall Study||4
8262930|NCT01782222|20373710|P2|NOT COMPLETED|Overall Study||11
8262931|NCT01782222|20373711|P1|NOT COMPLETED|Overall Study||8
8262932|NCT01782222|20373709|P3|COMPLETED|Overall Study||37
8262933|NCT01782222|20373710|P2|COMPLETED|Overall Study||30
8262934|NCT01782222|20373711|P1|COMPLETED|Overall Study||32
8262935|NCT01782222|20373709|P3|STARTED|Overall Study||41
8262936|NCT01782222|20373710|P2|STARTED|Overall Study||41
8262937|NCT01782222|20373711|P1|STARTED|Overall Study||40
8262938|NCT01782209|20373743|P1|NOT COMPLETED|Overall Study||110
8262939|NCT01782209|20373743|P1|COMPLETED|Overall Study||225
8262940|NCT01782209|20373743|P1|STARTED|Overall Study||335
8262941|NCT01782131|20373749|P2|NOT COMPLETED|Overall Study||115
8262942|NCT01782131|20373750|P1|NOT COMPLETED|Overall Study||109
8262943|NCT01782131|20373749|P2|COMPLETED|Overall Study||177
8262944|NCT01782131|20373750|P1|COMPLETED|Overall Study||184
8262945|NCT01782131|20373749|P2|Treated|Overall Study||287
8262946|NCT01782131|20373750|P1|Treated|Overall Study||288
8262947|NCT01782131|20373749|P2|STARTED|Overall Study||292
8262948|NCT01782131|20373750|P1|STARTED|Overall Study||293
8262949|NCT01781975|20373787|P2|NOT COMPLETED|Overall Study||1
8262950|NCT01781975|20373788|P1|NOT COMPLETED|Overall Study||2
8262951|NCT01781975|20373787|P2|COMPLETED|Overall Study||21
8262952|NCT01781975|20373788|P1|COMPLETED|Overall Study||43
8262953|NCT01781975|20373787|P2|Follow-Up Period|Overall Study||21
8262954|NCT01781975|20373788|P1|Follow-Up Period|Overall Study||43
8262955|NCT01781975|20373787|P2|Treatment Period|Overall Study||22
8262956|NCT01781975|20373788|P1|Treatment Period|Overall Study||44
8262957|NCT01781975|20373787|P2|STARTED|Overall Study||22
8262958|NCT01781975|20373788|P1|STARTED|Overall Study||45
8262959|NCT01781962|20373804|P1|NOT COMPLETED|Overall Study||5
8262960|NCT01781962|20373804|P1|COMPLETED|Overall Study||201
8262961|NCT01781962|20373804|P1|STARTED|Overall Study||206
8262962|NCT01781832|20373810|P1|NOT COMPLETED|Overall Study||1
8262963|NCT01781832|20373810|P1|COMPLETED|Overall Study||25
8262964|NCT01781832|20373810|P1|STARTED|Overall Study||26
8262965|NCT01781806|20373817|P2|NOT COMPLETED|Overall Study||3
8262966|NCT01781806|20373818|P1|NOT COMPLETED|Overall Study||79
8262967|NCT01781806|20373817|P2|COMPLETED|Overall Study||1
8262968|NCT01781806|20373818|P1|COMPLETED|Overall Study||218
8262969|NCT01781806|20373817|P2|Week 48|Overall Study||1
8262970|NCT01781806|20373818|P1|Week 48|Overall Study||222
8262971|NCT01781806|20373817|P2|Week 36|Overall Study||1
8262972|NCT01781806|20373818|P1|Week 36|Overall Study||247
8262973|NCT01781806|20373817|P2|Week 24|Overall Study||1
8262974|NCT01781806|20373818|P1|Week 24|Overall Study||260
8262975|NCT01781806|20373817|P2|Week 12|Overall Study||2
8262976|NCT01781806|20373818|P1|Week 12|Overall Study||272
8262977|NCT01781806|20373817|P2|Week 8|Overall Study||4
8262978|NCT01781806|20373818|P1|Week 8|Overall Study||278
8262979|NCT01781806|20373817|P2|Week 4|Overall Study||4
8262980|NCT01781806|20373818|P1|Week 4|Overall Study||284
8262981|NCT01781806|20373817|P2|Week 0|Overall Study||4
8262982|NCT01781806|20373818|P1|Week 0|Overall Study||297
8262983|NCT01781806|20373817|P2|STARTED|Overall Study||4
8262984|NCT01781806|20373818|P1|STARTED|Overall Study||297
8262985|NCT01781637|20373830|P2|NOT COMPLETED|Overall Study||6
8262986|NCT01781637|20373831|P1|NOT COMPLETED|Overall Study||4
8262987|NCT01781637|20373830|P2|COMPLETED|Overall Study||2
8262988|NCT01781637|20373831|P1|COMPLETED|Overall Study||24
8262989|NCT01781637|20373830|P2|STARTED|Overall Study||8
8262990|NCT01781637|20373831|P1|STARTED|Overall Study||28
8262991|NCT01781611|20373841|P2|NOT COMPLETED|Overall Study||0
8262992|NCT01781611|20373842|P1|NOT COMPLETED|Overall Study||4
8262993|NCT01781611|20373841|P2|COMPLETED|Overall Study||5
8262994|NCT01781611|20373842|P1|COMPLETED|Overall Study||9
8262995|NCT01781611|20373841|P2|STARTED|Overall Study||5
8262996|NCT01781611|20373842|P1|STARTED|Overall Study||13
8262997|NCT01781572|20373863|P3|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
8262998|NCT01781572|20373864|P2|NOT COMPLETED|MEK162 45mg LEE011 600mg||6
8262999|NCT01781572|20373865|P1|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
8263000|NCT01781572|20373863|P3|COMPLETED|MEK162 45mg LEE011 600mg||0
8263001|NCT01781572|20373864|P2|COMPLETED|MEK162 45mg LEE011 600mg||0
8263002|NCT01781572|20373865|P1|COMPLETED|MEK162 45mg LEE011 600mg||0
8263003|NCT01781572|20373863|P3|STARTED|MEK162 45mg LEE011 600mg||0
8263004|NCT01781572|20373864|P2|STARTED|MEK162 45mg LEE011 600mg||6
8263005|NCT01781572|20373865|P1|STARTED|MEK162 45mg LEE011 600mg||0
8263006|NCT01781572|20373863|P3|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
8263007|NCT01781572|20373864|P2|NOT COMPLETED|MEK162 45mg LEE011 450mg||9
8263008|NCT01781572|20373865|P1|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
8263009|NCT01781572|20373863|P3|COMPLETED|MEK162 45mg LEE011 450mg||0
8263010|NCT01781572|20373864|P2|COMPLETED|MEK162 45mg LEE011 450mg||0
8263011|NCT01781572|20373865|P1|COMPLETED|MEK162 45mg LEE011 450mg||0
8263012|NCT01781572|20373863|P3|STARTED|MEK162 45mg LEE011 450mg||0
8263013|NCT01781572|20373864|P2|STARTED|MEK162 45mg LEE011 450mg||9
8263014|NCT01781572|20373865|P1|STARTED|MEK162 45mg LEE011 450mg||0
8263015|NCT01781572|20373863|P3|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
8263016|NCT01781572|20373864|P2|NOT COMPLETED|MEK162 30mg LEE011 200mg||5
8263017|NCT01781572|20373865|P1|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
8263018|NCT01781572|20373863|P3|COMPLETED|MEK162 30mg LEE011 200mg||0
8263019|NCT01781572|20373864|P2|COMPLETED|MEK162 30mg LEE011 200mg||0
8263020|NCT01781572|20373865|P1|COMPLETED|MEK162 30mg LEE011 200mg||0
8263021|NCT01781572|20373863|P3|STARTED|MEK162 30mg LEE011 200mg||0
8263022|NCT01781572|20373864|P2|STARTED|MEK162 30mg LEE011 200mg||5
8263023|NCT01781572|20373865|P1|STARTED|MEK162 30mg LEE011 200mg||0
8263024|NCT01781572|20373863|P3|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||0
8263025|NCT01781572|20373864|P2|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||4
8263026|NCT01781572|20373865|P1|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||6
8263027|NCT01781572|20373863|P3|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
8263028|NCT01781572|20373864|P2|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
8263029|NCT01781572|20373865|P1|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
8263030|NCT01781572|20373863|P3|STARTED|MEK162 45mg BID+LEE011 300mg||0
8263031|NCT01781572|20373864|P2|STARTED|MEK162 45mg BID+LEE011 300mg||4
8263032|NCT01781572|20373865|P1|STARTED|MEK162 45mg BID+LEE011 300mg||6
8263033|NCT01781572|20373863|P3|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||0
8263034|NCT01781572|20373864|P2|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||2
8263035|NCT01781572|20373865|P1|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||4
8263036|NCT01781572|20373863|P3|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
8263037|NCT01781572|20373864|P2|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
8263038|NCT01781572|20373865|P1|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
8263039|NCT01781572|20373863|P3|STARTED|MEK162 30mg BID+LEE011 300mg||0
8263040|NCT01781572|20373864|P2|STARTED|MEK162 30mg BID+LEE011 300mg||2
8263041|NCT01781572|20373865|P1|STARTED|MEK162 30mg BID+LEE011 300mg||4
8263042|NCT01781572|20373863|P3|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8263043|NCT01781572|20373864|P2|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8263044|NCT01781572|20373865|P1|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||3
8263045|NCT01781572|20373863|P3|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8263046|NCT01781572|20373864|P2|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8263047|NCT01781572|20373865|P1|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
8263048|NCT01781572|20373863|P3|STARTED|MEK162 45mg BID+LEE011 250mg||0
8263049|NCT01781572|20373864|P2|STARTED|MEK162 45mg BID+LEE011 250mg||0
8263050|NCT01781572|20373865|P1|STARTED|MEK162 45mg BID+LEE011 250mg||3
8263051|NCT01781572|20373863|P3|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||41
8263052|NCT01781572|20373864|P2|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||6
8263053|NCT01781572|20373865|P1|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||16
8263054|NCT01781572|20373863|P3|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
8263055|NCT01781572|20373864|P2|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
8263056|NCT01781572|20373865|P1|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
8263057|NCT01781572|20373863|P3|STARTED|MEK162 45mg BID+LEE011 200mg||41
8263058|NCT01781572|20373864|P2|STARTED|MEK162 45mg BID+LEE011 200mg||6
8263059|NCT01781572|20373865|P1|STARTED|MEK162 45mg BID+LEE011 200mg||16
8263060|NCT01781481|20374107|P1|NOT COMPLETED|Overall Study||0
8263061|NCT01781481|20374107|P1|COMPLETED|Overall Study||148
8263062|NCT01781481|20374107|P1|STARTED|Overall Study||148
8263063|NCT01781468|20374169|P3|NOT COMPLETED|Overall Study||12
8263064|NCT01781468|20374170|P2|NOT COMPLETED|Overall Study||13
8263065|NCT01781468|20374171|P1|NOT COMPLETED|Overall Study||6
8263066|NCT01781468|20374169|P3|COMPLETED|Overall Study||97
8263067|NCT01781468|20374170|P2|COMPLETED|Overall Study||97
8263068|NCT01781468|20374171|P1|COMPLETED|Overall Study||103
8263069|NCT01781468|20374169|P3|STARTED|Overall Study||109
8263070|NCT01781468|20374170|P2|STARTED|Overall Study||110
8263071|NCT01781468|20374171|P1|STARTED|Overall Study||109
8263072|NCT01781429|20374206|P16|NOT COMPLETED|Overall Study||0
8263073|NCT01781429|20374207|P15|NOT COMPLETED|Overall Study||16
8263074|NCT01781429|20374208|P14|NOT COMPLETED|Overall Study||8
8263075|NCT01781429|20374209|P13|NOT COMPLETED|Overall Study||22
8263076|NCT01781429|20374210|P12|NOT COMPLETED|Overall Study||21
8263077|NCT01781429|20374211|P11|NOT COMPLETED|Overall Study||18
8263078|NCT01781429|20374212|P10|NOT COMPLETED|Overall Study||24
8263079|NCT01781429|20374213|P9|NOT COMPLETED|Overall Study||7
8263080|NCT01781429|20374214|P8|NOT COMPLETED|Overall Study||4
8263081|NCT01781429|20374215|P7|NOT COMPLETED|Overall Study||7
8263082|NCT01781429|20374216|P6|NOT COMPLETED|Overall Study||4
8263083|NCT01781429|20374217|P5|NOT COMPLETED|Overall Study||1
8263084|NCT01781429|20374218|P4|NOT COMPLETED|Overall Study||1
8263085|NCT01781429|20374219|P3|NOT COMPLETED|Overall Study||1
8263086|NCT01781429|20374220|P2|NOT COMPLETED|Overall Study||1
8263087|NCT01781429|20374221|P1|NOT COMPLETED|Overall Study||1
8263088|NCT01781429|20374206|P16|COMPLETED|Overall Study||0
8263089|NCT01781429|20374207|P15|COMPLETED|Overall Study||0
8263090|NCT01781429|20374208|P14|COMPLETED|Overall Study||0
8263091|NCT01781429|20374209|P13|COMPLETED|Overall Study||0
8263092|NCT01781429|20374210|P12|COMPLETED|Overall Study||0
8263093|NCT01781429|20374211|P11|COMPLETED|Overall Study||0
8263094|NCT01781429|20374212|P10|COMPLETED|Overall Study||0
8263095|NCT01781429|20374213|P9|COMPLETED|Overall Study||0
8263096|NCT01781429|20374214|P8|COMPLETED|Overall Study||0
8263097|NCT01781429|20374215|P7|COMPLETED|Overall Study||0
8263098|NCT01781429|20374216|P6|COMPLETED|Overall Study||0
8263099|NCT01781429|20374217|P5|COMPLETED|Overall Study||0
8263100|NCT01781429|20374218|P4|COMPLETED|Overall Study||0
8263101|NCT01781429|20374219|P3|COMPLETED|Overall Study||0
8263102|NCT01781429|20374220|P2|COMPLETED|Overall Study||0
8263103|NCT01781429|20374221|P1|COMPLETED|Overall Study||0
8263104|NCT01781429|20374206|P16|STARTED|Overall Study||0
8263105|NCT01781429|20374207|P15|STARTED|Overall Study||16
8263106|NCT01781429|20374208|P14|STARTED|Overall Study||8
8263107|NCT01781429|20374209|P13|STARTED|Overall Study||22
8263108|NCT01781429|20374210|P12|STARTED|Overall Study||21
8263109|NCT01781429|20374211|P11|STARTED|Overall Study||18
8263110|NCT01781429|20374212|P10|STARTED|Overall Study||24
8263111|NCT01781429|20374213|P9|STARTED|Overall Study||7
8263112|NCT01781429|20374214|P8|STARTED|Overall Study||4
8263113|NCT01781429|20374215|P7|STARTED|Overall Study||7
8263114|NCT01781429|20374216|P6|STARTED|Overall Study||4
8263115|NCT01781429|20374217|P5|STARTED|Overall Study||1
8263116|NCT01781429|20374218|P4|STARTED|Overall Study||1
8263117|NCT01781429|20374219|P3|STARTED|Overall Study||1
8263118|NCT01781429|20374220|P2|STARTED|Overall Study||1
8263119|NCT01781429|20374221|P1|STARTED|Overall Study||1
8263129|NCT01781299|20374298|P2|NOT COMPLETED|Overall Study||1
8263130|NCT01781299|20374299|P1|NOT COMPLETED|Overall Study||0
8263131|NCT01781299|20374298|P2|COMPLETED|Overall Study||4
8263132|NCT01781299|20374299|P1|COMPLETED|Overall Study||4
8263133|NCT01781299|20374298|P2|STARTED|Overall Study||5
8263134|NCT01781299|20374299|P1|STARTED|Overall Study||4
8263135|NCT01781286|20374307|P6|NOT COMPLETED|Overall Study||1
8263136|NCT01781286|20374308|P5|NOT COMPLETED|Overall Study||0
8263137|NCT01781286|20374309|P4|NOT COMPLETED|Overall Study||1
8263138|NCT01781286|20374310|P3|NOT COMPLETED|Overall Study||2
8263139|NCT01781286|20374311|P2|NOT COMPLETED|Overall Study||0
8263140|NCT01781286|20374312|P1|NOT COMPLETED|Overall Study||2
8263141|NCT01781286|20374307|P6|COMPLETED|Overall Study||2
8263142|NCT01781286|20374308|P5|COMPLETED|Overall Study||6
8263143|NCT01781286|20374309|P4|COMPLETED|Overall Study||7
8263144|NCT01781286|20374310|P3|COMPLETED|Overall Study||7
8263145|NCT01781286|20374311|P2|COMPLETED|Overall Study||4
8263146|NCT01781286|20374312|P1|COMPLETED|Overall Study||5
8263147|NCT01781286|20374307|P6|Started 3rd Intervention|Overall Study||2
8263148|NCT01781286|20374308|P5|Started 3rd Intervention|Overall Study||6
8263149|NCT01781286|20374309|P4|Started 3rd Intervention|Overall Study||7
8263150|NCT01781286|20374310|P3|Started 3rd Intervention|Overall Study||7
8263151|NCT01781286|20374311|P2|Started 3rd Intervention|Overall Study||4
8263152|NCT01781286|20374312|P1|Started 3rd Intervention|Overall Study||5
8263153|NCT01781286|20374307|P6|Started 2nd Intervention|Overall Study||2
8263154|NCT01781286|20374308|P5|Started 2nd Intervention|Overall Study||6
8263155|NCT01781286|20374309|P4|Started 2nd Intervention|Overall Study||8
8263156|NCT01781286|20374310|P3|Started 2nd Intervention|Overall Study||9
8263157|NCT01781286|20374311|P2|Started 2nd Intervention|Overall Study||4
8263158|NCT01781286|20374312|P1|Started 2nd Intervention|Overall Study||5
8263159|NCT01781286|20374307|P6|Started 1st Intervention|Overall Study||2
8263160|NCT01781286|20374308|P5|Started 1st Intervention|Overall Study||6
8263161|NCT01781286|20374309|P4|Started 1st Intervention|Overall Study||8
8263162|NCT01781286|20374310|P3|Started 1st Intervention|Overall Study||9
8263163|NCT01781286|20374311|P2|Started 1st Intervention|Overall Study||4
8263164|NCT01781286|20374312|P1|Started 1st Intervention|Overall Study||6
8263165|NCT01781286|20374307|P6|STARTED|Overall Study||3
8263166|NCT01781286|20374308|P5|STARTED|Overall Study||6
8263167|NCT01781286|20374309|P4|STARTED|Overall Study||8
8263168|NCT01781286|20374310|P3|STARTED|Overall Study||9
8263169|NCT01781286|20374311|P2|STARTED|Overall Study||4
8263170|NCT01781286|20374312|P1|STARTED|Overall Study||7
8263171|NCT01781234|20374337|P2|NOT COMPLETED|Overall Study||3
8263172|NCT01781234|20374338|P1|NOT COMPLETED|Overall Study||9
8263173|NCT01781234|20374337|P2|COMPLETED|Overall Study||21
8263174|NCT01781234|20374338|P1|COMPLETED|Overall Study||18
8263175|NCT01781234|20374337|P2|STARTED|Overall Study||24
8263176|NCT01781234|20374338|P1|STARTED|Overall Study||27
8263177|NCT01781208|20374348|P1|NOT COMPLETED|Overall Study||0
8263178|NCT01781208|20374348|P1|COMPLETED|Overall Study||62
8263179|NCT01781208|20374348|P1|Overall Study|Overall Study||62
8263180|NCT01781208|20374348|P1|STARTED|Overall Study||62
8263181|NCT01781169|20374355|P2|NOT COMPLETED|Overall Study||0
8263182|NCT01781169|20374356|P1|NOT COMPLETED|Overall Study||1
8263183|NCT01781169|20374355|P2|COMPLETED|Overall Study||21
8263184|NCT01781169|20374356|P1|COMPLETED|Overall Study||21
8263185|NCT01781169|20374355|P2|STARTED|Overall Study||21
8263186|NCT01781169|20374356|P1|STARTED|Overall Study||22
8263187|NCT01781078|20374364|P3|NOT COMPLETED|Overall Study||16
8263188|NCT01781078|20374365|P2|NOT COMPLETED|Overall Study||5
8263189|NCT01781078|20374366|P1|NOT COMPLETED|Overall Study||12
8263190|NCT01781078|20374364|P3|COMPLETED|Overall Study||0
8263191|NCT01781078|20374365|P2|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
8263192|NCT01781078|20374366|P1|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
8263193|NCT01781078|20374364|P3|STARTED|Overall Study||16
8263194|NCT01781078|20374365|P2|STARTED|Overall Study|Randomized post implantation|118
8263195|NCT01781078|20374366|P1|STARTED|Overall Study|Randomized post implantation|229
8263196|NCT01781026|20374376|P1|NOT COMPLETED|Overall Study||2
8263197|NCT01781026|20374376|P1|COMPLETED|Overall Study||0
8263198|NCT01781026|20374376|P1|STARTED|Overall Study||2
8263199|NCT01780987|20374382|P2|NOT COMPLETED|Overall Study||6
8263200|NCT01780987|20374383|P1|NOT COMPLETED|Overall Study||3
8263201|NCT01780987|20374382|P2|COMPLETED|Overall Study||34
8263202|NCT01780987|20374383|P1|COMPLETED|Overall Study||37
8263203|NCT01780987|20374382|P2|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
8263204|NCT01780987|20374383|P1|STARTED|Overall Study||40
8263205|NCT01780974|20374401|P2|NOT COMPLETED|Overall Study||3
8263206|NCT01780974|20374402|P1|NOT COMPLETED|Overall Study||2
8263207|NCT01780974|20374401|P2|COMPLETED|Overall Study||18
8263208|NCT01780974|20374402|P1|COMPLETED|Overall Study||19
8263209|NCT01780974|20374401|P2|STARTED|Overall Study||21
8263210|NCT01780974|20374402|P1|STARTED|Overall Study||21
8263211|NCT01780935|20374412|P2|NOT COMPLETED|Overall Study||336
8263212|NCT01780935|20374413|P1|NOT COMPLETED|Overall Study||335
8263213|NCT01780935|20374412|P2|COMPLETED|Overall Study||0
8263214|NCT01780935|20374413|P1|COMPLETED|Overall Study||0
8263215|NCT01780935|20374412|P2|Safety Set|Overall Study||336
8263216|NCT01780935|20374413|P1|Safety Set|Overall Study||334
8263217|NCT01780935|20374412|P2|STARTED|Overall Study||336
8263218|NCT01780935|20374413|P1|STARTED|Overall Study||335
8263219|NCT01780922|20374443|P6|NOT COMPLETED|Third Intervention (1 Day)||0
8263220|NCT01780922|20374444|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8263221|NCT01780922|20374445|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8263222|NCT01780922|20374446|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8263223|NCT01780922|20374447|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8263224|NCT01780922|20374448|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8263225|NCT01780922|20374443|P6|COMPLETED|Third Intervention (1 Day)||2
8263226|NCT01780922|20374444|P5|COMPLETED|Third Intervention (1 Day)||2
8263227|NCT01780922|20374445|P4|COMPLETED|Third Intervention (1 Day)||2
8263228|NCT01780922|20374446|P3|COMPLETED|Third Intervention (1 Day)||2
8263229|NCT01780922|20374447|P2|COMPLETED|Third Intervention (1 Day)||2
8263230|NCT01780922|20374448|P1|COMPLETED|Third Intervention (1 Day)||2
8263231|NCT01780922|20374443|P6|STARTED|Third Intervention (1 Day)||2
8263232|NCT01780922|20374444|P5|STARTED|Third Intervention (1 Day)||2
8263233|NCT01780922|20374445|P4|STARTED|Third Intervention (1 Day)||2
8263234|NCT01780922|20374446|P3|STARTED|Third Intervention (1 Day)||2
8263235|NCT01780922|20374447|P2|STARTED|Third Intervention (1 Day)||2
8263236|NCT01780922|20374448|P1|STARTED|Third Intervention (1 Day)||2
8263237|NCT01780922|20374443|P6|NOT COMPLETED|Washout (7 Days)||0
8263238|NCT01780922|20374444|P5|NOT COMPLETED|Washout (7 Days)||0
8263239|NCT01780922|20374445|P4|NOT COMPLETED|Washout (7 Days)||0
8263240|NCT01780922|20374446|P3|NOT COMPLETED|Washout (7 Days)||0
8263241|NCT01780922|20374447|P2|NOT COMPLETED|Washout (7 Days)||0
8263242|NCT01780922|20374448|P1|NOT COMPLETED|Washout (7 Days)||0
8263243|NCT01780922|20374443|P6|COMPLETED|Washout (7 Days)||2
8263244|NCT01780922|20374444|P5|COMPLETED|Washout (7 Days)||2
8263245|NCT01780922|20374445|P4|COMPLETED|Washout (7 Days)||2
8263246|NCT01780922|20374446|P3|COMPLETED|Washout (7 Days)||2
8263247|NCT01780922|20374447|P2|COMPLETED|Washout (7 Days)||2
8263248|NCT01780922|20374448|P1|COMPLETED|Washout (7 Days)||2
8263249|NCT01780922|20374443|P6|STARTED|Washout (7 Days)||2
8263250|NCT01780922|20374444|P5|STARTED|Washout (7 Days)||2
8263251|NCT01780922|20374445|P4|STARTED|Washout (7 Days)||2
8263252|NCT01780922|20374446|P3|STARTED|Washout (7 Days)||2
8263253|NCT01780922|20374447|P2|STARTED|Washout (7 Days)||2
8263254|NCT01780922|20374448|P1|STARTED|Washout (7 Days)||2
8263255|NCT01780922|20374443|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8263256|NCT01780922|20374444|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8263257|NCT01780922|20374445|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8263258|NCT01780922|20374446|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8263259|NCT01780922|20374447|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8263260|NCT01780922|20374448|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8263261|NCT01780922|20374443|P6|COMPLETED|Second Intervention (1 Day)||2
8263262|NCT01780922|20374444|P5|COMPLETED|Second Intervention (1 Day)||2
8263263|NCT01780922|20374445|P4|COMPLETED|Second Intervention (1 Day)||2
8263264|NCT01780922|20374446|P3|COMPLETED|Second Intervention (1 Day)||2
8263265|NCT01780922|20374447|P2|COMPLETED|Second Intervention (1 Day)||2
8263266|NCT01780922|20374448|P1|COMPLETED|Second Intervention (1 Day)||2
8263267|NCT01780922|20374443|P6|STARTED|Second Intervention (1 Day)||2
8263268|NCT01780922|20374444|P5|STARTED|Second Intervention (1 Day)||2
8263269|NCT01780922|20374445|P4|STARTED|Second Intervention (1 Day)||2
8263270|NCT01780922|20374446|P3|STARTED|Second Intervention (1 Day)||2
8263271|NCT01780922|20374447|P2|STARTED|Second Intervention (1 Day)||2
8263272|NCT01780922|20374448|P1|STARTED|Second Intervention (1 Day)||2
8263273|NCT01780922|20374443|P6|NOT COMPLETED|Washout (7 Days)||0
8263274|NCT01780922|20374444|P5|NOT COMPLETED|Washout (7 Days)||0
8263275|NCT01780922|20374445|P4|NOT COMPLETED|Washout (7 Days)||0
8263276|NCT01780922|20374446|P3|NOT COMPLETED|Washout (7 Days)||0
8263277|NCT01780922|20374447|P2|NOT COMPLETED|Washout (7 Days)||0
8263278|NCT01780922|20374448|P1|NOT COMPLETED|Washout (7 Days)||0
8263279|NCT01780922|20374443|P6|COMPLETED|Washout (7 Days)||2
8263280|NCT01780922|20374444|P5|COMPLETED|Washout (7 Days)||2
8263281|NCT01780922|20374445|P4|COMPLETED|Washout (7 Days)||2
8263282|NCT01780922|20374446|P3|COMPLETED|Washout (7 Days)||2
8263283|NCT01780922|20374447|P2|COMPLETED|Washout (7 Days)||2
8263284|NCT01780922|20374448|P1|COMPLETED|Washout (7 Days)||2
8263285|NCT01780922|20374443|P6|STARTED|Washout (7 Days)||2
8263286|NCT01780922|20374444|P5|STARTED|Washout (7 Days)||2
8263287|NCT01780922|20374445|P4|STARTED|Washout (7 Days)||2
8263288|NCT01780922|20374446|P3|STARTED|Washout (7 Days)||2
8263289|NCT01780922|20374447|P2|STARTED|Washout (7 Days)||2
8263290|NCT01780922|20374448|P1|STARTED|Washout (7 Days)||2
8263291|NCT01780922|20374443|P6|NOT COMPLETED|First Intervention (1 Day)||0
8263292|NCT01780922|20374444|P5|NOT COMPLETED|First Intervention (1 Day)||0
8263293|NCT01780922|20374445|P4|NOT COMPLETED|First Intervention (1 Day)||0
8263294|NCT01780922|20374446|P3|NOT COMPLETED|First Intervention (1 Day)||0
8263295|NCT01780922|20374447|P2|NOT COMPLETED|First Intervention (1 Day)||0
8263296|NCT01780922|20374448|P1|NOT COMPLETED|First Intervention (1 Day)||0
8263297|NCT01780922|20374443|P6|COMPLETED|First Intervention (1 Day)||2
8263298|NCT01780922|20374444|P5|COMPLETED|First Intervention (1 Day)||2
8263299|NCT01780922|20374445|P4|COMPLETED|First Intervention (1 Day)||2
8263300|NCT01780922|20374446|P3|COMPLETED|First Intervention (1 Day)||2
8263301|NCT01780922|20374447|P2|COMPLETED|First Intervention (1 Day)||2
8263302|NCT01780922|20374448|P1|COMPLETED|First Intervention (1 Day)||2
8263303|NCT01780922|20374443|P6|STARTED|First Intervention (1 Day)||2
8263304|NCT01780922|20374444|P5|STARTED|First Intervention (1 Day)||2
8263305|NCT01780922|20374445|P4|STARTED|First Intervention (1 Day)||2
8263306|NCT01780922|20374446|P3|STARTED|First Intervention (1 Day)||2
8263307|NCT01780922|20374447|P2|STARTED|First Intervention (1 Day)||2
8263308|NCT01780922|20374448|P1|STARTED|First Intervention (1 Day)||2
8263309|NCT01780870|20374503|P2|NOT COMPLETED|Overall Study||0
8263310|NCT01780870|20374504|P1|NOT COMPLETED|Overall Study||0
8263311|NCT01780870|20374503|P2|COMPLETED|Overall Study||5
8263312|NCT01780870|20374504|P1|COMPLETED|Overall Study||0
8263313|NCT01780870|20374503|P2|STARTED|Overall Study||5
8263314|NCT01780870|20374504|P1|STARTED|Overall Study||0
8263315|NCT01780831|20374518|P4|NOT COMPLETED|Overall Study||1
8263316|NCT01780831|20374519|P3|NOT COMPLETED|Overall Study||4
8263317|NCT01780831|20374520|P2|NOT COMPLETED|Overall Study||0
8263318|NCT01780831|20374521|P1|NOT COMPLETED|Overall Study||0
8263319|NCT01780831|20374518|P4|COMPLETED|Overall Study||9
8263320|NCT01780831|20374519|P3|COMPLETED|Overall Study||22
8263321|NCT01780831|20374520|P2|COMPLETED|Overall Study||6
8263322|NCT01780831|20374521|P1|COMPLETED|Overall Study||10
8263323|NCT01780831|20374518|P4|STARTED|Overall Study||10
8263324|NCT01780831|20374519|P3|STARTED|Overall Study||26
8263325|NCT01780831|20374520|P2|STARTED|Overall Study||6
8263326|NCT01780831|20374521|P1|STARTED|Overall Study||10
8263336|NCT01780584|20374608|P3|NOT COMPLETED|Overall Study||2
8263337|NCT01780584|20374609|P2|NOT COMPLETED|Overall Study||1
8263338|NCT01780584|20374610|P1|NOT COMPLETED|Overall Study||1
8263339|NCT01780584|20374608|P3|COMPLETED|Overall Study||13
8263340|NCT01780584|20374609|P2|COMPLETED|Overall Study||14
8263341|NCT01780584|20374610|P1|COMPLETED|Overall Study||14
8263342|NCT01780584|20374608|P3|STARTED|Overall Study||15
8263343|NCT01780584|20374609|P2|STARTED|Overall Study||15
8263344|NCT01780584|20374610|P1|STARTED|Overall Study||15
8263345|NCT01780545|20374632|P2|NOT COMPLETED|Overall Study||2
8263346|NCT01780545|20374633|P1|NOT COMPLETED|Overall Study||4
8263347|NCT01780545|20374632|P2|COMPLETED|Overall Study||99
8263348|NCT01780545|20374633|P1|COMPLETED|Overall Study||95
8263349|NCT01780545|20374632|P2|STARTED|Overall Study||101
8263350|NCT01780545|20374633|P1|STARTED|Overall Study||99
8263351|NCT01780506|20374651|P2|NOT COMPLETED|Open-Label Extension Phase||1
8263352|NCT01780506|20374652|P1|NOT COMPLETED|Open-Label Extension Phase||0
8263353|NCT01780506|20374651|P2|COMPLETED|Open-Label Extension Phase||94
8263354|NCT01780506|20374652|P1|COMPLETED|Open-Label Extension Phase||90
8263355|NCT01780506|20374651|P2|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
8263356|NCT01780506|20374652|P1|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
8263357|NCT01780506|20374651|P2|NOT COMPLETED|Double-Blind Phase||78
8263358|NCT01780506|20374652|P1|NOT COMPLETED|Double-Blind Phase||70
8263359|NCT01780506|20374651|P2|COMPLETED|Double-Blind Phase||356
8263360|NCT01780506|20374652|P1|COMPLETED|Double-Blind Phase||368
8263361|NCT01780506|20374651|P2|STARTED|Double-Blind Phase||434
8263362|NCT01780506|20374652|P1|STARTED|Double-Blind Phase||438
8263366|NCT01780389|20374710|P1|NOT COMPLETED|Overall Study||1
8263367|NCT01780389|20374710|P1|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
8263368|NCT01780389|20374710|P1|STARTED|Overall Study||5
8263369|NCT01780350|20374721|P1|NOT COMPLETED|Overall Study||0
8263370|NCT01780350|20374721|P1|COMPLETED|Overall Study||200
8263371|NCT01780350|20374721|P1|STARTED|Overall Study||200
8263372|NCT01780337|20374728|P2|NOT COMPLETED|Overall Study||0
8263373|NCT01780337|20374729|P1|NOT COMPLETED|Overall Study||0
8263374|NCT01780337|20374728|P2|COMPLETED|Overall Study||6
8263375|NCT01780337|20374729|P1|COMPLETED|Overall Study||6
8263376|NCT01780337|20374728|P2|STARTED|Overall Study||6
8263377|NCT01780337|20374729|P1|STARTED|Overall Study||6
8263378|NCT01780324|20374741|P2|NOT COMPLETED|Overall Study||6
8263379|NCT01780324|20374742|P1|NOT COMPLETED|Overall Study||1
8263380|NCT01780324|20374741|P2|COMPLETED|Overall Study||33
8263381|NCT01780324|20374742|P1|COMPLETED|Overall Study||40
8263382|NCT01780324|20374741|P2|STARTED|Overall Study||39
8263383|NCT01780324|20374742|P1|STARTED|Overall Study||41
8263384|NCT01779869|20374748|P1|NOT COMPLETED|Overall Study||2
8263385|NCT01779869|20374748|P1|COMPLETED|Overall Study||14
8263386|NCT01779869|20374748|P1|STARTED|Overall Study||16
8263387|NCT01779700|20374754|P2|NOT COMPLETED|Overall Study||5
8263388|NCT01779700|20374755|P1|NOT COMPLETED|Overall Study||4
8263389|NCT01779700|20374754|P2|COMPLETED|Overall Study||17
8263390|NCT01779700|20374755|P1|COMPLETED|Overall Study||14
8263391|NCT01779700|20374754|P2|STARTED|Overall Study||22
8263392|NCT01779700|20374755|P1|STARTED|Overall Study||18
8263393|NCT01779648|20374795|P2|NOT COMPLETED|Overall Study||0
8263394|NCT01779648|20374796|P1|NOT COMPLETED|Overall Study||1
8263395|NCT01779648|20374795|P2|COMPLETED|Overall Study||27
8263396|NCT01779648|20374796|P1|COMPLETED|Overall Study||27
8263397|NCT01779648|20374795|P2|STARTED|Overall Study||27
8263398|NCT01779648|20374796|P1|STARTED|Overall Study||28
8263399|NCT01779440|20374826|P2|NOT COMPLETED|Overall Study||5
8263400|NCT01779440|20374827|P1|NOT COMPLETED|Overall Study||3
8263401|NCT01779440|20374826|P2|COMPLETED|Overall Study||23
8263402|NCT01779440|20374827|P1|COMPLETED|Overall Study||27
8263403|NCT01779440|20374826|P2|STARTED|Overall Study||28
8263404|NCT01779440|20374827|P1|STARTED|Overall Study||30
8263405|NCT01779375|20374837|P2|NOT COMPLETED|Overall Study||3
8263406|NCT01779375|20374838|P1|NOT COMPLETED|Overall Study||2
8263407|NCT01779375|20374837|P2|COMPLETED|Overall Study||41
8263408|NCT01779375|20374838|P1|COMPLETED|Overall Study||45
8263409|NCT01779375|20374837|P2|STARTED|Overall Study||44
8263410|NCT01779375|20374838|P1|STARTED|Overall Study||47
8263411|NCT01779219|20374854|P2|NOT COMPLETED|Overall Study||0
8263412|NCT01779219|20374855|P1|NOT COMPLETED|Overall Study||0
8263413|NCT01779219|20374854|P2|COMPLETED|Overall Study|First interim analysis|21
8263414|NCT01779219|20374855|P1|COMPLETED|Overall Study|First interim analysis|21
8263415|NCT01779219|20374854|P2|STARTED|Overall Study|First interim analysis|21
8263416|NCT01779219|20374855|P1|STARTED|Overall Study|First interim analysis|21
8263417|NCT01779167|20374867|P1|NOT COMPLETED|Overall Study||1
8263418|NCT01779167|20374867|P1|COMPLETED|Overall Study||3
8263419|NCT01779167|20374867|P1|STARTED|Overall Study||4
8263420|NCT01779141|20374876|P1|NOT COMPLETED|Overall Study||181
8263421|NCT01779141|20374876|P1|COMPLETED|Overall Study||300
8263422|NCT01779141|20374876|P1|STARTED|Overall Study||481
8263423|NCT01779024|20374883|P2|NOT COMPLETED|2nd Visit - Functional MRI||0
8263424|NCT01779024|20374884|P1|NOT COMPLETED|2nd Visit - Functional MRI||0
8263425|NCT01779024|20374883|P2|COMPLETED|2nd Visit - Functional MRI||6
8263426|NCT01779024|20374884|P1|COMPLETED|2nd Visit - Functional MRI||5
8263427|NCT01779024|20374883|P2|STARTED|2nd Visit - Functional MRI||6
8263428|NCT01779024|20374884|P1|STARTED|2nd Visit - Functional MRI||5
8263429|NCT01779024|20374883|P2|NOT COMPLETED|1st Visit - Functional MRI||2
8263430|NCT01779024|20374884|P1|NOT COMPLETED|1st Visit - Functional MRI||2
8263431|NCT01779024|20374883|P2|COMPLETED|1st Visit - Functional MRI||5
8263432|NCT01779024|20374884|P1|COMPLETED|1st Visit - Functional MRI||4
8263433|NCT01779024|20374883|P2|STARTED|1st Visit - Functional MRI||7
8263434|NCT01779024|20374884|P1|STARTED|1st Visit - Functional MRI||6
8263435|NCT01779024|20374883|P2|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
8263436|NCT01779024|20374884|P1|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
8263437|NCT01779024|20374883|P2|COMPLETED|2nd Visit - Alcohol Self-Administration||9
8263438|NCT01779024|20374884|P1|COMPLETED|2nd Visit - Alcohol Self-Administration||6
8263439|NCT01779024|20374883|P2|STARTED|2nd Visit - Alcohol Self-Administration||9
8263440|NCT01779024|20374884|P1|STARTED|2nd Visit - Alcohol Self-Administration||8
8263441|NCT01779024|20374883|P2|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
8263442|NCT01779024|20374884|P1|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
8263443|NCT01779024|20374883|P2|COMPLETED|1st Visit - Alcohol Self-Administration||9
8263444|NCT01779024|20374884|P1|COMPLETED|1st Visit - Alcohol Self-Administration||8
8263445|NCT01779024|20374883|P2|STARTED|1st Visit - Alcohol Self-Administration||9
8263446|NCT01779024|20374884|P1|STARTED|1st Visit - Alcohol Self-Administration||8
8263447|NCT01778985|20374892|P2|NOT COMPLETED|Overall Study||3
8263448|NCT01778985|20374893|P1|NOT COMPLETED|Overall Study||7
8263449|NCT01778985|20374892|P2|COMPLETED|Overall Study||12
8263450|NCT01778985|20374893|P1|COMPLETED|Overall Study||8
8263451|NCT01778985|20374892|P2|STARTED|Overall Study||15
8263452|NCT01778985|20374893|P1|STARTED|Overall Study||15
8263453|NCT01778855|20374939|P2|NOT COMPLETED|Overall Study||1
8263454|NCT01778855|20374940|P1|NOT COMPLETED|Overall Study||0
8263455|NCT01778855|20374939|P2|COMPLETED|Overall Study||3
8263456|NCT01778855|20374940|P1|COMPLETED|Overall Study||2
8263457|NCT01778855|20374939|P2|STARTED|Overall Study||4
8263458|NCT01778855|20374940|P1|STARTED|Overall Study||2
8263459|NCT01778751|20374948|P2|NOT COMPLETED|Overall Study||2
8263460|NCT01778751|20374949|P1|NOT COMPLETED|Overall Study||2
8263461|NCT01778751|20374948|P2|COMPLETED|Overall Study||23
8263462|NCT01778751|20374949|P1|COMPLETED|Overall Study||23
8263463|NCT01778751|20374948|P2|STARTED|Overall Study||25
8263464|NCT01778751|20374949|P1|STARTED|Overall Study||25
8263465|NCT01778634|20374963|P2|NOT COMPLETED|Overall Study||0
8263466|NCT01778634|20374964|P1|NOT COMPLETED|Overall Study||0
8263467|NCT01778634|20374963|P2|COMPLETED|Overall Study||60
8263468|NCT01778634|20374964|P1|COMPLETED|Overall Study||61
8263469|NCT01778634|20374963|P2|STARTED|Overall Study||60
8263470|NCT01778634|20374964|P1|STARTED|Overall Study||61
8263471|NCT01778556|20375006|P2|NOT COMPLETED|Long-term Follow-up||0
8263472|NCT01778556|20375007|P1|NOT COMPLETED|Long-term Follow-up||1
8263473|NCT01778556|20375006|P2|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
8263474|NCT01778556|20375007|P1|COMPLETED|Long-term Follow-up||14
8263475|NCT01778556|20375006|P2|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
8263476|NCT01778556|20375007|P1|STARTED|Long-term Follow-up||15
8263477|NCT01778556|20375006|P2|NOT COMPLETED|Intervention 2 (14 Days)||0
8263478|NCT01778556|20375007|P1|NOT COMPLETED|Intervention 2 (14 Days)||1
8263479|NCT01778556|20375006|P2|COMPLETED|Intervention 2 (14 Days)||8
8263480|NCT01778556|20375007|P1|COMPLETED|Intervention 2 (14 Days)||14
8263481|NCT01778556|20375006|P2|STARTED|Intervention 2 (14 Days)||8
8263482|NCT01778556|20375007|P1|STARTED|Intervention 2 (14 Days)||15
8263483|NCT01778556|20375006|P2|NOT COMPLETED|Intervention 1 (5 Days)||2
8263484|NCT01778556|20375007|P1|NOT COMPLETED|Intervention 1 (5 Days)||0
8263485|NCT01778556|20375006|P2|COMPLETED|Intervention 1 (5 Days)||8
8263486|NCT01778556|20375007|P1|COMPLETED|Intervention 1 (5 Days)||15
8263487|NCT01778556|20375006|P2|STARTED|Intervention 1 (5 Days)||10
8263488|NCT01778556|20375007|P1|STARTED|Intervention 1 (5 Days)||15
8263489|NCT01778530|20375020|P1|NOT COMPLETED|Overall Study||2
8263490|NCT01778530|20375020|P1|COMPLETED|Overall Study||0
8263491|NCT01778530|20375020|P1|STARTED|Overall Study||2
8263492|NCT01778426|20375027|P2|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
8263493|NCT01778426|20375028|P1|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
8263494|NCT01778426|20375027|P2|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
8263495|NCT01778426|20375028|P1|COMPLETED|Intention-To-Treat (ITT) - Completer||198
8263496|NCT01778426|20375027|P2|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
8263497|NCT01778426|20375028|P1|STARTED|Intention-To-Treat (ITT) - Completer||198
8263498|NCT01778426|20375027|P2|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
8263499|NCT01778426|20375028|P1|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
8263500|NCT01778426|20375027|P2|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
8263501|NCT01778426|20375028|P1|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
8263502|NCT01778426|20375027|P2|STARTED|Overall Study - Full Analysis Set (FAS)||138
8263503|NCT01778426|20375028|P1|STARTED|Overall Study - Full Analysis Set (FAS)||264
8263504|NCT01778296|20375044|P1|NOT COMPLETED|Overall Study||0
8263505|NCT01778296|20375044|P1|COMPLETED|Overall Study|No patient was lost to follow-up.|12
8263506|NCT01778296|20375044|P1|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
8263507|NCT01778179|20375050|P2|NOT COMPLETED|Overall Study||3
8263508|NCT01778179|20375051|P1|NOT COMPLETED|Overall Study||2
8263509|NCT01778179|20375050|P2|COMPLETED|Overall Study||22
8263510|NCT01778179|20375051|P1|COMPLETED|Overall Study||23
8263511|NCT01778179|20375050|P2|STARTED|Overall Study||25
8263512|NCT01778179|20375051|P1|STARTED|Overall Study||25
8263513|NCT01778127|20375062|P3|NOT COMPLETED|Overall Study||6
8263514|NCT01778127|20375063|P2|NOT COMPLETED|Overall Study||2
8263515|NCT01778127|20375064|P1|NOT COMPLETED|Overall Study||8
8263516|NCT01778127|20375062|P3|COMPLETED|Overall Study||26
8263517|NCT01778127|20375063|P2|COMPLETED|Overall Study||31
8263518|NCT01778127|20375064|P1|COMPLETED|Overall Study||25
8263519|NCT01778127|20375062|P3|STARTED|Overall Study||32
8263520|NCT01778127|20375063|P2|STARTED|Overall Study||33
8263521|NCT01778127|20375064|P1|STARTED|Overall Study||33
8263522|NCT01778062|20375107|P2|NOT COMPLETED|Overall Study||11
8263523|NCT01778062|20375108|P1|NOT COMPLETED|Overall Study||6
8263524|NCT01778062|20375107|P2|COMPLETED|Overall Study||57
8263525|NCT01778062|20375108|P1|COMPLETED|Overall Study||62
8263526|NCT01778062|20375107|P2|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
8263527|NCT01778062|20375108|P1|Intent to Treat (ITT)|Overall Study||68
8263528|NCT01778062|20375107|P2|Safety Set|Overall Study||68
8263529|NCT01778062|20375108|P1|Safety Set|Overall Study||68
8263530|NCT01778062|20375107|P2|STARTED|Overall Study||68
8263531|NCT01778062|20375108|P1|STARTED|Overall Study||68
8263532|NCT01778049|20375122|P6|NOT COMPLETED|Double Blind Treatment Period||7
8263533|NCT01778049|20375123|P5|NOT COMPLETED|Double Blind Treatment Period||12
8263534|NCT01778049|20375124|P4|NOT COMPLETED|Double Blind Treatment Period||12
8263535|NCT01778049|20375125|P3|NOT COMPLETED|Double Blind Treatment Period||15
8263536|NCT01778049|20375126|P2|NOT COMPLETED|Double Blind Treatment Period||0
8263537|NCT01778049|20375127|P1|NOT COMPLETED|Double Blind Treatment Period||0
8263538|NCT01778049|20375122|P6|COMPLETED|Double Blind Treatment Period||105
8263539|NCT01778049|20375123|P5|COMPLETED|Double Blind Treatment Period||102
8263540|NCT01778049|20375124|P4|COMPLETED|Double Blind Treatment Period||118
8263541|NCT01778049|20375125|P3|COMPLETED|Double Blind Treatment Period||111
8263542|NCT01778049|20375126|P2|COMPLETED|Double Blind Treatment Period||0
8263543|NCT01778049|20375127|P1|COMPLETED|Double Blind Treatment Period||0
8263544|NCT01778049|20375122|P6|STARTED|Double Blind Treatment Period||112
8263545|NCT01778049|20375123|P5|STARTED|Double Blind Treatment Period||114
8263546|NCT01778049|20375124|P4|STARTED|Double Blind Treatment Period||130
8263547|NCT01778049|20375125|P3|STARTED|Double Blind Treatment Period||126
8263548|NCT01778049|20375126|P2|STARTED|Double Blind Treatment Period||0
8263549|NCT01778049|20375127|P1|STARTED|Double Blind Treatment Period||0
8263550|NCT01778049|20375122|P6|NOT COMPLETED|Open Label Treatment Period||0
8263551|NCT01778049|20375123|P5|NOT COMPLETED|Open Label Treatment Period||0
8263552|NCT01778049|20375124|P4|NOT COMPLETED|Open Label Treatment Period||0
8263553|NCT01778049|20375125|P3|NOT COMPLETED|Open Label Treatment Period||0
8263554|NCT01778049|20375126|P2|NOT COMPLETED|Open Label Treatment Period||129
8263555|NCT01778049|20375127|P1|NOT COMPLETED|Open Label Treatment Period||98
8263556|NCT01778049|20375122|P6|COMPLETED|Open Label Treatment Period||0
8263557|NCT01778049|20375123|P5|COMPLETED|Open Label Treatment Period||0
8263558|NCT01778049|20375124|P4|COMPLETED|Open Label Treatment Period||0
8263559|NCT01778049|20375125|P3|COMPLETED|Open Label Treatment Period||0
8263560|NCT01778049|20375126|P2|COMPLETED|Open Label Treatment Period||226
8263561|NCT01778049|20375127|P1|COMPLETED|Open Label Treatment Period||256
8263562|NCT01778049|20375122|P6|STARTED|Open Label Treatment Period||0
8263563|NCT01778049|20375123|P5|STARTED|Open Label Treatment Period||0
8263564|NCT01778049|20375124|P4|STARTED|Open Label Treatment Period||0
8263565|NCT01778049|20375125|P3|STARTED|Open Label Treatment Period||0
8263566|NCT01778049|20375126|P2|STARTED|Open Label Treatment Period||355
8263567|NCT01778049|20375127|P1|STARTED|Open Label Treatment Period||354
8263568|NCT01778023|20375145|P2|NOT COMPLETED|Overall Study||3
8263569|NCT01778023|20375146|P1|NOT COMPLETED|Overall Study||0
8263570|NCT01778023|20375145|P2|COMPLETED|Overall Study||15
8263571|NCT01778023|20375146|P1|COMPLETED|Overall Study||36
8263572|NCT01778023|20375145|P2|Exposed|Overall Study||15
8263573|NCT01778023|20375146|P1|Exposed|Overall Study||36
8263574|NCT01778023|20375145|P2|STARTED|Overall Study||18
8263575|NCT01778023|20375146|P1|STARTED|Overall Study||36
8263576|NCT01778010|20375163|P1|NOT COMPLETED|Overall Study||5
8263577|NCT01778010|20375163|P1|COMPLETED|Overall Study||8
8263578|NCT01778010|20375163|P1|STARTED|Overall Study||13
8263588|NCT01777945|20375216|P1|NOT COMPLETED|Overall Study||0
8263589|NCT01777945|20375216|P1|COMPLETED|Overall Study||46
8263590|NCT01777945|20375216|P1|Evaluable Participants|Overall Study||45
8263591|NCT01777945|20375216|P1|STARTED|Overall Study||46
8263592|NCT01777932|20375226|P1|NOT COMPLETED|Overall Study||205
8263593|NCT01777932|20375226|P1|COMPLETED|Overall Study||15
8263594|NCT01777932|20375226|P1|STARTED|Overall Study||220
8263595|NCT01777854|20375240|P2|NOT COMPLETED|Overall Study||3
8263596|NCT01777854|20375241|P1|NOT COMPLETED|Overall Study||3
8263597|NCT01777854|20375240|P2|COMPLETED|Overall Study||0
8263598|NCT01777854|20375241|P1|COMPLETED|Overall Study||0
8263599|NCT01777854|20375240|P2|STARTED|Overall Study||3
8263600|NCT01777854|20375241|P1|STARTED|Overall Study||3
8263601|NCT01777776|20375249|P4|NOT COMPLETED|Overall Study||4
8263602|NCT01777776|20375250|P3|NOT COMPLETED|Overall Study||6
8263603|NCT01777776|20375251|P2|NOT COMPLETED|Overall Study||12
8263604|NCT01777776|20375252|P1|NOT COMPLETED|Overall Study||6
8263605|NCT01777776|20375249|P4|COMPLETED|Overall Study||0
8263606|NCT01777776|20375250|P3|COMPLETED|Overall Study||0
8263607|NCT01777776|20375251|P2|COMPLETED|Overall Study||0
8263608|NCT01777776|20375252|P1|COMPLETED|Overall Study||0
8263609|NCT01777776|20375249|P4|STARTED|Overall Study||4
8263610|NCT01777776|20375250|P3|STARTED|Overall Study||6
8263611|NCT01777776|20375251|P2|STARTED|Overall Study||12
8263612|NCT01777776|20375252|P1|STARTED|Overall Study||6
8263613|NCT01777763|20375311|P2|NOT COMPLETED|Overall Study||47
8263614|NCT01777763|20375312|P1|NOT COMPLETED|Overall Study||4
8263615|NCT01777763|20375311|P2|COMPLETED|Overall Study||163
8263616|NCT01777763|20375312|P1|COMPLETED|Overall Study||16
8263617|NCT01777763|20375311|P2|STARTED|Overall Study||210
8263618|NCT01777763|20375312|P1|STARTED|Overall Study||20
8263619|NCT01777620|20375336|P2|NOT COMPLETED|Overall Study||0
8263620|NCT01777620|20375337|P1|NOT COMPLETED|Overall Study||1
8263621|NCT01777620|20375336|P2|COMPLETED|Overall Study||62
8263622|NCT01777620|20375337|P1|COMPLETED|Overall Study||62
8263623|NCT01777620|20375336|P2|STARTED|Overall Study||62
8263624|NCT01777620|20375337|P1|STARTED|Overall Study||63
8263625|NCT01777581|20375363|P2|NOT COMPLETED|Overall Study||2
8263626|NCT01777581|20375364|P1|NOT COMPLETED|Overall Study||3
8263627|NCT01777581|20375363|P2|COMPLETED|Overall Study||3
8263628|NCT01777581|20375364|P1|COMPLETED|Overall Study||5
8263629|NCT01777581|20375363|P2|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
8263630|NCT01777581|20375364|P1|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
8263631|NCT01777568|20375384|P2|NOT COMPLETED|Overall Study||0
8263632|NCT01777568|20375385|P1|NOT COMPLETED|Overall Study||0
8263633|NCT01777568|20375384|P2|COMPLETED|Overall Study||2896
8263634|NCT01777568|20375385|P1|COMPLETED|Overall Study||2853
8263635|NCT01777568|20375384|P2|STARTED|Overall Study||2896
8263636|NCT01777568|20375385|P1|STARTED|Overall Study||2853
8263637|NCT01777542|20375393|P2|NOT COMPLETED|Second Intervention (20 Weeks)||1
8263638|NCT01777542|20375394|P1|NOT COMPLETED|Second Intervention (20 Weeks)||0
8263639|NCT01777542|20375393|P2|COMPLETED|Second Intervention (20 Weeks)||14
8263640|NCT01777542|20375394|P1|COMPLETED|Second Intervention (20 Weeks)||15
8263641|NCT01777542|20375393|P2|STARTED|Second Intervention (20 Weeks)||15
8263642|NCT01777542|20375394|P1|STARTED|Second Intervention (20 Weeks)||15
8263643|NCT01777542|20375393|P2|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
8263644|NCT01777542|20375394|P1|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
8263645|NCT01777542|20375393|P2|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
8263646|NCT01777542|20375394|P1|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
8263647|NCT01777542|20375393|P2|STARTED|Washout Period (28 +/- 2 Weeks)||15
8263648|NCT01777542|20375394|P1|STARTED|Washout Period (28 +/- 2 Weeks)||15
8263649|NCT01777542|20375393|P2|NOT COMPLETED|First Intervention (20 Weeks)||0
8263650|NCT01777542|20375394|P1|NOT COMPLETED|First Intervention (20 Weeks)||0
8263651|NCT01777542|20375393|P2|COMPLETED|First Intervention (20 Weeks)||15
8263652|NCT01777542|20375394|P1|COMPLETED|First Intervention (20 Weeks)||15
8263653|NCT01777542|20375393|P2|STARTED|First Intervention (20 Weeks)||15
8263654|NCT01777542|20375394|P1|STARTED|First Intervention (20 Weeks)||15
8263655|NCT01777490|20375437|P4|NOT COMPLETED|Overall Study||1
8263656|NCT01777490|20375438|P3|NOT COMPLETED|Overall Study||1
8263657|NCT01777490|20375439|P2|NOT COMPLETED|Overall Study||0
8263658|NCT01777490|20375440|P1|NOT COMPLETED|Overall Study||0
8263659|NCT01777490|20375437|P4|COMPLETED|Overall Study||118
8263660|NCT01777490|20375438|P3|COMPLETED|Overall Study||118
8263661|NCT01777490|20375439|P2|COMPLETED|Overall Study||123
8263662|NCT01777490|20375440|P1|COMPLETED|Overall Study||123
8263663|NCT01777490|20375437|P4|STARTED|Overall Study||119
8263664|NCT01777490|20375438|P3|STARTED|Overall Study||119
8263665|NCT01777490|20375439|P2|STARTED|Overall Study||123
8263666|NCT01777490|20375440|P1|STARTED|Overall Study||123
8263667|NCT01777438|20375458|P2|NOT COMPLETED|Overall Study||0
8263668|NCT01777438|20375459|P1|NOT COMPLETED|Overall Study||0
8263669|NCT01777438|20375458|P2|COMPLETED|Overall Study||82
8263670|NCT01777438|20375459|P1|COMPLETED|Overall Study||352
8263671|NCT01777438|20375458|P2|STARTED|Overall Study||82
8263672|NCT01777438|20375459|P1|STARTED|Overall Study||352
8263673|NCT01777425|20375471|P1|NOT COMPLETED|Overall Study||0
8263674|NCT01777425|20375471|P1|COMPLETED|Overall Study||389
8263675|NCT01777425|20375471|P1|STARTED|Overall Study||389
8263676|NCT01777412|20375477|P1|NOT COMPLETED|Overall Study||0
8263677|NCT01777412|20375477|P1|COMPLETED|Overall Study||10
8263678|NCT01777412|20375477|P1|STARTED|Overall Study||10
8263679|NCT01777334|20375485|P2|NOT COMPLETED|Overall Study||63
8263680|NCT01777334|20375486|P1|NOT COMPLETED|Overall Study||53
8263681|NCT01777334|20375485|P2|COMPLETED|Overall Study||388
8263682|NCT01777334|20375486|P1|COMPLETED|Overall Study||401
8263683|NCT01777334|20375485|P2|STARTED|Overall Study||451
8263684|NCT01777334|20375486|P1|STARTED|Overall Study||454
8263685|NCT01777321|20375496|P2|NOT COMPLETED|Overall Study||1
8263686|NCT01777321|20375497|P1|NOT COMPLETED|Overall Study||0
8263687|NCT01777321|20375496|P2|COMPLETED|Overall Study||29
8263688|NCT01777321|20375497|P1|COMPLETED|Overall Study||30
8263689|NCT01777321|20375496|P2|STARTED|Overall Study||30
8263690|NCT01777321|20375497|P1|STARTED|Overall Study||30
8263691|NCT01777308|20375535|P2|NOT COMPLETED|Overall Study||3
8263692|NCT01777308|20375536|P1|NOT COMPLETED|Overall Study||14
8263693|NCT01777308|20375535|P2|COMPLETED|Overall Study||34
8263694|NCT01777308|20375536|P1|COMPLETED|Overall Study||105
8263695|NCT01777308|20375535|P2|Completed up to Month 73|Overall Study||37
8263696|NCT01777308|20375536|P1|Completed up to Month 73|Overall Study||118
8263697|NCT01777308|20375535|P2|STARTED|Overall Study||37
8263698|NCT01777308|20375536|P1|STARTED|Overall Study||119
8263699|NCT01777295|20375568|P2|NOT COMPLETED|Overall Study||3
8263700|NCT01777295|20375569|P1|NOT COMPLETED|Overall Study||4
8263701|NCT01777295|20375568|P2|COMPLETED|Overall Study||38
8263702|NCT01777295|20375569|P1|COMPLETED|Overall Study||36
8263703|NCT01777295|20375568|P2|STARTED|Overall Study||41
8263704|NCT01777295|20375569|P1|STARTED|Overall Study||40
8263705|NCT01777282|20375776|P5|NOT COMPLETED|Overall Study||7
8263706|NCT01777282|20375777|P4|NOT COMPLETED|Overall Study||2
8263707|NCT01777282|20375778|P3|NOT COMPLETED|Overall Study||6
8263708|NCT01777282|20375779|P2|NOT COMPLETED|Overall Study||4
8263709|NCT01777282|20375780|P1|NOT COMPLETED|Overall Study||11
8263710|NCT01777282|20375776|P5|COMPLETED|Overall Study||54
8263711|NCT01777282|20375777|P4|COMPLETED|Overall Study||59
8263712|NCT01777282|20375778|P3|COMPLETED|Overall Study||59
8263713|NCT01777282|20375779|P2|COMPLETED|Overall Study||63
8263714|NCT01777282|20375780|P1|COMPLETED|Overall Study||109
8263715|NCT01777282|20375776|P5|Completing Follow-up Period|Overall Study||54
8263716|NCT01777282|20375777|P4|Completing Follow-up Period|Overall Study||59
8263717|NCT01777282|20375778|P3|Completing Follow-up Period|Overall Study||59
8263718|NCT01777282|20375779|P2|Completing Follow-up Period|Overall Study||63
8263719|NCT01777282|20375780|P1|Completing Follow-up Period|Overall Study||109
8263720|NCT01777282|20375776|P5|Completing Treatment Period|Overall Study||54
8263721|NCT01777282|20375777|P4|Completing Treatment Period|Overall Study||59
8263722|NCT01777282|20375778|P3|Completing Treatment Period|Overall Study||59
8263723|NCT01777282|20375779|P2|Completing Treatment Period|Overall Study||63
8263724|NCT01777282|20375780|P1|Completing Treatment Period|Overall Study||109
8263725|NCT01777282|20375776|P5|STARTED|Overall Study||61
8263726|NCT01777282|20375777|P4|STARTED|Overall Study||61
8263727|NCT01777282|20375778|P3|STARTED|Overall Study||65
8263728|NCT01777282|20375779|P2|STARTED|Overall Study||67
8263729|NCT01777282|20375780|P1|STARTED|Overall Study||120
8263730|NCT01777269|20375824|P2|NOT COMPLETED|Overall Study||59
8263731|NCT01777269|20375825|P1|NOT COMPLETED|Overall Study||55
8263732|NCT01777269|20375824|P2|COMPLETED|Overall Study||184
8263733|NCT01777269|20375825|P1|COMPLETED|Overall Study||191
8263734|NCT01777269|20375824|P2|STARTED|Overall Study||243
8263735|NCT01777269|20375825|P1|STARTED|Overall Study||246
8263736|NCT01777217|20375853|P2|NOT COMPLETED|Overall Study||0
8263737|NCT01777217|20375854|P1|NOT COMPLETED|Overall Study||0
8263738|NCT01777217|20375853|P2|COMPLETED|Overall Study||4
8263739|NCT01777217|20375854|P1|COMPLETED|Overall Study||4
8263740|NCT01777217|20375853|P2|STARTED|Overall Study||4
8263741|NCT01777217|20375854|P1|STARTED|Overall Study||4
8263742|NCT01777191|20375862|P2|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
8263743|NCT01777191|20375863|P1|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
8263744|NCT01777191|20375862|P2|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
8263745|NCT01777191|20375863|P1|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
8263746|NCT01777191|20375862|P2|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
8263747|NCT01777191|20375863|P1|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
8263748|NCT01777191|20375862|P2|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
8263749|NCT01777191|20375863|P1|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
8263750|NCT01777191|20375862|P2|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
8263751|NCT01777191|20375863|P1|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
8263752|NCT01777191|20375862|P2|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
8263753|NCT01777191|20375863|P1|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
8263760|NCT01777139|20375910|P2|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4
8263761|NCT01777139|20375911|P1|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0
8263762|NCT01777139|20375910|P2|COMPLETED|SFUCP (Up to 1.4 Years)||0
8263763|NCT01777139|20375911|P1|COMPLETED|SFUCP (Up to 1.4 Years)||0
8263764|NCT01777139|20375910|P2|STARTED|SFUCP (Up to 1.4 Years)||4
8263765|NCT01777139|20375911|P1|STARTED|SFUCP (Up to 1.4 Years)||0
8263766|NCT01777139|20375910|P2|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
8263767|NCT01777139|20375911|P1|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30
8263768|NCT01777139|20375910|P2|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
8263769|NCT01777139|20375911|P1|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
8263770|NCT01777139|20375910|P2|STARTED|Primary Reporting Phase (Up to 4 Years)||0
8263771|NCT01777139|20375911|P1|STARTED|Primary Reporting Phase (Up to 4 Years)||30
8263772|NCT01777126|20375952|P2|NOT COMPLETED|Overall Study||0
8263773|NCT01777126|20375953|P1|NOT COMPLETED|Overall Study||0
8263774|NCT01777126|20375952|P2|COMPLETED|Overall Study||46
8263775|NCT01777126|20375953|P1|COMPLETED|Overall Study||48
8263776|NCT01777126|20375952|P2|STARTED|Overall Study||46
8263777|NCT01777126|20375953|P1|STARTED|Overall Study||48
8263793|NCT01776645|20376001|P2|NOT COMPLETED|Overall Study||14
8263794|NCT01776645|20376002|P1|NOT COMPLETED|Overall Study||14
8263795|NCT01776645|20376001|P2|COMPLETED|Overall Study||14
8263796|NCT01776645|20376002|P1|COMPLETED|Overall Study||14
8263797|NCT01776645|20376001|P2|STARTED|Overall Study||28
8263798|NCT01776645|20376002|P1|STARTED|Overall Study||28
8263799|NCT01776632|20376010|P2|NOT COMPLETED|Overall Study||29
8263800|NCT01776632|20376011|P1|NOT COMPLETED|Overall Study||27
8263801|NCT01776632|20376010|P2|COMPLETED|Overall Study||190
8263802|NCT01776632|20376011|P1|COMPLETED|Overall Study||190
8263803|NCT01776632|20376010|P2|STARTED|Overall Study||219
8263804|NCT01776632|20376011|P1|STARTED|Overall Study||217
8263805|NCT01776554|20376025|P2|NOT COMPLETED|Overall Study||23
8263806|NCT01776554|20376026|P1|NOT COMPLETED|Overall Study||17
8263807|NCT01776554|20376025|P2|COMPLETED|Overall Study||307
8263808|NCT01776554|20376026|P1|COMPLETED|Overall Study||315
8263809|NCT01776554|20376025|P2|STARTED|Overall Study||330
8263810|NCT01776554|20376026|P1|STARTED|Overall Study||332
8263811|NCT01776541|20376069|P2|NOT COMPLETED|Overall Study||75
8263812|NCT01776541|20376070|P1|NOT COMPLETED|Overall Study||56
8263813|NCT01776541|20376069|P2|COMPLETED|Overall Study||416
8263814|NCT01776541|20376070|P1|COMPLETED|Overall Study||432
8263815|NCT01776541|20376069|P2|STARTED|Overall Study||491
8263816|NCT01776541|20376070|P1|STARTED|Overall Study||488
8263829|NCT01776268|20376116|P2|NOT COMPLETED|Overall Study||0
8263830|NCT01776268|20376117|P1|NOT COMPLETED|Overall Study||0
8263831|NCT01776268|20376116|P2|COMPLETED|Overall Study||51
8263832|NCT01776268|20376117|P1|COMPLETED|Overall Study||48
8263833|NCT01776268|20376116|P2|STARTED|Overall Study||51
8263834|NCT01776268|20376117|P1|STARTED|Overall Study||48
8263835|NCT01776008|20376125|P1|NOT COMPLETED|Overall Study||2
8263836|NCT01776008|20376125|P1|COMPLETED|Overall Study||14
8263837|NCT01776008|20376125|P1|STARTED|Overall Study||16
8263838|NCT01775995|20376139|P2|NOT COMPLETED|Overall Study||1
8263839|NCT01775995|20376140|P1|NOT COMPLETED|Overall Study||1
8263840|NCT01775995|20376139|P2|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
8263841|NCT01775995|20376140|P1|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
8263842|NCT01775995|20376139|P2|STARTED|Overall Study||14
8263843|NCT01775995|20376140|P1|STARTED|Overall Study||21
8263844|NCT01775930|20376200|P1|NOT COMPLETED|Overall Study||1
8263845|NCT01775930|20376200|P1|COMPLETED|Overall Study||9
8263846|NCT01775930|20376200|P1|STARTED|Overall Study||10
8263847|NCT01775904|20376208|P1|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1
8263848|NCT01775904|20376208|P1|COMPLETED|LY2886721 ODT (Water, Fasting)||24
8263849|NCT01775904|20376208|P1|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24
8263850|NCT01775904|20376208|P1|STARTED|LY2886721 ODT (Water, Fasting)||25
8263851|NCT01775904|20376208|P1|NOT COMPLETED|Third Washout (7 Days)||0
8263852|NCT01775904|20376208|P1|COMPLETED|Third Washout (7 Days)||25
8263853|NCT01775904|20376208|P1|STARTED|Third Washout (7 Days)||25
8263854|NCT01775904|20376208|P1|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0
8263855|NCT01775904|20376208|P1|COMPLETED|LY2886721 ODT (Water, Fed)||25
8263856|NCT01775904|20376208|P1|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25
8263857|NCT01775904|20376208|P1|STARTED|LY2886721 ODT (Water, Fed)||25
8263858|NCT01775904|20376208|P1|NOT COMPLETED|Second Washout (7 Days)||0
8263859|NCT01775904|20376208|P1|COMPLETED|Second Washout (7 Days)||25
8263860|NCT01775904|20376208|P1|STARTED|Second Washout (7 Days)||25
8263861|NCT01775904|20376208|P1|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1
8263862|NCT01775904|20376208|P1|COMPLETED|LY2886721 Capsule (Water, Fasting)||25
8263863|NCT01775904|20376208|P1|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26
8263864|NCT01775904|20376208|P1|STARTED|LY2886721 Capsule (Water, Fasting)||26
8263865|NCT01775904|20376208|P1|NOT COMPLETED|First Washout (7 Days)||0
8263866|NCT01775904|20376208|P1|COMPLETED|First Washout (7 Days)||26
8263867|NCT01775904|20376208|P1|STARTED|First Washout (7 Days)||26
8264114|NCT01775189|20376396|P1|STARTED|Drug Discrimination Phase: Day 2||0
8263868|NCT01775904|20376208|P1|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0
8263869|NCT01775904|20376208|P1|COMPLETED|LY2886721 ODT (no Water, Fasting)||26
8263870|NCT01775904|20376208|P1|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26
8263871|NCT01775904|20376208|P1|STARTED|LY2886721 ODT (no Water, Fasting)||26
8263872|NCT01775865|20376233|P3|NOT COMPLETED|Overall Study||0
8263873|NCT01775865|20376234|P2|NOT COMPLETED|Overall Study||1
8263874|NCT01775865|20376235|P1|NOT COMPLETED|Overall Study||3
8263875|NCT01775865|20376233|P3|COMPLETED|Overall Study||17
8263876|NCT01775865|20376234|P2|COMPLETED|Overall Study||13
8263877|NCT01775865|20376235|P1|COMPLETED|Overall Study||11
8263878|NCT01775865|20376233|P3|STARTED|Overall Study||17
8263879|NCT01775865|20376234|P2|STARTED|Overall Study||14
8263880|NCT01775865|20376235|P1|STARTED|Overall Study||14
8263881|NCT01775852|20376251|P2|NOT COMPLETED|Overall Study||1
8263882|NCT01775852|20376252|P1|NOT COMPLETED|Overall Study||0
8263883|NCT01775852|20376251|P2|COMPLETED|Overall Study||13
8263884|NCT01775852|20376252|P1|COMPLETED|Overall Study||31
8263885|NCT01775852|20376251|P2|STARTED|Overall Study||14
8263886|NCT01775852|20376252|P1|STARTED|Overall Study||31
8263887|NCT01775800|20376266|P2|NOT COMPLETED|Overall Study||0
8263888|NCT01775800|20376267|P1|NOT COMPLETED|Overall Study||0
8263889|NCT01775800|20376266|P2|COMPLETED|Overall Study||8
8263890|NCT01775800|20376267|P1|COMPLETED|Overall Study||8
8263891|NCT01775800|20376266|P2|STARTED|Overall Study||8
8263892|NCT01775800|20376267|P1|STARTED|Overall Study||8
8263893|NCT01775787|20376274|P2|NOT COMPLETED|Second 7-10 Days||2
8263894|NCT01775787|20376275|P1|NOT COMPLETED|Second 7-10 Days||0
8263895|NCT01775787|20376274|P2|COMPLETED|Second 7-10 Days||6
8263896|NCT01775787|20376275|P1|COMPLETED|Second 7-10 Days||12
8263897|NCT01775787|20376274|P2|STARTED|Second 7-10 Days||8
8263898|NCT01775787|20376275|P1|STARTED|Second 7-10 Days||12
8263899|NCT01775787|20376274|P2|NOT COMPLETED|First 7-10 Days||6
8263900|NCT01775787|20376275|P1|NOT COMPLETED|First 7-10 Days||1
8263901|NCT01775787|20376274|P2|COMPLETED|First 7-10 Days||8
8263902|NCT01775787|20376275|P1|COMPLETED|First 7-10 Days||12
8263903|NCT01775787|20376274|P2|STARTED|First 7-10 Days||14
8263904|NCT01775787|20376275|P1|STARTED|First 7-10 Days||13
8263905|NCT01775774|20376286|P3|NOT COMPLETED|Overall Study||0
8263906|NCT01775774|20376287|P2|NOT COMPLETED|Overall Study||0
8263907|NCT01775774|20376288|P1|NOT COMPLETED|Overall Study||0
8263908|NCT01775774|20376286|P3|COMPLETED|Overall Study||3
8263909|NCT01775774|20376287|P2|COMPLETED|Overall Study||3
8263910|NCT01775774|20376288|P1|COMPLETED|Overall Study||3
8263911|NCT01775774|20376286|P3|STARTED|Overall Study||3
8263912|NCT01775774|20376287|P2|STARTED|Overall Study||3
8263913|NCT01775774|20376288|P1|STARTED|Overall Study||3
8263914|NCT01775735|20376316|P2|NOT COMPLETED|Open Label (24 Months)||4
8263915|NCT01775735|20376317|P1|NOT COMPLETED|Open Label (24 Months)||1
8263916|NCT01775735|20376316|P2|COMPLETED|Open Label (24 Months)||3
8263917|NCT01775735|20376317|P1|COMPLETED|Open Label (24 Months)||7
8263918|NCT01775735|20376316|P2|STARTED|Open Label (24 Months)||7
8263919|NCT01775735|20376317|P1|STARTED|Open Label (24 Months)||8
8263920|NCT01775735|20376316|P2|NOT COMPLETED|Intervention (6 Months)||0
8263921|NCT01775735|20376317|P1|NOT COMPLETED|Intervention (6 Months)||0
8263922|NCT01775735|20376316|P2|COMPLETED|Intervention (6 Months)||7
8263923|NCT01775735|20376317|P1|COMPLETED|Intervention (6 Months)||8
8263924|NCT01775735|20376316|P2|STARTED|Intervention (6 Months)||7
8263925|NCT01775735|20376317|P1|STARTED|Intervention (6 Months)||8
8263926|NCT01775722|20376323|P1|NOT COMPLETED|Overall Study||2
8263927|NCT01775722|20376323|P1|COMPLETED|Overall Study||20
8263928|NCT01775722|20376323|P1|STARTED|Overall Study||22
8263929|NCT01775670|20376331|P2|NOT COMPLETED|Overall Study||1
8263930|NCT01775670|20376332|P1|NOT COMPLETED|Overall Study||1
8263931|NCT01775670|20376331|P2|COMPLETED|Overall Study||2
8263932|NCT01775670|20376332|P1|COMPLETED|Overall Study||0
8263933|NCT01775670|20376331|P2|STARTED|Overall Study||3
8263934|NCT01775670|20376332|P1|STARTED|Overall Study||1
8263935|NCT01775553|20376358|P1|NOT COMPLETED|Overall Study||13
8263936|NCT01775553|20376358|P1|COMPLETED|Overall Study||0
8263937|NCT01775553|20376358|P1|STARTED|Overall Study||13
8263938|NCT01775501|20376366|P1|NOT COMPLETED|Overall Study||1
8263939|NCT01775501|20376366|P1|COMPLETED|Overall Study||39
8263940|NCT01775501|20376366|P1|STARTED|Overall Study||40
8263941|NCT01775371|20376377|P2|NOT COMPLETED|Overall Study||0
8263942|NCT01775371|20376378|P1|NOT COMPLETED|Overall Study||0
8263943|NCT01775371|20376377|P2|COMPLETED|Overall Study||330
8263944|NCT01775371|20376378|P1|COMPLETED|Overall Study||306
8263945|NCT01775371|20376377|P2|STARTED|Overall Study||330
8263946|NCT01775371|20376378|P1|STARTED|Overall Study||306
8263947|NCT01775189|20376390|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8263948|NCT01775189|20376391|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8263949|NCT01775189|20376392|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8263950|NCT01775189|20376393|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8263951|NCT01775189|20376394|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8263952|NCT01775189|20376395|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8263953|NCT01775189|20376396|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8263954|NCT01775189|20376390|P7|COMPLETED|Treatment Phase: Fourth Intervention||7
8263955|NCT01775189|20376391|P6|COMPLETED|Treatment Phase: Fourth Intervention||7
8263956|NCT01775189|20376392|P5|COMPLETED|Treatment Phase: Fourth Intervention||8
8263957|NCT01775189|20376393|P4|COMPLETED|Treatment Phase: Fourth Intervention||6
8263958|NCT01775189|20376394|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
8263959|NCT01775189|20376395|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
8263960|NCT01775189|20376396|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
8263961|NCT01775189|20376390|P7|STARTED|Treatment Phase: Fourth Intervention||7
8263962|NCT01775189|20376391|P6|STARTED|Treatment Phase: Fourth Intervention||7
8263963|NCT01775189|20376392|P5|STARTED|Treatment Phase: Fourth Intervention||8
8263964|NCT01775189|20376393|P4|STARTED|Treatment Phase: Fourth Intervention||6
8263965|NCT01775189|20376394|P3|STARTED|Treatment Phase: Fourth Intervention||0
8263966|NCT01775189|20376395|P2|STARTED|Treatment Phase: Fourth Intervention||0
8263967|NCT01775189|20376396|P1|STARTED|Treatment Phase: Fourth Intervention||0
8263968|NCT01775189|20376390|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||1
8263969|NCT01775189|20376391|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8263970|NCT01775189|20376392|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8263971|NCT01775189|20376393|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||1
8263972|NCT01775189|20376394|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8263973|NCT01775189|20376395|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8263974|NCT01775189|20376396|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8263975|NCT01775189|20376390|P7|COMPLETED|Treatment Phase: Washout Period 3||7
8263976|NCT01775189|20376391|P6|COMPLETED|Treatment Phase: Washout Period 3||7
8263977|NCT01775189|20376392|P5|COMPLETED|Treatment Phase: Washout Period 3||8
8263978|NCT01775189|20376393|P4|COMPLETED|Treatment Phase: Washout Period 3||6
8263979|NCT01775189|20376394|P3|COMPLETED|Treatment Phase: Washout Period 3||0
8263980|NCT01775189|20376395|P2|COMPLETED|Treatment Phase: Washout Period 3||0
8263981|NCT01775189|20376396|P1|COMPLETED|Treatment Phase: Washout Period 3||0
8263982|NCT01775189|20376390|P7|STARTED|Treatment Phase: Washout Period 3||8
8263983|NCT01775189|20376391|P6|STARTED|Treatment Phase: Washout Period 3||7
8263984|NCT01775189|20376392|P5|STARTED|Treatment Phase: Washout Period 3||8
8263985|NCT01775189|20376393|P4|STARTED|Treatment Phase: Washout Period 3||7
8263986|NCT01775189|20376394|P3|STARTED|Treatment Phase: Washout Period 3||0
8263987|NCT01775189|20376395|P2|STARTED|Treatment Phase: Washout Period 3||0
8263988|NCT01775189|20376396|P1|STARTED|Treatment Phase: Washout Period 3||0
8263989|NCT01775189|20376390|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
8263990|NCT01775189|20376391|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
8263991|NCT01775189|20376392|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
8263992|NCT01775189|20376393|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
8263993|NCT01775189|20376394|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
8263994|NCT01775189|20376395|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
8263995|NCT01775189|20376396|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
8263996|NCT01775189|20376390|P7|COMPLETED|Treatment Phase: Third Intervention||8
8263997|NCT01775189|20376391|P6|COMPLETED|Treatment Phase: Third Intervention||7
8263998|NCT01775189|20376392|P5|COMPLETED|Treatment Phase: Third Intervention||8
8263999|NCT01775189|20376393|P4|COMPLETED|Treatment Phase: Third Intervention||7
8264000|NCT01775189|20376394|P3|COMPLETED|Treatment Phase: Third Intervention||0
8264001|NCT01775189|20376395|P2|COMPLETED|Treatment Phase: Third Intervention||0
8264002|NCT01775189|20376396|P1|COMPLETED|Treatment Phase: Third Intervention||0
8264003|NCT01775189|20376390|P7|STARTED|Treatment Phase: Third Intervention||8
8264004|NCT01775189|20376391|P6|STARTED|Treatment Phase: Third Intervention||7
8264005|NCT01775189|20376392|P5|STARTED|Treatment Phase: Third Intervention||8
8264006|NCT01775189|20376393|P4|STARTED|Treatment Phase: Third Intervention||7
8264007|NCT01775189|20376394|P3|STARTED|Treatment Phase: Third Intervention||0
8264008|NCT01775189|20376395|P2|STARTED|Treatment Phase: Third Intervention||0
8264009|NCT01775189|20376396|P1|STARTED|Treatment Phase: Third Intervention||0
8264010|NCT01775189|20376390|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8264011|NCT01775189|20376391|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8264012|NCT01775189|20376392|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8264013|NCT01775189|20376393|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||1
8264014|NCT01775189|20376394|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8264015|NCT01775189|20376395|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8264016|NCT01775189|20376396|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8264017|NCT01775189|20376390|P7|COMPLETED|Treatment Phase: Washout Period 2||8
8264018|NCT01775189|20376391|P6|COMPLETED|Treatment Phase: Washout Period 2||7
8264019|NCT01775189|20376392|P5|COMPLETED|Treatment Phase: Washout Period 2||8
8264020|NCT01775189|20376393|P4|COMPLETED|Treatment Phase: Washout Period 2||7
8264021|NCT01775189|20376394|P3|COMPLETED|Treatment Phase: Washout Period 2||0
8264022|NCT01775189|20376395|P2|COMPLETED|Treatment Phase: Washout Period 2||0
8264023|NCT01775189|20376396|P1|COMPLETED|Treatment Phase: Washout Period 2||0
8264024|NCT01775189|20376390|P7|STARTED|Treatment Phase: Washout Period 2||8
8264025|NCT01775189|20376391|P6|STARTED|Treatment Phase: Washout Period 2||7
8264026|NCT01775189|20376392|P5|STARTED|Treatment Phase: Washout Period 2||8
8264027|NCT01775189|20376393|P4|STARTED|Treatment Phase: Washout Period 2||8
8264028|NCT01775189|20376394|P3|STARTED|Treatment Phase: Washout Period 2||0
8264029|NCT01775189|20376395|P2|STARTED|Treatment Phase: Washout Period 2||0
8264030|NCT01775189|20376396|P1|STARTED|Treatment Phase: Washout Period 2||0
8264031|NCT01775189|20376390|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
8264032|NCT01775189|20376391|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
8264033|NCT01775189|20376392|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
8264034|NCT01775189|20376393|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
8264035|NCT01775189|20376394|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
8264036|NCT01775189|20376395|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
8264037|NCT01775189|20376396|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
8264038|NCT01775189|20376390|P7|COMPLETED|Treatment Phase: Second Intervention||8
8264039|NCT01775189|20376391|P6|COMPLETED|Treatment Phase: Second Intervention||7
8264040|NCT01775189|20376392|P5|COMPLETED|Treatment Phase: Second Intervention||8
8264041|NCT01775189|20376393|P4|COMPLETED|Treatment Phase: Second Intervention||8
8264042|NCT01775189|20376394|P3|COMPLETED|Treatment Phase: Second Intervention||0
8264043|NCT01775189|20376395|P2|COMPLETED|Treatment Phase: Second Intervention||0
8264044|NCT01775189|20376396|P1|COMPLETED|Treatment Phase: Second Intervention||0
8264045|NCT01775189|20376390|P7|STARTED|Treatment Phase: Second Intervention||8
8264046|NCT01775189|20376391|P6|STARTED|Treatment Phase: Second Intervention||7
8264047|NCT01775189|20376392|P5|STARTED|Treatment Phase: Second Intervention||8
8264048|NCT01775189|20376393|P4|STARTED|Treatment Phase: Second Intervention||8
8264049|NCT01775189|20376394|P3|STARTED|Treatment Phase: Second Intervention||0
8264050|NCT01775189|20376395|P2|STARTED|Treatment Phase: Second Intervention||0
8264051|NCT01775189|20376396|P1|STARTED|Treatment Phase: Second Intervention||0
8264052|NCT01775189|20376390|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8264053|NCT01775189|20376391|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||1
8264054|NCT01775189|20376392|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8264055|NCT01775189|20376393|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8264056|NCT01775189|20376394|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8264057|NCT01775189|20376395|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8264058|NCT01775189|20376396|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8264059|NCT01775189|20376390|P7|COMPLETED|Treatment Phase: Washout Period 1||8
8264060|NCT01775189|20376391|P6|COMPLETED|Treatment Phase: Washout Period 1||7
8264061|NCT01775189|20376392|P5|COMPLETED|Treatment Phase: Washout Period 1||8
8264062|NCT01775189|20376393|P4|COMPLETED|Treatment Phase: Washout Period 1||8
8264063|NCT01775189|20376394|P3|COMPLETED|Treatment Phase: Washout Period 1||0
8264064|NCT01775189|20376395|P2|COMPLETED|Treatment Phase: Washout Period 1||0
8264065|NCT01775189|20376396|P1|COMPLETED|Treatment Phase: Washout Period 1||0
8264066|NCT01775189|20376390|P7|STARTED|Treatment Phase: Washout Period 1||8
8264067|NCT01775189|20376391|P6|STARTED|Treatment Phase: Washout Period 1||8
8264068|NCT01775189|20376392|P5|STARTED|Treatment Phase: Washout Period 1||8
8264069|NCT01775189|20376393|P4|STARTED|Treatment Phase: Washout Period 1||8
8264070|NCT01775189|20376394|P3|STARTED|Treatment Phase: Washout Period 1||0
8264071|NCT01775189|20376395|P2|STARTED|Treatment Phase: Washout Period 1||0
8264072|NCT01775189|20376396|P1|STARTED|Treatment Phase: Washout Period 1||0
8264073|NCT01775189|20376390|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
8264074|NCT01775189|20376391|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
8264075|NCT01775189|20376392|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
8264076|NCT01775189|20376393|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
8264077|NCT01775189|20376394|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
8264078|NCT01775189|20376395|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
8264079|NCT01775189|20376396|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
8264080|NCT01775189|20376390|P7|COMPLETED|Treatment Phase: First Intervention||8
8264081|NCT01775189|20376391|P6|COMPLETED|Treatment Phase: First Intervention||8
8264082|NCT01775189|20376392|P5|COMPLETED|Treatment Phase: First Intervention||8
8264083|NCT01775189|20376393|P4|COMPLETED|Treatment Phase: First Intervention||8
8264084|NCT01775189|20376394|P3|COMPLETED|Treatment Phase: First Intervention||0
8264085|NCT01775189|20376395|P2|COMPLETED|Treatment Phase: First Intervention||0
8264086|NCT01775189|20376396|P1|COMPLETED|Treatment Phase: First Intervention||0
8264087|NCT01775189|20376390|P7|STARTED|Treatment Phase: First Intervention||8
8264088|NCT01775189|20376391|P6|STARTED|Treatment Phase: First Intervention||8
8264089|NCT01775189|20376392|P5|STARTED|Treatment Phase: First Intervention||8
8264090|NCT01775189|20376393|P4|STARTED|Treatment Phase: First Intervention||8
8264091|NCT01775189|20376394|P3|STARTED|Treatment Phase: First Intervention||0
8264092|NCT01775189|20376395|P2|STARTED|Treatment Phase: First Intervention||0
8264093|NCT01775189|20376396|P1|STARTED|Treatment Phase: First Intervention||0
8264094|NCT01775189|20376390|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8264095|NCT01775189|20376391|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8264096|NCT01775189|20376392|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8264097|NCT01775189|20376393|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8264098|NCT01775189|20376394|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
8264099|NCT01775189|20376395|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
8264100|NCT01775189|20376396|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8264101|NCT01775189|20376390|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
8264102|NCT01775189|20376391|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
8264103|NCT01775189|20376392|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
8264104|NCT01775189|20376393|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
8264105|NCT01775189|20376394|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
8264106|NCT01775189|20376395|P2|COMPLETED|Drug Discrimination Phase: Day 2||16
8264107|NCT01775189|20376396|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
8264108|NCT01775189|20376390|P7|STARTED|Drug Discrimination Phase: Day 2||0
8264109|NCT01775189|20376391|P6|STARTED|Drug Discrimination Phase: Day 2||0
8264110|NCT01775189|20376392|P5|STARTED|Drug Discrimination Phase: Day 2||0
8264111|NCT01775189|20376393|P4|STARTED|Drug Discrimination Phase: Day 2||0
8264112|NCT01775189|20376394|P3|STARTED|Drug Discrimination Phase: Day 2||23
8264113|NCT01775189|20376395|P2|STARTED|Drug Discrimination Phase: Day 2||19
8264115|NCT01775189|20376390|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8264116|NCT01775189|20376391|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8264117|NCT01775189|20376392|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8264118|NCT01775189|20376393|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8264119|NCT01775189|20376394|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8264120|NCT01775189|20376395|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
8264121|NCT01775189|20376396|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8264122|NCT01775189|20376390|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
8264123|NCT01775189|20376391|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
8264124|NCT01775189|20376392|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
8264125|NCT01775189|20376393|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
8264126|NCT01775189|20376394|P3|COMPLETED|Drug Discrimination Phase: Day 1||23
8264127|NCT01775189|20376395|P2|COMPLETED|Drug Discrimination Phase: Day 1||19
8264128|NCT01775189|20376396|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
8264129|NCT01775189|20376390|P7|STARTED|Drug Discrimination Phase: Day 1||0
8264130|NCT01775189|20376391|P6|STARTED|Drug Discrimination Phase: Day 1||0
8264131|NCT01775189|20376392|P5|STARTED|Drug Discrimination Phase: Day 1||0
8264132|NCT01775189|20376393|P4|STARTED|Drug Discrimination Phase: Day 1||0
8264133|NCT01775189|20376394|P3|STARTED|Drug Discrimination Phase: Day 1||23
8264134|NCT01775189|20376395|P2|STARTED|Drug Discrimination Phase: Day 1||22
8264135|NCT01775189|20376396|P1|STARTED|Drug Discrimination Phase: Day 1||0
8264136|NCT01775189|20376390|P7|NOT COMPLETED|Naloxone Challenge Phase||0
8264137|NCT01775189|20376391|P6|NOT COMPLETED|Naloxone Challenge Phase||0
8264138|NCT01775189|20376392|P5|NOT COMPLETED|Naloxone Challenge Phase||0
8264139|NCT01775189|20376393|P4|NOT COMPLETED|Naloxone Challenge Phase||0
8264140|NCT01775189|20376394|P3|NOT COMPLETED|Naloxone Challenge Phase||0
8264141|NCT01775189|20376395|P2|NOT COMPLETED|Naloxone Challenge Phase||0
8264142|NCT01775189|20376396|P1|NOT COMPLETED|Naloxone Challenge Phase||0
8264143|NCT01775189|20376390|P7|COMPLETED|Naloxone Challenge Phase||0
8264144|NCT01775189|20376391|P6|COMPLETED|Naloxone Challenge Phase||0
8264145|NCT01775189|20376392|P5|COMPLETED|Naloxone Challenge Phase||0
8264146|NCT01775189|20376393|P4|COMPLETED|Naloxone Challenge Phase||0
8264147|NCT01775189|20376394|P3|COMPLETED|Naloxone Challenge Phase||0
8264148|NCT01775189|20376395|P2|COMPLETED|Naloxone Challenge Phase||0
8264149|NCT01775189|20376396|P1|COMPLETED|Naloxone Challenge Phase||45
8264150|NCT01775189|20376390|P7|STARTED|Naloxone Challenge Phase||0
8264151|NCT01775189|20376391|P6|STARTED|Naloxone Challenge Phase||0
8264152|NCT01775189|20376392|P5|STARTED|Naloxone Challenge Phase||0
8264153|NCT01775189|20376393|P4|STARTED|Naloxone Challenge Phase||0
8264154|NCT01775189|20376394|P3|STARTED|Naloxone Challenge Phase||0
8264155|NCT01775189|20376395|P2|STARTED|Naloxone Challenge Phase||0
8264156|NCT01775189|20376396|P1|STARTED|Naloxone Challenge Phase||45
8264157|NCT01775137|20376615|P1|NOT COMPLETED|Overall Study||11
8264158|NCT01775137|20376615|P1|COMPLETED|Overall Study||34
8264159|NCT01775137|20376615|P1|STARTED|Overall Study||45
8264160|NCT01775124|20376642|P2|NOT COMPLETED|Extension Period||18
8264161|NCT01775124|20376643|P1|NOT COMPLETED|Extension Period||12
8264162|NCT01775124|20376642|P2|COMPLETED|Extension Period||138
8264163|NCT01775124|20376643|P1|COMPLETED|Extension Period||145
8264164|NCT01775124|20376642|P2|STARTED|Extension Period||156
8264165|NCT01775124|20376643|P1|STARTED|Extension Period||157
8264166|NCT01775124|20376642|P2|NOT COMPLETED|Core Period||10
8264167|NCT01775124|20376643|P1|NOT COMPLETED|Core Period||11
8264168|NCT01775124|20376642|P2|COMPLETED|Core Period||156
8264169|NCT01775124|20376643|P1|COMPLETED|Core Period||157
8264170|NCT01775124|20376642|P2|Safety Set|Core Period||166
8264171|NCT01775124|20376643|P1|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
8264172|NCT01775124|20376642|P2|Per Protocol Set|Core Period||155
8264173|NCT01775124|20376643|P1|Per Protocol Set|Core Period||157
8264174|NCT01775124|20376642|P2|Full Analysis Set|Core Period||166
8264175|NCT01775124|20376643|P1|Full Analysis Set|Core Period||167
8264176|NCT01775124|20376642|P2|STARTED|Core Period||166
8264177|NCT01775124|20376643|P1|STARTED|Core Period||168
8264178|NCT01774981|20376678|P8|NOT COMPLETED|Overall Study||1
8264179|NCT01774981|20376679|P7|NOT COMPLETED|Overall Study||0
8264180|NCT01774981|20376680|P6|NOT COMPLETED|Overall Study||1
8264181|NCT01774981|20376681|P5|NOT COMPLETED|Overall Study||1
8264182|NCT01774981|20376682|P4|NOT COMPLETED|Overall Study||0
8264183|NCT01774981|20376683|P3|NOT COMPLETED|Overall Study||0
8264184|NCT01774981|20376684|P2|NOT COMPLETED|Overall Study||0
8264185|NCT01774981|20376685|P1|NOT COMPLETED|Overall Study||0
8264186|NCT01774981|20376678|P8|COMPLETED|Overall Study||11
8264187|NCT01774981|20376679|P7|COMPLETED|Overall Study||13
8264188|NCT01774981|20376680|P6|COMPLETED|Overall Study||13
8264189|NCT01774981|20376681|P5|COMPLETED|Overall Study||5
8264190|NCT01774981|20376682|P4|COMPLETED|Overall Study||4
8264191|NCT01774981|20376683|P3|COMPLETED|Overall Study||4
8264192|NCT01774981|20376684|P2|COMPLETED|Overall Study||4
8264193|NCT01774981|20376685|P1|COMPLETED|Overall Study||3
8264194|NCT01774981|20376678|P8|Received at Least 1 Dose of Study Drug|Overall Study||12
8264195|NCT01774981|20376679|P7|Received at Least 1 Dose of Study Drug|Overall Study||13
8264196|NCT01774981|20376680|P6|Received at Least 1 Dose of Study Drug|Overall Study||14
8264197|NCT01774981|20376681|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8264198|NCT01774981|20376682|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
8264199|NCT01774981|20376683|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
8264290|NCT01774305|20376938|P2|NOT COMPLETED|Overall Study||0
8264200|NCT01774981|20376684|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
8264201|NCT01774981|20376685|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8264202|NCT01774981|20376678|P8|STARTED|Overall Study||12
8264203|NCT01774981|20376679|P7|STARTED|Overall Study||13
8264204|NCT01774981|20376680|P6|STARTED|Overall Study||14
8264205|NCT01774981|20376681|P5|STARTED|Overall Study||6
8264206|NCT01774981|20376682|P4|STARTED|Overall Study||4
8264207|NCT01774981|20376683|P3|STARTED|Overall Study||4
8264208|NCT01774981|20376684|P2|STARTED|Overall Study||4
8264209|NCT01774981|20376685|P1|STARTED|Overall Study||3
8264210|NCT01774968|20376717|P2|NOT COMPLETED|Overall Study||35
8264211|NCT01774968|20376718|P1|NOT COMPLETED|Overall Study||30
8264212|NCT01774968|20376717|P2|COMPLETED|Overall Study||128
8264213|NCT01774968|20376718|P1|COMPLETED|Overall Study||132
8264214|NCT01774968|20376717|P2|Received at Least 1 Dose of Study Drug|Overall Study||161
8264215|NCT01774968|20376718|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
8264216|NCT01774968|20376717|P2|STARTED|Overall Study||163
8264217|NCT01774968|20376718|P1|STARTED|Overall Study||162
8264218|NCT01774929|20376752|P1|NOT COMPLETED|Overall Study||3
8264219|NCT01774929|20376752|P1|COMPLETED|Overall Study||32
8264220|NCT01774929|20376752|P1|STARTED|Overall Study||35
8264221|NCT01774903|20376758|P1|NOT COMPLETED|Overall Study||11
8264222|NCT01774903|20376758|P1|COMPLETED|Overall Study||34
8264223|NCT01774903|20376758|P1|STARTED|Overall Study||45
8264224|NCT01774851|20376767|P2|NOT COMPLETED|Overall Study||0
8264225|NCT01774851|20376768|P1|NOT COMPLETED|Overall Study||0
8264226|NCT01774851|20376767|P2|COMPLETED|Overall Study||42
8264227|NCT01774851|20376768|P1|COMPLETED|Overall Study||42
8264228|NCT01774851|20376767|P2|STARTED|Overall Study||42
8264229|NCT01774851|20376768|P1|STARTED|Overall Study||42
8264230|NCT01774799|20376778|P4|NOT COMPLETED|Overall Study||0
8264231|NCT01774799|20376779|P3|NOT COMPLETED|Overall Study||0
8264232|NCT01774799|20376780|P2|NOT COMPLETED|Overall Study||1
8264233|NCT01774799|20376781|P1|NOT COMPLETED|Overall Study||1
8264234|NCT01774799|20376778|P4|COMPLETED|Overall Study||190
8264235|NCT01774799|20376779|P3|COMPLETED|Overall Study||212
8264236|NCT01774799|20376780|P2|COMPLETED|Overall Study||189
8264237|NCT01774799|20376781|P1|COMPLETED|Overall Study||211
8264238|NCT01774799|20376778|P4|STARTED|Overall Study||190
8264239|NCT01774799|20376779|P3|STARTED|Overall Study||212
8264240|NCT01774799|20376780|P2|STARTED|Overall Study||190
8264241|NCT01774799|20376781|P1|STARTED|Overall Study||212
8264242|NCT01774786|20376797|P2|NOT COMPLETED|Overall Study||346
8264243|NCT01774786|20376798|P1|NOT COMPLETED|Overall Study||328
8264244|NCT01774786|20376797|P2|COMPLETED|Overall Study||46
8264245|NCT01774786|20376798|P1|COMPLETED|Overall Study||60
8264246|NCT01774786|20376797|P2|Received Placebo (No Pertuzumab)|Overall Study||388
8264247|NCT01774786|20376798|P1|Received Placebo (No Pertuzumab)|Overall Study||0
8264248|NCT01774786|20376797|P2|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
8264249|NCT01774786|20376798|P1|Received at Least One Dose of Pertuzumab|Overall Study||384
8264250|NCT01774786|20376797|P2|Did Not Receive Any Study Treatment|Overall Study|All 3 patients found ineligible for the study after enrollment and before treatment.|3
8264251|NCT01774786|20376798|P1|Did Not Receive Any Study Treatment|Overall Study|2 patients found ineligible after enrollment and 2 patients died before treatment.|4
8264252|NCT01774786|20376797|P2|STARTED|Overall Study||392
8264253|NCT01774786|20376798|P1|STARTED|Overall Study||388
8264254|NCT01774760|20376828|P1|NOT COMPLETED|Overall Study||0
8264255|NCT01774760|20376828|P1|COMPLETED|Overall Study||10
8264256|NCT01774760|20376828|P1|STARTED|Overall Study||10
8264265|NCT01774604|20376879|P2|NOT COMPLETED|Overall Study||0
8264266|NCT01774604|20376880|P1|NOT COMPLETED|Overall Study||0
8264267|NCT01774604|20376879|P2|COMPLETED|Overall Study||226
8264268|NCT01774604|20376880|P1|COMPLETED|Overall Study||223
8264269|NCT01774604|20376879|P2|STARTED|Overall Study||226
8264270|NCT01774604|20376880|P1|STARTED|Overall Study||223
8264271|NCT01774591|20376900|P2|NOT COMPLETED|Overall Study||4
8264272|NCT01774591|20376901|P1|NOT COMPLETED|Overall Study||1
8264273|NCT01774591|20376900|P2|COMPLETED|Overall Study||7
8264274|NCT01774591|20376901|P1|COMPLETED|Overall Study||9
8264275|NCT01774591|20376900|P2|STARTED|Overall Study||11
8264276|NCT01774591|20376901|P1|STARTED|Overall Study||10
8264277|NCT01774370|20376911|P1|NOT COMPLETED|Overall Study||129
8264278|NCT01774370|20376911|P1|COMPLETED|Overall Study||3053
8264279|NCT01774370|20376911|P1|STARTED|Overall Study||3182
8264280|NCT01774344|20376919|P2|NOT COMPLETED|Overall Study||121
8264281|NCT01774344|20376920|P1|NOT COMPLETED|Overall Study||62
8264282|NCT01774344|20376919|P2|COMPLETED|Overall Study||258
8264283|NCT01774344|20376920|P1|COMPLETED|Overall Study||132
8264284|NCT01774344|20376919|P2|Entered Survival FU|Overall Study||291
8264285|NCT01774344|20376920|P1|Entered Survival FU|Overall Study||145
8264286|NCT01774344|20376919|P2|Treated|Overall Study||374
8264287|NCT01774344|20376920|P1|Treated|Overall Study||193
8264288|NCT01774344|20376919|P2|STARTED|Overall Study||379
8264289|NCT01774344|20376920|P1|STARTED|Overall Study||194
8264291|NCT01774305|20376939|P1|NOT COMPLETED|Overall Study||1
8264292|NCT01774305|20376938|P2|COMPLETED|Overall Study||71
8264293|NCT01774305|20376939|P1|COMPLETED|Overall Study||70
8264294|NCT01774305|20376938|P2|STARTED|Overall Study||71
8264295|NCT01774305|20376939|P1|STARTED|Overall Study||71
8264296|NCT01774253|20376947|P1|NOT COMPLETED|Overall Study||9
8264297|NCT01774253|20376947|P1|COMPLETED|Overall Study||0
8264298|NCT01774253|20376947|P1|STARTED|Overall Study||9
8264299|NCT01774149|20376957|P2|NOT COMPLETED|Overall Study||3
8264300|NCT01774149|20376958|P1|NOT COMPLETED|Overall Study||1
8264301|NCT01774149|20376957|P2|COMPLETED|Overall Study||12
8264302|NCT01774149|20376958|P1|COMPLETED|Overall Study||14
8264303|NCT01774149|20376957|P2|STARTED|Overall Study||15
8264304|NCT01774149|20376958|P1|STARTED|Overall Study||15
8264305|NCT01774110|20376966|P1|NOT COMPLETED|Overall Study||7
8264306|NCT01774110|20376966|P1|COMPLETED|Overall Study||5
8264307|NCT01774110|20376966|P1|STARTED|Overall Study||12
8264308|NCT01774097|20376974|P2|NOT COMPLETED|Overall Study||2
8264309|NCT01774097|20376975|P1|NOT COMPLETED|Overall Study||2
8264310|NCT01774097|20376974|P2|COMPLETED|Overall Study||40
8264311|NCT01774097|20376975|P1|COMPLETED|Overall Study||38
8264312|NCT01774097|20376974|P2|STARTED|Overall Study||42
8264313|NCT01774097|20376975|P1|STARTED|Overall Study||40
8264314|NCT01774084|20377005|P2|NOT COMPLETED|Overall Study||0
8264315|NCT01774084|20377006|P1|NOT COMPLETED|Overall Study||1
8264316|NCT01774084|20377005|P2|COMPLETED|Overall Study||12
8264317|NCT01774084|20377006|P1|COMPLETED|Overall Study||10
8264318|NCT01774084|20377005|P2|STARTED|Overall Study||12
8264319|NCT01774084|20377006|P1|STARTED|Overall Study||11
8264320|NCT01774045|20377016|P2|NOT COMPLETED|Overall Study||0
8264321|NCT01774045|20377017|P1|NOT COMPLETED|Overall Study||0
8264322|NCT01774045|20377016|P2|COMPLETED|Overall Study||7
8264323|NCT01774045|20377017|P1|COMPLETED|Overall Study||23
8264324|NCT01774045|20377016|P2|STARTED|Overall Study||7
8264325|NCT01774045|20377017|P1|STARTED|Overall Study||23
8264326|NCT01773993|20377031|P1|NOT COMPLETED|Overall Study||35
8264327|NCT01773993|20377031|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499
8264328|NCT01773993|20377031|P1|STARTED|Overall Study||534
8264329|NCT01773967|20377050|P2|NOT COMPLETED|Overall Study||13
8264330|NCT01773967|20377051|P1|NOT COMPLETED|Overall Study||15
8264331|NCT01773967|20377050|P2|COMPLETED|Overall Study||475
8264332|NCT01773967|20377051|P1|COMPLETED|Overall Study||468
8264333|NCT01773967|20377050|P2|STARTED|Overall Study||488
8264334|NCT01773967|20377051|P1|STARTED|Overall Study||483
8264335|NCT01773954|20377061|P1|NOT COMPLETED|Overall Study||9
8264336|NCT01773954|20377061|P1|COMPLETED|Overall Study||31
8264337|NCT01773954|20377061|P1|STARTED|Overall Study||40
8264338|NCT01773889|20377066|P1|NOT COMPLETED|Overall Study||2
8264339|NCT01773889|20377066|P1|COMPLETED|Overall Study||0
8264340|NCT01773889|20377066|P1|STARTED|Overall Study||2
8264341|NCT01773473|20377072|P2|NOT COMPLETED|Overall Study||19
8264342|NCT01773473|20377073|P1|NOT COMPLETED|Overall Study||16
8264343|NCT01773473|20377072|P2|COMPLETED|Overall Study||177
8264344|NCT01773473|20377073|P1|COMPLETED|Overall Study||191
8264345|NCT01773473|20377072|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
8264346|NCT01773473|20377073|P1|Received at Least 1 Dose of Study Drug|Overall Study||207
8264347|NCT01773473|20377072|P2|STARTED|Overall Study||196
8264348|NCT01773473|20377073|P1|STARTED|Overall Study||207
8264349|NCT01773421|20377095|P7|NOT COMPLETED|Extension Phase||0
8264350|NCT01773421|20377096|P6|NOT COMPLETED|Extension Phase||2
8264351|NCT01773421|20377097|P5|NOT COMPLETED|Extension Phase||3
8264352|NCT01773421|20377098|P4|NOT COMPLETED|Extension Phase||0
8264353|NCT01773421|20377099|P3|NOT COMPLETED|Extension Phase||0
8264354|NCT01773421|20377100|P2|NOT COMPLETED|Extension Phase||0
8264355|NCT01773421|20377101|P1|NOT COMPLETED|Extension Phase||0
8264356|NCT01773421|20377095|P7|COMPLETED|Extension Phase||0
8264357|NCT01773421|20377096|P6|COMPLETED|Extension Phase||1
8264358|NCT01773421|20377097|P5|COMPLETED|Extension Phase||12
8264359|NCT01773421|20377098|P4|COMPLETED|Extension Phase||0
8264360|NCT01773421|20377099|P3|COMPLETED|Extension Phase||0
8264361|NCT01773421|20377100|P2|COMPLETED|Extension Phase||0
8264362|NCT01773421|20377101|P1|COMPLETED|Extension Phase||0
8264363|NCT01773421|20377095|P7|STARTED|Extension Phase||0
8264364|NCT01773421|20377096|P6|STARTED|Extension Phase||3
8264365|NCT01773421|20377097|P5|STARTED|Extension Phase||15
8264366|NCT01773421|20377098|P4|STARTED|Extension Phase||0
8264367|NCT01773421|20377099|P3|STARTED|Extension Phase||0
8264368|NCT01773421|20377100|P2|STARTED|Extension Phase||0
8264369|NCT01773421|20377101|P1|STARTED|Extension Phase||0
8264370|NCT01773421|20377095|P7|NOT COMPLETED|Treatment Phase||0
8264371|NCT01773421|20377096|P6|NOT COMPLETED|Treatment Phase||0
8264372|NCT01773421|20377097|P5|NOT COMPLETED|Treatment Phase||0
8264373|NCT01773421|20377098|P4|NOT COMPLETED|Treatment Phase||2
8264374|NCT01773421|20377099|P3|NOT COMPLETED|Treatment Phase||6
8264375|NCT01773421|20377100|P2|NOT COMPLETED|Treatment Phase||0
8264376|NCT01773421|20377101|P1|NOT COMPLETED|Treatment Phase||0
8264377|NCT01773421|20377095|P7|COMPLETED|Treatment Phase||0
8264378|NCT01773421|20377096|P6|COMPLETED|Treatment Phase||0
8264379|NCT01773421|20377097|P5|COMPLETED|Treatment Phase||0
8264380|NCT01773421|20377098|P4|COMPLETED|Treatment Phase||5
8264381|NCT01773421|20377099|P3|COMPLETED|Treatment Phase||13
8264382|NCT01773421|20377100|P2|COMPLETED|Treatment Phase||8
8264383|NCT01773421|20377101|P1|COMPLETED|Treatment Phase||7
8264384|NCT01773421|20377095|P7|STARTED|Treatment Phase||0
8264385|NCT01773421|20377096|P6|STARTED|Treatment Phase||0
8264386|NCT01773421|20377097|P5|STARTED|Treatment Phase||0
8264387|NCT01773421|20377098|P4|STARTED|Treatment Phase||7
8264388|NCT01773421|20377099|P3|STARTED|Treatment Phase||19
8264389|NCT01773421|20377100|P2|STARTED|Treatment Phase||8
8264390|NCT01773421|20377101|P1|STARTED|Treatment Phase||7
8264391|NCT01773291|20377132|P3|NOT COMPLETED|Overall Study||1
8264392|NCT01773291|20377133|P2|NOT COMPLETED|Overall Study||0
8264393|NCT01773291|20377134|P1|NOT COMPLETED|Overall Study||1
8264394|NCT01773291|20377132|P3|COMPLETED|Overall Study||6
8264395|NCT01773291|20377133|P2|COMPLETED|Overall Study||9
8264396|NCT01773291|20377134|P1|COMPLETED|Overall Study||7
8264397|NCT01773291|20377132|P3|STARTED|Overall Study||7
8264398|NCT01773291|20377133|P2|STARTED|Overall Study||9
8264399|NCT01773291|20377134|P1|STARTED|Overall Study||8
8264400|NCT01773226|20377145|P1|NOT COMPLETED|Overall Study||1
8264401|NCT01773226|20377145|P1|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
8264402|NCT01773226|20377145|P1|STARTED|Overall Study||11
8264403|NCT01773187|20377155|P2|NOT COMPLETED|Overall Study||32
8264404|NCT01773187|20377156|P1|NOT COMPLETED|Overall Study||53
8264405|NCT01773187|20377155|P2|COMPLETED|Overall Study||75
8264406|NCT01773187|20377156|P1|COMPLETED|Overall Study||167
8264407|NCT01773187|20377155|P2|STARTED|Overall Study||107
8264408|NCT01773187|20377156|P1|STARTED|Overall Study||220
8264409|NCT01773135|20377166|P1|NOT COMPLETED|Overall Study||0
8264410|NCT01773135|20377166|P1|COMPLETED|Overall Study||262
8264411|NCT01773135|20377166|P1|STARTED|Overall Study||262
8264412|NCT01773122|20377175|P4|NOT COMPLETED|Overall Study||1
8264413|NCT01773122|20377176|P3|NOT COMPLETED|Overall Study||0
8264414|NCT01773122|20377177|P2|NOT COMPLETED|Overall Study||1
8264415|NCT01773122|20377178|P1|NOT COMPLETED|Overall Study||3
8264416|NCT01773122|20377175|P4|COMPLETED|Overall Study||18
8264417|NCT01773122|20377176|P3|COMPLETED|Overall Study||19
8264418|NCT01773122|20377177|P2|COMPLETED|Overall Study||18
8264419|NCT01773122|20377178|P1|COMPLETED|Overall Study||17
8264420|NCT01773122|20377175|P4|STARTED|Overall Study||19
8264421|NCT01773122|20377176|P3|STARTED|Overall Study||19
8264422|NCT01773122|20377177|P2|STARTED|Overall Study||19
8264423|NCT01773122|20377178|P1|STARTED|Overall Study||20
8264424|NCT01773109|20377192|P1|NOT COMPLETED|Overall Study||3
8264425|NCT01773109|20377192|P1|COMPLETED|Overall Study||37
8264426|NCT01773109|20377192|P1|STARTED|Overall Study||40
8264427|NCT01773070|20377196|P1|NOT COMPLETED|Overall Study||81
8264428|NCT01773070|20377196|P1|COMPLETED|Overall Study||397
8264429|NCT01773070|20377196|P1|STARTED|Overall Study||478
8264430|NCT01772823|20377206|P2|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
8264431|NCT01772823|20377207|P1|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
8264432|NCT01772823|20377206|P2|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
8264433|NCT01772823|20377207|P1|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
8264434|NCT01772823|20377206|P2|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
8264435|NCT01772823|20377207|P1|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
8264436|NCT01772823|20377206|P2|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
8264437|NCT01772823|20377207|P1|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
8264438|NCT01772823|20377206|P2|COMPLETED|Treatment Phase (Week 0- Week 48)||52
8264439|NCT01772823|20377207|P1|COMPLETED|Treatment Phase (Week 0- Week 48)||88
8264440|NCT01772823|20377206|P2|STARTED|Treatment Phase (Week 0- Week 48)||70
8264441|NCT01772823|20377207|P1|STARTED|Treatment Phase (Week 0- Week 48)||116
8264442|NCT01772823|20377206|P2|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
8264443|NCT01772823|20377207|P1|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
8264444|NCT01772823|20377206|P2|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
8264445|NCT01772823|20377207|P1|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
8264446|NCT01772823|20377206|P2|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
8264447|NCT01772823|20377207|P1|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
8264448|NCT01772758|20377307|P4|NOT COMPLETED|Overall Study||0
8264449|NCT01772758|20377308|P3|NOT COMPLETED|Overall Study||0
8264450|NCT01772758|20377309|P2|NOT COMPLETED|Overall Study||0
8264451|NCT01772758|20377310|P1|NOT COMPLETED|Overall Study||0
8264452|NCT01772758|20377307|P4|COMPLETED|Overall Study||17
8264453|NCT01772758|20377308|P3|COMPLETED|Overall Study||12
8264454|NCT01772758|20377309|P2|COMPLETED|Overall Study||17
8264455|NCT01772758|20377310|P1|COMPLETED|Overall Study||18
8264456|NCT01772758|20377307|P4|STARTED|Overall Study||17
8264457|NCT01772758|20377308|P3|STARTED|Overall Study||12
8264458|NCT01772758|20377309|P2|STARTED|Overall Study||17
8264459|NCT01772758|20377310|P1|STARTED|Overall Study||18
8264460|NCT01772719|20377320|P1|NOT COMPLETED|Overall Study||7
8264461|NCT01772719|20377320|P1|COMPLETED|Overall Study||0
8264462|NCT01772719|20377320|P1|STARTED|Overall Study||7
8264463|NCT01772693|20377333|P2|NOT COMPLETED|Overall Study||1
8264464|NCT01772693|20377334|P1|NOT COMPLETED|Overall Study||6
8264465|NCT01772693|20377333|P2|COMPLETED|Overall Study||6
8264466|NCT01772693|20377334|P1|COMPLETED|Overall Study||14
8264467|NCT01772693|20377333|P2|STARTED|Overall Study||7
8264468|NCT01772693|20377334|P1|STARTED|Overall Study||20
8264469|NCT01772654|20377348|P2|NOT COMPLETED|Overall Study||0
8264470|NCT01772654|20377349|P1|NOT COMPLETED|Overall Study||0
8264471|NCT01772654|20377348|P2|COMPLETED|Overall Study||15
8264472|NCT01772654|20377349|P1|COMPLETED|Overall Study||2
8264473|NCT01772654|20377348|P2|STARTED|Overall Study||15
8264474|NCT01772654|20377349|P1|STARTED|Overall Study||2
8264475|NCT01772576|20377355|P1|NOT COMPLETED|Overall Study||34
8264476|NCT01772576|20377355|P1|COMPLETED|Overall Study||133
8264477|NCT01772576|20377355|P1|STARTED|Overall Study||167
8264478|NCT01772550|20377367|P3|NOT COMPLETED|Overall Study||6
8264479|NCT01772550|20377368|P2|NOT COMPLETED|Overall Study||1
8264480|NCT01772550|20377369|P1|NOT COMPLETED|Overall Study||1
8264481|NCT01772550|20377367|P3|COMPLETED|Overall Study||27
8264482|NCT01772550|20377368|P2|COMPLETED|Overall Study||102
8264483|NCT01772550|20377369|P1|COMPLETED|Overall Study||101
8264484|NCT01772550|20377367|P3|CT Cardiac|Overall Study||1
8264485|NCT01772550|20377368|P2|CT Cardiac|Overall Study||7
8264486|NCT01772550|20377369|P1|CT Cardiac|Overall Study||7
8264487|NCT01772550|20377367|P3|CT Kidney|Overall Study||6
8264488|NCT01772550|20377368|P2|CT Kidney|Overall Study||19
8264489|NCT01772550|20377369|P1|CT Kidney|Overall Study||12
8264490|NCT01772550|20377367|P3|CT Liver|Overall Study||8
8264491|NCT01772550|20377368|P2|CT Liver|Overall Study||14
8264492|NCT01772550|20377369|P1|CT Liver|Overall Study||18
8264493|NCT01772550|20377367|P3|CT Angiogram|Overall Study||4
8264494|NCT01772550|20377368|P2|CT Angiogram|Overall Study||25
8264495|NCT01772550|20377369|P1|CT Angiogram|Overall Study||24
8264496|NCT01772550|20377367|P3|CT Pancreas|Overall Study||8
8264497|NCT01772550|20377368|P2|CT Pancreas|Overall Study||36
8264498|NCT01772550|20377369|P1|CT Pancreas|Overall Study||40
8264499|NCT01772550|20377367|P3|STARTED|Overall Study||33
8264500|NCT01772550|20377368|P2|STARTED|Overall Study||103
8264501|NCT01772550|20377369|P1|STARTED|Overall Study||102
8264502|NCT01772537|20377410|P3|NOT COMPLETED|Overall Study||0
8264503|NCT01772537|20377411|P2|NOT COMPLETED|Overall Study||0
8264504|NCT01772537|20377412|P1|NOT COMPLETED|Overall Study||1
8264505|NCT01772537|20377410|P3|COMPLETED|Overall Study||6
8264506|NCT01772537|20377411|P2|COMPLETED|Overall Study||3
8264507|NCT01772537|20377412|P1|COMPLETED|Overall Study||4
8264508|NCT01772537|20377410|P3|STARTED|Overall Study||6
8264509|NCT01772537|20377411|P2|STARTED|Overall Study||3
8264510|NCT01772537|20377412|P1|STARTED|Overall Study||5
8264517|NCT01772368|20377441|P1|NOT COMPLETED|Overall Study||7
8264518|NCT01772368|20377441|P1|COMPLETED|Overall Study||65
8264519|NCT01772368|20377441|P1|Received Advair Diskus 100/50 mcg|Overall Study||66
8264520|NCT01772368|20377441|P1|Received FS MDPI 100/50 mcg|Overall Study||68
8264521|NCT01772368|20377441|P1|Received FS MDPI 100/25 mcg|Overall Study||67
8264522|NCT01772368|20377441|P1|Received FS MDPI 100/12.5mcg|Overall Study||69
8264523|NCT01772368|20377441|P1|Received FS MDPI 100/6.25 mcg|Overall Study||68
8264524|NCT01772368|20377441|P1|Received Fp MDPI 100 mcg|Overall Study||67
8264525|NCT01772368|20377441|P1|STARTED|Overall Study||72
8264526|NCT01772316|20377487|P1|NOT COMPLETED|Overall Study||7
8264527|NCT01772316|20377487|P1|COMPLETED|Overall Study||40
8264528|NCT01772316|20377487|P1|STARTED|Overall Study||47
8264529|NCT01772160|20377505|P1|NOT COMPLETED|Overall Study||48
8264530|NCT01772160|20377505|P1|COMPLETED|Overall Study||346
8264531|NCT01772160|20377505|P1|STARTED|Overall Study||394
8264532|NCT01772147|20377528|P3|NOT COMPLETED|Overall Study||18
8264533|NCT01772147|20377529|P2|NOT COMPLETED|Overall Study||25
8264534|NCT01772147|20377530|P1|NOT COMPLETED|Overall Study||31
8264535|NCT01772147|20377528|P3|COMPLETED|Overall Study||184
8264536|NCT01772147|20377529|P2|COMPLETED|Overall Study||178
8264537|NCT01772147|20377530|P1|COMPLETED|Overall Study||170
8264538|NCT01772147|20377528|P3|STARTED|Overall Study||202
8264539|NCT01772147|20377529|P2|STARTED|Overall Study||203
8264540|NCT01772147|20377530|P1|STARTED|Overall Study||201
8264541|NCT01772134|20377550|P3|NOT COMPLETED|Overall Study||22
8264542|NCT01772134|20377551|P2|NOT COMPLETED|Overall Study||14
8264543|NCT01772134|20377552|P1|NOT COMPLETED|Overall Study||29
8264544|NCT01772134|20377550|P3|COMPLETED|Overall Study||184
8264545|NCT01772134|20377551|P2|COMPLETED|Overall Study||190
8264546|NCT01772134|20377552|P1|COMPLETED|Overall Study||178
8264547|NCT01772134|20377550|P3|Received Randomized Study Medication|Overall Study||205
8264548|NCT01772134|20377551|P2|Received Randomized Study Medication|Overall Study||204
8264549|NCT01772134|20377552|P1|Received Randomized Study Medication|Overall Study||205
8264550|NCT01772134|20377550|P3|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
8264551|NCT01772134|20377551|P2|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
8264552|NCT01772134|20377552|P1|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
8264553|NCT01771991|20377571|P2|NOT COMPLETED|Overall Study||6
8264554|NCT01771991|20377572|P1|NOT COMPLETED|Overall Study||8
8264555|NCT01771991|20377571|P2|COMPLETED|Overall Study||30
8264556|NCT01771991|20377572|P1|COMPLETED|Overall Study||30
8264557|NCT01771991|20377571|P2|Started Treatment|Overall Study||34
8264558|NCT01771991|20377572|P1|Started Treatment|Overall Study||37
8264559|NCT01771991|20377571|P2|STARTED|Overall Study||36
8264560|NCT01771991|20377572|P1|STARTED|Overall Study||38
8264561|NCT01771965|20377586|P2|NOT COMPLETED|Overall Study||5
8264562|NCT01771965|20377587|P1|NOT COMPLETED|Overall Study||3
8264563|NCT01771965|20377586|P2|COMPLETED|Overall Study||4
8264564|NCT01771965|20377587|P1|COMPLETED|Overall Study||7
8264565|NCT01771965|20377586|P2|STARTED|Overall Study||9
8264566|NCT01771965|20377587|P1|STARTED|Overall Study||10
8264567|NCT01771952|20377595|P2|NOT COMPLETED|Overall Study||3
8264568|NCT01771952|20377596|P1|NOT COMPLETED|Overall Study||3
8264569|NCT01771952|20377595|P2|COMPLETED|Overall Study||38
8264570|NCT01771952|20377596|P1|COMPLETED|Overall Study||42
8264571|NCT01771952|20377595|P2|STARTED|Overall Study||41
8264572|NCT01771952|20377596|P1|STARTED|Overall Study||45
8264573|NCT01771913|20377608|P2|NOT COMPLETED|Overall Study||0
8264574|NCT01771913|20377609|P1|NOT COMPLETED|Overall Study||1
8264575|NCT01771913|20377608|P2|COMPLETED|Overall Study||11
8264576|NCT01771913|20377609|P1|COMPLETED|Overall Study||8
8264577|NCT01771913|20377608|P2|STARTED|Overall Study||11
8264578|NCT01771913|20377609|P1|STARTED|Overall Study||9
8264585|NCT01771731|20377638|P2|NOT COMPLETED|Overall Study||2
8264586|NCT01771731|20377639|P1|NOT COMPLETED|Overall Study||2
8264587|NCT01771731|20377638|P2|COMPLETED|Overall Study||12
8264588|NCT01771731|20377639|P1|COMPLETED|Overall Study||11
8264589|NCT01771731|20377638|P2|STARTED|Overall Study||14
8264590|NCT01771731|20377639|P1|STARTED|Overall Study||13
8264591|NCT01771666|20377645|P1|NOT COMPLETED|Overall Study||0
8264592|NCT01771666|20377645|P1|COMPLETED|Overall Study||23
8264593|NCT01771666|20377645|P1|STARTED|Overall Study||23
8264594|NCT01771627|20377652|P2|NOT COMPLETED|Overall Study||50
8264595|NCT01771627|20377653|P1|NOT COMPLETED|Overall Study||108
8264596|NCT01771627|20377652|P2|COMPLETED|Overall Study||50
8264597|NCT01771627|20377653|P1|COMPLETED|Overall Study||92
8264598|NCT01771627|20377652|P2|STARTED|Overall Study||100
8264599|NCT01771627|20377653|P1|STARTED|Overall Study||200
8264600|NCT01771250|20377659|P2|NOT COMPLETED|Period 2||0
8264601|NCT01771250|20377660|P1|NOT COMPLETED|Period 2||0
8264602|NCT01771250|20377659|P2|COMPLETED|Period 2||7
8264603|NCT01771250|20377660|P1|COMPLETED|Period 2||7
8264604|NCT01771250|20377659|P2|STARTED|Period 2||7
8264605|NCT01771250|20377660|P1|STARTED|Period 2||7
8264606|NCT01771250|20377659|P2|NOT COMPLETED|Period 1||0
8264607|NCT01771250|20377660|P1|NOT COMPLETED|Period 1||1
8264608|NCT01771250|20377659|P2|COMPLETED|Period 1||7
8264609|NCT01771250|20377660|P1|COMPLETED|Period 1||7
8264610|NCT01771250|20377659|P2|Received at Least One Dose of Study Drug|Period 1||7
8264611|NCT01771250|20377660|P1|Received at Least One Dose of Study Drug|Period 1||7
8264612|NCT01771250|20377659|P2|STARTED|Period 1||7
8264613|NCT01771250|20377660|P1|STARTED|Period 1||8
8264614|NCT01771172|20377672|P1|NOT COMPLETED|Overall Study||2
8264615|NCT01771172|20377672|P1|COMPLETED|Overall Study||46
8264616|NCT01771172|20377672|P1|STARTED|Overall Study||48
8264617|NCT01770912|20377678|P2|NOT COMPLETED|Overall Study||0
8264618|NCT01770912|20377679|P1|NOT COMPLETED|Overall Study||2
8264619|NCT01770912|20377678|P2|COMPLETED|Overall Study||12
8264620|NCT01770912|20377679|P1|COMPLETED|Overall Study||10
8264621|NCT01770912|20377678|P2|STARTED|Overall Study||12
8264622|NCT01770912|20377679|P1|STARTED|Overall Study||12
8264623|NCT01770860|20377713|P1|NOT COMPLETED|Overall Study||6
8264624|NCT01770860|20377713|P1|COMPLETED|Overall Study||40
8264625|NCT01770860|20377713|P1|Randomization|Overall Study|One participant withdrew before randomization|45
8264626|NCT01770860|20377713|P1|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
8264627|NCT01770743|20377761|P5|NOT COMPLETED|Overall Study||2
8264628|NCT01770743|20377762|P4|NOT COMPLETED|Overall Study||2
8264629|NCT01770743|20377763|P3|NOT COMPLETED|Overall Study||1
8264630|NCT01770743|20377764|P2|NOT COMPLETED|Overall Study||3
8264631|NCT01770743|20377765|P1|NOT COMPLETED|Overall Study||2
8264632|NCT01770743|20377761|P5|COMPLETED|Overall Study||21
8264633|NCT01770743|20377762|P4|COMPLETED|Overall Study||42
8264634|NCT01770743|20377763|P3|COMPLETED|Overall Study||22
8264635|NCT01770743|20377764|P2|COMPLETED|Overall Study||31
8264636|NCT01770743|20377765|P1|COMPLETED|Overall Study||42
8264637|NCT01770743|20377761|P5|Treated|Overall Study||23
8264638|NCT01770743|20377762|P4|Treated|Overall Study||44
8264639|NCT01770743|20377763|P3|Treated|Overall Study||23
8264640|NCT01770743|20377764|P2|Treated|Overall Study||34
8264641|NCT01770743|20377765|P1|Treated|Overall Study||44
8264642|NCT01770743|20377761|P5|STARTED|Overall Study||23
8264643|NCT01770743|20377762|P4|STARTED|Overall Study||44
8264644|NCT01770743|20377763|P3|STARTED|Overall Study||23
8264645|NCT01770743|20377764|P2|STARTED|Overall Study||34
8264646|NCT01770743|20377765|P1|STARTED|Overall Study||44
8264647|NCT01770691|20377817|P1|NOT COMPLETED|Overall Study||0
8264648|NCT01770691|20377817|P1|COMPLETED|Overall Study||7
8264649|NCT01770691|20377817|P1|STARTED|Overall Study||7
8264650|NCT01770652|20377828|P4|NOT COMPLETED|Overall Study||0
8264651|NCT01770652|20377829|P3|NOT COMPLETED|Overall Study||0
8264652|NCT01770652|20377830|P2|NOT COMPLETED|Overall Study||0
8264653|NCT01770652|20377831|P1|NOT COMPLETED|Overall Study||0
8264654|NCT01770652|20377828|P4|COMPLETED|Overall Study||8
8264655|NCT01770652|20377829|P3|COMPLETED|Overall Study||8
8264656|NCT01770652|20377830|P2|COMPLETED|Overall Study||8
8264657|NCT01770652|20377831|P1|COMPLETED|Overall Study||8
8264658|NCT01770652|20377828|P4|STARTED|Overall Study||8
8264659|NCT01770652|20377829|P3|STARTED|Overall Study||8
8264660|NCT01770652|20377830|P2|STARTED|Overall Study||8
8264661|NCT01770652|20377831|P1|STARTED|Overall Study||8
8264662|NCT01770509|20377867|P2|NOT COMPLETED|Overall Study||3
8264663|NCT01770509|20377868|P1|NOT COMPLETED|Overall Study||1
8264664|NCT01770509|20377867|P2|COMPLETED|Overall Study||14
8264665|NCT01770509|20377868|P1|COMPLETED|Overall Study||11
8264666|NCT01770509|20377867|P2|STARTED|Overall Study||17
8264667|NCT01770509|20377868|P1|STARTED|Overall Study||12
8264668|NCT01770483|20377884|P2|NOT COMPLETED|Overall Study||0
8264669|NCT01770483|20377885|P1|NOT COMPLETED|Overall Study||0
8264670|NCT01770483|20377884|P2|COMPLETED|Overall Study||33
8264671|NCT01770483|20377885|P1|COMPLETED|Overall Study||33
8264672|NCT01770483|20377884|P2|STARTED|Overall Study||33
8264673|NCT01770483|20377885|P1|STARTED|Overall Study||33
8264674|NCT01770431|20377895|P2|NOT COMPLETED|Overall Study||32
8264675|NCT01770431|20377896|P1|NOT COMPLETED|Overall Study||10
8264676|NCT01770431|20377895|P2|COMPLETED|Overall Study||316
8264677|NCT01770431|20377896|P1|COMPLETED|Overall Study||686
8264678|NCT01770431|20377895|P2|STARTED|Overall Study||348
8264679|NCT01770431|20377896|P1|STARTED|Overall Study||696
8264680|NCT01770392|20377904|P1|NOT COMPLETED|Nintedanib+ Rifampicin||0
8264681|NCT01770392|20377904|P1|COMPLETED|Nintedanib+ Rifampicin||25
8264682|NCT01770392|20377904|P1|STARTED|Nintedanib+ Rifampicin||25
8264683|NCT01770392|20377904|P1|NOT COMPLETED|Washout Period of at Least 14 Days||1
8264684|NCT01770392|20377904|P1|COMPLETED|Washout Period of at Least 14 Days||25
8264685|NCT01770392|20377904|P1|STARTED|Washout Period of at Least 14 Days||26
8264686|NCT01770392|20377904|P1|NOT COMPLETED|Nintedanib||0
8264687|NCT01770392|20377904|P1|COMPLETED|Nintedanib||26
8264688|NCT01770392|20377904|P1|STARTED|Nintedanib||26
8264689|NCT01770379|20377919|P3|NOT COMPLETED|Overall Study||42
8264690|NCT01770379|20377920|P2|NOT COMPLETED|Overall Study||44
8264691|NCT01770379|20377921|P1|NOT COMPLETED|Overall Study||39
8264692|NCT01770379|20377919|P3|COMPLETED|Overall Study||39
8264693|NCT01770379|20377920|P2|COMPLETED|Overall Study||37
8264694|NCT01770379|20377921|P1|COMPLETED|Overall Study||41
8264695|NCT01770379|20377919|P3|STARTED|Overall Study||81
8264696|NCT01770379|20377920|P2|STARTED|Overall Study||81
8264697|NCT01770379|20377921|P1|STARTED|Overall Study||80
8264698|NCT01770366|20377940|P2|NOT COMPLETED|Overall Study||2
8264699|NCT01770366|20377941|P1|NOT COMPLETED|Overall Study||2
8264700|NCT01770366|20377940|P2|COMPLETED|Overall Study||4
8264701|NCT01770366|20377941|P1|COMPLETED|Overall Study||2
8264702|NCT01770366|20377940|P2|STARTED|Overall Study||6
8264703|NCT01770366|20377941|P1|STARTED|Overall Study||4
8264704|NCT01770353|20377949|P2|NOT COMPLETED|Overall Study||12
8264705|NCT01770353|20377950|P1|NOT COMPLETED|Overall Study||6
8264706|NCT01770353|20377949|P2|COMPLETED|Overall Study||18
8264707|NCT01770353|20377950|P1|COMPLETED|Overall Study||9
8264708|NCT01770353|20377949|P2|Received FMX and MM-398|Overall Study||29
8264709|NCT01770353|20377950|P1|Received FMX and MM-398|Overall Study||13
8264710|NCT01770353|20377949|P2|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30
8264711|NCT01770353|20377950|P1|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15
8264712|NCT01770353|20377949|P2|STARTED|Overall Study||30
8264713|NCT01770353|20377950|P1|STARTED|Overall Study||15
8264714|NCT01770314|20378000|P2|NOT COMPLETED|Overall Study||0
8264715|NCT01770314|20378001|P1|NOT COMPLETED|Overall Study||0
8264716|NCT01770314|20378000|P2|COMPLETED|Overall Study||90
8264717|NCT01770314|20378001|P1|COMPLETED|Overall Study||86
8264718|NCT01770314|20378000|P2|Contributed Data to One-month Follow-up|Overall Study||66
8264719|NCT01770314|20378001|P1|Contributed Data to One-month Follow-up|Overall Study||61
8264720|NCT01770314|20378000|P2|Contributed Data to Post-test|Overall Study||67
8264721|NCT01770314|20378001|P1|Contributed Data to Post-test|Overall Study||65
8264722|NCT01770314|20378000|P2|Contributed Data to Baseline|Overall Study||72
8264723|NCT01770314|20378001|P1|Contributed Data to Baseline|Overall Study||68
8264724|NCT01770314|20378000|P2|STARTED|Overall Study||90
8264725|NCT01770314|20378001|P1|STARTED|Overall Study||86
8264726|NCT01770145|20378009|P1|NOT COMPLETED|Treatment||4
8264727|NCT01770145|20378009|P1|COMPLETED|Treatment||97
8264728|NCT01770145|20378009|P1|STARTED|Treatment||101
8264729|NCT01770145|20378009|P1|NOT COMPLETED|Baseline||26
8264730|NCT01770145|20378009|P1|COMPLETED|Baseline||101
8264731|NCT01770145|20378009|P1|STARTED|Baseline||127
8264732|NCT01769612|20378014|P1|NOT COMPLETED|Overall Study||0
8264733|NCT01769612|20378014|P1|COMPLETED|Overall Study||168
8264734|NCT01769612|20378014|P1|STARTED|Overall Study||168
8264735|NCT01769586|20378022|P2|NOT COMPLETED|Overall Study||0
8264736|NCT01769586|20378023|P1|NOT COMPLETED|Overall Study||0
8264737|NCT01769586|20378022|P2|COMPLETED|Overall Study||100
8264738|NCT01769586|20378023|P1|COMPLETED|Overall Study||100
8264739|NCT01769586|20378022|P2|STARTED|Overall Study||100
8264740|NCT01769586|20378023|P1|STARTED|Overall Study||100
8264741|NCT01769573|20378034|P5|NOT COMPLETED|Overall Study||0
8264742|NCT01769573|20378035|P4|NOT COMPLETED|Overall Study||0
8264743|NCT01769573|20378036|P3|NOT COMPLETED|Overall Study||0
8264744|NCT01769573|20378037|P2|NOT COMPLETED|Overall Study||0
8264745|NCT01769573|20378038|P1|NOT COMPLETED|Overall Study||0
8264746|NCT01769573|20378034|P5|COMPLETED|Overall Study||10
8264747|NCT01769573|20378035|P4|COMPLETED|Overall Study||0
8264748|NCT01769573|20378036|P3|COMPLETED|Overall Study||10
8264749|NCT01769573|20378037|P2|COMPLETED|Overall Study||6
8264750|NCT01769573|20378038|P1|COMPLETED|Overall Study||10
8264751|NCT01769573|20378034|P5|STARTED|Overall Study||10
8264752|NCT01769573|20378035|P4|STARTED|Overall Study||0
8264753|NCT01769573|20378036|P3|STARTED|Overall Study||10
8264754|NCT01769573|20378037|P2|STARTED|Overall Study||6
8264755|NCT01769573|20378038|P1|STARTED|Overall Study||10
8264756|NCT01769508|20378065|P1|NOT COMPLETED|Overall Study||6
8264757|NCT01769508|20378065|P1|COMPLETED|Overall Study||6
8264758|NCT01769508|20378065|P1|STARTED|Overall Study||12
8264759|NCT01769469|20378074|P1|NOT COMPLETED|Overall Study||35
8264760|NCT01769469|20378074|P1|COMPLETED|Overall Study||66
8264761|NCT01769469|20378074|P1|STARTED|Overall Study||101
8264762|NCT01769456|20378234|P1|NOT COMPLETED|Overall Study||37
8264763|NCT01769456|20378234|P1|COMPLETED|Overall Study||41
8264764|NCT01769456|20378234|P1|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
8264765|NCT01769443|20378255|P2|NOT COMPLETED|Overall Study||0
8264766|NCT01769443|20378256|P1|NOT COMPLETED|Overall Study||1
8264767|NCT01769443|20378255|P2|COMPLETED|Overall Study||1
8264768|NCT01769443|20378256|P1|COMPLETED|Overall Study||0
8264769|NCT01769443|20378255|P2|STARTED|Overall Study||1
8264770|NCT01769443|20378256|P1|STARTED|Overall Study||1
8264771|NCT01769404|20378298|P2|NOT COMPLETED|Treatment Period 2||0
8264772|NCT01769404|20378299|P1|NOT COMPLETED|Treatment Period 2||7
8264773|NCT01769404|20378298|P2|COMPLETED|Treatment Period 2||13
8264774|NCT01769404|20378299|P1|COMPLETED|Treatment Period 2||0
8264775|NCT01769404|20378298|P2|STARTED|Treatment Period 2||13
8264776|NCT01769404|20378299|P1|STARTED|Treatment Period 2||7
8264777|NCT01769404|20378298|P2|NOT COMPLETED|Treatment Period 1||0
8264778|NCT01769404|20378299|P1|NOT COMPLETED|Treatment Period 1||5
8264779|NCT01769404|20378298|P2|COMPLETED|Treatment Period 1||13
8264780|NCT01769404|20378299|P1|COMPLETED|Treatment Period 1||7
8264781|NCT01769404|20378298|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||13
8264782|NCT01769404|20378299|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
8264783|NCT01769404|20378298|P2|STARTED|Treatment Period 1||13
8264784|NCT01769404|20378299|P1|STARTED|Treatment Period 1||12
8264785|NCT01769391|20378321|P2|NOT COMPLETED|Overall Study||9
8264786|NCT01769391|20378322|P1|NOT COMPLETED|Overall Study||17
8264787|NCT01769391|20378321|P2|COMPLETED|Overall Study||48
8264788|NCT01769391|20378322|P1|COMPLETED|Overall Study||93
8264789|NCT01769391|20378321|P2|Received at Least One Dose of Study Drug|Overall Study||55
8264790|NCT01769391|20378322|P1|Received at Least One Dose of Study Drug|Overall Study||106
8264791|NCT01769391|20378321|P2|STARTED|Overall Study||57
8264792|NCT01769391|20378322|P1|STARTED|Overall Study||110
8264793|NCT01769378|20378341|P2|NOT COMPLETED|Overall Study||4
8264794|NCT01769378|20378342|P1|NOT COMPLETED|Overall Study||25
8264795|NCT01769378|20378341|P2|COMPLETED|Overall Study|Completed the study on study treatment|56
8264796|NCT01769378|20378342|P1|COMPLETED|Overall Study|Completed the study on study treatment|215
8264797|NCT01769378|20378341|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
8264798|NCT01769378|20378342|P1|Received at Least 1 Dose of Study Drug|Overall Study||239
8264799|NCT01769378|20378341|P2|STARTED|Overall Study||60
8264800|NCT01769378|20378342|P1|STARTED|Overall Study||240
8264801|NCT01769365|20378380|P3|NOT COMPLETED|Overall Study||2
8264802|NCT01769365|20378381|P2|NOT COMPLETED|Overall Study||2
8264803|NCT01769365|20378382|P1|NOT COMPLETED|Overall Study||0
8264804|NCT01769365|20378380|P3|COMPLETED|Overall Study||101
8264805|NCT01769365|20378381|P2|COMPLETED|Overall Study||100
8264806|NCT01769365|20378382|P1|COMPLETED|Overall Study||102
8264807|NCT01769365|20378380|P3|STARTED|Overall Study||103
8264808|NCT01769365|20378381|P2|STARTED|Overall Study||102
8264809|NCT01769365|20378382|P1|STARTED|Overall Study||102
8264810|NCT01769352|20378394|P4|NOT COMPLETED|Overall Study||0
8264811|NCT01769352|20378395|P3|NOT COMPLETED|Overall Study||0
8264812|NCT01769352|20378396|P2|NOT COMPLETED|Overall Study||0
8264813|NCT01769352|20378397|P1|NOT COMPLETED|Overall Study||0
8264814|NCT01769352|20378394|P4|COMPLETED|Overall Study||8
8264815|NCT01769352|20378395|P3|COMPLETED|Overall Study||9
8264816|NCT01769352|20378396|P2|COMPLETED|Overall Study||12
8264817|NCT01769352|20378397|P1|COMPLETED|Overall Study||13
8264818|NCT01769352|20378394|P4|STARTED|Overall Study||8
8264819|NCT01769352|20378395|P3|STARTED|Overall Study||9
8264820|NCT01769352|20378396|P2|STARTED|Overall Study||12
8264821|NCT01769352|20378397|P1|STARTED|Overall Study||13
8264822|NCT01769339|20378422|P1|NOT COMPLETED|Overall Study||43
8264823|NCT01769339|20378422|P1|COMPLETED|Overall Study||72
8264824|NCT01769339|20378422|P1|STARTED|Overall Study||115
8264825|NCT01769326|20378433|P4|NOT COMPLETED|Overall Study||0
8264826|NCT01769326|20378434|P3|NOT COMPLETED|Overall Study||1
8264827|NCT01769326|20378435|P2|NOT COMPLETED|Overall Study||4
8264828|NCT01769326|20378436|P1|NOT COMPLETED|Overall Study||2
8264829|NCT01769326|20378433|P4|COMPLETED|Overall Study||8
8264830|NCT01769326|20378434|P3|COMPLETED|Overall Study||8
8264831|NCT01769326|20378435|P2|COMPLETED|Overall Study||8
8264832|NCT01769326|20378436|P1|COMPLETED|Overall Study||9
8264833|NCT01769326|20378433|P4|STARTED|Overall Study||8
8264834|NCT01769326|20378434|P3|STARTED|Overall Study||9
8264835|NCT01769326|20378435|P2|STARTED|Overall Study||12
8264836|NCT01769326|20378436|P1|STARTED|Overall Study||11
8264837|NCT01769274|20378446|P3|NOT COMPLETED|Part B:Treatment Session2-Period4||0
8264838|NCT01769274|20378447|P2|NOT COMPLETED|Part B:Treatment Session2-Period4||0
8264839|NCT01769274|20378448|P1|NOT COMPLETED|Part B:Treatment Session2-Period4||0
8264840|NCT01769274|20378446|P3|COMPLETED|Part B:Treatment Session2-Period4||3
8264841|NCT01769274|20378447|P2|COMPLETED|Part B:Treatment Session2-Period4||2
8264842|NCT01769274|20378448|P1|COMPLETED|Part B:Treatment Session2-Period4||0
8264843|NCT01769274|20378446|P3|STARTED|Part B:Treatment Session2-Period4||3
8264844|NCT01769274|20378447|P2|STARTED|Part B:Treatment Session2-Period4||2
8264845|NCT01769274|20378448|P1|STARTED|Part B:Treatment Session2-Period4||0
8264846|NCT01769274|20378446|P3|NOT COMPLETED|Washout Period||0
8264847|NCT01769274|20378447|P2|NOT COMPLETED|Washout Period||0
8264848|NCT01769274|20378448|P1|NOT COMPLETED|Washout Period||0
8264849|NCT01769274|20378446|P3|COMPLETED|Washout Period||3
8264850|NCT01769274|20378447|P2|COMPLETED|Washout Period||2
8264851|NCT01769274|20378448|P1|COMPLETED|Washout Period||0
8264852|NCT01769274|20378446|P3|STARTED|Washout Period||3
8264853|NCT01769274|20378447|P2|STARTED|Washout Period||2
8264854|NCT01769274|20378448|P1|STARTED|Washout Period||0
8264855|NCT01769274|20378446|P3|NOT COMPLETED|Part B:Treatment Session2-Period3||0
8264856|NCT01769274|20378447|P2|NOT COMPLETED|Part B:Treatment Session2-Period3||0
8264857|NCT01769274|20378448|P1|NOT COMPLETED|Part B:Treatment Session2-Period3||0
8264858|NCT01769274|20378446|P3|COMPLETED|Part B:Treatment Session2-Period3||3
8264859|NCT01769274|20378447|P2|COMPLETED|Part B:Treatment Session2-Period3||2
8264860|NCT01769274|20378448|P1|COMPLETED|Part B:Treatment Session2-Period3||0
8264861|NCT01769274|20378446|P3|STARTED|Part B:Treatment Session2-Period3||3
8264862|NCT01769274|20378447|P2|STARTED|Part B:Treatment Session2-Period3||2
8264863|NCT01769274|20378448|P1|STARTED|Part B:Treatment Session2-Period3||0
8264864|NCT01769274|20378446|P3|NOT COMPLETED|Washout Period||0
8264865|NCT01769274|20378447|P2|NOT COMPLETED|Washout Period||0
8264866|NCT01769274|20378448|P1|NOT COMPLETED|Washout Period||0
8264867|NCT01769274|20378446|P3|COMPLETED|Washout Period||3
8264868|NCT01769274|20378447|P2|COMPLETED|Washout Period||2
8264869|NCT01769274|20378448|P1|COMPLETED|Washout Period||0
8264870|NCT01769274|20378446|P3|STARTED|Washout Period||3
8264871|NCT01769274|20378447|P2|STARTED|Washout Period||2
8264872|NCT01769274|20378448|P1|STARTED|Washout Period||0
8264873|NCT01769274|20378446|P3|NOT COMPLETED|Part B:Treatment Session1-Period2||0
8264874|NCT01769274|20378447|P2|NOT COMPLETED|Part B:Treatment Session1-Period2||0
8264875|NCT01769274|20378448|P1|NOT COMPLETED|Part B:Treatment Session1-Period2||0
8264876|NCT01769274|20378446|P3|COMPLETED|Part B:Treatment Session1-Period2||3
8264877|NCT01769274|20378447|P2|COMPLETED|Part B:Treatment Session1-Period2||2
8264878|NCT01769274|20378448|P1|COMPLETED|Part B:Treatment Session1-Period2||0
8264879|NCT01769274|20378446|P3|STARTED|Part B:Treatment Session1-Period2||3
8264880|NCT01769274|20378447|P2|STARTED|Part B:Treatment Session1-Period2||2
8264881|NCT01769274|20378448|P1|STARTED|Part B:Treatment Session1-Period2||0
8264882|NCT01769274|20378446|P3|NOT COMPLETED|Washout Period||0
8264883|NCT01769274|20378447|P2|NOT COMPLETED|Washout Period||0
8264884|NCT01769274|20378448|P1|NOT COMPLETED|Washout Period||0
8264885|NCT01769274|20378446|P3|COMPLETED|Washout Period||3
8264886|NCT01769274|20378447|P2|COMPLETED|Washout Period||2
8264887|NCT01769274|20378448|P1|COMPLETED|Washout Period||0
8264888|NCT01769274|20378446|P3|STARTED|Washout Period||3
8264889|NCT01769274|20378447|P2|STARTED|Washout Period||2
8264890|NCT01769274|20378448|P1|STARTED|Washout Period||0
8264891|NCT01769274|20378446|P3|NOT COMPLETED|Part B:Treatment Session1-Period1||0
8264892|NCT01769274|20378447|P2|NOT COMPLETED|Part B:Treatment Session1-Period1||0
8264893|NCT01769274|20378448|P1|NOT COMPLETED|Part B:Treatment Session1-Period1||0
8264894|NCT01769274|20378446|P3|COMPLETED|Part B:Treatment Session1-Period1||3
8264895|NCT01769274|20378447|P2|COMPLETED|Part B:Treatment Session1-Period1||2
8264896|NCT01769274|20378448|P1|COMPLETED|Part B:Treatment Session1-Period1||0
8264897|NCT01769274|20378446|P3|STARTED|Part B:Treatment Session1-Period1||3
8264898|NCT01769274|20378447|P2|STARTED|Part B:Treatment Session1-Period1||2
8264899|NCT01769274|20378448|P1|STARTED|Part B:Treatment Session1-Period1||0
8264900|NCT01769274|20378446|P3|NOT COMPLETED|Part A||0
8264901|NCT01769274|20378447|P2|NOT COMPLETED|Part A||0
8264902|NCT01769274|20378448|P1|NOT COMPLETED|Part A||0
8264903|NCT01769274|20378446|P3|COMPLETED|Part A||0
8264904|NCT01769274|20378447|P2|COMPLETED|Part A||0
8264905|NCT01769274|20378448|P1|COMPLETED|Part A||5
8264906|NCT01769274|20378446|P3|STARTED|Part A||0
8264907|NCT01769274|20378447|P2|STARTED|Part A||0
8264908|NCT01769274|20378448|P1|STARTED|Part A||5
8264909|NCT01769248|20378540|P2|NOT COMPLETED|Overall Study||12
8264910|NCT01769248|20378541|P1|NOT COMPLETED|Overall Study||28
8264911|NCT01769248|20378540|P2|COMPLETED|Overall Study||58
8264912|NCT01769248|20378541|P1|COMPLETED|Overall Study||42
8264913|NCT01769248|20378540|P2|Participants Who Crossed-over|Overall Study||12
8264914|NCT01769248|20378541|P1|Participants Who Crossed-over|Overall Study||28
8264915|NCT01769248|20378540|P2|STARTED|Overall Study||70
8264916|NCT01769248|20378541|P1|STARTED|Overall Study||70
8264917|NCT01769222|20378553|P2|NOT COMPLETED|Overall Study||0
8264918|NCT01769222|20378554|P1|NOT COMPLETED|Overall Study||0
8264919|NCT01769222|20378553|P2|COMPLETED|Overall Study||0
8264920|NCT01769222|20378554|P1|COMPLETED|Overall Study||3
8264921|NCT01769222|20378553|P2|STARTED|Overall Study||0
8264922|NCT01769222|20378554|P1|STARTED|Overall Study||3
8264923|NCT01769209|20378568|P1|NOT COMPLETED|Overall Study||0
8264924|NCT01769209|20378568|P1|COMPLETED|Overall Study||18
8264925|NCT01769209|20378568|P1|STARTED|Overall Study||18
8264926|NCT01769196|20378581|P2|NOT COMPLETED|Overall Study||272
8264927|NCT01769196|20378582|P1|NOT COMPLETED|Overall Study||272
8264928|NCT01769196|20378581|P2|COMPLETED|Overall Study||0
8264929|NCT01769196|20378582|P1|COMPLETED|Overall Study||0
8264930|NCT01769196|20378581|P2|STARTED|Overall Study||272
8264931|NCT01769196|20378582|P1|STARTED|Overall Study||272
8264938|NCT01769105|20378623|P2|NOT COMPLETED|Cross-over||0
8264939|NCT01769105|20378624|P1|NOT COMPLETED|Cross-over||5
8264940|NCT01769105|20378623|P2|COMPLETED|Cross-over|Was not intended by the study protocol|0
8264941|NCT01769105|20378624|P1|COMPLETED|Cross-over||9
8264942|NCT01769105|20378623|P2|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
8264943|NCT01769105|20378624|P1|STARTED|Cross-over||14
8264944|NCT01769105|20378623|P2|NOT COMPLETED|First Intervention||2
8264945|NCT01769105|20378624|P1|NOT COMPLETED|First Intervention||2
8264946|NCT01769105|20378623|P2|COMPLETED|First Intervention||17
8264947|NCT01769105|20378624|P1|COMPLETED|First Intervention||14
8264948|NCT01769105|20378623|P2|STARTED|First Intervention||19
8264949|NCT01769105|20378624|P1|STARTED|First Intervention||16
8264950|NCT01768858|20378643|P1|NOT COMPLETED|Overall Study||22
8264951|NCT01768858|20378643|P1|COMPLETED|Overall Study||74
8264952|NCT01768858|20378643|P1|STARTED|Overall Study||96
8264953|NCT01768832|20378658|P3|NOT COMPLETED|Overall Study||9
8264954|NCT01768832|20378659|P2|NOT COMPLETED|Overall Study||4
8264955|NCT01768832|20378660|P1|NOT COMPLETED|Overall Study||10
8264956|NCT01768832|20378658|P3|COMPLETED|Overall Study||26
8264957|NCT01768832|20378659|P2|COMPLETED|Overall Study||39
8264958|NCT01768832|20378660|P1|COMPLETED|Overall Study||31
8264959|NCT01768832|20378658|P3|STARTED|Overall Study||35
8264960|NCT01768832|20378659|P2|STARTED|Overall Study||43
8264961|NCT01768832|20378660|P1|STARTED|Overall Study||41
8264962|NCT01768676|20378694|P2|NOT COMPLETED|Overall Study||31
8264963|NCT01768676|20378695|P1|NOT COMPLETED|Overall Study||24
8264964|NCT01768676|20378694|P2|COMPLETED|Overall Study||60
8264965|NCT01768676|20378695|P1|COMPLETED|Overall Study||66
8264966|NCT01768676|20378694|P2|STARTED|Overall Study||91
8264967|NCT01768676|20378695|P1|STARTED|Overall Study||90
8264968|NCT01768637|20378711|P2|NOT COMPLETED|Overall Study||7
8264969|NCT01768637|20378712|P1|NOT COMPLETED|Overall Study||3
8264970|NCT01768637|20378711|P2|COMPLETED|Overall Study||12
8264971|NCT01768637|20378712|P1|COMPLETED|Overall Study||26
8264972|NCT01768637|20378711|P2|Completed Visit 2|Overall Study||13
8264973|NCT01768637|20378712|P1|Completed Visit 2|Overall Study||26
8264974|NCT01768637|20378711|P2|Completed Visit 1|Overall Study||16
8264975|NCT01768637|20378712|P1|Completed Visit 1|Overall Study||28
8264976|NCT01768637|20378711|P2|STARTED|Overall Study||19
8264977|NCT01768637|20378712|P1|STARTED|Overall Study||29
8264978|NCT01768572|20378725|P3|NOT COMPLETED|Overall Study||6
8264979|NCT01768572|20378726|P2|NOT COMPLETED|Overall Study||12
8264980|NCT01768572|20378727|P1|NOT COMPLETED|Overall Study||9
8264981|NCT01768572|20378725|P3|COMPLETED|Overall Study||96
8264982|NCT01768572|20378726|P2|COMPLETED|Overall Study||39
8264983|NCT01768572|20378727|P1|COMPLETED|Overall Study||40
8264984|NCT01768572|20378725|P3|STARTED|Overall Study||102
8264985|NCT01768572|20378726|P2|STARTED|Overall Study||51
8264986|NCT01768572|20378727|P1|STARTED|Overall Study||49
8264987|NCT01768559|20378738|P3|NOT COMPLETED|Overall Study||13
8264988|NCT01768559|20378739|P2|NOT COMPLETED|Overall Study||17
8264989|NCT01768559|20378740|P1|NOT COMPLETED|Overall Study||30
8264990|NCT01768559|20378738|P3|COMPLETED|Overall Study||285
8264991|NCT01768559|20378739|P2|COMPLETED|Overall Study||281
8264992|NCT01768559|20378740|P1|COMPLETED|Overall Study||268
8264993|NCT01768559|20378738|P3|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
8264994|NCT01768559|20378739|P2|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
8264995|NCT01768559|20378740|P1|Treated|Overall Study||298
8264996|NCT01768559|20378738|P3|STARTED|Overall Study||298
8264997|NCT01768559|20378739|P2|STARTED|Overall Study||298
8264998|NCT01768559|20378740|P1|STARTED|Overall Study||298
8264999|NCT01768520|20378791|P3|NOT COMPLETED|Overall Study||9
8265000|NCT01768520|20378792|P2|NOT COMPLETED|Overall Study||26
8265001|NCT01768520|20378793|P1|NOT COMPLETED|Overall Study||32
8265002|NCT01768520|20378791|P3|COMPLETED|Overall Study||30
8265003|NCT01768520|20378792|P2|COMPLETED|Overall Study||121
8265004|NCT01768520|20378793|P1|COMPLETED|Overall Study||120
8265005|NCT01768520|20378791|P3|STARTED|Overall Study||39
8265006|NCT01768520|20378792|P2|STARTED|Overall Study||147
8265007|NCT01768520|20378793|P1|STARTED|Overall Study||152
8265008|NCT01768325|20378806|P2|NOT COMPLETED|Overall Study||0
8265009|NCT01768325|20378807|P1|NOT COMPLETED|Overall Study||0
8265010|NCT01768325|20378806|P2|COMPLETED|Overall Study||41
8265011|NCT01768325|20378807|P1|COMPLETED|Overall Study||37
8265012|NCT01768325|20378806|P2|STARTED|Overall Study||41
8265013|NCT01768325|20378807|P1|STARTED|Overall Study||37
8265014|NCT01768286|20378821|P4|NOT COMPLETED|Overall Study||1
8265015|NCT01768286|20378822|P3|NOT COMPLETED|Overall Study||2
8265016|NCT01768286|20378823|P2|NOT COMPLETED|Overall Study||4
8265017|NCT01768286|20378824|P1|NOT COMPLETED|Overall Study||7
8265018|NCT01768286|20378821|P4|COMPLETED|Overall Study||110
8265019|NCT01768286|20378822|P3|COMPLETED|Overall Study||108
8265020|NCT01768286|20378823|P2|COMPLETED|Overall Study||107
8265021|NCT01768286|20378824|P1|COMPLETED|Overall Study||102
8265022|NCT01768286|20378821|P4|STARTED|Overall Study||111
8265023|NCT01768286|20378822|P3|STARTED|Overall Study||110
8265024|NCT01768286|20378823|P2|STARTED|Overall Study||111
8265025|NCT01768286|20378824|P1|STARTED|Overall Study||109
8265026|NCT01768117|20378886|P1|NOT COMPLETED|Overall Study||6
8265027|NCT01768117|20378886|P1|COMPLETED|Overall Study||7
8265028|NCT01768117|20378886|P1|STARTED|Overall Study||13
8265029|NCT01768013|20378894|P1|NOT COMPLETED|Overall Study||0
8265030|NCT01768013|20378894|P1|COMPLETED|Overall Study||13
8265031|NCT01768013|20378894|P1|STARTED|Overall Study||13
8265032|NCT01768000|20378927|P4|NOT COMPLETED|Overall Study||2
8265033|NCT01768000|20378928|P3|NOT COMPLETED|Overall Study||1
8265034|NCT01768000|20378929|P2|NOT COMPLETED|Overall Study||2
8265035|NCT01768000|20378930|P1|NOT COMPLETED|Overall Study||1
8265036|NCT01768000|20378927|P4|COMPLETED|Overall Study||8
8265037|NCT01768000|20378928|P3|COMPLETED|Overall Study||9
8265038|NCT01768000|20378929|P2|COMPLETED|Overall Study||8
8265039|NCT01768000|20378930|P1|COMPLETED|Overall Study||9
8265040|NCT01768000|20378927|P4|STARTED|Overall Study||10
8265041|NCT01768000|20378928|P3|STARTED|Overall Study||10
8265042|NCT01768000|20378929|P2|STARTED|Overall Study||10
8265043|NCT01768000|20378930|P1|STARTED|Overall Study||10
8265044|NCT01767987|20378950|P2|NOT COMPLETED|Overall Study||1
8265045|NCT01767987|20378951|P1|NOT COMPLETED|Overall Study||4
8265046|NCT01767987|20378950|P2|COMPLETED|Overall Study||1
8265047|NCT01767987|20378951|P1|COMPLETED|Overall Study||0
8265048|NCT01767987|20378950|P2|STARTED|Overall Study||2
8265049|NCT01767987|20378951|P1|STARTED|Overall Study||4
8265050|NCT01767935|20378973|P1|NOT COMPLETED|Overall Study||0
8265051|NCT01767935|20378973|P1|COMPLETED|Overall Study||1
8265052|NCT01767935|20378973|P1|STARTED|Overall Study||1
8265053|NCT01767909|20378983|P2|NOT COMPLETED|Overall Study||12
8265054|NCT01767909|20378984|P1|NOT COMPLETED|Overall Study||13
8265055|NCT01767909|20378983|P2|COMPLETED|Overall Study||107
8265056|NCT01767909|20378984|P1|COMPLETED|Overall Study||108
8265057|NCT01767909|20378983|P2|STARTED|Overall Study||119
8265058|NCT01767909|20378984|P1|STARTED|Overall Study||121
8265062|NCT01767701|20379010|P1|NOT COMPLETED|Overall Study||0
8265063|NCT01767701|20379010|P1|COMPLETED|Overall Study||20
8265064|NCT01767701|20379010|P1|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
8265065|NCT01767688|20379023|P2|NOT COMPLETED|Overall Study||0
8265066|NCT01767688|20379024|P1|NOT COMPLETED|Overall Study||0
8265067|NCT01767688|20379023|P2|COMPLETED|Overall Study||8
8265068|NCT01767688|20379024|P1|COMPLETED|Overall Study||8
8265069|NCT01767688|20379023|P2|STARTED|Overall Study||8
8265070|NCT01767688|20379024|P1|STARTED|Overall Study||8
8265074|NCT01767597|20379054|P2|NOT COMPLETED|Overall Study||1
8265075|NCT01767597|20379055|P1|NOT COMPLETED|Overall Study||4
8265076|NCT01767597|20379054|P2|COMPLETED|Overall Study||499
8265077|NCT01767597|20379055|P1|COMPLETED|Overall Study||496
8265078|NCT01767597|20379054|P2|STARTED|Overall Study||500
8265079|NCT01767597|20379055|P1|STARTED|Overall Study||500
8265080|NCT01767519|20379064|P3|NOT COMPLETED|Overall Study||5
8265081|NCT01767519|20379065|P2|NOT COMPLETED|Overall Study||13
8265082|NCT01767519|20379066|P1|NOT COMPLETED|Overall Study||14
8265083|NCT01767519|20379064|P3|COMPLETED|Overall Study||55
8265084|NCT01767519|20379065|P2|COMPLETED|Overall Study||138
8265085|NCT01767519|20379066|P1|COMPLETED|Overall Study||131
8265086|NCT01767519|20379064|P3|STARTED|Overall Study||60
8265087|NCT01767519|20379065|P2|STARTED|Overall Study||151
8265088|NCT01767519|20379066|P1|STARTED|Overall Study||145
8265089|NCT01767506|20379094|P2|NOT COMPLETED|Overall Study||0
8265090|NCT01767506|20379095|P1|NOT COMPLETED|Overall Study||0
8265091|NCT01767506|20379094|P2|COMPLETED|Overall Study|The study was conducted at the community level.|0
8265092|NCT01767506|20379095|P1|COMPLETED|Overall Study|The study was conducted at the community level.|0
8265093|NCT01767506|20379094|P2|STARTED|Overall Study|"26 communities were randomized to control group
~The study was conducted at the community level."|0
8265094|NCT01767506|20379095|P1|STARTED|Overall Study|"26 communities were randomized to intervention group
~The study was conducted at the community level."|0
8265095|NCT01767467|20379107|P2|NOT COMPLETED|End of Study Phase (up to Month 13)||63
8265096|NCT01767467|20379108|P1|NOT COMPLETED|End of Study Phase (up to Month 13)||47
8265097|NCT01767467|20379107|P2|COMPLETED|End of Study Phase (up to Month 13)||216
8265098|NCT01767467|20379108|P1|COMPLETED|End of Study Phase (up to Month 13)||236
8265099|NCT01767467|20379107|P2|STARTED|End of Study Phase (up to Month 13)||279
8265100|NCT01767467|20379108|P1|STARTED|End of Study Phase (up to Month 13)||283
8265101|NCT01767467|20379107|P2|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
8265102|NCT01767467|20379108|P1|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
8265103|NCT01767467|20379107|P2|COMPLETED|Vaccination Phase (up to Month 2)||259
8265104|NCT01767467|20379108|P1|COMPLETED|Vaccination Phase (up to Month 2)||266
8265105|NCT01767467|20379107|P2|STARTED|Vaccination Phase (up to Month 2)||279
8265106|NCT01767467|20379108|P1|STARTED|Vaccination Phase (up to Month 2)||283
8265107|NCT01767415|20379156|P1|NOT COMPLETED|Overall Study||0
8265108|NCT01767415|20379156|P1|COMPLETED|Overall Study||10
8265109|NCT01767415|20379156|P1|STARTED|Overall Study||10
8265110|NCT01767376|20379164|P3|NOT COMPLETED|Overall Study||0
8265111|NCT01767376|20379165|P2|NOT COMPLETED|Overall Study||3
8265112|NCT01767376|20379166|P1|NOT COMPLETED|Overall Study||4
8265113|NCT01767376|20379164|P3|COMPLETED|Overall Study||232
8265114|NCT01767376|20379165|P2|COMPLETED|Overall Study||225
8265115|NCT01767376|20379166|P1|COMPLETED|Overall Study||227
8265116|NCT01767376|20379164|P3|STARTED|Overall Study||232
8265117|NCT01767376|20379165|P2|STARTED|Overall Study||228
8265118|NCT01767376|20379166|P1|STARTED|Overall Study||231
8265119|NCT01767285|20379213|P2|NOT COMPLETED|Overall Study||6
8265120|NCT01767285|20379214|P1|NOT COMPLETED|Overall Study||7
8265121|NCT01767285|20379213|P2|COMPLETED|Overall Study||24
8265122|NCT01767285|20379214|P1|COMPLETED|Overall Study||22
8265123|NCT01767285|20379213|P2|STARTED|Overall Study||30
8265124|NCT01767285|20379214|P1|STARTED|Overall Study||29
8265131|NCT01767155|20379242|P2|NOT COMPLETED|Overall Study||15
8265132|NCT01767155|20379243|P1|NOT COMPLETED|Overall Study||13
8265133|NCT01767155|20379242|P2|COMPLETED|Overall Study||240
8265134|NCT01767155|20379243|P1|COMPLETED|Overall Study||243
8265135|NCT01767155|20379242|P2|Safety Population (SAF)|Overall Study||249
8265136|NCT01767155|20379243|P1|Safety Population (SAF)|Overall Study||252
8265137|NCT01767155|20379242|P2|Modified ITT (mITT)|Overall Study||249
8265138|NCT01767155|20379243|P1|Modified ITT (mITT)|Overall Study||252
8265139|NCT01767155|20379242|P2|STARTED|Overall Study|Patients allocated to doxorubicin|255
8265140|NCT01767155|20379243|P1|STARTED|Overall Study|Patients allocated to AEZS-108|256
8265141|NCT01767142|20379255|P1|NOT COMPLETED|Overall Study||3
8265142|NCT01767142|20379255|P1|COMPLETED|Overall Study||37
8265143|NCT01767142|20379255|P1|STARTED|Overall Study|Each subject was treated on a single thigh. therefore the number of units is 40.|40
8265150|NCT01767103|20379284|P3|NOT COMPLETED|Overall Study||0
8265151|NCT01767103|20379285|P2|NOT COMPLETED|Overall Study||0
8265152|NCT01767103|20379286|P1|NOT COMPLETED|Overall Study||0
8265153|NCT01767103|20379284|P3|COMPLETED|Overall Study||7
8265154|NCT01767103|20379285|P2|COMPLETED|Overall Study||7
8265155|NCT01767103|20379286|P1|COMPLETED|Overall Study||7
8265156|NCT01767103|20379284|P3|STARTED|Overall Study||7
8265157|NCT01767103|20379285|P2|STARTED|Overall Study||7
8265158|NCT01767103|20379286|P1|STARTED|Overall Study||7
8265159|NCT01767064|20379314|P2|NOT COMPLETED|Overall Study||0
8265160|NCT01767064|20379315|P1|NOT COMPLETED|Overall Study||0
8265161|NCT01767064|20379314|P2|COMPLETED|Overall Study||7
8265162|NCT01767064|20379315|P1|COMPLETED|Overall Study||7
8265163|NCT01767064|20379314|P2|STARTED|Overall Study||7
8265164|NCT01767064|20379315|P1|STARTED|Overall Study||7
8265165|NCT01766986|20379324|P3|NOT COMPLETED|Overall Study||0
8265166|NCT01766986|20379325|P2|NOT COMPLETED|Overall Study||0
8265167|NCT01766986|20379326|P1|NOT COMPLETED|Overall Study||0
8265168|NCT01766986|20379324|P3|COMPLETED|Overall Study||38
8265169|NCT01766986|20379325|P2|COMPLETED|Overall Study||51
8265170|NCT01766986|20379326|P1|COMPLETED|Overall Study||41
8265171|NCT01766986|20379324|P3|STARTED|Overall Study||38
8265172|NCT01766986|20379325|P2|STARTED|Overall Study||51
8265173|NCT01766986|20379326|P1|STARTED|Overall Study||41
8265174|NCT01766921|20379336|P2|NOT COMPLETED|Overall Study||17
8265175|NCT01766921|20379337|P1|NOT COMPLETED|Overall Study||24
8265176|NCT01766921|20379336|P2|COMPLETED|Overall Study||676
8265177|NCT01766921|20379337|P1|COMPLETED|Overall Study||676
8265178|NCT01766921|20379336|P2|STARTED|Overall Study||693
8265179|NCT01766921|20379337|P1|STARTED|Overall Study||700
8265180|NCT01766817|20379359|P3|NOT COMPLETED|Overall Study||13
8265181|NCT01766817|20379360|P2|NOT COMPLETED|Overall Study||11
8265182|NCT01766817|20379361|P1|NOT COMPLETED|Overall Study||11
8265183|NCT01766817|20379359|P3|COMPLETED|Overall Study||34
8265184|NCT01766817|20379360|P2|COMPLETED|Overall Study||37
8265185|NCT01766817|20379361|P1|COMPLETED|Overall Study||37
8265186|NCT01766817|20379359|P3|STARTED|Overall Study||47
8265187|NCT01766817|20379360|P2|STARTED|Overall Study||48
8265188|NCT01766817|20379361|P1|STARTED|Overall Study||48
8265189|NCT01766778|20379412|P2|NOT COMPLETED|Overall Study||4
8265190|NCT01766778|20379413|P1|NOT COMPLETED|Overall Study||5
8265191|NCT01766778|20379412|P2|COMPLETED|Overall Study||57
8265192|NCT01766778|20379413|P1|COMPLETED|Overall Study||51
8265193|NCT01766778|20379412|P2|STARTED|Overall Study||61
8265194|NCT01766778|20379413|P1|STARTED|Overall Study|Intent to treat population|56
8265195|NCT01766713|20379431|P2|NOT COMPLETED|Overall Study||3
8265196|NCT01766713|20379432|P1|NOT COMPLETED|Overall Study||2
8265197|NCT01766713|20379431|P2|COMPLETED|Overall Study||22
8265198|NCT01766713|20379432|P1|COMPLETED|Overall Study||23
8265199|NCT01766713|20379431|P2|STARTED|Overall Study||25
8265200|NCT01766713|20379432|P1|STARTED|Overall Study||25
8265201|NCT01766466|20379440|P4|NOT COMPLETED|Day 5||0
8265202|NCT01766466|20379441|P3|NOT COMPLETED|Day 5||0
8265203|NCT01766466|20379442|P2|NOT COMPLETED|Day 5||0
8265204|NCT01766466|20379443|P1|NOT COMPLETED|Day 5||0
8265205|NCT01766466|20379440|P4|COMPLETED|Day 5||6
8265206|NCT01766466|20379441|P3|COMPLETED|Day 5||0
8265207|NCT01766466|20379442|P2|COMPLETED|Day 5||6
8265208|NCT01766466|20379443|P1|COMPLETED|Day 5||0
8265209|NCT01766466|20379440|P4|STARTED|Day 5||6
8265210|NCT01766466|20379441|P3|STARTED|Day 5||0
8265211|NCT01766466|20379442|P2|STARTED|Day 5||6
8265212|NCT01766466|20379443|P1|STARTED|Day 5||0
8265213|NCT01766466|20379440|P4|NOT COMPLETED|Day 1||0
8265214|NCT01766466|20379441|P3|NOT COMPLETED|Day 1||0
8265215|NCT01766466|20379442|P2|NOT COMPLETED|Day 1||0
8265216|NCT01766466|20379443|P1|NOT COMPLETED|Day 1||0
8265217|NCT01766466|20379440|P4|COMPLETED|Day 1||0
8265218|NCT01766466|20379441|P3|COMPLETED|Day 1||6
8265219|NCT01766466|20379442|P2|COMPLETED|Day 1||0
8265220|NCT01766466|20379443|P1|COMPLETED|Day 1||6
8265221|NCT01766466|20379440|P4|STARTED|Day 1||0
8265222|NCT01766466|20379441|P3|STARTED|Day 1||6
8265223|NCT01766466|20379442|P2|STARTED|Day 1||0
8265224|NCT01766466|20379443|P1|STARTED|Day 1||6
8265228|NCT01766401|20379467|P2|NOT COMPLETED|Overall Study||56
8265229|NCT01766401|20379468|P1|NOT COMPLETED|Overall Study||37
8265230|NCT01766401|20379467|P2|COMPLETED|Overall Study||144
8265231|NCT01766401|20379468|P1|COMPLETED|Overall Study||161
8265232|NCT01766401|20379467|P2|STARTED|Overall Study||200
8265233|NCT01766401|20379468|P1|STARTED|Overall Study||198
8265234|NCT01766336|20379478|P2|NOT COMPLETED|Overall Study||75
8265235|NCT01766336|20379479|P1|NOT COMPLETED|Overall Study||90
8265236|NCT01766336|20379478|P2|COMPLETED|Overall Study||71
8265237|NCT01766336|20379479|P1|COMPLETED|Overall Study||60
8265238|NCT01766336|20379478|P2|STARTED|Overall Study||146
8265239|NCT01766336|20379479|P1|STARTED|Overall Study||150
8265240|NCT01766310|20379487|P2|NOT COMPLETED|Overall Study||3
8265241|NCT01766310|20379488|P1|NOT COMPLETED|Overall Study||1
8265242|NCT01766310|20379487|P2|COMPLETED|Overall Study||23
8265243|NCT01766310|20379488|P1|COMPLETED|Overall Study||23
8265244|NCT01766310|20379487|P2|STARTED|Overall Study||26
8265245|NCT01766310|20379488|P1|STARTED|Overall Study||24
8265246|NCT01766219|20379499|P3|NOT COMPLETED|Overall Study||0
8265247|NCT01766219|20379500|P2|NOT COMPLETED|Overall Study||0
8265248|NCT01766219|20379501|P1|NOT COMPLETED|Overall Study||0
8265249|NCT01766219|20379499|P3|COMPLETED|Overall Study||11
8265250|NCT01766219|20379500|P2|COMPLETED|Overall Study||2
8265251|NCT01766219|20379501|P1|COMPLETED|Overall Study||4
8265252|NCT01766219|20379499|P3|STARTED|Overall Study||11
8265253|NCT01766219|20379500|P2|STARTED|Overall Study||2
8265254|NCT01766219|20379501|P1|STARTED|Overall Study||4
8265255|NCT01766206|20379518|P1|NOT COMPLETED|Overall Study||51
8265256|NCT01766206|20379518|P1|COMPLETED|Overall Study||3888
8265257|NCT01766206|20379518|P1|STARTED|Overall Study||3939
8265258|NCT01766102|20379527|P2|NOT COMPLETED|Overall Study||0
8265259|NCT01766102|20379528|P1|NOT COMPLETED|Overall Study||0
8265260|NCT01766102|20379527|P2|COMPLETED|Overall Study||36
8265261|NCT01766102|20379528|P1|COMPLETED|Overall Study||36
8265262|NCT01766102|20379527|P2|STARTED|Overall Study||36
8265263|NCT01766102|20379528|P1|STARTED|Overall Study||36
8265264|NCT01766076|20379538|P2|NOT COMPLETED|Overall Study||0
8265265|NCT01766076|20379539|P1|NOT COMPLETED|Overall Study||0
8265266|NCT01766076|20379538|P2|COMPLETED|Overall Study||15
8265267|NCT01766076|20379539|P1|COMPLETED|Overall Study||15
8265268|NCT01766076|20379538|P2|STARTED|Overall Study||15
8265269|NCT01766076|20379539|P1|STARTED|Overall Study||15
8265270|NCT01766050|20379545|P1|NOT COMPLETED|Overall Study||4
8265271|NCT01766050|20379545|P1|COMPLETED|Overall Study||18
8265272|NCT01766050|20379545|P1|STARTED|Overall Study||22
8265273|NCT01766037|20379680|P2|NOT COMPLETED|Overall Study||29
8265274|NCT01766037|20379681|P1|NOT COMPLETED|Overall Study||29
8265275|NCT01766037|20379680|P2|COMPLETED|Overall Study||31
8265276|NCT01766037|20379681|P1|COMPLETED|Overall Study||82
8265277|NCT01766037|20379680|P2|STARTED|Overall Study||60
8265278|NCT01766037|20379681|P1|STARTED|Overall Study||111
8265279|NCT01766024|20379718|P2|NOT COMPLETED|Overall Study||0
8265280|NCT01766024|20379719|P1|NOT COMPLETED|Overall Study||0
8265281|NCT01766024|20379718|P2|COMPLETED|Overall Study||16
8265282|NCT01766024|20379719|P1|COMPLETED|Overall Study||16
8265283|NCT01766024|20379718|P2|STARTED|Overall Study||16
8265284|NCT01766024|20379719|P1|STARTED|Overall Study||16
8265285|NCT01765972|20379729|P4|NOT COMPLETED|Overall Study||0
8265286|NCT01765972|20379730|P3|NOT COMPLETED|Overall Study||0
8265287|NCT01765972|20379731|P2|NOT COMPLETED|Overall Study||0
8265288|NCT01765972|20379732|P1|NOT COMPLETED|Overall Study||0
8265289|NCT01765972|20379729|P4|COMPLETED|Overall Study||6
8265290|NCT01765972|20379730|P3|COMPLETED|Overall Study||6
8265291|NCT01765972|20379731|P2|COMPLETED|Overall Study||6
8265292|NCT01765972|20379732|P1|COMPLETED|Overall Study||6
8265293|NCT01765972|20379729|P4|STARTED|Overall Study||6
8265294|NCT01765972|20379730|P3|STARTED|Overall Study||6
8265295|NCT01765972|20379731|P2|STARTED|Overall Study||6
8265296|NCT01765972|20379732|P1|STARTED|Overall Study||6
8265297|NCT01765920|20379744|P2|NOT COMPLETED|Overall Study||6
8265298|NCT01765920|20379745|P1|NOT COMPLETED|Overall Study||2
8265299|NCT01765920|20379744|P2|COMPLETED|Overall Study||167
8265300|NCT01765920|20379745|P1|COMPLETED|Overall Study||167
8265301|NCT01765920|20379744|P2|STARTED|Overall Study||173
8265302|NCT01765920|20379745|P1|STARTED|Overall Study||169
8265303|NCT01765803|20379759|P1|NOT COMPLETED|Overall Study||0
8265304|NCT01765803|20379759|P1|COMPLETED|Overall Study||6
8265305|NCT01765803|20379759|P1|STARTED|Overall Study||6
8265306|NCT01765764|20379767|P3|NOT COMPLETED|Post-treatment Period||0
8265307|NCT01765764|20379768|P2|NOT COMPLETED|Post-treatment Period||0
8265308|NCT01765764|20379769|P1|NOT COMPLETED|Post-treatment Period||0
8265309|NCT01765764|20379767|P3|COMPLETED|Post-treatment Period||112
8265310|NCT01765764|20379768|P2|COMPLETED|Post-treatment Period||107
8265311|NCT01765764|20379769|P1|COMPLETED|Post-treatment Period||114
8265312|NCT01765764|20379767|P3|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
8265313|NCT01765764|20379768|P2|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
8265314|NCT01765764|20379769|P1|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
8265315|NCT01765764|20379767|P3|NOT COMPLETED|Treatment Period||6
8265316|NCT01765764|20379768|P2|NOT COMPLETED|Treatment Period||9
8265317|NCT01765764|20379769|P1|NOT COMPLETED|Treatment Period||3
8265318|NCT01765764|20379767|P3|COMPLETED|Treatment Period||115
8265319|NCT01765764|20379768|P2|COMPLETED|Treatment Period||109
8265320|NCT01765764|20379769|P1|COMPLETED|Treatment Period||115
8265321|NCT01765764|20379767|P3|STARTED|Treatment Period||121
8265322|NCT01765764|20379768|P2|STARTED|Treatment Period||118
8265323|NCT01765764|20379769|P1|STARTED|Treatment Period||118
8265324|NCT01765751|20379789|P3|NOT COMPLETED|Overall Study||1
8265325|NCT01765751|20379790|P2|NOT COMPLETED|Overall Study||2
8265326|NCT01765751|20379791|P1|NOT COMPLETED|Overall Study||0
8265327|NCT01765751|20379789|P3|COMPLETED|Overall Study||15
8265328|NCT01765751|20379790|P2|COMPLETED|Overall Study||14
8265329|NCT01765751|20379791|P1|COMPLETED|Overall Study||16
8265330|NCT01765751|20379789|P3|STARTED|Overall Study||16
8265331|NCT01765751|20379790|P2|STARTED|Overall Study||16
8265332|NCT01765751|20379791|P1|STARTED|Overall Study||16
8265333|NCT01765673|20379823|P1|NOT COMPLETED|Overall Study||1
8265334|NCT01765673|20379823|P1|COMPLETED|Overall Study||11
8265335|NCT01765673|20379823|P1|STARTED|Overall Study||12
8265336|NCT01765647|20379846|P1|NOT COMPLETED|Overall Study||0
8265337|NCT01765647|20379846|P1|COMPLETED|Overall Study|10 entered the AGY treatment phase and all 10 completed treatment.|10
8265338|NCT01765647|20379846|P1|STARTED|Overall Study|One began the run-in period, but was withdrawn prior to beginning treatment with AGY|10
8265339|NCT01765582|20379856|P3|NOT COMPLETED|Overall Study||95
8265340|NCT01765582|20379857|P2|NOT COMPLETED|Overall Study||92
8265341|NCT01765582|20379858|P1|NOT COMPLETED|Overall Study||93
8265342|NCT01765582|20379856|P3|COMPLETED|Overall Study||0
8265343|NCT01765582|20379857|P2|COMPLETED|Overall Study||0
8265344|NCT01765582|20379858|P1|COMPLETED|Overall Study||0
8265345|NCT01765582|20379856|P3|STARTED|Overall Study||95
8265346|NCT01765582|20379857|P2|STARTED|Overall Study||92
8265347|NCT01765582|20379858|P1|STARTED|Overall Study||93
8265348|NCT01765569|20379891|P1|NOT COMPLETED|Period C||1
8265349|NCT01765569|20379891|P1|COMPLETED|Period C||27
8265350|NCT01765569|20379891|P1|STARTED|Period C||28
8265351|NCT01765569|20379891|P1|NOT COMPLETED|Period B||1
8265352|NCT01765569|20379891|P1|COMPLETED|Period B||28
8265353|NCT01765569|20379891|P1|STARTED|Period B||29
8265354|NCT01765569|20379891|P1|NOT COMPLETED|Period A||0
8265355|NCT01765569|20379891|P1|COMPLETED|Period A||29
8265356|NCT01765569|20379891|P1|STARTED|Period A||29
8265357|NCT01765543|20379912|P1|NOT COMPLETED|Overall Study||3
8265358|NCT01765543|20379912|P1|COMPLETED|Overall Study||24
8265359|NCT01765543|20379912|P1|STARTED|Overall Study||27
8265360|NCT01765530|20379936|P2|NOT COMPLETED|Overall Study||1
8265361|NCT01765530|20379937|P1|NOT COMPLETED|Overall Study||1
8265362|NCT01765530|20379936|P2|COMPLETED|Overall Study||36
8265363|NCT01765530|20379937|P1|COMPLETED|Overall Study||36
8265364|NCT01765530|20379936|P2|STARTED|Overall Study||37
8265365|NCT01765530|20379937|P1|STARTED|Overall Study||37
8265366|NCT01765465|20379947|P2|NOT COMPLETED|Overall Study||4
8265367|NCT01765465|20379948|P1|NOT COMPLETED|Overall Study||7
8265368|NCT01765465|20379947|P2|COMPLETED|Overall Study||63
8265369|NCT01765465|20379948|P1|COMPLETED|Overall Study||64
8265370|NCT01765465|20379947|P2|STARTED|Overall Study||67
8265371|NCT01765465|20379948|P1|STARTED|Overall Study||71
8265372|NCT01765426|20379964|P4|NOT COMPLETED|Overall Study||0
8265373|NCT01765426|20379965|P3|NOT COMPLETED|Overall Study||0
8265374|NCT01765426|20379966|P2|NOT COMPLETED|Overall Study||1
8265375|NCT01765426|20379967|P1|NOT COMPLETED|Overall Study||0
8265376|NCT01765426|20379964|P4|COMPLETED|Overall Study||15
8265377|NCT01765426|20379965|P3|COMPLETED|Overall Study||17
8265378|NCT01765426|20379966|P2|COMPLETED|Overall Study||16
8265379|NCT01765426|20379967|P1|COMPLETED|Overall Study||18
8265380|NCT01765426|20379964|P4|Completed All Vaccinations|Overall Study||15
8265381|NCT01765426|20379965|P3|Completed All Vaccinations|Overall Study||17
8265382|NCT01765426|20379966|P2|Completed All Vaccinations|Overall Study||16
8265383|NCT01765426|20379967|P1|Completed All Vaccinations|Overall Study||17
8265384|NCT01765426|20379964|P4|STARTED|Overall Study||15
8265385|NCT01765426|20379965|P3|STARTED|Overall Study||17
8265386|NCT01765426|20379966|P2|STARTED|Overall Study||17
8265387|NCT01765426|20379967|P1|STARTED|Overall Study||18
8265388|NCT01765270|20380023|P2|NOT COMPLETED|Overall Study||1
8265389|NCT01765270|20380024|P1|NOT COMPLETED|Overall Study||1
8265390|NCT01765270|20380023|P2|COMPLETED|Overall Study||6
8265391|NCT01765270|20380024|P1|COMPLETED|Overall Study||4
8265392|NCT01765270|20380023|P2|STARTED|Overall Study||7
8265393|NCT01765270|20380024|P1|STARTED|Overall Study||5
8265394|NCT01765192|20380046|P2|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
8265395|NCT01765192|20380047|P1|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
8265396|NCT01765192|20380046|P2|COMPLETED|End of Treatment Period 2 to Final Visit||27
8265397|NCT01765192|20380047|P1|COMPLETED|End of Treatment Period 2 to Final Visit||30
8265398|NCT01765192|20380046|P2|STARTED|End of Treatment Period 2 to Final Visit||28
8265489|NCT01764945|20380217|P2|COMPLETED|Overall Study||4
8265399|NCT01765192|20380047|P1|STARTED|End of Treatment Period 2 to Final Visit||30
8265400|NCT01765192|20380046|P2|NOT COMPLETED|Treatment Period 2||2
8265401|NCT01765192|20380047|P1|NOT COMPLETED|Treatment Period 2||0
8265402|NCT01765192|20380046|P2|COMPLETED|Treatment Period 2||28
8265403|NCT01765192|20380047|P1|COMPLETED|Treatment Period 2||30
8265404|NCT01765192|20380046|P2|STARTED|Treatment Period 2||30
8265405|NCT01765192|20380047|P1|STARTED|Treatment Period 2||30
8265406|NCT01765192|20380046|P2|NOT COMPLETED|Washout Period||1
8265407|NCT01765192|20380047|P1|NOT COMPLETED|Washout Period||2
8265408|NCT01765192|20380046|P2|COMPLETED|Washout Period||30
8265409|NCT01765192|20380047|P1|COMPLETED|Washout Period||30
8265410|NCT01765192|20380046|P2|STARTED|Washout Period||31
8265411|NCT01765192|20380047|P1|STARTED|Washout Period||32
8265412|NCT01765192|20380046|P2|NOT COMPLETED|Treatment Period 1||1
8265413|NCT01765192|20380047|P1|NOT COMPLETED|Treatment Period 1||0
8265414|NCT01765192|20380046|P2|COMPLETED|Treatment Period 1||31
8265415|NCT01765192|20380047|P1|COMPLETED|Treatment Period 1||32
8265416|NCT01765192|20380046|P2|STARTED|Treatment Period 1||32
8265417|NCT01765192|20380047|P1|STARTED|Treatment Period 1||32
8265418|NCT01765179|20380065|P1|NOT COMPLETED|Overall Study||27
8265419|NCT01765179|20380065|P1|COMPLETED|Overall Study||117
8265420|NCT01765179|20380065|P1|STARTED|Overall Study||144
8265421|NCT01765153|20380072|P2|NOT COMPLETED|Rest Phase 2||1
8265422|NCT01765153|20380073|P1|NOT COMPLETED|Rest Phase 2||2
8265423|NCT01765153|20380072|P2|COMPLETED|Rest Phase 2||7
8265424|NCT01765153|20380073|P1|COMPLETED|Rest Phase 2||8
8265425|NCT01765153|20380072|P2|STARTED|Rest Phase 2||8
8265426|NCT01765153|20380073|P1|STARTED|Rest Phase 2||10
8265427|NCT01765153|20380072|P2|NOT COMPLETED|Training Phase 2||1
8265428|NCT01765153|20380073|P1|NOT COMPLETED|Training Phase 2||0
8265429|NCT01765153|20380072|P2|COMPLETED|Training Phase 2||8
8265430|NCT01765153|20380073|P1|COMPLETED|Training Phase 2||10
8265431|NCT01765153|20380072|P2|STARTED|Training Phase 2||9
8265432|NCT01765153|20380073|P1|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
8265433|NCT01765153|20380072|P2|NOT COMPLETED|Rest Phase 1||1
8265434|NCT01765153|20380073|P1|NOT COMPLETED|Rest Phase 1||0
8265435|NCT01765153|20380072|P2|COMPLETED|Rest Phase 1||9
8265436|NCT01765153|20380073|P1|COMPLETED|Rest Phase 1||9
8265437|NCT01765153|20380072|P2|STARTED|Rest Phase 1||10
8265438|NCT01765153|20380073|P1|STARTED|Rest Phase 1||9
8265439|NCT01765153|20380072|P2|NOT COMPLETED|Training Phase 1||1
8265440|NCT01765153|20380073|P1|NOT COMPLETED|Training Phase 1||1
8265441|NCT01765153|20380072|P2|COMPLETED|Training Phase 1||10
8265442|NCT01765153|20380073|P1|COMPLETED|Training Phase 1||9
8265443|NCT01765153|20380072|P2|STARTED|Training Phase 1||11
8265444|NCT01765153|20380073|P1|STARTED|Training Phase 1||10
8265445|NCT01764997|20380180|P5|NOT COMPLETED|Study Drug Treatment Period||36
8265446|NCT01764997|20380181|P4|NOT COMPLETED|Study Drug Treatment Period||0
8265447|NCT01764997|20380182|P3|NOT COMPLETED|Study Drug Treatment Period||0
8265448|NCT01764997|20380183|P2|NOT COMPLETED|Study Drug Treatment Period||1
8265449|NCT01764997|20380184|P1|NOT COMPLETED|Study Drug Treatment Period||0
8265450|NCT01764997|20380180|P5|COMPLETED|Study Drug Treatment Period||286
8265451|NCT01764997|20380181|P4|COMPLETED|Study Drug Treatment Period||13
8265452|NCT01764997|20380182|P3|COMPLETED|Study Drug Treatment Period||13
8265453|NCT01764997|20380183|P2|COMPLETED|Study Drug Treatment Period||16
8265454|NCT01764997|20380184|P1|COMPLETED|Study Drug Treatment Period||0
8265455|NCT01764997|20380180|P5|STARTED|Study Drug Treatment Period||322
8265456|NCT01764997|20380181|P4|STARTED|Study Drug Treatment Period||13
8265457|NCT01764997|20380182|P3|STARTED|Study Drug Treatment Period||13
8265458|NCT01764997|20380183|P2|STARTED|Study Drug Treatment Period||17
8265459|NCT01764997|20380184|P1|STARTED|Study Drug Treatment Period||0
8265460|NCT01764997|20380180|P5|NOT COMPLETED|Run-in Period||0
8265461|NCT01764997|20380181|P4|NOT COMPLETED|Run-in Period||0
8265462|NCT01764997|20380182|P3|NOT COMPLETED|Run-in Period||0
8265463|NCT01764997|20380183|P2|NOT COMPLETED|Run-in Period||0
8265464|NCT01764997|20380184|P1|NOT COMPLETED|Run-in Period||38
8265465|NCT01764997|20380180|P5|COMPLETED|Run-in Period||0
8265466|NCT01764997|20380181|P4|COMPLETED|Run-in Period||0
8265467|NCT01764997|20380182|P3|COMPLETED|Run-in Period||0
8265468|NCT01764997|20380183|P2|COMPLETED|Run-in Period||0
8265469|NCT01764997|20380184|P1|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
8265470|NCT01764997|20380180|P5|STARTED|Run-in Period||0
8265471|NCT01764997|20380181|P4|STARTED|Run-in Period||0
8265472|NCT01764997|20380182|P3|STARTED|Run-in Period||0
8265473|NCT01764997|20380183|P2|STARTED|Run-in Period||0
8265474|NCT01764997|20380184|P1|STARTED|Run-in Period||776
8265475|NCT01764945|20380211|P8|NOT COMPLETED|Overall Study||0
8265476|NCT01764945|20380212|P7|NOT COMPLETED|Overall Study||1
8265477|NCT01764945|20380213|P6|NOT COMPLETED|Overall Study||0
8265478|NCT01764945|20380214|P5|NOT COMPLETED|Overall Study||0
8265479|NCT01764945|20380215|P4|NOT COMPLETED|Overall Study||0
8265480|NCT01764945|20380216|P3|NOT COMPLETED|Overall Study||0
8265481|NCT01764945|20380217|P2|NOT COMPLETED|Overall Study||1
8265482|NCT01764945|20380218|P1|NOT COMPLETED|Overall Study||0
8265483|NCT01764945|20380211|P8|COMPLETED|Overall Study||9
8265484|NCT01764945|20380212|P7|COMPLETED|Overall Study||8
8265485|NCT01764945|20380213|P6|COMPLETED|Overall Study||8
8265486|NCT01764945|20380214|P5|COMPLETED|Overall Study||10
8265487|NCT01764945|20380215|P4|COMPLETED|Overall Study||5
8265488|NCT01764945|20380216|P3|COMPLETED|Overall Study||5
8265490|NCT01764945|20380218|P1|COMPLETED|Overall Study||5
8265491|NCT01764945|20380211|P8|STARTED|Overall Study||9
8265492|NCT01764945|20380212|P7|STARTED|Overall Study||9
8265493|NCT01764945|20380213|P6|STARTED|Overall Study||8
8265494|NCT01764945|20380214|P5|STARTED|Overall Study||10
8265495|NCT01764945|20380215|P4|STARTED|Overall Study||5
8265496|NCT01764945|20380216|P3|STARTED|Overall Study||5
8265497|NCT01764945|20380217|P2|STARTED|Overall Study||5
8265498|NCT01764945|20380218|P1|STARTED|Overall Study||5
8265499|NCT01764919|20380252|P1|NOT COMPLETED|Overall Study||0
8265500|NCT01764919|20380252|P1|COMPLETED|Overall Study||4
8265501|NCT01764919|20380252|P1|STARTED|Overall Study||4
8265502|NCT01764854|20380264|P4|NOT COMPLETED|Overall Study||2
8265503|NCT01764854|20380265|P3|NOT COMPLETED|Overall Study||6
8265504|NCT01764854|20380266|P2|NOT COMPLETED|Overall Study||0
8265505|NCT01764854|20380267|P1|NOT COMPLETED|Overall Study||0
8265506|NCT01764854|20380264|P4|COMPLETED|Overall Study||33
8265507|NCT01764854|20380265|P3|COMPLETED|Overall Study||31
8265508|NCT01764854|20380266|P2|COMPLETED|Overall Study||8
8265509|NCT01764854|20380267|P1|COMPLETED|Overall Study||8
8265510|NCT01764854|20380264|P4|STARTED|Overall Study||35
8265511|NCT01764854|20380265|P3|STARTED|Overall Study||37
8265512|NCT01764854|20380266|P2|STARTED|Overall Study||8
8265513|NCT01764854|20380267|P1|STARTED|Overall Study||8
8265514|NCT01764841|20380281|P4|NOT COMPLETED|Overall Study||19
8265515|NCT01764841|20380282|P3|NOT COMPLETED|Overall Study||14
8265516|NCT01764841|20380283|P2|NOT COMPLETED|Overall Study||26
8265517|NCT01764841|20380284|P1|NOT COMPLETED|Overall Study||23
8265518|NCT01764841|20380281|P4|COMPLETED|Overall Study||49
8265519|NCT01764841|20380282|P3|COMPLETED|Overall Study||56
8265520|NCT01764841|20380283|P2|COMPLETED|Overall Study||111
8265521|NCT01764841|20380284|P1|COMPLETED|Overall Study||118
8265522|NCT01764841|20380281|P4|Participants Received Treatment|Overall Study|safety population|68
8265523|NCT01764841|20380282|P3|Participants Received Treatment|Overall Study|safety population|69
8265524|NCT01764841|20380283|P2|Participants Received Treatment|Overall Study|safety population|136
8265525|NCT01764841|20380284|P1|Participants Received Treatment|Overall Study|safety population|141
8265526|NCT01764841|20380281|P4|STARTED|Overall Study||68
8265527|NCT01764841|20380282|P3|STARTED|Overall Study||70
8265528|NCT01764841|20380283|P2|STARTED|Overall Study||137
8265529|NCT01764841|20380284|P1|STARTED|Overall Study||141
8265530|NCT01764685|20380318|P2|NOT COMPLETED|Overall Study||1
8265531|NCT01764685|20380319|P1|NOT COMPLETED|Overall Study||0
8265532|NCT01764685|20380318|P2|COMPLETED|Overall Study||3
8265533|NCT01764685|20380319|P1|COMPLETED|Overall Study||0
8265534|NCT01764685|20380318|P2|STARTED|Overall Study||4
8265535|NCT01764685|20380319|P1|STARTED|Overall Study||0
8265536|NCT01764659|20380325|P1|NOT COMPLETED|Overall Study||2
8265537|NCT01764659|20380325|P1|COMPLETED|Overall Study||12
8265538|NCT01764659|20380325|P1|STARTED|Overall Study||14
8265539|NCT01764633|20380339|P2|NOT COMPLETED|Overall Study||93
8265540|NCT01764633|20380340|P1|NOT COMPLETED|Overall Study||118
8265541|NCT01764633|20380339|P2|COMPLETED|Overall Study||13691
8265542|NCT01764633|20380340|P1|COMPLETED|Overall Study||13662
8265543|NCT01764633|20380339|P2|Received Treatment|Overall Study||13769
8265544|NCT01764633|20380340|P1|Received Treatment|Overall Study||13756
8265545|NCT01764633|20380339|P2|STARTED|Overall Study||13784
8265546|NCT01764633|20380340|P1|STARTED|Overall Study||13780
8265547|NCT01764607|20380362|P1|NOT COMPLETED|Overall Study||0
8265548|NCT01764607|20380362|P1|COMPLETED|Overall Study||1
8265549|NCT01764607|20380362|P1|STARTED|Overall Study||1
8265550|NCT01764464|20380369|P2|NOT COMPLETED|Second Intervention (Cross-over)||0
8265551|NCT01764464|20380370|P1|NOT COMPLETED|Second Intervention (Cross-over)||2
8265552|NCT01764464|20380369|P2|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13
8265553|NCT01764464|20380370|P1|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12
8265554|NCT01764464|20380369|P2|STARTED|Second Intervention (Cross-over)|Started Gralise|13
8265555|NCT01764464|20380370|P1|STARTED|Second Intervention (Cross-over)|Started Placebo|14
8265556|NCT01764464|20380369|P2|NOT COMPLETED|First Intervention||3
8265557|NCT01764464|20380370|P1|NOT COMPLETED|First Intervention||2
8265558|NCT01764464|20380369|P2|COMPLETED|First Intervention|Completed Placebo|13
8265559|NCT01764464|20380370|P1|COMPLETED|First Intervention|Completed Gralise|14
8265560|NCT01764464|20380369|P2|STARTED|First Intervention|Started Placebo|16
8265561|NCT01764464|20380370|P1|STARTED|First Intervention|Started Gralise|16
8265562|NCT01764386|20380388|P2|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
8265563|NCT01764386|20380389|P1|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
8265564|NCT01764386|20380388|P2|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
8265565|NCT01764386|20380389|P1|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
8265566|NCT01764386|20380388|P2|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
8265567|NCT01764386|20380389|P1|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
8265568|NCT01764386|20380388|P2|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
8265569|NCT01764386|20380389|P1|STARTED|Uncontrolled Treatment Period (UTP)||71
8265570|NCT01764386|20380388|P2|NOT COMPLETED|Controlled Treatment Period (CTP)||7
8265571|NCT01764386|20380389|P1|NOT COMPLETED|Controlled Treatment Period (CTP)||82
8265572|NCT01764386|20380388|P2|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
8265573|NCT01764386|20380389|P1|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
8265574|NCT01764386|20380388|P2|STARTED|Controlled Treatment Period (CTP)||89
8265575|NCT01764386|20380389|P1|STARTED|Controlled Treatment Period (CTP)||153
8265576|NCT01764256|20380434|P4|NOT COMPLETED|Completed Study||1
8265577|NCT01764256|20380435|P3|NOT COMPLETED|Completed Study||0
8265578|NCT01764256|20380436|P2|NOT COMPLETED|Completed Study||0
8265579|NCT01764256|20380437|P1|NOT COMPLETED|Completed Study||0
8265580|NCT01764256|20380434|P4|COMPLETED|Completed Study||11
8265581|NCT01764256|20380435|P3|COMPLETED|Completed Study||11
8265582|NCT01764256|20380436|P2|COMPLETED|Completed Study||11
8265583|NCT01764256|20380437|P1|COMPLETED|Completed Study||10
8265584|NCT01764256|20380434|P4|STARTED|Completed Study||12
8265585|NCT01764256|20380435|P3|STARTED|Completed Study||11
8265586|NCT01764256|20380436|P2|STARTED|Completed Study||11
8265587|NCT01764256|20380437|P1|STARTED|Completed Study||10
8265588|NCT01764256|20380434|P4|NOT COMPLETED|Received All Vaccinations||0
8265589|NCT01764256|20380435|P3|NOT COMPLETED|Received All Vaccinations||1
8265590|NCT01764256|20380436|P2|NOT COMPLETED|Received All Vaccinations||1
8265591|NCT01764256|20380437|P1|NOT COMPLETED|Received All Vaccinations||2
8265592|NCT01764256|20380434|P4|COMPLETED|Received All Vaccinations||12
8265593|NCT01764256|20380435|P3|COMPLETED|Received All Vaccinations||11
8265594|NCT01764256|20380436|P2|COMPLETED|Received All Vaccinations||11
8265595|NCT01764256|20380437|P1|COMPLETED|Received All Vaccinations||10
8265596|NCT01764256|20380434|P4|STARTED|Received All Vaccinations||12
8265597|NCT01764256|20380435|P3|STARTED|Received All Vaccinations||12
8265598|NCT01764256|20380436|P2|STARTED|Received All Vaccinations||12
8265599|NCT01764256|20380437|P1|STARTED|Received All Vaccinations||12
8265600|NCT01764022|20380480|P2|NOT COMPLETED|Overall Study||14
8265601|NCT01764022|20380481|P1|NOT COMPLETED|Overall Study||8
8265602|NCT01764022|20380480|P2|COMPLETED|Overall Study||96
8265603|NCT01764022|20380481|P1|COMPLETED|Overall Study||107
8265604|NCT01764022|20380480|P2|Received at Least 1 Dose of Study Drug|Overall Study||110
8265605|NCT01764022|20380481|P1|Received at Least 1 Dose of Study Drug|Overall Study||113
8265606|NCT01764022|20380480|P2|STARTED|Overall Study||110
8265607|NCT01764022|20380481|P1|STARTED|Overall Study||115
8265608|NCT01763996|20380513|P2|NOT COMPLETED|Treatment Period 2||1
8265609|NCT01763996|20380514|P1|NOT COMPLETED|Treatment Period 2||0
8265610|NCT01763996|20380513|P2|COMPLETED|Treatment Period 2||14
8265611|NCT01763996|20380514|P1|COMPLETED|Treatment Period 2||15
8265612|NCT01763996|20380513|P2|STARTED|Treatment Period 2||15
8265613|NCT01763996|20380514|P1|STARTED|Treatment Period 2||15
8265614|NCT01763996|20380513|P2|NOT COMPLETED|Treatment Period 1||0
8265615|NCT01763996|20380514|P1|NOT COMPLETED|Treatment Period 1||0
8265616|NCT01763996|20380513|P2|COMPLETED|Treatment Period 1||15
8265617|NCT01763996|20380514|P1|COMPLETED|Treatment Period 1||15
8265618|NCT01763996|20380513|P2|STARTED|Treatment Period 1||15
8265619|NCT01763996|20380514|P1|STARTED|Treatment Period 1||15
8265620|NCT01763970|20380540|P1|NOT COMPLETED|Overall Study||0
8265621|NCT01763970|20380540|P1|COMPLETED|Overall Study||14
8265622|NCT01763970|20380540|P1|STARTED|Overall Study||14
8265623|NCT01763931|20380555|P2|NOT COMPLETED|Overall Study||1
8265624|NCT01763931|20380556|P1|NOT COMPLETED|Overall Study||0
8265625|NCT01763931|20380555|P2|COMPLETED|Overall Study||3
8265626|NCT01763931|20380556|P1|COMPLETED|Overall Study||2
8265627|NCT01763931|20380555|P2|STARTED|Overall Study||4
8265628|NCT01763931|20380556|P1|STARTED|Overall Study||2
8265629|NCT01763918|20380568|P4|NOT COMPLETED|Overall Study||2
8265630|NCT01763918|20380569|P3|NOT COMPLETED|Overall Study||10
8265631|NCT01763918|20380570|P2|NOT COMPLETED|Overall Study||1
8265632|NCT01763918|20380571|P1|NOT COMPLETED|Overall Study||6
8265633|NCT01763918|20380568|P4|COMPLETED|Overall Study||108
8265634|NCT01763918|20380569|P3|COMPLETED|Overall Study||101
8265635|NCT01763918|20380570|P2|COMPLETED|Overall Study||54
8265636|NCT01763918|20380571|P1|COMPLETED|Overall Study||49
8265637|NCT01763918|20380568|P4|Received Treatment|Overall Study||110
8265638|NCT01763918|20380569|P3|Received Treatment|Overall Study||110
8265639|NCT01763918|20380570|P2|Received Treatment|Overall Study||55
8265640|NCT01763918|20380571|P1|Received Treatment|Overall Study||54
8265641|NCT01763918|20380568|P4|STARTED|Overall Study||110
8265642|NCT01763918|20380569|P3|STARTED|Overall Study||111
8265643|NCT01763918|20380570|P2|STARTED|Overall Study||55
8265644|NCT01763918|20380571|P1|STARTED|Overall Study||55
8265645|NCT01763905|20380669|P4|NOT COMPLETED|Overall Study||1
8265646|NCT01763905|20380670|P3|NOT COMPLETED|Overall Study||9
8265647|NCT01763905|20380671|P2|NOT COMPLETED|Overall Study||1
8265648|NCT01763905|20380672|P1|NOT COMPLETED|Overall Study||6
8265649|NCT01763905|20380669|P4|COMPLETED|Overall Study||101
8265650|NCT01763905|20380670|P3|COMPLETED|Overall Study||94
8265651|NCT01763905|20380671|P2|COMPLETED|Overall Study||50
8265652|NCT01763905|20380672|P1|COMPLETED|Overall Study||45
8265653|NCT01763905|20380669|P4|STARTED|Overall Study||102
8265654|NCT01763905|20380670|P3|STARTED|Overall Study||103
8265655|NCT01763905|20380671|P2|STARTED|Overall Study||51
8265656|NCT01763905|20380672|P1|STARTED|Overall Study||51
8265657|NCT01763866|20380790|P24|NOT COMPLETED|Overall Study||2
8265658|NCT01763866|20380791|P23|NOT COMPLETED|Overall Study||3
8265659|NCT01763866|20380792|P22|NOT COMPLETED|Overall Study||1
8265660|NCT01763866|20380793|P21|NOT COMPLETED|Overall Study||4
8265661|NCT01763866|20380794|P20|NOT COMPLETED|Overall Study||2
8265662|NCT01763866|20380795|P19|NOT COMPLETED|Overall Study||6
8265663|NCT01763866|20380796|P18|NOT COMPLETED|Overall Study||1
8265664|NCT01763866|20380797|P17|NOT COMPLETED|Overall Study||1
8265665|NCT01763866|20380798|P16|NOT COMPLETED|Overall Study||3
8265666|NCT01763866|20380799|P15|NOT COMPLETED|Overall Study||12
8265667|NCT01763866|20380800|P14|NOT COMPLETED|Overall Study||0
8265668|NCT01763866|20380801|P13|NOT COMPLETED|Overall Study||4
8265669|NCT01763866|20380802|P12|NOT COMPLETED|Overall Study||2
8265670|NCT01763866|20380803|P11|NOT COMPLETED|Overall Study||8
8265671|NCT01763866|20380804|P10|NOT COMPLETED|Overall Study||1
8265672|NCT01763866|20380805|P9|NOT COMPLETED|Overall Study||3
8265673|NCT01763866|20380806|P8|NOT COMPLETED|Overall Study||0
8265674|NCT01763866|20380807|P7|NOT COMPLETED|Overall Study||7
8265675|NCT01763866|20380808|P6|NOT COMPLETED|Overall Study||3
8265676|NCT01763866|20380809|P5|NOT COMPLETED|Overall Study||2
8265677|NCT01763866|20380810|P4|NOT COMPLETED|Overall Study||0
8265678|NCT01763866|20380811|P3|NOT COMPLETED|Overall Study||5
8265679|NCT01763866|20380812|P2|NOT COMPLETED|Overall Study||1
8265680|NCT01763866|20380813|P1|NOT COMPLETED|Overall Study||2
8265681|NCT01763866|20380790|P24|COMPLETED|Overall Study||113
8265682|NCT01763866|20380791|P23|COMPLETED|Overall Study||109
8265683|NCT01763866|20380792|P22|COMPLETED|Overall Study||54
8265684|NCT01763866|20380793|P21|COMPLETED|Overall Study||52
8265685|NCT01763866|20380794|P20|COMPLETED|Overall Study||110
8265686|NCT01763866|20380795|P19|COMPLETED|Overall Study||105
8265687|NCT01763866|20380796|P18|COMPLETED|Overall Study||55
8265688|NCT01763866|20380797|P17|COMPLETED|Overall Study||55
8265689|NCT01763866|20380798|P16|COMPLETED|Overall Study||112
8265690|NCT01763866|20380799|P15|COMPLETED|Overall Study||102
8265691|NCT01763866|20380800|P14|COMPLETED|Overall Study||57
8265692|NCT01763866|20380801|P13|COMPLETED|Overall Study||54
8265693|NCT01763866|20380802|P12|COMPLETED|Overall Study||108
8265694|NCT01763866|20380803|P11|COMPLETED|Overall Study||102
8265695|NCT01763866|20380804|P10|COMPLETED|Overall Study||53
8265696|NCT01763866|20380805|P9|COMPLETED|Overall Study||53
8265697|NCT01763866|20380806|P8|COMPLETED|Overall Study||55
8265698|NCT01763866|20380807|P7|COMPLETED|Overall Study||48
8265699|NCT01763866|20380808|P6|COMPLETED|Overall Study||107
8265700|NCT01763866|20380809|P5|COMPLETED|Overall Study||108
8265701|NCT01763866|20380810|P4|COMPLETED|Overall Study||55
8265702|NCT01763866|20380811|P3|COMPLETED|Overall Study||51
8265703|NCT01763866|20380812|P2|COMPLETED|Overall Study||54
8265704|NCT01763866|20380813|P1|COMPLETED|Overall Study||54
8265705|NCT01763866|20380790|P24|Received Treatment|Overall Study||115
8265706|NCT01763866|20380791|P23|Received Treatment|Overall Study||112
8265707|NCT01763866|20380792|P22|Received Treatment|Overall Study||55
8265708|NCT01763866|20380793|P21|Received Treatment|Overall Study||56
8265709|NCT01763866|20380794|P20|Received Treatment|Overall Study||112
8265710|NCT01763866|20380795|P19|Received Treatment|Overall Study||111
8265711|NCT01763866|20380796|P18|Received Treatment|Overall Study||55
8265712|NCT01763866|20380797|P17|Received Treatment|Overall Study||56
8265713|NCT01763866|20380798|P16|Received Treatment|Overall Study||115
8265714|NCT01763866|20380799|P15|Received Treatment|Overall Study||113
8265715|NCT01763866|20380800|P14|Received Treatment|Overall Study||57
8265716|NCT01763866|20380801|P13|Received Treatment|Overall Study||58
8265717|NCT01763866|20380802|P12|Received Treatment|Overall Study||110
8265718|NCT01763866|20380803|P11|Received Treatment|Overall Study||109
8265719|NCT01763866|20380804|P10|Received Treatment|Overall Study||54
8265720|NCT01763866|20380805|P9|Received Treatment|Overall Study||56
8265721|NCT01763866|20380806|P8|Received Treatment|Overall Study||55
8265722|NCT01763866|20380807|P7|Received Treatment|Overall Study||55
8265723|NCT01763866|20380808|P6|Received Treatment|Overall Study||110
8265724|NCT01763866|20380809|P5|Received Treatment|Overall Study||110
8265725|NCT01763866|20380810|P4|Received Treatment|Overall Study||55
8265726|NCT01763866|20380811|P3|Received Treatment|Overall Study||56
8265727|NCT01763866|20380812|P2|Received Treatment|Overall Study||55
8265728|NCT01763866|20380813|P1|Received Treatment|Overall Study||56
8265729|NCT01763866|20380790|P24|STARTED|Overall Study||115
8265730|NCT01763866|20380791|P23|STARTED|Overall Study||112
8265731|NCT01763866|20380792|P22|STARTED|Overall Study||55
8265732|NCT01763866|20380793|P21|STARTED|Overall Study||56
8265733|NCT01763866|20380794|P20|STARTED|Overall Study||112
8265734|NCT01763866|20380795|P19|STARTED|Overall Study||111
8265735|NCT01763866|20380796|P18|STARTED|Overall Study||56
8265736|NCT01763866|20380797|P17|STARTED|Overall Study||56
8265737|NCT01763866|20380798|P16|STARTED|Overall Study||115
8265738|NCT01763866|20380799|P15|STARTED|Overall Study||114
8265739|NCT01763866|20380800|P14|STARTED|Overall Study||57
8265740|NCT01763866|20380801|P13|STARTED|Overall Study||58
8265741|NCT01763866|20380802|P12|STARTED|Overall Study||110
8265742|NCT01763866|20380803|P11|STARTED|Overall Study||110
8265743|NCT01763866|20380804|P10|STARTED|Overall Study||54
8265744|NCT01763866|20380805|P9|STARTED|Overall Study||56
8265745|NCT01763866|20380806|P8|STARTED|Overall Study||55
8265746|NCT01763866|20380807|P7|STARTED|Overall Study||55
8265747|NCT01763866|20380808|P6|STARTED|Overall Study||110
8265748|NCT01763866|20380809|P5|STARTED|Overall Study||110
8265749|NCT01763866|20380810|P4|STARTED|Overall Study||55
8265750|NCT01763866|20380811|P3|STARTED|Overall Study||56
8265751|NCT01763866|20380812|P2|STARTED|Overall Study||55
8265752|NCT01763866|20380813|P1|STARTED|Overall Study||56
8265753|NCT01763827|20381373|P6|NOT COMPLETED|Overall Study||2
8265754|NCT01763827|20381374|P5|NOT COMPLETED|Overall Study||6
8265755|NCT01763827|20381375|P4|NOT COMPLETED|Overall Study||1
8265756|NCT01763827|20381376|P3|NOT COMPLETED|Overall Study||4
8265757|NCT01763827|20381377|P2|NOT COMPLETED|Overall Study||1
8265758|NCT01763827|20381378|P1|NOT COMPLETED|Overall Study||3
8265759|NCT01763827|20381373|P6|COMPLETED|Overall Study||151
8265760|NCT01763827|20381374|P5|COMPLETED|Overall Study||147
8265761|NCT01763827|20381375|P4|COMPLETED|Overall Study||76
8265762|NCT01763827|20381376|P3|COMPLETED|Overall Study||73
8265763|NCT01763827|20381377|P2|COMPLETED|Overall Study||77
8265764|NCT01763827|20381378|P1|COMPLETED|Overall Study||74
8265765|NCT01763827|20381373|P6|Received at Least 1 Dose of Study Drug|Overall Study||153
8265766|NCT01763827|20381374|P5|Received at Least 1 Dose of Study Drug|Overall Study||153
8265767|NCT01763827|20381375|P4|Received at Least 1 Dose of Study Drug|Overall Study||77
8265768|NCT01763827|20381376|P3|Received at Least 1 Dose of Study Drug|Overall Study||77
8265769|NCT01763827|20381377|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
8265770|NCT01763827|20381378|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
8265771|NCT01763827|20381373|P6|STARTED|Overall Study||153
8265772|NCT01763827|20381374|P5|STARTED|Overall Study||153
8265773|NCT01763827|20381375|P4|STARTED|Overall Study||77
8265774|NCT01763827|20381376|P3|STARTED|Overall Study||77
8265775|NCT01763827|20381377|P2|STARTED|Overall Study||78
8265776|NCT01763827|20381378|P1|STARTED|Overall Study||77
8265777|NCT01763788|20381522|P4|NOT COMPLETED|Overall Study||0
8265778|NCT01763788|20381523|P3|NOT COMPLETED|Overall Study||1
8265779|NCT01763788|20381524|P2|NOT COMPLETED|Overall Study||0
8265780|NCT01763788|20381525|P1|NOT COMPLETED|Overall Study||0
8265781|NCT01763788|20381522|P4|COMPLETED|Overall Study||92
8265782|NCT01763788|20381523|P3|COMPLETED|Overall Study||90
8265783|NCT01763788|20381524|P2|COMPLETED|Overall Study||6
8265784|NCT01763788|20381525|P1|COMPLETED|Overall Study||3
8265785|NCT01763788|20381522|P4|Received at Least 1dose of Study Drug|Overall Study||91
8265786|NCT01763788|20381523|P3|Received at Least 1dose of Study Drug|Overall Study||90
8265787|NCT01763788|20381524|P2|Received at Least 1dose of Study Drug|Overall Study||6
8265788|NCT01763788|20381525|P1|Received at Least 1dose of Study Drug|Overall Study||3
8265789|NCT01763788|20381522|P4|STARTED|Overall Study||92
8265790|NCT01763788|20381523|P3|STARTED|Overall Study||91
8265791|NCT01763788|20381524|P2|STARTED|Overall Study||6
8265792|NCT01763788|20381525|P1|STARTED|Overall Study||3
8265793|NCT01763645|20381561|P2|NOT COMPLETED|Overall Study||24
8265794|NCT01763645|20381562|P1|NOT COMPLETED|Overall Study||26
8265795|NCT01763645|20381561|P2|COMPLETED|Overall Study|Completed the study according the protocol.|45
8265796|NCT01763645|20381562|P1|COMPLETED|Overall Study|Completed the study according the protocol.|43
8265797|NCT01763645|20381561|P2|Received at Least 1 Dose of Study Drug|Overall Study||66
8265798|NCT01763645|20381562|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
8265799|NCT01763645|20381561|P2|STARTED|Overall Study||69
8265800|NCT01763645|20381562|P1|STARTED|Overall Study||69
8265801|NCT01763606|20381582|P2|NOT COMPLETED|Overall Study||0
8265802|NCT01763606|20381583|P1|NOT COMPLETED|Overall Study||0
8265803|NCT01763606|20381582|P2|COMPLETED|Overall Study||10
8265804|NCT01763606|20381583|P1|COMPLETED|Overall Study||10
8265805|NCT01763606|20381582|P2|STARTED|Overall Study||10
8265806|NCT01763606|20381583|P1|STARTED|Overall Study||10
8265807|NCT01763567|20381592|P1|NOT COMPLETED|Overall Study||0
8265808|NCT01763567|20381592|P1|COMPLETED|Overall Study||19
8265809|NCT01763567|20381592|P1|STARTED|Overall Study||19
8265810|NCT01763346|20381602|P2|NOT COMPLETED|Overall Study||8
8265811|NCT01763346|20381603|P1|NOT COMPLETED|Overall Study||10
8265812|NCT01763346|20381602|P2|COMPLETED|Overall Study||36
8265813|NCT01763346|20381603|P1|COMPLETED|Overall Study||34
8265814|NCT01763346|20381602|P2|Received Intervention|Overall Study||38
8265815|NCT01763346|20381603|P1|Received Intervention|Overall Study||39
8265816|NCT01763346|20381602|P2|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44
8265817|NCT01763346|20381603|P1|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44
8265818|NCT01763333|20381627|P14|NOT COMPLETED|Overall Study||0
8265819|NCT01763333|20381628|P13|NOT COMPLETED|Overall Study||0
8265820|NCT01763333|20381629|P12|NOT COMPLETED|Overall Study||0
8265821|NCT01763333|20381630|P11|NOT COMPLETED|Overall Study||0
8265822|NCT01763333|20381631|P10|NOT COMPLETED|Overall Study||0
8265823|NCT01763333|20381632|P9|NOT COMPLETED|Overall Study||0
8265824|NCT01763333|20381633|P8|NOT COMPLETED|Overall Study||0
8265825|NCT01763333|20381634|P7|NOT COMPLETED|Overall Study||0
8265826|NCT01763333|20381635|P6|NOT COMPLETED|Overall Study||0
8265827|NCT01763333|20381636|P5|NOT COMPLETED|Overall Study||0
8265828|NCT01763333|20381637|P4|NOT COMPLETED|Overall Study||0
8265829|NCT01763333|20381638|P3|NOT COMPLETED|Overall Study||0
8265830|NCT01763333|20381639|P2|NOT COMPLETED|Overall Study||0
8265831|NCT01763333|20381640|P1|NOT COMPLETED|Overall Study||0
8265832|NCT01763333|20381627|P14|COMPLETED|Overall Study||3
8265833|NCT01763333|20381628|P13|COMPLETED|Overall Study||3
8265834|NCT01763333|20381629|P12|COMPLETED|Overall Study||3
8265835|NCT01763333|20381630|P11|COMPLETED|Overall Study||3
8265836|NCT01763333|20381631|P10|COMPLETED|Overall Study||18
8265837|NCT01763333|20381632|P9|COMPLETED|Overall Study||5
8265838|NCT01763333|20381633|P8|COMPLETED|Overall Study||6
8265839|NCT01763333|20381634|P7|COMPLETED|Overall Study||5
8265840|NCT01763333|20381635|P6|COMPLETED|Overall Study||6
8265841|NCT01763333|20381636|P5|COMPLETED|Overall Study||4
8265842|NCT01763333|20381637|P4|COMPLETED|Overall Study||6
8265843|NCT01763333|20381638|P3|COMPLETED|Overall Study||6
8265844|NCT01763333|20381639|P2|COMPLETED|Overall Study||6
8265845|NCT01763333|20381640|P1|COMPLETED|Overall Study||6
8265846|NCT01763333|20381627|P14|STARTED|Overall Study||3
8265847|NCT01763333|20381628|P13|STARTED|Overall Study||3
8265848|NCT01763333|20381629|P12|STARTED|Overall Study||3
8265849|NCT01763333|20381630|P11|STARTED|Overall Study||3
8265850|NCT01763333|20381631|P10|STARTED|Overall Study||18
8265851|NCT01763333|20381632|P9|STARTED|Overall Study||5
8265852|NCT01763333|20381633|P8|STARTED|Overall Study||6
8265853|NCT01763333|20381634|P7|STARTED|Overall Study||5
8265854|NCT01763333|20381635|P6|STARTED|Overall Study||6
8265855|NCT01763333|20381636|P5|STARTED|Overall Study||4
8265856|NCT01763333|20381637|P4|STARTED|Overall Study||6
8265857|NCT01763333|20381638|P3|STARTED|Overall Study||6
8265858|NCT01763333|20381639|P2|STARTED|Overall Study||6
8265859|NCT01763333|20381640|P1|STARTED|Overall Study||6
8265860|NCT01763203|20381746|P2|NOT COMPLETED|Overall Study||42
8265861|NCT01763203|20381747|P1|NOT COMPLETED|Overall Study||33
8265862|NCT01763203|20381746|P2|COMPLETED|Overall Study||204
8265863|NCT01763203|20381747|P1|COMPLETED|Overall Study||208
8265864|NCT01763203|20381746|P2|STARTED|Overall Study||246
8265865|NCT01763203|20381747|P1|STARTED|Overall Study||241
8265866|NCT01763047|20381793|P2|NOT COMPLETED|Period 2||5
8265867|NCT01763047|20381794|P1|NOT COMPLETED|Period 2||4
8265868|NCT01763047|20381793|P2|COMPLETED|Period 2||121
8265869|NCT01763047|20381794|P1|COMPLETED|Period 2||126
8265870|NCT01763047|20381793|P2|Hyperopes|Period 2||54
8265871|NCT01763047|20381794|P1|Hyperopes|Period 2||56
8265872|NCT01763047|20381793|P2|Myopes|Period 2||72
8265873|NCT01763047|20381794|P1|Myopes|Period 2||74
8265874|NCT01763047|20381793|P2|STARTED|Period 2||126
8265875|NCT01763047|20381794|P1|STARTED|Period 2||130
8265876|NCT01763047|20381793|P2|NOT COMPLETED|Period 1||11
8265877|NCT01763047|20381794|P1|NOT COMPLETED|Period 1||9
8265878|NCT01763047|20381793|P2|COMPLETED|Period 1||126
8265879|NCT01763047|20381794|P1|COMPLETED|Period 1||130
8265880|NCT01763047|20381793|P2|Hyperopes|Period 1||61
8265881|NCT01763047|20381794|P1|Hyperopes|Period 1||62
8265882|NCT01763047|20381793|P2|Myopes|Period 1||76
8265883|NCT01763047|20381794|P1|Myopes|Period 1||77
8265884|NCT01763047|20381793|P2|STARTED|Period 1||137
8265885|NCT01763047|20381794|P1|STARTED|Period 1||139
8265886|NCT01762982|20381810|P1|NOT COMPLETED|Overall Study||0
8265887|NCT01762982|20381810|P1|COMPLETED|Overall Study||36
8265888|NCT01762982|20381810|P1|Received Empty Finn Chamber|Overall Study||36
8265889|NCT01762982|20381810|P1|Received SLS|Overall Study||36
8265890|NCT01762982|20381810|P1|Received Benzalkonium Chloride|Overall Study||36
8265891|NCT01762982|20381810|P1|Received Saline Water|Overall Study||36
8265892|NCT01762982|20381810|P1|STARTED|Overall Study||36
8265893|NCT01762943|20381833|P2|NOT COMPLETED|Overall Study||2
8265894|NCT01762943|20381834|P1|NOT COMPLETED|Overall Study||4
8265895|NCT01762943|20381833|P2|COMPLETED|Overall Study||15
8265896|NCT01762943|20381834|P1|COMPLETED|Overall Study||15
8265897|NCT01762943|20381833|P2|Withdrawal|Overall Study||15
8265898|NCT01762943|20381834|P1|Withdrawal|Overall Study||15
8265899|NCT01762943|20381833|P2|Addback|Overall Study||15
8265900|NCT01762943|20381834|P1|Addback|Overall Study||16
8265901|NCT01762943|20381833|P2|Hypogonadism|Overall Study||15
8265902|NCT01762943|20381834|P1|Hypogonadism|Overall Study||18
8265903|NCT01762943|20381833|P2|STARTED|Overall Study||17
8265904|NCT01762943|20381834|P1|STARTED|Overall Study||19
8265905|NCT01762904|20381842|P1|NOT COMPLETED|Overall Study||0
8265906|NCT01762904|20381842|P1|COMPLETED|Overall Study|October, 2013|135
8265907|NCT01762904|20381842|P1|STARTED|Overall Study|January, 2013|135
8265908|NCT01762800|20381851|P2|NOT COMPLETED|Overall Study||21
8265909|NCT01762800|20381852|P1|NOT COMPLETED|Overall Study||19
8265910|NCT01762800|20381851|P2|COMPLETED|Overall Study||183
8265911|NCT01762800|20381852|P1|COMPLETED|Overall Study||183
8265912|NCT01762800|20381851|P2|STARTED|Overall Study||204
8265913|NCT01762800|20381852|P1|STARTED|Overall Study||202
8265914|NCT01762761|20381926|P2|NOT COMPLETED|Overall Study||65
8265915|NCT01762761|20381927|P1|NOT COMPLETED|Overall Study||39
8265916|NCT01762761|20381926|P2|COMPLETED|Overall Study||39
8265917|NCT01762761|20381927|P1|COMPLETED|Overall Study||12
8265918|NCT01762761|20381926|P2|STARTED|Overall Study||104
8265919|NCT01762761|20381927|P1|STARTED|Overall Study||51
8265920|NCT01762722|20381983|P2|NOT COMPLETED|Overall Study||0
8265921|NCT01762722|20381984|P1|NOT COMPLETED|Overall Study||0
8265922|NCT01762722|20381983|P2|COMPLETED|Overall Study||11
8265923|NCT01762722|20381984|P1|COMPLETED|Overall Study||12
8265924|NCT01762722|20381983|P2|STARTED|Overall Study||11
8265925|NCT01762722|20381984|P1|STARTED|Overall Study||12
8265926|NCT01762631|20381992|P2|NOT COMPLETED|Overall Study||0
8265927|NCT01762631|20381993|P1|NOT COMPLETED|Overall Study||0
8265928|NCT01762631|20381992|P2|COMPLETED|Overall Study||22
8265929|NCT01762631|20381993|P1|COMPLETED|Overall Study||53
8265930|NCT01762631|20381992|P2|STARTED|Overall Study||22
8265931|NCT01762631|20381993|P1|STARTED|Overall Study||53
8265932|NCT01762501|20382011|P2|NOT COMPLETED|Overall Study||23
8265933|NCT01762501|20382012|P1|NOT COMPLETED|Overall Study||27
8265934|NCT01762501|20382011|P2|COMPLETED|Overall Study||336
8265935|NCT01762501|20382012|P1|COMPLETED|Overall Study||332
8265936|NCT01762501|20382011|P2|STARTED|Overall Study||359
8265937|NCT01762501|20382012|P1|STARTED|Overall Study||359
8265938|NCT01762345|20382026|P1|NOT COMPLETED|Overall Study||7
8265939|NCT01762345|20382026|P1|COMPLETED|Overall Study||76
8265940|NCT01762345|20382026|P1|STARTED|Overall Study||83
8265941|NCT01762059|20382036|P1|NOT COMPLETED|Overall Study||0
8265942|NCT01762059|20382036|P1|COMPLETED|Overall Study||20
8265943|NCT01762059|20382036|P1|STARTED|Overall Study||20
8265944|NCT01761747|20382063|P1|NOT COMPLETED|Overall Study||1
8265945|NCT01761747|20382063|P1|COMPLETED|Overall Study||2
8265946|NCT01761747|20382063|P1|STARTED|Overall Study||3
8265947|NCT01761643|20382076|P2|NOT COMPLETED|Overall Study||42
8265948|NCT01761643|20382077|P1|NOT COMPLETED|Overall Study||32
8265949|NCT01761643|20382076|P2|COMPLETED|Overall Study||158
8265950|NCT01761643|20382077|P1|COMPLETED|Overall Study||166
8265951|NCT01761643|20382076|P2|STARTED|Overall Study||200
8265952|NCT01761643|20382077|P1|STARTED|Overall Study||198
8265953|NCT01761565|20382087|P1|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
8265954|NCT01761565|20382087|P1|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
8265955|NCT01761565|20382087|P1|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
8265956|NCT01761565|20382087|P1|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
8265957|NCT01761565|20382087|P1|COMPLETED|Single Dose of SUF NT 15 mcg||40
8265958|NCT01761565|20382087|P1|STARTED|Single Dose of SUF NT 15 mcg||40
8265959|NCT01761292|20382099|P1|NOT COMPLETED|Extension 3||0
8265960|NCT01761292|20382099|P1|COMPLETED|Extension 3||18
8265961|NCT01761292|20382099|P1|STARTED|Extension 3||18
8265962|NCT01761292|20382099|P1|NOT COMPLETED|Extension 2||0
8265963|NCT01761292|20382099|P1|COMPLETED|Extension 2||18
8265964|NCT01761292|20382099|P1|STARTED|Extension 2||18
8265965|NCT01761292|20382099|P1|NOT COMPLETED|Extension 1||1
8265966|NCT01761292|20382099|P1|COMPLETED|Extension 1||18
8265967|NCT01761292|20382099|P1|STARTED|Extension 1||19
8265968|NCT01761292|20382099|P1|NOT COMPLETED|Part 2||0
8265969|NCT01761292|20382099|P1|COMPLETED|Part 2||19
8265970|NCT01761292|20382099|P1|STARTED|Part 2|1 pt was enrolled in Part 1 but started the treatment in Part 2. So 19 pts started Part 2.|19
8265971|NCT01761292|20382099|P1|NOT COMPLETED|Part 1||2
8265972|NCT01761292|20382099|P1|COMPLETED|Part 1||18
8265973|NCT01761292|20382099|P1|Patients Receiving Drug in Part 1|Part 1|One patient was enrolled in Part 1 and started treatment in Part 2.|19
8265974|NCT01761292|20382099|P1|STARTED|Part 1||20
8265975|NCT01761279|20382118|P1|NOT COMPLETED|Overall Study||0
8265976|NCT01761279|20382118|P1|COMPLETED|Overall Study||84
8265977|NCT01761279|20382118|P1|STARTED|Overall Study||84
8265986|NCT01761175|20382162|P2|NOT COMPLETED|Overall Study||0
8265987|NCT01761175|20382163|P1|NOT COMPLETED|Overall Study||0
8265988|NCT01761175|20382162|P2|COMPLETED|Overall Study||112
8265989|NCT01761175|20382163|P1|COMPLETED|Overall Study||112
8265990|NCT01761175|20382162|P2|STARTED|Overall Study||112
8265991|NCT01761175|20382163|P1|STARTED|Overall Study||112
8265992|NCT01761162|20382191|P1|NOT COMPLETED|Overall Study||3
8265993|NCT01761162|20382191|P1|COMPLETED|Overall Study||226
8265994|NCT01761162|20382191|P1|STARTED|Overall Study||229
8265995|NCT01761084|20382201|P2|NOT COMPLETED|Overall Study||6
8265996|NCT01761084|20382202|P1|NOT COMPLETED|Overall Study||5
8265997|NCT01761084|20382201|P2|COMPLETED|Overall Study||64
8265998|NCT01761084|20382202|P1|COMPLETED|Overall Study||66
8265999|NCT01761084|20382201|P2|STARTED|Overall Study||70
8266000|NCT01761084|20382202|P1|STARTED|Overall Study||71
8266001|NCT01761019|20382251|P1|NOT COMPLETED|Overall Study||0
8266002|NCT01761019|20382251|P1|COMPLETED|Overall Study||8
8266003|NCT01761019|20382251|P1|STARTED|Overall Study||8
8266031|NCT01760941|20382361|P1|NOT COMPLETED|Overall Study||0
8266032|NCT01760941|20382361|P1|COMPLETED|Overall Study||1
8266033|NCT01760941|20382361|P1|STARTED|Overall Study||1
8266043|NCT01760876|20382420|P1|NOT COMPLETED|Overall Study||6
8266044|NCT01760876|20382420|P1|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
8266045|NCT01760876|20382420|P1|STARTED|Overall Study||106
8266046|NCT01760785|20382426|P2|NOT COMPLETED|Overall Study||0
8266047|NCT01760785|20382427|P1|NOT COMPLETED|Overall Study||0
8266048|NCT01760785|20382426|P2|COMPLETED|Overall Study||27
8266049|NCT01760785|20382427|P1|COMPLETED|Overall Study||23
8266050|NCT01760785|20382426|P2|STARTED|Overall Study||27
8266051|NCT01760785|20382427|P1|STARTED|Overall Study||23
8266052|NCT01760733|20382435|P1|NOT COMPLETED|Transplanted||217
8266053|NCT01760733|20382435|P1|COMPLETED|Transplanted||0
8266054|NCT01760733|20382435|P1|STARTED|Transplanted||217
8266055|NCT01760733|20382435|P1|NOT COMPLETED|Waiting List||72
8266056|NCT01760733|20382435|P1|COMPLETED|Waiting List|217 patients have been transplanted|217
8266057|NCT01760733|20382435|P1|STARTED|Waiting List|All patients included started in the waiting list group.|289
8266058|NCT01760473|20382440|P1|NOT COMPLETED|Overall Study||15
8266059|NCT01760473|20382440|P1|COMPLETED|Overall Study||12
8266060|NCT01760473|20382440|P1|STARTED|Overall Study||27
8266061|NCT01760447|20382465|P4|NOT COMPLETED|Weeks 20-54||4
8266062|NCT01760447|20382466|P3|NOT COMPLETED|Weeks 20-54||3
8266063|NCT01760447|20382467|P2|NOT COMPLETED|Weeks 20-54||2
8266064|NCT01760447|20382468|P1|NOT COMPLETED|Weeks 20-54||3
8266065|NCT01760447|20382465|P4|COMPLETED|Weeks 20-54||43
8266066|NCT01760447|20382466|P3|COMPLETED|Weeks 20-54||39
8266067|NCT01760447|20382467|P2|COMPLETED|Weeks 20-54||28
8266068|NCT01760447|20382468|P1|COMPLETED|Weeks 20-54||25
8266069|NCT01760447|20382465|P4|STARTED|Weeks 20-54||47
8266070|NCT01760447|20382466|P3|STARTED|Weeks 20-54||42
8266071|NCT01760447|20382467|P2|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|30
8266072|NCT01760447|20382468|P1|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|28
8266073|NCT01760447|20382465|P4|NOT COMPLETED|Weeks 0-20||4
8266074|NCT01760447|20382466|P3|NOT COMPLETED|Weeks 0-20||5
8266075|NCT01760447|20382467|P2|NOT COMPLETED|Weeks 0-20||0
8266076|NCT01760447|20382468|P1|NOT COMPLETED|Weeks 0-20||3
8266077|NCT01760447|20382465|P4|COMPLETED|Weeks 0-20||47
8266078|NCT01760447|20382466|P3|COMPLETED|Weeks 0-20||42
8266079|NCT01760447|20382467|P2|COMPLETED|Weeks 0-20||62
8266080|NCT01760447|20382468|P1|COMPLETED|Weeks 0-20||59
8266081|NCT01760447|20382465|P4|Treated|Weeks 0-20||51
8266082|NCT01760447|20382466|P3|Treated|Weeks 0-20||45
8266083|NCT01760447|20382467|P2|Treated|Weeks 0-20||62
8266084|NCT01760447|20382468|P1|Treated|Weeks 0-20||62
8266085|NCT01760447|20382465|P4|STARTED|Weeks 0-20||51
8266086|NCT01760447|20382466|P3|STARTED|Weeks 0-20||47
8266087|NCT01760447|20382467|P2|STARTED|Weeks 0-20||62
8266088|NCT01760447|20382468|P1|STARTED|Weeks 0-20|The first randomization for the participant who withdrew and re-randomized is not counted in the 62.|62
8266089|NCT01760304|20382528|P2|NOT COMPLETED|Overall Study||0
8266090|NCT01760304|20382529|P1|NOT COMPLETED|Overall Study||0
8266091|NCT01760304|20382528|P2|COMPLETED|Overall Study||3
8266092|NCT01760304|20382529|P1|COMPLETED|Overall Study||2
8266093|NCT01760304|20382528|P2|STARTED|Overall Study||3
8266094|NCT01760304|20382529|P1|STARTED|Overall Study||2
8266095|NCT01760239|20382541|P2|NOT COMPLETED|Overall Study||14316
8266096|NCT01760239|20382542|P1|NOT COMPLETED|Overall Study||16741
8266097|NCT01760239|20382541|P2|COMPLETED|Overall Study||226
8266098|NCT01760239|20382542|P1|COMPLETED|Overall Study||296
8266099|NCT01760239|20382541|P2|STARTED|Overall Study||14542
8266100|NCT01760239|20382542|P1|STARTED|Overall Study||17037
8266101|NCT01760187|20382562|P5|NOT COMPLETED|Overall Study||0
8266102|NCT01760187|20382563|P4|NOT COMPLETED|Overall Study||2
8266103|NCT01760187|20382564|P3|NOT COMPLETED|Overall Study||0
8266104|NCT01760187|20382565|P2|NOT COMPLETED|Overall Study||0
8266105|NCT01760187|20382566|P1|NOT COMPLETED|Overall Study||1
8266106|NCT01760187|20382562|P5|COMPLETED|Overall Study||16
8266107|NCT01760187|20382563|P4|COMPLETED|Overall Study||10
8266108|NCT01760187|20382564|P3|COMPLETED|Overall Study||12
8266109|NCT01760187|20382565|P2|COMPLETED|Overall Study||12
8266110|NCT01760187|20382566|P1|COMPLETED|Overall Study||19
8266111|NCT01760187|20382562|P5|STARTED|Overall Study||16
8266112|NCT01760187|20382563|P4|STARTED|Overall Study||12
8266113|NCT01760187|20382564|P3|STARTED|Overall Study||12
8266114|NCT01760187|20382565|P2|STARTED|Overall Study||12
8266115|NCT01760187|20382566|P1|STARTED|Overall Study||20
8266116|NCT01759862|20382796|P2|NOT COMPLETED|Overall Study||2
8266117|NCT01759862|20382797|P1|NOT COMPLETED|Overall Study||3
8266118|NCT01759862|20382796|P2|COMPLETED|Overall Study||25
8266119|NCT01759862|20382797|P1|COMPLETED|Overall Study||20
8266120|NCT01759862|20382796|P2|STARTED|Overall Study||27
8266121|NCT01759862|20382797|P1|STARTED|Overall Study||23
8266122|NCT01759602|20382807|P1|NOT COMPLETED|Overall Study||0
8266123|NCT01759602|20382807|P1|COMPLETED|Overall Study||10
8266124|NCT01759602|20382807|P1|STARTED|Overall Study||10
8266125|NCT01759511|20382815|P1|NOT COMPLETED|Overall Study||34
8266126|NCT01759511|20382815|P1|COMPLETED|Overall Study||0
8266127|NCT01759511|20382815|P1|STARTED|Overall Study||34
8266128|NCT01759446|20382828|P5|NOT COMPLETED|Overall Study||0
8266129|NCT01759446|20382829|P4|NOT COMPLETED|Overall Study||1
8266130|NCT01759446|20382830|P3|NOT COMPLETED|Overall Study||1
8266131|NCT01759446|20382831|P2|NOT COMPLETED|Overall Study||1
8266132|NCT01759446|20382832|P1|NOT COMPLETED|Overall Study||1
8266133|NCT01759446|20382828|P5|COMPLETED|Overall Study||8
8266134|NCT01759446|20382829|P4|COMPLETED|Overall Study||8
8266135|NCT01759446|20382830|P3|COMPLETED|Overall Study||8
8266136|NCT01759446|20382831|P2|COMPLETED|Overall Study||8
8266137|NCT01759446|20382832|P1|COMPLETED|Overall Study||8
8266138|NCT01759446|20382828|P5|STARTED|Overall Study||8
8266139|NCT01759446|20382829|P4|STARTED|Overall Study||9
8266140|NCT01759446|20382830|P3|STARTED|Overall Study||9
8266141|NCT01759446|20382831|P2|STARTED|Overall Study||9
8266142|NCT01759446|20382832|P1|STARTED|Overall Study||9
8266143|NCT01759420|20382844|P1|NOT COMPLETED|Overall Study||6
8266144|NCT01759420|20382844|P1|COMPLETED|Overall Study||22
8266145|NCT01759420|20382844|P1|STARTED|Overall Study||28
8266146|NCT01759407|20382851|P2|NOT COMPLETED|Overall Study||2
8266147|NCT01759407|20382852|P1|NOT COMPLETED|Overall Study||0
8266148|NCT01759407|20382851|P2|COMPLETED|Overall Study||7
8266149|NCT01759407|20382852|P1|COMPLETED|Overall Study||10
8266150|NCT01759407|20382851|P2|STARTED|Overall Study||9
8266151|NCT01759407|20382852|P1|STARTED|Overall Study||10
8266152|NCT01759381|20382864|P2|NOT COMPLETED|Overall Study||0
8266153|NCT01759381|20382865|P1|NOT COMPLETED|Overall Study||1
8266154|NCT01759381|20382864|P2|COMPLETED|Overall Study||11
8266155|NCT01759381|20382865|P1|COMPLETED|Overall Study||7
8266156|NCT01759381|20382864|P2|STARTED|Overall Study||11
8266157|NCT01759381|20382865|P1|STARTED|Overall Study||8
8266158|NCT01759368|20382873|P2|NOT COMPLETED|Overall Study||0
8266159|NCT01759368|20382874|P1|NOT COMPLETED|Overall Study||1
8266160|NCT01759368|20382873|P2|COMPLETED|Overall Study||47
8266161|NCT01759368|20382874|P1|COMPLETED|Overall Study||46
8266162|NCT01759368|20382873|P2|STARTED|Overall Study||47
8266163|NCT01759368|20382874|P1|STARTED|Overall Study||47
8266164|NCT01759290|20382892|P1|NOT COMPLETED|Overall Study||81
8266165|NCT01759290|20382892|P1|COMPLETED|Overall Study||1719
8266166|NCT01759290|20382892|P1|STARTED|Overall Study||1800
8266173|NCT01759264|20382961|P1|NOT COMPLETED|Overall Study||10
8266174|NCT01759264|20382961|P1|COMPLETED|Overall Study||91
8266175|NCT01759264|20382961|P1|STARTED|Overall Study||101
8266176|NCT01759251|20382974|P1|NOT COMPLETED|Follow-up Period||0
8266177|NCT01759251|20382974|P1|COMPLETED|Follow-up Period||305
8266178|NCT01759251|20382974|P1|STARTED|Follow-up Period||305
8266179|NCT01759251|20382974|P1|NOT COMPLETED|60 Days Treatment Period||0
8266180|NCT01759251|20382974|P1|COMPLETED|60 Days Treatment Period||305
8266181|NCT01759251|20382974|P1|STARTED|60 Days Treatment Period||305
8266182|NCT01759251|20382974|P1|NOT COMPLETED|30 Days Treatment Period||4
8266183|NCT01759251|20382974|P1|COMPLETED|30 Days Treatment Period||305
8266184|NCT01759251|20382974|P1|STARTED|30 Days Treatment Period||309
8266185|NCT01759160|20382980|P2|NOT COMPLETED|Overall Study||0
8266186|NCT01759160|20382981|P1|NOT COMPLETED|Overall Study||0
8266187|NCT01759160|20382980|P2|COMPLETED|Overall Study||30
8266188|NCT01759160|20382981|P1|COMPLETED|Overall Study||30
8266189|NCT01759160|20382980|P2|STARTED|Overall Study||30
8266190|NCT01759160|20382981|P1|STARTED|Overall Study||30
8266191|NCT01758900|20382989|P2|NOT COMPLETED|Overall Study||8
8266192|NCT01758900|20382990|P1|NOT COMPLETED|Overall Study||7
8266193|NCT01758900|20382989|P2|COMPLETED|Overall Study||100
8266194|NCT01758900|20382990|P1|COMPLETED|Overall Study||99
8266195|NCT01758900|20382989|P2|STARTED|Overall Study||108
8266196|NCT01758900|20382990|P1|STARTED|Overall Study||106
8266197|NCT01758731|20383008|P1|NOT COMPLETED|Overall Study||1
8266198|NCT01758731|20383008|P1|COMPLETED|Overall Study||16
8266199|NCT01758731|20383008|P1|STARTED|Overall Study||17
8266200|NCT01758588|20383014|P2|NOT COMPLETED|Overall Study||0
8266201|NCT01758588|20383015|P1|NOT COMPLETED|Overall Study||0
8266202|NCT01758588|20383014|P2|COMPLETED|Overall Study||3
8266203|NCT01758588|20383015|P1|COMPLETED|Overall Study||5
8266204|NCT01758588|20383014|P2|STARTED|Overall Study||3
8266205|NCT01758588|20383015|P1|STARTED|Overall Study||5
8266206|NCT01758523|20383027|P2|NOT COMPLETED|Overall Study||14
8266207|NCT01758523|20383028|P1|NOT COMPLETED|Overall Study||21
8266208|NCT01758523|20383027|P2|COMPLETED|Overall Study||54
8266209|NCT01758523|20383028|P1|COMPLETED|Overall Study||53
8266210|NCT01758523|20383027|P2|Attended >/= 1 Visit Post-randomization|Overall Study||67
8266211|NCT01758523|20383028|P1|Attended >/= 1 Visit Post-randomization|Overall Study||68
8266212|NCT01758523|20383027|P2|STARTED|Overall Study||68
8266213|NCT01758523|20383028|P1|STARTED|Overall Study||74
8266214|NCT01758432|20383053|P7|NOT COMPLETED|Overall Study||0
8266215|NCT01758432|20383054|P6|NOT COMPLETED|Overall Study||0
8266216|NCT01758432|20383055|P5|NOT COMPLETED|Overall Study||0
8266217|NCT01758432|20383056|P4|NOT COMPLETED|Overall Study||0
8266218|NCT01758432|20383057|P3|NOT COMPLETED|Overall Study||0
8266219|NCT01758432|20383058|P2|NOT COMPLETED|Overall Study||0
8266220|NCT01758432|20383059|P1|NOT COMPLETED|Overall Study||0
8266221|NCT01758432|20383053|P7|COMPLETED|Overall Study||6
8266222|NCT01758432|20383054|P6|COMPLETED|Overall Study||6
8266223|NCT01758432|20383055|P5|COMPLETED|Overall Study||6
8266224|NCT01758432|20383056|P4|COMPLETED|Overall Study||6
8266225|NCT01758432|20383057|P3|COMPLETED|Overall Study||6
8266226|NCT01758432|20383058|P2|COMPLETED|Overall Study||6
8266227|NCT01758432|20383059|P1|COMPLETED|Overall Study||18
8266228|NCT01758432|20383053|P7|STARTED|Overall Study||6
8266229|NCT01758432|20383054|P6|STARTED|Overall Study||6
8266230|NCT01758432|20383055|P5|STARTED|Overall Study||6
8266231|NCT01758432|20383056|P4|STARTED|Overall Study||6
8266232|NCT01758432|20383057|P3|STARTED|Overall Study||6
8266233|NCT01758432|20383058|P2|STARTED|Overall Study||6
8266234|NCT01758432|20383059|P1|STARTED|Overall Study||18
8266235|NCT01758289|20383131|P1|NOT COMPLETED|Overall Study||53
8266236|NCT01758289|20383131|P1|COMPLETED|Overall Study||52
8266237|NCT01758289|20383131|P1|STARTED|Overall Study||105
8266238|NCT01757964|20383150|P2|NOT COMPLETED|Overall Study||0
8266239|NCT01757964|20383151|P1|NOT COMPLETED|Overall Study||0
8266240|NCT01757964|20383150|P2|COMPLETED|Overall Study||4
8266241|NCT01757964|20383151|P1|COMPLETED|Overall Study||9
8266242|NCT01757964|20383150|P2|STARTED|Overall Study||4
8266243|NCT01757964|20383151|P1|STARTED|Overall Study||9
8266244|NCT01757847|20383157|P2|NOT COMPLETED|Overall Study||4
8266245|NCT01757847|20383158|P1|NOT COMPLETED|Overall Study||3
8266246|NCT01757847|20383157|P2|COMPLETED|Overall Study||42
8266247|NCT01757847|20383158|P1|COMPLETED|Overall Study||41
8266248|NCT01757847|20383157|P2|STARTED|Overall Study||46
8266249|NCT01757847|20383158|P1|STARTED|Overall Study||44
8266250|NCT01757821|20383166|P1|NOT COMPLETED|Overall Study||1
8266251|NCT01757821|20383166|P1|COMPLETED|Overall Study|10 subjects|10
8266252|NCT01757821|20383166|P1|STARTED|Overall Study|11 subjects|11
8266253|NCT01757717|20383174|P1|NOT COMPLETED|Overall Study||0
8266254|NCT01757717|20383174|P1|COMPLETED|Overall Study||3
8266255|NCT01757717|20383174|P1|STARTED|Overall Study||3
8266256|NCT01757704|20383181|P2|NOT COMPLETED|Overall Study||3
8266257|NCT01757704|20383182|P1|NOT COMPLETED|Overall Study||1
8266258|NCT01757704|20383181|P2|COMPLETED|Overall Study||10
8266259|NCT01757704|20383182|P1|COMPLETED|Overall Study||10
8266260|NCT01757704|20383181|P2|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
8266261|NCT01757704|20383182|P1|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
8266262|NCT01757691|20383200|P2|NOT COMPLETED|Overall Study||0
8266263|NCT01757691|20383201|P1|NOT COMPLETED|Overall Study||2
8266264|NCT01757691|20383200|P2|COMPLETED|Overall Study||0
8266265|NCT01757691|20383201|P1|COMPLETED|Overall Study||0
8266266|NCT01757691|20383200|P2|STARTED|Overall Study||0
8266267|NCT01757691|20383201|P1|STARTED|Overall Study||2
8266268|NCT01757678|20383214|P1|NOT COMPLETED|Overall Study||0
8266269|NCT01757678|20383214|P1|COMPLETED|Overall Study||276
8266270|NCT01757678|20383214|P1|STARTED|Overall Study||276
8266271|NCT01757665|20383228|P2|NOT COMPLETED|Overall Study||83
8266272|NCT01757665|20383229|P1|NOT COMPLETED|Overall Study||694
8266273|NCT01757665|20383228|P2|COMPLETED|Overall Study||0
8266274|NCT01757665|20383229|P1|COMPLETED|Overall Study||0
8266275|NCT01757665|20383228|P2|Implanted With Device|Overall Study||82
8266276|NCT01757665|20383229|P1|Implanted With Device|Overall Study||689
8266277|NCT01757665|20383228|P2|STARTED|Overall Study||83
8266278|NCT01757665|20383229|P1|STARTED|Overall Study||694
8266279|NCT01757561|20383382|P4|NOT COMPLETED|Overall Study||9
8266280|NCT01757561|20383383|P3|NOT COMPLETED|Overall Study||7
8266281|NCT01757561|20383384|P2|NOT COMPLETED|Overall Study||6
8266282|NCT01757561|20383385|P1|NOT COMPLETED|Overall Study||6
8266283|NCT01757561|20383382|P4|COMPLETED|Overall Study||25
8266284|NCT01757561|20383383|P3|COMPLETED|Overall Study||31
8266285|NCT01757561|20383384|P2|COMPLETED|Overall Study||28
8266286|NCT01757561|20383385|P1|COMPLETED|Overall Study||32
8266287|NCT01757561|20383382|P4|STARTED|Overall Study||34
8266288|NCT01757561|20383383|P3|STARTED|Overall Study||38
8266289|NCT01757561|20383384|P2|STARTED|Overall Study||34
8266290|NCT01757561|20383385|P1|STARTED|Overall Study||38
8266308|NCT01757301|20383461|P2|NOT COMPLETED|Overall Study||14
8266309|NCT01757301|20383462|P1|NOT COMPLETED|Overall Study||13
8266310|NCT01757301|20383461|P2|COMPLETED|Overall Study||133
8266311|NCT01757301|20383462|P1|COMPLETED|Overall Study||134
8266312|NCT01757301|20383461|P2|STARTED|Overall Study||147
8266313|NCT01757301|20383462|P1|STARTED|Overall Study||147
8266314|NCT01757275|20383478|P2|NOT COMPLETED|Overall Study||13
8266315|NCT01757275|20383479|P1|NOT COMPLETED|Overall Study||9
8266316|NCT01757275|20383478|P2|COMPLETED|Overall Study||98
8266317|NCT01757275|20383479|P1|COMPLETED|Overall Study||102
8266318|NCT01757275|20383478|P2|STARTED|Overall Study||111
8266319|NCT01757275|20383479|P1|STARTED|Overall Study||111
8266320|NCT01757197|20383501|P1|NOT COMPLETED|Overall Study||2
8266321|NCT01757197|20383501|P1|COMPLETED|Overall Study||0
8266322|NCT01757197|20383501|P1|STARTED|Overall Study||2
8266323|NCT01757184|20383510|P4|NOT COMPLETED|Open-label Period||3
8266324|NCT01757184|20383511|P3|NOT COMPLETED|Open-label Period||4
8266325|NCT01757184|20383512|P2|NOT COMPLETED|Open-label Period||0
8266326|NCT01757184|20383513|P1|NOT COMPLETED|Open-label Period||0
8266327|NCT01757184|20383510|P4|COMPLETED|Open-label Period||27
8266328|NCT01757184|20383511|P3|COMPLETED|Open-label Period||32
8266329|NCT01757184|20383512|P2|COMPLETED|Open-label Period||0
8266330|NCT01757184|20383513|P1|COMPLETED|Open-label Period||0
8266331|NCT01757184|20383510|P4|Received at Least 1 Dose of Study Drug|Open-label Period||30
8266332|NCT01757184|20383511|P3|Received at Least 1 Dose of Study Drug|Open-label Period||36
8266333|NCT01757184|20383512|P2|Received at Least 1 Dose of Study Drug|Open-label Period||0
8266334|NCT01757184|20383513|P1|Received at Least 1 Dose of Study Drug|Open-label Period||0
8266335|NCT01757184|20383510|P4|STARTED|Open-label Period||30
8266336|NCT01757184|20383511|P3|STARTED|Open-label Period|1 participant who did not complete Double-blind Period due to AE rechallenged for Open-label Period|36
8266337|NCT01757184|20383512|P2|STARTED|Open-label Period||0
8266338|NCT01757184|20383513|P1|STARTED|Open-label Period||0
8266339|NCT01757184|20383510|P4|NOT COMPLETED|Double-blind Period||0
8266340|NCT01757184|20383511|P3|NOT COMPLETED|Double-blind Period||0
8266341|NCT01757184|20383512|P2|NOT COMPLETED|Double-blind Period||0
8266342|NCT01757184|20383513|P1|NOT COMPLETED|Double-blind Period||1
8266343|NCT01757184|20383510|P4|COMPLETED|Double-blind Period||0
8266344|NCT01757184|20383511|P3|COMPLETED|Double-blind Period||0
8266345|NCT01757184|20383512|P2|COMPLETED|Double-blind Period||30
8266346|NCT01757184|20383513|P1|COMPLETED|Double-blind Period||35
8266347|NCT01757184|20383510|P4|Received at Least 1 Dose of Study Drug|Double-blind Period||0
8266348|NCT01757184|20383511|P3|Received at Least 1 Dose of Study Drug|Double-blind Period||0
8266349|NCT01757184|20383512|P2|Received at Least 1 Dose of Study Drug|Double-blind Period||30
8266350|NCT01757184|20383513|P1|Received at Least 1 Dose of Study Drug|Double-blind Period||36
8266351|NCT01757184|20383510|P4|STARTED|Double-blind Period||0
8266352|NCT01757184|20383511|P3|STARTED|Double-blind Period||0
8266353|NCT01757184|20383512|P2|STARTED|Double-blind Period||30
8266354|NCT01757184|20383513|P1|STARTED|Double-blind Period||36
8266355|NCT01757171|20383557|P2|NOT COMPLETED|Overall Study||1
8266356|NCT01757171|20383558|P1|NOT COMPLETED|Overall Study||8
8266357|NCT01757171|20383557|P2|COMPLETED|Overall Study||23
8266358|NCT01757171|20383558|P1|COMPLETED|Overall Study||53
8266359|NCT01757171|20383557|P2|STARTED|Overall Study||24
8266360|NCT01757171|20383558|P1|STARTED|Overall Study||61
8266361|NCT01756976|20383572|P2|NOT COMPLETED|Overall Study||0
8266362|NCT01756976|20383573|P1|NOT COMPLETED|Overall Study||3
8266363|NCT01756976|20383572|P2|COMPLETED|Overall Study||8
8266364|NCT01756976|20383573|P1|COMPLETED|Overall Study||73
8266365|NCT01756976|20383572|P2|STARTED|Overall Study||8
8266366|NCT01756976|20383573|P1|STARTED|Overall Study||76
8266367|NCT01756885|20383581|P2|NOT COMPLETED|Overall Study||26
8266368|NCT01756885|20383582|P1|NOT COMPLETED|Overall Study||23
8266369|NCT01756885|20383581|P2|COMPLETED|Overall Study||79
8266370|NCT01756885|20383582|P1|COMPLETED|Overall Study||79
8266371|NCT01756885|20383581|P2|STARTED|Overall Study||105
8266372|NCT01756885|20383582|P1|STARTED|Overall Study||102
8266373|NCT01756846|20383594|P2|NOT COMPLETED|Overall Study||12
8266374|NCT01756846|20383595|P1|NOT COMPLETED|Overall Study||6
8266375|NCT01756846|20383594|P2|COMPLETED|Overall Study||1821
8266376|NCT01756846|20383595|P1|COMPLETED|Overall Study||1827
8266377|NCT01756846|20383594|P2|STARTED|Overall Study||1833
8266378|NCT01756846|20383595|P1|STARTED|Overall Study||1833
8266379|NCT01756586|20383605|P2|NOT COMPLETED|Overall Study||2
8266380|NCT01756586|20383606|P1|NOT COMPLETED|Overall Study||2
8266381|NCT01756586|20383605|P2|COMPLETED|Overall Study||0
8266382|NCT01756586|20383606|P1|COMPLETED|Overall Study||0
8266383|NCT01756586|20383605|P2|STARTED|Overall Study||2
8266384|NCT01756586|20383606|P1|STARTED|Overall Study||2
8266385|NCT01756573|20383615|P3|NOT COMPLETED|Overall Study||0
8266386|NCT01756573|20383616|P2|NOT COMPLETED|Overall Study||0
8266387|NCT01756573|20383617|P1|NOT COMPLETED|Overall Study||0
8266388|NCT01756573|20383615|P3|COMPLETED|Overall Study||1
8266389|NCT01756573|20383616|P2|COMPLETED|Overall Study||1
8266390|NCT01756573|20383617|P1|COMPLETED|Overall Study||3
8266391|NCT01756573|20383615|P3|STARTED|Overall Study||1
8266392|NCT01756573|20383616|P2|STARTED|Overall Study||1
8266393|NCT01756573|20383617|P1|STARTED|Overall Study||3
8266394|NCT01756560|20383627|P2|NOT COMPLETED|Overall Study||0
8266395|NCT01756560|20383628|P1|NOT COMPLETED|Overall Study||2
8266396|NCT01756560|20383627|P2|COMPLETED|Overall Study||0
8266397|NCT01756560|20383628|P1|COMPLETED|Overall Study||0
8266398|NCT01756560|20383627|P2|STARTED|Overall Study||0
8266399|NCT01756560|20383628|P1|STARTED|Overall Study||2
8266400|NCT01756456|20383640|P6|NOT COMPLETED|Follow Up Period Phase I/II||33
8266401|NCT01756456|20383641|P5|NOT COMPLETED|Follow Up Period Phase I/II||26
8266402|NCT01756456|20383642|P4|NOT COMPLETED|Follow Up Period Phase I/II||33
8266403|NCT01756456|20383643|P3|NOT COMPLETED|Follow Up Period Phase I/II||1
8266404|NCT01756456|20383644|P2|NOT COMPLETED|Follow Up Period Phase I/II||1
8266405|NCT01756456|20383645|P1|NOT COMPLETED|Follow Up Period Phase I/II||1
8266406|NCT01756456|20383640|P6|COMPLETED|Follow Up Period Phase I/II||15
8266407|NCT01756456|20383641|P5|COMPLETED|Follow Up Period Phase I/II||13
8266408|NCT01756456|20383642|P4|COMPLETED|Follow Up Period Phase I/II||12
8266409|NCT01756456|20383643|P3|COMPLETED|Follow Up Period Phase I/II||1
8266410|NCT01756456|20383644|P2|COMPLETED|Follow Up Period Phase I/II||5
8266411|NCT01756456|20383645|P1|COMPLETED|Follow Up Period Phase I/II||5
8266412|NCT01756456|20383640|P6|STARTED|Follow Up Period Phase I/II||48
8266413|NCT01756456|20383641|P5|STARTED|Follow Up Period Phase I/II||39
8266414|NCT01756456|20383642|P4|STARTED|Follow Up Period Phase I/II||45
8266415|NCT01756456|20383643|P3|STARTED|Follow Up Period Phase I/II||2
8266416|NCT01756456|20383644|P2|STARTED|Follow Up Period Phase I/II||6
8266417|NCT01756456|20383645|P1|STARTED|Follow Up Period Phase I/II||6
8266418|NCT01756456|20383640|P6|NOT COMPLETED|Treatment Period: Phase I/II||4
8266419|NCT01756456|20383641|P5|NOT COMPLETED|Treatment Period: Phase I/II||13
8266420|NCT01756456|20383642|P4|NOT COMPLETED|Treatment Period: Phase I/II||7
8266421|NCT01756456|20383643|P3|NOT COMPLETED|Treatment Period: Phase I/II||2
8266422|NCT01756456|20383644|P2|NOT COMPLETED|Treatment Period: Phase I/II||1
8266423|NCT01756456|20383645|P1|NOT COMPLETED|Treatment Period: Phase I/II||1
8266424|NCT01756456|20383640|P6|COMPLETED|Treatment Period: Phase I/II||48
8266425|NCT01756456|20383641|P5|COMPLETED|Treatment Period: Phase I/II||39
8266426|NCT01756456|20383642|P4|COMPLETED|Treatment Period: Phase I/II||45
8266427|NCT01756456|20383643|P3|COMPLETED|Treatment Period: Phase I/II||2
8266428|NCT01756456|20383644|P2|COMPLETED|Treatment Period: Phase I/II||6
8266429|NCT01756456|20383645|P1|COMPLETED|Treatment Period: Phase I/II||6
8266430|NCT01756456|20383640|P6|STARTED|Treatment Period: Phase I/II||52
8266431|NCT01756456|20383641|P5|STARTED|Treatment Period: Phase I/II||52
8266432|NCT01756456|20383642|P4|STARTED|Treatment Period: Phase I/II||52
8266433|NCT01756456|20383643|P3|STARTED|Treatment Period: Phase I/II||4
8266434|NCT01756456|20383644|P2|STARTED|Treatment Period: Phase I/II||7
8266435|NCT01756456|20383645|P1|STARTED|Treatment Period: Phase I/II||7
8266436|NCT01756391|20383743|P1|NOT COMPLETED|Overall Study||32
8266437|NCT01756391|20383743|P1|COMPLETED|Overall Study||319
8266438|NCT01756391|20383743|P1|STARTED|Overall Study||351
8266439|NCT01756352|20383747|P1|NOT COMPLETED|Overall Study||1
8266440|NCT01756352|20383747|P1|COMPLETED|Overall Study||12
8266441|NCT01756352|20383747|P1|STARTED|Overall Study||13
8266442|NCT01756300|20383752|P1|NOT COMPLETED|Overall Study||2
8266443|NCT01756300|20383752|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
8266444|NCT01756300|20383752|P1|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
8266445|NCT01756274|20383774|P1|NOT COMPLETED|Overall Study||3
8266446|NCT01756274|20383774|P1|COMPLETED|Overall Study||159
8266447|NCT01756274|20383774|P1|STARTED|Overall Study||162
8266448|NCT01756235|20383781|P1|NOT COMPLETED|Overall Study||2
8266449|NCT01756235|20383781|P1|COMPLETED|Overall Study||460
8266450|NCT01756235|20383781|P1|STARTED|Overall Study||462
8266451|NCT01756209|20383806|P4|NOT COMPLETED|Overall Study||0
8266452|NCT01756209|20383807|P3|NOT COMPLETED|Overall Study||0
8266453|NCT01756209|20383808|P2|NOT COMPLETED|Overall Study||0
8266454|NCT01756209|20383809|P1|NOT COMPLETED|Overall Study||0
8266455|NCT01756209|20383806|P4|COMPLETED|Overall Study||40
8266456|NCT01756209|20383807|P3|COMPLETED|Overall Study||40
8266457|NCT01756209|20383808|P2|COMPLETED|Overall Study||40
8266458|NCT01756209|20383809|P1|COMPLETED|Overall Study||40
8266459|NCT01756209|20383806|P4|STARTED|Overall Study||40
8266460|NCT01756209|20383807|P3|STARTED|Overall Study||40
8266461|NCT01756209|20383808|P2|STARTED|Overall Study||40
8266462|NCT01756209|20383809|P1|STARTED|Overall Study||40
8266481|NCT01756079|20383834|P1|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
8266482|NCT01756079|20383834|P1|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
8266483|NCT01756079|20383834|P1|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
8266484|NCT01756079|20383834|P1|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
8266485|NCT01756079|20383834|P1|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
8266486|NCT01756079|20383834|P1|COMPLETED|Lead-in: Day 0 to Week 4||58
8266487|NCT01756079|20383834|P1|STARTED|Lead-in: Day 0 to Week 4||58
8266488|NCT01756053|20383840|P2|NOT COMPLETED|Period 2 (10 Days)||2
8266489|NCT01756053|20383841|P1|NOT COMPLETED|Period 2 (10 Days)||0
8266490|NCT01756053|20383840|P2|COMPLETED|Period 2 (10 Days)||6
8266491|NCT01756053|20383841|P1|COMPLETED|Period 2 (10 Days)||7
8266492|NCT01756053|20383840|P2|STARTED|Period 2 (10 Days)||8
8266493|NCT01756053|20383841|P1|STARTED|Period 2 (10 Days)||7
8266494|NCT01756053|20383840|P2|NOT COMPLETED|Washout Period (~21 Days)||0
8266495|NCT01756053|20383841|P1|NOT COMPLETED|Washout Period (~21 Days)||0
8266496|NCT01756053|20383840|P2|COMPLETED|Washout Period (~21 Days)||8
8266497|NCT01756053|20383841|P1|COMPLETED|Washout Period (~21 Days)||7
8266498|NCT01756053|20383840|P2|STARTED|Washout Period (~21 Days)||8
8266499|NCT01756053|20383841|P1|STARTED|Washout Period (~21 Days)||7
8266500|NCT01756053|20383840|P2|NOT COMPLETED|Period 1 (10 Days)||1
8266501|NCT01756053|20383841|P1|NOT COMPLETED|Period 1 (10 Days)||1
8266502|NCT01756053|20383840|P2|COMPLETED|Period 1 (10 Days)||8
8266503|NCT01756053|20383841|P1|COMPLETED|Period 1 (10 Days)||7
8266504|NCT01756053|20383840|P2|STARTED|Period 1 (10 Days)||9
8266505|NCT01756053|20383841|P1|STARTED|Period 1 (10 Days)||8
8266506|NCT01755949|20383867|P6|NOT COMPLETED|Overall Study||0
8266507|NCT01755949|20383868|P5|NOT COMPLETED|Overall Study||0
8266508|NCT01755949|20383869|P4|NOT COMPLETED|Overall Study||0
8266509|NCT01755949|20383870|P3|NOT COMPLETED|Overall Study||0
8266510|NCT01755949|20383871|P2|NOT COMPLETED|Overall Study||0
8266511|NCT01755949|20383872|P1|NOT COMPLETED|Overall Study||0
8266512|NCT01755949|20383867|P6|COMPLETED|Overall Study||3
8266513|NCT01755949|20383868|P5|COMPLETED|Overall Study||4
8266514|NCT01755949|20383869|P4|COMPLETED|Overall Study||5
8266515|NCT01755949|20383870|P3|COMPLETED|Overall Study||4
8266516|NCT01755949|20383871|P2|COMPLETED|Overall Study||5
8266517|NCT01755949|20383872|P1|COMPLETED|Overall Study||5
8266518|NCT01755949|20383867|P6|STARTED|Overall Study||3
8266519|NCT01755949|20383868|P5|STARTED|Overall Study||4
8266520|NCT01755949|20383869|P4|STARTED|Overall Study||5
8266521|NCT01755949|20383870|P3|STARTED|Overall Study||4
8266522|NCT01755949|20383871|P2|STARTED|Overall Study||5
8266523|NCT01755949|20383872|P1|STARTED|Overall Study||5
8266524|NCT01755858|20383900|P2|NOT COMPLETED|Overall Study||1
8266525|NCT01755858|20383901|P1|NOT COMPLETED|Overall Study||1
8266526|NCT01755858|20383900|P2|COMPLETED|Overall Study||8
8266527|NCT01755858|20383901|P1|COMPLETED|Overall Study||6
8266528|NCT01755858|20383900|P2|STARTED|Overall Study||9
8266529|NCT01755858|20383901|P1|STARTED|Overall Study||7
8266542|NCT01755702|20383946|P1|NOT COMPLETED|Period III||0
8266543|NCT01755702|20383946|P1|COMPLETED|Period III||58
8266544|NCT01755702|20383946|P1|Received Ibuprofen|Period III||18
8266545|NCT01755702|20383946|P1|Received Paracetamol/Caffeine|Period III||10
8266546|NCT01755702|20383946|P1|Received Placebo|Period III||13
8266547|NCT01755702|20383946|P1|Received Paracetamol|Period III||17
8266548|NCT01755702|20383946|P1|STARTED|Period III||58
8266549|NCT01755702|20383946|P1|NOT COMPLETED|Washout Period II||5
8266550|NCT01755702|20383946|P1|COMPLETED|Washout Period II||58
8266551|NCT01755702|20383946|P1|STARTED|Washout Period II||63
8266552|NCT01755702|20383946|P1|NOT COMPLETED|Period II||0
8266553|NCT01755702|20383946|P1|COMPLETED|Period II||63
8266554|NCT01755702|20383946|P1|Received Paracetamol|Period II||17
8266555|NCT01755702|20383946|P1|Received Paracetamol/Caffeine|Period II||20
8266556|NCT01755702|20383946|P1|Received Placebo|Period II||15
8266557|NCT01755702|20383946|P1|Received Ibuprofen|Period II||11
8266558|NCT01755702|20383946|P1|STARTED|Period II||63
8266559|NCT01755702|20383946|P1|NOT COMPLETED|Wash Out Period I||3
8266560|NCT01755702|20383946|P1|COMPLETED|Wash Out Period I||63
8266561|NCT01755702|20383946|P1|STARTED|Wash Out Period I||66
8266562|NCT01755702|20383946|P1|NOT COMPLETED|Period I||0
8266563|NCT01755702|20383946|P1|COMPLETED|Period I||66
8266564|NCT01755702|20383946|P1|Received Paracetamol/Caffeine|Period I||17
8266565|NCT01755702|20383946|P1|Received Ibuprofen|Period I||16
8266566|NCT01755702|20383946|P1|Received Placebo|Period I||17
8266567|NCT01755702|20383946|P1|Received Paracetamol|Period I||16
8266568|NCT01755702|20383946|P1|STARTED|Period I||66
8266569|NCT01755689|20383993|P5|NOT COMPLETED|Overall Study||6
8266570|NCT01755689|20383994|P4|NOT COMPLETED|Overall Study||6
8266571|NCT01755689|20383995|P3|NOT COMPLETED|Overall Study||6
8266572|NCT01755689|20383996|P2|NOT COMPLETED|Overall Study||5
8266573|NCT01755689|20383997|P1|NOT COMPLETED|Overall Study||3
8266574|NCT01755689|20383993|P5|COMPLETED|Overall Study||255
8266575|NCT01755689|20383994|P4|COMPLETED|Overall Study||254
8266576|NCT01755689|20383995|P3|COMPLETED|Overall Study||255
8266577|NCT01755689|20383996|P2|COMPLETED|Overall Study||254
8266578|NCT01755689|20383997|P1|COMPLETED|Overall Study||256
8266579|NCT01755689|20383993|P5|STARTED|Overall Study||261
8266580|NCT01755689|20383994|P4|STARTED|Overall Study||260
8266581|NCT01755689|20383995|P3|STARTED|Overall Study||261
8266582|NCT01755689|20383996|P2|STARTED|Overall Study||259
8266583|NCT01755689|20383997|P1|STARTED|Overall Study||259
8266584|NCT01755637|20384072|P2|NOT COMPLETED|Period 2||0
8266585|NCT01755637|20384073|P1|NOT COMPLETED|Period 2||0
8266586|NCT01755637|20384072|P2|COMPLETED|Period 2||27
8266587|NCT01755637|20384073|P1|COMPLETED|Period 2||28
8266588|NCT01755637|20384072|P2|STARTED|Period 2||27
8266589|NCT01755637|20384073|P1|STARTED|Period 2||28
8266590|NCT01755637|20384072|P2|NOT COMPLETED|Period 1||1
8266591|NCT01755637|20384073|P1|NOT COMPLETED|Period 1||0
8266592|NCT01755637|20384072|P2|COMPLETED|Period 1||27
8266593|NCT01755637|20384073|P1|COMPLETED|Period 1||28
8266594|NCT01755637|20384072|P2|STARTED|Period 1||28
8266595|NCT01755637|20384073|P1|STARTED|Period 1||28
8266596|NCT01755598|20384093|P2|NOT COMPLETED|Overall Study||283
8266597|NCT01755598|20384094|P1|NOT COMPLETED|Overall Study||265
8266598|NCT01755598|20384093|P2|COMPLETED|Overall Study||1504
8266599|NCT01755598|20384094|P1|COMPLETED|Overall Study||1521
8266600|NCT01755598|20384093|P2|STARTED|Overall Study||1787
8266601|NCT01755598|20384094|P1|STARTED|Overall Study||1786
8266602|NCT01755546|20384128|P1|NOT COMPLETED|Long Term Treatment||121
8266603|NCT01755546|20384128|P1|COMPLETED|Long Term Treatment||103
8266604|NCT01755546|20384128|P1|STARTED|Long Term Treatment||224
8266605|NCT01755546|20384128|P1|NOT COMPLETED|Titration Phase||70
8266606|NCT01755546|20384128|P1|COMPLETED|Titration Phase||224
8266607|NCT01755546|20384128|P1|STARTED|Titration Phase||294
8266608|NCT01755546|20384128|P1|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
8266609|NCT01755546|20384128|P1|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
8266610|NCT01755546|20384128|P1|STARTED|Screened and Taper (Rollover and DeNovo)||304
8266611|NCT01755455|20384132|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8266612|NCT01755455|20384133|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8266613|NCT01755455|20384132|P2|COMPLETED|Second Intervention (6 Weeks)||11
8266614|NCT01755455|20384133|P1|COMPLETED|Second Intervention (6 Weeks)||11
8266615|NCT01755455|20384132|P2|STARTED|Second Intervention (6 Weeks)||11
8266616|NCT01755455|20384133|P1|STARTED|Second Intervention (6 Weeks)||11
8266617|NCT01755455|20384132|P2|NOT COMPLETED|Washout (4 Weeks)||0
8266618|NCT01755455|20384133|P1|NOT COMPLETED|Washout (4 Weeks)||0
8266619|NCT01755455|20384132|P2|COMPLETED|Washout (4 Weeks)||11
8266620|NCT01755455|20384133|P1|COMPLETED|Washout (4 Weeks)||11
8266621|NCT01755455|20384132|P2|STARTED|Washout (4 Weeks)||11
8266622|NCT01755455|20384133|P1|STARTED|Washout (4 Weeks)||11
8266623|NCT01755455|20384132|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
8266624|NCT01755455|20384133|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
8266625|NCT01755455|20384132|P2|COMPLETED|First Intervention (6 Weeks)||11
8266626|NCT01755455|20384133|P1|COMPLETED|First Intervention (6 Weeks)||11
8266627|NCT01755455|20384132|P2|STARTED|First Intervention (6 Weeks)||11
8266628|NCT01755455|20384133|P1|STARTED|First Intervention (6 Weeks)||11
8266629|NCT01755416|20384145|P2|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
8266630|NCT01755416|20384146|P1|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
8266631|NCT01755416|20384145|P2|COMPLETED|Second Intervention (Upto 2 Days)||7
8266632|NCT01755416|20384146|P1|COMPLETED|Second Intervention (Upto 2 Days)||8
8266633|NCT01755416|20384145|P2|STARTED|Second Intervention (Upto 2 Days)||7
8266634|NCT01755416|20384146|P1|STARTED|Second Intervention (Upto 2 Days)||8
8266635|NCT01755416|20384145|P2|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
8266636|NCT01755416|20384146|P1|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
8266637|NCT01755416|20384145|P2|COMPLETED|First Intervention ( Upto 2 Days)||7
8266638|NCT01755416|20384146|P1|COMPLETED|First Intervention ( Upto 2 Days)||8
8266639|NCT01755416|20384145|P2|STARTED|First Intervention ( Upto 2 Days)||9
8266640|NCT01755416|20384146|P1|STARTED|First Intervention ( Upto 2 Days)||9
8266641|NCT01755234|20384154|P2|NOT COMPLETED|Overall Study||8
8266642|NCT01755234|20384155|P1|NOT COMPLETED|Overall Study||15
8266643|NCT01755234|20384154|P2|COMPLETED|Overall Study||37
8266644|NCT01755234|20384155|P1|COMPLETED|Overall Study||30
8266645|NCT01755234|20384154|P2|STARTED|Overall Study||45
8266646|NCT01755234|20384155|P1|STARTED|Overall Study||45
8266647|NCT01755169|20384171|P4|NOT COMPLETED|Overall Study||0
8266648|NCT01755169|20384172|P3|NOT COMPLETED|Overall Study||0
8266649|NCT01755169|20384173|P2|NOT COMPLETED|Overall Study||0
8266650|NCT01755169|20384174|P1|NOT COMPLETED|Overall Study||0
8266651|NCT01755169|20384171|P4|COMPLETED|Overall Study||1
8266652|NCT01755169|20384172|P3|COMPLETED|Overall Study||0
8266653|NCT01755169|20384173|P2|COMPLETED|Overall Study||1
8266654|NCT01755169|20384174|P1|COMPLETED|Overall Study||2
8266655|NCT01755169|20384171|P4|STARTED|Overall Study||1
8266656|NCT01755169|20384172|P3|STARTED|Overall Study||0
8266657|NCT01755169|20384173|P2|STARTED|Overall Study||1
8266658|NCT01755169|20384174|P1|STARTED|Overall Study||2
8266659|NCT01755156|20384186|P2|NOT COMPLETED|Phase B (Weeks 24-104)||36
8266660|NCT01755156|20384187|P1|NOT COMPLETED|Phase B (Weeks 24-104)||39
8266661|NCT01755156|20384186|P2|COMPLETED|Phase B (Weeks 24-104)||141
8266662|NCT01755156|20384187|P1|COMPLETED|Phase B (Weeks 24-104)||144
8266663|NCT01755156|20384186|P2|STARTED|Phase B (Weeks 24-104)||177
8266664|NCT01755156|20384187|P1|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
8266665|NCT01755156|20384186|P2|NOT COMPLETED|Phase A (Weeks 0-24)||24
8266666|NCT01755156|20384187|P1|NOT COMPLETED|Phase A (Weeks 0-24)||17
8266667|NCT01755156|20384186|P2|COMPLETED|Phase A (Weeks 0-24)||177
8266668|NCT01755156|20384187|P1|COMPLETED|Phase A (Weeks 0-24)||184
8266669|NCT01755156|20384186|P2|STARTED|Phase A (Weeks 0-24)||201
8266670|NCT01755156|20384187|P1|STARTED|Phase A (Weeks 0-24)||201
8266671|NCT01755143|20384233|P2|NOT COMPLETED|Overall Study||3
8266672|NCT01755143|20384234|P1|NOT COMPLETED|Overall Study||11
8266673|NCT01755143|20384233|P2|COMPLETED|Overall Study||86
8266674|NCT01755143|20384234|P1|COMPLETED|Overall Study||166
8266675|NCT01755143|20384233|P2|STARTED|Overall Study||89
8266676|NCT01755143|20384234|P1|STARTED|Overall Study||177
8266686|NCT01755026|20384278|P2|NOT COMPLETED|Overall Study||1
8266687|NCT01755026|20384279|P1|NOT COMPLETED|Overall Study||2
8266688|NCT01755026|20384278|P2|COMPLETED|Overall Study||11
8266689|NCT01755026|20384279|P1|COMPLETED|Overall Study||9
8266690|NCT01755026|20384278|P2|STARTED|Overall Study||12
8266691|NCT01755026|20384279|P1|STARTED|Overall Study||11
8266692|NCT01754987|20384287|P2|NOT COMPLETED|Overall Study||0
8266693|NCT01754987|20384288|P1|NOT COMPLETED|Overall Study||0
8266694|NCT01754987|20384287|P2|COMPLETED|Overall Study||0
8266695|NCT01754987|20384288|P1|COMPLETED|Overall Study||5
8266696|NCT01754987|20384287|P2|STARTED|Overall Study||0
8266697|NCT01754987|20384288|P1|STARTED|Overall Study||5
8266698|NCT01754922|20384302|P2|NOT COMPLETED|Overall Study||1
8266699|NCT01754922|20384303|P1|NOT COMPLETED|Overall Study||0
8266700|NCT01754922|20384302|P2|COMPLETED|Overall Study||17
8266701|NCT01754922|20384303|P1|COMPLETED|Overall Study||32
8266702|NCT01754922|20384302|P2|STARTED|Overall Study||18
8266703|NCT01754922|20384303|P1|STARTED|Overall Study||32
8266704|NCT01754909|20384315|P2|NOT COMPLETED|Overall Study||0
8266705|NCT01754909|20384316|P1|NOT COMPLETED|Overall Study||0
8266706|NCT01754909|20384315|P2|COMPLETED|Overall Study||23
8266707|NCT01754909|20384316|P1|COMPLETED|Overall Study||20
8266708|NCT01754909|20384315|P2|STARTED|Overall Study||23
8266709|NCT01754909|20384316|P1|STARTED|Overall Study||20
8266710|NCT01754766|20384329|P3|NOT COMPLETED|Overall Study||0
8266711|NCT01754766|20384330|P2|NOT COMPLETED|Overall Study||1
8266712|NCT01754766|20384331|P1|NOT COMPLETED|Overall Study||1
8266713|NCT01754766|20384329|P3|COMPLETED|Overall Study||30
8266714|NCT01754766|20384330|P2|COMPLETED|Overall Study||28
8266715|NCT01754766|20384331|P1|COMPLETED|Overall Study||30
8266716|NCT01754766|20384329|P3|STARTED|Overall Study||30
8266717|NCT01754766|20384330|P2|STARTED|Overall Study||29
8266718|NCT01754766|20384331|P1|STARTED|Overall Study||31
8266719|NCT01754727|20384345|P1|NOT COMPLETED|Overall Study||2
8266720|NCT01754727|20384345|P1|COMPLETED|Overall Study||450
8266721|NCT01754727|20384345|P1|STARTED|Overall Study||452
8266722|NCT01754714|20384363|P4|NOT COMPLETED|Overall Study||1
8266723|NCT01754714|20384364|P3|NOT COMPLETED|Overall Study||2
8266724|NCT01754714|20384365|P2|NOT COMPLETED|Overall Study||1
8266725|NCT01754714|20384366|P1|NOT COMPLETED|Overall Study||0
8266726|NCT01754714|20384363|P4|COMPLETED|Overall Study||27
8266727|NCT01754714|20384364|P3|COMPLETED|Overall Study||24
8266728|NCT01754714|20384365|P2|COMPLETED|Overall Study||26
8266729|NCT01754714|20384366|P1|COMPLETED|Overall Study||27
8266730|NCT01754714|20384363|P4|STARTED|Overall Study||28
8266731|NCT01754714|20384364|P3|STARTED|Overall Study||26
8266732|NCT01754714|20384365|P2|STARTED|Overall Study||27
8266733|NCT01754714|20384366|P1|STARTED|Overall Study||27
8266734|NCT01754688|20384456|P1|NOT COMPLETED|Overall Study||0
8266735|NCT01754688|20384456|P1|COMPLETED|Overall Study||624
8266736|NCT01754688|20384456|P1|STARTED|Overall Study||624
8266737|NCT01754623|20384461|P1|NOT COMPLETED|Overall Study||0
8266738|NCT01754623|20384461|P1|COMPLETED|Overall Study||9
8266739|NCT01754623|20384461|P1|STARTED|Overall Study||9
8266740|NCT01754519|20384468|P1|NOT COMPLETED|Overall Study||0
8266741|NCT01754519|20384468|P1|COMPLETED|Overall Study||1
8266742|NCT01754519|20384468|P1|STARTED|Overall Study||1
8266746|NCT01754480|20384487|P2|NOT COMPLETED|Primary Part II||11
8266747|NCT01754480|20384488|P1|NOT COMPLETED|Primary Part II||15
8266748|NCT01754480|20384487|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
8266749|NCT01754480|20384488|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
8266750|NCT01754480|20384487|P2|Completed Study up to Week 6|Primary Part II||108
8266751|NCT01754480|20384488|P1|Completed Study up to Week 6|Primary Part II||100
8266752|NCT01754480|20384487|P2|STARTED|Primary Part II||113
8266753|NCT01754480|20384488|P1|STARTED|Primary Part II||111
8266754|NCT01754480|20384487|P2|NOT COMPLETED|Part I + Part II (Overall Study)||23
8266755|NCT01754480|20384488|P1|NOT COMPLETED|Part I + Part II (Overall Study)||25
8266756|NCT01754480|20384487|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
8266757|NCT01754480|20384488|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
8266758|NCT01754480|20384487|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
8266759|NCT01754480|20384488|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
8266760|NCT01754480|20384487|P2|STARTED|Part I + Part II (Overall Study)||162
8266761|NCT01754480|20384488|P1|STARTED|Part I + Part II (Overall Study)||163
8266762|NCT01754467|20384502|P1|NOT COMPLETED|Overall Study||1
8266763|NCT01754467|20384502|P1|COMPLETED|Overall Study||8
8266764|NCT01754467|20384502|P1|STARTED|Overall Study||9
8266765|NCT01754402|20384512|P3|NOT COMPLETED|Overall Study||4
8266766|NCT01754402|20384513|P2|NOT COMPLETED|Overall Study||2
8266767|NCT01754402|20384514|P1|NOT COMPLETED|Overall Study||2
8266768|NCT01754402|20384512|P3|COMPLETED|Overall Study||26
8266769|NCT01754402|20384513|P2|COMPLETED|Overall Study||0
8266770|NCT01754402|20384514|P1|COMPLETED|Overall Study||4
8266771|NCT01754402|20384512|P3|STARTED|Overall Study||30
8266772|NCT01754402|20384513|P2|STARTED|Overall Study||2
8266773|NCT01754402|20384514|P1|STARTED|Overall Study||6
8266774|NCT01754389|20384526|P3|NOT COMPLETED|Overall Study||0
8266775|NCT01754389|20384527|P2|NOT COMPLETED|Overall Study||0
8266776|NCT01754389|20384528|P1|NOT COMPLETED|Overall Study||0
8266777|NCT01754389|20384526|P3|COMPLETED|Overall Study||47
8266778|NCT01754389|20384527|P2|COMPLETED|Overall Study||45
8266779|NCT01754389|20384528|P1|COMPLETED|Overall Study||46
8266780|NCT01754389|20384526|P3|STARTED|Overall Study||47
8266781|NCT01754389|20384527|P2|STARTED|Overall Study||45
8266782|NCT01754389|20384528|P1|STARTED|Overall Study||46
8266783|NCT01754376|20384548|P1|NOT COMPLETED|Overall Study||3
8266784|NCT01754376|20384548|P1|COMPLETED|Overall Study||3
8266785|NCT01754376|20384548|P1|Completed 2-week Lead in of Vemurafenib|Overall Study||6
8266786|NCT01754376|20384548|P1|STARTED|Overall Study||6
8266787|NCT01754259|20384559|P2|NOT COMPLETED|Overall Study||6
8266788|NCT01754259|20384560|P1|NOT COMPLETED|Overall Study||5
8266789|NCT01754259|20384559|P2|COMPLETED|Overall Study||18
8266790|NCT01754259|20384560|P1|COMPLETED|Overall Study||18
8266791|NCT01754259|20384559|P2|STARTED|Overall Study||24
8266792|NCT01754259|20384560|P1|STARTED|Overall Study||23
8266793|NCT01754207|20384568|P1|NOT COMPLETED|Overall Study||3
8266794|NCT01754207|20384568|P1|COMPLETED|Overall Study||17
8266795|NCT01754207|20384568|P1|STARTED|Overall Study||20
8266796|NCT01754194|20384574|P2|NOT COMPLETED|Overall Study||27
8266797|NCT01754194|20384575|P1|NOT COMPLETED|Overall Study||52
8266798|NCT01754194|20384574|P2|COMPLETED|Overall Study||97
8266799|NCT01754194|20384575|P1|COMPLETED|Overall Study||117
8266800|NCT01754194|20384574|P2|STARTED|Overall Study||124
8266801|NCT01754194|20384575|P1|STARTED|Overall Study||169
8266802|NCT01754129|20384595|P1|NOT COMPLETED|Overall Study||33
8266803|NCT01754129|20384595|P1|COMPLETED|Overall Study||115
8266804|NCT01754129|20384595|P1|Visit 3 (Year 2)|Overall Study||115
8266805|NCT01754129|20384595|P1|Visit 2 (Year 1)|Overall Study||129
8266806|NCT01754129|20384595|P1|Visit 1 (Enrollment Day)|Overall Study||145
8266807|NCT01754129|20384595|P1|STARTED|Overall Study||148
8266808|NCT01753999|20384618|P2|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23
8266809|NCT01753999|20384619|P1|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
8266810|NCT01753999|20384618|P2|COMPLETED|Period 2 -Cross to Alternate Arm||89
8266811|NCT01753999|20384619|P1|COMPLETED|Period 2 -Cross to Alternate Arm||99
8266812|NCT01753999|20384618|P2|Received Intervention|Period 2 -Cross to Alternate Arm||95
8266813|NCT01753999|20384619|P1|Received Intervention|Period 2 -Cross to Alternate Arm||103
8266814|NCT01753999|20384618|P2|STARTED|Period 2 -Cross to Alternate Arm||112
8266815|NCT01753999|20384619|P1|STARTED|Period 2 -Cross to Alternate Arm||116
8266816|NCT01753999|20384618|P2|NOT COMPLETED|Period 1 - Initial Assignment||50
8266817|NCT01753999|20384619|P1|NOT COMPLETED|Period 1 - Initial Assignment||39
8266818|NCT01753999|20384618|P2|COMPLETED|Period 1 - Initial Assignment||112
8266819|NCT01753999|20384619|P1|COMPLETED|Period 1 - Initial Assignment||116
8266820|NCT01753999|20384618|P2|Received Intervention|Period 1 - Initial Assignment||146
8266821|NCT01753999|20384619|P1|Received Intervention|Period 1 - Initial Assignment||144
8266822|NCT01753999|20384618|P2|STARTED|Period 1 - Initial Assignment||162
8266823|NCT01753999|20384619|P1|STARTED|Period 1 - Initial Assignment||155
8266824|NCT01753856|20384637|P2|NOT COMPLETED|Overall Study||2
8266825|NCT01753856|20384638|P1|NOT COMPLETED|Overall Study||3
8266826|NCT01753856|20384637|P2|COMPLETED|Overall Study||34
8266827|NCT01753856|20384638|P1|COMPLETED|Overall Study||30
8266828|NCT01753856|20384637|P2|Completed 3-Month Bone Biopsy|Overall Study||35
8266829|NCT01753856|20384638|P1|Completed 3-Month Bone Biopsy|Overall Study||31
8266830|NCT01753856|20384637|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
8266831|NCT01753856|20384638|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
8266832|NCT01753856|20384637|P2|STARTED|Overall Study||36
8266833|NCT01753856|20384638|P1|STARTED|Overall Study||33
8266834|NCT01753830|20384690|P2|NOT COMPLETED|Overall Study||3
8266835|NCT01753830|20384691|P1|NOT COMPLETED|Overall Study||7
8266836|NCT01753830|20384690|P2|COMPLETED|Overall Study||35
8266837|NCT01753830|20384691|P1|COMPLETED|Overall Study||30
8266838|NCT01753830|20384690|P2|STARTED|Overall Study||38
8266839|NCT01753830|20384691|P1|STARTED|Overall Study||37
8266840|NCT01753739|20384702|P5|NOT COMPLETED|Overall Study||3
8266841|NCT01753739|20384703|P4|NOT COMPLETED|Overall Study||7
8266842|NCT01753739|20384704|P3|NOT COMPLETED|Overall Study||5
8266843|NCT01753739|20384705|P2|NOT COMPLETED|Overall Study||5
8266844|NCT01753739|20384706|P1|NOT COMPLETED|Overall Study||4
8266845|NCT01753739|20384702|P5|COMPLETED|Overall Study||120
8266846|NCT01753739|20384703|P4|COMPLETED|Overall Study||117
8266847|NCT01753739|20384704|P3|COMPLETED|Overall Study||118
8266848|NCT01753739|20384705|P2|COMPLETED|Overall Study||118
8266849|NCT01753739|20384706|P1|COMPLETED|Overall Study||120
8266850|NCT01753739|20384702|P5|STARTED|Overall Study||123
8266851|NCT01753739|20384703|P4|STARTED|Overall Study||124
8266852|NCT01753739|20384704|P3|STARTED|Overall Study||123
8266853|NCT01753739|20384705|P2|STARTED|Overall Study||123
8266854|NCT01753739|20384706|P1|STARTED|Overall Study||124
8266855|NCT01753713|20384730|P2|NOT COMPLETED|Overall Study||0
8266856|NCT01753713|20384731|P1|NOT COMPLETED|Overall Study||0
8266857|NCT01753713|20384730|P2|COMPLETED|Overall Study||19
8266858|NCT01753713|20384731|P1|COMPLETED|Overall Study||14
8266859|NCT01753713|20384730|P2|STARTED|Overall Study||19
8266860|NCT01753713|20384731|P1|STARTED|Overall Study||14
8266861|NCT01753570|20384750|P3|NOT COMPLETED|Overall Study||1
8266862|NCT01753570|20384751|P2|NOT COMPLETED|Overall Study||5
8266863|NCT01753570|20384752|P1|NOT COMPLETED|Overall Study||2
8266864|NCT01753570|20384750|P3|COMPLETED|Overall Study||13
8266865|NCT01753570|20384751|P2|COMPLETED|Overall Study||25
8266866|NCT01753570|20384752|P1|COMPLETED|Overall Study||28
8266867|NCT01753570|20384750|P3|STARTED|Overall Study||14
8266868|NCT01753570|20384751|P2|STARTED|Overall Study||30
8266869|NCT01753570|20384752|P1|STARTED|Overall Study||30
8266870|NCT01753557|20384776|P2|NOT COMPLETED|Overall Study||0
8266871|NCT01753557|20384777|P1|NOT COMPLETED|Overall Study||0
8266872|NCT01753557|20384776|P2|COMPLETED|Overall Study||19
8266873|NCT01753557|20384777|P1|COMPLETED|Overall Study||35
8266874|NCT01753557|20384776|P2|STARTED|Overall Study||19
8266875|NCT01753557|20384777|P1|STARTED|Overall Study||35
8266876|NCT01753518|20384795|P2|NOT COMPLETED|Postpartum Follow-up||15
8266877|NCT01753518|20384796|P1|NOT COMPLETED|Postpartum Follow-up||22
8266878|NCT01753518|20384795|P2|COMPLETED|Postpartum Follow-up||88
8266879|NCT01753518|20384796|P1|COMPLETED|Postpartum Follow-up||81
8266880|NCT01753518|20384795|P2|STARTED|Postpartum Follow-up||103
8266881|NCT01753518|20384796|P1|STARTED|Postpartum Follow-up||103
8266882|NCT01753518|20384795|P2|NOT COMPLETED|Intention-to-Treat Analysis||7
8266883|NCT01753518|20384796|P1|NOT COMPLETED|Intention-to-Treat Analysis||7
8266884|NCT01753518|20384795|P2|COMPLETED|Intention-to-Treat Analysis||103
8266885|NCT01753518|20384796|P1|COMPLETED|Intention-to-Treat Analysis||103
8266886|NCT01753518|20384795|P2|STARTED|Intention-to-Treat Analysis||110
8266887|NCT01753518|20384796|P1|STARTED|Intention-to-Treat Analysis||110
8266888|NCT01753401|20384820|P4|NOT COMPLETED|Open Label Period (44 Weeks)||9
8266889|NCT01753401|20384821|P3|NOT COMPLETED|Open Label Period (44 Weeks)||4
8266890|NCT01753401|20384822|P2|NOT COMPLETED|Open Label Period (44 Weeks)||0
8266891|NCT01753401|20384823|P1|NOT COMPLETED|Open Label Period (44 Weeks)||0
8266892|NCT01753401|20384820|P4|COMPLETED|Open Label Period (44 Weeks)||13
8266893|NCT01753401|20384821|P3|COMPLETED|Open Label Period (44 Weeks)||7
8266894|NCT01753401|20384822|P2|COMPLETED|Open Label Period (44 Weeks)||0
8266895|NCT01753401|20384823|P1|COMPLETED|Open Label Period (44 Weeks)||0
8266896|NCT01753401|20384820|P4|Safety Analysis Set|Open Label Period (44 Weeks)||22
8266897|NCT01753401|20384821|P3|Safety Analysis Set|Open Label Period (44 Weeks)||11
8266898|NCT01753401|20384822|P2|Safety Analysis Set|Open Label Period (44 Weeks)||0
8266899|NCT01753401|20384823|P1|Safety Analysis Set|Open Label Period (44 Weeks)||0
8266900|NCT01753401|20384820|P4|mITT|Open Label Period (44 Weeks)||22
8266901|NCT01753401|20384821|P3|mITT|Open Label Period (44 Weeks)||11
8266902|NCT01753401|20384822|P2|mITT|Open Label Period (44 Weeks)||0
8266903|NCT01753401|20384823|P1|mITT|Open Label Period (44 Weeks)||0
8266904|NCT01753401|20384820|P4|STARTED|Open Label Period (44 Weeks)||22
8266905|NCT01753401|20384821|P3|STARTED|Open Label Period (44 Weeks)||11
8266906|NCT01753401|20384822|P2|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
8266907|NCT01753401|20384823|P1|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
8266908|NCT01753401|20384820|P4|NOT COMPLETED|Double-blind Period (8 Weeks)||0
8266909|NCT01753401|20384821|P3|NOT COMPLETED|Double-blind Period (8 Weeks)||0
8266910|NCT01753401|20384822|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||4
8266911|NCT01753401|20384823|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||1
8266912|NCT01753401|20384820|P4|COMPLETED|Double-blind Period (8 Weeks)||0
8266913|NCT01753401|20384821|P3|COMPLETED|Double-blind Period (8 Weeks)||0
8266914|NCT01753401|20384822|P2|COMPLETED|Double-blind Period (8 Weeks)||22
8266915|NCT01753401|20384823|P1|COMPLETED|Double-blind Period (8 Weeks)||11
8266916|NCT01753401|20384820|P4|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
8266917|NCT01753401|20384821|P3|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
8266918|NCT01753401|20384822|P2|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25
8266919|NCT01753401|20384823|P1|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11
8266920|NCT01753401|20384820|P4|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
8266921|NCT01753401|20384821|P3|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
8266922|NCT01753401|20384822|P2|STARTED|Double-blind Period (8 Weeks)||26
8266923|NCT01753401|20384823|P1|STARTED|Double-blind Period (8 Weeks)||12
8266924|NCT01753362|20384873|P2|NOT COMPLETED|Overall Study||8
8266925|NCT01753362|20384874|P1|NOT COMPLETED|Overall Study||10
8266926|NCT01753362|20384873|P2|COMPLETED|Overall Study||40
8266927|NCT01753362|20384874|P1|COMPLETED|Overall Study||26
8266928|NCT01753362|20384873|P2|STARTED|Overall Study||48
8266929|NCT01753362|20384874|P1|STARTED|Overall Study||36
8266930|NCT01753336|20384882|P1|NOT COMPLETED|Overall Study||20
8266931|NCT01753336|20384882|P1|COMPLETED|Overall Study||92
8266932|NCT01753336|20384882|P1|Cycle 3|Overall Study||93
8266933|NCT01753336|20384882|P1|Cycle 2|Overall Study||98
8266934|NCT01753336|20384882|P1|Cycle 1|Overall Study||112
8266935|NCT01753336|20384882|P1|STARTED|Overall Study||112
8266936|NCT01753323|20384894|P3|NOT COMPLETED|Overall Study||9
8266937|NCT01753323|20384895|P2|NOT COMPLETED|Overall Study||0
8266938|NCT01753323|20384896|P1|NOT COMPLETED|Overall Study||1
8266939|NCT01753323|20384894|P3|COMPLETED|Overall Study||13
8266940|NCT01753323|20384895|P2|COMPLETED|Overall Study||10
8266941|NCT01753323|20384896|P1|COMPLETED|Overall Study||10
8266942|NCT01753323|20384894|P3|Intent-to-treat Analysis Set|Overall Study||22
8266943|NCT01753323|20384895|P2|Intent-to-treat Analysis Set|Overall Study||10
8266944|NCT01753323|20384896|P1|Intent-to-treat Analysis Set|Overall Study||11
8266945|NCT01753323|20384894|P3|Safety Set|Overall Study||22
8266946|NCT01753323|20384895|P2|Safety Set|Overall Study||10
8266947|NCT01753323|20384896|P1|Safety Set|Overall Study||11
8266948|NCT01753323|20384894|P3|Pharmacokinetic(PK) Set|Overall Study||21
8266949|NCT01753323|20384895|P2|Pharmacokinetic(PK) Set|Overall Study||10
8266950|NCT01753323|20384896|P1|Pharmacokinetic(PK) Set|Overall Study||10
8266951|NCT01753323|20384894|P3|Pharmacodynamic (PD) Set|Overall Study||21
8266952|NCT01753323|20384895|P2|Pharmacodynamic (PD) Set|Overall Study||10
8266953|NCT01753323|20384896|P1|Pharmacodynamic (PD) Set|Overall Study||10
8266954|NCT01753323|20384894|P3|STARTED|Overall Study||22
8266955|NCT01753323|20384895|P2|STARTED|Overall Study||10
8266956|NCT01753323|20384896|P1|STARTED|Overall Study||11
8266957|NCT01753310|20384934|P2|NOT COMPLETED|Overall Study||24
8266958|NCT01753310|20384935|P1|NOT COMPLETED|Overall Study||32
8266959|NCT01753310|20384934|P2|COMPLETED|Overall Study||21
8266960|NCT01753310|20384935|P1|COMPLETED|Overall Study||57
8266961|NCT01753310|20384934|P2|STARTED|Overall Study||45
8266962|NCT01753310|20384935|P1|STARTED|Overall Study||89
8266963|NCT01753297|20384957|P2|NOT COMPLETED|Overall Study||36
8266964|NCT01753297|20384958|P1|NOT COMPLETED|Overall Study||41
8266965|NCT01753297|20384957|P2|COMPLETED|Overall Study||73
8266966|NCT01753297|20384958|P1|COMPLETED|Overall Study||76
8266967|NCT01753297|20384957|P2|Received Triptorelin Treatment|Overall Study||105
8266968|NCT01753297|20384958|P1|Received Triptorelin Treatment|Overall Study||0
8266969|NCT01753297|20384957|P2|STARTED|Overall Study||109
8266970|NCT01753297|20384958|P1|STARTED|Overall Study||117
8266971|NCT01753193|20384990|P1|NOT COMPLETED|Overall Study||46
8266972|NCT01753193|20384990|P1|COMPLETED|Overall Study||172
8266973|NCT01753193|20384990|P1|STARTED|Overall Study||218
8266974|NCT01753115|20385005|P3|NOT COMPLETED|Overall Study||14
8266975|NCT01753115|20385006|P2|NOT COMPLETED|Overall Study||15
8266976|NCT01753115|20385007|P1|NOT COMPLETED|Overall Study||12
8266977|NCT01753115|20385005|P3|COMPLETED|Overall Study||56
8266978|NCT01753115|20385006|P2|COMPLETED|Overall Study||25
8266979|NCT01753115|20385007|P1|COMPLETED|Overall Study||32
8266980|NCT01753115|20385005|P3|Treated|Overall Study||67
8266981|NCT01753115|20385006|P2|Treated|Overall Study||39
8266982|NCT01753115|20385007|P1|Treated|Overall Study||38
8266983|NCT01753115|20385005|P3|STARTED|Overall Study||70
8266984|NCT01753115|20385006|P2|STARTED|Overall Study||40
8266985|NCT01753115|20385007|P1|STARTED|Overall Study||44
8266986|NCT01753076|20385017|P2|NOT COMPLETED|Overall Study||46
8266987|NCT01753076|20385018|P1|NOT COMPLETED|Overall Study||41
8266988|NCT01753076|20385017|P2|COMPLETED|Overall Study||106
8266989|NCT01753076|20385018|P1|COMPLETED|Overall Study||110
8266990|NCT01753076|20385017|P2|STARTED|Overall Study||152
8266991|NCT01753076|20385018|P1|STARTED|Overall Study||151
8266992|NCT01752985|20385045|P3|NOT COMPLETED|Follow-up Period||0
8266993|NCT01752985|20385046|P2|NOT COMPLETED|Follow-up Period||0
8266994|NCT01752985|20385047|P1|NOT COMPLETED|Follow-up Period||0
8266995|NCT01752985|20385045|P3|COMPLETED|Follow-up Period||26
8266996|NCT01752985|20385046|P2|COMPLETED|Follow-up Period||27
8266997|NCT01752985|20385047|P1|COMPLETED|Follow-up Period||28
8266998|NCT01752985|20385045|P3|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26
8266999|NCT01752985|20385046|P2|STARTED|Follow-up Period||27
8267000|NCT01752985|20385047|P1|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28
8267001|NCT01752985|20385045|P3|NOT COMPLETED|Treatment Period||5
8267002|NCT01752985|20385046|P2|NOT COMPLETED|Treatment Period||3
8267003|NCT01752985|20385047|P1|NOT COMPLETED|Treatment Period||4
8267004|NCT01752985|20385045|P3|COMPLETED|Treatment Period||24
8267005|NCT01752985|20385046|P2|COMPLETED|Treatment Period||27
8267006|NCT01752985|20385047|P1|COMPLETED|Treatment Period||25
8267007|NCT01752985|20385045|P3|STARTED|Treatment Period||29
8267008|NCT01752985|20385046|P2|STARTED|Treatment Period||30
8267009|NCT01752985|20385047|P1|STARTED|Treatment Period||29
8267010|NCT01752933|20385075|P2|NOT COMPLETED|Overall Study and Follow-up||46
8267011|NCT01752933|20385076|P1|NOT COMPLETED|Overall Study and Follow-up||4
8267012|NCT01752933|20385075|P2|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
8267013|NCT01752933|20385076|P1|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
8267014|NCT01752933|20385075|P2|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46
8267015|NCT01752933|20385076|P1|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4
8267016|NCT01752933|20385075|P2|NOT COMPLETED|Treatment||46
8267017|NCT01752933|20385076|P1|NOT COMPLETED|Treatment||4
8267018|NCT01752933|20385075|P2|COMPLETED|Treatment|Completion not applicable for this survival study|0
8267019|NCT01752933|20385076|P1|COMPLETED|Treatment|Completion not applicable for this survival study|0
8267020|NCT01752933|20385075|P2|STARTED|Treatment|Includes all patients who received any treatment|46
8267021|NCT01752933|20385076|P1|STARTED|Treatment|Includes all patients who received any treatment|4
8267022|NCT01752907|20385094|P2|NOT COMPLETED|Overall Study||20
8267023|NCT01752907|20385095|P1|NOT COMPLETED|Overall Study||12
8267024|NCT01752907|20385094|P2|COMPLETED|Overall Study||133
8267025|NCT01752907|20385095|P1|COMPLETED|Overall Study||139
8267026|NCT01752907|20385094|P2|Received Pegfilgrastim|Overall Study||151
8267027|NCT01752907|20385095|P1|Received Pegfilgrastim|Overall Study||149
8267028|NCT01752907|20385094|P2|STARTED|Overall Study||153
8267029|NCT01752907|20385095|P1|STARTED|Overall Study||151
8267030|NCT01752855|20385115|P2|NOT COMPLETED|Overall Study||4
8267031|NCT01752855|20385116|P1|NOT COMPLETED|Overall Study||1
8267032|NCT01752855|20385115|P2|COMPLETED|Overall Study||40
8267033|NCT01752855|20385116|P1|COMPLETED|Overall Study||43
8267034|NCT01752855|20385115|P2|STARTED|Overall Study||44
8267035|NCT01752855|20385116|P1|STARTED|Overall Study||44
8267036|NCT01752842|20385132|P2|NOT COMPLETED|Overall Study||2
8267037|NCT01752842|20385133|P1|NOT COMPLETED|Overall Study||3
8267038|NCT01752842|20385132|P2|COMPLETED|Overall Study||34
8267039|NCT01752842|20385133|P1|COMPLETED|Overall Study||31
8267040|NCT01752842|20385132|P2|STARTED|Overall Study||36
8267041|NCT01752842|20385133|P1|STARTED|Overall Study||34
8267042|NCT01752712|20385145|P2|NOT COMPLETED|Overall Study||10
8267043|NCT01752712|20385146|P1|NOT COMPLETED|Overall Study||9
8267044|NCT01752712|20385145|P2|COMPLETED|Overall Study||21
8267045|NCT01752712|20385146|P1|COMPLETED|Overall Study||22
8267046|NCT01752712|20385145|P2|STARTED|Overall Study||31
8267047|NCT01752712|20385146|P1|STARTED|Overall Study||31
8267048|NCT01752634|20385168|P6|NOT COMPLETED|Week 24 to Week 260||0
8267049|NCT01752634|20385169|P5|NOT COMPLETED|Week 24 to Week 260||14
8267050|NCT01752634|20385170|P4|NOT COMPLETED|Week 24 to Week 260||14
8267051|NCT01752634|20385171|P3|NOT COMPLETED|Week 24 to Week 260||33
8267052|NCT01752634|20385172|P2|NOT COMPLETED|Week 24 to Week 260||30
8267053|NCT01752634|20385173|P1|NOT COMPLETED|Week 24 to Week 260||34
8267054|NCT01752634|20385168|P6|COMPLETED|Week 24 to Week 260||0
8267055|NCT01752634|20385169|P5|COMPLETED|Week 24 to Week 260||31
8267056|NCT01752634|20385170|P4|COMPLETED|Week 24 to Week 260||29
8267057|NCT01752634|20385171|P3|COMPLETED|Week 24 to Week 260||64
8267058|NCT01752634|20385172|P2|COMPLETED|Week 24 to Week 260||65
8267059|NCT01752634|20385173|P1|COMPLETED|Week 24 to Week 260||59
8267060|NCT01752634|20385168|P6|STARTED|Week 24 to Week 260||0
8267061|NCT01752634|20385169|P5|STARTED|Week 24 to Week 260||45
8267062|NCT01752634|20385170|P4|STARTED|Week 24 to Week 260||43
8267063|NCT01752634|20385171|P3|STARTED|Week 24 to Week 260||97
8267064|NCT01752634|20385172|P2|STARTED|Week 24 to Week 260||95
8267065|NCT01752634|20385173|P1|STARTED|Week 24 to Week 260||93
8267066|NCT01752634|20385168|P6|NOT COMPLETED|Up to Week 24 (Primary Analysis)||10
8267067|NCT01752634|20385169|P5|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
8267068|NCT01752634|20385170|P4|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
8267069|NCT01752634|20385171|P3|NOT COMPLETED|Up to Week 24 (Primary Analysis)||3
8267070|NCT01752634|20385172|P2|NOT COMPLETED|Up to Week 24 (Primary Analysis)||5
8267071|NCT01752634|20385173|P1|NOT COMPLETED|Up to Week 24 (Primary Analysis)||6
8267072|NCT01752634|20385168|P6|COMPLETED|Up to Week 24 (Primary Analysis)||0
8267073|NCT01752634|20385169|P5|COMPLETED|Up to Week 24 (Primary Analysis)||45
8267074|NCT01752634|20385170|P4|COMPLETED|Up to Week 24 (Primary Analysis)||43
8267075|NCT01752634|20385171|P3|COMPLETED|Up to Week 24 (Primary Analysis)||97
8267076|NCT01752634|20385172|P2|COMPLETED|Up to Week 24 (Primary Analysis)||95
8267077|NCT01752634|20385173|P1|COMPLETED|Up to Week 24 (Primary Analysis)||93
8267078|NCT01752634|20385168|P6|STARTED|Up to Week 24 (Primary Analysis)||10
8267079|NCT01752634|20385169|P5|STARTED|Up to Week 24 (Primary Analysis)||45
8267080|NCT01752634|20385170|P4|STARTED|Up to Week 24 (Primary Analysis)||43
8267081|NCT01752634|20385171|P3|STARTED|Up to Week 24 (Primary Analysis)||100
8267082|NCT01752634|20385172|P2|STARTED|Up to Week 24 (Primary Analysis)||100
8267083|NCT01752634|20385173|P1|STARTED|Up to Week 24 (Primary Analysis)||99
8267084|NCT01752426|20385215|P1|NOT COMPLETED|Overall Study||0
8267085|NCT01752426|20385215|P1|COMPLETED|Overall Study||30
8267086|NCT01752426|20385215|P1|STARTED|Overall Study||30
8267087|NCT01752400|20385220|P1|NOT COMPLETED|Overall Study||0
8267088|NCT01752400|20385220|P1|COMPLETED|Overall Study||6
8267089|NCT01752400|20385220|P1|STARTED|Overall Study||6
8267090|NCT01752036|20385231|P1|NOT COMPLETED|Overall Study||2
8267091|NCT01752036|20385231|P1|COMPLETED|Overall Study||31
8267092|NCT01752036|20385231|P1|STARTED|Overall Study||33
8267093|NCT01752023|20385244|P2|NOT COMPLETED|Overall Study||1
8267094|NCT01752023|20385245|P1|NOT COMPLETED|Overall Study||2
8267095|NCT01752023|20385244|P2|COMPLETED|Overall Study||0
8267096|NCT01752023|20385245|P1|COMPLETED|Overall Study||0
8267097|NCT01752023|20385244|P2|STARTED|Overall Study||1
8267098|NCT01752023|20385245|P1|STARTED|Overall Study||2
8267099|NCT01751971|20385263|P2|NOT COMPLETED|Overall Study||1
8267100|NCT01751971|20385264|P1|NOT COMPLETED|Overall Study||2
8267101|NCT01751971|20385263|P2|COMPLETED|Overall Study||24
8267102|NCT01751971|20385264|P1|COMPLETED|Overall Study||20
8267103|NCT01751971|20385263|P2|STARTED|Overall Study||25
8267104|NCT01751971|20385264|P1|STARTED|Overall Study||22
8267111|NCT01751867|20385392|P2|NOT COMPLETED|Overall Study||99
8267112|NCT01751867|20385393|P1|NOT COMPLETED|Overall Study||36
8267113|NCT01751867|20385392|P2|COMPLETED|Overall Study||0
8267114|NCT01751867|20385393|P1|COMPLETED|Overall Study||0
8267115|NCT01751867|20385392|P2|Treated|Overall Study||98
8267116|NCT01751867|20385393|P1|Treated|Overall Study||34
8267117|NCT01751867|20385392|P2|STARTED|Overall Study||99
8267118|NCT01751867|20385393|P1|STARTED|Overall Study||36
8267119|NCT01751802|20385413|P2|NOT COMPLETED|Overall Study||2
8267120|NCT01751802|20385414|P1|NOT COMPLETED|Overall Study||4
8267121|NCT01751802|20385413|P2|COMPLETED|Overall Study||2
8267122|NCT01751802|20385414|P1|COMPLETED|Overall Study||1
8267123|NCT01751802|20385413|P2|Completed Period 3|Overall Study||1
8267124|NCT01751802|20385414|P1|Completed Period 3|Overall Study||2
8267125|NCT01751802|20385413|P2|Completed Period 2|Overall Study||1
8267126|NCT01751802|20385414|P1|Completed Period 2|Overall Study||2
8267127|NCT01751802|20385413|P2|Completed Period 1|Overall Study||4
8267128|NCT01751802|20385414|P1|Completed Period 1|Overall Study||2
8267129|NCT01751802|20385413|P2|STARTED|Overall Study||4
8267130|NCT01751802|20385414|P1|STARTED|Overall Study||5
8267131|NCT01751724|20385428|P2|NOT COMPLETED|Overall Study||2
8267132|NCT01751724|20385429|P1|NOT COMPLETED|Overall Study||1
8267133|NCT01751724|20385428|P2|COMPLETED|Overall Study||42
8267134|NCT01751724|20385429|P1|COMPLETED|Overall Study||41
8267135|NCT01751724|20385428|P2|STARTED|Overall Study||44
8267136|NCT01751724|20385429|P1|STARTED|Overall Study||42
8267137|NCT01751646|20385457|P2|NOT COMPLETED|Overall Study||18
8267138|NCT01751646|20385458|P1|NOT COMPLETED|Overall Study||11
8267139|NCT01751646|20385457|P2|COMPLETED|Overall Study||87
8267140|NCT01751646|20385458|P1|COMPLETED|Overall Study||98
8267141|NCT01751646|20385457|P2|STARTED|Overall Study||105
8267142|NCT01751646|20385458|P1|STARTED|Overall Study||109
8267143|NCT01751568|20385609|P3|NOT COMPLETED|Overall Study||0
8267144|NCT01751568|20385610|P2|NOT COMPLETED|Overall Study||0
8267145|NCT01751568|20385611|P1|NOT COMPLETED|Overall Study||1
8267146|NCT01751568|20385609|P3|COMPLETED|Overall Study||13
8267147|NCT01751568|20385610|P2|COMPLETED|Overall Study||14
8267148|NCT01751568|20385611|P1|COMPLETED|Overall Study||12
8267149|NCT01751568|20385609|P3|STARTED|Overall Study||13
8267150|NCT01751568|20385610|P2|STARTED|Overall Study||14
8267151|NCT01751568|20385611|P1|STARTED|Overall Study||13
8267152|NCT01751412|20385640|P1|NOT COMPLETED|Overall Study||1
8267153|NCT01751412|20385640|P1|COMPLETED|Overall Study||11
8267154|NCT01751412|20385640|P1|STARTED|Overall Study||12
8267155|NCT01751399|20385654|P4|NOT COMPLETED|Overall Study||0
8267156|NCT01751399|20385655|P3|NOT COMPLETED|Overall Study||0
8267157|NCT01751399|20385656|P2|NOT COMPLETED|Overall Study||0
8267158|NCT01751399|20385657|P1|NOT COMPLETED|Overall Study||0
8267159|NCT01751399|20385654|P4|COMPLETED|Overall Study||7
8267160|NCT01751399|20385655|P3|COMPLETED|Overall Study||8
8267161|NCT01751399|20385656|P2|COMPLETED|Overall Study||8
8267162|NCT01751399|20385657|P1|COMPLETED|Overall Study||12
8267163|NCT01751399|20385654|P4|Received 1 Dose of Study Drug|Overall Study||7
8267164|NCT01751399|20385655|P3|Received 1 Dose of Study Drug|Overall Study||8
8267165|NCT01751399|20385656|P2|Received 1 Dose of Study Drug|Overall Study||8
8267166|NCT01751399|20385657|P1|Received 1 Dose of Study Drug|Overall Study||12
8267167|NCT01751399|20385654|P4|STARTED|Overall Study||7
8267168|NCT01751399|20385655|P3|STARTED|Overall Study||8
8267169|NCT01751399|20385656|P2|STARTED|Overall Study||8
8267170|NCT01751399|20385657|P1|STARTED|Overall Study||12
8267171|NCT01751386|20385673|P2|NOT COMPLETED|Overall Study||3
8267172|NCT01751386|20385674|P1|NOT COMPLETED|Overall Study||2
8267173|NCT01751386|20385673|P2|COMPLETED|Overall Study||16
8267174|NCT01751386|20385674|P1|COMPLETED|Overall Study||18
8267175|NCT01751386|20385673|P2|STARTED|Overall Study||19
8267176|NCT01751386|20385674|P1|STARTED|Overall Study||20
8267177|NCT01751308|20385685|P5|NOT COMPLETED|Phase 2||0
8267178|NCT01751308|20385686|P4|NOT COMPLETED|Phase 2||0
8267179|NCT01751308|20385687|P3|NOT COMPLETED|Phase 2||0
8267180|NCT01751308|20385688|P2|NOT COMPLETED|Phase 2||0
8267181|NCT01751308|20385689|P1|NOT COMPLETED|Phase 2||0
8267182|NCT01751308|20385685|P5|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
8267183|NCT01751308|20385686|P4|COMPLETED|Phase 2||0
8267184|NCT01751308|20385687|P3|COMPLETED|Phase 2||0
8267185|NCT01751308|20385688|P2|COMPLETED|Phase 2||0
8267186|NCT01751308|20385689|P1|COMPLETED|Phase 2||0
8267187|NCT01751308|20385685|P5|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
8267188|NCT01751308|20385686|P4|STARTED|Phase 2||0
8267189|NCT01751308|20385687|P3|STARTED|Phase 2||0
8267190|NCT01751308|20385688|P2|STARTED|Phase 2||0
8267191|NCT01751308|20385689|P1|STARTED|Phase 2||0
8267192|NCT01751308|20385685|P5|NOT COMPLETED|Phase 1||0
8267193|NCT01751308|20385686|P4|NOT COMPLETED|Phase 1||0
8267194|NCT01751308|20385687|P3|NOT COMPLETED|Phase 1||0
8267195|NCT01751308|20385688|P2|NOT COMPLETED|Phase 1||0
8267196|NCT01751308|20385689|P1|NOT COMPLETED|Phase 1||0
8267197|NCT01751308|20385685|P5|COMPLETED|Phase 1||0
8267198|NCT01751308|20385686|P4|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
8267199|NCT01751308|20385687|P3|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
8267200|NCT01751308|20385688|P2|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
8267201|NCT01751308|20385689|P1|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
8267202|NCT01751308|20385685|P5|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
8267203|NCT01751308|20385686|P4|STARTED|Phase 1||7
8267204|NCT01751308|20385687|P3|STARTED|Phase 1||7
8267205|NCT01751308|20385688|P2|STARTED|Phase 1||3
8267206|NCT01751308|20385689|P1|STARTED|Phase 1||6
8267213|NCT01751178|20385750|P3|NOT COMPLETED|Overall Study||2
8267214|NCT01751178|20385751|P2|NOT COMPLETED|Overall Study||0
8267215|NCT01751178|20385752|P1|NOT COMPLETED|Overall Study||3
8267216|NCT01751178|20385750|P3|COMPLETED|Overall Study||105
8267217|NCT01751178|20385751|P2|COMPLETED|Overall Study||109
8267218|NCT01751178|20385752|P1|COMPLETED|Overall Study||105
8267219|NCT01751178|20385750|P3|STARTED|Overall Study||107
8267220|NCT01751178|20385751|P2|STARTED|Overall Study||109
8267221|NCT01751178|20385752|P1|STARTED|Overall Study||108
8267222|NCT01751165|20385772|P3|NOT COMPLETED|Overall Study||3
8267223|NCT01751165|20385773|P2|NOT COMPLETED|Overall Study||3
8267224|NCT01751165|20385774|P1|NOT COMPLETED|Overall Study||2
8267225|NCT01751165|20385772|P3|COMPLETED|Overall Study||113
8267226|NCT01751165|20385773|P2|COMPLETED|Overall Study||116
8267227|NCT01751165|20385774|P1|COMPLETED|Overall Study||117
8267228|NCT01751165|20385772|P3|STARTED|Overall Study||116
8267229|NCT01751165|20385773|P2|STARTED|Overall Study||119
8267230|NCT01751165|20385774|P1|STARTED|Overall Study||119
8267231|NCT01751139|20385814|P1|NOT COMPLETED|Overall Study||2267
8267232|NCT01751139|20385814|P1|COMPLETED|Overall Study||1033
8267233|NCT01751139|20385814|P1|STARTED|Overall Study||3300
8267234|NCT01751113|20385832|P6|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
8267235|NCT01751113|20385833|P5|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8267236|NCT01751113|20385834|P4|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8267237|NCT01751113|20385835|P3|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8267238|NCT01751113|20385836|P2|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8267239|NCT01751113|20385837|P1|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
8267240|NCT01751113|20385832|P6|COMPLETED|Treatment Period 3 (4 Weeks)||9
8267241|NCT01751113|20385833|P5|COMPLETED|Treatment Period 3 (4 Weeks)||8
8267242|NCT01751113|20385834|P4|COMPLETED|Treatment Period 3 (4 Weeks)||8
8267243|NCT01751113|20385835|P3|COMPLETED|Treatment Period 3 (4 Weeks)||9
8267244|NCT01751113|20385836|P2|COMPLETED|Treatment Period 3 (4 Weeks)||8
8267245|NCT01751113|20385837|P1|COMPLETED|Treatment Period 3 (4 Weeks)||8
8267246|NCT01751113|20385832|P6|STARTED|Treatment Period 3 (4 Weeks)||10
8267247|NCT01751113|20385833|P5|STARTED|Treatment Period 3 (4 Weeks)||8
8267248|NCT01751113|20385834|P4|STARTED|Treatment Period 3 (4 Weeks)||8
8267249|NCT01751113|20385835|P3|STARTED|Treatment Period 3 (4 Weeks)||9
8267250|NCT01751113|20385836|P2|STARTED|Treatment Period 3 (4 Weeks)||8
8267251|NCT01751113|20385837|P1|STARTED|Treatment Period 3 (4 Weeks)||8
8267252|NCT01751113|20385832|P6|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8267253|NCT01751113|20385833|P5|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8267254|NCT01751113|20385834|P4|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8267255|NCT01751113|20385835|P3|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8267256|NCT01751113|20385836|P2|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8267257|NCT01751113|20385837|P1|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
8267258|NCT01751113|20385832|P6|COMPLETED|Washout Period 2 (2 Weeks)||10
8267259|NCT01751113|20385833|P5|COMPLETED|Washout Period 2 (2 Weeks)||8
8267260|NCT01751113|20385834|P4|COMPLETED|Washout Period 2 (2 Weeks)||8
8267261|NCT01751113|20385835|P3|COMPLETED|Washout Period 2 (2 Weeks)||9
8267262|NCT01751113|20385836|P2|COMPLETED|Washout Period 2 (2 Weeks)||8
8267263|NCT01751113|20385837|P1|COMPLETED|Washout Period 2 (2 Weeks)||8
8267264|NCT01751113|20385832|P6|STARTED|Washout Period 2 (2 Weeks)||10
8267265|NCT01751113|20385833|P5|STARTED|Washout Period 2 (2 Weeks)||8
8267266|NCT01751113|20385834|P4|STARTED|Washout Period 2 (2 Weeks)||8
8267267|NCT01751113|20385835|P3|STARTED|Washout Period 2 (2 Weeks)||9
8267268|NCT01751113|20385836|P2|STARTED|Washout Period 2 (2 Weeks)||8
8267269|NCT01751113|20385837|P1|STARTED|Washout Period 2 (2 Weeks)||8
8267270|NCT01751113|20385832|P6|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8267271|NCT01751113|20385833|P5|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8267272|NCT01751113|20385834|P4|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8267273|NCT01751113|20385835|P3|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8267274|NCT01751113|20385836|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8267275|NCT01751113|20385837|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
8267276|NCT01751113|20385832|P6|COMPLETED|Treatment Period 2 (4 Weeks)||10
8267277|NCT01751113|20385833|P5|COMPLETED|Treatment Period 2 (4 Weeks)||8
8267278|NCT01751113|20385834|P4|COMPLETED|Treatment Period 2 (4 Weeks)||8
8267279|NCT01751113|20385835|P3|COMPLETED|Treatment Period 2 (4 Weeks)||9
8267280|NCT01751113|20385836|P2|COMPLETED|Treatment Period 2 (4 Weeks)||8
8267281|NCT01751113|20385837|P1|COMPLETED|Treatment Period 2 (4 Weeks)||8
8267282|NCT01751113|20385832|P6|STARTED|Treatment Period 2 (4 Weeks)||10
8267283|NCT01751113|20385833|P5|STARTED|Treatment Period 2 (4 Weeks)||8
8267284|NCT01751113|20385834|P4|STARTED|Treatment Period 2 (4 Weeks)||8
8267285|NCT01751113|20385835|P3|STARTED|Treatment Period 2 (4 Weeks)||9
8267286|NCT01751113|20385836|P2|STARTED|Treatment Period 2 (4 Weeks)||8
8267287|NCT01751113|20385837|P1|STARTED|Treatment Period 2 (4 Weeks)||8
8267288|NCT01751113|20385832|P6|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8267289|NCT01751113|20385833|P5|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8267290|NCT01751113|20385834|P4|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8267291|NCT01751113|20385835|P3|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8267292|NCT01751113|20385836|P2|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8267293|NCT01751113|20385837|P1|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
8267294|NCT01751113|20385832|P6|COMPLETED|Washout Period 1 (2 Weeks)||10
8267295|NCT01751113|20385833|P5|COMPLETED|Washout Period 1 (2 Weeks)||8
8267296|NCT01751113|20385834|P4|COMPLETED|Washout Period 1 (2 Weeks)||8
8267297|NCT01751113|20385835|P3|COMPLETED|Washout Period 1 (2 Weeks)||9
8267298|NCT01751113|20385836|P2|COMPLETED|Washout Period 1 (2 Weeks)||8
8267299|NCT01751113|20385837|P1|COMPLETED|Washout Period 1 (2 Weeks)||8
8267300|NCT01751113|20385832|P6|STARTED|Washout Period 1 (2 Weeks)||10
8267301|NCT01751113|20385833|P5|STARTED|Washout Period 1 (2 Weeks)||8
8267302|NCT01751113|20385834|P4|STARTED|Washout Period 1 (2 Weeks)||8
8267303|NCT01751113|20385835|P3|STARTED|Washout Period 1 (2 Weeks)||9
8267304|NCT01751113|20385836|P2|STARTED|Washout Period 1 (2 Weeks)||8
8267305|NCT01751113|20385837|P1|STARTED|Washout Period 1 (2 Weeks)||8
8267306|NCT01751113|20385832|P6|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8267307|NCT01751113|20385833|P5|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
8267308|NCT01751113|20385834|P4|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
8267309|NCT01751113|20385835|P3|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8267310|NCT01751113|20385836|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8267311|NCT01751113|20385837|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
8267312|NCT01751113|20385832|P6|COMPLETED|Treatment Period 1 (4 Weeks)||10
8267313|NCT01751113|20385833|P5|COMPLETED|Treatment Period 1 (4 Weeks)||8
8267314|NCT01751113|20385834|P4|COMPLETED|Treatment Period 1 (4 Weeks)||8
8267315|NCT01751113|20385835|P3|COMPLETED|Treatment Period 1 (4 Weeks)||9
8267316|NCT01751113|20385836|P2|COMPLETED|Treatment Period 1 (4 Weeks)||8
8267317|NCT01751113|20385837|P1|COMPLETED|Treatment Period 1 (4 Weeks)||8
8267318|NCT01751113|20385832|P6|STARTED|Treatment Period 1 (4 Weeks)||10
8267319|NCT01751113|20385833|P5|STARTED|Treatment Period 1 (4 Weeks)||9
8267320|NCT01751113|20385834|P4|STARTED|Treatment Period 1 (4 Weeks)||9
8267321|NCT01751113|20385835|P3|STARTED|Treatment Period 1 (4 Weeks)||9
8267322|NCT01751113|20385836|P2|STARTED|Treatment Period 1 (4 Weeks)||8
8267323|NCT01751113|20385837|P1|STARTED|Treatment Period 1 (4 Weeks)||8
8267324|NCT01751087|20385878|P3|NOT COMPLETED|Overall Study||1
8267325|NCT01751087|20385879|P2|NOT COMPLETED|Overall Study||0
8267326|NCT01751087|20385880|P1|NOT COMPLETED|Overall Study||1
8267327|NCT01751087|20385878|P3|COMPLETED|Overall Study||99
8267328|NCT01751087|20385879|P2|COMPLETED|Overall Study||100
8267329|NCT01751087|20385880|P1|COMPLETED|Overall Study||99
8267330|NCT01751087|20385878|P3|STARTED|Overall Study||100
8267331|NCT01751087|20385879|P2|STARTED|Overall Study||100
8267332|NCT01751087|20385880|P1|STARTED|Overall Study||100
8267333|NCT01751061|20385914|P2|NOT COMPLETED|Overall Study||34
8267334|NCT01751061|20385915|P1|NOT COMPLETED|Overall Study||56
8267335|NCT01751061|20385914|P2|COMPLETED|Overall Study||172
8267336|NCT01751061|20385915|P1|COMPLETED|Overall Study||154
8267337|NCT01751061|20385914|P2|STARTED|Overall Study||206
8267338|NCT01751061|20385915|P1|STARTED|Overall Study||210
8267339|NCT01751022|20385936|P3|NOT COMPLETED|Overall Study||27
8267340|NCT01751022|20385937|P2|NOT COMPLETED|Overall Study||44
8267341|NCT01751022|20385938|P1|NOT COMPLETED|Overall Study||56
8267342|NCT01751022|20385936|P3|COMPLETED|Overall Study|6 month visit|273
8267343|NCT01751022|20385937|P2|COMPLETED|Overall Study|6 month visit|282
8267344|NCT01751022|20385938|P1|COMPLETED|Overall Study|6 month visit|443
8267345|NCT01751022|20385936|P3|STARTED|Overall Study||300
8267346|NCT01751022|20385937|P2|STARTED|Overall Study||326
8267347|NCT01751022|20385938|P1|STARTED|Overall Study||499
8267348|NCT01750931|20385970|P2|NOT COMPLETED|Period 2||0
8267349|NCT01750931|20385971|P1|NOT COMPLETED|Period 2||0
8267350|NCT01750931|20385970|P2|COMPLETED|Period 2||14
8267351|NCT01750931|20385971|P1|COMPLETED|Period 2||14
8267352|NCT01750931|20385970|P2|STARTED|Period 2||14
8267353|NCT01750931|20385971|P1|STARTED|Period 2||14
8267354|NCT01750931|20385970|P2|NOT COMPLETED|Wash Out||0
8267355|NCT01750931|20385971|P1|NOT COMPLETED|Wash Out||0
8267356|NCT01750931|20385970|P2|COMPLETED|Wash Out||14
8267357|NCT01750931|20385971|P1|COMPLETED|Wash Out||14
8267358|NCT01750931|20385970|P2|STARTED|Wash Out||14
8267359|NCT01750931|20385971|P1|STARTED|Wash Out||14
8267360|NCT01750931|20385970|P2|NOT COMPLETED|Period 1||0
8267361|NCT01750931|20385971|P1|NOT COMPLETED|Period 1||0
8267362|NCT01750931|20385970|P2|COMPLETED|Period 1||14
8267363|NCT01750931|20385971|P1|COMPLETED|Period 1||14
8267364|NCT01750931|20385970|P2|STARTED|Period 1||14
8267365|NCT01750931|20385971|P1|STARTED|Period 1||14
8267366|NCT01750840|20385989|P1|NOT COMPLETED|Overall Study||4
8267367|NCT01750840|20385989|P1|COMPLETED|Overall Study||4
8267368|NCT01750840|20385989|P1|STARTED|Overall Study||8
8267369|NCT01750697|20385994|P1|NOT COMPLETED|Overall Study||9
8267370|NCT01750697|20385994|P1|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16
8267371|NCT01750697|20385994|P1|Follow-up Phase|Overall Study|Completed required follow-up|24
8267372|NCT01750697|20385994|P1|Completed|Overall Study||25
8267373|NCT01750697|20385994|P1|STARTED|Overall Study||25
8267374|NCT01750684|20386006|P2|NOT COMPLETED|Overall Study||2
8267375|NCT01750684|20386007|P1|NOT COMPLETED|Overall Study||2
8267376|NCT01750684|20386006|P2|COMPLETED|Overall Study||5
8267377|NCT01750684|20386007|P1|COMPLETED|Overall Study||4
8267378|NCT01750684|20386006|P2|STARTED|Overall Study||7
8267379|NCT01750684|20386007|P1|STARTED|Overall Study||6
8267380|NCT01750502|20386017|P2|NOT COMPLETED|Overall Study||0
8267381|NCT01750502|20386018|P1|NOT COMPLETED|Overall Study||0
8267382|NCT01750502|20386017|P2|COMPLETED|Overall Study||186
8267383|NCT01750502|20386018|P1|COMPLETED|Overall Study||70
8267384|NCT01750502|20386017|P2|STARTED|Overall Study||186
8267385|NCT01750502|20386018|P1|STARTED|Overall Study||70
8267386|NCT01750398|20386031|P1|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
8267387|NCT01750398|20386031|P1|COMPLETED|Bipolar Androgen Thearpy Phase||26
8267388|NCT01750398|20386031|P1|STARTED|Bipolar Androgen Thearpy Phase||29
8267389|NCT01750398|20386031|P1|NOT COMPLETED|ADT Lead In Phase||4
8267390|NCT01750398|20386031|P1|COMPLETED|ADT Lead In Phase||29
8267391|NCT01750398|20386031|P1|STARTED|ADT Lead In Phase||33
8267392|NCT01750346|20386044|P3|NOT COMPLETED|Overall Study||0
8267393|NCT01750346|20386045|P2|NOT COMPLETED|Overall Study||0
8267394|NCT01750346|20386046|P1|NOT COMPLETED|Overall Study||1
8267395|NCT01750346|20386044|P3|COMPLETED|Overall Study||3
8267396|NCT01750346|20386045|P2|COMPLETED|Overall Study||2
8267397|NCT01750346|20386046|P1|COMPLETED|Overall Study||2
8267398|NCT01750346|20386044|P3|STARTED|Overall Study||3
8267399|NCT01750346|20386045|P2|STARTED|Overall Study||2
8267400|NCT01750346|20386046|P1|STARTED|Overall Study||3
8267401|NCT01750294|20386072|P1|NOT COMPLETED|Overall Study||2
8267402|NCT01750294|20386072|P1|COMPLETED|Overall Study||12
8267403|NCT01750294|20386072|P1|STARTED|Overall Study||14
8267419|NCT01750268|20386094|P2|NOT COMPLETED|Overall Study||5
8267420|NCT01750268|20386095|P1|NOT COMPLETED|Overall Study||2
8267421|NCT01750268|20386094|P2|COMPLETED|Overall Study||12
8267422|NCT01750268|20386095|P1|COMPLETED|Overall Study||13
8267423|NCT01750268|20386094|P2|STARTED|Overall Study||17
8267424|NCT01750268|20386095|P1|STARTED|Overall Study||15
8267425|NCT01750255|20386105|P2|NOT COMPLETED|Overall Study||5
8267426|NCT01750255|20386106|P1|NOT COMPLETED|Overall Study||6
8267427|NCT01750255|20386105|P2|COMPLETED|Overall Study||38
8267428|NCT01750255|20386106|P1|COMPLETED|Overall Study||43
8267429|NCT01750255|20386105|P2|STARTED|Overall Study||43
8267430|NCT01750255|20386106|P1|STARTED|Overall Study||49
8267431|NCT01750242|20386122|P1|NOT COMPLETED|Overall Study||3
8267432|NCT01750242|20386122|P1|COMPLETED|Overall Study||20
8267433|NCT01750242|20386122|P1|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
8267434|NCT01750242|20386122|P1|STARTED|Overall Study||23
8267435|NCT01750229|20386127|P1|NOT COMPLETED|Long-term Follow-up Phase||3
8267436|NCT01750229|20386127|P1|COMPLETED|Long-term Follow-up Phase||25
8267437|NCT01750229|20386127|P1|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
8267438|NCT01750229|20386127|P1|NOT COMPLETED|Randomized Crossover Phase||2
8267439|NCT01750229|20386127|P1|COMPLETED|Randomized Crossover Phase||28
8267440|NCT01750229|20386127|P1|Protocol Violation|Randomized Crossover Phase||4
8267441|NCT01750229|20386127|P1|Subjects Received 5882 Hz|Randomized Crossover Phase||24
8267442|NCT01750229|20386127|P1|Subjects Received 3030 Hz|Randomized Crossover Phase||24
8267443|NCT01750229|20386127|P1|Subjects Received 1200 Hz|Randomized Crossover Phase||24
8267444|NCT01750229|20386127|P1|Subject Received Sham|Randomized Crossover Phase||24
8267445|NCT01750229|20386127|P1|STARTED|Randomized Crossover Phase||30
8267446|NCT01750086|20386139|P2|NOT COMPLETED|Overall Study||1
8267447|NCT01750086|20386140|P1|NOT COMPLETED|Overall Study||1
8267448|NCT01750086|20386139|P2|COMPLETED|Overall Study||13
8267449|NCT01750086|20386140|P1|COMPLETED|Overall Study||12
8267450|NCT01750086|20386139|P2|STARTED|Overall Study||14
8267451|NCT01750086|20386140|P1|STARTED|Overall Study||13
8267455|NCT01749982|20386154|P4|NOT COMPLETED|Overall Study||3
8267456|NCT01749982|20386155|P3|NOT COMPLETED|Overall Study||0
8267457|NCT01749982|20386156|P2|NOT COMPLETED|Overall Study||0
8267458|NCT01749982|20386157|P1|NOT COMPLETED|Overall Study||0
8267459|NCT01749982|20386154|P4|COMPLETED|Overall Study||12
8267460|NCT01749982|20386155|P3|COMPLETED|Overall Study||15
8267461|NCT01749982|20386156|P2|COMPLETED|Overall Study||15
8267462|NCT01749982|20386157|P1|COMPLETED|Overall Study||15
8267463|NCT01749982|20386154|P4|STARTED|Overall Study||15
8267464|NCT01749982|20386155|P3|STARTED|Overall Study||15
8267465|NCT01749982|20386156|P2|STARTED|Overall Study||15
8267466|NCT01749982|20386157|P1|STARTED|Overall Study||15
8267467|NCT01749956|20386175|P1|NOT COMPLETED|Overall Study||15
8267468|NCT01749956|20386175|P1|COMPLETED|Overall Study||24
8267469|NCT01749956|20386175|P1|STARTED|Overall Study||39
8267470|NCT01749930|20386187|P2|NOT COMPLETED|Overall Study||12
8267471|NCT01749930|20386188|P1|NOT COMPLETED|Overall Study||30
8267472|NCT01749930|20386187|P2|COMPLETED|Overall Study|randomized population|125
8267473|NCT01749930|20386188|P1|COMPLETED|Overall Study|randomized population|253
8267474|NCT01749930|20386187|P2|STARTED|Overall Study|randomized population|137
8267475|NCT01749930|20386188|P1|STARTED|Overall Study|randomized population|283
8267476|NCT01749904|20386204|P2|NOT COMPLETED|Overall Study||11
8267477|NCT01749904|20386205|P1|NOT COMPLETED|Overall Study||22
8267478|NCT01749904|20386204|P2|COMPLETED|Overall Study|randomized population|123
8267479|NCT01749904|20386205|P1|COMPLETED|Overall Study|randomized population|264
8267480|NCT01749904|20386204|P2|STARTED|Overall Study|randomized population|134
8267481|NCT01749904|20386205|P1|STARTED|Overall Study|randomized population|286
8267482|NCT01749826|20386221|P2|NOT COMPLETED|Overall Study||0
8267483|NCT01749826|20386222|P1|NOT COMPLETED|Overall Study||20
8267484|NCT01749826|20386221|P2|COMPLETED|Overall Study||0
8267485|NCT01749826|20386222|P1|COMPLETED|Overall Study||0
8267486|NCT01749826|20386221|P2|STARTED|Overall Study||0
8267487|NCT01749826|20386222|P1|STARTED|Overall Study||20
8267488|NCT01749800|20386237|P3|NOT COMPLETED|Overall Study||0
8267489|NCT01749800|20386238|P2|NOT COMPLETED|Overall Study||1
8267490|NCT01749800|20386239|P1|NOT COMPLETED|Overall Study||3
8267491|NCT01749800|20386237|P3|COMPLETED|Overall Study||0
8267492|NCT01749800|20386238|P2|COMPLETED|Overall Study||0
8267493|NCT01749800|20386239|P1|COMPLETED|Overall Study||3
8267494|NCT01749800|20386237|P3|STARTED|Overall Study||0
8267495|NCT01749800|20386238|P2|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
8267496|NCT01749800|20386239|P1|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
8267497|NCT01749735|20386249|P2|NOT COMPLETED|Overall Study||0
8267498|NCT01749735|20386250|P1|NOT COMPLETED|Overall Study||1
8267499|NCT01749735|20386249|P2|COMPLETED|Overall Study||0
8267500|NCT01749735|20386250|P1|COMPLETED|Overall Study||1
8267501|NCT01749735|20386249|P2|STARTED|Overall Study||0
8267502|NCT01749735|20386250|P1|STARTED|Overall Study||2
8267503|NCT01749631|20386258|P1|NOT COMPLETED|Overall Study||0
8267504|NCT01749631|20386258|P1|COMPLETED|Overall Study||97
8267505|NCT01749631|20386258|P1|STARTED|Overall Study||97
8267506|NCT01749605|20386270|P2|NOT COMPLETED|Overall Study||3
8267507|NCT01749605|20386271|P1|NOT COMPLETED|Overall Study||4
8267508|NCT01749605|20386270|P2|COMPLETED|Overall Study||14
8267509|NCT01749605|20386271|P1|COMPLETED|Overall Study||14
8267510|NCT01749605|20386270|P2|STARTED|Overall Study||17
8267511|NCT01749605|20386271|P1|STARTED|Overall Study||18
8267512|NCT01749501|20386279|P2|NOT COMPLETED|Overall Study||0
8267513|NCT01749501|20386280|P1|NOT COMPLETED|Overall Study||0
8267514|NCT01749501|20386279|P2|COMPLETED|Overall Study||23
8267515|NCT01749501|20386280|P1|COMPLETED|Overall Study||22
8267516|NCT01749501|20386279|P2|STARTED|Overall Study||23
8267517|NCT01749501|20386280|P1|STARTED|Overall Study||22
8267518|NCT01749410|20386288|P1|NOT COMPLETED|Overall Study||0
8267519|NCT01749410|20386288|P1|COMPLETED|Overall Study||33
8267520|NCT01749410|20386288|P1|STARTED|Overall Study||33
8267521|NCT01749293|20386292|P1|NOT COMPLETED|Overall Study||0
8267522|NCT01749293|20386292|P1|COMPLETED|Overall Study||3
8267523|NCT01749293|20386292|P1|STARTED|Overall Study||3
8267524|NCT01749033|20386301|P3|NOT COMPLETED|Overall Study||1
8267525|NCT01749033|20386302|P2|NOT COMPLETED|Overall Study||5
8267526|NCT01749033|20386303|P1|NOT COMPLETED|Overall Study||3
8267527|NCT01749033|20386301|P3|COMPLETED|Overall Study||149
8267528|NCT01749033|20386302|P2|COMPLETED|Overall Study||145
8267529|NCT01749033|20386303|P1|COMPLETED|Overall Study||147
8267530|NCT01749033|20386301|P3|STARTED|Overall Study||150
8267531|NCT01749033|20386302|P2|STARTED|Overall Study||150
8267532|NCT01749033|20386303|P1|STARTED|Overall Study||150
8267533|NCT01748955|20386328|P2|NOT COMPLETED|Overall Study||5
8267534|NCT01748955|20386329|P1|NOT COMPLETED|Overall Study||3
8267535|NCT01748955|20386328|P2|COMPLETED|Overall Study||4
8267536|NCT01748955|20386329|P1|COMPLETED|Overall Study||3
8267537|NCT01748955|20386328|P2|STARTED|Overall Study||9
8267538|NCT01748955|20386329|P1|STARTED|Overall Study||6
8267539|NCT01748942|20386339|P2|NOT COMPLETED|Overall Study||4
8267540|NCT01748942|20386340|P1|NOT COMPLETED|Overall Study||4
8267541|NCT01748942|20386339|P2|COMPLETED|Overall Study||33
8267542|NCT01748942|20386340|P1|COMPLETED|Overall Study||35
8267543|NCT01748942|20386339|P2|STARTED|Overall Study||37
8267544|NCT01748942|20386340|P1|STARTED|Overall Study||39
8267563|NCT01748890|20386373|P1|NOT COMPLETED|Overall Study||4
8267564|NCT01748890|20386373|P1|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
8267565|NCT01748890|20386373|P1|STARTED|Overall Study||4
8267566|NCT01748799|20386385|P8|NOT COMPLETED|Overall Study||0
8267567|NCT01748799|20386386|P7|NOT COMPLETED|Overall Study||1
8267568|NCT01748799|20386387|P6|NOT COMPLETED|Overall Study||1
8267569|NCT01748799|20386388|P5|NOT COMPLETED|Overall Study||0
8267570|NCT01748799|20386389|P4|NOT COMPLETED|Overall Study||0
8267571|NCT01748799|20386390|P3|NOT COMPLETED|Overall Study||0
8267572|NCT01748799|20386391|P2|NOT COMPLETED|Overall Study||0
8267573|NCT01748799|20386392|P1|NOT COMPLETED|Overall Study||5
8267574|NCT01748799|20386385|P8|COMPLETED|Overall Study||1
8267575|NCT01748799|20386386|P7|COMPLETED|Overall Study||1
8267576|NCT01748799|20386387|P6|COMPLETED|Overall Study||1
8267577|NCT01748799|20386388|P5|COMPLETED|Overall Study||1
8267578|NCT01748799|20386389|P4|COMPLETED|Overall Study||2
8267579|NCT01748799|20386390|P3|COMPLETED|Overall Study||1
8267580|NCT01748799|20386391|P2|COMPLETED|Overall Study||1
8267581|NCT01748799|20386392|P1|COMPLETED|Overall Study||1
8267582|NCT01748799|20386385|P8|Completed Self-titrated Sativex|Overall Study||1
8267583|NCT01748799|20386386|P7|Completed Self-titrated Sativex|Overall Study||1
8267584|NCT01748799|20386387|P6|Completed Self-titrated Sativex|Overall Study||1
8267585|NCT01748799|20386388|P5|Completed Self-titrated Sativex|Overall Study||1
8267586|NCT01748799|20386389|P4|Completed Self-titrated Sativex|Overall Study||2
8267587|NCT01748799|20386390|P3|Completed Self-titrated Sativex|Overall Study||1
8267588|NCT01748799|20386391|P2|Completed Self-titrated Sativex|Overall Study||1
8267589|NCT01748799|20386392|P1|Completed Self-titrated Sativex|Overall Study||1
8267590|NCT01748799|20386385|P8|Completed SAU of Self-titrated Sativex|Overall Study||1
8267591|NCT01748799|20386386|P7|Completed SAU of Self-titrated Sativex|Overall Study||1
8267592|NCT01748799|20386387|P6|Completed SAU of Self-titrated Sativex|Overall Study||2
8267593|NCT01748799|20386388|P5|Completed SAU of Self-titrated Sativex|Overall Study||1
8267594|NCT01748799|20386389|P4|Completed SAU of Self-titrated Sativex|Overall Study||2
8267595|NCT01748799|20386390|P3|Completed SAU of Self-titrated Sativex|Overall Study||1
8267596|NCT01748799|20386391|P2|Completed SAU of Self-titrated Sativex|Overall Study||1
8267597|NCT01748799|20386392|P1|Completed SAU of Self-titrated Sativex|Overall Study||2
8267598|NCT01748799|20386385|P8|Completed Self-titrated Placebo|Overall Study||1
8267599|NCT01748799|20386386|P7|Completed Self-titrated Placebo|Overall Study||1
8267600|NCT01748799|20386387|P6|Completed Self-titrated Placebo|Overall Study||2
8267601|NCT01748799|20386388|P5|Completed Self-titrated Placebo|Overall Study||1
8267602|NCT01748799|20386389|P4|Completed Self-titrated Placebo|Overall Study||2
8267603|NCT01748799|20386390|P3|Completed Self-titrated Placebo|Overall Study||1
8267604|NCT01748799|20386391|P2|Completed Self-titrated Placebo|Overall Study||1
8267605|NCT01748799|20386392|P1|Completed Self-titrated Placebo|Overall Study||4
8267606|NCT01748799|20386385|P8|Completed SAU of Self-titrated Placebo|Overall Study||1
8267607|NCT01748799|20386386|P7|Completed SAU of Self-titrated Placebo|Overall Study||1
8267608|NCT01748799|20386387|P6|Completed SAU of Self-titrated Placebo|Overall Study||2
8267609|NCT01748799|20386388|P5|Completed SAU of Self-titrated Placebo|Overall Study||1
8267610|NCT01748799|20386389|P4|Completed SAU of Self-titrated Placebo|Overall Study||2
8267611|NCT01748799|20386390|P3|Completed SAU of Self-titrated Placebo|Overall Study||1
8267612|NCT01748799|20386391|P2|Completed SAU of Self-titrated Placebo|Overall Study||1
8267613|NCT01748799|20386392|P1|Completed SAU of Self-titrated Placebo|Overall Study||5
8267614|NCT01748799|20386385|P8|Completed Fixed Dose Sativex|Overall Study||1
8267615|NCT01748799|20386386|P7|Completed Fixed Dose Sativex|Overall Study||1
8267616|NCT01748799|20386387|P6|Completed Fixed Dose Sativex|Overall Study||1
8267617|NCT01748799|20386388|P5|Completed Fixed Dose Sativex|Overall Study||1
8267618|NCT01748799|20386389|P4|Completed Fixed Dose Sativex|Overall Study||2
8267619|NCT01748799|20386390|P3|Completed Fixed Dose Sativex|Overall Study||1
8267620|NCT01748799|20386391|P2|Completed Fixed Dose Sativex|Overall Study||1
8267621|NCT01748799|20386392|P1|Completed Fixed Dose Sativex|Overall Study||1
8267622|NCT01748799|20386385|P8|Completed SAU of Fixed Dose Sativex|Overall Study||1
8267623|NCT01748799|20386386|P7|Completed SAU of Fixed Dose Sativex|Overall Study||1
8267624|NCT01748799|20386387|P6|Completed SAU of Fixed Dose Sativex|Overall Study||1
8267625|NCT01748799|20386388|P5|Completed SAU of Fixed Dose Sativex|Overall Study||1
8267626|NCT01748799|20386389|P4|Completed SAU of Fixed Dose Sativex|Overall Study||2
8267627|NCT01748799|20386390|P3|Completed SAU of Fixed Dose Sativex|Overall Study||1
8267628|NCT01748799|20386391|P2|Completed SAU of Fixed Dose Sativex|Overall Study||1
8267629|NCT01748799|20386392|P1|Completed SAU of Fixed Dose Sativex|Overall Study||1
8267630|NCT01748799|20386385|P8|Completed Fixed Dose Placebo|Overall Study||1
8267631|NCT01748799|20386386|P7|Completed Fixed Dose Placebo|Overall Study||1
8267632|NCT01748799|20386387|P6|Completed Fixed Dose Placebo|Overall Study||1
8267633|NCT01748799|20386388|P5|Completed Fixed Dose Placebo|Overall Study||1
8267634|NCT01748799|20386389|P4|Completed Fixed Dose Placebo|Overall Study||2
8267635|NCT01748799|20386390|P3|Completed Fixed Dose Placebo|Overall Study||1
8267636|NCT01748799|20386391|P2|Completed Fixed Dose Placebo|Overall Study||1
8267637|NCT01748799|20386392|P1|Completed Fixed Dose Placebo|Overall Study||2
8267638|NCT01748799|20386385|P8|Completed SAU of Fixed Dose Placebo|Overall Study||1
8267639|NCT01748799|20386386|P7|Completed SAU of Fixed Dose Placebo|Overall Study||1
8267640|NCT01748799|20386387|P6|Completed SAU of Fixed Dose Placebo|Overall Study||1
8267641|NCT01748799|20386388|P5|Completed SAU of Fixed Dose Placebo|Overall Study||1
8267642|NCT01748799|20386389|P4|Completed SAU of Fixed Dose Placebo|Overall Study||2
8267643|NCT01748799|20386390|P3|Completed SAU of Fixed Dose Placebo|Overall Study||1
8267644|NCT01748799|20386391|P2|Completed SAU of Fixed Dose Placebo|Overall Study||1
8267645|NCT01748799|20386392|P1|Completed SAU of Fixed Dose Placebo|Overall Study||2
8267646|NCT01748799|20386385|P8|STARTED|Overall Study||1
8267647|NCT01748799|20386386|P7|STARTED|Overall Study||2
8267648|NCT01748799|20386387|P6|STARTED|Overall Study||2
8267649|NCT01748799|20386388|P5|STARTED|Overall Study||1
8267650|NCT01748799|20386389|P4|STARTED|Overall Study||2
8267651|NCT01748799|20386390|P3|STARTED|Overall Study||1
8267652|NCT01748799|20386391|P2|STARTED|Overall Study||1
8267653|NCT01748799|20386392|P1|STARTED|Overall Study||6
8267654|NCT01748760|20386428|P2|NOT COMPLETED|Overall Study||2
8267655|NCT01748760|20386429|P1|NOT COMPLETED|Overall Study||6
8267656|NCT01748760|20386428|P2|COMPLETED|Overall Study||23
8267657|NCT01748760|20386429|P1|COMPLETED|Overall Study||19
8267658|NCT01748760|20386428|P2|STARTED|Overall Study||25
8267659|NCT01748760|20386429|P1|STARTED|Overall Study||25
8267660|NCT01748695|20386435|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
8267661|NCT01748695|20386436|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8267662|NCT01748695|20386435|P2|COMPLETED|Second Intervention (4 Weeks)||11
8267663|NCT01748695|20386436|P1|COMPLETED|Second Intervention (4 Weeks)||14
8267664|NCT01748695|20386435|P2|STARTED|Second Intervention (4 Weeks)||11
8267665|NCT01748695|20386436|P1|STARTED|Second Intervention (4 Weeks)||14
8267666|NCT01748695|20386435|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8267667|NCT01748695|20386436|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8267668|NCT01748695|20386435|P2|COMPLETED|First Intervention (4 Weeks)||11
8267669|NCT01748695|20386436|P1|COMPLETED|First Intervention (4 Weeks)||14
8267670|NCT01748695|20386435|P2|STARTED|First Intervention (4 Weeks)||11
8267671|NCT01748695|20386436|P1|STARTED|First Intervention (4 Weeks)||14
8267672|NCT01748643|20386446|P2|NOT COMPLETED|Overall Study||0
8267673|NCT01748643|20386447|P1|NOT COMPLETED|Overall Study||0
8267674|NCT01748643|20386446|P2|COMPLETED|Overall Study||30
8267675|NCT01748643|20386447|P1|COMPLETED|Overall Study||30
8267676|NCT01748643|20386446|P2|STARTED|Overall Study||30
8267677|NCT01748643|20386447|P1|STARTED|Overall Study||30
8267678|NCT01748552|20386475|P12|NOT COMPLETED|Intervention Period 3 and Washout||0
8267679|NCT01748552|20386476|P11|NOT COMPLETED|Intervention Period 3 and Washout||0
8267680|NCT01748552|20386477|P10|NOT COMPLETED|Intervention Period 3 and Washout||0
8267681|NCT01748552|20386478|P9|NOT COMPLETED|Intervention Period 3 and Washout||0
8267682|NCT01748552|20386479|P8|NOT COMPLETED|Intervention Period 3 and Washout||0
8267683|NCT01748552|20386480|P7|NOT COMPLETED|Intervention Period 3 and Washout||0
8267684|NCT01748552|20386481|P6|NOT COMPLETED|Intervention Period 3 and Washout||0
8267685|NCT01748552|20386482|P5|NOT COMPLETED|Intervention Period 3 and Washout||0
8267686|NCT01748552|20386483|P4|NOT COMPLETED|Intervention Period 3 and Washout||0
8267687|NCT01748552|20386484|P3|NOT COMPLETED|Intervention Period 3 and Washout||0
8267688|NCT01748552|20386485|P2|NOT COMPLETED|Intervention Period 3 and Washout||0
8267689|NCT01748552|20386486|P1|NOT COMPLETED|Intervention Period 3 and Washout||0
8267690|NCT01748552|20386475|P12|COMPLETED|Intervention Period 3 and Washout||3
8267691|NCT01748552|20386476|P11|COMPLETED|Intervention Period 3 and Washout||3
8267692|NCT01748552|20386477|P10|COMPLETED|Intervention Period 3 and Washout||3
8267693|NCT01748552|20386478|P9|COMPLETED|Intervention Period 3 and Washout||0
8267694|NCT01748552|20386479|P8|COMPLETED|Intervention Period 3 and Washout||0
8267695|NCT01748552|20386480|P7|COMPLETED|Intervention Period 3 and Washout||0
8267696|NCT01748552|20386481|P6|COMPLETED|Intervention Period 3 and Washout||3
8267697|NCT01748552|20386482|P5|COMPLETED|Intervention Period 3 and Washout||3
8267698|NCT01748552|20386483|P4|COMPLETED|Intervention Period 3 and Washout||3
8267699|NCT01748552|20386484|P3|COMPLETED|Intervention Period 3 and Washout||2
8267700|NCT01748552|20386485|P2|COMPLETED|Intervention Period 3 and Washout||3
8267701|NCT01748552|20386486|P1|COMPLETED|Intervention Period 3 and Washout||3
8267702|NCT01748552|20386475|P12|STARTED|Intervention Period 3 and Washout||3
8267703|NCT01748552|20386476|P11|STARTED|Intervention Period 3 and Washout||3
8267704|NCT01748552|20386477|P10|STARTED|Intervention Period 3 and Washout||3
8267705|NCT01748552|20386478|P9|STARTED|Intervention Period 3 and Washout||0
8267706|NCT01748552|20386479|P8|STARTED|Intervention Period 3 and Washout||0
8267707|NCT01748552|20386480|P7|STARTED|Intervention Period 3 and Washout||0
8267708|NCT01748552|20386481|P6|STARTED|Intervention Period 3 and Washout||3
8267709|NCT01748552|20386482|P5|STARTED|Intervention Period 3 and Washout||3
8267710|NCT01748552|20386483|P4|STARTED|Intervention Period 3 and Washout||3
8267711|NCT01748552|20386484|P3|STARTED|Intervention Period 3 and Washout||2
8267712|NCT01748552|20386485|P2|STARTED|Intervention Period 3 and Washout||3
8267713|NCT01748552|20386486|P1|STARTED|Intervention Period 3 and Washout||3
8267714|NCT01748552|20386475|P12|NOT COMPLETED|Intervention Period 2 and Washout||0
8267715|NCT01748552|20386476|P11|NOT COMPLETED|Intervention Period 2 and Washout||0
8267716|NCT01748552|20386477|P10|NOT COMPLETED|Intervention Period 2 and Washout||0
8267717|NCT01748552|20386478|P9|NOT COMPLETED|Intervention Period 2 and Washout||3
8267718|NCT01748552|20386479|P8|NOT COMPLETED|Intervention Period 2 and Washout||3
8267719|NCT01748552|20386480|P7|NOT COMPLETED|Intervention Period 2 and Washout||3
8267720|NCT01748552|20386481|P6|NOT COMPLETED|Intervention Period 2 and Washout||0
8267721|NCT01748552|20386482|P5|NOT COMPLETED|Intervention Period 2 and Washout||0
8267722|NCT01748552|20386483|P4|NOT COMPLETED|Intervention Period 2 and Washout||0
8267723|NCT01748552|20386484|P3|NOT COMPLETED|Intervention Period 2 and Washout||1
8267724|NCT01748552|20386485|P2|NOT COMPLETED|Intervention Period 2 and Washout||0
8267725|NCT01748552|20386486|P1|NOT COMPLETED|Intervention Period 2 and Washout||0
8267726|NCT01748552|20386475|P12|COMPLETED|Intervention Period 2 and Washout||3
8267727|NCT01748552|20386476|P11|COMPLETED|Intervention Period 2 and Washout||3
8267728|NCT01748552|20386477|P10|COMPLETED|Intervention Period 2 and Washout||3
8267729|NCT01748552|20386478|P9|COMPLETED|Intervention Period 2 and Washout||0
8267730|NCT01748552|20386479|P8|COMPLETED|Intervention Period 2 and Washout||0
8267731|NCT01748552|20386480|P7|COMPLETED|Intervention Period 2 and Washout||0
8267732|NCT01748552|20386481|P6|COMPLETED|Intervention Period 2 and Washout||3
8267733|NCT01748552|20386482|P5|COMPLETED|Intervention Period 2 and Washout||3
8267734|NCT01748552|20386483|P4|COMPLETED|Intervention Period 2 and Washout||3
8267735|NCT01748552|20386484|P3|COMPLETED|Intervention Period 2 and Washout||2
8267736|NCT01748552|20386485|P2|COMPLETED|Intervention Period 2 and Washout||3
8267737|NCT01748552|20386486|P1|COMPLETED|Intervention Period 2 and Washout||3
8267738|NCT01748552|20386475|P12|STARTED|Intervention Period 2 and Washout||3
8267739|NCT01748552|20386476|P11|STARTED|Intervention Period 2 and Washout||3
8267740|NCT01748552|20386477|P10|STARTED|Intervention Period 2 and Washout||3
8267741|NCT01748552|20386478|P9|STARTED|Intervention Period 2 and Washout||3
8267742|NCT01748552|20386479|P8|STARTED|Intervention Period 2 and Washout||3
8267743|NCT01748552|20386480|P7|STARTED|Intervention Period 2 and Washout||3
8267744|NCT01748552|20386481|P6|STARTED|Intervention Period 2 and Washout||3
8267745|NCT01748552|20386482|P5|STARTED|Intervention Period 2 and Washout||3
8267746|NCT01748552|20386483|P4|STARTED|Intervention Period 2 and Washout||3
8267747|NCT01748552|20386484|P3|STARTED|Intervention Period 2 and Washout||3
8267748|NCT01748552|20386485|P2|STARTED|Intervention Period 2 and Washout||3
8267749|NCT01748552|20386486|P1|STARTED|Intervention Period 2 and Washout||3
8267750|NCT01748552|20386475|P12|NOT COMPLETED|Intervention Period 1 and Washout||0
8267751|NCT01748552|20386476|P11|NOT COMPLETED|Intervention Period 1 and Washout||0
8267752|NCT01748552|20386477|P10|NOT COMPLETED|Intervention Period 1 and Washout||0
8267753|NCT01748552|20386478|P9|NOT COMPLETED|Intervention Period 1 and Washout||0
8267754|NCT01748552|20386479|P8|NOT COMPLETED|Intervention Period 1 and Washout||0
8267755|NCT01748552|20386480|P7|NOT COMPLETED|Intervention Period 1 and Washout||0
8267756|NCT01748552|20386481|P6|NOT COMPLETED|Intervention Period 1 and Washout||0
8267757|NCT01748552|20386482|P5|NOT COMPLETED|Intervention Period 1 and Washout||0
8267758|NCT01748552|20386483|P4|NOT COMPLETED|Intervention Period 1 and Washout||0
8267759|NCT01748552|20386484|P3|NOT COMPLETED|Intervention Period 1 and Washout||0
8267760|NCT01748552|20386485|P2|NOT COMPLETED|Intervention Period 1 and Washout||0
8267761|NCT01748552|20386486|P1|NOT COMPLETED|Intervention Period 1 and Washout||0
8267762|NCT01748552|20386475|P12|COMPLETED|Intervention Period 1 and Washout||3
8267763|NCT01748552|20386476|P11|COMPLETED|Intervention Period 1 and Washout||3
8267764|NCT01748552|20386477|P10|COMPLETED|Intervention Period 1 and Washout||3
8267765|NCT01748552|20386478|P9|COMPLETED|Intervention Period 1 and Washout||3
8267766|NCT01748552|20386479|P8|COMPLETED|Intervention Period 1 and Washout||3
8267767|NCT01748552|20386480|P7|COMPLETED|Intervention Period 1 and Washout||3
8267768|NCT01748552|20386481|P6|COMPLETED|Intervention Period 1 and Washout||3
8267769|NCT01748552|20386482|P5|COMPLETED|Intervention Period 1 and Washout||3
8267770|NCT01748552|20386483|P4|COMPLETED|Intervention Period 1 and Washout||3
8267771|NCT01748552|20386484|P3|COMPLETED|Intervention Period 1 and Washout||3
8267772|NCT01748552|20386485|P2|COMPLETED|Intervention Period 1 and Washout||3
8267773|NCT01748552|20386486|P1|COMPLETED|Intervention Period 1 and Washout||3
8267774|NCT01748552|20386475|P12|STARTED|Intervention Period 1 and Washout||3
8267775|NCT01748552|20386476|P11|STARTED|Intervention Period 1 and Washout||3
8267776|NCT01748552|20386477|P10|STARTED|Intervention Period 1 and Washout||3
8267777|NCT01748552|20386478|P9|STARTED|Intervention Period 1 and Washout||3
8267778|NCT01748552|20386479|P8|STARTED|Intervention Period 1 and Washout||3
8267779|NCT01748552|20386480|P7|STARTED|Intervention Period 1 and Washout||3
8267780|NCT01748552|20386481|P6|STARTED|Intervention Period 1 and Washout||3
8267781|NCT01748552|20386482|P5|STARTED|Intervention Period 1 and Washout||3
8267782|NCT01748552|20386483|P4|STARTED|Intervention Period 1 and Washout||3
8267783|NCT01748552|20386484|P3|STARTED|Intervention Period 1 and Washout||3
8267784|NCT01748552|20386485|P2|STARTED|Intervention Period 1 and Washout||3
8267785|NCT01748552|20386486|P1|STARTED|Intervention Period 1 and Washout||3
8267786|NCT01748292|20386556|P2|NOT COMPLETED|Overall Study||12
8267787|NCT01748292|20386557|P1|NOT COMPLETED|Overall Study||2
8267788|NCT01748292|20386556|P2|COMPLETED|Overall Study||28
8267789|NCT01748292|20386557|P1|COMPLETED|Overall Study||18
8267790|NCT01748292|20386556|P2|STARTED|Overall Study||40
8267791|NCT01748292|20386557|P1|STARTED|Overall Study||20
8267792|NCT01748240|20386577|P1|NOT COMPLETED|Overall Study||0
8267793|NCT01748240|20386577|P1|COMPLETED|Overall Study||21
8267794|NCT01748240|20386577|P1|STARTED|Overall Study||21
8267795|NCT01748227|20386581|P1|NOT COMPLETED|Overall Study||3
8267796|NCT01748227|20386581|P1|COMPLETED|Overall Study||17
8267797|NCT01748227|20386581|P1|STARTED|Overall Study||20
8267798|NCT01748162|20386591|P2|NOT COMPLETED|Overall Study||5
8267799|NCT01748162|20386592|P1|NOT COMPLETED|Overall Study||5
8267800|NCT01748162|20386591|P2|COMPLETED|Overall Study||0
8267801|NCT01748162|20386592|P1|COMPLETED|Overall Study||0
8267802|NCT01748162|20386591|P2|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
8267803|NCT01748162|20386592|P1|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
8267804|NCT01748162|20386591|P2|Completed 6 Month Initial Treatment|Overall Study||0
8267805|NCT01748162|20386592|P1|Completed 6 Month Initial Treatment|Overall Study||0
8267806|NCT01748162|20386591|P2|Started 6 Month Initial Treatment Plan|Overall Study||2
8267807|NCT01748162|20386592|P1|Started 6 Month Initial Treatment Plan|Overall Study||2
8267808|NCT01748162|20386591|P2|STARTED|Overall Study||5
8267809|NCT01748162|20386592|P1|STARTED|Overall Study||5
8267810|NCT01748071|20386603|P3|NOT COMPLETED|Overall Study||0
8267811|NCT01748071|20386604|P2|NOT COMPLETED|Overall Study||2
8267812|NCT01748071|20386605|P1|NOT COMPLETED|Overall Study||2
8267813|NCT01748071|20386603|P3|COMPLETED|Overall Study||40
8267814|NCT01748071|20386604|P2|COMPLETED|Overall Study||38
8267815|NCT01748071|20386605|P1|COMPLETED|Overall Study||38
8267816|NCT01748071|20386603|P3|STARTED|Overall Study||40
8267817|NCT01748071|20386604|P2|STARTED|Overall Study||40
8267818|NCT01748071|20386605|P1|STARTED|Overall Study||40
8267819|NCT01748045|20386627|P2|NOT COMPLETED|Overall Study||0
8267820|NCT01748045|20386628|P1|NOT COMPLETED|Overall Study||0
8267821|NCT01748045|20386627|P2|COMPLETED|Overall Study||1
8267822|NCT01748045|20386628|P1|COMPLETED|Overall Study||2
8267823|NCT01748045|20386627|P2|STARTED|Overall Study||1
8267824|NCT01748045|20386628|P1|STARTED|Overall Study||2
8267825|NCT01747928|20386654|P8|NOT COMPLETED|Overall Study||0
8267826|NCT01747928|20386655|P7|NOT COMPLETED|Overall Study||0
8267827|NCT01747928|20386656|P6|NOT COMPLETED|Overall Study||0
8267828|NCT01747928|20386657|P5|NOT COMPLETED|Overall Study||0
8267829|NCT01747928|20386658|P4|NOT COMPLETED|Overall Study||0
8267830|NCT01747928|20386659|P3|NOT COMPLETED|Overall Study||0
8267831|NCT01747928|20386660|P2|NOT COMPLETED|Overall Study||0
8267832|NCT01747928|20386661|P1|NOT COMPLETED|Overall Study||0
8267833|NCT01747928|20386654|P8|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267834|NCT01747928|20386655|P7|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267835|NCT01747928|20386656|P6|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267836|NCT01747928|20386657|P5|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267837|NCT01747928|20386658|P4|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267838|NCT01747928|20386659|P3|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267839|NCT01747928|20386660|P2|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267840|NCT01747928|20386661|P1|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
8267841|NCT01747928|20386654|P8|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267842|NCT01747928|20386655|P7|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267843|NCT01747928|20386656|P6|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267844|NCT01747928|20386657|P5|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267845|NCT01747928|20386658|P4|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267846|NCT01747928|20386659|P3|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267847|NCT01747928|20386660|P2|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267848|NCT01747928|20386661|P1|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
8267849|NCT01747915|20386868|P3|NOT COMPLETED|Overall Study||6
8267850|NCT01747915|20386869|P2|NOT COMPLETED|Overall Study||11
8267851|NCT01747915|20386870|P1|NOT COMPLETED|Overall Study||15
8267852|NCT01747915|20386868|P3|COMPLETED|Overall Study||66
8267853|NCT01747915|20386869|P2|COMPLETED|Overall Study||61
8267854|NCT01747915|20386870|P1|COMPLETED|Overall Study||60
8267855|NCT01747915|20386868|P3|STARTED|Overall Study||72
8267856|NCT01747915|20386869|P2|STARTED|Overall Study||72
8267857|NCT01747915|20386870|P1|STARTED|Overall Study||75
8267858|NCT01747876|20386884|P3|NOT COMPLETED|Overall Study||12
8267859|NCT01747876|20386885|P2|NOT COMPLETED|Overall Study||15
8267860|NCT01747876|20386886|P1|NOT COMPLETED|Overall Study||5
8267861|NCT01747876|20386884|P3|COMPLETED|Overall Study||0
8267862|NCT01747876|20386885|P2|COMPLETED|Overall Study||0
8267863|NCT01747876|20386886|P1|COMPLETED|Overall Study||0
8267864|NCT01747876|20386884|P3|STARTED|Overall Study||12
8267865|NCT01747876|20386885|P2|STARTED|Overall Study||15
8267866|NCT01747876|20386886|P1|STARTED|Overall Study||5
8267867|NCT01747850|20386915|P3|NOT COMPLETED|Overall Study||6
8267868|NCT01747850|20386916|P2|NOT COMPLETED|Overall Study||7
8267869|NCT01747850|20386917|P1|NOT COMPLETED|Overall Study||1
8267870|NCT01747850|20386915|P3|COMPLETED|Overall Study||14
8267871|NCT01747850|20386916|P2|COMPLETED|Overall Study||13
8267872|NCT01747850|20386917|P1|COMPLETED|Overall Study||4
8267873|NCT01747850|20386915|P3|STARTED|Overall Study||20
8267874|NCT01747850|20386916|P2|STARTED|Overall Study||20
8267875|NCT01747850|20386917|P1|STARTED|Overall Study||5
8267876|NCT01747837|20386939|P2|NOT COMPLETED|Overall Study||6
8267877|NCT01747837|20386940|P1|NOT COMPLETED|Overall Study||9
8267878|NCT01747837|20386939|P2|COMPLETED|Overall Study||17
8267879|NCT01747837|20386940|P1|COMPLETED|Overall Study||16
8267880|NCT01747837|20386939|P2|STARTED|Overall Study||23
8267881|NCT01747837|20386940|P1|STARTED|Overall Study||25
8267882|NCT01747811|20386970|P2|NOT COMPLETED|Overall Study||4
8267883|NCT01747811|20386971|P1|NOT COMPLETED|Overall Study||2
8267884|NCT01747811|20386970|P2|COMPLETED|Overall Study||12
8267885|NCT01747811|20386971|P1|COMPLETED|Overall Study||14
8267886|NCT01747811|20386970|P2|STARTED|Overall Study||16
8267887|NCT01747811|20386971|P1|STARTED|Overall Study||16
8267888|NCT01747772|20386987|P1|NOT COMPLETED|Overall Study||9
8267889|NCT01747772|20386987|P1|COMPLETED|Overall Study||171
8267890|NCT01747772|20386987|P1|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
8267891|NCT01747772|20386987|P1|STARTED|Overall Study||180
8267892|NCT01747655|20386995|P2|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
8267893|NCT01747655|20386996|P1|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
8267894|NCT01747655|20386995|P2|COMPLETED|PEG-J Period (Continued Treatment)||15
8267895|NCT01747655|20386996|P1|COMPLETED|PEG-J Period (Continued Treatment)||41
8267896|NCT01747655|20386995|P2|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
8267897|NCT01747655|20386996|P1|STARTED|PEG-J Period (Continued Treatment)||41
8267898|NCT01747655|20386995|P2|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
8267899|NCT01747655|20386996|P1|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
8267900|NCT01747655|20386995|P2|COMPLETED|PEG-J Period (Duodopa Treatment)||6
8267901|NCT01747655|20386996|P1|COMPLETED|PEG-J Period (Duodopa Treatment)||44
8267902|NCT01747655|20386995|P2|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
8267903|NCT01747655|20386996|P1|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
8267904|NCT01747655|20386995|P2|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
8267905|NCT01747655|20386996|P1|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
8267906|NCT01747655|20386995|P2|COMPLETED|Temporary Naso-jejunal Tube Period||0
8267907|NCT01747655|20386996|P1|COMPLETED|Temporary Naso-jejunal Tube Period||64
8267908|NCT01747655|20386995|P2|STARTED|Temporary Naso-jejunal Tube Period||0
8267909|NCT01747655|20386996|P1|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
8267910|NCT01747629|20387026|P2|NOT COMPLETED|Overall Study||6
8267911|NCT01747629|20387027|P1|NOT COMPLETED|Overall Study||8
8267912|NCT01747629|20387026|P2|COMPLETED|Overall Study||69
8267913|NCT01747629|20387027|P1|COMPLETED|Overall Study||77
8267914|NCT01747629|20387026|P2|Treated|Overall Study|Safety set and full analysis set|75
8267915|NCT01747629|20387027|P1|Treated|Overall Study|Safety set and full analysis set|84
8267916|NCT01747629|20387026|P2|STARTED|Overall Study||75
8267917|NCT01747629|20387027|P1|STARTED|Overall Study||85
8267918|NCT01747551|20387061|P2|NOT COMPLETED|Overall Study||21
8267919|NCT01747551|20387062|P1|NOT COMPLETED|Overall Study||43
8267920|NCT01747551|20387061|P2|COMPLETED|Overall Study||0
8267921|NCT01747551|20387062|P1|COMPLETED|Overall Study||0
8267922|NCT01747551|20387061|P2|STARTED|Overall Study||21
8267923|NCT01747551|20387062|P1|STARTED|Overall Study||43
8267924|NCT01747499|20387079|P5|NOT COMPLETED|Overall Study||15
8267925|NCT01747499|20387080|P4|NOT COMPLETED|Overall Study||2
8267926|NCT01747499|20387081|P3|NOT COMPLETED|Overall Study||0
8267927|NCT01747499|20387082|P2|NOT COMPLETED|Overall Study||1
8267928|NCT01747499|20387083|P1|NOT COMPLETED|Overall Study||1
8267929|NCT01747499|20387079|P5|COMPLETED|Overall Study||24
8267930|NCT01747499|20387080|P4|COMPLETED|Overall Study||4
8267931|NCT01747499|20387081|P3|COMPLETED|Overall Study||3
8267932|NCT01747499|20387082|P2|COMPLETED|Overall Study||2
8267933|NCT01747499|20387083|P1|COMPLETED|Overall Study||2
8267934|NCT01747499|20387079|P5|STARTED|Overall Study||39
8267935|NCT01747499|20387080|P4|STARTED|Overall Study||6
8267936|NCT01747499|20387081|P3|STARTED|Overall Study||3
8267937|NCT01747499|20387082|P2|STARTED|Overall Study||3
8267938|NCT01747499|20387083|P1|STARTED|Overall Study||3
8267939|NCT01747486|20387119|P2|NOT COMPLETED|Stage 2||0
8267940|NCT01747486|20387120|P1|NOT COMPLETED|Stage 2||9
8267941|NCT01747486|20387119|P2|COMPLETED|Stage 2||0
8267942|NCT01747486|20387120|P1|COMPLETED|Stage 2||3
8267943|NCT01747486|20387119|P2|STARTED|Stage 2||0
8267944|NCT01747486|20387120|P1|STARTED|Stage 2||12
8267945|NCT01747486|20387119|P2|NOT COMPLETED|Stage 1||13
8267946|NCT01747486|20387120|P1|NOT COMPLETED|Stage 1||12
8267947|NCT01747486|20387119|P2|COMPLETED|Stage 1||2
8267948|NCT01747486|20387120|P1|COMPLETED|Stage 1||3
8267949|NCT01747486|20387119|P2|STARTED|Stage 1||15
8267950|NCT01747486|20387120|P1|STARTED|Stage 1||15
8267951|NCT01747343|20387126|P1|NOT COMPLETED|Underwear/Differential Reinforcement||0
8267952|NCT01747343|20387126|P1|COMPLETED|Underwear/Differential Reinforcement||4
8267953|NCT01747343|20387126|P1|STARTED|Underwear/Differential Reinforcement||4
8267954|NCT01747343|20387126|P1|NOT COMPLETED|Underwear||0
8267955|NCT01747343|20387126|P1|COMPLETED|Underwear||4
8267956|NCT01747343|20387126|P1|STARTED|Underwear||4
8267957|NCT01747343|20387126|P1|NOT COMPLETED|Baseline||0
8267958|NCT01747343|20387126|P1|COMPLETED|Baseline||4
8267959|NCT01747343|20387126|P1|STARTED|Baseline||4
8267960|NCT01747330|20387132|P1|NOT COMPLETED|Overall Study||0
8267961|NCT01747330|20387132|P1|COMPLETED|Overall Study||40
8267962|NCT01747330|20387132|P1|STARTED|Overall Study||40
8267963|NCT01746979|20387146|P2|NOT COMPLETED|Overall Study||347
8267964|NCT01746979|20387147|P1|NOT COMPLETED|Overall Study||346
8267965|NCT01746979|20387146|P2|COMPLETED|Overall Study||0
8267966|NCT01746979|20387147|P1|COMPLETED|Overall Study||0
8267967|NCT01746979|20387146|P2|STARTED|Overall Study||347
8267968|NCT01746979|20387147|P1|STARTED|Overall Study||346
8267969|NCT01746940|20387159|P4|NOT COMPLETED|Safety Second Phase||0
8267970|NCT01746940|20387160|P3|NOT COMPLETED|Safety Second Phase||0
8267971|NCT01746940|20387161|P2|NOT COMPLETED|Safety Second Phase||0
8267972|NCT01746940|20387162|P1|NOT COMPLETED|Safety Second Phase||0
8267973|NCT01746940|20387159|P4|COMPLETED|Safety Second Phase||0
8267974|NCT01746940|20387160|P3|COMPLETED|Safety Second Phase||0
8267975|NCT01746940|20387161|P2|COMPLETED|Safety Second Phase||18
8267976|NCT01746940|20387162|P1|COMPLETED|Safety Second Phase||18
8267977|NCT01746940|20387159|P4|STARTED|Safety Second Phase||0
8267978|NCT01746940|20387160|P3|STARTED|Safety Second Phase||0
8267979|NCT01746940|20387161|P2|STARTED|Safety Second Phase||18
8267980|NCT01746940|20387162|P1|STARTED|Safety Second Phase||18
8267981|NCT01746940|20387159|P4|NOT COMPLETED|Safety and Efficacy First Phase||3
8267982|NCT01746940|20387160|P3|NOT COMPLETED|Safety and Efficacy First Phase||0
8267983|NCT01746940|20387161|P2|NOT COMPLETED|Safety and Efficacy First Phase||0
8267984|NCT01746940|20387162|P1|NOT COMPLETED|Safety and Efficacy First Phase||0
8267985|NCT01746940|20387159|P4|COMPLETED|Safety and Efficacy First Phase||0
8267986|NCT01746940|20387160|P3|COMPLETED|Safety and Efficacy First Phase||40
8267987|NCT01746940|20387161|P2|COMPLETED|Safety and Efficacy First Phase||41
8267988|NCT01746940|20387162|P1|COMPLETED|Safety and Efficacy First Phase||39
8267989|NCT01746940|20387159|P4|STARTED|Safety and Efficacy First Phase||3
8267990|NCT01746940|20387160|P3|STARTED|Safety and Efficacy First Phase||40
8267991|NCT01746940|20387161|P2|STARTED|Safety and Efficacy First Phase||41
8267992|NCT01746940|20387162|P1|STARTED|Safety and Efficacy First Phase||39
8267993|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8267994|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8267995|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8267996|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8267997|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8267998|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8267999|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8268000|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8268001|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
8268002|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Sixth Intervention||5
8268003|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Sixth Intervention||6
8268004|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Sixth Intervention||5
8268005|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Sixth Intervention||5
8268006|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Sixth Intervention||6
8268007|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Sixth Intervention||5
8268008|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Sixth Intervention||0
8268009|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Sixth Intervention||0
8268010|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Sixth Intervention||0
8268011|NCT01746901|20387170|P9|STARTED|Treatment Phase: Sixth Intervention||5
8268012|NCT01746901|20387171|P8|STARTED|Treatment Phase: Sixth Intervention||6
8268013|NCT01746901|20387172|P7|STARTED|Treatment Phase: Sixth Intervention||5
8268014|NCT01746901|20387173|P6|STARTED|Treatment Phase: Sixth Intervention||5
8268015|NCT01746901|20387174|P5|STARTED|Treatment Phase: Sixth Intervention||6
8268016|NCT01746901|20387175|P4|STARTED|Treatment Phase: Sixth Intervention||5
8268017|NCT01746901|20387176|P3|STARTED|Treatment Phase: Sixth Intervention||0
8268018|NCT01746901|20387177|P2|STARTED|Treatment Phase: Sixth Intervention||0
8268019|NCT01746901|20387178|P1|STARTED|Treatment Phase: Sixth Intervention||0
8268020|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268021|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268022|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268023|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268024|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268025|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268026|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268027|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268028|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Washout Period 5||0
8268029|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Washout Period 5||5
8268030|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Washout Period 5||6
8268031|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Washout Period 5||5
8268032|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Washout Period 5||5
8268033|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Washout Period 5||6
8268034|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Washout Period 5||5
8268035|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Washout Period 5||0
8268036|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Washout Period 5||0
8268037|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Washout Period 5||0
8268038|NCT01746901|20387170|P9|STARTED|Treatment Phase: Washout Period 5||5
8268039|NCT01746901|20387171|P8|STARTED|Treatment Phase: Washout Period 5||6
8268040|NCT01746901|20387172|P7|STARTED|Treatment Phase: Washout Period 5||5
8268041|NCT01746901|20387173|P6|STARTED|Treatment Phase: Washout Period 5||5
8268042|NCT01746901|20387174|P5|STARTED|Treatment Phase: Washout Period 5||6
8268043|NCT01746901|20387175|P4|STARTED|Treatment Phase: Washout Period 5||5
8268044|NCT01746901|20387176|P3|STARTED|Treatment Phase: Washout Period 5||0
8268045|NCT01746901|20387177|P2|STARTED|Treatment Phase: Washout Period 5||0
8268046|NCT01746901|20387178|P1|STARTED|Treatment Phase: Washout Period 5||0
8268047|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268048|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268049|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268050|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268051|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268052|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268053|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268054|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268055|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
8268056|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Fifth Intervention||5
8268057|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Fifth Intervention||6
8268058|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Fifth Intervention||5
8268059|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Fifth Intervention||5
8268060|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Fifth Intervention||6
8268061|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Fifth Intervention||5
8268062|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Fifth Intervention||0
8268063|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Fifth Intervention||0
8268064|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Fifth Intervention||0
8268065|NCT01746901|20387170|P9|STARTED|Treatment Phase: Fifth Intervention||5
8268066|NCT01746901|20387171|P8|STARTED|Treatment Phase: Fifth Intervention||6
8268067|NCT01746901|20387172|P7|STARTED|Treatment Phase: Fifth Intervention||5
8268068|NCT01746901|20387173|P6|STARTED|Treatment Phase: Fifth Intervention||5
8268069|NCT01746901|20387174|P5|STARTED|Treatment Phase: Fifth Intervention||6
8268070|NCT01746901|20387175|P4|STARTED|Treatment Phase: Fifth Intervention||5
8268071|NCT01746901|20387176|P3|STARTED|Treatment Phase: Fifth Intervention||0
8268072|NCT01746901|20387177|P2|STARTED|Treatment Phase: Fifth Intervention||0
8268073|NCT01746901|20387178|P1|STARTED|Treatment Phase: Fifth Intervention||0
8268074|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268075|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268076|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268077|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268078|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268079|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268080|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268081|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268082|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Washout Period 4||0
8268083|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Washout Period 4||5
8268084|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Washout Period 4||6
8268085|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Washout Period 4||5
8268086|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Washout Period 4||5
8268087|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Washout Period 4||6
8268088|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Washout Period 4||5
8268089|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Washout Period 4||0
8268090|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Washout Period 4||0
8268091|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Washout Period 4||0
8268092|NCT01746901|20387170|P9|STARTED|Treatment Phase: Washout Period 4||5
8268093|NCT01746901|20387171|P8|STARTED|Treatment Phase: Washout Period 4||6
8268094|NCT01746901|20387172|P7|STARTED|Treatment Phase: Washout Period 4||5
8268095|NCT01746901|20387173|P6|STARTED|Treatment Phase: Washout Period 4||5
8268096|NCT01746901|20387174|P5|STARTED|Treatment Phase: Washout Period 4||6
8268097|NCT01746901|20387175|P4|STARTED|Treatment Phase: Washout Period 4||5
8268098|NCT01746901|20387176|P3|STARTED|Treatment Phase: Washout Period 4||0
8268099|NCT01746901|20387177|P2|STARTED|Treatment Phase: Washout Period 4||0
8268100|NCT01746901|20387178|P1|STARTED|Treatment Phase: Washout Period 4||0
8268101|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
8268102|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8268103|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
8268104|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
8268105|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8268106|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
8268107|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8268108|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8268109|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
8268110|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Fourth Intervention||5
8268111|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Fourth Intervention||6
8268112|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Fourth Intervention||5
8268113|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Fourth Intervention||5
8268114|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Fourth Intervention||6
8268115|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Fourth Intervention||5
8268116|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
8268117|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
8268118|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
8268119|NCT01746901|20387170|P9|STARTED|Treatment Phase: Fourth Intervention||7
8268120|NCT01746901|20387171|P8|STARTED|Treatment Phase: Fourth Intervention||6
8268121|NCT01746901|20387172|P7|STARTED|Treatment Phase: Fourth Intervention||6
8268122|NCT01746901|20387173|P6|STARTED|Treatment Phase: Fourth Intervention||6
8268123|NCT01746901|20387174|P5|STARTED|Treatment Phase: Fourth Intervention||6
8268124|NCT01746901|20387175|P4|STARTED|Treatment Phase: Fourth Intervention||6
8268125|NCT01746901|20387176|P3|STARTED|Treatment Phase: Fourth Intervention||0
8268126|NCT01746901|20387177|P2|STARTED|Treatment Phase: Fourth Intervention||0
8268127|NCT01746901|20387178|P1|STARTED|Treatment Phase: Fourth Intervention||0
8268128|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268129|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268130|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268131|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268132|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268133|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268134|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268135|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268136|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
8268137|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Washout Period 3||7
8268138|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Washout Period 3||6
8268139|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Washout Period 3||6
8268140|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Washout Period 3||6
8268141|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Washout Period 3||6
8268142|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Washout Period 3||6
8268143|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Washout Period 3||0
8268144|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Washout Period 3||0
8268145|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Washout Period 3||0
8268146|NCT01746901|20387170|P9|STARTED|Treatment Phase: Washout Period 3||7
8268147|NCT01746901|20387171|P8|STARTED|Treatment Phase: Washout Period 3||6
8268148|NCT01746901|20387172|P7|STARTED|Treatment Phase: Washout Period 3||6
8268149|NCT01746901|20387173|P6|STARTED|Treatment Phase: Washout Period 3||6
8268150|NCT01746901|20387174|P5|STARTED|Treatment Phase: Washout Period 3||6
8268151|NCT01746901|20387175|P4|STARTED|Treatment Phase: Washout Period 3||6
8268152|NCT01746901|20387176|P3|STARTED|Treatment Phase: Washout Period 3||0
8268153|NCT01746901|20387177|P2|STARTED|Treatment Phase: Washout Period 3||0
8268154|NCT01746901|20387178|P1|STARTED|Treatment Phase: Washout Period 3||0
8268155|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Third Intervention||0
8268156|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
8268157|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Third Intervention||1
8268158|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Third Intervention||1
8268159|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
8268160|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
8268161|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
8268162|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
8268163|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
8268164|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Third Intervention||7
8268165|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Third Intervention||6
8268166|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Third Intervention||6
8268167|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Third Intervention||6
8268168|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Third Intervention||6
8268169|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Third Intervention||6
8268170|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Third Intervention||0
8268171|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Third Intervention||0
8268172|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Third Intervention||0
8268173|NCT01746901|20387170|P9|STARTED|Treatment Phase: Third Intervention||7
8268174|NCT01746901|20387171|P8|STARTED|Treatment Phase: Third Intervention||6
8268175|NCT01746901|20387172|P7|STARTED|Treatment Phase: Third Intervention||7
8268176|NCT01746901|20387173|P6|STARTED|Treatment Phase: Third Intervention||7
8268177|NCT01746901|20387174|P5|STARTED|Treatment Phase: Third Intervention||6
8268178|NCT01746901|20387175|P4|STARTED|Treatment Phase: Third Intervention||6
8268179|NCT01746901|20387176|P3|STARTED|Treatment Phase: Third Intervention||0
8268180|NCT01746901|20387177|P2|STARTED|Treatment Phase: Third Intervention||0
8268181|NCT01746901|20387178|P1|STARTED|Treatment Phase: Third Intervention||0
8268182|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268183|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268184|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268185|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268186|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268187|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268188|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268189|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268190|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
8268191|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Washout Period 2||7
8268192|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Washout Period 2||6
8268193|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Washout Period 2||7
8268194|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Washout Period 2||7
8268195|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Washout Period 2||6
8268196|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Washout Period 2||6
8268197|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Washout Period 2||0
8268198|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Washout Period 2||0
8268199|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Washout Period 2||0
8268200|NCT01746901|20387170|P9|STARTED|Treatment Phase: Washout Period 2||7
8268201|NCT01746901|20387171|P8|STARTED|Treatment Phase: Washout Period 2||6
8268202|NCT01746901|20387172|P7|STARTED|Treatment Phase: Washout Period 2||7
8268203|NCT01746901|20387173|P6|STARTED|Treatment Phase: Washout Period 2||7
8268204|NCT01746901|20387174|P5|STARTED|Treatment Phase: Washout Period 2||6
8268205|NCT01746901|20387175|P4|STARTED|Treatment Phase: Washout Period 2||6
8268206|NCT01746901|20387176|P3|STARTED|Treatment Phase: Washout Period 2||0
8268207|NCT01746901|20387177|P2|STARTED|Treatment Phase: Washout Period 2||0
8268208|NCT01746901|20387178|P1|STARTED|Treatment Phase: Washout Period 2||0
8268209|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268210|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Second Intervention||1
8268288|NCT01746901|20387177|P2|STARTED|Treatment Phase: First Intervention||0
8268211|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268212|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268213|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268214|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268215|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268216|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268217|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
8268218|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Second Intervention||7
8268219|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Second Intervention||6
8268220|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Second Intervention||7
8268221|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Second Intervention||7
8268222|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Second Intervention||6
8268223|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Second Intervention||6
8268224|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Second Intervention||0
8268225|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Second Intervention||0
8268226|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Second Intervention||0
8268227|NCT01746901|20387170|P9|STARTED|Treatment Phase: Second Intervention||7
8268228|NCT01746901|20387171|P8|STARTED|Treatment Phase: Second Intervention||7
8268229|NCT01746901|20387172|P7|STARTED|Treatment Phase: Second Intervention||7
8268230|NCT01746901|20387173|P6|STARTED|Treatment Phase: Second Intervention||7
8268231|NCT01746901|20387174|P5|STARTED|Treatment Phase: Second Intervention||6
8268232|NCT01746901|20387175|P4|STARTED|Treatment Phase: Second Intervention||6
8268233|NCT01746901|20387176|P3|STARTED|Treatment Phase: Second Intervention||0
8268234|NCT01746901|20387177|P2|STARTED|Treatment Phase: Second Intervention||0
8268235|NCT01746901|20387178|P1|STARTED|Treatment Phase: Second Intervention||0
8268236|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268237|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268238|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268239|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268240|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268241|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268242|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268243|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268244|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
8268245|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: Washout Period 1||7
8268246|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: Washout Period 1||7
8268247|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: Washout Period 1||7
8268248|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: Washout Period 1||7
8268249|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: Washout Period 1||6
8268250|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: Washout Period 1||6
8268251|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: Washout Period 1||0
8268252|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: Washout Period 1||0
8268253|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: Washout Period 1||0
8268254|NCT01746901|20387170|P9|STARTED|Treatment Phase: Washout Period 1||7
8268255|NCT01746901|20387171|P8|STARTED|Treatment Phase: Washout Period 1||7
8268256|NCT01746901|20387172|P7|STARTED|Treatment Phase: Washout Period 1||7
8268257|NCT01746901|20387173|P6|STARTED|Treatment Phase: Washout Period 1||7
8268258|NCT01746901|20387174|P5|STARTED|Treatment Phase: Washout Period 1||6
8268259|NCT01746901|20387175|P4|STARTED|Treatment Phase: Washout Period 1||6
8268260|NCT01746901|20387176|P3|STARTED|Treatment Phase: Washout Period 1||0
8268261|NCT01746901|20387177|P2|STARTED|Treatment Phase: Washout Period 1||0
8268262|NCT01746901|20387178|P1|STARTED|Treatment Phase: Washout Period 1||0
8268263|NCT01746901|20387170|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
8268264|NCT01746901|20387171|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
8268265|NCT01746901|20387172|P7|NOT COMPLETED|Treatment Phase: First Intervention||1
8268266|NCT01746901|20387173|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
8268267|NCT01746901|20387174|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
8268268|NCT01746901|20387175|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
8268269|NCT01746901|20387176|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
8268270|NCT01746901|20387177|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
8268271|NCT01746901|20387178|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
8268272|NCT01746901|20387170|P9|COMPLETED|Treatment Phase: First Intervention||7
8268273|NCT01746901|20387171|P8|COMPLETED|Treatment Phase: First Intervention||7
8268274|NCT01746901|20387172|P7|COMPLETED|Treatment Phase: First Intervention||7
8268275|NCT01746901|20387173|P6|COMPLETED|Treatment Phase: First Intervention||7
8268276|NCT01746901|20387174|P5|COMPLETED|Treatment Phase: First Intervention||6
8268277|NCT01746901|20387175|P4|COMPLETED|Treatment Phase: First Intervention||6
8268278|NCT01746901|20387176|P3|COMPLETED|Treatment Phase: First Intervention||0
8268279|NCT01746901|20387177|P2|COMPLETED|Treatment Phase: First Intervention||0
8268280|NCT01746901|20387178|P1|COMPLETED|Treatment Phase: First Intervention||0
8268281|NCT01746901|20387170|P9|STARTED|Treatment Phase: First Intervention||7
8268282|NCT01746901|20387171|P8|STARTED|Treatment Phase: First Intervention||7
8268283|NCT01746901|20387172|P7|STARTED|Treatment Phase: First Intervention||8
8268284|NCT01746901|20387173|P6|STARTED|Treatment Phase: First Intervention||7
8268285|NCT01746901|20387174|P5|STARTED|Treatment Phase: First Intervention||6
8268286|NCT01746901|20387175|P4|STARTED|Treatment Phase: First Intervention||6
8268287|NCT01746901|20387176|P3|STARTED|Treatment Phase: First Intervention||0
8268289|NCT01746901|20387178|P1|STARTED|Treatment Phase: First Intervention||0
8268290|NCT01746901|20387170|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8268291|NCT01746901|20387171|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8268292|NCT01746901|20387172|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8268293|NCT01746901|20387173|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8268294|NCT01746901|20387174|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8268295|NCT01746901|20387175|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8268296|NCT01746901|20387176|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
8268297|NCT01746901|20387177|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
8268298|NCT01746901|20387178|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8268299|NCT01746901|20387170|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
8268300|NCT01746901|20387171|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
8268301|NCT01746901|20387172|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
8268302|NCT01746901|20387173|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
8268303|NCT01746901|20387174|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
8268304|NCT01746901|20387175|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
8268305|NCT01746901|20387176|P3|COMPLETED|Drug Discrimination Phase: Day 2||22
8268306|NCT01746901|20387177|P2|COMPLETED|Drug Discrimination Phase: Day 2||19
8268307|NCT01746901|20387178|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
8268308|NCT01746901|20387170|P9|STARTED|Drug Discrimination Phase: Day 2||0
8268309|NCT01746901|20387171|P8|STARTED|Drug Discrimination Phase: Day 2||0
8268310|NCT01746901|20387172|P7|STARTED|Drug Discrimination Phase: Day 2||0
8268311|NCT01746901|20387173|P6|STARTED|Drug Discrimination Phase: Day 2||0
8268312|NCT01746901|20387174|P5|STARTED|Drug Discrimination Phase: Day 2||0
8268313|NCT01746901|20387175|P4|STARTED|Drug Discrimination Phase: Day 2||0
8268314|NCT01746901|20387176|P3|STARTED|Drug Discrimination Phase: Day 2||36
8268315|NCT01746901|20387177|P2|STARTED|Drug Discrimination Phase: Day 2||33
8268316|NCT01746901|20387178|P1|STARTED|Drug Discrimination Phase: Day 2||0
8268317|NCT01746901|20387170|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268318|NCT01746901|20387171|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268319|NCT01746901|20387172|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268320|NCT01746901|20387173|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268321|NCT01746901|20387174|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268322|NCT01746901|20387175|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268323|NCT01746901|20387176|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268324|NCT01746901|20387177|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
8268325|NCT01746901|20387178|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8268326|NCT01746901|20387170|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
8268327|NCT01746901|20387171|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
8268328|NCT01746901|20387172|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
8268329|NCT01746901|20387173|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
8268330|NCT01746901|20387174|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
8268331|NCT01746901|20387175|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
8268332|NCT01746901|20387176|P3|COMPLETED|Drug Discrimination Phase: Day 1||36
8268333|NCT01746901|20387177|P2|COMPLETED|Drug Discrimination Phase: Day 1||33
8268334|NCT01746901|20387178|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
8268335|NCT01746901|20387170|P9|STARTED|Drug Discrimination Phase: Day 1||0
8268336|NCT01746901|20387171|P8|STARTED|Drug Discrimination Phase: Day 1||0
8268337|NCT01746901|20387172|P7|STARTED|Drug Discrimination Phase: Day 1||0
8268338|NCT01746901|20387173|P6|STARTED|Drug Discrimination Phase: Day 1||0
8268339|NCT01746901|20387174|P5|STARTED|Drug Discrimination Phase: Day 1||0
8268340|NCT01746901|20387175|P4|STARTED|Drug Discrimination Phase: Day 1||0
8268341|NCT01746901|20387176|P3|STARTED|Drug Discrimination Phase: Day 1||36
8268342|NCT01746901|20387177|P2|STARTED|Drug Discrimination Phase: Day 1||36
8268343|NCT01746901|20387178|P1|STARTED|Drug Discrimination Phase: Day 1||0
8268344|NCT01746901|20387170|P9|NOT COMPLETED|Naloxone Challenge Phase||0
8268345|NCT01746901|20387171|P8|NOT COMPLETED|Naloxone Challenge Phase||0
8268346|NCT01746901|20387172|P7|NOT COMPLETED|Naloxone Challenge Phase||0
8268347|NCT01746901|20387173|P6|NOT COMPLETED|Naloxone Challenge Phase||0
8268348|NCT01746901|20387174|P5|NOT COMPLETED|Naloxone Challenge Phase||0
8268349|NCT01746901|20387175|P4|NOT COMPLETED|Naloxone Challenge Phase||0
8268350|NCT01746901|20387176|P3|NOT COMPLETED|Naloxone Challenge Phase||0
8268351|NCT01746901|20387177|P2|NOT COMPLETED|Naloxone Challenge Phase||0
8268352|NCT01746901|20387178|P1|NOT COMPLETED|Naloxone Challenge Phase||3
8268353|NCT01746901|20387170|P9|COMPLETED|Naloxone Challenge Phase||0
8268354|NCT01746901|20387171|P8|COMPLETED|Naloxone Challenge Phase||0
8268355|NCT01746901|20387172|P7|COMPLETED|Naloxone Challenge Phase||0
8268356|NCT01746901|20387173|P6|COMPLETED|Naloxone Challenge Phase||0
8268357|NCT01746901|20387174|P5|COMPLETED|Naloxone Challenge Phase||0
8268358|NCT01746901|20387175|P4|COMPLETED|Naloxone Challenge Phase||0
8268359|NCT01746901|20387176|P3|COMPLETED|Naloxone Challenge Phase||0
8268360|NCT01746901|20387177|P2|COMPLETED|Naloxone Challenge Phase||0
8268361|NCT01746901|20387178|P1|COMPLETED|Naloxone Challenge Phase||72
8268362|NCT01746901|20387170|P9|STARTED|Naloxone Challenge Phase||0
8268363|NCT01746901|20387171|P8|STARTED|Naloxone Challenge Phase||0
8268364|NCT01746901|20387172|P7|STARTED|Naloxone Challenge Phase||0
8268365|NCT01746901|20387173|P6|STARTED|Naloxone Challenge Phase||0
8268366|NCT01746901|20387174|P5|STARTED|Naloxone Challenge Phase||0
8268367|NCT01746901|20387175|P4|STARTED|Naloxone Challenge Phase||0
8268368|NCT01746901|20387176|P3|STARTED|Naloxone Challenge Phase||0
8268369|NCT01746901|20387177|P2|STARTED|Naloxone Challenge Phase||0
8268370|NCT01746901|20387178|P1|STARTED|Naloxone Challenge Phase||75
8268371|NCT01746862|20387501|P2|NOT COMPLETED|Overall Study||3
8268372|NCT01746862|20387502|P1|NOT COMPLETED|Overall Study||8
8268373|NCT01746862|20387501|P2|COMPLETED|Overall Study||27
8268374|NCT01746862|20387502|P1|COMPLETED|Overall Study||52
8268375|NCT01746862|20387501|P2|Treated|Overall Study||30
8268376|NCT01746862|20387502|P1|Treated|Overall Study||59
8268377|NCT01746862|20387501|P2|STARTED|Overall Study||30
8268378|NCT01746862|20387502|P1|STARTED|Overall Study||60
8268379|NCT01746784|20387527|P5|NOT COMPLETED|Overall Study||0
8268380|NCT01746784|20387528|P4|NOT COMPLETED|Overall Study||0
8268381|NCT01746784|20387529|P3|NOT COMPLETED|Overall Study||0
8268382|NCT01746784|20387530|P2|NOT COMPLETED|Overall Study||0
8268383|NCT01746784|20387531|P1|NOT COMPLETED|Overall Study||0
8268384|NCT01746784|20387527|P5|COMPLETED|Overall Study||19
8268385|NCT01746784|20387528|P4|COMPLETED|Overall Study||9
8268386|NCT01746784|20387529|P3|COMPLETED|Overall Study||9
8268387|NCT01746784|20387530|P2|COMPLETED|Overall Study||10
8268388|NCT01746784|20387531|P1|COMPLETED|Overall Study||19
8268389|NCT01746784|20387527|P5|Enrolled|Overall Study||19
8268390|NCT01746784|20387528|P4|Enrolled|Overall Study||9
8268391|NCT01746784|20387529|P3|Enrolled|Overall Study||9
8268392|NCT01746784|20387530|P2|Enrolled|Overall Study||10
8268393|NCT01746784|20387531|P1|Enrolled|Overall Study||19
8268394|NCT01746784|20387527|P5|STARTED|Overall Study||19
8268395|NCT01746784|20387528|P4|STARTED|Overall Study||9
8268396|NCT01746784|20387529|P3|STARTED|Overall Study||9
8268397|NCT01746784|20387530|P2|STARTED|Overall Study||10
8268398|NCT01746784|20387531|P1|STARTED|Overall Study||19
8268399|NCT01746745|20387553|P1|NOT COMPLETED|Overall Study||0
8268400|NCT01746745|20387553|P1|COMPLETED|Overall Study||6
8268401|NCT01746745|20387553|P1|Received Study Drug|Overall Study||6
8268402|NCT01746745|20387553|P1|STARTED|Overall Study||6
8268403|NCT01746732|20387566|P3|NOT COMPLETED|Period 2||4
8268404|NCT01746732|20387567|P2|NOT COMPLETED|Period 2||0
8268405|NCT01746732|20387568|P1|NOT COMPLETED|Period 2||0
8268406|NCT01746732|20387566|P3|COMPLETED|Period 2||7
8268407|NCT01746732|20387567|P2|COMPLETED|Period 2||10
8268408|NCT01746732|20387568|P1|COMPLETED|Period 2||0
8268409|NCT01746732|20387566|P3|STARTED|Period 2||11
8268410|NCT01746732|20387567|P2|STARTED|Period 2||10
8268411|NCT01746732|20387568|P1|STARTED|Period 2||0
8268412|NCT01746732|20387566|P3|NOT COMPLETED|Period 1||0
8268413|NCT01746732|20387567|P2|NOT COMPLETED|Period 1||1
8268414|NCT01746732|20387568|P1|NOT COMPLETED|Period 1||0
8268415|NCT01746732|20387566|P3|COMPLETED|Period 1||11
8268416|NCT01746732|20387567|P2|COMPLETED|Period 1||10
8268417|NCT01746732|20387568|P1|COMPLETED|Period 1||0
8268418|NCT01746732|20387566|P3|STARTED|Period 1||11
8268419|NCT01746732|20387567|P2|STARTED|Period 1||11
8268420|NCT01746732|20387568|P1|STARTED|Period 1||0
8268421|NCT01746732|20387566|P3|NOT COMPLETED|Lead-In Period||0
8268422|NCT01746732|20387567|P2|NOT COMPLETED|Lead-In Period||0
8268423|NCT01746732|20387568|P1|NOT COMPLETED|Lead-In Period||1
8268424|NCT01746732|20387566|P3|COMPLETED|Lead-In Period||0
8268425|NCT01746732|20387567|P2|COMPLETED|Lead-In Period||0
8268426|NCT01746732|20387568|P1|COMPLETED|Lead-In Period||22
8268427|NCT01746732|20387566|P3|Participants Received at Least 1 Dose|Lead-In Period||0
8268428|NCT01746732|20387567|P2|Participants Received at Least 1 Dose|Lead-In Period||0
8268429|NCT01746732|20387568|P1|Participants Received at Least 1 Dose|Lead-In Period||22
8268430|NCT01746732|20387566|P3|STARTED|Lead-In Period||0
8268431|NCT01746732|20387567|P2|STARTED|Lead-In Period||0
8268432|NCT01746732|20387568|P1|STARTED|Lead-In Period||23
8268433|NCT01746511|20387591|P2|NOT COMPLETED|Overall Study||0
8268434|NCT01746511|20387592|P1|NOT COMPLETED|Overall Study||0
8268435|NCT01746511|20387591|P2|COMPLETED|Overall Study||39
8268436|NCT01746511|20387592|P1|COMPLETED|Overall Study||40
8268437|NCT01746511|20387591|P2|STARTED|Overall Study||39
8268438|NCT01746511|20387592|P1|STARTED|Overall Study||40
8268439|NCT01746420|20387611|P5|NOT COMPLETED|Overall Study||0
8268440|NCT01746420|20387612|P4|NOT COMPLETED|Overall Study||0
8268441|NCT01746420|20387613|P3|NOT COMPLETED|Overall Study||3
8268442|NCT01746420|20387614|P2|NOT COMPLETED|Overall Study||2
8268443|NCT01746420|20387615|P1|NOT COMPLETED|Overall Study||3
8268444|NCT01746420|20387611|P5|COMPLETED|Overall Study||20
8268445|NCT01746420|20387612|P4|COMPLETED|Overall Study||20
8268446|NCT01746420|20387613|P3|COMPLETED|Overall Study||17
8268447|NCT01746420|20387614|P2|COMPLETED|Overall Study||18
8268448|NCT01746420|20387615|P1|COMPLETED|Overall Study||17
8268449|NCT01746420|20387611|P5|STARTED|Overall Study||20
8268450|NCT01746420|20387612|P4|STARTED|Overall Study||20
8268451|NCT01746420|20387613|P3|STARTED|Overall Study||20
8268452|NCT01746420|20387614|P2|STARTED|Overall Study||20
8268453|NCT01746420|20387615|P1|STARTED|Overall Study||20
8268454|NCT01746368|20387649|P2|NOT COMPLETED|Overall Study||1
8268455|NCT01746368|20387650|P1|NOT COMPLETED|Overall Study||2
8268456|NCT01746368|20387649|P2|COMPLETED|Overall Study||16
8268457|NCT01746368|20387650|P1|COMPLETED|Overall Study||31
8268458|NCT01746368|20387649|P2|Analyzed for Satisfaction|Overall Study||16
8268459|NCT01746368|20387650|P1|Analyzed for Satisfaction|Overall Study||30
8268460|NCT01746368|20387649|P2|Analyzed for AD Completion Rate|Overall Study||17
8268461|NCT01746368|20387650|P1|Analyzed for AD Completion Rate|Overall Study||32
8268462|NCT01746368|20387649|P2|Assessment Completed|Overall Study||16
8268463|NCT01746368|20387650|P1|Assessment Completed|Overall Study||31
8268464|NCT01746368|20387649|P2|Recieved Allocated Intervention|Overall Study||8
8268465|NCT01746368|20387650|P1|Recieved Allocated Intervention|Overall Study||31
8268466|NCT01746368|20387649|P2|STARTED|Overall Study||17
8268467|NCT01746368|20387650|P1|STARTED|Overall Study||33
8268468|NCT01746264|20387658|P1|NOT COMPLETED|Overall Study||0
8268469|NCT01746264|20387658|P1|COMPLETED|Overall Study||19
8268470|NCT01746264|20387658|P1|STARTED|Overall Study||19
8268480|NCT01746173|20387705|P1|NOT COMPLETED|Overall Study||2
8268481|NCT01746173|20387705|P1|COMPLETED|Overall Study||3
8268482|NCT01746173|20387705|P1|STARTED|Overall Study||5
8268483|NCT01746108|20387713|P3|NOT COMPLETED|Overall Study||0
8268484|NCT01746108|20387714|P2|NOT COMPLETED|Overall Study||4
8268485|NCT01746108|20387715|P1|NOT COMPLETED|Overall Study||0
8268486|NCT01746108|20387713|P3|COMPLETED|Overall Study||6
8268487|NCT01746108|20387714|P2|COMPLETED|Overall Study||24
8268488|NCT01746108|20387715|P1|COMPLETED|Overall Study||18
8268489|NCT01746108|20387713|P3|STARTED|Overall Study||6
8268490|NCT01746108|20387714|P2|STARTED|Overall Study||28
8268491|NCT01746108|20387715|P1|STARTED|Overall Study||18
8268492|NCT01746095|20387755|P4|NOT COMPLETED|Overall Study||8
8268493|NCT01746095|20387756|P3|NOT COMPLETED|Overall Study||13
8268494|NCT01746095|20387757|P2|NOT COMPLETED|Overall Study||4
8268495|NCT01746095|20387758|P1|NOT COMPLETED|Overall Study||4
8268496|NCT01746095|20387755|P4|COMPLETED|Overall Study||15
8268497|NCT01746095|20387756|P3|COMPLETED|Overall Study||11
8268498|NCT01746095|20387757|P2|COMPLETED|Overall Study||16
8268499|NCT01746095|20387758|P1|COMPLETED|Overall Study||16
8268500|NCT01746095|20387755|P4|STARTED|Overall Study||23
8268501|NCT01746095|20387756|P3|STARTED|Overall Study||24
8268502|NCT01746095|20387757|P2|STARTED|Overall Study||20
8268503|NCT01746095|20387758|P1|STARTED|Overall Study||20
8268504|NCT01746043|20387808|P4|NOT COMPLETED|Overall Study||0
8268505|NCT01746043|20387809|P3|NOT COMPLETED|Overall Study||0
8268506|NCT01746043|20387810|P2|NOT COMPLETED|Overall Study||0
8268507|NCT01746043|20387811|P1|NOT COMPLETED|Overall Study||0
8268508|NCT01746043|20387808|P4|COMPLETED|Overall Study||5
8268509|NCT01746043|20387809|P3|COMPLETED|Overall Study||5
8268510|NCT01746043|20387810|P2|COMPLETED|Overall Study||4
8268511|NCT01746043|20387811|P1|COMPLETED|Overall Study||5
8268512|NCT01746043|20387808|P4|STARTED|Overall Study||5
8268513|NCT01746043|20387809|P3|STARTED|Overall Study||5
8268514|NCT01746043|20387810|P2|STARTED|Overall Study||4
8268515|NCT01746043|20387811|P1|STARTED|Overall Study||5
8268516|NCT01746017|20387832|P11|NOT COMPLETED|Period 4||0
8268517|NCT01746017|20387833|P10|NOT COMPLETED|Period 4||0
8268518|NCT01746017|20387834|P9|NOT COMPLETED|Period 4||0
8268519|NCT01746017|20387835|P8|NOT COMPLETED|Period 4||0
8268520|NCT01746017|20387836|P7|NOT COMPLETED|Period 4||0
8268521|NCT01746017|20387837|P6|NOT COMPLETED|Period 4||0
8268522|NCT01746017|20387838|P5|NOT COMPLETED|Period 4||0
8268523|NCT01746017|20387839|P4|NOT COMPLETED|Period 4||0
8268524|NCT01746017|20387840|P3|NOT COMPLETED|Period 4||0
8268525|NCT01746017|20387841|P2|NOT COMPLETED|Period 4||0
8268526|NCT01746017|20387842|P1|NOT COMPLETED|Period 4||0
8268527|NCT01746017|20387832|P11|COMPLETED|Period 4||0
8268528|NCT01746017|20387833|P10|COMPLETED|Period 4||0
8268529|NCT01746017|20387834|P9|COMPLETED|Period 4||0
8268530|NCT01746017|20387835|P8|COMPLETED|Period 4||2
8268531|NCT01746017|20387836|P7|COMPLETED|Period 4||2
8268532|NCT01746017|20387837|P6|COMPLETED|Period 4||1
8268533|NCT01746017|20387838|P5|COMPLETED|Period 4||2
8268534|NCT01746017|20387839|P4|COMPLETED|Period 4||2
8268535|NCT01746017|20387840|P3|COMPLETED|Period 4||2
8268536|NCT01746017|20387841|P2|COMPLETED|Period 4||2
8268537|NCT01746017|20387842|P1|COMPLETED|Period 4||2
8268538|NCT01746017|20387832|P11|STARTED|Period 4|Part B occurred only for 3 periods.|0
8268539|NCT01746017|20387833|P10|STARTED|Period 4|Part B occurred only for 3 periods.|0
8268540|NCT01746017|20387834|P9|STARTED|Period 4|Part B occurred only for 3 periods.|0
8268541|NCT01746017|20387835|P8|STARTED|Period 4||2
8268542|NCT01746017|20387836|P7|STARTED|Period 4||2
8268543|NCT01746017|20387837|P6|STARTED|Period 4||1
8268544|NCT01746017|20387838|P5|STARTED|Period 4||2
8268545|NCT01746017|20387839|P4|STARTED|Period 4||2
8268546|NCT01746017|20387840|P3|STARTED|Period 4||2
8268547|NCT01746017|20387841|P2|STARTED|Period 4||2
8268548|NCT01746017|20387842|P1|STARTED|Period 4||2
8268549|NCT01746017|20387832|P11|NOT COMPLETED|Period 3||0
8268550|NCT01746017|20387833|P10|NOT COMPLETED|Period 3||0
8268551|NCT01746017|20387834|P9|NOT COMPLETED|Period 3||0
8268552|NCT01746017|20387835|P8|NOT COMPLETED|Period 3||0
8268553|NCT01746017|20387836|P7|NOT COMPLETED|Period 3||0
8268554|NCT01746017|20387837|P6|NOT COMPLETED|Period 3||1
8268555|NCT01746017|20387838|P5|NOT COMPLETED|Period 3||0
8268556|NCT01746017|20387839|P4|NOT COMPLETED|Period 3||0
8268557|NCT01746017|20387840|P3|NOT COMPLETED|Period 3||0
8268558|NCT01746017|20387841|P2|NOT COMPLETED|Period 3||0
8268559|NCT01746017|20387842|P1|NOT COMPLETED|Period 3||0
8268560|NCT01746017|20387832|P11|COMPLETED|Period 3||3
8268561|NCT01746017|20387833|P10|COMPLETED|Period 3||3
8268562|NCT01746017|20387834|P9|COMPLETED|Period 3||3
8268563|NCT01746017|20387835|P8|COMPLETED|Period 3||2
8268564|NCT01746017|20387836|P7|COMPLETED|Period 3||2
8268565|NCT01746017|20387837|P6|COMPLETED|Period 3||1
8268566|NCT01746017|20387838|P5|COMPLETED|Period 3||2
8268567|NCT01746017|20387839|P4|COMPLETED|Period 3||2
8268568|NCT01746017|20387840|P3|COMPLETED|Period 3||2
8268569|NCT01746017|20387841|P2|COMPLETED|Period 3||2
8268570|NCT01746017|20387842|P1|COMPLETED|Period 3||2
8268571|NCT01746017|20387832|P11|STARTED|Period 3||3
8268572|NCT01746017|20387833|P10|STARTED|Period 3||3
8268573|NCT01746017|20387834|P9|STARTED|Period 3||3
8268574|NCT01746017|20387835|P8|STARTED|Period 3||2
8268575|NCT01746017|20387836|P7|STARTED|Period 3||2
8268576|NCT01746017|20387837|P6|STARTED|Period 3||2
8268577|NCT01746017|20387838|P5|STARTED|Period 3||2
8268578|NCT01746017|20387839|P4|STARTED|Period 3||2
8268579|NCT01746017|20387840|P3|STARTED|Period 3||2
8268580|NCT01746017|20387841|P2|STARTED|Period 3||2
8268581|NCT01746017|20387842|P1|STARTED|Period 3||2
8268582|NCT01746017|20387832|P11|NOT COMPLETED|Period 2||0
8268583|NCT01746017|20387833|P10|NOT COMPLETED|Period 2||0
8268584|NCT01746017|20387834|P9|NOT COMPLETED|Period 2||0
8268585|NCT01746017|20387835|P8|NOT COMPLETED|Period 2||0
8268586|NCT01746017|20387836|P7|NOT COMPLETED|Period 2||0
8268587|NCT01746017|20387837|P6|NOT COMPLETED|Period 2||0
8268588|NCT01746017|20387838|P5|NOT COMPLETED|Period 2||0
8268589|NCT01746017|20387839|P4|NOT COMPLETED|Period 2||0
8268590|NCT01746017|20387840|P3|NOT COMPLETED|Period 2||0
8268591|NCT01746017|20387841|P2|NOT COMPLETED|Period 2||0
8268592|NCT01746017|20387842|P1|NOT COMPLETED|Period 2||0
8268593|NCT01746017|20387832|P11|COMPLETED|Period 2||3
8268594|NCT01746017|20387833|P10|COMPLETED|Period 2||3
8268595|NCT01746017|20387834|P9|COMPLETED|Period 2||3
8268596|NCT01746017|20387835|P8|COMPLETED|Period 2||2
8268597|NCT01746017|20387836|P7|COMPLETED|Period 2||2
8268598|NCT01746017|20387837|P6|COMPLETED|Period 2||2
8268599|NCT01746017|20387838|P5|COMPLETED|Period 2||2
8268600|NCT01746017|20387839|P4|COMPLETED|Period 2||2
8268601|NCT01746017|20387840|P3|COMPLETED|Period 2||2
8268602|NCT01746017|20387841|P2|COMPLETED|Period 2||2
8268603|NCT01746017|20387842|P1|COMPLETED|Period 2||2
8268604|NCT01746017|20387832|P11|STARTED|Period 2||3
8268605|NCT01746017|20387833|P10|STARTED|Period 2||3
8268606|NCT01746017|20387834|P9|STARTED|Period 2||3
8268607|NCT01746017|20387835|P8|STARTED|Period 2||2
8268608|NCT01746017|20387836|P7|STARTED|Period 2||2
8268609|NCT01746017|20387837|P6|STARTED|Period 2||2
8268610|NCT01746017|20387838|P5|STARTED|Period 2||2
8268611|NCT01746017|20387839|P4|STARTED|Period 2||2
8268612|NCT01746017|20387840|P3|STARTED|Period 2||2
8268613|NCT01746017|20387841|P2|STARTED|Period 2||2
8268614|NCT01746017|20387842|P1|STARTED|Period 2||2
8268615|NCT01746017|20387832|P11|NOT COMPLETED|Period 1||0
8268616|NCT01746017|20387833|P10|NOT COMPLETED|Period 1||0
8268617|NCT01746017|20387834|P9|NOT COMPLETED|Period 1||0
8268618|NCT01746017|20387835|P8|NOT COMPLETED|Period 1||0
8268619|NCT01746017|20387836|P7|NOT COMPLETED|Period 1||1
8268620|NCT01746017|20387837|P6|NOT COMPLETED|Period 1||0
8268621|NCT01746017|20387838|P5|NOT COMPLETED|Period 1||0
8268622|NCT01746017|20387839|P4|NOT COMPLETED|Period 1||0
8268623|NCT01746017|20387840|P3|NOT COMPLETED|Period 1||0
8268624|NCT01746017|20387841|P2|NOT COMPLETED|Period 1||0
8268625|NCT01746017|20387842|P1|NOT COMPLETED|Period 1||0
8268626|NCT01746017|20387832|P11|COMPLETED|Period 1||3
8268627|NCT01746017|20387833|P10|COMPLETED|Period 1||3
8268628|NCT01746017|20387834|P9|COMPLETED|Period 1||3
8268629|NCT01746017|20387835|P8|COMPLETED|Period 1||2
8268630|NCT01746017|20387836|P7|COMPLETED|Period 1||2
8268631|NCT01746017|20387837|P6|COMPLETED|Period 1||2
8268632|NCT01746017|20387838|P5|COMPLETED|Period 1||2
8268633|NCT01746017|20387839|P4|COMPLETED|Period 1||2
8268634|NCT01746017|20387840|P3|COMPLETED|Period 1||2
8268635|NCT01746017|20387841|P2|COMPLETED|Period 1||2
8268636|NCT01746017|20387842|P1|COMPLETED|Period 1||2
8268637|NCT01746017|20387832|P11|Received at Least 1 Dose of Study Drug|Period 1||3
8268638|NCT01746017|20387833|P10|Received at Least 1 Dose of Study Drug|Period 1||3
8268639|NCT01746017|20387834|P9|Received at Least 1 Dose of Study Drug|Period 1||3
8268640|NCT01746017|20387835|P8|Received at Least 1 Dose of Study Drug|Period 1||2
8268641|NCT01746017|20387836|P7|Received at Least 1 Dose of Study Drug|Period 1||3
8268642|NCT01746017|20387837|P6|Received at Least 1 Dose of Study Drug|Period 1||2
8268643|NCT01746017|20387838|P5|Received at Least 1 Dose of Study Drug|Period 1||2
8268644|NCT01746017|20387839|P4|Received at Least 1 Dose of Study Drug|Period 1||2
8268645|NCT01746017|20387840|P3|Received at Least 1 Dose of Study Drug|Period 1||2
8268646|NCT01746017|20387841|P2|Received at Least 1 Dose of Study Drug|Period 1||2
8268647|NCT01746017|20387842|P1|Received at Least 1 Dose of Study Drug|Period 1||2
8268648|NCT01746017|20387832|P11|STARTED|Period 1||3
8268649|NCT01746017|20387833|P10|STARTED|Period 1||3
8268650|NCT01746017|20387834|P9|STARTED|Period 1||3
8268651|NCT01746017|20387835|P8|STARTED|Period 1||2
8268652|NCT01746017|20387836|P7|STARTED|Period 1||3
8268653|NCT01746017|20387837|P6|STARTED|Period 1||2
8268654|NCT01746017|20387838|P5|STARTED|Period 1||2
8268655|NCT01746017|20387839|P4|STARTED|Period 1||2
8268656|NCT01746017|20387840|P3|STARTED|Period 1||2
8268657|NCT01746017|20387841|P2|STARTED|Period 1||2
8268658|NCT01746017|20387842|P1|STARTED|Period 1||2
8268659|NCT01745952|20387918|P3|NOT COMPLETED|Overall Study||0
8268660|NCT01745952|20387919|P2|NOT COMPLETED|Overall Study||1
8268661|NCT01745952|20387920|P1|NOT COMPLETED|Overall Study||1
8268662|NCT01745952|20387918|P3|COMPLETED|Overall Study||3
8268663|NCT01745952|20387919|P2|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
8268664|NCT01745952|20387920|P1|COMPLETED|Overall Study||3
8268665|NCT01745952|20387918|P3|STARTED|Overall Study||3
8268666|NCT01745952|20387919|P2|STARTED|Overall Study||4
8268667|NCT01745952|20387920|P1|STARTED|Overall Study||4
8268668|NCT01745913|20387946|P2|NOT COMPLETED|Overall Study||1
8268669|NCT01745913|20387947|P1|NOT COMPLETED|Overall Study||1
8268670|NCT01745913|20387946|P2|COMPLETED|Overall Study||0
8268671|NCT01745913|20387947|P1|COMPLETED|Overall Study||0
8268672|NCT01745913|20387946|P2|STARTED|Overall Study||1
8268673|NCT01745913|20387947|P1|STARTED|Overall Study||1
8268674|NCT01745848|20387963|P1|NOT COMPLETED|Overall Study||6
8268675|NCT01745848|20387963|P1|COMPLETED|Overall Study||20
8268676|NCT01745848|20387963|P1|STARTED|Overall Study||26
8268677|NCT01745627|20387968|P1|NOT COMPLETED|Overall Study||22
8268678|NCT01745627|20387968|P1|COMPLETED|Overall Study||20
8268679|NCT01745627|20387968|P1|STARTED|Overall Study||42
8268680|NCT01745393|20387975|P2|NOT COMPLETED|12-month Follow-up||5
8268681|NCT01745393|20387976|P1|NOT COMPLETED|12-month Follow-up||6
8268682|NCT01745393|20387975|P2|COMPLETED|12-month Follow-up||151
8268683|NCT01745393|20387976|P1|COMPLETED|12-month Follow-up||136
8268684|NCT01745393|20387975|P2|STARTED|12-month Follow-up||156
8268685|NCT01745393|20387976|P1|STARTED|12-month Follow-up||142
8268686|NCT01745393|20387975|P2|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
8268687|NCT01745393|20387976|P1|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
8268688|NCT01745393|20387975|P2|COMPLETED|Treatment to End-of-treatment Assessment||156
8268689|NCT01745393|20387976|P1|COMPLETED|Treatment to End-of-treatment Assessment||142
8268690|NCT01745393|20387975|P2|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
8268691|NCT01745393|20387976|P1|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
8268692|NCT01745393|20387975|P2|STARTED|Treatment to End-of-treatment Assessment||164
8268693|NCT01745393|20387976|P1|STARTED|Treatment to End-of-treatment Assessment||163
8268694|NCT01745380|20387988|P2|NOT COMPLETED|Overall Study||1
8268695|NCT01745380|20387989|P1|NOT COMPLETED|Overall Study||1
8268696|NCT01745380|20387988|P2|COMPLETED|Overall Study||49
8268697|NCT01745380|20387989|P1|COMPLETED|Overall Study||99
8268698|NCT01745380|20387988|P2|STARTED|Overall Study||50
8268699|NCT01745380|20387989|P1|STARTED|Overall Study||100
8268700|NCT01745367|20388027|P2|NOT COMPLETED|Overall Study||22
8268701|NCT01745367|20388028|P1|NOT COMPLETED|Overall Study||8
8268702|NCT01745367|20388027|P2|COMPLETED|Overall Study||0
8268703|NCT01745367|20388028|P1|COMPLETED|Overall Study||0
8268704|NCT01745367|20388027|P2|Treated|Overall Study||21
8268705|NCT01745367|20388028|P1|Treated|Overall Study||8
8268706|NCT01745367|20388027|P2|STARTED|Overall Study||22
8268707|NCT01745367|20388028|P1|STARTED|Overall Study||8
8268708|NCT01745146|20388048|P2|NOT COMPLETED|Overall Study||3
8268709|NCT01745146|20388049|P1|NOT COMPLETED|Overall Study||3
8268710|NCT01745146|20388048|P2|COMPLETED|Overall Study||57
8268711|NCT01745146|20388049|P1|COMPLETED|Overall Study||27
8268712|NCT01745146|20388048|P2|Analysis|Overall Study||57
8268713|NCT01745146|20388049|P1|Analysis|Overall Study||27
8268714|NCT01745146|20388048|P2|Primary Outcome Assessment|Overall Study||57
8268715|NCT01745146|20388049|P1|Primary Outcome Assessment|Overall Study||27
8268716|NCT01745146|20388048|P2|Allocation to Intervention|Overall Study||60
8268717|NCT01745146|20388049|P1|Allocation to Intervention|Overall Study||30
8268718|NCT01745146|20388048|P2|STARTED|Overall Study||60
8268719|NCT01745146|20388049|P1|STARTED|Overall Study||30
8268720|NCT01745133|20388059|P3|NOT COMPLETED|Overall Study||4
8268721|NCT01745133|20388060|P2|NOT COMPLETED|Overall Study||4
8268722|NCT01745133|20388061|P1|NOT COMPLETED|Overall Study||6
8268723|NCT01745133|20388059|P3|COMPLETED|Overall Study||15
8268724|NCT01745133|20388060|P2|COMPLETED|Overall Study||16
8268725|NCT01745133|20388061|P1|COMPLETED|Overall Study||13
8268726|NCT01745133|20388059|P3|STARTED|Overall Study||19
8268727|NCT01745133|20388060|P2|STARTED|Overall Study||20
8268728|NCT01745133|20388061|P1|STARTED|Overall Study||19
8268729|NCT01745120|20388071|P2|NOT COMPLETED|Overall Study||0
8268730|NCT01745120|20388072|P1|NOT COMPLETED|Overall Study||1
8268731|NCT01745120|20388071|P2|COMPLETED|Overall Study||8
8268732|NCT01745120|20388072|P1|COMPLETED|Overall Study||10
8268733|NCT01745120|20388071|P2|STARTED|Overall Study||8
8268734|NCT01745120|20388072|P1|STARTED|Overall Study||11
8268735|NCT01745094|20388130|P4|NOT COMPLETED|Overall Study||3
8268736|NCT01745094|20388131|P3|NOT COMPLETED|Overall Study||12
8268737|NCT01745094|20388132|P2|NOT COMPLETED|Overall Study||0
8268738|NCT01745094|20388133|P1|NOT COMPLETED|Overall Study||5
8268739|NCT01745094|20388130|P4|COMPLETED|Overall Study||90
8268740|NCT01745094|20388131|P3|COMPLETED|Overall Study||46
8268741|NCT01745094|20388132|P2|COMPLETED|Overall Study||37
8268742|NCT01745094|20388133|P1|COMPLETED|Overall Study||30
8268743|NCT01745094|20388130|P4|STARTED|Overall Study||93
8268744|NCT01745094|20388131|P3|STARTED|Overall Study||58
8268745|NCT01745094|20388132|P2|STARTED|Overall Study||37
8268746|NCT01745094|20388133|P1|STARTED|Overall Study||35
8268747|NCT01745055|20388199|P1|NOT COMPLETED|Overall Study||0
8268748|NCT01745055|20388199|P1|COMPLETED|Overall Study||12
8268749|NCT01745055|20388199|P1|STARTED|Overall Study||12
8268750|NCT01744977|20388234|P2|NOT COMPLETED|Overall Study||5
8268751|NCT01744977|20388235|P1|NOT COMPLETED|Overall Study||11
8268752|NCT01744977|20388234|P2|COMPLETED|Overall Study||115
8268753|NCT01744977|20388235|P1|COMPLETED|Overall Study||109
8268754|NCT01744977|20388234|P2|6 Month Completed|Overall Study||115
8268755|NCT01744977|20388235|P1|6 Month Completed|Overall Study||113
8268756|NCT01744977|20388234|P2|STARTED|Overall Study||120
8268757|NCT01744977|20388235|P1|STARTED|Overall Study||120
8268758|NCT01744860|20388243|P1|NOT COMPLETED|Overall Study||0
8268759|NCT01744860|20388243|P1|COMPLETED|Overall Study||420
8268760|NCT01744860|20388243|P1|STARTED|Overall Study||420
8268761|NCT01744821|20388281|P4|NOT COMPLETED|Overall Study||0
8268762|NCT01744821|20388282|P3|NOT COMPLETED|Overall Study||0
8268763|NCT01744821|20388283|P2|NOT COMPLETED|Overall Study||0
8268764|NCT01744821|20388284|P1|NOT COMPLETED|Overall Study||0
8268765|NCT01744821|20388281|P4|COMPLETED|Overall Study||1
8268766|NCT01744821|20388282|P3|COMPLETED|Overall Study||2
8268767|NCT01744821|20388283|P2|COMPLETED|Overall Study||3
8268768|NCT01744821|20388284|P1|COMPLETED|Overall Study||1
8268769|NCT01744821|20388281|P4|STARTED|Overall Study||1
8268770|NCT01744821|20388282|P3|STARTED|Overall Study||2
8268771|NCT01744821|20388283|P2|STARTED|Overall Study||3
8268772|NCT01744821|20388284|P1|STARTED|Overall Study||1
8268773|NCT01744782|20388306|P1|NOT COMPLETED|Overall Study||1
8268774|NCT01744782|20388306|P1|COMPLETED|Overall Study||16
8268775|NCT01744782|20388306|P1|STARTED|Overall Study||17
8268776|NCT01744730|20388319|P5|NOT COMPLETED|Overall Study||0
8268777|NCT01744730|20388320|P4|NOT COMPLETED|Overall Study||0
8268778|NCT01744730|20388321|P3|NOT COMPLETED|Overall Study||0
8268779|NCT01744730|20388322|P2|NOT COMPLETED|Overall Study||0
8268780|NCT01744730|20388323|P1|NOT COMPLETED|Overall Study||0
8268781|NCT01744730|20388319|P5|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
8268782|NCT01744730|20388320|P4|COMPLETED|Overall Study||11
8268783|NCT01744730|20388321|P3|COMPLETED|Overall Study||4
8268784|NCT01744730|20388322|P2|COMPLETED|Overall Study||3
8268785|NCT01744730|20388323|P1|COMPLETED|Overall Study||4
8268786|NCT01744730|20388319|P5|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
8268787|NCT01744730|20388320|P4|STARTED|Overall Study||11
8268788|NCT01744730|20388321|P3|STARTED|Overall Study||4
8268789|NCT01744730|20388322|P2|STARTED|Overall Study||3
8268790|NCT01744730|20388323|P1|STARTED|Overall Study||4
8268791|NCT01744704|20388377|P12|NOT COMPLETED|Overall Study||0
8268792|NCT01744704|20388378|P11|NOT COMPLETED|Overall Study||0
8268793|NCT01744704|20388379|P10|NOT COMPLETED|Overall Study||0
8268794|NCT01744704|20388380|P9|NOT COMPLETED|Overall Study||0
8268795|NCT01744704|20388381|P8|NOT COMPLETED|Overall Study||0
8268796|NCT01744704|20388382|P7|NOT COMPLETED|Overall Study||0
8268797|NCT01744704|20388383|P6|NOT COMPLETED|Overall Study||0
8268798|NCT01744704|20388384|P5|NOT COMPLETED|Overall Study||0
8268799|NCT01744704|20388385|P4|NOT COMPLETED|Overall Study||0
8268800|NCT01744704|20388386|P3|NOT COMPLETED|Overall Study||0
8268801|NCT01744704|20388387|P2|NOT COMPLETED|Overall Study||0
8268802|NCT01744704|20388388|P1|NOT COMPLETED|Overall Study||0
8268803|NCT01744704|20388377|P12|COMPLETED|Overall Study||10
8268804|NCT01744704|20388378|P11|COMPLETED|Overall Study||9
8268805|NCT01744704|20388379|P10|COMPLETED|Overall Study||9
8268806|NCT01744704|20388380|P9|COMPLETED|Overall Study||3
8268807|NCT01744704|20388381|P8|COMPLETED|Overall Study||9
8268808|NCT01744704|20388382|P7|COMPLETED|Overall Study||6
8268809|NCT01744704|20388383|P6|COMPLETED|Overall Study||7
8268810|NCT01744704|20388384|P5|COMPLETED|Overall Study||6
8268811|NCT01744704|20388385|P4|COMPLETED|Overall Study||6
8268812|NCT01744704|20388386|P3|COMPLETED|Overall Study||3
8268813|NCT01744704|20388387|P2|COMPLETED|Overall Study||3
8268814|NCT01744704|20388388|P1|COMPLETED|Overall Study||3
8268815|NCT01744704|20388377|P12|STARTED|Overall Study||10
8268816|NCT01744704|20388378|P11|STARTED|Overall Study||9
8268817|NCT01744704|20388379|P10|STARTED|Overall Study||9
8268818|NCT01744704|20388380|P9|STARTED|Overall Study||3
8268819|NCT01744704|20388381|P8|STARTED|Overall Study||9
8268820|NCT01744704|20388382|P7|STARTED|Overall Study||6
8268821|NCT01744704|20388383|P6|STARTED|Overall Study||7
8268822|NCT01744704|20388384|P5|STARTED|Overall Study||6
8268823|NCT01744704|20388385|P4|STARTED|Overall Study||6
8268824|NCT01744704|20388386|P3|STARTED|Overall Study||3
8268825|NCT01744704|20388387|P2|STARTED|Overall Study||3
8268826|NCT01744704|20388388|P1|STARTED|Overall Study||3
8268827|NCT01744691|20388467|P1|NOT COMPLETED|Overall Study||43
8268828|NCT01744691|20388467|P1|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
8268829|NCT01744691|20388467|P1|STARTED|Overall Study|Participants who received study treatment|144
8268830|NCT01744665|20388472|P1|NOT COMPLETED|Re-initiation Phase||13
8268831|NCT01744665|20388472|P1|COMPLETED|Re-initiation Phase||4
8268832|NCT01744665|20388472|P1|STARTED|Re-initiation Phase||17
8268833|NCT01744665|20388472|P1|NOT COMPLETED|Treatment Free Remission Phase||0
8268834|NCT01744665|20388472|P1|COMPLETED|Treatment Free Remission Phase||32
8268835|NCT01744665|20388472|P1|STARTED|Treatment Free Remission Phase||32
8268836|NCT01744665|20388472|P1|NOT COMPLETED|Consolidation Phase||19
8268837|NCT01744665|20388472|P1|COMPLETED|Consolidation Phase||22
8268838|NCT01744665|20388472|P1|STARTED|Consolidation Phase||41
8268839|NCT01744665|20388472|P1|NOT COMPLETED|Monitoring Phase||18
8268840|NCT01744665|20388472|P1|COMPLETED|Monitoring Phase||41
8268841|NCT01744665|20388472|P1|STARTED|Monitoring Phase||59
8268842|NCT01744574|20388503|P4|NOT COMPLETED|Overall Study||11
8268843|NCT01744574|20388504|P3|NOT COMPLETED|Overall Study||20
8268844|NCT01744574|20388505|P2|NOT COMPLETED|Overall Study||25
8268845|NCT01744574|20388506|P1|NOT COMPLETED|Overall Study||24
8268846|NCT01744574|20388503|P4|COMPLETED|Overall Study||40
8268847|NCT01744574|20388504|P3|COMPLETED|Overall Study||32
8268848|NCT01744574|20388505|P2|COMPLETED|Overall Study||31
8268849|NCT01744574|20388506|P1|COMPLETED|Overall Study||33
8268850|NCT01744574|20388503|P4|STARTED|Overall Study||51
8268851|NCT01744574|20388504|P3|STARTED|Overall Study||52
8268852|NCT01744574|20388505|P2|STARTED|Overall Study||56
8268853|NCT01744574|20388506|P1|STARTED|Overall Study||57
8268854|NCT01744496|20388542|P2|NOT COMPLETED|Maintenance Period||4
8268855|NCT01744496|20388543|P1|NOT COMPLETED|Maintenance Period||4
8268856|NCT01744496|20388542|P2|COMPLETED|Maintenance Period||29
8268857|NCT01744496|20388543|P1|COMPLETED|Maintenance Period||27
8268858|NCT01744496|20388542|P2|STARTED|Maintenance Period||33
8268859|NCT01744496|20388543|P1|STARTED|Maintenance Period||31
8268860|NCT01744496|20388542|P2|NOT COMPLETED|Titration Period||2
8268861|NCT01744496|20388543|P1|NOT COMPLETED|Titration Period||2
8268862|NCT01744496|20388542|P2|COMPLETED|Titration Period||33
8268863|NCT01744496|20388543|P1|COMPLETED|Titration Period||31
8268864|NCT01744496|20388542|P2|STARTED|Titration Period||35
8268865|NCT01744496|20388543|P1|STARTED|Titration Period||33
8268866|NCT01744483|20388564|P3|NOT COMPLETED|Overall Study||28
8268867|NCT01744483|20388565|P2|NOT COMPLETED|Overall Study||22
8268868|NCT01744483|20388566|P1|NOT COMPLETED|Overall Study||29
8268869|NCT01744483|20388564|P3|COMPLETED|Overall Study||10
8268870|NCT01744483|20388565|P2|COMPLETED|Overall Study||13
8268871|NCT01744483|20388566|P1|COMPLETED|Overall Study||15
8268872|NCT01744483|20388564|P3|STARTED|Overall Study||38
8268873|NCT01744483|20388565|P2|STARTED|Overall Study||35
8268874|NCT01744483|20388566|P1|STARTED|Overall Study||44
8268875|NCT01744392|20388574|P1|NOT COMPLETED|Overall Study||1
8268876|NCT01744392|20388574|P1|COMPLETED|Overall Study||22
8268877|NCT01744392|20388574|P1|STARTED|Overall Study||23
8268878|NCT01744353|20388590|P3|NOT COMPLETED|Overall Study||0
8268879|NCT01744353|20388591|P2|NOT COMPLETED|Overall Study||0
8268880|NCT01744353|20388592|P1|NOT COMPLETED|Overall Study||0
8268881|NCT01744353|20388590|P3|COMPLETED|Overall Study||3
8268882|NCT01744353|20388591|P2|COMPLETED|Overall Study||26
8268883|NCT01744353|20388592|P1|COMPLETED|Overall Study||6
8268884|NCT01744353|20388590|P3|STARTED|Overall Study||3
8268885|NCT01744353|20388591|P2|STARTED|Overall Study||26
8268886|NCT01744353|20388592|P1|STARTED|Overall Study||6
8268887|NCT01744340|20388603|P2|NOT COMPLETED|Overall Study||0
8268888|NCT01744340|20388604|P1|NOT COMPLETED|Overall Study||0
8268889|NCT01744340|20388603|P2|COMPLETED|Overall Study||15
8268890|NCT01744340|20388604|P1|COMPLETED|Overall Study||8
8268891|NCT01744340|20388603|P2|STARTED|Overall Study||15
8268892|NCT01744340|20388604|P1|STARTED|Overall Study||8
8268893|NCT01744197|20388614|P2|NOT COMPLETED|Overall Study||3
8268894|NCT01744197|20388615|P1|NOT COMPLETED|Overall Study||4
8268895|NCT01744197|20388614|P2|COMPLETED|Overall Study||26
8268896|NCT01744197|20388615|P1|COMPLETED|Overall Study||28
8268897|NCT01744197|20388614|P2|STARTED|Overall Study||29
8268898|NCT01744197|20388615|P1|STARTED|Overall Study||32
8268911|NCT01743963|20388651|P2|NOT COMPLETED|Overall Study||0
8268912|NCT01743963|20388652|P1|NOT COMPLETED|Overall Study||0
8268913|NCT01743963|20388651|P2|COMPLETED|Overall Study||17
8268914|NCT01743963|20388652|P1|COMPLETED|Overall Study||21
8268915|NCT01743963|20388651|P2|STARTED|Overall Study||17
8268916|NCT01743963|20388652|P1|STARTED|Overall Study||21
8268917|NCT01743859|20388658|P1|NOT COMPLETED|Overall Study||9
8268918|NCT01743859|20388658|P1|COMPLETED|Overall Study||28
8268919|NCT01743859|20388658|P1|STARTED|Overall Study||37
8268926|NCT01743677|20388679|P6|NOT COMPLETED|Third Intervention Period||0
8268927|NCT01743677|20388680|P5|NOT COMPLETED|Third Intervention Period||0
8268928|NCT01743677|20388681|P4|NOT COMPLETED|Third Intervention Period||0
8268929|NCT01743677|20388682|P3|NOT COMPLETED|Third Intervention Period||0
8268930|NCT01743677|20388683|P2|NOT COMPLETED|Third Intervention Period||0
8268931|NCT01743677|20388684|P1|NOT COMPLETED|Third Intervention Period||0
8268932|NCT01743677|20388679|P6|COMPLETED|Third Intervention Period||10
8268933|NCT01743677|20388680|P5|COMPLETED|Third Intervention Period||10
8268934|NCT01743677|20388681|P4|COMPLETED|Third Intervention Period||10
8268935|NCT01743677|20388682|P3|COMPLETED|Third Intervention Period||10
8268936|NCT01743677|20388683|P2|COMPLETED|Third Intervention Period||10
8268937|NCT01743677|20388684|P1|COMPLETED|Third Intervention Period||10
8268938|NCT01743677|20388679|P6|STARTED|Third Intervention Period||10
8268939|NCT01743677|20388680|P5|STARTED|Third Intervention Period||10
8268940|NCT01743677|20388681|P4|STARTED|Third Intervention Period||10
8268941|NCT01743677|20388682|P3|STARTED|Third Intervention Period||10
8268942|NCT01743677|20388683|P2|STARTED|Third Intervention Period||10
8268943|NCT01743677|20388684|P1|STARTED|Third Intervention Period||10
8268944|NCT01743677|20388679|P6|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8268945|NCT01743677|20388680|P5|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8268946|NCT01743677|20388681|P4|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8268947|NCT01743677|20388682|P3|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8268948|NCT01743677|20388683|P2|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8268949|NCT01743677|20388684|P1|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
8268950|NCT01743677|20388679|P6|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8268951|NCT01743677|20388680|P5|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8268952|NCT01743677|20388681|P4|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8268953|NCT01743677|20388682|P3|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8268954|NCT01743677|20388683|P2|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8268955|NCT01743677|20388684|P1|COMPLETED|Washout Period 2 (at Least 7 Days)||10
8268956|NCT01743677|20388679|P6|STARTED|Washout Period 2 (at Least 7 Days)||10
8268957|NCT01743677|20388680|P5|STARTED|Washout Period 2 (at Least 7 Days)||10
8268958|NCT01743677|20388681|P4|STARTED|Washout Period 2 (at Least 7 Days)||10
8268959|NCT01743677|20388682|P3|STARTED|Washout Period 2 (at Least 7 Days)||10
8268960|NCT01743677|20388683|P2|STARTED|Washout Period 2 (at Least 7 Days)||10
8268961|NCT01743677|20388684|P1|STARTED|Washout Period 2 (at Least 7 Days)||10
8268962|NCT01743677|20388679|P6|NOT COMPLETED|Second Intervention Period||0
8268963|NCT01743677|20388680|P5|NOT COMPLETED|Second Intervention Period||0
8268964|NCT01743677|20388681|P4|NOT COMPLETED|Second Intervention Period||0
8268965|NCT01743677|20388682|P3|NOT COMPLETED|Second Intervention Period||0
8268966|NCT01743677|20388683|P2|NOT COMPLETED|Second Intervention Period||0
8268967|NCT01743677|20388684|P1|NOT COMPLETED|Second Intervention Period||0
8268968|NCT01743677|20388679|P6|COMPLETED|Second Intervention Period||10
8268969|NCT01743677|20388680|P5|COMPLETED|Second Intervention Period||10
8268970|NCT01743677|20388681|P4|COMPLETED|Second Intervention Period||10
8268971|NCT01743677|20388682|P3|COMPLETED|Second Intervention Period||10
8268972|NCT01743677|20388683|P2|COMPLETED|Second Intervention Period||10
8268973|NCT01743677|20388684|P1|COMPLETED|Second Intervention Period||10
8268974|NCT01743677|20388679|P6|STARTED|Second Intervention Period||10
8268975|NCT01743677|20388680|P5|STARTED|Second Intervention Period||10
8268976|NCT01743677|20388681|P4|STARTED|Second Intervention Period||10
8268977|NCT01743677|20388682|P3|STARTED|Second Intervention Period||10
8268978|NCT01743677|20388683|P2|STARTED|Second Intervention Period||10
8268979|NCT01743677|20388684|P1|STARTED|Second Intervention Period||10
8268980|NCT01743677|20388679|P6|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8268981|NCT01743677|20388680|P5|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8268982|NCT01743677|20388681|P4|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8268983|NCT01743677|20388682|P3|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8268984|NCT01743677|20388683|P2|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8268985|NCT01743677|20388684|P1|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
8268986|NCT01743677|20388679|P6|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8268987|NCT01743677|20388680|P5|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8268988|NCT01743677|20388681|P4|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8268989|NCT01743677|20388682|P3|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8268990|NCT01743677|20388683|P2|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8268991|NCT01743677|20388684|P1|COMPLETED|Washout Period 1 (at Least 7 Days)||10
8268992|NCT01743677|20388679|P6|STARTED|Washout Period 1 (at Least 7 Days)||10
8268993|NCT01743677|20388680|P5|STARTED|Washout Period 1 (at Least 7 Days)||10
8268994|NCT01743677|20388681|P4|STARTED|Washout Period 1 (at Least 7 Days)||10
8268995|NCT01743677|20388682|P3|STARTED|Washout Period 1 (at Least 7 Days)||10
8268996|NCT01743677|20388683|P2|STARTED|Washout Period 1 (at Least 7 Days)||10
8268997|NCT01743677|20388684|P1|STARTED|Washout Period 1 (at Least 7 Days)||10
8268998|NCT01743677|20388679|P6|NOT COMPLETED|First Intervention Period||0
8268999|NCT01743677|20388680|P5|NOT COMPLETED|First Intervention Period||0
8269000|NCT01743677|20388681|P4|NOT COMPLETED|First Intervention Period||0
8269001|NCT01743677|20388682|P3|NOT COMPLETED|First Intervention Period||0
8269002|NCT01743677|20388683|P2|NOT COMPLETED|First Intervention Period||0
8269003|NCT01743677|20388684|P1|NOT COMPLETED|First Intervention Period||0
8269004|NCT01743677|20388679|P6|COMPLETED|First Intervention Period||10
8269005|NCT01743677|20388680|P5|COMPLETED|First Intervention Period||10
8269006|NCT01743677|20388681|P4|COMPLETED|First Intervention Period||10
8269007|NCT01743677|20388682|P3|COMPLETED|First Intervention Period||10
8269008|NCT01743677|20388683|P2|COMPLETED|First Intervention Period||10
8269009|NCT01743677|20388684|P1|COMPLETED|First Intervention Period||10
8269010|NCT01743677|20388679|P6|STARTED|First Intervention Period||10
8269011|NCT01743677|20388680|P5|STARTED|First Intervention Period||10
8269012|NCT01743677|20388681|P4|STARTED|First Intervention Period||10
8269013|NCT01743677|20388682|P3|STARTED|First Intervention Period||10
8269014|NCT01743677|20388683|P2|STARTED|First Intervention Period||10
8269015|NCT01743677|20388684|P1|STARTED|First Intervention Period||10
8269016|NCT01743560|20388721|P1|NOT COMPLETED|Overall Study||43
8269017|NCT01743560|20388721|P1|COMPLETED|Overall Study||9
8269108|NCT01742949|20388947|P1|NOT COMPLETED|Overall Study||0
8269018|NCT01743560|20388721|P1|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49
8269019|NCT01743560|20388721|P1|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49
8269020|NCT01743560|20388721|P1|STARTED|Overall Study||52
8269021|NCT01743521|20388748|P4|NOT COMPLETED|Overall Study||0
8269022|NCT01743521|20388749|P3|NOT COMPLETED|Overall Study||0
8269023|NCT01743521|20388750|P2|NOT COMPLETED|Overall Study||0
8269024|NCT01743521|20388751|P1|NOT COMPLETED|Overall Study||0
8269025|NCT01743521|20388748|P4|COMPLETED|Overall Study||2
8269026|NCT01743521|20388749|P3|COMPLETED|Overall Study||2
8269027|NCT01743521|20388750|P2|COMPLETED|Overall Study||3
8269028|NCT01743521|20388751|P1|COMPLETED|Overall Study||7
8269029|NCT01743521|20388748|P4|STARTED|Overall Study||2
8269030|NCT01743521|20388749|P3|STARTED|Overall Study||2
8269031|NCT01743521|20388750|P2|STARTED|Overall Study||3
8269032|NCT01743521|20388751|P1|STARTED|Overall Study||7
8269033|NCT01743469|20388805|P4|NOT COMPLETED|Follow-up Period - Post-Treatment||16
8269034|NCT01743469|20388806|P3|NOT COMPLETED|Follow-up Period - Post-Treatment||23
8269035|NCT01743469|20388807|P2|NOT COMPLETED|Follow-up Period - Post-Treatment||48
8269036|NCT01743469|20388808|P1|NOT COMPLETED|Follow-up Period - Post-Treatment||45
8269037|NCT01743469|20388805|P4|COMPLETED|Follow-up Period - Post-Treatment||5
8269038|NCT01743469|20388806|P3|COMPLETED|Follow-up Period - Post-Treatment||14
8269039|NCT01743469|20388807|P2|COMPLETED|Follow-up Period - Post-Treatment||5
8269040|NCT01743469|20388808|P1|COMPLETED|Follow-up Period - Post-Treatment||6
8269041|NCT01743469|20388805|P4|STARTED|Follow-up Period - Post-Treatment||21
8269042|NCT01743469|20388806|P3|STARTED|Follow-up Period - Post-Treatment||37
8269043|NCT01743469|20388807|P2|STARTED|Follow-up Period - Post-Treatment||53
8269044|NCT01743469|20388808|P1|STARTED|Follow-up Period - Post-Treatment||51
8269045|NCT01743469|20388805|P4|NOT COMPLETED|Active Treatment Phase||21
8269046|NCT01743469|20388806|P3|NOT COMPLETED|Active Treatment Phase||38
8269047|NCT01743469|20388807|P2|NOT COMPLETED|Active Treatment Phase||55
8269048|NCT01743469|20388808|P1|NOT COMPLETED|Active Treatment Phase||53
8269049|NCT01743469|20388805|P4|COMPLETED|Active Treatment Phase||0
8269050|NCT01743469|20388806|P3|COMPLETED|Active Treatment Phase||0
8269051|NCT01743469|20388807|P2|COMPLETED|Active Treatment Phase||0
8269052|NCT01743469|20388808|P1|COMPLETED|Active Treatment Phase||0
8269053|NCT01743469|20388805|P4|STARTED|Active Treatment Phase||21
8269054|NCT01743469|20388806|P3|STARTED|Active Treatment Phase||38
8269055|NCT01743469|20388807|P2|STARTED|Active Treatment Phase||55
8269056|NCT01743469|20388808|P1|STARTED|Active Treatment Phase||53
8269077|NCT01743092|20388873|P2|NOT COMPLETED|Overall Study||15
8269078|NCT01743092|20388874|P1|NOT COMPLETED|Overall Study||14
8269079|NCT01743092|20388873|P2|COMPLETED|Overall Study||11
8269080|NCT01743092|20388874|P1|COMPLETED|Overall Study||19
8269081|NCT01743092|20388873|P2|STARTED|Overall Study||26
8269082|NCT01743092|20388874|P1|STARTED|Overall Study||33
8269083|NCT01743040|20388882|P1|NOT COMPLETED|Overall Study||229
8269084|NCT01743040|20388882|P1|COMPLETED|Overall Study||785
8269085|NCT01743040|20388882|P1|CT and/or Standard Angiogram|Overall Study||785
8269086|NCT01743040|20388882|P1|Nuclear Stress Test|Overall Study||992
8269087|NCT01743040|20388882|P1|CADence Testing|Overall Study||1013
8269088|NCT01743040|20388882|P1|STARTED|Overall Study||1014
8269089|NCT01743027|20388890|P4|NOT COMPLETED|Overall Study||1
8269090|NCT01743027|20388891|P3|NOT COMPLETED|Overall Study||9
8269091|NCT01743027|20388892|P2|NOT COMPLETED|Overall Study||5
8269092|NCT01743027|20388893|P1|NOT COMPLETED|Overall Study||5
8269093|NCT01743027|20388890|P4|COMPLETED|Overall Study||48
8269094|NCT01743027|20388891|P3|COMPLETED|Overall Study||90
8269095|NCT01743027|20388892|P2|COMPLETED|Overall Study||94
8269096|NCT01743027|20388893|P1|COMPLETED|Overall Study||93
8269097|NCT01743027|20388890|P4|STARTED|Overall Study||49
8269098|NCT01743027|20388891|P3|STARTED|Overall Study||99
8269099|NCT01743027|20388892|P2|STARTED|Overall Study||99
8269100|NCT01743027|20388893|P1|STARTED|Overall Study||98
8269101|NCT01743001|20388933|P2|NOT COMPLETED|Overall Study||0
8269102|NCT01743001|20388934|P1|NOT COMPLETED|Overall Study||3
8269103|NCT01743001|20388933|P2|COMPLETED|Overall Study||112
8269104|NCT01743001|20388934|P1|COMPLETED|Overall Study||111
8269105|NCT01743001|20388933|P2|STARTED|Overall Study||112
8269106|NCT01743001|20388934|P1|STARTED|Overall Study||114
8269107|NCT01742949|20388946|P2|NOT COMPLETED|Overall Study||0
8269109|NCT01742949|20388946|P2|COMPLETED|Overall Study||20
8269110|NCT01742949|20388947|P1|COMPLETED|Overall Study||20
8269111|NCT01742949|20388946|P2|STARTED|Overall Study||20
8269112|NCT01742949|20388947|P1|STARTED|Overall Study||20
8269113|NCT01742936|20388968|P2|NOT COMPLETED|Overall Study||0
8269114|NCT01742936|20388969|P1|NOT COMPLETED|Overall Study||0
8269115|NCT01742936|20388968|P2|COMPLETED|Overall Study||50
8269116|NCT01742936|20388969|P1|COMPLETED|Overall Study||50
8269117|NCT01742936|20388968|P2|STARTED|Overall Study||50
8269118|NCT01742936|20388969|P1|STARTED|Overall Study||50
8269119|NCT01742897|20388977|P1|NOT COMPLETED|Overall Study||5
8269120|NCT01742897|20388977|P1|COMPLETED|Overall Study||30
8269121|NCT01742897|20388977|P1|Treated|Overall Study||33
8269122|NCT01742897|20388977|P1|STARTED|Overall Study||35
8269123|NCT01742832|20388983|P2|NOT COMPLETED|Overall Study||5
8269124|NCT01742832|20388984|P1|NOT COMPLETED|Overall Study||1
8269125|NCT01742832|20388983|P2|COMPLETED|Overall Study||23
8269126|NCT01742832|20388984|P1|COMPLETED|Overall Study||19
8269127|NCT01742832|20388983|P2|STARTED|Overall Study||28
8269128|NCT01742832|20388984|P1|STARTED|Overall Study||20
8269129|NCT01742364|20388994|P4|NOT COMPLETED|Overall Study||0
8269130|NCT01742364|20388995|P3|NOT COMPLETED|Overall Study||0
8269131|NCT01742364|20388996|P2|NOT COMPLETED|Overall Study||0
8269132|NCT01742364|20388997|P1|NOT COMPLETED|Overall Study||0
8269133|NCT01742364|20388994|P4|COMPLETED|Overall Study||15
8269134|NCT01742364|20388995|P3|COMPLETED|Overall Study||15
8269135|NCT01742364|20388996|P2|COMPLETED|Overall Study||33
8269136|NCT01742364|20388997|P1|COMPLETED|Overall Study||33
8269137|NCT01742364|20388994|P4|STARTED|Overall Study||15
8269138|NCT01742364|20388995|P3|STARTED|Overall Study||15
8269139|NCT01742364|20388996|P2|STARTED|Overall Study||33
8269140|NCT01742364|20388997|P1|STARTED|Overall Study||33
8269141|NCT01742286|20389030|P7|NOT COMPLETED|Expansion Phase||36
8269142|NCT01742286|20389031|P6|NOT COMPLETED|Expansion Phase||0
8269143|NCT01742286|20389032|P5|NOT COMPLETED|Expansion Phase||0
8269144|NCT01742286|20389033|P4|NOT COMPLETED|Expansion Phase||0
8269145|NCT01742286|20389034|P3|NOT COMPLETED|Expansion Phase||7
8269146|NCT01742286|20389035|P2|NOT COMPLETED|Expansion Phase||0
8269147|NCT01742286|20389036|P1|NOT COMPLETED|Expansion Phase||0
8269148|NCT01742286|20389030|P7|COMPLETED|Expansion Phase||0
8269149|NCT01742286|20389031|P6|COMPLETED|Expansion Phase||0
8269150|NCT01742286|20389032|P5|COMPLETED|Expansion Phase||0
8269151|NCT01742286|20389033|P4|COMPLETED|Expansion Phase||0
8269152|NCT01742286|20389034|P3|COMPLETED|Expansion Phase||0
8269153|NCT01742286|20389035|P2|COMPLETED|Expansion Phase||0
8269154|NCT01742286|20389036|P1|COMPLETED|Expansion Phase||0
8269155|NCT01742286|20389030|P7|End of Treatment = Not Ccompleted|Expansion Phase||36
8269156|NCT01742286|20389031|P6|End of Treatment = Not Ccompleted|Expansion Phase||0
8269157|NCT01742286|20389032|P5|End of Treatment = Not Ccompleted|Expansion Phase||0
8269158|NCT01742286|20389033|P4|End of Treatment = Not Ccompleted|Expansion Phase||0
8269159|NCT01742286|20389034|P3|End of Treatment = Not Ccompleted|Expansion Phase||7
8269160|NCT01742286|20389035|P2|End of Treatment = Not Ccompleted|Expansion Phase||0
8269161|NCT01742286|20389036|P1|End of Treatment = Not Ccompleted|Expansion Phase||0
8269162|NCT01742286|20389030|P7|STARTED|Expansion Phase||36
8269163|NCT01742286|20389031|P6|STARTED|Expansion Phase||0
8269164|NCT01742286|20389032|P5|STARTED|Expansion Phase||0
8269165|NCT01742286|20389033|P4|STARTED|Expansion Phase||0
8269166|NCT01742286|20389034|P3|STARTED|Expansion Phase||7
8269167|NCT01742286|20389035|P2|STARTED|Expansion Phase||0
8269168|NCT01742286|20389036|P1|STARTED|Expansion Phase||0
8269169|NCT01742286|20389030|P7|NOT COMPLETED|Escalation Phase||6
8269170|NCT01742286|20389031|P6|NOT COMPLETED|Escalation Phase||5
8269171|NCT01742286|20389032|P5|NOT COMPLETED|Escalation Phase||4
8269172|NCT01742286|20389033|P4|NOT COMPLETED|Escalation Phase||2
8269173|NCT01742286|20389034|P3|NOT COMPLETED|Escalation Phase||6
8269174|NCT01742286|20389035|P2|NOT COMPLETED|Escalation Phase||12
8269175|NCT01742286|20389036|P1|NOT COMPLETED|Escalation Phase||5
8269176|NCT01742286|20389030|P7|COMPLETED|Escalation Phase||0
8269177|NCT01742286|20389031|P6|COMPLETED|Escalation Phase||0
8269178|NCT01742286|20389032|P5|COMPLETED|Escalation Phase||0
8269179|NCT01742286|20389033|P4|COMPLETED|Escalation Phase||0
8269180|NCT01742286|20389034|P3|COMPLETED|Escalation Phase||0
8269181|NCT01742286|20389035|P2|COMPLETED|Escalation Phase||0
8269182|NCT01742286|20389036|P1|COMPLETED|Escalation Phase||0
8269183|NCT01742286|20389030|P7|Ended Treatment = Not Completed)|Escalation Phase||6
8269184|NCT01742286|20389031|P6|Ended Treatment = Not Completed)|Escalation Phase||5
8269185|NCT01742286|20389032|P5|Ended Treatment = Not Completed)|Escalation Phase||4
8269186|NCT01742286|20389033|P4|Ended Treatment = Not Completed)|Escalation Phase||2
8269187|NCT01742286|20389034|P3|Ended Treatment = Not Completed)|Escalation Phase||6
8269188|NCT01742286|20389035|P2|Ended Treatment = Not Completed)|Escalation Phase||12
8269189|NCT01742286|20389036|P1|Ended Treatment = Not Completed)|Escalation Phase||5
8269190|NCT01742286|20389030|P7|STARTED|Escalation Phase||6
8269191|NCT01742286|20389031|P6|STARTED|Escalation Phase||5
8269192|NCT01742286|20389032|P5|STARTED|Escalation Phase||4
8269193|NCT01742286|20389033|P4|STARTED|Escalation Phase||2
8269194|NCT01742286|20389034|P3|STARTED|Escalation Phase||6
8269195|NCT01742286|20389035|P2|STARTED|Escalation Phase||12
8269196|NCT01742286|20389036|P1|STARTED|Escalation Phase||5
8269197|NCT01742208|20389137|P3|NOT COMPLETED|Overall Study||0
8269198|NCT01742208|20389138|P2|NOT COMPLETED|Overall Study||0
8269199|NCT01742208|20389139|P1|NOT COMPLETED|Overall Study||0
8269200|NCT01742208|20389137|P3|COMPLETED|Overall Study||16
8269201|NCT01742208|20389138|P2|COMPLETED|Overall Study||17
8269202|NCT01742208|20389139|P1|COMPLETED|Overall Study||3
8269203|NCT01742208|20389137|P3|STARTED|Overall Study||16
8269204|NCT01742208|20389138|P2|STARTED|Overall Study||17
8269205|NCT01742208|20389139|P1|STARTED|Overall Study||3
8269206|NCT01742091|20389169|P6|NOT COMPLETED|Overall Study||2
8269207|NCT01742091|20389170|P5|NOT COMPLETED|Overall Study||1
8269208|NCT01742091|20389171|P4|NOT COMPLETED|Overall Study||1
8269209|NCT01742091|20389172|P3|NOT COMPLETED|Overall Study||0
8269210|NCT01742091|20389173|P2|NOT COMPLETED|Overall Study||0
8269211|NCT01742091|20389174|P1|NOT COMPLETED|Overall Study||0
8269212|NCT01742091|20389169|P6|COMPLETED|Overall Study||10
8269213|NCT01742091|20389170|P5|COMPLETED|Overall Study||7
8269214|NCT01742091|20389171|P4|COMPLETED|Overall Study||8
8269215|NCT01742091|20389172|P3|COMPLETED|Overall Study||10
8269216|NCT01742091|20389173|P2|COMPLETED|Overall Study||11
8269217|NCT01742091|20389174|P1|COMPLETED|Overall Study||9
8269218|NCT01742091|20389169|P6|RECEIVED STUDY DRUG|Overall Study||12
8269219|NCT01742091|20389170|P5|RECEIVED STUDY DRUG|Overall Study||8
8269220|NCT01742091|20389171|P4|RECEIVED STUDY DRUG|Overall Study||9
8269221|NCT01742091|20389172|P3|RECEIVED STUDY DRUG|Overall Study||10
8269222|NCT01742091|20389173|P2|RECEIVED STUDY DRUG|Overall Study||11
8269223|NCT01742091|20389174|P1|RECEIVED STUDY DRUG|Overall Study||9
8269224|NCT01742091|20389169|P6|STARTED|Overall Study||12
8269225|NCT01742091|20389170|P5|STARTED|Overall Study||8
8269226|NCT01742091|20389171|P4|STARTED|Overall Study||9
8269227|NCT01742091|20389172|P3|STARTED|Overall Study||10
8269228|NCT01742091|20389173|P2|STARTED|Overall Study||11
8269229|NCT01742091|20389174|P1|STARTED|Overall Study||9
8269230|NCT01742078|20389220|P9|NOT COMPLETED|Overall Study||0
8269231|NCT01742078|20389221|P8|NOT COMPLETED|Overall Study||0
8269232|NCT01742078|20389222|P7|NOT COMPLETED|Overall Study||0
8269233|NCT01742078|20389223|P6|NOT COMPLETED|Overall Study||0
8269234|NCT01742078|20389224|P5|NOT COMPLETED|Overall Study||0
8269235|NCT01742078|20389225|P4|NOT COMPLETED|Overall Study||1
8269236|NCT01742078|20389226|P3|NOT COMPLETED|Overall Study||0
8269237|NCT01742078|20389227|P2|NOT COMPLETED|Overall Study||0
8269238|NCT01742078|20389228|P1|NOT COMPLETED|Overall Study||0
8269239|NCT01742078|20389220|P9|COMPLETED|Overall Study||12
8269240|NCT01742078|20389221|P8|COMPLETED|Overall Study||6
8269241|NCT01742078|20389222|P7|COMPLETED|Overall Study||6
8269242|NCT01742078|20389223|P6|COMPLETED|Overall Study||6
8269243|NCT01742078|20389224|P5|COMPLETED|Overall Study||6
8269244|NCT01742078|20389225|P4|COMPLETED|Overall Study||5
8269245|NCT01742078|20389226|P3|COMPLETED|Overall Study||6
8269246|NCT01742078|20389227|P2|COMPLETED|Overall Study||6
8269247|NCT01742078|20389228|P1|COMPLETED|Overall Study||6
8269248|NCT01742078|20389220|P9|RECEIVED STUDY DRUG|Overall Study||12
8269249|NCT01742078|20389221|P8|RECEIVED STUDY DRUG|Overall Study||6
8269250|NCT01742078|20389222|P7|RECEIVED STUDY DRUG|Overall Study||6
8269251|NCT01742078|20389223|P6|RECEIVED STUDY DRUG|Overall Study||6
8269252|NCT01742078|20389224|P5|RECEIVED STUDY DRUG|Overall Study||6
8269253|NCT01742078|20389225|P4|RECEIVED STUDY DRUG|Overall Study||6
8269254|NCT01742078|20389226|P3|RECEIVED STUDY DRUG|Overall Study||6
8269255|NCT01742078|20389227|P2|RECEIVED STUDY DRUG|Overall Study||6
8269256|NCT01742078|20389228|P1|RECEIVED STUDY DRUG|Overall Study||6
8269257|NCT01742078|20389220|P9|STARTED|Overall Study||12
8269258|NCT01742078|20389221|P8|STARTED|Overall Study||6
8269259|NCT01742078|20389222|P7|STARTED|Overall Study||6
8269260|NCT01742078|20389223|P6|STARTED|Overall Study||6
8269261|NCT01742078|20389224|P5|STARTED|Overall Study||6
8269262|NCT01742078|20389225|P4|STARTED|Overall Study||6
8269263|NCT01742078|20389226|P3|STARTED|Overall Study||6
8269264|NCT01742078|20389227|P2|STARTED|Overall Study||6
8269265|NCT01742078|20389228|P1|STARTED|Overall Study||6
8269266|NCT01742065|20389285|P2|NOT COMPLETED|Overall Study||0
8269267|NCT01742065|20389286|P1|NOT COMPLETED|Overall Study||0
8269268|NCT01742065|20389285|P2|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
8269269|NCT01742065|20389286|P1|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
8269270|NCT01742065|20389285|P2|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
8269271|NCT01742065|20389286|P1|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
8269272|NCT01741792|20389297|P3|NOT COMPLETED|Overall Study||12
8269273|NCT01741792|20389298|P2|NOT COMPLETED|Overall Study||1
8269274|NCT01741792|20389299|P1|NOT COMPLETED|Overall Study||6
8269275|NCT01741792|20389297|P3|COMPLETED|Overall Study||2
8269276|NCT01741792|20389298|P2|COMPLETED|Overall Study||1
8269277|NCT01741792|20389299|P1|COMPLETED|Overall Study||3
8269278|NCT01741792|20389297|P3|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
8269279|NCT01741792|20389298|P2|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
8269280|NCT01741792|20389299|P1|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
8269281|NCT01741792|20389297|P3|STARTED|Overall Study||14
8269282|NCT01741792|20389298|P2|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
8269283|NCT01741792|20389299|P1|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
8269284|NCT01741701|20389366|P2|NOT COMPLETED|Overall Study||2
8269285|NCT01741701|20389367|P1|NOT COMPLETED|Overall Study||5
8269286|NCT01741701|20389366|P2|COMPLETED|Overall Study||13
8269287|NCT01741701|20389367|P1|COMPLETED|Overall Study||13
8269288|NCT01741701|20389366|P2|STARTED|Overall Study||15
8269289|NCT01741701|20389367|P1|STARTED|Overall Study||18
8269290|NCT01741688|20389383|P1|NOT COMPLETED|Overall Study||3
8269291|NCT01741688|20389383|P1|COMPLETED|Overall Study||13
8269292|NCT01741688|20389383|P1|STARTED|Overall Study||16
8269293|NCT01741545|20389402|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||2
8269294|NCT01741545|20389403|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||1
8269295|NCT01741545|20389402|P2|COMPLETED|Follow-up Period (24 Weeks)||37
8269296|NCT01741545|20389403|P1|COMPLETED|Follow-up Period (24 Weeks)||11
8269297|NCT01741545|20389402|P2|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39
8269298|NCT01741545|20389403|P1|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12
8269299|NCT01741545|20389402|P2|NOT COMPLETED|Treatment Period||4
8269300|NCT01741545|20389403|P1|NOT COMPLETED|Treatment Period||1
8269301|NCT01741545|20389402|P2|COMPLETED|Treatment Period||35
8269302|NCT01741545|20389403|P1|COMPLETED|Treatment Period||11
8269303|NCT01741545|20389402|P2|STARTED|Treatment Period||39
8269304|NCT01741545|20389403|P1|STARTED|Treatment Period||12
8269305|NCT01741532|20389427|P2|NOT COMPLETED|Overall Study||3
8269306|NCT01741532|20389428|P1|NOT COMPLETED|Overall Study||10
8269307|NCT01741532|20389427|P2|COMPLETED|Overall Study||27
8269308|NCT01741532|20389428|P1|COMPLETED|Overall Study||49
8269309|NCT01741532|20389427|P2|Provided Post-baseline Efficacy Data|Overall Study||28
8269310|NCT01741532|20389428|P1|Provided Post-baseline Efficacy Data|Overall Study||58
8269311|NCT01741532|20389427|P2|Exposed|Overall Study||30
8269312|NCT01741532|20389428|P1|Exposed|Overall Study||58
8269313|NCT01741532|20389427|P2|STARTED|Overall Study||30
8269314|NCT01741532|20389428|P1|STARTED|Overall Study||59
8269321|NCT01741454|20389461|P4|NOT COMPLETED|Overall Study||22
8269322|NCT01741454|20389462|P3|NOT COMPLETED|Overall Study||17
8269323|NCT01741454|20389463|P2|NOT COMPLETED|Overall Study||6
8269324|NCT01741454|20389464|P1|NOT COMPLETED|Overall Study||13
8269325|NCT01741454|20389461|P4|COMPLETED|Overall Study||21
8269326|NCT01741454|20389462|P3|COMPLETED|Overall Study||22
8269327|NCT01741454|20389463|P2|COMPLETED|Overall Study||44
8269328|NCT01741454|20389464|P1|COMPLETED|Overall Study||36
8269329|NCT01741454|20389461|P4|STARTED|Overall Study||43
8269330|NCT01741454|20389462|P3|STARTED|Overall Study||39
8269331|NCT01741454|20389463|P2|STARTED|Overall Study||50
8269332|NCT01741454|20389464|P1|STARTED|Overall Study||49
8269333|NCT01741350|20389488|P2|NOT COMPLETED|12-Month Follow-up Assessment||2
8269334|NCT01741350|20389489|P1|NOT COMPLETED|12-Month Follow-up Assessment||3
8269335|NCT01741350|20389488|P2|COMPLETED|12-Month Follow-up Assessment||109
8269336|NCT01741350|20389489|P1|COMPLETED|12-Month Follow-up Assessment||111
8269337|NCT01741350|20389488|P2|STARTED|12-Month Follow-up Assessment||111
8269338|NCT01741350|20389489|P1|STARTED|12-Month Follow-up Assessment||114
8269339|NCT01741350|20389488|P2|NOT COMPLETED|6-Month Follow-up Assessment||8
8269340|NCT01741350|20389489|P1|NOT COMPLETED|6-Month Follow-up Assessment||15
8269341|NCT01741350|20389488|P2|COMPLETED|6-Month Follow-up Assessment||111
8269342|NCT01741350|20389489|P1|COMPLETED|6-Month Follow-up Assessment||114
8269343|NCT01741350|20389488|P2|STARTED|6-Month Follow-up Assessment||119
8269344|NCT01741350|20389489|P1|STARTED|6-Month Follow-up Assessment||129
8269345|NCT01741350|20389488|P2|NOT COMPLETED|3-Month Follow-up Assessment||22
8269346|NCT01741350|20389489|P1|NOT COMPLETED|3-Month Follow-up Assessment||6
8269347|NCT01741350|20389488|P2|COMPLETED|3-Month Follow-up Assessment||119
8269348|NCT01741350|20389489|P1|COMPLETED|3-Month Follow-up Assessment||129
8269349|NCT01741350|20389488|P2|STARTED|3-Month Follow-up Assessment||141
8269350|NCT01741350|20389489|P1|STARTED|3-Month Follow-up Assessment||135
8269351|NCT01741350|20389488|P2|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
8269352|NCT01741350|20389489|P1|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
8269353|NCT01741350|20389488|P2|COMPLETED|Post Intervention Assessment (at Week 4)||141
8269354|NCT01741350|20389489|P1|COMPLETED|Post Intervention Assessment (at Week 4)||135
8269355|NCT01741350|20389488|P2|STARTED|Post Intervention Assessment (at Week 4)||155
8269356|NCT01741350|20389489|P1|STARTED|Post Intervention Assessment (at Week 4)||149
8269357|NCT01741350|20389488|P2|NOT COMPLETED|Study Intervention||0
8269358|NCT01741350|20389489|P1|NOT COMPLETED|Study Intervention||0
8269359|NCT01741350|20389488|P2|COMPLETED|Study Intervention||155
8269360|NCT01741350|20389489|P1|COMPLETED|Study Intervention||149
8269361|NCT01741350|20389488|P2|STARTED|Study Intervention||155
8269362|NCT01741350|20389489|P1|STARTED|Study Intervention||149
8269363|NCT01741272|20389625|P2|NOT COMPLETED|Overall Study||0
8269364|NCT01741272|20389626|P1|NOT COMPLETED|Overall Study||0
8269365|NCT01741272|20389625|P2|COMPLETED|Overall Study||97
8269366|NCT01741272|20389626|P1|COMPLETED|Overall Study||92
8269367|NCT01741272|20389625|P2|STARTED|Overall Study||97
8269368|NCT01741272|20389626|P1|STARTED|Overall Study||92
8269369|NCT01741259|20389642|P2|NOT COMPLETED|Overall Study||6
8269370|NCT01741259|20389643|P1|NOT COMPLETED|Overall Study||6
8269371|NCT01741259|20389642|P2|COMPLETED|Overall Study||129
8269372|NCT01741259|20389643|P1|COMPLETED|Overall Study||127
8269373|NCT01741259|20389642|P2|STARTED|Overall Study||135
8269374|NCT01741259|20389643|P1|STARTED|Overall Study||133
8269375|NCT01741012|20389697|P1|NOT COMPLETED|Overall Study||3
8269376|NCT01741012|20389697|P1|COMPLETED|Overall Study||34
8269377|NCT01741012|20389697|P1|STARTED|Overall Study||37
8269378|NCT01740817|20389704|P2|NOT COMPLETED|Second Intervention (48 h)||0
8269379|NCT01740817|20389705|P1|NOT COMPLETED|Second Intervention (48 h)||0
8269380|NCT01740817|20389704|P2|COMPLETED|Second Intervention (48 h)||4
8269381|NCT01740817|20389705|P1|COMPLETED|Second Intervention (48 h)||8
8269382|NCT01740817|20389704|P2|STARTED|Second Intervention (48 h)||4
8269383|NCT01740817|20389705|P1|STARTED|Second Intervention (48 h)||8
8269384|NCT01740817|20389704|P2|NOT COMPLETED|Washout (4-6 Weeks)||0
8269385|NCT01740817|20389705|P1|NOT COMPLETED|Washout (4-6 Weeks)||0
8269386|NCT01740817|20389704|P2|COMPLETED|Washout (4-6 Weeks)||4
8269387|NCT01740817|20389705|P1|COMPLETED|Washout (4-6 Weeks)||8
8269388|NCT01740817|20389704|P2|STARTED|Washout (4-6 Weeks)||4
8269389|NCT01740817|20389705|P1|STARTED|Washout (4-6 Weeks)||8
8269390|NCT01740817|20389704|P2|NOT COMPLETED|First Intervention (48 h)||0
8269391|NCT01740817|20389705|P1|NOT COMPLETED|First Intervention (48 h)||0
8269392|NCT01740817|20389704|P2|COMPLETED|First Intervention (48 h)||4
8269393|NCT01740817|20389705|P1|COMPLETED|First Intervention (48 h)||8
8269394|NCT01740817|20389704|P2|STARTED|First Intervention (48 h)||4
8269395|NCT01740817|20389705|P1|STARTED|First Intervention (48 h)||8
8269396|NCT01740791|20389721|P6|NOT COMPLETED|Overall Study||11
8269397|NCT01740791|20389722|P5|NOT COMPLETED|Overall Study||3
8269398|NCT01740791|20389723|P4|NOT COMPLETED|Overall Study||7
8269399|NCT01740791|20389724|P3|NOT COMPLETED|Overall Study||6
8269400|NCT01740791|20389725|P2|NOT COMPLETED|Overall Study||3
8269401|NCT01740791|20389726|P1|NOT COMPLETED|Overall Study||12
8269402|NCT01740791|20389721|P6|COMPLETED|Overall Study||23
8269403|NCT01740791|20389722|P5|COMPLETED|Overall Study||6
8269404|NCT01740791|20389723|P4|COMPLETED|Overall Study||7
8269405|NCT01740791|20389724|P3|COMPLETED|Overall Study||11
8269406|NCT01740791|20389725|P2|COMPLETED|Overall Study||4
8269407|NCT01740791|20389726|P1|COMPLETED|Overall Study||10
8269408|NCT01740791|20389721|P6|STARTED|Overall Study||34
8269409|NCT01740791|20389722|P5|STARTED|Overall Study||9
8269410|NCT01740791|20389723|P4|STARTED|Overall Study||14
8269411|NCT01740791|20389724|P3|STARTED|Overall Study||17
8269412|NCT01740791|20389725|P2|STARTED|Overall Study||7
8269413|NCT01740791|20389726|P1|STARTED|Overall Study||22
8269414|NCT01740726|20389857|P2|NOT COMPLETED|Overall Study||0
8269415|NCT01740726|20389858|P1|NOT COMPLETED|Overall Study||0
8269416|NCT01740726|20389857|P2|COMPLETED|Overall Study||1
8269417|NCT01740726|20389858|P1|COMPLETED|Overall Study||0
8269418|NCT01740726|20389857|P2|STARTED|Overall Study||1
8269419|NCT01740726|20389858|P1|STARTED|Overall Study||0
8269420|NCT01740713|20389883|P3|NOT COMPLETED|Overall Study||1
8269421|NCT01740713|20389884|P2|NOT COMPLETED|Overall Study||2
8269422|NCT01740713|20389885|P1|NOT COMPLETED|Overall Study||0
8269423|NCT01740713|20389883|P3|COMPLETED|Overall Study||6
8269424|NCT01740713|20389884|P2|COMPLETED|Overall Study||6
8269425|NCT01740713|20389885|P1|COMPLETED|Overall Study||6
8269426|NCT01740713|20389883|P3|STARTED|Overall Study||7
8269427|NCT01740713|20389884|P2|STARTED|Overall Study||8
8269428|NCT01740713|20389885|P1|STARTED|Overall Study||6
8269429|NCT01740440|20389909|P1|NOT COMPLETED|Overall Study||3
8269430|NCT01740440|20389909|P1|COMPLETED|Overall Study||27
8269431|NCT01740440|20389909|P1|STARTED|Overall Study||30
8269432|NCT01740427|20389917|P2|NOT COMPLETED|Overall Study||222
8269433|NCT01740427|20389918|P1|NOT COMPLETED|Overall Study||444
8269434|NCT01740427|20389917|P2|COMPLETED|Overall Study||0
8269435|NCT01740427|20389918|P1|COMPLETED|Overall Study||0
8269436|NCT01740427|20389917|P2|STARTED|Overall Study||222
8269437|NCT01740427|20389918|P1|STARTED|Overall Study||444
8269438|NCT01740414|20389947|P2|NOT COMPLETED|Overall Study||8
8269439|NCT01740414|20389948|P1|NOT COMPLETED|Overall Study||9
8269440|NCT01740414|20389947|P2|COMPLETED|Overall Study||8
8269441|NCT01740414|20389948|P1|COMPLETED|Overall Study||3
8269442|NCT01740414|20389947|P2|STARTED|Overall Study||16
8269443|NCT01740414|20389948|P1|STARTED|Overall Study||12
8269444|NCT01740401|20389970|P1|NOT COMPLETED|Overall Study||10
8269445|NCT01740401|20389970|P1|COMPLETED|Overall Study||0
8269446|NCT01740401|20389970|P1|STARTED|Overall Study||10
8269447|NCT01740388|20389979|P2|NOT COMPLETED|Overall Study||44
8269448|NCT01740388|20389980|P1|NOT COMPLETED|Overall Study||46
8269449|NCT01740388|20389979|P2|COMPLETED|Overall Study||28
8269450|NCT01740388|20389980|P1|COMPLETED|Overall Study||18
8269451|NCT01740388|20389979|P2|STARTED|Overall Study||72
8269452|NCT01740388|20389980|P1|STARTED|Overall Study||64
8269453|NCT01740362|20390000|P4|NOT COMPLETED|Overall Study||0
8269454|NCT01740362|20390001|P3|NOT COMPLETED|Overall Study||0
8269455|NCT01740362|20390002|P2|NOT COMPLETED|Overall Study||0
8269456|NCT01740362|20390003|P1|NOT COMPLETED|Overall Study||0
8269457|NCT01740362|20390000|P4|COMPLETED|Overall Study||6
8269458|NCT01740362|20390001|P3|COMPLETED|Overall Study||6
8269459|NCT01740362|20390002|P2|COMPLETED|Overall Study||6
8269460|NCT01740362|20390003|P1|COMPLETED|Overall Study||6
8269461|NCT01740362|20390000|P4|STARTED|Overall Study||6
8269462|NCT01740362|20390001|P3|STARTED|Overall Study||6
8269463|NCT01740362|20390002|P2|STARTED|Overall Study||6
8269464|NCT01740362|20390003|P1|STARTED|Overall Study||6
8269465|NCT01740323|20390031|P2|NOT COMPLETED|Overall Study||0
8269466|NCT01740323|20390032|P1|NOT COMPLETED|Overall Study||2
8269467|NCT01740323|20390031|P2|COMPLETED|Overall Study||15
8269468|NCT01740323|20390032|P1|COMPLETED|Overall Study||13
8269469|NCT01740323|20390031|P2|STARTED|Overall Study||15
8269470|NCT01740323|20390032|P1|STARTED|Overall Study||15
8269486|NCT01740258|20390085|P1|NOT COMPLETED|Overall Study||0
8269487|NCT01740258|20390085|P1|COMPLETED|Overall Study||68
8269488|NCT01740258|20390085|P1|Entered Part D|Overall Study||42
8269489|NCT01740258|20390085|P1|Entered Part C|Overall Study||20
8269490|NCT01740258|20390085|P1|Entered Part B|Overall Study||62
8269491|NCT01740258|20390085|P1|Entered Part A|Overall Study||68
8269492|NCT01740258|20390085|P1|STARTED|Overall Study||68
8269493|NCT01740206|20390093|P2|NOT COMPLETED|Overall Study||0
8269494|NCT01740206|20390094|P1|NOT COMPLETED|Overall Study||0
8269495|NCT01740206|20390093|P2|COMPLETED|Overall Study||34
8269496|NCT01740206|20390094|P1|COMPLETED|Overall Study||14
8269497|NCT01740206|20390093|P2|STARTED|Overall Study||34
8269498|NCT01740206|20390094|P1|STARTED|Overall Study||14
8269499|NCT01740154|20390110|P1|NOT COMPLETED|Overall Study||1
8269500|NCT01740154|20390110|P1|COMPLETED|Overall Study||12
8269501|NCT01740154|20390110|P1|STARTED|Overall Study||13
8269502|NCT01740128|20390118|P2|NOT COMPLETED|Overall Study||7
8269503|NCT01740128|20390119|P1|NOT COMPLETED|Overall Study||6
8269504|NCT01740128|20390118|P2|COMPLETED|Overall Study||4
8269505|NCT01740128|20390119|P1|COMPLETED|Overall Study||4
8269506|NCT01740128|20390118|P2|STARTED|Overall Study||11
8269507|NCT01740128|20390119|P1|STARTED|Overall Study||10
8269508|NCT01740089|20390148|P3|NOT COMPLETED|After 12 Weeks||11
8269509|NCT01740089|20390149|P2|NOT COMPLETED|After 12 Weeks||3
8269510|NCT01740089|20390150|P1|NOT COMPLETED|After 12 Weeks||7
8269511|NCT01740089|20390148|P3|COMPLETED|After 12 Weeks|"Withdrawn due to:
~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
8269512|NCT01740089|20390149|P2|COMPLETED|After 12 Weeks|"Withdrawn due to:
~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
8269513|NCT01740089|20390150|P1|COMPLETED|After 12 Weeks|"Withdrawn due to:
~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
8269514|NCT01740089|20390148|P3|STARTED|After 12 Weeks||48
8269515|NCT01740089|20390149|P2|STARTED|After 12 Weeks||48
8269516|NCT01740089|20390150|P1|STARTED|After 12 Weeks||50
8269517|NCT01740089|20390148|P3|NOT COMPLETED|First 12 Weeks of Treatment||2
8269518|NCT01740089|20390149|P2|NOT COMPLETED|First 12 Weeks of Treatment||2
8269519|NCT01740089|20390150|P1|NOT COMPLETED|First 12 Weeks of Treatment||0
8269520|NCT01740089|20390148|P3|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:
~AE before W12 (n=2)"|48
8269521|NCT01740089|20390149|P2|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:
~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
8269522|NCT01740089|20390150|P1|COMPLETED|First 12 Weeks of Treatment||50
8269523|NCT01740089|20390148|P3|STARTED|First 12 Weeks of Treatment||50
8269524|NCT01740089|20390149|P2|STARTED|First 12 Weeks of Treatment||50
8269525|NCT01740089|20390150|P1|STARTED|First 12 Weeks of Treatment||50
8269526|NCT01739803|20390168|P2|NOT COMPLETED|Overall Study||6
8269527|NCT01739803|20390169|P1|NOT COMPLETED|Overall Study||9
8269528|NCT01739803|20390168|P2|COMPLETED|Overall Study||68
8269529|NCT01739803|20390169|P1|COMPLETED|Overall Study||67
8269530|NCT01739803|20390168|P2|STARTED|Overall Study||74
8269531|NCT01739803|20390169|P1|STARTED|Overall Study||76
8269532|NCT01739790|20390181|P2|NOT COMPLETED|Overall Study||4
8269533|NCT01739790|20390182|P1|NOT COMPLETED|Overall Study||2
8269534|NCT01739790|20390181|P2|COMPLETED|Overall Study||23
8269535|NCT01739790|20390182|P1|COMPLETED|Overall Study||22
8269536|NCT01739790|20390181|P2|STARTED|Overall Study||27
8269537|NCT01739790|20390182|P1|STARTED|Overall Study||24
8269538|NCT01739764|20390191|P3|NOT COMPLETED|Overall Study||126
8269539|NCT01739764|20390192|P2|NOT COMPLETED|Overall Study||36
8269540|NCT01739764|20390193|P1|NOT COMPLETED|Overall Study||26
8269541|NCT01739764|20390191|P3|COMPLETED|Overall Study||20
8269542|NCT01739764|20390192|P2|COMPLETED|Overall Study||4
8269543|NCT01739764|20390193|P1|COMPLETED|Overall Study||3
8269544|NCT01739764|20390191|P3|STARTED|Overall Study||146
8269545|NCT01739764|20390192|P2|STARTED|Overall Study||40
8269546|NCT01739764|20390193|P1|STARTED|Overall Study||29
8269547|NCT01739595|20390207|P3|NOT COMPLETED|Overall Study||2
8269548|NCT01739595|20390208|P2|NOT COMPLETED|Overall Study||1
8269549|NCT01739595|20390209|P1|NOT COMPLETED|Overall Study||13
8269550|NCT01739595|20390207|P3|COMPLETED|Overall Study||45
8269551|NCT01739595|20390208|P2|COMPLETED|Overall Study||21
8269552|NCT01739595|20390209|P1|COMPLETED|Overall Study||99
8269553|NCT01739595|20390207|P3|STARTED|Overall Study||47
8269554|NCT01739595|20390208|P2|STARTED|Overall Study||22
8269555|NCT01739595|20390209|P1|STARTED|Overall Study||112
8269556|NCT01739400|20390219|P2|NOT COMPLETED|Overall Study||9
8269557|NCT01739400|20390220|P1|NOT COMPLETED|Overall Study||17
8269558|NCT01739400|20390219|P2|COMPLETED|Overall Study||99
8269559|NCT01739400|20390220|P1|COMPLETED|Overall Study||92
8269560|NCT01739400|20390219|P2|Treated With 10 mg Macitentan|Overall Study||108
8269561|NCT01739400|20390220|P1|Treated With 10 mg Macitentan|Overall Study||109
8269562|NCT01739400|20390219|P2|STARTED|Overall Study||108
8269563|NCT01739400|20390220|P1|STARTED|Overall Study||109
8269564|NCT01739361|20390233|P2|NOT COMPLETED|Overall Study||1
8269565|NCT01739361|20390234|P1|NOT COMPLETED|Overall Study||3
8269566|NCT01739361|20390233|P2|COMPLETED|Overall Study||22
8269567|NCT01739361|20390234|P1|COMPLETED|Overall Study||18
8269568|NCT01739361|20390233|P2|STARTED|Overall Study||23
8269569|NCT01739361|20390234|P1|STARTED|Overall Study||21
8269570|NCT01739348|20390248|P4|NOT COMPLETED|Part II (Extension Study)||396
8269571|NCT01739348|20390249|P3|NOT COMPLETED|Part II (Extension Study)||61
8269572|NCT01739348|20390250|P2|NOT COMPLETED|Part II (Extension Study)||366
8269573|NCT01739348|20390251|P1|NOT COMPLETED|Part II (Extension Study)||379
8269574|NCT01739348|20390248|P4|COMPLETED|Part II (Extension Study)||0
8269575|NCT01739348|20390249|P3|COMPLETED|Part II (Extension Study)||0
8269576|NCT01739348|20390250|P2|COMPLETED|Part II (Extension Study)||0
8269577|NCT01739348|20390251|P1|COMPLETED|Part II (Extension Study)||0
8269578|NCT01739348|20390248|P4|Treated|Part II (Extension Study)||394
8269579|NCT01739348|20390249|P3|Treated|Part II (Extension Study)||61
8269580|NCT01739348|20390250|P2|Treated|Part II (Extension Study)||365
8269581|NCT01739348|20390251|P1|Treated|Part II (Extension Study)||379
8269582|NCT01739348|20390248|P4|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
8269583|NCT01739348|20390249|P3|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
8269584|NCT01739348|20390250|P2|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
8269585|NCT01739348|20390251|P1|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
8269586|NCT01739348|20390248|P4|NOT COMPLETED|Part I (Base Study)||189
8269587|NCT01739348|20390249|P3|NOT COMPLETED|Part I (Base Study)||26
8269588|NCT01739348|20390250|P2|NOT COMPLETED|Part I (Base Study)||203
8269589|NCT01739348|20390251|P1|NOT COMPLETED|Part I (Base Study)||202
8269590|NCT01739348|20390248|P4|COMPLETED|Part I (Base Study)||516
8269591|NCT01739348|20390249|P3|COMPLETED|Part I (Base Study)||77
8269592|NCT01739348|20390250|P2|COMPLETED|Part I (Base Study)||497
8269593|NCT01739348|20390251|P1|COMPLETED|Part I (Base Study)||501
8269594|NCT01739348|20390248|P4|Treated|Part I (Base Study)||705
8269595|NCT01739348|20390249|P3|Treated|Part I (Base Study)||103
8269596|NCT01739348|20390250|P2|Treated|Part I (Base Study)||700
8269597|NCT01739348|20390251|P1|Treated|Part I (Base Study)||702
8269598|NCT01739348|20390248|P4|STARTED|Part I (Base Study)||705
8269599|NCT01739348|20390249|P3|STARTED|Part I (Base Study)||103
8269600|NCT01739348|20390250|P2|STARTED|Part I (Base Study)||700
8269601|NCT01739348|20390251|P1|STARTED|Part I (Base Study)||703
8269602|NCT01739335|20390323|P2|NOT COMPLETED|Overall Study||5
8269603|NCT01739335|20390324|P1|NOT COMPLETED|Overall Study||7
8269604|NCT01739335|20390323|P2|COMPLETED|Overall Study||35
8269605|NCT01739335|20390324|P1|COMPLETED|Overall Study||34
8269606|NCT01739335|20390323|P2|STARTED|Overall Study||40
8269607|NCT01739335|20390324|P1|STARTED|Overall Study||41
8269614|NCT01739231|20390379|P4|NOT COMPLETED|Part B||2
8269615|NCT01739231|20390380|P3|NOT COMPLETED|Part B||2
8269616|NCT01739231|20390381|P2|NOT COMPLETED|Part B||5
8269617|NCT01739231|20390382|P1|NOT COMPLETED|Part B||7
8269618|NCT01739231|20390379|P4|COMPLETED|Part B||19
8269619|NCT01739231|20390380|P3|COMPLETED|Part B||10
8269620|NCT01739231|20390381|P2|COMPLETED|Part B||12
8269621|NCT01739231|20390382|P1|COMPLETED|Part B||13
8269622|NCT01739231|20390379|P4|Challenged|Part B||21
8269623|NCT01739231|20390380|P3|Challenged|Part B||10
8269624|NCT01739231|20390381|P2|Challenged|Part B||13
8269625|NCT01739231|20390382|P1|Challenged|Part B||13
8269626|NCT01739231|20390379|P4|STARTED|Part B||21
8269627|NCT01739231|20390380|P3|STARTED|Part B||12
8269628|NCT01739231|20390381|P2|STARTED|Part B||17
8269629|NCT01739231|20390382|P1|STARTED|Part B||20
8269630|NCT01739231|20390379|P4|NOT COMPLETED|Part A||0
8269631|NCT01739231|20390380|P3|NOT COMPLETED|Part A||0
8269632|NCT01739231|20390381|P2|NOT COMPLETED|Part A||7
8269633|NCT01739231|20390382|P1|NOT COMPLETED|Part A||4
8269634|NCT01739231|20390379|P4|COMPLETED|Part A||0
8269635|NCT01739231|20390380|P3|COMPLETED|Part A||12
8269636|NCT01739231|20390381|P2|COMPLETED|Part A||17
8269637|NCT01739231|20390382|P1|COMPLETED|Part A||20
8269638|NCT01739231|20390379|P4|Received All 3 Vaccinations|Part A||0
8269639|NCT01739231|20390380|P3|Received All 3 Vaccinations|Part A||12
8269640|NCT01739231|20390381|P2|Received All 3 Vaccinations|Part A||20
8269641|NCT01739231|20390382|P1|Received All 3 Vaccinations|Part A||21
8269642|NCT01739231|20390379|P4|STARTED|Part A||0
8269643|NCT01739231|20390380|P3|STARTED|Part A||12
8269644|NCT01739231|20390381|P2|STARTED|Part A||24
8269645|NCT01739231|20390382|P1|STARTED|Part A||24
8269646|NCT01738984|20390551|P2|NOT COMPLETED|Overall Study||39
8269647|NCT01738984|20390552|P1|NOT COMPLETED|Overall Study||64
8269648|NCT01738984|20390551|P2|COMPLETED|Overall Study||210
8269649|NCT01738984|20390552|P1|COMPLETED|Overall Study||186
8269650|NCT01738984|20390551|P2|STARTED|Overall Study||249
8269651|NCT01738984|20390552|P1|STARTED|Overall Study||250
8269652|NCT01738971|20390565|P3|NOT COMPLETED|Overall Study||17
8269653|NCT01738971|20390566|P2|NOT COMPLETED|Overall Study||30
8269654|NCT01738971|20390567|P1|NOT COMPLETED|Overall Study||19
8269655|NCT01738971|20390565|P3|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
8269656|NCT01738971|20390566|P2|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
8269657|NCT01738971|20390567|P1|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
8269658|NCT01738971|20390565|P3|STARTED|Overall Study|56 participants recruited to this arm|56
8269659|NCT01738971|20390566|P2|STARTED|Overall Study|58 participants recruited to this arm|58
8269660|NCT01738971|20390567|P1|STARTED|Overall Study|54 participants recruited to this arm|54
8269661|NCT01738919|20390583|P2|NOT COMPLETED|Overall Study||3
8269662|NCT01738919|20390584|P1|NOT COMPLETED|Overall Study||1
8269663|NCT01738919|20390583|P2|COMPLETED|Overall Study||14
8269664|NCT01738919|20390584|P1|COMPLETED|Overall Study||14
8269665|NCT01738919|20390583|P2|STARTED|Overall Study||17
8269666|NCT01738919|20390584|P1|STARTED|Overall Study||15
8269667|NCT01738750|20390602|P2|NOT COMPLETED|Overall Study||0
8269668|NCT01738750|20390603|P1|NOT COMPLETED|Overall Study||0
8269669|NCT01738750|20390602|P2|COMPLETED|Overall Study||51
8269670|NCT01738750|20390603|P1|COMPLETED|Overall Study||49
8269671|NCT01738750|20390602|P2|STARTED|Overall Study||51
8269672|NCT01738750|20390603|P1|STARTED|Overall Study||49
8269673|NCT01738737|20390616|P5|NOT COMPLETED|Overall Study||4
8269674|NCT01738737|20390617|P4|NOT COMPLETED|Overall Study||4
8269675|NCT01738737|20390618|P3|NOT COMPLETED|Overall Study||4
8269676|NCT01738737|20390619|P2|NOT COMPLETED|Overall Study||4
8269677|NCT01738737|20390620|P1|NOT COMPLETED|Overall Study||4
8269678|NCT01738737|20390616|P5|COMPLETED|Overall Study||25
8269679|NCT01738737|20390617|P4|COMPLETED|Overall Study||25
8269680|NCT01738737|20390618|P3|COMPLETED|Overall Study||25
8269681|NCT01738737|20390619|P2|COMPLETED|Overall Study||25
8269682|NCT01738737|20390620|P1|COMPLETED|Overall Study||25
8269683|NCT01738737|20390616|P5|STARTED|Overall Study||29
8269684|NCT01738737|20390617|P4|STARTED|Overall Study||29
8269685|NCT01738737|20390618|P3|STARTED|Overall Study||29
8269686|NCT01738737|20390619|P2|STARTED|Overall Study||29
8269687|NCT01738737|20390620|P1|STARTED|Overall Study||29
8269700|NCT01738672|20390725|P1|NOT COMPLETED|Overall Study||5
8269701|NCT01738672|20390725|P1|COMPLETED|Overall Study||11
8269702|NCT01738672|20390725|P1|STARTED|Overall Study||16
8269703|NCT01738646|20390734|P1|NOT COMPLETED|Overall Study||2
8269704|NCT01738646|20390734|P1|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
8269705|NCT01738646|20390734|P1|STARTED|Overall Study||40
8269706|NCT01738594|20390745|P8|NOT COMPLETED|Follow up for 1 Year||0
8269707|NCT01738594|20390746|P7|NOT COMPLETED|Follow up for 1 Year||0
8269708|NCT01738594|20390747|P6|NOT COMPLETED|Follow up for 1 Year||3
8269709|NCT01738594|20390748|P5|NOT COMPLETED|Follow up for 1 Year||0
8269710|NCT01738594|20390749|P4|NOT COMPLETED|Follow up for 1 Year||0
8269711|NCT01738594|20390750|P3|NOT COMPLETED|Follow up for 1 Year||0
8269712|NCT01738594|20390751|P2|NOT COMPLETED|Follow up for 1 Year||0
8269713|NCT01738594|20390752|P1|NOT COMPLETED|Follow up for 1 Year||0
8269714|NCT01738594|20390745|P8|COMPLETED|Follow up for 1 Year||0
8269715|NCT01738594|20390746|P7|COMPLETED|Follow up for 1 Year||0
8269716|NCT01738594|20390747|P6|COMPLETED|Follow up for 1 Year||0
8269717|NCT01738594|20390748|P5|COMPLETED|Follow up for 1 Year||1
8269718|NCT01738594|20390749|P4|COMPLETED|Follow up for 1 Year||0
8269719|NCT01738594|20390750|P3|COMPLETED|Follow up for 1 Year||0
8269720|NCT01738594|20390751|P2|COMPLETED|Follow up for 1 Year||2
8269721|NCT01738594|20390752|P1|COMPLETED|Follow up for 1 Year||0
8269722|NCT01738594|20390745|P8|STARTED|Follow up for 1 Year||0
8269723|NCT01738594|20390746|P7|STARTED|Follow up for 1 Year||0
8269724|NCT01738594|20390747|P6|STARTED|Follow up for 1 Year||3
8269725|NCT01738594|20390748|P5|STARTED|Follow up for 1 Year||1
8269726|NCT01738594|20390749|P4|STARTED|Follow up for 1 Year||0
8269727|NCT01738594|20390750|P3|STARTED|Follow up for 1 Year||0
8269728|NCT01738594|20390751|P2|STARTED|Follow up for 1 Year||2
8269729|NCT01738594|20390752|P1|STARTED|Follow up for 1 Year||0
8269730|NCT01738594|20390745|P8|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8269731|NCT01738594|20390746|P7|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8269732|NCT01738594|20390747|P6|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
8269733|NCT01738594|20390748|P5|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
8269734|NCT01738594|20390749|P4|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8269735|NCT01738594|20390750|P3|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8269736|NCT01738594|20390751|P2|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8269737|NCT01738594|20390752|P1|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
8269738|NCT01738594|20390745|P8|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269739|NCT01738594|20390746|P7|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269740|NCT01738594|20390747|P6|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269741|NCT01738594|20390748|P5|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269742|NCT01738594|20390749|P4|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269743|NCT01738594|20390750|P3|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269744|NCT01738594|20390751|P2|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269745|NCT01738594|20390752|P1|COMPLETED|Went on to Continue Treatment Cycle 5||0
8269746|NCT01738594|20390745|P8|STARTED|Went on to Continue Treatment Cycle 5||0
8269747|NCT01738594|20390746|P7|STARTED|Went on to Continue Treatment Cycle 5||0
8269748|NCT01738594|20390747|P6|STARTED|Went on to Continue Treatment Cycle 5||1
8269749|NCT01738594|20390748|P5|STARTED|Went on to Continue Treatment Cycle 5||1
8269750|NCT01738594|20390749|P4|STARTED|Went on to Continue Treatment Cycle 5||0
8269751|NCT01738594|20390750|P3|STARTED|Went on to Continue Treatment Cycle 5||0
8269752|NCT01738594|20390751|P2|STARTED|Went on to Continue Treatment Cycle 5||0
8269753|NCT01738594|20390752|P1|STARTED|Went on to Continue Treatment Cycle 5||0
8269754|NCT01738594|20390745|P8|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8269755|NCT01738594|20390746|P7|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8269756|NCT01738594|20390747|P6|NOT COMPLETED|Completed 4 Cycles of Treatment||1
8269757|NCT01738594|20390748|P5|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8269758|NCT01738594|20390749|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8269759|NCT01738594|20390750|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8269760|NCT01738594|20390751|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||2
8269761|NCT01738594|20390752|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||0
8269762|NCT01738594|20390745|P8|COMPLETED|Completed 4 Cycles of Treatment||0
8269763|NCT01738594|20390746|P7|COMPLETED|Completed 4 Cycles of Treatment||0
8269764|NCT01738594|20390747|P6|COMPLETED|Completed 4 Cycles of Treatment||1
8269765|NCT01738594|20390748|P5|COMPLETED|Completed 4 Cycles of Treatment||1
8269766|NCT01738594|20390749|P4|COMPLETED|Completed 4 Cycles of Treatment||0
8269767|NCT01738594|20390750|P3|COMPLETED|Completed 4 Cycles of Treatment||0
8269768|NCT01738594|20390751|P2|COMPLETED|Completed 4 Cycles of Treatment||0
8269769|NCT01738594|20390752|P1|COMPLETED|Completed 4 Cycles of Treatment||0
8269770|NCT01738594|20390745|P8|STARTED|Completed 4 Cycles of Treatment||0
8269771|NCT01738594|20390746|P7|STARTED|Completed 4 Cycles of Treatment||0
8269772|NCT01738594|20390747|P6|STARTED|Completed 4 Cycles of Treatment||2
8269773|NCT01738594|20390748|P5|STARTED|Completed 4 Cycles of Treatment||1
8269774|NCT01738594|20390749|P4|STARTED|Completed 4 Cycles of Treatment||0
8269775|NCT01738594|20390750|P3|STARTED|Completed 4 Cycles of Treatment||0
8269776|NCT01738594|20390751|P2|STARTED|Completed 4 Cycles of Treatment||2
8269777|NCT01738594|20390752|P1|STARTED|Completed 4 Cycles of Treatment||0
8269778|NCT01738594|20390745|P8|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269779|NCT01738594|20390746|P7|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269780|NCT01738594|20390747|P6|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
8269781|NCT01738594|20390748|P5|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269782|NCT01738594|20390749|P4|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269783|NCT01738594|20390750|P3|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269784|NCT01738594|20390751|P2|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269785|NCT01738594|20390752|P1|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269786|NCT01738594|20390745|P8|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269787|NCT01738594|20390746|P7|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269788|NCT01738594|20390747|P6|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
8269789|NCT01738594|20390748|P5|COMPLETED|Completed 2 Cycles/Reached 1st Response||1
8269790|NCT01738594|20390749|P4|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269791|NCT01738594|20390750|P3|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269792|NCT01738594|20390751|P2|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
8269793|NCT01738594|20390752|P1|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8269794|NCT01738594|20390745|P8|STARTED|Completed 2 Cycles/Reached 1st Response||0
8269795|NCT01738594|20390746|P7|STARTED|Completed 2 Cycles/Reached 1st Response||0
8269796|NCT01738594|20390747|P6|STARTED|Completed 2 Cycles/Reached 1st Response||3
8269797|NCT01738594|20390748|P5|STARTED|Completed 2 Cycles/Reached 1st Response||1
8269798|NCT01738594|20390749|P4|STARTED|Completed 2 Cycles/Reached 1st Response||0
8269799|NCT01738594|20390750|P3|STARTED|Completed 2 Cycles/Reached 1st Response||0
8269800|NCT01738594|20390751|P2|STARTED|Completed 2 Cycles/Reached 1st Response||2
8269801|NCT01738594|20390752|P1|STARTED|Completed 2 Cycles/Reached 1st Response||0
8269802|NCT01738594|20390745|P8|NOT COMPLETED|Registration and Treatment Start||0
8269803|NCT01738594|20390746|P7|NOT COMPLETED|Registration and Treatment Start||0
8269804|NCT01738594|20390747|P6|NOT COMPLETED|Registration and Treatment Start||0
8269805|NCT01738594|20390748|P5|NOT COMPLETED|Registration and Treatment Start||0
8269806|NCT01738594|20390749|P4|NOT COMPLETED|Registration and Treatment Start||0
8269807|NCT01738594|20390750|P3|NOT COMPLETED|Registration and Treatment Start||0
8269808|NCT01738594|20390751|P2|NOT COMPLETED|Registration and Treatment Start||1
8269809|NCT01738594|20390752|P1|NOT COMPLETED|Registration and Treatment Start||0
8269810|NCT01738594|20390745|P8|COMPLETED|Registration and Treatment Start||0
8269811|NCT01738594|20390746|P7|COMPLETED|Registration and Treatment Start||0
8269812|NCT01738594|20390747|P6|COMPLETED|Registration and Treatment Start||3
8269813|NCT01738594|20390748|P5|COMPLETED|Registration and Treatment Start||1
8269814|NCT01738594|20390749|P4|COMPLETED|Registration and Treatment Start||0
8269815|NCT01738594|20390750|P3|COMPLETED|Registration and Treatment Start||0
8269816|NCT01738594|20390751|P2|COMPLETED|Registration and Treatment Start||2
8269817|NCT01738594|20390752|P1|COMPLETED|Registration and Treatment Start||0
8269818|NCT01738594|20390745|P8|Treatment Started|Registration and Treatment Start||0
8269819|NCT01738594|20390746|P7|Treatment Started|Registration and Treatment Start||0
8269820|NCT01738594|20390747|P6|Treatment Started|Registration and Treatment Start||3
8269821|NCT01738594|20390748|P5|Treatment Started|Registration and Treatment Start||1
8269822|NCT01738594|20390749|P4|Treatment Started|Registration and Treatment Start||0
8269823|NCT01738594|20390750|P3|Treatment Started|Registration and Treatment Start||0
8269824|NCT01738594|20390751|P2|Treatment Started|Registration and Treatment Start||2
8269825|NCT01738594|20390752|P1|Treatment Started|Registration and Treatment Start||0
8269826|NCT01738594|20390745|P8|Registered to Study|Registration and Treatment Start||0
8269827|NCT01738594|20390746|P7|Registered to Study|Registration and Treatment Start||0
8269828|NCT01738594|20390747|P6|Registered to Study|Registration and Treatment Start||3
8269829|NCT01738594|20390748|P5|Registered to Study|Registration and Treatment Start||1
8269830|NCT01738594|20390749|P4|Registered to Study|Registration and Treatment Start||0
8269831|NCT01738594|20390750|P3|Registered to Study|Registration and Treatment Start||0
8269832|NCT01738594|20390751|P2|Registered to Study|Registration and Treatment Start||3
8269833|NCT01738594|20390752|P1|Registered to Study|Registration and Treatment Start||0
8269834|NCT01738594|20390745|P8|STARTED|Registration and Treatment Start||0
8269835|NCT01738594|20390746|P7|STARTED|Registration and Treatment Start||0
8269836|NCT01738594|20390747|P6|STARTED|Registration and Treatment Start||3
8269837|NCT01738594|20390748|P5|STARTED|Registration and Treatment Start||1
8269838|NCT01738594|20390749|P4|STARTED|Registration and Treatment Start||0
8269839|NCT01738594|20390750|P3|STARTED|Registration and Treatment Start||0
8269840|NCT01738594|20390751|P2|STARTED|Registration and Treatment Start||3
8269841|NCT01738594|20390752|P1|STARTED|Registration and Treatment Start||0
8269842|NCT01738581|20390770|P2|NOT COMPLETED|Overall Study||0
8269843|NCT01738581|20390771|P1|NOT COMPLETED|Overall Study||1
8269844|NCT01738581|20390770|P2|COMPLETED|Overall Study||4
8269845|NCT01738581|20390771|P1|COMPLETED|Overall Study||4
8269846|NCT01738581|20390770|P2|STARTED|Overall Study||4
8269847|NCT01738581|20390771|P1|STARTED|Overall Study||5
8269848|NCT01738503|20390795|P7|NOT COMPLETED|PET Imaging Sub-study||1
8269849|NCT01738503|20390796|P6|NOT COMPLETED|PET Imaging Sub-study||2
8269850|NCT01738503|20390797|P5|NOT COMPLETED|PET Imaging Sub-study||0
8269851|NCT01738503|20390798|P4|NOT COMPLETED|PET Imaging Sub-study||0
8269852|NCT01738503|20390799|P3|NOT COMPLETED|PET Imaging Sub-study||0
8269853|NCT01738503|20390800|P2|NOT COMPLETED|PET Imaging Sub-study||0
8269854|NCT01738503|20390801|P1|NOT COMPLETED|PET Imaging Sub-study||0
8269855|NCT01738503|20390795|P7|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
8269856|NCT01738503|20390796|P6|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
8269857|NCT01738503|20390797|P5|COMPLETED|PET Imaging Sub-study||0
8269858|NCT01738503|20390798|P4|COMPLETED|PET Imaging Sub-study||0
8269859|NCT01738503|20390799|P3|COMPLETED|PET Imaging Sub-study||0
8269860|NCT01738503|20390800|P2|COMPLETED|PET Imaging Sub-study||0
8269861|NCT01738503|20390801|P1|COMPLETED|PET Imaging Sub-study||0
8269862|NCT01738503|20390795|P7|STARTED|PET Imaging Sub-study||2
8269863|NCT01738503|20390796|P6|STARTED|PET Imaging Sub-study||3
8269864|NCT01738503|20390797|P5|STARTED|PET Imaging Sub-study||0
8269865|NCT01738503|20390798|P4|STARTED|PET Imaging Sub-study||0
8269866|NCT01738503|20390799|P3|STARTED|PET Imaging Sub-study||0
8269867|NCT01738503|20390800|P2|STARTED|PET Imaging Sub-study||0
8269868|NCT01738503|20390801|P1|STARTED|PET Imaging Sub-study||0
8269869|NCT01738503|20390795|P7|NOT COMPLETED|Treatment Period||8
8269870|NCT01738503|20390796|P6|NOT COMPLETED|Treatment Period||6
8269871|NCT01738503|20390797|P5|NOT COMPLETED|Treatment Period||8
8269872|NCT01738503|20390798|P4|NOT COMPLETED|Treatment Period||6
8269873|NCT01738503|20390799|P3|NOT COMPLETED|Treatment Period||5
8269874|NCT01738503|20390800|P2|NOT COMPLETED|Treatment Period||5
8269875|NCT01738503|20390801|P1|NOT COMPLETED|Treatment Period||0
8269876|NCT01738503|20390795|P7|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
8269877|NCT01738503|20390796|P6|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
8269878|NCT01738503|20390797|P5|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
8269879|NCT01738503|20390798|P4|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
8269880|NCT01738503|20390799|P3|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
8269881|NCT01738503|20390800|P2|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
8269882|NCT01738503|20390801|P1|COMPLETED|Treatment Period||0
8269883|NCT01738503|20390795|P7|STARTED|Treatment Period||14
8269884|NCT01738503|20390796|P6|STARTED|Treatment Period||15
8269885|NCT01738503|20390797|P5|STARTED|Treatment Period||15
8269886|NCT01738503|20390798|P4|STARTED|Treatment Period||15
8269887|NCT01738503|20390799|P3|STARTED|Treatment Period||15
8269888|NCT01738503|20390800|P2|STARTED|Treatment Period||15
8269889|NCT01738503|20390801|P1|STARTED|Treatment Period||0
8269890|NCT01738503|20390795|P7|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269891|NCT01738503|20390796|P6|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269892|NCT01738503|20390797|P5|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269893|NCT01738503|20390798|P4|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269894|NCT01738503|20390799|P3|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269895|NCT01738503|20390800|P2|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269896|NCT01738503|20390801|P1|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
8269897|NCT01738503|20390795|P7|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269898|NCT01738503|20390796|P6|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269899|NCT01738503|20390797|P5|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269900|NCT01738503|20390798|P4|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269901|NCT01738503|20390799|P3|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269902|NCT01738503|20390800|P2|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
8269903|NCT01738503|20390801|P1|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
8269904|NCT01738503|20390795|P7|STARTED|Induction/Stabilization (Days -14 to -1)||0
8269905|NCT01738503|20390796|P6|STARTED|Induction/Stabilization (Days -14 to -1)||0
8269906|NCT01738503|20390797|P5|STARTED|Induction/Stabilization (Days -14 to -1)||0
8269907|NCT01738503|20390798|P4|STARTED|Induction/Stabilization (Days -14 to -1)||0
8269908|NCT01738503|20390799|P3|STARTED|Induction/Stabilization (Days -14 to -1)||0
8269909|NCT01738503|20390800|P2|STARTED|Induction/Stabilization (Days -14 to -1)||0
8269910|NCT01738503|20390801|P1|STARTED|Induction/Stabilization (Days -14 to -1)||124
8269911|NCT01738477|20390999|P2|NOT COMPLETED|Overall Study||4
8269912|NCT01738477|20391000|P1|NOT COMPLETED|Overall Study||1
8269913|NCT01738477|20390999|P2|COMPLETED|Overall Study||124
8269914|NCT01738477|20391000|P1|COMPLETED|Overall Study||36
8269915|NCT01738477|20390999|P2|STARTED|Overall Study||128
8269916|NCT01738477|20391000|P1|STARTED|Overall Study||37
8269917|NCT01738438|20391028|P1|NOT COMPLETED|Overall Study||35
8269918|NCT01738438|20391028|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8269919|NCT01738438|20391028|P1|STARTED|Overall Study||35
8269920|NCT01738321|20391036|P2|NOT COMPLETED|Overall Study||0
8269921|NCT01738321|20391037|P1|NOT COMPLETED|Overall Study||0
8269922|NCT01738321|20391036|P2|COMPLETED|Overall Study||30
8269923|NCT01738321|20391037|P1|COMPLETED|Overall Study||33
8269924|NCT01738321|20391036|P2|STARTED|Overall Study||30
8269925|NCT01738321|20391037|P1|STARTED|Overall Study||33
8269926|NCT01738191|20391045|P2|NOT COMPLETED|Overall Study||1
8269927|NCT01738191|20391046|P1|NOT COMPLETED|Overall Study||4
8269928|NCT01738191|20391045|P2|COMPLETED|Overall Study||14
8269929|NCT01738191|20391046|P1|COMPLETED|Overall Study||11
8269930|NCT01738191|20391045|P2|STARTED|Overall Study||15
8269931|NCT01738191|20391046|P1|STARTED|Overall Study||15
8269932|NCT01737996|20391069|P3|NOT COMPLETED|Overall Study||2
8269933|NCT01737996|20391070|P2|NOT COMPLETED|Overall Study||1
8269934|NCT01737996|20391071|P1|NOT COMPLETED|Overall Study||0
8269935|NCT01737996|20391069|P3|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
8269936|NCT01737996|20391070|P2|COMPLETED|Overall Study||7
8269937|NCT01737996|20391071|P1|COMPLETED|Overall Study||8
8269938|NCT01737996|20391069|P3|STARTED|Overall Study||16
8269939|NCT01737996|20391070|P2|STARTED|Overall Study||8
8269940|NCT01737996|20391071|P1|STARTED|Overall Study||8
8269941|NCT01737944|20391112|P4|NOT COMPLETED|Overall Study||0
8269942|NCT01737944|20391113|P3|NOT COMPLETED|Overall Study||0
8269943|NCT01737944|20391114|P2|NOT COMPLETED|Overall Study||0
8269944|NCT01737944|20391115|P1|NOT COMPLETED|Overall Study||0
8269945|NCT01737944|20391112|P4|COMPLETED|Overall Study||9
8269946|NCT01737944|20391113|P3|COMPLETED|Overall Study||9
8269947|NCT01737944|20391114|P2|COMPLETED|Overall Study||9
8269948|NCT01737944|20391115|P1|COMPLETED|Overall Study||9
8269949|NCT01737944|20391112|P4|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
8269950|NCT01737944|20391113|P3|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
8269951|NCT01737944|20391114|P2|STARTED|Overall Study||9
8269952|NCT01737944|20391115|P1|STARTED|Overall Study||9
8269953|NCT01737931|20391133|P3|NOT COMPLETED|Overall Study||1
8269954|NCT01737931|20391134|P2|NOT COMPLETED|Overall Study||2
8269955|NCT01737931|20391135|P1|NOT COMPLETED|Overall Study||0
8269956|NCT01737931|20391133|P3|COMPLETED|Overall Study||38
8269957|NCT01737931|20391134|P2|COMPLETED|Overall Study||38
8269958|NCT01737931|20391135|P1|COMPLETED|Overall Study||38
8269959|NCT01737931|20391133|P3|STARTED|Overall Study||39
8269960|NCT01737931|20391134|P2|STARTED|Overall Study||40
8269961|NCT01737931|20391135|P1|STARTED|Overall Study||38
8269962|NCT01737879|20391150|P1|NOT COMPLETED|Overall Study||41
8269963|NCT01737879|20391150|P1|COMPLETED|Overall Study||0
8269964|NCT01737879|20391150|P1|Transitioned to Epoetin Alfa|Overall Study||0
8269965|NCT01737879|20391150|P1|Received Peginesatide|Overall Study||34
8269966|NCT01737879|20391150|P1|STARTED|Overall Study||41
8269967|NCT01737840|20391159|P2|NOT COMPLETED|Overall Study||2
8269968|NCT01737840|20391160|P1|NOT COMPLETED|Overall Study||2
8269969|NCT01737840|20391159|P2|COMPLETED|Overall Study||33
8269970|NCT01737840|20391160|P1|COMPLETED|Overall Study||33
8269971|NCT01737840|20391159|P2|STARTED|Overall Study||35
8269972|NCT01737840|20391160|P1|STARTED|Overall Study||35
8269973|NCT01737762|20391170|P2|NOT COMPLETED|Overall Study||17
8269974|NCT01737762|20391171|P1|NOT COMPLETED|Overall Study||20
8269975|NCT01737762|20391170|P2|COMPLETED|Overall Study||61
8269976|NCT01737762|20391171|P1|COMPLETED|Overall Study||57
8269977|NCT01737762|20391170|P2|STARTED|Overall Study||78
8269978|NCT01737762|20391171|P1|STARTED|Overall Study||77
8269979|NCT01737710|20391184|P5|NOT COMPLETED|Overall Study||0
8269980|NCT01737710|20391185|P4|NOT COMPLETED|Overall Study||0
8269981|NCT01737710|20391186|P3|NOT COMPLETED|Overall Study||3
8269982|NCT01737710|20391187|P2|NOT COMPLETED|Overall Study||4
8269983|NCT01737710|20391188|P1|NOT COMPLETED|Overall Study||2
8269984|NCT01737710|20391184|P5|COMPLETED|Overall Study||21
8269985|NCT01737710|20391185|P4|COMPLETED|Overall Study||23
8269986|NCT01737710|20391186|P3|COMPLETED|Overall Study||102
8269987|NCT01737710|20391187|P2|COMPLETED|Overall Study||101
8269988|NCT01737710|20391188|P1|COMPLETED|Overall Study||112
8269989|NCT01737710|20391184|P5|STARTED|Overall Study||21
8269990|NCT01737710|20391185|P4|STARTED|Overall Study||23
8269991|NCT01737710|20391186|P3|STARTED|Overall Study||105
8269992|NCT01737710|20391187|P2|STARTED|Overall Study||105
8269993|NCT01737710|20391188|P1|STARTED|Overall Study||114
8269994|NCT01737697|20391230|P15|NOT COMPLETED|Subacute Phase||1
8269995|NCT01737697|20391231|P14|NOT COMPLETED|Subacute Phase||2
8269996|NCT01737697|20391232|P13|NOT COMPLETED|Subacute Phase||2
8269997|NCT01737697|20391233|P12|NOT COMPLETED|Subacute Phase||3
8269998|NCT01737697|20391234|P11|NOT COMPLETED|Subacute Phase||6
8269999|NCT01737697|20391235|P10|NOT COMPLETED|Subacute Phase||2
8270000|NCT01737697|20391236|P9|NOT COMPLETED|Subacute Phase||2
8270001|NCT01737697|20391237|P8|NOT COMPLETED|Subacute Phase||3
8270002|NCT01737697|20391238|P7|NOT COMPLETED|Subacute Phase||1
8270003|NCT01737697|20391239|P6|NOT COMPLETED|Subacute Phase||3
8270004|NCT01737697|20391240|P5|NOT COMPLETED|Subacute Phase||0
8270005|NCT01737697|20391241|P4|NOT COMPLETED|Subacute Phase||0
8270006|NCT01737697|20391242|P3|NOT COMPLETED|Subacute Phase||0
8270007|NCT01737697|20391243|P2|NOT COMPLETED|Subacute Phase||0
8270008|NCT01737697|20391244|P1|NOT COMPLETED|Subacute Phase||0
8270009|NCT01737697|20391230|P15|COMPLETED|Subacute Phase||49
8270010|NCT01737697|20391231|P14|COMPLETED|Subacute Phase||44
8270011|NCT01737697|20391232|P13|COMPLETED|Subacute Phase||61
8270012|NCT01737697|20391233|P12|COMPLETED|Subacute Phase||58
8270013|NCT01737697|20391234|P11|COMPLETED|Subacute Phase||59
8270014|NCT01737697|20391235|P10|COMPLETED|Subacute Phase||66
8270015|NCT01737697|20391236|P9|COMPLETED|Subacute Phase||52
8270016|NCT01737697|20391237|P8|COMPLETED|Subacute Phase||43
8270017|NCT01737697|20391238|P7|COMPLETED|Subacute Phase||48
8270018|NCT01737697|20391239|P6|COMPLETED|Subacute Phase||38
8270019|NCT01737697|20391240|P5|COMPLETED|Subacute Phase||0
8270020|NCT01737697|20391241|P4|COMPLETED|Subacute Phase||0
8270021|NCT01737697|20391242|P3|COMPLETED|Subacute Phase||0
8270022|NCT01737697|20391243|P2|COMPLETED|Subacute Phase||0
8270023|NCT01737697|20391244|P1|COMPLETED|Subacute Phase||0
8270024|NCT01737697|20391230|P15|STARTED|Subacute Phase||50
8270025|NCT01737697|20391231|P14|STARTED|Subacute Phase||46
8270026|NCT01737697|20391232|P13|STARTED|Subacute Phase||63
8270027|NCT01737697|20391233|P12|STARTED|Subacute Phase||61
8270028|NCT01737697|20391234|P11|STARTED|Subacute Phase||65
8270029|NCT01737697|20391235|P10|STARTED|Subacute Phase||68
8270030|NCT01737697|20391236|P9|STARTED|Subacute Phase||54
8270031|NCT01737697|20391237|P8|STARTED|Subacute Phase||46
8270032|NCT01737697|20391238|P7|STARTED|Subacute Phase||49
8270033|NCT01737697|20391239|P6|STARTED|Subacute Phase||41
8270034|NCT01737697|20391240|P5|STARTED|Subacute Phase||0
8270035|NCT01737697|20391241|P4|STARTED|Subacute Phase||0
8270036|NCT01737697|20391242|P3|STARTED|Subacute Phase||0
8270037|NCT01737697|20391243|P2|STARTED|Subacute Phase||0
8270038|NCT01737697|20391244|P1|STARTED|Subacute Phase||0
8270039|NCT01737697|20391230|P15|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270040|NCT01737697|20391231|P14|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270041|NCT01737697|20391232|P13|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270042|NCT01737697|20391233|P12|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270043|NCT01737697|20391234|P11|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270044|NCT01737697|20391235|P10|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270045|NCT01737697|20391236|P9|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270046|NCT01737697|20391237|P8|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270047|NCT01737697|20391238|P7|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270048|NCT01737697|20391239|P6|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
8270049|NCT01737697|20391240|P5|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
8270050|NCT01737697|20391241|P4|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
8270051|NCT01737697|20391242|P3|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
8270052|NCT01737697|20391243|P2|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
8270053|NCT01737697|20391244|P1|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
8270054|NCT01737697|20391230|P15|COMPLETED|Acute Phase-Initial 48 Hours||0
8270055|NCT01737697|20391231|P14|COMPLETED|Acute Phase-Initial 48 Hours||0
8270056|NCT01737697|20391232|P13|COMPLETED|Acute Phase-Initial 48 Hours||0
8270057|NCT01737697|20391233|P12|COMPLETED|Acute Phase-Initial 48 Hours||0
8270058|NCT01737697|20391234|P11|COMPLETED|Acute Phase-Initial 48 Hours||0
8270059|NCT01737697|20391235|P10|COMPLETED|Acute Phase-Initial 48 Hours||0
8270060|NCT01737697|20391236|P9|COMPLETED|Acute Phase-Initial 48 Hours||0
8270061|NCT01737697|20391237|P8|COMPLETED|Acute Phase-Initial 48 Hours||0
8270062|NCT01737697|20391238|P7|COMPLETED|Acute Phase-Initial 48 Hours||0
8270063|NCT01737697|20391239|P6|COMPLETED|Acute Phase-Initial 48 Hours||0
8270064|NCT01737697|20391240|P5|COMPLETED|Acute Phase-Initial 48 Hours||140
8270065|NCT01737697|20391241|P4|COMPLETED|Acute Phase-Initial 48 Hours||152
8270066|NCT01737697|20391242|P3|COMPLETED|Acute Phase-Initial 48 Hours||137
8270067|NCT01737697|20391243|P2|COMPLETED|Acute Phase-Initial 48 Hours||150
8270068|NCT01737697|20391244|P1|COMPLETED|Acute Phase-Initial 48 Hours||157
8270069|NCT01737697|20391230|P15|STARTED|Acute Phase-Initial 48 Hours||0
8270070|NCT01737697|20391231|P14|STARTED|Acute Phase-Initial 48 Hours||0
8270071|NCT01737697|20391232|P13|STARTED|Acute Phase-Initial 48 Hours||0
8270072|NCT01737697|20391233|P12|STARTED|Acute Phase-Initial 48 Hours||0
8270073|NCT01737697|20391234|P11|STARTED|Acute Phase-Initial 48 Hours||0
8270074|NCT01737697|20391235|P10|STARTED|Acute Phase-Initial 48 Hours||0
8270075|NCT01737697|20391236|P9|STARTED|Acute Phase-Initial 48 Hours||0
8270076|NCT01737697|20391237|P8|STARTED|Acute Phase-Initial 48 Hours||0
8270077|NCT01737697|20391238|P7|STARTED|Acute Phase-Initial 48 Hours||0
8270078|NCT01737697|20391239|P6|STARTED|Acute Phase-Initial 48 Hours||0
8270079|NCT01737697|20391240|P5|STARTED|Acute Phase-Initial 48 Hours||143
8270080|NCT01737697|20391241|P4|STARTED|Acute Phase-Initial 48 Hours||158
8270081|NCT01737697|20391242|P3|STARTED|Acute Phase-Initial 48 Hours||141
8270082|NCT01737697|20391243|P2|STARTED|Acute Phase-Initial 48 Hours||154
8270083|NCT01737697|20391244|P1|STARTED|Acute Phase-Initial 48 Hours||158
8270084|NCT01737684|20391333|P3|NOT COMPLETED|Overall Study||0
8270085|NCT01737684|20391334|P2|NOT COMPLETED|Overall Study||0
8270086|NCT01737684|20391335|P1|NOT COMPLETED|Overall Study||0
8270087|NCT01737684|20391333|P3|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
8270088|NCT01737684|20391334|P2|COMPLETED|Overall Study||8
8270089|NCT01737684|20391335|P1|COMPLETED|Overall Study||8
8270090|NCT01737684|20391333|P3|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
8270091|NCT01737684|20391334|P2|STARTED|Overall Study||8
8270092|NCT01737684|20391335|P1|STARTED|Overall Study||8
8270093|NCT01737593|20391354|P3|NOT COMPLETED|Overall Study||0
8270094|NCT01737593|20391355|P2|NOT COMPLETED|Overall Study||0
8270095|NCT01737593|20391356|P1|NOT COMPLETED|Overall Study||0
8270096|NCT01737593|20391354|P3|COMPLETED|Overall Study||39
8270097|NCT01737593|20391355|P2|COMPLETED|Overall Study||32
8270098|NCT01737593|20391356|P1|COMPLETED|Overall Study||37
8270099|NCT01737593|20391354|P3|STARTED|Overall Study||39
8270100|NCT01737593|20391355|P2|STARTED|Overall Study||32
8270101|NCT01737593|20391356|P1|STARTED|Overall Study||37
8270102|NCT01737398|20391387|P2|NOT COMPLETED|Overall Study||8
8270103|NCT01737398|20391388|P1|NOT COMPLETED|Overall Study||26
8270104|NCT01737398|20391387|P2|COMPLETED|Overall Study||52
8270105|NCT01737398|20391388|P1|COMPLETED|Overall Study||87
8270106|NCT01737398|20391387|P2|Safety Set|Overall Study||60
8270107|NCT01737398|20391388|P1|Safety Set|Overall Study||112
8270108|NCT01737398|20391387|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
8270109|NCT01737398|20391388|P1|Received at Least 1 Dose of Study Drug|Overall Study||112
8270110|NCT01737398|20391387|P2|STARTED|Overall Study||60
8270111|NCT01737398|20391388|P1|STARTED|Overall Study||113
8270112|NCT01737281|20391432|P2|NOT COMPLETED|Overall Study||280
8270113|NCT01737281|20391433|P1|NOT COMPLETED|Overall Study||366
8270114|NCT01737281|20391432|P2|COMPLETED|Overall Study||689
8270115|NCT01737281|20391433|P1|COMPLETED|Overall Study||603
8270116|NCT01737281|20391432|P2|STARTED|Overall Study||969
8270117|NCT01737281|20391433|P1|STARTED|Overall Study||969
8270118|NCT01737268|20391441|P1|NOT COMPLETED|Overall Study||9
8270119|NCT01737268|20391441|P1|COMPLETED|Overall Study||11
8270120|NCT01737268|20391441|P1|Treated|Overall Study||20
8270121|NCT01737268|20391441|P1|STARTED|Overall Study||20
8270122|NCT01737021|20391455|P2|NOT COMPLETED|Overall Study||3
8270123|NCT01737021|20391456|P1|NOT COMPLETED|Overall Study||5
8270124|NCT01737021|20391455|P2|COMPLETED|Overall Study||6
8270125|NCT01737021|20391456|P1|COMPLETED|Overall Study||17
8270126|NCT01737021|20391455|P2|STARTED|Overall Study||9
8270127|NCT01737021|20391456|P1|STARTED|Overall Study||22
8270128|NCT01736930|20391462|P1|NOT COMPLETED|Overall Study||1
8270129|NCT01736930|20391462|P1|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
8270130|NCT01736930|20391462|P1|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
8270131|NCT01736917|20391502|P1|NOT COMPLETED|Overall Study||11
8270132|NCT01736917|20391502|P1|COMPLETED|Overall Study||54
8270133|NCT01736917|20391502|P1|STARTED|Overall Study||65
8270134|NCT01736865|20391511|P2|NOT COMPLETED|Overall Study||0
8270135|NCT01736865|20391512|P1|NOT COMPLETED|Overall Study||0
8270136|NCT01736865|20391511|P2|COMPLETED|Overall Study||66
8270137|NCT01736865|20391512|P1|COMPLETED|Overall Study||61
8270138|NCT01736865|20391511|P2|STARTED|Overall Study||66
8270139|NCT01736865|20391512|P1|STARTED|Overall Study||61
8270140|NCT01736852|20391526|P2|NOT COMPLETED|Overall Study||3
8270141|NCT01736852|20391527|P1|NOT COMPLETED|Overall Study||2
8270142|NCT01736852|20391526|P2|COMPLETED|Overall Study||61
8270143|NCT01736852|20391527|P1|COMPLETED|Overall Study||63
8270144|NCT01736852|20391526|P2|STARTED|Overall Study||64
8270145|NCT01736852|20391527|P1|STARTED|Overall Study||65
8270146|NCT01736696|20391542|P7|NOT COMPLETED|Overall Study||0
8270147|NCT01736696|20391543|P6|NOT COMPLETED|Overall Study||0
8270148|NCT01736696|20391544|P5|NOT COMPLETED|Overall Study||0
8270149|NCT01736696|20391545|P4|NOT COMPLETED|Overall Study||0
8270150|NCT01736696|20391546|P3|NOT COMPLETED|Overall Study||1
8270151|NCT01736696|20391547|P2|NOT COMPLETED|Overall Study||0
8270152|NCT01736696|20391548|P1|NOT COMPLETED|Overall Study||0
8270153|NCT01736696|20391542|P7|COMPLETED|Overall Study||13
8270154|NCT01736696|20391543|P6|COMPLETED|Overall Study||8
8270155|NCT01736696|20391544|P5|COMPLETED|Overall Study||9
8270156|NCT01736696|20391545|P4|COMPLETED|Overall Study||9
8270157|NCT01736696|20391546|P3|COMPLETED|Overall Study||9
8270158|NCT01736696|20391547|P2|COMPLETED|Overall Study||5
8270159|NCT01736696|20391548|P1|COMPLETED|Overall Study||5
8270160|NCT01736696|20391542|P7|STARTED|Overall Study||13
8270161|NCT01736696|20391543|P6|STARTED|Overall Study||8
8270162|NCT01736696|20391544|P5|STARTED|Overall Study||9
8270163|NCT01736696|20391545|P4|STARTED|Overall Study||9
8270164|NCT01736696|20391546|P3|STARTED|Overall Study||10
8270165|NCT01736696|20391547|P2|STARTED|Overall Study||5
8270166|NCT01736696|20391548|P1|STARTED|Overall Study||5
8270167|NCT01736683|20391870|P5|NOT COMPLETED|Overall Study||5
8270168|NCT01736683|20391871|P4|NOT COMPLETED|Overall Study||35
8270169|NCT01736683|20391872|P3|NOT COMPLETED|Overall Study||21
8270170|NCT01736683|20391873|P2|NOT COMPLETED|Overall Study||6
8270171|NCT01736683|20391874|P1|NOT COMPLETED|Overall Study||7
8270172|NCT01736683|20391870|P5|COMPLETED|Overall Study|# who completed treatment|0
8270173|NCT01736683|20391871|P4|COMPLETED|Overall Study|# who completed treatment|0
8270174|NCT01736683|20391872|P3|COMPLETED|Overall Study|# who completed treatment|0
8270175|NCT01736683|20391873|P2|COMPLETED|Overall Study|# who completed treatment|0
8270176|NCT01736683|20391874|P1|COMPLETED|Overall Study|# who completed treatment|0
8270177|NCT01736683|20391870|P5|STARTED|Overall Study||5
8270178|NCT01736683|20391871|P4|STARTED|Overall Study||35
8270179|NCT01736683|20391872|P3|STARTED|Overall Study||21
8270180|NCT01736683|20391873|P2|STARTED|Overall Study||6
8270181|NCT01736683|20391874|P1|STARTED|Overall Study||7
8270182|NCT01736657|20391936|P1|NOT COMPLETED|Overall Study||1
8270183|NCT01736657|20391936|P1|COMPLETED|Overall Study||72
8270184|NCT01736657|20391936|P1|STARTED|Overall Study||73
8270191|NCT01736566|20391985|P5|NOT COMPLETED|Long Term Follow-up||1
8270192|NCT01736566|20391986|P4|NOT COMPLETED|Long Term Follow-up||0
8270193|NCT01736566|20391987|P3|NOT COMPLETED|Long Term Follow-up||49
8270194|NCT01736566|20391988|P2|NOT COMPLETED|Long Term Follow-up||0
8270195|NCT01736566|20391989|P1|NOT COMPLETED|Long Term Follow-up||42
8270196|NCT01736566|20391985|P5|COMPLETED|Long Term Follow-up||0
8270197|NCT01736566|20391986|P4|COMPLETED|Long Term Follow-up||0
8270198|NCT01736566|20391987|P3|COMPLETED|Long Term Follow-up||0
8270199|NCT01736566|20391988|P2|COMPLETED|Long Term Follow-up||0
8270200|NCT01736566|20391989|P1|COMPLETED|Long Term Follow-up||0
8270201|NCT01736566|20391985|P5|STARTED|Long Term Follow-up||1
8270202|NCT01736566|20391986|P4|STARTED|Long Term Follow-up||0
8270203|NCT01736566|20391987|P3|STARTED|Long Term Follow-up||49
8270204|NCT01736566|20391988|P2|STARTED|Long Term Follow-up||0
8270205|NCT01736566|20391989|P1|STARTED|Long Term Follow-up||42
8270206|NCT01736566|20391985|P5|NOT COMPLETED|Main Study||4
8270207|NCT01736566|20391986|P4|NOT COMPLETED|Main Study||1
8270208|NCT01736566|20391987|P3|NOT COMPLETED|Main Study||1
8270209|NCT01736566|20391988|P2|NOT COMPLETED|Main Study||0
8270210|NCT01736566|20391989|P1|NOT COMPLETED|Main Study||1
8270211|NCT01736566|20391985|P5|COMPLETED|Main Study||6
8270212|NCT01736566|20391986|P4|COMPLETED|Main Study||51
8270213|NCT01736566|20391987|P3|COMPLETED|Main Study||49
8270214|NCT01736566|20391988|P2|COMPLETED|Main Study||50
8270215|NCT01736566|20391989|P1|COMPLETED|Main Study||50
8270216|NCT01736566|20391985|P5|STARTED|Main Study||10
8270217|NCT01736566|20391986|P4|STARTED|Main Study||52
8270218|NCT01736566|20391987|P3|STARTED|Main Study||50
8270219|NCT01736566|20391988|P2|STARTED|Main Study||50
8270220|NCT01736566|20391989|P1|STARTED|Main Study||51
8270221|NCT01736553|20392074|P2|NOT COMPLETED|Overall Study||4
8270222|NCT01736553|20392075|P1|NOT COMPLETED|Overall Study||19
8270223|NCT01736553|20392074|P2|COMPLETED|Overall Study||23
8270224|NCT01736553|20392075|P1|COMPLETED|Overall Study||7
8270225|NCT01736553|20392074|P2|STARTED|Overall Study||27
8270226|NCT01736553|20392075|P1|STARTED|Overall Study||26
8270227|NCT01736540|20392126|P1|NOT COMPLETED|Overall Study||15
8270228|NCT01736540|20392126|P1|COMPLETED|Overall Study||228
8270229|NCT01736540|20392126|P1|STARTED|Overall Study||243
8270230|NCT01736527|20392183|P1|NOT COMPLETED|Overall Study||0
8270231|NCT01736527|20392183|P1|COMPLETED|Overall Study||12
8270232|NCT01736527|20392183|P1|STARTED|Overall Study||12
8270239|NCT01736397|20392248|P2|NOT COMPLETED|Overall Study||24
8270240|NCT01736397|20392249|P1|NOT COMPLETED|Overall Study||14
8270241|NCT01736397|20392248|P2|COMPLETED|Overall Study||50
8270242|NCT01736397|20392249|P1|COMPLETED|Overall Study||61
8270243|NCT01736397|20392248|P2|STARTED|Overall Study||74
8270244|NCT01736397|20392249|P1|STARTED|Overall Study||75
8270245|NCT01736358|20392263|P2|NOT COMPLETED|Overall Study||2
8270246|NCT01736358|20392264|P1|NOT COMPLETED|Overall Study||5
8270247|NCT01736358|20392263|P2|COMPLETED|Overall Study||23
8270248|NCT01736358|20392264|P1|COMPLETED|Overall Study||20
8270249|NCT01736358|20392263|P2|STARTED|Overall Study||25
8270250|NCT01736358|20392264|P1|STARTED|Overall Study||25
8270251|NCT01736267|20392278|P1|NOT COMPLETED|Overall Study||0
8270252|NCT01736267|20392278|P1|COMPLETED|Overall Study||3
8270253|NCT01736267|20392278|P1|STARTED|Overall Study||3
8270254|NCT01736254|20392282|P1|NOT COMPLETED|Period 3 (Days 13 to 23)||1
8270255|NCT01736254|20392282|P1|COMPLETED|Period 3 (Days 13 to 23)||20
8270256|NCT01736254|20392282|P1|STARTED|Period 3 (Days 13 to 23)||21
8270257|NCT01736254|20392282|P1|NOT COMPLETED|Period 2 (Days 2 to 12)||3
8270258|NCT01736254|20392282|P1|COMPLETED|Period 2 (Days 2 to 12)||21
8270259|NCT01736254|20392282|P1|STARTED|Period 2 (Days 2 to 12)||24
8270260|NCT01736254|20392282|P1|NOT COMPLETED|Period 1 (Day 1)||0
8270261|NCT01736254|20392282|P1|COMPLETED|Period 1 (Day 1)||24
8270262|NCT01736254|20392282|P1|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
8270263|NCT01736254|20392282|P1|STARTED|Period 1 (Day 1)||24
8270264|NCT01736241|20392306|P7|NOT COMPLETED|Overall Study||0
8270265|NCT01736241|20392307|P6|NOT COMPLETED|Overall Study||0
8270266|NCT01736241|20392308|P5|NOT COMPLETED|Overall Study||0
8270267|NCT01736241|20392309|P4|NOT COMPLETED|Overall Study||0
8270268|NCT01736241|20392310|P3|NOT COMPLETED|Overall Study||0
8270269|NCT01736241|20392311|P2|NOT COMPLETED|Overall Study||0
8270270|NCT01736241|20392312|P1|NOT COMPLETED|Overall Study||0
8270271|NCT01736241|20392306|P7|COMPLETED|Overall Study||6
8270272|NCT01736241|20392307|P6|COMPLETED|Overall Study||6
8270273|NCT01736241|20392308|P5|COMPLETED|Overall Study||6
8270274|NCT01736241|20392309|P4|COMPLETED|Overall Study||5
8270275|NCT01736241|20392310|P3|COMPLETED|Overall Study||6
8270276|NCT01736241|20392311|P2|COMPLETED|Overall Study||6
8270277|NCT01736241|20392312|P1|COMPLETED|Overall Study||6
8270278|NCT01736241|20392306|P7|Received at Least One Dose of Study Drug|Overall Study||6
8270279|NCT01736241|20392307|P6|Received at Least One Dose of Study Drug|Overall Study||6
8270280|NCT01736241|20392308|P5|Received at Least One Dose of Study Drug|Overall Study||6
8270281|NCT01736241|20392309|P4|Received at Least One Dose of Study Drug|Overall Study||5
8270282|NCT01736241|20392310|P3|Received at Least One Dose of Study Drug|Overall Study||6
8270283|NCT01736241|20392311|P2|Received at Least One Dose of Study Drug|Overall Study||6
8270284|NCT01736241|20392312|P1|Received at Least One Dose of Study Drug|Overall Study||6
8270285|NCT01736241|20392306|P7|STARTED|Overall Study||6
8270286|NCT01736241|20392307|P6|STARTED|Overall Study||6
8270287|NCT01736241|20392308|P5|STARTED|Overall Study||6
8270288|NCT01736241|20392309|P4|STARTED|Overall Study||5
8270289|NCT01736241|20392310|P3|STARTED|Overall Study||6
8270290|NCT01736241|20392311|P2|STARTED|Overall Study||6
8270291|NCT01736241|20392312|P1|STARTED|Overall Study||6
8270292|NCT01736215|20392347|P1|NOT COMPLETED|Overall Study||14
8270293|NCT01736215|20392347|P1|COMPLETED|Overall Study||19
8270294|NCT01736215|20392347|P1|Treated|Overall Study||25
8270295|NCT01736215|20392347|P1|STARTED|Overall Study||33
8270296|NCT01736189|20392359|P1|NOT COMPLETED|Overall Study||46
8270297|NCT01736189|20392359|P1|COMPLETED|Overall Study||300
8270298|NCT01736189|20392359|P1|STARTED|Overall Study||346
8270303|NCT01736085|20392418|P6|NOT COMPLETED|Overall Study||0
8270304|NCT01736085|20392419|P5|NOT COMPLETED|Overall Study||0
8270305|NCT01736085|20392420|P4|NOT COMPLETED|Overall Study||0
8270306|NCT01736085|20392421|P3|NOT COMPLETED|Overall Study||0
8270307|NCT01736085|20392422|P2|NOT COMPLETED|Overall Study||0
8270308|NCT01736085|20392423|P1|NOT COMPLETED|Overall Study||0
8270309|NCT01736085|20392418|P6|COMPLETED|Overall Study||794
8270310|NCT01736085|20392419|P5|COMPLETED|Overall Study||530
8270311|NCT01736085|20392420|P4|COMPLETED|Overall Study||530
8270312|NCT01736085|20392421|P3|COMPLETED|Overall Study||793
8270313|NCT01736085|20392422|P2|COMPLETED|Overall Study||530
8270314|NCT01736085|20392423|P1|COMPLETED|Overall Study||529
8270315|NCT01736085|20392418|P6|STARTED|Overall Study||794
8270316|NCT01736085|20392419|P5|STARTED|Overall Study||530
8270317|NCT01736085|20392420|P4|STARTED|Overall Study||530
8270318|NCT01736085|20392421|P3|STARTED|Overall Study||793
8270319|NCT01736085|20392422|P2|STARTED|Overall Study||530
8270320|NCT01736085|20392423|P1|STARTED|Overall Study||529
8270321|NCT01735994|20392439|P2|NOT COMPLETED|Overall Study||66
8270322|NCT01735994|20392440|P1|NOT COMPLETED|Overall Study||63
8270323|NCT01735994|20392439|P2|COMPLETED|Overall Study||152
8270324|NCT01735994|20392440|P1|COMPLETED|Overall Study||200
8270325|NCT01735994|20392439|P2|Follow-Up #2 (12 Months)|Overall Study||174
8270326|NCT01735994|20392440|P1|Follow-Up #2 (12 Months)|Overall Study||212
8270327|NCT01735994|20392439|P2|Follow-Up #1 (6 Months)|Overall Study||163
8270328|NCT01735994|20392440|P1|Follow-Up #1 (6 Months)|Overall Study||213
8270329|NCT01735994|20392439|P2|Post Intervention (3 Weeks)|Overall Study||198
8270330|NCT01735994|20392440|P1|Post Intervention (3 Weeks)|Overall Study||239
8270331|NCT01735994|20392439|P2|STARTED|Overall Study||218
8270332|NCT01735994|20392440|P1|STARTED|Overall Study||263
8270333|NCT01735916|20392455|P3|NOT COMPLETED|Overall Study||7
8270334|NCT01735916|20392456|P2|NOT COMPLETED|Overall Study||19
8270335|NCT01735916|20392457|P1|NOT COMPLETED|Overall Study||18
8270336|NCT01735916|20392455|P3|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
8270337|NCT01735916|20392456|P2|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
8270338|NCT01735916|20392457|P1|COMPLETED|Overall Study||0
8270339|NCT01735916|20392455|P3|STARTED|Overall Study||7
8270340|NCT01735916|20392456|P2|STARTED|Overall Study||19
8270341|NCT01735916|20392457|P1|STARTED|Overall Study||18
8270342|NCT01735877|20392478|P2|NOT COMPLETED|Overall Study||0
8270343|NCT01735877|20392479|P1|NOT COMPLETED|Overall Study||1
8270344|NCT01735877|20392478|P2|COMPLETED|Overall Study||21
8270345|NCT01735877|20392479|P1|COMPLETED|Overall Study||26
8270346|NCT01735877|20392478|P2|STARTED|Overall Study||21
8270347|NCT01735877|20392479|P1|STARTED|Overall Study||27
8270348|NCT01735630|20392495|P2|NOT COMPLETED|Overall Study||18
8270349|NCT01735630|20392496|P1|NOT COMPLETED|Overall Study||18
8270350|NCT01735630|20392495|P2|COMPLETED|Overall Study||157
8270351|NCT01735630|20392496|P1|COMPLETED|Overall Study||157
8270352|NCT01735630|20392495|P2|STARTED|Overall Study||175
8270353|NCT01735630|20392496|P1|STARTED|Overall Study||175
8270354|NCT01735617|20392510|P1|NOT COMPLETED|Overall Study||0
8270355|NCT01735617|20392510|P1|COMPLETED|Overall Study||16
8270356|NCT01735617|20392510|P1|STARTED|Overall Study||16
8270357|NCT01735396|20392523|P1|NOT COMPLETED|Overall Study||1
8270358|NCT01735396|20392523|P1|COMPLETED|Overall Study||10
8270359|NCT01735396|20392523|P1|STARTED|Overall Study||11
8270360|NCT01735279|20392534|P2|NOT COMPLETED|Overall Study||8
8270361|NCT01735279|20392535|P1|NOT COMPLETED|Overall Study||11
8270362|NCT01735279|20392534|P2|COMPLETED|Overall Study||21
8270363|NCT01735279|20392535|P1|COMPLETED|Overall Study||18
8270364|NCT01735279|20392534|P2|STARTED|Overall Study||29
8270365|NCT01735279|20392535|P1|STARTED|Overall Study||29
8270366|NCT01735214|20392547|P1|NOT COMPLETED|Overall Study||0
8270367|NCT01735214|20392547|P1|COMPLETED|Overall Study||358
8270368|NCT01735214|20392547|P1|STARTED|Overall Study||358
8270369|NCT01735201|20392567|P8|NOT COMPLETED|Overall Study||2
8270370|NCT01735201|20392568|P7|NOT COMPLETED|Overall Study||3
8270371|NCT01735201|20392569|P6|NOT COMPLETED|Overall Study||5
8270372|NCT01735201|20392570|P5|NOT COMPLETED|Overall Study||1
8270373|NCT01735201|20392571|P4|NOT COMPLETED|Overall Study||2
8270374|NCT01735201|20392572|P3|NOT COMPLETED|Overall Study||0
8270375|NCT01735201|20392573|P2|NOT COMPLETED|Overall Study||1
8270376|NCT01735201|20392574|P1|NOT COMPLETED|Overall Study||3
8270377|NCT01735201|20392567|P8|COMPLETED|Overall Study||42
8270378|NCT01735201|20392568|P7|COMPLETED|Overall Study||42
8270379|NCT01735201|20392569|P6|COMPLETED|Overall Study||40
8270380|NCT01735201|20392570|P5|COMPLETED|Overall Study||44
8270381|NCT01735201|20392571|P4|COMPLETED|Overall Study||42
8270382|NCT01735201|20392572|P3|COMPLETED|Overall Study||44
8270383|NCT01735201|20392573|P2|COMPLETED|Overall Study||43
8270384|NCT01735201|20392574|P1|COMPLETED|Overall Study||42
8270385|NCT01735201|20392567|P8|STARTED|Overall Study||44
8270386|NCT01735201|20392568|P7|STARTED|Overall Study||45
8270387|NCT01735201|20392569|P6|STARTED|Overall Study||45
8270388|NCT01735201|20392570|P5|STARTED|Overall Study||45
8270389|NCT01735201|20392571|P4|STARTED|Overall Study||44
8270390|NCT01735201|20392572|P3|STARTED|Overall Study||44
8270391|NCT01735201|20392573|P2|STARTED|Overall Study||44
8270392|NCT01735201|20392574|P1|STARTED|Overall Study||45
8270393|NCT01735175|20392610|P2|NOT COMPLETED|Overall Study||13
8270394|NCT01735175|20392611|P1|NOT COMPLETED|Overall Study||29
8270395|NCT01735175|20392610|P2|COMPLETED|Overall Study||144
8270396|NCT01735175|20392611|P1|COMPLETED|Overall Study||130
8270397|NCT01735175|20392610|P2|Completed the 6-month SFU Visit|Overall Study||138
8270398|NCT01735175|20392611|P1|Completed the 6-month SFU Visit|Overall Study||120
8270399|NCT01735175|20392610|P2|Completed All Treatments as Planned|Overall Study||150
8270400|NCT01735175|20392611|P1|Completed All Treatments as Planned|Overall Study||140
8270401|NCT01735175|20392610|P2|Completed All Cycles|Overall Study||150
8270402|NCT01735175|20392611|P1|Completed All Cycles|Overall Study||141
8270403|NCT01735175|20392610|P2|STARTED|Overall Study||157
8270404|NCT01735175|20392611|P1|STARTED|Overall Study||159
8270405|NCT01734993|20392631|P1|NOT COMPLETED|Overall Study||2
8270406|NCT01734993|20392631|P1|COMPLETED|Overall Study||9
8270407|NCT01734993|20392631|P1|STARTED|Overall Study||11
8270408|NCT01734902|20392659|P2|NOT COMPLETED|Overall Study||2
8270409|NCT01734902|20392660|P1|NOT COMPLETED|Overall Study||0
8270410|NCT01734902|20392659|P2|COMPLETED|Overall Study||14
8270411|NCT01734902|20392660|P1|COMPLETED|Overall Study||14
8270412|NCT01734902|20392659|P2|STARTED|Overall Study||16
8270413|NCT01734902|20392660|P1|STARTED|Overall Study||14
8270414|NCT01734889|20392670|P1|NOT COMPLETED|Overall Study||0
8270415|NCT01734889|20392670|P1|COMPLETED|Overall Study||18
8270416|NCT01734889|20392670|P1|STARTED|Overall Study||18
8270417|NCT01734850|20392681|P3|NOT COMPLETED|Overall Study||4
8270418|NCT01734850|20392682|P2|NOT COMPLETED|Overall Study||2
8270419|NCT01734850|20392683|P1|NOT COMPLETED|Overall Study||3
8270420|NCT01734850|20392681|P3|COMPLETED|Overall Study||1
8270421|NCT01734850|20392682|P2|COMPLETED|Overall Study||2
8270422|NCT01734850|20392683|P1|COMPLETED|Overall Study||1
8270423|NCT01734850|20392681|P3|STARTED|Overall Study||5
8270424|NCT01734850|20392682|P2|STARTED|Overall Study||4
8270425|NCT01734850|20392683|P1|STARTED|Overall Study||4
8270426|NCT01734811|20392740|P2|NOT COMPLETED|Overall Study||3
8270427|NCT01734811|20392741|P1|NOT COMPLETED|Overall Study||4
8270428|NCT01734811|20392740|P2|COMPLETED|Overall Study||59
8270429|NCT01734811|20392741|P1|COMPLETED|Overall Study||54
8270430|NCT01734811|20392740|P2|STARTED|Overall Study||62
8270431|NCT01734811|20392741|P1|STARTED|Overall Study||58
8270432|NCT01734785|20392768|P4|NOT COMPLETED|Double-Blind Period||0
8270433|NCT01734785|20392769|P3|NOT COMPLETED|Double-Blind Period||5
8270434|NCT01734785|20392770|P2|NOT COMPLETED|Double-Blind Period||9
8270435|NCT01734785|20392771|P1|NOT COMPLETED|Double-Blind Period||5
8270436|NCT01734785|20392768|P4|COMPLETED|Double-Blind Period||0
8270437|NCT01734785|20392769|P3|COMPLETED|Double-Blind Period||105
8270438|NCT01734785|20392770|P2|COMPLETED|Double-Blind Period||103
8270439|NCT01734785|20392771|P1|COMPLETED|Double-Blind Period||106
8270440|NCT01734785|20392768|P4|STARTED|Double-Blind Period||0
8270441|NCT01734785|20392769|P3|STARTED|Double-Blind Period||110
8270442|NCT01734785|20392770|P2|STARTED|Double-Blind Period||112
8270443|NCT01734785|20392771|P1|STARTED|Double-Blind Period||111
8270444|NCT01734785|20392768|P4|NOT COMPLETED|Open-Label Period||273
8270445|NCT01734785|20392769|P3|NOT COMPLETED|Open-Label Period||0
8270446|NCT01734785|20392770|P2|NOT COMPLETED|Open-Label Period||0
8270447|NCT01734785|20392771|P1|NOT COMPLETED|Open-Label Period||0
8270448|NCT01734785|20392768|P4|COMPLETED|Open-Label Period||333
8270449|NCT01734785|20392769|P3|COMPLETED|Open-Label Period||0
8270450|NCT01734785|20392770|P2|COMPLETED|Open-Label Period||0
8270451|NCT01734785|20392771|P1|COMPLETED|Open-Label Period||0
8270452|NCT01734785|20392768|P4|STARTED|Open-Label Period||606
8270453|NCT01734785|20392769|P3|STARTED|Open-Label Period||0
8270454|NCT01734785|20392770|P2|STARTED|Open-Label Period||0
8270455|NCT01734785|20392771|P1|STARTED|Open-Label Period||0
8270456|NCT01734772|20392788|P2|NOT COMPLETED|Overall Study||3
8270457|NCT01734772|20392789|P1|NOT COMPLETED|Overall Study||1
8270458|NCT01734772|20392788|P2|COMPLETED|Overall Study||21
8270459|NCT01734772|20392789|P1|COMPLETED|Overall Study||23
8270460|NCT01734772|20392788|P2|STARTED|Overall Study||24
8270461|NCT01734772|20392789|P1|STARTED|Overall Study||24
8270462|NCT01734746|20392806|P1|NOT COMPLETED|Overall Study||1
8270463|NCT01734746|20392806|P1|COMPLETED|Overall Study||21
8270464|NCT01734746|20392806|P1|STARTED|Overall Study||22
8270465|NCT01734655|20392812|P1|NOT COMPLETED|Overall Study||0
8270466|NCT01734655|20392812|P1|COMPLETED|Overall Study||40
8270467|NCT01734655|20392812|P1|STARTED|Overall Study||40
8270468|NCT01734551|20392823|P2|NOT COMPLETED|Overall Study||0
8270469|NCT01734551|20392824|P1|NOT COMPLETED|Overall Study||0
8270470|NCT01734551|20392823|P2|COMPLETED|Overall Study||16
8270471|NCT01734551|20392824|P1|COMPLETED|Overall Study||15
8270472|NCT01734551|20392823|P2|STARTED|Overall Study||16
8270473|NCT01734551|20392824|P1|STARTED|Overall Study||15
8270474|NCT01734525|20392836|P1|NOT COMPLETED|Overall Study||0
8270475|NCT01734525|20392836|P1|COMPLETED|Overall Study||85
8270476|NCT01734525|20392836|P1|STARTED|Overall Study||85
8270477|NCT01734434|20392844|P4|NOT COMPLETED|Overall Study||23
8270478|NCT01734434|20392845|P3|NOT COMPLETED|Overall Study||129
8270479|NCT01734434|20392846|P2|NOT COMPLETED|Overall Study||12
8270480|NCT01734434|20392847|P1|NOT COMPLETED|Overall Study||10
8270481|NCT01734434|20392844|P4|COMPLETED|Overall Study||228
8270482|NCT01734434|20392845|P3|COMPLETED|Overall Study||1863
8270483|NCT01734434|20392846|P2|COMPLETED|Overall Study||488
8270484|NCT01734434|20392847|P1|COMPLETED|Overall Study||490
8270485|NCT01734434|20392844|P4|STARTED|Overall Study||251
8270486|NCT01734434|20392845|P3|STARTED|Overall Study||1992
8270487|NCT01734434|20392846|P2|STARTED|Overall Study||500
8270488|NCT01734434|20392847|P1|STARTED|Overall Study||500
8270489|NCT01734395|20392869|P1|NOT COMPLETED|Overall Study||410
8270490|NCT01734395|20392869|P1|COMPLETED|Overall Study||1472
8270491|NCT01734395|20392869|P1|STARTED|Overall Study||1882
8270492|NCT01734382|20392878|P3|NOT COMPLETED|Part 2||7
8270493|NCT01734382|20392879|P2|NOT COMPLETED|Part 2||2
8270494|NCT01734382|20392880|P1|NOT COMPLETED|Part 2||0
8270495|NCT01734382|20392878|P3|COMPLETED|Part 2||8
8270496|NCT01734382|20392879|P2|COMPLETED|Part 2||5
8270497|NCT01734382|20392880|P1|COMPLETED|Part 2||0
8270498|NCT01734382|20392878|P3|STARTED|Part 2||15
8270499|NCT01734382|20392879|P2|STARTED|Part 2||7
8270500|NCT01734382|20392880|P1|STARTED|Part 2||0
8270501|NCT01734382|20392878|P3|NOT COMPLETED|Part 1||0
8270502|NCT01734382|20392879|P2|NOT COMPLETED|Part 1||0
8270503|NCT01734382|20392880|P1|NOT COMPLETED|Part 1||2
8270504|NCT01734382|20392878|P3|COMPLETED|Part 1||0
8270505|NCT01734382|20392879|P2|COMPLETED|Part 1||0
8270506|NCT01734382|20392880|P1|COMPLETED|Part 1||17
8270507|NCT01734382|20392878|P3|STARTED|Part 1||0
8270508|NCT01734382|20392879|P2|STARTED|Part 1||0
8270509|NCT01734382|20392880|P1|STARTED|Part 1||19
8270510|NCT01734317|20392940|P1|NOT COMPLETED|Overall Study||0
8270511|NCT01734317|20392940|P1|COMPLETED|Overall Study||10
8270512|NCT01734317|20392940|P1|STARTED|Overall Study||10
8270513|NCT01734239|20392947|P2|NOT COMPLETED|Overall Study||0
8270514|NCT01734239|20392948|P1|NOT COMPLETED|Overall Study||0
8270515|NCT01734239|20392947|P2|COMPLETED|Overall Study||50
8270516|NCT01734239|20392948|P1|COMPLETED|Overall Study||52
8270517|NCT01734239|20392947|P2|STARTED|Overall Study||50
8270518|NCT01734239|20392948|P1|STARTED|Overall Study||52
8270519|NCT01734161|20392963|P2|NOT COMPLETED|Overall Study||8
8270520|NCT01734161|20392964|P1|NOT COMPLETED|Overall Study||6
8270521|NCT01734161|20392963|P2|COMPLETED|Overall Study||53
8270522|NCT01734161|20392964|P1|COMPLETED|Overall Study||55
8270523|NCT01734161|20392963|P2|STARTED|Overall Study||61
8270524|NCT01734161|20392964|P1|STARTED|Overall Study||61
8270525|NCT01733953|20392972|P2|NOT COMPLETED|Overall Study||7
8270526|NCT01733953|20392973|P1|NOT COMPLETED|Overall Study||5
8270527|NCT01733953|20392972|P2|COMPLETED|Overall Study||6
8270528|NCT01733953|20392973|P1|COMPLETED|Overall Study||9
8270529|NCT01733953|20392972|P2|STARTED|Overall Study||13
8270530|NCT01733953|20392973|P1|STARTED|Overall Study||14
8270531|NCT01733758|20392993|P4|NOT COMPLETED|Overall Study||8
8270532|NCT01733758|20392994|P3|NOT COMPLETED|Overall Study||15
8270533|NCT01733758|20392995|P2|NOT COMPLETED|Overall Study||12
8270534|NCT01733758|20392996|P1|NOT COMPLETED|Overall Study||15
8270535|NCT01733758|20392993|P4|COMPLETED|Overall Study||95
8270536|NCT01733758|20392994|P3|COMPLETED|Overall Study||135
8270537|NCT01733758|20392995|P2|COMPLETED|Overall Study||148
8270538|NCT01733758|20392996|P1|COMPLETED|Overall Study||62
8270539|NCT01733758|20392993|P4|STARTED|Overall Study||103
8270540|NCT01733758|20392994|P3|STARTED|Overall Study||150
8270541|NCT01733758|20392995|P2|STARTED|Overall Study||160
8270542|NCT01733758|20392996|P1|STARTED|Overall Study||77
8270543|NCT01733745|20393049|P2|NOT COMPLETED|Overall Study||0
8270544|NCT01733745|20393050|P1|NOT COMPLETED|Overall Study||0
8270545|NCT01733745|20393049|P2|COMPLETED|Overall Study||13
8270546|NCT01733745|20393050|P1|COMPLETED|Overall Study||13
8270547|NCT01733745|20393049|P2|STARTED|Overall Study||13
8270548|NCT01733745|20393050|P1|STARTED|Overall Study||13
8270549|NCT01733732|20393062|P2|NOT COMPLETED|Overall Study||0
8270550|NCT01733732|20393063|P1|NOT COMPLETED|Overall Study||2
8270551|NCT01733732|20393062|P2|COMPLETED|Overall Study||27
8270552|NCT01733732|20393063|P1|COMPLETED|Overall Study||25
8270553|NCT01733732|20393062|P2|STARTED|Overall Study||27
8270554|NCT01733732|20393063|P1|STARTED|Overall Study||27
8270555|NCT01733680|20393099|P2|NOT COMPLETED|Overall Study||1
8270556|NCT01733680|20393100|P1|NOT COMPLETED|Overall Study||0
8270557|NCT01733680|20393099|P2|COMPLETED|Overall Study||0
8270558|NCT01733680|20393100|P1|COMPLETED|Overall Study||2
8270559|NCT01733680|20393099|P2|STARTED|Overall Study||1
8270560|NCT01733680|20393100|P1|STARTED|Overall Study||2
8270561|NCT01733628|20393110|P1|NOT COMPLETED|Overall Study||0
8270562|NCT01733628|20393110|P1|COMPLETED|Overall Study||143
8270563|NCT01733628|20393110|P1|STARTED|Overall Study||143
8270564|NCT01733472|20393119|P2|NOT COMPLETED|Overall Study||0
8270565|NCT01733472|20393120|P1|NOT COMPLETED|Overall Study||0
8270566|NCT01733472|20393119|P2|COMPLETED|Overall Study||60
8270567|NCT01733472|20393120|P1|COMPLETED|Overall Study||60
8270568|NCT01733472|20393119|P2|STARTED|Overall Study||60
8270569|NCT01733472|20393120|P1|STARTED|Overall Study||60
8270570|NCT01733407|20393132|P2|NOT COMPLETED|Overall Study||0
8270571|NCT01733407|20393133|P1|NOT COMPLETED|Overall Study||2
8270572|NCT01733407|20393132|P2|COMPLETED|Overall Study||9
8270573|NCT01733407|20393133|P1|COMPLETED|Overall Study||7
8270574|NCT01733407|20393132|P2|STARTED|Overall Study||9
8270575|NCT01733407|20393133|P1|STARTED|Overall Study||9
8270576|NCT01733368|20393149|P1|NOT COMPLETED|Overall Study||31
8270577|NCT01733368|20393149|P1|COMPLETED|Overall Study||167
8270578|NCT01733368|20393149|P1|STARTED|Overall Study||198
8270579|NCT01733329|20393159|P2|NOT COMPLETED|Overall Study||1
8270580|NCT01733329|20393160|P1|NOT COMPLETED|Overall Study||2
8270581|NCT01733329|20393159|P2|COMPLETED|Overall Study||60
8270582|NCT01733329|20393160|P1|COMPLETED|Overall Study||60
8270583|NCT01733329|20393159|P2|STARTED|Overall Study||61
8270584|NCT01733329|20393160|P1|STARTED|Overall Study||62
8270585|NCT01733316|20393172|P1|NOT COMPLETED|Long Term Extension Phase||5
8270586|NCT01733316|20393172|P1|COMPLETED|Long Term Extension Phase||33
8270587|NCT01733316|20393172|P1|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
8270588|NCT01733316|20393172|P1|NOT COMPLETED|RP103 Phase||1
8270589|NCT01733316|20393172|P1|COMPLETED|RP103 Phase||40
8270590|NCT01733316|20393172|P1|STARTED|RP103 Phase||41
8270591|NCT01733316|20393172|P1|NOT COMPLETED|Cystagon® Phase||0
8270592|NCT01733316|20393172|P1|COMPLETED|Cystagon® Phase||41
8270593|NCT01733316|20393172|P1|STARTED|Cystagon® Phase||41
8270594|NCT01733277|20393188|P2|NOT COMPLETED|Overall Study||0
8270595|NCT01733277|20393189|P1|NOT COMPLETED|Overall Study||0
8270596|NCT01733277|20393188|P2|COMPLETED|Overall Study||25
8270597|NCT01733277|20393189|P1|COMPLETED|Overall Study||25
8270598|NCT01733277|20393188|P2|STARTED|Overall Study||25
8270599|NCT01733277|20393189|P1|STARTED|Overall Study||25
8270600|NCT01733238|20393199|P1|NOT COMPLETED|Overall Study||5
8270601|NCT01733238|20393199|P1|COMPLETED|Overall Study|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|8
8270602|NCT01733238|20393199|P1|STARTED|Overall Study||13
8270603|NCT01733212|20393206|P2|NOT COMPLETED|Overall Study||0
8270604|NCT01733212|20393207|P1|NOT COMPLETED|Overall Study||0
8270605|NCT01733212|20393206|P2|COMPLETED|Overall Study||123
8270606|NCT01733212|20393207|P1|COMPLETED|Overall Study||116
8270607|NCT01733212|20393206|P2|STARTED|Overall Study||123
8270608|NCT01733212|20393207|P1|STARTED|Overall Study||116
8270609|NCT01733121|20393215|P2|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
8270610|NCT01733121|20393216|P1|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
8270611|NCT01733121|20393215|P2|COMPLETED|Follow-Up Period (Week 6 to 8)||46
8270612|NCT01733121|20393216|P1|COMPLETED|Follow-Up Period (Week 6 to 8)||44
8270613|NCT01733121|20393215|P2|STARTED|Follow-Up Period (Week 6 to 8)||46
8270614|NCT01733121|20393216|P1|STARTED|Follow-Up Period (Week 6 to 8)||44
8270615|NCT01733121|20393215|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
8270616|NCT01733121|20393216|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
8270617|NCT01733121|20393215|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||46
8270618|NCT01733121|20393216|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||44
8270619|NCT01733121|20393215|P2|STARTED|Double-Blind Period (Week 0 to 6)||51
8270620|NCT01733121|20393216|P1|STARTED|Double-Blind Period (Week 0 to 6)||51
8270621|NCT01733069|20393230|P2|NOT COMPLETED|Overall Study||0
8270622|NCT01733069|20393231|P1|NOT COMPLETED|Overall Study||0
8270623|NCT01733069|20393230|P2|COMPLETED|Overall Study||1598
8270624|NCT01733069|20393231|P1|COMPLETED|Overall Study||264
8270625|NCT01733069|20393230|P2|STARTED|Overall Study||1598
8270626|NCT01733069|20393231|P1|STARTED|Overall Study||264
8270627|NCT01733056|20393240|P3|NOT COMPLETED|Overall Study||0
8270628|NCT01733056|20393241|P2|NOT COMPLETED|Overall Study||0
8270629|NCT01733056|20393242|P1|NOT COMPLETED|Overall Study||0
8270630|NCT01733056|20393240|P3|COMPLETED|Overall Study||12
8270631|NCT01733056|20393241|P2|COMPLETED|Overall Study||10
8270632|NCT01733056|20393242|P1|COMPLETED|Overall Study||21
8270633|NCT01733056|20393240|P3|STARTED|Overall Study||12
8270634|NCT01733056|20393241|P2|STARTED|Overall Study||10
8270635|NCT01733056|20393242|P1|STARTED|Overall Study||21
8270636|NCT01732926|20393258|P2|NOT COMPLETED|Overall Study||110
8270637|NCT01732926|20393259|P1|NOT COMPLETED|Overall Study||267
8270638|NCT01732926|20393258|P2|COMPLETED|Overall Study||45
8270639|NCT01732926|20393259|P1|COMPLETED|Overall Study||53
8270640|NCT01732926|20393258|P2|STARTED|Overall Study||155
8270641|NCT01732926|20393259|P1|STARTED|Overall Study||320
8270642|NCT01732913|20393275|P2|NOT COMPLETED|Overall Study||69
8270643|NCT01732913|20393276|P1|NOT COMPLETED|Overall Study||156
8270644|NCT01732913|20393275|P2|COMPLETED|Overall Study||28
8270645|NCT01732913|20393276|P1|COMPLETED|Overall Study||42
8270646|NCT01732913|20393275|P2|STARTED|Overall Study||97
8270647|NCT01732913|20393276|P1|STARTED|Overall Study||198
8270648|NCT01732874|20393292|P2|NOT COMPLETED|Overall Study||3
8270649|NCT01732874|20393293|P1|NOT COMPLETED|Overall Study||8
8270650|NCT01732874|20393292|P2|COMPLETED|Overall Study||8
8270651|NCT01732874|20393293|P1|COMPLETED|Overall Study||8
8270652|NCT01732874|20393292|P2|STARTED|Overall Study||11
8270653|NCT01732874|20393293|P1|STARTED|Overall Study||16
8270654|NCT01732835|20393299|P1|NOT COMPLETED|2-year Extended Follow-up||5
8270655|NCT01732835|20393299|P1|COMPLETED|2-year Extended Follow-up||39
8270656|NCT01732835|20393299|P1|STARTED|2-year Extended Follow-up||44
8270657|NCT01732835|20393299|P1|NOT COMPLETED|6-month Primary Endpoint||24
8270658|NCT01732835|20393299|P1|COMPLETED|6-month Primary Endpoint||44
8270659|NCT01732835|20393299|P1|STARTED|6-month Primary Endpoint||68
8270660|NCT01732822|20393332|P2|NOT COMPLETED|Overall Study||113
8270661|NCT01732822|20393333|P1|NOT COMPLETED|Overall Study||123
8270662|NCT01732822|20393332|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
8270663|NCT01732822|20393333|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
8270664|NCT01732822|20393332|P2|STARTED|Overall Study||6955
8270665|NCT01732822|20393333|P1|STARTED|Overall Study||6930
8270666|NCT01732809|20393405|P2|NOT COMPLETED|Overall Study||1
8270667|NCT01732809|20393406|P1|NOT COMPLETED|Overall Study||0
8270668|NCT01732809|20393405|P2|COMPLETED|Overall Study||9
8270669|NCT01732809|20393406|P1|COMPLETED|Overall Study||9
8270670|NCT01732809|20393405|P2|STARTED|Overall Study||10
8270671|NCT01732809|20393406|P1|STARTED|Overall Study||9
8270672|NCT01732796|20393425|P3|NOT COMPLETED|Overall Study||13
8270673|NCT01732796|20393426|P2|NOT COMPLETED|Overall Study||42
8270674|NCT01732796|20393427|P1|NOT COMPLETED|Overall Study||46
8270675|NCT01732796|20393425|P3|COMPLETED|Overall Study||38
8270676|NCT01732796|20393426|P2|COMPLETED|Overall Study||169
8270677|NCT01732796|20393427|P1|COMPLETED|Overall Study||162
8270678|NCT01732796|20393425|P3|STARTED|Overall Study||51
8270679|NCT01732796|20393426|P2|STARTED|Overall Study||211
8270680|NCT01732796|20393427|P1|STARTED|Overall Study||208
8270681|NCT01732783|20393446|P3|NOT COMPLETED|Overall Study||10
8270682|NCT01732783|20393447|P2|NOT COMPLETED|Overall Study||32
8270683|NCT01732783|20393448|P1|NOT COMPLETED|Overall Study||135
8270684|NCT01732783|20393446|P3|COMPLETED|Overall Study|Completed 12-month observation period.|2
8270685|NCT01732783|20393447|P2|COMPLETED|Overall Study|Completed 12-month observation period.|5
8270686|NCT01732783|20393448|P1|COMPLETED|Overall Study|Completed 12-month observation period.|29
8270687|NCT01732783|20393446|P3|STARTED|Overall Study||12
8270688|NCT01732783|20393447|P2|STARTED|Overall Study||37
8270689|NCT01732783|20393448|P1|STARTED|Overall Study||164
8270690|NCT01732770|20393512|P2|NOT COMPLETED|Overall Study||8
8270691|NCT01732770|20393513|P1|NOT COMPLETED|Overall Study||10
8270692|NCT01732770|20393512|P2|COMPLETED|Overall Study||313
8270693|NCT01732770|20393513|P1|COMPLETED|Overall Study||312
8270694|NCT01732770|20393512|P2|Received Study Treatment|Overall Study||320
8270695|NCT01732770|20393513|P1|Received Study Treatment|Overall Study||320
8270696|NCT01732770|20393512|P2|STARTED|Overall Study||321
8270697|NCT01732770|20393513|P1|STARTED|Overall Study||322
8270698|NCT01732757|20393528|P3|NOT COMPLETED|Overall Study||0
8270699|NCT01732757|20393529|P2|NOT COMPLETED|Overall Study||0
8270700|NCT01732757|20393530|P1|NOT COMPLETED|Overall Study||1
8270701|NCT01732757|20393528|P3|COMPLETED|Overall Study||52
8270702|NCT01732757|20393529|P2|COMPLETED|Overall Study||52
8270703|NCT01732757|20393530|P1|COMPLETED|Overall Study||52
8270704|NCT01732757|20393528|P3|STARTED|Overall Study||52
8270705|NCT01732757|20393529|P2|STARTED|Overall Study||52
8270706|NCT01732757|20393530|P1|STARTED|Overall Study||53
8270707|NCT01732718|20393568|P2|NOT COMPLETED|Second Intervention||0
8270708|NCT01732718|20393569|P1|NOT COMPLETED|Second Intervention||0
8270709|NCT01732718|20393568|P2|COMPLETED|Second Intervention||6
8270710|NCT01732718|20393569|P1|COMPLETED|Second Intervention||7
8270711|NCT01732718|20393568|P2|STARTED|Second Intervention||6
8270712|NCT01732718|20393569|P1|STARTED|Second Intervention||7
8270713|NCT01732718|20393568|P2|NOT COMPLETED|Washout (4 Weeks)||0
8270714|NCT01732718|20393569|P1|NOT COMPLETED|Washout (4 Weeks)||0
8270715|NCT01732718|20393568|P2|COMPLETED|Washout (4 Weeks)||6
8270716|NCT01732718|20393569|P1|COMPLETED|Washout (4 Weeks)||7
8270717|NCT01732718|20393568|P2|STARTED|Washout (4 Weeks)||6
8270718|NCT01732718|20393569|P1|STARTED|Washout (4 Weeks)||7
8270719|NCT01732718|20393568|P2|NOT COMPLETED|First Intervention||0
8270720|NCT01732718|20393569|P1|NOT COMPLETED|First Intervention||0
8270721|NCT01732718|20393568|P2|COMPLETED|First Intervention||6
8270722|NCT01732718|20393569|P1|COMPLETED|First Intervention||7
8270723|NCT01732718|20393568|P2|STARTED|First Intervention||6
8270724|NCT01732718|20393569|P1|STARTED|First Intervention||7
8270725|NCT01732692|20393607|P2|NOT COMPLETED|Overall Study||1
8270726|NCT01732692|20393608|P1|NOT COMPLETED|Overall Study||0
8270727|NCT01732692|20393607|P2|COMPLETED|Overall Study||69
8270728|NCT01732692|20393608|P1|COMPLETED|Overall Study||70
8270729|NCT01732692|20393607|P2|STARTED|Overall Study||70
8270730|NCT01732692|20393608|P1|STARTED|Overall Study||70
8270731|NCT01732640|20393622|P2|NOT COMPLETED|Overall Study||2
8270732|NCT01732640|20393623|P1|NOT COMPLETED|Overall Study||0
8270733|NCT01732640|20393622|P2|COMPLETED|Overall Study||1
8270734|NCT01732640|20393623|P1|COMPLETED|Overall Study||6
8270735|NCT01732640|20393622|P2|STARTED|Overall Study||3
8270736|NCT01732640|20393623|P1|STARTED|Overall Study||6
8270737|NCT01732627|20393640|P2|NOT COMPLETED|Overall Study||0
8270738|NCT01732627|20393641|P1|NOT COMPLETED|Overall Study||1
8270739|NCT01732627|20393640|P2|COMPLETED|Overall Study||100
8270740|NCT01732627|20393641|P1|COMPLETED|Overall Study||200
8270741|NCT01732627|20393640|P2|Safety Analysis Set (SafAS)|Overall Study||100
8270742|NCT01732627|20393641|P1|Safety Analysis Set (SafAS)|Overall Study||199
8270743|NCT01732627|20393640|P2|STARTED|Overall Study||100
8270744|NCT01732627|20393641|P1|STARTED|Overall Study||201
8270745|NCT01732588|20393674|P3|NOT COMPLETED|Third Intervention (7 Days)||0
8270746|NCT01732588|20393675|P2|NOT COMPLETED|Third Intervention (7 Days)||0
8270747|NCT01732588|20393676|P1|NOT COMPLETED|Third Intervention (7 Days)||0
8270748|NCT01732588|20393674|P3|COMPLETED|Third Intervention (7 Days)||4
8270749|NCT01732588|20393675|P2|COMPLETED|Third Intervention (7 Days)||2
8270750|NCT01732588|20393676|P1|COMPLETED|Third Intervention (7 Days)||4
8270751|NCT01732588|20393674|P3|STARTED|Third Intervention (7 Days)||4
8270752|NCT01732588|20393675|P2|STARTED|Third Intervention (7 Days)||2
8270753|NCT01732588|20393676|P1|STARTED|Third Intervention (7 Days)||4
8270754|NCT01732588|20393674|P3|NOT COMPLETED|Second Intervention (7 Days)||0
8270755|NCT01732588|20393675|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8270756|NCT01732588|20393676|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8270757|NCT01732588|20393674|P3|COMPLETED|Second Intervention (7 Days)||4
8270758|NCT01732588|20393675|P2|COMPLETED|Second Intervention (7 Days)||2
8270759|NCT01732588|20393676|P1|COMPLETED|Second Intervention (7 Days)||4
8270760|NCT01732588|20393674|P3|STARTED|Second Intervention (7 Days)||4
8270761|NCT01732588|20393675|P2|STARTED|Second Intervention (7 Days)||2
8270762|NCT01732588|20393676|P1|STARTED|Second Intervention (7 Days)||4
8270763|NCT01732588|20393674|P3|NOT COMPLETED|First Intervention (7 Days)||0
8270764|NCT01732588|20393675|P2|NOT COMPLETED|First Intervention (7 Days)||1
8270765|NCT01732588|20393676|P1|NOT COMPLETED|First Intervention (7 Days)||0
8270766|NCT01732588|20393674|P3|COMPLETED|First Intervention (7 Days)||4
8270767|NCT01732588|20393675|P2|COMPLETED|First Intervention (7 Days)||2
8270768|NCT01732588|20393676|P1|COMPLETED|First Intervention (7 Days)||4
8270769|NCT01732588|20393674|P3|STARTED|First Intervention (7 Days)||4
8270770|NCT01732588|20393675|P2|STARTED|First Intervention (7 Days)||3
8270771|NCT01732588|20393676|P1|STARTED|First Intervention (7 Days)||4
8270772|NCT01732549|20393692|P2|NOT COMPLETED|Overall Study||73
8270773|NCT01732549|20393693|P1|NOT COMPLETED|Overall Study||71
8270774|NCT01732549|20393692|P2|COMPLETED|Overall Study||0
8270775|NCT01732549|20393693|P1|COMPLETED|Overall Study||0
8270776|NCT01732549|20393692|P2|Withdrawn During Treatment:Final Analysi|Overall Study||73
8270777|NCT01732549|20393693|P1|Withdrawn During Treatment:Final Analysi|Overall Study||71
8270778|NCT01732549|20393692|P2|Ongoing Treatment Period:Final Analysis|Overall Study||0
8270779|NCT01732549|20393693|P1|Ongoing Treatment Period:Final Analysis|Overall Study||0
8270780|NCT01732549|20393692|P2|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
8270781|NCT01732549|20393693|P1|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
8270782|NCT01732549|20393692|P2|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
8270783|NCT01732549|20393693|P1|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
8270784|NCT01732549|20393692|P2|STARTED|Overall Study||73
8270785|NCT01732549|20393693|P1|STARTED|Overall Study||71
8270786|NCT01732536|20393715|P2|NOT COMPLETED|Overall Study||1
8270787|NCT01732536|20393716|P1|NOT COMPLETED|Overall Study||1
8270788|NCT01732536|20393715|P2|COMPLETED|Overall Study||46
8270789|NCT01732536|20393716|P1|COMPLETED|Overall Study||52
8270790|NCT01732536|20393715|P2|STARTED|Overall Study||47
8270791|NCT01732536|20393716|P1|STARTED|Overall Study||53
8270792|NCT01732510|20393739|P7|NOT COMPLETED|Overall Study||8
8270793|NCT01732510|20393740|P6|NOT COMPLETED|Overall Study||13
8270794|NCT01732510|20393741|P5|NOT COMPLETED|Overall Study||5
8270795|NCT01732510|20393742|P4|NOT COMPLETED|Overall Study||5
8270796|NCT01732510|20393743|P3|NOT COMPLETED|Overall Study||4
8270797|NCT01732510|20393744|P2|NOT COMPLETED|Overall Study||5
8270798|NCT01732510|20393745|P1|NOT COMPLETED|Overall Study||1
8270799|NCT01732510|20393739|P7|COMPLETED|Overall Study||0
8270800|NCT01732510|20393740|P6|COMPLETED|Overall Study||0
8270801|NCT01732510|20393741|P5|COMPLETED|Overall Study||3
8270802|NCT01732510|20393742|P4|COMPLETED|Overall Study||5
8270803|NCT01732510|20393743|P3|COMPLETED|Overall Study||4
8270804|NCT01732510|20393744|P2|COMPLETED|Overall Study||4
8270805|NCT01732510|20393745|P1|COMPLETED|Overall Study||8
8270806|NCT01732510|20393739|P7|STARTED|Overall Study||8
8270807|NCT01732510|20393740|P6|STARTED|Overall Study||13
8270808|NCT01732510|20393741|P5|STARTED|Overall Study||8
8270809|NCT01732510|20393742|P4|STARTED|Overall Study||10
8270810|NCT01732510|20393743|P3|STARTED|Overall Study||8
8270811|NCT01732510|20393744|P2|STARTED|Overall Study||9
8270812|NCT01732510|20393745|P1|STARTED|Overall Study||9
8270813|NCT01732484|20393824|P1|NOT COMPLETED|Overall Study||26
8270814|NCT01732484|20393824|P1|COMPLETED|Overall Study||74
8270815|NCT01732484|20393824|P1|Allocation|Overall Study||100
8270816|NCT01732484|20393824|P1|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
8270817|NCT01732484|20393824|P1|STARTED|Overall Study||100
8270818|NCT01732471|20393832|P1|NOT COMPLETED|Overall Study||1
8270819|NCT01732471|20393832|P1|COMPLETED|Overall Study||89
8270820|NCT01732471|20393832|P1|STARTED|Overall Study||90
8270821|NCT01732458|20393843|P4|NOT COMPLETED|Overall Study||2
8270822|NCT01732458|20393844|P3|NOT COMPLETED|Overall Study||3
8270823|NCT01732458|20393845|P2|NOT COMPLETED|Overall Study||5
8270824|NCT01732458|20393846|P1|NOT COMPLETED|Overall Study||3
8270825|NCT01732458|20393843|P4|COMPLETED|Overall Study||50
8270826|NCT01732458|20393844|P3|COMPLETED|Overall Study||55
8270827|NCT01732458|20393845|P2|COMPLETED|Overall Study||53
8270828|NCT01732458|20393846|P1|COMPLETED|Overall Study||57
8270829|NCT01732458|20393843|P4|Treated|Overall Study||52
8270830|NCT01732458|20393844|P3|Treated|Overall Study||56
8270831|NCT01732458|20393845|P2|Treated|Overall Study||55
8270832|NCT01732458|20393846|P1|Treated|Overall Study||57
8270833|NCT01732458|20393843|P4|STARTED|Overall Study||52
8270834|NCT01732458|20393844|P3|STARTED|Overall Study||58
8270835|NCT01732458|20393845|P2|STARTED|Overall Study||58
8270836|NCT01732458|20393846|P1|STARTED|Overall Study||60
8270837|NCT01732445|20393908|P1|NOT COMPLETED|Overall Study||0
8270838|NCT01732445|20393908|P1|COMPLETED|Overall Study||14
8270839|NCT01732445|20393908|P1|STARTED|Overall Study||14
8270840|NCT01732419|20393917|P2|NOT COMPLETED|Overall Study||4
8270841|NCT01732419|20393918|P1|NOT COMPLETED|Overall Study||8
8270842|NCT01732419|20393917|P2|COMPLETED|Overall Study||41
8270843|NCT01732419|20393918|P1|COMPLETED|Overall Study||37
8270844|NCT01732419|20393917|P2|STARTED|Overall Study||45
8270845|NCT01732419|20393918|P1|STARTED|Overall Study||45
8270846|NCT01732406|20393935|P3|NOT COMPLETED|Overall Study||0
8270847|NCT01732406|20393936|P2|NOT COMPLETED|Overall Study||0
8270848|NCT01732406|20393937|P1|NOT COMPLETED|Overall Study||0
8270849|NCT01732406|20393935|P3|COMPLETED|Overall Study||35
8270850|NCT01732406|20393936|P2|COMPLETED|Overall Study||60
8270851|NCT01732406|20393937|P1|COMPLETED|Overall Study||31
8270852|NCT01732406|20393935|P3|STARTED|Overall Study||35
8270853|NCT01732406|20393936|P2|STARTED|Overall Study||60
8270854|NCT01732406|20393937|P1|STARTED|Overall Study||31
8270861|NCT01732211|20393997|P1|NOT COMPLETED|Overall Study||0
8270862|NCT01732211|20393997|P1|COMPLETED|Overall Study||1
8270863|NCT01732211|20393997|P1|STARTED|Overall Study||1
8270864|NCT01732107|20394008|P1|NOT COMPLETED|Overall Study||13
8270865|NCT01732107|20394008|P1|COMPLETED|Overall Study||0
8270866|NCT01732107|20394008|P1|STARTED|Overall Study||13
8270867|NCT01731990|20394025|P2|NOT COMPLETED|Overall Study||8
8270868|NCT01731990|20394026|P1|NOT COMPLETED|Overall Study||4
8270869|NCT01731990|20394025|P2|COMPLETED|Overall Study||12
8270870|NCT01731990|20394026|P1|COMPLETED|Overall Study||14
8270871|NCT01731990|20394025|P2|STARTED|Overall Study||20
8270872|NCT01731990|20394026|P1|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
8270873|NCT01731938|20394042|P2|NOT COMPLETED|Primary Part II||13
8270874|NCT01731938|20394043|P1|NOT COMPLETED|Primary Part II||13
8270875|NCT01731938|20394042|P2|COMPLETED|Primary Part II||95
8270876|NCT01731938|20394043|P1|COMPLETED|Primary Part II||103
8270877|NCT01731938|20394042|P2|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
8270878|NCT01731938|20394043|P1|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
8270879|NCT01731938|20394042|P2|NOT COMPLETED|Preliminary Part I||8
8270880|NCT01731938|20394043|P1|NOT COMPLETED|Preliminary Part I||3
8270881|NCT01731938|20394042|P2|COMPLETED|Preliminary Part I||44
8270882|NCT01731938|20394043|P1|COMPLETED|Preliminary Part I||48
8270883|NCT01731938|20394042|P2|STARTED|Preliminary Part I||52
8270884|NCT01731938|20394043|P1|STARTED|Preliminary Part I||51
8270885|NCT01731912|20394055|P1|NOT COMPLETED|Overall Study||2
8270886|NCT01731912|20394055|P1|COMPLETED|Overall Study||14
8270887|NCT01731912|20394055|P1|STARTED|Overall Study||16
8270888|NCT01731886|20394062|P2|NOT COMPLETED|Overall Study||1
8270889|NCT01731886|20394063|P1|NOT COMPLETED|Overall Study||2
8270890|NCT01731886|20394062|P2|COMPLETED|Overall Study||28
8270891|NCT01731886|20394063|P1|COMPLETED|Overall Study||29
8270892|NCT01731886|20394062|P2|STARTED|Overall Study||29
8270893|NCT01731886|20394063|P1|STARTED|Overall Study||31
8270894|NCT01731691|20394080|P3|NOT COMPLETED|Overall Study||0
8270895|NCT01731691|20394081|P2|NOT COMPLETED|Overall Study||0
8270896|NCT01731691|20394082|P1|NOT COMPLETED|Overall Study||0
8270897|NCT01731691|20394080|P3|COMPLETED|Overall Study||4
8270898|NCT01731691|20394081|P2|COMPLETED|Overall Study||5
8270899|NCT01731691|20394082|P1|COMPLETED|Overall Study||3
8270900|NCT01731691|20394080|P3|STARTED|Overall Study||4
8270901|NCT01731691|20394081|P2|STARTED|Overall Study||5
8270902|NCT01731691|20394082|P1|STARTED|Overall Study||3
8270903|NCT01731678|20394108|P1|NOT COMPLETED|Overall Study||7
8270904|NCT01731678|20394108|P1|COMPLETED|Overall Study||32
8270905|NCT01731678|20394108|P1|STARTED|Overall Study||39
8270906|NCT01731600|20394114|P2|NOT COMPLETED|Overall Study||0
8270907|NCT01731600|20394115|P1|NOT COMPLETED|Overall Study||6
8270908|NCT01731600|20394114|P2|COMPLETED|Overall Study||34
8270909|NCT01731600|20394115|P1|COMPLETED|Overall Study||28
8270910|NCT01731600|20394114|P2|STARTED|Overall Study||34
8270911|NCT01731600|20394115|P1|STARTED|Overall Study||34
8270912|NCT01731470|20394169|P1|NOT COMPLETED|Overall Study||2
8270913|NCT01731470|20394169|P1|COMPLETED|Overall Study|Number of patients enrolled in the study|14
8270914|NCT01731470|20394169|P1|STARTED|Overall Study|Number of patients consented to participate in the study|16
8270915|NCT01731171|20394176|P2|NOT COMPLETED|Overall Study||7
8270916|NCT01731171|20394177|P1|NOT COMPLETED|Overall Study||7
8270917|NCT01731171|20394176|P2|COMPLETED|Overall Study||26
8270918|NCT01731171|20394177|P1|COMPLETED|Overall Study||26
8270919|NCT01731171|20394176|P2|STARTED|Overall Study||33
8270920|NCT01731171|20394177|P1|STARTED|Overall Study||33
8270921|NCT01731119|20394189|P1|NOT COMPLETED|Overall Study||2
8270922|NCT01731119|20394189|P1|COMPLETED|Overall Study||7
8270923|NCT01731119|20394189|P1|STARTED|Overall Study||9
8270924|NCT01731041|20394199|P2|NOT COMPLETED|Overall Study||0
8270925|NCT01731041|20394200|P1|NOT COMPLETED|Overall Study||0
8270926|NCT01731041|20394199|P2|COMPLETED|Overall Study||30
8270927|NCT01731041|20394200|P1|COMPLETED|Overall Study||30
8270928|NCT01731041|20394199|P2|STARTED|Overall Study||30
8270929|NCT01731041|20394200|P1|STARTED|Overall Study||30
8270930|NCT01731002|20394211|P3|NOT COMPLETED|Overall Study||3
8270931|NCT01731002|20394212|P2|NOT COMPLETED|Overall Study||4
8270932|NCT01731002|20394213|P1|NOT COMPLETED|Overall Study||4
8270933|NCT01731002|20394211|P3|COMPLETED|Overall Study||74
8270934|NCT01731002|20394212|P2|COMPLETED|Overall Study||68
8270935|NCT01731002|20394213|P1|COMPLETED|Overall Study||71
8270936|NCT01731002|20394211|P3|STARTED|Overall Study||77
8270937|NCT01731002|20394212|P2|STARTED|Overall Study||72
8270938|NCT01731002|20394213|P1|STARTED|Overall Study||75
8270939|NCT01730950|20394226|P2|NOT COMPLETED|Overall Study||6
8270940|NCT01730950|20394227|P1|NOT COMPLETED|Overall Study||6
8270941|NCT01730950|20394226|P2|COMPLETED|Overall Study||86
8270942|NCT01730950|20394227|P1|COMPLETED|Overall Study||84
8270943|NCT01730950|20394226|P2|Delayed Toxicity Population|Overall Study||83
8270944|NCT01730950|20394227|P1|Delayed Toxicity Population|Overall Study||0
8270945|NCT01730950|20394226|P2|6-month Progression-free Analysis|Overall Study||81
8270946|NCT01730950|20394227|P1|6-month Progression-free Analysis|Overall Study||79
8270947|NCT01730950|20394226|P2|Response Population|Overall Study||77
8270948|NCT01730950|20394227|P1|Response Population|Overall Study||78
8270949|NCT01730950|20394226|P2|Adverse Event Population|Overall Study||83
8270950|NCT01730950|20394227|P1|Adverse Event Population|Overall Study||76
8270951|NCT01730950|20394226|P2|Eligible Population|Overall Study||86
8270952|NCT01730950|20394227|P1|Eligible Population|Overall Study||84
8270953|NCT01730950|20394226|P2|STARTED|Overall Study||92
8270954|NCT01730950|20394227|P1|STARTED|Overall Study||90
8270955|NCT01730872|20394244|P3|NOT COMPLETED|Overall Study||0
8270956|NCT01730872|20394245|P2|NOT COMPLETED|Overall Study||0
8270957|NCT01730872|20394246|P1|NOT COMPLETED|Overall Study||0
8270958|NCT01730872|20394244|P3|COMPLETED|Overall Study||3
8270959|NCT01730872|20394245|P2|COMPLETED|Overall Study||5
8270960|NCT01730872|20394246|P1|COMPLETED|Overall Study||8
8270961|NCT01730872|20394244|P3|Full Analysis Set|Overall Study||0
8270962|NCT01730872|20394245|P2|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4
8270963|NCT01730872|20394246|P1|Full Analysis Set|Overall Study||8
8270964|NCT01730872|20394244|P3|STARTED|Overall Study||3
8270965|NCT01730872|20394245|P2|STARTED|Overall Study||5
8270966|NCT01730872|20394246|P1|STARTED|Overall Study||8
8270967|NCT01730846|20394260|P3|NOT COMPLETED|Overall Study||0
8270968|NCT01730846|20394261|P2|NOT COMPLETED|Overall Study||0
8270969|NCT01730846|20394262|P1|NOT COMPLETED|Overall Study||0
8270970|NCT01730846|20394260|P3|COMPLETED|Overall Study||13
8270971|NCT01730846|20394261|P2|COMPLETED|Overall Study||11
8270972|NCT01730846|20394262|P1|COMPLETED|Overall Study||11
8270973|NCT01730846|20394260|P3|STARTED|Overall Study||13
8270974|NCT01730846|20394261|P2|STARTED|Overall Study||11
8270975|NCT01730846|20394262|P1|STARTED|Overall Study||11
8270976|NCT01730729|20394273|P1|NOT COMPLETED|Overall Study||14
8270977|NCT01730729|20394273|P1|COMPLETED|Overall Study||6
8270978|NCT01730729|20394273|P1|Treated Cycle 3 and Beyond|Overall Study||6
8270979|NCT01730729|20394273|P1|Completed 2 Cycles/Reached 1st Response|Overall Study||18
8270980|NCT01730729|20394273|P1|STARTED|Overall Study||20
8270981|NCT01730586|20394287|P1|NOT COMPLETED|Overall Study||13
8270982|NCT01730586|20394287|P1|COMPLETED|Overall Study||21
8270983|NCT01730586|20394287|P1|STARTED|Overall Study||34
8270984|NCT01730534|20394296|P2|NOT COMPLETED|Overall Study||145
8270985|NCT01730534|20394297|P1|NOT COMPLETED|Overall Study||109
8270986|NCT01730534|20394296|P2|COMPLETED|Overall Study||8433
8270987|NCT01730534|20394297|P1|COMPLETED|Overall Study||8473
8270988|NCT01730534|20394296|P2|STARTED|Overall Study||8578
8270989|NCT01730534|20394297|P1|STARTED|Overall Study||8582
8270990|NCT01730378|20394311|P2|NOT COMPLETED|Overall Study||0
8270991|NCT01730378|20394312|P1|NOT COMPLETED|Overall Study||1
8270992|NCT01730378|20394311|P2|COMPLETED|Overall Study||47
8270993|NCT01730378|20394312|P1|COMPLETED|Overall Study||83
8270994|NCT01730378|20394311|P2|STARTED|Overall Study||47
8270995|NCT01730378|20394312|P1|STARTED|Overall Study||84
8270996|NCT01730339|20394343|P2|NOT COMPLETED|Overall Study||3
8270997|NCT01730339|20394344|P1|NOT COMPLETED|Overall Study||5
8270998|NCT01730339|20394343|P2|COMPLETED|Overall Study||52
8270999|NCT01730339|20394344|P1|COMPLETED|Overall Study||40
8271000|NCT01730339|20394343|P2|STARTED|Overall Study||55
8271001|NCT01730339|20394344|P1|STARTED|Overall Study||45
8271002|NCT01730053|20394384|P6|NOT COMPLETED|Overall Study||13
8271003|NCT01730053|20394385|P5|NOT COMPLETED|Overall Study||9
8271004|NCT01730053|20394386|P4|NOT COMPLETED|Overall Study||8
8271005|NCT01730053|20394387|P3|NOT COMPLETED|Overall Study||11
8271006|NCT01730053|20394388|P2|NOT COMPLETED|Overall Study||14
8271007|NCT01730053|20394389|P1|NOT COMPLETED|Overall Study||5
8271008|NCT01730053|20394384|P6|COMPLETED|Overall Study||41
8271009|NCT01730053|20394385|P5|COMPLETED|Overall Study||44
8271010|NCT01730053|20394386|P4|COMPLETED|Overall Study||45
8271011|NCT01730053|20394387|P3|COMPLETED|Overall Study||38
8271012|NCT01730053|20394388|P2|COMPLETED|Overall Study||34
8271013|NCT01730053|20394389|P1|COMPLETED|Overall Study||43
8271014|NCT01730053|20394384|P6|Treated|Overall Study||54
8271015|NCT01730053|20394385|P5|Treated|Overall Study||53
8271016|NCT01730053|20394386|P4|Treated|Overall Study||53
8271017|NCT01730053|20394387|P3|Treated|Overall Study||49
8271018|NCT01730053|20394388|P2|Treated|Overall Study||48
8271019|NCT01730053|20394389|P1|Treated|Overall Study||48
8271020|NCT01730053|20394384|P6|STARTED|Overall Study||54
8271021|NCT01730053|20394385|P5|STARTED|Overall Study||53
8271022|NCT01730053|20394386|P4|STARTED|Overall Study||53
8271023|NCT01730053|20394387|P3|STARTED|Overall Study||49
8271024|NCT01730053|20394388|P2|STARTED|Overall Study||48
8271025|NCT01730053|20394389|P1|STARTED|Overall Study||48
8271026|NCT01730040|20394548|P7|NOT COMPLETED|Overall Study||9
8271027|NCT01730040|20394549|P6|NOT COMPLETED|Overall Study||7
8271028|NCT01730040|20394550|P5|NOT COMPLETED|Overall Study||6
8271029|NCT01730040|20394551|P4|NOT COMPLETED|Overall Study||8
8271030|NCT01730040|20394552|P3|NOT COMPLETED|Overall Study||11
8271031|NCT01730040|20394553|P2|NOT COMPLETED|Overall Study||15
8271032|NCT01730040|20394554|P1|NOT COMPLETED|Overall Study||13
8271033|NCT01730040|20394548|P7|COMPLETED|Overall Study||38
8271034|NCT01730040|20394549|P6|COMPLETED|Overall Study||40
8271035|NCT01730040|20394550|P5|COMPLETED|Overall Study||39
8271036|NCT01730040|20394551|P4|COMPLETED|Overall Study||39
8271037|NCT01730040|20394552|P3|COMPLETED|Overall Study||46
8271038|NCT01730040|20394553|P2|COMPLETED|Overall Study||40
8271039|NCT01730040|20394554|P1|COMPLETED|Overall Study||44
8271040|NCT01730040|20394548|P7|Treated|Overall Study||47
8271041|NCT01730040|20394549|P6|Treated|Overall Study||46
8271042|NCT01730040|20394550|P5|Treated|Overall Study||45
8271043|NCT01730040|20394551|P4|Treated|Overall Study||47
8271044|NCT01730040|20394552|P3|Treated|Overall Study||57
8271045|NCT01730040|20394553|P2|Treated|Overall Study||55
8271046|NCT01730040|20394554|P1|Treated|Overall Study||57
8271047|NCT01730040|20394548|P7|STARTED|Overall Study||47
8271048|NCT01730040|20394549|P6|STARTED|Overall Study||47
8271049|NCT01730040|20394550|P5|STARTED|Overall Study||45
8271050|NCT01730040|20394551|P4|STARTED|Overall Study||47
8271051|NCT01730040|20394552|P3|STARTED|Overall Study||57
8271052|NCT01730040|20394553|P2|STARTED|Overall Study||55
8271053|NCT01730040|20394554|P1|STARTED|Overall Study||57
8271054|NCT01729923|20394731|P1|NOT COMPLETED|Overall Study||27
8271055|NCT01729923|20394731|P1|COMPLETED|Overall Study||0
8271056|NCT01729923|20394731|P1|STARTED|Overall Study||27
8271057|NCT01729871|20394743|P2|NOT COMPLETED|Overall Study||23
8271058|NCT01729871|20394744|P1|NOT COMPLETED|Overall Study||12
8271059|NCT01729871|20394743|P2|COMPLETED|Overall Study||101
8271060|NCT01729871|20394744|P1|COMPLETED|Overall Study||112
8271061|NCT01729871|20394743|P2|STARTED|Overall Study||124
8271062|NCT01729871|20394744|P1|STARTED|Overall Study||124
8271063|NCT01729845|20394763|P3|NOT COMPLETED|Efficacy of Dec/MEC||0
8271064|NCT01729845|20394764|P2|NOT COMPLETED|Efficacy of Dec/MEC||0
8271065|NCT01729845|20394765|P1|NOT COMPLETED|Efficacy of Dec/MEC||0
8271066|NCT01729845|20394763|P3|COMPLETED|Efficacy of Dec/MEC||0
8271067|NCT01729845|20394764|P2|COMPLETED|Efficacy of Dec/MEC||22
8271068|NCT01729845|20394765|P1|COMPLETED|Efficacy of Dec/MEC||0
8271069|NCT01729845|20394763|P3|STARTED|Efficacy of Dec/MEC||0
8271070|NCT01729845|20394764|P2|STARTED|Efficacy of Dec/MEC||22
8271071|NCT01729845|20394765|P1|STARTED|Efficacy of Dec/MEC||0
8271072|NCT01729845|20394763|P3|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
8271073|NCT01729845|20394764|P2|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
8271074|NCT01729845|20394765|P1|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
8271075|NCT01729845|20394763|P3|COMPLETED|Safety/Tolerability of Dec/MEC||12
8271076|NCT01729845|20394764|P2|COMPLETED|Safety/Tolerability of Dec/MEC||34
8271077|NCT01729845|20394765|P1|COMPLETED|Safety/Tolerability of Dec/MEC||6
8271078|NCT01729845|20394763|P3|STARTED|Safety/Tolerability of Dec/MEC||12
8271079|NCT01729845|20394764|P2|STARTED|Safety/Tolerability of Dec/MEC||34
8271080|NCT01729845|20394765|P1|STARTED|Safety/Tolerability of Dec/MEC||6
8271081|NCT01729819|20394778|P2|NOT COMPLETED|Overall Study||7
8271082|NCT01729819|20394779|P1|NOT COMPLETED|Overall Study||6
8271083|NCT01729819|20394778|P2|COMPLETED|Overall Study||50
8271084|NCT01729819|20394779|P1|COMPLETED|Overall Study||43
8271085|NCT01729819|20394778|P2|STARTED|Overall Study||57
8271086|NCT01729819|20394779|P1|STARTED|Overall Study||49
8271177|NCT01729728|20395014|P3|NOT COMPLETED|Overall Study||1
8271178|NCT01729728|20395015|P2|NOT COMPLETED|Overall Study||6
8271179|NCT01729728|20395016|P1|NOT COMPLETED|Overall Study||1
8271180|NCT01729728|20395014|P3|COMPLETED|Overall Study||16
8271181|NCT01729728|20395015|P2|COMPLETED|Overall Study||22
8271182|NCT01729728|20395016|P1|COMPLETED|Overall Study||20
8271183|NCT01729728|20395014|P3|STARTED|Overall Study||17
8271184|NCT01729728|20395015|P2|STARTED|Overall Study||28
8271185|NCT01729728|20395016|P1|STARTED|Overall Study||21
8271186|NCT01729598|20395149|P2|NOT COMPLETED|Overall Study||0
8271187|NCT01729598|20395150|P1|NOT COMPLETED|Overall Study||0
8271188|NCT01729598|20395149|P2|COMPLETED|Overall Study||4
8271189|NCT01729598|20395150|P1|COMPLETED|Overall Study||10
8271190|NCT01729598|20395149|P2|STARTED|Overall Study||4
8271191|NCT01729598|20395150|P1|STARTED|Overall Study||10
8271192|NCT01729559|20395166|P2|NOT COMPLETED|Overall Study||28
8271193|NCT01729559|20395167|P1|NOT COMPLETED|Overall Study||31
8271194|NCT01729559|20395166|P2|COMPLETED|Overall Study||216
8271195|NCT01729559|20395167|P1|COMPLETED|Overall Study||220
8271196|NCT01729559|20395166|P2|STARTED|Overall Study||244
8271197|NCT01729559|20395167|P1|STARTED|Overall Study||251
8271198|NCT01729338|20395179|P1|NOT COMPLETED|Overall Study||2
8271199|NCT01729338|20395179|P1|COMPLETED|Overall Study||14
8271200|NCT01729338|20395179|P1|STARTED|Overall Study||16
8271201|NCT01729247|20395194|P1|NOT COMPLETED|Overall Study||0
8271202|NCT01729247|20395194|P1|COMPLETED|Overall Study||50
8271203|NCT01729247|20395194|P1|STARTED|Overall Study||50
8271204|NCT01729208|20395210|P2|NOT COMPLETED|36 Months Follow-up||4
8271205|NCT01729208|20395211|P1|NOT COMPLETED|36 Months Follow-up||3
8271206|NCT01729208|20395210|P2|COMPLETED|36 Months Follow-up||56
8271207|NCT01729208|20395211|P1|COMPLETED|36 Months Follow-up||52
8271208|NCT01729208|20395210|P2|STARTED|36 Months Follow-up||60
8271209|NCT01729208|20395211|P1|STARTED|36 Months Follow-up||55
8271210|NCT01729208|20395210|P2|NOT COMPLETED|24 Months Follow-up||0
8271211|NCT01729208|20395211|P1|NOT COMPLETED|24 Months Follow-up||3
8271212|NCT01729208|20395210|P2|COMPLETED|24 Months Follow-up||60
8271213|NCT01729208|20395211|P1|COMPLETED|24 Months Follow-up||55
8271214|NCT01729208|20395210|P2|STARTED|24 Months Follow-up||60
8271215|NCT01729208|20395211|P1|STARTED|24 Months Follow-up||58
8271216|NCT01729208|20395210|P2|NOT COMPLETED|12 Months Follow-up||10
8271217|NCT01729208|20395211|P1|NOT COMPLETED|12 Months Follow-up||7
8271218|NCT01729208|20395210|P2|COMPLETED|12 Months Follow-up||60
8271219|NCT01729208|20395211|P1|COMPLETED|12 Months Follow-up||58
8271220|NCT01729208|20395210|P2|STARTED|12 Months Follow-up||70
8271221|NCT01729208|20395211|P1|STARTED|12 Months Follow-up||65
8271222|NCT01729208|20395210|P2|NOT COMPLETED|Baseline||4
8271223|NCT01729208|20395211|P1|NOT COMPLETED|Baseline||5
8271224|NCT01729208|20395210|P2|COMPLETED|Baseline||70
8271225|NCT01729208|20395211|P1|COMPLETED|Baseline||65
8271226|NCT01729208|20395210|P2|STARTED|Baseline||74
8271227|NCT01729208|20395211|P1|STARTED|Baseline||70
8271228|NCT01729156|20395244|P3|NOT COMPLETED|Overall Study||0
8271229|NCT01729156|20395245|P2|NOT COMPLETED|Overall Study||0
8271230|NCT01729156|20395246|P1|NOT COMPLETED|Overall Study||1
8271231|NCT01729156|20395244|P3|COMPLETED|Overall Study||12
8271232|NCT01729156|20395245|P2|COMPLETED|Overall Study||12
8271233|NCT01729156|20395246|P1|COMPLETED|Overall Study||11
8271234|NCT01729156|20395244|P3|STARTED|Overall Study||12
8271235|NCT01729156|20395245|P2|STARTED|Overall Study||12
8271236|NCT01729156|20395246|P1|STARTED|Overall Study||12
8271237|NCT01729039|20395274|P2|NOT COMPLETED|Overall Study||12
8271238|NCT01729039|20395275|P1|NOT COMPLETED|Overall Study||10
8271239|NCT01729039|20395274|P2|COMPLETED|Overall Study||14
8271240|NCT01729039|20395275|P1|COMPLETED|Overall Study||13
8271241|NCT01729039|20395274|P2|STARTED|Overall Study||26
8271242|NCT01729039|20395275|P1|STARTED|Overall Study||23
8271243|NCT01729026|20395291|P2|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
8271244|NCT01729026|20395292|P1|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
8271245|NCT01729026|20395291|P2|COMPLETED|3-month to 6-month (Final) Follow-up||6
8271246|NCT01729026|20395292|P1|COMPLETED|3-month to 6-month (Final) Follow-up||6
8271247|NCT01729026|20395291|P2|STARTED|3-month to 6-month (Final) Follow-up||8
8271248|NCT01729026|20395292|P1|STARTED|3-month to 6-month (Final) Follow-up||7
8271249|NCT01729026|20395291|P2|NOT COMPLETED|Randomization to 3-month Follow-up||2
8271250|NCT01729026|20395292|P1|NOT COMPLETED|Randomization to 3-month Follow-up||2
8271251|NCT01729026|20395291|P2|COMPLETED|Randomization to 3-month Follow-up||8
8271252|NCT01729026|20395292|P1|COMPLETED|Randomization to 3-month Follow-up||7
8271253|NCT01729026|20395291|P2|STARTED|Randomization to 3-month Follow-up||10
8271254|NCT01729026|20395292|P1|STARTED|Randomization to 3-month Follow-up||9
8271255|NCT01728844|20395324|P4|NOT COMPLETED|Overall Study||2
8271256|NCT01728844|20395325|P3|NOT COMPLETED|Overall Study||0
8271257|NCT01728844|20395326|P2|NOT COMPLETED|Overall Study||0
8271258|NCT01728844|20395327|P1|NOT COMPLETED|Overall Study||1
8271259|NCT01728844|20395324|P4|COMPLETED|Overall Study||21
8271260|NCT01728844|20395325|P3|COMPLETED|Overall Study||22
8271261|NCT01728844|20395326|P2|COMPLETED|Overall Study||21
8271262|NCT01728844|20395327|P1|COMPLETED|Overall Study||21
8271263|NCT01728844|20395324|P4|STARTED|Overall Study||23
8271264|NCT01728844|20395325|P3|STARTED|Overall Study||22
8271265|NCT01728844|20395326|P2|STARTED|Overall Study||21
8271266|NCT01728844|20395327|P1|STARTED|Overall Study||22
8271285|NCT01728792|20395395|P5|NOT COMPLETED|Overall Study||0
8271286|NCT01728792|20395396|P4|NOT COMPLETED|Overall Study||3
8271287|NCT01728792|20395397|P3|NOT COMPLETED|Overall Study||4
8271288|NCT01728792|20395398|P2|NOT COMPLETED|Overall Study||2
8271289|NCT01728792|20395399|P1|NOT COMPLETED|Overall Study||3
8271290|NCT01728792|20395395|P5|COMPLETED|Overall Study||16
8271291|NCT01728792|20395396|P4|COMPLETED|Overall Study||14
8271292|NCT01728792|20395397|P3|COMPLETED|Overall Study||13
8271293|NCT01728792|20395398|P2|COMPLETED|Overall Study||14
8271294|NCT01728792|20395399|P1|COMPLETED|Overall Study||11
8271295|NCT01728792|20395395|P5|STARTED|Overall Study||16
8271296|NCT01728792|20395396|P4|STARTED|Overall Study||17
8271297|NCT01728792|20395397|P3|STARTED|Overall Study||17
8271298|NCT01728792|20395398|P2|STARTED|Overall Study||16
8271299|NCT01728792|20395399|P1|STARTED|Overall Study||14
8271300|NCT01728636|20395448|P2|NOT COMPLETED|Overall Study||0
8271301|NCT01728636|20395449|P1|NOT COMPLETED|Overall Study||0
8271302|NCT01728636|20395448|P2|COMPLETED|Overall Study||30
8271303|NCT01728636|20395449|P1|COMPLETED|Overall Study||31
8271304|NCT01728636|20395448|P2|STARTED|Overall Study||30
8271305|NCT01728636|20395449|P1|STARTED|Overall Study||31
8271306|NCT01728623|20395468|P1|NOT COMPLETED|Overall Study||28
8271307|NCT01728623|20395468|P1|COMPLETED|Overall Study||23
8271308|NCT01728623|20395468|P1|ATC|Overall Study||17
8271309|NCT01728623|20395468|P1|MTC|Overall Study||9
8271310|NCT01728623|20395468|P1|DTC|Overall Study||25
8271311|NCT01728623|20395468|P1|STARTED|Overall Study||51
8271312|NCT01728584|20395494|P4|NOT COMPLETED|Overall Study||1
8271313|NCT01728584|20395495|P3|NOT COMPLETED|Overall Study||1
8271314|NCT01728584|20395496|P2|NOT COMPLETED|Overall Study||0
8271315|NCT01728584|20395497|P1|NOT COMPLETED|Overall Study||8
8271316|NCT01728584|20395494|P4|COMPLETED|Overall Study||29
8271317|NCT01728584|20395495|P3|COMPLETED|Overall Study||30
8271318|NCT01728584|20395496|P2|COMPLETED|Overall Study||30
8271319|NCT01728584|20395497|P1|COMPLETED|Overall Study||28
8271320|NCT01728584|20395494|P4|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
8271321|NCT01728584|20395495|P3|STARTED|Overall Study|Randomized|31
8271322|NCT01728584|20395496|P2|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
8271323|NCT01728584|20395497|P1|STARTED|Overall Study|Randomized|36
8271324|NCT01728454|20395552|P3|NOT COMPLETED|Stage 3||4
8271325|NCT01728454|20395553|P2|NOT COMPLETED|Stage 3||4
8271326|NCT01728454|20395554|P1|NOT COMPLETED|Stage 3||3
8271327|NCT01728454|20395552|P3|COMPLETED|Stage 3||7
8271328|NCT01728454|20395553|P2|COMPLETED|Stage 3||1
8271329|NCT01728454|20395554|P1|COMPLETED|Stage 3||3
8271330|NCT01728454|20395552|P3|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11
8271331|NCT01728454|20395553|P2|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5
8271332|NCT01728454|20395554|P1|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6
8271333|NCT01728454|20395552|P3|NOT COMPLETED|Stage 1 and 2||4
8271334|NCT01728454|20395553|P2|NOT COMPLETED|Stage 1 and 2||4
8271335|NCT01728454|20395554|P1|NOT COMPLETED|Stage 1 and 2||5
8271336|NCT01728454|20395552|P3|COMPLETED|Stage 1 and 2||19
8271337|NCT01728454|20395553|P2|COMPLETED|Stage 1 and 2||16
8271338|NCT01728454|20395554|P1|COMPLETED|Stage 1 and 2||12
8271339|NCT01728454|20395552|P3|STARTED|Stage 1 and 2||23
8271340|NCT01728454|20395553|P2|STARTED|Stage 1 and 2||20
8271341|NCT01728454|20395554|P1|STARTED|Stage 1 and 2||17
8271342|NCT01728376|20395604|P6|NOT COMPLETED|Overall Study||2
8271343|NCT01728376|20395605|P5|NOT COMPLETED|Overall Study||2
8271344|NCT01728376|20395606|P4|NOT COMPLETED|Overall Study||2
8271345|NCT01728376|20395607|P3|NOT COMPLETED|Overall Study||2
8271346|NCT01728376|20395608|P2|NOT COMPLETED|Overall Study||2
8271347|NCT01728376|20395609|P1|NOT COMPLETED|Overall Study||4
8271348|NCT01728376|20395604|P6|COMPLETED|Overall Study||5
8271349|NCT01728376|20395605|P5|COMPLETED|Overall Study||12
8271350|NCT01728376|20395606|P4|COMPLETED|Overall Study||7
8271351|NCT01728376|20395607|P3|COMPLETED|Overall Study||17
8271352|NCT01728376|20395608|P2|COMPLETED|Overall Study||9
8271353|NCT01728376|20395609|P1|COMPLETED|Overall Study||18
8271354|NCT01728376|20395604|P6|Treated|Overall Study||7
8271355|NCT01728376|20395605|P5|Treated|Overall Study||14
8271356|NCT01728376|20395606|P4|Treated|Overall Study||9
8271357|NCT01728376|20395607|P3|Treated|Overall Study||19
8271358|NCT01728376|20395608|P2|Treated|Overall Study||10
8271359|NCT01728376|20395609|P1|Treated|Overall Study||22
8271360|NCT01728376|20395604|P6|STARTED|Overall Study||7
8271361|NCT01728376|20395605|P5|STARTED|Overall Study||14
8271362|NCT01728376|20395606|P4|STARTED|Overall Study||9
8271363|NCT01728376|20395607|P3|STARTED|Overall Study||19
8271364|NCT01728376|20395608|P2|STARTED|Overall Study||11
8271365|NCT01728376|20395609|P1|STARTED|Overall Study||22
8271366|NCT01728337|20395671|P1|NOT COMPLETED|Overall Study||0
8271367|NCT01728337|20395671|P1|COMPLETED|Overall Study||80
8271368|NCT01728337|20395671|P1|STARTED|Overall Study||80
8271369|NCT01728324|20395682|P3|NOT COMPLETED|Termination of RBV||15
8271370|NCT01728324|20395683|P2|NOT COMPLETED|Termination of RBV||37
8271371|NCT01728324|20395684|P1|NOT COMPLETED|Termination of RBV||39
8271372|NCT01728324|20395682|P3|COMPLETED|Termination of RBV||57
8271373|NCT01728324|20395683|P2|COMPLETED|Termination of RBV||176
8271374|NCT01728324|20395684|P1|COMPLETED|Termination of RBV||172
8271375|NCT01728324|20395682|P3|STARTED|Termination of RBV||72
8271376|NCT01728324|20395683|P2|STARTED|Termination of RBV||213
8271377|NCT01728324|20395684|P1|STARTED|Termination of RBV||211
8271378|NCT01728324|20395682|P3|NOT COMPLETED|Termination of FDV||14
8271379|NCT01728324|20395683|P2|NOT COMPLETED|Termination of FDV||36
8271380|NCT01728324|20395684|P1|NOT COMPLETED|Termination of FDV||38
8271381|NCT01728324|20395682|P3|COMPLETED|Termination of FDV||58
8271382|NCT01728324|20395683|P2|COMPLETED|Termination of FDV||177
8271383|NCT01728324|20395684|P1|COMPLETED|Termination of FDV||173
8271384|NCT01728324|20395682|P3|STARTED|Termination of FDV||72
8271385|NCT01728324|20395683|P2|STARTED|Termination of FDV||213
8271386|NCT01728324|20395684|P1|STARTED|Termination of FDV||211
8271387|NCT01728324|20395682|P3|NOT COMPLETED|Termination of DBV||14
8271388|NCT01728324|20395683|P2|NOT COMPLETED|Termination of DBV||36
8271389|NCT01728324|20395684|P1|NOT COMPLETED|Termination of DBV||38
8271390|NCT01728324|20395682|P3|COMPLETED|Termination of DBV||58
8271391|NCT01728324|20395683|P2|COMPLETED|Termination of DBV||177
8271392|NCT01728324|20395684|P1|COMPLETED|Termination of DBV||173
8271393|NCT01728324|20395682|P3|STARTED|Termination of DBV||72
8271394|NCT01728324|20395683|P2|STARTED|Termination of DBV||213
8271395|NCT01728324|20395684|P1|STARTED|Termination of DBV||211
8271396|NCT01728246|20395705|P2|NOT COMPLETED|Overall Study||36
8271397|NCT01728246|20395706|P1|NOT COMPLETED|Overall Study||36
8271398|NCT01728246|20395705|P2|COMPLETED|Overall Study||195
8271399|NCT01728246|20395706|P1|COMPLETED|Overall Study||206
8271400|NCT01728246|20395705|P2|STARTED|Overall Study||231
8271401|NCT01728246|20395706|P1|STARTED|Overall Study||242
8271402|NCT01728194|20395724|P2|NOT COMPLETED|Overall Study||6
8271403|NCT01728194|20395725|P1|NOT COMPLETED|Overall Study||20
8271404|NCT01728194|20395724|P2|COMPLETED|Overall Study||61
8271405|NCT01728194|20395725|P1|COMPLETED|Overall Study||34
8271406|NCT01728194|20395724|P2|STARTED|Overall Study||67
8271407|NCT01728194|20395725|P1|STARTED|Overall Study||54
8271408|NCT01728116|20395735|P2|NOT COMPLETED|Overall Study||47
8271409|NCT01728116|20395736|P1|NOT COMPLETED|Overall Study||161
8271410|NCT01728116|20395735|P2|COMPLETED|Overall Study|Completed to Week 52|60
8271411|NCT01728116|20395736|P1|COMPLETED|Overall Study|Completed to Week 78|52
8271412|NCT01728116|20395735|P2|STARTED|Overall Study|Sham mITT subjects|107
8271413|NCT01728116|20395736|P1|STARTED|Overall Study|EndoBarrier mITT Subjects|213
8271414|NCT01728077|20395761|P2|NOT COMPLETED|Overall Study||5
8271415|NCT01728077|20395762|P1|NOT COMPLETED|Overall Study||8
8271416|NCT01728077|20395761|P2|COMPLETED|Overall Study||2
8271417|NCT01728077|20395762|P1|COMPLETED|Overall Study||11
8271418|NCT01728077|20395761|P2|STARTED|Overall Study||7
8271419|NCT01728077|20395762|P1|STARTED|Overall Study||19
8271420|NCT01727895|20395777|P2|NOT COMPLETED|Overall Study||0
8271421|NCT01727895|20395778|P1|NOT COMPLETED|Overall Study||0
8271422|NCT01727895|20395777|P2|COMPLETED|Overall Study||5
8271423|NCT01727895|20395778|P1|COMPLETED|Overall Study||10
8271424|NCT01727895|20395777|P2|STARTED|Overall Study||5
8271425|NCT01727895|20395778|P1|STARTED|Overall Study||10
8271426|NCT01727765|20395786|P2|NOT COMPLETED|Overall Study||0
8271427|NCT01727765|20395787|P1|NOT COMPLETED|Overall Study||0
8271428|NCT01727765|20395786|P2|COMPLETED|Overall Study||8
8271429|NCT01727765|20395787|P1|COMPLETED|Overall Study||8
8271430|NCT01727765|20395786|P2|STARTED|Overall Study||8
8271431|NCT01727765|20395787|P1|STARTED|Overall Study||8
8271432|NCT01727726|20395796|P3|NOT COMPLETED|Overall Study||20
8271433|NCT01727726|20395797|P2|NOT COMPLETED|Overall Study||14
8271434|NCT01727726|20395798|P1|NOT COMPLETED|Overall Study||26
8271435|NCT01727726|20395796|P3|COMPLETED|Overall Study||186
8271436|NCT01727726|20395797|P2|COMPLETED|Overall Study||86
8271437|NCT01727726|20395798|P1|COMPLETED|Overall Study||171
8271438|NCT01727726|20395796|P3|STARTED|Overall Study||206
8271439|NCT01727726|20395797|P2|STARTED|Overall Study||100
8271440|NCT01727726|20395798|P1|STARTED|Overall Study||197
8271441|NCT01727713|20395830|P1|NOT COMPLETED|Overall Study||35
8271442|NCT01727713|20395830|P1|COMPLETED|Overall Study||75
8271443|NCT01727713|20395830|P1|STARTED|Overall Study||110
8271444|NCT01727700|20395857|P3|NOT COMPLETED|Overall Study||2
8271445|NCT01727700|20395858|P2|NOT COMPLETED|Overall Study||10
8271446|NCT01727700|20395859|P1|NOT COMPLETED|Overall Study||2
8271447|NCT01727700|20395857|P3|COMPLETED|Overall Study||42
8271448|NCT01727700|20395858|P2|COMPLETED|Overall Study||35
8271449|NCT01727700|20395859|P1|COMPLETED|Overall Study||42
8271450|NCT01727700|20395857|P3|STARTED|Overall Study||44
8271451|NCT01727700|20395858|P2|STARTED|Overall Study||45
8271452|NCT01727700|20395859|P1|STARTED|Overall Study||44
8271453|NCT01727505|20395882|P2|NOT COMPLETED|Second 24 Hours||1
8271454|NCT01727505|20395883|P1|NOT COMPLETED|Second 24 Hours||0
8271455|NCT01727505|20395882|P2|COMPLETED|Second 24 Hours||10
8271456|NCT01727505|20395883|P1|COMPLETED|Second 24 Hours||14
8271457|NCT01727505|20395882|P2|STARTED|Second 24 Hours||11
8271458|NCT01727505|20395883|P1|STARTED|Second 24 Hours||14
8271459|NCT01727505|20395882|P2|NOT COMPLETED|First 24 Hours||1
8271460|NCT01727505|20395883|P1|NOT COMPLETED|First 24 Hours||0
8271461|NCT01727505|20395882|P2|COMPLETED|First 24 Hours||11
8271462|NCT01727505|20395883|P1|COMPLETED|First 24 Hours||14
8271463|NCT01727505|20395882|P2|STARTED|First 24 Hours||12
8271464|NCT01727505|20395883|P1|STARTED|First 24 Hours||14
8271471|NCT01727297|20395908|P2|NOT COMPLETED|Overall Study||51
8271472|NCT01727297|20395909|P1|NOT COMPLETED|Overall Study||102
8271473|NCT01727297|20395908|P2|COMPLETED|Overall Study||0
8271474|NCT01727297|20395909|P1|COMPLETED|Overall Study||293
8271475|NCT01727297|20395908|P2|STARTED|Overall Study||51
8271476|NCT01727297|20395909|P1|STARTED|Overall Study||395
8271477|NCT01727258|20395925|P3|NOT COMPLETED|Overall Study||1
8271478|NCT01727258|20395926|P2|NOT COMPLETED|Overall Study||3
8271479|NCT01727258|20395927|P1|NOT COMPLETED|Overall Study||2
8271480|NCT01727258|20395925|P3|COMPLETED|Overall Study||50
8271481|NCT01727258|20395926|P2|COMPLETED|Overall Study||48
8271482|NCT01727258|20395927|P1|COMPLETED|Overall Study||49
8271483|NCT01727258|20395925|P3|STARTED|Overall Study||51
8271484|NCT01727258|20395926|P2|STARTED|Overall Study||51
8271485|NCT01727258|20395927|P1|STARTED|Overall Study||51
8271486|NCT01727180|20395950|P1|NOT COMPLETED|Overall Study||0
8271487|NCT01727180|20395950|P1|COMPLETED|Overall Study||108
8271488|NCT01727180|20395950|P1|STARTED|Overall Study||108
8271489|NCT01727167|20395956|P2|NOT COMPLETED|Overall Study||0
8271490|NCT01727167|20395957|P1|NOT COMPLETED|Overall Study||0
8271491|NCT01727167|20395956|P2|COMPLETED|Overall Study||0
8271492|NCT01727167|20395957|P1|COMPLETED|Overall Study||1
8271493|NCT01727167|20395956|P2|STARTED|Overall Study||0
8271494|NCT01727167|20395957|P1|STARTED|Overall Study||1
8271495|NCT01727154|20395965|P1|NOT COMPLETED|Overall Study||59
8271496|NCT01727154|20395965|P1|COMPLETED|Overall Study||80
8271497|NCT01727154|20395965|P1|STARTED|Overall Study||139
8271498|NCT01727141|20395973|P4|NOT COMPLETED|Overall Study||15
8271499|NCT01727141|20395974|P3|NOT COMPLETED|Overall Study||3
8271500|NCT01727141|20395975|P2|NOT COMPLETED|Overall Study||9
8271501|NCT01727141|20395976|P1|NOT COMPLETED|Overall Study||5
8271502|NCT01727141|20395973|P4|COMPLETED|Overall Study||246
8271503|NCT01727141|20395974|P3|COMPLETED|Overall Study||258
8271504|NCT01727141|20395975|P2|COMPLETED|Overall Study||251
8271505|NCT01727141|20395976|P1|COMPLETED|Overall Study||255
8271506|NCT01727141|20395973|P4|Full Analysis Set|Overall Study||261
8271507|NCT01727141|20395974|P3|Full Analysis Set|Overall Study||261
8271508|NCT01727141|20395975|P2|Full Analysis Set|Overall Study||260
8271509|NCT01727141|20395976|P1|Full Analysis Set|Overall Study||258
8271510|NCT01727141|20395973|P4|Safety Set|Overall Study||260
8271511|NCT01727141|20395974|P3|Safety Set|Overall Study||262
8271512|NCT01727141|20395975|P2|Safety Set|Overall Study||260
8271513|NCT01727141|20395976|P1|Safety Set|Overall Study||258
8271514|NCT01727141|20395973|P4|STARTED|Overall Study||261
8271515|NCT01727141|20395974|P3|STARTED|Overall Study||261
8271516|NCT01727141|20395975|P2|STARTED|Overall Study||260
8271517|NCT01727141|20395976|P1|STARTED|Overall Study||260
8271518|NCT01727089|20396028|P2|NOT COMPLETED|Overall Study||0
8271519|NCT01727089|20396029|P1|NOT COMPLETED|Overall Study||0
8271520|NCT01727089|20396028|P2|COMPLETED|Overall Study||30
8271521|NCT01727089|20396029|P1|COMPLETED|Overall Study||29
8271522|NCT01727089|20396028|P2|STARTED|Overall Study||30
8271523|NCT01727089|20396029|P1|STARTED|Overall Study||29
8271524|NCT01727024|20396041|P2|NOT COMPLETED|Period 2||0
8271525|NCT01727024|20396042|P1|NOT COMPLETED|Period 2||0
8271526|NCT01727024|20396041|P2|COMPLETED|Period 2||64
8271527|NCT01727024|20396042|P1|COMPLETED|Period 2||68
8271528|NCT01727024|20396041|P2|STARTED|Period 2||64
8271529|NCT01727024|20396042|P1|STARTED|Period 2||68
8271530|NCT01727024|20396041|P2|NOT COMPLETED|Period 1||4
8271531|NCT01727024|20396042|P1|NOT COMPLETED|Period 1||3
8271532|NCT01727024|20396041|P2|COMPLETED|Period 1||64
8271533|NCT01727024|20396042|P1|COMPLETED|Period 1||68
8271534|NCT01727024|20396041|P2|STARTED|Period 1||68
8271535|NCT01727024|20396042|P1|STARTED|Period 1||71
8271536|NCT01726803|20396057|P2|NOT COMPLETED|Overall Study||1
8271537|NCT01726803|20396058|P1|NOT COMPLETED|Overall Study||7
8271538|NCT01726803|20396057|P2|COMPLETED|Overall Study||107
8271539|NCT01726803|20396058|P1|COMPLETED|Overall Study||105
8271540|NCT01726803|20396057|P2|STARTED|Overall Study||108
8271541|NCT01726803|20396058|P1|STARTED|Overall Study||112
8271542|NCT01726738|20396078|P1|NOT COMPLETED|Overall Study||0
8271543|NCT01726738|20396078|P1|COMPLETED|Overall Study||17
8271544|NCT01726738|20396078|P1|STARTED|Overall Study||17
8271551|NCT01726621|20396101|P1|NOT COMPLETED|Overall Study||4
8271552|NCT01726621|20396101|P1|COMPLETED|Overall Study||51
8271553|NCT01726621|20396101|P1|STARTED|Overall Study||55
8271554|NCT01726517|20396110|P5|NOT COMPLETED|Overall Study||0
8271555|NCT01726517|20396111|P4|NOT COMPLETED|Overall Study||0
8271556|NCT01726517|20396112|P3|NOT COMPLETED|Overall Study||1
8271557|NCT01726517|20396113|P2|NOT COMPLETED|Overall Study||0
8271558|NCT01726517|20396114|P1|NOT COMPLETED|Overall Study||0
8271559|NCT01726517|20396110|P5|COMPLETED|Overall Study||21
8271560|NCT01726517|20396111|P4|COMPLETED|Overall Study||19
8271561|NCT01726517|20396112|P3|COMPLETED|Overall Study||18
8271562|NCT01726517|20396113|P2|COMPLETED|Overall Study||21
8271563|NCT01726517|20396114|P1|COMPLETED|Overall Study||20
8271564|NCT01726517|20396110|P5|STARTED|Overall Study||21
8271565|NCT01726517|20396111|P4|STARTED|Overall Study||19
8271566|NCT01726517|20396112|P3|STARTED|Overall Study||19
8271567|NCT01726517|20396113|P2|STARTED|Overall Study||21
8271568|NCT01726517|20396114|P1|STARTED|Overall Study||20
8271569|NCT01726504|20396143|P2|NOT COMPLETED|Overall Study||28
8271570|NCT01726504|20396144|P1|NOT COMPLETED|Overall Study||12
8271571|NCT01726504|20396143|P2|COMPLETED|Overall Study||511
8271572|NCT01726504|20396144|P1|COMPLETED|Overall Study||524
8271573|NCT01726504|20396143|P2|STARTED|Overall Study||539
8271574|NCT01726504|20396144|P1|STARTED|Overall Study||536
8271575|NCT01726335|20396170|P1|NOT COMPLETED|Overall Study||24
8271576|NCT01726335|20396170|P1|COMPLETED|Overall Study||29
8271577|NCT01726335|20396170|P1|STARTED|Overall Study||53
8271578|NCT01726270|20396186|P1|NOT COMPLETED|Part 2, Actual-Use Phase||39
8271579|NCT01726270|20396186|P1|COMPLETED|Part 2, Actual-Use Phase||330
8271580|NCT01726270|20396186|P1|STARTED|Part 2, Actual-Use Phase|20 subjects were eligible for Part 2 but did not enter Part 2|369
8271581|NCT01726270|20396186|P1|NOT COMPLETED|Eligibility for Part 2||20
8271582|NCT01726270|20396186|P1|COMPLETED|Eligibility for Part 2||369
8271583|NCT01726270|20396186|P1|STARTED|Eligibility for Part 2|No. of subjects potentially eligible for Part 2|389
8271584|NCT01726270|20396186|P1|NOT COMPLETED|Part 1, Self-Selection Phase||10
8271585|NCT01726270|20396186|P1|COMPLETED|Part 1, Self-Selection Phase||679
8271586|NCT01726270|20396186|P1|STARTED|Part 1, Self-Selection Phase||689
8271587|NCT01726049|20396199|P2|NOT COMPLETED|Overall Study||4
8271588|NCT01726049|20396200|P1|NOT COMPLETED|Overall Study||5
8271589|NCT01726049|20396199|P2|COMPLETED|Overall Study||22
8271590|NCT01726049|20396200|P1|COMPLETED|Overall Study||21
8271591|NCT01726049|20396199|P2|STARTED|Overall Study||26
8271592|NCT01726049|20396200|P1|STARTED|Overall Study||26
8271593|NCT01726036|20396214|P2|NOT COMPLETED|Overall Study||7
8271594|NCT01726036|20396215|P1|NOT COMPLETED|Overall Study||16
8271595|NCT01726036|20396214|P2|COMPLETED|Overall Study||130
8271596|NCT01726036|20396215|P1|COMPLETED|Overall Study||121
8271597|NCT01726036|20396214|P2|STARTED|Overall Study||137
8271598|NCT01726036|20396215|P1|STARTED|Overall Study||137
8271599|NCT01726023|20396225|P2|NOT COMPLETED|Overall Study||26
8271600|NCT01726023|20396226|P1|NOT COMPLETED|Overall Study||29
8271601|NCT01726023|20396225|P2|COMPLETED|Overall Study||196
8271602|NCT01726023|20396226|P1|COMPLETED|Overall Study||190
8271603|NCT01726023|20396225|P2|STARTED|Overall Study||222
8271604|NCT01726023|20396226|P1|STARTED|Overall Study||219
8271605|NCT01725984|20396318|P2|NOT COMPLETED|Overall Study||0
8271606|NCT01725984|20396319|P1|NOT COMPLETED|Overall Study||0
8271607|NCT01725984|20396318|P2|COMPLETED|Overall Study||41
8271608|NCT01725984|20396319|P1|COMPLETED|Overall Study||39
8271609|NCT01725984|20396318|P2|STARTED|Overall Study||41
8271610|NCT01725984|20396319|P1|STARTED|Overall Study||39
8271611|NCT01725815|20396345|P2|NOT COMPLETED|Overall Study||0
8271612|NCT01725815|20396346|P1|NOT COMPLETED|Overall Study||0
8271613|NCT01725815|20396345|P2|COMPLETED|Overall Study||202
8271614|NCT01725815|20396346|P1|COMPLETED|Overall Study||198
8271615|NCT01725815|20396345|P2|STARTED|Overall Study||202
8271616|NCT01725815|20396346|P1|STARTED|Overall Study||198
8271617|NCT01725750|20396360|P2|NOT COMPLETED|Overall Study||10
8271618|NCT01725750|20396361|P1|NOT COMPLETED|Overall Study||2
8271619|NCT01725750|20396360|P2|COMPLETED|Overall Study||34
8271620|NCT01725750|20396361|P1|COMPLETED|Overall Study||42
8271621|NCT01725750|20396360|P2|STARTED|Overall Study||44
8271622|NCT01725750|20396361|P1|STARTED|Overall Study||44
8271623|NCT01725529|20396394|P3|NOT COMPLETED|Overall Study||10
8271624|NCT01725529|20396395|P2|NOT COMPLETED|Overall Study||16
8271625|NCT01725529|20396396|P1|NOT COMPLETED|Overall Study||15
8271626|NCT01725529|20396394|P3|COMPLETED|Overall Study||142
8271627|NCT01725529|20396395|P2|COMPLETED|Overall Study||137
8271628|NCT01725529|20396396|P1|COMPLETED|Overall Study||137
8271629|NCT01725529|20396394|P3|STARTED|Overall Study||152
8271630|NCT01725529|20396395|P2|STARTED|Overall Study||153
8271631|NCT01725529|20396396|P1|STARTED|Overall Study||152
8271632|NCT01725451|20396422|P4|NOT COMPLETED|Period 6||0
8271633|NCT01725451|20396423|P3|NOT COMPLETED|Period 6||0
8271634|NCT01725451|20396424|P2|NOT COMPLETED|Period 6||0
8271635|NCT01725451|20396425|P1|NOT COMPLETED|Period 6||0
8271636|NCT01725451|20396422|P4|COMPLETED|Period 6||7
8271637|NCT01725451|20396423|P3|COMPLETED|Period 6||6
8271638|NCT01725451|20396424|P2|COMPLETED|Period 6||6
8271639|NCT01725451|20396425|P1|COMPLETED|Period 6||7
8271640|NCT01725451|20396422|P4|STARTED|Period 6||7
8271641|NCT01725451|20396423|P3|STARTED|Period 6||6
8271642|NCT01725451|20396424|P2|STARTED|Period 6||6
8271643|NCT01725451|20396425|P1|STARTED|Period 6||7
8271644|NCT01725451|20396422|P4|NOT COMPLETED|Washout From Period 5||0
8271645|NCT01725451|20396423|P3|NOT COMPLETED|Washout From Period 5||0
8271646|NCT01725451|20396424|P2|NOT COMPLETED|Washout From Period 5||0
8271647|NCT01725451|20396425|P1|NOT COMPLETED|Washout From Period 5||0
8271648|NCT01725451|20396422|P4|COMPLETED|Washout From Period 5||7
8271649|NCT01725451|20396423|P3|COMPLETED|Washout From Period 5||6
8271650|NCT01725451|20396424|P2|COMPLETED|Washout From Period 5||6
8271651|NCT01725451|20396425|P1|COMPLETED|Washout From Period 5||7
8271652|NCT01725451|20396422|P4|STARTED|Washout From Period 5||7
8271653|NCT01725451|20396423|P3|STARTED|Washout From Period 5||6
8271654|NCT01725451|20396424|P2|STARTED|Washout From Period 5||6
8271655|NCT01725451|20396425|P1|STARTED|Washout From Period 5||7
8271656|NCT01725451|20396422|P4|NOT COMPLETED|Period 5||0
8271657|NCT01725451|20396423|P3|NOT COMPLETED|Period 5||0
8271658|NCT01725451|20396424|P2|NOT COMPLETED|Period 5||0
8271659|NCT01725451|20396425|P1|NOT COMPLETED|Period 5||0
8271660|NCT01725451|20396422|P4|COMPLETED|Period 5||7
8271661|NCT01725451|20396423|P3|COMPLETED|Period 5||6
8271662|NCT01725451|20396424|P2|COMPLETED|Period 5||6
8271663|NCT01725451|20396425|P1|COMPLETED|Period 5||7
8271664|NCT01725451|20396422|P4|STARTED|Period 5||7
8271665|NCT01725451|20396423|P3|STARTED|Period 5||6
8271666|NCT01725451|20396424|P2|STARTED|Period 5||6
8271667|NCT01725451|20396425|P1|STARTED|Period 5||7
8271668|NCT01725451|20396422|P4|NOT COMPLETED|Washout From Period 4||0
8271669|NCT01725451|20396423|P3|NOT COMPLETED|Washout From Period 4||0
8271670|NCT01725451|20396424|P2|NOT COMPLETED|Washout From Period 4||0
8271671|NCT01725451|20396425|P1|NOT COMPLETED|Washout From Period 4||0
8271672|NCT01725451|20396422|P4|COMPLETED|Washout From Period 4||7
8271673|NCT01725451|20396423|P3|COMPLETED|Washout From Period 4||6
8271674|NCT01725451|20396424|P2|COMPLETED|Washout From Period 4||6
8271675|NCT01725451|20396425|P1|COMPLETED|Washout From Period 4||7
8271676|NCT01725451|20396422|P4|STARTED|Washout From Period 4||7
8271677|NCT01725451|20396423|P3|STARTED|Washout From Period 4||6
8271678|NCT01725451|20396424|P2|STARTED|Washout From Period 4||6
8271679|NCT01725451|20396425|P1|STARTED|Washout From Period 4||7
8271680|NCT01725451|20396422|P4|NOT COMPLETED|Period 4||0
8271681|NCT01725451|20396423|P3|NOT COMPLETED|Period 4||1
8271682|NCT01725451|20396424|P2|NOT COMPLETED|Period 4||0
8271683|NCT01725451|20396425|P1|NOT COMPLETED|Period 4||0
8271684|NCT01725451|20396422|P4|COMPLETED|Period 4||7
8271685|NCT01725451|20396423|P3|COMPLETED|Period 4||6
8271686|NCT01725451|20396424|P2|COMPLETED|Period 4||6
8271687|NCT01725451|20396425|P1|COMPLETED|Period 4||7
8271688|NCT01725451|20396422|P4|STARTED|Period 4||7
8271689|NCT01725451|20396423|P3|STARTED|Period 4||7
8271690|NCT01725451|20396424|P2|STARTED|Period 4||6
8271691|NCT01725451|20396425|P1|STARTED|Period 4||7
8271692|NCT01725451|20396422|P4|NOT COMPLETED|Washout From Period 3||0
8271693|NCT01725451|20396423|P3|NOT COMPLETED|Washout From Period 3||1
8271694|NCT01725451|20396424|P2|NOT COMPLETED|Washout From Period 3||1
8271695|NCT01725451|20396425|P1|NOT COMPLETED|Washout From Period 3||0
8271696|NCT01725451|20396422|P4|COMPLETED|Washout From Period 3||7
8271697|NCT01725451|20396423|P3|COMPLETED|Washout From Period 3||7
8271698|NCT01725451|20396424|P2|COMPLETED|Washout From Period 3||6
8271699|NCT01725451|20396425|P1|COMPLETED|Washout From Period 3||7
8271700|NCT01725451|20396422|P4|STARTED|Washout From Period 3||7
8271701|NCT01725451|20396423|P3|STARTED|Washout From Period 3||8
8271702|NCT01725451|20396424|P2|STARTED|Washout From Period 3||7
8271703|NCT01725451|20396425|P1|STARTED|Washout From Period 3||7
8271704|NCT01725451|20396422|P4|NOT COMPLETED|Period 3||0
8271705|NCT01725451|20396423|P3|NOT COMPLETED|Period 3||0
8271706|NCT01725451|20396424|P2|NOT COMPLETED|Period 3||0
8271707|NCT01725451|20396425|P1|NOT COMPLETED|Period 3||0
8271708|NCT01725451|20396422|P4|COMPLETED|Period 3||7
8271709|NCT01725451|20396423|P3|COMPLETED|Period 3||8
8271710|NCT01725451|20396424|P2|COMPLETED|Period 3||7
8271711|NCT01725451|20396425|P1|COMPLETED|Period 3||7
8271712|NCT01725451|20396422|P4|STARTED|Period 3||7
8271713|NCT01725451|20396423|P3|STARTED|Period 3||8
8271714|NCT01725451|20396424|P2|STARTED|Period 3||7
8271715|NCT01725451|20396425|P1|STARTED|Period 3||7
8271716|NCT01725451|20396422|P4|NOT COMPLETED|Washout From Period 2||0
8271717|NCT01725451|20396423|P3|NOT COMPLETED|Washout From Period 2||0
8271718|NCT01725451|20396424|P2|NOT COMPLETED|Washout From Period 2||0
8271719|NCT01725451|20396425|P1|NOT COMPLETED|Washout From Period 2||0
8271720|NCT01725451|20396422|P4|COMPLETED|Washout From Period 2||7
8271721|NCT01725451|20396423|P3|COMPLETED|Washout From Period 2||8
8271722|NCT01725451|20396424|P2|COMPLETED|Washout From Period 2||7
8271723|NCT01725451|20396425|P1|COMPLETED|Washout From Period 2||7
8271724|NCT01725451|20396422|P4|STARTED|Washout From Period 2||7
8271725|NCT01725451|20396423|P3|STARTED|Washout From Period 2||8
8271726|NCT01725451|20396424|P2|STARTED|Washout From Period 2||7
8271727|NCT01725451|20396425|P1|STARTED|Washout From Period 2||7
8271728|NCT01725451|20396422|P4|NOT COMPLETED|Period 2||0
8271729|NCT01725451|20396423|P3|NOT COMPLETED|Period 2||0
8271730|NCT01725451|20396424|P2|NOT COMPLETED|Period 2||0
8271731|NCT01725451|20396425|P1|NOT COMPLETED|Period 2||0
8271732|NCT01725451|20396422|P4|COMPLETED|Period 2||7
8271733|NCT01725451|20396423|P3|COMPLETED|Period 2||8
8271734|NCT01725451|20396424|P2|COMPLETED|Period 2||7
8271735|NCT01725451|20396425|P1|COMPLETED|Period 2||7
8271736|NCT01725451|20396422|P4|STARTED|Period 2||7
8271737|NCT01725451|20396423|P3|STARTED|Period 2||8
8271738|NCT01725451|20396424|P2|STARTED|Period 2||7
8271739|NCT01725451|20396425|P1|STARTED|Period 2||7
8271740|NCT01725451|20396422|P4|NOT COMPLETED|Washout From Period 1||0
8271741|NCT01725451|20396423|P3|NOT COMPLETED|Washout From Period 1||0
8271742|NCT01725451|20396424|P2|NOT COMPLETED|Washout From Period 1||0
8271743|NCT01725451|20396425|P1|NOT COMPLETED|Washout From Period 1||0
8271744|NCT01725451|20396422|P4|COMPLETED|Washout From Period 1||7
8271745|NCT01725451|20396423|P3|COMPLETED|Washout From Period 1||8
8271746|NCT01725451|20396424|P2|COMPLETED|Washout From Period 1||7
8271747|NCT01725451|20396425|P1|COMPLETED|Washout From Period 1||7
8271748|NCT01725451|20396422|P4|STARTED|Washout From Period 1||7
8271749|NCT01725451|20396423|P3|STARTED|Washout From Period 1||8
8271750|NCT01725451|20396424|P2|STARTED|Washout From Period 1||7
8271751|NCT01725451|20396425|P1|STARTED|Washout From Period 1||7
8271752|NCT01725451|20396422|P4|NOT COMPLETED|Period 1||0
8271753|NCT01725451|20396423|P3|NOT COMPLETED|Period 1||0
8271754|NCT01725451|20396424|P2|NOT COMPLETED|Period 1||0
8271755|NCT01725451|20396425|P1|NOT COMPLETED|Period 1||1
8271756|NCT01725451|20396422|P4|COMPLETED|Period 1||7
8271757|NCT01725451|20396423|P3|COMPLETED|Period 1||8
8271758|NCT01725451|20396424|P2|COMPLETED|Period 1||7
8271759|NCT01725451|20396425|P1|COMPLETED|Period 1||7
8271760|NCT01725451|20396422|P4|STARTED|Period 1||7
8271761|NCT01725451|20396423|P3|STARTED|Period 1||8
8271762|NCT01725451|20396424|P2|STARTED|Period 1||7
8271763|NCT01725451|20396425|P1|STARTED|Period 1||8
8271764|NCT01725386|20396447|P2|NOT COMPLETED|Overall Study||46
8271765|NCT01725386|20396448|P1|NOT COMPLETED|Overall Study||175
8271766|NCT01725386|20396447|P2|COMPLETED|Overall Study||17
8271767|NCT01725386|20396448|P1|COMPLETED|Overall Study||13
8271768|NCT01725386|20396447|P2|STARTED|Overall Study||63
8271769|NCT01725386|20396448|P1|STARTED|Overall Study||188
8271770|NCT01725308|20396467|P3|NOT COMPLETED|Treatment Period II||64
8271771|NCT01725308|20396468|P2|NOT COMPLETED|Treatment Period II||29
8271772|NCT01725308|20396469|P1|NOT COMPLETED|Treatment Period II||55
8271773|NCT01725308|20396467|P3|COMPLETED|Treatment Period II||74
8271774|NCT01725308|20396468|P2|COMPLETED|Treatment Period II||31
8271775|NCT01725308|20396469|P1|COMPLETED|Treatment Period II||79
8271776|NCT01725308|20396467|P3|Treated|Treatment Period II||130
8271777|NCT01725308|20396468|P2|Treated|Treatment Period II||53
8271778|NCT01725308|20396469|P1|Treated|Treatment Period II||120
8271779|NCT01725308|20396467|P3|STARTED|Treatment Period II||138
8271780|NCT01725308|20396468|P2|STARTED|Treatment Period II||60
8271781|NCT01725308|20396469|P1|STARTED|Treatment Period II||134
8271782|NCT01725308|20396467|P3|NOT COMPLETED|Treatment Period I||41
8271783|NCT01725308|20396468|P2|NOT COMPLETED|Treatment Period I||14
8271784|NCT01725308|20396469|P1|NOT COMPLETED|Treatment Period I||44
8271785|NCT01725308|20396467|P3|COMPLETED|Treatment Period I||138
8271786|NCT01725308|20396468|P2|COMPLETED|Treatment Period I||60
8271787|NCT01725308|20396469|P1|COMPLETED|Treatment Period I||134
8271788|NCT01725308|20396467|P3|Treated|Treatment Period I||179
8271789|NCT01725308|20396468|P2|Treated|Treatment Period I||74
8271790|NCT01725308|20396469|P1|Treated|Treatment Period I||177
8271791|NCT01725308|20396467|P3|STARTED|Treatment Period I||179
8271792|NCT01725308|20396468|P2|STARTED|Treatment Period I||74
8271793|NCT01725308|20396469|P1|STARTED|Treatment Period I||178
8271794|NCT01725282|20396616|P4|NOT COMPLETED|Overall Study||7
8271795|NCT01725282|20396617|P3|NOT COMPLETED|Overall Study||8
8271796|NCT01725282|20396618|P2|NOT COMPLETED|Overall Study||5
8271797|NCT01725282|20396619|P1|NOT COMPLETED|Overall Study||2
8271798|NCT01725282|20396616|P4|COMPLETED|Overall Study||36
8271799|NCT01725282|20396617|P3|COMPLETED|Overall Study||33
8271800|NCT01725282|20396618|P2|COMPLETED|Overall Study||39
8271801|NCT01725282|20396619|P1|COMPLETED|Overall Study||42
8271802|NCT01725282|20396616|P4|STARTED|Overall Study||43
8271803|NCT01725282|20396617|P3|STARTED|Overall Study||41
8271804|NCT01725282|20396618|P2|STARTED|Overall Study||44
8271805|NCT01725282|20396619|P1|STARTED|Overall Study||44
8271806|NCT01725217|20396652|P3|NOT COMPLETED|Overall Study||0
8271807|NCT01725217|20396653|P2|NOT COMPLETED|Overall Study||0
8271808|NCT01725217|20396654|P1|NOT COMPLETED|Overall Study||1
8271809|NCT01725217|20396652|P3|COMPLETED|Overall Study||66
8271810|NCT01725217|20396653|P2|COMPLETED|Overall Study||66
8271811|NCT01725217|20396654|P1|COMPLETED|Overall Study||65
8271812|NCT01725217|20396652|P3|STARTED|Overall Study||66
8271813|NCT01725217|20396653|P2|STARTED|Overall Study||66
8271814|NCT01725217|20396654|P1|STARTED|Overall Study||66
8271815|NCT01725126|20396688|P6|NOT COMPLETED|Overall Study||0
8271816|NCT01725126|20396689|P5|NOT COMPLETED|Overall Study||0
8271817|NCT01725126|20396690|P4|NOT COMPLETED|Overall Study||1
8271818|NCT01725126|20396691|P3|NOT COMPLETED|Overall Study||0
8271819|NCT01725126|20396692|P2|NOT COMPLETED|Overall Study||1
8271820|NCT01725126|20396693|P1|NOT COMPLETED|Overall Study||0
8271821|NCT01725126|20396688|P6|COMPLETED|Overall Study||12
8271822|NCT01725126|20396689|P5|COMPLETED|Overall Study||6
8271823|NCT01725126|20396690|P4|COMPLETED|Overall Study||13
8271824|NCT01725126|20396691|P3|COMPLETED|Overall Study||6
8271825|NCT01725126|20396692|P2|COMPLETED|Overall Study||10
8271826|NCT01725126|20396693|P1|COMPLETED|Overall Study||4
8271827|NCT01725126|20396688|P6|STARTED|Overall Study||12
8271828|NCT01725126|20396689|P5|STARTED|Overall Study||6
8271829|NCT01725126|20396690|P4|STARTED|Overall Study||14
8271830|NCT01725126|20396691|P3|STARTED|Overall Study||6
8271831|NCT01725126|20396692|P2|STARTED|Overall Study||11
8271832|NCT01725126|20396693|P1|STARTED|Overall Study||4
8271833|NCT01724528|20396891|P2|NOT COMPLETED|Overall Study||3
8271834|NCT01724528|20396892|P1|NOT COMPLETED|Overall Study||4
8271835|NCT01724528|20396891|P2|COMPLETED|Overall Study||170
8271836|NCT01724528|20396892|P1|COMPLETED|Overall Study||169
8271837|NCT01724528|20396891|P2|STARTED|Overall Study||173
8271838|NCT01724528|20396892|P1|STARTED|Overall Study||173
8271839|NCT01724489|20396908|P2|NOT COMPLETED|Overall Study||12
8271840|NCT01724489|20396909|P1|NOT COMPLETED|Overall Study||16
8271841|NCT01724489|20396908|P2|COMPLETED|Overall Study||26
8271842|NCT01724489|20396909|P1|COMPLETED|Overall Study||23
8271843|NCT01724489|20396908|P2|STARTED|Overall Study||38
8271844|NCT01724489|20396909|P1|STARTED|Overall Study||39
8271845|NCT01724359|20396915|P1|NOT COMPLETED|Overall Study||31
8271846|NCT01724359|20396915|P1|COMPLETED|Overall Study||64
8271847|NCT01724359|20396915|P1|STARTED|Overall Study||95
8271848|NCT01724216|20396928|P1|NOT COMPLETED|Overall Study||1
8271849|NCT01724216|20396928|P1|COMPLETED|Overall Study||10
8271850|NCT01724216|20396928|P1|STARTED|Overall Study||11
8271851|NCT01724177|20396932|P1|NOT COMPLETED|Overall Study||26
8271852|NCT01724177|20396932|P1|COMPLETED|Overall Study||0
8271853|NCT01724177|20396932|P1|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
8271854|NCT01724177|20396932|P1|STARTED|Overall Study||26
8271855|NCT01724060|20396951|P8|NOT COMPLETED|Overall Study||0
8271856|NCT01724060|20396952|P7|NOT COMPLETED|Overall Study||0
8271857|NCT01724060|20396953|P6|NOT COMPLETED|Overall Study||0
8271858|NCT01724060|20396954|P5|NOT COMPLETED|Overall Study||0
8271859|NCT01724060|20396955|P4|NOT COMPLETED|Overall Study||0
8271860|NCT01724060|20396956|P3|NOT COMPLETED|Overall Study||0
8271861|NCT01724060|20396957|P2|NOT COMPLETED|Overall Study||0
8271862|NCT01724060|20396958|P1|NOT COMPLETED|Overall Study||0
8271863|NCT01724060|20396951|P8|COMPLETED|Overall Study||10
8271864|NCT01724060|20396952|P7|COMPLETED|Overall Study||10
8271865|NCT01724060|20396953|P6|COMPLETED|Overall Study||10
8271866|NCT01724060|20396954|P5|COMPLETED|Overall Study||10
8271867|NCT01724060|20396955|P4|COMPLETED|Overall Study||10
8271868|NCT01724060|20396956|P3|COMPLETED|Overall Study||10
8271869|NCT01724060|20396957|P2|COMPLETED|Overall Study||10
8271870|NCT01724060|20396958|P1|COMPLETED|Overall Study||10
8271871|NCT01724060|20396951|P8|STARTED|Overall Study||10
8271872|NCT01724060|20396952|P7|STARTED|Overall Study||10
8271873|NCT01724060|20396953|P6|STARTED|Overall Study||10
8271874|NCT01724060|20396954|P5|STARTED|Overall Study||10
8271875|NCT01724060|20396955|P4|STARTED|Overall Study||10
8271876|NCT01724060|20396956|P3|STARTED|Overall Study||10
8271877|NCT01724060|20396957|P2|STARTED|Overall Study||10
8271878|NCT01724060|20396958|P1|STARTED|Overall Study||10
8271879|NCT01724021|20396978|P2|NOT COMPLETED|Overall Study||133
8271880|NCT01724021|20396979|P1|NOT COMPLETED|Overall Study||127
8271881|NCT01724021|20396978|P2|COMPLETED|Overall Study||236
8271882|NCT01724021|20396979|P1|COMPLETED|Overall Study||244
8271883|NCT01724021|20396978|P2|STARTED|Overall Study||369
8271884|NCT01724021|20396979|P1|STARTED|Overall Study||371
8271885|NCT01723904|20397011|P1|NOT COMPLETED|Overall Study||11
8271886|NCT01723904|20397011|P1|COMPLETED|Overall Study||79
8271887|NCT01723904|20397011|P1|STARTED|Overall Study||90
8271888|NCT01723826|20397025|P4|NOT COMPLETED|Overall Study||90
8271889|NCT01723826|20397026|P3|NOT COMPLETED|Overall Study||57
8271890|NCT01723826|20397027|P2|NOT COMPLETED|Overall Study||36
8271891|NCT01723826|20397028|P1|NOT COMPLETED|Overall Study||27
8271892|NCT01723826|20397025|P4|COMPLETED|Overall Study||59
8271893|NCT01723826|20397026|P3|COMPLETED|Overall Study||44
8271894|NCT01723826|20397027|P2|COMPLETED|Overall Study||27
8271895|NCT01723826|20397028|P1|COMPLETED|Overall Study||20
8271896|NCT01723826|20397025|P4|STARTED|Overall Study||149
8271897|NCT01723826|20397026|P3|STARTED|Overall Study||101
8271898|NCT01723826|20397027|P2|STARTED|Overall Study||63
8271899|NCT01723826|20397028|P1|STARTED|Overall Study||47
8271900|NCT01723722|20397060|P2|NOT COMPLETED|Overall Study||0
8271901|NCT01723722|20397061|P1|NOT COMPLETED|Overall Study||0
8271902|NCT01723722|20397060|P2|COMPLETED|Overall Study||20
8271903|NCT01723722|20397061|P1|COMPLETED|Overall Study||20
8271904|NCT01723722|20397060|P2|STARTED|Overall Study||20
8271905|NCT01723722|20397061|P1|STARTED|Overall Study||20
8271906|NCT01723696|20397069|P2|NOT COMPLETED|Overall Study||13
8271907|NCT01723696|20397070|P1|NOT COMPLETED|Overall Study||17
8271908|NCT01723696|20397069|P2|COMPLETED|Overall Study||113
8271909|NCT01723696|20397070|P1|COMPLETED|Overall Study||109
8271910|NCT01723696|20397069|P2|STARTED|Overall Study||126
8271911|NCT01723696|20397070|P1|STARTED|Overall Study||126
8271912|NCT01723514|20397090|P8|NOT COMPLETED|Overall Study||0
8271913|NCT01723514|20397091|P7|NOT COMPLETED|Overall Study||0
8271914|NCT01723514|20397092|P6|NOT COMPLETED|Overall Study||0
8271915|NCT01723514|20397093|P5|NOT COMPLETED|Overall Study||0
8271916|NCT01723514|20397094|P4|NOT COMPLETED|Overall Study||0
8271917|NCT01723514|20397095|P3|NOT COMPLETED|Overall Study||0
8271918|NCT01723514|20397096|P2|NOT COMPLETED|Overall Study||0
8271919|NCT01723514|20397097|P1|NOT COMPLETED|Overall Study||0
8271920|NCT01723514|20397090|P8|COMPLETED|Overall Study||6
8271921|NCT01723514|20397091|P7|COMPLETED|Overall Study||6
8271922|NCT01723514|20397092|P6|COMPLETED|Overall Study||4
8271923|NCT01723514|20397093|P5|COMPLETED|Overall Study||6
8271924|NCT01723514|20397094|P4|COMPLETED|Overall Study||6
8271925|NCT01723514|20397095|P3|COMPLETED|Overall Study||6
8271926|NCT01723514|20397096|P2|COMPLETED|Overall Study||6
8271927|NCT01723514|20397097|P1|COMPLETED|Overall Study||8
8271928|NCT01723514|20397090|P8|STARTED|Overall Study||6
8271929|NCT01723514|20397091|P7|STARTED|Overall Study||6
8271930|NCT01723514|20397092|P6|STARTED|Overall Study||4
8271931|NCT01723514|20397093|P5|STARTED|Overall Study||6
8271932|NCT01723514|20397094|P4|STARTED|Overall Study||6
8271933|NCT01723514|20397095|P3|STARTED|Overall Study||6
8271934|NCT01723514|20397096|P2|STARTED|Overall Study||6
8271935|NCT01723514|20397097|P1|STARTED|Overall Study||8
8271936|NCT01723397|20397173|P2|NOT COMPLETED|Study Period 2||1
8271937|NCT01723397|20397174|P1|NOT COMPLETED|Study Period 2||0
8271938|NCT01723397|20397173|P2|COMPLETED|Study Period 2||5
8271939|NCT01723397|20397174|P1|COMPLETED|Study Period 2||7
8271940|NCT01723397|20397173|P2|STARTED|Study Period 2||6
8271941|NCT01723397|20397174|P1|STARTED|Study Period 2||7
8271942|NCT01723397|20397173|P2|NOT COMPLETED|Washout||0
8271943|NCT01723397|20397174|P1|NOT COMPLETED|Washout||0
8271944|NCT01723397|20397173|P2|COMPLETED|Washout||6
8271945|NCT01723397|20397174|P1|COMPLETED|Washout||7
8271946|NCT01723397|20397173|P2|STARTED|Washout||6
8271947|NCT01723397|20397174|P1|STARTED|Washout||7
8271948|NCT01723397|20397173|P2|NOT COMPLETED|Study Period 1||1
8271949|NCT01723397|20397174|P1|NOT COMPLETED|Study Period 1||0
8271950|NCT01723397|20397173|P2|COMPLETED|Study Period 1||6
8271951|NCT01723397|20397174|P1|COMPLETED|Study Period 1||7
8271952|NCT01723397|20397173|P2|STARTED|Study Period 1||7
8271953|NCT01723397|20397174|P1|STARTED|Study Period 1||7
8271954|NCT01723384|20397182|P2|NOT COMPLETED|Overall Study||0
8271955|NCT01723384|20397183|P1|NOT COMPLETED|Overall Study||0
8271956|NCT01723384|20397182|P2|COMPLETED|Overall Study||15
8271957|NCT01723384|20397183|P1|COMPLETED|Overall Study||15
8271958|NCT01723384|20397182|P2|STARTED|Overall Study||15
8271959|NCT01723384|20397183|P1|STARTED|Overall Study||15
8271960|NCT01723254|20397201|P8|NOT COMPLETED|Overall Study||3
8271961|NCT01723254|20397202|P7|NOT COMPLETED|Overall Study||1
8271962|NCT01723254|20397203|P6|NOT COMPLETED|Overall Study||2
8271963|NCT01723254|20397204|P5|NOT COMPLETED|Overall Study||2
8271964|NCT01723254|20397205|P4|NOT COMPLETED|Overall Study||2
8271965|NCT01723254|20397206|P3|NOT COMPLETED|Overall Study||3
8271966|NCT01723254|20397207|P2|NOT COMPLETED|Overall Study||3
8271967|NCT01723254|20397208|P1|NOT COMPLETED|Overall Study||1
8271968|NCT01723254|20397201|P8|COMPLETED|Overall Study||60
8271969|NCT01723254|20397202|P7|COMPLETED|Overall Study||19
8271970|NCT01723254|20397203|P6|COMPLETED|Overall Study||18
8271971|NCT01723254|20397204|P5|COMPLETED|Overall Study||18
8271972|NCT01723254|20397205|P4|COMPLETED|Overall Study||18
8271973|NCT01723254|20397206|P3|COMPLETED|Overall Study||17
8271974|NCT01723254|20397207|P2|COMPLETED|Overall Study||18
8271975|NCT01723254|20397208|P1|COMPLETED|Overall Study||5
8271976|NCT01723254|20397201|P8|STARTED|Overall Study||63
8271977|NCT01723254|20397202|P7|STARTED|Overall Study||20
8271978|NCT01723254|20397203|P6|STARTED|Overall Study||20
8271979|NCT01723254|20397204|P5|STARTED|Overall Study||20
8271980|NCT01723254|20397205|P4|STARTED|Overall Study||20
8271981|NCT01723254|20397206|P3|STARTED|Overall Study||20
8271982|NCT01723254|20397207|P2|STARTED|Overall Study||21
8271983|NCT01723254|20397208|P1|STARTED|Overall Study||6
8271984|NCT01723228|20397260|P2|NOT COMPLETED|Overall Study||11
8271985|NCT01723228|20397261|P1|NOT COMPLETED|Overall Study||8
8271986|NCT01723228|20397260|P2|COMPLETED|Overall Study||73
8271987|NCT01723228|20397261|P1|COMPLETED|Overall Study||78
8271988|NCT01723228|20397260|P2|STARTED|Overall Study||84
8271989|NCT01723228|20397261|P1|STARTED|Overall Study||86
8271990|NCT01723163|20397279|P2|NOT COMPLETED|12-Month Follow-up||28
8271991|NCT01723163|20397280|P1|NOT COMPLETED|12-Month Follow-up||24
8271992|NCT01723163|20397279|P2|COMPLETED|12-Month Follow-up||119
8271993|NCT01723163|20397280|P1|COMPLETED|12-Month Follow-up||111
8271994|NCT01723163|20397279|P2|STARTED|12-Month Follow-up||147
8271995|NCT01723163|20397280|P1|STARTED|12-Month Follow-up||135
8271996|NCT01723163|20397279|P2|NOT COMPLETED|6-Month Follow-up||15
8271997|NCT01723163|20397280|P1|NOT COMPLETED|6-Month Follow-up||18
8271998|NCT01723163|20397279|P2|COMPLETED|6-Month Follow-up||132
8271999|NCT01723163|20397280|P1|COMPLETED|6-Month Follow-up||118
8272000|NCT01723163|20397279|P2|STARTED|6-Month Follow-up||147
8272001|NCT01723163|20397280|P1|STARTED|6-Month Follow-up||136
8272002|NCT01723163|20397279|P2|NOT COMPLETED|3-Month Follow-up||19
8272003|NCT01723163|20397280|P1|NOT COMPLETED|3-Month Follow-up||13
8272004|NCT01723163|20397279|P2|COMPLETED|3-Month Follow-up||128
8272005|NCT01723163|20397280|P1|COMPLETED|3-Month Follow-up||124
8272006|NCT01723163|20397279|P2|STARTED|3-Month Follow-up||147
8272007|NCT01723163|20397280|P1|STARTED|3-Month Follow-up||137
8272008|NCT01723163|20397279|P2|NOT COMPLETED|Treatment Phase||7
8272009|NCT01723163|20397280|P1|NOT COMPLETED|Treatment Phase||19
8272010|NCT01723163|20397279|P2|COMPLETED|Treatment Phase||147
8272011|NCT01723163|20397280|P1|COMPLETED|Treatment Phase||137
8272012|NCT01723163|20397279|P2|STARTED|Treatment Phase||154
8272013|NCT01723163|20397280|P1|STARTED|Treatment Phase||156
8272014|NCT01723163|20397279|P2|NOT COMPLETED|Baseline||0
8272015|NCT01723163|20397280|P1|NOT COMPLETED|Baseline||0
8272016|NCT01723163|20397279|P2|COMPLETED|Baseline||154
8272017|NCT01723163|20397280|P1|COMPLETED|Baseline||156
8272018|NCT01723163|20397279|P2|STARTED|Baseline||154
8272019|NCT01723163|20397280|P1|STARTED|Baseline||156
8272020|NCT01723072|20397288|P2|NOT COMPLETED|Overall Study||21
8272021|NCT01723072|20397289|P1|NOT COMPLETED|Overall Study||11
8272022|NCT01723072|20397288|P2|COMPLETED|Overall Study||26
8272023|NCT01723072|20397289|P1|COMPLETED|Overall Study||33
8272024|NCT01723072|20397288|P2|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|47
8272025|NCT01723072|20397289|P1|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|44
8272026|NCT01722994|20397327|P2|NOT COMPLETED|Overall Study||17
8272027|NCT01722994|20397328|P1|NOT COMPLETED|Overall Study||25
8272028|NCT01722994|20397327|P2|COMPLETED|Overall Study||31
8272029|NCT01722994|20397328|P1|COMPLETED|Overall Study||24
8272030|NCT01722994|20397327|P2|STARTED|Overall Study||48
8272031|NCT01722994|20397328|P1|STARTED|Overall Study||49
8272032|NCT01722929|20397342|P1|NOT COMPLETED|Overall Study||0
8272033|NCT01722929|20397342|P1|COMPLETED|Overall Study||4
8272034|NCT01722929|20397342|P1|STARTED|Overall Study||4
8272035|NCT01722877|20397347|P1|NOT COMPLETED|Overall Study||2
8272036|NCT01722877|20397347|P1|COMPLETED|Overall Study||27
8272037|NCT01722877|20397347|P1|STARTED|Overall Study||29
8272038|NCT01722734|20397357|P3|NOT COMPLETED|Overall Study||2
8272039|NCT01722734|20397358|P2|NOT COMPLETED|Overall Study||1
8272040|NCT01722734|20397359|P1|NOT COMPLETED|Overall Study||2
8272041|NCT01722734|20397357|P3|COMPLETED|Overall Study||307
8272042|NCT01722734|20397358|P2|COMPLETED|Overall Study||276
8272043|NCT01722734|20397359|P1|COMPLETED|Overall Study||552
8272044|NCT01722734|20397357|P3|STARTED|Overall Study||309
8272045|NCT01722734|20397358|P2|STARTED|Overall Study||277
8272046|NCT01722734|20397359|P1|STARTED|Overall Study||554
8272047|NCT01722669|20397373|P6|NOT COMPLETED|Overall Study||2
8272048|NCT01722669|20397374|P5|NOT COMPLETED|Overall Study||0
8272049|NCT01722669|20397375|P4|NOT COMPLETED|Overall Study||0
8272050|NCT01722669|20397376|P3|NOT COMPLETED|Overall Study||0
8272051|NCT01722669|20397377|P2|NOT COMPLETED|Overall Study||0
8272052|NCT01722669|20397378|P1|NOT COMPLETED|Overall Study||0
8272053|NCT01722669|20397373|P6|COMPLETED|Overall Study||6
8272054|NCT01722669|20397374|P5|COMPLETED|Overall Study||10
8272055|NCT01722669|20397375|P4|COMPLETED|Overall Study||5
8272056|NCT01722669|20397376|P3|COMPLETED|Overall Study||5
8272057|NCT01722669|20397377|P2|COMPLETED|Overall Study||5
8272058|NCT01722669|20397378|P1|COMPLETED|Overall Study||5
8272059|NCT01722669|20397373|P6|STARTED|Overall Study|Antiphospholipid Antibody (ARM D): 6 evaluable and 2 withdrew consent without any data collected|8
8272060|NCT01722669|20397374|P5|STARTED|Overall Study||10
8272061|NCT01722669|20397375|P4|STARTED|Overall Study||5
8272062|NCT01722669|20397376|P3|STARTED|Overall Study||5
8272063|NCT01722669|20397377|P2|STARTED|Overall Study||5
8272064|NCT01722669|20397378|P1|STARTED|Overall Study||5
8272065|NCT01722643|20397400|P2|NOT COMPLETED|Overall Study||1
8272066|NCT01722643|20397401|P1|NOT COMPLETED|Overall Study||0
8272067|NCT01722643|20397400|P2|COMPLETED|Overall Study||30
8272068|NCT01722643|20397401|P1|COMPLETED|Overall Study||30
8272069|NCT01722643|20397400|P2|STARTED|Overall Study||31
8272070|NCT01722643|20397401|P1|STARTED|Overall Study||30
8272071|NCT01722552|20397409|P1|NOT COMPLETED|Overall Study||4
8272072|NCT01722552|20397409|P1|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
8272073|NCT01722552|20397409|P1|STARTED|Overall Study|Number of subjects enrolled|120
8272074|NCT01722487|20397419|P2|NOT COMPLETED|Overall Study||7
8272075|NCT01722487|20397420|P1|NOT COMPLETED|Overall Study||2
8272076|NCT01722487|20397419|P2|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
8272077|NCT01722487|20397420|P1|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
8272078|NCT01722487|20397419|P2|STARTED|Overall Study||133
8272079|NCT01722487|20397420|P1|STARTED|Overall Study||136
8272080|NCT01722435|20397438|P1|NOT COMPLETED|Overall Study||0
8272081|NCT01722435|20397438|P1|COMPLETED|Overall Study||78
8272082|NCT01722435|20397438|P1|STARTED|Overall Study||78
8272146|NCT01722318|20397499|P5|NOT COMPLETED|Overall Study||18
8272147|NCT01722318|20397500|P4|NOT COMPLETED|Overall Study||20
8272148|NCT01722318|20397501|P3|NOT COMPLETED|Overall Study||20
8272149|NCT01722318|20397502|P2|NOT COMPLETED|Overall Study||20
8272150|NCT01722318|20397503|P1|NOT COMPLETED|Overall Study||14
8272151|NCT01722318|20397499|P5|COMPLETED|Overall Study||68
8272152|NCT01722318|20397500|P4|COMPLETED|Overall Study||65
8272153|NCT01722318|20397501|P3|COMPLETED|Overall Study||66
8272154|NCT01722318|20397502|P2|COMPLETED|Overall Study||65
8272155|NCT01722318|20397503|P1|COMPLETED|Overall Study||72
8272156|NCT01722318|20397499|P5|STARTED|Overall Study||86
8272157|NCT01722318|20397500|P4|STARTED|Overall Study||85
8272158|NCT01722318|20397501|P3|STARTED|Overall Study||86
8272159|NCT01722318|20397502|P2|STARTED|Overall Study||85
8272160|NCT01722318|20397503|P1|STARTED|Overall Study||86
8272161|NCT01722292|20397533|P3|NOT COMPLETED|Overall Study||0
8272162|NCT01722292|20397534|P2|NOT COMPLETED|Overall Study||0
8272163|NCT01722292|20397535|P1|NOT COMPLETED|Overall Study||0
8272164|NCT01722292|20397533|P3|COMPLETED|Overall Study||14
8272165|NCT01722292|20397534|P2|COMPLETED|Overall Study||6
8272166|NCT01722292|20397535|P1|COMPLETED|Overall Study||6
8272167|NCT01722292|20397533|P3|Received at Least One Dose of Study Drug|Overall Study||14
8272168|NCT01722292|20397534|P2|Received at Least One Dose of Study Drug|Overall Study||6
8272169|NCT01722292|20397535|P1|Received at Least One Dose of Study Drug|Overall Study||6
8272170|NCT01722292|20397533|P3|STARTED|Overall Study||14
8272171|NCT01722292|20397534|P2|STARTED|Overall Study||6
8272172|NCT01722292|20397535|P1|STARTED|Overall Study||6
8272173|NCT01722266|20397571|P4|NOT COMPLETED|Overall Study||0
8272174|NCT01722266|20397572|P3|NOT COMPLETED|Overall Study||5
8272175|NCT01722266|20397573|P2|NOT COMPLETED|Overall Study||3
8272176|NCT01722266|20397574|P1|NOT COMPLETED|Overall Study||1
8272177|NCT01722266|20397571|P4|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
8272178|NCT01722266|20397572|P3|COMPLETED|Overall Study||13
8272179|NCT01722266|20397573|P2|COMPLETED|Overall Study||15
8272180|NCT01722266|20397574|P1|COMPLETED|Overall Study||17
8272181|NCT01722266|20397571|P4|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
8272182|NCT01722266|20397572|P3|STARTED|Overall Study||18
8272183|NCT01722266|20397573|P2|STARTED|Overall Study||18
8272184|NCT01722266|20397574|P1|STARTED|Overall Study||18
8272185|NCT01722162|20397602|P2|NOT COMPLETED|Overall Study||6
8272186|NCT01722162|20397603|P1|NOT COMPLETED|Overall Study||5
8272187|NCT01722162|20397602|P2|COMPLETED|Overall Study||18
8272188|NCT01722162|20397603|P1|COMPLETED|Overall Study||18
8272189|NCT01722162|20397602|P2|STARTED|Overall Study||24
8272190|NCT01722162|20397603|P1|STARTED|Overall Study||23
8272191|NCT01722097|20397613|P2|NOT COMPLETED|Overall Study||5
8272192|NCT01722097|20397614|P1|NOT COMPLETED|Overall Study||6
8272193|NCT01722097|20397613|P2|COMPLETED|Overall Study||50
8272194|NCT01722097|20397614|P1|COMPLETED|Overall Study||49
8272195|NCT01722097|20397613|P2|STARTED|Overall Study||55
8272196|NCT01722097|20397614|P1|STARTED|Overall Study||55
8272197|NCT01722071|20397622|P2|NOT COMPLETED|Overall Study||0
8272198|NCT01722071|20397623|P1|NOT COMPLETED|Overall Study||1
8272199|NCT01722071|20397622|P2|COMPLETED|Overall Study||10
8272200|NCT01722071|20397623|P1|COMPLETED|Overall Study||9
8272201|NCT01722071|20397622|P2|STARTED|Overall Study||10
8272202|NCT01722071|20397623|P1|STARTED|Overall Study||10
8272203|NCT01722045|20397629|P1|NOT COMPLETED|Overall Study||28
8272204|NCT01722045|20397629|P1|COMPLETED|Overall Study||126
8272205|NCT01722045|20397629|P1|STARTED|Overall Study||154
8272206|NCT01721967|20397639|P1|NOT COMPLETED|Overall Study||3
8272207|NCT01721967|20397639|P1|COMPLETED|Overall Study||11
8272208|NCT01721967|20397639|P1|STARTED|Overall Study||14
8272209|NCT01721954|20397650|P2|NOT COMPLETED|Overall Study||69
8272210|NCT01721954|20397651|P1|NOT COMPLETED|Overall Study||70
8272211|NCT01721954|20397650|P2|COMPLETED|Overall Study||35
8272212|NCT01721954|20397651|P1|COMPLETED|Overall Study||35
8272213|NCT01721954|20397650|P2|STARTED|Overall Study||104
8272214|NCT01721954|20397651|P1|STARTED|Overall Study||105
8272215|NCT01721837|20397659|P1|NOT COMPLETED|Overall Study||0
8272216|NCT01721837|20397659|P1|COMPLETED|Overall Study||2120
8272217|NCT01721837|20397659|P1|STARTED|Overall Study||2120
8272224|NCT01721759|20397686|P1|NOT COMPLETED|Overall Study||102
8272225|NCT01721759|20397686|P1|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
8272226|NCT01721759|20397686|P1|STARTED|Overall Study||117
8272227|NCT01721746|20397694|P3|NOT COMPLETED|Follow-Up Period||0
8272228|NCT01721746|20397695|P2|NOT COMPLETED|Follow-Up Period||0
8272229|NCT01721746|20397696|P1|NOT COMPLETED|Follow-Up Period||0
8272230|NCT01721746|20397694|P3|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
8272231|NCT01721746|20397695|P2|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
8272232|NCT01721746|20397696|P1|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
8272233|NCT01721746|20397694|P3|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
8272234|NCT01721746|20397695|P2|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
8272235|NCT01721746|20397696|P1|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
8272236|NCT01721746|20397694|P3|NOT COMPLETED|Treatment Period||57
8272237|NCT01721746|20397695|P2|NOT COMPLETED|Treatment Period||45
8272238|NCT01721746|20397696|P1|NOT COMPLETED|Treatment Period||233
8272239|NCT01721746|20397694|P3|COMPLETED|Treatment Period||0
8272240|NCT01721746|20397695|P2|COMPLETED|Treatment Period||0
8272241|NCT01721746|20397696|P1|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
8272242|NCT01721746|20397694|P3|STARTED|Treatment Period||57
8272243|NCT01721746|20397695|P2|STARTED|Treatment Period||45
8272244|NCT01721746|20397696|P1|STARTED|Treatment Period||268
8272245|NCT01721681|20397712|P1|NOT COMPLETED|Overall Study||0
8272246|NCT01721681|20397712|P1|COMPLETED|Overall Study||9
8272247|NCT01721681|20397712|P1|STARTED|Overall Study||9
8272248|NCT01721603|20397718|P1|NOT COMPLETED|Overall Study||0
8272249|NCT01721603|20397718|P1|COMPLETED|Overall Study||2
8272250|NCT01721603|20397718|P1|STARTED|Overall Study||2
8272251|NCT01721564|20397729|P1|NOT COMPLETED|Overall Study||0
8272252|NCT01721564|20397729|P1|COMPLETED|Overall Study||8
8272253|NCT01721564|20397729|P1|STARTED|Overall Study||8
8272254|NCT01721486|20397736|P2|NOT COMPLETED|Overall Study||1
8272255|NCT01721486|20397737|P1|NOT COMPLETED|Overall Study||1
8272256|NCT01721486|20397736|P2|COMPLETED|Overall Study||19
8272257|NCT01721486|20397737|P1|COMPLETED|Overall Study||20
8272258|NCT01721486|20397736|P2|STARTED|Overall Study||20
8272259|NCT01721486|20397737|P1|STARTED|Overall Study||21
8272260|NCT01721473|20397755|P6|NOT COMPLETED|Overall Study||0
8272261|NCT01721473|20397756|P5|NOT COMPLETED|Overall Study||0
8272262|NCT01721473|20397757|P4|NOT COMPLETED|Overall Study||0
8272263|NCT01721473|20397758|P3|NOT COMPLETED|Overall Study||0
8272264|NCT01721473|20397759|P2|NOT COMPLETED|Overall Study||0
8272265|NCT01721473|20397760|P1|NOT COMPLETED|Overall Study||0
8272266|NCT01721473|20397755|P6|COMPLETED|Overall Study||18
8272267|NCT01721473|20397756|P5|COMPLETED|Overall Study||22
8272268|NCT01721473|20397757|P4|COMPLETED|Overall Study||34
8272269|NCT01721473|20397758|P3|COMPLETED|Overall Study||41
8272270|NCT01721473|20397759|P2|COMPLETED|Overall Study||22
8272271|NCT01721473|20397760|P1|COMPLETED|Overall Study||47
8272272|NCT01721473|20397755|P6|STARTED|Overall Study||18
8272273|NCT01721473|20397756|P5|STARTED|Overall Study||22
8272274|NCT01721473|20397757|P4|STARTED|Overall Study||34
8272275|NCT01721473|20397758|P3|STARTED|Overall Study||41
8272276|NCT01721473|20397759|P2|STARTED|Overall Study||22
8272277|NCT01721473|20397760|P1|STARTED|Overall Study||47
8272278|NCT01721460|20397769|P1|NOT COMPLETED|Overall Study||1
8272279|NCT01721460|20397769|P1|COMPLETED|Overall Study||5
8272280|NCT01721460|20397769|P1|STARTED|Overall Study||6
8272281|NCT01721447|20397776|P1|NOT COMPLETED|Overall Study||0
8272282|NCT01721447|20397776|P1|COMPLETED|Overall Study||100
8272283|NCT01721447|20397776|P1|STARTED|Overall Study||100
8272284|NCT01721408|20397785|P2|NOT COMPLETED|Overall Study||24
8272285|NCT01721408|20397786|P1|NOT COMPLETED|Overall Study||36
8272286|NCT01721408|20397785|P2|COMPLETED|Overall Study||207
8272287|NCT01721408|20397786|P1|COMPLETED|Overall Study||196
8272288|NCT01721408|20397785|P2|STARTED|Overall Study|Number of participants treated.|231
8272289|NCT01721408|20397786|P1|STARTED|Overall Study|Number of participants treated.|232
8272290|NCT01721369|20397800|P1|NOT COMPLETED|Overall Study||12
8272291|NCT01721369|20397800|P1|COMPLETED|Overall Study||569
8272292|NCT01721369|20397800|P1|STARTED|Overall Study||581
8272293|NCT01721330|20397806|P2|NOT COMPLETED|Overall Study||1
8272294|NCT01721330|20397807|P1|NOT COMPLETED|Overall Study||0
8272295|NCT01721330|20397806|P2|COMPLETED|Overall Study||1
8272296|NCT01721330|20397807|P1|COMPLETED|Overall Study||1
8272297|NCT01721330|20397806|P2|STARTED|Overall Study||2
8272298|NCT01721330|20397807|P1|STARTED|Overall Study||1
8272299|NCT01721317|20397815|P2|NOT COMPLETED|Overall Study||4
8272300|NCT01721317|20397816|P1|NOT COMPLETED|Overall Study||2
8272301|NCT01721317|20397815|P2|COMPLETED|Overall Study||0
8272302|NCT01721317|20397816|P1|COMPLETED|Overall Study||0
8272303|NCT01721317|20397815|P2|STARTED|Overall Study||4
8272304|NCT01721317|20397816|P1|STARTED|Overall Study||2
8272305|NCT01721226|20397884|P2|NOT COMPLETED|Overall Study||7
8272306|NCT01721226|20397885|P1|NOT COMPLETED|Overall Study||5
8272307|NCT01721226|20397884|P2|COMPLETED|Overall Study||50
8272308|NCT01721226|20397885|P1|COMPLETED|Overall Study||50
8272309|NCT01721226|20397884|P2|Week 24|Overall Study||50
8272310|NCT01721226|20397885|P1|Week 24|Overall Study||50
8272311|NCT01721226|20397884|P2|Week 12|Overall Study||53
8272312|NCT01721226|20397885|P1|Week 12|Overall Study||48
8272313|NCT01721226|20397884|P2|Baseline|Overall Study||57
8272314|NCT01721226|20397885|P1|Baseline|Overall Study||53
8272315|NCT01721226|20397884|P2|STARTED|Overall Study||57
8272316|NCT01721226|20397885|P1|STARTED|Overall Study||55
8272317|NCT01721200|20397895|P2|NOT COMPLETED|Overall Study||5
8272318|NCT01721200|20397896|P1|NOT COMPLETED|Overall Study||3
8272319|NCT01721200|20397895|P2|COMPLETED|Overall Study||58
8272320|NCT01721200|20397896|P1|COMPLETED|Overall Study||59
8272321|NCT01721200|20397895|P2|Completed 2 Week Follow-up|Overall Study||61
8272322|NCT01721200|20397896|P1|Completed 2 Week Follow-up|Overall Study||60
8272323|NCT01721200|20397895|P2|STARTED|Overall Study||63
8272324|NCT01721200|20397896|P1|STARTED|Overall Study||62
8272325|NCT01721161|20397921|P2|NOT COMPLETED|Overall Study||7
8272326|NCT01721161|20397922|P1|NOT COMPLETED|Overall Study||4
8272327|NCT01721161|20397921|P2|COMPLETED|Overall Study||34
8272328|NCT01721161|20397922|P1|COMPLETED|Overall Study||37
8272329|NCT01721161|20397921|P2|STARTED|Overall Study||41
8272330|NCT01721161|20397922|P1|STARTED|Overall Study||41
8272331|NCT01721109|20397945|P1|NOT COMPLETED|Overall Study||7
8272332|NCT01721109|20397945|P1|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
8272333|NCT01721109|20397945|P1|STARTED|Overall Study||50
8272334|NCT01721096|20397960|P2|NOT COMPLETED|Overall Study||204
8272335|NCT01721096|20397961|P1|NOT COMPLETED|Overall Study||320
8272336|NCT01721096|20397960|P2|COMPLETED|Overall Study||9
8272337|NCT01721096|20397961|P1|COMPLETED|Overall Study||3
8272338|NCT01721096|20397960|P2|STARTED|Overall Study||213
8272339|NCT01721096|20397961|P1|STARTED|Overall Study||323
8272340|NCT01721070|20398140|P1|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
8272341|NCT01721070|20398140|P1|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
8272342|NCT01721070|20398140|P1|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
8272343|NCT01721070|20398140|P1|NOT COMPLETED|SUF NT 15 mcg||0
8272344|NCT01721070|20398140|P1|COMPLETED|SUF NT 15 mcg||19
8272345|NCT01721070|20398140|P1|STARTED|SUF NT 15 mcg||19
8272346|NCT01721057|20398151|P7|NOT COMPLETED|Follow Up||0
8272347|NCT01721057|20398152|P6|NOT COMPLETED|Follow Up||0
8272348|NCT01721057|20398153|P5|NOT COMPLETED|Follow Up||0
8272349|NCT01721057|20398154|P4|NOT COMPLETED|Follow Up||0
8272350|NCT01721057|20398155|P3|NOT COMPLETED|Follow Up||0
8272351|NCT01721057|20398156|P2|NOT COMPLETED|Follow Up||0
8272352|NCT01721057|20398157|P1|NOT COMPLETED|Follow Up||0
8272353|NCT01721057|20398151|P7|COMPLETED|Follow Up||22
8272354|NCT01721057|20398152|P6|COMPLETED|Follow Up||19
8272355|NCT01721057|20398153|P5|COMPLETED|Follow Up||17
8272356|NCT01721057|20398154|P4|COMPLETED|Follow Up||0
8272357|NCT01721057|20398155|P3|COMPLETED|Follow Up||0
8272358|NCT01721057|20398156|P2|COMPLETED|Follow Up||0
8272359|NCT01721057|20398157|P1|COMPLETED|Follow Up||0
8272360|NCT01721057|20398151|P7|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
8272361|NCT01721057|20398152|P6|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
8272362|NCT01721057|20398153|P5|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
8272363|NCT01721057|20398154|P4|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
8272364|NCT01721057|20398155|P3|STARTED|Follow Up||0
8272365|NCT01721057|20398156|P2|STARTED|Follow Up||0
8272366|NCT01721057|20398157|P1|STARTED|Follow Up||0
8272367|NCT01721057|20398151|P7|NOT COMPLETED|Rescue Period||0
8272368|NCT01721057|20398152|P6|NOT COMPLETED|Rescue Period||0
8272369|NCT01721057|20398153|P5|NOT COMPLETED|Rescue Period||0
8272370|NCT01721057|20398154|P4|NOT COMPLETED|Rescue Period||3
8272371|NCT01721057|20398155|P3|NOT COMPLETED|Rescue Period||0
8272372|NCT01721057|20398156|P2|NOT COMPLETED|Rescue Period||0
8272373|NCT01721057|20398157|P1|NOT COMPLETED|Rescue Period||0
8272374|NCT01721057|20398151|P7|COMPLETED|Rescue Period||0
8272375|NCT01721057|20398152|P6|COMPLETED|Rescue Period||0
8272376|NCT01721057|20398153|P5|COMPLETED|Rescue Period||0
8272377|NCT01721057|20398154|P4|COMPLETED|Rescue Period||88
8272378|NCT01721057|20398155|P3|COMPLETED|Rescue Period||0
8272379|NCT01721057|20398156|P2|COMPLETED|Rescue Period||0
8272380|NCT01721057|20398157|P1|COMPLETED|Rescue Period||0
8272381|NCT01721057|20398151|P7|STARTED|Rescue Period||0
8272382|NCT01721057|20398152|P6|STARTED|Rescue Period||0
8272383|NCT01721057|20398153|P5|STARTED|Rescue Period||0
8272384|NCT01721057|20398154|P4|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
8272385|NCT01721057|20398155|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8272386|NCT01721057|20398156|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8272387|NCT01721057|20398157|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8272388|NCT01721057|20398151|P7|NOT COMPLETED|Treatment Period||0
8272389|NCT01721057|20398152|P6|NOT COMPLETED|Treatment Period||0
8272390|NCT01721057|20398153|P5|NOT COMPLETED|Treatment Period||0
8272391|NCT01721057|20398154|P4|NOT COMPLETED|Treatment Period||0
8272392|NCT01721057|20398155|P3|NOT COMPLETED|Treatment Period||23
8272393|NCT01721057|20398156|P2|NOT COMPLETED|Treatment Period||19
8272394|NCT01721057|20398157|P1|NOT COMPLETED|Treatment Period||28
8272395|NCT01721057|20398151|P7|COMPLETED|Treatment Period||0
8272396|NCT01721057|20398152|P6|COMPLETED|Treatment Period||0
8272397|NCT01721057|20398153|P5|COMPLETED|Treatment Period||0
8272398|NCT01721057|20398154|P4|COMPLETED|Treatment Period||0
8272399|NCT01721057|20398155|P3|COMPLETED|Treatment Period|"Completers include rescued participants."|204
8272400|NCT01721057|20398156|P2|COMPLETED|Treatment Period|"Completers include rescued participants."|210
8272401|NCT01721057|20398157|P1|COMPLETED|Treatment Period|"Completers include rescued participants."|200
8272402|NCT01721057|20398151|P7|Rescued|Treatment Period||0
8272403|NCT01721057|20398152|P6|Rescued|Treatment Period||0
8272404|NCT01721057|20398153|P5|Rescued|Treatment Period||0
8272405|NCT01721057|20398154|P4|Rescued|Treatment Period||0
8272406|NCT01721057|20398155|P3|Rescued|Treatment Period||15
8272407|NCT01721057|20398156|P2|Rescued|Treatment Period||21
8272408|NCT01721057|20398157|P1|Rescued|Treatment Period||55
8272409|NCT01721057|20398151|P7|Received at Least 1 Dose of Study Drug|Treatment Period||0
8272410|NCT01721057|20398152|P6|Received at Least 1 Dose of Study Drug|Treatment Period||0
8272411|NCT01721057|20398153|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
8272412|NCT01721057|20398154|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
8272413|NCT01721057|20398155|P3|Received at Least 1 Dose of Study Drug|Treatment Period||227
8272414|NCT01721057|20398156|P2|Received at Least 1 Dose of Study Drug|Treatment Period||229
8272415|NCT01721057|20398157|P1|Received at Least 1 Dose of Study Drug|Treatment Period||228
8272416|NCT01721057|20398151|P7|STARTED|Treatment Period||0
8272417|NCT01721057|20398152|P6|STARTED|Treatment Period||0
8272418|NCT01721057|20398153|P5|STARTED|Treatment Period||0
8272419|NCT01721057|20398154|P4|STARTED|Treatment Period||0
8272420|NCT01721057|20398155|P3|STARTED|Treatment Period||227
8272421|NCT01721057|20398156|P2|STARTED|Treatment Period||229
8272422|NCT01721057|20398157|P1|STARTED|Treatment Period||228
8272423|NCT01721044|20398230|P3|NOT COMPLETED|Follow Up||0
8272424|NCT01721044|20398231|P2|NOT COMPLETED|Follow Up||0
8272425|NCT01721044|20398232|P1|NOT COMPLETED|Follow Up||0
8272426|NCT01721044|20398230|P3|COMPLETED|Follow Up||20
8272427|NCT01721044|20398231|P2|COMPLETED|Follow Up||9
8272428|NCT01721044|20398232|P1|COMPLETED|Follow Up||19
8272429|NCT01721044|20398230|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
8272430|NCT01721044|20398231|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
8272431|NCT01721044|20398232|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
8272432|NCT01721044|20398230|P3|NOT COMPLETED|Treatment Period||19
8272433|NCT01721044|20398231|P2|NOT COMPLETED|Treatment Period||17
8272434|NCT01721044|20398232|P1|NOT COMPLETED|Treatment Period||32
8272435|NCT01721044|20398230|P3|COMPLETED|Treatment Period||158
8272436|NCT01721044|20398231|P2|COMPLETED|Treatment Period||157
8272437|NCT01721044|20398232|P1|COMPLETED|Treatment Period||144
8272438|NCT01721044|20398230|P3|Rescue Week 16-24|Treatment Period||33
8272439|NCT01721044|20398231|P2|Rescue Week 16-24|Treatment Period||38
8272440|NCT01721044|20398232|P1|Rescue Week 16-24|Treatment Period||56
8272441|NCT01721044|20398230|P3|STARTED|Treatment Period||177
8272442|NCT01721044|20398231|P2|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
8272443|NCT01721044|20398232|P1|STARTED|Treatment Period||176
8272444|NCT01720797|20398305|P2|NOT COMPLETED|Overall Study||0
8272445|NCT01720797|20398306|P1|NOT COMPLETED|Overall Study||3
8272446|NCT01720797|20398305|P2|COMPLETED|Overall Study||9
8272447|NCT01720797|20398306|P1|COMPLETED|Overall Study||9
8272448|NCT01720797|20398305|P2|STARTED|Overall Study||9
8272449|NCT01720797|20398306|P1|STARTED|Overall Study||12
8272450|NCT01720667|20398314|P2|NOT COMPLETED|Overall Study||1
8272451|NCT01720667|20398315|P1|NOT COMPLETED|Overall Study||4
8272452|NCT01720667|20398314|P2|COMPLETED|Overall Study||41
8272453|NCT01720667|20398315|P1|COMPLETED|Overall Study||60
8272454|NCT01720667|20398314|P2|Modified ITT|Overall Study||30
8272455|NCT01720667|20398315|P1|Modified ITT|Overall Study||53
8272456|NCT01720667|20398314|P2|Received 2nd Infusion of Alternate Drug|Overall Study||6
8272457|NCT01720667|20398315|P1|Received 2nd Infusion of Alternate Drug|Overall Study||27
8272458|NCT01720667|20398314|P2|Recieved Alternate Intervention|Overall Study||10
8272459|NCT01720667|20398315|P1|Recieved Alternate Intervention|Overall Study||45
8272460|NCT01720667|20398314|P2|Recieved Second Infusion of Same Drug|Overall Study||20
8272461|NCT01720667|20398315|P1|Recieved Second Infusion of Same Drug|Overall Study||50
8272462|NCT01720667|20398314|P2|STARTED|Overall Study||42
8272463|NCT01720667|20398315|P1|STARTED|Overall Study||64
8272464|NCT01720602|20398329|P1|NOT COMPLETED|Overall Study||5
8272465|NCT01720602|20398329|P1|COMPLETED|Overall Study||10
8272466|NCT01720602|20398329|P1|STARTED|Overall Study||15
8272479|NCT01720446|20398373|P4|NOT COMPLETED|Overall Study||20
8272480|NCT01720446|20398374|P3|NOT COMPLETED|Overall Study||20
8272481|NCT01720446|20398375|P2|NOT COMPLETED|Overall Study||11
8272482|NCT01720446|20398376|P1|NOT COMPLETED|Overall Study||14
8272483|NCT01720446|20398373|P4|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
8272484|NCT01720446|20398374|P3|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
8272485|NCT01720446|20398375|P2|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
8272573|NCT01719783|20398607|P1|COMPLETED|Dose 1||30
8272486|NCT01720446|20398376|P1|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
8272487|NCT01720446|20398373|P4|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
8272488|NCT01720446|20398374|P3|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
8272489|NCT01720446|20398375|P2|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
8272490|NCT01720446|20398376|P1|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
8272491|NCT01720446|20398373|P4|STARTED|Overall Study||825
8272492|NCT01720446|20398374|P3|STARTED|Overall Study||824
8272493|NCT01720446|20398375|P2|STARTED|Overall Study||822
8272494|NCT01720446|20398376|P1|STARTED|Overall Study||826
8272495|NCT01720316|20398437|P2|NOT COMPLETED|Open-label Glycine||0
8272496|NCT01720316|20398438|P1|NOT COMPLETED|Open-label Glycine||0
8272497|NCT01720316|20398437|P2|COMPLETED|Open-label Glycine||1
8272498|NCT01720316|20398438|P1|COMPLETED|Open-label Glycine||1
8272499|NCT01720316|20398437|P2|STARTED|Open-label Glycine||1
8272500|NCT01720316|20398438|P1|STARTED|Open-label Glycine||1
8272501|NCT01720316|20398437|P2|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
8272502|NCT01720316|20398438|P1|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
8272503|NCT01720316|20398437|P2|COMPLETED|Double-Blind Glycine Placebo Crossover||1
8272504|NCT01720316|20398438|P1|COMPLETED|Double-Blind Glycine Placebo Crossover||1
8272505|NCT01720316|20398437|P2|STARTED|Double-Blind Glycine Placebo Crossover||1
8272506|NCT01720316|20398438|P1|STARTED|Double-Blind Glycine Placebo Crossover||1
8272507|NCT01720277|20398486|P2|NOT COMPLETED|Overall Study||558
8272508|NCT01720277|20398487|P1|NOT COMPLETED|Overall Study||503
8272509|NCT01720277|20398486|P2|COMPLETED|Overall Study|intent-to-treat approach|938
8272510|NCT01720277|20398487|P1|COMPLETED|Overall Study|intent-to-treat approach|958
8272511|NCT01720277|20398486|P2|STARTED|Overall Study||1496
8272512|NCT01720277|20398487|P1|STARTED|Overall Study||1461
8272513|NCT01720264|20398497|P1|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12
8272514|NCT01720264|20398497|P1|COMPLETED|Post-transplant (Day 16) to 1 Year||2
8272515|NCT01720264|20398497|P1|STARTED|Post-transplant (Day 16) to 1 Year||14
8272516|NCT01720264|20398497|P1|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1
8272517|NCT01720264|20398497|P1|COMPLETED|Transplant With Sitagliptin for 15 Days||14
8272518|NCT01720264|20398497|P1|STARTED|Transplant With Sitagliptin for 15 Days||15
8272519|NCT01720251|20398507|P3|NOT COMPLETED|Overall Study||0
8272520|NCT01720251|20398508|P2|NOT COMPLETED|Overall Study||2
8272521|NCT01720251|20398509|P1|NOT COMPLETED|Overall Study||1
8272522|NCT01720251|20398507|P3|COMPLETED|Overall Study||82
8272523|NCT01720251|20398508|P2|COMPLETED|Overall Study||77
8272524|NCT01720251|20398509|P1|COMPLETED|Overall Study||78
8272525|NCT01720251|20398507|P3|STARTED|Overall Study||82
8272526|NCT01720251|20398508|P2|STARTED|Overall Study||79
8272527|NCT01720251|20398509|P1|STARTED|Overall Study||79
8272528|NCT01720225|20398519|P2|NOT COMPLETED|Overall Study||1
8272529|NCT01720225|20398520|P1|NOT COMPLETED|Overall Study||3
8272530|NCT01720225|20398519|P2|COMPLETED|Overall Study||39
8272531|NCT01720225|20398520|P1|COMPLETED|Overall Study||70
8272532|NCT01720225|20398519|P2|STARTED|Overall Study||40
8272533|NCT01720225|20398520|P1|STARTED|Overall Study||73
8272534|NCT01720173|20398528|P1|NOT COMPLETED|Overall Study||0
8272535|NCT01720173|20398528|P1|COMPLETED|Overall Study||30
8272536|NCT01720173|20398528|P1|STARTED|Overall Study||30
8272537|NCT01720069|20398539|P3|NOT COMPLETED|Overall Study||15
8272538|NCT01720069|20398540|P2|NOT COMPLETED|Overall Study||15
8272539|NCT01720069|20398541|P1|NOT COMPLETED|Overall Study||5
8272540|NCT01720069|20398539|P3|COMPLETED|Overall Study||48
8272541|NCT01720069|20398540|P2|COMPLETED|Overall Study||56
8272542|NCT01720069|20398541|P1|COMPLETED|Overall Study||57
8272543|NCT01720069|20398539|P3|Full Anaylsis Set|Overall Study||63
8272544|NCT01720069|20398540|P2|Full Anaylsis Set|Overall Study||71
8272545|NCT01720069|20398541|P1|Full Anaylsis Set|Overall Study||62
8272546|NCT01720069|20398539|P3|STARTED|Overall Study||63
8272547|NCT01720069|20398540|P2|STARTED|Overall Study||71
8272548|NCT01720069|20398541|P1|STARTED|Overall Study||62
8272549|NCT01720043|20398567|P1|NOT COMPLETED|Overall Study||1
8272550|NCT01720043|20398567|P1|COMPLETED|Overall Study||7
8272551|NCT01720043|20398567|P1|STARTED|Overall Study||8
8272552|NCT01719900|20398573|P2|NOT COMPLETED|Overall Study||2
8272553|NCT01719900|20398574|P1|NOT COMPLETED|Overall Study||7
8272554|NCT01719900|20398573|P2|COMPLETED|Overall Study||22
8272555|NCT01719900|20398574|P1|COMPLETED|Overall Study||22
8272556|NCT01719900|20398573|P2|STARTED|Overall Study||24
8272557|NCT01719900|20398574|P1|STARTED|Overall Study||29
8272558|NCT01719861|20398596|P1|NOT COMPLETED|Cycle 2||1
8272559|NCT01719861|20398596|P1|COMPLETED|Cycle 2||1
8272560|NCT01719861|20398596|P1|STARTED|Cycle 2||2
8272561|NCT01719861|20398596|P1|NOT COMPLETED|Cycle 1||4
8272562|NCT01719861|20398596|P1|COMPLETED|Cycle 1||2
8272563|NCT01719861|20398596|P1|STARTED|Cycle 1||6
8272564|NCT01719783|20398606|P2|NOT COMPLETED|Dose 2||0
8272565|NCT01719783|20398607|P1|NOT COMPLETED|Dose 2||1
8272566|NCT01719783|20398606|P2|COMPLETED|Dose 2||10
8272567|NCT01719783|20398607|P1|COMPLETED|Dose 2||29
8272568|NCT01719783|20398606|P2|STARTED|Dose 2||10
8272569|NCT01719783|20398607|P1|STARTED|Dose 2||30
8272570|NCT01719783|20398606|P2|NOT COMPLETED|Dose 1||0
8272571|NCT01719783|20398607|P1|NOT COMPLETED|Dose 1||0
8272572|NCT01719783|20398606|P2|COMPLETED|Dose 1||10
8272574|NCT01719783|20398606|P2|STARTED|Dose 1||10
8272575|NCT01719783|20398607|P1|STARTED|Dose 1||30
8272576|NCT01719757|20398693|P1|NOT COMPLETED|Overall Study||101
8272577|NCT01719757|20398693|P1|COMPLETED|Overall Study||258
8272578|NCT01719757|20398693|P1|STARTED|Overall Study||359
8272579|NCT01719744|20398701|P1|NOT COMPLETED|Overall Study||0
8272580|NCT01719744|20398701|P1|COMPLETED|Overall Study||25
8272581|NCT01719744|20398701|P1|STARTED|Overall Study||25
8272582|NCT01719653|20398712|P5|NOT COMPLETED|Overall Study||21
8272583|NCT01719653|20398713|P4|NOT COMPLETED|Overall Study||18
8272584|NCT01719653|20398714|P3|NOT COMPLETED|Overall Study||18
8272585|NCT01719653|20398715|P2|NOT COMPLETED|Overall Study||13
8272586|NCT01719653|20398716|P1|NOT COMPLETED|Overall Study||9
8272587|NCT01719653|20398712|P5|COMPLETED|Overall Study||200
8272588|NCT01719653|20398713|P4|COMPLETED|Overall Study||200
8272589|NCT01719653|20398714|P3|COMPLETED|Overall Study||200
8272590|NCT01719653|20398715|P2|COMPLETED|Overall Study||200
8272591|NCT01719653|20398716|P1|COMPLETED|Overall Study||200
8272592|NCT01719653|20398712|P5|STARTED|Overall Study||221
8272593|NCT01719653|20398713|P4|STARTED|Overall Study||218
8272594|NCT01719653|20398714|P3|STARTED|Overall Study||218
8272595|NCT01719653|20398715|P2|STARTED|Overall Study||213
8272596|NCT01719653|20398716|P1|STARTED|Overall Study||209
8272597|NCT01719367|20398738|P2|NOT COMPLETED|Overall Study||0
8272598|NCT01719367|20398739|P1|NOT COMPLETED|Overall Study||0
8272599|NCT01719367|20398738|P2|COMPLETED|Overall Study||19
8272600|NCT01719367|20398739|P1|COMPLETED|Overall Study||19
8272601|NCT01719367|20398738|P2|STARTED|Overall Study||19
8272602|NCT01719367|20398739|P1|STARTED|Overall Study||19
8272603|NCT01719224|20398747|P2|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
8272604|NCT01719224|20398748|P1|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
8272605|NCT01719224|20398747|P2|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
8272606|NCT01719224|20398748|P1|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
8272607|NCT01719224|20398747|P2|STARTED|Intervention 2: Position Change(At 3.5h)||16
8272608|NCT01719224|20398748|P1|STARTED|Intervention 2: Position Change(At 3.5h)||14
8272609|NCT01719224|20398747|P2|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
8272610|NCT01719224|20398748|P1|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
8272611|NCT01719224|20398747|P2|COMPLETED|Intervention 1: Sleeping Position 1||16
8272612|NCT01719224|20398748|P1|COMPLETED|Intervention 1: Sleeping Position 1||14
8272613|NCT01719224|20398747|P2|STARTED|Intervention 1: Sleeping Position 1||18
8272614|NCT01719224|20398748|P1|STARTED|Intervention 1: Sleeping Position 1||18
8272615|NCT01719172|20398757|P1|NOT COMPLETED|Overall Study||2
8272616|NCT01719172|20398757|P1|COMPLETED|Overall Study||28
8272617|NCT01719172|20398757|P1|STARTED|Overall Study||30
8272618|NCT01719003|20398771|P9|NOT COMPLETED|Overall Study||4
8272619|NCT01719003|20398772|P8|NOT COMPLETED|Overall Study||20
8272620|NCT01719003|20398773|P7|NOT COMPLETED|Overall Study||20
8272621|NCT01719003|20398774|P6|NOT COMPLETED|Overall Study||12
8272622|NCT01719003|20398775|P5|NOT COMPLETED|Overall Study||17
8272623|NCT01719003|20398776|P4|NOT COMPLETED|Overall Study||13
8272624|NCT01719003|20398777|P3|NOT COMPLETED|Overall Study||17
8272625|NCT01719003|20398778|P2|NOT COMPLETED|Overall Study||17
8272626|NCT01719003|20398779|P1|NOT COMPLETED|Overall Study||9
8272627|NCT01719003|20398771|P9|COMPLETED|Overall Study||49
8272628|NCT01719003|20398772|P8|COMPLETED|Overall Study||151
8272629|NCT01719003|20398773|P7|COMPLETED|Overall Study||150
8272630|NCT01719003|20398774|P6|COMPLETED|Overall Study||160
8272631|NCT01719003|20398775|P5|COMPLETED|Overall Study||150
8272632|NCT01719003|20398776|P4|COMPLETED|Overall Study||156
8272633|NCT01719003|20398777|P3|COMPLETED|Overall Study||154
8272634|NCT01719003|20398778|P2|COMPLETED|Overall Study||153
8272635|NCT01719003|20398779|P1|COMPLETED|Overall Study||161
8272636|NCT01719003|20398771|P9|STARTED|Overall Study||53
8272637|NCT01719003|20398772|P8|STARTED|Overall Study||171
8272638|NCT01719003|20398773|P7|STARTED|Overall Study||170
8272639|NCT01719003|20398774|P6|STARTED|Overall Study||172
8272640|NCT01719003|20398775|P5|STARTED|Overall Study||167
8272641|NCT01719003|20398776|P4|STARTED|Overall Study||169
8272642|NCT01719003|20398777|P3|STARTED|Overall Study||171
8272643|NCT01719003|20398778|P2|STARTED|Overall Study||170
8272644|NCT01719003|20398779|P1|STARTED|Overall Study||170
8272645|NCT01718691|20398816|P2|NOT COMPLETED|Overall Study||1
8272646|NCT01718691|20398817|P1|NOT COMPLETED|Overall Study||18
8272647|NCT01718691|20398816|P2|COMPLETED|Overall Study||9
8272648|NCT01718691|20398817|P1|COMPLETED|Overall Study||42
8272649|NCT01718691|20398816|P2|STARTED|Overall Study||10
8272650|NCT01718691|20398817|P1|STARTED|Overall Study||60
8272651|NCT01718535|20398860|P10|NOT COMPLETED|Overall Study||0
8272652|NCT01718535|20398861|P9|NOT COMPLETED|Overall Study||0
8272653|NCT01718535|20398862|P8|NOT COMPLETED|Overall Study||0
8272654|NCT01718535|20398863|P7|NOT COMPLETED|Overall Study||0
8272655|NCT01718535|20398864|P6|NOT COMPLETED|Overall Study||0
8272656|NCT01718535|20398865|P5|NOT COMPLETED|Overall Study||0
8272657|NCT01718535|20398866|P4|NOT COMPLETED|Overall Study||1
8272658|NCT01718535|20398867|P3|NOT COMPLETED|Overall Study||0
8272659|NCT01718535|20398868|P2|NOT COMPLETED|Overall Study||0
8272660|NCT01718535|20398869|P1|NOT COMPLETED|Overall Study||1
8272661|NCT01718535|20398860|P10|COMPLETED|Overall Study||1
8272662|NCT01718535|20398861|P9|COMPLETED|Overall Study||15
8272663|NCT01718535|20398862|P8|COMPLETED|Overall Study||6
8272664|NCT01718535|20398863|P7|COMPLETED|Overall Study||11
8272665|NCT01718535|20398864|P6|COMPLETED|Overall Study||40
8272666|NCT01718535|20398865|P5|COMPLETED|Overall Study||1
8272667|NCT01718535|20398866|P4|COMPLETED|Overall Study||7
8272668|NCT01718535|20398867|P3|COMPLETED|Overall Study||19
8272669|NCT01718535|20398868|P2|COMPLETED|Overall Study||95
8272670|NCT01718535|20398869|P1|COMPLETED|Overall Study||130
8272671|NCT01718535|20398860|P10|First Pass|Overall Study||1
8272672|NCT01718535|20398861|P9|First Pass|Overall Study||15
8272673|NCT01718535|20398862|P8|First Pass|Overall Study||6
8272674|NCT01718535|20398863|P7|First Pass|Overall Study||11
8272675|NCT01718535|20398864|P6|First Pass|Overall Study||39
8272676|NCT01718535|20398865|P5|First Pass|Overall Study||1
8272677|NCT01718535|20398866|P4|First Pass|Overall Study||7
8272678|NCT01718535|20398867|P3|First Pass|Overall Study||19
8272679|NCT01718535|20398868|P2|First Pass|Overall Study||94
8272680|NCT01718535|20398869|P1|First Pass|Overall Study||128
8272681|NCT01718535|20398860|P10|STARTED|Overall Study||1
8272682|NCT01718535|20398861|P9|STARTED|Overall Study||15
8272683|NCT01718535|20398862|P8|STARTED|Overall Study||6
8272684|NCT01718535|20398863|P7|STARTED|Overall Study||11
8272685|NCT01718535|20398864|P6|STARTED|Overall Study||40
8272686|NCT01718535|20398865|P5|STARTED|Overall Study||1
8272687|NCT01718535|20398866|P4|STARTED|Overall Study||8
8272688|NCT01718535|20398867|P3|STARTED|Overall Study||19
8272689|NCT01718535|20398868|P2|STARTED|Overall Study||95
8272690|NCT01718535|20398869|P1|STARTED|Overall Study||131
8272691|NCT01718522|20398891|P1|NOT COMPLETED|Overall Study||8
8272692|NCT01718522|20398891|P1|COMPLETED|Overall Study||67
8272693|NCT01718522|20398891|P1|STARTED|Overall Study||75
8272708|NCT01718444|20399001|P2|NOT COMPLETED|Overall Study||0
8272709|NCT01718444|20399002|P1|NOT COMPLETED|Overall Study||0
8272710|NCT01718444|20399001|P2|COMPLETED|Overall Study||0
8272711|NCT01718444|20399002|P1|COMPLETED|Overall Study||0
8272712|NCT01718444|20399001|P2|STARTED|Overall Study||0
8272713|NCT01718444|20399002|P1|STARTED|Overall Study||0
8272714|NCT01718353|20399010|P2|NOT COMPLETED|Overall Study||5
8272715|NCT01718353|20399011|P1|NOT COMPLETED|Overall Study||12
8272716|NCT01718353|20399010|P2|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
8272717|NCT01718353|20399011|P1|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
8272718|NCT01718353|20399010|P2|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
8272719|NCT01718353|20399011|P1|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
8272720|NCT01718353|20399010|P2|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
8272721|NCT01718353|20399011|P1|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
8272722|NCT01718353|20399010|P2|Treated|Overall Study||22
8272723|NCT01718353|20399011|P1|Treated|Overall Study||39
8272724|NCT01718353|20399010|P2|STARTED|Overall Study||22
8272725|NCT01718353|20399011|P1|STARTED|Overall Study||41
8272726|NCT01718028|20399029|P2|NOT COMPLETED|Overall Study||0
8272727|NCT01718028|20399030|P1|NOT COMPLETED|Overall Study||0
8272728|NCT01718028|20399029|P2|COMPLETED|Overall Study||24
8272729|NCT01718028|20399030|P1|COMPLETED|Overall Study||25
8272730|NCT01718028|20399029|P2|STARTED|Overall Study||24
8272731|NCT01718028|20399030|P1|STARTED|Overall Study||25
8272732|NCT01717989|20399042|P1|NOT COMPLETED|Overall Study||1066
8272733|NCT01717989|20399042|P1|COMPLETED|Overall Study||1182
8272734|NCT01717989|20399042|P1|STARTED|Overall Study||2248
8272735|NCT01717976|20399110|P2|NOT COMPLETED|Overall Study||1
8272736|NCT01717976|20399111|P1|NOT COMPLETED|Overall Study||0
8272737|NCT01717976|20399110|P2|COMPLETED|Overall Study||256
8272738|NCT01717976|20399111|P1|COMPLETED|Overall Study||257
8272739|NCT01717976|20399110|P2|STARTED|Overall Study||257
8272740|NCT01717976|20399111|P1|STARTED|Overall Study||257
8272741|NCT01717898|20399125|P4|NOT COMPLETED|Overall Study||0
8272742|NCT01717898|20399126|P3|NOT COMPLETED|Overall Study||0
8272743|NCT01717898|20399127|P2|NOT COMPLETED|Overall Study||0
8272744|NCT01717898|20399128|P1|NOT COMPLETED|Overall Study||6
8272745|NCT01717898|20399125|P4|COMPLETED|Overall Study||0
8272746|NCT01717898|20399126|P3|COMPLETED|Overall Study||0
8272747|NCT01717898|20399127|P2|COMPLETED|Overall Study||0
8272748|NCT01717898|20399128|P1|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
8272749|NCT01717898|20399125|P4|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
8272750|NCT01717898|20399126|P3|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
8272751|NCT01717898|20399127|P2|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
8272752|NCT01717898|20399128|P1|STARTED|Overall Study||6
8272753|NCT01717872|20399155|P2|NOT COMPLETED|Overall Study||0
8272754|NCT01717872|20399156|P1|NOT COMPLETED|Overall Study||0
8272755|NCT01717872|20399155|P2|COMPLETED|Overall Study||25
8272756|NCT01717872|20399156|P1|COMPLETED|Overall Study||25
8272757|NCT01717872|20399155|P2|STARTED|Overall Study||25
8272758|NCT01717872|20399156|P1|STARTED|Overall Study||25
8272759|NCT01717859|20399166|P1|NOT COMPLETED|Overall Study||10
8272760|NCT01717859|20399166|P1|COMPLETED|Overall Study||44
8272761|NCT01717859|20399166|P1|3 Month|Overall Study||50
8272762|NCT01717859|20399166|P1|STARTED|Overall Study||54
8272763|NCT01717768|20399187|P12|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272764|NCT01717768|20399188|P11|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272765|NCT01717768|20399189|P10|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
8272766|NCT01717768|20399190|P9|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272767|NCT01717768|20399191|P8|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
8272768|NCT01717768|20399192|P7|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272769|NCT01717768|20399193|P6|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272770|NCT01717768|20399194|P5|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272771|NCT01717768|20399195|P4|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272772|NCT01717768|20399196|P3|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272773|NCT01717768|20399197|P2|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272774|NCT01717768|20399198|P1|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272775|NCT01717768|20399187|P12|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272776|NCT01717768|20399188|P11|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272777|NCT01717768|20399189|P10|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
8272778|NCT01717768|20399190|P9|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272779|NCT01717768|20399191|P8|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
8272780|NCT01717768|20399192|P7|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272781|NCT01717768|20399193|P6|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272782|NCT01717768|20399194|P5|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272783|NCT01717768|20399195|P4|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272784|NCT01717768|20399196|P3|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272785|NCT01717768|20399197|P2|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272786|NCT01717768|20399198|P1|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272787|NCT01717768|20399187|P12|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272788|NCT01717768|20399188|P11|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272789|NCT01717768|20399189|P10|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
8272790|NCT01717768|20399190|P9|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272791|NCT01717768|20399191|P8|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
8272792|NCT01717768|20399192|P7|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272793|NCT01717768|20399193|P6|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272794|NCT01717768|20399194|P5|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272795|NCT01717768|20399195|P4|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272796|NCT01717768|20399196|P3|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272797|NCT01717768|20399197|P2|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272798|NCT01717768|20399198|P1|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
8272799|NCT01717768|20399187|P12|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
8272800|NCT01717768|20399188|P11|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272801|NCT01717768|20399189|P10|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272802|NCT01717768|20399190|P9|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272803|NCT01717768|20399191|P8|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272804|NCT01717768|20399192|P7|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272805|NCT01717768|20399193|P6|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272806|NCT01717768|20399194|P5|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272807|NCT01717768|20399195|P4|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272808|NCT01717768|20399196|P3|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272809|NCT01717768|20399197|P2|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272810|NCT01717768|20399198|P1|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272811|NCT01717768|20399187|P12|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
8272812|NCT01717768|20399188|P11|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
8272813|NCT01717768|20399189|P10|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272814|NCT01717768|20399190|P9|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
8272815|NCT01717768|20399191|P8|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272816|NCT01717768|20399192|P7|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
8272817|NCT01717768|20399193|P6|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272818|NCT01717768|20399194|P5|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272819|NCT01717768|20399195|P4|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272820|NCT01717768|20399196|P3|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272821|NCT01717768|20399197|P2|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272822|NCT01717768|20399198|P1|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272823|NCT01717768|20399187|P12|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
8272824|NCT01717768|20399188|P11|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
8272825|NCT01717768|20399189|P10|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272826|NCT01717768|20399190|P9|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
8272827|NCT01717768|20399191|P8|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272828|NCT01717768|20399192|P7|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
8272829|NCT01717768|20399193|P6|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272830|NCT01717768|20399194|P5|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272831|NCT01717768|20399195|P4|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272832|NCT01717768|20399196|P3|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272833|NCT01717768|20399197|P2|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272834|NCT01717768|20399198|P1|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
8272835|NCT01717768|20399187|P12|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272836|NCT01717768|20399188|P11|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272837|NCT01717768|20399189|P10|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272838|NCT01717768|20399190|P9|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272839|NCT01717768|20399191|P8|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272840|NCT01717768|20399192|P7|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272841|NCT01717768|20399193|P6|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272842|NCT01717768|20399194|P5|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272843|NCT01717768|20399195|P4|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272844|NCT01717768|20399196|P3|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272845|NCT01717768|20399197|P2|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272846|NCT01717768|20399198|P1|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272847|NCT01717768|20399187|P12|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272848|NCT01717768|20399188|P11|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272849|NCT01717768|20399189|P10|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272850|NCT01717768|20399190|P9|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272851|NCT01717768|20399191|P8|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272852|NCT01717768|20399192|P7|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272853|NCT01717768|20399193|P6|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
8272854|NCT01717768|20399194|P5|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
8272855|NCT01717768|20399195|P4|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
8272856|NCT01717768|20399196|P3|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272857|NCT01717768|20399197|P2|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272858|NCT01717768|20399198|P1|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272859|NCT01717768|20399187|P12|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272860|NCT01717768|20399188|P11|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272861|NCT01717768|20399189|P10|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272862|NCT01717768|20399190|P9|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272863|NCT01717768|20399191|P8|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272864|NCT01717768|20399192|P7|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272865|NCT01717768|20399193|P6|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
8272866|NCT01717768|20399194|P5|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
8272867|NCT01717768|20399195|P4|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
8272868|NCT01717768|20399196|P3|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272869|NCT01717768|20399197|P2|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272870|NCT01717768|20399198|P1|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
8272871|NCT01717768|20399187|P12|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272872|NCT01717768|20399188|P11|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272873|NCT01717768|20399189|P10|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272874|NCT01717768|20399190|P9|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272875|NCT01717768|20399191|P8|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272876|NCT01717768|20399192|P7|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272877|NCT01717768|20399193|P6|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272878|NCT01717768|20399194|P5|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272879|NCT01717768|20399195|P4|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272880|NCT01717768|20399196|P3|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272881|NCT01717768|20399197|P2|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272882|NCT01717768|20399198|P1|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272883|NCT01717768|20399187|P12|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272884|NCT01717768|20399188|P11|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272885|NCT01717768|20399189|P10|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272886|NCT01717768|20399190|P9|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272887|NCT01717768|20399191|P8|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272888|NCT01717768|20399192|P7|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272889|NCT01717768|20399193|P6|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
8272890|NCT01717768|20399194|P5|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
8272891|NCT01717768|20399195|P4|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
8272892|NCT01717768|20399196|P3|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272893|NCT01717768|20399197|P2|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272894|NCT01717768|20399198|P1|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272895|NCT01717768|20399187|P12|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272896|NCT01717768|20399188|P11|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272897|NCT01717768|20399189|P10|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272898|NCT01717768|20399190|P9|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272899|NCT01717768|20399191|P8|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272900|NCT01717768|20399192|P7|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272901|NCT01717768|20399193|P6|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
8272902|NCT01717768|20399194|P5|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
8272903|NCT01717768|20399195|P4|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
8272904|NCT01717768|20399196|P3|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272905|NCT01717768|20399197|P2|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272906|NCT01717768|20399198|P1|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
8272907|NCT01717768|20399187|P12|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272908|NCT01717768|20399188|P11|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272909|NCT01717768|20399189|P10|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272910|NCT01717768|20399190|P9|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272911|NCT01717768|20399191|P8|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272912|NCT01717768|20399192|P7|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272913|NCT01717768|20399193|P6|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272914|NCT01717768|20399194|P5|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272915|NCT01717768|20399195|P4|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272916|NCT01717768|20399196|P3|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272917|NCT01717768|20399197|P2|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272918|NCT01717768|20399198|P1|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272919|NCT01717768|20399187|P12|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272920|NCT01717768|20399188|P11|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272921|NCT01717768|20399189|P10|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272922|NCT01717768|20399190|P9|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272923|NCT01717768|20399191|P8|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272924|NCT01717768|20399192|P7|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272925|NCT01717768|20399193|P6|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
8272926|NCT01717768|20399194|P5|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
8272927|NCT01717768|20399195|P4|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
8272928|NCT01717768|20399196|P3|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272929|NCT01717768|20399197|P2|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272930|NCT01717768|20399198|P1|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272931|NCT01717768|20399187|P12|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272932|NCT01717768|20399188|P11|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272933|NCT01717768|20399189|P10|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272934|NCT01717768|20399190|P9|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272935|NCT01717768|20399191|P8|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272936|NCT01717768|20399192|P7|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272937|NCT01717768|20399193|P6|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
8272938|NCT01717768|20399194|P5|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
8272939|NCT01717768|20399195|P4|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
8272940|NCT01717768|20399196|P3|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272941|NCT01717768|20399197|P2|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272942|NCT01717768|20399198|P1|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
8272943|NCT01717768|20399187|P12|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272944|NCT01717768|20399188|P11|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272945|NCT01717768|20399189|P10|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272946|NCT01717768|20399190|P9|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272947|NCT01717768|20399191|P8|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272948|NCT01717768|20399192|P7|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272949|NCT01717768|20399193|P6|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272950|NCT01717768|20399194|P5|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272951|NCT01717768|20399195|P4|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272952|NCT01717768|20399196|P3|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272953|NCT01717768|20399197|P2|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272954|NCT01717768|20399198|P1|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
8272955|NCT01717768|20399187|P12|COMPLETED|Part 2 (Duration of 15 Days)||0
8272956|NCT01717768|20399188|P11|COMPLETED|Part 2 (Duration of 15 Days)||0
8272957|NCT01717768|20399189|P10|COMPLETED|Part 2 (Duration of 15 Days)||0
8272958|NCT01717768|20399190|P9|COMPLETED|Part 2 (Duration of 15 Days)||0
8272959|NCT01717768|20399191|P8|COMPLETED|Part 2 (Duration of 15 Days)||0
8272960|NCT01717768|20399192|P7|COMPLETED|Part 2 (Duration of 15 Days)||0
8272961|NCT01717768|20399193|P6|COMPLETED|Part 2 (Duration of 15 Days)||0
8272962|NCT01717768|20399194|P5|COMPLETED|Part 2 (Duration of 15 Days)||0
8272963|NCT01717768|20399195|P4|COMPLETED|Part 2 (Duration of 15 Days)||0
8272964|NCT01717768|20399196|P3|COMPLETED|Part 2 (Duration of 15 Days)||17
8272965|NCT01717768|20399197|P2|COMPLETED|Part 2 (Duration of 15 Days)||0
8272966|NCT01717768|20399198|P1|COMPLETED|Part 2 (Duration of 15 Days)||0
8272967|NCT01717768|20399187|P12|STARTED|Part 2 (Duration of 15 Days)||0
8272968|NCT01717768|20399188|P11|STARTED|Part 2 (Duration of 15 Days)||0
8272969|NCT01717768|20399189|P10|STARTED|Part 2 (Duration of 15 Days)||0
8272970|NCT01717768|20399190|P9|STARTED|Part 2 (Duration of 15 Days)||0
8272971|NCT01717768|20399191|P8|STARTED|Part 2 (Duration of 15 Days)||0
8272972|NCT01717768|20399192|P7|STARTED|Part 2 (Duration of 15 Days)||0
8272973|NCT01717768|20399193|P6|STARTED|Part 2 (Duration of 15 Days)||0
8272974|NCT01717768|20399194|P5|STARTED|Part 2 (Duration of 15 Days)||0
8272975|NCT01717768|20399195|P4|STARTED|Part 2 (Duration of 15 Days)||0
8272976|NCT01717768|20399196|P3|STARTED|Part 2 (Duration of 15 Days)||17
8272977|NCT01717768|20399197|P2|STARTED|Part 2 (Duration of 15 Days)||0
8272978|NCT01717768|20399198|P1|STARTED|Part 2 (Duration of 15 Days)||0
8272979|NCT01717768|20399187|P12|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272980|NCT01717768|20399188|P11|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272981|NCT01717768|20399189|P10|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272982|NCT01717768|20399190|P9|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272983|NCT01717768|20399191|P8|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272984|NCT01717768|20399192|P7|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272985|NCT01717768|20399193|P6|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272986|NCT01717768|20399194|P5|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272987|NCT01717768|20399195|P4|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272988|NCT01717768|20399196|P3|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272989|NCT01717768|20399197|P2|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
8272990|NCT01717768|20399198|P1|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
8272991|NCT01717768|20399187|P12|COMPLETED|Part 1 (Duration of 15 Days)||0
8272992|NCT01717768|20399188|P11|COMPLETED|Part 1 (Duration of 15 Days)||0
8272993|NCT01717768|20399189|P10|COMPLETED|Part 1 (Duration of 15 Days)||0
8272994|NCT01717768|20399190|P9|COMPLETED|Part 1 (Duration of 15 Days)||0
8272995|NCT01717768|20399191|P8|COMPLETED|Part 1 (Duration of 15 Days)||0
8272996|NCT01717768|20399192|P7|COMPLETED|Part 1 (Duration of 15 Days)||0
8272997|NCT01717768|20399193|P6|COMPLETED|Part 1 (Duration of 15 Days)||0
8272998|NCT01717768|20399194|P5|COMPLETED|Part 1 (Duration of 15 Days)||0
8272999|NCT01717768|20399195|P4|COMPLETED|Part 1 (Duration of 15 Days)||0
8273000|NCT01717768|20399196|P3|COMPLETED|Part 1 (Duration of 15 Days)||0
8273001|NCT01717768|20399197|P2|COMPLETED|Part 1 (Duration of 15 Days)||16
8273002|NCT01717768|20399198|P1|COMPLETED|Part 1 (Duration of 15 Days)||17
8273003|NCT01717768|20399187|P12|STARTED|Part 1 (Duration of 15 Days)||0
8273004|NCT01717768|20399188|P11|STARTED|Part 1 (Duration of 15 Days)||0
8273005|NCT01717768|20399189|P10|STARTED|Part 1 (Duration of 15 Days)||0
8273006|NCT01717768|20399190|P9|STARTED|Part 1 (Duration of 15 Days)||0
8273007|NCT01717768|20399191|P8|STARTED|Part 1 (Duration of 15 Days)||0
8273008|NCT01717768|20399192|P7|STARTED|Part 1 (Duration of 15 Days)||0
8273009|NCT01717768|20399193|P6|STARTED|Part 1 (Duration of 15 Days)||0
8273010|NCT01717768|20399194|P5|STARTED|Part 1 (Duration of 15 Days)||0
8273011|NCT01717768|20399195|P4|STARTED|Part 1 (Duration of 15 Days)||0
8273012|NCT01717768|20399196|P3|STARTED|Part 1 (Duration of 15 Days)||0
8273013|NCT01717768|20399197|P2|STARTED|Part 1 (Duration of 15 Days)||17
8273014|NCT01717768|20399198|P1|STARTED|Part 1 (Duration of 15 Days)||17
8273015|NCT01717742|20399238|P2|NOT COMPLETED|Overall Study||2
8273016|NCT01717742|20399239|P1|NOT COMPLETED|Overall Study||5
8273017|NCT01717742|20399238|P2|COMPLETED|Overall Study||47
8273018|NCT01717742|20399239|P1|COMPLETED|Overall Study||43
8273019|NCT01717742|20399238|P2|STARTED|Overall Study||49
8273020|NCT01717742|20399239|P1|STARTED|Overall Study||48
8273021|NCT01717638|20399278|P13|NOT COMPLETED|Overall Study||19
8273022|NCT01717638|20399279|P12|NOT COMPLETED|Overall Study||0
8273023|NCT01717638|20399280|P11|NOT COMPLETED|Overall Study||0
8273024|NCT01717638|20399281|P10|NOT COMPLETED|Overall Study||1
8273025|NCT01717638|20399282|P9|NOT COMPLETED|Overall Study||2
8273026|NCT01717638|20399283|P8|NOT COMPLETED|Overall Study||1
8273027|NCT01717638|20399284|P7|NOT COMPLETED|Overall Study||2
8273028|NCT01717638|20399285|P6|NOT COMPLETED|Overall Study||1
8273029|NCT01717638|20399286|P5|NOT COMPLETED|Overall Study||1
8273030|NCT01717638|20399287|P4|NOT COMPLETED|Overall Study||0
8273031|NCT01717638|20399288|P3|NOT COMPLETED|Overall Study||1
8273032|NCT01717638|20399289|P2|NOT COMPLETED|Overall Study||1
8273033|NCT01717638|20399290|P1|NOT COMPLETED|Overall Study||0
8273034|NCT01717638|20399278|P13|COMPLETED|Overall Study||190
8273035|NCT01717638|20399279|P12|COMPLETED|Overall Study||12
8273036|NCT01717638|20399280|P11|COMPLETED|Overall Study||11
8273037|NCT01717638|20399281|P10|COMPLETED|Overall Study||99
8273038|NCT01717638|20399282|P9|COMPLETED|Overall Study||26
8273039|NCT01717638|20399283|P8|COMPLETED|Overall Study||28
8273040|NCT01717638|20399284|P7|COMPLETED|Overall Study||41
8273041|NCT01717638|20399285|P6|COMPLETED|Overall Study||54
8273042|NCT01717638|20399286|P5|COMPLETED|Overall Study||63
8273043|NCT01717638|20399287|P4|COMPLETED|Overall Study||66
8273044|NCT01717638|20399288|P3|COMPLETED|Overall Study||59
8273045|NCT01717638|20399289|P2|COMPLETED|Overall Study||60
8273046|NCT01717638|20399290|P1|COMPLETED|Overall Study||67
8273047|NCT01717638|20399278|P13|STARTED|Overall Study||209
8273048|NCT01717638|20399279|P12|STARTED|Overall Study||12
8273049|NCT01717638|20399280|P11|STARTED|Overall Study||11
8273050|NCT01717638|20399281|P10|STARTED|Overall Study||100
8273051|NCT01717638|20399282|P9|STARTED|Overall Study||28
8273052|NCT01717638|20399283|P8|STARTED|Overall Study||29
8273053|NCT01717638|20399284|P7|STARTED|Overall Study||43
8273054|NCT01717638|20399285|P6|STARTED|Overall Study||55
8273055|NCT01717638|20399286|P5|STARTED|Overall Study||64
8273056|NCT01717638|20399287|P4|STARTED|Overall Study||66
8273057|NCT01717638|20399288|P3|STARTED|Overall Study||60
8273058|NCT01717638|20399289|P2|STARTED|Overall Study||61
8273059|NCT01717638|20399290|P1|STARTED|Overall Study||67
8273060|NCT01717521|20399432|P1|NOT COMPLETED|Overall Study||0
8273061|NCT01717521|20399432|P1|COMPLETED|Overall Study||20
8273062|NCT01717521|20399432|P1|STARTED|Overall Study||20
8273063|NCT01717482|20399451|P2|NOT COMPLETED|Overall Study||0
8273064|NCT01717482|20399452|P1|NOT COMPLETED|Overall Study||4
8273065|NCT01717482|20399451|P2|COMPLETED|Overall Study||2
8273066|NCT01717482|20399452|P1|COMPLETED|Overall Study||0
8273067|NCT01717482|20399451|P2|STARTED|Overall Study||2
8273068|NCT01717482|20399452|P1|STARTED|Overall Study||4
8273069|NCT01717456|20399466|P2|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
8273070|NCT01717456|20399467|P1|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
8273071|NCT01717456|20399466|P2|COMPLETED|Follow-Up 6 Months After End of Tx||2
8273072|NCT01717456|20399467|P1|COMPLETED|Follow-Up 6 Months After End of Tx||7
8273073|NCT01717456|20399466|P2|STARTED|Follow-Up 6 Months After End of Tx||6
8273074|NCT01717456|20399467|P1|STARTED|Follow-Up 6 Months After End of Tx||11
8273075|NCT01717456|20399466|P2|NOT COMPLETED|End of Treatment||2
8273076|NCT01717456|20399467|P1|NOT COMPLETED|End of Treatment||0
8273077|NCT01717456|20399466|P2|COMPLETED|End of Treatment||6
8273078|NCT01717456|20399467|P1|COMPLETED|End of Treatment||11
8273079|NCT01717456|20399466|P2|STARTED|End of Treatment||8
8273080|NCT01717456|20399467|P1|STARTED|End of Treatment||11
8273081|NCT01717391|20399535|P1|NOT COMPLETED|Overall Study||9
8273082|NCT01717391|20399535|P1|COMPLETED|Overall Study||27
8273083|NCT01717391|20399535|P1|STARTED|Overall Study||36
8273164|NCT01717313|20399847|P2|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
8273165|NCT01717313|20399848|P1|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
8273166|NCT01717313|20399847|P2|COMPLETED|Phase B (Weeks 24 to 54)||135
8273167|NCT01717313|20399848|P1|COMPLETED|Phase B (Weeks 24 to 54)||134
8273168|NCT01717313|20399847|P2|STARTED|Phase B (Weeks 24 to 54)||151
8273169|NCT01717313|20399848|P1|STARTED|Phase B (Weeks 24 to 54)||146
8273170|NCT01717313|20399847|P2|NOT COMPLETED|Interphase||0
8273171|NCT01717313|20399848|P1|NOT COMPLETED|Interphase||1
8273172|NCT01717313|20399847|P2|COMPLETED|Interphase||151
8273173|NCT01717313|20399848|P1|COMPLETED|Interphase||146
8273174|NCT01717313|20399847|P2|STARTED|Interphase||151
8273175|NCT01717313|20399848|P1|STARTED|Interphase||147
8273176|NCT01717313|20399847|P2|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
8273177|NCT01717313|20399848|P1|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
8273178|NCT01717313|20399847|P2|COMPLETED|Phase A (Weeks 0 to 24)||151
8273179|NCT01717313|20399848|P1|COMPLETED|Phase A (Weeks 0 to 24)||147
8273180|NCT01717313|20399847|P2|STARTED|Phase A (Weeks 0 to 24)||164
8273181|NCT01717313|20399848|P1|STARTED|Phase A (Weeks 0 to 24)||165
8273182|NCT01717287|20399886|P2|NOT COMPLETED|Overall Study||3
8273183|NCT01717287|20399887|P1|NOT COMPLETED|Overall Study||0
8273184|NCT01717287|20399886|P2|COMPLETED|Overall Study||25
8273185|NCT01717287|20399887|P1|COMPLETED|Overall Study||4
8273186|NCT01717287|20399886|P2|STARTED|Overall Study||28
8273187|NCT01717287|20399887|P1|STARTED|Overall Study||4
8273188|NCT01717209|20399909|P1|NOT COMPLETED|Overall Study||0
8273189|NCT01717209|20399909|P1|COMPLETED|Overall Study||14
8273190|NCT01717209|20399909|P1|STARTED|Overall Study||14
8273194|NCT01717040|20399927|P2|NOT COMPLETED|Overall Study||5
8273195|NCT01717040|20399928|P1|NOT COMPLETED|Overall Study||5
8273196|NCT01717040|20399927|P2|COMPLETED|Overall Study||15
8273197|NCT01717040|20399928|P1|COMPLETED|Overall Study||12
8273198|NCT01717040|20399927|P2|STARTED|Overall Study||20
8273199|NCT01717040|20399928|P1|STARTED|Overall Study||17
8273200|NCT01717014|20399934|P1|NOT COMPLETED|Overall Study||0
8273201|NCT01717014|20399934|P1|COMPLETED|Overall Study||8
8273202|NCT01717014|20399934|P1|STARTED|Overall Study||8
8273203|NCT01717001|20399944|P2|NOT COMPLETED|Overall Study||4
8273204|NCT01717001|20399945|P1|NOT COMPLETED|Overall Study||6
8273205|NCT01717001|20399944|P2|COMPLETED|Overall Study||24
8273206|NCT01717001|20399945|P1|COMPLETED|Overall Study||32
8273207|NCT01717001|20399944|P2|STARTED|Overall Study||28
8273208|NCT01717001|20399945|P1|STARTED|Overall Study||38
8273209|NCT01716754|20399955|P4|NOT COMPLETED|Overall Study||8
8273210|NCT01716754|20399956|P3|NOT COMPLETED|Overall Study||14
8273211|NCT01716754|20399957|P2|NOT COMPLETED|Overall Study||4
8273212|NCT01716754|20399958|P1|NOT COMPLETED|Overall Study||11
8273213|NCT01716754|20399955|P4|COMPLETED|Overall Study||89
8273214|NCT01716754|20399956|P3|COMPLETED|Overall Study||121
8273215|NCT01716754|20399957|P2|COMPLETED|Overall Study||36
8273216|NCT01716754|20399958|P1|COMPLETED|Overall Study||188
8273217|NCT01716754|20399955|P4|Safety Set|Overall Study||96
8273218|NCT01716754|20399956|P3|Safety Set|Overall Study||131
8273219|NCT01716754|20399957|P2|Safety Set|Overall Study||40
8273220|NCT01716754|20399958|P1|Safety Set|Overall Study||199
8273221|NCT01716754|20399955|P4|FAS|Overall Study||96
8273222|NCT01716754|20399956|P3|FAS|Overall Study||131
8273223|NCT01716754|20399957|P2|FAS|Overall Study||40
8273224|NCT01716754|20399958|P1|FAS|Overall Study||199
8273225|NCT01716754|20399955|P4|STARTED|Overall Study||97
8273226|NCT01716754|20399956|P3|STARTED|Overall Study||135
8273227|NCT01716754|20399957|P2|STARTED|Overall Study||40
8273228|NCT01716754|20399958|P1|STARTED|Overall Study||199
8273229|NCT01716715|20399981|P2|NOT COMPLETED|Overall Study||4
8273230|NCT01716715|20399982|P1|NOT COMPLETED|Overall Study||2
8273231|NCT01716715|20399981|P2|COMPLETED|Overall Study||50
8273232|NCT01716715|20399982|P1|COMPLETED|Overall Study||55
8273233|NCT01716715|20399981|P2|STARTED|Overall Study||54
8273234|NCT01716715|20399982|P1|STARTED|Overall Study||57
8273235|NCT01716663|20399998|P1|NOT COMPLETED|Overall Study||6
8273236|NCT01716663|20399998|P1|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
8273237|NCT01716663|20399998|P1|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
8273238|NCT01716663|20399998|P1|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
8273253|NCT01716559|20400021|P1|NOT COMPLETED|Overall Study||111
8273254|NCT01716559|20400021|P1|COMPLETED|Overall Study||49
8273255|NCT01716559|20400021|P1|STARTED|Overall Study||160
8273256|NCT01716533|20400033|P4|NOT COMPLETED|Overall Study||8
8273257|NCT01716533|20400034|P3|NOT COMPLETED|Overall Study||5
8273258|NCT01716533|20400035|P2|NOT COMPLETED|Overall Study||0
8273259|NCT01716533|20400036|P1|NOT COMPLETED|Overall Study||0
8273260|NCT01716533|20400033|P4|COMPLETED|Overall Study||1
8273261|NCT01716533|20400034|P3|COMPLETED|Overall Study||0
8273262|NCT01716533|20400035|P2|COMPLETED|Overall Study||25
8273263|NCT01716533|20400036|P1|COMPLETED|Overall Study||7
8273264|NCT01716533|20400033|P4|STARTED|Overall Study||9
8273265|NCT01716533|20400034|P3|STARTED|Overall Study||5
8273266|NCT01716533|20400035|P2|STARTED|Overall Study||25
8273267|NCT01716533|20400036|P1|STARTED|Overall Study||7
8273268|NCT01716520|20400090|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
8273269|NCT01716520|20400091|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8273270|NCT01716520|20400092|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8273271|NCT01716520|20400093|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8273272|NCT01716520|20400094|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8273273|NCT01716520|20400095|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8273274|NCT01716520|20400090|P6|COMPLETED|Treatment Period 3 (14 Days)||23
8273275|NCT01716520|20400091|P5|COMPLETED|Treatment Period 3 (14 Days)||29
8273276|NCT01716520|20400092|P4|COMPLETED|Treatment Period 3 (14 Days)||28
8273277|NCT01716520|20400093|P3|COMPLETED|Treatment Period 3 (14 Days)||25
8273278|NCT01716520|20400094|P2|COMPLETED|Treatment Period 3 (14 Days)||27
8273279|NCT01716520|20400095|P1|COMPLETED|Treatment Period 3 (14 Days)||27
8273280|NCT01716520|20400090|P6|STARTED|Treatment Period 3 (14 Days)||25
8273281|NCT01716520|20400091|P5|STARTED|Treatment Period 3 (14 Days)||29
8273282|NCT01716520|20400092|P4|STARTED|Treatment Period 3 (14 Days)||28
8273283|NCT01716520|20400093|P3|STARTED|Treatment Period 3 (14 Days)||26
8273284|NCT01716520|20400094|P2|STARTED|Treatment Period 3 (14 Days)||27
8273285|NCT01716520|20400095|P1|STARTED|Treatment Period 3 (14 Days)||27
8273286|NCT01716520|20400090|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
8273287|NCT01716520|20400091|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8273288|NCT01716520|20400092|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
8273289|NCT01716520|20400093|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
8273290|NCT01716520|20400094|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
8273291|NCT01716520|20400095|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
8273292|NCT01716520|20400090|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||25
8273293|NCT01716520|20400091|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||29
8273294|NCT01716520|20400092|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||28
8273295|NCT01716520|20400093|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||26
8273296|NCT01716520|20400094|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||27
8273297|NCT01716520|20400095|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||27
8273298|NCT01716520|20400090|P6|STARTED|Washout Period 2 (10 to 14 Days)||27
8273299|NCT01716520|20400091|P5|STARTED|Washout Period 2 (10 to 14 Days)||29
8273300|NCT01716520|20400092|P4|STARTED|Washout Period 2 (10 to 14 Days)||28
8273301|NCT01716520|20400093|P3|STARTED|Washout Period 2 (10 to 14 Days)||27
8273302|NCT01716520|20400094|P2|STARTED|Washout Period 2 (10 to 14 Days)||28
8273303|NCT01716520|20400095|P1|STARTED|Washout Period 2 (10 to 14 Days)||29
8273304|NCT01716520|20400090|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8273305|NCT01716520|20400091|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||2
8273306|NCT01716520|20400092|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8273307|NCT01716520|20400093|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8273308|NCT01716520|20400094|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8273309|NCT01716520|20400095|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8273310|NCT01716520|20400090|P6|COMPLETED|Treatment Period 2 (14 Days)||27
8273311|NCT01716520|20400091|P5|COMPLETED|Treatment Period 2 (14 Days)||29
8273312|NCT01716520|20400092|P4|COMPLETED|Treatment Period 2 (14 Days)||28
8273313|NCT01716520|20400093|P3|COMPLETED|Treatment Period 2 (14 Days)||27
8273314|NCT01716520|20400094|P2|COMPLETED|Treatment Period 2 (14 Days)||28
8273315|NCT01716520|20400095|P1|COMPLETED|Treatment Period 2 (14 Days)||29
8273316|NCT01716520|20400090|P6|STARTED|Treatment Period 2 (14 Days)||27
8273317|NCT01716520|20400091|P5|STARTED|Treatment Period 2 (14 Days)||31
8273318|NCT01716520|20400092|P4|STARTED|Treatment Period 2 (14 Days)||29
8273319|NCT01716520|20400093|P3|STARTED|Treatment Period 2 (14 Days)||27
8273320|NCT01716520|20400094|P2|STARTED|Treatment Period 2 (14 Days)||28
8273321|NCT01716520|20400095|P1|STARTED|Treatment Period 2 (14 Days)||29
8273322|NCT01716520|20400090|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
8273323|NCT01716520|20400091|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8273324|NCT01716520|20400092|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8273325|NCT01716520|20400093|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
8273326|NCT01716520|20400094|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
8273327|NCT01716520|20400095|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
8273328|NCT01716520|20400090|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||27
8273329|NCT01716520|20400091|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||31
8273330|NCT01716520|20400092|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||29
8273331|NCT01716520|20400093|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||27
8273332|NCT01716520|20400094|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||28
8273333|NCT01716520|20400095|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||29
8273334|NCT01716520|20400090|P6|STARTED|Washout Period 1 (10 to 14 Days)||29
8273335|NCT01716520|20400091|P5|STARTED|Washout Period 1 (10 to 14 Days)||31
8273336|NCT01716520|20400092|P4|STARTED|Washout Period 1 (10 to 14 Days)||29
8273337|NCT01716520|20400093|P3|STARTED|Washout Period 1 (10 to 14 Days)||28
8273338|NCT01716520|20400094|P2|STARTED|Washout Period 1 (10 to 14 Days)||29
8273339|NCT01716520|20400095|P1|STARTED|Washout Period 1 (10 to 14 Days)||29
8273340|NCT01716520|20400090|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8273341|NCT01716520|20400091|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8273342|NCT01716520|20400092|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8273343|NCT01716520|20400093|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8273344|NCT01716520|20400094|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8273345|NCT01716520|20400095|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8273346|NCT01716520|20400090|P6|COMPLETED|Treatment Period 1 (14 Days)||29
8273347|NCT01716520|20400091|P5|COMPLETED|Treatment Period 1 (14 Days)||31
8273348|NCT01716520|20400092|P4|COMPLETED|Treatment Period 1 (14 Days)||29
8273349|NCT01716520|20400093|P3|COMPLETED|Treatment Period 1 (14 Days)||28
8273350|NCT01716520|20400094|P2|COMPLETED|Treatment Period 1 (14 Days)||29
8273351|NCT01716520|20400095|P1|COMPLETED|Treatment Period 1 (14 Days)||29
8273352|NCT01716520|20400090|P6|STARTED|Treatment Period 1 (14 Days)||30
8273353|NCT01716520|20400091|P5|STARTED|Treatment Period 1 (14 Days)||31
8273354|NCT01716520|20400092|P4|STARTED|Treatment Period 1 (14 Days)||30
8273355|NCT01716520|20400093|P3|STARTED|Treatment Period 1 (14 Days)||30
8273356|NCT01716520|20400094|P2|STARTED|Treatment Period 1 (14 Days)||30
8273357|NCT01716520|20400095|P1|STARTED|Treatment Period 1 (14 Days)||31
8273358|NCT01716468|20400111|P1|NOT COMPLETED|Overall Study||6
8273359|NCT01716468|20400111|P1|COMPLETED|Overall Study||11
8273360|NCT01716468|20400111|P1|STARTED|Overall Study||17
8273379|NCT01716234|20400150|P7|NOT COMPLETED|Overall Study||0
8273380|NCT01716234|20400151|P6|NOT COMPLETED|Overall Study||14
8273381|NCT01716234|20400152|P5|NOT COMPLETED|Overall Study||5
8273382|NCT01716234|20400153|P4|NOT COMPLETED|Overall Study||12
8273383|NCT01716234|20400154|P3|NOT COMPLETED|Overall Study||5
8273384|NCT01716234|20400155|P2|NOT COMPLETED|Overall Study||10
8273385|NCT01716234|20400156|P1|NOT COMPLETED|Overall Study||10
8273386|NCT01716234|20400150|P7|COMPLETED|Overall Study||1
8273387|NCT01716234|20400151|P6|COMPLETED|Overall Study||18
8273388|NCT01716234|20400152|P5|COMPLETED|Overall Study||10
8273389|NCT01716234|20400153|P4|COMPLETED|Overall Study||16
8273390|NCT01716234|20400154|P3|COMPLETED|Overall Study||15
8273391|NCT01716234|20400155|P2|COMPLETED|Overall Study||12
8273392|NCT01716234|20400156|P1|COMPLETED|Overall Study||14
8273393|NCT01716234|20400150|P7|Treated|Overall Study||1
8273394|NCT01716234|20400151|P6|Treated|Overall Study||30
8273395|NCT01716234|20400152|P5|Treated|Overall Study||15
8273396|NCT01716234|20400153|P4|Treated|Overall Study||28
8273397|NCT01716234|20400154|P3|Treated|Overall Study||19
8273398|NCT01716234|20400155|P2|Treated|Overall Study||21
8273399|NCT01716234|20400156|P1|Treated|Overall Study||22
8273400|NCT01716234|20400150|P7|STARTED|Overall Study||1
8273401|NCT01716234|20400151|P6|STARTED|Overall Study||32
8273402|NCT01716234|20400152|P5|STARTED|Overall Study||15
8273403|NCT01716234|20400153|P4|STARTED|Overall Study||28
8273404|NCT01716234|20400154|P3|STARTED|Overall Study||20
8273405|NCT01716234|20400155|P2|STARTED|Overall Study||22
8273406|NCT01716234|20400156|P1|STARTED|Overall Study||24
8273407|NCT01716221|20400193|P1|NOT COMPLETED|Overall Study||0
8273408|NCT01716221|20400193|P1|COMPLETED|Overall Study||1
8273409|NCT01716221|20400193|P1|STARTED|Overall Study||1
8273410|NCT01716169|20400219|P1|NOT COMPLETED|Overall Study||4
8273411|NCT01716169|20400219|P1|COMPLETED|Overall Study||6
8273412|NCT01716169|20400219|P1|Standard of Care Dressings Used|Overall Study||7
8273413|NCT01716169|20400219|P1|STARTED|Overall Study||10
8273414|NCT01716156|20400228|P3|NOT COMPLETED|Overall Study||2
8273415|NCT01716156|20400229|P2|NOT COMPLETED|Overall Study||1
8273416|NCT01716156|20400230|P1|NOT COMPLETED|Overall Study||2
8273417|NCT01716156|20400228|P3|COMPLETED|Overall Study||11
8273418|NCT01716156|20400229|P2|COMPLETED|Overall Study||3
8273419|NCT01716156|20400230|P1|COMPLETED|Overall Study||7
8273420|NCT01716156|20400228|P3|STARTED|Overall Study||13
8273421|NCT01716156|20400229|P2|STARTED|Overall Study||4
8273422|NCT01716156|20400230|P1|STARTED|Overall Study||9
8273435|NCT01716104|20400276|P2|NOT COMPLETED|Overall Study||7
8273436|NCT01716104|20400277|P1|NOT COMPLETED|Overall Study||6
8273437|NCT01716104|20400276|P2|COMPLETED|Overall Study||117
8273438|NCT01716104|20400277|P1|COMPLETED|Overall Study||119
8273439|NCT01716104|20400276|P2|STARTED|Overall Study||124
8273440|NCT01716104|20400277|P1|STARTED|Overall Study||125
8273441|NCT01716052|20400303|P2|NOT COMPLETED|Overall Study||1
8273442|NCT01716052|20400304|P1|NOT COMPLETED|Overall Study||1
8273443|NCT01716052|20400303|P2|COMPLETED|Overall Study||0
8273444|NCT01716052|20400304|P1|COMPLETED|Overall Study||0
8273445|NCT01716052|20400303|P2|STARTED|Overall Study||1
8273446|NCT01716052|20400304|P1|STARTED|Overall Study||1
8273447|NCT01716013|20400312|P2|NOT COMPLETED|Overall Study||0
8273448|NCT01716013|20400313|P1|NOT COMPLETED|Overall Study||3
8273449|NCT01716013|20400312|P2|COMPLETED|Overall Study||54
8273450|NCT01716013|20400313|P1|COMPLETED|Overall Study||105
8273451|NCT01716013|20400312|P2|STARTED|Overall Study||54
8273452|NCT01716013|20400313|P1|STARTED|Overall Study||108
8273453|NCT01715948|20400325|P1|NOT COMPLETED|Overall Study||1
8273454|NCT01715948|20400325|P1|COMPLETED|Overall Study||8
8273455|NCT01715948|20400325|P1|STARTED|Overall Study||9
8273456|NCT01715896|20400346|P2|NOT COMPLETED|Overall Study||11
8273457|NCT01715896|20400347|P1|NOT COMPLETED|Overall Study||3
8273458|NCT01715896|20400346|P2|COMPLETED|Overall Study||59
8273459|NCT01715896|20400347|P1|COMPLETED|Overall Study||65
8273460|NCT01715896|20400346|P2|STARTED|Overall Study||70
8273461|NCT01715896|20400347|P1|STARTED|Overall Study||68
8273462|NCT01715883|20400410|P1|NOT COMPLETED|Overall Study||1
8273463|NCT01715883|20400410|P1|COMPLETED|Overall Study||2
8273464|NCT01715883|20400410|P1|STARTED|Overall Study||3
8273465|NCT01715857|20400420|P1|NOT COMPLETED|Overall Study||96
8273466|NCT01715857|20400420|P1|COMPLETED|Overall Study||4004
8273467|NCT01715857|20400420|P1|STARTED|Overall Study||4100
8273468|NCT01715831|20400430|P1|NOT COMPLETED|Overall Study||1
8273469|NCT01715831|20400430|P1|COMPLETED|Overall Study||25
8273470|NCT01715831|20400430|P1|STARTED|Overall Study||26
8273471|NCT01715805|20400446|P4|NOT COMPLETED|Double-Blind or Continued Treatment||48
8273472|NCT01715805|20400447|P3|NOT COMPLETED|Double-Blind or Continued Treatment||56
8273473|NCT01715805|20400448|P2|NOT COMPLETED|Double-Blind or Continued Treatment||39
8273474|NCT01715805|20400449|P1|NOT COMPLETED|Double-Blind or Continued Treatment||0
8273475|NCT01715805|20400446|P4|COMPLETED|Double-Blind or Continued Treatment||222
8273476|NCT01715805|20400447|P3|COMPLETED|Double-Blind or Continued Treatment||213
8273477|NCT01715805|20400448|P2|COMPLETED|Double-Blind or Continued Treatment||222
8273478|NCT01715805|20400449|P1|COMPLETED|Double-Blind or Continued Treatment||0
8273479|NCT01715805|20400446|P4|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
8273480|NCT01715805|20400447|P3|Double-Blind Safety Population|Double-Blind or Continued Treatment||269
8273481|NCT01715805|20400448|P2|Double-Blind Safety Population|Double-Blind or Continued Treatment||258
8273482|NCT01715805|20400449|P1|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
8273483|NCT01715805|20400446|P4|STARTED|Double-Blind or Continued Treatment||270
8273484|NCT01715805|20400447|P3|STARTED|Double-Blind or Continued Treatment||269
8273485|NCT01715805|20400448|P2|STARTED|Double-Blind or Continued Treatment||261
8273486|NCT01715805|20400449|P1|STARTED|Double-Blind or Continued Treatment||0
8273487|NCT01715805|20400446|P4|NOT COMPLETED|Placebo + ADT Lead-in Period||0
8273488|NCT01715805|20400447|P3|NOT COMPLETED|Placebo + ADT Lead-in Period||0
8273489|NCT01715805|20400448|P2|NOT COMPLETED|Placebo + ADT Lead-in Period||0
8273490|NCT01715805|20400449|P1|NOT COMPLETED|Placebo + ADT Lead-in Period||215
8273491|NCT01715805|20400446|P4|COMPLETED|Placebo + ADT Lead-in Period||0
8273492|NCT01715805|20400447|P3|COMPLETED|Placebo + ADT Lead-in Period||0
8273493|NCT01715805|20400448|P2|COMPLETED|Placebo + ADT Lead-in Period||0
8273494|NCT01715805|20400449|P1|COMPLETED|Placebo + ADT Lead-in Period||807
8273495|NCT01715805|20400446|P4|STARTED|Placebo + ADT Lead-in Period||0
8273496|NCT01715805|20400447|P3|STARTED|Placebo + ADT Lead-in Period||0
8273497|NCT01715805|20400448|P2|STARTED|Placebo + ADT Lead-in Period||0
8273498|NCT01715805|20400449|P1|STARTED|Placebo + ADT Lead-in Period||1022
8273513|NCT01715298|20400478|P2|NOT COMPLETED|Overall Study||11
8273514|NCT01715298|20400479|P1|NOT COMPLETED|Overall Study||7
8273515|NCT01715298|20400478|P2|COMPLETED|Overall Study||205
8273516|NCT01715298|20400479|P1|COMPLETED|Overall Study||209
8273517|NCT01715298|20400478|P2|Full Analysis Set (FAS)|Overall Study||214
8273518|NCT01715298|20400479|P1|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
8273519|NCT01715298|20400478|P2|STARTED|Overall Study||216
8273520|NCT01715298|20400479|P1|STARTED|Overall Study||216
8273545|NCT01715233|20400538|P1|NOT COMPLETED|Overall Study||0
8273546|NCT01715233|20400538|P1|COMPLETED|Overall Study||21
8273547|NCT01715233|20400538|P1|STARTED|Overall Study||21
8273548|NCT01715207|20400546|P2|NOT COMPLETED|Overall Study||1
8273549|NCT01715207|20400547|P1|NOT COMPLETED|Overall Study||1
8273550|NCT01715207|20400546|P2|COMPLETED|Overall Study||14
8273551|NCT01715207|20400547|P1|COMPLETED|Overall Study||14
8273552|NCT01715207|20400546|P2|STARTED|Overall Study||15
8273553|NCT01715207|20400547|P1|STARTED|Overall Study||15
8273554|NCT01715129|20400555|P1|NOT COMPLETED|Overall Study||9
8273555|NCT01715129|20400555|P1|COMPLETED|Overall Study||117
8273556|NCT01715129|20400555|P1|STARTED|Overall Study||126
8273557|NCT01715064|20400574|P2|NOT COMPLETED|Overall Study||0
8273558|NCT01715064|20400575|P1|NOT COMPLETED|Overall Study||0
8273559|NCT01715064|20400574|P2|COMPLETED|Overall Study||18
8273560|NCT01715064|20400575|P1|COMPLETED|Overall Study||18
8273561|NCT01715064|20400574|P2|STARTED|Overall Study||18
8273562|NCT01715064|20400575|P1|STARTED|Overall Study||18
8273563|NCT01714947|20400581|P1|NOT COMPLETED|Part B||3
8273564|NCT01714947|20400581|P1|COMPLETED|Part B||0
8273565|NCT01714947|20400581|P1|STARTED|Part B||3
8273566|NCT01714947|20400581|P1|NOT COMPLETED|Part A||0
8273567|NCT01714947|20400581|P1|COMPLETED|Part A||3
8273568|NCT01714947|20400581|P1|STARTED|Part A||3
8273569|NCT01714921|20400610|P1|NOT COMPLETED|Overall Study||193
8273570|NCT01714921|20400610|P1|COMPLETED|Overall Study||311
8273571|NCT01714921|20400610|P1|STARTED|Overall Study||504
8273592|NCT01714804|20400719|P2|NOT COMPLETED|Overall Study||0
8273593|NCT01714804|20400720|P1|NOT COMPLETED|Overall Study||1
8273594|NCT01714804|20400719|P2|COMPLETED|Overall Study||30
8273595|NCT01714804|20400720|P1|COMPLETED|Overall Study||29
8273596|NCT01714804|20400719|P2|STARTED|Overall Study||30
8273597|NCT01714804|20400720|P1|STARTED|Overall Study||30
8273622|NCT01714687|20400813|P2|NOT COMPLETED|Overall Study||4
8273623|NCT01714687|20400814|P1|NOT COMPLETED|Overall Study||3
8273624|NCT01714687|20400813|P2|COMPLETED|Overall Study||26
8273625|NCT01714687|20400814|P1|COMPLETED|Overall Study||26
8273626|NCT01714687|20400813|P2|STARTED|Overall Study||30
8273627|NCT01714687|20400814|P1|STARTED|Overall Study||29
8273628|NCT01714635|20400838|P3|NOT COMPLETED|Overall Study||2
8273629|NCT01714635|20400839|P2|NOT COMPLETED|Overall Study||0
8273630|NCT01714635|20400840|P1|NOT COMPLETED|Overall Study||2
8273631|NCT01714635|20400838|P3|COMPLETED|Overall Study||146
8273632|NCT01714635|20400839|P2|COMPLETED|Overall Study||150
8273633|NCT01714635|20400840|P1|COMPLETED|Overall Study||145
8273634|NCT01714635|20400838|P3|STARTED|Overall Study||148
8273635|NCT01714635|20400839|P2|STARTED|Overall Study||150
8273636|NCT01714635|20400840|P1|STARTED|Overall Study||147
8273637|NCT01714609|20400856|P2|NOT COMPLETED|Overall Study||0
8273638|NCT01714609|20400857|P1|NOT COMPLETED|Overall Study||1
8273639|NCT01714609|20400856|P2|COMPLETED|Overall Study||5
8273640|NCT01714609|20400857|P1|COMPLETED|Overall Study||4
8273641|NCT01714609|20400856|P2|STARTED|Overall Study||5
8273642|NCT01714609|20400857|P1|STARTED|Overall Study||5
8273643|NCT01714544|20400863|P1|NOT COMPLETED|Overall Study||3
8273644|NCT01714544|20400863|P1|COMPLETED|Overall Study||57
8273645|NCT01714544|20400863|P1|STARTED|Overall Study||60
8273646|NCT01714505|20400867|P2|NOT COMPLETED|Admission 2 (40 Hours)||0
8273647|NCT01714505|20400868|P1|NOT COMPLETED|Admission 2 (40 Hours)||0
8273648|NCT01714505|20400867|P2|COMPLETED|Admission 2 (40 Hours)||9
8273649|NCT01714505|20400868|P1|COMPLETED|Admission 2 (40 Hours)||9
8273650|NCT01714505|20400867|P2|STARTED|Admission 2 (40 Hours)||9
8273651|NCT01714505|20400868|P1|STARTED|Admission 2 (40 Hours)||9
8273652|NCT01714505|20400867|P2|NOT COMPLETED|Admission 1 (40 Hours)||1
8273653|NCT01714505|20400868|P1|NOT COMPLETED|Admission 1 (40 Hours)||1
8273654|NCT01714505|20400867|P2|COMPLETED|Admission 1 (40 Hours)||9
8273655|NCT01714505|20400868|P1|COMPLETED|Admission 1 (40 Hours)||9
8273656|NCT01714505|20400867|P2|STARTED|Admission 1 (40 Hours)||10
8273657|NCT01714505|20400868|P1|STARTED|Admission 1 (40 Hours)||10
8273658|NCT01714492|20400878|P1|NOT COMPLETED|Overall Study||0
8273659|NCT01714492|20400878|P1|COMPLETED|Overall Study||8
8273660|NCT01714492|20400878|P1|STARTED|Overall Study||8
8273661|NCT01714336|20400889|P2|NOT COMPLETED|Overall Study||0
8273662|NCT01714336|20400890|P1|NOT COMPLETED|Overall Study||0
8273663|NCT01714336|20400889|P2|COMPLETED|Overall Study||69
8273664|NCT01714336|20400890|P1|COMPLETED|Overall Study||69
8273665|NCT01714336|20400889|P2|STARTED|Overall Study||69
8273666|NCT01714336|20400890|P1|STARTED|Overall Study||69
8273667|NCT01714323|20400912|P2|NOT COMPLETED|Overall Study||172
8273668|NCT01714323|20400913|P1|NOT COMPLETED|Overall Study||164
8273669|NCT01714323|20400912|P2|COMPLETED|Overall Study||508
8273670|NCT01714323|20400913|P1|COMPLETED|Overall Study||513
8273671|NCT01714323|20400912|P2|STARTED|Overall Study||680
8273672|NCT01714323|20400913|P1|STARTED|Overall Study||677
8273673|NCT01714310|20400934|P3|NOT COMPLETED|Double Blind Adjunctive Treatment||0
8273674|NCT01714310|20400935|P2|NOT COMPLETED|Double Blind Adjunctive Treatment||3
8273675|NCT01714310|20400936|P1|NOT COMPLETED|Double Blind Adjunctive Treatment||2
8273676|NCT01714310|20400934|P3|COMPLETED|Double Blind Adjunctive Treatment||0
8273677|NCT01714310|20400935|P2|COMPLETED|Double Blind Adjunctive Treatment||11
8273678|NCT01714310|20400936|P1|COMPLETED|Double Blind Adjunctive Treatment||10
8273679|NCT01714310|20400934|P3|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
8273680|NCT01714310|20400935|P2|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
8273681|NCT01714310|20400936|P1|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
8273682|NCT01714310|20400934|P3|NOT COMPLETED|Open Lisdexamfetamine Titration||4
8273683|NCT01714310|20400935|P2|NOT COMPLETED|Open Lisdexamfetamine Titration||0
8273684|NCT01714310|20400936|P1|NOT COMPLETED|Open Lisdexamfetamine Titration||0
8273685|NCT01714310|20400934|P3|COMPLETED|Open Lisdexamfetamine Titration||30
8273686|NCT01714310|20400935|P2|COMPLETED|Open Lisdexamfetamine Titration||0
8273687|NCT01714310|20400936|P1|COMPLETED|Open Lisdexamfetamine Titration||0
8273688|NCT01714310|20400934|P3|STARTED|Open Lisdexamfetamine Titration||34
8273689|NCT01714310|20400935|P2|STARTED|Open Lisdexamfetamine Titration||0
8273690|NCT01714310|20400936|P1|STARTED|Open Lisdexamfetamine Titration||0
8273691|NCT01714232|20400983|P1|NOT COMPLETED|Overall Study||0
8273692|NCT01714232|20400983|P1|COMPLETED|Overall Study||106
8273693|NCT01714232|20400983|P1|STARTED|Overall Study||106
8273694|NCT01714063|20400989|P1|NOT COMPLETED|Overall Study||2
8273695|NCT01714063|20400989|P1|COMPLETED|Overall Study||32
8273696|NCT01714063|20400989|P1|STARTED|Overall Study||34
8273697|NCT01714024|20401004|P3|NOT COMPLETED|Overall Study||3
8273698|NCT01714024|20401005|P2|NOT COMPLETED|Overall Study||6
8273699|NCT01714024|20401006|P1|NOT COMPLETED|Overall Study||1
8273700|NCT01714024|20401004|P3|COMPLETED|Overall Study||8
8273701|NCT01714024|20401005|P2|COMPLETED|Overall Study||12
8273702|NCT01714024|20401006|P1|COMPLETED|Overall Study||12
8273703|NCT01714024|20401004|P3|STARTED|Overall Study||11
8273704|NCT01714024|20401005|P2|STARTED|Overall Study||18
8273705|NCT01714024|20401006|P1|STARTED|Overall Study||13
8273706|NCT01713998|20401026|P3|NOT COMPLETED|Overall Study||2
8273707|NCT01713998|20401027|P2|NOT COMPLETED|Overall Study||0
8273708|NCT01713998|20401028|P1|NOT COMPLETED|Overall Study||3
8273709|NCT01713998|20401026|P3|COMPLETED|Overall Study||14
8273710|NCT01713998|20401027|P2|COMPLETED|Overall Study||15
8273711|NCT01713998|20401028|P1|COMPLETED|Overall Study||13
8273712|NCT01713998|20401026|P3|STARTED|Overall Study||16
8273713|NCT01713998|20401027|P2|STARTED|Overall Study||15
8273714|NCT01713998|20401028|P1|STARTED|Overall Study||16
8273715|NCT01713946|20401049|P3|NOT COMPLETED|Overall Study||44
8273716|NCT01713946|20401050|P2|NOT COMPLETED|Overall Study||45
8273717|NCT01713946|20401051|P1|NOT COMPLETED|Overall Study||43
8273718|NCT01713946|20401049|P3|COMPLETED|Overall Study||75
8273719|NCT01713946|20401050|P2|COMPLETED|Overall Study||85
8273720|NCT01713946|20401051|P1|COMPLETED|Overall Study||74
8273721|NCT01713946|20401049|P3|Did Not Cont. in Post-Ext Phase|Overall Study||0
8273722|NCT01713946|20401050|P2|Did Not Cont. in Post-Ext Phase|Overall Study||2
8273723|NCT01713946|20401051|P1|Did Not Cont. in Post-Ext Phase|Overall Study||1
8273724|NCT01713946|20401049|P3|Did Not Continue in Ext Phase|Overall Study||0
8273725|NCT01713946|20401050|P2|Did Not Continue in Ext Phase|Overall Study||3
8273726|NCT01713946|20401051|P1|Did Not Continue in Ext Phase|Overall Study||0
8273727|NCT01713946|20401049|P3|Completed Post-Ext Phase|Overall Study||75
8273728|NCT01713946|20401050|P2|Completed Post-Ext Phase|Overall Study||85
8273729|NCT01713946|20401051|P1|Completed Post-Ext Phase|Overall Study||74
8273730|NCT01713946|20401049|P3|Continued in Post-Ext. Phase|Overall Study||81
8273731|NCT01713946|20401050|P2|Continued in Post-Ext. Phase|Overall Study||90
8273732|NCT01713946|20401051|P1|Continued in Post-Ext. Phase|Overall Study||78
8273733|NCT01713946|20401049|P3|Completed Ext. Phase|Overall Study||81
8273734|NCT01713946|20401050|P2|Completed Ext. Phase|Overall Study||92
8273735|NCT01713946|20401051|P1|Completed Ext. Phase|Overall Study||79
8273736|NCT01713946|20401049|P3|Continued in Ext. Phase|Overall Study||114
8273737|NCT01713946|20401050|P2|Continued in Ext. Phase|Overall Study||119
8273738|NCT01713946|20401051|P1|Continued in Ext. Phase|Overall Study||110
8273739|NCT01713946|20401049|P3|Completed Core Phase|Overall Study||114
8273740|NCT01713946|20401050|P2|Completed Core Phase|Overall Study||122
8273741|NCT01713946|20401051|P1|Completed Core Phase|Overall Study||110
8273742|NCT01713946|20401049|P3|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
8273743|NCT01713946|20401050|P2|STARTED|Overall Study||130
8273744|NCT01713946|20401051|P1|STARTED|Overall Study||117
8273745|NCT01713933|20401142|P1|NOT COMPLETED|Overall Study||6
8273746|NCT01713933|20401142|P1|COMPLETED|Overall Study||31
8273747|NCT01713933|20401142|P1|STARTED|Overall Study||37
8273748|NCT01713868|20401158|P4|NOT COMPLETED|Overall Study||95
8273749|NCT01713868|20401159|P3|NOT COMPLETED|Overall Study||80
8273750|NCT01713868|20401160|P2|NOT COMPLETED|Overall Study||65
8273751|NCT01713868|20401161|P1|NOT COMPLETED|Overall Study||97
8273752|NCT01713868|20401158|P4|COMPLETED|Overall Study||305
8273753|NCT01713868|20401159|P3|COMPLETED|Overall Study||320
8273754|NCT01713868|20401160|P2|COMPLETED|Overall Study||335
8273755|NCT01713868|20401161|P1|COMPLETED|Overall Study||303
8273756|NCT01713868|20401158|P4|STARTED|Overall Study||400
8273757|NCT01713868|20401159|P3|STARTED|Overall Study||400
8273758|NCT01713868|20401160|P2|STARTED|Overall Study||400
8273759|NCT01713868|20401161|P1|STARTED|Overall Study||400
8273760|NCT01713686|20401191|P1|NOT COMPLETED|Overall Study||15
8273761|NCT01713686|20401191|P1|COMPLETED|Overall Study||110
8273762|NCT01713686|20401191|P1|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
8273763|NCT01713660|20401200|P1|NOT COMPLETED|Overall Study||0
8273764|NCT01713660|20401200|P1|COMPLETED|Overall Study||37
8273765|NCT01713660|20401200|P1|STARTED|Overall Study||37
8273766|NCT01713621|20401208|P2|NOT COMPLETED|Overall Study||16
8273767|NCT01713621|20401209|P1|NOT COMPLETED|Overall Study||7
8273768|NCT01713621|20401208|P2|COMPLETED|Overall Study||1
8273769|NCT01713621|20401209|P1|COMPLETED|Overall Study||1
8273770|NCT01713621|20401208|P2|STARTED|Overall Study||17
8273771|NCT01713621|20401209|P1|STARTED|Overall Study||8
8273772|NCT01713608|20401219|P4|NOT COMPLETED|Overall Study||0
8273773|NCT01713608|20401220|P3|NOT COMPLETED|Overall Study||0
8273774|NCT01713608|20401221|P2|NOT COMPLETED|Overall Study||0
8273775|NCT01713608|20401222|P1|NOT COMPLETED|Overall Study||0
8273776|NCT01713608|20401219|P4|COMPLETED|Overall Study||12
8273777|NCT01713608|20401220|P3|COMPLETED|Overall Study||8
8273778|NCT01713608|20401221|P2|COMPLETED|Overall Study||6
8273779|NCT01713608|20401222|P1|COMPLETED|Overall Study||8
8273780|NCT01713608|20401219|P4|STARTED|Overall Study||12
8273781|NCT01713608|20401220|P3|STARTED|Overall Study||8
8273782|NCT01713608|20401221|P2|STARTED|Overall Study||6
8273783|NCT01713608|20401222|P1|STARTED|Overall Study||8
8273784|NCT01713582|20401261|P21|NOT COMPLETED|Overall Study||15
8273785|NCT01713582|20401262|P20|NOT COMPLETED|Overall Study||5
8273786|NCT01713582|20401263|P19|NOT COMPLETED|Overall Study||5
8273787|NCT01713582|20401264|P18|NOT COMPLETED|Overall Study||3
8273788|NCT01713582|20401265|P17|NOT COMPLETED|Overall Study||7
8273789|NCT01713582|20401266|P16|NOT COMPLETED|Overall Study||6
8273790|NCT01713582|20401267|P15|NOT COMPLETED|Overall Study||7
8273791|NCT01713582|20401268|P14|NOT COMPLETED|Overall Study||4
8273792|NCT01713582|20401269|P13|NOT COMPLETED|Overall Study||3
8273793|NCT01713582|20401270|P12|NOT COMPLETED|Overall Study||5
8273794|NCT01713582|20401271|P11|NOT COMPLETED|Overall Study||16
8273795|NCT01713582|20401272|P10|NOT COMPLETED|Overall Study||18
8273796|NCT01713582|20401273|P9|NOT COMPLETED|Overall Study||6
8273797|NCT01713582|20401274|P8|NOT COMPLETED|Overall Study||6
8273798|NCT01713582|20401275|P7|NOT COMPLETED|Overall Study||7
8273799|NCT01713582|20401276|P6|NOT COMPLETED|Overall Study||8
8273800|NCT01713582|20401277|P5|NOT COMPLETED|Overall Study||4
8273801|NCT01713582|20401278|P4|NOT COMPLETED|Overall Study||3
8273802|NCT01713582|20401279|P3|NOT COMPLETED|Overall Study||4
8273803|NCT01713582|20401280|P2|NOT COMPLETED|Overall Study||3
8273804|NCT01713582|20401281|P1|NOT COMPLETED|Overall Study||3
8273805|NCT01713582|20401261|P21|COMPLETED|Overall Study||0
8273806|NCT01713582|20401262|P20|COMPLETED|Overall Study||0
8273807|NCT01713582|20401263|P19|COMPLETED|Overall Study||0
8273808|NCT01713582|20401264|P18|COMPLETED|Overall Study||0
8273809|NCT01713582|20401265|P17|COMPLETED|Overall Study||0
8273810|NCT01713582|20401266|P16|COMPLETED|Overall Study||0
8273811|NCT01713582|20401267|P15|COMPLETED|Overall Study||0
8273812|NCT01713582|20401268|P14|COMPLETED|Overall Study||0
8273813|NCT01713582|20401269|P13|COMPLETED|Overall Study||0
8273814|NCT01713582|20401270|P12|COMPLETED|Overall Study||0
8273815|NCT01713582|20401271|P11|COMPLETED|Overall Study||0
8273816|NCT01713582|20401272|P10|COMPLETED|Overall Study||0
8273817|NCT01713582|20401273|P9|COMPLETED|Overall Study||0
8273818|NCT01713582|20401274|P8|COMPLETED|Overall Study||0
8273819|NCT01713582|20401275|P7|COMPLETED|Overall Study||0
8273820|NCT01713582|20401276|P6|COMPLETED|Overall Study||0
8273821|NCT01713582|20401277|P5|COMPLETED|Overall Study||0
8273822|NCT01713582|20401278|P4|COMPLETED|Overall Study||0
8273823|NCT01713582|20401279|P3|COMPLETED|Overall Study||0
8273824|NCT01713582|20401280|P2|COMPLETED|Overall Study||0
8273825|NCT01713582|20401281|P1|COMPLETED|Overall Study||0
8273826|NCT01713582|20401261|P21|STARTED|Overall Study|Number treated|15
8273827|NCT01713582|20401262|P20|STARTED|Overall Study|Number treated|5
8273828|NCT01713582|20401263|P19|STARTED|Overall Study|Number treated|5
8273829|NCT01713582|20401264|P18|STARTED|Overall Study|Number treated|3
8273830|NCT01713582|20401265|P17|STARTED|Overall Study|Number treated|7
8273831|NCT01713582|20401266|P16|STARTED|Overall Study|Number treated|6
8273832|NCT01713582|20401267|P15|STARTED|Overall Study|Number treated|7
8273833|NCT01713582|20401268|P14|STARTED|Overall Study|Number treated|4
8273834|NCT01713582|20401269|P13|STARTED|Overall Study|Number treated|3
8273835|NCT01713582|20401270|P12|STARTED|Overall Study|Number treated|5
8273836|NCT01713582|20401271|P11|STARTED|Overall Study|Number treated|16
8273837|NCT01713582|20401272|P10|STARTED|Overall Study|Number treated|18
8273838|NCT01713582|20401273|P9|STARTED|Overall Study|Number treated|6
8273839|NCT01713582|20401274|P8|STARTED|Overall Study|Number treated|6
8273840|NCT01713582|20401275|P7|STARTED|Overall Study|Number treated|7
8273841|NCT01713582|20401276|P6|STARTED|Overall Study|Number treated|8
8273842|NCT01713582|20401277|P5|STARTED|Overall Study|Number treated|4
8273843|NCT01713582|20401278|P4|STARTED|Overall Study|Number treated|3
8273844|NCT01713582|20401279|P3|STARTED|Overall Study|Number treated|4
8273845|NCT01713582|20401280|P2|STARTED|Overall Study|Number treated|3
8273846|NCT01713582|20401281|P1|STARTED|Overall Study|Number treated|3
8273847|NCT01713530|20401444|P2|NOT COMPLETED|Overall Study||19
8273848|NCT01713530|20401445|P1|NOT COMPLETED|Overall Study||25
8273849|NCT01713530|20401444|P2|COMPLETED|Overall Study||117
8273850|NCT01713530|20401445|P1|COMPLETED|Overall Study||113
8273851|NCT01713530|20401444|P2|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
8273852|NCT01713530|20401445|P1|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
8273853|NCT01713530|20401444|P2|STARTED|Overall Study||136
8273854|NCT01713530|20401445|P1|STARTED|Overall Study||138
8273855|NCT01713400|20401463|P2|NOT COMPLETED|Overall Study||0
8273856|NCT01713400|20401464|P1|NOT COMPLETED|Overall Study||0
8273857|NCT01713400|20401463|P2|COMPLETED|Overall Study||15
8273858|NCT01713400|20401464|P1|COMPLETED|Overall Study||15
8273859|NCT01713400|20401463|P2|STARTED|Overall Study||15
8273860|NCT01713400|20401464|P1|STARTED|Overall Study||15
8273861|NCT01713348|20401476|P4|NOT COMPLETED|Overall Study||0
8273862|NCT01713348|20401477|P3|NOT COMPLETED|Overall Study||2
8273863|NCT01713348|20401478|P2|NOT COMPLETED|Overall Study||2
8273864|NCT01713348|20401479|P1|NOT COMPLETED|Overall Study||4
8273865|NCT01713348|20401476|P4|COMPLETED|Overall Study||15
8273866|NCT01713348|20401477|P3|COMPLETED|Overall Study||28
8273867|NCT01713348|20401478|P2|COMPLETED|Overall Study||11
8273868|NCT01713348|20401479|P1|COMPLETED|Overall Study||25
8273869|NCT01713348|20401476|P4|STARTED|Overall Study||15
8273870|NCT01713348|20401477|P3|STARTED|Overall Study||30
8273871|NCT01713348|20401478|P2|STARTED|Overall Study||13
8273872|NCT01713348|20401479|P1|STARTED|Overall Study||29
8273873|NCT01713283|20401509|P2|NOT COMPLETED|Overall Study||3
8273874|NCT01713283|20401510|P1|NOT COMPLETED|Overall Study||11
8273875|NCT01713283|20401509|P2|COMPLETED|Overall Study||26
8273876|NCT01713283|20401510|P1|COMPLETED|Overall Study||20
8273877|NCT01713283|20401509|P2|STARTED|Overall Study||29
8273878|NCT01713283|20401510|P1|STARTED|Overall Study||31
8273879|NCT01713036|20401532|P1|NOT COMPLETED|Overall Study||1
8273880|NCT01713036|20401532|P1|COMPLETED|Overall Study||5
8273881|NCT01713036|20401532|P1|STARTED|Overall Study||6
8273882|NCT01712984|20401572|P3|NOT COMPLETED|Overall Study||10
8273883|NCT01712984|20401573|P2|NOT COMPLETED|Overall Study||16
8273884|NCT01712984|20401574|P1|NOT COMPLETED|Overall Study||16
8273885|NCT01712984|20401572|P3|COMPLETED|Overall Study||836
8273886|NCT01712984|20401573|P2|COMPLETED|Overall Study||821
8273887|NCT01712984|20401574|P1|COMPLETED|Overall Study||1656
8273888|NCT01712984|20401572|P3|STARTED|Overall Study||846
8273889|NCT01712984|20401573|P2|STARTED|Overall Study||837
8273890|NCT01712984|20401574|P1|STARTED|Overall Study||1672
8273891|NCT01712854|20401594|P1|NOT COMPLETED|Overall Study||1
8273892|NCT01712854|20401594|P1|COMPLETED|Overall Study||8
8273893|NCT01712854|20401594|P1|STARTED|Overall Study||9
8273894|NCT01712776|20401601|P2|NOT COMPLETED|Overall Study||0
8273895|NCT01712776|20401602|P1|NOT COMPLETED|Overall Study||0
8273896|NCT01712776|20401601|P2|COMPLETED|Overall Study||50
8273897|NCT01712776|20401602|P1|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
8273898|NCT01712776|20401601|P2|STARTED|Overall Study||50
8273899|NCT01712776|20401602|P1|STARTED|Overall Study||50
8273900|NCT01712711|20401610|P2|NOT COMPLETED|Overall Study||0
8273901|NCT01712711|20401611|P1|NOT COMPLETED|Overall Study||0
8273902|NCT01712711|20401610|P2|COMPLETED|Overall Study||20
8273903|NCT01712711|20401611|P1|COMPLETED|Overall Study||20
8273904|NCT01712711|20401610|P2|STARTED|Overall Study||20
8273905|NCT01712711|20401611|P1|STARTED|Overall Study||20
8273906|NCT01712685|20401617|P1|NOT COMPLETED|Overall Study||1
8273907|NCT01712685|20401617|P1|COMPLETED|Overall Study||11
8273908|NCT01712685|20401617|P1|STARTED|Overall Study||12
8273909|NCT01712516|20401633|P4|NOT COMPLETED|Overall Study||13
8273910|NCT01712516|20401634|P3|NOT COMPLETED|Overall Study||6
8273911|NCT01712516|20401635|P2|NOT COMPLETED|Overall Study||10
8273912|NCT01712516|20401636|P1|NOT COMPLETED|Overall Study||6
8273913|NCT01712516|20401633|P4|COMPLETED|Overall Study||236
8273914|NCT01712516|20401634|P3|COMPLETED|Overall Study||245
8273915|NCT01712516|20401635|P2|COMPLETED|Overall Study||241
8273916|NCT01712516|20401636|P1|COMPLETED|Overall Study||244
8273917|NCT01712516|20401633|P4|Full Analysis Set|Overall Study||247
8273918|NCT01712516|20401634|P3|Full Analysis Set|Overall Study||250
8273919|NCT01712516|20401635|P2|Full Analysis Set|Overall Study||251
8273920|NCT01712516|20401636|P1|Full Analysis Set|Overall Study||250
8273921|NCT01712516|20401633|P4|Safety Set|Overall Study||248
8273922|NCT01712516|20401634|P3|Safety Set|Overall Study||251
8273923|NCT01712516|20401635|P2|Safety Set|Overall Study||251
8273924|NCT01712516|20401636|P1|Safety Set|Overall Study||250
8273925|NCT01712516|20401633|P4|STARTED|Overall Study||249
8273926|NCT01712516|20401634|P3|STARTED|Overall Study||251
8273927|NCT01712516|20401635|P2|STARTED|Overall Study||251
8273928|NCT01712516|20401636|P1|STARTED|Overall Study||250
8273929|NCT01712490|20401688|P2|NOT COMPLETED|Overall Study||670
8273930|NCT01712490|20401689|P1|NOT COMPLETED|Overall Study||664
8273931|NCT01712490|20401688|P2|COMPLETED|Overall Study||0
8273932|NCT01712490|20401689|P1|COMPLETED|Overall Study||0
8273933|NCT01712490|20401688|P2|Treated|Overall Study||659
8273934|NCT01712490|20401689|P1|Treated|Overall Study||662
8273935|NCT01712490|20401688|P2|STARTED|Overall Study||670
8273936|NCT01712490|20401689|P1|STARTED|Overall Study||664
8273937|NCT01712438|20401726|P1|NOT COMPLETED|Overall Study||37
8273938|NCT01712438|20401726|P1|COMPLETED|Overall Study||73
8273939|NCT01712438|20401726|P1|SURG Population|Overall Study||24
8273940|NCT01712438|20401726|P1|BLEED Population|Overall Study||94
8273941|NCT01712438|20401726|P1|PROPH Population|Overall Study||103
8273942|NCT01712438|20401726|P1|PP Population|Overall Study||95
8273943|NCT01712438|20401726|P1|ITT Population|Overall Study||108
8273944|NCT01712438|20401726|P1|SAF Population|Overall Study||108
8273945|NCT01712438|20401726|P1|STARTED|Overall Study||110
8273946|NCT01712399|20401736|P1|NOT COMPLETED|Overall Study||397
8273947|NCT01712399|20401736|P1|COMPLETED|Overall Study||0
8273948|NCT01712399|20401736|P1|STARTED|Overall Study||397
8273949|NCT01712360|20401753|P4|NOT COMPLETED|Overall Study||2
8273950|NCT01712360|20401754|P3|NOT COMPLETED|Overall Study||0
8273951|NCT01712360|20401755|P2|NOT COMPLETED|Overall Study||1
8273952|NCT01712360|20401756|P1|NOT COMPLETED|Overall Study||0
8273953|NCT01712360|20401753|P4|COMPLETED|Overall Study||4
8273954|NCT01712360|20401754|P3|COMPLETED|Overall Study||6
8273955|NCT01712360|20401755|P2|COMPLETED|Overall Study||21
8273956|NCT01712360|20401756|P1|COMPLETED|Overall Study||22
8273957|NCT01712360|20401753|P4|STARTED|Overall Study||6
8273958|NCT01712360|20401754|P3|STARTED|Overall Study||6
8273959|NCT01712360|20401755|P2|STARTED|Overall Study||22
8273960|NCT01712360|20401756|P1|STARTED|Overall Study||22
8273961|NCT01712334|20401782|P2|NOT COMPLETED|Treatment Period 2||0
8273962|NCT01712334|20401783|P1|NOT COMPLETED|Treatment Period 2||0
8273963|NCT01712334|20401782|P2|COMPLETED|Treatment Period 2||41
8273964|NCT01712334|20401783|P1|COMPLETED|Treatment Period 2||44
8273965|NCT01712334|20401782|P2|STARTED|Treatment Period 2||41
8273966|NCT01712334|20401783|P1|STARTED|Treatment Period 2||44
8273967|NCT01712334|20401782|P2|NOT COMPLETED|Treatment Period 1||2
8273968|NCT01712334|20401783|P1|NOT COMPLETED|Treatment Period 1||0
8273969|NCT01712334|20401782|P2|COMPLETED|Treatment Period 1||41
8273970|NCT01712334|20401783|P1|COMPLETED|Treatment Period 1||44
8273971|NCT01712334|20401782|P2|Received Treatment|Treatment Period 1||41
8273972|NCT01712334|20401783|P1|Received Treatment|Treatment Period 1||44
8273973|NCT01712334|20401782|P2|STARTED|Treatment Period 1||43
8273974|NCT01712334|20401783|P1|STARTED|Treatment Period 1||44
8273975|NCT01712256|20401791|P1|NOT COMPLETED|Overall Study||1
8273976|NCT01712256|20401791|P1|COMPLETED|Overall Study||32
8273977|NCT01712256|20401791|P1|STARTED|Overall Study||33
8273978|NCT01712230|20401803|P3|NOT COMPLETED|Overall Study||7
8273979|NCT01712230|20401804|P2|NOT COMPLETED|Overall Study||4
8273980|NCT01712230|20401805|P1|NOT COMPLETED|Overall Study||2
8273981|NCT01712230|20401803|P3|COMPLETED|Overall Study||11
8273982|NCT01712230|20401804|P2|COMPLETED|Overall Study||14
8273983|NCT01712230|20401805|P1|COMPLETED|Overall Study||9
8273984|NCT01712230|20401803|P3|STARTED|Overall Study||18
8273985|NCT01712230|20401804|P2|STARTED|Overall Study||18
8273986|NCT01712230|20401805|P1|STARTED|Overall Study||11
8273987|NCT01712204|20401821|P2|NOT COMPLETED|Overall Study||5
8273988|NCT01712204|20401822|P1|NOT COMPLETED|Overall Study||8
8273989|NCT01712204|20401821|P2|COMPLETED|Overall Study||36
8273990|NCT01712204|20401822|P1|COMPLETED|Overall Study||33
8273991|NCT01712204|20401821|P2|STARTED|Overall Study||41
8273992|NCT01712204|20401822|P1|STARTED|Overall Study||41
8273993|NCT01712178|20401830|P2|NOT COMPLETED|Overall Study||3
8273994|NCT01712178|20401831|P1|NOT COMPLETED|Overall Study||1
8273995|NCT01712178|20401830|P2|COMPLETED|Overall Study||47
8273996|NCT01712178|20401831|P1|COMPLETED|Overall Study||49
8273997|NCT01712178|20401830|P2|STARTED|Overall Study||50
8273998|NCT01712178|20401831|P1|STARTED|Overall Study||50
8273999|NCT01712074|20401856|P3|NOT COMPLETED|Double Blind Period||8
8274000|NCT01712074|20401857|P2|NOT COMPLETED|Double Blind Period||14
8274001|NCT01712074|20401858|P1|NOT COMPLETED|Double Blind Period||0
8274002|NCT01712074|20401856|P3|COMPLETED|Double Blind Period||86
8274003|NCT01712074|20401857|P2|COMPLETED|Double Blind Period||77
8274004|NCT01712074|20401858|P1|COMPLETED|Double Blind Period||0
8274005|NCT01712074|20401856|P3|STARTED|Double Blind Period||94
8274006|NCT01712074|20401857|P2|STARTED|Double Blind Period||91
8274007|NCT01712074|20401858|P1|STARTED|Double Blind Period||0
8274008|NCT01712074|20401856|P3|NOT COMPLETED|Placebo Run-in Period||0
8274009|NCT01712074|20401857|P2|NOT COMPLETED|Placebo Run-in Period||0
8274010|NCT01712074|20401858|P1|NOT COMPLETED|Placebo Run-in Period||10
8274011|NCT01712074|20401856|P3|COMPLETED|Placebo Run-in Period||0
8274012|NCT01712074|20401857|P2|COMPLETED|Placebo Run-in Period||0
8274013|NCT01712074|20401858|P1|COMPLETED|Placebo Run-in Period||185
8274014|NCT01712074|20401856|P3|STARTED|Placebo Run-in Period||0
8274015|NCT01712074|20401857|P2|STARTED|Placebo Run-in Period||0
8274016|NCT01712074|20401858|P1|STARTED|Placebo Run-in Period||195
8274017|NCT01712061|20401914|P3|NOT COMPLETED|Overall Study||11
8274018|NCT01712061|20401915|P2|NOT COMPLETED|Overall Study||26
8274019|NCT01712061|20401916|P1|NOT COMPLETED|Overall Study||10
8274020|NCT01712061|20401914|P3|COMPLETED|Overall Study||45
8274021|NCT01712061|20401915|P2|COMPLETED|Overall Study||114
8274022|NCT01712061|20401916|P1|COMPLETED|Overall Study||20
8274023|NCT01712061|20401914|P3|STARTED|Overall Study||56
8274024|NCT01712061|20401915|P2|STARTED|Overall Study||140
8274025|NCT01712061|20401916|P1|STARTED|Overall Study||30
8274026|NCT01712009|20401956|P3|NOT COMPLETED|Overall Study||21
8274027|NCT01712009|20401957|P2|NOT COMPLETED|Overall Study||29
8274028|NCT01712009|20401958|P1|NOT COMPLETED|Overall Study||38
8274029|NCT01712009|20401956|P3|COMPLETED|Overall Study||181
8274030|NCT01712009|20401957|P2|COMPLETED|Overall Study||171
8274031|NCT01712009|20401958|P1|COMPLETED|Overall Study||160
8274032|NCT01712009|20401956|P3|Received Naproxen / Loratadine|Overall Study||198
8274033|NCT01712009|20401957|P2|Received Naproxen / Loratadine|Overall Study||193
8274034|NCT01712009|20401958|P1|Received Naproxen / Loratadine|Overall Study||0
8274035|NCT01712009|20401956|P3|Received Pegfilgrastim|Overall Study||200
8274036|NCT01712009|20401957|P2|Received Pegfilgrastim|Overall Study||196
8274037|NCT01712009|20401958|P1|Received Pegfilgrastim|Overall Study||191
8274038|NCT01712009|20401956|P3|STARTED|Overall Study||202
8274039|NCT01712009|20401957|P2|STARTED|Overall Study||200
8274040|NCT01712009|20401958|P1|STARTED|Overall Study||198
8274041|NCT01711983|20401984|P1|NOT COMPLETED|36-Month Closure Evaluation||64
8274042|NCT01711983|20401984|P1|COMPLETED|36-Month Closure Evaluation||278
8274043|NCT01711983|20401984|P1|STARTED|36-Month Closure Evaluation||342
8274044|NCT01711983|20401984|P1|NOT COMPLETED|6-Month Closure Evaluation||26
8274045|NCT01711983|20401984|P1|COMPLETED|6-Month Closure Evaluation||342
8274046|NCT01711983|20401984|P1|STARTED|6-Month Closure Evaluation||368
8274047|NCT01711983|20401984|P1|NOT COMPLETED|6-Month Clinical Success Evaluation||32
8274048|NCT01711983|20401984|P1|COMPLETED|6-Month Clinical Success Evaluation||368
8274049|NCT01711983|20401984|P1|STARTED|6-Month Clinical Success Evaluation||400
8274050|NCT01711918|20401994|P1|NOT COMPLETED|Overall Study||2
8274051|NCT01711918|20401994|P1|COMPLETED|Overall Study||7
8274052|NCT01711918|20401994|P1|STARTED|Overall Study||9
8274053|NCT01711879|20402004|P2|NOT COMPLETED|Overall Study||0
8274054|NCT01711879|20402005|P1|NOT COMPLETED|Overall Study||1
8274055|NCT01711879|20402004|P2|COMPLETED|Overall Study||4
8274056|NCT01711879|20402005|P1|COMPLETED|Overall Study||2
8274057|NCT01711879|20402004|P2|STARTED|Overall Study||4
8274058|NCT01711879|20402005|P1|STARTED|Overall Study||3
8274059|NCT01711866|20402039|P1|NOT COMPLETED|Overall Study||8
8274060|NCT01711866|20402039|P1|COMPLETED|Overall Study||79
8274061|NCT01711866|20402039|P1|STARTED|Overall Study||87
8274062|NCT01711853|20402044|P1|NOT COMPLETED|Overall Study||3
8274063|NCT01711853|20402044|P1|COMPLETED|Overall Study||16
8274064|NCT01711853|20402044|P1|STARTED|Overall Study||19
8274065|NCT01711736|20402051|P2|NOT COMPLETED|Overall Study||8
8274066|NCT01711736|20402052|P1|NOT COMPLETED|Overall Study||12
8274067|NCT01711736|20402051|P2|COMPLETED|Overall Study|Up to Day 180|294
8274068|NCT01711736|20402052|P1|COMPLETED|Overall Study|Up to Day 180|287
8274069|NCT01711736|20402051|P2|STARTED|Overall Study||302
8274070|NCT01711736|20402052|P1|STARTED|Overall Study||299
8274071|NCT01711645|20402080|P1|NOT COMPLETED|Overall Study||19
8274072|NCT01711645|20402080|P1|COMPLETED|Overall Study||36
8274073|NCT01711645|20402080|P1|STARTED|Overall Study||55
8274074|NCT01711619|20402117|P2|NOT COMPLETED|Overall Study||24
8274075|NCT01711619|20402118|P1|NOT COMPLETED|Overall Study||18
8274076|NCT01711619|20402117|P2|COMPLETED|Overall Study||36
8274077|NCT01711619|20402118|P1|COMPLETED|Overall Study||38
8274078|NCT01711619|20402117|P2|STARTED|Overall Study||60
8274079|NCT01711619|20402118|P1|STARTED|Overall Study||56
8274095|NCT01711424|20402168|P1|NOT COMPLETED|Overall Study||0
8274096|NCT01711424|20402168|P1|COMPLETED|Overall Study||1209
8274097|NCT01711424|20402168|P1|STARTED|Overall Study||1209
8274098|NCT01711372|20402177|P2|NOT COMPLETED|Overall Study||0
8274099|NCT01711372|20402178|P1|NOT COMPLETED|Overall Study||0
8274100|NCT01711372|20402177|P2|COMPLETED|Overall Study||47
8274101|NCT01711372|20402178|P1|COMPLETED|Overall Study||66
8274102|NCT01711372|20402177|P2|STARTED|Overall Study||47
8274103|NCT01711372|20402178|P1|STARTED|Overall Study||66
8274104|NCT01711359|20402188|P3|NOT COMPLETED|Follow Up||28
8274105|NCT01711359|20402189|P2|NOT COMPLETED|Follow Up||15
8274106|NCT01711359|20402190|P1|NOT COMPLETED|Follow Up||25
8274107|NCT01711359|20402188|P3|COMPLETED|Follow Up||0
8274108|NCT01711359|20402189|P2|COMPLETED|Follow Up||0
8274109|NCT01711359|20402190|P1|COMPLETED|Follow Up||0
8274110|NCT01711359|20402188|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
8274111|NCT01711359|20402189|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
8274112|NCT01711359|20402190|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
8274113|NCT01711359|20402188|P3|NOT COMPLETED|Treatment Period||42
8274114|NCT01711359|20402189|P2|NOT COMPLETED|Treatment Period||24
8274115|NCT01711359|20402190|P1|NOT COMPLETED|Treatment Period||52
8274116|NCT01711359|20402188|P3|COMPLETED|Treatment Period||173
8274117|NCT01711359|20402189|P2|COMPLETED|Treatment Period||136
8274118|NCT01711359|20402190|P1|COMPLETED|Treatment Period||161
8274119|NCT01711359|20402188|P3|Rescued|Treatment Period||6
8274120|NCT01711359|20402189|P2|Rescued|Treatment Period||7
8274121|NCT01711359|20402190|P1|Rescued|Treatment Period||26
8274122|NCT01711359|20402188|P3|Received at Least One Dose of Study Drug|Treatment Period||215
8274123|NCT01711359|20402189|P2|Received at Least One Dose of Study Drug|Treatment Period||159
8274124|NCT01711359|20402190|P1|Received at Least One Dose of Study Drug|Treatment Period||210
8274125|NCT01711359|20402188|P3|STARTED|Treatment Period||215
8274126|NCT01711359|20402189|P2|STARTED|Treatment Period||160
8274127|NCT01711359|20402190|P1|STARTED|Treatment Period||213
8274128|NCT01711294|20402264|P3|NOT COMPLETED|Overall Study||0
8274129|NCT01711294|20402265|P2|NOT COMPLETED|Overall Study||0
8274130|NCT01711294|20402266|P1|NOT COMPLETED|Overall Study||0
8274131|NCT01711294|20402264|P3|COMPLETED|Overall Study||64
8274132|NCT01711294|20402265|P2|COMPLETED|Overall Study||65
8274133|NCT01711294|20402266|P1|COMPLETED|Overall Study||121
8274134|NCT01711294|20402264|P3|STARTED|Overall Study||64
8274135|NCT01711294|20402265|P2|STARTED|Overall Study||65
8274136|NCT01711294|20402266|P1|STARTED|Overall Study||121
8274137|NCT01711216|20402319|P1|NOT COMPLETED|Overall Study||217
8274138|NCT01711216|20402319|P1|COMPLETED|Overall Study||782
8274139|NCT01711216|20402319|P1|STARTED|Overall Study||999
8274140|NCT01711177|20402343|P3|NOT COMPLETED|Overall Study||0
8274141|NCT01711177|20402344|P2|NOT COMPLETED|Overall Study||0
8274142|NCT01711177|20402345|P1|NOT COMPLETED|Overall Study||0
8274143|NCT01711177|20402343|P3|COMPLETED|Overall Study||3
8274144|NCT01711177|20402344|P2|COMPLETED|Overall Study||3
8274145|NCT01711177|20402345|P1|COMPLETED|Overall Study||10
8274146|NCT01711177|20402343|P3|STARTED|Overall Study||3
8274147|NCT01711177|20402344|P2|STARTED|Overall Study||3
8274148|NCT01711177|20402345|P1|STARTED|Overall Study||10
8274149|NCT01710891|20402355|P2|NOT COMPLETED|Overall Study||0
8274150|NCT01710891|20402356|P1|NOT COMPLETED|Overall Study||0
8274151|NCT01710891|20402355|P2|COMPLETED|Overall Study||103
8274152|NCT01710891|20402356|P1|COMPLETED|Overall Study||95
8274153|NCT01710891|20402355|P2|STARTED|Overall Study||103
8274154|NCT01710891|20402356|P1|STARTED|Overall Study||95
8274155|NCT01710839|20402374|P2|NOT COMPLETED|Overall Study||6
8274156|NCT01710839|20402375|P1|NOT COMPLETED|Overall Study||1
8274157|NCT01710839|20402374|P2|COMPLETED|Overall Study||0
8274158|NCT01710839|20402375|P1|COMPLETED|Overall Study||23
8274159|NCT01710839|20402374|P2|STARTED|Overall Study||6
8274160|NCT01710839|20402375|P1|STARTED|Overall Study||24
8274161|NCT01710800|20402397|P1|NOT COMPLETED|Overall Study||22
8274162|NCT01710800|20402397|P1|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
8274163|NCT01710800|20402397|P1|Received Placebo Intervention|Overall Study||45
8274164|NCT01710800|20402397|P1|Received PPI Intervention|Overall Study||44
8274165|NCT01710800|20402397|P1|STARTED|Overall Study|63 patients consented to be part of the study|63
8274166|NCT01710787|20402406|P3|NOT COMPLETED|Overall Study||0
8274167|NCT01710787|20402407|P2|NOT COMPLETED|Overall Study||0
8274168|NCT01710787|20402408|P1|NOT COMPLETED|Overall Study||0
8274169|NCT01710787|20402406|P3|COMPLETED|Overall Study||22
8274170|NCT01710787|20402407|P2|COMPLETED|Overall Study||44
8274171|NCT01710787|20402408|P1|COMPLETED|Overall Study||44
8274172|NCT01710787|20402406|P3|STARTED|Overall Study||22
8274173|NCT01710787|20402407|P2|STARTED|Overall Study||44
8274174|NCT01710787|20402408|P1|STARTED|Overall Study||44
8274175|NCT01710709|20402461|P1|NOT COMPLETED|Overall Study||173
8274176|NCT01710709|20402461|P1|COMPLETED|Overall Study||291
8274177|NCT01710709|20402461|P1|STARTED|Overall Study||464
8274178|NCT01710657|20402476|P3|NOT COMPLETED|Overall Study||32
8274179|NCT01710657|20402477|P2|NOT COMPLETED|Overall Study||12
8274180|NCT01710657|20402478|P1|NOT COMPLETED|Overall Study||18
8274181|NCT01710657|20402476|P3|COMPLETED|Overall Study||148
8274182|NCT01710657|20402477|P2|COMPLETED|Overall Study||171
8274183|NCT01710657|20402478|P1|COMPLETED|Overall Study||166
8274184|NCT01710657|20402476|P3|Maintenance Period (12 Weeks)|Overall Study||168
8274185|NCT01710657|20402477|P2|Maintenance Period (12 Weeks)|Overall Study||175
8274186|NCT01710657|20402478|P1|Maintenance Period (12 Weeks)|Overall Study||176
8274187|NCT01710657|20402476|P3|Titration Period (4 Weeks)|Overall Study||180
8274188|NCT01710657|20402477|P2|Titration Period (4 Weeks)|Overall Study||183
8274189|NCT01710657|20402478|P1|Titration Period (4 Weeks)|Overall Study||184
8274190|NCT01710657|20402476|P3|STARTED|Overall Study||180
8274191|NCT01710657|20402477|P2|STARTED|Overall Study||183
8274192|NCT01710657|20402478|P1|STARTED|Overall Study||184
8274193|NCT01710527|20402495|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
8274194|NCT01710527|20402496|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
8274195|NCT01710527|20402495|P2|COMPLETED|Period 3: Intervention Period 2||15
8274196|NCT01710527|20402496|P1|COMPLETED|Period 3: Intervention Period 2||16
8274197|NCT01710527|20402495|P2|STARTED|Period 3: Intervention Period 2||15
8274198|NCT01710527|20402496|P1|STARTED|Period 3: Intervention Period 2||16
8274199|NCT01710527|20402495|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
8274200|NCT01710527|20402496|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8274201|NCT01710527|20402495|P2|COMPLETED|Period 2: Washout Period (7 Days)||15
8274202|NCT01710527|20402496|P1|COMPLETED|Period 2: Washout Period (7 Days)||16
8274203|NCT01710527|20402495|P2|STARTED|Period 2: Washout Period (7 Days)||16
8274204|NCT01710527|20402496|P1|STARTED|Period 2: Washout Period (7 Days)||16
8274205|NCT01710527|20402495|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
8274206|NCT01710527|20402496|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
8274207|NCT01710527|20402495|P2|COMPLETED|Period 1: Intervention Period 1||16
8274208|NCT01710527|20402496|P1|COMPLETED|Period 1: Intervention Period 1||16
8274209|NCT01710527|20402495|P2|STARTED|Period 1: Intervention Period 1||16
8274210|NCT01710527|20402496|P1|STARTED|Period 1: Intervention Period 1||16
8274211|NCT01710514|20402522|P2|NOT COMPLETED|Overall Study||7
8274212|NCT01710514|20402523|P1|NOT COMPLETED|Overall Study||7
8274213|NCT01710514|20402522|P2|COMPLETED|Overall Study||47
8274214|NCT01710514|20402523|P1|COMPLETED|Overall Study||47
8274215|NCT01710514|20402522|P2|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
8274216|NCT01710514|20402523|P1|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
8274217|NCT01710514|20402522|P2|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
8274218|NCT01710514|20402523|P1|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
8274219|NCT01710514|20402522|P2|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
8274220|NCT01710514|20402523|P1|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
8274221|NCT01710514|20402522|P2|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
8274222|NCT01710514|20402523|P1|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
8274223|NCT01710514|20402522|P2|STARTED|Overall Study||54
8274224|NCT01710514|20402523|P1|STARTED|Overall Study||54
8274234|NCT01710358|20402578|P3|NOT COMPLETED|Follow-up Period||0
8274235|NCT01710358|20402579|P2|NOT COMPLETED|Follow-up Period||0
8274236|NCT01710358|20402580|P1|NOT COMPLETED|Follow-up Period||0
8274237|NCT01710358|20402578|P3|COMPLETED|Follow-up Period||20
8274238|NCT01710358|20402579|P2|COMPLETED|Follow-up Period||76
8274239|NCT01710358|20402580|P1|COMPLETED|Follow-up Period||33
8274240|NCT01710358|20402578|P3|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
8274241|NCT01710358|20402579|P2|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
8274242|NCT01710358|20402580|P1|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
8274243|NCT01710358|20402578|P3|NOT COMPLETED|Rescue Period||0
8274244|NCT01710358|20402579|P2|NOT COMPLETED|Rescue Period||31
8274245|NCT01710358|20402580|P1|NOT COMPLETED|Rescue Period||0
8274246|NCT01710358|20402578|P3|COMPLETED|Rescue Period||0
8274247|NCT01710358|20402579|P2|COMPLETED|Rescue Period||196
8274248|NCT01710358|20402580|P1|COMPLETED|Rescue Period||0
8274249|NCT01710358|20402578|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8274250|NCT01710358|20402579|P2|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
8274251|NCT01710358|20402580|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
8274252|NCT01710358|20402578|P3|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
8274253|NCT01710358|20402579|P2|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
8274254|NCT01710358|20402580|P1|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
8274255|NCT01710358|20402578|P3|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
8274256|NCT01710358|20402579|P2|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
8274257|NCT01710358|20402580|P1|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
8274258|NCT01710358|20402578|P3|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
8274259|NCT01710358|20402579|P2|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
8274260|NCT01710358|20402580|P1|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
8274261|NCT01710358|20402578|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
8274262|NCT01710358|20402579|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
8274263|NCT01710358|20402580|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
8274264|NCT01710358|20402578|P3|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
8274265|NCT01710358|20402579|P2|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
8274266|NCT01710358|20402580|P1|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
8274267|NCT01710358|20402578|P3|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
8274268|NCT01710358|20402579|P2|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
8274269|NCT01710358|20402580|P1|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
8274270|NCT01710358|20402578|P3|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
8274271|NCT01710358|20402579|P2|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
8274272|NCT01710358|20402580|P1|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
8274273|NCT01710358|20402578|P3|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
8274274|NCT01710358|20402579|P2|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
8274275|NCT01710358|20402580|P1|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
8274276|NCT01710358|20402578|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
8274277|NCT01710358|20402579|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
8274278|NCT01710358|20402580|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
8274279|NCT01710358|20402578|P3|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
8274280|NCT01710358|20402579|P2|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
8274281|NCT01710358|20402580|P1|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
8274282|NCT01710345|20402651|P3|NOT COMPLETED|Overall Study||1
8274283|NCT01710345|20402652|P2|NOT COMPLETED|Overall Study||5
8274284|NCT01710345|20402653|P1|NOT COMPLETED|Overall Study||3
8274285|NCT01710345|20402651|P3|COMPLETED|Overall Study||19
8274286|NCT01710345|20402652|P2|COMPLETED|Overall Study||35
8274287|NCT01710345|20402653|P1|COMPLETED|Overall Study||37
8274288|NCT01710345|20402651|P3|STARTED|Overall Study||20
8274289|NCT01710345|20402652|P2|STARTED|Overall Study||40
8274290|NCT01710345|20402653|P1|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
8274291|NCT01710332|20402663|P2|NOT COMPLETED|Overall Study||0
8274292|NCT01710332|20402664|P1|NOT COMPLETED|Overall Study||0
8274293|NCT01710332|20402663|P2|COMPLETED|Overall Study||6
8274294|NCT01710332|20402664|P1|COMPLETED|Overall Study||6
8274295|NCT01710332|20402663|P2|STARTED|Overall Study||6
8274296|NCT01710332|20402664|P1|STARTED|Overall Study||6
8274297|NCT01710306|20402674|P2|NOT COMPLETED|Overall Study||30
8274298|NCT01710306|20402675|P1|NOT COMPLETED|Overall Study||18
8274299|NCT01710306|20402674|P2|COMPLETED|Overall Study||55
8274300|NCT01710306|20402675|P1|COMPLETED|Overall Study||68
8274301|NCT01710306|20402674|P2|STARTED|Overall Study||85
8274302|NCT01710306|20402675|P1|STARTED|Overall Study||86
8274303|NCT01710254|20402683|P1|NOT COMPLETED|Overall Study||0
8274304|NCT01710254|20402683|P1|COMPLETED|Overall Study||30
8274305|NCT01710254|20402683|P1|STARTED|Overall Study||30
8274306|NCT01710137|20402691|P2|NOT COMPLETED|Overall Study||14
8274307|NCT01710137|20402692|P1|NOT COMPLETED|Overall Study||24
8274308|NCT01710137|20402691|P2|COMPLETED|Overall Study||76
8274309|NCT01710137|20402692|P1|COMPLETED|Overall Study||65
8274310|NCT01710137|20402691|P2|STARTED|Overall Study||90
8274311|NCT01710137|20402692|P1|STARTED|Overall Study||89
8274312|NCT01710046|20402712|P2|NOT COMPLETED|Overall Study||0
8274313|NCT01710046|20402713|P1|NOT COMPLETED|Overall Study||1
8274314|NCT01710046|20402712|P2|COMPLETED|Overall Study||3
8274315|NCT01710046|20402713|P1|COMPLETED|Overall Study||8
8274316|NCT01710046|20402712|P2|STARTED|Overall Study||3
8274317|NCT01710046|20402713|P1|STARTED|Overall Study||9
8274318|NCT01710033|20402753|P5|NOT COMPLETED|Stage 2||1
8274319|NCT01710033|20402754|P4|NOT COMPLETED|Stage 2||0
8274320|NCT01710033|20402755|P3|NOT COMPLETED|Stage 2||0
8274321|NCT01710033|20402756|P2|NOT COMPLETED|Stage 2||0
8274322|NCT01710033|20402757|P1|NOT COMPLETED|Stage 2||0
8274323|NCT01710033|20402753|P5|COMPLETED|Stage 2||3
8274324|NCT01710033|20402754|P4|COMPLETED|Stage 2||0
8274325|NCT01710033|20402755|P3|COMPLETED|Stage 2||0
8274326|NCT01710033|20402756|P2|COMPLETED|Stage 2||0
8274327|NCT01710033|20402757|P1|COMPLETED|Stage 2||0
8274328|NCT01710033|20402753|P5|STARTED|Stage 2||4
8274329|NCT01710033|20402754|P4|STARTED|Stage 2||0
8274330|NCT01710033|20402755|P3|STARTED|Stage 2||0
8274331|NCT01710033|20402756|P2|STARTED|Stage 2||0
8274332|NCT01710033|20402757|P1|STARTED|Stage 2||0
8274333|NCT01710033|20402753|P5|NOT COMPLETED|Stage 1||0
8274334|NCT01710033|20402754|P4|NOT COMPLETED|Stage 1||0
8274335|NCT01710033|20402755|P3|NOT COMPLETED|Stage 1||0
8274336|NCT01710033|20402756|P2|NOT COMPLETED|Stage 1||0
8274337|NCT01710033|20402757|P1|NOT COMPLETED|Stage 1||0
8274338|NCT01710033|20402753|P5|COMPLETED|Stage 1||0
8274339|NCT01710033|20402754|P4|COMPLETED|Stage 1||6
8274340|NCT01710033|20402755|P3|COMPLETED|Stage 1||6
8274341|NCT01710033|20402756|P2|COMPLETED|Stage 1||6
8274342|NCT01710033|20402757|P1|COMPLETED|Stage 1||6
8274343|NCT01710033|20402753|P5|STARTED|Stage 1||0
8274344|NCT01710033|20402754|P4|STARTED|Stage 1||6
8274345|NCT01710033|20402755|P3|STARTED|Stage 1||6
8274346|NCT01710033|20402756|P2|STARTED|Stage 1||6
8274347|NCT01710033|20402757|P1|STARTED|Stage 1||6
8274348|NCT01710020|20402838|P1|NOT COMPLETED|Period 2||0
8274349|NCT01710020|20402838|P1|COMPLETED|Period 2||11
8274350|NCT01710020|20402838|P1|STARTED|Period 2||11
8274351|NCT01710020|20402838|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8274352|NCT01710020|20402838|P1|COMPLETED|Washout Period (at Least 14 Days)||11
8274353|NCT01710020|20402838|P1|STARTED|Washout Period (at Least 14 Days)||11
8274354|NCT01710020|20402838|P1|NOT COMPLETED|Period 1||1
8274355|NCT01710020|20402838|P1|COMPLETED|Period 1||11
8274356|NCT01710020|20402838|P1|STARTED|Period 1||12
8274363|NCT01709903|20402874|P2|NOT COMPLETED|Overall Study||39
8274364|NCT01709903|20402875|P1|NOT COMPLETED|Overall Study||29
8274365|NCT01709903|20402874|P2|COMPLETED|Overall Study||333
8274366|NCT01709903|20402875|P1|COMPLETED|Overall Study||343
8274367|NCT01709903|20402874|P2|STARTED|Overall Study|Randomized set|372
8274368|NCT01709903|20402875|P1|STARTED|Overall Study|Randomized set|372
8274369|NCT01709864|20402899|P2|NOT COMPLETED|Overall Study||11
8274370|NCT01709864|20402900|P1|NOT COMPLETED|Overall Study||7
8274371|NCT01709864|20402899|P2|COMPLETED|Overall Study||208
8274372|NCT01709864|20402900|P1|COMPLETED|Overall Study||215
8274373|NCT01709864|20402899|P2|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
8274374|NCT01709864|20402900|P1|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
8274375|NCT01709864|20402899|P2|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
8274376|NCT01709864|20402900|P1|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
8274377|NCT01709864|20402899|P2|STARTED|Overall Study||219
8274378|NCT01709864|20402900|P1|STARTED|Overall Study||222
8274379|NCT01709838|20402934|P1|NOT COMPLETED|Overall Study||67
8274380|NCT01709838|20402934|P1|COMPLETED|Overall Study||67
8274381|NCT01709838|20402934|P1|STARTED|Overall Study||134
8274382|NCT01709799|20402957|P3|NOT COMPLETED|Overall Study||3
8274383|NCT01709799|20402958|P2|NOT COMPLETED|Overall Study||3
8274384|NCT01709799|20402959|P1|NOT COMPLETED|Overall Study||3
8274385|NCT01709799|20402957|P3|COMPLETED|Overall Study||15
8274386|NCT01709799|20402958|P2|COMPLETED|Overall Study||18
8274387|NCT01709799|20402959|P1|COMPLETED|Overall Study||22
8274388|NCT01709799|20402957|P3|STARTED|Overall Study||18
8274389|NCT01709799|20402958|P2|STARTED|Overall Study||21
8274390|NCT01709799|20402959|P1|STARTED|Overall Study||25
8274391|NCT01709786|20402982|P1|NOT COMPLETED|Overall Study||0
8274392|NCT01709786|20402982|P1|COMPLETED|Overall Study||88
8274393|NCT01709786|20402982|P1|STARTED|Overall Study||88
8274394|NCT01709708|20402991|P2|NOT COMPLETED|Overall Study||2
8274395|NCT01709708|20402992|P1|NOT COMPLETED|Overall Study||1
8274396|NCT01709708|20402991|P2|COMPLETED|Overall Study||12
8274397|NCT01709708|20402992|P1|COMPLETED|Overall Study||26
8274398|NCT01709708|20402991|P2|STARTED|Overall Study||14
8274399|NCT01709708|20402992|P1|STARTED|Overall Study||27
8274400|NCT01709695|20403016|P2|NOT COMPLETED|Overall Study||1
8274401|NCT01709695|20403017|P1|NOT COMPLETED|Overall Study||1
8274402|NCT01709695|20403016|P2|COMPLETED|Overall Study||13
8274403|NCT01709695|20403017|P1|COMPLETED|Overall Study||12
8274404|NCT01709695|20403016|P2|STARTED|Overall Study||14
8274405|NCT01709695|20403017|P1|STARTED|Overall Study||13
8274406|NCT01709578|20403042|P3|NOT COMPLETED|Overall Study||51
8274407|NCT01709578|20403043|P2|NOT COMPLETED|Overall Study||56
8274408|NCT01709578|20403044|P1|NOT COMPLETED|Overall Study||80
8274409|NCT01709578|20403042|P3|COMPLETED|Overall Study||133
8274410|NCT01709578|20403043|P2|COMPLETED|Overall Study||125
8274411|NCT01709578|20403044|P1|COMPLETED|Overall Study||101
8274412|NCT01709578|20403042|P3|STARTED|Overall Study||184
8274413|NCT01709578|20403043|P2|STARTED|Overall Study||181
8274414|NCT01709578|20403044|P1|STARTED|Overall Study||181
8274415|NCT01709513|20403175|P3|NOT COMPLETED|Overall Study||30
8274416|NCT01709513|20403176|P2|NOT COMPLETED|Overall Study||43
8274417|NCT01709513|20403177|P1|NOT COMPLETED|Overall Study||21
8274418|NCT01709513|20403175|P3|COMPLETED|Overall Study||96
8274419|NCT01709513|20403176|P2|COMPLETED|Overall Study||82
8274420|NCT01709513|20403177|P1|COMPLETED|Overall Study||42
8274421|NCT01709513|20403175|P3|Treated|Overall Study||126
8274422|NCT01709513|20403176|P2|Treated|Overall Study||124
8274423|NCT01709513|20403177|P1|Treated|Overall Study||63
8274424|NCT01709513|20403175|P3|STARTED|Overall Study||126
8274425|NCT01709513|20403176|P2|STARTED|Overall Study||125
8274426|NCT01709513|20403177|P1|STARTED|Overall Study||63
8274427|NCT01709500|20403238|P2|NOT COMPLETED|Overall Study||82
8274428|NCT01709500|20403239|P1|NOT COMPLETED|Overall Study||167
8274429|NCT01709500|20403238|P2|COMPLETED|Overall Study||0
8274430|NCT01709500|20403239|P1|COMPLETED|Overall Study||0
8274431|NCT01709500|20403238|P2|Treated|Overall Study||81
8274432|NCT01709500|20403239|P1|Treated|Overall Study||167
8274433|NCT01709500|20403238|P2|STARTED|Overall Study||82
8274434|NCT01709500|20403239|P1|STARTED|Overall Study||167
8274435|NCT01709474|20403295|P2|NOT COMPLETED|Overall Study||0
8274436|NCT01709474|20403296|P1|NOT COMPLETED|Overall Study||0
8274437|NCT01709474|20403295|P2|COMPLETED|Overall Study||4
8274438|NCT01709474|20403296|P1|COMPLETED|Overall Study||3
8274439|NCT01709474|20403295|P2|STARTED|Overall Study||4
8274440|NCT01709474|20403296|P1|STARTED|Overall Study||3
8274441|NCT01709422|20403306|P2|NOT COMPLETED|Overall Study||0
8274442|NCT01709422|20403307|P1|NOT COMPLETED|Overall Study||0
8274443|NCT01709422|20403306|P2|COMPLETED|Overall Study||70
8274444|NCT01709422|20403307|P1|COMPLETED|Overall Study||70
8274445|NCT01709422|20403306|P2|STARTED|Overall Study||70
8274446|NCT01709422|20403307|P1|STARTED|Overall Study||70
8274447|NCT01709409|20403317|P2|NOT COMPLETED|Overall Study||0
8274448|NCT01709409|20403318|P1|NOT COMPLETED|Overall Study||1
8274449|NCT01709409|20403317|P2|COMPLETED|Overall Study||45
8274450|NCT01709409|20403318|P1|COMPLETED|Overall Study||42
8274451|NCT01709409|20403317|P2|STARTED|Overall Study||45
8274452|NCT01709409|20403318|P1|STARTED|Overall Study||43
8274453|NCT01709383|20403326|P2|NOT COMPLETED|Overall Study||0
8274454|NCT01709383|20403327|P1|NOT COMPLETED|Overall Study||1
8274455|NCT01709383|20403326|P2|COMPLETED|Overall Study||14
8274456|NCT01709383|20403327|P1|COMPLETED|Overall Study||23
8274457|NCT01709383|20403326|P2|Included in Analysis|Overall Study||13
8274458|NCT01709383|20403327|P1|Included in Analysis|Overall Study||22
8274459|NCT01709383|20403326|P2|Completed Follow-ups|Overall Study||14
8274460|NCT01709383|20403327|P1|Completed Follow-ups|Overall Study||23
8274461|NCT01709383|20403326|P2|Completed Treatment|Overall Study||14
8274462|NCT01709383|20403327|P1|Completed Treatment|Overall Study||24
8274463|NCT01709383|20403326|P2|STARTED|Overall Study||14
8274464|NCT01709383|20403327|P1|STARTED|Overall Study||24
8274465|NCT01709331|20403345|P1|NOT COMPLETED|Overall Study||1
8274466|NCT01709331|20403345|P1|COMPLETED|Overall Study||17
8274467|NCT01709331|20403345|P1|STARTED|Overall Study||18
8274468|NCT01709318|20403358|P7|NOT COMPLETED|Overall Study||11
8274469|NCT01709318|20403359|P6|NOT COMPLETED|Overall Study||4
8274470|NCT01709318|20403360|P5|NOT COMPLETED|Overall Study||4
8274471|NCT01709318|20403361|P4|NOT COMPLETED|Overall Study||6
8274472|NCT01709318|20403362|P3|NOT COMPLETED|Overall Study||6
8274473|NCT01709318|20403363|P2|NOT COMPLETED|Overall Study||7
8274474|NCT01709318|20403364|P1|NOT COMPLETED|Overall Study||9
8274475|NCT01709318|20403358|P7|COMPLETED|Overall Study||171
8274476|NCT01709318|20403359|P6|COMPLETED|Overall Study||80
8274477|NCT01709318|20403360|P5|COMPLETED|Overall Study||74
8274478|NCT01709318|20403361|P4|COMPLETED|Overall Study||72
8274479|NCT01709318|20403362|P3|COMPLETED|Overall Study||71
8274480|NCT01709318|20403363|P2|COMPLETED|Overall Study||78
8274481|NCT01709318|20403364|P1|COMPLETED|Overall Study||73
8274482|NCT01709318|20403358|P7|Treated|Overall Study||178
8274483|NCT01709318|20403359|P6|Treated|Overall Study||86
8274484|NCT01709318|20403360|P5|Treated|Overall Study||77
8274485|NCT01709318|20403361|P4|Treated|Overall Study||77
8274486|NCT01709318|20403362|P3|Treated|Overall Study||78
8274487|NCT01709318|20403363|P2|Treated|Overall Study||85
8274488|NCT01709318|20403364|P1|Treated|Overall Study||79
8274489|NCT01709318|20403358|P7|STARTED|Overall Study||182
8274490|NCT01709318|20403359|P6|STARTED|Overall Study||84
8274491|NCT01709318|20403360|P5|STARTED|Overall Study||78
8274492|NCT01709318|20403361|P4|STARTED|Overall Study||78
8274493|NCT01709318|20403362|P3|STARTED|Overall Study||77
8274494|NCT01709318|20403363|P2|STARTED|Overall Study||85
8274495|NCT01709318|20403364|P1|STARTED|Overall Study||82
8274496|NCT01709305|20403457|P5|NOT COMPLETED|Phase 2||47
8274497|NCT01709305|20403458|P4|NOT COMPLETED|Phase 2||48
8274498|NCT01709305|20403459|P3|NOT COMPLETED|Phase 2||45
8274499|NCT01709305|20403460|P2|NOT COMPLETED|Phase 2||52
8274500|NCT01709305|20403461|P1|NOT COMPLETED|Phase 2||0
8274501|NCT01709305|20403457|P5|COMPLETED|Phase 2||507
8274502|NCT01709305|20403458|P4|COMPLETED|Phase 2||508
8274503|NCT01709305|20403459|P3|COMPLETED|Phase 2||505
8274504|NCT01709305|20403460|P2|COMPLETED|Phase 2||500
8274505|NCT01709305|20403461|P1|COMPLETED|Phase 2||0
8274506|NCT01709305|20403457|P5|STARTED|Phase 2||554
8274507|NCT01709305|20403458|P4|STARTED|Phase 2||556
8274508|NCT01709305|20403459|P3|STARTED|Phase 2||550
8274509|NCT01709305|20403460|P2|STARTED|Phase 2||552
8274510|NCT01709305|20403461|P1|STARTED|Phase 2||0
8274511|NCT01709305|20403457|P5|NOT COMPLETED|Phase 1||0
8274512|NCT01709305|20403458|P4|NOT COMPLETED|Phase 1||0
8274513|NCT01709305|20403459|P3|NOT COMPLETED|Phase 1||0
8274514|NCT01709305|20403460|P2|NOT COMPLETED|Phase 1||0
8274515|NCT01709305|20403461|P1|NOT COMPLETED|Phase 1||637
8274516|NCT01709305|20403457|P5|COMPLETED|Phase 1||0
8274517|NCT01709305|20403458|P4|COMPLETED|Phase 1||0
8274518|NCT01709305|20403459|P3|COMPLETED|Phase 1||0
8274519|NCT01709305|20403460|P2|COMPLETED|Phase 1||0
8274520|NCT01709305|20403461|P1|COMPLETED|Phase 1||4933
8274521|NCT01709305|20403457|P5|STARTED|Phase 1||0
8274522|NCT01709305|20403458|P4|STARTED|Phase 1||0
8274523|NCT01709305|20403459|P3|STARTED|Phase 1||0
8274524|NCT01709305|20403460|P2|STARTED|Phase 1||0
8274525|NCT01709305|20403461|P1|STARTED|Phase 1||5570
8274526|NCT01709227|20403498|P2|NOT COMPLETED|Overall Study||9
8274527|NCT01709227|20403499|P1|NOT COMPLETED|Overall Study||1
8274528|NCT01709227|20403498|P2|COMPLETED|Overall Study||32
8274529|NCT01709227|20403499|P1|COMPLETED|Overall Study||31
8274530|NCT01709227|20403498|P2|STARTED|Overall Study||41
8274531|NCT01709227|20403499|P1|STARTED|Overall Study||32
8274532|NCT01709162|20403525|P2|NOT COMPLETED|Overall Study||5
8274533|NCT01709162|20403526|P1|NOT COMPLETED|Overall Study||6
8274534|NCT01709162|20403525|P2|COMPLETED|Overall Study|Completed treatment as per protocol|0
8274535|NCT01709162|20403526|P1|COMPLETED|Overall Study|Completed treatment as per protocol|12
8274536|NCT01709162|20403525|P2|Still Receiving Treatment|Overall Study||0
8274537|NCT01709162|20403526|P1|Still Receiving Treatment|Overall Study||0
8274538|NCT01709162|20403525|P2|Received Treatment|Overall Study||4
8274539|NCT01709162|20403526|P1|Received Treatment|Overall Study||18
8274540|NCT01709162|20403525|P2|STARTED|Overall Study|Randomized|5
8274541|NCT01709162|20403526|P1|STARTED|Overall Study|Randomized|18
8274542|NCT01709149|20403541|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||97
8274543|NCT01709149|20403542|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||26
8274544|NCT01709149|20403543|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8274545|NCT01709149|20403541|P3|COMPLETED|Double-blind, Placebo-controlled Phase||204
8274546|NCT01709149|20403542|P2|COMPLETED|Double-blind, Placebo-controlled Phase||269
8274547|NCT01709149|20403543|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
8274548|NCT01709149|20403541|P3|STARTED|Double-blind, Placebo-controlled Phase||301
8274549|NCT01709149|20403542|P2|STARTED|Double-blind, Placebo-controlled Phase||295
8274550|NCT01709149|20403543|P1|STARTED|Double-blind, Placebo-controlled Phase||0
8274551|NCT01709149|20403541|P3|NOT COMPLETED|Open-label Lead-in Phase||0
8274552|NCT01709149|20403542|P2|NOT COMPLETED|Open-label Lead-in Phase||0
8274553|NCT01709149|20403543|P1|NOT COMPLETED|Open-label Lead-in Phase||115
8274554|NCT01709149|20403541|P3|COMPLETED|Open-label Lead-in Phase||0
8274555|NCT01709149|20403542|P2|COMPLETED|Open-label Lead-in Phase||0
8274556|NCT01709149|20403543|P1|COMPLETED|Open-label Lead-in Phase||596
8274557|NCT01709149|20403541|P3|STARTED|Open-label Lead-in Phase||0
8274558|NCT01709149|20403542|P2|STARTED|Open-label Lead-in Phase||0
8274559|NCT01709149|20403543|P1|STARTED|Open-label Lead-in Phase||711
8274560|NCT01709136|20403562|P1|NOT COMPLETED|Overall Study||0
8274561|NCT01709136|20403562|P1|COMPLETED|Overall Study||3
8274562|NCT01709136|20403562|P1|STARTED|Overall Study||3
8274563|NCT01709110|20403571|P2|NOT COMPLETED|Overall Study||168
8274564|NCT01709110|20403572|P1|NOT COMPLETED|Overall Study||185
8274565|NCT01709110|20403571|P2|COMPLETED|Overall Study||515
8274566|NCT01709110|20403572|P1|COMPLETED|Overall Study||498
8274567|NCT01709110|20403571|P2|Received at Least One Dose of Study Drug|Overall Study||680
8274568|NCT01709110|20403572|P1|Received at Least One Dose of Study Drug|Overall Study||680
8274569|NCT01709110|20403571|P2|STARTED|Overall Study||683
8274570|NCT01709110|20403572|P1|STARTED|Overall Study||683
8274579|NCT01709032|20403619|P1|NOT COMPLETED|Overall Study||3
8274580|NCT01709032|20403619|P1|COMPLETED|Overall Study||6
8274581|NCT01709032|20403619|P1|STARTED|Overall Study||9
8274582|NCT01708967|20403626|P2|NOT COMPLETED|Overall Study||7
8274583|NCT01708967|20403627|P1|NOT COMPLETED|Overall Study||0
8274584|NCT01708967|20403626|P2|COMPLETED|Overall Study||43
8274585|NCT01708967|20403627|P1|COMPLETED|Overall Study||50
8274586|NCT01708967|20403626|P2|STARTED|Overall Study||50
8274587|NCT01708967|20403627|P1|STARTED|Overall Study||50
8274631|NCT01708915|20403684|P4|NOT COMPLETED|Overall Study||33
8274632|NCT01708915|20403685|P3|NOT COMPLETED|Overall Study||46
8274633|NCT01708915|20403686|P2|NOT COMPLETED|Overall Study||62
8274634|NCT01708915|20403687|P1|NOT COMPLETED|Overall Study||86
8274635|NCT01708915|20403684|P4|COMPLETED|Overall Study||169
8274636|NCT01708915|20403685|P3|COMPLETED|Overall Study||152
8274637|NCT01708915|20403686|P2|COMPLETED|Overall Study||139
8274638|NCT01708915|20403687|P1|COMPLETED|Overall Study||118
8274639|NCT01708915|20403684|P4|STARTED|Overall Study||202
8274640|NCT01708915|20403685|P3|STARTED|Overall Study||198
8274641|NCT01708915|20403686|P2|STARTED|Overall Study||201
8274642|NCT01708915|20403687|P1|STARTED|Overall Study||204
8274643|NCT01708902|20403716|P7|NOT COMPLETED|Overall Study||7
8274644|NCT01708902|20403717|P6|NOT COMPLETED|Overall Study||7
8274645|NCT01708902|20403718|P5|NOT COMPLETED|Overall Study||16
8274646|NCT01708902|20403719|P4|NOT COMPLETED|Overall Study||10
8274647|NCT01708902|20403720|P3|NOT COMPLETED|Overall Study||17
8274648|NCT01708902|20403721|P2|NOT COMPLETED|Overall Study||8
8274649|NCT01708902|20403722|P1|NOT COMPLETED|Overall Study||17
8274650|NCT01708902|20403716|P7|COMPLETED|Overall Study||65
8274651|NCT01708902|20403717|P6|COMPLETED|Overall Study||64
8274652|NCT01708902|20403718|P5|COMPLETED|Overall Study||131
8274653|NCT01708902|20403719|P4|COMPLETED|Overall Study||137
8274654|NCT01708902|20403720|P3|COMPLETED|Overall Study||127
8274655|NCT01708902|20403721|P2|COMPLETED|Overall Study||137
8274656|NCT01708902|20403722|P1|COMPLETED|Overall Study||130
8274657|NCT01708902|20403716|P7|STARTED|Overall Study||72
8274658|NCT01708902|20403717|P6|STARTED|Overall Study||71
8274659|NCT01708902|20403718|P5|STARTED|Overall Study||147
8274660|NCT01708902|20403719|P4|STARTED|Overall Study||147
8274661|NCT01708902|20403720|P3|STARTED|Overall Study||144
8274662|NCT01708902|20403721|P2|STARTED|Overall Study||145
8274663|NCT01708902|20403722|P1|STARTED|Overall Study||147
8274664|NCT01708629|20403785|P4|NOT COMPLETED|Overall Study||14
8274665|NCT01708629|20403786|P3|NOT COMPLETED|Overall Study||10
8274666|NCT01708629|20403787|P2|NOT COMPLETED|Overall Study||25
8274667|NCT01708629|20403788|P1|NOT COMPLETED|Overall Study||16
8274668|NCT01708629|20403785|P4|COMPLETED|Overall Study||301
8274669|NCT01708629|20403786|P3|COMPLETED|Overall Study||303
8274670|NCT01708629|20403787|P2|COMPLETED|Overall Study||604
8274671|NCT01708629|20403788|P1|COMPLETED|Overall Study||608
8274672|NCT01708629|20403785|P4|STARTED|Overall Study||315
8274673|NCT01708629|20403786|P3|STARTED|Overall Study||313
8274674|NCT01708629|20403787|P2|STARTED|Overall Study||629
8274675|NCT01708629|20403788|P1|STARTED|Overall Study||624
8274676|NCT01708603|20403805|P4|NOT COMPLETED|Overall Study||9
8274677|NCT01708603|20403806|P3|NOT COMPLETED|Overall Study||9
8274678|NCT01708603|20403807|P2|NOT COMPLETED|Overall Study||22
8274679|NCT01708603|20403808|P1|NOT COMPLETED|Overall Study||15
8274680|NCT01708603|20403805|P4|COMPLETED|Overall Study||300
8274681|NCT01708603|20403806|P3|COMPLETED|Overall Study||291
8274682|NCT01708603|20403807|P2|COMPLETED|Overall Study||588
8274683|NCT01708603|20403808|P1|COMPLETED|Overall Study||597
8274684|NCT01708603|20403805|P4|STARTED|Overall Study||309
8274685|NCT01708603|20403806|P3|STARTED|Overall Study||300
8274686|NCT01708603|20403807|P2|STARTED|Overall Study||610
8274687|NCT01708603|20403808|P1|STARTED|Overall Study||612
8274688|NCT01708590|20403829|P7|NOT COMPLETED|Withdrawal Phase||9
8274689|NCT01708590|20403830|P6|NOT COMPLETED|Withdrawal Phase||82
8274690|NCT01708590|20403831|P5|NOT COMPLETED|Withdrawal Phase||12
8274691|NCT01708590|20403832|P4|NOT COMPLETED|Withdrawal Phase||53
8274692|NCT01708590|20403833|P3|NOT COMPLETED|Withdrawal Phase||0
8274693|NCT01708590|20403834|P2|NOT COMPLETED|Withdrawal Phase||0
8274694|NCT01708590|20403835|P1|NOT COMPLETED|Withdrawal Phase||0
8274695|NCT01708590|20403829|P7|COMPLETED|Withdrawal Phase||74
8274696|NCT01708590|20403830|P6|COMPLETED|Withdrawal Phase||2
8274697|NCT01708590|20403831|P5|COMPLETED|Withdrawal Phase||45
8274698|NCT01708590|20403832|P4|COMPLETED|Withdrawal Phase||6
8274699|NCT01708590|20403833|P3|COMPLETED|Withdrawal Phase||0
8274700|NCT01708590|20403834|P2|COMPLETED|Withdrawal Phase||0
8274701|NCT01708590|20403835|P1|COMPLETED|Withdrawal Phase||0
8274702|NCT01708590|20403829|P7|STARTED|Withdrawal Phase||83
8274703|NCT01708590|20403830|P6|STARTED|Withdrawal Phase||84
8274704|NCT01708590|20403831|P5|STARTED|Withdrawal Phase||57
8274705|NCT01708590|20403832|P4|STARTED|Withdrawal Phase||59
8274706|NCT01708590|20403833|P3|STARTED|Withdrawal Phase||0
8274707|NCT01708590|20403834|P2|STARTED|Withdrawal Phase||0
8274708|NCT01708590|20403835|P1|STARTED|Withdrawal Phase||0
8274709|NCT01708590|20403829|P7|NOT COMPLETED|Induction Phase||0
8274710|NCT01708590|20403830|P6|NOT COMPLETED|Induction Phase||0
8274711|NCT01708590|20403831|P5|NOT COMPLETED|Induction Phase||0
8274712|NCT01708590|20403832|P4|NOT COMPLETED|Induction Phase||0
8274713|NCT01708590|20403833|P3|NOT COMPLETED|Induction Phase||11
8274714|NCT01708590|20403834|P2|NOT COMPLETED|Induction Phase||7
8274715|NCT01708590|20403835|P1|NOT COMPLETED|Induction Phase||10
8274716|NCT01708590|20403829|P7|COMPLETED|Induction Phase||0
8274717|NCT01708590|20403830|P6|COMPLETED|Induction Phase||0
8274718|NCT01708590|20403831|P5|COMPLETED|Induction Phase||0
8274719|NCT01708590|20403832|P4|COMPLETED|Induction Phase||0
8274720|NCT01708590|20403833|P3|COMPLETED|Induction Phase||209
8274721|NCT01708590|20403834|P2|COMPLETED|Induction Phase||212
8274722|NCT01708590|20403835|P1|COMPLETED|Induction Phase||212
8274723|NCT01708590|20403829|P7|STARTED|Induction Phase||0
8274724|NCT01708590|20403830|P6|STARTED|Induction Phase||0
8274725|NCT01708590|20403831|P5|STARTED|Induction Phase||0
8274726|NCT01708590|20403832|P4|STARTED|Induction Phase||0
8274727|NCT01708590|20403833|P3|STARTED|Induction Phase||220
8274728|NCT01708590|20403834|P2|STARTED|Induction Phase||219
8274729|NCT01708590|20403835|P1|STARTED|Induction Phase||222
8274730|NCT01708525|20403850|P1|NOT COMPLETED|Overall Study||0
8274731|NCT01708525|20403850|P1|COMPLETED|Overall Study||2
8274732|NCT01708525|20403850|P1|STARTED|Overall Study||2
8274733|NCT01708317|20403855|P1|NOT COMPLETED|Final Education Period||0
8274734|NCT01708317|20403855|P1|COMPLETED|Final Education Period||909
8274735|NCT01708317|20403855|P1|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
8274736|NCT01708317|20403855|P1|NOT COMPLETED|ACASI + Education Period||0
8274737|NCT01708317|20403855|P1|COMPLETED|ACASI + Education Period||2601
8274738|NCT01708317|20403855|P1|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
8274739|NCT01708317|20403855|P1|NOT COMPLETED|Initial Education Period||0
8274740|NCT01708317|20403855|P1|COMPLETED|Initial Education Period||982
8274741|NCT01708317|20403855|P1|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
8274742|NCT01708317|20403855|P1|NOT COMPLETED|2010 Control Period||0
8274743|NCT01708317|20403855|P1|COMPLETED|2010 Control Period||3929
8274744|NCT01708317|20403855|P1|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
8274745|NCT01708291|20403864|P2|NOT COMPLETED|Overall Study||1
8274746|NCT01708291|20403865|P1|NOT COMPLETED|Overall Study||2
8274747|NCT01708291|20403864|P2|COMPLETED|Overall Study||20
8274748|NCT01708291|20403865|P1|COMPLETED|Overall Study||19
8274749|NCT01708291|20403864|P2|STARTED|Overall Study||21
8274750|NCT01708291|20403865|P1|STARTED|Overall Study||21
8274751|NCT01708278|20403877|P6|NOT COMPLETED|Overall Study||0
8274752|NCT01708278|20403878|P5|NOT COMPLETED|Overall Study||0
8274753|NCT01708278|20403879|P4|NOT COMPLETED|Overall Study||0
8274754|NCT01708278|20403880|P3|NOT COMPLETED|Overall Study||0
8274755|NCT01708278|20403881|P2|NOT COMPLETED|Overall Study||0
8274756|NCT01708278|20403882|P1|NOT COMPLETED|Overall Study||0
8274757|NCT01708278|20403877|P6|COMPLETED|Overall Study||1
8274758|NCT01708278|20403878|P5|COMPLETED|Overall Study||1
8274759|NCT01708278|20403879|P4|COMPLETED|Overall Study||2
8274760|NCT01708278|20403880|P3|COMPLETED|Overall Study||2
8274761|NCT01708278|20403881|P2|COMPLETED|Overall Study||2
8274762|NCT01708278|20403882|P1|COMPLETED|Overall Study||1
8274763|NCT01708278|20403877|P6|STARTED|Overall Study||1
8274764|NCT01708278|20403878|P5|STARTED|Overall Study||1
8274765|NCT01708278|20403879|P4|STARTED|Overall Study||2
8274766|NCT01708278|20403880|P3|STARTED|Overall Study||2
8274767|NCT01708278|20403881|P2|STARTED|Overall Study||2
8274768|NCT01708278|20403882|P1|STARTED|Overall Study||1
8274769|NCT01708213|20403896|P1|NOT COMPLETED|Overall Study||1
8274770|NCT01708213|20403896|P1|COMPLETED|Overall Study||71
8274771|NCT01708213|20403896|P1|STARTED|Overall Study||72
8274772|NCT01708187|20403904|P2|NOT COMPLETED|Overall Study||1
8274773|NCT01708187|20403905|P1|NOT COMPLETED|Overall Study||0
8274774|NCT01708187|20403904|P2|COMPLETED|Overall Study||0
8274775|NCT01708187|20403905|P1|COMPLETED|Overall Study||1
8274776|NCT01708187|20403904|P2|STARTED|Overall Study||1
8274777|NCT01708187|20403905|P1|STARTED|Overall Study||1
8274778|NCT01708174|20403914|P3|NOT COMPLETED|Survival Follow-up||0
8274779|NCT01708174|20403915|P2|NOT COMPLETED|Survival Follow-up||0
8274780|NCT01708174|20403916|P1|NOT COMPLETED|Survival Follow-up||0
8274781|NCT01708174|20403914|P3|COMPLETED|Survival Follow-up||0
8274782|NCT01708174|20403915|P2|COMPLETED|Survival Follow-up||10
8274783|NCT01708174|20403916|P1|COMPLETED|Survival Follow-up||1
8274784|NCT01708174|20403914|P3|STARTED|Survival Follow-up||0
8274785|NCT01708174|20403915|P2|STARTED|Survival Follow-up||10
8274786|NCT01708174|20403916|P1|STARTED|Survival Follow-up||1
8274787|NCT01708174|20403914|P3|NOT COMPLETED|Treatment Period||1
8274788|NCT01708174|20403915|P2|NOT COMPLETED|Treatment Period||2
8274789|NCT01708174|20403916|P1|NOT COMPLETED|Treatment Period||1
8274790|NCT01708174|20403914|P3|COMPLETED|Treatment Period||3
8274791|NCT01708174|20403915|P2|COMPLETED|Treatment Period||14
8274792|NCT01708174|20403916|P1|COMPLETED|Treatment Period||1
8274793|NCT01708174|20403914|P3|Pharmacokinetic Analysis Set|Treatment Period||0
8274794|NCT01708174|20403915|P2|Pharmacokinetic Analysis Set|Treatment Period||13
8274795|NCT01708174|20403916|P1|Pharmacokinetic Analysis Set|Treatment Period||2
8274796|NCT01708174|20403914|P3|STARTED|Treatment Period||4
8274797|NCT01708174|20403915|P2|STARTED|Treatment Period||16
8274798|NCT01708174|20403916|P1|STARTED|Treatment Period||2
8274799|NCT01708161|20403948|P6|NOT COMPLETED|Overall Study||1
8274800|NCT01708161|20403949|P5|NOT COMPLETED|Overall Study||6
8274801|NCT01708161|20403950|P4|NOT COMPLETED|Overall Study||16
8274802|NCT01708161|20403951|P3|NOT COMPLETED|Overall Study||10
8274803|NCT01708161|20403952|P2|NOT COMPLETED|Overall Study||10
8274804|NCT01708161|20403953|P1|NOT COMPLETED|Overall Study||4
8274805|NCT01708161|20403948|P6|COMPLETED|Overall Study||0
8274806|NCT01708161|20403949|P5|COMPLETED|Overall Study||0
8274807|NCT01708161|20403950|P4|COMPLETED|Overall Study||0
8274808|NCT01708161|20403951|P3|COMPLETED|Overall Study||0
8274809|NCT01708161|20403952|P2|COMPLETED|Overall Study||0
8274810|NCT01708161|20403953|P1|COMPLETED|Overall Study||0
8274811|NCT01708161|20403948|P6|STARTED|Overall Study||1
8274812|NCT01708161|20403949|P5|STARTED|Overall Study||6
8274813|NCT01708161|20403950|P4|STARTED|Overall Study||16
8274814|NCT01708161|20403951|P3|STARTED|Overall Study||10
8274815|NCT01708161|20403952|P2|STARTED|Overall Study||10
8274816|NCT01708161|20403953|P1|STARTED|Overall Study||4
8274817|NCT01708122|20403995|P2|NOT COMPLETED|Overall Study||0
8274818|NCT01708122|20403996|P1|NOT COMPLETED|Overall Study||0
8274819|NCT01708122|20403995|P2|COMPLETED|Overall Study||26
8274820|NCT01708122|20403996|P1|COMPLETED|Overall Study||27
8274821|NCT01708122|20403995|P2|STARTED|Overall Study||26
8274822|NCT01708122|20403996|P1|STARTED|Overall Study||27
8274823|NCT01708057|20404004|P3|NOT COMPLETED|Overall Study||1
8274824|NCT01708057|20404005|P2|NOT COMPLETED|Overall Study||1
8274825|NCT01708057|20404006|P1|NOT COMPLETED|Overall Study||1
8274826|NCT01708057|20404004|P3|COMPLETED|Overall Study||0
8274827|NCT01708057|20404005|P2|COMPLETED|Overall Study||0
8274828|NCT01708057|20404006|P1|COMPLETED|Overall Study||0
8274829|NCT01708057|20404004|P3|STARTED|Overall Study||1
8274830|NCT01708057|20404005|P2|STARTED|Overall Study||1
8274831|NCT01708057|20404006|P1|STARTED|Overall Study||1
8274832|NCT01707992|20404065|P6|NOT COMPLETED|Active Treatment Phase (24 Months)||215
8274833|NCT01707992|20404066|P5|NOT COMPLETED|Active Treatment Phase (24 Months)||494
8274834|NCT01707992|20404067|P4|NOT COMPLETED|Active Treatment Phase (24 Months)||884
8274835|NCT01707992|20404068|P3|NOT COMPLETED|Active Treatment Phase (24 Months)||0
8274836|NCT01707992|20404069|P2|NOT COMPLETED|Active Treatment Phase (24 Months)||0
8274837|NCT01707992|20404070|P1|NOT COMPLETED|Active Treatment Phase (24 Months)||0
8274838|NCT01707992|20404065|P6|COMPLETED|Active Treatment Phase (24 Months)||0
8274839|NCT01707992|20404066|P5|COMPLETED|Active Treatment Phase (24 Months)||10
8274840|NCT01707992|20404067|P4|COMPLETED|Active Treatment Phase (24 Months)||7
8274841|NCT01707992|20404068|P3|COMPLETED|Active Treatment Phase (24 Months)||0
8274842|NCT01707992|20404069|P2|COMPLETED|Active Treatment Phase (24 Months)||0
8274843|NCT01707992|20404070|P1|COMPLETED|Active Treatment Phase (24 Months)||0
8274844|NCT01707992|20404065|P6|STARTED|Active Treatment Phase (24 Months)||215
8274845|NCT01707992|20404066|P5|STARTED|Active Treatment Phase (24 Months)||504
8274846|NCT01707992|20404067|P4|STARTED|Active Treatment Phase (24 Months)||891
8274847|NCT01707992|20404068|P3|STARTED|Active Treatment Phase (24 Months)||0
8274848|NCT01707992|20404069|P2|STARTED|Active Treatment Phase (24 Months)||0
8274849|NCT01707992|20404070|P1|STARTED|Active Treatment Phase (24 Months)||0
8274850|NCT01707992|20404065|P6|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
8274851|NCT01707992|20404066|P5|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
8274852|NCT01707992|20404067|P4|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
8274853|NCT01707992|20404068|P3|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200
8274854|NCT01707992|20404069|P2|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104
8274855|NCT01707992|20404070|P1|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144
8274856|NCT01707992|20404065|P6|COMPLETED|Placebo-Controlled Phase (24 Months)||0
8274857|NCT01707992|20404066|P5|COMPLETED|Placebo-Controlled Phase (24 Months)||0
8274858|NCT01707992|20404067|P4|COMPLETED|Placebo-Controlled Phase (24 Months)||0
8274859|NCT01707992|20404068|P3|COMPLETED|Placebo-Controlled Phase (24 Months)||532
8274860|NCT01707992|20404069|P2|COMPLETED|Placebo-Controlled Phase (24 Months)||623
8274861|NCT01707992|20404070|P1|COMPLETED|Placebo-Controlled Phase (24 Months)||596
8274862|NCT01707992|20404065|P6|STARTED|Placebo-Controlled Phase (24 Months)||0
8274863|NCT01707992|20404066|P5|STARTED|Placebo-Controlled Phase (24 Months)||0
8274864|NCT01707992|20404067|P4|STARTED|Placebo-Controlled Phase (24 Months)||0
8274865|NCT01707992|20404068|P3|STARTED|Placebo-Controlled Phase (24 Months)||732
8274866|NCT01707992|20404069|P2|STARTED|Placebo-Controlled Phase (24 Months)||727
8274867|NCT01707992|20404070|P1|STARTED|Placebo-Controlled Phase (24 Months)||740
8274868|NCT01707693|20404122|P2|NOT COMPLETED|Time 3 Measures @ 6 Mth||5
8274869|NCT01707693|20404123|P1|NOT COMPLETED|Time 3 Measures @ 6 Mth||0
8274870|NCT01707693|20404122|P2|COMPLETED|Time 3 Measures @ 6 Mth||49
8274871|NCT01707693|20404123|P1|COMPLETED|Time 3 Measures @ 6 Mth||46
8274872|NCT01707693|20404122|P2|STARTED|Time 3 Measures @ 6 Mth||54
8274873|NCT01707693|20404123|P1|STARTED|Time 3 Measures @ 6 Mth||46
8274874|NCT01707693|20404122|P2|NOT COMPLETED|Overall Study Allocation||8
8274875|NCT01707693|20404123|P1|NOT COMPLETED|Overall Study Allocation||13
8274876|NCT01707693|20404122|P2|COMPLETED|Overall Study Allocation||54
8274877|NCT01707693|20404123|P1|COMPLETED|Overall Study Allocation||46
8274878|NCT01707693|20404122|P2|STARTED|Overall Study Allocation||62
8274879|NCT01707693|20404123|P1|STARTED|Overall Study Allocation||59
8274892|NCT01707654|20404156|P1|NOT COMPLETED|Overall Study||0
8274893|NCT01707654|20404156|P1|COMPLETED|Overall Study||9
8274894|NCT01707654|20404156|P1|STARTED|Overall Study||9
8274895|NCT01707472|20404163|P3|NOT COMPLETED|Overall Study||0
8274896|NCT01707472|20404164|P2|NOT COMPLETED|Overall Study||0
8274897|NCT01707472|20404165|P1|NOT COMPLETED|Overall Study||0
8274898|NCT01707472|20404163|P3|COMPLETED|Overall Study||8
8274899|NCT01707472|20404164|P2|COMPLETED|Overall Study||6
8274900|NCT01707472|20404165|P1|COMPLETED|Overall Study||4
8274901|NCT01707472|20404163|P3|STARTED|Overall Study||8
8274902|NCT01707472|20404164|P2|STARTED|Overall Study||6
8274903|NCT01707472|20404165|P1|STARTED|Overall Study||4
8274904|NCT01707420|20404190|P2|NOT COMPLETED|Overall Study||0
8274905|NCT01707420|20404191|P1|NOT COMPLETED|Overall Study||0
8274906|NCT01707420|20404190|P2|COMPLETED|Overall Study||18
8274907|NCT01707420|20404191|P1|COMPLETED|Overall Study||18
8274908|NCT01707420|20404190|P2|STARTED|Overall Study||18
8274909|NCT01707420|20404191|P1|STARTED|Overall Study||18
8274910|NCT01707381|20404201|P2|NOT COMPLETED|Period 2||0
8274911|NCT01707381|20404202|P1|NOT COMPLETED|Period 2||0
8274912|NCT01707381|20404201|P2|COMPLETED|Period 2||11
8274913|NCT01707381|20404202|P1|COMPLETED|Period 2||10
8274914|NCT01707381|20404201|P2|STARTED|Period 2||11
8274915|NCT01707381|20404202|P1|STARTED|Period 2||10
8274916|NCT01707381|20404201|P2|NOT COMPLETED|Period 1||2
8274917|NCT01707381|20404202|P1|NOT COMPLETED|Period 1||2
8274918|NCT01707381|20404201|P2|COMPLETED|Period 1||11
8274919|NCT01707381|20404202|P1|COMPLETED|Period 1||10
8274920|NCT01707381|20404201|P2|STARTED|Period 1||13
8274921|NCT01707381|20404202|P1|STARTED|Period 1||12
8274922|NCT01707368|20404212|P1|NOT COMPLETED|Overall Study||168
8274923|NCT01707368|20404212|P1|COMPLETED|Overall Study||393
8274924|NCT01707368|20404212|P1|STARTED|Overall Study||561
8274925|NCT01707290|20404221|P2|NOT COMPLETED|Overall Study||1
8274926|NCT01707290|20404222|P1|NOT COMPLETED|Overall Study||86
8274927|NCT01707290|20404221|P2|COMPLETED|Overall Study||3
8274928|NCT01707290|20404222|P1|COMPLETED|Overall Study||35
8274929|NCT01707290|20404221|P2|STARTED|Overall Study||4
8274930|NCT01707290|20404222|P1|STARTED|Overall Study||121
8274931|NCT01707238|20404245|P2|NOT COMPLETED|Overall Study||0
8274932|NCT01707238|20404246|P1|NOT COMPLETED|Overall Study||0
8274933|NCT01707238|20404245|P2|COMPLETED|Overall Study||52
8274934|NCT01707238|20404246|P1|COMPLETED|Overall Study||48
8274935|NCT01707238|20404245|P2|STARTED|Overall Study||52
8274936|NCT01707238|20404246|P1|STARTED|Overall Study||48
8274937|NCT01707225|20404262|P1|NOT COMPLETED|Overall Study||0
8274938|NCT01707225|20404262|P1|COMPLETED|Overall Study||10
8274939|NCT01707225|20404262|P1|STARTED|Overall Study||10
8274940|NCT01707147|20404267|P1|NOT COMPLETED|Overall Study||100
8274941|NCT01707147|20404267|P1|COMPLETED|Overall Study||3119
8274942|NCT01707147|20404267|P1|STARTED|Overall Study||3219
8274943|NCT01707095|20404277|P2|NOT COMPLETED|Overall Study||0
8274944|NCT01707095|20404278|P1|NOT COMPLETED|Overall Study||0
8274945|NCT01707095|20404277|P2|COMPLETED|Overall Study||42
8274946|NCT01707095|20404278|P1|COMPLETED|Overall Study||42
8274947|NCT01707095|20404277|P2|STARTED|Overall Study||42
8274948|NCT01707095|20404278|P1|STARTED|Overall Study||42
8274949|NCT01707043|20404288|P2|NOT COMPLETED|Overall Study||0
8274950|NCT01707043|20404289|P1|NOT COMPLETED|Overall Study||0
8274951|NCT01707043|20404288|P2|COMPLETED|Overall Study||10
8274952|NCT01707043|20404289|P1|COMPLETED|Overall Study||10
8274953|NCT01707043|20404288|P2|STARTED|Overall Study||10
8274954|NCT01707043|20404289|P1|STARTED|Overall Study||10
8274955|NCT01707030|20404299|P2|NOT COMPLETED|Overall Study||17
8274956|NCT01707030|20404300|P1|NOT COMPLETED|Overall Study||11
8274957|NCT01707030|20404299|P2|COMPLETED|Overall Study||54
8274958|NCT01707030|20404300|P1|COMPLETED|Overall Study||56
8274959|NCT01707030|20404299|P2|STARTED|Overall Study||71
8274960|NCT01707030|20404300|P1|STARTED|Overall Study||67
8274961|NCT01707004|20404318|P1|NOT COMPLETED|Overall Study||3
8274962|NCT01707004|20404318|P1|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17
8274963|NCT01707004|20404318|P1|STARTED|Overall Study||20
8274964|NCT01706978|20404332|P2|NOT COMPLETED|Overall Study||6
8274965|NCT01706978|20404333|P1|NOT COMPLETED|Overall Study||9
8274966|NCT01706978|20404332|P2|COMPLETED|Overall Study||35
8274967|NCT01706978|20404333|P1|COMPLETED|Overall Study||38
8274968|NCT01706978|20404332|P2|STARTED|Overall Study||41
8274969|NCT01706978|20404333|P1|STARTED|Overall Study||47
8274970|NCT01706965|20404347|P2|NOT COMPLETED|Overall Study||1
8274971|NCT01706965|20404348|P1|NOT COMPLETED|Overall Study||1
8274972|NCT01706965|20404347|P2|COMPLETED|Overall Study||12
8274973|NCT01706965|20404348|P1|COMPLETED|Overall Study||13
8274974|NCT01706965|20404347|P2|STARTED|Overall Study||13
8274975|NCT01706965|20404348|P1|STARTED|Overall Study||14
8274976|NCT01706952|20404356|P1|NOT COMPLETED|Overall Study||8
8274977|NCT01706952|20404356|P1|COMPLETED|Overall Study||37
8274978|NCT01706952|20404356|P1|STARTED|Overall Study||45
8274979|NCT01706926|20404372|P4|NOT COMPLETED|Overall Study||5
8274980|NCT01706926|20404373|P3|NOT COMPLETED|Overall Study||6
8274981|NCT01706926|20404374|P2|NOT COMPLETED|Overall Study||4
8274982|NCT01706926|20404375|P1|NOT COMPLETED|Overall Study||6
8274983|NCT01706926|20404372|P4|COMPLETED|Overall Study||74
8274984|NCT01706926|20404373|P3|COMPLETED|Overall Study||79
8274985|NCT01706926|20404374|P2|COMPLETED|Overall Study||77
8274986|NCT01706926|20404375|P1|COMPLETED|Overall Study||75
8274987|NCT01706926|20404372|P4|STARTED|Overall Study||79
8274988|NCT01706926|20404373|P3|STARTED|Overall Study||85
8274989|NCT01706926|20404374|P2|STARTED|Overall Study||81
8274990|NCT01706926|20404375|P1|STARTED|Overall Study||81
8274991|NCT01706822|20404484|P1|NOT COMPLETED|Overall Study||0
8274992|NCT01706822|20404484|P1|COMPLETED|Overall Study||8
8274993|NCT01706822|20404484|P1|STARTED|Overall Study||8
8274994|NCT01706770|20404494|P2|NOT COMPLETED|Overall Study||0
8274995|NCT01706770|20404495|P1|NOT COMPLETED|Overall Study||2
8274996|NCT01706770|20404494|P2|COMPLETED|Overall Study||17
8274997|NCT01706770|20404495|P1|COMPLETED|Overall Study||31
8274998|NCT01706770|20404494|P2|STARTED|Overall Study||17
8274999|NCT01706770|20404495|P1|STARTED|Overall Study||33
8275000|NCT01706666|20404506|P3|NOT COMPLETED|Overall Study||0
8275001|NCT01706666|20404507|P2|NOT COMPLETED|Overall Study||0
8275002|NCT01706666|20404508|P1|NOT COMPLETED|Overall Study||0
8275003|NCT01706666|20404506|P3|COMPLETED|Overall Study||1
8275004|NCT01706666|20404507|P2|COMPLETED|Overall Study||1
8275005|NCT01706666|20404508|P1|COMPLETED|Overall Study||1
8275006|NCT01706666|20404506|P3|STARTED|Overall Study||1
8275007|NCT01706666|20404507|P2|STARTED|Overall Study||1
8275008|NCT01706666|20404508|P1|STARTED|Overall Study||1
8275009|NCT01706588|20404527|P5|NOT COMPLETED|Overall Study||0
8275010|NCT01706588|20404528|P4|NOT COMPLETED|Overall Study||0
8275011|NCT01706588|20404529|P3|NOT COMPLETED|Overall Study||0
8275012|NCT01706588|20404530|P2|NOT COMPLETED|Overall Study||0
8275013|NCT01706588|20404531|P1|NOT COMPLETED|Overall Study||0
8275014|NCT01706588|20404527|P5|COMPLETED|Overall Study||16
8275015|NCT01706588|20404528|P4|COMPLETED|Overall Study||14
8275016|NCT01706588|20404529|P3|COMPLETED|Overall Study||15
8275017|NCT01706588|20404530|P2|COMPLETED|Overall Study||15
8275018|NCT01706588|20404531|P1|COMPLETED|Overall Study||15
8275019|NCT01706588|20404527|P5|STARTED|Overall Study||16
8275020|NCT01706588|20404528|P4|STARTED|Overall Study||14
8275021|NCT01706588|20404529|P3|STARTED|Overall Study||15
8275022|NCT01706588|20404530|P2|STARTED|Overall Study||15
8275023|NCT01706588|20404531|P1|STARTED|Overall Study||15
8275024|NCT01706575|20404543|P1|NOT COMPLETED|Overall Study||12
8275025|NCT01706575|20404543|P1|COMPLETED|Overall Study||64
8275026|NCT01706575|20404543|P1|Treated|Overall Study||70
8275027|NCT01706575|20404543|P1|STARTED|Overall Study||76
8275028|NCT01706549|20404554|P1|NOT COMPLETED|Overall Study||0
8275029|NCT01706549|20404554|P1|COMPLETED|Overall Study||16
8275030|NCT01706549|20404554|P1|STARTED|Overall Study||16
8275031|NCT01706536|20404564|P5|NOT COMPLETED|Overall Study||2
8275032|NCT01706536|20404565|P4|NOT COMPLETED|Overall Study||4
8275033|NCT01706536|20404566|P3|NOT COMPLETED|Overall Study||5
8275034|NCT01706536|20404567|P2|NOT COMPLETED|Overall Study||4
8275035|NCT01706536|20404568|P1|NOT COMPLETED|Overall Study||4
8275036|NCT01706536|20404564|P5|COMPLETED|Overall Study||57
8275037|NCT01706536|20404565|P4|COMPLETED|Overall Study||53
8275038|NCT01706536|20404566|P3|COMPLETED|Overall Study||49
8275039|NCT01706536|20404567|P2|COMPLETED|Overall Study||51
8275040|NCT01706536|20404568|P1|COMPLETED|Overall Study||53
8275041|NCT01706536|20404564|P5|STARTED|Overall Study||59
8275042|NCT01706536|20404565|P4|STARTED|Overall Study||57
8275043|NCT01706536|20404566|P3|STARTED|Overall Study||54
8275044|NCT01706536|20404567|P2|STARTED|Overall Study||55
8275045|NCT01706536|20404568|P1|STARTED|Overall Study||57
8275046|NCT01706497|20404625|P1|NOT COMPLETED|Overall Study||0
8275047|NCT01706497|20404625|P1|COMPLETED|Overall Study||177
8275048|NCT01706497|20404625|P1|STARTED|Overall Study||177
8275055|NCT01706328|20404660|P3|NOT COMPLETED|12-week Double-blind Treatment Period||45
8275056|NCT01706328|20404661|P2|NOT COMPLETED|12-week Double-blind Treatment Period||46
8275057|NCT01706328|20404662|P1|NOT COMPLETED|12-week Double-blind Treatment Period||0
8275058|NCT01706328|20404660|P3|COMPLETED|12-week Double-blind Treatment Period||371
8275059|NCT01706328|20404661|P2|COMPLETED|12-week Double-blind Treatment Period||366
8275060|NCT01706328|20404662|P1|COMPLETED|12-week Double-blind Treatment Period||0
8275061|NCT01706328|20404660|P3|STARTED|12-week Double-blind Treatment Period||416
8275062|NCT01706328|20404661|P2|STARTED|12-week Double-blind Treatment Period||412
8275063|NCT01706328|20404662|P1|STARTED|12-week Double-blind Treatment Period||0
8275064|NCT01706328|20404660|P3|NOT COMPLETED|2-week Run-in Period||0
8275065|NCT01706328|20404661|P2|NOT COMPLETED|2-week Run-in Period||0
8275066|NCT01706328|20404662|P1|NOT COMPLETED|2-week Run-in Period||165
8275067|NCT01706328|20404660|P3|COMPLETED|2-week Run-in Period||0
8275068|NCT01706328|20404661|P2|COMPLETED|2-week Run-in Period||0
8275069|NCT01706328|20404662|P1|COMPLETED|2-week Run-in Period||828
8275070|NCT01706328|20404660|P3|STARTED|2-week Run-in Period||0
8275071|NCT01706328|20404661|P2|STARTED|2-week Run-in Period||0
8275072|NCT01706328|20404662|P1|STARTED|2-week Run-in Period||993
8275073|NCT01706263|20404672|P1|NOT COMPLETED|Overall Study||0
8275074|NCT01706263|20404672|P1|COMPLETED|Overall Study||28
8275075|NCT01706263|20404672|P1|STARTED|Overall Study||28
8275076|NCT01706250|20404681|P1|NOT COMPLETED|Overall Study||2
8275077|NCT01706250|20404681|P1|COMPLETED|Overall Study||18
8275078|NCT01706250|20404681|P1|STARTED|Overall Study||20
8275079|NCT01706198|20404712|P2|NOT COMPLETED|Overall Study||194
8275080|NCT01706198|20404713|P1|NOT COMPLETED|Overall Study||173
8275081|NCT01706198|20404712|P2|COMPLETED|Overall Study||1920
8275082|NCT01706198|20404713|P1|COMPLETED|Overall Study||1946
8275083|NCT01706198|20404712|P2|STARTED|Overall Study||2114
8275084|NCT01706198|20404713|P1|STARTED|Overall Study||2119
8275085|NCT01706159|20404765|P2|NOT COMPLETED|Overall Study||2
8275086|NCT01706159|20404766|P1|NOT COMPLETED|Overall Study||8
8275087|NCT01706159|20404765|P2|COMPLETED|Overall Study||4
8275088|NCT01706159|20404766|P1|COMPLETED|Overall Study||6
8275089|NCT01706159|20404765|P2|Completers (With Baron Score at Week 8)|Overall Study||3
8275090|NCT01706159|20404766|P1|Completers (With Baron Score at Week 8)|Overall Study||6
8275091|NCT01706159|20404765|P2|Exposed|Overall Study|One subject was not exposed to placebo.|5
8275092|NCT01706159|20404766|P1|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
8275093|NCT01706159|20404765|P2|STARTED|Overall Study||6
8275094|NCT01706159|20404766|P1|STARTED|Overall Study||14
8275095|NCT01706146|20404780|P1|NOT COMPLETED|Overall Study||6
8275096|NCT01706146|20404780|P1|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
8275097|NCT01706146|20404780|P1|STARTED|Overall Study||59
8275098|NCT01706081|20404787|P2|NOT COMPLETED|Overall Study||0
8275099|NCT01706081|20404788|P1|NOT COMPLETED|Overall Study||0
8275100|NCT01706081|20404787|P2|COMPLETED|Overall Study||42
8275101|NCT01706081|20404788|P1|COMPLETED|Overall Study||40
8275102|NCT01706081|20404787|P2|STARTED|Overall Study||42
8275103|NCT01706081|20404788|P1|STARTED|Overall Study||40
8275104|NCT01706003|20404800|P2|NOT COMPLETED|Overall Study||4
8275105|NCT01706003|20404801|P1|NOT COMPLETED|Overall Study||11
8275106|NCT01706003|20404800|P2|COMPLETED|Overall Study||18
8275107|NCT01706003|20404801|P1|COMPLETED|Overall Study||12
8275108|NCT01706003|20404800|P2|STARTED|Overall Study||22
8275109|NCT01706003|20404801|P1|STARTED|Overall Study||23
8275116|NCT01705730|20404828|P1|NOT COMPLETED|Overall Study||9
8275117|NCT01705730|20404828|P1|COMPLETED|Overall Study||59
8275118|NCT01705730|20404828|P1|STARTED|Overall Study|Participants who received study drug|68
8275119|NCT01705717|20404868|P2|NOT COMPLETED|Overall Study||5
8275120|NCT01705717|20404869|P1|NOT COMPLETED|Overall Study||2
8275121|NCT01705717|20404868|P2|COMPLETED|Overall Study||7
8275122|NCT01705717|20404869|P1|COMPLETED|Overall Study||35
8275123|NCT01705717|20404868|P2|STARTED|Overall Study||12
8275124|NCT01705717|20404869|P1|STARTED|Overall Study||37
8275125|NCT01705691|20404886|P2|NOT COMPLETED|Overall Study||6
8275126|NCT01705691|20404887|P1|NOT COMPLETED|Overall Study||3
8275127|NCT01705691|20404886|P2|COMPLETED|Overall Study||24
8275128|NCT01705691|20404887|P1|COMPLETED|Overall Study||16
8275129|NCT01705691|20404886|P2|STARTED|Overall Study||30
8275130|NCT01705691|20404887|P1|STARTED|Overall Study||19
8275131|NCT01705652|20404907|P2|NOT COMPLETED|Overall Study||3
8275132|NCT01705652|20404908|P1|NOT COMPLETED|Overall Study||3
8275133|NCT01705652|20404907|P2|COMPLETED|Overall Study||9
8275134|NCT01705652|20404908|P1|COMPLETED|Overall Study||6
8275135|NCT01705652|20404907|P2|STARTED|Overall Study||12
8275136|NCT01705652|20404908|P1|STARTED|Overall Study||9
8275137|NCT01705587|20404916|P2|NOT COMPLETED|Overall Study||1
8275138|NCT01705587|20404917|P1|NOT COMPLETED|Overall Study||0
8275139|NCT01705587|20404916|P2|COMPLETED|Overall Study||5
8275140|NCT01705587|20404917|P1|COMPLETED|Overall Study||7
8275141|NCT01705587|20404916|P2|STARTED|Overall Study||6
8275142|NCT01705587|20404917|P1|STARTED|Overall Study||7
8275143|NCT01705574|20404935|P4|NOT COMPLETED|Open-Label Extension Phase||5
8275144|NCT01705574|20404936|P3|NOT COMPLETED|Open-Label Extension Phase||11
8275145|NCT01705574|20404937|P2|NOT COMPLETED|Open-Label Extension Phase||0
8275146|NCT01705574|20404938|P1|NOT COMPLETED|Open-Label Extension Phase||15
8275147|NCT01705574|20404935|P4|COMPLETED|Open-Label Extension Phase||48
8275148|NCT01705574|20404936|P3|COMPLETED|Open-Label Extension Phase||148
8275149|NCT01705574|20404937|P2|COMPLETED|Open-Label Extension Phase||0
8275150|NCT01705574|20404938|P1|COMPLETED|Open-Label Extension Phase||231
8275151|NCT01705574|20404935|P4|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53
8275152|NCT01705574|20404936|P3|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159
8275153|NCT01705574|20404937|P2|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0
8275154|NCT01705574|20404938|P1|STARTED|Open-Label Extension Phase||246
8275155|NCT01705574|20404935|P4|NOT COMPLETED|Double-Blind Phase||0
8275156|NCT01705574|20404936|P3|NOT COMPLETED|Double-Blind Phase||0
8275157|NCT01705574|20404937|P2|NOT COMPLETED|Double-Blind Phase||41
8275158|NCT01705574|20404938|P1|NOT COMPLETED|Double-Blind Phase||33
8275159|NCT01705574|20404935|P4|COMPLETED|Double-Blind Phase||0
8275160|NCT01705574|20404936|P3|COMPLETED|Double-Blind Phase||0
8275161|NCT01705574|20404937|P2|COMPLETED|Double-Blind Phase||249
8275162|NCT01705574|20404938|P1|COMPLETED|Double-Blind Phase||260
8275163|NCT01705574|20404935|P4|STARTED|Double-Blind Phase||0
8275164|NCT01705574|20404936|P3|STARTED|Double-Blind Phase||0
8275165|NCT01705574|20404937|P2|STARTED|Double-Blind Phase||290
8275166|NCT01705574|20404938|P1|STARTED|Double-Blind Phase||293
8275167|NCT01705509|20404955|P1|NOT COMPLETED|CPET w/ Ranexa||2
8275168|NCT01705509|20404955|P1|COMPLETED|CPET w/ Ranexa||5
8275169|NCT01705509|20404955|P1|STARTED|CPET w/ Ranexa||7
8275170|NCT01705509|20404955|P1|NOT COMPLETED|Inclusion CPET||7
8275171|NCT01705509|20404955|P1|COMPLETED|Inclusion CPET||7
8275172|NCT01705509|20404955|P1|STARTED|Inclusion CPET||14
8275173|NCT01705496|20404959|P1|NOT COMPLETED|Overall Study||4
8275174|NCT01705496|20404959|P1|COMPLETED|Overall Study||19
8275175|NCT01705496|20404959|P1|STARTED|Overall Study||23
8275176|NCT01705288|20404971|P2|NOT COMPLETED|Overall Study||0
8275177|NCT01705288|20404972|P1|NOT COMPLETED|Overall Study||0
8275178|NCT01705288|20404971|P2|COMPLETED|Overall Study||51
8275179|NCT01705288|20404972|P1|COMPLETED|Overall Study||52
8275180|NCT01705288|20404971|P2|STARTED|Overall Study||51
8275181|NCT01705288|20404972|P1|STARTED|Overall Study||52
8275182|NCT01705236|20404982|P1|NOT COMPLETED|Overall Study||27
8275183|NCT01705236|20404982|P1|COMPLETED|Overall Study||60
8275184|NCT01705236|20404982|P1|STARTED|Overall Study||87
8275185|NCT01705145|20404991|P1|NOT COMPLETED|Part B||1
8275186|NCT01705145|20404991|P1|COMPLETED|Part B||33
8275187|NCT01705145|20404991|P1|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
8275188|NCT01705145|20404991|P1|NOT COMPLETED|Part A||0
8275189|NCT01705145|20404991|P1|COMPLETED|Part A||9
8275190|NCT01705145|20404991|P1|STARTED|Part A||9
8275191|NCT01705106|20405019|P1|NOT COMPLETED|Overall Study||0
8275192|NCT01705106|20405019|P1|COMPLETED|Overall Study||21
8275193|NCT01705106|20405019|P1|STARTED|Overall Study||21
8275214|NCT01704976|20405146|P2|NOT COMPLETED|Overall Study||2
8275215|NCT01704976|20405147|P1|NOT COMPLETED|Overall Study||1
8275216|NCT01704976|20405146|P2|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
8275217|NCT01704976|20405147|P1|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
8275218|NCT01704976|20405146|P2|STARTED|Overall Study||13
8275219|NCT01704976|20405147|P1|STARTED|Overall Study||14
8275220|NCT01704846|20405163|P2|NOT COMPLETED|Treatment Period 4||0
8275221|NCT01704846|20405164|P1|NOT COMPLETED|Treatment Period 4||0
8275222|NCT01704846|20405163|P2|COMPLETED|Treatment Period 4||29
8275223|NCT01704846|20405164|P1|COMPLETED|Treatment Period 4||30
8275224|NCT01704846|20405163|P2|STARTED|Treatment Period 4||29
8275225|NCT01704846|20405164|P1|STARTED|Treatment Period 4||30
8275226|NCT01704846|20405163|P2|NOT COMPLETED|Treatment Period 3||0
8275227|NCT01704846|20405164|P1|NOT COMPLETED|Treatment Period 3||0
8275228|NCT01704846|20405163|P2|COMPLETED|Treatment Period 3||29
8275229|NCT01704846|20405164|P1|COMPLETED|Treatment Period 3||30
8275230|NCT01704846|20405163|P2|STARTED|Treatment Period 3||29
8275231|NCT01704846|20405164|P1|STARTED|Treatment Period 3||30
8275232|NCT01704846|20405163|P2|NOT COMPLETED|Treatment Period 2||1
8275233|NCT01704846|20405164|P1|NOT COMPLETED|Treatment Period 2||0
8275234|NCT01704846|20405163|P2|COMPLETED|Treatment Period 2||29
8275235|NCT01704846|20405164|P1|COMPLETED|Treatment Period 2||30
8275236|NCT01704846|20405163|P2|STARTED|Treatment Period 2||30
8275237|NCT01704846|20405164|P1|STARTED|Treatment Period 2||30
8275238|NCT01704846|20405163|P2|NOT COMPLETED|Treatment Period 1||0
8275239|NCT01704846|20405164|P1|NOT COMPLETED|Treatment Period 1||0
8275240|NCT01704846|20405163|P2|COMPLETED|Treatment Period 1||30
8275241|NCT01704846|20405164|P1|COMPLETED|Treatment Period 1||30
8275242|NCT01704846|20405163|P2|STARTED|Treatment Period 1||30
8275243|NCT01704846|20405164|P1|STARTED|Treatment Period 1||30
8275244|NCT01704781|20405187|P5|NOT COMPLETED|Overall Study||0
8275245|NCT01704781|20405188|P4|NOT COMPLETED|Overall Study||0
8275246|NCT01704781|20405189|P3|NOT COMPLETED|Overall Study||0
8275247|NCT01704781|20405190|P2|NOT COMPLETED|Overall Study||0
8275248|NCT01704781|20405191|P1|NOT COMPLETED|Overall Study||0
8275249|NCT01704781|20405187|P5|COMPLETED|Overall Study||12
8275250|NCT01704781|20405188|P4|COMPLETED|Overall Study||12
8275251|NCT01704781|20405189|P3|COMPLETED|Overall Study||6
8275252|NCT01704781|20405190|P2|COMPLETED|Overall Study||3
8275253|NCT01704781|20405191|P1|COMPLETED|Overall Study||3
8275254|NCT01704781|20405187|P5|STARTED|Overall Study||12
8275255|NCT01704781|20405188|P4|STARTED|Overall Study||12
8275256|NCT01704781|20405189|P3|STARTED|Overall Study||6
8275257|NCT01704781|20405190|P2|STARTED|Overall Study||3
8275258|NCT01704781|20405191|P1|STARTED|Overall Study||3
8275267|NCT01704651|20405234|P2|NOT COMPLETED|Overall Study||7
8275268|NCT01704651|20405235|P1|NOT COMPLETED|Overall Study||5
8275269|NCT01704651|20405234|P2|COMPLETED|Overall Study||68
8275270|NCT01704651|20405235|P1|COMPLETED|Overall Study||66
8275271|NCT01704651|20405234|P2|STARTED|Overall Study||75
8275272|NCT01704651|20405235|P1|STARTED|Overall Study||71
8275273|NCT01704599|20405243|P1|NOT COMPLETED|Overall Study||1
8275274|NCT01704599|20405243|P1|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
8275275|NCT01704599|20405243|P1|STARTED|Overall Study|Study was started January 22, 2010|8
8275276|NCT01704521|20405272|P2|NOT COMPLETED|Overall Study||0
8275277|NCT01704521|20405273|P1|NOT COMPLETED|Overall Study||0
8275278|NCT01704521|20405272|P2|COMPLETED|Overall Study||2
8275279|NCT01704521|20405273|P1|COMPLETED|Overall Study||3
8275280|NCT01704521|20405272|P2|STARTED|Overall Study||2
8275281|NCT01704521|20405273|P1|STARTED|Overall Study||3
8275282|NCT01704495|20405283|P4|NOT COMPLETED|Optional Safety Extension||31
8275283|NCT01704495|20405284|P3|NOT COMPLETED|Optional Safety Extension||31
8275284|NCT01704495|20405285|P2|NOT COMPLETED|Optional Safety Extension||33
8275285|NCT01704495|20405286|P1|NOT COMPLETED|Optional Safety Extension||29
8275286|NCT01704495|20405283|P4|COMPLETED|Optional Safety Extension||85
8275287|NCT01704495|20405284|P3|COMPLETED|Optional Safety Extension||83
8275288|NCT01704495|20405285|P2|COMPLETED|Optional Safety Extension||88
8275289|NCT01704495|20405286|P1|COMPLETED|Optional Safety Extension||87
8275290|NCT01704495|20405283|P4|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
8275291|NCT01704495|20405284|P3|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
8275292|NCT01704495|20405285|P2|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
8275293|NCT01704495|20405286|P1|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
8275294|NCT01704495|20405283|P4|NOT COMPLETED|Subjects Randomized||17
8275295|NCT01704495|20405284|P3|NOT COMPLETED|Subjects Randomized||16
8275296|NCT01704495|20405285|P2|NOT COMPLETED|Subjects Randomized||15
8275297|NCT01704495|20405286|P1|NOT COMPLETED|Subjects Randomized||22
8275298|NCT01704495|20405283|P4|COMPLETED|Subjects Randomized||145
8275299|NCT01704495|20405284|P3|COMPLETED|Subjects Randomized||144
8275300|NCT01704495|20405285|P2|COMPLETED|Subjects Randomized||141
8275301|NCT01704495|20405286|P1|COMPLETED|Subjects Randomized||140
8275302|NCT01704495|20405283|P4|STARTED|Subjects Randomized||162
8275303|NCT01704495|20405284|P3|STARTED|Subjects Randomized||160
8275304|NCT01704495|20405285|P2|STARTED|Subjects Randomized||156
8275305|NCT01704495|20405286|P1|STARTED|Subjects Randomized||162
8275306|NCT01704456|20405462|P2|NOT COMPLETED|Overall Study||14
8275307|NCT01704456|20405463|P1|NOT COMPLETED|Overall Study||8
8275308|NCT01704456|20405462|P2|COMPLETED|Overall Study||49
8275309|NCT01704456|20405463|P1|COMPLETED|Overall Study||59
8275310|NCT01704456|20405462|P2|STARTED|Overall Study||63
8275311|NCT01704456|20405463|P1|STARTED|Overall Study||67
8275330|NCT01704287|20405525|P5|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
8275331|NCT01704287|20405526|P4|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
8275332|NCT01704287|20405527|P3|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
8275333|NCT01704287|20405528|P2|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
8275334|NCT01704287|20405529|P1|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
8275335|NCT01704287|20405525|P5|COMPLETED|Switch to Pembrolizumab Treatment Period||7
8275336|NCT01704287|20405526|P4|COMPLETED|Switch to Pembrolizumab Treatment Period||15
8275337|NCT01704287|20405527|P3|COMPLETED|Switch to Pembrolizumab Treatment Period||0
8275338|NCT01704287|20405528|P2|COMPLETED|Switch to Pembrolizumab Treatment Period||0
8275339|NCT01704287|20405529|P1|COMPLETED|Switch to Pembrolizumab Treatment Period||0
8275340|NCT01704287|20405525|P5|STARTED|Switch to Pembrolizumab Treatment Period||45
8275341|NCT01704287|20405526|P4|STARTED|Switch to Pembrolizumab Treatment Period||53
8275342|NCT01704287|20405527|P3|STARTED|Switch to Pembrolizumab Treatment Period||0
8275343|NCT01704287|20405528|P2|STARTED|Switch to Pembrolizumab Treatment Period||0
8275344|NCT01704287|20405529|P1|STARTED|Switch to Pembrolizumab Treatment Period||0
8275345|NCT01704287|20405525|P5|NOT COMPLETED|Initial Treatment Period||0
8275346|NCT01704287|20405526|P4|NOT COMPLETED|Initial Treatment Period||0
8275347|NCT01704287|20405527|P3|NOT COMPLETED|Initial Treatment Period||173
8275348|NCT01704287|20405528|P2|NOT COMPLETED|Initial Treatment Period||134
8275349|NCT01704287|20405529|P1|NOT COMPLETED|Initial Treatment Period||147
8275350|NCT01704287|20405525|P5|COMPLETED|Initial Treatment Period||0
8275351|NCT01704287|20405526|P4|COMPLETED|Initial Treatment Period||0
8275352|NCT01704287|20405527|P3|COMPLETED|Initial Treatment Period||6
8275353|NCT01704287|20405528|P2|COMPLETED|Initial Treatment Period||47
8275354|NCT01704287|20405529|P1|COMPLETED|Initial Treatment Period||33
8275355|NCT01704287|20405525|P5|Treated|Initial Treatment Period||0
8275356|NCT01704287|20405526|P4|Treated|Initial Treatment Period||0
8275357|NCT01704287|20405527|P3|Treated|Initial Treatment Period||171
8275358|NCT01704287|20405528|P2|Treated|Initial Treatment Period||179
8275359|NCT01704287|20405529|P1|Treated|Initial Treatment Period||178
8275360|NCT01704287|20405525|P5|STARTED|Initial Treatment Period||0
8275361|NCT01704287|20405526|P4|STARTED|Initial Treatment Period||0
8275362|NCT01704287|20405527|P3|STARTED|Initial Treatment Period||179
8275363|NCT01704287|20405528|P2|STARTED|Initial Treatment Period||181
8275364|NCT01704287|20405529|P1|STARTED|Initial Treatment Period||180
8275365|NCT01704261|20405577|P2|NOT COMPLETED|Overall Study||15
8275366|NCT01704261|20405578|P1|NOT COMPLETED|Overall Study||13
8275367|NCT01704261|20405577|P2|COMPLETED|Overall Study||138
8275368|NCT01704261|20405578|P1|COMPLETED|Overall Study||141
8275369|NCT01704261|20405577|P2|STARTED|Overall Study||153
8275370|NCT01704261|20405578|P1|STARTED|Overall Study||154
8275371|NCT01704196|20405594|P2|NOT COMPLETED|Overall Study||24
8275372|NCT01704196|20405595|P1|NOT COMPLETED|Overall Study||19
8275373|NCT01704196|20405594|P2|COMPLETED|Overall Study||65
8275374|NCT01704196|20405595|P1|COMPLETED|Overall Study||71
8275375|NCT01704196|20405594|P2|STARTED|Overall Study||89
8275376|NCT01704196|20405595|P1|STARTED|Overall Study||90
8275377|NCT01704079|20405605|P2|NOT COMPLETED|Overall Study||23
8275378|NCT01704079|20405606|P1|NOT COMPLETED|Overall Study||14
8275379|NCT01704079|20405605|P2|COMPLETED|Overall Study||121
8275380|NCT01704079|20405606|P1|COMPLETED|Overall Study||58
8275381|NCT01704079|20405605|P2|Entered Extension Study|Overall Study||102
8275382|NCT01704079|20405606|P1|Entered Extension Study|Overall Study||53
8275383|NCT01704079|20405605|P2|STARTED|Overall Study||144
8275384|NCT01704079|20405606|P1|STARTED|Overall Study||72
8275397|NCT01703858|20405655|P3|NOT COMPLETED|Overall Study||0
8275398|NCT01703858|20405656|P2|NOT COMPLETED|Overall Study||1
8275399|NCT01703858|20405657|P1|NOT COMPLETED|Overall Study||0
8275400|NCT01703858|20405655|P3|COMPLETED|Overall Study||5
8275401|NCT01703858|20405656|P2|COMPLETED|Overall Study||4
8275402|NCT01703858|20405657|P1|COMPLETED|Overall Study||5
8275403|NCT01703858|20405655|P3|STARTED|Overall Study||5
8275404|NCT01703858|20405656|P2|STARTED|Overall Study||5
8275405|NCT01703858|20405657|P1|STARTED|Overall Study||5
8275406|NCT01703845|20405682|P2|NOT COMPLETED|Overall Study||0
8275407|NCT01703845|20405683|P1|NOT COMPLETED|Overall Study||3
8275408|NCT01703845|20405682|P2|COMPLETED|Overall Study||16
8275409|NCT01703845|20405683|P1|COMPLETED|Overall Study||13
8275410|NCT01703845|20405682|P2|STARTED|Overall Study|started are actually the randomized|16
8275411|NCT01703845|20405683|P1|STARTED|Overall Study|started are actually the randomized|16
8275412|NCT01703832|20405720|P2|NOT COMPLETED|Overall Study||0
8275413|NCT01703832|20405721|P1|NOT COMPLETED|Overall Study||1
8275414|NCT01703832|20405720|P2|COMPLETED|Overall Study||32
8275415|NCT01703832|20405721|P1|COMPLETED|Overall Study||32
8275416|NCT01703832|20405720|P2|STARTED|Overall Study||32
8275417|NCT01703832|20405721|P1|STARTED|Overall Study||33
8275418|NCT01703819|20405753|P2|NOT COMPLETED|Overall Study||2
8275419|NCT01703819|20405754|P1|NOT COMPLETED|Overall Study||0
8275420|NCT01703819|20405753|P2|COMPLETED|Overall Study||30
8275421|NCT01703819|20405754|P1|COMPLETED|Overall Study||34
8275422|NCT01703819|20405753|P2|STARTED|Overall Study||32
8275423|NCT01703819|20405754|P1|STARTED|Overall Study||34
8275424|NCT01703741|20405784|P1|NOT COMPLETED|Overall Study||18
8275425|NCT01703741|20405784|P1|COMPLETED|Overall Study||127
8275426|NCT01703741|20405784|P1|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
8275427|NCT01703741|20405784|P1|STARTED|Overall Study||145
8275428|NCT01703702|20405802|P2|NOT COMPLETED|Overall Study||22
8275429|NCT01703702|20405803|P1|NOT COMPLETED|Overall Study||36
8275430|NCT01703702|20405802|P2|COMPLETED|Overall Study||288
8275431|NCT01703702|20405803|P1|COMPLETED|Overall Study||272
8275432|NCT01703702|20405802|P2|STARTED|Overall Study||310
8275433|NCT01703702|20405803|P1|STARTED|Overall Study||308
8275434|NCT01703663|20405820|P2|NOT COMPLETED|Second Treatment Period||0
8275435|NCT01703663|20405821|P1|NOT COMPLETED|Second Treatment Period||0
8275436|NCT01703663|20405820|P2|COMPLETED|Second Treatment Period||8
8275437|NCT01703663|20405821|P1|COMPLETED|Second Treatment Period||11
8275438|NCT01703663|20405820|P2|STARTED|Second Treatment Period||8
8275439|NCT01703663|20405821|P1|STARTED|Second Treatment Period||11
8275440|NCT01703663|20405820|P2|NOT COMPLETED|First Treatment Period||0
8275441|NCT01703663|20405821|P1|NOT COMPLETED|First Treatment Period||0
8275442|NCT01703663|20405820|P2|COMPLETED|First Treatment Period||20
8275443|NCT01703663|20405821|P1|COMPLETED|First Treatment Period||20
8275444|NCT01703663|20405820|P2|STARTED|First Treatment Period||20
8275445|NCT01703663|20405821|P1|STARTED|First Treatment Period||20
8275446|NCT01703598|20405827|P1|NOT COMPLETED|Overall Study||0
8275447|NCT01703598|20405827|P1|COMPLETED|Overall Study||69
8275448|NCT01703598|20405827|P1|STARTED|Overall Study||69
8275449|NCT01703507|20405833|P2|NOT COMPLETED|Overall Study||0
8275450|NCT01703507|20405834|P1|NOT COMPLETED|Overall Study||1
8275451|NCT01703507|20405833|P2|COMPLETED|Overall Study||11
8275452|NCT01703507|20405834|P1|COMPLETED|Overall Study||5
8275453|NCT01703507|20405833|P2|STARTED|Overall Study||11
8275454|NCT01703507|20405834|P1|STARTED|Overall Study||6
8275455|NCT01703286|20405850|P6|NOT COMPLETED|Period 3 Including Washout||0
8275456|NCT01703286|20405851|P5|NOT COMPLETED|Period 3 Including Washout||0
8275457|NCT01703286|20405852|P4|NOT COMPLETED|Period 3 Including Washout||0
8275458|NCT01703286|20405853|P3|NOT COMPLETED|Period 3 Including Washout||0
8275459|NCT01703286|20405854|P2|NOT COMPLETED|Period 3 Including Washout||0
8275460|NCT01703286|20405855|P1|NOT COMPLETED|Period 3 Including Washout||0
8275461|NCT01703286|20405850|P6|COMPLETED|Period 3 Including Washout||6
8275462|NCT01703286|20405851|P5|COMPLETED|Period 3 Including Washout||7
8275463|NCT01703286|20405852|P4|COMPLETED|Period 3 Including Washout||5
8275464|NCT01703286|20405853|P3|COMPLETED|Period 3 Including Washout||7
8275465|NCT01703286|20405854|P2|COMPLETED|Period 3 Including Washout||7
8275466|NCT01703286|20405855|P1|COMPLETED|Period 3 Including Washout||7
8275467|NCT01703286|20405850|P6|STARTED|Period 3 Including Washout||6
8275468|NCT01703286|20405851|P5|STARTED|Period 3 Including Washout||7
8275469|NCT01703286|20405852|P4|STARTED|Period 3 Including Washout||5
8275470|NCT01703286|20405853|P3|STARTED|Period 3 Including Washout||7
8275471|NCT01703286|20405854|P2|STARTED|Period 3 Including Washout||7
8275472|NCT01703286|20405855|P1|STARTED|Period 3 Including Washout||7
8275473|NCT01703286|20405850|P6|NOT COMPLETED|Period 2 Including Washout||0
8275474|NCT01703286|20405851|P5|NOT COMPLETED|Period 2 Including Washout||0
8275475|NCT01703286|20405852|P4|NOT COMPLETED|Period 2 Including Washout||1
8275476|NCT01703286|20405853|P3|NOT COMPLETED|Period 2 Including Washout||0
8275477|NCT01703286|20405854|P2|NOT COMPLETED|Period 2 Including Washout||0
8275478|NCT01703286|20405855|P1|NOT COMPLETED|Period 2 Including Washout||0
8275479|NCT01703286|20405850|P6|COMPLETED|Period 2 Including Washout||6
8275480|NCT01703286|20405851|P5|COMPLETED|Period 2 Including Washout||7
8275481|NCT01703286|20405852|P4|COMPLETED|Period 2 Including Washout||5
8275482|NCT01703286|20405853|P3|COMPLETED|Period 2 Including Washout||7
8275483|NCT01703286|20405854|P2|COMPLETED|Period 2 Including Washout||7
8275484|NCT01703286|20405855|P1|COMPLETED|Period 2 Including Washout||7
8275485|NCT01703286|20405850|P6|STARTED|Period 2 Including Washout||6
8275486|NCT01703286|20405851|P5|STARTED|Period 2 Including Washout||7
8275487|NCT01703286|20405852|P4|STARTED|Period 2 Including Washout||6
8275488|NCT01703286|20405853|P3|STARTED|Period 2 Including Washout||7
8275489|NCT01703286|20405854|P2|STARTED|Period 2 Including Washout||7
8275490|NCT01703286|20405855|P1|STARTED|Period 2 Including Washout||7
8275491|NCT01703286|20405850|P6|NOT COMPLETED|Period 1 Including Washout||1
8275492|NCT01703286|20405851|P5|NOT COMPLETED|Period 1 Including Washout||0
8275493|NCT01703286|20405852|P4|NOT COMPLETED|Period 1 Including Washout||1
8275494|NCT01703286|20405853|P3|NOT COMPLETED|Period 1 Including Washout||0
8275495|NCT01703286|20405854|P2|NOT COMPLETED|Period 1 Including Washout||0
8275496|NCT01703286|20405855|P1|NOT COMPLETED|Period 1 Including Washout||0
8275497|NCT01703286|20405850|P6|COMPLETED|Period 1 Including Washout||6
8275498|NCT01703286|20405851|P5|COMPLETED|Period 1 Including Washout||7
8275499|NCT01703286|20405852|P4|COMPLETED|Period 1 Including Washout||6
8275500|NCT01703286|20405853|P3|COMPLETED|Period 1 Including Washout||7
8275501|NCT01703286|20405854|P2|COMPLETED|Period 1 Including Washout||7
8275502|NCT01703286|20405855|P1|COMPLETED|Period 1 Including Washout||7
8275503|NCT01703286|20405850|P6|STARTED|Period 1 Including Washout||7
8275504|NCT01703286|20405851|P5|STARTED|Period 1 Including Washout||7
8275505|NCT01703286|20405852|P4|STARTED|Period 1 Including Washout||7
8275506|NCT01703286|20405853|P3|STARTED|Period 1 Including Washout||7
8275507|NCT01703286|20405854|P2|STARTED|Period 1 Including Washout||7
8275508|NCT01703286|20405855|P1|STARTED|Period 1 Including Washout||7
8275509|NCT01703260|20405878|P3|NOT COMPLETED|Overall Study||3
8275510|NCT01703260|20405879|P2|NOT COMPLETED|Overall Study||4
8275511|NCT01703260|20405880|P1|NOT COMPLETED|Overall Study||3
8275512|NCT01703260|20405878|P3|COMPLETED|Overall Study||3
8275513|NCT01703260|20405879|P2|COMPLETED|Overall Study||3
8275514|NCT01703260|20405880|P1|COMPLETED|Overall Study||4
8275515|NCT01703260|20405878|P3|STARTED|Overall Study||6
8275516|NCT01703260|20405879|P2|STARTED|Overall Study||7
8275517|NCT01703260|20405880|P1|STARTED|Overall Study||7
8275518|NCT01703221|20405906|P3|NOT COMPLETED|Phase B - (Week 25 to 52)||5
8275519|NCT01703221|20405907|P2|NOT COMPLETED|Phase B - (Week 25 to 52)||14
8275520|NCT01703221|20405908|P1|NOT COMPLETED|Phase B - (Week 25 to 52)||16
8275521|NCT01703221|20405906|P3|COMPLETED|Phase B - (Week 25 to 52)||75
8275522|NCT01703221|20405907|P2|COMPLETED|Phase B - (Week 25 to 52)||147
8275523|NCT01703221|20405908|P1|COMPLETED|Phase B - (Week 25 to 52)||143
8275524|NCT01703221|20405906|P3|STARTED|Phase B - (Week 25 to 52)||80
8275525|NCT01703221|20405907|P2|STARTED|Phase B - (Week 25 to 52)||161
8275526|NCT01703221|20405908|P1|STARTED|Phase B - (Week 25 to 52)||159
8275527|NCT01703221|20405906|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
8275528|NCT01703221|20405907|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
8275529|NCT01703221|20405908|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
8275530|NCT01703221|20405906|P3|COMPLETED|Phase A (Up to 24 Weeks)||80
8275531|NCT01703221|20405907|P2|COMPLETED|Phase A (Up to 24 Weeks)||161
8275532|NCT01703221|20405908|P1|COMPLETED|Phase A (Up to 24 Weeks)||159
8275533|NCT01703221|20405906|P3|STARTED|Phase A (Up to 24 Weeks)||83
8275534|NCT01703221|20405907|P2|STARTED|Phase A (Up to 24 Weeks)||165
8275535|NCT01703221|20405908|P1|STARTED|Phase A (Up to 24 Weeks)||166
8275536|NCT01703208|20405939|P2|NOT COMPLETED|Overall Study||2102
8275537|NCT01703208|20405940|P1|NOT COMPLETED|Overall Study||2100
8275538|NCT01703208|20405939|P2|COMPLETED|Overall Study||0
8275539|NCT01703208|20405940|P1|COMPLETED|Overall Study||0
8275540|NCT01703208|20405939|P2|Treated|Overall Study||2100
8275541|NCT01703208|20405940|P1|Treated|Overall Study||2092
8275542|NCT01703208|20405939|P2|STARTED|Overall Study||2102
8275543|NCT01703208|20405940|P1|STARTED|Overall Study||2100
8275544|NCT01703169|20405994|P1|NOT COMPLETED|Overall Study||0
8275545|NCT01703169|20405994|P1|COMPLETED|Overall Study||13
8275546|NCT01703169|20405994|P1|STARTED|Overall Study||13
8275547|NCT01703091|20406004|P2|NOT COMPLETED|Overall Study||4
8275548|NCT01703091|20406005|P1|NOT COMPLETED|Overall Study||9
8275549|NCT01703091|20406004|P2|COMPLETED|Overall Study||95
8275550|NCT01703091|20406005|P1|COMPLETED|Overall Study||89
8275551|NCT01703091|20406004|P2|Received at Least One Dose of Study Drug|Overall Study||98
8275552|NCT01703091|20406005|P1|Received at Least One Dose of Study Drug|Overall Study||94
8275553|NCT01703091|20406004|P2|STARTED|Overall Study||99
8275554|NCT01703091|20406005|P1|STARTED|Overall Study||98
8275555|NCT01703065|20406023|P2|NOT COMPLETED|Overall Study||0
8275556|NCT01703065|20406024|P1|NOT COMPLETED|Overall Study||1
8275557|NCT01703065|20406023|P2|COMPLETED|Overall Study||0
8275558|NCT01703065|20406024|P1|COMPLETED|Overall Study||8
8275559|NCT01703065|20406023|P2|STARTED|Overall Study||0
8275560|NCT01703065|20406024|P1|STARTED|Overall Study||9
8275561|NCT01703039|20406039|P2|NOT COMPLETED|Overall Study||5
8275562|NCT01703039|20406040|P1|NOT COMPLETED|Overall Study||3
8275563|NCT01703039|20406039|P2|COMPLETED|Overall Study||7
8275564|NCT01703039|20406040|P1|COMPLETED|Overall Study||6
8275565|NCT01703039|20406039|P2|STARTED|Overall Study||12
8275566|NCT01703039|20406040|P1|STARTED|Overall Study||9
8275567|NCT01703000|20406054|P1|NOT COMPLETED|Overall Study||1
8275568|NCT01703000|20406054|P1|COMPLETED|Overall Study||99
8275569|NCT01703000|20406054|P1|STARTED|Overall Study||100
8275570|NCT01702987|20406087|P2|NOT COMPLETED|Overall Study||0
8275571|NCT01702987|20406088|P1|NOT COMPLETED|Overall Study||1
8275572|NCT01702987|20406087|P2|COMPLETED|Overall Study||12
8275573|NCT01702987|20406088|P1|COMPLETED|Overall Study||9
8275574|NCT01702987|20406087|P2|STARTED|Overall Study||12
8275575|NCT01702987|20406088|P1|STARTED|Overall Study||10
8275576|NCT01702961|20406094|P1|NOT COMPLETED|Overall Study||47
8275577|NCT01702961|20406094|P1|COMPLETED|Overall Study||28
8275578|NCT01702961|20406094|P1|STARTED|Overall Study||75
8275579|NCT01702909|20406100|P1|NOT COMPLETED|Overall Study||0
8275580|NCT01702909|20406100|P1|COMPLETED|Overall Study||7
8275581|NCT01702909|20406100|P1|STARTED|Overall Study||7
8275582|NCT01702896|20406106|P1|NOT COMPLETED|Overall Study||8
8275583|NCT01702896|20406106|P1|COMPLETED|Overall Study||0
8275584|NCT01702896|20406106|P1|STARTED|Overall Study||8
8275585|NCT01702844|20406112|P1|NOT COMPLETED|Overall Study||19
8275586|NCT01702844|20406112|P1|COMPLETED|Overall Study||23
8275587|NCT01702844|20406112|P1|Disease Progression|Overall Study||23
8275588|NCT01702844|20406112|P1|STARTED|Overall Study||42
8275589|NCT01702558|20406124|P5|NOT COMPLETED|Overall Study||42
8275590|NCT01702558|20406125|P4|NOT COMPLETED|Overall Study||47
8275591|NCT01702558|20406126|P3|NOT COMPLETED|Overall Study||5
8275592|NCT01702558|20406127|P2|NOT COMPLETED|Overall Study||4
8275593|NCT01702558|20406128|P1|NOT COMPLETED|Overall Study||4
8275594|NCT01702558|20406124|P5|COMPLETED|Overall Study||38
8275595|NCT01702558|20406125|P4|COMPLETED|Overall Study||34
8275596|NCT01702558|20406126|P3|COMPLETED|Overall Study||1
8275597|NCT01702558|20406127|P2|COMPLETED|Overall Study||1
8275598|NCT01702558|20406128|P1|COMPLETED|Overall Study||3
8275599|NCT01702558|20406124|P5|STARTED|Overall Study||80
8275600|NCT01702558|20406125|P4|STARTED|Overall Study||81
8275601|NCT01702558|20406126|P3|STARTED|Overall Study||6
8275602|NCT01702558|20406127|P2|STARTED|Overall Study||5
8275603|NCT01702558|20406128|P1|STARTED|Overall Study||7
8275604|NCT01702532|20406193|P2|NOT COMPLETED|Overall Study||1
8275605|NCT01702532|20406194|P1|NOT COMPLETED|Overall Study||0
8275606|NCT01702532|20406193|P2|COMPLETED|Overall Study||160
8275607|NCT01702532|20406194|P1|COMPLETED|Overall Study||161
8275608|NCT01702532|20406193|P2|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
8275609|NCT01702532|20406194|P1|Safety Population|Overall Study||161
8275610|NCT01702532|20406193|P2|STARTED|Overall Study||161
8275611|NCT01702532|20406194|P1|STARTED|Overall Study||161
8275612|NCT01702519|20406204|P2|NOT COMPLETED|Period 2||0
8275613|NCT01702519|20406205|P1|NOT COMPLETED|Period 2||0
8275614|NCT01702519|20406204|P2|COMPLETED|Period 2||18
8275615|NCT01702519|20406205|P1|COMPLETED|Period 2||19
8275616|NCT01702519|20406204|P2|STARTED|Period 2||18
8275617|NCT01702519|20406205|P1|STARTED|Period 2||19
8275618|NCT01702519|20406204|P2|NOT COMPLETED|Washout Period||2
8275619|NCT01702519|20406205|P1|NOT COMPLETED|Washout Period||1
8275620|NCT01702519|20406204|P2|COMPLETED|Washout Period||18
8275621|NCT01702519|20406205|P1|COMPLETED|Washout Period||19
8275622|NCT01702519|20406204|P2|STARTED|Washout Period||20
8275623|NCT01702519|20406205|P1|STARTED|Washout Period||20
8275624|NCT01702519|20406204|P2|NOT COMPLETED|Period 1||0
8275625|NCT01702519|20406205|P1|NOT COMPLETED|Period 1||0
8275626|NCT01702519|20406204|P2|COMPLETED|Period 1||20
8275627|NCT01702519|20406205|P1|COMPLETED|Period 1||20
8275628|NCT01702519|20406204|P2|STARTED|Period 1||20
8275629|NCT01702519|20406205|P1|STARTED|Period 1||20
8275630|NCT01702454|20406223|P2|NOT COMPLETED|Overall Study||8
8275631|NCT01702454|20406224|P1|NOT COMPLETED|Overall Study||3
8275632|NCT01702454|20406223|P2|COMPLETED|Overall Study||221
8275633|NCT01702454|20406224|P1|COMPLETED|Overall Study||238
8275634|NCT01702454|20406223|P2|STARTED|Overall Study||229
8275635|NCT01702454|20406224|P1|STARTED|Overall Study||241
8275636|NCT01702428|20406306|P4|NOT COMPLETED|Overall Study||57
8275637|NCT01702428|20406307|P3|NOT COMPLETED|Overall Study||53
8275638|NCT01702428|20406308|P2|NOT COMPLETED|Overall Study||70
8275639|NCT01702428|20406309|P1|NOT COMPLETED|Overall Study||64
8275640|NCT01702428|20406306|P4|COMPLETED|Overall Study||1232
8275641|NCT01702428|20406307|P3|COMPLETED|Overall Study||1190
8275642|NCT01702428|20406308|P2|COMPLETED|Overall Study||1162
8275643|NCT01702428|20406309|P1|COMPLETED|Overall Study||1175
8275644|NCT01702428|20406306|P4|STARTED|Overall Study||1289
8275645|NCT01702428|20406307|P3|STARTED|Overall Study||1243
8275646|NCT01702428|20406308|P2|STARTED|Overall Study||1232
8275647|NCT01702428|20406309|P1|STARTED|Overall Study||1239
8275648|NCT01702363|20406396|P1|NOT COMPLETED|Overall Study||20
8275649|NCT01702363|20406396|P1|COMPLETED|Overall Study||111
8275650|NCT01702363|20406396|P1|STARTED|Overall Study||131
8275651|NCT01702311|20406413|P2|NOT COMPLETED|Overall Study||13
8275652|NCT01702311|20406414|P1|NOT COMPLETED|Overall Study||16
8275653|NCT01702311|20406413|P2|COMPLETED|Overall Study||100
8275654|NCT01702311|20406414|P1|COMPLETED|Overall Study||106
8275655|NCT01702311|20406413|P2|STARTED|Overall Study||113
8275656|NCT01702311|20406414|P1|STARTED|Overall Study||122
8275657|NCT01702298|20406444|P1|NOT COMPLETED|Overall Study||1
8275658|NCT01702298|20406444|P1|COMPLETED|Overall Study||41
8275659|NCT01702298|20406444|P1|STARTED|Overall Study||42
8275660|NCT01702259|20406457|P2|NOT COMPLETED|Overall Study||0
8275661|NCT01702259|20406458|P1|NOT COMPLETED|Overall Study||0
8275662|NCT01702259|20406457|P2|COMPLETED|Overall Study||34
8275663|NCT01702259|20406458|P1|COMPLETED|Overall Study||34
8275664|NCT01702259|20406457|P2|STARTED|Overall Study||34
8275665|NCT01702259|20406458|P1|STARTED|Overall Study||34
8275666|NCT01702246|20406472|P1|NOT COMPLETED|Overall Study||5
8275667|NCT01702246|20406472|P1|COMPLETED|Overall Study||19
8275668|NCT01702246|20406472|P1|STARTED|Overall Study||24
8275669|NCT01702233|20406484|P3|NOT COMPLETED|Overall Study||5
8275670|NCT01702233|20406485|P2|NOT COMPLETED|Overall Study||3
8275671|NCT01702233|20406486|P1|NOT COMPLETED|Overall Study||6
8275672|NCT01702233|20406484|P3|COMPLETED|Overall Study||31
8275673|NCT01702233|20406485|P2|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
8275674|NCT01702233|20406486|P1|COMPLETED|Overall Study||66
8275675|NCT01702233|20406484|P3|Per Protocol Set|Overall Study||27
8275676|NCT01702233|20406485|P2|Per Protocol Set|Overall Study||58
8275677|NCT01702233|20406486|P1|Per Protocol Set|Overall Study||58
8275678|NCT01702233|20406484|P3|Full Analysis Set (ITT)|Overall Study||31
8275679|NCT01702233|20406485|P2|Full Analysis Set (ITT)|Overall Study||63
8275680|NCT01702233|20406486|P1|Full Analysis Set (ITT)|Overall Study||66
8275681|NCT01702233|20406484|P3|STARTED|Overall Study||36
8275682|NCT01702233|20406485|P2|STARTED|Overall Study||67
8275683|NCT01702233|20406486|P1|STARTED|Overall Study||72
8275684|NCT01702025|20406526|P4|NOT COMPLETED|Overall Study||0
8275685|NCT01702025|20406527|P3|NOT COMPLETED|Overall Study||1
8275686|NCT01702025|20406528|P2|NOT COMPLETED|Overall Study||1
8275687|NCT01702025|20406529|P1|NOT COMPLETED|Overall Study||2
8275688|NCT01702025|20406526|P4|COMPLETED|Overall Study||10
8275689|NCT01702025|20406527|P3|COMPLETED|Overall Study||9
8275690|NCT01702025|20406528|P2|COMPLETED|Overall Study||9
8275691|NCT01702025|20406529|P1|COMPLETED|Overall Study||9
8275692|NCT01702025|20406526|P4|STARTED|Overall Study||10
8275693|NCT01702025|20406527|P3|STARTED|Overall Study||10
8275694|NCT01702025|20406528|P2|STARTED|Overall Study||10
8275695|NCT01702025|20406529|P1|STARTED|Overall Study||11
8275696|NCT01701999|20406545|P2|NOT COMPLETED|Overall Study||0
8275697|NCT01701999|20406546|P1|NOT COMPLETED|Overall Study||0
8275698|NCT01701999|20406545|P2|COMPLETED|Overall Study||37
8275699|NCT01701999|20406546|P1|COMPLETED|Overall Study||8
8275700|NCT01701999|20406545|P2|STARTED|Overall Study||37
8275701|NCT01701999|20406546|P1|STARTED|Overall Study||8
8275702|NCT01701973|20406558|P8|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275703|NCT01701973|20406559|P7|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275704|NCT01701973|20406560|P6|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275705|NCT01701973|20406561|P5|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275706|NCT01701973|20406562|P4|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275707|NCT01701973|20406563|P3|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275708|NCT01701973|20406564|P2|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275709|NCT01701973|20406565|P1|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275710|NCT01701973|20406558|P8|COMPLETED|Aim 2: Second Intervention (1 Day)||3
8275711|NCT01701973|20406559|P7|COMPLETED|Aim 2: Second Intervention (1 Day)||5
8275712|NCT01701973|20406560|P6|COMPLETED|Aim 2: Second Intervention (1 Day)||3
8275713|NCT01701973|20406561|P5|COMPLETED|Aim 2: Second Intervention (1 Day)||2
8275714|NCT01701973|20406562|P4|COMPLETED|Aim 2: Second Intervention (1 Day)||4
8275715|NCT01701973|20406563|P3|COMPLETED|Aim 2: Second Intervention (1 Day)||5
8275716|NCT01701973|20406564|P2|COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275717|NCT01701973|20406565|P1|COMPLETED|Aim 2: Second Intervention (1 Day)||0
8275718|NCT01701973|20406558|P8|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
8275719|NCT01701973|20406559|P7|STARTED|Aim 2: Second Intervention (1 Day)||5
8275720|NCT01701973|20406560|P6|STARTED|Aim 2: Second Intervention (1 Day)||3
8275721|NCT01701973|20406561|P5|STARTED|Aim 2: Second Intervention (1 Day)||2
8275722|NCT01701973|20406562|P4|STARTED|Aim 2: Second Intervention (1 Day)||4
8275723|NCT01701973|20406563|P3|STARTED|Aim 2: Second Intervention (1 Day)||5
8275724|NCT01701973|20406564|P2|STARTED|Aim 2: Second Intervention (1 Day)||0
8275725|NCT01701973|20406565|P1|STARTED|Aim 2: Second Intervention (1 Day)||0
8275726|NCT01701973|20406558|P8|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275727|NCT01701973|20406559|P7|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275728|NCT01701973|20406560|P6|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275729|NCT01701973|20406561|P5|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275730|NCT01701973|20406562|P4|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275731|NCT01701973|20406563|P3|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275732|NCT01701973|20406564|P2|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275733|NCT01701973|20406565|P1|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
8275734|NCT01701973|20406558|P8|COMPLETED|Aim 2: First Intervention (1 Day)||4
8275735|NCT01701973|20406559|P7|COMPLETED|Aim 2: First Intervention (1 Day)||5
8275736|NCT01701973|20406560|P6|COMPLETED|Aim 2: First Intervention (1 Day)||3
8275737|NCT01701973|20406561|P5|COMPLETED|Aim 2: First Intervention (1 Day)||2
8275738|NCT01701973|20406562|P4|COMPLETED|Aim 2: First Intervention (1 Day)||4
8275739|NCT01701973|20406563|P3|COMPLETED|Aim 2: First Intervention (1 Day)||5
8275740|NCT01701973|20406564|P2|COMPLETED|Aim 2: First Intervention (1 Day)||0
8275741|NCT01701973|20406565|P1|COMPLETED|Aim 2: First Intervention (1 Day)||0
8275742|NCT01701973|20406558|P8|STARTED|Aim 2: First Intervention (1 Day)||4
8275743|NCT01701973|20406559|P7|STARTED|Aim 2: First Intervention (1 Day)||5
8275744|NCT01701973|20406560|P6|STARTED|Aim 2: First Intervention (1 Day)||3
8275745|NCT01701973|20406561|P5|STARTED|Aim 2: First Intervention (1 Day)||2
8275746|NCT01701973|20406562|P4|STARTED|Aim 2: First Intervention (1 Day)||4
8275747|NCT01701973|20406563|P3|STARTED|Aim 2: First Intervention (1 Day)||5
8275748|NCT01701973|20406564|P2|STARTED|Aim 2: First Intervention (1 Day)||0
8275749|NCT01701973|20406565|P1|STARTED|Aim 2: First Intervention (1 Day)||0
8275750|NCT01701973|20406558|P8|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275751|NCT01701973|20406559|P7|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275752|NCT01701973|20406560|P6|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275753|NCT01701973|20406561|P5|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275754|NCT01701973|20406562|P4|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275755|NCT01701973|20406563|P3|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275756|NCT01701973|20406564|P2|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275757|NCT01701973|20406565|P1|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275758|NCT01701973|20406558|P8|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275759|NCT01701973|20406559|P7|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275760|NCT01701973|20406560|P6|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275761|NCT01701973|20406561|P5|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275762|NCT01701973|20406562|P4|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275763|NCT01701973|20406563|P3|COMPLETED|Aim 1: Second Intervention (1 Day)||0
8275764|NCT01701973|20406564|P2|COMPLETED|Aim 1: Second Intervention (1 Day)||17
8275765|NCT01701973|20406565|P1|COMPLETED|Aim 1: Second Intervention (1 Day)||22
8275766|NCT01701973|20406558|P8|STARTED|Aim 1: Second Intervention (1 Day)||0
8275767|NCT01701973|20406559|P7|STARTED|Aim 1: Second Intervention (1 Day)||0
8275768|NCT01701973|20406560|P6|STARTED|Aim 1: Second Intervention (1 Day)||0
8275769|NCT01701973|20406561|P5|STARTED|Aim 1: Second Intervention (1 Day)||0
8275770|NCT01701973|20406562|P4|STARTED|Aim 1: Second Intervention (1 Day)||0
8275771|NCT01701973|20406563|P3|STARTED|Aim 1: Second Intervention (1 Day)||0
8275772|NCT01701973|20406564|P2|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
8275773|NCT01701973|20406565|P1|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
8275774|NCT01701973|20406558|P8|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8275775|NCT01701973|20406559|P7|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8275776|NCT01701973|20406560|P6|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8275777|NCT01701973|20406561|P5|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8275778|NCT01701973|20406562|P4|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8275779|NCT01701973|20406563|P3|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8275780|NCT01701973|20406564|P2|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
8275781|NCT01701973|20406565|P1|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
8275782|NCT01701973|20406558|P8|COMPLETED|Aim 1: First Intervention (1 Day)||0
8275783|NCT01701973|20406559|P7|COMPLETED|Aim 1: First Intervention (1 Day)||0
8275784|NCT01701973|20406560|P6|COMPLETED|Aim 1: First Intervention (1 Day)||0
8275785|NCT01701973|20406561|P5|COMPLETED|Aim 1: First Intervention (1 Day)||0
8275786|NCT01701973|20406562|P4|COMPLETED|Aim 1: First Intervention (1 Day)||0
8275787|NCT01701973|20406563|P3|COMPLETED|Aim 1: First Intervention (1 Day)||0
8275788|NCT01701973|20406564|P2|COMPLETED|Aim 1: First Intervention (1 Day)||20
8275789|NCT01701973|20406565|P1|COMPLETED|Aim 1: First Intervention (1 Day)||23
8275790|NCT01701973|20406558|P8|STARTED|Aim 1: First Intervention (1 Day)||0
8275791|NCT01701973|20406559|P7|STARTED|Aim 1: First Intervention (1 Day)||0
8275792|NCT01701973|20406560|P6|STARTED|Aim 1: First Intervention (1 Day)||0
8275793|NCT01701973|20406561|P5|STARTED|Aim 1: First Intervention (1 Day)||0
8275794|NCT01701973|20406562|P4|STARTED|Aim 1: First Intervention (1 Day)||0
8275795|NCT01701973|20406563|P3|STARTED|Aim 1: First Intervention (1 Day)||0
8275796|NCT01701973|20406564|P2|STARTED|Aim 1: First Intervention (1 Day)||21
8275797|NCT01701973|20406565|P1|STARTED|Aim 1: First Intervention (1 Day)||23
8275801|NCT01701622|20406619|P1|NOT COMPLETED|Overall Study||0
8275802|NCT01701622|20406619|P1|COMPLETED|Overall Study||1
8275803|NCT01701622|20406619|P1|STARTED|Overall Study||1
8275804|NCT01701583|20406626|P2|NOT COMPLETED|Overall Study||0
8275805|NCT01701583|20406627|P1|NOT COMPLETED|Overall Study||2
8275806|NCT01701583|20406626|P2|COMPLETED|Overall Study||3
8275807|NCT01701583|20406627|P1|COMPLETED|Overall Study||5
8275808|NCT01701583|20406626|P2|STARTED|Overall Study||3
8275809|NCT01701583|20406627|P1|STARTED|Overall Study||7
8275810|NCT01701505|20406642|P6|NOT COMPLETED|Overall Study||0
8275811|NCT01701505|20406643|P5|NOT COMPLETED|Overall Study||0
8275812|NCT01701505|20406644|P4|NOT COMPLETED|Overall Study||0
8275813|NCT01701505|20406645|P3|NOT COMPLETED|Overall Study||0
8275814|NCT01701505|20406646|P2|NOT COMPLETED|Overall Study||0
8275815|NCT01701505|20406647|P1|NOT COMPLETED|Overall Study||0
8275816|NCT01701505|20406642|P6|COMPLETED|Overall Study||8
8275817|NCT01701505|20406643|P5|COMPLETED|Overall Study||8
8275818|NCT01701505|20406644|P4|COMPLETED|Overall Study||8
8275819|NCT01701505|20406645|P3|COMPLETED|Overall Study||8
8275820|NCT01701505|20406646|P2|COMPLETED|Overall Study||8
8275821|NCT01701505|20406647|P1|COMPLETED|Overall Study||8
8275822|NCT01701505|20406642|P6|STARTED|Overall Study||8
8275823|NCT01701505|20406643|P5|STARTED|Overall Study||8
8275824|NCT01701505|20406644|P4|STARTED|Overall Study||8
8275825|NCT01701505|20406645|P3|STARTED|Overall Study||8
8275826|NCT01701505|20406646|P2|STARTED|Overall Study||8
8275827|NCT01701505|20406647|P1|STARTED|Overall Study||8
8275828|NCT01701414|20406699|P2|NOT COMPLETED|Overall Study||1
8275829|NCT01701414|20406700|P1|NOT COMPLETED|Overall Study||1
8275830|NCT01701414|20406699|P2|COMPLETED|Overall Study||18
8275831|NCT01701414|20406700|P1|COMPLETED|Overall Study||18
8275832|NCT01701414|20406699|P2|STARTED|Overall Study||19
8275833|NCT01701414|20406700|P1|STARTED|Overall Study||19
8275834|NCT01701401|20406710|P4|NOT COMPLETED|Overall Study||6
8275835|NCT01701401|20406711|P3|NOT COMPLETED|Overall Study||5
8275836|NCT01701401|20406712|P2|NOT COMPLETED|Overall Study||9
8275837|NCT01701401|20406713|P1|NOT COMPLETED|Overall Study||10
8275838|NCT01701401|20406710|P4|COMPLETED|Overall Study||212
8275839|NCT01701401|20406711|P3|COMPLETED|Overall Study||212
8275840|NCT01701401|20406712|P2|COMPLETED|Overall Study||209
8275841|NCT01701401|20406713|P1|COMPLETED|Overall Study||207
8275842|NCT01701401|20406710|P4|STARTED|Overall Study||218
8275843|NCT01701401|20406711|P3|STARTED|Overall Study||217
8275844|NCT01701401|20406712|P2|STARTED|Overall Study||218
8275845|NCT01701401|20406713|P1|STARTED|Overall Study||217
8275846|NCT01701375|20406759|P1|NOT COMPLETED|Overall Study||0
8275847|NCT01701375|20406759|P1|COMPLETED|Overall Study||2
8275848|NCT01701375|20406759|P1|STARTED|Overall Study||2
8275849|NCT01701271|20406763|P1|NOT COMPLETED|Overall Study||0
8275850|NCT01701271|20406763|P1|COMPLETED|Overall Study||20
8275851|NCT01701271|20406763|P1|STARTED|Overall Study||20
8275852|NCT01701258|20406773|P13|NOT COMPLETED|EEG (Session 4)||0
8275853|NCT01701258|20406774|P12|NOT COMPLETED|EEG (Session 4)||0
8275854|NCT01701258|20406775|P11|NOT COMPLETED|EEG (Session 4)||0
8275855|NCT01701258|20406776|P10|NOT COMPLETED|EEG (Session 4)||0
8275856|NCT01701258|20406777|P9|NOT COMPLETED|EEG (Session 4)||0
8275857|NCT01701258|20406778|P8|NOT COMPLETED|EEG (Session 4)||0
8275858|NCT01701258|20406779|P7|NOT COMPLETED|EEG (Session 4)||0
8275859|NCT01701258|20406780|P6|NOT COMPLETED|EEG (Session 4)||0
8275860|NCT01701258|20406781|P5|NOT COMPLETED|EEG (Session 4)||0
8275861|NCT01701258|20406782|P4|NOT COMPLETED|EEG (Session 4)||0
8275862|NCT01701258|20406783|P3|NOT COMPLETED|EEG (Session 4)||0
8275863|NCT01701258|20406784|P2|NOT COMPLETED|EEG (Session 4)||0
8275864|NCT01701258|20406785|P1|NOT COMPLETED|EEG (Session 4)||0
8275865|NCT01701258|20406773|P13|COMPLETED|EEG (Session 4)||0
8275866|NCT01701258|20406774|P12|COMPLETED|EEG (Session 4)||0
8275867|NCT01701258|20406775|P11|COMPLETED|EEG (Session 4)||17
8275868|NCT01701258|20406776|P10|COMPLETED|EEG (Session 4)||0
8275869|NCT01701258|20406777|P9|COMPLETED|EEG (Session 4)||0
8275870|NCT01701258|20406778|P8|COMPLETED|EEG (Session 4)||16
8275871|NCT01701258|20406779|P7|COMPLETED|EEG (Session 4)||0
8275872|NCT01701258|20406780|P6|COMPLETED|EEG (Session 4)||0
8275873|NCT01701258|20406781|P5|COMPLETED|EEG (Session 4)||14
8275874|NCT01701258|20406782|P4|COMPLETED|EEG (Session 4)||0
8275875|NCT01701258|20406783|P3|COMPLETED|EEG (Session 4)||0
8275876|NCT01701258|20406784|P2|COMPLETED|EEG (Session 4)||19
8275877|NCT01701258|20406785|P1|COMPLETED|EEG (Session 4)||0
8275878|NCT01701258|20406773|P13|STARTED|EEG (Session 4)||0
8275879|NCT01701258|20406774|P12|STARTED|EEG (Session 4)||0
8275880|NCT01701258|20406775|P11|STARTED|EEG (Session 4)||17
8275881|NCT01701258|20406776|P10|STARTED|EEG (Session 4)||0
8275882|NCT01701258|20406777|P9|STARTED|EEG (Session 4)||0
8275883|NCT01701258|20406778|P8|STARTED|EEG (Session 4)||16
8275884|NCT01701258|20406779|P7|STARTED|EEG (Session 4)||0
8275885|NCT01701258|20406780|P6|STARTED|EEG (Session 4)||0
8275886|NCT01701258|20406781|P5|STARTED|EEG (Session 4)||14
8275887|NCT01701258|20406782|P4|STARTED|EEG (Session 4)||0
8275888|NCT01701258|20406783|P3|STARTED|EEG (Session 4)||0
8275889|NCT01701258|20406784|P2|STARTED|EEG (Session 4)||19
8275890|NCT01701258|20406785|P1|STARTED|EEG (Session 4)||0
8275891|NCT01701258|20406773|P13|NOT COMPLETED|PET (Session 3)||0
8275892|NCT01701258|20406774|P12|NOT COMPLETED|PET (Session 3)||0
8275893|NCT01701258|20406775|P11|NOT COMPLETED|PET (Session 3)||0
8275894|NCT01701258|20406776|P10|NOT COMPLETED|PET (Session 3)||0
8275895|NCT01701258|20406777|P9|NOT COMPLETED|PET (Session 3)||0
8275896|NCT01701258|20406778|P8|NOT COMPLETED|PET (Session 3)||0
8275897|NCT01701258|20406779|P7|NOT COMPLETED|PET (Session 3)||0
8275898|NCT01701258|20406780|P6|NOT COMPLETED|PET (Session 3)||0
8275899|NCT01701258|20406781|P5|NOT COMPLETED|PET (Session 3)||0
8275900|NCT01701258|20406782|P4|NOT COMPLETED|PET (Session 3)||0
8275901|NCT01701258|20406783|P3|NOT COMPLETED|PET (Session 3)||0
8275902|NCT01701258|20406784|P2|NOT COMPLETED|PET (Session 3)||0
8275903|NCT01701258|20406785|P1|NOT COMPLETED|PET (Session 3)||0
8275904|NCT01701258|20406773|P13|COMPLETED|PET (Session 3)||0
8275905|NCT01701258|20406774|P12|COMPLETED|PET (Session 3)||0
8275906|NCT01701258|20406775|P11|COMPLETED|PET (Session 3)||18
8275907|NCT01701258|20406776|P10|COMPLETED|PET (Session 3)||0
8275908|NCT01701258|20406777|P9|COMPLETED|PET (Session 3)||0
8275909|NCT01701258|20406778|P8|COMPLETED|PET (Session 3)||19
8275910|NCT01701258|20406779|P7|COMPLETED|PET (Session 3)||0
8275911|NCT01701258|20406780|P6|COMPLETED|PET (Session 3)||0
8275912|NCT01701258|20406781|P5|COMPLETED|PET (Session 3)||16
8275913|NCT01701258|20406782|P4|COMPLETED|PET (Session 3)||0
8275914|NCT01701258|20406783|P3|COMPLETED|PET (Session 3)||0
8275915|NCT01701258|20406784|P2|COMPLETED|PET (Session 3)||20
8275916|NCT01701258|20406785|P1|COMPLETED|PET (Session 3)||0
8275917|NCT01701258|20406773|P13|STARTED|PET (Session 3)||0
8275918|NCT01701258|20406774|P12|STARTED|PET (Session 3)||0
8275919|NCT01701258|20406775|P11|STARTED|PET (Session 3)||18
8275920|NCT01701258|20406776|P10|STARTED|PET (Session 3)||0
8275921|NCT01701258|20406777|P9|STARTED|PET (Session 3)||0
8275922|NCT01701258|20406778|P8|STARTED|PET (Session 3)||19
8275923|NCT01701258|20406779|P7|STARTED|PET (Session 3)||0
8275924|NCT01701258|20406780|P6|STARTED|PET (Session 3)||0
8275925|NCT01701258|20406781|P5|STARTED|PET (Session 3)||16
8275926|NCT01701258|20406782|P4|STARTED|PET (Session 3)||0
8275927|NCT01701258|20406783|P3|STARTED|PET (Session 3)||0
8275928|NCT01701258|20406784|P2|STARTED|PET (Session 3)||20
8275929|NCT01701258|20406785|P1|STARTED|PET (Session 3)||0
8275930|NCT01701258|20406773|P13|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275931|NCT01701258|20406774|P12|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275932|NCT01701258|20406775|P11|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275933|NCT01701258|20406776|P10|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275934|NCT01701258|20406777|P9|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275935|NCT01701258|20406778|P8|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275936|NCT01701258|20406779|P7|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275937|NCT01701258|20406780|P6|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275938|NCT01701258|20406781|P5|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275939|NCT01701258|20406782|P4|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275940|NCT01701258|20406783|P3|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275941|NCT01701258|20406784|P2|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275942|NCT01701258|20406785|P1|NOT COMPLETED|Drug+fMRI (Session 2)||0
8275943|NCT01701258|20406773|P13|COMPLETED|Drug+fMRI (Session 2)||7
8275944|NCT01701258|20406774|P12|COMPLETED|Drug+fMRI (Session 2)||10
8275945|NCT01701258|20406775|P11|COMPLETED|Drug+fMRI (Session 2)||0
8275946|NCT01701258|20406776|P10|COMPLETED|Drug+fMRI (Session 2)||6
8275947|NCT01701258|20406777|P9|COMPLETED|Drug+fMRI (Session 2)||6
8275948|NCT01701258|20406778|P8|COMPLETED|Drug+fMRI (Session 2)||0
8275949|NCT01701258|20406779|P7|COMPLETED|Drug+fMRI (Session 2)||8
8275950|NCT01701258|20406780|P6|COMPLETED|Drug+fMRI (Session 2)||9
8275951|NCT01701258|20406781|P5|COMPLETED|Drug+fMRI (Session 2)||0
8275952|NCT01701258|20406782|P4|COMPLETED|Drug+fMRI (Session 2)||11
8275953|NCT01701258|20406783|P3|COMPLETED|Drug+fMRI (Session 2)||11
8275954|NCT01701258|20406784|P2|COMPLETED|Drug+fMRI (Session 2)||0
8275955|NCT01701258|20406785|P1|COMPLETED|Drug+fMRI (Session 2)||0
8275956|NCT01701258|20406773|P13|Received Drug Challenge|Drug+fMRI (Session 2)||7
8275957|NCT01701258|20406774|P12|Received Drug Challenge|Drug+fMRI (Session 2)||10
8275958|NCT01701258|20406775|P11|Received Drug Challenge|Drug+fMRI (Session 2)||0
8275959|NCT01701258|20406776|P10|Received Drug Challenge|Drug+fMRI (Session 2)||6
8275960|NCT01701258|20406777|P9|Received Drug Challenge|Drug+fMRI (Session 2)||6
8275961|NCT01701258|20406778|P8|Received Drug Challenge|Drug+fMRI (Session 2)||0
8275962|NCT01701258|20406779|P7|Received Drug Challenge|Drug+fMRI (Session 2)||8
8275963|NCT01701258|20406780|P6|Received Drug Challenge|Drug+fMRI (Session 2)||9
8275964|NCT01701258|20406781|P5|Received Drug Challenge|Drug+fMRI (Session 2)||0
8275965|NCT01701258|20406782|P4|Received Drug Challenge|Drug+fMRI (Session 2)||11
8275966|NCT01701258|20406783|P3|Received Drug Challenge|Drug+fMRI (Session 2)||11
8275967|NCT01701258|20406784|P2|Received Drug Challenge|Drug+fMRI (Session 2)||0
8275968|NCT01701258|20406785|P1|Received Drug Challenge|Drug+fMRI (Session 2)||0
8275969|NCT01701258|20406773|P13|STARTED|Drug+fMRI (Session 2)||7
8275970|NCT01701258|20406774|P12|STARTED|Drug+fMRI (Session 2)||10
8275971|NCT01701258|20406775|P11|STARTED|Drug+fMRI (Session 2)||0
8275972|NCT01701258|20406776|P10|STARTED|Drug+fMRI (Session 2)||6
8275973|NCT01701258|20406777|P9|STARTED|Drug+fMRI (Session 2)||6
8275974|NCT01701258|20406778|P8|STARTED|Drug+fMRI (Session 2)||0
8275975|NCT01701258|20406779|P7|STARTED|Drug+fMRI (Session 2)||8
8275976|NCT01701258|20406780|P6|STARTED|Drug+fMRI (Session 2)||9
8275977|NCT01701258|20406781|P5|STARTED|Drug+fMRI (Session 2)||0
8275978|NCT01701258|20406782|P4|STARTED|Drug+fMRI (Session 2)||11
8275979|NCT01701258|20406783|P3|STARTED|Drug+fMRI (Session 2)||11
8275980|NCT01701258|20406784|P2|STARTED|Drug+fMRI (Session 2)||0
8275981|NCT01701258|20406785|P1|STARTED|Drug+fMRI (Session 2)||0
8275982|NCT01701258|20406773|P13|NOT COMPLETED|Assessment and Scheduling||0
8275983|NCT01701258|20406774|P12|NOT COMPLETED|Assessment and Scheduling||0
8275984|NCT01701258|20406775|P11|NOT COMPLETED|Assessment and Scheduling||0
8275985|NCT01701258|20406776|P10|NOT COMPLETED|Assessment and Scheduling||0
8275986|NCT01701258|20406777|P9|NOT COMPLETED|Assessment and Scheduling||0
8275987|NCT01701258|20406778|P8|NOT COMPLETED|Assessment and Scheduling||0
8275988|NCT01701258|20406779|P7|NOT COMPLETED|Assessment and Scheduling||0
8275989|NCT01701258|20406780|P6|NOT COMPLETED|Assessment and Scheduling||0
8275990|NCT01701258|20406781|P5|NOT COMPLETED|Assessment and Scheduling||0
8275991|NCT01701258|20406782|P4|NOT COMPLETED|Assessment and Scheduling||0
8275992|NCT01701258|20406783|P3|NOT COMPLETED|Assessment and Scheduling||0
8275993|NCT01701258|20406784|P2|NOT COMPLETED|Assessment and Scheduling||0
8275994|NCT01701258|20406785|P1|NOT COMPLETED|Assessment and Scheduling||83
8275995|NCT01701258|20406773|P13|COMPLETED|Assessment and Scheduling||0
8275996|NCT01701258|20406774|P12|COMPLETED|Assessment and Scheduling||0
8275997|NCT01701258|20406775|P11|COMPLETED|Assessment and Scheduling||0
8275998|NCT01701258|20406776|P10|COMPLETED|Assessment and Scheduling||0
8275999|NCT01701258|20406777|P9|COMPLETED|Assessment and Scheduling||0
8276000|NCT01701258|20406778|P8|COMPLETED|Assessment and Scheduling||0
8276001|NCT01701258|20406779|P7|COMPLETED|Assessment and Scheduling||0
8276002|NCT01701258|20406780|P6|COMPLETED|Assessment and Scheduling||0
8276003|NCT01701258|20406781|P5|COMPLETED|Assessment and Scheduling||0
8276004|NCT01701258|20406782|P4|COMPLETED|Assessment and Scheduling||0
8276005|NCT01701258|20406783|P3|COMPLETED|Assessment and Scheduling||0
8276006|NCT01701258|20406784|P2|COMPLETED|Assessment and Scheduling||0
8276007|NCT01701258|20406785|P1|COMPLETED|Assessment and Scheduling||70
8276008|NCT01701258|20406773|P13|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276009|NCT01701258|20406774|P12|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276010|NCT01701258|20406775|P11|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276085|NCT01701115|20406854|P2|COMPLETED|Overall Study||77
8276011|NCT01701258|20406776|P10|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276012|NCT01701258|20406777|P9|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276013|NCT01701258|20406778|P8|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276014|NCT01701258|20406779|P7|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276015|NCT01701258|20406780|P6|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276016|NCT01701258|20406781|P5|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276017|NCT01701258|20406782|P4|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276018|NCT01701258|20406783|P3|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276019|NCT01701258|20406784|P2|Returned for EEG (Session 4)|Assessment and Scheduling||0
8276020|NCT01701258|20406785|P1|Returned for EEG (Session 4)|Assessment and Scheduling||66
8276021|NCT01701258|20406773|P13|Returned for PET (Session 3)|Assessment and Scheduling||0
8276022|NCT01701258|20406774|P12|Returned for PET (Session 3)|Assessment and Scheduling||0
8276023|NCT01701258|20406775|P11|Returned for PET (Session 3)|Assessment and Scheduling||0
8276024|NCT01701258|20406776|P10|Returned for PET (Session 3)|Assessment and Scheduling||0
8276025|NCT01701258|20406777|P9|Returned for PET (Session 3)|Assessment and Scheduling||0
8276026|NCT01701258|20406778|P8|Returned for PET (Session 3)|Assessment and Scheduling||0
8276027|NCT01701258|20406779|P7|Returned for PET (Session 3)|Assessment and Scheduling||0
8276028|NCT01701258|20406780|P6|Returned for PET (Session 3)|Assessment and Scheduling||0
8276029|NCT01701258|20406781|P5|Returned for PET (Session 3)|Assessment and Scheduling||0
8276030|NCT01701258|20406782|P4|Returned for PET (Session 3)|Assessment and Scheduling||0
8276031|NCT01701258|20406783|P3|Returned for PET (Session 3)|Assessment and Scheduling||0
8276032|NCT01701258|20406784|P2|Returned for PET (Session 3)|Assessment and Scheduling||0
8276033|NCT01701258|20406785|P1|Returned for PET (Session 3)|Assessment and Scheduling||73
8276034|NCT01701258|20406773|P13|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276035|NCT01701258|20406774|P12|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276036|NCT01701258|20406775|P11|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276037|NCT01701258|20406776|P10|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276038|NCT01701258|20406777|P9|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276039|NCT01701258|20406778|P8|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276040|NCT01701258|20406779|P7|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276041|NCT01701258|20406780|P6|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276042|NCT01701258|20406781|P5|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276043|NCT01701258|20406782|P4|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276044|NCT01701258|20406783|P3|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276045|NCT01701258|20406784|P2|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
8276046|NCT01701258|20406785|P1|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
8276047|NCT01701258|20406773|P13|Eligible After Screening Visit|Assessment and Scheduling||0
8276048|NCT01701258|20406774|P12|Eligible After Screening Visit|Assessment and Scheduling||0
8276049|NCT01701258|20406775|P11|Eligible After Screening Visit|Assessment and Scheduling||0
8276050|NCT01701258|20406776|P10|Eligible After Screening Visit|Assessment and Scheduling||0
8276051|NCT01701258|20406777|P9|Eligible After Screening Visit|Assessment and Scheduling||0
8276052|NCT01701258|20406778|P8|Eligible After Screening Visit|Assessment and Scheduling||0
8276053|NCT01701258|20406779|P7|Eligible After Screening Visit|Assessment and Scheduling||0
8276054|NCT01701258|20406780|P6|Eligible After Screening Visit|Assessment and Scheduling||0
8276055|NCT01701258|20406781|P5|Eligible After Screening Visit|Assessment and Scheduling||0
8276056|NCT01701258|20406782|P4|Eligible After Screening Visit|Assessment and Scheduling||0
8276057|NCT01701258|20406783|P3|Eligible After Screening Visit|Assessment and Scheduling||0
8276058|NCT01701258|20406784|P2|Eligible After Screening Visit|Assessment and Scheduling||0
8276059|NCT01701258|20406785|P1|Eligible After Screening Visit|Assessment and Scheduling||96
8276060|NCT01701258|20406773|P13|STARTED|Assessment and Scheduling||0
8276061|NCT01701258|20406774|P12|STARTED|Assessment and Scheduling||0
8276062|NCT01701258|20406775|P11|STARTED|Assessment and Scheduling||0
8276063|NCT01701258|20406776|P10|STARTED|Assessment and Scheduling||0
8276064|NCT01701258|20406777|P9|STARTED|Assessment and Scheduling||0
8276065|NCT01701258|20406778|P8|STARTED|Assessment and Scheduling||0
8276066|NCT01701258|20406779|P7|STARTED|Assessment and Scheduling||0
8276067|NCT01701258|20406780|P6|STARTED|Assessment and Scheduling||0
8276068|NCT01701258|20406781|P5|STARTED|Assessment and Scheduling||0
8276069|NCT01701258|20406782|P4|STARTED|Assessment and Scheduling||0
8276070|NCT01701258|20406783|P3|STARTED|Assessment and Scheduling||0
8276071|NCT01701258|20406784|P2|STARTED|Assessment and Scheduling||0
8276072|NCT01701258|20406785|P1|STARTED|Assessment and Scheduling||153
8276073|NCT01701245|20406839|P2|NOT COMPLETED|Overall Study||15
8276074|NCT01701245|20406840|P1|NOT COMPLETED|Overall Study||12
8276075|NCT01701245|20406839|P2|COMPLETED|Overall Study||33
8276076|NCT01701245|20406840|P1|COMPLETED|Overall Study||37
8276077|NCT01701245|20406839|P2|FAS Matched Data|Overall Study||32
8276078|NCT01701245|20406840|P1|FAS Matched Data|Overall Study||42
8276079|NCT01701245|20406839|P2|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
8276080|NCT01701245|20406840|P1|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
8276081|NCT01701245|20406839|P2|STARTED|Overall Study||48
8276082|NCT01701245|20406840|P1|STARTED|Overall Study||49
8276083|NCT01701115|20406854|P2|NOT COMPLETED|Overall Study||0
8276084|NCT01701115|20406855|P1|NOT COMPLETED|Overall Study||2
8276086|NCT01701115|20406855|P1|COMPLETED|Overall Study||75
8276087|NCT01701115|20406854|P2|STARTED|Overall Study||77
8276088|NCT01701115|20406855|P1|STARTED|Overall Study||77
8276089|NCT01701102|20406871|P4|NOT COMPLETED|Overall Study||0
8276090|NCT01701102|20406872|P3|NOT COMPLETED|Overall Study||0
8276091|NCT01701102|20406873|P2|NOT COMPLETED|Overall Study||0
8276092|NCT01701102|20406874|P1|NOT COMPLETED|Overall Study||0
8276093|NCT01701102|20406871|P4|COMPLETED|Overall Study||18
8276094|NCT01701102|20406872|P3|COMPLETED|Overall Study||10
8276095|NCT01701102|20406873|P2|COMPLETED|Overall Study||6
8276096|NCT01701102|20406874|P1|COMPLETED|Overall Study||22
8276097|NCT01701102|20406871|P4|STARTED|Overall Study||18
8276098|NCT01701102|20406872|P3|STARTED|Overall Study||10
8276099|NCT01701102|20406873|P2|STARTED|Overall Study||6
8276100|NCT01701102|20406874|P1|STARTED|Overall Study||22
8276101|NCT01701063|20406887|P3|NOT COMPLETED|Overall Study||2
8276102|NCT01701063|20406888|P2|NOT COMPLETED|Overall Study||1
8276103|NCT01701063|20406889|P1|NOT COMPLETED|Overall Study||0
8276104|NCT01701063|20406887|P3|COMPLETED|Overall Study||8
8276105|NCT01701063|20406888|P2|COMPLETED|Overall Study||18
8276106|NCT01701063|20406889|P1|COMPLETED|Overall Study||13
8276107|NCT01701063|20406887|P3|STARTED|Overall Study||10
8276108|NCT01701063|20406888|P2|STARTED|Overall Study||19
8276109|NCT01701063|20406889|P1|STARTED|Overall Study||13
8276110|NCT01701037|20406931|P1|NOT COMPLETED|Overall Study||0
8276111|NCT01701037|20406931|P1|COMPLETED|Overall Study||13
8276112|NCT01701037|20406931|P1|STARTED|Overall Study||13
8276113|NCT01701024|20406942|P2|NOT COMPLETED|Overall Study||9
8276114|NCT01701024|20406943|P1|NOT COMPLETED|Overall Study||10
8276115|NCT01701024|20406942|P2|COMPLETED|Overall Study||236
8276116|NCT01701024|20406943|P1|COMPLETED|Overall Study||243
8276117|NCT01701024|20406942|P2|STARTED|Overall Study||245
8276118|NCT01701024|20406943|P1|STARTED|Overall Study||253
8276119|NCT01701011|20406958|P3|NOT COMPLETED|Overall Study||34
8276120|NCT01701011|20406959|P2|NOT COMPLETED|Overall Study||24
8276121|NCT01701011|20406960|P1|NOT COMPLETED|Overall Study||35
8276122|NCT01701011|20406958|P3|COMPLETED|Overall Study||90
8276123|NCT01701011|20406959|P2|COMPLETED|Overall Study||102
8276124|NCT01701011|20406960|P1|COMPLETED|Overall Study||92
8276125|NCT01701011|20406958|P3|STARTED|Overall Study||124
8276126|NCT01701011|20406959|P2|STARTED|Overall Study||126
8276127|NCT01701011|20406960|P1|STARTED|Overall Study||127
8276128|NCT01700985|20406973|P2|NOT COMPLETED|Overall Study||1
8276129|NCT01700985|20406974|P1|NOT COMPLETED|Overall Study||0
8276130|NCT01700985|20406973|P2|COMPLETED|Overall Study||20
8276131|NCT01700985|20406974|P1|COMPLETED|Overall Study||23
8276132|NCT01700985|20406973|P2|STARTED|Overall Study||21
8276133|NCT01700985|20406974|P1|STARTED|Overall Study||23
8276134|NCT01700959|20406996|P6|NOT COMPLETED|Overall Study||25
8276135|NCT01700959|20406997|P5|NOT COMPLETED|Overall Study||27
8276136|NCT01700959|20406998|P4|NOT COMPLETED|Overall Study||35
8276137|NCT01700959|20406999|P3|NOT COMPLETED|Overall Study||40
8276138|NCT01700959|20407000|P2|NOT COMPLETED|Overall Study||24
8276139|NCT01700959|20407001|P1|NOT COMPLETED|Overall Study||27
8276140|NCT01700959|20406996|P6|COMPLETED|Overall Study||72
8276141|NCT01700959|20406997|P5|COMPLETED|Overall Study||69
8276142|NCT01700959|20406998|P4|COMPLETED|Overall Study||70
8276143|NCT01700959|20406999|P3|COMPLETED|Overall Study||65
8276144|NCT01700959|20407000|P2|COMPLETED|Overall Study||64
8276145|NCT01700959|20407001|P1|COMPLETED|Overall Study||62
8276146|NCT01700959|20406996|P6|STARTED|Overall Study||97
8276147|NCT01700959|20406997|P5|STARTED|Overall Study||96
8276148|NCT01700959|20406998|P4|STARTED|Overall Study||105
8276149|NCT01700959|20406999|P3|STARTED|Overall Study||105
8276150|NCT01700959|20407000|P2|STARTED|Overall Study||88
8276151|NCT01700959|20407001|P1|STARTED|Overall Study||89
8276152|NCT01700907|20407025|P2|NOT COMPLETED|Overall Study||0
8276153|NCT01700907|20407026|P1|NOT COMPLETED|Overall Study||0
8276154|NCT01700907|20407025|P2|COMPLETED|Overall Study||10
8276155|NCT01700907|20407026|P1|COMPLETED|Overall Study||10
8276156|NCT01700907|20407025|P2|STARTED|Overall Study||10
8276157|NCT01700907|20407026|P1|STARTED|Overall Study||10
8276158|NCT01700829|20407042|P2|NOT COMPLETED|Overall Study||1
8276159|NCT01700829|20407043|P1|NOT COMPLETED|Overall Study||1
8276160|NCT01700829|20407042|P2|COMPLETED|Overall Study||40
8276161|NCT01700829|20407043|P1|COMPLETED|Overall Study||40
8276162|NCT01700829|20407042|P2|STARTED|Overall Study||41
8276163|NCT01700829|20407043|P1|STARTED|Overall Study||41
8276164|NCT01700816|20407055|P2|NOT COMPLETED|Overall Study||0
8276165|NCT01700816|20407056|P1|NOT COMPLETED|Overall Study||0
8276166|NCT01700816|20407055|P2|COMPLETED|Overall Study||19
8276167|NCT01700816|20407056|P1|COMPLETED|Overall Study||21
8276168|NCT01700816|20407055|P2|STARTED|Overall Study||19
8276169|NCT01700816|20407056|P1|STARTED|Overall Study||21
8276170|NCT01700725|20407085|P3|NOT COMPLETED|Overall Study||0
8276171|NCT01700725|20407086|P2|NOT COMPLETED|Overall Study||0
8276172|NCT01700725|20407087|P1|NOT COMPLETED|Overall Study||0
8276173|NCT01700725|20407085|P3|COMPLETED|Overall Study||12
8276174|NCT01700725|20407086|P2|COMPLETED|Overall Study||14
8276175|NCT01700725|20407087|P1|COMPLETED|Overall Study||14
8276176|NCT01700725|20407085|P3|STARTED|Overall Study||12
8276177|NCT01700725|20407086|P2|STARTED|Overall Study||14
8276178|NCT01700725|20407087|P1|STARTED|Overall Study||14
8276179|NCT01700621|20407103|P2|NOT COMPLETED|Analyzed for Immunogenicity||7
8276180|NCT01700621|20407104|P1|NOT COMPLETED|Analyzed for Immunogenicity||13
8276181|NCT01700621|20407103|P2|COMPLETED|Analyzed for Immunogenicity||233
8276182|NCT01700621|20407104|P1|COMPLETED|Analyzed for Immunogenicity||227
8276183|NCT01700621|20407103|P2|STARTED|Analyzed for Immunogenicity||240
8276184|NCT01700621|20407104|P1|STARTED|Analyzed for Immunogenicity||240
8276185|NCT01700621|20407103|P2|NOT COMPLETED|Received Study Vaccines||0
8276186|NCT01700621|20407104|P1|NOT COMPLETED|Received Study Vaccines||0
8276187|NCT01700621|20407103|P2|COMPLETED|Received Study Vaccines||240
8276188|NCT01700621|20407104|P1|COMPLETED|Received Study Vaccines||240
8276189|NCT01700621|20407103|P2|STARTED|Received Study Vaccines||240
8276190|NCT01700621|20407104|P1|STARTED|Received Study Vaccines||240
8276191|NCT01700530|20407142|P3|NOT COMPLETED|Overall Study||1
8276192|NCT01700530|20407143|P2|NOT COMPLETED|Overall Study||3
8276193|NCT01700530|20407144|P1|NOT COMPLETED|Overall Study||0
8276194|NCT01700530|20407142|P3|COMPLETED|Overall Study||19
8276195|NCT01700530|20407143|P2|COMPLETED|Overall Study||18
8276196|NCT01700530|20407144|P1|COMPLETED|Overall Study||9
8276197|NCT01700530|20407142|P3|STARTED|Overall Study||20
8276198|NCT01700530|20407143|P2|STARTED|Overall Study||21
8276199|NCT01700530|20407144|P1|STARTED|Overall Study||9
8276200|NCT01700517|20407158|P3|NOT COMPLETED|Overall Study||0
8276201|NCT01700517|20407159|P2|NOT COMPLETED|Overall Study||0
8276202|NCT01700517|20407160|P1|NOT COMPLETED|Overall Study||0
8276203|NCT01700517|20407158|P3|COMPLETED|Overall Study||40
8276204|NCT01700517|20407159|P2|COMPLETED|Overall Study||40
8276205|NCT01700517|20407160|P1|COMPLETED|Overall Study||40
8276206|NCT01700517|20407158|P3|STARTED|Overall Study||40
8276207|NCT01700517|20407159|P2|STARTED|Overall Study||40
8276208|NCT01700517|20407160|P1|STARTED|Overall Study||40
8276217|NCT01700387|20407193|P2|NOT COMPLETED|Overall Study||4
8276218|NCT01700387|20407194|P1|NOT COMPLETED|Overall Study||4
8276219|NCT01700387|20407193|P2|COMPLETED|Overall Study||6
8276220|NCT01700387|20407194|P1|COMPLETED|Overall Study||6
8276221|NCT01700387|20407193|P2|STARTED|Overall Study||10
8276222|NCT01700387|20407194|P1|STARTED|Overall Study||10
8276223|NCT01700348|20407224|P1|NOT COMPLETED|Overall Study||23
8276224|NCT01700348|20407224|P1|COMPLETED|Overall Study||93
8276225|NCT01700348|20407224|P1|STARTED|Overall Study||116
8276226|NCT01700335|20407233|P2|NOT COMPLETED|Overall Study||4
8276227|NCT01700335|20407234|P1|NOT COMPLETED|Overall Study||1
8276228|NCT01700335|20407233|P2|COMPLETED|Overall Study||2
8276229|NCT01700335|20407234|P1|COMPLETED|Overall Study||2
8276230|NCT01700335|20407233|P2|STARTED|Overall Study||6
8276231|NCT01700335|20407234|P1|STARTED|Overall Study||3
8276232|NCT01700205|20407247|P2|NOT COMPLETED|Overall Study||15
8276233|NCT01700205|20407248|P1|NOT COMPLETED|Overall Study||15
8276234|NCT01700205|20407247|P2|COMPLETED|Overall Study|Mother-Infant Dyads|39
8276235|NCT01700205|20407248|P1|COMPLETED|Overall Study|Mother-Infant Dyads|44
8276236|NCT01700205|20407247|P2|STARTED|Overall Study|Mother-Infant Dyads|54
8276237|NCT01700205|20407248|P1|STARTED|Overall Study|Mother-Infant Dyads|59
8276238|NCT01700192|20407270|P2|NOT COMPLETED|Overall Study||128
8276239|NCT01700192|20407271|P1|NOT COMPLETED|Overall Study||180
8276240|NCT01700192|20407270|P2|COMPLETED|Overall Study||613
8276241|NCT01700192|20407271|P1|COMPLETED|Overall Study||561
8276242|NCT01700192|20407270|P2|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
8276243|NCT01700192|20407271|P1|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
8276244|NCT01700192|20407270|P2|Treated|Overall Study||741
8276245|NCT01700192|20407271|P1|Treated|Overall Study||740
8276246|NCT01700192|20407270|P2|STARTED|Overall Study||741
8276247|NCT01700192|20407271|P1|STARTED|Overall Study||741
8276248|NCT01700179|20407289|P1|NOT COMPLETED|Overall Study||2
8276249|NCT01700179|20407289|P1|COMPLETED|Overall Study||6
8276250|NCT01700179|20407289|P1|STARTED|Overall Study||8
8276251|NCT01700140|20407296|P3|NOT COMPLETED|Overall Study||1
8276252|NCT01700140|20407297|P2|NOT COMPLETED|Overall Study||9
8276253|NCT01700140|20407298|P1|NOT COMPLETED|Overall Study||6
8276254|NCT01700140|20407296|P3|COMPLETED|Overall Study||61
8276255|NCT01700140|20407297|P2|COMPLETED|Overall Study||57
8276256|NCT01700140|20407298|P1|COMPLETED|Overall Study||55
8276257|NCT01700140|20407296|P3|STARTED|Overall Study||62
8276258|NCT01700140|20407297|P2|STARTED|Overall Study||66
8276259|NCT01700140|20407298|P1|STARTED|Overall Study||61
8276260|NCT01700049|20407330|P1|NOT COMPLETED|Overall Study||1
8276261|NCT01700049|20407330|P1|COMPLETED|Overall Study||27
8276262|NCT01700049|20407330|P1|STARTED|Overall Study||28
8276263|NCT01700036|20407336|P1|NOT COMPLETED|Overall Study||0
8276264|NCT01700036|20407336|P1|COMPLETED|Overall Study||40
8276265|NCT01700036|20407336|P1|STARTED|Overall Study||40
8276266|NCT01699867|20407345|P1|NOT COMPLETED|Overall Study||3
8276267|NCT01699867|20407345|P1|COMPLETED|Overall Study||47
8276268|NCT01699867|20407345|P1|STARTED|Overall Study||50
8276269|NCT01699815|20407352|P2|NOT COMPLETED|Overall Study||8
8276270|NCT01699815|20407353|P1|NOT COMPLETED|Overall Study||5
8276271|NCT01699815|20407352|P2|COMPLETED|Overall Study||56
8276272|NCT01699815|20407353|P1|COMPLETED|Overall Study||57
8276273|NCT01699815|20407352|P2|STARTED|Overall Study||64
8276274|NCT01699815|20407353|P1|STARTED|Overall Study||62
8276287|NCT01699763|20407428|P1|NOT COMPLETED|Overall Study||0
8276288|NCT01699763|20407428|P1|COMPLETED|Overall Study||112
8276289|NCT01699763|20407428|P1|STARTED|Overall Study||112
8276290|NCT01699750|20407436|P2|NOT COMPLETED|Overall Study||3
8276291|NCT01699750|20407437|P1|NOT COMPLETED|Overall Study||0
8276292|NCT01699750|20407436|P2|COMPLETED|Overall Study||33
8276293|NCT01699750|20407437|P1|COMPLETED|Overall Study||34
8276294|NCT01699750|20407436|P2|STARTED|Overall Study||36
8276295|NCT01699750|20407437|P1|STARTED|Overall Study||34
8276296|NCT01699698|20407461|P2|NOT COMPLETED|Overall Study||5
8276297|NCT01699698|20407462|P1|NOT COMPLETED|Overall Study||2
8276298|NCT01699698|20407461|P2|COMPLETED|Overall Study||56
8276299|NCT01699698|20407462|P1|COMPLETED|Overall Study||42
8276300|NCT01699698|20407461|P2|STARTED|Overall Study||61
8276301|NCT01699698|20407462|P1|STARTED|Overall Study||44
8276302|NCT01699685|20407472|P2|NOT COMPLETED|Period 2||0
8276303|NCT01699685|20407473|P1|NOT COMPLETED|Period 2||1
8276304|NCT01699685|20407472|P2|COMPLETED|Period 2||36
8276305|NCT01699685|20407473|P1|COMPLETED|Period 2||35
8276306|NCT01699685|20407472|P2|STARTED|Period 2||36
8276307|NCT01699685|20407473|P1|STARTED|Period 2||36
8276308|NCT01699685|20407472|P2|NOT COMPLETED|Period 1||3
8276309|NCT01699685|20407473|P1|NOT COMPLETED|Period 1||3
8276310|NCT01699685|20407472|P2|COMPLETED|Period 1||36
8276311|NCT01699685|20407473|P1|COMPLETED|Period 1||36
8276312|NCT01699685|20407472|P2|Full Analysis Population (FAS)|Period 1||38
8276313|NCT01699685|20407473|P1|Full Analysis Population (FAS)|Period 1||38
8276314|NCT01699685|20407472|P2|Safety Population|Period 1||38
8276315|NCT01699685|20407473|P1|Safety Population|Period 1||39
8276316|NCT01699685|20407472|P2|STARTED|Period 1||39
8276317|NCT01699685|20407473|P1|STARTED|Period 1||39
8276318|NCT01699607|20407491|P2|NOT COMPLETED|Overall Study||0
8276319|NCT01699607|20407492|P1|NOT COMPLETED|Overall Study||0
8276320|NCT01699607|20407491|P2|COMPLETED|Overall Study||4
8276321|NCT01699607|20407492|P1|COMPLETED|Overall Study||6
8276322|NCT01699607|20407491|P2|STARTED|Overall Study||4
8276323|NCT01699607|20407492|P1|STARTED|Overall Study||6
8276324|NCT01699503|20407499|P2|NOT COMPLETED|Overall Study||1005
8276325|NCT01699503|20407500|P1|NOT COMPLETED|Overall Study||1000
8276326|NCT01699503|20407499|P2|COMPLETED|Overall Study||992
8276327|NCT01699503|20407500|P1|COMPLETED|Overall Study||1008
8276328|NCT01699503|20407499|P2|6 Month Follow-up|Overall Study||893
8276329|NCT01699503|20407500|P1|6 Month Follow-up|Overall Study||903
8276330|NCT01699503|20407499|P2|1 Month Follow-up|Overall Study||1022
8276331|NCT01699503|20407500|P1|1 Month Follow-up|Overall Study||998
8276332|NCT01699503|20407499|P2|Baseline|Overall Study||1693
8276333|NCT01699503|20407500|P1|Baseline|Overall Study||1723
8276334|NCT01699503|20407499|P2|STARTED|Overall Study||1997
8276335|NCT01699503|20407500|P1|STARTED|Overall Study||2008
8276336|NCT01699373|20407516|P2|NOT COMPLETED|Overall Study||0
8276337|NCT01699373|20407517|P1|NOT COMPLETED|Overall Study||0
8276338|NCT01699373|20407516|P2|COMPLETED|Overall Study||85
8276339|NCT01699373|20407517|P1|COMPLETED|Overall Study||85
8276340|NCT01699373|20407516|P2|STARTED|Overall Study||85
8276341|NCT01699373|20407517|P1|STARTED|Overall Study||85
8276348|NCT01699087|20407542|P1|NOT COMPLETED|Overall Study||24
8276349|NCT01699087|20407542|P1|COMPLETED|Overall Study||152
8276350|NCT01699087|20407542|P1|Treated|Overall Study||161
8276351|NCT01699087|20407542|P1|STARTED|Overall Study||176
8276352|NCT01699022|20407556|P1|NOT COMPLETED|Overall Study||3
8276353|NCT01699022|20407556|P1|COMPLETED|Overall Study||14
8276354|NCT01699022|20407556|P1|STARTED|Overall Study||17
8276359|NCT01698879|20407583|P3|NOT COMPLETED|Overall Study||0
8276360|NCT01698879|20407584|P2|NOT COMPLETED|Overall Study||0
8276361|NCT01698879|20407585|P1|NOT COMPLETED|Overall Study||1
8276362|NCT01698879|20407583|P3|COMPLETED|Overall Study||20
8276363|NCT01698879|20407584|P2|COMPLETED|Overall Study||20
8276364|NCT01698879|20407585|P1|COMPLETED|Overall Study||5
8276365|NCT01698879|20407583|P3|STARTED|Overall Study||20
8276366|NCT01698879|20407584|P2|STARTED|Overall Study||20
8276367|NCT01698879|20407585|P1|STARTED|Overall Study||6
8276368|NCT01698814|20407608|P2|NOT COMPLETED|Overall Study||3
8276369|NCT01698814|20407609|P1|NOT COMPLETED|Overall Study||2
8276370|NCT01698814|20407608|P2|COMPLETED|Overall Study||166
8276371|NCT01698814|20407609|P1|COMPLETED|Overall Study||329
8276372|NCT01698814|20407608|P2|STARTED|Overall Study||169
8276373|NCT01698814|20407609|P1|STARTED|Overall Study||331
8276374|NCT01698801|20407615|P1|NOT COMPLETED|Follow Up Phase||5
8276375|NCT01698801|20407615|P1|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
8276376|NCT01698801|20407615|P1|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
8276377|NCT01698801|20407615|P1|NOT COMPLETED|Treatment Phase||11
8276378|NCT01698801|20407615|P1|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
8276379|NCT01698801|20407615|P1|STARTED|Treatment Phase||26
8276380|NCT01698775|20407626|P2|NOT COMPLETED|Phase B||11
8276381|NCT01698775|20407627|P1|NOT COMPLETED|Phase B||14
8276382|NCT01698775|20407626|P2|COMPLETED|Phase B||86
8276383|NCT01698775|20407627|P1|COMPLETED|Phase B||84
8276384|NCT01698775|20407626|P2|STARTED|Phase B||97
8276385|NCT01698775|20407627|P1|STARTED|Phase B||98
8276386|NCT01698775|20407626|P2|NOT COMPLETED|Phase A||9
8276387|NCT01698775|20407627|P1|NOT COMPLETED|Phase A||9
8276388|NCT01698775|20407626|P2|COMPLETED|Phase A||97
8276389|NCT01698775|20407627|P1|COMPLETED|Phase A||98
8276390|NCT01698775|20407626|P2|STARTED|Phase A||106
8276391|NCT01698775|20407627|P1|STARTED|Phase A||107
8276392|NCT01698710|20407653|P1|NOT COMPLETED|Overall Study||0
8276393|NCT01698710|20407653|P1|COMPLETED|Overall Study||5
8276394|NCT01698710|20407653|P1|STARTED|Overall Study||5
8276395|NCT01698684|20407662|P3|NOT COMPLETED|Overall Study||21
8276396|NCT01698684|20407663|P2|NOT COMPLETED|Overall Study||23
8276397|NCT01698684|20407664|P1|NOT COMPLETED|Overall Study||29
8276398|NCT01698684|20407662|P3|COMPLETED|Overall Study||127
8276399|NCT01698684|20407663|P2|COMPLETED|Overall Study||124
8276400|NCT01698684|20407664|P1|COMPLETED|Overall Study||116
8276401|NCT01698684|20407662|P3|Safety Population|Overall Study||146
8276402|NCT01698684|20407663|P2|Safety Population|Overall Study||146
8276403|NCT01698684|20407664|P1|Safety Population|Overall Study||143
8276404|NCT01698684|20407662|P3|ITT Population|Overall Study||139
8276405|NCT01698684|20407663|P2|ITT Population|Overall Study||139
8276406|NCT01698684|20407664|P1|ITT Population|Overall Study||136
8276407|NCT01698684|20407662|P3|STARTED|Overall Study||148
8276408|NCT01698684|20407663|P2|STARTED|Overall Study||147
8276409|NCT01698684|20407664|P1|STARTED|Overall Study||145
8276410|NCT01698554|20407676|P4|NOT COMPLETED|Overall Study||2
8276411|NCT01698554|20407677|P3|NOT COMPLETED|Overall Study||2
8276412|NCT01698554|20407678|P2|NOT COMPLETED|Overall Study||10
8276413|NCT01698554|20407679|P1|NOT COMPLETED|Overall Study||6
8276414|NCT01698554|20407676|P4|COMPLETED|Overall Study||77
8276415|NCT01698554|20407677|P3|COMPLETED|Overall Study||73
8276416|NCT01698554|20407678|P2|COMPLETED|Overall Study||147
8276417|NCT01698554|20407679|P1|COMPLETED|Overall Study||147
8276418|NCT01698554|20407676|P4|STARTED|Overall Study||79
8276419|NCT01698554|20407677|P3|STARTED|Overall Study||75
8276420|NCT01698554|20407678|P2|STARTED|Overall Study||157
8276421|NCT01698554|20407679|P1|STARTED|Overall Study||153
8276422|NCT01698528|20407707|P2|NOT COMPLETED|Overall Study||4
8276423|NCT01698528|20407708|P1|NOT COMPLETED|Overall Study||1
8276424|NCT01698528|20407707|P2|COMPLETED|Overall Study||16
8276425|NCT01698528|20407708|P1|COMPLETED|Overall Study||19
8276426|NCT01698528|20407707|P2|STARTED|Overall Study||20
8276427|NCT01698528|20407708|P1|STARTED|Overall Study||20
8276428|NCT01698502|20407724|P2|NOT COMPLETED|Overall Study||0
8276429|NCT01698502|20407725|P1|NOT COMPLETED|Overall Study||0
8276430|NCT01698502|20407724|P2|COMPLETED|Overall Study||10
8276431|NCT01698502|20407725|P1|COMPLETED|Overall Study||11
8276432|NCT01698502|20407724|P2|STARTED|Overall Study||10
8276433|NCT01698502|20407725|P1|STARTED|Overall Study||11
8276434|NCT01698463|20407733|P1|NOT COMPLETED|Overall Study||0
8276435|NCT01698463|20407733|P1|COMPLETED|Overall Study||11
8276436|NCT01698463|20407733|P1|STARTED|Overall Study||11
8276437|NCT01698333|20407743|P1|NOT COMPLETED|Overall Study||0
8276438|NCT01698333|20407743|P1|COMPLETED|Overall Study||25
8276439|NCT01698333|20407743|P1|STARTED|Overall Study||25
8276440|NCT01698320|20407749|P3|NOT COMPLETED|40-Week Open-Label Period||10
8276441|NCT01698320|20407750|P2|NOT COMPLETED|40-Week Open-Label Period||19
8276442|NCT01698320|20407751|P1|NOT COMPLETED|40-Week Open-Label Period||0
8276443|NCT01698320|20407749|P3|COMPLETED|40-Week Open-Label Period||146
8276444|NCT01698320|20407750|P2|COMPLETED|40-Week Open-Label Period||146
8276445|NCT01698320|20407751|P1|COMPLETED|40-Week Open-Label Period||0
8276446|NCT01698320|20407749|P3|STARTED|40-Week Open-Label Period||156
8276447|NCT01698320|20407750|P2|STARTED|40-Week Open-Label Period||165
8276448|NCT01698320|20407751|P1|STARTED|40-Week Open-Label Period||0
8276449|NCT01698320|20407749|P3|NOT COMPLETED|12-Week Double-Blind Period||12
8276450|NCT01698320|20407750|P2|NOT COMPLETED|12-Week Double-Blind Period||4
8276451|NCT01698320|20407751|P1|NOT COMPLETED|12-Week Double-Blind Period||0
8276452|NCT01698320|20407749|P3|COMPLETED|12-Week Double-Blind Period||156
8276453|NCT01698320|20407750|P2|COMPLETED|12-Week Double-Blind Period||165
8276454|NCT01698320|20407751|P1|COMPLETED|12-Week Double-Blind Period||0
8276455|NCT01698320|20407749|P3|Safety Population|12-Week Double-Blind Period||168
8276456|NCT01698320|20407750|P2|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
8276457|NCT01698320|20407751|P1|Safety Population|12-Week Double-Blind Period||0
8276458|NCT01698320|20407749|P3|STARTED|12-Week Double-Blind Period||168
8276459|NCT01698320|20407750|P2|STARTED|12-Week Double-Blind Period||169
8276460|NCT01698320|20407751|P1|STARTED|12-Week Double-Blind Period||0
8276461|NCT01698320|20407749|P3|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
8276462|NCT01698320|20407750|P2|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
8276463|NCT01698320|20407751|P1|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
8276464|NCT01698320|20407749|P3|COMPLETED|Run-In Period (Week -1 to Day 0)||0
8276465|NCT01698320|20407750|P2|COMPLETED|Run-In Period (Week -1 to Day 0)||0
8276466|NCT01698320|20407751|P1|COMPLETED|Run-In Period (Week -1 to Day 0)||337
8276467|NCT01698320|20407749|P3|STARTED|Run-In Period (Week -1 to Day 0)||0
8276468|NCT01698320|20407750|P2|STARTED|Run-In Period (Week -1 to Day 0)||0
8276469|NCT01698320|20407751|P1|STARTED|Run-In Period (Week -1 to Day 0)||364
8276470|NCT01698268|20407771|P2|NOT COMPLETED|Overall Study||1
8276471|NCT01698268|20407772|P1|NOT COMPLETED|Overall Study||2
8276472|NCT01698268|20407771|P2|COMPLETED|Overall Study||24
8276473|NCT01698268|20407772|P1|COMPLETED|Overall Study||23
8276474|NCT01698268|20407771|P2|STARTED|Overall Study||25
8276475|NCT01698268|20407772|P1|STARTED|Overall Study||25
8276476|NCT01698008|20407780|P2|NOT COMPLETED|Overall Study||2
8276477|NCT01698008|20407781|P1|NOT COMPLETED|Overall Study||1
8276478|NCT01698008|20407780|P2|COMPLETED|Overall Study||0
8276479|NCT01698008|20407781|P1|COMPLETED|Overall Study||2
8276480|NCT01698008|20407780|P2|STARTED|Overall Study||2
8276481|NCT01698008|20407781|P1|STARTED|Overall Study||3
8276482|NCT01697969|20407787|P1|NOT COMPLETED|Overall Study||3
8276483|NCT01697969|20407787|P1|COMPLETED|Overall Study||10
8276484|NCT01697969|20407787|P1|STARTED|Overall Study||13
8276485|NCT01697956|20407794|P2|NOT COMPLETED|Overall Study||1
8276486|NCT01697956|20407795|P1|NOT COMPLETED|Overall Study||1
8276487|NCT01697956|20407794|P2|COMPLETED|Overall Study||31
8276488|NCT01697956|20407795|P1|COMPLETED|Overall Study||66
8276489|NCT01697956|20407794|P2|Per Protocol Population|Overall Study||31
8276490|NCT01697956|20407795|P1|Per Protocol Population|Overall Study||66
8276491|NCT01697956|20407794|P2|STARTED|Overall Study|enrolled and randomized|32
8276492|NCT01697956|20407795|P1|STARTED|Overall Study|enrolled and randomized|67
8276493|NCT01697800|20407825|P2|NOT COMPLETED|Overall Study||1
8276494|NCT01697800|20407826|P1|NOT COMPLETED|Overall Study||0
8276495|NCT01697800|20407825|P2|COMPLETED|Overall Study||24
8276496|NCT01697800|20407826|P1|COMPLETED|Overall Study||15
8276497|NCT01697800|20407825|P2|STARTED|Overall Study||25
8276498|NCT01697800|20407826|P1|STARTED|Overall Study||15
8276499|NCT01697748|20407834|P2|NOT COMPLETED|Overall Study||68
8276500|NCT01697748|20407835|P1|NOT COMPLETED|Overall Study||58
8276501|NCT01697748|20407834|P2|COMPLETED|Overall Study||260
8276502|NCT01697748|20407835|P1|COMPLETED|Overall Study||271
8276503|NCT01697748|20407834|P2|STARTED|Overall Study||328
8276504|NCT01697748|20407835|P1|STARTED|Overall Study||329
8276505|NCT01697709|20407853|P2|NOT COMPLETED|Overall Study||28
8276506|NCT01697709|20407854|P1|NOT COMPLETED|Overall Study||30
8276507|NCT01697709|20407853|P2|COMPLETED|Overall Study||38
8276508|NCT01697709|20407854|P1|COMPLETED|Overall Study||34
8276509|NCT01697709|20407853|P2|STARTED|Overall Study||66
8276510|NCT01697709|20407854|P1|STARTED|Overall Study||64
8276511|NCT01697696|20407864|P2|NOT COMPLETED|Overall Study||47
8276512|NCT01697696|20407865|P1|NOT COMPLETED|Overall Study||47
8276513|NCT01697696|20407864|P2|COMPLETED|Overall Study||210
8276514|NCT01697696|20407865|P1|COMPLETED|Overall Study||207
8276515|NCT01697696|20407864|P2|Full Analysis Set (FAS)|Overall Study||255
8276516|NCT01697696|20407865|P1|Full Analysis Set (FAS)|Overall Study||251
8276517|NCT01697696|20407864|P2|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
8276518|NCT01697696|20407865|P1|Safety Set|Overall Study||251
8276519|NCT01697696|20407864|P2|STARTED|Overall Study||257
8276520|NCT01697696|20407865|P1|STARTED|Overall Study||254
8276521|NCT01697592|20407897|P10|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
8276522|NCT01697592|20407898|P9|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
8276523|NCT01697592|20407899|P8|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
8276524|NCT01697592|20407900|P7|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
8276525|NCT01697592|20407901|P6|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
8276526|NCT01697592|20407902|P5|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
8276527|NCT01697592|20407903|P4|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
8276528|NCT01697592|20407904|P3|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
8276529|NCT01697592|20407905|P2|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
8276530|NCT01697592|20407906|P1|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
8276531|NCT01697592|20407897|P10|COMPLETED|Phase B (Week 25 to Week 52)||30
8276532|NCT01697592|20407898|P9|COMPLETED|Phase B (Week 25 to Week 52)||32
8276533|NCT01697592|20407899|P8|COMPLETED|Phase B (Week 25 to Week 52)||32
8276534|NCT01697592|20407900|P7|COMPLETED|Phase B (Week 25 to Week 52)||31
8276535|NCT01697592|20407901|P6|COMPLETED|Phase B (Week 25 to Week 52)||60
8276536|NCT01697592|20407902|P5|COMPLETED|Phase B (Week 25 to Week 52)||67
8276537|NCT01697592|20407903|P4|COMPLETED|Phase B (Week 25 to Week 52)||60
8276538|NCT01697592|20407904|P3|COMPLETED|Phase B (Week 25 to Week 52)||64
8276539|NCT01697592|20407905|P2|COMPLETED|Phase B (Week 25 to Week 52)||61
8276540|NCT01697592|20407906|P1|COMPLETED|Phase B (Week 25 to Week 52)||118
8276541|NCT01697592|20407897|P10|STARTED|Phase B (Week 25 to Week 52)||30
8276542|NCT01697592|20407898|P9|STARTED|Phase B (Week 25 to Week 52)||34
8276543|NCT01697592|20407899|P8|STARTED|Phase B (Week 25 to Week 52)||33
8276544|NCT01697592|20407900|P7|STARTED|Phase B (Week 25 to Week 52)||32
8276545|NCT01697592|20407901|P6|STARTED|Phase B (Week 25 to Week 52)||62
8276546|NCT01697592|20407902|P5|STARTED|Phase B (Week 25 to Week 52)||67
8276547|NCT01697592|20407903|P4|STARTED|Phase B (Week 25 to Week 52)||63
8276548|NCT01697592|20407904|P3|STARTED|Phase B (Week 25 to Week 52)||65
8276549|NCT01697592|20407905|P2|STARTED|Phase B (Week 25 to Week 52)||62
8276550|NCT01697592|20407906|P1|STARTED|Phase B (Week 25 to Week 52)||123
8276551|NCT01697592|20407897|P10|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
8276552|NCT01697592|20407898|P9|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
8276553|NCT01697592|20407899|P8|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
8276554|NCT01697592|20407900|P7|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
8276555|NCT01697592|20407901|P6|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
8276556|NCT01697592|20407902|P5|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
8276557|NCT01697592|20407903|P4|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
8276558|NCT01697592|20407904|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
8276559|NCT01697592|20407905|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
8276560|NCT01697592|20407906|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
8276561|NCT01697592|20407897|P10|COMPLETED|Phase A (Up to 24 Weeks)||30
8276562|NCT01697592|20407898|P9|COMPLETED|Phase A (Up to 24 Weeks)||34
8276563|NCT01697592|20407899|P8|COMPLETED|Phase A (Up to 24 Weeks)||33
8276564|NCT01697592|20407900|P7|COMPLETED|Phase A (Up to 24 Weeks)||32
8276565|NCT01697592|20407901|P6|COMPLETED|Phase A (Up to 24 Weeks)||62
8276566|NCT01697592|20407902|P5|COMPLETED|Phase A (Up to 24 Weeks)||67
8276567|NCT01697592|20407903|P4|COMPLETED|Phase A (Up to 24 Weeks)||63
8276568|NCT01697592|20407904|P3|COMPLETED|Phase A (Up to 24 Weeks)||65
8276569|NCT01697592|20407905|P2|COMPLETED|Phase A (Up to 24 Weeks)||62
8276570|NCT01697592|20407906|P1|COMPLETED|Phase A (Up to 24 Weeks)||123
8276571|NCT01697592|20407897|P10|STARTED|Phase A (Up to 24 Weeks)||32
8276572|NCT01697592|20407898|P9|STARTED|Phase A (Up to 24 Weeks)||34
8276573|NCT01697592|20407899|P8|STARTED|Phase A (Up to 24 Weeks)||33
8276574|NCT01697592|20407900|P7|STARTED|Phase A (Up to 24 Weeks)||34
8276575|NCT01697592|20407901|P6|STARTED|Phase A (Up to 24 Weeks)||63
8276576|NCT01697592|20407902|P5|STARTED|Phase A (Up to 24 Weeks)||67
8276577|NCT01697592|20407903|P4|STARTED|Phase A (Up to 24 Weeks)||65
8276578|NCT01697592|20407904|P3|STARTED|Phase A (Up to 24 Weeks)||66
8276579|NCT01697592|20407905|P2|STARTED|Phase A (Up to 24 Weeks)||65
8276580|NCT01697592|20407906|P1|STARTED|Phase A (Up to 24 Weeks)||126
8276581|NCT01697579|20407975|P7|NOT COMPLETED|Optional Extension-Cycles 2-6||69
8276582|NCT01697579|20407976|P6|NOT COMPLETED|Optional Extension-Cycles 2-6||35
8276583|NCT01697579|20407977|P5|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8276584|NCT01697579|20407978|P4|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8276585|NCT01697579|20407979|P3|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8276586|NCT01697579|20407980|P2|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8276587|NCT01697579|20407981|P1|NOT COMPLETED|Optional Extension-Cycles 2-6||0
8276588|NCT01697579|20407975|P7|COMPLETED|Optional Extension-Cycles 2-6||37
8276589|NCT01697579|20407976|P6|COMPLETED|Optional Extension-Cycles 2-6||12
8276590|NCT01697579|20407977|P5|COMPLETED|Optional Extension-Cycles 2-6||0
8276591|NCT01697579|20407978|P4|COMPLETED|Optional Extension-Cycles 2-6||0
8276592|NCT01697579|20407979|P3|COMPLETED|Optional Extension-Cycles 2-6||0
8276593|NCT01697579|20407980|P2|COMPLETED|Optional Extension-Cycles 2-6||0
8276594|NCT01697579|20407981|P1|COMPLETED|Optional Extension-Cycles 2-6||0
8276595|NCT01697579|20407975|P7|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
8276596|NCT01697579|20407976|P6|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
8276597|NCT01697579|20407977|P5|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
8276598|NCT01697579|20407978|P4|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
8276599|NCT01697579|20407979|P3|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
8276600|NCT01697579|20407980|P2|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
8276601|NCT01697579|20407981|P1|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
8276602|NCT01697579|20407975|P7|NOT COMPLETED|Base Study-Cycle 1||0
8276603|NCT01697579|20407976|P6|NOT COMPLETED|Base Study-Cycle 1||0
8276604|NCT01697579|20407977|P5|NOT COMPLETED|Base Study-Cycle 1||3
8276605|NCT01697579|20407978|P4|NOT COMPLETED|Base Study-Cycle 1||1
8276606|NCT01697579|20407979|P3|NOT COMPLETED|Base Study-Cycle 1||1
8276607|NCT01697579|20407980|P2|NOT COMPLETED|Base Study-Cycle 1||1
8276608|NCT01697579|20407981|P1|NOT COMPLETED|Base Study-Cycle 1||2
8276609|NCT01697579|20407975|P7|COMPLETED|Base Study-Cycle 1||0
8276610|NCT01697579|20407976|P6|COMPLETED|Base Study-Cycle 1||0
8276611|NCT01697579|20407977|P5|COMPLETED|Base Study-Cycle 1||35
8276612|NCT01697579|20407978|P4|COMPLETED|Base Study-Cycle 1||40
8276613|NCT01697579|20407979|P3|COMPLETED|Base Study-Cycle 1||43
8276614|NCT01697579|20407980|P2|COMPLETED|Base Study-Cycle 1||42
8276615|NCT01697579|20407981|P1|COMPLETED|Base Study-Cycle 1||72
8276616|NCT01697579|20407975|P7|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
8276617|NCT01697579|20407976|P6|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
8276618|NCT01697579|20407977|P5|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
8276619|NCT01697579|20407978|P4|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
8276620|NCT01697579|20407979|P3|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
8276621|NCT01697579|20407980|P2|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
8276622|NCT01697579|20407981|P1|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
8276623|NCT01697501|20408093|P1|NOT COMPLETED|Overall Study||2
8276624|NCT01697501|20408093|P1|COMPLETED|Overall Study||86
8276625|NCT01697501|20408093|P1|STARTED|Overall Study||88
8276626|NCT01697462|20408136|P1|NOT COMPLETED|Overall Study||77
8276627|NCT01697462|20408136|P1|COMPLETED|Overall Study||181
8276628|NCT01697462|20408136|P1|STARTED|Overall Study||258
8276629|NCT01697449|20408143|P1|NOT COMPLETED|Overall Study||90
8276630|NCT01697449|20408143|P1|COMPLETED|Overall Study||101
8276631|NCT01697449|20408143|P1|STARTED|Overall Study||191
8276632|NCT01697358|20408154|P2|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
8276633|NCT01697358|20408155|P1|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
8276634|NCT01697358|20408154|P2|COMPLETED|Period II: 6-24M Long-term Follow-up||52
8276635|NCT01697358|20408155|P1|COMPLETED|Period II: 6-24M Long-term Follow-up||48
8276636|NCT01697358|20408154|P2|STARTED|Period II: 6-24M Long-term Follow-up||107
8276637|NCT01697358|20408155|P1|STARTED|Period II: 6-24M Long-term Follow-up||97
8276638|NCT01697358|20408154|P2|NOT COMPLETED|Period I: Randomization to 6 Months||1
8276639|NCT01697358|20408155|P1|NOT COMPLETED|Period I: Randomization to 6 Months||13
8276640|NCT01697358|20408154|P2|COMPLETED|Period I: Randomization to 6 Months||107
8276641|NCT01697358|20408155|P1|COMPLETED|Period I: Randomization to 6 Months||97
8276642|NCT01697358|20408154|P2|STARTED|Period I: Randomization to 6 Months||108
8276643|NCT01697358|20408155|P1|STARTED|Period I: Randomization to 6 Months||110
8276644|NCT01697345|20408171|P1|NOT COMPLETED|Overall Study||1
8276645|NCT01697345|20408171|P1|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
8276646|NCT01697345|20408171|P1|STARTED|Overall Study||13
8276647|NCT01697332|20408190|P1|NOT COMPLETED|Overall Study||0
8276648|NCT01697332|20408190|P1|COMPLETED|Overall Study||1
8276649|NCT01697332|20408190|P1|STARTED|Overall Study||1
8276650|NCT01697319|20408196|P1|NOT COMPLETED|Extension Phase||15
8276651|NCT01697319|20408196|P1|COMPLETED|Extension Phase||0
8276652|NCT01697319|20408196|P1|STARTED|Extension Phase||15
8276653|NCT01697319|20408196|P1|NOT COMPLETED|Primary Phase||1
8276654|NCT01697319|20408196|P1|COMPLETED|Primary Phase||15
8276655|NCT01697319|20408196|P1|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
8276674|NCT01696955|20408278|P2|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
8276675|NCT01696955|20408279|P1|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
8276676|NCT01696955|20408278|P2|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
8276677|NCT01696955|20408279|P1|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
8276678|NCT01696955|20408278|P2|STARTED|Failure on Cetuximab-Received Tivantinib||15
8276679|NCT01696955|20408279|P1|STARTED|Failure on Cetuximab-Received Tivantinib||0
8276680|NCT01696955|20408278|P2|NOT COMPLETED|Main Study||1
8276681|NCT01696955|20408279|P1|NOT COMPLETED|Main Study||2
8276682|NCT01696955|20408278|P2|COMPLETED|Main Study||38
8276683|NCT01696955|20408279|P1|COMPLETED|Main Study||40
8276684|NCT01696955|20408278|P2|STARTED|Main Study||39
8276685|NCT01696955|20408279|P1|STARTED|Main Study||42
8276686|NCT01696942|20408304|P2|NOT COMPLETED|Overall Study||3
8276687|NCT01696942|20408305|P1|NOT COMPLETED|Overall Study||2
8276688|NCT01696942|20408304|P2|COMPLETED|Overall Study||2
8276689|NCT01696942|20408305|P1|COMPLETED|Overall Study||3
8276690|NCT01696942|20408304|P2|STARTED|Overall Study||5
8276691|NCT01696942|20408305|P1|STARTED|Overall Study||5
8276695|NCT01696877|20408320|P2|NOT COMPLETED|Overall Study||1
8276696|NCT01696877|20408321|P1|NOT COMPLETED|Overall Study||0
8276697|NCT01696877|20408320|P2|COMPLETED|Overall Study||13
8276698|NCT01696877|20408321|P1|COMPLETED|Overall Study||15
8276699|NCT01696877|20408320|P2|STARTED|Overall Study||14
8276700|NCT01696877|20408321|P1|STARTED|Overall Study||15
8276725|NCT01696760|20408352|P2|NOT COMPLETED|Overall Study||0
8276726|NCT01696760|20408353|P1|NOT COMPLETED|Overall Study||0
8276727|NCT01696760|20408352|P2|COMPLETED|Overall Study||3
8276728|NCT01696760|20408353|P1|COMPLETED|Overall Study||9
8276729|NCT01696760|20408352|P2|STARTED|Overall Study||3
8276730|NCT01696760|20408353|P1|STARTED|Overall Study||9
8276731|NCT01696695|20408371|P1|NOT COMPLETED|Overall Study||882
8276732|NCT01696695|20408371|P1|COMPLETED|Overall Study||0
8276733|NCT01696695|20408371|P1|STARTED|Overall Study||882
8276734|NCT01696643|20408383|P2|NOT COMPLETED|Overall Study||535
8276735|NCT01696643|20408384|P1|NOT COMPLETED|Overall Study||529
8276736|NCT01696643|20408383|P2|COMPLETED|Overall Study||169
8276737|NCT01696643|20408384|P1|COMPLETED|Overall Study||174
8276738|NCT01696643|20408383|P2|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
8276739|NCT01696643|20408384|P1|Received at Least 1 Dose of Study Drug|Overall Study||701
8276740|NCT01696643|20408383|P2|STARTED|Overall Study||704
8276741|NCT01696643|20408384|P1|STARTED|Overall Study||703
8276742|NCT01696396|20408403|P4|NOT COMPLETED|Overall Study||14
8276743|NCT01696396|20408404|P3|NOT COMPLETED|Overall Study||26
8276744|NCT01696396|20408405|P2|NOT COMPLETED|Overall Study||7
8276745|NCT01696396|20408406|P1|NOT COMPLETED|Overall Study||31
8276746|NCT01696396|20408403|P4|COMPLETED|Overall Study||28
8276747|NCT01696396|20408404|P3|COMPLETED|Overall Study||59
8276748|NCT01696396|20408405|P2|COMPLETED|Overall Study||20
8276749|NCT01696396|20408406|P1|COMPLETED|Overall Study||69
8276750|NCT01696396|20408403|P4|Entered Open-label Period|Overall Study||37
8276751|NCT01696396|20408404|P3|Entered Open-label Period|Overall Study||75
8276752|NCT01696396|20408405|P2|Entered Open-label Period|Overall Study||21
8276753|NCT01696396|20408406|P1|Entered Open-label Period|Overall Study||84
8276754|NCT01696396|20408403|P4|Received Study Drug|Overall Study||41
8276755|NCT01696396|20408404|P3|Received Study Drug|Overall Study||84
8276756|NCT01696396|20408405|P2|Received Study Drug|Overall Study||26
8276757|NCT01696396|20408406|P1|Received Study Drug|Overall Study||98
8276758|NCT01696396|20408403|P4|STARTED|Overall Study||42
8276759|NCT01696396|20408404|P3|STARTED|Overall Study||85
8276760|NCT01696396|20408405|P2|STARTED|Overall Study||27
8276761|NCT01696396|20408406|P1|STARTED|Overall Study||100
8276762|NCT01696357|20408450|P2|NOT COMPLETED|Overall Study||1
8276763|NCT01696357|20408451|P1|NOT COMPLETED|Overall Study||2
8276764|NCT01696357|20408450|P2|COMPLETED|Overall Study||41
8276765|NCT01696357|20408451|P1|COMPLETED|Overall Study||40
8276766|NCT01696357|20408450|P2|STARTED|Overall Study||42
8276767|NCT01696357|20408451|P1|STARTED|Overall Study||42
8276860|NCT01696214|20408498|P4|NOT COMPLETED|Overall Study||0
8276861|NCT01696214|20408499|P3|NOT COMPLETED|Overall Study||0
8276862|NCT01696214|20408500|P2|NOT COMPLETED|Overall Study||0
8276863|NCT01696214|20408501|P1|NOT COMPLETED|Overall Study||1
8276864|NCT01696214|20408498|P4|COMPLETED|Overall Study||5
8276865|NCT01696214|20408499|P3|COMPLETED|Overall Study||5
8276866|NCT01696214|20408500|P2|COMPLETED|Overall Study||5
8276867|NCT01696214|20408501|P1|COMPLETED|Overall Study||4
8276868|NCT01696214|20408498|P4|STARTED|Overall Study||5
8276869|NCT01696214|20408499|P3|STARTED|Overall Study||5
8276870|NCT01696214|20408500|P2|STARTED|Overall Study||5
8276871|NCT01696214|20408501|P1|STARTED|Overall Study||5
8276872|NCT01696188|20408521|P2|NOT COMPLETED|Overall Study||1
8276873|NCT01696188|20408522|P1|NOT COMPLETED|Overall Study||1
8276874|NCT01696188|20408521|P2|COMPLETED|Overall Study||42
8276875|NCT01696188|20408522|P1|COMPLETED|Overall Study||40
8276876|NCT01696188|20408521|P2|STARTED|Overall Study||43
8276877|NCT01696188|20408522|P1|STARTED|Overall Study||41
8276878|NCT01696084|20408536|P2|NOT COMPLETED|Overall Study||146
8276879|NCT01696084|20408537|P1|NOT COMPLETED|Overall Study||131
8276880|NCT01696084|20408536|P2|COMPLETED|Overall Study||10
8276881|NCT01696084|20408537|P1|COMPLETED|Overall Study||22
8276882|NCT01696084|20408536|P2|STARTED|Overall Study||156
8276883|NCT01696084|20408537|P1|STARTED|Overall Study||153
8276884|NCT01696071|20408553|P2|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
8276885|NCT01696071|20408554|P1|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
8276886|NCT01696071|20408553|P2|COMPLETED|Treatment Period 2: 4 Weeks||47
8276887|NCT01696071|20408554|P1|COMPLETED|Treatment Period 2: 4 Weeks||50
8276888|NCT01696071|20408553|P2|STARTED|Treatment Period 2: 4 Weeks||47
8276889|NCT01696071|20408554|P1|STARTED|Treatment Period 2: 4 Weeks||51
8276890|NCT01696071|20408553|P2|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
8276891|NCT01696071|20408554|P1|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
8276892|NCT01696071|20408553|P2|COMPLETED|Treatment Period 1: 4 Weeks||47
8276893|NCT01696071|20408554|P1|COMPLETED|Treatment Period 1: 4 Weeks||51
8276894|NCT01696071|20408553|P2|STARTED|Treatment Period 1: 4 Weeks||47
8276895|NCT01696071|20408554|P1|STARTED|Treatment Period 1: 4 Weeks||51
8276896|NCT01696058|20408582|P2|NOT COMPLETED|Overall Study||31
8276897|NCT01696058|20408583|P1|NOT COMPLETED|Overall Study||43
8276898|NCT01696058|20408582|P2|COMPLETED|Overall Study||538
8276899|NCT01696058|20408583|P1|COMPLETED|Overall Study||523
8276900|NCT01696058|20408582|P2|STARTED|Overall Study||569
8276901|NCT01696058|20408583|P1|STARTED|Overall Study||566
8276902|NCT01696045|20408611|P2|NOT COMPLETED|Overall Study||7
8276903|NCT01696045|20408612|P1|NOT COMPLETED|Overall Study||3
8276904|NCT01696045|20408611|P2|COMPLETED|Overall Study||1
8276905|NCT01696045|20408612|P1|COMPLETED|Overall Study||1
8276906|NCT01696045|20408611|P2|STARTED|Overall Study||8
8276907|NCT01696045|20408612|P1|STARTED|Overall Study||4
8276908|NCT01695993|20408631|P3|NOT COMPLETED|Overall Study||6
8276909|NCT01695993|20408632|P2|NOT COMPLETED|Overall Study||5
8276910|NCT01695993|20408633|P1|NOT COMPLETED|Overall Study||5
8276911|NCT01695993|20408631|P3|COMPLETED|Overall Study||75
8276912|NCT01695993|20408632|P2|COMPLETED|Overall Study||75
8276913|NCT01695993|20408633|P1|COMPLETED|Overall Study||76
8276914|NCT01695993|20408631|P3|STARTED|Overall Study||81
8276915|NCT01695993|20408632|P2|STARTED|Overall Study||80
8276916|NCT01695993|20408633|P1|STARTED|Overall Study||81
8276917|NCT01695954|20408643|P2|NOT COMPLETED|Overall Study||2
8276918|NCT01695954|20408644|P1|NOT COMPLETED|Overall Study||4
8276919|NCT01695954|20408643|P2|COMPLETED|Overall Study||14
8276920|NCT01695954|20408644|P1|COMPLETED|Overall Study||14
8276921|NCT01695954|20408643|P2|STARTED|Overall Study||16
8276922|NCT01695954|20408644|P1|STARTED|Overall Study||18
8276923|NCT01695772|20408654|P1|NOT COMPLETED|Overall Study||38
8276924|NCT01695772|20408654|P1|COMPLETED|Overall Study||12
8276925|NCT01695772|20408654|P1|STARTED|Overall Study||50
8276926|NCT01695746|20408666|P1|NOT COMPLETED|Overall Study||12
8276927|NCT01695746|20408666|P1|COMPLETED|Overall Study||96
8276928|NCT01695746|20408666|P1|STARTED|Overall Study||108
8276929|NCT01695668|20408682|P2|NOT COMPLETED|Overall Study||17
8276930|NCT01695668|20408683|P1|NOT COMPLETED|Overall Study||15
8276931|NCT01695668|20408682|P2|COMPLETED|Overall Study||20
8276932|NCT01695668|20408683|P1|COMPLETED|Overall Study||23
8276933|NCT01695668|20408682|P2|STARTED|Overall Study||37
8276934|NCT01695668|20408683|P1|STARTED|Overall Study||38
8276935|NCT01695473|20408689|P1|NOT COMPLETED|Overall Study||0
8276936|NCT01695473|20408689|P1|COMPLETED|Overall Study||11
8276937|NCT01695473|20408689|P1|STARTED|Overall Study||11
8276938|NCT01695369|20408696|P1|NOT COMPLETED|Overall Study||0
8276939|NCT01695369|20408696|P1|COMPLETED|Overall Study||61
8276940|NCT01695369|20408696|P1|STARTED|Overall Study||61
8276941|NCT01695330|20408702|P2|NOT COMPLETED|Overall Study||0
8276942|NCT01695330|20408703|P1|NOT COMPLETED|Overall Study||47
8276943|NCT01695330|20408702|P2|COMPLETED|Overall Study||0
8276944|NCT01695330|20408703|P1|COMPLETED|Overall Study||5
8276945|NCT01695330|20408702|P2|STARTED|Overall Study||0
8276946|NCT01695330|20408703|P1|STARTED|Overall Study||52
8276947|NCT01695304|20408709|P2|NOT COMPLETED|Overall Study||0
8276948|NCT01695304|20408710|P1|NOT COMPLETED|Overall Study||0
8276949|NCT01695304|20408709|P2|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
8276950|NCT01695304|20408710|P1|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
8276951|NCT01695304|20408709|P2|STARTED|Overall Study||120
8276952|NCT01695304|20408710|P1|STARTED|Overall Study||120
8276953|NCT01695291|20408720|P2|NOT COMPLETED|Overall Study||7
8276954|NCT01695291|20408721|P1|NOT COMPLETED|Overall Study||2
8276955|NCT01695291|20408720|P2|COMPLETED|Overall Study||14
8276956|NCT01695291|20408721|P1|COMPLETED|Overall Study||8
8276957|NCT01695291|20408720|P2|STARTED|Overall Study||21
8276958|NCT01695291|20408721|P1|STARTED|Overall Study||10
8276959|NCT01695239|20408733|P14|NOT COMPLETED|Post-Treatment Follow-Up Period||5
8276960|NCT01695239|20408734|P13|NOT COMPLETED|Post-Treatment Follow-Up Period||9
8276961|NCT01695239|20408735|P12|NOT COMPLETED|Post-Treatment Follow-Up Period||1
8276962|NCT01695239|20408736|P11|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276963|NCT01695239|20408737|P10|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276964|NCT01695239|20408738|P9|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276965|NCT01695239|20408739|P8|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276966|NCT01695239|20408740|P7|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276967|NCT01695239|20408741|P6|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276968|NCT01695239|20408742|P5|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276969|NCT01695239|20408743|P4|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276970|NCT01695239|20408744|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276971|NCT01695239|20408745|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276972|NCT01695239|20408746|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||0
8276973|NCT01695239|20408733|P14|COMPLETED|Post-Treatment Follow-Up Period||166
8276974|NCT01695239|20408734|P13|COMPLETED|Post-Treatment Follow-Up Period||156
8276975|NCT01695239|20408735|P12|COMPLETED|Post-Treatment Follow-Up Period||0
8276976|NCT01695239|20408736|P11|COMPLETED|Post-Treatment Follow-Up Period||20
8276977|NCT01695239|20408737|P10|COMPLETED|Post-Treatment Follow-Up Period||0
8276978|NCT01695239|20408738|P9|COMPLETED|Post-Treatment Follow-Up Period||0
8276979|NCT01695239|20408739|P8|COMPLETED|Post-Treatment Follow-Up Period||0
8276980|NCT01695239|20408740|P7|COMPLETED|Post-Treatment Follow-Up Period||0
8276981|NCT01695239|20408741|P6|COMPLETED|Post-Treatment Follow-Up Period||0
8276982|NCT01695239|20408742|P5|COMPLETED|Post-Treatment Follow-Up Period||0
8276983|NCT01695239|20408743|P4|COMPLETED|Post-Treatment Follow-Up Period||0
8276984|NCT01695239|20408744|P3|COMPLETED|Post-Treatment Follow-Up Period||0
8276985|NCT01695239|20408745|P2|COMPLETED|Post-Treatment Follow-Up Period||0
8276986|NCT01695239|20408746|P1|COMPLETED|Post-Treatment Follow-Up Period||0
8276987|NCT01695239|20408733|P14|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171
8276988|NCT01695239|20408734|P13|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165
8276989|NCT01695239|20408735|P12|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1
8276990|NCT01695239|20408736|P11|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20
8276991|NCT01695239|20408737|P10|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
8276992|NCT01695239|20408738|P9|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
8276993|NCT01695239|20408739|P8|STARTED|Post-Treatment Follow-Up Period||0
8276994|NCT01695239|20408740|P7|STARTED|Post-Treatment Follow-Up Period||0
8276995|NCT01695239|20408741|P6|STARTED|Post-Treatment Follow-Up Period||0
8276996|NCT01695239|20408742|P5|STARTED|Post-Treatment Follow-Up Period||0
8276997|NCT01695239|20408743|P4|STARTED|Post-Treatment Follow-Up Period||0
8276998|NCT01695239|20408744|P3|STARTED|Post-Treatment Follow-Up Period||0
8276999|NCT01695239|20408745|P2|STARTED|Post-Treatment Follow-Up Period||0
8277000|NCT01695239|20408746|P1|STARTED|Post-Treatment Follow-Up Period||0
8277001|NCT01695239|20408733|P14|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277002|NCT01695239|20408734|P13|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277003|NCT01695239|20408735|P12|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277004|NCT01695239|20408736|P11|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277005|NCT01695239|20408737|P10|NOT COMPLETED|Extension Long-Term Extension Periods||61
8277006|NCT01695239|20408738|P9|NOT COMPLETED|Extension Long-Term Extension Periods||66
8277007|NCT01695239|20408739|P8|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277008|NCT01695239|20408740|P7|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277009|NCT01695239|20408741|P6|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277010|NCT01695239|20408742|P5|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277011|NCT01695239|20408743|P4|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277012|NCT01695239|20408744|P3|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277013|NCT01695239|20408745|P2|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277014|NCT01695239|20408746|P1|NOT COMPLETED|Extension Long-Term Extension Periods||0
8277015|NCT01695239|20408733|P14|COMPLETED|Extension Long-Term Extension Periods||0
8277016|NCT01695239|20408734|P13|COMPLETED|Extension Long-Term Extension Periods||0
8277017|NCT01695239|20408735|P12|COMPLETED|Extension Long-Term Extension Periods||0
8277018|NCT01695239|20408736|P11|COMPLETED|Extension Long-Term Extension Periods||0
8277019|NCT01695239|20408737|P10|COMPLETED|Extension Long-Term Extension Periods||122
8277020|NCT01695239|20408738|P9|COMPLETED|Extension Long-Term Extension Periods||121
8277021|NCT01695239|20408739|P8|COMPLETED|Extension Long-Term Extension Periods||0
8277022|NCT01695239|20408740|P7|COMPLETED|Extension Long-Term Extension Periods||0
8277023|NCT01695239|20408741|P6|COMPLETED|Extension Long-Term Extension Periods||0
8277024|NCT01695239|20408742|P5|COMPLETED|Extension Long-Term Extension Periods||0
8277025|NCT01695239|20408743|P4|COMPLETED|Extension Long-Term Extension Periods||0
8277026|NCT01695239|20408744|P3|COMPLETED|Extension Long-Term Extension Periods||0
8277027|NCT01695239|20408745|P2|COMPLETED|Extension Long-Term Extension Periods||0
8277028|NCT01695239|20408746|P1|COMPLETED|Extension Long-Term Extension Periods||0
8277029|NCT01695239|20408733|P14|STARTED|Extension Long-Term Extension Periods||0
8277030|NCT01695239|20408734|P13|STARTED|Extension Long-Term Extension Periods||0
8277031|NCT01695239|20408735|P12|STARTED|Extension Long-Term Extension Periods||0
8277032|NCT01695239|20408736|P11|STARTED|Extension Long-Term Extension Periods||0
8277033|NCT01695239|20408737|P10|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183
8277034|NCT01695239|20408738|P9|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187
8277035|NCT01695239|20408739|P8|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0
8277036|NCT01695239|20408740|P7|STARTED|Extension Long-Term Extension Periods||0
8277037|NCT01695239|20408741|P6|STARTED|Extension Long-Term Extension Periods||0
8277038|NCT01695239|20408742|P5|STARTED|Extension Long-Term Extension Periods||0
8277039|NCT01695239|20408743|P4|STARTED|Extension Long-Term Extension Periods||0
8277040|NCT01695239|20408744|P3|STARTED|Extension Long-Term Extension Periods||0
8277041|NCT01695239|20408745|P2|STARTED|Extension Long-Term Extension Periods||0
8277042|NCT01695239|20408746|P1|STARTED|Extension Long-Term Extension Periods||0
8277043|NCT01695239|20408733|P14|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277044|NCT01695239|20408734|P13|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277045|NCT01695239|20408735|P12|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277046|NCT01695239|20408736|P11|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277047|NCT01695239|20408737|P10|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277048|NCT01695239|20408738|P9|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277049|NCT01695239|20408739|P8|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11
8277050|NCT01695239|20408740|P7|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277051|NCT01695239|20408741|P6|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277052|NCT01695239|20408742|P5|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277053|NCT01695239|20408743|P4|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277054|NCT01695239|20408744|P3|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277055|NCT01695239|20408745|P2|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277056|NCT01695239|20408746|P1|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277057|NCT01695239|20408733|P14|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277058|NCT01695239|20408734|P13|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277059|NCT01695239|20408735|P12|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277060|NCT01695239|20408736|P11|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277061|NCT01695239|20408737|P10|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277062|NCT01695239|20408738|P9|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277063|NCT01695239|20408739|P8|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77
8277064|NCT01695239|20408740|P7|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277065|NCT01695239|20408741|P6|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277066|NCT01695239|20408742|P5|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277067|NCT01695239|20408743|P4|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277068|NCT01695239|20408744|P3|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277069|NCT01695239|20408745|P2|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277070|NCT01695239|20408746|P1|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
8277071|NCT01695239|20408733|P14|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277072|NCT01695239|20408734|P13|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277073|NCT01695239|20408735|P12|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277074|NCT01695239|20408736|P11|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277075|NCT01695239|20408737|P10|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277076|NCT01695239|20408738|P9|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277077|NCT01695239|20408739|P8|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88
8277078|NCT01695239|20408740|P7|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
8277079|NCT01695239|20408741|P6|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
8277080|NCT01695239|20408742|P5|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
8277081|NCT01695239|20408743|P4|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277082|NCT01695239|20408744|P3|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277083|NCT01695239|20408745|P2|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277084|NCT01695239|20408746|P1|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
8277085|NCT01695239|20408733|P14|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277086|NCT01695239|20408734|P13|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277087|NCT01695239|20408735|P12|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277088|NCT01695239|20408736|P11|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277089|NCT01695239|20408737|P10|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277090|NCT01695239|20408738|P9|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277091|NCT01695239|20408739|P8|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277092|NCT01695239|20408740|P7|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277093|NCT01695239|20408741|P6|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277094|NCT01695239|20408742|P5|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277095|NCT01695239|20408743|P4|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277096|NCT01695239|20408744|P3|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277097|NCT01695239|20408745|P2|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277098|NCT01695239|20408746|P1|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277099|NCT01695239|20408733|P14|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277100|NCT01695239|20408734|P13|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277101|NCT01695239|20408735|P12|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277102|NCT01695239|20408736|P11|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277103|NCT01695239|20408737|P10|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277104|NCT01695239|20408738|P9|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277105|NCT01695239|20408739|P8|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277106|NCT01695239|20408740|P7|COMPLETED|IR Participants (Week 16 Up To Week 24)||9
8277107|NCT01695239|20408741|P6|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
8277108|NCT01695239|20408742|P5|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
8277109|NCT01695239|20408743|P4|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277110|NCT01695239|20408744|P3|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277111|NCT01695239|20408745|P2|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277112|NCT01695239|20408746|P1|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
8277113|NCT01695239|20408733|P14|STARTED|IR Participants (Week 16 Up To Week 24)||0
8277114|NCT01695239|20408734|P13|STARTED|IR Participants (Week 16 Up To Week 24)||0
8277115|NCT01695239|20408735|P12|STARTED|IR Participants (Week 16 Up To Week 24)||0
8277116|NCT01695239|20408736|P11|STARTED|IR Participants (Week 16 Up To Week 24)||0
8277117|NCT01695239|20408737|P10|STARTED|IR Participants (Week 16 Up To Week 24)||0
8277118|NCT01695239|20408738|P9|STARTED|IR Participants (Week 16 Up To Week 24)||0
8277119|NCT01695239|20408739|P8|STARTED|IR Participants (Week 16 Up To Week 24)||0
8277120|NCT01695239|20408740|P7|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9
8277121|NCT01695239|20408741|P6|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24
8277122|NCT01695239|20408742|P5|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24
8277123|NCT01695239|20408743|P4|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
8277124|NCT01695239|20408744|P3|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
8277125|NCT01695239|20408745|P2|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
8277126|NCT01695239|20408746|P1|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
8277127|NCT01695239|20408733|P14|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277128|NCT01695239|20408734|P13|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277129|NCT01695239|20408735|P12|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277130|NCT01695239|20408736|P11|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277131|NCT01695239|20408737|P10|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277132|NCT01695239|20408738|P9|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277133|NCT01695239|20408739|P8|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277134|NCT01695239|20408740|P7|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277135|NCT01695239|20408741|P6|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277136|NCT01695239|20408742|P5|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8277137|NCT01695239|20408743|P4|NOT COMPLETED|Double-Blind (DB) Treatment Period||7
8277138|NCT01695239|20408744|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||10
8277139|NCT01695239|20408745|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||4
8277140|NCT01695239|20408746|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||15
8277141|NCT01695239|20408733|P14|COMPLETED|Double-Blind (DB) Treatment Period||0
8277142|NCT01695239|20408734|P13|COMPLETED|Double-Blind (DB) Treatment Period||0
8277143|NCT01695239|20408735|P12|COMPLETED|Double-Blind (DB) Treatment Period||0
8277144|NCT01695239|20408736|P11|COMPLETED|Double-Blind (DB) Treatment Period||0
8277145|NCT01695239|20408737|P10|COMPLETED|Double-Blind (DB) Treatment Period||0
8277146|NCT01695239|20408738|P9|COMPLETED|Double-Blind (DB) Treatment Period||0
8277147|NCT01695239|20408739|P8|COMPLETED|Double-Blind (DB) Treatment Period||0
8277148|NCT01695239|20408740|P7|COMPLETED|Double-Blind (DB) Treatment Period||0
8277149|NCT01695239|20408741|P6|COMPLETED|Double-Blind (DB) Treatment Period||0
8277150|NCT01695239|20408742|P5|COMPLETED|Double-Blind (DB) Treatment Period||0
8277151|NCT01695239|20408743|P4|COMPLETED|Double-Blind (DB) Treatment Period||96
8277152|NCT01695239|20408744|P3|COMPLETED|Double-Blind (DB) Treatment Period||97
8277153|NCT01695239|20408745|P2|COMPLETED|Double-Blind (DB) Treatment Period||97
8277154|NCT01695239|20408746|P1|COMPLETED|Double-Blind (DB) Treatment Period||91
8277155|NCT01695239|20408733|P14|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277156|NCT01695239|20408734|P13|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277157|NCT01695239|20408735|P12|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277158|NCT01695239|20408736|P11|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277159|NCT01695239|20408737|P10|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277160|NCT01695239|20408738|P9|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277161|NCT01695239|20408739|P8|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277162|NCT01695239|20408740|P7|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277163|NCT01695239|20408741|P6|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277164|NCT01695239|20408742|P5|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
8277165|NCT01695239|20408743|P4|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10
8277166|NCT01695239|20408744|P3|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11
8277167|NCT01695239|20408745|P2|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9
8277168|NCT01695239|20408746|P1|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27
8277169|NCT01695239|20408733|P14|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277170|NCT01695239|20408734|P13|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277171|NCT01695239|20408735|P12|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277172|NCT01695239|20408736|P11|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277173|NCT01695239|20408737|P10|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277174|NCT01695239|20408738|P9|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277175|NCT01695239|20408739|P8|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277176|NCT01695239|20408740|P7|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277177|NCT01695239|20408741|P6|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277178|NCT01695239|20408742|P5|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
8277179|NCT01695239|20408743|P4|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102
8277180|NCT01695239|20408744|P3|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107
8277181|NCT01695239|20408745|P2|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101
8277182|NCT01695239|20408746|P1|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106
8277183|NCT01695239|20408733|P14|STARTED|Double-Blind (DB) Treatment Period||0
8277184|NCT01695239|20408734|P13|STARTED|Double-Blind (DB) Treatment Period||0
8277185|NCT01695239|20408735|P12|STARTED|Double-Blind (DB) Treatment Period||0
8277186|NCT01695239|20408736|P11|STARTED|Double-Blind (DB) Treatment Period||0
8277187|NCT01695239|20408737|P10|STARTED|Double-Blind (DB) Treatment Period||0
8277188|NCT01695239|20408738|P9|STARTED|Double-Blind (DB) Treatment Period||0
8277189|NCT01695239|20408739|P8|STARTED|Double-Blind (DB) Treatment Period||0
8277190|NCT01695239|20408740|P7|STARTED|Double-Blind (DB) Treatment Period||0
8277191|NCT01695239|20408741|P6|STARTED|Double-Blind (DB) Treatment Period||0
8277192|NCT01695239|20408742|P5|STARTED|Double-Blind (DB) Treatment Period||0
8277193|NCT01695239|20408743|P4|STARTED|Double-Blind (DB) Treatment Period||103
8277194|NCT01695239|20408744|P3|STARTED|Double-Blind (DB) Treatment Period||107
8277195|NCT01695239|20408745|P2|STARTED|Double-Blind (DB) Treatment Period||101
8277196|NCT01695239|20408746|P1|STARTED|Double-Blind (DB) Treatment Period||106
8277197|NCT01695135|20408887|P4|NOT COMPLETED|Open Label Extension Treatment Phase||70
8277198|NCT01695135|20408888|P3|NOT COMPLETED|Open Label Extension Treatment Phase||40
8277199|NCT01695135|20408889|P2|NOT COMPLETED|Open Label Extension Treatment Phase||0
8277200|NCT01695135|20408890|P1|NOT COMPLETED|Open Label Extension Treatment Phase||0
8277201|NCT01695135|20408887|P4|COMPLETED|Open Label Extension Treatment Phase||10
8277202|NCT01695135|20408888|P3|COMPLETED|Open Label Extension Treatment Phase||9
8277203|NCT01695135|20408889|P2|COMPLETED|Open Label Extension Treatment Phase||0
8277204|NCT01695135|20408890|P1|COMPLETED|Open Label Extension Treatment Phase||0
8277205|NCT01695135|20408887|P4|STARTED|Open Label Extension Treatment Phase||80
8277206|NCT01695135|20408888|P3|STARTED|Open Label Extension Treatment Phase||49
8277207|NCT01695135|20408889|P2|STARTED|Open Label Extension Treatment Phase||0
8277208|NCT01695135|20408890|P1|STARTED|Open Label Extension Treatment Phase||0
8277209|NCT01695135|20408887|P4|NOT COMPLETED|Double-blind Treatment Phase||0
8277210|NCT01695135|20408888|P3|NOT COMPLETED|Double-blind Treatment Phase||0
8277211|NCT01695135|20408889|P2|NOT COMPLETED|Double-blind Treatment Phase||139
8277212|NCT01695135|20408890|P1|NOT COMPLETED|Double-blind Treatment Phase||71
8277213|NCT01695135|20408887|P4|COMPLETED|Double-blind Treatment Phase||0
8277214|NCT01695135|20408888|P3|COMPLETED|Double-blind Treatment Phase||0
8277215|NCT01695135|20408889|P2|COMPLETED|Double-blind Treatment Phase||4
8277216|NCT01695135|20408890|P1|COMPLETED|Double-blind Treatment Phase||0
8277217|NCT01695135|20408887|P4|STARTED|Double-blind Treatment Phase||0
8277218|NCT01695135|20408888|P3|STARTED|Double-blind Treatment Phase||0
8277219|NCT01695135|20408889|P2|STARTED|Double-blind Treatment Phase||143
8277220|NCT01695135|20408890|P1|STARTED|Double-blind Treatment Phase||71
8277221|NCT01695044|20408914|P1|NOT COMPLETED|Overall Study||102
8277222|NCT01695044|20408914|P1|COMPLETED|Overall Study||17
8277223|NCT01695044|20408914|P1|STARTED|Overall Study||119
8277224|NCT01694966|20408927|P3|NOT COMPLETED|Overall Study||34
8277225|NCT01694966|20408928|P2|NOT COMPLETED|Overall Study||15
8277226|NCT01694966|20408929|P1|NOT COMPLETED|Overall Study||34
8277227|NCT01694966|20408927|P3|COMPLETED|Overall Study||464
8277228|NCT01694966|20408928|P2|COMPLETED|Overall Study||232
8277229|NCT01694966|20408929|P1|COMPLETED|Overall Study||470
8277230|NCT01694966|20408927|P3|STARTED|Overall Study||498
8277231|NCT01694966|20408928|P2|STARTED|Overall Study||247
8277232|NCT01694966|20408929|P1|STARTED|Overall Study||504
8277233|NCT01694771|20408939|P2|NOT COMPLETED|Overall Study||40
8277234|NCT01694771|20408940|P1|NOT COMPLETED|Overall Study||40
8277235|NCT01694771|20408939|P2|COMPLETED|Overall Study||525
8277236|NCT01694771|20408940|P1|COMPLETED|Overall Study||527
8277237|NCT01694771|20408939|P2|STARTED|Overall Study||565
8277238|NCT01694771|20408940|P1|STARTED|Overall Study||567
8277239|NCT01694706|20408964|P3|NOT COMPLETED|Overall Study||0
8277240|NCT01694706|20408965|P2|NOT COMPLETED|Overall Study||1
8277241|NCT01694706|20408966|P1|NOT COMPLETED|Overall Study||1
8277242|NCT01694706|20408964|P3|COMPLETED|Overall Study||5
8277243|NCT01694706|20408965|P2|COMPLETED|Overall Study||4
8277244|NCT01694706|20408966|P1|COMPLETED|Overall Study||4
8277245|NCT01694706|20408964|P3|Received Faldaprevir Fed|Overall Study||5
8277246|NCT01694706|20408965|P2|Received Faldaprevir Fed|Overall Study||5
8277247|NCT01694706|20408966|P1|Received Faldaprevir Fed|Overall Study||4
8277248|NCT01694706|20408964|P3|Received Faldaprevir +OMP|Overall Study||5
8277249|NCT01694706|20408965|P2|Received Faldaprevir +OMP|Overall Study||5
8277250|NCT01694706|20408966|P1|Received Faldaprevir +OMP|Overall Study||5
8277251|NCT01694706|20408964|P3|Received Faldaprevir|Overall Study||5
8277252|NCT01694706|20408965|P2|Received Faldaprevir|Overall Study||5
8277253|NCT01694706|20408966|P1|Received Faldaprevir|Overall Study||5
8277254|NCT01694706|20408964|P3|STARTED|Overall Study||5
8277255|NCT01694706|20408965|P2|STARTED|Overall Study||5
8277256|NCT01694706|20408966|P1|STARTED|Overall Study||5
8277257|NCT01694667|20408983|P2|NOT COMPLETED|Overall Study||0
8277258|NCT01694667|20408984|P1|NOT COMPLETED|Overall Study||0
8277259|NCT01694667|20408983|P2|COMPLETED|Overall Study||28
8277260|NCT01694667|20408984|P1|COMPLETED|Overall Study||29
8277261|NCT01694667|20408983|P2|STARTED|Overall Study||28
8277262|NCT01694667|20408984|P1|STARTED|Overall Study||29
8277263|NCT01694641|20409004|P2|NOT COMPLETED|Overall Study||10
8277264|NCT01694641|20409005|P1|NOT COMPLETED|Overall Study||12
8277265|NCT01694641|20409004|P2|COMPLETED|Overall Study||71
8277266|NCT01694641|20409005|P1|COMPLETED|Overall Study||68
8277267|NCT01694641|20409004|P2|STARTED|Overall Study||81
8277268|NCT01694641|20409005|P1|STARTED|Overall Study||80
8277269|NCT01694563|20409013|P1|NOT COMPLETED|Overall Study||87
8277270|NCT01694563|20409013|P1|COMPLETED|Overall Study||278
8277271|NCT01694563|20409013|P1|STARTED|Overall Study||365
8277272|NCT01694485|20409025|P5|NOT COMPLETED|Overall Study||25
8277273|NCT01694485|20409026|P4|NOT COMPLETED|Overall Study||38
8277274|NCT01694485|20409027|P3|NOT COMPLETED|Overall Study||13
8277275|NCT01694485|20409028|P2|NOT COMPLETED|Overall Study||7
8277276|NCT01694485|20409029|P1|NOT COMPLETED|Overall Study||33
8277277|NCT01694485|20409025|P5|COMPLETED|Overall Study||55
8277278|NCT01694485|20409026|P4|COMPLETED|Overall Study||62
8277279|NCT01694485|20409027|P3|COMPLETED|Overall Study||27
8277280|NCT01694485|20409028|P2|COMPLETED|Overall Study||15
8277281|NCT01694485|20409029|P1|COMPLETED|Overall Study||84
8277282|NCT01694485|20409025|P5|Entered Open-label Period|Overall Study||68
8277283|NCT01694485|20409026|P4|Entered Open-label Period|Overall Study||88
8277284|NCT01694485|20409027|P3|Entered Open-label Period|Overall Study||36
8277285|NCT01694485|20409028|P2|Entered Open-label Period|Overall Study||19
8277286|NCT01694485|20409029|P1|Entered Open-label Period|Overall Study||100
8277287|NCT01694485|20409025|P5|Completed Week 8 Assessment|Overall Study||76
8277288|NCT01694485|20409026|P4|Completed Week 8 Assessment|Overall Study||94
8277289|NCT01694485|20409027|P3|Completed Week 8 Assessment|Overall Study||38
8277290|NCT01694485|20409028|P2|Completed Week 8 Assessment|Overall Study||18
8277291|NCT01694485|20409029|P1|Completed Week 8 Assessment|Overall Study||106
8277292|NCT01694485|20409025|P5|Received Treatment|Overall Study||79
8277293|NCT01694485|20409026|P4|Received Treatment|Overall Study||98
8277294|NCT01694485|20409027|P3|Received Treatment|Overall Study||40
8277295|NCT01694485|20409028|P2|Received Treatment|Overall Study||21
8277296|NCT01694485|20409029|P1|Received Treatment|Overall Study||116
8277297|NCT01694485|20409025|P5|STARTED|Overall Study||80
8277298|NCT01694485|20409026|P4|STARTED|Overall Study||100
8277299|NCT01694485|20409027|P3|STARTED|Overall Study||40
8277300|NCT01694485|20409028|P2|STARTED|Overall Study||22
8277301|NCT01694485|20409029|P1|STARTED|Overall Study||117
8277302|NCT01694433|20409063|P2|NOT COMPLETED|Overall Study||4
8277303|NCT01694433|20409064|P1|NOT COMPLETED|Overall Study||11
8277304|NCT01694433|20409063|P2|COMPLETED|Overall Study||29
8277305|NCT01694433|20409064|P1|COMPLETED|Overall Study||22
8277306|NCT01694433|20409063|P2|Baseline Visit|Overall Study||32
8277307|NCT01694433|20409064|P1|Baseline Visit|Overall Study||33
8277308|NCT01694433|20409063|P2|STARTED|Overall Study||33
8277309|NCT01694433|20409064|P1|STARTED|Overall Study||33
8277310|NCT01694420|20409072|P1|NOT COMPLETED|Overall Study||3
8277311|NCT01694420|20409072|P1|COMPLETED|Overall Study||30
8277312|NCT01694420|20409072|P1|STARTED|Overall Study||33
8277313|NCT01694199|20409083|P2|NOT COMPLETED|Overall Study||0
8277314|NCT01694199|20409084|P1|NOT COMPLETED|Overall Study||0
8277315|NCT01694199|20409083|P2|COMPLETED|Overall Study||68
8277316|NCT01694199|20409084|P1|COMPLETED|Overall Study||71
8277317|NCT01694199|20409083|P2|STARTED|Overall Study||68
8277318|NCT01694199|20409084|P1|STARTED|Overall Study||71
8277325|NCT01694121|20409109|P2|NOT COMPLETED|Overall Study||0
8277326|NCT01694121|20409110|P1|NOT COMPLETED|Overall Study||1
8277327|NCT01694121|20409109|P2|COMPLETED|Overall Study||227
8277328|NCT01694121|20409110|P1|COMPLETED|Overall Study||227
8277329|NCT01694121|20409109|P2|STARTED|Overall Study||227
8277330|NCT01694121|20409110|P1|STARTED|Overall Study||228
8277331|NCT01694108|20409124|P2|NOT COMPLETED|Overall Study||0
8277332|NCT01694108|20409125|P1|NOT COMPLETED|Overall Study||0
8277333|NCT01694108|20409124|P2|COMPLETED|Overall Study|100% follow-up|2133
8277334|NCT01694108|20409125|P1|COMPLETED|Overall Study|100% follow-up|2129
8277335|NCT01694108|20409124|P2|STARTED|Overall Study||2133
8277336|NCT01694108|20409125|P1|STARTED|Overall Study||2129
8277337|NCT01693900|20409181|P2|NOT COMPLETED|Overall Study||0
8277338|NCT01693900|20409182|P1|NOT COMPLETED|Overall Study||0
8277339|NCT01693900|20409181|P2|COMPLETED|Overall Study||25
8277340|NCT01693900|20409182|P1|COMPLETED|Overall Study||25
8277341|NCT01693900|20409181|P2|STARTED|Overall Study||25
8277342|NCT01693900|20409182|P1|STARTED|Overall Study||25
8277343|NCT01693653|20409196|P2|NOT COMPLETED|Overall Study||0
8277344|NCT01693653|20409197|P1|NOT COMPLETED|Overall Study||0
8277345|NCT01693653|20409196|P2|COMPLETED|Overall Study||0
8277346|NCT01693653|20409197|P1|COMPLETED|Overall Study||1
8277347|NCT01693653|20409196|P2|STARTED|Overall Study||0
8277348|NCT01693653|20409197|P1|STARTED|Overall Study||1
8277349|NCT01693614|20409224|P3|NOT COMPLETED|Overall Study||24
8277350|NCT01693614|20409225|P2|NOT COMPLETED|Overall Study||22
8277351|NCT01693614|20409226|P1|NOT COMPLETED|Overall Study||26
8277352|NCT01693614|20409224|P3|COMPLETED|Overall Study||0
8277353|NCT01693614|20409225|P2|COMPLETED|Overall Study||0
8277354|NCT01693614|20409226|P1|COMPLETED|Overall Study||0
8277355|NCT01693614|20409224|P3|STARTED|Overall Study||24
8277356|NCT01693614|20409225|P2|STARTED|Overall Study||22
8277357|NCT01693614|20409226|P1|STARTED|Overall Study||26
8277358|NCT01693523|20409251|P3|NOT COMPLETED|Overall Study||8
8277359|NCT01693523|20409252|P2|NOT COMPLETED|Overall Study||8
8277360|NCT01693523|20409253|P1|NOT COMPLETED|Overall Study||5
8277361|NCT01693523|20409251|P3|COMPLETED|Overall Study||27
8277362|NCT01693523|20409252|P2|COMPLETED|Overall Study||13
8277363|NCT01693523|20409253|P1|COMPLETED|Overall Study||18
8277364|NCT01693523|20409251|P3|STARTED|Overall Study||35
8277365|NCT01693523|20409252|P2|STARTED|Overall Study||21
8277366|NCT01693523|20409253|P1|STARTED|Overall Study||23
8277367|NCT01693484|20409263|P1|NOT COMPLETED|Overall Study||13
8277368|NCT01693484|20409263|P1|COMPLETED|Overall Study|Study closed by PI|0
8277369|NCT01693484|20409263|P1|STARTED|Overall Study||13
8277370|NCT01693367|20409269|P2|NOT COMPLETED|Overall Study||2
8277371|NCT01693367|20409270|P1|NOT COMPLETED|Overall Study||1
8277372|NCT01693367|20409269|P2|COMPLETED|Overall Study||1
8277373|NCT01693367|20409270|P1|COMPLETED|Overall Study||1
8277374|NCT01693367|20409269|P2|STARTED|Overall Study||3
8277375|NCT01693367|20409270|P1|STARTED|Overall Study||2
8277376|NCT01693250|20409288|P2|NOT COMPLETED|Overall Study||2
8277377|NCT01693250|20409289|P1|NOT COMPLETED|Overall Study||2
8277378|NCT01693250|20409288|P2|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15
8277379|NCT01693250|20409289|P1|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21
8277380|NCT01693250|20409288|P2|STARTED|Overall Study|three month post baseline assessment|17
8277381|NCT01693250|20409289|P1|STARTED|Overall Study|3 months post baseline assessment|23
8277382|NCT01693185|20409299|P2|NOT COMPLETED|Overall Study||6
8277383|NCT01693185|20409300|P1|NOT COMPLETED|Overall Study||0
8277384|NCT01693185|20409299|P2|COMPLETED|Overall Study||27
8277385|NCT01693185|20409300|P1|COMPLETED|Overall Study||27
8277386|NCT01693185|20409299|P2|STARTED|Overall Study||33
8277387|NCT01693185|20409300|P1|STARTED|Overall Study||27
8277388|NCT01693120|20409316|P1|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
8277389|NCT01693120|20409316|P1|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
8277390|NCT01693120|20409316|P1|STARTED|Phased RF Study Procedure and Follow-up||129
8277391|NCT01693120|20409316|P1|NOT COMPLETED|Enrollment||70
8277392|NCT01693120|20409316|P1|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
8277393|NCT01693120|20409316|P1|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
8277394|NCT01693068|20409325|P3|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
8277395|NCT01693068|20409326|P2|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
8277396|NCT01693068|20409327|P1|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
8277397|NCT01693068|20409325|P3|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
8277398|NCT01693068|20409326|P2|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
8277399|NCT01693068|20409327|P1|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
8277400|NCT01693068|20409325|P3|Treated|Cross-over (Dacarbazine To Pimasertib)||41
8277401|NCT01693068|20409326|P2|Treated|Cross-over (Dacarbazine To Pimasertib)||0
8277402|NCT01693068|20409327|P1|Treated|Cross-over (Dacarbazine To Pimasertib)||0
8277403|NCT01693068|20409325|P3|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
8277404|NCT01693068|20409326|P2|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
8277405|NCT01693068|20409327|P1|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
8277406|NCT01693068|20409325|P3|NOT COMPLETED|Randomization Period||0
8277407|NCT01693068|20409326|P2|NOT COMPLETED|Randomization Period||5
8277408|NCT01693068|20409327|P1|NOT COMPLETED|Randomization Period||2
8277409|NCT01693068|20409325|P3|COMPLETED|Randomization Period||0
8277410|NCT01693068|20409326|P2|COMPLETED|Randomization Period||125
8277411|NCT01693068|20409327|P1|COMPLETED|Randomization Period||62
8277412|NCT01693068|20409325|P3|Treated|Randomization Period||0
8277413|NCT01693068|20409326|P2|Treated|Randomization Period||130
8277414|NCT01693068|20409327|P1|Treated|Randomization Period||61
8277415|NCT01693068|20409325|P3|STARTED|Randomization Period||0
8277416|NCT01693068|20409326|P2|STARTED|Randomization Period||130
8277417|NCT01693068|20409327|P1|STARTED|Randomization Period||64
8277418|NCT01693029|20409359|P2|NOT COMPLETED|Overall Study||57
8277419|NCT01693029|20409360|P1|NOT COMPLETED|Overall Study||44
8277420|NCT01693029|20409359|P2|COMPLETED|Overall Study||161
8277421|NCT01693029|20409360|P1|COMPLETED|Overall Study||173
8277422|NCT01693029|20409359|P2|STARTED|Overall Study||218
8277423|NCT01693029|20409360|P1|STARTED|Overall Study||217
8277424|NCT01692964|20409372|P1|NOT COMPLETED|Overall Study||0
8277425|NCT01692964|20409372|P1|COMPLETED|Overall Study||237
8277426|NCT01692964|20409372|P1|STARTED|Overall Study||237
8277427|NCT01692951|20409381|P4|NOT COMPLETED|Overall Study||0
8277428|NCT01692951|20409382|P3|NOT COMPLETED|Overall Study||0
8277429|NCT01692951|20409383|P2|NOT COMPLETED|Overall Study||0
8277430|NCT01692951|20409384|P1|NOT COMPLETED|Overall Study||0
8277431|NCT01692951|20409381|P4|COMPLETED|Overall Study||54
8277432|NCT01692951|20409382|P3|COMPLETED|Overall Study||18
8277433|NCT01692951|20409383|P2|COMPLETED|Overall Study||111
8277434|NCT01692951|20409384|P1|COMPLETED|Overall Study||37
8277435|NCT01692951|20409381|P4|STARTED|Overall Study||54
8277436|NCT01692951|20409382|P3|STARTED|Overall Study||18
8277437|NCT01692951|20409383|P2|STARTED|Overall Study||111
8277438|NCT01692951|20409384|P1|STARTED|Overall Study||37
8277439|NCT01692938|20409396|P2|NOT COMPLETED|Overall Study||4
8277440|NCT01692938|20409397|P1|NOT COMPLETED|Overall Study||4
8277441|NCT01692938|20409396|P2|COMPLETED|Overall Study||12
8277442|NCT01692938|20409397|P1|COMPLETED|Overall Study||12
8277443|NCT01692938|20409396|P2|STARTED|Overall Study||16
8277444|NCT01692938|20409397|P1|STARTED|Overall Study||16
8277445|NCT01692782|20409408|P3|NOT COMPLETED|Overall Study||10
8277446|NCT01692782|20409409|P2|NOT COMPLETED|Overall Study||56
8277447|NCT01692782|20409410|P1|NOT COMPLETED|Overall Study||20
8277448|NCT01692782|20409408|P3|COMPLETED|Overall Study||100
8277449|NCT01692782|20409409|P2|COMPLETED|Overall Study||59
8277450|NCT01692782|20409410|P1|COMPLETED|Overall Study||96
8277451|NCT01692782|20409408|P3|STARTED|Overall Study||110
8277452|NCT01692782|20409409|P2|STARTED|Overall Study||115
8277453|NCT01692782|20409410|P1|STARTED|Overall Study||116
8277454|NCT01692756|20409437|P4|NOT COMPLETED|Overall Study||0
8277455|NCT01692756|20409438|P3|NOT COMPLETED|Overall Study||2
8277456|NCT01692756|20409439|P2|NOT COMPLETED|Overall Study||1
8277457|NCT01692756|20409440|P1|NOT COMPLETED|Overall Study||1
8277458|NCT01692756|20409437|P4|COMPLETED|Overall Study||12
8277459|NCT01692756|20409438|P3|COMPLETED|Overall Study||11
8277460|NCT01692756|20409439|P2|COMPLETED|Overall Study||11
8277461|NCT01692756|20409440|P1|COMPLETED|Overall Study||11
8277462|NCT01692756|20409437|P4|STARTED|Overall Study||12
8277463|NCT01692756|20409438|P3|STARTED|Overall Study||13
8277464|NCT01692756|20409439|P2|STARTED|Overall Study||12
8277465|NCT01692756|20409440|P1|STARTED|Overall Study||12
8277466|NCT01692743|20409501|P3|NOT COMPLETED|Overall Study||27
8277467|NCT01692743|20409502|P2|NOT COMPLETED|Overall Study||35
8277468|NCT01692743|20409503|P1|NOT COMPLETED|Overall Study||27
8277469|NCT01692743|20409501|P3|COMPLETED|Overall Study||88
8277470|NCT01692743|20409502|P2|COMPLETED|Overall Study||81
8277471|NCT01692743|20409503|P1|COMPLETED|Overall Study||90
8277472|NCT01692743|20409501|P3|STARTED|Overall Study||115
8277473|NCT01692743|20409502|P2|STARTED|Overall Study||116
8277474|NCT01692743|20409503|P1|STARTED|Overall Study||117
8277475|NCT01692730|20409519|P2|NOT COMPLETED|Overall Study||227
8277476|NCT01692730|20409520|P1|NOT COMPLETED|Overall Study||225
8277477|NCT01692730|20409519|P2|COMPLETED|Overall Study||502
8277478|NCT01692730|20409520|P1|COMPLETED|Overall Study||498
8277479|NCT01692730|20409519|P2|STARTED|Overall Study||729
8277480|NCT01692730|20409520|P1|STARTED|Overall Study||723
8277481|NCT01692691|20409528|P1|NOT COMPLETED|Overall Study||0
8277482|NCT01692691|20409528|P1|COMPLETED|Overall Study||1
8277483|NCT01692691|20409528|P1|STARTED|Overall Study||1
8277484|NCT01692626|20409534|P2|NOT COMPLETED|Overall Study||6
8277485|NCT01692626|20409535|P1|NOT COMPLETED|Overall Study||4
8277486|NCT01692626|20409534|P2|COMPLETED|Overall Study||1
8277487|NCT01692626|20409535|P1|COMPLETED|Overall Study||2
8277488|NCT01692626|20409534|P2|STARTED|Overall Study||7
8277489|NCT01692626|20409535|P1|STARTED|Overall Study||6
8277490|NCT01692496|20409540|P1|NOT COMPLETED|Overall Study||0
8277491|NCT01692496|20409540|P1|COMPLETED|Overall Study||52
8277492|NCT01692496|20409540|P1|3 Weeks Pazopanib (Per Protocol PP)|Overall Study||50
8277493|NCT01692496|20409540|P1|STARTED|Overall Study||52
8277494|NCT01692340|20409553|P3|NOT COMPLETED|Overall Study||0
8277495|NCT01692340|20409554|P2|NOT COMPLETED|Overall Study||0
8277496|NCT01692340|20409555|P1|NOT COMPLETED|Overall Study||0
8277497|NCT01692340|20409553|P3|COMPLETED|Overall Study||0
8277498|NCT01692340|20409554|P2|COMPLETED|Overall Study||4
8277499|NCT01692340|20409555|P1|COMPLETED|Overall Study||8
8277500|NCT01692340|20409553|P3|STARTED|Overall Study||0
8277501|NCT01692340|20409554|P2|STARTED|Overall Study||4
8277502|NCT01692340|20409555|P1|STARTED|Overall Study||8
8277503|NCT01692301|20409570|P2|NOT COMPLETED|Overall Study||42
8277504|NCT01692301|20409571|P1|NOT COMPLETED|Overall Study||45
8277505|NCT01692301|20409570|P2|COMPLETED|Overall Study||183
8277506|NCT01692301|20409571|P1|COMPLETED|Overall Study||184
8277507|NCT01692301|20409570|P2|STARTED|Overall Study||225
8277508|NCT01692301|20409571|P1|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
8277509|NCT01692275|20409603|P2|NOT COMPLETED|Overall Study||59
8277510|NCT01692275|20409604|P1|NOT COMPLETED|Overall Study||66
8277511|NCT01692275|20409603|P2|COMPLETED|Overall Study||316
8277512|NCT01692275|20409604|P1|COMPLETED|Overall Study||309
8277513|NCT01692275|20409603|P2|STARTED|Overall Study||375
8277514|NCT01692275|20409604|P1|STARTED|Overall Study||375
8277515|NCT01692197|20409664|P1|NOT COMPLETED|Overall Study||3
8277516|NCT01692197|20409664|P1|COMPLETED|Overall Study||40
8277517|NCT01692197|20409664|P1|STARTED|Overall Study||43
8277518|NCT01691950|20409673|P2|NOT COMPLETED|Overall Study||0
8277519|NCT01691950|20409674|P1|NOT COMPLETED|Overall Study||10
8277520|NCT01691950|20409673|P2|COMPLETED|Overall Study||10
8277521|NCT01691950|20409674|P1|COMPLETED|Overall Study||10
8277522|NCT01691950|20409673|P2|STARTED|Overall Study||10
8277523|NCT01691950|20409674|P1|STARTED|Overall Study||20
8277524|NCT01691898|20409686|P6|NOT COMPLETED|Overall Study||35
8277525|NCT01691898|20409687|P5|NOT COMPLETED|Overall Study||14
8277526|NCT01691898|20409688|P4|NOT COMPLETED|Overall Study||5
8277527|NCT01691898|20409689|P3|NOT COMPLETED|Overall Study||9
8277528|NCT01691898|20409690|P2|NOT COMPLETED|Overall Study||44
8277529|NCT01691898|20409691|P1|NOT COMPLETED|Overall Study||47
8277530|NCT01691898|20409686|P6|COMPLETED|Overall Study||5
8277531|NCT01691898|20409687|P5|COMPLETED|Overall Study||26
8277532|NCT01691898|20409688|P4|COMPLETED|Overall Study||4
8277533|NCT01691898|20409689|P3|COMPLETED|Overall Study||11
8277534|NCT01691898|20409690|P2|COMPLETED|Overall Study||15
8277535|NCT01691898|20409691|P1|COMPLETED|Overall Study||16
8277536|NCT01691898|20409686|P6|STARTED|Overall Study||40
8277537|NCT01691898|20409687|P5|STARTED|Overall Study||40
8277538|NCT01691898|20409688|P4|STARTED|Overall Study||9
8277539|NCT01691898|20409689|P3|STARTED|Overall Study||20
8277540|NCT01691898|20409690|P2|STARTED|Overall Study||59
8277541|NCT01691898|20409691|P1|STARTED|Overall Study||63
8277542|NCT01691885|20409845|P2|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
8277543|NCT01691885|20409846|P1|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
8277544|NCT01691885|20409845|P2|COMPLETED|Treatment Period 2 (7-14 Days)||21
8277545|NCT01691885|20409846|P1|COMPLETED|Treatment Period 2 (7-14 Days)||21
8277546|NCT01691885|20409845|P2|STARTED|Treatment Period 2 (7-14 Days)||21
8277547|NCT01691885|20409846|P1|STARTED|Treatment Period 2 (7-14 Days)||21
8277548|NCT01691885|20409845|P2|NOT COMPLETED|Washout Period (7-9 Days)||1
8277549|NCT01691885|20409846|P1|NOT COMPLETED|Washout Period (7-9 Days)||0
8277550|NCT01691885|20409845|P2|COMPLETED|Washout Period (7-9 Days)||21
8277551|NCT01691885|20409846|P1|COMPLETED|Washout Period (7-9 Days)||21
8277552|NCT01691885|20409845|P2|STARTED|Washout Period (7-9 Days)||22
8277553|NCT01691885|20409846|P1|STARTED|Washout Period (7-9 Days)||21
8277554|NCT01691885|20409845|P2|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
8277555|NCT01691885|20409846|P1|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
8277556|NCT01691885|20409845|P2|COMPLETED|Treatment Period 1(7-14 Days)||22
8277557|NCT01691885|20409846|P1|COMPLETED|Treatment Period 1(7-14 Days)||21
8277558|NCT01691885|20409845|P2|STARTED|Treatment Period 1(7-14 Days)||23
8277559|NCT01691885|20409846|P1|STARTED|Treatment Period 1(7-14 Days)||22
8277560|NCT01691859|20409852|P1|NOT COMPLETED|Overall Study||347
8277561|NCT01691859|20409852|P1|COMPLETED|Overall Study||0
8277562|NCT01691859|20409852|P1|STARTED|Overall Study||347
8277563|NCT01691833|20409874|P3|NOT COMPLETED|Overall Study||0
8277564|NCT01691833|20409875|P2|NOT COMPLETED|Overall Study||1
8277565|NCT01691833|20409876|P1|NOT COMPLETED|Overall Study||1
8277566|NCT01691833|20409874|P3|COMPLETED|Overall Study||13
8277567|NCT01691833|20409875|P2|COMPLETED|Overall Study||49
8277568|NCT01691833|20409876|P1|COMPLETED|Overall Study||49
8277569|NCT01691833|20409874|P3|STARTED|Overall Study||13
8277570|NCT01691833|20409875|P2|STARTED|Overall Study||50
8277571|NCT01691833|20409876|P1|STARTED|Overall Study||50
8277581|NCT01691794|20409939|P3|NOT COMPLETED|Overall Study||10
8277582|NCT01691794|20409940|P2|NOT COMPLETED|Overall Study||18
8277583|NCT01691794|20409941|P1|NOT COMPLETED|Overall Study||1
8277584|NCT01691794|20409939|P3|COMPLETED|Overall Study|Completed baseline to End of Study|13
8277585|NCT01691794|20409940|P2|COMPLETED|Overall Study|Completed baseline to End of Study|15
8277586|NCT01691794|20409941|P1|COMPLETED|Overall Study|Completed baseline to End of Study|2
8277587|NCT01691794|20409939|P3|STARTED|Overall Study||23
8277588|NCT01691794|20409940|P2|STARTED|Overall Study||33
8277589|NCT01691794|20409941|P1|STARTED|Overall Study||3
8277590|NCT01691781|20409957|P2|NOT COMPLETED|Overall Study||7
8277591|NCT01691781|20409958|P1|NOT COMPLETED|Overall Study||7
8277592|NCT01691781|20409957|P2|COMPLETED|Overall Study||15
8277593|NCT01691781|20409958|P1|COMPLETED|Overall Study||12
8277594|NCT01691781|20409957|P2|STARTED|Overall Study||22
8277595|NCT01691781|20409958|P1|STARTED|Overall Study||19
8277596|NCT01691768|20409970|P2|NOT COMPLETED|Overall Study||16
8277597|NCT01691768|20409971|P1|NOT COMPLETED|Overall Study||15
8277598|NCT01691768|20409970|P2|COMPLETED|Overall Study||167
8277599|NCT01691768|20409971|P1|COMPLETED|Overall Study||174
8277600|NCT01691768|20409970|P2|STARTED|Overall Study||183
8277601|NCT01691768|20409971|P1|STARTED|Overall Study||189
8277602|NCT01691690|20409995|P2|NOT COMPLETED|Overall Study||4
8277603|NCT01691690|20409996|P1|NOT COMPLETED|Overall Study||7
8277604|NCT01691690|20409995|P2|COMPLETED|Overall Study||121
8277605|NCT01691690|20409996|P1|COMPLETED|Overall Study||118
8277606|NCT01691690|20409995|P2|STARTED|Overall Study||125
8277607|NCT01691690|20409996|P1|STARTED|Overall Study||125
8277608|NCT01691612|20410006|P1|NOT COMPLETED|Overall Study||7
8277609|NCT01691612|20410006|P1|COMPLETED|Overall Study||7
8277610|NCT01691612|20410006|P1|Second Visit (Bronchoscopy)|Overall Study||7
8277611|NCT01691612|20410006|P1|First Visit (Allergen Challenge)|Overall Study||8
8277612|NCT01691612|20410006|P1|STARTED|Overall Study||14
8277613|NCT01691560|20410017|P4|NOT COMPLETED|Overall Study||0
8277614|NCT01691560|20410018|P3|NOT COMPLETED|Overall Study||0
8277615|NCT01691560|20410019|P2|NOT COMPLETED|Overall Study||0
8277616|NCT01691560|20410020|P1|NOT COMPLETED|Overall Study||0
8277617|NCT01691560|20410017|P4|COMPLETED|Overall Study||33
8277618|NCT01691560|20410018|P3|COMPLETED|Overall Study||34
8277619|NCT01691560|20410019|P2|COMPLETED|Overall Study||33
8277620|NCT01691560|20410020|P1|COMPLETED|Overall Study||34
8277621|NCT01691560|20410017|P4|STARTED|Overall Study||33
8277622|NCT01691560|20410018|P3|STARTED|Overall Study||34
8277623|NCT01691560|20410019|P2|STARTED|Overall Study||33
8277624|NCT01691560|20410020|P1|STARTED|Overall Study||34
8277625|NCT01691534|20410057|P7|NOT COMPLETED|Overall Study||1
8277626|NCT01691534|20410058|P6|NOT COMPLETED|Overall Study||1
8277627|NCT01691534|20410059|P5|NOT COMPLETED|Overall Study||0
8277628|NCT01691534|20410060|P4|NOT COMPLETED|Overall Study||1
8277629|NCT01691534|20410061|P3|NOT COMPLETED|Overall Study||1
8277630|NCT01691534|20410062|P2|NOT COMPLETED|Overall Study||1
8277631|NCT01691534|20410063|P1|NOT COMPLETED|Overall Study||0
8277632|NCT01691534|20410057|P7|COMPLETED|Overall Study||14
8277633|NCT01691534|20410058|P6|COMPLETED|Overall Study||14
8277634|NCT01691534|20410059|P5|COMPLETED|Overall Study||15
8277635|NCT01691534|20410060|P4|COMPLETED|Overall Study||14
8277636|NCT01691534|20410061|P3|COMPLETED|Overall Study||14
8277637|NCT01691534|20410062|P2|COMPLETED|Overall Study||14
8277638|NCT01691534|20410063|P1|COMPLETED|Overall Study||15
8277639|NCT01691534|20410057|P7|STARTED|Overall Study||15
8277640|NCT01691534|20410058|P6|STARTED|Overall Study||15
8277641|NCT01691534|20410059|P5|STARTED|Overall Study||15
8277642|NCT01691534|20410060|P4|STARTED|Overall Study||15
8277643|NCT01691534|20410061|P3|STARTED|Overall Study||15
8277644|NCT01691534|20410062|P2|STARTED|Overall Study||15
8277645|NCT01691534|20410063|P1|STARTED|Overall Study||15
8277646|NCT01691521|20410117|P3|NOT COMPLETED|Overall Study||9
8277647|NCT01691521|20410118|P2|NOT COMPLETED|Overall Study||16
8277648|NCT01691521|20410119|P1|NOT COMPLETED|Overall Study||12
8277649|NCT01691521|20410117|P3|COMPLETED|Overall Study||185
8277650|NCT01691521|20410118|P2|COMPLETED|Overall Study||175
8277651|NCT01691521|20410119|P1|COMPLETED|Overall Study||179
8277652|NCT01691521|20410117|P3|STARTED|Overall Study||194
8277653|NCT01691521|20410118|P2|STARTED|Overall Study||191
8277654|NCT01691521|20410119|P1|STARTED|Overall Study||191
8277655|NCT01691508|20410141|P2|NOT COMPLETED|Overall Study||3
8277656|NCT01691508|20410142|P1|NOT COMPLETED|Overall Study||4
8277657|NCT01691508|20410141|P2|COMPLETED|Overall Study||66
8277658|NCT01691508|20410142|P1|COMPLETED|Overall Study||62
8277659|NCT01691508|20410141|P2|STARTED|Overall Study||69
8277660|NCT01691508|20410142|P1|STARTED|Overall Study||66
8277661|NCT01691482|20410156|P2|NOT COMPLETED|Treatment Period 2||2
8277662|NCT01691482|20410157|P1|NOT COMPLETED|Treatment Period 2||1
8277663|NCT01691482|20410156|P2|COMPLETED|Treatment Period 2||26
8277664|NCT01691482|20410157|P1|COMPLETED|Treatment Period 2||27
8277665|NCT01691482|20410156|P2|STARTED|Treatment Period 2||28
8277666|NCT01691482|20410157|P1|STARTED|Treatment Period 2||28
8277667|NCT01691482|20410156|P2|NOT COMPLETED|Treatment Period 1||0
8277668|NCT01691482|20410157|P1|NOT COMPLETED|Treatment Period 1||0
8277669|NCT01691482|20410156|P2|COMPLETED|Treatment Period 1||28
8277670|NCT01691482|20410157|P1|COMPLETED|Treatment Period 1||28
8277671|NCT01691482|20410156|P2|STARTED|Treatment Period 1||28
8277672|NCT01691482|20410157|P1|STARTED|Treatment Period 1||28
8277673|NCT01691430|20410175|P2|NOT COMPLETED|Overall Study||20
8277674|NCT01691430|20410176|P1|NOT COMPLETED|Overall Study||22
8277675|NCT01691430|20410175|P2|COMPLETED|Overall Study||73
8277676|NCT01691430|20410176|P1|COMPLETED|Overall Study||70
8277677|NCT01691430|20410175|P2|Received Medication|Overall Study||93
8277678|NCT01691430|20410176|P1|Received Medication|Overall Study||92
8277679|NCT01691430|20410175|P2|STARTED|Overall Study||93
8277680|NCT01691430|20410176|P1|STARTED|Overall Study||92
8277681|NCT01691378|20410202|P2|NOT COMPLETED|Overall Study||2
8277682|NCT01691378|20410203|P1|NOT COMPLETED|Overall Study||7
8277683|NCT01691378|20410202|P2|COMPLETED|Overall Study||20
8277684|NCT01691378|20410203|P1|COMPLETED|Overall Study||15
8277685|NCT01691378|20410202|P2|STARTED|Overall Study||22
8277686|NCT01691378|20410203|P1|STARTED|Overall Study||22
8277687|NCT01691339|20410217|P4|NOT COMPLETED|Overall Study||0
8277688|NCT01691339|20410218|P3|NOT COMPLETED|Overall Study||0
8277689|NCT01691339|20410219|P2|NOT COMPLETED|Overall Study||0
8277690|NCT01691339|20410220|P1|NOT COMPLETED|Overall Study||0
8277691|NCT01691339|20410217|P4|COMPLETED|Overall Study||49
8277692|NCT01691339|20410218|P3|COMPLETED|Overall Study||51
8277693|NCT01691339|20410219|P2|COMPLETED|Overall Study||50
8277694|NCT01691339|20410220|P1|COMPLETED|Overall Study||50
8277695|NCT01691339|20410217|P4|STARTED|Overall Study||49
8277696|NCT01691339|20410218|P3|STARTED|Overall Study||51
8277697|NCT01691339|20410219|P2|STARTED|Overall Study||50
8277698|NCT01691339|20410220|P1|STARTED|Overall Study||50
8277699|NCT01691326|20410248|P2|NOT COMPLETED|Overall Study||0
8277700|NCT01691326|20410249|P1|NOT COMPLETED|Overall Study||0
8277701|NCT01691326|20410248|P2|COMPLETED|Overall Study||30
8277702|NCT01691326|20410249|P1|COMPLETED|Overall Study||30
8277703|NCT01691326|20410248|P2|STARTED|Overall Study||30
8277704|NCT01691326|20410249|P1|STARTED|Overall Study||30
8277705|NCT01691313|20410267|P4|NOT COMPLETED|Overall Study||0
8277706|NCT01691313|20410268|P3|NOT COMPLETED|Overall Study||0
8277707|NCT01691313|20410269|P2|NOT COMPLETED|Overall Study||0
8277708|NCT01691313|20410270|P1|NOT COMPLETED|Overall Study||0
8277709|NCT01691313|20410267|P4|COMPLETED|Overall Study||25
8277710|NCT01691313|20410268|P3|COMPLETED|Overall Study||25
8277711|NCT01691313|20410269|P2|COMPLETED|Overall Study||32
8277712|NCT01691313|20410270|P1|COMPLETED|Overall Study||22
8277713|NCT01691313|20410267|P4|STARTED|Overall Study||25
8277714|NCT01691313|20410268|P3|STARTED|Overall Study||25
8277715|NCT01691313|20410269|P2|STARTED|Overall Study||32
8277716|NCT01691313|20410270|P1|STARTED|Overall Study||22
8277717|NCT01691248|20410286|P2|NOT COMPLETED|Overall Study||114
8277718|NCT01691248|20410287|P1|NOT COMPLETED|Overall Study||111
8277719|NCT01691248|20410286|P2|COMPLETED|Overall Study||192
8277720|NCT01691248|20410287|P1|COMPLETED|Overall Study||194
8277721|NCT01691248|20410286|P2|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
8277722|NCT01691248|20410287|P1|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
8277723|NCT01691248|20410286|P2|Treated|Overall Study|Received at least 1 dose of study drug|299
8277724|NCT01691248|20410287|P1|Treated|Overall Study|Received at least 1 dose of study drug|301
8277725|NCT01691248|20410286|P2|STARTED|Overall Study|Randomized|306
8277726|NCT01691248|20410287|P1|STARTED|Overall Study|Randomized|305
8277727|NCT01691105|20410299|P2|NOT COMPLETED|12 Month Biochemical Verification||502
8277728|NCT01691105|20410300|P1|NOT COMPLETED|12 Month Biochemical Verification||424
8277729|NCT01691105|20410299|P2|COMPLETED|12 Month Biochemical Verification||65
8277730|NCT01691105|20410300|P1|COMPLETED|12 Month Biochemical Verification||53
8277731|NCT01691105|20410299|P2|STARTED|12 Month Biochemical Verification||567
8277732|NCT01691105|20410300|P1|STARTED|12 Month Biochemical Verification||477
8277733|NCT01691105|20410299|P2|NOT COMPLETED|12 Month Follow-up||101
8277734|NCT01691105|20410300|P1|NOT COMPLETED|12 Month Follow-up||72
8277735|NCT01691105|20410299|P2|COMPLETED|12 Month Follow-up||466
8277736|NCT01691105|20410300|P1|COMPLETED|12 Month Follow-up||405
8277737|NCT01691105|20410299|P2|STARTED|12 Month Follow-up||567
8277738|NCT01691105|20410300|P1|STARTED|12 Month Follow-up||477
8277739|NCT01691105|20410299|P2|NOT COMPLETED|6 Month Follow-up||71
8277740|NCT01691105|20410300|P1|NOT COMPLETED|6 Month Follow-up||52
8277741|NCT01691105|20410299|P2|COMPLETED|6 Month Follow-up||496
8277742|NCT01691105|20410300|P1|COMPLETED|6 Month Follow-up||425
8277743|NCT01691105|20410299|P2|STARTED|6 Month Follow-up||567
8277744|NCT01691105|20410300|P1|STARTED|6 Month Follow-up||477
8277745|NCT01691105|20410299|P2|NOT COMPLETED|1 Month Follow-up||41
8277746|NCT01691105|20410300|P1|NOT COMPLETED|1 Month Follow-up||43
8277747|NCT01691105|20410299|P2|COMPLETED|1 Month Follow-up||526
8277748|NCT01691105|20410300|P1|COMPLETED|1 Month Follow-up||434
8277749|NCT01691105|20410299|P2|STARTED|1 Month Follow-up||567
8277750|NCT01691105|20410300|P1|STARTED|1 Month Follow-up||477
8277751|NCT01691105|20410299|P2|NOT COMPLETED|Baseline||0
8277752|NCT01691105|20410300|P1|NOT COMPLETED|Baseline||0
8277753|NCT01691105|20410299|P2|COMPLETED|Baseline||567
8277754|NCT01691105|20410300|P1|COMPLETED|Baseline||477
8277755|NCT01691105|20410299|P2|STARTED|Baseline||567
8277756|NCT01691105|20410300|P1|STARTED|Baseline||477
8277757|NCT01691092|20410320|P1|NOT COMPLETED|Overall Study||41
8277758|NCT01691092|20410320|P1|COMPLETED|Overall Study||38
8277759|NCT01691092|20410320|P1|STARTED|Overall Study||79
8277760|NCT01691079|20410326|P2|NOT COMPLETED|Overall Study||0
8277761|NCT01691079|20410327|P1|NOT COMPLETED|Overall Study||0
8277762|NCT01691079|20410326|P2|COMPLETED|Overall Study||0
8277763|NCT01691079|20410327|P1|COMPLETED|Overall Study||0
8277764|NCT01691079|20410326|P2|STARTED|Overall Study||0
8277765|NCT01691079|20410327|P1|STARTED|Overall Study||0
8277766|NCT01691027|20410335|P1|NOT COMPLETED|Video Games Training||0
8277767|NCT01691027|20410335|P1|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
8277768|NCT01691027|20410335|P1|STARTED|Video Games Training|Four subjects started video game training module|4
8277769|NCT01691027|20410335|P1|NOT COMPLETED|Line and Circle Tracing Training||0
8277770|NCT01691027|20410335|P1|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
8277771|NCT01691027|20410335|P1|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
8277772|NCT01691027|20410335|P1|NOT COMPLETED|Scotoma Awareness||0
8277773|NCT01691027|20410335|P1|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
8277774|NCT01691027|20410335|P1|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
8277775|NCT01691014|20410344|P4|NOT COMPLETED|Overall Study||5
8277776|NCT01691014|20410345|P3|NOT COMPLETED|Overall Study||11
8277777|NCT01691014|20410346|P2|NOT COMPLETED|Overall Study||15
8277778|NCT01691014|20410347|P1|NOT COMPLETED|Overall Study||3
8277779|NCT01691014|20410344|P4|COMPLETED|Overall Study||4
8277780|NCT01691014|20410345|P3|COMPLETED|Overall Study||25
8277781|NCT01691014|20410346|P2|COMPLETED|Overall Study||11
8277782|NCT01691014|20410347|P1|COMPLETED|Overall Study||5
8277783|NCT01691014|20410344|P4|STARTED|Overall Study||9
8277784|NCT01691014|20410345|P3|STARTED|Overall Study||36
8277785|NCT01691014|20410346|P2|STARTED|Overall Study||26
8277786|NCT01691014|20410347|P1|STARTED|Overall Study||8
8277787|NCT01690988|20410392|P3|NOT COMPLETED|Overall Study||7
8277788|NCT01690988|20410393|P2|NOT COMPLETED|Overall Study||5
8277789|NCT01690988|20410394|P1|NOT COMPLETED|Overall Study||6
8277790|NCT01690988|20410392|P3|COMPLETED|Overall Study||216
8277791|NCT01690988|20410393|P2|COMPLETED|Overall Study||217
8277792|NCT01690988|20410394|P1|COMPLETED|Overall Study||221
8277793|NCT01690988|20410392|P3|STARTED|Overall Study||223
8277794|NCT01690988|20410393|P2|STARTED|Overall Study||222
8277795|NCT01690988|20410394|P1|STARTED|Overall Study||227
8277796|NCT01690923|20410419|P2|NOT COMPLETED|Overall Study||1
8277797|NCT01690923|20410420|P1|NOT COMPLETED|Overall Study||0
8277798|NCT01690923|20410419|P2|COMPLETED|Overall Study||10
8277799|NCT01690923|20410420|P1|COMPLETED|Overall Study||10
8277800|NCT01690923|20410419|P2|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
8277801|NCT01690923|20410420|P1|STARTED|Overall Study||10
8277802|NCT01690663|20410429|P4|NOT COMPLETED|Overall Study||4
8277803|NCT01690663|20410430|P3|NOT COMPLETED|Overall Study||3
8277804|NCT01690663|20410431|P2|NOT COMPLETED|Overall Study||3
8277805|NCT01690663|20410432|P1|NOT COMPLETED|Overall Study||3
8277806|NCT01690663|20410429|P4|COMPLETED|Overall Study||20
8277807|NCT01690663|20410430|P3|COMPLETED|Overall Study||19
8277808|NCT01690663|20410431|P2|COMPLETED|Overall Study||17
8277809|NCT01690663|20410432|P1|COMPLETED|Overall Study||20
8277810|NCT01690663|20410429|P4|STARTED|Overall Study||24
8277811|NCT01690663|20410430|P3|STARTED|Overall Study||22
8277812|NCT01690663|20410431|P2|STARTED|Overall Study||20
8277813|NCT01690663|20410432|P1|STARTED|Overall Study||23
8277814|NCT01690546|20410446|P1|NOT COMPLETED|Overall Study||9
8277815|NCT01690546|20410446|P1|COMPLETED|Overall Study||26
8277816|NCT01690546|20410446|P1|Extended Release Injectable NTX|Overall Study||27
8277817|NCT01690546|20410446|P1|STARTED|Overall Study||35
8277818|NCT01690299|20410462|P6|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
8277819|NCT01690299|20410463|P5|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
8277820|NCT01690299|20410464|P4|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
8277821|NCT01690299|20410465|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8277822|NCT01690299|20410466|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8277823|NCT01690299|20410467|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8277824|NCT01690299|20410462|P6|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
8277825|NCT01690299|20410463|P5|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
8277826|NCT01690299|20410464|P4|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
8277827|NCT01690299|20410465|P3|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8277828|NCT01690299|20410466|P2|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8277829|NCT01690299|20410467|P1|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
8277830|NCT01690299|20410462|P6|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
8277831|NCT01690299|20410463|P5|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
8277832|NCT01690299|20410464|P4|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
8277833|NCT01690299|20410465|P3|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
8277834|NCT01690299|20410466|P2|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
8277835|NCT01690299|20410467|P1|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
8277836|NCT01690299|20410462|P6|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
8277837|NCT01690299|20410463|P5|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
8277838|NCT01690299|20410464|P4|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
8277839|NCT01690299|20410465|P3|STARTED|Apremilast Extension Phase (Weeks16-104)||0
8277840|NCT01690299|20410466|P2|STARTED|Apremilast Extension Phase (Weeks16-104)||0
8277841|NCT01690299|20410467|P1|STARTED|Apremilast Extension Phase (Weeks16-104)||0
8277842|NCT01690299|20410462|P6|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8277843|NCT01690299|20410463|P5|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8277844|NCT01690299|20410464|P4|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8277845|NCT01690299|20410465|P3|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
8277846|NCT01690299|20410466|P2|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
8277847|NCT01690299|20410467|P1|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
8277848|NCT01690299|20410462|P6|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8277849|NCT01690299|20410463|P5|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8277850|NCT01690299|20410464|P4|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
8277851|NCT01690299|20410465|P3|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
8277852|NCT01690299|20410466|P2|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
8277853|NCT01690299|20410467|P1|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
8277854|NCT01690299|20410462|P6|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
8277855|NCT01690299|20410463|P5|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
8277856|NCT01690299|20410464|P4|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
8277857|NCT01690299|20410465|P3|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
8277858|NCT01690299|20410466|P2|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
8277859|NCT01690299|20410467|P1|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
8277860|NCT01690299|20410462|P6|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
8277861|NCT01690299|20410463|P5|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
8277862|NCT01690299|20410464|P4|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
8277863|NCT01690299|20410465|P3|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
8277864|NCT01690299|20410466|P2|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
8277865|NCT01690299|20410467|P1|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
8277866|NCT01690273|20410512|P3|NOT COMPLETED|Overall Study||0
8277867|NCT01690273|20410513|P2|NOT COMPLETED|Overall Study||0
8277868|NCT01690273|20410514|P1|NOT COMPLETED|Overall Study||0
8277869|NCT01690273|20410512|P3|COMPLETED|Overall Study||20
8277870|NCT01690273|20410513|P2|COMPLETED|Overall Study||17
8277871|NCT01690273|20410514|P1|COMPLETED|Overall Study||18
8277872|NCT01690273|20410512|P3|STARTED|Overall Study||20
8277873|NCT01690273|20410513|P2|STARTED|Overall Study||17
8277874|NCT01690273|20410514|P1|STARTED|Overall Study||18
8277875|NCT01690143|20410564|P1|NOT COMPLETED|Overall Study||1
8277876|NCT01690143|20410564|P1|COMPLETED|Overall Study||44
8277877|NCT01690143|20410564|P1|STARTED|Overall Study||45
8277878|NCT01690130|20410574|P2|NOT COMPLETED|Overall Study||0
8277879|NCT01690130|20410575|P1|NOT COMPLETED|Overall Study||1
8277880|NCT01690130|20410574|P2|COMPLETED|Overall Study||9
8277881|NCT01690130|20410575|P1|COMPLETED|Overall Study||9
8277882|NCT01690130|20410574|P2|STARTED|Overall Study||9
8277883|NCT01690130|20410575|P1|STARTED|Overall Study||10
8277884|NCT01690117|20410585|P2|NOT COMPLETED|Overall Study||14
8277885|NCT01690117|20410586|P1|NOT COMPLETED|Overall Study||16
8277886|NCT01690117|20410585|P2|COMPLETED|Overall Study||31
8277887|NCT01690117|20410586|P1|COMPLETED|Overall Study||31
8277888|NCT01690117|20410585|P2|Post-Measurement|Overall Study||40
8277889|NCT01690117|20410586|P1|Post-Measurement|Overall Study||41
8277890|NCT01690117|20410585|P2|STARTED|Overall Study||45
8277891|NCT01690117|20410586|P1|STARTED|Overall Study||47
8277892|NCT01690052|20410622|P2|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
8277893|NCT01690052|20410623|P1|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
8277894|NCT01690052|20410622|P2|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
8277895|NCT01690052|20410623|P1|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
8277896|NCT01690052|20410622|P2|STARTED|SECOND INTERVENTION: 4 WEEKS||6
8277897|NCT01690052|20410623|P1|STARTED|SECOND INTERVENTION: 4 WEEKS||6
8277898|NCT01690052|20410622|P2|NOT COMPLETED|Washout Period of 1 Week||0
8277899|NCT01690052|20410623|P1|NOT COMPLETED|Washout Period of 1 Week||0
8277900|NCT01690052|20410622|P2|COMPLETED|Washout Period of 1 Week||6
8277901|NCT01690052|20410623|P1|COMPLETED|Washout Period of 1 Week||6
8277902|NCT01690052|20410622|P2|STARTED|Washout Period of 1 Week||6
8277903|NCT01690052|20410623|P1|STARTED|Washout Period of 1 Week||6
8277904|NCT01690052|20410622|P2|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
8277905|NCT01690052|20410623|P1|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
8277906|NCT01690052|20410622|P2|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
8277907|NCT01690052|20410623|P1|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
8277908|NCT01690052|20410622|P2|STARTED|FIRST INTERVENTION: 4 WEEKS||8
8277909|NCT01690052|20410623|P1|STARTED|FIRST INTERVENTION: 4 WEEKS||7
8277910|NCT01690000|20410631|P2|NOT COMPLETED|Overall Study||6
8277911|NCT01690000|20410632|P1|NOT COMPLETED|Overall Study||3
8277912|NCT01690000|20410631|P2|COMPLETED|Overall Study||35
8277913|NCT01690000|20410632|P1|COMPLETED|Overall Study||37
8277914|NCT01690000|20410631|P2|STARTED|Overall Study||41
8277915|NCT01690000|20410632|P1|STARTED|Overall Study||40
8277916|NCT01689974|20410640|P2|NOT COMPLETED|Overall Study||5
8277917|NCT01689974|20410641|P1|NOT COMPLETED|Overall Study||5
8277918|NCT01689974|20410640|P2|COMPLETED|Overall Study||0
8277919|NCT01689974|20410641|P1|COMPLETED|Overall Study||0
8277920|NCT01689974|20410640|P2|STARTED|Overall Study||5
8277921|NCT01689974|20410641|P1|STARTED|Overall Study||5
8277922|NCT01689909|20410649|P2|NOT COMPLETED|Overall Study||0
8277923|NCT01689909|20410650|P1|NOT COMPLETED|Overall Study||0
8277924|NCT01689909|20410649|P2|COMPLETED|Overall Study||52
8277925|NCT01689909|20410650|P1|COMPLETED|Overall Study||51
8277926|NCT01689909|20410649|P2|STARTED|Overall Study||52
8277927|NCT01689909|20410650|P1|STARTED|Overall Study||51
8277928|NCT01689857|20410672|P2|NOT COMPLETED|Overall Study||2
8277929|NCT01689857|20410673|P1|NOT COMPLETED|Overall Study||5
8277930|NCT01689857|20410672|P2|COMPLETED|Overall Study||18
8277931|NCT01689857|20410673|P1|COMPLETED|Overall Study||15
8277932|NCT01689857|20410672|P2|STARTED|Overall Study||20
8277933|NCT01689857|20410673|P1|STARTED|Overall Study||20
8277934|NCT01689779|20410681|P2|NOT COMPLETED|Overall Study||0
8277935|NCT01689779|20410682|P1|NOT COMPLETED|Overall Study||0
8277936|NCT01689779|20410681|P2|COMPLETED|Overall Study||32
8277937|NCT01689779|20410682|P1|COMPLETED|Overall Study||28
8277938|NCT01689779|20410681|P2|STARTED|Overall Study||32
8277939|NCT01689779|20410682|P1|STARTED|Overall Study||28
8277949|NCT01689701|20410745|P2|NOT COMPLETED|Overall Study||6
8277950|NCT01689701|20410746|P1|NOT COMPLETED|Overall Study||5
8277951|NCT01689701|20410745|P2|COMPLETED|Overall Study||21
8277952|NCT01689701|20410746|P1|COMPLETED|Overall Study||22
8277953|NCT01689701|20410745|P2|STARTED|Overall Study||27
8277954|NCT01689701|20410746|P1|STARTED|Overall Study||27
8277955|NCT01689649|20410766|P1|NOT COMPLETED|Overall Study||22
8277956|NCT01689649|20410766|P1|COMPLETED|Overall Study||117
8277957|NCT01689649|20410766|P1|STARTED|Overall Study||139
8277958|NCT01689532|20410778|P2|NOT COMPLETED|Overall Study||9
8277959|NCT01689532|20410779|P1|NOT COMPLETED|Overall Study||14
8277960|NCT01689532|20410778|P2|COMPLETED|Overall Study||52
8277961|NCT01689532|20410779|P1|COMPLETED|Overall Study||47
8277962|NCT01689532|20410778|P2|STARTED|Overall Study||61
8277963|NCT01689532|20410779|P1|STARTED|Overall Study||61
8277964|NCT01689519|20410843|P2|NOT COMPLETED|Safety Population||245
8277965|NCT01689519|20410844|P1|NOT COMPLETED|Safety Population||248
8277966|NCT01689519|20410843|P2|COMPLETED|Safety Population||0
8277967|NCT01689519|20410844|P1|COMPLETED|Safety Population||0
8277968|NCT01689519|20410843|P2|STARTED|Safety Population||245
8277969|NCT01689519|20410844|P1|STARTED|Safety Population||248
8277970|NCT01689519|20410843|P2|NOT COMPLETED|Intent to Treat||248
8277971|NCT01689519|20410844|P1|NOT COMPLETED|Intent to Treat||247
8277972|NCT01689519|20410843|P2|COMPLETED|Intent to Treat||0
8277973|NCT01689519|20410844|P1|COMPLETED|Intent to Treat||0
8277974|NCT01689519|20410843|P2|STARTED|Intent to Treat||248
8277975|NCT01689519|20410844|P1|STARTED|Intent to Treat||247
8277976|NCT01689441|20410858|P2|NOT COMPLETED|Overall Study||0
8277977|NCT01689441|20410859|P1|NOT COMPLETED|Overall Study||0
8277978|NCT01689441|20410858|P2|COMPLETED|Overall Study||31
8277979|NCT01689441|20410859|P1|COMPLETED|Overall Study||36
8277980|NCT01689441|20410858|P2|STARTED|Overall Study||31
8277981|NCT01689441|20410859|P1|STARTED|Overall Study||36
8277982|NCT01689363|20410869|P8|NOT COMPLETED|Overall Study||0
8277983|NCT01689363|20410870|P7|NOT COMPLETED|Overall Study||0
8277984|NCT01689363|20410871|P6|NOT COMPLETED|Overall Study||0
8277985|NCT01689363|20410872|P5|NOT COMPLETED|Overall Study||0
8277986|NCT01689363|20410873|P4|NOT COMPLETED|Overall Study||0
8277987|NCT01689363|20410874|P3|NOT COMPLETED|Overall Study||0
8277988|NCT01689363|20410875|P2|NOT COMPLETED|Overall Study||1
8277989|NCT01689363|20410876|P1|NOT COMPLETED|Overall Study||0
8277990|NCT01689363|20410869|P8|COMPLETED|Overall Study||32
8277991|NCT01689363|20410870|P7|COMPLETED|Overall Study||32
8277992|NCT01689363|20410871|P6|COMPLETED|Overall Study||31
8277993|NCT01689363|20410872|P5|COMPLETED|Overall Study||31
8277994|NCT01689363|20410873|P4|COMPLETED|Overall Study||31
8277995|NCT01689363|20410874|P3|COMPLETED|Overall Study||32
8277996|NCT01689363|20410875|P2|COMPLETED|Overall Study||31
8277997|NCT01689363|20410876|P1|COMPLETED|Overall Study||32
8277998|NCT01689363|20410869|P8|STARTED|Overall Study||32
8277999|NCT01689363|20410870|P7|STARTED|Overall Study||32
8278000|NCT01689363|20410871|P6|STARTED|Overall Study||31
8278001|NCT01689363|20410872|P5|STARTED|Overall Study||31
8278002|NCT01689363|20410873|P4|STARTED|Overall Study||31
8278003|NCT01689363|20410874|P3|STARTED|Overall Study||32
8278004|NCT01689363|20410875|P2|STARTED|Overall Study||32
8278005|NCT01689363|20410876|P1|STARTED|Overall Study||32
8278006|NCT01689350|20410922|P2|NOT COMPLETED|Overall Study||0
8278007|NCT01689350|20410923|P1|NOT COMPLETED|Overall Study||0
8278008|NCT01689350|20410922|P2|COMPLETED|Overall Study||45
8278009|NCT01689350|20410923|P1|COMPLETED|Overall Study||47
8278010|NCT01689350|20410922|P2|STARTED|Overall Study||45
8278011|NCT01689350|20410923|P1|STARTED|Overall Study||47
8278012|NCT01689337|20410931|P1|NOT COMPLETED|Overall Study||1
8278013|NCT01689337|20410931|P1|COMPLETED|Overall Study||0
8278014|NCT01689337|20410931|P1|STARTED|Overall Study||1
8278015|NCT01689324|20410946|P1|NOT COMPLETED|Overall Study||0
8278016|NCT01689324|20410946|P1|COMPLETED|Overall Study||43
8278017|NCT01689324|20410946|P1|STARTED|Overall Study||43
8278018|NCT01689207|20410970|P11|NOT COMPLETED|Overall Study||0
8278019|NCT01689207|20410971|P10|NOT COMPLETED|Overall Study||0
8278020|NCT01689207|20410972|P9|NOT COMPLETED|Overall Study||1
8278021|NCT01689207|20410973|P8|NOT COMPLETED|Overall Study||0
8278022|NCT01689207|20410974|P7|NOT COMPLETED|Overall Study||0
8278023|NCT01689207|20410975|P6|NOT COMPLETED|Overall Study||1
8278024|NCT01689207|20410976|P5|NOT COMPLETED|Overall Study||2
8278025|NCT01689207|20410977|P4|NOT COMPLETED|Overall Study||0
8278026|NCT01689207|20410978|P3|NOT COMPLETED|Overall Study||0
8278027|NCT01689207|20410979|P2|NOT COMPLETED|Overall Study||1
8278028|NCT01689207|20410980|P1|NOT COMPLETED|Overall Study||0
8278029|NCT01689207|20410970|P11|COMPLETED|Overall Study|Subjects completed study|8
8278030|NCT01689207|20410971|P10|COMPLETED|Overall Study|Subjects completed study|10
8278031|NCT01689207|20410972|P9|COMPLETED|Overall Study|Subjects completed study|5
8278032|NCT01689207|20410973|P8|COMPLETED|Overall Study|Subjects completed study|10
8278033|NCT01689207|20410974|P7|COMPLETED|Overall Study|Subjects completed study|10
8278034|NCT01689207|20410975|P6|COMPLETED|Overall Study|Subjects completed study|7
8278035|NCT01689207|20410976|P5|COMPLETED|Overall Study|Subjects completed study|2
8278036|NCT01689207|20410977|P4|COMPLETED|Overall Study|Subjects completed study|8
8278037|NCT01689207|20410978|P3|COMPLETED|Overall Study|Subjects completed study|16
8278038|NCT01689207|20410979|P2|COMPLETED|Overall Study|Subjects completed study|7
8278039|NCT01689207|20410980|P1|COMPLETED|Overall Study|Subjects completed study|4
8278040|NCT01689207|20410970|P11|STARTED|Overall Study|Subjects randomised|8
8278041|NCT01689207|20410971|P10|STARTED|Overall Study|Subjects randomised|10
8278042|NCT01689207|20410972|P9|STARTED|Overall Study|Subjects randomised|6
8278043|NCT01689207|20410973|P8|STARTED|Overall Study|Subjects randomised|10
8278044|NCT01689207|20410974|P7|STARTED|Overall Study|Subjects randomised|10
8278045|NCT01689207|20410975|P6|STARTED|Overall Study|Subjects randomised|8
8278046|NCT01689207|20410976|P5|STARTED|Overall Study|Subjects randomised|4
8278047|NCT01689207|20410977|P4|STARTED|Overall Study|Subjects randomised|8
8278048|NCT01689207|20410978|P3|STARTED|Overall Study|Subjects randomised|16
8278049|NCT01689207|20410979|P2|STARTED|Overall Study|Subjects randomised|8
8278050|NCT01689207|20410980|P1|STARTED|Overall Study|Subjects randomised|4
8278051|NCT01689155|20411076|P1|NOT COMPLETED|Overall Study||0
8278052|NCT01689155|20411076|P1|COMPLETED|Overall Study||116
8278053|NCT01689155|20411076|P1|STARTED|Overall Study||116
8278054|NCT01688999|20411088|P3|NOT COMPLETED|Overall Study||3
8278055|NCT01688999|20411089|P2|NOT COMPLETED|Overall Study||1
8278056|NCT01688999|20411090|P1|NOT COMPLETED|Overall Study||8
8278057|NCT01688999|20411088|P3|COMPLETED|Overall Study||10
8278058|NCT01688999|20411089|P2|COMPLETED|Overall Study||5
8278059|NCT01688999|20411090|P1|COMPLETED|Overall Study||42
8278060|NCT01688999|20411088|P3|STARTED|Overall Study||13
8278061|NCT01688999|20411089|P2|STARTED|Overall Study||6
8278062|NCT01688999|20411090|P1|STARTED|Overall Study||50
8278063|NCT01688973|20411106|P2|NOT COMPLETED|Overall Study||3
8278064|NCT01688973|20411107|P1|NOT COMPLETED|Overall Study||2
8278065|NCT01688973|20411106|P2|COMPLETED|Overall Study||25
8278066|NCT01688973|20411107|P1|COMPLETED|Overall Study||25
8278067|NCT01688973|20411106|P2|Eligible/Evaluable Patients|Overall Study||25
8278068|NCT01688973|20411107|P1|Eligible/Evaluable Patients|Overall Study||25
8278069|NCT01688973|20411106|P2|STARTED|Overall Study||28
8278070|NCT01688973|20411107|P1|STARTED|Overall Study||27
8278071|NCT01688921|20411121|P2|NOT COMPLETED|Overall Study||15
8278072|NCT01688921|20411122|P1|NOT COMPLETED|Overall Study||16
8278073|NCT01688921|20411121|P2|COMPLETED|Overall Study||608
8278074|NCT01688921|20411122|P1|COMPLETED|Overall Study||611
8278075|NCT01688921|20411121|P2|STARTED|Overall Study||623
8278076|NCT01688921|20411122|P1|STARTED|Overall Study||627
8278077|NCT01688895|20411145|P1|NOT COMPLETED|Overall Study||0
8278078|NCT01688895|20411145|P1|COMPLETED|Overall Study||150
8278079|NCT01688895|20411145|P1|STARTED|Overall Study||150
8278080|NCT01688882|20411154|P2|NOT COMPLETED|Overall Study||1
8278081|NCT01688882|20411155|P1|NOT COMPLETED|Overall Study||3
8278082|NCT01688882|20411154|P2|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
8278083|NCT01688882|20411155|P1|COMPLETED|Overall Study||10
8278084|NCT01688882|20411154|P2|Safety Follow-up|Overall Study||5
8278085|NCT01688882|20411155|P1|Safety Follow-up|Overall Study||11
8278086|NCT01688882|20411154|P2|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
8278087|NCT01688882|20411155|P1|STARTED|Overall Study||13
8278088|NCT01688856|20411172|P3|NOT COMPLETED|Overall Study||3
8278089|NCT01688856|20411173|P2|NOT COMPLETED|Overall Study||4
8278090|NCT01688856|20411174|P1|NOT COMPLETED|Overall Study||7
8278091|NCT01688856|20411172|P3|COMPLETED|Overall Study||8
8278092|NCT01688856|20411173|P2|COMPLETED|Overall Study||24
8278093|NCT01688856|20411174|P1|COMPLETED|Overall Study||21
8278094|NCT01688856|20411172|P3|STARTED|Overall Study||11
8278095|NCT01688856|20411173|P2|STARTED|Overall Study||28
8278096|NCT01688856|20411174|P1|STARTED|Overall Study||28
8278097|NCT01688843|20411194|P1|NOT COMPLETED|Overall Study||0
8278098|NCT01688843|20411194|P1|COMPLETED|Overall Study||1060
8278099|NCT01688843|20411194|P1|STARTED|Overall Study||1060
8278100|NCT01688830|20411226|P21|NOT COMPLETED|Overall Study||0
8278101|NCT01688830|20411227|P20|NOT COMPLETED|Overall Study||0
8278102|NCT01688830|20411228|P19|NOT COMPLETED|Overall Study||0
8278103|NCT01688830|20411229|P18|NOT COMPLETED|Overall Study||0
8278104|NCT01688830|20411230|P17|NOT COMPLETED|Overall Study||0
8278105|NCT01688830|20411231|P16|NOT COMPLETED|Overall Study||0
8278106|NCT01688830|20411232|P15|NOT COMPLETED|Overall Study||0
8278107|NCT01688830|20411233|P14|NOT COMPLETED|Overall Study||0
8278108|NCT01688830|20411234|P13|NOT COMPLETED|Overall Study||0
8278109|NCT01688830|20411235|P12|NOT COMPLETED|Overall Study||0
8278110|NCT01688830|20411236|P11|NOT COMPLETED|Overall Study||1
8278111|NCT01688830|20411237|P10|NOT COMPLETED|Overall Study||0
8278112|NCT01688830|20411238|P9|NOT COMPLETED|Overall Study||0
8278113|NCT01688830|20411239|P8|NOT COMPLETED|Overall Study||0
8278114|NCT01688830|20411240|P7|NOT COMPLETED|Overall Study||0
8278115|NCT01688830|20411241|P6|NOT COMPLETED|Overall Study||0
8278116|NCT01688830|20411242|P5|NOT COMPLETED|Overall Study||0
8278117|NCT01688830|20411243|P4|NOT COMPLETED|Overall Study||0
8278118|NCT01688830|20411244|P3|NOT COMPLETED|Overall Study||0
8278119|NCT01688830|20411245|P2|NOT COMPLETED|Overall Study||0
8278120|NCT01688830|20411246|P1|NOT COMPLETED|Overall Study||0
8278121|NCT01688830|20411226|P21|COMPLETED|Overall Study||9
8278122|NCT01688830|20411227|P20|COMPLETED|Overall Study||3
8278123|NCT01688830|20411228|P19|COMPLETED|Overall Study||8
8278124|NCT01688830|20411229|P18|COMPLETED|Overall Study||9
8278125|NCT01688830|20411230|P17|COMPLETED|Overall Study||9
8278126|NCT01688830|20411231|P16|COMPLETED|Overall Study||9
8278127|NCT01688830|20411232|P15|COMPLETED|Overall Study||6
8278128|NCT01688830|20411233|P14|COMPLETED|Overall Study||6
8278129|NCT01688830|20411234|P13|COMPLETED|Overall Study||6
8278130|NCT01688830|20411235|P12|COMPLETED|Overall Study||6
8278131|NCT01688830|20411236|P11|COMPLETED|Overall Study||5
8278132|NCT01688830|20411237|P10|COMPLETED|Overall Study||6
8278133|NCT01688830|20411238|P9|COMPLETED|Overall Study||6
8278134|NCT01688830|20411239|P8|COMPLETED|Overall Study||6
8278135|NCT01688830|20411240|P7|COMPLETED|Overall Study||12
8278136|NCT01688830|20411241|P6|COMPLETED|Overall Study||6
8278137|NCT01688830|20411242|P5|COMPLETED|Overall Study||5
8278138|NCT01688830|20411243|P4|COMPLETED|Overall Study||6
8278139|NCT01688830|20411244|P3|COMPLETED|Overall Study||6
8278140|NCT01688830|20411245|P2|COMPLETED|Overall Study||6
8278141|NCT01688830|20411246|P1|COMPLETED|Overall Study||21
8278142|NCT01688830|20411226|P21|STARTED|Overall Study||9
8278143|NCT01688830|20411227|P20|STARTED|Overall Study||3
8278144|NCT01688830|20411228|P19|STARTED|Overall Study||8
8278145|NCT01688830|20411229|P18|STARTED|Overall Study||9
8278146|NCT01688830|20411230|P17|STARTED|Overall Study||9
8278147|NCT01688830|20411231|P16|STARTED|Overall Study||9
8278148|NCT01688830|20411232|P15|STARTED|Overall Study||6
8278149|NCT01688830|20411233|P14|STARTED|Overall Study||6
8278150|NCT01688830|20411234|P13|STARTED|Overall Study||6
8278151|NCT01688830|20411235|P12|STARTED|Overall Study||6
8278152|NCT01688830|20411236|P11|STARTED|Overall Study||6
8278153|NCT01688830|20411237|P10|STARTED|Overall Study||6
8278154|NCT01688830|20411238|P9|STARTED|Overall Study||6
8278155|NCT01688830|20411239|P8|STARTED|Overall Study||6
8278156|NCT01688830|20411240|P7|STARTED|Overall Study||12
8278157|NCT01688830|20411241|P6|STARTED|Overall Study||6
8278158|NCT01688830|20411242|P5|STARTED|Overall Study||5
8278159|NCT01688830|20411243|P4|STARTED|Overall Study||6
8278160|NCT01688830|20411244|P3|STARTED|Overall Study||6
8278161|NCT01688830|20411245|P2|STARTED|Overall Study||6
8278162|NCT01688830|20411246|P1|STARTED|Overall Study||21
8278163|NCT01688739|20411400|P10|NOT COMPLETED|Overall Study||0
8278164|NCT01688739|20411401|P9|NOT COMPLETED|Overall Study||0
8278165|NCT01688739|20411402|P8|NOT COMPLETED|Overall Study||0
8278166|NCT01688739|20411403|P7|NOT COMPLETED|Overall Study||0
8278167|NCT01688739|20411404|P6|NOT COMPLETED|Overall Study||0
8278168|NCT01688739|20411405|P5|NOT COMPLETED|Overall Study||0
8278169|NCT01688739|20411406|P4|NOT COMPLETED|Overall Study||0
8278170|NCT01688739|20411407|P3|NOT COMPLETED|Overall Study||0
8278171|NCT01688739|20411408|P2|NOT COMPLETED|Overall Study||0
8278172|NCT01688739|20411409|P1|NOT COMPLETED|Overall Study||1
8278173|NCT01688739|20411400|P10|COMPLETED|Overall Study||6
8278174|NCT01688739|20411401|P9|COMPLETED|Overall Study||6
8278175|NCT01688739|20411402|P8|COMPLETED|Overall Study||6
8278176|NCT01688739|20411403|P7|COMPLETED|Overall Study||6
8278177|NCT01688739|20411404|P6|COMPLETED|Overall Study||6
8278178|NCT01688739|20411405|P5|COMPLETED|Overall Study||6
8278179|NCT01688739|20411406|P4|COMPLETED|Overall Study||6
8278180|NCT01688739|20411407|P3|COMPLETED|Overall Study||3
8278181|NCT01688739|20411408|P2|COMPLETED|Overall Study||3
8278182|NCT01688739|20411409|P1|COMPLETED|Overall Study||12
8278183|NCT01688739|20411400|P10|Received Study Drug|Overall Study||6
8278184|NCT01688739|20411401|P9|Received Study Drug|Overall Study||6
8278185|NCT01688739|20411402|P8|Received Study Drug|Overall Study||6
8278186|NCT01688739|20411403|P7|Received Study Drug|Overall Study||6
8278187|NCT01688739|20411404|P6|Received Study Drug|Overall Study||6
8278188|NCT01688739|20411405|P5|Received Study Drug|Overall Study||6
8278189|NCT01688739|20411406|P4|Received Study Drug|Overall Study||6
8278190|NCT01688739|20411407|P3|Received Study Drug|Overall Study||3
8278191|NCT01688739|20411408|P2|Received Study Drug|Overall Study||3
8278192|NCT01688739|20411409|P1|Received Study Drug|Overall Study||12
8278193|NCT01688739|20411400|P10|STARTED|Overall Study||6
8278194|NCT01688739|20411401|P9|STARTED|Overall Study||6
8278195|NCT01688739|20411402|P8|STARTED|Overall Study||6
8278196|NCT01688739|20411403|P7|STARTED|Overall Study||6
8278197|NCT01688739|20411404|P6|STARTED|Overall Study||6
8278198|NCT01688739|20411405|P5|STARTED|Overall Study||6
8278199|NCT01688739|20411406|P4|STARTED|Overall Study||6
8278200|NCT01688739|20411407|P3|STARTED|Overall Study||3
8278201|NCT01688739|20411408|P2|STARTED|Overall Study||3
8278202|NCT01688739|20411409|P1|STARTED|Overall Study||13
8278203|NCT01688726|20411485|P2|NOT COMPLETED|Overall Study||1
8278204|NCT01688726|20411486|P1|NOT COMPLETED|Overall Study||1
8278205|NCT01688726|20411485|P2|COMPLETED|Overall Study||44
8278206|NCT01688726|20411486|P1|COMPLETED|Overall Study||45
8278207|NCT01688726|20411485|P2|STARTED|Overall Study||45
8278208|NCT01688726|20411486|P1|STARTED|Overall Study||46
8278209|NCT01688635|20411498|P2|NOT COMPLETED|Period 4||0
8278210|NCT01688635|20411499|P1|NOT COMPLETED|Period 4||0
8278211|NCT01688635|20411498|P2|COMPLETED|Period 4||42
8278212|NCT01688635|20411499|P1|COMPLETED|Period 4||40
8278213|NCT01688635|20411498|P2|STARTED|Period 4||42
8278214|NCT01688635|20411499|P1|STARTED|Period 4||40
8278215|NCT01688635|20411498|P2|NOT COMPLETED|Washout 3||0
8278216|NCT01688635|20411499|P1|NOT COMPLETED|Washout 3||1
8278217|NCT01688635|20411498|P2|COMPLETED|Washout 3||42
8278218|NCT01688635|20411499|P1|COMPLETED|Washout 3||40
8278219|NCT01688635|20411498|P2|STARTED|Washout 3||42
8278220|NCT01688635|20411499|P1|STARTED|Washout 3||41
8278221|NCT01688635|20411498|P2|NOT COMPLETED|Period 3||0
8278222|NCT01688635|20411499|P1|NOT COMPLETED|Period 3||0
8278223|NCT01688635|20411498|P2|COMPLETED|Period 3||42
8278224|NCT01688635|20411499|P1|COMPLETED|Period 3||41
8278225|NCT01688635|20411498|P2|STARTED|Period 3||42
8278226|NCT01688635|20411499|P1|STARTED|Period 3||41
8278227|NCT01688635|20411498|P2|NOT COMPLETED|Washout 2||2
8278228|NCT01688635|20411499|P1|NOT COMPLETED|Washout 2||3
8278229|NCT01688635|20411498|P2|COMPLETED|Washout 2||42
8278230|NCT01688635|20411499|P1|COMPLETED|Washout 2||41
8278231|NCT01688635|20411498|P2|STARTED|Washout 2||44
8278232|NCT01688635|20411499|P1|STARTED|Washout 2||44
8278233|NCT01688635|20411498|P2|NOT COMPLETED|Period 2||0
8278234|NCT01688635|20411499|P1|NOT COMPLETED|Period 2||0
8278235|NCT01688635|20411498|P2|COMPLETED|Period 2||44
8278236|NCT01688635|20411499|P1|COMPLETED|Period 2||44
8278237|NCT01688635|20411498|P2|STARTED|Period 2||44
8278238|NCT01688635|20411499|P1|STARTED|Period 2||44
8278239|NCT01688635|20411498|P2|NOT COMPLETED|Washout 1||2
8278240|NCT01688635|20411499|P1|NOT COMPLETED|Washout 1||1
8278241|NCT01688635|20411498|P2|COMPLETED|Washout 1||44
8278242|NCT01688635|20411499|P1|COMPLETED|Washout 1||44
8278243|NCT01688635|20411498|P2|STARTED|Washout 1||46
8278244|NCT01688635|20411499|P1|STARTED|Washout 1||45
8278245|NCT01688635|20411498|P2|NOT COMPLETED|Period 1||0
8278246|NCT01688635|20411499|P1|NOT COMPLETED|Period 1||0
8278247|NCT01688635|20411498|P2|COMPLETED|Period 1||46
8278248|NCT01688635|20411499|P1|COMPLETED|Period 1||45
8278249|NCT01688635|20411498|P2|Received at Least 1 Dose of Study Drug|Period 1||46
8278250|NCT01688635|20411499|P1|Received at Least 1 Dose of Study Drug|Period 1||45
8278251|NCT01688635|20411498|P2|STARTED|Period 1||46
8278252|NCT01688635|20411499|P1|STARTED|Period 1||45
8278253|NCT01688609|20411511|P1|NOT COMPLETED|Overall Study||0
8278254|NCT01688609|20411511|P1|COMPLETED|Overall Study||18
8278255|NCT01688609|20411511|P1|STARTED|Overall Study||18
8278256|NCT01688596|20411521|P2|NOT COMPLETED|Overall Study||9
8278257|NCT01688596|20411522|P1|NOT COMPLETED|Overall Study||8
8278258|NCT01688596|20411521|P2|COMPLETED|Overall Study||59
8278259|NCT01688596|20411522|P1|COMPLETED|Overall Study||59
8278260|NCT01688596|20411521|P2|STARTED|Overall Study||68
8278261|NCT01688596|20411522|P1|STARTED|Overall Study||67
8278262|NCT01688466|20411546|P2|NOT COMPLETED|Overall Study||7
8278263|NCT01688466|20411547|P1|NOT COMPLETED|Overall Study||2
8278264|NCT01688466|20411546|P2|COMPLETED|Overall Study||10
8278265|NCT01688466|20411547|P1|COMPLETED|Overall Study||15
8278266|NCT01688466|20411546|P2|STARTED|Overall Study||17
8278267|NCT01688466|20411547|P1|STARTED|Overall Study||17
8278268|NCT01688336|20411555|P1|NOT COMPLETED|Overall Study||0
8278269|NCT01688336|20411555|P1|COMPLETED|Overall Study||9
8278270|NCT01688336|20411555|P1|STARTED|Overall Study||9
8278271|NCT01688310|20411567|P2|NOT COMPLETED|Overall Study||0
8278272|NCT01688310|20411568|P1|NOT COMPLETED|Overall Study||0
8278273|NCT01688310|20411567|P2|COMPLETED|Overall Study||100
8278274|NCT01688310|20411568|P1|COMPLETED|Overall Study||100
8278275|NCT01688310|20411567|P2|STARTED|Overall Study||100
8278276|NCT01688310|20411568|P1|STARTED|Overall Study||100
8278277|NCT01688141|20411588|P2|NOT COMPLETED|Overall Study||0
8278278|NCT01688141|20411589|P1|NOT COMPLETED|Overall Study||0
8278279|NCT01688141|20411588|P2|COMPLETED|Overall Study||11651
8278280|NCT01688141|20411589|P1|COMPLETED|Overall Study||11706
8278281|NCT01688141|20411588|P2|STARTED|Overall Study||11651
8278282|NCT01688141|20411589|P1|STARTED|Overall Study||11706
8278283|NCT01688102|20411609|P2|NOT COMPLETED|Overall Study||18
8278284|NCT01688102|20411610|P1|NOT COMPLETED|Overall Study||16
8278285|NCT01688102|20411609|P2|COMPLETED|Overall Study||40
8278286|NCT01688102|20411610|P1|COMPLETED|Overall Study||44
8278287|NCT01688102|20411609|P2|STARTED|Overall Study||58
8278288|NCT01688102|20411610|P1|STARTED|Overall Study||60
8278289|NCT01688050|20411638|P1|NOT COMPLETED|Overall Study||31
8278290|NCT01688050|20411638|P1|COMPLETED|Overall Study||19
8278291|NCT01688050|20411638|P1|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|22
8278292|NCT01688050|20411638|P1|STARTED|Overall Study||50
8278293|NCT01688037|20411647|P3|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
8278294|NCT01688037|20411648|P2|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
8278295|NCT01688037|20411649|P1|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
8278296|NCT01688037|20411647|P3|COMPLETED|Follow-up Period (Week 12 to 16)||17
8278297|NCT01688037|20411648|P2|COMPLETED|Follow-up Period (Week 12 to 16)||21
8278298|NCT01688037|20411649|P1|COMPLETED|Follow-up Period (Week 12 to 16)||42
8278299|NCT01688037|20411647|P3|STARTED|Follow-up Period (Week 12 to 16)||17
8278300|NCT01688037|20411648|P2|STARTED|Follow-up Period (Week 12 to 16)||22
8278301|NCT01688037|20411649|P1|STARTED|Follow-up Period (Week 12 to 16)||42
8278302|NCT01688037|20411647|P3|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
8278303|NCT01688037|20411648|P2|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
8278304|NCT01688037|20411649|P1|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
8278305|NCT01688037|20411647|P3|COMPLETED|Open-Label Period (Week 6 to 12)||17
8278306|NCT01688037|20411648|P2|COMPLETED|Open-Label Period (Week 6 to 12)||22
8278307|NCT01688037|20411649|P1|COMPLETED|Open-Label Period (Week 6 to 12)||42
8278308|NCT01688037|20411647|P3|STARTED|Open-Label Period (Week 6 to 12)||21
8278309|NCT01688037|20411648|P2|STARTED|Open-Label Period (Week 6 to 12)||25
8278310|NCT01688037|20411649|P1|STARTED|Open-Label Period (Week 6 to 12)||47
8278311|NCT01688037|20411647|P3|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
8278312|NCT01688037|20411648|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
8278313|NCT01688037|20411649|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
8278314|NCT01688037|20411647|P3|COMPLETED|Double-Blind Period (Week 0 to 6)||21
8278315|NCT01688037|20411648|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||25
8278316|NCT01688037|20411649|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||47
8278317|NCT01688037|20411647|P3|STARTED|Double-Blind Period (Week 0 to 6)||27
8278318|NCT01688037|20411648|P2|STARTED|Double-Blind Period (Week 0 to 6)||28
8278319|NCT01688037|20411649|P1|STARTED|Double-Blind Period (Week 0 to 6)||54
8278320|NCT01687998|20411665|P2|NOT COMPLETED|Overall Study||120
8278321|NCT01687998|20411666|P1|NOT COMPLETED|Overall Study||112
8278322|NCT01687998|20411665|P2|COMPLETED|Overall Study||5934
8278323|NCT01687998|20411666|P1|COMPLETED|Overall Study||5926
8278420|NCT01687296|20411886|P2|NOT COMPLETED|Overall Study||5
8278324|NCT01687998|20411665|P2|Received at Least One Dose of Study Drug|Overall Study||6052
8278325|NCT01687998|20411666|P1|Received at Least One Dose of Study Drug|Overall Study||6036
8278326|NCT01687998|20411665|P2|STARTED|Overall Study||6054
8278327|NCT01687998|20411666|P1|STARTED|Overall Study||6038
8278328|NCT01687972|20411684|P2|NOT COMPLETED|Overall Study||0
8278329|NCT01687972|20411685|P1|NOT COMPLETED|Overall Study||0
8278330|NCT01687972|20411684|P2|COMPLETED|Overall Study||44
8278331|NCT01687972|20411685|P1|COMPLETED|Overall Study||44
8278332|NCT01687972|20411684|P2|STARTED|Overall Study||44
8278333|NCT01687972|20411685|P1|STARTED|Overall Study||44
8278334|NCT01687790|20411695|P1|NOT COMPLETED|Overall Study||0
8278335|NCT01687790|20411695|P1|COMPLETED|Overall Study||60
8278336|NCT01687790|20411695|P1|STARTED|Overall Study||60
8278337|NCT01687712|20411702|P2|NOT COMPLETED|Cycle 3||24
8278338|NCT01687712|20411703|P1|NOT COMPLETED|Cycle 3||24
8278339|NCT01687712|20411702|P2|COMPLETED|Cycle 3||0
8278340|NCT01687712|20411703|P1|COMPLETED|Cycle 3||4
8278341|NCT01687712|20411702|P2|Clinical Pregnancy|Cycle 3||0
8278342|NCT01687712|20411703|P1|Clinical Pregnancy|Cycle 3||5
8278343|NCT01687712|20411702|P2|Biochemically Pregnant|Cycle 3||2
8278344|NCT01687712|20411703|P1|Biochemically Pregnant|Cycle 3||7
8278345|NCT01687712|20411702|P2|Embryo Transfer|Cycle 3||24
8278346|NCT01687712|20411703|P1|Embryo Transfer|Cycle 3||26
8278347|NCT01687712|20411702|P2|Fertilization Performed|Cycle 3||24
8278348|NCT01687712|20411703|P1|Fertilization Performed|Cycle 3||27
8278349|NCT01687712|20411702|P2|Ooctye/Ovum Pick-Up|Cycle 3||24
8278350|NCT01687712|20411703|P1|Ooctye/Ovum Pick-Up|Cycle 3||27
8278351|NCT01687712|20411702|P2|Received hCG|Cycle 3||24
8278352|NCT01687712|20411703|P1|Received hCG|Cycle 3||27
8278353|NCT01687712|20411702|P2|STARTED|Cycle 3||24
8278354|NCT01687712|20411703|P1|STARTED|Cycle 3||28
8278355|NCT01687712|20411702|P2|NOT COMPLETED|Cycle 2||95
8278356|NCT01687712|20411703|P1|NOT COMPLETED|Cycle 2||93
8278357|NCT01687712|20411702|P2|COMPLETED|Cycle 2||25
8278358|NCT01687712|20411703|P1|COMPLETED|Cycle 2||16
8278359|NCT01687712|20411702|P2|Clinical Pregnancy|Cycle 2||26
8278360|NCT01687712|20411703|P1|Clinical Pregnancy|Cycle 2||17
8278361|NCT01687712|20411702|P2|Biochemical Pregnancy|Cycle 2||43
8278362|NCT01687712|20411703|P1|Biochemical Pregnancy|Cycle 2||35
8278363|NCT01687712|20411702|P2|Embryo Transfer|Cycle 2||117
8278364|NCT01687712|20411703|P1|Embryo Transfer|Cycle 2||101
8278365|NCT01687712|20411702|P2|Fertilization Performed|Cycle 2||119
8278366|NCT01687712|20411703|P1|Fertilization Performed|Cycle 2||106
8278367|NCT01687712|20411702|P2|Oocyte/Ovum Pick Up|Cycle 2||119
8278368|NCT01687712|20411703|P1|Oocyte/Ovum Pick Up|Cycle 2||107
8278369|NCT01687712|20411702|P2|Received hCG|Cycle 2||119
8278370|NCT01687712|20411703|P1|Received hCG|Cycle 2||107
8278371|NCT01687712|20411702|P2|STARTED|Cycle 2||120
8278372|NCT01687712|20411703|P1|STARTED|Cycle 2||109
8278373|NCT01687712|20411702|P2|NOT COMPLETED|Cycle 1||429
8278374|NCT01687712|20411703|P1|NOT COMPLETED|Cycle 1||448
8278375|NCT01687712|20411702|P2|COMPLETED|Cycle 1||122
8278376|NCT01687712|20411703|P1|COMPLETED|Cycle 1||101
8278377|NCT01687712|20411702|P2|Clinical Pregnancy|Cycle 1||138
8278378|NCT01687712|20411703|P1|Clinical Pregnancy|Cycle 1||114
8278379|NCT01687712|20411702|P2|Biochemical Pregnancy|Cycle 1||203
8278380|NCT01687712|20411703|P1|Biochemical Pregnancy|Cycle 1||163
8278381|NCT01687712|20411702|P2|Embryo Transfer|Cycle 1||483
8278382|NCT01687712|20411703|P1|Embryo Transfer|Cycle 1||466
8278383|NCT01687712|20411702|P2|Fertilization Performed|Cycle 1||512
8278384|NCT01687712|20411703|P1|Fertilization Performed|Cycle 1||508
8278385|NCT01687712|20411702|P2|Oocyte/Ovum Pick Up|Cycle 1||517
8278386|NCT01687712|20411703|P1|Oocyte/Ovum Pick Up|Cycle 1||513
8278387|NCT01687712|20411702|P2|Received hCG|Cycle 1||520
8278388|NCT01687712|20411703|P1|Received hCG|Cycle 1||516
8278389|NCT01687712|20411702|P2|STARTED|Cycle 1||551
8278390|NCT01687712|20411703|P1|STARTED|Cycle 1||549
8278391|NCT01687673|20411741|P1|NOT COMPLETED|Overall Study||1
8278392|NCT01687673|20411741|P1|COMPLETED|Overall Study||28
8278393|NCT01687673|20411741|P1|STARTED|Overall Study||29
8278394|NCT01687478|20411755|P2|NOT COMPLETED|Overall Study||39
8278395|NCT01687478|20411756|P1|NOT COMPLETED|Overall Study||32
8278396|NCT01687478|20411755|P2|COMPLETED|Overall Study||49
8278397|NCT01687478|20411756|P1|COMPLETED|Overall Study||56
8278398|NCT01687478|20411755|P2|Safety Analysis Set|Overall Study||87
8278399|NCT01687478|20411756|P1|Safety Analysis Set|Overall Study||88
8278400|NCT01687478|20411755|P2|STARTED|Overall Study||88
8278401|NCT01687478|20411756|P1|STARTED|Overall Study||88
8278402|NCT01687413|20411780|P2|NOT COMPLETED|Overall Study||4
8278403|NCT01687413|20411781|P1|NOT COMPLETED|Overall Study||1
8278404|NCT01687413|20411780|P2|COMPLETED|Overall Study||11
8278405|NCT01687413|20411781|P1|COMPLETED|Overall Study||26
8278406|NCT01687413|20411780|P2|STARTED|Overall Study||15
8278407|NCT01687413|20411781|P1|STARTED|Overall Study||27
8278408|NCT01687400|20411857|P1|NOT COMPLETED|Overall Study||0
8278409|NCT01687400|20411857|P1|COMPLETED|Overall Study||114
8278410|NCT01687400|20411857|P1|STARTED|Overall Study||114
8278411|NCT01687387|20411871|P3|NOT COMPLETED|Overall Study||38
8278412|NCT01687387|20411872|P2|NOT COMPLETED|Overall Study||38
8278413|NCT01687387|20411873|P1|NOT COMPLETED|Overall Study||41
8278414|NCT01687387|20411871|P3|COMPLETED|Overall Study||13
8278415|NCT01687387|20411872|P2|COMPLETED|Overall Study||12
8278416|NCT01687387|20411873|P1|COMPLETED|Overall Study||10
8278417|NCT01687387|20411871|P3|STARTED|Overall Study||51
8278418|NCT01687387|20411872|P2|STARTED|Overall Study||50
8278419|NCT01687387|20411873|P1|STARTED|Overall Study||51
8278421|NCT01687296|20411887|P1|NOT COMPLETED|Overall Study||7
8278422|NCT01687296|20411886|P2|COMPLETED|Overall Study||123
8278423|NCT01687296|20411887|P1|COMPLETED|Overall Study||116
8278424|NCT01687296|20411886|P2|STARTED|Overall Study||128
8278425|NCT01687296|20411887|P1|STARTED|Overall Study||123
8278426|NCT01687283|20411909|P2|NOT COMPLETED|Overall Study||27
8278427|NCT01687283|20411910|P1|NOT COMPLETED|Overall Study||35
8278428|NCT01687283|20411909|P2|COMPLETED|Overall Study||130
8278429|NCT01687283|20411910|P1|COMPLETED|Overall Study||123
8278430|NCT01687283|20411909|P2|STARTED|Overall Study||157
8278431|NCT01687283|20411910|P1|STARTED|Overall Study||158
8278432|NCT01687270|20411933|P1|NOT COMPLETED|Overall Study||12
8278433|NCT01687270|20411933|P1|COMPLETED|Overall Study||28
8278434|NCT01687270|20411933|P1|STARTED|Overall Study||40
8278435|NCT01687257|20411944|P3|NOT COMPLETED|Overall Study||6
8278436|NCT01687257|20411945|P2|NOT COMPLETED|Overall Study||4
8278437|NCT01687257|20411946|P1|NOT COMPLETED|Overall Study||8
8278438|NCT01687257|20411944|P3|COMPLETED|Overall Study||15
8278439|NCT01687257|20411945|P2|COMPLETED|Overall Study||0
8278440|NCT01687257|20411946|P1|COMPLETED|Overall Study||17
8278441|NCT01687257|20411944|P3|STARTED|Overall Study||21
8278442|NCT01687257|20411945|P2|STARTED|Overall Study||4
8278443|NCT01687257|20411946|P1|STARTED|Overall Study||25
8278444|NCT01687244|20411974|P2|NOT COMPLETED|Overall Study||0
8278445|NCT01687244|20411975|P1|NOT COMPLETED|Overall Study||0
8278446|NCT01687244|20411974|P2|COMPLETED|Overall Study||19
8278447|NCT01687244|20411975|P1|COMPLETED|Overall Study||21
8278448|NCT01687244|20411974|P2|STARTED|Overall Study||19
8278449|NCT01687244|20411975|P1|STARTED|Overall Study||21
8278468|NCT01687179|20412057|P2|NOT COMPLETED|Overall Study||4
8278469|NCT01687179|20412058|P1|NOT COMPLETED|Overall Study||1
8278470|NCT01687179|20412057|P2|COMPLETED|Overall Study||6
8278471|NCT01687179|20412058|P1|COMPLETED|Overall Study||2
8278472|NCT01687179|20412057|P2|STARTED|Overall Study||10
8278473|NCT01687179|20412058|P1|STARTED|Overall Study||3
8278474|NCT01687166|20412068|P4|NOT COMPLETED|Overall Study||2
8278475|NCT01687166|20412069|P3|NOT COMPLETED|Overall Study||14
8278476|NCT01687166|20412070|P2|NOT COMPLETED|Overall Study||27
8278477|NCT01687166|20412071|P1|NOT COMPLETED|Overall Study||28
8278478|NCT01687166|20412068|P4|COMPLETED|Overall Study||1
8278479|NCT01687166|20412069|P3|COMPLETED|Overall Study||42
8278480|NCT01687166|20412070|P2|COMPLETED|Overall Study||145
8278481|NCT01687166|20412071|P1|COMPLETED|Overall Study||139
8278482|NCT01687166|20412068|P4|STARTED|Overall Study||3
8278483|NCT01687166|20412069|P3|STARTED|Overall Study||56
8278484|NCT01687166|20412070|P2|STARTED|Overall Study||172
8278485|NCT01687166|20412071|P1|STARTED|Overall Study||167
8278486|NCT01687114|20412083|P1|NOT COMPLETED|Overall Study||0
8278487|NCT01687114|20412083|P1|COMPLETED|Overall Study||5
8278488|NCT01687114|20412083|P1|STARTED|Overall Study||5
8278489|NCT01687101|20412087|P1|NOT COMPLETED|Overall Study||7
8278490|NCT01687101|20412087|P1|COMPLETED|Overall Study||25
8278491|NCT01687101|20412087|P1|STARTED|Overall Study||32
8278492|NCT01687088|20412093|P2|NOT COMPLETED|Overall Study||0
8278493|NCT01687088|20412094|P1|NOT COMPLETED|Overall Study||0
8278494|NCT01687088|20412093|P2|COMPLETED|Overall Study||50
8278495|NCT01687088|20412094|P1|COMPLETED|Overall Study||50
8278496|NCT01687088|20412093|P2|STARTED|Overall Study||50
8278497|NCT01687088|20412094|P1|STARTED|Overall Study||50
8278498|NCT01687036|20412100|P1|NOT COMPLETED|Overall Study||0
8278499|NCT01687036|20412100|P1|COMPLETED|Overall Study||10
8278500|NCT01687036|20412100|P1|STARTED|Overall Study||10
8278501|NCT01686958|20412112|P1|NOT COMPLETED|Overall Study||1
8278502|NCT01686958|20412112|P1|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
8278503|NCT01686958|20412112|P1|STARTED|Overall Study||30
8278504|NCT01686932|20412125|P2|NOT COMPLETED|Period 2||0
8278505|NCT01686932|20412126|P1|NOT COMPLETED|Period 2||0
8278506|NCT01686932|20412125|P2|COMPLETED|Period 2||25
8278507|NCT01686932|20412126|P1|COMPLETED|Period 2||24
8278508|NCT01686932|20412125|P2|STARTED|Period 2||25
8278509|NCT01686932|20412126|P1|STARTED|Period 2||24
8278510|NCT01686932|20412125|P2|NOT COMPLETED|Period 1||1
8278511|NCT01686932|20412126|P1|NOT COMPLETED|Period 1||1
8278512|NCT01686932|20412125|P2|COMPLETED|Period 1||25
8278513|NCT01686932|20412126|P1|COMPLETED|Period 1||24
8278514|NCT01686932|20412125|P2|STARTED|Period 1||26
8278515|NCT01686932|20412126|P1|STARTED|Period 1||25
8278516|NCT01686828|20412156|P4|NOT COMPLETED|Overall Study||0
8278517|NCT01686828|20412157|P3|NOT COMPLETED|Overall Study||1
8278518|NCT01686828|20412158|P2|NOT COMPLETED|Overall Study||1
8278519|NCT01686828|20412159|P1|NOT COMPLETED|Overall Study||1
8278520|NCT01686828|20412156|P4|COMPLETED|Overall Study||13
8278521|NCT01686828|20412157|P3|COMPLETED|Overall Study||12
8278522|NCT01686828|20412158|P2|COMPLETED|Overall Study||13
8278523|NCT01686828|20412159|P1|COMPLETED|Overall Study||12
8278524|NCT01686828|20412156|P4|STARTED|Overall Study||13
8278525|NCT01686828|20412157|P3|STARTED|Overall Study||13
8278526|NCT01686828|20412158|P2|STARTED|Overall Study||14
8278527|NCT01686828|20412159|P1|STARTED|Overall Study||13
8278528|NCT01686750|20412179|P2|NOT COMPLETED|Overall Study||0
8278529|NCT01686750|20412180|P1|NOT COMPLETED|Overall Study||0
8278530|NCT01686750|20412179|P2|COMPLETED|Overall Study||10725
8278531|NCT01686750|20412180|P1|COMPLETED|Overall Study||11001
8278532|NCT01686750|20412179|P2|STARTED|Overall Study||10725
8278533|NCT01686750|20412180|P1|STARTED|Overall Study||11001
8278534|NCT01686646|20412220|P4|NOT COMPLETED|Overall Study||0
8278535|NCT01686646|20412221|P3|NOT COMPLETED|Overall Study||0
8278536|NCT01686646|20412222|P2|NOT COMPLETED|Overall Study||0
8278537|NCT01686646|20412223|P1|NOT COMPLETED|Overall Study||0
8278538|NCT01686646|20412220|P4|COMPLETED|Overall Study||75
8278539|NCT01686646|20412221|P3|COMPLETED|Overall Study||75
8278540|NCT01686646|20412222|P2|COMPLETED|Overall Study||45
8278541|NCT01686646|20412223|P1|COMPLETED|Overall Study||45
8278542|NCT01686646|20412220|P4|Safety Population|Overall Study||75
8278543|NCT01686646|20412221|P3|Safety Population|Overall Study||74
8278544|NCT01686646|20412222|P2|Safety Population|Overall Study||45
8278545|NCT01686646|20412223|P1|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
8278546|NCT01686646|20412220|P4|Intent to Treat Population|Overall Study||75
8278547|NCT01686646|20412221|P3|Intent to Treat Population|Overall Study||75
8278548|NCT01686646|20412222|P2|Intent to Treat Population|Overall Study||45
8278549|NCT01686646|20412223|P1|Intent to Treat Population|Overall Study||45
8278550|NCT01686646|20412220|P4|STARTED|Overall Study||75
8278551|NCT01686646|20412221|P3|STARTED|Overall Study||75
8278552|NCT01686646|20412222|P2|STARTED|Overall Study||45
8278553|NCT01686646|20412223|P1|STARTED|Overall Study||45
8278554|NCT01686633|20412272|P3|NOT COMPLETED|Overall Study||25
8278555|NCT01686633|20412273|P2|NOT COMPLETED|Overall Study||32
8278556|NCT01686633|20412274|P1|NOT COMPLETED|Overall Study||51
8278557|NCT01686633|20412272|P3|COMPLETED|Overall Study||321
8278558|NCT01686633|20412273|P2|COMPLETED|Overall Study||314
8278559|NCT01686633|20412274|P1|COMPLETED|Overall Study||296
8278560|NCT01686633|20412272|P3|STARTED|Overall Study||346
8278561|NCT01686633|20412273|P2|STARTED|Overall Study||346
8278562|NCT01686633|20412274|P1|STARTED|Overall Study||347
8278563|NCT01686581|20412297|P1|NOT COMPLETED|Overall Study||177
8278564|NCT01686581|20412297|P1|COMPLETED|Overall Study||464
8278565|NCT01686581|20412297|P1|Completed 24 Months|Overall Study||128
8278566|NCT01686581|20412297|P1|Safety Analysis Set; Received Study Drug|Overall Study||633
8278567|NCT01686581|20412297|P1|STARTED|Overall Study||641
8278568|NCT01686568|20412310|P2|NOT COMPLETED|Sub-Study||2
8278569|NCT01686568|20412311|P1|NOT COMPLETED|Sub-Study||2
8278570|NCT01686568|20412310|P2|COMPLETED|Sub-Study||9
8278571|NCT01686568|20412311|P1|COMPLETED|Sub-Study||12
8278572|NCT01686568|20412310|P2|STARTED|Sub-Study||11
8278573|NCT01686568|20412311|P1|STARTED|Sub-Study||14
8278574|NCT01686568|20412310|P2|NOT COMPLETED|Main Study||4
8278575|NCT01686568|20412311|P1|NOT COMPLETED|Main Study||2
8278576|NCT01686568|20412310|P2|COMPLETED|Main Study||11
8278577|NCT01686568|20412311|P1|COMPLETED|Main Study||14
8278578|NCT01686568|20412310|P2|STARTED|Main Study||15
8278579|NCT01686568|20412311|P1|STARTED|Main Study||16
8278580|NCT01686503|20412337|P4|NOT COMPLETED|Overall Study||1
8278581|NCT01686503|20412338|P3|NOT COMPLETED|Overall Study||2
8278582|NCT01686503|20412339|P2|NOT COMPLETED|Overall Study||3
8278583|NCT01686503|20412340|P1|NOT COMPLETED|Overall Study||1
8278584|NCT01686503|20412337|P4|COMPLETED|Overall Study||32
8278585|NCT01686503|20412338|P3|COMPLETED|Overall Study||64
8278586|NCT01686503|20412339|P2|COMPLETED|Overall Study||63
8278587|NCT01686503|20412340|P1|COMPLETED|Overall Study||65
8278588|NCT01686503|20412337|P4|STARTED|Overall Study||33
8278589|NCT01686503|20412338|P3|STARTED|Overall Study||66
8278590|NCT01686503|20412339|P2|STARTED|Overall Study||66
8278591|NCT01686503|20412340|P1|STARTED|Overall Study||66
8278592|NCT01686451|20412356|P2|NOT COMPLETED|Overall Study||0
8278593|NCT01686451|20412357|P1|NOT COMPLETED|Overall Study||0
8278594|NCT01686451|20412356|P2|COMPLETED|Overall Study||27
8278595|NCT01686451|20412357|P1|COMPLETED|Overall Study||33
8278596|NCT01686451|20412356|P2|STARTED|Overall Study||27
8278597|NCT01686451|20412357|P1|STARTED|Overall Study||33
8278598|NCT01686438|20412388|P3|NOT COMPLETED|Overall Study||13
8278599|NCT01686438|20412389|P2|NOT COMPLETED|Overall Study||9
8278600|NCT01686438|20412390|P1|NOT COMPLETED|Overall Study||8
8278601|NCT01686438|20412388|P3|COMPLETED|Overall Study||24
8278602|NCT01686438|20412389|P2|COMPLETED|Overall Study||26
8278603|NCT01686438|20412390|P1|COMPLETED|Overall Study||7
8278604|NCT01686438|20412388|P3|6-Month Follow Up|Overall Study||24
8278605|NCT01686438|20412389|P2|6-Month Follow Up|Overall Study||26
8278606|NCT01686438|20412390|P1|6-Month Follow Up|Overall Study||7
8278607|NCT01686438|20412388|P3|3-Month Follow Up|Overall Study||17
8278608|NCT01686438|20412389|P2|3-Month Follow Up|Overall Study||21
8278609|NCT01686438|20412390|P1|3-Month Follow Up|Overall Study||7
8278610|NCT01686438|20412388|P3|2-Week Follow Up|Overall Study||27
8278611|NCT01686438|20412389|P2|2-Week Follow Up|Overall Study||31
8278612|NCT01686438|20412390|P1|2-Week Follow Up|Overall Study||12
8278613|NCT01686438|20412388|P3|STARTED|Overall Study||37
8278614|NCT01686438|20412389|P2|STARTED|Overall Study||35
8278615|NCT01686438|20412390|P1|STARTED|Overall Study||15
8278616|NCT01686373|20412438|P2|NOT COMPLETED|Overall Study||2
8278617|NCT01686373|20412439|P1|NOT COMPLETED|Overall Study||3
8278618|NCT01686373|20412438|P2|COMPLETED|Overall Study||38
8278619|NCT01686373|20412439|P1|COMPLETED|Overall Study||31
8278620|NCT01686373|20412438|P2|Received 15 Treatment Sessions|Overall Study||39
8278621|NCT01686373|20412439|P1|Received 15 Treatment Sessions|Overall Study||33
8278622|NCT01686373|20412438|P2|STARTED|Overall Study||40
8278623|NCT01686373|20412439|P1|STARTED|Overall Study||34
8278624|NCT01686165|20412445|P1|NOT COMPLETED|Overall Study||0
8278625|NCT01686165|20412445|P1|COMPLETED|Overall Study||5
8278626|NCT01686165|20412445|P1|STARTED|Overall Study||5
8278627|NCT01686152|20412455|P3|NOT COMPLETED|Overall Study||9
8278628|NCT01686152|20412456|P2|NOT COMPLETED|Overall Study||35
8278629|NCT01686152|20412457|P1|NOT COMPLETED|Overall Study||41
8278630|NCT01686152|20412455|P3|COMPLETED|Overall Study||75
8278631|NCT01686152|20412456|P2|COMPLETED|Overall Study||218
8278632|NCT01686152|20412457|P1|COMPLETED|Overall Study||211
8278633|NCT01686152|20412455|P3|STARTED|Overall Study||84
8278634|NCT01686152|20412456|P2|STARTED|Overall Study||253
8278635|NCT01686152|20412457|P1|STARTED|Overall Study||252
8278636|NCT01685996|20412467|P2|NOT COMPLETED|Overall Study||13
8278637|NCT01685996|20412468|P1|NOT COMPLETED|Overall Study||16
8278638|NCT01685996|20412467|P2|COMPLETED|Overall Study||27
8278639|NCT01685996|20412468|P1|COMPLETED|Overall Study||18
8278640|NCT01685996|20412467|P2|STARTED|Overall Study||40
8278641|NCT01685996|20412468|P1|STARTED|Overall Study||34
8278642|NCT01685983|20412476|P1|NOT COMPLETED|Overall Study||82
8278643|NCT01685983|20412476|P1|COMPLETED|Overall Study||0
8278644|NCT01685983|20412476|P1|STARTED|Overall Study||82
8278645|NCT01685840|20412488|P2|NOT COMPLETED|Overall Study||332
8278646|NCT01685840|20412489|P1|NOT COMPLETED|Overall Study||329
8278647|NCT01685840|20412488|P2|COMPLETED|Overall Study||114
8278648|NCT01685840|20412489|P1|COMPLETED|Overall Study||119
8278649|NCT01685840|20412488|P2|STARTED|Overall Study||446
8278650|NCT01685840|20412489|P1|STARTED|Overall Study||448
8278651|NCT01685801|20412533|P4|NOT COMPLETED|Open-label Period (8 Weeks)||0
8278652|NCT01685801|20412534|P3|NOT COMPLETED|Open-label Period (8 Weeks)||0
8278653|NCT01685801|20412535|P2|NOT COMPLETED|Open-label Period (8 Weeks)||0
8278654|NCT01685801|20412536|P1|NOT COMPLETED|Open-label Period (8 Weeks)||0
8278655|NCT01685801|20412533|P4|COMPLETED|Open-label Period (8 Weeks)||4
8278656|NCT01685801|20412534|P3|COMPLETED|Open-label Period (8 Weeks)||7
8278657|NCT01685801|20412535|P2|COMPLETED|Open-label Period (8 Weeks)||5
8278658|NCT01685801|20412536|P1|COMPLETED|Open-label Period (8 Weeks)||5
8278659|NCT01685801|20412533|P4|STARTED|Open-label Period (8 Weeks)||4
8278660|NCT01685801|20412534|P3|STARTED|Open-label Period (8 Weeks)||7
8278661|NCT01685801|20412535|P2|STARTED|Open-label Period (8 Weeks)||5
8278662|NCT01685801|20412536|P1|STARTED|Open-label Period (8 Weeks)||5
8278663|NCT01685801|20412533|P4|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
8278664|NCT01685801|20412534|P3|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
8278665|NCT01685801|20412535|P2|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
8278666|NCT01685801|20412536|P1|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
8278667|NCT01685801|20412533|P4|COMPLETED|Washout Period 2 (4 Weeks)||4
8278668|NCT01685801|20412534|P3|COMPLETED|Washout Period 2 (4 Weeks)||7
8278669|NCT01685801|20412535|P2|COMPLETED|Washout Period 2 (4 Weeks)||5
8278670|NCT01685801|20412536|P1|COMPLETED|Washout Period 2 (4 Weeks)||5
8278671|NCT01685801|20412533|P4|STARTED|Washout Period 2 (4 Weeks)||4
8278672|NCT01685801|20412534|P3|STARTED|Washout Period 2 (4 Weeks)||7
8278673|NCT01685801|20412535|P2|STARTED|Washout Period 2 (4 Weeks)||5
8278674|NCT01685801|20412536|P1|STARTED|Washout Period 2 (4 Weeks)||5
8278675|NCT01685801|20412533|P4|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
8278676|NCT01685801|20412534|P3|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
8278677|NCT01685801|20412535|P2|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
8278678|NCT01685801|20412536|P1|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
8278679|NCT01685801|20412533|P4|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
8278680|NCT01685801|20412534|P3|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
8278681|NCT01685801|20412535|P2|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
8278682|NCT01685801|20412536|P1|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
8278683|NCT01685801|20412533|P4|STARTED|Cycle 2 Period 2 (2 Weeks)||5
8278684|NCT01685801|20412534|P3|STARTED|Cycle 2 Period 2 (2 Weeks)||7
8278685|NCT01685801|20412535|P2|STARTED|Cycle 2 Period 2 (2 Weeks)||6
8278686|NCT01685801|20412536|P1|STARTED|Cycle 2 Period 2 (2 Weeks)||5
8278687|NCT01685801|20412533|P4|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
8278688|NCT01685801|20412534|P3|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
8278689|NCT01685801|20412535|P2|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
8278690|NCT01685801|20412536|P1|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
8278691|NCT01685801|20412533|P4|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
8278692|NCT01685801|20412534|P3|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
8278693|NCT01685801|20412535|P2|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
8278694|NCT01685801|20412536|P1|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
8278695|NCT01685801|20412533|P4|STARTED|Cycle 2 Period 1 (2 Weeks)||5
8278696|NCT01685801|20412534|P3|STARTED|Cycle 2 Period 1 (2 Weeks)||7
8278697|NCT01685801|20412535|P2|STARTED|Cycle 2 Period 1 (2 Weeks)||6
8278698|NCT01685801|20412536|P1|STARTED|Cycle 2 Period 1 (2 Weeks)||5
8278699|NCT01685801|20412533|P4|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
8278700|NCT01685801|20412534|P3|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
8278701|NCT01685801|20412535|P2|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
8278702|NCT01685801|20412536|P1|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
8278703|NCT01685801|20412533|P4|COMPLETED|Washout Period 1 (4 Weeks)||5
8278704|NCT01685801|20412534|P3|COMPLETED|Washout Period 1 (4 Weeks)||7
8278705|NCT01685801|20412535|P2|COMPLETED|Washout Period 1 (4 Weeks)||6
8278706|NCT01685801|20412536|P1|COMPLETED|Washout Period 1 (4 Weeks)||5
8278707|NCT01685801|20412533|P4|STARTED|Washout Period 1 (4 Weeks)||5
8278708|NCT01685801|20412534|P3|STARTED|Washout Period 1 (4 Weeks)||7
8278709|NCT01685801|20412535|P2|STARTED|Washout Period 1 (4 Weeks)||6
8278710|NCT01685801|20412536|P1|STARTED|Washout Period 1 (4 Weeks)||5
8278711|NCT01685801|20412533|P4|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
8278712|NCT01685801|20412534|P3|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
8278713|NCT01685801|20412535|P2|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
8278714|NCT01685801|20412536|P1|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
8278715|NCT01685801|20412533|P4|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
8278716|NCT01685801|20412534|P3|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
8278717|NCT01685801|20412535|P2|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
8278718|NCT01685801|20412536|P1|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
8278719|NCT01685801|20412533|P4|STARTED|Cycle 1 Period 2 (2 Weeks)||6
8278720|NCT01685801|20412534|P3|STARTED|Cycle 1 Period 2 (2 Weeks)||7
8278721|NCT01685801|20412535|P2|STARTED|Cycle 1 Period 2 (2 Weeks)||6
8278722|NCT01685801|20412536|P1|STARTED|Cycle 1 Period 2 (2 Weeks)||5
8278723|NCT01685801|20412533|P4|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8278724|NCT01685801|20412534|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8278725|NCT01685801|20412535|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8278726|NCT01685801|20412536|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
8278727|NCT01685801|20412533|P4|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
8278728|NCT01685801|20412534|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
8278729|NCT01685801|20412535|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
8278730|NCT01685801|20412536|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
8278731|NCT01685801|20412533|P4|STARTED|Cycle 1 Period 1 (2 Weeks)||6
8278732|NCT01685801|20412534|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||7
8278733|NCT01685801|20412535|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||6
8278734|NCT01685801|20412536|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||5
8278735|NCT01685697|20412558|P2|NOT COMPLETED|Overall Study||3
8278736|NCT01685697|20412559|P1|NOT COMPLETED|Overall Study||3
8278737|NCT01685697|20412558|P2|COMPLETED|Overall Study||28
8278738|NCT01685697|20412559|P1|COMPLETED|Overall Study||28
8278739|NCT01685697|20412558|P2|STARTED|Overall Study||31
8278740|NCT01685697|20412559|P1|STARTED|Overall Study||31
8278741|NCT01685684|20412567|P3|NOT COMPLETED|Double-blind Maintenance Phase||96
8278742|NCT01685684|20412568|P2|NOT COMPLETED|Double-blind Maintenance Phase||71
8278743|NCT01685684|20412569|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
8278744|NCT01685684|20412567|P3|COMPLETED|Double-blind Maintenance Phase||100
8278745|NCT01685684|20412568|P2|COMPLETED|Double-blind Maintenance Phase||122
8278746|NCT01685684|20412569|P1|COMPLETED|Double-blind Maintenance Phase||0
8278747|NCT01685684|20412567|P3|STARTED|Double-blind Maintenance Phase||196
8278748|NCT01685684|20412568|P2|STARTED|Double-blind Maintenance Phase||193
8278749|NCT01685684|20412569|P1|STARTED|Double-blind Maintenance Phase||0
8278750|NCT01685684|20412567|P3|NOT COMPLETED|Titration Phase||0
8278751|NCT01685684|20412568|P2|NOT COMPLETED|Titration Phase||0
8278752|NCT01685684|20412569|P1|NOT COMPLETED|Titration Phase||351
8278753|NCT01685684|20412567|P3|COMPLETED|Titration Phase||0
8278754|NCT01685684|20412568|P2|COMPLETED|Titration Phase||0
8278755|NCT01685684|20412569|P1|COMPLETED|Titration Phase||389
8278756|NCT01685684|20412567|P3|STARTED|Titration Phase||0
8278757|NCT01685684|20412568|P2|STARTED|Titration Phase||0
8278758|NCT01685684|20412569|P1|STARTED|Titration Phase||740
8278759|NCT01685606|20412593|P1|NOT COMPLETED|Overall Study||1
8278760|NCT01685606|20412593|P1|COMPLETED|Overall Study||5
8278761|NCT01685606|20412593|P1|STARTED|Overall Study||6
8278762|NCT01685567|20412598|P1|NOT COMPLETED|Overall Study||0
8278763|NCT01685567|20412598|P1|COMPLETED|Overall Study||219
8278764|NCT01685567|20412598|P1|STARTED|Overall Study||219
8278765|NCT01685463|20412608|P2|NOT COMPLETED|Overall Study||0
8278766|NCT01685463|20412609|P1|NOT COMPLETED|Overall Study||0
8278767|NCT01685463|20412608|P2|COMPLETED|Overall Study||8
8278768|NCT01685463|20412609|P1|COMPLETED|Overall Study||10
8278769|NCT01685463|20412608|P2|STARTED|Overall Study||8
8278770|NCT01685463|20412609|P1|STARTED|Overall Study||10
8278771|NCT01685437|20412621|P1|NOT COMPLETED|Overall Study||31
8278772|NCT01685437|20412621|P1|COMPLETED|Overall Study||158
8278773|NCT01685437|20412621|P1|STARTED|Overall Study||189
8278774|NCT01685372|20412635|P2|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
8278775|NCT01685372|20412636|P1|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
8278776|NCT01685372|20412635|P2|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
8278777|NCT01685372|20412636|P1|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
8278778|NCT01685372|20412635|P2|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
8278779|NCT01685372|20412636|P1|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
8278780|NCT01685372|20412635|P2|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
8278781|NCT01685372|20412636|P1|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
8278782|NCT01685372|20412635|P2|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
8278783|NCT01685372|20412636|P1|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
8278784|NCT01685372|20412635|P2|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
8278785|NCT01685372|20412636|P1|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
8278786|NCT01685372|20412635|P2|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
8278787|NCT01685372|20412636|P1|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
8278788|NCT01685372|20412635|P2|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
8278789|NCT01685372|20412636|P1|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
8278790|NCT01685372|20412635|P2|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
8278791|NCT01685372|20412636|P1|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
8278798|NCT01685242|20412669|P2|NOT COMPLETED|Overall Study||3
8278799|NCT01685242|20412670|P1|NOT COMPLETED|Overall Study||1
8278800|NCT01685242|20412669|P2|COMPLETED|Overall Study||47
8278801|NCT01685242|20412670|P1|COMPLETED|Overall Study||49
8278802|NCT01685242|20412669|P2|STARTED|Overall Study||50
8278803|NCT01685242|20412670|P1|STARTED|Overall Study||50
8278804|NCT01685229|20412726|P2|NOT COMPLETED|Overall Study||16
8278805|NCT01685229|20412727|P1|NOT COMPLETED|Overall Study||26
8278806|NCT01685229|20412726|P2|COMPLETED|Overall Study||36
8278807|NCT01685229|20412727|P1|COMPLETED|Overall Study||120
8278808|NCT01685229|20412726|P2|STARTED|Overall Study||52
8278809|NCT01685229|20412727|P1|STARTED|Overall Study||146
8278841|NCT01685138|20412820|P1|NOT COMPLETED|Overall Study||92
8278842|NCT01685138|20412820|P1|COMPLETED|Overall Study||32
8278843|NCT01685138|20412820|P1|Discontinued From Study|Overall Study||51
8278844|NCT01685138|20412820|P1|Entered Survival Follow-up|Overall Study||63
8278845|NCT01685138|20412820|P1|Entered Post-treatment Efficacy f/up|Overall Study||10
8278846|NCT01685138|20412820|P1|Discontinued From Treatment Phase|Overall Study||124
8278847|NCT01685138|20412820|P1|STARTED|Overall Study||124
8278848|NCT01685073|20412836|P2|NOT COMPLETED|Overall Study||32
8278849|NCT01685073|20412837|P1|NOT COMPLETED|Overall Study||30
8278850|NCT01685073|20412836|P2|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33
8278851|NCT01685073|20412837|P1|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32
8278852|NCT01685073|20412836|P2|STARTED|Overall Study|Randomized|65
8278853|NCT01685073|20412837|P1|STARTED|Overall Study|Randomized|62
8278854|NCT01685060|20412845|P1|NOT COMPLETED|Overall Study||140
8278855|NCT01685060|20412845|P1|COMPLETED|Overall Study||0
8278856|NCT01685060|20412845|P1|Discontinued From Study|Overall Study||35
8278857|NCT01685060|20412845|P1|Entered Survival Follow up|Overall Study||98
8278858|NCT01685060|20412845|P1|Entered Post-treatment Efficacy f/u|Overall Study||7
8278859|NCT01685060|20412845|P1|STARTED|Overall Study||140
8278860|NCT01685047|20412860|P1|NOT COMPLETED|Overall Study||85
8278861|NCT01685047|20412860|P1|COMPLETED|Overall Study||396
8278862|NCT01685047|20412860|P1|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481
8278863|NCT01685021|20412864|P1|NOT COMPLETED|Overall Study||16
8278864|NCT01685021|20412864|P1|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
8278865|NCT01685021|20412864|P1|STARTED|Overall Study||22
8278866|NCT01684943|20412876|P3|NOT COMPLETED|Overall Study||1
8278867|NCT01684943|20412877|P2|NOT COMPLETED|Overall Study||1
8278868|NCT01684943|20412878|P1|NOT COMPLETED|Overall Study||9
8278869|NCT01684943|20412876|P3|COMPLETED|Overall Study||0
8278870|NCT01684943|20412877|P2|COMPLETED|Overall Study||2
8278871|NCT01684943|20412878|P1|COMPLETED|Overall Study||20
8278872|NCT01684943|20412876|P3|STARTED|Overall Study||1
8278873|NCT01684943|20412877|P2|STARTED|Overall Study||3
8278874|NCT01684943|20412878|P1|STARTED|Overall Study||29
8278875|NCT01684930|20412897|P2|NOT COMPLETED|Overall Study||1
8278876|NCT01684930|20412898|P1|NOT COMPLETED|Overall Study||3
8278877|NCT01684930|20412897|P2|COMPLETED|Overall Study||13
8278878|NCT01684930|20412898|P1|COMPLETED|Overall Study||9
8278879|NCT01684930|20412897|P2|STARTED|Overall Study||14
8278880|NCT01684930|20412898|P1|STARTED|Overall Study||12
8278881|NCT01684917|20412918|P4|NOT COMPLETED|Overall Study||0
8278882|NCT01684917|20412919|P3|NOT COMPLETED|Overall Study||0
8278883|NCT01684917|20412920|P2|NOT COMPLETED|Overall Study||0
8278884|NCT01684917|20412921|P1|NOT COMPLETED|Overall Study||0
8278885|NCT01684917|20412918|P4|COMPLETED|Overall Study||5
8278886|NCT01684917|20412919|P3|COMPLETED|Overall Study||13
8278887|NCT01684917|20412920|P2|COMPLETED|Overall Study||7
8278888|NCT01684917|20412921|P1|COMPLETED|Overall Study||11
8278889|NCT01684917|20412918|P4|STARTED|Overall Study||5
8278890|NCT01684917|20412919|P3|STARTED|Overall Study||13
8278891|NCT01684917|20412920|P2|STARTED|Overall Study||7
8278892|NCT01684917|20412921|P1|STARTED|Overall Study||11
8278893|NCT01684878|20412955|P4|NOT COMPLETED|Part 2: Randomized Phase||78
8278894|NCT01684878|20412956|P3|NOT COMPLETED|Part 2: Randomized Phase||78
8278895|NCT01684878|20412957|P2|NOT COMPLETED|Part 2: Randomized Phase||0
8278896|NCT01684878|20412958|P1|NOT COMPLETED|Part 2: Randomized Phase||0
8278897|NCT01684878|20412955|P4|COMPLETED|Part 2: Randomized Phase||0
8278898|NCT01684878|20412956|P3|COMPLETED|Part 2: Randomized Phase||0
8278899|NCT01684878|20412957|P2|COMPLETED|Part 2: Randomized Phase||0
8278900|NCT01684878|20412958|P1|COMPLETED|Part 2: Randomized Phase||0
8278901|NCT01684878|20412955|P4|Participants Mis-randomized|Part 2: Randomized Phase||0
8278902|NCT01684878|20412956|P3|Participants Mis-randomized|Part 2: Randomized Phase||2
8278903|NCT01684878|20412957|P2|Participants Mis-randomized|Part 2: Randomized Phase||0
8278904|NCT01684878|20412958|P1|Participants Mis-randomized|Part 2: Randomized Phase||0
8278905|NCT01684878|20412955|P4|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
8278906|NCT01684878|20412956|P3|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
8278907|NCT01684878|20412957|P2|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
8278908|NCT01684878|20412958|P1|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
8278909|NCT01684878|20412955|P4|STARTED|Part 2: Randomized Phase||78
8278910|NCT01684878|20412956|P3|STARTED|Part 2: Randomized Phase||78
8278911|NCT01684878|20412957|P2|STARTED|Part 2: Randomized Phase||0
8278912|NCT01684878|20412958|P1|STARTED|Part 2: Randomized Phase||0
8278913|NCT01684878|20412955|P4|NOT COMPLETED|Part 1: Safety Run in Phase||0
8278914|NCT01684878|20412956|P3|NOT COMPLETED|Part 1: Safety Run in Phase||0
8278915|NCT01684878|20412957|P2|NOT COMPLETED|Part 1: Safety Run in Phase||23
8278916|NCT01684878|20412958|P1|NOT COMPLETED|Part 1: Safety Run in Phase||16
8278917|NCT01684878|20412955|P4|COMPLETED|Part 1: Safety Run in Phase||0
8278918|NCT01684878|20412956|P3|COMPLETED|Part 1: Safety Run in Phase||0
8278919|NCT01684878|20412957|P2|COMPLETED|Part 1: Safety Run in Phase||5
8278920|NCT01684878|20412958|P1|COMPLETED|Part 1: Safety Run in Phase||6
8278921|NCT01684878|20412955|P4|STARTED|Part 1: Safety Run in Phase||0
8278922|NCT01684878|20412956|P3|STARTED|Part 1: Safety Run in Phase||0
8278923|NCT01684878|20412957|P2|STARTED|Part 1: Safety Run in Phase||28
8278924|NCT01684878|20412958|P1|STARTED|Part 1: Safety Run in Phase||22
8278925|NCT01684839|20412982|P1|NOT COMPLETED|Overall Study||0
8278926|NCT01684839|20412982|P1|COMPLETED|Overall Study||9
8278927|NCT01684839|20412982|P1|STARTED|Overall Study||9
8278928|NCT01684826|20412986|P1|NOT COMPLETED|Overall Study||10
8278929|NCT01684826|20412986|P1|COMPLETED|Overall Study||39
8278930|NCT01684826|20412986|P1|Collected Dose and Image Information|Overall Study||39
8278931|NCT01684826|20412986|P1|STARTED|Overall Study||49
8278932|NCT01684748|20412994|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
8278933|NCT01684748|20412995|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
8278934|NCT01684748|20412994|P2|COMPLETED|Second Intervention - 8 Weeks||8
8278935|NCT01684748|20412995|P1|COMPLETED|Second Intervention - 8 Weeks||8
8278936|NCT01684748|20412994|P2|STARTED|Second Intervention - 8 Weeks||8
8278937|NCT01684748|20412995|P1|STARTED|Second Intervention - 8 Weeks||8
8278938|NCT01684748|20412994|P2|NOT COMPLETED|First Intervention - 8 Weeks||2
8278939|NCT01684748|20412995|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
8278940|NCT01684748|20412994|P2|COMPLETED|First Intervention - 8 Weeks||8
8278941|NCT01684748|20412995|P1|COMPLETED|First Intervention - 8 Weeks||8
8278942|NCT01684748|20412994|P2|STARTED|First Intervention - 8 Weeks||10
8278943|NCT01684748|20412995|P1|STARTED|First Intervention - 8 Weeks||10
8278956|NCT01684592|20413025|P2|NOT COMPLETED|Overall Study||24
8278957|NCT01684592|20413026|P1|NOT COMPLETED|Overall Study||26
8278958|NCT01684592|20413025|P2|COMPLETED|Overall Study||40
8278959|NCT01684592|20413026|P1|COMPLETED|Overall Study||38
8278960|NCT01684592|20413025|P2|STARTED|Overall Study||64
8278961|NCT01684592|20413026|P1|STARTED|Overall Study||64
8278962|NCT01684566|20413046|P2|NOT COMPLETED|Overall Study||7
8278963|NCT01684566|20413047|P1|NOT COMPLETED|Overall Study||16
8278964|NCT01684566|20413046|P2|COMPLETED|Overall Study||49
8278965|NCT01684566|20413047|P1|COMPLETED|Overall Study||44
8278966|NCT01684566|20413046|P2|Treated (ITT)|Overall Study||52
8278967|NCT01684566|20413047|P1|Treated (ITT)|Overall Study||57
8278968|NCT01684566|20413046|P2|STARTED|Overall Study||56
8278969|NCT01684566|20413047|P1|STARTED|Overall Study||60
8278970|NCT01684436|20413069|P1|NOT COMPLETED|Overall Study||1
8278971|NCT01684436|20413069|P1|COMPLETED|Overall Study||29
8278972|NCT01684436|20413069|P1|STARTED|Overall Study||30
8278973|NCT01684423|20413083|P5|NOT COMPLETED|Overall Study||0
8278974|NCT01684423|20413084|P4|NOT COMPLETED|Overall Study||0
8278975|NCT01684423|20413085|P3|NOT COMPLETED|Overall Study||1
8278976|NCT01684423|20413086|P2|NOT COMPLETED|Overall Study||0
8278977|NCT01684423|20413087|P1|NOT COMPLETED|Overall Study||0
8278978|NCT01684423|20413083|P5|COMPLETED|Overall Study||7
8278979|NCT01684423|20413084|P4|COMPLETED|Overall Study||19
8278980|NCT01684423|20413085|P3|COMPLETED|Overall Study||12
8278981|NCT01684423|20413086|P2|COMPLETED|Overall Study||13
8278982|NCT01684423|20413087|P1|COMPLETED|Overall Study||11
8278983|NCT01684423|20413083|P5|STARTED|Overall Study||7
8278984|NCT01684423|20413084|P4|STARTED|Overall Study||19
8278985|NCT01684423|20413085|P3|STARTED|Overall Study||13
8278986|NCT01684423|20413086|P2|STARTED|Overall Study||13
8278987|NCT01684423|20413087|P1|STARTED|Overall Study||11
8278988|NCT01684410|20413124|P3|NOT COMPLETED|Overall Study||0
8278989|NCT01684410|20413125|P2|NOT COMPLETED|Overall Study||0
8278990|NCT01684410|20413126|P1|NOT COMPLETED|Overall Study||0
8278991|NCT01684410|20413124|P3|COMPLETED|Overall Study||10
8278992|NCT01684410|20413125|P2|COMPLETED|Overall Study||10
8278993|NCT01684410|20413126|P1|COMPLETED|Overall Study||10
8278994|NCT01684410|20413124|P3|STARTED|Overall Study||10
8278995|NCT01684410|20413125|P2|STARTED|Overall Study||10
8278996|NCT01684410|20413126|P1|STARTED|Overall Study||10
8278997|NCT01684215|20413144|P4|NOT COMPLETED|Phase 2||43
8278998|NCT01684215|20413145|P3|NOT COMPLETED|Phase 2||0
8278999|NCT01684215|20413146|P2|NOT COMPLETED|Phase 2||0
8279000|NCT01684215|20413147|P1|NOT COMPLETED|Phase 2||0
8279001|NCT01684215|20413144|P4|COMPLETED|Phase 2||0
8279002|NCT01684215|20413145|P3|COMPLETED|Phase 2||0
8279003|NCT01684215|20413146|P2|COMPLETED|Phase 2||0
8279004|NCT01684215|20413147|P1|COMPLETED|Phase 2||0
8279005|NCT01684215|20413144|P4|Treated|Phase 2||42
8279006|NCT01684215|20413145|P3|Treated|Phase 2||0
8279007|NCT01684215|20413146|P2|Treated|Phase 2||0
8279008|NCT01684215|20413147|P1|Treated|Phase 2||0
8279009|NCT01684215|20413144|P4|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43
8279010|NCT01684215|20413145|P3|STARTED|Phase 2||0
8279011|NCT01684215|20413146|P2|STARTED|Phase 2||0
8279012|NCT01684215|20413147|P1|STARTED|Phase 2||0
8279013|NCT01684215|20413144|P4|NOT COMPLETED|Phase 1, Part 2||0
8279014|NCT01684215|20413145|P3|NOT COMPLETED|Phase 1, Part 2||6
8279015|NCT01684215|20413146|P2|NOT COMPLETED|Phase 1, Part 2||0
8279016|NCT01684215|20413147|P1|NOT COMPLETED|Phase 1, Part 2||0
8279017|NCT01684215|20413144|P4|COMPLETED|Phase 1, Part 2||0
8279018|NCT01684215|20413145|P3|COMPLETED|Phase 1, Part 2||0
8279019|NCT01684215|20413146|P2|COMPLETED|Phase 1, Part 2||0
8279020|NCT01684215|20413147|P1|COMPLETED|Phase 1, Part 2||0
8279021|NCT01684215|20413144|P4|STARTED|Phase 1, Part 2||0
8279022|NCT01684215|20413145|P3|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6
8279023|NCT01684215|20413146|P2|STARTED|Phase 1, Part 2||0
8279024|NCT01684215|20413147|P1|STARTED|Phase 1, Part 2||0
8279025|NCT01684215|20413144|P4|NOT COMPLETED|Phase 1, Part 1||0
8279026|NCT01684215|20413145|P3|NOT COMPLETED|Phase 1, Part 1||0
8279027|NCT01684215|20413146|P2|NOT COMPLETED|Phase 1, Part 1||6
8279028|NCT01684215|20413147|P1|NOT COMPLETED|Phase 1, Part 1||6
8279029|NCT01684215|20413144|P4|COMPLETED|Phase 1, Part 1||0
8279030|NCT01684215|20413145|P3|COMPLETED|Phase 1, Part 1||0
8279031|NCT01684215|20413146|P2|COMPLETED|Phase 1, Part 1||0
8279032|NCT01684215|20413147|P1|COMPLETED|Phase 1, Part 1||0
8279033|NCT01684215|20413144|P4|Treated|Phase 1, Part 1||0
8279034|NCT01684215|20413145|P3|Treated|Phase 1, Part 1||0
8279035|NCT01684215|20413146|P2|Treated|Phase 1, Part 1||6
8279036|NCT01684215|20413147|P1|Treated|Phase 1, Part 1||6
8279037|NCT01684215|20413144|P4|STARTED|Phase 1, Part 1||0
8279038|NCT01684215|20413145|P3|STARTED|Phase 1, Part 1||0
8279039|NCT01684215|20413146|P2|STARTED|Phase 1, Part 1||6
8279040|NCT01684215|20413147|P1|STARTED|Phase 1, Part 1||6
8279041|NCT01684046|20413221|P2|NOT COMPLETED|Period 2, Second 30 Days||0
8279042|NCT01684046|20413222|P1|NOT COMPLETED|Period 2, Second 30 Days||0
8279043|NCT01684046|20413221|P2|COMPLETED|Period 2, Second 30 Days||93
8279044|NCT01684046|20413222|P1|COMPLETED|Period 2, Second 30 Days||97
8279045|NCT01684046|20413221|P2|STARTED|Period 2, Second 30 Days||93
8279046|NCT01684046|20413222|P1|STARTED|Period 2, Second 30 Days||97
8279047|NCT01684046|20413221|P2|NOT COMPLETED|Period 1, First 30 Days||2
8279048|NCT01684046|20413222|P1|NOT COMPLETED|Period 1, First 30 Days||0
8279049|NCT01684046|20413221|P2|COMPLETED|Period 1, First 30 Days||93
8279050|NCT01684046|20413222|P1|COMPLETED|Period 1, First 30 Days||97
8279051|NCT01684046|20413221|P2|STARTED|Period 1, First 30 Days||95
8279052|NCT01684046|20413222|P1|STARTED|Period 1, First 30 Days||97
8279053|NCT01684033|20413228|P2|NOT COMPLETED|Period 2, Second 30 Days||0
8279054|NCT01684033|20413229|P1|NOT COMPLETED|Period 2, Second 30 Days||1
8279055|NCT01684033|20413228|P2|COMPLETED|Period 2, Second 30 Days||98
8279056|NCT01684033|20413229|P1|COMPLETED|Period 2, Second 30 Days||94
8279057|NCT01684033|20413228|P2|STARTED|Period 2, Second 30 Days||98
8279058|NCT01684033|20413229|P1|STARTED|Period 2, Second 30 Days||95
8279059|NCT01684033|20413228|P2|NOT COMPLETED|Period 1, First 30 Days||1
8279060|NCT01684033|20413229|P1|NOT COMPLETED|Period 1, First 30 Days||4
8279061|NCT01684033|20413228|P2|COMPLETED|Period 1, First 30 Days||98
8279062|NCT01684033|20413229|P1|COMPLETED|Period 1, First 30 Days||95
8279063|NCT01684033|20413228|P2|STARTED|Period 1, First 30 Days||99
8279064|NCT01684033|20413229|P1|STARTED|Period 1, First 30 Days||99
8279065|NCT01684020|20413239|P2|NOT COMPLETED|Overall Study||0
8279066|NCT01684020|20413240|P1|NOT COMPLETED|Overall Study||1
8279067|NCT01684020|20413239|P2|COMPLETED|Overall Study||5
8279068|NCT01684020|20413240|P1|COMPLETED|Overall Study||4
8279069|NCT01684020|20413239|P2|STARTED|Overall Study||5
8279070|NCT01684020|20413240|P1|STARTED|Overall Study||5
8279071|NCT01684007|20413264|P2|NOT COMPLETED|Overall Study||0
8279072|NCT01684007|20413265|P1|NOT COMPLETED|Overall Study||0
8279073|NCT01684007|20413264|P2|COMPLETED|Overall Study||50
8279074|NCT01684007|20413265|P1|COMPLETED|Overall Study||53
8279075|NCT01684007|20413264|P2|STARTED|Overall Study||50
8279076|NCT01684007|20413265|P1|STARTED|Overall Study||53
8279077|NCT01683994|20413278|P5|NOT COMPLETED|Overall Study||1
8279078|NCT01683994|20413279|P4|NOT COMPLETED|Overall Study||3
8279079|NCT01683994|20413280|P3|NOT COMPLETED|Overall Study||0
8279080|NCT01683994|20413281|P2|NOT COMPLETED|Overall Study||0
8279081|NCT01683994|20413282|P1|NOT COMPLETED|Overall Study||1
8279082|NCT01683994|20413278|P5|COMPLETED|Overall Study||12
8279083|NCT01683994|20413279|P4|COMPLETED|Overall Study||10
8279084|NCT01683994|20413280|P3|COMPLETED|Overall Study||7
8279085|NCT01683994|20413281|P2|COMPLETED|Overall Study||8
8279086|NCT01683994|20413282|P1|COMPLETED|Overall Study||3
8279087|NCT01683994|20413278|P5|# of Patients Who Received Treatment|Overall Study||13
8279088|NCT01683994|20413279|P4|# of Patients Who Received Treatment|Overall Study||12
8279089|NCT01683994|20413280|P3|# of Patients Who Received Treatment|Overall Study||7
8279090|NCT01683994|20413281|P2|# of Patients Who Received Treatment|Overall Study||8
8279091|NCT01683994|20413282|P1|# of Patients Who Received Treatment|Overall Study||4
8279092|NCT01683994|20413278|P5|STARTED|Overall Study||13
8279093|NCT01683994|20413279|P4|STARTED|Overall Study||13
8279094|NCT01683994|20413280|P3|STARTED|Overall Study||7
8279095|NCT01683994|20413281|P2|STARTED|Overall Study||8
8279096|NCT01683994|20413282|P1|STARTED|Overall Study||4
8279097|NCT01683864|20413311|P3|NOT COMPLETED|Overall Study||0
8279098|NCT01683864|20413312|P2|NOT COMPLETED|Overall Study||0
8279099|NCT01683864|20413313|P1|NOT COMPLETED|Overall Study||0
8279100|NCT01683864|20413311|P3|COMPLETED|Overall Study||0
8279101|NCT01683864|20413312|P2|COMPLETED|Overall Study||0
8279102|NCT01683864|20413313|P1|COMPLETED|Overall Study||0
8279103|NCT01683864|20413311|P3|STARTED|Overall Study||0
8279104|NCT01683864|20413312|P2|STARTED|Overall Study||0
8279105|NCT01683864|20413313|P1|STARTED|Overall Study||0
8279106|NCT01683838|20413323|P2|NOT COMPLETED|Overall Study||12
8279107|NCT01683838|20413324|P1|NOT COMPLETED|Overall Study||26
8279108|NCT01683838|20413323|P2|COMPLETED|Overall Study||88
8279109|NCT01683838|20413324|P1|COMPLETED|Overall Study||78
8279110|NCT01683838|20413323|P2|Efficacy Population|Overall Study||93
8279111|NCT01683838|20413324|P1|Efficacy Population|Overall Study||89
8279112|NCT01683838|20413323|P2|Safety Population|Overall Study||100
8279113|NCT01683838|20413324|P1|Safety Population|Overall Study||103
8279114|NCT01683838|20413323|P2|Intent to Treat (ITT) Population|Overall Study||100
8279115|NCT01683838|20413324|P1|Intent to Treat (ITT) Population|Overall Study||103
8279116|NCT01683838|20413323|P2|STARTED|Overall Study||100
8279117|NCT01683838|20413324|P1|STARTED|Overall Study||104
8279118|NCT01683812|20413346|P1|NOT COMPLETED|Overall Study||0
8279119|NCT01683812|20413346|P1|COMPLETED|Overall Study||23
8279120|NCT01683812|20413346|P1|STARTED|Overall Study||23
8279121|NCT01683630|20413353|P2|NOT COMPLETED|Overall Study||0
8279122|NCT01683630|20413354|P1|NOT COMPLETED|Overall Study||0
8279123|NCT01683630|20413353|P2|COMPLETED|Overall Study||445
8279124|NCT01683630|20413354|P1|COMPLETED|Overall Study||1404
8279125|NCT01683630|20413353|P2|STARTED|Overall Study||445
8279126|NCT01683630|20413354|P1|STARTED|Overall Study||1404
8279127|NCT01683604|20413364|P1|NOT COMPLETED|Overall Study||5
8279128|NCT01683604|20413364|P1|COMPLETED|Overall Study||32
8279129|NCT01683604|20413364|P1|STARTED|Overall Study||37
8279130|NCT01683565|20413529|P2|NOT COMPLETED|Overall Study||1
8279131|NCT01683565|20413530|P1|NOT COMPLETED|Overall Study||3
8279132|NCT01683565|20413529|P2|COMPLETED|Overall Study||15
8279133|NCT01683565|20413530|P1|COMPLETED|Overall Study||12
8279134|NCT01683565|20413529|P2|STARTED|Overall Study||16
8279135|NCT01683565|20413530|P1|STARTED|Overall Study||15
8279136|NCT01683526|20413544|P2|NOT COMPLETED|Overall Study||0
8279137|NCT01683526|20413545|P1|NOT COMPLETED|Overall Study||0
8279138|NCT01683526|20413544|P2|COMPLETED|Overall Study||57
8279139|NCT01683526|20413545|P1|COMPLETED|Overall Study||60
8279140|NCT01683526|20413544|P2|STARTED|Overall Study||57
8279141|NCT01683526|20413545|P1|STARTED|Overall Study||60
8279142|NCT01683409|20413564|P5|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
8279143|NCT01683409|20413565|P4|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
8279144|NCT01683409|20413566|P3|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
8279145|NCT01683409|20413567|P2|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
8279146|NCT01683409|20413568|P1|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
8279147|NCT01683409|20413564|P5|COMPLETED|Washout Period 2 (Weeks 29-32)||9
8279148|NCT01683409|20413565|P4|COMPLETED|Washout Period 2 (Weeks 29-32)||6
8279149|NCT01683409|20413566|P3|COMPLETED|Washout Period 2 (Weeks 29-32)||7
8279150|NCT01683409|20413567|P2|COMPLETED|Washout Period 2 (Weeks 29-32)||6
8279151|NCT01683409|20413568|P1|COMPLETED|Washout Period 2 (Weeks 29-32)||6
8279152|NCT01683409|20413564|P5|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
8279153|NCT01683409|20413565|P4|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
8279154|NCT01683409|20413566|P3|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
8279155|NCT01683409|20413567|P2|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
8279156|NCT01683409|20413568|P1|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
8279157|NCT01683409|20413564|P5|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
8279158|NCT01683409|20413565|P4|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
8279159|NCT01683409|20413566|P3|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
8279160|NCT01683409|20413567|P2|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
8279161|NCT01683409|20413568|P1|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
8279162|NCT01683409|20413564|P5|COMPLETED|Washout Period 1 (Weeks 25-28)||20
8279163|NCT01683409|20413565|P4|COMPLETED|Washout Period 1 (Weeks 25-28)||22
8279164|NCT01683409|20413566|P3|COMPLETED|Washout Period 1 (Weeks 25-28)||25
8279165|NCT01683409|20413567|P2|COMPLETED|Washout Period 1 (Weeks 25-28)||17
8279166|NCT01683409|20413568|P1|COMPLETED|Washout Period 1 (Weeks 25-28)||24
8279167|NCT01683409|20413564|P5|STARTED|Washout Period 1 (Weeks 25-28)||23
8279168|NCT01683409|20413565|P4|STARTED|Washout Period 1 (Weeks 25-28)||24
8279169|NCT01683409|20413566|P3|STARTED|Washout Period 1 (Weeks 25-28)||26
8279170|NCT01683409|20413567|P2|STARTED|Washout Period 1 (Weeks 25-28)||21
8279171|NCT01683409|20413568|P1|STARTED|Washout Period 1 (Weeks 25-28)||27
8279172|NCT01683409|20413564|P5|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
8279173|NCT01683409|20413565|P4|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
8279174|NCT01683409|20413566|P3|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
8279175|NCT01683409|20413567|P2|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
8279176|NCT01683409|20413568|P1|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
8279177|NCT01683409|20413564|P5|COMPLETED|Treatment Period (Weeks 1-24)||23
8279178|NCT01683409|20413565|P4|COMPLETED|Treatment Period (Weeks 1-24)||24
8279179|NCT01683409|20413566|P3|COMPLETED|Treatment Period (Weeks 1-24)||26
8279180|NCT01683409|20413567|P2|COMPLETED|Treatment Period (Weeks 1-24)||21
8279181|NCT01683409|20413568|P1|COMPLETED|Treatment Period (Weeks 1-24)||27
8279182|NCT01683409|20413564|P5|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
8279183|NCT01683409|20413565|P4|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
8279184|NCT01683409|20413566|P3|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
8279185|NCT01683409|20413567|P2|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
8279186|NCT01683409|20413568|P1|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
8279187|NCT01683409|20413564|P5|STARTED|Treatment Period (Weeks 1-24)||25
8279188|NCT01683409|20413565|P4|STARTED|Treatment Period (Weeks 1-24)||26
8279189|NCT01683409|20413566|P3|STARTED|Treatment Period (Weeks 1-24)||27
8279190|NCT01683409|20413567|P2|STARTED|Treatment Period (Weeks 1-24)||25
8279191|NCT01683409|20413568|P1|STARTED|Treatment Period (Weeks 1-24)||27
8279192|NCT01683383|20413611|P2|NOT COMPLETED|Overall Study||0
8279193|NCT01683383|20413612|P1|NOT COMPLETED|Overall Study||1
8279194|NCT01683383|20413611|P2|COMPLETED|Overall Study||51
8279195|NCT01683383|20413612|P1|COMPLETED|Overall Study||49
8279196|NCT01683383|20413611|P2|Transported and Treated|Overall Study||51
8279197|NCT01683383|20413612|P1|Transported and Treated|Overall Study||49
8279198|NCT01683383|20413611|P2|STARTED|Overall Study||51
8279199|NCT01683383|20413612|P1|STARTED|Overall Study||50
8279200|NCT01683331|20413628|P2|NOT COMPLETED|Overall Study||0
8279201|NCT01683331|20413629|P1|NOT COMPLETED|Overall Study||0
8279202|NCT01683331|20413628|P2|COMPLETED|Overall Study||18
8279203|NCT01683331|20413629|P1|COMPLETED|Overall Study||18
8279204|NCT01683331|20413628|P2|24 Months|Overall Study||18
8279205|NCT01683331|20413629|P1|24 Months|Overall Study||18
8279206|NCT01683331|20413628|P2|12 Months|Overall Study||18
8279207|NCT01683331|20413629|P1|12 Months|Overall Study||18
8279208|NCT01683331|20413628|P2|Began Dosage|Overall Study||18
8279209|NCT01683331|20413629|P1|Began Dosage|Overall Study||18
8279210|NCT01683331|20413628|P2|STARTED|Overall Study||18
8279211|NCT01683331|20413629|P1|STARTED|Overall Study||18
8279212|NCT01683266|20413639|P2|NOT COMPLETED|Overall Study||50
8279213|NCT01683266|20413640|P1|NOT COMPLETED|Overall Study||55
8279214|NCT01683266|20413639|P2|COMPLETED|Overall Study||225
8279215|NCT01683266|20413640|P1|COMPLETED|Overall Study||219
8279216|NCT01683266|20413639|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
8279217|NCT01683266|20413640|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
8279218|NCT01683266|20413639|P2|STARTED|Overall Study||275
8279219|NCT01683266|20413640|P1|STARTED|Overall Study||274
8279220|NCT01683071|20413674|P6|NOT COMPLETED|Part 2||15
8279221|NCT01683071|20413675|P5|NOT COMPLETED|Part 2||17
8279222|NCT01683071|20413676|P4|NOT COMPLETED|Part 2||0
8279223|NCT01683071|20413677|P3|NOT COMPLETED|Part 2||0
8279224|NCT01683071|20413678|P2|NOT COMPLETED|Part 2||0
8279225|NCT01683071|20413679|P1|NOT COMPLETED|Part 2||0
8279226|NCT01683071|20413674|P6|COMPLETED|Part 2||82
8279227|NCT01683071|20413675|P5|COMPLETED|Part 2||82
8279228|NCT01683071|20413676|P4|COMPLETED|Part 2||0
8279229|NCT01683071|20413677|P3|COMPLETED|Part 2||0
8279230|NCT01683071|20413678|P2|COMPLETED|Part 2||0
8279231|NCT01683071|20413679|P1|COMPLETED|Part 2||0
8279232|NCT01683071|20413674|P6|STARTED|Part 2||97
8279233|NCT01683071|20413675|P5|STARTED|Part 2||99
8279234|NCT01683071|20413676|P4|STARTED|Part 2||0
8279235|NCT01683071|20413677|P3|STARTED|Part 2||0
8279236|NCT01683071|20413678|P2|STARTED|Part 2||0
8279237|NCT01683071|20413679|P1|STARTED|Part 2||0
8279238|NCT01683071|20413674|P6|NOT COMPLETED|Part 1||0
8279239|NCT01683071|20413675|P5|NOT COMPLETED|Part 1||0
8279240|NCT01683071|20413676|P4|NOT COMPLETED|Part 1||5
8279241|NCT01683071|20413677|P3|NOT COMPLETED|Part 1||3
8279242|NCT01683071|20413678|P2|NOT COMPLETED|Part 1||4
8279243|NCT01683071|20413679|P1|NOT COMPLETED|Part 1||4
8279244|NCT01683071|20413674|P6|COMPLETED|Part 1||0
8279245|NCT01683071|20413675|P5|COMPLETED|Part 1||0
8279246|NCT01683071|20413676|P4|COMPLETED|Part 1||20
8279247|NCT01683071|20413677|P3|COMPLETED|Part 1||22
8279248|NCT01683071|20413678|P2|COMPLETED|Part 1||22
8279249|NCT01683071|20413679|P1|COMPLETED|Part 1||21
8279250|NCT01683071|20413674|P6|STARTED|Part 1||0
8279251|NCT01683071|20413675|P5|STARTED|Part 1||0
8279252|NCT01683071|20413676|P4|STARTED|Part 1||25
8279253|NCT01683071|20413677|P3|STARTED|Part 1||25
8279254|NCT01683071|20413678|P2|STARTED|Part 1||26
8279255|NCT01683071|20413679|P1|STARTED|Part 1||25
8279256|NCT01683058|20413705|P1|NOT COMPLETED|Overall Study||29
8279257|NCT01683058|20413705|P1|COMPLETED|Overall Study||45
8279258|NCT01683058|20413705|P1|STARTED|Overall Study||74
8279259|NCT01683019|20413736|P3|NOT COMPLETED|Overall Study||4
8279260|NCT01683019|20413737|P2|NOT COMPLETED|Overall Study||1
8279261|NCT01683019|20413738|P1|NOT COMPLETED|Overall Study||2
8279262|NCT01683019|20413736|P3|COMPLETED|Overall Study||15
8279263|NCT01683019|20413737|P2|COMPLETED|Overall Study||14
8279264|NCT01683019|20413738|P1|COMPLETED|Overall Study||16
8279265|NCT01683019|20413736|P3|STARTED|Overall Study||19
8279266|NCT01683019|20413737|P2|STARTED|Overall Study||15
8279267|NCT01683019|20413738|P1|STARTED|Overall Study||18
8279268|NCT01682954|20413748|P2|NOT COMPLETED|Overall Study||5
8279269|NCT01682954|20413749|P1|NOT COMPLETED|Overall Study||5
8279270|NCT01682954|20413748|P2|COMPLETED|Overall Study||33
8279271|NCT01682954|20413749|P1|COMPLETED|Overall Study||35
8279272|NCT01682954|20413748|P2|STARTED|Overall Study||38
8279273|NCT01682954|20413749|P1|STARTED|Overall Study||40
8279274|NCT01682928|20413759|P2|NOT COMPLETED|Overall Study||0
8279275|NCT01682928|20413760|P1|NOT COMPLETED|Overall Study||0
8279276|NCT01682928|20413759|P2|COMPLETED|Overall Study||2
8279277|NCT01682928|20413760|P1|COMPLETED|Overall Study||2
8279278|NCT01682928|20413759|P2|STARTED|Overall Study|2 subjects in this Arm|2
8279279|NCT01682928|20413760|P1|STARTED|Overall Study|2 subjects in this Arm|2
8279280|NCT01682876|20413772|P4|NOT COMPLETED|Overall Study||19
8279281|NCT01682876|20413773|P3|NOT COMPLETED|Overall Study||11
8279282|NCT01682876|20413774|P2|NOT COMPLETED|Overall Study||20
8279283|NCT01682876|20413775|P1|NOT COMPLETED|Overall Study||21
8279284|NCT01682876|20413772|P4|COMPLETED|Overall Study||157
8279285|NCT01682876|20413773|P3|COMPLETED|Overall Study||169
8279286|NCT01682876|20413774|P2|COMPLETED|Overall Study||163
8279287|NCT01682876|20413775|P1|COMPLETED|Overall Study||155
8279288|NCT01682876|20413772|P4|STARTED|Overall Study||176
8279289|NCT01682876|20413773|P3|STARTED|Overall Study||180
8279290|NCT01682876|20413774|P2|STARTED|Overall Study||183
8279291|NCT01682876|20413775|P1|STARTED|Overall Study||176
8279292|NCT01682863|20413821|P3|NOT COMPLETED|Overall Study||24
8279293|NCT01682863|20413822|P2|NOT COMPLETED|Overall Study||17
8279294|NCT01682863|20413823|P1|NOT COMPLETED|Overall Study||27
8279295|NCT01682863|20413821|P3|COMPLETED|Overall Study||183
8279296|NCT01682863|20413822|P2|COMPLETED|Overall Study||187
8279297|NCT01682863|20413823|P1|COMPLETED|Overall Study||177
8279298|NCT01682863|20413821|P3|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
8279299|NCT01682863|20413822|P2|Randomized Set|Overall Study||204
8279300|NCT01682863|20413823|P1|Randomized Set|Overall Study||204
8279301|NCT01682863|20413821|P3|Full Analysis Set (FAS)|Overall Study||206
8279302|NCT01682863|20413822|P2|Full Analysis Set (FAS)|Overall Study||204
8279303|NCT01682863|20413823|P1|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
8279304|NCT01682863|20413821|P3|Safety Set|Overall Study||206
8279305|NCT01682863|20413822|P2|Safety Set|Overall Study||204
8279306|NCT01682863|20413823|P1|Safety Set|Overall Study||204
8279307|NCT01682863|20413821|P3|STARTED|Overall Study||207
8279308|NCT01682863|20413822|P2|STARTED|Overall Study||204
8279309|NCT01682863|20413823|P1|STARTED|Overall Study||204
8279310|NCT01682837|20413852|P1|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
8279311|NCT01682837|20413852|P1|COMPLETED|Fourth Intervention (4 Weeks)||30
8279312|NCT01682837|20413852|P1|Received Placebo|Fourth Intervention (4 Weeks)||7
8279313|NCT01682837|20413852|P1|Received KCl|Fourth Intervention (4 Weeks)||8
8279314|NCT01682837|20413852|P1|Received KCit|Fourth Intervention (4 Weeks)||9
8279315|NCT01682837|20413852|P1|Received KMgCit|Fourth Intervention (4 Weeks)||6
8279316|NCT01682837|20413852|P1|STARTED|Fourth Intervention (4 Weeks)||30
8279317|NCT01682837|20413852|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
8279318|NCT01682837|20413852|P1|COMPLETED|Third Intervention (4 Weeks)||30
8279319|NCT01682837|20413852|P1|Received Placebo|Third Intervention (4 Weeks)||7
8279320|NCT01682837|20413852|P1|Received KCl|Third Intervention (4 Weeks)||7
8279321|NCT01682837|20413852|P1|Received KCit|Third Intervention (4 Weeks)||7
8279322|NCT01682837|20413852|P1|Received KMgCit|Third Intervention (4 Weeks)||9
8279323|NCT01682837|20413852|P1|STARTED|Third Intervention (4 Weeks)||30
8279324|NCT01682837|20413852|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8279325|NCT01682837|20413852|P1|COMPLETED|Second Intervention (4 Weeks)||30
8279326|NCT01682837|20413852|P1|Received Placebo|Second Intervention (4 Weeks)||9
8279327|NCT01682837|20413852|P1|Received KCl|Second Intervention (4 Weeks)||8
8279328|NCT01682837|20413852|P1|Received KCit|Second Intervention (4 Weeks)||6
8279329|NCT01682837|20413852|P1|Received KMgCit|Second Intervention (4 Weeks)||7
8279330|NCT01682837|20413852|P1|STARTED|Second Intervention (4 Weeks)||30
8279331|NCT01682837|20413852|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8279332|NCT01682837|20413852|P1|COMPLETED|First Intervention (4 Weeks)||30
8279333|NCT01682837|20413852|P1|Received Placebo|First Intervention (4 Weeks)||7
8279334|NCT01682837|20413852|P1|Received KCl|First Intervention (4 Weeks)||7
8279335|NCT01682837|20413852|P1|Received KCit|First Intervention (4 Weeks)||8
8279336|NCT01682837|20413852|P1|Received KMgCit|First Intervention (4 Weeks)||8
8279337|NCT01682837|20413852|P1|STARTED|First Intervention (4 Weeks)||30
8279338|NCT01682837|20413852|P1|NOT COMPLETED|Baseline||5
8279339|NCT01682837|20413852|P1|COMPLETED|Baseline||30
8279340|NCT01682837|20413852|P1|STARTED|Baseline||35
8279341|NCT01682759|20413896|P2|NOT COMPLETED|Overall Study||70
8279342|NCT01682759|20413897|P1|NOT COMPLETED|Overall Study||69
8279343|NCT01682759|20413896|P2|COMPLETED|Overall Study||305
8279344|NCT01682759|20413897|P1|COMPLETED|Overall Study||307
8279345|NCT01682759|20413896|P2|Treated|Overall Study||375
8279346|NCT01682759|20413897|P1|Treated|Overall Study||375
8279347|NCT01682759|20413896|P2|STARTED|Overall Study||375
8279348|NCT01682759|20413897|P1|STARTED|Overall Study||376
8279349|NCT01682720|20413921|P4|NOT COMPLETED|Overall Study||39
8279350|NCT01682720|20413922|P3|NOT COMPLETED|Overall Study||7
8279351|NCT01682720|20413923|P2|NOT COMPLETED|Overall Study||5
8279352|NCT01682720|20413924|P1|NOT COMPLETED|Overall Study||85
8279353|NCT01682720|20413921|P4|COMPLETED|Overall Study||211
8279354|NCT01682720|20413922|P3|COMPLETED|Overall Study||5
8279355|NCT01682720|20413923|P2|COMPLETED|Overall Study||69
8279356|NCT01682720|20413924|P1|COMPLETED|Overall Study||0
8279357|NCT01682720|20413921|P4|Included in Full Analysis Set|Overall Study||250
8279358|NCT01682720|20413922|P3|Included in Full Analysis Set|Overall Study||11
8279359|NCT01682720|20413923|P2|Included in Full Analysis Set|Overall Study||73
8279360|NCT01682720|20413924|P1|Included in Full Analysis Set|Overall Study||0
8279361|NCT01682720|20413921|P4|STARTED|Overall Study||250
8279362|NCT01682720|20413922|P3|STARTED|Overall Study||12
8279363|NCT01682720|20413923|P2|STARTED|Overall Study||74
8279364|NCT01682720|20413924|P1|STARTED|Overall Study||85
8279365|NCT01682681|20413941|P1|NOT COMPLETED|Overall Study||332
8279366|NCT01682681|20413941|P1|COMPLETED|Overall Study||902
8279367|NCT01682681|20413941|P1|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
8279368|NCT01682681|20413941|P1|STARTED|Overall Study||1234
8279369|NCT01682642|20413951|P2|NOT COMPLETED|Overall Study||1
8279370|NCT01682642|20413952|P1|NOT COMPLETED|Overall Study||0
8279371|NCT01682642|20413951|P2|COMPLETED|Overall Study||58
8279372|NCT01682642|20413952|P1|COMPLETED|Overall Study||61
8279373|NCT01682642|20413951|P2|STARTED|Overall Study||59
8279374|NCT01682642|20413952|P1|STARTED|Overall Study||61
8279375|NCT01682603|20413970|P1|NOT COMPLETED|Overall Study||3
8279376|NCT01682603|20413970|P1|COMPLETED|Overall Study||34
8279377|NCT01682603|20413970|P1|STARTED|Overall Study||37
8279378|NCT01682538|20413984|P1|NOT COMPLETED|Overall Study||0
8279379|NCT01682538|20413984|P1|COMPLETED|Overall Study||12
8279380|NCT01682538|20413984|P1|STARTED|Overall Study||12
8279381|NCT01682512|20414015|P3|NOT COMPLETED|Overall Study||18
8279382|NCT01682512|20414016|P2|NOT COMPLETED|Overall Study||71
8279383|NCT01682512|20414017|P1|NOT COMPLETED|Overall Study||72
8279384|NCT01682512|20414015|P3|COMPLETED|Overall Study||48
8279385|NCT01682512|20414016|P2|COMPLETED|Overall Study||40
8279386|NCT01682512|20414017|P1|COMPLETED|Overall Study||44
8279387|NCT01682512|20414015|P3|Randomized in Part-II|Overall Study||0
8279388|NCT01682512|20414016|P2|Randomized in Part-II|Overall Study||46
8279389|NCT01682512|20414017|P1|Randomized in Part-II|Overall Study||50
8279390|NCT01682512|20414015|P3|Randomized in Part-I|Overall Study||66
8279391|NCT01682512|20414016|P2|Randomized in Part-I|Overall Study||65
8279392|NCT01682512|20414017|P1|Randomized in Part-I|Overall Study||66
8279393|NCT01682512|20414015|P3|STARTED|Overall Study||66
8279394|NCT01682512|20414016|P2|STARTED|Overall Study||111
8279395|NCT01682512|20414017|P1|STARTED|Overall Study||116
8279396|NCT01682460|20414042|P1|NOT COMPLETED|Overall Study||4
8279397|NCT01682460|20414042|P1|COMPLETED|Overall Study||11
8279398|NCT01682460|20414042|P1|STARTED|Overall Study||15
8279399|NCT01682213|20414057|P1|NOT COMPLETED|Overall Study||2
8279400|NCT01682213|20414057|P1|COMPLETED|Overall Study||21
8279401|NCT01682213|20414057|P1|STARTED|Overall Study||23
8279402|NCT01682148|20414065|P2|NOT COMPLETED|Overall Study||3
8279403|NCT01682148|20414066|P1|NOT COMPLETED|Overall Study||4
8279404|NCT01682148|20414065|P2|COMPLETED|Overall Study||41
8279405|NCT01682148|20414066|P1|COMPLETED|Overall Study||40
8279406|NCT01682148|20414065|P2|STARTED|Overall Study||44
8279407|NCT01682148|20414066|P1|STARTED|Overall Study||44
8279408|NCT01682135|20414090|P3|NOT COMPLETED|Overall Study||0
8279409|NCT01682135|20414091|P2|NOT COMPLETED|Overall Study||0
8279410|NCT01682135|20414092|P1|NOT COMPLETED|Overall Study||0
8279411|NCT01682135|20414090|P3|COMPLETED|Overall Study||12
8279412|NCT01682135|20414091|P2|COMPLETED|Overall Study||10
8279413|NCT01682135|20414092|P1|COMPLETED|Overall Study||6
8279414|NCT01682135|20414090|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
8279415|NCT01682135|20414091|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
8279416|NCT01682135|20414092|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8279417|NCT01682135|20414090|P3|STARTED|Overall Study||12
8279418|NCT01682135|20414091|P2|STARTED|Overall Study||10
8279419|NCT01682135|20414092|P1|STARTED|Overall Study||6
8279426|NCT01682044|20414139|P1|NOT COMPLETED|Overall Study||4
8279427|NCT01682044|20414139|P1|COMPLETED|Overall Study||16
8279428|NCT01682044|20414139|P1|STARTED|Overall Study||20
8279429|NCT01682031|20414151|P2|NOT COMPLETED|Overall Study||5
8279430|NCT01682031|20414152|P1|NOT COMPLETED|Overall Study||1
8279431|NCT01682031|20414151|P2|COMPLETED|Overall Study||5
8279432|NCT01682031|20414152|P1|COMPLETED|Overall Study||7
8279433|NCT01682031|20414151|P2|STARTED|Overall Study||10
8279434|NCT01682031|20414152|P1|STARTED|Overall Study||8
8279435|NCT01681992|20414175|P3|NOT COMPLETED|Overall Study||83
8279436|NCT01681992|20414176|P2|NOT COMPLETED|Overall Study||70
8279437|NCT01681992|20414177|P1|NOT COMPLETED|Overall Study||66
8279438|NCT01681992|20414175|P3|COMPLETED|Overall Study||1443
8279439|NCT01681992|20414176|P2|COMPLETED|Overall Study||1427
8279440|NCT01681992|20414177|P1|COMPLETED|Overall Study||1427
8279441|NCT01681992|20414175|P3|STARTED|Overall Study||1526
8279442|NCT01681992|20414176|P2|STARTED|Overall Study||1497
8279443|NCT01681992|20414177|P1|STARTED|Overall Study||1493
8279444|NCT01681849|20414266|P3|NOT COMPLETED|Overall Study||39
8279445|NCT01681849|20414267|P2|NOT COMPLETED|Overall Study||7
8279446|NCT01681849|20414268|P1|NOT COMPLETED|Overall Study||8
8279447|NCT01681849|20414266|P3|COMPLETED|Overall Study||17
8279448|NCT01681849|20414267|P2|COMPLETED|Overall Study||6
8279449|NCT01681849|20414268|P1|COMPLETED|Overall Study||7
8279450|NCT01681849|20414266|P3|STARTED|Overall Study||56
8279451|NCT01681849|20414267|P2|STARTED|Overall Study||13
8279452|NCT01681849|20414268|P1|STARTED|Overall Study||15
8279453|NCT01681836|20414277|P2|NOT COMPLETED|Second Intervention||1
8279454|NCT01681836|20414278|P1|NOT COMPLETED|Second Intervention||0
8279455|NCT01681836|20414277|P2|COMPLETED|Second Intervention||4
8279456|NCT01681836|20414278|P1|COMPLETED|Second Intervention||6
8279457|NCT01681836|20414277|P2|STARTED|Second Intervention||5
8279458|NCT01681836|20414278|P1|STARTED|Second Intervention||6
8279459|NCT01681836|20414277|P2|NOT COMPLETED|Washout Period of 3-7 Days||0
8279460|NCT01681836|20414278|P1|NOT COMPLETED|Washout Period of 3-7 Days||0
8279461|NCT01681836|20414277|P2|COMPLETED|Washout Period of 3-7 Days||5
8279462|NCT01681836|20414278|P1|COMPLETED|Washout Period of 3-7 Days||6
8279463|NCT01681836|20414277|P2|STARTED|Washout Period of 3-7 Days||5
8279464|NCT01681836|20414278|P1|STARTED|Washout Period of 3-7 Days||6
8279465|NCT01681836|20414277|P2|NOT COMPLETED|First Intervention||0
8279466|NCT01681836|20414278|P1|NOT COMPLETED|First Intervention||0
8279467|NCT01681836|20414277|P2|COMPLETED|First Intervention||5
8279468|NCT01681836|20414278|P1|COMPLETED|First Intervention||6
8279469|NCT01681836|20414277|P2|STARTED|First Intervention||5
8279470|NCT01681836|20414278|P1|STARTED|First Intervention||6
8279471|NCT01681810|20414302|P1|NOT COMPLETED|Overall Study||0
8279472|NCT01681810|20414302|P1|COMPLETED|Overall Study||20
8279473|NCT01681810|20414302|P1|STARTED|Overall Study||20
8279474|NCT01681771|20414312|P2|NOT COMPLETED|Overall Study||2
8279475|NCT01681771|20414313|P1|NOT COMPLETED|Overall Study||4
8279476|NCT01681771|20414312|P2|COMPLETED|Overall Study||23
8279477|NCT01681771|20414313|P1|COMPLETED|Overall Study||21
8279478|NCT01681771|20414312|P2|STARTED|Overall Study||25
8279479|NCT01681771|20414313|P1|STARTED|Overall Study||25
8279480|NCT01681628|20414321|P2|NOT COMPLETED|19 Months Follow-up||43
8279481|NCT01681628|20414322|P1|NOT COMPLETED|19 Months Follow-up||62
8279482|NCT01681628|20414321|P2|COMPLETED|19 Months Follow-up||64
8279483|NCT01681628|20414322|P1|COMPLETED|19 Months Follow-up||52
8279484|NCT01681628|20414321|P2|STARTED|19 Months Follow-up||107
8279485|NCT01681628|20414322|P1|STARTED|19 Months Follow-up||114
8279486|NCT01681628|20414321|P2|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
8279487|NCT01681628|20414322|P1|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
8279488|NCT01681628|20414321|P2|COMPLETED|Time 2 to Time 3 (One Week Later).||107
8279489|NCT01681628|20414322|P1|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
8279490|NCT01681628|20414321|P2|STARTED|Time 2 to Time 3 (One Week Later).||122
8279491|NCT01681628|20414322|P1|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
8279492|NCT01681628|20414321|P2|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
8279493|NCT01681628|20414322|P1|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
8279494|NCT01681628|20414321|P2|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
8279495|NCT01681628|20414322|P1|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
8279496|NCT01681628|20414321|P2|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
8279497|NCT01681628|20414322|P1|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
8279498|NCT01681589|20414336|P3|NOT COMPLETED|Overall Study||0
8279499|NCT01681589|20414337|P2|NOT COMPLETED|Overall Study||0
8279500|NCT01681589|20414338|P1|NOT COMPLETED|Overall Study||0
8279501|NCT01681589|20414336|P3|COMPLETED|Overall Study||0
8279502|NCT01681589|20414337|P2|COMPLETED|Overall Study||0
8279503|NCT01681589|20414338|P1|COMPLETED|Overall Study||0
8279504|NCT01681589|20414336|P3|STARTED|Overall Study||0
8279505|NCT01681589|20414337|P2|STARTED|Overall Study||0
8279506|NCT01681589|20414338|P1|STARTED|Overall Study||0
8279507|NCT01681576|20414351|P2|NOT COMPLETED|Period 2||1
8279508|NCT01681576|20414352|P1|NOT COMPLETED|Period 2||4
8279509|NCT01681576|20414351|P2|COMPLETED|Period 2||35
8279510|NCT01681576|20414352|P1|COMPLETED|Period 2||30
8279511|NCT01681576|20414351|P2|STARTED|Period 2|Period 2: LCZ696 400mg|36
8279512|NCT01681576|20414352|P1|STARTED|Period 2|Period 2: Valsartan 320mg|34
8279513|NCT01681576|20414351|P2|NOT COMPLETED|Period 1||0
8279514|NCT01681576|20414352|P1|NOT COMPLETED|Period 1||2
8279515|NCT01681576|20414351|P2|COMPLETED|Period 1||36
8279516|NCT01681576|20414352|P1|COMPLETED|Period 1||34
8279517|NCT01681576|20414351|P2|STARTED|Period 1||36
8279518|NCT01681576|20414352|P1|STARTED|Period 1||36
8279519|NCT01681511|20414368|P2|NOT COMPLETED|Overall Study||14
8279520|NCT01681511|20414369|P1|NOT COMPLETED|Overall Study||18
8279521|NCT01681511|20414368|P2|COMPLETED|Overall Study||35
8279522|NCT01681511|20414369|P1|COMPLETED|Overall Study||28
8279523|NCT01681511|20414368|P2|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
8279524|NCT01681511|20414369|P1|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
8279525|NCT01681511|20414368|P2|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
8279526|NCT01681511|20414369|P1|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
8279527|NCT01681511|20414368|P2|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
8279528|NCT01681511|20414369|P1|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
8279529|NCT01681472|20414387|P4|NOT COMPLETED|Overall Study||0
8279530|NCT01681472|20414388|P3|NOT COMPLETED|Overall Study||0
8279531|NCT01681472|20414389|P2|NOT COMPLETED|Overall Study||1
8279532|NCT01681472|20414390|P1|NOT COMPLETED|Overall Study||0
8279533|NCT01681472|20414387|P4|COMPLETED|Overall Study||8
8279534|NCT01681472|20414388|P3|COMPLETED|Overall Study||8
8279535|NCT01681472|20414389|P2|COMPLETED|Overall Study||7
8279536|NCT01681472|20414390|P1|COMPLETED|Overall Study||8
8279537|NCT01681472|20414387|P4|STARTED|Overall Study||8
8279538|NCT01681472|20414388|P3|STARTED|Overall Study||8
8279539|NCT01681472|20414389|P2|STARTED|Overall Study||8
8279540|NCT01681472|20414390|P1|STARTED|Overall Study||8
8279541|NCT01681433|20414570|P2|NOT COMPLETED|Overall Study||33
8279542|NCT01681433|20414571|P1|NOT COMPLETED|Overall Study||32
8279543|NCT01681433|20414570|P2|COMPLETED|Overall Study||3
8279544|NCT01681433|20414571|P1|COMPLETED|Overall Study||4
8279545|NCT01681433|20414570|P2|STARTED|Overall Study||36
8279546|NCT01681433|20414571|P1|STARTED|Overall Study||36
8279547|NCT01681368|20414589|P1|NOT COMPLETED|Overall Study||2
8279548|NCT01681368|20414589|P1|COMPLETED|Overall Study||9
8279549|NCT01681368|20414589|P1|STARTED|Overall Study||11
8279550|NCT01681277|20414606|P5|NOT COMPLETED|Overall Study||0
8279551|NCT01681277|20414607|P4|NOT COMPLETED|Overall Study||0
8279552|NCT01681277|20414608|P3|NOT COMPLETED|Overall Study||0
8279553|NCT01681277|20414609|P2|NOT COMPLETED|Overall Study||0
8279554|NCT01681277|20414610|P1|NOT COMPLETED|Overall Study||1
8279555|NCT01681277|20414606|P5|COMPLETED|Overall Study||9
8279556|NCT01681277|20414607|P4|COMPLETED|Overall Study||9
8279557|NCT01681277|20414608|P3|COMPLETED|Overall Study||9
8279558|NCT01681277|20414609|P2|COMPLETED|Overall Study||9
8279559|NCT01681277|20414610|P1|COMPLETED|Overall Study||11
8279560|NCT01681277|20414606|P5|STARTED|Overall Study||9
8279561|NCT01681277|20414607|P4|STARTED|Overall Study||9
8279562|NCT01681277|20414608|P3|STARTED|Overall Study||9
8279563|NCT01681277|20414609|P2|STARTED|Overall Study||9
8279564|NCT01681277|20414610|P1|STARTED|Overall Study||12
8279565|NCT01681212|20414651|P1|NOT COMPLETED|Overall Study||6
8279566|NCT01681212|20414651|P1|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
8279567|NCT01681212|20414651|P1|Received Treatment|Overall Study||15
8279568|NCT01681212|20414651|P1|STARTED|Overall Study|Enrolled|21
8279569|NCT01681186|20414665|P8|NOT COMPLETED|Fourth Intervention||1
8279570|NCT01681186|20414666|P7|NOT COMPLETED|Fourth Intervention||0
8279571|NCT01681186|20414667|P6|NOT COMPLETED|Fourth Intervention||0
8279572|NCT01681186|20414668|P5|NOT COMPLETED|Fourth Intervention||0
8279573|NCT01681186|20414669|P4|NOT COMPLETED|Fourth Intervention||0
8279574|NCT01681186|20414670|P3|NOT COMPLETED|Fourth Intervention||0
8279575|NCT01681186|20414671|P2|NOT COMPLETED|Fourth Intervention||0
8279576|NCT01681186|20414672|P1|NOT COMPLETED|Fourth Intervention||0
8279577|NCT01681186|20414665|P8|COMPLETED|Fourth Intervention||5
8279578|NCT01681186|20414666|P7|COMPLETED|Fourth Intervention||5
8279579|NCT01681186|20414667|P6|COMPLETED|Fourth Intervention||0
8279580|NCT01681186|20414668|P5|COMPLETED|Fourth Intervention||0
8279581|NCT01681186|20414669|P4|COMPLETED|Fourth Intervention||0
8279582|NCT01681186|20414670|P3|COMPLETED|Fourth Intervention||0
8279583|NCT01681186|20414671|P2|COMPLETED|Fourth Intervention||0
8279584|NCT01681186|20414672|P1|COMPLETED|Fourth Intervention||0
8279585|NCT01681186|20414665|P8|STARTED|Fourth Intervention||6
8279586|NCT01681186|20414666|P7|STARTED|Fourth Intervention||5
8279587|NCT01681186|20414667|P6|STARTED|Fourth Intervention||0
8279588|NCT01681186|20414668|P5|STARTED|Fourth Intervention||0
8279589|NCT01681186|20414669|P4|STARTED|Fourth Intervention||0
8279590|NCT01681186|20414670|P3|STARTED|Fourth Intervention||0
8279591|NCT01681186|20414671|P2|STARTED|Fourth Intervention||0
8279592|NCT01681186|20414672|P1|STARTED|Fourth Intervention||0
8279593|NCT01681186|20414665|P8|NOT COMPLETED|Washout Period From Third Intervention||0
8279594|NCT01681186|20414666|P7|NOT COMPLETED|Washout Period From Third Intervention||1
8279595|NCT01681186|20414667|P6|NOT COMPLETED|Washout Period From Third Intervention||0
8279596|NCT01681186|20414668|P5|NOT COMPLETED|Washout Period From Third Intervention||0
8279597|NCT01681186|20414669|P4|NOT COMPLETED|Washout Period From Third Intervention||0
8279598|NCT01681186|20414670|P3|NOT COMPLETED|Washout Period From Third Intervention||0
8279599|NCT01681186|20414671|P2|NOT COMPLETED|Washout Period From Third Intervention||0
8279600|NCT01681186|20414672|P1|NOT COMPLETED|Washout Period From Third Intervention||0
8279601|NCT01681186|20414665|P8|COMPLETED|Washout Period From Third Intervention||6
8279602|NCT01681186|20414666|P7|COMPLETED|Washout Period From Third Intervention||5
8279603|NCT01681186|20414667|P6|COMPLETED|Washout Period From Third Intervention||0
8279604|NCT01681186|20414668|P5|COMPLETED|Washout Period From Third Intervention||0
8279605|NCT01681186|20414669|P4|COMPLETED|Washout Period From Third Intervention||0
8279606|NCT01681186|20414670|P3|COMPLETED|Washout Period From Third Intervention||0
8279607|NCT01681186|20414671|P2|COMPLETED|Washout Period From Third Intervention||0
8279608|NCT01681186|20414672|P1|COMPLETED|Washout Period From Third Intervention||0
8279609|NCT01681186|20414665|P8|STARTED|Washout Period From Third Intervention||6
8279610|NCT01681186|20414666|P7|STARTED|Washout Period From Third Intervention||6
8279611|NCT01681186|20414667|P6|STARTED|Washout Period From Third Intervention||0
8279612|NCT01681186|20414668|P5|STARTED|Washout Period From Third Intervention||0
8279613|NCT01681186|20414669|P4|STARTED|Washout Period From Third Intervention||0
8279614|NCT01681186|20414670|P3|STARTED|Washout Period From Third Intervention||0
8279615|NCT01681186|20414671|P2|STARTED|Washout Period From Third Intervention||0
8279616|NCT01681186|20414672|P1|STARTED|Washout Period From Third Intervention||0
8279617|NCT01681186|20414665|P8|NOT COMPLETED|Third Intervention||0
8279618|NCT01681186|20414666|P7|NOT COMPLETED|Third Intervention||0
8279619|NCT01681186|20414667|P6|NOT COMPLETED|Third Intervention||0
8279620|NCT01681186|20414668|P5|NOT COMPLETED|Third Intervention||0
8279621|NCT01681186|20414669|P4|NOT COMPLETED|Third Intervention||0
8279622|NCT01681186|20414670|P3|NOT COMPLETED|Third Intervention||0
8279623|NCT01681186|20414671|P2|NOT COMPLETED|Third Intervention||0
8279624|NCT01681186|20414672|P1|NOT COMPLETED|Third Intervention||0
8279625|NCT01681186|20414665|P8|COMPLETED|Third Intervention||6
8279626|NCT01681186|20414666|P7|COMPLETED|Third Intervention||6
8279627|NCT01681186|20414667|P6|COMPLETED|Third Intervention||0
8279628|NCT01681186|20414668|P5|COMPLETED|Third Intervention||0
8279629|NCT01681186|20414669|P4|COMPLETED|Third Intervention||0
8279630|NCT01681186|20414670|P3|COMPLETED|Third Intervention||0
8279631|NCT01681186|20414671|P2|COMPLETED|Third Intervention||0
8279632|NCT01681186|20414672|P1|COMPLETED|Third Intervention||0
8279633|NCT01681186|20414665|P8|STARTED|Third Intervention||6
8279634|NCT01681186|20414666|P7|STARTED|Third Intervention||6
8279635|NCT01681186|20414667|P6|STARTED|Third Intervention||0
8279636|NCT01681186|20414668|P5|STARTED|Third Intervention||0
8279637|NCT01681186|20414669|P4|STARTED|Third Intervention||0
8279638|NCT01681186|20414670|P3|STARTED|Third Intervention||0
8279639|NCT01681186|20414671|P2|STARTED|Third Intervention||0
8279640|NCT01681186|20414672|P1|STARTED|Third Intervention||0
8279641|NCT01681186|20414665|P8|NOT COMPLETED|Washout Period From Second Intervention||1
8279642|NCT01681186|20414666|P7|NOT COMPLETED|Washout Period From Second Intervention||1
8279643|NCT01681186|20414667|P6|NOT COMPLETED|Washout Period From Second Intervention||0
8279644|NCT01681186|20414668|P5|NOT COMPLETED|Washout Period From Second Intervention||0
8279645|NCT01681186|20414669|P4|NOT COMPLETED|Washout Period From Second Intervention||0
8279646|NCT01681186|20414670|P3|NOT COMPLETED|Washout Period From Second Intervention||0
8279647|NCT01681186|20414671|P2|NOT COMPLETED|Washout Period From Second Intervention||0
8279648|NCT01681186|20414672|P1|NOT COMPLETED|Washout Period From Second Intervention||0
8279649|NCT01681186|20414665|P8|COMPLETED|Washout Period From Second Intervention||6
8279650|NCT01681186|20414666|P7|COMPLETED|Washout Period From Second Intervention||6
8279651|NCT01681186|20414667|P6|COMPLETED|Washout Period From Second Intervention||0
8279652|NCT01681186|20414668|P5|COMPLETED|Washout Period From Second Intervention||0
8279653|NCT01681186|20414669|P4|COMPLETED|Washout Period From Second Intervention||0
8279654|NCT01681186|20414670|P3|COMPLETED|Washout Period From Second Intervention||0
8279655|NCT01681186|20414671|P2|COMPLETED|Washout Period From Second Intervention||0
8279656|NCT01681186|20414672|P1|COMPLETED|Washout Period From Second Intervention||0
8279657|NCT01681186|20414665|P8|STARTED|Washout Period From Second Intervention||7
8279658|NCT01681186|20414666|P7|STARTED|Washout Period From Second Intervention||7
8279659|NCT01681186|20414667|P6|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8279660|NCT01681186|20414668|P5|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8279661|NCT01681186|20414669|P4|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8279662|NCT01681186|20414670|P3|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8279663|NCT01681186|20414671|P2|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8279664|NCT01681186|20414672|P1|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
8279665|NCT01681186|20414665|P8|NOT COMPLETED|Second Intervention||0
8279666|NCT01681186|20414666|P7|NOT COMPLETED|Second Intervention||0
8279667|NCT01681186|20414667|P6|NOT COMPLETED|Second Intervention||0
8279668|NCT01681186|20414668|P5|NOT COMPLETED|Second Intervention||0
8279669|NCT01681186|20414669|P4|NOT COMPLETED|Second Intervention||0
8279670|NCT01681186|20414670|P3|NOT COMPLETED|Second Intervention||0
8279671|NCT01681186|20414671|P2|NOT COMPLETED|Second Intervention||0
8279672|NCT01681186|20414672|P1|NOT COMPLETED|Second Intervention||0
8279673|NCT01681186|20414665|P8|COMPLETED|Second Intervention||7
8279674|NCT01681186|20414666|P7|COMPLETED|Second Intervention||7
8279675|NCT01681186|20414667|P6|COMPLETED|Second Intervention||2
8279676|NCT01681186|20414668|P5|COMPLETED|Second Intervention||3
8279677|NCT01681186|20414669|P4|COMPLETED|Second Intervention||3
8279678|NCT01681186|20414670|P3|COMPLETED|Second Intervention||2
8279679|NCT01681186|20414671|P2|COMPLETED|Second Intervention||2
8279680|NCT01681186|20414672|P1|COMPLETED|Second Intervention||4
8279681|NCT01681186|20414665|P8|STARTED|Second Intervention||7
8279682|NCT01681186|20414666|P7|STARTED|Second Intervention||7
8279683|NCT01681186|20414667|P6|STARTED|Second Intervention||2
8279684|NCT01681186|20414668|P5|STARTED|Second Intervention||3
8279685|NCT01681186|20414669|P4|STARTED|Second Intervention||3
8279686|NCT01681186|20414670|P3|STARTED|Second Intervention||2
8279687|NCT01681186|20414671|P2|STARTED|Second Intervention||2
8279688|NCT01681186|20414672|P1|STARTED|Second Intervention||4
8279689|NCT01681186|20414665|P8|NOT COMPLETED|Washout Period From First Intervention||0
8279690|NCT01681186|20414666|P7|NOT COMPLETED|Washout Period From First Intervention||0
8279691|NCT01681186|20414667|P6|NOT COMPLETED|Washout Period From First Intervention||0
8279692|NCT01681186|20414668|P5|NOT COMPLETED|Washout Period From First Intervention||0
8279693|NCT01681186|20414669|P4|NOT COMPLETED|Washout Period From First Intervention||0
8279694|NCT01681186|20414670|P3|NOT COMPLETED|Washout Period From First Intervention||0
8279695|NCT01681186|20414671|P2|NOT COMPLETED|Washout Period From First Intervention||0
8279696|NCT01681186|20414672|P1|NOT COMPLETED|Washout Period From First Intervention||0
8279697|NCT01681186|20414665|P8|COMPLETED|Washout Period From First Intervention||7
8279698|NCT01681186|20414666|P7|COMPLETED|Washout Period From First Intervention||7
8279699|NCT01681186|20414667|P6|COMPLETED|Washout Period From First Intervention||2
8279700|NCT01681186|20414668|P5|COMPLETED|Washout Period From First Intervention||3
8279701|NCT01681186|20414669|P4|COMPLETED|Washout Period From First Intervention||3
8279702|NCT01681186|20414670|P3|COMPLETED|Washout Period From First Intervention||2
8279703|NCT01681186|20414671|P2|COMPLETED|Washout Period From First Intervention||2
8279704|NCT01681186|20414672|P1|COMPLETED|Washout Period From First Intervention||4
8279705|NCT01681186|20414665|P8|STARTED|Washout Period From First Intervention||7
8279706|NCT01681186|20414666|P7|STARTED|Washout Period From First Intervention||7
8279707|NCT01681186|20414667|P6|STARTED|Washout Period From First Intervention||2
8279708|NCT01681186|20414668|P5|STARTED|Washout Period From First Intervention||3
8279709|NCT01681186|20414669|P4|STARTED|Washout Period From First Intervention||3
8279710|NCT01681186|20414670|P3|STARTED|Washout Period From First Intervention||2
8279711|NCT01681186|20414671|P2|STARTED|Washout Period From First Intervention||2
8279712|NCT01681186|20414672|P1|STARTED|Washout Period From First Intervention||4
8279713|NCT01681186|20414665|P8|NOT COMPLETED|First Intervention||0
8279714|NCT01681186|20414666|P7|NOT COMPLETED|First Intervention||0
8279715|NCT01681186|20414667|P6|NOT COMPLETED|First Intervention||0
8279716|NCT01681186|20414668|P5|NOT COMPLETED|First Intervention||0
8279717|NCT01681186|20414669|P4|NOT COMPLETED|First Intervention||0
8279718|NCT01681186|20414670|P3|NOT COMPLETED|First Intervention||0
8279719|NCT01681186|20414671|P2|NOT COMPLETED|First Intervention||0
8279720|NCT01681186|20414672|P1|NOT COMPLETED|First Intervention||0
8279721|NCT01681186|20414665|P8|COMPLETED|First Intervention||7
8279722|NCT01681186|20414666|P7|COMPLETED|First Intervention||7
8279723|NCT01681186|20414667|P6|COMPLETED|First Intervention||2
8279724|NCT01681186|20414668|P5|COMPLETED|First Intervention||3
8279725|NCT01681186|20414669|P4|COMPLETED|First Intervention||3
8279726|NCT01681186|20414670|P3|COMPLETED|First Intervention||2
8279727|NCT01681186|20414671|P2|COMPLETED|First Intervention||2
8279728|NCT01681186|20414672|P1|COMPLETED|First Intervention||4
8279729|NCT01681186|20414665|P8|STARTED|First Intervention||7
8279730|NCT01681186|20414666|P7|STARTED|First Intervention||7
8279731|NCT01681186|20414667|P6|STARTED|First Intervention||2
8279732|NCT01681186|20414668|P5|STARTED|First Intervention||3
8279733|NCT01681186|20414669|P4|STARTED|First Intervention||3
8279734|NCT01681186|20414670|P3|STARTED|First Intervention||2
8279735|NCT01681186|20414671|P2|STARTED|First Intervention||2
8279736|NCT01681186|20414672|P1|STARTED|First Intervention||4
8279743|NCT01681095|20414734|P2|NOT COMPLETED|Overall Study||0
8279744|NCT01681095|20414735|P1|NOT COMPLETED|Overall Study||0
8279745|NCT01681095|20414734|P2|COMPLETED|Overall Study||55
8279746|NCT01681095|20414735|P1|COMPLETED|Overall Study||55
8279747|NCT01681095|20414734|P2|STARTED|Overall Study||55
8279748|NCT01681095|20414735|P1|STARTED|Overall Study||55
8279749|NCT01681069|20414775|P2|NOT COMPLETED|Overall Study||7
8279750|NCT01681069|20414776|P1|NOT COMPLETED|Overall Study||5
8279751|NCT01681069|20414775|P2|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
8279752|NCT01681069|20414776|P1|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
8279753|NCT01681069|20414775|P2|Full Analysis Set (FAS)|Overall Study||60
8279754|NCT01681069|20414776|P1|Full Analysis Set (FAS)|Overall Study||57
8279755|NCT01681069|20414775|P2|STARTED|Overall Study||60
8279756|NCT01681069|20414776|P1|STARTED|Overall Study||60
8279757|NCT01681030|20414789|P3|NOT COMPLETED|Overall Study||0
8279758|NCT01681030|20414790|P2|NOT COMPLETED|Overall Study||0
8279759|NCT01681030|20414791|P1|NOT COMPLETED|Overall Study||0
8279760|NCT01681030|20414789|P3|COMPLETED|Overall Study||11
8279761|NCT01681030|20414790|P2|COMPLETED|Overall Study||18
8279762|NCT01681030|20414791|P1|COMPLETED|Overall Study||13
8279763|NCT01681030|20414789|P3|STARTED|Overall Study||11
8279764|NCT01681030|20414790|P2|STARTED|Overall Study||18
8279765|NCT01681030|20414791|P1|STARTED|Overall Study||13
8279766|NCT01681004|20414813|P2|NOT COMPLETED|Study Completion||8
8279767|NCT01681004|20414814|P1|NOT COMPLETED|Study Completion||12
8279768|NCT01681004|20414813|P2|COMPLETED|Study Completion||36
8279769|NCT01681004|20414814|P1|COMPLETED|Study Completion||89
8279770|NCT01681004|20414813|P2|STARTED|Study Completion||44
8279771|NCT01681004|20414814|P1|STARTED|Study Completion||101
8279772|NCT01681004|20414813|P2|NOT COMPLETED|Primary Endpoint: 6 Months||2
8279773|NCT01681004|20414814|P1|NOT COMPLETED|Primary Endpoint: 6 Months||1
8279774|NCT01681004|20414813|P2|COMPLETED|Primary Endpoint: 6 Months||44
8279775|NCT01681004|20414814|P1|COMPLETED|Primary Endpoint: 6 Months||101
8279776|NCT01681004|20414813|P2|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
8279777|NCT01681004|20414814|P1|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
8279778|NCT01681004|20414813|P2|STARTED|Primary Endpoint: 6 Months||46
8279779|NCT01681004|20414814|P1|STARTED|Primary Endpoint: 6 Months||102
8279780|NCT01680991|20414871|P3|NOT COMPLETED|Overall Study||4
8279781|NCT01680991|20414872|P2|NOT COMPLETED|Overall Study||19
8279782|NCT01680991|20414873|P1|NOT COMPLETED|Overall Study||8
8279783|NCT01680991|20414871|P3|COMPLETED|Overall Study||9
8279784|NCT01680991|20414872|P2|COMPLETED|Overall Study||4
8279785|NCT01680991|20414873|P1|COMPLETED|Overall Study||4
8279786|NCT01680991|20414871|P3|STARTED|Overall Study||13
8279787|NCT01680991|20414872|P2|STARTED|Overall Study||23
8279788|NCT01680991|20414873|P1|STARTED|Overall Study||12
8279801|NCT01680900|20414950|P2|NOT COMPLETED|Overall Study||1
8279802|NCT01680900|20414951|P1|NOT COMPLETED|Overall Study||4
8279803|NCT01680900|20414950|P2|COMPLETED|Overall Study||11
8279804|NCT01680900|20414951|P1|COMPLETED|Overall Study||20
8279805|NCT01680900|20414950|P2|STARTED|Overall Study||12
8279806|NCT01680900|20414951|P1|STARTED|Overall Study||24
8279807|NCT01680887|20414969|P2|NOT COMPLETED|Overall Study||24
8279808|NCT01680887|20414970|P1|NOT COMPLETED|Overall Study||29
8279809|NCT01680887|20414969|P2|COMPLETED|Overall Study||52
8279810|NCT01680887|20414970|P1|COMPLETED|Overall Study||51
8279811|NCT01680887|20414969|P2|STARTED|Overall Study||76
8279812|NCT01680887|20414970|P1|STARTED|Overall Study||80
8279813|NCT01680861|20414980|P2|NOT COMPLETED|First 12 Months Post-transplant||0
8279814|NCT01680861|20414981|P1|NOT COMPLETED|First 12 Months Post-transplant||0
8279815|NCT01680861|20414980|P2|COMPLETED|First 12 Months Post-transplant||15
8279816|NCT01680861|20414981|P1|COMPLETED|First 12 Months Post-transplant||15
8279817|NCT01680861|20414980|P2|STARTED|First 12 Months Post-transplant||15
8279818|NCT01680861|20414981|P1|STARTED|First 12 Months Post-transplant||15
8279819|NCT01680861|20414980|P2|NOT COMPLETED|Early Post-transplant Period||1
8279820|NCT01680861|20414981|P1|NOT COMPLETED|Early Post-transplant Period||1
8279821|NCT01680861|20414980|P2|COMPLETED|Early Post-transplant Period||15
8279822|NCT01680861|20414981|P1|COMPLETED|Early Post-transplant Period||15
8279823|NCT01680861|20414980|P2|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
8279824|NCT01680861|20414981|P1|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
8279825|NCT01680848|20414999|P1|NOT COMPLETED|Overall Study||93
8279826|NCT01680848|20414999|P1|COMPLETED|Overall Study||189
8279827|NCT01680848|20414999|P1|STARTED|Overall Study||282
8279828|NCT01680835|20415003|P1|NOT COMPLETED|Overall Study||25
8279829|NCT01680835|20415003|P1|COMPLETED|Overall Study||83
8279830|NCT01680835|20415003|P1|STARTED|Overall Study||108
8279831|NCT01680783|20415019|P2|NOT COMPLETED|Overall Study||0
8279832|NCT01680783|20415020|P1|NOT COMPLETED|Overall Study||0
8279833|NCT01680783|20415019|P2|COMPLETED|Overall Study||44
8279834|NCT01680783|20415020|P1|COMPLETED|Overall Study||39
8279835|NCT01680783|20415019|P2|STARTED|Overall Study||44
8279836|NCT01680783|20415020|P1|STARTED|Overall Study||39
8279837|NCT01680666|20415038|P2|NOT COMPLETED|Overall Study||0
8279838|NCT01680666|20415039|P1|NOT COMPLETED|Overall Study||0
8279839|NCT01680666|20415038|P2|COMPLETED|Overall Study||66
8279840|NCT01680666|20415039|P1|COMPLETED|Overall Study||84
8279841|NCT01680666|20415038|P2|STARTED|Overall Study||66
8279842|NCT01680666|20415039|P1|STARTED|Overall Study||84
8279843|NCT01680653|20415053|P1|NOT COMPLETED|Overall Study||0
8279844|NCT01680653|20415053|P1|COMPLETED|Overall Study||57
8279845|NCT01680653|20415053|P1|STARTED|Overall Study||57
8279846|NCT01680549|20415065|P2|NOT COMPLETED|Overall Study||8
8279847|NCT01680549|20415066|P1|NOT COMPLETED|Overall Study||5
8279848|NCT01680549|20415065|P2|COMPLETED|Overall Study||17
8279849|NCT01680549|20415066|P1|COMPLETED|Overall Study||20
8279850|NCT01680549|20415065|P2|STARTED|Overall Study||25
8279851|NCT01680549|20415066|P1|STARTED|Overall Study||25
8279852|NCT01680497|20415078|P1|NOT COMPLETED|Overall Study||2
8279853|NCT01680497|20415078|P1|COMPLETED|Overall Study||68
8279854|NCT01680497|20415078|P1|STARTED|Overall Study||70
8279855|NCT01680341|20415090|P2|NOT COMPLETED|Overall Study||17
8279856|NCT01680341|20415091|P1|NOT COMPLETED|Overall Study||21
8279857|NCT01680341|20415090|P2|COMPLETED|Overall Study||119
8279858|NCT01680341|20415091|P1|COMPLETED|Overall Study||115
8279859|NCT01680341|20415090|P2|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
8279860|NCT01680341|20415091|P1|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
8279861|NCT01680341|20415090|P2|STARTED|Overall Study||136
8279862|NCT01680341|20415091|P1|STARTED|Overall Study||136
8279863|NCT01680328|20415111|P1|NOT COMPLETED|Overall Study||2
8279864|NCT01680328|20415111|P1|COMPLETED|Overall Study||80
8279865|NCT01680328|20415111|P1|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
8279866|NCT01680328|20415111|P1|STARTED|Overall Study||82
8279867|NCT01680172|20415149|P2|NOT COMPLETED|Overall Study||0
8279868|NCT01680172|20415150|P1|NOT COMPLETED|Overall Study||0
8279869|NCT01680172|20415149|P2|COMPLETED|Overall Study||2
8279870|NCT01680172|20415150|P1|COMPLETED|Overall Study||3
8279871|NCT01680172|20415149|P2|STARTED|Overall Study||2
8279872|NCT01680172|20415150|P1|STARTED|Overall Study||3
8279873|NCT01680159|20415162|P1|NOT COMPLETED|Increased Dose Period||8
8279874|NCT01680159|20415162|P1|COMPLETED|Increased Dose Period||43
8279875|NCT01680159|20415162|P1|STARTED|Increased Dose Period||51
8279876|NCT01680159|20415162|P1|NOT COMPLETED|Screening Period||7
8279877|NCT01680159|20415162|P1|COMPLETED|Screening Period||39
8279878|NCT01680159|20415162|P1|STARTED|Screening Period||46
8279879|NCT01680016|20415189|P4|NOT COMPLETED|Overall Study||5
8279880|NCT01680016|20415190|P3|NOT COMPLETED|Overall Study||5
8279881|NCT01680016|20415191|P2|NOT COMPLETED|Overall Study||8
8279882|NCT01680016|20415192|P1|NOT COMPLETED|Overall Study||6
8279883|NCT01680016|20415189|P4|COMPLETED|Overall Study||195
8279884|NCT01680016|20415190|P3|COMPLETED|Overall Study||196
8279885|NCT01680016|20415191|P2|COMPLETED|Overall Study||114
8279886|NCT01680016|20415192|P1|COMPLETED|Overall Study||115
8279887|NCT01680016|20415189|P4|STARTED|Overall Study||200
8279888|NCT01680016|20415190|P3|STARTED|Overall Study||201
8279889|NCT01680016|20415191|P2|STARTED|Overall Study||122
8279890|NCT01680016|20415192|P1|STARTED|Overall Study||121
8279891|NCT01679613|20415254|P4|NOT COMPLETED|Overall Study||2
8279892|NCT01679613|20415255|P3|NOT COMPLETED|Overall Study||2
8279893|NCT01679613|20415256|P2|NOT COMPLETED|Overall Study||1
8279894|NCT01679613|20415257|P1|NOT COMPLETED|Overall Study||0
8279895|NCT01679613|20415254|P4|COMPLETED|Overall Study||11
8279896|NCT01679613|20415255|P3|COMPLETED|Overall Study||11
8279897|NCT01679613|20415256|P2|COMPLETED|Overall Study||3
8279898|NCT01679613|20415257|P1|COMPLETED|Overall Study||4
8279899|NCT01679613|20415254|P4|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
8279900|NCT01679613|20415255|P3|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
8279901|NCT01679613|20415256|P2|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
8279902|NCT01679613|20415257|P1|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
8279903|NCT01679613|20415254|P4|Received Nintedanib (Main)|Overall Study||11
8279904|NCT01679613|20415255|P3|Received Nintedanib (Main)|Overall Study||13
8279905|NCT01679613|20415256|P2|Received Nintedanib (Main)|Overall Study||0
8279906|NCT01679613|20415257|P1|Received Nintedanib (Main)|Overall Study||0
8279907|NCT01679613|20415254|P4|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
8279908|NCT01679613|20415255|P3|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
8279909|NCT01679613|20415256|P2|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
8279910|NCT01679613|20415257|P1|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
8279911|NCT01679613|20415254|P4|Received Nintedanib (Pilot)|Overall Study||0
8279912|NCT01679613|20415255|P3|Received Nintedanib (Pilot)|Overall Study||0
8279913|NCT01679613|20415256|P2|Received Nintedanib (Pilot)|Overall Study||3
8279914|NCT01679613|20415257|P1|Received Nintedanib (Pilot)|Overall Study||4
8279915|NCT01679613|20415254|P4|STARTED|Overall Study||13
8279916|NCT01679613|20415255|P3|STARTED|Overall Study||13
8279917|NCT01679613|20415256|P2|STARTED|Overall Study||4
8279918|NCT01679613|20415257|P1|STARTED|Overall Study||4
8279919|NCT01679600|20415270|P2|NOT COMPLETED|Overall Study||0
8279920|NCT01679600|20415271|P1|NOT COMPLETED|Overall Study||0
8279921|NCT01679600|20415270|P2|COMPLETED|Overall Study||7
8279922|NCT01679600|20415271|P1|COMPLETED|Overall Study||7
8279923|NCT01679600|20415270|P2|STARTED|Overall Study||7
8279924|NCT01679600|20415271|P1|STARTED|Overall Study||7
8279925|NCT01679405|20415279|P2|NOT COMPLETED|Overall Study||5
8279926|NCT01679405|20415280|P1|NOT COMPLETED|Overall Study||2
8279927|NCT01679405|20415279|P2|COMPLETED|Overall Study||1
8279928|NCT01679405|20415280|P1|COMPLETED|Overall Study||1
8279929|NCT01679405|20415279|P2|STARTED|Overall Study||6
8279930|NCT01679405|20415280|P1|STARTED|Overall Study||3
8279931|NCT01679314|20415296|P2|NOT COMPLETED|Overall Study||0
8279932|NCT01679314|20415297|P1|NOT COMPLETED|Overall Study||2
8279933|NCT01679314|20415296|P2|COMPLETED|Overall Study||28
8279934|NCT01679314|20415297|P1|COMPLETED|Overall Study||24
8279935|NCT01679314|20415296|P2|STARTED|Overall Study||28
8279936|NCT01679314|20415297|P1|STARTED|Overall Study||26
8279937|NCT01679301|20415315|P3|NOT COMPLETED|Study Period||0
8279938|NCT01679301|20415316|P2|NOT COMPLETED|Study Period||0
8279939|NCT01679301|20415317|P1|NOT COMPLETED|Study Period||0
8279940|NCT01679301|20415315|P3|COMPLETED|Study Period||4
8279941|NCT01679301|20415316|P2|COMPLETED|Study Period||4
8279942|NCT01679301|20415317|P1|COMPLETED|Study Period||0
8279943|NCT01679301|20415315|P3|STARTED|Study Period||4
8279944|NCT01679301|20415316|P2|STARTED|Study Period||4
8279945|NCT01679301|20415317|P1|STARTED|Study Period||0
8279946|NCT01679301|20415315|P3|NOT COMPLETED|Screening Period||0
8279947|NCT01679301|20415316|P2|NOT COMPLETED|Screening Period||0
8279948|NCT01679301|20415317|P1|NOT COMPLETED|Screening Period||3
8279949|NCT01679301|20415315|P3|COMPLETED|Screening Period||0
8279950|NCT01679301|20415316|P2|COMPLETED|Screening Period||0
8279951|NCT01679301|20415317|P1|COMPLETED|Screening Period||8
8279952|NCT01679301|20415315|P3|STARTED|Screening Period||0
8279953|NCT01679301|20415316|P2|STARTED|Screening Period||0
8279954|NCT01679301|20415317|P1|STARTED|Screening Period||11
8279955|NCT01679236|20415325|P2|NOT COMPLETED|Overall Study||15
8279956|NCT01679236|20415326|P1|NOT COMPLETED|Overall Study||15
8279957|NCT01679236|20415325|P2|COMPLETED|Overall Study||10
8279958|NCT01679236|20415326|P1|COMPLETED|Overall Study||15
8279959|NCT01679236|20415325|P2|STARTED|Overall Study||25
8279960|NCT01679236|20415326|P1|STARTED|Overall Study||30
8279961|NCT01679197|20415332|P1|NOT COMPLETED|Overall Study||4
8279962|NCT01679197|20415332|P1|COMPLETED|Overall Study||19
8279963|NCT01679197|20415332|P1|STARTED|Overall Study||23
8279964|NCT01679028|20415351|P6|NOT COMPLETED|Overall Study||0
8279965|NCT01679028|20415352|P5|NOT COMPLETED|Overall Study||0
8279966|NCT01679028|20415353|P4|NOT COMPLETED|Overall Study||0
8279967|NCT01679028|20415354|P3|NOT COMPLETED|Overall Study||0
8279968|NCT01679028|20415355|P2|NOT COMPLETED|Overall Study||0
8279969|NCT01679028|20415356|P1|NOT COMPLETED|Overall Study||0
8279970|NCT01679028|20415351|P6|COMPLETED|Overall Study||6
8279971|NCT01679028|20415352|P5|COMPLETED|Overall Study||2
8279972|NCT01679028|20415353|P4|COMPLETED|Overall Study||4
8279973|NCT01679028|20415354|P3|COMPLETED|Overall Study||2
8279974|NCT01679028|20415355|P2|COMPLETED|Overall Study||4
8279975|NCT01679028|20415356|P1|COMPLETED|Overall Study||2
8279976|NCT01679028|20415351|P6|STARTED|Overall Study||6
8279977|NCT01679028|20415352|P5|STARTED|Overall Study||2
8279978|NCT01679028|20415353|P4|STARTED|Overall Study||4
8279979|NCT01679028|20415354|P3|STARTED|Overall Study||2
8279980|NCT01679028|20415355|P2|STARTED|Overall Study||4
8279981|NCT01679028|20415356|P1|STARTED|Overall Study||2
8279982|NCT01679002|20415373|P3|NOT COMPLETED|Overall Study||0
8279983|NCT01679002|20415374|P2|NOT COMPLETED|Overall Study||1
8279984|NCT01679002|20415375|P1|NOT COMPLETED|Overall Study||1
8279985|NCT01679002|20415373|P3|COMPLETED|Overall Study||4
8279986|NCT01679002|20415374|P2|COMPLETED|Overall Study||3
8279987|NCT01679002|20415375|P1|COMPLETED|Overall Study||3
8279988|NCT01679002|20415373|P3|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
8279989|NCT01679002|20415374|P2|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
8279990|NCT01679002|20415375|P1|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
8279991|NCT01679002|20415373|P3|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
8279992|NCT01679002|20415374|P2|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
8279993|NCT01679002|20415375|P1|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
8279994|NCT01679002|20415373|P3|BIA 2-093 900 mg Once-daily Period|Overall Study||4
8279995|NCT01679002|20415374|P2|BIA 2-093 900 mg Once-daily Period|Overall Study||3
8279996|NCT01679002|20415375|P1|BIA 2-093 900 mg Once-daily Period|Overall Study||4
8279997|NCT01679002|20415373|P3|STARTED|Overall Study||4
8279998|NCT01679002|20415374|P2|STARTED|Overall Study||4
8279999|NCT01679002|20415375|P1|STARTED|Overall Study||4
8280000|NCT01678976|20415391|P2|NOT COMPLETED|Second Period||0
8280001|NCT01678976|20415392|P1|NOT COMPLETED|Second Period||0
8280002|NCT01678976|20415391|P2|COMPLETED|Second Period||6
8280003|NCT01678976|20415392|P1|COMPLETED|Second Period||6
8280004|NCT01678976|20415391|P2|STARTED|Second Period||6
8280005|NCT01678976|20415392|P1|STARTED|Second Period||6
8280006|NCT01678976|20415391|P2|NOT COMPLETED|First Period||1
8280007|NCT01678976|20415392|P1|NOT COMPLETED|First Period||0
8280008|NCT01678976|20415391|P2|COMPLETED|First Period||6
8280009|NCT01678976|20415392|P1|COMPLETED|First Period||6
8280010|NCT01678976|20415391|P2|STARTED|First Period||7
8280011|NCT01678976|20415392|P1|STARTED|First Period||6
8280012|NCT01678924|20415406|P4|NOT COMPLETED|Overall Study||18
8280013|NCT01678924|20415407|P3|NOT COMPLETED|Overall Study||2
8280014|NCT01678924|20415408|P2|NOT COMPLETED|Overall Study||12
8280015|NCT01678924|20415409|P1|NOT COMPLETED|Overall Study||10
8280016|NCT01678924|20415406|P4|COMPLETED|Overall Study||105
8280017|NCT01678924|20415407|P3|COMPLETED|Overall Study||28
8280018|NCT01678924|20415408|P2|COMPLETED|Overall Study||51
8280019|NCT01678924|20415409|P1|COMPLETED|Overall Study||54
8280020|NCT01678924|20415406|P4|STARTED|Overall Study||123
8280021|NCT01678924|20415407|P3|STARTED|Overall Study||30
8280022|NCT01678924|20415408|P2|STARTED|Overall Study||63
8280023|NCT01678924|20415409|P1|STARTED|Overall Study||64
8280024|NCT01678911|20415540|P2|NOT COMPLETED|Second Intervention||0
8280025|NCT01678911|20415541|P1|NOT COMPLETED|Second Intervention||2
8280026|NCT01678911|20415540|P2|COMPLETED|Second Intervention||1
8280027|NCT01678911|20415541|P1|COMPLETED|Second Intervention||2
8280028|NCT01678911|20415540|P2|STARTED|Second Intervention||1
8280029|NCT01678911|20415541|P1|STARTED|Second Intervention||4
8280030|NCT01678911|20415540|P2|NOT COMPLETED|First Intervention||0
8280031|NCT01678911|20415541|P1|NOT COMPLETED|First Intervention||0
8280032|NCT01678911|20415540|P2|COMPLETED|First Intervention||1
8280033|NCT01678911|20415541|P1|COMPLETED|First Intervention||4
8280034|NCT01678911|20415540|P2|Cross Over|First Intervention||1
8280035|NCT01678911|20415541|P1|Cross Over|First Intervention||4
8280036|NCT01678911|20415540|P2|STARTED|First Intervention||1
8280037|NCT01678911|20415541|P1|STARTED|First Intervention||4
8280038|NCT01678898|20415558|P3|NOT COMPLETED|PB-102-F02||0
8280039|NCT01678898|20415559|P2|NOT COMPLETED|PB-102-F02||0
8280040|NCT01678898|20415560|P1|NOT COMPLETED|PB-102-F02||0
8280041|NCT01678898|20415558|P3|COMPLETED|PB-102-F02||4
8280042|NCT01678898|20415559|P2|COMPLETED|PB-102-F02||6
8280043|NCT01678898|20415560|P1|COMPLETED|PB-102-F02||6
8280044|NCT01678898|20415558|P3|STARTED|PB-102-F02||4
8280045|NCT01678898|20415559|P2|STARTED|PB-102-F02||6
8280046|NCT01678898|20415560|P1|STARTED|PB-102-F02||6
8280047|NCT01678898|20415558|P3|NOT COMPLETED|PB-102-F01||0
8280048|NCT01678898|20415559|P2|NOT COMPLETED|PB-102-F01||2
8280049|NCT01678898|20415560|P1|NOT COMPLETED|PB-102-F01||0
8280050|NCT01678898|20415558|P3|COMPLETED|PB-102-F01||4
8280051|NCT01678898|20415559|P2|COMPLETED|PB-102-F01||6
8280052|NCT01678898|20415560|P1|COMPLETED|PB-102-F01||6
8280053|NCT01678898|20415558|P3|STARTED|PB-102-F01||4
8280054|NCT01678898|20415559|P2|STARTED|PB-102-F01||8
8280055|NCT01678898|20415560|P1|STARTED|PB-102-F01||6
8280056|NCT01678885|20415640|P5|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
8280057|NCT01678885|20415641|P4|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280058|NCT01678885|20415642|P3|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280059|NCT01678885|20415643|P2|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280060|NCT01678885|20415644|P1|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280061|NCT01678885|20415640|P5|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
8280062|NCT01678885|20415641|P4|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280063|NCT01678885|20415642|P3|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280064|NCT01678885|20415643|P2|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280065|NCT01678885|20415644|P1|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
8280066|NCT01678885|20415640|P5|STARTED|Phase II; 8 Week Low Calorie Diet||87
8280067|NCT01678885|20415641|P4|STARTED|Phase II; 8 Week Low Calorie Diet||0
8280068|NCT01678885|20415642|P3|STARTED|Phase II; 8 Week Low Calorie Diet||0
8280069|NCT01678885|20415643|P2|STARTED|Phase II; 8 Week Low Calorie Diet||0
8280070|NCT01678885|20415644|P1|STARTED|Phase II; 8 Week Low Calorie Diet||0
8280071|NCT01678885|20415640|P5|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
8280072|NCT01678885|20415641|P4|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
8280073|NCT01678885|20415642|P3|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
8280074|NCT01678885|20415643|P2|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
8280075|NCT01678885|20415644|P1|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
8280076|NCT01678885|20415640|P5|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
8280077|NCT01678885|20415641|P4|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
8280078|NCT01678885|20415642|P3|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
8280079|NCT01678885|20415643|P2|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
8280080|NCT01678885|20415644|P1|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
8280081|NCT01678885|20415640|P5|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
8280082|NCT01678885|20415641|P4|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
8280083|NCT01678885|20415642|P3|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
8280084|NCT01678885|20415643|P2|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
8280085|NCT01678885|20415644|P1|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
8280086|NCT01678846|20415654|P2|NOT COMPLETED|Overall Study||0
8280087|NCT01678846|20415655|P1|NOT COMPLETED|Overall Study||0
8280088|NCT01678846|20415654|P2|COMPLETED|Overall Study||1899
8280089|NCT01678846|20415655|P1|COMPLETED|Overall Study||1921
8280090|NCT01678846|20415654|P2|STARTED|Overall Study||1899
8280091|NCT01678846|20415655|P1|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
8280092|NCT01678820|20415670|P3|NOT COMPLETED|Overall Study||57
8280093|NCT01678820|20415671|P2|NOT COMPLETED|Overall Study||63
8280094|NCT01678820|20415672|P1|NOT COMPLETED|Overall Study||62
8280095|NCT01678820|20415670|P3|COMPLETED|Overall Study||43
8280096|NCT01678820|20415671|P2|COMPLETED|Overall Study||36
8280097|NCT01678820|20415672|P1|COMPLETED|Overall Study||38
8280098|NCT01678820|20415670|P3|Treated With Double-blind Study Drug|Overall Study||98
8280099|NCT01678820|20415671|P2|Treated With Double-blind Study Drug|Overall Study||97
8280100|NCT01678820|20415672|P1|Treated With Double-blind Study Drug|Overall Study||100
8280101|NCT01678820|20415670|P3|STARTED|Overall Study||100
8280102|NCT01678820|20415671|P2|STARTED|Overall Study||99
8280103|NCT01678820|20415672|P1|STARTED|Overall Study||100
8280104|NCT01678807|20415717|P3|NOT COMPLETED|Overall Study||0
8280105|NCT01678807|20415718|P2|NOT COMPLETED|Overall Study||5
8280106|NCT01678807|20415719|P1|NOT COMPLETED|Overall Study||4
8280107|NCT01678807|20415717|P3|COMPLETED|Overall Study||65
8280108|NCT01678807|20415718|P2|COMPLETED|Overall Study||60
8280109|NCT01678807|20415719|P1|COMPLETED|Overall Study||61
8280110|NCT01678807|20415717|P3|STARTED|Overall Study||65
8280111|NCT01678807|20415718|P2|STARTED|Overall Study||65
8280112|NCT01678807|20415719|P1|STARTED|Overall Study||65
8280113|NCT01678560|20415732|P2|NOT COMPLETED|Overall Study||6
8280114|NCT01678560|20415733|P1|NOT COMPLETED|Overall Study||4
8280115|NCT01678560|20415732|P2|COMPLETED|Overall Study||20
8280116|NCT01678560|20415733|P1|COMPLETED|Overall Study||22
8280117|NCT01678560|20415732|P2|STARTED|Overall Study||26
8280118|NCT01678560|20415733|P1|STARTED|Overall Study||26
8280122|NCT01678313|20415754|P2|NOT COMPLETED|Prostate Biopsy at 3 Months||12
8280123|NCT01678313|20415755|P1|NOT COMPLETED|Prostate Biopsy at 3 Months||11
8280124|NCT01678313|20415754|P2|COMPLETED|Prostate Biopsy at 3 Months||37
8280125|NCT01678313|20415755|P1|COMPLETED|Prostate Biopsy at 3 Months||45
8280126|NCT01678313|20415754|P2|STARTED|Prostate Biopsy at 3 Months||49
8280127|NCT01678313|20415755|P1|STARTED|Prostate Biopsy at 3 Months||56
8280128|NCT01678313|20415754|P2|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
8280129|NCT01678313|20415755|P1|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
8280130|NCT01678313|20415754|P2|COMPLETED|PSA >4 ng/dL at 3 Months||49
8280131|NCT01678313|20415755|P1|COMPLETED|PSA >4 ng/dL at 3 Months||56
8280132|NCT01678313|20415754|P2|STARTED|PSA >4 ng/dL at 3 Months||58
8280133|NCT01678313|20415755|P1|STARTED|PSA >4 ng/dL at 3 Months||64
8280134|NCT01678313|20415754|P2|NOT COMPLETED|Completed the 3-month Therapy||12
8280135|NCT01678313|20415755|P1|NOT COMPLETED|Completed the 3-month Therapy||6
8280136|NCT01678313|20415754|P2|COMPLETED|Completed the 3-month Therapy||58
8280137|NCT01678313|20415755|P1|COMPLETED|Completed the 3-month Therapy||64
8280138|NCT01678313|20415754|P2|STARTED|Completed the 3-month Therapy||70
8280139|NCT01678313|20415755|P1|STARTED|Completed the 3-month Therapy||70
8280140|NCT01678209|20415774|P3|NOT COMPLETED|Overall Study||18
8280141|NCT01678209|20415775|P2|NOT COMPLETED|Overall Study||18
8280142|NCT01678209|20415776|P1|NOT COMPLETED|Overall Study||17
8280143|NCT01678209|20415774|P3|COMPLETED|Overall Study||22
8280144|NCT01678209|20415775|P2|COMPLETED|Overall Study||22
8280145|NCT01678209|20415776|P1|COMPLETED|Overall Study||30
8280146|NCT01678209|20415774|P3|STARTED|Overall Study||40
8280147|NCT01678209|20415775|P2|STARTED|Overall Study||40
8280148|NCT01678209|20415776|P1|STARTED|Overall Study||47
8280149|NCT01678196|20415804|P2|NOT COMPLETED|Overall Study||0
8280150|NCT01678196|20415805|P1|NOT COMPLETED|Overall Study||0
8280151|NCT01678196|20415804|P2|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
8280152|NCT01678196|20415805|P1|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
8280153|NCT01678196|20415804|P2|STARTED|Overall Study||32
8280154|NCT01678196|20415805|P1|STARTED|Overall Study||34
8280155|NCT01678144|20415817|P1|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0
8280156|NCT01678144|20415817|P1|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5
8280157|NCT01678144|20415817|P1|STARTED|Stage 2: MAR Regular and MAR Expanded||5
8280158|NCT01678144|20415817|P1|NOT COMPLETED|Stage 1: MAR Classic||1
8280159|NCT01678144|20415817|P1|COMPLETED|Stage 1: MAR Classic||6
8280160|NCT01678144|20415817|P1|STARTED|Stage 1: MAR Classic||7
8280161|NCT01678131|20415836|P3|NOT COMPLETED|Overall Study||2
8280162|NCT01678131|20415837|P2|NOT COMPLETED|Overall Study||1
8280163|NCT01678131|20415838|P1|NOT COMPLETED|Overall Study||0
8280164|NCT01678131|20415836|P3|COMPLETED|Overall Study||9
8280165|NCT01678131|20415837|P2|COMPLETED|Overall Study||9
8280166|NCT01678131|20415838|P1|COMPLETED|Overall Study||10
8280167|NCT01678131|20415836|P3|STARTED|Overall Study||11
8280168|NCT01678131|20415837|P2|STARTED|Overall Study||10
8280169|NCT01678131|20415838|P1|STARTED|Overall Study||10
8280170|NCT01677988|20415846|P1|NOT COMPLETED|Overall Study||2
8280171|NCT01677988|20415846|P1|COMPLETED|Overall Study||1
8280172|NCT01677988|20415846|P1|STARTED|Overall Study||3
8280173|NCT01677936|20415859|P2|NOT COMPLETED|Overall Study||5
8280174|NCT01677936|20415860|P1|NOT COMPLETED|Overall Study||9
8280175|NCT01677936|20415859|P2|COMPLETED|Overall Study|Full analysis dataset completers|15
8280176|NCT01677936|20415860|P1|COMPLETED|Overall Study|Full analysis dataset completers|22
8280177|NCT01677936|20415859|P2|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
8280178|NCT01677936|20415860|P1|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
8280179|NCT01677910|20415871|P4|NOT COMPLETED|Open-Label Extension Period (OLE)||36
8280180|NCT01677910|20415872|P3|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8280181|NCT01677910|20415873|P2|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8280182|NCT01677910|20415874|P1|NOT COMPLETED|Open-Label Extension Period (OLE)||0
8280183|NCT01677910|20415871|P4|COMPLETED|Open-Label Extension Period (OLE)||79
8280184|NCT01677910|20415872|P3|COMPLETED|Open-Label Extension Period (OLE)||0
8280185|NCT01677910|20415873|P2|COMPLETED|Open-Label Extension Period (OLE)||0
8280186|NCT01677910|20415874|P1|COMPLETED|Open-Label Extension Period (OLE)||0
8280187|NCT01677910|20415871|P4|STARTED|Open-Label Extension Period (OLE)||115
8280188|NCT01677910|20415872|P3|STARTED|Open-Label Extension Period (OLE)||0
8280189|NCT01677910|20415873|P2|STARTED|Open-Label Extension Period (OLE)||0
8280190|NCT01677910|20415874|P1|STARTED|Open-Label Extension Period (OLE)||0
8280191|NCT01677910|20415871|P4|NOT COMPLETED|Double-Blind Treatment Period||0
8280192|NCT01677910|20415872|P3|NOT COMPLETED|Double-Blind Treatment Period||7
8280193|NCT01677910|20415873|P2|NOT COMPLETED|Double-Blind Treatment Period||3
8280194|NCT01677910|20415874|P1|NOT COMPLETED|Double-Blind Treatment Period||7
8280195|NCT01677910|20415871|P4|COMPLETED|Double-Blind Treatment Period||0
8280196|NCT01677910|20415872|P3|COMPLETED|Double-Blind Treatment Period||38
8280197|NCT01677910|20415873|P2|COMPLETED|Double-Blind Treatment Period||42
8280198|NCT01677910|20415874|P1|COMPLETED|Double-Blind Treatment Period||38
8280199|NCT01677910|20415871|P4|STARTED|Double-Blind Treatment Period||0
8280200|NCT01677910|20415872|P3|STARTED|Double-Blind Treatment Period||45
8280201|NCT01677910|20415873|P2|STARTED|Double-Blind Treatment Period||45
8280202|NCT01677910|20415874|P1|STARTED|Double-Blind Treatment Period||45
8280203|NCT01677858|20415901|P5|NOT COMPLETED|Overall Study||85
8280204|NCT01677858|20415902|P4|NOT COMPLETED|Overall Study||6
8280205|NCT01677858|20415903|P3|NOT COMPLETED|Overall Study||14
8280206|NCT01677858|20415904|P2|NOT COMPLETED|Overall Study||2
8280207|NCT01677858|20415905|P1|NOT COMPLETED|Overall Study||3
8280208|NCT01677858|20415901|P5|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
8280209|NCT01677858|20415902|P4|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
8280210|NCT01677858|20415903|P3|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
8280211|NCT01677858|20415904|P2|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
8280212|NCT01677858|20415905|P1|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
8280213|NCT01677858|20415901|P5|STARTED|Overall Study||89
8280214|NCT01677858|20415902|P4|STARTED|Overall Study||6
8280215|NCT01677858|20415903|P3|STARTED|Overall Study||15
8280216|NCT01677858|20415904|P2|STARTED|Overall Study||3
8280217|NCT01677858|20415905|P1|STARTED|Overall Study||3
8280218|NCT01677767|20415978|P1|NOT COMPLETED|Overall Study||22
8280219|NCT01677767|20415978|P1|COMPLETED|Overall Study||102
8280220|NCT01677767|20415978|P1|STARTED|Overall Study||124
8280221|NCT01677624|20415992|P1|NOT COMPLETED|Overall Study||1
8280222|NCT01677624|20415992|P1|COMPLETED|Overall Study||27
8280223|NCT01677624|20415992|P1|STARTED|Overall Study||28
8280224|NCT01677507|20415997|P2|NOT COMPLETED|Second Assigment||5
8280225|NCT01677507|20415998|P1|NOT COMPLETED|Second Assigment||3
8280226|NCT01677507|20415997|P2|COMPLETED|Second Assigment||51
8280227|NCT01677507|20415998|P1|COMPLETED|Second Assigment||60
8280228|NCT01677507|20415997|P2|STARTED|Second Assigment||56
8280229|NCT01677507|20415998|P1|STARTED|Second Assigment||63
8280230|NCT01677507|20415997|P2|NOT COMPLETED|Initial Assignment||2
8280231|NCT01677507|20415998|P1|NOT COMPLETED|Initial Assignment||0
8280232|NCT01677507|20415997|P2|COMPLETED|Initial Assignment||56
8280233|NCT01677507|20415998|P1|COMPLETED|Initial Assignment||63
8280234|NCT01677507|20415997|P2|STARTED|Initial Assignment||58
8280235|NCT01677507|20415998|P1|STARTED|Initial Assignment||63
8280236|NCT01677377|20416011|P3|NOT COMPLETED|Overall Study||6
8280237|NCT01677377|20416012|P2|NOT COMPLETED|Overall Study||1
8280238|NCT01677377|20416013|P1|NOT COMPLETED|Overall Study||1
8280239|NCT01677377|20416011|P3|COMPLETED|Overall Study||9
8280240|NCT01677377|20416012|P2|COMPLETED|Overall Study||14
8280241|NCT01677377|20416013|P1|COMPLETED|Overall Study||14
8280242|NCT01677377|20416011|P3|STARTED|Overall Study||15
8280243|NCT01677377|20416012|P2|STARTED|Overall Study||15
8280244|NCT01677377|20416013|P1|STARTED|Overall Study||15
8280245|NCT01677312|20416212|P2|NOT COMPLETED|Overall Study||0
8280246|NCT01677312|20416213|P1|NOT COMPLETED|Overall Study||0
8280247|NCT01677312|20416212|P2|COMPLETED|Overall Study||36
8280248|NCT01677312|20416213|P1|COMPLETED|Overall Study||36
8280249|NCT01677312|20416212|P2|STARTED|Overall Study||36
8280250|NCT01677312|20416213|P1|STARTED|Overall Study||36
8280251|NCT01677299|20416229|P4|NOT COMPLETED|Overall Study||1
8280252|NCT01677299|20416230|P3|NOT COMPLETED|Overall Study||1
8280253|NCT01677299|20416231|P2|NOT COMPLETED|Overall Study||3
8280254|NCT01677299|20416232|P1|NOT COMPLETED|Overall Study||0
8280255|NCT01677299|20416229|P4|COMPLETED|Overall Study||5
8280256|NCT01677299|20416230|P3|COMPLETED|Overall Study||5
8280257|NCT01677299|20416231|P2|COMPLETED|Overall Study||3
8280258|NCT01677299|20416232|P1|COMPLETED|Overall Study||6
8280259|NCT01677299|20416229|P4|STARTED|Overall Study||6
8280260|NCT01677299|20416230|P3|STARTED|Overall Study||6
8280261|NCT01677299|20416231|P2|STARTED|Overall Study||6
8280262|NCT01677299|20416232|P1|STARTED|Overall Study||6
8280263|NCT01677286|20416254|P1|NOT COMPLETED|Overall Study||11
8280264|NCT01677286|20416254|P1|COMPLETED|Overall Study||14
8280265|NCT01677286|20416254|P1|STARTED|Overall Study||25
8280266|NCT01677195|20416264|P3|NOT COMPLETED|Overall Study||30
8280267|NCT01677195|20416265|P2|NOT COMPLETED|Overall Study||32
8280268|NCT01677195|20416266|P1|NOT COMPLETED|Overall Study||29
8280269|NCT01677195|20416264|P3|COMPLETED|Overall Study||50
8280270|NCT01677195|20416265|P2|COMPLETED|Overall Study||51
8280271|NCT01677195|20416266|P1|COMPLETED|Overall Study||42
8280272|NCT01677195|20416264|P3|STARTED|Overall Study||80
8280273|NCT01677195|20416265|P2|STARTED|Overall Study||83
8280274|NCT01677195|20416266|P1|STARTED|Overall Study||71
8280275|NCT01677182|20416277|P3|NOT COMPLETED|Overall Study||39
8280276|NCT01677182|20416278|P2|NOT COMPLETED|Overall Study||28
8280277|NCT01677182|20416279|P1|NOT COMPLETED|Overall Study||34
8280278|NCT01677182|20416277|P3|COMPLETED|Overall Study||143
8280279|NCT01677182|20416278|P2|COMPLETED|Overall Study||141
8280280|NCT01677182|20416279|P1|COMPLETED|Overall Study||150
8280281|NCT01677182|20416277|P3|STARTED|Overall Study||182
8280282|NCT01677182|20416278|P2|STARTED|Overall Study||169
8280283|NCT01677182|20416279|P1|STARTED|Overall Study||184
8280284|NCT01676961|20416311|P1|NOT COMPLETED|Overall Study||5
8280285|NCT01676961|20416311|P1|COMPLETED|Overall Study||0
8280286|NCT01676961|20416311|P1|STARTED|Overall Study||5
8280287|NCT01676909|20416318|P2|NOT COMPLETED|Overall Study||14
8280288|NCT01676909|20416319|P1|NOT COMPLETED|Overall Study||18
8280289|NCT01676909|20416318|P2|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104
8280290|NCT01676909|20416319|P1|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106
8280291|NCT01676909|20416318|P2|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107
8280292|NCT01676909|20416319|P1|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105
8280293|NCT01676909|20416318|P2|STARTED|Overall Study||118
8280294|NCT01676909|20416319|P1|STARTED|Overall Study||124
8280295|NCT01676896|20416384|P3|NOT COMPLETED|Overall Study||19
8280296|NCT01676896|20416385|P2|NOT COMPLETED|Overall Study||7
8280297|NCT01676896|20416386|P1|NOT COMPLETED|Overall Study||12
8280298|NCT01676896|20416384|P3|COMPLETED|Overall Study||81
8280299|NCT01676896|20416385|P2|COMPLETED|Overall Study||89
8280300|NCT01676896|20416386|P1|COMPLETED|Overall Study||84
8280301|NCT01676896|20416384|P3|STARTED|Overall Study||100
8280302|NCT01676896|20416385|P2|STARTED|Overall Study||96
8280303|NCT01676896|20416386|P1|STARTED|Overall Study||96
8280304|NCT01676831|20416483|P2|NOT COMPLETED|Overall Study||1
8280305|NCT01676831|20416484|P1|NOT COMPLETED|Overall Study||0
8280306|NCT01676831|20416483|P2|COMPLETED|Overall Study||4
8280307|NCT01676831|20416484|P1|COMPLETED|Overall Study||8
8280308|NCT01676831|20416483|P2|STARTED|Overall Study||5
8280309|NCT01676831|20416484|P1|STARTED|Overall Study||8
8280310|NCT01676727|20416494|P1|NOT COMPLETED|Overall Study||32
8280311|NCT01676727|20416494|P1|COMPLETED|Overall Study||68
8280312|NCT01676727|20416494|P1|Implanted|Overall Study||92
8280313|NCT01676727|20416494|P1|STARTED|Overall Study||100
8280314|NCT01676714|20416499|P1|NOT COMPLETED|Overall Study||0
8280315|NCT01676714|20416499|P1|COMPLETED|Overall Study||10
8280316|NCT01676714|20416499|P1|STARTED|Overall Study||10
8280317|NCT01676701|20416508|P2|NOT COMPLETED|Overall Study||4
8280318|NCT01676701|20416509|P1|NOT COMPLETED|Overall Study||4
8280319|NCT01676701|20416508|P2|COMPLETED|Overall Study||0
8280320|NCT01676701|20416509|P1|COMPLETED|Overall Study||0
8280321|NCT01676701|20416508|P2|Completed Post-Treatment Follow-Up|Overall Study||4
8280322|NCT01676701|20416509|P1|Completed Post-Treatment Follow-Up|Overall Study||4
8280323|NCT01676701|20416508|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
8280324|NCT01676701|20416509|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
8280325|NCT01676701|20416508|P2|STARTED|Overall Study||4
8280326|NCT01676701|20416509|P1|STARTED|Overall Study||4
8280327|NCT01676532|20416535|P1|NOT COMPLETED|Overall Study||0
8280328|NCT01676532|20416535|P1|COMPLETED|Overall Study||127
8280329|NCT01676532|20416535|P1|STARTED|Overall Study||127
8280330|NCT01676415|20416546|P2|NOT COMPLETED|Overall Study||0
8280331|NCT01676415|20416547|P1|NOT COMPLETED|Overall Study||0
8280332|NCT01676415|20416546|P2|COMPLETED|Overall Study||5
8280333|NCT01676415|20416547|P1|COMPLETED|Overall Study||4
8280334|NCT01676415|20416546|P2|STARTED|Overall Study||5
8280335|NCT01676415|20416547|P1|STARTED|Overall Study||4
8280336|NCT01676311|20416561|P2|NOT COMPLETED|Overall Study||2
8280337|NCT01676311|20416562|P1|NOT COMPLETED|Overall Study||0
8280338|NCT01676311|20416561|P2|COMPLETED|Overall Study||5
8280339|NCT01676311|20416562|P1|COMPLETED|Overall Study||7
8280340|NCT01676311|20416561|P2|STARTED|Overall Study||7
8280341|NCT01676311|20416562|P1|STARTED|Overall Study||7
8280342|NCT01676298|20416584|P8|NOT COMPLETED|Overall Study||0
8280343|NCT01676298|20416585|P7|NOT COMPLETED|Overall Study||0
8280344|NCT01676298|20416586|P6|NOT COMPLETED|Overall Study||0
8280345|NCT01676298|20416587|P5|NOT COMPLETED|Overall Study||0
8280346|NCT01676298|20416588|P4|NOT COMPLETED|Overall Study||0
8280347|NCT01676298|20416589|P3|NOT COMPLETED|Overall Study||0
8280348|NCT01676298|20416590|P2|NOT COMPLETED|Overall Study||0
8280349|NCT01676298|20416591|P1|NOT COMPLETED|Overall Study||0
8280350|NCT01676298|20416584|P8|COMPLETED|Overall Study||1
8280351|NCT01676298|20416585|P7|COMPLETED|Overall Study||1
8280352|NCT01676298|20416586|P6|COMPLETED|Overall Study||1
8280353|NCT01676298|20416587|P5|COMPLETED|Overall Study||1
8280354|NCT01676298|20416588|P4|COMPLETED|Overall Study||1
8280355|NCT01676298|20416589|P3|COMPLETED|Overall Study||1
8280356|NCT01676298|20416590|P2|COMPLETED|Overall Study||1
8280357|NCT01676298|20416591|P1|COMPLETED|Overall Study||1
8280358|NCT01676298|20416584|P8|Participated in All Tests|Overall Study||1
8280359|NCT01676298|20416585|P7|Participated in All Tests|Overall Study||1
8280360|NCT01676298|20416586|P6|Participated in All Tests|Overall Study||1
8280361|NCT01676298|20416587|P5|Participated in All Tests|Overall Study||1
8280362|NCT01676298|20416588|P4|Participated in All Tests|Overall Study||1
8280363|NCT01676298|20416589|P3|Participated in All Tests|Overall Study||1
8280364|NCT01676298|20416590|P2|Participated in All Tests|Overall Study||1
8280365|NCT01676298|20416591|P1|Participated in All Tests|Overall Study||1
8280366|NCT01676298|20416584|P8|All Genotypes Confirmed With Reference|Overall Study||1
8280367|NCT01676298|20416585|P7|All Genotypes Confirmed With Reference|Overall Study||1
8280368|NCT01676298|20416586|P6|All Genotypes Confirmed With Reference|Overall Study||1
8280369|NCT01676298|20416587|P5|All Genotypes Confirmed With Reference|Overall Study||1
8280370|NCT01676298|20416588|P4|All Genotypes Confirmed With Reference|Overall Study||1
8280371|NCT01676298|20416589|P3|All Genotypes Confirmed With Reference|Overall Study||1
8280372|NCT01676298|20416590|P2|All Genotypes Confirmed With Reference|Overall Study||1
8280373|NCT01676298|20416591|P1|All Genotypes Confirmed With Reference|Overall Study||1
8280374|NCT01676298|20416584|P8|STARTED|Overall Study||1
8280375|NCT01676298|20416585|P7|STARTED|Overall Study||1
8280376|NCT01676298|20416586|P6|STARTED|Overall Study||1
8280377|NCT01676298|20416587|P5|STARTED|Overall Study||1
8280378|NCT01676298|20416588|P4|STARTED|Overall Study||1
8280379|NCT01676298|20416589|P3|STARTED|Overall Study||1
8280380|NCT01676298|20416590|P2|STARTED|Overall Study||1
8280381|NCT01676298|20416591|P1|STARTED|Overall Study||1
8280382|NCT01676220|20416611|P2|NOT COMPLETED|Overall Study||125
8280383|NCT01676220|20416612|P1|NOT COMPLETED|Overall Study||102
8280384|NCT01676220|20416611|P2|COMPLETED|Overall Study||314
8280385|NCT01676220|20416612|P1|COMPLETED|Overall Study||337
8280386|NCT01676220|20416611|P2|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|430
8280387|NCT01676220|20416612|P1|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|432
8280388|NCT01676220|20416611|P2|Treated|Overall Study||438
8280389|NCT01676220|20416612|P1|Treated|Overall Study||435
8280390|NCT01676220|20416611|P2|STARTED|Overall Study||439
8280391|NCT01676220|20416612|P1|STARTED|Overall Study||439
8280392|NCT01676116|20416644|P2|NOT COMPLETED|Overall Study||29
8280393|NCT01676116|20416645|P1|NOT COMPLETED|Overall Study||16
8280394|NCT01676116|20416644|P2|COMPLETED|Overall Study||117
8280395|NCT01676116|20416645|P1|COMPLETED|Overall Study||276
8280396|NCT01676116|20416644|P2|STARTED|Overall Study||146
8280397|NCT01676116|20416645|P1|STARTED|Overall Study||292
8280398|NCT01676012|20416667|P1|NOT COMPLETED|Overall Study||3
8280399|NCT01676012|20416667|P1|COMPLETED|Overall Study||29
8280400|NCT01676012|20416667|P1|STARTED|Overall Study||32
8280401|NCT01675960|20416673|P2|NOT COMPLETED|Overall Study||0
8280402|NCT01675960|20416674|P1|NOT COMPLETED|Overall Study||0
8280403|NCT01675960|20416673|P2|COMPLETED|Overall Study||0
8280404|NCT01675960|20416674|P1|COMPLETED|Overall Study||2
8280405|NCT01675960|20416673|P2|STARTED|Overall Study||0
8280406|NCT01675960|20416674|P1|STARTED|Overall Study||2
8280407|NCT01675830|20416682|P1|NOT COMPLETED|Overall Study||0
8280408|NCT01675830|20416682|P1|COMPLETED|Overall Study||10
8280409|NCT01675830|20416682|P1|STARTED|Overall Study||10
8280410|NCT01675778|20416687|P1|NOT COMPLETED|Overall Study||0
8280411|NCT01675778|20416687|P1|COMPLETED|Overall Study||174
8280412|NCT01675778|20416687|P1|STARTED|Overall Study||174
8280413|NCT01675765|20416711|P2|NOT COMPLETED|Overall Study||8
8280414|NCT01675765|20416712|P1|NOT COMPLETED|Overall Study||11
8280415|NCT01675765|20416711|P2|COMPLETED|Overall Study||14
8280416|NCT01675765|20416712|P1|COMPLETED|Overall Study||27
8280417|NCT01675765|20416711|P2|STARTED|Overall Study||22
8280418|NCT01675765|20416712|P1|STARTED|Overall Study||38
8280419|NCT01675661|20416728|P2|NOT COMPLETED|Overall Study||46
8280420|NCT01675661|20416729|P1|NOT COMPLETED|Overall Study||40
8280421|NCT01675661|20416728|P2|COMPLETED|Overall Study||103
8280422|NCT01675661|20416729|P1|COMPLETED|Overall Study||113
8280423|NCT01675661|20416728|P2|STARTED|Overall Study||149
8280424|NCT01675661|20416729|P1|STARTED|Overall Study||153
8280425|NCT01675635|20416737|P2|NOT COMPLETED|Overall Study||0
8280426|NCT01675635|20416738|P1|NOT COMPLETED|Overall Study||0
8280427|NCT01675635|20416737|P2|COMPLETED|Overall Study||117
8280428|NCT01675635|20416738|P1|COMPLETED|Overall Study||117
8280429|NCT01675635|20416737|P2|STARTED|Overall Study||117
8280430|NCT01675635|20416738|P1|STARTED|Overall Study||117
8280431|NCT01675622|20416758|P2|NOT COMPLETED|Overall Study||24
8280432|NCT01675622|20416759|P1|NOT COMPLETED|Overall Study||26
8280433|NCT01675622|20416758|P2|COMPLETED|Overall Study||96
8280434|NCT01675622|20416759|P1|COMPLETED|Overall Study||96
8280435|NCT01675622|20416758|P2|STARTED|Overall Study||120
8280436|NCT01675622|20416759|P1|STARTED|Overall Study||122
8280437|NCT01675596|20416783|P1|NOT COMPLETED|Overall Study||8
8280438|NCT01675596|20416783|P1|COMPLETED|Overall Study||191
8280439|NCT01675596|20416783|P1|STARTED|Overall Study|One patient did not receive the study device.|199
8280440|NCT01675544|20416789|P1|NOT COMPLETED|Overall Study||2
8280441|NCT01675544|20416789|P1|COMPLETED|Overall Study||44
8280442|NCT01675544|20416789|P1|STARTED|Overall Study||46
8280443|NCT01675531|20416794|P1|NOT COMPLETED|Overall Study||25
8280444|NCT01675531|20416794|P1|COMPLETED|Overall Study||41
8280445|NCT01675531|20416794|P1|STARTED|Overall Study||66
8280446|NCT01675492|20416801|P1|NOT COMPLETED|Overall Study||42
8280447|NCT01675492|20416801|P1|COMPLETED|Overall Study||42
8280448|NCT01675492|20416801|P1|STARTED|Overall Study||84
8280449|NCT01675479|20416806|P1|NOT COMPLETED|Overall Study||11
8280450|NCT01675479|20416806|P1|COMPLETED|Overall Study||58
8280451|NCT01675479|20416806|P1|STARTED|Overall Study||69
8280452|NCT01675453|20416813|P2|NOT COMPLETED|Overall Study||0
8280453|NCT01675453|20416814|P1|NOT COMPLETED|Overall Study||0
8280454|NCT01675453|20416813|P2|COMPLETED|Overall Study||20
8280455|NCT01675453|20416814|P1|COMPLETED|Overall Study||20
8280456|NCT01675453|20416813|P2|STARTED|Overall Study||20
8280457|NCT01675453|20416814|P1|STARTED|Overall Study||20
8280458|NCT01675427|20416820|P1|NOT COMPLETED|Overall Study||34
8280459|NCT01675427|20416820|P1|COMPLETED|Overall Study||4732
8280460|NCT01675427|20416820|P1|STARTED|Overall Study||4766
8280461|NCT01675297|20417107|P2|NOT COMPLETED|Overall Study||48
8280462|NCT01675297|20417108|P1|NOT COMPLETED|Overall Study||164
8280463|NCT01675297|20417107|P2|COMPLETED|Overall Study||199
8280464|NCT01675297|20417108|P1|COMPLETED|Overall Study||642
8280465|NCT01675297|20417107|P2|STARTED|Overall Study||247
8280466|NCT01675297|20417108|P1|STARTED|Overall Study||806
8280467|NCT01675167|20417120|P3|NOT COMPLETED|Double-blind Treatment Phase||110
8280468|NCT01675167|20417121|P2|NOT COMPLETED|Double-blind Treatment Phase||48
8280469|NCT01675167|20417122|P1|NOT COMPLETED|Double-blind Treatment Phase||0
8280470|NCT01675167|20417120|P3|COMPLETED|Double-blind Treatment Phase||147
8280471|NCT01675167|20417121|P2|COMPLETED|Double-blind Treatment Phase||206
8280472|NCT01675167|20417122|P1|COMPLETED|Double-blind Treatment Phase||0
8280473|NCT01675167|20417120|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
8280474|NCT01675167|20417121|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
8280475|NCT01675167|20417122|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
8280476|NCT01675167|20417120|P3|NOT COMPLETED|Open-label Titration Phase||0
8280477|NCT01675167|20417121|P2|NOT COMPLETED|Open-label Titration Phase||0
8280478|NCT01675167|20417122|P1|NOT COMPLETED|Open-label Titration Phase||304
8280479|NCT01675167|20417120|P3|COMPLETED|Open-label Titration Phase||0
8280480|NCT01675167|20417121|P2|COMPLETED|Open-label Titration Phase||0
8280481|NCT01675167|20417122|P1|COMPLETED|Open-label Titration Phase||511
8280482|NCT01675167|20417120|P3|STARTED|Open-label Titration Phase||0
8280483|NCT01675167|20417121|P2|STARTED|Open-label Titration Phase||0
8280484|NCT01675167|20417122|P1|STARTED|Open-label Titration Phase||815
8280485|NCT01675141|20417144|P1|NOT COMPLETED|Overall Study||11
8280486|NCT01675141|20417144|P1|COMPLETED|Overall Study||0
8280487|NCT01675141|20417144|P1|STARTED|Overall Study||11
8280488|NCT01675128|20417157|P3|NOT COMPLETED|Overall Study||1
8280489|NCT01675128|20417158|P2|NOT COMPLETED|Overall Study||2
8280490|NCT01675128|20417159|P1|NOT COMPLETED|Overall Study||2
8280491|NCT01675128|20417157|P3|COMPLETED|Overall Study||9
8280492|NCT01675128|20417158|P2|COMPLETED|Overall Study||8
8280493|NCT01675128|20417159|P1|COMPLETED|Overall Study||2
8280494|NCT01675128|20417157|P3|STARTED|Overall Study||10
8280495|NCT01675128|20417158|P2|STARTED|Overall Study||10
8280496|NCT01675128|20417159|P1|STARTED|Overall Study||4
8280497|NCT01675063|20417181|P1|NOT COMPLETED|Overall Study||0
8280498|NCT01675063|20417181|P1|COMPLETED|Overall Study||77
8280499|NCT01675063|20417181|P1|STARTED|Overall Study||77
8280500|NCT01675050|20417187|P2|NOT COMPLETED|Second Period Treatment||0
8280501|NCT01675050|20417188|P1|NOT COMPLETED|Second Period Treatment||0
8280502|NCT01675050|20417187|P2|COMPLETED|Second Period Treatment||2
8280503|NCT01675050|20417188|P1|COMPLETED|Second Period Treatment||1
8280504|NCT01675050|20417187|P2|STARTED|Second Period Treatment||2
8280505|NCT01675050|20417188|P1|STARTED|Second Period Treatment||1
8280506|NCT01675050|20417187|P2|NOT COMPLETED|Wash Out Period||0
8280507|NCT01675050|20417188|P1|NOT COMPLETED|Wash Out Period||0
8280508|NCT01675050|20417187|P2|COMPLETED|Wash Out Period||2
8280509|NCT01675050|20417188|P1|COMPLETED|Wash Out Period||1
8280510|NCT01675050|20417187|P2|STARTED|Wash Out Period||2
8280511|NCT01675050|20417188|P1|STARTED|Wash Out Period||1
8280512|NCT01675050|20417187|P2|NOT COMPLETED|Period One Treatment||0
8280513|NCT01675050|20417188|P1|NOT COMPLETED|Period One Treatment||1
8280514|NCT01675050|20417187|P2|COMPLETED|Period One Treatment||2
8280515|NCT01675050|20417188|P1|COMPLETED|Period One Treatment||1
8280516|NCT01675050|20417187|P2|STARTED|Period One Treatment||2
8280517|NCT01675050|20417188|P1|STARTED|Period One Treatment||2
8280518|NCT01675011|20417198|P2|NOT COMPLETED|Overall Study||1
8280519|NCT01675011|20417199|P1|NOT COMPLETED|Overall Study||3
8280520|NCT01675011|20417198|P2|COMPLETED|Overall Study||0
8280521|NCT01675011|20417199|P1|COMPLETED|Overall Study||0
8280522|NCT01675011|20417198|P2|STARTED|Overall Study||1
8280523|NCT01675011|20417199|P1|STARTED|Overall Study||3
8280530|NCT01674712|20417227|P5|NOT COMPLETED|Overall Study||11
8280531|NCT01674712|20417228|P4|NOT COMPLETED|Overall Study||8
8280532|NCT01674712|20417229|P3|NOT COMPLETED|Overall Study||9
8280533|NCT01674712|20417230|P2|NOT COMPLETED|Overall Study||9
8280534|NCT01674712|20417231|P1|NOT COMPLETED|Overall Study||10
8280535|NCT01674712|20417227|P5|COMPLETED|Overall Study||102
8280536|NCT01674712|20417228|P4|COMPLETED|Overall Study||108
8280537|NCT01674712|20417229|P3|COMPLETED|Overall Study||106
8280538|NCT01674712|20417230|P2|COMPLETED|Overall Study||108
8280539|NCT01674712|20417231|P1|COMPLETED|Overall Study||104
8280540|NCT01674712|20417227|P5|Safety Subject Sample|Overall Study||112
8280541|NCT01674712|20417228|P4|Safety Subject Sample|Overall Study||115
8280542|NCT01674712|20417229|P3|Safety Subject Sample|Overall Study||113
8280543|NCT01674712|20417230|P2|Safety Subject Sample|Overall Study||117
8280544|NCT01674712|20417231|P1|Safety Subject Sample|Overall Study||111
8280545|NCT01674712|20417227|P5|Full Analysis Subject Sample|Overall Study||111
8280546|NCT01674712|20417228|P4|Full Analysis Subject Sample|Overall Study||112
8280547|NCT01674712|20417229|P3|Full Analysis Subject Sample|Overall Study||110
8280548|NCT01674712|20417230|P2|Full Analysis Subject Sample|Overall Study||114
8280549|NCT01674712|20417231|P1|Full Analysis Subject Sample|Overall Study||109
8280550|NCT01674712|20417227|P5|STARTED|Overall Study||113
8280551|NCT01674712|20417228|P4|STARTED|Overall Study||116
8280552|NCT01674712|20417229|P3|STARTED|Overall Study||115
8280553|NCT01674712|20417230|P2|STARTED|Overall Study||117
8280554|NCT01674712|20417231|P1|STARTED|Overall Study||114
8280555|NCT01674647|20417255|P2|NOT COMPLETED|30-day Safety Follow-up Period||41
8280556|NCT01674647|20417256|P1|NOT COMPLETED|30-day Safety Follow-up Period||58
8280557|NCT01674647|20417255|P2|COMPLETED|30-day Safety Follow-up Period||446
8280558|NCT01674647|20417256|P1|COMPLETED|30-day Safety Follow-up Period||924
8280559|NCT01674647|20417255|P2|STARTED|30-day Safety Follow-up Period||487
8280560|NCT01674647|20417256|P1|STARTED|30-day Safety Follow-up Period||982
8280561|NCT01674647|20417255|P2|NOT COMPLETED|Treatment Period||102
8280562|NCT01674647|20417256|P1|NOT COMPLETED|Treatment Period||156
8280563|NCT01674647|20417255|P2|COMPLETED|Treatment Period||400
8280564|NCT01674647|20417256|P1|COMPLETED|Treatment Period||846
8280565|NCT01674647|20417255|P2|Subjects Received Treatment|Treatment Period||499
8280566|NCT01674647|20417256|P1|Subjects Received Treatment|Treatment Period||988
8280567|NCT01674647|20417255|P2|STARTED|Treatment Period||502
8280568|NCT01674647|20417256|P1|STARTED|Treatment Period||1002
8280569|NCT01674634|20417282|P1|NOT COMPLETED|Overall Study||6
8280570|NCT01674634|20417282|P1|COMPLETED|Overall Study||709
8280571|NCT01674634|20417282|P1|STARTED|Overall Study||715
8280572|NCT01674621|20417302|P5|NOT COMPLETED|Overall Study||6
8280573|NCT01674621|20417303|P4|NOT COMPLETED|Overall Study||6
8280574|NCT01674621|20417304|P3|NOT COMPLETED|Overall Study||7
8280575|NCT01674621|20417305|P2|NOT COMPLETED|Overall Study||8
8280576|NCT01674621|20417306|P1|NOT COMPLETED|Overall Study||5
8280577|NCT01674621|20417302|P5|COMPLETED|Overall Study||44
8280578|NCT01674621|20417303|P4|COMPLETED|Overall Study||45
8280579|NCT01674621|20417304|P3|COMPLETED|Overall Study||41
8280580|NCT01674621|20417305|P2|COMPLETED|Overall Study||43
8280581|NCT01674621|20417306|P1|COMPLETED|Overall Study||45
8280582|NCT01674621|20417302|P5|Safety Population|Overall Study||50
8280583|NCT01674621|20417303|P4|Safety Population|Overall Study||51
8280584|NCT01674621|20417304|P3|Safety Population|Overall Study||47
8280585|NCT01674621|20417305|P2|Safety Population|Overall Study||51
8280586|NCT01674621|20417306|P1|Safety Population|Overall Study||50
8280587|NCT01674621|20417302|P5|Modified Intent-to-Treat Population|Overall Study||46
8280588|NCT01674621|20417303|P4|Modified Intent-to-Treat Population|Overall Study||49
8280589|NCT01674621|20417304|P3|Modified Intent-to-Treat Population|Overall Study||43
8280590|NCT01674621|20417305|P2|Modified Intent-to-Treat Population|Overall Study||46
8280591|NCT01674621|20417306|P1|Modified Intent-to-Treat Population|Overall Study||47
8280592|NCT01674621|20417302|P5|STARTED|Overall Study||50
8280593|NCT01674621|20417303|P4|STARTED|Overall Study||51
8280594|NCT01674621|20417304|P3|STARTED|Overall Study||48
8280595|NCT01674621|20417305|P2|STARTED|Overall Study||51
8280596|NCT01674621|20417306|P1|STARTED|Overall Study||50
8280597|NCT01674569|20417383|P6|NOT COMPLETED|Overall Study||2
8280598|NCT01674569|20417384|P5|NOT COMPLETED|Overall Study||2
8280599|NCT01674569|20417385|P4|NOT COMPLETED|Overall Study||1
8280600|NCT01674569|20417386|P3|NOT COMPLETED|Overall Study||2
8280601|NCT01674569|20417387|P2|NOT COMPLETED|Overall Study||3
8280602|NCT01674569|20417388|P1|NOT COMPLETED|Overall Study||0
8280603|NCT01674569|20417383|P6|COMPLETED|Overall Study||1
8280604|NCT01674569|20417384|P5|COMPLETED|Overall Study||5
8280605|NCT01674569|20417385|P4|COMPLETED|Overall Study||9
8280606|NCT01674569|20417386|P3|COMPLETED|Overall Study||2
8280607|NCT01674569|20417387|P2|COMPLETED|Overall Study||5
8280608|NCT01674569|20417388|P1|COMPLETED|Overall Study||3
8280609|NCT01674569|20417383|P6|STARTED|Overall Study||3
8280610|NCT01674569|20417384|P5|STARTED|Overall Study||7
8280611|NCT01674569|20417385|P4|STARTED|Overall Study||10
8280612|NCT01674569|20417386|P3|STARTED|Overall Study||4
8280613|NCT01674569|20417387|P2|STARTED|Overall Study||8
8280614|NCT01674569|20417388|P1|STARTED|Overall Study||3
8280615|NCT01674478|20417394|P2|NOT COMPLETED|Overall Study||0
8280616|NCT01674478|20417395|P1|NOT COMPLETED|Overall Study||0
8280617|NCT01674478|20417394|P2|COMPLETED|Overall Study||9
8280618|NCT01674478|20417395|P1|COMPLETED|Overall Study||9
8280619|NCT01674478|20417394|P2|STARTED|Overall Study||9
8280620|NCT01674478|20417395|P1|STARTED|Overall Study||9
8280621|NCT01674062|20417409|P2|NOT COMPLETED|Overall Study||29
8280622|NCT01674062|20417410|P1|NOT COMPLETED|Overall Study||66
8280623|NCT01674062|20417409|P2|COMPLETED|Overall Study||0
8280624|NCT01674062|20417410|P1|COMPLETED|Overall Study||0
8280625|NCT01674062|20417409|P2|STARTED|Overall Study||29
8280626|NCT01674062|20417410|P1|STARTED|Overall Study||66
8280627|NCT01674010|20417425|P3|NOT COMPLETED|Randomization Phase 2||61
8280628|NCT01674010|20417426|P2|NOT COMPLETED|Randomization Phase 2||62
8280629|NCT01674010|20417427|P1|NOT COMPLETED|Randomization Phase 2||0
8280630|NCT01674010|20417425|P3|COMPLETED|Randomization Phase 2||3
8280631|NCT01674010|20417426|P2|COMPLETED|Randomization Phase 2||3
8280632|NCT01674010|20417427|P1|COMPLETED|Randomization Phase 2||0
8280633|NCT01674010|20417425|P3|STARTED|Randomization Phase 2||64
8280634|NCT01674010|20417426|P2|STARTED|Randomization Phase 2||65
8280635|NCT01674010|20417427|P1|STARTED|Randomization Phase 2||0
8280636|NCT01674010|20417425|P3|NOT COMPLETED|Open Treatment Phase 1||0
8280637|NCT01674010|20417426|P2|NOT COMPLETED|Open Treatment Phase 1||0
8280638|NCT01674010|20417427|P1|NOT COMPLETED|Open Treatment Phase 1||180
8280639|NCT01674010|20417425|P3|COMPLETED|Open Treatment Phase 1||0
8280640|NCT01674010|20417426|P2|COMPLETED|Open Treatment Phase 1||0
8280641|NCT01674010|20417427|P1|COMPLETED|Open Treatment Phase 1||129
8280642|NCT01674010|20417425|P3|STARTED|Open Treatment Phase 1||0
8280643|NCT01674010|20417426|P2|STARTED|Open Treatment Phase 1||0
8280644|NCT01674010|20417427|P1|STARTED|Open Treatment Phase 1||309
8280645|NCT01673984|20417446|P2|NOT COMPLETED|Overall Study||6
8280646|NCT01673984|20417447|P1|NOT COMPLETED|Overall Study||10
8280647|NCT01673984|20417446|P2|COMPLETED|Overall Study||1
8280648|NCT01673984|20417447|P1|COMPLETED|Overall Study||4
8280649|NCT01673984|20417446|P2|STARTED|Overall Study||7
8280650|NCT01673984|20417447|P1|STARTED|Overall Study||14
8280651|NCT01673919|20417465|P1|NOT COMPLETED|Overall Study||0
8280652|NCT01673919|20417465|P1|COMPLETED|Overall Study||7
8280653|NCT01673919|20417465|P1|STARTED|Overall Study||7
8280654|NCT01673893|20417489|P1|NOT COMPLETED|Overall Study||0
8280655|NCT01673893|20417489|P1|COMPLETED|Overall Study||59
8280656|NCT01673893|20417489|P1|STARTED|Overall Study||59
8280657|NCT01673867|20417497|P2|NOT COMPLETED|Treatment||268
8280658|NCT01673867|20417498|P1|NOT COMPLETED|Treatment||244
8280659|NCT01673867|20417497|P2|COMPLETED|Treatment||0
8280660|NCT01673867|20417498|P1|COMPLETED|Treatment||43
8280661|NCT01673867|20417497|P2|STARTED|Treatment||268
8280662|NCT01673867|20417498|P1|STARTED|Treatment||287
8280663|NCT01673867|20417497|P2|NOT COMPLETED|Randomization||22
8280664|NCT01673867|20417498|P1|NOT COMPLETED|Randomization||5
8280665|NCT01673867|20417497|P2|COMPLETED|Randomization||268
8280666|NCT01673867|20417498|P1|COMPLETED|Randomization||287
8280667|NCT01673867|20417497|P2|STARTED|Randomization||290
8280668|NCT01673867|20417498|P1|STARTED|Randomization||292
8280669|NCT01673854|20417524|P1|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
8280670|NCT01673854|20417524|P1|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
8280671|NCT01673854|20417524|P1|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
8280672|NCT01673854|20417524|P1|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
8280673|NCT01673854|20417524|P1|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
8280674|NCT01673854|20417524|P1|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
8280675|NCT01673854|20417524|P1|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
8280676|NCT01673854|20417524|P1|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
8280677|NCT01673854|20417524|P1|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
8280678|NCT01673828|20417534|P2|NOT COMPLETED|Overall Study||0
8280679|NCT01673828|20417535|P1|NOT COMPLETED|Overall Study||0
8280680|NCT01673828|20417534|P2|COMPLETED|Overall Study||6
8280681|NCT01673828|20417535|P1|COMPLETED|Overall Study||7
8280682|NCT01673828|20417534|P2|STARTED|Overall Study||6
8280683|NCT01673828|20417535|P1|STARTED|Overall Study||7
8280684|NCT01673802|20417541|P1|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
8280685|NCT01673802|20417541|P1|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
8280686|NCT01673802|20417541|P1|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
8280687|NCT01673802|20417541|P1|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
8280688|NCT01673802|20417541|P1|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
8280689|NCT01673802|20417541|P1|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
8280690|NCT01673698|20417547|P2|NOT COMPLETED|Overall Study||13
8280691|NCT01673698|20417548|P1|NOT COMPLETED|Overall Study||51
8280692|NCT01673698|20417547|P2|COMPLETED|Overall Study||126
8280693|NCT01673698|20417548|P1|COMPLETED|Overall Study||136
8280694|NCT01673698|20417547|P2|STARTED|Overall Study||139
8280695|NCT01673698|20417548|P1|STARTED|Overall Study||187
8280696|NCT01673646|20417559|P3|NOT COMPLETED|Overall Study||4
8280697|NCT01673646|20417560|P2|NOT COMPLETED|Overall Study||7
8280698|NCT01673646|20417561|P1|NOT COMPLETED|Overall Study||4
8280699|NCT01673646|20417559|P3|COMPLETED|Overall Study||7
8280700|NCT01673646|20417560|P2|COMPLETED|Overall Study||4
8280701|NCT01673646|20417561|P1|COMPLETED|Overall Study||7
8280702|NCT01673646|20417559|P3|Discontinued Beyond 24 Months|Overall Study||1
8280703|NCT01673646|20417560|P2|Discontinued Beyond 24 Months|Overall Study||4
8280704|NCT01673646|20417561|P1|Discontinued Beyond 24 Months|Overall Study||0
8280705|NCT01673646|20417559|P3|Treated Beyond 24 Months|Overall Study||8
8280706|NCT01673646|20417560|P2|Treated Beyond 24 Months|Overall Study||8
8280707|NCT01673646|20417561|P1|Treated Beyond 24 Months|Overall Study||7
8280708|NCT01673646|20417559|P3|Did Not Enter Ext. Phase|Overall Study||1
8280709|NCT01673646|20417560|P2|Did Not Enter Ext. Phase|Overall Study||1
8280710|NCT01673646|20417561|P1|Did Not Enter Ext. Phase|Overall Study||2
8280711|NCT01673646|20417559|P3|Entered Ext. Phase|Overall Study||9
8280712|NCT01673646|20417560|P2|Entered Ext. Phase|Overall Study||9
8280713|NCT01673646|20417561|P1|Entered Ext. Phase|Overall Study||7
8280714|NCT01673646|20417559|P3|Completed Core Phase|Overall Study||10
8280715|NCT01673646|20417560|P2|Completed Core Phase|Overall Study||10
8280716|NCT01673646|20417561|P1|Completed Core Phase|Overall Study||9
8280717|NCT01673646|20417559|P3|Entered/Treated in Core Phase|Overall Study||11
8280718|NCT01673646|20417560|P2|Entered/Treated in Core Phase|Overall Study||11
8280719|NCT01673646|20417561|P1|Entered/Treated in Core Phase|Overall Study||11
8280720|NCT01673646|20417559|P3|STARTED|Overall Study||11
8280721|NCT01673646|20417560|P2|STARTED|Overall Study||11
8280722|NCT01673646|20417561|P1|STARTED|Overall Study||11
8280723|NCT01673620|20417600|P2|NOT COMPLETED|Overall Study||0
8280724|NCT01673620|20417601|P1|NOT COMPLETED|Overall Study||1
8280725|NCT01673620|20417600|P2|COMPLETED|Overall Study||22
8280726|NCT01673620|20417601|P1|COMPLETED|Overall Study||46
8280727|NCT01673620|20417600|P2|STARTED|Overall Study||22
8280728|NCT01673620|20417601|P1|STARTED|Overall Study||47
8280729|NCT01673594|20417611|P2|NOT COMPLETED|Overall Study||6
8280730|NCT01673594|20417612|P1|NOT COMPLETED|Overall Study||6
8280731|NCT01673594|20417611|P2|COMPLETED|Overall Study||13
8280732|NCT01673594|20417612|P1|COMPLETED|Overall Study||12
8280733|NCT01673594|20417611|P2|STARTED|Overall Study||19
8280734|NCT01673594|20417612|P1|STARTED|Overall Study||18
8280735|NCT01673568|20417622|P2|NOT COMPLETED|Overall Study||0
8280736|NCT01673568|20417623|P1|NOT COMPLETED|Overall Study||0
8280737|NCT01673568|20417622|P2|COMPLETED|Overall Study||28
8280738|NCT01673568|20417623|P1|COMPLETED|Overall Study||28
8280739|NCT01673568|20417622|P2|STARTED|Overall Study||28
8280740|NCT01673568|20417623|P1|STARTED|Overall Study||28
8280741|NCT01673490|20417631|P1|NOT COMPLETED|Overall Study||7
8280742|NCT01673490|20417631|P1|COMPLETED|Overall Study||52
8280743|NCT01673490|20417631|P1|STARTED|Overall Study||59
8280744|NCT01673425|20417644|P1|NOT COMPLETED|Overall Study||1
8280745|NCT01673425|20417644|P1|COMPLETED|Overall Study||4
8280746|NCT01673425|20417644|P1|STARTED|Overall Study||5
8280747|NCT01673386|20417648|P2|NOT COMPLETED|Overall Study||27
8280748|NCT01673386|20417649|P1|NOT COMPLETED|Overall Study||25
8280749|NCT01673386|20417648|P2|COMPLETED|Overall Study|Of 4 subjects, 3 subjects discontinued sunitinib early, completed planned treatment with tivozanib.|4
8280750|NCT01673386|20417649|P1|COMPLETED|Overall Study|Of 2 subjects, 1 subject discontinued tivozanib early, completed planned treatment with sunitinib.|2
8280751|NCT01673386|20417648|P2|STARTED|Overall Study||31
8280752|NCT01673386|20417649|P1|STARTED|Overall Study||27
8280753|NCT01673373|20417679|P1|NOT COMPLETED|Overall Study||2
8280754|NCT01673373|20417679|P1|COMPLETED|Overall Study|Completed primary endpoint follow up.|66
8280755|NCT01673373|20417679|P1|STARTED|Overall Study||68
8280756|NCT01673347|20417695|P1|NOT COMPLETED|Overall Study||7
8280757|NCT01673347|20417695|P1|COMPLETED|Overall Study||17
8280758|NCT01673347|20417695|P1|STARTED|Overall Study||24
8280759|NCT01673282|20417704|P2|NOT COMPLETED|Overall Study||26
8280760|NCT01673282|20417705|P1|NOT COMPLETED|Overall Study||33
8280761|NCT01673282|20417704|P2|COMPLETED|Overall Study||132
8280762|NCT01673282|20417705|P1|COMPLETED|Overall Study||120
8280763|NCT01673282|20417704|P2|STARTED|Overall Study||158
8280764|NCT01673282|20417705|P1|STARTED|Overall Study||153
8280765|NCT01673256|20417711|P1|NOT COMPLETED|Overall Study||0
8280766|NCT01673256|20417711|P1|COMPLETED|Overall Study||90
8280767|NCT01673256|20417711|P1|STARTED|Overall Study||90
8280768|NCT01673191|20417717|P2|NOT COMPLETED|Overall Study||0
8280769|NCT01673191|20417718|P1|NOT COMPLETED|Overall Study||0
8280770|NCT01673191|20417717|P2|COMPLETED|Overall Study||11
8280771|NCT01673191|20417718|P1|COMPLETED|Overall Study||26
8280772|NCT01673191|20417717|P2|STARTED|Overall Study||11
8280773|NCT01673191|20417718|P1|STARTED|Overall Study||26
8280774|NCT01673178|20417741|P5|NOT COMPLETED|Overall Study||2
8280775|NCT01673178|20417742|P4|NOT COMPLETED|Overall Study||8
8280776|NCT01673178|20417743|P3|NOT COMPLETED|Overall Study||3
8280777|NCT01673178|20417744|P2|NOT COMPLETED|Overall Study||2
8280778|NCT01673178|20417745|P1|NOT COMPLETED|Overall Study||3
8280779|NCT01673178|20417741|P5|COMPLETED|Overall Study||19
8280780|NCT01673178|20417742|P4|COMPLETED|Overall Study||14
8280781|NCT01673178|20417743|P3|COMPLETED|Overall Study||18
8280782|NCT01673178|20417744|P2|COMPLETED|Overall Study||19
8280783|NCT01673178|20417745|P1|COMPLETED|Overall Study||19
8280784|NCT01673178|20417741|P5|STARTED|Overall Study||21
8280785|NCT01673178|20417742|P4|STARTED|Overall Study||22
8280786|NCT01673178|20417743|P3|STARTED|Overall Study||21
8280787|NCT01673178|20417744|P2|STARTED|Overall Study||21
8280788|NCT01673178|20417745|P1|STARTED|Overall Study||22
8280789|NCT01673126|20417984|P2|NOT COMPLETED|Overall Study||3
8280790|NCT01673126|20417985|P1|NOT COMPLETED|Overall Study||4
8280791|NCT01673126|20417984|P2|COMPLETED|Overall Study||23
8280792|NCT01673126|20417985|P1|COMPLETED|Overall Study||32
8280793|NCT01673126|20417984|P2|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
8280794|NCT01673126|20417985|P1|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
8280795|NCT01673113|20417993|P2|NOT COMPLETED|Overall Study||0
8280796|NCT01673113|20417994|P1|NOT COMPLETED|Overall Study||0
8280797|NCT01673113|20417993|P2|COMPLETED|Overall Study||11
8280798|NCT01673113|20417994|P1|COMPLETED|Overall Study||11
8280799|NCT01673113|20417993|P2|STARTED|Overall Study||11
8280800|NCT01673113|20417994|P1|STARTED|Overall Study||11
8280801|NCT01673061|20418003|P2|NOT COMPLETED|Overall Study||0
8280802|NCT01673061|20418004|P1|NOT COMPLETED|Overall Study||0
8280803|NCT01673061|20418003|P2|COMPLETED|Overall Study||0
8280804|NCT01673061|20418004|P1|COMPLETED|Overall Study||0
8280805|NCT01673061|20418003|P2|STARTED|Overall Study||0
8280806|NCT01673061|20418004|P1|STARTED|Overall Study||0
8280807|NCT01673022|20418020|P1|NOT COMPLETED|Overall Study||8
8280808|NCT01673022|20418020|P1|COMPLETED|Overall Study||422
8280809|NCT01673022|20418020|P1|STARTED|Overall Study||430
8280810|NCT01673009|20418024|P1|NOT COMPLETED|Overall Study||13
8280811|NCT01673009|20418024|P1|COMPLETED|Overall Study||23
8280812|NCT01673009|20418024|P1|STARTED|Overall Study||36
8280813|NCT01672996|20418036|P3|NOT COMPLETED|Overall Study||0
8280814|NCT01672996|20418037|P2|NOT COMPLETED|Overall Study||0
8280815|NCT01672996|20418038|P1|NOT COMPLETED|Overall Study||0
8280816|NCT01672996|20418036|P3|COMPLETED|Overall Study||6
8280817|NCT01672996|20418037|P2|COMPLETED|Overall Study||30
8280818|NCT01672996|20418038|P1|COMPLETED|Overall Study||30
8280819|NCT01672996|20418036|P3|STARTED|Overall Study||6
8280820|NCT01672996|20418037|P2|STARTED|Overall Study||30
8280821|NCT01672996|20418038|P1|STARTED|Overall Study||30
8280822|NCT01672983|20418074|P6|NOT COMPLETED|Overall Study||0
8280823|NCT01672983|20418075|P5|NOT COMPLETED|Overall Study||0
8280824|NCT01672983|20418076|P4|NOT COMPLETED|Overall Study||0
8280825|NCT01672983|20418077|P3|NOT COMPLETED|Overall Study||0
8280826|NCT01672983|20418078|P2|NOT COMPLETED|Overall Study||0
8280827|NCT01672983|20418079|P1|NOT COMPLETED|Overall Study||0
8280828|NCT01672983|20418074|P6|COMPLETED|Overall Study||18
8280829|NCT01672983|20418075|P5|COMPLETED|Overall Study||19
8280830|NCT01672983|20418076|P4|COMPLETED|Overall Study||18
8280831|NCT01672983|20418077|P3|COMPLETED|Overall Study||19
8280832|NCT01672983|20418078|P2|COMPLETED|Overall Study||18
8280833|NCT01672983|20418079|P1|COMPLETED|Overall Study||18
8280834|NCT01672983|20418074|P6|Completed Study Drug|Overall Study||17
8280835|NCT01672983|20418075|P5|Completed Study Drug|Overall Study||12
8280836|NCT01672983|20418076|P4|Completed Study Drug|Overall Study||18
8280837|NCT01672983|20418077|P3|Completed Study Drug|Overall Study||18
8280838|NCT01672983|20418078|P2|Completed Study Drug|Overall Study||17
8280839|NCT01672983|20418079|P1|Completed Study Drug|Overall Study||18
8280840|NCT01672983|20418074|P6|STARTED|Overall Study||18
8280841|NCT01672983|20418075|P5|STARTED|Overall Study||19
8280842|NCT01672983|20418076|P4|STARTED|Overall Study||18
8280843|NCT01672983|20418077|P3|STARTED|Overall Study||19
8280844|NCT01672983|20418078|P2|STARTED|Overall Study||18
8280845|NCT01672983|20418079|P1|STARTED|Overall Study||18
8280846|NCT01672970|20418109|P1|NOT COMPLETED|Overall Study||47
8280847|NCT01672970|20418109|P1|COMPLETED|Overall Study||244
8280848|NCT01672970|20418109|P1|Treated|Overall Study||290
8280849|NCT01672970|20418109|P1|STARTED|Overall Study||291
8280850|NCT01672957|20418145|P1|NOT COMPLETED|Overall Study||55
8280851|NCT01672957|20418145|P1|COMPLETED|Overall Study||73
8280852|NCT01672957|20418145|P1|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
8280853|NCT01672957|20418145|P1|STARTED|Overall Study||128
8280854|NCT01672892|20418160|P2|NOT COMPLETED|Overall Study||3
8280855|NCT01672892|20418161|P1|NOT COMPLETED|Overall Study||7
8280856|NCT01672892|20418160|P2|COMPLETED|Overall Study||149
8280857|NCT01672892|20418161|P1|COMPLETED|Overall Study||130
8280858|NCT01672892|20418160|P2|Adverse Event Population|Overall Study||144
8280859|NCT01672892|20418161|P1|Adverse Event Population|Overall Study||125
8280860|NCT01672892|20418160|P2|Eligible Population|Overall Study||149
8280861|NCT01672892|20418161|P1|Eligible Population|Overall Study||130
8280862|NCT01672892|20418160|P2|STARTED|Overall Study||152
8280863|NCT01672892|20418161|P1|STARTED|Overall Study||137
8280864|NCT01672879|20418190|P3|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8
8280865|NCT01672879|20418191|P2|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17
8280866|NCT01672879|20418192|P1|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15
8280867|NCT01672879|20418190|P3|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
8280868|NCT01672879|20418191|P2|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
8280869|NCT01672879|20418192|P1|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
8280870|NCT01672879|20418190|P3|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8
8280871|NCT01672879|20418191|P2|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17
8280872|NCT01672879|20418192|P1|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
8280873|NCT01672879|20418190|P3|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
8280874|NCT01672879|20418191|P2|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
8280875|NCT01672879|20418192|P1|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87
8280876|NCT01672879|20418190|P3|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
8280877|NCT01672879|20418191|P2|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
8280878|NCT01672879|20418192|P1|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
8280879|NCT01672879|20418190|P3|STARTED|Blinded Phase (Up to 240 Weeks)||86
8280880|NCT01672879|20418191|P2|STARTED|Blinded Phase (Up to 240 Weeks)||86
8280881|NCT01672879|20418192|P1|STARTED|Blinded Phase (Up to 240 Weeks)||87
8280882|NCT01672866|20418207|P3|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16
8280883|NCT01672866|20418208|P2|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15
8280884|NCT01672866|20418209|P1|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11
8280885|NCT01672866|20418207|P3|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
8280886|NCT01672866|20418208|P2|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
8280887|NCT01672866|20418209|P1|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
8280888|NCT01672866|20418207|P3|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16
8280889|NCT01672866|20418208|P2|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
8280890|NCT01672866|20418209|P1|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11
8280891|NCT01672866|20418207|P3|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
8280892|NCT01672866|20418208|P2|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
8280893|NCT01672866|20418209|P1|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
8280894|NCT01672866|20418207|P3|COMPLETED|Blinded Phase (up to 240 Weeks)||0
8280895|NCT01672866|20418208|P2|COMPLETED|Blinded Phase (up to 240 Weeks)||0
8280896|NCT01672866|20418209|P1|COMPLETED|Blinded Phase (up to 240 Weeks)||0
8280897|NCT01672866|20418207|P3|STARTED|Blinded Phase (up to 240 Weeks)||74
8280898|NCT01672866|20418208|P2|STARTED|Blinded Phase (up to 240 Weeks)||74
8280899|NCT01672866|20418209|P1|STARTED|Blinded Phase (up to 240 Weeks)||74
8280900|NCT01672853|20418224|P3|NOT COMPLETED|Overall Study||14
8280901|NCT01672853|20418225|P2|NOT COMPLETED|Overall Study||17
8280902|NCT01672853|20418226|P1|NOT COMPLETED|Overall Study||10
8280903|NCT01672853|20418224|P3|COMPLETED|Overall Study||65
8280904|NCT01672853|20418225|P2|COMPLETED|Overall Study||60
8280905|NCT01672853|20418226|P1|COMPLETED|Overall Study||69
8280906|NCT01672853|20418224|P3|STARTED|Overall Study||79
8280907|NCT01672853|20418225|P2|STARTED|Overall Study||77
8280908|NCT01672853|20418226|P1|STARTED|Overall Study||79
8280909|NCT01672827|20418243|P1|NOT COMPLETED|Overall Study||0
8280910|NCT01672827|20418243|P1|COMPLETED|Overall Study||276
8280911|NCT01672827|20418243|P1|STARTED|Overall Study||276
8280912|NCT01672801|20418251|P2|NOT COMPLETED|Overall Study||1
8280913|NCT01672801|20418252|P1|NOT COMPLETED|Overall Study||0
8280914|NCT01672801|20418251|P2|COMPLETED|Overall Study||8
8280915|NCT01672801|20418252|P1|COMPLETED|Overall Study||9
8280916|NCT01672801|20418251|P2|STARTED|Overall Study||9
8280917|NCT01672801|20418252|P1|STARTED|Overall Study||9
8280918|NCT01672788|20418260|P4|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8280919|NCT01672788|20418261|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8280920|NCT01672788|20418262|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8280921|NCT01672788|20418263|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8280922|NCT01672788|20418260|P4|COMPLETED|Treatment Period 4 (3 Days)||8
8280923|NCT01672788|20418261|P3|COMPLETED|Treatment Period 4 (3 Days)||9
8280924|NCT01672788|20418262|P2|COMPLETED|Treatment Period 4 (3 Days)||9
8280925|NCT01672788|20418263|P1|COMPLETED|Treatment Period 4 (3 Days)||9
8280926|NCT01672788|20418260|P4|STARTED|Treatment Period 4 (3 Days)||8
8280927|NCT01672788|20418261|P3|STARTED|Treatment Period 4 (3 Days)||9
8280928|NCT01672788|20418262|P2|STARTED|Treatment Period 4 (3 Days)||9
8280929|NCT01672788|20418263|P1|STARTED|Treatment Period 4 (3 Days)||9
8280930|NCT01672788|20418260|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8280931|NCT01672788|20418261|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8280932|NCT01672788|20418262|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8280933|NCT01672788|20418263|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8280934|NCT01672788|20418260|P4|COMPLETED|Washout Period 3 (7 Days)||8
8280935|NCT01672788|20418261|P3|COMPLETED|Washout Period 3 (7 Days)||9
8280936|NCT01672788|20418262|P2|COMPLETED|Washout Period 3 (7 Days)||9
8280937|NCT01672788|20418263|P1|COMPLETED|Washout Period 3 (7 Days)||9
8280938|NCT01672788|20418260|P4|STARTED|Washout Period 3 (7 Days)||8
8280939|NCT01672788|20418261|P3|STARTED|Washout Period 3 (7 Days)||9
8280940|NCT01672788|20418262|P2|STARTED|Washout Period 3 (7 Days)||9
8280941|NCT01672788|20418263|P1|STARTED|Washout Period 3 (7 Days)||9
8280942|NCT01672788|20418260|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8280943|NCT01672788|20418261|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8280944|NCT01672788|20418262|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8280945|NCT01672788|20418263|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8280946|NCT01672788|20418260|P4|COMPLETED|Treatment Period 3 (3 Days)||8
8280947|NCT01672788|20418261|P3|COMPLETED|Treatment Period 3 (3 Days)||9
8280948|NCT01672788|20418262|P2|COMPLETED|Treatment Period 3 (3 Days)||9
8280949|NCT01672788|20418263|P1|COMPLETED|Treatment Period 3 (3 Days)||9
8280950|NCT01672788|20418260|P4|STARTED|Treatment Period 3 (3 Days)||8
8280951|NCT01672788|20418261|P3|STARTED|Treatment Period 3 (3 Days)||9
8280952|NCT01672788|20418262|P2|STARTED|Treatment Period 3 (3 Days)||9
8280953|NCT01672788|20418263|P1|STARTED|Treatment Period 3 (3 Days)||9
8280954|NCT01672788|20418260|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
8280955|NCT01672788|20418261|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8280956|NCT01672788|20418262|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8280957|NCT01672788|20418263|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8280958|NCT01672788|20418260|P4|COMPLETED|Washout Period 2 (7 Days)||8
8280959|NCT01672788|20418261|P3|COMPLETED|Washout Period 2 (7 Days)||9
8280960|NCT01672788|20418262|P2|COMPLETED|Washout Period 2 (7 Days)||9
8280961|NCT01672788|20418263|P1|COMPLETED|Washout Period 2 (7 Days)||9
8280962|NCT01672788|20418260|P4|STARTED|Washout Period 2 (7 Days)||9
8280963|NCT01672788|20418261|P3|STARTED|Washout Period 2 (7 Days)||9
8280964|NCT01672788|20418262|P2|STARTED|Washout Period 2 (7 Days)||9
8280965|NCT01672788|20418263|P1|STARTED|Washout Period 2 (7 Days)||9
8280966|NCT01672788|20418260|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8280967|NCT01672788|20418261|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8280968|NCT01672788|20418262|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8280969|NCT01672788|20418263|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8280970|NCT01672788|20418260|P4|COMPLETED|Treatment Period 2 (3 Days)||9
8280971|NCT01672788|20418261|P3|COMPLETED|Treatment Period 2 (3 Days)||9
8280972|NCT01672788|20418262|P2|COMPLETED|Treatment Period 2 (3 Days)||9
8280973|NCT01672788|20418263|P1|COMPLETED|Treatment Period 2 (3 Days)||9
8280974|NCT01672788|20418260|P4|STARTED|Treatment Period 2 (3 Days)||9
8280975|NCT01672788|20418261|P3|STARTED|Treatment Period 2 (3 Days)||9
8280976|NCT01672788|20418262|P2|STARTED|Treatment Period 2 (3 Days)||9
8280977|NCT01672788|20418263|P1|STARTED|Treatment Period 2 (3 Days)||9
8280978|NCT01672788|20418260|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8280979|NCT01672788|20418261|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8280980|NCT01672788|20418262|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8280981|NCT01672788|20418263|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8280982|NCT01672788|20418260|P4|COMPLETED|Washout Period 1 (7 Days)||9
8280983|NCT01672788|20418261|P3|COMPLETED|Washout Period 1 (7 Days)||9
8280984|NCT01672788|20418262|P2|COMPLETED|Washout Period 1 (7 Days)||9
8280985|NCT01672788|20418263|P1|COMPLETED|Washout Period 1 (7 Days)||9
8280986|NCT01672788|20418260|P4|STARTED|Washout Period 1 (7 Days)||9
8280987|NCT01672788|20418261|P3|STARTED|Washout Period 1 (7 Days)||9
8280988|NCT01672788|20418262|P2|STARTED|Washout Period 1 (7 Days)||9
8280989|NCT01672788|20418263|P1|STARTED|Washout Period 1 (7 Days)||9
8280990|NCT01672788|20418260|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8280991|NCT01672788|20418261|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8280992|NCT01672788|20418262|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8280993|NCT01672788|20418263|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8280994|NCT01672788|20418260|P4|COMPLETED|Treatment Period 1 (3 Days)||9
8280995|NCT01672788|20418261|P3|COMPLETED|Treatment Period 1 (3 Days)||9
8280996|NCT01672788|20418262|P2|COMPLETED|Treatment Period 1 (3 Days)||9
8280997|NCT01672788|20418263|P1|COMPLETED|Treatment Period 1 (3 Days)||9
8280998|NCT01672788|20418260|P4|STARTED|Treatment Period 1 (3 Days)||9
8280999|NCT01672788|20418261|P3|STARTED|Treatment Period 1 (3 Days)||9
8281000|NCT01672788|20418262|P2|STARTED|Treatment Period 1 (3 Days)||9
8281001|NCT01672788|20418263|P1|STARTED|Treatment Period 1 (3 Days)||9
8281002|NCT01672736|20418293|P1|NOT COMPLETED|Overall Study||3
8281003|NCT01672736|20418293|P1|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
8281004|NCT01672736|20418293|P1|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
8281005|NCT01672723|20418297|P2|NOT COMPLETED|Second Intervention||0
8281006|NCT01672723|20418298|P1|NOT COMPLETED|Second Intervention||0
8281007|NCT01672723|20418297|P2|COMPLETED|Second Intervention||15
8281008|NCT01672723|20418298|P1|COMPLETED|Second Intervention||16
8281009|NCT01672723|20418297|P2|STARTED|Second Intervention||15
8281010|NCT01672723|20418298|P1|STARTED|Second Intervention||16
8281011|NCT01672723|20418297|P2|NOT COMPLETED|Washout Period of 10 Days||0
8281012|NCT01672723|20418298|P1|NOT COMPLETED|Washout Period of 10 Days||0
8281013|NCT01672723|20418297|P2|COMPLETED|Washout Period of 10 Days||15
8281014|NCT01672723|20418298|P1|COMPLETED|Washout Period of 10 Days||16
8281015|NCT01672723|20418297|P2|STARTED|Washout Period of 10 Days||15
8281016|NCT01672723|20418298|P1|STARTED|Washout Period of 10 Days||16
8281017|NCT01672723|20418297|P2|NOT COMPLETED|First Intervention||0
8281018|NCT01672723|20418298|P1|NOT COMPLETED|First Intervention||3
8281019|NCT01672723|20418297|P2|COMPLETED|First Intervention||15
8281020|NCT01672723|20418298|P1|COMPLETED|First Intervention||16
8281021|NCT01672723|20418297|P2|STARTED|First Intervention||15
8281022|NCT01672723|20418298|P1|STARTED|First Intervention||19
8281023|NCT01672710|20418310|P2|NOT COMPLETED|3 Month Follow up||4
8281024|NCT01672710|20418311|P1|NOT COMPLETED|3 Month Follow up||6
8281025|NCT01672710|20418310|P2|COMPLETED|3 Month Follow up||5
8281026|NCT01672710|20418311|P1|COMPLETED|3 Month Follow up||16
8281027|NCT01672710|20418310|P2|STARTED|3 Month Follow up||9
8281028|NCT01672710|20418311|P1|STARTED|3 Month Follow up||22
8281029|NCT01672710|20418310|P2|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
8281030|NCT01672710|20418311|P1|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
8281031|NCT01672710|20418310|P2|COMPLETED|Waitlist Assessed After Sauna Regimen||9
8281032|NCT01672710|20418311|P1|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
8281033|NCT01672710|20418310|P2|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
8281034|NCT01672710|20418311|P1|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
8281035|NCT01672710|20418310|P2|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
8281036|NCT01672710|20418311|P1|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
8281037|NCT01672710|20418310|P2|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
8281038|NCT01672710|20418311|P1|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
8281039|NCT01672710|20418310|P2|STARTED|Controlled Comparison 5 Week Follow-up||10
8281040|NCT01672710|20418311|P1|STARTED|Controlled Comparison 5 Week Follow-up||22
8281041|NCT01672658|20418321|P2|NOT COMPLETED|Overall Study||1
8281042|NCT01672658|20418322|P1|NOT COMPLETED|Overall Study||0
8281043|NCT01672658|20418321|P2|COMPLETED|Overall Study||14
8281044|NCT01672658|20418322|P1|COMPLETED|Overall Study||16
8281045|NCT01672658|20418321|P2|STARTED|Overall Study||15
8281046|NCT01672658|20418322|P1|STARTED|Overall Study||16
8281047|NCT01672294|20418346|P4|NOT COMPLETED|Overall Study||13
8281048|NCT01672294|20418347|P3|NOT COMPLETED|Overall Study||11
8281049|NCT01672294|20418348|P2|NOT COMPLETED|Overall Study||21
8281050|NCT01672294|20418349|P1|NOT COMPLETED|Overall Study||6
8281051|NCT01672294|20418346|P4|COMPLETED|Overall Study||59
8281052|NCT01672294|20418347|P3|COMPLETED|Overall Study||61
8281053|NCT01672294|20418348|P2|COMPLETED|Overall Study||50
8281054|NCT01672294|20418349|P1|COMPLETED|Overall Study||65
8281055|NCT01672294|20418346|P4|STARTED|Overall Study||72
8281056|NCT01672294|20418347|P3|STARTED|Overall Study||72
8281057|NCT01672294|20418348|P2|STARTED|Overall Study||71
8281058|NCT01672294|20418349|P1|STARTED|Overall Study||71
8281059|NCT01672242|20418371|P2|NOT COMPLETED|Period 2||0
8281060|NCT01672242|20418372|P1|NOT COMPLETED|Period 2||0
8281061|NCT01672242|20418371|P2|COMPLETED|Period 2||2
8281062|NCT01672242|20418372|P1|COMPLETED|Period 2||4
8281063|NCT01672242|20418371|P2|STARTED|Period 2||2
8281064|NCT01672242|20418372|P1|STARTED|Period 2||4
8281065|NCT01672242|20418371|P2|NOT COMPLETED|Period 1||0
8281066|NCT01672242|20418372|P1|NOT COMPLETED|Period 1||0
8281067|NCT01672242|20418371|P2|COMPLETED|Period 1||2
8281068|NCT01672242|20418372|P1|COMPLETED|Period 1||4
8281069|NCT01672242|20418371|P2|STARTED|Period 1||2
8281070|NCT01672242|20418372|P1|STARTED|Period 1||4
8281071|NCT01671839|20418378|P1|NOT COMPLETED|Overall Study||18
8281072|NCT01671839|20418378|P1|COMPLETED|Overall Study||37
8281073|NCT01671839|20418378|P1|5-year Follow-up|Overall Study||37
8281074|NCT01671839|20418378|P1|3-year Follow-up|Overall Study||45
8281075|NCT01671839|20418378|P1|STARTED|Overall Study||55
8281076|NCT01671748|20418394|P2|NOT COMPLETED|12 Week Treatment Phase||0
8281077|NCT01671748|20418395|P1|NOT COMPLETED|12 Week Treatment Phase||0
8281078|NCT01671748|20418394|P2|COMPLETED|12 Week Treatment Phase||17
8281079|NCT01671748|20418395|P1|COMPLETED|12 Week Treatment Phase||19
8281080|NCT01671748|20418394|P2|STARTED|12 Week Treatment Phase||17
8281081|NCT01671748|20418395|P1|STARTED|12 Week Treatment Phase||19
8281082|NCT01671748|20418394|P2|NOT COMPLETED|4 Week run-in Phase||0
8281083|NCT01671748|20418395|P1|NOT COMPLETED|4 Week run-in Phase||11
8281084|NCT01671748|20418394|P2|COMPLETED|4 Week run-in Phase||0
8281085|NCT01671748|20418395|P1|COMPLETED|4 Week run-in Phase||36
8281086|NCT01671748|20418394|P2|STARTED|4 Week run-in Phase||0
8281087|NCT01671748|20418395|P1|STARTED|4 Week run-in Phase||47
8281088|NCT01671605|20418415|P2|NOT COMPLETED|Overall Study||0
8281089|NCT01671605|20418416|P1|NOT COMPLETED|Overall Study||0
8281090|NCT01671605|20418415|P2|COMPLETED|Overall Study||31
8281091|NCT01671605|20418416|P1|COMPLETED|Overall Study||72
8281092|NCT01671605|20418415|P2|STARTED|Overall Study||31
8281093|NCT01671605|20418416|P1|STARTED|Overall Study||72
8281094|NCT01671488|20418422|P1|NOT COMPLETED|Overall Study||1
8281095|NCT01671488|20418422|P1|COMPLETED|Overall Study||10
8281096|NCT01671488|20418422|P1|STARTED|Overall Study||11
8281097|NCT01671345|20418430|P2|NOT COMPLETED|Overall Study||9
8281098|NCT01671345|20418431|P1|NOT COMPLETED|Overall Study||13
8281099|NCT01671345|20418430|P2|COMPLETED|Overall Study||83
8281100|NCT01671345|20418431|P1|COMPLETED|Overall Study||64
8281101|NCT01671345|20418430|P2|STARTED|Overall Study||92
8281102|NCT01671345|20418431|P1|STARTED|Overall Study||77
8281103|NCT01671332|20418445|P2|NOT COMPLETED|Overall Study||1
8281104|NCT01671332|20418446|P1|NOT COMPLETED|Overall Study||1
8281105|NCT01671332|20418445|P2|COMPLETED|Overall Study||39
8281106|NCT01671332|20418446|P1|COMPLETED|Overall Study||39
8281107|NCT01671332|20418445|P2|Crossed Over to Docetaxel Plus Suramin|Overall Study|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|13
8281108|NCT01671332|20418446|P1|Crossed Over to Docetaxel Plus Suramin|Overall Study||0
8281109|NCT01671332|20418445|P2|STARTED|Overall Study||40
8281110|NCT01671332|20418446|P1|STARTED|Overall Study||40
8281111|NCT01671319|20418460|P1|NOT COMPLETED|Overall Study||1
8281112|NCT01671319|20418460|P1|COMPLETED|Overall Study||41
8281113|NCT01671319|20418460|P1|STARTED|Overall Study||42
8281114|NCT01671293|20418468|P2|NOT COMPLETED|Overall Study||2
8281115|NCT01671293|20418469|P1|NOT COMPLETED|Overall Study||3
8281116|NCT01671293|20418468|P2|COMPLETED|Overall Study||32
8281117|NCT01671293|20418469|P1|COMPLETED|Overall Study||33
8281118|NCT01671293|20418468|P2|STARTED|Overall Study||34
8281119|NCT01671293|20418469|P1|STARTED|Overall Study||36
8281120|NCT01671280|20418475|P1|NOT COMPLETED|Overall Study||2
8281121|NCT01671280|20418475|P1|COMPLETED|Overall Study||401
8281122|NCT01671280|20418475|P1|STARTED|Overall Study|The number is enrollment.|403
8281123|NCT01671176|20418481|P1|NOT COMPLETED|Overall Study||0
8281124|NCT01671176|20418481|P1|COMPLETED|Overall Study||30
8281125|NCT01671176|20418481|P1|STARTED|Overall Study||30
8281129|NCT01671085|20418498|P2|NOT COMPLETED|Overall Study||0
8281130|NCT01671085|20418499|P1|NOT COMPLETED|Overall Study||1
8281131|NCT01671085|20418498|P2|COMPLETED|Overall Study||2
8281132|NCT01671085|20418499|P1|COMPLETED|Overall Study||10
8281133|NCT01671085|20418498|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
8281134|NCT01671085|20418499|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
8281135|NCT01671085|20418498|P2|STARTED|Overall Study||2
8281136|NCT01671085|20418499|P1|STARTED|Overall Study|1 participant who dropped out was replaced.|11
8281137|NCT01671059|20418510|P1|NOT COMPLETED|Overall Study||5
8281138|NCT01671059|20418510|P1|COMPLETED|Overall Study||75
8281139|NCT01671059|20418510|P1|STARTED|Overall Study||80
8281140|NCT01671007|20418542|P9|NOT COMPLETED|Overall Study||0
8281141|NCT01671007|20418543|P8|NOT COMPLETED|Overall Study||132
8281142|NCT01671007|20418544|P7|NOT COMPLETED|Overall Study||21
8281143|NCT01671007|20418545|P6|NOT COMPLETED|Overall Study||112
8281144|NCT01671007|20418546|P5|NOT COMPLETED|Overall Study||25
8281145|NCT01671007|20418547|P4|NOT COMPLETED|Overall Study||368
8281146|NCT01671007|20418548|P3|NOT COMPLETED|Overall Study||366
8281147|NCT01671007|20418549|P2|NOT COMPLETED|Overall Study||651
8281148|NCT01671007|20418550|P1|NOT COMPLETED|Overall Study||321
8281149|NCT01671007|20418542|P9|COMPLETED|Overall Study||2
8281150|NCT01671007|20418543|P8|COMPLETED|Overall Study||394
8281151|NCT01671007|20418544|P7|COMPLETED|Overall Study||59
8281152|NCT01671007|20418545|P6|COMPLETED|Overall Study||401
8281153|NCT01671007|20418546|P5|COMPLETED|Overall Study||155
8281154|NCT01671007|20418547|P4|COMPLETED|Overall Study||1846
8281155|NCT01671007|20418548|P3|COMPLETED|Overall Study||1667
8281156|NCT01671007|20418549|P2|COMPLETED|Overall Study||2183
8281157|NCT01671007|20418550|P1|COMPLETED|Overall Study||1768
8281158|NCT01671007|20418542|P9|All Eligible|Overall Study||2
8281159|NCT01671007|20418543|P8|All Eligible|Overall Study||507
8281160|NCT01671007|20418544|P7|All Eligible|Overall Study||79
8281161|NCT01671007|20418545|P6|All Eligible|Overall Study||507
8281162|NCT01671007|20418546|P5|All Eligible|Overall Study||180
8281163|NCT01671007|20418547|P4|All Eligible|Overall Study||2197
8281164|NCT01671007|20418548|P3|All Eligible|Overall Study||2008
8281165|NCT01671007|20418549|P2|All Eligible|Overall Study||2758
8281166|NCT01671007|20418550|P1|All Eligible|Overall Study||2066
8281167|NCT01671007|20418542|P9|STARTED|Overall Study||2
8281168|NCT01671007|20418543|P8|STARTED|Overall Study||526
8281169|NCT01671007|20418544|P7|STARTED|Overall Study||80
8281170|NCT01671007|20418545|P6|STARTED|Overall Study||513
8281171|NCT01671007|20418546|P5|STARTED|Overall Study||180
8281172|NCT01671007|20418547|P4|STARTED|Overall Study||2214
8281173|NCT01671007|20418548|P3|STARTED|Overall Study||2033
8281174|NCT01671007|20418549|P2|STARTED|Overall Study||2834
8281175|NCT01671007|20418550|P1|STARTED|Overall Study||2089
8281176|NCT01670825|20418585|P2|NOT COMPLETED|Overall Study||0
8281177|NCT01670825|20418586|P1|NOT COMPLETED|Overall Study||0
8281178|NCT01670825|20418585|P2|COMPLETED|Overall Study||39
8281179|NCT01670825|20418586|P1|COMPLETED|Overall Study||42
8281180|NCT01670825|20418585|P2|STARTED|Overall Study||39
8281181|NCT01670825|20418586|P1|STARTED|Overall Study||42
8281182|NCT01670760|20418652|P1|NOT COMPLETED|Overall Study||0
8281183|NCT01670760|20418652|P1|COMPLETED|Overall Study||20
8281184|NCT01670760|20418652|P1|STARTED|Overall Study||20
8281185|NCT01670721|20418656|P1|NOT COMPLETED|Overall Study||53
8281186|NCT01670721|20418656|P1|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
8281187|NCT01670721|20418656|P1|STARTED|Overall Study||175
8281188|NCT01670656|20418668|P5|NOT COMPLETED|Overall Study||11
8281189|NCT01670656|20418669|P4|NOT COMPLETED|Overall Study||6
8281190|NCT01670656|20418670|P3|NOT COMPLETED|Overall Study||8
8281191|NCT01670656|20418671|P2|NOT COMPLETED|Overall Study||7
8281192|NCT01670656|20418672|P1|NOT COMPLETED|Overall Study||3
8281193|NCT01670656|20418668|P5|COMPLETED|Overall Study||79
8281194|NCT01670656|20418669|P4|COMPLETED|Overall Study||79
8281195|NCT01670656|20418670|P3|COMPLETED|Overall Study||79
8281196|NCT01670656|20418671|P2|COMPLETED|Overall Study||84
8281197|NCT01670656|20418672|P1|COMPLETED|Overall Study||83
8281198|NCT01670656|20418668|P5|Treated|Overall Study||90
8281199|NCT01670656|20418669|P4|Treated|Overall Study||85
8281200|NCT01670656|20418670|P3|Treated|Overall Study||86
8281201|NCT01670656|20418671|P2|Treated|Overall Study||91
8281202|NCT01670656|20418672|P1|Treated|Overall Study||86
8281203|NCT01670656|20418668|P5|STARTED|Overall Study||90
8281204|NCT01670656|20418669|P4|STARTED|Overall Study||85
8281205|NCT01670656|20418670|P3|STARTED|Overall Study||87
8281206|NCT01670656|20418671|P2|STARTED|Overall Study||91
8281207|NCT01670656|20418672|P1|STARTED|Overall Study||86
8281208|NCT01670526|20418701|P2|NOT COMPLETED|Overall Study||6
8281209|NCT01670526|20418702|P1|NOT COMPLETED|Overall Study||12
8281210|NCT01670526|20418701|P2|COMPLETED|Overall Study||39
8281211|NCT01670526|20418702|P1|COMPLETED|Overall Study||37
8281212|NCT01670526|20418701|P2|STARTED|Overall Study||45
8281213|NCT01670526|20418702|P1|STARTED|Overall Study||49
8281220|NCT01670487|20418733|P2|NOT COMPLETED|Overall Study||0
8281221|NCT01670487|20418734|P1|NOT COMPLETED|Overall Study||0
8281222|NCT01670487|20418733|P2|COMPLETED|Overall Study||150
8281223|NCT01670487|20418734|P1|COMPLETED|Overall Study||150
8281224|NCT01670487|20418733|P2|STARTED|Overall Study||150
8281225|NCT01670487|20418734|P1|STARTED|Overall Study||150
8281226|NCT01670292|20418740|P1|NOT COMPLETED|Overall Study||14
8281227|NCT01670292|20418740|P1|COMPLETED|Overall Study||68
8281228|NCT01670292|20418740|P1|STARTED|Overall Study||82
8281229|NCT01670279|20418781|P4|NOT COMPLETED|Overall Study||1
8281230|NCT01670279|20418782|P3|NOT COMPLETED|Overall Study||0
8281231|NCT01670279|20418783|P2|NOT COMPLETED|Overall Study||2
8281232|NCT01670279|20418784|P1|NOT COMPLETED|Overall Study||0
8281233|NCT01670279|20418781|P4|COMPLETED|Overall Study||4
8281234|NCT01670279|20418782|P3|COMPLETED|Overall Study||0
8281235|NCT01670279|20418783|P2|COMPLETED|Overall Study||5
8281236|NCT01670279|20418784|P1|COMPLETED|Overall Study||6
8281237|NCT01670279|20418781|P4|STARTED|Overall Study||5
8281238|NCT01670279|20418782|P3|STARTED|Overall Study||0
8281239|NCT01670279|20418783|P2|STARTED|Overall Study||7
8281240|NCT01670279|20418784|P1|STARTED|Overall Study||6
8281241|NCT01670201|20418819|P1|NOT COMPLETED|Overall Study||0
8281242|NCT01670201|20418819|P1|COMPLETED|Overall Study||8
8281243|NCT01670201|20418819|P1|STARTED|Overall Study||8
8281244|NCT01670188|20418826|P2|NOT COMPLETED|Overall Study||1
8281245|NCT01670188|20418827|P1|NOT COMPLETED|Overall Study||0
8281246|NCT01670188|20418826|P2|COMPLETED|Overall Study||39
8281247|NCT01670188|20418827|P1|COMPLETED|Overall Study||38
8281248|NCT01670188|20418826|P2|STARTED|Overall Study||40
8281249|NCT01670188|20418827|P1|STARTED|Overall Study||38
8281250|NCT01670110|20418835|P2|NOT COMPLETED|Overall Study||3
8281251|NCT01670110|20418836|P1|NOT COMPLETED|Overall Study||4
8281252|NCT01670110|20418835|P2|COMPLETED|Overall Study||12
8281253|NCT01670110|20418836|P1|COMPLETED|Overall Study||29
8281254|NCT01670110|20418835|P2|STARTED|Overall Study||15
8281255|NCT01670110|20418836|P1|STARTED|Overall Study||33
8281256|NCT01670045|20418856|P1|NOT COMPLETED|Overall Study||16
8281257|NCT01670045|20418856|P1|COMPLETED|Overall Study||27
8281258|NCT01670045|20418856|P1|STARTED|Overall Study||43
8281259|NCT01670019|20418874|P2|NOT COMPLETED|Overall Study||0
8281260|NCT01670019|20418875|P1|NOT COMPLETED|Overall Study||9
8281261|NCT01670019|20418874|P2|COMPLETED|Overall Study||23
8281262|NCT01670019|20418875|P1|COMPLETED|Overall Study||14
8281263|NCT01670019|20418874|P2|STARTED|Overall Study||23
8281264|NCT01670019|20418875|P1|STARTED|Overall Study||23
8281265|NCT01669902|20418889|P1|NOT COMPLETED|Overall Study||29
8281266|NCT01669902|20418889|P1|COMPLETED|Overall Study||78
8281267|NCT01669902|20418889|P1|STARTED|Overall Study||107
8281268|NCT01669863|20418916|P1|NOT COMPLETED|Overall Study||0
8281269|NCT01669863|20418916|P1|COMPLETED|Overall Study||6
8281270|NCT01669863|20418916|P1|STARTED|Overall Study||6
8281271|NCT01669811|20418924|P2|NOT COMPLETED|Overall Study||11
8281272|NCT01669811|20418925|P1|NOT COMPLETED|Overall Study||3
8281273|NCT01669811|20418924|P2|COMPLETED|Overall Study||131
8281274|NCT01669811|20418925|P1|COMPLETED|Overall Study||142
8281275|NCT01669811|20418924|P2|STARTED|Overall Study||142
8281276|NCT01669811|20418925|P1|STARTED|Overall Study||145
8281277|NCT01669798|20418943|P1|NOT COMPLETED|Overall Study||5
8281278|NCT01669798|20418943|P1|COMPLETED|Overall Study||27
8281279|NCT01669798|20418943|P1|STARTED|Overall Study||32
8281280|NCT01669785|20418959|P3|NOT COMPLETED|Overall Study||0
8281281|NCT01669785|20418960|P2|NOT COMPLETED|Overall Study||0
8281282|NCT01669785|20418961|P1|NOT COMPLETED|Overall Study||0
8281283|NCT01669785|20418959|P3|COMPLETED|Overall Study||46
8281284|NCT01669785|20418960|P2|COMPLETED|Overall Study||48
8281285|NCT01669785|20418961|P1|COMPLETED|Overall Study||45
8281286|NCT01669785|20418959|P3|STARTED|Overall Study||46
8281287|NCT01669785|20418960|P2|STARTED|Overall Study||48
8281288|NCT01669785|20418961|P1|STARTED|Overall Study||45
8281289|NCT01669720|20418998|P2|NOT COMPLETED|Overall Study||0
8281290|NCT01669720|20418999|P1|NOT COMPLETED|Overall Study||0
8281291|NCT01669720|20418998|P2|COMPLETED|Overall Study||3
8281292|NCT01669720|20418999|P1|COMPLETED|Overall Study||7
8281293|NCT01669720|20418998|P2|STARTED|Overall Study||3
8281294|NCT01669720|20418999|P1|STARTED|Overall Study||7
8281295|NCT01669642|20419012|P6|NOT COMPLETED|Overall Study||10
8281296|NCT01669642|20419013|P5|NOT COMPLETED|Overall Study||0
8281297|NCT01669642|20419014|P4|NOT COMPLETED|Overall Study||1
8281298|NCT01669642|20419015|P3|NOT COMPLETED|Overall Study||0
8281299|NCT01669642|20419016|P2|NOT COMPLETED|Overall Study||0
8281300|NCT01669642|20419017|P1|NOT COMPLETED|Overall Study||0
8281301|NCT01669642|20419012|P6|COMPLETED|Overall Study||0
8281302|NCT01669642|20419013|P5|COMPLETED|Overall Study||20
8281303|NCT01669642|20419014|P4|COMPLETED|Overall Study||20
8281304|NCT01669642|20419015|P3|COMPLETED|Overall Study||20
8281305|NCT01669642|20419016|P2|COMPLETED|Overall Study||20
8281306|NCT01669642|20419017|P1|COMPLETED|Overall Study||20
8281307|NCT01669642|20419012|P6|STARTED|Overall Study||10
8281308|NCT01669642|20419013|P5|STARTED|Overall Study||20
8281309|NCT01669642|20419014|P4|STARTED|Overall Study||21
8281310|NCT01669642|20419015|P3|STARTED|Overall Study||20
8281311|NCT01669642|20419016|P2|STARTED|Overall Study||20
8281312|NCT01669642|20419017|P1|STARTED|Overall Study||20
8281313|NCT01669629|20419049|P2|NOT COMPLETED|Period 2||0
8281314|NCT01669629|20419050|P1|NOT COMPLETED|Period 2||0
8281315|NCT01669629|20419049|P2|COMPLETED|Period 2||89
8281316|NCT01669629|20419050|P1|COMPLETED|Period 2||91
8281317|NCT01669629|20419049|P2|STARTED|Period 2||89
8281318|NCT01669629|20419050|P1|STARTED|Period 2||91
8281319|NCT01669629|20419049|P2|NOT COMPLETED|Period 1||2
8281320|NCT01669629|20419050|P1|NOT COMPLETED|Period 1||1
8281321|NCT01669629|20419049|P2|COMPLETED|Period 1||89
8281322|NCT01669629|20419050|P1|COMPLETED|Period 1||91
8281323|NCT01669629|20419049|P2|STARTED|Period 1||91
8281324|NCT01669629|20419050|P1|STARTED|Period 1||92
8281325|NCT01669603|20419066|P2|NOT COMPLETED|Overall Study||38
8281326|NCT01669603|20419067|P1|NOT COMPLETED|Overall Study||37
8281327|NCT01669603|20419066|P2|COMPLETED|Overall Study||57
8281328|NCT01669603|20419067|P1|COMPLETED|Overall Study||58
8281329|NCT01669603|20419066|P2|STARTED|Overall Study||95
8281330|NCT01669603|20419067|P1|STARTED|Overall Study||95
8281331|NCT01669577|20419073|P1|NOT COMPLETED|Overall Study||134
8281332|NCT01669577|20419073|P1|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
8281333|NCT01669577|20419073|P1|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
8281334|NCT01669538|20419079|P2|NOT COMPLETED|Overall Study||9
8281335|NCT01669538|20419080|P1|NOT COMPLETED|Overall Study||12
8281336|NCT01669538|20419079|P2|COMPLETED|Overall Study||33
8281337|NCT01669538|20419080|P1|COMPLETED|Overall Study||28
8281338|NCT01669538|20419079|P2|STARTED|Overall Study||42
8281339|NCT01669538|20419080|P1|STARTED|Overall Study||40
8281340|NCT01669434|20419094|P2|NOT COMPLETED|Overall Study||7
8281341|NCT01669434|20419095|P1|NOT COMPLETED|Overall Study||9
8281342|NCT01669434|20419094|P2|COMPLETED|Overall Study||138
8281343|NCT01669434|20419095|P1|COMPLETED|Overall Study||137
8281344|NCT01669434|20419094|P2|STARTED|Overall Study||145
8281345|NCT01669434|20419095|P1|STARTED|Overall Study||146
8281346|NCT01669421|20419111|P1|NOT COMPLETED|Phase 3: Standard Dose Therapy||0
8281347|NCT01669421|20419111|P1|COMPLETED|Phase 3: Standard Dose Therapy||8
8281348|NCT01669421|20419111|P1|STARTED|Phase 3: Standard Dose Therapy||8
8281349|NCT01669421|20419111|P1|NOT COMPLETED|Phase 2: Double Dose Therapy||0
8281350|NCT01669421|20419111|P1|COMPLETED|Phase 2: Double Dose Therapy||8
8281351|NCT01669421|20419111|P1|STARTED|Phase 2: Double Dose Therapy||8
8281352|NCT01669421|20419111|P1|NOT COMPLETED|Phase 1: Standard Dose Therapy||2
8281353|NCT01669421|20419111|P1|COMPLETED|Phase 1: Standard Dose Therapy||8
8281354|NCT01669421|20419111|P1|STARTED|Phase 1: Standard Dose Therapy||10
8281355|NCT01669174|20419130|P2|NOT COMPLETED|Overall Study||6
8281356|NCT01669174|20419131|P1|NOT COMPLETED|Overall Study||6
8281357|NCT01669174|20419130|P2|COMPLETED|Overall Study||28
8281358|NCT01669174|20419131|P1|COMPLETED|Overall Study||27
8281359|NCT01669174|20419130|P2|STARTED|Overall Study||34
8281360|NCT01669174|20419131|P1|STARTED|Overall Study||33
8281361|NCT01669148|20419142|P1|NOT COMPLETED|Overall Study||70
8281362|NCT01669148|20419142|P1|COMPLETED|Overall Study||426
8281363|NCT01669148|20419142|P1|STARTED|Overall Study||496
8281364|NCT01669122|20419147|P1|NOT COMPLETED|Period IV||0
8281365|NCT01669122|20419147|P1|COMPLETED|Period IV||37
8281366|NCT01669122|20419147|P1|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
8281367|NCT01669122|20419147|P1|NOT COMPLETED|Period III||0
8281368|NCT01669122|20419147|P1|COMPLETED|Period III||37
8281369|NCT01669122|20419147|P1|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
8281370|NCT01669122|20419147|P1|NOT COMPLETED|Washout Period III||0
8281371|NCT01669122|20419147|P1|COMPLETED|Washout Period III||37
8281372|NCT01669122|20419147|P1|STARTED|Washout Period III||37
8281373|NCT01669122|20419147|P1|NOT COMPLETED|Washout Period II||2
8281374|NCT01669122|20419147|P1|COMPLETED|Washout Period II||37
8281375|NCT01669122|20419147|P1|STARTED|Washout Period II||39
8281376|NCT01669122|20419147|P1|NOT COMPLETED|Period II||0
8281377|NCT01669122|20419147|P1|COMPLETED|Period II||39
8281378|NCT01669122|20419147|P1|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
8281379|NCT01669122|20419147|P1|NOT COMPLETED|Washout Period I||0
8281380|NCT01669122|20419147|P1|COMPLETED|Washout Period I||39
8281381|NCT01669122|20419147|P1|STARTED|Washout Period I||39
8281382|NCT01669122|20419147|P1|NOT COMPLETED|Period I||1
8281383|NCT01669122|20419147|P1|COMPLETED|Period I||39
8281384|NCT01669122|20419147|P1|Safety Population|Period I||39
8281385|NCT01669122|20419147|P1|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
8281386|NCT01669096|20419177|P1|NOT COMPLETED|Overall Study||0
8281387|NCT01669096|20419177|P1|COMPLETED|Overall Study||20
8281388|NCT01669096|20419177|P1|STARTED|Overall Study||20
8281389|NCT01668966|20419214|P1|NOT COMPLETED|Overall Study||4
8281390|NCT01668966|20419214|P1|COMPLETED|Overall Study||19
8281391|NCT01668966|20419214|P1|Treated|Overall Study||21
8281392|NCT01668966|20419214|P1|STARTED|Overall Study||23
8281393|NCT01668940|20419234|P4|NOT COMPLETED|Overall Study||0
8281394|NCT01668940|20419235|P3|NOT COMPLETED|Overall Study||0
8281395|NCT01668940|20419236|P2|NOT COMPLETED|Overall Study||0
8281396|NCT01668940|20419237|P1|NOT COMPLETED|Overall Study||0
8281397|NCT01668940|20419234|P4|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
8281398|NCT01668940|20419235|P3|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|9
8281399|NCT01668940|20419236|P2|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
8281400|NCT01668940|20419237|P1|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|17
8281401|NCT01668940|20419234|P4|STARTED|Overall Study||14
8281402|NCT01668940|20419235|P3|STARTED|Overall Study||9
8281403|NCT01668940|20419236|P2|STARTED|Overall Study||14
8281404|NCT01668940|20419237|P1|STARTED|Overall Study||17
8281405|NCT01668836|20419251|P4|NOT COMPLETED|Overall Study||0
8281406|NCT01668836|20419252|P3|NOT COMPLETED|Overall Study||0
8281407|NCT01668836|20419253|P2|NOT COMPLETED|Overall Study||0
8281408|NCT01668836|20419254|P1|NOT COMPLETED|Overall Study||0
8281409|NCT01668836|20419251|P4|COMPLETED|Overall Study||12
8281410|NCT01668836|20419252|P3|COMPLETED|Overall Study||12
8281411|NCT01668836|20419253|P2|COMPLETED|Overall Study||12
8281412|NCT01668836|20419254|P1|COMPLETED|Overall Study||12
8281413|NCT01668836|20419251|P4|STARTED|Overall Study||12
8281414|NCT01668836|20419252|P3|STARTED|Overall Study||12
8281415|NCT01668836|20419253|P2|STARTED|Overall Study||12
8281416|NCT01668836|20419254|P1|STARTED|Overall Study||12
8281417|NCT01668797|20419310|P4|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
8281418|NCT01668797|20419311|P3|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
8281419|NCT01668797|20419312|P2|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
8281420|NCT01668797|20419313|P1|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
8281421|NCT01668797|20419310|P4|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
8281422|NCT01668797|20419311|P3|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
8281423|NCT01668797|20419312|P2|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
8281424|NCT01668797|20419313|P1|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
8281425|NCT01668797|20419310|P4|STARTED|Phase C (Double-Blind Maintenance Phase)||105
8281426|NCT01668797|20419311|P3|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
8281427|NCT01668797|20419312|P2|STARTED|Phase C (Double-Blind Maintenance Phase)||0
8281428|NCT01668797|20419313|P1|STARTED|Phase C (Double-Blind Maintenance Phase)||0
8281429|NCT01668797|20419310|P4|NOT COMPLETED|Phase B (Stabilization Phase)||0
8281430|NCT01668797|20419311|P3|NOT COMPLETED|Phase B (Stabilization Phase)||0
8281431|NCT01668797|20419312|P2|NOT COMPLETED|Phase B (Stabilization Phase)||262
8281432|NCT01668797|20419313|P1|NOT COMPLETED|Phase B (Stabilization Phase)||0
8281433|NCT01668797|20419310|P4|COMPLETED|Phase B (Stabilization Phase)||0
8281434|NCT01668797|20419311|P3|COMPLETED|Phase B (Stabilization Phase)||0
8281435|NCT01668797|20419312|P2|COMPLETED|Phase B (Stabilization Phase)||202
8281436|NCT01668797|20419313|P1|COMPLETED|Phase B (Stabilization Phase)||0
8281437|NCT01668797|20419310|P4|STARTED|Phase B (Stabilization Phase)||0
8281438|NCT01668797|20419311|P3|STARTED|Phase B (Stabilization Phase)||0
8281439|NCT01668797|20419312|P2|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
8281440|NCT01668797|20419313|P1|STARTED|Phase B (Stabilization Phase)||0
8281441|NCT01668797|20419310|P4|NOT COMPLETED|Phase A (Conversion Phase)||0
8281442|NCT01668797|20419311|P3|NOT COMPLETED|Phase A (Conversion Phase)||0
8281443|NCT01668797|20419312|P2|NOT COMPLETED|Phase A (Conversion Phase)||0
8281444|NCT01668797|20419313|P1|NOT COMPLETED|Phase A (Conversion Phase)||60
8281445|NCT01668797|20419310|P4|COMPLETED|Phase A (Conversion Phase)||0
8281446|NCT01668797|20419311|P3|COMPLETED|Phase A (Conversion Phase)||0
8281447|NCT01668797|20419312|P2|COMPLETED|Phase A (Conversion Phase)||0
8281448|NCT01668797|20419313|P1|COMPLETED|Phase A (Conversion Phase)||346
8281449|NCT01668797|20419310|P4|STARTED|Phase A (Conversion Phase)||0
8281450|NCT01668797|20419311|P3|STARTED|Phase A (Conversion Phase)||0
8281451|NCT01668797|20419312|P2|STARTED|Phase A (Conversion Phase)||0
8281452|NCT01668797|20419313|P1|STARTED|Phase A (Conversion Phase)||406
8281453|NCT01668784|20419378|P2|NOT COMPLETED|Treated (Overall)||369
8281454|NCT01668784|20419379|P1|NOT COMPLETED|Treated (Overall)||339
8281455|NCT01668784|20419378|P2|COMPLETED|Treated (Overall)||28
8281456|NCT01668784|20419379|P1|COMPLETED|Treated (Overall)||67
8281457|NCT01668784|20419378|P2|STARTED|Treated (Overall)||397
8281458|NCT01668784|20419379|P1|STARTED|Treated (Overall)||406
8281459|NCT01668784|20419378|P2|NOT COMPLETED|Randomized (Pre-treatment)||14
8281460|NCT01668784|20419379|P1|NOT COMPLETED|Randomized (Pre-treatment)||4
8281461|NCT01668784|20419378|P2|COMPLETED|Randomized (Pre-treatment)||397
8281462|NCT01668784|20419379|P1|COMPLETED|Randomized (Pre-treatment)||406
8281463|NCT01668784|20419378|P2|STARTED|Randomized (Pre-treatment)||411
8281464|NCT01668784|20419379|P1|STARTED|Randomized (Pre-treatment)||410
8281477|NCT01668654|20419432|P1|NOT COMPLETED|Overall Study||4
8281478|NCT01668654|20419432|P1|COMPLETED|Overall Study||0
8281479|NCT01668654|20419432|P1|STARTED|Overall Study||4
8281480|NCT01668628|20419475|P3|NOT COMPLETED|Overall Study||0
8281481|NCT01668628|20419476|P2|NOT COMPLETED|Overall Study||0
8281482|NCT01668628|20419477|P1|NOT COMPLETED|Overall Study||2
8281483|NCT01668628|20419475|P3|COMPLETED|Overall Study||367
8281484|NCT01668628|20419476|P2|COMPLETED|Overall Study||359
8281485|NCT01668628|20419477|P1|COMPLETED|Overall Study||347
8281486|NCT01668628|20419475|P3|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
8281487|NCT01668628|20419476|P2|STARTED|Overall Study||359
8281488|NCT01668628|20419477|P1|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
8281489|NCT01668589|20419493|P4|NOT COMPLETED|Overall Study||35
8281490|NCT01668589|20419494|P3|NOT COMPLETED|Overall Study||35
8281491|NCT01668589|20419495|P2|NOT COMPLETED|Overall Study||58
8281492|NCT01668589|20419496|P1|NOT COMPLETED|Overall Study||139
8281493|NCT01668589|20419493|P4|COMPLETED|Overall Study||266
8281494|NCT01668589|20419494|P3|COMPLETED|Overall Study||265
8281495|NCT01668589|20419495|P2|COMPLETED|Overall Study||242
8281496|NCT01668589|20419496|P1|COMPLETED|Overall Study||461
8281497|NCT01668589|20419493|P4|Received Denosumab|Overall Study||301
8281498|NCT01668589|20419494|P3|Received Denosumab|Overall Study||300
8281499|NCT01668589|20419495|P2|Received Denosumab|Overall Study||300
8281500|NCT01668589|20419496|P1|Received Denosumab|Overall Study||599
8281501|NCT01668589|20419493|P4|STARTED|Overall Study||301
8281502|NCT01668589|20419494|P3|STARTED|Overall Study||300
8281503|NCT01668589|20419495|P2|STARTED|Overall Study||300
8281504|NCT01668589|20419496|P1|STARTED|Overall Study||600
8281505|NCT01668537|20419536|P2|NOT COMPLETED|Overall Study||10
8281506|NCT01668537|20419537|P1|NOT COMPLETED|Overall Study||22
8281507|NCT01668537|20419536|P2|COMPLETED|Overall Study||314
8281508|NCT01668537|20419537|P1|COMPLETED|Overall Study||305
8281509|NCT01668537|20419536|P2|STARTED|Overall Study||324
8281510|NCT01668537|20419537|P1|STARTED|Overall Study||327
8281511|NCT01668355|20419579|P2|NOT COMPLETED|Overall Study||2
8281512|NCT01668355|20419580|P1|NOT COMPLETED|Overall Study||9
8281513|NCT01668355|20419579|P2|COMPLETED|Overall Study||165
8281514|NCT01668355|20419580|P1|COMPLETED|Overall Study||155
8281515|NCT01668355|20419579|P2|STARTED|Overall Study||167
8281516|NCT01668355|20419580|P1|STARTED|Overall Study||164
8281517|NCT01668173|20419600|P1|NOT COMPLETED|Overall Study||7
8281518|NCT01668173|20419600|P1|COMPLETED|Overall Study||0
8281519|NCT01668173|20419600|P1|STARTED|Overall Study||7
8281520|NCT01668147|20419604|P1|NOT COMPLETED|Overall Study||6
8281521|NCT01668147|20419604|P1|COMPLETED|Overall Study||7
8281522|NCT01668147|20419604|P1|STARTED|Overall Study||13
8281523|NCT01668030|20419612|P2|NOT COMPLETED|Overall Study||0
8281524|NCT01668030|20419613|P1|NOT COMPLETED|Overall Study||0
8281525|NCT01668030|20419612|P2|COMPLETED|Overall Study||10
8281526|NCT01668030|20419613|P1|COMPLETED|Overall Study||10
8281527|NCT01668030|20419612|P2|STARTED|Overall Study||10
8281528|NCT01668030|20419613|P1|STARTED|Overall Study||10
8281529|NCT01668017|20419623|P5|NOT COMPLETED|Overall Study||0
8281530|NCT01668017|20419624|P4|NOT COMPLETED|Overall Study||0
8281531|NCT01668017|20419625|P3|NOT COMPLETED|Overall Study||0
8281532|NCT01668017|20419626|P2|NOT COMPLETED|Overall Study||0
8281533|NCT01668017|20419627|P1|NOT COMPLETED|Overall Study||0
8281534|NCT01668017|20419623|P5|COMPLETED|Overall Study||2
8281535|NCT01668017|20419624|P4|COMPLETED|Overall Study||5
8281536|NCT01668017|20419625|P3|COMPLETED|Overall Study||6
8281537|NCT01668017|20419626|P2|COMPLETED|Overall Study||9
8281538|NCT01668017|20419627|P1|COMPLETED|Overall Study||4
8281539|NCT01668017|20419623|P5|STARTED|Overall Study||2
8281540|NCT01668017|20419624|P4|STARTED|Overall Study||5
8281541|NCT01668017|20419625|P3|STARTED|Overall Study||6
8281542|NCT01668017|20419626|P2|STARTED|Overall Study||9
8281543|NCT01668017|20419627|P1|STARTED|Overall Study||4
8281544|NCT01668004|20419734|P1|NOT COMPLETED|Overall Study||25
8281545|NCT01668004|20419734|P1|COMPLETED|Overall Study||76
8281546|NCT01668004|20419734|P1|Treated|Overall Study||101
8281547|NCT01668004|20419734|P1|STARTED|Overall Study||101
8281548|NCT01667978|20419747|P2|NOT COMPLETED|Overall Study||0
8281549|NCT01667978|20419748|P1|NOT COMPLETED|Overall Study||2
8281550|NCT01667978|20419747|P2|COMPLETED|Overall Study||17
8281551|NCT01667978|20419748|P1|COMPLETED|Overall Study||16
8281552|NCT01667978|20419747|P2|STARTED|Overall Study||17
8281553|NCT01667978|20419748|P1|STARTED|Overall Study||18
8281554|NCT01667926|20419756|P3|NOT COMPLETED|Overall Study||11
8281555|NCT01667926|20419757|P2|NOT COMPLETED|Overall Study||4
8281556|NCT01667926|20419758|P1|NOT COMPLETED|Overall Study||5
8281557|NCT01667926|20419756|P3|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
8281558|NCT01667926|20419757|P2|COMPLETED|Overall Study||9
8281559|NCT01667926|20419758|P1|COMPLETED|Overall Study||8
8281560|NCT01667926|20419756|P3|STARTED|Overall Study||11
8281561|NCT01667926|20419757|P2|STARTED|Overall Study||13
8281562|NCT01667926|20419758|P1|STARTED|Overall Study||13
8281563|NCT01667900|20419771|P20|NOT COMPLETED|Part B||0
8281564|NCT01667900|20419772|P19|NOT COMPLETED|Part B||0
8281565|NCT01667900|20419773|P18|NOT COMPLETED|Part B||0
8281566|NCT01667900|20419774|P17|NOT COMPLETED|Part B||1
8281567|NCT01667900|20419775|P16|NOT COMPLETED|Part B||0
8281568|NCT01667900|20419776|P15|NOT COMPLETED|Part B||0
8281569|NCT01667900|20419777|P14|NOT COMPLETED|Part B||0
8281570|NCT01667900|20419778|P13|NOT COMPLETED|Part B||0
8281571|NCT01667900|20419779|P12|NOT COMPLETED|Part B||0
8281572|NCT01667900|20419780|P11|NOT COMPLETED|Part B||0
8281573|NCT01667900|20419781|P10|NOT COMPLETED|Part B||0
8281574|NCT01667900|20419782|P9|NOT COMPLETED|Part B||0
8281575|NCT01667900|20419783|P8|NOT COMPLETED|Part B||0
8281576|NCT01667900|20419784|P7|NOT COMPLETED|Part B||0
8281577|NCT01667900|20419785|P6|NOT COMPLETED|Part B||0
8281578|NCT01667900|20419786|P5|NOT COMPLETED|Part B||0
8281579|NCT01667900|20419787|P4|NOT COMPLETED|Part B||0
8281580|NCT01667900|20419788|P3|NOT COMPLETED|Part B||0
8281581|NCT01667900|20419789|P2|NOT COMPLETED|Part B||0
8281582|NCT01667900|20419790|P1|NOT COMPLETED|Part B||0
8281583|NCT01667900|20419771|P20|COMPLETED|Part B||10
8281584|NCT01667900|20419772|P19|COMPLETED|Part B||10
8281585|NCT01667900|20419773|P18|COMPLETED|Part B||11
8281586|NCT01667900|20419774|P17|COMPLETED|Part B||10
8281587|NCT01667900|20419775|P16|COMPLETED|Part B||0
8281588|NCT01667900|20419776|P15|COMPLETED|Part B||0
8281589|NCT01667900|20419777|P14|COMPLETED|Part B||0
8281590|NCT01667900|20419778|P13|COMPLETED|Part B||0
8281591|NCT01667900|20419779|P12|COMPLETED|Part B||0
8281592|NCT01667900|20419780|P11|COMPLETED|Part B||0
8281593|NCT01667900|20419781|P10|COMPLETED|Part B||0
8281594|NCT01667900|20419782|P9|COMPLETED|Part B||0
8281595|NCT01667900|20419783|P8|COMPLETED|Part B||0
8281596|NCT01667900|20419784|P7|COMPLETED|Part B||0
8281597|NCT01667900|20419785|P6|COMPLETED|Part B||0
8281598|NCT01667900|20419786|P5|COMPLETED|Part B||0
8281599|NCT01667900|20419787|P4|COMPLETED|Part B||0
8281600|NCT01667900|20419788|P3|COMPLETED|Part B||0
8281601|NCT01667900|20419789|P2|COMPLETED|Part B||0
8281602|NCT01667900|20419790|P1|COMPLETED|Part B||0
8281603|NCT01667900|20419771|P20|STARTED|Part B||10
8281604|NCT01667900|20419772|P19|STARTED|Part B||10
8281605|NCT01667900|20419773|P18|STARTED|Part B||11
8281606|NCT01667900|20419774|P17|STARTED|Part B||11
8281607|NCT01667900|20419775|P16|STARTED|Part B|Part A participants did not participate in Part B.|0
8281608|NCT01667900|20419776|P15|STARTED|Part B|Part A participants did not participate in Part B.|0
8281609|NCT01667900|20419777|P14|STARTED|Part B|Part A participants did not participate in Part B.|0
8281610|NCT01667900|20419778|P13|STARTED|Part B|Part A participants did not participate in Part B.|0
8281611|NCT01667900|20419779|P12|STARTED|Part B|Part A participants did not participate in Part B.|0
8281612|NCT01667900|20419780|P11|STARTED|Part B|Part A participants did not participate in Part B.|0
8281613|NCT01667900|20419781|P10|STARTED|Part B|Part A participants did not participate in Part B.|0
8281614|NCT01667900|20419782|P9|STARTED|Part B|Part A participants did not participate in Part B.|0
8281615|NCT01667900|20419783|P8|STARTED|Part B|Part A participants did not participate in Part B.|0
8281616|NCT01667900|20419784|P7|STARTED|Part B|Part A participants did not participate in Part B.|0
8281617|NCT01667900|20419785|P6|STARTED|Part B|Part A participants did not participate in Part B.|0
8281618|NCT01667900|20419786|P5|STARTED|Part B|Part A participants did not participate in Part B.|0
8281619|NCT01667900|20419787|P4|STARTED|Part B|Part A participants did not participate in Part B.|0
8281620|NCT01667900|20419788|P3|STARTED|Part B|Part A participants did not participate in Part B.|0
8281621|NCT01667900|20419789|P2|STARTED|Part B|Part A participants did not participate in Part B.|0
8281622|NCT01667900|20419790|P1|STARTED|Part B|Part A participants did not participate in Part B.|0
8281623|NCT01667900|20419771|P20|NOT COMPLETED|Part A, Period 3||0
8281624|NCT01667900|20419772|P19|NOT COMPLETED|Part A, Period 3||0
8281625|NCT01667900|20419773|P18|NOT COMPLETED|Part A, Period 3||0
8281626|NCT01667900|20419774|P17|NOT COMPLETED|Part A, Period 3||0
8281627|NCT01667900|20419775|P16|NOT COMPLETED|Part A, Period 3||0
8281628|NCT01667900|20419776|P15|NOT COMPLETED|Part A, Period 3||0
8281629|NCT01667900|20419777|P14|NOT COMPLETED|Part A, Period 3||0
8281630|NCT01667900|20419778|P13|NOT COMPLETED|Part A, Period 3||0
8281631|NCT01667900|20419779|P12|NOT COMPLETED|Part A, Period 3||0
8281632|NCT01667900|20419780|P11|NOT COMPLETED|Part A, Period 3||0
8281633|NCT01667900|20419781|P10|NOT COMPLETED|Part A, Period 3||0
8281634|NCT01667900|20419782|P9|NOT COMPLETED|Part A, Period 3||0
8281635|NCT01667900|20419783|P8|NOT COMPLETED|Part A, Period 3||0
8281636|NCT01667900|20419784|P7|NOT COMPLETED|Part A, Period 3||0
8281637|NCT01667900|20419785|P6|NOT COMPLETED|Part A, Period 3||0
8281638|NCT01667900|20419786|P5|NOT COMPLETED|Part A, Period 3||0
8281639|NCT01667900|20419787|P4|NOT COMPLETED|Part A, Period 3||0
8281640|NCT01667900|20419788|P3|NOT COMPLETED|Part A, Period 3||0
8281641|NCT01667900|20419789|P2|NOT COMPLETED|Part A, Period 3||0
8281642|NCT01667900|20419790|P1|NOT COMPLETED|Part A, Period 3||0
8281643|NCT01667900|20419771|P20|COMPLETED|Part A, Period 3||0
8281644|NCT01667900|20419772|P19|COMPLETED|Part A, Period 3||0
8281645|NCT01667900|20419773|P18|COMPLETED|Part A, Period 3||0
8281646|NCT01667900|20419774|P17|COMPLETED|Part A, Period 3||0
8281647|NCT01667900|20419775|P16|COMPLETED|Part A, Period 3||1
8281648|NCT01667900|20419776|P15|COMPLETED|Part A, Period 3||1
8281649|NCT01667900|20419777|P14|COMPLETED|Part A, Period 3||1
8281650|NCT01667900|20419778|P13|COMPLETED|Part A, Period 3||1
8281651|NCT01667900|20419779|P12|COMPLETED|Part A, Period 3||1
8281652|NCT01667900|20419780|P11|COMPLETED|Part A, Period 3||1
8281653|NCT01667900|20419781|P10|COMPLETED|Part A, Period 3||1
8281654|NCT01667900|20419782|P9|COMPLETED|Part A, Period 3||1
8281655|NCT01667900|20419783|P8|COMPLETED|Part A, Period 3||1
8281656|NCT01667900|20419784|P7|COMPLETED|Part A, Period 3||1
8281657|NCT01667900|20419785|P6|COMPLETED|Part A, Period 3||1
8281658|NCT01667900|20419786|P5|COMPLETED|Part A, Period 3||1
8281659|NCT01667900|20419787|P4|COMPLETED|Part A, Period 3||1
8281660|NCT01667900|20419788|P3|COMPLETED|Part A, Period 3||1
8281661|NCT01667900|20419789|P2|COMPLETED|Part A, Period 3||1
8281662|NCT01667900|20419790|P1|COMPLETED|Part A, Period 3||1
8281663|NCT01667900|20419771|P20|STARTED|Part A, Period 3||0
8281664|NCT01667900|20419772|P19|STARTED|Part A, Period 3||0
8281665|NCT01667900|20419773|P18|STARTED|Part A, Period 3||0
8281666|NCT01667900|20419774|P17|STARTED|Part A, Period 3||0
8281667|NCT01667900|20419775|P16|STARTED|Part A, Period 3||1
8281668|NCT01667900|20419776|P15|STARTED|Part A, Period 3||1
8281669|NCT01667900|20419777|P14|STARTED|Part A, Period 3||1
8281670|NCT01667900|20419778|P13|STARTED|Part A, Period 3||1
8281671|NCT01667900|20419779|P12|STARTED|Part A, Period 3||1
8281672|NCT01667900|20419780|P11|STARTED|Part A, Period 3||1
8281673|NCT01667900|20419781|P10|STARTED|Part A, Period 3||1
8281674|NCT01667900|20419782|P9|STARTED|Part A, Period 3||1
8281675|NCT01667900|20419783|P8|STARTED|Part A, Period 3||1
8281676|NCT01667900|20419784|P7|STARTED|Part A, Period 3||1
8281677|NCT01667900|20419785|P6|STARTED|Part A, Period 3||1
8281678|NCT01667900|20419786|P5|STARTED|Part A, Period 3||1
8281679|NCT01667900|20419787|P4|STARTED|Part A, Period 3||1
8281680|NCT01667900|20419788|P3|STARTED|Part A, Period 3||1
8281681|NCT01667900|20419789|P2|STARTED|Part A, Period 3||1
8281682|NCT01667900|20419790|P1|STARTED|Part A, Period 3||1
8281683|NCT01667900|20419771|P20|NOT COMPLETED|Part A, Washout 2||0
8281684|NCT01667900|20419772|P19|NOT COMPLETED|Part A, Washout 2||0
8281685|NCT01667900|20419773|P18|NOT COMPLETED|Part A, Washout 2||0
8281686|NCT01667900|20419774|P17|NOT COMPLETED|Part A, Washout 2||0
8281687|NCT01667900|20419775|P16|NOT COMPLETED|Part A, Washout 2||0
8281688|NCT01667900|20419776|P15|NOT COMPLETED|Part A, Washout 2||0
8281689|NCT01667900|20419777|P14|NOT COMPLETED|Part A, Washout 2||0
8281690|NCT01667900|20419778|P13|NOT COMPLETED|Part A, Washout 2||0
8281691|NCT01667900|20419779|P12|NOT COMPLETED|Part A, Washout 2||0
8281692|NCT01667900|20419780|P11|NOT COMPLETED|Part A, Washout 2||0
8281693|NCT01667900|20419781|P10|NOT COMPLETED|Part A, Washout 2||0
8281694|NCT01667900|20419782|P9|NOT COMPLETED|Part A, Washout 2||0
8281695|NCT01667900|20419783|P8|NOT COMPLETED|Part A, Washout 2||0
8281696|NCT01667900|20419784|P7|NOT COMPLETED|Part A, Washout 2||0
8281697|NCT01667900|20419785|P6|NOT COMPLETED|Part A, Washout 2||0
8281698|NCT01667900|20419786|P5|NOT COMPLETED|Part A, Washout 2||0
8281699|NCT01667900|20419787|P4|NOT COMPLETED|Part A, Washout 2||0
8281700|NCT01667900|20419788|P3|NOT COMPLETED|Part A, Washout 2||0
8281701|NCT01667900|20419789|P2|NOT COMPLETED|Part A, Washout 2||0
8281702|NCT01667900|20419790|P1|NOT COMPLETED|Part A, Washout 2||0
8281703|NCT01667900|20419771|P20|COMPLETED|Part A, Washout 2||0
8281704|NCT01667900|20419772|P19|COMPLETED|Part A, Washout 2||0
8281705|NCT01667900|20419773|P18|COMPLETED|Part A, Washout 2||0
8281706|NCT01667900|20419774|P17|COMPLETED|Part A, Washout 2||0
8281707|NCT01667900|20419775|P16|COMPLETED|Part A, Washout 2||1
8281708|NCT01667900|20419776|P15|COMPLETED|Part A, Washout 2||1
8281709|NCT01667900|20419777|P14|COMPLETED|Part A, Washout 2||1
8281710|NCT01667900|20419778|P13|COMPLETED|Part A, Washout 2||1
8281711|NCT01667900|20419779|P12|COMPLETED|Part A, Washout 2||1
8281712|NCT01667900|20419780|P11|COMPLETED|Part A, Washout 2||1
8281713|NCT01667900|20419781|P10|COMPLETED|Part A, Washout 2||1
8281714|NCT01667900|20419782|P9|COMPLETED|Part A, Washout 2||1
8281715|NCT01667900|20419783|P8|COMPLETED|Part A, Washout 2||1
8281716|NCT01667900|20419784|P7|COMPLETED|Part A, Washout 2||1
8281717|NCT01667900|20419785|P6|COMPLETED|Part A, Washout 2||1
8281718|NCT01667900|20419786|P5|COMPLETED|Part A, Washout 2||1
8281719|NCT01667900|20419787|P4|COMPLETED|Part A, Washout 2||1
8281720|NCT01667900|20419788|P3|COMPLETED|Part A, Washout 2||1
8281721|NCT01667900|20419789|P2|COMPLETED|Part A, Washout 2||1
8281722|NCT01667900|20419790|P1|COMPLETED|Part A, Washout 2||1
8281723|NCT01667900|20419771|P20|STARTED|Part A, Washout 2||0
8281724|NCT01667900|20419772|P19|STARTED|Part A, Washout 2||0
8281725|NCT01667900|20419773|P18|STARTED|Part A, Washout 2||0
8281726|NCT01667900|20419774|P17|STARTED|Part A, Washout 2||0
8281727|NCT01667900|20419775|P16|STARTED|Part A, Washout 2||1
8281728|NCT01667900|20419776|P15|STARTED|Part A, Washout 2||1
8281729|NCT01667900|20419777|P14|STARTED|Part A, Washout 2||1
8281730|NCT01667900|20419778|P13|STARTED|Part A, Washout 2||1
8281731|NCT01667900|20419779|P12|STARTED|Part A, Washout 2||1
8281732|NCT01667900|20419780|P11|STARTED|Part A, Washout 2||1
8281733|NCT01667900|20419781|P10|STARTED|Part A, Washout 2||1
8281734|NCT01667900|20419782|P9|STARTED|Part A, Washout 2||1
8281735|NCT01667900|20419783|P8|STARTED|Part A, Washout 2||1
8281736|NCT01667900|20419784|P7|STARTED|Part A, Washout 2||1
8281737|NCT01667900|20419785|P6|STARTED|Part A, Washout 2||1
8281738|NCT01667900|20419786|P5|STARTED|Part A, Washout 2||1
8281739|NCT01667900|20419787|P4|STARTED|Part A, Washout 2||1
8281740|NCT01667900|20419788|P3|STARTED|Part A, Washout 2||1
8281741|NCT01667900|20419789|P2|STARTED|Part A, Washout 2||1
8281742|NCT01667900|20419790|P1|STARTED|Part A, Washout 2||1
8281743|NCT01667900|20419771|P20|NOT COMPLETED|Part A, Period 2||0
8281744|NCT01667900|20419772|P19|NOT COMPLETED|Part A, Period 2||0
8281745|NCT01667900|20419773|P18|NOT COMPLETED|Part A, Period 2||0
8281746|NCT01667900|20419774|P17|NOT COMPLETED|Part A, Period 2||0
8281747|NCT01667900|20419775|P16|NOT COMPLETED|Part A, Period 2||0
8281748|NCT01667900|20419776|P15|NOT COMPLETED|Part A, Period 2||0
8281749|NCT01667900|20419777|P14|NOT COMPLETED|Part A, Period 2||0
8281750|NCT01667900|20419778|P13|NOT COMPLETED|Part A, Period 2||0
8281751|NCT01667900|20419779|P12|NOT COMPLETED|Part A, Period 2||0
8281752|NCT01667900|20419780|P11|NOT COMPLETED|Part A, Period 2||0
8281753|NCT01667900|20419781|P10|NOT COMPLETED|Part A, Period 2||0
8281754|NCT01667900|20419782|P9|NOT COMPLETED|Part A, Period 2||0
8281755|NCT01667900|20419783|P8|NOT COMPLETED|Part A, Period 2||0
8281756|NCT01667900|20419784|P7|NOT COMPLETED|Part A, Period 2||0
8281757|NCT01667900|20419785|P6|NOT COMPLETED|Part A, Period 2||0
8281758|NCT01667900|20419786|P5|NOT COMPLETED|Part A, Period 2||0
8281759|NCT01667900|20419787|P4|NOT COMPLETED|Part A, Period 2||0
8281760|NCT01667900|20419788|P3|NOT COMPLETED|Part A, Period 2||0
8281761|NCT01667900|20419789|P2|NOT COMPLETED|Part A, Period 2||0
8281762|NCT01667900|20419790|P1|NOT COMPLETED|Part A, Period 2||0
8281763|NCT01667900|20419771|P20|COMPLETED|Part A, Period 2||0
8281764|NCT01667900|20419772|P19|COMPLETED|Part A, Period 2||0
8281765|NCT01667900|20419773|P18|COMPLETED|Part A, Period 2||0
8281766|NCT01667900|20419774|P17|COMPLETED|Part A, Period 2||0
8281767|NCT01667900|20419775|P16|COMPLETED|Part A, Period 2||1
8281768|NCT01667900|20419776|P15|COMPLETED|Part A, Period 2||1
8281769|NCT01667900|20419777|P14|COMPLETED|Part A, Period 2||1
8281770|NCT01667900|20419778|P13|COMPLETED|Part A, Period 2||1
8281771|NCT01667900|20419779|P12|COMPLETED|Part A, Period 2||1
8281772|NCT01667900|20419780|P11|COMPLETED|Part A, Period 2||1
8281773|NCT01667900|20419781|P10|COMPLETED|Part A, Period 2||1
8281774|NCT01667900|20419782|P9|COMPLETED|Part A, Period 2||1
8281775|NCT01667900|20419783|P8|COMPLETED|Part A, Period 2||1
8281776|NCT01667900|20419784|P7|COMPLETED|Part A, Period 2||1
8281777|NCT01667900|20419785|P6|COMPLETED|Part A, Period 2||1
8281778|NCT01667900|20419786|P5|COMPLETED|Part A, Period 2||1
8281779|NCT01667900|20419787|P4|COMPLETED|Part A, Period 2||1
8281780|NCT01667900|20419788|P3|COMPLETED|Part A, Period 2||1
8281781|NCT01667900|20419789|P2|COMPLETED|Part A, Period 2||1
8281782|NCT01667900|20419790|P1|COMPLETED|Part A, Period 2||1
8281783|NCT01667900|20419771|P20|STARTED|Part A, Period 2||0
8281784|NCT01667900|20419772|P19|STARTED|Part A, Period 2||0
8281785|NCT01667900|20419773|P18|STARTED|Part A, Period 2||0
8281786|NCT01667900|20419774|P17|STARTED|Part A, Period 2||0
8281787|NCT01667900|20419775|P16|STARTED|Part A, Period 2||1
8281788|NCT01667900|20419776|P15|STARTED|Part A, Period 2||1
8281789|NCT01667900|20419777|P14|STARTED|Part A, Period 2||1
8281790|NCT01667900|20419778|P13|STARTED|Part A, Period 2||1
8281791|NCT01667900|20419779|P12|STARTED|Part A, Period 2||1
8281792|NCT01667900|20419780|P11|STARTED|Part A, Period 2||1
8281793|NCT01667900|20419781|P10|STARTED|Part A, Period 2||1
8281794|NCT01667900|20419782|P9|STARTED|Part A, Period 2||1
8281795|NCT01667900|20419783|P8|STARTED|Part A, Period 2||1
8281796|NCT01667900|20419784|P7|STARTED|Part A, Period 2||1
8281797|NCT01667900|20419785|P6|STARTED|Part A, Period 2||1
8281798|NCT01667900|20419786|P5|STARTED|Part A, Period 2||1
8281799|NCT01667900|20419787|P4|STARTED|Part A, Period 2||1
8281800|NCT01667900|20419788|P3|STARTED|Part A, Period 2||1
8281801|NCT01667900|20419789|P2|STARTED|Part A, Period 2||1
8281802|NCT01667900|20419790|P1|STARTED|Part A, Period 2||1
8281803|NCT01667900|20419771|P20|NOT COMPLETED|Part A, Washout 1||0
8281804|NCT01667900|20419772|P19|NOT COMPLETED|Part A, Washout 1||0
8281805|NCT01667900|20419773|P18|NOT COMPLETED|Part A, Washout 1||0
8281806|NCT01667900|20419774|P17|NOT COMPLETED|Part A, Washout 1||0
8281807|NCT01667900|20419775|P16|NOT COMPLETED|Part A, Washout 1||0
8281808|NCT01667900|20419776|P15|NOT COMPLETED|Part A, Washout 1||0
8281809|NCT01667900|20419777|P14|NOT COMPLETED|Part A, Washout 1||0
8281810|NCT01667900|20419778|P13|NOT COMPLETED|Part A, Washout 1||0
8281811|NCT01667900|20419779|P12|NOT COMPLETED|Part A, Washout 1||0
8281812|NCT01667900|20419780|P11|NOT COMPLETED|Part A, Washout 1||0
8281813|NCT01667900|20419781|P10|NOT COMPLETED|Part A, Washout 1||0
8281814|NCT01667900|20419782|P9|NOT COMPLETED|Part A, Washout 1||0
8281815|NCT01667900|20419783|P8|NOT COMPLETED|Part A, Washout 1||0
8281816|NCT01667900|20419784|P7|NOT COMPLETED|Part A, Washout 1||0
8281817|NCT01667900|20419785|P6|NOT COMPLETED|Part A, Washout 1||0
8281818|NCT01667900|20419786|P5|NOT COMPLETED|Part A, Washout 1||0
8281819|NCT01667900|20419787|P4|NOT COMPLETED|Part A, Washout 1||0
8281820|NCT01667900|20419788|P3|NOT COMPLETED|Part A, Washout 1||0
8281821|NCT01667900|20419789|P2|NOT COMPLETED|Part A, Washout 1||0
8281822|NCT01667900|20419790|P1|NOT COMPLETED|Part A, Washout 1||0
8281823|NCT01667900|20419771|P20|COMPLETED|Part A, Washout 1||0
8281824|NCT01667900|20419772|P19|COMPLETED|Part A, Washout 1||0
8281825|NCT01667900|20419773|P18|COMPLETED|Part A, Washout 1||0
8281826|NCT01667900|20419774|P17|COMPLETED|Part A, Washout 1||0
8281827|NCT01667900|20419775|P16|COMPLETED|Part A, Washout 1||1
8281828|NCT01667900|20419776|P15|COMPLETED|Part A, Washout 1||1
8281829|NCT01667900|20419777|P14|COMPLETED|Part A, Washout 1||1
8281830|NCT01667900|20419778|P13|COMPLETED|Part A, Washout 1||1
8281831|NCT01667900|20419779|P12|COMPLETED|Part A, Washout 1||1
8281832|NCT01667900|20419780|P11|COMPLETED|Part A, Washout 1||1
8281833|NCT01667900|20419781|P10|COMPLETED|Part A, Washout 1||1
8281834|NCT01667900|20419782|P9|COMPLETED|Part A, Washout 1||1
8281835|NCT01667900|20419783|P8|COMPLETED|Part A, Washout 1||1
8281836|NCT01667900|20419784|P7|COMPLETED|Part A, Washout 1||1
8281837|NCT01667900|20419785|P6|COMPLETED|Part A, Washout 1||1
8281838|NCT01667900|20419786|P5|COMPLETED|Part A, Washout 1||1
8281839|NCT01667900|20419787|P4|COMPLETED|Part A, Washout 1||1
8281840|NCT01667900|20419788|P3|COMPLETED|Part A, Washout 1||1
8281841|NCT01667900|20419789|P2|COMPLETED|Part A, Washout 1||1
8281842|NCT01667900|20419790|P1|COMPLETED|Part A, Washout 1||1
8281843|NCT01667900|20419771|P20|STARTED|Part A, Washout 1||0
8281844|NCT01667900|20419772|P19|STARTED|Part A, Washout 1||0
8281845|NCT01667900|20419773|P18|STARTED|Part A, Washout 1||0
8281846|NCT01667900|20419774|P17|STARTED|Part A, Washout 1||0
8281847|NCT01667900|20419775|P16|STARTED|Part A, Washout 1||1
8281848|NCT01667900|20419776|P15|STARTED|Part A, Washout 1||1
8281849|NCT01667900|20419777|P14|STARTED|Part A, Washout 1||1
8281850|NCT01667900|20419778|P13|STARTED|Part A, Washout 1||1
8281851|NCT01667900|20419779|P12|STARTED|Part A, Washout 1||1
8281852|NCT01667900|20419780|P11|STARTED|Part A, Washout 1||1
8281853|NCT01667900|20419781|P10|STARTED|Part A, Washout 1||1
8281854|NCT01667900|20419782|P9|STARTED|Part A, Washout 1||1
8281855|NCT01667900|20419783|P8|STARTED|Part A, Washout 1||1
8281856|NCT01667900|20419784|P7|STARTED|Part A, Washout 1||1
8281857|NCT01667900|20419785|P6|STARTED|Part A, Washout 1||1
8281858|NCT01667900|20419786|P5|STARTED|Part A, Washout 1||1
8281859|NCT01667900|20419787|P4|STARTED|Part A, Washout 1||1
8281860|NCT01667900|20419788|P3|STARTED|Part A, Washout 1||1
8281861|NCT01667900|20419789|P2|STARTED|Part A, Washout 1||1
8281862|NCT01667900|20419790|P1|STARTED|Part A, Washout 1||1
8281863|NCT01667900|20419771|P20|NOT COMPLETED|Part A, Period 1||0
8281864|NCT01667900|20419772|P19|NOT COMPLETED|Part A, Period 1||0
8281865|NCT01667900|20419773|P18|NOT COMPLETED|Part A, Period 1||0
8281866|NCT01667900|20419774|P17|NOT COMPLETED|Part A, Period 1||0
8281867|NCT01667900|20419775|P16|NOT COMPLETED|Part A, Period 1||0
8281868|NCT01667900|20419776|P15|NOT COMPLETED|Part A, Period 1||0
8281869|NCT01667900|20419777|P14|NOT COMPLETED|Part A, Period 1||0
8281870|NCT01667900|20419778|P13|NOT COMPLETED|Part A, Period 1||0
8281871|NCT01667900|20419779|P12|NOT COMPLETED|Part A, Period 1||0
8281872|NCT01667900|20419780|P11|NOT COMPLETED|Part A, Period 1||0
8281873|NCT01667900|20419781|P10|NOT COMPLETED|Part A, Period 1||0
8281874|NCT01667900|20419782|P9|NOT COMPLETED|Part A, Period 1||0
8281875|NCT01667900|20419783|P8|NOT COMPLETED|Part A, Period 1||0
8281876|NCT01667900|20419784|P7|NOT COMPLETED|Part A, Period 1||0
8281877|NCT01667900|20419785|P6|NOT COMPLETED|Part A, Period 1||0
8281878|NCT01667900|20419786|P5|NOT COMPLETED|Part A, Period 1||0
8281879|NCT01667900|20419787|P4|NOT COMPLETED|Part A, Period 1||0
8281880|NCT01667900|20419788|P3|NOT COMPLETED|Part A, Period 1||0
8281881|NCT01667900|20419789|P2|NOT COMPLETED|Part A, Period 1||0
8281882|NCT01667900|20419790|P1|NOT COMPLETED|Part A, Period 1||0
8281883|NCT01667900|20419771|P20|COMPLETED|Part A, Period 1||0
8281884|NCT01667900|20419772|P19|COMPLETED|Part A, Period 1||0
8281885|NCT01667900|20419773|P18|COMPLETED|Part A, Period 1||0
8281886|NCT01667900|20419774|P17|COMPLETED|Part A, Period 1||0
8281887|NCT01667900|20419775|P16|COMPLETED|Part A, Period 1||1
8281888|NCT01667900|20419776|P15|COMPLETED|Part A, Period 1||1
8281889|NCT01667900|20419777|P14|COMPLETED|Part A, Period 1||1
8281890|NCT01667900|20419778|P13|COMPLETED|Part A, Period 1||1
8281891|NCT01667900|20419779|P12|COMPLETED|Part A, Period 1||1
8281892|NCT01667900|20419780|P11|COMPLETED|Part A, Period 1||1
8281893|NCT01667900|20419781|P10|COMPLETED|Part A, Period 1||1
8281894|NCT01667900|20419782|P9|COMPLETED|Part A, Period 1||1
8281895|NCT01667900|20419783|P8|COMPLETED|Part A, Period 1||1
8281896|NCT01667900|20419784|P7|COMPLETED|Part A, Period 1||1
8281897|NCT01667900|20419785|P6|COMPLETED|Part A, Period 1||1
8281898|NCT01667900|20419786|P5|COMPLETED|Part A, Period 1||1
8281899|NCT01667900|20419787|P4|COMPLETED|Part A, Period 1||1
8281900|NCT01667900|20419788|P3|COMPLETED|Part A, Period 1||1
8281901|NCT01667900|20419789|P2|COMPLETED|Part A, Period 1||1
8281902|NCT01667900|20419790|P1|COMPLETED|Part A, Period 1||1
8281903|NCT01667900|20419771|P20|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
8281904|NCT01667900|20419772|P19|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
8281905|NCT01667900|20419773|P18|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
8281906|NCT01667900|20419774|P17|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
8281907|NCT01667900|20419775|P16|STARTED|Part A, Period 1||1
8281908|NCT01667900|20419776|P15|STARTED|Part A, Period 1||1
8281909|NCT01667900|20419777|P14|STARTED|Part A, Period 1||1
8281910|NCT01667900|20419778|P13|STARTED|Part A, Period 1||1
8281911|NCT01667900|20419779|P12|STARTED|Part A, Period 1||1
8281912|NCT01667900|20419780|P11|STARTED|Part A, Period 1||1
8281913|NCT01667900|20419781|P10|STARTED|Part A, Period 1||1
8281914|NCT01667900|20419782|P9|STARTED|Part A, Period 1||1
8281915|NCT01667900|20419783|P8|STARTED|Part A, Period 1||1
8281916|NCT01667900|20419784|P7|STARTED|Part A, Period 1||1
8281917|NCT01667900|20419785|P6|STARTED|Part A, Period 1||1
8281918|NCT01667900|20419786|P5|STARTED|Part A, Period 1||1
8281919|NCT01667900|20419787|P4|STARTED|Part A, Period 1||1
8281920|NCT01667900|20419788|P3|STARTED|Part A, Period 1||1
8281921|NCT01667900|20419789|P2|STARTED|Part A, Period 1||1
8281922|NCT01667900|20419790|P1|STARTED|Part A, Period 1||1
8281923|NCT01667848|20419830|P2|NOT COMPLETED|Overall Study||0
8281924|NCT01667848|20419831|P1|NOT COMPLETED|Overall Study||0
8281925|NCT01667848|20419830|P2|COMPLETED|Overall Study||81
8281926|NCT01667848|20419831|P1|COMPLETED|Overall Study||67
8281927|NCT01667848|20419830|P2|STARTED|Overall Study||81
8281928|NCT01667848|20419831|P1|STARTED|Overall Study||67
8281929|NCT01667796|20419841|P2|NOT COMPLETED|Overall Study||1
8281930|NCT01667796|20419842|P1|NOT COMPLETED|Overall Study||3
8281931|NCT01667796|20419841|P2|COMPLETED|Overall Study||29
8281932|NCT01667796|20419842|P1|COMPLETED|Overall Study||24
8281933|NCT01667796|20419841|P2|STARTED|Overall Study||30
8281934|NCT01667796|20419842|P1|STARTED|Overall Study||27
8281935|NCT01667731|20419860|P5|NOT COMPLETED|Overall Study||28
8281936|NCT01667731|20419861|P4|NOT COMPLETED|Overall Study||2
8281937|NCT01667731|20419862|P3|NOT COMPLETED|Overall Study||2
8281938|NCT01667731|20419863|P2|NOT COMPLETED|Overall Study||16
8281939|NCT01667731|20419864|P1|NOT COMPLETED|Overall Study||5
8281940|NCT01667731|20419860|P5|COMPLETED|Overall Study||87
8281941|NCT01667731|20419861|P4|COMPLETED|Overall Study||15
8281942|NCT01667731|20419862|P3|COMPLETED|Overall Study||22
8281943|NCT01667731|20419863|P2|COMPLETED|Overall Study||26
8281944|NCT01667731|20419864|P1|COMPLETED|Overall Study||21
8281945|NCT01667731|20419860|P5|STARTED|Overall Study||115
8281946|NCT01667731|20419861|P4|STARTED|Overall Study||17
8281947|NCT01667731|20419862|P3|STARTED|Overall Study||24
8281948|NCT01667731|20419863|P2|STARTED|Overall Study||42
8281949|NCT01667731|20419864|P1|STARTED|Overall Study||26
8281950|NCT01667679|20419919|P2|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
8281951|NCT01667679|20419920|P1|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
8281952|NCT01667679|20419919|P2|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
8281953|NCT01667679|20419920|P1|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
8281954|NCT01667679|20419919|P2|STARTED|Treatment Period 2 (<=12 Weeks)||107
8281955|NCT01667679|20419920|P1|STARTED|Treatment Period 2 (<=12 Weeks)||122
8281956|NCT01667679|20419919|P2|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
8281957|NCT01667679|20419920|P1|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
8281958|NCT01667679|20419919|P2|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
8281959|NCT01667679|20419920|P1|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
8281960|NCT01667679|20419919|P2|STARTED|Treatment Period 1 (<=12 Weeks)||137
8281961|NCT01667679|20419920|P1|STARTED|Treatment Period 1 (<=12 Weeks)||138
8281962|NCT01667562|20419978|P2|NOT COMPLETED|Erlotinib Phase||3
8281963|NCT01667562|20419979|P1|NOT COMPLETED|Erlotinib Phase||0
8281964|NCT01667562|20419978|P2|COMPLETED|Erlotinib Phase||27
8281965|NCT01667562|20419979|P1|COMPLETED|Erlotinib Phase||0
8281966|NCT01667562|20419978|P2|STARTED|Erlotinib Phase||30
8281967|NCT01667562|20419979|P1|STARTED|Erlotinib Phase||0
8281968|NCT01667562|20419978|P2|NOT COMPLETED|Diagnostic Phase||0
8281969|NCT01667562|20419979|P1|NOT COMPLETED|Diagnostic Phase||30
8281970|NCT01667562|20419978|P2|COMPLETED|Diagnostic Phase||0
8281971|NCT01667562|20419979|P1|COMPLETED|Diagnostic Phase||345
8281972|NCT01667562|20419978|P2|STARTED|Diagnostic Phase||0
8281973|NCT01667562|20419979|P1|STARTED|Diagnostic Phase||375
8281974|NCT01667549|20419993|P5|NOT COMPLETED|Overall Study||1
8281975|NCT01667549|20419994|P4|NOT COMPLETED|Overall Study||6
8281976|NCT01667549|20419995|P3|NOT COMPLETED|Overall Study||7
8281977|NCT01667549|20419996|P2|NOT COMPLETED|Overall Study||5
8281978|NCT01667549|20419997|P1|NOT COMPLETED|Overall Study||3
8281979|NCT01667549|20419993|P5|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
8281980|NCT01667549|20419994|P4|COMPLETED|Overall Study|14 dyads= 14 infants, 14 mothers|14
8281981|NCT01667549|20419995|P3|COMPLETED|Overall Study|14 dyads=14 infants, 14 mothers|14
8281982|NCT01667549|20419996|P2|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
8281983|NCT01667549|20419997|P1|COMPLETED|Overall Study|17 dyads=17 infants, 17 mothers|17
8281984|NCT01667549|20419993|P5|STARTED|Overall Study|16 dyads=16 infants, 16 mothers|16
8281985|NCT01667549|20419994|P4|STARTED|Overall Study|20 dyads= 20 infants, 20 mothers|20
8281986|NCT01667549|20419995|P3|STARTED|Overall Study|21 dyads=21 infants, 21 mothers|21
8281987|NCT01667549|20419996|P2|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
8281988|NCT01667549|20419997|P1|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
8281989|NCT01667536|20420029|P1|NOT COMPLETED|Overall Study||0
8281990|NCT01667536|20420029|P1|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
8281991|NCT01667536|20420029|P1|STARTED|Overall Study||105
8281992|NCT01667471|20420040|P1|NOT COMPLETED|Overall Study||0
8281993|NCT01667471|20420040|P1|COMPLETED|Overall Study||7
8281994|NCT01667471|20420040|P1|STARTED|Overall Study||7
8281995|NCT01667432|20420056|P1|NOT COMPLETED|Overall Study||57
8281996|NCT01667432|20420056|P1|COMPLETED|Overall Study||84
8281997|NCT01667432|20420056|P1|STARTED|Overall Study||141
8281998|NCT01667419|20420065|P4|NOT COMPLETED|Overall Study||39
8281999|NCT01667419|20420066|P3|NOT COMPLETED|Overall Study||36
8282000|NCT01667419|20420067|P2|NOT COMPLETED|Overall Study||47
8282001|NCT01667419|20420068|P1|NOT COMPLETED|Overall Study||43
8282002|NCT01667419|20420065|P4|COMPLETED|Overall Study||52
8282003|NCT01667419|20420066|P3|COMPLETED|Overall Study||57
8282004|NCT01667419|20420067|P2|COMPLETED|Overall Study||110
8282005|NCT01667419|20420068|P1|COMPLETED|Overall Study||114
8282006|NCT01667419|20420065|P4|STARTED|Overall Study||91
8282007|NCT01667419|20420066|P3|STARTED|Overall Study||93
8282008|NCT01667419|20420067|P2|STARTED|Overall Study||157
8282009|NCT01667419|20420068|P1|STARTED|Overall Study||157
8282010|NCT01667250|20420098|P3|NOT COMPLETED|Randomised Period||0
8282011|NCT01667250|20420099|P2|NOT COMPLETED|Randomised Period||1
8282012|NCT01667250|20420100|P1|NOT COMPLETED|Randomised Period||1
8282013|NCT01667250|20420098|P3|COMPLETED|Randomised Period||0
8282014|NCT01667250|20420099|P2|COMPLETED|Randomised Period||28
8282015|NCT01667250|20420100|P1|COMPLETED|Randomised Period||29
8282016|NCT01667250|20420098|P3|STARTED|Randomised Period||0
8282017|NCT01667250|20420099|P2|STARTED|Randomised Period||29
8282018|NCT01667250|20420100|P1|STARTED|Randomised Period||30
8282019|NCT01667250|20420098|P3|NOT COMPLETED|Run-in (no Treatment)||14
8282020|NCT01667250|20420099|P2|NOT COMPLETED|Run-in (no Treatment)||0
8282021|NCT01667250|20420100|P1|NOT COMPLETED|Run-in (no Treatment)||0
8282022|NCT01667250|20420098|P3|COMPLETED|Run-in (no Treatment)||59
8282023|NCT01667250|20420099|P2|COMPLETED|Run-in (no Treatment)||0
8282024|NCT01667250|20420100|P1|COMPLETED|Run-in (no Treatment)||0
8282025|NCT01667250|20420098|P3|STARTED|Run-in (no Treatment)||73
8282026|NCT01667250|20420099|P2|STARTED|Run-in (no Treatment)||0
8282027|NCT01667250|20420100|P1|STARTED|Run-in (no Treatment)||0
8282028|NCT01667224|20420116|P2|NOT COMPLETED|Overall Study||2
8282029|NCT01667224|20420117|P1|NOT COMPLETED|Overall Study||4
8282030|NCT01667224|20420116|P2|COMPLETED|Overall Study||38
8282031|NCT01667224|20420117|P1|COMPLETED|Overall Study||36
8282032|NCT01667224|20420116|P2|STARTED|Overall Study||40
8282033|NCT01667224|20420117|P1|STARTED|Overall Study||40
8282034|NCT01667107|20420131|P2|NOT COMPLETED|Overall Study||7
8282035|NCT01667107|20420132|P1|NOT COMPLETED|Overall Study||4
8282036|NCT01667107|20420131|P2|COMPLETED|Overall Study||11
8282037|NCT01667107|20420132|P1|COMPLETED|Overall Study||4
8282038|NCT01667107|20420131|P2|STARTED|Overall Study||18
8282039|NCT01667107|20420132|P1|STARTED|Overall Study||8
8282040|NCT01667029|20420148|P2|NOT COMPLETED|Overall Study||1
8282041|NCT01667029|20420149|P1|NOT COMPLETED|Overall Study||1
8282042|NCT01667029|20420148|P2|COMPLETED|Overall Study||3
8282043|NCT01667029|20420149|P1|COMPLETED|Overall Study||3
8282044|NCT01667029|20420148|P2|STARTED|Overall Study||4
8282045|NCT01667029|20420149|P1|STARTED|Overall Study||4
8282046|NCT01666951|20420191|P2|NOT COMPLETED|Overall Study||1
8282047|NCT01666951|20420192|P1|NOT COMPLETED|Overall Study||1
8282048|NCT01666951|20420191|P2|COMPLETED|Overall Study||17
8282049|NCT01666951|20420192|P1|COMPLETED|Overall Study||17
8282050|NCT01666951|20420191|P2|STARTED|Overall Study||18
8282051|NCT01666951|20420192|P1|STARTED|Overall Study||18
8282052|NCT01666912|20420230|P2|NOT COMPLETED|Overall Study||11
8282053|NCT01666912|20420231|P1|NOT COMPLETED|Overall Study||21
8282054|NCT01666912|20420230|P2|COMPLETED|Overall Study||37
8282055|NCT01666912|20420231|P1|COMPLETED|Overall Study||27
8282056|NCT01666912|20420230|P2|STARTED|Overall Study||48
8282057|NCT01666912|20420231|P1|STARTED|Overall Study||48
8282058|NCT01666782|20420243|P2|NOT COMPLETED|Overall Study||1
8282059|NCT01666782|20420244|P1|NOT COMPLETED|Overall Study||4
8282060|NCT01666782|20420243|P2|COMPLETED|Overall Study||50
8282061|NCT01666782|20420244|P1|COMPLETED|Overall Study||50
8282062|NCT01666782|20420243|P2|STARTED|Overall Study||51
8282063|NCT01666782|20420244|P1|STARTED|Overall Study||54
8282064|NCT01666652|20420265|P5|NOT COMPLETED|Overall Study||1
8282065|NCT01666652|20420266|P4|NOT COMPLETED|Overall Study||4
8282066|NCT01666652|20420267|P3|NOT COMPLETED|Overall Study||1
8282067|NCT01666652|20420268|P2|NOT COMPLETED|Overall Study||1
8282068|NCT01666652|20420269|P1|NOT COMPLETED|Overall Study||2
8282069|NCT01666652|20420265|P5|COMPLETED|Overall Study||19
8282070|NCT01666652|20420266|P4|COMPLETED|Overall Study||16
8282071|NCT01666652|20420267|P3|COMPLETED|Overall Study||19
8282072|NCT01666652|20420268|P2|COMPLETED|Overall Study||19
8282073|NCT01666652|20420269|P1|COMPLETED|Overall Study||18
8282074|NCT01666652|20420265|P5|STARTED|Overall Study||20
8282075|NCT01666652|20420266|P4|STARTED|Overall Study||20
8282076|NCT01666652|20420267|P3|STARTED|Overall Study||20
8282077|NCT01666652|20420268|P2|STARTED|Overall Study||20
8282078|NCT01666652|20420269|P1|STARTED|Overall Study||20
8282079|NCT01666444|20420318|P2|NOT COMPLETED|Overall Study||1
8282080|NCT01666444|20420319|P1|NOT COMPLETED|Overall Study||2
8282081|NCT01666444|20420318|P2|COMPLETED|Overall Study||147
8282082|NCT01666444|20420319|P1|COMPLETED|Overall Study||147
8282083|NCT01666444|20420318|P2|STARTED|Overall Study||148
8282084|NCT01666444|20420319|P1|STARTED|Overall Study||149
8282085|NCT01666314|20420337|P4|NOT COMPLETED|Overall Study||36
8282086|NCT01666314|20420338|P3|NOT COMPLETED|Overall Study||36
8282087|NCT01666314|20420339|P2|NOT COMPLETED|Overall Study||32
8282088|NCT01666314|20420340|P1|NOT COMPLETED|Overall Study||33
8282089|NCT01666314|20420337|P4|COMPLETED|Overall Study||0
8282090|NCT01666314|20420338|P3|COMPLETED|Overall Study||0
8282091|NCT01666314|20420339|P2|COMPLETED|Overall Study||0
8282092|NCT01666314|20420340|P1|COMPLETED|Overall Study||0
8282093|NCT01666314|20420337|P4|STARTED|Overall Study||36
8282094|NCT01666314|20420338|P3|STARTED|Overall Study||36
8282095|NCT01666314|20420339|P2|STARTED|Overall Study||32
8282096|NCT01666314|20420340|P1|STARTED|Overall Study||33
8282097|NCT01666210|20420451|P2|NOT COMPLETED|Overall Study||1
8282098|NCT01666210|20420452|P1|NOT COMPLETED|Overall Study||2
8282099|NCT01666210|20420451|P2|COMPLETED|Overall Study||29
8282100|NCT01666210|20420452|P1|COMPLETED|Overall Study||28
8282101|NCT01666210|20420451|P2|STARTED|Overall Study||30
8282102|NCT01666210|20420452|P1|STARTED|Overall Study||30
8282103|NCT01666197|20420464|P2|NOT COMPLETED|Overall Study||0
8282104|NCT01666197|20420465|P1|NOT COMPLETED|Overall Study||0
8282105|NCT01666197|20420464|P2|COMPLETED|Overall Study||50
8282106|NCT01666197|20420465|P1|COMPLETED|Overall Study||50
8282107|NCT01666197|20420464|P2|STARTED|Overall Study||50
8282108|NCT01666197|20420465|P1|STARTED|Overall Study||50
8282109|NCT01666145|20420471|P1|NOT COMPLETED|Overall Study||0
8282110|NCT01666145|20420471|P1|COMPLETED|Overall Study||14
8282111|NCT01666145|20420471|P1|STARTED|Overall Study||14
8282112|NCT01666119|20420476|P1|NOT COMPLETED|Overall Study||52
8282113|NCT01666119|20420476|P1|COMPLETED|Overall Study||197
8282114|NCT01666119|20420476|P1|STARTED|Overall Study||249
8282115|NCT01666002|20420483|P2|NOT COMPLETED|Overall Study||0
8282116|NCT01666002|20420484|P1|NOT COMPLETED|Overall Study||5
8282117|NCT01666002|20420483|P2|COMPLETED|Overall Study||10
8282118|NCT01666002|20420484|P1|COMPLETED|Overall Study||12
8282119|NCT01666002|20420483|P2|STARTED|Overall Study||10
8282120|NCT01666002|20420484|P1|STARTED|Overall Study||17
8282121|NCT01665950|20420495|P3|NOT COMPLETED|Overall Study||1
8282122|NCT01665950|20420496|P2|NOT COMPLETED|Overall Study||0
8282123|NCT01665950|20420497|P1|NOT COMPLETED|Overall Study||1
8282124|NCT01665950|20420495|P3|COMPLETED|Overall Study||1
8282125|NCT01665950|20420496|P2|COMPLETED|Overall Study||0
8282126|NCT01665950|20420497|P1|COMPLETED|Overall Study||1
8282127|NCT01665950|20420495|P3|STARTED|Overall Study||2
8282128|NCT01665950|20420496|P2|STARTED|Overall Study||0
8282129|NCT01665950|20420497|P1|STARTED|Overall Study||2
8282130|NCT01665911|20420505|P1|NOT COMPLETED|Overall Study||6
8282131|NCT01665911|20420505|P1|COMPLETED|Overall Study||22
8282132|NCT01665911|20420505|P1|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
8282133|NCT01665911|20420505|P1|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
8282134|NCT01665911|20420505|P1|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
8282135|NCT01665911|20420505|P1|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
8282136|NCT01665911|20420505|P1|0 mg Fluoride in 200 ml Milk|Overall Study||22
8282137|NCT01665911|20420505|P1|STARTED|Overall Study||28
8282138|NCT01665872|20420513|P2|NOT COMPLETED|12 Month Follow-up||3
8282139|NCT01665872|20420514|P1|NOT COMPLETED|12 Month Follow-up||14
8282140|NCT01665872|20420513|P2|COMPLETED|12 Month Follow-up||47
8282141|NCT01665872|20420514|P1|COMPLETED|12 Month Follow-up||58
8282142|NCT01665872|20420513|P2|STARTED|12 Month Follow-up||50
8282143|NCT01665872|20420514|P1|STARTED|12 Month Follow-up||72
8282144|NCT01665872|20420513|P2|NOT COMPLETED|6 Month Follow-up||1
8282145|NCT01665872|20420514|P1|NOT COMPLETED|6 Month Follow-up||6
8282146|NCT01665872|20420513|P2|COMPLETED|6 Month Follow-up||49
8282147|NCT01665872|20420514|P1|COMPLETED|6 Month Follow-up||66
8282148|NCT01665872|20420513|P2|STARTED|6 Month Follow-up||50
8282149|NCT01665872|20420514|P1|STARTED|6 Month Follow-up||72
8282150|NCT01665872|20420513|P2|NOT COMPLETED|Treatment||17
8282151|NCT01665872|20420514|P1|NOT COMPLETED|Treatment||15
8282152|NCT01665872|20420513|P2|COMPLETED|Treatment||50
8282153|NCT01665872|20420514|P1|COMPLETED|Treatment||72
8282154|NCT01665872|20420513|P2|STARTED|Treatment||67
8282155|NCT01665872|20420514|P1|STARTED|Treatment||87
8282156|NCT01665872|20420513|P2|NOT COMPLETED|Screening||0
8282157|NCT01665872|20420514|P1|NOT COMPLETED|Screening||0
8282158|NCT01665872|20420513|P2|COMPLETED|Screening||172
8282159|NCT01665872|20420514|P1|COMPLETED|Screening||172
8282160|NCT01665872|20420513|P2|STARTED|Screening||172
8282161|NCT01665872|20420514|P1|STARTED|Screening||172
8282162|NCT01665807|20420531|P3|NOT COMPLETED|Overall Study||1
8282163|NCT01665807|20420532|P2|NOT COMPLETED|Overall Study||0
8282164|NCT01665807|20420533|P1|NOT COMPLETED|Overall Study||2
8282165|NCT01665807|20420531|P3|COMPLETED|Overall Study||401
8282166|NCT01665807|20420532|P2|COMPLETED|Overall Study||58
8282167|NCT01665807|20420533|P1|COMPLETED|Overall Study||409
8282168|NCT01665807|20420531|P3|STARTED|Overall Study||402
8282169|NCT01665807|20420532|P2|STARTED|Overall Study||58
8282170|NCT01665807|20420533|P1|STARTED|Overall Study||411
8282171|NCT01665768|20420544|P1|NOT COMPLETED|Overall Study||23
8282172|NCT01665768|20420544|P1|COMPLETED|Overall Study||26
8282173|NCT01665768|20420544|P1|STARTED|Overall Study||49
8282174|NCT01665599|20420549|P1|NOT COMPLETED|Overall Study||8
8282175|NCT01665599|20420549|P1|COMPLETED|Overall Study||172
8282176|NCT01665599|20420549|P1|STARTED|Overall Study||180
8282177|NCT01665508|20420569|P1|NOT COMPLETED|Overall Study||5
8282178|NCT01665508|20420569|P1|COMPLETED|Overall Study||7
8282179|NCT01665508|20420569|P1|STARTED|Overall Study||12
8282180|NCT01665430|20420585|P1|NOT COMPLETED|Overall Study||9
8282181|NCT01665430|20420585|P1|COMPLETED|Overall Study||29
8282182|NCT01665430|20420585|P1|STARTED|Overall Study||38
8282183|NCT01665170|20420601|P2|NOT COMPLETED|Overall Study||0
8282184|NCT01665170|20420602|P1|NOT COMPLETED|Overall Study||0
8282185|NCT01665170|20420601|P2|COMPLETED|Overall Study||30
8282186|NCT01665170|20420602|P1|COMPLETED|Overall Study|Last TSST/ last patient out|30
8282187|NCT01665170|20420601|P2|After TSST|Overall Study||30
8282188|NCT01665170|20420602|P1|After TSST|Overall Study||30
8282189|NCT01665170|20420601|P2|During TSST|Overall Study||30
8282190|NCT01665170|20420602|P1|During TSST|Overall Study||30
8282191|NCT01665170|20420601|P2|Bevore TSST|Overall Study||30
8282192|NCT01665170|20420602|P1|Bevore TSST|Overall Study||30
8282193|NCT01665170|20420601|P2|STARTED|Overall Study||30
8282194|NCT01665170|20420602|P1|STARTED|Overall Study|First patient in|30
8282195|NCT01665157|20420653|P3|NOT COMPLETED|Overall Study||0
8282196|NCT01665157|20420654|P2|NOT COMPLETED|Overall Study||0
8282197|NCT01665157|20420655|P1|NOT COMPLETED|Overall Study||0
8282198|NCT01665157|20420653|P3|COMPLETED|Overall Study||60
8282199|NCT01665157|20420654|P2|COMPLETED|Overall Study||60
8282200|NCT01665157|20420655|P1|COMPLETED|Overall Study||60
8282201|NCT01665157|20420653|P3|STARTED|Overall Study||60
8282202|NCT01665157|20420654|P2|STARTED|Overall Study||60
8282203|NCT01665157|20420655|P1|STARTED|Overall Study||60
8282214|NCT01665092|20420694|P4|NOT COMPLETED|Overall Study||1
8282215|NCT01665092|20420695|P3|NOT COMPLETED|Overall Study||2
8282216|NCT01665092|20420696|P2|NOT COMPLETED|Overall Study||0
8282217|NCT01665092|20420697|P1|NOT COMPLETED|Overall Study||0
8282218|NCT01665092|20420694|P4|COMPLETED|Overall Study||105
8282219|NCT01665092|20420695|P3|COMPLETED|Overall Study||32
8282220|NCT01665092|20420696|P2|COMPLETED|Overall Study||35
8282221|NCT01665092|20420697|P1|COMPLETED|Overall Study||75
8282222|NCT01665092|20420694|P4|STARTED|Overall Study||106
8282223|NCT01665092|20420695|P3|STARTED|Overall Study||34
8282224|NCT01665092|20420696|P2|STARTED|Overall Study||35
8282225|NCT01665092|20420697|P1|STARTED|Overall Study||75
8282226|NCT01665053|20420709|P2|NOT COMPLETED|Overall Study||15
8282227|NCT01665053|20420710|P1|NOT COMPLETED|Overall Study||32
8282228|NCT01665053|20420709|P2|COMPLETED|Overall Study||831
8282229|NCT01665053|20420710|P1|COMPLETED|Overall Study||806
8282230|NCT01665053|20420709|P2|Death With No 12-month Clinical FU|Overall Study||9
8282231|NCT01665053|20420710|P1|Death With No 12-month Clinical FU|Overall Study||9
8282232|NCT01665053|20420709|P2|No 12-Month F/U|Overall Study||15
8282233|NCT01665053|20420710|P1|No 12-Month F/U|Overall Study||32
8282234|NCT01665053|20420709|P2|Completed 12-Month Clinical F/U|Overall Study||822
8282235|NCT01665053|20420710|P1|Completed 12-Month Clinical F/U|Overall Study||797
8282236|NCT01665053|20420709|P2|STARTED|Overall Study||846
8282237|NCT01665053|20420710|P1|STARTED|Overall Study||838
8282238|NCT01665040|20420748|P1|NOT COMPLETED|Overall Study||4
8282239|NCT01665040|20420748|P1|COMPLETED|Overall Study||36
8282240|NCT01665040|20420748|P1|STARTED|Overall Study||40
8282241|NCT01664975|20420755|P2|NOT COMPLETED|Overall Study||3
8282242|NCT01664975|20420756|P1|NOT COMPLETED|Overall Study||5
8282243|NCT01664975|20420755|P2|COMPLETED|Overall Study||51
8282244|NCT01664975|20420756|P1|COMPLETED|Overall Study||52
8282245|NCT01664975|20420755|P2|STARTED|Overall Study||54
8282246|NCT01664975|20420756|P1|STARTED|Overall Study||57
8282247|NCT01664949|20420764|P2|NOT COMPLETED|Overall Study||25
8282248|NCT01664949|20420765|P1|NOT COMPLETED|Overall Study||24
8282249|NCT01664949|20420764|P2|COMPLETED|Overall Study||211
8282250|NCT01664949|20420765|P1|COMPLETED|Overall Study||200
8282251|NCT01664949|20420764|P2|STARTED|Overall Study||236
8282252|NCT01664949|20420765|P1|STARTED|Overall Study||224
8282253|NCT01664923|20420781|P2|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23
8282254|NCT01664923|20420782|P1|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41
8282255|NCT01664923|20420781|P2|COMPLETED|Period 2: Open-label Phase-36 Months||15
8282256|NCT01664923|20420782|P1|COMPLETED|Period 2: Open-label Phase-36 Months||52
8282257|NCT01664923|20420781|P2|Treated|Period 2: Open-label Phase-36 Months||37
8282258|NCT01664923|20420782|P1|Treated|Period 2: Open-label Phase-36 Months||93
8282259|NCT01664923|20420781|P2|STARTED|Period 2: Open-label Phase-36 Months||38
8282260|NCT01664923|20420782|P1|STARTED|Period 2: Open-label Phase-36 Months||93
8282261|NCT01664923|20420781|P2|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160
8282262|NCT01664923|20420782|P1|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105
8282263|NCT01664923|20420781|P2|COMPLETED|Period1:Double Blind Phase-29 Months||38
8282264|NCT01664923|20420782|P1|COMPLETED|Period1:Double Blind Phase-29 Months||93
8282265|NCT01664923|20420781|P2|Received Study Treatment|Period1:Double Blind Phase-29 Months||198
8282266|NCT01664923|20420782|P1|Received Study Treatment|Period1:Double Blind Phase-29 Months||197
8282267|NCT01664923|20420781|P2|STARTED|Period1:Double Blind Phase-29 Months||198
8282268|NCT01664923|20420782|P1|STARTED|Period1:Double Blind Phase-29 Months||198
8282269|NCT01664897|20420802|P1|NOT COMPLETED|Overall Study||0
8282270|NCT01664897|20420802|P1|COMPLETED|Overall Study||29
8282271|NCT01664897|20420802|P1|STARTED|Overall Study||29
8282272|NCT01664858|20420813|P3|NOT COMPLETED|Overall Study||6
8282273|NCT01664858|20420814|P2|NOT COMPLETED|Overall Study||13
8282274|NCT01664858|20420815|P1|NOT COMPLETED|Overall Study||14
8282275|NCT01664858|20420813|P3|COMPLETED|Overall Study||234
8282276|NCT01664858|20420814|P2|COMPLETED|Overall Study||468
8282277|NCT01664858|20420815|P1|COMPLETED|Overall Study||467
8282278|NCT01664858|20420813|P3|STARTED|Overall Study||240
8282279|NCT01664858|20420814|P2|STARTED|Overall Study||481
8282280|NCT01664858|20420815|P1|STARTED|Overall Study||481
8282281|NCT01664806|20420831|P2|NOT COMPLETED|Overall Study||0
8282282|NCT01664806|20420832|P1|NOT COMPLETED|Overall Study||0
8282283|NCT01664806|20420831|P2|COMPLETED|Overall Study||20
8282284|NCT01664806|20420832|P1|COMPLETED|Overall Study||20
8282285|NCT01664806|20420831|P2|STARTED|Overall Study||20
8282286|NCT01664806|20420832|P1|STARTED|Overall Study||20
8282287|NCT01664793|20420842|P2|NOT COMPLETED|Overall Study||0
8282288|NCT01664793|20420843|P1|NOT COMPLETED|Overall Study||0
8282289|NCT01664793|20420842|P2|COMPLETED|Overall Study||38626
8282290|NCT01664793|20420843|P1|COMPLETED|Overall Study||49039
8282291|NCT01664793|20420842|P2|STARTED|Overall Study||38626
8282292|NCT01664793|20420843|P1|STARTED|Overall Study||49039
8282293|NCT01664741|20420854|P3|NOT COMPLETED|Overall Study||0
8282294|NCT01664741|20420855|P2|NOT COMPLETED|Overall Study||0
8282295|NCT01664741|20420856|P1|NOT COMPLETED|Overall Study||0
8282296|NCT01664741|20420854|P3|COMPLETED|Overall Study||13
8282297|NCT01664741|20420855|P2|COMPLETED|Overall Study||6
8282298|NCT01664741|20420856|P1|COMPLETED|Overall Study||6
8282299|NCT01664741|20420854|P3|STARTED|Overall Study||13
8282300|NCT01664741|20420855|P2|STARTED|Overall Study||6
8282301|NCT01664741|20420856|P1|STARTED|Overall Study||6
8282302|NCT01664624|20420873|P4|NOT COMPLETED|Overall Study||0
8282303|NCT01664624|20420874|P3|NOT COMPLETED|Overall Study||0
8282304|NCT01664624|20420875|P2|NOT COMPLETED|Overall Study||1
8282305|NCT01664624|20420876|P1|NOT COMPLETED|Overall Study||0
8282306|NCT01664624|20420873|P4|COMPLETED|Overall Study||9
8282307|NCT01664624|20420874|P3|COMPLETED|Overall Study||10
8282308|NCT01664624|20420875|P2|COMPLETED|Overall Study||10
8282309|NCT01664624|20420876|P1|COMPLETED|Overall Study||10
8282310|NCT01664624|20420873|P4|STARTED|Overall Study||9
8282311|NCT01664624|20420874|P3|STARTED|Overall Study||10
8282312|NCT01664624|20420875|P2|STARTED|Overall Study||11
8282313|NCT01664624|20420876|P1|STARTED|Overall Study||10
8282314|NCT01664559|20420908|P2|NOT COMPLETED|Overall Study||0
8282315|NCT01664559|20420909|P1|NOT COMPLETED|Overall Study||0
8282316|NCT01664559|20420908|P2|COMPLETED|Overall Study||33
8282317|NCT01664559|20420909|P1|COMPLETED|Overall Study||34
8282318|NCT01664559|20420908|P2|STARTED|Overall Study||33
8282319|NCT01664559|20420909|P1|STARTED|Overall Study||34
8282320|NCT01664533|20420923|P1|NOT COMPLETED|Overall Study||57
8282321|NCT01664533|20420923|P1|COMPLETED|Overall Study||0
8282322|NCT01664533|20420923|P1|STARTED|Overall Study||57
8282323|NCT01664494|20420931|P1|NOT COMPLETED|Overall Study||193
8282324|NCT01664494|20420931|P1|COMPLETED|Overall Study||370
8282325|NCT01664494|20420931|P1|STARTED|Overall Study||563
8282326|NCT01664247|20420938|P2|NOT COMPLETED|Overall Study||41
8282327|NCT01664247|20420939|P1|NOT COMPLETED|Overall Study||14
8282328|NCT01664247|20420938|P2|COMPLETED|Overall Study||131
8282329|NCT01664247|20420939|P1|COMPLETED|Overall Study||160
8282330|NCT01664247|20420938|P2|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
8282331|NCT01664247|20420939|P1|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
8282332|NCT01664247|20420938|P2|STARTED|Overall Study||172
8282333|NCT01664247|20420939|P1|STARTED|Overall Study||174
8282334|NCT01664130|20420961|P1|NOT COMPLETED|Overall Study||2
8282335|NCT01664130|20420961|P1|COMPLETED|Overall Study||33
8282336|NCT01664130|20420961|P1|STARTED|Overall Study||35
8282337|NCT01664117|20420984|P1|NOT COMPLETED|Overall Study||0
8282338|NCT01664117|20420984|P1|COMPLETED|Overall Study||209
8282339|NCT01664117|20420984|P1|STARTED|Overall Study||209
8282340|NCT01664104|20421039|P1|NOT COMPLETED|Overall Study||16
8282341|NCT01664104|20421039|P1|COMPLETED|Overall Study||120
8282342|NCT01664104|20421039|P1|STARTED|Overall Study||136
8282343|NCT01664091|20421106|P1|NOT COMPLETED|Overall Study||6
8282344|NCT01664091|20421106|P1|COMPLETED|Overall Study||26
8282345|NCT01664091|20421106|P1|STARTED|Overall Study||32
8282346|NCT01664078|20421114|P1|NOT COMPLETED|Overall Study||69
8282347|NCT01664078|20421114|P1|COMPLETED|Overall Study||121
8282348|NCT01664078|20421114|P1|STARTED|Overall Study||190
8282349|NCT01664052|20421167|P2|NOT COMPLETED|Phase 2||4
8282350|NCT01664052|20421168|P1|NOT COMPLETED|Phase 2||0
8282351|NCT01664052|20421167|P2|COMPLETED|Phase 2||31
8282352|NCT01664052|20421168|P1|COMPLETED|Phase 2||0
8282353|NCT01664052|20421167|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
8282354|NCT01664052|20421168|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
8282355|NCT01664052|20421167|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
8282356|NCT01664052|20421168|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
8282357|NCT01664052|20421167|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
8282358|NCT01664052|20421168|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
8282359|NCT01664052|20421167|P2|HSG 1 Hour Post Placement|Phase 2||31
8282360|NCT01664052|20421168|P1|HSG 1 Hour Post Placement|Phase 2||0
8282361|NCT01664052|20421167|P2|Insert Placed|Phase 2||31
8282362|NCT01664052|20421168|P1|Insert Placed|Phase 2||0
8282363|NCT01664052|20421167|P2|STARTED|Phase 2||35
8282364|NCT01664052|20421168|P1|STARTED|Phase 2|Screened and enrolled|0
8282365|NCT01664052|20421167|P2|NOT COMPLETED|Phase 1||0
8282366|NCT01664052|20421168|P1|NOT COMPLETED|Phase 1||7
8282367|NCT01664052|20421167|P2|COMPLETED|Phase 1||0
8282368|NCT01664052|20421168|P1|COMPLETED|Phase 1||24
8282369|NCT01664052|20421167|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
8282370|NCT01664052|20421168|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
8282371|NCT01664052|20421167|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
8282372|NCT01664052|20421168|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
8282373|NCT01664052|20421167|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
8282374|NCT01664052|20421168|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
8282375|NCT01664052|20421167|P2|HSG 1 Hour Post Placement|Phase 1||0
8282376|NCT01664052|20421168|P1|HSG 1 Hour Post Placement|Phase 1||24
8282377|NCT01664052|20421167|P2|Insert Placed in at Least One Tube|Phase 1||0
8282378|NCT01664052|20421168|P1|Insert Placed in at Least One Tube|Phase 1||25
8282379|NCT01664052|20421167|P2|STARTED|Phase 1||0
8282380|NCT01664052|20421168|P1|STARTED|Phase 1|Screening and enrollment|31
8282381|NCT01664039|20421186|P2|NOT COMPLETED|Overall Study||9
8282382|NCT01664039|20421187|P1|NOT COMPLETED|Overall Study||6
8282383|NCT01664039|20421186|P2|COMPLETED|Overall Study||43
8282384|NCT01664039|20421187|P1|COMPLETED|Overall Study||46
8282385|NCT01664039|20421186|P2|STARTED|Overall Study||52
8282386|NCT01664039|20421187|P1|STARTED|Overall Study||52
8282387|NCT01663987|20421209|P2|NOT COMPLETED|Overall Study||6
8282388|NCT01663987|20421210|P1|NOT COMPLETED|Overall Study||13
8282389|NCT01663987|20421209|P2|COMPLETED|Overall Study||34
8282390|NCT01663987|20421210|P1|COMPLETED|Overall Study||26
8282391|NCT01663987|20421209|P2|STARTED|Overall Study||40
8282392|NCT01663987|20421210|P1|STARTED|Overall Study||39
8282393|NCT01663935|20421238|P1|NOT COMPLETED|Overall Study||0
8282394|NCT01663935|20421238|P1|COMPLETED|Overall Study||20
8282395|NCT01663935|20421238|P1|STARTED|Overall Study||20
8282396|NCT01663922|20421243|P2|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
8282397|NCT01663922|20421244|P1|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
8282398|NCT01663922|20421243|P2|COMPLETED|Third Intervention (14 Days or 5 Days)||9
8282399|NCT01663922|20421244|P1|COMPLETED|Third Intervention (14 Days or 5 Days)||8
8282400|NCT01663922|20421243|P2|STARTED|Third Intervention (14 Days or 5 Days)||9
8282401|NCT01663922|20421244|P1|STARTED|Third Intervention (14 Days or 5 Days)||8
8282402|NCT01663922|20421243|P2|NOT COMPLETED|Washout (7 Days)||0
8282403|NCT01663922|20421244|P1|NOT COMPLETED|Washout (7 Days)||0
8282404|NCT01663922|20421243|P2|COMPLETED|Washout (7 Days)||9
8282405|NCT01663922|20421244|P1|COMPLETED|Washout (7 Days)||8
8282406|NCT01663922|20421243|P2|STARTED|Washout (7 Days)||9
8282407|NCT01663922|20421244|P1|STARTED|Washout (7 Days)||8
8282408|NCT01663922|20421243|P2|NOT COMPLETED|Second Intervention (14 Days)||0
8282409|NCT01663922|20421244|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8282410|NCT01663922|20421243|P2|COMPLETED|Second Intervention (14 Days)||9
8282411|NCT01663922|20421244|P1|COMPLETED|Second Intervention (14 Days)||8
8282412|NCT01663922|20421243|P2|STARTED|Second Intervention (14 Days)||9
8282413|NCT01663922|20421244|P1|STARTED|Second Intervention (14 Days)||8
8282414|NCT01663922|20421243|P2|NOT COMPLETED|Washout (7 Days)||0
8282415|NCT01663922|20421244|P1|NOT COMPLETED|Washout (7 Days)||0
8282416|NCT01663922|20421243|P2|COMPLETED|Washout (7 Days)||9
8282417|NCT01663922|20421244|P1|COMPLETED|Washout (7 Days)||8
8282418|NCT01663922|20421243|P2|STARTED|Washout (7 Days)||9
8282419|NCT01663922|20421244|P1|STARTED|Washout (7 Days)||8
8282420|NCT01663922|20421243|P2|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
8282421|NCT01663922|20421244|P1|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
8282422|NCT01663922|20421243|P2|COMPLETED|First Intervention (14 Days or 5 Days)||9
8282423|NCT01663922|20421244|P1|COMPLETED|First Intervention (14 Days or 5 Days)||8
8282424|NCT01663922|20421243|P2|STARTED|First Intervention (14 Days or 5 Days)||9
8282425|NCT01663922|20421244|P1|STARTED|First Intervention (14 Days or 5 Days)||8
8282426|NCT01663896|20421249|P1|NOT COMPLETED|Overall Study||43
8282427|NCT01663896|20421249|P1|COMPLETED|Overall Study||375
8282428|NCT01663896|20421249|P1|STARTED|Overall Study||418
8282429|NCT01663857|20421260|P4|NOT COMPLETED|Overall Study||4
8282430|NCT01663857|20421261|P3|NOT COMPLETED|Overall Study||10
8282431|NCT01663857|20421262|P2|NOT COMPLETED|Overall Study||1
8282432|NCT01663857|20421263|P1|NOT COMPLETED|Overall Study||0
8282433|NCT01663857|20421260|P4|COMPLETED|Overall Study||48
8282434|NCT01663857|20421261|P3|COMPLETED|Overall Study||48
8282435|NCT01663857|20421262|P2|COMPLETED|Overall Study||1
8282436|NCT01663857|20421263|P1|COMPLETED|Overall Study||6
8282437|NCT01663857|20421260|P4|Received at Least One Dose of Study Drug|Overall Study||52
8282438|NCT01663857|20421261|P3|Received at Least One Dose of Study Drug|Overall Study||58
8282439|NCT01663857|20421262|P2|Received at Least One Dose of Study Drug|Overall Study||2
8282440|NCT01663857|20421263|P1|Received at Least One Dose of Study Drug|Overall Study||6
8282441|NCT01663857|20421260|P4|STARTED|Overall Study||52
8282442|NCT01663857|20421261|P3|STARTED|Overall Study||58
8282443|NCT01663857|20421262|P2|STARTED|Overall Study||2
8282444|NCT01663857|20421263|P1|STARTED|Overall Study||6
8282445|NCT01663779|20421282|P2|NOT COMPLETED|Overall Study||0
8282446|NCT01663779|20421283|P1|NOT COMPLETED|Overall Study||0
8282447|NCT01663779|20421282|P2|COMPLETED|Overall Study||23
8282448|NCT01663779|20421283|P1|COMPLETED|Overall Study||27
8282449|NCT01663779|20421282|P2|STARTED|Overall Study||23
8282450|NCT01663779|20421283|P1|STARTED|Overall Study||27
8282451|NCT01663740|20421291|P2|NOT COMPLETED|Overall Study||8
8282452|NCT01663740|20421292|P1|NOT COMPLETED|Overall Study||16
8282453|NCT01663740|20421291|P2|COMPLETED|Overall Study||13
8282454|NCT01663740|20421292|P1|COMPLETED|Overall Study||22
8282455|NCT01663740|20421291|P2|STARTED|Overall Study|Safety Population|21
8282456|NCT01663740|20421292|P1|STARTED|Overall Study|Safety Population|38
8282457|NCT01663727|20421352|P2|NOT COMPLETED|Overall Study||238
8282458|NCT01663727|20421353|P1|NOT COMPLETED|Overall Study||242
8282459|NCT01663727|20421352|P2|COMPLETED|Overall Study||1
8282460|NCT01663727|20421353|P1|COMPLETED|Overall Study||0
8282461|NCT01663727|20421352|P2|STARTED|Overall Study||239
8282462|NCT01663727|20421353|P1|STARTED|Overall Study||242
8282463|NCT01663714|20421385|P1|NOT COMPLETED|Long-Term Follow-Up||6
8282464|NCT01663714|20421385|P1|COMPLETED|Long-Term Follow-Up||16
8282465|NCT01663714|20421385|P1|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
8282466|NCT01663714|20421385|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
8282467|NCT01663714|20421385|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
8282468|NCT01663714|20421385|P1|STARTED|Dosimetric and Therapeutic Treatment||30
8282469|NCT01663636|20421414|P2|NOT COMPLETED|Parent SMS Acceptability Assessment||0
8282470|NCT01663636|20421415|P1|NOT COMPLETED|Parent SMS Acceptability Assessment||0
8282471|NCT01663636|20421414|P2|COMPLETED|Parent SMS Acceptability Assessment||130
8282472|NCT01663636|20421415|P1|COMPLETED|Parent SMS Acceptability Assessment||135
8282473|NCT01663636|20421414|P2|STARTED|Parent SMS Acceptability Assessment||130
8282474|NCT01663636|20421415|P1|STARTED|Parent SMS Acceptability Assessment||135
8282475|NCT01663636|20421414|P2|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
8282476|NCT01663636|20421415|P1|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
8282477|NCT01663636|20421414|P2|COMPLETED|Infant SMS Reminder Feasibility Study||130
8282478|NCT01663636|20421415|P1|COMPLETED|Infant SMS Reminder Feasibility Study||135
8282479|NCT01663636|20421414|P2|STARTED|Infant SMS Reminder Feasibility Study||161
8282480|NCT01663636|20421415|P1|STARTED|Infant SMS Reminder Feasibility Study||160
8282481|NCT01663623|20421423|P2|NOT COMPLETED|Overall Study||20
8282482|NCT01663623|20421424|P1|NOT COMPLETED|Overall Study||12
8282483|NCT01663623|20421423|P2|COMPLETED|Overall Study||33
8282484|NCT01663623|20421424|P1|COMPLETED|Overall Study||40
8282485|NCT01663623|20421423|P2|STARTED|Overall Study||53
8282486|NCT01663623|20421424|P1|STARTED|Overall Study||52
8282487|NCT01663532|20421434|P2|NOT COMPLETED|Overall Study||107
8282488|NCT01663532|20421435|P1|NOT COMPLETED|Overall Study||74
8282489|NCT01663532|20421434|P2|COMPLETED|Overall Study||65
8282490|NCT01663532|20421435|P1|COMPLETED|Overall Study||94
8282491|NCT01663532|20421434|P2|STARTED|Overall Study||172
8282492|NCT01663532|20421435|P1|STARTED|Overall Study||168
8282493|NCT01663506|20421453|P1|NOT COMPLETED|Overall Study||8
8282494|NCT01663506|20421453|P1|COMPLETED|Overall Study||15
8282495|NCT01663506|20421453|P1|STARTED|Overall Study||23
8282496|NCT01663402|20421484|P2|NOT COMPLETED|Overall Study||2084
8282497|NCT01663402|20421485|P1|NOT COMPLETED|Overall Study||1515
8282498|NCT01663402|20421484|P2|COMPLETED|Overall Study||7378
8282499|NCT01663402|20421485|P1|COMPLETED|Overall Study||7947
8282500|NCT01663402|20421484|P2|Treated|Overall Study||9451
8282501|NCT01663402|20421485|P1|Treated|Overall Study||9443
8282502|NCT01663402|20421484|P2|STARTED|Overall Study||9462
8282503|NCT01663402|20421485|P1|STARTED|Overall Study||9462
8282504|NCT01663363|20421519|P1|NOT COMPLETED|Overall Study||0
8282505|NCT01663363|20421519|P1|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
8282506|NCT01663363|20421519|P1|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
8282507|NCT01663285|20421524|P1|NOT COMPLETED|Overall Study||0
8282508|NCT01663285|20421524|P1|COMPLETED|Overall Study||1
8282509|NCT01663285|20421524|P1|STARTED|Overall Study||1
8282510|NCT01663272|20421530|P3|NOT COMPLETED|Overall Study||0
8282511|NCT01663272|20421531|P2|NOT COMPLETED|Overall Study||0
8282512|NCT01663272|20421532|P1|NOT COMPLETED|Overall Study||0
8282513|NCT01663272|20421530|P3|COMPLETED|Overall Study||1
8282514|NCT01663272|20421531|P2|COMPLETED|Overall Study||6
8282515|NCT01663272|20421532|P1|COMPLETED|Overall Study||5
8282516|NCT01663272|20421530|P3|STARTED|Overall Study||1
8282517|NCT01663272|20421531|P2|STARTED|Overall Study||6
8282518|NCT01663272|20421532|P1|STARTED|Overall Study||5
8282519|NCT01663259|20421537|P1|NOT COMPLETED|Overall Study||0
8282520|NCT01663259|20421537|P1|COMPLETED|Overall Study||42
8282521|NCT01663259|20421537|P1|STARTED|Overall Study||42
8282522|NCT01663233|20421551|P2|NOT COMPLETED|Overall Study||7
8282523|NCT01663233|20421552|P1|NOT COMPLETED|Overall Study||4
8282524|NCT01663233|20421551|P2|COMPLETED|Overall Study||129
8282525|NCT01663233|20421552|P1|COMPLETED|Overall Study||126
8282526|NCT01663233|20421551|P2|STARTED|Overall Study||136
8282527|NCT01663233|20421552|P1|STARTED|Overall Study||130
8282528|NCT01663103|20421576|P2|NOT COMPLETED|Overall Study||2
8282529|NCT01663103|20421577|P1|NOT COMPLETED|Overall Study||3
8282530|NCT01663103|20421576|P2|COMPLETED|Overall Study||19
8282531|NCT01663103|20421577|P1|COMPLETED|Overall Study||18
8282532|NCT01663103|20421576|P2|STARTED|Overall Study||21
8282533|NCT01663103|20421577|P1|STARTED|Overall Study||21
8282534|NCT01663012|20421593|P1|NOT COMPLETED|Overall Study||0
8282535|NCT01663012|20421593|P1|COMPLETED|Overall Study||20
8282536|NCT01663012|20421593|P1|STARTED|Overall Study||20
8282537|NCT01662999|20421605|P6|NOT COMPLETED|Period 3||0
8282538|NCT01662999|20421606|P5|NOT COMPLETED|Period 3||0
8282539|NCT01662999|20421607|P4|NOT COMPLETED|Period 3||0
8282540|NCT01662999|20421608|P3|NOT COMPLETED|Period 3||0
8282541|NCT01662999|20421609|P2|NOT COMPLETED|Period 3||1
8282542|NCT01662999|20421610|P1|NOT COMPLETED|Period 3||0
8282543|NCT01662999|20421605|P6|COMPLETED|Period 3||7
8282544|NCT01662999|20421606|P5|COMPLETED|Period 3||7
8282545|NCT01662999|20421607|P4|COMPLETED|Period 3||7
8282546|NCT01662999|20421608|P3|COMPLETED|Period 3||7
8282547|NCT01662999|20421609|P2|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
8282548|NCT01662999|20421610|P1|COMPLETED|Period 3||7
8282549|NCT01662999|20421605|P6|STARTED|Period 3||7
8282550|NCT01662999|20421606|P5|STARTED|Period 3||7
8282551|NCT01662999|20421607|P4|STARTED|Period 3||7
8282552|NCT01662999|20421608|P3|STARTED|Period 3||7
8282553|NCT01662999|20421609|P2|STARTED|Period 3||7
8282554|NCT01662999|20421610|P1|STARTED|Period 3||7
8282555|NCT01662999|20421605|P6|NOT COMPLETED|Period 2||0
8282556|NCT01662999|20421606|P5|NOT COMPLETED|Period 2||0
8282557|NCT01662999|20421607|P4|NOT COMPLETED|Period 2||0
8282558|NCT01662999|20421608|P3|NOT COMPLETED|Period 2||0
8282559|NCT01662999|20421609|P2|NOT COMPLETED|Period 2||0
8282560|NCT01662999|20421610|P1|NOT COMPLETED|Period 2||0
8282561|NCT01662999|20421605|P6|COMPLETED|Period 2||7
8282562|NCT01662999|20421606|P5|COMPLETED|Period 2||7
8282563|NCT01662999|20421607|P4|COMPLETED|Period 2||7
8282564|NCT01662999|20421608|P3|COMPLETED|Period 2||7
8282565|NCT01662999|20421609|P2|COMPLETED|Period 2||7
8282566|NCT01662999|20421610|P1|COMPLETED|Period 2||7
8282567|NCT01662999|20421605|P6|STARTED|Period 2||7
8282568|NCT01662999|20421606|P5|STARTED|Period 2||7
8282569|NCT01662999|20421607|P4|STARTED|Period 2||7
8282570|NCT01662999|20421608|P3|STARTED|Period 2||7
8282571|NCT01662999|20421609|P2|STARTED|Period 2||7
8282572|NCT01662999|20421610|P1|STARTED|Period 2||7
8282573|NCT01662999|20421605|P6|NOT COMPLETED|Period 1||0
8282574|NCT01662999|20421606|P5|NOT COMPLETED|Period 1||0
8282575|NCT01662999|20421607|P4|NOT COMPLETED|Period 1||0
8282576|NCT01662999|20421608|P3|NOT COMPLETED|Period 1||0
8282577|NCT01662999|20421609|P2|NOT COMPLETED|Period 1||0
8282578|NCT01662999|20421610|P1|NOT COMPLETED|Period 1||0
8282579|NCT01662999|20421605|P6|COMPLETED|Period 1||7
8282580|NCT01662999|20421606|P5|COMPLETED|Period 1||7
8282581|NCT01662999|20421607|P4|COMPLETED|Period 1||7
8282582|NCT01662999|20421608|P3|COMPLETED|Period 1||7
8282583|NCT01662999|20421609|P2|COMPLETED|Period 1||7
8282584|NCT01662999|20421610|P1|COMPLETED|Period 1||7
8282585|NCT01662999|20421605|P6|STARTED|Period 1||7
8282586|NCT01662999|20421606|P5|STARTED|Period 1||7
8282587|NCT01662999|20421607|P4|STARTED|Period 1||7
8282588|NCT01662999|20421608|P3|STARTED|Period 1||7
8282589|NCT01662999|20421609|P2|STARTED|Period 1||7
8282590|NCT01662999|20421610|P1|STARTED|Period 1||7
8282591|NCT01662986|20421681|P2|NOT COMPLETED|Overall Study||13
8282592|NCT01662986|20421682|P1|NOT COMPLETED|Overall Study||18
8282593|NCT01662986|20421681|P2|COMPLETED|Overall Study||26
8282594|NCT01662986|20421682|P1|COMPLETED|Overall Study||22
8282595|NCT01662986|20421681|P2|STARTED|Overall Study||39
8282596|NCT01662986|20421682|P1|STARTED|Overall Study||40
8282597|NCT01662960|20421718|P4|NOT COMPLETED|3 Month Follow-up||2
8282598|NCT01662960|20421719|P3|NOT COMPLETED|3 Month Follow-up||3
8282599|NCT01662960|20421720|P2|NOT COMPLETED|3 Month Follow-up||3
8282600|NCT01662960|20421721|P1|NOT COMPLETED|3 Month Follow-up||3
8282601|NCT01662960|20421718|P4|COMPLETED|3 Month Follow-up||13
8282602|NCT01662960|20421719|P3|COMPLETED|3 Month Follow-up||5
8282603|NCT01662960|20421720|P2|COMPLETED|3 Month Follow-up||16
8282604|NCT01662960|20421721|P1|COMPLETED|3 Month Follow-up||21
8282605|NCT01662960|20421718|P4|STARTED|3 Month Follow-up||15
8282606|NCT01662960|20421719|P3|STARTED|3 Month Follow-up||8
8282607|NCT01662960|20421720|P2|STARTED|3 Month Follow-up||19
8282608|NCT01662960|20421721|P1|STARTED|3 Month Follow-up||24
8282609|NCT01662960|20421718|P4|NOT COMPLETED|End of 4 Week Treatment Period||0
8282610|NCT01662960|20421719|P3|NOT COMPLETED|End of 4 Week Treatment Period||1
8282611|NCT01662960|20421720|P2|NOT COMPLETED|End of 4 Week Treatment Period||4
8282612|NCT01662960|20421721|P1|NOT COMPLETED|End of 4 Week Treatment Period||1
8282613|NCT01662960|20421718|P4|COMPLETED|End of 4 Week Treatment Period||15
8282614|NCT01662960|20421719|P3|COMPLETED|End of 4 Week Treatment Period||8
8282615|NCT01662960|20421720|P2|COMPLETED|End of 4 Week Treatment Period||19
8282616|NCT01662960|20421721|P1|COMPLETED|End of 4 Week Treatment Period||24
8282617|NCT01662960|20421718|P4|STARTED|End of 4 Week Treatment Period||15
8282618|NCT01662960|20421719|P3|STARTED|End of 4 Week Treatment Period||9
8282619|NCT01662960|20421720|P2|STARTED|End of 4 Week Treatment Period||23
8282620|NCT01662960|20421721|P1|STARTED|End of 4 Week Treatment Period||25
8282621|NCT01662908|20421753|P2|NOT COMPLETED|Overall Study||5
8282622|NCT01662908|20421754|P1|NOT COMPLETED|Overall Study||6
8282623|NCT01662908|20421753|P2|COMPLETED|Overall Study||23
8282624|NCT01662908|20421754|P1|COMPLETED|Overall Study||50
8282625|NCT01662908|20421753|P2|STARTED|Overall Study||28
8282626|NCT01662908|20421754|P1|STARTED|Overall Study||56
8282627|NCT01662895|20421770|P2|NOT COMPLETED|Overall Study||1
8282628|NCT01662895|20421771|P1|NOT COMPLETED|Overall Study||0
8282629|NCT01662895|20421770|P2|COMPLETED|Overall Study||20
8282630|NCT01662895|20421771|P1|COMPLETED|Overall Study||21
8282631|NCT01662895|20421770|P2|Initiated Study Drug|Overall Study||21
8282632|NCT01662895|20421771|P1|Initiated Study Drug|Overall Study||21
8282633|NCT01662895|20421770|P2|STARTED|Overall Study||21
8282634|NCT01662895|20421771|P1|STARTED|Overall Study||21
8282635|NCT01662882|20421794|P3|NOT COMPLETED|Overall Study||0
8282636|NCT01662882|20421795|P2|NOT COMPLETED|Overall Study||0
8282637|NCT01662882|20421796|P1|NOT COMPLETED|Overall Study||0
8282638|NCT01662882|20421794|P3|COMPLETED|Overall Study||15
8282639|NCT01662882|20421795|P2|COMPLETED|Overall Study||18
8282640|NCT01662882|20421796|P1|COMPLETED|Overall Study||15
8282641|NCT01662882|20421794|P3|STARTED|Overall Study||15
8282642|NCT01662882|20421795|P2|STARTED|Overall Study||18
8282643|NCT01662882|20421796|P1|STARTED|Overall Study||15
8282644|NCT01662856|20421809|P2|NOT COMPLETED|Primary Part II||2
8282645|NCT01662856|20421810|P1|NOT COMPLETED|Primary Part II||10
8282646|NCT01662856|20421809|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
8282647|NCT01662856|20421810|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
8282648|NCT01662856|20421809|P2|Completed Study up to Week 6|Primary Part II||56
8282649|NCT01662856|20421810|P1|Completed Study up to Week 6|Primary Part II||106
8282650|NCT01662856|20421809|P2|STARTED|Primary Part II||57
8282651|NCT01662856|20421810|P1|STARTED|Primary Part II||109
8282652|NCT01662856|20421809|P2|NOT COMPLETED|Part I + Part II (Overall Study)||2
8282653|NCT01662856|20421810|P1|NOT COMPLETED|Part I + Part II (Overall Study)||16
8282654|NCT01662856|20421809|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
8282655|NCT01662856|20421810|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
8282656|NCT01662856|20421809|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
8282657|NCT01662856|20421810|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
8282658|NCT01662856|20421809|P2|STARTED|Part I + Part II (Overall Study)||57
8282659|NCT01662856|20421810|P1|STARTED|Part I + Part II (Overall Study)||168
8282660|NCT01662791|20421824|P2|NOT COMPLETED|Part 2 - Interventional||0
8282661|NCT01662791|20421825|P1|NOT COMPLETED|Part 2 - Interventional||0
8282662|NCT01662791|20421824|P2|COMPLETED|Part 2 - Interventional||0
8282663|NCT01662791|20421825|P1|COMPLETED|Part 2 - Interventional||8
8282664|NCT01662791|20421824|P2|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
8282665|NCT01662791|20421825|P1|STARTED|Part 2 - Interventional||8
8282666|NCT01662791|20421824|P2|NOT COMPLETED|Part 1 - Observational||0
8282667|NCT01662791|20421825|P1|NOT COMPLETED|Part 1 - Observational||0
8282668|NCT01662791|20421824|P2|COMPLETED|Part 1 - Observational||41
8282669|NCT01662791|20421825|P1|COMPLETED|Part 1 - Observational||8
8282670|NCT01662791|20421824|P2|STARTED|Part 1 - Observational||41
8282671|NCT01662791|20421825|P1|STARTED|Part 1 - Observational||8
8282672|NCT01662778|20421847|P4|NOT COMPLETED|Period 4||0
8282673|NCT01662778|20421848|P3|NOT COMPLETED|Period 4||0
8282674|NCT01662778|20421849|P2|NOT COMPLETED|Period 4||0
8282675|NCT01662778|20421850|P1|NOT COMPLETED|Period 4||0
8282676|NCT01662778|20421847|P4|COMPLETED|Period 4||4
8282677|NCT01662778|20421848|P3|COMPLETED|Period 4||6
8282678|NCT01662778|20421849|P2|COMPLETED|Period 4||5
8282679|NCT01662778|20421850|P1|COMPLETED|Period 4||6
8282680|NCT01662778|20421847|P4|STARTED|Period 4||4
8282681|NCT01662778|20421848|P3|STARTED|Period 4||6
8282682|NCT01662778|20421849|P2|STARTED|Period 4||5
8282683|NCT01662778|20421850|P1|STARTED|Period 4||6
8282684|NCT01662778|20421847|P4|NOT COMPLETED|Period 3||0
8282685|NCT01662778|20421848|P3|NOT COMPLETED|Period 3||0
8282686|NCT01662778|20421849|P2|NOT COMPLETED|Period 3||0
8282687|NCT01662778|20421850|P1|NOT COMPLETED|Period 3||0
8282688|NCT01662778|20421847|P4|COMPLETED|Period 3||4
8282689|NCT01662778|20421848|P3|COMPLETED|Period 3||6
8282690|NCT01662778|20421849|P2|COMPLETED|Period 3||5
8282691|NCT01662778|20421850|P1|COMPLETED|Period 3||6
8282692|NCT01662778|20421847|P4|STARTED|Period 3||4
8282693|NCT01662778|20421848|P3|STARTED|Period 3||6
8282694|NCT01662778|20421849|P2|STARTED|Period 3||5
8282695|NCT01662778|20421850|P1|STARTED|Period 3||6
8282696|NCT01662778|20421847|P4|NOT COMPLETED|Period 2||0
8282697|NCT01662778|20421848|P3|NOT COMPLETED|Period 2||0
8282698|NCT01662778|20421849|P2|NOT COMPLETED|Period 2||0
8282699|NCT01662778|20421850|P1|NOT COMPLETED|Period 2||0
8282700|NCT01662778|20421847|P4|COMPLETED|Period 2||4
8282701|NCT01662778|20421848|P3|COMPLETED|Period 2||6
8282702|NCT01662778|20421849|P2|COMPLETED|Period 2||5
8282703|NCT01662778|20421850|P1|COMPLETED|Period 2||6
8282704|NCT01662778|20421847|P4|STARTED|Period 2||4
8282705|NCT01662778|20421848|P3|STARTED|Period 2||6
8282706|NCT01662778|20421849|P2|STARTED|Period 2||5
8282707|NCT01662778|20421850|P1|STARTED|Period 2||6
8282708|NCT01662778|20421847|P4|NOT COMPLETED|Period 1||0
8282709|NCT01662778|20421848|P3|NOT COMPLETED|Period 1||0
8282710|NCT01662778|20421849|P2|NOT COMPLETED|Period 1||0
8282711|NCT01662778|20421850|P1|NOT COMPLETED|Period 1||0
8282712|NCT01662778|20421847|P4|COMPLETED|Period 1||4
8282713|NCT01662778|20421848|P3|COMPLETED|Period 1||6
8282714|NCT01662778|20421849|P2|COMPLETED|Period 1||5
8282715|NCT01662778|20421850|P1|COMPLETED|Period 1||6
8282716|NCT01662778|20421847|P4|STARTED|Period 1||4
8282717|NCT01662778|20421848|P3|STARTED|Period 1||6
8282718|NCT01662778|20421849|P2|STARTED|Period 1||5
8282719|NCT01662778|20421850|P1|STARTED|Period 1||6
8282720|NCT01662765|20421874|P2|NOT COMPLETED|Overall Study||2
8282721|NCT01662765|20421875|P1|NOT COMPLETED|Overall Study||1
8282722|NCT01662765|20421874|P2|COMPLETED|Overall Study||40
8282723|NCT01662765|20421875|P1|COMPLETED|Overall Study||41
8282724|NCT01662765|20421874|P2|STARTED|Overall Study||42
8282725|NCT01662765|20421875|P1|STARTED|Overall Study||42
8282726|NCT01662752|20421887|P1|NOT COMPLETED|Overall Study||0
8282727|NCT01662752|20421887|P1|COMPLETED|Overall Study||30
8282728|NCT01662752|20421887|P1|STARTED|Overall Study||30
8282729|NCT01662648|20421895|P2|NOT COMPLETED|Overall Study||178
8282730|NCT01662648|20421896|P1|NOT COMPLETED|Overall Study||147
8282731|NCT01662648|20421895|P2|COMPLETED|Overall Study||419
8282732|NCT01662648|20421896|P1|COMPLETED|Overall Study||373
8282733|NCT01662648|20421895|P2|STARTED|Overall Study||597
8282734|NCT01662648|20421896|P1|STARTED|Overall Study||520
8282735|NCT01662635|20421918|P1|NOT COMPLETED|Overall Study||30
8282736|NCT01662635|20421918|P1|COMPLETED|Overall Study||200
8282737|NCT01662635|20421918|P1|STARTED|Overall Study||230
8282738|NCT01662583|20421927|P3|NOT COMPLETED|Overall Study||0
8282739|NCT01662583|20421928|P2|NOT COMPLETED|Overall Study||0
8282740|NCT01662583|20421929|P1|NOT COMPLETED|Overall Study||0
8282741|NCT01662583|20421927|P3|COMPLETED|Overall Study||219
8282742|NCT01662583|20421928|P2|COMPLETED|Overall Study||225
8282743|NCT01662583|20421929|P1|COMPLETED|Overall Study||216
8282744|NCT01662583|20421927|P3|STARTED|Overall Study||219
8282745|NCT01662583|20421928|P2|STARTED|Overall Study||225
8282746|NCT01662583|20421929|P1|STARTED|Overall Study||216
8282747|NCT01662531|20421942|P1|NOT COMPLETED|Overall Study||0
8282748|NCT01662531|20421942|P1|COMPLETED|Overall Study||27
8282749|NCT01662531|20421942|P1|STARTED|Overall Study||27
8282750|NCT01662505|20421969|P3|NOT COMPLETED|Overall Study||8
8282751|NCT01662505|20421970|P2|NOT COMPLETED|Overall Study||4
8282752|NCT01662505|20421971|P1|NOT COMPLETED|Overall Study||7
8282753|NCT01662505|20421969|P3|COMPLETED|Overall Study||0
8282754|NCT01662505|20421970|P2|COMPLETED|Overall Study||0
8282755|NCT01662505|20421971|P1|COMPLETED|Overall Study||0
8282756|NCT01662505|20421969|P3|STARTED|Overall Study||8
8282757|NCT01662505|20421970|P2|STARTED|Overall Study||4
8282758|NCT01662505|20421971|P1|STARTED|Overall Study||7
8282759|NCT01662492|20421995|P3|NOT COMPLETED|Overall Study||6
8282760|NCT01662492|20421996|P2|NOT COMPLETED|Overall Study||1
8282761|NCT01662492|20421997|P1|NOT COMPLETED|Overall Study||3
8282762|NCT01662492|20421995|P3|COMPLETED|Overall Study||31
8282763|NCT01662492|20421996|P2|COMPLETED|Overall Study||42
8282764|NCT01662492|20421997|P1|COMPLETED|Overall Study||42
8282765|NCT01662492|20421995|P3|STARTED|Overall Study||37
8282766|NCT01662492|20421996|P2|STARTED|Overall Study||43
8282767|NCT01662492|20421997|P1|STARTED|Overall Study||45
8282768|NCT01662440|20422021|P4|NOT COMPLETED|Overall Study||4
8282769|NCT01662440|20422022|P3|NOT COMPLETED|Overall Study||6
8282770|NCT01662440|20422023|P2|NOT COMPLETED|Overall Study||6
8282771|NCT01662440|20422024|P1|NOT COMPLETED|Overall Study||9
8282772|NCT01662440|20422021|P4|COMPLETED|Overall Study||52
8282773|NCT01662440|20422022|P3|COMPLETED|Overall Study||215
8282774|NCT01662440|20422023|P2|COMPLETED|Overall Study||211
8282775|NCT01662440|20422024|P1|COMPLETED|Overall Study||158
8282776|NCT01662440|20422021|P4|STARTED|Overall Study||56
8282777|NCT01662440|20422022|P3|STARTED|Overall Study||221
8282778|NCT01662440|20422023|P2|STARTED|Overall Study||217
8282779|NCT01662440|20422024|P1|STARTED|Overall Study||167
8282780|NCT01662362|20422072|P1|NOT COMPLETED|Overall Study||38
8282781|NCT01662362|20422072|P1|COMPLETED|Overall Study||25
8282782|NCT01662362|20422072|P1|STARTED|Overall Study||63
8282783|NCT01662336|20422077|P1|NOT COMPLETED|Overall Study||66
8282784|NCT01662336|20422077|P1|COMPLETED|Overall Study||107
8282785|NCT01662336|20422077|P1|Completed Month 12 Visit|Overall Study||109
8282786|NCT01662336|20422077|P1|Completed Month 6 Visit|Overall Study||142
8282787|NCT01662336|20422077|P1|STARTED|Overall Study||173
8282788|NCT01662310|20422103|P5|NOT COMPLETED|Open-Label Extension Phase||10
8282789|NCT01662310|20422104|P4|NOT COMPLETED|Open-Label Extension Phase||11
8282790|NCT01662310|20422105|P3|NOT COMPLETED|Open-Label Extension Phase||0
8282791|NCT01662310|20422106|P2|NOT COMPLETED|Open-Label Extension Phase||0
8282792|NCT01662310|20422107|P1|NOT COMPLETED|Open-Label Extension Phase||0
8282793|NCT01662310|20422103|P5|COMPLETED|Open-Label Extension Phase||49
8282794|NCT01662310|20422104|P4|COMPLETED|Open-Label Extension Phase||36
8282795|NCT01662310|20422105|P3|COMPLETED|Open-Label Extension Phase||0
8282796|NCT01662310|20422106|P2|COMPLETED|Open-Label Extension Phase||0
8282797|NCT01662310|20422107|P1|COMPLETED|Open-Label Extension Phase||0
8282798|NCT01662310|20422103|P5|STARTED|Open-Label Extension Phase||59
8282799|NCT01662310|20422104|P4|STARTED|Open-Label Extension Phase||47
8282800|NCT01662310|20422105|P3|STARTED|Open-Label Extension Phase||0
8282801|NCT01662310|20422106|P2|STARTED|Open-Label Extension Phase||0
8282802|NCT01662310|20422107|P1|STARTED|Open-Label Extension Phase||0
8282803|NCT01662310|20422103|P5|NOT COMPLETED|Double-Blind Phase||0
8282804|NCT01662310|20422104|P4|NOT COMPLETED|Double-Blind Phase||0
8282805|NCT01662310|20422105|P3|NOT COMPLETED|Double-Blind Phase||5
8282806|NCT01662310|20422106|P2|NOT COMPLETED|Double-Blind Phase||15
8282807|NCT01662310|20422107|P1|NOT COMPLETED|Double-Blind Phase||0
8282808|NCT01662310|20422103|P5|COMPLETED|Double-Blind Phase||0
8282809|NCT01662310|20422104|P4|COMPLETED|Double-Blind Phase||0
8282810|NCT01662310|20422105|P3|COMPLETED|Double-Blind Phase||66
8282811|NCT01662310|20422106|P2|COMPLETED|Double-Blind Phase||50
8282812|NCT01662310|20422107|P1|COMPLETED|Double-Blind Phase||0
8282813|NCT01662310|20422103|P5|Treated|Double-Blind Phase||0
8282814|NCT01662310|20422104|P4|Treated|Double-Blind Phase||0
8282815|NCT01662310|20422105|P3|Treated|Double-Blind Phase||71
8282816|NCT01662310|20422106|P2|Treated|Double-Blind Phase||64
8282817|NCT01662310|20422107|P1|Treated|Double-Blind Phase||0
8282818|NCT01662310|20422103|P5|STARTED|Double-Blind Phase||0
8282819|NCT01662310|20422104|P4|STARTED|Double-Blind Phase||0
8282820|NCT01662310|20422105|P3|STARTED|Double-Blind Phase||71
8282821|NCT01662310|20422106|P2|STARTED|Double-Blind Phase||65
8282822|NCT01662310|20422107|P1|STARTED|Double-Blind Phase||0
8282823|NCT01662310|20422103|P5|NOT COMPLETED|Run-In or Stabilization Phase||0
8282824|NCT01662310|20422104|P4|NOT COMPLETED|Run-In or Stabilization Phase||0
8282825|NCT01662310|20422105|P3|NOT COMPLETED|Run-In or Stabilization Phase||0
8282826|NCT01662310|20422106|P2|NOT COMPLETED|Run-In or Stabilization Phase||0
8282827|NCT01662310|20422107|P1|NOT COMPLETED|Run-In or Stabilization Phase||65
8282828|NCT01662310|20422103|P5|COMPLETED|Run-In or Stabilization Phase||0
8282829|NCT01662310|20422104|P4|COMPLETED|Run-In or Stabilization Phase||0
8282830|NCT01662310|20422105|P3|COMPLETED|Run-In or Stabilization Phase||0
8282831|NCT01662310|20422106|P2|COMPLETED|Run-In or Stabilization Phase||0
8282832|NCT01662310|20422107|P1|COMPLETED|Run-In or Stabilization Phase||136
8282833|NCT01662310|20422103|P5|STARTED|Run-In or Stabilization Phase||0
8282834|NCT01662310|20422104|P4|STARTED|Run-In or Stabilization Phase||0
8282835|NCT01662310|20422105|P3|STARTED|Run-In or Stabilization Phase||0
8282836|NCT01662310|20422106|P2|STARTED|Run-In or Stabilization Phase||0
8282837|NCT01662310|20422107|P1|STARTED|Run-In or Stabilization Phase||201
8282838|NCT01662297|20422141|P2|NOT COMPLETED|Overall Study||0
8282839|NCT01662297|20422142|P1|NOT COMPLETED|Overall Study||0
8282840|NCT01662297|20422141|P2|COMPLETED|Overall Study||1
8282841|NCT01662297|20422142|P1|COMPLETED|Overall Study||0
8282842|NCT01662297|20422141|P2|STARTED|Overall Study||1
8282843|NCT01662297|20422142|P1|STARTED|Overall Study||0
8282844|NCT01662115|20422167|P3|NOT COMPLETED|Overall Study||0
8282845|NCT01662115|20422168|P2|NOT COMPLETED|Overall Study||0
8282846|NCT01662115|20422169|P1|NOT COMPLETED|Overall Study||0
8282847|NCT01662115|20422167|P3|COMPLETED|Overall Study||0
8282848|NCT01662115|20422168|P2|COMPLETED|Overall Study||2
8282849|NCT01662115|20422169|P1|COMPLETED|Overall Study||2
8282850|NCT01662115|20422167|P3|STARTED|Overall Study||0
8282851|NCT01662115|20422168|P2|STARTED|Overall Study||2
8282852|NCT01662115|20422169|P1|STARTED|Overall Study||2
8282853|NCT01662102|20422188|P2|NOT COMPLETED|Overall Study||0
8282854|NCT01662102|20422189|P1|NOT COMPLETED|Overall Study||1
8282855|NCT01662102|20422188|P2|COMPLETED|Overall Study||0
8282856|NCT01662102|20422189|P1|COMPLETED|Overall Study||0
8282857|NCT01662102|20422188|P2|STARTED|Overall Study||0
8282858|NCT01662102|20422189|P1|STARTED|Overall Study||1
8282859|NCT01662063|20422197|P3|NOT COMPLETED|Overall Study||1
8282860|NCT01662063|20422198|P2|NOT COMPLETED|Overall Study||29
8282861|NCT01662063|20422199|P1|NOT COMPLETED|Overall Study||5
8282862|NCT01662063|20422197|P3|COMPLETED|Overall Study||0
8282863|NCT01662063|20422198|P2|COMPLETED|Overall Study||144
8282864|NCT01662063|20422199|P1|COMPLETED|Overall Study||39
8282865|NCT01662063|20422197|P3|STARTED|Overall Study||1
8282866|NCT01662063|20422198|P2|STARTED|Overall Study||173
8282867|NCT01662063|20422199|P1|STARTED|Overall Study||44
8282868|NCT01662024|20422278|P1|NOT COMPLETED|Overall Study||5
8282869|NCT01662024|20422278|P1|COMPLETED|Overall Study||15
8282870|NCT01662024|20422278|P1|STARTED|Overall Study||20
8282871|NCT01661972|20422290|P2|NOT COMPLETED|Overall Study||4
8282872|NCT01661972|20422291|P1|NOT COMPLETED|Overall Study||2
8282873|NCT01661972|20422290|P2|COMPLETED|Overall Study||46
8282874|NCT01661972|20422291|P1|COMPLETED|Overall Study||11
8282875|NCT01661972|20422290|P2|STARTED|Overall Study||50
8282876|NCT01661972|20422291|P1|STARTED|Overall Study||13
8282877|NCT01661946|20422303|P2|NOT COMPLETED|Overall Study||0
8282878|NCT01661946|20422304|P1|NOT COMPLETED|Overall Study||0
8282879|NCT01661946|20422303|P2|COMPLETED|Overall Study||5
8282880|NCT01661946|20422304|P1|COMPLETED|Overall Study||5
8282881|NCT01661946|20422303|P2|STARTED|Overall Study||5
8282882|NCT01661946|20422304|P1|STARTED|Overall Study||5
8282883|NCT01661933|20422310|P1|NOT COMPLETED|High-dose Gluten Challenge||2
8282884|NCT01661933|20422310|P1|COMPLETED|High-dose Gluten Challenge||8
8282885|NCT01661933|20422310|P1|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
8282886|NCT01661933|20422310|P1|NOT COMPLETED|Low-dose Gluten Challenge||2
8282887|NCT01661933|20422310|P1|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
8282888|NCT01661933|20422310|P1|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
8282889|NCT01661933|20422310|P1|NOT COMPLETED|Gluten Micro-challenge||0
8282890|NCT01661933|20422310|P1|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
8282891|NCT01661933|20422310|P1|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
8282895|NCT01661790|20422325|P2|NOT COMPLETED|Overall Study||2
8282896|NCT01661790|20422326|P1|NOT COMPLETED|Overall Study||0
8282897|NCT01661790|20422325|P2|COMPLETED|Overall Study||34
8282898|NCT01661790|20422326|P1|COMPLETED|Overall Study||36
8282899|NCT01661790|20422325|P2|STARTED|Overall Study||36
8282900|NCT01661790|20422326|P1|STARTED|Overall Study||36
8282901|NCT01661764|20422338|P6|NOT COMPLETED|Overall Study||2
8282902|NCT01661764|20422339|P5|NOT COMPLETED|Overall Study||3
8282903|NCT01661764|20422340|P4|NOT COMPLETED|Overall Study||2
8282904|NCT01661764|20422341|P3|NOT COMPLETED|Overall Study||3
8282905|NCT01661764|20422342|P2|NOT COMPLETED|Overall Study||5
8282906|NCT01661764|20422343|P1|NOT COMPLETED|Overall Study||2
8282907|NCT01661764|20422338|P6|COMPLETED|Overall Study||18
8282908|NCT01661764|20422339|P5|COMPLETED|Overall Study||16
8282909|NCT01661764|20422340|P4|COMPLETED|Overall Study||24
8282910|NCT01661764|20422341|P3|COMPLETED|Overall Study||22
8282911|NCT01661764|20422342|P2|COMPLETED|Overall Study||20
8282912|NCT01661764|20422343|P1|COMPLETED|Overall Study||24
8282913|NCT01661764|20422338|P6|STARTED|Overall Study||20
8282914|NCT01661764|20422339|P5|STARTED|Overall Study||19
8282915|NCT01661764|20422340|P4|STARTED|Overall Study||26
8282916|NCT01661764|20422341|P3|STARTED|Overall Study||25
8282917|NCT01661764|20422342|P2|STARTED|Overall Study||25
8282918|NCT01661764|20422343|P1|STARTED|Overall Study||26
8282919|NCT01661712|20422407|P2|NOT COMPLETED|Overall Study||0
8282920|NCT01661712|20422408|P1|NOT COMPLETED|Overall Study||0
8282921|NCT01661712|20422407|P2|COMPLETED|Overall Study|sham stimulation night|18
8282922|NCT01661712|20422408|P1|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
8282923|NCT01661712|20422407|P2|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
8282924|NCT01661712|20422408|P1|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
8282925|NCT01661712|20422407|P2|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
8282926|NCT01661712|20422408|P1|STARTED|Overall Study|initial sham stimulation night|18
8282927|NCT01661686|20422426|P2|NOT COMPLETED|Overall Study||2
8282928|NCT01661686|20422427|P1|NOT COMPLETED|Overall Study||2
8282929|NCT01661686|20422426|P2|COMPLETED|Overall Study||47
8282930|NCT01661686|20422427|P1|COMPLETED|Overall Study||47
8282931|NCT01661686|20422426|P2|STARTED|Overall Study||49
8282932|NCT01661686|20422427|P1|STARTED|Overall Study||49
8282933|NCT01661621|20422443|P2|NOT COMPLETED|Overall Study||0
8282934|NCT01661621|20422444|P1|NOT COMPLETED|Overall Study||0
8282935|NCT01661621|20422443|P2|COMPLETED|Overall Study||279
8282936|NCT01661621|20422444|P1|COMPLETED|Overall Study||116
8282937|NCT01661621|20422443|P2|STARTED|Overall Study||279
8282938|NCT01661621|20422444|P1|STARTED|Overall Study||116
8282939|NCT01661595|20422468|P4|NOT COMPLETED|Phase 2: Week 5-8.||0
8282940|NCT01661595|20422469|P3|NOT COMPLETED|Phase 2: Week 5-8.||1
8282941|NCT01661595|20422470|P2|NOT COMPLETED|Phase 2: Week 5-8.||0
8282942|NCT01661595|20422471|P1|NOT COMPLETED|Phase 2: Week 5-8.||0
8282943|NCT01661595|20422468|P4|COMPLETED|Phase 2: Week 5-8.||4
8282944|NCT01661595|20422469|P3|COMPLETED|Phase 2: Week 5-8.||4
8282945|NCT01661595|20422470|P2|COMPLETED|Phase 2: Week 5-8.||4
8282946|NCT01661595|20422471|P1|COMPLETED|Phase 2: Week 5-8.||4
8282947|NCT01661595|20422468|P4|STARTED|Phase 2: Week 5-8.||4
8282948|NCT01661595|20422469|P3|STARTED|Phase 2: Week 5-8.||5
8282949|NCT01661595|20422470|P2|STARTED|Phase 2: Week 5-8.||4
8282950|NCT01661595|20422471|P1|STARTED|Phase 2: Week 5-8.||4
8282951|NCT01661595|20422468|P4|NOT COMPLETED|Phase 1: Week 0-4||0
8282952|NCT01661595|20422469|P3|NOT COMPLETED|Phase 1: Week 0-4||0
8282953|NCT01661595|20422470|P2|NOT COMPLETED|Phase 1: Week 0-4||0
8282954|NCT01661595|20422471|P1|NOT COMPLETED|Phase 1: Week 0-4||1
8282955|NCT01661595|20422468|P4|COMPLETED|Phase 1: Week 0-4||4
8282956|NCT01661595|20422469|P3|COMPLETED|Phase 1: Week 0-4||5
8282957|NCT01661595|20422470|P2|COMPLETED|Phase 1: Week 0-4||4
8282958|NCT01661595|20422471|P1|COMPLETED|Phase 1: Week 0-4||4
8282959|NCT01661595|20422468|P4|STARTED|Phase 1: Week 0-4||4
8282960|NCT01661595|20422469|P3|STARTED|Phase 1: Week 0-4||5
8282961|NCT01661595|20422470|P2|STARTED|Phase 1: Week 0-4||4
8282962|NCT01661595|20422471|P1|STARTED|Phase 1: Week 0-4||5
8282963|NCT01661283|20422576|P1|NOT COMPLETED|Overall Study||0
8282964|NCT01661283|20422576|P1|COMPLETED|Overall Study||25
8282965|NCT01661283|20422576|P1|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25
8282966|NCT01661270|20422587|P2|NOT COMPLETED|Overall Study||0
8282967|NCT01661270|20422588|P1|NOT COMPLETED|Overall Study||0
8282968|NCT01661270|20422587|P2|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
8282969|NCT01661270|20422588|P1|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
8282970|NCT01661270|20422587|P2|Other Reasons|Overall Study||2
8282971|NCT01661270|20422588|P1|Other Reasons|Overall Study||0
8282972|NCT01661270|20422587|P2|Participant's Request|Overall Study|Met EOT criteria|48
8282973|NCT01661270|20422588|P1|Participant's Request|Overall Study|Met EOT criteria|15
8282974|NCT01661270|20422587|P2|Physician Decision|Overall Study|Met EOT criteria|8
8282975|NCT01661270|20422588|P1|Physician Decision|Overall Study|Met EOT criteria|1
8282976|NCT01661270|20422587|P2|Disease Progression|Overall Study|Met EOT criteria|118
8282977|NCT01661270|20422588|P1|Disease Progression|Overall Study|Met EOT criteria|67
8282978|NCT01661270|20422587|P2|Adverse Event|Overall Study|Met EOT criteria|47
8282979|NCT01661270|20422588|P1|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
8282980|NCT01661270|20422587|P2|STARTED|Overall Study||223
8282981|NCT01661270|20422588|P1|STARTED|Overall Study||109
8282982|NCT01661205|20422599|P1|NOT COMPLETED|Overall Study||2
8282983|NCT01661205|20422599|P1|COMPLETED|Overall Study||24
8282984|NCT01661205|20422599|P1|STARTED|Overall Study||26
8282985|NCT01661179|20422610|P1|NOT COMPLETED|Overall Study||6
8282986|NCT01661179|20422610|P1|COMPLETED|Overall Study||8
8282987|NCT01661179|20422610|P1|STARTED|Overall Study||14
8282988|NCT01661140|20422614|P3|NOT COMPLETED|Double-Blind Period||50
8282989|NCT01661140|20422615|P2|NOT COMPLETED|Double-Blind Period||41
8282990|NCT01661140|20422616|P1|NOT COMPLETED|Double-Blind Period||0
8282991|NCT01661140|20422614|P3|COMPLETED|Double-Blind Period||86
8282992|NCT01661140|20422615|P2|COMPLETED|Double-Blind Period||95
8282993|NCT01661140|20422616|P1|COMPLETED|Double-Blind Period||0
8282994|NCT01661140|20422614|P3|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
8282995|NCT01661140|20422615|P2|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
8282996|NCT01661140|20422616|P1|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
8282997|NCT01661140|20422614|P3|NOT COMPLETED|Open-Label Period||0
8282998|NCT01661140|20422615|P2|NOT COMPLETED|Open-Label Period||0
8282999|NCT01661140|20422616|P1|NOT COMPLETED|Open-Label Period||76
8283000|NCT01661140|20422614|P3|COMPLETED|Open-Label Period||0
8283001|NCT01661140|20422615|P2|COMPLETED|Open-Label Period||0
8283002|NCT01661140|20422616|P1|COMPLETED|Open-Label Period||351
8283003|NCT01661140|20422614|P3|STARTED|Open-Label Period||0
8283004|NCT01661140|20422615|P2|STARTED|Open-Label Period||0
8283005|NCT01661140|20422616|P1|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
8283006|NCT01661114|20422657|P1|NOT COMPLETED|Overall Study||0
8283007|NCT01661114|20422657|P1|COMPLETED|Overall Study||39
8283008|NCT01661114|20422657|P1|STARTED|Overall Study||39
8283009|NCT01661088|20422662|P1|NOT COMPLETED|IMRT With FDR Gemcitabine||2
8283010|NCT01661088|20422662|P1|COMPLETED|IMRT With FDR Gemcitabine||19
8283011|NCT01661088|20422662|P1|STARTED|IMRT With FDR Gemcitabine||21
8283012|NCT01661088|20422662|P1|NOT COMPLETED|FOLFIRINOX||4
8283013|NCT01661088|20422662|P1|COMPLETED|FOLFIRINOX||21
8283014|NCT01661088|20422662|P1|STARTED|FOLFIRINOX||25
8283015|NCT01661062|20422668|P1|NOT COMPLETED|Overall Study||5
8283016|NCT01661062|20422668|P1|COMPLETED|Overall Study||18
8283017|NCT01661062|20422668|P1|STARTED|Overall Study||23
8283018|NCT01660906|20422673|P1|NOT COMPLETED|Overall Study||3
8283019|NCT01660906|20422673|P1|COMPLETED|Overall Study||36
8283020|NCT01660906|20422673|P1|STARTED|Overall Study||39
8283021|NCT01660893|20422685|P3|NOT COMPLETED|Overall Study||0
8283022|NCT01660893|20422686|P2|NOT COMPLETED|Overall Study||0
8283023|NCT01660893|20422687|P1|NOT COMPLETED|Overall Study||0
8283024|NCT01660893|20422685|P3|COMPLETED|Overall Study||6
8283025|NCT01660893|20422686|P2|COMPLETED|Overall Study||10
8283026|NCT01660893|20422687|P1|COMPLETED|Overall Study||10
8283027|NCT01660893|20422685|P3|STARTED|Overall Study||6
8283028|NCT01660893|20422686|P2|STARTED|Overall Study||10
8283029|NCT01660893|20422687|P1|STARTED|Overall Study||10
8283030|NCT01660815|20422734|P1|NOT COMPLETED|Overall Study||0
8283031|NCT01660815|20422734|P1|COMPLETED|Overall Study||7
8283032|NCT01660815|20422734|P1|STARTED|Overall Study||7
8283033|NCT01660802|20422741|P2|NOT COMPLETED|Overall Study||11
8283034|NCT01660802|20422742|P1|NOT COMPLETED|Overall Study||4
8283035|NCT01660802|20422741|P2|COMPLETED|Overall Study||121
8283036|NCT01660802|20422742|P1|COMPLETED|Overall Study||126
8283037|NCT01660802|20422741|P2|STARTED|Overall Study||132
8283038|NCT01660802|20422742|P1|STARTED|Overall Study||130
8283039|NCT01660763|20422756|P2|NOT COMPLETED|Overall Study||61
8283040|NCT01660763|20422757|P1|NOT COMPLETED|Overall Study||100
8283041|NCT01660763|20422756|P2|COMPLETED|Overall Study||43
8283042|NCT01660763|20422757|P1|COMPLETED|Overall Study||215
8283043|NCT01660763|20422756|P2|STARTED|Overall Study||104
8283044|NCT01660763|20422757|P1|STARTED|Overall Study||315
8283048|NCT01660698|20422780|P2|NOT COMPLETED|Overall Study||0
8283049|NCT01660698|20422781|P1|NOT COMPLETED|Overall Study||0
8283050|NCT01660698|20422780|P2|COMPLETED|Overall Study||10
8283051|NCT01660698|20422781|P1|COMPLETED|Overall Study||10
8283052|NCT01660698|20422780|P2|STARTED|Overall Study||10
8283053|NCT01660698|20422781|P1|STARTED|Overall Study||10
8283054|NCT01660672|20422791|P1|NOT COMPLETED|Overall Study||0
8283055|NCT01660672|20422791|P1|COMPLETED|Overall Study||7
8283056|NCT01660672|20422791|P1|STARTED|Overall Study||7
8283066|NCT01660412|20422835|P2|NOT COMPLETED|Overall Study||3
8283067|NCT01660412|20422836|P1|NOT COMPLETED|Overall Study||0
8283068|NCT01660412|20422835|P2|COMPLETED|Overall Study||28
8283069|NCT01660412|20422836|P1|COMPLETED|Overall Study||29
8283070|NCT01660412|20422835|P2|Injection 4|Overall Study||31
8283071|NCT01660412|20422836|P1|Injection 4|Overall Study||29
8283072|NCT01660412|20422835|P2|Injection 3|Overall Study||31
8283073|NCT01660412|20422836|P1|Injection 3|Overall Study||29
8283074|NCT01660412|20422835|P2|Injection 2|Overall Study||31
8283075|NCT01660412|20422836|P1|Injection 2|Overall Study||29
8283076|NCT01660412|20422835|P2|Injection 1|Overall Study||31
8283077|NCT01660412|20422836|P1|Injection 1|Overall Study||29
8283078|NCT01660412|20422835|P2|Other|Overall Study||4
8283079|NCT01660412|20422836|P1|Other|Overall Study||2
8283080|NCT01660412|20422835|P2|Appendicular Structures|Overall Study||11
8283081|NCT01660412|20422836|P1|Appendicular Structures|Overall Study||17
8283082|NCT01660412|20422835|P2|Thorax|Overall Study||9
8283083|NCT01660412|20422836|P1|Thorax|Overall Study||9
8283084|NCT01660412|20422835|P2|Head|Overall Study||4
8283085|NCT01660412|20422836|P1|Head|Overall Study||1
8283086|NCT01660412|20422835|P2|STARTED|Overall Study||31
8283087|NCT01660412|20422836|P1|STARTED|Overall Study||29
8283088|NCT01660334|20422842|P1|NOT COMPLETED|Overall Study||1
8283089|NCT01660334|20422842|P1|COMPLETED|Overall Study||12
8283090|NCT01660334|20422842|P1|STARTED|Overall Study||13
8283091|NCT01660321|20422847|P1|NOT COMPLETED|Overall Study||0
8283092|NCT01660321|20422847|P1|COMPLETED|Overall Study||26
8283093|NCT01660321|20422847|P1|STARTED|Overall Study||26
8283094|NCT01660230|20422871|P12|NOT COMPLETED|Overall Study||0
8283095|NCT01660230|20422872|P11|NOT COMPLETED|Overall Study||0
8283096|NCT01660230|20422873|P10|NOT COMPLETED|Overall Study||0
8283097|NCT01660230|20422874|P9|NOT COMPLETED|Overall Study||0
8283098|NCT01660230|20422875|P8|NOT COMPLETED|Overall Study||0
8283099|NCT01660230|20422876|P7|NOT COMPLETED|Overall Study||0
8283100|NCT01660230|20422877|P6|NOT COMPLETED|Overall Study||0
8283101|NCT01660230|20422878|P5|NOT COMPLETED|Overall Study||0
8283102|NCT01660230|20422879|P4|NOT COMPLETED|Overall Study||0
8283103|NCT01660230|20422880|P3|NOT COMPLETED|Overall Study||0
8283104|NCT01660230|20422881|P2|NOT COMPLETED|Overall Study||0
8283105|NCT01660230|20422882|P1|NOT COMPLETED|Overall Study||0
8283106|NCT01660230|20422871|P12|COMPLETED|Overall Study||14
8283107|NCT01660230|20422872|P11|COMPLETED|Overall Study||6
8283108|NCT01660230|20422873|P10|COMPLETED|Overall Study||6
8283109|NCT01660230|20422874|P9|COMPLETED|Overall Study||6
8283110|NCT01660230|20422875|P8|COMPLETED|Overall Study||6
8283111|NCT01660230|20422876|P7|COMPLETED|Overall Study||4
8283112|NCT01660230|20422877|P6|COMPLETED|Overall Study||2
8283113|NCT01660230|20422878|P5|COMPLETED|Overall Study||4
8283114|NCT01660230|20422879|P4|COMPLETED|Overall Study||4
8283115|NCT01660230|20422880|P3|COMPLETED|Overall Study||4
8283116|NCT01660230|20422881|P2|COMPLETED|Overall Study||4
8283117|NCT01660230|20422882|P1|COMPLETED|Overall Study||4
8283118|NCT01660230|20422871|P12|STARTED|Overall Study||14
8283119|NCT01660230|20422872|P11|STARTED|Overall Study||6
8283120|NCT01660230|20422873|P10|STARTED|Overall Study||6
8283121|NCT01660230|20422874|P9|STARTED|Overall Study||6
8283122|NCT01660230|20422875|P8|STARTED|Overall Study||6
8283123|NCT01660230|20422876|P7|STARTED|Overall Study||4
8283124|NCT01660230|20422877|P6|STARTED|Overall Study||2
8283125|NCT01660230|20422878|P5|STARTED|Overall Study||4
8283126|NCT01660230|20422879|P4|STARTED|Overall Study||4
8283127|NCT01660230|20422880|P3|STARTED|Overall Study||4
8283128|NCT01660230|20422881|P2|STARTED|Overall Study||4
8283129|NCT01660230|20422882|P1|STARTED|Overall Study||4
8283130|NCT01660191|20423054|P3|NOT COMPLETED|End of Treatment||1
8283131|NCT01660191|20423055|P2|NOT COMPLETED|End of Treatment||6
8283132|NCT01660191|20423056|P1|NOT COMPLETED|End of Treatment||1
8283133|NCT01660191|20423054|P3|COMPLETED|End of Treatment||43
8283134|NCT01660191|20423055|P2|COMPLETED|End of Treatment||39
8283135|NCT01660191|20423056|P1|COMPLETED|End of Treatment||44
8283136|NCT01660191|20423054|P3|STARTED|End of Treatment||44
8283137|NCT01660191|20423055|P2|STARTED|End of Treatment||45
8283138|NCT01660191|20423056|P1|STARTED|End of Treatment||45
8283139|NCT01660191|20423054|P3|NOT COMPLETED|Randomization||0
8283140|NCT01660191|20423055|P2|NOT COMPLETED|Randomization||0
8283141|NCT01660191|20423056|P1|NOT COMPLETED|Randomization||0
8283142|NCT01660191|20423054|P3|COMPLETED|Randomization||44
8283143|NCT01660191|20423055|P2|COMPLETED|Randomization||45
8283144|NCT01660191|20423056|P1|COMPLETED|Randomization||45
8283145|NCT01660191|20423054|P3|STARTED|Randomization||44
8283146|NCT01660191|20423055|P2|STARTED|Randomization||45
8283147|NCT01660191|20423056|P1|STARTED|Randomization||45
8283148|NCT01660191|20423054|P3|NOT COMPLETED|Enrollment and Washout||0
8283149|NCT01660191|20423055|P2|NOT COMPLETED|Enrollment and Washout||0
8283150|NCT01660191|20423056|P1|NOT COMPLETED|Enrollment and Washout||0
8283151|NCT01660191|20423054|P3|COMPLETED|Enrollment and Washout||44
8283152|NCT01660191|20423055|P2|COMPLETED|Enrollment and Washout||45
8283153|NCT01660191|20423056|P1|COMPLETED|Enrollment and Washout||45
8283154|NCT01660191|20423054|P3|STARTED|Enrollment and Washout||44
8283155|NCT01660191|20423055|P2|STARTED|Enrollment and Washout||45
8283156|NCT01660191|20423056|P1|STARTED|Enrollment and Washout||45
8283157|NCT01660022|20423085|P6|NOT COMPLETED|Second Sequence (42 Days)||0
8283158|NCT01660022|20423086|P5|NOT COMPLETED|Second Sequence (42 Days)||0
8283159|NCT01660022|20423087|P4|NOT COMPLETED|Second Sequence (42 Days)||0
8283160|NCT01660022|20423088|P3|NOT COMPLETED|Second Sequence (42 Days)||0
8283161|NCT01660022|20423089|P2|NOT COMPLETED|Second Sequence (42 Days)||0
8283162|NCT01660022|20423090|P1|NOT COMPLETED|Second Sequence (42 Days)||0
8283163|NCT01660022|20423085|P6|COMPLETED|Second Sequence (42 Days)||16
8283164|NCT01660022|20423086|P5|COMPLETED|Second Sequence (42 Days)||6
8283165|NCT01660022|20423087|P4|COMPLETED|Second Sequence (42 Days)||7
8283166|NCT01660022|20423088|P3|COMPLETED|Second Sequence (42 Days)||8
8283167|NCT01660022|20423089|P2|COMPLETED|Second Sequence (42 Days)||7
8283168|NCT01660022|20423090|P1|COMPLETED|Second Sequence (42 Days)||8
8283169|NCT01660022|20423085|P6|STARTED|Second Sequence (42 Days)||16
8283170|NCT01660022|20423086|P5|STARTED|Second Sequence (42 Days)||6
8283171|NCT01660022|20423087|P4|STARTED|Second Sequence (42 Days)||7
8283172|NCT01660022|20423088|P3|STARTED|Second Sequence (42 Days)||8
8283173|NCT01660022|20423089|P2|STARTED|Second Sequence (42 Days)||7
8283174|NCT01660022|20423090|P1|STARTED|Second Sequence (42 Days)||8
8283175|NCT01660022|20423085|P6|NOT COMPLETED|First Sequence (7 Days)||4
8283176|NCT01660022|20423086|P5|NOT COMPLETED|First Sequence (7 Days)||1
8283177|NCT01660022|20423087|P4|NOT COMPLETED|First Sequence (7 Days)||1
8283178|NCT01660022|20423088|P3|NOT COMPLETED|First Sequence (7 Days)||0
8283179|NCT01660022|20423089|P2|NOT COMPLETED|First Sequence (7 Days)||1
8283180|NCT01660022|20423090|P1|NOT COMPLETED|First Sequence (7 Days)||0
8283181|NCT01660022|20423085|P6|COMPLETED|First Sequence (7 Days)||16
8283182|NCT01660022|20423086|P5|COMPLETED|First Sequence (7 Days)||6
8283183|NCT01660022|20423087|P4|COMPLETED|First Sequence (7 Days)||7
8283184|NCT01660022|20423088|P3|COMPLETED|First Sequence (7 Days)||8
8283185|NCT01660022|20423089|P2|COMPLETED|First Sequence (7 Days)||7
8283186|NCT01660022|20423090|P1|COMPLETED|First Sequence (7 Days)||8
8283187|NCT01660022|20423085|P6|STARTED|First Sequence (7 Days)||20
8283188|NCT01660022|20423086|P5|STARTED|First Sequence (7 Days)||7
8283189|NCT01660022|20423087|P4|STARTED|First Sequence (7 Days)||8
8283190|NCT01660022|20423088|P3|STARTED|First Sequence (7 Days)||8
8283191|NCT01660022|20423089|P2|STARTED|First Sequence (7 Days)||8
8283192|NCT01660022|20423090|P1|STARTED|First Sequence (7 Days)||8
8283193|NCT01659996|20423149|P3|NOT COMPLETED|Overall Study||11
8283194|NCT01659996|20423150|P2|NOT COMPLETED|Overall Study||7
8283195|NCT01659996|20423151|P1|NOT COMPLETED|Overall Study||8
8283196|NCT01659996|20423149|P3|COMPLETED|Overall Study||461
8283197|NCT01659996|20423150|P2|COMPLETED|Overall Study||388
8283198|NCT01659996|20423151|P1|COMPLETED|Overall Study||413
8283199|NCT01659996|20423149|P3|STARTED|Overall Study||472
8283200|NCT01659996|20423150|P2|STARTED|Overall Study||395
8283201|NCT01659996|20423151|P1|STARTED|Overall Study||421
8283202|NCT01659866|20423185|P2|NOT COMPLETED|Overall Study||0
8283203|NCT01659866|20423186|P1|NOT COMPLETED|Overall Study||0
8283204|NCT01659866|20423185|P2|COMPLETED|Overall Study||80
8283205|NCT01659866|20423186|P1|COMPLETED|Overall Study||430
8283206|NCT01659866|20423185|P2|STARTED|Overall Study||80
8283207|NCT01659866|20423186|P1|STARTED|Overall Study||430
8283208|NCT01659853|20423192|P2|NOT COMPLETED|Treatment Period 2||0
8283209|NCT01659853|20423193|P1|NOT COMPLETED|Treatment Period 2||0
8283210|NCT01659853|20423192|P2|COMPLETED|Treatment Period 2||35
8283211|NCT01659853|20423193|P1|COMPLETED|Treatment Period 2||33
8283212|NCT01659853|20423192|P2|STARTED|Treatment Period 2||35
8283213|NCT01659853|20423193|P1|STARTED|Treatment Period 2||33
8283214|NCT01659853|20423192|P2|NOT COMPLETED|Washout , 3 to 7 Days||0
8283215|NCT01659853|20423193|P1|NOT COMPLETED|Washout , 3 to 7 Days||2
8283216|NCT01659853|20423192|P2|COMPLETED|Washout , 3 to 7 Days||35
8283217|NCT01659853|20423193|P1|COMPLETED|Washout , 3 to 7 Days||33
8283218|NCT01659853|20423192|P2|STARTED|Washout , 3 to 7 Days||35
8283219|NCT01659853|20423193|P1|STARTED|Washout , 3 to 7 Days||35
8283220|NCT01659853|20423192|P2|NOT COMPLETED|Treatment Period 1||0
8283221|NCT01659853|20423193|P1|NOT COMPLETED|Treatment Period 1||0
8283222|NCT01659853|20423192|P2|COMPLETED|Treatment Period 1||35
8283223|NCT01659853|20423193|P1|COMPLETED|Treatment Period 1||35
8283224|NCT01659853|20423192|P2|STARTED|Treatment Period 1||35
8283225|NCT01659853|20423193|P1|STARTED|Treatment Period 1||35
8283226|NCT01659736|20423203|P2|NOT COMPLETED|3-month Follow-up||1
8283227|NCT01659736|20423204|P1|NOT COMPLETED|3-month Follow-up||0
8283228|NCT01659736|20423203|P2|COMPLETED|3-month Follow-up||9
8283229|NCT01659736|20423204|P1|COMPLETED|3-month Follow-up||9
8283230|NCT01659736|20423203|P2|STARTED|3-month Follow-up||10
8283231|NCT01659736|20423204|P1|STARTED|3-month Follow-up||9
8283232|NCT01659736|20423203|P2|NOT COMPLETED|Treatment Period||2
8283233|NCT01659736|20423204|P1|NOT COMPLETED|Treatment Period||5
8283234|NCT01659736|20423203|P2|COMPLETED|Treatment Period||10
8283235|NCT01659736|20423204|P1|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
8283236|NCT01659736|20423203|P2|STARTED|Treatment Period||12
8283237|NCT01659736|20423204|P1|STARTED|Treatment Period||14
8283238|NCT01659567|20423218|P1|NOT COMPLETED|Overall Study||123
8283239|NCT01659567|20423218|P1|COMPLETED|Overall Study||393
8283240|NCT01659567|20423218|P1|STARTED|Overall Study||516
8283241|NCT01659554|20423235|P1|NOT COMPLETED|Overall Study||4
8283242|NCT01659554|20423235|P1|COMPLETED|Overall Study||0
8283243|NCT01659554|20423235|P1|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
8283244|NCT01659320|20423242|P1|NOT COMPLETED|Overall Study||3
8283245|NCT01659320|20423242|P1|COMPLETED|Overall Study||13
8283246|NCT01659320|20423242|P1|STARTED|Overall Study||16
8283247|NCT01659268|20423248|P2|NOT COMPLETED|Overall Study||0
8283248|NCT01659268|20423249|P1|NOT COMPLETED|Overall Study||0
8283249|NCT01659268|20423248|P2|COMPLETED|Overall Study||8
8283250|NCT01659268|20423249|P1|COMPLETED|Overall Study||9
8283251|NCT01659268|20423248|P2|STARTED|Overall Study||8
8283252|NCT01659268|20423249|P1|STARTED|Overall Study||9
8283253|NCT01659125|20423261|P1|NOT COMPLETED|Overall Study||14
8283254|NCT01659125|20423261|P1|COMPLETED|Overall Study||12
8283255|NCT01659125|20423261|P1|Completed 6-month Follow-up|Overall Study||12
8283256|NCT01659125|20423261|P1|Completed 3-month Follow-up|Overall Study||16
8283257|NCT01659125|20423261|P1|Completed the Posttreatment Assessment|Overall Study||17
8283258|NCT01659125|20423261|P1|Initiated Treatment|Overall Study||24
8283259|NCT01659125|20423261|P1|STARTED|Overall Study||26
8283260|NCT01659021|20423268|P2|NOT COMPLETED|Long-Term Follow Up||4
8283261|NCT01659021|20423269|P1|NOT COMPLETED|Long-Term Follow Up||5
8283262|NCT01659021|20423268|P2|COMPLETED|Long-Term Follow Up||65
8283263|NCT01659021|20423269|P1|COMPLETED|Long-Term Follow Up||133
8283264|NCT01659021|20423268|P2|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69
8283265|NCT01659021|20423269|P1|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138
8283266|NCT01659021|20423268|P2|NOT COMPLETED|Main Study||37
8283267|NCT01659021|20423269|P1|NOT COMPLETED|Main Study||74
8283268|NCT01659021|20423268|P2|COMPLETED|Main Study||50
8283269|NCT01659021|20423269|P1|COMPLETED|Main Study||100
8283270|NCT01659021|20423268|P2|Randomized and Treated|Main Study||86
8283271|NCT01659021|20423269|P1|Randomized and Treated|Main Study||173
8283272|NCT01659021|20423268|P2|STARTED|Main Study||87
8283273|NCT01659021|20423269|P1|STARTED|Main Study||174
8283274|NCT01658995|20423287|P2|NOT COMPLETED|Overall Study||0
8283275|NCT01658995|20423288|P1|NOT COMPLETED|Overall Study||0
8283276|NCT01658995|20423287|P2|COMPLETED|Overall Study||40
8283277|NCT01658995|20423288|P1|COMPLETED|Overall Study||42
8283278|NCT01658995|20423287|P2|STARTED|Overall Study||40
8283279|NCT01658995|20423288|P1|STARTED|Overall Study||42
8283280|NCT01658943|20423300|P2|NOT COMPLETED|Overall Study||67
8283281|NCT01658943|20423301|P1|NOT COMPLETED|Overall Study||70
8283282|NCT01658943|20423300|P2|COMPLETED|Overall Study||0
8283283|NCT01658943|20423301|P1|COMPLETED|Overall Study||0
8283284|NCT01658943|20423300|P2|Eligible and Began Protocol Therapy|Overall Study||58
8283285|NCT01658943|20423301|P1|Eligible and Began Protocol Therapy|Overall Study||62
8283286|NCT01658943|20423300|P2|Eligible|Overall Study||58
8283287|NCT01658943|20423301|P1|Eligible|Overall Study||63
8283288|NCT01658943|20423300|P2|STARTED|Overall Study||67
8283289|NCT01658943|20423301|P1|STARTED|Overall Study||70
8283290|NCT01658904|20423316|P3|NOT COMPLETED|Overall Study||0
8283291|NCT01658904|20423317|P2|NOT COMPLETED|Overall Study||0
8283292|NCT01658904|20423318|P1|NOT COMPLETED|Overall Study||2
8283293|NCT01658904|20423316|P3|COMPLETED|Overall Study||0
8283294|NCT01658904|20423317|P2|COMPLETED|Overall Study||0
8283295|NCT01658904|20423318|P1|COMPLETED|Overall Study||1
8283296|NCT01658904|20423316|P3|STARTED|Overall Study||0
8283297|NCT01658904|20423317|P2|STARTED|Overall Study||0
8283298|NCT01658904|20423318|P1|STARTED|Overall Study||3
8283299|NCT01658839|20423335|P1|NOT COMPLETED|Overall Study||0
8283300|NCT01658839|20423335|P1|COMPLETED|Overall Study||25
8283301|NCT01658839|20423335|P1|STARTED|Overall Study||25
8283302|NCT01658813|20423344|P1|NOT COMPLETED|Overall Study||3
8283303|NCT01658813|20423344|P1|COMPLETED|Overall Study||15
8283304|NCT01658813|20423344|P1|Treated|Overall Study||18
8283305|NCT01658813|20423344|P1|Eligible|Overall Study||18
8283306|NCT01658813|20423344|P1|STARTED|Overall Study||18
8283307|NCT01658735|20423355|P3|NOT COMPLETED|Overall Study||4
8283308|NCT01658735|20423356|P2|NOT COMPLETED|Overall Study||7
8283309|NCT01658735|20423357|P1|NOT COMPLETED|Overall Study||5
8283310|NCT01658735|20423355|P3|COMPLETED|Overall Study||34
8283311|NCT01658735|20423356|P2|COMPLETED|Overall Study||29
8283312|NCT01658735|20423357|P1|COMPLETED|Overall Study||34
8283313|NCT01658735|20423355|P3|STARTED|Overall Study||38
8283314|NCT01658735|20423356|P2|STARTED|Overall Study||36
8283315|NCT01658735|20423357|P1|STARTED|Overall Study||39
8283316|NCT01658657|20423388|P2|NOT COMPLETED|Overall Study||3
8283317|NCT01658657|20423389|P1|NOT COMPLETED|Overall Study||3
8283318|NCT01658657|20423388|P2|COMPLETED|Overall Study||7
8283319|NCT01658657|20423389|P1|COMPLETED|Overall Study||4
8283320|NCT01658657|20423388|P2|STARTED|Overall Study||10
8283321|NCT01658657|20423389|P1|STARTED|Overall Study||7
8283322|NCT01658579|20423399|P4|NOT COMPLETED|Treatment Period B||1
8283323|NCT01658579|20423400|P3|NOT COMPLETED|Treatment Period B||0
8283324|NCT01658579|20423401|P2|NOT COMPLETED|Treatment Period B||0
8283325|NCT01658579|20423402|P1|NOT COMPLETED|Treatment Period B||0
8283326|NCT01658579|20423399|P4|COMPLETED|Treatment Period B||12
8283327|NCT01658579|20423400|P3|COMPLETED|Treatment Period B||14
8283328|NCT01658579|20423401|P2|COMPLETED|Treatment Period B||15
8283329|NCT01658579|20423402|P1|COMPLETED|Treatment Period B||14
8283330|NCT01658579|20423399|P4|STARTED|Treatment Period B||13
8283331|NCT01658579|20423400|P3|STARTED|Treatment Period B||14
8283332|NCT01658579|20423401|P2|STARTED|Treatment Period B||15
8283333|NCT01658579|20423402|P1|STARTED|Treatment Period B||14
8283334|NCT01658579|20423399|P4|NOT COMPLETED|Treatment Period A||1
8283335|NCT01658579|20423400|P3|NOT COMPLETED|Treatment Period A||1
8283336|NCT01658579|20423401|P2|NOT COMPLETED|Treatment Period A||0
8283337|NCT01658579|20423402|P1|NOT COMPLETED|Treatment Period A||1
8283338|NCT01658579|20423399|P4|COMPLETED|Treatment Period A||13
8283339|NCT01658579|20423400|P3|COMPLETED|Treatment Period A||14
8283340|NCT01658579|20423401|P2|COMPLETED|Treatment Period A||15
8283341|NCT01658579|20423402|P1|COMPLETED|Treatment Period A||14
8283342|NCT01658579|20423399|P4|STARTED|Treatment Period A||14
8283343|NCT01658579|20423400|P3|STARTED|Treatment Period A||15
8283344|NCT01658579|20423401|P2|STARTED|Treatment Period A||15
8283345|NCT01658579|20423402|P1|STARTED|Treatment Period A||15
8283346|NCT01658514|20423430|P3|NOT COMPLETED|Overall Study||2
8283347|NCT01658514|20423431|P2|NOT COMPLETED|Overall Study||0
8283348|NCT01658514|20423432|P1|NOT COMPLETED|Overall Study||1
8283349|NCT01658514|20423430|P3|COMPLETED|Overall Study||12
8283350|NCT01658514|20423431|P2|COMPLETED|Overall Study||11
8283351|NCT01658514|20423432|P1|COMPLETED|Overall Study||13
8283352|NCT01658514|20423430|P3|Completed - Severe RI Cohort Only|Overall Study||3
8283353|NCT01658514|20423431|P2|Completed - Severe RI Cohort Only|Overall Study||2
8283354|NCT01658514|20423432|P1|Completed - Severe RI Cohort Only|Overall Study||3
8283355|NCT01658514|20423430|P3|Started - Severe RI Cohort Only|Overall Study||3
8283356|NCT01658514|20423431|P2|Started - Severe RI Cohort Only|Overall Study||2
8283357|NCT01658514|20423432|P1|Started - Severe RI Cohort Only|Overall Study||3
8283358|NCT01658514|20423430|P3|Completed - Moderate RI Cohort Only|Overall Study||2
8283359|NCT01658514|20423431|P2|Completed - Moderate RI Cohort Only|Overall Study||4
8283360|NCT01658514|20423432|P1|Completed - Moderate RI Cohort Only|Overall Study||3
8283361|NCT01658514|20423430|P3|Started - Moderate RI Cohort Only|Overall Study||4
8283362|NCT01658514|20423431|P2|Started - Moderate RI Cohort Only|Overall Study||4
8283363|NCT01658514|20423432|P1|Started - Moderate RI Cohort Only|Overall Study||4
8283364|NCT01658514|20423430|P3|Completed - Mild RI Cohort Only|Overall Study||4
8283365|NCT01658514|20423431|P2|Completed - Mild RI Cohort Only|Overall Study||3
8283366|NCT01658514|20423432|P1|Completed - Mild RI Cohort Only|Overall Study||4
8283367|NCT01658514|20423430|P3|Started - Mild RI Cohort Only|Overall Study||4
8283368|NCT01658514|20423431|P2|Started - Mild RI Cohort Only|Overall Study||3
8283369|NCT01658514|20423432|P1|Started - Mild RI Cohort Only|Overall Study||4
8283370|NCT01658514|20423430|P3|Completed - Normal RF Cohort Only|Overall Study||3
8283371|NCT01658514|20423431|P2|Completed - Normal RF Cohort Only|Overall Study||2
8283372|NCT01658514|20423432|P1|Completed - Normal RF Cohort Only|Overall Study||3
8283373|NCT01658514|20423430|P3|Started - Normal RF Cohort Only|Overall Study||3
8283374|NCT01658514|20423431|P2|Started - Normal RF Cohort Only|Overall Study||2
8283375|NCT01658514|20423432|P1|Started - Normal RF Cohort Only|Overall Study||3
8283376|NCT01658514|20423430|P3|Completed Treatment C|Overall Study||12
8283377|NCT01658514|20423431|P2|Completed Treatment C|Overall Study||11
8283378|NCT01658514|20423432|P1|Completed Treatment C|Overall Study||13
8283379|NCT01658514|20423430|P3|Completed Treatment B|Overall Study||14
8283380|NCT01658514|20423431|P2|Completed Treatment B|Overall Study||11
8283381|NCT01658514|20423432|P1|Completed Treatment B|Overall Study||13
8283382|NCT01658514|20423430|P3|Completed Treatment A|Overall Study||12
8283383|NCT01658514|20423431|P2|Completed Treatment A|Overall Study||11
8283384|NCT01658514|20423432|P1|Completed Treatment A|Overall Study||14
8283385|NCT01658514|20423430|P3|STARTED|Overall Study||14
8283386|NCT01658514|20423431|P2|STARTED|Overall Study||11
8283387|NCT01658514|20423432|P1|STARTED|Overall Study||14
8283388|NCT01658436|20423443|P2|NOT COMPLETED|Overall Study||11
8283389|NCT01658436|20423444|P1|NOT COMPLETED|Overall Study||20
8283390|NCT01658436|20423443|P2|COMPLETED|Overall Study||0
8283391|NCT01658436|20423444|P1|COMPLETED|Overall Study||0
8283392|NCT01658436|20423443|P2|STARTED|Overall Study||11
8283393|NCT01658436|20423444|P1|STARTED|Overall Study||20
8283394|NCT01658228|20423453|P2|NOT COMPLETED|Overall Study||8
8283395|NCT01658228|20423454|P1|NOT COMPLETED|Overall Study||7
8283396|NCT01658228|20423453|P2|COMPLETED|Overall Study||23
8283397|NCT01658228|20423454|P1|COMPLETED|Overall Study||23
8283398|NCT01658228|20423453|P2|STARTED|Overall Study||31
8283399|NCT01658228|20423454|P1|STARTED|Overall Study||30
8283400|NCT01658150|20423464|P1|NOT COMPLETED|Overall Study||1
8283401|NCT01658150|20423464|P1|COMPLETED|Overall Study||10
8283402|NCT01658150|20423464|P1|STARTED|Overall Study||11
8283403|NCT01658072|20423486|P2|NOT COMPLETED|Overall Study||2
8283404|NCT01658072|20423487|P1|NOT COMPLETED|Overall Study||4
8283405|NCT01658072|20423486|P2|COMPLETED|Overall Study||43
8283406|NCT01658072|20423487|P1|COMPLETED|Overall Study||41
8283407|NCT01658072|20423486|P2|STARTED|Overall Study||45
8283408|NCT01658072|20423487|P1|STARTED|Overall Study||45
8283409|NCT01658059|20423493|P2|NOT COMPLETED|Second Intervention- 2 Days||0
8283410|NCT01658059|20423494|P1|NOT COMPLETED|Second Intervention- 2 Days||0
8283411|NCT01658059|20423493|P2|COMPLETED|Second Intervention- 2 Days||5
8283412|NCT01658059|20423494|P1|COMPLETED|Second Intervention- 2 Days||6
8283413|NCT01658059|20423493|P2|STARTED|Second Intervention- 2 Days||5
8283414|NCT01658059|20423494|P1|STARTED|Second Intervention- 2 Days||6
8283415|NCT01658059|20423493|P2|NOT COMPLETED|Washout Period- 14 Days||0
8283416|NCT01658059|20423494|P1|NOT COMPLETED|Washout Period- 14 Days||0
8283417|NCT01658059|20423493|P2|COMPLETED|Washout Period- 14 Days||5
8283418|NCT01658059|20423494|P1|COMPLETED|Washout Period- 14 Days||6
8283419|NCT01658059|20423493|P2|STARTED|Washout Period- 14 Days||5
8283420|NCT01658059|20423494|P1|STARTED|Washout Period- 14 Days||6
8283421|NCT01658059|20423493|P2|NOT COMPLETED|First Intervention- 2 Days||5
8283422|NCT01658059|20423494|P1|NOT COMPLETED|First Intervention- 2 Days||6
8283423|NCT01658059|20423493|P2|COMPLETED|First Intervention- 2 Days||5
8283424|NCT01658059|20423494|P1|COMPLETED|First Intervention- 2 Days||6
8283425|NCT01658059|20423493|P2|STARTED|First Intervention- 2 Days||10
8283426|NCT01658059|20423494|P1|STARTED|First Intervention- 2 Days||12
8283427|NCT01658020|20423502|P2|NOT COMPLETED|Overall Study||9
8283428|NCT01658020|20423503|P1|NOT COMPLETED|Overall Study||8
8283429|NCT01658020|20423502|P2|COMPLETED|Overall Study||158
8283430|NCT01658020|20423503|P1|COMPLETED|Overall Study||167
8283431|NCT01658020|20423502|P2|STARTED|Overall Study||167
8283432|NCT01658020|20423503|P1|STARTED|Overall Study||175
8283433|NCT01657903|20423519|P1|NOT COMPLETED|Overall Study||2
8283434|NCT01657903|20423519|P1|COMPLETED|Overall Study||54
8283435|NCT01657903|20423519|P1|Received NaF/KNO3 Toothpaste 2|Overall Study||55
8283436|NCT01657903|20423519|P1|Received NaF/KNO3 Toothpaste 3|Overall Study||54
8283525|NCT01657292|20423788|P1|STARTED|Overall Study||61
8283437|NCT01657903|20423519|P1|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
8283438|NCT01657903|20423519|P1|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
8283439|NCT01657903|20423519|P1|STARTED|Overall Study||56
8283440|NCT01657877|20423541|P1|NOT COMPLETED|Overall Study||14
8283441|NCT01657877|20423541|P1|COMPLETED|Overall Study||65
8283442|NCT01657877|20423541|P1|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
8283443|NCT01657877|20423541|P1|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
8283444|NCT01657877|20423541|P1|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
8283445|NCT01657877|20423541|P1|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
8283446|NCT01657877|20423541|P1|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
8283447|NCT01657877|20423541|P1|STARTED|Overall Study||79
8283448|NCT01657799|20423561|P3|NOT COMPLETED|Overall Study||102
8283449|NCT01657799|20423562|P2|NOT COMPLETED|Overall Study||103
8283450|NCT01657799|20423563|P1|NOT COMPLETED|Overall Study||102
8283451|NCT01657799|20423561|P3|COMPLETED|Overall Study||0
8283452|NCT01657799|20423562|P2|COMPLETED|Overall Study||0
8283453|NCT01657799|20423563|P1|COMPLETED|Overall Study||0
8283454|NCT01657799|20423561|P3|Received Treatment|Overall Study||102
8283455|NCT01657799|20423562|P2|Received Treatment|Overall Study||103
8283456|NCT01657799|20423563|P1|Received Treatment|Overall Study||101
8283457|NCT01657799|20423561|P3|STARTED|Overall Study||102
8283458|NCT01657799|20423562|P2|STARTED|Overall Study||103
8283459|NCT01657799|20423563|P1|STARTED|Overall Study||102
8283460|NCT01657760|20423582|P4|NOT COMPLETED|Overall Study||3
8283461|NCT01657760|20423583|P3|NOT COMPLETED|Overall Study||1
8283462|NCT01657760|20423584|P2|NOT COMPLETED|Overall Study||1
8283463|NCT01657760|20423585|P1|NOT COMPLETED|Overall Study||1
8283464|NCT01657760|20423582|P4|COMPLETED|Overall Study||4
8283465|NCT01657760|20423583|P3|COMPLETED|Overall Study||6
8283466|NCT01657760|20423584|P2|COMPLETED|Overall Study||6
8283467|NCT01657760|20423585|P1|COMPLETED|Overall Study||4
8283468|NCT01657760|20423582|P4|STARTED|Overall Study||7
8283469|NCT01657760|20423583|P3|STARTED|Overall Study||7
8283470|NCT01657760|20423584|P2|STARTED|Overall Study||7
8283471|NCT01657760|20423585|P1|STARTED|Overall Study||5
8283472|NCT01657617|20423597|P1|NOT COMPLETED|Overall Study||0
8283473|NCT01657617|20423597|P1|COMPLETED|Overall Study||35
8283474|NCT01657617|20423597|P1|STARTED|Overall Study||35
8283475|NCT01657461|20423604|P2|NOT COMPLETED|Overall Study||20
8283476|NCT01657461|20423605|P1|NOT COMPLETED|Overall Study||10
8283477|NCT01657461|20423604|P2|COMPLETED|Overall Study||78
8283478|NCT01657461|20423605|P1|COMPLETED|Overall Study||88
8283479|NCT01657461|20423604|P2|STARTED|Overall Study||98
8283480|NCT01657461|20423605|P1|STARTED|Overall Study||98
8283481|NCT01657370|20423635|P6|NOT COMPLETED|Overall Study||4
8283482|NCT01657370|20423636|P5|NOT COMPLETED|Overall Study||7
8283483|NCT01657370|20423637|P4|NOT COMPLETED|Overall Study||5
8283484|NCT01657370|20423638|P3|NOT COMPLETED|Overall Study||7
8283485|NCT01657370|20423639|P2|NOT COMPLETED|Overall Study||4
8283486|NCT01657370|20423640|P1|NOT COMPLETED|Overall Study||6
8283487|NCT01657370|20423635|P6|COMPLETED|Overall Study||27
8283488|NCT01657370|20423636|P5|COMPLETED|Overall Study||27
8283489|NCT01657370|20423637|P4|COMPLETED|Overall Study||28
8283490|NCT01657370|20423638|P3|COMPLETED|Overall Study||25
8283491|NCT01657370|20423639|P2|COMPLETED|Overall Study||28
8283492|NCT01657370|20423640|P1|COMPLETED|Overall Study||27
8283493|NCT01657370|20423635|P6|STARTED|Overall Study||31
8283494|NCT01657370|20423636|P5|STARTED|Overall Study||34
8283495|NCT01657370|20423637|P4|STARTED|Overall Study||33
8283496|NCT01657370|20423638|P3|STARTED|Overall Study||32
8283497|NCT01657370|20423639|P2|STARTED|Overall Study||32
8283498|NCT01657370|20423640|P1|STARTED|Overall Study||33
8283499|NCT01657344|20423722|P7|NOT COMPLETED|Overall Study||0
8283500|NCT01657344|20423723|P6|NOT COMPLETED|Overall Study||0
8283501|NCT01657344|20423724|P5|NOT COMPLETED|Overall Study||0
8283502|NCT01657344|20423725|P4|NOT COMPLETED|Overall Study||0
8283503|NCT01657344|20423726|P3|NOT COMPLETED|Overall Study||0
8283504|NCT01657344|20423727|P2|NOT COMPLETED|Overall Study||0
8283505|NCT01657344|20423728|P1|NOT COMPLETED|Overall Study||0
8283506|NCT01657344|20423722|P7|COMPLETED|Overall Study||140776
8283507|NCT01657344|20423723|P6|COMPLETED|Overall Study||316477
8283508|NCT01657344|20423724|P5|COMPLETED|Overall Study||157802
8283509|NCT01657344|20423725|P4|COMPLETED|Overall Study||376517
8283510|NCT01657344|20423726|P3|COMPLETED|Overall Study||196300
8283511|NCT01657344|20423727|P2|COMPLETED|Overall Study||409967
8283512|NCT01657344|20423728|P1|COMPLETED|Overall Study||421622
8283513|NCT01657344|20423722|P7|STARTED|Overall Study||140776
8283514|NCT01657344|20423723|P6|STARTED|Overall Study||316477
8283515|NCT01657344|20423724|P5|STARTED|Overall Study||157802
8283516|NCT01657344|20423725|P4|STARTED|Overall Study||376517
8283517|NCT01657344|20423726|P3|STARTED|Overall Study||196300
8283518|NCT01657344|20423727|P2|STARTED|Overall Study||409967
8283519|NCT01657344|20423728|P1|STARTED|Overall Study||421622
8283520|NCT01657305|20423738|P1|NOT COMPLETED|Overall Study||25
8283521|NCT01657305|20423738|P1|COMPLETED|Overall Study||82
8283522|NCT01657305|20423738|P1|STARTED|Overall Study||107
8283523|NCT01657292|20423788|P1|NOT COMPLETED|Overall Study||10
8283524|NCT01657292|20423788|P1|COMPLETED|Overall Study||51
8283526|NCT01657266|20423797|P2|NOT COMPLETED|Overall Study||5
8283527|NCT01657266|20423798|P1|NOT COMPLETED|Overall Study||4
8283528|NCT01657266|20423797|P2|COMPLETED|Overall Study||70
8283529|NCT01657266|20423798|P1|COMPLETED|Overall Study||69
8283530|NCT01657266|20423797|P2|STARTED|Overall Study||75
8283531|NCT01657266|20423798|P1|STARTED|Overall Study||73
8283532|NCT01657253|20423820|P2|NOT COMPLETED|Overall Study||18
8283533|NCT01657253|20423821|P1|NOT COMPLETED|Overall Study||17
8283534|NCT01657253|20423820|P2|COMPLETED|Overall Study||72
8283535|NCT01657253|20423821|P1|COMPLETED|Overall Study||76
8283536|NCT01657253|20423820|P2|STARTED|Overall Study||90
8283537|NCT01657253|20423821|P1|STARTED|Overall Study||93
8283538|NCT01657162|20423833|P2|NOT COMPLETED|Overall Study||75
8283539|NCT01657162|20423834|P1|NOT COMPLETED|Overall Study||59
8283540|NCT01657162|20423833|P2|COMPLETED|Overall Study||506
8283541|NCT01657162|20423834|P1|COMPLETED|Overall Study||499
8283542|NCT01657162|20423833|P2|Study 005 mITT Population|Overall Study||568
8283543|NCT01657162|20423834|P1|Study 005 mITT Population|Overall Study||544
8283544|NCT01657162|20423833|P2|Study 005 Safety Population|Overall Study||580
8283545|NCT01657162|20423834|P1|Study 005 Safety Population|Overall Study||553
8283546|NCT01657162|20423833|P2|Study 005 ITT Population|Overall Study||581
8283547|NCT01657162|20423834|P1|Study 005 ITT Population|Overall Study||558
8283548|NCT01657162|20423833|P2|Completed Study 003|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|637
8283549|NCT01657162|20423834|P1|Completed Study 003|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|606
8283550|NCT01657162|20423833|P2|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|711
8283551|NCT01657162|20423834|P1|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|690
8283552|NCT01657162|20423833|P2|Study 003 ITT Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|821
8283553|NCT01657162|20423834|P1|Study 003 ITT Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|824
8283554|NCT01657162|20423833|P2|STARTED|Overall Study||581
8283555|NCT01657162|20423834|P1|STARTED|Overall Study||558
8283556|NCT01657032|20423862|P2|NOT COMPLETED|Overall Study||7
8283557|NCT01657032|20423863|P1|NOT COMPLETED|Overall Study||0
8283558|NCT01657032|20423862|P2|COMPLETED|Overall Study||37
8283559|NCT01657032|20423863|P1|COMPLETED|Overall Study||44
8283560|NCT01657032|20423862|P2|STARTED|Overall Study||44
8283561|NCT01657032|20423863|P1|STARTED|Overall Study||44
8283565|NCT01656967|20423903|P2|NOT COMPLETED|Overall Study||2
8283566|NCT01656967|20423904|P1|NOT COMPLETED|Overall Study||4
8283567|NCT01656967|20423903|P2|COMPLETED|Overall Study||31
8283568|NCT01656967|20423904|P1|COMPLETED|Overall Study||29
8283569|NCT01656967|20423903|P2|ETT Insertion|Overall Study||31
8283570|NCT01656967|20423904|P1|ETT Insertion|Overall Study||29
8283571|NCT01656967|20423903|P2|SGA Placement|Overall Study||33
8283572|NCT01656967|20423904|P1|SGA Placement|Overall Study||32
8283573|NCT01656967|20423903|P2|STARTED|Overall Study||33
8283574|NCT01656967|20423904|P1|STARTED|Overall Study||33
8283575|NCT01656889|20423930|P2|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
8283576|NCT01656889|20423931|P1|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
8283577|NCT01656889|20423930|P2|COMPLETED|Post Treatment Follow-Up, 3 Months||204
8283578|NCT01656889|20423931|P1|COMPLETED|Post Treatment Follow-Up, 3 Months||206
8283579|NCT01656889|20423930|P2|STARTED|Post Treatment Follow-Up, 3 Months||213
8283580|NCT01656889|20423931|P1|STARTED|Post Treatment Follow-Up, 3 Months||210
8283581|NCT01656889|20423930|P2|NOT COMPLETED|Treatment Period, 12 Weeks||11
8283582|NCT01656889|20423931|P1|NOT COMPLETED|Treatment Period, 12 Weeks||12
8283583|NCT01656889|20423930|P2|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
8283584|NCT01656889|20423931|P1|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
8283585|NCT01656889|20423930|P2|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
8283586|NCT01656889|20423931|P1|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
8283587|NCT01656850|20423951|P2|NOT COMPLETED|Second Intervention (3 Months)||0
8283588|NCT01656850|20423952|P1|NOT COMPLETED|Second Intervention (3 Months)||0
8283589|NCT01656850|20423951|P2|COMPLETED|Second Intervention (3 Months)||16
8283590|NCT01656850|20423952|P1|COMPLETED|Second Intervention (3 Months)||17
8283591|NCT01656850|20423951|P2|STARTED|Second Intervention (3 Months)||16
8283592|NCT01656850|20423952|P1|STARTED|Second Intervention (3 Months)||17
8283593|NCT01656850|20423951|P2|NOT COMPLETED|Washout (2 Weeks)||0
8283594|NCT01656850|20423952|P1|NOT COMPLETED|Washout (2 Weeks)||0
8283595|NCT01656850|20423951|P2|COMPLETED|Washout (2 Weeks)||16
8283596|NCT01656850|20423952|P1|COMPLETED|Washout (2 Weeks)||17
8283597|NCT01656850|20423951|P2|STARTED|Washout (2 Weeks)||16
8283598|NCT01656850|20423952|P1|STARTED|Washout (2 Weeks)||17
8283599|NCT01656850|20423951|P2|NOT COMPLETED|First Intervention (3 Months)||4
8283600|NCT01656850|20423952|P1|NOT COMPLETED|First Intervention (3 Months)||3
8283601|NCT01656850|20423951|P2|COMPLETED|First Intervention (3 Months)||16
8283602|NCT01656850|20423952|P1|COMPLETED|First Intervention (3 Months)||17
8283603|NCT01656850|20423951|P2|STARTED|First Intervention (3 Months)||20
8283604|NCT01656850|20423952|P1|STARTED|First Intervention (3 Months)||20
8283605|NCT01656772|20424032|P2|NOT COMPLETED|Overall Study||0
8283606|NCT01656772|20424033|P1|NOT COMPLETED|Overall Study||0
8283607|NCT01656772|20424032|P2|COMPLETED|Overall Study||77
8283608|NCT01656772|20424033|P1|COMPLETED|Overall Study||43
8283609|NCT01656772|20424032|P2|STARTED|Overall Study||77
8283610|NCT01656772|20424033|P1|STARTED|Overall Study||43
8283611|NCT01656759|20424043|P2|NOT COMPLETED|Overall Study||3
8283612|NCT01656759|20424044|P1|NOT COMPLETED|Overall Study||2
8283613|NCT01656759|20424043|P2|COMPLETED|Overall Study||22
8283614|NCT01656759|20424044|P1|COMPLETED|Overall Study||25
8283615|NCT01656759|20424043|P2|STARTED|Overall Study||25
8283616|NCT01656759|20424044|P1|STARTED|Overall Study||27
8283617|NCT01656733|20424058|P2|NOT COMPLETED|Overall Study||4
8283618|NCT01656733|20424059|P1|NOT COMPLETED|Overall Study||0
8283619|NCT01656733|20424058|P2|COMPLETED|Overall Study||66
8283620|NCT01656733|20424059|P1|COMPLETED|Overall Study||67
8283621|NCT01656733|20424058|P2|Visit 8 (6 Months Postpartum)|Overall Study||28
8283622|NCT01656733|20424059|P1|Visit 8 (6 Months Postpartum)|Overall Study||30
8283623|NCT01656733|20424058|P2|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50
8283624|NCT01656733|20424059|P1|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47
8283625|NCT01656733|20424058|P2|Participants With Perinatal Outcomes|Overall Study||66
8283626|NCT01656733|20424059|P1|Participants With Perinatal Outcomes|Overall Study||67
8283627|NCT01656733|20424058|P2|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47
8283628|NCT01656733|20424059|P1|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39
8283629|NCT01656733|20424058|P2|Visit 5 (6 Weeks After Quit Date)|Overall Study||36
8283630|NCT01656733|20424059|P1|Visit 5 (6 Weeks After Quit Date)|Overall Study||37
8283631|NCT01656733|20424058|P2|Visit 4 (4 Weeks After Quit Date)|Overall Study||30
8283632|NCT01656733|20424059|P1|Visit 4 (4 Weeks After Quit Date)|Overall Study||32
8283633|NCT01656733|20424058|P2|Visit 3 (3 Weeks After Quit Date)|Overall Study||34
8283634|NCT01656733|20424059|P1|Visit 3 (3 Weeks After Quit Date)|Overall Study||33
8283635|NCT01656733|20424058|P2|Visit 2 (2 Weeks After Quit Date)|Overall Study||44
8283636|NCT01656733|20424059|P1|Visit 2 (2 Weeks After Quit Date)|Overall Study||32
8283637|NCT01656733|20424058|P2|Visit 1 (1 Week After Quit Date)|Overall Study||42
8283638|NCT01656733|20424059|P1|Visit 1 (1 Week After Quit Date)|Overall Study||45
8283639|NCT01656733|20424058|P2|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70
8283640|NCT01656733|20424059|P1|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67
8283641|NCT01656629|20424074|P3|NOT COMPLETED|Overall Study||2
8283642|NCT01656629|20424075|P2|NOT COMPLETED|Overall Study||2
8283643|NCT01656629|20424076|P1|NOT COMPLETED|Overall Study||5
8283644|NCT01656629|20424074|P3|COMPLETED|Overall Study||14
8283645|NCT01656629|20424075|P2|COMPLETED|Overall Study||16
8283646|NCT01656629|20424076|P1|COMPLETED|Overall Study||16
8283647|NCT01656629|20424074|P3|STARTED|Overall Study||16
8283648|NCT01656629|20424075|P2|STARTED|Overall Study||18
8283649|NCT01656629|20424076|P1|STARTED|Overall Study||21
8283650|NCT01656486|20424090|P1|NOT COMPLETED|Overall Study||0
8283651|NCT01656486|20424090|P1|COMPLETED|Overall Study||1
8283652|NCT01656486|20424090|P1|STARTED|Overall Study||1
8283653|NCT01656460|20424094|P4|NOT COMPLETED|Overall Study||0
8283654|NCT01656460|20424095|P3|NOT COMPLETED|Overall Study||0
8283655|NCT01656460|20424096|P2|NOT COMPLETED|Overall Study||0
8283656|NCT01656460|20424097|P1|NOT COMPLETED|Overall Study||0
8283657|NCT01656460|20424094|P4|COMPLETED|Overall Study||3
8283658|NCT01656460|20424095|P3|COMPLETED|Overall Study||3
8283659|NCT01656460|20424096|P2|COMPLETED|Overall Study||3
8283660|NCT01656460|20424097|P1|COMPLETED|Overall Study||3
8283661|NCT01656460|20424094|P4|STARTED|Overall Study||3
8283662|NCT01656460|20424095|P3|STARTED|Overall Study||3
8283663|NCT01656460|20424096|P2|STARTED|Overall Study||3
8283664|NCT01656460|20424097|P1|STARTED|Overall Study||3
8283665|NCT01656434|20424109|P2|NOT COMPLETED|Overall Study||580
8283666|NCT01656434|20424110|P1|NOT COMPLETED|Overall Study||2401
8283667|NCT01656434|20424109|P2|COMPLETED|Overall Study||40
8283668|NCT01656434|20424110|P1|COMPLETED|Overall Study||152
8283669|NCT01656434|20424109|P2|Treated|Overall Study||604
8283670|NCT01656434|20424110|P1|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
8283671|NCT01656434|20424109|P2|STARTED|Overall Study||620
8283672|NCT01656434|20424110|P1|STARTED|Overall Study||2553
8283673|NCT01656408|20424136|P10|NOT COMPLETED|Overall Study||3
8283674|NCT01656408|20424137|P9|NOT COMPLETED|Overall Study||2
8283675|NCT01656408|20424138|P8|NOT COMPLETED|Overall Study||1
8283676|NCT01656408|20424139|P7|NOT COMPLETED|Overall Study||1
8283677|NCT01656408|20424140|P6|NOT COMPLETED|Overall Study||2
8283678|NCT01656408|20424141|P5|NOT COMPLETED|Overall Study||1
8283679|NCT01656408|20424142|P4|NOT COMPLETED|Overall Study||0
8283680|NCT01656408|20424143|P3|NOT COMPLETED|Overall Study||2
8283681|NCT01656408|20424144|P2|NOT COMPLETED|Overall Study||0
8283682|NCT01656408|20424145|P1|NOT COMPLETED|Overall Study||1
8283683|NCT01656408|20424136|P10|COMPLETED|Overall Study||15
8283684|NCT01656408|20424137|P9|COMPLETED|Overall Study||16
8283685|NCT01656408|20424138|P8|COMPLETED|Overall Study||7
8283686|NCT01656408|20424139|P7|COMPLETED|Overall Study||9
8283687|NCT01656408|20424140|P6|COMPLETED|Overall Study||7
8283688|NCT01656408|20424141|P5|COMPLETED|Overall Study||8
8283689|NCT01656408|20424142|P4|COMPLETED|Overall Study||7
8283690|NCT01656408|20424143|P3|COMPLETED|Overall Study||6
8283691|NCT01656408|20424144|P2|COMPLETED|Overall Study||8
8283692|NCT01656408|20424145|P1|COMPLETED|Overall Study||7
8283693|NCT01656408|20424136|P10|STARTED|Overall Study||18
8283694|NCT01656408|20424137|P9|STARTED|Overall Study||18
8283695|NCT01656408|20424138|P8|STARTED|Overall Study||8
8283696|NCT01656408|20424139|P7|STARTED|Overall Study||10
8283697|NCT01656408|20424140|P6|STARTED|Overall Study||9
8283698|NCT01656408|20424141|P5|STARTED|Overall Study||9
8283699|NCT01656408|20424142|P4|STARTED|Overall Study||7
8283700|NCT01656408|20424143|P3|STARTED|Overall Study||8
8283701|NCT01656408|20424144|P2|STARTED|Overall Study||8
8283702|NCT01656408|20424145|P1|STARTED|Overall Study||8
8283703|NCT01656395|20424340|P8|NOT COMPLETED|Overall Study||0
8283704|NCT01656395|20424341|P7|NOT COMPLETED|Overall Study||0
8283705|NCT01656395|20424342|P6|NOT COMPLETED|Overall Study||40
8283706|NCT01656395|20424343|P5|NOT COMPLETED|Overall Study||14
8283707|NCT01656395|20424344|P4|NOT COMPLETED|Overall Study||12
8283708|NCT01656395|20424345|P3|NOT COMPLETED|Overall Study||36
8283709|NCT01656395|20424346|P2|NOT COMPLETED|Overall Study||34
8283710|NCT01656395|20424347|P1|NOT COMPLETED|Overall Study||17
8283711|NCT01656395|20424340|P8|COMPLETED|Overall Study||0
8283712|NCT01656395|20424341|P7|COMPLETED|Overall Study||0
8283713|NCT01656395|20424342|P6|COMPLETED|Overall Study||94
8283714|NCT01656395|20424343|P5|COMPLETED|Overall Study||46
8283715|NCT01656395|20424344|P4|COMPLETED|Overall Study||41
8283716|NCT01656395|20424345|P3|COMPLETED|Overall Study||106
8283717|NCT01656395|20424346|P2|COMPLETED|Overall Study||93
8283718|NCT01656395|20424347|P1|COMPLETED|Overall Study||43
8283719|NCT01656395|20424340|P8|Treated Participants|Overall Study||0
8283720|NCT01656395|20424341|P7|Treated Participants|Overall Study||0
8283721|NCT01656395|20424342|P6|Treated Participants|Overall Study||126
8283722|NCT01656395|20424343|P5|Treated Participants|Overall Study||60
8283723|NCT01656395|20424344|P4|Treated Participants|Overall Study||52
8283724|NCT01656395|20424345|P3|Treated Participants|Overall Study||135
8283725|NCT01656395|20424346|P2|Treated Participants|Overall Study||126
8283726|NCT01656395|20424347|P1|Treated Participants|Overall Study||58
8283727|NCT01656395|20424340|P8|STARTED|Overall Study||0
8283728|NCT01656395|20424341|P7|STARTED|Overall Study||0
8283729|NCT01656395|20424342|P6|STARTED|Overall Study||134
8283730|NCT01656395|20424343|P5|STARTED|Overall Study||60
8283731|NCT01656395|20424344|P4|STARTED|Overall Study||53
8283732|NCT01656395|20424345|P3|STARTED|Overall Study||142
8283733|NCT01656395|20424346|P2|STARTED|Overall Study||127
8283734|NCT01656395|20424347|P1|STARTED|Overall Study||60
8283735|NCT01656304|20424433|P1|NOT COMPLETED|Overall Study||1
8283736|NCT01656304|20424433|P1|COMPLETED|Overall Study||15
8283737|NCT01656304|20424433|P1|STARTED|Overall Study||16
8283738|NCT01656252|20424442|P1|NOT COMPLETED|Phase II||0
8283739|NCT01656252|20424442|P1|COMPLETED|Phase II||0
8283740|NCT01656252|20424442|P1|STARTED|Phase II||0
8283741|NCT01656252|20424442|P1|NOT COMPLETED|Phase I||0
8283742|NCT01656252|20424442|P1|COMPLETED|Phase I||14
8283743|NCT01656252|20424442|P1|STARTED|Phase I||14
8283744|NCT01656200|20424474|P1|NOT COMPLETED|Overall Study||1
8283745|NCT01656200|20424474|P1|COMPLETED|Overall Study||16
8283746|NCT01656200|20424474|P1|STARTED|Overall Study||17
8283747|NCT01656187|20424482|P2|NOT COMPLETED|Second Intervention (24 Weeks)||3
8283748|NCT01656187|20424483|P1|NOT COMPLETED|Second Intervention (24 Weeks)||1
8283749|NCT01656187|20424482|P2|COMPLETED|Second Intervention (24 Weeks)||19
8283750|NCT01656187|20424483|P1|COMPLETED|Second Intervention (24 Weeks)||13
8283751|NCT01656187|20424482|P2|STARTED|Second Intervention (24 Weeks)||22
8283752|NCT01656187|20424483|P1|STARTED|Second Intervention (24 Weeks)||14
8283753|NCT01656187|20424482|P2|NOT COMPLETED|Washout (4 Weeks)||1
8283754|NCT01656187|20424483|P1|NOT COMPLETED|Washout (4 Weeks)||0
8283755|NCT01656187|20424482|P2|COMPLETED|Washout (4 Weeks)||22
8283756|NCT01656187|20424483|P1|COMPLETED|Washout (4 Weeks)||14
8283757|NCT01656187|20424482|P2|STARTED|Washout (4 Weeks)||23
8283758|NCT01656187|20424483|P1|STARTED|Washout (4 Weeks)||14
8283759|NCT01656187|20424482|P2|NOT COMPLETED|First Intervention (24 Weeks)||3
8283760|NCT01656187|20424483|P1|NOT COMPLETED|First Intervention (24 Weeks)||6
8283761|NCT01656187|20424482|P2|COMPLETED|First Intervention (24 Weeks)||23
8283762|NCT01656187|20424483|P1|COMPLETED|First Intervention (24 Weeks)||14
8283763|NCT01656187|20424482|P2|STARTED|First Intervention (24 Weeks)||26
8283764|NCT01656187|20424483|P1|STARTED|First Intervention (24 Weeks)||20
8283765|NCT01656161|20424489|P1|NOT COMPLETED|Overall Study||7
8283766|NCT01656161|20424489|P1|COMPLETED|Overall Study|Per protocol analysis set|113
8283767|NCT01656161|20424489|P1|Received Triptorelin at Day 169|Overall Study||115
8283768|NCT01656161|20424489|P1|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
8283769|NCT01656161|20424489|P1|STARTED|Overall Study|Intention to treat analysis set|120
8283770|NCT01656031|20424503|P1|NOT COMPLETED|Overall Study||0
8283771|NCT01656031|20424503|P1|COMPLETED|Overall Study||39
8283772|NCT01656031|20424503|P1|STARTED|Overall Study||39
8283773|NCT01655901|20424507|P6|NOT COMPLETED|Third Intervention (Hour 3)||0
8283774|NCT01655901|20424508|P5|NOT COMPLETED|Third Intervention (Hour 3)||1
8283775|NCT01655901|20424509|P4|NOT COMPLETED|Third Intervention (Hour 3)||0
8283776|NCT01655901|20424510|P3|NOT COMPLETED|Third Intervention (Hour 3)||1
8283777|NCT01655901|20424511|P2|NOT COMPLETED|Third Intervention (Hour 3)||1
8283778|NCT01655901|20424512|P1|NOT COMPLETED|Third Intervention (Hour 3)||1
8283779|NCT01655901|20424507|P6|COMPLETED|Third Intervention (Hour 3)||5
8283780|NCT01655901|20424508|P5|COMPLETED|Third Intervention (Hour 3)||4
8283781|NCT01655901|20424509|P4|COMPLETED|Third Intervention (Hour 3)||5
8283782|NCT01655901|20424510|P3|COMPLETED|Third Intervention (Hour 3)||4
8283783|NCT01655901|20424511|P2|COMPLETED|Third Intervention (Hour 3)||4
8283784|NCT01655901|20424512|P1|COMPLETED|Third Intervention (Hour 3)||4
8283785|NCT01655901|20424507|P6|STARTED|Third Intervention (Hour 3)||5
8283786|NCT01655901|20424508|P5|STARTED|Third Intervention (Hour 3)||5
8283787|NCT01655901|20424509|P4|STARTED|Third Intervention (Hour 3)||5
8283788|NCT01655901|20424510|P3|STARTED|Third Intervention (Hour 3)||5
8283789|NCT01655901|20424511|P2|STARTED|Third Intervention (Hour 3)||5
8283790|NCT01655901|20424512|P1|STARTED|Third Intervention (Hour 3)||5
8283791|NCT01655901|20424507|P6|NOT COMPLETED|Washout (1 Week)||0
8283792|NCT01655901|20424508|P5|NOT COMPLETED|Washout (1 Week)||0
8283793|NCT01655901|20424509|P4|NOT COMPLETED|Washout (1 Week)||0
8283794|NCT01655901|20424510|P3|NOT COMPLETED|Washout (1 Week)||0
8283795|NCT01655901|20424511|P2|NOT COMPLETED|Washout (1 Week)||0
8283796|NCT01655901|20424512|P1|NOT COMPLETED|Washout (1 Week)||0
8283797|NCT01655901|20424507|P6|COMPLETED|Washout (1 Week)||5
8283798|NCT01655901|20424508|P5|COMPLETED|Washout (1 Week)||5
8283799|NCT01655901|20424509|P4|COMPLETED|Washout (1 Week)||5
8283800|NCT01655901|20424510|P3|COMPLETED|Washout (1 Week)||5
8283801|NCT01655901|20424511|P2|COMPLETED|Washout (1 Week)||5
8283802|NCT01655901|20424512|P1|COMPLETED|Washout (1 Week)||5
8283803|NCT01655901|20424507|P6|STARTED|Washout (1 Week)||5
8283804|NCT01655901|20424508|P5|STARTED|Washout (1 Week)||5
8283805|NCT01655901|20424509|P4|STARTED|Washout (1 Week)||5
8283806|NCT01655901|20424510|P3|STARTED|Washout (1 Week)||5
8283807|NCT01655901|20424511|P2|STARTED|Washout (1 Week)||5
8283808|NCT01655901|20424512|P1|STARTED|Washout (1 Week)||5
8283809|NCT01655901|20424507|P6|NOT COMPLETED|Second Intervention (Hour 2)||0
8283810|NCT01655901|20424508|P5|NOT COMPLETED|Second Intervention (Hour 2)||0
8283811|NCT01655901|20424509|P4|NOT COMPLETED|Second Intervention (Hour 2)||0
8283812|NCT01655901|20424510|P3|NOT COMPLETED|Second Intervention (Hour 2)||0
8283813|NCT01655901|20424511|P2|NOT COMPLETED|Second Intervention (Hour 2)||0
8283814|NCT01655901|20424512|P1|NOT COMPLETED|Second Intervention (Hour 2)||0
8283815|NCT01655901|20424507|P6|COMPLETED|Second Intervention (Hour 2)||5
8283816|NCT01655901|20424508|P5|COMPLETED|Second Intervention (Hour 2)||5
8283817|NCT01655901|20424509|P4|COMPLETED|Second Intervention (Hour 2)||5
8283818|NCT01655901|20424510|P3|COMPLETED|Second Intervention (Hour 2)||5
8283819|NCT01655901|20424511|P2|COMPLETED|Second Intervention (Hour 2)||5
8283820|NCT01655901|20424512|P1|COMPLETED|Second Intervention (Hour 2)||5
8283821|NCT01655901|20424507|P6|STARTED|Second Intervention (Hour 2)||5
8283822|NCT01655901|20424508|P5|STARTED|Second Intervention (Hour 2)||5
8283823|NCT01655901|20424509|P4|STARTED|Second Intervention (Hour 2)||5
8283824|NCT01655901|20424510|P3|STARTED|Second Intervention (Hour 2)||5
8283825|NCT01655901|20424511|P2|STARTED|Second Intervention (Hour 2)||5
8283826|NCT01655901|20424512|P1|STARTED|Second Intervention (Hour 2)||5
8283827|NCT01655901|20424507|P6|NOT COMPLETED|Washout (1 Week)||0
8283828|NCT01655901|20424508|P5|NOT COMPLETED|Washout (1 Week)||0
8283829|NCT01655901|20424509|P4|NOT COMPLETED|Washout (1 Week)||0
8283830|NCT01655901|20424510|P3|NOT COMPLETED|Washout (1 Week)||0
8283831|NCT01655901|20424511|P2|NOT COMPLETED|Washout (1 Week)||0
8283832|NCT01655901|20424512|P1|NOT COMPLETED|Washout (1 Week)||0
8283833|NCT01655901|20424507|P6|COMPLETED|Washout (1 Week)||5
8283834|NCT01655901|20424508|P5|COMPLETED|Washout (1 Week)||5
8283835|NCT01655901|20424509|P4|COMPLETED|Washout (1 Week)||5
8283836|NCT01655901|20424510|P3|COMPLETED|Washout (1 Week)||5
8283837|NCT01655901|20424511|P2|COMPLETED|Washout (1 Week)||5
8283838|NCT01655901|20424512|P1|COMPLETED|Washout (1 Week)||5
8283839|NCT01655901|20424507|P6|STARTED|Washout (1 Week)||5
8283840|NCT01655901|20424508|P5|STARTED|Washout (1 Week)||5
8283841|NCT01655901|20424509|P4|STARTED|Washout (1 Week)||5
8283842|NCT01655901|20424510|P3|STARTED|Washout (1 Week)||5
8283843|NCT01655901|20424511|P2|STARTED|Washout (1 Week)||5
8283844|NCT01655901|20424512|P1|STARTED|Washout (1 Week)||5
8283845|NCT01655901|20424507|P6|NOT COMPLETED|First Intervention (Hour 1)||0
8283846|NCT01655901|20424508|P5|NOT COMPLETED|First Intervention (Hour 1)||0
8283847|NCT01655901|20424509|P4|NOT COMPLETED|First Intervention (Hour 1)||0
8283848|NCT01655901|20424510|P3|NOT COMPLETED|First Intervention (Hour 1)||0
8283849|NCT01655901|20424511|P2|NOT COMPLETED|First Intervention (Hour 1)||0
8283850|NCT01655901|20424512|P1|NOT COMPLETED|First Intervention (Hour 1)||0
8283851|NCT01655901|20424507|P6|COMPLETED|First Intervention (Hour 1)||5
8283852|NCT01655901|20424508|P5|COMPLETED|First Intervention (Hour 1)||5
8283853|NCT01655901|20424509|P4|COMPLETED|First Intervention (Hour 1)||5
8283854|NCT01655901|20424510|P3|COMPLETED|First Intervention (Hour 1)||5
8283855|NCT01655901|20424511|P2|COMPLETED|First Intervention (Hour 1)||5
8283856|NCT01655901|20424512|P1|COMPLETED|First Intervention (Hour 1)||5
8283857|NCT01655901|20424507|P6|STARTED|First Intervention (Hour 1)||5
8283858|NCT01655901|20424508|P5|STARTED|First Intervention (Hour 1)||5
8283859|NCT01655901|20424509|P4|STARTED|First Intervention (Hour 1)||5
8283860|NCT01655901|20424510|P3|STARTED|First Intervention (Hour 1)||5
8283861|NCT01655901|20424511|P2|STARTED|First Intervention (Hour 1)||5
8283862|NCT01655901|20424512|P1|STARTED|First Intervention (Hour 1)||5
8283863|NCT01655823|20424526|P5|NOT COMPLETED|Overall Study||1
8283864|NCT01655823|20424527|P4|NOT COMPLETED|Overall Study||1
8283865|NCT01655823|20424528|P3|NOT COMPLETED|Overall Study||0
8283866|NCT01655823|20424529|P2|NOT COMPLETED|Overall Study||2
8283867|NCT01655823|20424530|P1|NOT COMPLETED|Overall Study||0
8283868|NCT01655823|20424526|P5|COMPLETED|Overall Study||25
8283869|NCT01655823|20424527|P4|COMPLETED|Overall Study||24
8283870|NCT01655823|20424528|P3|COMPLETED|Overall Study||24
8283871|NCT01655823|20424529|P2|COMPLETED|Overall Study||23
8283872|NCT01655823|20424530|P1|COMPLETED|Overall Study||25
8283873|NCT01655823|20424526|P5|STARTED|Overall Study||26
8283874|NCT01655823|20424527|P4|STARTED|Overall Study||25
8283875|NCT01655823|20424528|P3|STARTED|Overall Study||24
8283876|NCT01655823|20424529|P2|STARTED|Overall Study||25
8283877|NCT01655823|20424530|P1|STARTED|Overall Study||25
8283878|NCT01655719|20424542|P1|NOT COMPLETED|Overall Study||0
8283879|NCT01655719|20424542|P1|COMPLETED|Overall Study||1
8283880|NCT01655719|20424542|P1|STARTED|Overall Study||1
8283881|NCT01655563|20424550|P2|NOT COMPLETED|Overall Study||0
8283882|NCT01655563|20424551|P1|NOT COMPLETED|Overall Study||0
8283883|NCT01655563|20424550|P2|COMPLETED|Overall Study||35
8283884|NCT01655563|20424551|P1|COMPLETED|Overall Study||18
8283885|NCT01655563|20424550|P2|STARTED|Overall Study||35
8283886|NCT01655563|20424551|P1|STARTED|Overall Study||18
8283887|NCT01655498|20424561|P1|NOT COMPLETED|Overall Study||5
8283888|NCT01655498|20424561|P1|COMPLETED|Overall Study||56
8283889|NCT01655498|20424561|P1|STARTED|Overall Study||61
8283890|NCT01655381|20424568|P1|NOT COMPLETED|Overall Study||3
8283891|NCT01655381|20424568|P1|COMPLETED|Overall Study||12
8283892|NCT01655381|20424568|P1|STARTED|Overall Study||15
8283893|NCT01655329|20424588|P1|NOT COMPLETED|Overall Study||0
8283894|NCT01655329|20424588|P1|COMPLETED|Overall Study||10
8283895|NCT01655329|20424588|P1|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
8283896|NCT01655069|20424608|P4|NOT COMPLETED|Overall Study||4
8283897|NCT01655069|20424609|P3|NOT COMPLETED|Overall Study||2
8283898|NCT01655069|20424610|P2|NOT COMPLETED|Overall Study||12
8283899|NCT01655069|20424611|P1|NOT COMPLETED|Overall Study||8
8283900|NCT01655069|20424608|P4|COMPLETED|Overall Study||11
8283901|NCT01655069|20424609|P3|COMPLETED|Overall Study||12
8283902|NCT01655069|20424610|P2|COMPLETED|Overall Study||46
8283903|NCT01655069|20424611|P1|COMPLETED|Overall Study||53
8283904|NCT01655069|20424608|P4|Full Analysis Set (FAS)|Overall Study||15
8283905|NCT01655069|20424609|P3|Full Analysis Set (FAS)|Overall Study||14
8283906|NCT01655069|20424610|P2|Full Analysis Set (FAS)|Overall Study||57
8283907|NCT01655069|20424611|P1|Full Analysis Set (FAS)|Overall Study||60
8283908|NCT01655069|20424608|P4|Safety Analysis Set (SAF)|Overall Study||15
8283909|NCT01655069|20424609|P3|Safety Analysis Set (SAF)|Overall Study||14
8283910|NCT01655069|20424610|P2|Safety Analysis Set (SAF)|Overall Study||57
8283911|NCT01655069|20424611|P1|Safety Analysis Set (SAF)|Overall Study||61
8283912|NCT01655069|20424608|P4|STARTED|Overall Study||15
8283913|NCT01655069|20424609|P3|STARTED|Overall Study||14
8283914|NCT01655069|20424610|P2|STARTED|Overall Study||58
8283915|NCT01655069|20424611|P1|STARTED|Overall Study||61
8283916|NCT01655043|20424626|P1|NOT COMPLETED|Overall Study||0
8283917|NCT01655043|20424626|P1|COMPLETED|Overall Study||20
8283918|NCT01655043|20424626|P1|STARTED|Overall Study||20
8283919|NCT01654887|20424632|P2|NOT COMPLETED|Overall Study||0
8283920|NCT01654887|20424633|P1|NOT COMPLETED|Overall Study||0
8283921|NCT01654887|20424632|P2|COMPLETED|Overall Study||88
8283922|NCT01654887|20424633|P1|COMPLETED|Overall Study||103
8283923|NCT01654887|20424632|P2|STARTED|Overall Study||88
8283924|NCT01654887|20424633|P1|STARTED|Overall Study||103
8283925|NCT01654861|20424649|P1|NOT COMPLETED|Overall Study||0
8283926|NCT01654861|20424649|P1|COMPLETED|Overall Study||3
8283927|NCT01654861|20424649|P1|STARTED|Overall Study||3
8283928|NCT01654796|20424657|P3|NOT COMPLETED|Overall Study||1
8283929|NCT01654796|20424658|P2|NOT COMPLETED|Overall Study||3
8283930|NCT01654796|20424659|P1|NOT COMPLETED|Overall Study||1
8283931|NCT01654796|20424657|P3|COMPLETED|Overall Study||28
8283932|NCT01654796|20424658|P2|COMPLETED|Overall Study||26
8283933|NCT01654796|20424659|P1|COMPLETED|Overall Study||25
8283934|NCT01654796|20424657|P3|STARTED|Overall Study||29
8283935|NCT01654796|20424658|P2|STARTED|Overall Study||29
8283936|NCT01654796|20424659|P1|STARTED|Overall Study||26
8283937|NCT01654666|20424671|P3|NOT COMPLETED|Overall Study||14
8283938|NCT01654666|20424672|P2|NOT COMPLETED|Overall Study||13
8283939|NCT01654666|20424673|P1|NOT COMPLETED|Overall Study||15
8283940|NCT01654666|20424671|P3|COMPLETED|Overall Study||49
8283941|NCT01654666|20424672|P2|COMPLETED|Overall Study||50
8283942|NCT01654666|20424673|P1|COMPLETED|Overall Study||48
8283943|NCT01654666|20424671|P3|Primary Analysis|Overall Study||54
8283944|NCT01654666|20424672|P2|Primary Analysis|Overall Study||56
8283945|NCT01654666|20424673|P1|Primary Analysis|Overall Study||52
8283946|NCT01654666|20424671|P3|STARTED|Overall Study||63
8283947|NCT01654666|20424672|P2|STARTED|Overall Study||63
8283948|NCT01654666|20424673|P1|STARTED|Overall Study||63
8283949|NCT01654601|20424698|P2|NOT COMPLETED|2nd Administration||1
8283950|NCT01654601|20424699|P1|NOT COMPLETED|2nd Administration||1
8283951|NCT01654601|20424698|P2|COMPLETED|2nd Administration||11
8283952|NCT01654601|20424699|P1|COMPLETED|2nd Administration||11
8283953|NCT01654601|20424698|P2|STARTED|2nd Administration||12
8283954|NCT01654601|20424699|P1|STARTED|2nd Administration||12
8283955|NCT01654601|20424698|P2|NOT COMPLETED|1st Administration||2
8283956|NCT01654601|20424699|P1|NOT COMPLETED|1st Administration||2
8283957|NCT01654601|20424698|P2|COMPLETED|1st Administration||12
8283958|NCT01654601|20424699|P1|COMPLETED|1st Administration||12
8283959|NCT01654601|20424698|P2|STARTED|1st Administration||14
8283960|NCT01654601|20424699|P1|STARTED|1st Administration||14
8283961|NCT01654549|20424713|P2|NOT COMPLETED|Overall Study||1
8283962|NCT01654549|20424714|P1|NOT COMPLETED|Overall Study||0
8283963|NCT01654549|20424713|P2|COMPLETED|Overall Study||19
8283964|NCT01654549|20424714|P1|COMPLETED|Overall Study||20
8283965|NCT01654549|20424713|P2|STARTED|Overall Study||20
8283966|NCT01654549|20424714|P1|STARTED|Overall Study||20
8283967|NCT01654536|20424726|P2|NOT COMPLETED|Overall Study||38
8283968|NCT01654536|20424727|P1|NOT COMPLETED|Overall Study||44
8283969|NCT01654536|20424726|P2|COMPLETED|Overall Study||331
8283970|NCT01654536|20424727|P1|COMPLETED|Overall Study||324
8283971|NCT01654536|20424726|P2|STARTED|Overall Study||369
8283972|NCT01654536|20424727|P1|STARTED|Overall Study||368
8283973|NCT01654523|20424763|P1|NOT COMPLETED|Overall Study||1
8283974|NCT01654523|20424763|P1|COMPLETED|Overall Study||19
8283975|NCT01654523|20424763|P1|STARTED|Overall Study||20
8283976|NCT01654445|20424769|P2|NOT COMPLETED|Overall Study||0
8283977|NCT01654445|20424770|P1|NOT COMPLETED|Overall Study||0
8283978|NCT01654445|20424769|P2|COMPLETED|Overall Study||25
8283979|NCT01654445|20424770|P1|COMPLETED|Overall Study||25
8283980|NCT01654445|20424769|P2|STARTED|Overall Study||25
8283981|NCT01654445|20424770|P1|STARTED|Overall Study||25
8283982|NCT01654380|20424782|P4|NOT COMPLETED|Part B, Period 4||0
8283983|NCT01654380|20424783|P3|NOT COMPLETED|Part B, Period 4||0
8283984|NCT01654380|20424784|P2|NOT COMPLETED|Part B, Period 4||0
8283985|NCT01654380|20424785|P1|NOT COMPLETED|Part B, Period 4||0
8283986|NCT01654380|20424782|P4|COMPLETED|Part B, Period 4||7
8283987|NCT01654380|20424783|P3|COMPLETED|Part B, Period 4||6
8283988|NCT01654380|20424784|P2|COMPLETED|Part B, Period 4||0
8283989|NCT01654380|20424785|P1|COMPLETED|Part B, Period 4||0
8283990|NCT01654380|20424782|P4|STARTED|Part B, Period 4||7
8283991|NCT01654380|20424783|P3|STARTED|Part B, Period 4||6
8283992|NCT01654380|20424784|P2|STARTED|Part B, Period 4||0
8283993|NCT01654380|20424785|P1|STARTED|Part B, Period 4||0
8283994|NCT01654380|20424782|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8283995|NCT01654380|20424783|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8283996|NCT01654380|20424784|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8283997|NCT01654380|20424785|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8283998|NCT01654380|20424782|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
8283999|NCT01654380|20424783|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
8284000|NCT01654380|20424784|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
8284001|NCT01654380|20424785|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
8284002|NCT01654380|20424782|P4|STARTED|Part B, Washout of at Least 6 Days||7
8284003|NCT01654380|20424783|P3|STARTED|Part B, Washout of at Least 6 Days||6
8284004|NCT01654380|20424784|P2|STARTED|Part B, Washout of at Least 6 Days||0
8284005|NCT01654380|20424785|P1|STARTED|Part B, Washout of at Least 6 Days||0
8284006|NCT01654380|20424782|P4|NOT COMPLETED|Part B, Period 3||0
8284007|NCT01654380|20424783|P3|NOT COMPLETED|Part B, Period 3||0
8284008|NCT01654380|20424784|P2|NOT COMPLETED|Part B, Period 3||0
8284009|NCT01654380|20424785|P1|NOT COMPLETED|Part B, Period 3||0
8284010|NCT01654380|20424782|P4|COMPLETED|Part B, Period 3||7
8284011|NCT01654380|20424783|P3|COMPLETED|Part B, Period 3||6
8284012|NCT01654380|20424784|P2|COMPLETED|Part B, Period 3||0
8284013|NCT01654380|20424785|P1|COMPLETED|Part B, Period 3||0
8284014|NCT01654380|20424782|P4|STARTED|Part B, Period 3||7
8284015|NCT01654380|20424783|P3|STARTED|Part B, Period 3||6
8284016|NCT01654380|20424784|P2|STARTED|Part B, Period 3||0
8284017|NCT01654380|20424785|P1|STARTED|Part B, Period 3||0
8284018|NCT01654380|20424782|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284019|NCT01654380|20424783|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284020|NCT01654380|20424784|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284021|NCT01654380|20424785|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284022|NCT01654380|20424782|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
8284023|NCT01654380|20424783|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
8284024|NCT01654380|20424784|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
8284025|NCT01654380|20424785|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
8284026|NCT01654380|20424782|P4|STARTED|Part B, Washout of at Least 6 Days||7
8284027|NCT01654380|20424783|P3|STARTED|Part B, Washout of at Least 6 Days||6
8284028|NCT01654380|20424784|P2|STARTED|Part B, Washout of at Least 6 Days||0
8284029|NCT01654380|20424785|P1|STARTED|Part B, Washout of at Least 6 Days||0
8284030|NCT01654380|20424782|P4|NOT COMPLETED|Part B, Period 2||0
8284031|NCT01654380|20424783|P3|NOT COMPLETED|Part B, Period 2||0
8284032|NCT01654380|20424784|P2|NOT COMPLETED|Part B, Period 2||0
8284033|NCT01654380|20424785|P1|NOT COMPLETED|Part B, Period 2||0
8284034|NCT01654380|20424782|P4|COMPLETED|Part B, Period 2||7
8284035|NCT01654380|20424783|P3|COMPLETED|Part B, Period 2||6
8284036|NCT01654380|20424784|P2|COMPLETED|Part B, Period 2||0
8284037|NCT01654380|20424785|P1|COMPLETED|Part B, Period 2||0
8284038|NCT01654380|20424782|P4|STARTED|Part B, Period 2||7
8284039|NCT01654380|20424783|P3|STARTED|Part B, Period 2||6
8284040|NCT01654380|20424784|P2|STARTED|Part B, Period 2||0
8284041|NCT01654380|20424785|P1|STARTED|Part B, Period 2||0
8284042|NCT01654380|20424782|P4|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284043|NCT01654380|20424783|P3|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284044|NCT01654380|20424784|P2|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284045|NCT01654380|20424785|P1|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
8284046|NCT01654380|20424782|P4|COMPLETED|Part B, Washout of at Least 6 Days||7
8284047|NCT01654380|20424783|P3|COMPLETED|Part B, Washout of at Least 6 Days||6
8284048|NCT01654380|20424784|P2|COMPLETED|Part B, Washout of at Least 6 Days||0
8284049|NCT01654380|20424785|P1|COMPLETED|Part B, Washout of at Least 6 Days||0
8284050|NCT01654380|20424782|P4|STARTED|Part B, Washout of at Least 6 Days||7
8284051|NCT01654380|20424783|P3|STARTED|Part B, Washout of at Least 6 Days||6
8284052|NCT01654380|20424784|P2|STARTED|Part B, Washout of at Least 6 Days||0
8284053|NCT01654380|20424785|P1|STARTED|Part B, Washout of at Least 6 Days||0
8284054|NCT01654380|20424782|P4|NOT COMPLETED|Part B, Period 1||0
8284055|NCT01654380|20424783|P3|NOT COMPLETED|Part B, Period 1||1
8284056|NCT01654380|20424784|P2|NOT COMPLETED|Part B, Period 1||0
8284057|NCT01654380|20424785|P1|NOT COMPLETED|Part B, Period 1||0
8284058|NCT01654380|20424782|P4|COMPLETED|Part B, Period 1||7
8284059|NCT01654380|20424783|P3|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6
8284060|NCT01654380|20424784|P2|COMPLETED|Part B, Period 1||0
8284061|NCT01654380|20424785|P1|COMPLETED|Part B, Period 1||0
8284062|NCT01654380|20424782|P4|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
8284063|NCT01654380|20424783|P3|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
8284064|NCT01654380|20424784|P2|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
8284065|NCT01654380|20424785|P1|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
8284066|NCT01654380|20424782|P4|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
8284067|NCT01654380|20424783|P3|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
8284068|NCT01654380|20424784|P2|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
8284069|NCT01654380|20424785|P1|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
8284070|NCT01654380|20424782|P4|NOT COMPLETED|Part A, Period 4||0
8284071|NCT01654380|20424783|P3|NOT COMPLETED|Part A, Period 4||0
8284072|NCT01654380|20424784|P2|NOT COMPLETED|Part A, Period 4||0
8284073|NCT01654380|20424785|P1|NOT COMPLETED|Part A, Period 4||0
8284074|NCT01654380|20424782|P4|COMPLETED|Part A, Period 4||0
8284075|NCT01654380|20424783|P3|COMPLETED|Part A, Period 4||0
8284076|NCT01654380|20424784|P2|COMPLETED|Part A, Period 4||4
8284077|NCT01654380|20424785|P1|COMPLETED|Part A, Period 4||4
8284078|NCT01654380|20424782|P4|STARTED|Part A, Period 4||0
8284079|NCT01654380|20424783|P3|STARTED|Part A, Period 4||0
8284080|NCT01654380|20424784|P2|STARTED|Part A, Period 4||4
8284081|NCT01654380|20424785|P1|STARTED|Part A, Period 4||4
8284082|NCT01654380|20424782|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284083|NCT01654380|20424783|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284084|NCT01654380|20424784|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284085|NCT01654380|20424785|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284086|NCT01654380|20424782|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
8284087|NCT01654380|20424783|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
8284088|NCT01654380|20424784|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
8284089|NCT01654380|20424785|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
8284090|NCT01654380|20424782|P4|STARTED|Part A, Washout of at Least 6 Days||0
8284091|NCT01654380|20424783|P3|STARTED|Part A, Washout of at Least 6 Days||0
8284092|NCT01654380|20424784|P2|STARTED|Part A, Washout of at Least 6 Days||4
8284093|NCT01654380|20424785|P1|STARTED|Part A, Washout of at Least 6 Days||4
8284094|NCT01654380|20424782|P4|NOT COMPLETED|Part A, Period 3||0
8284095|NCT01654380|20424783|P3|NOT COMPLETED|Part A, Period 3||0
8284096|NCT01654380|20424784|P2|NOT COMPLETED|Part A, Period 3||0
8284097|NCT01654380|20424785|P1|NOT COMPLETED|Part A, Period 3||0
8284098|NCT01654380|20424782|P4|COMPLETED|Part A, Period 3||0
8284099|NCT01654380|20424783|P3|COMPLETED|Part A, Period 3||0
8284100|NCT01654380|20424784|P2|COMPLETED|Part A, Period 3||4
8284101|NCT01654380|20424785|P1|COMPLETED|Part A, Period 3||4
8284102|NCT01654380|20424782|P4|STARTED|Part A, Period 3||0
8284103|NCT01654380|20424783|P3|STARTED|Part A, Period 3||0
8284104|NCT01654380|20424784|P2|STARTED|Part A, Period 3||4
8284105|NCT01654380|20424785|P1|STARTED|Part A, Period 3||4
8284106|NCT01654380|20424782|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284107|NCT01654380|20424783|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284108|NCT01654380|20424784|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284109|NCT01654380|20424785|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284110|NCT01654380|20424782|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
8284111|NCT01654380|20424783|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
8284112|NCT01654380|20424784|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
8284113|NCT01654380|20424785|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
8284114|NCT01654380|20424782|P4|STARTED|Part A, Washout of at Least 6 Days||0
8284115|NCT01654380|20424783|P3|STARTED|Part A, Washout of at Least 6 Days||0
8284116|NCT01654380|20424784|P2|STARTED|Part A, Washout of at Least 6 Days||4
8284117|NCT01654380|20424785|P1|STARTED|Part A, Washout of at Least 6 Days||4
8284118|NCT01654380|20424782|P4|NOT COMPLETED|Part A, Period 2||0
8284119|NCT01654380|20424783|P3|NOT COMPLETED|Part A, Period 2||0
8284120|NCT01654380|20424784|P2|NOT COMPLETED|Part A, Period 2||0
8284121|NCT01654380|20424785|P1|NOT COMPLETED|Part A, Period 2||0
8284122|NCT01654380|20424782|P4|COMPLETED|Part A, Period 2||0
8284123|NCT01654380|20424783|P3|COMPLETED|Part A, Period 2||0
8284124|NCT01654380|20424784|P2|COMPLETED|Part A, Period 2||4
8284125|NCT01654380|20424785|P1|COMPLETED|Part A, Period 2||4
8284126|NCT01654380|20424782|P4|STARTED|Part A, Period 2||0
8284127|NCT01654380|20424783|P3|STARTED|Part A, Period 2||0
8284128|NCT01654380|20424784|P2|STARTED|Part A, Period 2||4
8284129|NCT01654380|20424785|P1|STARTED|Part A, Period 2||4
8284130|NCT01654380|20424782|P4|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284131|NCT01654380|20424783|P3|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284132|NCT01654380|20424784|P2|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284133|NCT01654380|20424785|P1|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
8284134|NCT01654380|20424782|P4|COMPLETED|Part A, Washout of at Least 6 Days||0
8284135|NCT01654380|20424783|P3|COMPLETED|Part A, Washout of at Least 6 Days||0
8284136|NCT01654380|20424784|P2|COMPLETED|Part A, Washout of at Least 6 Days||4
8284137|NCT01654380|20424785|P1|COMPLETED|Part A, Washout of at Least 6 Days||4
8284138|NCT01654380|20424782|P4|STARTED|Part A, Washout of at Least 6 Days||0
8284139|NCT01654380|20424783|P3|STARTED|Part A, Washout of at Least 6 Days||0
8284140|NCT01654380|20424784|P2|STARTED|Part A, Washout of at Least 6 Days||4
8284141|NCT01654380|20424785|P1|STARTED|Part A, Washout of at Least 6 Days||4
8284142|NCT01654380|20424782|P4|NOT COMPLETED|Part A, Period 1||0
8284143|NCT01654380|20424783|P3|NOT COMPLETED|Part A, Period 1||0
8284144|NCT01654380|20424784|P2|NOT COMPLETED|Part A, Period 1||0
8284145|NCT01654380|20424785|P1|NOT COMPLETED|Part A, Period 1||0
8284146|NCT01654380|20424782|P4|COMPLETED|Part A, Period 1||0
8284147|NCT01654380|20424783|P3|COMPLETED|Part A, Period 1||0
8284148|NCT01654380|20424784|P2|COMPLETED|Part A, Period 1||4
8284149|NCT01654380|20424785|P1|COMPLETED|Part A, Period 1||4
8284150|NCT01654380|20424782|P4|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
8284151|NCT01654380|20424783|P3|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
8284152|NCT01654380|20424784|P2|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
8284153|NCT01654380|20424785|P1|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
8284154|NCT01654380|20424782|P4|STARTED|Part A, Period 1||0
8284155|NCT01654380|20424783|P3|STARTED|Part A, Period 1||0
8284156|NCT01654380|20424784|P2|STARTED|Part A, Period 1||4
8284157|NCT01654380|20424785|P1|STARTED|Part A, Period 1||4
8284158|NCT01654315|20424813|P3|NOT COMPLETED|Overall Study||0
8284159|NCT01654315|20424814|P2|NOT COMPLETED|Overall Study||0
8284160|NCT01654315|20424815|P1|NOT COMPLETED|Overall Study||0
8284161|NCT01654315|20424813|P3|COMPLETED|Overall Study||9
8284162|NCT01654315|20424814|P2|COMPLETED|Overall Study||10
8284163|NCT01654315|20424815|P1|COMPLETED|Overall Study||15
8284164|NCT01654315|20424813|P3|STARTED|Overall Study||9
8284165|NCT01654315|20424814|P2|STARTED|Overall Study||10
8284166|NCT01654315|20424815|P1|STARTED|Overall Study||15
8284167|NCT01654302|20424828|P2|NOT COMPLETED|Second Intervention (Day 7)||1
8284168|NCT01654302|20424829|P1|NOT COMPLETED|Second Intervention (Day 7)||1
8284169|NCT01654302|20424828|P2|COMPLETED|Second Intervention (Day 7)||19
8284170|NCT01654302|20424829|P1|COMPLETED|Second Intervention (Day 7)||19
8284171|NCT01654302|20424828|P2|STARTED|Second Intervention (Day 7)||20
8284172|NCT01654302|20424829|P1|STARTED|Second Intervention (Day 7)||20
8284173|NCT01654302|20424828|P2|NOT COMPLETED|First Intervention (Day 1)||0
8284174|NCT01654302|20424829|P1|NOT COMPLETED|First Intervention (Day 1)||0
8284175|NCT01654302|20424828|P2|COMPLETED|First Intervention (Day 1)||20
8284176|NCT01654302|20424829|P1|COMPLETED|First Intervention (Day 1)||20
8284177|NCT01654302|20424828|P2|STARTED|First Intervention (Day 1)||20
8284178|NCT01654302|20424829|P1|STARTED|First Intervention (Day 1)||20
8284179|NCT01654289|20424838|P3|NOT COMPLETED|Overall Study||5
8284180|NCT01654289|20424839|P2|NOT COMPLETED|Overall Study||28
8284181|NCT01654289|20424840|P1|NOT COMPLETED|Overall Study||27
8284182|NCT01654289|20424838|P3|COMPLETED|Overall Study||133
8284183|NCT01654289|20424839|P2|COMPLETED|Overall Study||109
8284184|NCT01654289|20424840|P1|COMPLETED|Overall Study||111
8284185|NCT01654289|20424838|P3|STARTED|Overall Study||138
8284186|NCT01654289|20424839|P2|STARTED|Overall Study||137
8284187|NCT01654289|20424840|P1|STARTED|Overall Study||138
8284188|NCT01654276|20424878|P1|NOT COMPLETED|Overall Study||6
8284189|NCT01654276|20424878|P1|COMPLETED|Overall Study||18
8284190|NCT01654276|20424878|P1|Visit 4 (6months)|Overall Study||18
8284191|NCT01654276|20424878|P1|Visit 3 (4 Months)|Overall Study||18
8284192|NCT01654276|20424878|P1|Visit 2 (2 Months)|Overall Study||19
8284193|NCT01654276|20424878|P1|STARTED|Overall Study||24
8284194|NCT01654263|20424902|P6|NOT COMPLETED|Overall Study||1
8284195|NCT01654263|20424903|P5|NOT COMPLETED|Overall Study||1
8284196|NCT01654263|20424904|P4|NOT COMPLETED|Overall Study||1
8284197|NCT01654263|20424905|P3|NOT COMPLETED|Overall Study||2
8284198|NCT01654263|20424906|P2|NOT COMPLETED|Overall Study||0
8284199|NCT01654263|20424907|P1|NOT COMPLETED|Overall Study||0
8284200|NCT01654263|20424902|P6|COMPLETED|Overall Study||148
8284201|NCT01654263|20424903|P5|COMPLETED|Overall Study||139
8284202|NCT01654263|20424904|P4|COMPLETED|Overall Study||144
8284203|NCT01654263|20424905|P3|COMPLETED|Overall Study||137
8284204|NCT01654263|20424906|P2|COMPLETED|Overall Study||147
8284205|NCT01654263|20424907|P1|COMPLETED|Overall Study||164
8284206|NCT01654263|20424902|P6|STARTED|Overall Study||149
8284207|NCT01654263|20424903|P5|STARTED|Overall Study||140
8284208|NCT01654263|20424904|P4|STARTED|Overall Study||145
8284209|NCT01654263|20424905|P3|STARTED|Overall Study||139
8284210|NCT01654263|20424906|P2|STARTED|Overall Study||147
8284211|NCT01654263|20424907|P1|STARTED|Overall Study||164
8284212|NCT01654250|20424932|P2|NOT COMPLETED|Overall Study||0
8284213|NCT01654250|20424933|P1|NOT COMPLETED|Overall Study||1
8284214|NCT01654250|20424932|P2|COMPLETED|Overall Study||42
8284215|NCT01654250|20424933|P1|COMPLETED|Overall Study||43
8284216|NCT01654250|20424932|P2|STARTED|Overall Study||42
8284217|NCT01654250|20424933|P1|STARTED|Overall Study||44
8284218|NCT01654224|20424950|P2|NOT COMPLETED|Overall Study||12
8284219|NCT01654224|20424951|P1|NOT COMPLETED|Overall Study||6
8284220|NCT01654224|20424950|P2|COMPLETED|Overall Study||98
8284221|NCT01654224|20424951|P1|COMPLETED|Overall Study||89
8284222|NCT01654224|20424950|P2|STARTED|Overall Study||110
8284223|NCT01654224|20424951|P1|STARTED|Overall Study||95
8284224|NCT01654107|20424963|P2|NOT COMPLETED|Overall Study||8
8284225|NCT01654107|20424964|P1|NOT COMPLETED|Overall Study||3
8284226|NCT01654107|20424963|P2|COMPLETED|Overall Study||22
8284227|NCT01654107|20424964|P1|COMPLETED|Overall Study||25
8284228|NCT01654107|20424963|P2|STARTED|Overall Study||30
8284229|NCT01654107|20424964|P1|STARTED|Overall Study||28
8284230|NCT01654068|20424970|P1|NOT COMPLETED|Overall Study||0
8284231|NCT01654068|20424970|P1|COMPLETED|Overall Study||14
8284232|NCT01654068|20424970|P1|STARTED|Overall Study||14
8284233|NCT01653964|20424976|P1|NOT COMPLETED|Overall Study||0
8284234|NCT01653964|20424976|P1|COMPLETED|Overall Study||82
8284235|NCT01653964|20424976|P1|STARTED|Overall Study||82
8284236|NCT01653912|20424982|P6|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
8284237|NCT01653912|20424983|P5|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8284238|NCT01653912|20424984|P4|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8284239|NCT01653912|20424985|P3|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8284240|NCT01653912|20424986|P2|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8284241|NCT01653912|20424987|P1|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
8284242|NCT01653912|20424982|P6|COMPLETED|Phase 2: GSK2110183 125 mg||22
8284243|NCT01653912|20424983|P5|COMPLETED|Phase 2: GSK2110183 125 mg||0
8284244|NCT01653912|20424984|P4|COMPLETED|Phase 2: GSK2110183 125 mg||0
8284245|NCT01653912|20424985|P3|COMPLETED|Phase 2: GSK2110183 125 mg||0
8284246|NCT01653912|20424986|P2|COMPLETED|Phase 2: GSK2110183 125 mg||0
8284247|NCT01653912|20424987|P1|COMPLETED|Phase 2: GSK2110183 125 mg||0
8284248|NCT01653912|20424982|P6|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
8284249|NCT01653912|20424983|P5|STARTED|Phase 2: GSK2110183 125 mg||0
8284250|NCT01653912|20424984|P4|STARTED|Phase 2: GSK2110183 125 mg||0
8284251|NCT01653912|20424985|P3|STARTED|Phase 2: GSK2110183 125 mg||0
8284252|NCT01653912|20424986|P2|STARTED|Phase 2: GSK2110183 125 mg||0
8284253|NCT01653912|20424987|P1|STARTED|Phase 2: GSK2110183 125 mg||0
8284254|NCT01653912|20424982|P6|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284255|NCT01653912|20424983|P5|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284256|NCT01653912|20424984|P4|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284257|NCT01653912|20424985|P3|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284258|NCT01653912|20424986|P2|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284259|NCT01653912|20424987|P1|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284260|NCT01653912|20424982|P6|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284261|NCT01653912|20424983|P5|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
8284262|NCT01653912|20424984|P4|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284263|NCT01653912|20424985|P3|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284264|NCT01653912|20424986|P2|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284265|NCT01653912|20424987|P1|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284266|NCT01653912|20424982|P6|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284267|NCT01653912|20424983|P5|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
8284268|NCT01653912|20424984|P4|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284269|NCT01653912|20424985|P3|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284270|NCT01653912|20424986|P2|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284271|NCT01653912|20424987|P1|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
8284272|NCT01653912|20424982|P6|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284273|NCT01653912|20424983|P5|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284274|NCT01653912|20424984|P4|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
8284275|NCT01653912|20424985|P3|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284276|NCT01653912|20424986|P2|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284277|NCT01653912|20424987|P1|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284278|NCT01653912|20424982|P6|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284279|NCT01653912|20424983|P5|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284280|NCT01653912|20424984|P4|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
8284281|NCT01653912|20424985|P3|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284282|NCT01653912|20424986|P2|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284283|NCT01653912|20424987|P1|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284284|NCT01653912|20424982|P6|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284285|NCT01653912|20424983|P5|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284286|NCT01653912|20424984|P4|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
8284287|NCT01653912|20424985|P3|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284288|NCT01653912|20424986|P2|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284289|NCT01653912|20424987|P1|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
8284290|NCT01653912|20424982|P6|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284291|NCT01653912|20424983|P5|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284292|NCT01653912|20424984|P4|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284293|NCT01653912|20424985|P3|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
8284294|NCT01653912|20424986|P2|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284295|NCT01653912|20424987|P1|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284296|NCT01653912|20424982|P6|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284297|NCT01653912|20424983|P5|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284298|NCT01653912|20424984|P4|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284299|NCT01653912|20424985|P3|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
8284300|NCT01653912|20424986|P2|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284301|NCT01653912|20424987|P1|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284302|NCT01653912|20424982|P6|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284303|NCT01653912|20424983|P5|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284304|NCT01653912|20424984|P4|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284305|NCT01653912|20424985|P3|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
8284306|NCT01653912|20424986|P2|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284307|NCT01653912|20424987|P1|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
8284308|NCT01653912|20424982|P6|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284395|NCT01653262|20425129|P1|NOT COMPLETED|Overall Study||3
8284309|NCT01653912|20424983|P5|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284310|NCT01653912|20424984|P4|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284311|NCT01653912|20424985|P3|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284312|NCT01653912|20424986|P2|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
8284313|NCT01653912|20424987|P1|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284314|NCT01653912|20424982|P6|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284315|NCT01653912|20424983|P5|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284316|NCT01653912|20424984|P4|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284317|NCT01653912|20424985|P3|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284318|NCT01653912|20424986|P2|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
8284319|NCT01653912|20424987|P1|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284320|NCT01653912|20424982|P6|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284321|NCT01653912|20424983|P5|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284322|NCT01653912|20424984|P4|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284323|NCT01653912|20424985|P3|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284324|NCT01653912|20424986|P2|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
8284325|NCT01653912|20424987|P1|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
8284326|NCT01653912|20424982|P6|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284327|NCT01653912|20424983|P5|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284328|NCT01653912|20424984|P4|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284329|NCT01653912|20424985|P3|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284330|NCT01653912|20424986|P2|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284331|NCT01653912|20424987|P1|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284332|NCT01653912|20424982|P6|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284333|NCT01653912|20424983|P5|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284334|NCT01653912|20424984|P4|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284335|NCT01653912|20424985|P3|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284336|NCT01653912|20424986|P2|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284337|NCT01653912|20424987|P1|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
8284338|NCT01653912|20424982|P6|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284339|NCT01653912|20424983|P5|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284340|NCT01653912|20424984|P4|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284341|NCT01653912|20424985|P3|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284342|NCT01653912|20424986|P2|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
8284343|NCT01653912|20424987|P1|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
8284344|NCT01653782|20425005|P3|NOT COMPLETED|Overall Study||6
8284345|NCT01653782|20425006|P2|NOT COMPLETED|Overall Study||18
8284346|NCT01653782|20425007|P1|NOT COMPLETED|Overall Study||16
8284347|NCT01653782|20425005|P3|COMPLETED|Overall Study||46
8284348|NCT01653782|20425006|P2|COMPLETED|Overall Study||37
8284349|NCT01653782|20425007|P1|COMPLETED|Overall Study||36
8284350|NCT01653782|20425005|P3|STARTED|Overall Study||52
8284351|NCT01653782|20425006|P2|STARTED|Overall Study||55
8284352|NCT01653782|20425007|P1|STARTED|Overall Study||52
8284353|NCT01653743|20425017|P2|NOT COMPLETED|Overall Study||0
8284354|NCT01653743|20425018|P1|NOT COMPLETED|Overall Study||4
8284355|NCT01653743|20425017|P2|COMPLETED|Overall Study||27
8284356|NCT01653743|20425018|P1|COMPLETED|Overall Study||50
8284357|NCT01653743|20425017|P2|STARTED|Overall Study||27
8284358|NCT01653743|20425018|P1|STARTED|Overall Study||54
8284359|NCT01653704|20425034|P2|NOT COMPLETED|Overall Study||1
8284360|NCT01653704|20425035|P1|NOT COMPLETED|Overall Study||2
8284361|NCT01653704|20425034|P2|COMPLETED|Overall Study||20
8284362|NCT01653704|20425035|P1|COMPLETED|Overall Study||19
8284363|NCT01653704|20425034|P2|STARTED|Overall Study||21
8284364|NCT01653704|20425035|P1|STARTED|Overall Study||21
8284365|NCT01653587|20425043|P2|NOT COMPLETED|Overall Study||0
8284366|NCT01653587|20425044|P1|NOT COMPLETED|Overall Study||0
8284367|NCT01653587|20425043|P2|COMPLETED|Overall Study||120
8284368|NCT01653587|20425044|P1|COMPLETED|Overall Study||120
8284369|NCT01653587|20425043|P2|STARTED|Overall Study||120
8284370|NCT01653587|20425044|P1|STARTED|Overall Study||120
8284371|NCT01653509|20425056|P2|NOT COMPLETED|Overall Study||0
8284372|NCT01653509|20425057|P1|NOT COMPLETED|Overall Study||0
8284373|NCT01653509|20425056|P2|COMPLETED|Overall Study||13
8284374|NCT01653509|20425057|P1|COMPLETED|Overall Study||12
8284375|NCT01653509|20425056|P2|STARTED|Overall Study||13
8284376|NCT01653509|20425057|P1|STARTED|Overall Study||12
8284377|NCT01653418|20425075|P1|NOT COMPLETED|Overall Study||0
8284378|NCT01653418|20425075|P1|COMPLETED|Overall Study||10
8284379|NCT01653418|20425075|P1|STARTED|Overall Study||10
8284380|NCT01653405|20425089|P2|NOT COMPLETED|Overall Study||1068803
8284381|NCT01653405|20425090|P1|NOT COMPLETED|Overall Study||3765
8284382|NCT01653405|20425089|P2|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979
8284383|NCT01653405|20425090|P1|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029
8284384|NCT01653405|20425089|P2|STARTED|Overall Study||1248782
8284385|NCT01653405|20425090|P1|STARTED|Overall Study||11794
8284386|NCT01653327|20425104|P1|NOT COMPLETED|Overall Study||1
8284387|NCT01653327|20425104|P1|COMPLETED|Overall Study||10
8284388|NCT01653327|20425104|P1|STARTED|Overall Study||11
8284389|NCT01653288|20425114|P2|NOT COMPLETED|Overall Study||1
8284390|NCT01653288|20425115|P1|NOT COMPLETED|Overall Study||10
8284391|NCT01653288|20425114|P2|COMPLETED|Overall Study||35
8284392|NCT01653288|20425115|P1|COMPLETED|Overall Study||26
8284393|NCT01653288|20425114|P2|STARTED|Overall Study||36
8284394|NCT01653288|20425115|P1|STARTED|Overall Study||36
8284396|NCT01653262|20425129|P1|COMPLETED|Overall Study||26
8284397|NCT01653262|20425129|P1|STARTED|Overall Study||29
8284398|NCT01653210|20425142|P1|NOT COMPLETED|Overall Study||3
8284399|NCT01653210|20425142|P1|COMPLETED|Overall Study||12
8284400|NCT01653210|20425142|P1|STARTED|Overall Study||15
8284401|NCT01653158|20425147|P8|NOT COMPLETED|Overall Study||15
8284402|NCT01653158|20425148|P7|NOT COMPLETED|Overall Study||2
8284403|NCT01653158|20425149|P6|NOT COMPLETED|Overall Study||1
8284404|NCT01653158|20425150|P5|NOT COMPLETED|Overall Study||1
8284405|NCT01653158|20425151|P4|NOT COMPLETED|Overall Study||2
8284406|NCT01653158|20425152|P3|NOT COMPLETED|Overall Study||0
8284407|NCT01653158|20425153|P2|NOT COMPLETED|Overall Study||0
8284408|NCT01653158|20425154|P1|NOT COMPLETED|Overall Study||1
8284409|NCT01653158|20425147|P8|COMPLETED|Overall Study||4
8284410|NCT01653158|20425148|P7|COMPLETED|Overall Study||7
8284411|NCT01653158|20425149|P6|COMPLETED|Overall Study||2
8284412|NCT01653158|20425150|P5|COMPLETED|Overall Study||2
8284413|NCT01653158|20425151|P4|COMPLETED|Overall Study||1
8284414|NCT01653158|20425152|P3|COMPLETED|Overall Study||3
8284415|NCT01653158|20425153|P2|COMPLETED|Overall Study||3
8284416|NCT01653158|20425154|P1|COMPLETED|Overall Study||2
8284417|NCT01653158|20425147|P8|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
8284418|NCT01653158|20425148|P7|STARTED|Overall Study||9
8284419|NCT01653158|20425149|P6|STARTED|Overall Study||3
8284420|NCT01653158|20425150|P5|STARTED|Overall Study||3
8284421|NCT01653158|20425151|P4|STARTED|Overall Study||3
8284422|NCT01653158|20425152|P3|STARTED|Overall Study||3
8284423|NCT01653158|20425153|P2|STARTED|Overall Study||3
8284424|NCT01653158|20425154|P1|STARTED|Overall Study||3
8284425|NCT01653132|20425426|P2|NOT COMPLETED|Second Intervention||0
8284426|NCT01653132|20425427|P1|NOT COMPLETED|Second Intervention||0
8284427|NCT01653132|20425426|P2|COMPLETED|Second Intervention||5
8284428|NCT01653132|20425427|P1|COMPLETED|Second Intervention||4
8284429|NCT01653132|20425426|P2|STARTED|Second Intervention||5
8284430|NCT01653132|20425427|P1|STARTED|Second Intervention||4
8284431|NCT01653132|20425426|P2|NOT COMPLETED|Washout 1-2 Months||0
8284432|NCT01653132|20425427|P1|NOT COMPLETED|Washout 1-2 Months||0
8284433|NCT01653132|20425426|P2|COMPLETED|Washout 1-2 Months||5
8284434|NCT01653132|20425427|P1|COMPLETED|Washout 1-2 Months||4
8284435|NCT01653132|20425426|P2|STARTED|Washout 1-2 Months||5
8284436|NCT01653132|20425427|P1|STARTED|Washout 1-2 Months||4
8284437|NCT01653132|20425426|P2|NOT COMPLETED|First Intervention||0
8284438|NCT01653132|20425427|P1|NOT COMPLETED|First Intervention||1
8284439|NCT01653132|20425426|P2|COMPLETED|First Intervention||5
8284440|NCT01653132|20425427|P1|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
8284441|NCT01653132|20425426|P2|STARTED|First Intervention||5
8284442|NCT01653132|20425427|P1|STARTED|First Intervention||5
8284443|NCT01653028|20425446|P5|NOT COMPLETED|Overall Study||0
8284444|NCT01653028|20425447|P4|NOT COMPLETED|Overall Study||0
8284445|NCT01653028|20425448|P3|NOT COMPLETED|Overall Study||0
8284446|NCT01653028|20425449|P2|NOT COMPLETED|Overall Study||0
8284447|NCT01653028|20425450|P1|NOT COMPLETED|Overall Study||0
8284448|NCT01653028|20425446|P5|COMPLETED|Overall Study||29
8284449|NCT01653028|20425447|P4|COMPLETED|Overall Study||10
8284450|NCT01653028|20425448|P3|COMPLETED|Overall Study||11
8284451|NCT01653028|20425449|P2|COMPLETED|Overall Study||10
8284452|NCT01653028|20425450|P1|COMPLETED|Overall Study||12
8284453|NCT01653028|20425446|P5|STARTED|Overall Study||29
8284454|NCT01653028|20425447|P4|STARTED|Overall Study||10
8284455|NCT01653028|20425448|P3|STARTED|Overall Study||11
8284456|NCT01653028|20425449|P2|STARTED|Overall Study||10
8284457|NCT01653028|20425450|P1|STARTED|Overall Study||12
8284458|NCT01652976|20425477|P1|NOT COMPLETED|Overall Study||0
8284459|NCT01652976|20425477|P1|COMPLETED|Overall Study||44
8284460|NCT01652976|20425477|P1|STARTED|Overall Study||44
8284461|NCT01652885|20425491|P1|NOT COMPLETED|Overall Study||1
8284462|NCT01652885|20425491|P1|COMPLETED|Overall Study||22
8284463|NCT01652885|20425491|P1|STARTED|Overall Study||23
8284464|NCT01652872|20425518|P2|NOT COMPLETED|Overall Study||153
8284465|NCT01652872|20425519|P1|NOT COMPLETED|Overall Study||145
8284466|NCT01652872|20425518|P2|COMPLETED|Overall Study||226
8284467|NCT01652872|20425519|P1|COMPLETED|Overall Study||232
8284468|NCT01652872|20425518|P2|Received Investigational Product|Overall Study||377
8284469|NCT01652872|20425519|P1|Received Investigational Product|Overall Study||377
8284470|NCT01652872|20425518|P2|STARTED|Overall Study||379
8284471|NCT01652872|20425519|P1|STARTED|Overall Study||377
8284472|NCT01652729|20425536|P3|NOT COMPLETED|Overall Study||14
8284473|NCT01652729|20425537|P2|NOT COMPLETED|Overall Study||13
8284474|NCT01652729|20425538|P1|NOT COMPLETED|Overall Study||27
8284475|NCT01652729|20425536|P3|COMPLETED|Overall Study||47
8284476|NCT01652729|20425537|P2|COMPLETED|Overall Study||109
8284477|NCT01652729|20425538|P1|COMPLETED|Overall Study|The double-enrolled subject's reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
8284478|NCT01652729|20425536|P3|Meal Test Evaluable|Overall Study||15
8284479|NCT01652729|20425537|P2|Meal Test Evaluable|Overall Study||31
8284480|NCT01652729|20425538|P1|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
8284481|NCT01652729|20425536|P3|Meal Test Subjects|Overall Study||20
8284482|NCT01652729|20425537|P2|Meal Test Subjects|Overall Study||41
8284483|NCT01652729|20425538|P1|Meal Test Subjects|Overall Study||60
8284484|NCT01652729|20425536|P3|Evaluable|Overall Study||43
8284485|NCT01652729|20425537|P2|Evaluable|Overall Study||91
8284486|NCT01652729|20425538|P1|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
8284487|NCT01652729|20425536|P3|Treated|Overall Study||61
8284488|NCT01652729|20425537|P2|Treated|Overall Study||122
8284489|NCT01652729|20425538|P1|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
8284490|NCT01652729|20425536|P3|Modified Intent-to-Treat|Overall Study||61
8284491|NCT01652729|20425537|P2|Modified Intent-to-Treat|Overall Study||122
8284492|NCT01652729|20425538|P1|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
8284493|NCT01652729|20425536|P3|STARTED|Overall Study||61
8284494|NCT01652729|20425537|P2|STARTED|Overall Study||122
8284495|NCT01652729|20425538|P1|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
8284496|NCT01652716|20425560|P2|NOT COMPLETED|Overall Study||46
8284497|NCT01652716|20425561|P1|NOT COMPLETED|Overall Study||56
8284498|NCT01652716|20425560|P2|COMPLETED|Overall Study|* completed study|102
8284499|NCT01652716|20425561|P1|COMPLETED|Overall Study|* completed study|173
8284500|NCT01652716|20425560|P2|Completed 28-week|Overall Study||118
8284501|NCT01652716|20425561|P1|Completed 28-week|Overall Study||197
8284502|NCT01652716|20425560|P2|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
8284503|NCT01652716|20425561|P1|STARTED|Overall Study||229
8284504|NCT01652703|20425581|P6|NOT COMPLETED|Overall Study||2
8284505|NCT01652703|20425582|P5|NOT COMPLETED|Overall Study||1
8284506|NCT01652703|20425583|P4|NOT COMPLETED|Overall Study||2
8284507|NCT01652703|20425584|P3|NOT COMPLETED|Overall Study||3
8284508|NCT01652703|20425585|P2|NOT COMPLETED|Overall Study||1
8284509|NCT01652703|20425586|P1|NOT COMPLETED|Overall Study||0
8284510|NCT01652703|20425581|P6|COMPLETED|Overall Study||51
8284511|NCT01652703|20425582|P5|COMPLETED|Overall Study||51
8284512|NCT01652703|20425583|P4|COMPLETED|Overall Study||50
8284513|NCT01652703|20425584|P3|COMPLETED|Overall Study||47
8284514|NCT01652703|20425585|P2|COMPLETED|Overall Study||50
8284515|NCT01652703|20425586|P1|COMPLETED|Overall Study||52
8284516|NCT01652703|20425581|P6|Received Treatment|Overall Study||53
8284517|NCT01652703|20425582|P5|Received Treatment|Overall Study||51
8284518|NCT01652703|20425583|P4|Received Treatment|Overall Study||52
8284519|NCT01652703|20425584|P3|Received Treatment|Overall Study||49
8284520|NCT01652703|20425585|P2|Received Treatment|Overall Study||50
8284521|NCT01652703|20425586|P1|Received Treatment|Overall Study||52
8284522|NCT01652703|20425581|P6|STARTED|Overall Study||53
8284523|NCT01652703|20425582|P5|STARTED|Overall Study||52
8284524|NCT01652703|20425583|P4|STARTED|Overall Study||52
8284525|NCT01652703|20425584|P3|STARTED|Overall Study||50
8284526|NCT01652703|20425585|P2|STARTED|Overall Study||51
8284527|NCT01652703|20425586|P1|STARTED|Overall Study||52
8284528|NCT01652690|20425644|P2|NOT COMPLETED|Overall Study||21
8284529|NCT01652690|20425645|P1|NOT COMPLETED|Overall Study||35
8284530|NCT01652690|20425644|P2|COMPLETED|Overall Study||279
8284531|NCT01652690|20425645|P1|COMPLETED|Overall Study||265
8284532|NCT01652690|20425644|P2|STARTED|Overall Study||300
8284533|NCT01652690|20425645|P1|STARTED|Overall Study||300
8284534|NCT01652664|20425679|P2|NOT COMPLETED|Overall Study||1
8284535|NCT01652664|20425680|P1|NOT COMPLETED|Overall Study||6
8284536|NCT01652664|20425679|P2|COMPLETED|Overall Study||74
8284537|NCT01652664|20425680|P1|COMPLETED|Overall Study||71
8284538|NCT01652664|20425679|P2|STARTED|Overall Study||75
8284539|NCT01652664|20425680|P1|STARTED|Overall Study||77
8284540|NCT01652573|20425689|P2|NOT COMPLETED|Overall Study||1
8284541|NCT01652573|20425690|P1|NOT COMPLETED|Overall Study||0
8284542|NCT01652573|20425689|P2|COMPLETED|Overall Study||10
8284543|NCT01652573|20425690|P1|COMPLETED|Overall Study||10
8284544|NCT01652573|20425689|P2|STARTED|Overall Study||11
8284545|NCT01652573|20425690|P1|STARTED|Overall Study||10
8284546|NCT01652534|20425732|P2|NOT COMPLETED|Overall Study||0
8284547|NCT01652534|20425733|P1|NOT COMPLETED|Overall Study||1
8284548|NCT01652534|20425732|P2|COMPLETED|Overall Study||1
8284549|NCT01652534|20425733|P1|COMPLETED|Overall Study||1
8284550|NCT01652534|20425732|P2|STARTED|Overall Study||1
8284551|NCT01652534|20425733|P1|STARTED|Overall Study||2
8284552|NCT01652495|20425761|P2|NOT COMPLETED|Overall Study||2
8284553|NCT01652495|20425762|P1|NOT COMPLETED|Overall Study||2
8284554|NCT01652495|20425761|P2|COMPLETED|Overall Study||20
8284555|NCT01652495|20425762|P1|COMPLETED|Overall Study||20
8284556|NCT01652495|20425761|P2|STARTED|Overall Study||22
8284557|NCT01652495|20425762|P1|STARTED|Overall Study||22
8284558|NCT01652469|20425774|P2|NOT COMPLETED|Overall Study||6
8284559|NCT01652469|20425775|P1|NOT COMPLETED|Overall Study||1
8284560|NCT01652469|20425774|P2|COMPLETED|Overall Study||36
8284561|NCT01652469|20425775|P1|COMPLETED|Overall Study||37
8284562|NCT01652469|20425774|P2|STARTED|Overall Study||42
8284563|NCT01652469|20425775|P1|STARTED|Overall Study||38
8284564|NCT01652287|20425791|P2|NOT COMPLETED|Overall Study||0
8284565|NCT01652287|20425792|P1|NOT COMPLETED|Overall Study||2
8284566|NCT01652287|20425791|P2|COMPLETED|Overall Study||31
8284567|NCT01652287|20425792|P1|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
8284568|NCT01652287|20425791|P2|STARTED|Overall Study||31
8284569|NCT01652287|20425792|P1|STARTED|Overall Study||31
8284570|NCT01652040|20425800|P2|NOT COMPLETED|Overall Study||2
8284571|NCT01652040|20425801|P1|NOT COMPLETED|Overall Study||2
8284572|NCT01652040|20425800|P2|COMPLETED|Overall Study||11
8284573|NCT01652040|20425801|P1|COMPLETED|Overall Study||11
8284574|NCT01652040|20425800|P2|STARTED|Overall Study||13
8284575|NCT01652040|20425801|P1|STARTED|Overall Study||13
8284576|NCT01652001|20425811|P2|NOT COMPLETED|Overall Study||6
8284577|NCT01652001|20425812|P1|NOT COMPLETED|Overall Study||9
8284578|NCT01652001|20425811|P2|COMPLETED|Overall Study||79
8284579|NCT01652001|20425812|P1|COMPLETED|Overall Study||91
8284580|NCT01652001|20425811|P2|STARTED|Overall Study||85
8284581|NCT01652001|20425812|P1|STARTED|Overall Study||100
8284582|NCT01651949|20425823|P3|NOT COMPLETED|Overall Study||31
8284583|NCT01651949|20425824|P2|NOT COMPLETED|Overall Study||86
8284584|NCT01651949|20425825|P1|NOT COMPLETED|Overall Study||53
8284585|NCT01651949|20425823|P3|COMPLETED|Overall Study||282
8284586|NCT01651949|20425824|P2|COMPLETED|Overall Study||1015
8284587|NCT01651949|20425825|P1|COMPLETED|Overall Study||1053
8284588|NCT01651949|20425823|P3|Vaccination 3|Overall Study||291
8284589|NCT01651949|20425824|P2|Vaccination 3|Overall Study||1037
8284590|NCT01651949|20425825|P1|Vaccination 3|Overall Study||1067
8284591|NCT01651949|20425823|P3|Vaccination 2|Overall Study||298
8284592|NCT01651949|20425824|P2|Vaccination 2|Overall Study||1069
8284593|NCT01651949|20425825|P1|Vaccination 2|Overall Study||1089
8284594|NCT01651949|20425823|P3|Vaccination 1|Overall Study||313
8284595|NCT01651949|20425824|P2|Vaccination 1|Overall Study||1099
8284596|NCT01651949|20425825|P1|Vaccination 1|Overall Study||1103
8284597|NCT01651949|20425823|P3|STARTED|Overall Study||313
8284598|NCT01651949|20425824|P2|STARTED|Overall Study||1101
8284599|NCT01651949|20425825|P1|STARTED|Overall Study||1106
8284618|NCT01651806|20425873|P5|NOT COMPLETED|Overall Study||0
8284619|NCT01651806|20425874|P4|NOT COMPLETED|Overall Study||0
8284620|NCT01651806|20425875|P3|NOT COMPLETED|Overall Study||0
8284621|NCT01651806|20425876|P2|NOT COMPLETED|Overall Study||0
8284622|NCT01651806|20425877|P1|NOT COMPLETED|Overall Study||0
8284623|NCT01651806|20425873|P5|COMPLETED|Overall Study||8
8284624|NCT01651806|20425874|P4|COMPLETED|Overall Study||7
8284625|NCT01651806|20425875|P3|COMPLETED|Overall Study||25
8284626|NCT01651806|20425876|P2|COMPLETED|Overall Study||12
8284627|NCT01651806|20425877|P1|COMPLETED|Overall Study||13
8284628|NCT01651806|20425873|P5|STARTED|Overall Study||8
8284629|NCT01651806|20425874|P4|STARTED|Overall Study||7
8284630|NCT01651806|20425875|P3|STARTED|Overall Study||25
8284631|NCT01651806|20425876|P2|STARTED|Overall Study||12
8284632|NCT01651806|20425877|P1|STARTED|Overall Study||13
8284633|NCT01651793|20425894|P4|NOT COMPLETED|Overall Study||1
8284634|NCT01651793|20425895|P3|NOT COMPLETED|Overall Study||0
8284635|NCT01651793|20425896|P2|NOT COMPLETED|Overall Study||0
8284636|NCT01651793|20425897|P1|NOT COMPLETED|Overall Study||0
8284637|NCT01651793|20425894|P4|COMPLETED|Overall Study||5
8284638|NCT01651793|20425895|P3|COMPLETED|Overall Study||6
8284639|NCT01651793|20425896|P2|COMPLETED|Overall Study||6
8284640|NCT01651793|20425897|P1|COMPLETED|Overall Study||6
8284641|NCT01651793|20425894|P4|STARTED|Overall Study||6
8284642|NCT01651793|20425895|P3|STARTED|Overall Study||6
8284643|NCT01651793|20425896|P2|STARTED|Overall Study||6
8284644|NCT01651793|20425897|P1|STARTED|Overall Study||6
8284645|NCT01651780|20425917|P2|NOT COMPLETED|Overall Study||10
8284646|NCT01651780|20425918|P1|NOT COMPLETED|Overall Study||11
8284647|NCT01651780|20425917|P2|COMPLETED|Overall Study||388
8284648|NCT01651780|20425918|P1|COMPLETED|Overall Study||394
8284649|NCT01651780|20425917|P2|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
8284650|NCT01651780|20425918|P1|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
8284651|NCT01651780|20425917|P2|Received at Least 1 Dose of Study Drug|Overall Study||394
8284652|NCT01651780|20425918|P1|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
8284653|NCT01651780|20425917|P2|Intent-To-Treat (ITT) Population|Overall Study||398
8284654|NCT01651780|20425918|P1|Intent-To-Treat (ITT) Population|Overall Study||404
8284655|NCT01651780|20425917|P2|STARTED|Overall Study||398
8284656|NCT01651780|20425918|P1|STARTED|Overall Study||405
8284711|NCT01651260|20426020|P1|NOT COMPLETED|Overall Study||3
8284712|NCT01651260|20426020|P1|COMPLETED|Overall Study||62
8284713|NCT01651260|20426020|P1|STARTED|Overall Study||65
8284714|NCT01651208|20426027|P2|NOT COMPLETED|Overall Study||16
8284715|NCT01651208|20426028|P1|NOT COMPLETED|Overall Study||14
8284716|NCT01651208|20426027|P2|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
8284717|NCT01651208|20426028|P1|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
8284718|NCT01651208|20426027|P2|STARTED|Overall Study||225
8284719|NCT01651208|20426028|P1|STARTED|Overall Study||227
8284720|NCT01651117|20426040|P4|NOT COMPLETED|Overall Study||2
8284721|NCT01651117|20426041|P3|NOT COMPLETED|Overall Study||2
8284722|NCT01651117|20426042|P2|NOT COMPLETED|Overall Study||3
8284723|NCT01651117|20426043|P1|NOT COMPLETED|Overall Study||2
8284724|NCT01651117|20426040|P4|COMPLETED|Overall Study||68
8284725|NCT01651117|20426041|P3|COMPLETED|Overall Study||47
8284726|NCT01651117|20426042|P2|COMPLETED|Overall Study||202
8284727|NCT01651117|20426043|P1|COMPLETED|Overall Study||154
8284728|NCT01651117|20426040|P4|STARTED|Overall Study||70
8284729|NCT01651117|20426041|P3|STARTED|Overall Study||49
8284730|NCT01651117|20426042|P2|STARTED|Overall Study||205
8284731|NCT01651117|20426043|P1|STARTED|Overall Study||156
8284732|NCT01651104|20426109|P1|NOT COMPLETED|Overall Study||0
8284733|NCT01651104|20426109|P1|COMPLETED|Overall Study||63
8284734|NCT01651104|20426109|P1|STARTED|Overall Study||63
8284738|NCT01651052|20426123|P1|NOT COMPLETED|Overall Study||26
8284739|NCT01651052|20426123|P1|COMPLETED|Overall Study||107
8284740|NCT01651052|20426123|P1|Study Valve Group|Overall Study||133
8284741|NCT01651052|20426123|P1|STARTED|Overall Study||133
8284742|NCT01651039|20426143|P1|NOT COMPLETED|Overall Study||30
8284743|NCT01651039|20426143|P1|COMPLETED|Overall Study||2
8284744|NCT01651039|20426143|P1|STARTED|Overall Study||32
8284745|NCT01651000|20426156|P2|NOT COMPLETED|Overall Study||28
8284746|NCT01651000|20426157|P1|NOT COMPLETED|Overall Study||10
8284747|NCT01651000|20426156|P2|COMPLETED|Overall Study||113
8284748|NCT01651000|20426157|P1|COMPLETED|Overall Study||62
8284749|NCT01651000|20426156|P2|Entered Extension Study|Overall Study||93
8284750|NCT01651000|20426157|P1|Entered Extension Study|Overall Study||50
8284751|NCT01651000|20426156|P2|STARTED|Overall Study||141
8284752|NCT01651000|20426157|P1|STARTED|Overall Study||72
8284753|NCT01650844|20426171|P2|NOT COMPLETED|Overall Study||4
8284754|NCT01650844|20426172|P1|NOT COMPLETED|Overall Study||1
8284755|NCT01650844|20426171|P2|COMPLETED|Overall Study||196
8284756|NCT01650844|20426172|P1|COMPLETED|Overall Study||199
8284757|NCT01650844|20426171|P2|STARTED|Overall Study||200
8284758|NCT01650844|20426172|P1|STARTED|Overall Study||200
8284759|NCT01650831|20426178|P1|NOT COMPLETED|Overall Study||1
8284760|NCT01650831|20426178|P1|COMPLETED|Overall Study||112
8284761|NCT01650831|20426178|P1|STARTED|Overall Study||113
8284762|NCT01650805|20426188|P2|NOT COMPLETED|Overall Study||0
8284763|NCT01650805|20426189|P1|NOT COMPLETED|Overall Study||1
8284764|NCT01650805|20426188|P2|COMPLETED|Overall Study||152
8284765|NCT01650805|20426189|P1|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
8284766|NCT01650805|20426188|P2|STARTED|Overall Study||152
8284767|NCT01650805|20426189|P1|STARTED|Overall Study|Started means patient has been randomized.|155
8284768|NCT01650779|20426199|P1|NOT COMPLETED|Overall Study||1
8284769|NCT01650779|20426199|P1|COMPLETED|Overall Study||14
8284770|NCT01650779|20426199|P1|STARTED|Overall Study||15
8284771|NCT01650636|20426208|P2|NOT COMPLETED|9 Month Visit||0
8284772|NCT01650636|20426209|P1|NOT COMPLETED|9 Month Visit||0
8284773|NCT01650636|20426208|P2|COMPLETED|9 Month Visit||129
8284774|NCT01650636|20426209|P1|COMPLETED|9 Month Visit||135
8284775|NCT01650636|20426208|P2|STARTED|9 Month Visit||129
8284776|NCT01650636|20426209|P1|STARTED|9 Month Visit||135
8284777|NCT01650636|20426208|P2|NOT COMPLETED|Washout up to 9 Months||3
8284778|NCT01650636|20426209|P1|NOT COMPLETED|Washout up to 9 Months||6
8284779|NCT01650636|20426208|P2|COMPLETED|Washout up to 9 Months||129
8284780|NCT01650636|20426209|P1|COMPLETED|Washout up to 9 Months||135
8284781|NCT01650636|20426208|P2|STARTED|Washout up to 9 Months||132
8284782|NCT01650636|20426209|P1|STARTED|Washout up to 9 Months||141
8284783|NCT01650636|20426208|P2|NOT COMPLETED|5 Month Visit||0
8284784|NCT01650636|20426209|P1|NOT COMPLETED|5 Month Visit||0
8284785|NCT01650636|20426208|P2|COMPLETED|5 Month Visit||132
8284786|NCT01650636|20426209|P1|COMPLETED|5 Month Visit||141
8284787|NCT01650636|20426208|P2|STARTED|5 Month Visit||132
8284788|NCT01650636|20426209|P1|STARTED|5 Month Visit||141
8284789|NCT01650636|20426208|P2|NOT COMPLETED|Washout up to 5 Months||18
8284790|NCT01650636|20426209|P1|NOT COMPLETED|Washout up to 5 Months||9
8284791|NCT01650636|20426208|P2|COMPLETED|Washout up to 5 Months||132
8284792|NCT01650636|20426209|P1|COMPLETED|Washout up to 5 Months||141
8284793|NCT01650636|20426208|P2|STARTED|Washout up to 5 Months||150
8284794|NCT01650636|20426209|P1|STARTED|Washout up to 5 Months||150
8284795|NCT01650636|20426208|P2|NOT COMPLETED|Intervention Phase||0
8284796|NCT01650636|20426209|P1|NOT COMPLETED|Intervention Phase||0
8284797|NCT01650636|20426208|P2|COMPLETED|Intervention Phase||150
8284798|NCT01650636|20426209|P1|COMPLETED|Intervention Phase||150
8284799|NCT01650636|20426208|P2|STARTED|Intervention Phase||150
8284800|NCT01650636|20426209|P1|STARTED|Intervention Phase||150
8284801|NCT01650584|20426229|P1|NOT COMPLETED|Overall Study||0
8284802|NCT01650584|20426229|P1|COMPLETED|Overall Study||35
8284803|NCT01650584|20426229|P1|STARTED|Overall Study|Each participant received one of 2 treatments in each eye.|35
8284804|NCT01650545|20426236|P2|NOT COMPLETED|Overall Study||0
8284805|NCT01650545|20426237|P1|NOT COMPLETED|Overall Study||0
8284806|NCT01650545|20426236|P2|COMPLETED|Overall Study||10
8284807|NCT01650545|20426237|P1|COMPLETED|Overall Study||11
8284808|NCT01650545|20426236|P2|STARTED|Overall Study||10
8284809|NCT01650545|20426237|P1|STARTED|Overall Study||11
8284810|NCT01650519|20426249|P2|NOT COMPLETED|Overall Study||0
8284811|NCT01650519|20426250|P1|NOT COMPLETED|Overall Study||1
8284812|NCT01650519|20426249|P2|COMPLETED|Overall Study||31
8284813|NCT01650519|20426250|P1|COMPLETED|Overall Study||19
8284814|NCT01650519|20426249|P2|STARTED|Overall Study||31
8284815|NCT01650519|20426250|P1|STARTED|Overall Study||20
8284816|NCT01650402|20426270|P2|NOT COMPLETED|Overall Study||14
8284817|NCT01650402|20426271|P1|NOT COMPLETED|Overall Study||20
8284818|NCT01650402|20426270|P2|COMPLETED|Overall Study||86
8284819|NCT01650402|20426271|P1|COMPLETED|Overall Study||79
8284820|NCT01650402|20426270|P2|STARTED|Overall Study||100
8284821|NCT01650402|20426271|P1|STARTED|Overall Study||99
8284822|NCT01650350|20426279|P1|NOT COMPLETED|Overall Study||0
8284823|NCT01650350|20426279|P1|COMPLETED|Overall Study||7
8284824|NCT01650350|20426279|P1|STARTED|Overall Study||7
8284825|NCT01650324|20426290|P5|NOT COMPLETED|Overall Study||0
8284826|NCT01650324|20426291|P4|NOT COMPLETED|Overall Study||0
8284827|NCT01650324|20426292|P3|NOT COMPLETED|Overall Study||0
8284828|NCT01650324|20426293|P2|NOT COMPLETED|Overall Study||0
8284829|NCT01650324|20426294|P1|NOT COMPLETED|Overall Study||0
8284830|NCT01650324|20426290|P5|COMPLETED|Overall Study||6
8284831|NCT01650324|20426291|P4|COMPLETED|Overall Study||6
8284832|NCT01650324|20426292|P3|COMPLETED|Overall Study||6
8284833|NCT01650324|20426293|P2|COMPLETED|Overall Study||6
8284834|NCT01650324|20426294|P1|COMPLETED|Overall Study||8
8284835|NCT01650324|20426290|P5|STARTED|Overall Study||6
8284836|NCT01650324|20426291|P4|STARTED|Overall Study||6
8284837|NCT01650324|20426292|P3|STARTED|Overall Study||6
8284838|NCT01650324|20426293|P2|STARTED|Overall Study||6
8284839|NCT01650324|20426294|P1|STARTED|Overall Study||8
8284840|NCT01650298|20426325|P2|NOT COMPLETED|Overall Study||6
8284841|NCT01650298|20426326|P1|NOT COMPLETED|Overall Study||5
8284842|NCT01650298|20426325|P2|COMPLETED|Overall Study||42
8284843|NCT01650298|20426326|P1|COMPLETED|Overall Study||11
8284844|NCT01650298|20426325|P2|STARTED|Overall Study||48
8284845|NCT01650298|20426326|P1|STARTED|Overall Study||16
8284846|NCT01650285|20426332|P1|NOT COMPLETED|Overall Study||1
8284847|NCT01650285|20426332|P1|COMPLETED|Overall Study||4
8284848|NCT01650285|20426332|P1|STARTED|Overall Study||5
8284849|NCT01650259|20426339|P2|NOT COMPLETED|Overall Study||235
8284850|NCT01650259|20426340|P1|NOT COMPLETED|Overall Study||1043
8284851|NCT01650259|20426339|P2|COMPLETED|Overall Study||2128
8284852|NCT01650259|20426340|P1|COMPLETED|Overall Study||1470
8284853|NCT01650259|20426339|P2|STARTED|Overall Study|Started are the registered patients|2363
8284854|NCT01650259|20426340|P1|STARTED|Overall Study|Started are the registered patients|2513
8284855|NCT01650246|20426345|P1|NOT COMPLETED|Overall Study||143
8284856|NCT01650246|20426345|P1|COMPLETED|Overall Study||0
8284857|NCT01650246|20426345|P1|STARTED|Overall Study||143
8284858|NCT01650194|20426350|P1|NOT COMPLETED|Overall Study||47
8284859|NCT01650194|20426350|P1|COMPLETED|Overall Study||13
8284860|NCT01650194|20426350|P1|Treated|Overall Study||60
8284861|NCT01650194|20426350|P1|STARTED|Overall Study||60
8284862|NCT01649947|20426375|P2|NOT COMPLETED|Overall Study||18
8284863|NCT01649947|20426376|P1|NOT COMPLETED|Overall Study||12
8284864|NCT01649947|20426375|P2|COMPLETED|Overall Study||2
8284865|NCT01649947|20426376|P1|COMPLETED|Overall Study||0
8284866|NCT01649947|20426375|P2|STARTED|Overall Study||20
8284867|NCT01649947|20426376|P1|STARTED|Overall Study||12
8284868|NCT01649856|20426386|P2|NOT COMPLETED|Overall Study||78
8284869|NCT01649856|20426387|P1|NOT COMPLETED|Overall Study||139
8284870|NCT01649856|20426386|P2|COMPLETED|Overall Study||125
8284871|NCT01649856|20426387|P1|COMPLETED|Overall Study||230
8284872|NCT01649856|20426386|P2|STARTED|Overall Study||203
8284873|NCT01649856|20426387|P1|STARTED|Overall Study||369
8284874|NCT01649804|20426419|P1|NOT COMPLETED|Overall Study||8
8284875|NCT01649804|20426419|P1|COMPLETED|Overall Study||4
8284876|NCT01649804|20426419|P1|STARTED|Overall Study||12
8284877|NCT01649791|20426431|P1|NOT COMPLETED|Overall Study||3
8284878|NCT01649791|20426431|P1|COMPLETED|Overall Study||5
8284879|NCT01649791|20426431|P1|STARTED|Overall Study||8
8284880|NCT01649765|20426440|P2|NOT COMPLETED|Overall Study||8
8284881|NCT01649765|20426441|P1|NOT COMPLETED|Overall Study||9
8284882|NCT01649765|20426440|P2|COMPLETED|Overall Study||45
8284883|NCT01649765|20426441|P1|COMPLETED|Overall Study||31
8284884|NCT01649765|20426440|P2|STARTED|Overall Study||53
8284885|NCT01649765|20426441|P1|STARTED|Overall Study||40
8284886|NCT01649609|20426469|P2|NOT COMPLETED|Overall Study||0
8284887|NCT01649609|20426470|P1|NOT COMPLETED|Overall Study||0
8284888|NCT01649609|20426469|P2|COMPLETED|Overall Study||20
8284889|NCT01649609|20426470|P1|COMPLETED|Overall Study||20
8284890|NCT01649609|20426469|P2|STARTED|Overall Study||20
8284891|NCT01649609|20426470|P1|STARTED|Overall Study||20
8284892|NCT01649596|20426480|P2|NOT COMPLETED|Overall Study||0
8284893|NCT01649596|20426481|P1|NOT COMPLETED|Overall Study||0
8284894|NCT01649596|20426480|P2|COMPLETED|Overall Study||48
8284895|NCT01649596|20426481|P1|COMPLETED|Overall Study||46
8284896|NCT01649596|20426480|P2|STARTED|Overall Study||48
8284897|NCT01649596|20426481|P1|STARTED|Overall Study||46
8284898|NCT01649557|20426492|P3|NOT COMPLETED|Overall Study||9
8284899|NCT01649557|20426493|P2|NOT COMPLETED|Overall Study||14
8284900|NCT01649557|20426494|P1|NOT COMPLETED|Overall Study||44
8284901|NCT01649557|20426492|P3|COMPLETED|Overall Study||15
8284902|NCT01649557|20426493|P2|COMPLETED|Overall Study||27
8284903|NCT01649557|20426494|P1|COMPLETED|Overall Study||135
8284904|NCT01649557|20426492|P3|52-week Enrollers|Overall Study||2
8284905|NCT01649557|20426493|P2|52-week Enrollers|Overall Study||6
8284906|NCT01649557|20426494|P1|52-week Enrollers|Overall Study||20
8284907|NCT01649557|20426492|P3|6-week Enrollers|Overall Study||22
8284908|NCT01649557|20426493|P2|6-week Enrollers|Overall Study||35
8284909|NCT01649557|20426494|P1|6-week Enrollers|Overall Study||159
8284910|NCT01649557|20426492|P3|STARTED|Overall Study||24
8284911|NCT01649557|20426493|P2|STARTED|Overall Study||41
8284912|NCT01649557|20426494|P1|STARTED|Overall Study||179
8284913|NCT01649505|20426531|P2|NOT COMPLETED|Overall Study||1
8284914|NCT01649505|20426532|P1|NOT COMPLETED|Overall Study||1
8284915|NCT01649505|20426531|P2|COMPLETED|Overall Study||0
8284916|NCT01649505|20426532|P1|COMPLETED|Overall Study||0
8284917|NCT01649505|20426531|P2|STARTED|Overall Study||1
8284918|NCT01649505|20426532|P1|STARTED|Overall Study||1
8284919|NCT01649427|20426540|P2|NOT COMPLETED|Overall Study||12
8284920|NCT01649427|20426541|P1|NOT COMPLETED|Overall Study||11
8284921|NCT01649427|20426540|P2|COMPLETED|Overall Study||26
8284922|NCT01649427|20426541|P1|COMPLETED|Overall Study||24
8284923|NCT01649427|20426540|P2|STARTED|Overall Study||38
8284924|NCT01649427|20426541|P1|STARTED|Overall Study||35
8284925|NCT01649375|20426560|P5|NOT COMPLETED|Week 16 up to Week 260||5
8284926|NCT01649375|20426561|P4|NOT COMPLETED|Week 16 up to Week 260||12
8284927|NCT01649375|20426562|P3|NOT COMPLETED|Week 16 up to Week 260||0
8284928|NCT01649375|20426563|P2|NOT COMPLETED|Week 16 up to Week 260||13
8284929|NCT01649375|20426564|P1|NOT COMPLETED|Week 16 up to Week 260||20
8284930|NCT01649375|20426560|P5|COMPLETED|Week 16 up to Week 260||29
8284931|NCT01649375|20426561|P4|COMPLETED|Week 16 up to Week 260||20
8284932|NCT01649375|20426562|P3|COMPLETED|Week 16 up to Week 260||0
8284933|NCT01649375|20426563|P2|COMPLETED|Week 16 up to Week 260||53
8284934|NCT01649375|20426564|P1|COMPLETED|Week 16 up to Week 260||48
8284935|NCT01649375|20426560|P5|STARTED|Week 16 up to Week 260||34
8284936|NCT01649375|20426561|P4|STARTED|Week 16 up to Week 260||32
8284937|NCT01649375|20426562|P3|STARTED|Week 16 up to Week 260||0
8284938|NCT01649375|20426563|P2|STARTED|Week 16 up to Week 260||66
8284939|NCT01649375|20426564|P1|STARTED|Week 16 up to Week 260||68
8284940|NCT01649375|20426560|P5|NOT COMPLETED|Up to Week 16||0
8284941|NCT01649375|20426561|P4|NOT COMPLETED|Up to Week 16||0
8284942|NCT01649375|20426562|P3|NOT COMPLETED|Up to Week 16||8
8284943|NCT01649375|20426563|P2|NOT COMPLETED|Up to Week 16||6
8284944|NCT01649375|20426564|P1|NOT COMPLETED|Up to Week 16||5
8284945|NCT01649375|20426560|P5|COMPLETED|Up to Week 16||0
8284946|NCT01649375|20426561|P4|COMPLETED|Up to Week 16||0
8284947|NCT01649375|20426562|P3|COMPLETED|Up to Week 16||66
8284948|NCT01649375|20426563|P2|COMPLETED|Up to Week 16||66
8284949|NCT01649375|20426564|P1|COMPLETED|Up to Week 16||68
8284950|NCT01649375|20426560|P5|STARTED|Up to Week 16||0
8284951|NCT01649375|20426561|P4|STARTED|Up to Week 16||0
8284952|NCT01649375|20426562|P3|STARTED|Up to Week 16||74
8284953|NCT01649375|20426563|P2|STARTED|Up to Week 16||72
8284954|NCT01649375|20426564|P1|STARTED|Up to Week 16||73
8284955|NCT01649362|20426595|P2|NOT COMPLETED|Overall Study||14
8284956|NCT01649362|20426596|P1|NOT COMPLETED|Overall Study||1
8284957|NCT01649362|20426595|P2|COMPLETED|Overall Study||40
8284958|NCT01649362|20426596|P1|COMPLETED|Overall Study||46
8284959|NCT01649362|20426595|P2|STARTED|Overall Study||54
8284960|NCT01649362|20426596|P1|STARTED|Overall Study||47
8284961|NCT01649297|20426611|P5|NOT COMPLETED|Overall Study||4
8284962|NCT01649297|20426612|P4|NOT COMPLETED|Overall Study||19
8284963|NCT01649297|20426613|P3|NOT COMPLETED|Overall Study||17
8284964|NCT01649297|20426614|P2|NOT COMPLETED|Overall Study||13
8284965|NCT01649297|20426615|P1|NOT COMPLETED|Overall Study||14
8284966|NCT01649297|20426611|P5|COMPLETED|Overall Study||103
8284967|NCT01649297|20426612|P4|COMPLETED|Overall Study||201
8284968|NCT01649297|20426613|P3|COMPLETED|Overall Study||202
8284969|NCT01649297|20426614|P2|COMPLETED|Overall Study||205
8284970|NCT01649297|20426615|P1|COMPLETED|Overall Study||205
8284971|NCT01649297|20426611|P5|STARTED|Overall Study|randomised|107
8284972|NCT01649297|20426612|P4|STARTED|Overall Study|randomised|220
8284973|NCT01649297|20426613|P3|STARTED|Overall Study|randomised|219
8284974|NCT01649297|20426614|P2|STARTED|Overall Study|randomised|218
8284975|NCT01649297|20426615|P1|STARTED|Overall Study|randomised|219
8284976|NCT01649271|20426634|P2|NOT COMPLETED|Overall Study||7
8284977|NCT01649271|20426635|P1|NOT COMPLETED|Overall Study||6
8284978|NCT01649271|20426634|P2|COMPLETED|Overall Study||0
8284979|NCT01649271|20426635|P1|COMPLETED|Overall Study||0
8284980|NCT01649271|20426634|P2|STARTED|Overall Study||7
8284981|NCT01649271|20426635|P1|STARTED|Overall Study||6
8284982|NCT01649232|20426650|P2|NOT COMPLETED|Overall Study||0
8284983|NCT01649232|20426651|P1|NOT COMPLETED|Overall Study||2
8284984|NCT01649232|20426650|P2|COMPLETED|Overall Study||30
8284985|NCT01649232|20426651|P1|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
8284986|NCT01649232|20426650|P2|STARTED|Overall Study||30
8284987|NCT01649232|20426651|P1|STARTED|Overall Study||30
8284991|NCT01648959|20426679|P1|NOT COMPLETED|Overall Study||0
8284992|NCT01648959|20426679|P1|COMPLETED|Overall Study||5
8284993|NCT01648959|20426679|P1|STARTED|Overall Study||5
8284994|NCT01648920|20426683|P1|NOT COMPLETED|Overall Study||0
8284995|NCT01648920|20426683|P1|COMPLETED|Overall Study||50
8284996|NCT01648920|20426683|P1|STARTED|Overall Study||50
8284997|NCT01648790|20426707|P5|NOT COMPLETED|Treatment 5||0
8284998|NCT01648790|20426708|P4|NOT COMPLETED|Treatment 5||0
8284999|NCT01648790|20426709|P3|NOT COMPLETED|Treatment 5||0
8285000|NCT01648790|20426710|P2|NOT COMPLETED|Treatment 5||0
8285001|NCT01648790|20426711|P1|NOT COMPLETED|Treatment 5||0
8285002|NCT01648790|20426707|P5|COMPLETED|Treatment 5||4
8285003|NCT01648790|20426708|P4|COMPLETED|Treatment 5||3
8285004|NCT01648790|20426709|P3|COMPLETED|Treatment 5||4
8285005|NCT01648790|20426710|P2|COMPLETED|Treatment 5||4
8285006|NCT01648790|20426711|P1|COMPLETED|Treatment 5||4
8285007|NCT01648790|20426707|P5|STARTED|Treatment 5||4
8285008|NCT01648790|20426708|P4|STARTED|Treatment 5||3
8285009|NCT01648790|20426709|P3|STARTED|Treatment 5||4
8285010|NCT01648790|20426710|P2|STARTED|Treatment 5||4
8285011|NCT01648790|20426711|P1|STARTED|Treatment 5||4
8285012|NCT01648790|20426707|P5|NOT COMPLETED|Treatment 4||0
8285013|NCT01648790|20426708|P4|NOT COMPLETED|Treatment 4||0
8285014|NCT01648790|20426709|P3|NOT COMPLETED|Treatment 4||0
8285015|NCT01648790|20426710|P2|NOT COMPLETED|Treatment 4||0
8285016|NCT01648790|20426711|P1|NOT COMPLETED|Treatment 4||0
8285017|NCT01648790|20426707|P5|COMPLETED|Treatment 4||4
8285018|NCT01648790|20426708|P4|COMPLETED|Treatment 4||3
8285019|NCT01648790|20426709|P3|COMPLETED|Treatment 4||4
8285020|NCT01648790|20426710|P2|COMPLETED|Treatment 4||4
8285021|NCT01648790|20426711|P1|COMPLETED|Treatment 4||4
8285022|NCT01648790|20426707|P5|STARTED|Treatment 4||4
8285023|NCT01648790|20426708|P4|STARTED|Treatment 4||3
8285024|NCT01648790|20426709|P3|STARTED|Treatment 4||4
8285025|NCT01648790|20426710|P2|STARTED|Treatment 4||4
8285026|NCT01648790|20426711|P1|STARTED|Treatment 4||4
8285027|NCT01648790|20426707|P5|NOT COMPLETED|Treatment 3||0
8285028|NCT01648790|20426708|P4|NOT COMPLETED|Treatment 3||1
8285029|NCT01648790|20426709|P3|NOT COMPLETED|Treatment 3||0
8285030|NCT01648790|20426710|P2|NOT COMPLETED|Treatment 3||0
8285031|NCT01648790|20426711|P1|NOT COMPLETED|Treatment 3||0
8285032|NCT01648790|20426707|P5|COMPLETED|Treatment 3||4
8285033|NCT01648790|20426708|P4|COMPLETED|Treatment 3||3
8285034|NCT01648790|20426709|P3|COMPLETED|Treatment 3||4
8285035|NCT01648790|20426710|P2|COMPLETED|Treatment 3||4
8285036|NCT01648790|20426711|P1|COMPLETED|Treatment 3||4
8285037|NCT01648790|20426707|P5|STARTED|Treatment 3||4
8285038|NCT01648790|20426708|P4|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
8285039|NCT01648790|20426709|P3|STARTED|Treatment 3||4
8285040|NCT01648790|20426710|P2|STARTED|Treatment 3||4
8285041|NCT01648790|20426711|P1|STARTED|Treatment 3||4
8285042|NCT01648790|20426707|P5|NOT COMPLETED|Treatment 2||0
8285043|NCT01648790|20426708|P4|NOT COMPLETED|Treatment 2||0
8285044|NCT01648790|20426709|P3|NOT COMPLETED|Treatment 2||0
8285045|NCT01648790|20426710|P2|NOT COMPLETED|Treatment 2||0
8285046|NCT01648790|20426711|P1|NOT COMPLETED|Treatment 2||0
8285047|NCT01648790|20426707|P5|COMPLETED|Treatment 2||4
8285048|NCT01648790|20426708|P4|COMPLETED|Treatment 2||4
8285049|NCT01648790|20426709|P3|COMPLETED|Treatment 2||4
8285050|NCT01648790|20426710|P2|COMPLETED|Treatment 2||4
8285051|NCT01648790|20426711|P1|COMPLETED|Treatment 2||4
8285052|NCT01648790|20426707|P5|STARTED|Treatment 2||4
8285053|NCT01648790|20426708|P4|STARTED|Treatment 2||4
8285054|NCT01648790|20426709|P3|STARTED|Treatment 2||4
8285055|NCT01648790|20426710|P2|STARTED|Treatment 2||4
8285056|NCT01648790|20426711|P1|STARTED|Treatment 2||4
8285057|NCT01648790|20426707|P5|NOT COMPLETED|Treatment 1||0
8285058|NCT01648790|20426708|P4|NOT COMPLETED|Treatment 1||0
8285059|NCT01648790|20426709|P3|NOT COMPLETED|Treatment 1||0
8285060|NCT01648790|20426710|P2|NOT COMPLETED|Treatment 1||0
8285061|NCT01648790|20426711|P1|NOT COMPLETED|Treatment 1||0
8285062|NCT01648790|20426707|P5|COMPLETED|Treatment 1||4
8285063|NCT01648790|20426708|P4|COMPLETED|Treatment 1||4
8285064|NCT01648790|20426709|P3|COMPLETED|Treatment 1||4
8285065|NCT01648790|20426710|P2|COMPLETED|Treatment 1||4
8285066|NCT01648790|20426711|P1|COMPLETED|Treatment 1||4
8285067|NCT01648790|20426707|P5|Received at Least 1 Dose of Study Drug|Treatment 1||4
8285068|NCT01648790|20426708|P4|Received at Least 1 Dose of Study Drug|Treatment 1||4
8285069|NCT01648790|20426709|P3|Received at Least 1 Dose of Study Drug|Treatment 1||4
8285070|NCT01648790|20426710|P2|Received at Least 1 Dose of Study Drug|Treatment 1||4
8285071|NCT01648790|20426711|P1|Received at Least 1 Dose of Study Drug|Treatment 1||4
8285072|NCT01648790|20426707|P5|STARTED|Treatment 1||4
8285073|NCT01648790|20426708|P4|STARTED|Treatment 1||4
8285074|NCT01648790|20426709|P3|STARTED|Treatment 1||4
8285075|NCT01648790|20426710|P2|STARTED|Treatment 1||4
8285076|NCT01648790|20426711|P1|STARTED|Treatment 1||4
8285077|NCT01648764|20426746|P14|NOT COMPLETED|Overall Study||3
8285078|NCT01648764|20426747|P13|NOT COMPLETED|Overall Study||4
8285079|NCT01648764|20426748|P12|NOT COMPLETED|Overall Study||5
8285080|NCT01648764|20426749|P11|NOT COMPLETED|Overall Study||0
8285081|NCT01648764|20426750|P10|NOT COMPLETED|Overall Study||3
8285082|NCT01648764|20426751|P9|NOT COMPLETED|Overall Study||0
8285083|NCT01648764|20426752|P8|NOT COMPLETED|Overall Study||0
8285084|NCT01648764|20426753|P7|NOT COMPLETED|Overall Study||5
8285085|NCT01648764|20426754|P6|NOT COMPLETED|Overall Study||2
8285086|NCT01648764|20426755|P5|NOT COMPLETED|Overall Study||0
8285087|NCT01648764|20426756|P4|NOT COMPLETED|Overall Study||0
8285088|NCT01648764|20426757|P3|NOT COMPLETED|Overall Study||0
8285089|NCT01648764|20426758|P2|NOT COMPLETED|Overall Study||1
8285090|NCT01648764|20426759|P1|NOT COMPLETED|Overall Study||0
8285091|NCT01648764|20426746|P14|COMPLETED|Overall Study||9
8285092|NCT01648764|20426747|P13|COMPLETED|Overall Study||3
8285093|NCT01648764|20426748|P12|COMPLETED|Overall Study||4
8285094|NCT01648764|20426749|P11|COMPLETED|Overall Study||3
8285095|NCT01648764|20426750|P10|COMPLETED|Overall Study||4
8285096|NCT01648764|20426751|P9|COMPLETED|Overall Study||3
8285097|NCT01648764|20426752|P8|COMPLETED|Overall Study||3
8285098|NCT01648764|20426753|P7|COMPLETED|Overall Study||4
8285099|NCT01648764|20426754|P6|COMPLETED|Overall Study||3
8285100|NCT01648764|20426755|P5|COMPLETED|Overall Study||3
8285101|NCT01648764|20426756|P4|COMPLETED|Overall Study||3
8285102|NCT01648764|20426757|P3|COMPLETED|Overall Study||3
8285103|NCT01648764|20426758|P2|COMPLETED|Overall Study||2
8285104|NCT01648764|20426759|P1|COMPLETED|Overall Study||3
8285105|NCT01648764|20426746|P14|Received at Least 1 Dose of Study Drug|Overall Study||12
8285106|NCT01648764|20426747|P13|Received at Least 1 Dose of Study Drug|Overall Study||7
8285107|NCT01648764|20426748|P12|Received at Least 1 Dose of Study Drug|Overall Study||9
8285108|NCT01648764|20426749|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
8285109|NCT01648764|20426750|P10|Received at Least 1 Dose of Study Drug|Overall Study||7
8285110|NCT01648764|20426751|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
8285111|NCT01648764|20426752|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
8285112|NCT01648764|20426753|P7|Received at Least 1 Dose of Study Drug|Overall Study||9
8285113|NCT01648764|20426754|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
8285114|NCT01648764|20426755|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
8285115|NCT01648764|20426756|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8285116|NCT01648764|20426757|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8285117|NCT01648764|20426758|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8285118|NCT01648764|20426759|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8285119|NCT01648764|20426746|P14|STARTED|Overall Study||12
8285120|NCT01648764|20426747|P13|STARTED|Overall Study||7
8285121|NCT01648764|20426748|P12|STARTED|Overall Study||9
8285122|NCT01648764|20426749|P11|STARTED|Overall Study||3
8285123|NCT01648764|20426750|P10|STARTED|Overall Study||7
8285124|NCT01648764|20426751|P9|STARTED|Overall Study||3
8285125|NCT01648764|20426752|P8|STARTED|Overall Study||3
8285126|NCT01648764|20426753|P7|STARTED|Overall Study||9
8285127|NCT01648764|20426754|P6|STARTED|Overall Study||5
8285128|NCT01648764|20426755|P5|STARTED|Overall Study||3
8285129|NCT01648764|20426756|P4|STARTED|Overall Study||3
8285130|NCT01648764|20426757|P3|STARTED|Overall Study||3
8285131|NCT01648764|20426758|P2|STARTED|Overall Study||3
8285132|NCT01648764|20426759|P1|STARTED|Overall Study||3
8285133|NCT01648699|20426911|P1|NOT COMPLETED|Overall Study||5
8285134|NCT01648699|20426911|P1|COMPLETED|Overall Study||15
8285135|NCT01648699|20426911|P1|STARTED|Overall Study||20
8285136|NCT01648582|20426940|P3|NOT COMPLETED|Overall Study||32
8285137|NCT01648582|20426941|P2|NOT COMPLETED|Overall Study||38
8285138|NCT01648582|20426942|P1|NOT COMPLETED|Overall Study||32
8285139|NCT01648582|20426940|P3|COMPLETED|Overall Study||227
8285140|NCT01648582|20426941|P2|COMPLETED|Overall Study||219
8285141|NCT01648582|20426942|P1|COMPLETED|Overall Study||226
8285142|NCT01648582|20426940|P3|Modified Intent-to-Treat Population|Overall Study||250
8285143|NCT01648582|20426941|P2|Modified Intent-to-Treat Population|Overall Study||252
8285144|NCT01648582|20426942|P1|Modified Intent-to-Treat Population|Overall Study||253
8285145|NCT01648582|20426940|P3|Received at Least One Dose of Study Drug|Overall Study||259
8285146|NCT01648582|20426941|P2|Received at Least One Dose of Study Drug|Overall Study||257
8285147|NCT01648582|20426942|P1|Received at Least One Dose of Study Drug|Overall Study||258
8285148|NCT01648582|20426940|P3|STARTED|Overall Study||259
8285149|NCT01648582|20426941|P2|STARTED|Overall Study||257
8285150|NCT01648582|20426942|P1|STARTED|Overall Study||258
8285151|NCT01648530|20427011|P1|NOT COMPLETED|Overall Study||10874
8285152|NCT01648530|20427011|P1|COMPLETED|Overall Study||5915
8285153|NCT01648530|20427011|P1|STARTED|Overall Study||16789
8285154|NCT01648491|20427017|P1|NOT COMPLETED|Overall Study||0
8285155|NCT01648491|20427017|P1|COMPLETED|Overall Study||1
8285156|NCT01648491|20427017|P1|STARTED|Overall Study||1
8285157|NCT01648452|20427024|P1|NOT COMPLETED|Overall Study||0
8285158|NCT01648452|20427024|P1|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
8285159|NCT01648452|20427024|P1|STARTED|Overall Study||5
8285160|NCT01648348|20427045|P6|NOT COMPLETED|Overall Study||6
8285161|NCT01648348|20427046|P5|NOT COMPLETED|Overall Study||3
8285162|NCT01648348|20427047|P4|NOT COMPLETED|Overall Study||0
8285163|NCT01648348|20427048|P3|NOT COMPLETED|Overall Study||1
8285164|NCT01648348|20427049|P2|NOT COMPLETED|Overall Study||0
8285165|NCT01648348|20427050|P1|NOT COMPLETED|Overall Study||2
8285166|NCT01648348|20427045|P6|COMPLETED|Overall Study||43
8285167|NCT01648348|20427046|P5|COMPLETED|Overall Study||49
8285168|NCT01648348|20427047|P4|COMPLETED|Overall Study||3
8285169|NCT01648348|20427048|P3|COMPLETED|Overall Study||3
8285170|NCT01648348|20427049|P2|COMPLETED|Overall Study||3
8285171|NCT01648348|20427050|P1|COMPLETED|Overall Study||3
8285172|NCT01648348|20427045|P6|STARTED|Overall Study||49
8285173|NCT01648348|20427046|P5|STARTED|Overall Study||52
8285174|NCT01648348|20427047|P4|STARTED|Overall Study||3
8285175|NCT01648348|20427048|P3|STARTED|Overall Study||4
8285176|NCT01648348|20427049|P2|STARTED|Overall Study||3
8285177|NCT01648348|20427050|P1|STARTED|Overall Study||5
8285178|NCT01648322|20427079|P4|NOT COMPLETED|Overall Study||4
8285179|NCT01648322|20427080|P3|NOT COMPLETED|Overall Study||5
8285180|NCT01648322|20427081|P2|NOT COMPLETED|Overall Study||5
8285181|NCT01648322|20427082|P1|NOT COMPLETED|Overall Study||2
8285182|NCT01648322|20427079|P4|COMPLETED|Overall Study||61
8285183|NCT01648322|20427080|P3|COMPLETED|Overall Study||60
8285184|NCT01648322|20427081|P2|COMPLETED|Overall Study||62
8285185|NCT01648322|20427082|P1|COMPLETED|Overall Study||33
8285186|NCT01648322|20427079|P4|STARTED|Overall Study||65
8285187|NCT01648322|20427080|P3|STARTED|Overall Study||65
8285188|NCT01648322|20427081|P2|STARTED|Overall Study||67
8285189|NCT01648322|20427082|P1|STARTED|Overall Study||35
8285190|NCT01648296|20427128|P2|NOT COMPLETED|Overall Study||0
8285191|NCT01648296|20427129|P1|NOT COMPLETED|Overall Study||0
8285192|NCT01648296|20427128|P2|COMPLETED|Overall Study||17
8285193|NCT01648296|20427129|P1|COMPLETED|Overall Study||11
8285194|NCT01648296|20427128|P2|STARTED|Overall Study||17
8285195|NCT01648296|20427129|P1|STARTED|Overall Study||11
8285196|NCT01648283|20427137|P1|NOT COMPLETED|Overall Study||14
8285197|NCT01648283|20427137|P1|COMPLETED|Overall Study||64
8285198|NCT01648283|20427137|P1|STARTED|Overall Study||78
8285199|NCT01648270|20427143|P1|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0
8285200|NCT01648270|20427143|P1|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13
8285201|NCT01648270|20427143|P1|STARTED|Cyclosporine + Sublingual Buprenorphine||13
8285202|NCT01648270|20427143|P1|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0
8285203|NCT01648270|20427143|P1|COMPLETED|Cyclosporine Plus IV Buprenorphine||13
8285204|NCT01648270|20427143|P1|STARTED|Cyclosporine Plus IV Buprenorphine||13
8285205|NCT01648270|20427143|P1|NOT COMPLETED|Sublingual Buprenorphine||0
8285206|NCT01648270|20427143|P1|COMPLETED|Sublingual Buprenorphine||13
8285207|NCT01648270|20427143|P1|STARTED|Sublingual Buprenorphine||13
8285208|NCT01648270|20427143|P1|NOT COMPLETED|Intravenous Buprenorphine||12
8285209|NCT01648270|20427143|P1|COMPLETED|Intravenous Buprenorphine||13
8285210|NCT01648270|20427143|P1|STARTED|Intravenous Buprenorphine||25
8285211|NCT01648166|20427155|P2|NOT COMPLETED|Overall Study||100
8285212|NCT01648166|20427156|P1|NOT COMPLETED|Overall Study||53
8285213|NCT01648166|20427155|P2|COMPLETED|Overall Study||267
8285214|NCT01648166|20427156|P1|COMPLETED|Overall Study||100
8285215|NCT01648166|20427155|P2|STARTED|Overall Study||367
8285216|NCT01648166|20427156|P1|STARTED|Overall Study||153
8285217|NCT01648140|20427166|P4|NOT COMPLETED|Overall Study||2
8285218|NCT01648140|20427167|P3|NOT COMPLETED|Overall Study||8
8285219|NCT01648140|20427168|P2|NOT COMPLETED|Overall Study||12
8285220|NCT01648140|20427169|P1|NOT COMPLETED|Overall Study||12
8285221|NCT01648140|20427166|P4|COMPLETED|Overall Study||11
8285222|NCT01648140|20427167|P3|COMPLETED|Overall Study||9
8285223|NCT01648140|20427168|P2|COMPLETED|Overall Study||28
8285224|NCT01648140|20427169|P1|COMPLETED|Overall Study||29
8285225|NCT01648140|20427166|P4|STARTED|Overall Study||13
8285226|NCT01648140|20427167|P3|STARTED|Overall Study||17
8285227|NCT01648140|20427168|P2|STARTED|Overall Study||40
8285228|NCT01648140|20427169|P1|STARTED|Overall Study||41
8285229|NCT01648101|20427334|P3|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
8285230|NCT01648101|20427335|P2|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
8285231|NCT01648101|20427336|P1|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
8285232|NCT01648101|20427334|P3|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
8285233|NCT01648101|20427335|P2|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
8285234|NCT01648101|20427336|P1|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
8285235|NCT01648101|20427334|P3|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
8285236|NCT01648101|20427335|P2|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
8285237|NCT01648101|20427336|P1|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
8285238|NCT01648101|20427334|P3|NOT COMPLETED|Transition Phase (4 Weeks)||4
8285239|NCT01648101|20427335|P2|NOT COMPLETED|Transition Phase (4 Weeks)||5
8285240|NCT01648101|20427336|P1|NOT COMPLETED|Transition Phase (4 Weeks)||5
8285241|NCT01648101|20427334|P3|COMPLETED|Transition Phase (4 Weeks)||5
8285242|NCT01648101|20427335|P2|COMPLETED|Transition Phase (4 Weeks)||13
8285243|NCT01648101|20427336|P1|COMPLETED|Transition Phase (4 Weeks)||12
8285244|NCT01648101|20427334|P3|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
8285245|NCT01648101|20427335|P2|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
8285246|NCT01648101|20427336|P1|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
8285247|NCT01648101|20427334|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
8285248|NCT01648101|20427335|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
8285249|NCT01648101|20427336|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
8285250|NCT01648101|20427334|P3|COMPLETED|Maintenance Phase (12 Weeks)||12
8285251|NCT01648101|20427335|P2|COMPLETED|Maintenance Phase (12 Weeks)||20
8285252|NCT01648101|20427336|P1|COMPLETED|Maintenance Phase (12 Weeks)||20
8285253|NCT01648101|20427334|P3|STARTED|Maintenance Phase (12 Weeks)||18
8285254|NCT01648101|20427335|P2|STARTED|Maintenance Phase (12 Weeks)||23
8285255|NCT01648101|20427336|P1|STARTED|Maintenance Phase (12 Weeks)||23
8285256|NCT01648101|20427334|P3|NOT COMPLETED|Titration Phase (4 Weeks)||6
8285257|NCT01648101|20427335|P2|NOT COMPLETED|Titration Phase (4 Weeks)||3
8285258|NCT01648101|20427336|P1|NOT COMPLETED|Titration Phase (4 Weeks)||2
8285259|NCT01648101|20427334|P3|COMPLETED|Titration Phase (4 Weeks)||18
8285260|NCT01648101|20427335|P2|COMPLETED|Titration Phase (4 Weeks)||23
8285261|NCT01648101|20427336|P1|COMPLETED|Titration Phase (4 Weeks)||23
8285262|NCT01648101|20427334|P3|STARTED|Titration Phase (4 Weeks)||24
8285263|NCT01648101|20427335|P2|STARTED|Titration Phase (4 Weeks)||26
8285264|NCT01648101|20427336|P1|STARTED|Titration Phase (4 Weeks)||25
8285265|NCT01647958|20427386|P2|NOT COMPLETED|Extended Follow-up Phase||0
8285266|NCT01647958|20427387|P1|NOT COMPLETED|Extended Follow-up Phase||8
8285267|NCT01647958|20427386|P2|COMPLETED|Extended Follow-up Phase||0
8285268|NCT01647958|20427387|P1|COMPLETED|Extended Follow-up Phase|The 8 lost to follow up patients are of the combined Treatment and Control cohort of 52 patients|52
8285269|NCT01647958|20427386|P2|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients combined into 1 cohort for this period=60, 0 under Control|0
8285270|NCT01647958|20427387|P1|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients were combined into 1 cohort for this follow up. 39+21=60|60
8285271|NCT01647958|20427386|P2|NOT COMPLETED|Continuation Phase||0
8285272|NCT01647958|20427387|P1|NOT COMPLETED|Continuation Phase||39
8285273|NCT01647958|20427386|P2|COMPLETED|Continuation Phase|21 Control patients received TIF crossover procedure following 6-month follow-up visit.|21
8285274|NCT01647958|20427387|P1|COMPLETED|Continuation Phase|Treatment-arm patients received TIF procedure during Initial Study phase|0
8285275|NCT01647958|20427386|P2|STARTED|Continuation Phase||21
8285276|NCT01647958|20427387|P1|STARTED|Continuation Phase||39
8285277|NCT01647958|20427386|P2|NOT COMPLETED|Initial Study||3
8285278|NCT01647958|20427387|P1|NOT COMPLETED|Initial Study||2
8285279|NCT01647958|20427386|P2|COMPLETED|Initial Study||21
8285280|NCT01647958|20427387|P1|COMPLETED|Initial Study||39
8285281|NCT01647958|20427386|P2|STARTED|Initial Study||24
8285282|NCT01647958|20427387|P1|STARTED|Initial Study||41
8285283|NCT01647945|20427439|P4|NOT COMPLETED|Overall Study||1
8285284|NCT01647945|20427440|P3|NOT COMPLETED|Overall Study||2
8285285|NCT01647945|20427441|P2|NOT COMPLETED|Overall Study||0
8285286|NCT01647945|20427442|P1|NOT COMPLETED|Overall Study||0
8285287|NCT01647945|20427439|P4|COMPLETED|Overall Study||5
8285288|NCT01647945|20427440|P3|COMPLETED|Overall Study||3
8285289|NCT01647945|20427441|P2|COMPLETED|Overall Study||6
8285290|NCT01647945|20427442|P1|COMPLETED|Overall Study||6
8285291|NCT01647945|20427439|P4|STARTED|Overall Study||6
8285292|NCT01647945|20427440|P3|STARTED|Overall Study||5
8285293|NCT01647945|20427441|P2|STARTED|Overall Study||6
8285294|NCT01647945|20427442|P1|STARTED|Overall Study||6
8285295|NCT01647737|20427462|P2|NOT COMPLETED|Overall Study||5
8285296|NCT01647737|20427463|P1|NOT COMPLETED|Overall Study||4
8285297|NCT01647737|20427462|P2|COMPLETED|Overall Study||25
8285298|NCT01647737|20427463|P1|COMPLETED|Overall Study||26
8285299|NCT01647737|20427462|P2|STARTED|Overall Study||30
8285300|NCT01647737|20427463|P1|STARTED|Overall Study||30
8285301|NCT01647711|20427474|P5|NOT COMPLETED|Overall Study||6
8285302|NCT01647711|20427475|P4|NOT COMPLETED|Overall Study||11
8285303|NCT01647711|20427476|P3|NOT COMPLETED|Overall Study||9
8285304|NCT01647711|20427477|P2|NOT COMPLETED|Overall Study||3
8285305|NCT01647711|20427478|P1|NOT COMPLETED|Overall Study||6
8285306|NCT01647711|20427474|P5|COMPLETED|Overall Study||0
8285307|NCT01647711|20427475|P4|COMPLETED|Overall Study||0
8285308|NCT01647711|20427476|P3|COMPLETED|Overall Study||0
8285309|NCT01647711|20427477|P2|COMPLETED|Overall Study||0
8285310|NCT01647711|20427478|P1|COMPLETED|Overall Study||0
8285311|NCT01647711|20427474|P5|STARTED|Overall Study||6
8285312|NCT01647711|20427475|P4|STARTED|Overall Study||11
8285313|NCT01647711|20427476|P3|STARTED|Overall Study||9
8285314|NCT01647711|20427477|P2|STARTED|Overall Study||3
8285315|NCT01647711|20427478|P1|STARTED|Overall Study||6
8285316|NCT01647581|20427505|P2|NOT COMPLETED|Overall Study||31
8285317|NCT01647581|20427506|P1|NOT COMPLETED|Overall Study||17
8285318|NCT01647581|20427505|P2|COMPLETED|Overall Study||520
8285319|NCT01647581|20427506|P1|COMPLETED|Overall Study||530
8285320|NCT01647581|20427505|P2|STARTED|Overall Study||551
8285321|NCT01647581|20427506|P1|STARTED|Overall Study||547
8285322|NCT01647542|20427515|P3|NOT COMPLETED|Overall Study||72
8285323|NCT01647542|20427516|P2|NOT COMPLETED|Overall Study||73
8285324|NCT01647542|20427517|P1|NOT COMPLETED|Overall Study||76
8285325|NCT01647542|20427515|P3|COMPLETED|Overall Study||59
8285326|NCT01647542|20427516|P2|COMPLETED|Overall Study||58
8285327|NCT01647542|20427517|P1|COMPLETED|Overall Study||55
8285328|NCT01647542|20427515|P3|STARTED|Overall Study||131
8285329|NCT01647542|20427516|P2|STARTED|Overall Study||131
8285330|NCT01647542|20427517|P1|STARTED|Overall Study||131
8285391|NCT01647464|20427581|P1|NOT COMPLETED|Overall Study||0
8285392|NCT01647464|20427581|P1|COMPLETED|Overall Study||10
8285393|NCT01647464|20427581|P1|STARTED|Overall Study||10
8285394|NCT01647438|20427587|P2|NOT COMPLETED|Overall Study||0
8285395|NCT01647438|20427588|P1|NOT COMPLETED|Overall Study||0
8285396|NCT01647438|20427587|P2|COMPLETED|Overall Study||31
8285397|NCT01647438|20427588|P1|COMPLETED|Overall Study||32
8285398|NCT01647438|20427587|P2|STARTED|Overall Study||31
8285399|NCT01647438|20427588|P1|STARTED|Overall Study||32
8285400|NCT01647282|20427598|P2|NOT COMPLETED|Overall Study||5
8285401|NCT01647282|20427599|P1|NOT COMPLETED|Overall Study||7
8285402|NCT01647282|20427598|P2|COMPLETED|Overall Study||25
8285403|NCT01647282|20427599|P1|COMPLETED|Overall Study||23
8285404|NCT01647282|20427598|P2|STARTED|Overall Study||30
8285405|NCT01647282|20427599|P1|STARTED|Overall Study||30
8285406|NCT01647217|20427609|P2|NOT COMPLETED|Overall Study||1
8285407|NCT01647217|20427610|P1|NOT COMPLETED|Overall Study||1
8285408|NCT01647217|20427609|P2|COMPLETED|Overall Study||8
8285409|NCT01647217|20427610|P1|COMPLETED|Overall Study||7
8285410|NCT01647217|20427609|P2|STARTED|Overall Study||9
8285411|NCT01647217|20427610|P1|STARTED|Overall Study||8
8285412|NCT01646827|20427620|P2|NOT COMPLETED|Overall Study||5
8285413|NCT01646827|20427621|P1|NOT COMPLETED|Overall Study||2
8285414|NCT01646827|20427620|P2|COMPLETED|Overall Study||14
8285415|NCT01646827|20427621|P1|COMPLETED|Overall Study||16
8285416|NCT01646827|20427620|P2|STARTED|Overall Study||19
8285417|NCT01646827|20427621|P1|STARTED|Overall Study||18
8285418|NCT01646814|20427651|P2|NOT COMPLETED|Overall Study||6
8285419|NCT01646814|20427652|P1|NOT COMPLETED|Overall Study||11
8285420|NCT01646814|20427651|P2|COMPLETED|Overall Study||120
8285421|NCT01646814|20427652|P1|COMPLETED|Overall Study||110
8285422|NCT01646814|20427651|P2|STARTED|Overall Study||126
8285423|NCT01646814|20427652|P1|STARTED|Overall Study||121
8285424|NCT01646762|20427658|P1|NOT COMPLETED|Overall Study||0
8285425|NCT01646762|20427658|P1|COMPLETED|Overall Study||13
8285426|NCT01646762|20427658|P1|STARTED|Overall Study||13
8285427|NCT01646671|20427670|P3|NOT COMPLETED|Overall Study||0
8285428|NCT01646671|20427671|P2|NOT COMPLETED|Overall Study||0
8285429|NCT01646671|20427672|P1|NOT COMPLETED|Overall Study||0
8285430|NCT01646671|20427670|P3|COMPLETED|Overall Study||21
8285431|NCT01646671|20427671|P2|COMPLETED|Overall Study||11
8285432|NCT01646671|20427672|P1|COMPLETED|Overall Study||3
8285433|NCT01646671|20427670|P3|STARTED|Overall Study||21
8285434|NCT01646671|20427671|P2|STARTED|Overall Study||11
8285435|NCT01646671|20427672|P1|STARTED|Overall Study||3
8285436|NCT01646645|20427706|P1|NOT COMPLETED|Overall Study||30
8285437|NCT01646645|20427706|P1|COMPLETED|Overall Study||28
8285438|NCT01646645|20427706|P1|STARTED|Overall Study||58
8285439|NCT01646398|20427713|P2|NOT COMPLETED|Overall Study||0
8285440|NCT01646398|20427714|P1|NOT COMPLETED|Overall Study||1
8285441|NCT01646398|20427713|P2|COMPLETED|Overall Study||382
8285442|NCT01646398|20427714|P1|COMPLETED|Overall Study||381
8285443|NCT01646398|20427713|P2|STARTED|Overall Study||382
8285444|NCT01646398|20427714|P1|STARTED|Overall Study||382
8285445|NCT01646385|20427730|P2|NOT COMPLETED|Overall Study||871
8285446|NCT01646385|20427731|P1|NOT COMPLETED|Overall Study||838
8285447|NCT01646385|20427730|P2|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
8285448|NCT01646385|20427731|P1|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
8285449|NCT01646385|20427730|P2|STARTED|Overall Study||2864
8285450|NCT01646385|20427731|P1|STARTED|Overall Study||3529
8285451|NCT01646346|20427762|P1|NOT COMPLETED|Overall Study||0
8285452|NCT01646346|20427762|P1|COMPLETED|Overall Study||46
8285453|NCT01646346|20427762|P1|STARTED|Overall Study||46
8285454|NCT01646320|20427774|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
8285455|NCT01646320|20427775|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
8285456|NCT01646320|20427774|P2|COMPLETED|Long-term Period (Weeks 24 to 52)||140
8285457|NCT01646320|20427775|P1|COMPLETED|Long-term Period (Weeks 24 to 52)||141
8285458|NCT01646320|20427774|P2|STARTED|Long-term Period (Weeks 24 to 52)||147
8285459|NCT01646320|20427775|P1|STARTED|Long-term Period (Weeks 24 to 52)||147
8285460|NCT01646320|20427774|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
8285461|NCT01646320|20427775|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
8285462|NCT01646320|20427774|P2|COMPLETED|Short-term Period (Day 1 to Week 24)||153
8285463|NCT01646320|20427775|P1|COMPLETED|Short-term Period (Day 1 to Week 24)||148
8285464|NCT01646320|20427774|P2|STARTED|Short-term Period (Day 1 to Week 24)||160
8285465|NCT01646320|20427775|P1|STARTED|Short-term Period (Day 1 to Week 24)||160
8285466|NCT01646268|20427791|P2|NOT COMPLETED|Overall Study||16
8285467|NCT01646268|20427792|P1|NOT COMPLETED|Overall Study||11
8285468|NCT01646268|20427791|P2|COMPLETED|Overall Study||107
8285469|NCT01646268|20427792|P1|COMPLETED|Overall Study||113
8285470|NCT01646268|20427791|P2|STARTED|Overall Study||123
8285471|NCT01646268|20427792|P1|STARTED|Overall Study||124
8285472|NCT01646255|20427806|P2|NOT COMPLETED|Overall Study||14
8285473|NCT01646255|20427807|P1|NOT COMPLETED|Overall Study||21
8285474|NCT01646255|20427806|P2|COMPLETED|Overall Study||160
8285475|NCT01646255|20427807|P1|COMPLETED|Overall Study||151
8285476|NCT01646255|20427806|P2|STARTED|Overall Study||174
8285477|NCT01646255|20427807|P1|STARTED|Overall Study||172
8285478|NCT01646216|20427839|P2|NOT COMPLETED|Overall Study||13
8285479|NCT01646216|20427840|P1|NOT COMPLETED|Overall Study||11
8285480|NCT01646216|20427839|P2|COMPLETED|Overall Study||4
8285481|NCT01646216|20427840|P1|COMPLETED|Overall Study||6
8285482|NCT01646216|20427839|P2|STARTED|Overall Study||17
8285483|NCT01646216|20427840|P1|STARTED|Overall Study||17
8285484|NCT01646203|20427862|P3|NOT COMPLETED|Overall Study||1
8285485|NCT01646203|20427863|P2|NOT COMPLETED|Overall Study||2
8285486|NCT01646203|20427864|P1|NOT COMPLETED|Overall Study||2
8285487|NCT01646203|20427862|P3|COMPLETED|Overall Study||6
8285488|NCT01646203|20427863|P2|COMPLETED|Overall Study||3
8285489|NCT01646203|20427864|P1|COMPLETED|Overall Study||0
8285490|NCT01646203|20427862|P3|Received at Least One Dose of Study Drug|Overall Study||7
8285491|NCT01646203|20427863|P2|Received at Least One Dose of Study Drug|Overall Study||5
8285492|NCT01646203|20427864|P1|Received at Least One Dose of Study Drug|Overall Study||2
8285493|NCT01646203|20427862|P3|STARTED|Overall Study||7
8285494|NCT01646203|20427863|P2|STARTED|Overall Study||5
8285495|NCT01646203|20427864|P1|STARTED|Overall Study||2
8285496|NCT01646177|20427893|P12|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||83
8285497|NCT01646177|20427894|P11|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||80
8285498|NCT01646177|20427895|P10|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||76
8285499|NCT01646177|20427896|P9|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||31
8285500|NCT01646177|20427897|P8|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285501|NCT01646177|20427898|P7|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285502|NCT01646177|20427899|P6|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285503|NCT01646177|20427900|P5|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285504|NCT01646177|20427901|P4|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285505|NCT01646177|20427902|P3|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285506|NCT01646177|20427903|P2|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285507|NCT01646177|20427904|P1|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285508|NCT01646177|20427893|P12|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||230
8285509|NCT01646177|20427894|P11|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||225
8285510|NCT01646177|20427895|P10|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||233
8285511|NCT01646177|20427896|P9|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||126
8285512|NCT01646177|20427897|P8|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285513|NCT01646177|20427898|P7|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285514|NCT01646177|20427899|P6|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285515|NCT01646177|20427900|P5|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285516|NCT01646177|20427901|P4|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285517|NCT01646177|20427902|P3|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285518|NCT01646177|20427903|P2|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285519|NCT01646177|20427904|P1|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
8285520|NCT01646177|20427893|P12|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||313
8285521|NCT01646177|20427894|P11|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||305
8285522|NCT01646177|20427895|P10|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||309
8285523|NCT01646177|20427896|P9|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||157
8285524|NCT01646177|20427897|P8|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285525|NCT01646177|20427898|P7|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285526|NCT01646177|20427899|P6|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285527|NCT01646177|20427900|P5|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285528|NCT01646177|20427901|P4|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285529|NCT01646177|20427902|P3|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285530|NCT01646177|20427903|P2|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285531|NCT01646177|20427904|P1|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
8285532|NCT01646177|20427893|P12|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|313
8285533|NCT01646177|20427894|P11|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|305
8285534|NCT01646177|20427895|P10|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|309
8285535|NCT01646177|20427896|P9|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|157
8285536|NCT01646177|20427897|P8|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8285537|NCT01646177|20427898|P7|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8285538|NCT01646177|20427899|P6|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8285539|NCT01646177|20427900|P5|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8285540|NCT01646177|20427901|P4|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
8285541|NCT01646177|20427902|P3|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
8285542|NCT01646177|20427903|P2|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
8285543|NCT01646177|20427904|P1|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
8285544|NCT01646177|20427893|P12|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285545|NCT01646177|20427894|P11|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285546|NCT01646177|20427895|P10|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285547|NCT01646177|20427896|P9|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285548|NCT01646177|20427897|P8|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||107
8285549|NCT01646177|20427898|P7|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||116
8285550|NCT01646177|20427899|P6|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||113
8285551|NCT01646177|20427900|P5|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||48
8285552|NCT01646177|20427901|P4|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285553|NCT01646177|20427902|P3|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285554|NCT01646177|20427903|P2|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285555|NCT01646177|20427904|P1|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285556|NCT01646177|20427893|P12|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285557|NCT01646177|20427894|P11|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285558|NCT01646177|20427895|P10|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285559|NCT01646177|20427896|P9|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285560|NCT01646177|20427897|P8|COMPLETED|Long-Term Extension Period (Week 12-264)||255
8285561|NCT01646177|20427898|P7|COMPLETED|Long-Term Extension Period (Week 12-264)||244
8285562|NCT01646177|20427899|P6|COMPLETED|Long-Term Extension Period (Week 12-264)||256
8285563|NCT01646177|20427900|P5|COMPLETED|Long-Term Extension Period (Week 12-264)||135
8285564|NCT01646177|20427901|P4|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285565|NCT01646177|20427902|P3|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285566|NCT01646177|20427903|P2|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285567|NCT01646177|20427904|P1|COMPLETED|Long-Term Extension Period (Week 12-264)||0
8285568|NCT01646177|20427893|P12|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285569|NCT01646177|20427894|P11|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285570|NCT01646177|20427895|P10|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285571|NCT01646177|20427896|P9|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285572|NCT01646177|20427897|P8|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||362
8285573|NCT01646177|20427898|P7|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||360
8285574|NCT01646177|20427899|P6|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||369
8285575|NCT01646177|20427900|P5|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||183
8285576|NCT01646177|20427901|P4|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285577|NCT01646177|20427902|P3|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285578|NCT01646177|20427903|P2|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285579|NCT01646177|20427904|P1|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
8285580|NCT01646177|20427893|P12|STARTED|Long-Term Extension Period (Week 12-264)||0
8285581|NCT01646177|20427894|P11|STARTED|Long-Term Extension Period (Week 12-264)||0
8285582|NCT01646177|20427895|P10|STARTED|Long-Term Extension Period (Week 12-264)||0
8285583|NCT01646177|20427896|P9|STARTED|Long-Term Extension Period (Week 12-264)||0
8285584|NCT01646177|20427897|P8|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|362
8285585|NCT01646177|20427898|P7|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|360
8285586|NCT01646177|20427899|P6|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|369
8285587|NCT01646177|20427900|P5|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|183
8285588|NCT01646177|20427901|P4|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
8285589|NCT01646177|20427902|P3|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
8285590|NCT01646177|20427903|P2|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
8285591|NCT01646177|20427904|P1|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
8285592|NCT01646177|20427893|P12|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285593|NCT01646177|20427894|P11|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285594|NCT01646177|20427895|P10|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285595|NCT01646177|20427896|P9|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285596|NCT01646177|20427897|P8|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285597|NCT01646177|20427898|P7|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285598|NCT01646177|20427899|P6|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285599|NCT01646177|20427900|P5|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285600|NCT01646177|20427901|P4|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
8285601|NCT01646177|20427902|P3|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
8285602|NCT01646177|20427903|P2|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
8285603|NCT01646177|20427904|P1|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
8285604|NCT01646177|20427893|P12|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285605|NCT01646177|20427894|P11|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285606|NCT01646177|20427895|P10|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285607|NCT01646177|20427896|P9|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285608|NCT01646177|20427897|P8|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285609|NCT01646177|20427898|P7|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285610|NCT01646177|20427899|P6|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285611|NCT01646177|20427900|P5|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
8285612|NCT01646177|20427901|P4|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
8285613|NCT01646177|20427902|P3|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
8285614|NCT01646177|20427903|P2|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
8285615|NCT01646177|20427904|P1|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
8285616|NCT01646177|20427893|P12|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285617|NCT01646177|20427894|P11|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285618|NCT01646177|20427895|P10|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285619|NCT01646177|20427896|P9|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285620|NCT01646177|20427897|P8|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285621|NCT01646177|20427898|P7|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285622|NCT01646177|20427899|P6|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285623|NCT01646177|20427900|P5|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
8285624|NCT01646177|20427901|P4|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||384
8285625|NCT01646177|20427902|P3|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
8285626|NCT01646177|20427903|P2|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
8285627|NCT01646177|20427904|P1|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||193
8285628|NCT01646177|20427893|P12|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285629|NCT01646177|20427894|P11|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285630|NCT01646177|20427895|P10|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285631|NCT01646177|20427896|P9|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285632|NCT01646177|20427897|P8|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285633|NCT01646177|20427898|P7|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285634|NCT01646177|20427899|P6|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285635|NCT01646177|20427900|P5|STARTED|Blinded Induction Dosing (Week 0-12)||0
8285636|NCT01646177|20427901|P4|STARTED|Blinded Induction Dosing (Week 0-12)||385
8285637|NCT01646177|20427902|P3|STARTED|Blinded Induction Dosing (Week 0-12)||386
8285638|NCT01646177|20427903|P2|STARTED|Blinded Induction Dosing (Week 0-12)||382
8285639|NCT01646177|20427904|P1|STARTED|Blinded Induction Dosing (Week 0-12)||193
8285640|NCT01646151|20427990|P1|NOT COMPLETED|Overall Study||170
8285641|NCT01646151|20427990|P1|COMPLETED|Overall Study||2410
8285642|NCT01646151|20427990|P1|STARTED|Overall Study||2580
8285643|NCT01646138|20428006|P5|NOT COMPLETED|Overall Study||2
8285644|NCT01646138|20428007|P4|NOT COMPLETED|Overall Study||0
8285645|NCT01646138|20428008|P3|NOT COMPLETED|Overall Study||0
8285646|NCT01646138|20428009|P2|NOT COMPLETED|Overall Study||0
8285647|NCT01646138|20428010|P1|NOT COMPLETED|Overall Study||0
8285648|NCT01646138|20428006|P5|COMPLETED|Overall Study||13
8285649|NCT01646138|20428007|P4|COMPLETED|Overall Study||19
8285650|NCT01646138|20428008|P3|COMPLETED|Overall Study||5
8285651|NCT01646138|20428009|P2|COMPLETED|Overall Study||4
8285652|NCT01646138|20428010|P1|COMPLETED|Overall Study||5
8285653|NCT01646138|20428006|P5|STARTED|Overall Study||15
8285654|NCT01646138|20428007|P4|STARTED|Overall Study||19
8285655|NCT01646138|20428008|P3|STARTED|Overall Study||5
8285656|NCT01646138|20428009|P2|STARTED|Overall Study||4
8285657|NCT01646138|20428010|P1|STARTED|Overall Study||5
8285658|NCT01646125|20428024|P2|NOT COMPLETED|Overall Study||28
8285659|NCT01646125|20428025|P1|NOT COMPLETED|Overall Study||31
8285660|NCT01646125|20428024|P2|COMPLETED|Overall Study||0
8285661|NCT01646125|20428025|P1|COMPLETED|Overall Study||0
8285662|NCT01646125|20428024|P2|STARTED|Overall Study||28
8285663|NCT01646125|20428025|P1|STARTED|Overall Study||31
8285664|NCT01646073|20428050|P2|NOT COMPLETED|Period B (12 Weeks)||13
8285665|NCT01646073|20428051|P1|NOT COMPLETED|Period B (12 Weeks)||1
8285666|NCT01646073|20428050|P2|COMPLETED|Period B (12 Weeks)||320
8285667|NCT01646073|20428051|P1|COMPLETED|Period B (12 Weeks)||84
8285668|NCT01646073|20428050|P2|STARTED|Period B (12 Weeks)||333
8285669|NCT01646073|20428051|P1|STARTED|Period B (12 Weeks)||85
8285670|NCT01646073|20428050|P2|NOT COMPLETED|Period A (12 Weeks)||5
8285671|NCT01646073|20428051|P1|NOT COMPLETED|Period A (12 Weeks)||2
8285672|NCT01646073|20428050|P2|COMPLETED|Period A (12 Weeks)||333
8285673|NCT01646073|20428051|P1|COMPLETED|Period A (12 Weeks)||85
8285674|NCT01646073|20428050|P2|STARTED|Period A (12 Weeks)||338
8285675|NCT01646073|20428051|P1|STARTED|Period A (12 Weeks)||87
8285676|NCT01646021|20428092|P2|NOT COMPLETED|Overall Study||141
8285677|NCT01646021|20428093|P1|NOT COMPLETED|Overall Study||139
8285678|NCT01646021|20428092|P2|COMPLETED|Overall Study||0
8285679|NCT01646021|20428093|P1|COMPLETED|Overall Study||0
8285680|NCT01646021|20428092|P2|Treated|Overall Study||139
8285681|NCT01646021|20428093|P1|Treated|Overall Study||139
8285682|NCT01646021|20428092|P2|STARTED|Overall Study||141
8285683|NCT01646021|20428093|P1|STARTED|Overall Study||139
8285684|NCT01645930|20428130|P1|NOT COMPLETED|Overall Study||43
8285685|NCT01645930|20428130|P1|COMPLETED|Overall Study||0
8285686|NCT01645930|20428130|P1|STARTED|Overall Study||43
8285687|NCT01645735|20428147|P2|NOT COMPLETED|Overall Study||1
8285688|NCT01645735|20428148|P1|NOT COMPLETED|Overall Study||4
8285689|NCT01645735|20428147|P2|COMPLETED|Overall Study||16
8285690|NCT01645735|20428148|P1|COMPLETED|Overall Study||28
8285691|NCT01645735|20428147|P2|STARTED|Overall Study||17
8285692|NCT01645735|20428148|P1|STARTED|Overall Study||32
8285693|NCT01645709|20428162|P2|NOT COMPLETED|Overall Study||0
8285694|NCT01645709|20428163|P1|NOT COMPLETED|Overall Study||0
8285695|NCT01645709|20428162|P2|COMPLETED|Overall Study|Study was terminated; not made unblind|0
8285696|NCT01645709|20428163|P1|COMPLETED|Overall Study|Study was terminated; not made unblind|0
8285697|NCT01645709|20428162|P2|STARTED|Overall Study|Study was terminated; not made unblind|0
8285698|NCT01645709|20428163|P1|STARTED|Overall Study|Study was terminated; not made unblind|0
8285699|NCT01645280|20428190|P5|NOT COMPLETED|Overall Study||8
8285700|NCT01645280|20428191|P4|NOT COMPLETED|Overall Study||6
8285701|NCT01645280|20428192|P3|NOT COMPLETED|Overall Study||6
8285702|NCT01645280|20428193|P2|NOT COMPLETED|Overall Study||3
8285703|NCT01645280|20428194|P1|NOT COMPLETED|Overall Study||6
8285704|NCT01645280|20428190|P5|COMPLETED|Overall Study||47
8285705|NCT01645280|20428191|P4|COMPLETED|Overall Study||48
8285706|NCT01645280|20428192|P3|COMPLETED|Overall Study||49
8285707|NCT01645280|20428193|P2|COMPLETED|Overall Study||51
8285708|NCT01645280|20428194|P1|COMPLETED|Overall Study||49
8285709|NCT01645280|20428190|P5|STARTED|Overall Study||55
8285710|NCT01645280|20428191|P4|STARTED|Overall Study||54
8285711|NCT01645280|20428192|P3|STARTED|Overall Study||55
8285712|NCT01645280|20428193|P2|STARTED|Overall Study||54
8285713|NCT01645280|20428194|P1|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
8285714|NCT01645176|20428222|P1|NOT COMPLETED|Overall Study||5
8285715|NCT01645176|20428222|P1|COMPLETED|Overall Study||16
8285716|NCT01645176|20428222|P1|STARTED|Overall Study||21
8285717|NCT01645111|20428226|P1|NOT COMPLETED|Overall Study||15
8285718|NCT01645111|20428226|P1|COMPLETED|Overall Study||35
8285719|NCT01645111|20428226|P1|STARTED|Overall Study||50
8285720|NCT01645098|20428232|P2|NOT COMPLETED|Overall Study||0
8285721|NCT01645098|20428233|P1|NOT COMPLETED|Overall Study||0
8285722|NCT01645098|20428232|P2|COMPLETED|Overall Study||29
8285723|NCT01645098|20428233|P1|COMPLETED|Overall Study||24
8285724|NCT01645098|20428232|P2|STARTED|Overall Study||29
8285725|NCT01645098|20428233|P1|STARTED|Overall Study||24
8285726|NCT01645059|20428247|P1|NOT COMPLETED|Overall Study||0
8285727|NCT01645059|20428247|P1|COMPLETED|Overall Study||129
8285728|NCT01645059|20428247|P1|STARTED|Overall Study||129
8285729|NCT01644890|20428267|P2|NOT COMPLETED|Overall Study||215
8285730|NCT01644890|20428268|P1|NOT COMPLETED|Overall Study||216
8285731|NCT01644890|20428267|P2|COMPLETED|Overall Study||3
8285732|NCT01644890|20428268|P1|COMPLETED|Overall Study||2
8285733|NCT01644890|20428267|P2|STARTED|Overall Study||218
8285734|NCT01644890|20428268|P1|STARTED|Overall Study||218
8285735|NCT01644734|20428278|P1|NOT COMPLETED|Overall Study||266
8285736|NCT01644734|20428278|P1|COMPLETED|Overall Study||1016
8285737|NCT01644734|20428278|P1|STARTED|Overall Study|Patients with documentation of treatment.|1282
8285738|NCT01644695|20428283|P1|NOT COMPLETED|Overall Study||0
8285739|NCT01644695|20428283|P1|COMPLETED|Overall Study||85
8285740|NCT01644695|20428283|P1|STARTED|Overall Study||85
8285741|NCT01644643|20428292|P4|NOT COMPLETED|Overall Study||10
8285742|NCT01644643|20428293|P3|NOT COMPLETED|Overall Study||5
8285743|NCT01644643|20428294|P2|NOT COMPLETED|Overall Study||0
8285744|NCT01644643|20428295|P1|NOT COMPLETED|Overall Study||2
8285745|NCT01644643|20428292|P4|COMPLETED|Overall Study||143
8285746|NCT01644643|20428293|P3|COMPLETED|Overall Study||148
8285747|NCT01644643|20428294|P2|COMPLETED|Overall Study||12
8285748|NCT01644643|20428295|P1|COMPLETED|Overall Study||13
8285749|NCT01644643|20428292|P4|STARTED|Overall Study||153
8285750|NCT01644643|20428293|P3|STARTED|Overall Study||153
8285751|NCT01644643|20428294|P2|STARTED|Overall Study||12
8285752|NCT01644643|20428295|P1|STARTED|Overall Study||15
8285753|NCT01644617|20428460|P3|NOT COMPLETED|Overall Study||7
8285754|NCT01644617|20428461|P2|NOT COMPLETED|Overall Study||5
8285755|NCT01644617|20428462|P1|NOT COMPLETED|Overall Study||6
8285756|NCT01644617|20428460|P3|COMPLETED|Overall Study||34
8285757|NCT01644617|20428461|P2|COMPLETED|Overall Study||36
8285758|NCT01644617|20428462|P1|COMPLETED|Overall Study||36
8285759|NCT01644617|20428460|P3|STARTED|Overall Study||41
8285760|NCT01644617|20428461|P2|STARTED|Overall Study||41
8285761|NCT01644617|20428462|P1|STARTED|Overall Study||42
8285789|NCT01644500|20428561|P3|NOT COMPLETED|Overall Study||15
8285790|NCT01644500|20428562|P2|NOT COMPLETED|Overall Study||24
8285791|NCT01644500|20428563|P1|NOT COMPLETED|Overall Study||22
8285792|NCT01644500|20428561|P3|COMPLETED|Overall Study||230
8285793|NCT01644500|20428562|P2|COMPLETED|Overall Study||224
8285794|NCT01644500|20428563|P1|COMPLETED|Overall Study||222
8285795|NCT01644500|20428561|P3|Modified Intent-to-treat Population|Overall Study||242
8285796|NCT01644500|20428562|P2|Modified Intent-to-treat Population|Overall Study||239
8285797|NCT01644500|20428563|P1|Modified Intent-to-treat Population|Overall Study||239
8285798|NCT01644500|20428561|P3|Received at Least One Dose of Study Drug|Overall Study||243
8285799|NCT01644500|20428562|P2|Received at Least One Dose of Study Drug|Overall Study||248
8285800|NCT01644500|20428563|P1|Received at Least One Dose of Study Drug|Overall Study||244
8285801|NCT01644500|20428561|P3|STARTED|Overall Study||245
8285802|NCT01644500|20428562|P2|STARTED|Overall Study||248
8285803|NCT01644500|20428563|P1|STARTED|Overall Study||244
8285804|NCT01644474|20428633|P2|NOT COMPLETED|Overall Study||8
8285805|NCT01644474|20428634|P1|NOT COMPLETED|Overall Study||7
8285806|NCT01644474|20428633|P2|COMPLETED|Overall Study||44
8285807|NCT01644474|20428634|P1|COMPLETED|Overall Study||44
8285808|NCT01644474|20428633|P2|Treated|Overall Study||52
8285809|NCT01644474|20428634|P1|Treated|Overall Study||51
8285810|NCT01644474|20428633|P2|STARTED|Overall Study|Randomized|52
8285811|NCT01644474|20428634|P1|STARTED|Overall Study|Randomized|51
8285812|NCT01644396|20428674|P1|NOT COMPLETED|Overall Study||0
8285813|NCT01644396|20428674|P1|COMPLETED|Overall Study||50
8285814|NCT01644396|20428674|P1|STARTED|Overall Study||50
8285815|NCT01644331|20428718|P2|NOT COMPLETED|Overall Study||10
8285816|NCT01644331|20428719|P1|NOT COMPLETED|Overall Study||11
8285817|NCT01644331|20428718|P2|COMPLETED|Overall Study||118
8285818|NCT01644331|20428719|P1|COMPLETED|Overall Study||118
8285819|NCT01644331|20428718|P2|STARTED|Overall Study||128
8285820|NCT01644331|20428719|P1|STARTED|Overall Study||129
8285821|NCT01644292|20428751|P1|NOT COMPLETED|Overall Study||0
8285822|NCT01644292|20428751|P1|COMPLETED|Overall Study||2
8285823|NCT01644292|20428751|P1|STARTED|Overall Study||2
8285824|NCT01644240|20428758|P3|NOT COMPLETED|Overall Study||0
8285825|NCT01644240|20428759|P2|NOT COMPLETED|Overall Study||0
8285826|NCT01644240|20428760|P1|NOT COMPLETED|Overall Study||0
8285827|NCT01644240|20428758|P3|COMPLETED|Overall Study||6
8285828|NCT01644240|20428759|P2|COMPLETED|Overall Study||4
8285829|NCT01644240|20428760|P1|COMPLETED|Overall Study||6
8285830|NCT01644240|20428758|P3|STARTED|Overall Study||6
8285831|NCT01644240|20428759|P2|STARTED|Overall Study||4
8285832|NCT01644240|20428760|P1|STARTED|Overall Study||6
8285833|NCT01644188|20428818|P2|NOT COMPLETED|Overall Study||75
8285834|NCT01644188|20428819|P1|NOT COMPLETED|Overall Study||122
8285835|NCT01644188|20428818|P2|COMPLETED|Overall Study||166
8285836|NCT01644188|20428819|P1|COMPLETED|Overall Study||357
8285837|NCT01644188|20428818|P2|Treated|Overall Study||241
8285838|NCT01644188|20428819|P1|Treated|Overall Study||479
8285839|NCT01644188|20428818|P2|STARTED|Overall Study|Randomized|241
8285840|NCT01644188|20428819|P1|STARTED|Overall Study|Randomized|479
8285841|NCT01644175|20428877|P2|NOT COMPLETED|Overall Study||53
8285842|NCT01644175|20428878|P1|NOT COMPLETED|Overall Study||32
8285843|NCT01644175|20428877|P2|COMPLETED|Overall Study||156
8285844|NCT01644175|20428878|P1|COMPLETED|Overall Study||75
8285845|NCT01644175|20428877|P2|Treated|Overall Study||207
8285846|NCT01644175|20428878|P1|Treated|Overall Study||107
8285847|NCT01644175|20428877|P2|STARTED|Overall Study|Randomized|209
8285848|NCT01644175|20428878|P1|STARTED|Overall Study|Randomized|107
8285849|NCT01644149|20428930|P2|NOT COMPLETED|Overall Study||1
8285850|NCT01644149|20428931|P1|NOT COMPLETED|Overall Study||4
8285851|NCT01644149|20428930|P2|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39
8285852|NCT01644149|20428931|P1|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39
8285853|NCT01644149|20428930|P2|STARTED|Overall Study||40
8285854|NCT01644149|20428931|P1|STARTED|Overall Study||43
8285855|NCT01644058|20428941|P1|NOT COMPLETED|Overall Study||0
8285856|NCT01644058|20428941|P1|COMPLETED|Overall Study||18
8285857|NCT01644058|20428941|P1|STARTED|Overall Study||18
8285858|NCT01643928|20428951|P5|NOT COMPLETED|Overall Study||2
8285859|NCT01643928|20428952|P4|NOT COMPLETED|Overall Study||3
8285860|NCT01643928|20428953|P3|NOT COMPLETED|Overall Study||3
8285861|NCT01643928|20428954|P2|NOT COMPLETED|Overall Study||2
8285862|NCT01643928|20428955|P1|NOT COMPLETED|Overall Study||10
8285863|NCT01643928|20428951|P5|COMPLETED|Overall Study||28
8285864|NCT01643928|20428952|P4|COMPLETED|Overall Study||27
8285865|NCT01643928|20428953|P3|COMPLETED|Overall Study||30
8285866|NCT01643928|20428954|P2|COMPLETED|Overall Study||30
8285867|NCT01643928|20428955|P1|COMPLETED|Overall Study||48
8285868|NCT01643928|20428951|P5|STARTED|Overall Study||30
8285869|NCT01643928|20428952|P4|STARTED|Overall Study||30
8285870|NCT01643928|20428953|P3|STARTED|Overall Study||33
8285871|NCT01643928|20428954|P2|STARTED|Overall Study||32
8285872|NCT01643928|20428955|P1|STARTED|Overall Study||58
8285873|NCT01643902|20429240|P1|NOT COMPLETED|Overall Study||0
8285874|NCT01643902|20429240|P1|COMPLETED|Overall Study||20
8285875|NCT01643902|20429240|P1|STARTED|Overall Study||20
8285876|NCT01643876|20429245|P1|NOT COMPLETED|Overall Study||0
8285877|NCT01643876|20429245|P1|COMPLETED|Overall Study||48
8285878|NCT01643876|20429245|P1|STARTED|Overall Study||48
8285879|NCT01643850|20429259|P9|NOT COMPLETED|Overall Study||1
8285880|NCT01643850|20429260|P8|NOT COMPLETED|Overall Study||0
8285881|NCT01643850|20429261|P7|NOT COMPLETED|Overall Study||1
8285882|NCT01643850|20429262|P6|NOT COMPLETED|Overall Study||0
8285883|NCT01643850|20429263|P5|NOT COMPLETED|Overall Study||3
8285884|NCT01643850|20429264|P4|NOT COMPLETED|Overall Study||0
8285885|NCT01643850|20429265|P3|NOT COMPLETED|Overall Study||1
8285886|NCT01643850|20429266|P2|NOT COMPLETED|Overall Study||0
8285887|NCT01643850|20429267|P1|NOT COMPLETED|Overall Study||0
8285888|NCT01643850|20429259|P9|COMPLETED|Overall Study||3
8285889|NCT01643850|20429260|P8|COMPLETED|Overall Study||4
8285890|NCT01643850|20429261|P7|COMPLETED|Overall Study||3
8285891|NCT01643850|20429262|P6|COMPLETED|Overall Study||3
8285892|NCT01643850|20429263|P5|COMPLETED|Overall Study||0
8285893|NCT01643850|20429264|P4|COMPLETED|Overall Study||3
8285894|NCT01643850|20429265|P3|COMPLETED|Overall Study||7
8285895|NCT01643850|20429266|P2|COMPLETED|Overall Study||2
8285896|NCT01643850|20429267|P1|COMPLETED|Overall Study||5
8285897|NCT01643850|20429259|P9|STARTED|Overall Study||4
8285898|NCT01643850|20429260|P8|STARTED|Overall Study||4
8285899|NCT01643850|20429261|P7|STARTED|Overall Study||4
8285900|NCT01643850|20429262|P6|STARTED|Overall Study||3
8285901|NCT01643850|20429263|P5|STARTED|Overall Study||3
8285902|NCT01643850|20429264|P4|STARTED|Overall Study||3
8285903|NCT01643850|20429265|P3|STARTED|Overall Study||8
8285904|NCT01643850|20429266|P2|STARTED|Overall Study||2
8285905|NCT01643850|20429267|P1|STARTED|Overall Study||5
8285906|NCT01643798|20429406|P2|NOT COMPLETED|Pretreatment 2 and Stimulation||0
8285907|NCT01643798|20429407|P1|NOT COMPLETED|Pretreatment 2 and Stimulation||0
8285908|NCT01643798|20429406|P2|COMPLETED|Pretreatment 2 and Stimulation||8
8285909|NCT01643798|20429407|P1|COMPLETED|Pretreatment 2 and Stimulation||6
8285910|NCT01643798|20429406|P2|STARTED|Pretreatment 2 and Stimulation||8
8285911|NCT01643798|20429407|P1|STARTED|Pretreatment 2 and Stimulation||6
8285912|NCT01643798|20429406|P2|NOT COMPLETED|Pretreatment 1 and Stimulation||0
8285913|NCT01643798|20429407|P1|NOT COMPLETED|Pretreatment 1 and Stimulation||1
8285914|NCT01643798|20429406|P2|COMPLETED|Pretreatment 1 and Stimulation||8
8285915|NCT01643798|20429407|P1|COMPLETED|Pretreatment 1 and Stimulation||6
8285916|NCT01643798|20429406|P2|STARTED|Pretreatment 1 and Stimulation||8
8285917|NCT01643798|20429407|P1|STARTED|Pretreatment 1 and Stimulation||7
8285918|NCT01643772|20429422|P4|NOT COMPLETED|Overall Study||2
8285919|NCT01643772|20429423|P3|NOT COMPLETED|Overall Study||0
8285920|NCT01643772|20429424|P2|NOT COMPLETED|Overall Study||0
8285921|NCT01643772|20429425|P1|NOT COMPLETED|Overall Study||0
8285922|NCT01643772|20429422|P4|COMPLETED|Overall Study||14
8285923|NCT01643772|20429423|P3|COMPLETED|Overall Study||15
8285924|NCT01643772|20429424|P2|COMPLETED|Overall Study||15
8285925|NCT01643772|20429425|P1|COMPLETED|Overall Study||15
8285926|NCT01643772|20429422|P4|STARTED|Overall Study||16
8285927|NCT01643772|20429423|P3|STARTED|Overall Study||15
8285928|NCT01643772|20429424|P2|STARTED|Overall Study||15
8285929|NCT01643772|20429425|P1|STARTED|Overall Study||15
8285930|NCT01643668|20429465|P1|NOT COMPLETED|Overall Study||1
8285931|NCT01643668|20429465|P1|COMPLETED|Overall Study||33
8285932|NCT01643668|20429465|P1|STARTED|Overall Study||34
8285933|NCT01643616|20429479|P2|NOT COMPLETED|Overall Study||0
8285934|NCT01643616|20429480|P1|NOT COMPLETED|Overall Study||0
8285935|NCT01643616|20429479|P2|COMPLETED|Overall Study||125
8285936|NCT01643616|20429480|P1|COMPLETED|Overall Study||125
8285937|NCT01643616|20429479|P2|STARTED|Overall Study||125
8285938|NCT01643616|20429480|P1|STARTED|Overall Study||125
8285939|NCT01643525|20429490|P1|NOT COMPLETED|Overall Study||0
8285940|NCT01643525|20429490|P1|COMPLETED|Overall Study||29
8285941|NCT01643525|20429490|P1|STARTED|Overall Study||29
8285942|NCT01643473|20429496|P2|NOT COMPLETED|Overall Study||0
8285943|NCT01643473|20429497|P1|NOT COMPLETED|Overall Study||1
8285944|NCT01643473|20429496|P2|COMPLETED|Overall Study||21
8285945|NCT01643473|20429497|P1|COMPLETED|Overall Study||20
8285946|NCT01643473|20429496|P2|STARTED|Overall Study||21
8285947|NCT01643473|20429497|P1|STARTED|Overall Study||21
8285948|NCT01643382|20429511|P2|NOT COMPLETED|Overall Study||0
8285949|NCT01643382|20429512|P1|NOT COMPLETED|Overall Study||0
8285950|NCT01643382|20429511|P2|COMPLETED|Overall Study||30
8285951|NCT01643382|20429512|P1|COMPLETED|Overall Study||30
8285952|NCT01643382|20429511|P2|STARTED|Overall Study||30
8285953|NCT01643382|20429512|P1|STARTED|Overall Study||30
8285954|NCT01643213|20429520|P2|NOT COMPLETED|Overall Study||0
8285955|NCT01643213|20429521|P1|NOT COMPLETED|Overall Study||1
8285956|NCT01643213|20429520|P2|COMPLETED|Overall Study||14
8285957|NCT01643213|20429521|P1|COMPLETED|Overall Study||12
8285958|NCT01643213|20429520|P2|STARTED|Overall Study||14
8285959|NCT01643213|20429521|P1|STARTED|Overall Study||13
8285960|NCT01643044|20429529|P2|NOT COMPLETED|Overall Study||5
8285961|NCT01643044|20429530|P1|NOT COMPLETED|Overall Study||4
8285962|NCT01643044|20429529|P2|COMPLETED|Overall Study||19
8285963|NCT01643044|20429530|P1|COMPLETED|Overall Study||20
8285964|NCT01643044|20429529|P2|STARTED|Overall Study||24
8285965|NCT01643044|20429530|P1|STARTED|Overall Study||24
8285966|NCT01642914|20429539|P3|NOT COMPLETED|Overall Study||40
8285967|NCT01642914|20429540|P2|NOT COMPLETED|Overall Study||32
8285968|NCT01642914|20429541|P1|NOT COMPLETED|Overall Study||46
8285969|NCT01642914|20429539|P3|COMPLETED|Overall Study||120
8285970|NCT01642914|20429540|P2|COMPLETED|Overall Study||122
8285971|NCT01642914|20429541|P1|COMPLETED|Overall Study||127
8285972|NCT01642914|20429539|P3|STARTED|Overall Study||160
8285973|NCT01642914|20429540|P2|STARTED|Overall Study||154
8285974|NCT01642914|20429541|P1|STARTED|Overall Study||173
8285975|NCT01642732|20429616|P1|NOT COMPLETED|Overall Study||1
8285976|NCT01642732|20429616|P1|COMPLETED|Overall Study||0
8285977|NCT01642732|20429616|P1|STARTED|Overall Study||1
8285978|NCT01642615|20429621|P3|NOT COMPLETED|Double Blind Maintenance Phase||6
8285979|NCT01642615|20429622|P2|NOT COMPLETED|Double Blind Maintenance Phase||7
8285980|NCT01642615|20429623|P1|NOT COMPLETED|Double Blind Maintenance Phase||0
8285981|NCT01642615|20429621|P3|COMPLETED|Double Blind Maintenance Phase||20
8285982|NCT01642615|20429622|P2|COMPLETED|Double Blind Maintenance Phase||18
8285983|NCT01642615|20429623|P1|COMPLETED|Double Blind Maintenance Phase||0
8285984|NCT01642615|20429621|P3|STARTED|Double Blind Maintenance Phase||26
8285985|NCT01642615|20429622|P2|STARTED|Double Blind Maintenance Phase||25
8285986|NCT01642615|20429623|P1|STARTED|Double Blind Maintenance Phase||0
8285987|NCT01642615|20429621|P3|NOT COMPLETED|Open Label Maintenance Phase||0
8285988|NCT01642615|20429622|P2|NOT COMPLETED|Open Label Maintenance Phase||0
8285989|NCT01642615|20429623|P1|NOT COMPLETED|Open Label Maintenance Phase||5
8285990|NCT01642615|20429621|P3|COMPLETED|Open Label Maintenance Phase||0
8285991|NCT01642615|20429622|P2|COMPLETED|Open Label Maintenance Phase||0
8285992|NCT01642615|20429623|P1|COMPLETED|Open Label Maintenance Phase||58
8285993|NCT01642615|20429621|P3|Safety Analysis Set|Open Label Maintenance Phase||0
8285994|NCT01642615|20429622|P2|Safety Analysis Set|Open Label Maintenance Phase||0
8285995|NCT01642615|20429623|P1|Safety Analysis Set|Open Label Maintenance Phase||62
8285996|NCT01642615|20429621|P3|STARTED|Open Label Maintenance Phase||0
8285997|NCT01642615|20429622|P2|STARTED|Open Label Maintenance Phase||0
8285998|NCT01642615|20429623|P1|STARTED|Open Label Maintenance Phase||63
8285999|NCT01642602|20429637|P1|NOT COMPLETED|Overall Study||2
8286000|NCT01642602|20429637|P1|COMPLETED|Overall Study||102
8286001|NCT01642602|20429637|P1|STARTED|Overall Study||104
8286002|NCT01642589|20429644|P2|NOT COMPLETED|Overall Study||1
8286003|NCT01642589|20429645|P1|NOT COMPLETED|Overall Study||1
8286004|NCT01642589|20429644|P2|COMPLETED|Overall Study||99
8286005|NCT01642589|20429645|P1|COMPLETED|Overall Study||199
8286006|NCT01642589|20429644|P2|STARTED|Overall Study||100
8286007|NCT01642589|20429645|P1|STARTED|Overall Study||200
8286008|NCT01642485|20429659|P8|NOT COMPLETED|Period 2, Day 3||0
8286009|NCT01642485|20429660|P7|NOT COMPLETED|Period 2, Day 3||0
8286010|NCT01642485|20429661|P6|NOT COMPLETED|Period 2, Day 3||0
8286011|NCT01642485|20429662|P5|NOT COMPLETED|Period 2, Day 3||0
8286012|NCT01642485|20429663|P4|NOT COMPLETED|Period 2, Day 3||0
8286013|NCT01642485|20429664|P3|NOT COMPLETED|Period 2, Day 3||0
8286014|NCT01642485|20429665|P2|NOT COMPLETED|Period 2, Day 3||0
8286015|NCT01642485|20429666|P1|NOT COMPLETED|Period 2, Day 3||0
8286016|NCT01642485|20429659|P8|COMPLETED|Period 2, Day 3||4
8286017|NCT01642485|20429660|P7|COMPLETED|Period 2, Day 3||4
8286018|NCT01642485|20429661|P6|COMPLETED|Period 2, Day 3||4
8286019|NCT01642485|20429662|P5|COMPLETED|Period 2, Day 3||4
8286020|NCT01642485|20429663|P4|COMPLETED|Period 2, Day 3||4
8286021|NCT01642485|20429664|P3|COMPLETED|Period 2, Day 3||4
8286022|NCT01642485|20429665|P2|COMPLETED|Period 2, Day 3||4
8286023|NCT01642485|20429666|P1|COMPLETED|Period 2, Day 3||4
8286024|NCT01642485|20429659|P8|STARTED|Period 2, Day 3||4
8286025|NCT01642485|20429660|P7|STARTED|Period 2, Day 3||4
8286026|NCT01642485|20429661|P6|STARTED|Period 2, Day 3||4
8286027|NCT01642485|20429662|P5|STARTED|Period 2, Day 3||4
8286028|NCT01642485|20429663|P4|STARTED|Period 2, Day 3||4
8286029|NCT01642485|20429664|P3|STARTED|Period 2, Day 3||4
8286030|NCT01642485|20429665|P2|STARTED|Period 2, Day 3||4
8286031|NCT01642485|20429666|P1|STARTED|Period 2, Day 3||4
8286032|NCT01642485|20429659|P8|NOT COMPLETED|Period 2, Day 2||0
8286033|NCT01642485|20429660|P7|NOT COMPLETED|Period 2, Day 2||0
8286034|NCT01642485|20429661|P6|NOT COMPLETED|Period 2, Day 2||0
8286035|NCT01642485|20429662|P5|NOT COMPLETED|Period 2, Day 2||0
8286036|NCT01642485|20429663|P4|NOT COMPLETED|Period 2, Day 2||0
8286037|NCT01642485|20429664|P3|NOT COMPLETED|Period 2, Day 2||0
8286038|NCT01642485|20429665|P2|NOT COMPLETED|Period 2, Day 2||0
8286039|NCT01642485|20429666|P1|NOT COMPLETED|Period 2, Day 2||0
8286040|NCT01642485|20429659|P8|COMPLETED|Period 2, Day 2||4
8286041|NCT01642485|20429660|P7|COMPLETED|Period 2, Day 2||4
8286042|NCT01642485|20429661|P6|COMPLETED|Period 2, Day 2||4
8286043|NCT01642485|20429662|P5|COMPLETED|Period 2, Day 2||4
8286044|NCT01642485|20429663|P4|COMPLETED|Period 2, Day 2||4
8286045|NCT01642485|20429664|P3|COMPLETED|Period 2, Day 2||4
8286046|NCT01642485|20429665|P2|COMPLETED|Period 2, Day 2||4
8286047|NCT01642485|20429666|P1|COMPLETED|Period 2, Day 2||4
8286048|NCT01642485|20429659|P8|STARTED|Period 2, Day 2||4
8286049|NCT01642485|20429660|P7|STARTED|Period 2, Day 2||4
8286050|NCT01642485|20429661|P6|STARTED|Period 2, Day 2||4
8286051|NCT01642485|20429662|P5|STARTED|Period 2, Day 2||4
8286052|NCT01642485|20429663|P4|STARTED|Period 2, Day 2||4
8286053|NCT01642485|20429664|P3|STARTED|Period 2, Day 2||4
8286054|NCT01642485|20429665|P2|STARTED|Period 2, Day 2||4
8286055|NCT01642485|20429666|P1|STARTED|Period 2, Day 2||4
8286056|NCT01642485|20429659|P8|NOT COMPLETED|Period 2, Day 1||0
8286057|NCT01642485|20429660|P7|NOT COMPLETED|Period 2, Day 1||0
8286058|NCT01642485|20429661|P6|NOT COMPLETED|Period 2, Day 1||0
8286059|NCT01642485|20429662|P5|NOT COMPLETED|Period 2, Day 1||0
8286060|NCT01642485|20429663|P4|NOT COMPLETED|Period 2, Day 1||0
8286061|NCT01642485|20429664|P3|NOT COMPLETED|Period 2, Day 1||0
8286062|NCT01642485|20429665|P2|NOT COMPLETED|Period 2, Day 1||0
8286063|NCT01642485|20429666|P1|NOT COMPLETED|Period 2, Day 1||0
8286064|NCT01642485|20429659|P8|COMPLETED|Period 2, Day 1||4
8286065|NCT01642485|20429660|P7|COMPLETED|Period 2, Day 1||4
8286066|NCT01642485|20429661|P6|COMPLETED|Period 2, Day 1||4
8286067|NCT01642485|20429662|P5|COMPLETED|Period 2, Day 1||4
8286068|NCT01642485|20429663|P4|COMPLETED|Period 2, Day 1||4
8286069|NCT01642485|20429664|P3|COMPLETED|Period 2, Day 1||4
8286070|NCT01642485|20429665|P2|COMPLETED|Period 2, Day 1||4
8286071|NCT01642485|20429666|P1|COMPLETED|Period 2, Day 1||4
8286072|NCT01642485|20429659|P8|STARTED|Period 2, Day 1||4
8286073|NCT01642485|20429660|P7|STARTED|Period 2, Day 1||4
8286074|NCT01642485|20429661|P6|STARTED|Period 2, Day 1||4
8286075|NCT01642485|20429662|P5|STARTED|Period 2, Day 1||4
8286076|NCT01642485|20429663|P4|STARTED|Period 2, Day 1||4
8286077|NCT01642485|20429664|P3|STARTED|Period 2, Day 1||4
8286078|NCT01642485|20429665|P2|STARTED|Period 2, Day 1||4
8286079|NCT01642485|20429666|P1|STARTED|Period 2, Day 1||4
8286080|NCT01642485|20429659|P8|NOT COMPLETED|Period 1, Day 3||0
8286081|NCT01642485|20429660|P7|NOT COMPLETED|Period 1, Day 3||0
8286082|NCT01642485|20429661|P6|NOT COMPLETED|Period 1, Day 3||0
8286083|NCT01642485|20429662|P5|NOT COMPLETED|Period 1, Day 3||0
8286084|NCT01642485|20429663|P4|NOT COMPLETED|Period 1, Day 3||0
8286085|NCT01642485|20429664|P3|NOT COMPLETED|Period 1, Day 3||0
8286086|NCT01642485|20429665|P2|NOT COMPLETED|Period 1, Day 3||0
8286087|NCT01642485|20429666|P1|NOT COMPLETED|Period 1, Day 3||0
8286088|NCT01642485|20429659|P8|COMPLETED|Period 1, Day 3||4
8286089|NCT01642485|20429660|P7|COMPLETED|Period 1, Day 3||4
8286090|NCT01642485|20429661|P6|COMPLETED|Period 1, Day 3||4
8286091|NCT01642485|20429662|P5|COMPLETED|Period 1, Day 3||4
8286092|NCT01642485|20429663|P4|COMPLETED|Period 1, Day 3||4
8286093|NCT01642485|20429664|P3|COMPLETED|Period 1, Day 3||4
8286094|NCT01642485|20429665|P2|COMPLETED|Period 1, Day 3||4
8286095|NCT01642485|20429666|P1|COMPLETED|Period 1, Day 3||4
8286096|NCT01642485|20429659|P8|STARTED|Period 1, Day 3||4
8286097|NCT01642485|20429660|P7|STARTED|Period 1, Day 3||4
8286098|NCT01642485|20429661|P6|STARTED|Period 1, Day 3||4
8286099|NCT01642485|20429662|P5|STARTED|Period 1, Day 3||4
8286100|NCT01642485|20429663|P4|STARTED|Period 1, Day 3||4
8286101|NCT01642485|20429664|P3|STARTED|Period 1, Day 3||4
8286102|NCT01642485|20429665|P2|STARTED|Period 1, Day 3||4
8286103|NCT01642485|20429666|P1|STARTED|Period 1, Day 3||4
8286104|NCT01642485|20429659|P8|NOT COMPLETED|Period 1, Day 2||0
8286105|NCT01642485|20429660|P7|NOT COMPLETED|Period 1, Day 2||0
8286106|NCT01642485|20429661|P6|NOT COMPLETED|Period 1, Day 2||0
8286107|NCT01642485|20429662|P5|NOT COMPLETED|Period 1, Day 2||0
8286108|NCT01642485|20429663|P4|NOT COMPLETED|Period 1, Day 2||0
8286109|NCT01642485|20429664|P3|NOT COMPLETED|Period 1, Day 2||0
8286110|NCT01642485|20429665|P2|NOT COMPLETED|Period 1, Day 2||0
8286111|NCT01642485|20429666|P1|NOT COMPLETED|Period 1, Day 2||0
8286112|NCT01642485|20429659|P8|COMPLETED|Period 1, Day 2||4
8286113|NCT01642485|20429660|P7|COMPLETED|Period 1, Day 2||4
8286114|NCT01642485|20429661|P6|COMPLETED|Period 1, Day 2||4
8286115|NCT01642485|20429662|P5|COMPLETED|Period 1, Day 2||4
8286116|NCT01642485|20429663|P4|COMPLETED|Period 1, Day 2||4
8286117|NCT01642485|20429664|P3|COMPLETED|Period 1, Day 2||4
8286118|NCT01642485|20429665|P2|COMPLETED|Period 1, Day 2||4
8286119|NCT01642485|20429666|P1|COMPLETED|Period 1, Day 2||4
8286120|NCT01642485|20429659|P8|STARTED|Period 1, Day 2||4
8286121|NCT01642485|20429660|P7|STARTED|Period 1, Day 2||4
8286122|NCT01642485|20429661|P6|STARTED|Period 1, Day 2||4
8286123|NCT01642485|20429662|P5|STARTED|Period 1, Day 2||4
8286124|NCT01642485|20429663|P4|STARTED|Period 1, Day 2||4
8286125|NCT01642485|20429664|P3|STARTED|Period 1, Day 2||4
8286126|NCT01642485|20429665|P2|STARTED|Period 1, Day 2||4
8286127|NCT01642485|20429666|P1|STARTED|Period 1, Day 2||4
8286128|NCT01642485|20429659|P8|NOT COMPLETED|Period 1, Day 1||0
8286129|NCT01642485|20429660|P7|NOT COMPLETED|Period 1, Day 1||0
8286130|NCT01642485|20429661|P6|NOT COMPLETED|Period 1, Day 1||0
8286131|NCT01642485|20429662|P5|NOT COMPLETED|Period 1, Day 1||0
8286132|NCT01642485|20429663|P4|NOT COMPLETED|Period 1, Day 1||0
8286133|NCT01642485|20429664|P3|NOT COMPLETED|Period 1, Day 1||0
8286134|NCT01642485|20429665|P2|NOT COMPLETED|Period 1, Day 1||0
8286135|NCT01642485|20429666|P1|NOT COMPLETED|Period 1, Day 1||0
8286136|NCT01642485|20429659|P8|COMPLETED|Period 1, Day 1||4
8286137|NCT01642485|20429660|P7|COMPLETED|Period 1, Day 1||4
8286138|NCT01642485|20429661|P6|COMPLETED|Period 1, Day 1||4
8286139|NCT01642485|20429662|P5|COMPLETED|Period 1, Day 1||4
8286140|NCT01642485|20429663|P4|COMPLETED|Period 1, Day 1||4
8286141|NCT01642485|20429664|P3|COMPLETED|Period 1, Day 1||4
8286142|NCT01642485|20429665|P2|COMPLETED|Period 1, Day 1||4
8286143|NCT01642485|20429666|P1|COMPLETED|Period 1, Day 1||4
8286144|NCT01642485|20429659|P8|STARTED|Period 1, Day 1||4
8286145|NCT01642485|20429660|P7|STARTED|Period 1, Day 1||4
8286146|NCT01642485|20429661|P6|STARTED|Period 1, Day 1||4
8286147|NCT01642485|20429662|P5|STARTED|Period 1, Day 1||4
8286148|NCT01642485|20429663|P4|STARTED|Period 1, Day 1||4
8286149|NCT01642485|20429664|P3|STARTED|Period 1, Day 1||4
8286150|NCT01642485|20429665|P2|STARTED|Period 1, Day 1||4
8286151|NCT01642485|20429666|P1|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
8286158|NCT01642277|20429731|P2|NOT COMPLETED|Overall Study||0
8286159|NCT01642277|20429732|P1|NOT COMPLETED|Overall Study||24
8286160|NCT01642277|20429731|P2|COMPLETED|Overall Study||60
8286161|NCT01642277|20429732|P1|COMPLETED|Overall Study||50
8286162|NCT01642277|20429731|P2|STARTED|Overall Study||60
8286163|NCT01642277|20429732|P1|STARTED|Overall Study||74
8286164|NCT01642251|20429744|P4|NOT COMPLETED|Overall Study||23
8286165|NCT01642251|20429745|P3|NOT COMPLETED|Overall Study||22
8286166|NCT01642251|20429746|P2|NOT COMPLETED|Overall Study||0
8286167|NCT01642251|20429747|P1|NOT COMPLETED|Overall Study||0
8286168|NCT01642251|20429744|P4|COMPLETED|Overall Study||49
8286169|NCT01642251|20429745|P3|COMPLETED|Overall Study||53
8286170|NCT01642251|20429746|P2|COMPLETED|Overall Study||6
8286171|NCT01642251|20429747|P1|COMPLETED|Overall Study||3
8286172|NCT01642251|20429744|P4|Eligible and Treated|Overall Study||64
8286173|NCT01642251|20429745|P3|Eligible and Treated|Overall Study||64
8286174|NCT01642251|20429746|P2|Eligible and Treated|Overall Study||6
8286175|NCT01642251|20429747|P1|Eligible and Treated|Overall Study||3
8286176|NCT01642251|20429744|P4|Eligible|Overall Study||69
8286177|NCT01642251|20429745|P3|Eligible|Overall Study||72
8286178|NCT01642251|20429746|P2|Eligible|Overall Study||6
8286179|NCT01642251|20429747|P1|Eligible|Overall Study||3
8286180|NCT01642251|20429744|P4|Started Protocol Therapy|Overall Study||66
8286181|NCT01642251|20429745|P3|Started Protocol Therapy|Overall Study||66
8286182|NCT01642251|20429746|P2|Started Protocol Therapy|Overall Study||6
8286183|NCT01642251|20429747|P1|Started Protocol Therapy|Overall Study||3
8286184|NCT01642251|20429744|P4|STARTED|Overall Study||72
8286185|NCT01642251|20429745|P3|STARTED|Overall Study||75
8286186|NCT01642251|20429746|P2|STARTED|Overall Study||6
8286187|NCT01642251|20429747|P1|STARTED|Overall Study||3
8286188|NCT01642238|20429762|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8286189|NCT01642238|20429763|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8286190|NCT01642238|20429762|P2|COMPLETED|Second Intervention (1 Day)||8
8286191|NCT01642238|20429763|P1|COMPLETED|Second Intervention (1 Day)||7
8286192|NCT01642238|20429762|P2|STARTED|Second Intervention (1 Day)||8
8286193|NCT01642238|20429763|P1|STARTED|Second Intervention (1 Day)||7
8286194|NCT01642238|20429762|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
8286195|NCT01642238|20429763|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
8286196|NCT01642238|20429762|P2|COMPLETED|Washout (1-2 Weeks)||8
8286197|NCT01642238|20429763|P1|COMPLETED|Washout (1-2 Weeks)||7
8286198|NCT01642238|20429762|P2|STARTED|Washout (1-2 Weeks)||8
8286199|NCT01642238|20429763|P1|STARTED|Washout (1-2 Weeks)||7
8286200|NCT01642238|20429762|P2|NOT COMPLETED|First Intervention (1 Day)||0
8286201|NCT01642238|20429763|P1|NOT COMPLETED|First Intervention (1 Day)||0
8286202|NCT01642238|20429762|P2|COMPLETED|First Intervention (1 Day)||8
8286203|NCT01642238|20429763|P1|COMPLETED|First Intervention (1 Day)||7
8286204|NCT01642238|20429762|P2|STARTED|First Intervention (1 Day)||8
8286205|NCT01642238|20429763|P1|STARTED|First Intervention (1 Day)||7
8286251|NCT01642147|20429839|P2|NOT COMPLETED|Overall Study||0
8286252|NCT01642147|20429840|P1|NOT COMPLETED|Overall Study||0
8286253|NCT01642147|20429839|P2|COMPLETED|Overall Study||30
8286254|NCT01642147|20429840|P1|COMPLETED|Overall Study||30
8286255|NCT01642147|20429839|P2|STARTED|Overall Study||30
8286256|NCT01642147|20429840|P1|STARTED|Overall Study||30
8286257|NCT01642082|20429868|P1|NOT COMPLETED|Overall Study||0
8286258|NCT01642082|20429868|P1|COMPLETED|Overall Study||28
8286259|NCT01642082|20429868|P1|STARTED|Overall Study||28
8286260|NCT01642004|20429884|P2|NOT COMPLETED|Treatment||127
8286261|NCT01642004|20429885|P1|NOT COMPLETED|Treatment||110
8286262|NCT01642004|20429884|P2|COMPLETED|Treatment||2
8286263|NCT01642004|20429885|P1|COMPLETED|Treatment||21
8286264|NCT01642004|20429884|P2|STARTED|Treatment||129
8286265|NCT01642004|20429885|P1|STARTED|Treatment||131
8286266|NCT01642004|20429884|P2|NOT COMPLETED|Randomization||8
8286267|NCT01642004|20429885|P1|NOT COMPLETED|Randomization||4
8286268|NCT01642004|20429884|P2|COMPLETED|Randomization||129
8286269|NCT01642004|20429885|P1|COMPLETED|Randomization||131
8286270|NCT01642004|20429884|P2|STARTED|Randomization||137
8286271|NCT01642004|20429885|P1|STARTED|Randomization||135
8286272|NCT01641991|20429919|P4|NOT COMPLETED|Overall Study||16
8286273|NCT01641991|20429920|P3|NOT COMPLETED|Overall Study||17
8286274|NCT01641991|20429921|P2|NOT COMPLETED|Overall Study||8
8286275|NCT01641991|20429922|P1|NOT COMPLETED|Overall Study||9
8286276|NCT01641991|20429919|P4|COMPLETED|Overall Study||66
8286277|NCT01641991|20429920|P3|COMPLETED|Overall Study||65
8286278|NCT01641991|20429921|P2|COMPLETED|Overall Study||74
8286279|NCT01641991|20429922|P1|COMPLETED|Overall Study||73
8286280|NCT01641991|20429919|P4|STARTED|Overall Study||82
8286281|NCT01641991|20429920|P3|STARTED|Overall Study||82
8286282|NCT01641991|20429921|P2|STARTED|Overall Study||82
8286283|NCT01641991|20429922|P1|STARTED|Overall Study||82
8286284|NCT01641978|20429998|P1|NOT COMPLETED|Overall Study||0
8286285|NCT01641978|20429998|P1|COMPLETED|Overall Study||125
8286286|NCT01641978|20429998|P1|STARTED|Overall Study||125
8286287|NCT01641952|20430006|P1|NOT COMPLETED|Overall Study||34
8286288|NCT01641952|20430006|P1|COMPLETED|Overall Study||471
8286289|NCT01641952|20430006|P1|Treated|Overall Study||504
8286290|NCT01641952|20430006|P1|STARTED|Overall Study||505
8286291|NCT01641939|20430022|P3|NOT COMPLETED|Overall Study||70
8286292|NCT01641939|20430023|P2|NOT COMPLETED|Overall Study||228
8286293|NCT01641939|20430024|P1|NOT COMPLETED|Overall Study||117
8286294|NCT01641939|20430022|P3|COMPLETED|Overall Study||0
8286295|NCT01641939|20430023|P2|COMPLETED|Overall Study||0
8286296|NCT01641939|20430024|P1|COMPLETED|Overall Study||0
8286297|NCT01641939|20430022|P3|Stage 2|Overall Study||0
8286298|NCT01641939|20430023|P2|Stage 2|Overall Study||153
8286299|NCT01641939|20430024|P1|Stage 2|Overall Study||80
8286300|NCT01641939|20430022|P3|Stage 1|Overall Study||70
8286301|NCT01641939|20430023|P2|Stage 1|Overall Study||75
8286302|NCT01641939|20430024|P1|Stage 1|Overall Study||37
8286303|NCT01641939|20430022|P3|STARTED|Overall Study||70
8286304|NCT01641939|20430023|P2|STARTED|Overall Study||228
8286305|NCT01641939|20430024|P1|STARTED|Overall Study||117
8286306|NCT01641926|20430067|P4|NOT COMPLETED|Overall Study||4
8286307|NCT01641926|20430068|P3|NOT COMPLETED|Overall Study||11
8286308|NCT01641926|20430069|P2|NOT COMPLETED|Overall Study||15
8286309|NCT01641926|20430070|P1|NOT COMPLETED|Overall Study||28
8286310|NCT01641926|20430067|P4|COMPLETED|Overall Study||53
8286311|NCT01641926|20430068|P3|COMPLETED|Overall Study||46
8286312|NCT01641926|20430069|P2|COMPLETED|Overall Study||130
8286313|NCT01641926|20430070|P1|COMPLETED|Overall Study||115
8286314|NCT01641926|20430067|P4|Treated (All Participants as Treated)|Overall Study||57
8286315|NCT01641926|20430068|P3|Treated (All Participants as Treated)|Overall Study||56
8286316|NCT01641926|20430069|P2|Treated (All Participants as Treated)|Overall Study||144
8286317|NCT01641926|20430070|P1|Treated (All Participants as Treated)|Overall Study||142
8286318|NCT01641926|20430067|P4|STARTED|Overall Study||57
8286319|NCT01641926|20430068|P3|STARTED|Overall Study||57
8286320|NCT01641926|20430069|P2|STARTED|Overall Study||145
8286321|NCT01641926|20430070|P1|STARTED|Overall Study||143
8286322|NCT01641900|20430098|P2|NOT COMPLETED|Overall Study||2
8286323|NCT01641900|20430099|P1|NOT COMPLETED|Overall Study||2
8286324|NCT01641900|20430098|P2|COMPLETED|Overall Study||29
8286325|NCT01641900|20430099|P1|COMPLETED|Overall Study||26
8286326|NCT01641900|20430098|P2|Completed Drug Intervention|Overall Study||29
8286327|NCT01641900|20430099|P1|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
8286328|NCT01641900|20430098|P2|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
8286329|NCT01641900|20430099|P1|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
8286330|NCT01641900|20430098|P2|STARTED|Overall Study||31
8286331|NCT01641900|20430099|P1|STARTED|Overall Study||28
8286332|NCT01641861|20430111|P2|NOT COMPLETED|Overall Study||25
8286333|NCT01641861|20430112|P1|NOT COMPLETED|Overall Study||35
8286334|NCT01641861|20430111|P2|COMPLETED|Overall Study||217
8286335|NCT01641861|20430112|P1|COMPLETED|Overall Study||211
8286336|NCT01641861|20430111|P2|STARTED|Overall Study||242
8286337|NCT01641861|20430112|P1|STARTED|Overall Study||246
8286338|NCT01641835|20430126|P1|NOT COMPLETED|Overall Study||0
8286339|NCT01641835|20430126|P1|COMPLETED|Overall Study||303
8286340|NCT01641835|20430126|P1|STARTED|Overall Study||303
8286341|NCT01641822|20430133|P3|NOT COMPLETED|Comparative Phase||10
8286342|NCT01641822|20430134|P2|NOT COMPLETED|Comparative Phase||6
8286343|NCT01641822|20430135|P1|NOT COMPLETED|Comparative Phase||0
8286344|NCT01641822|20430133|P3|COMPLETED|Comparative Phase||37
8286345|NCT01641822|20430134|P2|COMPLETED|Comparative Phase||37
8286346|NCT01641822|20430135|P1|COMPLETED|Comparative Phase||0
8286347|NCT01641822|20430133|P3|Received Randomized Study Drug Treatment|Comparative Phase||46
8286348|NCT01641822|20430134|P2|Received Randomized Study Drug Treatment|Comparative Phase||42
8286349|NCT01641822|20430135|P1|Received Randomized Study Drug Treatment|Comparative Phase||0
8286350|NCT01641822|20430133|P3|STARTED|Comparative Phase||47
8286351|NCT01641822|20430134|P2|STARTED|Comparative Phase||43
8286352|NCT01641822|20430135|P1|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
8286353|NCT01641822|20430133|P3|NOT COMPLETED|Run-in Phase||0
8286354|NCT01641822|20430134|P2|NOT COMPLETED|Run-in Phase||0
8286355|NCT01641822|20430135|P1|NOT COMPLETED|Run-in Phase||14
8286356|NCT01641822|20430133|P3|COMPLETED|Run-in Phase||0
8286357|NCT01641822|20430134|P2|COMPLETED|Run-in Phase||0
8286358|NCT01641822|20430135|P1|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
8286359|NCT01641822|20430133|P3|STARTED|Run-in Phase||0
8286360|NCT01641822|20430134|P2|STARTED|Run-in Phase||0
8286361|NCT01641822|20430135|P1|STARTED|Run-in Phase||107
8286362|NCT01641809|20430156|P4|NOT COMPLETED|Open-label (Week 96 to Week 324)||0
8286363|NCT01641809|20430157|P3|NOT COMPLETED|Open-label (Week 96 to Week 324)||8
8286364|NCT01641809|20430158|P2|NOT COMPLETED|Open-label (Week 96 to Week 324)||12
8286365|NCT01641809|20430159|P1|NOT COMPLETED|Open-label (Week 96 to Week 324)||16
8286366|NCT01641809|20430156|P4|COMPLETED|Open-label (Week 96 to Week 324)||0
8286367|NCT01641809|20430157|P3|COMPLETED|Open-label (Week 96 to Week 324)||43
8286368|NCT01641809|20430158|P2|COMPLETED|Open-label (Week 96 to Week 324)||35
8286369|NCT01641809|20430159|P1|COMPLETED|Open-label (Week 96 to Week 324)||30
8286370|NCT01641809|20430156|P4|STARTED|Open-label (Week 96 to Week 324)|Participants completed study at Week 96 and did not enter open-label phase|0
8286371|NCT01641809|20430157|P3|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|51
8286372|NCT01641809|20430158|P2|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|47
8286373|NCT01641809|20430159|P1|STARTED|Open-label (Week 96 to Week 324)||46
8286374|NCT01641809|20430156|P4|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
8286375|NCT01641809|20430157|P3|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3
8286376|NCT01641809|20430158|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5
8286377|NCT01641809|20430159|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
8286378|NCT01641809|20430156|P4|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41
8286379|NCT01641809|20430157|P3|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52
8286380|NCT01641809|20430158|P2|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48
8286381|NCT01641809|20430159|P1|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46
8286382|NCT01641809|20430156|P4|STARTED|Maintenance Phase (Week 24 to Week 96)||47
8286383|NCT01641809|20430157|P3|STARTED|Maintenance Phase (Week 24 to Week 96)||55
8286384|NCT01641809|20430158|P2|STARTED|Maintenance Phase (Week 24 to Week 96)||53
8286385|NCT01641809|20430159|P1|STARTED|Maintenance Phase (Week 24 to Week 96)||52
8286386|NCT01641809|20430156|P4|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15
8286387|NCT01641809|20430157|P3|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6
8286388|NCT01641809|20430158|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7
8286389|NCT01641809|20430159|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8
8286390|NCT01641809|20430156|P4|COMPLETED|Induction Phase (Day 1 to Week 24)||47
8286391|NCT01641809|20430157|P3|COMPLETED|Induction Phase (Day 1 to Week 24)||55
8286392|NCT01641809|20430158|P2|COMPLETED|Induction Phase (Day 1 to Week 24)||53
8286393|NCT01641809|20430159|P1|COMPLETED|Induction Phase (Day 1 to Week 24)||52
8286394|NCT01641809|20430156|P4|STARTED|Induction Phase (Day 1 to Week 24)||62
8286395|NCT01641809|20430157|P3|STARTED|Induction Phase (Day 1 to Week 24)||61
8286396|NCT01641809|20430158|P2|STARTED|Induction Phase (Day 1 to Week 24)||60
8286397|NCT01641809|20430159|P1|STARTED|Induction Phase (Day 1 to Week 24)||60
8286398|NCT01641692|20430343|P8|NOT COMPLETED|Washout Period 3 or Follow-up||0
8286399|NCT01641692|20430344|P7|NOT COMPLETED|Washout Period 3 or Follow-up||1
8286400|NCT01641692|20430345|P6|NOT COMPLETED|Washout Period 3 or Follow-up||2
8286401|NCT01641692|20430346|P5|NOT COMPLETED|Washout Period 3 or Follow-up||0
8286402|NCT01641692|20430347|P4|NOT COMPLETED|Washout Period 3 or Follow-up||1
8286403|NCT01641692|20430348|P3|NOT COMPLETED|Washout Period 3 or Follow-up||1
8286404|NCT01641692|20430349|P2|NOT COMPLETED|Washout Period 3 or Follow-up||0
8286405|NCT01641692|20430350|P1|NOT COMPLETED|Washout Period 3 or Follow-up||1
8286406|NCT01641692|20430343|P8|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
8286407|NCT01641692|20430344|P7|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
8286408|NCT01641692|20430345|P6|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
8286409|NCT01641692|20430346|P5|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
8286410|NCT01641692|20430347|P4|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
8286411|NCT01641692|20430348|P3|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
8286412|NCT01641692|20430349|P2|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
8286413|NCT01641692|20430350|P1|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
8286414|NCT01641692|20430343|P8|STARTED|Washout Period 3 or Follow-up||38
8286415|NCT01641692|20430344|P7|STARTED|Washout Period 3 or Follow-up||33
8286416|NCT01641692|20430345|P6|STARTED|Washout Period 3 or Follow-up||39
8286417|NCT01641692|20430346|P5|STARTED|Washout Period 3 or Follow-up||40
8286418|NCT01641692|20430347|P4|STARTED|Washout Period 3 or Follow-up||42
8286419|NCT01641692|20430348|P3|STARTED|Washout Period 3 or Follow-up||37
8286420|NCT01641692|20430349|P2|STARTED|Washout Period 3 or Follow-up||32
8286421|NCT01641692|20430350|P1|STARTED|Washout Period 3 or Follow-up||43
8286422|NCT01641692|20430343|P8|NOT COMPLETED|Treatment Period 3||0
8286423|NCT01641692|20430344|P7|NOT COMPLETED|Treatment Period 3||2
8286424|NCT01641692|20430345|P6|NOT COMPLETED|Treatment Period 3||0
8286425|NCT01641692|20430346|P5|NOT COMPLETED|Treatment Period 3||0
8286426|NCT01641692|20430347|P4|NOT COMPLETED|Treatment Period 3||0
8286427|NCT01641692|20430348|P3|NOT COMPLETED|Treatment Period 3||1
8286428|NCT01641692|20430349|P2|NOT COMPLETED|Treatment Period 3||1
8286429|NCT01641692|20430350|P1|NOT COMPLETED|Treatment Period 3||0
8286430|NCT01641692|20430343|P8|COMPLETED|Treatment Period 3||38
8286431|NCT01641692|20430344|P7|COMPLETED|Treatment Period 3||33
8286432|NCT01641692|20430345|P6|COMPLETED|Treatment Period 3||39
8286433|NCT01641692|20430346|P5|COMPLETED|Treatment Period 3||40
8286434|NCT01641692|20430347|P4|COMPLETED|Treatment Period 3||42
8286435|NCT01641692|20430348|P3|COMPLETED|Treatment Period 3||37
8286436|NCT01641692|20430349|P2|COMPLETED|Treatment Period 3||32
8286437|NCT01641692|20430350|P1|COMPLETED|Treatment Period 3||43
8286438|NCT01641692|20430343|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
8286439|NCT01641692|20430344|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
8286440|NCT01641692|20430345|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
8286441|NCT01641692|20430346|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
8286442|NCT01641692|20430347|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
8286443|NCT01641692|20430348|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
8286444|NCT01641692|20430349|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
8286445|NCT01641692|20430350|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
8286446|NCT01641692|20430343|P8|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
8286447|NCT01641692|20430344|P7|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
8286448|NCT01641692|20430345|P6|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
8286449|NCT01641692|20430346|P5|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
8286450|NCT01641692|20430347|P4|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
8286451|NCT01641692|20430348|P3|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
8286452|NCT01641692|20430349|P2|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
8286453|NCT01641692|20430350|P1|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
8286454|NCT01641692|20430343|P8|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
8286455|NCT01641692|20430344|P7|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
8286456|NCT01641692|20430345|P6|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
8286457|NCT01641692|20430346|P5|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
8286458|NCT01641692|20430347|P4|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
8286459|NCT01641692|20430348|P3|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
8286460|NCT01641692|20430349|P2|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
8286461|NCT01641692|20430350|P1|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
8286462|NCT01641692|20430343|P8|STARTED|Washout Period 2 (12-14 Days)||35
8286463|NCT01641692|20430344|P7|STARTED|Washout Period 2 (12-14 Days)||43
8286464|NCT01641692|20430345|P6|STARTED|Washout Period 2 (12-14 Days)||43
8286465|NCT01641692|20430346|P5|STARTED|Washout Period 2 (12-14 Days)||37
8286466|NCT01641692|20430347|P4|STARTED|Washout Period 2 (12-14 Days)||41
8286467|NCT01641692|20430348|P3|STARTED|Washout Period 2 (12-14 Days)||40
8286468|NCT01641692|20430349|P2|STARTED|Washout Period 2 (12-14 Days)||46
8286469|NCT01641692|20430350|P1|STARTED|Washout Period 2 (12-14 Days)||30
8286470|NCT01641692|20430343|P8|NOT COMPLETED|Treatment Period 2||1
8286471|NCT01641692|20430344|P7|NOT COMPLETED|Treatment Period 2||0
8286472|NCT01641692|20430345|P6|NOT COMPLETED|Treatment Period 2||2
8286473|NCT01641692|20430346|P5|NOT COMPLETED|Treatment Period 2||0
8286474|NCT01641692|20430347|P4|NOT COMPLETED|Treatment Period 2||0
8286475|NCT01641692|20430348|P3|NOT COMPLETED|Treatment Period 2||0
8286476|NCT01641692|20430349|P2|NOT COMPLETED|Treatment Period 2||0
8286477|NCT01641692|20430350|P1|NOT COMPLETED|Treatment Period 2||3
8286478|NCT01641692|20430343|P8|COMPLETED|Treatment Period 2||35
8286479|NCT01641692|20430344|P7|COMPLETED|Treatment Period 2||43
8286480|NCT01641692|20430345|P6|COMPLETED|Treatment Period 2||43
8286481|NCT01641692|20430346|P5|COMPLETED|Treatment Period 2||37
8286482|NCT01641692|20430347|P4|COMPLETED|Treatment Period 2||41
8286483|NCT01641692|20430348|P3|COMPLETED|Treatment Period 2||40
8286484|NCT01641692|20430349|P2|COMPLETED|Treatment Period 2||46
8286485|NCT01641692|20430350|P1|COMPLETED|Treatment Period 2||30
8286486|NCT01641692|20430343|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
8286487|NCT01641692|20430344|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
8286488|NCT01641692|20430345|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
8286489|NCT01641692|20430346|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
8286490|NCT01641692|20430347|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
8286491|NCT01641692|20430348|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
8286492|NCT01641692|20430349|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
8286493|NCT01641692|20430350|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
8286494|NCT01641692|20430343|P8|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
8286495|NCT01641692|20430344|P7|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
8286496|NCT01641692|20430345|P6|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
8286497|NCT01641692|20430346|P5|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
8286498|NCT01641692|20430347|P4|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
8286499|NCT01641692|20430348|P3|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
8286500|NCT01641692|20430349|P2|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
8286501|NCT01641692|20430350|P1|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
8286502|NCT01641692|20430343|P8|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
8286503|NCT01641692|20430344|P7|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
8286504|NCT01641692|20430345|P6|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
8286505|NCT01641692|20430346|P5|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
8286506|NCT01641692|20430347|P4|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
8286507|NCT01641692|20430348|P3|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
8286508|NCT01641692|20430349|P2|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
8286509|NCT01641692|20430350|P1|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
8286510|NCT01641692|20430343|P8|STARTED|Washout Period 1 (12-14 Days)||48
8286511|NCT01641692|20430344|P7|STARTED|Washout Period 1 (12-14 Days)||38
8286512|NCT01641692|20430345|P6|STARTED|Washout Period 1 (12-14 Days)||37
8286513|NCT01641692|20430346|P5|STARTED|Washout Period 1 (12-14 Days)||39
8286514|NCT01641692|20430347|P4|STARTED|Washout Period 1 (12-14 Days)||41
8286515|NCT01641692|20430348|P3|STARTED|Washout Period 1 (12-14 Days)||50
8286516|NCT01641692|20430349|P2|STARTED|Washout Period 1 (12-14 Days)||45
8286517|NCT01641692|20430350|P1|STARTED|Washout Period 1 (12-14 Days)||40
8286518|NCT01641692|20430343|P8|NOT COMPLETED|Treatment Period 1||3
8286519|NCT01641692|20430344|P7|NOT COMPLETED|Treatment Period 1||0
8286520|NCT01641692|20430345|P6|NOT COMPLETED|Treatment Period 1||2
8286521|NCT01641692|20430346|P5|NOT COMPLETED|Treatment Period 1||4
8286522|NCT01641692|20430347|P4|NOT COMPLETED|Treatment Period 1||0
8286523|NCT01641692|20430348|P3|NOT COMPLETED|Treatment Period 1||1
8286524|NCT01641692|20430349|P2|NOT COMPLETED|Treatment Period 1||0
8286525|NCT01641692|20430350|P1|NOT COMPLETED|Treatment Period 1||2
8286526|NCT01641692|20430343|P8|COMPLETED|Treatment Period 1||48
8286527|NCT01641692|20430344|P7|COMPLETED|Treatment Period 1||38
8286528|NCT01641692|20430345|P6|COMPLETED|Treatment Period 1||37
8286529|NCT01641692|20430346|P5|COMPLETED|Treatment Period 1||39
8286530|NCT01641692|20430347|P4|COMPLETED|Treatment Period 1||41
8286531|NCT01641692|20430348|P3|COMPLETED|Treatment Period 1||50
8286532|NCT01641692|20430349|P2|COMPLETED|Treatment Period 1||45
8286533|NCT01641692|20430350|P1|COMPLETED|Treatment Period 1||40
8286534|NCT01641692|20430343|P8|STARTED|Treatment Period 1||51
8286535|NCT01641692|20430344|P7|STARTED|Treatment Period 1||38
8286536|NCT01641692|20430345|P6|STARTED|Treatment Period 1||39
8286537|NCT01641692|20430346|P5|STARTED|Treatment Period 1||43
8286538|NCT01641692|20430347|P4|STARTED|Treatment Period 1||41
8286539|NCT01641692|20430348|P3|STARTED|Treatment Period 1||51
8286540|NCT01641692|20430349|P2|STARTED|Treatment Period 1||45
8286541|NCT01641692|20430350|P1|STARTED|Treatment Period 1||42
8286542|NCT01641653|20430539|P2|NOT COMPLETED|Overall Study||0
8286543|NCT01641653|20430540|P1|NOT COMPLETED|Overall Study||0
8286544|NCT01641653|20430539|P2|COMPLETED|Overall Study||30
8286545|NCT01641653|20430540|P1|COMPLETED|Overall Study||30
8286546|NCT01641653|20430539|P2|STARTED|Overall Study||30
8286547|NCT01641653|20430540|P1|STARTED|Overall Study||30
8286548|NCT01641640|20430550|P1|NOT COMPLETED|Overall Study||36
8286549|NCT01641640|20430550|P1|COMPLETED|Overall Study||292
8286550|NCT01641640|20430550|P1|Enrolled and Treated|Overall Study||327
8286551|NCT01641640|20430550|P1|STARTED|Overall Study||328
8286552|NCT01641601|20430561|P2|NOT COMPLETED|Overall Study||5
8286553|NCT01641601|20430562|P1|NOT COMPLETED|Overall Study||3
8286554|NCT01641601|20430561|P2|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
8286555|NCT01641601|20430562|P1|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
8286556|NCT01641601|20430561|P2|STARTED|Overall Study||5
8286557|NCT01641601|20430562|P1|STARTED|Overall Study||3
8286558|NCT01641471|20430572|P2|NOT COMPLETED|Overall Study||27
8286559|NCT01641471|20430573|P1|NOT COMPLETED|Overall Study||23
8286560|NCT01641471|20430572|P2|COMPLETED|Overall Study||31
8286561|NCT01641471|20430573|P1|COMPLETED|Overall Study||35
8286562|NCT01641471|20430572|P2|STARTED|Overall Study||58
8286563|NCT01641471|20430573|P1|STARTED|Overall Study||58
8286564|NCT01641445|20430587|P2|NOT COMPLETED|Overall Study||5
8286565|NCT01641445|20430588|P1|NOT COMPLETED|Overall Study||10
8286566|NCT01641445|20430587|P2|COMPLETED|Overall Study||36
8286567|NCT01641445|20430588|P1|COMPLETED|Overall Study||31
8286568|NCT01641445|20430587|P2|STARTED|Overall Study||41
8286569|NCT01641445|20430588|P1|STARTED|Overall Study||41
8286588|NCT01641367|20430620|P8|NOT COMPLETED|Randomized Adherence Intervention||24
8286589|NCT01641367|20430621|P7|NOT COMPLETED|Randomized Adherence Intervention||19
8286590|NCT01641367|20430622|P6|NOT COMPLETED|Randomized Adherence Intervention||0
8286591|NCT01641367|20430623|P5|NOT COMPLETED|Randomized Adherence Intervention||0
8286592|NCT01641367|20430624|P4|NOT COMPLETED|Randomized Adherence Intervention||0
8286593|NCT01641367|20430625|P3|NOT COMPLETED|Randomized Adherence Intervention||0
8286594|NCT01641367|20430626|P2|NOT COMPLETED|Randomized Adherence Intervention||0
8286595|NCT01641367|20430627|P1|NOT COMPLETED|Randomized Adherence Intervention||0
8286596|NCT01641367|20430620|P8|COMPLETED|Randomized Adherence Intervention||240
8286597|NCT01641367|20430621|P7|COMPLETED|Randomized Adherence Intervention||238
8286598|NCT01641367|20430622|P6|COMPLETED|Randomized Adherence Intervention||0
8286599|NCT01641367|20430623|P5|COMPLETED|Randomized Adherence Intervention||0
8286600|NCT01641367|20430624|P4|COMPLETED|Randomized Adherence Intervention||0
8286601|NCT01641367|20430625|P3|COMPLETED|Randomized Adherence Intervention||0
8286602|NCT01641367|20430626|P2|COMPLETED|Randomized Adherence Intervention||0
8286603|NCT01641367|20430627|P1|COMPLETED|Randomized Adherence Intervention||0
8286604|NCT01641367|20430620|P8|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202
8286605|NCT01641367|20430621|P7|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196
8286606|NCT01641367|20430622|P6|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8286607|NCT01641367|20430623|P5|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8286608|NCT01641367|20430624|P4|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8286609|NCT01641367|20430625|P3|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8286610|NCT01641367|20430626|P2|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8286611|NCT01641367|20430627|P1|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
8286612|NCT01641367|20430620|P8|STARTED|Randomized Adherence Intervention||264
8286613|NCT01641367|20430621|P7|STARTED|Randomized Adherence Intervention||257
8286614|NCT01641367|20430622|P6|STARTED|Randomized Adherence Intervention||0
8286615|NCT01641367|20430623|P5|STARTED|Randomized Adherence Intervention||0
8286616|NCT01641367|20430624|P4|STARTED|Randomized Adherence Intervention||0
8286617|NCT01641367|20430625|P3|STARTED|Randomized Adherence Intervention||0
8286618|NCT01641367|20430626|P2|STARTED|Randomized Adherence Intervention||0
8286619|NCT01641367|20430627|P1|STARTED|Randomized Adherence Intervention||0
8286620|NCT01641367|20430620|P8|NOT COMPLETED|Cohorts||0
8286621|NCT01641367|20430621|P7|NOT COMPLETED|Cohorts||0
8286622|NCT01641367|20430622|P6|NOT COMPLETED|Cohorts||1
8286623|NCT01641367|20430623|P5|NOT COMPLETED|Cohorts||3
8286624|NCT01641367|20430624|P4|NOT COMPLETED|Cohorts||0
8286625|NCT01641367|20430625|P3|NOT COMPLETED|Cohorts||4
8286626|NCT01641367|20430626|P2|NOT COMPLETED|Cohorts||1
8286627|NCT01641367|20430627|P1|NOT COMPLETED|Cohorts||34
8286628|NCT01641367|20430620|P8|COMPLETED|Cohorts||0
8286629|NCT01641367|20430621|P7|COMPLETED|Cohorts||0
8286630|NCT01641367|20430622|P6|COMPLETED|Cohorts||33
8286631|NCT01641367|20430623|P5|COMPLETED|Cohorts||67
8286632|NCT01641367|20430624|P4|COMPLETED|Cohorts||8
8286633|NCT01641367|20430625|P3|COMPLETED|Cohorts||68
8286634|NCT01641367|20430626|P2|COMPLETED|Cohorts||73
8286635|NCT01641367|20430627|P1|COMPLETED|Cohorts||253
8286636|NCT01641367|20430620|P8|Followed 72 Weeks on Step 1/2|Cohorts||0
8286637|NCT01641367|20430621|P7|Followed 72 Weeks on Step 1/2|Cohorts||0
8286638|NCT01641367|20430622|P6|Followed 72 Weeks on Step 1/2|Cohorts||30
8286639|NCT01641367|20430623|P5|Followed 72 Weeks on Step 1/2|Cohorts||52
8286640|NCT01641367|20430624|P4|Followed 72 Weeks on Step 1/2|Cohorts||6
8286641|NCT01641367|20430625|P3|Followed 72 Weeks on Step 1/2|Cohorts||60
8286642|NCT01641367|20430626|P2|Followed 72 Weeks on Step 1/2|Cohorts||60
8286643|NCT01641367|20430627|P1|Followed 72 Weeks on Step 1/2|Cohorts||211
8286644|NCT01641367|20430620|P8|STARTED|Cohorts||0
8286645|NCT01641367|20430621|P7|STARTED|Cohorts||0
8286646|NCT01641367|20430622|P6|STARTED|Cohorts||34
8286647|NCT01641367|20430623|P5|STARTED|Cohorts||70
8286648|NCT01641367|20430624|P4|STARTED|Cohorts||8
8286649|NCT01641367|20430625|P3|STARTED|Cohorts||72
8286650|NCT01641367|20430626|P2|STARTED|Cohorts||74
8286651|NCT01641367|20430627|P1|STARTED|Cohorts||287
8286652|NCT01641237|20430878|P4|NOT COMPLETED|Period IV||0
8286653|NCT01641237|20430879|P3|NOT COMPLETED|Period IV||0
8286654|NCT01641237|20430880|P2|NOT COMPLETED|Period IV||0
8286655|NCT01641237|20430881|P1|NOT COMPLETED|Period IV||0
8286656|NCT01641237|20430878|P4|COMPLETED|Period IV||15
8286657|NCT01641237|20430879|P3|COMPLETED|Period IV||15
8286658|NCT01641237|20430880|P2|COMPLETED|Period IV||15
8286659|NCT01641237|20430881|P1|COMPLETED|Period IV||15
8286660|NCT01641237|20430878|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
8286661|NCT01641237|20430879|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
8286662|NCT01641237|20430880|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
8286663|NCT01641237|20430881|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
8286664|NCT01641237|20430878|P4|NOT COMPLETED|Period III||0
8286665|NCT01641237|20430879|P3|NOT COMPLETED|Period III||0
8286666|NCT01641237|20430880|P2|NOT COMPLETED|Period III||0
8286667|NCT01641237|20430881|P1|NOT COMPLETED|Period III||1
8286668|NCT01641237|20430878|P4|COMPLETED|Period III||16
8286669|NCT01641237|20430879|P3|COMPLETED|Period III||15
8286670|NCT01641237|20430880|P2|COMPLETED|Period III||14
8286671|NCT01641237|20430881|P1|COMPLETED|Period III||15
8286672|NCT01641237|20430878|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
8286673|NCT01641237|20430879|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
8286674|NCT01641237|20430880|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
8286675|NCT01641237|20430881|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
8286676|NCT01641237|20430878|P4|NOT COMPLETED|Period II||0
8286677|NCT01641237|20430879|P3|NOT COMPLETED|Period II||0
8286678|NCT01641237|20430880|P2|NOT COMPLETED|Period II||0
8286679|NCT01641237|20430881|P1|NOT COMPLETED|Period II||1
8286680|NCT01641237|20430878|P4|COMPLETED|Period II||15
8286681|NCT01641237|20430879|P3|COMPLETED|Period II||16
8286682|NCT01641237|20430880|P2|COMPLETED|Period II||16
8286683|NCT01641237|20430881|P1|COMPLETED|Period II||14
8286684|NCT01641237|20430878|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
8286685|NCT01641237|20430879|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
8286686|NCT01641237|20430880|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
8286687|NCT01641237|20430881|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
8286688|NCT01641237|20430878|P4|NOT COMPLETED|Period I||0
8286689|NCT01641237|20430879|P3|NOT COMPLETED|Period I||0
8286690|NCT01641237|20430880|P2|NOT COMPLETED|Period I||0
8286691|NCT01641237|20430881|P1|NOT COMPLETED|Period I||0
8286692|NCT01641237|20430878|P4|COMPLETED|Period I||15
8286693|NCT01641237|20430879|P3|COMPLETED|Period I||15
8286694|NCT01641237|20430880|P2|COMPLETED|Period I||16
8286695|NCT01641237|20430881|P1|COMPLETED|Period I||16
8286696|NCT01641237|20430878|P4|STARTED|Period I||15
8286697|NCT01641237|20430879|P3|STARTED|Period I||15
8286698|NCT01641237|20430880|P2|STARTED|Period I||16
8286699|NCT01641237|20430881|P1|STARTED|Period I||16
8286700|NCT01641198|20430906|P3|NOT COMPLETED|At 15-20 Years of Function||2
8286701|NCT01641198|20430907|P2|NOT COMPLETED|At 15-20 Years of Function||1
8286702|NCT01641198|20430908|P1|NOT COMPLETED|At 15-20 Years of Function||6
8286703|NCT01641198|20430906|P3|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9
8286704|NCT01641198|20430907|P2|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6
8286705|NCT01641198|20430908|P1|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6
8286706|NCT01641198|20430906|P3|STARTED|At 15-20 Years of Function||11
8286707|NCT01641198|20430907|P2|STARTED|At 15-20 Years of Function||7
8286708|NCT01641198|20430908|P1|STARTED|At 15-20 Years of Function||12
8286709|NCT01641198|20430906|P3|NOT COMPLETED|After 24 Months of Function||6
8286710|NCT01641198|20430907|P2|NOT COMPLETED|After 24 Months of Function||9
8286711|NCT01641198|20430908|P1|NOT COMPLETED|After 24 Months of Function||4
8286712|NCT01641198|20430906|P3|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11
8286713|NCT01641198|20430907|P2|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7
8286714|NCT01641198|20430908|P1|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12
8286715|NCT01641198|20430906|P3|STARTED|After 24 Months of Function||17
8286716|NCT01641198|20430907|P2|STARTED|After 24 Months of Function||16
8286717|NCT01641198|20430908|P1|STARTED|After 24 Months of Function||16
8286718|NCT01641198|20430906|P3|NOT COMPLETED|After 12 Months of Function||2
8286719|NCT01641198|20430907|P2|NOT COMPLETED|After 12 Months of Function||3
8286720|NCT01641198|20430908|P1|NOT COMPLETED|After 12 Months of Function||4
8286721|NCT01641198|20430906|P3|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17
8286722|NCT01641198|20430907|P2|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16
8286723|NCT01641198|20430908|P1|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16
8286724|NCT01641198|20430906|P3|STARTED|After 12 Months of Function||19
8286725|NCT01641198|20430907|P2|STARTED|After 12 Months of Function||19
8286726|NCT01641198|20430908|P1|STARTED|After 12 Months of Function||20
8286727|NCT01641159|20430924|P2|NOT COMPLETED|Overall Study||2
8286728|NCT01641159|20430925|P1|NOT COMPLETED|Overall Study||2
8286729|NCT01641159|20430924|P2|COMPLETED|Overall Study||25
8286730|NCT01641159|20430925|P1|COMPLETED|Overall Study||33
8286731|NCT01641159|20430924|P2|STARTED|Overall Study||27
8286732|NCT01641159|20430925|P1|STARTED|Overall Study||35
8286742|NCT01641120|20430979|P1|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
8286743|NCT01641120|20430979|P1|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
8286744|NCT01641120|20430979|P1|STARTED|30 Gauge Needle Weeks 2 and 3||20
8286745|NCT01641120|20430979|P1|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
8286746|NCT01641120|20430979|P1|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
8286747|NCT01641120|20430979|P1|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
8286748|NCT01641081|20430991|P10|NOT COMPLETED|Period 5||0
8286749|NCT01641081|20430992|P9|NOT COMPLETED|Period 5||0
8286750|NCT01641081|20430993|P8|NOT COMPLETED|Period 5||0
8286751|NCT01641081|20430994|P7|NOT COMPLETED|Period 5||0
8286752|NCT01641081|20430995|P6|NOT COMPLETED|Period 5||0
8286753|NCT01641081|20430996|P5|NOT COMPLETED|Period 5||0
8286754|NCT01641081|20430997|P4|NOT COMPLETED|Period 5||0
8286755|NCT01641081|20430998|P3|NOT COMPLETED|Period 5||2
8286756|NCT01641081|20430999|P2|NOT COMPLETED|Period 5||0
8286757|NCT01641081|20431000|P1|NOT COMPLETED|Period 5||0
8286758|NCT01641081|20430991|P10|COMPLETED|Period 5||14
8286759|NCT01641081|20430992|P9|COMPLETED|Period 5||14
8286760|NCT01641081|20430993|P8|COMPLETED|Period 5||14
8286761|NCT01641081|20430994|P7|COMPLETED|Period 5||16
8286762|NCT01641081|20430995|P6|COMPLETED|Period 5||18
8286763|NCT01641081|20430996|P5|COMPLETED|Period 5||16
8286764|NCT01641081|20430997|P4|COMPLETED|Period 5||20
8286765|NCT01641081|20430998|P3|COMPLETED|Period 5||12
8286766|NCT01641081|20430999|P2|COMPLETED|Period 5||17
8286767|NCT01641081|20431000|P1|COMPLETED|Period 5||16
8286768|NCT01641081|20430991|P10|STARTED|Period 5||14
8286769|NCT01641081|20430992|P9|STARTED|Period 5||14
8286770|NCT01641081|20430993|P8|STARTED|Period 5||14
8286771|NCT01641081|20430994|P7|STARTED|Period 5||16
8286772|NCT01641081|20430995|P6|STARTED|Period 5||18
8286773|NCT01641081|20430996|P5|STARTED|Period 5||16
8286774|NCT01641081|20430997|P4|STARTED|Period 5||20
8286775|NCT01641081|20430998|P3|STARTED|Period 5||14
8286776|NCT01641081|20430999|P2|STARTED|Period 5||17
8286777|NCT01641081|20431000|P1|STARTED|Period 5||16
8286778|NCT01641081|20430991|P10|NOT COMPLETED|Period 4||0
8286779|NCT01641081|20430992|P9|NOT COMPLETED|Period 4||0
8286780|NCT01641081|20430993|P8|NOT COMPLETED|Period 4||0
8286781|NCT01641081|20430994|P7|NOT COMPLETED|Period 4||0
8286782|NCT01641081|20430995|P6|NOT COMPLETED|Period 4||0
8286783|NCT01641081|20430996|P5|NOT COMPLETED|Period 4||0
8286784|NCT01641081|20430997|P4|NOT COMPLETED|Period 4||1
8286785|NCT01641081|20430998|P3|NOT COMPLETED|Period 4||0
8286786|NCT01641081|20430999|P2|NOT COMPLETED|Period 4||1
8286787|NCT01641081|20431000|P1|NOT COMPLETED|Period 4||0
8286788|NCT01641081|20430991|P10|COMPLETED|Period 4||14
8286789|NCT01641081|20430992|P9|COMPLETED|Period 4||14
8286790|NCT01641081|20430993|P8|COMPLETED|Period 4||14
8286791|NCT01641081|20430994|P7|COMPLETED|Period 4||16
8286792|NCT01641081|20430995|P6|COMPLETED|Period 4||18
8286793|NCT01641081|20430996|P5|COMPLETED|Period 4||16
8286794|NCT01641081|20430997|P4|COMPLETED|Period 4||20
8286795|NCT01641081|20430998|P3|COMPLETED|Period 4||14
8286796|NCT01641081|20430999|P2|COMPLETED|Period 4||17
8286797|NCT01641081|20431000|P1|COMPLETED|Period 4||16
8286798|NCT01641081|20430991|P10|STARTED|Period 4||14
8286799|NCT01641081|20430992|P9|STARTED|Period 4||14
8286800|NCT01641081|20430993|P8|STARTED|Period 4||14
8286801|NCT01641081|20430994|P7|STARTED|Period 4||16
8286802|NCT01641081|20430995|P6|STARTED|Period 4||18
8286803|NCT01641081|20430996|P5|STARTED|Period 4||16
8286804|NCT01641081|20430997|P4|STARTED|Period 4||21
8286805|NCT01641081|20430998|P3|STARTED|Period 4||14
8286806|NCT01641081|20430999|P2|STARTED|Period 4||18
8286807|NCT01641081|20431000|P1|STARTED|Period 4||16
8286808|NCT01641081|20430991|P10|NOT COMPLETED|Period 3||0
8286809|NCT01641081|20430992|P9|NOT COMPLETED|Period 3||1
8286810|NCT01641081|20430993|P8|NOT COMPLETED|Period 3||0
8286811|NCT01641081|20430994|P7|NOT COMPLETED|Period 3||0
8286812|NCT01641081|20430995|P6|NOT COMPLETED|Period 3||0
8286813|NCT01641081|20430996|P5|NOT COMPLETED|Period 3||0
8286814|NCT01641081|20430997|P4|NOT COMPLETED|Period 3||0
8286815|NCT01641081|20430998|P3|NOT COMPLETED|Period 3||1
8286816|NCT01641081|20430999|P2|NOT COMPLETED|Period 3||0
8286817|NCT01641081|20431000|P1|NOT COMPLETED|Period 3||0
8286818|NCT01641081|20430991|P10|COMPLETED|Period 3||14
8286819|NCT01641081|20430992|P9|COMPLETED|Period 3||14
8286820|NCT01641081|20430993|P8|COMPLETED|Period 3||14
8286821|NCT01641081|20430994|P7|COMPLETED|Period 3||16
8286822|NCT01641081|20430995|P6|COMPLETED|Period 3||18
8286823|NCT01641081|20430996|P5|COMPLETED|Period 3||16
8286824|NCT01641081|20430997|P4|COMPLETED|Period 3||21
8286825|NCT01641081|20430998|P3|COMPLETED|Period 3||14
8286826|NCT01641081|20430999|P2|COMPLETED|Period 3||18
8286827|NCT01641081|20431000|P1|COMPLETED|Period 3||16
8286828|NCT01641081|20430991|P10|STARTED|Period 3||14
8286829|NCT01641081|20430992|P9|STARTED|Period 3||15
8286830|NCT01641081|20430993|P8|STARTED|Period 3||14
8286831|NCT01641081|20430994|P7|STARTED|Period 3||16
8286832|NCT01641081|20430995|P6|STARTED|Period 3||18
8286833|NCT01641081|20430996|P5|STARTED|Period 3||16
8286834|NCT01641081|20430997|P4|STARTED|Period 3||21
8286835|NCT01641081|20430998|P3|STARTED|Period 3||15
8286836|NCT01641081|20430999|P2|STARTED|Period 3||18
8286837|NCT01641081|20431000|P1|STARTED|Period 3||16
8286838|NCT01641081|20430991|P10|NOT COMPLETED|Period 2||0
8286839|NCT01641081|20430992|P9|NOT COMPLETED|Period 2||0
8286840|NCT01641081|20430993|P8|NOT COMPLETED|Period 2||0
8286841|NCT01641081|20430994|P7|NOT COMPLETED|Period 2||2
8286842|NCT01641081|20430995|P6|NOT COMPLETED|Period 2||1
8286843|NCT01641081|20430996|P5|NOT COMPLETED|Period 2||0
8286844|NCT01641081|20430997|P4|NOT COMPLETED|Period 2||1
8286845|NCT01641081|20430998|P3|NOT COMPLETED|Period 2||0
8286846|NCT01641081|20430999|P2|NOT COMPLETED|Period 2||0
8286847|NCT01641081|20431000|P1|NOT COMPLETED|Period 2||1
8286848|NCT01641081|20430991|P10|COMPLETED|Period 2||14
8286849|NCT01641081|20430992|P9|COMPLETED|Period 2||15
8286850|NCT01641081|20430993|P8|COMPLETED|Period 2||14
8286851|NCT01641081|20430994|P7|COMPLETED|Period 2||16
8286852|NCT01641081|20430995|P6|COMPLETED|Period 2||18
8286853|NCT01641081|20430996|P5|COMPLETED|Period 2||16
8286854|NCT01641081|20430997|P4|COMPLETED|Period 2||21
8286855|NCT01641081|20430998|P3|COMPLETED|Period 2||15
8286856|NCT01641081|20430999|P2|COMPLETED|Period 2||18
8286857|NCT01641081|20431000|P1|COMPLETED|Period 2||16
8286858|NCT01641081|20430991|P10|STARTED|Period 2||14
8286859|NCT01641081|20430992|P9|STARTED|Period 2||15
8286860|NCT01641081|20430993|P8|STARTED|Period 2||14
8286861|NCT01641081|20430994|P7|STARTED|Period 2||18
8286862|NCT01641081|20430995|P6|STARTED|Period 2||19
8286863|NCT01641081|20430996|P5|STARTED|Period 2||16
8286864|NCT01641081|20430997|P4|STARTED|Period 2||22
8286865|NCT01641081|20430998|P3|STARTED|Period 2||15
8286866|NCT01641081|20430999|P2|STARTED|Period 2||18
8286867|NCT01641081|20431000|P1|STARTED|Period 2||17
8286868|NCT01641081|20430991|P10|NOT COMPLETED|Period 1||0
8286869|NCT01641081|20430992|P9|NOT COMPLETED|Period 1||0
8286870|NCT01641081|20430993|P8|NOT COMPLETED|Period 1||3
8286871|NCT01641081|20430994|P7|NOT COMPLETED|Period 1||1
8286872|NCT01641081|20430995|P6|NOT COMPLETED|Period 1||0
8286873|NCT01641081|20430996|P5|NOT COMPLETED|Period 1||1
8286874|NCT01641081|20430997|P4|NOT COMPLETED|Period 1||0
8286875|NCT01641081|20430998|P3|NOT COMPLETED|Period 1||0
8286876|NCT01641081|20430999|P2|NOT COMPLETED|Period 1||0
8286877|NCT01641081|20431000|P1|NOT COMPLETED|Period 1||1
8286878|NCT01641081|20430991|P10|COMPLETED|Period 1||14
8286879|NCT01641081|20430992|P9|COMPLETED|Period 1||15
8286880|NCT01641081|20430993|P8|COMPLETED|Period 1||14
8286881|NCT01641081|20430994|P7|COMPLETED|Period 1||18
8286882|NCT01641081|20430995|P6|COMPLETED|Period 1||19
8286883|NCT01641081|20430996|P5|COMPLETED|Period 1||16
8286884|NCT01641081|20430997|P4|COMPLETED|Period 1||22
8286885|NCT01641081|20430998|P3|COMPLETED|Period 1||15
8286886|NCT01641081|20430999|P2|COMPLETED|Period 1||18
8286887|NCT01641081|20431000|P1|COMPLETED|Period 1||17
8286888|NCT01641081|20430991|P10|STARTED|Period 1||14
8286889|NCT01641081|20430992|P9|STARTED|Period 1||15
8286890|NCT01641081|20430993|P8|STARTED|Period 1||17
8286891|NCT01641081|20430994|P7|STARTED|Period 1||19
8286892|NCT01641081|20430995|P6|STARTED|Period 1||19
8286893|NCT01641081|20430996|P5|STARTED|Period 1||17
8286894|NCT01641081|20430997|P4|STARTED|Period 1||22
8286895|NCT01641081|20430998|P3|STARTED|Period 1||15
8286896|NCT01641081|20430999|P2|STARTED|Period 1||18
8286897|NCT01641081|20431000|P1|STARTED|Period 1||18
8286898|NCT01641042|20431019|P2|NOT COMPLETED|Overall Study||0
8286899|NCT01641042|20431020|P1|NOT COMPLETED|Overall Study||0
8286900|NCT01641042|20431019|P2|COMPLETED|Overall Study||43
8286901|NCT01641042|20431020|P1|COMPLETED|Overall Study||43
8286902|NCT01641042|20431019|P2|STARTED|Overall Study||43
8286903|NCT01641042|20431020|P1|STARTED|Overall Study||43
8286904|NCT01640964|20431069|P3|NOT COMPLETED|Overall Study||3
8286905|NCT01640964|20431070|P2|NOT COMPLETED|Overall Study||1
8286906|NCT01640964|20431071|P1|NOT COMPLETED|Overall Study||1
8286907|NCT01640964|20431069|P3|COMPLETED|Overall Study||3
8286908|NCT01640964|20431070|P2|COMPLETED|Overall Study||19
8286909|NCT01640964|20431071|P1|COMPLETED|Overall Study||19
8286910|NCT01640964|20431069|P3|STARTED|Overall Study||6
8286911|NCT01640964|20431070|P2|STARTED|Overall Study||20
8286912|NCT01640964|20431071|P1|STARTED|Overall Study||20
8286913|NCT01640951|20431094|P8|NOT COMPLETED|Overall Study||16
8286914|NCT01640951|20431095|P7|NOT COMPLETED|Overall Study||18
8286915|NCT01640951|20431096|P6|NOT COMPLETED|Overall Study||47
8286916|NCT01640951|20431097|P5|NOT COMPLETED|Overall Study||13
8286917|NCT01640951|20431098|P4|NOT COMPLETED|Overall Study||45
8286918|NCT01640951|20431099|P3|NOT COMPLETED|Overall Study||42
8286919|NCT01640951|20431100|P2|NOT COMPLETED|Overall Study||15
8286920|NCT01640951|20431101|P1|NOT COMPLETED|Overall Study||46
8286921|NCT01640951|20431094|P8|COMPLETED|Overall Study||17
8286922|NCT01640951|20431095|P7|COMPLETED|Overall Study||94
8286923|NCT01640951|20431096|P6|COMPLETED|Overall Study||13
8286924|NCT01640951|20431097|P5|COMPLETED|Overall Study||82
8286925|NCT01640951|20431098|P4|COMPLETED|Overall Study||10
8286926|NCT01640951|20431099|P3|COMPLETED|Overall Study||126
8286927|NCT01640951|20431100|P2|COMPLETED|Overall Study||60
8286928|NCT01640951|20431101|P1|COMPLETED|Overall Study||31
8286929|NCT01640951|20431094|P8|STARTED|Overall Study||33
8286930|NCT01640951|20431095|P7|STARTED|Overall Study||112
8286931|NCT01640951|20431096|P6|STARTED|Overall Study||60
8286932|NCT01640951|20431097|P5|STARTED|Overall Study||95
8286933|NCT01640951|20431098|P4|STARTED|Overall Study||55
8286934|NCT01640951|20431099|P3|STARTED|Overall Study||168
8286935|NCT01640951|20431100|P2|STARTED|Overall Study||75
8286936|NCT01640951|20431101|P1|STARTED|Overall Study||77
8286937|NCT01640925|20431203|P2|NOT COMPLETED|Overall Study||11
8286938|NCT01640925|20431204|P1|NOT COMPLETED|Overall Study||14
8286939|NCT01640925|20431203|P2|COMPLETED|Overall Study||164
8286940|NCT01640925|20431204|P1|COMPLETED|Overall Study||161
8286941|NCT01640925|20431203|P2|STARTED|Overall Study||175
8286942|NCT01640925|20431204|P1|STARTED|Overall Study||175
8286943|NCT01640873|20431218|P2|NOT COMPLETED|Overall Study||1
8286944|NCT01640873|20431219|P1|NOT COMPLETED|Overall Study||2
8286945|NCT01640873|20431218|P2|COMPLETED|Overall Study||10
8286946|NCT01640873|20431219|P1|COMPLETED|Overall Study||20
8286947|NCT01640873|20431218|P2|STARTED|Overall Study||11
8286948|NCT01640873|20431219|P1|STARTED|Overall Study||22
8286949|NCT01640834|20431238|P3|NOT COMPLETED|Overall Study||0
8286950|NCT01640834|20431239|P2|NOT COMPLETED|Overall Study||0
8286951|NCT01640834|20431240|P1|NOT COMPLETED|Overall Study||0
8286952|NCT01640834|20431238|P3|COMPLETED|Overall Study||4
8286953|NCT01640834|20431239|P2|COMPLETED|Overall Study||8
8286954|NCT01640834|20431240|P1|COMPLETED|Overall Study||8
8286955|NCT01640834|20431238|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
8286956|NCT01640834|20431239|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8286957|NCT01640834|20431240|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8286958|NCT01640834|20431238|P3|STARTED|Overall Study||4
8286959|NCT01640834|20431239|P2|STARTED|Overall Study||8
8286960|NCT01640834|20431240|P1|STARTED|Overall Study||8
8286961|NCT01640808|20431269|P2|NOT COMPLETED|Overall Study||16
8286962|NCT01640808|20431270|P1|NOT COMPLETED|Overall Study||58
8286963|NCT01640808|20431269|P2|COMPLETED|Overall Study||291
8286964|NCT01640808|20431270|P1|COMPLETED|Overall Study||251
8286965|NCT01640808|20431269|P2|Subjects Received Treatment|Overall Study||305
8286966|NCT01640808|20431270|P1|Subjects Received Treatment|Overall Study||305
8286967|NCT01640808|20431269|P2|STARTED|Overall Study||307
8286968|NCT01640808|20431270|P1|STARTED|Overall Study||309
8286969|NCT01640548|20431280|P1|NOT COMPLETED|Overall Study||0
8286970|NCT01640548|20431280|P1|COMPLETED|Overall Study||309
8286971|NCT01640548|20431280|P1|STARTED|Overall Study||309
8286972|NCT01640379|20431296|P2|NOT COMPLETED|Overall Study||12
8286973|NCT01640379|20431297|P1|NOT COMPLETED|Overall Study||14
8286974|NCT01640379|20431296|P2|COMPLETED|Overall Study||125
8286975|NCT01640379|20431297|P1|COMPLETED|Overall Study||135
8286976|NCT01640379|20431296|P2|STARTED|Overall Study||137
8286977|NCT01640379|20431297|P1|STARTED|Overall Study||149
8286978|NCT01640366|20431305|P1|NOT COMPLETED|Overall Study||22
8286979|NCT01640366|20431305|P1|COMPLETED|Overall Study||178
8286980|NCT01640366|20431305|P1|Day 90 Follow-up|Overall Study||178
8286981|NCT01640366|20431305|P1|Day 42 Follow-up|Overall Study||177
8286982|NCT01640366|20431305|P1|Day 21 Follow-up|Overall Study||185
8286983|NCT01640366|20431305|P1|STARTED|Overall Study||200
8286984|NCT01640353|20431318|P1|NOT COMPLETED|Overall Study||45
8286985|NCT01640353|20431318|P1|COMPLETED|Overall Study||149
8286986|NCT01640353|20431318|P1|Month 18|Overall Study||150
8286987|NCT01640353|20431318|P1|Month 12|Overall Study||160
8286988|NCT01640353|20431318|P1|Month 6|Overall Study||168
8286989|NCT01640353|20431318|P1|Month 3|Overall Study||169
8286990|NCT01640353|20431318|P1|Month 1|Overall Study||171
8286991|NCT01640353|20431318|P1|Treated|Overall Study||172
8286992|NCT01640353|20431318|P1|STARTED|Overall Study||194
8286993|NCT01640340|20431330|P2|NOT COMPLETED|Overall Study||0
8286994|NCT01640340|20431331|P1|NOT COMPLETED|Overall Study||0
8286995|NCT01640340|20431330|P2|COMPLETED|Overall Study||20
8286996|NCT01640340|20431331|P1|COMPLETED|Overall Study||20
8286997|NCT01640340|20431330|P2|Overall Complete Response Rate|Overall Study||20
8286998|NCT01640340|20431331|P1|Overall Complete Response Rate|Overall Study||20
8286999|NCT01640340|20431330|P2|STARTED|Overall Study||20
8287000|NCT01640340|20431331|P1|STARTED|Overall Study||20
8287001|NCT01640327|20431351|P2|NOT COMPLETED|Overall Study||0
8287002|NCT01640327|20431352|P1|NOT COMPLETED|Overall Study||0
8287003|NCT01640327|20431351|P2|COMPLETED|Overall Study||63
8287004|NCT01640327|20431352|P1|COMPLETED|Overall Study||63
8287005|NCT01640327|20431351|P2|STARTED|Overall Study||63
8287006|NCT01640327|20431352|P1|STARTED|Overall Study||63
8287007|NCT01640314|20431366|P2|NOT COMPLETED|Overall Study||1
8287008|NCT01640314|20431367|P1|NOT COMPLETED|Overall Study||0
8287009|NCT01640314|20431366|P2|COMPLETED|Overall Study||62
8287010|NCT01640314|20431367|P1|COMPLETED|Overall Study||63
8287011|NCT01640314|20431366|P2|STARTED|Overall Study||63
8287012|NCT01640314|20431367|P1|STARTED|Overall Study||63
8287013|NCT01640288|20431383|P2|NOT COMPLETED|Overall Study||23
8287014|NCT01640288|20431384|P1|NOT COMPLETED|Overall Study||30
8287015|NCT01640288|20431383|P2|COMPLETED|Overall Study||48
8287016|NCT01640288|20431384|P1|COMPLETED|Overall Study|One subject was lost to followup but rec'd the gas and images were obtained|70
8287017|NCT01640288|20431383|P2|Did Not Receive Allocated Intervention|Overall Study||18
8287018|NCT01640288|20431384|P1|Did Not Receive Allocated Intervention|Overall Study||26
8287019|NCT01640288|20431383|P2|Received Allocated Intervention|Overall Study|53 rec'd the gas (exc. 1 images not obtained due to equipment failure, 4 poor images = 48 )|48
8287020|NCT01640288|20431384|P1|Received Allocated Intervention|Overall Study|74 rec'd the gas (inc. 4 images were not obtained due to equipment failure = 70)|70
8287021|NCT01640288|20431383|P2|STARTED|Overall Study||71
8287022|NCT01640288|20431384|P1|STARTED|Overall Study||100
8287023|NCT01640249|20431401|P7|NOT COMPLETED|Period 3||0
8287024|NCT01640249|20431402|P6|NOT COMPLETED|Period 3||0
8287025|NCT01640249|20431403|P5|NOT COMPLETED|Period 3||0
8287026|NCT01640249|20431404|P4|NOT COMPLETED|Period 3||1
8287027|NCT01640249|20431405|P3|NOT COMPLETED|Period 3||0
8287028|NCT01640249|20431406|P2|NOT COMPLETED|Period 3||0
8287029|NCT01640249|20431407|P1|NOT COMPLETED|Period 3||0
8287030|NCT01640249|20431401|P7|COMPLETED|Period 3||0
8287031|NCT01640249|20431402|P6|COMPLETED|Period 3||0
8287032|NCT01640249|20431403|P5|COMPLETED|Period 3||0
8287033|NCT01640249|20431404|P4|COMPLETED|Period 3||1
8287034|NCT01640249|20431405|P3|COMPLETED|Period 3||2
8287035|NCT01640249|20431406|P2|COMPLETED|Period 3||2
8287036|NCT01640249|20431407|P1|COMPLETED|Period 3||2
8287037|NCT01640249|20431401|P7|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
8287038|NCT01640249|20431402|P6|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
8287039|NCT01640249|20431403|P5|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
8287040|NCT01640249|20431404|P4|STARTED|Period 3||2
8287041|NCT01640249|20431405|P3|STARTED|Period 3||2
8287042|NCT01640249|20431406|P2|STARTED|Period 3||2
8287043|NCT01640249|20431407|P1|STARTED|Period 3||2
8287044|NCT01640249|20431401|P7|NOT COMPLETED|Period 2||0
8287045|NCT01640249|20431402|P6|NOT COMPLETED|Period 2||0
8287046|NCT01640249|20431403|P5|NOT COMPLETED|Period 2||0
8287047|NCT01640249|20431404|P4|NOT COMPLETED|Period 2||0
8287048|NCT01640249|20431405|P3|NOT COMPLETED|Period 2||0
8287049|NCT01640249|20431406|P2|NOT COMPLETED|Period 2||0
8287050|NCT01640249|20431407|P1|NOT COMPLETED|Period 2||0
8287051|NCT01640249|20431401|P7|COMPLETED|Period 2||2
8287052|NCT01640249|20431402|P6|COMPLETED|Period 2||4
8287053|NCT01640249|20431403|P5|COMPLETED|Period 2||2
8287054|NCT01640249|20431404|P4|COMPLETED|Period 2||2
8287055|NCT01640249|20431405|P3|COMPLETED|Period 2||2
8287056|NCT01640249|20431406|P2|COMPLETED|Period 2||2
8287057|NCT01640249|20431407|P1|COMPLETED|Period 2||2
8287058|NCT01640249|20431401|P7|STARTED|Period 2||2
8287059|NCT01640249|20431402|P6|STARTED|Period 2||4
8287060|NCT01640249|20431403|P5|STARTED|Period 2||2
8287061|NCT01640249|20431404|P4|STARTED|Period 2||2
8287062|NCT01640249|20431405|P3|STARTED|Period 2||2
8287063|NCT01640249|20431406|P2|STARTED|Period 2||2
8287064|NCT01640249|20431407|P1|STARTED|Period 2||2
8287065|NCT01640249|20431401|P7|NOT COMPLETED|Period 1||0
8287066|NCT01640249|20431402|P6|NOT COMPLETED|Period 1||1
8287067|NCT01640249|20431403|P5|NOT COMPLETED|Period 1||0
8287068|NCT01640249|20431404|P4|NOT COMPLETED|Period 1||0
8287069|NCT01640249|20431405|P3|NOT COMPLETED|Period 1||0
8287070|NCT01640249|20431406|P2|NOT COMPLETED|Period 1||0
8287071|NCT01640249|20431407|P1|NOT COMPLETED|Period 1||1
8287072|NCT01640249|20431401|P7|COMPLETED|Period 1||2
8287073|NCT01640249|20431402|P6|COMPLETED|Period 1||4
8287074|NCT01640249|20431403|P5|COMPLETED|Period 1||2
8287075|NCT01640249|20431404|P4|COMPLETED|Period 1||2
8287076|NCT01640249|20431405|P3|COMPLETED|Period 1||2
8287077|NCT01640249|20431406|P2|COMPLETED|Period 1||2
8287078|NCT01640249|20431407|P1|COMPLETED|Period 1||2
8287079|NCT01640249|20431401|P7|Received at Least 1 Dose of Study Drug|Period 1||2
8287080|NCT01640249|20431402|P6|Received at Least 1 Dose of Study Drug|Period 1||5
8287081|NCT01640249|20431403|P5|Received at Least 1 Dose of Study Drug|Period 1||2
8287082|NCT01640249|20431404|P4|Received at Least 1 Dose of Study Drug|Period 1||2
8287083|NCT01640249|20431405|P3|Received at Least 1 Dose of Study Drug|Period 1||2
8287084|NCT01640249|20431406|P2|Received at Least 1 Dose of Study Drug|Period 1||2
8287085|NCT01640249|20431407|P1|Received at Least 1 Dose of Study Drug|Period 1||3
8287086|NCT01640249|20431401|P7|STARTED|Period 1||2
8287087|NCT01640249|20431402|P6|STARTED|Period 1||5
8287088|NCT01640249|20431403|P5|STARTED|Period 1||2
8287089|NCT01640249|20431404|P4|STARTED|Period 1||2
8287090|NCT01640249|20431405|P3|STARTED|Period 1||2
8287091|NCT01640249|20431406|P2|STARTED|Period 1||2
8287092|NCT01640249|20431407|P1|STARTED|Period 1||3
8287093|NCT01640197|20431433|P2|NOT COMPLETED|Overall Study||0
8287094|NCT01640197|20431434|P1|NOT COMPLETED|Overall Study||0
8287095|NCT01640197|20431433|P2|COMPLETED|Overall Study||30
8287096|NCT01640197|20431434|P1|COMPLETED|Overall Study||30
8287097|NCT01640197|20431433|P2|STARTED|Overall Study||30
8287098|NCT01640197|20431434|P1|STARTED|Overall Study||30
8287099|NCT01640184|20431455|P3|NOT COMPLETED|Overall Study||2
8287100|NCT01640184|20431456|P2|NOT COMPLETED|Overall Study||2
8287101|NCT01640184|20431457|P1|NOT COMPLETED|Overall Study||8
8287102|NCT01640184|20431455|P3|COMPLETED|Overall Study||20
8287103|NCT01640184|20431456|P2|COMPLETED|Overall Study||21
8287104|NCT01640184|20431457|P1|COMPLETED|Overall Study||26
8287105|NCT01640184|20431455|P3|STARTED|Overall Study||22
8287106|NCT01640184|20431456|P2|STARTED|Overall Study||23
8287107|NCT01640184|20431457|P1|STARTED|Overall Study||34
8287108|NCT01640171|20431479|P1|NOT COMPLETED|Overall Study||0
8287109|NCT01640171|20431479|P1|COMPLETED|Overall Study||57
8287110|NCT01640171|20431479|P1|STARTED|Overall Study||57
8287111|NCT01640054|20431486|P1|NOT COMPLETED|Overall Study||6
8287112|NCT01640054|20431486|P1|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
8287113|NCT01640054|20431486|P1|Did Not Receive Treatment|Overall Study||0
8287114|NCT01640054|20431486|P1|STARTED|Overall Study|Patients who received treatment|115
8287115|NCT01639872|20431496|P2|NOT COMPLETED|Overall Study||5
8287116|NCT01639872|20431497|P1|NOT COMPLETED|Overall Study||10
8287117|NCT01639872|20431496|P2|COMPLETED|Overall Study||20
8287118|NCT01639872|20431497|P1|COMPLETED|Overall Study||14
8287119|NCT01639872|20431496|P2|STARTED|Overall Study||25
8287120|NCT01639872|20431497|P1|STARTED|Overall Study||24
8287121|NCT01639833|20431507|P2|NOT COMPLETED|Overall Study||4
8287122|NCT01639833|20431508|P1|NOT COMPLETED|Overall Study||6
8287123|NCT01639833|20431507|P2|COMPLETED|Overall Study||41
8287124|NCT01639833|20431508|P1|COMPLETED|Overall Study||39
8287125|NCT01639833|20431507|P2|STARTED|Overall Study||45
8287126|NCT01639833|20431508|P1|STARTED|Overall Study||45
8287127|NCT01639755|20431516|P1|NOT COMPLETED|Overall Study||19
8287128|NCT01639755|20431516|P1|COMPLETED|Overall Study||0
8287129|NCT01639755|20431516|P1|STARTED|Overall Study||19
8287130|NCT01639742|20431524|P1|NOT COMPLETED|Overall Study||18
8287131|NCT01639742|20431524|P1|COMPLETED|Overall Study||0
8287132|NCT01639742|20431524|P1|STARTED|Overall Study||18
8287133|NCT01639729|20431532|P6|NOT COMPLETED|Overall Study||0
8287134|NCT01639729|20431533|P5|NOT COMPLETED|Overall Study||0
8287135|NCT01639729|20431534|P4|NOT COMPLETED|Overall Study||1
8287136|NCT01639729|20431535|P3|NOT COMPLETED|Overall Study||1
8287137|NCT01639729|20431536|P2|NOT COMPLETED|Overall Study||0
8287138|NCT01639729|20431537|P1|NOT COMPLETED|Overall Study||1
8287139|NCT01639729|20431532|P6|COMPLETED|Overall Study||4
8287140|NCT01639729|20431533|P5|COMPLETED|Overall Study||4
8287141|NCT01639729|20431534|P4|COMPLETED|Overall Study||4
8287142|NCT01639729|20431535|P3|COMPLETED|Overall Study||3
8287143|NCT01639729|20431536|P2|COMPLETED|Overall Study||4
8287144|NCT01639729|20431537|P1|COMPLETED|Overall Study||3
8287145|NCT01639729|20431532|P6|STARTED|Overall Study||4
8287146|NCT01639729|20431533|P5|STARTED|Overall Study||4
8287147|NCT01639729|20431534|P4|STARTED|Overall Study||5
8287148|NCT01639729|20431535|P3|STARTED|Overall Study||4
8287149|NCT01639729|20431536|P2|STARTED|Overall Study||4
8287150|NCT01639729|20431537|P1|STARTED|Overall Study||4
8287151|NCT01639703|20431559|P1|NOT COMPLETED|Overall Study||12
8287152|NCT01639703|20431559|P1|COMPLETED|Overall Study||84
8287153|NCT01639703|20431559|P1|STARTED|Overall Study||96
8287154|NCT01639599|20431603|P3|NOT COMPLETED|Overall Study||0
8287155|NCT01639599|20431604|P2|NOT COMPLETED|Overall Study||1
8287156|NCT01639599|20431605|P1|NOT COMPLETED|Overall Study||0
8287157|NCT01639599|20431603|P3|COMPLETED|Overall Study||50
8287158|NCT01639599|20431604|P2|COMPLETED|Overall Study||49
8287159|NCT01639599|20431605|P1|COMPLETED|Overall Study||50
8287160|NCT01639599|20431603|P3|STARTED|Overall Study||50
8287161|NCT01639599|20431604|P2|STARTED|Overall Study||50
8287162|NCT01639599|20431605|P1|STARTED|Overall Study||50
8287163|NCT01639560|20431624|P2|NOT COMPLETED|Overall Study||29
8287164|NCT01639560|20431625|P1|NOT COMPLETED|Overall Study||19
8287165|NCT01639560|20431624|P2|COMPLETED|Overall Study||19
8287166|NCT01639560|20431625|P1|COMPLETED|Overall Study||26
8287167|NCT01639560|20431624|P2|End of Treatment|Overall Study||20
8287168|NCT01639560|20431625|P1|End of Treatment|Overall Study||28
8287169|NCT01639560|20431624|P2|STARTED|Overall Study||48
8287170|NCT01639560|20431625|P1|STARTED|Overall Study||45
8287171|NCT01639495|20431637|P1|NOT COMPLETED|Overall Study||16
8287172|NCT01639495|20431637|P1|COMPLETED|Overall Study||132
8287173|NCT01639495|20431637|P1|Primary Effectiveness Cohort|Overall Study||138
8287174|NCT01639495|20431637|P1|Safety Cohort|Overall Study||144
8287175|NCT01639495|20431637|P1|STARTED|Overall Study|Patients who signed the informed consent.|148
8287176|NCT01639469|20431647|P2|NOT COMPLETED|Overall Study||3
8287177|NCT01639469|20431648|P1|NOT COMPLETED|Overall Study||5
8287178|NCT01639469|20431647|P2|COMPLETED|Overall Study||77
8287179|NCT01639469|20431648|P1|COMPLETED|Overall Study||84
8287180|NCT01639469|20431647|P2|STARTED|Overall Study||80
8287181|NCT01639469|20431648|P1|STARTED|Overall Study||89
8287182|NCT01639443|20431656|P2|NOT COMPLETED|Overall Study||0
8287183|NCT01639443|20431657|P1|NOT COMPLETED|Overall Study||0
8287275|NCT01638013|20431992|P3|COMPLETED|Overall Study||296
8287184|NCT01639443|20431656|P2|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
8287185|NCT01639443|20431657|P1|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
8287186|NCT01639443|20431656|P2|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
8287187|NCT01639443|20431657|P1|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
8287188|NCT01639352|20431673|P1|NOT COMPLETED|Overall Study||0
8287189|NCT01639352|20431673|P1|COMPLETED|Overall Study||20
8287190|NCT01639352|20431673|P1|STARTED|Overall Study||20
8287197|NCT01639222|20431703|P1|NOT COMPLETED|Overall Study||0
8287198|NCT01639222|20431703|P1|COMPLETED|Overall Study||55
8287199|NCT01639222|20431703|P1|STARTED|Overall Study||55
8287200|NCT01639157|20431713|P2|NOT COMPLETED|Overall Study||0
8287201|NCT01639157|20431714|P1|NOT COMPLETED|Overall Study||0
8287202|NCT01639157|20431713|P2|COMPLETED|Overall Study||5
8287203|NCT01639157|20431714|P1|COMPLETED|Overall Study||4
8287204|NCT01639157|20431713|P2|STARTED|Overall Study||5
8287205|NCT01639157|20431714|P1|STARTED|Overall Study||4
8287206|NCT01639144|20431774|P2|NOT COMPLETED|Overall Study||5
8287207|NCT01639144|20431775|P1|NOT COMPLETED|Overall Study||10
8287208|NCT01639144|20431774|P2|COMPLETED|Overall Study||250
8287209|NCT01639144|20431775|P1|COMPLETED|Overall Study||250
8287210|NCT01639144|20431774|P2|STARTED|Overall Study||255
8287211|NCT01639144|20431775|P1|STARTED|Overall Study||260
8287212|NCT01639040|20431783|P2|NOT COMPLETED|Overall Study||0
8287213|NCT01639040|20431784|P1|NOT COMPLETED|Overall Study||1
8287214|NCT01639040|20431783|P2|COMPLETED|Overall Study||21
8287215|NCT01639040|20431784|P1|COMPLETED|Overall Study||9
8287216|NCT01639040|20431783|P2|STARTED|Overall Study||21
8287217|NCT01639040|20431784|P1|STARTED|Overall Study||10
8287218|NCT01639001|20431802|P2|NOT COMPLETED|Overall Study||77
8287219|NCT01639001|20431803|P1|NOT COMPLETED|Overall Study||75
8287220|NCT01639001|20431802|P2|COMPLETED|Overall Study||26
8287221|NCT01639001|20431803|P1|COMPLETED|Overall Study||29
8287222|NCT01639001|20431802|P2|Treated|Overall Study||101
8287223|NCT01639001|20431803|P1|Treated|Overall Study||104
8287224|NCT01639001|20431802|P2|STARTED|Overall Study||103
8287225|NCT01639001|20431803|P1|STARTED|Overall Study||104
8287226|NCT01638819|20431849|P2|NOT COMPLETED|Overall Study||0
8287227|NCT01638819|20431850|P1|NOT COMPLETED|Overall Study||1
8287228|NCT01638819|20431849|P2|COMPLETED|Overall Study||15
8287229|NCT01638819|20431850|P1|COMPLETED|Overall Study||14
8287230|NCT01638819|20431849|P2|Second Intervention (24 Weeks)|Overall Study||15
8287231|NCT01638819|20431850|P1|Second Intervention (24 Weeks)|Overall Study||14
8287232|NCT01638819|20431849|P2|First Intervention (8 Weeks)|Overall Study||15
8287233|NCT01638819|20431850|P1|First Intervention (8 Weeks)|Overall Study||15
8287234|NCT01638819|20431849|P2|STARTED|Overall Study||15
8287235|NCT01638819|20431850|P1|STARTED|Overall Study||15
8287236|NCT01638559|20431859|P1|NOT COMPLETED|Overall Study||3
8287237|NCT01638559|20431859|P1|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85
8287238|NCT01638559|20431859|P1|STARTED|Overall Study||88
8287239|NCT01638546|20431877|P2|NOT COMPLETED|Overall Study||3
8287240|NCT01638546|20431878|P1|NOT COMPLETED|Overall Study||1
8287241|NCT01638546|20431877|P2|COMPLETED|Overall Study||42
8287242|NCT01638546|20431878|P1|COMPLETED|Overall Study||51
8287243|NCT01638546|20431877|P2|STARTED|Overall Study||45
8287244|NCT01638546|20431878|P1|STARTED|Overall Study||52
8287245|NCT01638507|20431890|P1|NOT COMPLETED|Overall Study||6
8287246|NCT01638507|20431890|P1|COMPLETED|Overall Study||224
8287247|NCT01638507|20431890|P1|STARTED|Overall Study||230
8287248|NCT01638468|20431903|P1|NOT COMPLETED|Overall Study||0
8287249|NCT01638468|20431903|P1|COMPLETED|Overall Study||7
8287250|NCT01638468|20431903|P1|STARTED|Overall Study||7
8287251|NCT01638429|20431917|P1|NOT COMPLETED|Overall Study||1
8287252|NCT01638429|20431917|P1|COMPLETED|Overall Study||11
8287253|NCT01638429|20431917|P1|Post-treatment Testing|Overall Study||11
8287254|NCT01638429|20431917|P1|Antibiotic Treatment|Overall Study||11
8287255|NCT01638429|20431917|P1|Pre-treatment Testing|Overall Study||11
8287256|NCT01638429|20431917|P1|STARTED|Overall Study||12
8287257|NCT01638416|20431947|P2|NOT COMPLETED|Overall Study||42
8287258|NCT01638416|20431948|P1|NOT COMPLETED|Overall Study||33
8287259|NCT01638416|20431947|P2|COMPLETED|Overall Study||2462
8287260|NCT01638416|20431948|P1|COMPLETED|Overall Study||2457
8287261|NCT01638416|20431947|P2|STARTED|Overall Study||2504
8287262|NCT01638416|20431948|P1|STARTED|Overall Study||2490
8287263|NCT01638390|20431968|P1|NOT COMPLETED|Overall Study||21
8287264|NCT01638390|20431968|P1|COMPLETED|Overall Study|treated eyes|336
8287265|NCT01638390|20431968|P1|STARTED|Overall Study|enrolled|357
8287266|NCT01638312|20431982|P2|NOT COMPLETED|Overall Study||0
8287267|NCT01638312|20431983|P1|NOT COMPLETED|Overall Study||0
8287268|NCT01638312|20431982|P2|COMPLETED|Overall Study||30
8287269|NCT01638312|20431983|P1|COMPLETED|Overall Study||20
8287270|NCT01638312|20431982|P2|STARTED|Overall Study||30
8287271|NCT01638312|20431983|P1|STARTED|Overall Study||20
8287272|NCT01638013|20431992|P3|NOT COMPLETED|Overall Study||121
8287273|NCT01638013|20431993|P2|NOT COMPLETED|Overall Study||78
8287274|NCT01638013|20431994|P1|NOT COMPLETED|Overall Study||131
8287276|NCT01638013|20431993|P2|COMPLETED|Overall Study||147
8287277|NCT01638013|20431994|P1|COMPLETED|Overall Study||70
8287278|NCT01638013|20431992|P3|STARTED|Overall Study||417
8287279|NCT01638013|20431993|P2|STARTED|Overall Study||225
8287280|NCT01638013|20431994|P1|STARTED|Overall Study||201
8287281|NCT01638000|20432127|P2|NOT COMPLETED|Overall Study||71
8287282|NCT01638000|20432128|P1|NOT COMPLETED|Overall Study||60
8287283|NCT01638000|20432127|P2|COMPLETED|Overall Study||873
8287284|NCT01638000|20432128|P1|COMPLETED|Overall Study||883
8287285|NCT01638000|20432127|P2|Received at Least 1 Double-Blind Dose|Overall Study||934
8287286|NCT01638000|20432128|P1|Received at Least 1 Double-Blind Dose|Overall Study||936
8287287|NCT01638000|20432127|P2|STARTED|Overall Study||944
8287288|NCT01638000|20432128|P1|STARTED|Overall Study||943
8287289|NCT01637961|20432226|P1|NOT COMPLETED|Overall Study||2
8287290|NCT01637961|20432226|P1|COMPLETED|Overall Study|Eligible and treated patients.|21
8287291|NCT01637961|20432226|P1|STARTED|Overall Study||23
8287292|NCT01637935|20432241|P2|NOT COMPLETED|Overall Study||0
8287293|NCT01637935|20432242|P1|NOT COMPLETED|Overall Study||0
8287294|NCT01637935|20432241|P2|COMPLETED|Overall Study||158918
8287295|NCT01637935|20432242|P1|COMPLETED|Overall Study||34181
8287296|NCT01637935|20432241|P2|STARTED|Overall Study||158918
8287297|NCT01637935|20432242|P1|STARTED|Overall Study||34181
8287298|NCT01637922|20432258|P2|NOT COMPLETED|Overall Study||5
8287299|NCT01637922|20432259|P1|NOT COMPLETED|Overall Study||2
8287300|NCT01637922|20432258|P2|COMPLETED|Overall Study||14
8287301|NCT01637922|20432259|P1|COMPLETED|Overall Study||13
8287302|NCT01637922|20432258|P2|STARTED|Overall Study||19
8287303|NCT01637922|20432259|P1|STARTED|Overall Study||15
8287304|NCT01637870|20432282|P1|NOT COMPLETED|Overall Study||0
8287305|NCT01637870|20432282|P1|COMPLETED|Overall Study||110
8287306|NCT01637870|20432282|P1|STARTED|Overall Study||110
8287307|NCT01637623|20432289|P3|NOT COMPLETED|Overall Study||3
8287308|NCT01637623|20432290|P2|NOT COMPLETED|Overall Study||0
8287309|NCT01637623|20432291|P1|NOT COMPLETED|Overall Study||1
8287310|NCT01637623|20432289|P3|COMPLETED|Overall Study||25
8287311|NCT01637623|20432290|P2|COMPLETED|Overall Study||30
8287312|NCT01637623|20432291|P1|COMPLETED|Overall Study||28
8287313|NCT01637623|20432289|P3|Analyzed|Overall Study||28
8287314|NCT01637623|20432290|P2|Analyzed|Overall Study||30
8287315|NCT01637623|20432291|P1|Analyzed|Overall Study||28
8287316|NCT01637623|20432289|P3|Did Not Receive Intervention|Overall Study||1
8287317|NCT01637623|20432290|P2|Did Not Receive Intervention|Overall Study||0
8287318|NCT01637623|20432291|P1|Did Not Receive Intervention|Overall Study||1
8287319|NCT01637623|20432289|P3|Received Intervention|Overall Study||27
8287320|NCT01637623|20432290|P2|Received Intervention|Overall Study||30
8287321|NCT01637623|20432291|P1|Received Intervention|Overall Study||28
8287322|NCT01637623|20432289|P3|STARTED|Overall Study||28
8287323|NCT01637623|20432290|P2|STARTED|Overall Study||30
8287324|NCT01637623|20432291|P1|STARTED|Overall Study||29
8287325|NCT01637584|20432331|P2|NOT COMPLETED|Overall Study||3
8287326|NCT01637584|20432332|P1|NOT COMPLETED|Overall Study||1
8287327|NCT01637584|20432331|P2|COMPLETED|Overall Study||17
8287328|NCT01637584|20432332|P1|COMPLETED|Overall Study||19
8287329|NCT01637584|20432331|P2|STARTED|Overall Study||20
8287330|NCT01637584|20432332|P1|STARTED|Overall Study||20
8287331|NCT01637402|20432339|P2|NOT COMPLETED|Treatment Regiments Post Week 12||4
8287332|NCT01637402|20432340|P1|NOT COMPLETED|Treatment Regiments Post Week 12||9
8287333|NCT01637402|20432339|P2|COMPLETED|Treatment Regiments Post Week 12||14
8287334|NCT01637402|20432340|P1|COMPLETED|Treatment Regiments Post Week 12||5
8287335|NCT01637402|20432339|P2|STARTED|Treatment Regiments Post Week 12|Patients who progressed after decline on standard dose|18
8287336|NCT01637402|20432340|P1|STARTED|Treatment Regiments Post Week 12|Patients continuing on standard dose|14
8287337|NCT01637402|20432339|P2|NOT COMPLETED|Week 12 Evaluation||0
8287338|NCT01637402|20432340|P1|NOT COMPLETED|Week 12 Evaluation||6
8287339|NCT01637402|20432339|P2|COMPLETED|Week 12 Evaluation||0
8287340|NCT01637402|20432340|P1|COMPLETED|Week 12 Evaluation||32
8287341|NCT01637402|20432339|P2|STARTED|Week 12 Evaluation|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
8287342|NCT01637402|20432340|P1|STARTED|Week 12 Evaluation||38
8287343|NCT01637402|20432339|P2|NOT COMPLETED|Standard Dose Regimen||0
8287344|NCT01637402|20432340|P1|NOT COMPLETED|Standard Dose Regimen||3
8287345|NCT01637402|20432339|P2|COMPLETED|Standard Dose Regimen||0
8287346|NCT01637402|20432340|P1|COMPLETED|Standard Dose Regimen||38
8287347|NCT01637402|20432339|P2|STARTED|Standard Dose Regimen|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
8287348|NCT01637402|20432340|P1|STARTED|Standard Dose Regimen||41
8287349|NCT01637272|20432371|P1|NOT COMPLETED|Overall Study||20
8287350|NCT01637272|20432371|P1|COMPLETED|Overall Study||23
8287351|NCT01637272|20432371|P1|Completed Core But Did no Enter Ext..|Overall Study||4
8287352|NCT01637272|20432371|P1|Entered Extension Phase|Overall Study||27
8287353|NCT01637272|20432371|P1|Completed Core Phase (sc + LAR)|Overall Study||31
8287354|NCT01637272|20432371|P1|Completed sc Phase|Overall Study||33
8287355|NCT01637272|20432371|P1|STARTED|Overall Study||43
8287356|NCT01637246|20432433|P1|NOT COMPLETED|Overall Study||2139
8287357|NCT01637246|20432433|P1|COMPLETED|Overall Study||2246
8287358|NCT01637246|20432433|P1|STARTED|Overall Study||4385
8287359|NCT01637090|20432441|P1|NOT COMPLETED|Overall Study||3
8287360|NCT01637090|20432441|P1|COMPLETED|Overall Study||0
8287361|NCT01637090|20432441|P1|STARTED|Overall Study||3
8287362|NCT01637077|20432451|P2|NOT COMPLETED|Overall Study||1
8287363|NCT01637077|20432452|P1|NOT COMPLETED|Overall Study||4
8287364|NCT01637077|20432451|P2|COMPLETED|Overall Study||22
8287365|NCT01637077|20432452|P1|COMPLETED|Overall Study||19
8287366|NCT01637077|20432451|P2|STARTED|Overall Study||23
8287367|NCT01637077|20432452|P1|STARTED|Overall Study||23
8287368|NCT01636986|20432480|P2|NOT COMPLETED|Overall Study||2
8287369|NCT01636986|20432481|P1|NOT COMPLETED|Overall Study||0
8287370|NCT01636986|20432480|P2|COMPLETED|Overall Study||30
8287371|NCT01636986|20432481|P1|COMPLETED|Overall Study||30
8287372|NCT01636986|20432480|P2|STARTED|Overall Study||32
8287373|NCT01636986|20432481|P1|STARTED|Overall Study||30
8287374|NCT01636960|20432487|P1|NOT COMPLETED|Maintenance Phase||7
8287375|NCT01636960|20432487|P1|COMPLETED|Maintenance Phase||0
8287376|NCT01636960|20432487|P1|STARTED|Maintenance Phase||7
8287377|NCT01636960|20432487|P1|NOT COMPLETED|Induction Phase||2
8287378|NCT01636960|20432487|P1|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
8287379|NCT01636960|20432487|P1|STARTED|Induction Phase||9
8287380|NCT01636947|20432495|P2|NOT COMPLETED|Overall Study||11
8287381|NCT01636947|20432496|P1|NOT COMPLETED|Overall Study||12
8287382|NCT01636947|20432495|P2|COMPLETED|Overall Study||239
8287383|NCT01636947|20432496|P1|COMPLETED|Overall Study||232
8287384|NCT01636947|20432495|P2|Treated|Overall Study||248
8287385|NCT01636947|20432496|P1|Treated|Overall Study||242
8287386|NCT01636947|20432495|P2|STARTED|Overall Study||250
8287387|NCT01636947|20432496|P1|STARTED|Overall Study||244
8287388|NCT01636934|20432518|P2|NOT COMPLETED|Overall Study||3
8287389|NCT01636934|20432519|P1|NOT COMPLETED|Overall Study||6
8287390|NCT01636934|20432518|P2|COMPLETED|Overall Study||21
8287391|NCT01636934|20432519|P1|COMPLETED|Overall Study||19
8287392|NCT01636934|20432518|P2|STARTED|Overall Study||24
8287393|NCT01636934|20432519|P1|STARTED|Overall Study||25
8287394|NCT01636882|20432527|P1|NOT COMPLETED|Overall Study||0
8287395|NCT01636882|20432527|P1|COMPLETED|Overall Study||16
8287396|NCT01636882|20432527|P1|STARTED|Overall Study||16
8287397|NCT01636778|20432531|P3|NOT COMPLETED|Follow-up Period After Part 2||4
8287398|NCT01636778|20432532|P2|NOT COMPLETED|Follow-up Period After Part 2||0
8287399|NCT01636778|20432533|P1|NOT COMPLETED|Follow-up Period After Part 2||0
8287400|NCT01636778|20432531|P3|COMPLETED|Follow-up Period After Part 2||37
8287401|NCT01636778|20432532|P2|COMPLETED|Follow-up Period After Part 2||0
8287402|NCT01636778|20432533|P1|COMPLETED|Follow-up Period After Part 2||0
8287403|NCT01636778|20432531|P3|STARTED|Follow-up Period After Part 2||41
8287404|NCT01636778|20432532|P2|STARTED|Follow-up Period After Part 2||0
8287405|NCT01636778|20432533|P1|STARTED|Follow-up Period After Part 2||0
8287406|NCT01636778|20432531|P3|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
8287407|NCT01636778|20432532|P2|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
8287408|NCT01636778|20432533|P1|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
8287409|NCT01636778|20432531|P3|COMPLETED|Antiviral Treatment Period (Part 2)||0
8287410|NCT01636778|20432532|P2|COMPLETED|Antiviral Treatment Period (Part 2)||31
8287411|NCT01636778|20432533|P1|COMPLETED|Antiviral Treatment Period (Part 2)||0
8287412|NCT01636778|20432531|P3|STARTED|Antiviral Treatment Period (Part 2)||0
8287413|NCT01636778|20432532|P2|STARTED|Antiviral Treatment Period (Part 2)||41
8287414|NCT01636778|20432533|P1|STARTED|Antiviral Treatment Period (Part 2)||0
8287415|NCT01636778|20432531|P3|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
8287416|NCT01636778|20432532|P2|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
8287417|NCT01636778|20432533|P1|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
8287418|NCT01636778|20432531|P3|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
8287419|NCT01636778|20432532|P2|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
8287420|NCT01636778|20432533|P1|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
8287421|NCT01636778|20432531|P3|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
8287422|NCT01636778|20432532|P2|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
8287423|NCT01636778|20432533|P1|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
8287424|NCT01636765|20432596|P1|NOT COMPLETED|Overall Study||0
8287425|NCT01636765|20432596|P1|COMPLETED|Overall Study||104
8287426|NCT01636765|20432596|P1|STARTED|Overall Study||104
8287427|NCT01636713|20432604|P3|NOT COMPLETED|Overall Study||23
8287428|NCT01636713|20432605|P2|NOT COMPLETED|Overall Study||28
8287429|NCT01636713|20432606|P1|NOT COMPLETED|Overall Study||32
8287430|NCT01636713|20432604|P3|COMPLETED|Overall Study||170
8287431|NCT01636713|20432605|P2|COMPLETED|Overall Study||166
8287432|NCT01636713|20432606|P1|COMPLETED|Overall Study||161
8287433|NCT01636713|20432604|P3|STARTED|Overall Study||193
8287434|NCT01636713|20432605|P2|STARTED|Overall Study||194
8287435|NCT01636713|20432606|P1|STARTED|Overall Study||193
8287436|NCT01636687|20432623|P5|NOT COMPLETED|Follow-up Period||1
8287437|NCT01636687|20432624|P4|NOT COMPLETED|Follow-up Period||0
8287438|NCT01636687|20432625|P3|NOT COMPLETED|Follow-up Period||0
8287439|NCT01636687|20432626|P2|NOT COMPLETED|Follow-up Period||0
8287440|NCT01636687|20432627|P1|NOT COMPLETED|Follow-up Period||1
8287441|NCT01636687|20432623|P5|COMPLETED|Follow-up Period||1
8287442|NCT01636687|20432624|P4|COMPLETED|Follow-up Period||20
8287443|NCT01636687|20432625|P3|COMPLETED|Follow-up Period||21
8287444|NCT01636687|20432626|P2|COMPLETED|Follow-up Period||45
8287445|NCT01636687|20432627|P1|COMPLETED|Follow-up Period||37
8287446|NCT01636687|20432623|P5|STARTED|Follow-up Period||2
8287447|NCT01636687|20432624|P4|STARTED|Follow-up Period||20
8287448|NCT01636687|20432625|P3|STARTED|Follow-up Period||21
8287449|NCT01636687|20432626|P2|STARTED|Follow-up Period||45
8287450|NCT01636687|20432627|P1|STARTED|Follow-up Period||38
8287451|NCT01636687|20432623|P5|NOT COMPLETED|Extension Period||0
8287452|NCT01636687|20432624|P4|NOT COMPLETED|Extension Period||28
8287453|NCT01636687|20432625|P3|NOT COMPLETED|Extension Period||25
8287454|NCT01636687|20432626|P2|NOT COMPLETED|Extension Period||54
8287455|NCT01636687|20432627|P1|NOT COMPLETED|Extension Period||47
8287456|NCT01636687|20432623|P5|COMPLETED|Extension Period||0
8287457|NCT01636687|20432624|P4|COMPLETED|Extension Period||0
8287458|NCT01636687|20432625|P3|COMPLETED|Extension Period||0
8287459|NCT01636687|20432626|P2|COMPLETED|Extension Period||0
8287460|NCT01636687|20432627|P1|COMPLETED|Extension Period||0
8287461|NCT01636687|20432623|P5|STARTED|Extension Period||0
8287462|NCT01636687|20432624|P4|STARTED|Extension Period||28
8287463|NCT01636687|20432625|P3|STARTED|Extension Period||25
8287464|NCT01636687|20432626|P2|STARTED|Extension Period||54
8287465|NCT01636687|20432627|P1|STARTED|Extension Period||47
8287466|NCT01636687|20432623|P5|NOT COMPLETED|Maintenance Period||2
8287467|NCT01636687|20432624|P4|NOT COMPLETED|Maintenance Period||0
8287468|NCT01636687|20432625|P3|NOT COMPLETED|Maintenance Period||2
8287469|NCT01636687|20432626|P2|NOT COMPLETED|Maintenance Period||2
8287470|NCT01636687|20432627|P1|NOT COMPLETED|Maintenance Period||8
8287471|NCT01636687|20432623|P5|COMPLETED|Maintenance Period||1
8287472|NCT01636687|20432624|P4|COMPLETED|Maintenance Period||28
8287473|NCT01636687|20432625|P3|COMPLETED|Maintenance Period||26
8287474|NCT01636687|20432626|P2|COMPLETED|Maintenance Period||58
8287475|NCT01636687|20432627|P1|COMPLETED|Maintenance Period||50
8287476|NCT01636687|20432623|P5|STARTED|Maintenance Period||3
8287477|NCT01636687|20432624|P4|STARTED|Maintenance Period||28
8287478|NCT01636687|20432625|P3|STARTED|Maintenance Period||28
8287479|NCT01636687|20432626|P2|STARTED|Maintenance Period||60
8287480|NCT01636687|20432627|P1|STARTED|Maintenance Period||58
8287481|NCT01636687|20432623|P5|NOT COMPLETED|Induction Period||2
8287482|NCT01636687|20432624|P4|NOT COMPLETED|Induction Period||0
8287483|NCT01636687|20432625|P3|NOT COMPLETED|Induction Period||0
8287484|NCT01636687|20432626|P2|NOT COMPLETED|Induction Period||0
8287485|NCT01636687|20432627|P1|NOT COMPLETED|Induction Period||3
8287486|NCT01636687|20432623|P5|COMPLETED|Induction Period||59
8287487|NCT01636687|20432624|P4|COMPLETED|Induction Period||0
8287488|NCT01636687|20432625|P3|COMPLETED|Induction Period||0
8287489|NCT01636687|20432626|P2|COMPLETED|Induction Period||60
8287490|NCT01636687|20432627|P1|COMPLETED|Induction Period||58
8287491|NCT01636687|20432623|P5|STARTED|Induction Period||61
8287492|NCT01636687|20432624|P4|STARTED|Induction Period||0
8287493|NCT01636687|20432625|P3|STARTED|Induction Period||0
8287494|NCT01636687|20432626|P2|STARTED|Induction Period||60
8287495|NCT01636687|20432627|P1|STARTED|Induction Period||61
8287496|NCT01636661|20432716|P2|NOT COMPLETED|Overall Study||0
8287497|NCT01636661|20432717|P1|NOT COMPLETED|Overall Study||0
8287498|NCT01636661|20432716|P2|COMPLETED|Overall Study||6
8287499|NCT01636661|20432717|P1|COMPLETED|Overall Study||5
8287500|NCT01636661|20432716|P2|STARTED|Overall Study||6
8287501|NCT01636661|20432717|P1|STARTED|Overall Study||5
8287502|NCT01636466|20432727|P2|NOT COMPLETED|Overall Study||0
8287503|NCT01636466|20432728|P1|NOT COMPLETED|Overall Study||1
8287504|NCT01636466|20432727|P2|COMPLETED|Overall Study||0
8287505|NCT01636466|20432728|P1|COMPLETED|Overall Study||0
8287506|NCT01636466|20432727|P2|STARTED|Overall Study||0
8287507|NCT01636466|20432728|P1|STARTED|Overall Study||1
8287508|NCT01636453|20432736|P1|NOT COMPLETED|Overall Study||8
8287509|NCT01636453|20432736|P1|COMPLETED|Overall Study||112
8287510|NCT01636453|20432736|P1|STARTED|Overall Study||120
8287511|NCT01636414|20432755|P3|NOT COMPLETED|Overall Study||9
8287512|NCT01636414|20432756|P2|NOT COMPLETED|Overall Study||6
8287513|NCT01636414|20432757|P1|NOT COMPLETED|Overall Study||3
8287514|NCT01636414|20432755|P3|COMPLETED|Overall Study||65
8287515|NCT01636414|20432756|P2|COMPLETED|Overall Study||60
8287516|NCT01636414|20432757|P1|COMPLETED|Overall Study||61
8287517|NCT01636414|20432755|P3|STARTED|Overall Study||74
8287518|NCT01636414|20432756|P2|STARTED|Overall Study||66
8287519|NCT01636414|20432757|P1|STARTED|Overall Study||64
8287520|NCT01636362|20432768|P1|NOT COMPLETED|Overall Study||8
8287521|NCT01636362|20432768|P1|COMPLETED|Overall Study||37
8287522|NCT01636362|20432768|P1|STARTED|Overall Study||45
8287523|NCT01636297|20432777|P3|NOT COMPLETED|Overall Study||1
8287524|NCT01636297|20432778|P2|NOT COMPLETED|Overall Study||4
8287525|NCT01636297|20432779|P1|NOT COMPLETED|Overall Study||4
8287526|NCT01636297|20432777|P3|COMPLETED|Overall Study||19
8287527|NCT01636297|20432778|P2|COMPLETED|Overall Study||36
8287528|NCT01636297|20432779|P1|COMPLETED|Overall Study||36
8287529|NCT01636297|20432777|P3|STARTED|Overall Study||20
8287530|NCT01636297|20432778|P2|STARTED|Overall Study||40
8287531|NCT01636297|20432779|P1|STARTED|Overall Study||40
8287532|NCT01636284|20432793|P1|NOT COMPLETED|Overall Study||0
8287533|NCT01636284|20432793|P1|COMPLETED|Overall Study||16
8287534|NCT01636284|20432793|P1|STARTED|Overall Study||16
8287535|NCT01636258|20432801|P2|NOT COMPLETED|Overall Study||0
8287536|NCT01636258|20432802|P1|NOT COMPLETED|Overall Study||1
8287537|NCT01636258|20432801|P2|COMPLETED|Overall Study||14
8287538|NCT01636258|20432802|P1|COMPLETED|Overall Study||12
8287539|NCT01636258|20432801|P2|STARTED|Overall Study||14
8287540|NCT01636258|20432802|P1|STARTED|Overall Study||13
8287547|NCT01636102|20432827|P2|NOT COMPLETED|Overall Study||0
8287548|NCT01636102|20432828|P1|NOT COMPLETED|Overall Study||0
8287549|NCT01636102|20432827|P2|COMPLETED|Overall Study||63
8287550|NCT01636102|20432828|P1|COMPLETED|Overall Study||63
8287551|NCT01636102|20432827|P2|STARTED|Overall Study||63
8287552|NCT01636102|20432828|P1|STARTED|Overall Study||63
8287553|NCT01636076|20432842|P2|NOT COMPLETED|Overall Study||25
8287554|NCT01636076|20432843|P1|NOT COMPLETED|Overall Study||17
8287555|NCT01636076|20432842|P2|COMPLETED|Overall Study||288
8287556|NCT01636076|20432843|P1|COMPLETED|Overall Study||299
8287557|NCT01636076|20432842|P2|STARTED|Overall Study||313
8287558|NCT01636076|20432843|P1|STARTED|Overall Study||316
8287559|NCT01636063|20432905|P2|NOT COMPLETED|Overall Study||0
8287560|NCT01636063|20432906|P1|NOT COMPLETED|Overall Study||0
8287561|NCT01636063|20432905|P2|COMPLETED|Overall Study||21
8287562|NCT01636063|20432906|P1|COMPLETED|Overall Study||21
8287563|NCT01636063|20432905|P2|STARTED|Overall Study||21
8287564|NCT01636063|20432906|P1|STARTED|Overall Study||21
8287565|NCT01635998|20432914|P2|NOT COMPLETED|Overall Study||7
8287566|NCT01635998|20432915|P1|NOT COMPLETED|Overall Study||4
8287567|NCT01635998|20432914|P2|COMPLETED|Overall Study||15
8287568|NCT01635998|20432915|P1|COMPLETED|Overall Study||24
8287569|NCT01635998|20432914|P2|STARTED|Overall Study||22
8287570|NCT01635998|20432915|P1|STARTED|Overall Study||28
8287571|NCT01635933|20432943|P2|NOT COMPLETED|Overall Study||8
8287572|NCT01635933|20432944|P1|NOT COMPLETED|Overall Study||2
8287573|NCT01635933|20432943|P2|COMPLETED|Overall Study||177
8287574|NCT01635933|20432944|P1|COMPLETED|Overall Study||176
8287575|NCT01635933|20432943|P2|STARTED|Overall Study||185
8287576|NCT01635933|20432944|P1|STARTED|Overall Study||178
8287577|NCT01635920|20432956|P2|NOT COMPLETED|Overall Study||1
8287578|NCT01635920|20432957|P1|NOT COMPLETED|Overall Study||3
8287579|NCT01635920|20432956|P2|COMPLETED|Overall Study||125
8287580|NCT01635920|20432957|P1|COMPLETED|Overall Study||122
8287581|NCT01635920|20432956|P2|STARTED|Overall Study||126
8287582|NCT01635920|20432957|P1|STARTED|Overall Study||125
8287583|NCT01635881|20432965|P1|NOT COMPLETED|Overall Study||0
8287584|NCT01635881|20432965|P1|COMPLETED|Overall Study||60
8287585|NCT01635881|20432965|P1|STARTED|Overall Study||60
8287586|NCT01635855|20432970|P1|NOT COMPLETED|Overall Study||4
8287587|NCT01635855|20432970|P1|COMPLETED|Overall Study||113
8287588|NCT01635855|20432970|P1|STARTED|Overall Study||117
8287589|NCT01635764|20432979|P1|NOT COMPLETED|Overall Study||273
8287590|NCT01635764|20432979|P1|COMPLETED|Overall Study||235
8287591|NCT01635764|20432979|P1|STARTED|Overall Study||508
8287592|NCT01635504|20433007|P1|NOT COMPLETED|Overall Study||0
8287593|NCT01635504|20433007|P1|COMPLETED|Overall Study||5
8287594|NCT01635504|20433007|P1|STARTED|Overall Study||5
8287595|NCT01635439|20433014|P2|NOT COMPLETED|Overall Study||0
8287596|NCT01635439|20433015|P1|NOT COMPLETED|Overall Study||0
8287597|NCT01635439|20433014|P2|COMPLETED|Overall Study||100
8287598|NCT01635439|20433015|P1|COMPLETED|Overall Study||100
8287599|NCT01635439|20433014|P2|STARTED|Overall Study||100
8287600|NCT01635439|20433015|P1|STARTED|Overall Study||100
8287601|NCT01635283|20433029|P1|NOT COMPLETED|Overall Study||4
8287602|NCT01635283|20433029|P1|COMPLETED|Overall Study||1
8287603|NCT01635283|20433029|P1|STARTED|Overall Study||5
8287604|NCT01635244|20433040|P3|NOT COMPLETED|Overall Study||2
8287605|NCT01635244|20433041|P2|NOT COMPLETED|Overall Study||1
8287606|NCT01635244|20433042|P1|NOT COMPLETED|Overall Study||1
8287607|NCT01635244|20433040|P3|COMPLETED|Overall Study||18
8287608|NCT01635244|20433041|P2|COMPLETED|Overall Study||21
8287609|NCT01635244|20433042|P1|COMPLETED|Overall Study||17
8287610|NCT01635244|20433040|P3|STARTED|Overall Study||20
8287611|NCT01635244|20433041|P2|STARTED|Overall Study||22
8287612|NCT01635244|20433042|P1|STARTED|Overall Study||18
8287613|NCT01635218|20433053|P3|NOT COMPLETED|Overall Study||6
8287614|NCT01635218|20433054|P2|NOT COMPLETED|Overall Study||7
8287615|NCT01635218|20433055|P1|NOT COMPLETED|Overall Study||3
8287616|NCT01635218|20433053|P3|COMPLETED|Overall Study||37
8287617|NCT01635218|20433054|P2|COMPLETED|Overall Study||39
8287618|NCT01635218|20433055|P1|COMPLETED|Overall Study||41
8287619|NCT01635218|20433053|P3|STARTED|Overall Study||43
8287620|NCT01635218|20433054|P2|STARTED|Overall Study||46
8287621|NCT01635218|20433055|P1|STARTED|Overall Study||44
8287622|NCT01635153|20433077|P2|NOT COMPLETED|Overall Study||43
8287623|NCT01635153|20433078|P1|NOT COMPLETED|Overall Study||40
8287624|NCT01635153|20433077|P2|COMPLETED|Overall Study||36
8287625|NCT01635153|20433078|P1|COMPLETED|Overall Study||32
8287626|NCT01635153|20433077|P2|STARTED|Overall Study||79
8287627|NCT01635153|20433078|P1|STARTED|Overall Study||72
8287628|NCT01635101|20433091|P3|NOT COMPLETED|Overall Study||17
8287629|NCT01635101|20433092|P2|NOT COMPLETED|Overall Study||12
8287630|NCT01635101|20433093|P1|NOT COMPLETED|Overall Study||9
8287631|NCT01635101|20433091|P3|COMPLETED|Overall Study||52
8287632|NCT01635101|20433092|P2|COMPLETED|Overall Study||55
8287633|NCT01635101|20433093|P1|COMPLETED|Overall Study||52
8287634|NCT01635101|20433091|P3|Pharmacokinetics Evaluable Population|Overall Study||58
8287635|NCT01635101|20433092|P2|Pharmacokinetics Evaluable Population|Overall Study||59
8287636|NCT01635101|20433093|P1|Pharmacokinetics Evaluable Population|Overall Study||50
8287637|NCT01635101|20433091|P3|Modified Intent to Treat (mITT)|Overall Study||69
8287638|NCT01635101|20433092|P2|Modified Intent to Treat (mITT)|Overall Study||67
8287639|NCT01635101|20433093|P1|Modified Intent to Treat (mITT)|Overall Study||61
8287640|NCT01635101|20433091|P3|Safety Population|Overall Study||69
8287641|NCT01635101|20433092|P2|Safety Population|Overall Study||67
8287642|NCT01635101|20433093|P1|Safety Population|Overall Study||61
8287643|NCT01635101|20433091|P3|STARTED|Overall Study||69
8287644|NCT01635101|20433092|P2|STARTED|Overall Study||67
8287645|NCT01635101|20433093|P1|STARTED|Overall Study||61
8287646|NCT01635062|20433118|P2|NOT COMPLETED|Overall Study||0
8287647|NCT01635062|20433119|P1|NOT COMPLETED|Overall Study||0
8287648|NCT01635062|20433118|P2|COMPLETED|Overall Study||9
8287649|NCT01635062|20433119|P1|COMPLETED|Overall Study||9
8287650|NCT01635062|20433118|P2|Post-Randomization Sodium Loaded|Overall Study||9
8287651|NCT01635062|20433119|P1|Post-Randomization Sodium Loaded|Overall Study||9
8287652|NCT01635062|20433118|P2|Post-randomization Sodium Restriction|Overall Study||9
8287653|NCT01635062|20433119|P1|Post-randomization Sodium Restriction|Overall Study||9
8287654|NCT01635062|20433118|P2|Sodium Loading Baseline Visit|Overall Study||9
8287655|NCT01635062|20433119|P1|Sodium Loading Baseline Visit|Overall Study||9
8287656|NCT01635062|20433118|P2|Sodium Restriction Baseline Visit|Overall Study||9
8287657|NCT01635062|20433119|P1|Sodium Restriction Baseline Visit|Overall Study||9
8287658|NCT01635062|20433118|P2|STARTED|Overall Study||9
8287659|NCT01635062|20433119|P1|STARTED|Overall Study||9
8287660|NCT01634854|20433131|P2|NOT COMPLETED|Overall Study||7
8287661|NCT01634854|20433132|P1|NOT COMPLETED|Overall Study||2
8287662|NCT01634854|20433131|P2|COMPLETED|Overall Study||59
8287663|NCT01634854|20433132|P1|COMPLETED|Overall Study||62
8287664|NCT01634854|20433131|P2|STARTED|Overall Study||66
8287665|NCT01634854|20433132|P1|STARTED|Overall Study||64
8287666|NCT01634659|20433152|P2|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
8287667|NCT01634659|20433153|P1|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
8287668|NCT01634659|20433152|P2|COMPLETED|Period 2 - Second 8 Days of Wear||158
8287669|NCT01634659|20433153|P1|COMPLETED|Period 2 - Second 8 Days of Wear||152
8287670|NCT01634659|20433152|P2|STARTED|Period 2 - Second 8 Days of Wear||158
8287671|NCT01634659|20433153|P1|STARTED|Period 2 - Second 8 Days of Wear||155
8287672|NCT01634659|20433152|P2|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
8287673|NCT01634659|20433153|P1|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
8287674|NCT01634659|20433152|P2|COMPLETED|Period 1 - First 8 Days of Wear||158
8287675|NCT01634659|20433153|P1|COMPLETED|Period 1 - First 8 Days of Wear||155
8287676|NCT01634659|20433152|P2|STARTED|Period 1 - First 8 Days of Wear||158
8287677|NCT01634659|20433153|P1|STARTED|Period 1 - First 8 Days of Wear||155
8287678|NCT01634620|20433163|P1|NOT COMPLETED|Overall Study||0
8287679|NCT01634620|20433163|P1|COMPLETED|Overall Study||200
8287680|NCT01634620|20433163|P1|STARTED|Overall Study||200
8287681|NCT01634555|20433183|P1|NOT COMPLETED|Overall Study||4
8287682|NCT01634555|20433183|P1|COMPLETED|Overall Study|Completed the required treatment and assessment.|25
8287683|NCT01634555|20433183|P1|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
8287684|NCT01634555|20433183|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
8287685|NCT01634555|20433183|P1|STARTED|Overall Study||29
8287686|NCT01634360|20433194|P2|NOT COMPLETED|Overall Study||136
8287687|NCT01634360|20433195|P1|NOT COMPLETED|Overall Study||49
8287688|NCT01634360|20433194|P2|COMPLETED|Overall Study||0
8287689|NCT01634360|20433195|P1|COMPLETED|Overall Study||0
8287690|NCT01634360|20433194|P2|STARTED|Overall Study||136
8287691|NCT01634360|20433195|P1|STARTED|Overall Study||49
8287692|NCT01634269|20433205|P1|NOT COMPLETED|Overall Study||2
8287693|NCT01634269|20433205|P1|COMPLETED|Overall Study||18
8287694|NCT01634269|20433205|P1|24 Month|Overall Study||18
8287695|NCT01634269|20433205|P1|12 Month|Overall Study||20
8287696|NCT01634269|20433205|P1|6 Month|Overall Study||20
8287697|NCT01634269|20433205|P1|30 Days|Overall Study||20
8287698|NCT01634269|20433205|P1|STARTED|Overall Study||20
8287699|NCT01634256|20433252|P2|NOT COMPLETED|Overall Study||8
8287700|NCT01634256|20433253|P1|NOT COMPLETED|Overall Study||4
8287701|NCT01634256|20433252|P2|COMPLETED|Overall Study||22
8287702|NCT01634256|20433253|P1|COMPLETED|Overall Study||26
8287703|NCT01634256|20433252|P2|STARTED|Overall Study||30
8287704|NCT01634256|20433253|P1|STARTED|Overall Study||30
8287705|NCT01634243|20433269|P2|NOT COMPLETED|Overall Study||5
8287706|NCT01634243|20433270|P1|NOT COMPLETED|Overall Study||6
8287707|NCT01634243|20433269|P2|COMPLETED|Overall Study||38
8287708|NCT01634243|20433270|P1|COMPLETED|Overall Study||15
8287709|NCT01634243|20433269|P2|STARTED|Overall Study||43
8287710|NCT01634243|20433270|P1|STARTED|Overall Study||21
8287711|NCT01634165|20433296|P4|NOT COMPLETED|Period 4||0
8287712|NCT01634165|20433297|P3|NOT COMPLETED|Period 4||0
8287713|NCT01634165|20433298|P2|NOT COMPLETED|Period 4||0
8287714|NCT01634165|20433299|P1|NOT COMPLETED|Period 4||0
8287715|NCT01634165|20433296|P4|COMPLETED|Period 4||6
8287716|NCT01634165|20433297|P3|COMPLETED|Period 4||6
8287717|NCT01634165|20433298|P2|COMPLETED|Period 4||5
8287718|NCT01634165|20433299|P1|COMPLETED|Period 4||6
8287719|NCT01634165|20433296|P4|STARTED|Period 4||6
8287720|NCT01634165|20433297|P3|STARTED|Period 4||6
8287721|NCT01634165|20433298|P2|STARTED|Period 4||5
8287722|NCT01634165|20433299|P1|STARTED|Period 4||6
8287723|NCT01634165|20433296|P4|NOT COMPLETED|Period 3||0
8287724|NCT01634165|20433297|P3|NOT COMPLETED|Period 3||0
8287725|NCT01634165|20433298|P2|NOT COMPLETED|Period 3||0
8287726|NCT01634165|20433299|P1|NOT COMPLETED|Period 3||0
8287727|NCT01634165|20433296|P4|COMPLETED|Period 3||6
8287728|NCT01634165|20433297|P3|COMPLETED|Period 3||6
8287729|NCT01634165|20433298|P2|COMPLETED|Period 3||5
8287730|NCT01634165|20433299|P1|COMPLETED|Period 3||6
8287731|NCT01634165|20433296|P4|STARTED|Period 3||6
8287732|NCT01634165|20433297|P3|STARTED|Period 3||6
8287733|NCT01634165|20433298|P2|STARTED|Period 3||5
8287734|NCT01634165|20433299|P1|STARTED|Period 3||6
8287735|NCT01634165|20433296|P4|NOT COMPLETED|Period 2||0
8287736|NCT01634165|20433297|P3|NOT COMPLETED|Period 2||0
8287737|NCT01634165|20433298|P2|NOT COMPLETED|Period 2||1
8287738|NCT01634165|20433299|P1|NOT COMPLETED|Period 2||0
8287739|NCT01634165|20433296|P4|COMPLETED|Period 2||6
8287740|NCT01634165|20433297|P3|COMPLETED|Period 2||6
8287741|NCT01634165|20433298|P2|COMPLETED|Period 2||5
8287742|NCT01634165|20433299|P1|COMPLETED|Period 2||6
8287743|NCT01634165|20433296|P4|STARTED|Period 2||6
8287744|NCT01634165|20433297|P3|STARTED|Period 2||6
8287745|NCT01634165|20433298|P2|STARTED|Period 2||6
8287746|NCT01634165|20433299|P1|STARTED|Period 2||6
8287747|NCT01634165|20433296|P4|NOT COMPLETED|Period 1||0
8287748|NCT01634165|20433297|P3|NOT COMPLETED|Period 1||0
8287749|NCT01634165|20433298|P2|NOT COMPLETED|Period 1||0
8287750|NCT01634165|20433299|P1|NOT COMPLETED|Period 1||0
8287751|NCT01634165|20433296|P4|COMPLETED|Period 1||6
8287752|NCT01634165|20433297|P3|COMPLETED|Period 1||6
8287753|NCT01634165|20433298|P2|COMPLETED|Period 1||6
8287754|NCT01634165|20433299|P1|COMPLETED|Period 1||6
8287755|NCT01634165|20433296|P4|Received at Least 1 Dose of Study Drug|Period 1||6
8287756|NCT01634165|20433297|P3|Received at Least 1 Dose of Study Drug|Period 1||6
8287757|NCT01634165|20433298|P2|Received at Least 1 Dose of Study Drug|Period 1||6
8287758|NCT01634165|20433299|P1|Received at Least 1 Dose of Study Drug|Period 1||6
8287759|NCT01634165|20433296|P4|STARTED|Period 1||6
8287760|NCT01634165|20433297|P3|STARTED|Period 1||6
8287761|NCT01634165|20433298|P2|STARTED|Period 1||6
8287762|NCT01634165|20433299|P1|STARTED|Period 1||6
8287763|NCT01634152|20433332|P3|NOT COMPLETED|Overall Study||4
8287764|NCT01634152|20433333|P2|NOT COMPLETED|Overall Study||1
8287765|NCT01634152|20433334|P1|NOT COMPLETED|Overall Study||4
8287766|NCT01634152|20433332|P3|COMPLETED|Overall Study||126
8287767|NCT01634152|20433333|P2|COMPLETED|Overall Study||136
8287768|NCT01634152|20433334|P1|COMPLETED|Overall Study||130
8287769|NCT01634152|20433332|P3|STARTED|Overall Study||130
8287770|NCT01634152|20433333|P2|STARTED|Overall Study||137
8287771|NCT01634152|20433334|P1|STARTED|Overall Study||134
8287772|NCT01634139|20433417|P3|NOT COMPLETED|Overall Study||5
8287773|NCT01634139|20433418|P2|NOT COMPLETED|Overall Study||6
8287774|NCT01634139|20433419|P1|NOT COMPLETED|Overall Study||10
8287775|NCT01634139|20433417|P3|COMPLETED|Overall Study||130
8287776|NCT01634139|20433418|P2|COMPLETED|Overall Study||130
8287777|NCT01634139|20433419|P1|COMPLETED|Overall Study||122
8287778|NCT01634139|20433417|P3|STARTED|Overall Study||135
8287779|NCT01634139|20433418|P2|STARTED|Overall Study||136
8287780|NCT01634139|20433419|P1|STARTED|Overall Study||132
8287781|NCT01634113|20433520|P3|NOT COMPLETED|Overall Study||1
8287782|NCT01634113|20433521|P2|NOT COMPLETED|Overall Study||0
8287783|NCT01634113|20433522|P1|NOT COMPLETED|Overall Study||0
8287784|NCT01634113|20433520|P3|COMPLETED|Overall Study||31
8287785|NCT01634113|20433521|P2|COMPLETED|Overall Study||36
8287786|NCT01634113|20433522|P1|COMPLETED|Overall Study||34
8287787|NCT01634113|20433520|P3|STARTED|Overall Study||32
8287788|NCT01634113|20433521|P2|STARTED|Overall Study||36
8287789|NCT01634113|20433522|P1|STARTED|Overall Study||34
8287790|NCT01634100|20433566|P6|NOT COMPLETED|Overall Study||0
8287791|NCT01634100|20433567|P5|NOT COMPLETED|Overall Study||0
8287792|NCT01634100|20433568|P4|NOT COMPLETED|Overall Study||0
8287793|NCT01634100|20433569|P3|NOT COMPLETED|Overall Study||1
8287794|NCT01634100|20433570|P2|NOT COMPLETED|Overall Study||0
8287795|NCT01634100|20433571|P1|NOT COMPLETED|Overall Study||1
8287796|NCT01634100|20433566|P6|COMPLETED|Overall Study||3
8287797|NCT01634100|20433567|P5|COMPLETED|Overall Study||3
8287798|NCT01634100|20433568|P4|COMPLETED|Overall Study||3
8287799|NCT01634100|20433569|P3|COMPLETED|Overall Study||2
8287800|NCT01634100|20433570|P2|COMPLETED|Overall Study||3
8287801|NCT01634100|20433571|P1|COMPLETED|Overall Study||2
8287802|NCT01634100|20433566|P6|Received Empa + Probenecid|Overall Study||3
8287803|NCT01634100|20433567|P5|Received Empa + Probenecid|Overall Study||3
8287804|NCT01634100|20433568|P4|Received Empa + Probenecid|Overall Study||3
8287805|NCT01634100|20433569|P3|Received Empa + Probenecid|Overall Study||2
8287806|NCT01634100|20433570|P2|Received Empa + Probenecid|Overall Study||3
8287807|NCT01634100|20433571|P1|Received Empa + Probenecid|Overall Study||2
8287808|NCT01634100|20433566|P6|Received Empa + Rifampicin|Overall Study||3
8287809|NCT01634100|20433567|P5|Received Empa + Rifampicin|Overall Study||3
8287810|NCT01634100|20433568|P4|Received Empa + Rifampicin|Overall Study||3
8287811|NCT01634100|20433569|P3|Received Empa + Rifampicin|Overall Study||3
8287812|NCT01634100|20433570|P2|Received Empa + Rifampicin|Overall Study||3
8287813|NCT01634100|20433571|P1|Received Empa + Rifampicin|Overall Study||3
8287814|NCT01634100|20433566|P6|Received Empa Alone|Overall Study||3
8287815|NCT01634100|20433567|P5|Received Empa Alone|Overall Study||3
8287816|NCT01634100|20433568|P4|Received Empa Alone|Overall Study||3
8287817|NCT01634100|20433569|P3|Received Empa Alone|Overall Study||3
8287818|NCT01634100|20433570|P2|Received Empa Alone|Overall Study||3
8287819|NCT01634100|20433571|P1|Received Empa Alone|Overall Study||3
8287820|NCT01634100|20433566|P6|STARTED|Overall Study||3
8287821|NCT01634100|20433567|P5|STARTED|Overall Study||3
8287822|NCT01634100|20433568|P4|STARTED|Overall Study||3
8287823|NCT01634100|20433569|P3|STARTED|Overall Study||3
8287824|NCT01634100|20433570|P2|STARTED|Overall Study||3
8287825|NCT01634100|20433571|P1|STARTED|Overall Study||3
8287826|NCT01633944|20433587|P3|NOT COMPLETED|Double-blind Treatment Phase||58
8287827|NCT01633944|20433588|P2|NOT COMPLETED|Double-blind Treatment Phase||54
8287828|NCT01633944|20433589|P1|NOT COMPLETED|Double-blind Treatment Phase||0
8287829|NCT01633944|20433587|P3|COMPLETED|Double-blind Treatment Phase||174
8287830|NCT01633944|20433588|P2|COMPLETED|Double-blind Treatment Phase||176
8287831|NCT01633944|20433589|P1|COMPLETED|Double-blind Treatment Phase||0
8287832|NCT01633944|20433587|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
8287833|NCT01633944|20433588|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
8287834|NCT01633944|20433589|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
8287835|NCT01633944|20433587|P3|NOT COMPLETED|Open-label Titration Phase||0
8287836|NCT01633944|20433588|P2|NOT COMPLETED|Open-label Titration Phase||0
8287837|NCT01633944|20433589|P1|NOT COMPLETED|Open-label Titration Phase||290
8287838|NCT01633944|20433587|P3|COMPLETED|Open-label Titration Phase||0
8287839|NCT01633944|20433588|P2|COMPLETED|Open-label Titration Phase||0
8287840|NCT01633944|20433589|P1|COMPLETED|Open-label Titration Phase||462
8287841|NCT01633944|20433587|P3|STARTED|Open-label Titration Phase||0
8287842|NCT01633944|20433588|P2|STARTED|Open-label Titration Phase||0
8287843|NCT01633944|20433589|P1|STARTED|Open-label Titration Phase||752
8287844|NCT01633892|20433609|P1|NOT COMPLETED|Overall Study||0
8287845|NCT01633892|20433609|P1|COMPLETED|Overall Study||5
8287846|NCT01633892|20433609|P1|STARTED|Overall Study||5
8287847|NCT01633853|20433619|P2|NOT COMPLETED|Overall Study||0
8287848|NCT01633853|20433620|P1|NOT COMPLETED|Overall Study||0
8287849|NCT01633853|20433619|P2|COMPLETED|Overall Study||100
8287850|NCT01633853|20433620|P1|COMPLETED|Overall Study||104
8287851|NCT01633853|20433619|P2|STARTED|Overall Study||100
8287852|NCT01633853|20433620|P1|STARTED|Overall Study||104
8287853|NCT01633827|20433634|P2|NOT COMPLETED|Second Intervention||0
8287854|NCT01633827|20433635|P1|NOT COMPLETED|Second Intervention||0
8287855|NCT01633827|20433634|P2|COMPLETED|Second Intervention||11
8287856|NCT01633827|20433635|P1|COMPLETED|Second Intervention||11
8287857|NCT01633827|20433634|P2|STARTED|Second Intervention||11
8287858|NCT01633827|20433635|P1|STARTED|Second Intervention||11
8287859|NCT01633827|20433634|P2|NOT COMPLETED|Washout Period||0
8287860|NCT01633827|20433635|P1|NOT COMPLETED|Washout Period||0
8287861|NCT01633827|20433634|P2|COMPLETED|Washout Period||11
8287862|NCT01633827|20433635|P1|COMPLETED|Washout Period||11
8287863|NCT01633827|20433634|P2|STARTED|Washout Period||11
8287864|NCT01633827|20433635|P1|STARTED|Washout Period||11
8287865|NCT01633827|20433634|P2|NOT COMPLETED|First Intervention||0
8287866|NCT01633827|20433635|P1|NOT COMPLETED|First Intervention||0
8287867|NCT01633827|20433634|P2|COMPLETED|First Intervention||11
8287868|NCT01633827|20433635|P1|COMPLETED|First Intervention||11
8287869|NCT01633827|20433634|P2|STARTED|First Intervention||11
8287870|NCT01633827|20433635|P1|STARTED|First Intervention||11
8287871|NCT01633814|20433648|P1|NOT COMPLETED|Overall Study||0
8287872|NCT01633814|20433648|P1|COMPLETED|Overall Study||4
8287873|NCT01633814|20433648|P1|STARTED|Overall Study||4
8287874|NCT01633788|20433657|P4|NOT COMPLETED|Overall Study||13
8287875|NCT01633788|20433658|P3|NOT COMPLETED|Overall Study||10
8287876|NCT01633788|20433659|P2|NOT COMPLETED|Overall Study||8
8287877|NCT01633788|20433660|P1|NOT COMPLETED|Overall Study||7
8287878|NCT01633788|20433657|P4|COMPLETED|Overall Study||45
8287879|NCT01633788|20433658|P3|COMPLETED|Overall Study||49
8287880|NCT01633788|20433659|P2|COMPLETED|Overall Study||50
8287881|NCT01633788|20433660|P1|COMPLETED|Overall Study||50
8287882|NCT01633788|20433657|P4|STARTED|Overall Study||58
8287883|NCT01633788|20433658|P3|STARTED|Overall Study||59
8287884|NCT01633788|20433659|P2|STARTED|Overall Study||58
8287885|NCT01633788|20433660|P1|STARTED|Overall Study||57
8287886|NCT01633320|20433680|P2|NOT COMPLETED|Overall Study||0
8287887|NCT01633320|20433681|P1|NOT COMPLETED|Overall Study||0
8287888|NCT01633320|20433680|P2|COMPLETED|Overall Study||68
8287889|NCT01633320|20433681|P1|COMPLETED|Overall Study||132
8287890|NCT01633320|20433680|P2|STARTED|Overall Study||68
8287891|NCT01633320|20433681|P1|STARTED|Overall Study||132
8287892|NCT01633112|20433692|P3|NOT COMPLETED|Overall Study||92
8287893|NCT01633112|20433693|P2|NOT COMPLETED|Overall Study||60
8287894|NCT01633112|20433694|P1|NOT COMPLETED|Overall Study||53
8287895|NCT01633112|20433692|P3|COMPLETED|Overall Study||250
8287896|NCT01633112|20433693|P2|COMPLETED|Overall Study||310
8287897|NCT01633112|20433694|P1|COMPLETED|Overall Study||299
8287898|NCT01633112|20433692|P3|STARTED|Overall Study||342
8287899|NCT01633112|20433693|P2|STARTED|Overall Study||370
8287900|NCT01633112|20433694|P1|STARTED|Overall Study||352
8287901|NCT01633060|20433729|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
8287902|NCT01633060|20433730|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16
8287903|NCT01633060|20433729|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8287904|NCT01633060|20433730|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8287905|NCT01633060|20433729|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
8287906|NCT01633060|20433730|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16
8287907|NCT01633060|20433729|P2|NOT COMPLETED|Treatment Phase||140
8287908|NCT01633060|20433730|P1|NOT COMPLETED|Treatment Phase||288
8287909|NCT01633060|20433729|P2|COMPLETED|Treatment Phase||0
8287910|NCT01633060|20433730|P1|COMPLETED|Treatment Phase||0
8287911|NCT01633060|20433729|P2|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0
8287912|NCT01633060|20433730|P1|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63
8287913|NCT01633060|20433729|P2|Safety Set (SS)|Treatment Phase||140
8287914|NCT01633060|20433730|P1|Safety Set (SS)|Treatment Phase||288
8287915|NCT01633060|20433729|P2|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81
8287916|NCT01633060|20433730|P1|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132
8287917|NCT01633060|20433729|P2|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35
8287918|NCT01633060|20433730|P1|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100
8287919|NCT01633060|20433729|P2|STARTED|Treatment Phase||140
8287920|NCT01633060|20433730|P1|STARTED|Treatment Phase||288
8287921|NCT01633060|20433729|P2|NOT COMPLETED|Randomization Phase||3
8287922|NCT01633060|20433730|P1|NOT COMPLETED|Randomization Phase||1
8287923|NCT01633060|20433729|P2|COMPLETED|Randomization Phase||140
8287924|NCT01633060|20433730|P1|COMPLETED|Randomization Phase||288
8287925|NCT01633060|20433729|P2|STARTED|Randomization Phase|All randomized patients|143
8287926|NCT01633060|20433730|P1|STARTED|Randomization Phase|All randomized patients|289
8287927|NCT01632995|20433755|P1|NOT COMPLETED|Main Study Follow-up Period||120
8287928|NCT01632995|20433755|P1|COMPLETED|Main Study Follow-up Period||437
8287929|NCT01632995|20433755|P1|STARTED|Main Study Follow-up Period||557
8287930|NCT01632995|20433755|P1|NOT COMPLETED|Pre-screening to Enrollment Period||512
8287931|NCT01632995|20433755|P1|COMPLETED|Pre-screening to Enrollment Period||557
8287932|NCT01632995|20433755|P1|STARTED|Pre-screening to Enrollment Period||1069
8287933|NCT01632904|20433770|P2|NOT COMPLETED|Overall Study||6
8287934|NCT01632904|20433771|P1|NOT COMPLETED|Overall Study||7
8287935|NCT01632904|20433770|P2|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
8287936|NCT01632904|20433771|P1|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
8287937|NCT01632904|20433770|P2|STARTED|Overall Study||56
8287938|NCT01632904|20433771|P1|STARTED|Overall Study||54
8287939|NCT01632891|20433782|P2|NOT COMPLETED|Overall Study||1
8287940|NCT01632891|20433783|P1|NOT COMPLETED|Overall Study||1
8287941|NCT01632891|20433782|P2|COMPLETED|Overall Study||25
8287942|NCT01632891|20433783|P1|COMPLETED|Overall Study||25
8287943|NCT01632891|20433782|P2|STARTED|Overall Study||26
8287944|NCT01632891|20433783|P1|STARTED|Overall Study||26
8287945|NCT01632878|20433807|P1|NOT COMPLETED|Treatment||158
8287946|NCT01632878|20433807|P1|COMPLETED|Treatment||1105
8287947|NCT01632878|20433807|P1|STARTED|Treatment||1263
8287948|NCT01632878|20433807|P1|NOT COMPLETED|Screening||268
8287949|NCT01632878|20433807|P1|COMPLETED|Screening||1263
8287950|NCT01632878|20433807|P1|STARTED|Screening||1531
8287951|NCT01632800|20433811|P1|NOT COMPLETED|Overall Study||1
8287952|NCT01632800|20433811|P1|COMPLETED|Overall Study||25
8287953|NCT01632800|20433811|P1|STARTED|Overall Study||26
8287954|NCT01632735|20433817|P2|NOT COMPLETED|Overall Study||3
8287955|NCT01632735|20433818|P1|NOT COMPLETED|Overall Study||4
8287956|NCT01632735|20433817|P2|COMPLETED|Overall Study||37
8287957|NCT01632735|20433818|P1|COMPLETED|Overall Study||36
8287958|NCT01632735|20433817|P2|STARTED|Overall Study||40
8287959|NCT01632735|20433818|P1|STARTED|Overall Study||40
8287960|NCT01632709|20433834|P4|NOT COMPLETED|Overall Study||1
8287961|NCT01632709|20433835|P3|NOT COMPLETED|Overall Study||0
8287962|NCT01632709|20433836|P2|NOT COMPLETED|Overall Study||1
8287963|NCT01632709|20433837|P1|NOT COMPLETED|Overall Study||2
8287964|NCT01632709|20433834|P4|COMPLETED|Overall Study||3
8287965|NCT01632709|20433835|P3|COMPLETED|Overall Study||5
8287966|NCT01632709|20433836|P2|COMPLETED|Overall Study||2
8287967|NCT01632709|20433837|P1|COMPLETED|Overall Study||2
8287968|NCT01632709|20433834|P4|Completed Visit 2 (Received Injection)|Overall Study||3
8287969|NCT01632709|20433835|P3|Completed Visit 2 (Received Injection)|Overall Study||5
8287970|NCT01632709|20433836|P2|Completed Visit 2 (Received Injection)|Overall Study||2
8287971|NCT01632709|20433837|P1|Completed Visit 2 (Received Injection)|Overall Study||4
8287972|NCT01632709|20433834|P4|STARTED|Overall Study||4
8287973|NCT01632709|20433835|P3|STARTED|Overall Study||5
8287974|NCT01632709|20433836|P2|STARTED|Overall Study||3
8287975|NCT01632709|20433837|P1|STARTED|Overall Study||4
8287976|NCT01632683|20433863|P2|NOT COMPLETED|Overall Study||0
8287977|NCT01632683|20433864|P1|NOT COMPLETED|Overall Study||0
8287978|NCT01632683|20433863|P2|COMPLETED|Overall Study||552
8287979|NCT01632683|20433864|P1|COMPLETED|Overall Study||548
8287980|NCT01632683|20433863|P2|STARTED|Overall Study||552
8287981|NCT01632683|20433864|P1|STARTED|Overall Study||548
8287982|NCT01632579|20433878|P9|NOT COMPLETED|Period 3 (Third Intervention)||0
8287983|NCT01632579|20433879|P8|NOT COMPLETED|Period 3 (Third Intervention)||0
8287984|NCT01632579|20433880|P7|NOT COMPLETED|Period 3 (Third Intervention)||0
8287985|NCT01632579|20433881|P6|NOT COMPLETED|Period 3 (Third Intervention)||0
8287986|NCT01632579|20433882|P5|NOT COMPLETED|Period 3 (Third Intervention)||0
8287987|NCT01632579|20433883|P4|NOT COMPLETED|Period 3 (Third Intervention)||0
8287988|NCT01632579|20433884|P3|NOT COMPLETED|Period 3 (Third Intervention)||0
8287989|NCT01632579|20433885|P2|NOT COMPLETED|Period 3 (Third Intervention)||0
8287990|NCT01632579|20433886|P1|NOT COMPLETED|Period 3 (Third Intervention)||0
8287991|NCT01632579|20433878|P9|COMPLETED|Period 3 (Third Intervention)||2
8287992|NCT01632579|20433879|P8|COMPLETED|Period 3 (Third Intervention)||6
8287993|NCT01632579|20433880|P7|COMPLETED|Period 3 (Third Intervention)||2
8287994|NCT01632579|20433881|P6|COMPLETED|Period 3 (Third Intervention)||2
8287995|NCT01632579|20433882|P5|COMPLETED|Period 3 (Third Intervention)||6
8287996|NCT01632579|20433883|P4|COMPLETED|Period 3 (Third Intervention)||2
8287997|NCT01632579|20433884|P3|COMPLETED|Period 3 (Third Intervention)||2
8287998|NCT01632579|20433885|P2|COMPLETED|Period 3 (Third Intervention)||6
8287999|NCT01632579|20433886|P1|COMPLETED|Period 3 (Third Intervention)||0
8288000|NCT01632579|20433878|P9|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8288001|NCT01632579|20433879|P8|Received at Least 1 Dose|Period 3 (Third Intervention)||6
8288002|NCT01632579|20433880|P7|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8288003|NCT01632579|20433881|P6|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8288004|NCT01632579|20433882|P5|Received at Least 1 Dose|Period 3 (Third Intervention)||6
8288005|NCT01632579|20433883|P4|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8288006|NCT01632579|20433884|P3|Received at Least 1 Dose|Period 3 (Third Intervention)||2
8288007|NCT01632579|20433885|P2|Received at Least 1 Dose|Period 3 (Third Intervention)||6
8288008|NCT01632579|20433886|P1|Received at Least 1 Dose|Period 3 (Third Intervention)||0
8288009|NCT01632579|20433878|P9|STARTED|Period 3 (Third Intervention)||2
8288010|NCT01632579|20433879|P8|STARTED|Period 3 (Third Intervention)||6
8288011|NCT01632579|20433880|P7|STARTED|Period 3 (Third Intervention)||2
8288012|NCT01632579|20433881|P6|STARTED|Period 3 (Third Intervention)||2
8288013|NCT01632579|20433882|P5|STARTED|Period 3 (Third Intervention)||6
8288014|NCT01632579|20433883|P4|STARTED|Period 3 (Third Intervention)||2
8288015|NCT01632579|20433884|P3|STARTED|Period 3 (Third Intervention)||2
8288016|NCT01632579|20433885|P2|STARTED|Period 3 (Third Intervention)||6
8288017|NCT01632579|20433886|P1|STARTED|Period 3 (Third Intervention)||0
8288018|NCT01632579|20433878|P9|NOT COMPLETED|Washout Period||0
8288019|NCT01632579|20433879|P8|NOT COMPLETED|Washout Period||0
8288020|NCT01632579|20433880|P7|NOT COMPLETED|Washout Period||0
8288021|NCT01632579|20433881|P6|NOT COMPLETED|Washout Period||0
8288022|NCT01632579|20433882|P5|NOT COMPLETED|Washout Period||0
8288023|NCT01632579|20433883|P4|NOT COMPLETED|Washout Period||0
8288024|NCT01632579|20433884|P3|NOT COMPLETED|Washout Period||0
8288025|NCT01632579|20433885|P2|NOT COMPLETED|Washout Period||0
8288026|NCT01632579|20433886|P1|NOT COMPLETED|Washout Period||0
8288027|NCT01632579|20433878|P9|COMPLETED|Washout Period||2
8288028|NCT01632579|20433879|P8|COMPLETED|Washout Period||6
8288029|NCT01632579|20433880|P7|COMPLETED|Washout Period||2
8288030|NCT01632579|20433881|P6|COMPLETED|Washout Period||2
8288031|NCT01632579|20433882|P5|COMPLETED|Washout Period||6
8288032|NCT01632579|20433883|P4|COMPLETED|Washout Period||2
8288033|NCT01632579|20433884|P3|COMPLETED|Washout Period||2
8288034|NCT01632579|20433885|P2|COMPLETED|Washout Period||6
8288035|NCT01632579|20433886|P1|COMPLETED|Washout Period||0
8288036|NCT01632579|20433878|P9|STARTED|Washout Period||2
8288037|NCT01632579|20433879|P8|STARTED|Washout Period||6
8288038|NCT01632579|20433880|P7|STARTED|Washout Period||2
8288039|NCT01632579|20433881|P6|STARTED|Washout Period||2
8288040|NCT01632579|20433882|P5|STARTED|Washout Period||6
8288041|NCT01632579|20433883|P4|STARTED|Washout Period||2
8288042|NCT01632579|20433884|P3|STARTED|Washout Period||2
8288043|NCT01632579|20433885|P2|STARTED|Washout Period||6
8288044|NCT01632579|20433886|P1|STARTED|Washout Period||0
8288045|NCT01632579|20433878|P9|NOT COMPLETED|Period 2 (Second Intervention)||0
8288046|NCT01632579|20433879|P8|NOT COMPLETED|Period 2 (Second Intervention)||0
8288047|NCT01632579|20433880|P7|NOT COMPLETED|Period 2 (Second Intervention)||0
8288048|NCT01632579|20433881|P6|NOT COMPLETED|Period 2 (Second Intervention)||0
8288049|NCT01632579|20433882|P5|NOT COMPLETED|Period 2 (Second Intervention)||0
8288050|NCT01632579|20433883|P4|NOT COMPLETED|Period 2 (Second Intervention)||0
8288051|NCT01632579|20433884|P3|NOT COMPLETED|Period 2 (Second Intervention)||0
8288052|NCT01632579|20433885|P2|NOT COMPLETED|Period 2 (Second Intervention)||0
8288053|NCT01632579|20433886|P1|NOT COMPLETED|Period 2 (Second Intervention)||1
8288054|NCT01632579|20433878|P9|COMPLETED|Period 2 (Second Intervention)||2
8288055|NCT01632579|20433879|P8|COMPLETED|Period 2 (Second Intervention)||6
8288056|NCT01632579|20433880|P7|COMPLETED|Period 2 (Second Intervention)||2
8288057|NCT01632579|20433881|P6|COMPLETED|Period 2 (Second Intervention)||2
8288058|NCT01632579|20433882|P5|COMPLETED|Period 2 (Second Intervention)||6
8288059|NCT01632579|20433883|P4|COMPLETED|Period 2 (Second Intervention)||2
8288060|NCT01632579|20433884|P3|COMPLETED|Period 2 (Second Intervention)||2
8288061|NCT01632579|20433885|P2|COMPLETED|Period 2 (Second Intervention)||6
8288062|NCT01632579|20433886|P1|COMPLETED|Period 2 (Second Intervention)||0
8288063|NCT01632579|20433878|P9|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8288064|NCT01632579|20433879|P8|Received at Least 1 Dose|Period 2 (Second Intervention)||6
8288065|NCT01632579|20433880|P7|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8288066|NCT01632579|20433881|P6|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8288067|NCT01632579|20433882|P5|Received at Least 1 Dose|Period 2 (Second Intervention)||6
8288068|NCT01632579|20433883|P4|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8288069|NCT01632579|20433884|P3|Received at Least 1 Dose|Period 2 (Second Intervention)||2
8288070|NCT01632579|20433885|P2|Received at Least 1 Dose|Period 2 (Second Intervention)||6
8288071|NCT01632579|20433886|P1|Received at Least 1 Dose|Period 2 (Second Intervention)||1
8288072|NCT01632579|20433878|P9|STARTED|Period 2 (Second Intervention)||2
8288073|NCT01632579|20433879|P8|STARTED|Period 2 (Second Intervention)||6
8288074|NCT01632579|20433880|P7|STARTED|Period 2 (Second Intervention)||2
8288075|NCT01632579|20433881|P6|STARTED|Period 2 (Second Intervention)||2
8288076|NCT01632579|20433882|P5|STARTED|Period 2 (Second Intervention)||6
8288077|NCT01632579|20433883|P4|STARTED|Period 2 (Second Intervention)||2
8288078|NCT01632579|20433884|P3|STARTED|Period 2 (Second Intervention)||2
8288079|NCT01632579|20433885|P2|STARTED|Period 2 (Second Intervention)||6
8288080|NCT01632579|20433886|P1|STARTED|Period 2 (Second Intervention)||1
8288081|NCT01632579|20433878|P9|NOT COMPLETED|Washout Period||0
8288082|NCT01632579|20433879|P8|NOT COMPLETED|Washout Period||0
8288083|NCT01632579|20433880|P7|NOT COMPLETED|Washout Period||0
8288084|NCT01632579|20433881|P6|NOT COMPLETED|Washout Period||0
8288085|NCT01632579|20433882|P5|NOT COMPLETED|Washout Period||0
8288086|NCT01632579|20433883|P4|NOT COMPLETED|Washout Period||0
8288087|NCT01632579|20433884|P3|NOT COMPLETED|Washout Period||0
8288088|NCT01632579|20433885|P2|NOT COMPLETED|Washout Period||0
8288089|NCT01632579|20433886|P1|NOT COMPLETED|Washout Period||1
8288090|NCT01632579|20433878|P9|COMPLETED|Washout Period||2
8288091|NCT01632579|20433879|P8|COMPLETED|Washout Period||6
8288092|NCT01632579|20433880|P7|COMPLETED|Washout Period||2
8288093|NCT01632579|20433881|P6|COMPLETED|Washout Period||2
8288094|NCT01632579|20433882|P5|COMPLETED|Washout Period||6
8288095|NCT01632579|20433883|P4|COMPLETED|Washout Period||2
8288096|NCT01632579|20433884|P3|COMPLETED|Washout Period||2
8288097|NCT01632579|20433885|P2|COMPLETED|Washout Period||6
8288098|NCT01632579|20433886|P1|COMPLETED|Washout Period||1
8288099|NCT01632579|20433878|P9|STARTED|Washout Period||2
8288100|NCT01632579|20433879|P8|STARTED|Washout Period||6
8288101|NCT01632579|20433880|P7|STARTED|Washout Period||2
8288102|NCT01632579|20433881|P6|STARTED|Washout Period||2
8288103|NCT01632579|20433882|P5|STARTED|Washout Period||6
8288104|NCT01632579|20433883|P4|STARTED|Washout Period||2
8288105|NCT01632579|20433884|P3|STARTED|Washout Period||2
8288106|NCT01632579|20433885|P2|STARTED|Washout Period||6
8288107|NCT01632579|20433886|P1|STARTED|Washout Period||2
8288108|NCT01632579|20433878|P9|NOT COMPLETED|Period 1 (First Intervention)||0
8288109|NCT01632579|20433879|P8|NOT COMPLETED|Period 1 (First Intervention)||0
8288110|NCT01632579|20433880|P7|NOT COMPLETED|Period 1 (First Intervention)||0
8288111|NCT01632579|20433881|P6|NOT COMPLETED|Period 1 (First Intervention)||0
8288112|NCT01632579|20433882|P5|NOT COMPLETED|Period 1 (First Intervention)||0
8288113|NCT01632579|20433883|P4|NOT COMPLETED|Period 1 (First Intervention)||0
8288114|NCT01632579|20433884|P3|NOT COMPLETED|Period 1 (First Intervention)||0
8288115|NCT01632579|20433885|P2|NOT COMPLETED|Period 1 (First Intervention)||0
8288116|NCT01632579|20433886|P1|NOT COMPLETED|Period 1 (First Intervention)||0
8288117|NCT01632579|20433878|P9|COMPLETED|Period 1 (First Intervention)||2
8288118|NCT01632579|20433879|P8|COMPLETED|Period 1 (First Intervention)||6
8288119|NCT01632579|20433880|P7|COMPLETED|Period 1 (First Intervention)||2
8288120|NCT01632579|20433881|P6|COMPLETED|Period 1 (First Intervention)||2
8288121|NCT01632579|20433882|P5|COMPLETED|Period 1 (First Intervention)||6
8288122|NCT01632579|20433883|P4|COMPLETED|Period 1 (First Intervention)||2
8288123|NCT01632579|20433884|P3|COMPLETED|Period 1 (First Intervention)||2
8288124|NCT01632579|20433885|P2|COMPLETED|Period 1 (First Intervention)||6
8288125|NCT01632579|20433886|P1|COMPLETED|Period 1 (First Intervention)||2
8288126|NCT01632579|20433878|P9|Received at Least 1 Dose|Period 1 (First Intervention)||2
8288127|NCT01632579|20433879|P8|Received at Least 1 Dose|Period 1 (First Intervention)||6
8288128|NCT01632579|20433880|P7|Received at Least 1 Dose|Period 1 (First Intervention)||2
8288129|NCT01632579|20433881|P6|Received at Least 1 Dose|Period 1 (First Intervention)||2
8288130|NCT01632579|20433882|P5|Received at Least 1 Dose|Period 1 (First Intervention)||6
8288131|NCT01632579|20433883|P4|Received at Least 1 Dose|Period 1 (First Intervention)||2
8288132|NCT01632579|20433884|P3|Received at Least 1 Dose|Period 1 (First Intervention)||2
8288133|NCT01632579|20433885|P2|Received at Least 1 Dose|Period 1 (First Intervention)||6
8288134|NCT01632579|20433886|P1|Received at Least 1 Dose|Period 1 (First Intervention)||2
8288135|NCT01632579|20433878|P9|STARTED|Period 1 (First Intervention)||2
8288136|NCT01632579|20433879|P8|STARTED|Period 1 (First Intervention)||6
8288137|NCT01632579|20433880|P7|STARTED|Period 1 (First Intervention)||2
8288138|NCT01632579|20433881|P6|STARTED|Period 1 (First Intervention)||2
8288139|NCT01632579|20433882|P5|STARTED|Period 1 (First Intervention)||6
8288140|NCT01632579|20433883|P4|STARTED|Period 1 (First Intervention)||2
8288141|NCT01632579|20433884|P3|STARTED|Period 1 (First Intervention)||2
8288142|NCT01632579|20433885|P2|STARTED|Period 1 (First Intervention)||6
8288143|NCT01632579|20433886|P1|STARTED|Period 1 (First Intervention)||2
8288144|NCT01632566|20433953|P5|NOT COMPLETED|Overall Study||2
8288145|NCT01632566|20433954|P4|NOT COMPLETED|Overall Study||2
8288146|NCT01632566|20433955|P3|NOT COMPLETED|Overall Study||9
8288147|NCT01632566|20433956|P2|NOT COMPLETED|Overall Study||3
8288148|NCT01632566|20433957|P1|NOT COMPLETED|Overall Study||0
8288149|NCT01632566|20433953|P5|COMPLETED|Overall Study||4
8288150|NCT01632566|20433954|P4|COMPLETED|Overall Study||4
8288151|NCT01632566|20433955|P3|COMPLETED|Overall Study||0
8288152|NCT01632566|20433956|P2|COMPLETED|Overall Study||7
8288153|NCT01632566|20433957|P1|COMPLETED|Overall Study||8
8288154|NCT01632566|20433953|P5|Received at Least One Dose Simvastatin|Overall Study||4
8288155|NCT01632566|20433954|P4|Received at Least One Dose Simvastatin|Overall Study||4
8288156|NCT01632566|20433955|P3|Received at Least One Dose Simvastatin|Overall Study||9
8288157|NCT01632566|20433956|P2|Received at Least One Dose Simvastatin|Overall Study||10
8288158|NCT01632566|20433957|P1|Received at Least One Dose Simvastatin|Overall Study||0
8288159|NCT01632566|20433953|P5|Received at Least One Dose LY3031207|Overall Study||0
8288160|NCT01632566|20433954|P4|Received at Least One Dose LY3031207|Overall Study||0
8288161|NCT01632566|20433955|P3|Received at Least One Dose LY3031207|Overall Study||9
8288162|NCT01632566|20433956|P2|Received at Least One Dose LY3031207|Overall Study||10
8288163|NCT01632566|20433957|P1|Received at Least One Dose LY3031207|Overall Study||8
8288164|NCT01632566|20433953|P5|STARTED|Overall Study||6
8288165|NCT01632566|20433954|P4|STARTED|Overall Study||6
8288166|NCT01632566|20433955|P3|STARTED|Overall Study||9
8288167|NCT01632566|20433956|P2|STARTED|Overall Study||10
8288168|NCT01632566|20433957|P1|STARTED|Overall Study||8
8288169|NCT01632423|20433995|P1|NOT COMPLETED|Overall Study||246
8288170|NCT01632423|20433995|P1|COMPLETED|Overall Study||10091
8288171|NCT01632423|20433995|P1|STARTED|Overall Study||10337
8288172|NCT01632345|20434008|P7|NOT COMPLETED|Treatment: Part II||11
8288173|NCT01632345|20434009|P6|NOT COMPLETED|Treatment: Part II||11
8288174|NCT01632345|20434010|P5|NOT COMPLETED|Treatment: Part II||0
8288175|NCT01632345|20434011|P4|NOT COMPLETED|Treatment: Part II||0
8288176|NCT01632345|20434012|P3|NOT COMPLETED|Treatment: Part II||0
8288177|NCT01632345|20434013|P2|NOT COMPLETED|Treatment: Part II||0
8288178|NCT01632345|20434014|P1|NOT COMPLETED|Treatment: Part II||0
8288179|NCT01632345|20434008|P7|COMPLETED|Treatment: Part II||55
8288180|NCT01632345|20434009|P6|COMPLETED|Treatment: Part II||55
8288181|NCT01632345|20434010|P5|COMPLETED|Treatment: Part II||0
8288182|NCT01632345|20434011|P4|COMPLETED|Treatment: Part II||0
8288183|NCT01632345|20434012|P3|COMPLETED|Treatment: Part II||0
8288184|NCT01632345|20434013|P2|COMPLETED|Treatment: Part II||0
8288185|NCT01632345|20434014|P1|COMPLETED|Treatment: Part II||0
8288186|NCT01632345|20434008|P7|Treated|Treatment: Part II||66
8288187|NCT01632345|20434009|P6|Treated|Treatment: Part II||66
8288188|NCT01632345|20434010|P5|Treated|Treatment: Part II||0
8288189|NCT01632345|20434011|P4|Treated|Treatment: Part II||0
8288190|NCT01632345|20434012|P3|Treated|Treatment: Part II||0
8288191|NCT01632345|20434013|P2|Treated|Treatment: Part II||0
8288192|NCT01632345|20434014|P1|Treated|Treatment: Part II||0
8288193|NCT01632345|20434008|P7|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
8288194|NCT01632345|20434009|P6|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
8288195|NCT01632345|20434010|P5|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8288196|NCT01632345|20434011|P4|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8288197|NCT01632345|20434012|P3|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8288198|NCT01632345|20434013|P2|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8288199|NCT01632345|20434014|P1|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
8288200|NCT01632345|20434008|P7|NOT COMPLETED|Treatment: Part I||0
8288201|NCT01632345|20434009|P6|NOT COMPLETED|Treatment: Part I||0
8288202|NCT01632345|20434010|P5|NOT COMPLETED|Treatment: Part I||13
8288203|NCT01632345|20434011|P4|NOT COMPLETED|Treatment: Part I||8
8288204|NCT01632345|20434012|P3|NOT COMPLETED|Treatment: Part I||10
8288205|NCT01632345|20434013|P2|NOT COMPLETED|Treatment: Part I||15
8288206|NCT01632345|20434014|P1|NOT COMPLETED|Treatment: Part I||12
8288207|NCT01632345|20434008|P7|COMPLETED|Treatment: Part I||0
8288208|NCT01632345|20434009|P6|COMPLETED|Treatment: Part I||0
8288209|NCT01632345|20434010|P5|COMPLETED|Treatment: Part I||30
8288210|NCT01632345|20434011|P4|COMPLETED|Treatment: Part I||33
8288211|NCT01632345|20434012|P3|COMPLETED|Treatment: Part I||32
8288212|NCT01632345|20434013|P2|COMPLETED|Treatment: Part I||28
8288213|NCT01632345|20434014|P1|COMPLETED|Treatment: Part I||29
8288214|NCT01632345|20434008|P7|Treated|Treatment: Part I||0
8288215|NCT01632345|20434009|P6|Treated|Treatment: Part I||0
8288216|NCT01632345|20434010|P5|Treated|Treatment: Part I||43
8288217|NCT01632345|20434011|P4|Treated|Treatment: Part I||41
8288218|NCT01632345|20434012|P3|Treated|Treatment: Part I||42
8288219|NCT01632345|20434013|P2|Treated|Treatment: Part I||43
8288220|NCT01632345|20434014|P1|Treated|Treatment: Part I||40
8288221|NCT01632345|20434008|P7|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
8288222|NCT01632345|20434009|P6|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
8288223|NCT01632345|20434010|P5|STARTED|Treatment: Part I||43
8288224|NCT01632345|20434011|P4|STARTED|Treatment: Part I||41
8288225|NCT01632345|20434012|P3|STARTED|Treatment: Part I||42
8288226|NCT01632345|20434013|P2|STARTED|Treatment: Part I||43
8288227|NCT01632345|20434014|P1|STARTED|Treatment: Part I||41
8288228|NCT01632345|20434008|P7|NOT COMPLETED|Randomized Participants||0
8288229|NCT01632345|20434009|P6|NOT COMPLETED|Randomized Participants||0
8288230|NCT01632345|20434010|P5|NOT COMPLETED|Randomized Participants||0
8288231|NCT01632345|20434011|P4|NOT COMPLETED|Randomized Participants||0
8288232|NCT01632345|20434012|P3|NOT COMPLETED|Randomized Participants||0
8288233|NCT01632345|20434013|P2|NOT COMPLETED|Randomized Participants||0
8288234|NCT01632345|20434014|P1|NOT COMPLETED|Randomized Participants||0
8288235|NCT01632345|20434008|P7|COMPLETED|Randomized Participants||66
8288236|NCT01632345|20434009|P6|COMPLETED|Randomized Participants||66
8288237|NCT01632345|20434010|P5|COMPLETED|Randomized Participants||43
8288238|NCT01632345|20434011|P4|COMPLETED|Randomized Participants||41
8288239|NCT01632345|20434012|P3|COMPLETED|Randomized Participants||42
8288240|NCT01632345|20434013|P2|COMPLETED|Randomized Participants||43
8288241|NCT01632345|20434014|P1|COMPLETED|Randomized Participants||41
8288242|NCT01632345|20434008|P7|STARTED|Randomized Participants||66
8288243|NCT01632345|20434009|P6|STARTED|Randomized Participants||66
8288244|NCT01632345|20434010|P5|STARTED|Randomized Participants||43
8288245|NCT01632345|20434011|P4|STARTED|Randomized Participants||41
8288246|NCT01632345|20434012|P3|STARTED|Randomized Participants||42
8288247|NCT01632345|20434013|P2|STARTED|Randomized Participants||43
8288248|NCT01632345|20434014|P1|STARTED|Randomized Participants||41
8288249|NCT01632306|20434076|P3|NOT COMPLETED|Overall Study||0
8288250|NCT01632306|20434077|P2|NOT COMPLETED|Overall Study||0
8288251|NCT01632306|20434078|P1|NOT COMPLETED|Overall Study||1
8288252|NCT01632306|20434076|P3|COMPLETED|Overall Study||0
8288253|NCT01632306|20434077|P2|COMPLETED|Overall Study||10
8288254|NCT01632306|20434078|P1|COMPLETED|Overall Study||2
8288255|NCT01632306|20434076|P3|Received at Least One Dose of Study Drug|Overall Study||0
8288256|NCT01632306|20434077|P2|Received at Least One Dose of Study Drug|Overall Study||10
8288257|NCT01632306|20434078|P1|Received at Least One Dose of Study Drug|Overall Study||3
8288258|NCT01632306|20434076|P3|STARTED|Overall Study||0
8288259|NCT01632306|20434077|P2|STARTED|Overall Study||10
8288260|NCT01632306|20434078|P1|STARTED|Overall Study||3
8288261|NCT01632280|20434094|P2|NOT COMPLETED|Overall Study||0
8288262|NCT01632280|20434095|P1|NOT COMPLETED|Overall Study||1
8288263|NCT01632280|20434094|P2|COMPLETED|Overall Study||6
8288264|NCT01632280|20434095|P1|COMPLETED|Overall Study||5
8288265|NCT01632280|20434094|P2|STARTED|Overall Study||6
8288266|NCT01632280|20434095|P1|STARTED|Overall Study||6
8288267|NCT01632267|20434105|P1|NOT COMPLETED|Overall Study||7
8288268|NCT01632267|20434105|P1|COMPLETED|Overall Study||97
8288269|NCT01632267|20434105|P1|STARTED|Overall Study||104
8288270|NCT01632241|20434111|P2|NOT COMPLETED|Open-label (Week 52 to Week 76)||22
8288271|NCT01632241|20434112|P1|NOT COMPLETED|Open-label (Week 52 to Week 76)||10
8288272|NCT01632241|20434111|P2|COMPLETED|Open-label (Week 52 to Week 76)||220
8288273|NCT01632241|20434112|P1|COMPLETED|Open-label (Week 52 to Week 76)||107
8288274|NCT01632241|20434111|P2|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|242
8288275|NCT01632241|20434112|P1|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|117
8288276|NCT01632241|20434111|P2|NOT COMPLETED|Double-blinded (Up to Week 52)||79
8288277|NCT01632241|20434112|P1|NOT COMPLETED|Double-blinded (Up to Week 52)||44
8288278|NCT01632241|20434111|P2|COMPLETED|Double-blinded (Up to Week 52)||252
8288279|NCT01632241|20434112|P1|COMPLETED|Double-blinded (Up to Week 52)||121
8288280|NCT01632241|20434111|P2|STARTED|Double-blinded (Up to Week 52)||331
8288281|NCT01632241|20434112|P1|STARTED|Double-blinded (Up to Week 52)||165
8288282|NCT01632215|20434162|P2|NOT COMPLETED|Overall Study||1
8288283|NCT01632215|20434163|P1|NOT COMPLETED|Overall Study||2
8288284|NCT01632215|20434162|P2|COMPLETED|Overall Study||19
8288285|NCT01632215|20434163|P1|COMPLETED|Overall Study||18
8288286|NCT01632215|20434162|P2|STARTED|Overall Study||20
8288287|NCT01632215|20434163|P1|STARTED|Overall Study||20
8288288|NCT01632202|20434173|P2|NOT COMPLETED|Overall Study||0
8288289|NCT01632202|20434174|P1|NOT COMPLETED|Overall Study||0
8288290|NCT01632202|20434173|P2|COMPLETED|Overall Study||7
8288291|NCT01632202|20434174|P1|COMPLETED|Overall Study||1
8288292|NCT01632202|20434173|P2|STARTED|Overall Study||7
8288293|NCT01632202|20434174|P1|STARTED|Overall Study||1
8288294|NCT01632150|20434182|P1|NOT COMPLETED|Overall Study||40
8288295|NCT01632150|20434182|P1|COMPLETED|Overall Study|Completed=still receiving treatment|0
8288296|NCT01632150|20434182|P1|Received Cyclophosphamide|Overall Study||11
8288297|NCT01632150|20434182|P1|STARTED|Overall Study||40
8288298|NCT01632020|20434191|P2|NOT COMPLETED|Overall Study||0
8288299|NCT01632020|20434192|P1|NOT COMPLETED|Overall Study||2
8288300|NCT01632020|20434191|P2|COMPLETED|Overall Study||3
8288301|NCT01632020|20434192|P1|COMPLETED|Overall Study||2
8288302|NCT01632020|20434191|P2|STARTED|Overall Study||3
8288303|NCT01632020|20434192|P1|STARTED|Overall Study||4
8288304|NCT01631929|20434202|P2|NOT COMPLETED|Overall Study||0
8288305|NCT01631929|20434203|P1|NOT COMPLETED|Overall Study||0
8288306|NCT01631929|20434202|P2|COMPLETED|Overall Study||6
8288307|NCT01631929|20434203|P1|COMPLETED|Overall Study||6
8288308|NCT01631929|20434202|P2|STARTED|Overall Study||6
8288309|NCT01631929|20434203|P1|STARTED|Overall Study||6
8288310|NCT01631864|20434211|P2|NOT COMPLETED|Overall Study||4
8288311|NCT01631864|20434212|P1|NOT COMPLETED|Overall Study||2
8288312|NCT01631864|20434211|P2|COMPLETED|Overall Study||44
8288313|NCT01631864|20434212|P1|COMPLETED|Overall Study||48
8288314|NCT01631864|20434211|P2|STARTED|Overall Study||48
8288315|NCT01631864|20434212|P1|STARTED|Overall Study||50
8288316|NCT01631825|20434224|P1|NOT COMPLETED|Overall Study||65
8288317|NCT01631825|20434224|P1|COMPLETED|Overall Study||256
8288318|NCT01631825|20434224|P1|STARTED|Overall Study||321
8288319|NCT01631812|20434244|P1|NOT COMPLETED|Overall Study||37
8288320|NCT01631812|20434244|P1|COMPLETED|Overall Study||93
8288321|NCT01631812|20434244|P1|STARTED|Overall Study||130
8288322|NCT01631747|20434254|P2|NOT COMPLETED|One Year Infant Outcomes||9
8288323|NCT01631747|20434255|P1|NOT COMPLETED|One Year Infant Outcomes||13
8288324|NCT01631747|20434254|P2|COMPLETED|One Year Infant Outcomes||130
8288325|NCT01631747|20434255|P1|COMPLETED|One Year Infant Outcomes||123
8288326|NCT01631747|20434254|P2|STARTED|One Year Infant Outcomes||139
8288327|NCT01631747|20434255|P1|STARTED|One Year Infant Outcomes||136
8288328|NCT01631747|20434254|P2|NOT COMPLETED|Live Birth||1
8288329|NCT01631747|20434255|P1|NOT COMPLETED|Live Birth||4
8288330|NCT01631747|20434254|P2|COMPLETED|Live Birth||139
8288331|NCT01631747|20434255|P1|COMPLETED|Live Birth||136
8288332|NCT01631747|20434254|P2|STARTED|Live Birth||140
8288333|NCT01631747|20434255|P1|STARTED|Live Birth||140
8288334|NCT01631747|20434254|P2|NOT COMPLETED|Randomization Through End of Pregnancy||0
8288335|NCT01631747|20434255|P1|NOT COMPLETED|Randomization Through End of Pregnancy||1
8288336|NCT01631747|20434254|P2|COMPLETED|Randomization Through End of Pregnancy||140
8288337|NCT01631747|20434255|P1|COMPLETED|Randomization Through End of Pregnancy||140
8288338|NCT01631747|20434254|P2|STARTED|Randomization Through End of Pregnancy||140
8288339|NCT01631747|20434255|P1|STARTED|Randomization Through End of Pregnancy||141
8288340|NCT01631682|20434297|P4|NOT COMPLETED|Overall Study||2
8288341|NCT01631682|20434298|P3|NOT COMPLETED|Overall Study||31
8288342|NCT01631682|20434299|P2|NOT COMPLETED|Overall Study||45
8288343|NCT01631682|20434300|P1|NOT COMPLETED|Overall Study||31
8288344|NCT01631682|20434297|P4|COMPLETED|Overall Study||5
8288345|NCT01631682|20434298|P3|COMPLETED|Overall Study||13
8288346|NCT01631682|20434299|P2|COMPLETED|Overall Study||21
8288347|NCT01631682|20434300|P1|COMPLETED|Overall Study||24
8288348|NCT01631682|20434297|P4|STARTED|Overall Study||7
8288349|NCT01631682|20434298|P3|STARTED|Overall Study||44
8288350|NCT01631682|20434299|P2|STARTED|Overall Study||66
8288351|NCT01631682|20434300|P1|STARTED|Overall Study||55
8288352|NCT01631656|20434312|P2|NOT COMPLETED|Overall Study||0
8288353|NCT01631656|20434313|P1|NOT COMPLETED|Overall Study||0
8288354|NCT01631656|20434312|P2|COMPLETED|Overall Study||5
8288355|NCT01631656|20434313|P1|COMPLETED|Overall Study||5
8288356|NCT01631656|20434312|P2|STARTED|Overall Study||5
8288357|NCT01631656|20434313|P1|STARTED|Overall Study||5
8288358|NCT01631630|20434321|P2|NOT COMPLETED|Overall Study||0
8288359|NCT01631630|20434322|P1|NOT COMPLETED|Overall Study||3
8288360|NCT01631630|20434321|P2|COMPLETED|Overall Study||8
8288361|NCT01631630|20434322|P1|COMPLETED|Overall Study||5
8288362|NCT01631630|20434321|P2|STARTED|Overall Study||8
8288363|NCT01631630|20434322|P1|STARTED|Overall Study||8
8288364|NCT01631474|20434437|P5|NOT COMPLETED|Overall Study||13
8288365|NCT01631474|20434438|P4|NOT COMPLETED|Overall Study||11
8288366|NCT01631474|20434439|P3|NOT COMPLETED|Overall Study||9
8288367|NCT01631474|20434440|P2|NOT COMPLETED|Overall Study||12
8288368|NCT01631474|20434441|P1|NOT COMPLETED|Overall Study||14
8288369|NCT01631474|20434437|P5|COMPLETED|Overall Study||62
8288370|NCT01631474|20434438|P4|COMPLETED|Overall Study||59
8288371|NCT01631474|20434439|P3|COMPLETED|Overall Study||61
8288372|NCT01631474|20434440|P2|COMPLETED|Overall Study||64
8288373|NCT01631474|20434441|P1|COMPLETED|Overall Study||58
8288374|NCT01631474|20434437|P5|STARTED|Overall Study||75
8288375|NCT01631474|20434438|P4|STARTED|Overall Study||70
8288376|NCT01631474|20434439|P3|STARTED|Overall Study||70
8288377|NCT01631474|20434440|P2|STARTED|Overall Study||76
8288378|NCT01631474|20434441|P1|STARTED|Overall Study||72
8288379|NCT01631435|20434478|P1|NOT COMPLETED|Overall Study||9
8288380|NCT01631435|20434478|P1|COMPLETED|Overall Study||66
8288381|NCT01631435|20434478|P1|STARTED|Overall Study||75
8288382|NCT01631331|20434483|P1|NOT COMPLETED|Overall Study||4
8288383|NCT01631331|20434483|P1|COMPLETED|Overall Study||11
8288384|NCT01631331|20434483|P1|STARTED|Overall Study||15
8288385|NCT01631227|20434492|P2|NOT COMPLETED|Overall Study||22
8288386|NCT01631227|20434493|P1|NOT COMPLETED|Overall Study||30
8288387|NCT01631227|20434492|P2|COMPLETED|Overall Study||310
8288388|NCT01631227|20434493|P1|COMPLETED|Overall Study||303
8288389|NCT01631227|20434492|P2|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
8288390|NCT01631227|20434493|P1|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
8288391|NCT01631227|20434492|P2|Safety Subject Sample|Overall Study||332
8288392|NCT01631227|20434493|P1|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
8288393|NCT01631227|20434492|P2|STARTED|Overall Study||332
8288394|NCT01631227|20434493|P1|STARTED|Overall Study||333
8288395|NCT01631214|20434501|P2|NOT COMPLETED|Overall Study||523
8288396|NCT01631214|20434502|P1|NOT COMPLETED|Overall Study||544
8288397|NCT01631214|20434501|P2|COMPLETED|Overall Study||1523
8288398|NCT01631214|20434502|P1|COMPLETED|Overall Study||1503
8288399|NCT01631214|20434501|P2|Completed Primary Analysis Period|Overall Study||1574
8288400|NCT01631214|20434502|P1|Completed Primary Analysis Period|Overall Study||1576
8288401|NCT01631214|20434501|P2|Completed Double-blind Period|Overall Study||1831
8288402|NCT01631214|20434502|P1|Completed Double-blind Period|Overall Study||1823
8288403|NCT01631214|20434501|P2|Received Double-blind Treatment|Overall Study||2038
8288404|NCT01631214|20434502|P1|Received Double-blind Treatment|Overall Study||2040
8288405|NCT01631214|20434501|P2|STARTED|Overall Study||2046
8288406|NCT01631214|20434502|P1|STARTED|Overall Study||2047
8288407|NCT01631149|20434566|P2|NOT COMPLETED|Overall Study||0
8288408|NCT01631149|20434567|P1|NOT COMPLETED|Overall Study||0
8288409|NCT01631149|20434566|P2|COMPLETED|Overall Study||12
8288410|NCT01631149|20434567|P1|COMPLETED|Overall Study||12
8288411|NCT01631149|20434566|P2|STARTED|Overall Study||12
8288412|NCT01631149|20434567|P1|STARTED|Overall Study||12
8288413|NCT01631110|20434583|P2|NOT COMPLETED|Overall Study||0
8288414|NCT01631110|20434584|P1|NOT COMPLETED|Overall Study||0
8288415|NCT01631110|20434583|P2|COMPLETED|Overall Study||55
8288416|NCT01631110|20434584|P1|COMPLETED|Overall Study||55
8288417|NCT01631110|20434583|P2|STARTED|Overall Study||55
8288418|NCT01631110|20434584|P1|STARTED|Overall Study||55
8288419|NCT01631071|20434598|P2|NOT COMPLETED|Overall Study||0
8288420|NCT01631071|20434599|P1|NOT COMPLETED|Overall Study||0
8288421|NCT01631071|20434598|P2|COMPLETED|Overall Study||55
8288422|NCT01631071|20434599|P1|COMPLETED|Overall Study||55
8288423|NCT01631071|20434598|P2|STARTED|Overall Study||55
8288424|NCT01631071|20434599|P1|STARTED|Overall Study||55
8288425|NCT01630811|20434611|P2|NOT COMPLETED|Second Washout (4 Weeks)||0
8288426|NCT01630811|20434612|P1|NOT COMPLETED|Second Washout (4 Weeks)||0
8288427|NCT01630811|20434611|P2|COMPLETED|Second Washout (4 Weeks)||6
8288428|NCT01630811|20434612|P1|COMPLETED|Second Washout (4 Weeks)||6
8288429|NCT01630811|20434611|P2|STARTED|Second Washout (4 Weeks)||6
8288430|NCT01630811|20434612|P1|STARTED|Second Washout (4 Weeks)||6
8288431|NCT01630811|20434611|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
8288432|NCT01630811|20434612|P1|NOT COMPLETED|Second Intervention (8 Weeks)||1
8288433|NCT01630811|20434611|P2|COMPLETED|Second Intervention (8 Weeks)||6
8288434|NCT01630811|20434612|P1|COMPLETED|Second Intervention (8 Weeks)||6
8288435|NCT01630811|20434611|P2|STARTED|Second Intervention (8 Weeks)||6
8288436|NCT01630811|20434612|P1|STARTED|Second Intervention (8 Weeks)||7
8288437|NCT01630811|20434611|P2|NOT COMPLETED|Washout (4 Weeks)||0
8288438|NCT01630811|20434612|P1|NOT COMPLETED|Washout (4 Weeks)||0
8288439|NCT01630811|20434611|P2|COMPLETED|Washout (4 Weeks)||6
8288440|NCT01630811|20434612|P1|COMPLETED|Washout (4 Weeks)||7
8288441|NCT01630811|20434611|P2|STARTED|Washout (4 Weeks)||6
8288442|NCT01630811|20434612|P1|STARTED|Washout (4 Weeks)||7
8288443|NCT01630811|20434611|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
8288444|NCT01630811|20434612|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
8288445|NCT01630811|20434611|P2|COMPLETED|First Intervention (8 Weeks)||6
8288446|NCT01630811|20434612|P1|COMPLETED|First Intervention (8 Weeks)||7
8288447|NCT01630811|20434611|P2|STARTED|First Intervention (8 Weeks)||6
8288448|NCT01630811|20434612|P1|STARTED|First Intervention (8 Weeks)||7
8288449|NCT01630694|20434624|P2|NOT COMPLETED|Overall Study||0
8288450|NCT01630694|20434625|P1|NOT COMPLETED|Overall Study||0
8288451|NCT01630694|20434624|P2|COMPLETED|Overall Study||16
8288452|NCT01630694|20434625|P1|COMPLETED|Overall Study||12
8288453|NCT01630694|20434624|P2|STARTED|Overall Study||16
8288454|NCT01630694|20434625|P1|STARTED|Overall Study||12
8288455|NCT01630616|20434639|P6|NOT COMPLETED|Overall Study||0
8288456|NCT01630616|20434640|P5|NOT COMPLETED|Overall Study||0
8288457|NCT01630616|20434641|P4|NOT COMPLETED|Overall Study||3
8288458|NCT01630616|20434642|P3|NOT COMPLETED|Overall Study||0
8288459|NCT01630616|20434643|P2|NOT COMPLETED|Overall Study||0
8288460|NCT01630616|20434644|P1|NOT COMPLETED|Overall Study||0
8288461|NCT01630616|20434639|P6|COMPLETED|Overall Study||2
8288462|NCT01630616|20434640|P5|COMPLETED|Overall Study||6
8288463|NCT01630616|20434641|P4|COMPLETED|Overall Study||9
8288464|NCT01630616|20434642|P3|COMPLETED|Overall Study||3
8288465|NCT01630616|20434643|P2|COMPLETED|Overall Study||3
8288466|NCT01630616|20434644|P1|COMPLETED|Overall Study||5
8288467|NCT01630616|20434639|P6|STARTED|Overall Study||2
8288468|NCT01630616|20434640|P5|STARTED|Overall Study||6
8288469|NCT01630616|20434641|P4|STARTED|Overall Study||12
8288470|NCT01630616|20434642|P3|STARTED|Overall Study||3
8288471|NCT01630616|20434643|P2|STARTED|Overall Study||3
8288472|NCT01630616|20434644|P1|STARTED|Overall Study||5
8288473|NCT01630200|20434719|P2|NOT COMPLETED|Overall Study||6
8288474|NCT01630200|20434720|P1|NOT COMPLETED|Overall Study||7
8288475|NCT01630200|20434719|P2|COMPLETED|Overall Study||34
8288476|NCT01630200|20434720|P1|COMPLETED|Overall Study||33
8288477|NCT01630200|20434719|P2|STARTED|Overall Study||40
8288478|NCT01630200|20434720|P1|STARTED|Overall Study||40
8288479|NCT01630135|20434744|P2|NOT COMPLETED|Overall Study||2
8288480|NCT01630135|20434745|P1|NOT COMPLETED|Overall Study||0
8288481|NCT01630135|20434744|P2|COMPLETED|Overall Study||128
8288482|NCT01630135|20434745|P1|COMPLETED|Overall Study||131
8288483|NCT01630135|20434744|P2|STARTED|Overall Study||130
8288484|NCT01630135|20434745|P1|STARTED|Overall Study||131
8288485|NCT01630109|20434784|P3|NOT COMPLETED|Overall Study||0
8288486|NCT01630109|20434785|P2|NOT COMPLETED|Overall Study||0
8288487|NCT01630109|20434786|P1|NOT COMPLETED|Overall Study||0
8288488|NCT01630109|20434784|P3|COMPLETED|Overall Study||3
8288489|NCT01630109|20434785|P2|COMPLETED|Overall Study||1
8288490|NCT01630109|20434786|P1|COMPLETED|Overall Study||1
8288491|NCT01630109|20434784|P3|STARTED|Overall Study||3
8288492|NCT01630109|20434785|P2|STARTED|Overall Study||1
8288493|NCT01630109|20434786|P1|STARTED|Overall Study||1
8288494|NCT01629966|20434809|P3|NOT COMPLETED|Overall Study||66
8288495|NCT01629966|20434810|P2|NOT COMPLETED|Overall Study||52
8288496|NCT01629966|20434811|P1|NOT COMPLETED|Overall Study||41
8288497|NCT01629966|20434809|P3|COMPLETED|Overall Study||159
8288498|NCT01629966|20434810|P2|COMPLETED|Overall Study||175
8288499|NCT01629966|20434811|P1|COMPLETED|Overall Study||180
8288500|NCT01629966|20434809|P3|STARTED|Overall Study||225
8288501|NCT01629966|20434810|P2|STARTED|Overall Study||227
8288502|NCT01629966|20434811|P1|STARTED|Overall Study||221
8288503|NCT01629953|20434824|P2|NOT COMPLETED|Overall Study||15
8288504|NCT01629953|20434825|P1|NOT COMPLETED|Overall Study||13
8288505|NCT01629953|20434824|P2|COMPLETED|Overall Study||60
8288506|NCT01629953|20434825|P1|COMPLETED|Overall Study||52
8288507|NCT01629953|20434824|P2|STARTED|Overall Study||75
8288508|NCT01629953|20434825|P1|STARTED|Overall Study||65
8288509|NCT01629862|20434835|P2|NOT COMPLETED|Overall Study||2
8288510|NCT01629862|20434836|P1|NOT COMPLETED|Overall Study||2
8288511|NCT01629862|20434835|P2|COMPLETED|Overall Study||23
8288512|NCT01629862|20434836|P1|COMPLETED|Overall Study||26
8288513|NCT01629862|20434835|P2|STARTED|Overall Study||25
8288514|NCT01629862|20434836|P1|STARTED|Overall Study||28
8288515|NCT01629823|20434845|P3|NOT COMPLETED|Washout Period||0
8288516|NCT01629823|20434846|P2|NOT COMPLETED|Washout Period||6
8288517|NCT01629823|20434847|P1|NOT COMPLETED|Washout Period||3
8288518|NCT01629823|20434845|P3|COMPLETED|Washout Period||50
8288519|NCT01629823|20434846|P2|COMPLETED|Washout Period||51
8288520|NCT01629823|20434847|P1|COMPLETED|Washout Period||51
8288521|NCT01629823|20434845|P3|STARTED|Washout Period||50
8288522|NCT01629823|20434846|P2|STARTED|Washout Period||57
8288523|NCT01629823|20434847|P1|STARTED|Washout Period||54
8288524|NCT01629823|20434845|P3|NOT COMPLETED|Trial Period||10
8288525|NCT01629823|20434846|P2|NOT COMPLETED|Trial Period||13
8288526|NCT01629823|20434847|P1|NOT COMPLETED|Trial Period||13
8288527|NCT01629823|20434845|P3|COMPLETED|Trial Period||49
8288528|NCT01629823|20434846|P2|COMPLETED|Trial Period||56
8288529|NCT01629823|20434847|P1|COMPLETED|Trial Period||53
8288530|NCT01629823|20434845|P3|STARTED|Trial Period||59
8288531|NCT01629823|20434846|P2|STARTED|Trial Period||69
8288532|NCT01629823|20434847|P1|STARTED|Trial Period||66
8288533|NCT01629797|20434855|P1|NOT COMPLETED|Overall Study||18
8288534|NCT01629797|20434855|P1|COMPLETED|Overall Study||82
8288535|NCT01629797|20434855|P1|STARTED|Overall Study||100
8288536|NCT01629784|20434862|P1|NOT COMPLETED|Overall Study||6
8288537|NCT01629784|20434862|P1|COMPLETED|Overall Study||25
8288538|NCT01629784|20434862|P1|STARTED|Overall Study||31
8288539|NCT01629771|20434871|P2|NOT COMPLETED|Overall Study||0
8288540|NCT01629771|20434872|P1|NOT COMPLETED|Overall Study||0
8288541|NCT01629771|20434871|P2|COMPLETED|Overall Study||36
8288542|NCT01629771|20434872|P1|COMPLETED|Overall Study||36
8288543|NCT01629771|20434871|P2|STARTED|Overall Study||36
8288544|NCT01629771|20434872|P1|STARTED|Overall Study||36
8288545|NCT01629706|20434882|P1|NOT COMPLETED|Phase 2 Habitual||10
8288546|NCT01629706|20434882|P1|COMPLETED|Phase 2 Habitual||48
8288547|NCT01629706|20434882|P1|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
8288548|NCT01629706|20434882|P1|NOT COMPLETED|Phase 1 PureVision||9
8288549|NCT01629706|20434882|P1|COMPLETED|Phase 1 PureVision||35
8288550|NCT01629706|20434882|P1|STARTED|Phase 1 PureVision||44
8288551|NCT01629693|20434910|P2|NOT COMPLETED|Overall Study||10
8288552|NCT01629693|20434911|P1|NOT COMPLETED|Overall Study||5
8288553|NCT01629693|20434910|P2|COMPLETED|Overall Study||178
8288554|NCT01629693|20434911|P1|COMPLETED|Overall Study||188
8288555|NCT01629693|20434910|P2|STARTED|Overall Study||188
8288556|NCT01629693|20434911|P1|STARTED|Overall Study||193
8288557|NCT01629667|20434920|P3|NOT COMPLETED|Overall Study||45
8288558|NCT01629667|20434921|P2|NOT COMPLETED|Overall Study||41
8288559|NCT01629667|20434922|P1|NOT COMPLETED|Overall Study||47
8288560|NCT01629667|20434920|P3|COMPLETED|Overall Study||14
8288561|NCT01629667|20434921|P2|COMPLETED|Overall Study||17
8288562|NCT01629667|20434922|P1|COMPLETED|Overall Study||12
8288563|NCT01629667|20434920|P3|Randomized and Treated|Overall Study||59
8288564|NCT01629667|20434921|P2|Randomized and Treated|Overall Study||57
8288565|NCT01629667|20434922|P1|Randomized and Treated|Overall Study||57
8288566|NCT01629667|20434920|P3|STARTED|Overall Study||59
8288567|NCT01629667|20434921|P2|STARTED|Overall Study||58
8288568|NCT01629667|20434922|P1|STARTED|Overall Study||59
8288569|NCT01629615|20435004|P1|NOT COMPLETED|Overall Study||0
8288570|NCT01629615|20435004|P1|COMPLETED|Overall Study||50
8288571|NCT01629615|20435004|P1|STARTED|Overall Study||50
8288572|NCT01629589|20435013|P2|NOT COMPLETED|Overall Study||7
8288573|NCT01629589|20435014|P1|NOT COMPLETED|Overall Study||8
8288574|NCT01629589|20435013|P2|COMPLETED|Overall Study||204
8288575|NCT01629589|20435014|P1|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
8288576|NCT01629589|20435013|P2|STARTED|Overall Study||211
8288577|NCT01629589|20435014|P1|STARTED|Overall Study||212
8288578|NCT01629563|20435032|P2|NOT COMPLETED|Overall Study||53
8288579|NCT01629563|20435033|P1|NOT COMPLETED|Overall Study||61
8288580|NCT01629563|20435032|P2|COMPLETED|Overall Study||170
8288581|NCT01629563|20435033|P1|COMPLETED|Overall Study||167
8288582|NCT01629563|20435032|P2|Started Treatment Course 4|Overall Study||176
8288583|NCT01629563|20435033|P1|Started Treatment Course 4|Overall Study||178
8288584|NCT01629563|20435032|P2|Started Treatment Course 3|Overall Study||190
8288585|NCT01629563|20435033|P1|Started Treatment Course 3|Overall Study||191
8288586|NCT01629563|20435032|P2|Started Treatment Course 2|Overall Study||207
8288587|NCT01629563|20435033|P1|Started Treatment Course 2|Overall Study||213
8288588|NCT01629563|20435032|P2|Safety Population|Overall Study||221
8288589|NCT01629563|20435033|P1|Safety Population|Overall Study||230
8288590|NCT01629563|20435032|P2|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223
8288591|NCT01629563|20435033|P1|STARTED|Overall Study||228
8288592|NCT01629511|20435055|P4|NOT COMPLETED|Overall Study||0
8288593|NCT01629511|20435056|P3|NOT COMPLETED|Overall Study||0
8288594|NCT01629511|20435057|P2|NOT COMPLETED|Overall Study||0
8288595|NCT01629511|20435058|P1|NOT COMPLETED|Overall Study||0
8288596|NCT01629511|20435055|P4|COMPLETED|Overall Study||3
8288597|NCT01629511|20435056|P3|COMPLETED|Overall Study||8
8288598|NCT01629511|20435057|P2|COMPLETED|Overall Study||0
8288599|NCT01629511|20435058|P1|COMPLETED|Overall Study||4
8288600|NCT01629511|20435055|P4|STARTED|Overall Study||3
8288601|NCT01629511|20435056|P3|STARTED|Overall Study||8
8288602|NCT01629511|20435057|P2|STARTED|Overall Study||0
8288603|NCT01629511|20435058|P1|STARTED|Overall Study||4
8288604|NCT01629329|20435090|P2|NOT COMPLETED|Overall Study||0
8288605|NCT01629329|20435091|P1|NOT COMPLETED|Overall Study||0
8288606|NCT01629329|20435090|P2|COMPLETED|Overall Study||0
8288607|NCT01629329|20435091|P1|COMPLETED|Overall Study||0
8288608|NCT01629329|20435090|P2|STARTED|Overall Study||0
8288609|NCT01629329|20435091|P1|STARTED|Overall Study||0
8288610|NCT01629290|20435099|P1|NOT COMPLETED|Overall Study||0
8288611|NCT01629290|20435099|P1|COMPLETED|Overall Study||15
8288612|NCT01629290|20435099|P1|STARTED|Overall Study||15
8288613|NCT01629134|20435109|P1|NOT COMPLETED|Overall Study||0
8288614|NCT01629134|20435109|P1|COMPLETED|Overall Study||62
8288615|NCT01629134|20435109|P1|STARTED|Overall Study||62
8288616|NCT01628965|20435122|P1|NOT COMPLETED|Overall Study||49
8288617|NCT01628965|20435122|P1|COMPLETED|Overall Study||94
8288618|NCT01628965|20435122|P1|STARTED|Overall Study||143
8288619|NCT01628926|20435131|P3|NOT COMPLETED|Overall Study||17
8288620|NCT01628926|20435132|P2|NOT COMPLETED|Overall Study||23
8288621|NCT01628926|20435133|P1|NOT COMPLETED|Overall Study||26
8288622|NCT01628926|20435131|P3|COMPLETED|Overall Study||68
8288623|NCT01628926|20435132|P2|COMPLETED|Overall Study||144
8288624|NCT01628926|20435133|P1|COMPLETED|Overall Study||142
8288625|NCT01628926|20435131|P3|STARTED|Overall Study||85
8288626|NCT01628926|20435132|P2|STARTED|Overall Study||167
8288627|NCT01628926|20435133|P1|STARTED|Overall Study||168
8288628|NCT01628913|20435182|P2|NOT COMPLETED|Overall Study||31
8288629|NCT01628913|20435183|P1|NOT COMPLETED|Overall Study||31
8288630|NCT01628913|20435182|P2|COMPLETED|Overall Study||0
8288631|NCT01628913|20435183|P1|COMPLETED|Overall Study||0
8288632|NCT01628913|20435182|P2|STARTED|Overall Study||31
8288633|NCT01628913|20435183|P1|STARTED|Overall Study||31
8288634|NCT01628874|20435197|P2|NOT COMPLETED|Overall Study||3
8288635|NCT01628874|20435198|P1|NOT COMPLETED|Overall Study||5
8288636|NCT01628874|20435197|P2|COMPLETED|Overall Study||29
8288637|NCT01628874|20435198|P1|COMPLETED|Overall Study||29
8288638|NCT01628874|20435197|P2|STARTED|Overall Study||32
8288639|NCT01628874|20435198|P1|STARTED|Overall Study||34
8288640|NCT01628848|20435214|P2|NOT COMPLETED|Overall Study||14
8288641|NCT01628848|20435215|P1|NOT COMPLETED|Overall Study||12
8288642|NCT01628848|20435214|P2|COMPLETED|Overall Study||73
8288643|NCT01628848|20435215|P1|COMPLETED|Overall Study||75
8288644|NCT01628848|20435214|P2|STARTED|Overall Study||87
8288645|NCT01628848|20435215|P1|STARTED|Overall Study||87
8288646|NCT01628718|20435245|P2|NOT COMPLETED|Overall Study||25
8288647|NCT01628718|20435246|P1|NOT COMPLETED|Overall Study||27
8288648|NCT01628718|20435245|P2|COMPLETED|Overall Study||37
8288649|NCT01628718|20435246|P1|COMPLETED|Overall Study||33
8288650|NCT01628718|20435245|P2|STARTED|Overall Study||62
8288651|NCT01628718|20435246|P1|STARTED|Overall Study||60
8288652|NCT01628692|20435258|P6|NOT COMPLETED|Overall Study||9
8288653|NCT01628692|20435259|P5|NOT COMPLETED|Overall Study||4
8288654|NCT01628692|20435260|P4|NOT COMPLETED|Overall Study||1
8288655|NCT01628692|20435261|P3|NOT COMPLETED|Overall Study||8
8288656|NCT01628692|20435262|P2|NOT COMPLETED|Overall Study||6
8288657|NCT01628692|20435263|P1|NOT COMPLETED|Overall Study||7
8288658|NCT01628692|20435258|P6|COMPLETED|Overall Study||0
8288659|NCT01628692|20435259|P5|COMPLETED|Overall Study||8
8288660|NCT01628692|20435260|P4|COMPLETED|Overall Study||19
8288661|NCT01628692|20435261|P3|COMPLETED|Overall Study||43
8288662|NCT01628692|20435262|P2|COMPLETED|Overall Study||17
8288663|NCT01628692|20435263|P1|COMPLETED|Overall Study||46
8288664|NCT01628692|20435258|P6|STARTED|Overall Study||9
8288665|NCT01628692|20435259|P5|STARTED|Overall Study||12
8288666|NCT01628692|20435260|P4|STARTED|Overall Study||20
8288667|NCT01628692|20435261|P3|STARTED|Overall Study||51
8288668|NCT01628692|20435262|P2|STARTED|Overall Study||23
8288669|NCT01628692|20435263|P1|STARTED|Overall Study||53
8288670|NCT01628614|20435307|P1|NOT COMPLETED|Overall Study||1775
8288671|NCT01628614|20435307|P1|COMPLETED|Overall Study||3037
8288672|NCT01628614|20435307|P1|STARTED|Overall Study||4812
8288673|NCT01628601|20435313|P1|NOT COMPLETED|Overall Study||41
8288674|NCT01628601|20435313|P1|COMPLETED|Overall Study||351
8288675|NCT01628601|20435313|P1|STARTED|Overall Study||392
8288676|NCT01628588|20435321|P1|NOT COMPLETED|Overall Study||16
8288677|NCT01628588|20435321|P1|COMPLETED|Overall Study||838
8288678|NCT01628588|20435321|P1|STARTED|Overall Study||854
8288679|NCT01628549|20435333|P4|NOT COMPLETED|Overall Study||9
8288680|NCT01628549|20435334|P3|NOT COMPLETED|Overall Study||10
8288681|NCT01628549|20435335|P2|NOT COMPLETED|Overall Study||12
8288682|NCT01628549|20435336|P1|NOT COMPLETED|Overall Study||9
8288683|NCT01628549|20435333|P4|COMPLETED|Overall Study||57
8288684|NCT01628549|20435334|P3|COMPLETED|Overall Study||60
8288685|NCT01628549|20435335|P2|COMPLETED|Overall Study||64
8288686|NCT01628549|20435336|P1|COMPLETED|Overall Study||64
8288687|NCT01628549|20435333|P4|STARTED|Overall Study||66
8288688|NCT01628549|20435334|P3|STARTED|Overall Study||70
8288689|NCT01628549|20435335|P2|STARTED|Overall Study||76
8288690|NCT01628549|20435336|P1|STARTED|Overall Study||73
8288691|NCT01628523|20435370|P1|NOT COMPLETED|Overall Study||0
8288692|NCT01628523|20435370|P1|COMPLETED|Overall Study||219
8288693|NCT01628523|20435370|P1|STARTED|Overall Study||219
8288694|NCT01628510|20435377|P2|NOT COMPLETED|Overall Study||5
8288695|NCT01628510|20435378|P1|NOT COMPLETED|Overall Study||3
8288696|NCT01628510|20435377|P2|COMPLETED|Overall Study||44
8288697|NCT01628510|20435378|P1|COMPLETED|Overall Study||48
8288698|NCT01628510|20435377|P2|STARTED|Overall Study||49
8288699|NCT01628510|20435378|P1|STARTED|Overall Study||51
8288700|NCT01628367|20435388|P2|NOT COMPLETED|Overall Study||0
8288701|NCT01628367|20435389|P1|NOT COMPLETED|Overall Study||1
8288702|NCT01628367|20435388|P2|COMPLETED|Overall Study||16
8288703|NCT01628367|20435389|P1|COMPLETED|Overall Study||15
8288704|NCT01628367|20435388|P2|STARTED|Overall Study||16
8288705|NCT01628367|20435389|P1|STARTED|Overall Study||16
8288706|NCT01628250|20435401|P2|NOT COMPLETED|Overall Study||0
8288707|NCT01628250|20435402|P1|NOT COMPLETED|Overall Study||0
8288708|NCT01628250|20435401|P2|COMPLETED|Overall Study||50
8288709|NCT01628250|20435402|P1|COMPLETED|Overall Study||49
8288710|NCT01628250|20435401|P2|STARTED|Overall Study||50
8288711|NCT01628250|20435402|P1|STARTED|Overall Study||49
8288712|NCT01628198|20435408|P1|NOT COMPLETED|Overall Study||18
8288713|NCT01628198|20435408|P1|COMPLETED|Overall Study||20
8288714|NCT01628198|20435408|P1|STARTED|Overall Study||38
8288715|NCT01628159|20435421|P1|NOT COMPLETED|Overall Study||164
8288716|NCT01628159|20435421|P1|COMPLETED|Overall Study||493
8288717|NCT01628159|20435421|P1|STARTED|Overall Study||657
8288718|NCT01628120|20435435|P1|NOT COMPLETED|Overall Study||44
8288719|NCT01628120|20435435|P1|COMPLETED|Overall Study||129
8288720|NCT01628120|20435435|P1|Treated|Overall Study||170
8288721|NCT01628120|20435435|P1|STARTED|Overall Study||173
8288722|NCT01628107|20435460|P1|NOT COMPLETED|Overall Study||119
8288723|NCT01628107|20435460|P1|COMPLETED|Overall Study||295
8288724|NCT01628107|20435460|P1|Treated|Overall Study||406
8288725|NCT01628107|20435460|P1|STARTED|Overall Study||414
8288726|NCT01628042|20435489|P4|NOT COMPLETED|Overall Study||0
8288727|NCT01628042|20435490|P3|NOT COMPLETED|Overall Study||0
8288728|NCT01628042|20435491|P2|NOT COMPLETED|Overall Study||0
8288729|NCT01628042|20435492|P1|NOT COMPLETED|Overall Study||0
8288730|NCT01628042|20435489|P4|COMPLETED|Overall Study||8
8288731|NCT01628042|20435490|P3|COMPLETED|Overall Study||8
8288732|NCT01628042|20435491|P2|COMPLETED|Overall Study||8
8288733|NCT01628042|20435492|P1|COMPLETED|Overall Study||8
8288734|NCT01628042|20435489|P4|STARTED|Overall Study||8
8288735|NCT01628042|20435490|P3|STARTED|Overall Study||8
8288736|NCT01628042|20435491|P2|STARTED|Overall Study||8
8288737|NCT01628042|20435492|P1|STARTED|Overall Study||8
8288738|NCT01628016|20435513|P3|NOT COMPLETED|Posttraining to 5 Follow-ups||5
8288739|NCT01628016|20435514|P2|NOT COMPLETED|Posttraining to 5 Follow-ups||7
8288740|NCT01628016|20435515|P1|NOT COMPLETED|Posttraining to 5 Follow-ups||4
8288741|NCT01628016|20435513|P3|COMPLETED|Posttraining to 5 Follow-ups||18
8288742|NCT01628016|20435514|P2|COMPLETED|Posttraining to 5 Follow-ups||20
8288743|NCT01628016|20435515|P1|COMPLETED|Posttraining to 5 Follow-ups||23
8288744|NCT01628016|20435513|P3|STARTED|Posttraining to 5 Follow-ups||23
8288745|NCT01628016|20435514|P2|STARTED|Posttraining to 5 Follow-ups||27
8288746|NCT01628016|20435515|P1|STARTED|Posttraining to 5 Follow-ups||27
8288747|NCT01628016|20435513|P3|NOT COMPLETED|Pretraining to Posttraining||0
8288748|NCT01628016|20435514|P2|NOT COMPLETED|Pretraining to Posttraining||0
8288749|NCT01628016|20435515|P1|NOT COMPLETED|Pretraining to Posttraining||0
8288750|NCT01628016|20435513|P3|COMPLETED|Pretraining to Posttraining||23
8288751|NCT01628016|20435514|P2|COMPLETED|Pretraining to Posttraining||27
8288752|NCT01628016|20435515|P1|COMPLETED|Pretraining to Posttraining||27
8288753|NCT01628016|20435513|P3|STARTED|Pretraining to Posttraining||23
8288754|NCT01628016|20435514|P2|STARTED|Pretraining to Posttraining||27
8288755|NCT01628016|20435515|P1|STARTED|Pretraining to Posttraining||27
8288756|NCT01627899|20435526|P1|NOT COMPLETED|Overall Study||5
8288757|NCT01627899|20435526|P1|COMPLETED|Overall Study||0
8288758|NCT01627899|20435526|P1|STARTED|Overall Study||5
8288759|NCT01627860|20435536|P2|NOT COMPLETED|Overall Study||6
8288760|NCT01627860|20435537|P1|NOT COMPLETED|Overall Study||12
8288761|NCT01627860|20435536|P2|COMPLETED|Overall Study||14
8288762|NCT01627860|20435537|P1|COMPLETED|Overall Study||23
8288763|NCT01627860|20435536|P2|STARTED|Overall Study||20
8288764|NCT01627860|20435537|P1|STARTED|Overall Study||35
8288765|NCT01627782|20435551|P4|NOT COMPLETED|Overall Study||6
8288766|NCT01627782|20435552|P3|NOT COMPLETED|Overall Study||15
8288767|NCT01627782|20435553|P2|NOT COMPLETED|Overall Study||6
8288768|NCT01627782|20435554|P1|NOT COMPLETED|Overall Study||16
8288769|NCT01627782|20435551|P4|COMPLETED|Overall Study||11
8288770|NCT01627782|20435552|P3|COMPLETED|Overall Study||1
8288771|NCT01627782|20435553|P2|COMPLETED|Overall Study||12
8288772|NCT01627782|20435554|P1|COMPLETED|Overall Study||1
8288773|NCT01627782|20435551|P4|Treated|Overall Study||17
8288774|NCT01627782|20435552|P3|Treated|Overall Study||16
8288775|NCT01627782|20435553|P2|Treated|Overall Study||18
8288776|NCT01627782|20435554|P1|Treated|Overall Study||16
8288777|NCT01627782|20435551|P4|STARTED|Overall Study||17
8288778|NCT01627782|20435552|P3|STARTED|Overall Study||16
8288779|NCT01627782|20435553|P2|STARTED|Overall Study||18
8288780|NCT01627782|20435554|P1|STARTED|Overall Study||17
8288781|NCT01627691|20435610|P1|NOT COMPLETED|Overall Study||18
8288782|NCT01627691|20435610|P1|COMPLETED|Overall Study||232
8288783|NCT01627691|20435610|P1|Primary Endpoint (30days)|Overall Study||239
8288784|NCT01627691|20435610|P1|STARTED|Overall Study||250
8288785|NCT01627574|20435623|P2|NOT COMPLETED|Overall Study||18
8288786|NCT01627574|20435624|P1|NOT COMPLETED|Overall Study||21
8288787|NCT01627574|20435623|P2|COMPLETED|Overall Study||112
8288788|NCT01627574|20435624|P1|COMPLETED|Overall Study||121
8288789|NCT01627574|20435623|P2|STARTED|Overall Study||130
8288790|NCT01627574|20435624|P1|STARTED|Overall Study||142
8288791|NCT01627561|20435638|P2|NOT COMPLETED|Overall Study||3
8288792|NCT01627561|20435639|P1|NOT COMPLETED|Overall Study||1
8288793|NCT01627561|20435638|P2|COMPLETED|Overall Study||71
8288794|NCT01627561|20435639|P1|COMPLETED|Overall Study||73
8288795|NCT01627561|20435638|P2|STARTED|Overall Study||74
8288796|NCT01627561|20435639|P1|STARTED|Overall Study||74
8288797|NCT01627340|20435705|P2|NOT COMPLETED|Overall Study||4
8288798|NCT01627340|20435706|P1|NOT COMPLETED|Overall Study||12
8288799|NCT01627340|20435705|P2|COMPLETED|Overall Study||254
8288800|NCT01627340|20435706|P1|COMPLETED|Overall Study||404
8288801|NCT01627340|20435705|P2|STARTED|Overall Study||258
8288802|NCT01627340|20435706|P1|STARTED|Overall Study||416
8288803|NCT01627327|20435724|P2|NOT COMPLETED|Overall Study||39
8288804|NCT01627327|20435725|P1|NOT COMPLETED|Overall Study||19
8288805|NCT01627327|20435724|P2|COMPLETED|Overall Study||274
8288806|NCT01627327|20435725|P1|COMPLETED|Overall Study||291
8288807|NCT01627327|20435724|P2|STARTED|Overall Study||313
8288808|NCT01627327|20435725|P1|STARTED|Overall Study||310
8288821|NCT01627249|20435775|P3|NOT COMPLETED|Overall Study||12
8288822|NCT01627249|20435776|P2|NOT COMPLETED|Overall Study||12
8288823|NCT01627249|20435777|P1|NOT COMPLETED|Overall Study||16
8288824|NCT01627249|20435775|P3|COMPLETED|Overall Study||206
8288825|NCT01627249|20435776|P2|COMPLETED|Overall Study||206
8288826|NCT01627249|20435777|P1|COMPLETED|Overall Study||208
8288827|NCT01627249|20435775|P3|STARTED|Overall Study||218
8288828|NCT01627249|20435776|P2|STARTED|Overall Study||218
8288829|NCT01627249|20435777|P1|STARTED|Overall Study||224
8288830|NCT01627067|20435812|P1|NOT COMPLETED|Overall Study||1
8288831|NCT01627067|20435812|P1|COMPLETED|Overall Study||22
8288832|NCT01627067|20435812|P1|STARTED|Overall Study||23
8288833|NCT01627002|20435822|P9|NOT COMPLETED|Overall Study||0
8288834|NCT01627002|20435823|P8|NOT COMPLETED|Overall Study||0
8288835|NCT01627002|20435824|P7|NOT COMPLETED|Overall Study||0
8288836|NCT01627002|20435825|P6|NOT COMPLETED|Overall Study||0
8288837|NCT01627002|20435826|P5|NOT COMPLETED|Overall Study||0
8288838|NCT01627002|20435827|P4|NOT COMPLETED|Overall Study||0
8288839|NCT01627002|20435828|P3|NOT COMPLETED|Overall Study||0
8288840|NCT01627002|20435829|P2|NOT COMPLETED|Overall Study||0
8288841|NCT01627002|20435830|P1|NOT COMPLETED|Overall Study||0
8288842|NCT01627002|20435822|P9|COMPLETED|Overall Study||7
8288843|NCT01627002|20435823|P8|COMPLETED|Overall Study||5
8288844|NCT01627002|20435824|P7|COMPLETED|Overall Study||10
8288845|NCT01627002|20435825|P6|COMPLETED|Overall Study||9
8288846|NCT01627002|20435826|P5|COMPLETED|Overall Study||2
8288847|NCT01627002|20435827|P4|COMPLETED|Overall Study||4
8288848|NCT01627002|20435828|P3|COMPLETED|Overall Study||4
8288849|NCT01627002|20435829|P2|COMPLETED|Overall Study||4
8288850|NCT01627002|20435830|P1|COMPLETED|Overall Study||4
8288851|NCT01627002|20435822|P9|STARTED|Overall Study||7
8288852|NCT01627002|20435823|P8|STARTED|Overall Study||5
8288853|NCT01627002|20435824|P7|STARTED|Overall Study||10
8288854|NCT01627002|20435825|P6|STARTED|Overall Study||9
8288855|NCT01627002|20435826|P5|STARTED|Overall Study||2
8288856|NCT01627002|20435827|P4|STARTED|Overall Study||4
8288857|NCT01627002|20435828|P3|STARTED|Overall Study||4
8288858|NCT01627002|20435829|P2|STARTED|Overall Study||4
8288859|NCT01627002|20435830|P1|STARTED|Overall Study||4
8288860|NCT01626989|20435881|P3|NOT COMPLETED|Second Intervention (Night 2)||0
8288861|NCT01626989|20435882|P2|NOT COMPLETED|Second Intervention (Night 2)||0
8288862|NCT01626989|20435883|P1|NOT COMPLETED|Second Intervention (Night 2)||0
8288863|NCT01626989|20435881|P3|COMPLETED|Second Intervention (Night 2)||12
8288864|NCT01626989|20435882|P2|COMPLETED|Second Intervention (Night 2)||15
8288865|NCT01626989|20435883|P1|COMPLETED|Second Intervention (Night 2)||0
8288866|NCT01626989|20435881|P3|STARTED|Second Intervention (Night 2)||12
8288867|NCT01626989|20435882|P2|STARTED|Second Intervention (Night 2)||15
8288868|NCT01626989|20435883|P1|STARTED|Second Intervention (Night 2)||0
8288869|NCT01626989|20435881|P3|NOT COMPLETED|Fist Intervention (Night 1)||0
8288870|NCT01626989|20435882|P2|NOT COMPLETED|Fist Intervention (Night 1)||0
8288871|NCT01626989|20435883|P1|NOT COMPLETED|Fist Intervention (Night 1)||0
8288872|NCT01626989|20435881|P3|COMPLETED|Fist Intervention (Night 1)||12
8288873|NCT01626989|20435882|P2|COMPLETED|Fist Intervention (Night 1)||15
8288874|NCT01626989|20435883|P1|COMPLETED|Fist Intervention (Night 1)||0
8288875|NCT01626989|20435881|P3|STARTED|Fist Intervention (Night 1)||12
8288876|NCT01626989|20435882|P2|STARTED|Fist Intervention (Night 1)||15
8288877|NCT01626989|20435883|P1|STARTED|Fist Intervention (Night 1)||0
8288878|NCT01626989|20435881|P3|NOT COMPLETED|Screening Period||0
8288879|NCT01626989|20435882|P2|NOT COMPLETED|Screening Period||0
8288880|NCT01626989|20435883|P1|NOT COMPLETED|Screening Period||17
8288881|NCT01626989|20435881|P3|COMPLETED|Screening Period||0
8288882|NCT01626989|20435882|P2|COMPLETED|Screening Period||0
8288883|NCT01626989|20435883|P1|COMPLETED|Screening Period||27
8288884|NCT01626989|20435881|P3|STARTED|Screening Period||0
8288885|NCT01626989|20435882|P2|STARTED|Screening Period||0
8288886|NCT01626989|20435883|P1|STARTED|Screening Period||44
8288887|NCT01626820|20435932|P2|NOT COMPLETED|Overall Study||0
8288888|NCT01626820|20435933|P1|NOT COMPLETED|Overall Study||0
8288889|NCT01626820|20435932|P2|COMPLETED|Overall Study||57
8288890|NCT01626820|20435933|P1|COMPLETED|Overall Study||56
8288891|NCT01626820|20435932|P2|STARTED|Overall Study||57
8288892|NCT01626820|20435933|P1|STARTED|Overall Study||56
8288893|NCT01626690|20435955|P2|NOT COMPLETED|Overall Study||0
8288894|NCT01626690|20435956|P1|NOT COMPLETED|Overall Study||2
8288895|NCT01626690|20435955|P2|COMPLETED|Overall Study||51
8288896|NCT01626690|20435956|P1|COMPLETED|Overall Study||47
8288897|NCT01626690|20435955|P2|STARTED|Overall Study||51
8288898|NCT01626690|20435956|P1|STARTED|Overall Study||49
8288899|NCT01626664|20435978|P3|NOT COMPLETED|Crossover Period||0
8288900|NCT01626664|20435979|P2|NOT COMPLETED|Crossover Period||0
8288901|NCT01626664|20435980|P1|NOT COMPLETED|Crossover Period||0
8288902|NCT01626664|20435978|P3|COMPLETED|Crossover Period||18
8288903|NCT01626664|20435979|P2|COMPLETED|Crossover Period||0
8288904|NCT01626664|20435980|P1|COMPLETED|Crossover Period||0
8288905|NCT01626664|20435978|P3|STARTED|Crossover Period||18
8288906|NCT01626664|20435979|P2|STARTED|Crossover Period||0
8288907|NCT01626664|20435980|P1|STARTED|Crossover Period||0
8288908|NCT01626664|20435978|P3|NOT COMPLETED|Randomization Period||0
8288909|NCT01626664|20435979|P2|NOT COMPLETED|Randomization Period||0
8288910|NCT01626664|20435980|P1|NOT COMPLETED|Randomization Period||0
8288911|NCT01626664|20435978|P3|COMPLETED|Randomization Period||0
8288912|NCT01626664|20435979|P2|COMPLETED|Randomization Period||24
8288913|NCT01626664|20435980|P1|COMPLETED|Randomization Period||47
8288914|NCT01626664|20435978|P3|STARTED|Randomization Period||0
8288915|NCT01626664|20435979|P2|STARTED|Randomization Period||24
8288916|NCT01626664|20435980|P1|STARTED|Randomization Period||47
8288917|NCT01626495|20435993|P1|NOT COMPLETED|Overall Study||52
8288918|NCT01626495|20435993|P1|COMPLETED|Overall Study|Follow up phase completed as per protocol|21
8288919|NCT01626495|20435993|P1|Intervention|Overall Study||62
8288920|NCT01626495|20435993|P1|STARTED|Overall Study|Number of enrolled subjects|73
8288921|NCT01626456|20436002|P2|NOT COMPLETED|Overall Study||117
8288922|NCT01626456|20436003|P1|NOT COMPLETED|Overall Study||35
8288923|NCT01626456|20436002|P2|COMPLETED|Overall Study||251
8288924|NCT01626456|20436003|P1|COMPLETED|Overall Study||75
8288925|NCT01626456|20436002|P2|STARTED|Overall Study||368
8288926|NCT01626456|20436003|P1|STARTED|Overall Study||110
8288927|NCT01626391|20436033|P2|NOT COMPLETED|Overall Study||0
8288928|NCT01626391|20436034|P1|NOT COMPLETED|Overall Study||2
8288929|NCT01626391|20436033|P2|COMPLETED|Overall Study||4
8288930|NCT01626391|20436034|P1|COMPLETED|Overall Study||3
8288931|NCT01626391|20436033|P2|STARTED|Overall Study||4
8288932|NCT01626391|20436034|P1|STARTED|Overall Study||5
8288933|NCT01626352|20436040|P1|NOT COMPLETED|Overall Study||10
8288934|NCT01626352|20436040|P1|COMPLETED|Overall Study||12
8288935|NCT01626352|20436040|P1|STARTED|Overall Study||22
8288936|NCT01626118|20436054|P4|NOT COMPLETED|Overall Study||3
8288937|NCT01626118|20436055|P3|NOT COMPLETED|Overall Study||2
8288938|NCT01626118|20436056|P2|NOT COMPLETED|Overall Study||2
8288939|NCT01626118|20436057|P1|NOT COMPLETED|Overall Study||2
8288940|NCT01626118|20436054|P4|COMPLETED|Overall Study||91
8288941|NCT01626118|20436055|P3|COMPLETED|Overall Study||90
8288942|NCT01626118|20436056|P2|COMPLETED|Overall Study||91
8288943|NCT01626118|20436057|P1|COMPLETED|Overall Study||92
8288944|NCT01626118|20436054|P4|STARTED|Overall Study||94
8288945|NCT01626118|20436055|P3|STARTED|Overall Study||92
8288946|NCT01626118|20436056|P2|STARTED|Overall Study||93
8288947|NCT01626118|20436057|P1|STARTED|Overall Study||94
8288948|NCT01626092|20436095|P1|NOT COMPLETED|Overall Study||0
8288949|NCT01626092|20436095|P1|COMPLETED|Overall Study||3
8288950|NCT01626092|20436095|P1|STARTED|Overall Study||3
8288951|NCT01626079|20436103|P2|NOT COMPLETED|Overall Study||216
8288952|NCT01626079|20436104|P1|NOT COMPLETED|Overall Study||167
8288953|NCT01626079|20436103|P2|COMPLETED|Overall Study||96
8288954|NCT01626079|20436104|P1|COMPLETED|Overall Study||135
8288955|NCT01626079|20436103|P2|STARTED|Overall Study||312
8288956|NCT01626079|20436104|P1|STARTED|Overall Study||302
8288957|NCT01625988|20436477|P2|NOT COMPLETED|Overall Study||13
8288958|NCT01625988|20436478|P1|NOT COMPLETED|Overall Study||14
8288959|NCT01625988|20436477|P2|COMPLETED|Overall Study||97
8288960|NCT01625988|20436478|P1|COMPLETED|Overall Study||94
8288961|NCT01625988|20436477|P2|Received at Least One Dose of Study Drug|Overall Study||110
8288962|NCT01625988|20436478|P1|Received at Least One Dose of Study Drug|Overall Study||107
8288963|NCT01625988|20436477|P2|STARTED|Overall Study||110
8288964|NCT01625988|20436478|P1|STARTED|Overall Study|One participant was randomized inappropriately and was discontinued before start of study treatment.|108
8288965|NCT01625923|20436492|P1|NOT COMPLETED|Overall Study||0
8288966|NCT01625923|20436492|P1|COMPLETED|Overall Study||3
8288967|NCT01625923|20436492|P1|STARTED|Overall Study||3
8288968|NCT01625910|20436502|P2|NOT COMPLETED|Overall Study||4
8288969|NCT01625910|20436503|P1|NOT COMPLETED|Overall Study||3
8288970|NCT01625910|20436502|P2|COMPLETED|Overall Study||33
8288971|NCT01625910|20436503|P1|COMPLETED|Overall Study||32
8288972|NCT01625910|20436502|P2|STARTED|Overall Study||37
8288973|NCT01625910|20436503|P1|STARTED|Overall Study||35
8288974|NCT01625845|20436513|P2|NOT COMPLETED|Overall Study||3
8288975|NCT01625845|20436514|P1|NOT COMPLETED|Overall Study||5
8288976|NCT01625845|20436513|P2|COMPLETED|Overall Study||3
8288977|NCT01625845|20436514|P1|COMPLETED|Overall Study||5
8288978|NCT01625845|20436513|P2|STARTED|Overall Study||6
8288979|NCT01625845|20436514|P1|STARTED|Overall Study||10
8288980|NCT01625689|20436534|P2|NOT COMPLETED|Overall Study||1
8288981|NCT01625689|20436535|P1|NOT COMPLETED|Overall Study||2
8288982|NCT01625689|20436534|P2|COMPLETED|Overall Study||149
8288983|NCT01625689|20436535|P1|COMPLETED|Overall Study||148
8288984|NCT01625689|20436534|P2|STARTED|Overall Study||150
8288985|NCT01625689|20436535|P1|STARTED|Overall Study||150
8288986|NCT01625507|20436545|P1|NOT COMPLETED|Overall Study||10
8288987|NCT01625507|20436545|P1|COMPLETED|Overall Study||63
8288988|NCT01625507|20436545|P1|STARTED|Overall Study||73
8288989|NCT01625455|20436560|P2|NOT COMPLETED|Overall Study||0
8288990|NCT01625455|20436561|P1|NOT COMPLETED|Overall Study||0
8288991|NCT01625455|20436560|P2|COMPLETED|Overall Study||3
8288992|NCT01625455|20436561|P1|COMPLETED|Overall Study||2
8288993|NCT01625455|20436560|P2|STARTED|Overall Study||3
8288994|NCT01625455|20436561|P1|STARTED|Overall Study||2
8288995|NCT01625416|20436571|P2|NOT COMPLETED|Overall Study||7
8288996|NCT01625416|20436572|P1|NOT COMPLETED|Overall Study||9
8288997|NCT01625416|20436571|P2|COMPLETED|Overall Study||54
8288998|NCT01625416|20436572|P1|COMPLETED|Overall Study||51
8288999|NCT01625416|20436571|P2|STARTED|Overall Study||61
8289000|NCT01625416|20436572|P1|STARTED|Overall Study||60
8289001|NCT01625377|20436590|P2|NOT COMPLETED|Overall Study||22
8289002|NCT01625377|20436591|P1|NOT COMPLETED|Overall Study||7
8289003|NCT01625377|20436590|P2|COMPLETED|Overall Study||71
8289004|NCT01625377|20436591|P1|COMPLETED|Overall Study||88
8289005|NCT01625377|20436590|P2|Intent to Treat Population|Overall Study||90
8289006|NCT01625377|20436591|P1|Intent to Treat Population|Overall Study||93
8289007|NCT01625377|20436590|P2|Safety Set of Population|Overall Study||90
8289008|NCT01625377|20436591|P1|Safety Set of Population|Overall Study||94
8289009|NCT01625377|20436590|P2|STARTED|Overall Study||93
8289010|NCT01625377|20436591|P1|STARTED|Overall Study|"Started indicates randomized patients."|95
8289011|NCT01625338|20436624|P3|NOT COMPLETED|Overall Study||39
8289012|NCT01625338|20436625|P2|NOT COMPLETED|Overall Study||44
8289013|NCT01625338|20436626|P1|NOT COMPLETED|Overall Study||32
8289014|NCT01625338|20436624|P3|COMPLETED|Overall Study||181
8289015|NCT01625338|20436625|P2|COMPLETED|Overall Study||156
8289016|NCT01625338|20436626|P1|COMPLETED|Overall Study||82
8289017|NCT01625338|20436624|P3|STARTED|Overall Study||220
8289018|NCT01625338|20436625|P2|STARTED|Overall Study||200
8289019|NCT01625338|20436626|P1|STARTED|Overall Study||114
8289055|NCT01625221|20436738|P1|NOT COMPLETED|Overall Study||7
8289056|NCT01625221|20436738|P1|COMPLETED|Overall Study||28
8289057|NCT01625221|20436738|P1|STARTED|Overall Study||35
8289058|NCT01625182|20436745|P2|NOT COMPLETED|Overall Study||11
8289059|NCT01625182|20436746|P1|NOT COMPLETED|Overall Study||20
8289060|NCT01625182|20436745|P2|COMPLETED|Overall Study||41
8289061|NCT01625182|20436746|P1|COMPLETED|Overall Study||34
8289062|NCT01625182|20436745|P2|STARTED|Overall Study||52
8289063|NCT01625182|20436746|P1|STARTED|Overall Study||54
8289064|NCT01625169|20436759|P1|NOT COMPLETED|Overall Study||0
8289065|NCT01625169|20436759|P1|COMPLETED|Overall Study||9
8289066|NCT01625169|20436759|P1|STARTED|Overall Study||9
8289067|NCT01625104|20436774|P2|NOT COMPLETED|Overall Study||0
8289068|NCT01625104|20436775|P1|NOT COMPLETED|Overall Study||0
8289069|NCT01625104|20436774|P2|COMPLETED|Overall Study||434
8289070|NCT01625104|20436775|P1|COMPLETED|Overall Study||448
8289071|NCT01625104|20436774|P2|STARTED|Overall Study||434
8289072|NCT01625104|20436775|P1|STARTED|Overall Study||448
8289073|NCT01625091|20436783|P2|NOT COMPLETED|Post-intervention||2
8289074|NCT01625091|20436784|P1|NOT COMPLETED|Post-intervention||4
8289075|NCT01625091|20436783|P2|COMPLETED|Post-intervention||85
8289076|NCT01625091|20436784|P1|COMPLETED|Post-intervention||81
8289077|NCT01625091|20436783|P2|7 Months|Post-intervention||85
8289078|NCT01625091|20436784|P1|7 Months|Post-intervention||81
8289079|NCT01625091|20436783|P2|STARTED|Post-intervention||87
8289080|NCT01625091|20436784|P1|STARTED|Post-intervention||85
8289081|NCT01625091|20436783|P2|NOT COMPLETED|Intervention||11
8289082|NCT01625091|20436784|P1|NOT COMPLETED|Intervention||11
8289083|NCT01625091|20436783|P2|COMPLETED|Intervention||87
8289084|NCT01625091|20436784|P1|COMPLETED|Intervention||85
8289085|NCT01625091|20436783|P2|4 Months|Intervention||87
8289086|NCT01625091|20436784|P1|4 Months|Intervention||85
8289087|NCT01625091|20436783|P2|2 Months|Intervention||93
8289088|NCT01625091|20436784|P1|2 Months|Intervention||90
8289089|NCT01625091|20436783|P2|STARTED|Intervention||98
8289090|NCT01625091|20436784|P1|STARTED|Intervention||96
8289094|NCT01624974|20436802|P2|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
8289095|NCT01624974|20436803|P1|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
8289096|NCT01624974|20436802|P2|COMPLETED|Period V of Treatment (4 Weeks)||42
8289097|NCT01624974|20436803|P1|COMPLETED|Period V of Treatment (4 Weeks)||39
8289098|NCT01624974|20436802|P2|STARTED|Period V of Treatment (4 Weeks)||42
8289099|NCT01624974|20436803|P1|STARTED|Period V of Treatment (4 Weeks)||44
8289100|NCT01624974|20436802|P2|NOT COMPLETED|Period IV Washout (4 Weeks)||3
8289101|NCT01624974|20436803|P1|NOT COMPLETED|Period IV Washout (4 Weeks)||3
8289102|NCT01624974|20436802|P2|COMPLETED|Period IV Washout (4 Weeks)||42
8289103|NCT01624974|20436803|P1|COMPLETED|Period IV Washout (4 Weeks)||44
8289104|NCT01624974|20436802|P2|STARTED|Period IV Washout (4 Weeks)||45
8289105|NCT01624974|20436803|P1|STARTED|Period IV Washout (4 Weeks)||47
8289106|NCT01624974|20436802|P2|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
8289107|NCT01624974|20436803|P1|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
8289108|NCT01624974|20436802|P2|COMPLETED|Period III of Treatment (4 Weeks)||45
8289109|NCT01624974|20436803|P1|COMPLETED|Period III of Treatment (4 Weeks)||47
8289110|NCT01624974|20436802|P2|STARTED|Period III of Treatment (4 Weeks)||53
8289111|NCT01624974|20436803|P1|STARTED|Period III of Treatment (4 Weeks)||54
8289112|NCT01624948|20436827|P2|NOT COMPLETED|Overall Study||0
8289113|NCT01624948|20436828|P1|NOT COMPLETED|Overall Study||0
8289114|NCT01624948|20436827|P2|COMPLETED|Overall Study||20
8289115|NCT01624948|20436828|P1|COMPLETED|Overall Study||20
8289116|NCT01624948|20436827|P2|STARTED|Overall Study||20
8289117|NCT01624948|20436828|P1|STARTED|Overall Study||20
8289118|NCT01624870|20436844|P1|NOT COMPLETED|Overall Study||27
8289119|NCT01624870|20436844|P1|COMPLETED|Overall Study|Completed 6 month follow up|173
8289120|NCT01624870|20436844|P1|STARTED|Overall Study|provided informed consent|200
8289121|NCT01624740|20436852|P2|NOT COMPLETED|Second Intervention (3-4 Days)||0
8289122|NCT01624740|20436853|P1|NOT COMPLETED|Second Intervention (3-4 Days)||1
8289123|NCT01624740|20436852|P2|COMPLETED|Second Intervention (3-4 Days)||9
8289124|NCT01624740|20436853|P1|COMPLETED|Second Intervention (3-4 Days)||8
8289125|NCT01624740|20436852|P2|STARTED|Second Intervention (3-4 Days)||9
8289126|NCT01624740|20436853|P1|STARTED|Second Intervention (3-4 Days)||9
8289127|NCT01624740|20436852|P2|NOT COMPLETED|Washout (1 Hour)||0
8289128|NCT01624740|20436853|P1|NOT COMPLETED|Washout (1 Hour)||0
8289129|NCT01624740|20436852|P2|COMPLETED|Washout (1 Hour)||9
8289130|NCT01624740|20436853|P1|COMPLETED|Washout (1 Hour)||9
8289131|NCT01624740|20436852|P2|STARTED|Washout (1 Hour)||9
8289132|NCT01624740|20436853|P1|STARTED|Washout (1 Hour)||9
8289133|NCT01624740|20436852|P2|NOT COMPLETED|First Intervention (3-4 Days)||0
8289134|NCT01624740|20436853|P1|NOT COMPLETED|First Intervention (3-4 Days)||0
8289135|NCT01624740|20436852|P2|COMPLETED|First Intervention (3-4 Days)||9
8289136|NCT01624740|20436853|P1|COMPLETED|First Intervention (3-4 Days)||9
8289137|NCT01624740|20436852|P2|STARTED|First Intervention (3-4 Days)||9
8289138|NCT01624740|20436853|P1|STARTED|First Intervention (3-4 Days)||9
8289139|NCT01624662|20436864|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
8289140|NCT01624662|20436865|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
8289141|NCT01624662|20436866|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
8289142|NCT01624662|20436867|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
8289143|NCT01624662|20436864|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
8289144|NCT01624662|20436865|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
8289145|NCT01624662|20436866|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
8289146|NCT01624662|20436867|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
8289147|NCT01624662|20436864|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||79
8289148|NCT01624662|20436865|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||72
8289149|NCT01624662|20436866|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||78
8289150|NCT01624662|20436867|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||70
8289151|NCT01624662|20436864|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
8289152|NCT01624662|20436865|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
8289153|NCT01624662|20436866|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
8289154|NCT01624662|20436867|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
8289155|NCT01624662|20436864|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
8289156|NCT01624662|20436865|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
8289157|NCT01624662|20436866|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
8289158|NCT01624662|20436867|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
8289159|NCT01624662|20436864|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
8289160|NCT01624662|20436865|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
8289161|NCT01624662|20436866|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
8289162|NCT01624662|20436867|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
8289163|NCT01624467|20436938|P1|NOT COMPLETED|Overall Study||31
8289164|NCT01624467|20436938|P1|COMPLETED|Overall Study||44
8289165|NCT01624467|20436938|P1|Received at Least One Dose of Study Drug|Overall Study||75
8289166|NCT01624467|20436938|P1|STARTED|Overall Study||75
8289167|NCT01624363|20436951|P1|NOT COMPLETED|Overall Study||0
8289168|NCT01624363|20436951|P1|COMPLETED|Overall Study||341
8289169|NCT01624363|20436951|P1|STARTED|Overall Study||341
8289170|NCT01624350|20436955|P1|NOT COMPLETED|Overall Study||25
8289171|NCT01624350|20436955|P1|COMPLETED|Overall Study||75
8289172|NCT01624350|20436955|P1|STARTED|Overall Study||100
8289173|NCT01624259|20436977|P2|NOT COMPLETED|Overall Study||31
8289174|NCT01624259|20436978|P1|NOT COMPLETED|Overall Study||30
8289175|NCT01624259|20436977|P2|COMPLETED|Overall Study|Completed the study on study treatment|269
8289176|NCT01624259|20436978|P1|COMPLETED|Overall Study|Completed the study on study treatment|269
8289177|NCT01624259|20436977|P2|Received at Least One Dose of Study Drug|Overall Study||300
8289178|NCT01624259|20436978|P1|Received at Least One Dose of Study Drug|Overall Study||299
8289179|NCT01624259|20436977|P2|STARTED|Overall Study||300
8289180|NCT01624259|20436978|P1|STARTED|Overall Study||299
8289181|NCT01624233|20437027|P1|NOT COMPLETED|Period 6: Follow-up||9
8289182|NCT01624233|20437027|P1|COMPLETED|Period 6: Follow-up||79
8289183|NCT01624233|20437027|P1|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
8289184|NCT01624233|20437027|P1|NOT COMPLETED|Period 5 - Retreatment Period||10
8289185|NCT01624233|20437027|P1|COMPLETED|Period 5 - Retreatment Period||70
8289186|NCT01624233|20437027|P1|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
8289187|NCT01624233|20437027|P1|NOT COMPLETED|Period 4 - Drug Free Period||61
8289188|NCT01624233|20437027|P1|COMPLETED|Period 4 - Drug Free Period||9
8289189|NCT01624233|20437027|P1|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
8289190|NCT01624233|20437027|P1|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
8289191|NCT01624233|20437027|P1|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
8289192|NCT01624233|20437027|P1|NOT COMPLETED|Period 3 - Maintenance||7
8289193|NCT01624233|20437027|P1|COMPLETED|Period 3 - Maintenance||83
8289194|NCT01624233|20437027|P1|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
8289195|NCT01624233|20437027|P1|STARTED|Period 3 - Maintenance||90
8289196|NCT01624233|20437027|P1|NOT COMPLETED|Period 2 - Induction||1
8289197|NCT01624233|20437027|P1|COMPLETED|Period 2 - Induction||90
8289198|NCT01624233|20437027|P1|Plaque Ps|Period 2 - Induction||78
8289199|NCT01624233|20437027|P1|Pustular Ps|Period 2 - Induction||5
8289200|NCT01624233|20437027|P1|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
8289201|NCT01624233|20437027|P1|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
8289202|NCT01624233|20437027|P1|STARTED|Period 2 - Induction||91
8289203|NCT01624194|20437059|P2|NOT COMPLETED|Overall Study||0
8289204|NCT01624194|20437060|P1|NOT COMPLETED|Overall Study||2
8289205|NCT01624194|20437059|P2|COMPLETED|Overall Study||18
8289206|NCT01624194|20437060|P1|COMPLETED|Overall Study||14
8289207|NCT01624194|20437059|P2|STARTED|Overall Study||18
8289208|NCT01624194|20437060|P1|STARTED|Overall Study||16
8289209|NCT01624168|20437101|P3|NOT COMPLETED|Overall Study||6
8289210|NCT01624168|20437102|P2|NOT COMPLETED|Overall Study||12
8289211|NCT01624168|20437103|P1|NOT COMPLETED|Overall Study||4
8289212|NCT01624168|20437101|P3|COMPLETED|Overall Study||22
8289213|NCT01624168|20437102|P2|COMPLETED|Overall Study||16
8289214|NCT01624168|20437103|P1|COMPLETED|Overall Study||15
8289215|NCT01624168|20437101|P3|STARTED|Overall Study||28
8289216|NCT01624168|20437102|P2|STARTED|Overall Study||28
8289217|NCT01624168|20437103|P1|STARTED|Overall Study||19
8289218|NCT01624142|20437128|P2|NOT COMPLETED|Overall Study||16
8289219|NCT01624142|20437129|P1|NOT COMPLETED|Overall Study||32
8289220|NCT01624142|20437128|P2|COMPLETED|Overall Study||178
8289221|NCT01624142|20437129|P1|COMPLETED|Overall Study||74
8289222|NCT01624142|20437128|P2|STARTED|Overall Study||194
8289223|NCT01624142|20437129|P1|STARTED|Overall Study||106
8289224|NCT01624090|20437154|P4|NOT COMPLETED|Overall Study||0
8289225|NCT01624090|20437155|P3|NOT COMPLETED|Overall Study||7
8289226|NCT01624090|20437156|P2|NOT COMPLETED|Overall Study||2
8289227|NCT01624090|20437157|P1|NOT COMPLETED|Overall Study||0
8289228|NCT01624090|20437154|P4|COMPLETED|Overall Study||2
8289229|NCT01624090|20437155|P3|COMPLETED|Overall Study||3
8289230|NCT01624090|20437156|P2|COMPLETED|Overall Study||0
8289231|NCT01624090|20437157|P1|COMPLETED|Overall Study||2
8289232|NCT01624090|20437154|P4|STARTED|Overall Study||2
8289233|NCT01624090|20437155|P3|STARTED|Overall Study||10
8289234|NCT01624090|20437156|P2|STARTED|Overall Study||2
8289235|NCT01624090|20437157|P1|STARTED|Overall Study||2
8289236|NCT01623869|20437171|P1|NOT COMPLETED|Overall Study||0
8289237|NCT01623869|20437171|P1|COMPLETED|Overall Study||16
8289238|NCT01623869|20437171|P1|STARTED|Overall Study||16
8289239|NCT01623830|20437179|P2|NOT COMPLETED|Overall Study||9
8289240|NCT01623830|20437180|P1|NOT COMPLETED|Overall Study||7
8289241|NCT01623830|20437179|P2|COMPLETED|Overall Study||35
8289242|NCT01623830|20437180|P1|COMPLETED|Overall Study||38
8289243|NCT01623830|20437179|P2|STARTED|Overall Study||44
8289244|NCT01623830|20437180|P1|STARTED|Overall Study||45
8289245|NCT01623752|20437197|P3|NOT COMPLETED|Phase 2 (78 Weeks)||0
8289246|NCT01623752|20437198|P2|NOT COMPLETED|Phase 2 (78 Weeks)||18
8289247|NCT01623752|20437199|P1|NOT COMPLETED|Phase 2 (78 Weeks)||66
8289248|NCT01623752|20437197|P3|COMPLETED|Phase 2 (78 Weeks)||0
8289249|NCT01623752|20437198|P2|COMPLETED|Phase 2 (78 Weeks)||98
8289250|NCT01623752|20437199|P1|COMPLETED|Phase 2 (78 Weeks)||225
8289251|NCT01623752|20437197|P3|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0
8289252|NCT01623752|20437198|P2|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116
8289253|NCT01623752|20437199|P1|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291
8289254|NCT01623752|20437197|P3|NOT COMPLETED|Phase 1 (78 Weeks)||2
8289255|NCT01623752|20437198|P2|NOT COMPLETED|Phase 1 (78 Weeks)||207
8289256|NCT01623752|20437199|P1|NOT COMPLETED|Phase 1 (78 Weeks)||631
8289257|NCT01623752|20437197|P3|COMPLETED|Phase 1 (78 Weeks)||1
8289258|NCT01623752|20437198|P2|COMPLETED|Phase 1 (78 Weeks)||233
8289259|NCT01623752|20437199|P1|COMPLETED|Phase 1 (78 Weeks)||747
8289260|NCT01623752|20437197|P3|STARTED|Phase 1 (78 Weeks)||3
8289261|NCT01623752|20437198|P2|STARTED|Phase 1 (78 Weeks)||440
8289262|NCT01623752|20437199|P1|STARTED|Phase 1 (78 Weeks)||1378
8289263|NCT01623739|20437284|P2|NOT COMPLETED|Overall Study||4
8289264|NCT01623739|20437285|P1|NOT COMPLETED|Overall Study||2
8289265|NCT01623739|20437284|P2|COMPLETED|Overall Study||15
8289266|NCT01623739|20437285|P1|COMPLETED|Overall Study||17
8289267|NCT01623739|20437284|P2|STARTED|Overall Study||19
8289268|NCT01623739|20437285|P1|STARTED|Overall Study||19
8289269|NCT01623596|20437302|P2|NOT COMPLETED|Overall Study||100
8289270|NCT01623596|20437303|P1|NOT COMPLETED|Overall Study||62
8289271|NCT01623596|20437302|P2|COMPLETED|Overall Study||339
8289272|NCT01623596|20437303|P1|COMPLETED|Overall Study||374
8289273|NCT01623596|20437302|P2|On Switched Treatment|Overall Study||214
8289274|NCT01623596|20437303|P1|On Switched Treatment|Overall Study||22
8289275|NCT01623596|20437302|P2|On Randomized Treatment|Overall Study||125
8289276|NCT01623596|20437303|P1|On Randomized Treatment|Overall Study||352
8289277|NCT01623596|20437302|P2|STARTED|Overall Study||439
8289278|NCT01623596|20437303|P1|STARTED|Overall Study||436
8289279|NCT01623531|20437321|P2|NOT COMPLETED|Overall Study||2
8289280|NCT01623531|20437322|P1|NOT COMPLETED|Overall Study||4
8289281|NCT01623531|20437321|P2|COMPLETED|Overall Study||29
8289282|NCT01623531|20437322|P1|COMPLETED|Overall Study||27
8289283|NCT01623531|20437321|P2|STARTED|Overall Study||31
8289284|NCT01623531|20437322|P1|STARTED|Overall Study||31
8289285|NCT01623479|20437362|P1|NOT COMPLETED|Overall Study||0
8289286|NCT01623479|20437362|P1|COMPLETED|Overall Study||585
8289287|NCT01623479|20437362|P1|STARTED|Overall Study||585
8289288|NCT01623466|20437370|P2|NOT COMPLETED|Overall Study||0
8289289|NCT01623466|20437371|P1|NOT COMPLETED|Overall Study||1
8289290|NCT01623466|20437370|P2|COMPLETED|Overall Study||18
8289291|NCT01623466|20437371|P1|COMPLETED|Overall Study||17
8289292|NCT01623466|20437370|P2|STARTED|Overall Study||18
8289293|NCT01623466|20437371|P1|STARTED|Overall Study||18
8289294|NCT01623323|20437385|P1|NOT COMPLETED|Overall Study||104
8289295|NCT01623323|20437385|P1|COMPLETED|Overall Study||601
8289296|NCT01623323|20437385|P1|STARTED|Overall Study||705
8289297|NCT01623310|20437389|P1|NOT COMPLETED|Overall Study||79
8289298|NCT01623310|20437389|P1|COMPLETED|Overall Study||144
8289299|NCT01623310|20437389|P1|STARTED|Overall Study||223
8289300|NCT01623271|20437398|P1|NOT COMPLETED|Overall Study||2
8289301|NCT01623271|20437398|P1|COMPLETED|Overall Study||3
8289302|NCT01623271|20437398|P1|STARTED|Overall Study||5
8289312|NCT01623154|20437415|P1|NOT COMPLETED|Overall Study||4
8289313|NCT01623154|20437415|P1|COMPLETED|Overall Study||95
8289314|NCT01623154|20437415|P1|Available for Analysis|Overall Study||95
8289315|NCT01623154|20437415|P1|STARTED|Overall Study||99
8289316|NCT01623115|20437423|P2|NOT COMPLETED|Overall Study||77
8289317|NCT01623115|20437424|P1|NOT COMPLETED|Overall Study||33
8289318|NCT01623115|20437423|P2|COMPLETED|Overall Study||246
8289319|NCT01623115|20437424|P1|COMPLETED|Overall Study||130
8289320|NCT01623115|20437423|P2|Treated|Overall Study||322
8289321|NCT01623115|20437424|P1|Treated|Overall Study||163
8289322|NCT01623115|20437423|P2|STARTED|Overall Study|Randomized|323
8289323|NCT01623115|20437424|P1|STARTED|Overall Study|Randomized|163
8289324|NCT01623050|20437484|P1|NOT COMPLETED|Overall Study||9
8289325|NCT01623050|20437484|P1|COMPLETED|Overall Study||27
8289326|NCT01623050|20437484|P1|Treated|Overall Study||34
8289327|NCT01623050|20437484|P1|STARTED|Overall Study||36
8289328|NCT01623037|20437492|P1|NOT COMPLETED|Overall Study||0
8289329|NCT01623037|20437492|P1|COMPLETED|Overall Study||15
8289330|NCT01623037|20437492|P1|STARTED|Overall Study||15
8289331|NCT01622699|20437503|P2|NOT COMPLETED|Overall Study||0
8289332|NCT01622699|20437504|P1|NOT COMPLETED|Overall Study||0
8289333|NCT01622699|20437503|P2|COMPLETED|Overall Study||217
8289334|NCT01622699|20437504|P1|COMPLETED|Overall Study||213
8289335|NCT01622699|20437503|P2|STARTED|Overall Study||217
8289336|NCT01622699|20437504|P1|STARTED|Overall Study||213
8289337|NCT01622673|20437522|P6|NOT COMPLETED|Treatment Period 5||0
8289338|NCT01622673|20437523|P5|NOT COMPLETED|Treatment Period 5||0
8289339|NCT01622673|20437524|P4|NOT COMPLETED|Treatment Period 5||0
8289340|NCT01622673|20437525|P3|NOT COMPLETED|Treatment Period 5||0
8289341|NCT01622673|20437526|P2|NOT COMPLETED|Treatment Period 5||0
8289342|NCT01622673|20437527|P1|NOT COMPLETED|Treatment Period 5||0
8289343|NCT01622673|20437522|P6|COMPLETED|Treatment Period 5||4
8289344|NCT01622673|20437523|P5|COMPLETED|Treatment Period 5||4
8289345|NCT01622673|20437524|P4|COMPLETED|Treatment Period 5||4
8289346|NCT01622673|20437525|P3|COMPLETED|Treatment Period 5||4
8289347|NCT01622673|20437526|P2|COMPLETED|Treatment Period 5||3
8289348|NCT01622673|20437527|P1|COMPLETED|Treatment Period 5||4
8289349|NCT01622673|20437522|P6|STARTED|Treatment Period 5||4
8289350|NCT01622673|20437523|P5|STARTED|Treatment Period 5||4
8289351|NCT01622673|20437524|P4|STARTED|Treatment Period 5||4
8289352|NCT01622673|20437525|P3|STARTED|Treatment Period 5||4
8289353|NCT01622673|20437526|P2|STARTED|Treatment Period 5||3
8289354|NCT01622673|20437527|P1|STARTED|Treatment Period 5||4
8289355|NCT01622673|20437522|P6|NOT COMPLETED|Treatment Period 4||0
8289356|NCT01622673|20437523|P5|NOT COMPLETED|Treatment Period 4||0
8289357|NCT01622673|20437524|P4|NOT COMPLETED|Treatment Period 4||0
8289358|NCT01622673|20437525|P3|NOT COMPLETED|Treatment Period 4||0
8289359|NCT01622673|20437526|P2|NOT COMPLETED|Treatment Period 4||0
8289360|NCT01622673|20437527|P1|NOT COMPLETED|Treatment Period 4||0
8289361|NCT01622673|20437522|P6|COMPLETED|Treatment Period 4||4
8289362|NCT01622673|20437523|P5|COMPLETED|Treatment Period 4||4
8289363|NCT01622673|20437524|P4|COMPLETED|Treatment Period 4||4
8289364|NCT01622673|20437525|P3|COMPLETED|Treatment Period 4||4
8289365|NCT01622673|20437526|P2|COMPLETED|Treatment Period 4||3
8289366|NCT01622673|20437527|P1|COMPLETED|Treatment Period 4||4
8289367|NCT01622673|20437522|P6|STARTED|Treatment Period 4||4
8289368|NCT01622673|20437523|P5|STARTED|Treatment Period 4||4
8289369|NCT01622673|20437524|P4|STARTED|Treatment Period 4||4
8289370|NCT01622673|20437525|P3|STARTED|Treatment Period 4||4
8289371|NCT01622673|20437526|P2|STARTED|Treatment Period 4||3
8289372|NCT01622673|20437527|P1|STARTED|Treatment Period 4||4
8289373|NCT01622673|20437522|P6|NOT COMPLETED|Treatment Period 3||0
8289374|NCT01622673|20437523|P5|NOT COMPLETED|Treatment Period 3||0
8289375|NCT01622673|20437524|P4|NOT COMPLETED|Treatment Period 3||0
8289376|NCT01622673|20437525|P3|NOT COMPLETED|Treatment Period 3||0
8289377|NCT01622673|20437526|P2|NOT COMPLETED|Treatment Period 3||1
8289378|NCT01622673|20437527|P1|NOT COMPLETED|Treatment Period 3||0
8289379|NCT01622673|20437522|P6|COMPLETED|Treatment Period 3||4
8289380|NCT01622673|20437523|P5|COMPLETED|Treatment Period 3||4
8289381|NCT01622673|20437524|P4|COMPLETED|Treatment Period 3||4
8289382|NCT01622673|20437525|P3|COMPLETED|Treatment Period 3||4
8289383|NCT01622673|20437526|P2|COMPLETED|Treatment Period 3||3
8289384|NCT01622673|20437527|P1|COMPLETED|Treatment Period 3||4
8289385|NCT01622673|20437522|P6|STARTED|Treatment Period 3||4
8289386|NCT01622673|20437523|P5|STARTED|Treatment Period 3||4
8289387|NCT01622673|20437524|P4|STARTED|Treatment Period 3||4
8289388|NCT01622673|20437525|P3|STARTED|Treatment Period 3||4
8289389|NCT01622673|20437526|P2|STARTED|Treatment Period 3||4
8289390|NCT01622673|20437527|P1|STARTED|Treatment Period 3||4
8289391|NCT01622673|20437522|P6|NOT COMPLETED|Treatment Period 2||0
8289392|NCT01622673|20437523|P5|NOT COMPLETED|Treatment Period 2||0
8289393|NCT01622673|20437524|P4|NOT COMPLETED|Treatment Period 2||1
8289394|NCT01622673|20437525|P3|NOT COMPLETED|Treatment Period 2||0
8289395|NCT01622673|20437526|P2|NOT COMPLETED|Treatment Period 2||0
8289396|NCT01622673|20437527|P1|NOT COMPLETED|Treatment Period 2||0
8289397|NCT01622673|20437522|P6|COMPLETED|Treatment Period 2||4
8289398|NCT01622673|20437523|P5|COMPLETED|Treatment Period 2||4
8289399|NCT01622673|20437524|P4|COMPLETED|Treatment Period 2||4
8289400|NCT01622673|20437525|P3|COMPLETED|Treatment Period 2||4
8289401|NCT01622673|20437526|P2|COMPLETED|Treatment Period 2||4
8289402|NCT01622673|20437527|P1|COMPLETED|Treatment Period 2||4
8289403|NCT01622673|20437522|P6|STARTED|Treatment Period 2||4
8289404|NCT01622673|20437523|P5|STARTED|Treatment Period 2||4
8289405|NCT01622673|20437524|P4|STARTED|Treatment Period 2||5
8289406|NCT01622673|20437525|P3|STARTED|Treatment Period 2||4
8289407|NCT01622673|20437526|P2|STARTED|Treatment Period 2||4
8289408|NCT01622673|20437527|P1|STARTED|Treatment Period 2||4
8289409|NCT01622673|20437522|P6|NOT COMPLETED|Treatment Period 1||0
8289410|NCT01622673|20437523|P5|NOT COMPLETED|Treatment Period 1||0
8289411|NCT01622673|20437524|P4|NOT COMPLETED|Treatment Period 1||1
8289412|NCT01622673|20437525|P3|NOT COMPLETED|Treatment Period 1||0
8289413|NCT01622673|20437526|P2|NOT COMPLETED|Treatment Period 1||1
8289414|NCT01622673|20437527|P1|NOT COMPLETED|Treatment Period 1||0
8289415|NCT01622673|20437522|P6|COMPLETED|Treatment Period 1||4
8289416|NCT01622673|20437523|P5|COMPLETED|Treatment Period 1||4
8289417|NCT01622673|20437524|P4|COMPLETED|Treatment Period 1||5
8289418|NCT01622673|20437525|P3|COMPLETED|Treatment Period 1||4
8289419|NCT01622673|20437526|P2|COMPLETED|Treatment Period 1||4
8289420|NCT01622673|20437527|P1|COMPLETED|Treatment Period 1||4
8289421|NCT01622673|20437522|P6|STARTED|Treatment Period 1||4
8289422|NCT01622673|20437523|P5|STARTED|Treatment Period 1||4
8289423|NCT01622673|20437524|P4|STARTED|Treatment Period 1||6
8289424|NCT01622673|20437525|P3|STARTED|Treatment Period 1||4
8289425|NCT01622673|20437526|P2|STARTED|Treatment Period 1||5
8289426|NCT01622673|20437527|P1|STARTED|Treatment Period 1||4
8289427|NCT01622660|20437562|P1|NOT COMPLETED|Overall Study||1
8289428|NCT01622660|20437562|P1|COMPLETED|Overall Study||1
8289429|NCT01622660|20437562|P1|STARTED|Overall Study||2
8289430|NCT01622569|20437570|P4|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
8289431|NCT01622569|20437571|P3|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
8289432|NCT01622569|20437572|P2|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
8289433|NCT01622569|20437573|P1|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
8289434|NCT01622569|20437570|P4|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
8289435|NCT01622569|20437571|P3|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
8289436|NCT01622569|20437572|P2|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
8289437|NCT01622569|20437573|P1|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
8289438|NCT01622569|20437570|P4|STARTED|Open-Label Extension Phase (Wks 17-24)||75
8289439|NCT01622569|20437571|P3|STARTED|Open-Label Extension Phase (Wks 17-24)||67
8289440|NCT01622569|20437572|P2|STARTED|Open-Label Extension Phase (Wks 17-24)||72
8289441|NCT01622569|20437573|P1|STARTED|Open-Label Extension Phase (Wks 17-24)||68
8289442|NCT01622569|20437570|P4|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
8289443|NCT01622569|20437571|P3|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
8289444|NCT01622569|20437572|P2|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
8289445|NCT01622569|20437573|P1|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
8289446|NCT01622569|20437570|P4|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
8289447|NCT01622569|20437571|P3|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
8289448|NCT01622569|20437572|P2|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
8289449|NCT01622569|20437573|P1|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
8289450|NCT01622569|20437570|P4|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
8289451|NCT01622569|20437571|P3|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
8289452|NCT01622569|20437572|P2|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
8289453|NCT01622569|20437573|P1|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
8289454|NCT01622543|20437642|P2|NOT COMPLETED|Overall Study||0
8289455|NCT01622543|20437643|P1|NOT COMPLETED|Overall Study||0
8289456|NCT01622543|20437642|P2|COMPLETED|Overall Study||52
8289457|NCT01622543|20437643|P1|COMPLETED|Overall Study||51
8289458|NCT01622543|20437642|P2|STARTED|Overall Study||52
8289459|NCT01622543|20437643|P1|STARTED|Overall Study||51
8289460|NCT01622348|20437658|P3|NOT COMPLETED|Overall Study||1
8289461|NCT01622348|20437659|P2|NOT COMPLETED|Overall Study||0
8289462|NCT01622348|20437660|P1|NOT COMPLETED|Overall Study||1
8289463|NCT01622348|20437658|P3|COMPLETED|Overall Study||14
8289464|NCT01622348|20437659|P2|COMPLETED|Overall Study||14
8289465|NCT01622348|20437660|P1|COMPLETED|Overall Study||14
8289466|NCT01622348|20437658|P3|STARTED|Overall Study||15
8289467|NCT01622348|20437659|P2|STARTED|Overall Study||14
8289468|NCT01622348|20437660|P1|STARTED|Overall Study||15
8289469|NCT01622296|20437668|P2|NOT COMPLETED|Second Intervention||0
8289470|NCT01622296|20437669|P1|NOT COMPLETED|Second Intervention||0
8289471|NCT01622296|20437668|P2|COMPLETED|Second Intervention||10
8289472|NCT01622296|20437669|P1|COMPLETED|Second Intervention||10
8289473|NCT01622296|20437668|P2|STARTED|Second Intervention||10
8289474|NCT01622296|20437669|P1|STARTED|Second Intervention||10
8289475|NCT01622296|20437668|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
8289476|NCT01622296|20437669|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
8289477|NCT01622296|20437668|P2|COMPLETED|Washout Period of at Least 1 Week||10
8289478|NCT01622296|20437669|P1|COMPLETED|Washout Period of at Least 1 Week||10
8289479|NCT01622296|20437668|P2|STARTED|Washout Period of at Least 1 Week||10
8289480|NCT01622296|20437669|P1|STARTED|Washout Period of at Least 1 Week||10
8289481|NCT01622296|20437668|P2|NOT COMPLETED|First Intervention||0
8289482|NCT01622296|20437669|P1|NOT COMPLETED|First Intervention||0
8289483|NCT01622296|20437668|P2|COMPLETED|First Intervention||10
8289484|NCT01622296|20437669|P1|COMPLETED|First Intervention||10
8289485|NCT01622296|20437668|P2|STARTED|First Intervention||10
8289486|NCT01622296|20437669|P1|STARTED|First Intervention||10
8289487|NCT01622257|20437677|P3|NOT COMPLETED|Overall Study||0
8289488|NCT01622257|20437678|P2|NOT COMPLETED|Overall Study||0
8289489|NCT01622257|20437679|P1|NOT COMPLETED|Overall Study||0
8289490|NCT01622257|20437677|P3|COMPLETED|Overall Study||66
8289491|NCT01622257|20437678|P2|COMPLETED|Overall Study||66
8289492|NCT01622257|20437679|P1|COMPLETED|Overall Study||66
8289493|NCT01622257|20437677|P3|STARTED|Overall Study||66
8289494|NCT01622257|20437678|P2|STARTED|Overall Study||66
8289495|NCT01622257|20437679|P1|STARTED|Overall Study||66
8289496|NCT01622231|20437699|P1|NOT COMPLETED|Overall Study||2
8289497|NCT01622231|20437699|P1|COMPLETED|Overall Study||59
8289498|NCT01622231|20437699|P1|STARTED|Overall Study||61
8289499|NCT01621880|20437729|P2|NOT COMPLETED|Overall Study||5
8289500|NCT01621880|20437730|P1|NOT COMPLETED|Overall Study||10
8289501|NCT01621880|20437729|P2|COMPLETED|Overall Study||49
8289502|NCT01621880|20437730|P1|COMPLETED|Overall Study||48
8289503|NCT01621880|20437729|P2|STARTED|Overall Study||54
8289504|NCT01621880|20437730|P1|STARTED|Overall Study||58
8289505|NCT01621802|20437744|P6|NOT COMPLETED|Overall Study||12
8289506|NCT01621802|20437745|P5|NOT COMPLETED|Overall Study||35
8289507|NCT01621802|20437746|P4|NOT COMPLETED|Overall Study||11
8289508|NCT01621802|20437747|P3|NOT COMPLETED|Overall Study||33
8289509|NCT01621802|20437748|P2|NOT COMPLETED|Overall Study||23
8289510|NCT01621802|20437749|P1|NOT COMPLETED|Overall Study||47
8289511|NCT01621802|20437744|P6|COMPLETED|Overall Study||477
8289512|NCT01621802|20437745|P5|COMPLETED|Overall Study||1284
8289513|NCT01621802|20437746|P4|COMPLETED|Overall Study||292
8289514|NCT01621802|20437747|P3|COMPLETED|Overall Study||763
8289515|NCT01621802|20437748|P2|COMPLETED|Overall Study||275
8289516|NCT01621802|20437749|P1|COMPLETED|Overall Study||755
8289517|NCT01621802|20437744|P6|STARTED|Overall Study||489
8289518|NCT01621802|20437745|P5|STARTED|Overall Study||1319
8289519|NCT01621802|20437746|P4|STARTED|Overall Study||303
8289520|NCT01621802|20437747|P3|STARTED|Overall Study||796
8289521|NCT01621802|20437748|P2|STARTED|Overall Study||298
8289522|NCT01621802|20437749|P1|STARTED|Overall Study||802
8289523|NCT01621776|20437856|P3|NOT COMPLETED|Overall Study||0
8289524|NCT01621776|20437857|P2|NOT COMPLETED|Overall Study||0
8289525|NCT01621776|20437858|P1|NOT COMPLETED|Overall Study||0
8289526|NCT01621776|20437856|P3|COMPLETED|Overall Study||18
8289527|NCT01621776|20437857|P2|COMPLETED|Overall Study||40
8289528|NCT01621776|20437858|P1|COMPLETED|Overall Study||41
8289529|NCT01621776|20437856|P3|STARTED|Overall Study||18
8289530|NCT01621776|20437857|P2|STARTED|Overall Study||40
8289531|NCT01621776|20437858|P1|STARTED|Overall Study||41
8289532|NCT01621737|20437872|P1|NOT COMPLETED|Overall Study||0
8289533|NCT01621737|20437872|P1|COMPLETED|Overall Study||0
8289534|NCT01621737|20437872|P1|STARTED|Overall Study||0
8289535|NCT01621672|20437892|P2|NOT COMPLETED|Overall Study||0
8289536|NCT01621672|20437893|P1|NOT COMPLETED|Overall Study||0
8289537|NCT01621672|20437892|P2|COMPLETED|Overall Study||17
8289538|NCT01621672|20437893|P1|COMPLETED|Overall Study||25
8289539|NCT01621672|20437892|P2|STARTED|Overall Study||17
8289540|NCT01621672|20437893|P1|STARTED|Overall Study||25
8289541|NCT01621633|20437903|P4|NOT COMPLETED|Overall Study||0
8289542|NCT01621633|20437904|P3|NOT COMPLETED|Overall Study||0
8289543|NCT01621633|20437905|P2|NOT COMPLETED|Overall Study||0
8289544|NCT01621633|20437906|P1|NOT COMPLETED|Overall Study||0
8289545|NCT01621633|20437903|P4|COMPLETED|Overall Study||8
8289546|NCT01621633|20437904|P3|COMPLETED|Overall Study||8
8289547|NCT01621633|20437905|P2|COMPLETED|Overall Study||8
8289548|NCT01621633|20437906|P1|COMPLETED|Overall Study||8
8289549|NCT01621633|20437903|P4|STARTED|Overall Study||8
8289550|NCT01621633|20437904|P3|STARTED|Overall Study||8
8289551|NCT01621633|20437905|P2|STARTED|Overall Study||8
8289552|NCT01621633|20437906|P1|STARTED|Overall Study||8
8289553|NCT01621542|20437934|P6|NOT COMPLETED|Overall Study||9
8289554|NCT01621542|20437935|P5|NOT COMPLETED|Overall Study||9
8289555|NCT01621542|20437936|P4|NOT COMPLETED|Overall Study||28
8289556|NCT01621542|20437937|P3|NOT COMPLETED|Overall Study||6
8289557|NCT01621542|20437938|P2|NOT COMPLETED|Overall Study||5
8289558|NCT01621542|20437939|P1|NOT COMPLETED|Overall Study||5
8289559|NCT01621542|20437934|P6|COMPLETED|Overall Study||0
8289560|NCT01621542|20437935|P5|COMPLETED|Overall Study||0
8289561|NCT01621542|20437936|P4|COMPLETED|Overall Study||0
8289562|NCT01621542|20437937|P3|COMPLETED|Overall Study||0
8289563|NCT01621542|20437938|P2|COMPLETED|Overall Study||0
8289564|NCT01621542|20437939|P1|COMPLETED|Overall Study||0
8289565|NCT01621542|20437934|P6|STARTED|Overall Study||9
8289566|NCT01621542|20437935|P5|STARTED|Overall Study||9
8289567|NCT01621542|20437936|P4|STARTED|Overall Study||28
8289568|NCT01621542|20437937|P3|STARTED|Overall Study||6
8289569|NCT01621542|20437938|P2|STARTED|Overall Study||5
8289570|NCT01621542|20437939|P1|STARTED|Overall Study||5
8289571|NCT01621490|20437980|P9|NOT COMPLETED|Overall Study||8
8289572|NCT01621490|20437981|P8|NOT COMPLETED|Overall Study||10
8289573|NCT01621490|20437982|P7|NOT COMPLETED|Overall Study||11
8289574|NCT01621490|20437983|P6|NOT COMPLETED|Overall Study||24
8289575|NCT01621490|20437984|P5|NOT COMPLETED|Overall Study||6
8289576|NCT01621490|20437985|P4|NOT COMPLETED|Overall Study||9
8289577|NCT01621490|20437986|P3|NOT COMPLETED|Overall Study||11
8289578|NCT01621490|20437987|P2|NOT COMPLETED|Overall Study||44
8289579|NCT01621490|20437988|P1|NOT COMPLETED|Overall Study||41
8289580|NCT01621490|20437980|P9|COMPLETED|Overall Study||2
8289581|NCT01621490|20437981|P8|COMPLETED|Overall Study||0
8289582|NCT01621490|20437982|P7|COMPLETED|Overall Study||0
8289583|NCT01621490|20437983|P6|COMPLETED|Overall Study||1
8289584|NCT01621490|20437984|P5|COMPLETED|Overall Study||0
8289585|NCT01621490|20437985|P4|COMPLETED|Overall Study||1
8289586|NCT01621490|20437986|P3|COMPLETED|Overall Study||0
8289587|NCT01621490|20437987|P2|COMPLETED|Overall Study||0
8289588|NCT01621490|20437988|P1|COMPLETED|Overall Study||0
8289589|NCT01621490|20437980|P9|STARTED|Overall Study||10
8289590|NCT01621490|20437981|P8|STARTED|Overall Study||10
8289591|NCT01621490|20437982|P7|STARTED|Overall Study||11
8289592|NCT01621490|20437983|P6|STARTED|Overall Study||25
8289593|NCT01621490|20437984|P5|STARTED|Overall Study||6
8289594|NCT01621490|20437985|P4|STARTED|Overall Study||10
8289595|NCT01621490|20437986|P3|STARTED|Overall Study||11
8289596|NCT01621490|20437987|P2|STARTED|Overall Study||44
8289597|NCT01621490|20437988|P1|STARTED|Overall Study||41
8289598|NCT01621477|20438214|P1|NOT COMPLETED|Overall Study||0
8289599|NCT01621477|20438214|P1|COMPLETED|Overall Study||17
8289600|NCT01621477|20438214|P1|STARTED|Overall Study||17
8289601|NCT01621230|20438226|P2|NOT COMPLETED|Overall Study||0
8289602|NCT01621230|20438227|P1|NOT COMPLETED|Overall Study||0
8289603|NCT01621230|20438226|P2|COMPLETED|Overall Study||156
8289604|NCT01621230|20438227|P1|COMPLETED|Overall Study||154
8289605|NCT01621230|20438226|P2|STARTED|Overall Study||156
8289606|NCT01621230|20438227|P1|STARTED|Overall Study||154
8289607|NCT01621191|20438240|P1|NOT COMPLETED|Overall Study||25
8289608|NCT01621191|20438240|P1|COMPLETED|Overall Study||124
8289609|NCT01621191|20438240|P1|Had at Least 1 Post-Baseline Observation|Overall Study||148
8289610|NCT01621191|20438240|P1|Received at Least 1 Dose of Study Drug|Overall Study||149
8289611|NCT01621191|20438240|P1|STARTED|Overall Study||149
8289612|NCT01621178|20438254|P3|NOT COMPLETED|Overall Study||36
8289613|NCT01621178|20438255|P2|NOT COMPLETED|Overall Study||30
8289614|NCT01621178|20438256|P1|NOT COMPLETED|Overall Study||31
8289615|NCT01621178|20438254|P3|COMPLETED|Overall Study||157
8289616|NCT01621178|20438255|P2|COMPLETED|Overall Study||160
8289617|NCT01621178|20438256|P1|COMPLETED|Overall Study||163
8289618|NCT01621178|20438254|P3|Modified Intent to Treat Population|Overall Study||183
8289619|NCT01621178|20438255|P2|Modified Intent to Treat Population|Overall Study||180
8289620|NCT01621178|20438256|P1|Modified Intent to Treat Population|Overall Study||186
8289621|NCT01621178|20438254|P3|Received at Least One Dose of Study Drug|Overall Study||192
8289622|NCT01621178|20438255|P2|Received at Least One Dose of Study Drug|Overall Study||190
8289623|NCT01621178|20438256|P1|Received at Least One Dose of Study Drug|Overall Study||194
8289624|NCT01621178|20438254|P3|STARTED|Overall Study||193
8289625|NCT01621178|20438255|P2|STARTED|Overall Study||190
8289626|NCT01621178|20438256|P1|STARTED|Overall Study||194
8289627|NCT01621126|20438348|P1|NOT COMPLETED|Overall Study||6
8289628|NCT01621126|20438348|P1|COMPLETED|Overall Study||34
8289629|NCT01621126|20438348|P1|STARTED|Overall Study||40
8289630|NCT01621009|20438356|P4|NOT COMPLETED|Overall Study||53
8289631|NCT01621009|20438357|P3|NOT COMPLETED|Overall Study||63
8289632|NCT01621009|20438358|P2|NOT COMPLETED|Overall Study||51
8289633|NCT01621009|20438359|P1|NOT COMPLETED|Overall Study||43
8289634|NCT01621009|20438356|P4|COMPLETED|Overall Study||60
8289635|NCT01621009|20438357|P3|COMPLETED|Overall Study||58
8289636|NCT01621009|20438358|P2|COMPLETED|Overall Study||65
8289637|NCT01621009|20438359|P1|COMPLETED|Overall Study||70
8289638|NCT01621009|20438356|P4|STARTED|Overall Study||113
8289639|NCT01621009|20438357|P3|STARTED|Overall Study||121
8289640|NCT01621009|20438358|P2|STARTED|Overall Study||116
8289641|NCT01621009|20438359|P1|STARTED|Overall Study||113
8289642|NCT01620983|20438370|P3|NOT COMPLETED|Overall Study||15
8289643|NCT01620983|20438371|P2|NOT COMPLETED|Overall Study||22
8289644|NCT01620983|20438372|P1|NOT COMPLETED|Overall Study||19
8289645|NCT01620983|20438370|P3|COMPLETED|Overall Study||122
8289646|NCT01620983|20438371|P2|COMPLETED|Overall Study||113
8289647|NCT01620983|20438372|P1|COMPLETED|Overall Study||111
8289648|NCT01620983|20438370|P3|STARTED|Overall Study||137
8289649|NCT01620983|20438371|P2|STARTED|Overall Study||135
8289650|NCT01620983|20438372|P1|STARTED|Overall Study||130
8289651|NCT01620762|20438401|P3|NOT COMPLETED|Overall Study||53
8289652|NCT01620762|20438402|P2|NOT COMPLETED|Overall Study||58
8289653|NCT01620762|20438403|P1|NOT COMPLETED|Overall Study||48
8289654|NCT01620762|20438401|P3|COMPLETED|Overall Study||417
8289655|NCT01620762|20438402|P2|COMPLETED|Overall Study||412
8289656|NCT01620762|20438403|P1|COMPLETED|Overall Study||420
8289657|NCT01620762|20438401|P3|STARTED|Overall Study||470
8289658|NCT01620762|20438402|P2|STARTED|Overall Study||470
8289659|NCT01620762|20438403|P1|STARTED|Overall Study||468
8289660|NCT01620593|20438431|P2|NOT COMPLETED|Overall Study||1
8289661|NCT01620593|20438432|P1|NOT COMPLETED|Overall Study||4
8289662|NCT01620593|20438431|P2|COMPLETED|Overall Study||19
8289663|NCT01620593|20438432|P1|COMPLETED|Overall Study||17
8289664|NCT01620593|20438431|P2|STARTED|Overall Study||20
8289665|NCT01620593|20438432|P1|STARTED|Overall Study||21
8289666|NCT01620567|20438448|P2|NOT COMPLETED|Overall Study||5
8289667|NCT01620567|20438449|P1|NOT COMPLETED|Overall Study||3
8289668|NCT01620567|20438448|P2|COMPLETED|Overall Study||20
8289669|NCT01620567|20438449|P1|COMPLETED|Overall Study||20
8289670|NCT01620567|20438448|P2|STARTED|Overall Study||25
8289671|NCT01620567|20438449|P1|STARTED|Overall Study||23
8289672|NCT01620528|20438464|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||14
8289673|NCT01620528|20438465|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||17
8289674|NCT01620528|20438466|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||20
8289675|NCT01620528|20438464|P3|COMPLETED|Post-Treatment Follow-Up Period||37
8289676|NCT01620528|20438465|P2|COMPLETED|Post-Treatment Follow-Up Period||31
8289677|NCT01620528|20438466|P1|COMPLETED|Post-Treatment Follow-Up Period||48
8289678|NCT01620528|20438464|P3|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
8289679|NCT01620528|20438465|P2|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
8289680|NCT01620528|20438466|P1|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
8289681|NCT01620528|20438464|P3|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
8289682|NCT01620528|20438465|P2|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
8289683|NCT01620528|20438466|P1|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
8289684|NCT01620528|20438464|P3|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
8289685|NCT01620528|20438465|P2|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
8289686|NCT01620528|20438466|P1|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
8289687|NCT01620528|20438464|P3|NOT COMPLETED|Treatment Period||66
8289688|NCT01620528|20438465|P2|NOT COMPLETED|Treatment Period||53
8289689|NCT01620528|20438466|P1|NOT COMPLETED|Treatment Period||100
8289690|NCT01620528|20438464|P3|COMPLETED|Treatment Period||183
8289691|NCT01620528|20438465|P2|COMPLETED|Treatment Period||196
8289692|NCT01620528|20438466|P1|COMPLETED|Treatment Period||274
8289693|NCT01620528|20438464|P3|STARTED|Treatment Period|1 subject did not receive study drug|249
8289694|NCT01620528|20438465|P2|STARTED|Treatment Period||249
8289695|NCT01620528|20438466|P1|STARTED|Treatment Period||374
8289696|NCT01620489|20438806|P2|NOT COMPLETED|Overall Study||34
8289697|NCT01620489|20438807|P1|NOT COMPLETED|Overall Study||35
8289698|NCT01620489|20438806|P2|COMPLETED|Overall Study|2 subjects did not take trial product|105
8289699|NCT01620489|20438807|P1|COMPLETED|Overall Study||105
8289700|NCT01620489|20438806|P2|Exposed|Overall Study|2 subjects did not take trial product|137
8289701|NCT01620489|20438807|P1|Exposed|Overall Study||140
8289702|NCT01620489|20438806|P2|STARTED|Overall Study||139
8289703|NCT01620489|20438807|P1|STARTED|Overall Study||140
8289724|NCT01620177|20438909|P1|NOT COMPLETED|Overall Study||79
8289725|NCT01620177|20438909|P1|COMPLETED|Overall Study||19
8289726|NCT01620177|20438909|P1|STARTED|Overall Study||98
8289727|NCT01620138|20438934|P2|NOT COMPLETED|Overall Study||0
8289728|NCT01620138|20438935|P1|NOT COMPLETED|Overall Study||6
8289729|NCT01620138|20438934|P2|COMPLETED|Overall Study||9
8289730|NCT01620138|20438935|P1|COMPLETED|Overall Study||6
8289731|NCT01620138|20438934|P2|STARTED|Overall Study||9
8289732|NCT01620138|20438935|P1|STARTED|Overall Study||12
8289733|NCT01620086|20438943|P3|NOT COMPLETED|Overall Study||0
8289734|NCT01620086|20438944|P2|NOT COMPLETED|Overall Study||7
8289735|NCT01620086|20438945|P1|NOT COMPLETED|Overall Study||5
8289736|NCT01620086|20438943|P3|COMPLETED|Overall Study||2
8289737|NCT01620086|20438944|P2|COMPLETED|Overall Study||4
8289738|NCT01620086|20438945|P1|COMPLETED|Overall Study||8
8289739|NCT01620086|20438943|P3|STARTED|Overall Study||2
8289740|NCT01620086|20438944|P2|STARTED|Overall Study||11
8289741|NCT01620086|20438945|P1|STARTED|Overall Study||13
8289742|NCT01620060|20438964|P1|NOT COMPLETED|Overall Study||15
8289743|NCT01620060|20438964|P1|COMPLETED|Overall Study||90
8289744|NCT01620060|20438964|P1|STARTED|Overall Study||105
8289745|NCT01620047|20438973|P3|NOT COMPLETED|Overall Study||0
8289746|NCT01620047|20438974|P2|NOT COMPLETED|Overall Study||0
8289747|NCT01620047|20438975|P1|NOT COMPLETED|Overall Study||0
8289748|NCT01620047|20438973|P3|COMPLETED|Overall Study||20
8289749|NCT01620047|20438974|P2|COMPLETED|Overall Study||20
8289750|NCT01620047|20438975|P1|COMPLETED|Overall Study||20
8289751|NCT01620047|20438973|P3|STARTED|Overall Study||20
8289752|NCT01620047|20438974|P2|STARTED|Overall Study||20
8289753|NCT01620047|20438975|P1|STARTED|Overall Study||20
8289754|NCT01619982|20438985|P2|NOT COMPLETED|Overall Study||0
8289755|NCT01619982|20438986|P1|NOT COMPLETED|Overall Study||0
8289756|NCT01619982|20438985|P2|COMPLETED|Overall Study||12
8289757|NCT01619982|20438986|P1|COMPLETED|Overall Study||20
8289758|NCT01619982|20438985|P2|STARTED|Overall Study||12
8289759|NCT01619982|20438986|P1|STARTED|Overall Study||20
8289760|NCT01619878|20439002|P1|NOT COMPLETED|Follow-up at 12 Months of Age||3
8289761|NCT01619878|20439002|P1|COMPLETED|Follow-up at 12 Months of Age||17
8289762|NCT01619878|20439002|P1|STARTED|Follow-up at 12 Months of Age||20
8289763|NCT01619878|20439002|P1|NOT COMPLETED|6 Week Follow-up Phase||1
8289764|NCT01619878|20439002|P1|COMPLETED|6 Week Follow-up Phase||19
8289765|NCT01619878|20439002|P1|STARTED|6 Week Follow-up Phase||20
8289766|NCT01619852|20439016|P2|NOT COMPLETED|3 Month Follow up||34
8289767|NCT01619852|20439017|P1|NOT COMPLETED|3 Month Follow up||31
8289768|NCT01619852|20439016|P2|COMPLETED|3 Month Follow up||40
8289769|NCT01619852|20439017|P1|COMPLETED|3 Month Follow up||43
8289770|NCT01619852|20439016|P2|STARTED|3 Month Follow up||74
8289771|NCT01619852|20439017|P1|STARTED|3 Month Follow up||74
8289772|NCT01619852|20439016|P2|NOT COMPLETED|24 Hour Assessment||1
8289773|NCT01619852|20439017|P1|NOT COMPLETED|24 Hour Assessment||1
8289774|NCT01619852|20439016|P2|COMPLETED|24 Hour Assessment||74
8289775|NCT01619852|20439017|P1|COMPLETED|24 Hour Assessment||74
8289776|NCT01619852|20439016|P2|STARTED|24 Hour Assessment||75
8289777|NCT01619852|20439017|P1|STARTED|24 Hour Assessment||75
8289778|NCT01619800|20439033|P2|NOT COMPLETED|Overall Study||0
8289779|NCT01619800|20439034|P1|NOT COMPLETED|Overall Study||2
8289780|NCT01619800|20439033|P2|COMPLETED|Overall Study||0
8289781|NCT01619800|20439034|P1|COMPLETED|Overall Study||0
8289782|NCT01619800|20439033|P2|STARTED|Overall Study||0
8289783|NCT01619800|20439034|P1|STARTED|Overall Study||2
8289784|NCT01619787|20439042|P1|NOT COMPLETED|Overall Study||5
8289785|NCT01619787|20439042|P1|COMPLETED|Overall Study||212
8289786|NCT01619787|20439042|P1|STARTED|Overall Study||217
8289787|NCT01619774|20439051|P1|NOT COMPLETED|Overall Study||0
8289788|NCT01619774|20439051|P1|COMPLETED|Overall Study||23
8289789|NCT01619774|20439051|P1|STARTED|Overall Study||23
8289790|NCT01619579|20439059|P2|NOT COMPLETED|Overall Study||3
8289791|NCT01619579|20439060|P1|NOT COMPLETED|Overall Study||0
8289792|NCT01619579|20439059|P2|COMPLETED|Overall Study||14
8289793|NCT01619579|20439060|P1|COMPLETED|Overall Study||5
8289794|NCT01619579|20439059|P2|STARTED|Overall Study||17
8289795|NCT01619579|20439060|P1|STARTED|Overall Study||5
8289796|NCT01619423|20439074|P4|NOT COMPLETED|Part 2b||0
8289797|NCT01619423|20439075|P3|NOT COMPLETED|Part 2b||0
8289798|NCT01619423|20439076|P2|NOT COMPLETED|Part 2b||0
8289799|NCT01619423|20439077|P1|NOT COMPLETED|Part 2b||0
8289800|NCT01619423|20439074|P4|COMPLETED|Part 2b||0
8289801|NCT01619423|20439075|P3|COMPLETED|Part 2b||45
8289802|NCT01619423|20439076|P2|COMPLETED|Part 2b||44
8289803|NCT01619423|20439077|P1|COMPLETED|Part 2b||45
8289804|NCT01619423|20439074|P4|STARTED|Part 2b||0
8289805|NCT01619423|20439075|P3|STARTED|Part 2b||45
8289806|NCT01619423|20439076|P2|STARTED|Part 2b||44
8289807|NCT01619423|20439077|P1|STARTED|Part 2b||45
8289808|NCT01619423|20439074|P4|NOT COMPLETED|Part 2a||0
8289809|NCT01619423|20439075|P3|NOT COMPLETED|Part 2a||0
8289810|NCT01619423|20439076|P2|NOT COMPLETED|Part 2a||0
8289811|NCT01619423|20439077|P1|NOT COMPLETED|Part 2a||0
8289812|NCT01619423|20439074|P4|COMPLETED|Part 2a||11
8289813|NCT01619423|20439075|P3|COMPLETED|Part 2a||0
8289814|NCT01619423|20439076|P2|COMPLETED|Part 2a||13
8289815|NCT01619423|20439077|P1|COMPLETED|Part 2a||15
8289816|NCT01619423|20439074|P4|STARTED|Part 2a||11
8289817|NCT01619423|20439075|P3|STARTED|Part 2a||0
8289818|NCT01619423|20439076|P2|STARTED|Part 2a||13
8289819|NCT01619423|20439077|P1|STARTED|Part 2a||15
8289820|NCT01619423|20439074|P4|NOT COMPLETED|Part 1 (Dose Escalation)||0
8289821|NCT01619423|20439075|P3|NOT COMPLETED|Part 1 (Dose Escalation)||0
8289822|NCT01619423|20439076|P2|NOT COMPLETED|Part 1 (Dose Escalation)||2
8289823|NCT01619423|20439077|P1|NOT COMPLETED|Part 1 (Dose Escalation)||0
8289824|NCT01619423|20439074|P4|COMPLETED|Part 1 (Dose Escalation)||5
8289825|NCT01619423|20439075|P3|COMPLETED|Part 1 (Dose Escalation)||3
8289826|NCT01619423|20439076|P2|COMPLETED|Part 1 (Dose Escalation)||3
8289827|NCT01619423|20439077|P1|COMPLETED|Part 1 (Dose Escalation)||0
8289828|NCT01619423|20439074|P4|STARTED|Part 1 (Dose Escalation)||5
8289829|NCT01619423|20439075|P3|STARTED|Part 1 (Dose Escalation)||3
8289830|NCT01619423|20439076|P2|STARTED|Part 1 (Dose Escalation)||5
8289831|NCT01619423|20439077|P1|STARTED|Part 1 (Dose Escalation)||0
8289832|NCT01619410|20439090|P2|NOT COMPLETED|Overall Study||4
8289833|NCT01619410|20439091|P1|NOT COMPLETED|Overall Study||7
8289834|NCT01619410|20439090|P2|COMPLETED|Overall Study||7
8289835|NCT01619410|20439091|P1|COMPLETED|Overall Study||7
8289836|NCT01619410|20439090|P2|STARTED|Overall Study||11
8289837|NCT01619410|20439091|P1|STARTED|Overall Study||14
8289841|NCT01619059|20439109|P2|NOT COMPLETED|Long-Term (LT) Treatment Period||9
8289842|NCT01619059|20439110|P1|NOT COMPLETED|Long-Term (LT) Treatment Period||8
8289843|NCT01619059|20439109|P2|COMPLETED|Long-Term (LT) Treatment Period||133
8289844|NCT01619059|20439110|P1|COMPLETED|Long-Term (LT) Treatment Period||147
8289845|NCT01619059|20439109|P2|STARTED|Long-Term (LT) Treatment Period||142
8289846|NCT01619059|20439110|P1|STARTED|Long-Term (LT) Treatment Period||155
8289847|NCT01619059|20439109|P2|NOT COMPLETED|Short-Term (ST) Treatment Period||11
8289848|NCT01619059|20439110|P1|NOT COMPLETED|Short-Term (ST) Treatment Period||6
8289849|NCT01619059|20439109|P2|COMPLETED|Short-Term (ST) Treatment Period||142
8289850|NCT01619059|20439110|P1|COMPLETED|Short-Term (ST) Treatment Period||156
8289851|NCT01619059|20439109|P2|STARTED|Short-Term (ST) Treatment Period||153
8289852|NCT01619059|20439110|P1|STARTED|Short-Term (ST) Treatment Period||162
8289853|NCT01618968|20439126|P4|NOT COMPLETED|Overall Study||1
8289854|NCT01618968|20439127|P3|NOT COMPLETED|Overall Study||0
8289855|NCT01618968|20439128|P2|NOT COMPLETED|Overall Study||0
8289856|NCT01618968|20439129|P1|NOT COMPLETED|Overall Study||1
8289857|NCT01618968|20439126|P4|COMPLETED|Overall Study||11
8289858|NCT01618968|20439127|P3|COMPLETED|Overall Study||12
8289859|NCT01618968|20439128|P2|COMPLETED|Overall Study||12
8289860|NCT01618968|20439129|P1|COMPLETED|Overall Study||12
8289861|NCT01618968|20439126|P4|Received Treatment C|Overall Study||11
8289862|NCT01618968|20439127|P3|Received Treatment C|Overall Study||12
8289863|NCT01618968|20439128|P2|Received Treatment C|Overall Study||12
8289864|NCT01618968|20439129|P1|Received Treatment C|Overall Study||12
8289865|NCT01618968|20439126|P4|Received Treatment B|Overall Study||12
8289866|NCT01618968|20439127|P3|Received Treatment B|Overall Study||12
8289867|NCT01618968|20439128|P2|Received Treatment B|Overall Study||12
8289868|NCT01618968|20439129|P1|Received Treatment B|Overall Study||13
8289869|NCT01618968|20439126|P4|Received Treatment A|Overall Study||11
8289870|NCT01618968|20439127|P3|Received Treatment A|Overall Study||12
8289871|NCT01618968|20439128|P2|Received Treatment A|Overall Study||12
8289872|NCT01618968|20439129|P1|Received Treatment A|Overall Study||12
8289873|NCT01618968|20439126|P4|STARTED|Overall Study||12
8289874|NCT01618968|20439127|P3|STARTED|Overall Study||12
8289875|NCT01618968|20439128|P2|STARTED|Overall Study||12
8289876|NCT01618968|20439129|P1|STARTED|Overall Study||13
8289877|NCT01618955|20439148|P4|NOT COMPLETED|Overall Study||0
8289878|NCT01618955|20439149|P3|NOT COMPLETED|Overall Study||0
8289879|NCT01618955|20439150|P2|NOT COMPLETED|Overall Study||0
8289880|NCT01618955|20439151|P1|NOT COMPLETED|Overall Study||0
8289881|NCT01618955|20439148|P4|COMPLETED|Overall Study||20
8289882|NCT01618955|20439149|P3|COMPLETED|Overall Study||31
8289883|NCT01618955|20439150|P2|COMPLETED|Overall Study||30
8289884|NCT01618955|20439151|P1|COMPLETED|Overall Study||20
8289885|NCT01618955|20439148|P4|STARTED|Overall Study||20
8289886|NCT01618955|20439149|P3|STARTED|Overall Study||31
8289887|NCT01618955|20439150|P2|STARTED|Overall Study||30
8289888|NCT01618955|20439151|P1|STARTED|Overall Study||20
8289889|NCT01618942|20439175|P2|NOT COMPLETED|Overall Study||0
8289890|NCT01618942|20439176|P1|NOT COMPLETED|Overall Study||0
8289891|NCT01618942|20439175|P2|COMPLETED|Overall Study||50
8289892|NCT01618942|20439176|P1|COMPLETED|Overall Study||50
8289893|NCT01618942|20439175|P2|STARTED|Overall Study||50
8289894|NCT01618942|20439176|P1|STARTED|Overall Study||50
8289895|NCT01618916|20439202|P6|NOT COMPLETED|Overall Study||0
8289896|NCT01618916|20439203|P5|NOT COMPLETED|Overall Study||1
8289897|NCT01618916|20439204|P4|NOT COMPLETED|Overall Study||2
8289898|NCT01618916|20439205|P3|NOT COMPLETED|Overall Study||1
8289899|NCT01618916|20439206|P2|NOT COMPLETED|Overall Study||1
8289900|NCT01618916|20439207|P1|NOT COMPLETED|Overall Study||2
8289901|NCT01618916|20439202|P6|COMPLETED|Overall Study||4
8289902|NCT01618916|20439203|P5|COMPLETED|Overall Study||4
8289903|NCT01618916|20439204|P4|COMPLETED|Overall Study||7
8289904|NCT01618916|20439205|P3|COMPLETED|Overall Study||10
8289905|NCT01618916|20439206|P2|COMPLETED|Overall Study||9
8289906|NCT01618916|20439207|P1|COMPLETED|Overall Study||10
8289907|NCT01618916|20439202|P6|Received At Least 1 Dose of Study Drug|Overall Study||4
8289908|NCT01618916|20439203|P5|Received At Least 1 Dose of Study Drug|Overall Study||5
8289909|NCT01618916|20439204|P4|Received At Least 1 Dose of Study Drug|Overall Study||9
8289910|NCT01618916|20439205|P3|Received At Least 1 Dose of Study Drug|Overall Study||11
8289911|NCT01618916|20439206|P2|Received At Least 1 Dose of Study Drug|Overall Study||10
8289912|NCT01618916|20439207|P1|Received At Least 1 Dose of Study Drug|Overall Study||12
8289913|NCT01618916|20439202|P6|STARTED|Overall Study||4
8289914|NCT01618916|20439203|P5|STARTED|Overall Study||5
8289915|NCT01618916|20439204|P4|STARTED|Overall Study||9
8289916|NCT01618916|20439205|P3|STARTED|Overall Study||11
8289917|NCT01618916|20439206|P2|STARTED|Overall Study||10
8289918|NCT01618916|20439207|P1|STARTED|Overall Study||12
8289919|NCT01618864|20439237|P1|NOT COMPLETED|Overall Study||4
8289920|NCT01618864|20439237|P1|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
8289921|NCT01618864|20439237|P1|Completed 2 Weeks|Overall Study||19
8289922|NCT01618864|20439237|P1|STARTED|Overall Study||23
8289923|NCT01618838|20439246|P1|NOT COMPLETED|Overall Study||4
8289924|NCT01618838|20439246|P1|COMPLETED|Overall Study||0
8289925|NCT01618838|20439246|P1|STARTED|Overall Study||4
8289926|NCT01618708|20439254|P2|NOT COMPLETED|Overall Study||46
8289927|NCT01618708|20439255|P1|NOT COMPLETED|Overall Study||44
8289928|NCT01618708|20439254|P2|COMPLETED|Overall Study||136
8289929|NCT01618708|20439255|P1|COMPLETED|Overall Study||131
8289930|NCT01618708|20439254|P2|Treated|Overall Study||180
8289931|NCT01618708|20439255|P1|Treated|Overall Study||172
8289932|NCT01618708|20439254|P2|STARTED|Overall Study||182
8289933|NCT01618708|20439255|P1|STARTED|Overall Study||175
8289950|NCT01618669|20439298|P2|NOT COMPLETED|Overall Study||23
8289951|NCT01618669|20439299|P1|NOT COMPLETED|Overall Study||34
8289952|NCT01618669|20439298|P2|COMPLETED|Overall Study||546
8289953|NCT01618669|20439299|P1|COMPLETED|Overall Study||544
8289954|NCT01618669|20439298|P2|Received Treatment|Overall Study||567
8289955|NCT01618669|20439299|P1|Received Treatment|Overall Study||575
8289956|NCT01618669|20439298|P2|STARTED|Overall Study||569
8289957|NCT01618669|20439299|P1|STARTED|Overall Study||578
8289958|NCT01618422|20439345|P2|NOT COMPLETED|Overall Study||0
8289959|NCT01618422|20439346|P1|NOT COMPLETED|Overall Study||0
8289960|NCT01618422|20439345|P2|COMPLETED|Overall Study||111
8289961|NCT01618422|20439346|P1|COMPLETED|Overall Study||114
8289962|NCT01618422|20439345|P2|STARTED|Overall Study||111
8289963|NCT01618422|20439346|P1|STARTED|Overall Study||114
8289964|NCT01618344|20439352|P1|NOT COMPLETED|Overall Study||9
8289965|NCT01618344|20439352|P1|COMPLETED|Overall Study||23
8289966|NCT01618344|20439352|P1|STARTED|Overall Study||32
8289967|NCT01618305|20439358|P2|NOT COMPLETED|Overall Study||10
8289968|NCT01618305|20439359|P1|NOT COMPLETED|Overall Study||15
8289969|NCT01618305|20439358|P2|COMPLETED|Overall Study||196
8289970|NCT01618305|20439359|P1|COMPLETED|Overall Study||187
8289971|NCT01618305|20439358|P2|STARTED|Overall Study||206
8289972|NCT01618305|20439359|P1|STARTED|Overall Study||202
8289973|NCT01618266|20439401|P1|NOT COMPLETED|Overall Study||96
8289974|NCT01618266|20439401|P1|COMPLETED|Overall Study||279
8289975|NCT01618266|20439401|P1|STARTED|Overall Study||375
8289976|NCT01618240|20439416|P1|NOT COMPLETED|Overall Study||0
8289977|NCT01618240|20439416|P1|COMPLETED|Overall Study||30
8289978|NCT01618240|20439416|P1|STARTED|Overall Study||30
8289979|NCT01618227|20439423|P2|NOT COMPLETED|Overall Study||2
8289980|NCT01618227|20439424|P1|NOT COMPLETED|Overall Study||0
8289981|NCT01618227|20439423|P2|COMPLETED|Overall Study||0
8289982|NCT01618227|20439424|P1|COMPLETED|Overall Study||2
8289983|NCT01618227|20439423|P2|STARTED|Overall Study||2
8289984|NCT01618227|20439424|P1|STARTED|Overall Study||2
8289985|NCT01618214|20439438|P2|NOT COMPLETED|Overall Study||13
8289986|NCT01618214|20439439|P1|NOT COMPLETED|Overall Study||10
8289987|NCT01618214|20439438|P2|COMPLETED|Overall Study||159
8289988|NCT01618214|20439439|P1|COMPLETED|Overall Study||162
8289989|NCT01618214|20439438|P2|Exposed|Overall Study||172
8289990|NCT01618214|20439439|P1|Exposed|Overall Study||172
8289991|NCT01618214|20439438|P2|STARTED|Overall Study||172
8289992|NCT01618214|20439439|P1|STARTED|Overall Study||172
8289993|NCT01618162|20439455|P2|NOT COMPLETED|Overall Study||35
8289994|NCT01618162|20439456|P1|NOT COMPLETED|Overall Study||38
8289995|NCT01618162|20439455|P2|COMPLETED|Overall Study||111
8289996|NCT01618162|20439456|P1|COMPLETED|Overall Study||251
8289997|NCT01618162|20439455|P2|Exposed|Overall Study||146
8289998|NCT01618162|20439456|P1|Exposed|Overall Study||288
8289999|NCT01618162|20439455|P2|STARTED|Overall Study||146
8290000|NCT01618162|20439456|P1|STARTED|Overall Study||289
8290001|NCT01618019|20439476|P2|NOT COMPLETED|Overall Study||14
8290002|NCT01618019|20439477|P1|NOT COMPLETED|Overall Study||14
8290003|NCT01618019|20439476|P2|COMPLETED|Overall Study||40
8290004|NCT01618019|20439477|P1|COMPLETED|Overall Study||41
8290005|NCT01618019|20439476|P2|STARTED|Overall Study||54
8290006|NCT01618019|20439477|P1|STARTED|Overall Study||55
8290007|NCT01617967|20439503|P6|NOT COMPLETED|Overall Study||1
8290008|NCT01617967|20439504|P5|NOT COMPLETED|Overall Study||0
8290009|NCT01617967|20439505|P4|NOT COMPLETED|Overall Study||1
8290010|NCT01617967|20439506|P3|NOT COMPLETED|Overall Study||0
8290011|NCT01617967|20439507|P2|NOT COMPLETED|Overall Study||0
8290012|NCT01617967|20439508|P1|NOT COMPLETED|Overall Study||1
8290013|NCT01617967|20439503|P6|COMPLETED|Overall Study||8
8290014|NCT01617967|20439504|P5|COMPLETED|Overall Study||3
8290015|NCT01617967|20439505|P4|COMPLETED|Overall Study||6
8290016|NCT01617967|20439506|P3|COMPLETED|Overall Study||3
8290017|NCT01617967|20439507|P2|COMPLETED|Overall Study||3
8290018|NCT01617967|20439508|P1|COMPLETED|Overall Study||3
8290019|NCT01617967|20439503|P6|STARTED|Overall Study||9
8290020|NCT01617967|20439504|P5|STARTED|Overall Study||3
8290021|NCT01617967|20439505|P4|STARTED|Overall Study||7
8290022|NCT01617967|20439506|P3|STARTED|Overall Study||3
8290023|NCT01617967|20439507|P2|STARTED|Overall Study||3
8290024|NCT01617967|20439508|P1|STARTED|Overall Study||4
8290025|NCT01617681|20439562|P5|NOT COMPLETED|Period 2 Open Label||6
8290026|NCT01617681|20439563|P4|NOT COMPLETED|Period 2 Open Label||0
8290027|NCT01617681|20439564|P3|NOT COMPLETED|Period 2 Open Label||0
8290028|NCT01617681|20439565|P2|NOT COMPLETED|Period 2 Open Label||0
8290029|NCT01617681|20439566|P1|NOT COMPLETED|Period 2 Open Label||0
8290030|NCT01617681|20439562|P5|COMPLETED|Period 2 Open Label||114
8290031|NCT01617681|20439563|P4|COMPLETED|Period 2 Open Label||0
8290032|NCT01617681|20439564|P3|COMPLETED|Period 2 Open Label||0
8290033|NCT01617681|20439565|P2|COMPLETED|Period 2 Open Label||0
8290034|NCT01617681|20439566|P1|COMPLETED|Period 2 Open Label||0
8290035|NCT01617681|20439562|P5|STARTED|Period 2 Open Label||120
8290036|NCT01617681|20439563|P4|STARTED|Period 2 Open Label||0
8290037|NCT01617681|20439564|P3|STARTED|Period 2 Open Label||0
8290038|NCT01617681|20439565|P2|STARTED|Period 2 Open Label||0
8290039|NCT01617681|20439566|P1|STARTED|Period 2 Open Label||0
8290040|NCT01617681|20439562|P5|NOT COMPLETED|Period 1 Double Blind||0
8290041|NCT01617681|20439563|P4|NOT COMPLETED|Period 1 Double Blind||2
8290042|NCT01617681|20439564|P3|NOT COMPLETED|Period 1 Double Blind||1
8290043|NCT01617681|20439565|P2|NOT COMPLETED|Period 1 Double Blind||1
8290044|NCT01617681|20439566|P1|NOT COMPLETED|Period 1 Double Blind||3
8290045|NCT01617681|20439562|P5|COMPLETED|Period 1 Double Blind||0
8290046|NCT01617681|20439563|P4|COMPLETED|Period 1 Double Blind||29
8290047|NCT01617681|20439564|P3|COMPLETED|Period 1 Double Blind||32
8290048|NCT01617681|20439565|P2|COMPLETED|Period 1 Double Blind||30
8290049|NCT01617681|20439566|P1|COMPLETED|Period 1 Double Blind||29
8290050|NCT01617681|20439562|P5|Full Analysis Set (FAS)|Period 1 Double Blind||0
8290051|NCT01617681|20439563|P4|Full Analysis Set (FAS)|Period 1 Double Blind||31
8290052|NCT01617681|20439564|P3|Full Analysis Set (FAS)|Period 1 Double Blind||33
8290053|NCT01617681|20439565|P2|Full Analysis Set (FAS)|Period 1 Double Blind||31
8290054|NCT01617681|20439566|P1|Full Analysis Set (FAS)|Period 1 Double Blind||31
8290055|NCT01617681|20439562|P5|STARTED|Period 1 Double Blind||0
8290056|NCT01617681|20439563|P4|STARTED|Period 1 Double Blind||31
8290057|NCT01617681|20439564|P3|STARTED|Period 1 Double Blind||33
8290058|NCT01617681|20439565|P2|STARTED|Period 1 Double Blind||31
8290059|NCT01617681|20439566|P1|STARTED|Period 1 Double Blind||32
8290060|NCT01617668|20439587|P4|NOT COMPLETED|Overall Study||15
8290061|NCT01617668|20439588|P3|NOT COMPLETED|Overall Study||23
8290062|NCT01617668|20439589|P2|NOT COMPLETED|Overall Study||9
8290063|NCT01617668|20439590|P1|NOT COMPLETED|Overall Study||13
8290064|NCT01617668|20439587|P4|COMPLETED|Overall Study||38
8290065|NCT01617668|20439588|P3|COMPLETED|Overall Study||32
8290066|NCT01617668|20439589|P2|COMPLETED|Overall Study||41
8290067|NCT01617668|20439590|P1|COMPLETED|Overall Study||38
8290068|NCT01617668|20439587|P4|Randomized Patients|Overall Study||55
8290069|NCT01617668|20439588|P3|Randomized Patients|Overall Study||55
8290070|NCT01617668|20439589|P2|Randomized Patients|Overall Study||54
8290071|NCT01617668|20439590|P1|Randomized Patients|Overall Study||51
8290072|NCT01617668|20439587|P4|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
8290073|NCT01617668|20439588|P3|STARTED|Overall Study||55
8290074|NCT01617668|20439589|P2|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
8290075|NCT01617668|20439590|P1|STARTED|Overall Study||51
8290076|NCT01617655|20439631|P2|NOT COMPLETED|Overall Study||29
8290077|NCT01617655|20439632|P1|NOT COMPLETED|Overall Study||9
8290078|NCT01617655|20439631|P2|COMPLETED|Overall Study||43
8290079|NCT01617655|20439632|P1|COMPLETED|Overall Study||26
8290080|NCT01617655|20439631|P2|Treated|Overall Study||72
8290081|NCT01617655|20439632|P1|Treated|Overall Study||35
8290082|NCT01617655|20439631|P2|STARTED|Overall Study|Randomized|72
8290083|NCT01617655|20439632|P1|STARTED|Overall Study|Randomized|35
8290084|NCT01617629|20439692|P1|NOT COMPLETED|Overall Study||6
8290085|NCT01617629|20439692|P1|COMPLETED|Overall Study||3
8290086|NCT01617629|20439692|P1|STARTED|Overall Study||9
8290087|NCT01617603|20439700|P3|NOT COMPLETED|Overall Study||1
8290088|NCT01617603|20439701|P2|NOT COMPLETED|Overall Study||2
8290089|NCT01617603|20439702|P1|NOT COMPLETED|Overall Study||3
8290090|NCT01617603|20439700|P3|COMPLETED|Overall Study||20
8290091|NCT01617603|20439701|P2|COMPLETED|Overall Study||19
8290092|NCT01617603|20439702|P1|COMPLETED|Overall Study||17
8290093|NCT01617603|20439700|P3|STARTED|Overall Study||21
8290094|NCT01617603|20439701|P2|STARTED|Overall Study||21
8290095|NCT01617603|20439702|P1|STARTED|Overall Study||20
8290096|NCT01617577|20439712|P2|NOT COMPLETED|Overall Study||0
8290097|NCT01617577|20439713|P1|NOT COMPLETED|Overall Study||0
8290098|NCT01617577|20439712|P2|COMPLETED|Overall Study||3
8290099|NCT01617577|20439713|P1|COMPLETED|Overall Study||5
8290100|NCT01617577|20439712|P2|STARTED|Overall Study||3
8290101|NCT01617577|20439713|P1|STARTED|Overall Study||5
8290102|NCT01617460|20439720|P1|NOT COMPLETED|Overall Study||40
8290103|NCT01617460|20439720|P1|COMPLETED|Overall Study||46
8290104|NCT01617460|20439720|P1|STARTED|Overall Study||86
8290105|NCT01617447|20439726|P2|NOT COMPLETED|Overall Study||3
8290106|NCT01617447|20439727|P1|NOT COMPLETED|Overall Study||0
8290107|NCT01617447|20439726|P2|COMPLETED|Overall Study||42
8290108|NCT01617447|20439727|P1|COMPLETED|Overall Study||47
8290109|NCT01617447|20439726|P2|STARTED|Overall Study||45
8290110|NCT01617447|20439727|P1|STARTED|Overall Study||47
8290111|NCT01617434|20439735|P2|NOT COMPLETED|Overall Study||51
8290112|NCT01617434|20439736|P1|NOT COMPLETED|Overall Study||35
8290113|NCT01617434|20439735|P2|COMPLETED|Overall Study||174
8290114|NCT01617434|20439736|P1|COMPLETED|Overall Study||191
8290115|NCT01617434|20439735|P2|Exposed|Overall Study||225
8290116|NCT01617434|20439736|P1|Exposed|Overall Study||225
8290117|NCT01617434|20439735|P2|STARTED|Overall Study||225
8290118|NCT01617434|20439736|P1|STARTED|Overall Study||226
8290119|NCT01617421|20439758|P1|NOT COMPLETED|Overall Study||6
8290120|NCT01617421|20439758|P1|COMPLETED|Overall Study||12
8290121|NCT01617421|20439758|P1|STARTED|Overall Study||18
8290122|NCT01617369|20439765|P1|NOT COMPLETED|Overall Study||0
8290123|NCT01617369|20439765|P1|COMPLETED|Overall Study||12
8290124|NCT01617369|20439765|P1|STARTED|Overall Study||12
8290125|NCT01617187|20439775|P4|NOT COMPLETED|Treatment Through Study Completion||10
8290126|NCT01617187|20439776|P3|NOT COMPLETED|Treatment Through Study Completion||5
8290127|NCT01617187|20439777|P2|NOT COMPLETED|Treatment Through Study Completion||11
8290128|NCT01617187|20439778|P1|NOT COMPLETED|Treatment Through Study Completion||11
8290129|NCT01617187|20439775|P4|COMPLETED|Treatment Through Study Completion||91
8290130|NCT01617187|20439776|P3|COMPLETED|Treatment Through Study Completion||41
8290131|NCT01617187|20439777|P2|COMPLETED|Treatment Through Study Completion||102
8290132|NCT01617187|20439778|P1|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
8290133|NCT01617187|20439775|P4|STARTED|Treatment Through Study Completion|Treated|101
8290134|NCT01617187|20439776|P3|STARTED|Treatment Through Study Completion|Treated|46
8290135|NCT01617187|20439777|P2|STARTED|Treatment Through Study Completion|Treated|113
8290136|NCT01617187|20439778|P1|STARTED|Treatment Through Study Completion|Treated|97
8290137|NCT01617187|20439775|P4|NOT COMPLETED|Randomization Through Start Treatment||2
8290138|NCT01617187|20439776|P3|NOT COMPLETED|Randomization Through Start Treatment||0
8290139|NCT01617187|20439777|P2|NOT COMPLETED|Randomization Through Start Treatment||0
8290140|NCT01617187|20439778|P1|NOT COMPLETED|Randomization Through Start Treatment||1
8290141|NCT01617187|20439775|P4|COMPLETED|Randomization Through Start Treatment||101
8290142|NCT01617187|20439776|P3|COMPLETED|Randomization Through Start Treatment||46
8290143|NCT01617187|20439777|P2|COMPLETED|Randomization Through Start Treatment||113
8290144|NCT01617187|20439778|P1|COMPLETED|Randomization Through Start Treatment||97
8290145|NCT01617187|20439775|P4|STARTED|Randomization Through Start Treatment|Randomized|103
8290146|NCT01617187|20439776|P3|STARTED|Randomization Through Start Treatment|Randomized|46
8290147|NCT01617187|20439777|P2|STARTED|Randomization Through Start Treatment|Randomized|113
8290148|NCT01617187|20439778|P1|STARTED|Randomization Through Start Treatment|Randomized|98
8290149|NCT01617148|20439848|P1|NOT COMPLETED|Overall Study||0
8290150|NCT01617148|20439848|P1|COMPLETED|Overall Study||26
8290151|NCT01617148|20439848|P1|STARTED|Overall Study||26
8290152|NCT01617083|20439862|P3|NOT COMPLETED|Overall Study||0
8290153|NCT01617083|20439863|P2|NOT COMPLETED|Overall Study||0
8290154|NCT01617083|20439864|P1|NOT COMPLETED|Overall Study||0
8290155|NCT01617083|20439862|P3|COMPLETED|Overall Study||15
8290156|NCT01617083|20439863|P2|COMPLETED|Overall Study||14
8290157|NCT01617083|20439864|P1|COMPLETED|Overall Study||18
8290158|NCT01617083|20439862|P3|STARTED|Overall Study||15
8290159|NCT01617083|20439863|P2|STARTED|Overall Study||14
8290160|NCT01617083|20439864|P1|STARTED|Overall Study||18
8290161|NCT01617070|20439875|P1|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
8290162|NCT01617070|20439875|P1|COMPLETED|BH4 and LNAA (4 Weeks)||9
8290163|NCT01617070|20439875|P1|STARTED|BH4 and LNAA (4 Weeks)||10
8290164|NCT01617070|20439875|P1|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
8290165|NCT01617070|20439875|P1|COMPLETED|BH4 Therapy (4 Weeks)||10
8290166|NCT01617070|20439875|P1|STARTED|BH4 Therapy (4 Weeks)||10
8290167|NCT01617070|20439875|P1|NOT COMPLETED|Washout (4 Weeks)||0
8290168|NCT01617070|20439875|P1|COMPLETED|Washout (4 Weeks)||10
8290169|NCT01617070|20439875|P1|STARTED|Washout (4 Weeks)||10
8290170|NCT01617070|20439875|P1|NOT COMPLETED|LNAA (4 Weeks)||0
8290171|NCT01617070|20439875|P1|COMPLETED|LNAA (4 Weeks)||10
8290172|NCT01617070|20439875|P1|STARTED|LNAA (4 Weeks)||10
8290173|NCT01617005|20439893|P1|NOT COMPLETED|Overall Study||2
8290174|NCT01617005|20439893|P1|COMPLETED|Overall Study||48
8290175|NCT01617005|20439893|P1|STARTED|Overall Study||50
8290176|NCT01616953|20439902|P2|NOT COMPLETED|Overall Study||0
8290177|NCT01616953|20439903|P1|NOT COMPLETED|Overall Study||2
8290178|NCT01616953|20439902|P2|COMPLETED|Overall Study||8
8290179|NCT01616953|20439903|P1|COMPLETED|Overall Study||8
8290180|NCT01616953|20439902|P2|6 Months Post-loading|Overall Study||8
8290181|NCT01616953|20439903|P1|6 Months Post-loading|Overall Study||8
8290182|NCT01616953|20439902|P2|Implant Uncovery|Overall Study||8
8290183|NCT01616953|20439903|P1|Implant Uncovery|Overall Study||8
8290184|NCT01616953|20439902|P2|Implant Placement Surgery|Overall Study||8
8290185|NCT01616953|20439903|P1|Implant Placement Surgery|Overall Study||9
8290186|NCT01616953|20439902|P2|STARTED|Overall Study||8
8290187|NCT01616953|20439903|P1|STARTED|Overall Study||10
8290188|NCT01616771|20439911|P1|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
8290189|NCT01616771|20439911|P1|COMPLETED|Smaller Sized GVL for 5 Sec||19
8290190|NCT01616771|20439911|P1|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
8290191|NCT01616771|20439911|P1|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
8290192|NCT01616771|20439911|P1|COMPLETED|GVL Selected by Weight for 5 Sec||23
8290193|NCT01616771|20439911|P1|STARTED|GVL Selected by Weight for 5 Sec||23
8290194|NCT01616771|20439911|P1|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
8290195|NCT01616771|20439911|P1|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
8290196|NCT01616771|20439911|P1|STARTED|Macintosh Laryngoscopy for 5 Sec||23
8290197|NCT01616693|20439924|P4|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
8290198|NCT01616693|20439925|P3|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
8290199|NCT01616693|20439926|P2|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
8290200|NCT01616693|20439927|P1|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
8290201|NCT01616693|20439924|P4|COMPLETED|Blood Analyzed for Immunogenicity||135
8290202|NCT01616693|20439925|P3|COMPLETED|Blood Analyzed for Immunogenicity||136
8290203|NCT01616693|20439926|P2|COMPLETED|Blood Analyzed for Immunogenicity||143
8290204|NCT01616693|20439927|P1|COMPLETED|Blood Analyzed for Immunogenicity||137
8290205|NCT01616693|20439924|P4|STARTED|Blood Analyzed for Immunogenicity||136
8290206|NCT01616693|20439925|P3|STARTED|Blood Analyzed for Immunogenicity||142
8290207|NCT01616693|20439926|P2|STARTED|Blood Analyzed for Immunogenicity||145
8290208|NCT01616693|20439927|P1|STARTED|Blood Analyzed for Immunogenicity||141
8290209|NCT01616693|20439924|P4|NOT COMPLETED|Received Both Vaccines||19
8290210|NCT01616693|20439925|P3|NOT COMPLETED|Received Both Vaccines||12
8290211|NCT01616693|20439926|P2|NOT COMPLETED|Received Both Vaccines||10
8290212|NCT01616693|20439927|P1|NOT COMPLETED|Received Both Vaccines||13
8290213|NCT01616693|20439924|P4|COMPLETED|Received Both Vaccines||136
8290214|NCT01616693|20439925|P3|COMPLETED|Received Both Vaccines||142
8290215|NCT01616693|20439926|P2|COMPLETED|Received Both Vaccines||145
8290216|NCT01616693|20439927|P1|COMPLETED|Received Both Vaccines||141
8290217|NCT01616693|20439924|P4|STARTED|Received Both Vaccines||155
8290218|NCT01616693|20439925|P3|STARTED|Received Both Vaccines||154
8290219|NCT01616693|20439926|P2|STARTED|Received Both Vaccines||155
8290220|NCT01616693|20439927|P1|STARTED|Received Both Vaccines||154
8290221|NCT01616693|20439924|P4|NOT COMPLETED|Evaluated for Safety||0
8290222|NCT01616693|20439925|P3|NOT COMPLETED|Evaluated for Safety||1
8290223|NCT01616693|20439926|P2|NOT COMPLETED|Evaluated for Safety||0
8290224|NCT01616693|20439927|P1|NOT COMPLETED|Evaluated for Safety||1
8290225|NCT01616693|20439924|P4|COMPLETED|Evaluated for Safety||155
8290226|NCT01616693|20439925|P3|COMPLETED|Evaluated for Safety||154
8290227|NCT01616693|20439926|P2|COMPLETED|Evaluated for Safety||155
8290228|NCT01616693|20439927|P1|COMPLETED|Evaluated for Safety||154
8290229|NCT01616693|20439924|P4|STARTED|Evaluated for Safety||155
8290230|NCT01616693|20439925|P3|STARTED|Evaluated for Safety||155
8290231|NCT01616693|20439926|P2|STARTED|Evaluated for Safety||155
8290232|NCT01616693|20439927|P1|STARTED|Evaluated for Safety||155
8290233|NCT01616576|20439979|P2|NOT COMPLETED|Overall Study||0
8290234|NCT01616576|20439980|P1|NOT COMPLETED|Overall Study||0
8290235|NCT01616576|20439979|P2|COMPLETED|Overall Study||18
8290236|NCT01616576|20439980|P1|COMPLETED|Overall Study||18
8290237|NCT01616576|20439979|P2|STARTED|Overall Study||18
8290238|NCT01616576|20439980|P1|STARTED|Overall Study||18
8290239|NCT01616459|20439993|P4|NOT COMPLETED|Overall Study||8
8290240|NCT01616459|20439994|P3|NOT COMPLETED|Overall Study||10
8290241|NCT01616459|20439995|P2|NOT COMPLETED|Overall Study||17
8290242|NCT01616459|20439996|P1|NOT COMPLETED|Overall Study||4
8290243|NCT01616459|20439993|P4|COMPLETED|Overall Study||233
8290244|NCT01616459|20439994|P3|COMPLETED|Overall Study||220
8290245|NCT01616459|20439995|P2|COMPLETED|Overall Study||223
8290246|NCT01616459|20439996|P1|COMPLETED|Overall Study||236
8290247|NCT01616459|20439993|P4|STARTED|Overall Study||241
8290248|NCT01616459|20439994|P3|STARTED|Overall Study||230
8290249|NCT01616459|20439995|P2|STARTED|Overall Study||240
8290250|NCT01616459|20439996|P1|STARTED|Overall Study||240
8290251|NCT01616173|20440097|P3|NOT COMPLETED|Overall Study||0
8290252|NCT01616173|20440098|P2|NOT COMPLETED|Overall Study||2
8290253|NCT01616173|20440099|P1|NOT COMPLETED|Overall Study||0
8290254|NCT01616173|20440097|P3|COMPLETED|Overall Study||27
8290255|NCT01616173|20440098|P2|COMPLETED|Overall Study||24
8290256|NCT01616173|20440099|P1|COMPLETED|Overall Study||27
8290257|NCT01616173|20440097|P3|STARTED|Overall Study||27
8290258|NCT01616173|20440098|P2|STARTED|Overall Study||26
8290259|NCT01616173|20440099|P1|STARTED|Overall Study||27
8290260|NCT01616160|20440113|P1|NOT COMPLETED|Overall Study||2
8290261|NCT01616160|20440113|P1|COMPLETED|Overall Study||9
8290262|NCT01616160|20440113|P1|STARTED|Overall Study||11
8290263|NCT01616082|20440120|P2|NOT COMPLETED|Overall Study||2
8290264|NCT01616082|20440121|P1|NOT COMPLETED|Overall Study||0
8290265|NCT01616082|20440120|P2|COMPLETED|Overall Study||18
8290266|NCT01616082|20440121|P1|COMPLETED|Overall Study||19
8290267|NCT01616082|20440120|P2|STARTED|Overall Study||20
8290268|NCT01616082|20440121|P1|STARTED|Overall Study||19
8290269|NCT01616056|20440131|P1|NOT COMPLETED|Overall Study||1
8290270|NCT01616056|20440131|P1|COMPLETED|Overall Study||19
8290271|NCT01616056|20440131|P1|STARTED|Overall Study||20
8290272|NCT01615939|20440145|P2|NOT COMPLETED|Overall Study||0
8290273|NCT01615939|20440146|P1|NOT COMPLETED|Overall Study||5
8290274|NCT01615939|20440145|P2|COMPLETED|Overall Study||4
8290275|NCT01615939|20440146|P1|COMPLETED|Overall Study||8
8290276|NCT01615939|20440145|P2|STARTED|Overall Study||4
8290277|NCT01615939|20440146|P1|STARTED|Overall Study||13
8290278|NCT01615822|20440159|P3|NOT COMPLETED|Period 2||2
8290279|NCT01615822|20440160|P2|NOT COMPLETED|Period 2||1
8290280|NCT01615822|20440161|P1|NOT COMPLETED|Period 2||0
8290281|NCT01615822|20440159|P3|COMPLETED|Period 2||4
8290282|NCT01615822|20440160|P2|COMPLETED|Period 2||8
8290283|NCT01615822|20440161|P1|COMPLETED|Period 2||7
8290284|NCT01615822|20440159|P3|STARTED|Period 2||6
8290285|NCT01615822|20440160|P2|STARTED|Period 2||9
8290286|NCT01615822|20440161|P1|STARTED|Period 2||7
8290287|NCT01615822|20440159|P3|NOT COMPLETED|Period 1||0
8290288|NCT01615822|20440160|P2|NOT COMPLETED|Period 1||2
8290289|NCT01615822|20440161|P1|NOT COMPLETED|Period 1||1
8290290|NCT01615822|20440159|P3|COMPLETED|Period 1||6
8290291|NCT01615822|20440160|P2|COMPLETED|Period 1||9
8290292|NCT01615822|20440161|P1|COMPLETED|Period 1||7
8290293|NCT01615822|20440159|P3|STARTED|Period 1||6
8290294|NCT01615822|20440160|P2|STARTED|Period 1||11
8290295|NCT01615822|20440161|P1|STARTED|Period 1||8
8290296|NCT01615809|20440178|P1|NOT COMPLETED|Overall Study||10
8290297|NCT01615809|20440178|P1|COMPLETED|Overall Study||22
8290298|NCT01615809|20440178|P1|STARTED|Overall Study|basal visit|32
8290299|NCT01615731|20440186|P2|NOT COMPLETED|Overall Study||2
8290300|NCT01615731|20440187|P1|NOT COMPLETED|Overall Study||3
8290301|NCT01615731|20440186|P2|COMPLETED|Overall Study||24
8290302|NCT01615731|20440187|P1|COMPLETED|Overall Study||21
8290303|NCT01615731|20440186|P2|STARTED|Overall Study||26
8290304|NCT01615731|20440187|P1|STARTED|Overall Study||24
8290305|NCT01615484|20440209|P2|NOT COMPLETED|Overall Study||0
8290306|NCT01615484|20440210|P1|NOT COMPLETED|Overall Study||0
8290307|NCT01615484|20440209|P2|COMPLETED|Overall Study||24
8290308|NCT01615484|20440210|P1|COMPLETED|Overall Study||0
8290309|NCT01615484|20440209|P2|STARTED|Overall Study||24
8290310|NCT01615484|20440210|P1|STARTED|Overall Study||0
8290311|NCT01615367|20440228|P2|NOT COMPLETED|Overall Study||6
8290312|NCT01615367|20440229|P1|NOT COMPLETED|Overall Study||5
8290313|NCT01615367|20440228|P2|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
8290314|NCT01615367|20440229|P1|COMPLETED|Overall Study||14
8290315|NCT01615367|20440228|P2|STARTED|Overall Study||19
8290316|NCT01615367|20440229|P1|STARTED|Overall Study||19
8290317|NCT01615328|20440249|P2|NOT COMPLETED|Overall Study||5
8290318|NCT01615328|20440250|P1|NOT COMPLETED|Overall Study||3
8290319|NCT01615328|20440249|P2|COMPLETED|Overall Study||38
8290320|NCT01615328|20440250|P1|COMPLETED|Overall Study||39
8290321|NCT01615328|20440249|P2|STARTED|Overall Study||43
8290322|NCT01615328|20440250|P1|STARTED|Overall Study||42
8290323|NCT01615263|20440262|P2|NOT COMPLETED|Overall Study||2
8290324|NCT01615263|20440263|P1|NOT COMPLETED|Overall Study||0
8290325|NCT01615263|20440262|P2|COMPLETED|Overall Study||18
8290326|NCT01615263|20440263|P1|COMPLETED|Overall Study||20
8290327|NCT01615263|20440262|P2|STARTED|Overall Study||20
8290328|NCT01615263|20440263|P1|STARTED|Overall Study||20
8290329|NCT01615198|20440277|P2|NOT COMPLETED|Overall Study||19
8290330|NCT01615198|20440278|P1|NOT COMPLETED|Overall Study||24
8290331|NCT01615198|20440277|P2|COMPLETED|Overall Study||273
8290332|NCT01615198|20440278|P1|COMPLETED|Overall Study||272
8290333|NCT01615198|20440277|P2|ABPM Dipper Status Subset|Overall Study||84
8290334|NCT01615198|20440278|P1|ABPM Dipper Status Subset|Overall Study||82
8290335|NCT01615198|20440277|P2|Safety Set|Overall Study||292
8290336|NCT01615198|20440278|P1|Safety Set|Overall Study||296
8290337|NCT01615198|20440277|P2|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
8290338|NCT01615198|20440278|P1|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
8290339|NCT01615198|20440277|P2|Full Analysis Set|Overall Study||292
8290340|NCT01615198|20440278|P1|Full Analysis Set|Overall Study||296
8290341|NCT01615198|20440277|P2|STARTED|Overall Study||292
8290342|NCT01615198|20440278|P1|STARTED|Overall Study||296
8290343|NCT01615029|20440311|P5|NOT COMPLETED|Overall Study||32
8290344|NCT01615029|20440312|P4|NOT COMPLETED|Overall Study||3
8290345|NCT01615029|20440313|P3|NOT COMPLETED|Overall Study||4
8290346|NCT01615029|20440314|P2|NOT COMPLETED|Overall Study||3
8290347|NCT01615029|20440315|P1|NOT COMPLETED|Overall Study||3
8290348|NCT01615029|20440311|P5|COMPLETED|Overall Study||0
8290349|NCT01615029|20440312|P4|COMPLETED|Overall Study||0
8290350|NCT01615029|20440313|P3|COMPLETED|Overall Study||0
8290351|NCT01615029|20440314|P2|COMPLETED|Overall Study||0
8290352|NCT01615029|20440315|P1|COMPLETED|Overall Study||0
8290353|NCT01615029|20440311|P5|STARTED|Overall Study||32
8290354|NCT01615029|20440312|P4|STARTED|Overall Study||3
8290355|NCT01615029|20440313|P3|STARTED|Overall Study||4
8290356|NCT01615029|20440314|P2|STARTED|Overall Study||3
8290357|NCT01615029|20440315|P1|STARTED|Overall Study||3
8290358|NCT01614912|20440336|P1|NOT COMPLETED|Overall Study||125
8290359|NCT01614912|20440336|P1|COMPLETED|Overall Study||159
8290360|NCT01614912|20440336|P1|STARTED|Overall Study||284
8290361|NCT01614899|20440350|P3|NOT COMPLETED|Overall Study||42
8290362|NCT01614899|20440351|P2|NOT COMPLETED|Overall Study||39
8290363|NCT01614899|20440352|P1|NOT COMPLETED|Overall Study||44
8290364|NCT01614899|20440350|P3|COMPLETED|Overall Study||110
8290365|NCT01614899|20440351|P2|COMPLETED|Overall Study||116
8290366|NCT01614899|20440352|P1|COMPLETED|Overall Study||106
8290367|NCT01614899|20440350|P3|STARTED|Overall Study||152
8290368|NCT01614899|20440351|P2|STARTED|Overall Study||155
8290369|NCT01614899|20440352|P1|STARTED|Overall Study||150
8290370|NCT01614886|20440383|P2|NOT COMPLETED|Overall Study||26
8290371|NCT01614886|20440384|P1|NOT COMPLETED|Overall Study||20
8290372|NCT01614886|20440383|P2|COMPLETED|Overall Study||83
8290373|NCT01614886|20440384|P1|COMPLETED|Overall Study||87
8290374|NCT01614886|20440383|P2|Full Analysis Set (FAS)|Overall Study||105
8290375|NCT01614886|20440384|P1|Full Analysis Set (FAS)|Overall Study||104
8290376|NCT01614886|20440383|P2|Safety Population (SAF)|Overall Study||108
8290377|NCT01614886|20440384|P1|Safety Population (SAF)|Overall Study||107
8290378|NCT01614886|20440383|P2|STARTED|Overall Study||109
8290379|NCT01614886|20440384|P1|STARTED|Overall Study||107
8290380|NCT01614847|20440400|P2|NOT COMPLETED|Day 2 (24 Hours Later)||0
8290381|NCT01614847|20440401|P1|NOT COMPLETED|Day 2 (24 Hours Later)||0
8290382|NCT01614847|20440400|P2|COMPLETED|Day 2 (24 Hours Later)||4
8290383|NCT01614847|20440401|P1|COMPLETED|Day 2 (24 Hours Later)||4
8290384|NCT01614847|20440400|P2|STARTED|Day 2 (24 Hours Later)|On Day 2, these subjects received Drop A (hyaluronate).|4
8290385|NCT01614847|20440401|P1|STARTED|Day 2 (24 Hours Later)|On Day 2, these subject will received Drop B (normal saline).|4
8290386|NCT01614847|20440400|P2|NOT COMPLETED|Day 1||0
8290387|NCT01614847|20440401|P1|NOT COMPLETED|Day 1||0
8290388|NCT01614847|20440400|P2|COMPLETED|Day 1|See Arm 1 comments.|4
8290389|NCT01614847|20440401|P1|COMPLETED|Day 1||4
8290390|NCT01614847|20440400|P2|STARTED|Day 1|The other 4 subjects, not to Group 1, received Drop B (saline) on Day 1.|4
8290391|NCT01614847|20440401|P1|STARTED|Day 1|Four subjects chosen at random received Drop A (hyaluronate) during Day 1.|4
8290392|NCT01614821|20440412|P1|NOT COMPLETED|Overall Study||0
8290393|NCT01614821|20440412|P1|COMPLETED|Overall Study||63
8290394|NCT01614821|20440412|P1|STARTED|Overall Study||63
8290395|NCT01614795|20440425|P4|NOT COMPLETED|Overall Study||12
8290396|NCT01614795|20440426|P3|NOT COMPLETED|Overall Study||11
8290397|NCT01614795|20440427|P2|NOT COMPLETED|Overall Study||12
8290398|NCT01614795|20440428|P1|NOT COMPLETED|Overall Study||11
8290399|NCT01614795|20440425|P4|COMPLETED|Overall Study||0
8290400|NCT01614795|20440426|P3|COMPLETED|Overall Study||0
8290401|NCT01614795|20440427|P2|COMPLETED|Overall Study||0
8290402|NCT01614795|20440428|P1|COMPLETED|Overall Study||0
8290403|NCT01614795|20440425|P4|STARTED|Overall Study||12
8290404|NCT01614795|20440426|P3|STARTED|Overall Study||11
8290405|NCT01614795|20440427|P2|STARTED|Overall Study||12
8290406|NCT01614795|20440428|P1|STARTED|Overall Study||11
8290407|NCT01614769|20440448|P6|NOT COMPLETED|Period 3||0
8290408|NCT01614769|20440449|P5|NOT COMPLETED|Period 3||0
8290409|NCT01614769|20440450|P4|NOT COMPLETED|Period 3||0
8290410|NCT01614769|20440451|P3|NOT COMPLETED|Period 3||1
8290411|NCT01614769|20440452|P2|NOT COMPLETED|Period 3||0
8290412|NCT01614769|20440453|P1|NOT COMPLETED|Period 3||0
8290413|NCT01614769|20440448|P6|COMPLETED|Period 3||1
8290414|NCT01614769|20440449|P5|COMPLETED|Period 3||1
8290415|NCT01614769|20440450|P4|COMPLETED|Period 3||0
8290416|NCT01614769|20440451|P3|COMPLETED|Period 3||1
8290417|NCT01614769|20440452|P2|COMPLETED|Period 3||1
8290418|NCT01614769|20440453|P1|COMPLETED|Period 3||1
8290419|NCT01614769|20440448|P6|STARTED|Period 3||1
8290420|NCT01614769|20440449|P5|STARTED|Period 3||1
8290421|NCT01614769|20440450|P4|STARTED|Period 3||0
8290422|NCT01614769|20440451|P3|STARTED|Period 3||2
8290423|NCT01614769|20440452|P2|STARTED|Period 3||1
8290424|NCT01614769|20440453|P1|STARTED|Period 3||1
8290425|NCT01614769|20440448|P6|NOT COMPLETED|7-Day Washout||0
8290426|NCT01614769|20440449|P5|NOT COMPLETED|7-Day Washout||0
8290427|NCT01614769|20440450|P4|NOT COMPLETED|7-Day Washout||0
8290428|NCT01614769|20440451|P3|NOT COMPLETED|7-Day Washout||0
8290429|NCT01614769|20440452|P2|NOT COMPLETED|7-Day Washout||0
8290430|NCT01614769|20440453|P1|NOT COMPLETED|7-Day Washout||0
8290431|NCT01614769|20440448|P6|COMPLETED|7-Day Washout||1
8290432|NCT01614769|20440449|P5|COMPLETED|7-Day Washout||1
8290433|NCT01614769|20440450|P4|COMPLETED|7-Day Washout||0
8290434|NCT01614769|20440451|P3|COMPLETED|7-Day Washout||2
8290435|NCT01614769|20440452|P2|COMPLETED|7-Day Washout||1
8290436|NCT01614769|20440453|P1|COMPLETED|7-Day Washout||1
8290437|NCT01614769|20440448|P6|STARTED|7-Day Washout||1
8290438|NCT01614769|20440449|P5|STARTED|7-Day Washout||1
8290439|NCT01614769|20440450|P4|STARTED|7-Day Washout||0
8290440|NCT01614769|20440451|P3|STARTED|7-Day Washout||2
8290441|NCT01614769|20440452|P2|STARTED|7-Day Washout||1
8290442|NCT01614769|20440453|P1|STARTED|7-Day Washout||1
8290443|NCT01614769|20440448|P6|NOT COMPLETED|Period 2||0
8290444|NCT01614769|20440449|P5|NOT COMPLETED|Period 2||0
8290445|NCT01614769|20440450|P4|NOT COMPLETED|Period 2||0
8290446|NCT01614769|20440451|P3|NOT COMPLETED|Period 2||0
8290447|NCT01614769|20440452|P2|NOT COMPLETED|Period 2||0
8290448|NCT01614769|20440453|P1|NOT COMPLETED|Period 2||0
8290449|NCT01614769|20440448|P6|COMPLETED|Period 2||1
8290450|NCT01614769|20440449|P5|COMPLETED|Period 2||1
8290451|NCT01614769|20440450|P4|COMPLETED|Period 2||0
8290452|NCT01614769|20440451|P3|COMPLETED|Period 2||2
8290453|NCT01614769|20440452|P2|COMPLETED|Period 2||1
8290454|NCT01614769|20440453|P1|COMPLETED|Period 2||1
8290455|NCT01614769|20440448|P6|STARTED|Period 2||1
8290456|NCT01614769|20440449|P5|STARTED|Period 2||1
8290457|NCT01614769|20440450|P4|STARTED|Period 2||0
8290458|NCT01614769|20440451|P3|STARTED|Period 2||2
8290459|NCT01614769|20440452|P2|STARTED|Period 2||1
8290460|NCT01614769|20440453|P1|STARTED|Period 2||1
8290461|NCT01614769|20440448|P6|NOT COMPLETED|7-Day Washout||0
8290462|NCT01614769|20440449|P5|NOT COMPLETED|7-Day Washout||0
8290463|NCT01614769|20440450|P4|NOT COMPLETED|7-Day Washout||0
8290464|NCT01614769|20440451|P3|NOT COMPLETED|7-Day Washout||0
8290465|NCT01614769|20440452|P2|NOT COMPLETED|7-Day Washout||0
8290466|NCT01614769|20440453|P1|NOT COMPLETED|7-Day Washout||0
8290467|NCT01614769|20440448|P6|COMPLETED|7-Day Washout||1
8290468|NCT01614769|20440449|P5|COMPLETED|7-Day Washout||1
8290469|NCT01614769|20440450|P4|COMPLETED|7-Day Washout||0
8290470|NCT01614769|20440451|P3|COMPLETED|7-Day Washout||2
8290471|NCT01614769|20440452|P2|COMPLETED|7-Day Washout||1
8290472|NCT01614769|20440453|P1|COMPLETED|7-Day Washout||1
8290473|NCT01614769|20440448|P6|STARTED|7-Day Washout||1
8290474|NCT01614769|20440449|P5|STARTED|7-Day Washout||1
8290475|NCT01614769|20440450|P4|STARTED|7-Day Washout||0
8290476|NCT01614769|20440451|P3|STARTED|7-Day Washout||2
8290477|NCT01614769|20440452|P2|STARTED|7-Day Washout||1
8290478|NCT01614769|20440453|P1|STARTED|7-Day Washout||1
8290479|NCT01614769|20440448|P6|NOT COMPLETED|Period 1||1
8290480|NCT01614769|20440449|P5|NOT COMPLETED|Period 1||0
8290481|NCT01614769|20440450|P4|NOT COMPLETED|Period 1||2
8290482|NCT01614769|20440451|P3|NOT COMPLETED|Period 1||0
8290483|NCT01614769|20440452|P2|NOT COMPLETED|Period 1||0
8290484|NCT01614769|20440453|P1|NOT COMPLETED|Period 1||1
8290485|NCT01614769|20440448|P6|COMPLETED|Period 1||1
8290486|NCT01614769|20440449|P5|COMPLETED|Period 1||1
8290487|NCT01614769|20440450|P4|COMPLETED|Period 1||0
8290488|NCT01614769|20440451|P3|COMPLETED|Period 1||2
8290489|NCT01614769|20440452|P2|COMPLETED|Period 1||1
8290490|NCT01614769|20440453|P1|COMPLETED|Period 1||1
8290491|NCT01614769|20440448|P6|STARTED|Period 1||2
8290492|NCT01614769|20440449|P5|STARTED|Period 1||1
8290493|NCT01614769|20440450|P4|STARTED|Period 1||2
8290494|NCT01614769|20440451|P3|STARTED|Period 1||2
8290495|NCT01614769|20440452|P2|STARTED|Period 1||1
8290496|NCT01614769|20440453|P1|STARTED|Period 1||2
8290497|NCT01614743|20440469|P2|NOT COMPLETED|Overall Study||0
8290498|NCT01614743|20440470|P1|NOT COMPLETED|Overall Study||1
8290499|NCT01614743|20440469|P2|COMPLETED|Overall Study|Subject in the placebo group (5) also received the treatment (IncobotulinumtoxinA) at Visit 5.|5
8290500|NCT01614743|20440470|P1|COMPLETED|Overall Study||3
8290501|NCT01614743|20440469|P2|STARTED|Overall Study||5
8290502|NCT01614743|20440470|P1|STARTED|Overall Study||4
8290503|NCT01614613|20440482|P1|NOT COMPLETED|Overall Study||0
8290504|NCT01614613|20440482|P1|COMPLETED|Overall Study||146
8290505|NCT01614613|20440482|P1|STARTED|Overall Study||146
8290506|NCT01614600|20440490|P1|NOT COMPLETED|Overall Study||4
8290507|NCT01614600|20440490|P1|COMPLETED|Overall Study||84
8290508|NCT01614600|20440490|P1|STARTED|Overall Study||88
8290512|NCT01614509|20440510|P2|NOT COMPLETED|Overall Study||3
8290513|NCT01614509|20440511|P1|NOT COMPLETED|Overall Study||1
8290514|NCT01614509|20440510|P2|COMPLETED|Overall Study||18
8290515|NCT01614509|20440511|P1|COMPLETED|Overall Study||23
8290516|NCT01614509|20440510|P2|STARTED|Overall Study||21
8290517|NCT01614509|20440511|P1|STARTED|Overall Study||24
8290518|NCT01614470|20440521|P3|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8290519|NCT01614470|20440522|P2|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8290520|NCT01614470|20440523|P1|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8290521|NCT01614470|20440521|P3|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
8290522|NCT01614470|20440522|P2|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8290523|NCT01614470|20440523|P1|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
8290524|NCT01614470|20440521|P3|STARTED|Part 2: Open-label Period (16 Weeks)||36
8290525|NCT01614470|20440522|P2|STARTED|Part 2: Open-label Period (16 Weeks)||0
8290526|NCT01614470|20440523|P1|STARTED|Part 2: Open-label Period (16 Weeks)||0
8290527|NCT01614470|20440521|P3|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
8290528|NCT01614470|20440522|P2|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
8290529|NCT01614470|20440523|P1|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
8290530|NCT01614470|20440521|P3|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
8290531|NCT01614470|20440522|P2|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
8290532|NCT01614470|20440523|P1|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
8290533|NCT01614470|20440521|P3|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
8290534|NCT01614470|20440522|P2|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
8290535|NCT01614470|20440523|P1|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
8290536|NCT01614470|20440521|P3|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
8290537|NCT01614470|20440522|P2|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
8290538|NCT01614470|20440523|P1|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
8290539|NCT01614470|20440521|P3|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
8290540|NCT01614470|20440522|P2|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
8290541|NCT01614470|20440523|P1|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
8290542|NCT01614470|20440521|P3|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
8290543|NCT01614470|20440522|P2|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
8290544|NCT01614470|20440523|P1|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
8290545|NCT01614470|20440521|P3|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
8290546|NCT01614470|20440522|P2|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
8290547|NCT01614470|20440523|P1|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
8290548|NCT01614470|20440521|P3|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
8290549|NCT01614470|20440522|P2|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
8290550|NCT01614470|20440523|P1|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
8290551|NCT01614470|20440521|P3|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
8290552|NCT01614470|20440522|P2|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
8290553|NCT01614470|20440523|P1|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
8290554|NCT01614457|20440545|P2|NOT COMPLETED|Overall Study||0
8290555|NCT01614457|20440546|P1|NOT COMPLETED|Overall Study||2
8290556|NCT01614457|20440545|P2|COMPLETED|Overall Study||35
8290557|NCT01614457|20440546|P1|COMPLETED|Overall Study||32
8290558|NCT01614457|20440545|P2|STARTED|Overall Study||35
8290559|NCT01614457|20440546|P1|STARTED|Overall Study||34
8290560|NCT01614392|20440564|P2|NOT COMPLETED|Overall Study||3
8290561|NCT01614392|20440565|P1|NOT COMPLETED|Overall Study||1
8290562|NCT01614392|20440564|P2|COMPLETED|Overall Study||24
8290563|NCT01614392|20440565|P1|COMPLETED|Overall Study||24
8290564|NCT01614392|20440564|P2|STARTED|Overall Study||27
8290565|NCT01614392|20440565|P1|STARTED|Overall Study||25
8290566|NCT01614249|20440573|P2|NOT COMPLETED|Overall Study||23
8290567|NCT01614249|20440574|P1|NOT COMPLETED|Overall Study||11
8290568|NCT01614249|20440573|P2|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
8290569|NCT01614249|20440574|P1|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
8290570|NCT01614249|20440573|P2|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
8290571|NCT01614249|20440574|P1|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
8290572|NCT01614249|20440573|P2|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
8290573|NCT01614249|20440574|P1|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
8290574|NCT01614249|20440573|P2|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
8290575|NCT01614249|20440574|P1|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
8290576|NCT01614210|20440580|P1|NOT COMPLETED|Overall Study||0
8290577|NCT01614210|20440580|P1|COMPLETED|Overall Study||52
8290578|NCT01614210|20440580|P1|STARTED|Overall Study||52
8290579|NCT01614093|20440588|P1|NOT COMPLETED|Overall Study||1
8290580|NCT01614093|20440588|P1|COMPLETED|Overall Study||16
8290581|NCT01614093|20440588|P1|STARTED|Overall Study||17
8290582|NCT01613768|20440593|P1|NOT COMPLETED|Overall Study||0
8290583|NCT01613768|20440593|P1|COMPLETED|Overall Study||29
8290584|NCT01613768|20440593|P1|STARTED|Overall Study||29
8290585|NCT01613716|20440601|P1|NOT COMPLETED|Overall Study||7
8290586|NCT01613716|20440601|P1|COMPLETED|Overall Study||23
8290587|NCT01613716|20440601|P1|STARTED|Overall Study||30
8290588|NCT01613599|20440606|P1|NOT COMPLETED|Overall Study||25
8290589|NCT01613599|20440606|P1|COMPLETED|Overall Study||72
8290590|NCT01613599|20440606|P1|STARTED|Overall Study||97
8290591|NCT01613417|20440621|P2|NOT COMPLETED|Second Injection||0
8290592|NCT01613417|20440622|P1|NOT COMPLETED|Second Injection||0
8290593|NCT01613417|20440621|P2|COMPLETED|Second Injection||109
8290594|NCT01613417|20440622|P1|COMPLETED|Second Injection||100
8290595|NCT01613417|20440621|P2|STARTED|Second Injection||109
8290596|NCT01613417|20440622|P1|STARTED|Second Injection||100
8290597|NCT01613417|20440621|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||7
8290598|NCT01613417|20440622|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||13
8290599|NCT01613417|20440621|P2|COMPLETED|Washout (no Second Injection/MRI)||109
8290600|NCT01613417|20440622|P1|COMPLETED|Washout (no Second Injection/MRI)||100
8290601|NCT01613417|20440621|P2|STARTED|Washout (no Second Injection/MRI)||116
8290602|NCT01613417|20440622|P1|STARTED|Washout (no Second Injection/MRI)||113
8290603|NCT01613417|20440621|P2|NOT COMPLETED|First Injection||0
8290604|NCT01613417|20440622|P1|NOT COMPLETED|First Injection||0
8290605|NCT01613417|20440621|P2|COMPLETED|First Injection||116
8290606|NCT01613417|20440622|P1|COMPLETED|First Injection||113
8290607|NCT01613417|20440621|P2|STARTED|First Injection||116
8290608|NCT01613417|20440622|P1|STARTED|First Injection||113
8290609|NCT01613378|20440659|P1|NOT COMPLETED|Overall Study||39
8290610|NCT01613378|20440659|P1|COMPLETED|Overall Study||161
8290611|NCT01613378|20440659|P1|STARTED|Overall Study||200
8290612|NCT01613339|20440677|P2|NOT COMPLETED|Overall Study||1
8290613|NCT01613339|20440678|P1|NOT COMPLETED|Overall Study||3
8290614|NCT01613339|20440677|P2|COMPLETED|Overall Study||21
8290615|NCT01613339|20440678|P1|COMPLETED|Overall Study||21
8290616|NCT01613339|20440677|P2|STARTED|Overall Study||22
8290617|NCT01613339|20440678|P1|STARTED|Overall Study||24
8290618|NCT01613326|20440689|P2|NOT COMPLETED|Overall Study||14
8290619|NCT01613326|20440690|P1|NOT COMPLETED|Overall Study||13
8290620|NCT01613326|20440689|P2|COMPLETED|Overall Study||316
8290621|NCT01613326|20440690|P1|COMPLETED|Overall Study||314
8290622|NCT01613326|20440689|P2|STARTED|Overall Study||330
8290623|NCT01613326|20440690|P1|STARTED|Overall Study||327
8290624|NCT01613313|20440724|P4|NOT COMPLETED|Overall Study||0
8290625|NCT01613313|20440725|P3|NOT COMPLETED|Overall Study||0
8290626|NCT01613313|20440726|P2|NOT COMPLETED|Overall Study||0
8290627|NCT01613313|20440727|P1|NOT COMPLETED|Overall Study||0
8290628|NCT01613313|20440724|P4|COMPLETED|Overall Study||4
8290629|NCT01613313|20440725|P3|COMPLETED|Overall Study||4
8290630|NCT01613313|20440726|P2|COMPLETED|Overall Study||4
8290631|NCT01613313|20440727|P1|COMPLETED|Overall Study||2
8290632|NCT01613313|20440724|P4|STARTED|Overall Study||4
8290633|NCT01613313|20440725|P3|STARTED|Overall Study||4
8290634|NCT01613313|20440726|P2|STARTED|Overall Study||4
8290635|NCT01613313|20440727|P1|STARTED|Overall Study||2
8290636|NCT01613248|20440747|P6|NOT COMPLETED|Overall Study||38
8290637|NCT01613248|20440748|P5|NOT COMPLETED|Overall Study||35
8290638|NCT01613248|20440749|P4|NOT COMPLETED|Overall Study||38
8290639|NCT01613248|20440750|P3|NOT COMPLETED|Overall Study||33
8290640|NCT01613248|20440751|P2|NOT COMPLETED|Overall Study||34
8290641|NCT01613248|20440752|P1|NOT COMPLETED|Overall Study||29
8290642|NCT01613248|20440747|P6|COMPLETED|Overall Study||102
8290643|NCT01613248|20440748|P5|COMPLETED|Overall Study||104
8290644|NCT01613248|20440749|P4|COMPLETED|Overall Study||101
8290645|NCT01613248|20440750|P3|COMPLETED|Overall Study||106
8290646|NCT01613248|20440751|P2|COMPLETED|Overall Study||104
8290647|NCT01613248|20440752|P1|COMPLETED|Overall Study||110
8290648|NCT01613248|20440747|P6|STARTED|Overall Study||140
8290649|NCT01613248|20440748|P5|STARTED|Overall Study||139
8290650|NCT01613248|20440749|P4|STARTED|Overall Study||139
8290651|NCT01613248|20440750|P3|STARTED|Overall Study||139
8290652|NCT01613248|20440751|P2|STARTED|Overall Study||138
8290653|NCT01613248|20440752|P1|STARTED|Overall Study||139
8290654|NCT01613222|20440850|P1|NOT COMPLETED|Overall Study||12
8290655|NCT01613222|20440850|P1|COMPLETED|Overall Study||51
8290656|NCT01613222|20440850|P1|STARTED|Overall Study||63
8290657|NCT01613131|20440865|P2|NOT COMPLETED|Overall Study||5
8290658|NCT01613131|20440866|P1|NOT COMPLETED|Overall Study||3
8290659|NCT01613131|20440865|P2|COMPLETED|Overall Study||13
8290660|NCT01613131|20440866|P1|COMPLETED|Overall Study||17
8290661|NCT01613131|20440865|P2|STARTED|Overall Study||18
8290662|NCT01613131|20440866|P1|STARTED|Overall Study||20
8290663|NCT01613027|20440894|P1|NOT COMPLETED|Overall Study||8
8290664|NCT01613027|20440894|P1|COMPLETED|Overall Study||127
8290665|NCT01613027|20440894|P1|STARTED|Overall Study||135
8290666|NCT01613014|20440915|P2|NOT COMPLETED|Overall Study||12
8290667|NCT01613014|20440916|P1|NOT COMPLETED|Overall Study||18
8290668|NCT01613014|20440915|P2|COMPLETED|Overall Study||63
8290669|NCT01613014|20440916|P1|COMPLETED|Overall Study||57
8290670|NCT01613014|20440915|P2|STARTED|Overall Study||75
8290671|NCT01613014|20440916|P1|STARTED|Overall Study||75
8290672|NCT01612884|20440924|P2|NOT COMPLETED|Overall Study||0
8290673|NCT01612884|20440925|P1|NOT COMPLETED|Overall Study||0
8290674|NCT01612884|20440924|P2|COMPLETED|Overall Study||18
8290675|NCT01612884|20440925|P1|COMPLETED|Overall Study||19
8290676|NCT01612884|20440924|P2|STARTED|Overall Study||18
8290677|NCT01612884|20440925|P1|STARTED|Overall Study||19
8290678|NCT01612858|20440937|P2|NOT COMPLETED|Overall Study||1
8290679|NCT01612858|20440938|P1|NOT COMPLETED|Overall Study||5
8290680|NCT01612858|20440937|P2|COMPLETED|Overall Study||3
8290681|NCT01612858|20440938|P1|COMPLETED|Overall Study||11
8290682|NCT01612858|20440937|P2|STARTED|Overall Study||4
8290683|NCT01612858|20440938|P1|STARTED|Overall Study||16
8290684|NCT01612793|20440948|P2|NOT COMPLETED|Overall Study||0
8290685|NCT01612793|20440949|P1|NOT COMPLETED|Overall Study||0
8290686|NCT01612793|20440948|P2|COMPLETED|Overall Study||2
8290687|NCT01612793|20440949|P1|COMPLETED|Overall Study||2
8290688|NCT01612793|20440948|P2|STARTED|Overall Study||2
8290689|NCT01612793|20440949|P1|STARTED|Overall Study||2
8290690|NCT01612780|20440955|P1|NOT COMPLETED|Overall Study||6
8290691|NCT01612780|20440955|P1|COMPLETED|Overall Study||76
8290692|NCT01612780|20440955|P1|STARTED|Overall Study||82
8290693|NCT01612767|20440961|P1|NOT COMPLETED|Overall Study||42
8290694|NCT01612767|20440961|P1|COMPLETED|Overall Study||287
8290695|NCT01612767|20440961|P1|STARTED|Overall Study||329
8290696|NCT01612702|20441017|P2|NOT COMPLETED|Overall Study||11
8290697|NCT01612702|20441018|P1|NOT COMPLETED|Overall Study||11
8290698|NCT01612702|20441017|P2|COMPLETED|Overall Study||134
8290699|NCT01612702|20441018|P1|COMPLETED|Overall Study||135
8290700|NCT01612702|20441017|P2|STARTED|Overall Study||145
8290701|NCT01612702|20441018|P1|STARTED|Overall Study||146
8290702|NCT01612676|20441032|P4|NOT COMPLETED|Overall Study||3
8290703|NCT01612676|20441033|P3|NOT COMPLETED|Overall Study||1
8290704|NCT01612676|20441034|P2|NOT COMPLETED|Overall Study||4
8290705|NCT01612676|20441035|P1|NOT COMPLETED|Overall Study||2
8290706|NCT01612676|20441032|P4|COMPLETED|Overall Study||10
8290707|NCT01612676|20441033|P3|COMPLETED|Overall Study||4
8290708|NCT01612676|20441034|P2|COMPLETED|Overall Study||3
8290709|NCT01612676|20441035|P1|COMPLETED|Overall Study||4
8290710|NCT01612676|20441032|P4|Dosed|Overall Study||13
8290711|NCT01612676|20441033|P3|Dosed|Overall Study||5
8290712|NCT01612676|20441034|P2|Dosed|Overall Study||7
8290713|NCT01612676|20441035|P1|Dosed|Overall Study||5
8290714|NCT01612676|20441032|P4|STARTED|Overall Study||13
8290715|NCT01612676|20441033|P3|STARTED|Overall Study||5
8290716|NCT01612676|20441034|P2|STARTED|Overall Study||7
8290717|NCT01612676|20441035|P1|STARTED|Overall Study||6
8290718|NCT01612546|20441091|P1|NOT COMPLETED|Overall Study||0
8290719|NCT01612546|20441091|P1|COMPLETED|Overall Study||10
8290720|NCT01612546|20441091|P1|STARTED|Overall Study||10
8290721|NCT01612494|20441101|P2|NOT COMPLETED|Overall Study||0
8290722|NCT01612494|20441102|P1|NOT COMPLETED|Overall Study||0
8290723|NCT01612494|20441101|P2|COMPLETED|Overall Study||23
8290724|NCT01612494|20441102|P1|COMPLETED|Overall Study||21
8290725|NCT01612494|20441101|P2|STARTED|Overall Study||23
8290726|NCT01612494|20441102|P1|STARTED|Overall Study||21
8290727|NCT01612351|20441108|P1|NOT COMPLETED|Post-Operative Treatment||0
8290728|NCT01612351|20441108|P1|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
8290729|NCT01612351|20441108|P1|STARTED|Post-Operative Treatment||39
8290730|NCT01612351|20441108|P1|NOT COMPLETED|Transoral Surgery||0
8290731|NCT01612351|20441108|P1|COMPLETED|Transoral Surgery||39
8290732|NCT01612351|20441108|P1|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
8290733|NCT01612351|20441108|P1|NOT COMPLETED|Chemotherapy||0
8290734|NCT01612351|20441108|P1|COMPLETED|Chemotherapy||40
8290735|NCT01612351|20441108|P1|STARTED|Chemotherapy||40
8290736|NCT01612221|20441122|P2|NOT COMPLETED|Overall Study||0
8290737|NCT01612221|20441123|P1|NOT COMPLETED|Overall Study||0
8290738|NCT01612221|20441122|P2|COMPLETED|Overall Study||50
8290739|NCT01612221|20441123|P1|COMPLETED|Overall Study||50
8290740|NCT01612221|20441122|P2|STARTED|Overall Study||50
8290741|NCT01612221|20441123|P1|STARTED|Overall Study||50
8290742|NCT01612156|20441133|P2|NOT COMPLETED|Overall Study||0
8290743|NCT01612156|20441134|P1|NOT COMPLETED|Overall Study||2
8290744|NCT01612156|20441133|P2|COMPLETED|Overall Study||48
8290745|NCT01612156|20441134|P1|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
8290746|NCT01612156|20441133|P2|STARTED|Overall Study||48
8290747|NCT01612156|20441134|P1|STARTED|Overall Study||42
8290748|NCT01612000|20441146|P4|NOT COMPLETED|Overall Study||10
8290749|NCT01612000|20441147|P3|NOT COMPLETED|Overall Study||7
8290750|NCT01612000|20441148|P2|NOT COMPLETED|Overall Study||5
8290751|NCT01612000|20441149|P1|NOT COMPLETED|Overall Study||9
8290752|NCT01612000|20441146|P4|COMPLETED|Overall Study||76
8290753|NCT01612000|20441147|P3|COMPLETED|Overall Study||78
8290754|NCT01612000|20441148|P2|COMPLETED|Overall Study||81
8290755|NCT01612000|20441149|P1|COMPLETED|Overall Study||75
8290756|NCT01612000|20441146|P4|STARTED|Overall Study||86
8290757|NCT01612000|20441147|P3|STARTED|Overall Study||85
8290758|NCT01612000|20441148|P2|STARTED|Overall Study||86
8290759|NCT01612000|20441149|P1|STARTED|Overall Study||84
8290769|NCT01611948|20441213|P2|NOT COMPLETED|Overall Study||12
8290770|NCT01611948|20441214|P1|NOT COMPLETED|Overall Study||14
8290771|NCT01611948|20441213|P2|COMPLETED|Overall Study||26
8290772|NCT01611948|20441214|P1|COMPLETED|Overall Study||18
8290773|NCT01611948|20441213|P2|STARTED|Overall Study||38
8290774|NCT01611948|20441214|P1|STARTED|Overall Study||32
8290775|NCT01611935|20441222|P2|NOT COMPLETED|Overall Study||0
8290776|NCT01611935|20441223|P1|NOT COMPLETED|Overall Study||1
8290777|NCT01611935|20441222|P2|COMPLETED|Overall Study||51
8290778|NCT01611935|20441223|P1|COMPLETED|Overall Study||49
8290779|NCT01611935|20441222|P2|STARTED|Overall Study||51
8290780|NCT01611935|20441223|P1|STARTED|Overall Study||50
8290781|NCT01611883|20441235|P2|NOT COMPLETED|Overall Study||1
8290782|NCT01611883|20441236|P1|NOT COMPLETED|Overall Study||1
8290783|NCT01611883|20441235|P2|COMPLETED|Overall Study||76
8290784|NCT01611883|20441236|P1|COMPLETED|Overall Study||74
8290785|NCT01611883|20441235|P2|STARTED|Overall Study||77
8290786|NCT01611883|20441236|P1|STARTED|Overall Study||75
8290787|NCT01611857|20441262|P2|NOT COMPLETED|Overall Study||2
8290788|NCT01611857|20441263|P1|NOT COMPLETED|Overall Study||0
8290789|NCT01611857|20441262|P2|COMPLETED|Overall Study||32
8290790|NCT01611857|20441263|P1|COMPLETED|Overall Study||15
8290791|NCT01611857|20441262|P2|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
8290792|NCT01611857|20441263|P1|Tivantinib 360 mg|Overall Study||7
8290793|NCT01611857|20441262|P2|Tivantinib 240 mg|Overall Study||0
8290794|NCT01611857|20441263|P1|Tivantinib 240 mg|Overall Study||3
8290795|NCT01611857|20441262|P2|Tivantinib 120 mg|Overall Study||0
8290796|NCT01611857|20441263|P1|Tivantinib 120 mg|Overall Study||5
8290797|NCT01611857|20441262|P2|STARTED|Overall Study||34
8290798|NCT01611857|20441263|P1|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
8290799|NCT01611792|20441275|P2|NOT COMPLETED|Followup: at 6 Months||13
8290800|NCT01611792|20441276|P1|NOT COMPLETED|Followup: at 6 Months||6
8290801|NCT01611792|20441275|P2|COMPLETED|Followup: at 6 Months||7
8290802|NCT01611792|20441276|P1|COMPLETED|Followup: at 6 Months||11
8290803|NCT01611792|20441275|P2|STARTED|Followup: at 6 Months||20
8290804|NCT01611792|20441276|P1|STARTED|Followup: at 6 Months||17
8290805|NCT01611792|20441275|P2|NOT COMPLETED|Follow-up: at 11 Weeks||0
8290806|NCT01611792|20441276|P1|NOT COMPLETED|Follow-up: at 11 Weeks||0
8290807|NCT01611792|20441275|P2|COMPLETED|Follow-up: at 11 Weeks||20
8290808|NCT01611792|20441276|P1|COMPLETED|Follow-up: at 11 Weeks||17
8290809|NCT01611792|20441275|P2|STARTED|Follow-up: at 11 Weeks||20
8290810|NCT01611792|20441276|P1|STARTED|Follow-up: at 11 Weeks||17
8290811|NCT01611792|20441275|P2|NOT COMPLETED|Initial Period: Time 0||9
8290812|NCT01611792|20441276|P1|NOT COMPLETED|Initial Period: Time 0||12
8290813|NCT01611792|20441275|P2|COMPLETED|Initial Period: Time 0||20
8290814|NCT01611792|20441276|P1|COMPLETED|Initial Period: Time 0||17
8290815|NCT01611792|20441275|P2|STARTED|Initial Period: Time 0||29
8290816|NCT01611792|20441276|P1|STARTED|Initial Period: Time 0||29
8290817|NCT01611779|20441292|P1|NOT COMPLETED|Overall Study||0
8290818|NCT01611779|20441292|P1|COMPLETED|Overall Study||5
8290819|NCT01611779|20441292|P1|STARTED|Overall Study||5
8290820|NCT01611662|20441301|P1|NOT COMPLETED|Overall Study||1
8290821|NCT01611662|20441301|P1|COMPLETED|Overall Study||31
8290822|NCT01611662|20441301|P1|STARTED|Overall Study||32
8290823|NCT01611571|20441308|P3|NOT COMPLETED|Overall Study||1
8290824|NCT01611571|20441309|P2|NOT COMPLETED|Overall Study||0
8290825|NCT01611571|20441310|P1|NOT COMPLETED|Overall Study||1
8290826|NCT01611571|20441308|P3|COMPLETED|Overall Study||9
8290827|NCT01611571|20441309|P2|COMPLETED|Overall Study||10
8290828|NCT01611571|20441310|P1|COMPLETED|Overall Study||10
8290829|NCT01611571|20441308|P3|STARTED|Overall Study||10
8290830|NCT01611571|20441309|P2|STARTED|Overall Study||10
8290831|NCT01611571|20441310|P1|STARTED|Overall Study||11
8290832|NCT01611558|20441330|P1|NOT COMPLETED|Maintenance Phase||2
8290833|NCT01611558|20441330|P1|COMPLETED|Maintenance Phase||0
8290834|NCT01611558|20441330|P1|STARTED|Maintenance Phase||2
8290835|NCT01611558|20441330|P1|NOT COMPLETED|Induction Phase||38
8290836|NCT01611558|20441330|P1|COMPLETED|Induction Phase||2
8290837|NCT01611558|20441330|P1|STARTED|Induction Phase||40
8290838|NCT01611298|20441336|P1|NOT COMPLETED|Overall Study||2
8290839|NCT01611298|20441336|P1|COMPLETED|Overall Study||5
8290840|NCT01611298|20441336|P1|STARTED|Overall Study||7
8290841|NCT01611259|20441341|P1|NOT COMPLETED|Overall Study||14
8290842|NCT01611259|20441341|P1|COMPLETED|Overall Study||34
8290843|NCT01611259|20441341|P1|STARTED|Overall Study||48
8290844|NCT01611194|20441347|P2|NOT COMPLETED|Overall Study||3
8290845|NCT01611194|20441348|P1|NOT COMPLETED|Overall Study||0
8290846|NCT01611194|20441347|P2|COMPLETED|Overall Study||32
8290847|NCT01611194|20441348|P1|COMPLETED|Overall Study||36
8290848|NCT01611194|20441347|P2|STARTED|Overall Study||35
8290849|NCT01611194|20441348|P1|STARTED|Overall Study||36
8290850|NCT01611155|20441386|P2|NOT COMPLETED|Overall Study||7
8290851|NCT01611155|20441387|P1|NOT COMPLETED|Overall Study||9
8290852|NCT01611155|20441386|P2|COMPLETED|Overall Study||18
8290853|NCT01611155|20441387|P1|COMPLETED|Overall Study||16
8290854|NCT01611155|20441386|P2|Received Treatment|Overall Study||25
8290855|NCT01611155|20441387|P1|Received Treatment|Overall Study||25
8290856|NCT01611155|20441386|P2|STARTED|Overall Study||25
8290857|NCT01611155|20441387|P1|STARTED|Overall Study||25
8290858|NCT01611090|20441397|P3|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||5
8290859|NCT01611090|20441398|P2|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
8290860|NCT01611090|20441399|P1|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
8290861|NCT01611090|20441397|P3|COMPLETED|Cross Over (Placebo to Ibrutinib)||178
8290862|NCT01611090|20441398|P2|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
8290863|NCT01611090|20441399|P1|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
8290864|NCT01611090|20441397|P3|Treated|Cross Over (Placebo to Ibrutinib)||183
8290865|NCT01611090|20441398|P2|Treated|Cross Over (Placebo to Ibrutinib)||0
8290866|NCT01611090|20441399|P1|Treated|Cross Over (Placebo to Ibrutinib)||0
8290867|NCT01611090|20441397|P3|STARTED|Cross Over (Placebo to Ibrutinib)||183
8290868|NCT01611090|20441398|P2|STARTED|Cross Over (Placebo to Ibrutinib)||0
8290869|NCT01611090|20441399|P1|STARTED|Cross Over (Placebo to Ibrutinib)||0
8290870|NCT01611090|20441397|P3|NOT COMPLETED|Randomized Period||0
8290871|NCT01611090|20441398|P2|NOT COMPLETED|Randomized Period||29
8290872|NCT01611090|20441399|P1|NOT COMPLETED|Randomized Period||30
8290873|NCT01611090|20441397|P3|COMPLETED|Randomized Period||0
8290874|NCT01611090|20441398|P2|COMPLETED|Randomized Period||260
8290875|NCT01611090|20441399|P1|COMPLETED|Randomized Period||259
8290876|NCT01611090|20441397|P3|Treated|Randomized Period||0
8290877|NCT01611090|20441398|P2|Treated|Randomized Period||287
8290878|NCT01611090|20441399|P1|Treated|Randomized Period||287
8290879|NCT01611090|20441397|P3|STARTED|Randomized Period||0
8290880|NCT01611090|20441398|P2|STARTED|Randomized Period||289
8290881|NCT01611090|20441399|P1|STARTED|Randomized Period||289
8290882|NCT01610791|20441432|P1|NOT COMPLETED|Overall Study||21
8290883|NCT01610791|20441432|P1|COMPLETED|Overall Study||100
8290884|NCT01610791|20441432|P1|STARTED|Overall Study||121
8290885|NCT01610752|20441456|P3|NOT COMPLETED|Overall Study||4
8290886|NCT01610752|20441457|P2|NOT COMPLETED|Overall Study||0
8290887|NCT01610752|20441458|P1|NOT COMPLETED|Overall Study||0
8290888|NCT01610752|20441456|P3|COMPLETED|Overall Study||13
8290889|NCT01610752|20441457|P2|COMPLETED|Overall Study||19
8290890|NCT01610752|20441458|P1|COMPLETED|Overall Study||18
8290891|NCT01610752|20441456|P3|STARTED|Overall Study||17
8290892|NCT01610752|20441457|P2|STARTED|Overall Study||19
8290893|NCT01610752|20441458|P1|STARTED|Overall Study||18
8290894|NCT01610713|20441480|P2|NOT COMPLETED|Overall Study||1
8290895|NCT01610713|20441481|P1|NOT COMPLETED|Overall Study||6
8290896|NCT01610713|20441480|P2|COMPLETED|Overall Study||76
8290897|NCT01610713|20441481|P1|COMPLETED|Overall Study||71
8290898|NCT01610713|20441480|P2|STARTED|Overall Study||77
8290899|NCT01610713|20441481|P1|STARTED|Overall Study||77
8290900|NCT01610700|20441539|P2|NOT COMPLETED|Overall Study||3
8290901|NCT01610700|20441540|P1|NOT COMPLETED|Overall Study||3
8290902|NCT01610700|20441539|P2|COMPLETED|Overall Study||77
8290903|NCT01610700|20441540|P1|COMPLETED|Overall Study||77
8290904|NCT01610700|20441539|P2|STARTED|Overall Study||80
8290905|NCT01610700|20441540|P1|STARTED|Overall Study||80
8290906|NCT01610687|20441594|P1|NOT COMPLETED|Overall Study||67
8290907|NCT01610687|20441594|P1|COMPLETED|Overall Study||70
8290908|NCT01610687|20441594|P1|STARTED|Overall Study||137
8290909|NCT01610596|20441607|P2|NOT COMPLETED|Overall Study||1
8290910|NCT01610596|20441608|P1|NOT COMPLETED|Overall Study||0
8290911|NCT01610596|20441607|P2|COMPLETED|Overall Study||35
8290912|NCT01610596|20441608|P1|COMPLETED|Overall Study||36
8290913|NCT01610596|20441607|P2|STARTED|Overall Study||36
8290914|NCT01610596|20441608|P1|STARTED|Overall Study||36
8290915|NCT01610570|20441624|P4|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290916|NCT01610570|20441625|P3|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290917|NCT01610570|20441626|P2|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290918|NCT01610570|20441627|P1|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290919|NCT01610570|20441624|P4|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290920|NCT01610570|20441625|P3|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290921|NCT01610570|20441626|P2|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290922|NCT01610570|20441627|P1|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
8290923|NCT01610570|20441624|P4|STARTED|Ph II >/= 12 mo. & </=17yrs||0
8290924|NCT01610570|20441625|P3|STARTED|Ph II >/= 12 mo. & </=17yrs||0
8290925|NCT01610570|20441626|P2|STARTED|Ph II >/= 12 mo. & </=17yrs||0
8290926|NCT01610570|20441627|P1|STARTED|Ph II >/= 12 mo. & </=17yrs||0
8290927|NCT01610570|20441624|P4|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8290928|NCT01610570|20441625|P3|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8290929|NCT01610570|20441626|P2|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8290930|NCT01610570|20441627|P1|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8290931|NCT01610570|20441624|P4|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
8290932|NCT01610570|20441625|P3|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8290933|NCT01610570|20441626|P2|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8290934|NCT01610570|20441627|P1|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
8290935|NCT01610570|20441624|P4|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
8290936|NCT01610570|20441625|P3|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
8290937|NCT01610570|20441626|P2|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
8290938|NCT01610570|20441627|P1|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
8290939|NCT01610570|20441624|P4|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8290940|NCT01610570|20441625|P3|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8290941|NCT01610570|20441626|P2|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8290942|NCT01610570|20441627|P1|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8290943|NCT01610570|20441624|P4|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8290944|NCT01610570|20441625|P3|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8290945|NCT01610570|20441626|P2|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
8290946|NCT01610570|20441627|P1|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
8290947|NCT01610570|20441624|P4|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
8290948|NCT01610570|20441625|P3|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
8290949|NCT01610570|20441626|P2|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
8290950|NCT01610570|20441627|P1|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
8290951|NCT01610557|20441666|P5|NOT COMPLETED|Post-36-Week Extension Phase||3
8290952|NCT01610557|20441667|P4|NOT COMPLETED|Post-36-Week Extension Phase||0
8290953|NCT01610557|20441668|P3|NOT COMPLETED|Post-36-Week Extension Phase||0
8290954|NCT01610557|20441669|P2|NOT COMPLETED|Post-36-Week Extension Phase||0
8290955|NCT01610557|20441670|P1|NOT COMPLETED|Post-36-Week Extension Phase||0
8290956|NCT01610557|20441666|P5|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
8290957|NCT01610557|20441667|P4|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290958|NCT01610557|20441668|P3|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290959|NCT01610557|20441669|P2|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290960|NCT01610557|20441670|P1|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290961|NCT01610557|20441666|P5|STARTED|Post-36-Week Extension Phase||55
8290962|NCT01610557|20441667|P4|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290963|NCT01610557|20441668|P3|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290964|NCT01610557|20441669|P2|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290965|NCT01610557|20441670|P1|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
8290966|NCT01610557|20441666|P5|NOT COMPLETED|36-Week Randomized Crossover Phase||0
8290967|NCT01610557|20441667|P4|NOT COMPLETED|36-Week Randomized Crossover Phase||0
8290968|NCT01610557|20441668|P3|NOT COMPLETED|36-Week Randomized Crossover Phase||0
8290969|NCT01610557|20441669|P2|NOT COMPLETED|36-Week Randomized Crossover Phase||1
8290970|NCT01610557|20441670|P1|NOT COMPLETED|36-Week Randomized Crossover Phase||0
8291051|NCT01610154|20441850|P1|COMPLETED|Overall Study||84
8290971|NCT01610557|20441666|P5|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
8290972|NCT01610557|20441667|P4|COMPLETED|36-Week Randomized Crossover Phase||13
8290973|NCT01610557|20441668|P3|COMPLETED|36-Week Randomized Crossover Phase||14
8290974|NCT01610557|20441669|P2|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
8290975|NCT01610557|20441670|P1|COMPLETED|36-Week Randomized Crossover Phase||16
8290976|NCT01610557|20441666|P5|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
8290977|NCT01610557|20441667|P4|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
8290978|NCT01610557|20441668|P3|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
8290979|NCT01610557|20441669|P2|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
8290980|NCT01610557|20441670|P1|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
8290981|NCT01610492|20441683|P1|NOT COMPLETED|Overall Study||6
8290982|NCT01610492|20441683|P1|COMPLETED|Overall Study||8
8290983|NCT01610492|20441683|P1|STARTED|Overall Study||14
8290984|NCT01610453|20441727|P1|NOT COMPLETED|Overall Study||0
8290985|NCT01610453|20441727|P1|COMPLETED|Overall Study||150
8290986|NCT01610453|20441727|P1|STARTED|Overall Study||150
8290987|NCT01610427|20441732|P1|NOT COMPLETED|Overall Study||0
8290988|NCT01610427|20441732|P1|COMPLETED|Overall Study||22
8290989|NCT01610427|20441732|P1|STARTED|Overall Study||22
8290990|NCT01610414|20441749|P2|NOT COMPLETED|After Month 25||53
8290991|NCT01610414|20441750|P1|NOT COMPLETED|After Month 25||48
8290992|NCT01610414|20441749|P2|COMPLETED|After Month 25||871
8290993|NCT01610414|20441750|P1|COMPLETED|After Month 25||874
8290994|NCT01610414|20441749|P2|STARTED|After Month 25||924
8290995|NCT01610414|20441750|P1|STARTED|After Month 25||922
8290996|NCT01610414|20441749|P2|NOT COMPLETED|Month 13 - Month 25||70
8290997|NCT01610414|20441750|P1|NOT COMPLETED|Month 13 - Month 25||65
8290998|NCT01610414|20441749|P2|COMPLETED|Month 13 - Month 25||854
8290999|NCT01610414|20441750|P1|COMPLETED|Month 13 - Month 25||857
8291000|NCT01610414|20441749|P2|STARTED|Month 13 - Month 25||924
8291001|NCT01610414|20441750|P1|STARTED|Month 13 - Month 25||922
8291002|NCT01610414|20441749|P2|NOT COMPLETED|Study Start - Month 13||129
8291003|NCT01610414|20441750|P1|NOT COMPLETED|Study Start - Month 13||115
8291004|NCT01610414|20441749|P2|COMPLETED|Study Start - Month 13||795
8291005|NCT01610414|20441750|P1|COMPLETED|Study Start - Month 13||807
8291006|NCT01610414|20441749|P2|STARTED|Study Start - Month 13||924
8291007|NCT01610414|20441750|P1|STARTED|Study Start - Month 13||922
8291008|NCT01610297|20441779|P1|NOT COMPLETED|Overall Study||1
8291009|NCT01610297|20441779|P1|COMPLETED|Overall Study||26
8291010|NCT01610297|20441779|P1|STARTED|Overall Study||27
8291011|NCT01610284|20441789|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||29
8291012|NCT01610284|20441790|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||89
8291013|NCT01610284|20441789|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8291014|NCT01610284|20441790|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8291015|NCT01610284|20441789|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|29
8291016|NCT01610284|20441790|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|89
8291017|NCT01610284|20441789|P2|NOT COMPLETED|Treatment Phase||569
8291018|NCT01610284|20441790|P1|NOT COMPLETED|Treatment Phase||574
8291019|NCT01610284|20441789|P2|COMPLETED|Treatment Phase||0
8291020|NCT01610284|20441790|P1|COMPLETED|Treatment Phase||0
8291021|NCT01610284|20441789|P2|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||0
8291022|NCT01610284|20441790|P1|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||35
8291023|NCT01610284|20441789|P2|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||0
8291024|NCT01610284|20441790|P1|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||93
8291025|NCT01610284|20441789|P2|STARTED|Treatment Phase||569
8291026|NCT01610284|20441790|P1|STARTED|Treatment Phase||574
8291027|NCT01610284|20441789|P2|NOT COMPLETED|Randomization Phase||2
8291028|NCT01610284|20441790|P1|NOT COMPLETED|Randomization Phase||2
8291029|NCT01610284|20441789|P2|COMPLETED|Randomization Phase||569
8291030|NCT01610284|20441790|P1|COMPLETED|Randomization Phase||574
8291031|NCT01610284|20441789|P2|Safety Set (SS)|Randomization Phase||570
8291032|NCT01610284|20441790|P1|Safety Set (SS)|Randomization Phase||573
8291033|NCT01610284|20441789|P2|STARTED|Randomization Phase||571
8291034|NCT01610284|20441790|P1|STARTED|Randomization Phase||576
8291035|NCT01610271|20441812|P2|NOT COMPLETED|Overall Study||4
8291036|NCT01610271|20441813|P1|NOT COMPLETED|Overall Study||2
8291037|NCT01610271|20441812|P2|COMPLETED|Overall Study||146
8291038|NCT01610271|20441813|P1|COMPLETED|Overall Study||148
8291039|NCT01610271|20441812|P2|STARTED|Overall Study||150
8291040|NCT01610271|20441813|P1|STARTED|Overall Study||150
8291041|NCT01610167|20441828|P3|NOT COMPLETED|Overall Study||2
8291042|NCT01610167|20441829|P2|NOT COMPLETED|Overall Study||0
8291043|NCT01610167|20441830|P1|NOT COMPLETED|Overall Study||0
8291044|NCT01610167|20441828|P3|COMPLETED|Overall Study||48
8291045|NCT01610167|20441829|P2|COMPLETED|Overall Study||49
8291046|NCT01610167|20441830|P1|COMPLETED|Overall Study||52
8291047|NCT01610167|20441828|P3|STARTED|Overall Study||50
8291048|NCT01610167|20441829|P2|STARTED|Overall Study||49
8291049|NCT01610167|20441830|P1|STARTED|Overall Study||52
8291050|NCT01610154|20441850|P1|NOT COMPLETED|Overall Study||1
8291052|NCT01610154|20441850|P1|STARTED|Overall Study||85
8291053|NCT01610076|20441867|P2|NOT COMPLETED|Overall Study||5
8291054|NCT01610076|20441868|P1|NOT COMPLETED|Overall Study||3
8291055|NCT01610076|20441867|P2|COMPLETED|Overall Study||100
8291056|NCT01610076|20441868|P1|COMPLETED|Overall Study||100
8291057|NCT01610076|20441867|P2|STARTED|Overall Study||105
8291058|NCT01610076|20441868|P1|STARTED|Overall Study||103
8291059|NCT01610063|20441879|P2|NOT COMPLETED|Overall Study||20
8291060|NCT01610063|20441880|P1|NOT COMPLETED|Overall Study||42
8291061|NCT01610063|20441879|P2|COMPLETED|Overall Study||93
8291062|NCT01610063|20441880|P1|COMPLETED|Overall Study||72
8291063|NCT01610063|20441879|P2|Completed 8-week|Overall Study||93
8291064|NCT01610063|20441880|P1|Completed 8-week|Overall Study||72
8291065|NCT01610063|20441879|P2|Completed 4-week|Overall Study||98
8291066|NCT01610063|20441880|P1|Completed 4-week|Overall Study||86
8291067|NCT01610063|20441879|P2|Completed 2-week|Overall Study||105
8291068|NCT01610063|20441880|P1|Completed 2-week|Overall Study||97
8291069|NCT01610063|20441879|P2|Baseline|Overall Study||113
8291070|NCT01610063|20441880|P1|Baseline|Overall Study||114
8291071|NCT01610063|20441879|P2|STARTED|Overall Study||113
8291072|NCT01610063|20441880|P1|STARTED|Overall Study||114
8291073|NCT01610037|20441903|P3|NOT COMPLETED|Treatment and Follow up Period||26
8291074|NCT01610037|20441904|P2|NOT COMPLETED|Treatment and Follow up Period||28
8291075|NCT01610037|20441905|P1|NOT COMPLETED|Treatment and Follow up Period||25
8291076|NCT01610037|20441903|P3|COMPLETED|Treatment and Follow up Period||378
8291077|NCT01610037|20441904|P2|COMPLETED|Treatment and Follow up Period||377
8291078|NCT01610037|20441905|P1|COMPLETED|Treatment and Follow up Period||382
8291079|NCT01610037|20441903|P3|STARTED|Treatment and Follow up Period||404
8291080|NCT01610037|20441904|P2|STARTED|Treatment and Follow up Period||405
8291081|NCT01610037|20441905|P1|STARTED|Treatment and Follow up Period||407
8291082|NCT01610037|20441903|P3|NOT COMPLETED|All Patients||84
8291083|NCT01610037|20441904|P2|NOT COMPLETED|All Patients||51
8291084|NCT01610037|20441905|P1|NOT COMPLETED|All Patients||59
8291085|NCT01610037|20441903|P3|COMPLETED|All Patients||320
8291086|NCT01610037|20441904|P2|COMPLETED|All Patients||354
8291087|NCT01610037|20441905|P1|COMPLETED|All Patients||348
8291088|NCT01610037|20441903|P3|Full Analysis Set (FAS)|All Patients||403
8291089|NCT01610037|20441904|P2|Full Analysis Set (FAS)|All Patients||405
8291090|NCT01610037|20441905|P1|Full Analysis Set (FAS)|All Patients||407
8291091|NCT01610037|20441903|P3|Randomized Set (RAN)|All Patients||404
8291092|NCT01610037|20441904|P2|Randomized Set (RAN)|All Patients||405
8291093|NCT01610037|20441905|P1|Randomized Set (RAN)|All Patients||407
8291094|NCT01610037|20441903|P3|STARTED|All Patients||404
8291095|NCT01610037|20441904|P2|STARTED|All Patients||405
8291096|NCT01610037|20441905|P1|STARTED|All Patients||407
8291097|NCT01610011|20441948|P2|NOT COMPLETED|Overall Study||0
8291098|NCT01610011|20441949|P1|NOT COMPLETED|Overall Study||10
8291099|NCT01610011|20441948|P2|COMPLETED|Overall Study||2
8291100|NCT01610011|20441949|P1|COMPLETED|Overall Study||9
8291101|NCT01610011|20441948|P2|STARTED|Overall Study||2
8291102|NCT01610011|20441949|P1|STARTED|Overall Study||19
8291103|NCT01609933|20441955|P1|NOT COMPLETED|Overall Study||4
8291104|NCT01609933|20441955|P1|COMPLETED|Overall Study||28
8291105|NCT01609933|20441955|P1|STARTED|Overall Study||32
8291133|NCT01609582|20442015|P2|NOT COMPLETED|Overall Study||1604
8291134|NCT01609582|20442016|P1|NOT COMPLETED|Overall Study||1603
8291135|NCT01609582|20442015|P2|COMPLETED|Overall Study||0
8291136|NCT01609582|20442016|P1|COMPLETED|Overall Study||0
8291137|NCT01609582|20442015|P2|Treated|Overall Study||1601
8291138|NCT01609582|20442016|P1|Treated|Overall Study||1603
8291139|NCT01609582|20442015|P2|STARTED|Overall Study||1604
8291140|NCT01609582|20442016|P1|STARTED|Overall Study||1603
8291141|NCT01609543|20442024|P1|NOT COMPLETED|Overall Study||42
8291142|NCT01609543|20442024|P1|COMPLETED|Overall Study||20
8291143|NCT01609543|20442024|P1|STARTED|Overall Study||62
8291144|NCT01609478|20442033|P3|NOT COMPLETED|Overall Study||9
8291145|NCT01609478|20442034|P2|NOT COMPLETED|Overall Study||2
8291146|NCT01609478|20442035|P1|NOT COMPLETED|Overall Study||7
8291147|NCT01609478|20442033|P3|COMPLETED|Overall Study||107
8291148|NCT01609478|20442034|P2|COMPLETED|Overall Study||106
8291149|NCT01609478|20442035|P1|COMPLETED|Overall Study||104
8291150|NCT01609478|20442033|P3|Full Analysis Set (FAS)|Overall Study||115
8291151|NCT01609478|20442034|P2|Full Analysis Set (FAS)|Overall Study||108
8291152|NCT01609478|20442035|P1|Full Analysis Set (FAS)|Overall Study||110
8291153|NCT01609478|20442033|P3|STARTED|Overall Study||116
8291154|NCT01609478|20442034|P2|STARTED|Overall Study||108
8291155|NCT01609478|20442035|P1|STARTED|Overall Study||111
8291156|NCT01609348|20442101|P2|NOT COMPLETED|Overall Study||0
8291157|NCT01609348|20442102|P1|NOT COMPLETED|Overall Study||0
8291158|NCT01609348|20442101|P2|COMPLETED|Overall Study||2
8291159|NCT01609348|20442102|P1|COMPLETED|Overall Study||3
8291160|NCT01609348|20442101|P2|STARTED|Overall Study||2
8291161|NCT01609348|20442102|P1|STARTED|Overall Study||3
8291165|NCT01609257|20442121|P2|NOT COMPLETED|Overall Study||8
8291166|NCT01609257|20442122|P1|NOT COMPLETED|Overall Study||6
8291167|NCT01609257|20442121|P2|COMPLETED|Overall Study||57
8291168|NCT01609257|20442122|P1|COMPLETED|Overall Study||61
8291169|NCT01609257|20442121|P2|Received Challenge Product|Overall Study||53
8291170|NCT01609257|20442122|P1|Received Challenge Product|Overall Study||56
8291171|NCT01609257|20442121|P2|Received 2 Doses|Overall Study||64
8291172|NCT01609257|20442122|P1|Received 2 Doses|Overall Study||63
8291173|NCT01609257|20442121|P2|STARTED|Overall Study||65
8291174|NCT01609257|20442122|P1|STARTED|Overall Study||67
8291175|NCT01609231|20442194|P2|NOT COMPLETED|Overall Study||3
8291176|NCT01609231|20442195|P1|NOT COMPLETED|Overall Study||3
8291177|NCT01609231|20442194|P2|COMPLETED|Overall Study||2
8291178|NCT01609231|20442195|P1|COMPLETED|Overall Study||3
8291179|NCT01609231|20442194|P2|STARTED|Overall Study||5
8291180|NCT01609231|20442195|P1|STARTED|Overall Study||6
8291181|NCT01609062|20442205|P2|NOT COMPLETED|Extension Phase||10
8291182|NCT01609062|20442206|P1|NOT COMPLETED|Extension Phase||15
8291183|NCT01609062|20442205|P2|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
8291184|NCT01609062|20442206|P1|COMPLETED|Extension Phase||0
8291185|NCT01609062|20442205|P2|STARTED|Extension Phase||10
8291186|NCT01609062|20442206|P1|STARTED|Extension Phase||15
8291187|NCT01609062|20442205|P2|NOT COMPLETED|Primary Phase||0
8291188|NCT01609062|20442206|P1|NOT COMPLETED|Primary Phase||0
8291189|NCT01609062|20442205|P2|COMPLETED|Primary Phase||10
8291190|NCT01609062|20442206|P1|COMPLETED|Primary Phase||15
8291191|NCT01609062|20442205|P2|STARTED|Primary Phase||10
8291192|NCT01609062|20442206|P1|STARTED|Primary Phase||15
8291193|NCT01609023|20442249|P1|NOT COMPLETED|Overall Study||33
8291194|NCT01609023|20442249|P1|COMPLETED|Overall Study||34
8291195|NCT01609023|20442249|P1|STARTED|Overall Study||67
8291196|NCT01609010|20442261|P2|NOT COMPLETED|Overall Study||37
8291197|NCT01609010|20442262|P1|NOT COMPLETED|Overall Study||43
8291198|NCT01609010|20442261|P2|COMPLETED|Overall Study||120
8291199|NCT01609010|20442262|P1|COMPLETED|Overall Study||113
8291200|NCT01609010|20442261|P2|Entering Cycle 2|Overall Study||124
8291201|NCT01609010|20442262|P1|Entering Cycle 2|Overall Study||120
8291202|NCT01609010|20442261|P2|STARTED|Overall Study||157
8291203|NCT01609010|20442262|P1|STARTED|Overall Study||156
8291204|NCT01608971|20442288|P2|NOT COMPLETED|Overall Study||0
8291205|NCT01608971|20442289|P1|NOT COMPLETED|Overall Study||0
8291206|NCT01608971|20442288|P2|COMPLETED|Overall Study||15
8291207|NCT01608971|20442289|P1|COMPLETED|Overall Study||15
8291208|NCT01608971|20442288|P2|STARTED|Overall Study||15
8291209|NCT01608971|20442289|P1|STARTED|Overall Study||15
8291210|NCT01608815|20442304|P3|NOT COMPLETED|Overall Study||0
8291211|NCT01608815|20442305|P2|NOT COMPLETED|Overall Study||0
8291212|NCT01608815|20442306|P1|NOT COMPLETED|Overall Study||0
8291213|NCT01608815|20442304|P3|COMPLETED|Overall Study||5
8291214|NCT01608815|20442305|P2|COMPLETED|Overall Study||7
8291215|NCT01608815|20442306|P1|COMPLETED|Overall Study||188
8291216|NCT01608815|20442304|P3|STARTED|Overall Study||5
8291217|NCT01608815|20442305|P2|STARTED|Overall Study||7
8291218|NCT01608815|20442306|P1|STARTED|Overall Study||188
8291219|NCT01608724|20442323|P1|NOT COMPLETED|Overall Study||243
8291220|NCT01608724|20442323|P1|COMPLETED|Overall Study||1180
8291221|NCT01608724|20442323|P1|Treated|Overall Study||1361
8291222|NCT01608724|20442323|P1|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
8291223|NCT01608672|20442330|P1|NOT COMPLETED|Overall Study||0
8291224|NCT01608672|20442330|P1|COMPLETED|Overall Study||207
8291225|NCT01608672|20442330|P1|STARTED|Overall Study||207
8291226|NCT01608659|20442336|P1|NOT COMPLETED|Overall Study||16
8291227|NCT01608659|20442336|P1|COMPLETED|Overall Study||94
8291228|NCT01608659|20442336|P1|STARTED|Overall Study||110
8291235|NCT01608321|20442365|P2|NOT COMPLETED|Overall Study||0
8291236|NCT01608321|20442366|P1|NOT COMPLETED|Overall Study||1
8291237|NCT01608321|20442365|P2|COMPLETED|Overall Study||4
8291238|NCT01608321|20442366|P1|COMPLETED|Overall Study||12
8291239|NCT01608321|20442365|P2|STARTED|Overall Study||4
8291240|NCT01608321|20442366|P1|STARTED|Overall Study||13
8291241|NCT01608308|20442374|P2|NOT COMPLETED|Overall Study||2
8291242|NCT01608308|20442375|P1|NOT COMPLETED|Overall Study||0
8291243|NCT01608308|20442374|P2|COMPLETED|Overall Study||29
8291244|NCT01608308|20442375|P1|COMPLETED|Overall Study||31
8291245|NCT01608308|20442374|P2|STARTED|Overall Study||31
8291246|NCT01608308|20442375|P1|STARTED|Overall Study||31
8291247|NCT01608295|20442399|P2|NOT COMPLETED|Overall Study||5
8291248|NCT01608295|20442400|P1|NOT COMPLETED|Overall Study||6
8291249|NCT01608295|20442399|P2|COMPLETED|Overall Study||25
8291250|NCT01608295|20442400|P1|COMPLETED|Overall Study||20
8291251|NCT01608295|20442399|P2|STARTED|Overall Study||30
8291252|NCT01608295|20442400|P1|STARTED|Overall Study||26
8291253|NCT01608100|20442411|P1|NOT COMPLETED|Overall Study||0
8291254|NCT01608100|20442411|P1|COMPLETED|Overall Study||1101
8291255|NCT01608100|20442411|P1|STARTED|Overall Study||1101
8291256|NCT01608087|20442438|P3|NOT COMPLETED|Overall Study||0
8291257|NCT01608087|20442439|P2|NOT COMPLETED|Overall Study||2
8291258|NCT01608087|20442440|P1|NOT COMPLETED|Overall Study||0
8291259|NCT01608087|20442438|P3|COMPLETED|Overall Study||31
8291260|NCT01608087|20442439|P2|COMPLETED|Overall Study||28
8291261|NCT01608087|20442440|P1|COMPLETED|Overall Study||30
8291262|NCT01608087|20442438|P3|STARTED|Overall Study||31
8291263|NCT01608087|20442439|P2|STARTED|Overall Study||30
8291264|NCT01608087|20442440|P1|STARTED|Overall Study||30
8291265|NCT01608061|20442456|P2|NOT COMPLETED|Extension Period||2
8291266|NCT01608061|20442457|P1|NOT COMPLETED|Extension Period||0
8291267|NCT01608061|20442456|P2|COMPLETED|Extension Period||14
8291268|NCT01608061|20442457|P1|COMPLETED|Extension Period||14
8291269|NCT01608061|20442456|P2|STARTED|Extension Period||16
8291270|NCT01608061|20442457|P1|STARTED|Extension Period||14
8291271|NCT01608061|20442456|P2|NOT COMPLETED|Long Term Follow-Up||5
8291272|NCT01608061|20442457|P1|NOT COMPLETED|Long Term Follow-Up||7
8291273|NCT01608061|20442456|P2|COMPLETED|Long Term Follow-Up||16
8291274|NCT01608061|20442457|P1|COMPLETED|Long Term Follow-Up||14
8291275|NCT01608061|20442456|P2|STARTED|Long Term Follow-Up||21
8291276|NCT01608061|20442457|P1|STARTED|Long Term Follow-Up||21
8291277|NCT01608061|20442456|P2|NOT COMPLETED|Blinded Period||0
8291278|NCT01608061|20442457|P1|NOT COMPLETED|Blinded Period||0
8291279|NCT01608061|20442456|P2|COMPLETED|Blinded Period||21
8291280|NCT01608061|20442457|P1|COMPLETED|Blinded Period||21
8291281|NCT01608061|20442456|P2|STARTED|Blinded Period||21
8291282|NCT01608061|20442457|P1|STARTED|Blinded Period||21
8291283|NCT01607957|20442470|P2|NOT COMPLETED|Overall Study||215
8291284|NCT01607957|20442471|P1|NOT COMPLETED|Overall Study||372
8291285|NCT01607957|20442470|P2|COMPLETED|Overall Study||51
8291286|NCT01607957|20442471|P1|COMPLETED|Overall Study||162
8291287|NCT01607957|20442470|P2|Treated|Overall Study||265
8291288|NCT01607957|20442471|P1|Treated|Overall Study||533
8291289|NCT01607957|20442470|P2|STARTED|Overall Study||266
8291290|NCT01607957|20442471|P1|STARTED|Overall Study||534
8291291|NCT01607853|20442481|P1|NOT COMPLETED|Overall Study||0
8291292|NCT01607853|20442481|P1|COMPLETED|Overall Study||24
8291293|NCT01607853|20442481|P1|STARTED|Overall Study||24
8291294|NCT01607658|20442592|P4|NOT COMPLETED|Overall Study||11
8291295|NCT01607658|20442593|P3|NOT COMPLETED|Overall Study||11
8291296|NCT01607658|20442594|P2|NOT COMPLETED|Overall Study||11
8291297|NCT01607658|20442595|P1|NOT COMPLETED|Overall Study||9
8291298|NCT01607658|20442592|P4|COMPLETED|Overall Study||52
8291299|NCT01607658|20442593|P3|COMPLETED|Overall Study||47
8291300|NCT01607658|20442594|P2|COMPLETED|Overall Study||56
8291301|NCT01607658|20442595|P1|COMPLETED|Overall Study||56
8291302|NCT01607658|20442592|P4|STARTED|Overall Study||63
8291303|NCT01607658|20442593|P3|STARTED|Overall Study||58
8291304|NCT01607658|20442594|P2|STARTED|Overall Study||67
8291305|NCT01607658|20442595|P1|STARTED|Overall Study||65
8291306|NCT01607645|20442619|P2|NOT COMPLETED|Overall Study||0
8291307|NCT01607645|20442620|P1|NOT COMPLETED|Overall Study||0
8291308|NCT01607645|20442619|P2|COMPLETED|Overall Study||3
8291309|NCT01607645|20442620|P1|COMPLETED|Overall Study||4
8291310|NCT01607645|20442619|P2|STARTED|Overall Study||3
8291311|NCT01607645|20442620|P1|STARTED|Overall Study||4
8291312|NCT01607593|20442650|P1|NOT COMPLETED|Overall Study||93
8291313|NCT01607593|20442650|P1|COMPLETED|Overall Study||29
8291314|NCT01607593|20442650|P1|STARTED|Overall Study||122
8291315|NCT01607554|20442656|P1|NOT COMPLETED|Overall Study||2
8291316|NCT01607554|20442656|P1|COMPLETED|Overall Study||0
8291317|NCT01607554|20442656|P1|STARTED|Overall Study||2
8291318|NCT01607476|20442669|P3|NOT COMPLETED|Overall Study||3
8291319|NCT01607476|20442670|P2|NOT COMPLETED|Overall Study||0
8291320|NCT01607476|20442671|P1|NOT COMPLETED|Overall Study||1
8291321|NCT01607476|20442669|P3|COMPLETED|Overall Study||30
8291322|NCT01607476|20442670|P2|COMPLETED|Overall Study||30
8291323|NCT01607476|20442671|P1|COMPLETED|Overall Study||24
8291324|NCT01607476|20442669|P3|STARTED|Overall Study||33
8291325|NCT01607476|20442670|P2|STARTED|Overall Study||30
8291326|NCT01607476|20442671|P1|STARTED|Overall Study||25
8291327|NCT01607450|20442689|P7|NOT COMPLETED|Overall Study||0
8291328|NCT01607450|20442690|P6|NOT COMPLETED|Overall Study||0
8291329|NCT01607450|20442691|P5|NOT COMPLETED|Overall Study||0
8291330|NCT01607450|20442692|P4|NOT COMPLETED|Overall Study||0
8291331|NCT01607450|20442693|P3|NOT COMPLETED|Overall Study||0
8291332|NCT01607450|20442694|P2|NOT COMPLETED|Overall Study||0
8291333|NCT01607450|20442695|P1|NOT COMPLETED|Overall Study||0
8291334|NCT01607450|20442689|P7|COMPLETED|Overall Study||0
8291335|NCT01607450|20442690|P6|COMPLETED|Overall Study||0
8291336|NCT01607450|20442691|P5|COMPLETED|Overall Study||1
8291337|NCT01607450|20442692|P4|COMPLETED|Overall Study||11
8291338|NCT01607450|20442693|P3|COMPLETED|Overall Study||7
8291339|NCT01607450|20442694|P2|COMPLETED|Overall Study||8
8291340|NCT01607450|20442695|P1|COMPLETED|Overall Study||6
8291341|NCT01607450|20442689|P7|STARTED|Overall Study||0
8291342|NCT01607450|20442690|P6|STARTED|Overall Study||0
8291343|NCT01607450|20442691|P5|STARTED|Overall Study||1
8291344|NCT01607450|20442692|P4|STARTED|Overall Study||11
8291345|NCT01607450|20442693|P3|STARTED|Overall Study||7
8291346|NCT01607450|20442694|P2|STARTED|Overall Study||8
8291347|NCT01607450|20442695|P1|STARTED|Overall Study||6
8291348|NCT01607411|20442739|P4|NOT COMPLETED|Period IV||0
8291349|NCT01607411|20442740|P3|NOT COMPLETED|Period IV||0
8291350|NCT01607411|20442741|P2|NOT COMPLETED|Period IV||0
8291351|NCT01607411|20442742|P1|NOT COMPLETED|Period IV||0
8291352|NCT01607411|20442739|P4|COMPLETED|Period IV||14
8291353|NCT01607411|20442740|P3|COMPLETED|Period IV||14
8291354|NCT01607411|20442741|P2|COMPLETED|Period IV||14
8291355|NCT01607411|20442742|P1|COMPLETED|Period IV||13
8291356|NCT01607411|20442739|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
8291357|NCT01607411|20442740|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
8291358|NCT01607411|20442741|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
8291359|NCT01607411|20442742|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
8291360|NCT01607411|20442739|P4|NOT COMPLETED|Period III||0
8291361|NCT01607411|20442740|P3|NOT COMPLETED|Period III||0
8291362|NCT01607411|20442741|P2|NOT COMPLETED|Period III||0
8291363|NCT01607411|20442742|P1|NOT COMPLETED|Period III||0
8291364|NCT01607411|20442739|P4|COMPLETED|Period III||13
8291365|NCT01607411|20442740|P3|COMPLETED|Period III||14
8291366|NCT01607411|20442741|P2|COMPLETED|Period III||14
8291367|NCT01607411|20442742|P1|COMPLETED|Period III||14
8291368|NCT01607411|20442739|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
8291369|NCT01607411|20442740|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
8291370|NCT01607411|20442741|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
8291371|NCT01607411|20442742|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
8291372|NCT01607411|20442739|P4|NOT COMPLETED|Period II||0
8291373|NCT01607411|20442740|P3|NOT COMPLETED|Period II||0
8291374|NCT01607411|20442741|P2|NOT COMPLETED|Period II||0
8291375|NCT01607411|20442742|P1|NOT COMPLETED|Period II||0
8291376|NCT01607411|20442739|P4|COMPLETED|Period II||14
8291377|NCT01607411|20442740|P3|COMPLETED|Period II||13
8291378|NCT01607411|20442741|P2|COMPLETED|Period II||14
8291379|NCT01607411|20442742|P1|COMPLETED|Period II||14
8291380|NCT01607411|20442739|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
8291381|NCT01607411|20442740|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
8291382|NCT01607411|20442741|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
8291383|NCT01607411|20442742|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
8291384|NCT01607411|20442739|P4|NOT COMPLETED|Period I||0
8291385|NCT01607411|20442740|P3|NOT COMPLETED|Period I||0
8291386|NCT01607411|20442741|P2|NOT COMPLETED|Period I||0
8291387|NCT01607411|20442742|P1|NOT COMPLETED|Period I||0
8291388|NCT01607411|20442739|P4|COMPLETED|Period I||14
8291389|NCT01607411|20442740|P3|COMPLETED|Period I||14
8291390|NCT01607411|20442741|P2|COMPLETED|Period I||13
8291391|NCT01607411|20442742|P1|COMPLETED|Period I||14
8291392|NCT01607411|20442739|P4|STARTED|Period I||14
8291393|NCT01607411|20442740|P3|STARTED|Period I||14
8291394|NCT01607411|20442741|P2|STARTED|Period I||13
8291395|NCT01607411|20442742|P1|STARTED|Period I||14
8291396|NCT01607398|20442765|P2|NOT COMPLETED|Overall Study||2
8291397|NCT01607398|20442766|P1|NOT COMPLETED|Overall Study||2
8291398|NCT01607398|20442765|P2|COMPLETED|Overall Study||26
8291399|NCT01607398|20442766|P1|COMPLETED|Overall Study||26
8291400|NCT01607398|20442765|P2|STARTED|Overall Study||28
8291401|NCT01607398|20442766|P1|STARTED|Overall Study||28
8291402|NCT01607346|20442810|P1|NOT COMPLETED|Overall Study||3
8291403|NCT01607346|20442810|P1|COMPLETED|Overall Study||7
8291404|NCT01607346|20442810|P1|STARTED|Overall Study||10
8291405|NCT01607320|20442826|P2|NOT COMPLETED|Overall Study||0
8291406|NCT01607320|20442827|P1|NOT COMPLETED|Overall Study||0
8291407|NCT01607320|20442826|P2|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
8291408|NCT01607320|20442827|P1|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
8291409|NCT01607320|20442826|P2|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
8291410|NCT01607320|20442827|P1|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
8291411|NCT01607255|20442835|P3|NOT COMPLETED|Overall Study||0
8291412|NCT01607255|20442836|P2|NOT COMPLETED|Overall Study||0
8291413|NCT01607255|20442837|P1|NOT COMPLETED|Overall Study||0
8291414|NCT01607255|20442835|P3|COMPLETED|Overall Study||159
8291415|NCT01607255|20442836|P2|COMPLETED|Overall Study||160
8291416|NCT01607255|20442837|P1|COMPLETED|Overall Study||161
8291417|NCT01607255|20442835|P3|STARTED|Overall Study||159
8291418|NCT01607255|20442836|P2|STARTED|Overall Study||160
8291419|NCT01607255|20442837|P1|STARTED|Overall Study||161
8291420|NCT01607203|20442847|P2|NOT COMPLETED|Overall Study||0
8291421|NCT01607203|20442848|P1|NOT COMPLETED|Overall Study||0
8291422|NCT01607203|20442847|P2|COMPLETED|Overall Study||61
8291423|NCT01607203|20442848|P1|COMPLETED|Overall Study||59
8291424|NCT01607203|20442847|P2|STARTED|Overall Study||61
8291425|NCT01607203|20442848|P1|STARTED|Overall Study||59
8291426|NCT01607112|20442860|P2|NOT COMPLETED|Overall Study||0
8291427|NCT01607112|20442861|P1|NOT COMPLETED|Overall Study||0
8291428|NCT01607112|20442860|P2|COMPLETED|Overall Study||59
8291429|NCT01607112|20442861|P1|COMPLETED|Overall Study||60
8291430|NCT01607112|20442860|P2|STARTED|Overall Study||59
8291431|NCT01607112|20442861|P1|STARTED|Overall Study||60
8291432|NCT01606852|20442897|P2|NOT COMPLETED|Overall Study||0
8291433|NCT01606852|20442898|P1|NOT COMPLETED|Overall Study||0
8291434|NCT01606852|20442897|P2|COMPLETED|Overall Study||8
8291435|NCT01606852|20442898|P1|COMPLETED|Overall Study||7
8291436|NCT01606852|20442897|P2|STARTED|Overall Study||8
8291437|NCT01606852|20442898|P1|STARTED|Overall Study||7
8291438|NCT01606800|20442908|P2|NOT COMPLETED|Overall Study||2
8291439|NCT01606800|20442909|P1|NOT COMPLETED|Overall Study||5
8291440|NCT01606800|20442908|P2|COMPLETED|Overall Study||21
8291441|NCT01606800|20442909|P1|COMPLETED|Overall Study||17
8291442|NCT01606800|20442908|P2|Treated|Overall Study||23
8291443|NCT01606800|20442909|P1|Treated|Overall Study||22
8291444|NCT01606800|20442908|P2|STARTED|Overall Study||23
8291445|NCT01606800|20442909|P1|STARTED|Overall Study||22
8291446|NCT01606787|20442917|P2|NOT COMPLETED|Overall Study||7
8291447|NCT01606787|20442918|P1|NOT COMPLETED|Overall Study||4
8291448|NCT01606787|20442917|P2|COMPLETED|Overall Study||98
8291449|NCT01606787|20442918|P1|COMPLETED|Overall Study||101
8291450|NCT01606787|20442917|P2|STARTED|Overall Study||105
8291451|NCT01606787|20442918|P1|STARTED|Overall Study||105
8291452|NCT01606761|20442929|P5|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
8291453|NCT01606761|20442930|P4|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
8291454|NCT01606761|20442931|P3|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
8291455|NCT01606761|20442932|P2|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
8291456|NCT01606761|20442933|P1|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
8291457|NCT01606761|20442929|P5|COMPLETED|Safety Follow-up Period (Week 52-68)||11
8291458|NCT01606761|20442930|P4|COMPLETED|Safety Follow-up Period (Week 52-68)||7
8291459|NCT01606761|20442931|P3|COMPLETED|Safety Follow-up Period (Week 52-68)||45
8291460|NCT01606761|20442932|P2|COMPLETED|Safety Follow-up Period (Week 52-68)||55
8291461|NCT01606761|20442933|P1|COMPLETED|Safety Follow-up Period (Week 52-68)||24
8291462|NCT01606761|20442929|P5|Safety Population|Safety Follow-up Period (Week 52-68)||19
8291463|NCT01606761|20442930|P4|Safety Population|Safety Follow-up Period (Week 52-68)||7
8291464|NCT01606761|20442931|P3|Safety Population|Safety Follow-up Period (Week 52-68)||62
8291465|NCT01606761|20442932|P2|Safety Population|Safety Follow-up Period (Week 52-68)||65
8291466|NCT01606761|20442933|P1|Safety Population|Safety Follow-up Period (Week 52-68)||28
8291467|NCT01606761|20442929|P5|STARTED|Safety Follow-up Period (Week 52-68)||19
8291468|NCT01606761|20442930|P4|STARTED|Safety Follow-up Period (Week 52-68)||9
8291469|NCT01606761|20442931|P3|STARTED|Safety Follow-up Period (Week 52-68)||62
8291470|NCT01606761|20442932|P2|STARTED|Safety Follow-up Period (Week 52-68)||65
8291471|NCT01606761|20442933|P1|STARTED|Safety Follow-up Period (Week 52-68)||28
8291472|NCT01606761|20442929|P5|NOT COMPLETED|Week 24 to Week 52||20
8291473|NCT01606761|20442930|P4|NOT COMPLETED|Week 24 to Week 52||17
8291474|NCT01606761|20442931|P3|NOT COMPLETED|Week 24 to Week 52||33
8291475|NCT01606761|20442932|P2|NOT COMPLETED|Week 24 to Week 52||33
8291476|NCT01606761|20442933|P1|NOT COMPLETED|Week 24 to Week 52||0
8291477|NCT01606761|20442929|P5|COMPLETED|Week 24 to Week 52||106
8291478|NCT01606761|20442930|P4|COMPLETED|Week 24 to Week 52||109
8291479|NCT01606761|20442931|P3|COMPLETED|Week 24 to Week 52||212
8291480|NCT01606761|20442932|P2|COMPLETED|Week 24 to Week 52||204
8291481|NCT01606761|20442933|P1|COMPLETED|Week 24 to Week 52||0
8291482|NCT01606761|20442929|P5|Treated|Week 24 to Week 52||126
8291483|NCT01606761|20442930|P4|Treated|Week 24 to Week 52||124
8291484|NCT01606761|20442931|P3|Treated|Week 24 to Week 52||245
8291485|NCT01606761|20442932|P2|Treated|Week 24 to Week 52||237
8291486|NCT01606761|20442933|P1|Treated|Week 24 to Week 52||0
8291487|NCT01606761|20442929|P5|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
8291488|NCT01606761|20442930|P4|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
8291489|NCT01606761|20442931|P3|STARTED|Week 24 to Week 52||245
8291490|NCT01606761|20442932|P2|STARTED|Week 24 to Week 52||237
8291491|NCT01606761|20442933|P1|STARTED|Week 24 to Week 52||0
8291492|NCT01606761|20442929|P5|NOT COMPLETED|Prior to Week 24||0
8291493|NCT01606761|20442930|P4|NOT COMPLETED|Prior to Week 24||0
8291494|NCT01606761|20442931|P3|NOT COMPLETED|Prior to Week 24||47
8291495|NCT01606761|20442932|P2|NOT COMPLETED|Prior to Week 24||55
8291496|NCT01606761|20442933|P1|NOT COMPLETED|Prior to Week 24||42
8291497|NCT01606761|20442929|P5|COMPLETED|Prior to Week 24||0
8291498|NCT01606761|20442930|P4|COMPLETED|Prior to Week 24||0
8291499|NCT01606761|20442931|P3|COMPLETED|Prior to Week 24||245
8291500|NCT01606761|20442932|P2|COMPLETED|Prior to Week 24||237
8291501|NCT01606761|20442933|P1|COMPLETED|Prior to Week 24||252
8291502|NCT01606761|20442929|P5|Participants Re-randomized at Week 18|Prior to Week 24||0
8291503|NCT01606761|20442930|P4|Participants Re-randomized at Week 18|Prior to Week 24||0
8291504|NCT01606761|20442931|P3|Participants Re-randomized at Week 18|Prior to Week 24||0
8291505|NCT01606761|20442932|P2|Participants Re-randomized at Week 18|Prior to Week 24||0
8291506|NCT01606761|20442933|P1|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
8291507|NCT01606761|20442929|P5|STARTED|Prior to Week 24||0
8291508|NCT01606761|20442930|P4|STARTED|Prior to Week 24||0
8291509|NCT01606761|20442931|P3|STARTED|Prior to Week 24||292
8291510|NCT01606761|20442932|P2|STARTED|Prior to Week 24||292
8291511|NCT01606761|20442933|P1|STARTED|Prior to Week 24||294
8291512|NCT01606748|20442959|P2|NOT COMPLETED|Overall Study||0
8291513|NCT01606748|20442960|P1|NOT COMPLETED|Overall Study||3
8291514|NCT01606748|20442959|P2|COMPLETED|Overall Study||17
8291515|NCT01606748|20442960|P1|COMPLETED|Overall Study||15
8291516|NCT01606748|20442959|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
8291517|NCT01606748|20442960|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
8291518|NCT01606748|20442959|P2|STARTED|Overall Study||17
8291519|NCT01606748|20442960|P1|STARTED|Overall Study||18
8291520|NCT01606735|20442991|P3|NOT COMPLETED|Overall Study||0
8291521|NCT01606735|20442992|P2|NOT COMPLETED|Overall Study||0
8291522|NCT01606735|20442993|P1|NOT COMPLETED|Overall Study||0
8291523|NCT01606735|20442991|P3|COMPLETED|Overall Study||58
8291524|NCT01606735|20442992|P2|COMPLETED|Overall Study||56
8291525|NCT01606735|20442993|P1|COMPLETED|Overall Study||58
8291526|NCT01606735|20442991|P3|STARTED|Overall Study||58
8291527|NCT01606735|20442992|P2|STARTED|Overall Study||56
8291528|NCT01606735|20442993|P1|STARTED|Overall Study||58
8291529|NCT01606709|20443003|P2|NOT COMPLETED|Overall Study||0
8291530|NCT01606709|20443004|P1|NOT COMPLETED|Overall Study||0
8291531|NCT01606709|20443003|P2|COMPLETED|Overall Study||3
8291532|NCT01606709|20443004|P1|COMPLETED|Overall Study||4
8291533|NCT01606709|20443003|P2|STARTED|Overall Study||3
8291534|NCT01606709|20443004|P1|STARTED|Overall Study||4
8291535|NCT01606670|20443012|P1|NOT COMPLETED|Overall Study||16
8291536|NCT01606670|20443012|P1|COMPLETED|Overall Study||77
8291537|NCT01606670|20443012|P1|Full Analysis Set|Overall Study||70
8291538|NCT01606670|20443012|P1|Safety Set|Overall Study||93
8291539|NCT01606670|20443012|P1|STARTED|Overall Study||93
8291540|NCT01606319|20443022|P2|NOT COMPLETED|Overall Study||40
8291541|NCT01606319|20443023|P1|NOT COMPLETED|Overall Study||34
8291542|NCT01606319|20443022|P2|COMPLETED|Overall Study||110
8291543|NCT01606319|20443023|P1|COMPLETED|Overall Study||116
8291544|NCT01606319|20443022|P2|STARTED|Overall Study||150
8291545|NCT01606319|20443023|P1|STARTED|Overall Study||150
8291546|NCT01606306|20443041|P6|NOT COMPLETED|Overall Study||11
8291547|NCT01606306|20443042|P5|NOT COMPLETED|Overall Study||11
8291548|NCT01606306|20443043|P4|NOT COMPLETED|Overall Study||13
8291549|NCT01606306|20443044|P3|NOT COMPLETED|Overall Study||14
8291550|NCT01606306|20443045|P2|NOT COMPLETED|Overall Study||10
8291551|NCT01606306|20443046|P1|NOT COMPLETED|Overall Study||15
8291552|NCT01606306|20443041|P6|COMPLETED|Overall Study||36
8291553|NCT01606306|20443042|P5|COMPLETED|Overall Study||41
8291554|NCT01606306|20443043|P4|COMPLETED|Overall Study||38
8291555|NCT01606306|20443044|P3|COMPLETED|Overall Study||37
8291556|NCT01606306|20443045|P2|COMPLETED|Overall Study||39
8291557|NCT01606306|20443046|P1|COMPLETED|Overall Study||35
8291558|NCT01606306|20443041|P6|Completed Third Treatment Period|Overall Study||36
8291559|NCT01606306|20443042|P5|Completed Third Treatment Period|Overall Study||41
8291560|NCT01606306|20443043|P4|Completed Third Treatment Period|Overall Study||38
8291561|NCT01606306|20443044|P3|Completed Third Treatment Period|Overall Study||37
8291562|NCT01606306|20443045|P2|Completed Third Treatment Period|Overall Study||39
8291563|NCT01606306|20443046|P1|Completed Third Treatment Period|Overall Study||35
8291564|NCT01606306|20443041|P6|Completed Second Treatment Period|Overall Study||41
8291565|NCT01606306|20443042|P5|Completed Second Treatment Period|Overall Study||46
8291566|NCT01606306|20443043|P4|Completed Second Treatment Period|Overall Study||44
8291567|NCT01606306|20443044|P3|Completed Second Treatment Period|Overall Study||43
8291568|NCT01606306|20443045|P2|Completed Second Treatment Period|Overall Study||38
8291569|NCT01606306|20443046|P1|Completed Second Treatment Period|Overall Study||41
8291570|NCT01606306|20443041|P6|Completed First Treatment Period|Overall Study||44
8291571|NCT01606306|20443042|P5|Completed First Treatment Period|Overall Study||47
8291572|NCT01606306|20443043|P4|Completed First Treatment Period|Overall Study||45
8291573|NCT01606306|20443044|P3|Completed First Treatment Period|Overall Study||47
8291574|NCT01606306|20443045|P2|Completed First Treatment Period|Overall Study||47
8291575|NCT01606306|20443046|P1|Completed First Treatment Period|Overall Study||43
8291576|NCT01606306|20443041|P6|STARTED|Overall Study||47
8291577|NCT01606306|20443042|P5|STARTED|Overall Study||52
8291578|NCT01606306|20443043|P4|STARTED|Overall Study||51
8291579|NCT01606306|20443044|P3|STARTED|Overall Study||51
8291580|NCT01606306|20443045|P2|STARTED|Overall Study||49
8291581|NCT01606306|20443046|P1|STARTED|Overall Study||50
8291582|NCT01606254|20443056|P4|NOT COMPLETED|Overall Study||3
8291583|NCT01606254|20443057|P3|NOT COMPLETED|Overall Study||0
8291584|NCT01606254|20443058|P2|NOT COMPLETED|Overall Study||4
8291585|NCT01606254|20443059|P1|NOT COMPLETED|Overall Study||2
8291586|NCT01606254|20443056|P4|COMPLETED|Overall Study||11
8291587|NCT01606254|20443057|P3|COMPLETED|Overall Study||14
8291588|NCT01606254|20443058|P2|COMPLETED|Overall Study||10
8291589|NCT01606254|20443059|P1|COMPLETED|Overall Study||12
8291590|NCT01606254|20443056|P4|STARTED|Overall Study||14
8291591|NCT01606254|20443057|P3|STARTED|Overall Study||14
8291592|NCT01606254|20443058|P2|STARTED|Overall Study||14
8291593|NCT01606254|20443059|P1|STARTED|Overall Study||14
8291594|NCT01606228|20443141|P1|NOT COMPLETED|Overall Study||29
8291595|NCT01606228|20443141|P1|COMPLETED|Overall Study||159
8291596|NCT01606228|20443141|P1|STARTED|Overall Study||188
8291597|NCT01606202|20443158|P2|NOT COMPLETED|Overall Study||3
8291598|NCT01606202|20443159|P1|NOT COMPLETED|Overall Study||7
8291599|NCT01606202|20443158|P2|COMPLETED|Overall Study||57
8291600|NCT01606202|20443159|P1|COMPLETED|Overall Study||49
8291601|NCT01606202|20443158|P2|STARTED|Overall Study||60
8291602|NCT01606202|20443159|P1|STARTED|Overall Study||56
8291603|NCT01606189|20443191|P6|NOT COMPLETED|Third Intenvention (14-20 Days)||1
8291604|NCT01606189|20443192|P5|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8291605|NCT01606189|20443193|P4|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8291606|NCT01606189|20443194|P3|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8291607|NCT01606189|20443195|P2|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8291608|NCT01606189|20443196|P1|NOT COMPLETED|Third Intenvention (14-20 Days)||0
8291609|NCT01606189|20443191|P6|COMPLETED|Third Intenvention (14-20 Days)||6
8291610|NCT01606189|20443192|P5|COMPLETED|Third Intenvention (14-20 Days)||8
8291611|NCT01606189|20443193|P4|COMPLETED|Third Intenvention (14-20 Days)||8
8291612|NCT01606189|20443194|P3|COMPLETED|Third Intenvention (14-20 Days)||8
8291613|NCT01606189|20443195|P2|COMPLETED|Third Intenvention (14-20 Days)||8
8291614|NCT01606189|20443196|P1|COMPLETED|Third Intenvention (14-20 Days)||8
8291615|NCT01606189|20443191|P6|STARTED|Third Intenvention (14-20 Days)||7
8291616|NCT01606189|20443192|P5|STARTED|Third Intenvention (14-20 Days)||8
8291617|NCT01606189|20443193|P4|STARTED|Third Intenvention (14-20 Days)||8
8291618|NCT01606189|20443194|P3|STARTED|Third Intenvention (14-20 Days)||8
8291619|NCT01606189|20443195|P2|STARTED|Third Intenvention (14-20 Days)||8
8291620|NCT01606189|20443196|P1|STARTED|Third Intenvention (14-20 Days)||8
8291621|NCT01606189|20443191|P6|NOT COMPLETED|Second Intenvention (14-20 Days)||1
8291622|NCT01606189|20443192|P5|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8291623|NCT01606189|20443193|P4|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8291624|NCT01606189|20443194|P3|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8291625|NCT01606189|20443195|P2|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8291626|NCT01606189|20443196|P1|NOT COMPLETED|Second Intenvention (14-20 Days)||0
8291627|NCT01606189|20443191|P6|COMPLETED|Second Intenvention (14-20 Days)||7
8291628|NCT01606189|20443192|P5|COMPLETED|Second Intenvention (14-20 Days)||8
8291629|NCT01606189|20443193|P4|COMPLETED|Second Intenvention (14-20 Days)||8
8291630|NCT01606189|20443194|P3|COMPLETED|Second Intenvention (14-20 Days)||8
8291631|NCT01606189|20443195|P2|COMPLETED|Second Intenvention (14-20 Days)||8
8291632|NCT01606189|20443196|P1|COMPLETED|Second Intenvention (14-20 Days)||8
8291633|NCT01606189|20443191|P6|STARTED|Second Intenvention (14-20 Days)||8
8291634|NCT01606189|20443192|P5|STARTED|Second Intenvention (14-20 Days)||8
8291635|NCT01606189|20443193|P4|STARTED|Second Intenvention (14-20 Days)||8
8291636|NCT01606189|20443194|P3|STARTED|Second Intenvention (14-20 Days)||8
8291637|NCT01606189|20443195|P2|STARTED|Second Intenvention (14-20 Days)||8
8291638|NCT01606189|20443196|P1|STARTED|Second Intenvention (14-20 Days)||8
8291639|NCT01606189|20443191|P6|NOT COMPLETED|First Intenvention (14-20 Days)||0
8291640|NCT01606189|20443192|P5|NOT COMPLETED|First Intenvention (14-20 Days)||0
8291641|NCT01606189|20443193|P4|NOT COMPLETED|First Intenvention (14-20 Days)||0
8291642|NCT01606189|20443194|P3|NOT COMPLETED|First Intenvention (14-20 Days)||0
8291643|NCT01606189|20443195|P2|NOT COMPLETED|First Intenvention (14-20 Days)||0
8291644|NCT01606189|20443196|P1|NOT COMPLETED|First Intenvention (14-20 Days)||0
8291645|NCT01606189|20443191|P6|COMPLETED|First Intenvention (14-20 Days)||8
8291646|NCT01606189|20443192|P5|COMPLETED|First Intenvention (14-20 Days)||8
8291647|NCT01606189|20443193|P4|COMPLETED|First Intenvention (14-20 Days)||8
8291648|NCT01606189|20443194|P3|COMPLETED|First Intenvention (14-20 Days)||8
8291649|NCT01606189|20443195|P2|COMPLETED|First Intenvention (14-20 Days)||8
8291650|NCT01606189|20443196|P1|COMPLETED|First Intenvention (14-20 Days)||8
8291651|NCT01606189|20443191|P6|STARTED|First Intenvention (14-20 Days)||8
8291652|NCT01606189|20443192|P5|STARTED|First Intenvention (14-20 Days)||8
8291653|NCT01606189|20443193|P4|STARTED|First Intenvention (14-20 Days)||8
8291654|NCT01606189|20443194|P3|STARTED|First Intenvention (14-20 Days)||8
8291655|NCT01606189|20443195|P2|STARTED|First Intenvention (14-20 Days)||8
8291656|NCT01606189|20443196|P1|STARTED|First Intenvention (14-20 Days)||8
8291657|NCT01606176|20443230|P2|NOT COMPLETED|Overall Study||3
8291658|NCT01606176|20443231|P1|NOT COMPLETED|Overall Study||4
8291659|NCT01606176|20443230|P2|COMPLETED|Overall Study||31
8291660|NCT01606176|20443231|P1|COMPLETED|Overall Study||32
8291661|NCT01606176|20443230|P2|STARTED|Overall Study||34
8291662|NCT01606176|20443231|P1|STARTED|Overall Study||36
8291663|NCT01606150|20443267|P2|NOT COMPLETED|Overall Study||0
8291664|NCT01606150|20443268|P1|NOT COMPLETED|Overall Study||0
8291665|NCT01606150|20443267|P2|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
8291666|NCT01606150|20443268|P1|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
8291667|NCT01606150|20443267|P2|STARTED|Overall Study||0
8291668|NCT01606150|20443268|P1|STARTED|Overall Study||0
8291669|NCT01606137|20443276|P1|NOT COMPLETED|Overall Study||262
8291670|NCT01606137|20443276|P1|COMPLETED|Overall Study||245
8291671|NCT01606137|20443276|P1|STARTED|Overall Study||507
8291672|NCT01606124|20443298|P2|NOT COMPLETED|Overall Study||0
8291673|NCT01606124|20443299|P1|NOT COMPLETED|Overall Study||0
8291674|NCT01606124|20443298|P2|COMPLETED|Overall Study||20
8291675|NCT01606124|20443299|P1|COMPLETED|Overall Study||19
8291676|NCT01606124|20443298|P2|STARTED|Overall Study||20
8291677|NCT01606124|20443299|P1|STARTED|Overall Study||19
8291678|NCT01606007|20443310|P3|NOT COMPLETED|Overall Study||10
8291679|NCT01606007|20443311|P2|NOT COMPLETED|Overall Study||19
8291680|NCT01606007|20443312|P1|NOT COMPLETED|Overall Study||15
8291681|NCT01606007|20443310|P3|COMPLETED|Overall Study||169
8291682|NCT01606007|20443311|P2|COMPLETED|Overall Study||160
8291683|NCT01606007|20443312|P1|COMPLETED|Overall Study||161
8291684|NCT01606007|20443310|P3|STARTED|Overall Study||179
8291685|NCT01606007|20443311|P2|STARTED|Overall Study||179
8291686|NCT01606007|20443312|P1|STARTED|Overall Study||176
8291687|NCT01605942|20443334|P2|NOT COMPLETED|Overall Study||0
8291688|NCT01605942|20443335|P1|NOT COMPLETED|Overall Study||0
8291689|NCT01605942|20443334|P2|COMPLETED|Overall Study||2
8291690|NCT01605942|20443335|P1|COMPLETED|Overall Study||6
8291691|NCT01605942|20443334|P2|STARTED|Overall Study||2
8291692|NCT01605942|20443335|P1|STARTED|Overall Study||6
8291693|NCT01605916|20443347|P5|NOT COMPLETED|Overall Study||6
8291694|NCT01605916|20443348|P4|NOT COMPLETED|Overall Study||6
8291695|NCT01605916|20443349|P3|NOT COMPLETED|Overall Study||3
8291696|NCT01605916|20443350|P2|NOT COMPLETED|Overall Study||4
8291697|NCT01605916|20443351|P1|NOT COMPLETED|Overall Study||4
8291698|NCT01605916|20443347|P5|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
8291699|NCT01605916|20443348|P4|COMPLETED|Overall Study||0
8291700|NCT01605916|20443349|P3|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
8291701|NCT01605916|20443350|P2|COMPLETED|Overall Study||0
8291702|NCT01605916|20443351|P1|COMPLETED|Overall Study||0
8291703|NCT01605916|20443347|P5|STARTED|Overall Study||7
8291704|NCT01605916|20443348|P4|STARTED|Overall Study||6
8291705|NCT01605916|20443349|P3|STARTED|Overall Study||4
8291706|NCT01605916|20443350|P2|STARTED|Overall Study||4
8291707|NCT01605916|20443351|P1|STARTED|Overall Study||4
8291708|NCT01605903|20443426|P2|NOT COMPLETED|Overall Study||0
8291709|NCT01605903|20443427|P1|NOT COMPLETED|Overall Study||0
8291710|NCT01605903|20443426|P2|COMPLETED|Overall Study||343
8291711|NCT01605903|20443427|P1|COMPLETED|Overall Study||345
8291712|NCT01605903|20443426|P2|STARTED|Overall Study||343
8291713|NCT01605903|20443427|P1|STARTED|Overall Study||345
8291714|NCT01605890|20443433|P1|NOT COMPLETED|Overall Study||2
8291715|NCT01605890|20443433|P1|COMPLETED|Overall Study||28
8291716|NCT01605890|20443433|P1|STARTED|Overall Study||30
8291717|NCT01605877|20443448|P1|NOT COMPLETED|Overall Study||1
8291718|NCT01605877|20443448|P1|COMPLETED|Overall Study||63
8291719|NCT01605877|20443448|P1|STARTED|Overall Study||64
8291720|NCT01605825|20443512|P2|NOT COMPLETED|Overall Study||3
8291721|NCT01605825|20443513|P1|NOT COMPLETED|Overall Study||10
8291722|NCT01605825|20443512|P2|COMPLETED|Overall Study||25
8291723|NCT01605825|20443513|P1|COMPLETED|Overall Study||45
8291724|NCT01605825|20443512|P2|STARTED|Overall Study||28
8291725|NCT01605825|20443513|P1|STARTED|Overall Study||55
8291726|NCT01605799|20443521|P2|NOT COMPLETED|Overall Study||1
8291727|NCT01605799|20443522|P1|NOT COMPLETED|Overall Study||2
8291728|NCT01605799|20443521|P2|COMPLETED|Overall Study||15
8291729|NCT01605799|20443522|P1|COMPLETED|Overall Study||15
8291730|NCT01605799|20443521|P2|STARTED|Overall Study||16
8291731|NCT01605799|20443522|P1|STARTED|Overall Study||17
8291732|NCT01605669|20443530|P1|NOT COMPLETED|Overall Study||0
8291733|NCT01605669|20443530|P1|COMPLETED|Overall Study||50
8291734|NCT01605669|20443530|P1|STARTED|Overall Study||50
8291735|NCT01605617|20443537|P2|NOT COMPLETED|Second Intervention||0
8291736|NCT01605617|20443538|P1|NOT COMPLETED|Second Intervention||0
8291737|NCT01605617|20443537|P2|COMPLETED|Second Intervention||0
8291738|NCT01605617|20443538|P1|COMPLETED|Second Intervention||0
8291739|NCT01605617|20443537|P2|STARTED|Second Intervention||0
8291740|NCT01605617|20443538|P1|STARTED|Second Intervention||0
8291741|NCT01605617|20443537|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
8291742|NCT01605617|20443538|P1|NOT COMPLETED|Washout Period of 4 Weeks||2
8291743|NCT01605617|20443537|P2|COMPLETED|Washout Period of 4 Weeks||0
8291744|NCT01605617|20443538|P1|COMPLETED|Washout Period of 4 Weeks||0
8291745|NCT01605617|20443537|P2|STARTED|Washout Period of 4 Weeks||1
8291746|NCT01605617|20443538|P1|STARTED|Washout Period of 4 Weeks||2
8291747|NCT01605617|20443537|P2|NOT COMPLETED|First Intervention||1
8291748|NCT01605617|20443538|P1|NOT COMPLETED|First Intervention||0
8291749|NCT01605617|20443537|P2|COMPLETED|First Intervention||1
8291750|NCT01605617|20443538|P1|COMPLETED|First Intervention||2
8291751|NCT01605617|20443537|P2|STARTED|First Intervention||2
8291752|NCT01605617|20443538|P1|STARTED|First Intervention||2
8291753|NCT01605552|20443558|P2|NOT COMPLETED|Overall Study||2
8291754|NCT01605552|20443559|P1|NOT COMPLETED|Overall Study||6
8291755|NCT01605552|20443558|P2|COMPLETED|Overall Study||14
8291756|NCT01605552|20443559|P1|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
8291757|NCT01605552|20443558|P2|STARTED|Overall Study||16
8291758|NCT01605552|20443559|P1|STARTED|Overall Study||13
8291759|NCT01605539|20443573|P3|NOT COMPLETED|Overall Study||0
8291760|NCT01605539|20443574|P2|NOT COMPLETED|Overall Study||1
8291761|NCT01605539|20443575|P1|NOT COMPLETED|Overall Study||0
8291762|NCT01605539|20443573|P3|COMPLETED|Overall Study||4
8291763|NCT01605539|20443574|P2|COMPLETED|Overall Study||2
8291764|NCT01605539|20443575|P1|COMPLETED|Overall Study||3
8291765|NCT01605539|20443573|P3|STARTED|Overall Study||4
8291766|NCT01605539|20443574|P2|STARTED|Overall Study||3
8291767|NCT01605539|20443575|P1|STARTED|Overall Study||3
8291768|NCT01605461|20443597|P1|NOT COMPLETED|Overall Study||4
8291769|NCT01605461|20443597|P1|COMPLETED|Overall Study||8
8291770|NCT01605461|20443597|P1|STARTED|Overall Study||12
8291771|NCT01605435|20443606|P2|NOT COMPLETED|Overall Study||0
8291772|NCT01605435|20443607|P1|NOT COMPLETED|Overall Study||0
8291773|NCT01605435|20443606|P2|COMPLETED|Overall Study||3
8291774|NCT01605435|20443607|P1|COMPLETED|Overall Study||2
8291775|NCT01605435|20443606|P2|STARTED|Overall Study||3
8291776|NCT01605435|20443607|P1|STARTED|Overall Study||2
8291777|NCT01605396|20443656|P2|NOT COMPLETED|Overall Study||40
8291778|NCT01605396|20443657|P1|NOT COMPLETED|Overall Study||40
8291779|NCT01605396|20443656|P2|COMPLETED|Overall Study||0
8291780|NCT01605396|20443657|P1|COMPLETED|Overall Study||0
8291781|NCT01605396|20443656|P2|Treated|Overall Study||40
8291782|NCT01605396|20443657|P1|Treated|Overall Study||39
8291783|NCT01605396|20443656|P2|STARTED|Overall Study||40
8291784|NCT01605396|20443657|P1|STARTED|Overall Study||40
8291785|NCT01605370|20443671|P2|NOT COMPLETED|Overall Study||0
8291786|NCT01605370|20443672|P1|NOT COMPLETED|Overall Study||1
8291787|NCT01605370|20443671|P2|COMPLETED|Overall Study||0
8291788|NCT01605370|20443672|P1|COMPLETED|Overall Study||0
8291789|NCT01605370|20443671|P2|STARTED|Overall Study||0
8291790|NCT01605370|20443672|P1|STARTED|Overall Study||1
8291791|NCT01605292|20443680|P2|NOT COMPLETED|Overall Study||0
8291792|NCT01605292|20443681|P1|NOT COMPLETED|Overall Study||0
8291793|NCT01605292|20443680|P2|COMPLETED|Overall Study||347
8291794|NCT01605292|20443681|P1|COMPLETED|Overall Study||351
8291795|NCT01605292|20443680|P2|STARTED|Overall Study||347
8291796|NCT01605292|20443681|P1|STARTED|Overall Study||351
8291797|NCT01605227|20443707|P2|NOT COMPLETED|Overall Study||329
8291798|NCT01605227|20443708|P1|NOT COMPLETED|Overall Study||621
8291799|NCT01605227|20443707|P2|COMPLETED|Overall Study||17
8291800|NCT01605227|20443708|P1|COMPLETED|Overall Study||61
8291801|NCT01605227|20443707|P2|STARTED|Overall Study||346
8291802|NCT01605227|20443708|P1|STARTED|Overall Study||682
8291803|NCT01605136|20443720|P2|NOT COMPLETED|Safety Follow-Up Period||2
8291804|NCT01605136|20443721|P1|NOT COMPLETED|Safety Follow-Up Period||1
8291805|NCT01605136|20443720|P2|COMPLETED|Safety Follow-Up Period||40
8291806|NCT01605136|20443721|P1|COMPLETED|Safety Follow-Up Period||44
8291807|NCT01605136|20443720|P2|STARTED|Safety Follow-Up Period||42
8291808|NCT01605136|20443721|P1|STARTED|Safety Follow-Up Period||45
8291809|NCT01605136|20443720|P2|NOT COMPLETED|Study Period||3
8291810|NCT01605136|20443721|P1|NOT COMPLETED|Study Period||3
8291811|NCT01605136|20443720|P2|COMPLETED|Study Period||42
8291812|NCT01605136|20443721|P1|COMPLETED|Study Period||45
8291813|NCT01605136|20443720|P2|STARTED|Study Period||45
8291814|NCT01605136|20443721|P1|STARTED|Study Period||48
8291815|NCT01605032|20443739|P1|NOT COMPLETED|Overall Study||1
8291816|NCT01605032|20443739|P1|COMPLETED|Overall Study||18
8291817|NCT01605032|20443739|P1|STARTED|Overall Study||19
8291818|NCT01605019|20443750|P2|NOT COMPLETED|Overall Study||0
8291819|NCT01605019|20443751|P1|NOT COMPLETED|Overall Study||3
8291820|NCT01605019|20443750|P2|COMPLETED|Overall Study||0
8291821|NCT01605019|20443751|P1|COMPLETED|Overall Study||1
8291822|NCT01605019|20443750|P2|STARTED|Overall Study||0
8291823|NCT01605019|20443751|P1|STARTED|Overall Study||4
8291842|NCT01604850|20443794|P2|NOT COMPLETED|Overall Study||30
8291843|NCT01604850|20443795|P1|NOT COMPLETED|Overall Study||52
8291844|NCT01604850|20443794|P2|COMPLETED|Overall Study||69
8291845|NCT01604850|20443795|P1|COMPLETED|Overall Study||51
8291846|NCT01604850|20443794|P2|Enrolled and Treated|Overall Study||98
8291847|NCT01604850|20443795|P1|Enrolled and Treated|Overall Study||103
8291848|NCT01604850|20443794|P2|STARTED|Overall Study||99
8291849|NCT01604850|20443795|P1|STARTED|Overall Study||103
8291850|NCT01604824|20443815|P6|NOT COMPLETED|Open-label Extension (OLE) Period||0
8291851|NCT01604824|20443816|P5|NOT COMPLETED|Open-label Extension (OLE) Period||3
8291852|NCT01604824|20443817|P4|NOT COMPLETED|Open-label Extension (OLE) Period||0
8291853|NCT01604824|20443818|P3|NOT COMPLETED|Open-label Extension (OLE) Period||0
8291854|NCT01604824|20443819|P2|NOT COMPLETED|Open-label Extension (OLE) Period||0
8291855|NCT01604824|20443820|P1|NOT COMPLETED|Open-label Extension (OLE) Period||0
8291856|NCT01604824|20443815|P6|COMPLETED|Open-label Extension (OLE) Period||10
8291857|NCT01604824|20443816|P5|COMPLETED|Open-label Extension (OLE) Period||10
8291858|NCT01604824|20443817|P4|COMPLETED|Open-label Extension (OLE) Period||0
8291859|NCT01604824|20443818|P3|COMPLETED|Open-label Extension (OLE) Period||0
8291860|NCT01604824|20443819|P2|COMPLETED|Open-label Extension (OLE) Period||0
8291861|NCT01604824|20443820|P1|COMPLETED|Open-label Extension (OLE) Period||0
8291862|NCT01604824|20443815|P6|Completed Study|Open-label Extension (OLE) Period||10
8291863|NCT01604824|20443816|P5|Completed Study|Open-label Extension (OLE) Period||10
8291864|NCT01604824|20443817|P4|Completed Study|Open-label Extension (OLE) Period||0
8291865|NCT01604824|20443818|P3|Completed Study|Open-label Extension (OLE) Period||0
8291866|NCT01604824|20443819|P2|Completed Study|Open-label Extension (OLE) Period||0
8291867|NCT01604824|20443820|P1|Completed Study|Open-label Extension (OLE) Period||0
8291868|NCT01604824|20443815|P6|Started Open-label Extension Period|Open-label Extension (OLE) Period||10
8291869|NCT01604824|20443816|P5|Started Open-label Extension Period|Open-label Extension (OLE) Period|Two subjects chose not to enter OLE period|11
8291870|NCT01604824|20443817|P4|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
8291871|NCT01604824|20443818|P3|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
8291872|NCT01604824|20443819|P2|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
8291873|NCT01604824|20443820|P1|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
8291874|NCT01604824|20443815|P6|STARTED|Open-label Extension (OLE) Period|Completed DB follow-up (Day 155)|10
8291875|NCT01604824|20443816|P5|STARTED|Open-label Extension (OLE) Period|Completed DB Period (Day 99)|13
8291876|NCT01604824|20443817|P4|STARTED|Open-label Extension (OLE) Period||0
8291877|NCT01604824|20443818|P3|STARTED|Open-label Extension (OLE) Period||0
8291878|NCT01604824|20443819|P2|STARTED|Open-label Extension (OLE) Period||0
8291879|NCT01604824|20443820|P1|STARTED|Open-label Extension (OLE) Period||0
8291880|NCT01604824|20443815|P6|NOT COMPLETED|Double-blind (DB) Period||0
8291881|NCT01604824|20443816|P5|NOT COMPLETED|Double-blind (DB) Period||0
8291882|NCT01604824|20443817|P4|NOT COMPLETED|Double-blind (DB) Period||0
8291883|NCT01604824|20443818|P3|NOT COMPLETED|Double-blind (DB) Period||0
8291884|NCT01604824|20443819|P2|NOT COMPLETED|Double-blind (DB) Period||0
8291885|NCT01604824|20443820|P1|NOT COMPLETED|Double-blind (DB) Period||0
8291886|NCT01604824|20443815|P6|COMPLETED|Double-blind (DB) Period||0
8291887|NCT01604824|20443816|P5|COMPLETED|Double-blind (DB) Period||0
8291888|NCT01604824|20443817|P4|COMPLETED|Double-blind (DB) Period||5
8291889|NCT01604824|20443818|P3|COMPLETED|Double-blind (DB) Period||5
8291890|NCT01604824|20443819|P2|COMPLETED|Double-blind (DB) Period||7
8291891|NCT01604824|20443820|P1|COMPLETED|Double-blind (DB) Period||6
8291892|NCT01604824|20443815|P6|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
8291893|NCT01604824|20443816|P5|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
8291894|NCT01604824|20443817|P4|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
8291895|NCT01604824|20443818|P3|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
8291896|NCT01604824|20443819|P2|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||7
8291897|NCT01604824|20443820|P1|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||6
8291898|NCT01604824|20443815|P6|Completed DB Period (Day 99)|Double-blind (DB) Period||0
8291899|NCT01604824|20443816|P5|Completed DB Period (Day 99)|Double-blind (DB) Period||0
8291900|NCT01604824|20443817|P4|Completed DB Period (Day 99)|Double-blind (DB) Period||5
8291901|NCT01604824|20443818|P3|Completed DB Period (Day 99)|Double-blind (DB) Period||5
8291902|NCT01604824|20443819|P2|Completed DB Period (Day 99)|Double-blind (DB) Period||7
8291903|NCT01604824|20443820|P1|Completed DB Period (Day 99)|Double-blind (DB) Period||6
8291904|NCT01604824|20443815|P6|STARTED|Double-blind (DB) Period||0
8291905|NCT01604824|20443816|P5|STARTED|Double-blind (DB) Period||0
8291906|NCT01604824|20443817|P4|STARTED|Double-blind (DB) Period||5
8291907|NCT01604824|20443818|P3|STARTED|Double-blind (DB) Period||5
8291908|NCT01604824|20443819|P2|STARTED|Double-blind (DB) Period||7
8291909|NCT01604824|20443820|P1|STARTED|Double-blind (DB) Period||6
8291910|NCT01604785|20443850|P2|NOT COMPLETED|Overall Study||1
8291911|NCT01604785|20443851|P1|NOT COMPLETED|Overall Study||7
8291912|NCT01604785|20443850|P2|COMPLETED|Overall Study||36
8291913|NCT01604785|20443851|P1|COMPLETED|Overall Study||30
8291914|NCT01604785|20443850|P2|STARTED|Overall Study||37
8291915|NCT01604785|20443851|P1|STARTED|Overall Study||37
8291916|NCT01604772|20443861|P1|NOT COMPLETED|Overall Study||0
8291917|NCT01604772|20443861|P1|COMPLETED|Overall Study||16
8291918|NCT01604772|20443861|P1|STARTED|Overall Study||16
8291919|NCT01604408|20443870|P2|NOT COMPLETED|Observation Period||3
8291920|NCT01604408|20443871|P1|NOT COMPLETED|Observation Period||1
8291921|NCT01604408|20443870|P2|COMPLETED|Observation Period||84
8291922|NCT01604408|20443871|P1|COMPLETED|Observation Period||85
8291923|NCT01604408|20443870|P2|STARTED|Observation Period||87
8291924|NCT01604408|20443871|P1|STARTED|Observation Period||86
8291925|NCT01604408|20443870|P2|NOT COMPLETED|Treatment Period 6||2
8291926|NCT01604408|20443871|P1|NOT COMPLETED|Treatment Period 6||2
8291927|NCT01604408|20443870|P2|COMPLETED|Treatment Period 6||87
8291928|NCT01604408|20443871|P1|COMPLETED|Treatment Period 6||86
8291929|NCT01604408|20443870|P2|STARTED|Treatment Period 6||89
8291930|NCT01604408|20443871|P1|STARTED|Treatment Period 6||88
8291931|NCT01604408|20443870|P2|NOT COMPLETED|Treatment Period 5||0
8291932|NCT01604408|20443871|P1|NOT COMPLETED|Treatment Period 5||4
8291933|NCT01604408|20443870|P2|COMPLETED|Treatment Period 5||89
8291934|NCT01604408|20443871|P1|COMPLETED|Treatment Period 5||88
8291935|NCT01604408|20443870|P2|STARTED|Treatment Period 5||89
8291936|NCT01604408|20443871|P1|STARTED|Treatment Period 5||92
8291937|NCT01604408|20443870|P2|NOT COMPLETED|Treatment Period 4||2
8291938|NCT01604408|20443871|P1|NOT COMPLETED|Treatment Period 4||3
8291939|NCT01604408|20443870|P2|COMPLETED|Treatment Period 4||89
8291940|NCT01604408|20443871|P1|COMPLETED|Treatment Period 4||92
8291941|NCT01604408|20443870|P2|STARTED|Treatment Period 4||91
8291942|NCT01604408|20443871|P1|STARTED|Treatment Period 4||95
8291943|NCT01604408|20443870|P2|NOT COMPLETED|Treatment Period 3||5
8291944|NCT01604408|20443871|P1|NOT COMPLETED|Treatment Period 3||5
8291945|NCT01604408|20443870|P2|COMPLETED|Treatment Period 3||91
8291946|NCT01604408|20443871|P1|COMPLETED|Treatment Period 3||95
8291947|NCT01604408|20443870|P2|STARTED|Treatment Period 3||96
8291948|NCT01604408|20443871|P1|STARTED|Treatment Period 3||100
8291949|NCT01604408|20443870|P2|NOT COMPLETED|Treatment Period 2||2
8291950|NCT01604408|20443871|P1|NOT COMPLETED|Treatment Period 2||2
8291951|NCT01604408|20443870|P2|COMPLETED|Treatment Period 2||96
8291952|NCT01604408|20443871|P1|COMPLETED|Treatment Period 2||100
8291953|NCT01604408|20443870|P2|STARTED|Treatment Period 2||98
8291954|NCT01604408|20443871|P1|STARTED|Treatment Period 2||102
8291955|NCT01604408|20443870|P2|NOT COMPLETED|Treatment Period 1||1
8291956|NCT01604408|20443871|P1|NOT COMPLETED|Treatment Period 1||0
8291957|NCT01604408|20443870|P2|COMPLETED|Treatment Period 1||98
8291958|NCT01604408|20443871|P1|COMPLETED|Treatment Period 1||102
8291959|NCT01604408|20443870|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
8291960|NCT01604408|20443871|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
8291961|NCT01604408|20443870|P2|STARTED|Treatment Period 1||99
8291962|NCT01604408|20443871|P1|STARTED|Treatment Period 1||102
8291963|NCT01604343|20443886|P5|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
8291964|NCT01604343|20443887|P4|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
8291965|NCT01604343|20443888|P3|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
8291966|NCT01604343|20443889|P2|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
8291967|NCT01604343|20443890|P1|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
8291968|NCT01604343|20443886|P5|COMPLETED|Safety Follow-up Period (Week 104-120)||85
8291969|NCT01604343|20443887|P4|COMPLETED|Safety Follow-up Period (Week 104-120)||26
8291970|NCT01604343|20443888|P3|COMPLETED|Safety Follow-up Period (Week 104-120)||72
8291971|NCT01604343|20443889|P2|COMPLETED|Safety Follow-up Period (Week 104-120)||20
8291972|NCT01604343|20443890|P1|COMPLETED|Safety Follow-up Period (Week 104-120)||79
8291973|NCT01604343|20443886|P5|Safety Population|Safety Follow-up Period (Week 104-120)||114
8291974|NCT01604343|20443887|P4|Safety Population|Safety Follow-up Period (Week 104-120)||36
8291975|NCT01604343|20443888|P3|Safety Population|Safety Follow-up Period (Week 104-120)||105
8291976|NCT01604343|20443889|P2|Safety Population|Safety Follow-up Period (Week 104-120)||26
8291977|NCT01604343|20443890|P1|Safety Population|Safety Follow-up Period (Week 104-120)||109
8291978|NCT01604343|20443886|P5|STARTED|Safety Follow-up Period (Week 104-120)||114
8291979|NCT01604343|20443887|P4|STARTED|Safety Follow-up Period (Week 104-120)||36
8291980|NCT01604343|20443888|P3|STARTED|Safety Follow-up Period (Week 104-120)||105
8291981|NCT01604343|20443889|P2|STARTED|Safety Follow-up Period (Week 104-120)||27
8291982|NCT01604343|20443890|P1|STARTED|Safety Follow-up Period (Week 104-120)||109
8291983|NCT01604343|20443886|P5|NOT COMPLETED|Week 52 to Week 104||41
8291984|NCT01604343|20443887|P4|NOT COMPLETED|Week 52 to Week 104||46
8291985|NCT01604343|20443888|P3|NOT COMPLETED|Week 52 to Week 104||67
8291986|NCT01604343|20443889|P2|NOT COMPLETED|Week 52 to Week 104||43
8291987|NCT01604343|20443890|P1|NOT COMPLETED|Week 52 to Week 104||0
8291988|NCT01604343|20443886|P5|COMPLETED|Week 52 to Week 104||429
8291989|NCT01604343|20443887|P4|COMPLETED|Week 52 to Week 104||195
8291990|NCT01604343|20443888|P3|COMPLETED|Week 52 to Week 104||414
8291991|NCT01604343|20443889|P2|COMPLETED|Week 52 to Week 104||200
8291992|NCT01604343|20443890|P1|COMPLETED|Week 52 to Week 104||0
8291993|NCT01604343|20443886|P5|Treated|Week 52 to Week 104||470
8291994|NCT01604343|20443887|P4|Treated|Week 52 to Week 104||241
8291995|NCT01604343|20443888|P3|Treated|Week 52 to Week 104||481
8291996|NCT01604343|20443889|P2|Treated|Week 52 to Week 104||242
8291997|NCT01604343|20443890|P1|Treated|Week 52 to Week 104||0
8291998|NCT01604343|20443886|P5|STARTED|Week 52 to Week 104||470
8291999|NCT01604343|20443887|P4|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
8292000|NCT01604343|20443888|P3|STARTED|Week 52 to Week 104||481
8292001|NCT01604343|20443889|P2|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
8292002|NCT01604343|20443890|P1|STARTED|Week 52 to Week 104||0
8292003|NCT01604343|20443886|P5|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
8292004|NCT01604343|20443887|P4|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
8292005|NCT01604343|20443888|P3|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
8292006|NCT01604343|20443889|P2|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
8292007|NCT01604343|20443890|P1|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
8292008|NCT01604343|20443886|P5|COMPLETED|Prior to W52 Administration(Through W52)||470
8292009|NCT01604343|20443887|P4|COMPLETED|Prior to W52 Administration(Through W52)||0
8292010|NCT01604343|20443888|P3|COMPLETED|Prior to W52 Administration(Through W52)||481
8292011|NCT01604343|20443889|P2|COMPLETED|Prior to W52 Administration(Through W52)||0
8292012|NCT01604343|20443890|P1|COMPLETED|Prior to W52 Administration(Through W52)||458
8292013|NCT01604343|20443886|P5|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
8292014|NCT01604343|20443887|P4|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
8292015|NCT01604343|20443888|P3|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
8292016|NCT01604343|20443889|P2|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
8292017|NCT01604343|20443890|P1|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
8292018|NCT01604343|20443886|P5|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
8292019|NCT01604343|20443887|P4|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
8292020|NCT01604343|20443888|P3|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
8292021|NCT01604343|20443889|P2|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
8292022|NCT01604343|20443890|P1|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
8292023|NCT01604343|20443886|P5|STARTED|Prior to W52 Administration(Through W52)||557
8292024|NCT01604343|20443887|P4|STARTED|Prior to W52 Administration(Through W52)||0
8292025|NCT01604343|20443888|P3|STARTED|Prior to W52 Administration(Through W52)||557
8292026|NCT01604343|20443889|P2|STARTED|Prior to W52 Administration(Through W52)||0
8292027|NCT01604343|20443890|P1|STARTED|Prior to W52 Administration(Through W52)||556
8292028|NCT01604291|20444003|P4|NOT COMPLETED|Overall Study||0
8292029|NCT01604291|20444004|P3|NOT COMPLETED|Overall Study||0
8292030|NCT01604291|20444005|P2|NOT COMPLETED|Overall Study||0
8292031|NCT01604291|20444006|P1|NOT COMPLETED|Overall Study||0
8292032|NCT01604291|20444003|P4|COMPLETED|Overall Study||44
8292033|NCT01604291|20444004|P3|COMPLETED|Overall Study||193
8292034|NCT01604291|20444005|P2|COMPLETED|Overall Study||443
8292035|NCT01604291|20444006|P1|COMPLETED|Overall Study||311
8292036|NCT01604291|20444003|P4|STARTED|Overall Study||44
8292037|NCT01604291|20444004|P3|STARTED|Overall Study||193
8292038|NCT01604291|20444005|P2|STARTED|Overall Study||443
8292039|NCT01604291|20444006|P1|STARTED|Overall Study||311
8292040|NCT01604278|20444055|P2|NOT COMPLETED|Overall Study||13
8292041|NCT01604278|20444056|P1|NOT COMPLETED|Overall Study||14
8292042|NCT01604278|20444055|P2|COMPLETED|Overall Study||210
8292043|NCT01604278|20444056|P1|COMPLETED|Overall Study||212
8292044|NCT01604278|20444055|P2|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
8292045|NCT01604278|20444056|P1|Full Analysis Set|Overall Study||226
8292046|NCT01604278|20444055|P2|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
8292047|NCT01604278|20444056|P1|Safety Set|Overall Study||226
8292048|NCT01604278|20444055|P2|STARTED|Overall Study||223
8292049|NCT01604278|20444056|P1|STARTED|Overall Study||226
8292050|NCT01604265|20444082|P2|NOT COMPLETED|Overall Study||0
8292051|NCT01604265|20444083|P1|NOT COMPLETED|Overall Study||2
8292052|NCT01604265|20444082|P2|COMPLETED|Overall Study||32
8292053|NCT01604265|20444083|P1|COMPLETED|Overall Study||32
8292054|NCT01604265|20444082|P2|STARTED|Overall Study||32
8292055|NCT01604265|20444083|P1|STARTED|Overall Study||34
8292056|NCT01604122|20444119|P2|NOT COMPLETED|Overall Study||0
8292057|NCT01604122|20444120|P1|NOT COMPLETED|Overall Study||0
8292058|NCT01604122|20444119|P2|COMPLETED|Overall Study||32
8292059|NCT01604122|20444120|P1|COMPLETED|Overall Study||60
8292060|NCT01604122|20444119|P2|STARTED|Overall Study||32
8292061|NCT01604122|20444120|P1|STARTED|Overall Study||60
8292062|NCT01604109|20444167|P2|NOT COMPLETED|Overall Study||34
8292063|NCT01604109|20444168|P1|NOT COMPLETED|Overall Study||33
8292064|NCT01604109|20444167|P2|COMPLETED|Overall Study||112
8292065|NCT01604109|20444168|P1|COMPLETED|Overall Study||117
8292066|NCT01604109|20444167|P2|STARTED|Overall Study||146
8292067|NCT01604109|20444168|P1|STARTED|Overall Study||150
8292068|NCT01603940|20444176|P2|NOT COMPLETED|Overall Study||0
8292069|NCT01603940|20444177|P1|NOT COMPLETED|Overall Study||0
8292070|NCT01603940|20444176|P2|COMPLETED|Overall Study||14
8292071|NCT01603940|20444177|P1|COMPLETED|Overall Study||16
8292072|NCT01603940|20444176|P2|STARTED|Overall Study||14
8292073|NCT01603940|20444177|P1|STARTED|Overall Study||16
8292074|NCT01603875|20444194|P3|NOT COMPLETED|Overall Study||9
8292075|NCT01603875|20444195|P2|NOT COMPLETED|Overall Study||8
8292076|NCT01603875|20444196|P1|NOT COMPLETED|Overall Study||7
8292077|NCT01603875|20444194|P3|COMPLETED|Overall Study||26
8292078|NCT01603875|20444195|P2|COMPLETED|Overall Study||27
8292079|NCT01603875|20444196|P1|COMPLETED|Overall Study||28
8292080|NCT01603875|20444194|P3|STARTED|Overall Study||35
8292081|NCT01603875|20444195|P2|STARTED|Overall Study||35
8292082|NCT01603875|20444196|P1|STARTED|Overall Study||35
8292083|NCT01603641|20444216|P1|NOT COMPLETED|Overall Study||35
8292084|NCT01603641|20444216|P1|COMPLETED|Overall Study||335
8292085|NCT01603641|20444216|P1|Modified Intent-to-treat Population|Overall Study||366
8292086|NCT01603641|20444216|P1|Safety Population (Treated)|Overall Study||367
8292087|NCT01603641|20444216|P1|STARTED|Overall Study||370
8292088|NCT01603628|20444223|P3|NOT COMPLETED|Overall Study||2
8292089|NCT01603628|20444224|P2|NOT COMPLETED|Overall Study||3
8292090|NCT01603628|20444225|P1|NOT COMPLETED|Overall Study||3
8292091|NCT01603628|20444223|P3|COMPLETED|Overall Study||128
8292092|NCT01603628|20444224|P2|COMPLETED|Overall Study||123
8292093|NCT01603628|20444225|P1|COMPLETED|Overall Study||125
8292094|NCT01603628|20444223|P3|Safety Population: Received Treatment|Overall Study||128
8292095|NCT01603628|20444224|P2|Safety Population: Received Treatment|Overall Study||126
8292096|NCT01603628|20444225|P1|Safety Population: Received Treatment|Overall Study||128
8292097|NCT01603628|20444223|P3|STARTED|Overall Study||130
8292098|NCT01603628|20444224|P2|STARTED|Overall Study||126
8292099|NCT01603628|20444225|P1|STARTED|Overall Study||128
8292100|NCT01603615|20444242|P1|NOT COMPLETED|Overall Study||34
8292101|NCT01603615|20444242|P1|COMPLETED|Overall Study||186
8292102|NCT01603615|20444242|P1|Safety Population (Treated)|Overall Study||213
8292103|NCT01603615|20444242|P1|STARTED|Overall Study||220
8292104|NCT01603602|20444249|P3|NOT COMPLETED|Overall Study||1
8292105|NCT01603602|20444250|P2|NOT COMPLETED|Overall Study||0
8292106|NCT01603602|20444251|P1|NOT COMPLETED|Overall Study||2
8292107|NCT01603602|20444249|P3|COMPLETED|Overall Study||79
8292108|NCT01603602|20444250|P2|COMPLETED|Overall Study||78
8292109|NCT01603602|20444251|P1|COMPLETED|Overall Study||75
8292110|NCT01603602|20444249|P3|STARTED|Overall Study||80
8292111|NCT01603602|20444250|P2|STARTED|Overall Study||78
8292112|NCT01603602|20444251|P1|STARTED|Overall Study||77
8292113|NCT01603459|20444271|P1|NOT COMPLETED|Overall Study||18
8292114|NCT01603459|20444271|P1|COMPLETED|Overall Study||137
8292115|NCT01603459|20444271|P1|STARTED|Overall Study||155
8292116|NCT01603420|20444393|P2|NOT COMPLETED|Overall Study||0
8292117|NCT01603420|20444394|P1|NOT COMPLETED|Overall Study||0
8292118|NCT01603420|20444393|P2|COMPLETED|Overall Study||1
8292119|NCT01603420|20444394|P1|COMPLETED|Overall Study||1
8292120|NCT01603420|20444393|P2|STARTED|Overall Study||1
8292121|NCT01603420|20444394|P1|STARTED|Overall Study||1
8292122|NCT01603394|20444422|P1|NOT COMPLETED|Overall Study||1
8292123|NCT01603394|20444422|P1|COMPLETED|Overall Study||8
8292124|NCT01603394|20444422|P1|STARTED|Overall Study||9
8292125|NCT01603368|20444439|P2|NOT COMPLETED|Overall Study||0
8292126|NCT01603368|20444440|P1|NOT COMPLETED|Overall Study||0
8292127|NCT01603368|20444439|P2|COMPLETED|Overall Study||66
8292128|NCT01603368|20444440|P1|COMPLETED|Overall Study||68
8292129|NCT01603368|20444439|P2|STARTED|Overall Study||66
8292130|NCT01603368|20444440|P1|STARTED|Overall Study||68
8292131|NCT01603355|20444476|P1|NOT COMPLETED|Overall Study||2
8292132|NCT01603355|20444476|P1|COMPLETED|Overall Study||1
8292133|NCT01603355|20444476|P1|STARTED|Overall Study||3
8292134|NCT01603277|20444482|P2|NOT COMPLETED|Overall Study||18
8292135|NCT01603277|20444483|P1|NOT COMPLETED|Overall Study||14
8292136|NCT01603277|20444482|P2|COMPLETED|Overall Study||64
8292137|NCT01603277|20444483|P1|COMPLETED|Overall Study||64
8292138|NCT01603277|20444482|P2|STARTED|Overall Study||82
8292139|NCT01603277|20444483|P1|STARTED|Overall Study||78
8292140|NCT01603121|20444489|P2|NOT COMPLETED|Second Intervention, 10 Hours||0
8292141|NCT01603121|20444490|P1|NOT COMPLETED|Second Intervention, 10 Hours||1
8292142|NCT01603121|20444489|P2|COMPLETED|Second Intervention, 10 Hours||0
8292143|NCT01603121|20444490|P1|COMPLETED|Second Intervention, 10 Hours||0
8292144|NCT01603121|20444489|P2|STARTED|Second Intervention, 10 Hours||0
8292145|NCT01603121|20444490|P1|STARTED|Second Intervention, 10 Hours||1
8292146|NCT01603121|20444489|P2|NOT COMPLETED|First Intervention, 10 Hours||0
8292147|NCT01603121|20444490|P1|NOT COMPLETED|First Intervention, 10 Hours||0
8292148|NCT01603121|20444489|P2|COMPLETED|First Intervention, 10 Hours||0
8292149|NCT01603121|20444490|P1|COMPLETED|First Intervention, 10 Hours||1
8292150|NCT01603121|20444489|P2|STARTED|First Intervention, 10 Hours||0
8292151|NCT01603121|20444490|P1|STARTED|First Intervention, 10 Hours||1
8292152|NCT01603082|20444502|P2|NOT COMPLETED|Overall Study||1
8292153|NCT01603082|20444503|P1|NOT COMPLETED|Overall Study||2
8292154|NCT01603082|20444502|P2|COMPLETED|Overall Study|Completed the study|48
8292155|NCT01603082|20444503|P1|COMPLETED|Overall Study|Completed the study.|49
8292156|NCT01603082|20444502|P2|STARTED|Overall Study|Randomized|49
8292157|NCT01603082|20444503|P1|STARTED|Overall Study|Randomized|51
8292158|NCT01603056|20444513|P2|NOT COMPLETED|Overall Study||14
8292159|NCT01603056|20444514|P1|NOT COMPLETED|Overall Study||34
8292160|NCT01603056|20444513|P2|COMPLETED|Overall Study||190
8292161|NCT01603056|20444514|P1|COMPLETED|Overall Study||379
8292162|NCT01603056|20444513|P2|STARTED|Overall Study||204
8292163|NCT01603056|20444514|P1|STARTED|Overall Study||413
8292164|NCT01603043|20444544|P2|NOT COMPLETED|Overall Study||3
8292165|NCT01603043|20444545|P1|NOT COMPLETED|Overall Study||7
8292166|NCT01603043|20444544|P2|COMPLETED|Overall Study||0
8292167|NCT01603043|20444545|P1|COMPLETED|Overall Study||0
8292168|NCT01603043|20444544|P2|STARTED|Overall Study||3
8292169|NCT01603043|20444545|P1|STARTED|Overall Study||7
8292170|NCT01602965|20444557|P2|NOT COMPLETED|Overall Study||2
8292171|NCT01602965|20444558|P1|NOT COMPLETED|Overall Study||4
8292172|NCT01602965|20444557|P2|COMPLETED|Overall Study||18
8292173|NCT01602965|20444558|P1|COMPLETED|Overall Study||16
8292174|NCT01602965|20444557|P2|STARTED|Overall Study||20
8292175|NCT01602965|20444558|P1|STARTED|Overall Study||20
8292176|NCT01602744|20444566|P2|NOT COMPLETED|Overall Study||23
8292177|NCT01602744|20444567|P1|NOT COMPLETED|Overall Study||30
8292178|NCT01602744|20444566|P2|COMPLETED|Overall Study||160
8292179|NCT01602744|20444567|P1|COMPLETED|Overall Study||146
8292180|NCT01602744|20444566|P2|STARTED|Overall Study||183
8292181|NCT01602744|20444567|P1|STARTED|Overall Study||176
8292182|NCT01602731|20444583|P1|NOT COMPLETED|Overall Study||30
8292183|NCT01602731|20444583|P1|COMPLETED|Overall Study||15
8292184|NCT01602731|20444583|P1|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
8292185|NCT01602731|20444583|P1|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
8292186|NCT01602731|20444583|P1|STARTED|Overall Study||45
8292187|NCT01602692|20444591|P2|NOT COMPLETED|Overall Study||0
8292188|NCT01602692|20444592|P1|NOT COMPLETED|Overall Study||0
8292189|NCT01602692|20444591|P2|COMPLETED|Overall Study||20
8292190|NCT01602692|20444592|P1|COMPLETED|Overall Study||20
8292191|NCT01602692|20444591|P2|STARTED|Overall Study||20
8292192|NCT01602692|20444592|P1|STARTED|Overall Study||20
8292193|NCT01602679|20444612|P2|NOT COMPLETED|Overall Study||0
8292194|NCT01602679|20444613|P1|NOT COMPLETED|Overall Study||0
8292195|NCT01602679|20444612|P2|COMPLETED|Overall Study||3
8292196|NCT01602679|20444613|P1|COMPLETED|Overall Study||4
8292197|NCT01602679|20444612|P2|STARTED|Overall Study||3
8292198|NCT01602679|20444613|P1|STARTED|Overall Study||4
8292199|NCT01602666|20444625|P2|NOT COMPLETED|Radiation Therapy on Protocol||31
8292200|NCT01602666|20444626|P1|NOT COMPLETED|Radiation Therapy on Protocol||10
8292201|NCT01602666|20444625|P2|COMPLETED|Radiation Therapy on Protocol||82
8292202|NCT01602666|20444626|P1|COMPLETED|Radiation Therapy on Protocol||60
8292203|NCT01602666|20444625|P2|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||16
8292204|NCT01602666|20444626|P1|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||0
8292205|NCT01602666|20444625|P2|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||74
8292206|NCT01602666|20444626|P1|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||0
8292207|NCT01602666|20444625|P2|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||0
8292208|NCT01602666|20444626|P1|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||66
8292209|NCT01602666|20444625|P2|STARTED|Radiation Therapy on Protocol||113
8292210|NCT01602666|20444626|P1|STARTED|Radiation Therapy on Protocol||70
8292211|NCT01602666|20444625|P2|NOT COMPLETED|Induction Chemotherapy||24
8292212|NCT01602666|20444626|P1|NOT COMPLETED|Induction Chemotherapy||37
8292213|NCT01602666|20444625|P2|COMPLETED|Induction Chemotherapy||113
8292214|NCT01602666|20444626|P1|COMPLETED|Induction Chemotherapy||70
8292215|NCT01602666|20444625|P2|STARTED|Induction Chemotherapy||137
8292216|NCT01602666|20444626|P1|STARTED|Induction Chemotherapy||107
8292217|NCT01602614|20444642|P4|NOT COMPLETED|Overall Study||0
8292218|NCT01602614|20444643|P3|NOT COMPLETED|Overall Study||0
8292219|NCT01602614|20444644|P2|NOT COMPLETED|Overall Study||0
8292220|NCT01602614|20444645|P1|NOT COMPLETED|Overall Study||0
8292221|NCT01602614|20444642|P4|COMPLETED|Overall Study||0
8292222|NCT01602614|20444643|P3|COMPLETED|Overall Study||8
8292223|NCT01602614|20444644|P2|COMPLETED|Overall Study||10
8292224|NCT01602614|20444645|P1|COMPLETED|Overall Study||0
8292225|NCT01602614|20444642|P4|STARTED|Overall Study||0
8292226|NCT01602614|20444643|P3|STARTED|Overall Study||8
8292227|NCT01602614|20444644|P2|STARTED|Overall Study||10
8292228|NCT01602614|20444645|P1|STARTED|Overall Study||0
8292229|NCT01602562|20444713|P2|NOT COMPLETED|Overall Study||3
8292230|NCT01602562|20444714|P1|NOT COMPLETED|Overall Study||5
8292231|NCT01602562|20444713|P2|COMPLETED|Overall Study||16
8292232|NCT01602562|20444714|P1|COMPLETED|Overall Study||16
8292233|NCT01602562|20444713|P2|STARTED|Overall Study||19
8292234|NCT01602562|20444714|P1|STARTED|Overall Study||21
8292235|NCT01602549|20444750|P2|NOT COMPLETED|Overall Study||1
8292236|NCT01602549|20444751|P1|NOT COMPLETED|Overall Study||1
8292237|NCT01602549|20444750|P2|COMPLETED|Overall Study||37
8292238|NCT01602549|20444751|P1|COMPLETED|Overall Study||18
8292239|NCT01602549|20444750|P2|STARTED|Overall Study||38
8292240|NCT01602549|20444751|P1|STARTED|Overall Study||19
8292241|NCT01602510|20444830|P3|NOT COMPLETED|Randomized Phase||73
8292242|NCT01602510|20444831|P2|NOT COMPLETED|Randomized Phase||74
8292243|NCT01602510|20444832|P1|NOT COMPLETED|Randomized Phase||0
8292244|NCT01602510|20444830|P3|COMPLETED|Randomized Phase||58
8292245|NCT01602510|20444831|P2|COMPLETED|Randomized Phase||59
8292246|NCT01602510|20444832|P1|COMPLETED|Randomized Phase||0
8292247|NCT01602510|20444830|P3|STARTED|Randomized Phase||131
8292248|NCT01602510|20444831|P2|STARTED|Randomized Phase||133
8292249|NCT01602510|20444832|P1|STARTED|Randomized Phase||0
8292250|NCT01602510|20444830|P3|NOT COMPLETED|Open Label Phase||0
8292251|NCT01602510|20444831|P2|NOT COMPLETED|Open Label Phase||0
8292252|NCT01602510|20444832|P1|NOT COMPLETED|Open Label Phase||303
8292253|NCT01602510|20444830|P3|COMPLETED|Open Label Phase||0
8292254|NCT01602510|20444831|P2|COMPLETED|Open Label Phase||0
8292255|NCT01602510|20444832|P1|COMPLETED|Open Label Phase||117
8292256|NCT01602510|20444830|P3|STARTED|Open Label Phase||0
8292257|NCT01602510|20444831|P2|STARTED|Open Label Phase||0
8292258|NCT01602510|20444832|P1|STARTED|Open Label Phase||420
8292259|NCT01602484|20444858|P2|NOT COMPLETED|Overall Study||1
8292260|NCT01602484|20444859|P1|NOT COMPLETED|Overall Study||0
8292261|NCT01602484|20444858|P2|COMPLETED|Overall Study||24
8292262|NCT01602484|20444859|P1|COMPLETED|Overall Study||25
8292263|NCT01602484|20444858|P2|STARTED|Overall Study||25
8292264|NCT01602484|20444859|P1|STARTED|Overall Study||25
8292265|NCT01602471|20444871|P1|NOT COMPLETED|Overall Study||0
8292266|NCT01602471|20444871|P1|COMPLETED|Overall Study||4
8292267|NCT01602471|20444871|P1|STARTED|Overall Study||4
8292268|NCT01602419|20444875|P1|NOT COMPLETED|Overall Study||29
8292269|NCT01602419|20444875|P1|COMPLETED|Overall Study||91
8292270|NCT01602419|20444875|P1|EFF Population|Overall Study||91
8292271|NCT01602419|20444875|P1|ITT Population|Overall Study||102
8292272|NCT01602419|20444875|P1|SAF Population|Overall Study||111
8292273|NCT01602419|20444875|P1|STARTED|Overall Study||120
8292280|NCT01602341|20444955|P2|NOT COMPLETED|Overall Study||1
8292281|NCT01602341|20444956|P1|NOT COMPLETED|Overall Study||0
8292282|NCT01602341|20444955|P2|COMPLETED|Overall Study||41
8292283|NCT01602341|20444956|P1|COMPLETED|Overall Study||44
8292284|NCT01602341|20444955|P2|STARTED|Overall Study||42
8292285|NCT01602341|20444956|P1|STARTED|Overall Study||44
8292286|NCT01602315|20444997|P7|NOT COMPLETED|Overall Study||29
8292287|NCT01602315|20444998|P6|NOT COMPLETED|Overall Study||35
8292288|NCT01602315|20444999|P5|NOT COMPLETED|Overall Study||71
8292289|NCT01602315|20445000|P4|NOT COMPLETED|Overall Study||6
8292290|NCT01602315|20445001|P3|NOT COMPLETED|Overall Study||18
8292291|NCT01602315|20445002|P2|NOT COMPLETED|Overall Study||5
8292292|NCT01602315|20445003|P1|NOT COMPLETED|Overall Study||16
8292293|NCT01602315|20444997|P7|COMPLETED|Overall Study||0
8292294|NCT01602315|20444998|P6|COMPLETED|Overall Study||0
8292295|NCT01602315|20444999|P5|COMPLETED|Overall Study||0
8292296|NCT01602315|20445000|P4|COMPLETED|Overall Study||0
8292297|NCT01602315|20445001|P3|COMPLETED|Overall Study||0
8292298|NCT01602315|20445002|P2|COMPLETED|Overall Study||0
8292299|NCT01602315|20445003|P1|COMPLETED|Overall Study||0
8292300|NCT01602315|20444997|P7|STARTED|Overall Study||29
8292301|NCT01602315|20444998|P6|STARTED|Overall Study||35
8292302|NCT01602315|20444999|P5|STARTED|Overall Study||71
8292303|NCT01602315|20445000|P4|STARTED|Overall Study||6
8292304|NCT01602315|20445001|P3|STARTED|Overall Study||18
8292305|NCT01602315|20445002|P2|STARTED|Overall Study||5
8292306|NCT01602315|20445003|P1|STARTED|Overall Study||16
8292307|NCT01602224|20445092|P3|NOT COMPLETED|Overall Study||6
8292308|NCT01602224|20445093|P2|NOT COMPLETED|Overall Study||8
8292309|NCT01602224|20445094|P1|NOT COMPLETED|Overall Study||8
8292310|NCT01602224|20445092|P3|COMPLETED|Overall Study||66
8292311|NCT01602224|20445093|P2|COMPLETED|Overall Study||66
8292312|NCT01602224|20445094|P1|COMPLETED|Overall Study||66
8292313|NCT01602224|20445092|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
8292314|NCT01602224|20445093|P2|Received at Least 1 Dose of Study Drug|Overall Study||74
8292315|NCT01602224|20445094|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
8292316|NCT01602224|20445092|P3|STARTED|Overall Study||72
8292317|NCT01602224|20445093|P2|STARTED|Overall Study||74
8292318|NCT01602224|20445094|P1|STARTED|Overall Study||74
8292319|NCT01602198|20445140|P2|NOT COMPLETED|Overall Study||0
8292320|NCT01602198|20445141|P1|NOT COMPLETED|Overall Study||0
8292321|NCT01602198|20445140|P2|COMPLETED|Overall Study||1
8292322|NCT01602198|20445141|P1|COMPLETED|Overall Study||0
8292323|NCT01602198|20445140|P2|STARTED|Overall Study||1
8292324|NCT01602198|20445141|P1|STARTED|Overall Study||0
8292325|NCT01602172|20445150|P3|NOT COMPLETED|Overall Study||0
8292326|NCT01602172|20445151|P2|NOT COMPLETED|Overall Study||6
8292327|NCT01602172|20445152|P1|NOT COMPLETED|Overall Study||5
8292328|NCT01602172|20445150|P3|COMPLETED|Overall Study||22
8292329|NCT01602172|20445151|P2|COMPLETED|Overall Study||17
8292330|NCT01602172|20445152|P1|COMPLETED|Overall Study||32
8292331|NCT01602172|20445150|P3|STARTED|Overall Study||22
8292332|NCT01602172|20445151|P2|STARTED|Overall Study||23
8292333|NCT01602172|20445152|P1|STARTED|Overall Study||37
8292334|NCT01602120|20445179|P4|NOT COMPLETED|Overall Study||53
8292335|NCT01602120|20445180|P3|NOT COMPLETED|Overall Study||17
8292336|NCT01602120|20445181|P2|NOT COMPLETED|Overall Study||60
8292337|NCT01602120|20445182|P1|NOT COMPLETED|Overall Study||29
8292338|NCT01602120|20445179|P4|COMPLETED|Overall Study||0
8292339|NCT01602120|20445180|P3|COMPLETED|Overall Study||0
8292340|NCT01602120|20445181|P2|COMPLETED|Overall Study||0
8292341|NCT01602120|20445182|P1|COMPLETED|Overall Study||0
8292342|NCT01602120|20445179|P4|STARTED|Overall Study||53
8292343|NCT01602120|20445180|P3|STARTED|Overall Study||17
8292344|NCT01602120|20445181|P2|STARTED|Overall Study||60
8292345|NCT01602120|20445182|P1|STARTED|Overall Study||29
8292346|NCT01602068|20445196|P2|NOT COMPLETED|Overall Study||0
8292347|NCT01602068|20445197|P1|NOT COMPLETED|Overall Study||0
8292348|NCT01602068|20445196|P2|COMPLETED|Overall Study||22
8292349|NCT01602068|20445197|P1|COMPLETED|Overall Study||23
8292350|NCT01602068|20445196|P2|STARTED|Overall Study|Day before surgery|22
8292351|NCT01602068|20445197|P1|STARTED|Overall Study|Day before surgery|23
8292352|NCT01602016|20445203|P1|NOT COMPLETED|Overall Study||0
8292353|NCT01602016|20445203|P1|COMPLETED|Overall Study||0
8292354|NCT01602016|20445203|P1|STARTED|Overall Study||0
8292355|NCT01601977|20445210|P1|NOT COMPLETED|Overall Study||0
8292356|NCT01601977|20445210|P1|COMPLETED|Overall Study||10
8292357|NCT01601977|20445210|P1|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
8292358|NCT01601873|20445230|P2|NOT COMPLETED|Overall Study||3
8292359|NCT01601873|20445231|P1|NOT COMPLETED|Overall Study||2
8292360|NCT01601873|20445230|P2|COMPLETED|Overall Study||44
8292361|NCT01601873|20445231|P1|COMPLETED|Overall Study||48
8292362|NCT01601873|20445230|P2|STARTED|Overall Study||47
8292363|NCT01601873|20445231|P1|STARTED|Overall Study||50
8292364|NCT01601847|20445257|P2|NOT COMPLETED|Overall Study||10
8292365|NCT01601847|20445258|P1|NOT COMPLETED|Overall Study||13
8292366|NCT01601847|20445257|P2|COMPLETED|Overall Study||137
8292367|NCT01601847|20445258|P1|COMPLETED|Overall Study||140
8292368|NCT01601847|20445257|P2|STARTED|Overall Study||147
8292369|NCT01601847|20445258|P1|STARTED|Overall Study||153
8292370|NCT01601821|20445270|P2|NOT COMPLETED|Overall Study||29
8292371|NCT01601821|20445271|P1|NOT COMPLETED|Overall Study||29
8292372|NCT01601821|20445270|P2|COMPLETED|Overall Study||91
8292373|NCT01601821|20445271|P1|COMPLETED|Overall Study||96
8292374|NCT01601821|20445270|P2|STARTED|Overall Study||120
8292375|NCT01601821|20445271|P1|STARTED|Overall Study||125
8292376|NCT01601782|20445301|P1|NOT COMPLETED|Overall Study||0
8292377|NCT01601782|20445301|P1|COMPLETED|Overall Study||16
8292378|NCT01601782|20445301|P1|STARTED|Overall Study||16
8292379|NCT01601704|20445307|P2|NOT COMPLETED|Overall Study||4
8292380|NCT01601704|20445308|P1|NOT COMPLETED|Overall Study||1
8292381|NCT01601704|20445307|P2|COMPLETED|Overall Study||4450
8292382|NCT01601704|20445308|P1|COMPLETED|Overall Study||4455
8292383|NCT01601704|20445307|P2|Treated|Overall Study||4450
8292384|NCT01601704|20445308|P1|Treated|Overall Study||4455
8292385|NCT01601704|20445307|P2|STARTED|Overall Study||4454
8292386|NCT01601704|20445308|P1|STARTED|Overall Study||4456
8292387|NCT01601691|20445322|P1|NOT COMPLETED|Overall Study||0
8292388|NCT01601691|20445322|P1|COMPLETED|Overall Study||10
8292389|NCT01601691|20445322|P1|STARTED|Overall Study||10
8292390|NCT01601652|20445326|P1|NOT COMPLETED|Overall Study||1
8292391|NCT01601652|20445326|P1|COMPLETED|Overall Study||11
8292392|NCT01601652|20445326|P1|STARTED|Overall Study||12
8292393|NCT01601626|20445334|P3|NOT COMPLETED|Overall Study||2
8292394|NCT01601626|20445335|P2|NOT COMPLETED|Overall Study||5
8292395|NCT01601626|20445336|P1|NOT COMPLETED|Overall Study||3
8292396|NCT01601626|20445334|P3|COMPLETED|Overall Study||21
8292397|NCT01601626|20445335|P2|COMPLETED|Overall Study||19
8292398|NCT01601626|20445336|P1|COMPLETED|Overall Study||21
8292399|NCT01601626|20445334|P3|STARTED|Overall Study||23
8292400|NCT01601626|20445335|P2|STARTED|Overall Study||24
8292401|NCT01601626|20445336|P1|STARTED|Overall Study||24
8292402|NCT01601535|20445425|P6|NOT COMPLETED|Phase 2||12
8292403|NCT01601535|20445426|P5|NOT COMPLETED|Phase 2||19
8292404|NCT01601535|20445427|P4|NOT COMPLETED|Phase 2||0
8292405|NCT01601535|20445428|P3|NOT COMPLETED|Phase 2||0
8292406|NCT01601535|20445429|P2|NOT COMPLETED|Phase 2||0
8292407|NCT01601535|20445430|P1|NOT COMPLETED|Phase 2||0
8292408|NCT01601535|20445425|P6|COMPLETED|Phase 2||0
8292409|NCT01601535|20445426|P5|COMPLETED|Phase 2||1
8292410|NCT01601535|20445427|P4|COMPLETED|Phase 2||0
8292411|NCT01601535|20445428|P3|COMPLETED|Phase 2||0
8292412|NCT01601535|20445429|P2|COMPLETED|Phase 2||0
8292413|NCT01601535|20445430|P1|COMPLETED|Phase 2||0
8292414|NCT01601535|20445425|P6|STARTED|Phase 2||12
8292415|NCT01601535|20445426|P5|STARTED|Phase 2||20
8292416|NCT01601535|20445427|P4|STARTED|Phase 2||0
8292417|NCT01601535|20445428|P3|STARTED|Phase 2||0
8292418|NCT01601535|20445429|P2|STARTED|Phase 2||0
8292419|NCT01601535|20445430|P1|STARTED|Phase 2||0
8292420|NCT01601535|20445425|P6|NOT COMPLETED|Phase 1||0
8292421|NCT01601535|20445426|P5|NOT COMPLETED|Phase 1||0
8292422|NCT01601535|20445427|P4|NOT COMPLETED|Phase 1||4
8292423|NCT01601535|20445428|P3|NOT COMPLETED|Phase 1||5
8292424|NCT01601535|20445429|P2|NOT COMPLETED|Phase 1||6
8292425|NCT01601535|20445430|P1|NOT COMPLETED|Phase 1||6
8292426|NCT01601535|20445425|P6|COMPLETED|Phase 1||0
8292427|NCT01601535|20445426|P5|COMPLETED|Phase 1||0
8292428|NCT01601535|20445427|P4|COMPLETED|Phase 1||0
8292429|NCT01601535|20445428|P3|COMPLETED|Phase 1||1
8292430|NCT01601535|20445429|P2|COMPLETED|Phase 1||0
8292431|NCT01601535|20445430|P1|COMPLETED|Phase 1||0
8292432|NCT01601535|20445425|P6|STARTED|Phase 1||0
8292433|NCT01601535|20445426|P5|STARTED|Phase 1||0
8292434|NCT01601535|20445427|P4|STARTED|Phase 1||4
8292435|NCT01601535|20445428|P3|STARTED|Phase 1||6
8292436|NCT01601535|20445429|P2|STARTED|Phase 1||6
8292437|NCT01601535|20445430|P1|STARTED|Phase 1||6
8292438|NCT01601496|20445486|P1|NOT COMPLETED|Overall Study||15
8292439|NCT01601496|20445486|P1|COMPLETED|Overall Study|Completed 12-M F/up|102
8292440|NCT01601496|20445486|P1|STARTED|Overall Study|Enrolled|117
8292441|NCT01601470|20445494|P1|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
8292442|NCT01601470|20445494|P1|COMPLETED|Period 3 - LCZ696+Sildenafil||27
8292443|NCT01601470|20445494|P1|Safety Set|Period 3 - LCZ696+Sildenafil||27
8292444|NCT01601470|20445494|P1|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
8292445|NCT01601470|20445494|P1|STARTED|Period 3 - LCZ696+Sildenafil||27
8292446|NCT01601470|20445494|P1|NOT COMPLETED|Period 2 - LCZ696||1
8292447|NCT01601470|20445494|P1|COMPLETED|Period 2 - LCZ696||27
8292448|NCT01601470|20445494|P1|Safety Set|Period 2 - LCZ696||27
8292449|NCT01601470|20445494|P1|PK Analysis Set|Period 2 - LCZ696||27
8292450|NCT01601470|20445494|P1|STARTED|Period 2 - LCZ696||28
8292451|NCT01601470|20445494|P1|NOT COMPLETED|Period 1 - Sildenafil||0
8292452|NCT01601470|20445494|P1|COMPLETED|Period 1 - Sildenafil||28
8292453|NCT01601470|20445494|P1|Safety Set|Period 1 - Sildenafil||28
8292454|NCT01601470|20445494|P1|PK Analysis Set|Period 1 - Sildenafil||28
8292455|NCT01601470|20445494|P1|STARTED|Period 1 - Sildenafil||28
8292456|NCT01601431|20445511|P2|NOT COMPLETED|Overall Study||3
8292457|NCT01601431|20445512|P1|NOT COMPLETED|Overall Study||12
8292458|NCT01601431|20445511|P2|COMPLETED|Overall Study||214
8292459|NCT01601431|20445512|P1|COMPLETED|Overall Study||211
8292460|NCT01601431|20445511|P2|STARTED|Overall Study||217
8292461|NCT01601431|20445512|P1|STARTED|Overall Study||223
8292462|NCT01601236|20445524|P6|NOT COMPLETED|Overall Study||1
8292463|NCT01601236|20445525|P5|NOT COMPLETED|Overall Study||3
8292464|NCT01601236|20445526|P4|NOT COMPLETED|Overall Study||2
8292465|NCT01601236|20445527|P3|NOT COMPLETED|Overall Study||6
8292466|NCT01601236|20445528|P2|NOT COMPLETED|Overall Study||1
8292467|NCT01601236|20445529|P1|NOT COMPLETED|Overall Study||5
8292468|NCT01601236|20445524|P6|COMPLETED|Overall Study||0
8292469|NCT01601236|20445525|P5|COMPLETED|Overall Study||0
8292470|NCT01601236|20445526|P4|COMPLETED|Overall Study||4
8292471|NCT01601236|20445527|P3|COMPLETED|Overall Study||8
8292472|NCT01601236|20445528|P2|COMPLETED|Overall Study||2
8292473|NCT01601236|20445529|P1|COMPLETED|Overall Study||2
8292474|NCT01601236|20445524|P6|STARTED|Overall Study||1
8292475|NCT01601236|20445525|P5|STARTED|Overall Study||3
8292476|NCT01601236|20445526|P4|STARTED|Overall Study||6
8292477|NCT01601236|20445527|P3|STARTED|Overall Study||14
8292478|NCT01601236|20445528|P2|STARTED|Overall Study||3
8292479|NCT01601236|20445529|P1|STARTED|Overall Study||7
8292480|NCT01601132|20445565|P1|NOT COMPLETED|Overall Study||2
8292481|NCT01601132|20445565|P1|COMPLETED|Overall Study||28
8292482|NCT01601132|20445565|P1|STARTED|Overall Study||30
8292483|NCT01601067|20445584|P2|NOT COMPLETED|Overall Study||22
8292484|NCT01601067|20445585|P1|NOT COMPLETED|Overall Study||33
8292485|NCT01601067|20445584|P2|COMPLETED|Overall Study||34
8292486|NCT01601067|20445585|P1|COMPLETED|Overall Study||30
8292487|NCT01601067|20445584|P2|STARTED|Overall Study||56
8292488|NCT01601067|20445585|P1|STARTED|Overall Study||63
8292489|NCT01600950|20445593|P2|NOT COMPLETED|Period 2||0
8292490|NCT01600950|20445594|P1|NOT COMPLETED|Period 2||0
8292491|NCT01600950|20445593|P2|COMPLETED|Period 2||10
8292492|NCT01600950|20445594|P1|COMPLETED|Period 2||10
8292493|NCT01600950|20445593|P2|STARTED|Period 2||10
8292494|NCT01600950|20445594|P1|STARTED|Period 2||10
8292495|NCT01600950|20445593|P2|NOT COMPLETED|Period 1||0
8292496|NCT01600950|20445594|P1|NOT COMPLETED|Period 1||0
8292497|NCT01600950|20445593|P2|COMPLETED|Period 1||10
8292498|NCT01600950|20445594|P1|COMPLETED|Period 1||10
8292499|NCT01600950|20445593|P2|STARTED|Period 1||10
8292500|NCT01600950|20445594|P1|STARTED|Period 1||10
8292501|NCT01600885|20445610|P2|NOT COMPLETED|Second Period||0
8292502|NCT01600885|20445611|P1|NOT COMPLETED|Second Period||0
8292503|NCT01600885|20445610|P2|COMPLETED|Second Period||8
8292504|NCT01600885|20445611|P1|COMPLETED|Second Period||8
8292505|NCT01600885|20445610|P2|STARTED|Second Period||8
8292506|NCT01600885|20445611|P1|STARTED|Second Period||8
8292507|NCT01600885|20445610|P2|NOT COMPLETED|Wash Out Period||0
8292508|NCT01600885|20445611|P1|NOT COMPLETED|Wash Out Period||0
8292509|NCT01600885|20445610|P2|COMPLETED|Wash Out Period||8
8292510|NCT01600885|20445611|P1|COMPLETED|Wash Out Period||8
8292511|NCT01600885|20445610|P2|STARTED|Wash Out Period||8
8292512|NCT01600885|20445611|P1|STARTED|Wash Out Period||8
8292513|NCT01600885|20445610|P2|NOT COMPLETED|First Period||1
8292514|NCT01600885|20445611|P1|NOT COMPLETED|First Period||2
8292515|NCT01600885|20445610|P2|COMPLETED|First Period||8
8292516|NCT01600885|20445611|P1|COMPLETED|First Period||8
8292517|NCT01600885|20445610|P2|STARTED|First Period||9
8292518|NCT01600885|20445611|P1|STARTED|First Period||10
8292519|NCT01600729|20445621|P1|NOT COMPLETED|Overall Study||1
8292520|NCT01600729|20445621|P1|COMPLETED|Overall Study||65
8292521|NCT01600729|20445621|P1|STARTED|Overall Study||66
8292522|NCT01600716|20445628|P2|NOT COMPLETED|Overall Study||7
8292523|NCT01600716|20445629|P1|NOT COMPLETED|Overall Study||7
8292524|NCT01600716|20445628|P2|COMPLETED|Overall Study||71
8292525|NCT01600716|20445629|P1|COMPLETED|Overall Study||59
8292526|NCT01600716|20445628|P2|STARTED|Overall Study||78
8292527|NCT01600716|20445629|P1|STARTED|Overall Study||66
8292528|NCT01600703|20445645|P2|NOT COMPLETED|Second Intervention||0
8292529|NCT01600703|20445646|P1|NOT COMPLETED|Second Intervention||0
8292530|NCT01600703|20445645|P2|COMPLETED|Second Intervention||8
8292531|NCT01600703|20445646|P1|COMPLETED|Second Intervention||7
8292532|NCT01600703|20445645|P2|STARTED|Second Intervention||8
8292533|NCT01600703|20445646|P1|STARTED|Second Intervention||7
8292534|NCT01600703|20445645|P2|NOT COMPLETED|First Intervention||0
8292535|NCT01600703|20445646|P1|NOT COMPLETED|First Intervention||0
8292536|NCT01600703|20445645|P2|COMPLETED|First Intervention||8
8292537|NCT01600703|20445646|P1|COMPLETED|First Intervention||7
8292538|NCT01600703|20445645|P2|STARTED|First Intervention||8
8292539|NCT01600703|20445646|P1|STARTED|First Intervention||7
8292540|NCT01600677|20445656|P2|NOT COMPLETED|Overall Study||0
8292541|NCT01600677|20445657|P1|NOT COMPLETED|Overall Study||0
8292542|NCT01600677|20445656|P2|COMPLETED|Overall Study||4
8292543|NCT01600677|20445657|P1|COMPLETED|Overall Study||7
8292544|NCT01600677|20445656|P2|STARTED|Overall Study||4
8292545|NCT01600677|20445657|P1|STARTED|Overall Study||7
8292546|NCT01600638|20445667|P1|NOT COMPLETED|Overall Study||0
8292547|NCT01600638|20445667|P1|COMPLETED|Overall Study||25
8292548|NCT01600638|20445667|P1|STARTED|Overall Study||25
8292549|NCT01600586|20445677|P2|NOT COMPLETED|Overall Study||3
8292550|NCT01600586|20445678|P1|NOT COMPLETED|Overall Study||3
8292551|NCT01600586|20445677|P2|COMPLETED|Overall Study||48
8292552|NCT01600586|20445678|P1|COMPLETED|Overall Study||46
8292553|NCT01600586|20445677|P2|STARTED|Overall Study||51
8292554|NCT01600586|20445678|P1|STARTED|Overall Study||49
8292555|NCT01600495|20445694|P2|NOT COMPLETED|Overall Study||0
8292556|NCT01600495|20445695|P1|NOT COMPLETED|Overall Study||0
8292557|NCT01600495|20445694|P2|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
8292558|NCT01600495|20445695|P1|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
8292559|NCT01600495|20445694|P2|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
8292560|NCT01600495|20445695|P1|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
8292561|NCT01600482|20445709|P2|NOT COMPLETED|Overall Study||0
8292562|NCT01600482|20445710|P1|NOT COMPLETED|Overall Study||0
8292563|NCT01600482|20445709|P2|COMPLETED|Overall Study||59
8292564|NCT01600482|20445710|P1|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
8292565|NCT01600482|20445709|P2|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
8292566|NCT01600482|20445710|P1|STARTED|Overall Study||148
8292567|NCT01600326|20445730|P2|NOT COMPLETED|Overall Study||1
8292568|NCT01600326|20445731|P1|NOT COMPLETED|Overall Study||1
8292569|NCT01600326|20445730|P2|COMPLETED|Overall Study||14
8292570|NCT01600326|20445731|P1|COMPLETED|Overall Study||14
8292571|NCT01600326|20445730|P2|Primary Outcome Measure Data Collection|Overall Study||15
8292572|NCT01600326|20445731|P1|Primary Outcome Measure Data Collection|Overall Study||15
8292573|NCT01600326|20445730|P2|STARTED|Overall Study||15
8292574|NCT01600326|20445731|P1|STARTED|Overall Study||15
8292575|NCT01600287|20445741|P2|NOT COMPLETED|Overall Study||0
8292576|NCT01600287|20445742|P1|NOT COMPLETED|Overall Study||0
8292577|NCT01600287|20445741|P2|COMPLETED|Overall Study||20
8292578|NCT01600287|20445742|P1|COMPLETED|Overall Study||20
8292579|NCT01600287|20445741|P2|STARTED|Overall Study||20
8292580|NCT01600287|20445742|P1|STARTED|Overall Study||20
8292581|NCT01600222|20445782|P1|NOT COMPLETED|Overall Study||2
8292582|NCT01600222|20445782|P1|COMPLETED|Overall Study||35
8292583|NCT01600222|20445782|P1|STARTED|Overall Study||37
8292584|NCT01600170|20445807|P2|NOT COMPLETED|Period 2||0
8292585|NCT01600170|20445808|P1|NOT COMPLETED|Period 2||1
8292586|NCT01600170|20445807|P2|COMPLETED|Period 2||5
8292587|NCT01600170|20445808|P1|COMPLETED|Period 2|One subject moved away from the area due to job responsibilities and dropped out of study.|5
8292588|NCT01600170|20445807|P2|STARTED|Period 2|These 5 were on placebo in Period 1 and on Atorvastatin in Period 2.|5
8292589|NCT01600170|20445808|P1|STARTED|Period 2|These 6 were on atorvastatin in period 1 and on placebo in Period 2.|6
8292590|NCT01600170|20445807|P2|NOT COMPLETED|Period 1||0
8292591|NCT01600170|20445808|P1|NOT COMPLETED|Period 1||0
8292592|NCT01600170|20445807|P2|COMPLETED|Period 1||5
8292593|NCT01600170|20445808|P1|COMPLETED|Period 1||6
8292594|NCT01600170|20445807|P2|STARTED|Period 1|Participants were assigned placebo for 12 wks followed by a washout and then atorvastatin.|5
8292595|NCT01600170|20445808|P1|STARTED|Period 1|Participants were assigned atorvastatin for 12 wks followed by a washout and then placebo.|6
8292596|NCT01600105|20445832|P2|NOT COMPLETED|Sub Study V||0
8292597|NCT01600105|20445833|P1|NOT COMPLETED|Sub Study V||2
8292598|NCT01600105|20445832|P2|COMPLETED|Sub Study V||0
8292599|NCT01600105|20445833|P1|COMPLETED|Sub Study V||50
8292600|NCT01600105|20445832|P2|STARTED|Sub Study V||0
8292601|NCT01600105|20445833|P1|STARTED|Sub Study V||52
8292602|NCT01600105|20445832|P2|NOT COMPLETED|Sub Study IV||0
8292603|NCT01600105|20445833|P1|NOT COMPLETED|Sub Study IV||0
8292604|NCT01600105|20445832|P2|COMPLETED|Sub Study IV||8
8292605|NCT01600105|20445833|P1|COMPLETED|Sub Study IV||41
8292606|NCT01600105|20445832|P2|STARTED|Sub Study IV||8
8292607|NCT01600105|20445833|P1|STARTED|Sub Study IV||41
8292608|NCT01600105|20445832|P2|NOT COMPLETED|Sub Study III||0
8292609|NCT01600105|20445833|P1|NOT COMPLETED|Sub Study III||5
8292610|NCT01600105|20445832|P2|COMPLETED|Sub Study III||0
8292611|NCT01600105|20445833|P1|COMPLETED|Sub Study III||34
8292612|NCT01600105|20445832|P2|STARTED|Sub Study III||0
8292613|NCT01600105|20445833|P1|STARTED|Sub Study III||39
8292614|NCT01600105|20445832|P2|NOT COMPLETED|Sub Study II||0
8292615|NCT01600105|20445833|P1|NOT COMPLETED|Sub Study II||5
8292616|NCT01600105|20445832|P2|COMPLETED|Sub Study II||0
8292617|NCT01600105|20445833|P1|COMPLETED|Sub Study II||60
8292618|NCT01600105|20445832|P2|STARTED|Sub Study II||0
8292619|NCT01600105|20445833|P1|STARTED|Sub Study II||65
8292620|NCT01600105|20445832|P2|NOT COMPLETED|Sub Study I||10
8292621|NCT01600105|20445833|P1|NOT COMPLETED|Sub Study I||0
8292622|NCT01600105|20445832|P2|COMPLETED|Sub Study I||11
8292623|NCT01600105|20445833|P1|COMPLETED|Sub Study I||19
8292624|NCT01600105|20445832|P2|STARTED|Sub Study I||21
8292625|NCT01600105|20445833|P1|STARTED|Sub Study I||19
8292626|NCT01600105|20445832|P2|NOT COMPLETED|Total Participants||10
8292627|NCT01600105|20445833|P1|NOT COMPLETED|Total Participants||41
8292628|NCT01600105|20445832|P2|COMPLETED|Total Participants||11
8292629|NCT01600105|20445833|P1|COMPLETED|Total Participants||214
8292630|NCT01600105|20445832|P2|STARTED|Total Participants||21
8292631|NCT01600105|20445833|P1|STARTED|Total Participants||255
8292632|NCT01600092|20445861|P2|NOT COMPLETED|Overall Study||16
8292633|NCT01600092|20445862|P1|NOT COMPLETED|Overall Study||18
8292634|NCT01600092|20445861|P2|COMPLETED|Overall Study||491
8292635|NCT01600092|20445862|P1|COMPLETED|Overall Study||495
8292636|NCT01600092|20445861|P2|Received All 3 Vaccinations|Overall Study||494
8292637|NCT01600092|20445862|P1|Received All 3 Vaccinations|Overall Study||500
8292638|NCT01600092|20445861|P2|Received at Least 1 Vaccination|Overall Study||504
8292639|NCT01600092|20445862|P1|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
8292640|NCT01600092|20445861|P2|STARTED|Overall Study||507
8292641|NCT01600092|20445862|P1|STARTED|Overall Study||513
8292642|NCT01600053|20445876|P1|NOT COMPLETED|Overall Study||11
8292643|NCT01600053|20445876|P1|COMPLETED|Overall Study||0
8292644|NCT01600053|20445876|P1|STARTED|Overall Study||11
8292645|NCT01600014|20445881|P2|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
8292646|NCT01600014|20445882|P1|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
8292647|NCT01600014|20445881|P2|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
8292648|NCT01600014|20445882|P1|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
8292649|NCT01600014|20445881|P2|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
8292650|NCT01600014|20445882|P1|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
8292651|NCT01600014|20445881|P2|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
8292652|NCT01600014|20445882|P1|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
8292653|NCT01600014|20445881|P2|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
8292654|NCT01600014|20445882|P1|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
8292655|NCT01600014|20445881|P2|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
8292656|NCT01600014|20445882|P1|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
8292657|NCT01600014|20445881|P2|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
8292658|NCT01600014|20445882|P1|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
8292659|NCT01600014|20445881|P2|COMPLETED|1. Cycle & Observation Period D1 to W52||0
8292660|NCT01600014|20445882|P1|COMPLETED|1. Cycle & Observation Period D1 to W52||162
8292661|NCT01600014|20445881|P2|STARTED|1. Cycle & Observation Period D1 to W52||0
8292662|NCT01600014|20445882|P1|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
8292663|NCT01599832|20445900|P1|NOT COMPLETED|Overall Study||0
8292664|NCT01599832|20445900|P1|COMPLETED|Overall Study||20
8292665|NCT01599832|20445900|P1|STARTED|Overall Study||20
8292666|NCT01599806|20445910|P2|NOT COMPLETED|Overall Study||41
8292667|NCT01599806|20445911|P1|NOT COMPLETED|Overall Study||43
8292668|NCT01599806|20445910|P2|COMPLETED|Overall Study||476
8292669|NCT01599806|20445911|P1|COMPLETED|Overall Study||473
8292670|NCT01599806|20445910|P2|STARTED|Overall Study||517
8292671|NCT01599806|20445911|P1|STARTED|Overall Study||516
8292672|NCT01599793|20446035|P1|NOT COMPLETED|Overall Study||2
8292673|NCT01599793|20446035|P1|COMPLETED|Overall Study||17
8292674|NCT01599793|20446035|P1|STARTED|Overall Study||19
8292675|NCT01599754|20446047|P2|NOT COMPLETED|Overall Study||360
8292676|NCT01599754|20446048|P1|NOT COMPLETED|Overall Study||363
8292677|NCT01599754|20446047|P2|COMPLETED|Overall Study||1
8292678|NCT01599754|20446048|P1|COMPLETED|Overall Study||0
8292679|NCT01599754|20446047|P2|Treated|Overall Study||360
8292680|NCT01599754|20446048|P1|Treated|Overall Study||360
8292681|NCT01599754|20446047|P2|STARTED|Overall Study||361
8292682|NCT01599754|20446048|P1|STARTED|Overall Study||363
8292683|NCT01599741|20446070|P1|NOT COMPLETED|Overall Study||3
8292684|NCT01599741|20446070|P1|COMPLETED|Overall Study||48
8292685|NCT01599741|20446070|P1|Collected Dose and Image Information|Overall Study||48
8292686|NCT01599741|20446070|P1|STARTED|Overall Study||51
8292687|NCT01599650|20446079|P3|NOT COMPLETED|Overall Study||27
8292688|NCT01599650|20446080|P2|NOT COMPLETED|Overall Study||26
8292689|NCT01599650|20446081|P1|NOT COMPLETED|Overall Study||22
8292690|NCT01599650|20446079|P3|COMPLETED|Overall Study||65
8292691|NCT01599650|20446080|P2|COMPLETED|Overall Study||154
8292692|NCT01599650|20446081|P1|COMPLETED|Overall Study||161
8292693|NCT01599650|20446079|P3|Completed 6 Mos|Overall Study||80
8292694|NCT01599650|20446080|P2|Completed 6 Mos|Overall Study||170
8292695|NCT01599650|20446081|P1|Completed 6 Mos|Overall Study||174
8292696|NCT01599650|20446079|P3|STARTED|Overall Study||92
8292697|NCT01599650|20446080|P2|STARTED|Overall Study||180
8292698|NCT01599650|20446081|P1|STARTED|Overall Study||183
8292699|NCT01599637|20446120|P3|NOT COMPLETED|Overall Study||0
8292700|NCT01599637|20446121|P2|NOT COMPLETED|Overall Study||2
8292701|NCT01599637|20446122|P1|NOT COMPLETED|Overall Study||1
8292702|NCT01599637|20446120|P3|COMPLETED|Overall Study||10
8292703|NCT01599637|20446121|P2|COMPLETED|Overall Study||8
8292704|NCT01599637|20446122|P1|COMPLETED|Overall Study||19
8292705|NCT01599637|20446120|P3|STARTED|Overall Study||10
8292706|NCT01599637|20446121|P2|STARTED|Overall Study||10
8292707|NCT01599637|20446122|P1|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
8292708|NCT01599585|20446169|P2|NOT COMPLETED|Overall Study||17
8292709|NCT01599585|20446170|P1|NOT COMPLETED|Overall Study||22
8292710|NCT01599585|20446169|P2|COMPLETED|Overall Study||42
8292711|NCT01599585|20446170|P1|COMPLETED|Overall Study||40
8292712|NCT01599585|20446169|P2|STARTED|Overall Study||59
8292713|NCT01599585|20446170|P1|STARTED|Overall Study||62
8292714|NCT01599325|20446208|P1|NOT COMPLETED|Extension Phase||15
8292715|NCT01599325|20446208|P1|COMPLETED|Extension Phase||0
8292716|NCT01599325|20446208|P1|STARTED|Extension Phase||15
8292717|NCT01599325|20446208|P1|NOT COMPLETED|Primary Parent Phase||57
8292718|NCT01599325|20446208|P1|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15
8292719|NCT01599325|20446208|P1|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12
8292720|NCT01599325|20446208|P1|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72
8292721|NCT01599325|20446208|P1|STARTED|Primary Parent Phase||72
8292722|NCT01599234|20446232|P2|NOT COMPLETED|Overall Study||15
8292723|NCT01599234|20446233|P1|NOT COMPLETED|Overall Study||17
8292724|NCT01599234|20446232|P2|COMPLETED|Overall Study||155
8292725|NCT01599234|20446233|P1|COMPLETED|Overall Study||150
8292726|NCT01599234|20446232|P2|STARTED|Overall Study||170
8292727|NCT01599234|20446233|P1|STARTED|Overall Study||167
8292728|NCT01599104|20446258|P3|NOT COMPLETED|Overall Study||26
8292729|NCT01599104|20446259|P2|NOT COMPLETED|Overall Study||14
8292730|NCT01599104|20446260|P1|NOT COMPLETED|Overall Study||16
8292731|NCT01599104|20446258|P3|COMPLETED|Overall Study||363
8292732|NCT01599104|20446259|P2|COMPLETED|Overall Study||371
8292733|NCT01599104|20446260|P1|COMPLETED|Overall Study||371
8292734|NCT01599104|20446258|P3|STARTED|Overall Study||389
8292735|NCT01599104|20446259|P2|STARTED|Overall Study||385
8292736|NCT01599104|20446260|P1|STARTED|Overall Study||387
8292737|NCT01598987|20446298|P1|NOT COMPLETED|Baseline to 24 Month||8
8292738|NCT01598987|20446298|P1|COMPLETED|Baseline to 24 Month||48
8292739|NCT01598987|20446298|P1|STARTED|Baseline to 24 Month||56
8292740|NCT01598987|20446298|P1|NOT COMPLETED|Baseline to Month 12||6
8292741|NCT01598987|20446298|P1|COMPLETED|Baseline to Month 12||50
8292742|NCT01598987|20446298|P1|STARTED|Baseline to Month 12||56
8292749|NCT01598896|20446357|P2|NOT COMPLETED|Overall Study||2
8292750|NCT01598896|20446358|P1|NOT COMPLETED|Overall Study||0
8292751|NCT01598896|20446357|P2|COMPLETED|Overall Study||2
8292752|NCT01598896|20446358|P1|COMPLETED|Overall Study||3
8292753|NCT01598896|20446357|P2|STARTED|Overall Study||4
8292754|NCT01598896|20446358|P1|STARTED|Overall Study||3
8292755|NCT01598831|20446372|P2|NOT COMPLETED|Overall Study||136
8292756|NCT01598831|20446373|P1|NOT COMPLETED|Overall Study||119
8292757|NCT01598831|20446372|P2|COMPLETED|Overall Study||278
8292758|NCT01598831|20446373|P1|COMPLETED|Overall Study||283
8292759|NCT01598831|20446372|P2|Received at Least 1 Dose Study Treatment|Overall Study||405
8292760|NCT01598831|20446373|P1|Received at Least 1 Dose Study Treatment|Overall Study||395
8292761|NCT01598831|20446372|P2|STARTED|Overall Study||414
8292762|NCT01598831|20446373|P1|STARTED|Overall Study||402
8292763|NCT01598779|20446389|P1|NOT COMPLETED|Overall Study||0
8292764|NCT01598779|20446389|P1|COMPLETED|Overall Study||150
8292765|NCT01598779|20446389|P1|STARTED|Overall Study||150
8292766|NCT01598753|20446397|P4|NOT COMPLETED|Overall Study||15
8292767|NCT01598753|20446398|P3|NOT COMPLETED|Overall Study||8
8292768|NCT01598753|20446399|P2|NOT COMPLETED|Overall Study||15
8292769|NCT01598753|20446400|P1|NOT COMPLETED|Overall Study||12
8292770|NCT01598753|20446397|P4|COMPLETED|Overall Study||19
8292771|NCT01598753|20446398|P3|COMPLETED|Overall Study||24
8292772|NCT01598753|20446399|P2|COMPLETED|Overall Study||16
8292773|NCT01598753|20446400|P1|COMPLETED|Overall Study||25
8292774|NCT01598753|20446397|P4|STARTED|Overall Study||34
8292775|NCT01598753|20446398|P3|STARTED|Overall Study||32
8292776|NCT01598753|20446399|P2|STARTED|Overall Study||31
8292777|NCT01598753|20446400|P1|STARTED|Overall Study||37
8292778|NCT01598740|20446412|P2|NOT COMPLETED|Period 2||0
8292779|NCT01598740|20446413|P1|NOT COMPLETED|Period 2||1
8292780|NCT01598740|20446412|P2|COMPLETED|Period 2||9
8292781|NCT01598740|20446413|P1|COMPLETED|Period 2||7
8292782|NCT01598740|20446412|P2|STARTED|Period 2||9
8292783|NCT01598740|20446413|P1|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
8292784|NCT01598740|20446412|P2|NOT COMPLETED|Period 1||0
8292785|NCT01598740|20446413|P1|NOT COMPLETED|Period 1||0
8292786|NCT01598740|20446412|P2|COMPLETED|Period 1||9
8292787|NCT01598740|20446413|P1|COMPLETED|Period 1||9
8292788|NCT01598740|20446412|P2|STARTED|Period 1||9
8292789|NCT01598740|20446413|P1|STARTED|Period 1||9
8292790|NCT01598701|20446423|P2|NOT COMPLETED|Overall Study||9
8292791|NCT01598701|20446424|P1|NOT COMPLETED|Overall Study||5
8292792|NCT01598701|20446423|P2|COMPLETED|Overall Study||41
8292793|NCT01598701|20446424|P1|COMPLETED|Overall Study||45
8292794|NCT01598701|20446423|P2|STARTED|Overall Study||50
8292795|NCT01598701|20446424|P1|STARTED|Overall Study||50
8292796|NCT01598662|20446440|P2|NOT COMPLETED|Overall Study||21
8292797|NCT01598662|20446441|P1|NOT COMPLETED|Overall Study||11
8292798|NCT01598662|20446440|P2|COMPLETED|Overall Study||0
8292799|NCT01598662|20446441|P1|COMPLETED|Overall Study||0
8292800|NCT01598662|20446440|P2|Patients Returned for 6 wk Postpartum|Overall Study||2
8292801|NCT01598662|20446441|P1|Patients Returned for 6 wk Postpartum|Overall Study||0
8292802|NCT01598662|20446440|P2|Patients Who Received IUD|Overall Study||18
8292803|NCT01598662|20446441|P1|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
8292804|NCT01598662|20446440|P2|STARTED|Overall Study||21
8292805|NCT01598662|20446441|P1|STARTED|Overall Study||11
8292806|NCT01598610|20446447|P1|NOT COMPLETED|Overall Study||1
8292807|NCT01598610|20446447|P1|COMPLETED|Overall Study||219
8292808|NCT01598610|20446447|P1|STARTED|Overall Study||220
8292809|NCT01598545|20446456|P1|NOT COMPLETED|Overall Study||0
8292810|NCT01598545|20446456|P1|COMPLETED|Overall Study||20
8292811|NCT01598545|20446456|P1|STARTED|Overall Study||20
8292812|NCT01598532|20446464|P1|NOT COMPLETED|Overall Study||11
8292813|NCT01598532|20446464|P1|COMPLETED|Overall Study||11
8292814|NCT01598532|20446464|P1|STARTED|Overall Study||22
8292815|NCT01598506|20446473|P1|NOT COMPLETED|Overall Study||2
8292816|NCT01598506|20446473|P1|COMPLETED|Overall Study||20
8292817|NCT01598506|20446473|P1|STARTED|Overall Study||22
8292818|NCT01598428|20446478|P1|NOT COMPLETED|Overall Study||0
8292819|NCT01598428|20446478|P1|COMPLETED|Overall Study||20
8292820|NCT01598428|20446478|P1|STARTED|Overall Study||20
8292821|NCT01598350|20446487|P1|NOT COMPLETED|Overall Study||0
8292822|NCT01598350|20446487|P1|COMPLETED|Overall Study||6
8292823|NCT01598350|20446487|P1|STARTED|Overall Study||6
8292824|NCT01598311|20446493|P2|NOT COMPLETED|Overall Study||61
8292825|NCT01598311|20446494|P1|NOT COMPLETED|Overall Study||47
8292826|NCT01598311|20446493|P2|COMPLETED|Overall Study||244
8292827|NCT01598311|20446494|P1|COMPLETED|Overall Study||256
8292828|NCT01598311|20446493|P2|Treated and Confirmed CDAD|Overall Study||292
8292829|NCT01598311|20446494|P1|Treated and Confirmed CDAD|Overall Study||285
8292830|NCT01598311|20446493|P2|Treated|Overall Study||301
8292831|NCT01598311|20446494|P1|Treated|Overall Study||294
8292832|NCT01598311|20446493|P2|STARTED|Overall Study||305
8292833|NCT01598311|20446494|P1|STARTED|Overall Study||303
8292834|NCT01598298|20446510|P2|NOT COMPLETED|Overall Study||41
8292835|NCT01598298|20446511|P1|NOT COMPLETED|Overall Study||40
8292836|NCT01598298|20446510|P2|COMPLETED|Overall Study||108
8292837|NCT01598298|20446511|P1|COMPLETED|Overall Study||110
8292838|NCT01598298|20446510|P2|Patients Evaluable for Adverse Events|Overall Study||141
8292839|NCT01598298|20446511|P1|Patients Evaluable for Adverse Events|Overall Study||138
8292840|NCT01598298|20446510|P2|Patients Evaluable for Primary Endpoint|Overall Study||128
8292841|NCT01598298|20446511|P1|Patients Evaluable for Primary Endpoint|Overall Study||127
8292842|NCT01598298|20446510|P2|STARTED|Overall Study||149
8292843|NCT01598298|20446511|P1|STARTED|Overall Study||150
8292844|NCT01598207|20446523|P2|NOT COMPLETED|Overall Study||0
8292845|NCT01598207|20446524|P1|NOT COMPLETED|Overall Study||1
8292846|NCT01598207|20446523|P2|COMPLETED|Overall Study||6
8292847|NCT01598207|20446524|P1|COMPLETED|Overall Study||6
8292848|NCT01598207|20446523|P2|STARTED|Overall Study||6
8292849|NCT01598207|20446524|P1|STARTED|Overall Study||7
8292850|NCT01598194|20446544|P2|NOT COMPLETED|Overall Study||0
8292851|NCT01598194|20446545|P1|NOT COMPLETED|Overall Study||0
8292852|NCT01598194|20446544|P2|COMPLETED|Overall Study||30
8292853|NCT01598194|20446545|P1|COMPLETED|Overall Study||30
8292854|NCT01598194|20446544|P2|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
8292855|NCT01598194|20446545|P1|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
8292856|NCT01598194|20446544|P2|1 Pass With 22Gpc for Cytology|Overall Study||30
8292857|NCT01598194|20446545|P1|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
8292858|NCT01598194|20446544|P2|2 Passes With 25G for Cytology|Overall Study||30
8292859|NCT01598194|20446545|P1|2 Passes With 25G for Cytology|Overall Study||30
8292860|NCT01598194|20446544|P2|STARTED|Overall Study||30
8292861|NCT01598194|20446545|P1|STARTED|Overall Study||30
8292862|NCT01598129|20446555|P1|NOT COMPLETED|Overall Study||9
8292863|NCT01598129|20446555|P1|COMPLETED|Overall Study||3
8292864|NCT01598129|20446555|P1|STARTED|Overall Study||12
8292865|NCT01598090|20446567|P3|NOT COMPLETED|Follow-up Period||28
8292866|NCT01598090|20446568|P2|NOT COMPLETED|Follow-up Period||35
8292867|NCT01598090|20446569|P1|NOT COMPLETED|Follow-up Period||5
8292868|NCT01598090|20446567|P3|COMPLETED|Follow-up Period||171
8292869|NCT01598090|20446568|P2|COMPLETED|Follow-up Period||364
8292870|NCT01598090|20446569|P1|COMPLETED|Follow-up Period||21
8292871|NCT01598090|20446567|P3|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199
8292872|NCT01598090|20446568|P2|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399
8292873|NCT01598090|20446569|P1|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26
8292874|NCT01598090|20446567|P3|NOT COMPLETED|Treatment Period||35
8292875|NCT01598090|20446568|P2|NOT COMPLETED|Treatment Period||72
8292876|NCT01598090|20446569|P1|NOT COMPLETED|Treatment Period||11
8292877|NCT01598090|20446567|P3|COMPLETED|Treatment Period||171
8292878|NCT01598090|20446568|P2|COMPLETED|Treatment Period||339
8292879|NCT01598090|20446569|P1|COMPLETED|Treatment Period||16
8292880|NCT01598090|20446567|P3|STARTED|Treatment Period||206
8292881|NCT01598090|20446568|P2|STARTED|Treatment Period||411
8292882|NCT01598090|20446569|P1|STARTED|Treatment Period||27
8292883|NCT01598064|20446595|P2|NOT COMPLETED|Overall Study||0
8292884|NCT01598064|20446596|P1|NOT COMPLETED|Overall Study||0
8292885|NCT01598064|20446595|P2|COMPLETED|Overall Study||24
8292886|NCT01598064|20446596|P1|COMPLETED|Overall Study||25
8292887|NCT01598064|20446595|P2|STARTED|Overall Study||24
8292888|NCT01598064|20446596|P1|STARTED|Overall Study||25
8292889|NCT01598025|20446606|P2|NOT COMPLETED|Overall Study||3
8292890|NCT01598025|20446607|P1|NOT COMPLETED|Overall Study||0
8292891|NCT01598025|20446606|P2|COMPLETED|Overall Study||0
8292892|NCT01598025|20446607|P1|COMPLETED|Overall Study||0
8292893|NCT01598025|20446606|P2|STARTED|Overall Study||3
8292894|NCT01598025|20446607|P1|STARTED|Overall Study||0
8292903|NCT01597856|20446632|P3|NOT COMPLETED|Overall Study||54
8292904|NCT01597856|20446633|P2|NOT COMPLETED|Overall Study||26
8292905|NCT01597856|20446634|P1|NOT COMPLETED|Overall Study||22
8292906|NCT01597856|20446632|P3|COMPLETED|Overall Study||120
8292907|NCT01597856|20446633|P2|COMPLETED|Overall Study||61
8292908|NCT01597856|20446634|P1|COMPLETED|Overall Study||63
8292909|NCT01597856|20446632|P3|Week 4 Follow-up|Overall Study||129
8292910|NCT01597856|20446633|P2|Week 4 Follow-up|Overall Study||67
8292911|NCT01597856|20446634|P1|Week 4 Follow-up|Overall Study||62
8292912|NCT01597856|20446632|P3|STARTED|Overall Study||174
8292913|NCT01597856|20446633|P2|STARTED|Overall Study||87
8292914|NCT01597856|20446634|P1|STARTED|Overall Study||85
8292915|NCT01597843|20446651|P3|NOT COMPLETED|Overall Study||0
8292916|NCT01597843|20446652|P2|NOT COMPLETED|Overall Study||0
8292917|NCT01597843|20446653|P1|NOT COMPLETED|Overall Study||0
8292918|NCT01597843|20446651|P3|COMPLETED|Overall Study||81
8292919|NCT01597843|20446652|P2|COMPLETED|Overall Study||122
8292920|NCT01597843|20446653|P1|COMPLETED|Overall Study||79
8292921|NCT01597843|20446651|P3|Survey 3 Responses|Overall Study||76
8292922|NCT01597843|20446652|P2|Survey 3 Responses|Overall Study||56
8292923|NCT01597843|20446653|P1|Survey 3 Responses|Overall Study||65
8292924|NCT01597843|20446651|P3|Survey 2 Responses|Overall Study||58
8292925|NCT01597843|20446652|P2|Survey 2 Responses|Overall Study||42
8292926|NCT01597843|20446653|P1|Survey 2 Responses|Overall Study||52
8292927|NCT01597843|20446651|P3|Survey 1 Responses|Overall Study||59
8292928|NCT01597843|20446652|P2|Survey 1 Responses|Overall Study||71
8292929|NCT01597843|20446653|P1|Survey 1 Responses|Overall Study||45
8292930|NCT01597843|20446651|P3|STARTED|Overall Study||81
8292931|NCT01597843|20446652|P2|STARTED|Overall Study||122
8292932|NCT01597843|20446653|P1|STARTED|Overall Study||79
8292933|NCT01597791|20446663|P2|NOT COMPLETED|Overall Study||10
8292934|NCT01597791|20446664|P1|NOT COMPLETED|Overall Study||8
8292935|NCT01597791|20446663|P2|COMPLETED|Overall Study||18
8292936|NCT01597791|20446664|P1|COMPLETED|Overall Study||20
8292937|NCT01597791|20446663|P2|STARTED|Overall Study||28
8292938|NCT01597791|20446664|P1|STARTED|Overall Study||28
8292939|NCT01597687|20446673|P3|NOT COMPLETED|Overall Study||0
8292940|NCT01597687|20446674|P2|NOT COMPLETED|Overall Study||0
8292941|NCT01597687|20446675|P1|NOT COMPLETED|Overall Study||0
8292942|NCT01597687|20446673|P3|COMPLETED|Overall Study||147
8292943|NCT01597687|20446674|P2|COMPLETED|Overall Study||89
8292944|NCT01597687|20446675|P1|COMPLETED|Overall Study||76
8292945|NCT01597687|20446673|P3|STARTED|Overall Study||147
8292946|NCT01597687|20446674|P2|STARTED|Overall Study||89
8292947|NCT01597687|20446675|P1|STARTED|Overall Study||76
8292948|NCT01597635|20446751|P3|NOT COMPLETED|Part B||4
8292949|NCT01597635|20446752|P2|NOT COMPLETED|Part B||6
8292950|NCT01597635|20446753|P1|NOT COMPLETED|Part B||0
8292951|NCT01597635|20446751|P3|COMPLETED|Part B||15
8292952|NCT01597635|20446752|P2|COMPLETED|Part B||14
8292953|NCT01597635|20446753|P1|COMPLETED|Part B||0
8292954|NCT01597635|20446751|P3|STARTED|Part B||19
8292955|NCT01597635|20446752|P2|STARTED|Part B||20
8292956|NCT01597635|20446753|P1|STARTED|Part B||0
8292957|NCT01597635|20446751|P3|NOT COMPLETED|Part A||0
8292958|NCT01597635|20446752|P2|NOT COMPLETED|Part A||0
8292959|NCT01597635|20446753|P1|NOT COMPLETED|Part A||3
8292960|NCT01597635|20446751|P3|COMPLETED|Part A||0
8292961|NCT01597635|20446752|P2|COMPLETED|Part A||0
8292962|NCT01597635|20446753|P1|COMPLETED|Part A||2
8292963|NCT01597635|20446751|P3|STARTED|Part A||0
8292964|NCT01597635|20446752|P2|STARTED|Part A||0
8292965|NCT01597635|20446753|P1|STARTED|Part A||5
8292966|NCT01597622|20446816|P1|NOT COMPLETED|Overall Study||38
8292967|NCT01597622|20446816|P1|COMPLETED|Overall Study||104
8292968|NCT01597622|20446816|P1|STARTED|Overall Study||142
8292969|NCT01597596|20446823|P2|NOT COMPLETED|Overall Study||1
8292970|NCT01597596|20446824|P1|NOT COMPLETED|Overall Study||1
8292971|NCT01597596|20446823|P2|COMPLETED|Overall Study||2
8292972|NCT01597596|20446824|P1|COMPLETED|Overall Study||0
8292973|NCT01597596|20446823|P2|STARTED|Overall Study||3
8292974|NCT01597596|20446824|P1|STARTED|Overall Study||1
8292975|NCT01597557|20446838|P2|NOT COMPLETED|Overall Study||3
8292976|NCT01597557|20446839|P1|NOT COMPLETED|Overall Study||4
8292977|NCT01597557|20446838|P2|COMPLETED|Overall Study||126
8292978|NCT01597557|20446839|P1|COMPLETED|Overall Study||128
8292979|NCT01597557|20446838|P2|STARTED|Overall Study||129
8292980|NCT01597557|20446839|P1|STARTED|Overall Study||132
8292981|NCT01597505|20446851|P2|NOT COMPLETED|Overall Study||33
8292982|NCT01597505|20446852|P1|NOT COMPLETED|Overall Study||44
8292983|NCT01597505|20446851|P2|COMPLETED|Overall Study||265
8292984|NCT01597505|20446852|P1|COMPLETED|Overall Study||264
8292985|NCT01597505|20446851|P2|Treated|Overall Study||286
8292986|NCT01597505|20446852|P1|Treated|Overall Study|One participant was instead randomized to vancomycin|305
8292987|NCT01597505|20446851|P2|STARTED|Overall Study|Randomized participants|298
8292988|NCT01597505|20446852|P1|STARTED|Overall Study|Randomized participants|308
8292989|NCT01597492|20446886|P2|NOT COMPLETED|Overall Study||4
8292990|NCT01597492|20446887|P1|NOT COMPLETED|Overall Study||6
8292991|NCT01597492|20446886|P2|COMPLETED|Overall Study||41
8292992|NCT01597492|20446887|P1|COMPLETED|Overall Study||28
8292993|NCT01597492|20446886|P2|STARTED|Overall Study||45
8292994|NCT01597492|20446887|P1|STARTED|Overall Study||34
8292995|NCT01597479|20446895|P2|NOT COMPLETED|Overall Study||0
8292996|NCT01597479|20446896|P1|NOT COMPLETED|Overall Study||2
8292997|NCT01597479|20446895|P2|COMPLETED|Overall Study||26
8292998|NCT01597479|20446896|P1|COMPLETED|Overall Study||24
8292999|NCT01597479|20446895|P2|STARTED|Overall Study||26
8293000|NCT01597479|20446896|P1|STARTED|Overall Study||26
8293001|NCT01597440|20446905|P2|NOT COMPLETED|Overall Study||0
8293002|NCT01597440|20446906|P1|NOT COMPLETED|Overall Study||0
8293003|NCT01597440|20446905|P2|COMPLETED|Overall Study||0
8293004|NCT01597440|20446906|P1|COMPLETED|Overall Study||1
8293005|NCT01597440|20446905|P2|STARTED|Overall Study||0
8293006|NCT01597440|20446906|P1|STARTED|Overall Study||1
8293034|NCT01597375|20447182|P2|NOT COMPLETED|Second Intervention||1
8293035|NCT01597375|20447183|P1|NOT COMPLETED|Second Intervention||1
8293036|NCT01597375|20447182|P2|COMPLETED|Second Intervention||21
8293037|NCT01597375|20447183|P1|COMPLETED|Second Intervention||19
8293038|NCT01597375|20447182|P2|STARTED|Second Intervention||22
8293039|NCT01597375|20447183|P1|STARTED|Second Intervention||20
8293040|NCT01597375|20447182|P2|NOT COMPLETED|Washout (2 Weeks)||0
8293041|NCT01597375|20447183|P1|NOT COMPLETED|Washout (2 Weeks)||1
8293042|NCT01597375|20447182|P2|COMPLETED|Washout (2 Weeks)||22
8293043|NCT01597375|20447183|P1|COMPLETED|Washout (2 Weeks)||20
8293044|NCT01597375|20447182|P2|STARTED|Washout (2 Weeks)||22
8293045|NCT01597375|20447183|P1|STARTED|Washout (2 Weeks)||21
8293046|NCT01597375|20447182|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
8293047|NCT01597375|20447183|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
8293048|NCT01597375|20447182|P2|COMPLETED|First Intervention (4 Weeks)||22
8293049|NCT01597375|20447183|P1|COMPLETED|First Intervention (4 Weeks)||21
8293050|NCT01597375|20447182|P2|STARTED|First Intervention (4 Weeks)||23
8293051|NCT01597375|20447183|P1|STARTED|First Intervention (4 Weeks)||23
8293052|NCT01597258|20447200|P1|NOT COMPLETED|Overall Study||1
8293053|NCT01597258|20447200|P1|COMPLETED|Overall Study||2028
8293054|NCT01597258|20447200|P1|STARTED|Overall Study||2029
8293055|NCT01597245|20447209|P21|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||36
8293056|NCT01597245|20447210|P20|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||167
8293057|NCT01597245|20447211|P19|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||10
8293058|NCT01597245|20447212|P18|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||6
8293059|NCT01597245|20447213|P17|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||16
8293060|NCT01597245|20447214|P16|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293061|NCT01597245|20447215|P15|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293062|NCT01597245|20447216|P14|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293063|NCT01597245|20447217|P13|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293064|NCT01597245|20447218|P12|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293065|NCT01597245|20447219|P11|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293066|NCT01597245|20447220|P10|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293067|NCT01597245|20447221|P9|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293068|NCT01597245|20447222|P8|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293069|NCT01597245|20447223|P7|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293070|NCT01597245|20447224|P6|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293071|NCT01597245|20447225|P5|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293072|NCT01597245|20447226|P4|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293073|NCT01597245|20447227|P3|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293074|NCT01597245|20447228|P2|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293075|NCT01597245|20447229|P1|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293076|NCT01597245|20447209|P21|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||212
8293077|NCT01597245|20447210|P20|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||489
8293078|NCT01597245|20447211|P19|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||14
8293079|NCT01597245|20447212|P18|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293080|NCT01597245|20447213|P17|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293081|NCT01597245|20447214|P16|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293082|NCT01597245|20447215|P15|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293083|NCT01597245|20447216|P14|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293084|NCT01597245|20447217|P13|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293085|NCT01597245|20447218|P12|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293086|NCT01597245|20447219|P11|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293087|NCT01597245|20447220|P10|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293088|NCT01597245|20447221|P9|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293089|NCT01597245|20447222|P8|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293090|NCT01597245|20447223|P7|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293091|NCT01597245|20447224|P6|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293092|NCT01597245|20447225|P5|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293093|NCT01597245|20447226|P4|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293094|NCT01597245|20447227|P3|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293095|NCT01597245|20447228|P2|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293096|NCT01597245|20447229|P1|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293448|NCT01596699|20447522|P1|COMPLETED|Overall Study||10
8293097|NCT01597245|20447209|P21|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|248
8293098|NCT01597245|20447210|P20|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|656
8293099|NCT01597245|20447211|P19|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|24
8293100|NCT01597245|20447212|P18|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|6
8293101|NCT01597245|20447213|P17|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|16
8293102|NCT01597245|20447214|P16|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8293103|NCT01597245|20447215|P15|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
8293104|NCT01597245|20447216|P14|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293105|NCT01597245|20447217|P13|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293106|NCT01597245|20447218|P12|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293107|NCT01597245|20447219|P11|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293108|NCT01597245|20447220|P10|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293109|NCT01597245|20447221|P9|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293110|NCT01597245|20447222|P8|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293111|NCT01597245|20447223|P7|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293112|NCT01597245|20447224|P6|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293113|NCT01597245|20447225|P5|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293114|NCT01597245|20447226|P4|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293115|NCT01597245|20447227|P3|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293116|NCT01597245|20447228|P2|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293117|NCT01597245|20447229|P1|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
8293118|NCT01597245|20447209|P21|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293119|NCT01597245|20447210|P20|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293120|NCT01597245|20447211|P19|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293121|NCT01597245|20447212|P18|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293122|NCT01597245|20447213|P17|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293123|NCT01597245|20447214|P16|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||228
8293124|NCT01597245|20447215|P15|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||225
8293125|NCT01597245|20447216|P14|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||26
8293126|NCT01597245|20447217|P13|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293127|NCT01597245|20447218|P12|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293128|NCT01597245|20447219|P11|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293129|NCT01597245|20447220|P10|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293130|NCT01597245|20447221|P9|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293131|NCT01597245|20447222|P8|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293132|NCT01597245|20447223|P7|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293133|NCT01597245|20447224|P6|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293134|NCT01597245|20447225|P5|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293135|NCT01597245|20447226|P4|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293136|NCT01597245|20447227|P3|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293137|NCT01597245|20447228|P2|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293138|NCT01597245|20447229|P1|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293139|NCT01597245|20447209|P21|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293140|NCT01597245|20447210|P20|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293141|NCT01597245|20447211|P19|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293142|NCT01597245|20447212|P18|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293143|NCT01597245|20447213|P17|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293144|NCT01597245|20447214|P16|COMPLETED|Long Term Extension (Week 60 - Week 264)||774
8293145|NCT01597245|20447215|P15|COMPLETED|Long Term Extension (Week 60 - Week 264)||754
8293146|NCT01597245|20447216|P14|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293147|NCT01597245|20447217|P13|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293148|NCT01597245|20447218|P12|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293149|NCT01597245|20447219|P11|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293150|NCT01597245|20447220|P10|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293151|NCT01597245|20447221|P9|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293152|NCT01597245|20447222|P8|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293153|NCT01597245|20447223|P7|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293154|NCT01597245|20447224|P6|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293155|NCT01597245|20447225|P5|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293156|NCT01597245|20447226|P4|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293157|NCT01597245|20447227|P3|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293158|NCT01597245|20447228|P2|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293159|NCT01597245|20447229|P1|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
8293160|NCT01597245|20447209|P21|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293161|NCT01597245|20447210|P20|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293162|NCT01597245|20447211|P19|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293163|NCT01597245|20447212|P18|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293164|NCT01597245|20447213|P17|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293165|NCT01597245|20447214|P16|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe in all dosing regimens, including participants who switched PBO to ixe.|1002
8293166|NCT01597245|20447215|P15|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe at the start of the long-term extension.|979
8293167|NCT01597245|20447216|P14|STARTED|Long Term Extension (Week 60 - Week 264)|Participants who received placebo at the start of the long-term extension period.|26
8293168|NCT01597245|20447217|P13|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293169|NCT01597245|20447218|P12|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293170|NCT01597245|20447219|P11|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293171|NCT01597245|20447220|P10|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293172|NCT01597245|20447221|P9|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293173|NCT01597245|20447222|P8|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293174|NCT01597245|20447223|P7|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293175|NCT01597245|20447224|P6|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293176|NCT01597245|20447225|P5|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
8293177|NCT01597245|20447226|P4|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293178|NCT01597245|20447227|P3|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293179|NCT01597245|20447228|P2|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293180|NCT01597245|20447229|P1|STARTED|Long Term Extension (Week 60 - Week 264)||0
8293181|NCT01597245|20447209|P21|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293182|NCT01597245|20447210|P20|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293183|NCT01597245|20447211|P19|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293184|NCT01597245|20447212|P18|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293185|NCT01597245|20447213|P17|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293186|NCT01597245|20447214|P16|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293187|NCT01597245|20447215|P15|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293188|NCT01597245|20447216|P14|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293189|NCT01597245|20447217|P13|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
8293190|NCT01597245|20447218|P12|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
8293191|NCT01597245|20447219|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
8293192|NCT01597245|20447220|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||121
8293193|NCT01597245|20447221|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
8293194|NCT01597245|20447222|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
8293195|NCT01597245|20447223|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
8293196|NCT01597245|20447224|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||38
8293197|NCT01597245|20447225|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||161
8293198|NCT01597245|20447226|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293199|NCT01597245|20447227|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293200|NCT01597245|20447228|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293201|NCT01597245|20447229|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293202|NCT01597245|20447209|P21|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293203|NCT01597245|20447210|P20|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293204|NCT01597245|20447211|P19|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293205|NCT01597245|20447212|P18|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293206|NCT01597245|20447213|P17|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293207|NCT01597245|20447214|P16|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293208|NCT01597245|20447215|P15|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293209|NCT01597245|20447216|P14|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293210|NCT01597245|20447217|P13|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
8293211|NCT01597245|20447218|P12|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
8293212|NCT01597245|20447219|P11|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
8293213|NCT01597245|20447220|P10|COMPLETED|Maintenance Period (Week 12 to Week 60)||11
8293214|NCT01597245|20447221|P9|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
8293215|NCT01597245|20447222|P8|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293216|NCT01597245|20447223|P7|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
8293217|NCT01597245|20447224|P6|COMPLETED|Maintenance Period (Week 12 to Week 60)||149
8293218|NCT01597245|20447225|P5|COMPLETED|Maintenance Period (Week 12 to Week 60)||15
8293219|NCT01597245|20447226|P4|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293220|NCT01597245|20447227|P3|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293221|NCT01597245|20447228|P2|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293222|NCT01597245|20447229|P1|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
8293223|NCT01597245|20447209|P21|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293224|NCT01597245|20447210|P20|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293225|NCT01597245|20447211|P19|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293226|NCT01597245|20447212|P18|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293227|NCT01597245|20447213|P17|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293228|NCT01597245|20447214|P16|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293229|NCT01597245|20447215|P15|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293230|NCT01597245|20447216|P14|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293231|NCT01597245|20447217|P13|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
8293232|NCT01597245|20447218|P12|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
8293233|NCT01597245|20447219|P11|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
8293234|NCT01597245|20447220|P10|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
8293235|NCT01597245|20447221|P9|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
8293236|NCT01597245|20447222|P8|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
8293237|NCT01597245|20447223|P7|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
8293238|NCT01597245|20447224|P6|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
8293239|NCT01597245|20447225|P5|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
8293240|NCT01597245|20447226|P4|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293241|NCT01597245|20447227|P3|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293242|NCT01597245|20447228|P2|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293243|NCT01597245|20447229|P1|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
8293244|NCT01597245|20447209|P21|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293245|NCT01597245|20447210|P20|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293246|NCT01597245|20447211|P19|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293247|NCT01597245|20447212|P18|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293248|NCT01597245|20447213|P17|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293249|NCT01597245|20447214|P16|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293250|NCT01597245|20447215|P15|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293251|NCT01597245|20447216|P14|STARTED|Maintenance Period (Week 12 to Week 60)||0
8293252|NCT01597245|20447217|P13|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|49
8293253|NCT01597245|20447218|P12|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|75
8293254|NCT01597245|20447219|P11|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|200
8293255|NCT01597245|20447220|P10|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|132
8293256|NCT01597245|20447221|P9|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|155
8293257|NCT01597245|20447222|P8|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|3
8293258|NCT01597245|20447223|P7|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|181
8293259|NCT01597245|20447224|P6|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|187
8293260|NCT01597245|20447225|P5|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|176
8293261|NCT01597245|20447226|P4|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
8293262|NCT01597245|20447227|P3|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
8293263|NCT01597245|20447228|P2|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
8293264|NCT01597245|20447229|P1|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
8293265|NCT01597245|20447209|P21|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293266|NCT01597245|20447210|P20|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293267|NCT01597245|20447211|P19|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293268|NCT01597245|20447212|P18|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293269|NCT01597245|20447213|P17|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293270|NCT01597245|20447214|P16|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293271|NCT01597245|20447215|P15|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293272|NCT01597245|20447216|P14|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293273|NCT01597245|20447217|P13|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293274|NCT01597245|20447218|P12|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293275|NCT01597245|20447219|P11|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293276|NCT01597245|20447220|P10|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293277|NCT01597245|20447221|P9|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293278|NCT01597245|20447222|P8|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293279|NCT01597245|20447223|P7|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293280|NCT01597245|20447224|P6|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293281|NCT01597245|20447225|P5|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
8293282|NCT01597245|20447226|P4|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
8293283|NCT01597245|20447227|P3|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
8293284|NCT01597245|20447228|P2|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
8293285|NCT01597245|20447229|P1|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
8293286|NCT01597245|20447209|P21|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293287|NCT01597245|20447210|P20|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293288|NCT01597245|20447211|P19|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293289|NCT01597245|20447212|P18|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293290|NCT01597245|20447213|P17|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293291|NCT01597245|20447214|P16|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293292|NCT01597245|20447215|P15|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293293|NCT01597245|20447216|P14|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293294|NCT01597245|20447217|P13|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293295|NCT01597245|20447218|P12|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293296|NCT01597245|20447219|P11|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293297|NCT01597245|20447220|P10|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293298|NCT01597245|20447221|P9|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293299|NCT01597245|20447222|P8|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293300|NCT01597245|20447223|P7|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293301|NCT01597245|20447224|P6|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293302|NCT01597245|20447225|P5|COMPLETED|Induction Period (Week 0 - Week 12)||0
8293303|NCT01597245|20447226|P4|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
8293304|NCT01597245|20447227|P3|COMPLETED|Induction Period (Week 0 - Week 12)||328
8293305|NCT01597245|20447228|P2|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
8293306|NCT01597245|20447229|P1|COMPLETED|Induction Period (Week 0 - Week 12)||158
8293307|NCT01597245|20447209|P21|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293308|NCT01597245|20447210|P20|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293309|NCT01597245|20447211|P19|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293310|NCT01597245|20447212|P18|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293311|NCT01597245|20447213|P17|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293312|NCT01597245|20447214|P16|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293313|NCT01597245|20447215|P15|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293314|NCT01597245|20447216|P14|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293315|NCT01597245|20447217|P13|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293316|NCT01597245|20447218|P12|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293317|NCT01597245|20447219|P11|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293318|NCT01597245|20447220|P10|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293319|NCT01597245|20447221|P9|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293320|NCT01597245|20447222|P8|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293321|NCT01597245|20447223|P7|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293322|NCT01597245|20447224|P6|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293323|NCT01597245|20447225|P5|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
8293324|NCT01597245|20447226|P4|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
8293325|NCT01597245|20447227|P3|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
8293326|NCT01597245|20447228|P2|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
8293327|NCT01597245|20447229|P1|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
8293328|NCT01597245|20447209|P21|STARTED|Induction Period (Week 0 - Week 12)||0
8293329|NCT01597245|20447210|P20|STARTED|Induction Period (Week 0 - Week 12)||0
8293330|NCT01597245|20447211|P19|STARTED|Induction Period (Week 0 - Week 12)||0
8293331|NCT01597245|20447212|P18|STARTED|Induction Period (Week 0 - Week 12)||0
8293332|NCT01597245|20447213|P17|STARTED|Induction Period (Week 0 - Week 12)||0
8293333|NCT01597245|20447214|P16|STARTED|Induction Period (Week 0 - Week 12)||0
8293334|NCT01597245|20447215|P15|STARTED|Induction Period (Week 0 - Week 12)||0
8293335|NCT01597245|20447216|P14|STARTED|Induction Period (Week 0 - Week 12)||0
8293336|NCT01597245|20447217|P13|STARTED|Induction Period (Week 0 - Week 12)||0
8293337|NCT01597245|20447218|P12|STARTED|Induction Period (Week 0 - Week 12)||0
8293338|NCT01597245|20447219|P11|STARTED|Induction Period (Week 0 - Week 12)||0
8293339|NCT01597245|20447220|P10|STARTED|Induction Period (Week 0 - Week 12)||0
8293340|NCT01597245|20447221|P9|STARTED|Induction Period (Week 0 - Week 12)||0
8293341|NCT01597245|20447222|P8|STARTED|Induction Period (Week 0 - Week 12)||0
8293342|NCT01597245|20447223|P7|STARTED|Induction Period (Week 0 - Week 12)||0
8293343|NCT01597245|20447224|P6|STARTED|Induction Period (Week 0 - Week 12)||0
8293344|NCT01597245|20447225|P5|STARTED|Induction Period (Week 0 - Week 12)||0
8293345|NCT01597245|20447226|P4|STARTED|Induction Period (Week 0 - Week 12)||351
8293346|NCT01597245|20447227|P3|STARTED|Induction Period (Week 0 - Week 12)||347
8293347|NCT01597245|20447228|P2|STARTED|Induction Period (Week 0 - Week 12)||358
8293348|NCT01597245|20447229|P1|STARTED|Induction Period (Week 0 - Week 12)||168
8293349|NCT01597193|20447327|P7|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11
8293350|NCT01597193|20447328|P6|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23
8293351|NCT01597193|20447329|P5|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16
8293352|NCT01597193|20447330|P4|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20
8293353|NCT01597193|20447331|P3|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14
8293354|NCT01597193|20447332|P2|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293355|NCT01597193|20447333|P1|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293356|NCT01597193|20447327|P7|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293357|NCT01597193|20447328|P6|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293358|NCT01597193|20447329|P5|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293359|NCT01597193|20447330|P4|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293360|NCT01597193|20447331|P3|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293361|NCT01597193|20447332|P2|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293362|NCT01597193|20447333|P1|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
8293363|NCT01597193|20447327|P7|STARTED|Stage 2: Dose Expansion (1067 Days)||11
8293364|NCT01597193|20447328|P6|STARTED|Stage 2: Dose Expansion (1067 Days)||23
8293365|NCT01597193|20447329|P5|STARTED|Stage 2: Dose Expansion (1067 Days)||16
8293366|NCT01597193|20447330|P4|STARTED|Stage 2: Dose Expansion (1067 Days)||20
8293367|NCT01597193|20447331|P3|STARTED|Stage 2: Dose Expansion (1067 Days)||14
8293368|NCT01597193|20447332|P2|STARTED|Stage 2: Dose Expansion (1067 Days)||0
8293369|NCT01597193|20447333|P1|STARTED|Stage 2: Dose Expansion (1067 Days)||0
8293370|NCT01597193|20447327|P7|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293371|NCT01597193|20447328|P6|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293372|NCT01597193|20447329|P5|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293373|NCT01597193|20447330|P4|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293374|NCT01597193|20447331|P3|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293375|NCT01597193|20447332|P2|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8
8293376|NCT01597193|20447333|P1|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7
8293377|NCT01597193|20447327|P7|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293378|NCT01597193|20447328|P6|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293379|NCT01597193|20447329|P5|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293380|NCT01597193|20447330|P4|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293381|NCT01597193|20447331|P3|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293382|NCT01597193|20447332|P2|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293383|NCT01597193|20447333|P1|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
8293384|NCT01597193|20447327|P7|STARTED|Stage 1: Dose Escalation (141 Days)||0
8293385|NCT01597193|20447328|P6|STARTED|Stage 1: Dose Escalation (141 Days)||0
8293386|NCT01597193|20447329|P5|STARTED|Stage 1: Dose Escalation (141 Days)||0
8293387|NCT01597193|20447330|P4|STARTED|Stage 1: Dose Escalation (141 Days)||0
8293388|NCT01597193|20447331|P3|STARTED|Stage 1: Dose Escalation (141 Days)||0
8293389|NCT01597193|20447332|P2|STARTED|Stage 1: Dose Escalation (141 Days)||8
8293390|NCT01597193|20447333|P1|STARTED|Stage 1: Dose Escalation (141 Days)||7
8293391|NCT01597141|20447414|P2|NOT COMPLETED|Overall Study||0
8293392|NCT01597141|20447415|P1|NOT COMPLETED|Overall Study||0
8293393|NCT01597141|20447414|P2|COMPLETED|Overall Study||50
8293394|NCT01597141|20447415|P1|COMPLETED|Overall Study||50
8293395|NCT01597141|20447414|P2|STARTED|Overall Study||50
8293396|NCT01597141|20447415|P1|STARTED|Overall Study||50
8293397|NCT01597128|20447425|P2|NOT COMPLETED|Overall Study||0
8293398|NCT01597128|20447426|P1|NOT COMPLETED|Overall Study||0
8293399|NCT01597128|20447425|P2|COMPLETED|Overall Study||17
8293400|NCT01597128|20447426|P1|COMPLETED|Overall Study||18
8293401|NCT01597128|20447425|P2|STARTED|Overall Study||17
8293402|NCT01597128|20447426|P1|STARTED|Overall Study||18
8293403|NCT01597050|20447452|P2|NOT COMPLETED|Overall Study||0
8293404|NCT01597050|20447453|P1|NOT COMPLETED|Overall Study||1
8293405|NCT01597050|20447452|P2|COMPLETED|Overall Study||18
8293406|NCT01597050|20447453|P1|COMPLETED|Overall Study||35
8293407|NCT01597050|20447452|P2|STARTED|Overall Study||18
8293408|NCT01597050|20447453|P1|STARTED|Overall Study||36
8293409|NCT01596972|20447461|P2|NOT COMPLETED|Overall Study||14
8293410|NCT01596972|20447462|P1|NOT COMPLETED|Overall Study||1
8293411|NCT01596972|20447461|P2|COMPLETED|Overall Study||12
8293412|NCT01596972|20447462|P1|COMPLETED|Overall Study||24
8293413|NCT01596972|20447461|P2|STARTED|Overall Study||26
8293414|NCT01596972|20447462|P1|STARTED|Overall Study||25
8293415|NCT01596842|20447474|P2|NOT COMPLETED|Overall Study||0
8293416|NCT01596842|20447475|P1|NOT COMPLETED|Overall Study||2
8293417|NCT01596842|20447474|P2|COMPLETED|Overall Study||7
8293418|NCT01596842|20447475|P1|COMPLETED|Overall Study||8
8293419|NCT01596842|20447474|P2|STARTED|Overall Study||7
8293420|NCT01596842|20447475|P1|STARTED|Overall Study||10
8293421|NCT01596751|20447491|P8|NOT COMPLETED|Overall Study||0
8293422|NCT01596751|20447492|P7|NOT COMPLETED|Overall Study||0
8293423|NCT01596751|20447493|P6|NOT COMPLETED|Overall Study||0
8293424|NCT01596751|20447494|P5|NOT COMPLETED|Overall Study||0
8293425|NCT01596751|20447495|P4|NOT COMPLETED|Overall Study||0
8293426|NCT01596751|20447496|P3|NOT COMPLETED|Overall Study||0
8293427|NCT01596751|20447497|P2|NOT COMPLETED|Overall Study||0
8293428|NCT01596751|20447498|P1|NOT COMPLETED|Overall Study||0
8293429|NCT01596751|20447491|P8|COMPLETED|Overall Study||22
8293430|NCT01596751|20447492|P7|COMPLETED|Overall Study||17
8293431|NCT01596751|20447493|P6|COMPLETED|Overall Study||6
8293432|NCT01596751|20447494|P5|COMPLETED|Overall Study||4
8293433|NCT01596751|20447495|P4|COMPLETED|Overall Study||6
8293434|NCT01596751|20447496|P3|COMPLETED|Overall Study||3
8293435|NCT01596751|20447497|P2|COMPLETED|Overall Study||4
8293436|NCT01596751|20447498|P1|COMPLETED|Overall Study||5
8293437|NCT01596751|20447491|P8|STARTED|Overall Study||22
8293438|NCT01596751|20447492|P7|STARTED|Overall Study||17
8293439|NCT01596751|20447493|P6|STARTED|Overall Study||6
8293440|NCT01596751|20447494|P5|STARTED|Overall Study||4
8293441|NCT01596751|20447495|P4|STARTED|Overall Study||6
8293442|NCT01596751|20447496|P3|STARTED|Overall Study||3
8293443|NCT01596751|20447497|P2|STARTED|Overall Study||4
8293444|NCT01596751|20447498|P1|STARTED|Overall Study||5
8293445|NCT01596699|20447521|P2|NOT COMPLETED|Overall Study||0
8293446|NCT01596699|20447522|P1|NOT COMPLETED|Overall Study||0
8293447|NCT01596699|20447521|P2|COMPLETED|Overall Study||6
8293449|NCT01596699|20447521|P2|STARTED|Overall Study||6
8293450|NCT01596699|20447522|P1|STARTED|Overall Study||10
8293451|NCT01596582|20447534|P2|NOT COMPLETED|Overall Study||7
8293452|NCT01596582|20447535|P1|NOT COMPLETED|Overall Study||4
8293453|NCT01596582|20447534|P2|COMPLETED|Overall Study||173
8293454|NCT01596582|20447535|P1|COMPLETED|Overall Study||168
8293455|NCT01596582|20447534|P2|STARTED|Overall Study||180
8293456|NCT01596582|20447535|P1|STARTED|Overall Study||172
8293457|NCT01596504|20447562|P3|NOT COMPLETED|Overall Study||1
8293458|NCT01596504|20447563|P2|NOT COMPLETED|Overall Study||3
8293459|NCT01596504|20447564|P1|NOT COMPLETED|Overall Study||2
8293460|NCT01596504|20447562|P3|COMPLETED|Overall Study||46
8293461|NCT01596504|20447563|P2|COMPLETED|Overall Study||44
8293462|NCT01596504|20447564|P1|COMPLETED|Overall Study||46
8293463|NCT01596504|20447562|P3|STARTED|Overall Study||47
8293464|NCT01596504|20447563|P2|STARTED|Overall Study||47
8293465|NCT01596504|20447564|P1|STARTED|Overall Study||48
8293466|NCT01596335|20447622|P2|NOT COMPLETED|Overall Study||9
8293467|NCT01596335|20447623|P1|NOT COMPLETED|Overall Study||5
8293468|NCT01596335|20447622|P2|COMPLETED|Overall Study||6
8293469|NCT01596335|20447623|P1|COMPLETED|Overall Study||11
8293470|NCT01596335|20447622|P2|STARTED|Overall Study||15
8293471|NCT01596335|20447623|P1|STARTED|Overall Study||16
8293472|NCT01596283|20447635|P2|NOT COMPLETED|Overall Study||0
8293473|NCT01596283|20447636|P1|NOT COMPLETED|Overall Study||0
8293474|NCT01596283|20447635|P2|COMPLETED|Overall Study||66
8293475|NCT01596283|20447636|P1|COMPLETED|Overall Study||69
8293476|NCT01596283|20447635|P2|STARTED|Overall Study||66
8293477|NCT01596283|20447636|P1|STARTED|Overall Study||69
8293478|NCT01596231|20447652|P2|NOT COMPLETED|Overall Study||0
8293479|NCT01596231|20447653|P1|NOT COMPLETED|Overall Study||0
8293480|NCT01596231|20447652|P2|COMPLETED|Overall Study||10
8293481|NCT01596231|20447653|P1|COMPLETED|Overall Study||10
8293482|NCT01596231|20447652|P2|STARTED|Overall Study||10
8293483|NCT01596231|20447653|P1|STARTED|Overall Study||10
8293484|NCT01596127|20447659|P1|NOT COMPLETED|Overall Study||1
8293485|NCT01596127|20447659|P1|COMPLETED|Overall Study||3
8293486|NCT01596127|20447659|P1|STARTED|Overall Study||4
8293487|NCT01596088|20447664|P1|NOT COMPLETED|Overall Study||0
8293488|NCT01596088|20447664|P1|COMPLETED|Overall Study||2
8293489|NCT01596088|20447664|P1|STARTED|Overall Study||2
8293490|NCT01596062|20447671|P3|NOT COMPLETED|Overall Study||3
8293491|NCT01596062|20447672|P2|NOT COMPLETED|Overall Study||0
8293492|NCT01596062|20447673|P1|NOT COMPLETED|Overall Study||1
8293493|NCT01596062|20447671|P3|COMPLETED|Overall Study||4
8293494|NCT01596062|20447672|P2|COMPLETED|Overall Study||6
8293495|NCT01596062|20447673|P1|COMPLETED|Overall Study||2
8293496|NCT01596062|20447671|P3|STARTED|Overall Study||7
8293497|NCT01596062|20447672|P2|STARTED|Overall Study||6
8293498|NCT01596062|20447673|P1|STARTED|Overall Study||3
8293499|NCT01595854|20447710|P5|NOT COMPLETED|Overall Study||0
8293500|NCT01595854|20447711|P4|NOT COMPLETED|Overall Study||0
8293501|NCT01595854|20447712|P3|NOT COMPLETED|Overall Study||0
8293502|NCT01595854|20447713|P2|NOT COMPLETED|Overall Study||0
8293503|NCT01595854|20447714|P1|NOT COMPLETED|Overall Study||0
8293504|NCT01595854|20447710|P5|COMPLETED|Overall Study||12
8293505|NCT01595854|20447711|P4|COMPLETED|Overall Study||4
8293506|NCT01595854|20447712|P3|COMPLETED|Overall Study||8
8293507|NCT01595854|20447713|P2|COMPLETED|Overall Study||4
8293508|NCT01595854|20447714|P1|COMPLETED|Overall Study||8
8293509|NCT01595854|20447710|P5|STARTED|Overall Study||12
8293510|NCT01595854|20447711|P4|STARTED|Overall Study||4
8293511|NCT01595854|20447712|P3|STARTED|Overall Study||8
8293512|NCT01595854|20447713|P2|STARTED|Overall Study||4
8293513|NCT01595854|20447714|P1|STARTED|Overall Study||8
8293514|NCT01595646|20447737|P3|NOT COMPLETED|Overall Study||0
8293515|NCT01595646|20447738|P2|NOT COMPLETED|Overall Study||0
8293516|NCT01595646|20447739|P1|NOT COMPLETED|Overall Study||1
8293517|NCT01595646|20447737|P3|COMPLETED|Overall Study||12
8293518|NCT01595646|20447738|P2|COMPLETED|Overall Study||12
8293519|NCT01595646|20447739|P1|COMPLETED|Overall Study||12
8293520|NCT01595646|20447737|P3|STARTED|Overall Study||12
8293521|NCT01595646|20447738|P2|STARTED|Overall Study||12
8293522|NCT01595646|20447739|P1|STARTED|Overall Study||13
8293523|NCT01595529|20447761|P2|NOT COMPLETED|Overall Study||20
8293524|NCT01595529|20447762|P1|NOT COMPLETED|Overall Study||24
8293525|NCT01595529|20447761|P2|COMPLETED|Overall Study||325
8293526|NCT01595529|20447762|P1|COMPLETED|Overall Study||324
8293527|NCT01595529|20447761|P2|Completed All Milestones|Overall Study||318
8293528|NCT01595529|20447762|P1|Completed All Milestones|Overall Study||318
8293529|NCT01595529|20447761|P2|Per-protocol With Stool Sample at TOC|Overall Study||289
8293530|NCT01595529|20447762|P1|Per-protocol With Stool Sample at TOC|Overall Study||280
8293531|NCT01595529|20447761|P2|Per-protocol Without Treatment Failure|Overall Study||305
8293532|NCT01595529|20447762|P1|Per-protocol Without Treatment Failure|Overall Study||306
8293533|NCT01595529|20447761|P2|Per-protocol, Completed 80% of Dose|Overall Study||314
8293534|NCT01595529|20447762|P1|Per-protocol, Completed 80% of Dose|Overall Study||308
8293535|NCT01595529|20447761|P2|ITT With Stool Sample at TOC|Overall Study||310
8293536|NCT01595529|20447762|P1|ITT With Stool Sample at TOC|Overall Study||298
8293537|NCT01595529|20447761|P2|ITT Without Treatment Failure|Overall Study||322
8293538|NCT01595529|20447762|P1|ITT Without Treatment Failure|Overall Study||326
8293539|NCT01595529|20447761|P2|Evaluated for Primary Endpoint, ITT|Overall Study||336
8293540|NCT01595529|20447762|P1|Evaluated for Primary Endpoint, ITT|Overall Study||328
8293541|NCT01595529|20447761|P2|Treated|Overall Study||340
8293542|NCT01595529|20447762|P1|Treated|Overall Study||337
8293543|NCT01595529|20447761|P2|STARTED|Overall Study||345
8293544|NCT01595529|20447762|P1|STARTED|Overall Study||348
8293545|NCT01595516|20447793|P3|NOT COMPLETED|Overall Study||0
8293546|NCT01595516|20447794|P2|NOT COMPLETED|Overall Study||0
8293547|NCT01595516|20447795|P1|NOT COMPLETED|Overall Study||0
8293548|NCT01595516|20447793|P3|COMPLETED|Overall Study||12
8293549|NCT01595516|20447794|P2|COMPLETED|Overall Study||16
8293550|NCT01595516|20447795|P1|COMPLETED|Overall Study||16
8293551|NCT01595516|20447793|P3|STARTED|Overall Study||12
8293552|NCT01595516|20447794|P2|STARTED|Overall Study||16
8293553|NCT01595516|20447795|P1|STARTED|Overall Study||16
8293554|NCT01595438|20447825|P2|NOT COMPLETED|Overall Study||41
8293555|NCT01595438|20447826|P1|NOT COMPLETED|Overall Study||43
8293556|NCT01595438|20447825|P2|COMPLETED|Overall Study||476
8293557|NCT01595438|20447826|P1|COMPLETED|Overall Study||473
8293558|NCT01595438|20447825|P2|STARTED|Overall Study||517
8293559|NCT01595438|20447826|P1|STARTED|Overall Study||516
8293560|NCT01595386|20447952|P2|NOT COMPLETED|Overall Study||0
8293561|NCT01595386|20447953|P1|NOT COMPLETED|Overall Study||0
8293562|NCT01595386|20447952|P2|COMPLETED|Overall Study||19
8293563|NCT01595386|20447953|P1|COMPLETED|Overall Study||21
8293564|NCT01595386|20447952|P2|STARTED|Overall Study||19
8293565|NCT01595386|20447953|P1|STARTED|Overall Study||21
8293566|NCT01595282|20447981|P2|NOT COMPLETED|Overall Study||0
8293567|NCT01595282|20447982|P1|NOT COMPLETED|Overall Study||0
8293568|NCT01595282|20447981|P2|COMPLETED|Overall Study||47
8293569|NCT01595282|20447982|P1|COMPLETED|Overall Study||47
8293570|NCT01595282|20447981|P2|STARTED|Overall Study||47
8293571|NCT01595282|20447982|P1|STARTED|Overall Study||47
8293572|NCT01595009|20447994|P4|NOT COMPLETED|Extension||11
8293573|NCT01595009|20447995|P3|NOT COMPLETED|Extension||4
8293574|NCT01595009|20447996|P2|NOT COMPLETED|Extension||0
8293575|NCT01595009|20447997|P1|NOT COMPLETED|Extension||0
8293576|NCT01595009|20447994|P4|COMPLETED|Extension||0
8293577|NCT01595009|20447995|P3|COMPLETED|Extension||0
8293578|NCT01595009|20447996|P2|COMPLETED|Extension||0
8293579|NCT01595009|20447997|P1|COMPLETED|Extension||0
8293580|NCT01595009|20447994|P4|STARTED|Extension||11
8293581|NCT01595009|20447995|P3|STARTED|Extension||4
8293582|NCT01595009|20447996|P2|STARTED|Extension||0
8293583|NCT01595009|20447997|P1|STARTED|Extension||0
8293584|NCT01595009|20447994|P4|NOT COMPLETED|Core||0
8293585|NCT01595009|20447995|P3|NOT COMPLETED|Core||0
8293586|NCT01595009|20447996|P2|NOT COMPLETED|Core||120
8293587|NCT01595009|20447997|P1|NOT COMPLETED|Core||126
8293588|NCT01595009|20447994|P4|COMPLETED|Core||0
8293589|NCT01595009|20447995|P3|COMPLETED|Core||0
8293590|NCT01595009|20447996|P2|COMPLETED|Core||0
8293591|NCT01595009|20447997|P1|COMPLETED|Core||0
8293592|NCT01595009|20447994|P4|STARTED|Core||0
8293593|NCT01595009|20447995|P3|STARTED|Core||0
8293594|NCT01595009|20447996|P2|STARTED|Core||120
8293595|NCT01595009|20447997|P1|STARTED|Core||126
8293596|NCT01594970|20448032|P3|NOT COMPLETED|Overall Study||66
8293597|NCT01594970|20448033|P2|NOT COMPLETED|Overall Study||82
8293598|NCT01594970|20448034|P1|NOT COMPLETED|Overall Study||75
8293599|NCT01594970|20448032|P3|COMPLETED|Overall Study||191
8293600|NCT01594970|20448033|P2|COMPLETED|Overall Study||166
8293601|NCT01594970|20448034|P1|COMPLETED|Overall Study||220
8293602|NCT01594970|20448032|P3|STARTED|Overall Study||257
8293603|NCT01594970|20448033|P2|STARTED|Overall Study||248
8293604|NCT01594970|20448034|P1|STARTED|Overall Study||295
8293605|NCT01594853|20448053|P2|NOT COMPLETED|Overall Study||3
8293606|NCT01594853|20448054|P1|NOT COMPLETED|Overall Study||2
8293607|NCT01594853|20448053|P2|COMPLETED|Overall Study||12
8293608|NCT01594853|20448054|P1|COMPLETED|Overall Study||14
8293609|NCT01594853|20448053|P2|STARTED|Overall Study||15
8293610|NCT01594853|20448054|P1|STARTED|Overall Study||16
8293611|NCT01594827|20448062|P2|NOT COMPLETED|Overall Study||0
8293612|NCT01594827|20448063|P1|NOT COMPLETED|Overall Study||4
8293613|NCT01594827|20448062|P2|COMPLETED|Overall Study||15
8293614|NCT01594827|20448063|P1|COMPLETED|Overall Study||10
8293615|NCT01594827|20448062|P2|STARTED|Overall Study||15
8293616|NCT01594827|20448063|P1|STARTED|Overall Study||14
8293617|NCT01594762|20448087|P2|NOT COMPLETED|Overall Study||10
8293618|NCT01594762|20448088|P1|NOT COMPLETED|Overall Study||11
8293619|NCT01594762|20448087|P2|COMPLETED|Overall Study||93
8293620|NCT01594762|20448088|P1|COMPLETED|Overall Study||86
8293621|NCT01594762|20448087|P2|STARTED|Overall Study||103
8293622|NCT01594762|20448088|P1|STARTED|Overall Study||97
8293623|NCT01594749|20448100|P2|NOT COMPLETED|Overall Study||18
8293624|NCT01594749|20448101|P1|NOT COMPLETED|Overall Study||22
8293625|NCT01594749|20448100|P2|COMPLETED|Overall Study||490
8293626|NCT01594749|20448101|P1|COMPLETED|Overall Study||485
8293627|NCT01594749|20448100|P2|Treated|Overall Study||498
8293628|NCT01594749|20448101|P1|Treated|Overall Study||503
8293629|NCT01594749|20448100|P2|STARTED|Overall Study||508
8293630|NCT01594749|20448101|P1|STARTED|Overall Study||507
8293631|NCT01594528|20448120|P3|NOT COMPLETED|Overall Study||0
8293632|NCT01594528|20448121|P2|NOT COMPLETED|Overall Study||0
8293633|NCT01594528|20448122|P1|NOT COMPLETED|Overall Study||0
8293634|NCT01594528|20448120|P3|COMPLETED|Overall Study||16
8293635|NCT01594528|20448121|P2|COMPLETED|Overall Study||17
8293636|NCT01594528|20448122|P1|COMPLETED|Overall Study||16
8293637|NCT01594528|20448120|P3|STARTED|Overall Study||16
8293638|NCT01594528|20448121|P2|STARTED|Overall Study||17
8293639|NCT01594528|20448122|P1|STARTED|Overall Study||16
8293640|NCT01594515|20448138|P10|NOT COMPLETED|Overall Study||0
8293641|NCT01594515|20448139|P9|NOT COMPLETED|Overall Study||0
8293642|NCT01594515|20448140|P8|NOT COMPLETED|Overall Study||0
8293643|NCT01594515|20448141|P7|NOT COMPLETED|Overall Study||0
8293644|NCT01594515|20448142|P6|NOT COMPLETED|Overall Study||0
8293645|NCT01594515|20448143|P5|NOT COMPLETED|Overall Study||0
8293646|NCT01594515|20448144|P4|NOT COMPLETED|Overall Study||0
8293647|NCT01594515|20448145|P3|NOT COMPLETED|Overall Study||0
8293648|NCT01594515|20448146|P2|NOT COMPLETED|Overall Study||0
8293649|NCT01594515|20448147|P1|NOT COMPLETED|Overall Study||0
8293650|NCT01594515|20448138|P10|COMPLETED|Overall Study||16
8293651|NCT01594515|20448139|P9|COMPLETED|Overall Study||6
8293652|NCT01594515|20448140|P8|COMPLETED|Overall Study||6
8293653|NCT01594515|20448141|P7|COMPLETED|Overall Study||6
8293654|NCT01594515|20448142|P6|COMPLETED|Overall Study||6
8293655|NCT01594515|20448143|P5|COMPLETED|Overall Study||6
8293656|NCT01594515|20448144|P4|COMPLETED|Overall Study||6
8293657|NCT01594515|20448145|P3|COMPLETED|Overall Study||6
8293658|NCT01594515|20448146|P2|COMPLETED|Overall Study||6
8293659|NCT01594515|20448147|P1|COMPLETED|Overall Study||6
8293660|NCT01594515|20448138|P10|STARTED|Overall Study||16
8293661|NCT01594515|20448139|P9|STARTED|Overall Study||6
8293662|NCT01594515|20448140|P8|STARTED|Overall Study||6
8293663|NCT01594515|20448141|P7|STARTED|Overall Study||6
8293664|NCT01594515|20448142|P6|STARTED|Overall Study||6
8293665|NCT01594515|20448143|P5|STARTED|Overall Study||6
8293666|NCT01594515|20448144|P4|STARTED|Overall Study||6
8293667|NCT01594515|20448145|P3|STARTED|Overall Study||6
8293668|NCT01594515|20448146|P2|STARTED|Overall Study||6
8293669|NCT01594515|20448147|P1|STARTED|Overall Study||6
8293670|NCT01594476|20448239|P2|NOT COMPLETED|Overall Study||3
8293671|NCT01594476|20448240|P1|NOT COMPLETED|Overall Study||1
8293672|NCT01594476|20448239|P2|COMPLETED|Overall Study||97
8293673|NCT01594476|20448240|P1|COMPLETED|Overall Study||100
8293674|NCT01594476|20448239|P2|Pregnant|Overall Study||5
8293675|NCT01594476|20448240|P1|Pregnant|Overall Study||2
8293676|NCT01594476|20448239|P2|IUD Expulsion|Overall Study||0
8293677|NCT01594476|20448240|P1|IUD Expulsion|Overall Study||2
8293678|NCT01594476|20448239|P2|IUD Removal|Overall Study||5
8293679|NCT01594476|20448240|P1|IUD Removal|Overall Study||3
8293680|NCT01594476|20448239|P2|Excluded After Allocation|Overall Study||3
8293681|NCT01594476|20448240|P1|Excluded After Allocation|Overall Study||1
8293682|NCT01594476|20448239|P2|Received Intervention|Overall Study||73
8293683|NCT01594476|20448240|P1|Received Intervention|Overall Study||66
8293684|NCT01594476|20448239|P2|STARTED|Overall Study||100
8293685|NCT01594476|20448240|P1|STARTED|Overall Study||101
8293686|NCT01594424|20448258|P1|NOT COMPLETED|Overall Study||2
8293687|NCT01594424|20448258|P1|COMPLETED|Overall Study||8
8293688|NCT01594424|20448258|P1|STARTED|Overall Study||10
8293689|NCT01594411|20448262|P1|NOT COMPLETED|Overall Study||2
8293690|NCT01594411|20448262|P1|COMPLETED|Overall Study||249
8293691|NCT01594411|20448262|P1|STARTED|Overall Study||251
8293692|NCT01594385|20448271|P2|NOT COMPLETED|Overall Study||0
8293693|NCT01594385|20448272|P1|NOT COMPLETED|Overall Study||0
8293694|NCT01594385|20448271|P2|COMPLETED|Overall Study||13
8293695|NCT01594385|20448272|P1|COMPLETED|Overall Study||17
8293696|NCT01594385|20448271|P2|STARTED|Overall Study||13
8293697|NCT01594385|20448272|P1|STARTED|Overall Study||17
8293698|NCT01594333|20448296|P2|NOT COMPLETED|Overall Study||151
8293699|NCT01594333|20448297|P1|NOT COMPLETED|Overall Study||161
8293700|NCT01594333|20448296|P2|COMPLETED|Overall Study||2244
8293701|NCT01594333|20448297|P1|COMPLETED|Overall Study||2230
8293702|NCT01594333|20448296|P2|STARTED|Overall Study||2395
8293703|NCT01594333|20448297|P1|STARTED|Overall Study||2391
8293704|NCT01594294|20448325|P2|NOT COMPLETED|Overall Study||4
8293705|NCT01594294|20448326|P1|NOT COMPLETED|Overall Study||3
8293706|NCT01594294|20448325|P2|COMPLETED|Overall Study||36
8293707|NCT01594294|20448326|P1|COMPLETED|Overall Study||36
8293708|NCT01594294|20448325|P2|STARTED|Overall Study||40
8293709|NCT01594294|20448326|P1|STARTED|Overall Study||39
8293710|NCT01594281|20448343|P3|NOT COMPLETED|Non-Interventional Follow Up Phase||2
8293711|NCT01594281|20448344|P2|NOT COMPLETED|Non-Interventional Follow Up Phase||2
8293712|NCT01594281|20448345|P1|NOT COMPLETED|Non-Interventional Follow Up Phase||3
8293713|NCT01594281|20448343|P3|COMPLETED|Non-Interventional Follow Up Phase||23
8293714|NCT01594281|20448344|P2|COMPLETED|Non-Interventional Follow Up Phase||19
8293715|NCT01594281|20448345|P1|COMPLETED|Non-Interventional Follow Up Phase||25
8293716|NCT01594281|20448343|P3|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25
8293717|NCT01594281|20448344|P2|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20
8293718|NCT01594281|20448345|P1|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28
8293719|NCT01594281|20448343|P3|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25
8293720|NCT01594281|20448344|P2|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21
8293721|NCT01594281|20448345|P1|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28
8293722|NCT01594281|20448343|P3|NOT COMPLETED|Interventional Core Phase||8
8293723|NCT01594281|20448344|P2|NOT COMPLETED|Interventional Core Phase||10
8293724|NCT01594281|20448345|P1|NOT COMPLETED|Interventional Core Phase||7
8293725|NCT01594281|20448343|P3|COMPLETED|Interventional Core Phase||28
8293726|NCT01594281|20448344|P2|COMPLETED|Interventional Core Phase||26
8293727|NCT01594281|20448345|P1|COMPLETED|Interventional Core Phase||29
8293728|NCT01594281|20448343|P3|Full Analysis Set (FAS)|Interventional Core Phase||36
8293729|NCT01594281|20448344|P2|Full Analysis Set (FAS)|Interventional Core Phase||35
8293730|NCT01594281|20448345|P1|Full Analysis Set (FAS)|Interventional Core Phase||35
8293731|NCT01594281|20448343|P3|STARTED|Interventional Core Phase||36
8293732|NCT01594281|20448344|P2|STARTED|Interventional Core Phase||36
8293733|NCT01594281|20448345|P1|STARTED|Interventional Core Phase||36
8293734|NCT01594125|20448385|P5|NOT COMPLETED|Overall Study||7
8293735|NCT01594125|20448386|P4|NOT COMPLETED|Overall Study||4
8293736|NCT01594125|20448387|P3|NOT COMPLETED|Overall Study||3
8293737|NCT01594125|20448388|P2|NOT COMPLETED|Overall Study||12
8293738|NCT01594125|20448389|P1|NOT COMPLETED|Overall Study||4
8293739|NCT01594125|20448385|P5|COMPLETED|Overall Study||0
8293740|NCT01594125|20448386|P4|COMPLETED|Overall Study||0
8293741|NCT01594125|20448387|P3|COMPLETED|Overall Study||0
8293742|NCT01594125|20448388|P2|COMPLETED|Overall Study||0
8293743|NCT01594125|20448389|P1|COMPLETED|Overall Study||0
8293744|NCT01594125|20448385|P5|STARTED|Overall Study||7
8293745|NCT01594125|20448386|P4|STARTED|Overall Study||4
8293746|NCT01594125|20448387|P3|STARTED|Overall Study||3
8293747|NCT01594125|20448388|P2|STARTED|Overall Study||12
8293748|NCT01594125|20448389|P1|STARTED|Overall Study||4
8293749|NCT01593852|20448423|P2|NOT COMPLETED|Overall Study||0
8293750|NCT01593852|20448424|P1|NOT COMPLETED|Overall Study||0
8293751|NCT01593852|20448423|P2|COMPLETED|Overall Study||68
8293752|NCT01593852|20448424|P1|COMPLETED|Overall Study||68
8293753|NCT01593852|20448423|P2|STARTED|Overall Study||68
8293754|NCT01593852|20448424|P1|STARTED|Overall Study||68
8293755|NCT01593787|20448449|P3|NOT COMPLETED|Overall Study||0
8293756|NCT01593787|20448450|P2|NOT COMPLETED|Overall Study||0
8293757|NCT01593787|20448451|P1|NOT COMPLETED|Overall Study||1
8293758|NCT01593787|20448449|P3|COMPLETED|Overall Study||18
8293759|NCT01593787|20448450|P2|COMPLETED|Overall Study||8
8293760|NCT01593787|20448451|P1|COMPLETED|Overall Study||5
8293761|NCT01593787|20448449|P3|STARTED|Overall Study||18
8293762|NCT01593787|20448450|P2|STARTED|Overall Study||8
8293763|NCT01593787|20448451|P1|STARTED|Overall Study||6
8293764|NCT01593748|20448491|P2|NOT COMPLETED|Overall Study||0
8293765|NCT01593748|20448492|P1|NOT COMPLETED|Overall Study||0
8293766|NCT01593748|20448491|P2|COMPLETED|Overall Study||45
8293767|NCT01593748|20448492|P1|COMPLETED|Overall Study||45
8293768|NCT01593748|20448491|P2|STARTED|Overall Study||45
8293769|NCT01593748|20448492|P1|STARTED|Overall Study||45
8293770|NCT01593722|20448508|P2|NOT COMPLETED|Overall Study||0
8293771|NCT01593722|20448509|P1|NOT COMPLETED|Overall Study||0
8293772|NCT01593722|20448508|P2|COMPLETED|Overall Study||6
8293773|NCT01593722|20448509|P1|COMPLETED|Overall Study||6
8293774|NCT01593722|20448508|P2|STARTED|Overall Study||6
8293775|NCT01593722|20448509|P1|STARTED|Overall Study||6
8293776|NCT01593696|20448527|P4|NOT COMPLETED|Dose Expansion||0
8293777|NCT01593696|20448528|P3|NOT COMPLETED|Dose Expansion||1
8293778|NCT01593696|20448529|P2|NOT COMPLETED|Dose Expansion||0
8293779|NCT01593696|20448530|P1|NOT COMPLETED|Dose Expansion||0
8293780|NCT01593696|20448527|P4|COMPLETED|Dose Expansion||16
8293781|NCT01593696|20448528|P3|COMPLETED|Dose Expansion||15
8293782|NCT01593696|20448529|P2|COMPLETED|Dose Expansion||0
8293783|NCT01593696|20448530|P1|COMPLETED|Dose Expansion||0
8293784|NCT01593696|20448527|P4|STARTED|Dose Expansion||16
8293785|NCT01593696|20448528|P3|STARTED|Dose Expansion||16
8293786|NCT01593696|20448529|P2|STARTED|Dose Expansion||0
8293787|NCT01593696|20448530|P1|STARTED|Dose Expansion||0
8293788|NCT01593696|20448527|P4|NOT COMPLETED|Dose Escalation||0
8293789|NCT01593696|20448528|P3|NOT COMPLETED|Dose Escalation||0
8293790|NCT01593696|20448529|P2|NOT COMPLETED|Dose Escalation||0
8293791|NCT01593696|20448530|P1|NOT COMPLETED|Dose Escalation||2
8293792|NCT01593696|20448527|P4|COMPLETED|Dose Escalation||0
8293793|NCT01593696|20448528|P3|COMPLETED|Dose Escalation||0
8293794|NCT01593696|20448529|P2|COMPLETED|Dose Escalation||5
8293795|NCT01593696|20448530|P1|COMPLETED|Dose Escalation||14
8293796|NCT01593696|20448527|P4|No Prior Transplant|Dose Escalation||0
8293797|NCT01593696|20448528|P3|No Prior Transplant|Dose Escalation||0
8293798|NCT01593696|20448529|P2|No Prior Transplant|Dose Escalation||4
8293799|NCT01593696|20448530|P1|No Prior Transplant|Dose Escalation||9
8293800|NCT01593696|20448527|P4|Prior Transplant|Dose Escalation||0
8293801|NCT01593696|20448528|P3|Prior Transplant|Dose Escalation||0
8293802|NCT01593696|20448529|P2|Prior Transplant|Dose Escalation||1
8293803|NCT01593696|20448530|P1|Prior Transplant|Dose Escalation||7
8293804|NCT01593696|20448527|P4|STARTED|Dose Escalation||0
8293805|NCT01593696|20448528|P3|STARTED|Dose Escalation||0
8293806|NCT01593696|20448529|P2|STARTED|Dose Escalation||5
8293807|NCT01593696|20448530|P1|STARTED|Dose Escalation||16
8293808|NCT01593670|20448564|P1|NOT COMPLETED|Overall Study||0
8293809|NCT01593670|20448564|P1|COMPLETED|Overall Study||9
8293810|NCT01593670|20448564|P1|STARTED|Overall Study||9
8293811|NCT01593592|20448574|P2|NOT COMPLETED|Overall Study||0
8293812|NCT01593592|20448575|P1|NOT COMPLETED|Overall Study||0
8293813|NCT01593592|20448574|P2|COMPLETED|Overall Study||35
8293814|NCT01593592|20448575|P1|COMPLETED|Overall Study||35
8293815|NCT01593592|20448574|P2|STARTED|Overall Study||35
8293816|NCT01593592|20448575|P1|STARTED|Overall Study||35
8293817|NCT01593254|20448587|P2|NOT COMPLETED|Follow-Up Period||11
8293818|NCT01593254|20448588|P1|NOT COMPLETED|Follow-Up Period||3
8293819|NCT01593254|20448587|P2|COMPLETED|Follow-Up Period||17
8293820|NCT01593254|20448588|P1|COMPLETED|Follow-Up Period||11
8293821|NCT01593254|20448587|P2|STARTED|Follow-Up Period||28
8293822|NCT01593254|20448588|P1|STARTED|Follow-Up Period||14
8293823|NCT01593254|20448587|P2|NOT COMPLETED|Treatment Period||31
8293824|NCT01593254|20448588|P1|NOT COMPLETED|Treatment Period||14
8293825|NCT01593254|20448587|P2|COMPLETED|Treatment Period||143
8293826|NCT01593254|20448588|P1|COMPLETED|Treatment Period||72
8293827|NCT01593254|20448587|P2|Crossed Over to Dasatinib|Treatment Period||0
8293828|NCT01593254|20448588|P1|Crossed Over to Dasatinib|Treatment Period||42
8293829|NCT01593254|20448587|P2|STARTED|Treatment Period||174
8293830|NCT01593254|20448588|P1|STARTED|Treatment Period||86
8293831|NCT01593215|20448597|P2|NOT COMPLETED|Overall Study||0
8293832|NCT01593215|20448598|P1|NOT COMPLETED|Overall Study||1
8293833|NCT01593215|20448597|P2|COMPLETED|Overall Study||25
8293834|NCT01593215|20448598|P1|COMPLETED|Overall Study||24
8293835|NCT01593215|20448597|P2|STARTED|Overall Study||25
8293836|NCT01593215|20448598|P1|STARTED|Overall Study||25
8293837|NCT01592864|20448606|P2|NOT COMPLETED|Overall Study||1
8293838|NCT01592864|20448607|P1|NOT COMPLETED|Overall Study||0
8293839|NCT01592864|20448606|P2|COMPLETED|Overall Study||57
8293840|NCT01592864|20448607|P1|COMPLETED|Overall Study||60
8293841|NCT01592864|20448606|P2|STARTED|Overall Study||58
8293842|NCT01592864|20448607|P1|STARTED|Overall Study||60
8293843|NCT01592851|20448621|P2|NOT COMPLETED|Overall Study||0
8293844|NCT01592851|20448622|P1|NOT COMPLETED|Overall Study||0
8293845|NCT01592851|20448621|P2|COMPLETED|Overall Study||57
8293846|NCT01592851|20448622|P1|COMPLETED|Overall Study||56
8293847|NCT01592851|20448621|P2|STARTED|Overall Study||57
8293848|NCT01592851|20448622|P1|STARTED|Overall Study||56
8293849|NCT01592799|20448638|P1|NOT COMPLETED|Overall Study||0
8293850|NCT01592799|20448638|P1|COMPLETED|Overall Study||501
8293851|NCT01592799|20448638|P1|STARTED|Overall Study||501
8293852|NCT01592786|20448668|P1|NOT COMPLETED|Overall Study||138
8293853|NCT01592786|20448668|P1|COMPLETED|Overall Study||765
8293854|NCT01592786|20448668|P1|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
8293855|NCT01592773|20448672|P1|NOT COMPLETED|Overall Study||666
8293856|NCT01592773|20448672|P1|COMPLETED|Overall Study||81
8293857|NCT01592773|20448672|P1|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
8293858|NCT01592760|20448679|P3|NOT COMPLETED|24-hour Follow-Up||2
8293859|NCT01592760|20448680|P2|NOT COMPLETED|24-hour Follow-Up||3
8293860|NCT01592760|20448681|P1|NOT COMPLETED|24-hour Follow-Up||4
8293861|NCT01592760|20448679|P3|COMPLETED|24-hour Follow-Up||43
8293862|NCT01592760|20448680|P2|COMPLETED|24-hour Follow-Up||87
8293863|NCT01592760|20448681|P1|COMPLETED|24-hour Follow-Up||86
8293864|NCT01592760|20448679|P3|STARTED|24-hour Follow-Up||45
8293865|NCT01592760|20448680|P2|STARTED|24-hour Follow-Up||90
8293866|NCT01592760|20448681|P1|STARTED|24-hour Follow-Up||90
8293867|NCT01592760|20448679|P3|NOT COMPLETED|Perioperative to Discharge||0
8293868|NCT01592760|20448680|P2|NOT COMPLETED|Perioperative to Discharge||0
8293869|NCT01592760|20448681|P1|NOT COMPLETED|Perioperative to Discharge||0
8293870|NCT01592760|20448679|P3|COMPLETED|Perioperative to Discharge||45
8293871|NCT01592760|20448680|P2|COMPLETED|Perioperative to Discharge||90
8293872|NCT01592760|20448681|P1|COMPLETED|Perioperative to Discharge||90
8293873|NCT01592760|20448679|P3|STARTED|Perioperative to Discharge||45
8293874|NCT01592760|20448680|P2|STARTED|Perioperative to Discharge||90
8293875|NCT01592760|20448681|P1|STARTED|Perioperative to Discharge||90
8293876|NCT01592747|20448725|P3|NOT COMPLETED|Overall Study||108
8293877|NCT01592747|20448726|P2|NOT COMPLETED|Overall Study||111
8293878|NCT01592747|20448727|P1|NOT COMPLETED|Overall Study||116
8293879|NCT01592747|20448725|P3|COMPLETED|Overall Study||50
8293880|NCT01592747|20448726|P2|COMPLETED|Overall Study||50
8293881|NCT01592747|20448727|P1|COMPLETED|Overall Study||44
8293882|NCT01592747|20448725|P3|STARTED|Overall Study|Based on Randomized Population|158
8293883|NCT01592747|20448726|P2|STARTED|Overall Study|Based on Randomized Population|161
8293884|NCT01592747|20448727|P1|STARTED|Overall Study|Based on Randomized Population|160
8293885|NCT01592708|20448770|P2|NOT COMPLETED|Overall Study||0
8293886|NCT01592708|20448771|P1|NOT COMPLETED|Overall Study||3
8293887|NCT01592708|20448770|P2|COMPLETED|Overall Study||137
8293888|NCT01592708|20448771|P1|COMPLETED|Overall Study||93
8293889|NCT01592708|20448770|P2|STARTED|Overall Study||137
8293890|NCT01592708|20448771|P1|STARTED|Overall Study||96
8293891|NCT01592695|20448787|P2|NOT COMPLETED|Overall Study||4
8293892|NCT01592695|20448788|P1|NOT COMPLETED|Overall Study||8
8293893|NCT01592695|20448787|P2|COMPLETED|Overall Study||28
8293894|NCT01592695|20448788|P1|COMPLETED|Overall Study||23
8293895|NCT01592695|20448787|P2|STARTED|Overall Study||32
8293896|NCT01592695|20448788|P1|STARTED|Overall Study||31
8293897|NCT01592500|20448810|P4|NOT COMPLETED|Overall Study||2
8293898|NCT01592500|20448811|P3|NOT COMPLETED|Overall Study||0
8293899|NCT01592500|20448812|P2|NOT COMPLETED|Overall Study||0
8293900|NCT01592500|20448813|P1|NOT COMPLETED|Overall Study||1
8293901|NCT01592500|20448810|P4|COMPLETED|Overall Study||11
8293902|NCT01592500|20448811|P3|COMPLETED|Overall Study||14
8293903|NCT01592500|20448812|P2|COMPLETED|Overall Study||15
8293904|NCT01592500|20448813|P1|COMPLETED|Overall Study||13
8293905|NCT01592500|20448810|P4|STARTED|Overall Study|Randomized Participants|13
8293906|NCT01592500|20448811|P3|STARTED|Overall Study||14
8293907|NCT01592500|20448812|P2|STARTED|Overall Study||15
8293908|NCT01592500|20448813|P1|STARTED|Overall Study|Randomized Participants|14
8293909|NCT01592435|20448835|P1|NOT COMPLETED|Overall Study||0
8293910|NCT01592435|20448835|P1|COMPLETED|Overall Study||76
8293911|NCT01592435|20448835|P1|STARTED|Overall Study||76
8293912|NCT01592409|20448843|P2|NOT COMPLETED|Overall Study||1
8293913|NCT01592409|20448844|P1|NOT COMPLETED|Overall Study||0
8293914|NCT01592409|20448843|P2|COMPLETED|Overall Study||31
8293915|NCT01592409|20448844|P1|COMPLETED|Overall Study||67
8293916|NCT01592409|20448843|P2|STARTED|Overall Study||32
8293917|NCT01592409|20448844|P1|STARTED|Overall Study||67
8293918|NCT01592396|20448852|P2|NOT COMPLETED|Overall Study||0
8293919|NCT01592396|20448853|P1|NOT COMPLETED|Overall Study||0
8293920|NCT01592396|20448852|P2|COMPLETED|Overall Study||10
8293921|NCT01592396|20448853|P1|COMPLETED|Overall Study||10
8293922|NCT01592396|20448852|P2|STARTED|Overall Study||10
8293923|NCT01592396|20448853|P1|STARTED|Overall Study||10
8293924|NCT01592383|20448868|P1|NOT COMPLETED|Overall Study||1
8293925|NCT01592383|20448868|P1|COMPLETED|Overall Study||1
8293926|NCT01592383|20448868|P1|STARTED|Overall Study||2
8293927|NCT01592344|20448879|P2|NOT COMPLETED|Overall Study||5
8293928|NCT01592344|20448880|P1|NOT COMPLETED|Overall Study||4
8293929|NCT01592344|20448879|P2|COMPLETED|Overall Study||44
8293930|NCT01592344|20448880|P1|COMPLETED|Overall Study||41
8293931|NCT01592344|20448879|P2|STARTED|Overall Study||49
8293932|NCT01592344|20448880|P1|STARTED|Overall Study||45
8293933|NCT01592292|20448894|P4|NOT COMPLETED|Overall Study||1
8293934|NCT01592292|20448895|P3|NOT COMPLETED|Overall Study||3
8293935|NCT01592292|20448896|P2|NOT COMPLETED|Overall Study||5
8293936|NCT01592292|20448897|P1|NOT COMPLETED|Overall Study||6
8293937|NCT01592292|20448894|P4|COMPLETED|Overall Study||10
8293938|NCT01592292|20448895|P3|COMPLETED|Overall Study||10
8293939|NCT01592292|20448896|P2|COMPLETED|Overall Study||15
8293940|NCT01592292|20448897|P1|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
8293941|NCT01592292|20448894|P4|Standard Population Set (SPS)|Overall Study||7
8293942|NCT01592292|20448895|P3|Standard Population Set (SPS)|Overall Study||7
8293943|NCT01592292|20448896|P2|Standard Population Set (SPS)|Overall Study||10
8293944|NCT01592292|20448897|P1|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
8293945|NCT01592292|20448894|P4|Intention to Treat (ITT) Set|Overall Study||8
8293946|NCT01592292|20448895|P3|Intention to Treat (ITT) Set|Overall Study||10
8293947|NCT01592292|20448896|P2|Intention to Treat (ITT) Set|Overall Study||13
8293948|NCT01592292|20448897|P1|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
8293949|NCT01592292|20448894|P4|STARTED|Overall Study||11
8293950|NCT01592292|20448895|P3|STARTED|Overall Study||13
8293951|NCT01592292|20448896|P2|STARTED|Overall Study||20
8293952|NCT01592292|20448897|P1|STARTED|Overall Study||46
8293953|NCT01592240|20448936|P7|NOT COMPLETED|Overall Study||3
8293954|NCT01592240|20448937|P6|NOT COMPLETED|Overall Study||3
8293955|NCT01592240|20448938|P5|NOT COMPLETED|Overall Study||7
8293956|NCT01592240|20448939|P4|NOT COMPLETED|Overall Study||3
8293957|NCT01592240|20448940|P3|NOT COMPLETED|Overall Study||7
8293958|NCT01592240|20448941|P2|NOT COMPLETED|Overall Study||11
8293959|NCT01592240|20448942|P1|NOT COMPLETED|Overall Study||3
8293960|NCT01592240|20448936|P7|COMPLETED|Overall Study||48
8293961|NCT01592240|20448937|P6|COMPLETED|Overall Study||47
8293962|NCT01592240|20448938|P5|COMPLETED|Overall Study||44
8293963|NCT01592240|20448939|P4|COMPLETED|Overall Study||47
8293964|NCT01592240|20448940|P3|COMPLETED|Overall Study||45
8293965|NCT01592240|20448941|P2|COMPLETED|Overall Study||39
8293966|NCT01592240|20448942|P1|COMPLETED|Overall Study||47
8293967|NCT01592240|20448936|P7|STARTED|Overall Study||51
8293968|NCT01592240|20448937|P6|STARTED|Overall Study||50
8293969|NCT01592240|20448938|P5|STARTED|Overall Study||51
8293970|NCT01592240|20448939|P4|STARTED|Overall Study||50
8293971|NCT01592240|20448940|P3|STARTED|Overall Study||52
8293972|NCT01592240|20448941|P2|STARTED|Overall Study||50
8293973|NCT01592240|20448942|P1|STARTED|Overall Study||50
8293974|NCT01592071|20449122|P1|NOT COMPLETED|Overall Study||0
8293975|NCT01592071|20449122|P1|COMPLETED|Overall Study||120
8293976|NCT01592071|20449122|P1|STARTED|Overall Study||120
8293977|NCT01592045|20449135|P2|NOT COMPLETED|Overall Study||2
8293978|NCT01592045|20449136|P1|NOT COMPLETED|Overall Study||5
8293979|NCT01592045|20449135|P2|COMPLETED|Overall Study||12
8293980|NCT01592045|20449136|P1|COMPLETED|Overall Study||9
8293981|NCT01592045|20449135|P2|Completed Course 5|Overall Study||12
8293982|NCT01592045|20449136|P1|Completed Course 5|Overall Study||9
8293983|NCT01592045|20449135|P2|Completed Course 4|Overall Study||12
8293984|NCT01592045|20449136|P1|Completed Course 4|Overall Study||11
8293985|NCT01592045|20449135|P2|Completed Course 3|Overall Study||13
8293986|NCT01592045|20449136|P1|Completed Course 3|Overall Study||11
8293987|NCT01592045|20449135|P2|Completed Course 2|Overall Study||13
8293988|NCT01592045|20449136|P1|Completed Course 2|Overall Study||13
8293989|NCT01592045|20449135|P2|Completed Course 1|Overall Study||14
8293990|NCT01592045|20449136|P1|Completed Course 1|Overall Study||13
8293991|NCT01592045|20449135|P2|STARTED|Overall Study||14
8293992|NCT01592045|20449136|P1|STARTED|Overall Study||14
8293993|NCT01592006|20449144|P1|NOT COMPLETED|Overall Study||0
8293994|NCT01592006|20449144|P1|COMPLETED|Overall Study||3
8293995|NCT01592006|20449144|P1|STARTED|Overall Study||3
8293996|NCT01591954|20449149|P1|NOT COMPLETED|Overall Study||0
8293997|NCT01591954|20449149|P1|COMPLETED|Overall Study||1
8293998|NCT01591954|20449149|P1|STARTED|Overall Study||1
8293999|NCT01591863|20449154|P1|NOT COMPLETED|Overall Study||14
8294000|NCT01591863|20449154|P1|COMPLETED|Overall Study||24
8294001|NCT01591863|20449154|P1|STARTED|Overall Study||38
8294002|NCT01591837|20449166|P2|NOT COMPLETED|Overall Study||0
8294003|NCT01591837|20449167|P1|NOT COMPLETED|Overall Study||0
8294004|NCT01591837|20449166|P2|COMPLETED|Overall Study||60
8294005|NCT01591837|20449167|P1|COMPLETED|Overall Study||60
8294006|NCT01591837|20449166|P2|STARTED|Overall Study||60
8294007|NCT01591837|20449167|P1|STARTED|Overall Study||60
8294008|NCT01591785|20449183|P2|NOT COMPLETED|Overall Study||2
8294009|NCT01591785|20449184|P1|NOT COMPLETED|Overall Study||4
8294010|NCT01591785|20449183|P2|COMPLETED|Overall Study||28
8294011|NCT01591785|20449184|P1|COMPLETED|Overall Study||26
8294012|NCT01591785|20449183|P2|STARTED|Overall Study||30
8294013|NCT01591785|20449184|P1|STARTED|Overall Study||30
8294014|NCT01591746|20449198|P2|NOT COMPLETED|Overall Study||0
8294015|NCT01591746|20449199|P1|NOT COMPLETED|Overall Study||0
8294016|NCT01591746|20449198|P2|COMPLETED|Overall Study||63
8294017|NCT01591746|20449199|P1|COMPLETED|Overall Study||68
8294018|NCT01591746|20449198|P2|STARTED|Overall Study||63
8294019|NCT01591746|20449199|P1|STARTED|Overall Study||68
8294023|NCT01591681|20449226|P1|NOT COMPLETED|Overall Study||4
8294024|NCT01591681|20449226|P1|COMPLETED|Overall Study||45
8294025|NCT01591681|20449226|P1|STARTED|Overall Study||49
8294026|NCT01591655|20449254|P2|NOT COMPLETED|Overall Study||63
8294027|NCT01591655|20449255|P1|NOT COMPLETED|Overall Study||72
8294028|NCT01591655|20449254|P2|COMPLETED|Overall Study||57
8294029|NCT01591655|20449255|P1|COMPLETED|Overall Study||168
8294030|NCT01591655|20449254|P2|STARTED|Overall Study||120
8294031|NCT01591655|20449255|P1|STARTED|Overall Study||240
8294032|NCT01591616|20449273|P1|NOT COMPLETED|Overall Study||1
8294033|NCT01591616|20449273|P1|COMPLETED|Overall Study||15
8294034|NCT01591616|20449273|P1|STARTED|Overall Study||16
8294035|NCT01591499|20449414|P4|NOT COMPLETED|Second Intervention (up to 24 Days)||3
8294036|NCT01591499|20449415|P3|NOT COMPLETED|Second Intervention (up to 24 Days)||3
8294037|NCT01591499|20449416|P2|NOT COMPLETED|Second Intervention (up to 24 Days)||3
8294038|NCT01591499|20449417|P1|NOT COMPLETED|Second Intervention (up to 24 Days)||6
8294039|NCT01591499|20449414|P4|COMPLETED|Second Intervention (up to 24 Days)||34
8294040|NCT01591499|20449415|P3|COMPLETED|Second Intervention (up to 24 Days)||28
8294041|NCT01591499|20449416|P2|COMPLETED|Second Intervention (up to 24 Days)||34
8294042|NCT01591499|20449417|P1|COMPLETED|Second Intervention (up to 24 Days)||27
8294043|NCT01591499|20449414|P4|STARTED|Second Intervention (up to 24 Days)||37
8294044|NCT01591499|20449415|P3|STARTED|Second Intervention (up to 24 Days)||31
8294045|NCT01591499|20449416|P2|STARTED|Second Intervention (up to 24 Days)||37
8294046|NCT01591499|20449417|P1|STARTED|Second Intervention (up to 24 Days)||33
8294047|NCT01591499|20449414|P4|NOT COMPLETED|First Intervention (up to 24 Days)||0
8294048|NCT01591499|20449415|P3|NOT COMPLETED|First Intervention (up to 24 Days)||0
8294049|NCT01591499|20449416|P2|NOT COMPLETED|First Intervention (up to 24 Days)||0
8294050|NCT01591499|20449417|P1|NOT COMPLETED|First Intervention (up to 24 Days)||0
8294051|NCT01591499|20449414|P4|COMPLETED|First Intervention (up to 24 Days)||37
8294052|NCT01591499|20449415|P3|COMPLETED|First Intervention (up to 24 Days)||31
8294053|NCT01591499|20449416|P2|COMPLETED|First Intervention (up to 24 Days)||37
8294054|NCT01591499|20449417|P1|COMPLETED|First Intervention (up to 24 Days)||33
8294055|NCT01591499|20449414|P4|STARTED|First Intervention (up to 24 Days)||37
8294056|NCT01591499|20449415|P3|STARTED|First Intervention (up to 24 Days)||31
8294057|NCT01591499|20449416|P2|STARTED|First Intervention (up to 24 Days)||37
8294058|NCT01591499|20449417|P1|STARTED|First Intervention (up to 24 Days)||33
8294059|NCT01591499|20449414|P4|NOT COMPLETED|Baseline Visit||2
8294060|NCT01591499|20449415|P3|NOT COMPLETED|Baseline Visit||0
8294061|NCT01591499|20449416|P2|NOT COMPLETED|Baseline Visit||2
8294062|NCT01591499|20449417|P1|NOT COMPLETED|Baseline Visit||0
8294063|NCT01591499|20449414|P4|COMPLETED|Baseline Visit||37
8294064|NCT01591499|20449415|P3|COMPLETED|Baseline Visit||31
8294065|NCT01591499|20449416|P2|COMPLETED|Baseline Visit||37
8294066|NCT01591499|20449417|P1|COMPLETED|Baseline Visit||33
8294067|NCT01591499|20449414|P4|STARTED|Baseline Visit||39
8294068|NCT01591499|20449415|P3|STARTED|Baseline Visit||31
8294069|NCT01591499|20449416|P2|STARTED|Baseline Visit||39
8294070|NCT01591499|20449417|P1|STARTED|Baseline Visit||33
8294071|NCT01591460|20449483|P1|NOT COMPLETED|Overall Study||26
8294072|NCT01591460|20449483|P1|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
8294073|NCT01591460|20449483|P1|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
8294074|NCT01591408|20449565|P2|NOT COMPLETED|Overall Study||8
8294075|NCT01591408|20449566|P1|NOT COMPLETED|Overall Study||12
8294076|NCT01591408|20449565|P2|COMPLETED|Overall Study||24
8294077|NCT01591408|20449566|P1|COMPLETED|Overall Study||24
8294078|NCT01591408|20449565|P2|STARTED|Overall Study||32
8294079|NCT01591408|20449566|P1|STARTED|Overall Study||36
8294080|NCT01591382|20449574|P2|NOT COMPLETED|Overall Study||2
8294081|NCT01591382|20449575|P1|NOT COMPLETED|Overall Study||3
8294082|NCT01591382|20449574|P2|COMPLETED|Overall Study||30
8294083|NCT01591382|20449575|P1|COMPLETED|Overall Study||29
8294084|NCT01591382|20449574|P2|STARTED|Overall Study||32
8294085|NCT01591382|20449575|P1|STARTED|Overall Study||32
8294086|NCT01591317|20449592|P3|NOT COMPLETED|Overall Study||0
8294087|NCT01591317|20449593|P2|NOT COMPLETED|Overall Study||0
8294088|NCT01591317|20449594|P1|NOT COMPLETED|Overall Study||0
8294089|NCT01591317|20449592|P3|COMPLETED|Overall Study||10
8294090|NCT01591317|20449593|P2|COMPLETED|Overall Study||10
8294091|NCT01591317|20449594|P1|COMPLETED|Overall Study||10
8294092|NCT01591317|20449592|P3|STARTED|Overall Study||10
8294093|NCT01591317|20449593|P2|STARTED|Overall Study||10
8294094|NCT01591317|20449594|P1|STARTED|Overall Study||10
8294095|NCT01591161|20449622|P2|NOT COMPLETED|Overall Study||56
8294096|NCT01591161|20449623|P1|NOT COMPLETED|Overall Study||71
8294097|NCT01591161|20449622|P2|COMPLETED|Overall Study||68
8294098|NCT01591161|20449623|P1|COMPLETED|Overall Study||174
8294099|NCT01591161|20449622|P2|STARTED|Overall Study||124
8294100|NCT01591161|20449623|P1|STARTED|Overall Study||245
8294101|NCT01591096|20449643|P1|NOT COMPLETED|Overall Study||1
8294102|NCT01591096|20449643|P1|COMPLETED|Overall Study||0
8294103|NCT01591096|20449643|P1|STARTED|Overall Study||1
8294104|NCT01591044|20449652|P3|NOT COMPLETED|Overall Study||4
8294105|NCT01591044|20449653|P2|NOT COMPLETED|Overall Study||9
8294106|NCT01591044|20449654|P1|NOT COMPLETED|Overall Study||7
8294107|NCT01591044|20449652|P3|COMPLETED|Overall Study||96
8294108|NCT01591044|20449653|P2|COMPLETED|Overall Study||91
8294109|NCT01591044|20449654|P1|COMPLETED|Overall Study||94
8294110|NCT01591044|20449652|P3|STARTED|Overall Study||100
8294111|NCT01591044|20449653|P2|STARTED|Overall Study||100
8294112|NCT01591044|20449654|P1|STARTED|Overall Study||101
8294113|NCT01591018|20449664|P2|NOT COMPLETED|Overall Study||0
8294114|NCT01591018|20449665|P1|NOT COMPLETED|Overall Study||0
8294115|NCT01591018|20449664|P2|COMPLETED|Overall Study||60
8294116|NCT01591018|20449665|P1|COMPLETED|Overall Study||60
8294117|NCT01591018|20449664|P2|STARTED|Overall Study||60
8294118|NCT01591018|20449665|P1|STARTED|Overall Study||60
8294119|NCT01591005|20449679|P4|NOT COMPLETED|Overall Study||0
8294120|NCT01591005|20449680|P3|NOT COMPLETED|Overall Study||0
8294121|NCT01591005|20449681|P2|NOT COMPLETED|Overall Study||0
8294122|NCT01591005|20449682|P1|NOT COMPLETED|Overall Study||0
8294123|NCT01591005|20449679|P4|COMPLETED|Overall Study||68
8294124|NCT01591005|20449680|P3|COMPLETED|Overall Study||68
8294125|NCT01591005|20449681|P2|COMPLETED|Overall Study||53
8294126|NCT01591005|20449682|P1|COMPLETED|Overall Study||53
8294127|NCT01591005|20449679|P4|STARTED|Overall Study||68
8294128|NCT01591005|20449680|P3|STARTED|Overall Study||68
8294129|NCT01591005|20449681|P2|STARTED|Overall Study||53
8294130|NCT01591005|20449682|P1|STARTED|Overall Study||53
8294131|NCT01590979|20449718|P2|NOT COMPLETED|Overall Study||0
8294132|NCT01590979|20449719|P1|NOT COMPLETED|Overall Study||0
8294133|NCT01590979|20449718|P2|COMPLETED|Overall Study||27
8294134|NCT01590979|20449719|P1|COMPLETED|Overall Study||27
8294135|NCT01590979|20449718|P2|STARTED|Overall Study||27
8294136|NCT01590979|20449719|P1|STARTED|Overall Study||27
8294137|NCT01590888|20449728|P3|NOT COMPLETED|Overall Study||1
8294138|NCT01590888|20449729|P2|NOT COMPLETED|Overall Study||0
8294139|NCT01590888|20449730|P1|NOT COMPLETED|Overall Study||4
8294140|NCT01590888|20449728|P3|COMPLETED|Overall Study||34
8294141|NCT01590888|20449729|P2|COMPLETED|Overall Study||38
8294142|NCT01590888|20449730|P1|COMPLETED|Overall Study||32
8294143|NCT01590888|20449728|P3|STARTED|Overall Study||35
8294144|NCT01590888|20449729|P2|STARTED|Overall Study||38
8294145|NCT01590888|20449730|P1|STARTED|Overall Study||36
8294146|NCT01590875|20449776|P2|NOT COMPLETED|Overall Study||0
8294147|NCT01590875|20449777|P1|NOT COMPLETED|Overall Study||0
8294148|NCT01590875|20449776|P2|COMPLETED|Overall Study||10
8294149|NCT01590875|20449777|P1|COMPLETED|Overall Study||10
8294150|NCT01590875|20449776|P2|STARTED|Overall Study||10
8294151|NCT01590875|20449777|P1|STARTED|Overall Study||10
8294152|NCT01590810|20449790|P5|NOT COMPLETED|Overall Study||0
8294153|NCT01590810|20449791|P4|NOT COMPLETED|Overall Study||0
8294154|NCT01590810|20449792|P3|NOT COMPLETED|Overall Study||1
8294155|NCT01590810|20449793|P2|NOT COMPLETED|Overall Study||1
8294156|NCT01590810|20449794|P1|NOT COMPLETED|Overall Study||0
8294157|NCT01590810|20449790|P5|COMPLETED|Overall Study||2
8294158|NCT01590810|20449791|P4|COMPLETED|Overall Study||8
8294159|NCT01590810|20449792|P3|COMPLETED|Overall Study||7
8294160|NCT01590810|20449793|P2|COMPLETED|Overall Study||7
8294161|NCT01590810|20449794|P1|COMPLETED|Overall Study||8
8294162|NCT01590810|20449790|P5|STARTED|Overall Study||2
8294163|NCT01590810|20449791|P4|STARTED|Overall Study||8
8294164|NCT01590810|20449792|P3|STARTED|Overall Study||8
8294165|NCT01590810|20449793|P2|STARTED|Overall Study||8
8294166|NCT01590810|20449794|P1|STARTED|Overall Study||8
8294167|NCT01590797|20449939|P2|NOT COMPLETED|Overall Study||16
8294168|NCT01590797|20449940|P1|NOT COMPLETED|Overall Study||17
8294169|NCT01590797|20449939|P2|COMPLETED|Overall Study||217
8294170|NCT01590797|20449940|P1|COMPLETED|Overall Study||217
8294171|NCT01590797|20449939|P2|STARTED|Overall Study||233
8294172|NCT01590797|20449940|P1|STARTED|Overall Study||234
8294173|NCT01590771|20449956|P2|NOT COMPLETED|Overall Study||39
8294174|NCT01590771|20449957|P1|NOT COMPLETED|Overall Study||19
8294175|NCT01590771|20449956|P2|COMPLETED|Overall Study||210
8294176|NCT01590771|20449957|P1|COMPLETED|Overall Study||230
8294177|NCT01590771|20449956|P2|STARTED|Overall Study||249
8294178|NCT01590771|20449957|P1|STARTED|Overall Study||249
8294179|NCT01590758|20449985|P2|NOT COMPLETED|Overall Study||7
8294180|NCT01590758|20449986|P1|NOT COMPLETED|Overall Study||5
8294181|NCT01590758|20449985|P2|COMPLETED|Overall Study||97
8294182|NCT01590758|20449986|P1|COMPLETED|Overall Study||80
8294183|NCT01590758|20449985|P2|STARTED|Overall Study||104
8294184|NCT01590758|20449986|P1|STARTED|Overall Study||85
8294185|NCT01590563|20449996|P1|NOT COMPLETED|Overall Study||1
8294186|NCT01590563|20449996|P1|COMPLETED|Overall Study||14
8294187|NCT01590563|20449996|P1|STARTED|Overall Study||15
8294188|NCT01590550|20450002|P1|NOT COMPLETED|Overall Study||0
8294189|NCT01590550|20450002|P1|COMPLETED|Overall Study||18
8294190|NCT01590550|20450002|P1|STARTED|Overall Study||18
8294197|NCT01590394|20450017|P1|NOT COMPLETED|Overall Study||0
8294198|NCT01590394|20450017|P1|COMPLETED|Overall Study||3
8294199|NCT01590394|20450017|P1|STARTED|Overall Study||3
8294200|NCT01590264|20450021|P1|NOT COMPLETED|Overall Study||0
8294201|NCT01590264|20450021|P1|COMPLETED|Overall Study||5
8294202|NCT01590264|20450021|P1|STARTED|Overall Study||5
8294203|NCT01590238|20450026|P1|NOT COMPLETED|Overall Study||2
8294204|NCT01590238|20450026|P1|COMPLETED|Overall Study||13
8294205|NCT01590238|20450026|P1|STARTED|Overall Study||15
8294206|NCT01590212|20450033|P3|NOT COMPLETED|Overall Study||5
8294207|NCT01590212|20450034|P2|NOT COMPLETED|Overall Study||4
8294208|NCT01590212|20450035|P1|NOT COMPLETED|Overall Study||3
8294209|NCT01590212|20450033|P3|COMPLETED|Overall Study||9
8294210|NCT01590212|20450034|P2|COMPLETED|Overall Study||5
8294211|NCT01590212|20450035|P1|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
8294212|NCT01590212|20450033|P3|Post-intervention|Overall Study|failed contact=1|10
8294213|NCT01590212|20450034|P2|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
8294214|NCT01590212|20450035|P1|Post-intervention|Overall Study|failed contact=3|7
8294215|NCT01590212|20450033|P3|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
8294216|NCT01590212|20450034|P2|Baseline (Pre-intervention)|Overall Study||9
8294217|NCT01590212|20450035|P1|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
8294218|NCT01590212|20450033|P3|STARTED|Overall Study||14
8294219|NCT01590212|20450034|P2|STARTED|Overall Study||9
8294220|NCT01590212|20450035|P1|STARTED|Overall Study||12
8294221|NCT01590082|20450054|P2|NOT COMPLETED|Overall Study||0
8294222|NCT01590082|20450055|P1|NOT COMPLETED|Overall Study||2
8294223|NCT01590082|20450054|P2|COMPLETED|Overall Study||1
8294224|NCT01590082|20450055|P1|COMPLETED|Overall Study||9
8294225|NCT01590082|20450054|P2|STARTED|Overall Study||1
8294226|NCT01590082|20450055|P1|STARTED|Overall Study||11
8294227|NCT01590017|20450061|P1|NOT COMPLETED|Overall Study||4
8294228|NCT01590017|20450061|P1|COMPLETED|Overall Study||37
8294229|NCT01590017|20450061|P1|STARTED|Overall Study||41
8294230|NCT01589978|20450066|P1|NOT COMPLETED|Overall Study||0
8294231|NCT01589978|20450066|P1|COMPLETED|Overall Study||2681
8294232|NCT01589978|20450066|P1|STARTED|Overall Study||2681
8294233|NCT01589926|20450092|P2|NOT COMPLETED|Overall Study||0
8294234|NCT01589926|20450093|P1|NOT COMPLETED|Overall Study||0
8294235|NCT01589926|20450092|P2|COMPLETED|Overall Study||0
8294236|NCT01589926|20450093|P1|COMPLETED|Overall Study||0
8294237|NCT01589926|20450092|P2|STARTED|Overall Study||0
8294238|NCT01589926|20450093|P1|STARTED|Overall Study||0
8294239|NCT01589822|20450114|P3|NOT COMPLETED|Overall Study||1
8294240|NCT01589822|20450115|P2|NOT COMPLETED|Overall Study||3
8294241|NCT01589822|20450116|P1|NOT COMPLETED|Overall Study||4
8294242|NCT01589822|20450114|P3|COMPLETED|Overall Study||40
8294243|NCT01589822|20450115|P2|COMPLETED|Overall Study||86
8294244|NCT01589822|20450116|P1|COMPLETED|Overall Study||80
8294245|NCT01589822|20450114|P3|STARTED|Overall Study||41
8294246|NCT01589822|20450115|P2|STARTED|Overall Study||89
8294247|NCT01589822|20450116|P1|STARTED|Overall Study||84
8294248|NCT01589770|20450135|P2|NOT COMPLETED|Overall Study||5
8294249|NCT01589770|20450136|P1|NOT COMPLETED|Overall Study||8
8294250|NCT01589770|20450135|P2|COMPLETED|Overall Study||56
8294251|NCT01589770|20450136|P1|COMPLETED|Overall Study||59
8294252|NCT01589770|20450135|P2|STARTED|Overall Study||61
8294253|NCT01589770|20450136|P1|STARTED|Overall Study||67
8294254|NCT01589653|20450146|P2|NOT COMPLETED|Overall Study||11
8294255|NCT01589653|20450147|P1|NOT COMPLETED|Overall Study||7
8294256|NCT01589653|20450146|P2|COMPLETED|Overall Study||68
8294257|NCT01589653|20450147|P1|COMPLETED|Overall Study||69
8294258|NCT01589653|20450146|P2|Exposed|Overall Study||78
8294259|NCT01589653|20450147|P1|Exposed|Overall Study||76
8294260|NCT01589653|20450146|P2|STARTED|Overall Study||79
8294261|NCT01589653|20450147|P1|STARTED|Overall Study||76
8294262|NCT01589601|20450163|P2|NOT COMPLETED|Overall Study||49
8294263|NCT01589601|20450164|P1|NOT COMPLETED|Overall Study||47
8294264|NCT01589601|20450163|P2|COMPLETED|Overall Study||26
8294265|NCT01589601|20450164|P1|COMPLETED|Overall Study||28
8294266|NCT01589601|20450163|P2|STARTED|Overall Study||75
8294267|NCT01589601|20450164|P1|STARTED|Overall Study||75
8294268|NCT01589510|20450182|P1|NOT COMPLETED|Overall Study||33
8294269|NCT01589510|20450182|P1|COMPLETED|Overall Study||386
8294270|NCT01589510|20450182|P1|STARTED|Overall Study||419
8294271|NCT01589497|20450197|P4|NOT COMPLETED|Overall Study||1
8294272|NCT01589497|20450198|P3|NOT COMPLETED|Overall Study||1
8294273|NCT01589497|20450199|P2|NOT COMPLETED|Overall Study||1
8294274|NCT01589497|20450200|P1|NOT COMPLETED|Overall Study||1
8294275|NCT01589497|20450197|P4|COMPLETED|Overall Study||17
8294276|NCT01589497|20450198|P3|COMPLETED|Overall Study||15
8294277|NCT01589497|20450199|P2|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
8294278|NCT01589497|20450200|P1|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
8294279|NCT01589497|20450197|P4|STARTED|Overall Study||18
8294280|NCT01589497|20450198|P3|STARTED|Overall Study||16
8294281|NCT01589497|20450199|P2|STARTED|Overall Study||17
8294282|NCT01589497|20450200|P1|STARTED|Overall Study||18
8294283|NCT01589484|20450301|P1|NOT COMPLETED|Overall Study||4
8294284|NCT01589484|20450301|P1|COMPLETED|Overall Study||100
8294285|NCT01589484|20450301|P1|STARTED|Overall Study||104
8294286|NCT01589445|20450306|P1|NOT COMPLETED|002 (Metformin)-3 Months||9
8294287|NCT01589445|20450306|P1|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
8294288|NCT01589445|20450306|P1|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
8294289|NCT01589445|20450306|P1|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
8294290|NCT01589445|20450306|P1|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
8294291|NCT01589445|20450306|P1|STARTED|001 (Pioglitazone) -3 Months||77
8294292|NCT01589315|20450322|P1|NOT COMPLETED|Overall Study||1
8294293|NCT01589315|20450322|P1|COMPLETED|Overall Study||16
8294294|NCT01589315|20450322|P1|STARTED|Overall Study||17
8294300|NCT01589237|20450349|P4|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
8294301|NCT01589237|20450350|P3|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
8294302|NCT01589237|20450351|P2|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
8294303|NCT01589237|20450352|P1|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
8294304|NCT01589237|20450349|P4|COMPLETED|Part B (Planned for 78 Week-terminated)||0
8294305|NCT01589237|20450350|P3|COMPLETED|Part B (Planned for 78 Week-terminated)||0
8294306|NCT01589237|20450351|P2|COMPLETED|Part B (Planned for 78 Week-terminated)||0
8294307|NCT01589237|20450352|P1|COMPLETED|Part B (Planned for 78 Week-terminated)||0
8294308|NCT01589237|20450349|P4|STARTED|Part B (Planned for 78 Week-terminated)||4
8294309|NCT01589237|20450350|P3|STARTED|Part B (Planned for 78 Week-terminated)||4
8294310|NCT01589237|20450351|P2|STARTED|Part B (Planned for 78 Week-terminated)||6
8294311|NCT01589237|20450352|P1|STARTED|Part B (Planned for 78 Week-terminated)||5
8294312|NCT01589237|20450349|P4|NOT COMPLETED|Part A (52 Weeks)||0
8294313|NCT01589237|20450350|P3|NOT COMPLETED|Part A (52 Weeks)||2
8294314|NCT01589237|20450351|P2|NOT COMPLETED|Part A (52 Weeks)||3
8294315|NCT01589237|20450352|P1|NOT COMPLETED|Part A (52 Weeks)||2
8294316|NCT01589237|20450349|P4|COMPLETED|Part A (52 Weeks)||5
8294317|NCT01589237|20450350|P3|COMPLETED|Part A (52 Weeks)||8
8294318|NCT01589237|20450351|P2|COMPLETED|Part A (52 Weeks)||9
8294319|NCT01589237|20450352|P1|COMPLETED|Part A (52 Weeks)||9
8294320|NCT01589237|20450349|P4|STARTED|Part A (52 Weeks)||5
8294321|NCT01589237|20450350|P3|STARTED|Part A (52 Weeks)||10
8294322|NCT01589237|20450351|P2|STARTED|Part A (52 Weeks)||12
8294323|NCT01589237|20450352|P1|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
8294324|NCT01589185|20450403|P5|NOT COMPLETED|Overall Study||1
8294325|NCT01589185|20450404|P4|NOT COMPLETED|Overall Study||3
8294326|NCT01589185|20450405|P3|NOT COMPLETED|Overall Study||4
8294327|NCT01589185|20450406|P2|NOT COMPLETED|Overall Study||2
8294328|NCT01589185|20450407|P1|NOT COMPLETED|Overall Study||2
8294329|NCT01589185|20450403|P5|COMPLETED|Overall Study||15
8294330|NCT01589185|20450404|P4|COMPLETED|Overall Study||5
8294331|NCT01589185|20450405|P3|COMPLETED|Overall Study||6
8294332|NCT01589185|20450406|P2|COMPLETED|Overall Study||6
8294333|NCT01589185|20450407|P1|COMPLETED|Overall Study||4
8294334|NCT01589185|20450403|P5|STARTED|Overall Study||16
8294335|NCT01589185|20450404|P4|STARTED|Overall Study||8
8294336|NCT01589185|20450405|P3|STARTED|Overall Study||10
8294337|NCT01589185|20450406|P2|STARTED|Overall Study||8
8294338|NCT01589185|20450407|P1|STARTED|Overall Study||6
8294339|NCT01589094|20450440|P1|NOT COMPLETED|Overall Study||2
8294340|NCT01589094|20450440|P1|COMPLETED|Overall Study||49
8294341|NCT01589094|20450440|P1|STARTED|Overall Study||51
8294342|NCT01588990|20450447|P1|NOT COMPLETED|Phase B||16
8294343|NCT01588990|20450447|P1|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37
8294344|NCT01588990|20450447|P1|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53
8294345|NCT01588990|20450447|P1|NOT COMPLETED|Phase A||70
8294346|NCT01588990|20450447|P1|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58
8294347|NCT01588990|20450447|P1|STARTED|Phase A||128
8294348|NCT01588951|20450475|P3|NOT COMPLETED|Overall Study||1
8294349|NCT01588951|20450476|P2|NOT COMPLETED|Overall Study||0
8294350|NCT01588951|20450477|P1|NOT COMPLETED|Overall Study||0
8294351|NCT01588951|20450475|P3|COMPLETED|Overall Study||5
8294352|NCT01588951|20450476|P2|COMPLETED|Overall Study||2
8294353|NCT01588951|20450477|P1|COMPLETED|Overall Study||2
8294354|NCT01588951|20450475|P3|STARTED|Overall Study||6
8294355|NCT01588951|20450476|P2|STARTED|Overall Study||2
8294356|NCT01588951|20450477|P1|STARTED|Overall Study||2
8294357|NCT01588821|20450485|P1|NOT COMPLETED|Overall Study||0
8294358|NCT01588821|20450485|P1|COMPLETED|Overall Study||37
8294359|NCT01588821|20450485|P1|STARTED|Overall Study||37
8294360|NCT01588561|20450495|P2|NOT COMPLETED|Overall Study||0
8294361|NCT01588561|20450496|P1|NOT COMPLETED|Overall Study||0
8294362|NCT01588561|20450495|P2|COMPLETED|Overall Study||1
8294363|NCT01588561|20450496|P1|COMPLETED|Overall Study||14
8294364|NCT01588561|20450495|P2|Second Injection (Visit 2)|Overall Study||1
8294365|NCT01588561|20450496|P1|Second Injection (Visit 2)|Overall Study||14
8294366|NCT01588561|20450495|P2|Rest Period|Overall Study||1
8294367|NCT01588561|20450496|P1|Rest Period|Overall Study||14
8294368|NCT01588561|20450495|P2|First Injection (Visit 1)|Overall Study||1
8294369|NCT01588561|20450496|P1|First Injection (Visit 1)|Overall Study||14
8294370|NCT01588561|20450495|P2|STARTED|Overall Study||1
8294371|NCT01588561|20450496|P1|STARTED|Overall Study||14
8294372|NCT01588548|20450513|P6|NOT COMPLETED|Overall Study||6
8294373|NCT01588548|20450514|P5|NOT COMPLETED|Overall Study||6
8294374|NCT01588548|20450515|P4|NOT COMPLETED|Overall Study||7
8294375|NCT01588548|20450516|P3|NOT COMPLETED|Overall Study||6
8294376|NCT01588548|20450517|P2|NOT COMPLETED|Overall Study||7
8294377|NCT01588548|20450518|P1|NOT COMPLETED|Overall Study||3
8294378|NCT01588548|20450513|P6|COMPLETED|Overall Study||0
8294379|NCT01588548|20450514|P5|COMPLETED|Overall Study||0
8294380|NCT01588548|20450515|P4|COMPLETED|Overall Study||0
8294381|NCT01588548|20450516|P3|COMPLETED|Overall Study||0
8294382|NCT01588548|20450517|P2|COMPLETED|Overall Study||0
8294383|NCT01588548|20450518|P1|COMPLETED|Overall Study||0
8294384|NCT01588548|20450513|P6|Cycle 1 Day 21|Overall Study||3
8294385|NCT01588548|20450514|P5|Cycle 1 Day 21|Overall Study||3
8294386|NCT01588548|20450515|P4|Cycle 1 Day 21|Overall Study||5
8294387|NCT01588548|20450516|P3|Cycle 1 Day 21|Overall Study||2
8294388|NCT01588548|20450517|P2|Cycle 1 Day 21|Overall Study||5
8294389|NCT01588548|20450518|P1|Cycle 1 Day 21|Overall Study||3
8294390|NCT01588548|20450513|P6|STARTED|Overall Study||6
8294391|NCT01588548|20450514|P5|STARTED|Overall Study||6
8294392|NCT01588548|20450515|P4|STARTED|Overall Study||7
8294393|NCT01588548|20450516|P3|STARTED|Overall Study||6
8294394|NCT01588548|20450517|P2|STARTED|Overall Study||7
8294395|NCT01588548|20450518|P1|STARTED|Overall Study||3
8294396|NCT01588509|20450534|P2|NOT COMPLETED|Overall Study||0
8294397|NCT01588509|20450535|P1|NOT COMPLETED|Overall Study||1
8294398|NCT01588509|20450534|P2|COMPLETED|Overall Study||30
8294399|NCT01588509|20450535|P1|COMPLETED|Overall Study||29
8294400|NCT01588509|20450534|P2|Received Treatment|Overall Study||30
8294401|NCT01588509|20450535|P1|Received Treatment|Overall Study||30
8294402|NCT01588509|20450534|P2|STARTED|Overall Study||30
8294403|NCT01588509|20450535|P1|STARTED|Overall Study||30
8294404|NCT01588496|20450558|P3|NOT COMPLETED|Overall Study||0
8294405|NCT01588496|20450559|P2|NOT COMPLETED|Overall Study||1
8294406|NCT01588496|20450560|P1|NOT COMPLETED|Overall Study||0
8294407|NCT01588496|20450558|P3|COMPLETED|Overall Study||33
8294408|NCT01588496|20450559|P2|COMPLETED|Overall Study||16
8294409|NCT01588496|20450560|P1|COMPLETED|Overall Study||8
8294410|NCT01588496|20450558|P3|Received Treatment|Overall Study||33
8294411|NCT01588496|20450559|P2|Received Treatment|Overall Study||16
8294412|NCT01588496|20450560|P1|Received Treatment|Overall Study||8
8294413|NCT01588496|20450558|P3|STARTED|Overall Study||33
8294414|NCT01588496|20450559|P2|STARTED|Overall Study||17
8294415|NCT01588496|20450560|P1|STARTED|Overall Study||8
8294416|NCT01588470|20450585|P1|NOT COMPLETED|Overall Study||80
8294417|NCT01588470|20450585|P1|COMPLETED|Overall Study|Completed Dec. 2011|50
8294418|NCT01588470|20450585|P1|STARTED|Overall Study|First enrolled April 2007|130
8294419|NCT01588457|20450596|P4|NOT COMPLETED|Randomization 2||5
8294420|NCT01588457|20450597|P3|NOT COMPLETED|Randomization 2||5
8294421|NCT01588457|20450598|P2|NOT COMPLETED|Randomization 2||28
8294422|NCT01588457|20450599|P1|NOT COMPLETED|Randomization 2||20
8294423|NCT01588457|20450596|P4|COMPLETED|Randomization 2||13
8294424|NCT01588457|20450597|P3|COMPLETED|Randomization 2||12
8294425|NCT01588457|20450598|P2|COMPLETED|Randomization 2||3
8294426|NCT01588457|20450599|P1|COMPLETED|Randomization 2||1
8294427|NCT01588457|20450596|P4|STARTED|Randomization 2|Assignment of Lamotrigine plus monotherapy for symptoms of depression|18
8294428|NCT01588457|20450597|P3|STARTED|Randomization 2|Assignment of Quetiapine plus monotherapy for symptoms of depression|17
8294429|NCT01588457|20450598|P2|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|31
8294430|NCT01588457|20450599|P1|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|21
8294431|NCT01588457|20450596|P4|NOT COMPLETED|Randomization 1||0
8294432|NCT01588457|20450597|P3|NOT COMPLETED|Randomization 1||0
8294433|NCT01588457|20450598|P2|NOT COMPLETED|Randomization 1||16
8294434|NCT01588457|20450599|P1|NOT COMPLETED|Randomization 1||23
8294435|NCT01588457|20450596|P4|COMPLETED|Randomization 1||0
8294436|NCT01588457|20450597|P3|COMPLETED|Randomization 1||0
8294437|NCT01588457|20450598|P2|COMPLETED|Randomization 1||43
8294438|NCT01588457|20450599|P1|COMPLETED|Randomization 1||30
8294439|NCT01588457|20450596|P4|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
8294440|NCT01588457|20450597|P3|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
8294441|NCT01588457|20450598|P2|STARTED|Randomization 1||59
8294442|NCT01588457|20450599|P1|STARTED|Randomization 1||53
8294443|NCT01588444|20450621|P2|NOT COMPLETED|Overall Study||0
8294444|NCT01588444|20450622|P1|NOT COMPLETED|Overall Study||0
8294445|NCT01588444|20450621|P2|COMPLETED|Overall Study||20
8294446|NCT01588444|20450622|P1|COMPLETED|Overall Study||20
8294447|NCT01588444|20450621|P2|STARTED|Overall Study||20
8294448|NCT01588444|20450622|P1|STARTED|Overall Study||20
8294449|NCT01588418|20450628|P2|NOT COMPLETED|Overall Study||0
8294450|NCT01588418|20450629|P1|NOT COMPLETED|Overall Study||0
8294451|NCT01588418|20450628|P2|COMPLETED|Overall Study||4
8294452|NCT01588418|20450629|P1|COMPLETED|Overall Study||11
8294453|NCT01588418|20450628|P2|STARTED|Overall Study||4
8294454|NCT01588418|20450629|P1|STARTED|Overall Study||11
8294455|NCT01588405|20450635|P1|NOT COMPLETED|Overall Study||2
8294456|NCT01588405|20450635|P1|COMPLETED|Overall Study||31
8294457|NCT01588405|20450635|P1|STARTED|Overall Study||33
8294458|NCT01588366|20450664|P6|NOT COMPLETED|Overall Study||2
8294459|NCT01588366|20450665|P5|NOT COMPLETED|Overall Study||0
8294460|NCT01588366|20450666|P4|NOT COMPLETED|Overall Study||1
8294461|NCT01588366|20450667|P3|NOT COMPLETED|Overall Study||0
8294462|NCT01588366|20450668|P2|NOT COMPLETED|Overall Study||1
8294463|NCT01588366|20450669|P1|NOT COMPLETED|Overall Study||0
8294464|NCT01588366|20450664|P6|COMPLETED|Overall Study||7
8294465|NCT01588366|20450665|P5|COMPLETED|Overall Study||3
8294466|NCT01588366|20450666|P4|COMPLETED|Overall Study||6
8294467|NCT01588366|20450667|P3|COMPLETED|Overall Study||2
8294468|NCT01588366|20450668|P2|COMPLETED|Overall Study||6
8294469|NCT01588366|20450669|P1|COMPLETED|Overall Study||2
8294470|NCT01588366|20450664|P6|Received at Least One Dose of Study Drug|Overall Study||9
8294471|NCT01588366|20450665|P5|Received at Least One Dose of Study Drug|Overall Study||3
8294472|NCT01588366|20450666|P4|Received at Least One Dose of Study Drug|Overall Study||7
8294473|NCT01588366|20450667|P3|Received at Least One Dose of Study Drug|Overall Study||2
8294474|NCT01588366|20450668|P2|Received at Least One Dose of Study Drug|Overall Study||7
8294475|NCT01588366|20450669|P1|Received at Least One Dose of Study Drug|Overall Study||2
8294476|NCT01588366|20450664|P6|STARTED|Overall Study||9
8294477|NCT01588366|20450665|P5|STARTED|Overall Study||3
8294478|NCT01588366|20450666|P4|STARTED|Overall Study||7
8294479|NCT01588366|20450667|P3|STARTED|Overall Study||2
8294480|NCT01588366|20450668|P2|STARTED|Overall Study||7
8294481|NCT01588366|20450669|P1|STARTED|Overall Study||2
8294482|NCT01588353|20450697|P3|NOT COMPLETED|Step3||2
8294483|NCT01588353|20450698|P2|NOT COMPLETED|Step3||0
8294484|NCT01588353|20450699|P1|NOT COMPLETED|Step3||0
8294485|NCT01588353|20450697|P3|COMPLETED|Step3||23
8294486|NCT01588353|20450698|P2|COMPLETED|Step3||0
8294487|NCT01588353|20450699|P1|COMPLETED|Step3||0
8294488|NCT01588353|20450697|P3|STARTED|Step3||25
8294489|NCT01588353|20450698|P2|STARTED|Step3||0
8294490|NCT01588353|20450699|P1|STARTED|Step3||0
8294491|NCT01588353|20450697|P3|NOT COMPLETED|Step2||0
8294492|NCT01588353|20450698|P2|NOT COMPLETED|Step2||1
8294493|NCT01588353|20450699|P1|NOT COMPLETED|Step2||0
8294494|NCT01588353|20450697|P3|COMPLETED|Step2||0
8294495|NCT01588353|20450698|P2|COMPLETED|Step2||70
8294496|NCT01588353|20450699|P1|COMPLETED|Step2||0
8294497|NCT01588353|20450697|P3|STARTED|Step2||0
8294498|NCT01588353|20450698|P2|STARTED|Step2||71
8294499|NCT01588353|20450699|P1|STARTED|Step2||0
8294500|NCT01588353|20450697|P3|NOT COMPLETED|Step1||0
8294501|NCT01588353|20450698|P2|NOT COMPLETED|Step1||0
8294502|NCT01588353|20450699|P1|NOT COMPLETED|Step1||0
8294503|NCT01588353|20450697|P3|COMPLETED|Step1||0
8294504|NCT01588353|20450698|P2|COMPLETED|Step1||0
8294505|NCT01588353|20450699|P1|COMPLETED|Step1||6
8294506|NCT01588353|20450697|P3|STARTED|Step1||0
8294507|NCT01588353|20450698|P2|STARTED|Step1||0
8294508|NCT01588353|20450699|P1|STARTED|Step1||6
8294509|NCT01588236|20450718|P3|NOT COMPLETED|Overall Study||25
8294510|NCT01588236|20450719|P2|NOT COMPLETED|Overall Study||28
8294511|NCT01588236|20450720|P1|NOT COMPLETED|Overall Study||16
8294512|NCT01588236|20450718|P3|COMPLETED|Overall Study||69
8294513|NCT01588236|20450719|P2|COMPLETED|Overall Study||66
8294514|NCT01588236|20450720|P1|COMPLETED|Overall Study||76
8294515|NCT01588236|20450718|P3|STARTED|Overall Study||94
8294516|NCT01588236|20450719|P2|STARTED|Overall Study||94
8294517|NCT01588236|20450720|P1|STARTED|Overall Study||92
8294518|NCT01588197|20450748|P2|NOT COMPLETED|Overall Study||1
8294519|NCT01588197|20450749|P1|NOT COMPLETED|Overall Study||1
8294520|NCT01588197|20450748|P2|COMPLETED|Overall Study||9
8294521|NCT01588197|20450749|P1|COMPLETED|Overall Study||9
8294522|NCT01588197|20450748|P2|STARTED|Overall Study||10
8294523|NCT01588197|20450749|P1|STARTED|Overall Study||10
8294524|NCT01588184|20450765|P6|NOT COMPLETED|Overall Study||4
8294525|NCT01588184|20450766|P5|NOT COMPLETED|Overall Study||2
8294526|NCT01588184|20450767|P4|NOT COMPLETED|Overall Study||3
8294527|NCT01588184|20450768|P3|NOT COMPLETED|Overall Study||2
8294528|NCT01588184|20450769|P2|NOT COMPLETED|Overall Study||13
8294529|NCT01588184|20450770|P1|NOT COMPLETED|Overall Study||3
8294530|NCT01588184|20450765|P6|COMPLETED|Overall Study||10
8294531|NCT01588184|20450766|P5|COMPLETED|Overall Study||14
8294532|NCT01588184|20450767|P4|COMPLETED|Overall Study||3
8294533|NCT01588184|20450768|P3|COMPLETED|Overall Study||5
8294534|NCT01588184|20450769|P2|COMPLETED|Overall Study||28
8294535|NCT01588184|20450770|P1|COMPLETED|Overall Study||8
8294536|NCT01588184|20450765|P6|STARTED|Overall Study||14
8294537|NCT01588184|20450766|P5|STARTED|Overall Study||16
8294538|NCT01588184|20450767|P4|STARTED|Overall Study||6
8294539|NCT01588184|20450768|P3|STARTED|Overall Study||7
8294540|NCT01588184|20450769|P2|STARTED|Overall Study||41
8294541|NCT01588184|20450770|P1|STARTED|Overall Study||11
8294542|NCT01588158|20450798|P2|NOT COMPLETED|Overall Study||0
8294543|NCT01588158|20450799|P1|NOT COMPLETED|Overall Study||0
8294544|NCT01588158|20450798|P2|COMPLETED|Overall Study||3
8294545|NCT01588158|20450799|P1|COMPLETED|Overall Study||4
8294546|NCT01588158|20450798|P2|STARTED|Overall Study||3
8294547|NCT01588158|20450799|P1|STARTED|Overall Study||4
8294548|NCT01588106|20450823|P2|NOT COMPLETED|Overall Study||4
8294549|NCT01588106|20450824|P1|NOT COMPLETED|Overall Study||5
8294550|NCT01588106|20450823|P2|COMPLETED|Overall Study||72
8294551|NCT01588106|20450824|P1|COMPLETED|Overall Study||73
8294552|NCT01588106|20450823|P2|STARTED|Overall Study||76
8294553|NCT01588106|20450824|P1|STARTED|Overall Study||78
8294554|NCT01587989|20450832|P3|NOT COMPLETED|Randomized Study Treatment||1
8294555|NCT01587989|20450833|P2|NOT COMPLETED|Randomized Study Treatment||2
8294556|NCT01587989|20450834|P1|NOT COMPLETED|Randomized Study Treatment||0
8294557|NCT01587989|20450832|P3|COMPLETED|Randomized Study Treatment||32
8294558|NCT01587989|20450833|P2|COMPLETED|Randomized Study Treatment||30
8294559|NCT01587989|20450834|P1|COMPLETED|Randomized Study Treatment||0
8294560|NCT01587989|20450832|P3|STARTED|Randomized Study Treatment||33
8294561|NCT01587989|20450833|P2|STARTED|Randomized Study Treatment||32
8294562|NCT01587989|20450834|P1|STARTED|Randomized Study Treatment||0
8294563|NCT01587989|20450832|P3|NOT COMPLETED|12-Week Open-Label Run-In Period||0
8294564|NCT01587989|20450833|P2|NOT COMPLETED|12-Week Open-Label Run-In Period||0
8294565|NCT01587989|20450834|P1|NOT COMPLETED|12-Week Open-Label Run-In Period||12
8294566|NCT01587989|20450832|P3|COMPLETED|12-Week Open-Label Run-In Period||0
8294567|NCT01587989|20450833|P2|COMPLETED|12-Week Open-Label Run-In Period||0
8294568|NCT01587989|20450834|P1|COMPLETED|12-Week Open-Label Run-In Period||65
8294569|NCT01587989|20450832|P3|STARTED|12-Week Open-Label Run-In Period||0
8294570|NCT01587989|20450833|P2|STARTED|12-Week Open-Label Run-In Period||0
8294571|NCT01587989|20450834|P1|STARTED|12-Week Open-Label Run-In Period||77
8294572|NCT01587963|20450858|P2|NOT COMPLETED|Overall Study||0
8294573|NCT01587963|20450859|P1|NOT COMPLETED|Overall Study||1
8294574|NCT01587963|20450858|P2|COMPLETED|Overall Study||4
8294575|NCT01587963|20450859|P1|COMPLETED|Overall Study||6
8294576|NCT01587963|20450858|P2|STARTED|Overall Study||4
8294577|NCT01587963|20450859|P1|STARTED|Overall Study||7
8294578|NCT01587950|20450865|P1|NOT COMPLETED|Period 3||0
8294579|NCT01587950|20450865|P1|COMPLETED|Period 3||12
8294580|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
8294581|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
8294582|NCT01587950|20450865|P1|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
8294583|NCT01587950|20450865|P1|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
8294584|NCT01587950|20450865|P1|Received Sterile Water (5 Minutes)|Period 3||5
8294585|NCT01587950|20450865|P1|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
8294586|NCT01587950|20450865|P1|Received Sterile Water (2 Minutes)|Period 3||2
8294587|NCT01587950|20450865|P1|Received Sterile Water (10 Minutes)|Period 3||5
8294588|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
8294589|NCT01587950|20450865|P1|STARTED|Period 3||12
8294590|NCT01587950|20450865|P1|NOT COMPLETED|Washout 2||0
8294591|NCT01587950|20450865|P1|COMPLETED|Washout 2||12
8294592|NCT01587950|20450865|P1|STARTED|Washout 2||12
8294593|NCT01587950|20450865|P1|NOT COMPLETED|Period 2||0
8294594|NCT01587950|20450865|P1|COMPLETED|Period 2||12
8294595|NCT01587950|20450865|P1|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
8294596|NCT01587950|20450865|P1|Received Sterile Water (10 Minutes)|Period 2||2
8294597|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
8294598|NCT01587950|20450865|P1|Received Sterile Water (5 Minutes)|Period 2||2
8294599|NCT01587950|20450865|P1|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
8294600|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
8294601|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
8294602|NCT01587950|20450865|P1|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
8294603|NCT01587950|20450865|P1|Received Sterile Water (2 Minutes)|Period 2||8
8294604|NCT01587950|20450865|P1|STARTED|Period 2||12
8294605|NCT01587950|20450865|P1|NOT COMPLETED|Washout 1||0
8294606|NCT01587950|20450865|P1|COMPLETED|Washout 1||12
8294607|NCT01587950|20450865|P1|STARTED|Washout 1||12
8294608|NCT01587950|20450865|P1|NOT COMPLETED|Period 1||0
8294609|NCT01587950|20450865|P1|COMPLETED|Period 1||12
8294610|NCT01587950|20450865|P1|Received Sterile Water (5 Minutes)|Period 1||5
8294611|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
8294612|NCT01587950|20450865|P1|Received Sterile Water (10 Minutes)|Period 1||5
8294613|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
8294614|NCT01587950|20450865|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
8294615|NCT01587950|20450865|P1|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
8294616|NCT01587950|20450865|P1|Received Sterile Water (2 Minutes)|Period 1||2
8294617|NCT01587950|20450865|P1|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
8294618|NCT01587950|20450865|P1|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
8294619|NCT01587950|20450865|P1|STARTED|Period 1||12
8294620|NCT01587924|20450899|P4|NOT COMPLETED|Overall Study||1
8294621|NCT01587924|20450900|P3|NOT COMPLETED|Overall Study||4
8294622|NCT01587924|20450901|P2|NOT COMPLETED|Overall Study||4
8294623|NCT01587924|20450902|P1|NOT COMPLETED|Overall Study||4
8294624|NCT01587924|20450899|P4|COMPLETED|Overall Study||19
8294625|NCT01587924|20450900|P3|COMPLETED|Overall Study||17
8294626|NCT01587924|20450901|P2|COMPLETED|Overall Study||17
8294627|NCT01587924|20450902|P1|COMPLETED|Overall Study||17
8294628|NCT01587924|20450899|P4|STARTED|Overall Study||20
8294629|NCT01587924|20450900|P3|STARTED|Overall Study||21
8294630|NCT01587924|20450901|P2|STARTED|Overall Study||21
8294631|NCT01587924|20450902|P1|STARTED|Overall Study||21
8294632|NCT01587898|20451003|P4|NOT COMPLETED|Overall Study||2
8294633|NCT01587898|20451004|P3|NOT COMPLETED|Overall Study||2
8294634|NCT01587898|20451005|P2|NOT COMPLETED|Overall Study||5
8294635|NCT01587898|20451006|P1|NOT COMPLETED|Overall Study||4
8294636|NCT01587898|20451003|P4|COMPLETED|Overall Study||17
8294637|NCT01587898|20451004|P3|COMPLETED|Overall Study||16
8294638|NCT01587898|20451005|P2|COMPLETED|Overall Study||12
8294639|NCT01587898|20451006|P1|COMPLETED|Overall Study||14
8294640|NCT01587898|20451003|P4|STARTED|Overall Study||19
8294641|NCT01587898|20451004|P3|STARTED|Overall Study||18
8294642|NCT01587898|20451005|P2|STARTED|Overall Study||17
8294643|NCT01587898|20451006|P1|STARTED|Overall Study||18
8294644|NCT01587885|20451182|P2|NOT COMPLETED|Treatment Period 2||0
8294645|NCT01587885|20451183|P1|NOT COMPLETED|Treatment Period 2||0
8294646|NCT01587885|20451182|P2|COMPLETED|Treatment Period 2||19
8294647|NCT01587885|20451183|P1|COMPLETED|Treatment Period 2||26
8294648|NCT01587885|20451182|P2|STARTED|Treatment Period 2||19
8294649|NCT01587885|20451183|P1|STARTED|Treatment Period 2||26
8294650|NCT01587885|20451182|P2|NOT COMPLETED|Treatment Period 1||3
8294651|NCT01587885|20451183|P1|NOT COMPLETED|Treatment Period 1||0
8294652|NCT01587885|20451182|P2|COMPLETED|Treatment Period 1||19
8294653|NCT01587885|20451183|P1|COMPLETED|Treatment Period 1||26
8294654|NCT01587885|20451182|P2|STARTED|Treatment Period 1||22
8294655|NCT01587885|20451183|P1|STARTED|Treatment Period 1||26
8294656|NCT01587703|20451214|P19|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294657|NCT01587703|20451215|P18|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294658|NCT01587703|20451216|P17|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||13
8294659|NCT01587703|20451217|P16|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||21
8294660|NCT01587703|20451218|P15|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||19
8294661|NCT01587703|20451219|P14|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||22
8294662|NCT01587703|20451220|P13|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||14
8294663|NCT01587703|20451221|P12|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||12
8294664|NCT01587703|20451222|P11|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294665|NCT01587703|20451223|P10|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294666|NCT01587703|20451224|P9|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294667|NCT01587703|20451225|P8|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294668|NCT01587703|20451226|P7|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294669|NCT01587703|20451227|P6|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294670|NCT01587703|20451228|P5|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294671|NCT01587703|20451229|P4|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294672|NCT01587703|20451230|P3|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294673|NCT01587703|20451231|P2|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294674|NCT01587703|20451232|P1|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294675|NCT01587703|20451214|P19|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294676|NCT01587703|20451215|P18|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294677|NCT01587703|20451216|P17|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294678|NCT01587703|20451217|P16|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294679|NCT01587703|20451218|P15|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294680|NCT01587703|20451219|P14|COMPLETED|Part2(Median Exposure of 1.41 Months)||1
8294681|NCT01587703|20451220|P13|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294682|NCT01587703|20451221|P12|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294683|NCT01587703|20451222|P11|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294684|NCT01587703|20451223|P10|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294685|NCT01587703|20451224|P9|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294686|NCT01587703|20451225|P8|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294687|NCT01587703|20451226|P7|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294688|NCT01587703|20451227|P6|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294689|NCT01587703|20451228|P5|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294690|NCT01587703|20451229|P4|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294691|NCT01587703|20451230|P3|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294692|NCT01587703|20451231|P2|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294693|NCT01587703|20451232|P1|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
8294694|NCT01587703|20451214|P19|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294695|NCT01587703|20451215|P18|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294696|NCT01587703|20451216|P17|STARTED|Part2(Median Exposure of 1.41 Months)||13
8294697|NCT01587703|20451217|P16|STARTED|Part2(Median Exposure of 1.41 Months)||21
8294698|NCT01587703|20451218|P15|STARTED|Part2(Median Exposure of 1.41 Months)||19
8294699|NCT01587703|20451219|P14|STARTED|Part2(Median Exposure of 1.41 Months)||23
8294700|NCT01587703|20451220|P13|STARTED|Part2(Median Exposure of 1.41 Months)||14
8294701|NCT01587703|20451221|P12|STARTED|Part2(Median Exposure of 1.41 Months)||12
8294702|NCT01587703|20451222|P11|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294703|NCT01587703|20451223|P10|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294704|NCT01587703|20451224|P9|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294705|NCT01587703|20451225|P8|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294706|NCT01587703|20451226|P7|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294707|NCT01587703|20451227|P6|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294708|NCT01587703|20451228|P5|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294709|NCT01587703|20451229|P4|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294710|NCT01587703|20451230|P3|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294711|NCT01587703|20451231|P2|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294712|NCT01587703|20451232|P1|STARTED|Part2(Median Exposure of 1.41 Months)||0
8294713|NCT01587703|20451214|P19|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
8294714|NCT01587703|20451215|P18|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
8294715|NCT01587703|20451216|P17|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294716|NCT01587703|20451217|P16|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294717|NCT01587703|20451218|P15|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8295099|NCT01587027|20451854|P2|COMPLETED|Discharge (1 Day)||8
8294718|NCT01587703|20451219|P14|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294719|NCT01587703|20451220|P13|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294720|NCT01587703|20451221|P12|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294721|NCT01587703|20451222|P11|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294722|NCT01587703|20451223|P10|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294723|NCT01587703|20451224|P9|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294724|NCT01587703|20451225|P8|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294725|NCT01587703|20451226|P7|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294726|NCT01587703|20451227|P6|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294727|NCT01587703|20451228|P5|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294728|NCT01587703|20451229|P4|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294729|NCT01587703|20451230|P3|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294730|NCT01587703|20451231|P2|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294731|NCT01587703|20451232|P1|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294732|NCT01587703|20451214|P19|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294733|NCT01587703|20451215|P18|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294734|NCT01587703|20451216|P17|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294735|NCT01587703|20451217|P16|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294736|NCT01587703|20451218|P15|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294737|NCT01587703|20451219|P14|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294738|NCT01587703|20451220|P13|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294739|NCT01587703|20451221|P12|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294740|NCT01587703|20451222|P11|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294741|NCT01587703|20451223|P10|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294742|NCT01587703|20451224|P9|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294743|NCT01587703|20451225|P8|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294744|NCT01587703|20451226|P7|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294745|NCT01587703|20451227|P6|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294746|NCT01587703|20451228|P5|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294747|NCT01587703|20451229|P4|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294748|NCT01587703|20451230|P3|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294749|NCT01587703|20451231|P2|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294750|NCT01587703|20451232|P1|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
8294751|NCT01587703|20451214|P19|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
8294752|NCT01587703|20451215|P18|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
8294753|NCT01587703|20451216|P17|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294754|NCT01587703|20451217|P16|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294755|NCT01587703|20451218|P15|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294756|NCT01587703|20451219|P14|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294757|NCT01587703|20451220|P13|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294758|NCT01587703|20451221|P12|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294759|NCT01587703|20451222|P11|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294760|NCT01587703|20451223|P10|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294761|NCT01587703|20451224|P9|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294762|NCT01587703|20451225|P8|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294763|NCT01587703|20451226|P7|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294764|NCT01587703|20451227|P6|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294765|NCT01587703|20451228|P5|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294766|NCT01587703|20451229|P4|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294767|NCT01587703|20451230|P3|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294768|NCT01587703|20451231|P2|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294769|NCT01587703|20451232|P1|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
8294770|NCT01587703|20451214|P19|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294771|NCT01587703|20451215|P18|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294772|NCT01587703|20451216|P17|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294773|NCT01587703|20451217|P16|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294774|NCT01587703|20451218|P15|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294775|NCT01587703|20451219|P14|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294776|NCT01587703|20451220|P13|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294777|NCT01587703|20451221|P12|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294778|NCT01587703|20451222|P11|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294779|NCT01587703|20451223|P10|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294780|NCT01587703|20451224|P9|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294781|NCT01587703|20451225|P8|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294782|NCT01587703|20451226|P7|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294783|NCT01587703|20451227|P6|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294784|NCT01587703|20451228|P5|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294785|NCT01587703|20451229|P4|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294786|NCT01587703|20451230|P3|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294787|NCT01587703|20451231|P2|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294788|NCT01587703|20451232|P1|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294789|NCT01587703|20451214|P19|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
8294790|NCT01587703|20451215|P18|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
8294791|NCT01587703|20451216|P17|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294792|NCT01587703|20451217|P16|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294793|NCT01587703|20451218|P15|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294794|NCT01587703|20451219|P14|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294795|NCT01587703|20451220|P13|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294796|NCT01587703|20451221|P12|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294797|NCT01587703|20451222|P11|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294798|NCT01587703|20451223|P10|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294799|NCT01587703|20451224|P9|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294800|NCT01587703|20451225|P8|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294801|NCT01587703|20451226|P7|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294802|NCT01587703|20451227|P6|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294803|NCT01587703|20451228|P5|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294804|NCT01587703|20451229|P4|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294805|NCT01587703|20451230|P3|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294806|NCT01587703|20451231|P2|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294807|NCT01587703|20451232|P1|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
8294808|NCT01587703|20451214|P19|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
8294809|NCT01587703|20451215|P18|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
8294810|NCT01587703|20451216|P17|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294811|NCT01587703|20451217|P16|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294812|NCT01587703|20451218|P15|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294813|NCT01587703|20451219|P14|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294814|NCT01587703|20451220|P13|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294815|NCT01587703|20451221|P12|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294816|NCT01587703|20451222|P11|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294817|NCT01587703|20451223|P10|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294818|NCT01587703|20451224|P9|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294819|NCT01587703|20451225|P8|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294820|NCT01587703|20451226|P7|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294821|NCT01587703|20451227|P6|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294822|NCT01587703|20451228|P5|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294823|NCT01587703|20451229|P4|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294824|NCT01587703|20451230|P3|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294825|NCT01587703|20451231|P2|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294826|NCT01587703|20451232|P1|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
8294827|NCT01587703|20451214|P19|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294828|NCT01587703|20451215|P18|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294829|NCT01587703|20451216|P17|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294830|NCT01587703|20451217|P16|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294831|NCT01587703|20451218|P15|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294832|NCT01587703|20451219|P14|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294833|NCT01587703|20451220|P13|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294834|NCT01587703|20451221|P12|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294835|NCT01587703|20451222|P11|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294836|NCT01587703|20451223|P10|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294837|NCT01587703|20451224|P9|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294838|NCT01587703|20451225|P8|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294839|NCT01587703|20451226|P7|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294840|NCT01587703|20451227|P6|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294841|NCT01587703|20451228|P5|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294842|NCT01587703|20451229|P4|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294843|NCT01587703|20451230|P3|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294844|NCT01587703|20451231|P2|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294845|NCT01587703|20451232|P1|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294846|NCT01587703|20451214|P19|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
8294847|NCT01587703|20451215|P18|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
8294848|NCT01587703|20451216|P17|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294849|NCT01587703|20451217|P16|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294850|NCT01587703|20451218|P15|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294851|NCT01587703|20451219|P14|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294852|NCT01587703|20451220|P13|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294853|NCT01587703|20451221|P12|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294854|NCT01587703|20451222|P11|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294855|NCT01587703|20451223|P10|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294856|NCT01587703|20451224|P9|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294857|NCT01587703|20451225|P8|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294858|NCT01587703|20451226|P7|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294859|NCT01587703|20451227|P6|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294860|NCT01587703|20451228|P5|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294861|NCT01587703|20451229|P4|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294862|NCT01587703|20451230|P3|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294863|NCT01587703|20451231|P2|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294864|NCT01587703|20451232|P1|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
8294865|NCT01587703|20451214|P19|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
8294866|NCT01587703|20451215|P18|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
8294867|NCT01587703|20451216|P17|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294868|NCT01587703|20451217|P16|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294869|NCT01587703|20451218|P15|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294870|NCT01587703|20451219|P14|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294871|NCT01587703|20451220|P13|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294872|NCT01587703|20451221|P12|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294873|NCT01587703|20451222|P11|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294874|NCT01587703|20451223|P10|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294875|NCT01587703|20451224|P9|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294876|NCT01587703|20451225|P8|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294877|NCT01587703|20451226|P7|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294878|NCT01587703|20451227|P6|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294879|NCT01587703|20451228|P5|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294880|NCT01587703|20451229|P4|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294881|NCT01587703|20451230|P3|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294882|NCT01587703|20451231|P2|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294883|NCT01587703|20451232|P1|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
8294884|NCT01587703|20451214|P19|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294885|NCT01587703|20451215|P18|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294886|NCT01587703|20451216|P17|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294887|NCT01587703|20451217|P16|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294888|NCT01587703|20451218|P15|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294889|NCT01587703|20451219|P14|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294890|NCT01587703|20451220|P13|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294891|NCT01587703|20451221|P12|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294892|NCT01587703|20451222|P11|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294893|NCT01587703|20451223|P10|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294894|NCT01587703|20451224|P9|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294895|NCT01587703|20451225|P8|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294896|NCT01587703|20451226|P7|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294897|NCT01587703|20451227|P6|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294898|NCT01587703|20451228|P5|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294899|NCT01587703|20451229|P4|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294900|NCT01587703|20451230|P3|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294901|NCT01587703|20451231|P2|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294902|NCT01587703|20451232|P1|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294903|NCT01587703|20451214|P19|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
8294904|NCT01587703|20451215|P18|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
8294905|NCT01587703|20451216|P17|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294906|NCT01587703|20451217|P16|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294907|NCT01587703|20451218|P15|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294908|NCT01587703|20451219|P14|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294909|NCT01587703|20451220|P13|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294910|NCT01587703|20451221|P12|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294911|NCT01587703|20451222|P11|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294912|NCT01587703|20451223|P10|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294913|NCT01587703|20451224|P9|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294914|NCT01587703|20451225|P8|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294915|NCT01587703|20451226|P7|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294916|NCT01587703|20451227|P6|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294917|NCT01587703|20451228|P5|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294918|NCT01587703|20451229|P4|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294919|NCT01587703|20451230|P3|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294920|NCT01587703|20451231|P2|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294921|NCT01587703|20451232|P1|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294922|NCT01587703|20451214|P19|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
8294923|NCT01587703|20451215|P18|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
8294924|NCT01587703|20451216|P17|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294925|NCT01587703|20451217|P16|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294926|NCT01587703|20451218|P15|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294927|NCT01587703|20451219|P14|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294928|NCT01587703|20451220|P13|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294929|NCT01587703|20451221|P12|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294930|NCT01587703|20451222|P11|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294931|NCT01587703|20451223|P10|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294932|NCT01587703|20451224|P9|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294933|NCT01587703|20451225|P8|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294934|NCT01587703|20451226|P7|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294935|NCT01587703|20451227|P6|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294936|NCT01587703|20451228|P5|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294937|NCT01587703|20451229|P4|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294938|NCT01587703|20451230|P3|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294939|NCT01587703|20451231|P2|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294940|NCT01587703|20451232|P1|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
8294941|NCT01587703|20451214|P19|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294942|NCT01587703|20451215|P18|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294943|NCT01587703|20451216|P17|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294944|NCT01587703|20451217|P16|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294945|NCT01587703|20451218|P15|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294946|NCT01587703|20451219|P14|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294947|NCT01587703|20451220|P13|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294948|NCT01587703|20451221|P12|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294949|NCT01587703|20451222|P11|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||5
8294950|NCT01587703|20451223|P10|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||10
8294951|NCT01587703|20451224|P9|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||3
8294952|NCT01587703|20451225|P8|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294953|NCT01587703|20451226|P7|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294954|NCT01587703|20451227|P6|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294955|NCT01587703|20451228|P5|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294956|NCT01587703|20451229|P4|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294957|NCT01587703|20451230|P3|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294958|NCT01587703|20451231|P2|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294959|NCT01587703|20451232|P1|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294960|NCT01587703|20451214|P19|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294961|NCT01587703|20451215|P18|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294962|NCT01587703|20451216|P17|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294963|NCT01587703|20451217|P16|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294964|NCT01587703|20451218|P15|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294965|NCT01587703|20451219|P14|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294966|NCT01587703|20451220|P13|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294967|NCT01587703|20451221|P12|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294968|NCT01587703|20451222|P11|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294969|NCT01587703|20451223|P10|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294970|NCT01587703|20451224|P9|COMPLETED|Part1 BID(Median Exposure of 1.41months)||1
8294971|NCT01587703|20451225|P8|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294972|NCT01587703|20451226|P7|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294973|NCT01587703|20451227|P6|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294974|NCT01587703|20451228|P5|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294975|NCT01587703|20451229|P4|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294976|NCT01587703|20451230|P3|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294977|NCT01587703|20451231|P2|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294978|NCT01587703|20451232|P1|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
8294979|NCT01587703|20451214|P19|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294980|NCT01587703|20451215|P18|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294981|NCT01587703|20451216|P17|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294982|NCT01587703|20451217|P16|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294983|NCT01587703|20451218|P15|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294984|NCT01587703|20451219|P14|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294985|NCT01587703|20451220|P13|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294986|NCT01587703|20451221|P12|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294987|NCT01587703|20451222|P11|STARTED|Part1 BID(Median Exposure of 1.41months)||5
8294988|NCT01587703|20451223|P10|STARTED|Part1 BID(Median Exposure of 1.41months)||10
8294989|NCT01587703|20451224|P9|STARTED|Part1 BID(Median Exposure of 1.41months)||4
8294990|NCT01587703|20451225|P8|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294991|NCT01587703|20451226|P7|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294992|NCT01587703|20451227|P6|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294993|NCT01587703|20451228|P5|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294994|NCT01587703|20451229|P4|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294995|NCT01587703|20451230|P3|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294996|NCT01587703|20451231|P2|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294997|NCT01587703|20451232|P1|STARTED|Part1 BID(Median Exposure of 1.41months)||0
8294998|NCT01587703|20451214|P19|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8294999|NCT01587703|20451215|P18|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295000|NCT01587703|20451216|P17|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295001|NCT01587703|20451217|P16|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295002|NCT01587703|20451218|P15|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295003|NCT01587703|20451219|P14|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295004|NCT01587703|20451220|P13|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295005|NCT01587703|20451221|P12|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295006|NCT01587703|20451222|P11|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295007|NCT01587703|20451223|P10|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295008|NCT01587703|20451224|P9|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295009|NCT01587703|20451225|P8|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||9
8295010|NCT01587703|20451226|P7|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||32
8295011|NCT01587703|20451227|P6|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||8
8295012|NCT01587703|20451228|P5|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
8295013|NCT01587703|20451229|P4|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
8295014|NCT01587703|20451230|P3|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
8295015|NCT01587703|20451231|P2|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
8295016|NCT01587703|20451232|P1|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
8295017|NCT01587703|20451214|P19|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295018|NCT01587703|20451215|P18|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295019|NCT01587703|20451216|P17|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295020|NCT01587703|20451217|P16|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295021|NCT01587703|20451218|P15|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295022|NCT01587703|20451219|P14|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295023|NCT01587703|20451220|P13|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295024|NCT01587703|20451221|P12|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295025|NCT01587703|20451222|P11|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295026|NCT01587703|20451223|P10|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295027|NCT01587703|20451224|P9|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295028|NCT01587703|20451225|P8|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295029|NCT01587703|20451226|P7|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295030|NCT01587703|20451227|P6|COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
8295031|NCT01587703|20451228|P5|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295032|NCT01587703|20451229|P4|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295033|NCT01587703|20451230|P3|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295034|NCT01587703|20451231|P2|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295035|NCT01587703|20451232|P1|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
8295036|NCT01587703|20451214|P19|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295037|NCT01587703|20451215|P18|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295038|NCT01587703|20451216|P17|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295039|NCT01587703|20451217|P16|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295040|NCT01587703|20451218|P15|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295041|NCT01587703|20451219|P14|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295042|NCT01587703|20451220|P13|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295043|NCT01587703|20451221|P12|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295044|NCT01587703|20451222|P11|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295045|NCT01587703|20451223|P10|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295046|NCT01587703|20451224|P9|STARTED|Part1 QD(Median Exposure of 1.38months)||0
8295047|NCT01587703|20451225|P8|STARTED|Part1 QD(Median Exposure of 1.38months)||9
8295048|NCT01587703|20451226|P7|STARTED|Part1 QD(Median Exposure of 1.38months)||32
8295049|NCT01587703|20451227|P6|STARTED|Part1 QD(Median Exposure of 1.38months)||9
8295050|NCT01587703|20451228|P5|STARTED|Part1 QD(Median Exposure of 1.38months)||4
8295051|NCT01587703|20451229|P4|STARTED|Part1 QD(Median Exposure of 1.38months)||3
8295052|NCT01587703|20451230|P3|STARTED|Part1 QD(Median Exposure of 1.38months)||1
8295053|NCT01587703|20451231|P2|STARTED|Part1 QD(Median Exposure of 1.38months)||4
8295054|NCT01587703|20451232|P1|STARTED|Part1 QD(Median Exposure of 1.38months)||3
8295055|NCT01587651|20451639|P3|NOT COMPLETED|Overall Study||1
8295056|NCT01587651|20451640|P2|NOT COMPLETED|Overall Study||3
8295057|NCT01587651|20451641|P1|NOT COMPLETED|Overall Study||0
8295058|NCT01587651|20451639|P3|COMPLETED|Overall Study||34
8295059|NCT01587651|20451640|P2|COMPLETED|Overall Study||38
8295060|NCT01587651|20451641|P1|COMPLETED|Overall Study||34
8295061|NCT01587651|20451639|P3|STARTED|Overall Study||35
8295062|NCT01587651|20451640|P2|STARTED|Overall Study||41
8295063|NCT01587651|20451641|P1|STARTED|Overall Study||34
8295064|NCT01587274|20451671|P3|NOT COMPLETED|Overall Study||3
8295065|NCT01587274|20451672|P2|NOT COMPLETED|Overall Study||5
8295066|NCT01587274|20451673|P1|NOT COMPLETED|Overall Study||4
8295067|NCT01587274|20451671|P3|COMPLETED|Overall Study||104
8295068|NCT01587274|20451672|P2|COMPLETED|Overall Study||103
8295069|NCT01587274|20451673|P1|COMPLETED|Overall Study||104
8295070|NCT01587274|20451671|P3|STARTED|Overall Study||107
8295071|NCT01587274|20451672|P2|STARTED|Overall Study||108
8295072|NCT01587274|20451673|P1|STARTED|Overall Study||108
8295073|NCT01587118|20451681|P1|NOT COMPLETED|Overall Study||7
8295074|NCT01587118|20451681|P1|COMPLETED|Overall Study||11
8295075|NCT01587118|20451681|P1|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
8295076|NCT01587105|20451688|P2|NOT COMPLETED|Overall Study||43
8295077|NCT01587105|20451689|P1|NOT COMPLETED|Overall Study||6
8295078|NCT01587105|20451688|P2|COMPLETED|Overall Study||138
8295079|NCT01587105|20451689|P1|COMPLETED|Overall Study||144
8295080|NCT01587105|20451688|P2|STARTED|Overall Study||181
8295081|NCT01587105|20451689|P1|STARTED|Overall Study||150
8295082|NCT01587079|20451705|P1|NOT COMPLETED|Overall Study||39
8295083|NCT01587079|20451705|P1|COMPLETED|Overall Study||120
8295084|NCT01587079|20451705|P1|STARTED|Overall Study||159
8295085|NCT01587040|20451831|P4|NOT COMPLETED|Overall Study||4
8295086|NCT01587040|20451832|P3|NOT COMPLETED|Overall Study||37
8295087|NCT01587040|20451833|P2|NOT COMPLETED|Overall Study||3
8295088|NCT01587040|20451834|P1|NOT COMPLETED|Overall Study||17
8295089|NCT01587040|20451831|P4|COMPLETED|Overall Study||0
8295090|NCT01587040|20451832|P3|COMPLETED|Overall Study||0
8295091|NCT01587040|20451833|P2|COMPLETED|Overall Study||0
8295092|NCT01587040|20451834|P1|COMPLETED|Overall Study||0
8295093|NCT01587040|20451831|P4|STARTED|Overall Study||4
8295094|NCT01587040|20451832|P3|STARTED|Overall Study||37
8295095|NCT01587040|20451833|P2|STARTED|Overall Study||3
8295096|NCT01587040|20451834|P1|STARTED|Overall Study||17
8295097|NCT01587027|20451854|P2|NOT COMPLETED|Discharge (1 Day)||0
8295098|NCT01587027|20451855|P1|NOT COMPLETED|Discharge (1 Day)||0
8295100|NCT01587027|20451855|P1|COMPLETED|Discharge (1 Day)||8
8295101|NCT01587027|20451854|P2|STARTED|Discharge (1 Day)||8
8295102|NCT01587027|20451855|P1|STARTED|Discharge (1 Day)||8
8295103|NCT01587027|20451854|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8295104|NCT01587027|20451855|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8295105|NCT01587027|20451854|P2|COMPLETED|Third Intervention (1 Day)||8
8295106|NCT01587027|20451855|P1|COMPLETED|Third Intervention (1 Day)||8
8295107|NCT01587027|20451854|P2|STARTED|Third Intervention (1 Day)||8
8295108|NCT01587027|20451855|P1|STARTED|Third Intervention (1 Day)||8
8295109|NCT01587027|20451854|P2|NOT COMPLETED|Washout (1 Day)||0
8295110|NCT01587027|20451855|P1|NOT COMPLETED|Washout (1 Day)||0
8295111|NCT01587027|20451854|P2|COMPLETED|Washout (1 Day)||8
8295112|NCT01587027|20451855|P1|COMPLETED|Washout (1 Day)||8
8295113|NCT01587027|20451854|P2|STARTED|Washout (1 Day)||8
8295114|NCT01587027|20451855|P1|STARTED|Washout (1 Day)||8
8295115|NCT01587027|20451854|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8295116|NCT01587027|20451855|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8295117|NCT01587027|20451854|P2|COMPLETED|Second Intervention (1 Day)||8
8295118|NCT01587027|20451855|P1|COMPLETED|Second Intervention (1 Day)||8
8295119|NCT01587027|20451854|P2|STARTED|Second Intervention (1 Day)||8
8295120|NCT01587027|20451855|P1|STARTED|Second Intervention (1 Day)||8
8295121|NCT01587027|20451854|P2|NOT COMPLETED|Washout (1 Day)||0
8295122|NCT01587027|20451855|P1|NOT COMPLETED|Washout (1 Day)||0
8295123|NCT01587027|20451854|P2|COMPLETED|Washout (1 Day)||8
8295124|NCT01587027|20451855|P1|COMPLETED|Washout (1 Day)||8
8295125|NCT01587027|20451854|P2|STARTED|Washout (1 Day)||8
8295126|NCT01587027|20451855|P1|STARTED|Washout (1 Day)||8
8295127|NCT01587027|20451854|P2|NOT COMPLETED|First Intervention (1 Day)||0
8295128|NCT01587027|20451855|P1|NOT COMPLETED|First Intervention (1 Day)||0
8295129|NCT01587027|20451854|P2|COMPLETED|First Intervention (1 Day)||8
8295130|NCT01587027|20451855|P1|COMPLETED|First Intervention (1 Day)||8
8295131|NCT01587027|20451854|P2|STARTED|First Intervention (1 Day)||8
8295132|NCT01587027|20451855|P1|STARTED|First Intervention (1 Day)||8
8295133|NCT01587014|20451861|P1|NOT COMPLETED|Overall Study||2
8295134|NCT01587014|20451861|P1|COMPLETED|Overall Study||24
8295135|NCT01587014|20451861|P1|STARTED|Overall Study||26
8295136|NCT01587001|20451868|P2|NOT COMPLETED|Overall Study||1
8295137|NCT01587001|20451869|P1|NOT COMPLETED|Overall Study||6
8295138|NCT01587001|20451868|P2|COMPLETED|Overall Study||2
8295139|NCT01587001|20451869|P1|COMPLETED|Overall Study||8
8295140|NCT01587001|20451868|P2|STARTED|Overall Study||3
8295141|NCT01587001|20451869|P1|STARTED|Overall Study||14
8295142|NCT01586975|20451880|P3|NOT COMPLETED|Overall Study||0
8295143|NCT01586975|20451881|P2|NOT COMPLETED|Overall Study||0
8295144|NCT01586975|20451882|P1|NOT COMPLETED|Overall Study||0
8295145|NCT01586975|20451880|P3|COMPLETED|Overall Study||46
8295146|NCT01586975|20451881|P2|COMPLETED|Overall Study||32
8295147|NCT01586975|20451882|P1|COMPLETED|Overall Study||15
8295148|NCT01586975|20451880|P3|STARTED|Overall Study||46
8295149|NCT01586975|20451881|P2|STARTED|Overall Study||32
8295150|NCT01586975|20451882|P1|STARTED|Overall Study||15
8295151|NCT01586962|20451890|P1|NOT COMPLETED|Overall Study||0
8295152|NCT01586962|20451890|P1|COMPLETED|Overall Study||56
8295153|NCT01586962|20451890|P1|STARTED|Overall Study||56
8295160|NCT01586897|20451954|P2|NOT COMPLETED|Overall Study||0
8295161|NCT01586897|20451955|P1|NOT COMPLETED|Overall Study||0
8295162|NCT01586897|20451954|P2|COMPLETED|Overall Study||26
8295163|NCT01586897|20451955|P1|COMPLETED|Overall Study||26
8295164|NCT01586897|20451954|P2|STARTED|Overall Study||26
8295165|NCT01586897|20451955|P1|STARTED|Overall Study||26
8295166|NCT01586819|20451973|P2|NOT COMPLETED|Overall Study||0
8295167|NCT01586819|20451974|P1|NOT COMPLETED|Overall Study||1
8295168|NCT01586819|20451973|P2|COMPLETED|Overall Study||14
8295169|NCT01586819|20451974|P1|COMPLETED|Overall Study||11
8295170|NCT01586819|20451973|P2|STARTED|Overall Study||14
8295171|NCT01586819|20451974|P1|STARTED|Overall Study||12
8295172|NCT01586806|20451985|P3|NOT COMPLETED|Overall Study||2
8295173|NCT01586806|20451986|P2|NOT COMPLETED|Overall Study||4
8295174|NCT01586806|20451987|P1|NOT COMPLETED|Overall Study||3
8295175|NCT01586806|20451985|P3|COMPLETED|Overall Study||63
8295176|NCT01586806|20451986|P2|COMPLETED|Overall Study||61
8295177|NCT01586806|20451987|P1|COMPLETED|Overall Study||62
8295178|NCT01586806|20451985|P3|STARTED|Overall Study||65
8295179|NCT01586806|20451986|P2|STARTED|Overall Study||65
8295180|NCT01586806|20451987|P1|STARTED|Overall Study||65
8295181|NCT01586741|20452010|P3|NOT COMPLETED|Overall Study||2
8295182|NCT01586741|20452011|P2|NOT COMPLETED|Overall Study||0
8295183|NCT01586741|20452012|P1|NOT COMPLETED|Overall Study||1
8295184|NCT01586741|20452010|P3|COMPLETED|Overall Study||30
8295185|NCT01586741|20452011|P2|COMPLETED|Overall Study||29
8295186|NCT01586741|20452012|P1|COMPLETED|Overall Study||27
8295187|NCT01586741|20452010|P3|STARTED|Overall Study||32
8295188|NCT01586741|20452011|P2|STARTED|Overall Study||29
8295189|NCT01586741|20452012|P1|STARTED|Overall Study||28
8295190|NCT01586364|20452020|P1|NOT COMPLETED|Overall Study||117
8295191|NCT01586364|20452020|P1|COMPLETED|Overall Study||184
8295192|NCT01586364|20452020|P1|STARTED|Overall Study||301
8295193|NCT01586338|20452073|P1|NOT COMPLETED|Overall Study||8
8295194|NCT01586338|20452073|P1|COMPLETED|Overall Study||229
8295195|NCT01586338|20452073|P1|STARTED|Overall Study||237
8295196|NCT01586312|20452085|P2|NOT COMPLETED|Overall Study||0
8295197|NCT01586312|20452086|P1|NOT COMPLETED|Overall Study||0
8295198|NCT01586312|20452085|P2|COMPLETED|Overall Study||15
8295199|NCT01586312|20452086|P1|COMPLETED|Overall Study||15
8295200|NCT01586312|20452085|P2|STARTED|Overall Study||15
8295201|NCT01586312|20452086|P1|STARTED|Overall Study||15
8295202|NCT01586195|20452096|P1|NOT COMPLETED|Overall Study||26
8295203|NCT01586195|20452096|P1|COMPLETED|Overall Study||5
8295204|NCT01586195|20452096|P1|STARTED|Overall Study||31
8295205|NCT01586156|20452110|P3|NOT COMPLETED|Overall Study||0
8295206|NCT01586156|20452111|P2|NOT COMPLETED|Overall Study||1
8295207|NCT01586156|20452112|P1|NOT COMPLETED|Overall Study||0
8295208|NCT01586156|20452110|P3|COMPLETED|Overall Study||10
8295209|NCT01586156|20452111|P2|COMPLETED|Overall Study||9
8295210|NCT01586156|20452112|P1|COMPLETED|Overall Study||10
8295211|NCT01586156|20452110|P3|STARTED|Overall Study||10
8295212|NCT01586156|20452111|P2|STARTED|Overall Study||10
8295213|NCT01586156|20452112|P1|STARTED|Overall Study||10
8295214|NCT01586091|20452141|P3|NOT COMPLETED|Overall Study||0
8295215|NCT01586091|20452142|P2|NOT COMPLETED|Overall Study||0
8295216|NCT01586091|20452143|P1|NOT COMPLETED|Overall Study||0
8295217|NCT01586091|20452141|P3|COMPLETED|Overall Study||6
8295218|NCT01586091|20452142|P2|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
8295219|NCT01586091|20452143|P1|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
8295220|NCT01586091|20452141|P3|STARTED|Overall Study||6
8295221|NCT01586091|20452142|P2|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
8295222|NCT01586091|20452143|P1|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
8295223|NCT01586026|20452157|P3|NOT COMPLETED|Overall Study||0
8295224|NCT01586026|20452158|P2|NOT COMPLETED|Overall Study||0
8295225|NCT01586026|20452159|P1|NOT COMPLETED|Overall Study||0
8295226|NCT01586026|20452157|P3|COMPLETED|Overall Study||271
8295227|NCT01586026|20452158|P2|COMPLETED|Overall Study||414
8295228|NCT01586026|20452159|P1|COMPLETED|Overall Study||350
8295229|NCT01586026|20452157|P3|STARTED|Overall Study||271
8295230|NCT01586026|20452158|P2|STARTED|Overall Study||414
8295231|NCT01586026|20452159|P1|STARTED|Overall Study||350
8295232|NCT01585987|20452169|P2|NOT COMPLETED|Treated||49
8295233|NCT01585987|20452170|P1|NOT COMPLETED|Treated||54
8295234|NCT01585987|20452169|P2|COMPLETED|Treated||2
8295235|NCT01585987|20452170|P1|COMPLETED|Treated||3
8295236|NCT01585987|20452169|P2|STARTED|Treated||51
8295237|NCT01585987|20452170|P1|STARTED|Treated||57
8295238|NCT01585987|20452169|P2|NOT COMPLETED|Randomized||6
8295239|NCT01585987|20452170|P1|NOT COMPLETED|Randomized||0
8295240|NCT01585987|20452169|P2|COMPLETED|Randomized||51
8295241|NCT01585987|20452170|P1|COMPLETED|Randomized||57
8295242|NCT01585987|20452169|P2|STARTED|Randomized||57
8295243|NCT01585987|20452170|P1|STARTED|Randomized||57
8295244|NCT01585961|20452185|P1|NOT COMPLETED|Overall Study||33
8295245|NCT01585961|20452185|P1|COMPLETED|Overall Study||478
8295246|NCT01585961|20452185|P1|Safety|Overall Study|Patients ablated with study catheter|508
8295247|NCT01585961|20452185|P1|STARTED|Overall Study||511
8295248|NCT01585779|20452202|P2|NOT COMPLETED|Overall Study||7
8295249|NCT01585779|20452203|P1|NOT COMPLETED|Overall Study||10
8295250|NCT01585779|20452202|P2|COMPLETED|Overall Study||21
8295251|NCT01585779|20452203|P1|COMPLETED|Overall Study||26
8295252|NCT01585779|20452202|P2|STARTED|Overall Study||28
8295253|NCT01585779|20452203|P1|STARTED|Overall Study||36
8295254|NCT01585766|20452263|P6|NOT COMPLETED|Overall Study||0
8295255|NCT01585766|20452264|P5|NOT COMPLETED|Overall Study||0
8295256|NCT01585766|20452265|P4|NOT COMPLETED|Overall Study||0
8295257|NCT01585766|20452266|P3|NOT COMPLETED|Overall Study||2
8295258|NCT01585766|20452267|P2|NOT COMPLETED|Overall Study||2
8295259|NCT01585766|20452268|P1|NOT COMPLETED|Overall Study||0
8295260|NCT01585766|20452263|P6|COMPLETED|Overall Study||6
8295261|NCT01585766|20452264|P5|COMPLETED|Overall Study||3
8295262|NCT01585766|20452265|P4|COMPLETED|Overall Study||4
8295263|NCT01585766|20452266|P3|COMPLETED|Overall Study||1
8295264|NCT01585766|20452267|P2|COMPLETED|Overall Study||3
8295265|NCT01585766|20452268|P1|COMPLETED|Overall Study||7
8295266|NCT01585766|20452263|P6|STARTED|Overall Study||6
8295267|NCT01585766|20452264|P5|STARTED|Overall Study||3
8295268|NCT01585766|20452265|P4|STARTED|Overall Study||4
8295269|NCT01585766|20452266|P3|STARTED|Overall Study||3
8295270|NCT01585766|20452267|P2|STARTED|Overall Study||5
8295271|NCT01585766|20452268|P1|STARTED|Overall Study||7
8295272|NCT01585597|20452367|P1|NOT COMPLETED|Overall Study||0
8295273|NCT01585597|20452367|P1|COMPLETED|Overall Study||20
8295274|NCT01585597|20452367|P1|STARTED|Overall Study||20
8295275|NCT01585584|20452372|P1|NOT COMPLETED|Overall Study||4
8295276|NCT01585584|20452372|P1|COMPLETED|Overall Study||6
8295277|NCT01585584|20452372|P1|STARTED|Overall Study||10
8295278|NCT01585558|20452379|P3|NOT COMPLETED|Overall Study||15
8295279|NCT01585558|20452380|P2|NOT COMPLETED|Overall Study||12
8295280|NCT01585558|20452381|P1|NOT COMPLETED|Overall Study||13
8295281|NCT01585558|20452379|P3|COMPLETED|Overall Study||34
8295282|NCT01585558|20452380|P2|COMPLETED|Overall Study||57
8295283|NCT01585558|20452381|P1|COMPLETED|Overall Study||49
8295284|NCT01585558|20452379|P3|STARTED|Overall Study||49
8295285|NCT01585558|20452380|P2|STARTED|Overall Study||69
8295286|NCT01585558|20452381|P1|STARTED|Overall Study||62
8295287|NCT01585441|20452562|P2|NOT COMPLETED|Overall Study||0
8295288|NCT01585441|20452563|P1|NOT COMPLETED|Overall Study||0
8295289|NCT01585441|20452562|P2|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
8295290|NCT01585441|20452563|P1|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
8295291|NCT01585441|20452562|P2|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
8295292|NCT01585441|20452563|P1|Final Study Safety Visit|Overall Study||3
8295293|NCT01585441|20452562|P2|Received Finasteride at Month 3|Overall Study||2
8295294|NCT01585441|20452563|P1|Received Finasteride at Month 3|Overall Study||2
8295295|NCT01585441|20452562|P2|Month 3|Overall Study||3
8295296|NCT01585441|20452563|P1|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
8295297|NCT01585441|20452562|P2|STARTED|Overall Study||3
8295298|NCT01585441|20452563|P1|STARTED|Overall Study||3
8295299|NCT01585428|20452615|P2|NOT COMPLETED|Overall Study||0
8295300|NCT01585428|20452616|P1|NOT COMPLETED|Overall Study||1
8295301|NCT01585428|20452615|P2|COMPLETED|Overall Study||11
8295302|NCT01585428|20452616|P1|COMPLETED|Overall Study||17
8295303|NCT01585428|20452615|P2|STARTED|Overall Study||11
8295304|NCT01585428|20452616|P1|STARTED|Overall Study||18
8295305|NCT01585324|20452624|P1|NOT COMPLETED|Overall Study||0
8295306|NCT01585324|20452624|P1|COMPLETED|Overall Study||30
8295307|NCT01585324|20452624|P1|STARTED|Overall Study||30
8295308|NCT01585298|20452640|P1|NOT COMPLETED|Overall Study||37
8295309|NCT01585298|20452640|P1|COMPLETED|Overall Study||6961
8295310|NCT01585298|20452640|P1|STARTED|Overall Study||6998
8295311|NCT01585272|20452648|P1|NOT COMPLETED|Overall Study||39
8295312|NCT01585272|20452648|P1|COMPLETED|Overall Study||82
8295313|NCT01585272|20452648|P1|Exelon Patch 10 cm2|Overall Study||96
8295314|NCT01585272|20452648|P1|Exelon Patch 5 cm2|Overall Study||114
8295315|NCT01585272|20452648|P1|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
8295316|NCT01585272|20452648|P1|STARTED|Overall Study||121
8295317|NCT01585246|20452661|P5|NOT COMPLETED|Overall Study||2
8295318|NCT01585246|20452662|P4|NOT COMPLETED|Overall Study||4
8295319|NCT01585246|20452663|P3|NOT COMPLETED|Overall Study||4
8295320|NCT01585246|20452664|P2|NOT COMPLETED|Overall Study||1
8295321|NCT01585246|20452665|P1|NOT COMPLETED|Overall Study||0
8295322|NCT01585246|20452661|P5|COMPLETED|Overall Study||9
8295323|NCT01585246|20452662|P4|COMPLETED|Overall Study||6
8295324|NCT01585246|20452663|P3|COMPLETED|Overall Study||16
8295325|NCT01585246|20452664|P2|COMPLETED|Overall Study||3
8295326|NCT01585246|20452665|P1|COMPLETED|Overall Study||3
8295327|NCT01585246|20452661|P5|STARTED|Overall Study||11
8295328|NCT01585246|20452662|P4|STARTED|Overall Study||10
8295329|NCT01585246|20452663|P3|STARTED|Overall Study||20
8295330|NCT01585246|20452664|P2|STARTED|Overall Study||4
8295331|NCT01585246|20452665|P1|STARTED|Overall Study||3
8295332|NCT01585207|20452680|P1|NOT COMPLETED|Overall Study||0
8295333|NCT01585207|20452680|P1|COMPLETED|Overall Study||4
8295334|NCT01585207|20452680|P1|STARTED|Overall Study||4
8295335|NCT01585194|20452684|P1|NOT COMPLETED|Overall Study||4
8295336|NCT01585194|20452684|P1|COMPLETED|Overall Study||35
8295337|NCT01585194|20452684|P1|STARTED|Overall Study||39
8295350|NCT01585155|20452716|P1|NOT COMPLETED|Overall Study||5
8295351|NCT01585155|20452716|P1|COMPLETED|Overall Study||16
8295352|NCT01585155|20452716|P1|STARTED|Overall Study||21
8295353|NCT01585129|20452725|P2|NOT COMPLETED|Overall Study||0
8295354|NCT01585129|20452726|P1|NOT COMPLETED|Overall Study||0
8295355|NCT01585129|20452725|P2|COMPLETED|Overall Study||39
8295356|NCT01585129|20452726|P1|COMPLETED|Overall Study||41
8295357|NCT01585129|20452725|P2|STARTED|Overall Study||39
8295358|NCT01585129|20452726|P1|STARTED|Overall Study||41
8295359|NCT01585038|20452738|P2|NOT COMPLETED|Overall Study||2
8295360|NCT01585038|20452739|P1|NOT COMPLETED|Overall Study||2
8295361|NCT01585038|20452738|P2|COMPLETED|Overall Study||18
8295362|NCT01585038|20452739|P1|COMPLETED|Overall Study||18
8295363|NCT01585038|20452738|P2|STARTED|Overall Study||20
8295364|NCT01585038|20452739|P1|STARTED|Overall Study||20
8295365|NCT01585025|20452754|P3|NOT COMPLETED|Overall Study||4
8295366|NCT01585025|20452755|P2|NOT COMPLETED|Overall Study||3
8295367|NCT01585025|20452756|P1|NOT COMPLETED|Overall Study||0
8295368|NCT01585025|20452754|P3|COMPLETED|Overall Study||8
8295369|NCT01585025|20452755|P2|COMPLETED|Overall Study||10
8295370|NCT01585025|20452756|P1|COMPLETED|Overall Study||10
8295371|NCT01585025|20452754|P3|STARTED|Overall Study||12
8295372|NCT01585025|20452755|P2|STARTED|Overall Study||13
8295373|NCT01585025|20452756|P1|STARTED|Overall Study||10
8295374|NCT01584843|20452786|P6|NOT COMPLETED|Second Treatment Period||1
8295375|NCT01584843|20452787|P5|NOT COMPLETED|Second Treatment Period||0
8295376|NCT01584843|20452788|P4|NOT COMPLETED|Second Treatment Period||0
8295377|NCT01584843|20452789|P3|NOT COMPLETED|Second Treatment Period||0
8295378|NCT01584843|20452790|P2|NOT COMPLETED|Second Treatment Period||0
8295379|NCT01584843|20452791|P1|NOT COMPLETED|Second Treatment Period||0
8295380|NCT01584843|20452786|P6|COMPLETED|Second Treatment Period||0
8295381|NCT01584843|20452787|P5|COMPLETED|Second Treatment Period||3
8295382|NCT01584843|20452788|P4|COMPLETED|Second Treatment Period||6
8295383|NCT01584843|20452789|P3|COMPLETED|Second Treatment Period||2
8295384|NCT01584843|20452790|P2|COMPLETED|Second Treatment Period||1
8295385|NCT01584843|20452791|P1|COMPLETED|Second Treatment Period||2
8295386|NCT01584843|20452786|P6|STARTED|Second Treatment Period||1
8295387|NCT01584843|20452787|P5|STARTED|Second Treatment Period||3
8295388|NCT01584843|20452788|P4|STARTED|Second Treatment Period||6
8295389|NCT01584843|20452789|P3|STARTED|Second Treatment Period||2
8295390|NCT01584843|20452790|P2|STARTED|Second Treatment Period||1
8295391|NCT01584843|20452791|P1|STARTED|Second Treatment Period||2
8295392|NCT01584843|20452786|P6|NOT COMPLETED|First Treatment Period||2
8295393|NCT01584843|20452787|P5|NOT COMPLETED|First Treatment Period||0
8295394|NCT01584843|20452788|P4|NOT COMPLETED|First Treatment Period||0
8295395|NCT01584843|20452789|P3|NOT COMPLETED|First Treatment Period||1
8295396|NCT01584843|20452790|P2|NOT COMPLETED|First Treatment Period||0
8295397|NCT01584843|20452791|P1|NOT COMPLETED|First Treatment Period||0
8295398|NCT01584843|20452786|P6|COMPLETED|First Treatment Period||9
8295399|NCT01584843|20452787|P5|COMPLETED|First Treatment Period||10
8295400|NCT01584843|20452788|P4|COMPLETED|First Treatment Period||10
8295401|NCT01584843|20452789|P3|COMPLETED|First Treatment Period||2
8295402|NCT01584843|20452790|P2|COMPLETED|First Treatment Period||4
8295403|NCT01584843|20452791|P1|COMPLETED|First Treatment Period||3
8295404|NCT01584843|20452786|P6|STARTED|First Treatment Period||11
8295405|NCT01584843|20452787|P5|STARTED|First Treatment Period||10
8295406|NCT01584843|20452788|P4|STARTED|First Treatment Period||10
8295407|NCT01584843|20452789|P3|STARTED|First Treatment Period||3
8295408|NCT01584843|20452790|P2|STARTED|First Treatment Period||4
8295409|NCT01584843|20452791|P1|STARTED|First Treatment Period||3
8295418|NCT01584609|20452943|P2|NOT COMPLETED|Overall Study||4
8295419|NCT01584609|20452944|P1|NOT COMPLETED|Overall Study||12
8295420|NCT01584609|20452943|P2|COMPLETED|Overall Study||96
8295421|NCT01584609|20452944|P1|COMPLETED|Overall Study||86
8295422|NCT01584609|20452943|P2|STARTED|Overall Study||100
8295423|NCT01584609|20452944|P1|STARTED|Overall Study||98
8295424|NCT01584544|20452969|P5|NOT COMPLETED|Overall Study||0
8295425|NCT01584544|20452970|P4|NOT COMPLETED|Overall Study||0
8295426|NCT01584544|20452971|P3|NOT COMPLETED|Overall Study||0
8295427|NCT01584544|20452972|P2|NOT COMPLETED|Overall Study||0
8295428|NCT01584544|20452973|P1|NOT COMPLETED|Overall Study||0
8295429|NCT01584544|20452969|P5|COMPLETED|Overall Study||6
8295430|NCT01584544|20452970|P4|COMPLETED|Overall Study||3
8295431|NCT01584544|20452971|P3|COMPLETED|Overall Study||6
8295432|NCT01584544|20452972|P2|COMPLETED|Overall Study||6
8295433|NCT01584544|20452973|P1|COMPLETED|Overall Study||3
8295434|NCT01584544|20452969|P5|STARTED|Overall Study||6
8295435|NCT01584544|20452970|P4|STARTED|Overall Study||3
8295436|NCT01584544|20452971|P3|STARTED|Overall Study||6
8295437|NCT01584544|20452972|P2|STARTED|Overall Study||6
8295438|NCT01584544|20452973|P1|STARTED|Overall Study||3
8295439|NCT01584518|20452987|P2|NOT COMPLETED|Overall Study||0
8295440|NCT01584518|20452988|P1|NOT COMPLETED|Overall Study||0
8295441|NCT01584518|20452987|P2|COMPLETED|Overall Study||25
8295442|NCT01584518|20452988|P1|COMPLETED|Overall Study||25
8295443|NCT01584518|20452987|P2|STARTED|Overall Study||25
8295444|NCT01584518|20452988|P1|STARTED|Overall Study||25
8295445|NCT01584479|20452998|P4|NOT COMPLETED|Overall Study||0
8295446|NCT01584479|20452999|P3|NOT COMPLETED|Overall Study||0
8295447|NCT01584479|20453000|P2|NOT COMPLETED|Overall Study||0
8295448|NCT01584479|20453001|P1|NOT COMPLETED|Overall Study||0
8295449|NCT01584479|20452998|P4|COMPLETED|Overall Study||1847
8295450|NCT01584479|20452999|P3|COMPLETED|Overall Study||852
8295451|NCT01584479|20453000|P2|COMPLETED|Overall Study||1686
8295452|NCT01584479|20453001|P1|COMPLETED|Overall Study||732
8295453|NCT01584479|20452998|P4|STARTED|Overall Study||1847
8295454|NCT01584479|20452999|P3|STARTED|Overall Study||852
8295455|NCT01584479|20453000|P2|STARTED|Overall Study||1686
8295456|NCT01584479|20453001|P1|STARTED|Overall Study||732
8295457|NCT01584388|20453011|P1|NOT COMPLETED|Overall Study||0
8295458|NCT01584388|20453011|P1|COMPLETED|Overall Study||30
8295459|NCT01584388|20453011|P1|STARTED|Overall Study||30
8295460|NCT01584232|20453031|P2|NOT COMPLETED|Overall Study||3
8295461|NCT01584232|20453032|P1|NOT COMPLETED|Overall Study||8
8295462|NCT01584232|20453031|P2|COMPLETED|Overall Study||177
8295463|NCT01584232|20453032|P1|COMPLETED|Overall Study||173
8295464|NCT01584232|20453031|P2|Received at Least 1 Dose of Study Drug|Overall Study||180
8295465|NCT01584232|20453032|P1|Received at Least 1 Dose of Study Drug|Overall Study||181
8295466|NCT01584232|20453031|P2|STARTED|Overall Study||180
8295467|NCT01584232|20453032|P1|STARTED|Overall Study||181
8295468|NCT01584024|20453048|P1|NOT COMPLETED|Overall Study||13
8295469|NCT01584024|20453048|P1|COMPLETED|Overall Study||29
8295470|NCT01584024|20453048|P1|STARTED|Overall Study||42
8295471|NCT01583985|20453057|P2|NOT COMPLETED|Overall Study||3
8295472|NCT01583985|20453058|P1|NOT COMPLETED|Overall Study||3
8295473|NCT01583985|20453057|P2|COMPLETED|Overall Study||117
8295474|NCT01583985|20453058|P1|COMPLETED|Overall Study||117
8295475|NCT01583985|20453057|P2|Included in Primary Analysis|Overall Study||119
8295476|NCT01583985|20453058|P1|Included in Primary Analysis|Overall Study||119
8295477|NCT01583985|20453057|P2|STARTED|Overall Study||120
8295478|NCT01583985|20453058|P1|STARTED|Overall Study||120
8295479|NCT01583894|20453072|P1|NOT COMPLETED|Overall Study||15
8295480|NCT01583894|20453072|P1|COMPLETED|Overall Study||813
8295481|NCT01583894|20453072|P1|STARTED|Overall Study||828
8295482|NCT01583868|20453078|P2|NOT COMPLETED|Overall Study||4
8295483|NCT01583868|20453079|P1|NOT COMPLETED|Overall Study||4
8295484|NCT01583868|20453078|P2|COMPLETED|Overall Study||104
8295485|NCT01583868|20453079|P1|COMPLETED|Overall Study||104
8295486|NCT01583868|20453078|P2|STARTED|Overall Study||108
8295487|NCT01583868|20453079|P1|STARTED|Overall Study||108
8295488|NCT01583686|20453098|P5|NOT COMPLETED|Overall Study||0
8295489|NCT01583686|20453099|P4|NOT COMPLETED|Overall Study||0
8295490|NCT01583686|20453100|P3|NOT COMPLETED|Overall Study||0
8295491|NCT01583686|20453101|P2|NOT COMPLETED|Overall Study||0
8295492|NCT01583686|20453102|P1|NOT COMPLETED|Overall Study||0
8295493|NCT01583686|20453098|P5|COMPLETED|Overall Study||3
8295494|NCT01583686|20453099|P4|COMPLETED|Overall Study||3
8295495|NCT01583686|20453100|P3|COMPLETED|Overall Study||3
8295496|NCT01583686|20453101|P2|COMPLETED|Overall Study||3
8295497|NCT01583686|20453102|P1|COMPLETED|Overall Study||3
8295498|NCT01583686|20453098|P5|STARTED|Overall Study||3
8295499|NCT01583686|20453099|P4|STARTED|Overall Study||3
8295500|NCT01583686|20453100|P3|STARTED|Overall Study||3
8295501|NCT01583686|20453101|P2|STARTED|Overall Study||3
8295502|NCT01583686|20453102|P1|STARTED|Overall Study||3
8295503|NCT01583647|20453119|P2|NOT COMPLETED|Overall Study||0
8295504|NCT01583647|20453120|P1|NOT COMPLETED|Overall Study||0
8295505|NCT01583647|20453119|P2|COMPLETED|Overall Study||0
8295506|NCT01583647|20453120|P1|COMPLETED|Overall Study||10
8295507|NCT01583647|20453119|P2|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
8295508|NCT01583647|20453120|P1|STARTED|Overall Study||10
8295509|NCT01583543|20453132|P1|NOT COMPLETED|Overall Study||0
8295510|NCT01583543|20453132|P1|COMPLETED|Overall Study||12
8295511|NCT01583543|20453132|P1|STARTED|Overall Study||12
8295512|NCT01583530|20453145|P6|NOT COMPLETED|Overall Study||3
8295513|NCT01583530|20453146|P5|NOT COMPLETED|Overall Study||5
8295514|NCT01583530|20453147|P4|NOT COMPLETED|Overall Study||1
8295515|NCT01583530|20453148|P3|NOT COMPLETED|Overall Study||0
8295516|NCT01583530|20453149|P2|NOT COMPLETED|Overall Study||3
8295517|NCT01583530|20453150|P1|NOT COMPLETED|Overall Study||0
8295518|NCT01583530|20453145|P6|COMPLETED|Overall Study||17
8295519|NCT01583530|20453146|P5|COMPLETED|Overall Study||15
8295520|NCT01583530|20453147|P4|COMPLETED|Overall Study||18
8295521|NCT01583530|20453148|P3|COMPLETED|Overall Study||20
8295522|NCT01583530|20453149|P2|COMPLETED|Overall Study||17
8295523|NCT01583530|20453150|P1|COMPLETED|Overall Study||19
8295524|NCT01583530|20453145|P6|STARTED|Overall Study||20
8295525|NCT01583530|20453146|P5|STARTED|Overall Study||20
8295526|NCT01583530|20453147|P4|STARTED|Overall Study||19
8295527|NCT01583530|20453148|P3|STARTED|Overall Study||20
8295528|NCT01583530|20453149|P2|STARTED|Overall Study||20
8295529|NCT01583530|20453150|P1|STARTED|Overall Study||19
8295530|NCT01583452|20453196|P2|NOT COMPLETED|Overall Study||0
8295531|NCT01583452|20453197|P1|NOT COMPLETED|Overall Study||0
8295532|NCT01583452|20453196|P2|COMPLETED|Overall Study||20
8295533|NCT01583452|20453197|P1|COMPLETED|Overall Study||21
8295534|NCT01583452|20453196|P2|STARTED|Overall Study||20
8295535|NCT01583452|20453197|P1|STARTED|Overall Study||21
8295536|NCT01583374|20453212|P9|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10
8295537|NCT01583374|20453213|P8|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9
8295538|NCT01583374|20453214|P7|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18
8295539|NCT01583374|20453215|P6|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17
8295540|NCT01583374|20453216|P5|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31
8295541|NCT01583374|20453217|P4|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13
8295542|NCT01583374|20453218|P3|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20
8295543|NCT01583374|20453219|P2|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26
8295544|NCT01583374|20453220|P1|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0
8295545|NCT01583374|20453212|P9|COMPLETED|Long-Term Extension Phase Weeks 52-260||10
8295546|NCT01583374|20453213|P8|COMPLETED|Long-Term Extension Phase Weeks 52-260||12
8295547|NCT01583374|20453214|P7|COMPLETED|Long-Term Extension Phase Weeks 52-260||20
8295548|NCT01583374|20453215|P6|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
8295549|NCT01583374|20453216|P5|COMPLETED|Long-Term Extension Phase Weeks 52-260||50
8295550|NCT01583374|20453217|P4|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
8295551|NCT01583374|20453218|P3|COMPLETED|Long-Term Extension Phase Weeks 52-260||41
8295552|NCT01583374|20453219|P2|COMPLETED|Long-Term Extension Phase Weeks 52-260||40
8295553|NCT01583374|20453220|P1|COMPLETED|Long-Term Extension Phase Weeks 52-260||0
8295554|NCT01583374|20453212|P9|STARTED|Long-Term Extension Phase Weeks 52-260||20
8295555|NCT01583374|20453213|P8|STARTED|Long-Term Extension Phase Weeks 52-260||21
8295556|NCT01583374|20453214|P7|STARTED|Long-Term Extension Phase Weeks 52-260||38
8295557|NCT01583374|20453215|P6|STARTED|Long-Term Extension Phase Weeks 52-260||39
8295558|NCT01583374|20453216|P5|STARTED|Long-Term Extension Phase Weeks 52-260||81
8295559|NCT01583374|20453217|P4|STARTED|Long-Term Extension Phase Weeks 52-260||35
8295560|NCT01583374|20453218|P3|STARTED|Long-Term Extension Phase Weeks 52-260||61
8295561|NCT01583374|20453219|P2|STARTED|Long-Term Extension Phase Weeks 52-260||66
8295562|NCT01583374|20453220|P1|STARTED|Long-Term Extension Phase Weeks 52-260||0
8295563|NCT01583374|20453212|P9|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2
8295564|NCT01583374|20453213|P8|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3
8295565|NCT01583374|20453214|P7|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
8295566|NCT01583374|20453215|P6|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
8295567|NCT01583374|20453216|P5|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
8295568|NCT01583374|20453217|P4|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
8295569|NCT01583374|20453218|P3|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4
8295570|NCT01583374|20453219|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
8295571|NCT01583374|20453220|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0
8295572|NCT01583374|20453212|P9|COMPLETED|Extension Phase (Weeks 24 to 52)||21
8295573|NCT01583374|20453213|P8|COMPLETED|Extension Phase (Weeks 24 to 52)||22
8295574|NCT01583374|20453214|P7|COMPLETED|Extension Phase (Weeks 24 to 52)||43
8295575|NCT01583374|20453215|P6|COMPLETED|Extension Phase (Weeks 24 to 52)||43
8295576|NCT01583374|20453216|P5|COMPLETED|Extension Phase (Weeks 24 to 52)||85
8295577|NCT01583374|20453217|P4|COMPLETED|Extension Phase (Weeks 24 to 52)||41
8295578|NCT01583374|20453218|P3|COMPLETED|Extension Phase (Weeks 24 to 52)||61
8295579|NCT01583374|20453219|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||69
8295580|NCT01583374|20453220|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||0
8295581|NCT01583374|20453212|P9|STARTED|Extension Phase (Weeks 24 to 52)||23
8295582|NCT01583374|20453213|P8|STARTED|Extension Phase (Weeks 24 to 52)||25
8295583|NCT01583374|20453214|P7|STARTED|Extension Phase (Weeks 24 to 52)||48
8295584|NCT01583374|20453215|P6|STARTED|Extension Phase (Weeks 24 to 52)||48
8295585|NCT01583374|20453216|P5|STARTED|Extension Phase (Weeks 24 to 52)||91
8295586|NCT01583374|20453217|P4|STARTED|Extension Phase (Weeks 24 to 52)||47
8295587|NCT01583374|20453218|P3|STARTED|Extension Phase (Weeks 24 to 52)||65
8295588|NCT01583374|20453219|P2|STARTED|Extension Phase (Weeks 24 to 52)||74
8295589|NCT01583374|20453220|P1|STARTED|Extension Phase (Weeks 24 to 52)||0
8295590|NCT01583374|20453212|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295591|NCT01583374|20453213|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295592|NCT01583374|20453214|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295593|NCT01583374|20453215|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295594|NCT01583374|20453216|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295595|NCT01583374|20453217|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295596|NCT01583374|20453218|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25
8295597|NCT01583374|20453219|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16
8295598|NCT01583374|20453220|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19
8295599|NCT01583374|20453212|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295600|NCT01583374|20453213|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295601|NCT01583374|20453214|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295602|NCT01583374|20453215|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295603|NCT01583374|20453216|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295604|NCT01583374|20453217|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8295605|NCT01583374|20453218|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138
8295606|NCT01583374|20453219|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147
8295607|NCT01583374|20453220|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145
8295608|NCT01583374|20453212|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8295609|NCT01583374|20453213|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8295610|NCT01583374|20453214|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8295611|NCT01583374|20453215|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8295612|NCT01583374|20453216|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8295613|NCT01583374|20453217|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8295614|NCT01583374|20453218|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49
8295615|NCT01583374|20453219|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49
8295616|NCT01583374|20453220|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51
8295617|NCT01583374|20453212|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8295618|NCT01583374|20453213|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8295619|NCT01583374|20453214|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8295620|NCT01583374|20453215|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8295621|NCT01583374|20453216|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8295622|NCT01583374|20453217|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8295623|NCT01583374|20453218|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144
8295624|NCT01583374|20453219|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151
8295625|NCT01583374|20453220|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150
8295626|NCT01583374|20453212|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8295627|NCT01583374|20453213|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8295716|NCT01582451|20453441|P2|STARTED|Overall Study||159
8295628|NCT01583374|20453214|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8295629|NCT01583374|20453215|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8295630|NCT01583374|20453216|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8295631|NCT01583374|20453217|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8295632|NCT01583374|20453218|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
8295633|NCT01583374|20453219|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
8295634|NCT01583374|20453220|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||164
8295635|NCT01583374|20453212|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
8295636|NCT01583374|20453213|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
8295637|NCT01583374|20453214|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
8295638|NCT01583374|20453215|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
8295639|NCT01583374|20453216|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
8295640|NCT01583374|20453217|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
8295641|NCT01583374|20453218|P3|STARTED|Placebo-controlled Phase (Week 0-24)||163
8295642|NCT01583374|20453219|P2|STARTED|Placebo-controlled Phase (Week 0-24)||163
8295643|NCT01583374|20453220|P1|STARTED|Placebo-controlled Phase (Week 0-24)||164
8295644|NCT01583218|20453262|P2|NOT COMPLETED|Overall Study||283
8295645|NCT01583218|20453263|P1|NOT COMPLETED|Overall Study||289
8295646|NCT01583218|20453262|P2|COMPLETED|Overall Study||3471
8295647|NCT01583218|20453263|P1|COMPLETED|Overall Study||3470
8295648|NCT01583218|20453262|P2|STARTED|Overall Study||3754
8295649|NCT01583218|20453263|P1|STARTED|Overall Study||3759
8295650|NCT01583179|20453283|P2|NOT COMPLETED|Overall Study||2
8295651|NCT01583179|20453284|P1|NOT COMPLETED|Overall Study||1
8295652|NCT01583179|20453283|P2|COMPLETED|Overall Study||10
8295653|NCT01583179|20453284|P1|COMPLETED|Overall Study||13
8295654|NCT01583179|20453283|P2|STARTED|Overall Study||12
8295655|NCT01583179|20453284|P1|STARTED|Overall Study||14
8295656|NCT01583166|20453294|P2|NOT COMPLETED|Overall Study||6
8295657|NCT01583166|20453295|P1|NOT COMPLETED|Overall Study||4
8295658|NCT01583166|20453294|P2|COMPLETED|Overall Study||39
8295659|NCT01583166|20453295|P1|COMPLETED|Overall Study||41
8295660|NCT01583166|20453294|P2|STARTED|Overall Study||45
8295661|NCT01583166|20453295|P1|STARTED|Overall Study||45
8295662|NCT01583101|20453309|P2|NOT COMPLETED|Overall Study||0
8295663|NCT01583101|20453310|P1|NOT COMPLETED|Overall Study||0
8295664|NCT01583101|20453309|P2|COMPLETED|Overall Study||1161
8295665|NCT01583101|20453310|P1|COMPLETED|Overall Study||1076
8295666|NCT01583101|20453309|P2|STARTED|Overall Study||1161
8295667|NCT01583101|20453310|P1|STARTED|Overall Study||1076
8295668|NCT01582971|20453318|P2|NOT COMPLETED|Overall Study||37
8295669|NCT01582971|20453319|P1|NOT COMPLETED|Overall Study||39
8295670|NCT01582971|20453318|P2|COMPLETED|Overall Study||91
8295671|NCT01582971|20453319|P1|COMPLETED|Overall Study||89
8295672|NCT01582971|20453318|P2|STARTED|Overall Study||128
8295673|NCT01582971|20453319|P1|STARTED|Overall Study||128
8295674|NCT01582945|20453337|P1|NOT COMPLETED|Overall Study||2
8295675|NCT01582945|20453337|P1|COMPLETED|Overall Study||12
8295676|NCT01582945|20453337|P1|STARTED|Overall Study||14
8295677|NCT01582880|20453341|P1|NOT COMPLETED|Overall Study||0
8295678|NCT01582880|20453341|P1|COMPLETED|Overall Study||1
8295679|NCT01582880|20453341|P1|STARTED|Overall Study||1
8295680|NCT01582854|20453351|P2|NOT COMPLETED|Overall Study||34
8295681|NCT01582854|20453352|P1|NOT COMPLETED|Overall Study||36
8295682|NCT01582854|20453351|P2|COMPLETED|Overall Study||221
8295683|NCT01582854|20453352|P1|COMPLETED|Overall Study||212
8295684|NCT01582854|20453351|P2|STARTED|Overall Study||255
8295685|NCT01582854|20453352|P1|STARTED|Overall Study||248
8295686|NCT01582789|20453380|P2|NOT COMPLETED|Second Intervention (14 Days)||0
8295687|NCT01582789|20453381|P1|NOT COMPLETED|Second Intervention (14 Days)||1
8295688|NCT01582789|20453380|P2|COMPLETED|Second Intervention (14 Days)||27
8295689|NCT01582789|20453381|P1|COMPLETED|Second Intervention (14 Days)||33
8295690|NCT01582789|20453380|P2|STARTED|Second Intervention (14 Days)||27
8295691|NCT01582789|20453381|P1|STARTED|Second Intervention (14 Days)||34
8295692|NCT01582789|20453380|P2|NOT COMPLETED|First Intervention (14 Days)||0
8295693|NCT01582789|20453381|P1|NOT COMPLETED|First Intervention (14 Days)||0
8295694|NCT01582789|20453380|P2|COMPLETED|First Intervention (14 Days)||27
8295695|NCT01582789|20453381|P1|COMPLETED|First Intervention (14 Days)||34
8295696|NCT01582789|20453380|P2|STARTED|First Intervention (14 Days)||27
8295697|NCT01582789|20453381|P1|STARTED|First Intervention (14 Days)||34
8295698|NCT01582490|20453399|P2|NOT COMPLETED|Overall Study||1
8295699|NCT01582490|20453400|P1|NOT COMPLETED|Overall Study||1
8295700|NCT01582490|20453399|P2|COMPLETED|Overall Study||9
8295701|NCT01582490|20453400|P1|COMPLETED|Overall Study||8
8295702|NCT01582490|20453399|P2|STARTED|Overall Study||10
8295703|NCT01582490|20453400|P1|STARTED|Overall Study||9
8295710|NCT01582451|20453441|P2|NOT COMPLETED|Overall Study||20
8295711|NCT01582451|20453442|P1|NOT COMPLETED|Overall Study||32
8295712|NCT01582451|20453441|P2|COMPLETED|Overall Study||139
8295713|NCT01582451|20453442|P1|COMPLETED|Overall Study||275
8295714|NCT01582451|20453441|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
8295715|NCT01582451|20453442|P1|Received at Least 1 Dose of Study Drug|Overall Study||305
8295717|NCT01582451|20453442|P1|STARTED|Overall Study||307
8295718|NCT01582308|20453484|P10|NOT COMPLETED|Period 5||0
8295719|NCT01582308|20453485|P9|NOT COMPLETED|Period 5||0
8295720|NCT01582308|20453486|P8|NOT COMPLETED|Period 5||0
8295721|NCT01582308|20453487|P7|NOT COMPLETED|Period 5||0
8295722|NCT01582308|20453488|P6|NOT COMPLETED|Period 5||0
8295723|NCT01582308|20453489|P5|NOT COMPLETED|Period 5||0
8295724|NCT01582308|20453490|P4|NOT COMPLETED|Period 5||0
8295725|NCT01582308|20453491|P3|NOT COMPLETED|Period 5||0
8295726|NCT01582308|20453492|P2|NOT COMPLETED|Period 5||0
8295727|NCT01582308|20453493|P1|NOT COMPLETED|Period 5||0
8295728|NCT01582308|20453484|P10|COMPLETED|Period 5||1
8295729|NCT01582308|20453485|P9|COMPLETED|Period 5||2
8295730|NCT01582308|20453486|P8|COMPLETED|Period 5||2
8295731|NCT01582308|20453487|P7|COMPLETED|Period 5||2
8295732|NCT01582308|20453488|P6|COMPLETED|Period 5||1
8295733|NCT01582308|20453489|P5|COMPLETED|Period 5||2
8295734|NCT01582308|20453490|P4|COMPLETED|Period 5||2
8295735|NCT01582308|20453491|P3|COMPLETED|Period 5||2
8295736|NCT01582308|20453492|P2|COMPLETED|Period 5||2
8295737|NCT01582308|20453493|P1|COMPLETED|Period 5||1
8295738|NCT01582308|20453484|P10|STARTED|Period 5||1
8295739|NCT01582308|20453485|P9|STARTED|Period 5||2
8295740|NCT01582308|20453486|P8|STARTED|Period 5||2
8295741|NCT01582308|20453487|P7|STARTED|Period 5||2
8295742|NCT01582308|20453488|P6|STARTED|Period 5||1
8295743|NCT01582308|20453489|P5|STARTED|Period 5||2
8295744|NCT01582308|20453490|P4|STARTED|Period 5||2
8295745|NCT01582308|20453491|P3|STARTED|Period 5||2
8295746|NCT01582308|20453492|P2|STARTED|Period 5||2
8295747|NCT01582308|20453493|P1|STARTED|Period 5||1
8295748|NCT01582308|20453484|P10|NOT COMPLETED|10-day Washout Following Period 4||0
8295749|NCT01582308|20453485|P9|NOT COMPLETED|10-day Washout Following Period 4||0
8295750|NCT01582308|20453486|P8|NOT COMPLETED|10-day Washout Following Period 4||0
8295751|NCT01582308|20453487|P7|NOT COMPLETED|10-day Washout Following Period 4||0
8295752|NCT01582308|20453488|P6|NOT COMPLETED|10-day Washout Following Period 4||0
8295753|NCT01582308|20453489|P5|NOT COMPLETED|10-day Washout Following Period 4||0
8295754|NCT01582308|20453490|P4|NOT COMPLETED|10-day Washout Following Period 4||0
8295755|NCT01582308|20453491|P3|NOT COMPLETED|10-day Washout Following Period 4||0
8295756|NCT01582308|20453492|P2|NOT COMPLETED|10-day Washout Following Period 4||0
8295757|NCT01582308|20453493|P1|NOT COMPLETED|10-day Washout Following Period 4||0
8295758|NCT01582308|20453484|P10|COMPLETED|10-day Washout Following Period 4||1
8295759|NCT01582308|20453485|P9|COMPLETED|10-day Washout Following Period 4||2
8295760|NCT01582308|20453486|P8|COMPLETED|10-day Washout Following Period 4||2
8295761|NCT01582308|20453487|P7|COMPLETED|10-day Washout Following Period 4||2
8295762|NCT01582308|20453488|P6|COMPLETED|10-day Washout Following Period 4||1
8295763|NCT01582308|20453489|P5|COMPLETED|10-day Washout Following Period 4||2
8295764|NCT01582308|20453490|P4|COMPLETED|10-day Washout Following Period 4||2
8295765|NCT01582308|20453491|P3|COMPLETED|10-day Washout Following Period 4||2
8295766|NCT01582308|20453492|P2|COMPLETED|10-day Washout Following Period 4||2
8295767|NCT01582308|20453493|P1|COMPLETED|10-day Washout Following Period 4||1
8295768|NCT01582308|20453484|P10|STARTED|10-day Washout Following Period 4||1
8295769|NCT01582308|20453485|P9|STARTED|10-day Washout Following Period 4||2
8295770|NCT01582308|20453486|P8|STARTED|10-day Washout Following Period 4||2
8295771|NCT01582308|20453487|P7|STARTED|10-day Washout Following Period 4||2
8295772|NCT01582308|20453488|P6|STARTED|10-day Washout Following Period 4||1
8295773|NCT01582308|20453489|P5|STARTED|10-day Washout Following Period 4||2
8295774|NCT01582308|20453490|P4|STARTED|10-day Washout Following Period 4||2
8295775|NCT01582308|20453491|P3|STARTED|10-day Washout Following Period 4||2
8295776|NCT01582308|20453492|P2|STARTED|10-day Washout Following Period 4||2
8295777|NCT01582308|20453493|P1|STARTED|10-day Washout Following Period 4||1
8295778|NCT01582308|20453484|P10|NOT COMPLETED|Period 4||1
8295779|NCT01582308|20453485|P9|NOT COMPLETED|Period 4||0
8295780|NCT01582308|20453486|P8|NOT COMPLETED|Period 4||0
8295781|NCT01582308|20453487|P7|NOT COMPLETED|Period 4||0
8295782|NCT01582308|20453488|P6|NOT COMPLETED|Period 4||1
8295783|NCT01582308|20453489|P5|NOT COMPLETED|Period 4||0
8295784|NCT01582308|20453490|P4|NOT COMPLETED|Period 4||0
8295785|NCT01582308|20453491|P3|NOT COMPLETED|Period 4||0
8295786|NCT01582308|20453492|P2|NOT COMPLETED|Period 4||0
8295787|NCT01582308|20453493|P1|NOT COMPLETED|Period 4||1
8295788|NCT01582308|20453484|P10|COMPLETED|Period 4||1
8295789|NCT01582308|20453485|P9|COMPLETED|Period 4||2
8295790|NCT01582308|20453486|P8|COMPLETED|Period 4||2
8295791|NCT01582308|20453487|P7|COMPLETED|Period 4||2
8295792|NCT01582308|20453488|P6|COMPLETED|Period 4||1
8295793|NCT01582308|20453489|P5|COMPLETED|Period 4||2
8295794|NCT01582308|20453490|P4|COMPLETED|Period 4||2
8295795|NCT01582308|20453491|P3|COMPLETED|Period 4||2
8295796|NCT01582308|20453492|P2|COMPLETED|Period 4||2
8295797|NCT01582308|20453493|P1|COMPLETED|Period 4||1
8295798|NCT01582308|20453484|P10|STARTED|Period 4||2
8295799|NCT01582308|20453485|P9|STARTED|Period 4||2
8295800|NCT01582308|20453486|P8|STARTED|Period 4||2
8295801|NCT01582308|20453487|P7|STARTED|Period 4||2
8295802|NCT01582308|20453488|P6|STARTED|Period 4||2
8295803|NCT01582308|20453489|P5|STARTED|Period 4||2
8295804|NCT01582308|20453490|P4|STARTED|Period 4||2
8295805|NCT01582308|20453491|P3|STARTED|Period 4||2
8295806|NCT01582308|20453492|P2|STARTED|Period 4||2
8295807|NCT01582308|20453493|P1|STARTED|Period 4||2
8295808|NCT01582308|20453484|P10|NOT COMPLETED|10-day Washout Following Period 3||0
8295809|NCT01582308|20453485|P9|NOT COMPLETED|10-day Washout Following Period 3||0
8295810|NCT01582308|20453486|P8|NOT COMPLETED|10-day Washout Following Period 3||0
8295811|NCT01582308|20453487|P7|NOT COMPLETED|10-day Washout Following Period 3||0
8295812|NCT01582308|20453488|P6|NOT COMPLETED|10-day Washout Following Period 3||0
8295813|NCT01582308|20453489|P5|NOT COMPLETED|10-day Washout Following Period 3||0
8295814|NCT01582308|20453490|P4|NOT COMPLETED|10-day Washout Following Period 3||0
8295815|NCT01582308|20453491|P3|NOT COMPLETED|10-day Washout Following Period 3||0
8295816|NCT01582308|20453492|P2|NOT COMPLETED|10-day Washout Following Period 3||0
8295817|NCT01582308|20453493|P1|NOT COMPLETED|10-day Washout Following Period 3||0
8295818|NCT01582308|20453484|P10|COMPLETED|10-day Washout Following Period 3||2
8295819|NCT01582308|20453485|P9|COMPLETED|10-day Washout Following Period 3||2
8295820|NCT01582308|20453486|P8|COMPLETED|10-day Washout Following Period 3||2
8295821|NCT01582308|20453487|P7|COMPLETED|10-day Washout Following Period 3||2
8295822|NCT01582308|20453488|P6|COMPLETED|10-day Washout Following Period 3||2
8295823|NCT01582308|20453489|P5|COMPLETED|10-day Washout Following Period 3||2
8295824|NCT01582308|20453490|P4|COMPLETED|10-day Washout Following Period 3||2
8295825|NCT01582308|20453491|P3|COMPLETED|10-day Washout Following Period 3||2
8295826|NCT01582308|20453492|P2|COMPLETED|10-day Washout Following Period 3||2
8295827|NCT01582308|20453493|P1|COMPLETED|10-day Washout Following Period 3||2
8295828|NCT01582308|20453484|P10|STARTED|10-day Washout Following Period 3||2
8295829|NCT01582308|20453485|P9|STARTED|10-day Washout Following Period 3||2
8295830|NCT01582308|20453486|P8|STARTED|10-day Washout Following Period 3||2
8295831|NCT01582308|20453487|P7|STARTED|10-day Washout Following Period 3||2
8295832|NCT01582308|20453488|P6|STARTED|10-day Washout Following Period 3||2
8295833|NCT01582308|20453489|P5|STARTED|10-day Washout Following Period 3||2
8295834|NCT01582308|20453490|P4|STARTED|10-day Washout Following Period 3||2
8295835|NCT01582308|20453491|P3|STARTED|10-day Washout Following Period 3||2
8295836|NCT01582308|20453492|P2|STARTED|10-day Washout Following Period 3||2
8295837|NCT01582308|20453493|P1|STARTED|10-day Washout Following Period 3||2
8295838|NCT01582308|20453484|P10|NOT COMPLETED|Period 3||0
8295839|NCT01582308|20453485|P9|NOT COMPLETED|Period 3||0
8295840|NCT01582308|20453486|P8|NOT COMPLETED|Period 3||0
8295841|NCT01582308|20453487|P7|NOT COMPLETED|Period 3||0
8295842|NCT01582308|20453488|P6|NOT COMPLETED|Period 3||0
8295843|NCT01582308|20453489|P5|NOT COMPLETED|Period 3||0
8295844|NCT01582308|20453490|P4|NOT COMPLETED|Period 3||0
8295845|NCT01582308|20453491|P3|NOT COMPLETED|Period 3||0
8295846|NCT01582308|20453492|P2|NOT COMPLETED|Period 3||0
8295847|NCT01582308|20453493|P1|NOT COMPLETED|Period 3||0
8295848|NCT01582308|20453484|P10|COMPLETED|Period 3||2
8295849|NCT01582308|20453485|P9|COMPLETED|Period 3||2
8295850|NCT01582308|20453486|P8|COMPLETED|Period 3||2
8295851|NCT01582308|20453487|P7|COMPLETED|Period 3||2
8295852|NCT01582308|20453488|P6|COMPLETED|Period 3||2
8295853|NCT01582308|20453489|P5|COMPLETED|Period 3||2
8295854|NCT01582308|20453490|P4|COMPLETED|Period 3||2
8295855|NCT01582308|20453491|P3|COMPLETED|Period 3||2
8295856|NCT01582308|20453492|P2|COMPLETED|Period 3||2
8295857|NCT01582308|20453493|P1|COMPLETED|Period 3||2
8295858|NCT01582308|20453484|P10|STARTED|Period 3||2
8295859|NCT01582308|20453485|P9|STARTED|Period 3||2
8295860|NCT01582308|20453486|P8|STARTED|Period 3||2
8295861|NCT01582308|20453487|P7|STARTED|Period 3||2
8295862|NCT01582308|20453488|P6|STARTED|Period 3||2
8295863|NCT01582308|20453489|P5|STARTED|Period 3||2
8295864|NCT01582308|20453490|P4|STARTED|Period 3||2
8295865|NCT01582308|20453491|P3|STARTED|Period 3||2
8295866|NCT01582308|20453492|P2|STARTED|Period 3||2
8295867|NCT01582308|20453493|P1|STARTED|Period 3||2
8295868|NCT01582308|20453484|P10|NOT COMPLETED|10-day Washout Following Period 2||0
8295869|NCT01582308|20453485|P9|NOT COMPLETED|10-day Washout Following Period 2||0
8295870|NCT01582308|20453486|P8|NOT COMPLETED|10-day Washout Following Period 2||0
8295871|NCT01582308|20453487|P7|NOT COMPLETED|10-day Washout Following Period 2||0
8295872|NCT01582308|20453488|P6|NOT COMPLETED|10-day Washout Following Period 2||0
8295873|NCT01582308|20453489|P5|NOT COMPLETED|10-day Washout Following Period 2||0
8295874|NCT01582308|20453490|P4|NOT COMPLETED|10-day Washout Following Period 2||0
8295875|NCT01582308|20453491|P3|NOT COMPLETED|10-day Washout Following Period 2||0
8295876|NCT01582308|20453492|P2|NOT COMPLETED|10-day Washout Following Period 2||0
8295877|NCT01582308|20453493|P1|NOT COMPLETED|10-day Washout Following Period 2||0
8295878|NCT01582308|20453484|P10|COMPLETED|10-day Washout Following Period 2||2
8295879|NCT01582308|20453485|P9|COMPLETED|10-day Washout Following Period 2||2
8295880|NCT01582308|20453486|P8|COMPLETED|10-day Washout Following Period 2||2
8295881|NCT01582308|20453487|P7|COMPLETED|10-day Washout Following Period 2||2
8295882|NCT01582308|20453488|P6|COMPLETED|10-day Washout Following Period 2||2
8295883|NCT01582308|20453489|P5|COMPLETED|10-day Washout Following Period 2||2
8295884|NCT01582308|20453490|P4|COMPLETED|10-day Washout Following Period 2||2
8295885|NCT01582308|20453491|P3|COMPLETED|10-day Washout Following Period 2||2
8295886|NCT01582308|20453492|P2|COMPLETED|10-day Washout Following Period 2||2
8295887|NCT01582308|20453493|P1|COMPLETED|10-day Washout Following Period 2||2
8295888|NCT01582308|20453484|P10|STARTED|10-day Washout Following Period 2||2
8295889|NCT01582308|20453485|P9|STARTED|10-day Washout Following Period 2||2
8295890|NCT01582308|20453486|P8|STARTED|10-day Washout Following Period 2||2
8295891|NCT01582308|20453487|P7|STARTED|10-day Washout Following Period 2||2
8295892|NCT01582308|20453488|P6|STARTED|10-day Washout Following Period 2||2
8295893|NCT01582308|20453489|P5|STARTED|10-day Washout Following Period 2||2
8295894|NCT01582308|20453490|P4|STARTED|10-day Washout Following Period 2||2
8295895|NCT01582308|20453491|P3|STARTED|10-day Washout Following Period 2||2
8295896|NCT01582308|20453492|P2|STARTED|10-day Washout Following Period 2||2
8295897|NCT01582308|20453493|P1|STARTED|10-day Washout Following Period 2||2
8295898|NCT01582308|20453484|P10|NOT COMPLETED|Period 2||0
8295899|NCT01582308|20453485|P9|NOT COMPLETED|Period 2||0
8295900|NCT01582308|20453486|P8|NOT COMPLETED|Period 2||0
8295901|NCT01582308|20453487|P7|NOT COMPLETED|Period 2||0
8295902|NCT01582308|20453488|P6|NOT COMPLETED|Period 2||0
8295903|NCT01582308|20453489|P5|NOT COMPLETED|Period 2||0
8295904|NCT01582308|20453490|P4|NOT COMPLETED|Period 2||0
8295905|NCT01582308|20453491|P3|NOT COMPLETED|Period 2||0
8295906|NCT01582308|20453492|P2|NOT COMPLETED|Period 2||0
8295907|NCT01582308|20453493|P1|NOT COMPLETED|Period 2||0
8295908|NCT01582308|20453484|P10|COMPLETED|Period 2||2
8295909|NCT01582308|20453485|P9|COMPLETED|Period 2||2
8295910|NCT01582308|20453486|P8|COMPLETED|Period 2||2
8295911|NCT01582308|20453487|P7|COMPLETED|Period 2||2
8295912|NCT01582308|20453488|P6|COMPLETED|Period 2||2
8295913|NCT01582308|20453489|P5|COMPLETED|Period 2||2
8295914|NCT01582308|20453490|P4|COMPLETED|Period 2||2
8295915|NCT01582308|20453491|P3|COMPLETED|Period 2||2
8295916|NCT01582308|20453492|P2|COMPLETED|Period 2||2
8295917|NCT01582308|20453493|P1|COMPLETED|Period 2||2
8295918|NCT01582308|20453484|P10|STARTED|Period 2||2
8295919|NCT01582308|20453485|P9|STARTED|Period 2||2
8295920|NCT01582308|20453486|P8|STARTED|Period 2||2
8295921|NCT01582308|20453487|P7|STARTED|Period 2||2
8295922|NCT01582308|20453488|P6|STARTED|Period 2||2
8295923|NCT01582308|20453489|P5|STARTED|Period 2||2
8295924|NCT01582308|20453490|P4|STARTED|Period 2||2
8295925|NCT01582308|20453491|P3|STARTED|Period 2||2
8295926|NCT01582308|20453492|P2|STARTED|Period 2||2
8295927|NCT01582308|20453493|P1|STARTED|Period 2||2
8295928|NCT01582308|20453484|P10|NOT COMPLETED|10-day Washout Following Period 1||0
8295929|NCT01582308|20453485|P9|NOT COMPLETED|10-day Washout Following Period 1||0
8295930|NCT01582308|20453486|P8|NOT COMPLETED|10-day Washout Following Period 1||0
8295931|NCT01582308|20453487|P7|NOT COMPLETED|10-day Washout Following Period 1||0
8295932|NCT01582308|20453488|P6|NOT COMPLETED|10-day Washout Following Period 1||0
8295933|NCT01582308|20453489|P5|NOT COMPLETED|10-day Washout Following Period 1||1
8295934|NCT01582308|20453490|P4|NOT COMPLETED|10-day Washout Following Period 1||0
8295935|NCT01582308|20453491|P3|NOT COMPLETED|10-day Washout Following Period 1||0
8295936|NCT01582308|20453492|P2|NOT COMPLETED|10-day Washout Following Period 1||0
8295937|NCT01582308|20453493|P1|NOT COMPLETED|10-day Washout Following Period 1||0
8295938|NCT01582308|20453484|P10|COMPLETED|10-day Washout Following Period 1||2
8295939|NCT01582308|20453485|P9|COMPLETED|10-day Washout Following Period 1||2
8295940|NCT01582308|20453486|P8|COMPLETED|10-day Washout Following Period 1||2
8295941|NCT01582308|20453487|P7|COMPLETED|10-day Washout Following Period 1||2
8295942|NCT01582308|20453488|P6|COMPLETED|10-day Washout Following Period 1||2
8295943|NCT01582308|20453489|P5|COMPLETED|10-day Washout Following Period 1||2
8295944|NCT01582308|20453490|P4|COMPLETED|10-day Washout Following Period 1||2
8295945|NCT01582308|20453491|P3|COMPLETED|10-day Washout Following Period 1||2
8295946|NCT01582308|20453492|P2|COMPLETED|10-day Washout Following Period 1||2
8295947|NCT01582308|20453493|P1|COMPLETED|10-day Washout Following Period 1||2
8295948|NCT01582308|20453484|P10|STARTED|10-day Washout Following Period 1||2
8295949|NCT01582308|20453485|P9|STARTED|10-day Washout Following Period 1||2
8295950|NCT01582308|20453486|P8|STARTED|10-day Washout Following Period 1||2
8295951|NCT01582308|20453487|P7|STARTED|10-day Washout Following Period 1||2
8295952|NCT01582308|20453488|P6|STARTED|10-day Washout Following Period 1||2
8295953|NCT01582308|20453489|P5|STARTED|10-day Washout Following Period 1||3
8295954|NCT01582308|20453490|P4|STARTED|10-day Washout Following Period 1||2
8295955|NCT01582308|20453491|P3|STARTED|10-day Washout Following Period 1||2
8295956|NCT01582308|20453492|P2|STARTED|10-day Washout Following Period 1||2
8295957|NCT01582308|20453493|P1|STARTED|10-day Washout Following Period 1||2
8295958|NCT01582308|20453484|P10|NOT COMPLETED|Period 1||0
8295959|NCT01582308|20453485|P9|NOT COMPLETED|Period 1||0
8295960|NCT01582308|20453486|P8|NOT COMPLETED|Period 1||0
8295961|NCT01582308|20453487|P7|NOT COMPLETED|Period 1||1
8295962|NCT01582308|20453488|P6|NOT COMPLETED|Period 1||0
8295963|NCT01582308|20453489|P5|NOT COMPLETED|Period 1||0
8295964|NCT01582308|20453490|P4|NOT COMPLETED|Period 1||0
8295965|NCT01582308|20453491|P3|NOT COMPLETED|Period 1||0
8295966|NCT01582308|20453492|P2|NOT COMPLETED|Period 1||0
8295967|NCT01582308|20453493|P1|NOT COMPLETED|Period 1||0
8295968|NCT01582308|20453484|P10|COMPLETED|Period 1||2
8295969|NCT01582308|20453485|P9|COMPLETED|Period 1||2
8295970|NCT01582308|20453486|P8|COMPLETED|Period 1||2
8295971|NCT01582308|20453487|P7|COMPLETED|Period 1||2
8295972|NCT01582308|20453488|P6|COMPLETED|Period 1||2
8295973|NCT01582308|20453489|P5|COMPLETED|Period 1||3
8295974|NCT01582308|20453490|P4|COMPLETED|Period 1||2
8295975|NCT01582308|20453491|P3|COMPLETED|Period 1||2
8295976|NCT01582308|20453492|P2|COMPLETED|Period 1||2
8295977|NCT01582308|20453493|P1|COMPLETED|Period 1||2
8295978|NCT01582308|20453484|P10|STARTED|Period 1||2
8295979|NCT01582308|20453485|P9|STARTED|Period 1||2
8295980|NCT01582308|20453486|P8|STARTED|Period 1||2
8295981|NCT01582308|20453487|P7|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
8295982|NCT01582308|20453488|P6|STARTED|Period 1||2
8295983|NCT01582308|20453489|P5|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
8295984|NCT01582308|20453490|P4|STARTED|Period 1||2
8295985|NCT01582308|20453491|P3|STARTED|Period 1||2
8295986|NCT01582308|20453492|P2|STARTED|Period 1||2
8295987|NCT01582308|20453493|P1|STARTED|Period 1||2
8295988|NCT01582282|20453521|P3|NOT COMPLETED|Overall Study||0
8295989|NCT01582282|20453522|P2|NOT COMPLETED|Overall Study||2
8295990|NCT01582282|20453523|P1|NOT COMPLETED|Overall Study||2
8295991|NCT01582282|20453521|P3|COMPLETED|Overall Study||8
8295992|NCT01582282|20453522|P2|COMPLETED|Overall Study||12
8295993|NCT01582282|20453523|P1|COMPLETED|Overall Study||13
8295994|NCT01582282|20453521|P3|STARTED|Overall Study||8
8295995|NCT01582282|20453522|P2|STARTED|Overall Study||14
8295996|NCT01582282|20453523|P1|STARTED|Overall Study||15
8295997|NCT01582243|20453546|P1|NOT COMPLETED|Overall Study||3
8295998|NCT01582243|20453546|P1|COMPLETED|Overall Study||37
8295999|NCT01582243|20453546|P1|STARTED|Overall Study||40
8296000|NCT01582178|20453557|P2|NOT COMPLETED|Overall Study||5
8296001|NCT01582178|20453558|P1|NOT COMPLETED|Overall Study||6
8296002|NCT01582178|20453557|P2|COMPLETED|Overall Study||101
8296003|NCT01582178|20453558|P1|COMPLETED|Overall Study||100
8296004|NCT01582178|20453557|P2|STARTED|Overall Study||106
8296005|NCT01582178|20453558|P1|STARTED|Overall Study||106
8296006|NCT01582152|20453566|P2|NOT COMPLETED|Overall Study||6
8296007|NCT01582152|20453567|P1|NOT COMPLETED|Overall Study||6
8296008|NCT01582152|20453566|P2|COMPLETED|Overall Study||0
8296009|NCT01582152|20453567|P1|COMPLETED|Overall Study||0
8296010|NCT01582152|20453566|P2|STARTED|Overall Study||6
8296011|NCT01582152|20453567|P1|STARTED|Overall Study||6
8296012|NCT01582139|20453577|P2|NOT COMPLETED|Overall Study||0
8296013|NCT01582139|20453578|P1|NOT COMPLETED|Overall Study||0
8296014|NCT01582139|20453577|P2|COMPLETED|Overall Study||6
8296015|NCT01582139|20453578|P1|COMPLETED|Overall Study||6
8296016|NCT01582139|20453577|P2|STARTED|Overall Study||6
8296017|NCT01582139|20453578|P1|STARTED|Overall Study||6
8296018|NCT01582100|20453590|P1|NOT COMPLETED|Overall Study||2
8296019|NCT01582100|20453590|P1|COMPLETED|Overall Study||0
8296020|NCT01582100|20453590|P1|STARTED|Overall Study||2
8296021|NCT01582061|20453596|P2|NOT COMPLETED|Overall Study||36
8296022|NCT01582061|20453597|P1|NOT COMPLETED|Overall Study||28
8296023|NCT01582061|20453596|P2|COMPLETED|Overall Study||19
8296024|NCT01582061|20453597|P1|COMPLETED|Overall Study||21
8296025|NCT01582061|20453596|P2|STARTED|Overall Study||55
8296026|NCT01582061|20453597|P1|STARTED|Overall Study||49
8296027|NCT01582009|20453647|P1|NOT COMPLETED|Overall Study||2
8296028|NCT01582009|20453647|P1|COMPLETED|Overall Study||24
8296029|NCT01582009|20453647|P1|STARTED|Overall Study||26
8296030|NCT01581970|20453655|P1|NOT COMPLETED|Overall Study||0
8296031|NCT01581970|20453655|P1|COMPLETED|Overall Study||7
8296032|NCT01581970|20453655|P1|STARTED|Overall Study||7
8296033|NCT01581931|20453664|P2|NOT COMPLETED|Second Period||0
8296034|NCT01581931|20453665|P1|NOT COMPLETED|Second Period||0
8296035|NCT01581931|20453664|P2|COMPLETED|Second Period||15
8296036|NCT01581931|20453665|P1|COMPLETED|Second Period||16
8296037|NCT01581931|20453664|P2|STARTED|Second Period||15
8296038|NCT01581931|20453665|P1|STARTED|Second Period||16
8296039|NCT01581931|20453664|P2|NOT COMPLETED|Washout||1
8296040|NCT01581931|20453665|P1|NOT COMPLETED|Washout||0
8296041|NCT01581931|20453664|P2|COMPLETED|Washout||15
8296042|NCT01581931|20453665|P1|COMPLETED|Washout||16
8296043|NCT01581931|20453664|P2|STARTED|Washout||16
8296044|NCT01581931|20453665|P1|STARTED|Washout||16
8296045|NCT01581931|20453664|P2|NOT COMPLETED|First Period||0
8296046|NCT01581931|20453665|P1|NOT COMPLETED|First Period||0
8296047|NCT01581931|20453664|P2|COMPLETED|First Period||16
8296048|NCT01581931|20453665|P1|COMPLETED|First Period||16
8296049|NCT01581931|20453664|P2|STARTED|First Period||16
8296050|NCT01581931|20453665|P1|STARTED|First Period||16
8296051|NCT01581710|20453679|P2|NOT COMPLETED|Second Intervention (14days)||2
8296052|NCT01581710|20453680|P1|NOT COMPLETED|Second Intervention (14days)||0
8296053|NCT01581710|20453679|P2|COMPLETED|Second Intervention (14days)||12
8296054|NCT01581710|20453680|P1|COMPLETED|Second Intervention (14days)||18
8296055|NCT01581710|20453679|P2|STARTED|Second Intervention (14days)||14
8296056|NCT01581710|20453680|P1|STARTED|Second Intervention (14days)||18
8296057|NCT01581710|20453679|P2|NOT COMPLETED|Washout Period (14days)||0
8296058|NCT01581710|20453680|P1|NOT COMPLETED|Washout Period (14days)||0
8296059|NCT01581710|20453679|P2|COMPLETED|Washout Period (14days)||14
8296060|NCT01581710|20453680|P1|COMPLETED|Washout Period (14days)||18
8296061|NCT01581710|20453679|P2|STARTED|Washout Period (14days)||14
8296062|NCT01581710|20453680|P1|STARTED|Washout Period (14days)||18
8296063|NCT01581710|20453679|P2|NOT COMPLETED|First Intervention (14days)||0
8296064|NCT01581710|20453680|P1|NOT COMPLETED|First Intervention (14days)||0
8296065|NCT01581710|20453679|P2|COMPLETED|First Intervention (14days)||14
8296066|NCT01581710|20453680|P1|COMPLETED|First Intervention (14days)||18
8296067|NCT01581710|20453679|P2|STARTED|First Intervention (14days)||14
8296068|NCT01581710|20453680|P1|STARTED|First Intervention (14days)||18
8296069|NCT01581684|20453718|P10|NOT COMPLETED|Overall Study||0
8296070|NCT01581684|20453719|P9|NOT COMPLETED|Overall Study||1
8296071|NCT01581684|20453720|P8|NOT COMPLETED|Overall Study||0
8296072|NCT01581684|20453721|P7|NOT COMPLETED|Overall Study||0
8296073|NCT01581684|20453722|P6|NOT COMPLETED|Overall Study||0
8296074|NCT01581684|20453723|P5|NOT COMPLETED|Overall Study||0
8296075|NCT01581684|20453724|P4|NOT COMPLETED|Overall Study||0
8296076|NCT01581684|20453725|P3|NOT COMPLETED|Overall Study||0
8296077|NCT01581684|20453726|P2|NOT COMPLETED|Overall Study||0
8296078|NCT01581684|20453727|P1|NOT COMPLETED|Overall Study||0
8296079|NCT01581684|20453718|P10|COMPLETED|Overall Study||5
8296080|NCT01581684|20453719|P9|COMPLETED|Overall Study||0
8296081|NCT01581684|20453720|P8|COMPLETED|Overall Study||6
8296082|NCT01581684|20453721|P7|COMPLETED|Overall Study||6
8296083|NCT01581684|20453722|P6|COMPLETED|Overall Study||6
8296084|NCT01581684|20453723|P5|COMPLETED|Overall Study||6
8296085|NCT01581684|20453724|P4|COMPLETED|Overall Study||6
8296086|NCT01581684|20453725|P3|COMPLETED|Overall Study||6
8296087|NCT01581684|20453726|P2|COMPLETED|Overall Study||6
8296088|NCT01581684|20453727|P1|COMPLETED|Overall Study||14
8296089|NCT01581684|20453718|P10|STARTED|Overall Study||5
8296090|NCT01581684|20453719|P9|STARTED|Overall Study||1
8296091|NCT01581684|20453720|P8|STARTED|Overall Study||6
8296092|NCT01581684|20453721|P7|STARTED|Overall Study||6
8296093|NCT01581684|20453722|P6|STARTED|Overall Study||6
8296094|NCT01581684|20453723|P5|STARTED|Overall Study||6
8296095|NCT01581684|20453724|P4|STARTED|Overall Study||6
8296096|NCT01581684|20453725|P3|STARTED|Overall Study||6
8296097|NCT01581684|20453726|P2|STARTED|Overall Study||6
8296098|NCT01581684|20453727|P1|STARTED|Overall Study||14
8296099|NCT01581658|20453802|P4|NOT COMPLETED|Overall Study||0
8296100|NCT01581658|20453803|P3|NOT COMPLETED|Overall Study||0
8296101|NCT01581658|20453804|P2|NOT COMPLETED|Overall Study||0
8296102|NCT01581658|20453805|P1|NOT COMPLETED|Overall Study||0
8296103|NCT01581658|20453802|P4|COMPLETED|Overall Study||8
8296104|NCT01581658|20453803|P3|COMPLETED|Overall Study||8
8296105|NCT01581658|20453804|P2|COMPLETED|Overall Study||8
8296106|NCT01581658|20453805|P1|COMPLETED|Overall Study||8
8296107|NCT01581658|20453802|P4|STARTED|Overall Study||8
8296108|NCT01581658|20453803|P3|STARTED|Overall Study||8
8296109|NCT01581658|20453804|P2|STARTED|Overall Study||8
8296110|NCT01581658|20453805|P1|STARTED|Overall Study||8
8296111|NCT01581619|20453823|P1|NOT COMPLETED|Overall Study||2
8296112|NCT01581619|20453823|P1|COMPLETED|Overall Study||52
8296113|NCT01581619|20453823|P1|STARTED|Overall Study||54
8296114|NCT01581541|20453831|P11|NOT COMPLETED|Overall Study||0
8296115|NCT01581541|20453832|P10|NOT COMPLETED|Overall Study||0
8296116|NCT01581541|20453833|P9|NOT COMPLETED|Overall Study||0
8296117|NCT01581541|20453834|P8|NOT COMPLETED|Overall Study||0
8296118|NCT01581541|20453835|P7|NOT COMPLETED|Overall Study||0
8296119|NCT01581541|20453836|P6|NOT COMPLETED|Overall Study||0
8296120|NCT01581541|20453837|P5|NOT COMPLETED|Overall Study||0
8296121|NCT01581541|20453838|P4|NOT COMPLETED|Overall Study||0
8296122|NCT01581541|20453839|P3|NOT COMPLETED|Overall Study||0
8296123|NCT01581541|20453840|P2|NOT COMPLETED|Overall Study||0
8296124|NCT01581541|20453841|P1|NOT COMPLETED|Overall Study||0
8296125|NCT01581541|20453831|P11|COMPLETED|Overall Study||1
8296126|NCT01581541|20453832|P10|COMPLETED|Overall Study||3
8296127|NCT01581541|20453833|P9|COMPLETED|Overall Study||1
8296128|NCT01581541|20453834|P8|COMPLETED|Overall Study||2
8296129|NCT01581541|20453835|P7|COMPLETED|Overall Study||1
8296130|NCT01581541|20453836|P6|COMPLETED|Overall Study||3
8296131|NCT01581541|20453837|P5|COMPLETED|Overall Study||2
8296132|NCT01581541|20453838|P4|COMPLETED|Overall Study||1
8296133|NCT01581541|20453839|P3|COMPLETED|Overall Study||1
8296134|NCT01581541|20453840|P2|COMPLETED|Overall Study||1
8296135|NCT01581541|20453841|P1|COMPLETED|Overall Study||1
8296136|NCT01581541|20453831|P11|STARTED|Overall Study||1
8296137|NCT01581541|20453832|P10|STARTED|Overall Study||3
8296138|NCT01581541|20453833|P9|STARTED|Overall Study||1
8296139|NCT01581541|20453834|P8|STARTED|Overall Study||2
8296140|NCT01581541|20453835|P7|STARTED|Overall Study||1
8296141|NCT01581541|20453836|P6|STARTED|Overall Study||3
8296142|NCT01581541|20453837|P5|STARTED|Overall Study||2
8296143|NCT01581541|20453838|P4|STARTED|Overall Study||1
8296144|NCT01581541|20453839|P3|STARTED|Overall Study||1
8296145|NCT01581541|20453840|P2|STARTED|Overall Study||1
8296146|NCT01581541|20453841|P1|STARTED|Overall Study||1
8296147|NCT01581437|20453965|P1|NOT COMPLETED|Overall Study||0
8296148|NCT01581437|20453965|P1|COMPLETED|Overall Study||78
8296149|NCT01581437|20453965|P1|STARTED|Overall Study||78
8296150|NCT01581307|20453976|P1|NOT COMPLETED|Overall Study||1
8296151|NCT01581307|20453976|P1|COMPLETED|Overall Study||8
8296152|NCT01581307|20453976|P1|STARTED|Overall Study||9
8296153|NCT01581281|20453985|P3|NOT COMPLETED|Overall Study||12
8296154|NCT01581281|20453986|P2|NOT COMPLETED|Overall Study||6
8296155|NCT01581281|20453987|P1|NOT COMPLETED|Overall Study||15
8296156|NCT01581281|20453985|P3|COMPLETED|Overall Study||132
8296157|NCT01581281|20453986|P2|COMPLETED|Overall Study||66
8296158|NCT01581281|20453987|P1|COMPLETED|Overall Study||130
8296159|NCT01581281|20453985|P3|STARTED|Overall Study||144
8296160|NCT01581281|20453986|P2|STARTED|Overall Study||72
8296161|NCT01581281|20453987|P1|STARTED|Overall Study||145
8296162|NCT01581021|20454009|P2|NOT COMPLETED|Overall Study||11
8296163|NCT01581021|20454010|P1|NOT COMPLETED|Overall Study||10
8296164|NCT01581021|20454009|P2|COMPLETED|Overall Study||18
8296165|NCT01581021|20454010|P1|COMPLETED|Overall Study||19
8296166|NCT01581021|20454009|P2|STARTED|Overall Study||29
8296167|NCT01581021|20454010|P1|STARTED|Overall Study||29
8296168|NCT01581008|20454024|P2|NOT COMPLETED|Overall Study||6
8296169|NCT01581008|20454025|P1|NOT COMPLETED|Overall Study||1
8296170|NCT01581008|20454024|P2|COMPLETED|Overall Study||7
8296171|NCT01581008|20454025|P1|COMPLETED|Overall Study||16
8296172|NCT01581008|20454024|P2|STARTED|Overall Study||13
8296173|NCT01581008|20454025|P1|STARTED|Overall Study||17
8296174|NCT01580995|20454037|P2|NOT COMPLETED|Overall Study||2
8296175|NCT01580995|20454038|P1|NOT COMPLETED|Overall Study||2
8296176|NCT01580995|20454037|P2|COMPLETED|Overall Study||7
8296177|NCT01580995|20454038|P1|COMPLETED|Overall Study||8
8296178|NCT01580995|20454037|P2|STARTED|Overall Study||9
8296179|NCT01580995|20454038|P1|STARTED|Overall Study||10
8296180|NCT01580969|20454047|P3|NOT COMPLETED|Overall Study||0
8296181|NCT01580969|20454048|P2|NOT COMPLETED|Overall Study||0
8296182|NCT01580969|20454049|P1|NOT COMPLETED|Overall Study||3
8296183|NCT01580969|20454047|P3|COMPLETED|Overall Study||13
8296184|NCT01580969|20454048|P2|COMPLETED|Overall Study||3
8296185|NCT01580969|20454049|P1|COMPLETED|Overall Study||3
8296186|NCT01580969|20454047|P3|STARTED|Overall Study||13
8296187|NCT01580969|20454048|P2|STARTED|Overall Study||3
8296188|NCT01580969|20454049|P1|STARTED|Overall Study||6
8296189|NCT01580904|20454083|P2|NOT COMPLETED|Overall Study||7
8296190|NCT01580904|20454084|P1|NOT COMPLETED|Overall Study||4
8296191|NCT01580904|20454083|P2|COMPLETED|Overall Study||42
8296192|NCT01580904|20454084|P1|COMPLETED|Overall Study||47
8296193|NCT01580904|20454083|P2|STARTED|Overall Study||49
8296194|NCT01580904|20454084|P1|STARTED|Overall Study||51
8296195|NCT01580670|20454096|P1|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2
8296196|NCT01580670|20454096|P1|COMPLETED|Maintenance Period (Week 14 to 54)||12
8296197|NCT01580670|20454096|P1|STARTED|Maintenance Period (Week 14 to 54)||14
8296198|NCT01580670|20454096|P1|NOT COMPLETED|Induction Period (Week 0 to 14)||0
8296199|NCT01580670|20454096|P1|COMPLETED|Induction Period (Week 0 to 14)||14
8296200|NCT01580670|20454096|P1|STARTED|Induction Period (Week 0 to 14)||14
8296201|NCT01580618|20454107|P2|NOT COMPLETED|Overall Study||0
8296202|NCT01580618|20454108|P1|NOT COMPLETED|Overall Study||1
8296203|NCT01580618|20454107|P2|COMPLETED|Overall Study||12
8296204|NCT01580618|20454108|P1|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
8296205|NCT01580618|20454107|P2|STARTED|Overall Study||12
8296206|NCT01580618|20454108|P1|STARTED|Overall Study||8
8296207|NCT01580592|20454124|P3|NOT COMPLETED|Overall Study||0
8296208|NCT01580592|20454125|P2|NOT COMPLETED|Overall Study||0
8296209|NCT01580592|20454126|P1|NOT COMPLETED|Overall Study||0
8296210|NCT01580592|20454124|P3|COMPLETED|Overall Study||12
8296211|NCT01580592|20454125|P2|COMPLETED|Overall Study||9
8296212|NCT01580592|20454126|P1|COMPLETED|Overall Study||10
8296213|NCT01580592|20454124|P3|STARTED|Overall Study||12
8296214|NCT01580592|20454125|P2|STARTED|Overall Study||9
8296215|NCT01580592|20454126|P1|STARTED|Overall Study||10
8296216|NCT01580488|20454137|P1|NOT COMPLETED|Overall Study||1
8296217|NCT01580488|20454137|P1|COMPLETED|Overall Study||23
8296218|NCT01580488|20454137|P1|STARTED|Overall Study||24
8296219|NCT01580423|20454181|P2|NOT COMPLETED|Second Intervention||0
8296220|NCT01580423|20454182|P1|NOT COMPLETED|Second Intervention||0
8296221|NCT01580423|20454181|P2|COMPLETED|Second Intervention||8
8296222|NCT01580423|20454182|P1|COMPLETED|Second Intervention||8
8296223|NCT01580423|20454181|P2|STARTED|Second Intervention||8
8296224|NCT01580423|20454182|P1|STARTED|Second Intervention||8
8296225|NCT01580423|20454181|P2|NOT COMPLETED|First Intervention||0
8296226|NCT01580423|20454182|P1|NOT COMPLETED|First Intervention||0
8296227|NCT01580423|20454181|P2|COMPLETED|First Intervention||8
8296228|NCT01580423|20454182|P1|COMPLETED|First Intervention||8
8296229|NCT01580423|20454181|P2|STARTED|First Intervention||8
8296230|NCT01580423|20454182|P1|STARTED|First Intervention||8
8296231|NCT01580410|20454194|P2|NOT COMPLETED|Overall Study||8
8296232|NCT01580410|20454195|P1|NOT COMPLETED|Overall Study||11
8296233|NCT01580410|20454194|P2|COMPLETED|Overall Study||60
8296234|NCT01580410|20454195|P1|COMPLETED|Overall Study||57
8296235|NCT01580410|20454194|P2|STARTED|Overall Study||68
8296236|NCT01580410|20454195|P1|STARTED|Overall Study||68
8296237|NCT01580306|20454211|P4|NOT COMPLETED|Overall Study||0
8296238|NCT01580306|20454212|P3|NOT COMPLETED|Overall Study||0
8296239|NCT01580306|20454213|P2|NOT COMPLETED|Overall Study||0
8296240|NCT01580306|20454214|P1|NOT COMPLETED|Overall Study||0
8296241|NCT01580306|20454211|P4|COMPLETED|Overall Study||8
8296242|NCT01580306|20454212|P3|COMPLETED|Overall Study||8
8296243|NCT01580306|20454213|P2|COMPLETED|Overall Study||8
8296244|NCT01580306|20454214|P1|COMPLETED|Overall Study||8
8296245|NCT01580306|20454211|P4|STARTED|Overall Study||8
8296246|NCT01580306|20454212|P3|STARTED|Overall Study||8
8296247|NCT01580306|20454213|P2|STARTED|Overall Study||8
8296248|NCT01580306|20454214|P1|STARTED|Overall Study||8
8296249|NCT01580293|20454243|P3|NOT COMPLETED|Part B||2
8296250|NCT01580293|20454244|P2|NOT COMPLETED|Part B||0
8296251|NCT01580293|20454245|P1|NOT COMPLETED|Part B||0
8296252|NCT01580293|20454243|P3|COMPLETED|Part B||17
8296253|NCT01580293|20454244|P2|COMPLETED|Part B||0
8296254|NCT01580293|20454245|P1|COMPLETED|Part B||0
8296255|NCT01580293|20454243|P3|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
8296256|NCT01580293|20454244|P2|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
8296257|NCT01580293|20454245|P1|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
8296258|NCT01580293|20454243|P3|NOT COMPLETED|Part A_Extension||0
8296259|NCT01580293|20454244|P2|NOT COMPLETED|Part A_Extension||12
8296260|NCT01580293|20454245|P1|NOT COMPLETED|Part A_Extension||0
8296261|NCT01580293|20454243|P3|COMPLETED|Part A_Extension||0
8296262|NCT01580293|20454244|P2|COMPLETED|Part A_Extension||95
8296263|NCT01580293|20454245|P1|COMPLETED|Part A_Extension||14
8296264|NCT01580293|20454243|P3|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
8296265|NCT01580293|20454244|P2|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
8296266|NCT01580293|20454245|P1|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
8296267|NCT01580293|20454243|P3|NOT COMPLETED|Part A_Main Trial||0
8296268|NCT01580293|20454244|P2|NOT COMPLETED|Part A_Main Trial||6
8296269|NCT01580293|20454245|P1|NOT COMPLETED|Part A_Main Trial||2
8296270|NCT01580293|20454243|P3|COMPLETED|Part A_Main Trial||0
8296271|NCT01580293|20454244|P2|COMPLETED|Part A_Main Trial||108
8296272|NCT01580293|20454245|P1|COMPLETED|Part A_Main Trial||18
8296273|NCT01580293|20454243|P3|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
8296274|NCT01580293|20454244|P2|STARTED|Part A_Main Trial||114
8296275|NCT01580293|20454245|P1|STARTED|Part A_Main Trial||20
8296276|NCT01580098|20454330|P3|NOT COMPLETED|Overall Study||3
8296277|NCT01580098|20454331|P2|NOT COMPLETED|Overall Study||13
8296278|NCT01580098|20454332|P1|NOT COMPLETED|Overall Study||15
8296279|NCT01580098|20454330|P3|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
8296280|NCT01580098|20454331|P2|COMPLETED|Overall Study||101
8296281|NCT01580098|20454332|P1|COMPLETED|Overall Study||61
8296282|NCT01580098|20454330|P3|STARTED|Overall Study||3
8296283|NCT01580098|20454331|P2|STARTED|Overall Study||114
8296284|NCT01580098|20454332|P1|STARTED|Overall Study||76
8296285|NCT01580072|20454355|P3|NOT COMPLETED|Overall Study||0
8296286|NCT01580072|20454356|P2|NOT COMPLETED|Overall Study||9
8296287|NCT01580072|20454357|P1|NOT COMPLETED|Overall Study||12
8296288|NCT01580072|20454355|P3|COMPLETED|Overall Study||0
8296289|NCT01580072|20454356|P2|COMPLETED|Overall Study||28
8296290|NCT01580072|20454357|P1|COMPLETED|Overall Study||16
8296291|NCT01580072|20454355|P3|STARTED|Overall Study||0
8296292|NCT01580072|20454356|P2|STARTED|Overall Study||37
8296293|NCT01580072|20454357|P1|STARTED|Overall Study||28
8296294|NCT01580020|20454385|P4|NOT COMPLETED|Overall Study||2
8296295|NCT01580020|20454386|P3|NOT COMPLETED|Overall Study||4
8296296|NCT01580020|20454387|P2|NOT COMPLETED|Overall Study||7
8296297|NCT01580020|20454388|P1|NOT COMPLETED|Overall Study||1
8296298|NCT01580020|20454385|P4|COMPLETED|Overall Study||20
8296299|NCT01580020|20454386|P3|COMPLETED|Overall Study||57
8296300|NCT01580020|20454387|P2|COMPLETED|Overall Study||33
8296301|NCT01580020|20454388|P1|COMPLETED|Overall Study||51
8296302|NCT01580020|20454385|P4|STARTED|Overall Study||22
8296303|NCT01580020|20454386|P3|STARTED|Overall Study||61
8296304|NCT01580020|20454387|P2|STARTED|Overall Study||40
8296305|NCT01580020|20454388|P1|STARTED|Overall Study||52
8296306|NCT01579916|20454432|P2|NOT COMPLETED|Overall Study||2
8296307|NCT01579916|20454433|P1|NOT COMPLETED|Overall Study||8
8296308|NCT01579916|20454432|P2|COMPLETED|Overall Study||59
8296309|NCT01579916|20454433|P1|COMPLETED|Overall Study||234
8296310|NCT01579916|20454432|P2|STARTED|Overall Study||61
8296311|NCT01579916|20454433|P1|STARTED|Overall Study||242
8296312|NCT01579812|20454459|P1|NOT COMPLETED|Overall Study||52
8296313|NCT01579812|20454459|P1|COMPLETED|Overall Study||38
8296314|NCT01579812|20454459|P1|STARTED|Overall Study||90
8296315|NCT01579747|20454469|P2|NOT COMPLETED|Overall Study||0
8296316|NCT01579747|20454470|P1|NOT COMPLETED|Overall Study||0
8296317|NCT01579747|20454469|P2|COMPLETED|Overall Study||12
8296318|NCT01579747|20454470|P1|COMPLETED|Overall Study||12
8296319|NCT01579747|20454469|P2|STARTED|Overall Study||12
8296320|NCT01579747|20454470|P1|STARTED|Overall Study||12
8296321|NCT01579669|20454480|P2|NOT COMPLETED|Overall Study||0
8296322|NCT01579669|20454481|P1|NOT COMPLETED|Overall Study||36
8296323|NCT01579669|20454480|P2|COMPLETED|Overall Study||41
8296324|NCT01579669|20454481|P1|COMPLETED|Overall Study||134
8296325|NCT01579669|20454480|P2|STARTED|Overall Study||41
8296326|NCT01579669|20454481|P1|STARTED|Overall Study||170
8296327|NCT01579578|20454493|P2|NOT COMPLETED|Overall Study||12
8296328|NCT01579578|20454494|P1|NOT COMPLETED|Overall Study||13
8296329|NCT01579578|20454493|P2|COMPLETED|Overall Study||0
8296330|NCT01579578|20454494|P1|COMPLETED|Overall Study||0
8296331|NCT01579578|20454493|P2|Ongoing|Overall Study||0
8296332|NCT01579578|20454494|P1|Ongoing|Overall Study||3
8296333|NCT01579578|20454493|P2|STARTED|Overall Study||12
8296334|NCT01579578|20454494|P1|STARTED|Overall Study||13
8296335|NCT01579565|20454506|P2|NOT COMPLETED|Treated||3
8296336|NCT01579565|20454507|P1|NOT COMPLETED|Treated||2
8296337|NCT01579565|20454506|P2|COMPLETED|Treated||201
8296338|NCT01579565|20454507|P1|COMPLETED|Treated||200
8296339|NCT01579565|20454506|P2|STARTED|Treated||204
8296340|NCT01579565|20454507|P1|STARTED|Treated||202
8296341|NCT01579565|20454506|P2|NOT COMPLETED|Randomized||5
8296342|NCT01579565|20454507|P1|NOT COMPLETED|Randomized||5
8296343|NCT01579565|20454506|P2|COMPLETED|Randomized||204
8296344|NCT01579565|20454507|P1|COMPLETED|Randomized||202
8296345|NCT01579565|20454506|P2|STARTED|Randomized||209
8296346|NCT01579565|20454507|P1|STARTED|Randomized||207
8296347|NCT01579513|20454537|P2|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27
8296348|NCT01579513|20454538|P1|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20
8296349|NCT01579513|20454537|P2|COMPLETED|1 Year Neurodevelopmental Follow up||68
8296350|NCT01579513|20454538|P1|COMPLETED|1 Year Neurodevelopmental Follow up||61
8296351|NCT01579513|20454537|P2|STARTED|1 Year Neurodevelopmental Follow up||95
8296352|NCT01579513|20454538|P1|STARTED|1 Year Neurodevelopmental Follow up||81
8296353|NCT01579513|20454537|P2|NOT COMPLETED|Primary Hospitalization||4
8296354|NCT01579513|20454538|P1|NOT COMPLETED|Primary Hospitalization||10
8296355|NCT01579513|20454537|P2|COMPLETED|Primary Hospitalization||95
8296356|NCT01579513|20454538|P1|COMPLETED|Primary Hospitalization||81
8296357|NCT01579513|20454537|P2|STARTED|Primary Hospitalization||99
8296358|NCT01579513|20454538|P1|STARTED|Primary Hospitalization||91
8296359|NCT01579474|20454558|P6|NOT COMPLETED|Overall Study||1
8296360|NCT01579474|20454559|P5|NOT COMPLETED|Overall Study||1
8296361|NCT01579474|20454560|P4|NOT COMPLETED|Overall Study||0
8296362|NCT01579474|20454561|P3|NOT COMPLETED|Overall Study||2
8296363|NCT01579474|20454562|P2|NOT COMPLETED|Overall Study||13
8296364|NCT01579474|20454563|P1|NOT COMPLETED|Overall Study||3
8296365|NCT01579474|20454558|P6|COMPLETED|Overall Study||1
8296366|NCT01579474|20454559|P5|COMPLETED|Overall Study||9
8296367|NCT01579474|20454560|P4|COMPLETED|Overall Study||3
8296368|NCT01579474|20454561|P3|COMPLETED|Overall Study||27
8296369|NCT01579474|20454562|P2|COMPLETED|Overall Study||30
8296370|NCT01579474|20454563|P1|COMPLETED|Overall Study||41
8296371|NCT01579474|20454558|P6|STARTED|Overall Study||2
8296372|NCT01579474|20454559|P5|STARTED|Overall Study||10
8296373|NCT01579474|20454560|P4|STARTED|Overall Study||3
8296374|NCT01579474|20454561|P3|STARTED|Overall Study||29
8296375|NCT01579474|20454562|P2|STARTED|Overall Study||43
8296376|NCT01579474|20454563|P1|STARTED|Overall Study||44
8296377|NCT01579318|20454637|P1|NOT COMPLETED|Overall Study||1
8296378|NCT01579318|20454637|P1|COMPLETED|Overall Study||1
8296379|NCT01579318|20454637|P1|STARTED|Overall Study||2
8296380|NCT01579305|20454650|P2|NOT COMPLETED|Overall Study||27
8296381|NCT01579305|20454651|P1|NOT COMPLETED|Overall Study||21
8296382|NCT01579305|20454650|P2|COMPLETED|Overall Study||115
8296383|NCT01579305|20454651|P1|COMPLETED|Overall Study||118
8296384|NCT01579305|20454650|P2|Continued After Treatment|Overall Study||141
8296385|NCT01579305|20454651|P1|Continued After Treatment|Overall Study||139
8296386|NCT01579305|20454650|P2|Discontinued Before Treatment|Overall Study||1
8296387|NCT01579305|20454651|P1|Discontinued Before Treatment|Overall Study||0
8296388|NCT01579305|20454650|P2|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
8296389|NCT01579305|20454651|P1|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
8296390|NCT01579214|20454659|P2|NOT COMPLETED|Overall Study||0
8296391|NCT01579214|20454660|P1|NOT COMPLETED|Overall Study||0
8296392|NCT01579214|20454659|P2|COMPLETED|Overall Study||138
8296393|NCT01579214|20454660|P1|COMPLETED|Overall Study||45
8296394|NCT01579214|20454659|P2|STARTED|Overall Study||138
8296395|NCT01579214|20454660|P1|STARTED|Overall Study||45
8296396|NCT01579084|20454678|P10|NOT COMPLETED|Overall Study||0
8296397|NCT01579084|20454679|P9|NOT COMPLETED|Overall Study||0
8296398|NCT01579084|20454680|P8|NOT COMPLETED|Overall Study||0
8296399|NCT01579084|20454681|P7|NOT COMPLETED|Overall Study||0
8296400|NCT01579084|20454682|P6|NOT COMPLETED|Overall Study||0
8296401|NCT01579084|20454683|P5|NOT COMPLETED|Overall Study||0
8296402|NCT01579084|20454684|P4|NOT COMPLETED|Overall Study||0
8296403|NCT01579084|20454685|P3|NOT COMPLETED|Overall Study||0
8296404|NCT01579084|20454686|P2|NOT COMPLETED|Overall Study||0
8296405|NCT01579084|20454687|P1|NOT COMPLETED|Overall Study||0
8296406|NCT01579084|20454678|P10|COMPLETED|Overall Study||4
8296407|NCT01579084|20454679|P9|COMPLETED|Overall Study||4
8296408|NCT01579084|20454680|P8|COMPLETED|Overall Study||4
8296409|NCT01579084|20454681|P7|COMPLETED|Overall Study||4
8296410|NCT01579084|20454682|P6|COMPLETED|Overall Study||8
8296411|NCT01579084|20454683|P5|COMPLETED|Overall Study||8
8296412|NCT01579084|20454684|P4|COMPLETED|Overall Study||8
8296413|NCT01579084|20454685|P3|COMPLETED|Overall Study||8
8296414|NCT01579084|20454686|P2|COMPLETED|Overall Study||8
8296415|NCT01579084|20454687|P1|COMPLETED|Overall Study||8
8296416|NCT01579084|20454678|P10|STARTED|Overall Study||4
8296417|NCT01579084|20454679|P9|STARTED|Overall Study||4
8296418|NCT01579084|20454680|P8|STARTED|Overall Study||4
8296419|NCT01579084|20454681|P7|STARTED|Overall Study||4
8296420|NCT01579084|20454682|P6|STARTED|Overall Study||8
8296421|NCT01579084|20454683|P5|STARTED|Overall Study||8
8296422|NCT01579084|20454684|P4|STARTED|Overall Study||8
8296423|NCT01579084|20454685|P3|STARTED|Overall Study||8
8296424|NCT01579084|20454686|P2|STARTED|Overall Study||8
8296425|NCT01579084|20454687|P1|STARTED|Overall Study||8
8296426|NCT01579045|20454715|P1|NOT COMPLETED|Overall Study||0
8296427|NCT01579045|20454715|P1|COMPLETED|Overall Study||24
8296428|NCT01579045|20454715|P1|STARTED|Overall Study||24
8296429|NCT01579006|20454732|P1|NOT COMPLETED|Overall Study||33
8296430|NCT01579006|20454732|P1|COMPLETED|Overall Study||151
8296431|NCT01579006|20454732|P1|STARTED|Overall Study||184
8296432|NCT01578993|20454771|P1|NOT COMPLETED|Overall Study||0
8296433|NCT01578993|20454771|P1|COMPLETED|Overall Study||101
8296434|NCT01578993|20454771|P1|STARTED|Overall Study||101
8296435|NCT01578980|20454775|P1|NOT COMPLETED|Overall Study||0
8296436|NCT01578980|20454775|P1|COMPLETED|Overall Study||20
8296437|NCT01578980|20454775|P1|STARTED|Overall Study||20
8296438|NCT01578967|20454780|P1|NOT COMPLETED|Overall Study||0
8296439|NCT01578967|20454780|P1|COMPLETED|Overall Study||41
8296440|NCT01578967|20454780|P1|STARTED|Overall Study||41
8296441|NCT01578902|20454789|P1|NOT COMPLETED|Overall Study||0
8296442|NCT01578902|20454789|P1|COMPLETED|Overall Study||84
8296443|NCT01578902|20454789|P1|STARTED|Overall Study||84
8296444|NCT01578850|20454800|P3|NOT COMPLETED|Period 2||14
8296445|NCT01578850|20454801|P2|NOT COMPLETED|Period 2||13
8296446|NCT01578850|20454802|P1|NOT COMPLETED|Period 2||0
8296447|NCT01578850|20454800|P3|COMPLETED|Period 2||162
8296448|NCT01578850|20454801|P2|COMPLETED|Period 2||154
8296449|NCT01578850|20454802|P1|COMPLETED|Period 2||0
8296450|NCT01578850|20454800|P3|STARTED|Period 2|One participants in PBO did not receive treatment.|176
8296451|NCT01578850|20454801|P2|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
8296452|NCT01578850|20454802|P1|STARTED|Period 2||0
8296453|NCT01578850|20454800|P3|NOT COMPLETED|Period 1||0
8296454|NCT01578850|20454801|P2|NOT COMPLETED|Period 1||0
8296455|NCT01578850|20454802|P1|NOT COMPLETED|Period 1||37
8296456|NCT01578850|20454800|P3|COMPLETED|Period 1||0
8296457|NCT01578850|20454801|P2|COMPLETED|Period 1||0
8296458|NCT01578850|20454802|P1|COMPLETED|Period 1||452
8296459|NCT01578850|20454800|P3|STARTED|Period 1||0
8296460|NCT01578850|20454801|P2|STARTED|Period 1||0
8296461|NCT01578850|20454802|P1|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
8296462|NCT01578785|20454854|P2|NOT COMPLETED|Overall Study||119
8296463|NCT01578785|20454855|P1|NOT COMPLETED|Overall Study||59
8296464|NCT01578785|20454854|P2|COMPLETED|Overall Study||0
8296465|NCT01578785|20454855|P1|COMPLETED|Overall Study||0
8296466|NCT01578785|20454854|P2|STARTED|Overall Study||119
8296467|NCT01578785|20454855|P1|STARTED|Overall Study||59
8296468|NCT01578772|20454867|P1|NOT COMPLETED|Overall Study||0
8296469|NCT01578772|20454867|P1|COMPLETED|Overall Study||17
8296470|NCT01578772|20454867|P1|STARTED|Overall Study||17
8296471|NCT01578707|20454876|P2|NOT COMPLETED|Overall Study||0
8296472|NCT01578707|20454877|P1|NOT COMPLETED|Overall Study||0
8296473|NCT01578707|20454876|P2|COMPLETED|Overall Study||195
8296474|NCT01578707|20454877|P1|COMPLETED|Overall Study||196
8296475|NCT01578707|20454876|P2|STARTED|Overall Study||195
8296476|NCT01578707|20454877|P1|STARTED|Overall Study||196
8296477|NCT01578577|20454896|P3|NOT COMPLETED|Overall Study||35
8296478|NCT01578577|20454897|P2|NOT COMPLETED|Overall Study||40
8296479|NCT01578577|20454898|P1|NOT COMPLETED|Overall Study||51
8296480|NCT01578577|20454896|P3|COMPLETED|Overall Study||278
8296481|NCT01578577|20454897|P2|COMPLETED|Overall Study||262
8296482|NCT01578577|20454898|P1|COMPLETED|Overall Study||254
8296483|NCT01578577|20454896|P3|STARTED|Overall Study||313
8296484|NCT01578577|20454897|P2|STARTED|Overall Study||302
8296485|NCT01578577|20454898|P1|STARTED|Overall Study||305
8296486|NCT01578551|20454920|P2|NOT COMPLETED|Overall Study||0
8296487|NCT01578551|20454921|P1|NOT COMPLETED|Overall Study||1
8296488|NCT01578551|20454920|P2|COMPLETED|Overall Study||6
8296489|NCT01578551|20454921|P1|COMPLETED|Overall Study||18
8296490|NCT01578551|20454920|P2|STARTED|Overall Study||6
8296491|NCT01578551|20454921|P1|STARTED|Overall Study||19
8296492|NCT01578499|20454933|P2|NOT COMPLETED|Overall Study||43
8296493|NCT01578499|20454934|P1|NOT COMPLETED|Overall Study||34
8296494|NCT01578499|20454933|P2|COMPLETED|Overall Study||22
8296495|NCT01578499|20454934|P1|COMPLETED|Overall Study||32
8296496|NCT01578499|20454933|P2|Intent to Treat Population: CD30+|Overall Study||64
8296497|NCT01578499|20454934|P1|Intent to Treat Population: CD30+|Overall Study||64
8296498|NCT01578499|20454933|P2|Safety Population: Treated|Overall Study||62
8296499|NCT01578499|20454934|P1|Safety Population: Treated|Overall Study||66
8296500|NCT01578499|20454933|P2|STARTED|Overall Study||65
8296501|NCT01578499|20454934|P1|STARTED|Overall Study||66
8296502|NCT01578486|20454968|P1|NOT COMPLETED|Overall Study||5
8296503|NCT01578486|20454968|P1|COMPLETED|Overall Study||8
8296504|NCT01578486|20454968|P1|STARTED|Overall Study||13
8296505|NCT01578330|20454979|P1|NOT COMPLETED|Overall Study||7
8296506|NCT01578330|20454979|P1|COMPLETED|Overall Study||35
8296507|NCT01578330|20454979|P1|Per Protocol Population|Overall Study||35
8296508|NCT01578330|20454979|P1|STARTED|Overall Study||42
8296509|NCT01578317|20454988|P2|NOT COMPLETED|Overall Study||1
8296510|NCT01578317|20454989|P1|NOT COMPLETED|Overall Study||0
8296511|NCT01578317|20454988|P2|COMPLETED|Overall Study||20
8296512|NCT01578317|20454989|P1|COMPLETED|Overall Study||22
8296513|NCT01578317|20454988|P2|Analysis Population|Overall Study||20
8296514|NCT01578317|20454989|P1|Analysis Population|Overall Study||22
8296515|NCT01578317|20454988|P2|STARTED|Overall Study||21
8296516|NCT01578317|20454989|P1|STARTED|Overall Study||22
8296517|NCT01578278|20454999|P4|NOT COMPLETED|Overall Study||9
8296518|NCT01578278|20455000|P3|NOT COMPLETED|Overall Study||4
8296519|NCT01578278|20455001|P2|NOT COMPLETED|Overall Study||2
8296520|NCT01578278|20455002|P1|NOT COMPLETED|Overall Study||4
8296521|NCT01578278|20454999|P4|COMPLETED|Overall Study||139
8296522|NCT01578278|20455000|P3|COMPLETED|Overall Study||150
8296523|NCT01578278|20455001|P2|COMPLETED|Overall Study||150
8296524|NCT01578278|20455002|P1|COMPLETED|Overall Study||148
8296525|NCT01578278|20454999|P4|STARTED|Overall Study||148
8296526|NCT01578278|20455000|P3|STARTED|Overall Study||154
8296527|NCT01578278|20455001|P2|STARTED|Overall Study||152
8296528|NCT01578278|20455002|P1|STARTED|Overall Study||152
8296535|NCT01578187|20455021|P1|NOT COMPLETED|Usability Phase||1
8296536|NCT01578187|20455021|P1|COMPLETED|Usability Phase||47
8296537|NCT01578187|20455021|P1|STARTED|Usability Phase||48
8296538|NCT01578187|20455021|P1|NOT COMPLETED|Label Comprehension Phase||0
8296539|NCT01578187|20455021|P1|COMPLETED|Label Comprehension Phase||63
8296540|NCT01578187|20455021|P1|STARTED|Label Comprehension Phase||63
8296541|NCT01578044|20455029|P2|NOT COMPLETED|Overall Study||0
8296542|NCT01578044|20455030|P1|NOT COMPLETED|Overall Study||0
8296543|NCT01578044|20455029|P2|COMPLETED|Overall Study||6
8296544|NCT01578044|20455030|P1|COMPLETED|Overall Study||6
8296545|NCT01578044|20455029|P2|STARTED|Overall Study||6
8296546|NCT01578044|20455030|P1|STARTED|Overall Study||6
8296547|NCT01578031|20455040|P4|NOT COMPLETED|Overall Study||0
8296548|NCT01578031|20455041|P3|NOT COMPLETED|Overall Study||0
8296549|NCT01578031|20455042|P2|NOT COMPLETED|Overall Study||34
8296550|NCT01578031|20455043|P1|NOT COMPLETED|Overall Study||62
8296551|NCT01578031|20455040|P4|COMPLETED|Overall Study|Only baseline data collected|30
8296552|NCT01578031|20455041|P3|COMPLETED|Overall Study|Only baseline data collected|12
8296553|NCT01578031|20455042|P2|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
8296554|NCT01578031|20455043|P1|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
8296555|NCT01578031|20455040|P4|STARTED|Overall Study||30
8296556|NCT01578031|20455041|P3|STARTED|Overall Study||12
8296557|NCT01578031|20455042|P2|STARTED|Overall Study||69
8296558|NCT01578031|20455043|P1|STARTED|Overall Study||129
8296559|NCT01577966|20455059|P1|NOT COMPLETED|Overall Study||0
8296560|NCT01577966|20455059|P1|COMPLETED|Overall Study||9
8296561|NCT01577966|20455059|P1|STARTED|Overall Study||9
8296562|NCT01577758|20455063|P8|NOT COMPLETED|mCRC Expansion Phase||25
8296563|NCT01577758|20455064|P7|NOT COMPLETED|mCRC Expansion Phase||0
8296564|NCT01577758|20455065|P6|NOT COMPLETED|mCRC Expansion Phase||0
8296565|NCT01577758|20455066|P5|NOT COMPLETED|mCRC Expansion Phase||0
8296566|NCT01577758|20455067|P4|NOT COMPLETED|mCRC Expansion Phase||0
8296567|NCT01577758|20455068|P3|NOT COMPLETED|mCRC Expansion Phase||0
8296568|NCT01577758|20455069|P2|NOT COMPLETED|mCRC Expansion Phase||0
8296569|NCT01577758|20455070|P1|NOT COMPLETED|mCRC Expansion Phase||0
8296570|NCT01577758|20455063|P8|COMPLETED|mCRC Expansion Phase||0
8296571|NCT01577758|20455064|P7|COMPLETED|mCRC Expansion Phase||0
8296572|NCT01577758|20455065|P6|COMPLETED|mCRC Expansion Phase||0
8296573|NCT01577758|20455066|P5|COMPLETED|mCRC Expansion Phase||0
8296574|NCT01577758|20455067|P4|COMPLETED|mCRC Expansion Phase||0
8296575|NCT01577758|20455068|P3|COMPLETED|mCRC Expansion Phase||0
8296576|NCT01577758|20455069|P2|COMPLETED|mCRC Expansion Phase||0
8296577|NCT01577758|20455070|P1|COMPLETED|mCRC Expansion Phase||0
8296578|NCT01577758|20455063|P8|STARTED|mCRC Expansion Phase||25
8296579|NCT01577758|20455064|P7|STARTED|mCRC Expansion Phase||0
8296580|NCT01577758|20455065|P6|STARTED|mCRC Expansion Phase||0
8296581|NCT01577758|20455066|P5|STARTED|mCRC Expansion Phase||0
8296582|NCT01577758|20455067|P4|STARTED|mCRC Expansion Phase||0
8296583|NCT01577758|20455068|P3|STARTED|mCRC Expansion Phase||0
8296584|NCT01577758|20455069|P2|STARTED|mCRC Expansion Phase||0
8296585|NCT01577758|20455070|P1|STARTED|mCRC Expansion Phase||0
8296586|NCT01577758|20455063|P8|NOT COMPLETED|Dose Escalation Phase||0
8296587|NCT01577758|20455064|P7|NOT COMPLETED|Dose Escalation Phase||1
8296588|NCT01577758|20455065|P6|NOT COMPLETED|Dose Escalation Phase||4
8296589|NCT01577758|20455066|P5|NOT COMPLETED|Dose Escalation Phase||6
8296590|NCT01577758|20455067|P4|NOT COMPLETED|Dose Escalation Phase||2
8296591|NCT01577758|20455068|P3|NOT COMPLETED|Dose Escalation Phase||2
8296592|NCT01577758|20455069|P2|NOT COMPLETED|Dose Escalation Phase||2
8296593|NCT01577758|20455070|P1|NOT COMPLETED|Dose Escalation Phase||2
8296594|NCT01577758|20455063|P8|COMPLETED|Dose Escalation Phase||0
8296595|NCT01577758|20455064|P7|COMPLETED|Dose Escalation Phase||0
8296596|NCT01577758|20455065|P6|COMPLETED|Dose Escalation Phase||0
8296597|NCT01577758|20455066|P5|COMPLETED|Dose Escalation Phase||0
8296598|NCT01577758|20455067|P4|COMPLETED|Dose Escalation Phase||0
8296599|NCT01577758|20455068|P3|COMPLETED|Dose Escalation Phase||0
8296600|NCT01577758|20455069|P2|COMPLETED|Dose Escalation Phase||0
8296601|NCT01577758|20455070|P1|COMPLETED|Dose Escalation Phase||0
8296602|NCT01577758|20455063|P8|STARTED|Dose Escalation Phase||0
8296603|NCT01577758|20455064|P7|STARTED|Dose Escalation Phase||1
8296604|NCT01577758|20455065|P6|STARTED|Dose Escalation Phase||4
8296605|NCT01577758|20455066|P5|STARTED|Dose Escalation Phase||6
8296606|NCT01577758|20455067|P4|STARTED|Dose Escalation Phase||2
8296607|NCT01577758|20455068|P3|STARTED|Dose Escalation Phase||2
8296608|NCT01577758|20455069|P2|STARTED|Dose Escalation Phase||2
8296609|NCT01577758|20455070|P1|STARTED|Dose Escalation Phase||2
8296610|NCT01577745|20455109|P6|NOT COMPLETED|Overall Study||4
8296611|NCT01577745|20455110|P5|NOT COMPLETED|Overall Study||5
8296612|NCT01577745|20455111|P4|NOT COMPLETED|Overall Study||6
8296613|NCT01577745|20455112|P3|NOT COMPLETED|Overall Study||2
8296614|NCT01577745|20455113|P2|NOT COMPLETED|Overall Study||3
8296615|NCT01577745|20455114|P1|NOT COMPLETED|Overall Study||3
8296616|NCT01577745|20455109|P6|COMPLETED|Overall Study||1
8296617|NCT01577745|20455110|P5|COMPLETED|Overall Study||0
8296618|NCT01577745|20455111|P4|COMPLETED|Overall Study||0
8296619|NCT01577745|20455112|P3|COMPLETED|Overall Study||1
8296620|NCT01577745|20455113|P2|COMPLETED|Overall Study||0
8296621|NCT01577745|20455114|P1|COMPLETED|Overall Study||0
8296622|NCT01577745|20455109|P6|STARTED|Overall Study||5
8296623|NCT01577745|20455110|P5|STARTED|Overall Study||5
8296624|NCT01577745|20455111|P4|STARTED|Overall Study||6
8296625|NCT01577745|20455112|P3|STARTED|Overall Study||3
8296626|NCT01577745|20455113|P2|STARTED|Overall Study||3
8296627|NCT01577745|20455114|P1|STARTED|Overall Study||3
8296628|NCT01577732|20455231|P1|NOT COMPLETED|Overall Study||0
8296629|NCT01577732|20455231|P1|COMPLETED|Overall Study||300
8296630|NCT01577732|20455231|P1|STARTED|Overall Study||300
8296631|NCT01577706|20455238|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8296632|NCT01577706|20455239|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8296633|NCT01577706|20455240|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8296634|NCT01577706|20455238|P3|COMPLETED|Third Intervention (1 Day)||3
8296635|NCT01577706|20455239|P2|COMPLETED|Third Intervention (1 Day)||1
8296636|NCT01577706|20455240|P1|COMPLETED|Third Intervention (1 Day)||3
8296637|NCT01577706|20455238|P3|STARTED|Third Intervention (1 Day)||3
8296638|NCT01577706|20455239|P2|STARTED|Third Intervention (1 Day)||1
8296639|NCT01577706|20455240|P1|STARTED|Third Intervention (1 Day)||3
8296640|NCT01577706|20455238|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
8296641|NCT01577706|20455239|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
8296642|NCT01577706|20455240|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
8296643|NCT01577706|20455238|P3|COMPLETED|Washout (at Least 1 Week)||3
8296644|NCT01577706|20455239|P2|COMPLETED|Washout (at Least 1 Week)||1
8296645|NCT01577706|20455240|P1|COMPLETED|Washout (at Least 1 Week)||3
8296646|NCT01577706|20455238|P3|STARTED|Washout (at Least 1 Week)||3
8296647|NCT01577706|20455239|P2|STARTED|Washout (at Least 1 Week)||1
8296648|NCT01577706|20455240|P1|STARTED|Washout (at Least 1 Week)||3
8296649|NCT01577706|20455238|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8296650|NCT01577706|20455239|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8296651|NCT01577706|20455240|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8296652|NCT01577706|20455238|P3|COMPLETED|Second Intervention (1 Day)||3
8296653|NCT01577706|20455239|P2|COMPLETED|Second Intervention (1 Day)||1
8296654|NCT01577706|20455240|P1|COMPLETED|Second Intervention (1 Day)||3
8296655|NCT01577706|20455238|P3|STARTED|Second Intervention (1 Day)||3
8296656|NCT01577706|20455239|P2|STARTED|Second Intervention (1 Day)||1
8296657|NCT01577706|20455240|P1|STARTED|Second Intervention (1 Day)||3
8296658|NCT01577706|20455238|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
8296659|NCT01577706|20455239|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
8296660|NCT01577706|20455240|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
8296661|NCT01577706|20455238|P3|COMPLETED|Washout (at Least 1 Week)||3
8296662|NCT01577706|20455239|P2|COMPLETED|Washout (at Least 1 Week)||1
8296663|NCT01577706|20455240|P1|COMPLETED|Washout (at Least 1 Week)||3
8296664|NCT01577706|20455238|P3|STARTED|Washout (at Least 1 Week)||3
8296665|NCT01577706|20455239|P2|STARTED|Washout (at Least 1 Week)||1
8296666|NCT01577706|20455240|P1|STARTED|Washout (at Least 1 Week)||3
8296667|NCT01577706|20455238|P3|NOT COMPLETED|First Intervention (1 Day)||0
8296668|NCT01577706|20455239|P2|NOT COMPLETED|First Intervention (1 Day)||0
8296669|NCT01577706|20455240|P1|NOT COMPLETED|First Intervention (1 Day)||0
8296670|NCT01577706|20455238|P3|COMPLETED|First Intervention (1 Day)||3
8296671|NCT01577706|20455239|P2|COMPLETED|First Intervention (1 Day)||1
8296672|NCT01577706|20455240|P1|COMPLETED|First Intervention (1 Day)||3
8296673|NCT01577706|20455238|P3|STARTED|First Intervention (1 Day)||3
8296674|NCT01577706|20455239|P2|STARTED|First Intervention (1 Day)||1
8296675|NCT01577706|20455240|P1|STARTED|First Intervention (1 Day)||3
8296676|NCT01577628|20455268|P3|NOT COMPLETED|Overall Study||2
8296677|NCT01577628|20455269|P2|NOT COMPLETED|Overall Study||0
8296678|NCT01577628|20455270|P1|NOT COMPLETED|Overall Study||0
8296679|NCT01577628|20455268|P3|COMPLETED|Overall Study||0
8296680|NCT01577628|20455269|P2|COMPLETED|Overall Study||0
8296681|NCT01577628|20455270|P1|COMPLETED|Overall Study||0
8296682|NCT01577628|20455268|P3|STARTED|Overall Study||2
8296683|NCT01577628|20455269|P2|STARTED|Overall Study||0
8296684|NCT01577628|20455270|P1|STARTED|Overall Study||0
8296685|NCT01577537|20455296|P2|NOT COMPLETED|Overall Study||7
8296686|NCT01577537|20455297|P1|NOT COMPLETED|Overall Study||8
8296687|NCT01577537|20455296|P2|COMPLETED|Overall Study||116
8296688|NCT01577537|20455297|P1|COMPLETED|Overall Study||120
8296689|NCT01577537|20455296|P2|STARTED|Overall Study||123
8296690|NCT01577537|20455297|P1|STARTED|Overall Study||128
8296691|NCT01577381|20455315|P4|NOT COMPLETED|Overall Study||2
8296692|NCT01577381|20455316|P3|NOT COMPLETED|Overall Study||3
8296693|NCT01577381|20455317|P2|NOT COMPLETED|Overall Study||3
8296694|NCT01577381|20455318|P1|NOT COMPLETED|Overall Study||2
8296695|NCT01577381|20455315|P4|COMPLETED|Overall Study||0
8296696|NCT01577381|20455316|P3|COMPLETED|Overall Study||0
8296697|NCT01577381|20455317|P2|COMPLETED|Overall Study||0
8296698|NCT01577381|20455318|P1|COMPLETED|Overall Study||0
8296699|NCT01577381|20455315|P4|STARTED|Overall Study||2
8296700|NCT01577381|20455316|P3|STARTED|Overall Study||3
8296701|NCT01577381|20455317|P2|STARTED|Overall Study||3
8296702|NCT01577381|20455318|P1|STARTED|Overall Study||2
8296703|NCT01577329|20455449|P2|NOT COMPLETED|Overall Study||0
8296704|NCT01577329|20455450|P1|NOT COMPLETED|Overall Study||3
8296705|NCT01577329|20455449|P2|COMPLETED|Overall Study||22
8296706|NCT01577329|20455450|P1|COMPLETED|Overall Study||16
8296707|NCT01577329|20455449|P2|STARTED|Overall Study||22
8296708|NCT01577329|20455450|P1|STARTED|Overall Study||19
8296709|NCT01577238|20455458|P2|NOT COMPLETED|Overall Study||12
8296710|NCT01577238|20455459|P1|NOT COMPLETED|Overall Study||10
8296711|NCT01577238|20455458|P2|COMPLETED|Overall Study||111
8296712|NCT01577238|20455459|P1|COMPLETED|Overall Study||117
8296713|NCT01577238|20455458|P2|STARTED|Overall Study||123
8296714|NCT01577238|20455459|P1|STARTED|Overall Study||127
8296715|NCT01577186|20455473|P1|NOT COMPLETED|Overall Study||130
8296716|NCT01577186|20455473|P1|COMPLETED|Overall Study||350
8296717|NCT01577186|20455473|P1|STARTED|Overall Study||480
8296718|NCT01577160|20455481|P1|NOT COMPLETED|Overall Study||98
8296719|NCT01577160|20455481|P1|COMPLETED|Overall Study||255
8296720|NCT01577160|20455481|P1|STARTED|Overall Study||353
8296721|NCT01577108|20455491|P2|NOT COMPLETED|Overall Study||6
8296722|NCT01577108|20455492|P1|NOT COMPLETED|Overall Study||5
8296723|NCT01577108|20455491|P2|COMPLETED|Overall Study||50
8296724|NCT01577108|20455492|P1|COMPLETED|Overall Study||49
8296725|NCT01577108|20455491|P2|STARTED|Overall Study||56
8296726|NCT01577108|20455492|P1|STARTED|Overall Study||54
8296737|NCT01576939|20455507|P1|NOT COMPLETED|Overall Study||0
8296738|NCT01576939|20455507|P1|COMPLETED|Overall Study||30
8296739|NCT01576939|20455507|P1|STARTED|Overall Study||30
8296740|NCT01576874|20455517|P2|NOT COMPLETED|Overall Study||0
8296741|NCT01576874|20455518|P1|NOT COMPLETED|Overall Study||0
8296742|NCT01576874|20455517|P2|COMPLETED|Overall Study||72
8296743|NCT01576874|20455518|P1|COMPLETED|Overall Study||72
8296744|NCT01576874|20455517|P2|STARTED|Overall Study||72
8296745|NCT01576874|20455518|P1|STARTED|Overall Study||72
8296746|NCT01576809|20455528|P1|NOT COMPLETED|Overall Study||0
8296747|NCT01576809|20455528|P1|COMPLETED|Overall Study||51
8296748|NCT01576809|20455528|P1|STARTED|Overall Study||51
8296755|NCT01576718|20455563|P7|NOT COMPLETED|Treatment Period||30
8296756|NCT01576718|20455564|P6|NOT COMPLETED|Treatment Period||48
8296757|NCT01576718|20455565|P5|NOT COMPLETED|Treatment Period||27
8296758|NCT01576718|20455566|P4|NOT COMPLETED|Treatment Period||31
8296759|NCT01576718|20455567|P3|NOT COMPLETED|Treatment Period||20
8296760|NCT01576718|20455568|P2|NOT COMPLETED|Treatment Period||25
8296761|NCT01576718|20455569|P1|NOT COMPLETED|Treatment Period||0
8296762|NCT01576718|20455563|P7|COMPLETED|Treatment Period||77
8296763|NCT01576718|20455564|P6|COMPLETED|Treatment Period||58
8296764|NCT01576718|20455565|P5|COMPLETED|Treatment Period||80
8296765|NCT01576718|20455566|P4|COMPLETED|Treatment Period||75
8296766|NCT01576718|20455567|P3|COMPLETED|Treatment Period||87
8296767|NCT01576718|20455568|P2|COMPLETED|Treatment Period||82
8296768|NCT01576718|20455569|P1|COMPLETED|Treatment Period||0
8296769|NCT01576718|20455563|P7|Efficacy Population (Full Analysis Set)|Treatment Period||103
8296770|NCT01576718|20455564|P6|Efficacy Population (Full Analysis Set)|Treatment Period||105
8296771|NCT01576718|20455565|P5|Efficacy Population (Full Analysis Set)|Treatment Period||107
8296772|NCT01576718|20455566|P4|Efficacy Population (Full Analysis Set)|Treatment Period||102
8296773|NCT01576718|20455567|P3|Efficacy Population (Full Analysis Set)|Treatment Period||106
8296774|NCT01576718|20455568|P2|Efficacy Population (Full Analysis Set)|Treatment Period||107
8296775|NCT01576718|20455569|P1|Efficacy Population (Full Analysis Set)|Treatment Period||0
8296776|NCT01576718|20455563|P7|Safety Population|Treatment Period||106
8296777|NCT01576718|20455564|P6|Safety Population|Treatment Period||106
8296778|NCT01576718|20455565|P5|Safety Population|Treatment Period||107
8296779|NCT01576718|20455566|P4|Safety Population|Treatment Period||106
8296780|NCT01576718|20455567|P3|Safety Population|Treatment Period||107
8296781|NCT01576718|20455568|P2|Safety Population|Treatment Period||107
8296782|NCT01576718|20455569|P1|Safety Population|Treatment Period||0
8296783|NCT01576718|20455563|P7|STARTED|Treatment Period||107
8296784|NCT01576718|20455564|P6|STARTED|Treatment Period||106
8296785|NCT01576718|20455565|P5|STARTED|Treatment Period||107
8296786|NCT01576718|20455566|P4|STARTED|Treatment Period||106
8296787|NCT01576718|20455567|P3|STARTED|Treatment Period||107
8296788|NCT01576718|20455568|P2|STARTED|Treatment Period||107
8296789|NCT01576718|20455569|P1|STARTED|Treatment Period||0
8296790|NCT01576718|20455563|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296791|NCT01576718|20455564|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296792|NCT01576718|20455565|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296793|NCT01576718|20455566|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296794|NCT01576718|20455567|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296795|NCT01576718|20455568|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296796|NCT01576718|20455569|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
8296797|NCT01576718|20455563|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296798|NCT01576718|20455564|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296799|NCT01576718|20455565|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296800|NCT01576718|20455566|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296801|NCT01576718|20455567|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296802|NCT01576718|20455568|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8296803|NCT01576718|20455569|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
8296804|NCT01576718|20455563|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8296805|NCT01576718|20455564|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8296806|NCT01576718|20455565|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8296807|NCT01576718|20455566|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8296808|NCT01576718|20455567|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8296809|NCT01576718|20455568|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8296810|NCT01576718|20455569|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||889
8296811|NCT01576705|20455665|P4|NOT COMPLETED|Overall Study||3
8296812|NCT01576705|20455666|P3|NOT COMPLETED|Overall Study||5
8296813|NCT01576705|20455667|P2|NOT COMPLETED|Overall Study||8
8296814|NCT01576705|20455668|P1|NOT COMPLETED|Overall Study||3
8296815|NCT01576705|20455665|P4|COMPLETED|Overall Study||41
8296816|NCT01576705|20455666|P3|COMPLETED|Overall Study||38
8296817|NCT01576705|20455667|P2|COMPLETED|Overall Study||37
8296818|NCT01576705|20455668|P1|COMPLETED|Overall Study||40
8296819|NCT01576705|20455665|P4|STARTED|Overall Study||44
8296820|NCT01576705|20455666|P3|STARTED|Overall Study||43
8296821|NCT01576705|20455667|P2|STARTED|Overall Study||45
8296822|NCT01576705|20455668|P1|STARTED|Overall Study||43
8296823|NCT01576588|20455682|P1|NOT COMPLETED|Overall Study||2
8296824|NCT01576588|20455682|P1|COMPLETED|Overall Study||23
8296825|NCT01576588|20455682|P1|STARTED|Overall Study||25
8296826|NCT01576575|20455689|P1|NOT COMPLETED|Buprenorphine + Ketoconazole||0
8296827|NCT01576575|20455689|P1|COMPLETED|Buprenorphine + Ketoconazole||14
8296828|NCT01576575|20455689|P1|STARTED|Buprenorphine + Ketoconazole||14
8296829|NCT01576575|20455689|P1|NOT COMPLETED|Buprenorphine + Grapefruit||1
8296830|NCT01576575|20455689|P1|COMPLETED|Buprenorphine + Grapefruit||14
8296831|NCT01576575|20455689|P1|STARTED|Buprenorphine + Grapefruit||15
8296832|NCT01576575|20455689|P1|NOT COMPLETED|Buprenorphine + Rifampin||3
8296833|NCT01576575|20455689|P1|COMPLETED|Buprenorphine + Rifampin||15
8296834|NCT01576575|20455689|P1|STARTED|Buprenorphine + Rifampin||18
8296835|NCT01576575|20455689|P1|NOT COMPLETED|Buprenorphine Control||3
8296836|NCT01576575|20455689|P1|COMPLETED|Buprenorphine Control||18
8296837|NCT01576575|20455689|P1|STARTED|Buprenorphine Control||21
8296838|NCT01576549|20455699|P1|NOT COMPLETED|Overall Study||2
8296839|NCT01576549|20455699|P1|COMPLETED|Overall Study||0
8296840|NCT01576549|20455699|P1|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
8296841|NCT01576549|20455699|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
8296842|NCT01576549|20455699|P1|STARTED|Overall Study||2
8296843|NCT01576536|20455707|P1|NOT COMPLETED|Overall Study||0
8296844|NCT01576536|20455707|P1|COMPLETED|Overall Study||117
8296845|NCT01576536|20455707|P1|STARTED|Overall Study||117
8296846|NCT01576484|20455715|P2|NOT COMPLETED|Overall Study||19
8296847|NCT01576484|20455716|P1|NOT COMPLETED|Overall Study||5
8296848|NCT01576484|20455715|P2|COMPLETED|Overall Study||27
8296849|NCT01576484|20455716|P1|COMPLETED|Overall Study||7
8296850|NCT01576484|20455715|P2|STARTED|Overall Study||46
8296851|NCT01576484|20455716|P1|STARTED|Overall Study||12
8296852|NCT01576471|20455782|P2|NOT COMPLETED|Overall Study||9
8296853|NCT01576471|20455783|P1|NOT COMPLETED|Overall Study||8
8296854|NCT01576471|20455782|P2|COMPLETED|Overall Study||116
8296855|NCT01576471|20455783|P1|COMPLETED|Overall Study||117
8296856|NCT01576471|20455782|P2|STARTED|Overall Study||125
8296857|NCT01576471|20455783|P1|STARTED|Overall Study||125
8296858|NCT01576406|20455795|P6|NOT COMPLETED|Overall Study||12
8296859|NCT01576406|20455796|P5|NOT COMPLETED|Overall Study||8
8296860|NCT01576406|20455797|P4|NOT COMPLETED|Overall Study||9
8296861|NCT01576406|20455798|P3|NOT COMPLETED|Overall Study||16
8296862|NCT01576406|20455799|P2|NOT COMPLETED|Overall Study||8
8296863|NCT01576406|20455800|P1|NOT COMPLETED|Overall Study||6
8296864|NCT01576406|20455795|P6|COMPLETED|Overall Study||4
8296865|NCT01576406|20455796|P5|COMPLETED|Overall Study||8
8296866|NCT01576406|20455797|P4|COMPLETED|Overall Study||1
8296867|NCT01576406|20455798|P3|COMPLETED|Overall Study||4
8296868|NCT01576406|20455799|P2|COMPLETED|Overall Study||7
8296869|NCT01576406|20455800|P1|COMPLETED|Overall Study||5
8296870|NCT01576406|20455795|P6|STARTED|Overall Study||16
8296871|NCT01576406|20455796|P5|STARTED|Overall Study||16
8296872|NCT01576406|20455797|P4|STARTED|Overall Study||10
8296873|NCT01576406|20455798|P3|STARTED|Overall Study||20
8296874|NCT01576406|20455799|P2|STARTED|Overall Study||15
8296875|NCT01576406|20455800|P1|STARTED|Overall Study||11
8296876|NCT01576367|20456048|P1|NOT COMPLETED|Overall Study||3
8296877|NCT01576367|20456048|P1|COMPLETED|Overall Study||14
8296878|NCT01576367|20456048|P1|STARTED|Overall Study||17
8296879|NCT01576341|20456056|P1|NOT COMPLETED|Overall Study||93
8296880|NCT01576341|20456056|P1|COMPLETED|Overall Study||324
8296881|NCT01576341|20456056|P1|STARTED|Overall Study||417
8296882|NCT01576276|20456065|P2|NOT COMPLETED|Overall Study||11
8296883|NCT01576276|20456066|P1|NOT COMPLETED|Overall Study||8
8296884|NCT01576276|20456065|P2|COMPLETED|Overall Study||18
8296885|NCT01576276|20456066|P1|COMPLETED|Overall Study||14
8296886|NCT01576276|20456065|P2|STARTED|Overall Study||29
8296887|NCT01576276|20456066|P1|STARTED|Overall Study||22
8296888|NCT01576172|20456075|P2|NOT COMPLETED|Overall Study||1
8296889|NCT01576172|20456076|P1|NOT COMPLETED|Overall Study||5
8296890|NCT01576172|20456075|P2|COMPLETED|Overall Study||79
8296891|NCT01576172|20456076|P1|COMPLETED|Overall Study||74
8296892|NCT01576172|20456075|P2|STARTED|Overall Study||80
8296893|NCT01576172|20456076|P1|STARTED|Overall Study||79
8296894|NCT01576159|20456094|P4|NOT COMPLETED|Overall Study||1
8296895|NCT01576159|20456095|P3|NOT COMPLETED|Overall Study||1
8296896|NCT01576159|20456096|P2|NOT COMPLETED|Overall Study||1
8296897|NCT01576159|20456097|P1|NOT COMPLETED|Overall Study||1
8296898|NCT01576159|20456094|P4|COMPLETED|Overall Study||11
8296899|NCT01576159|20456095|P3|COMPLETED|Overall Study||11
8296900|NCT01576159|20456096|P2|COMPLETED|Overall Study||11
8296901|NCT01576159|20456097|P1|COMPLETED|Overall Study||11
8296902|NCT01576159|20456094|P4|STARTED|Overall Study||12
8296903|NCT01576159|20456095|P3|STARTED|Overall Study||12
8296904|NCT01576159|20456096|P2|STARTED|Overall Study||12
8296905|NCT01576159|20456097|P1|STARTED|Overall Study||12
8296906|NCT01576146|20456115|P1|NOT COMPLETED|Extension Period 2||17
8296907|NCT01576146|20456115|P1|COMPLETED|Extension Period 2||0
8296908|NCT01576146|20456115|P1|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
8296909|NCT01576146|20456115|P1|NOT COMPLETED|Extension Period 1||10
8296910|NCT01576146|20456115|P1|COMPLETED|Extension Period 1||20
8296911|NCT01576146|20456115|P1|STARTED|Extension Period 1||30
8296912|NCT01576120|20456124|P2|NOT COMPLETED|Overall Study||0
8296913|NCT01576120|20456125|P1|NOT COMPLETED|Overall Study||0
8296914|NCT01576120|20456124|P2|COMPLETED|Overall Study||19
8296915|NCT01576120|20456125|P1|COMPLETED|Overall Study||21
8296916|NCT01576120|20456124|P2|STARTED|Overall Study||19
8296917|NCT01576120|20456125|P1|STARTED|Overall Study||21
8296918|NCT01576055|20456133|P2|NOT COMPLETED|Overall Study||6
8296919|NCT01576055|20456134|P1|NOT COMPLETED|Overall Study||19
8296920|NCT01576055|20456133|P2|COMPLETED|Overall Study||64
8296921|NCT01576055|20456134|P1|COMPLETED|Overall Study||178
8296922|NCT01576055|20456133|P2|STARTED|Overall Study||70
8296923|NCT01576055|20456134|P1|STARTED|Overall Study||197
8296924|NCT01576042|20456148|P2|NOT COMPLETED|Overall Study||0
8296925|NCT01576042|20456149|P1|NOT COMPLETED|Overall Study||2
8296926|NCT01576042|20456148|P2|COMPLETED|Overall Study||14
8296927|NCT01576042|20456149|P1|COMPLETED|Overall Study||11
8296928|NCT01576042|20456148|P2|Switched to the Other Arm|Overall Study||1
8296929|NCT01576042|20456149|P1|Switched to the Other Arm|Overall Study||5
8296930|NCT01576042|20456148|P2|STARTED|Overall Study||14
8296931|NCT01576042|20456149|P1|STARTED|Overall Study||13
8296932|NCT01576016|20456171|P2|NOT COMPLETED|MRI Safety||74
8296933|NCT01576016|20456172|P1|NOT COMPLETED|MRI Safety||0
8296934|NCT01576016|20456171|P2|COMPLETED|MRI Safety||181
8296935|NCT01576016|20456172|P1|COMPLETED|MRI Safety||0
8296936|NCT01576016|20456171|P2|STARTED|MRI Safety|255 enrollments includes 30 supplemental scans performed in Australia using the same scan protocol.|255
8296937|NCT01576016|20456172|P1|STARTED|MRI Safety||0
8296938|NCT01576016|20456171|P2|NOT COMPLETED|Lead Safety||0
8296939|NCT01576016|20456172|P1|NOT COMPLETED|Lead Safety||273
8296940|NCT01576016|20456171|P2|COMPLETED|Lead Safety||0
8296941|NCT01576016|20456172|P1|COMPLETED|Lead Safety||647
8296942|NCT01576016|20456171|P2|STARTED|Lead Safety||0
8296943|NCT01576016|20456172|P1|STARTED|Lead Safety||920
8296944|NCT01576003|20456191|P3|NOT COMPLETED|Overall Study||0
8296945|NCT01576003|20456192|P2|NOT COMPLETED|Overall Study||2
8296946|NCT01576003|20456193|P1|NOT COMPLETED|Overall Study||1
8296947|NCT01576003|20456191|P3|COMPLETED|Overall Study||4
8296948|NCT01576003|20456192|P2|COMPLETED|Overall Study||1
8296949|NCT01576003|20456193|P1|COMPLETED|Overall Study||1
8296950|NCT01576003|20456191|P3|STARTED|Overall Study||4
8296951|NCT01576003|20456192|P2|STARTED|Overall Study||3
8296952|NCT01576003|20456193|P1|STARTED|Overall Study||2
8296953|NCT01575912|20456211|P3|NOT COMPLETED|Overall Study||0
8296954|NCT01575912|20456212|P2|NOT COMPLETED|Overall Study||0
8296955|NCT01575912|20456213|P1|NOT COMPLETED|Overall Study||0
8296956|NCT01575912|20456211|P3|COMPLETED|Overall Study||30
8296957|NCT01575912|20456212|P2|COMPLETED|Overall Study||32
8296958|NCT01575912|20456213|P1|COMPLETED|Overall Study||30
8296959|NCT01575912|20456211|P3|STARTED|Overall Study||30
8296960|NCT01575912|20456212|P2|STARTED|Overall Study||32
8296961|NCT01575912|20456213|P1|STARTED|Overall Study||30
8296962|NCT01575899|20456224|P3|NOT COMPLETED|Overall Study||2
8296963|NCT01575899|20456225|P2|NOT COMPLETED|Overall Study||5
8296964|NCT01575899|20456226|P1|NOT COMPLETED|Overall Study||5
8296965|NCT01575899|20456224|P3|COMPLETED|Overall Study||60
8296966|NCT01575899|20456225|P2|COMPLETED|Overall Study||68
8296967|NCT01575899|20456226|P1|COMPLETED|Overall Study||68
8296968|NCT01575899|20456224|P3|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
8296969|NCT01575899|20456225|P2|STARTED|Overall Study||73
8296970|NCT01575899|20456226|P1|STARTED|Overall Study||73
8296971|NCT01575873|20456240|P4|NOT COMPLETED|Overall Study||67
8296972|NCT01575873|20456241|P3|NOT COMPLETED|Overall Study||74
8296973|NCT01575873|20456242|P2|NOT COMPLETED|Overall Study||36
8296974|NCT01575873|20456243|P1|NOT COMPLETED|Overall Study||28
8296975|NCT01575873|20456240|P4|COMPLETED|Overall Study||186
8296976|NCT01575873|20456241|P3|COMPLETED|Overall Study||178
8296977|NCT01575873|20456242|P2|COMPLETED|Overall Study||109
8296978|NCT01575873|20456243|P1|COMPLETED|Overall Study||117
8296979|NCT01575873|20456240|P4|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
8296980|NCT01575873|20456241|P3|Received Study Drug|Overall Study|Participants who received oral risedronate|246
8296981|NCT01575873|20456242|P2|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
8296982|NCT01575873|20456243|P1|Received Study Drug|Overall Study|Participants who received oral risedronate|140
8296983|NCT01575873|20456240|P4|STARTED|Overall Study||253
8296984|NCT01575873|20456241|P3|STARTED|Overall Study||252
8296985|NCT01575873|20456242|P2|STARTED|Overall Study||145
8296986|NCT01575873|20456243|P1|STARTED|Overall Study||145
8296987|NCT01575860|20456267|P1|NOT COMPLETED|Overall Study||2
8296988|NCT01575860|20456267|P1|COMPLETED|Overall Study||6
8296989|NCT01575860|20456267|P1|STARTED|Overall Study||8
8296990|NCT01575834|20456275|P2|NOT COMPLETED|Overall Study||738
8296991|NCT01575834|20456276|P1|NOT COMPLETED|Overall Study||699
8296992|NCT01575834|20456275|P2|COMPLETED|Overall Study|Completed 36-month study period|2851
8296993|NCT01575834|20456276|P1|COMPLETED|Overall Study|Completed 36-month study period|2892
8296994|NCT01575834|20456275|P2|Completed 24-month Study Period|Overall Study||2994
8296995|NCT01575834|20456276|P1|Completed 24-month Study Period|Overall Study||3032
8296996|NCT01575834|20456275|P2|Completed Double-blind Period|Overall Study||3185
8296997|NCT01575834|20456276|P1|Completed Double-blind Period|Overall Study||3205
8296998|NCT01575834|20456275|P2|Received Double-blind Treatment|Overall Study||3575
8296999|NCT01575834|20456276|P1|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
8297000|NCT01575834|20456275|P2|STARTED|Overall Study||3589
8297001|NCT01575834|20456276|P1|STARTED|Overall Study||3591
8297002|NCT01575808|20456328|P2|NOT COMPLETED|Overall Study||0
8297003|NCT01575808|20456329|P1|NOT COMPLETED|Overall Study||3
8297004|NCT01575808|20456328|P2|COMPLETED|Overall Study||68
8297005|NCT01575808|20456329|P1|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
8297006|NCT01575808|20456328|P2|STARTED|Overall Study||68
8297007|NCT01575808|20456329|P1|STARTED|Overall Study||103
8297008|NCT01575769|20456376|P1|NOT COMPLETED|Overall Study||41
8297009|NCT01575769|20456376|P1|COMPLETED|Overall Study||0
8297010|NCT01575769|20456376|P1|STARTED|Overall Study||41
8297011|NCT01575756|20456402|P2|NOT COMPLETED|Treatment Period 2||0
8297012|NCT01575756|20456403|P1|NOT COMPLETED|Treatment Period 2||0
8297013|NCT01575756|20456402|P2|COMPLETED|Treatment Period 2||11
8297014|NCT01575756|20456403|P1|COMPLETED|Treatment Period 2||11
8297015|NCT01575756|20456402|P2|STARTED|Treatment Period 2||11
8297016|NCT01575756|20456403|P1|STARTED|Treatment Period 2||11
8297017|NCT01575756|20456402|P2|NOT COMPLETED|Treatment Period 1||0
8297018|NCT01575756|20456403|P1|NOT COMPLETED|Treatment Period 1||0
8297019|NCT01575756|20456402|P2|COMPLETED|Treatment Period 1||11
8297020|NCT01575756|20456403|P1|COMPLETED|Treatment Period 1||11
8297021|NCT01575756|20456402|P2|STARTED|Treatment Period 1||11
8297022|NCT01575756|20456403|P1|STARTED|Treatment Period 1||11
8297023|NCT01575561|20456434|P1|NOT COMPLETED|Overall Study||39
8297024|NCT01575561|20456434|P1|COMPLETED|Overall Study||338
8297025|NCT01575561|20456434|P1|STARTED|Overall Study||377
8297026|NCT01575522|20456446|P1|NOT COMPLETED|Overall Study||0
8297027|NCT01575522|20456446|P1|COMPLETED|Overall Study||22
8297028|NCT01575522|20456446|P1|STARTED|Overall Study||22
8297029|NCT01575275|20456454|P1|NOT COMPLETED|Overall Study||0
8297030|NCT01575275|20456454|P1|COMPLETED|Overall Study||8
8297031|NCT01575275|20456454|P1|STARTED|Overall Study||8
8297032|NCT01575197|20456464|P3|NOT COMPLETED|Overall Study||6
8297033|NCT01575197|20456465|P2|NOT COMPLETED|Overall Study||9
8297034|NCT01575197|20456466|P1|NOT COMPLETED|Overall Study||3
8297035|NCT01575197|20456464|P3|COMPLETED|Overall Study||146
8297036|NCT01575197|20456465|P2|COMPLETED|Overall Study||143
8297037|NCT01575197|20456466|P1|COMPLETED|Overall Study||149
8297038|NCT01575197|20456464|P3|STARTED|Overall Study||152
8297039|NCT01575197|20456465|P2|STARTED|Overall Study||152
8297040|NCT01575197|20456466|P1|STARTED|Overall Study||152
8297041|NCT01575106|20456479|P1|NOT COMPLETED|Overall Study||14
8297042|NCT01575106|20456479|P1|COMPLETED|Overall Study||24
8297043|NCT01575106|20456479|P1|STARTED|Overall Study||38
8297044|NCT01575080|20456485|P1|NOT COMPLETED|Overall Study||0
8297045|NCT01575080|20456485|P1|COMPLETED|Overall Study||102
8297046|NCT01575080|20456485|P1|STARTED|Overall Study||102
8297047|NCT01575054|20456494|P2|NOT COMPLETED|Overall Study||26
8297048|NCT01575054|20456495|P1|NOT COMPLETED|Overall Study||29
8297049|NCT01575054|20456494|P2|COMPLETED|Overall Study||209
8297050|NCT01575054|20456495|P1|COMPLETED|Overall Study||204
8297051|NCT01575054|20456494|P2|STARTED|Overall Study||235
8297052|NCT01575054|20456495|P1|STARTED|Overall Study||233
8297053|NCT01575028|20456511|P2|NOT COMPLETED|Overall Study||1
8297054|NCT01575028|20456512|P1|NOT COMPLETED|Overall Study||0
8297055|NCT01575028|20456511|P2|COMPLETED|Overall Study||0
8297056|NCT01575028|20456512|P1|COMPLETED|Overall Study||2
8297057|NCT01575028|20456511|P2|STARTED|Overall Study||1
8297058|NCT01575028|20456512|P1|STARTED|Overall Study||2
8297059|NCT01574807|20456518|P2|NOT COMPLETED|Second Appointment||0
8297060|NCT01574807|20456519|P1|NOT COMPLETED|Second Appointment||0
8297061|NCT01574807|20456518|P2|COMPLETED|Second Appointment||50
8297062|NCT01574807|20456519|P1|COMPLETED|Second Appointment||50
8297063|NCT01574807|20456518|P2|STARTED|Second Appointment||50
8297064|NCT01574807|20456519|P1|STARTED|Second Appointment||50
8297065|NCT01574807|20456518|P2|NOT COMPLETED|Wash Out Period 2 Weeks||0
8297066|NCT01574807|20456519|P1|NOT COMPLETED|Wash Out Period 2 Weeks||0
8297067|NCT01574807|20456518|P2|COMPLETED|Wash Out Period 2 Weeks||50
8297068|NCT01574807|20456519|P1|COMPLETED|Wash Out Period 2 Weeks||50
8297069|NCT01574807|20456518|P2|STARTED|Wash Out Period 2 Weeks||50
8297070|NCT01574807|20456519|P1|STARTED|Wash Out Period 2 Weeks||50
8297071|NCT01574807|20456518|P2|NOT COMPLETED|First Appointment||0
8297072|NCT01574807|20456519|P1|NOT COMPLETED|First Appointment||0
8297073|NCT01574807|20456518|P2|COMPLETED|First Appointment||50
8297074|NCT01574807|20456519|P1|COMPLETED|First Appointment||50
8297075|NCT01574807|20456518|P2|STARTED|First Appointment||50
8297076|NCT01574807|20456519|P1|STARTED|First Appointment||50
8297077|NCT01574716|20456529|P5|NOT COMPLETED|Part 2||70
8297078|NCT01574716|20456530|P4|NOT COMPLETED|Part 2||137
8297079|NCT01574716|20456531|P3|NOT COMPLETED|Part 2||0
8297080|NCT01574716|20456532|P2|NOT COMPLETED|Part 2||0
8297081|NCT01574716|20456533|P1|NOT COMPLETED|Part 2||0
8297082|NCT01574716|20456529|P5|COMPLETED|Part 2||0
8297083|NCT01574716|20456530|P4|COMPLETED|Part 2||2
8297084|NCT01574716|20456531|P3|COMPLETED|Part 2||0
8297085|NCT01574716|20456532|P2|COMPLETED|Part 2||0
8297086|NCT01574716|20456533|P1|COMPLETED|Part 2||0
8297087|NCT01574716|20456529|P5|Treated Participants|Part 2||67
8297088|NCT01574716|20456530|P4|Treated Participants|Part 2||140
8297089|NCT01574716|20456531|P3|Treated Participants|Part 2||0
8297090|NCT01574716|20456532|P2|Treated Participants|Part 2||0
8297091|NCT01574716|20456533|P1|Treated Participants|Part 2||0
8297092|NCT01574716|20456529|P5|STARTED|Part 2||70
8297093|NCT01574716|20456530|P4|STARTED|Part 2||139
8297094|NCT01574716|20456531|P3|STARTED|Part 2||0
8297095|NCT01574716|20456532|P2|STARTED|Part 2||0
8297096|NCT01574716|20456533|P1|STARTED|Part 2||0
8297097|NCT01574716|20456529|P5|NOT COMPLETED|Part 1||0
8297098|NCT01574716|20456530|P4|NOT COMPLETED|Part 1||0
8297099|NCT01574716|20456531|P3|NOT COMPLETED|Part 1||9
8297100|NCT01574716|20456532|P2|NOT COMPLETED|Part 1||4
8297101|NCT01574716|20456533|P1|NOT COMPLETED|Part 1||3
8297102|NCT01574716|20456529|P5|COMPLETED|Part 1||0
8297103|NCT01574716|20456530|P4|COMPLETED|Part 1||0
8297104|NCT01574716|20456531|P3|COMPLETED|Part 1||0
8297105|NCT01574716|20456532|P2|COMPLETED|Part 1||0
8297106|NCT01574716|20456533|P1|COMPLETED|Part 1||0
8297107|NCT01574716|20456529|P5|STARTED|Part 1||0
8297108|NCT01574716|20456530|P4|STARTED|Part 1||0
8297109|NCT01574716|20456531|P3|STARTED|Part 1||9
8297110|NCT01574716|20456532|P2|STARTED|Part 1||4
8297111|NCT01574716|20456533|P1|STARTED|Part 1||3
8297112|NCT01574703|20456556|P4|NOT COMPLETED|Overall Study||114
8297113|NCT01574703|20456557|P3|NOT COMPLETED|Overall Study||105
8297114|NCT01574703|20456558|P2|NOT COMPLETED|Overall Study||112
8297115|NCT01574703|20456559|P1|NOT COMPLETED|Overall Study||125
8297116|NCT01574703|20456556|P4|COMPLETED|Overall Study||1007
8297117|NCT01574703|20456557|P3|COMPLETED|Overall Study||1011
8297118|NCT01574703|20456558|P2|COMPLETED|Overall Study||1054
8297119|NCT01574703|20456559|P1|COMPLETED|Overall Study||1067
8297120|NCT01574703|20456556|P4|STARTED|Overall Study||1121
8297121|NCT01574703|20456557|P3|STARTED|Overall Study||1116
8297122|NCT01574703|20456558|P2|STARTED|Overall Study||1166
8297123|NCT01574703|20456559|P1|STARTED|Overall Study||1192
8297124|NCT01574651|20456603|P2|NOT COMPLETED|Overall Study||52
8297125|NCT01574651|20456604|P1|NOT COMPLETED|Overall Study||61
8297126|NCT01574651|20456603|P2|COMPLETED|Overall Study||406
8297127|NCT01574651|20456604|P1|COMPLETED|Overall Study||415
8297128|NCT01574651|20456603|P2|Per Protocol Set (PPS)|Overall Study||374
8297129|NCT01574651|20456604|P1|Per Protocol Set (PPS)|Overall Study||373
8297130|NCT01574651|20456603|P2|Full Analysis Set (FAS)|Overall Study||458
8297131|NCT01574651|20456604|P1|Full Analysis Set (FAS)|Overall Study||476
8297132|NCT01574651|20456603|P2|STARTED|Overall Study||458
8297133|NCT01574651|20456604|P1|STARTED|Overall Study||476
8297134|NCT01574612|20456626|P1|NOT COMPLETED|Overall Study||8
8297135|NCT01574612|20456626|P1|COMPLETED|Overall Study||46
8297136|NCT01574612|20456626|P1|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
8297137|NCT01574352|20456632|P2|NOT COMPLETED|Overall Study||13
8297138|NCT01574352|20456633|P1|NOT COMPLETED|Overall Study||7
8297139|NCT01574352|20456632|P2|COMPLETED|Overall Study|Participated in the last follow up measurement.|38
8297140|NCT01574352|20456633|P1|COMPLETED|Overall Study|Participated in the last follow up measurement.|48
8297141|NCT01574352|20456632|P2|STARTED|Overall Study|56 participants where randomized, but 5 dropped out prior to baseline measurements.|51
8297142|NCT01574352|20456633|P1|STARTED|Overall Study|59 participants where randomized, but 4 dropped out prior to baseline measurements.|55
8297143|NCT01574326|20456645|P2|NOT COMPLETED|Overall Study||19
8297144|NCT01574326|20456646|P1|NOT COMPLETED|Overall Study||16
8297145|NCT01574326|20456645|P2|COMPLETED|Overall Study||31
8297146|NCT01574326|20456646|P1|COMPLETED|Overall Study||35
8297147|NCT01574326|20456645|P2|Treated|Overall Study||49
8297148|NCT01574326|20456646|P1|Treated|Overall Study||51
8297149|NCT01574326|20456645|P2|STARTED|Overall Study||50
8297150|NCT01574326|20456646|P1|STARTED|Overall Study||51
8297151|NCT01574287|20456657|P1|NOT COMPLETED|Overall Study||0
8297152|NCT01574287|20456657|P1|COMPLETED|Overall Study||4
8297153|NCT01574287|20456657|P1|STARTED|Overall Study||4
8297154|NCT01574248|20456664|P2|NOT COMPLETED|Overall Study||0
8297155|NCT01574248|20456665|P1|NOT COMPLETED|Overall Study||3
8297156|NCT01574248|20456664|P2|COMPLETED|Overall Study||18
8297157|NCT01574248|20456665|P1|COMPLETED|Overall Study||12
8297158|NCT01574248|20456664|P2|STARTED|Overall Study||18
8297159|NCT01574248|20456665|P1|STARTED|Overall Study||15
8297160|NCT01574183|20456685|P2|NOT COMPLETED|Overall Study||18
8297161|NCT01574183|20456686|P1|NOT COMPLETED|Overall Study||27
8297162|NCT01574183|20456685|P2|COMPLETED|Overall Study||17
8297163|NCT01574183|20456686|P1|COMPLETED|Overall Study||14
8297164|NCT01574183|20456685|P2|STARTED|Overall Study||35
8297165|NCT01574183|20456686|P1|STARTED|Overall Study||41
8297166|NCT01574157|20456698|P2|NOT COMPLETED|Overall Study||8
8297167|NCT01574157|20456699|P1|NOT COMPLETED|Overall Study||4
8297168|NCT01574157|20456698|P2|COMPLETED|Overall Study||31
8297169|NCT01574157|20456699|P1|COMPLETED|Overall Study||31
8297170|NCT01574157|20456698|P2|Month 3|Overall Study||33
8297171|NCT01574157|20456699|P1|Month 3|Overall Study||31
8297172|NCT01574157|20456698|P2|STARTED|Overall Study||39
8297173|NCT01574157|20456699|P1|STARTED|Overall Study||35
8297174|NCT01574144|20456715|P1|NOT COMPLETED|Overall Study||0
8297175|NCT01574144|20456715|P1|COMPLETED|Overall Study||70
8297176|NCT01574144|20456715|P1|STARTED|Overall Study||70
8297177|NCT01574105|20456722|P2|NOT COMPLETED|Overall Study||0
8297178|NCT01574105|20456723|P1|NOT COMPLETED|Overall Study||0
8297179|NCT01574105|20456722|P2|COMPLETED|Overall Study||37
8297180|NCT01574105|20456723|P1|COMPLETED|Overall Study||29
8297181|NCT01574105|20456722|P2|STARTED|Overall Study||37
8297182|NCT01574105|20456723|P1|STARTED|Overall Study||29
8297183|NCT01574079|20456733|P2|NOT COMPLETED|Overall Study||2
8297184|NCT01574079|20456734|P1|NOT COMPLETED|Overall Study||1
8297185|NCT01574079|20456733|P2|COMPLETED|Overall Study||13
8297186|NCT01574079|20456734|P1|COMPLETED|Overall Study||17
8297187|NCT01574079|20456733|P2|STARTED|Overall Study||15
8297188|NCT01574079|20456734|P1|STARTED|Overall Study||18
8297189|NCT01573949|20456744|P1|NOT COMPLETED|Overall Study||0
8297190|NCT01573949|20456744|P1|COMPLETED|Overall Study||7
8297191|NCT01573949|20456744|P1|STARTED|Overall Study||7
8297192|NCT01573910|20456753|P2|NOT COMPLETED|Overall Study||17
8297193|NCT01573910|20456754|P1|NOT COMPLETED|Overall Study||20
8297194|NCT01573910|20456753|P2|COMPLETED|Overall Study||476
8297195|NCT01573910|20456754|P1|COMPLETED|Overall Study||469
8297196|NCT01573910|20456753|P2|STARTED|Overall Study||493
8297197|NCT01573910|20456754|P1|STARTED|Overall Study||489
8297198|NCT01573767|20456766|P4|NOT COMPLETED|Overall Study||24
8297199|NCT01573767|20456767|P3|NOT COMPLETED|Overall Study||14
8297200|NCT01573767|20456768|P2|NOT COMPLETED|Overall Study||21
8297201|NCT01573767|20456769|P1|NOT COMPLETED|Overall Study||22
8297202|NCT01573767|20456766|P4|COMPLETED|Overall Study||90
8297203|NCT01573767|20456767|P3|COMPLETED|Overall Study||99
8297204|NCT01573767|20456768|P2|COMPLETED|Overall Study||93
8297205|NCT01573767|20456769|P1|COMPLETED|Overall Study||93
8297206|NCT01573767|20456766|P4|STARTED|Overall Study||114
8297207|NCT01573767|20456767|P3|STARTED|Overall Study||113
8297208|NCT01573767|20456768|P2|STARTED|Overall Study||114
8297209|NCT01573767|20456769|P1|STARTED|Overall Study||115
8297210|NCT01573702|20456803|P1|NOT COMPLETED|Overall Study||0
8297211|NCT01573702|20456803|P1|COMPLETED|Overall Study||25
8297212|NCT01573702|20456803|P1|STARTED|Overall Study||25
8297213|NCT01573624|20456811|P7|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
8297214|NCT01573624|20456812|P6|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
8297215|NCT01573624|20456813|P5|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
8297216|NCT01573624|20456814|P4|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
8297217|NCT01573624|20456815|P3|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
8297218|NCT01573624|20456816|P2|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
8297219|NCT01573624|20456817|P1|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
8297220|NCT01573624|20456811|P7|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
8297221|NCT01573624|20456812|P6|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
8297222|NCT01573624|20456813|P5|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
8297223|NCT01573624|20456814|P4|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
8297224|NCT01573624|20456815|P3|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
8297225|NCT01573624|20456816|P2|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
8297226|NCT01573624|20456817|P1|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
8297227|NCT01573624|20456811|P7|STARTED|Period 6 : Follow-up Period (7 Days)||48
8297228|NCT01573624|20456812|P6|STARTED|Period 6 : Follow-up Period (7 Days)||39
8297229|NCT01573624|20456813|P5|STARTED|Period 6 : Follow-up Period (7 Days)||51
8297230|NCT01573624|20456814|P4|STARTED|Period 6 : Follow-up Period (7 Days)||53
8297231|NCT01573624|20456815|P3|STARTED|Period 6 : Follow-up Period (7 Days)||43
8297232|NCT01573624|20456816|P2|STARTED|Period 6 : Follow-up Period (7 Days)||47
8297233|NCT01573624|20456817|P1|STARTED|Period 6 : Follow-up Period (7 Days)||46
8297234|NCT01573624|20456811|P7|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
8297235|NCT01573624|20456812|P6|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
8297236|NCT01573624|20456813|P5|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
8297237|NCT01573624|20456814|P4|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
8297238|NCT01573624|20456815|P3|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
8297239|NCT01573624|20456816|P2|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
8297240|NCT01573624|20456817|P1|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
8297241|NCT01573624|20456811|P7|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
8297242|NCT01573624|20456812|P6|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
8297243|NCT01573624|20456813|P5|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
8297244|NCT01573624|20456814|P4|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
8297245|NCT01573624|20456815|P3|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
8297246|NCT01573624|20456816|P2|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
8297247|NCT01573624|20456817|P1|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
8297248|NCT01573624|20456811|P7|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
8297249|NCT01573624|20456812|P6|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
8297250|NCT01573624|20456813|P5|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
8297251|NCT01573624|20456814|P4|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
8297252|NCT01573624|20456815|P3|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
8297253|NCT01573624|20456816|P2|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
8297254|NCT01573624|20456817|P1|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
8297255|NCT01573624|20456811|P7|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
8297256|NCT01573624|20456812|P6|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
8297257|NCT01573624|20456813|P5|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
8297258|NCT01573624|20456814|P4|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
8297259|NCT01573624|20456815|P3|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
8297260|NCT01573624|20456816|P2|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
8297516|NCT01572792|20457215|P2|NOT COMPLETED|Extension Study||29
8297261|NCT01573624|20456817|P1|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
8297262|NCT01573624|20456811|P7|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
8297263|NCT01573624|20456812|P6|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
8297264|NCT01573624|20456813|P5|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
8297265|NCT01573624|20456814|P4|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
8297266|NCT01573624|20456815|P3|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
8297267|NCT01573624|20456816|P2|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
8297268|NCT01573624|20456817|P1|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
8297269|NCT01573624|20456811|P7|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
8297270|NCT01573624|20456812|P6|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
8297271|NCT01573624|20456813|P5|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
8297272|NCT01573624|20456814|P4|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
8297273|NCT01573624|20456815|P3|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
8297274|NCT01573624|20456816|P2|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
8297275|NCT01573624|20456817|P1|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
8297276|NCT01573624|20456811|P7|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
8297277|NCT01573624|20456812|P6|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
8297278|NCT01573624|20456813|P5|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
8297279|NCT01573624|20456814|P4|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
8297280|NCT01573624|20456815|P3|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
8297281|NCT01573624|20456816|P2|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
8297282|NCT01573624|20456817|P1|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
8297283|NCT01573624|20456811|P7|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
8297284|NCT01573624|20456812|P6|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
8297285|NCT01573624|20456813|P5|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
8297286|NCT01573624|20456814|P4|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
8297287|NCT01573624|20456815|P3|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
8297288|NCT01573624|20456816|P2|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
8297289|NCT01573624|20456817|P1|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
8297290|NCT01573624|20456811|P7|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
8297291|NCT01573624|20456812|P6|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
8297292|NCT01573624|20456813|P5|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
8297293|NCT01573624|20456814|P4|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
8297294|NCT01573624|20456815|P3|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
8297295|NCT01573624|20456816|P2|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
8297296|NCT01573624|20456817|P1|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
8297297|NCT01573624|20456811|P7|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
8297298|NCT01573624|20456812|P6|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
8297299|NCT01573624|20456813|P5|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
8297300|NCT01573624|20456814|P4|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
8297301|NCT01573624|20456815|P3|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
8297302|NCT01573624|20456816|P2|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
8297303|NCT01573624|20456817|P1|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
8297304|NCT01573624|20456811|P7|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
8297305|NCT01573624|20456812|P6|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
8297306|NCT01573624|20456813|P5|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
8297307|NCT01573624|20456814|P4|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
8297308|NCT01573624|20456815|P3|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
8297309|NCT01573624|20456816|P2|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
8297310|NCT01573624|20456817|P1|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
8297311|NCT01573624|20456811|P7|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
8297312|NCT01573624|20456812|P6|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
8297313|NCT01573624|20456813|P5|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
8297314|NCT01573624|20456814|P4|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
8297315|NCT01573624|20456815|P3|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
8297316|NCT01573624|20456816|P2|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
8297317|NCT01573624|20456817|P1|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
8297318|NCT01573624|20456811|P7|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
8297319|NCT01573624|20456812|P6|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
8297320|NCT01573624|20456813|P5|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
8297321|NCT01573624|20456814|P4|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
8297322|NCT01573624|20456815|P3|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
8297323|NCT01573624|20456816|P2|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
8297324|NCT01573624|20456817|P1|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
8297325|NCT01573624|20456811|P7|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
8297326|NCT01573624|20456812|P6|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
8297327|NCT01573624|20456813|P5|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
8297328|NCT01573624|20456814|P4|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
8297329|NCT01573624|20456815|P3|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
8297330|NCT01573624|20456816|P2|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
8297331|NCT01573624|20456817|P1|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
8297332|NCT01573624|20456811|P7|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
8297333|NCT01573624|20456812|P6|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
8297334|NCT01573624|20456813|P5|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
8297335|NCT01573624|20456814|P4|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
8297336|NCT01573624|20456815|P3|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
8297337|NCT01573624|20456816|P2|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
8297338|NCT01573624|20456817|P1|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
8297339|NCT01573572|20456864|P1|NOT COMPLETED|Overall Study||28
8297340|NCT01573572|20456864|P1|COMPLETED|Overall Study||103
8297341|NCT01573572|20456864|P1|STARTED|Overall Study||131
8297342|NCT01573533|20456868|P1|NOT COMPLETED|Overall Study||0
8297343|NCT01573533|20456868|P1|COMPLETED|Overall Study||9
8297344|NCT01573533|20456868|P1|STARTED|Overall Study||9
8297345|NCT01573442|20456877|P2|NOT COMPLETED|Overall Study||10
8297346|NCT01573442|20456878|P1|NOT COMPLETED|Overall Study||9
8297347|NCT01573442|20456877|P2|COMPLETED|Overall Study||104
8297348|NCT01573442|20456878|P1|COMPLETED|Overall Study||104
8297349|NCT01573442|20456877|P2|STARTED|Overall Study||114
8297350|NCT01573442|20456878|P1|STARTED|Overall Study||113
8297351|NCT01573325|20456914|P1|NOT COMPLETED|Overall Study||0
8297352|NCT01573325|20456914|P1|COMPLETED|Overall Study||50
8297353|NCT01573325|20456914|P1|STARTED|Overall Study||50
8297354|NCT01573273|20456923|P12|NOT COMPLETED|MRI 2||0
8297355|NCT01573273|20456924|P11|NOT COMPLETED|MRI 2||0
8297356|NCT01573273|20456925|P10|NOT COMPLETED|MRI 2||0
8297357|NCT01573273|20456926|P9|NOT COMPLETED|MRI 2||0
8297358|NCT01573273|20456927|P8|NOT COMPLETED|MRI 2||0
8297359|NCT01573273|20456928|P7|NOT COMPLETED|MRI 2||0
8297360|NCT01573273|20456929|P6|NOT COMPLETED|MRI 2||0
8297361|NCT01573273|20456930|P5|NOT COMPLETED|MRI 2||0
8297362|NCT01573273|20456931|P4|NOT COMPLETED|MRI 2||0
8297363|NCT01573273|20456932|P3|NOT COMPLETED|MRI 2||0
8297364|NCT01573273|20456933|P2|NOT COMPLETED|MRI 2||0
8297365|NCT01573273|20456934|P1|NOT COMPLETED|MRI 2||0
8297366|NCT01573273|20456923|P12|COMPLETED|MRI 2||28
8297367|NCT01573273|20456924|P11|COMPLETED|MRI 2||27
8297368|NCT01573273|20456925|P10|COMPLETED|MRI 2||0
8297369|NCT01573273|20456926|P9|COMPLETED|MRI 2||0
8297370|NCT01573273|20456927|P8|COMPLETED|MRI 2||0
8297371|NCT01573273|20456928|P7|COMPLETED|MRI 2||0
8297372|NCT01573273|20456929|P6|COMPLETED|MRI 2||18
8297373|NCT01573273|20456930|P5|COMPLETED|MRI 2||23
8297374|NCT01573273|20456931|P4|COMPLETED|MRI 2||0
8297375|NCT01573273|20456932|P3|COMPLETED|MRI 2||0
8297376|NCT01573273|20456933|P2|COMPLETED|MRI 2||0
8297377|NCT01573273|20456934|P1|COMPLETED|MRI 2||0
8297378|NCT01573273|20456923|P12|STARTED|MRI 2||28
8297379|NCT01573273|20456924|P11|STARTED|MRI 2||27
8297380|NCT01573273|20456925|P10|STARTED|MRI 2||0
8297381|NCT01573273|20456926|P9|STARTED|MRI 2||0
8297382|NCT01573273|20456927|P8|STARTED|MRI 2||0
8297383|NCT01573273|20456928|P7|STARTED|MRI 2||0
8297384|NCT01573273|20456929|P6|STARTED|MRI 2||18
8297385|NCT01573273|20456930|P5|STARTED|MRI 2||23
8297386|NCT01573273|20456931|P4|STARTED|MRI 2||0
8297387|NCT01573273|20456932|P3|STARTED|MRI 2||0
8297388|NCT01573273|20456933|P2|STARTED|MRI 2||0
8297389|NCT01573273|20456934|P1|STARTED|MRI 2||0
8297390|NCT01573273|20456923|P12|NOT COMPLETED|MRI 1||0
8297391|NCT01573273|20456924|P11|NOT COMPLETED|MRI 1||0
8297392|NCT01573273|20456925|P10|NOT COMPLETED|MRI 1||0
8297393|NCT01573273|20456926|P9|NOT COMPLETED|MRI 1||0
8297394|NCT01573273|20456927|P8|NOT COMPLETED|MRI 1||0
8297395|NCT01573273|20456928|P7|NOT COMPLETED|MRI 1||0
8297396|NCT01573273|20456929|P6|NOT COMPLETED|MRI 1||0
8297397|NCT01573273|20456930|P5|NOT COMPLETED|MRI 1||0
8297398|NCT01573273|20456931|P4|NOT COMPLETED|MRI 1||0
8297399|NCT01573273|20456932|P3|NOT COMPLETED|MRI 1||0
8297400|NCT01573273|20456933|P2|NOT COMPLETED|MRI 1||0
8297401|NCT01573273|20456934|P1|NOT COMPLETED|MRI 1||0
8297402|NCT01573273|20456923|P12|COMPLETED|MRI 1||0
8297403|NCT01573273|20456924|P11|COMPLETED|MRI 1||0
8297404|NCT01573273|20456925|P10|COMPLETED|MRI 1||29
8297405|NCT01573273|20456926|P9|COMPLETED|MRI 1||28
8297406|NCT01573273|20456927|P8|COMPLETED|MRI 1||0
8297407|NCT01573273|20456928|P7|COMPLETED|MRI 1||0
8297408|NCT01573273|20456929|P6|COMPLETED|MRI 1||0
8297409|NCT01573273|20456930|P5|COMPLETED|MRI 1||0
8297410|NCT01573273|20456931|P4|COMPLETED|MRI 1||23
8297411|NCT01573273|20456932|P3|COMPLETED|MRI 1||19
8297412|NCT01573273|20456933|P2|COMPLETED|MRI 1||0
8297413|NCT01573273|20456934|P1|COMPLETED|MRI 1||0
8297414|NCT01573273|20456923|P12|STARTED|MRI 1||0
8297415|NCT01573273|20456924|P11|STARTED|MRI 1||0
8297416|NCT01573273|20456925|P10|STARTED|MRI 1||29
8297417|NCT01573273|20456926|P9|STARTED|MRI 1||28
8297418|NCT01573273|20456927|P8|STARTED|MRI 1||0
8297419|NCT01573273|20456928|P7|STARTED|MRI 1||0
8297420|NCT01573273|20456929|P6|STARTED|MRI 1||0
8297421|NCT01573273|20456930|P5|STARTED|MRI 1||0
8297422|NCT01573273|20456931|P4|STARTED|MRI 1||23
8297423|NCT01573273|20456932|P3|STARTED|MRI 1||19
8297424|NCT01573273|20456933|P2|STARTED|MRI 1||0
8297425|NCT01573273|20456934|P1|STARTED|MRI 1||0
8297426|NCT01573273|20456923|P12|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297427|NCT01573273|20456924|P11|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297428|NCT01573273|20456925|P10|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297429|NCT01573273|20456926|P9|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297430|NCT01573273|20456927|P8|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297431|NCT01573273|20456928|P7|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297432|NCT01573273|20456929|P6|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297433|NCT01573273|20456930|P5|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297434|NCT01573273|20456931|P4|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297435|NCT01573273|20456932|P3|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297436|NCT01573273|20456933|P2|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297437|NCT01573273|20456934|P1|NOT COMPLETED|TSST : Trier Social Stress Task||0
8297438|NCT01573273|20456923|P12|COMPLETED|TSST : Trier Social Stress Task||0
8297439|NCT01573273|20456924|P11|COMPLETED|TSST : Trier Social Stress Task||0
8297440|NCT01573273|20456925|P10|COMPLETED|TSST : Trier Social Stress Task||0
8297441|NCT01573273|20456926|P9|COMPLETED|TSST : Trier Social Stress Task||0
8297442|NCT01573273|20456927|P8|COMPLETED|TSST : Trier Social Stress Task||31
8297443|NCT01573273|20456928|P7|COMPLETED|TSST : Trier Social Stress Task||32
8297444|NCT01573273|20456929|P6|COMPLETED|TSST : Trier Social Stress Task||0
8297445|NCT01573273|20456930|P5|COMPLETED|TSST : Trier Social Stress Task||0
8297446|NCT01573273|20456931|P4|COMPLETED|TSST : Trier Social Stress Task||0
8297447|NCT01573273|20456932|P3|COMPLETED|TSST : Trier Social Stress Task||0
8297448|NCT01573273|20456933|P2|COMPLETED|TSST : Trier Social Stress Task||25
8297449|NCT01573273|20456934|P1|COMPLETED|TSST : Trier Social Stress Task||24
8297450|NCT01573273|20456923|P12|STARTED|TSST : Trier Social Stress Task||0
8297451|NCT01573273|20456924|P11|STARTED|TSST : Trier Social Stress Task||0
8297452|NCT01573273|20456925|P10|STARTED|TSST : Trier Social Stress Task||0
8297453|NCT01573273|20456926|P9|STARTED|TSST : Trier Social Stress Task||0
8297454|NCT01573273|20456927|P8|STARTED|TSST : Trier Social Stress Task||31
8297455|NCT01573273|20456928|P7|STARTED|TSST : Trier Social Stress Task||32
8297456|NCT01573273|20456929|P6|STARTED|TSST : Trier Social Stress Task||0
8297457|NCT01573273|20456930|P5|STARTED|TSST : Trier Social Stress Task||0
8297458|NCT01573273|20456931|P4|STARTED|TSST : Trier Social Stress Task||0
8297459|NCT01573273|20456932|P3|STARTED|TSST : Trier Social Stress Task||0
8297460|NCT01573273|20456933|P2|STARTED|TSST : Trier Social Stress Task||25
8297461|NCT01573273|20456934|P1|STARTED|TSST : Trier Social Stress Task||24
8297462|NCT01573260|20456974|P2|NOT COMPLETED|Overall Study||0
8297463|NCT01573260|20456975|P1|NOT COMPLETED|Overall Study||0
8297464|NCT01573260|20456974|P2|COMPLETED|Overall Study||15
8297465|NCT01573260|20456975|P1|COMPLETED|Overall Study||18
8297466|NCT01573260|20456974|P2|STARTED|Overall Study||15
8297467|NCT01573260|20456975|P1|STARTED|Overall Study||18
8297468|NCT01573052|20457009|P2|NOT COMPLETED|Overall Study||6
8297469|NCT01573052|20457010|P1|NOT COMPLETED|Overall Study||3
8297470|NCT01573052|20457009|P2|COMPLETED|Overall Study||11
8297471|NCT01573052|20457010|P1|COMPLETED|Overall Study||6
8297472|NCT01573052|20457009|P2|STARTED|Overall Study||17
8297473|NCT01573052|20457010|P1|STARTED|Overall Study||9
8297474|NCT01573000|20457022|P2|NOT COMPLETED|Long-Term Follow-Up||1
8297475|NCT01573000|20457023|P1|NOT COMPLETED|Long-Term Follow-Up||3
8297476|NCT01573000|20457022|P2|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
8297477|NCT01573000|20457023|P1|COMPLETED|Long-Term Follow-Up||11
8297478|NCT01573000|20457022|P2|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
8297479|NCT01573000|20457023|P1|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
8297480|NCT01573000|20457022|P2|NOT COMPLETED|Crossover Phase||18
8297481|NCT01573000|20457023|P1|NOT COMPLETED|Crossover Phase||0
8297482|NCT01573000|20457022|P2|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
8297483|NCT01573000|20457023|P1|COMPLETED|Crossover Phase||0
8297484|NCT01573000|20457022|P2|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
8297485|NCT01573000|20457023|P1|STARTED|Crossover Phase||0
8297486|NCT01573000|20457022|P2|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
8297487|NCT01573000|20457023|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
8297488|NCT01573000|20457022|P2|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
8297489|NCT01573000|20457023|P1|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
8297490|NCT01573000|20457022|P2|STARTED|Dosimetric and Therapeutic Treatment||36
8297491|NCT01573000|20457023|P1|STARTED|Dosimetric and Therapeutic Treatment||42
8297492|NCT01572948|20457119|P2|NOT COMPLETED|Overall Study||1
8297493|NCT01572948|20457120|P1|NOT COMPLETED|Overall Study||1
8297494|NCT01572948|20457119|P2|COMPLETED|Overall Study||15
8297495|NCT01572948|20457120|P1|COMPLETED|Overall Study||10
8297496|NCT01572948|20457119|P2|STARTED|Overall Study||16
8297497|NCT01572948|20457120|P1|STARTED|Overall Study||11
8297498|NCT01572922|20457136|P1|NOT COMPLETED|Overall Study||3
8297499|NCT01572922|20457136|P1|COMPLETED|Overall Study||139
8297500|NCT01572922|20457136|P1|STARTED|Overall Study||142
8297501|NCT01572909|20457148|P2|NOT COMPLETED|Overall Study||25
8297502|NCT01572909|20457149|P1|NOT COMPLETED|Overall Study||32
8297503|NCT01572909|20457148|P2|COMPLETED|Overall Study||123
8297504|NCT01572909|20457149|P1|COMPLETED|Overall Study||120
8297505|NCT01572909|20457148|P2|STARTED|Overall Study||148
8297506|NCT01572909|20457149|P1|STARTED|Overall Study||152
8297507|NCT01572844|20457193|P2|NOT COMPLETED|Overall Study||1
8297508|NCT01572844|20457194|P1|NOT COMPLETED|Overall Study||1
8297509|NCT01572844|20457193|P2|COMPLETED|Overall Study||2
8297510|NCT01572844|20457194|P1|COMPLETED|Overall Study||2
8297511|NCT01572844|20457193|P2|STARTED|Overall Study||3
8297512|NCT01572844|20457194|P1|STARTED|Overall Study||3
8297513|NCT01572792|20457212|P5|NOT COMPLETED|Extension Study||32
8297514|NCT01572792|20457213|P4|NOT COMPLETED|Extension Study||29
8297515|NCT01572792|20457214|P3|NOT COMPLETED|Extension Study||26
8297517|NCT01572792|20457216|P1|NOT COMPLETED|Extension Study||25
8297518|NCT01572792|20457212|P5|COMPLETED|Extension Study||160
8297519|NCT01572792|20457213|P4|COMPLETED|Extension Study||165
8297520|NCT01572792|20457214|P3|COMPLETED|Extension Study||179
8297521|NCT01572792|20457215|P2|COMPLETED|Extension Study||155
8297522|NCT01572792|20457216|P1|COMPLETED|Extension Study||121
8297523|NCT01572792|20457212|P5|STARTED|Extension Study||192
8297524|NCT01572792|20457213|P4|STARTED|Extension Study||194
8297525|NCT01572792|20457214|P3|STARTED|Extension Study||205
8297526|NCT01572792|20457215|P2|STARTED|Extension Study||184
8297527|NCT01572792|20457216|P1|STARTED|Extension Study||146
8297528|NCT01572792|20457212|P5|NOT COMPLETED|Lead-in Study||69
8297529|NCT01572792|20457213|P4|NOT COMPLETED|Lead-in Study||72
8297530|NCT01572792|20457214|P3|NOT COMPLETED|Lead-in Study||62
8297531|NCT01572792|20457215|P2|NOT COMPLETED|Lead-in Study||66
8297532|NCT01572792|20457216|P1|NOT COMPLETED|Lead-in Study||101
8297533|NCT01572792|20457212|P5|COMPLETED|Lead-in Study||270
8297534|NCT01572792|20457213|P4|COMPLETED|Lead-in Study||268
8297535|NCT01572792|20457214|P3|COMPLETED|Lead-in Study||276
8297536|NCT01572792|20457215|P2|COMPLETED|Lead-in Study||272
8297537|NCT01572792|20457216|P1|COMPLETED|Lead-in Study||236
8297538|NCT01572792|20457212|P5|STARTED|Lead-in Study||339
8297539|NCT01572792|20457213|P4|STARTED|Lead-in Study||340
8297540|NCT01572792|20457214|P3|STARTED|Lead-in Study||338
8297541|NCT01572792|20457215|P2|STARTED|Lead-in Study||338
8297542|NCT01572792|20457216|P1|STARTED|Lead-in Study||337
8297543|NCT01572740|20457265|P2|NOT COMPLETED|Overall Study||5
8297544|NCT01572740|20457266|P1|NOT COMPLETED|Overall Study||6
8297545|NCT01572740|20457265|P2|COMPLETED|Overall Study||125
8297546|NCT01572740|20457266|P1|COMPLETED|Overall Study||121
8297547|NCT01572740|20457265|P2|STARTED|Overall Study||130
8297548|NCT01572740|20457266|P1|STARTED|Overall Study||127
8297549|NCT01572727|20457296|P2|NOT COMPLETED|Overall Study||209
8297550|NCT01572727|20457297|P1|NOT COMPLETED|Overall Study||207
8297551|NCT01572727|20457296|P2|COMPLETED|Overall Study||0
8297552|NCT01572727|20457297|P1|COMPLETED|Overall Study||0
8297553|NCT01572727|20457296|P2|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
8297554|NCT01572727|20457297|P1|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
8297555|NCT01572727|20457296|P2|STARTED|Overall Study||209
8297556|NCT01572727|20457297|P1|STARTED|Overall Study||207
8297557|NCT01572675|20457319|P2|NOT COMPLETED|Overall Study||223
8297558|NCT01572675|20457320|P1|NOT COMPLETED|Overall Study||237
8297559|NCT01572675|20457319|P2|COMPLETED|Overall Study||56
8297560|NCT01572675|20457320|P1|COMPLETED|Overall Study||31
8297561|NCT01572675|20457319|P2|STARTED|Overall Study||279
8297562|NCT01572675|20457320|P1|STARTED|Overall Study||268
8297563|NCT01572428|20457419|P2|NOT COMPLETED|Overall Study||1
8297564|NCT01572428|20457420|P1|NOT COMPLETED|Overall Study||3
8297565|NCT01572428|20457419|P2|COMPLETED|Overall Study||401
8297566|NCT01572428|20457420|P1|COMPLETED|Overall Study||399
8297567|NCT01572428|20457419|P2|STARTED|Overall Study||402
8297568|NCT01572428|20457420|P1|STARTED|Overall Study||402
8297569|NCT01572389|20457438|P2|NOT COMPLETED|Overall Study||21
8297570|NCT01572389|20457439|P1|NOT COMPLETED|Overall Study||46
8297571|NCT01572389|20457438|P2|COMPLETED|Overall Study||68
8297572|NCT01572389|20457439|P1|COMPLETED|Overall Study||90
8297573|NCT01572389|20457438|P2|STARTED|Overall Study||89
8297574|NCT01572389|20457439|P1|STARTED|Overall Study||136
8297575|NCT01572298|20457449|P2|NOT COMPLETED|Overall Study||1
8297576|NCT01572298|20457450|P1|NOT COMPLETED|Overall Study||2
8297577|NCT01572298|20457449|P2|COMPLETED|Overall Study||12
8297578|NCT01572298|20457450|P1|COMPLETED|Overall Study||12
8297579|NCT01572298|20457449|P2|STARTED|Overall Study||13
8297580|NCT01572298|20457450|P1|STARTED|Overall Study||14
8297581|NCT01572207|20457460|P2|NOT COMPLETED|Overall Study||3
8297582|NCT01572207|20457461|P1|NOT COMPLETED|Overall Study||2
8297583|NCT01572207|20457460|P2|COMPLETED|Overall Study||13
8297584|NCT01572207|20457461|P1|COMPLETED|Overall Study||12
8297585|NCT01572207|20457460|P2|STARTED|Overall Study||16
8297586|NCT01572207|20457461|P1|STARTED|Overall Study||14
8297587|NCT01572038|20457471|P1|NOT COMPLETED|Overall Study||991
8297588|NCT01572038|20457471|P1|COMPLETED|Overall Study||445
8297589|NCT01572038|20457471|P1|Received at Least One Dose of Study Drug|Overall Study||1436
8297590|NCT01572038|20457471|P1|STARTED|Overall Study|All participants who were enrolled in the study.|1436
8297591|NCT01571557|20457577|P1|NOT COMPLETED|Overall Study||0
8297592|NCT01571557|20457577|P1|COMPLETED|Overall Study||573
8297593|NCT01571557|20457577|P1|STARTED|Overall Study||573
8297594|NCT01571453|20457586|P2|NOT COMPLETED|Overall Study||62
8297595|NCT01571453|20457587|P1|NOT COMPLETED|Overall Study||38
8297596|NCT01571453|20457586|P2|COMPLETED|Overall Study||164
8297597|NCT01571453|20457587|P1|COMPLETED|Overall Study||173
8297598|NCT01571453|20457586|P2|STARTED|Overall Study||226
8297599|NCT01571453|20457587|P1|STARTED|Overall Study||211
8297600|NCT01571427|20457605|P2|NOT COMPLETED|Overall Study||0
8297601|NCT01571427|20457606|P1|NOT COMPLETED|Overall Study||0
8297602|NCT01571427|20457605|P2|COMPLETED|Overall Study||42
8297603|NCT01571427|20457606|P1|COMPLETED|Overall Study||41
8297604|NCT01571427|20457605|P2|STARTED|Overall Study||42
8297605|NCT01571427|20457606|P1|STARTED|Overall Study||41
8297606|NCT01571362|20457634|P3|NOT COMPLETED|Double-Blind Treatment Period||39
8297607|NCT01571362|20457635|P2|NOT COMPLETED|Double-Blind Treatment Period||53
8297608|NCT01571362|20457636|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8297609|NCT01571362|20457634|P3|COMPLETED|Double-Blind Treatment Period||107
8297610|NCT01571362|20457635|P2|COMPLETED|Double-Blind Treatment Period||81
8297611|NCT01571362|20457636|P1|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
8297612|NCT01571362|20457634|P3|STARTED|Double-Blind Treatment Period||146
8297613|NCT01571362|20457635|P2|STARTED|Double-Blind Treatment Period||134
8297614|NCT01571362|20457636|P1|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
8297615|NCT01571362|20457634|P3|NOT COMPLETED|Open-Label Conversion + Titration Period||0
8297616|NCT01571362|20457635|P2|NOT COMPLETED|Open-Label Conversion + Titration Period||0
8297617|NCT01571362|20457636|P1|NOT COMPLETED|Open-Label Conversion + Titration Period||129
8297618|NCT01571362|20457634|P3|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
8297619|NCT01571362|20457635|P2|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
8297620|NCT01571362|20457636|P1|COMPLETED|Open-Label Conversion + Titration Period||281
8297621|NCT01571362|20457634|P3|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
8297622|NCT01571362|20457635|P2|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
8297623|NCT01571362|20457636|P1|STARTED|Open-Label Conversion + Titration Period||410
8297624|NCT01571284|20457806|P1|NOT COMPLETED|Overall Study||169
8297625|NCT01571284|20457806|P1|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
8297626|NCT01571284|20457806|P1|Safety Population|Overall Study||779
8297627|NCT01571284|20457806|P1|STARTED|Overall Study||781
8297634|NCT01570868|20457842|P2|NOT COMPLETED|Overall Study||8
8297635|NCT01570868|20457843|P1|NOT COMPLETED|Overall Study||43
8297636|NCT01570868|20457842|P2|COMPLETED|Overall Study||0
8297637|NCT01570868|20457843|P1|COMPLETED|Overall Study||0
8297638|NCT01570868|20457842|P2|STARTED|Overall Study||8
8297639|NCT01570868|20457843|P1|STARTED|Overall Study||43
8297640|NCT01570751|20457855|P2|NOT COMPLETED|Period B (16 Weeks)||1
8297641|NCT01570751|20457856|P1|NOT COMPLETED|Period B (16 Weeks)||1
8297642|NCT01570751|20457855|P2|COMPLETED|Period B (16 Weeks)||66
8297643|NCT01570751|20457856|P1|COMPLETED|Period B (16 Weeks)||69
8297644|NCT01570751|20457855|P2|Exposed|Period B (16 Weeks)||67
8297645|NCT01570751|20457856|P1|Exposed|Period B (16 Weeks)||70
8297646|NCT01570751|20457855|P2|STARTED|Period B (16 Weeks)||67
8297647|NCT01570751|20457856|P1|STARTED|Period B (16 Weeks)||70
8297648|NCT01570751|20457855|P2|NOT COMPLETED|Period A (16 Weeks)||5
8297649|NCT01570751|20457856|P1|NOT COMPLETED|Period A (16 Weeks)||3
8297650|NCT01570751|20457855|P2|COMPLETED|Period A (16 Weeks)||67
8297651|NCT01570751|20457856|P1|COMPLETED|Period A (16 Weeks)||70
8297652|NCT01570751|20457855|P2|Exposed|Period A (16 Weeks)||72
8297653|NCT01570751|20457856|P1|Exposed|Period A (16 Weeks)||73
8297654|NCT01570751|20457855|P2|STARTED|Period A (16 Weeks)||72
8297655|NCT01570751|20457856|P1|STARTED|Period A (16 Weeks)||73
8297656|NCT01570686|20457874|P2|NOT COMPLETED|Overall Study||16
8297657|NCT01570686|20457875|P1|NOT COMPLETED|Overall Study||22
8297658|NCT01570686|20457874|P2|COMPLETED|Overall Study||278
8297659|NCT01570686|20457875|P1|COMPLETED|Overall Study||274
8297660|NCT01570686|20457874|P2|Safety and Full Analysis Set (FAS)|Overall Study||294
8297661|NCT01570686|20457875|P1|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
8297662|NCT01570686|20457874|P2|STARTED|Overall Study||294
8297663|NCT01570686|20457875|P1|STARTED|Overall Study||296
8297664|NCT01570634|20457901|P1|NOT COMPLETED|Overall Study||0
8297665|NCT01570634|20457901|P1|COMPLETED|Overall Study||2
8297666|NCT01570634|20457901|P1|STARTED|Overall Study||2
8297667|NCT01570491|20457911|P2|NOT COMPLETED|Overall Study||1
8297668|NCT01570491|20457912|P1|NOT COMPLETED|Overall Study||5
8297669|NCT01570491|20457911|P2|COMPLETED|Overall Study||18
8297670|NCT01570491|20457912|P1|COMPLETED|Overall Study||14
8297671|NCT01570491|20457911|P2|STARTED|Overall Study||19
8297672|NCT01570491|20457912|P1|STARTED|Overall Study||19
8297673|NCT01570387|20457928|P4|NOT COMPLETED|Overall Study||2
8297674|NCT01570387|20457929|P3|NOT COMPLETED|Overall Study||0
8297675|NCT01570387|20457930|P2|NOT COMPLETED|Overall Study||0
8297676|NCT01570387|20457931|P1|NOT COMPLETED|Overall Study||1
8297677|NCT01570387|20457928|P4|COMPLETED|Overall Study||10
8297678|NCT01570387|20457929|P3|COMPLETED|Overall Study||6
8297679|NCT01570387|20457930|P2|COMPLETED|Overall Study||3
8297680|NCT01570387|20457931|P1|COMPLETED|Overall Study||5
8297681|NCT01570387|20457928|P4|Response to Maximal Tolerated Dose|Overall Study||6
8297682|NCT01570387|20457929|P3|Response to Maximal Tolerated Dose|Overall Study||3
8297683|NCT01570387|20457930|P2|Response to Maximal Tolerated Dose|Overall Study||0
8297684|NCT01570387|20457931|P1|Response to Maximal Tolerated Dose|Overall Study||0
8297685|NCT01570387|20457928|P4|Dose Limiting Toxicity|Overall Study||12
8297686|NCT01570387|20457929|P3|Dose Limiting Toxicity|Overall Study||6
8297687|NCT01570387|20457930|P2|Dose Limiting Toxicity|Overall Study||0
8297688|NCT01570387|20457931|P1|Dose Limiting Toxicity|Overall Study||0
8297689|NCT01570387|20457928|P4|STARTED|Overall Study||12
8297690|NCT01570387|20457929|P3|STARTED|Overall Study||6
8297691|NCT01570387|20457930|P2|STARTED|Overall Study||3
8297692|NCT01570387|20457931|P1|STARTED|Overall Study||6
8297693|NCT01570361|20457943|P2|NOT COMPLETED|Overall Study||75
8297694|NCT01570361|20457944|P1|NOT COMPLETED|Overall Study||82
8297695|NCT01570361|20457943|P2|COMPLETED|Overall Study||52
8297696|NCT01570361|20457944|P1|COMPLETED|Overall Study||46
8297697|NCT01570361|20457943|P2|AAD Therapy Only|Overall Study||108
8297698|NCT01570361|20457944|P1|AAD Therapy Only|Overall Study||0
8297699|NCT01570361|20457943|P2|Cross-over (AAD Therapy to RF Ablation)|Overall Study||15
8297700|NCT01570361|20457944|P1|Cross-over (AAD Therapy to RF Ablation)|Overall Study||0
8297701|NCT01570361|20457943|P2|Received Study Treatment|Overall Study||123
8297702|NCT01570361|20457944|P1|Received Study Treatment|Overall Study||102
8297703|NCT01570361|20457943|P2|STARTED|Overall Study||127
8297704|NCT01570361|20457944|P1|STARTED|Overall Study||128
8297705|NCT01570348|20457971|P1|NOT COMPLETED|Overall Study||0
8297706|NCT01570348|20457971|P1|COMPLETED|Overall Study||2
8297707|NCT01570348|20457971|P1|STARTED|Overall Study||2
8297708|NCT01570309|20457987|P2|NOT COMPLETED|Overall Study||3
8297709|NCT01570309|20457988|P1|NOT COMPLETED|Overall Study||3
8297710|NCT01570309|20457987|P2|COMPLETED|Overall Study||45
8297711|NCT01570309|20457988|P1|COMPLETED|Overall Study||45
8297712|NCT01570309|20457987|P2|STARTED|Overall Study||48
8297713|NCT01570309|20457988|P1|STARTED|Overall Study||48
8297714|NCT01570283|20458005|P6|NOT COMPLETED|Cohort 3: Dose Level 3||2
8297715|NCT01570283|20458006|P5|NOT COMPLETED|Cohort 3: Dose Level 3||0
8297716|NCT01570283|20458007|P4|NOT COMPLETED|Cohort 3: Dose Level 3||0
8297717|NCT01570283|20458008|P3|NOT COMPLETED|Cohort 3: Dose Level 3||0
8297718|NCT01570283|20458009|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
8297719|NCT01570283|20458010|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
8297720|NCT01570283|20458005|P6|COMPLETED|Cohort 3: Dose Level 3||10
8297721|NCT01570283|20458006|P5|COMPLETED|Cohort 3: Dose Level 3||1
8297722|NCT01570283|20458007|P4|COMPLETED|Cohort 3: Dose Level 3||0
8297723|NCT01570283|20458008|P3|COMPLETED|Cohort 3: Dose Level 3||0
8297724|NCT01570283|20458009|P2|COMPLETED|Cohort 3: Dose Level 3||0
8297725|NCT01570283|20458010|P1|COMPLETED|Cohort 3: Dose Level 3||0
8297726|NCT01570283|20458005|P6|STARTED|Cohort 3: Dose Level 3||12
8297727|NCT01570283|20458006|P5|STARTED|Cohort 3: Dose Level 3||1
8297728|NCT01570283|20458007|P4|STARTED|Cohort 3: Dose Level 3||0
8297729|NCT01570283|20458008|P3|STARTED|Cohort 3: Dose Level 3||0
8297730|NCT01570283|20458009|P2|STARTED|Cohort 3: Dose Level 3||0
8297731|NCT01570283|20458010|P1|STARTED|Cohort 3: Dose Level 3||0
8297732|NCT01570283|20458005|P6|NOT COMPLETED|Cohort 2: Dose Level 2||0
8297733|NCT01570283|20458006|P5|NOT COMPLETED|Cohort 2: Dose Level 2||0
8297734|NCT01570283|20458007|P4|NOT COMPLETED|Cohort 2: Dose Level 2||1
8297735|NCT01570283|20458008|P3|NOT COMPLETED|Cohort 2: Dose Level 2||1
8297736|NCT01570283|20458009|P2|NOT COMPLETED|Cohort 2: Dose Level 2||0
8297737|NCT01570283|20458010|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
8297738|NCT01570283|20458005|P6|COMPLETED|Cohort 2: Dose Level 2||0
8297739|NCT01570283|20458006|P5|COMPLETED|Cohort 2: Dose Level 2||0
8297740|NCT01570283|20458007|P4|COMPLETED|Cohort 2: Dose Level 2||1
8297741|NCT01570283|20458008|P3|COMPLETED|Cohort 2: Dose Level 2||1
8297742|NCT01570283|20458009|P2|COMPLETED|Cohort 2: Dose Level 2||0
8297743|NCT01570283|20458010|P1|COMPLETED|Cohort 2: Dose Level 2||0
8297744|NCT01570283|20458005|P6|STARTED|Cohort 2: Dose Level 2||0
8297745|NCT01570283|20458006|P5|STARTED|Cohort 2: Dose Level 2||0
8297746|NCT01570283|20458007|P4|STARTED|Cohort 2: Dose Level 2||2
8297747|NCT01570283|20458008|P3|STARTED|Cohort 2: Dose Level 2||2
8297748|NCT01570283|20458009|P2|STARTED|Cohort 2: Dose Level 2||0
8297749|NCT01570283|20458010|P1|STARTED|Cohort 2: Dose Level 2||0
8297750|NCT01570283|20458005|P6|NOT COMPLETED|Cohort 1: Dose Level 1||0
8297751|NCT01570283|20458006|P5|NOT COMPLETED|Cohort 1: Dose Level 1||0
8297752|NCT01570283|20458007|P4|NOT COMPLETED|Cohort 1: Dose Level 1||0
8297753|NCT01570283|20458008|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
8297754|NCT01570283|20458009|P2|NOT COMPLETED|Cohort 1: Dose Level 1||2
8297755|NCT01570283|20458010|P1|NOT COMPLETED|Cohort 1: Dose Level 1||0
8297756|NCT01570283|20458005|P6|COMPLETED|Cohort 1: Dose Level 1||0
8297757|NCT01570283|20458006|P5|COMPLETED|Cohort 1: Dose Level 1||0
8297758|NCT01570283|20458007|P4|COMPLETED|Cohort 1: Dose Level 1||0
8297759|NCT01570283|20458008|P3|COMPLETED|Cohort 1: Dose Level 1||0
8297760|NCT01570283|20458009|P2|COMPLETED|Cohort 1: Dose Level 1||1
8297761|NCT01570283|20458010|P1|COMPLETED|Cohort 1: Dose Level 1||1
8297762|NCT01570283|20458005|P6|STARTED|Cohort 1: Dose Level 1||0
8297763|NCT01570283|20458006|P5|STARTED|Cohort 1: Dose Level 1||0
8297764|NCT01570283|20458007|P4|STARTED|Cohort 1: Dose Level 1||0
8297765|NCT01570283|20458008|P3|STARTED|Cohort 1: Dose Level 1||0
8297766|NCT01570283|20458009|P2|STARTED|Cohort 1: Dose Level 1||3
8297767|NCT01570283|20458010|P1|STARTED|Cohort 1: Dose Level 1||1
8297768|NCT01570244|20458027|P1|NOT COMPLETED|Microgynon+Faldaprevir||1
8297769|NCT01570244|20458027|P1|COMPLETED|Microgynon+Faldaprevir||15
8297770|NCT01570244|20458027|P1|STARTED|Microgynon+Faldaprevir||16
8297771|NCT01570244|20458027|P1|NOT COMPLETED|Microgynon||0
8297772|NCT01570244|20458027|P1|COMPLETED|Microgynon||16
8297773|NCT01570244|20458027|P1|STARTED|Microgynon||16
8297774|NCT01570192|20458049|P2|NOT COMPLETED|Overall Study||13
8297775|NCT01570192|20458050|P1|NOT COMPLETED|Overall Study||7
8297776|NCT01570192|20458049|P2|COMPLETED|Overall Study||17
8297777|NCT01570192|20458050|P1|COMPLETED|Overall Study||6
8297778|NCT01570192|20458049|P2|STARTED|Overall Study||30
8297779|NCT01570192|20458050|P1|STARTED|Overall Study||13
8297780|NCT01570036|20458090|P2|NOT COMPLETED|Overall Study||122
8297781|NCT01570036|20458091|P1|NOT COMPLETED|Overall Study||118
8297782|NCT01570036|20458090|P2|COMPLETED|Overall Study||17
8297783|NCT01570036|20458091|P1|COMPLETED|Overall Study||18
8297784|NCT01570036|20458090|P2|Booster Series Completed|Overall Study||30
8297785|NCT01570036|20458091|P1|Booster Series Completed|Overall Study||40
8297786|NCT01570036|20458090|P2|Primary Vaccine Series Completed|Overall Study||132
8297787|NCT01570036|20458091|P1|Primary Vaccine Series Completed|Overall Study||121
8297788|NCT01570036|20458090|P2|STARTED|Overall Study||139
8297789|NCT01570036|20458091|P1|STARTED|Overall Study||136
8297790|NCT01569841|20458103|P2|NOT COMPLETED|Period B (6 Weeks)||0
8297791|NCT01569841|20458104|P1|NOT COMPLETED|Period B (6 Weeks)||0
8297792|NCT01569841|20458103|P2|COMPLETED|Period B (6 Weeks)||11
8297793|NCT01569841|20458104|P1|COMPLETED|Period B (6 Weeks)||12
8297794|NCT01569841|20458103|P2|Exposed|Period B (6 Weeks)||11
8297795|NCT01569841|20458104|P1|Exposed|Period B (6 Weeks)||12
8297796|NCT01569841|20458103|P2|STARTED|Period B (6 Weeks)||11
8297797|NCT01569841|20458104|P1|STARTED|Period B (6 Weeks)||12
8297798|NCT01569841|20458103|P2|NOT COMPLETED|Period A (6 Weeks)||1
8297799|NCT01569841|20458104|P1|NOT COMPLETED|Period A (6 Weeks)||0
8297800|NCT01569841|20458103|P2|COMPLETED|Period A (6 Weeks)||11
8297801|NCT01569841|20458104|P1|COMPLETED|Period A (6 Weeks)||12
8297802|NCT01569841|20458103|P2|Exposed|Period A (6 Weeks)||12
8297803|NCT01569841|20458104|P1|Exposed|Period A (6 Weeks)||12
8297804|NCT01569841|20458103|P2|STARTED|Period A (6 Weeks)||12
8297805|NCT01569841|20458104|P1|STARTED|Period A (6 Weeks)||12
8297806|NCT01569828|20458122|P2|NOT COMPLETED|Overall Study||0
8297807|NCT01569828|20458123|P1|NOT COMPLETED|Overall Study||0
8297808|NCT01569828|20458122|P2|COMPLETED|Overall Study||6
8297809|NCT01569828|20458123|P1|COMPLETED|Overall Study||6
8297810|NCT01569828|20458122|P2|STARTED|Overall Study||6
8297811|NCT01569828|20458123|P1|STARTED|Overall Study||6
8297812|NCT01569815|20458145|P4|NOT COMPLETED|Overall Study||0
8297813|NCT01569815|20458146|P3|NOT COMPLETED|Overall Study||0
8297814|NCT01569815|20458147|P2|NOT COMPLETED|Overall Study||0
8297815|NCT01569815|20458148|P1|NOT COMPLETED|Overall Study||0
8297816|NCT01569815|20458145|P4|COMPLETED|Overall Study||8
8297817|NCT01569815|20458146|P3|COMPLETED|Overall Study||8
8297818|NCT01569815|20458147|P2|COMPLETED|Overall Study||8
8297819|NCT01569815|20458148|P1|COMPLETED|Overall Study||8
8297820|NCT01569815|20458145|P4|STARTED|Overall Study||8
8297821|NCT01569815|20458146|P3|STARTED|Overall Study||8
8297822|NCT01569815|20458147|P2|STARTED|Overall Study||8
8297823|NCT01569815|20458148|P1|STARTED|Overall Study||8
8297824|NCT01569763|20458193|P2|NOT COMPLETED|Overall Study||7
8297825|NCT01569763|20458194|P1|NOT COMPLETED|Overall Study||3
8297826|NCT01569763|20458193|P2|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
8297827|NCT01569763|20458194|P1|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
8297828|NCT01569763|20458193|P2|Treated|Overall Study||51
8297829|NCT01569763|20458194|P1|Treated|Overall Study||102
8297830|NCT01569763|20458193|P2|STARTED|Overall Study||51
8297831|NCT01569763|20458194|P1|STARTED|Overall Study||102
8297832|NCT01569737|20458204|P1|NOT COMPLETED|Overall Study||3
8297833|NCT01569737|20458204|P1|COMPLETED|Overall Study||95
8297834|NCT01569737|20458204|P1|STARTED|Overall Study||98
8297835|NCT01569607|20458210|P2|NOT COMPLETED|Overall Study||1
8297836|NCT01569607|20458211|P1|NOT COMPLETED|Overall Study||1
8297837|NCT01569607|20458210|P2|COMPLETED|Overall Study||10
8297838|NCT01569607|20458211|P1|COMPLETED|Overall Study||10
8297839|NCT01569607|20458210|P2|STARTED|Overall Study||11
8297840|NCT01569607|20458211|P1|STARTED|Overall Study||11
8297841|NCT01569594|20458233|P1|NOT COMPLETED|Overall Study||67
8297842|NCT01569594|20458233|P1|COMPLETED|Overall Study||163
8297843|NCT01569594|20458233|P1|STARTED|Overall Study||230
8297844|NCT01569568|20458239|P2|NOT COMPLETED|Overall Study||2
8297845|NCT01569568|20458240|P1|NOT COMPLETED|Overall Study||0
8297846|NCT01569568|20458239|P2|COMPLETED|Overall Study||27
8297847|NCT01569568|20458240|P1|COMPLETED|Overall Study||20
8297848|NCT01569568|20458239|P2|STARTED|Overall Study||29
8297849|NCT01569568|20458240|P1|STARTED|Overall Study||20
8297850|NCT01569529|20458254|P2|NOT COMPLETED|Overall Study||0
8297851|NCT01569529|20458255|P1|NOT COMPLETED|Overall Study||0
8297852|NCT01569529|20458254|P2|COMPLETED|Overall Study||394
8297853|NCT01569529|20458255|P1|COMPLETED|Overall Study||2676
8297854|NCT01569529|20458254|P2|STARTED|Overall Study||394
8297855|NCT01569529|20458255|P1|STARTED|Overall Study||2676
8297856|NCT01569464|20458263|P2|NOT COMPLETED|Overall Study||5
8297857|NCT01569464|20458264|P1|NOT COMPLETED|Overall Study||10
8297858|NCT01569464|20458263|P2|COMPLETED|Overall Study||44
8297859|NCT01569464|20458264|P1|COMPLETED|Overall Study||91
8297860|NCT01569464|20458263|P2|STARTED|Overall Study||49
8297861|NCT01569464|20458264|P1|STARTED|Overall Study||101
8297862|NCT01569451|20458302|P2|NOT COMPLETED|Overall Study||13
8297863|NCT01569451|20458303|P1|NOT COMPLETED|Overall Study||14
8297864|NCT01569451|20458302|P2|COMPLETED|Overall Study||14
8297865|NCT01569451|20458303|P1|COMPLETED|Overall Study||12
8297866|NCT01569451|20458302|P2|STARTED|Overall Study||27
8297867|NCT01569451|20458303|P1|STARTED|Overall Study||26
8297868|NCT01569438|20458331|P2|NOT COMPLETED|Overall Study||22
8297869|NCT01569438|20458332|P1|NOT COMPLETED|Overall Study||7
8297870|NCT01569438|20458331|P2|COMPLETED|Overall Study||33
8297871|NCT01569438|20458332|P1|COMPLETED|Overall Study||45
8297872|NCT01569438|20458331|P2|Titration Set|Overall Study||36
8297873|NCT01569438|20458332|P1|Titration Set|Overall Study||38
8297874|NCT01569438|20458331|P2|Treated|Overall Study||54
8297875|NCT01569438|20458332|P1|Treated|Overall Study||51
8297876|NCT01569438|20458331|P2|STARTED|Overall Study||55
8297877|NCT01569438|20458332|P1|STARTED|Overall Study||52
8297878|NCT01569295|20458346|P2|NOT COMPLETED|Overall Study||209
8297879|NCT01569295|20458347|P1|NOT COMPLETED|Overall Study||207
8297880|NCT01569295|20458346|P2|COMPLETED|Overall Study||0
8297881|NCT01569295|20458347|P1|COMPLETED|Overall Study||0
8297882|NCT01569295|20458346|P2|Long-Term Follow-up|Overall Study||161
8297883|NCT01569295|20458347|P1|Long-Term Follow-up|Overall Study||109
8297884|NCT01569295|20458346|P2|STARTED|Overall Study||209
8297885|NCT01569295|20458347|P1|STARTED|Overall Study||207
8297886|NCT01569191|20458363|P2|NOT COMPLETED|Overall Study||0
8297887|NCT01569191|20458364|P1|NOT COMPLETED|Overall Study||0
8297888|NCT01569191|20458363|P2|COMPLETED|Overall Study||7
8297889|NCT01569191|20458364|P1|COMPLETED|Overall Study||11
8297890|NCT01569191|20458363|P2|STARTED|Overall Study||7
8297891|NCT01569191|20458364|P1|STARTED|Overall Study||11
8297892|NCT01569152|20458384|P3|NOT COMPLETED|Safety Extension, Period 3||55
8297893|NCT01569152|20458385|P2|NOT COMPLETED|Safety Extension, Period 3||0
8297894|NCT01569152|20458386|P1|NOT COMPLETED|Safety Extension, Period 3||0
8297895|NCT01569152|20458384|P3|COMPLETED|Safety Extension, Period 3||0
8297896|NCT01569152|20458385|P2|COMPLETED|Safety Extension, Period 3||0
8297897|NCT01569152|20458386|P1|COMPLETED|Safety Extension, Period 3||0
8297898|NCT01569152|20458384|P3|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
8297899|NCT01569152|20458385|P2|STARTED|Safety Extension, Period 3||0
8297900|NCT01569152|20458386|P1|STARTED|Safety Extension, Period 3||0
8297901|NCT01569152|20458384|P3|NOT COMPLETED|Phase IIa, Period 1||0
8297902|NCT01569152|20458385|P2|NOT COMPLETED|Phase IIa, Period 1||32
8297903|NCT01569152|20458386|P1|NOT COMPLETED|Phase IIa, Period 1||21
8297904|NCT01569152|20458384|P3|COMPLETED|Phase IIa, Period 1||0
8297905|NCT01569152|20458385|P2|COMPLETED|Phase IIa, Period 1||9
8297906|NCT01569152|20458386|P1|COMPLETED|Phase IIa, Period 1||20
8297907|NCT01569152|20458384|P3|STARTED|Phase IIa, Period 1||0
8297908|NCT01569152|20458385|P2|STARTED|Phase IIa, Period 1||41
8297909|NCT01569152|20458386|P1|STARTED|Phase IIa, Period 1||41
8297910|NCT01569126|20458449|P6|NOT COMPLETED|Overall Study||0
8297911|NCT01569126|20458450|P5|NOT COMPLETED|Overall Study||0
8297912|NCT01569126|20458451|P4|NOT COMPLETED|Overall Study||0
8297913|NCT01569126|20458452|P3|NOT COMPLETED|Overall Study||0
8297914|NCT01569126|20458453|P2|NOT COMPLETED|Overall Study||0
8297915|NCT01569126|20458454|P1|NOT COMPLETED|Overall Study||0
8297916|NCT01569126|20458449|P6|COMPLETED|Overall Study||12
8297917|NCT01569126|20458450|P5|COMPLETED|Overall Study||12
8297918|NCT01569126|20458451|P4|COMPLETED|Overall Study||8
8297919|NCT01569126|20458452|P3|COMPLETED|Overall Study||8
8297920|NCT01569126|20458453|P2|COMPLETED|Overall Study||8
8297921|NCT01569126|20458454|P1|COMPLETED|Overall Study||8
8297922|NCT01569126|20458449|P6|Received at Least 1 Dose of Study Drug|Overall Study||12
8297923|NCT01569126|20458450|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
8297924|NCT01569126|20458451|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
8297925|NCT01569126|20458452|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
8297926|NCT01569126|20458453|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8297927|NCT01569126|20458454|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8297928|NCT01569126|20458449|P6|STARTED|Overall Study||12
8297929|NCT01569126|20458450|P5|STARTED|Overall Study||12
8297930|NCT01569126|20458451|P4|STARTED|Overall Study||8
8297931|NCT01569126|20458452|P3|STARTED|Overall Study||8
8297932|NCT01569126|20458453|P2|STARTED|Overall Study||8
8297933|NCT01569126|20458454|P1|STARTED|Overall Study||8
8297934|NCT01569087|20458492|P3|NOT COMPLETED|Overall Study||1
8297935|NCT01569087|20458493|P2|NOT COMPLETED|Overall Study||0
8297936|NCT01569087|20458494|P1|NOT COMPLETED|Overall Study||1
8297937|NCT01569087|20458492|P3|COMPLETED|Overall Study||18
8297938|NCT01569087|20458493|P2|COMPLETED|Overall Study||20
8297939|NCT01569087|20458494|P1|COMPLETED|Overall Study||20
8297940|NCT01569087|20458492|P3|STARTED|Overall Study||19
8297941|NCT01569087|20458493|P2|STARTED|Overall Study||20
8297942|NCT01569087|20458494|P1|STARTED|Overall Study||21
8297943|NCT01569074|20458522|P5|NOT COMPLETED|Overall Study||8
8297944|NCT01569074|20458523|P4|NOT COMPLETED|Overall Study||8
8297945|NCT01569074|20458524|P3|NOT COMPLETED|Overall Study||12
8297946|NCT01569074|20458525|P2|NOT COMPLETED|Overall Study||9
8297947|NCT01569074|20458526|P1|NOT COMPLETED|Overall Study||7
8297948|NCT01569074|20458522|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
8297949|NCT01569074|20458523|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
8297950|NCT01569074|20458524|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
8297951|NCT01569074|20458525|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
8297952|NCT01569074|20458526|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
8297953|NCT01569074|20458522|P5|Randomised But Did Not Receive Treatment|Overall Study||0
8297954|NCT01569074|20458523|P4|Randomised But Did Not Receive Treatment|Overall Study||0
8297955|NCT01569074|20458524|P3|Randomised But Did Not Receive Treatment|Overall Study||0
8297956|NCT01569074|20458525|P2|Randomised But Did Not Receive Treatment|Overall Study||0
8297957|NCT01569074|20458526|P1|Randomised But Did Not Receive Treatment|Overall Study||0
8297958|NCT01569074|20458522|P5|STARTED|Overall Study|Patients who received treatment|33
8297959|NCT01569074|20458523|P4|STARTED|Overall Study|Patients who received treatment|33
8297960|NCT01569074|20458524|P3|STARTED|Overall Study|Patients who received treatment|33
8297961|NCT01569074|20458525|P2|STARTED|Overall Study|Patients who received treatment|33
8297962|NCT01569074|20458526|P1|STARTED|Overall Study|Patients who received treatment|31
8297963|NCT01569022|20458582|P2|NOT COMPLETED|Second Intervention||2
8297964|NCT01569022|20458583|P1|NOT COMPLETED|Second Intervention||2
8297965|NCT01569022|20458582|P2|COMPLETED|Second Intervention||18
8297966|NCT01569022|20458583|P1|COMPLETED|Second Intervention||17
8297967|NCT01569022|20458582|P2|STARTED|Second Intervention||20
8297968|NCT01569022|20458583|P1|STARTED|Second Intervention||19
8297969|NCT01569022|20458582|P2|NOT COMPLETED|First Intervention||1
8297970|NCT01569022|20458583|P1|NOT COMPLETED|First Intervention||2
8297971|NCT01569022|20458582|P2|COMPLETED|First Intervention||20
8297972|NCT01569022|20458583|P1|COMPLETED|First Intervention||19
8297973|NCT01569022|20458582|P2|STARTED|First Intervention||21
8297974|NCT01569022|20458583|P1|STARTED|First Intervention||21
8297975|NCT01568944|20458597|P2|NOT COMPLETED|Overall Study||0
8297976|NCT01568944|20458598|P1|NOT COMPLETED|Overall Study||0
8297977|NCT01568944|20458597|P2|COMPLETED|Overall Study||10
8297978|NCT01568944|20458598|P1|COMPLETED|Overall Study||8
8297979|NCT01568944|20458597|P2|STARTED|Overall Study||10
8297980|NCT01568944|20458598|P1|STARTED|Overall Study||8
8297981|NCT01568905|20458617|P3|NOT COMPLETED|Overall Study||0
8297982|NCT01568905|20458618|P2|NOT COMPLETED|Overall Study||0
8297983|NCT01568905|20458619|P1|NOT COMPLETED|Overall Study||1
8297984|NCT01568905|20458617|P3|COMPLETED|Overall Study||12
8297985|NCT01568905|20458618|P2|COMPLETED|Overall Study||11
8297986|NCT01568905|20458619|P1|COMPLETED|Overall Study||12
8297987|NCT01568905|20458617|P3|STARTED|Overall Study||12
8297988|NCT01568905|20458618|P2|STARTED|Overall Study||11
8297989|NCT01568905|20458619|P1|STARTED|Overall Study||13
8297990|NCT01568892|20458638|P2|NOT COMPLETED|Open-label Phase||3
8297991|NCT01568892|20458639|P1|NOT COMPLETED|Open-label Phase||6
8297992|NCT01568892|20458638|P2|COMPLETED|Open-label Phase||13
8297993|NCT01568892|20458639|P1|COMPLETED|Open-label Phase||7
8297994|NCT01568892|20458638|P2|STARTED|Open-label Phase||16
8297995|NCT01568892|20458639|P1|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
8297996|NCT01568892|20458638|P2|NOT COMPLETED|Double-blind Phase||0
8297997|NCT01568892|20458639|P1|NOT COMPLETED|Double-blind Phase||0
8297998|NCT01568892|20458638|P2|COMPLETED|Double-blind Phase||16
8297999|NCT01568892|20458639|P1|COMPLETED|Double-blind Phase||14
8298000|NCT01568892|20458638|P2|STARTED|Double-blind Phase||16
8298001|NCT01568892|20458639|P1|STARTED|Double-blind Phase||14
8298002|NCT01568866|20458709|P2|NOT COMPLETED|Overall Study||416
8298003|NCT01568866|20458710|P1|NOT COMPLETED|Overall Study||438
8298004|NCT01568866|20458709|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
8298005|NCT01568866|20458710|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
8298006|NCT01568866|20458709|P2|Received Treatment|Overall Study||463
8298007|NCT01568866|20458710|P1|Received Treatment|Overall Study||456
8298008|NCT01568866|20458709|P2|STARTED|Overall Study||464
8298009|NCT01568866|20458710|P1|STARTED|Overall Study||465
8298010|NCT01568827|20458732|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
8298011|NCT01568827|20458733|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
8298012|NCT01568827|20458732|P2|COMPLETED|Intervention 2 (5 Days)||5
8298013|NCT01568827|20458733|P1|COMPLETED|Intervention 2 (5 Days)||5
8298014|NCT01568827|20458732|P2|STARTED|Intervention 2 (5 Days)||5
8298015|NCT01568827|20458733|P1|STARTED|Intervention 2 (5 Days)||5
8298016|NCT01568827|20458732|P2|NOT COMPLETED|Washout (2 Days)||0
8298017|NCT01568827|20458733|P1|NOT COMPLETED|Washout (2 Days)||0
8298018|NCT01568827|20458732|P2|COMPLETED|Washout (2 Days)||5
8298019|NCT01568827|20458733|P1|COMPLETED|Washout (2 Days)||5
8298020|NCT01568827|20458732|P2|STARTED|Washout (2 Days)||5
8298021|NCT01568827|20458733|P1|STARTED|Washout (2 Days)||5
8298022|NCT01568827|20458732|P2|NOT COMPLETED|First Intervention (6 Days)||0
8298023|NCT01568827|20458733|P1|NOT COMPLETED|First Intervention (6 Days)||0
8298024|NCT01568827|20458732|P2|COMPLETED|First Intervention (6 Days)||5
8298025|NCT01568827|20458733|P1|COMPLETED|First Intervention (6 Days)||5
8298026|NCT01568827|20458732|P2|STARTED|First Intervention (6 Days)||5
8298027|NCT01568827|20458733|P1|STARTED|First Intervention (6 Days)||5
8298028|NCT01568606|20458739|P1|NOT COMPLETED|Overall Study||0
8298029|NCT01568606|20458739|P1|COMPLETED|Overall Study||20
8298030|NCT01568606|20458739|P1|STARTED|Overall Study||20
8298031|NCT01568593|20458745|P2|NOT COMPLETED|Overall Study||3
8298032|NCT01568593|20458746|P1|NOT COMPLETED|Overall Study||7
8298033|NCT01568593|20458745|P2|COMPLETED|Overall Study||42
8298034|NCT01568593|20458746|P1|COMPLETED|Overall Study||41
8298035|NCT01568593|20458745|P2|STARTED|Overall Study||45
8298036|NCT01568593|20458746|P1|STARTED|Overall Study||48
8298037|NCT01568528|20458755|P3|NOT COMPLETED|Overall Study||0
8298038|NCT01568528|20458756|P2|NOT COMPLETED|Overall Study||0
8298039|NCT01568528|20458757|P1|NOT COMPLETED|Overall Study||0
8298040|NCT01568528|20458755|P3|COMPLETED|Overall Study||9
8298041|NCT01568528|20458756|P2|COMPLETED|Overall Study||11
8298042|NCT01568528|20458757|P1|COMPLETED|Overall Study||19
8298043|NCT01568528|20458755|P3|STARTED|Overall Study||9
8298044|NCT01568528|20458756|P2|STARTED|Overall Study||11
8298045|NCT01568528|20458757|P1|STARTED|Overall Study||19
8298046|NCT01568424|20458777|P1|NOT COMPLETED|Overall Study||0
8298047|NCT01568424|20458777|P1|COMPLETED|Overall Study||25
8298048|NCT01568424|20458777|P1|STARTED|Overall Study||25
8298049|NCT01568112|20458791|P4|NOT COMPLETED|Overall Study||12
8298050|NCT01568112|20458792|P3|NOT COMPLETED|Overall Study||7
8298051|NCT01568112|20458793|P2|NOT COMPLETED|Overall Study||8
8298052|NCT01568112|20458794|P1|NOT COMPLETED|Overall Study||5
8298053|NCT01568112|20458791|P4|COMPLETED|Overall Study||30
8298054|NCT01568112|20458792|P3|COMPLETED|Overall Study||36
8298055|NCT01568112|20458793|P2|COMPLETED|Overall Study||36
8298056|NCT01568112|20458794|P1|COMPLETED|Overall Study||39
8298057|NCT01568112|20458791|P4|STARTED|Overall Study||42
8298058|NCT01568112|20458792|P3|STARTED|Overall Study||43
8298059|NCT01568112|20458793|P2|STARTED|Overall Study||44
8298060|NCT01568112|20458794|P1|STARTED|Overall Study||44
8298061|NCT01568073|20458917|P5|NOT COMPLETED|Overall Study||9
8298062|NCT01568073|20458918|P4|NOT COMPLETED|Overall Study||11
8298063|NCT01568073|20458919|P3|NOT COMPLETED|Overall Study||12
8298064|NCT01568073|20458920|P2|NOT COMPLETED|Overall Study||15
8298065|NCT01568073|20458921|P1|NOT COMPLETED|Overall Study||11
8298066|NCT01568073|20458917|P5|COMPLETED|Overall Study||107
8298067|NCT01568073|20458918|P4|COMPLETED|Overall Study||108
8298068|NCT01568073|20458919|P3|COMPLETED|Overall Study||110
8298069|NCT01568073|20458920|P2|COMPLETED|Overall Study||107
8298070|NCT01568073|20458921|P1|COMPLETED|Overall Study||110
8298071|NCT01568073|20458917|P5|STARTED|Overall Study||116
8298072|NCT01568073|20458918|P4|STARTED|Overall Study||119
8298073|NCT01568073|20458919|P3|STARTED|Overall Study||122
8298074|NCT01568073|20458920|P2|STARTED|Overall Study||122
8298075|NCT01568073|20458921|P1|STARTED|Overall Study||121
8298076|NCT01568047|20458952|P4|NOT COMPLETED|Overall Study||1
8298077|NCT01568047|20458953|P3|NOT COMPLETED|Overall Study||1
8298078|NCT01568047|20458954|P2|NOT COMPLETED|Overall Study||1
8298079|NCT01568047|20458955|P1|NOT COMPLETED|Overall Study||1
8298080|NCT01568047|20458952|P4|COMPLETED|Overall Study||9
8298081|NCT01568047|20458953|P3|COMPLETED|Overall Study||9
8298082|NCT01568047|20458954|P2|COMPLETED|Overall Study||9
8298083|NCT01568047|20458955|P1|COMPLETED|Overall Study||9
8298084|NCT01568047|20458952|P4|STARTED|Overall Study||10
8298085|NCT01568047|20458953|P3|STARTED|Overall Study||10
8298086|NCT01568047|20458954|P2|STARTED|Overall Study||10
8298087|NCT01568047|20458955|P1|STARTED|Overall Study||10
8298088|NCT01568034|20458973|P4|NOT COMPLETED|Overall Study||0
8298089|NCT01568034|20458974|P3|NOT COMPLETED|Overall Study||0
8298090|NCT01568034|20458975|P2|NOT COMPLETED|Overall Study||0
8298091|NCT01568034|20458976|P1|NOT COMPLETED|Overall Study||1
8298092|NCT01568034|20458973|P4|COMPLETED|Overall Study||3
8298093|NCT01568034|20458974|P3|COMPLETED|Overall Study||3
8298094|NCT01568034|20458975|P2|COMPLETED|Overall Study||2
8298095|NCT01568034|20458976|P1|COMPLETED|Overall Study||1
8298096|NCT01568034|20458973|P4|Placebo|Overall Study||3
8298097|NCT01568034|20458974|P3|Placebo|Overall Study||3
8298098|NCT01568034|20458975|P2|Placebo|Overall Study||2
8298099|NCT01568034|20458976|P1|Placebo|Overall Study||1
8298100|NCT01568034|20458973|P4|100 mg BIA 9-1067|Overall Study||3
8298101|NCT01568034|20458974|P3|100 mg BIA 9-1067|Overall Study||3
8298102|NCT01568034|20458975|P2|100 mg BIA 9-1067|Overall Study||2
8298103|NCT01568034|20458976|P1|100 mg BIA 9-1067|Overall Study||2
8298104|NCT01568034|20458973|P4|50 mg BIA 9-1067|Overall Study||3
8298105|NCT01568034|20458974|P3|50 mg BIA 9-1067|Overall Study||3
8298106|NCT01568034|20458975|P2|50 mg BIA 9-1067|Overall Study||2
8298107|NCT01568034|20458976|P1|50 mg BIA 9-1067|Overall Study||2
8298108|NCT01568034|20458973|P4|25 mg BIA 9-1067|Overall Study||3
8298109|NCT01568034|20458974|P3|25 mg BIA 9-1067|Overall Study||3
8298110|NCT01568034|20458975|P2|25 mg BIA 9-1067|Overall Study||2
8298111|NCT01568034|20458976|P1|25 mg BIA 9-1067|Overall Study||2
8298112|NCT01568034|20458973|P4|STARTED|Overall Study||3
8298113|NCT01568034|20458974|P3|STARTED|Overall Study||3
8298114|NCT01568034|20458975|P2|STARTED|Overall Study||2
8298115|NCT01568034|20458976|P1|STARTED|Overall Study||2
8298116|NCT01568021|20458994|P1|NOT COMPLETED|Overall Study||16
8298117|NCT01568021|20458994|P1|COMPLETED|Overall Study||83
8298118|NCT01568021|20458994|P1|STARTED|Overall Study||99
8298119|NCT01568008|20459000|P1|NOT COMPLETED|Overall Study||234
8298120|NCT01568008|20459000|P1|COMPLETED|Overall Study||699
8298121|NCT01568008|20459000|P1|STARTED|Overall Study||933
8298122|NCT01567943|20459011|P3|NOT COMPLETED|Overall Study||0
8298123|NCT01567943|20459012|P2|NOT COMPLETED|Overall Study||10
8298124|NCT01567943|20459013|P1|NOT COMPLETED|Overall Study||14
8298125|NCT01567943|20459011|P3|COMPLETED|Overall Study||44
8298126|NCT01567943|20459012|P2|COMPLETED|Overall Study||29
8298127|NCT01567943|20459013|P1|COMPLETED|Overall Study||26
8298128|NCT01567943|20459011|P3|STARTED|Overall Study||44
8298129|NCT01567943|20459012|P2|STARTED|Overall Study||39
8298130|NCT01567943|20459013|P1|STARTED|Overall Study||40
8298131|NCT01567891|20459021|P1|NOT COMPLETED|Overall Study||3
8298132|NCT01567891|20459021|P1|COMPLETED|Overall Study||6
8298133|NCT01567891|20459021|P1|Received T-cell|Overall Study||6
8298134|NCT01567891|20459021|P1|STARTED|Overall Study||9
8298135|NCT01567865|20459039|P4|NOT COMPLETED|Evaluated for Immunogenicity||30
8298136|NCT01567865|20459040|P3|NOT COMPLETED|Evaluated for Immunogenicity||19
8298137|NCT01567865|20459041|P2|NOT COMPLETED|Evaluated for Immunogenicity||25
8298138|NCT01567865|20459042|P1|NOT COMPLETED|Evaluated for Immunogenicity||17
8298139|NCT01567865|20459039|P4|COMPLETED|Evaluated for Immunogenicity||194
8298140|NCT01567865|20459040|P3|COMPLETED|Evaluated for Immunogenicity||192
8298141|NCT01567865|20459041|P2|COMPLETED|Evaluated for Immunogenicity||195
8298142|NCT01567865|20459042|P1|COMPLETED|Evaluated for Immunogenicity||146
8298143|NCT01567865|20459039|P4|STARTED|Evaluated for Immunogenicity||224
8298144|NCT01567865|20459040|P3|STARTED|Evaluated for Immunogenicity||211
8298145|NCT01567865|20459041|P2|STARTED|Evaluated for Immunogenicity||220
8298146|NCT01567865|20459042|P1|STARTED|Evaluated for Immunogenicity||163
8298147|NCT01567865|20459039|P4|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
8298148|NCT01567865|20459040|P3|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
8298149|NCT01567865|20459041|P2|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
8298150|NCT01567865|20459042|P1|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
8298151|NCT01567865|20459039|P4|COMPLETED|Enrolled and Vaccinated (Day 0)||224
8298152|NCT01567865|20459040|P3|COMPLETED|Enrolled and Vaccinated (Day 0)||211
8298153|NCT01567865|20459041|P2|COMPLETED|Enrolled and Vaccinated (Day 0)||220
8298154|NCT01567865|20459042|P1|COMPLETED|Enrolled and Vaccinated (Day 0)||163
8298155|NCT01567865|20459039|P4|STARTED|Enrolled and Vaccinated (Day 0)||224
8298156|NCT01567865|20459040|P3|STARTED|Enrolled and Vaccinated (Day 0)||211
8298157|NCT01567865|20459041|P2|STARTED|Enrolled and Vaccinated (Day 0)||220
8298158|NCT01567865|20459042|P1|STARTED|Enrolled and Vaccinated (Day 0)||163
8298159|NCT01567852|20459072|P2|NOT COMPLETED|Overall Study||7
8298160|NCT01567852|20459073|P1|NOT COMPLETED|Overall Study||4
8298161|NCT01567852|20459072|P2|COMPLETED|Overall Study||5
8298162|NCT01567852|20459073|P1|COMPLETED|Overall Study||4
8298163|NCT01567852|20459072|P2|STARTED|Overall Study||12
8298164|NCT01567852|20459073|P1|STARTED|Overall Study||8
8298165|NCT01567839|20459081|P1|NOT COMPLETED|Overall Study||0
8298166|NCT01567839|20459081|P1|COMPLETED|Overall Study||60
8298167|NCT01567839|20459081|P1|STARTED|Overall Study||60
8298168|NCT01567826|20459091|P2|NOT COMPLETED|Overall Study||2
8298169|NCT01567826|20459092|P1|NOT COMPLETED|Overall Study||3
8298170|NCT01567826|20459091|P2|COMPLETED|Overall Study||42
8298171|NCT01567826|20459092|P1|COMPLETED|Overall Study||40
8298172|NCT01567826|20459091|P2|STARTED|Overall Study||44
8298173|NCT01567826|20459092|P1|STARTED|Overall Study||43
8298174|NCT01567527|20459118|P5|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
8298175|NCT01567527|20459119|P4|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
8298176|NCT01567527|20459120|P3|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8298177|NCT01567527|20459121|P2|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8298178|NCT01567527|20459122|P1|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
8298179|NCT01567527|20459118|P5|COMPLETED|Double-blind, Placebo-controlled Phase||38
8298180|NCT01567527|20459119|P4|COMPLETED|Double-blind, Placebo-controlled Phase||64
8298181|NCT01567527|20459120|P3|COMPLETED|Double-blind, Placebo-controlled Phase||0
8298182|NCT01567527|20459121|P2|COMPLETED|Double-blind, Placebo-controlled Phase||0
8298183|NCT01567527|20459122|P1|COMPLETED|Double-blind, Placebo-controlled Phase||0
8298184|NCT01567527|20459118|P5|STARTED|Double-blind, Placebo-controlled Phase||133
8298185|NCT01567527|20459119|P4|STARTED|Double-blind, Placebo-controlled Phase||133
8298186|NCT01567527|20459120|P3|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
8298187|NCT01567527|20459121|P2|STARTED|Double-blind, Placebo-controlled Phase||0
8298188|NCT01567527|20459122|P1|STARTED|Double-blind, Placebo-controlled Phase||0
8298189|NCT01567527|20459118|P5|NOT COMPLETED|IM Depot Stabilization.||0
8298190|NCT01567527|20459119|P4|NOT COMPLETED|IM Depot Stabilization.||0
8298191|NCT01567527|20459120|P3|NOT COMPLETED|IM Depot Stabilization.||159
8298192|NCT01567527|20459121|P2|NOT COMPLETED|IM Depot Stabilization.||0
8298193|NCT01567527|20459122|P1|NOT COMPLETED|IM Depot Stabilization.||0
8298194|NCT01567527|20459118|P5|COMPLETED|IM Depot Stabilization.||0
8298195|NCT01567527|20459119|P4|COMPLETED|IM Depot Stabilization.||0
8298196|NCT01567527|20459120|P3|COMPLETED|IM Depot Stabilization.||266
8298197|NCT01567527|20459121|P2|COMPLETED|IM Depot Stabilization.||0
8298198|NCT01567527|20459122|P1|COMPLETED|IM Depot Stabilization.||0
8298199|NCT01567527|20459118|P5|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
8298200|NCT01567527|20459119|P4|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
8298201|NCT01567527|20459120|P3|STARTED|IM Depot Stabilization.||425
8298202|NCT01567527|20459121|P2|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
8298203|NCT01567527|20459122|P1|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
8298204|NCT01567527|20459118|P5|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298205|NCT01567527|20459119|P4|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298206|NCT01567527|20459120|P3|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298207|NCT01567527|20459121|P2|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
8298208|NCT01567527|20459122|P1|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298209|NCT01567527|20459118|P5|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298210|NCT01567527|20459119|P4|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298211|NCT01567527|20459120|P3|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298212|NCT01567527|20459121|P2|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
8298213|NCT01567527|20459122|P1|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
8298214|NCT01567527|20459118|P5|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298215|NCT01567527|20459119|P4|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298216|NCT01567527|20459120|P3|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298305|NCT01566773|20459270|P1|GP MDI 1.2 µg BID|Overall Study||57
8298217|NCT01567527|20459121|P2|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
8298218|NCT01567527|20459122|P1|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298219|NCT01567527|20459118|P5|NOT COMPLETED|Conversion Phase.||0
8298220|NCT01567527|20459119|P4|NOT COMPLETED|Conversion Phase.||0
8298221|NCT01567527|20459120|P3|NOT COMPLETED|Conversion Phase.||0
8298222|NCT01567527|20459121|P2|NOT COMPLETED|Conversion Phase.||0
8298223|NCT01567527|20459122|P1|NOT COMPLETED|Conversion Phase.||99
8298224|NCT01567527|20459118|P5|COMPLETED|Conversion Phase.||0
8298225|NCT01567527|20459119|P4|COMPLETED|Conversion Phase.||0
8298226|NCT01567527|20459120|P3|COMPLETED|Conversion Phase.||0
8298227|NCT01567527|20459121|P2|COMPLETED|Conversion Phase.||0
8298228|NCT01567527|20459122|P1|COMPLETED|Conversion Phase.||367
8298229|NCT01567527|20459118|P5|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298230|NCT01567527|20459119|P4|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298231|NCT01567527|20459120|P3|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298232|NCT01567527|20459121|P2|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
8298233|NCT01567527|20459122|P1|STARTED|Conversion Phase.||466
8298234|NCT01567462|20459139|P2|NOT COMPLETED|Overall Study||7
8298235|NCT01567462|20459140|P1|NOT COMPLETED|Overall Study||4
8298236|NCT01567462|20459139|P2|COMPLETED|Overall Study||38
8298237|NCT01567462|20459140|P1|COMPLETED|Overall Study||41
8298238|NCT01567462|20459139|P2|STARTED|Overall Study||45
8298239|NCT01567462|20459140|P1|STARTED|Overall Study||45
8298240|NCT01567371|20459152|P1|NOT COMPLETED|Overall Study||0
8298241|NCT01567371|20459152|P1|COMPLETED|Overall Study||30
8298242|NCT01567371|20459152|P1|STARTED|Overall Study||30
8298243|NCT01567306|20459163|P6|NOT COMPLETED|Overall Study||3
8298244|NCT01567306|20459164|P5|NOT COMPLETED|Overall Study||7
8298245|NCT01567306|20459165|P4|NOT COMPLETED|Overall Study||5
8298246|NCT01567306|20459166|P3|NOT COMPLETED|Overall Study||0
8298247|NCT01567306|20459167|P2|NOT COMPLETED|Overall Study||2
8298248|NCT01567306|20459168|P1|NOT COMPLETED|Overall Study||3
8298249|NCT01567306|20459163|P6|COMPLETED|Overall Study||23
8298250|NCT01567306|20459164|P5|COMPLETED|Overall Study||18
8298251|NCT01567306|20459165|P4|COMPLETED|Overall Study||19
8298252|NCT01567306|20459166|P3|COMPLETED|Overall Study||24
8298253|NCT01567306|20459167|P2|COMPLETED|Overall Study||23
8298254|NCT01567306|20459168|P1|COMPLETED|Overall Study||24
8298255|NCT01567306|20459163|P6|STARTED|Overall Study||26
8298256|NCT01567306|20459164|P5|STARTED|Overall Study||25
8298257|NCT01567306|20459165|P4|STARTED|Overall Study||24
8298258|NCT01567306|20459166|P3|STARTED|Overall Study||24
8298259|NCT01567306|20459167|P2|STARTED|Overall Study||25
8298260|NCT01567306|20459168|P1|STARTED|Overall Study||27
8298261|NCT01567163|20459182|P1|NOT COMPLETED|Overall Study||4
8298262|NCT01567163|20459182|P1|COMPLETED|Overall Study||18
8298263|NCT01567163|20459182|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
8298264|NCT01567163|20459182|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
8298265|NCT01567163|20459182|P1|STARTED|Overall Study||22
8298266|NCT01567150|20459194|P2|NOT COMPLETED|Overall Study||2
8298267|NCT01567150|20459195|P1|NOT COMPLETED|Overall Study||2
8298268|NCT01567150|20459194|P2|COMPLETED|Overall Study||16
8298269|NCT01567150|20459195|P1|COMPLETED|Overall Study||19
8298270|NCT01567150|20459194|P2|STARTED|Overall Study||18
8298271|NCT01567150|20459195|P1|STARTED|Overall Study||21
8298272|NCT01567085|20459203|P1|NOT COMPLETED|Overall Study||20
8298273|NCT01567085|20459203|P1|COMPLETED|Overall Study||60
8298274|NCT01567085|20459203|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
8298275|NCT01567085|20459203|P1|STARTED|Overall Study||80
8298276|NCT01567020|20459213|P4|NOT COMPLETED|Overall Study||1
8298277|NCT01567020|20459214|P3|NOT COMPLETED|Overall Study||2
8298278|NCT01567020|20459215|P2|NOT COMPLETED|Overall Study||5
8298279|NCT01567020|20459216|P1|NOT COMPLETED|Overall Study||7
8298280|NCT01567020|20459213|P4|COMPLETED|Overall Study||10
8298281|NCT01567020|20459214|P3|COMPLETED|Overall Study||18
8298282|NCT01567020|20459215|P2|COMPLETED|Overall Study||41
8298283|NCT01567020|20459216|P1|COMPLETED|Overall Study||21
8298284|NCT01567020|20459213|P4|STARTED|Overall Study||11
8298285|NCT01567020|20459214|P3|STARTED|Overall Study||20
8298286|NCT01567020|20459215|P2|STARTED|Overall Study||46
8298287|NCT01567020|20459216|P1|STARTED|Overall Study||28
8298288|NCT01566981|20459240|P2|NOT COMPLETED|Overall Study||8
8298289|NCT01566981|20459241|P1|NOT COMPLETED|Overall Study||5
8298290|NCT01566981|20459240|P2|COMPLETED|Overall Study||54
8298291|NCT01566981|20459241|P1|COMPLETED|Overall Study||53
8298292|NCT01566981|20459240|P2|STARTED|Overall Study||62
8298293|NCT01566981|20459241|P1|STARTED|Overall Study||58
8298294|NCT01566838|20459253|P2|NOT COMPLETED|Overall Study||0
8298295|NCT01566838|20459254|P1|NOT COMPLETED|Overall Study||3
8298296|NCT01566838|20459253|P2|COMPLETED|Overall Study||42
8298297|NCT01566838|20459254|P1|COMPLETED|Overall Study||38
8298298|NCT01566838|20459253|P2|STARTED|Overall Study||42
8298299|NCT01566838|20459254|P1|STARTED|Overall Study||41
8298300|NCT01566773|20459270|P1|NOT COMPLETED|Overall Study||30
8298301|NCT01566773|20459270|P1|COMPLETED|Overall Study||110
8298302|NCT01566773|20459270|P1|Spiriva® Handihaler®|Overall Study||62
8298303|NCT01566773|20459270|P1|Placebo MDI|Overall Study||62
8298304|NCT01566773|20459270|P1|GP MDI 0.6 µg BID|Overall Study||59
8298306|NCT01566773|20459270|P1|GP MDI 2.4 µg BID|Overall Study||64
8298307|NCT01566773|20459270|P1|GP MDI 4.6 µg BID|Overall Study||62
8298308|NCT01566773|20459270|P1|GP MDI 9 µg BID|Overall Study||64
8298309|NCT01566773|20459270|P1|GP MDI 18 µg BID|Overall Study||64
8298310|NCT01566773|20459270|P1|STARTED|Overall Study||140
8298325|NCT01566682|20459608|P1|NOT COMPLETED|Overall Study||46
8298326|NCT01566682|20459608|P1|COMPLETED|Overall Study||374
8298327|NCT01566682|20459608|P1|STARTED|Overall Study||420
8298328|NCT01566630|20459614|P2|NOT COMPLETED|Overall Study||0
8298329|NCT01566630|20459615|P1|NOT COMPLETED|Overall Study||0
8298330|NCT01566630|20459614|P2|COMPLETED|Overall Study||1
8298331|NCT01566630|20459615|P1|COMPLETED|Overall Study||2
8298332|NCT01566630|20459614|P2|STARTED|Overall Study||1
8298333|NCT01566630|20459615|P1|STARTED|Overall Study||2
8298334|NCT01566604|20459671|P2|NOT COMPLETED|Overall Study||11
8298335|NCT01566604|20459672|P1|NOT COMPLETED|Overall Study||24
8298336|NCT01566604|20459671|P2|COMPLETED|Overall Study||143
8298337|NCT01566604|20459672|P1|COMPLETED|Overall Study||282
8298338|NCT01566604|20459671|P2|FAS, Serial Spirometry Subgroup|Overall Study||58
8298339|NCT01566604|20459672|P1|FAS, Serial Spirometry Subgroup|Overall Study||134
8298340|NCT01566604|20459671|P2|Full Analysis Set (FAS)|Overall Study||154
8298341|NCT01566604|20459672|P1|Full Analysis Set (FAS)|Overall Study||305
8298342|NCT01566604|20459671|P2|Safety Set|Overall Study||154
8298343|NCT01566604|20459672|P1|Safety Set|Overall Study||305
8298344|NCT01566604|20459671|P2|STARTED|Overall Study||154
8298345|NCT01566604|20459672|P1|STARTED|Overall Study||306
8298346|NCT01566539|20459706|P9|NOT COMPLETED|Within Subject Group||0
8298347|NCT01566539|20459707|P8|NOT COMPLETED|Within Subject Group||0
8298348|NCT01566539|20459708|P7|NOT COMPLETED|Within Subject Group||0
8298349|NCT01566539|20459709|P6|NOT COMPLETED|Within Subject Group||0
8298350|NCT01566539|20459710|P5|NOT COMPLETED|Within Subject Group||0
8298351|NCT01566539|20459711|P4|NOT COMPLETED|Within Subject Group||3
8298352|NCT01566539|20459712|P3|NOT COMPLETED|Within Subject Group||0
8298353|NCT01566539|20459713|P2|NOT COMPLETED|Within Subject Group||0
8298354|NCT01566539|20459714|P1|NOT COMPLETED|Within Subject Group||0
8298355|NCT01566539|20459706|P9|COMPLETED|Within Subject Group||0
8298356|NCT01566539|20459707|P8|COMPLETED|Within Subject Group||0
8298357|NCT01566539|20459708|P7|COMPLETED|Within Subject Group||0
8298358|NCT01566539|20459709|P6|COMPLETED|Within Subject Group||0
8298359|NCT01566539|20459710|P5|COMPLETED|Within Subject Group||0
8298360|NCT01566539|20459711|P4|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
8298361|NCT01566539|20459712|P3|COMPLETED|Within Subject Group||0
8298362|NCT01566539|20459713|P2|COMPLETED|Within Subject Group||0
8298363|NCT01566539|20459714|P1|COMPLETED|Within Subject Group||0
8298364|NCT01566539|20459706|P9|STARTED|Within Subject Group||0
8298365|NCT01566539|20459707|P8|STARTED|Within Subject Group||0
8298366|NCT01566539|20459708|P7|STARTED|Within Subject Group||0
8298367|NCT01566539|20459709|P6|STARTED|Within Subject Group||0
8298368|NCT01566539|20459710|P5|STARTED|Within Subject Group||0
8298369|NCT01566539|20459711|P4|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
8298370|NCT01566539|20459712|P3|STARTED|Within Subject Group||0
8298371|NCT01566539|20459713|P2|STARTED|Within Subject Group||0
8298372|NCT01566539|20459714|P1|STARTED|Within Subject Group||0
8298373|NCT01566539|20459706|P9|NOT COMPLETED|Main Study Period||0
8298374|NCT01566539|20459707|P8|NOT COMPLETED|Main Study Period||0
8298375|NCT01566539|20459708|P7|NOT COMPLETED|Main Study Period||0
8298376|NCT01566539|20459709|P6|NOT COMPLETED|Main Study Period||3
8298377|NCT01566539|20459710|P5|NOT COMPLETED|Main Study Period||0
8298378|NCT01566539|20459711|P4|NOT COMPLETED|Main Study Period||0
8298379|NCT01566539|20459712|P3|NOT COMPLETED|Main Study Period||0
8298380|NCT01566539|20459713|P2|NOT COMPLETED|Main Study Period||0
8298381|NCT01566539|20459714|P1|NOT COMPLETED|Main Study Period||1
8298382|NCT01566539|20459706|P9|COMPLETED|Main Study Period||1
8298383|NCT01566539|20459707|P8|COMPLETED|Main Study Period||30
8298384|NCT01566539|20459708|P7|COMPLETED|Main Study Period||30
8298385|NCT01566539|20459709|P6|COMPLETED|Main Study Period||40
8298386|NCT01566539|20459710|P5|COMPLETED|Main Study Period||40
8298387|NCT01566539|20459711|P4|COMPLETED|Main Study Period||0
8298388|NCT01566539|20459712|P3|COMPLETED|Main Study Period||104
8298389|NCT01566539|20459713|P2|COMPLETED|Main Study Period||100
8298390|NCT01566539|20459714|P1|COMPLETED|Main Study Period||100
8298391|NCT01566539|20459706|P9|STARTED|Main Study Period||1
8298392|NCT01566539|20459707|P8|STARTED|Main Study Period||30
8298393|NCT01566539|20459708|P7|STARTED|Main Study Period||30
8298394|NCT01566539|20459709|P6|STARTED|Main Study Period||43
8298395|NCT01566539|20459710|P5|STARTED|Main Study Period||40
8298396|NCT01566539|20459711|P4|STARTED|Main Study Period||0
8298397|NCT01566539|20459712|P3|STARTED|Main Study Period||104
8298398|NCT01566539|20459713|P2|STARTED|Main Study Period||100
8298399|NCT01566539|20459714|P1|STARTED|Main Study Period||101
8298400|NCT01566526|20459767|P1|NOT COMPLETED|Overall Study||0
8298401|NCT01566526|20459767|P1|COMPLETED|Overall Study||26
8298402|NCT01566526|20459767|P1|STARTED|Overall Study||26
8298403|NCT01566500|20459777|P1|NOT COMPLETED|Overall Study||0
8298404|NCT01566500|20459777|P1|COMPLETED|Overall Study||140
8298405|NCT01566500|20459777|P1|STARTED|Overall Study||140
8298406|NCT01566461|20459783|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
8298407|NCT01566461|20459784|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
8298408|NCT01566461|20459783|P2|COMPLETED|IN.PACT SFA II Phase||55
8298409|NCT01566461|20459784|P1|COMPLETED|IN.PACT SFA II Phase||109
8298410|NCT01566461|20459783|P2|STARTED|IN.PACT SFA II Phase||60
8298411|NCT01566461|20459784|P1|STARTED|IN.PACT SFA II Phase||121
8298412|NCT01566461|20459783|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
8298413|NCT01566461|20459784|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
8298414|NCT01566461|20459783|P2|COMPLETED|IN.PACT SFA I Phase||49
8298415|NCT01566461|20459784|P1|COMPLETED|IN.PACT SFA I Phase||88
8298416|NCT01566461|20459783|P2|STARTED|IN.PACT SFA I Phase||51
8298417|NCT01566461|20459784|P1|STARTED|IN.PACT SFA I Phase||99
8298418|NCT01566448|20459828|P1|NOT COMPLETED|Overall Study||0
8298419|NCT01566448|20459828|P1|COMPLETED|Overall Study||30
8298420|NCT01566448|20459828|P1|STARTED|Overall Study||30
8298421|NCT01566435|20459837|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
8298422|NCT01566435|20459837|P1|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
8298423|NCT01566435|20459837|P1|STARTED|ACF Definitive Chemoradiation-cetuximab||2
8298424|NCT01566435|20459837|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
8298425|NCT01566435|20459837|P1|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
8298426|NCT01566435|20459837|P1|STARTED|ACF Definitive Chemoradiation-cisplatin||28
8298427|NCT01566435|20459837|P1|NOT COMPLETED|ACF Induction Therapy||0
8298428|NCT01566435|20459837|P1|COMPLETED|ACF Induction Therapy||30
8298429|NCT01566435|20459837|P1|STARTED|ACF Induction Therapy||30
8298430|NCT01566409|20459858|P2|NOT COMPLETED|Overall Study||5
8298431|NCT01566409|20459859|P1|NOT COMPLETED|Overall Study||2
8298432|NCT01566409|20459858|P2|COMPLETED|Overall Study||48
8298433|NCT01566409|20459859|P1|COMPLETED|Overall Study||47
8298434|NCT01566409|20459858|P2|STARTED|Overall Study||53
8298435|NCT01566409|20459859|P1|STARTED|Overall Study||49
8298436|NCT01566370|20459867|P2|NOT COMPLETED|Overall Study||1
8298437|NCT01566370|20459868|P1|NOT COMPLETED|Overall Study||2
8298438|NCT01566370|20459867|P2|COMPLETED|Overall Study||0
8298439|NCT01566370|20459868|P1|COMPLETED|Overall Study||0
8298440|NCT01566370|20459867|P2|STARTED|Overall Study||1
8298441|NCT01566370|20459868|P1|STARTED|Overall Study||2
8298442|NCT01566331|20459894|P2|NOT COMPLETED|Overall Study||0
8298443|NCT01566331|20459895|P1|NOT COMPLETED|Overall Study||0
8298444|NCT01566331|20459894|P2|COMPLETED|Overall Study||40
8298445|NCT01566331|20459895|P1|COMPLETED|Overall Study||40
8298446|NCT01566331|20459894|P2|STARTED|Overall Study||40
8298447|NCT01566331|20459895|P1|STARTED|Overall Study||40
8298448|NCT01566214|20459903|P2|NOT COMPLETED|Overall Study||0
8298449|NCT01566214|20459904|P1|NOT COMPLETED|Overall Study||3
8298450|NCT01566214|20459903|P2|COMPLETED|Overall Study||6
8298451|NCT01566214|20459904|P1|COMPLETED|Overall Study||3
8298452|NCT01566214|20459903|P2|STARTED|Overall Study||6
8298453|NCT01566214|20459904|P1|STARTED|Overall Study||6
8298454|NCT01566162|20459934|P1|NOT COMPLETED|Overall Study||36
8298455|NCT01566162|20459934|P1|COMPLETED|Overall Study||155
8298456|NCT01566162|20459934|P1|STARTED|Overall Study||191
8298457|NCT01566149|20459948|P2|NOT COMPLETED|Overall Study||2
8298458|NCT01566149|20459949|P1|NOT COMPLETED|Overall Study||3
8298459|NCT01566149|20459948|P2|COMPLETED|Overall Study||23
8298460|NCT01566149|20459949|P1|COMPLETED|Overall Study||21
8298461|NCT01566149|20459948|P2|STARTED|Overall Study||25
8298462|NCT01566149|20459949|P1|STARTED|Overall Study||24
8298463|NCT01566084|20459965|P2|NOT COMPLETED|Overall Study||0
8298464|NCT01566084|20459966|P1|NOT COMPLETED|Overall Study||0
8298465|NCT01566084|20459965|P2|COMPLETED|Overall Study||10
8298466|NCT01566084|20459966|P1|COMPLETED|Overall Study||7
8298467|NCT01566084|20459965|P2|STARTED|Overall Study||10
8298468|NCT01566084|20459966|P1|STARTED|Overall Study||7
8298469|NCT01565993|20459982|P2|NOT COMPLETED|Overall Study||3
8298470|NCT01565993|20459983|P1|NOT COMPLETED|Overall Study||0
8298471|NCT01565993|20459982|P2|COMPLETED|Overall Study||39
8298472|NCT01565993|20459983|P1|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
8298473|NCT01565993|20459982|P2|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
8298474|NCT01565993|20459983|P1|STARTED|Overall Study||66
8298475|NCT01565980|20459991|P2|NOT COMPLETED|Overall Study||4
8298476|NCT01565980|20459992|P1|NOT COMPLETED|Overall Study||4
8298477|NCT01565980|20459991|P2|COMPLETED|Overall Study||16
8298478|NCT01565980|20459992|P1|COMPLETED|Overall Study||16
8298479|NCT01565980|20459991|P2|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
8298480|NCT01565980|20459992|P1|STARTED|Overall Study||20
8298487|NCT01565928|20460055|P1|NOT COMPLETED|Overall Study||22
8298488|NCT01565928|20460055|P1|COMPLETED|Overall Study||0
8298489|NCT01565928|20460055|P1|STARTED|Overall Study||22
8298490|NCT01565902|20460072|P4|NOT COMPLETED|Overall Study||0
8298491|NCT01565902|20460073|P3|NOT COMPLETED|Overall Study||0
8298492|NCT01565902|20460074|P2|NOT COMPLETED|Overall Study||0
8298493|NCT01565902|20460075|P1|NOT COMPLETED|Overall Study||0
8298494|NCT01565902|20460072|P4|COMPLETED|Overall Study||16
8298495|NCT01565902|20460073|P3|COMPLETED|Overall Study||8
8298496|NCT01565902|20460074|P2|COMPLETED|Overall Study||8
8298497|NCT01565902|20460075|P1|COMPLETED|Overall Study||8
8298498|NCT01565902|20460072|P4|STARTED|Overall Study||16
8298499|NCT01565902|20460073|P3|STARTED|Overall Study||8
8298500|NCT01565902|20460074|P2|STARTED|Overall Study||8
8298501|NCT01565902|20460075|P1|STARTED|Overall Study||8
8298502|NCT01565889|20460109|P6|NOT COMPLETED|Part B||4
8298503|NCT01565889|20460110|P5|NOT COMPLETED|Part B||0
8298504|NCT01565889|20460111|P4|NOT COMPLETED|Part B||0
8298505|NCT01565889|20460112|P3|NOT COMPLETED|Part B||0
8298506|NCT01565889|20460113|P2|NOT COMPLETED|Part B||0
8298507|NCT01565889|20460114|P1|NOT COMPLETED|Part B||0
8298508|NCT01565889|20460109|P6|COMPLETED|Part B||19
8298509|NCT01565889|20460110|P5|COMPLETED|Part B||0
8298510|NCT01565889|20460111|P4|COMPLETED|Part B||0
8298511|NCT01565889|20460112|P3|COMPLETED|Part B||0
8298512|NCT01565889|20460113|P2|COMPLETED|Part B||0
8298513|NCT01565889|20460114|P1|COMPLETED|Part B||0
8298514|NCT01565889|20460109|P6|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
8298515|NCT01565889|20460110|P5|STARTED|Part B||0
8298516|NCT01565889|20460111|P4|STARTED|Part B||0
8298517|NCT01565889|20460112|P3|STARTED|Part B||0
8298518|NCT01565889|20460113|P2|STARTED|Part B||0
8298519|NCT01565889|20460114|P1|STARTED|Part B||0
8298520|NCT01565889|20460109|P6|NOT COMPLETED|Part A||0
8298521|NCT01565889|20460110|P5|NOT COMPLETED|Part A||0
8298522|NCT01565889|20460111|P4|NOT COMPLETED|Part A||0
8298523|NCT01565889|20460112|P3|NOT COMPLETED|Part A||0
8298524|NCT01565889|20460113|P2|NOT COMPLETED|Part A||0
8298525|NCT01565889|20460114|P1|NOT COMPLETED|Part A||1
8298526|NCT01565889|20460109|P6|COMPLETED|Part A||0
8298527|NCT01565889|20460110|P5|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
8298528|NCT01565889|20460111|P4|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
8298529|NCT01565889|20460112|P3|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
8298530|NCT01565889|20460113|P2|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
8298531|NCT01565889|20460114|P1|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
8298532|NCT01565889|20460109|P6|STARTED|Part A||0
8298533|NCT01565889|20460110|P5|STARTED|Part A||7
8298534|NCT01565889|20460111|P4|STARTED|Part A||7
8298535|NCT01565889|20460112|P3|STARTED|Part A||8
8298536|NCT01565889|20460113|P2|STARTED|Part A||4
8298537|NCT01565889|20460114|P1|STARTED|Part A||12
8298538|NCT01565850|20460145|P2|NOT COMPLETED|Overall Study||8
8298539|NCT01565850|20460146|P1|NOT COMPLETED|Overall Study||20
8298540|NCT01565850|20460145|P2|COMPLETED|Overall Study||42
8298541|NCT01565850|20460146|P1|COMPLETED|Overall Study||83
8298542|NCT01565850|20460145|P2|STARTED|Overall Study||50
8298543|NCT01565850|20460146|P1|STARTED|Overall Study||103
8298544|NCT01565707|20460166|P4|NOT COMPLETED|Overall Study||5
8298545|NCT01565707|20460167|P3|NOT COMPLETED|Overall Study||3
8298546|NCT01565707|20460168|P2|NOT COMPLETED|Overall Study||8
8298547|NCT01565707|20460169|P1|NOT COMPLETED|Overall Study||9
8298548|NCT01565707|20460166|P4|COMPLETED|Overall Study||17
8298549|NCT01565707|20460167|P3|COMPLETED|Overall Study||16
8298550|NCT01565707|20460168|P2|COMPLETED|Overall Study||65
8298551|NCT01565707|20460169|P1|COMPLETED|Overall Study||66
8298552|NCT01565707|20460166|P4|Treated|Overall Study||22
8298553|NCT01565707|20460167|P3|Treated|Overall Study||19
8298554|NCT01565707|20460168|P2|Treated|Overall Study||73
8298555|NCT01565707|20460169|P1|Treated|Overall Study||73
8298556|NCT01565707|20460166|P4|STARTED|Overall Study||22
8298557|NCT01565707|20460167|P3|STARTED|Overall Study||19
8298558|NCT01565707|20460168|P2|STARTED|Overall Study||73
8298559|NCT01565707|20460169|P1|STARTED|Overall Study||75
8298560|NCT01565694|20460260|P1|NOT COMPLETED|Fixed-Dose Assessment Period||4
8298561|NCT01565694|20460260|P1|COMPLETED|Fixed-Dose Assessment Period||58
8298562|NCT01565694|20460260|P1|STARTED|Fixed-Dose Assessment Period||62
8298563|NCT01565694|20460260|P1|NOT COMPLETED|Dose-Titration Period||14
8298564|NCT01565694|20460260|P1|COMPLETED|Dose-Titration Period||62
8298565|NCT01565694|20460260|P1|STARTED|Dose-Titration Period||76
8298566|NCT01565668|20460281|P2|NOT COMPLETED|Overall Study||38
8298567|NCT01565668|20460282|P1|NOT COMPLETED|Overall Study||38
8298568|NCT01565668|20460281|P2|COMPLETED|Overall Study||0
8298569|NCT01565668|20460282|P1|COMPLETED|Overall Study||0
8298570|NCT01565668|20460281|P2|Completed Long-term Follow-up|Overall Study||0
8298571|NCT01565668|20460282|P1|Completed Long-term Follow-up|Overall Study||0
8298572|NCT01565668|20460281|P2|Started Long-term Follow-up|Overall Study||33
8298573|NCT01565668|20460282|P1|Started Long-term Follow-up|Overall Study||36
8298574|NCT01565668|20460281|P2|Completed 30-day Follow-up|Overall Study||5
8298575|NCT01565668|20460282|P1|Completed 30-day Follow-up|Overall Study||11
8298576|NCT01565668|20460281|P2|Started 30-day Follow-up|Overall Study||37
8298577|NCT01565668|20460282|P1|Started 30-day Follow-up|Overall Study||37
8298578|NCT01565668|20460281|P2|Completed Treatment Per Protocol|Overall Study||0
8298579|NCT01565668|20460282|P1|Completed Treatment Per Protocol|Overall Study||0
8298580|NCT01565668|20460281|P2|STARTED|Overall Study||38
8298581|NCT01565668|20460282|P1|STARTED|Overall Study||38
8298582|NCT01565642|20460306|P2|NOT COMPLETED|Overall Study||1
8298583|NCT01565642|20460307|P1|NOT COMPLETED|Overall Study||2
8298584|NCT01565642|20460306|P2|COMPLETED|Overall Study||150
8298585|NCT01565642|20460307|P1|COMPLETED|Overall Study||149
8298586|NCT01565642|20460306|P2|STARTED|Overall Study||151
8298587|NCT01565642|20460307|P1|STARTED|Overall Study||151
8298588|NCT01565616|20460329|P1|NOT COMPLETED|Overall Study||0
8298589|NCT01565616|20460329|P1|COMPLETED|Overall Study||22
8298590|NCT01565616|20460329|P1|Second Component: Related or Unrelated|Overall Study||17
8298591|NCT01565616|20460329|P1|First Component: 5 Related Donors|Overall Study||5
8298592|NCT01565616|20460329|P1|STARTED|Overall Study||22
8298593|NCT01565564|20460342|P2|NOT COMPLETED|Overall Study||1
8298594|NCT01565564|20460343|P1|NOT COMPLETED|Overall Study||5
8298595|NCT01565564|20460342|P2|COMPLETED|Overall Study||361
8298596|NCT01565564|20460343|P1|COMPLETED|Overall Study||339
8298597|NCT01565564|20460342|P2|STARTED|Overall Study||362
8298598|NCT01565564|20460343|P1|STARTED|Overall Study||344
8298599|NCT01565551|20460353|P2|NOT COMPLETED|Overall Study||0
8298600|NCT01565551|20460354|P1|NOT COMPLETED|Overall Study||0
8298601|NCT01565551|20460353|P2|COMPLETED|Overall Study||51
8298602|NCT01565551|20460354|P1|COMPLETED|Overall Study||586
8298603|NCT01565551|20460353|P2|6-Month Outcomes|Overall Study||30
8298604|NCT01565551|20460354|P1|6-Month Outcomes|Overall Study||412
8298605|NCT01565551|20460353|P2|Neuroimaging|Overall Study||25
8298606|NCT01565551|20460354|P1|Neuroimaging|Overall Study||233
8298607|NCT01565551|20460353|P2|Biospecimens/Biomarkers|Overall Study||22
8298608|NCT01565551|20460354|P1|Biospecimens/Biomarkers|Overall Study||479
8298609|NCT01565551|20460353|P2|Clinical/Demographics|Overall Study||51
8298610|NCT01565551|20460354|P1|Clinical/Demographics|Overall Study||586
8298611|NCT01565551|20460353|P2|STARTED|Overall Study||51
8298612|NCT01565551|20460354|P1|STARTED|Overall Study||586
8298613|NCT01565538|20460362|P2|NOT COMPLETED|Overall Study||0
8298614|NCT01565538|20460363|P1|NOT COMPLETED|Overall Study||0
8298615|NCT01565538|20460362|P2|COMPLETED|Overall Study||62
8298616|NCT01565538|20460363|P1|COMPLETED|Overall Study||61
8298617|NCT01565538|20460362|P2|STARTED|Overall Study||62
8298618|NCT01565538|20460363|P1|STARTED|Overall Study||61
8298619|NCT01565499|20460373|P1|NOT COMPLETED|Overall Study||8
8298620|NCT01565499|20460373|P1|COMPLETED|Overall Study||75
8298621|NCT01565499|20460373|P1|STARTED|Overall Study||83
8298622|NCT01565382|20460387|P2|NOT COMPLETED|Overall Study||0
8298623|NCT01565382|20460388|P1|NOT COMPLETED|Overall Study||0
8298624|NCT01565382|20460387|P2|COMPLETED|Overall Study||7
8298625|NCT01565382|20460388|P1|COMPLETED|Overall Study||40
8298626|NCT01565382|20460387|P2|STARTED|Overall Study||7
8298627|NCT01565382|20460388|P1|STARTED|Overall Study||40
8298628|NCT01565369|20460393|P1|NOT COMPLETED|Overall Study||0
8298629|NCT01565369|20460393|P1|COMPLETED|Overall Study||35
8298630|NCT01565369|20460393|P1|STARTED|Overall Study||35
8298631|NCT01565356|20460399|P1|NOT COMPLETED|Overall Study||0
8298632|NCT01565356|20460399|P1|COMPLETED|Overall Study||41
8298633|NCT01565356|20460399|P1|STARTED|Overall Study||41
8298634|NCT01565343|20460407|P3|NOT COMPLETED|Overall Study||0
8298635|NCT01565343|20460408|P2|NOT COMPLETED|Overall Study||0
8298636|NCT01565343|20460409|P1|NOT COMPLETED|Overall Study||1
8298637|NCT01565343|20460407|P3|COMPLETED|Overall Study||10
8298638|NCT01565343|20460408|P2|COMPLETED|Overall Study||4
8298639|NCT01565343|20460409|P1|COMPLETED|Overall Study||10
8298640|NCT01565343|20460407|P3|STARTED|Overall Study||10
8298641|NCT01565343|20460408|P2|STARTED|Overall Study||4
8298642|NCT01565343|20460409|P1|STARTED|Overall Study||11
8298643|NCT01565330|20460420|P4|NOT COMPLETED|Overall Study||0
8298644|NCT01565330|20460421|P3|NOT COMPLETED|Overall Study||0
8298645|NCT01565330|20460422|P2|NOT COMPLETED|Overall Study||0
8298646|NCT01565330|20460423|P1|NOT COMPLETED|Overall Study||0
8298647|NCT01565330|20460420|P4|COMPLETED|Overall Study||7
8298648|NCT01565330|20460421|P3|COMPLETED|Overall Study||4
8298649|NCT01565330|20460422|P2|COMPLETED|Overall Study||4
8298650|NCT01565330|20460423|P1|COMPLETED|Overall Study||5
8298651|NCT01565330|20460420|P4|STARTED|Overall Study||7
8298652|NCT01565330|20460421|P3|STARTED|Overall Study||4
8298653|NCT01565330|20460422|P2|STARTED|Overall Study||4
8298654|NCT01565330|20460423|P1|STARTED|Overall Study||5
8298655|NCT01565291|20460439|P2|NOT COMPLETED|Overall Study||0
8298656|NCT01565291|20460440|P1|NOT COMPLETED|Overall Study||1
8298657|NCT01565291|20460439|P2|COMPLETED|Overall Study||16
8298658|NCT01565291|20460440|P1|COMPLETED|Overall Study||15
8298659|NCT01565291|20460439|P2|STARTED|Overall Study||16
8298660|NCT01565291|20460440|P1|STARTED|Overall Study||16
8298661|NCT01565148|20460452|P4|NOT COMPLETED|Overall Study||13
8298662|NCT01565148|20460453|P3|NOT COMPLETED|Overall Study||7
8298663|NCT01565148|20460454|P2|NOT COMPLETED|Overall Study||15
8298664|NCT01565148|20460455|P1|NOT COMPLETED|Overall Study||15
8298665|NCT01565148|20460452|P4|COMPLETED|Overall Study||32
8298666|NCT01565148|20460453|P3|COMPLETED|Overall Study||40
8298667|NCT01565148|20460454|P2|COMPLETED|Overall Study||31
8298668|NCT01565148|20460455|P1|COMPLETED|Overall Study||32
8298669|NCT01565148|20460452|P4|STARTED|Overall Study||45
8298670|NCT01565148|20460453|P3|STARTED|Overall Study||47
8298671|NCT01565148|20460454|P2|STARTED|Overall Study||46
8298672|NCT01565148|20460455|P1|STARTED|Overall Study||47
8298673|NCT01565083|20460491|P2|NOT COMPLETED|Overall Study||39
8298674|NCT01565083|20460492|P1|NOT COMPLETED|Overall Study||33
8298675|NCT01565083|20460491|P2|COMPLETED|Overall Study||68
8298676|NCT01565083|20460492|P1|COMPLETED|Overall Study||73
8298677|NCT01565083|20460491|P2|STARTED|Overall Study||107
8298678|NCT01565083|20460492|P1|STARTED|Overall Study||106
8298679|NCT01564953|20460518|P1|NOT COMPLETED|Overall Study||0
8298680|NCT01564953|20460518|P1|COMPLETED|Overall Study||143
8298681|NCT01564953|20460518|P1|STARTED|Overall Study||143
8298682|NCT01564914|20460528|P2|NOT COMPLETED|Overall Study||0
8298683|NCT01564914|20460529|P1|NOT COMPLETED|Overall Study||0
8298684|NCT01564914|20460528|P2|COMPLETED|Overall Study||6
8298685|NCT01564914|20460529|P1|COMPLETED|Overall Study||16
8298686|NCT01564914|20460528|P2|STARTED|Overall Study||6
8298687|NCT01564914|20460529|P1|STARTED|Overall Study||16
8298688|NCT01564862|20460543|P3|NOT COMPLETED|Overall Study||30
8298689|NCT01564862|20460544|P2|NOT COMPLETED|Overall Study||34
8298690|NCT01564862|20460545|P1|NOT COMPLETED|Overall Study||30
8298691|NCT01564862|20460543|P3|COMPLETED|Overall Study||164
8298692|NCT01564862|20460544|P2|COMPLETED|Overall Study||176
8298693|NCT01564862|20460545|P1|COMPLETED|Overall Study||168
8298694|NCT01564862|20460543|P3|Received Treatment|Overall Study||191
8298695|NCT01564862|20460544|P2|Received Treatment|Overall Study||207
8298696|NCT01564862|20460545|P1|Received Treatment|Overall Study||196
8298697|NCT01564862|20460543|P3|STARTED|Overall Study||194
8298698|NCT01564862|20460544|P2|STARTED|Overall Study||210
8298699|NCT01564862|20460545|P1|STARTED|Overall Study||198
8298700|NCT01564784|20460596|P2|NOT COMPLETED|Overall Study||133
8298701|NCT01564784|20460597|P1|NOT COMPLETED|Overall Study||134
8298702|NCT01564784|20460596|P2|COMPLETED|Overall Study||10
8298703|NCT01564784|20460597|P1|COMPLETED|Overall Study||30
8298704|NCT01564784|20460596|P2|STARTED|Overall Study|Treated (162 randomized)|143
8298705|NCT01564784|20460597|P1|STARTED|Overall Study|Treated (164 randomized)|164
8298706|NCT01564758|20460624|P1|NOT COMPLETED|Overall Study||14
8298707|NCT01564758|20460624|P1|COMPLETED|Overall Study||85
8298708|NCT01564758|20460624|P1|STARTED|Overall Study||99
8298709|NCT01564732|20460631|P2|NOT COMPLETED|Overall Study||5
8298710|NCT01564732|20460632|P1|NOT COMPLETED|Overall Study||6
8298711|NCT01564732|20460631|P2|COMPLETED|Overall Study||0
8298712|NCT01564732|20460632|P1|COMPLETED|Overall Study||0
8298713|NCT01564732|20460631|P2|STARTED|Overall Study||5
8298714|NCT01564732|20460632|P1|STARTED|Overall Study||6
8298715|NCT01564706|20460648|P1|NOT COMPLETED|Overall Study||0
8298716|NCT01564706|20460648|P1|COMPLETED|Overall Study||9
8298717|NCT01564706|20460648|P1|STARTED|Overall Study||9
8298718|NCT01564693|20460655|P3|NOT COMPLETED|Overall Study||0
8298719|NCT01564693|20460656|P2|NOT COMPLETED|Overall Study||0
8298720|NCT01564693|20460657|P1|NOT COMPLETED|Overall Study||0
8298721|NCT01564693|20460655|P3|COMPLETED|Overall Study||2
8298722|NCT01564693|20460656|P2|COMPLETED|Overall Study||4
8298723|NCT01564693|20460657|P1|COMPLETED|Overall Study||9
8298724|NCT01564693|20460655|P3|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
8298725|NCT01564693|20460656|P2|STARTED|Overall Study||4
8298726|NCT01564693|20460657|P1|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
8298727|NCT01564654|20460665|P1|NOT COMPLETED|Overall Study||0
8298728|NCT01564654|20460665|P1|COMPLETED|Overall Study|106 knees (bilateral)|89
8298729|NCT01564654|20460665|P1|STARTED|Overall Study|106 knees (bilateral)|89
8298730|NCT01564628|20460672|P3|NOT COMPLETED|Overall Study||2
8298731|NCT01564628|20460673|P2|NOT COMPLETED|Overall Study||2
8298732|NCT01564628|20460674|P1|NOT COMPLETED|Overall Study||4
8298733|NCT01564628|20460672|P3|COMPLETED|Overall Study||61
8298734|NCT01564628|20460673|P2|COMPLETED|Overall Study||56
8298735|NCT01564628|20460674|P1|COMPLETED|Overall Study||181
8298736|NCT01564628|20460672|P3|STARTED|Overall Study||63
8298737|NCT01564628|20460673|P2|STARTED|Overall Study||58
8298738|NCT01564628|20460674|P1|STARTED|Overall Study||185
8298739|NCT01564537|20460680|P2|NOT COMPLETED|Overall Study||6
8298740|NCT01564537|20460681|P1|NOT COMPLETED|Overall Study||6
8298741|NCT01564537|20460680|P2|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
8298742|NCT01564537|20460681|P1|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
8298743|NCT01564537|20460680|P2|Safety Population: Received Study Drug|Overall Study||360
8298744|NCT01564537|20460681|P1|Safety Population: Received Study Drug|Overall Study||360
8298745|NCT01564537|20460680|P2|STARTED|Overall Study||362
8298746|NCT01564537|20460681|P1|STARTED|Overall Study||360
8298747|NCT01564459|20460704|P3|NOT COMPLETED|Double-blind Treatment||1
8298748|NCT01564459|20460705|P2|NOT COMPLETED|Double-blind Treatment||0
8298749|NCT01564459|20460706|P1|NOT COMPLETED|Double-blind Treatment||0
8298750|NCT01564459|20460704|P3|COMPLETED|Double-blind Treatment||82
8298751|NCT01564459|20460705|P2|COMPLETED|Double-blind Treatment||87
8298752|NCT01564459|20460706|P1|COMPLETED|Double-blind Treatment||0
8298753|NCT01564459|20460704|P3|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
8298754|NCT01564459|20460705|P2|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
8298755|NCT01564459|20460706|P1|STARTED|Double-blind Treatment||0
8298756|NCT01564459|20460704|P3|NOT COMPLETED|Run-In||0
8298757|NCT01564459|20460705|P2|NOT COMPLETED|Run-In||0
8298758|NCT01564459|20460706|P1|NOT COMPLETED|Run-In||12
8298759|NCT01564459|20460704|P3|COMPLETED|Run-In||83
8298760|NCT01564459|20460705|P2|COMPLETED|Run-In||87
8298761|NCT01564459|20460706|P1|COMPLETED|Run-In||0
8298762|NCT01564459|20460704|P3|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
8298763|NCT01564459|20460705|P2|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
8298764|NCT01564459|20460706|P1|STARTED|Run-In||12
8298765|NCT01564407|20460730|P5|NOT COMPLETED|Overall Study||0
8298766|NCT01564407|20460731|P4|NOT COMPLETED|Overall Study||1
8298767|NCT01564407|20460732|P3|NOT COMPLETED|Overall Study||0
8298768|NCT01564407|20460733|P2|NOT COMPLETED|Overall Study||2
8298769|NCT01564407|20460734|P1|NOT COMPLETED|Overall Study||0
8298770|NCT01564407|20460730|P5|COMPLETED|Overall Study||0
8298771|NCT01564407|20460731|P4|COMPLETED|Overall Study||1
8298772|NCT01564407|20460732|P3|COMPLETED|Overall Study||4
8298773|NCT01564407|20460733|P2|COMPLETED|Overall Study||3
8298774|NCT01564407|20460734|P1|COMPLETED|Overall Study||4
8298775|NCT01564407|20460730|P5|STARTED|Overall Study||0
8298776|NCT01564407|20460731|P4|STARTED|Overall Study||2
8298777|NCT01564407|20460732|P3|STARTED|Overall Study||4
8298778|NCT01564407|20460733|P2|STARTED|Overall Study||5
8298779|NCT01564407|20460734|P1|STARTED|Overall Study||4
8298780|NCT01564394|20460775|P2|NOT COMPLETED|Overall Study||10
8298781|NCT01564394|20460776|P1|NOT COMPLETED|Overall Study||6
8298782|NCT01564394|20460775|P2|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
8298783|NCT01564394|20460776|P1|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
8298784|NCT01564394|20460775|P2|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
8298785|NCT01564394|20460776|P1|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
8298786|NCT01564277|20460790|P2|NOT COMPLETED|Overall Study||1
8298787|NCT01564277|20460791|P1|NOT COMPLETED|Overall Study||1
8298788|NCT01564277|20460790|P2|COMPLETED|Overall Study||11
8298789|NCT01564277|20460791|P1|COMPLETED|Overall Study||11
8298790|NCT01564277|20460790|P2|STARTED|Overall Study||12
8298791|NCT01564277|20460791|P1|STARTED|Overall Study||12
8298792|NCT01563978|20460809|P2|NOT COMPLETED|Overall Study||2
8298793|NCT01563978|20460810|P1|NOT COMPLETED|Overall Study||4
8298794|NCT01563978|20460809|P2|COMPLETED|Overall Study||65
8298795|NCT01563978|20460810|P1|COMPLETED|Overall Study||64
8298796|NCT01563978|20460809|P2|Randomised But Did Not Receive Treatment|Overall Study||0
8298797|NCT01563978|20460810|P1|Randomised But Did Not Receive Treatment|Overall Study||0
8298798|NCT01563978|20460809|P2|STARTED|Overall Study|Patients who received treatment.|67
8298799|NCT01563978|20460810|P1|STARTED|Overall Study|Patients who received treatment.|68
8298800|NCT01563913|20460836|P2|NOT COMPLETED|Overall Study||0
8298801|NCT01563913|20460837|P1|NOT COMPLETED|Overall Study||2
8298802|NCT01563913|20460836|P2|COMPLETED|Overall Study||15
8298803|NCT01563913|20460837|P1|COMPLETED|Overall Study||13
8298804|NCT01563913|20460836|P2|STARTED|Overall Study||15
8298805|NCT01563913|20460837|P1|STARTED|Overall Study||15
8298806|NCT01563536|20460849|P2|NOT COMPLETED|Overall Study||2
8298807|NCT01563536|20460850|P1|NOT COMPLETED|Overall Study||1
8298808|NCT01563536|20460849|P2|COMPLETED|Overall Study||4
8298809|NCT01563536|20460850|P1|COMPLETED|Overall Study||5
8298810|NCT01563536|20460849|P2|STARTED|Overall Study||6
8298811|NCT01563536|20460850|P1|STARTED|Overall Study||6
8298812|NCT01563406|20460882|P4|NOT COMPLETED|Overall Study||0
8298813|NCT01563406|20460883|P3|NOT COMPLETED|Overall Study||0
8298814|NCT01563406|20460884|P2|NOT COMPLETED|Overall Study||0
8298815|NCT01563406|20460885|P1|NOT COMPLETED|Overall Study||0
8298816|NCT01563406|20460882|P4|COMPLETED|Overall Study|112 hubs|29
8298817|NCT01563406|20460883|P3|COMPLETED|Overall Study|101 hubs|30
8298818|NCT01563406|20460884|P2|COMPLETED|Overall Study|102 hubs|30
8298819|NCT01563406|20460885|P1|COMPLETED|Overall Study|194 hubs|60
8298820|NCT01563406|20460882|P4|STARTED|Overall Study|112 hubs|29
8298821|NCT01563406|20460883|P3|STARTED|Overall Study|101 hubs|30
8298822|NCT01563406|20460884|P2|STARTED|Overall Study|102 hubs|30
8298823|NCT01563406|20460885|P1|STARTED|Overall Study|194 hubs|60
8298824|NCT01563198|20460903|P1|NOT COMPLETED|After Training||0
8298825|NCT01563198|20460903|P1|COMPLETED|After Training||47979
8298826|NCT01563198|20460903|P1|STARTED|After Training||47979
8298827|NCT01563198|20460903|P1|NOT COMPLETED|Baseline||0
8298828|NCT01563198|20460903|P1|COMPLETED|Baseline||49733
8298829|NCT01563198|20460903|P1|STARTED|Baseline||49733
8298830|NCT01563185|20460909|P1|NOT COMPLETED|Overall Study||2
8298831|NCT01563185|20460909|P1|COMPLETED|Overall Study||10
8298832|NCT01563185|20460909|P1|STARTED|Overall Study||12
8298833|NCT01563172|20460923|P1|NOT COMPLETED|Overall Study||13
8298834|NCT01563172|20460923|P1|COMPLETED|Overall Study||52
8298835|NCT01563172|20460923|P1|Control Dentifrice|Overall Study||60
8298836|NCT01563172|20460923|P1|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
8298837|NCT01563172|20460923|P1|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
8298838|NCT01563172|20460923|P1|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
8298839|NCT01563172|20460923|P1|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
8298840|NCT01563172|20460923|P1|STARTED|Overall Study||65
8298841|NCT01563081|20460952|P2|NOT COMPLETED|Overall Study||0
8298842|NCT01563081|20460953|P1|NOT COMPLETED|Overall Study||0
8298843|NCT01563081|20460952|P2|COMPLETED|Overall Study||30
8298844|NCT01563081|20460953|P1|COMPLETED|Overall Study||30
8298845|NCT01563081|20460952|P2|STARTED|Overall Study||30
8298846|NCT01563081|20460953|P1|STARTED|Overall Study||30
8298847|NCT01563055|20460966|P1|NOT COMPLETED|Overall Study||0
8298848|NCT01563055|20460966|P1|COMPLETED|Overall Study||10
8298849|NCT01563055|20460966|P1|STARTED|Overall Study||10
8298850|NCT01563029|20461029|P5|NOT COMPLETED|Overall Study||29
8298851|NCT01563029|20461030|P4|NOT COMPLETED|Overall Study||33
8298852|NCT01563029|20461031|P3|NOT COMPLETED|Overall Study||33
8298853|NCT01563029|20461032|P2|NOT COMPLETED|Overall Study||24
8298854|NCT01563029|20461033|P1|NOT COMPLETED|Overall Study||53
8298855|NCT01563029|20461029|P5|COMPLETED|Overall Study||89
8298856|NCT01563029|20461030|P4|COMPLETED|Overall Study||85
8298857|NCT01563029|20461031|P3|COMPLETED|Overall Study||87
8298858|NCT01563029|20461032|P2|COMPLETED|Overall Study||94
8298859|NCT01563029|20461033|P1|COMPLETED|Overall Study||66
8298860|NCT01563029|20461029|P5|STARTED|Overall Study||118
8298861|NCT01563029|20461030|P4|STARTED|Overall Study||118
8298862|NCT01563029|20461031|P3|STARTED|Overall Study||120
8298863|NCT01563029|20461032|P2|STARTED|Overall Study||118
8298864|NCT01563029|20461033|P1|STARTED|Overall Study||119
8298865|NCT01563003|20461083|P2|NOT COMPLETED|Overall Study||0
8298866|NCT01563003|20461084|P1|NOT COMPLETED|Overall Study||0
8298867|NCT01563003|20461083|P2|COMPLETED|Overall Study||15
8298868|NCT01563003|20461084|P1|COMPLETED|Overall Study||16
8298869|NCT01563003|20461083|P2|STARTED|Overall Study||15
8298870|NCT01563003|20461084|P1|STARTED|Overall Study||16
8298871|NCT01562886|20461094|P1|NOT COMPLETED|Overall Study||1
8298872|NCT01562886|20461094|P1|COMPLETED|Overall Study||13
8298873|NCT01562886|20461094|P1|STARTED|Overall Study||14
8298874|NCT01562873|20461099|P2|NOT COMPLETED|Overall Study||0
8298875|NCT01562873|20461100|P1|NOT COMPLETED|Overall Study||21
8298876|NCT01562873|20461099|P2|COMPLETED|Overall Study||0
8298877|NCT01562873|20461100|P1|COMPLETED|Overall Study||0
8298878|NCT01562873|20461099|P2|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
8298879|NCT01562873|20461100|P1|STARTED|Overall Study||21
8298880|NCT01562782|20461109|P2|NOT COMPLETED|Overall Study||5
8298881|NCT01562782|20461110|P1|NOT COMPLETED|Overall Study||4
8298882|NCT01562782|20461109|P2|COMPLETED|Overall Study||15
8298883|NCT01562782|20461110|P1|COMPLETED|Overall Study||15
8298884|NCT01562782|20461109|P2|STARTED|Overall Study||20
8298885|NCT01562782|20461110|P1|STARTED|Overall Study||19
8298886|NCT01562756|20461134|P1|NOT COMPLETED|Overall Study||0
8298887|NCT01562756|20461134|P1|COMPLETED|Overall Study||6
8298888|NCT01562756|20461134|P1|STARTED|Overall Study||6
8298889|NCT01562743|20461139|P1|NOT COMPLETED|Overall Study||52
8298890|NCT01562743|20461139|P1|COMPLETED|Overall Study||133
8298891|NCT01562743|20461139|P1|STARTED|Overall Study||185
8298892|NCT01562678|20461151|P2|NOT COMPLETED|Overall Study||2
8298893|NCT01562678|20461152|P1|NOT COMPLETED|Overall Study||6
8298894|NCT01562678|20461151|P2|COMPLETED|Overall Study||12
8298895|NCT01562678|20461152|P1|COMPLETED|Overall Study||8
8298896|NCT01562678|20461151|P2|STARTED|Overall Study||14
8298897|NCT01562678|20461152|P1|STARTED|Overall Study||14
8298898|NCT01562613|20461158|P1|NOT COMPLETED|Overall Study||4
8298899|NCT01562613|20461158|P1|COMPLETED|Overall Study||529
8298900|NCT01562613|20461158|P1|STARTED|Overall Study||533
8298901|NCT01562548|20461168|P4|NOT COMPLETED|Overall Study||0
8298902|NCT01562548|20461169|P3|NOT COMPLETED|Overall Study||1
8298903|NCT01562548|20461170|P2|NOT COMPLETED|Overall Study||0
8298904|NCT01562548|20461171|P1|NOT COMPLETED|Overall Study||0
8298905|NCT01562548|20461168|P4|COMPLETED|Overall Study||14
8298906|NCT01562548|20461169|P3|COMPLETED|Overall Study||24
8298907|NCT01562548|20461170|P2|COMPLETED|Overall Study||15
8298908|NCT01562548|20461171|P1|COMPLETED|Overall Study||25
8298909|NCT01562548|20461168|P4|STARTED|Overall Study||14
8298910|NCT01562548|20461169|P3|STARTED|Overall Study||25
8298911|NCT01562548|20461170|P2|STARTED|Overall Study||15
8298912|NCT01562548|20461171|P1|STARTED|Overall Study||25
8298922|NCT01562379|20461476|P5|NOT COMPLETED|Overall Study||40
8298923|NCT01562379|20461477|P4|NOT COMPLETED|Overall Study||57
8298924|NCT01562379|20461478|P3|NOT COMPLETED|Overall Study||62
8298925|NCT01562379|20461479|P2|NOT COMPLETED|Overall Study||97
8298926|NCT01562379|20461480|P1|NOT COMPLETED|Overall Study||126
8298927|NCT01562379|20461476|P5|COMPLETED|Overall Study||785
8298928|NCT01562379|20461477|P4|COMPLETED|Overall Study||786
8298929|NCT01562379|20461478|P3|COMPLETED|Overall Study||789
8298930|NCT01562379|20461479|P2|COMPLETED|Overall Study||1395
8298931|NCT01562379|20461480|P1|COMPLETED|Overall Study||1312
8298932|NCT01562379|20461476|P5|STARTED|Overall Study||825
8298933|NCT01562379|20461477|P4|STARTED|Overall Study||843
8298934|NCT01562379|20461478|P3|STARTED|Overall Study||851
8298935|NCT01562379|20461479|P2|STARTED|Overall Study||1492
8298936|NCT01562379|20461480|P1|STARTED|Overall Study||1438
8298937|NCT01562327|20461492|P1|NOT COMPLETED|Overall Study||8
8298938|NCT01562327|20461492|P1|COMPLETED|Overall Study||42
8298939|NCT01562327|20461492|P1|STARTED|Overall Study||50
8298940|NCT01562314|20461522|P2|NOT COMPLETED|Overall Study||8
8298941|NCT01562314|20461523|P1|NOT COMPLETED|Overall Study||13
8298942|NCT01562314|20461522|P2|COMPLETED|Overall Study||23
8298943|NCT01562314|20461523|P1|COMPLETED|Overall Study||16
8298944|NCT01562314|20461522|P2|Per Protocol (PP) Analysis Set|Overall Study||27
8298945|NCT01562314|20461523|P1|Per Protocol (PP) Analysis Set|Overall Study||17
8298946|NCT01562314|20461522|P2|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
8298947|NCT01562314|20461523|P1|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
8298948|NCT01562314|20461522|P2|Received at Least 1 Dose of Study Drug|Overall Study||31
8298949|NCT01562314|20461523|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
8298950|NCT01562314|20461522|P2|STARTED|Overall Study||31
8298951|NCT01562314|20461523|P1|STARTED|Overall Study||29
8298952|NCT01562275|20461580|P13|NOT COMPLETED|Stage 2||5
8298953|NCT01562275|20461581|P12|NOT COMPLETED|Stage 2||14
8298954|NCT01562275|20461582|P11|NOT COMPLETED|Stage 2||0
8298955|NCT01562275|20461583|P10|NOT COMPLETED|Stage 2||0
8298956|NCT01562275|20461584|P9|NOT COMPLETED|Stage 2||0
8298957|NCT01562275|20461585|P8|NOT COMPLETED|Stage 2||0
8298958|NCT01562275|20461586|P7|NOT COMPLETED|Stage 2||0
8298959|NCT01562275|20461587|P6|NOT COMPLETED|Stage 2||0
8298960|NCT01562275|20461588|P5|NOT COMPLETED|Stage 2||0
8298961|NCT01562275|20461589|P4|NOT COMPLETED|Stage 2||0
8298962|NCT01562275|20461590|P3|NOT COMPLETED|Stage 2||0
8298963|NCT01562275|20461591|P2|NOT COMPLETED|Stage 2||0
8298964|NCT01562275|20461592|P1|NOT COMPLETED|Stage 2||0
8298965|NCT01562275|20461580|P13|COMPLETED|Stage 2||0
8298966|NCT01562275|20461581|P12|COMPLETED|Stage 2||0
8298967|NCT01562275|20461582|P11|COMPLETED|Stage 2||0
8298968|NCT01562275|20461583|P10|COMPLETED|Stage 2||0
8298969|NCT01562275|20461584|P9|COMPLETED|Stage 2||0
8298970|NCT01562275|20461585|P8|COMPLETED|Stage 2||0
8298971|NCT01562275|20461586|P7|COMPLETED|Stage 2||0
8298972|NCT01562275|20461587|P6|COMPLETED|Stage 2||0
8298973|NCT01562275|20461588|P5|COMPLETED|Stage 2||0
8298974|NCT01562275|20461589|P4|COMPLETED|Stage 2||0
8298975|NCT01562275|20461590|P3|COMPLETED|Stage 2||0
8298976|NCT01562275|20461591|P2|COMPLETED|Stage 2||0
8298977|NCT01562275|20461592|P1|COMPLETED|Stage 2||0
8298978|NCT01562275|20461580|P13|STARTED|Stage 2||5
8298979|NCT01562275|20461581|P12|STARTED|Stage 2||14
8298980|NCT01562275|20461582|P11|STARTED|Stage 2||0
8298981|NCT01562275|20461583|P10|STARTED|Stage 2||0
8298982|NCT01562275|20461584|P9|STARTED|Stage 2||0
8298983|NCT01562275|20461585|P8|STARTED|Stage 2||0
8298984|NCT01562275|20461586|P7|STARTED|Stage 2||0
8298985|NCT01562275|20461587|P6|STARTED|Stage 2||0
8298986|NCT01562275|20461588|P5|STARTED|Stage 2||0
8298987|NCT01562275|20461589|P4|STARTED|Stage 2||0
8298988|NCT01562275|20461590|P3|STARTED|Stage 2||0
8298989|NCT01562275|20461591|P2|STARTED|Stage 2||0
8298990|NCT01562275|20461592|P1|STARTED|Stage 2||0
8298991|NCT01562275|20461580|P13|NOT COMPLETED|Stage 1||0
8298992|NCT01562275|20461581|P12|NOT COMPLETED|Stage 1||0
8298993|NCT01562275|20461582|P11|NOT COMPLETED|Stage 1||3
8298994|NCT01562275|20461583|P10|NOT COMPLETED|Stage 1||7
8298995|NCT01562275|20461584|P9|NOT COMPLETED|Stage 1||3
8298996|NCT01562275|20461585|P8|NOT COMPLETED|Stage 1||7
8298997|NCT01562275|20461586|P7|NOT COMPLETED|Stage 1||3
8298998|NCT01562275|20461587|P6|NOT COMPLETED|Stage 1||4
8298999|NCT01562275|20461588|P5|NOT COMPLETED|Stage 1||4
8299000|NCT01562275|20461589|P4|NOT COMPLETED|Stage 1||4
8299001|NCT01562275|20461590|P3|NOT COMPLETED|Stage 1||3
8299002|NCT01562275|20461591|P2|NOT COMPLETED|Stage 1||7
8299003|NCT01562275|20461592|P1|NOT COMPLETED|Stage 1||3
8299004|NCT01562275|20461580|P13|COMPLETED|Stage 1||0
8299005|NCT01562275|20461581|P12|COMPLETED|Stage 1||0
8299006|NCT01562275|20461582|P11|COMPLETED|Stage 1||0
8299007|NCT01562275|20461583|P10|COMPLETED|Stage 1||0
8299008|NCT01562275|20461584|P9|COMPLETED|Stage 1||0
8299009|NCT01562275|20461585|P8|COMPLETED|Stage 1||0
8299010|NCT01562275|20461586|P7|COMPLETED|Stage 1||0
8299011|NCT01562275|20461587|P6|COMPLETED|Stage 1||0
8299012|NCT01562275|20461588|P5|COMPLETED|Stage 1||0
8299013|NCT01562275|20461589|P4|COMPLETED|Stage 1||0
8299014|NCT01562275|20461590|P3|COMPLETED|Stage 1||0
8299015|NCT01562275|20461591|P2|COMPLETED|Stage 1||0
8299016|NCT01562275|20461592|P1|COMPLETED|Stage 1||0
8299017|NCT01562275|20461580|P13|STARTED|Stage 1||0
8299018|NCT01562275|20461581|P12|STARTED|Stage 1||0
8299019|NCT01562275|20461582|P11|STARTED|Stage 1||3
8299020|NCT01562275|20461583|P10|STARTED|Stage 1||7
8299021|NCT01562275|20461584|P9|STARTED|Stage 1||3
8299022|NCT01562275|20461585|P8|STARTED|Stage 1||7
8299023|NCT01562275|20461586|P7|STARTED|Stage 1||3
8299024|NCT01562275|20461587|P6|STARTED|Stage 1||4
8299025|NCT01562275|20461588|P5|STARTED|Stage 1||4
8299026|NCT01562275|20461589|P4|STARTED|Stage 1||4
8299027|NCT01562275|20461590|P3|STARTED|Stage 1||3
8299028|NCT01562275|20461591|P2|STARTED|Stage 1||7
8299029|NCT01562275|20461592|P1|STARTED|Stage 1||3
8299030|NCT01562132|20461724|P2|NOT COMPLETED|Overall Study||0
8299031|NCT01562132|20461725|P1|NOT COMPLETED|Overall Study||0
8299032|NCT01562132|20461724|P2|COMPLETED|Overall Study||3
8299033|NCT01562132|20461725|P1|COMPLETED|Overall Study||3
8299034|NCT01562132|20461724|P2|STARTED|Overall Study||3
8299035|NCT01562132|20461725|P1|STARTED|Overall Study||3
8299042|NCT01561989|20461754|P2|NOT COMPLETED|Overall Study||6
8299043|NCT01561989|20461755|P1|NOT COMPLETED|Overall Study||5
8299044|NCT01561989|20461754|P2|COMPLETED|Overall Study||0
8299045|NCT01561989|20461755|P1|COMPLETED|Overall Study||0
8299046|NCT01561989|20461754|P2|STARTED|Overall Study||6
8299047|NCT01561989|20461755|P1|STARTED|Overall Study||5
8299048|NCT01561976|20461777|P6|NOT COMPLETED|Period 3||0
8299049|NCT01561976|20461778|P5|NOT COMPLETED|Period 3||0
8299050|NCT01561976|20461779|P4|NOT COMPLETED|Period 3||0
8299051|NCT01561976|20461780|P3|NOT COMPLETED|Period 3||0
8299052|NCT01561976|20461781|P2|NOT COMPLETED|Period 3||0
8299053|NCT01561976|20461782|P1|NOT COMPLETED|Period 3||0
8299054|NCT01561976|20461777|P6|COMPLETED|Period 3||4
8299055|NCT01561976|20461778|P5|COMPLETED|Period 3||5
8299056|NCT01561976|20461779|P4|COMPLETED|Period 3||4
8299057|NCT01561976|20461780|P3|COMPLETED|Period 3||3
8299058|NCT01561976|20461781|P2|COMPLETED|Period 3||5
8299059|NCT01561976|20461782|P1|COMPLETED|Period 3||4
8299060|NCT01561976|20461777|P6|STARTED|Period 3||4
8299061|NCT01561976|20461778|P5|STARTED|Period 3||5
8299062|NCT01561976|20461779|P4|STARTED|Period 3||4
8299063|NCT01561976|20461780|P3|STARTED|Period 3||3
8299064|NCT01561976|20461781|P2|STARTED|Period 3||5
8299065|NCT01561976|20461782|P1|STARTED|Period 3||4
8299066|NCT01561976|20461777|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8299067|NCT01561976|20461778|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8299068|NCT01561976|20461779|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8299069|NCT01561976|20461780|P3|NOT COMPLETED|Washout Period 2 (7 Days)||1
8299070|NCT01561976|20461781|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8299071|NCT01561976|20461782|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
8299072|NCT01561976|20461777|P6|COMPLETED|Washout Period 2 (7 Days)||4
8299073|NCT01561976|20461778|P5|COMPLETED|Washout Period 2 (7 Days)||5
8299074|NCT01561976|20461779|P4|COMPLETED|Washout Period 2 (7 Days)||4
8299075|NCT01561976|20461780|P3|COMPLETED|Washout Period 2 (7 Days)||3
8299076|NCT01561976|20461781|P2|COMPLETED|Washout Period 2 (7 Days)||5
8299077|NCT01561976|20461782|P1|COMPLETED|Washout Period 2 (7 Days)||4
8299078|NCT01561976|20461777|P6|STARTED|Washout Period 2 (7 Days)||4
8299079|NCT01561976|20461778|P5|STARTED|Washout Period 2 (7 Days)||5
8299080|NCT01561976|20461779|P4|STARTED|Washout Period 2 (7 Days)||4
8299081|NCT01561976|20461780|P3|STARTED|Washout Period 2 (7 Days)||4
8299082|NCT01561976|20461781|P2|STARTED|Washout Period 2 (7 Days)||5
8299083|NCT01561976|20461782|P1|STARTED|Washout Period 2 (7 Days)||5
8299084|NCT01561976|20461777|P6|NOT COMPLETED|Period 2||0
8299085|NCT01561976|20461778|P5|NOT COMPLETED|Period 2||0
8299086|NCT01561976|20461779|P4|NOT COMPLETED|Period 2||0
8299087|NCT01561976|20461780|P3|NOT COMPLETED|Period 2||0
8299088|NCT01561976|20461781|P2|NOT COMPLETED|Period 2||0
8299089|NCT01561976|20461782|P1|NOT COMPLETED|Period 2||0
8299090|NCT01561976|20461777|P6|COMPLETED|Period 2||4
8299091|NCT01561976|20461778|P5|COMPLETED|Period 2||5
8299092|NCT01561976|20461779|P4|COMPLETED|Period 2||4
8299093|NCT01561976|20461780|P3|COMPLETED|Period 2||4
8299094|NCT01561976|20461781|P2|COMPLETED|Period 2||5
8299095|NCT01561976|20461782|P1|COMPLETED|Period 2||5
8299096|NCT01561976|20461777|P6|STARTED|Period 2||4
8299097|NCT01561976|20461778|P5|STARTED|Period 2||5
8299098|NCT01561976|20461779|P4|STARTED|Period 2||4
8299099|NCT01561976|20461780|P3|STARTED|Period 2||4
8299100|NCT01561976|20461781|P2|STARTED|Period 2||5
8299101|NCT01561976|20461782|P1|STARTED|Period 2||5
8299102|NCT01561976|20461777|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
8299103|NCT01561976|20461778|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8299104|NCT01561976|20461779|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
8299105|NCT01561976|20461780|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8299106|NCT01561976|20461781|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8299107|NCT01561976|20461782|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8299108|NCT01561976|20461777|P6|COMPLETED|Washout Period 1 (7 Days)||4
8299109|NCT01561976|20461778|P5|COMPLETED|Washout Period 1 (7 Days)||5
8299110|NCT01561976|20461779|P4|COMPLETED|Washout Period 1 (7 Days)||4
8299111|NCT01561976|20461780|P3|COMPLETED|Washout Period 1 (7 Days)||4
8299112|NCT01561976|20461781|P2|COMPLETED|Washout Period 1 (7 Days)||5
8299113|NCT01561976|20461782|P1|COMPLETED|Washout Period 1 (7 Days)||5
8299114|NCT01561976|20461777|P6|STARTED|Washout Period 1 (7 Days)||5
8299115|NCT01561976|20461778|P5|STARTED|Washout Period 1 (7 Days)||5
8299116|NCT01561976|20461779|P4|STARTED|Washout Period 1 (7 Days)||5
8299117|NCT01561976|20461780|P3|STARTED|Washout Period 1 (7 Days)||4
8299118|NCT01561976|20461781|P2|STARTED|Washout Period 1 (7 Days)||5
8299119|NCT01561976|20461782|P1|STARTED|Washout Period 1 (7 Days)||5
8299120|NCT01561976|20461777|P6|NOT COMPLETED|Period 1||0
8299121|NCT01561976|20461778|P5|NOT COMPLETED|Period 1||0
8299122|NCT01561976|20461779|P4|NOT COMPLETED|Period 1||0
8299123|NCT01561976|20461780|P3|NOT COMPLETED|Period 1||1
8299124|NCT01561976|20461781|P2|NOT COMPLETED|Period 1||0
8299125|NCT01561976|20461782|P1|NOT COMPLETED|Period 1||0
8299126|NCT01561976|20461777|P6|COMPLETED|Period 1||5
8299127|NCT01561976|20461778|P5|COMPLETED|Period 1||5
8299128|NCT01561976|20461779|P4|COMPLETED|Period 1||5
8299129|NCT01561976|20461780|P3|COMPLETED|Period 1||4
8299130|NCT01561976|20461781|P2|COMPLETED|Period 1||5
8299131|NCT01561976|20461782|P1|COMPLETED|Period 1||5
8299132|NCT01561976|20461777|P6|STARTED|Period 1||5
8299133|NCT01561976|20461778|P5|STARTED|Period 1||5
8299134|NCT01561976|20461779|P4|STARTED|Period 1||5
8299135|NCT01561976|20461780|P3|STARTED|Period 1||5
8299136|NCT01561976|20461781|P2|STARTED|Period 1||5
8299137|NCT01561976|20461782|P1|STARTED|Period 1||5
8299138|NCT01561898|20461815|P4|NOT COMPLETED|Overall Study||20
8299139|NCT01561898|20461816|P3|NOT COMPLETED|Overall Study||44
8299140|NCT01561898|20461817|P2|NOT COMPLETED|Overall Study||41
8299141|NCT01561898|20461818|P1|NOT COMPLETED|Overall Study||2
8299142|NCT01561898|20461815|P4|COMPLETED|Overall Study||12
8299143|NCT01561898|20461816|P3|COMPLETED|Overall Study||53
8299144|NCT01561898|20461817|P2|COMPLETED|Overall Study||51
8299145|NCT01561898|20461818|P1|COMPLETED|Overall Study||5
8299146|NCT01561898|20461815|P4|STARTED|Overall Study||32
8299147|NCT01561898|20461816|P3|STARTED|Overall Study||97
8299148|NCT01561898|20461817|P2|STARTED|Overall Study||92
8299149|NCT01561898|20461818|P1|STARTED|Overall Study||7
8299150|NCT01561833|20461830|P1|NOT COMPLETED|Overall Study||0
8299151|NCT01561833|20461830|P1|COMPLETED|Overall Study||12
8299152|NCT01561833|20461830|P1|STARTED|Overall Study||12
8299153|NCT01561755|20461836|P2|NOT COMPLETED|Overall Study||1
8299154|NCT01561755|20461837|P1|NOT COMPLETED|Overall Study||0
8299155|NCT01561755|20461836|P2|COMPLETED|Overall Study||5
8299156|NCT01561755|20461837|P1|COMPLETED|Overall Study||6
8299157|NCT01561755|20461836|P2|STARTED|Overall Study||6
8299158|NCT01561755|20461837|P1|STARTED|Overall Study||6
8299159|NCT01561716|20461861|P6|NOT COMPLETED|Overall Study||0
8299160|NCT01561716|20461862|P5|NOT COMPLETED|Overall Study||0
8299161|NCT01561716|20461863|P4|NOT COMPLETED|Overall Study||0
8299162|NCT01561716|20461864|P3|NOT COMPLETED|Overall Study||0
8299163|NCT01561716|20461865|P2|NOT COMPLETED|Overall Study||0
8299164|NCT01561716|20461866|P1|NOT COMPLETED|Overall Study||0
8299165|NCT01561716|20461861|P6|COMPLETED|Overall Study||5
8299166|NCT01561716|20461862|P5|COMPLETED|Overall Study||5
8299167|NCT01561716|20461863|P4|COMPLETED|Overall Study||5
8299168|NCT01561716|20461864|P3|COMPLETED|Overall Study||5
8299169|NCT01561716|20461865|P2|COMPLETED|Overall Study||5
8299170|NCT01561716|20461866|P1|COMPLETED|Overall Study||5
8299171|NCT01561716|20461861|P6|STARTED|Overall Study||5
8299172|NCT01561716|20461862|P5|STARTED|Overall Study||5
8299173|NCT01561716|20461863|P4|STARTED|Overall Study||5
8299174|NCT01561716|20461864|P3|STARTED|Overall Study||5
8299175|NCT01561716|20461865|P2|STARTED|Overall Study||5
8299176|NCT01561716|20461866|P1|STARTED|Overall Study||5
8299177|NCT01561703|20461882|P2|NOT COMPLETED|Overall Study||6
8299178|NCT01561703|20461883|P1|NOT COMPLETED|Overall Study||8
8299179|NCT01561703|20461882|P2|COMPLETED|Overall Study||24
8299180|NCT01561703|20461883|P1|COMPLETED|Overall Study||20
8299181|NCT01561703|20461882|P2|STARTED|Overall Study||30
8299182|NCT01561703|20461883|P1|STARTED|Overall Study||28
8299183|NCT01561560|20461889|P2|NOT COMPLETED|Second Two Weeks of Wear||1
8299184|NCT01561560|20461890|P1|NOT COMPLETED|Second Two Weeks of Wear||0
8299185|NCT01561560|20461889|P2|COMPLETED|Second Two Weeks of Wear||58
8299186|NCT01561560|20461890|P1|COMPLETED|Second Two Weeks of Wear||60
8299187|NCT01561560|20461889|P2|STARTED|Second Two Weeks of Wear||59
8299188|NCT01561560|20461890|P1|STARTED|Second Two Weeks of Wear||60
8299189|NCT01561560|20461889|P2|NOT COMPLETED|First Two Weeks of Wear||2
8299190|NCT01561560|20461890|P1|NOT COMPLETED|First Two Weeks of Wear||0
8299191|NCT01561560|20461889|P2|COMPLETED|First Two Weeks of Wear||59
8299192|NCT01561560|20461890|P1|COMPLETED|First Two Weeks of Wear||60
8299193|NCT01561560|20461889|P2|STARTED|First Two Weeks of Wear||61
8299194|NCT01561560|20461890|P1|STARTED|First Two Weeks of Wear||60
8299195|NCT01561495|20461896|P1|NOT COMPLETED|Overall Study||0
8299196|NCT01561495|20461896|P1|COMPLETED|Overall Study||1
8299197|NCT01561495|20461896|P1|STARTED|Overall Study||1
8299198|NCT01561469|20461902|P2|NOT COMPLETED|Overall Study||0
8299199|NCT01561469|20461903|P1|NOT COMPLETED|Overall Study||0
8299200|NCT01561469|20461902|P2|COMPLETED|Overall Study||87
8299201|NCT01561469|20461903|P1|COMPLETED|Overall Study||101
8299202|NCT01561469|20461902|P2|STARTED|Overall Study||87
8299203|NCT01561469|20461903|P1|STARTED|Overall Study||101
8299204|NCT01561430|20461925|P4|NOT COMPLETED|Overall Study||13
8299205|NCT01561430|20461926|P3|NOT COMPLETED|Overall Study||17
8299206|NCT01561430|20461927|P2|NOT COMPLETED|Overall Study||15
8299207|NCT01561430|20461928|P1|NOT COMPLETED|Overall Study||1
8299208|NCT01561430|20461925|P4|COMPLETED|Overall Study||7
8299209|NCT01561430|20461926|P3|COMPLETED|Overall Study||1
8299210|NCT01561430|20461927|P2|COMPLETED|Overall Study||8
8299211|NCT01561430|20461928|P1|COMPLETED|Overall Study||8
8299212|NCT01561430|20461925|P4|Received at Least One Dose of Study Drug|Overall Study||20
8299213|NCT01561430|20461926|P3|Received at Least One Dose of Study Drug|Overall Study||18
8299214|NCT01561430|20461927|P2|Received at Least One Dose of Study Drug|Overall Study||23
8299215|NCT01561430|20461928|P1|Received at Least One Dose of Study Drug|Overall Study||9
8299216|NCT01561430|20461925|P4|STARTED|Overall Study||20
8299217|NCT01561430|20461926|P3|STARTED|Overall Study||18
8299218|NCT01561430|20461927|P2|STARTED|Overall Study||23
8299219|NCT01561430|20461928|P1|STARTED|Overall Study||9
8299220|NCT01561378|20461968|P2|NOT COMPLETED|Overall Study||0
8299221|NCT01561378|20461969|P1|NOT COMPLETED|Overall Study||0
8299222|NCT01561378|20461968|P2|COMPLETED|Overall Study||11
8299223|NCT01561378|20461969|P1|COMPLETED|Overall Study||11
8299224|NCT01561378|20461968|P2|STARTED|Overall Study||11
8299225|NCT01561378|20461969|P1|STARTED|Overall Study||11
8299226|NCT01561313|20461991|P2|NOT COMPLETED|Overall Study||0
8299227|NCT01561313|20461992|P1|NOT COMPLETED|Overall Study||2
8299228|NCT01561313|20461991|P2|COMPLETED|Overall Study||31
8299229|NCT01561313|20461992|P1|COMPLETED|Overall Study||31
8299230|NCT01561313|20461991|P2|STARTED|Overall Study||31
8299231|NCT01561313|20461992|P1|STARTED|Overall Study||33
8299232|NCT01561300|20462010|P2|NOT COMPLETED|Second Intervention||0
8299233|NCT01561300|20462011|P1|NOT COMPLETED|Second Intervention||0
8299234|NCT01561300|20462010|P2|COMPLETED|Second Intervention||15
8299235|NCT01561300|20462011|P1|COMPLETED|Second Intervention||14
8299236|NCT01561300|20462010|P2|STARTED|Second Intervention||15
8299237|NCT01561300|20462011|P1|STARTED|Second Intervention||14
8299238|NCT01561300|20462010|P2|NOT COMPLETED|Washout on Placebo||0
8299239|NCT01561300|20462011|P1|NOT COMPLETED|Washout on Placebo||0
8299240|NCT01561300|20462010|P2|COMPLETED|Washout on Placebo||15
8299241|NCT01561300|20462011|P1|COMPLETED|Washout on Placebo||14
8299242|NCT01561300|20462010|P2|STARTED|Washout on Placebo||15
8299243|NCT01561300|20462011|P1|STARTED|Washout on Placebo||14
8299244|NCT01561300|20462010|P2|NOT COMPLETED|First Intervention||0
8299245|NCT01561300|20462011|P1|NOT COMPLETED|First Intervention||0
8299246|NCT01561300|20462010|P2|COMPLETED|First Intervention||15
8299247|NCT01561300|20462011|P1|COMPLETED|First Intervention||14
8299248|NCT01561300|20462010|P2|STARTED|First Intervention||15
8299249|NCT01561300|20462011|P1|STARTED|First Intervention||14
8299250|NCT01561300|20462010|P2|NOT COMPLETED|Run in on Placebo||0
8299251|NCT01561300|20462011|P1|NOT COMPLETED|Run in on Placebo||1
8299252|NCT01561300|20462010|P2|COMPLETED|Run in on Placebo||15
8299253|NCT01561300|20462011|P1|COMPLETED|Run in on Placebo||14
8299254|NCT01561300|20462010|P2|STARTED|Run in on Placebo||15
8299255|NCT01561300|20462011|P1|STARTED|Run in on Placebo||15
8299256|NCT01561079|20462022|P1|NOT COMPLETED|Overall Study||78
8299257|NCT01561079|20462022|P1|COMPLETED|Overall Study||49
8299258|NCT01561079|20462022|P1|STARTED|Overall Study||127
8299259|NCT01561053|20462069|P4|NOT COMPLETED|Overall Study||23
8299260|NCT01561053|20462070|P3|NOT COMPLETED|Overall Study||21
8299261|NCT01561053|20462071|P2|NOT COMPLETED|Overall Study||36
8299262|NCT01561053|20462072|P1|NOT COMPLETED|Overall Study||35
8299263|NCT01561053|20462069|P4|COMPLETED|Overall Study||64
8299264|NCT01561053|20462070|P3|COMPLETED|Overall Study||61
8299265|NCT01561053|20462071|P2|COMPLETED|Overall Study||56
8299266|NCT01561053|20462072|P1|COMPLETED|Overall Study||51
8299267|NCT01561053|20462069|P4|Evaluable Subjects|Overall Study||80
8299268|NCT01561053|20462070|P3|Evaluable Subjects|Overall Study||78
8299269|NCT01561053|20462071|P2|Evaluable Subjects|Overall Study||86
8299270|NCT01561053|20462072|P1|Evaluable Subjects|Overall Study||78
8299271|NCT01561053|20462069|P4|Randomized Not Treated|Overall Study||7
8299272|NCT01561053|20462070|P3|Randomized Not Treated|Overall Study||4
8299273|NCT01561053|20462071|P2|Randomized Not Treated|Overall Study||6
8299274|NCT01561053|20462072|P1|Randomized Not Treated|Overall Study||8
8299275|NCT01561053|20462069|P4|Patients With Baseline MMSE:22-26|Overall Study||45
8299276|NCT01561053|20462070|P3|Patients With Baseline MMSE:22-26|Overall Study||35
8299277|NCT01561053|20462071|P2|Patients With Baseline MMSE:22-26|Overall Study||52
8299278|NCT01561053|20462072|P1|Patients With Baseline MMSE:22-26|Overall Study||39
8299279|NCT01561053|20462069|P4|Patients With Baseline MMSE:18-21|Overall Study||42
8299280|NCT01561053|20462070|P3|Patients With Baseline MMSE:18-21|Overall Study||47
8299281|NCT01561053|20462071|P2|Patients With Baseline MMSE:18-21|Overall Study||40
8299282|NCT01561053|20462072|P1|Patients With Baseline MMSE:18-21|Overall Study||47
8299283|NCT01561053|20462069|P4|STARTED|Overall Study||87
8299284|NCT01561053|20462070|P3|STARTED|Overall Study||82
8299285|NCT01561053|20462071|P2|STARTED|Overall Study||92
8299286|NCT01561053|20462072|P1|STARTED|Overall Study||86
8299287|NCT01560988|20462108|P2|NOT COMPLETED|Second Intervention (Six Weeks)||2
8299288|NCT01560988|20462109|P1|NOT COMPLETED|Second Intervention (Six Weeks)||2
8299289|NCT01560988|20462108|P2|COMPLETED|Second Intervention (Six Weeks)||22
8299290|NCT01560988|20462109|P1|COMPLETED|Second Intervention (Six Weeks)||18
8299291|NCT01560988|20462108|P2|STARTED|Second Intervention (Six Weeks)||24
8299292|NCT01560988|20462109|P1|STARTED|Second Intervention (Six Weeks)||20
8299293|NCT01560988|20462108|P2|NOT COMPLETED|Washout (Six Weeks)||2
8299294|NCT01560988|20462109|P1|NOT COMPLETED|Washout (Six Weeks)||2
8299295|NCT01560988|20462108|P2|COMPLETED|Washout (Six Weeks)||24
8299296|NCT01560988|20462109|P1|COMPLETED|Washout (Six Weeks)||20
8299297|NCT01560988|20462108|P2|STARTED|Washout (Six Weeks)||26
8299298|NCT01560988|20462109|P1|STARTED|Washout (Six Weeks)||22
8299299|NCT01560988|20462108|P2|NOT COMPLETED|First Intervention (Six Weeks)||4
8299300|NCT01560988|20462109|P1|NOT COMPLETED|First Intervention (Six Weeks)||10
8299301|NCT01560988|20462108|P2|COMPLETED|First Intervention (Six Weeks)||26
8299302|NCT01560988|20462109|P1|COMPLETED|First Intervention (Six Weeks)||22
8299303|NCT01560988|20462108|P2|STARTED|First Intervention (Six Weeks)||30
8299304|NCT01560988|20462109|P1|STARTED|First Intervention (Six Weeks)||32
8299305|NCT01560975|20462132|P1|NOT COMPLETED|Overall Study||0
8299306|NCT01560975|20462132|P1|COMPLETED|Overall Study||10
8299307|NCT01560975|20462132|P1|STARTED|Overall Study||10
8299308|NCT01560949|20462145|P1|NOT COMPLETED|Surgery Phase||3
8299309|NCT01560949|20462145|P1|COMPLETED|Surgery Phase||15
8299310|NCT01560949|20462145|P1|STARTED|Surgery Phase||18
8299311|NCT01560949|20462145|P1|NOT COMPLETED|Chemoradiation Phase: With Gemcitabine||0
8299312|NCT01560949|20462145|P1|COMPLETED|Chemoradiation Phase: With Gemcitabine||23
8299313|NCT01560949|20462145|P1|STARTED|Chemoradiation Phase: With Gemcitabine||23
8299314|NCT01560949|20462145|P1|NOT COMPLETED|Systemic Phase: mFOLFIRINOX||6
8299315|NCT01560949|20462145|P1|COMPLETED|Systemic Phase: mFOLFIRINOX||27
8299316|NCT01560949|20462145|P1|STARTED|Systemic Phase: mFOLFIRINOX||33
8299317|NCT01560923|20462160|P2|NOT COMPLETED|Overall Study||0
8299318|NCT01560923|20462161|P1|NOT COMPLETED|Overall Study||0
8299319|NCT01560923|20462160|P2|COMPLETED|Overall Study||22
8299320|NCT01560923|20462161|P1|COMPLETED|Overall Study||24
8299321|NCT01560923|20462160|P2|STARTED|Overall Study||22
8299322|NCT01560923|20462161|P1|STARTED|Overall Study||24
8299323|NCT01560871|20462179|P2|NOT COMPLETED|Overall Study||2
8299324|NCT01560871|20462180|P1|NOT COMPLETED|Overall Study||6
8299325|NCT01560871|20462179|P2|COMPLETED|Overall Study||5
8299326|NCT01560871|20462180|P1|COMPLETED|Overall Study||3
8299327|NCT01560871|20462179|P2|STARTED|Overall Study||7
8299328|NCT01560871|20462180|P1|STARTED|Overall Study||9
8299329|NCT01560819|20462196|P2|NOT COMPLETED|Overall Study||0
8299330|NCT01560819|20462197|P1|NOT COMPLETED|Overall Study||1
8299331|NCT01560819|20462196|P2|COMPLETED|Overall Study||10
8299332|NCT01560819|20462197|P1|COMPLETED|Overall Study||9
8299333|NCT01560819|20462196|P2|STARTED|Overall Study||10
8299334|NCT01560819|20462197|P1|STARTED|Overall Study||10
8299335|NCT01560780|20462203|P2|NOT COMPLETED|Overall Study||12
8299336|NCT01560780|20462204|P1|NOT COMPLETED|Overall Study||13
8299337|NCT01560780|20462203|P2|COMPLETED|Overall Study||30
8299338|NCT01560780|20462204|P1|COMPLETED|Overall Study||29
8299339|NCT01560780|20462203|P2|Completed Study Drug for 12 Months|Overall Study||27
8299340|NCT01560780|20462204|P1|Completed Study Drug for 12 Months|Overall Study||27
8299341|NCT01560780|20462203|P2|Clinical Follow-Up at 12 Months|Overall Study||42
8299342|NCT01560780|20462204|P1|Clinical Follow-Up at 12 Months|Overall Study||42
8299343|NCT01560780|20462203|P2|STARTED|Overall Study||42
8299344|NCT01560780|20462204|P1|STARTED|Overall Study||42
8299345|NCT01560624|20462224|P2|NOT COMPLETED|Overall Study||189
8299346|NCT01560624|20462225|P1|NOT COMPLETED|Overall Study||198
8299347|NCT01560624|20462224|P2|COMPLETED|Overall Study||155
8299348|NCT01560624|20462225|P1|COMPLETED|Overall Study||148
8299349|NCT01560624|20462224|P2|Early Discontinuation From Treatment|Overall Study||56
8299350|NCT01560624|20462225|P1|Early Discontinuation From Treatment|Overall Study||107
8299351|NCT01560624|20462224|P2|Clinical Worsening Event|Overall Study||133
8299352|NCT01560624|20462225|P1|Clinical Worsening Event|Overall Study||91
8299353|NCT01560624|20462224|P2|STARTED|Overall Study||344
8299354|NCT01560624|20462225|P1|STARTED|Overall Study||346
8299355|NCT01560507|20462240|P3|NOT COMPLETED|Overall Study||2
8299356|NCT01560507|20462241|P2|NOT COMPLETED|Overall Study||2
8299357|NCT01560507|20462242|P1|NOT COMPLETED|Overall Study||4
8299358|NCT01560507|20462240|P3|COMPLETED|Overall Study||0
8299359|NCT01560507|20462241|P2|COMPLETED|Overall Study||0
8299360|NCT01560507|20462242|P1|COMPLETED|Overall Study||1
8299361|NCT01560507|20462240|P3|STARTED|Overall Study||2
8299362|NCT01560507|20462241|P2|STARTED|Overall Study||2
8299363|NCT01560507|20462242|P1|STARTED|Overall Study||5
8299364|NCT01560429|20462255|P2|NOT COMPLETED|Overall Study||6
8299365|NCT01560429|20462256|P1|NOT COMPLETED|Overall Study||3
8299366|NCT01560429|20462255|P2|COMPLETED|Overall Study||20
8299367|NCT01560429|20462256|P1|COMPLETED|Overall Study||23
8299368|NCT01560429|20462255|P2|STARTED|Overall Study||26
8299369|NCT01560429|20462256|P1|STARTED|Overall Study||26
8299370|NCT01560416|20462266|P2|NOT COMPLETED|Crossover Phase||0
8299371|NCT01560416|20462267|P1|NOT COMPLETED|Crossover Phase||0
8299372|NCT01560416|20462266|P2|COMPLETED|Crossover Phase||0
8299373|NCT01560416|20462267|P1|COMPLETED|Crossover Phase||7
8299374|NCT01560416|20462266|P2|STARTED|Crossover Phase||0
8299375|NCT01560416|20462267|P1|STARTED|Crossover Phase||7
8299376|NCT01560416|20462266|P2|NOT COMPLETED|Randomized Phase||0
8299377|NCT01560416|20462267|P1|NOT COMPLETED|Randomized Phase||7
8299378|NCT01560416|20462266|P2|COMPLETED|Randomized Phase||35
8299379|NCT01560416|20462267|P1|COMPLETED|Randomized Phase||8
8299380|NCT01560416|20462266|P2|STARTED|Randomized Phase||35
8299381|NCT01560416|20462267|P1|STARTED|Randomized Phase||15
8299388|NCT01560377|20462292|P1|NOT COMPLETED|Overall Study||0
8299389|NCT01560377|20462292|P1|COMPLETED|Overall Study||147
8299390|NCT01560377|20462292|P1|Eligible for Analysis|Overall Study||139
8299391|NCT01560377|20462292|P1|STARTED|Overall Study||147
8299392|NCT01560286|20462297|P1|NOT COMPLETED|Overall Study||0
8299393|NCT01560286|20462297|P1|COMPLETED|Overall Study||24
8299394|NCT01560286|20462297|P1|STARTED|Overall Study||24
8299395|NCT01560260|20462310|P1|NOT COMPLETED|Overall Study||0
8299396|NCT01560260|20462310|P1|COMPLETED|Overall Study||20
8299397|NCT01560260|20462310|P1|STARTED|Overall Study||20
8299398|NCT01560234|20462334|P8|NOT COMPLETED|Overall Study||2
8299399|NCT01560234|20462335|P7|NOT COMPLETED|Overall Study||0
8299400|NCT01560234|20462336|P6|NOT COMPLETED|Overall Study||2
8299401|NCT01560234|20462337|P5|NOT COMPLETED|Overall Study||0
8299402|NCT01560234|20462338|P4|NOT COMPLETED|Overall Study||0
8299403|NCT01560234|20462339|P3|NOT COMPLETED|Overall Study||1
8299404|NCT01560234|20462340|P2|NOT COMPLETED|Overall Study||0
8299405|NCT01560234|20462341|P1|NOT COMPLETED|Overall Study||3
8299406|NCT01560234|20462334|P8|COMPLETED|Overall Study||6
8299407|NCT01560234|20462335|P7|COMPLETED|Overall Study||4
8299408|NCT01560234|20462336|P6|COMPLETED|Overall Study||2
8299409|NCT01560234|20462337|P5|COMPLETED|Overall Study||4
8299410|NCT01560234|20462338|P4|COMPLETED|Overall Study||3
8299411|NCT01560234|20462339|P3|COMPLETED|Overall Study||3
8299412|NCT01560234|20462340|P2|COMPLETED|Overall Study||4
8299413|NCT01560234|20462341|P1|COMPLETED|Overall Study||13
8299414|NCT01560234|20462334|P8|STARTED|Overall Study||8
8299415|NCT01560234|20462335|P7|STARTED|Overall Study||4
8299416|NCT01560234|20462336|P6|STARTED|Overall Study||4
8299417|NCT01560234|20462337|P5|STARTED|Overall Study||4
8299418|NCT01560234|20462338|P4|STARTED|Overall Study||3
8299419|NCT01560234|20462339|P3|STARTED|Overall Study||4
8299420|NCT01560234|20462340|P2|STARTED|Overall Study||4
8299421|NCT01560234|20462341|P1|STARTED|Overall Study||16
8299422|NCT01560143|20462415|P1|NOT COMPLETED|Overall Study||0
8299423|NCT01560143|20462415|P1|COMPLETED|Overall Study||12
8299424|NCT01560143|20462415|P1|STARTED|Overall Study||12
8299425|NCT01559948|20462421|P2|NOT COMPLETED|Overall Study||0
8299426|NCT01559948|20462422|P1|NOT COMPLETED|Overall Study||0
8299427|NCT01559948|20462421|P2|COMPLETED|Overall Study||15
8299428|NCT01559948|20462422|P1|COMPLETED|Overall Study||15
8299429|NCT01559948|20462421|P2|STARTED|Overall Study||15
8299430|NCT01559948|20462422|P1|STARTED|Overall Study||15
8299440|NCT01559922|20462446|P2|NOT COMPLETED|Overall Study||10
8299441|NCT01559922|20462447|P1|NOT COMPLETED|Overall Study||4
8299442|NCT01559922|20462446|P2|COMPLETED|Overall Study||87
8299443|NCT01559922|20462447|P1|COMPLETED|Overall Study||46
8299444|NCT01559922|20462446|P2|STARTED|Overall Study||97
8299445|NCT01559922|20462447|P1|STARTED|Overall Study||50
8299446|NCT01559857|20462455|P2|NOT COMPLETED|Overall Study||0
8299447|NCT01559857|20462456|P1|NOT COMPLETED|Overall Study||0
8299448|NCT01559857|20462455|P2|COMPLETED|Overall Study||18
8299449|NCT01559857|20462456|P1|COMPLETED|Overall Study||19
8299450|NCT01559857|20462455|P2|STARTED|Overall Study||18
8299451|NCT01559857|20462456|P1|STARTED|Overall Study||19
8299452|NCT01559844|20462472|P1|NOT COMPLETED|Overall Study||25
8299453|NCT01559844|20462472|P1|COMPLETED|Overall Study||36
8299454|NCT01559844|20462472|P1|STARTED|Overall Study||61
8299455|NCT01559675|20462485|P2|NOT COMPLETED|Overall Study||14
8299456|NCT01559675|20462486|P1|NOT COMPLETED|Overall Study||15
8299457|NCT01559675|20462485|P2|COMPLETED|Overall Study||49
8299458|NCT01559675|20462486|P1|COMPLETED|Overall Study||43
8299459|NCT01559675|20462485|P2|STARTED|Overall Study||63
8299460|NCT01559675|20462486|P1|STARTED|Overall Study||58
8299461|NCT01559649|20462494|P2|NOT COMPLETED|Overall Study||6
8299462|NCT01559649|20462495|P1|NOT COMPLETED|Overall Study||19
8299463|NCT01559649|20462494|P2|COMPLETED|Overall Study||9
8299464|NCT01559649|20462495|P1|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
8299465|NCT01559649|20462494|P2|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
8299466|NCT01559649|20462495|P1|STARTED|Overall Study||269
8299467|NCT01559506|20462508|P2|NOT COMPLETED|Overall Study||3
8299468|NCT01559506|20462509|P1|NOT COMPLETED|Overall Study||0
8299469|NCT01559506|20462508|P2|COMPLETED|Overall Study||18
8299470|NCT01559506|20462509|P1|COMPLETED|Overall Study||20
8299471|NCT01559506|20462508|P2|STARTED|Overall Study||21
8299472|NCT01559506|20462509|P1|STARTED|Overall Study||20
8299473|NCT01559454|20462517|P2|NOT COMPLETED|Overall Study||6
8299474|NCT01559454|20462518|P1|NOT COMPLETED|Overall Study||3
8299475|NCT01559454|20462517|P2|COMPLETED|Overall Study||4
8299476|NCT01559454|20462518|P1|COMPLETED|Overall Study||6
8299477|NCT01559454|20462517|P2|STARTED|Overall Study||10
8299478|NCT01559454|20462518|P1|STARTED|Overall Study||9
8299479|NCT01559389|20462536|P2|NOT COMPLETED|Overall Study||20
8299480|NCT01559389|20462537|P1|NOT COMPLETED|Overall Study||20
8299481|NCT01559389|20462536|P2|COMPLETED|Overall Study||49
8299482|NCT01559389|20462537|P1|COMPLETED|Overall Study||49
8299483|NCT01559389|20462536|P2|STARTED|Overall Study||69
8299484|NCT01559389|20462537|P1|STARTED|Overall Study||69
8299485|NCT01559311|20462550|P3|NOT COMPLETED|Overall Study||8
8299486|NCT01559311|20462551|P2|NOT COMPLETED|Overall Study||6
8299487|NCT01559311|20462552|P1|NOT COMPLETED|Overall Study||3
8299488|NCT01559311|20462550|P3|COMPLETED|Overall Study|12-Month|26
8299489|NCT01559311|20462551|P2|COMPLETED|Overall Study|12-Month|28
8299490|NCT01559311|20462552|P1|COMPLETED|Overall Study|12-Month|27
8299491|NCT01559311|20462550|P3|6-Month|Overall Study||28
8299492|NCT01559311|20462551|P2|6-Month|Overall Study||33
8299493|NCT01559311|20462552|P1|6-Month|Overall Study||27
8299494|NCT01559311|20462550|P3|3-Month|Overall Study||29
8299495|NCT01559311|20462551|P2|3-Month|Overall Study||34
8299496|NCT01559311|20462552|P1|3-Month|Overall Study||27
8299497|NCT01559311|20462550|P3|1-Month|Overall Study||29
8299498|NCT01559311|20462551|P2|1-Month|Overall Study||34
8299499|NCT01559311|20462552|P1|1-Month|Overall Study||27
8299500|NCT01559311|20462550|P3|Implant|Overall Study||32
8299501|NCT01559311|20462551|P2|Implant|Overall Study||34
8299502|NCT01559311|20462552|P1|Implant|Overall Study||28
8299503|NCT01559311|20462550|P3|STARTED|Overall Study|Enrollment & Baseline|34
8299504|NCT01559311|20462551|P2|STARTED|Overall Study|Enrollment & Baseline|34
8299505|NCT01559311|20462552|P1|STARTED|Overall Study|Enrollment & Baseline|30
8299506|NCT01559259|20462568|P5|NOT COMPLETED|Overall Study||0
8299507|NCT01559259|20462569|P4|NOT COMPLETED|Overall Study||1
8299508|NCT01559259|20462570|P3|NOT COMPLETED|Overall Study||1
8299509|NCT01559259|20462571|P2|NOT COMPLETED|Overall Study||1
8299510|NCT01559259|20462572|P1|NOT COMPLETED|Overall Study||0
8299511|NCT01559259|20462568|P5|COMPLETED|Overall Study||92
8299512|NCT01559259|20462569|P4|COMPLETED|Overall Study||88
8299513|NCT01559259|20462570|P3|COMPLETED|Overall Study||92
8299514|NCT01559259|20462571|P2|COMPLETED|Overall Study||89
8299515|NCT01559259|20462572|P1|COMPLETED|Overall Study||30
8299516|NCT01559259|20462568|P5|STARTED|Overall Study||92
8299517|NCT01559259|20462569|P4|STARTED|Overall Study||89
8299518|NCT01559259|20462570|P3|STARTED|Overall Study||93
8299519|NCT01559259|20462571|P2|STARTED|Overall Study||90
8299520|NCT01559259|20462572|P1|STARTED|Overall Study||30
8299521|NCT01559129|20462661|P2|NOT COMPLETED|Open-label Extension Period||2
8299522|NCT01559129|20462662|P1|NOT COMPLETED|Open-label Extension Period||6
8299523|NCT01559129|20462661|P2|COMPLETED|Open-label Extension Period||0
8299524|NCT01559129|20462662|P1|COMPLETED|Open-label Extension Period||0
8299525|NCT01559129|20462661|P2|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2
8299526|NCT01559129|20462662|P1|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6
8299527|NCT01559129|20462661|P2|NOT COMPLETED|Treatment Phase||7
8299528|NCT01559129|20462662|P1|NOT COMPLETED|Treatment Phase||5
8299529|NCT01559129|20462661|P2|COMPLETED|Treatment Phase||4
8299530|NCT01559129|20462662|P1|COMPLETED|Treatment Phase||7
8299531|NCT01559129|20462661|P2|Received Treatment|Treatment Phase||10
8299532|NCT01559129|20462662|P1|Received Treatment|Treatment Phase||12
8299533|NCT01559129|20462661|P2|STARTED|Treatment Phase||11
8299534|NCT01559129|20462662|P1|STARTED|Treatment Phase||12
8299535|NCT01559116|20462738|P1|NOT COMPLETED|Overall Study||26
8299536|NCT01559116|20462738|P1|COMPLETED|Overall Study|Completed all 4 treatment periods|193
8299537|NCT01559116|20462738|P1|STARTED|Overall Study|Randomised|219
8299538|NCT01559090|20462809|P3|NOT COMPLETED|Stage II||0
8299539|NCT01559090|20462810|P2|NOT COMPLETED|Stage II||0
8299540|NCT01559090|20462811|P1|NOT COMPLETED|Stage II||1
8299541|NCT01559090|20462809|P3|COMPLETED|Stage II||2
8299542|NCT01559090|20462810|P2|COMPLETED|Stage II||3
8299543|NCT01559090|20462811|P1|COMPLETED|Stage II||3
8299544|NCT01559090|20462809|P3|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2
8299545|NCT01559090|20462810|P2|STARTED|Stage II||3
8299546|NCT01559090|20462811|P1|STARTED|Stage II||4
8299547|NCT01559090|20462809|P3|NOT COMPLETED|Stage I||3
8299548|NCT01559090|20462810|P2|NOT COMPLETED|Stage I||2
8299549|NCT01559090|20462811|P1|NOT COMPLETED|Stage I||2
8299550|NCT01559090|20462809|P3|COMPLETED|Stage I||3
8299551|NCT01559090|20462810|P2|COMPLETED|Stage I||3
8299552|NCT01559090|20462811|P1|COMPLETED|Stage I||4
8299553|NCT01559090|20462809|P3|STARTED|Stage I||6
8299554|NCT01559090|20462810|P2|STARTED|Stage I||5
8299555|NCT01559090|20462811|P1|STARTED|Stage I||6
8299556|NCT01559064|20462831|P3|NOT COMPLETED|Overall Study||2
8299557|NCT01559064|20462832|P2|NOT COMPLETED|Overall Study||1
8299558|NCT01559064|20462833|P1|NOT COMPLETED|Overall Study||1
8299559|NCT01559064|20462831|P3|COMPLETED|Overall Study||57
8299560|NCT01559064|20462832|P2|COMPLETED|Overall Study||39
8299561|NCT01559064|20462833|P1|COMPLETED|Overall Study||15
8299562|NCT01559064|20462831|P3|STARTED|Overall Study||59
8299563|NCT01559064|20462832|P2|STARTED|Overall Study||40
8299564|NCT01559064|20462833|P1|STARTED|Overall Study||16
8299565|NCT01559012|20462843|P2|NOT COMPLETED|Overall Study||1
8299566|NCT01559012|20462844|P1|NOT COMPLETED|Overall Study||0
8299567|NCT01559012|20462843|P2|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
8299568|NCT01559012|20462844|P1|COMPLETED|Overall Study||6
8299569|NCT01559012|20462843|P2|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
8299570|NCT01559012|20462844|P1|STARTED|Overall Study||6
8299571|NCT01558791|20462869|P2|NOT COMPLETED|Overall Study||0
8299572|NCT01558791|20462870|P1|NOT COMPLETED|Overall Study||0
8299573|NCT01558791|20462869|P2|COMPLETED|Overall Study||629
8299574|NCT01558791|20462870|P1|COMPLETED|Overall Study||607
8299575|NCT01558791|20462869|P2|STARTED|Overall Study||629
8299576|NCT01558791|20462870|P1|STARTED|Overall Study||607
8299577|NCT01558752|20462884|P2|NOT COMPLETED|Overall Study||0
8299578|NCT01558752|20462885|P1|NOT COMPLETED|Overall Study||2
8299579|NCT01558752|20462884|P2|COMPLETED|Overall Study||46
8299580|NCT01558752|20462885|P1|COMPLETED|Overall Study||40
8299581|NCT01558752|20462884|P2|STARTED|Overall Study||46
8299582|NCT01558752|20462885|P1|STARTED|Overall Study||42
8299583|NCT01558739|20462891|P1|NOT COMPLETED|Overall Study||17
8299584|NCT01558739|20462891|P1|COMPLETED|Overall Study||31
8299585|NCT01558739|20462891|P1|STARTED|Overall Study||48
8299586|NCT01558700|20462905|P2|NOT COMPLETED|Overall Study||0
8299587|NCT01558700|20462906|P1|NOT COMPLETED|Overall Study||0
8299588|NCT01558700|20462905|P2|COMPLETED|Overall Study||21
8299589|NCT01558700|20462906|P1|COMPLETED|Overall Study||19
8299590|NCT01558700|20462905|P2|STARTED|Overall Study||21
8299591|NCT01558700|20462906|P1|STARTED|Overall Study||19
8299592|NCT01558674|20462916|P2|NOT COMPLETED|Part 2||0
8299593|NCT01558674|20462917|P1|NOT COMPLETED|Part 2||0
8299594|NCT01558674|20462916|P2|COMPLETED|Part 2||0
8299595|NCT01558674|20462917|P1|COMPLETED|Part 2||0
8299596|NCT01558674|20462916|P2|STARTED|Part 2||0
8299597|NCT01558674|20462917|P1|STARTED|Part 2||0
8299598|NCT01558674|20462916|P2|NOT COMPLETED|Part 1||0
8299599|NCT01558674|20462917|P1|NOT COMPLETED|Part 1||11
8299600|NCT01558674|20462916|P2|COMPLETED|Part 1||0
8299601|NCT01558674|20462917|P1|COMPLETED|Part 1||0
8299602|NCT01558674|20462916|P2|STARTED|Part 1||0
8299603|NCT01558674|20462917|P1|STARTED|Part 1||11
8299604|NCT01558661|20462961|P1|NOT COMPLETED|Overall Study||0
8299605|NCT01558661|20462961|P1|COMPLETED|Overall Study||33
8299606|NCT01558661|20462961|P1|Second Stage|Overall Study||15
8299607|NCT01558661|20462961|P1|First Stage|Overall Study||18
8299608|NCT01558661|20462961|P1|STARTED|Overall Study||33
8299609|NCT01558635|20462968|P1|NOT COMPLETED|Overall Study||6
8299610|NCT01558635|20462968|P1|COMPLETED|Overall Study||11
8299611|NCT01558635|20462968|P1|6 Months Post-procedure|Overall Study||14
8299612|NCT01558635|20462968|P1|3 Months Post-procedure|Overall Study||14
8299613|NCT01558635|20462968|P1|Discharge /1 Month Post-procedure|Overall Study||15
8299614|NCT01558635|20462968|P1|Treated|Overall Study||17
8299615|NCT01558635|20462968|P1|STARTED|Overall Study||17
8299616|NCT01558596|20462985|P2|NOT COMPLETED|Overall Study||1
8299617|NCT01558596|20462986|P1|NOT COMPLETED|Overall Study||3
8299618|NCT01558596|20462985|P2|COMPLETED|Overall Study||100
8299619|NCT01558596|20462986|P1|COMPLETED|Overall Study||101
8299620|NCT01558596|20462985|P2|STARTED|Overall Study||101
8299621|NCT01558596|20462986|P1|STARTED|Overall Study||104
8299622|NCT01558492|20462992|P1|NOT COMPLETED|Overall Study||0
8299623|NCT01558492|20462992|P1|COMPLETED|Overall Study||3
8299624|NCT01558492|20462992|P1|STARTED|Overall Study||3
8299625|NCT01558297|20463001|P3|NOT COMPLETED|Overall Study||1
8299626|NCT01558297|20463002|P2|NOT COMPLETED|Overall Study||2
8299627|NCT01558297|20463003|P1|NOT COMPLETED|Overall Study||2
8299628|NCT01558297|20463001|P3|COMPLETED|Overall Study||29
8299629|NCT01558297|20463002|P2|COMPLETED|Overall Study||27
8299630|NCT01558297|20463003|P1|COMPLETED|Overall Study||28
8299631|NCT01558297|20463001|P3|STARTED|Overall Study||30
8299632|NCT01558297|20463002|P2|STARTED|Overall Study||29
8299633|NCT01558297|20463003|P1|STARTED|Overall Study||30
8299634|NCT01558271|20463020|P3|NOT COMPLETED|Overall Study||17
8299635|NCT01558271|20463021|P2|NOT COMPLETED|Overall Study||11
8299636|NCT01558271|20463022|P1|NOT COMPLETED|Overall Study||18
8299637|NCT01558271|20463020|P3|COMPLETED|Overall Study||124
8299638|NCT01558271|20463021|P2|COMPLETED|Overall Study||59
8299639|NCT01558271|20463022|P1|COMPLETED|Overall Study||263
8299640|NCT01558271|20463020|P3|Completed 26 Weeks|Overall Study||128
8299641|NCT01558271|20463021|P2|Completed 26 Weeks|Overall Study||63
8299642|NCT01558271|20463022|P1|Completed 26 Weeks|Overall Study||271
8299643|NCT01558271|20463020|P3|Received at Least 1 Dose of Study Drug|Overall Study||137
8299644|NCT01558271|20463021|P2|Received at Least 1 Dose of Study Drug|Overall Study||70
8299645|NCT01558271|20463022|P1|Received at Least 1 Dose of Study Drug|Overall Study||280
8299646|NCT01558271|20463020|P3|STARTED|Overall Study||141
8299647|NCT01558271|20463021|P2|STARTED|Overall Study||70
8299648|NCT01558271|20463022|P1|STARTED|Overall Study||281
8299649|NCT01558128|20463084|P1|NOT COMPLETED|Overall Study||0
8299650|NCT01558128|20463084|P1|COMPLETED|Overall Study||1
8299651|NCT01558128|20463084|P1|STARTED|Overall Study||1
8299652|NCT01558089|20463088|P1|NOT COMPLETED|Overall Study||13
8299653|NCT01558089|20463088|P1|COMPLETED|Overall Study||63
8299654|NCT01558089|20463088|P1|STARTED|Overall Study||76
8299655|NCT01558063|20463105|P6|NOT COMPLETED|Overall Study||0
8299656|NCT01558063|20463106|P5|NOT COMPLETED|Overall Study||0
8299657|NCT01558063|20463107|P4|NOT COMPLETED|Overall Study||0
8299658|NCT01558063|20463108|P3|NOT COMPLETED|Overall Study||0
8299659|NCT01558063|20463109|P2|NOT COMPLETED|Overall Study||0
8299660|NCT01558063|20463110|P1|NOT COMPLETED|Overall Study||0
8299661|NCT01558063|20463105|P6|COMPLETED|Overall Study||5
8299662|NCT01558063|20463106|P5|COMPLETED|Overall Study||9
8299663|NCT01558063|20463107|P4|COMPLETED|Overall Study||5
8299664|NCT01558063|20463108|P3|COMPLETED|Overall Study||8
8299665|NCT01558063|20463109|P2|COMPLETED|Overall Study||6
8299666|NCT01558063|20463110|P1|COMPLETED|Overall Study||5
8299667|NCT01558063|20463105|P6|STARTED|Overall Study||5
8299668|NCT01558063|20463106|P5|STARTED|Overall Study||9
8299669|NCT01558063|20463107|P4|STARTED|Overall Study||5
8299670|NCT01558063|20463108|P3|STARTED|Overall Study||8
8299671|NCT01558063|20463109|P2|STARTED|Overall Study||6
8299672|NCT01558063|20463110|P1|STARTED|Overall Study||5
8299673|NCT01557959|20463131|P1|NOT COMPLETED|Overall Study||0
8299674|NCT01557959|20463131|P1|COMPLETED|Overall Study||45
8299675|NCT01557959|20463131|P1|STARTED|Overall Study||45
8299676|NCT01557946|20463141|P2|NOT COMPLETED|Overall Study||0
8299677|NCT01557946|20463142|P1|NOT COMPLETED|Overall Study||3
8299678|NCT01557946|20463141|P2|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
8299679|NCT01557946|20463142|P1|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
8299680|NCT01557946|20463141|P2|STARTED|Overall Study||12
8299681|NCT01557946|20463142|P1|STARTED|Overall Study||20
8299682|NCT01557920|20463148|P2|NOT COMPLETED|Overall Study||3
8299683|NCT01557920|20463149|P1|NOT COMPLETED|Overall Study||3
8299684|NCT01557920|20463148|P2|COMPLETED|Overall Study||6
8299685|NCT01557920|20463149|P1|COMPLETED|Overall Study||6
8299686|NCT01557920|20463148|P2|STARTED|Overall Study||9
8299687|NCT01557920|20463149|P1|STARTED|Overall Study||9
8299688|NCT01557894|20463184|P2|NOT COMPLETED|Overall Study||5
8299689|NCT01557894|20463185|P1|NOT COMPLETED|Overall Study||3
8299690|NCT01557894|20463184|P2|COMPLETED|Overall Study||33
8299691|NCT01557894|20463185|P1|COMPLETED|Overall Study||35
8299692|NCT01557894|20463184|P2|STARTED|Overall Study||38
8299693|NCT01557894|20463185|P1|STARTED|Overall Study||38
8299694|NCT01557881|20463199|P1|NOT COMPLETED|Overall Study||0
8299695|NCT01557881|20463199|P1|COMPLETED|Overall Study||98
8299696|NCT01557881|20463199|P1|STARTED|Overall Study||98
8299697|NCT01557868|20463207|P2|NOT COMPLETED|Overall Study||30
8299698|NCT01557868|20463208|P1|NOT COMPLETED|Overall Study||27
8299699|NCT01557868|20463207|P2|COMPLETED|Overall Study||65
8299700|NCT01557868|20463208|P1|COMPLETED|Overall Study||76
8299701|NCT01557868|20463207|P2|STARTED|Overall Study||95
8299702|NCT01557868|20463208|P1|STARTED|Overall Study||103
8299703|NCT01557842|20463218|P2|NOT COMPLETED|Overall Study||6
8299704|NCT01557842|20463219|P1|NOT COMPLETED|Overall Study||9
8299705|NCT01557842|20463218|P2|COMPLETED|Overall Study||0
8299706|NCT01557842|20463219|P1|COMPLETED|Overall Study||0
8299707|NCT01557842|20463218|P2|STARTED|Overall Study||6
8299708|NCT01557842|20463219|P1|STARTED|Overall Study||9
8299709|NCT01557790|20463227|P1|NOT COMPLETED|Overall Study||1
8299710|NCT01557790|20463227|P1|COMPLETED|Overall Study||4
8299711|NCT01557790|20463227|P1|STARTED|Overall Study||5
8299715|NCT01557699|20463238|P3|NOT COMPLETED|Overall Study||0
8299716|NCT01557699|20463239|P2|NOT COMPLETED|Overall Study||0
8299717|NCT01557699|20463240|P1|NOT COMPLETED|Overall Study||0
8299718|NCT01557699|20463238|P3|COMPLETED|Overall Study||20
8299719|NCT01557699|20463239|P2|COMPLETED|Overall Study||20
8299720|NCT01557699|20463240|P1|COMPLETED|Overall Study||20
8299721|NCT01557699|20463238|P3|STARTED|Overall Study||20
8299722|NCT01557699|20463239|P2|STARTED|Overall Study||20
8299723|NCT01557699|20463240|P1|STARTED|Overall Study||20
8299724|NCT01557595|20463272|P1|NOT COMPLETED|Overall Study||8
8299725|NCT01557595|20463272|P1|COMPLETED|Overall Study||14
8299726|NCT01557595|20463272|P1|STARTED|Overall Study||22
8299727|NCT01557582|20463276|P1|NOT COMPLETED|Overall Study||6
8299728|NCT01557582|20463276|P1|COMPLETED|Overall Study||97
8299729|NCT01557582|20463276|P1|STARTED|Overall Study||103
8299730|NCT01557569|20463284|P2|NOT COMPLETED|Overall Study||7
8299731|NCT01557569|20463285|P1|NOT COMPLETED|Overall Study||5
8299732|NCT01557569|20463284|P2|COMPLETED|Overall Study||0
8299733|NCT01557569|20463285|P1|COMPLETED|Overall Study||1
8299734|NCT01557569|20463284|P2|Completed 2-wk Residential Stay|Overall Study||1
8299735|NCT01557569|20463285|P1|Completed 2-wk Residential Stay|Overall Study||3
8299736|NCT01557569|20463284|P2|STARTED|Overall Study|Those who received at least one dose of medication|7
8299737|NCT01557569|20463285|P1|STARTED|Overall Study|Those who received at least one dose of medication|6
8299738|NCT01557517|20463293|P2|NOT COMPLETED|Overall Study||4
8299739|NCT01557517|20463294|P1|NOT COMPLETED|Overall Study||2
8299740|NCT01557517|20463293|P2|COMPLETED|Overall Study||17
8299741|NCT01557517|20463294|P1|COMPLETED|Overall Study||17
8299742|NCT01557517|20463293|P2|STARTED|Overall Study||21
8299743|NCT01557517|20463294|P1|STARTED|Overall Study||19
8299744|NCT01557504|20463320|P2|NOT COMPLETED|Overall Study||0
8299745|NCT01557504|20463321|P1|NOT COMPLETED|Overall Study||1
8299746|NCT01557504|20463320|P2|COMPLETED|Overall Study||12
8299747|NCT01557504|20463321|P1|COMPLETED|Overall Study||12
8299748|NCT01557504|20463320|P2|STARTED|Overall Study||12
8299749|NCT01557504|20463321|P1|STARTED|Overall Study||13
8299750|NCT01557400|20463344|P1|NOT COMPLETED|Overall Study||57
8299751|NCT01557400|20463344|P1|COMPLETED|Overall Study||37
8299752|NCT01557400|20463344|P1|Received at Least 1 Dose of Study Drug|Overall Study||94
8299753|NCT01557400|20463344|P1|STARTED|Overall Study||94
8299754|NCT01557348|20463356|P2|NOT COMPLETED|Overall Study||90
8299755|NCT01557348|20463357|P1|NOT COMPLETED|Overall Study||80
8299756|NCT01557348|20463356|P2|COMPLETED|Overall Study||417
8299757|NCT01557348|20463357|P1|COMPLETED|Overall Study||524
8299758|NCT01557348|20463356|P2|Safety Population|Overall Study||507
8299759|NCT01557348|20463357|P1|Safety Population|Overall Study||604
8299760|NCT01557348|20463356|P2|STARTED|Overall Study||507
8299761|NCT01557348|20463357|P1|STARTED|Overall Study||604
8299762|NCT01557322|20463399|P2|NOT COMPLETED|Overall Study||0
8299763|NCT01557322|20463400|P1|NOT COMPLETED|Overall Study||0
8299764|NCT01557322|20463399|P2|COMPLETED|Overall Study||1543
8299765|NCT01557322|20463400|P1|COMPLETED|Overall Study||211
8299766|NCT01557322|20463399|P2|STARTED|Overall Study||1543
8299767|NCT01557322|20463400|P1|STARTED|Overall Study||211
8299768|NCT01557283|20463474|P1|NOT COMPLETED|Overall Study||44
8299769|NCT01557283|20463474|P1|COMPLETED|Overall Study||96
8299770|NCT01557283|20463474|P1|STARTED|Overall Study||140
8299771|NCT01557166|20463486|P2|NOT COMPLETED|Overall Study||37
8299772|NCT01557166|20463487|P1|NOT COMPLETED|Overall Study||46
8299773|NCT01557166|20463486|P2|COMPLETED|Overall Study||142
8299774|NCT01557166|20463487|P1|COMPLETED|Overall Study||134
8299775|NCT01557166|20463486|P2|Exposed|Overall Study||179
8299776|NCT01557166|20463487|P1|Exposed|Overall Study||176
8299777|NCT01557166|20463486|P2|STARTED|Overall Study||179
8299778|NCT01557166|20463487|P1|STARTED|Overall Study||180
8299779|NCT01556997|20463502|P3|NOT COMPLETED|Overall Study||32
8299780|NCT01556997|20463503|P2|NOT COMPLETED|Overall Study||28
8299781|NCT01556997|20463504|P1|NOT COMPLETED|Overall Study||26
8299782|NCT01556997|20463502|P3|COMPLETED|Overall Study||246
8299783|NCT01556997|20463503|P2|COMPLETED|Overall Study||252
8299784|NCT01556997|20463504|P1|COMPLETED|Overall Study||253
8299785|NCT01556997|20463502|P3|STARTED|Overall Study||278
8299786|NCT01556997|20463503|P2|STARTED|Overall Study||280
8299787|NCT01556997|20463504|P1|STARTED|Overall Study||279
8299788|NCT01556932|20463515|P2|NOT COMPLETED|Second Treament||0
8299789|NCT01556932|20463516|P1|NOT COMPLETED|Second Treament||0
8299790|NCT01556932|20463515|P2|COMPLETED|Second Treament||8
8299791|NCT01556932|20463516|P1|COMPLETED|Second Treament||12
8299792|NCT01556932|20463515|P2|Recieved|Second Treament||8
8299793|NCT01556932|20463516|P1|Recieved|Second Treament||12
8299794|NCT01556932|20463515|P2|STARTED|Second Treament||8
8299795|NCT01556932|20463516|P1|STARTED|Second Treament||12
8299796|NCT01556932|20463515|P2|NOT COMPLETED|Time Point 60 Minutes||1
8299797|NCT01556932|20463516|P1|NOT COMPLETED|Time Point 60 Minutes||1
8299798|NCT01556932|20463515|P2|COMPLETED|Time Point 60 Minutes||8
8299799|NCT01556932|20463516|P1|COMPLETED|Time Point 60 Minutes||12
8299800|NCT01556932|20463515|P2|Recieved|Time Point 60 Minutes||8
8299801|NCT01556932|20463516|P1|Recieved|Time Point 60 Minutes||12
8299802|NCT01556932|20463515|P2|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
8299803|NCT01556932|20463516|P1|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
8299804|NCT01556932|20463515|P2|NOT COMPLETED|Baseline First Treatment||0
8299805|NCT01556932|20463516|P1|NOT COMPLETED|Baseline First Treatment||0
8299806|NCT01556932|20463515|P2|COMPLETED|Baseline First Treatment||9
8299807|NCT01556932|20463516|P1|COMPLETED|Baseline First Treatment||13
8299808|NCT01556932|20463515|P2|Recieved|Baseline First Treatment||9
8299809|NCT01556932|20463516|P1|Recieved|Baseline First Treatment||13
8299810|NCT01556932|20463515|P2|STARTED|Baseline First Treatment||9
8299811|NCT01556932|20463516|P1|STARTED|Baseline First Treatment||13
8299812|NCT01556906|20463521|P1|NOT COMPLETED|Overall Study||0
8299813|NCT01556906|20463521|P1|COMPLETED|Overall Study||6
8299814|NCT01556906|20463521|P1|STARTED|Overall Study||6
8299815|NCT01556763|20463542|P3|NOT COMPLETED|Overall Study||0
8299816|NCT01556763|20463543|P2|NOT COMPLETED|Overall Study||1
8299817|NCT01556763|20463544|P1|NOT COMPLETED|Overall Study||0
8299818|NCT01556763|20463542|P3|COMPLETED|Overall Study||8
8299819|NCT01556763|20463543|P2|COMPLETED|Overall Study||8
8299820|NCT01556763|20463544|P1|COMPLETED|Overall Study||4
8299821|NCT01556763|20463542|P3|STARTED|Overall Study||8
8299822|NCT01556763|20463543|P2|STARTED|Overall Study||9
8299823|NCT01556763|20463544|P1|STARTED|Overall Study||4
8299824|NCT01556724|20463582|P2|NOT COMPLETED|Overall Study||0
8299825|NCT01556724|20463583|P1|NOT COMPLETED|Overall Study||0
8299826|NCT01556724|20463582|P2|COMPLETED|Overall Study||14
8299827|NCT01556724|20463583|P1|COMPLETED|Overall Study||16
8299828|NCT01556724|20463582|P2|STARTED|Overall Study||14
8299829|NCT01556724|20463583|P1|STARTED|Overall Study||16
8299830|NCT01556633|20463599|P2|NOT COMPLETED|Overall Study||0
8299831|NCT01556633|20463600|P1|NOT COMPLETED|Overall Study||0
8299832|NCT01556633|20463599|P2|COMPLETED|Overall Study||6
8299833|NCT01556633|20463600|P1|COMPLETED|Overall Study||10
8299834|NCT01556633|20463599|P2|STARTED|Overall Study||6
8299835|NCT01556633|20463600|P1|STARTED|Overall Study||10
8299836|NCT01556594|20463625|P3|NOT COMPLETED|Overall Study||0
8299837|NCT01556594|20463626|P2|NOT COMPLETED|Overall Study||0
8299838|NCT01556594|20463627|P1|NOT COMPLETED|Overall Study||0
8299839|NCT01556594|20463625|P3|COMPLETED|Overall Study||6
8299840|NCT01556594|20463626|P2|COMPLETED|Overall Study||2
8299841|NCT01556594|20463627|P1|COMPLETED|Overall Study||10
8299842|NCT01556594|20463625|P3|STARTED|Overall Study||6
8299843|NCT01556594|20463626|P2|STARTED|Overall Study||2
8299844|NCT01556594|20463627|P1|STARTED|Overall Study||10
8299845|NCT01556581|20463663|P2|NOT COMPLETED|Overall Study||0
8299846|NCT01556581|20463664|P1|NOT COMPLETED|Overall Study||0
8299847|NCT01556581|20463663|P2|COMPLETED|Overall Study||58
8299848|NCT01556581|20463664|P1|COMPLETED|Overall Study||61
8299849|NCT01556581|20463663|P2|STARTED|Overall Study||58
8299850|NCT01556581|20463664|P1|STARTED|Overall Study||61
8299851|NCT01556451|20463674|P1|NOT COMPLETED|Overall Study||0
8299852|NCT01556451|20463674|P1|COMPLETED|Overall Study||180
8299853|NCT01556451|20463674|P1|STARTED|Overall Study||180
8299854|NCT01556438|20463683|P2|NOT COMPLETED|Overall Study||11
8299855|NCT01556438|20463684|P1|NOT COMPLETED|Overall Study||4
8299856|NCT01556438|20463683|P2|COMPLETED|Overall Study||1
8299857|NCT01556438|20463684|P1|COMPLETED|Overall Study||0
8299858|NCT01556438|20463683|P2|Received BTZ SC|Overall Study||8
8299859|NCT01556438|20463684|P1|Received BTZ SC|Overall Study||0
8299860|NCT01556438|20463683|P2|Received BTZ IV|Overall Study||4
8299861|NCT01556438|20463684|P1|Received BTZ IV|Overall Study||4
8299862|NCT01556438|20463683|P2|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12
8299863|NCT01556438|20463684|P1|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4
8299864|NCT01556438|20463683|P2|STARTED|Overall Study||12
8299865|NCT01556438|20463684|P1|STARTED|Overall Study||4
8299866|NCT01556425|20463713|P4|NOT COMPLETED|Overall Study||0
8299867|NCT01556425|20463714|P3|NOT COMPLETED|Overall Study||0
8299868|NCT01556425|20463715|P2|NOT COMPLETED|Overall Study||0
8299869|NCT01556425|20463716|P1|NOT COMPLETED|Overall Study||0
8299870|NCT01556425|20463713|P4|COMPLETED|Overall Study||18
8299871|NCT01556425|20463714|P3|COMPLETED|Overall Study||18
8299872|NCT01556425|20463715|P2|COMPLETED|Overall Study||23
8299873|NCT01556425|20463716|P1|COMPLETED|Overall Study||25
8299874|NCT01556425|20463713|P4|STARTED|Overall Study||18
8299875|NCT01556425|20463714|P3|STARTED|Overall Study||18
8299876|NCT01556425|20463715|P2|STARTED|Overall Study||23
8299877|NCT01556425|20463716|P1|STARTED|Overall Study||25
8299878|NCT01556347|20463730|P1|NOT COMPLETED|Recovery Phase||0
8299879|NCT01556347|20463730|P1|COMPLETED|Recovery Phase||2
8299880|NCT01556347|20463730|P1|STARTED|Recovery Phase||2
8299881|NCT01556347|20463730|P1|NOT COMPLETED|Bortezomib Treatment Phase||0
8299882|NCT01556347|20463730|P1|COMPLETED|Bortezomib Treatment Phase||2
8299883|NCT01556347|20463730|P1|STARTED|Bortezomib Treatment Phase||2
8299884|NCT01556347|20463730|P1|NOT COMPLETED|Induction Immunotherapy||0
8299885|NCT01556347|20463730|P1|COMPLETED|Induction Immunotherapy||2
8299886|NCT01556347|20463730|P1|STARTED|Induction Immunotherapy||2
8299887|NCT01556204|20463760|P2|NOT COMPLETED|Overall Study||0
8299888|NCT01556204|20463761|P1|NOT COMPLETED|Overall Study||0
8299889|NCT01556204|20463760|P2|COMPLETED|Overall Study||38
8299890|NCT01556204|20463761|P1|COMPLETED|Overall Study||35
8299891|NCT01556204|20463760|P2|STARTED|Overall Study||38
8299892|NCT01556204|20463761|P1|STARTED|Overall Study||35
8299893|NCT01556165|20463771|P2|NOT COMPLETED|Overall Study||7
8299894|NCT01556165|20463772|P1|NOT COMPLETED|Overall Study||12
8299895|NCT01556165|20463771|P2|COMPLETED|Overall Study||58
8299896|NCT01556165|20463772|P1|COMPLETED|Overall Study||53
8299897|NCT01556165|20463771|P2|STARTED|Overall Study||65
8299898|NCT01556165|20463772|P1|STARTED|Overall Study||65
8299899|NCT01556100|20463784|P1|NOT COMPLETED|Overall Study||6
8299900|NCT01556100|20463784|P1|COMPLETED|Overall Study||34
8299901|NCT01556100|20463784|P1|STARTED|Overall Study||40
8299902|NCT01556061|20463791|P2|NOT COMPLETED|Overall Study||0
8299903|NCT01556061|20463792|P1|NOT COMPLETED|Overall Study||0
8299904|NCT01556061|20463791|P2|COMPLETED|Overall Study||25
8299905|NCT01556061|20463792|P1|COMPLETED|Overall Study||25
8299906|NCT01556061|20463791|P2|STARTED|Overall Study||25
8299907|NCT01556061|20463792|P1|STARTED|Overall Study||25
8299908|NCT01556009|20463804|P2|NOT COMPLETED|Overall Study||0
8299909|NCT01556009|20463805|P1|NOT COMPLETED|Overall Study||0
8299910|NCT01556009|20463804|P2|COMPLETED|Overall Study||0
8299911|NCT01556009|20463805|P1|COMPLETED|Overall Study||0
8299912|NCT01556009|20463804|P2|STARTED|Overall Study||0
8299913|NCT01556009|20463805|P1|STARTED|Overall Study||0
8299914|NCT01555983|20463813|P6|NOT COMPLETED|Overall Study||1
8299915|NCT01555983|20463814|P5|NOT COMPLETED|Overall Study||1
8299916|NCT01555983|20463815|P4|NOT COMPLETED|Overall Study||0
8299917|NCT01555983|20463816|P3|NOT COMPLETED|Overall Study||0
8299918|NCT01555983|20463817|P2|NOT COMPLETED|Overall Study||0
8299919|NCT01555983|20463818|P1|NOT COMPLETED|Overall Study||1
8299920|NCT01555983|20463813|P6|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
8299921|NCT01555983|20463814|P5|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
8299922|NCT01555983|20463815|P4|COMPLETED|Overall Study||7
8299923|NCT01555983|20463816|P3|COMPLETED|Overall Study||7
8299924|NCT01555983|20463817|P2|COMPLETED|Overall Study||7
8299925|NCT01555983|20463818|P1|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
8299926|NCT01555983|20463813|P6|STARTED|Overall Study||7
8299927|NCT01555983|20463814|P5|STARTED|Overall Study||5
8299928|NCT01555983|20463815|P4|STARTED|Overall Study||7
8299929|NCT01555983|20463816|P3|STARTED|Overall Study||7
8299930|NCT01555983|20463817|P2|STARTED|Overall Study||7
8299931|NCT01555983|20463818|P1|STARTED|Overall Study||9
8299932|NCT01555957|20463828|P2|NOT COMPLETED|Overall Study||0
8299933|NCT01555957|20463829|P1|NOT COMPLETED|Overall Study||0
8299934|NCT01555957|20463828|P2|COMPLETED|Overall Study||20
8299935|NCT01555957|20463829|P1|COMPLETED|Overall Study||20
8299936|NCT01555957|20463828|P2|STARTED|Overall Study||20
8299937|NCT01555957|20463829|P1|STARTED|Overall Study||20
8299938|NCT01555931|20463839|P2|NOT COMPLETED|Overall Study||5
8299939|NCT01555931|20463840|P1|NOT COMPLETED|Overall Study||2
8299940|NCT01555931|20463839|P2|COMPLETED|Overall Study||13
8299941|NCT01555931|20463840|P1|COMPLETED|Overall Study||15
8299942|NCT01555931|20463839|P2|STARTED|Overall Study||18
8299943|NCT01555931|20463840|P1|STARTED|Overall Study||17
8299944|NCT01555762|20463848|P1|NOT COMPLETED|Overall Study||274
8299945|NCT01555762|20463848|P1|COMPLETED|Overall Study||128
8299946|NCT01555762|20463848|P1|Efficacy Population|Overall Study||358
8299947|NCT01555762|20463848|P1|Safety Population|Overall Study||383
8299948|NCT01555762|20463848|P1|STARTED|Overall Study||402
8299949|NCT01555697|20463866|P8|NOT COMPLETED|Overall Study||0
8299950|NCT01555697|20463867|P7|NOT COMPLETED|Overall Study||0
8299951|NCT01555697|20463868|P6|NOT COMPLETED|Overall Study||0
8299952|NCT01555697|20463869|P5|NOT COMPLETED|Overall Study||0
8299953|NCT01555697|20463870|P4|NOT COMPLETED|Overall Study||0
8299954|NCT01555697|20463871|P3|NOT COMPLETED|Overall Study||0
8299955|NCT01555697|20463872|P2|NOT COMPLETED|Overall Study||0
8299956|NCT01555697|20463873|P1|NOT COMPLETED|Overall Study||0
8299957|NCT01555697|20463866|P8|COMPLETED|Overall Study||10
8299958|NCT01555697|20463867|P7|COMPLETED|Overall Study||10
8299959|NCT01555697|20463868|P6|COMPLETED|Overall Study||10
8299960|NCT01555697|20463869|P5|COMPLETED|Overall Study||10
8299961|NCT01555697|20463870|P4|COMPLETED|Overall Study||10
8299962|NCT01555697|20463871|P3|COMPLETED|Overall Study||10
8299963|NCT01555697|20463872|P2|COMPLETED|Overall Study||10
8299964|NCT01555697|20463873|P1|COMPLETED|Overall Study||10
8299965|NCT01555697|20463866|P8|6 Hours Lab Testing Day 2|Overall Study||10
8299966|NCT01555697|20463867|P7|6 Hours Lab Testing Day 2|Overall Study||10
8299967|NCT01555697|20463868|P6|6 Hours Lab Testing Day 2|Overall Study||10
8299968|NCT01555697|20463869|P5|6 Hours Lab Testing Day 2|Overall Study||10
8299969|NCT01555697|20463870|P4|6 Hours Lab Testing Day 2|Overall Study||10
8299970|NCT01555697|20463871|P3|6 Hours Lab Testing Day 2|Overall Study||10
8299971|NCT01555697|20463872|P2|6 Hours Lab Testing Day 2|Overall Study||10
8299972|NCT01555697|20463873|P1|6 Hours Lab Testing Day 2|Overall Study||10
8299973|NCT01555697|20463866|P8|Approx 7 Day Washout|Overall Study||10
8299974|NCT01555697|20463867|P7|Approx 7 Day Washout|Overall Study||10
8299975|NCT01555697|20463868|P6|Approx 7 Day Washout|Overall Study||10
8299976|NCT01555697|20463869|P5|Approx 7 Day Washout|Overall Study||10
8299977|NCT01555697|20463870|P4|Approx 7 Day Washout|Overall Study||10
8299978|NCT01555697|20463871|P3|Approx 7 Day Washout|Overall Study||10
8299979|NCT01555697|20463872|P2|Approx 7 Day Washout|Overall Study||10
8299980|NCT01555697|20463873|P1|Approx 7 Day Washout|Overall Study||10
8299981|NCT01555697|20463866|P8|6 Hours Lab Testing Day 1|Overall Study||10
8299982|NCT01555697|20463867|P7|6 Hours Lab Testing Day 1|Overall Study||10
8299983|NCT01555697|20463868|P6|6 Hours Lab Testing Day 1|Overall Study||10
8299984|NCT01555697|20463869|P5|6 Hours Lab Testing Day 1|Overall Study||10
8299985|NCT01555697|20463870|P4|6 Hours Lab Testing Day 1|Overall Study||10
8299986|NCT01555697|20463871|P3|6 Hours Lab Testing Day 1|Overall Study||10
8299987|NCT01555697|20463872|P2|6 Hours Lab Testing Day 1|Overall Study||10
8299988|NCT01555697|20463873|P1|6 Hours Lab Testing Day 1|Overall Study||10
8299989|NCT01555697|20463866|P8|STARTED|Overall Study||10
8299990|NCT01555697|20463867|P7|STARTED|Overall Study||10
8299991|NCT01555697|20463868|P6|STARTED|Overall Study||10
8299992|NCT01555697|20463869|P5|STARTED|Overall Study||10
8299993|NCT01555697|20463870|P4|STARTED|Overall Study||10
8299994|NCT01555697|20463871|P3|STARTED|Overall Study||10
8299995|NCT01555697|20463872|P2|STARTED|Overall Study||10
8299996|NCT01555697|20463873|P1|STARTED|Overall Study||10
8299997|NCT01555567|20463897|P4|NOT COMPLETED|Return to Activity||1
8299998|NCT01555567|20463898|P3|NOT COMPLETED|Return to Activity||0
8299999|NCT01555567|20463899|P2|NOT COMPLETED|Return to Activity||2
8300000|NCT01555567|20463900|P1|NOT COMPLETED|Return to Activity||1
8300001|NCT01555567|20463897|P4|COMPLETED|Return to Activity||8
8300002|NCT01555567|20463898|P3|COMPLETED|Return to Activity||8
8300003|NCT01555567|20463899|P2|COMPLETED|Return to Activity||10
8300004|NCT01555567|20463900|P1|COMPLETED|Return to Activity||10
8300005|NCT01555567|20463897|P4|STARTED|Return to Activity||9
8300006|NCT01555567|20463898|P3|STARTED|Return to Activity||8
8300007|NCT01555567|20463899|P2|STARTED|Return to Activity||12
8300008|NCT01555567|20463900|P1|STARTED|Return to Activity||11
8300009|NCT01555567|20463897|P4|NOT COMPLETED|12 Week||0
8300010|NCT01555567|20463898|P3|NOT COMPLETED|12 Week||1
8300011|NCT01555567|20463899|P2|NOT COMPLETED|12 Week||1
8300012|NCT01555567|20463900|P1|NOT COMPLETED|12 Week||1
8300013|NCT01555567|20463897|P4|COMPLETED|12 Week||9
8300014|NCT01555567|20463898|P3|COMPLETED|12 Week||8
8300015|NCT01555567|20463899|P2|COMPLETED|12 Week||12
8300016|NCT01555567|20463900|P1|COMPLETED|12 Week||11
8300017|NCT01555567|20463897|P4|STARTED|12 Week||9
8300018|NCT01555567|20463898|P3|STARTED|12 Week||9
8300019|NCT01555567|20463899|P2|STARTED|12 Week||13
8300020|NCT01555567|20463900|P1|STARTED|12 Week||12
8300030|NCT01555489|20463921|P1|NOT COMPLETED|Overall Study||0
8300031|NCT01555489|20463921|P1|COMPLETED|Overall Study||11
8300032|NCT01555489|20463921|P1|STARTED|Overall Study||11
8300033|NCT01555463|20463928|P2|NOT COMPLETED|Follow up||45
8300034|NCT01555463|20463929|P1|NOT COMPLETED|Follow up||38
8300035|NCT01555463|20463928|P2|COMPLETED|Follow up||394
8300036|NCT01555463|20463929|P1|COMPLETED|Follow up||409
8300037|NCT01555463|20463928|P2|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
8300038|NCT01555463|20463929|P1|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
8300039|NCT01555463|20463928|P2|NOT COMPLETED|Treatment||79
8300040|NCT01555463|20463929|P1|NOT COMPLETED|Treatment||64
8300041|NCT01555463|20463928|P2|COMPLETED|Treatment||399
8300042|NCT01555463|20463929|P1|COMPLETED|Treatment||419
8300043|NCT01555463|20463928|P2|STARTED|Treatment||478
8300044|NCT01555463|20463929|P1|STARTED|Treatment||483
8300045|NCT01555164|20463971|P2|NOT COMPLETED|Overall Study||35
8300046|NCT01555164|20463972|P1|NOT COMPLETED|Overall Study||40
8300047|NCT01555164|20463971|P2|COMPLETED|Overall Study||185
8300048|NCT01555164|20463972|P1|COMPLETED|Overall Study||182
8300049|NCT01555164|20463971|P2|STARTED|Overall Study||220
8300050|NCT01555164|20463972|P1|STARTED|Overall Study||222
8300051|NCT01555151|20463986|P4|NOT COMPLETED|Overall Study||10
8300052|NCT01555151|20463987|P3|NOT COMPLETED|Overall Study||6
8300053|NCT01555151|20463988|P2|NOT COMPLETED|Overall Study||8
8300054|NCT01555151|20463989|P1|NOT COMPLETED|Overall Study||13
8300055|NCT01555151|20463986|P4|COMPLETED|Overall Study||176
8300056|NCT01555151|20463987|P3|COMPLETED|Overall Study||178
8300057|NCT01555151|20463988|P2|COMPLETED|Overall Study||173
8300058|NCT01555151|20463989|P1|COMPLETED|Overall Study||175
8300059|NCT01555151|20463986|P4|Safety Set (SAF)|Overall Study||186
8300060|NCT01555151|20463987|P3|Safety Set (SAF)|Overall Study||183
8300061|NCT01555151|20463988|P2|Safety Set (SAF)|Overall Study||180
8300062|NCT01555151|20463989|P1|Safety Set (SAF)|Overall Study||186
8300063|NCT01555151|20463986|P4|STARTED|Overall Study||186
8300064|NCT01555151|20463987|P3|STARTED|Overall Study||184
8300065|NCT01555151|20463988|P2|STARTED|Overall Study||181
8300066|NCT01555151|20463989|P1|STARTED|Overall Study||188
8300067|NCT01555138|20464042|P2|NOT COMPLETED|Overall Study||38
8300068|NCT01555138|20464043|P1|NOT COMPLETED|Overall Study||47
8300069|NCT01555138|20464042|P2|COMPLETED|Overall Study||250
8300070|NCT01555138|20464043|P1|COMPLETED|Overall Study||246
8300071|NCT01555138|20464042|P2|STARTED|Overall Study||288
8300072|NCT01555138|20464043|P1|STARTED|Overall Study||293
8300073|NCT01555125|20464072|P5|NOT COMPLETED|Follow-Up Period||0
8300074|NCT01555125|20464073|P4|NOT COMPLETED|Follow-Up Period||1
8300075|NCT01555125|20464074|P3|NOT COMPLETED|Follow-Up Period||1
8300076|NCT01555125|20464075|P2|NOT COMPLETED|Follow-Up Period||1
8300077|NCT01555125|20464076|P1|NOT COMPLETED|Follow-Up Period||4
8300078|NCT01555125|20464072|P5|COMPLETED|Follow-Up Period||0
8300079|NCT01555125|20464073|P4|COMPLETED|Follow-Up Period||17
8300080|NCT01555125|20464074|P3|COMPLETED|Follow-Up Period||18
8300081|NCT01555125|20464075|P2|COMPLETED|Follow-Up Period||30
8300082|NCT01555125|20464076|P1|COMPLETED|Follow-Up Period||32
8300083|NCT01555125|20464072|P5|STARTED|Follow-Up Period||0
8300084|NCT01555125|20464073|P4|STARTED|Follow-Up Period||18
8300085|NCT01555125|20464074|P3|STARTED|Follow-Up Period||19
8300086|NCT01555125|20464075|P2|STARTED|Follow-Up Period||31
8300087|NCT01555125|20464076|P1|STARTED|Follow-Up Period||36
8300088|NCT01555125|20464072|P5|NOT COMPLETED|Extension||0
8300089|NCT01555125|20464073|P4|NOT COMPLETED|Extension||22
8300090|NCT01555125|20464074|P3|NOT COMPLETED|Extension||23
8300091|NCT01555125|20464075|P2|NOT COMPLETED|Extension||51
8300092|NCT01555125|20464076|P1|NOT COMPLETED|Extension||45
8300093|NCT01555125|20464072|P5|COMPLETED|Extension||0
8300094|NCT01555125|20464073|P4|COMPLETED|Extension||1
8300095|NCT01555125|20464074|P3|COMPLETED|Extension||0
8300096|NCT01555125|20464075|P2|COMPLETED|Extension||0
8300097|NCT01555125|20464076|P1|COMPLETED|Extension||1
8300098|NCT01555125|20464072|P5|STARTED|Extension||0
8300099|NCT01555125|20464073|P4|STARTED|Extension||23
8300100|NCT01555125|20464074|P3|STARTED|Extension||23
8300101|NCT01555125|20464075|P2|STARTED|Extension||51
8300102|NCT01555125|20464076|P1|STARTED|Extension||46
8300103|NCT01555125|20464072|P5|NOT COMPLETED|Maintenance Period||0
8300104|NCT01555125|20464073|P4|NOT COMPLETED|Maintenance Period||2
8300105|NCT01555125|20464074|P3|NOT COMPLETED|Maintenance Period||4
8300106|NCT01555125|20464075|P2|NOT COMPLETED|Maintenance Period||4
8300107|NCT01555125|20464076|P1|NOT COMPLETED|Maintenance Period||10
8300108|NCT01555125|20464072|P5|COMPLETED|Maintenance Period||0
8300109|NCT01555125|20464073|P4|COMPLETED|Maintenance Period||25
8300110|NCT01555125|20464074|P3|COMPLETED|Maintenance Period||25
8300111|NCT01555125|20464075|P2|COMPLETED|Maintenance Period||52
8300112|NCT01555125|20464076|P1|COMPLETED|Maintenance Period||48
8300113|NCT01555125|20464072|P5|STARTED|Maintenance Period||0
8300114|NCT01555125|20464073|P4|STARTED|Maintenance Period||27
8300115|NCT01555125|20464074|P3|STARTED|Maintenance Period||29
8300116|NCT01555125|20464075|P2|STARTED|Maintenance Period||56
8300117|NCT01555125|20464076|P1|STARTED|Maintenance Period||58
8300118|NCT01555125|20464072|P5|NOT COMPLETED|Induction Period||3
8300119|NCT01555125|20464073|P4|NOT COMPLETED|Induction Period||0
8300120|NCT01555125|20464074|P3|NOT COMPLETED|Induction Period||0
8300121|NCT01555125|20464075|P2|NOT COMPLETED|Induction Period||3
8300122|NCT01555125|20464076|P1|NOT COMPLETED|Induction Period||1
8300123|NCT01555125|20464072|P5|COMPLETED|Induction Period||56
8300124|NCT01555125|20464073|P4|COMPLETED|Induction Period||0
8300125|NCT01555125|20464074|P3|COMPLETED|Induction Period||0
8300126|NCT01555125|20464075|P2|COMPLETED|Induction Period||56
8300127|NCT01555125|20464076|P1|COMPLETED|Induction Period||58
8300128|NCT01555125|20464072|P5|STARTED|Induction Period||59
8300129|NCT01555125|20464073|P4|STARTED|Induction Period||0
8300130|NCT01555125|20464074|P3|STARTED|Induction Period||0
8300131|NCT01555125|20464075|P2|STARTED|Induction Period||59
8300132|NCT01555125|20464076|P1|STARTED|Induction Period||59
8300133|NCT01555073|20464169|P4|NOT COMPLETED|Overall Study||5
8300134|NCT01555073|20464170|P3|NOT COMPLETED|Overall Study||0
8300135|NCT01555073|20464171|P2|NOT COMPLETED|Overall Study||2
8300136|NCT01555073|20464172|P1|NOT COMPLETED|Overall Study||1
8300137|NCT01555073|20464169|P4|COMPLETED|Overall Study||1
8300138|NCT01555073|20464170|P3|COMPLETED|Overall Study||7
8300139|NCT01555073|20464171|P2|COMPLETED|Overall Study||1
8300140|NCT01555073|20464172|P1|COMPLETED|Overall Study||6
8300141|NCT01555073|20464169|P4|STARTED|Overall Study||6
8300142|NCT01555073|20464170|P3|STARTED|Overall Study||7
8300143|NCT01555073|20464171|P2|STARTED|Overall Study||3
8300144|NCT01555073|20464172|P1|STARTED|Overall Study||7
8300145|NCT01555021|20464188|P2|NOT COMPLETED|Overall Study||2
8300146|NCT01555021|20464189|P1|NOT COMPLETED|Overall Study||1
8300147|NCT01555021|20464188|P2|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
8300148|NCT01555021|20464189|P1|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
8300149|NCT01555021|20464188|P2|STARTED|Overall Study||2
8300150|NCT01555021|20464189|P1|STARTED|Overall Study||2
8300151|NCT01554982|20464201|P1|NOT COMPLETED|Overall Study||43
8300152|NCT01554982|20464201|P1|COMPLETED|Overall Study||125
8300153|NCT01554982|20464201|P1|Received Drug|Overall Study||166
8300154|NCT01554982|20464201|P1|STARTED|Overall Study||168
8300155|NCT01554904|20464214|P1|NOT COMPLETED|Overall Study||4
8300156|NCT01554904|20464214|P1|COMPLETED|Overall Study||14
8300157|NCT01554904|20464214|P1|Home Sleep Study 2|Overall Study||14
8300158|NCT01554904|20464214|P1|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
8300159|NCT01554904|20464214|P1|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
8300160|NCT01554904|20464214|P1|Home Sleep Study 1|Overall Study|After informed consent signed.|18
8300161|NCT01554904|20464214|P1|STARTED|Overall Study||18
8300162|NCT01554891|20464222|P3|NOT COMPLETED|Overall Study||2
8300163|NCT01554891|20464223|P2|NOT COMPLETED|Overall Study||5
8300164|NCT01554891|20464224|P1|NOT COMPLETED|Overall Study||7
8300165|NCT01554891|20464222|P3|COMPLETED|Overall Study||55
8300166|NCT01554891|20464223|P2|COMPLETED|Overall Study||115
8300167|NCT01554891|20464224|P1|COMPLETED|Overall Study||98
8300168|NCT01554891|20464222|P3|STARTED|Overall Study||57
8300169|NCT01554891|20464223|P2|STARTED|Overall Study||120
8300170|NCT01554891|20464224|P1|STARTED|Overall Study||105
8300171|NCT01554683|20464232|P6|NOT COMPLETED|Overall Study||0
8300172|NCT01554683|20464233|P5|NOT COMPLETED|Overall Study||0
8300173|NCT01554683|20464234|P4|NOT COMPLETED|Overall Study||0
8300174|NCT01554683|20464235|P3|NOT COMPLETED|Overall Study||0
8300175|NCT01554683|20464236|P2|NOT COMPLETED|Overall Study||0
8300176|NCT01554683|20464237|P1|NOT COMPLETED|Overall Study||0
8300177|NCT01554683|20464232|P6|COMPLETED|Overall Study||0
8300178|NCT01554683|20464233|P5|COMPLETED|Overall Study||1
8300179|NCT01554683|20464234|P4|COMPLETED|Overall Study||2
8300180|NCT01554683|20464235|P3|COMPLETED|Overall Study||3
8300181|NCT01554683|20464236|P2|COMPLETED|Overall Study||1
8300182|NCT01554683|20464237|P1|COMPLETED|Overall Study||2
8300183|NCT01554683|20464232|P6|STARTED|Overall Study||0
8300184|NCT01554683|20464233|P5|STARTED|Overall Study||1
8300185|NCT01554683|20464234|P4|STARTED|Overall Study||2
8300186|NCT01554683|20464235|P3|STARTED|Overall Study||3
8300187|NCT01554683|20464236|P2|STARTED|Overall Study||1
8300188|NCT01554683|20464237|P1|STARTED|Overall Study||2
8300207|NCT01554579|20464312|P2|NOT COMPLETED|Overall Study||27
8300208|NCT01554579|20464313|P1|NOT COMPLETED|Overall Study||10
8300209|NCT01554579|20464312|P2|COMPLETED|Overall Study||58
8300210|NCT01554579|20464313|P1|COMPLETED|Overall Study||76
8300211|NCT01554579|20464312|P2|STARTED|Overall Study||85
8300212|NCT01554579|20464313|P1|STARTED|Overall Study||86
8300213|NCT01554527|20464326|P3|NOT COMPLETED|Overall Study||8
8300214|NCT01554527|20464327|P2|NOT COMPLETED|Overall Study||0
8300215|NCT01554527|20464328|P1|NOT COMPLETED|Overall Study||1
8300216|NCT01554527|20464326|P3|COMPLETED|Overall Study||25
8300217|NCT01554527|20464327|P2|COMPLETED|Overall Study||38
8300218|NCT01554527|20464328|P1|COMPLETED|Overall Study||33
8300219|NCT01554527|20464326|P3|Completed as a Control|Overall Study||1
8300220|NCT01554527|20464327|P2|Completed as a Control|Overall Study||0
8300221|NCT01554527|20464328|P1|Completed as a Control|Overall Study||33
8300222|NCT01554527|20464326|P3|Initiated CPAP Treatment at Home|Overall Study||28
8300223|NCT01554527|20464327|P2|Initiated CPAP Treatment at Home|Overall Study||38
8300224|NCT01554527|20464328|P1|Initiated CPAP Treatment at Home|Overall Study||0
8300225|NCT01554527|20464326|P3|Had CPAP Titration|Overall Study||30
8300226|NCT01554527|20464327|P2|Had CPAP Titration|Overall Study||38
8300227|NCT01554527|20464328|P1|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0
8300228|NCT01554527|20464326|P3|Crossed Over to Control|Overall Study||2
8300229|NCT01554527|20464327|P2|Crossed Over to Control|Overall Study||0
8300230|NCT01554527|20464328|P1|Crossed Over to Control|Overall Study||0
8300231|NCT01554527|20464326|P3|STARTED|Overall Study||33
8300232|NCT01554527|20464327|P2|STARTED|Overall Study||38
8300233|NCT01554527|20464328|P1|STARTED|Overall Study||34
8300234|NCT01554488|20464357|P2|NOT COMPLETED|Overall Study||3
8300235|NCT01554488|20464358|P1|NOT COMPLETED|Overall Study||1
8300236|NCT01554488|20464357|P2|COMPLETED|Overall Study||9
8300237|NCT01554488|20464358|P1|COMPLETED|Overall Study||12
8300238|NCT01554488|20464357|P2|STARTED|Overall Study||12
8300239|NCT01554488|20464358|P1|STARTED|Overall Study||13
8300240|NCT01554241|20464384|P4|NOT COMPLETED|Overall Study||1
8300241|NCT01554241|20464385|P3|NOT COMPLETED|Overall Study||4
8300242|NCT01554241|20464386|P2|NOT COMPLETED|Overall Study||1
8300243|NCT01554241|20464387|P1|NOT COMPLETED|Overall Study||3
8300244|NCT01554241|20464384|P4|COMPLETED|Overall Study||13
8300245|NCT01554241|20464385|P3|COMPLETED|Overall Study||20
8300246|NCT01554241|20464386|P2|COMPLETED|Overall Study||19
8300247|NCT01554241|20464387|P1|COMPLETED|Overall Study||20
8300248|NCT01554241|20464384|P4|STARTED|Overall Study||14
8300249|NCT01554241|20464385|P3|STARTED|Overall Study||24
8300250|NCT01554241|20464386|P2|STARTED|Overall Study||20
8300251|NCT01554241|20464387|P1|STARTED|Overall Study||23
8300252|NCT01554176|20464403|P5|NOT COMPLETED|Run-out Phase||0
8300253|NCT01554176|20464404|P4|NOT COMPLETED|Run-out Phase||1
8300254|NCT01554176|20464405|P3|NOT COMPLETED|Run-out Phase||0
8300255|NCT01554176|20464406|P2|NOT COMPLETED|Run-out Phase||0
8300256|NCT01554176|20464407|P1|NOT COMPLETED|Run-out Phase||0
8300257|NCT01554176|20464403|P5|COMPLETED|Run-out Phase||59
8300258|NCT01554176|20464404|P4|COMPLETED|Run-out Phase||27
8300259|NCT01554176|20464405|P3|COMPLETED|Run-out Phase||29
8300260|NCT01554176|20464406|P2|COMPLETED|Run-out Phase||0
8300261|NCT01554176|20464407|P1|COMPLETED|Run-out Phase||0
8300262|NCT01554176|20464403|P5|Treated|Run-out Phase||59
8300263|NCT01554176|20464404|P4|Treated|Run-out Phase||28
8300264|NCT01554176|20464405|P3|Treated|Run-out Phase||29
8300265|NCT01554176|20464406|P2|Treated|Run-out Phase||0
8300266|NCT01554176|20464407|P1|Treated|Run-out Phase||0
8300267|NCT01554176|20464403|P5|STARTED|Run-out Phase||59
8300268|NCT01554176|20464404|P4|STARTED|Run-out Phase||28
8300269|NCT01554176|20464405|P3|STARTED|Run-out Phase||29
8300270|NCT01554176|20464406|P2|STARTED|Run-out Phase||0
8300271|NCT01554176|20464407|P1|STARTED|Run-out Phase||0
8300272|NCT01554176|20464403|P5|NOT COMPLETED|Treatment Phase||0
8300273|NCT01554176|20464404|P4|NOT COMPLETED|Treatment Phase||0
8300274|NCT01554176|20464405|P3|NOT COMPLETED|Treatment Phase||0
8300275|NCT01554176|20464406|P2|NOT COMPLETED|Treatment Phase||5
8300276|NCT01554176|20464407|P1|NOT COMPLETED|Treatment Phase||8
8300277|NCT01554176|20464403|P5|COMPLETED|Treatment Phase||0
8300278|NCT01554176|20464404|P4|COMPLETED|Treatment Phase||0
8300279|NCT01554176|20464405|P3|COMPLETED|Treatment Phase||0
8300280|NCT01554176|20464406|P2|COMPLETED|Treatment Phase||59
8300281|NCT01554176|20464407|P1|COMPLETED|Treatment Phase||57
8300282|NCT01554176|20464403|P5|Treated|Treatment Phase||0
8300283|NCT01554176|20464404|P4|Treated|Treatment Phase||0
8300284|NCT01554176|20464405|P3|Treated|Treatment Phase||0
8300285|NCT01554176|20464406|P2|Treated|Treatment Phase||64
8300286|NCT01554176|20464407|P1|Treated|Treatment Phase||64
8300287|NCT01554176|20464403|P5|STARTED|Treatment Phase||0
8300288|NCT01554176|20464404|P4|STARTED|Treatment Phase||0
8300289|NCT01554176|20464405|P3|STARTED|Treatment Phase||0
8300290|NCT01554176|20464406|P2|STARTED|Treatment Phase||64
8300291|NCT01554176|20464407|P1|STARTED|Treatment Phase||65
8300292|NCT01554163|20464434|P2|NOT COMPLETED|Overall Study||10
8300293|NCT01554163|20464435|P1|NOT COMPLETED|Overall Study||8
8300294|NCT01554163|20464434|P2|COMPLETED|Overall Study||109
8300295|NCT01554163|20464435|P1|COMPLETED|Overall Study||112
8300296|NCT01554163|20464434|P2|Number Treated|Overall Study||119
8300297|NCT01554163|20464435|P1|Number Treated|Overall Study||119
8300298|NCT01554163|20464434|P2|STARTED|Overall Study||119
8300299|NCT01554163|20464435|P1|STARTED|Overall Study||120
8300300|NCT01553916|20464453|P1|NOT COMPLETED|Overall Study||3
8300301|NCT01553916|20464453|P1|COMPLETED|Overall Study||16
8300302|NCT01553916|20464453|P1|STARTED|Overall Study||19
8300303|NCT01553851|20464470|P1|NOT COMPLETED|Overall Study||3
8300304|NCT01553851|20464470|P1|COMPLETED|Overall Study||17
8300305|NCT01553851|20464470|P1|STARTED|Overall Study||20
8300306|NCT01553747|20464485|P3|NOT COMPLETED|Overall Study||109
8300307|NCT01553747|20464486|P2|NOT COMPLETED|Overall Study||119
8300308|NCT01553747|20464487|P1|NOT COMPLETED|Overall Study||131
8300309|NCT01553747|20464485|P3|COMPLETED|Overall Study||273
8300310|NCT01553747|20464486|P2|COMPLETED|Overall Study||264
8300311|NCT01553747|20464487|P1|COMPLETED|Overall Study||250
8300312|NCT01553747|20464485|P3|Participated in Blinded-Placebo Period|Overall Study||272
8300313|NCT01553747|20464486|P2|Participated in Blinded-Placebo Period|Overall Study||253
8300314|NCT01553747|20464487|P1|Participated in Blinded-Placebo Period|Overall Study||246
8300315|NCT01553747|20464485|P3|Attended Week 26 Visit|Overall Study||278
8300316|NCT01553747|20464486|P2|Attended Week 26 Visit|Overall Study||271
8300317|NCT01553747|20464487|P1|Attended Week 26 Visit|Overall Study||259
8300318|NCT01553747|20464485|P3|Attended Week 12 Visit|Overall Study||312
8300319|NCT01553747|20464486|P2|Attended Week 12 Visit|Overall Study||301
8300320|NCT01553747|20464487|P1|Attended Week 12 Visit|Overall Study||296
8300321|NCT01553747|20464485|P3|STARTED|Overall Study||382
8300322|NCT01553747|20464486|P2|STARTED|Overall Study||383
8300323|NCT01553747|20464487|P1|STARTED|Overall Study||381
8300324|NCT01553708|20464539|P2|NOT COMPLETED|Overall Study||0
8300325|NCT01553708|20464540|P1|NOT COMPLETED|Overall Study||0
8300326|NCT01553708|20464539|P2|COMPLETED|Overall Study||17
8300327|NCT01553708|20464540|P1|COMPLETED|Overall Study||17
8300328|NCT01553708|20464539|P2|STARTED|Overall Study||17
8300329|NCT01553708|20464540|P1|STARTED|Overall Study||17
8300330|NCT01553591|20464549|P3|NOT COMPLETED|Overall Study||158
8300331|NCT01553591|20464550|P2|NOT COMPLETED|Overall Study||169
8300332|NCT01553591|20464551|P1|NOT COMPLETED|Overall Study||172
8300333|NCT01553591|20464549|P3|COMPLETED|Overall Study||269
8300334|NCT01553591|20464550|P2|COMPLETED|Overall Study||257
8300335|NCT01553591|20464551|P1|COMPLETED|Overall Study||257
8300336|NCT01553591|20464549|P3|Attended Week 26 Visit|Overall Study||290
8300337|NCT01553591|20464550|P2|Attended Week 26 Visit|Overall Study||291
8300338|NCT01553591|20464551|P1|Attended Week 26 Visit|Overall Study||289
8300339|NCT01553591|20464549|P3|Attended Week 12 Visit|Overall Study||342
8300340|NCT01553591|20464550|P2|Attended Week 12 Visit|Overall Study||330
8300341|NCT01553591|20464551|P1|Attended Week 12 Visit|Overall Study||341
8300342|NCT01553591|20464549|P3|STARTED|Overall Study||427
8300343|NCT01553591|20464550|P2|STARTED|Overall Study||426
8300344|NCT01553591|20464551|P1|STARTED|Overall Study||429
8300345|NCT01553539|20464601|P1|NOT COMPLETED|Overall Study||0
8300346|NCT01553539|20464601|P1|COMPLETED|Overall Study||20
8300347|NCT01553539|20464601|P1|STARTED|Overall Study||20
8300348|NCT01553318|20464611|P2|NOT COMPLETED|Overall Study||2
8300349|NCT01553318|20464612|P1|NOT COMPLETED|Overall Study||3
8300350|NCT01553318|20464611|P2|COMPLETED|Overall Study||25
8300351|NCT01553318|20464612|P1|COMPLETED|Overall Study||21
8300352|NCT01553318|20464611|P2|STARTED|Overall Study||27
8300353|NCT01553318|20464612|P1|STARTED|Overall Study||24
8300354|NCT01553292|20464624|P1|NOT COMPLETED|Overall Study||0
8300355|NCT01553292|20464624|P1|COMPLETED|Overall Study||21
8300356|NCT01553292|20464624|P1|STARTED|Overall Study||21
8300357|NCT01553279|20464642|P2|NOT COMPLETED|Period 2: Toddler Vaccinations||7
8300358|NCT01553279|20464643|P1|NOT COMPLETED|Period 2: Toddler Vaccinations||3
8300359|NCT01553279|20464642|P2|COMPLETED|Period 2: Toddler Vaccinations||132
8300360|NCT01553279|20464643|P1|COMPLETED|Period 2: Toddler Vaccinations||134
8300361|NCT01553279|20464642|P2|STARTED|Period 2: Toddler Vaccinations||139
8300362|NCT01553279|20464643|P1|STARTED|Period 2: Toddler Vaccinations||137
8300363|NCT01553279|20464642|P2|NOT COMPLETED|Interim Period||2
8300364|NCT01553279|20464643|P1|NOT COMPLETED|Interim Period||3
8300365|NCT01553279|20464642|P2|COMPLETED|Interim Period||139
8300366|NCT01553279|20464643|P1|COMPLETED|Interim Period||137
8300367|NCT01553279|20464642|P2|STARTED|Interim Period||141
8300368|NCT01553279|20464643|P1|STARTED|Interim Period||140
8300369|NCT01553279|20464642|P2|NOT COMPLETED|Part 1 (Infant Vaccinations)||1
8300370|NCT01553279|20464643|P1|NOT COMPLETED|Part 1 (Infant Vaccinations)||2
8300371|NCT01553279|20464642|P2|COMPLETED|Part 1 (Infant Vaccinations)||141
8300372|NCT01553279|20464643|P1|COMPLETED|Part 1 (Infant Vaccinations)||140
8300373|NCT01553279|20464642|P2|STARTED|Part 1 (Infant Vaccinations)||142
8300374|NCT01553279|20464643|P1|STARTED|Part 1 (Infant Vaccinations)||142
8300375|NCT01553240|20464700|P1|NOT COMPLETED|Overall Study||0
8300376|NCT01553240|20464700|P1|COMPLETED|Overall Study||0
8300377|NCT01553240|20464700|P1|STARTED|Overall Study||0
8300378|NCT01553201|20464707|P2|NOT COMPLETED|Overall Study||0
8300379|NCT01553201|20464708|P1|NOT COMPLETED|Overall Study||0
8300380|NCT01553201|20464707|P2|COMPLETED|Overall Study||15
8300381|NCT01553201|20464708|P1|COMPLETED|Overall Study||15
8300382|NCT01553201|20464707|P2|STARTED|Overall Study||15
8300383|NCT01553201|20464708|P1|STARTED|Overall Study||15
8300384|NCT01553188|20464718|P4|NOT COMPLETED|Overall Study||0
8300385|NCT01553188|20464719|P3|NOT COMPLETED|Overall Study||2
8300386|NCT01553188|20464720|P2|NOT COMPLETED|Overall Study||1
8300387|NCT01553188|20464721|P1|NOT COMPLETED|Overall Study||1
8300388|NCT01553188|20464718|P4|COMPLETED|Overall Study||11
8300389|NCT01553188|20464719|P3|COMPLETED|Overall Study||14
8300390|NCT01553188|20464720|P2|COMPLETED|Overall Study||5
8300391|NCT01553188|20464721|P1|COMPLETED|Overall Study||2
8300392|NCT01553188|20464718|P4|STARTED|Overall Study||11
8300393|NCT01553188|20464719|P3|STARTED|Overall Study||16
8300394|NCT01553188|20464720|P2|STARTED|Overall Study||6
8300395|NCT01553188|20464721|P1|STARTED|Overall Study||3
8300396|NCT01553136|20464748|P2|NOT COMPLETED|Overall Study||22
8300397|NCT01553136|20464749|P1|NOT COMPLETED|Overall Study||16
8300398|NCT01553136|20464748|P2|COMPLETED|Overall Study||45
8300399|NCT01553136|20464749|P1|COMPLETED|Overall Study||48
8300400|NCT01553136|20464748|P2|Completed Treatment|Overall Study||52
8300401|NCT01553136|20464749|P1|Completed Treatment|Overall Study||55
8300402|NCT01553136|20464748|P2|STARTED|Overall Study||67
8300403|NCT01553136|20464749|P1|STARTED|Overall Study||64
8300404|NCT01553084|20464766|P3|NOT COMPLETED|Overall Study||35
8300405|NCT01553084|20464767|P2|NOT COMPLETED|Overall Study||13
8300406|NCT01553084|20464768|P1|NOT COMPLETED|Overall Study||15
8300407|NCT01553084|20464766|P3|COMPLETED|Overall Study||389
8300408|NCT01553084|20464767|P2|COMPLETED|Overall Study||408
8300409|NCT01553084|20464768|P1|COMPLETED|Overall Study||226
8300410|NCT01553084|20464766|P3|STARTED|Overall Study||424
8300411|NCT01553084|20464767|P2|STARTED|Overall Study||421
8300412|NCT01553084|20464768|P1|STARTED|Overall Study||241
8300413|NCT01553058|20464787|P3|NOT COMPLETED|Overall Study||3
8300414|NCT01553058|20464788|P2|NOT COMPLETED|Overall Study||1
8300415|NCT01553058|20464789|P1|NOT COMPLETED|Overall Study||1
8300416|NCT01553058|20464787|P3|COMPLETED|Overall Study||30
8300417|NCT01553058|20464788|P2|COMPLETED|Overall Study||30
8300418|NCT01553058|20464789|P1|COMPLETED|Overall Study||32
8300419|NCT01553058|20464787|P3|STARTED|Overall Study||33
8300420|NCT01553058|20464788|P2|STARTED|Overall Study||31
8300421|NCT01553058|20464789|P1|STARTED|Overall Study||33
8300422|NCT01552954|20464850|P2|NOT COMPLETED|Overall Study||6
8300423|NCT01552954|20464851|P1|NOT COMPLETED|Overall Study||5
8300424|NCT01552954|20464850|P2|COMPLETED|Overall Study||119
8300425|NCT01552954|20464851|P1|COMPLETED|Overall Study||126
8300426|NCT01552954|20464850|P2|STARTED|Overall Study||125
8300427|NCT01552954|20464851|P1|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
8300494|NCT01552889|20464966|P2|NOT COMPLETED|Overall Study||5
8300495|NCT01552889|20464967|P1|NOT COMPLETED|Overall Study||11
8300496|NCT01552889|20464966|P2|COMPLETED|Overall Study||95
8300497|NCT01552889|20464967|P1|COMPLETED|Overall Study||90
8300498|NCT01552889|20464966|P2|STARTED|Overall Study||100
8300499|NCT01552889|20464967|P1|STARTED|Overall Study||101
8300500|NCT01552876|20464977|P2|NOT COMPLETED|Overall Study||0
8300501|NCT01552876|20464978|P1|NOT COMPLETED|Overall Study||0
8300502|NCT01552876|20464977|P2|COMPLETED|Overall Study||20
8300503|NCT01552876|20464978|P1|COMPLETED|Overall Study||20
8300504|NCT01552876|20464977|P2|STARTED|Overall Study||20
8300505|NCT01552876|20464978|P1|STARTED|Overall Study||20
8300506|NCT01552772|20464994|P1|NOT COMPLETED|Overall Study||4
8300507|NCT01552772|20464994|P1|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
8300508|NCT01552772|20464994|P1|STARTED|Overall Study||60
8300509|NCT01552694|20465010|P2|NOT COMPLETED|Overall Study||2
8300510|NCT01552694|20465011|P1|NOT COMPLETED|Overall Study||0
8300511|NCT01552694|20465010|P2|COMPLETED|Overall Study||18
8300512|NCT01552694|20465011|P1|COMPLETED|Overall Study||18
8300513|NCT01552694|20465010|P2|STARTED|Overall Study||20
8300514|NCT01552694|20465011|P1|STARTED|Overall Study||18
8300515|NCT01552681|20465027|P2|NOT COMPLETED|Overall Study||1
8300516|NCT01552681|20465028|P1|NOT COMPLETED|Overall Study||5
8300517|NCT01552681|20465027|P2|COMPLETED|Overall Study||18
8300518|NCT01552681|20465028|P1|COMPLETED|Overall Study||28
8300519|NCT01552681|20465027|P2|STARTED|Overall Study||19
8300520|NCT01552681|20465028|P1|STARTED|Overall Study||33
8300521|NCT01552603|20465076|P1|NOT COMPLETED|Overall Study||1
8300522|NCT01552603|20465076|P1|COMPLETED|Overall Study||13
8300523|NCT01552603|20465076|P1|STARTED|Overall Study||14
8300524|NCT01552408|20465083|P2|NOT COMPLETED|Overall Study||2
8300525|NCT01552408|20465084|P1|NOT COMPLETED|Overall Study||4
8300526|NCT01552408|20465083|P2|COMPLETED|Overall Study||18
8300527|NCT01552408|20465084|P1|COMPLETED|Overall Study||16
8300528|NCT01552408|20465083|P2|STARTED|Overall Study||20
8300529|NCT01552408|20465084|P1|STARTED|Overall Study||20
8300540|NCT01552343|20465135|P2|NOT COMPLETED|Overall Study||0
8300541|NCT01552343|20465136|P1|NOT COMPLETED|Overall Study||0
8300542|NCT01552343|20465135|P2|COMPLETED|Overall Study||27
8300543|NCT01552343|20465136|P1|COMPLETED|Overall Study||29
8300544|NCT01552343|20465135|P2|STARTED|Overall Study||27
8300545|NCT01552343|20465136|P1|STARTED|Overall Study||29
8300546|NCT01552213|20465159|P2|NOT COMPLETED|Overall Study||8
8300547|NCT01552213|20465160|P1|NOT COMPLETED|Overall Study||13
8300548|NCT01552213|20465159|P2|COMPLETED|Overall Study||37
8300549|NCT01552213|20465160|P1|COMPLETED|Overall Study||37
8300550|NCT01552213|20465159|P2|Analyzed|Overall Study||41
8300551|NCT01552213|20465160|P1|Analyzed|Overall Study||42
8300552|NCT01552213|20465159|P2|STARTED|Overall Study||45
8300553|NCT01552213|20465160|P1|STARTED|Overall Study||50
8300554|NCT01552057|20465196|P2|NOT COMPLETED|Overall Study||48
8300555|NCT01552057|20465197|P1|NOT COMPLETED|Overall Study||30
8300556|NCT01552057|20465196|P2|COMPLETED|Overall Study||149
8300557|NCT01552057|20465197|P1|COMPLETED|Overall Study||166
8300558|NCT01552057|20465196|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
8300559|NCT01552057|20465197|P1|Received at Least 1 Dose of Study Drug|Overall Study||194
8300560|NCT01552057|20465196|P2|STARTED|Overall Study||197
8300561|NCT01552057|20465197|P1|STARTED|Overall Study||196
8300562|NCT01551979|20465231|P2|NOT COMPLETED|Overall Study||2
8300563|NCT01551979|20465232|P1|NOT COMPLETED|Overall Study||2
8300564|NCT01551979|20465231|P2|COMPLETED|Overall Study||5
8300565|NCT01551979|20465232|P1|COMPLETED|Overall Study||8
8300566|NCT01551979|20465231|P2|1 Week Post Treatment|Overall Study||6
8300567|NCT01551979|20465232|P1|1 Week Post Treatment|Overall Study||10
8300568|NCT01551979|20465231|P2|Last Day of Treatment (After 5 Days)|Overall Study||7
8300569|NCT01551979|20465232|P1|Last Day of Treatment (After 5 Days)|Overall Study||10
8300570|NCT01551979|20465231|P2|STARTED|Overall Study||7
8300571|NCT01551979|20465232|P1|STARTED|Overall Study||10
8300572|NCT01551888|20465248|P2|NOT COMPLETED|Period 2||0
8300573|NCT01551888|20465249|P1|NOT COMPLETED|Period 2||0
8300574|NCT01551888|20465248|P2|COMPLETED|Period 2||12
8300575|NCT01551888|20465249|P1|COMPLETED|Period 2||12
8300576|NCT01551888|20465248|P2|STARTED|Period 2||12
8300577|NCT01551888|20465249|P1|STARTED|Period 2||12
8300578|NCT01551888|20465248|P2|NOT COMPLETED|Period 1||0
8300579|NCT01551888|20465249|P1|NOT COMPLETED|Period 1||0
8300580|NCT01551888|20465248|P2|COMPLETED|Period 1||12
8300581|NCT01551888|20465249|P1|COMPLETED|Period 1||12
8300582|NCT01551888|20465248|P2|STARTED|Period 1||12
8300583|NCT01551888|20465249|P1|STARTED|Period 1||12
8300584|NCT01551758|20465263|P2|NOT COMPLETED|Overall Study||105
8300585|NCT01551758|20465264|P1|NOT COMPLETED|Overall Study||94
8300586|NCT01551758|20465263|P2|COMPLETED|Overall Study||1291
8300587|NCT01551758|20465264|P1|COMPLETED|Overall Study||1309
8300588|NCT01551758|20465263|P2|STARTED|Overall Study||1396
8300589|NCT01551758|20465264|P1|STARTED|Overall Study||1403
8300593|NCT01551693|20465311|P2|NOT COMPLETED|Overall Study||2
8300594|NCT01551693|20465312|P1|NOT COMPLETED|Overall Study||1
8300595|NCT01551693|20465311|P2|COMPLETED|Overall Study||0
8300596|NCT01551693|20465312|P1|COMPLETED|Overall Study||0
8300597|NCT01551693|20465311|P2|STARTED|Overall Study||2
8300598|NCT01551693|20465312|P1|STARTED|Overall Study||1
8300599|NCT01551550|20465324|P2|NOT COMPLETED|Overall Study||1
8300600|NCT01551550|20465325|P1|NOT COMPLETED|Overall Study||0
8300601|NCT01551550|20465324|P2|COMPLETED|Overall Study||40
8300602|NCT01551550|20465325|P1|COMPLETED|Overall Study||41
8300603|NCT01551550|20465324|P2|STARTED|Overall Study||41
8300604|NCT01551550|20465325|P1|STARTED|Overall Study||41
8300605|NCT01551420|20465333|P2|NOT COMPLETED|Home Use (Part B)||1
8300606|NCT01551420|20465334|P1|NOT COMPLETED|Home Use (Part B)||6
8300607|NCT01551420|20465333|P2|COMPLETED|Home Use (Part B)||7
8300608|NCT01551420|20465334|P1|COMPLETED|Home Use (Part B)||18
8300609|NCT01551420|20465333|P2|STARTED|Home Use (Part B)||8
8300610|NCT01551420|20465334|P1|STARTED|Home Use (Part B)||24
8300611|NCT01551420|20465333|P2|NOT COMPLETED|Screened for Part B Eligibility||3
8300612|NCT01551420|20465334|P1|NOT COMPLETED|Screened for Part B Eligibility||9
8300613|NCT01551420|20465333|P2|COMPLETED|Screened for Part B Eligibility||8
8300614|NCT01551420|20465334|P1|COMPLETED|Screened for Part B Eligibility||24
8300615|NCT01551420|20465333|P2|STARTED|Screened for Part B Eligibility||11
8300616|NCT01551420|20465334|P1|STARTED|Screened for Part B Eligibility||33
8300617|NCT01551420|20465333|P2|NOT COMPLETED|In-laboratory (Part A)||2
8300618|NCT01551420|20465334|P1|NOT COMPLETED|In-laboratory (Part A)||6
8300619|NCT01551420|20465333|P2|COMPLETED|In-laboratory (Part A)||11
8300620|NCT01551420|20465334|P1|COMPLETED|In-laboratory (Part A)||33
8300621|NCT01551420|20465333|P2|STARTED|In-laboratory (Part A)||13
8300622|NCT01551420|20465334|P1|STARTED|In-laboratory (Part A)||39
8300623|NCT01551355|20465364|P6|NOT COMPLETED|Overall Study||6
8300624|NCT01551355|20465365|P5|NOT COMPLETED|Overall Study||9
8300625|NCT01551355|20465366|P4|NOT COMPLETED|Overall Study||24
8300626|NCT01551355|20465367|P3|NOT COMPLETED|Overall Study||34
8300627|NCT01551355|20465368|P2|NOT COMPLETED|Overall Study||49
8300628|NCT01551355|20465369|P1|NOT COMPLETED|Overall Study||51
8300629|NCT01551355|20465364|P6|COMPLETED|Overall Study||65
8300630|NCT01551355|20465365|P5|COMPLETED|Overall Study||55
8300631|NCT01551355|20465366|P4|COMPLETED|Overall Study||411
8300632|NCT01551355|20465367|P3|COMPLETED|Overall Study||459
8300633|NCT01551355|20465368|P2|COMPLETED|Overall Study||545
8300634|NCT01551355|20465369|P1|COMPLETED|Overall Study||571
8300635|NCT01551355|20465364|P6|STARTED|Overall Study||71
8300636|NCT01551355|20465365|P5|STARTED|Overall Study||64
8300637|NCT01551355|20465366|P4|STARTED|Overall Study||435
8300638|NCT01551355|20465367|P3|STARTED|Overall Study||493
8300639|NCT01551355|20465368|P2|STARTED|Overall Study||594
8300640|NCT01551355|20465369|P1|STARTED|Overall Study||622
8300641|NCT01551303|20465383|P2|NOT COMPLETED|Overall Study||7
8300642|NCT01551303|20465384|P1|NOT COMPLETED|Overall Study||4
8300643|NCT01551303|20465383|P2|COMPLETED|Overall Study||15
8300644|NCT01551303|20465384|P1|COMPLETED|Overall Study||21
8300645|NCT01551303|20465383|P2|STARTED|Overall Study||22
8300646|NCT01551303|20465384|P1|STARTED|Overall Study||25
8300647|NCT01551212|20465392|P2|NOT COMPLETED|Overall Study||20
8300648|NCT01551212|20465393|P1|NOT COMPLETED|Overall Study||5
8300649|NCT01551212|20465392|P2|COMPLETED|Overall Study||148
8300650|NCT01551212|20465393|P1|COMPLETED|Overall Study||166
8300651|NCT01551212|20465392|P2|Per Protocol Set (PP)|Overall Study||101
8300652|NCT01551212|20465393|P1|Per Protocol Set (PP)|Overall Study||110
8300653|NCT01551212|20465392|P2|Safety Set|Overall Study||164
8300654|NCT01551212|20465393|P1|Safety Set|Overall Study||169
8300655|NCT01551212|20465392|P2|Full Anylsis Set (FAS)|Overall Study||164
8300656|NCT01551212|20465393|P1|Full Anylsis Set (FAS)|Overall Study||169
8300657|NCT01551212|20465392|P2|STARTED|Overall Study||168
8300658|NCT01551212|20465393|P1|STARTED|Overall Study||171
8300659|NCT01551199|20465411|P1|NOT COMPLETED|Overall Study||5
8300660|NCT01551199|20465411|P1|COMPLETED|Overall Study||2
8300661|NCT01551199|20465411|P1|STARTED|Overall Study||7
8300662|NCT01551186|20465419|P2|NOT COMPLETED|Overall Study||13
8300663|NCT01551186|20465420|P1|NOT COMPLETED|Overall Study||20
8300664|NCT01551186|20465419|P2|COMPLETED|Overall Study||40
8300665|NCT01551186|20465420|P1|COMPLETED|Overall Study||30
8300666|NCT01551186|20465419|P2|STARTED|Overall Study||53
8300667|NCT01551186|20465420|P1|STARTED|Overall Study||50
8300668|NCT01551173|20465428|P2|NOT COMPLETED|Overall Study||32
8300669|NCT01551173|20465429|P1|NOT COMPLETED|Overall Study||28
8300670|NCT01551173|20465428|P2|COMPLETED|Overall Study||186
8300671|NCT01551173|20465429|P1|COMPLETED|Overall Study||190
8300672|NCT01551173|20465428|P2|Full Analysis Set (FAS)|Overall Study||214
8300673|NCT01551173|20465429|P1|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
8300674|NCT01551173|20465428|P2|STARTED|Overall Study||218
8300675|NCT01551173|20465429|P1|STARTED|Overall Study|"Started indicates randomized"|218
8300676|NCT01551095|20465440|P1|NOT COMPLETED|Overall Study||0
8300677|NCT01551095|20465440|P1|COMPLETED|Overall Study||7
8300678|NCT01551095|20465440|P1|STARTED|Overall Study||7
8300679|NCT01551082|20465445|P1|NOT COMPLETED|Overall Study||0
8300680|NCT01551082|20465445|P1|COMPLETED|Overall Study||12
8300681|NCT01551082|20465445|P1|STARTED|Overall Study||12
8300682|NCT01551056|20465451|P2|NOT COMPLETED|Overall Study||0
8300683|NCT01551056|20465452|P1|NOT COMPLETED|Overall Study||2
8300684|NCT01551056|20465451|P2|COMPLETED|Overall Study||45
8300685|NCT01551056|20465452|P1|COMPLETED|Overall Study||44
8300686|NCT01551056|20465451|P2|STARTED|Overall Study||45
8300687|NCT01551056|20465452|P1|STARTED|Overall Study||46
8300688|NCT01550965|20465506|P1|NOT COMPLETED|Overall Study||110
8300689|NCT01550965|20465506|P1|COMPLETED|Overall Study||353
8300690|NCT01550965|20465506|P1|STARTED|Overall Study||463
8300691|NCT01550952|20465525|P1|NOT COMPLETED|Overall Study||0
8300692|NCT01550952|20465525|P1|COMPLETED|Overall Study||10
8300693|NCT01550952|20465525|P1|STARTED|Overall Study||10
8300694|NCT01550809|20465535|P2|NOT COMPLETED|Overall Study||0
8300695|NCT01550809|20465536|P1|NOT COMPLETED|Overall Study||0
8300696|NCT01550809|20465535|P2|COMPLETED|Overall Study||6
8300697|NCT01550809|20465536|P1|COMPLETED|Overall Study||6
8300698|NCT01550809|20465535|P2|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
8300699|NCT01550809|20465536|P1|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
8300700|NCT01550757|20465550|P4|NOT COMPLETED|Overall Study||54
8300701|NCT01550757|20465551|P3|NOT COMPLETED|Overall Study||45
8300702|NCT01550757|20465552|P2|NOT COMPLETED|Overall Study||14
8300703|NCT01550757|20465553|P1|NOT COMPLETED|Overall Study||23
8300704|NCT01550757|20465550|P4|COMPLETED|Overall Study||90
8300705|NCT01550757|20465551|P3|COMPLETED|Overall Study||85
8300706|NCT01550757|20465552|P2|COMPLETED|Overall Study||38
8300707|NCT01550757|20465553|P1|COMPLETED|Overall Study||33
8300708|NCT01550757|20465550|P4|STARTED|Overall Study||144
8300709|NCT01550757|20465551|P3|STARTED|Overall Study||130
8300710|NCT01550757|20465552|P2|STARTED|Overall Study||52
8300711|NCT01550757|20465553|P1|STARTED|Overall Study||56
8300712|NCT01550744|20465563|P3|NOT COMPLETED|Double-Blind||67
8300713|NCT01550744|20465564|P2|NOT COMPLETED|Double-Blind||17
8300714|NCT01550744|20465565|P1|NOT COMPLETED|Double-Blind||0
8300715|NCT01550744|20465563|P3|COMPLETED|Double-Blind||235
8300716|NCT01550744|20465564|P2|COMPLETED|Double-Blind||59
8300717|NCT01550744|20465565|P1|COMPLETED|Double-Blind||0
8300718|NCT01550744|20465563|P3|STARTED|Double-Blind||302
8300719|NCT01550744|20465564|P2|STARTED|Double-Blind||76
8300720|NCT01550744|20465565|P1|STARTED|Double-Blind||0
8300721|NCT01550744|20465563|P3|NOT COMPLETED|Open-Label||0
8300722|NCT01550744|20465564|P2|NOT COMPLETED|Open-Label||0
8300723|NCT01550744|20465565|P1|NOT COMPLETED|Open-Label||100
8300724|NCT01550744|20465563|P3|COMPLETED|Open-Label||0
8300725|NCT01550744|20465564|P2|COMPLETED|Open-Label||0
8300726|NCT01550744|20465565|P1|COMPLETED|Open-Label||378
8300727|NCT01550744|20465563|P3|STARTED|Open-Label||0
8300728|NCT01550744|20465564|P2|STARTED|Open-Label||0
8300729|NCT01550744|20465565|P1|STARTED|Open-Label||478
8300730|NCT01550731|20465580|P2|NOT COMPLETED|Overall Study||0
8300731|NCT01550731|20465581|P1|NOT COMPLETED|Overall Study||0
8300732|NCT01550731|20465580|P2|COMPLETED|Overall Study||209
8300733|NCT01550731|20465581|P1|COMPLETED|Overall Study||205
8300734|NCT01550731|20465580|P2|STARTED|Overall Study||209
8300735|NCT01550731|20465581|P1|STARTED|Overall Study||205
8300736|NCT01550705|20465589|P1|NOT COMPLETED|Overall Study||1
8300737|NCT01550705|20465589|P1|COMPLETED|Overall Study||10
8300738|NCT01550705|20465589|P1|STARTED|Overall Study||11
8300739|NCT01550549|20465594|P1|NOT COMPLETED|Overall Study||0
8300740|NCT01550549|20465594|P1|COMPLETED|Overall Study||151
8300741|NCT01550549|20465594|P1|STARTED|Overall Study||151
8300742|NCT01550510|20465608|P2|NOT COMPLETED|Overall Study||0
8300743|NCT01550510|20465609|P1|NOT COMPLETED|Overall Study||0
8300744|NCT01550510|20465608|P2|COMPLETED|Overall Study||0
8300745|NCT01550510|20465609|P1|COMPLETED|Overall Study||4
8300746|NCT01550510|20465608|P2|STARTED|Overall Study||0
8300747|NCT01550510|20465609|P1|STARTED|Overall Study||4
8300748|NCT01550471|20465617|P6|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8300749|NCT01550471|20465618|P5|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8300750|NCT01550471|20465619|P4|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8300751|NCT01550471|20465620|P3|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8300752|NCT01550471|20465621|P2|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8300753|NCT01550471|20465622|P1|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
8300754|NCT01550471|20465617|P6|COMPLETED|Third Wash Out Period (3 Weeks)||3
8300755|NCT01550471|20465618|P5|COMPLETED|Third Wash Out Period (3 Weeks)||4
8300756|NCT01550471|20465619|P4|COMPLETED|Third Wash Out Period (3 Weeks)||4
8300757|NCT01550471|20465620|P3|COMPLETED|Third Wash Out Period (3 Weeks)||3
8300758|NCT01550471|20465621|P2|COMPLETED|Third Wash Out Period (3 Weeks)||4
8300759|NCT01550471|20465622|P1|COMPLETED|Third Wash Out Period (3 Weeks)||3
8300760|NCT01550471|20465617|P6|STARTED|Third Wash Out Period (3 Weeks)||3
8300761|NCT01550471|20465618|P5|STARTED|Third Wash Out Period (3 Weeks)||4
8300762|NCT01550471|20465619|P4|STARTED|Third Wash Out Period (3 Weeks)||4
8300763|NCT01550471|20465620|P3|STARTED|Third Wash Out Period (3 Weeks)||3
8300764|NCT01550471|20465621|P2|STARTED|Third Wash Out Period (3 Weeks)||4
8300765|NCT01550471|20465622|P1|STARTED|Third Wash Out Period (3 Weeks)||3
8300766|NCT01550471|20465617|P6|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8300767|NCT01550471|20465618|P5|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8300768|NCT01550471|20465619|P4|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8300769|NCT01550471|20465620|P3|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8300770|NCT01550471|20465621|P2|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8300771|NCT01550471|20465622|P1|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
8300772|NCT01550471|20465617|P6|COMPLETED|Third Treatment Period (3 Weeks)||3
8300773|NCT01550471|20465618|P5|COMPLETED|Third Treatment Period (3 Weeks)||4
8300774|NCT01550471|20465619|P4|COMPLETED|Third Treatment Period (3 Weeks)||4
8300775|NCT01550471|20465620|P3|COMPLETED|Third Treatment Period (3 Weeks)||3
8300776|NCT01550471|20465621|P2|COMPLETED|Third Treatment Period (3 Weeks)||4
8300777|NCT01550471|20465622|P1|COMPLETED|Third Treatment Period (3 Weeks)||3
8300778|NCT01550471|20465617|P6|STARTED|Third Treatment Period (3 Weeks)||3
8300779|NCT01550471|20465618|P5|STARTED|Third Treatment Period (3 Weeks)||4
8300780|NCT01550471|20465619|P4|STARTED|Third Treatment Period (3 Weeks)||4
8300781|NCT01550471|20465620|P3|STARTED|Third Treatment Period (3 Weeks)||3
8300782|NCT01550471|20465621|P2|STARTED|Third Treatment Period (3 Weeks)||4
8300783|NCT01550471|20465622|P1|STARTED|Third Treatment Period (3 Weeks)||3
8300784|NCT01550471|20465617|P6|NOT COMPLETED|Second Wash Out Period (3 Weeks)||1
8300785|NCT01550471|20465618|P5|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8300786|NCT01550471|20465619|P4|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8300787|NCT01550471|20465620|P3|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8300788|NCT01550471|20465621|P2|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8300789|NCT01550471|20465622|P1|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
8300790|NCT01550471|20465617|P6|COMPLETED|Second Wash Out Period (3 Weeks)||3
8300791|NCT01550471|20465618|P5|COMPLETED|Second Wash Out Period (3 Weeks)||4
8300792|NCT01550471|20465619|P4|COMPLETED|Second Wash Out Period (3 Weeks)||4
8300793|NCT01550471|20465620|P3|COMPLETED|Second Wash Out Period (3 Weeks)||3
8300794|NCT01550471|20465621|P2|COMPLETED|Second Wash Out Period (3 Weeks)||4
8300795|NCT01550471|20465622|P1|COMPLETED|Second Wash Out Period (3 Weeks)||3
8300796|NCT01550471|20465617|P6|STARTED|Second Wash Out Period (3 Weeks)||4
8300797|NCT01550471|20465618|P5|STARTED|Second Wash Out Period (3 Weeks)||4
8300798|NCT01550471|20465619|P4|STARTED|Second Wash Out Period (3 Weeks)||4
8300799|NCT01550471|20465620|P3|STARTED|Second Wash Out Period (3 Weeks)||3
8300800|NCT01550471|20465621|P2|STARTED|Second Wash Out Period (3 Weeks)||4
8300801|NCT01550471|20465622|P1|STARTED|Second Wash Out Period (3 Weeks)||3
8300802|NCT01550471|20465617|P6|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8300803|NCT01550471|20465618|P5|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8300804|NCT01550471|20465619|P4|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8300805|NCT01550471|20465620|P3|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8300806|NCT01550471|20465621|P2|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8300807|NCT01550471|20465622|P1|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
8300808|NCT01550471|20465617|P6|COMPLETED|Second Treatment Period (3 Weeks)||4
8300809|NCT01550471|20465618|P5|COMPLETED|Second Treatment Period (3 Weeks)||4
8300810|NCT01550471|20465619|P4|COMPLETED|Second Treatment Period (3 Weeks)||4
8300811|NCT01550471|20465620|P3|COMPLETED|Second Treatment Period (3 Weeks)||3
8300812|NCT01550471|20465621|P2|COMPLETED|Second Treatment Period (3 Weeks)||4
8300813|NCT01550471|20465622|P1|COMPLETED|Second Treatment Period (3 Weeks)||3
8300814|NCT01550471|20465617|P6|STARTED|Second Treatment Period (3 Weeks)||4
8300815|NCT01550471|20465618|P5|STARTED|Second Treatment Period (3 Weeks)||4
8300816|NCT01550471|20465619|P4|STARTED|Second Treatment Period (3 Weeks)||4
8300817|NCT01550471|20465620|P3|STARTED|Second Treatment Period (3 Weeks)||3
8300818|NCT01550471|20465621|P2|STARTED|Second Treatment Period (3 Weeks)||4
8300819|NCT01550471|20465622|P1|STARTED|Second Treatment Period (3 Weeks)||3
8300820|NCT01550471|20465617|P6|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8300821|NCT01550471|20465618|P5|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8300822|NCT01550471|20465619|P4|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8300823|NCT01550471|20465620|P3|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8300824|NCT01550471|20465621|P2|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8300825|NCT01550471|20465622|P1|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
8300826|NCT01550471|20465617|P6|COMPLETED|First Wash Out Period (3 Weeks)||4
8300827|NCT01550471|20465618|P5|COMPLETED|First Wash Out Period (3 Weeks)||4
8300828|NCT01550471|20465619|P4|COMPLETED|First Wash Out Period (3 Weeks)||4
8300829|NCT01550471|20465620|P3|COMPLETED|First Wash Out Period (3 Weeks)||3
8300830|NCT01550471|20465621|P2|COMPLETED|First Wash Out Period (3 Weeks)||4
8300831|NCT01550471|20465622|P1|COMPLETED|First Wash Out Period (3 Weeks)||3
8300832|NCT01550471|20465617|P6|STARTED|First Wash Out Period (3 Weeks)||4
8300833|NCT01550471|20465618|P5|STARTED|First Wash Out Period (3 Weeks)||4
8300834|NCT01550471|20465619|P4|STARTED|First Wash Out Period (3 Weeks)||4
8300835|NCT01550471|20465620|P3|STARTED|First Wash Out Period (3 Weeks)||3
8300836|NCT01550471|20465621|P2|STARTED|First Wash Out Period (3 Weeks)||4
8300837|NCT01550471|20465622|P1|STARTED|First Wash Out Period (3 Weeks)||3
8300838|NCT01550471|20465617|P6|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8300839|NCT01550471|20465618|P5|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8300840|NCT01550471|20465619|P4|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8300841|NCT01550471|20465620|P3|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8300842|NCT01550471|20465621|P2|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8300843|NCT01550471|20465622|P1|NOT COMPLETED|First Treatment Period (3 Weeks)||0
8300844|NCT01550471|20465617|P6|COMPLETED|First Treatment Period (3 Weeks)||4
8300845|NCT01550471|20465618|P5|COMPLETED|First Treatment Period (3 Weeks)||4
8300846|NCT01550471|20465619|P4|COMPLETED|First Treatment Period (3 Weeks)||4
8300847|NCT01550471|20465620|P3|COMPLETED|First Treatment Period (3 Weeks)||3
8300848|NCT01550471|20465621|P2|COMPLETED|First Treatment Period (3 Weeks)||4
8300849|NCT01550471|20465622|P1|COMPLETED|First Treatment Period (3 Weeks)||3
8300850|NCT01550471|20465617|P6|STARTED|First Treatment Period (3 Weeks)||4
8300851|NCT01550471|20465618|P5|STARTED|First Treatment Period (3 Weeks)||4
8300852|NCT01550471|20465619|P4|STARTED|First Treatment Period (3 Weeks)||4
8300853|NCT01550471|20465620|P3|STARTED|First Treatment Period (3 Weeks)||3
8300854|NCT01550471|20465621|P2|STARTED|First Treatment Period (3 Weeks)||4
8300855|NCT01550471|20465622|P1|STARTED|First Treatment Period (3 Weeks)||3
8300856|NCT01550471|20465617|P6|NOT COMPLETED|Run-In Period (3 Weeks)||0
8300857|NCT01550471|20465618|P5|NOT COMPLETED|Run-In Period (3 Weeks)||0
8300858|NCT01550471|20465619|P4|NOT COMPLETED|Run-In Period (3 Weeks)||0
8300859|NCT01550471|20465620|P3|NOT COMPLETED|Run-In Period (3 Weeks)||0
8300860|NCT01550471|20465621|P2|NOT COMPLETED|Run-In Period (3 Weeks)||0
8300861|NCT01550471|20465622|P1|NOT COMPLETED|Run-In Period (3 Weeks)||0
8300862|NCT01550471|20465617|P6|COMPLETED|Run-In Period (3 Weeks)||4
8300863|NCT01550471|20465618|P5|COMPLETED|Run-In Period (3 Weeks)||4
8300864|NCT01550471|20465619|P4|COMPLETED|Run-In Period (3 Weeks)||4
8300865|NCT01550471|20465620|P3|COMPLETED|Run-In Period (3 Weeks)||3
8300866|NCT01550471|20465621|P2|COMPLETED|Run-In Period (3 Weeks)||4
8300867|NCT01550471|20465622|P1|COMPLETED|Run-In Period (3 Weeks)||3
8300868|NCT01550471|20465617|P6|STARTED|Run-In Period (3 Weeks)||4
8300869|NCT01550471|20465618|P5|STARTED|Run-In Period (3 Weeks)||4
8300870|NCT01550471|20465619|P4|STARTED|Run-In Period (3 Weeks)||4
8300871|NCT01550471|20465620|P3|STARTED|Run-In Period (3 Weeks)||3
8300872|NCT01550471|20465621|P2|STARTED|Run-In Period (3 Weeks)||4
8300873|NCT01550471|20465622|P1|STARTED|Run-In Period (3 Weeks)||3
8300874|NCT01550367|20465631|P1|NOT COMPLETED|Overall Study||0
8300875|NCT01550367|20465631|P1|COMPLETED|Overall Study||30
8300876|NCT01550367|20465631|P1|600 mg/d HCQ|Overall Study||17
8300877|NCT01550367|20465631|P1|1200 mg/d HCQ|Overall Study||13
8300878|NCT01550367|20465631|P1|STARTED|Overall Study||30
8300879|NCT01550341|20465658|P2|NOT COMPLETED|Overall Study||0
8300880|NCT01550341|20465659|P1|NOT COMPLETED|Overall Study||0
8300881|NCT01550341|20465658|P2|COMPLETED|Overall Study||18
8300882|NCT01550341|20465659|P1|COMPLETED|Overall Study||32
8300883|NCT01550341|20465658|P2|STARTED|Overall Study||18
8300884|NCT01550341|20465659|P1|STARTED|Overall Study||32
8300885|NCT01550302|20465693|P2|NOT COMPLETED|Overall Study||0
8300886|NCT01550302|20465694|P1|NOT COMPLETED|Overall Study||0
8300887|NCT01550302|20465693|P2|COMPLETED|Overall Study||5
8300888|NCT01550302|20465694|P1|COMPLETED|Overall Study||5
8300889|NCT01550302|20465693|P2|STARTED|Overall Study||5
8300890|NCT01550302|20465694|P1|STARTED|Overall Study||5
8300891|NCT01550289|20465714|P2|NOT COMPLETED|Overall Study||4
8300892|NCT01550289|20465715|P1|NOT COMPLETED|Overall Study||13
8300893|NCT01550289|20465714|P2|COMPLETED|Overall Study||57
8300894|NCT01550289|20465715|P1|COMPLETED|Overall Study||115
8300895|NCT01550289|20465714|P2|STARTED|Overall Study||61
8300896|NCT01550289|20465715|P1|STARTED|Overall Study||128
8300897|NCT01550224|20465747|P2|NOT COMPLETED|Overall Study||0
8300898|NCT01550224|20465748|P1|NOT COMPLETED|Overall Study||0
8300899|NCT01550224|20465747|P2|COMPLETED|Overall Study||20
8300900|NCT01550224|20465748|P1|COMPLETED|Overall Study||3
8300901|NCT01550224|20465747|P2|STARTED|Overall Study||20
8300902|NCT01550224|20465748|P1|STARTED|Overall Study||3
8300903|NCT01549977|20465772|P2|NOT COMPLETED|Overall Study||0
8300904|NCT01549977|20465773|P1|NOT COMPLETED|Overall Study||0
8300905|NCT01549977|20465772|P2|COMPLETED|Overall Study||0
8300906|NCT01549977|20465773|P1|COMPLETED|Overall Study||1
8300907|NCT01549977|20465772|P2|STARTED|Overall Study||0
8300908|NCT01549977|20465773|P1|STARTED|Overall Study||1
8300909|NCT01549964|20465791|P4|NOT COMPLETED|80-Week Extension Period||137
8300910|NCT01549964|20465792|P3|NOT COMPLETED|80-Week Extension Period||140
8300911|NCT01549964|20465793|P2|NOT COMPLETED|80-Week Extension Period||138
8300912|NCT01549964|20465794|P1|NOT COMPLETED|80-Week Extension Period||66
8300913|NCT01549964|20465791|P4|COMPLETED|80-Week Extension Period||0
8300914|NCT01549964|20465792|P3|COMPLETED|80-Week Extension Period||0
8300915|NCT01549964|20465793|P2|COMPLETED|80-Week Extension Period||0
8300916|NCT01549964|20465794|P1|COMPLETED|80-Week Extension Period||0
8300917|NCT01549964|20465791|P4|STARTED|80-Week Extension Period||137
8300918|NCT01549964|20465792|P3|STARTED|80-Week Extension Period||140
8300919|NCT01549964|20465793|P2|STARTED|80-Week Extension Period||138
8300920|NCT01549964|20465794|P1|STARTED|80-Week Extension Period||66
8300921|NCT01549964|20465791|P4|NOT COMPLETED|24-Week Treatment Period||121
8300922|NCT01549964|20465792|P3|NOT COMPLETED|24-Week Treatment Period||116
8300923|NCT01549964|20465793|P2|NOT COMPLETED|24-Week Treatment Period||111
8300924|NCT01549964|20465794|P1|NOT COMPLETED|24-Week Treatment Period||61
8300925|NCT01549964|20465791|P4|COMPLETED|24-Week Treatment Period||140
8300926|NCT01549964|20465792|P3|COMPLETED|24-Week Treatment Period||147
8300927|NCT01549964|20465793|P2|COMPLETED|24-Week Treatment Period||149
8300928|NCT01549964|20465794|P1|COMPLETED|24-Week Treatment Period||71
8300929|NCT01549964|20465791|P4|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
8300930|NCT01549964|20465792|P3|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
8300931|NCT01549964|20465793|P2|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
8300932|NCT01549964|20465794|P1|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
8300933|NCT01549964|20465791|P4|STARTED|24-Week Treatment Period||261
8300934|NCT01549964|20465792|P3|STARTED|24-Week Treatment Period||263
8300935|NCT01549964|20465793|P2|STARTED|24-Week Treatment Period||260
8300936|NCT01549964|20465794|P1|STARTED|24-Week Treatment Period||132
8300937|NCT01549951|20465812|P1|NOT COMPLETED|Overall Study||50
8300938|NCT01549951|20465812|P1|COMPLETED|Overall Study||0
8300939|NCT01549951|20465812|P1|Primary Reason Off Study Treatment|Overall Study||50
8300940|NCT01549951|20465812|P1|STARTED|Overall Study||50
8300941|NCT01549925|20465830|P2|NOT COMPLETED|Overall Study||0
8300942|NCT01549925|20465831|P1|NOT COMPLETED|Overall Study||0
8300943|NCT01549925|20465830|P2|COMPLETED|Overall Study||25
8300944|NCT01549925|20465831|P1|COMPLETED|Overall Study||25
8300945|NCT01549925|20465830|P2|STARTED|Overall Study||25
8300946|NCT01549925|20465831|P1|STARTED|Overall Study||25
8300947|NCT01549873|20465839|P2|NOT COMPLETED|Overall Study||1
8300948|NCT01549873|20465840|P1|NOT COMPLETED|Overall Study||0
8300949|NCT01549873|20465839|P2|COMPLETED|Overall Study||14
8300950|NCT01549873|20465840|P1|COMPLETED|Overall Study||15
8300951|NCT01549873|20465839|P2|STARTED|Overall Study||15
8300952|NCT01549873|20465840|P1|STARTED|Overall Study||15
8300953|NCT01549860|20465852|P2|NOT COMPLETED|Overall Study||1
8300954|NCT01549860|20465853|P1|NOT COMPLETED|Overall Study||2
8300955|NCT01549860|20465852|P2|COMPLETED|Overall Study||40
8300956|NCT01549860|20465853|P1|COMPLETED|Overall Study||38
8300957|NCT01549860|20465852|P2|STARTED|Overall Study||41
8300958|NCT01549860|20465853|P1|STARTED|Overall Study||40
8300959|NCT01549652|20465866|P4|NOT COMPLETED|Overall Study||11
8300960|NCT01549652|20465867|P3|NOT COMPLETED|Overall Study||17
8300961|NCT01549652|20465868|P2|NOT COMPLETED|Overall Study||12
8300962|NCT01549652|20465869|P1|NOT COMPLETED|Overall Study||12
8300963|NCT01549652|20465866|P4|COMPLETED|Overall Study||25
8300964|NCT01549652|20465867|P3|COMPLETED|Overall Study||23
8300965|NCT01549652|20465868|P2|COMPLETED|Overall Study||18
8300966|NCT01549652|20465869|P1|COMPLETED|Overall Study||15
8300967|NCT01549652|20465866|P4|STARTED|Overall Study||36
8300968|NCT01549652|20465867|P3|STARTED|Overall Study||40
8300969|NCT01549652|20465868|P2|STARTED|Overall Study||30
8300970|NCT01549652|20465869|P1|STARTED|Overall Study||27
8300971|NCT01549613|20465887|P2|NOT COMPLETED|Overall Study||11
8300972|NCT01549613|20465888|P1|NOT COMPLETED|Overall Study||11
8300973|NCT01549613|20465887|P2|COMPLETED|Overall Study||39
8300974|NCT01549613|20465888|P1|COMPLETED|Overall Study||39
8300975|NCT01549613|20465887|P2|STARTED|Overall Study||50
8300976|NCT01549613|20465888|P1|STARTED|Overall Study||50
8300977|NCT01549587|20465896|P2|NOT COMPLETED|Overall Study||37
8300978|NCT01549587|20465897|P1|NOT COMPLETED|Overall Study||39
8300979|NCT01549587|20465896|P2|COMPLETED|Overall Study||336
8300980|NCT01549587|20465897|P1|COMPLETED|Overall Study||334
8300981|NCT01549587|20465896|P2|STARTED|Overall Study||373
8300982|NCT01549587|20465897|P1|STARTED|Overall Study||373
8300983|NCT01549405|20465915|P2|NOT COMPLETED|Overall Study||0
8300984|NCT01549405|20465916|P1|NOT COMPLETED|Overall Study||0
8300985|NCT01549405|20465915|P2|COMPLETED|Overall Study||20
8300986|NCT01549405|20465916|P1|COMPLETED|Overall Study||20
8300987|NCT01549405|20465915|P2|STARTED|Overall Study||20
8300988|NCT01549405|20465916|P1|STARTED|Overall Study||20
8300989|NCT01549392|20465926|P2|NOT COMPLETED|Overall Study||0
8300990|NCT01549392|20465927|P1|NOT COMPLETED|Overall Study||1
8300991|NCT01549392|20465926|P2|COMPLETED|Overall Study||0
8300992|NCT01549392|20465927|P1|COMPLETED|Overall Study||2
8300993|NCT01549392|20465926|P2|STARTED|Overall Study||0
8300994|NCT01549392|20465927|P1|STARTED|Overall Study||3
8300995|NCT01549340|20465933|P1|NOT COMPLETED|Overall Study||8405
8300996|NCT01549340|20465933|P1|COMPLETED|Overall Study|Completed 5 years of AIT|385
8300997|NCT01549340|20465933|P1|Started AIT|Overall Study||3182
8300998|NCT01549340|20465933|P1|STARTED|Overall Study|Advised to receive AIT|8790
8300999|NCT01549314|20465947|P3|NOT COMPLETED|Overall Study||2
8301000|NCT01549314|20465948|P2|NOT COMPLETED|Overall Study||5
8301001|NCT01549314|20465949|P1|NOT COMPLETED|Overall Study||4
8301002|NCT01549314|20465947|P3|COMPLETED|Overall Study||24
8301003|NCT01549314|20465948|P2|COMPLETED|Overall Study||21
8301004|NCT01549314|20465949|P1|COMPLETED|Overall Study||23
8301005|NCT01549314|20465947|P3|STARTED|Overall Study||26
8301006|NCT01549314|20465948|P2|STARTED|Overall Study||26
8301007|NCT01549314|20465949|P1|STARTED|Overall Study|1 subject signed the consent form but dropped out prior to any study procedures or data collection.|27
8301008|NCT01549275|20465965|P2|NOT COMPLETED|Overall Study||0
8301009|NCT01549275|20465966|P1|NOT COMPLETED|Overall Study||1
8301010|NCT01549275|20465965|P2|COMPLETED|Overall Study||29
8301011|NCT01549275|20465966|P1|COMPLETED|Overall Study||75
8301012|NCT01549275|20465965|P2|STARTED|Overall Study||29
8301013|NCT01549275|20465966|P1|STARTED|Overall Study||76
8301014|NCT01549223|20465978|P2|NOT COMPLETED|Overall Study||0
8301015|NCT01549223|20465979|P1|NOT COMPLETED|Overall Study||0
8301016|NCT01549223|20465978|P2|COMPLETED|Overall Study||30
8301017|NCT01549223|20465979|P1|COMPLETED|Overall Study||30
8301018|NCT01549223|20465978|P2|STARTED|Overall Study||30
8301019|NCT01549223|20465979|P1|STARTED|Overall Study||30
8301020|NCT01549041|20465989|P2|NOT COMPLETED|Overall Study||8
8301021|NCT01549041|20465990|P1|NOT COMPLETED|Overall Study||2
8301022|NCT01549041|20465989|P2|COMPLETED|Overall Study||10
8301023|NCT01549041|20465990|P1|COMPLETED|Overall Study||10
8301024|NCT01549041|20465989|P2|STARTED|Overall Study||18
8301025|NCT01549041|20465990|P1|STARTED|Overall Study||12
8301026|NCT01549002|20466000|P2|NOT COMPLETED|Overall Study||4
8301027|NCT01549002|20466001|P1|NOT COMPLETED|Overall Study||0
8301028|NCT01549002|20466000|P2|COMPLETED|Overall Study||6
8301029|NCT01549002|20466001|P1|COMPLETED|Overall Study||10
8301030|NCT01549002|20466000|P2|STARTED|Overall Study||10
8301031|NCT01549002|20466001|P1|STARTED|Overall Study||10
8301032|NCT01548885|20466011|P1|NOT COMPLETED|Overall Study||0
8301033|NCT01548885|20466011|P1|COMPLETED|Overall Study||146
8301034|NCT01548885|20466011|P1|STARTED|Overall Study||146
8301035|NCT01548833|20466016|P1|NOT COMPLETED|Overall Study||0
8301036|NCT01548833|20466016|P1|COMPLETED|Overall Study||39
8301037|NCT01548833|20466016|P1|STARTED|Overall Study||39
8301038|NCT01548768|20466028|P4|NOT COMPLETED|Overall Study||4
8301039|NCT01548768|20466029|P3|NOT COMPLETED|Overall Study||1
8301040|NCT01548768|20466030|P2|NOT COMPLETED|Overall Study||2
8301041|NCT01548768|20466031|P1|NOT COMPLETED|Overall Study||1
8301042|NCT01548768|20466028|P4|COMPLETED|Overall Study||117
8301043|NCT01548768|20466029|P3|COMPLETED|Overall Study||15
8301044|NCT01548768|20466030|P2|COMPLETED|Overall Study||2
8301045|NCT01548768|20466031|P1|COMPLETED|Overall Study||7
8301046|NCT01548768|20466028|P4|STARTED|Overall Study||121
8301047|NCT01548768|20466029|P3|STARTED|Overall Study||16
8301048|NCT01548768|20466030|P2|STARTED|Overall Study||4
8301049|NCT01548768|20466031|P1|STARTED|Overall Study||8
8301050|NCT01548742|20466048|P2|NOT COMPLETED|Overall Study||4
8301051|NCT01548742|20466049|P1|NOT COMPLETED|Overall Study||13
8301052|NCT01548742|20466048|P2|COMPLETED|Overall Study||54
8301053|NCT01548742|20466049|P1|COMPLETED|Overall Study||45
8301054|NCT01548742|20466048|P2|STARTED|Overall Study||58
8301055|NCT01548742|20466049|P1|STARTED|Overall Study||58
8301056|NCT01548690|20466067|P4|NOT COMPLETED|Overall Study||5
8301057|NCT01548690|20466068|P3|NOT COMPLETED|Overall Study||5
8301058|NCT01548690|20466069|P2|NOT COMPLETED|Overall Study||3
8301059|NCT01548690|20466070|P1|NOT COMPLETED|Overall Study||0
8301060|NCT01548690|20466067|P4|COMPLETED|Overall Study||10
8301061|NCT01548690|20466068|P3|COMPLETED|Overall Study||8
8301062|NCT01548690|20466069|P2|COMPLETED|Overall Study||7
8301063|NCT01548690|20466070|P1|COMPLETED|Overall Study||9
8301064|NCT01548690|20466067|P4|Evaluable (72 Hours on Infusion)|Overall Study||12
8301065|NCT01548690|20466068|P3|Evaluable (72 Hours on Infusion)|Overall Study||12
8301066|NCT01548690|20466069|P2|Evaluable (72 Hours on Infusion)|Overall Study||6
8301067|NCT01548690|20466070|P1|Evaluable (72 Hours on Infusion)|Overall Study||6
8301068|NCT01548690|20466067|P4|STARTED|Overall Study||15
8301069|NCT01548690|20466068|P3|STARTED|Overall Study||13
8301070|NCT01548690|20466069|P2|STARTED|Overall Study||10
8301071|NCT01548690|20466070|P1|STARTED|Overall Study||9
8301072|NCT01548651|20466098|P2|NOT COMPLETED|Overall Study||0
8301073|NCT01548651|20466099|P1|NOT COMPLETED|Overall Study||1
8301074|NCT01548651|20466098|P2|COMPLETED|Overall Study||4
8301075|NCT01548651|20466099|P1|COMPLETED|Overall Study||3
8301076|NCT01548651|20466098|P2|STARTED|Overall Study||4
8301077|NCT01548651|20466099|P1|STARTED|Overall Study||4
8301078|NCT01548638|20466109|P1|NOT COMPLETED|Overall Study||4
8301079|NCT01548638|20466109|P1|COMPLETED|Overall Study||9
8301080|NCT01548638|20466109|P1|STARTED|Overall Study||13
8301081|NCT01548599|20466121|P2|NOT COMPLETED|Overall Study||2
8301082|NCT01548599|20466122|P1|NOT COMPLETED|Overall Study||6
8301083|NCT01548599|20466121|P2|COMPLETED|Overall Study||66
8301084|NCT01548599|20466122|P1|COMPLETED|Overall Study||66
8301085|NCT01548599|20466121|P2|STARTED|Overall Study||68
8301086|NCT01548599|20466122|P1|STARTED|Overall Study||72
8301087|NCT01548573|20466138|P1|NOT COMPLETED|Overall Study||5
8301088|NCT01548573|20466138|P1|COMPLETED|Overall Study||14
8301089|NCT01548573|20466138|P1|STARTED|Overall Study||19
8301090|NCT01548417|20466147|P2|NOT COMPLETED|Overall Study||2
8301091|NCT01548417|20466148|P1|NOT COMPLETED|Overall Study||0
8301092|NCT01548417|20466147|P2|COMPLETED|Overall Study||26
8301093|NCT01548417|20466148|P1|COMPLETED|Overall Study||28
8301094|NCT01548417|20466147|P2|STARTED|Overall Study||28
8301095|NCT01548417|20466148|P1|STARTED|Overall Study||28
8301096|NCT01548404|20466158|P2|NOT COMPLETED|Overall Study||14
8301097|NCT01548404|20466159|P1|NOT COMPLETED|Overall Study||30
8301098|NCT01548404|20466158|P2|COMPLETED|Overall Study||41
8301099|NCT01548404|20466159|P1|COMPLETED|Overall Study||24
8301100|NCT01548404|20466158|P2|STARTED|Overall Study||55
8301101|NCT01548404|20466159|P1|STARTED|Overall Study||54
8301102|NCT01548339|20466183|P2|NOT COMPLETED|Overall Study||1
8301103|NCT01548339|20466184|P1|NOT COMPLETED|Overall Study||6
8301104|NCT01548339|20466183|P2|COMPLETED|Overall Study||41
8301105|NCT01548339|20466184|P1|COMPLETED|Overall Study||38
8301106|NCT01548339|20466183|P2|STARTED|Overall Study||42
8301107|NCT01548339|20466184|P1|STARTED|Overall Study||44
8301108|NCT01548287|20466198|P5|NOT COMPLETED|Randomized Period||0
8301109|NCT01548287|20466199|P4|NOT COMPLETED|Randomized Period||0
8301110|NCT01548287|20466200|P3|NOT COMPLETED|Randomized Period||7
8301111|NCT01548287|20466201|P2|NOT COMPLETED|Randomized Period||2
8301112|NCT01548287|20466202|P1|NOT COMPLETED|Randomized Period||0
8301113|NCT01548287|20466198|P5|COMPLETED|Randomized Period||0
8301114|NCT01548287|20466199|P4|COMPLETED|Randomized Period||20
8301115|NCT01548287|20466200|P3|COMPLETED|Randomized Period||13
8301116|NCT01548287|20466201|P2|COMPLETED|Randomized Period||20
8301117|NCT01548287|20466202|P1|COMPLETED|Randomized Period||19
8301118|NCT01548287|20466198|P5|STARTED|Randomized Period||0
8301119|NCT01548287|20466199|P4|STARTED|Randomized Period||20
8301120|NCT01548287|20466200|P3|STARTED|Randomized Period||20
8301121|NCT01548287|20466201|P2|STARTED|Randomized Period||22
8301122|NCT01548287|20466202|P1|STARTED|Randomized Period||19
8301123|NCT01548287|20466198|P5|NOT COMPLETED|Screening||83
8301124|NCT01548287|20466199|P4|NOT COMPLETED|Screening||0
8301125|NCT01548287|20466200|P3|NOT COMPLETED|Screening||0
8301126|NCT01548287|20466201|P2|NOT COMPLETED|Screening||0
8301127|NCT01548287|20466202|P1|NOT COMPLETED|Screening||0
8301128|NCT01548287|20466198|P5|COMPLETED|Screening||0
8301129|NCT01548287|20466199|P4|COMPLETED|Screening||20
8301130|NCT01548287|20466200|P3|COMPLETED|Screening||20
8301131|NCT01548287|20466201|P2|COMPLETED|Screening||22
8301132|NCT01548287|20466202|P1|COMPLETED|Screening||19
8301133|NCT01548287|20466198|P5|STARTED|Screening||83
8301134|NCT01548287|20466199|P4|STARTED|Screening||20
8301135|NCT01548287|20466200|P3|STARTED|Screening||20
8301136|NCT01548287|20466201|P2|STARTED|Screening||22
8301137|NCT01548287|20466202|P1|STARTED|Screening||19
8301138|NCT01548040|20466234|P2|NOT COMPLETED|Overall Study||10
8301139|NCT01548040|20466235|P1|NOT COMPLETED|Overall Study||13
8301140|NCT01548040|20466234|P2|COMPLETED|Overall Study||45
8301141|NCT01548040|20466235|P1|COMPLETED|Overall Study||43
8301142|NCT01548040|20466234|P2|STARTED|Overall Study||55
8301143|NCT01548040|20466235|P1|STARTED|Overall Study||56
8301144|NCT01547806|20466243|P1|NOT COMPLETED|Overall Study||0
8301145|NCT01547806|20466243|P1|COMPLETED|Overall Study||49
8301146|NCT01547806|20466243|P1|STARTED|Overall Study||49
8301147|NCT01547728|20466259|P1|NOT COMPLETED|Overall Study||41
8301148|NCT01547728|20466259|P1|COMPLETED|Overall Study||1
8301149|NCT01547728|20466259|P1|STARTED|Overall Study||42
8301150|NCT01547715|20466266|P3|NOT COMPLETED|Overall Study||0
8301151|NCT01547715|20466267|P2|NOT COMPLETED|Overall Study||0
8301152|NCT01547715|20466268|P1|NOT COMPLETED|Overall Study||0
8301153|NCT01547715|20466266|P3|COMPLETED|Overall Study||60
8301154|NCT01547715|20466267|P2|COMPLETED|Overall Study||60
8301155|NCT01547715|20466268|P1|COMPLETED|Overall Study||60
8301156|NCT01547715|20466266|P3|STARTED|Overall Study||60
8301157|NCT01547715|20466267|P2|STARTED|Overall Study||60
8301158|NCT01547715|20466268|P1|STARTED|Overall Study||60
8301159|NCT01547598|20466368|P2|NOT COMPLETED|Overall Study||5
8301160|NCT01547598|20466369|P1|NOT COMPLETED|Overall Study||6
8301161|NCT01547598|20466368|P2|COMPLETED|Overall Study||63
8301162|NCT01547598|20466369|P1|COMPLETED|Overall Study||61
8301163|NCT01547598|20466368|P2|STARTED|Overall Study||68
8301164|NCT01547598|20466369|P1|STARTED|Overall Study||67
8301165|NCT01547390|20466386|P2|NOT COMPLETED|Overall Study||10
8301166|NCT01547390|20466387|P1|NOT COMPLETED|Overall Study||13
8301167|NCT01547390|20466386|P2|COMPLETED|Overall Study||16
8301168|NCT01547390|20466387|P1|COMPLETED|Overall Study||14
8301169|NCT01547390|20466386|P2|STARTED|Overall Study||26
8301170|NCT01547390|20466387|P1|STARTED|Overall Study||27
8301171|NCT01547299|20466397|P2|NOT COMPLETED|Overall Study||2
8301172|NCT01547299|20466398|P1|NOT COMPLETED|Overall Study||2
8301173|NCT01547299|20466397|P2|COMPLETED|Overall Study||25
8301174|NCT01547299|20466398|P1|COMPLETED|Overall Study||23
8301175|NCT01547299|20466397|P2|STARTED|Overall Study||27
8301176|NCT01547299|20466398|P1|STARTED|Overall Study||25
8301177|NCT01547286|20466464|P1|NOT COMPLETED|Overall Study||2
8301178|NCT01547286|20466464|P1|COMPLETED|Overall Study||5
8301179|NCT01547286|20466464|P1|STARTED|Overall Study||7
8301180|NCT01547247|20466473|P2|NOT COMPLETED|Overall Study||6
8301181|NCT01547247|20466474|P1|NOT COMPLETED|Overall Study||6
8301182|NCT01547247|20466473|P2|COMPLETED|Overall Study||98
8301183|NCT01547247|20466474|P1|COMPLETED|Overall Study||98
8301184|NCT01547247|20466473|P2|STARTED|Overall Study||104
8301185|NCT01547247|20466474|P1|STARTED|Overall Study||104
8301186|NCT01547130|20466484|P2|NOT COMPLETED|Overall Study||5
8301187|NCT01547130|20466485|P1|NOT COMPLETED|Overall Study||9
8301188|NCT01547130|20466484|P2|COMPLETED|Overall Study||68
8301189|NCT01547130|20466485|P1|COMPLETED|Overall Study||65
8301190|NCT01547130|20466484|P2|STARTED|Overall Study||73
8301191|NCT01547130|20466485|P1|STARTED|Overall Study||74
8301198|NCT01546922|20466508|P2|NOT COMPLETED|Second Period of 10 Weeks||3
8301199|NCT01546922|20466509|P1|NOT COMPLETED|Second Period of 10 Weeks||3
8301200|NCT01546922|20466508|P2|COMPLETED|Second Period of 10 Weeks||25
8301201|NCT01546922|20466509|P1|COMPLETED|Second Period of 10 Weeks||22
8301202|NCT01546922|20466508|P2|STARTED|Second Period of 10 Weeks||28
8301203|NCT01546922|20466509|P1|STARTED|Second Period of 10 Weeks||25
8301204|NCT01546922|20466508|P2|NOT COMPLETED|First Period of 10 Weeks||2
8301205|NCT01546922|20466509|P1|NOT COMPLETED|First Period of 10 Weeks||5
8301206|NCT01546922|20466508|P2|COMPLETED|First Period of 10 Weeks||28
8301207|NCT01546922|20466509|P1|COMPLETED|First Period of 10 Weeks||25
8301208|NCT01546922|20466508|P2|STARTED|First Period of 10 Weeks||30
8301209|NCT01546922|20466509|P1|STARTED|First Period of 10 Weeks||30
8301210|NCT01546883|20466515|P1|NOT COMPLETED|Overall Study||12
8301211|NCT01546883|20466515|P1|COMPLETED|Overall Study||2
8301212|NCT01546883|20466515|P1|STARTED|Overall Study||14
8301213|NCT01546857|20466521|P2|NOT COMPLETED|Overall Study||3
8301214|NCT01546857|20466522|P1|NOT COMPLETED|Overall Study||2
8301215|NCT01546857|20466521|P2|COMPLETED|Overall Study||17
8301216|NCT01546857|20466522|P1|COMPLETED|Overall Study||12
8301217|NCT01546857|20466521|P2|STARTED|Overall Study||20
8301218|NCT01546857|20466522|P1|STARTED|Overall Study||14
8301219|NCT01546688|20466536|P2|NOT COMPLETED|Overall Study||5
8301220|NCT01546688|20466537|P1|NOT COMPLETED|Overall Study||3
8301221|NCT01546688|20466536|P2|COMPLETED|Overall Study||28
8301222|NCT01546688|20466537|P1|COMPLETED|Overall Study||15
8301223|NCT01546688|20466536|P2|STARTED|Overall Study||33
8301224|NCT01546688|20466537|P1|STARTED|Overall Study||18
8301225|NCT01546675|20466551|P2|NOT COMPLETED|Overall Study||0
8301226|NCT01546675|20466552|P1|NOT COMPLETED|Overall Study||0
8301227|NCT01546675|20466551|P2|COMPLETED|Overall Study||1
8301228|NCT01546675|20466552|P1|COMPLETED|Overall Study||1
8301229|NCT01546675|20466551|P2|STARTED|Overall Study||1
8301230|NCT01546675|20466552|P1|STARTED|Overall Study||1
8301231|NCT01546649|20466569|P2|NOT COMPLETED|Overall Study||9
8301232|NCT01546649|20466570|P1|NOT COMPLETED|Overall Study||8
8301233|NCT01546649|20466569|P2|COMPLETED|Overall Study||75
8301234|NCT01546649|20466570|P1|COMPLETED|Overall Study||75
8301235|NCT01546649|20466569|P2|STARTED|Overall Study||84
8301236|NCT01546649|20466570|P1|STARTED|Overall Study||83
8301237|NCT01546636|20466592|P2|NOT COMPLETED|Overall Study||0
8301238|NCT01546636|20466593|P1|NOT COMPLETED|Overall Study||0
8301239|NCT01546636|20466592|P2|COMPLETED|Overall Study||34
8301240|NCT01546636|20466593|P1|COMPLETED|Overall Study||36
8301241|NCT01546636|20466592|P2|STARTED|Overall Study||34
8301242|NCT01546636|20466593|P1|STARTED|Overall Study||36
8301243|NCT01546623|20466605|P2|NOT COMPLETED|Overall Study||6
8301244|NCT01546623|20466606|P1|NOT COMPLETED|Overall Study||6
8301245|NCT01546623|20466605|P2|COMPLETED|Overall Study||74
8301246|NCT01546623|20466606|P1|COMPLETED|Overall Study||76
8301247|NCT01546623|20466605|P2|Received Study Drug|Overall Study||79
8301248|NCT01546623|20466606|P1|Received Study Drug|Overall Study||81
8301249|NCT01546623|20466605|P2|STARTED|Overall Study||80
8301250|NCT01546623|20466606|P1|STARTED|Overall Study||82
8301251|NCT01546519|20466636|P4|NOT COMPLETED|Overall Study||6
8301252|NCT01546519|20466637|P3|NOT COMPLETED|Overall Study||8
8301253|NCT01546519|20466638|P2|NOT COMPLETED|Overall Study||8
8301254|NCT01546519|20466639|P1|NOT COMPLETED|Overall Study||9
8301255|NCT01546519|20466636|P4|COMPLETED|Overall Study||0
8301256|NCT01546519|20466637|P3|COMPLETED|Overall Study||0
8301257|NCT01546519|20466638|P2|COMPLETED|Overall Study||0
8301258|NCT01546519|20466639|P1|COMPLETED|Overall Study||0
8301259|NCT01546519|20466636|P4|Safety-Evaluable Participants|Overall Study||6
8301260|NCT01546519|20466637|P3|Safety-Evaluable Participants|Overall Study||8
8301261|NCT01546519|20466638|P2|Safety-Evaluable Participants|Overall Study||8
8301262|NCT01546519|20466639|P1|Safety-Evaluable Participants|Overall Study||9
8301263|NCT01546519|20466636|P4|STARTED|Overall Study||6
8301264|NCT01546519|20466637|P3|STARTED|Overall Study||8
8301265|NCT01546519|20466638|P2|STARTED|Overall Study||8
8301266|NCT01546519|20466639|P1|STARTED|Overall Study||9
8301267|NCT01546454|20466681|P1|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
8301268|NCT01546454|20466681|P1|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
8301269|NCT01546454|20466681|P1|STARTED|Estrogen/Progesterone Replacement Cycle||4
8301270|NCT01546454|20466681|P1|NOT COMPLETED|Eligard Treatment||0
8301271|NCT01546454|20466681|P1|COMPLETED|Eligard Treatment||4
8301272|NCT01546454|20466681|P1|STARTED|Eligard Treatment||4
8301273|NCT01546454|20466681|P1|NOT COMPLETED|Oral Contraceptive Cycle||0
8301274|NCT01546454|20466681|P1|COMPLETED|Oral Contraceptive Cycle||4
8301275|NCT01546454|20466681|P1|STARTED|Oral Contraceptive Cycle||4
8301276|NCT01546454|20466681|P1|NOT COMPLETED|Natural Menstrual Cycle||0
8301277|NCT01546454|20466681|P1|COMPLETED|Natural Menstrual Cycle||4
8301278|NCT01546454|20466681|P1|STARTED|Natural Menstrual Cycle||4
8301279|NCT01546402|20466689|P2|NOT COMPLETED|Overall Study||0
8301280|NCT01546402|20466690|P1|NOT COMPLETED|Overall Study||0
8301281|NCT01546402|20466689|P2|COMPLETED|Overall Study||10
8301282|NCT01546402|20466690|P1|COMPLETED|Overall Study||10
8301283|NCT01546402|20466689|P2|STARTED|Overall Study||10
8301284|NCT01546402|20466690|P1|STARTED|Overall Study||10
8301285|NCT01546285|20466698|P1|NOT COMPLETED|Overall Study||0
8301286|NCT01546285|20466698|P1|COMPLETED|Overall Study||66
8301287|NCT01546285|20466698|P1|STARTED|Overall Study||66
8301288|NCT01546207|20466704|P1|NOT COMPLETED|Overall Study||1
8301289|NCT01546207|20466704|P1|COMPLETED|Overall Study||3
8301290|NCT01546207|20466704|P1|STARTED|Overall Study||4
8301291|NCT01546194|20466710|P2|NOT COMPLETED|Overall Study||35
8301292|NCT01546194|20466711|P1|NOT COMPLETED|Overall Study||36
8301293|NCT01546194|20466710|P2|COMPLETED|Overall Study||65
8301294|NCT01546194|20466711|P1|COMPLETED|Overall Study||64
8301295|NCT01546194|20466710|P2|STARTED|Overall Study||100
8301296|NCT01546194|20466711|P1|STARTED|Overall Study||100
8301297|NCT01546168|20466719|P2|NOT COMPLETED|Overall Study||0
8301298|NCT01546168|20466720|P1|NOT COMPLETED|Overall Study||4
8301299|NCT01546168|20466719|P2|COMPLETED|Overall Study||33
8301300|NCT01546168|20466720|P1|COMPLETED|Overall Study||51
8301301|NCT01546168|20466719|P2|STARTED|Overall Study||33
8301302|NCT01546168|20466720|P1|STARTED|Overall Study||55
8301303|NCT01546155|20466732|P1|NOT COMPLETED|Overall Study||3
8301304|NCT01546155|20466732|P1|COMPLETED|Overall Study||8
8301305|NCT01546155|20466732|P1|STARTED|Overall Study||11
8301306|NCT01546142|20466738|P2|NOT COMPLETED|Overall Study||34
8301307|NCT01546142|20466739|P1|NOT COMPLETED|Overall Study||44
8301308|NCT01546142|20466738|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
8301309|NCT01546142|20466739|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
8301310|NCT01546142|20466738|P2|Received Treatment|Overall Study||257
8301311|NCT01546142|20466739|P1|Received Treatment|Overall Study||257
8301312|NCT01546142|20466738|P2|STARTED|Overall Study||258
8301313|NCT01546142|20466739|P1|STARTED|Overall Study||258
8301314|NCT01546038|20466757|P9|NOT COMPLETED|Overall Study||43
8301315|NCT01546038|20466758|P8|NOT COMPLETED|Overall Study||84
8301316|NCT01546038|20466759|P7|NOT COMPLETED|Overall Study||53
8301317|NCT01546038|20466760|P6|NOT COMPLETED|Overall Study||4
8301318|NCT01546038|20466761|P5|NOT COMPLETED|Overall Study||10
8301319|NCT01546038|20466762|P4|NOT COMPLETED|Overall Study||3
8301320|NCT01546038|20466763|P3|NOT COMPLETED|Overall Study||4
8301321|NCT01546038|20466764|P2|NOT COMPLETED|Overall Study||6
8301322|NCT01546038|20466765|P1|NOT COMPLETED|Overall Study||16
8301323|NCT01546038|20466757|P9|COMPLETED|Overall Study||1
8301324|NCT01546038|20466758|P8|COMPLETED|Overall Study||4
8301325|NCT01546038|20466759|P7|COMPLETED|Overall Study||18
8301326|NCT01546038|20466760|P6|COMPLETED|Overall Study||2
8301327|NCT01546038|20466761|P5|COMPLETED|Overall Study||6
8301328|NCT01546038|20466762|P4|COMPLETED|Overall Study||0
8301329|NCT01546038|20466763|P3|COMPLETED|Overall Study||0
8301330|NCT01546038|20466764|P2|COMPLETED|Overall Study||0
8301331|NCT01546038|20466765|P1|COMPLETED|Overall Study||1
8301332|NCT01546038|20466757|P9|Received Treatment|Overall Study||41
8301333|NCT01546038|20466758|P8|Received Treatment|Overall Study||84
8301334|NCT01546038|20466759|P7|Received Treatment|Overall Study||69
8301335|NCT01546038|20466760|P6|Received Treatment|Overall Study||6
8301336|NCT01546038|20466761|P5|Received Treatment|Overall Study||16
8301337|NCT01546038|20466762|P4|Received Treatment|Overall Study||3
8301338|NCT01546038|20466763|P3|Received Treatment|Overall Study||4
8301339|NCT01546038|20466764|P2|Received Treatment|Overall Study||6
8301340|NCT01546038|20466765|P1|Received Treatment|Overall Study||17
8301341|NCT01546038|20466757|P9|STARTED|Overall Study||44
8301342|NCT01546038|20466758|P8|STARTED|Overall Study||88
8301343|NCT01546038|20466759|P7|STARTED|Overall Study||71
8301344|NCT01546038|20466760|P6|STARTED|Overall Study||6
8301345|NCT01546038|20466761|P5|STARTED|Overall Study||16
8301346|NCT01546038|20466762|P4|STARTED|Overall Study||3
8301347|NCT01546038|20466763|P3|STARTED|Overall Study||4
8301348|NCT01546038|20466764|P2|STARTED|Overall Study||6
8301349|NCT01546038|20466765|P1|STARTED|Overall Study||17
8301350|NCT01545843|20466928|P3|NOT COMPLETED|Overall Study||4
8301351|NCT01545843|20466929|P2|NOT COMPLETED|Overall Study||7
8301352|NCT01545843|20466930|P1|NOT COMPLETED|Overall Study||3
8301353|NCT01545843|20466928|P3|COMPLETED|Overall Study||21
8301354|NCT01545843|20466929|P2|COMPLETED|Overall Study||17
8301355|NCT01545843|20466930|P1|COMPLETED|Overall Study||16
8301356|NCT01545843|20466928|P3|STARTED|Overall Study||25
8301357|NCT01545843|20466929|P2|STARTED|Overall Study||24
8301358|NCT01545843|20466930|P1|STARTED|Overall Study||19
8301359|NCT01545817|20466959|P2|NOT COMPLETED|Everolimus||38
8301360|NCT01545817|20466960|P1|NOT COMPLETED|Everolimus||0
8301361|NCT01545817|20466959|P2|COMPLETED|Everolimus||0
8301362|NCT01545817|20466960|P1|COMPLETED|Everolimus||0
8301363|NCT01545817|20466959|P2|STARTED|Everolimus||38
8301364|NCT01545817|20466960|P1|STARTED|Everolimus||0
8301365|NCT01545817|20466959|P2|NOT COMPLETED|Pazopanib||0
8301366|NCT01545817|20466960|P1|NOT COMPLETED|Pazopanib||74
8301367|NCT01545817|20466959|P2|COMPLETED|Pazopanib||0
8301368|NCT01545817|20466960|P1|COMPLETED|Pazopanib||0
8301369|NCT01545817|20466959|P2|STARTED|Pazopanib||0
8301370|NCT01545817|20466960|P1|STARTED|Pazopanib||74
8301374|NCT01545700|20466988|P6|NOT COMPLETED|Overall Study||0
8301375|NCT01545700|20466989|P5|NOT COMPLETED|Overall Study||1
8301376|NCT01545700|20466990|P4|NOT COMPLETED|Overall Study||0
8301377|NCT01545700|20466991|P3|NOT COMPLETED|Overall Study||2
8301378|NCT01545700|20466992|P2|NOT COMPLETED|Overall Study||1
8301379|NCT01545700|20466993|P1|NOT COMPLETED|Overall Study||1
8301380|NCT01545700|20466988|P6|COMPLETED|Overall Study||33
8301381|NCT01545700|20466989|P5|COMPLETED|Overall Study||32
8301382|NCT01545700|20466990|P4|COMPLETED|Overall Study||34
8301383|NCT01545700|20466991|P3|COMPLETED|Overall Study||31
8301384|NCT01545700|20466992|P2|COMPLETED|Overall Study||32
8301385|NCT01545700|20466993|P1|COMPLETED|Overall Study||33
8301386|NCT01545700|20466988|P6|STARTED|Overall Study||33
8301387|NCT01545700|20466989|P5|STARTED|Overall Study||33
8301388|NCT01545700|20466990|P4|STARTED|Overall Study||34
8301389|NCT01545700|20466991|P3|STARTED|Overall Study||33
8301390|NCT01545700|20466992|P2|STARTED|Overall Study||33
8301391|NCT01545700|20466993|P1|STARTED|Overall Study||34
8301392|NCT01545648|20467027|P1|NOT COMPLETED|Overall Study||0
8301393|NCT01545648|20467027|P1|COMPLETED|Overall Study||4
8301394|NCT01545648|20467027|P1|6 Months of Treatment|Overall Study||4
8301395|NCT01545648|20467027|P1|STARTED|Overall Study||4
8301396|NCT01545583|20467042|P9|NOT COMPLETED|Overall Study||0
8301397|NCT01545583|20467043|P8|NOT COMPLETED|Overall Study||0
8301398|NCT01545583|20467044|P7|NOT COMPLETED|Overall Study||0
8301399|NCT01545583|20467045|P6|NOT COMPLETED|Overall Study||0
8301400|NCT01545583|20467046|P5|NOT COMPLETED|Overall Study||0
8301401|NCT01545583|20467047|P4|NOT COMPLETED|Overall Study||0
8301402|NCT01545583|20467048|P3|NOT COMPLETED|Overall Study||0
8301403|NCT01545583|20467049|P2|NOT COMPLETED|Overall Study||0
8301404|NCT01545583|20467050|P1|NOT COMPLETED|Overall Study||0
8301405|NCT01545583|20467042|P9|COMPLETED|Overall Study||6
8301406|NCT01545583|20467043|P8|COMPLETED|Overall Study||6
8301407|NCT01545583|20467044|P7|COMPLETED|Overall Study||6
8301408|NCT01545583|20467045|P6|COMPLETED|Overall Study||6
8301409|NCT01545583|20467046|P5|COMPLETED|Overall Study||6
8301410|NCT01545583|20467047|P4|COMPLETED|Overall Study||6
8301411|NCT01545583|20467048|P3|COMPLETED|Overall Study||6
8301412|NCT01545583|20467049|P2|COMPLETED|Overall Study||2
8301413|NCT01545583|20467050|P1|COMPLETED|Overall Study||12
8301414|NCT01545583|20467042|P9|Received at Least 1 Dose of Study Drug|Overall Study||6
8301415|NCT01545583|20467043|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
8301416|NCT01545583|20467044|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
8301417|NCT01545583|20467045|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
8301418|NCT01545583|20467046|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8301419|NCT01545583|20467047|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8301420|NCT01545583|20467048|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8301421|NCT01545583|20467049|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
8301422|NCT01545583|20467050|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
8301423|NCT01545583|20467042|P9|STARTED|Overall Study||6
8301424|NCT01545583|20467043|P8|STARTED|Overall Study||6
8301425|NCT01545583|20467044|P7|STARTED|Overall Study||6
8301426|NCT01545583|20467045|P6|STARTED|Overall Study||6
8301427|NCT01545583|20467046|P5|STARTED|Overall Study||6
8301428|NCT01545583|20467047|P4|STARTED|Overall Study||6
8301429|NCT01545583|20467048|P3|STARTED|Overall Study||6
8301430|NCT01545583|20467049|P2|STARTED|Overall Study||2
8301431|NCT01545583|20467050|P1|STARTED|Overall Study||12
8301432|NCT01545518|20467102|P1|NOT COMPLETED|Overall Study||0
8301433|NCT01545518|20467102|P1|COMPLETED|Overall Study||20
8301434|NCT01545518|20467102|P1|STARTED|Overall Study||20
8301435|NCT01545388|20467109|P3|NOT COMPLETED|Overall Study||8
8301436|NCT01545388|20467110|P2|NOT COMPLETED|Overall Study||11
8301437|NCT01545388|20467111|P1|NOT COMPLETED|Overall Study||8
8301438|NCT01545388|20467109|P3|COMPLETED|Overall Study||58
8301439|NCT01545388|20467110|P2|COMPLETED|Overall Study||122
8301440|NCT01545388|20467111|P1|COMPLETED|Overall Study||130
8301441|NCT01545388|20467109|P3|STARTED|Overall Study||66
8301442|NCT01545388|20467110|P2|STARTED|Overall Study||133
8301443|NCT01545388|20467111|P1|STARTED|Overall Study||138
8301444|NCT01545375|20467130|P2|NOT COMPLETED|Overall Study||90
8301445|NCT01545375|20467131|P1|NOT COMPLETED|Overall Study||97
8301446|NCT01545375|20467130|P2|COMPLETED|Overall Study||813
8301447|NCT01545375|20467131|P1|COMPLETED|Overall Study||803
8301448|NCT01545375|20467130|P2|STARTED|Overall Study||903
8301449|NCT01545375|20467131|P1|STARTED|Overall Study||900
8301450|NCT01545336|20467187|P2|NOT COMPLETED|Overall Study||0
8301451|NCT01545336|20467188|P1|NOT COMPLETED|Overall Study||0
8301452|NCT01545336|20467187|P2|COMPLETED|Overall Study||6
8301453|NCT01545336|20467188|P1|COMPLETED|Overall Study||12
8301454|NCT01545336|20467187|P2|STARTED|Overall Study||6
8301455|NCT01545336|20467188|P1|STARTED|Overall Study||12
8301456|NCT01545232|20467200|P2|NOT COMPLETED|Overall Study||0
8301457|NCT01545232|20467201|P1|NOT COMPLETED|Overall Study||0
8301458|NCT01545232|20467200|P2|COMPLETED|Overall Study||342
8301459|NCT01545232|20467201|P1|COMPLETED|Overall Study||338
8301460|NCT01545232|20467200|P2|STARTED|Overall Study||342
8301461|NCT01545232|20467201|P1|STARTED|Overall Study||338
8301462|NCT01545193|20467233|P2|NOT COMPLETED|Overall Study||1
8301463|NCT01545193|20467234|P1|NOT COMPLETED|Overall Study||0
8301464|NCT01545193|20467233|P2|COMPLETED|Overall Study||149
8301465|NCT01545193|20467234|P1|COMPLETED|Overall Study||150
8301466|NCT01545193|20467233|P2|STARTED|Overall Study||150
8301467|NCT01545193|20467234|P1|STARTED|Overall Study||150
8301468|NCT01545141|20467250|P4|NOT COMPLETED|Overall Study||0
8301469|NCT01545141|20467251|P3|NOT COMPLETED|Overall Study||0
8301470|NCT01545141|20467252|P2|NOT COMPLETED|Overall Study||0
8301471|NCT01545141|20467253|P1|NOT COMPLETED|Overall Study||0
8301472|NCT01545141|20467250|P4|COMPLETED|Overall Study||7
8301473|NCT01545141|20467251|P3|COMPLETED|Overall Study||3
8301474|NCT01545141|20467252|P2|COMPLETED|Overall Study||3
8301475|NCT01545141|20467253|P1|COMPLETED|Overall Study||2
8301476|NCT01545141|20467250|P4|STARTED|Overall Study||7
8301477|NCT01545141|20467251|P3|STARTED|Overall Study||3
8301478|NCT01545141|20467252|P2|STARTED|Overall Study||3
8301479|NCT01545141|20467253|P1|STARTED|Overall Study||2
8301480|NCT01545076|20467263|P5|NOT COMPLETED|IgPro10 Rescue Period||0
8301481|NCT01545076|20467264|P4|NOT COMPLETED|IgPro10 Rescue Period||0
8301482|NCT01545076|20467265|P3|NOT COMPLETED|IgPro10 Rescue Period||0
8301483|NCT01545076|20467266|P2|NOT COMPLETED|IgPro10 Rescue Period||0
8301484|NCT01545076|20467267|P1|NOT COMPLETED|IgPro10 Rescue Period||0
8301485|NCT01545076|20467263|P5|COMPLETED|IgPro10 Rescue Period||60
8301486|NCT01545076|20467264|P4|COMPLETED|IgPro10 Rescue Period||0
8301487|NCT01545076|20467265|P3|COMPLETED|IgPro10 Rescue Period||0
8301488|NCT01545076|20467266|P2|COMPLETED|IgPro10 Rescue Period||0
8301489|NCT01545076|20467267|P1|COMPLETED|IgPro10 Rescue Period||0
8301490|NCT01545076|20467263|P5|STARTED|IgPro10 Rescue Period||60
8301491|NCT01545076|20467264|P4|STARTED|IgPro10 Rescue Period||0
8301492|NCT01545076|20467265|P3|STARTED|IgPro10 Rescue Period||0
8301493|NCT01545076|20467266|P2|STARTED|IgPro10 Rescue Period||0
8301494|NCT01545076|20467267|P1|STARTED|IgPro10 Rescue Period||0
8301495|NCT01545076|20467263|P5|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
8301496|NCT01545076|20467264|P4|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
8301497|NCT01545076|20467265|P3|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
8301498|NCT01545076|20467266|P2|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
8301499|NCT01545076|20467267|P1|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
8301500|NCT01545076|20467263|P5|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
8301501|NCT01545076|20467264|P4|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
8301502|NCT01545076|20467265|P3|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
8301503|NCT01545076|20467266|P2|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
8301504|NCT01545076|20467267|P1|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
8301505|NCT01545076|20467263|P5|STARTED|IgPro20 Subcutaneous Treatment Period||0
8301506|NCT01545076|20467264|P4|STARTED|IgPro20 Subcutaneous Treatment Period||57
8301507|NCT01545076|20467265|P3|STARTED|IgPro20 Subcutaneous Treatment Period||57
8301508|NCT01545076|20467266|P2|STARTED|IgPro20 Subcutaneous Treatment Period||58
8301509|NCT01545076|20467267|P1|STARTED|IgPro20 Subcutaneous Treatment Period||0
8301510|NCT01545076|20467263|P5|NOT COMPLETED|IgPro10 Restabilization Period||0
8301511|NCT01545076|20467264|P4|NOT COMPLETED|IgPro10 Restabilization Period||0
8301512|NCT01545076|20467265|P3|NOT COMPLETED|IgPro10 Restabilization Period||0
8301513|NCT01545076|20467266|P2|NOT COMPLETED|IgPro10 Restabilization Period||0
8301514|NCT01545076|20467267|P1|NOT COMPLETED|IgPro10 Restabilization Period||36
8301515|NCT01545076|20467263|P5|COMPLETED|IgPro10 Restabilization Period||0
8301516|NCT01545076|20467264|P4|COMPLETED|IgPro10 Restabilization Period||0
8301517|NCT01545076|20467265|P3|COMPLETED|IgPro10 Restabilization Period||0
8301518|NCT01545076|20467266|P2|COMPLETED|IgPro10 Restabilization Period||0
8301519|NCT01545076|20467267|P1|COMPLETED|IgPro10 Restabilization Period||172
8301520|NCT01545076|20467263|P5|STARTED|IgPro10 Restabilization Period||0
8301521|NCT01545076|20467264|P4|STARTED|IgPro10 Restabilization Period||0
8301522|NCT01545076|20467265|P3|STARTED|IgPro10 Restabilization Period||0
8301523|NCT01545076|20467266|P2|STARTED|IgPro10 Restabilization Period||0
8301524|NCT01545076|20467267|P1|STARTED|IgPro10 Restabilization Period||208
8301525|NCT01544998|20467317|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
8301526|NCT01544998|20467318|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
8301527|NCT01544998|20467317|P2|COMPLETED|Second Intervention (3 Hours)||15
8301528|NCT01544998|20467318|P1|COMPLETED|Second Intervention (3 Hours)||26
8301529|NCT01544998|20467317|P2|STARTED|Second Intervention (3 Hours)||15
8301530|NCT01544998|20467318|P1|STARTED|Second Intervention (3 Hours)||26
8301531|NCT01544998|20467317|P2|NOT COMPLETED|Washout (1 Week)||0
8301532|NCT01544998|20467318|P1|NOT COMPLETED|Washout (1 Week)||0
8301533|NCT01544998|20467317|P2|COMPLETED|Washout (1 Week)||15
8301534|NCT01544998|20467318|P1|COMPLETED|Washout (1 Week)||26
8301535|NCT01544998|20467317|P2|STARTED|Washout (1 Week)||15
8301536|NCT01544998|20467318|P1|STARTED|Washout (1 Week)||26
8301537|NCT01544998|20467317|P2|NOT COMPLETED|First Intervention (3 Hours)||0
8301538|NCT01544998|20467318|P1|NOT COMPLETED|First Intervention (3 Hours)||0
8301539|NCT01544998|20467317|P2|COMPLETED|First Intervention (3 Hours)||15
8301540|NCT01544998|20467318|P1|COMPLETED|First Intervention (3 Hours)||26
8301541|NCT01544998|20467317|P2|STARTED|First Intervention (3 Hours)||15
8301542|NCT01544998|20467318|P1|STARTED|First Intervention (3 Hours)||26
8301543|NCT01544920|20467338|P2|NOT COMPLETED|Overall Study||23
8301544|NCT01544920|20467339|P1|NOT COMPLETED|Overall Study||19
8301545|NCT01544920|20467338|P2|COMPLETED|Overall Study||346
8301546|NCT01544920|20467339|P1|COMPLETED|Overall Study||349
8301547|NCT01544920|20467338|P2|STARTED|Overall Study||369
8301548|NCT01544920|20467339|P1|STARTED|Overall Study||368
8301549|NCT01544595|20467353|P6|NOT COMPLETED|Status at Week 156||15
8301550|NCT01544595|20467354|P5|NOT COMPLETED|Status at Week 156||38
8301551|NCT01544595|20467355|P4|NOT COMPLETED|Status at Week 156||166
8301552|NCT01544595|20467356|P3|NOT COMPLETED|Status at Week 156||140
8301553|NCT01544595|20467357|P2|NOT COMPLETED|Status at Week 156||78
8301554|NCT01544595|20467358|P1|NOT COMPLETED|Status at Week 156||117
8301555|NCT01544595|20467353|P6|COMPLETED|Status at Week 156||38
8301556|NCT01544595|20467354|P5|COMPLETED|Status at Week 156||60
8301557|NCT01544595|20467355|P4|COMPLETED|Status at Week 156||15
8301558|NCT01544595|20467356|P3|COMPLETED|Status at Week 156||10
8301559|NCT01544595|20467357|P2|COMPLETED|Status at Week 156||285
8301560|NCT01544595|20467358|P1|COMPLETED|Status at Week 156||184
8301561|NCT01544595|20467353|P6|STARTED|Status at Week 156||53
8301562|NCT01544595|20467354|P5|STARTED|Status at Week 156||98
8301563|NCT01544595|20467355|P4|STARTED|Status at Week 156||181
8301564|NCT01544595|20467356|P3|STARTED|Status at Week 156||150
8301565|NCT01544595|20467357|P2|STARTED|Status at Week 156||363
8301566|NCT01544595|20467358|P1|STARTED|Status at Week 156||301
8301567|NCT01544595|20467353|P6|NOT COMPLETED|Status at Week 68||0
8301568|NCT01544595|20467354|P5|NOT COMPLETED|Status at Week 68||0
8301569|NCT01544595|20467355|P4|NOT COMPLETED|Status at Week 68||51
8301570|NCT01544595|20467356|P3|NOT COMPLETED|Status at Week 68||63
8301571|NCT01544595|20467357|P2|NOT COMPLETED|Status at Week 68||17
8301572|NCT01544595|20467358|P1|NOT COMPLETED|Status at Week 68||39
8301573|NCT01544595|20467353|P6|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
8301574|NCT01544595|20467354|P5|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
8301575|NCT01544595|20467355|P4|COMPLETED|Status at Week 68||130
8301576|NCT01544595|20467356|P3|COMPLETED|Status at Week 68||87
8301577|NCT01544595|20467357|P2|COMPLETED|Status at Week 68||346
8301578|NCT01544595|20467358|P1|COMPLETED|Status at Week 68||262
8301579|NCT01544595|20467353|P6|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
8301580|NCT01544595|20467354|P5|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
8301581|NCT01544595|20467355|P4|STARTED|Status at Week 68||181
8301582|NCT01544595|20467356|P3|STARTED|Status at Week 68||150
8301583|NCT01544595|20467357|P2|STARTED|Status at Week 68||363
8301584|NCT01544595|20467358|P1|STARTED|Status at Week 68||301
8301585|NCT01544582|20467434|P4|NOT COMPLETED|Analysis Population||39
8301586|NCT01544582|20467435|P3|NOT COMPLETED|Analysis Population||102
8301587|NCT01544582|20467436|P2|NOT COMPLETED|Analysis Population||118
8301588|NCT01544582|20467437|P1|NOT COMPLETED|Analysis Population||0
8301589|NCT01544582|20467434|P4|COMPLETED|Analysis Population||35
8301590|NCT01544582|20467435|P3|COMPLETED|Analysis Population||205
8301591|NCT01544582|20467436|P2|COMPLETED|Analysis Population||180
8301592|NCT01544582|20467437|P1|COMPLETED|Analysis Population||0
8301593|NCT01544582|20467434|P4|STARTED|Analysis Population||74
8301594|NCT01544582|20467435|P3|STARTED|Analysis Population||307
8301595|NCT01544582|20467436|P2|STARTED|Analysis Population||298
8301596|NCT01544582|20467437|P1|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
8301597|NCT01544582|20467434|P4|NOT COMPLETED|Screening/Eligibility||0
8301598|NCT01544582|20467435|P3|NOT COMPLETED|Screening/Eligibility||0
8301599|NCT01544582|20467436|P2|NOT COMPLETED|Screening/Eligibility||0
8301600|NCT01544582|20467437|P1|NOT COMPLETED|Screening/Eligibility||34
8301601|NCT01544582|20467434|P4|COMPLETED|Screening/Eligibility||0
8301602|NCT01544582|20467435|P3|COMPLETED|Screening/Eligibility||0
8301603|NCT01544582|20467436|P2|COMPLETED|Screening/Eligibility||0
8301604|NCT01544582|20467437|P1|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
8301605|NCT01544582|20467434|P4|Analysis Population|Screening/Eligibility||0
8301606|NCT01544582|20467435|P3|Analysis Population|Screening/Eligibility||0
8301607|NCT01544582|20467436|P2|Analysis Population|Screening/Eligibility||0
8301608|NCT01544582|20467437|P1|Analysis Population|Screening/Eligibility||679
8301609|NCT01544582|20467434|P4|STARTED|Screening/Eligibility||0
8301610|NCT01544582|20467435|P3|STARTED|Screening/Eligibility||0
8301611|NCT01544582|20467436|P2|STARTED|Screening/Eligibility||0
8301612|NCT01544582|20467437|P1|STARTED|Screening/Eligibility||713
8301613|NCT01544491|20467497|P2|NOT COMPLETED|Overall Study||3
8301614|NCT01544491|20467498|P1|NOT COMPLETED|Overall Study||5
8301615|NCT01544491|20467497|P2|COMPLETED|Overall Study||51
8301616|NCT01544491|20467498|P1|COMPLETED|Overall Study||47
8301617|NCT01544491|20467497|P2|STARTED|Overall Study||54
8301618|NCT01544491|20467498|P1|STARTED|Overall Study||52
8301619|NCT01544478|20467524|P1|NOT COMPLETED|Overall Study||118
8301620|NCT01544478|20467524|P1|COMPLETED|Overall Study||912
8301621|NCT01544478|20467524|P1|Vaccination 3|Overall Study||1019
8301622|NCT01544478|20467524|P1|Vaccination 2|Overall Study||1026
8301623|NCT01544478|20467524|P1|Vaccination 1|Overall Study||1030
8301624|NCT01544478|20467524|P1|STARTED|Overall Study||1030
8301625|NCT01544361|20467533|P5|NOT COMPLETED|Overall Study||0
8301626|NCT01544361|20467534|P4|NOT COMPLETED|Overall Study||0
8301627|NCT01544361|20467535|P3|NOT COMPLETED|Overall Study||0
8301628|NCT01544361|20467536|P2|NOT COMPLETED|Overall Study||0
8301629|NCT01544361|20467537|P1|NOT COMPLETED|Overall Study||0
8301630|NCT01544361|20467533|P5|COMPLETED|Overall Study||6
8301631|NCT01544361|20467534|P4|COMPLETED|Overall Study||6
8301632|NCT01544361|20467535|P3|COMPLETED|Overall Study||6
8301633|NCT01544361|20467536|P2|COMPLETED|Overall Study||6
8301634|NCT01544361|20467537|P1|COMPLETED|Overall Study||8
8301635|NCT01544361|20467533|P5|STARTED|Overall Study||6
8301636|NCT01544361|20467534|P4|STARTED|Overall Study||6
8301637|NCT01544361|20467535|P3|STARTED|Overall Study||6
8301638|NCT01544361|20467536|P2|STARTED|Overall Study||6
8301639|NCT01544361|20467537|P1|STARTED|Overall Study||8
8301640|NCT01544348|20467567|P8|NOT COMPLETED|Overall Study||0
8301641|NCT01544348|20467568|P7|NOT COMPLETED|Overall Study||2
8301642|NCT01544348|20467569|P6|NOT COMPLETED|Overall Study||3
8301643|NCT01544348|20467570|P5|NOT COMPLETED|Overall Study||1
8301644|NCT01544348|20467571|P4|NOT COMPLETED|Overall Study||0
8301645|NCT01544348|20467572|P3|NOT COMPLETED|Overall Study||0
8301646|NCT01544348|20467573|P2|NOT COMPLETED|Overall Study||0
8301647|NCT01544348|20467574|P1|NOT COMPLETED|Overall Study||2
8301648|NCT01544348|20467567|P8|COMPLETED|Overall Study||8
8301649|NCT01544348|20467568|P7|COMPLETED|Overall Study||12
8301650|NCT01544348|20467569|P6|COMPLETED|Overall Study||16
8301651|NCT01544348|20467570|P5|COMPLETED|Overall Study||15
8301652|NCT01544348|20467571|P4|COMPLETED|Overall Study||3
8301653|NCT01544348|20467572|P3|COMPLETED|Overall Study||3
8301654|NCT01544348|20467573|P2|COMPLETED|Overall Study||6
8301655|NCT01544348|20467574|P1|COMPLETED|Overall Study||15
8301656|NCT01544348|20467567|P8|Treated|Overall Study||8
8301657|NCT01544348|20467568|P7|Treated|Overall Study||14
8301658|NCT01544348|20467569|P6|Treated|Overall Study||18
8301659|NCT01544348|20467570|P5|Treated|Overall Study||15
8301660|NCT01544348|20467571|P4|Treated|Overall Study||3
8301661|NCT01544348|20467572|P3|Treated|Overall Study||3
8301662|NCT01544348|20467573|P2|Treated|Overall Study||6
8301663|NCT01544348|20467574|P1|Treated|Overall Study||17
8301664|NCT01544348|20467567|P8|STARTED|Overall Study||8
8301665|NCT01544348|20467568|P7|STARTED|Overall Study||14
8301666|NCT01544348|20467569|P6|STARTED|Overall Study||19
8301667|NCT01544348|20467570|P5|STARTED|Overall Study||16
8301668|NCT01544348|20467571|P4|STARTED|Overall Study||3
8301669|NCT01544348|20467572|P3|STARTED|Overall Study||3
8301670|NCT01544348|20467573|P2|STARTED|Overall Study||6
8301671|NCT01544348|20467574|P1|STARTED|Overall Study||17
8301672|NCT01544309|20467616|P2|NOT COMPLETED|Overall Study||11
8301673|NCT01544309|20467617|P1|NOT COMPLETED|Overall Study||20
8301674|NCT01544309|20467616|P2|COMPLETED|Overall Study||514
8301675|NCT01544309|20467617|P1|COMPLETED|Overall Study||504
8301676|NCT01544309|20467616|P2|STARTED|Overall Study||525
8301677|NCT01544309|20467617|P1|STARTED|Overall Study||524
8301678|NCT01544179|20467655|P2|NOT COMPLETED|Overall Study||46
8301679|NCT01544179|20467656|P1|NOT COMPLETED|Overall Study||63
8301680|NCT01544179|20467655|P2|COMPLETED|Overall Study|Patients are ongoing in the study|86
8301681|NCT01544179|20467656|P1|COMPLETED|Overall Study|Patients are ongoing in the study|70
8301682|NCT01544179|20467655|P2|Did Not Receive Treatment|Overall Study||0
8301683|NCT01544179|20467656|P1|Did Not Receive Treatment|Overall Study||1
8301684|NCT01544179|20467655|P2|Received Treatment|Overall Study||132
8301685|NCT01544179|20467656|P1|Received Treatment|Overall Study||132
8301686|NCT01544179|20467655|P2|STARTED|Overall Study||132
8301687|NCT01544179|20467656|P1|STARTED|Overall Study||133
8301688|NCT01544166|20467684|P1|NOT COMPLETED|Overall Study||0
8301689|NCT01544166|20467684|P1|COMPLETED|Overall Study||44
8301690|NCT01544166|20467684|P1|STARTED|Overall Study||44
8301691|NCT01544153|20467749|P4|NOT COMPLETED|Overall Study||0
8301692|NCT01544153|20467750|P3|NOT COMPLETED|Overall Study||1
8301693|NCT01544153|20467751|P2|NOT COMPLETED|Overall Study||1
8301694|NCT01544153|20467752|P1|NOT COMPLETED|Overall Study||0
8301695|NCT01544153|20467749|P4|COMPLETED|Overall Study||1317
8301696|NCT01544153|20467750|P3|COMPLETED|Overall Study||1313
8301697|NCT01544153|20467751|P2|COMPLETED|Overall Study||1323
8301698|NCT01544153|20467752|P1|COMPLETED|Overall Study||1337
8301699|NCT01544153|20467749|P4|STARTED|Overall Study||1317
8301700|NCT01544153|20467750|P3|STARTED|Overall Study||1314
8301701|NCT01544153|20467751|P2|STARTED|Overall Study||1324
8301702|NCT01544153|20467752|P1|STARTED|Overall Study||1337
8301703|NCT01544127|20467769|P3|NOT COMPLETED|Overall Study||14
8301704|NCT01544127|20467770|P2|NOT COMPLETED|Overall Study||6
8301705|NCT01544127|20467771|P1|NOT COMPLETED|Overall Study||11
8301706|NCT01544127|20467769|P3|COMPLETED|Overall Study||52
8301707|NCT01544127|20467770|P2|COMPLETED|Overall Study||27
8301708|NCT01544127|20467771|P1|COMPLETED|Overall Study||22
8301709|NCT01544127|20467769|P3|STARTED|Overall Study||66
8301710|NCT01544127|20467770|P2|STARTED|Overall Study||33
8301711|NCT01544127|20467771|P1|STARTED|Overall Study||33
8301712|NCT01544114|20467791|P3|NOT COMPLETED|Overall Study||5
8301713|NCT01544114|20467792|P2|NOT COMPLETED|Overall Study||4
8301714|NCT01544114|20467793|P1|NOT COMPLETED|Overall Study||1
8301715|NCT01544114|20467791|P3|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
8301716|NCT01544114|20467792|P2|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
8301717|NCT01544114|20467793|P1|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
8301718|NCT01544114|20467791|P3|STARTED|Overall Study||22
8301719|NCT01544114|20467792|P2|STARTED|Overall Study||20
8301720|NCT01544114|20467793|P1|STARTED|Overall Study||4
8301721|NCT01544088|20467824|P2|NOT COMPLETED|Overall Study||21
8301722|NCT01544088|20467825|P1|NOT COMPLETED|Overall Study||37
8301723|NCT01544088|20467824|P2|COMPLETED|Overall Study||79
8301724|NCT01544088|20467825|P1|COMPLETED|Overall Study||61
8301725|NCT01544088|20467824|P2|STARTED|Overall Study||100
8301726|NCT01544088|20467825|P1|STARTED|Overall Study||98
8301727|NCT01544062|20467839|P2|NOT COMPLETED|Overall Study||0
8301728|NCT01544062|20467840|P1|NOT COMPLETED|Overall Study||0
8301729|NCT01544062|20467839|P2|COMPLETED|Overall Study||35
8301730|NCT01544062|20467840|P1|COMPLETED|Overall Study||33
8301731|NCT01544062|20467839|P2|STARTED|Overall Study||35
8301732|NCT01544062|20467840|P1|STARTED|Overall Study||33
8301733|NCT01544023|20467886|P1|NOT COMPLETED|Overall Study||0
8301734|NCT01544023|20467886|P1|COMPLETED|Overall Study||207
8301735|NCT01544023|20467886|P1|STARTED|Overall Study|retrospective|207
8301736|NCT01543958|20467891|P1|NOT COMPLETED|Overall Study||4
8301737|NCT01543958|20467891|P1|COMPLETED|Overall Study||36
8301738|NCT01543958|20467891|P1|STARTED|Overall Study||40
8301739|NCT01543828|20467946|P2|NOT COMPLETED|Treatment 2||0
8301740|NCT01543828|20467947|P1|NOT COMPLETED|Treatment 2||1
8301741|NCT01543828|20467946|P2|COMPLETED|Treatment 2||19
8301742|NCT01543828|20467947|P1|COMPLETED|Treatment 2||19
8301743|NCT01543828|20467946|P2|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
8301744|NCT01543828|20467947|P1|STARTED|Treatment 2||20
8301745|NCT01543828|20467946|P2|NOT COMPLETED|Treatment 1||0
8301746|NCT01543828|20467947|P1|NOT COMPLETED|Treatment 1||0
8301747|NCT01543828|20467946|P2|COMPLETED|Treatment 1||20
8301748|NCT01543828|20467947|P1|COMPLETED|Treatment 1||20
8301749|NCT01543828|20467946|P2|STARTED|Treatment 1||20
8301750|NCT01543828|20467947|P1|STARTED|Treatment 1||20
8301751|NCT01543776|20467957|P2|NOT COMPLETED|Overall Study||2
8301752|NCT01543776|20467958|P1|NOT COMPLETED|Overall Study||2
8301753|NCT01543776|20467957|P2|COMPLETED|Overall Study||34
8301754|NCT01543776|20467958|P1|COMPLETED|Overall Study||34
8301755|NCT01543776|20467957|P2|STARTED|Overall Study||36
8301756|NCT01543776|20467958|P1|STARTED|Overall Study||36
8301757|NCT01543685|20467977|P5|NOT COMPLETED|Overall Study||4
8301758|NCT01543685|20467978|P4|NOT COMPLETED|Overall Study||0
8301759|NCT01543685|20467979|P3|NOT COMPLETED|Overall Study||2
8301760|NCT01543685|20467980|P2|NOT COMPLETED|Overall Study||3
8301761|NCT01543685|20467981|P1|NOT COMPLETED|Overall Study||3
8301762|NCT01543685|20467977|P5|COMPLETED|Overall Study||90
8301763|NCT01543685|20467978|P4|COMPLETED|Overall Study||93
8301764|NCT01543685|20467979|P3|COMPLETED|Overall Study||89
8301765|NCT01543685|20467980|P2|COMPLETED|Overall Study||88
8301766|NCT01543685|20467981|P1|COMPLETED|Overall Study||90
8301767|NCT01543685|20467977|P5|STARTED|Overall Study||94
8301768|NCT01543685|20467978|P4|STARTED|Overall Study||93
8301769|NCT01543685|20467979|P3|STARTED|Overall Study||91
8301770|NCT01543685|20467980|P2|STARTED|Overall Study||91
8301771|NCT01543685|20467981|P1|STARTED|Overall Study||93
8301772|NCT01543607|20468028|P1|NOT COMPLETED|Overall Study||0
8301773|NCT01543607|20468028|P1|COMPLETED|Overall Study||1
8301774|NCT01543607|20468028|P1|STARTED|Overall Study||1
8301775|NCT01543581|20468034|P2|NOT COMPLETED|Overall Study||0
8301776|NCT01543581|20468035|P1|NOT COMPLETED|Overall Study||0
8301777|NCT01543581|20468034|P2|COMPLETED|Overall Study||0
8301778|NCT01543581|20468035|P1|COMPLETED|Overall Study||1
8301779|NCT01543581|20468034|P2|STARTED|Overall Study||0
8301780|NCT01543581|20468035|P1|STARTED|Overall Study||1
8301781|NCT01543568|20468041|P1|NOT COMPLETED|Overall Study||1
8301782|NCT01543568|20468041|P1|COMPLETED|Overall Study||45
8301783|NCT01543568|20468041|P1|STARTED|Overall Study||46
8301784|NCT01543503|20468053|P2|NOT COMPLETED|Overall Study||87
8301785|NCT01543503|20468054|P1|NOT COMPLETED|Overall Study||76
8301786|NCT01543503|20468053|P2|COMPLETED|Overall Study||711
8301787|NCT01543503|20468054|P1|COMPLETED|Overall Study||350
8301788|NCT01543503|20468053|P2|STARTED|Overall Study||798
8301789|NCT01543503|20468054|P1|STARTED|Overall Study||426
8301790|NCT01543204|20468098|P1|NOT COMPLETED|Overall Study||8
8301791|NCT01543204|20468098|P1|COMPLETED|Overall Study||56
8301792|NCT01543204|20468098|P1|STARTED|Overall Study||64
8301793|NCT01543178|20468145|P3|NOT COMPLETED|Double-blind Period||37
8301794|NCT01543178|20468146|P2|NOT COMPLETED|Double-blind Period||44
8301795|NCT01543178|20468147|P1|NOT COMPLETED|Double-blind Period||0
8301796|NCT01543178|20468145|P3|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
8301797|NCT01543178|20468146|P2|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
8301798|NCT01543178|20468147|P1|COMPLETED|Double-blind Period||0
8301799|NCT01543178|20468145|P3|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
8301800|NCT01543178|20468146|P2|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
8301801|NCT01543178|20468147|P1|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
8301802|NCT01543178|20468145|P3|NOT COMPLETED|Open-label Period||0
8301803|NCT01543178|20468146|P2|NOT COMPLETED|Open-label Period||0
8301804|NCT01543178|20468147|P1|NOT COMPLETED|Open-label Period||1947
8301805|NCT01543178|20468145|P3|COMPLETED|Open-label Period||0
8301806|NCT01543178|20468146|P2|COMPLETED|Open-label Period||0
8301807|NCT01543178|20468147|P1|COMPLETED|Open-label Period||636
8301808|NCT01543178|20468145|P3|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
8301809|NCT01543178|20468146|P2|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
8301810|NCT01543178|20468147|P1|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
8301811|NCT01543087|20468160|P6|NOT COMPLETED|Booster Stage (26 Months)||0
8301812|NCT01543087|20468161|P5|NOT COMPLETED|Booster Stage (26 Months)||2
8301813|NCT01543087|20468162|P4|NOT COMPLETED|Booster Stage (26 Months)||0
8301814|NCT01543087|20468163|P3|NOT COMPLETED|Booster Stage (26 Months)||1
8301815|NCT01543087|20468164|P2|NOT COMPLETED|Booster Stage (26 Months)||1
8301816|NCT01543087|20468165|P1|NOT COMPLETED|Booster Stage (26 Months)||0
8301817|NCT01543087|20468160|P6|COMPLETED|Booster Stage (26 Months)||32
8301818|NCT01543087|20468161|P5|COMPLETED|Booster Stage (26 Months)||54
8301819|NCT01543087|20468162|P4|COMPLETED|Booster Stage (26 Months)||64
8301820|NCT01543087|20468163|P3|COMPLETED|Booster Stage (26 Months)||91
8301821|NCT01543087|20468164|P2|COMPLETED|Booster Stage (26 Months)||59
8301822|NCT01543087|20468165|P1|COMPLETED|Booster Stage (26 Months)||0
8301823|NCT01543087|20468160|P6|Vaccinated|Booster Stage (26 Months)||32
8301824|NCT01543087|20468161|P5|Vaccinated|Booster Stage (26 Months)||54
8301825|NCT01543087|20468162|P4|Vaccinated|Booster Stage (26 Months)||64
8301826|NCT01543087|20468163|P3|Vaccinated|Booster Stage (26 Months)||92
8301827|NCT01543087|20468164|P2|Vaccinated|Booster Stage (26 Months)||59
8301828|NCT01543087|20468165|P1|Vaccinated|Booster Stage (26 Months)||0
8301829|NCT01543087|20468160|P6|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|32
8301830|NCT01543087|20468161|P5|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|56
8301831|NCT01543087|20468162|P4|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|64
8301832|NCT01543087|20468163|P3|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|92
8301833|NCT01543087|20468164|P2|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|60
8301834|NCT01543087|20468165|P1|STARTED|Booster Stage (26 Months)|Group1 participants (primary study B1971015)were not invited to participate in Booster stage (BS).|0
8301835|NCT01543087|20468160|P6|NOT COMPLETED|Stage 1 (48 Months)||0
8301836|NCT01543087|20468161|P5|NOT COMPLETED|Stage 1 (48 Months)||3
8301837|NCT01543087|20468162|P4|NOT COMPLETED|Stage 1 (48 Months)||8
8301838|NCT01543087|20468163|P3|NOT COMPLETED|Stage 1 (48 Months)||40
8301839|NCT01543087|20468164|P2|NOT COMPLETED|Stage 1 (48 Months)||10
8301840|NCT01543087|20468165|P1|NOT COMPLETED|Stage 1 (48 Months)||14
8301841|NCT01543087|20468160|P6|COMPLETED|Stage 1 (48 Months)||46
8301842|NCT01543087|20468161|P5|COMPLETED|Stage 1 (48 Months)||83
8301843|NCT01543087|20468162|P4|COMPLETED|Stage 1 (48 Months)||108
8301844|NCT01543087|20468163|P3|COMPLETED|Stage 1 (48 Months)||237
8301845|NCT01543087|20468164|P2|COMPLETED|Stage 1 (48 Months)||93
8301846|NCT01543087|20468165|P1|COMPLETED|Stage 1 (48 Months)||56
8301847|NCT01543087|20468160|P6|Safety Population|Stage 1 (48 Months)||46
8301848|NCT01543087|20468161|P5|Safety Population|Stage 1 (48 Months)||86
8301849|NCT01543087|20468162|P4|Safety Population|Stage 1 (48 Months)||116
8301850|NCT01543087|20468163|P3|Safety Population|Stage 1 (48 Months)||277
8301851|NCT01543087|20468164|P2|Safety Population|Stage 1 (48 Months)||101
8301852|NCT01543087|20468165|P1|Safety Population|Stage 1 (48 Months)||70
8301853|NCT01543087|20468160|P6|STARTED|Stage 1 (48 Months)||46
8301854|NCT01543087|20468161|P5|STARTED|Stage 1 (48 Months)||86
8301855|NCT01543087|20468162|P4|STARTED|Stage 1 (48 Months)||116
8301856|NCT01543087|20468163|P3|STARTED|Stage 1 (48 Months)||277
8301857|NCT01543087|20468164|P2|STARTED|Stage 1 (48 Months)||103
8301858|NCT01543087|20468165|P1|STARTED|Stage 1 (48 Months)||70
8301859|NCT01543074|20468306|P4|NOT COMPLETED|Overall Study||0
8301860|NCT01543074|20468307|P3|NOT COMPLETED|Overall Study||0
8301861|NCT01543074|20468308|P2|NOT COMPLETED|Overall Study||0
8301862|NCT01543074|20468309|P1|NOT COMPLETED|Overall Study||0
8301863|NCT01543074|20468306|P4|COMPLETED|Overall Study||6
8301864|NCT01543074|20468307|P3|COMPLETED|Overall Study||5
8301865|NCT01543074|20468308|P2|COMPLETED|Overall Study||7
8301866|NCT01543074|20468309|P1|COMPLETED|Overall Study||5
8301867|NCT01543074|20468306|P4|STARTED|Overall Study||6
8301868|NCT01543074|20468307|P3|STARTED|Overall Study||5
8301869|NCT01543074|20468308|P2|STARTED|Overall Study||7
8301870|NCT01543074|20468309|P1|STARTED|Overall Study||5
8301871|NCT01542957|20468329|P2|NOT COMPLETED|12-month Follow-up||13
8301872|NCT01542957|20468330|P1|NOT COMPLETED|12-month Follow-up||16
8301873|NCT01542957|20468329|P2|COMPLETED|12-month Follow-up||40
8301874|NCT01542957|20468330|P1|COMPLETED|12-month Follow-up||37
8301875|NCT01542957|20468329|P2|STARTED|12-month Follow-up||53
8301876|NCT01542957|20468330|P1|STARTED|12-month Follow-up||53
8301877|NCT01542957|20468329|P2|NOT COMPLETED|3-month Follow-up||8
8301878|NCT01542957|20468330|P1|NOT COMPLETED|3-month Follow-up||3
8301879|NCT01542957|20468329|P2|COMPLETED|3-month Follow-up||45
8301880|NCT01542957|20468330|P1|COMPLETED|3-month Follow-up||50
8301881|NCT01542957|20468329|P2|STARTED|3-month Follow-up||53
8301882|NCT01542957|20468330|P1|STARTED|3-month Follow-up||53
8301883|NCT01542957|20468329|P2|NOT COMPLETED|End of Therapy||10
8301884|NCT01542957|20468330|P1|NOT COMPLETED|End of Therapy||12
8301885|NCT01542957|20468329|P2|COMPLETED|End of Therapy||53
8301886|NCT01542957|20468330|P1|COMPLETED|End of Therapy||53
8301887|NCT01542957|20468329|P2|STARTED|End of Therapy||63
8301888|NCT01542957|20468330|P1|STARTED|End of Therapy||65
8301889|NCT01542788|20468342|P2|NOT COMPLETED|Overall Study||71
8301890|NCT01542788|20468343|P1|NOT COMPLETED|Overall Study||55
8301891|NCT01542788|20468342|P2|COMPLETED|Overall Study||0
8301892|NCT01542788|20468343|P1|COMPLETED|Overall Study||154
8301893|NCT01542788|20468342|P2|Randomized and Treated|Overall Study||71
8301894|NCT01542788|20468343|P1|Randomized and Treated|Overall Study||207
8301895|NCT01542788|20468342|P2|STARTED|Overall Study||71
8301896|NCT01542788|20468343|P1|STARTED|Overall Study||209
8301897|NCT01542684|20468359|P1|NOT COMPLETED|Overall Study||0
8301898|NCT01542684|20468359|P1|COMPLETED|Overall Study||8
8301899|NCT01542684|20468359|P1|STARTED|Overall Study||8
8301900|NCT01542645|20468365|P2|NOT COMPLETED|Overall Study||3
8301901|NCT01542645|20468366|P1|NOT COMPLETED|Overall Study||5
8301902|NCT01542645|20468365|P2|COMPLETED|Overall Study||79
8301903|NCT01542645|20468366|P1|COMPLETED|Overall Study||77
8301904|NCT01542645|20468365|P2|STARTED|Overall Study||82
8301905|NCT01542645|20468366|P1|STARTED|Overall Study||82
8301906|NCT01542632|20468390|P6|NOT COMPLETED|Overall Study||0
8301907|NCT01542632|20468391|P5|NOT COMPLETED|Overall Study||4
8301908|NCT01542632|20468392|P4|NOT COMPLETED|Overall Study||2
8301909|NCT01542632|20468393|P3|NOT COMPLETED|Overall Study||1
8301910|NCT01542632|20468394|P2|NOT COMPLETED|Overall Study||1
8301911|NCT01542632|20468395|P1|NOT COMPLETED|Overall Study||0
8301912|NCT01542632|20468390|P6|COMPLETED|Overall Study||24
8301913|NCT01542632|20468391|P5|COMPLETED|Overall Study||17
8301914|NCT01542632|20468392|P4|COMPLETED|Overall Study||19
8301915|NCT01542632|20468393|P3|COMPLETED|Overall Study||23
8301916|NCT01542632|20468394|P2|COMPLETED|Overall Study||24
8301917|NCT01542632|20468395|P1|COMPLETED|Overall Study||25
8301918|NCT01542632|20468390|P6|STARTED|Overall Study||24
8301919|NCT01542632|20468391|P5|STARTED|Overall Study||21
8301920|NCT01542632|20468392|P4|STARTED|Overall Study||21
8301921|NCT01542632|20468393|P3|STARTED|Overall Study||24
8301922|NCT01542632|20468394|P2|STARTED|Overall Study||25
8301923|NCT01542632|20468395|P1|STARTED|Overall Study||25
8301924|NCT01542541|20468441|P2|NOT COMPLETED|Overall Study||0
8301925|NCT01542541|20468442|P1|NOT COMPLETED|Overall Study||8
8301926|NCT01542541|20468441|P2|COMPLETED|Overall Study||30
8301927|NCT01542541|20468442|P1|COMPLETED|Overall Study||30
8301928|NCT01542541|20468441|P2|STARTED|Overall Study||30
8301929|NCT01542541|20468442|P1|STARTED|Overall Study||38
8301930|NCT01542528|20468452|P2|NOT COMPLETED|Overall Study||7
8301931|NCT01542528|20468453|P1|NOT COMPLETED|Overall Study||12
8301932|NCT01542528|20468452|P2|COMPLETED|Overall Study||49
8301933|NCT01542528|20468453|P1|COMPLETED|Overall Study||49
8301934|NCT01542528|20468452|P2|STARTED|Overall Study||56
8301935|NCT01542528|20468453|P1|STARTED|Overall Study||61
8301936|NCT01542502|20468461|P2|NOT COMPLETED|Overall Study||0
8301937|NCT01542502|20468462|P1|NOT COMPLETED|Overall Study||0
8301938|NCT01542502|20468461|P2|COMPLETED|Overall Study||6
8301939|NCT01542502|20468462|P1|COMPLETED|Overall Study||6
8301940|NCT01542502|20468461|P2|STARTED|Overall Study||6
8301941|NCT01542502|20468462|P1|STARTED|Overall Study||6
8301942|NCT01542398|20468472|P2|NOT COMPLETED|Overall Study||13
8301943|NCT01542398|20468473|P1|NOT COMPLETED|Overall Study||8
8301944|NCT01542398|20468472|P2|COMPLETED|Overall Study||67
8301945|NCT01542398|20468473|P1|COMPLETED|Overall Study||71
8301946|NCT01542398|20468472|P2|Post-Intervention Assessment|Overall Study||80
8301947|NCT01542398|20468473|P1|Post-Intervention Assessment|Overall Study||78
8301948|NCT01542398|20468472|P2|STARTED|Overall Study||80
8301949|NCT01542398|20468473|P1|STARTED|Overall Study||79
8301950|NCT01542372|20468481|P2|NOT COMPLETED|Overall Study||0
8301951|NCT01542372|20468482|P1|NOT COMPLETED|Overall Study||0
8301952|NCT01542372|20468481|P2|COMPLETED|Overall Study||11
8301953|NCT01542372|20468482|P1|COMPLETED|Overall Study||11
8301954|NCT01542372|20468481|P2|STARTED|Overall Study||11
8301955|NCT01542372|20468482|P1|STARTED|Overall Study||11
8301956|NCT01542307|20468497|P2|NOT COMPLETED|Overall Study||0
8301957|NCT01542307|20468498|P1|NOT COMPLETED|Overall Study||0
8301958|NCT01542307|20468497|P2|COMPLETED|Overall Study||22
8301959|NCT01542307|20468498|P1|COMPLETED|Overall Study||22
8301960|NCT01542307|20468497|P2|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
8301961|NCT01542307|20468498|P1|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
8301962|NCT01542255|20468518|P1|NOT COMPLETED|Overall Study||0
8301963|NCT01542255|20468518|P1|COMPLETED|Overall Study||7
8301964|NCT01542255|20468518|P1|Analyzed for Time to Progression|Overall Study||7
8301965|NCT01542255|20468518|P1|STARTED|Overall Study||7
8301966|NCT01542229|20468525|P2|NOT COMPLETED|Overall Study||36
8301967|NCT01542229|20468526|P1|NOT COMPLETED|Overall Study||23
8301968|NCT01542229|20468525|P2|COMPLETED|Overall Study||30
8301969|NCT01542229|20468526|P1|COMPLETED|Overall Study||45
8301970|NCT01542229|20468525|P2|STARTED|Overall Study||66
8301971|NCT01542229|20468526|P1|STARTED|Overall Study||68
8301972|NCT01542125|20468552|P2|NOT COMPLETED|Overall Study||0
8301973|NCT01542125|20468553|P1|NOT COMPLETED|Overall Study||0
8301974|NCT01542125|20468552|P2|COMPLETED|Overall Study||141
8301975|NCT01542125|20468553|P1|COMPLETED|Overall Study||140
8301976|NCT01542125|20468552|P2|STARTED|Overall Study||141
8301977|NCT01542125|20468553|P1|STARTED|Overall Study||140
8301978|NCT01542034|20468561|P2|NOT COMPLETED|Overall Study||23
8301979|NCT01542034|20468562|P1|NOT COMPLETED|Overall Study||30
8301980|NCT01542034|20468561|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
8301981|NCT01542034|20468562|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
8301982|NCT01542034|20468561|P2|Received Treatment|Overall Study||249
8301983|NCT01542034|20468562|P1|Received Treatment|Overall Study||256
8301984|NCT01542034|20468561|P2|STARTED|Overall Study||250
8301985|NCT01542034|20468562|P1|STARTED|Overall Study||256
8301986|NCT01541969|20468576|P2|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
8301987|NCT01541969|20468577|P1|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
8301988|NCT01541969|20468576|P2|COMPLETED|Open Label Extension (12-36 Weeks)||35
8301989|NCT01541969|20468577|P1|COMPLETED|Open Label Extension (12-36 Weeks)||33
8301990|NCT01541969|20468576|P2|STARTED|Open Label Extension (12-36 Weeks)||48
8301991|NCT01541969|20468577|P1|STARTED|Open Label Extension (12-36 Weeks)||44
8301992|NCT01541969|20468576|P2|NOT COMPLETED|Double-blind (0-12 Weeks)||2
8301993|NCT01541969|20468577|P1|NOT COMPLETED|Double-blind (0-12 Weeks)||6
8301994|NCT01541969|20468576|P2|COMPLETED|Double-blind (0-12 Weeks)||48
8301995|NCT01541969|20468577|P1|COMPLETED|Double-blind (0-12 Weeks)||44
8301996|NCT01541969|20468576|P2|STARTED|Double-blind (0-12 Weeks)||50
8301997|NCT01541969|20468577|P1|STARTED|Double-blind (0-12 Weeks)||50
8301998|NCT01541930|20468593|P1|NOT COMPLETED|Overall Study||1
8301999|NCT01541930|20468593|P1|COMPLETED|Overall Study||20
8302000|NCT01541930|20468593|P1|STARTED|Overall Study||21
8302001|NCT01541917|20468615|P2|NOT COMPLETED|Overall Study||9
8302002|NCT01541917|20468616|P1|NOT COMPLETED|Overall Study||15
8302003|NCT01541917|20468615|P2|COMPLETED|Overall Study||136
8302004|NCT01541917|20468616|P1|COMPLETED|Overall Study||129
8302005|NCT01541917|20468615|P2|STARTED|Overall Study||145
8302006|NCT01541917|20468616|P1|STARTED|Overall Study||144
8302007|NCT01541891|20468634|P2|NOT COMPLETED|Overall Study||1
8302008|NCT01541891|20468635|P1|NOT COMPLETED|Overall Study||1
8302009|NCT01541891|20468634|P2|COMPLETED|Overall Study||14
8302010|NCT01541891|20468635|P1|COMPLETED|Overall Study||14
8302011|NCT01541891|20468634|P2|STARTED|Overall Study||15
8302012|NCT01541891|20468635|P1|STARTED|Overall Study||15
8302013|NCT01541865|20468645|P1|NOT COMPLETED|Overall Study||22
8302014|NCT01541865|20468645|P1|COMPLETED|Overall Study||124
8302015|NCT01541865|20468645|P1|STARTED|Overall Study||146
8302016|NCT01541826|20468663|P3|NOT COMPLETED|Overall Study||0
8302017|NCT01541826|20468664|P2|NOT COMPLETED|Overall Study||3
8302018|NCT01541826|20468665|P1|NOT COMPLETED|Overall Study||4
8302019|NCT01541826|20468663|P3|COMPLETED|Overall Study||6
8302020|NCT01541826|20468664|P2|COMPLETED|Overall Study||25
8302021|NCT01541826|20468665|P1|COMPLETED|Overall Study||24
8302022|NCT01541826|20468663|P3|STARTED|Overall Study||6
8302023|NCT01541826|20468664|P2|STARTED|Overall Study||28
8302024|NCT01541826|20468665|P1|STARTED|Overall Study||28
8302025|NCT01541748|20468732|P1|NOT COMPLETED|Overall Study||31
8302026|NCT01541748|20468732|P1|COMPLETED|Overall Study||43
8302027|NCT01541748|20468732|P1|STARTED|Overall Study|74 subjects were consented; however, 5 were screen failures and 1 did not receive the study device.|74
8302028|NCT01541735|20468755|P2|NOT COMPLETED|Overall Study||0
8302029|NCT01541735|20468756|P1|NOT COMPLETED|Overall Study||0
8302030|NCT01541735|20468755|P2|COMPLETED|Overall Study||7
8302031|NCT01541735|20468756|P1|COMPLETED|Overall Study||7
8302032|NCT01541735|20468755|P2|STARTED|Overall Study||7
8302033|NCT01541735|20468756|P1|STARTED|Overall Study||7
8302034|NCT01541644|20468768|P1|NOT COMPLETED|Overall Study||3
8302035|NCT01541644|20468768|P1|COMPLETED|Overall Study||24
8302036|NCT01541644|20468768|P1|STARTED|Overall Study||27
8302037|NCT01541553|20468774|P2|NOT COMPLETED|Overall Study||14
8302038|NCT01541553|20468775|P1|NOT COMPLETED|Overall Study||12
8302039|NCT01541553|20468774|P2|COMPLETED|Overall Study||148
8302040|NCT01541553|20468775|P1|COMPLETED|Overall Study||155
8302041|NCT01541553|20468774|P2|STARTED|Overall Study||162
8302042|NCT01541553|20468775|P1|STARTED|Overall Study||167
8302043|NCT01541397|20468787|P2|NOT COMPLETED|Overall Study||2
8302044|NCT01541397|20468788|P1|NOT COMPLETED|Overall Study||4
8302045|NCT01541397|20468787|P2|COMPLETED|Overall Study||0
8302046|NCT01541397|20468788|P1|COMPLETED|Overall Study||0
8302047|NCT01541397|20468787|P2|STARTED|Overall Study||2
8302048|NCT01541397|20468788|P1|STARTED|Overall Study||4
8302049|NCT01541384|20468803|P3|NOT COMPLETED|Overall Study||2
8302050|NCT01541384|20468804|P2|NOT COMPLETED|Overall Study||1
8302051|NCT01541384|20468805|P1|NOT COMPLETED|Overall Study||0
8302052|NCT01541384|20468803|P3|COMPLETED|Overall Study||38
8302053|NCT01541384|20468804|P2|COMPLETED|Overall Study||39
8302054|NCT01541384|20468805|P1|COMPLETED|Overall Study||40
8302055|NCT01541384|20468803|P3|STARTED|Overall Study||40
8302056|NCT01541384|20468804|P2|STARTED|Overall Study||40
8302057|NCT01541384|20468805|P1|STARTED|Overall Study||40
8302058|NCT01541371|20468813|P1|NOT COMPLETED|Overall Study||77
8302059|NCT01541371|20468813|P1|COMPLETED|Overall Study||326
8302060|NCT01541371|20468813|P1|Full Analysis Set|Overall Study||394
8302061|NCT01541371|20468813|P1|STARTED|Overall Study||403
8302062|NCT01541358|20468836|P1|NOT COMPLETED|Overall Study||0
8302063|NCT01541358|20468836|P1|COMPLETED|Overall Study||2
8302064|NCT01541358|20468836|P1|STARTED|Overall Study||2
8302065|NCT01541254|20468842|P1|NOT COMPLETED|Overall Study||6
8302066|NCT01541254|20468842|P1|COMPLETED|Overall Study||30
8302067|NCT01541254|20468842|P1|STARTED|Overall Study||36
8302082|NCT01540981|20468996|P2|NOT COMPLETED|Overall Study||0
8302083|NCT01540981|20468997|P1|NOT COMPLETED|Overall Study||1
8302084|NCT01540981|20468996|P2|COMPLETED|Overall Study||6
8302085|NCT01540981|20468997|P1|COMPLETED|Overall Study||5
8302086|NCT01540981|20468996|P2|STARTED|Overall Study||6
8302087|NCT01540981|20468997|P1|STARTED|Overall Study||6
8302088|NCT01540851|20469007|P2|NOT COMPLETED|Overall Study||18
8302089|NCT01540851|20469008|P1|NOT COMPLETED|Overall Study||21
8302090|NCT01540851|20469007|P2|COMPLETED|Overall Study||136
8302091|NCT01540851|20469008|P1|COMPLETED|Overall Study||133
8302092|NCT01540851|20469007|P2|STARTED|Overall Study||154
8302093|NCT01540851|20469008|P1|STARTED|Overall Study||154
8302094|NCT01540838|20469020|P2|NOT COMPLETED|Overall Study||23
8302095|NCT01540838|20469021|P1|NOT COMPLETED|Overall Study||22
8302096|NCT01540838|20469020|P2|COMPLETED|Overall Study||164
8302097|NCT01540838|20469021|P1|COMPLETED|Overall Study||166
8302098|NCT01540838|20469020|P2|STARTED|Overall Study||187
8302099|NCT01540838|20469021|P1|STARTED|Overall Study||188
8302100|NCT01540825|20469054|P11|NOT COMPLETED|Overall Study||0
8302101|NCT01540825|20469055|P10|NOT COMPLETED|Overall Study||0
8302102|NCT01540825|20469056|P9|NOT COMPLETED|Overall Study||0
8302103|NCT01540825|20469057|P8|NOT COMPLETED|Overall Study||0
8302104|NCT01540825|20469058|P7|NOT COMPLETED|Overall Study||0
8302105|NCT01540825|20469059|P6|NOT COMPLETED|Overall Study||0
8302106|NCT01540825|20469060|P5|NOT COMPLETED|Overall Study||0
8302107|NCT01540825|20469061|P4|NOT COMPLETED|Overall Study||0
8302108|NCT01540825|20469062|P3|NOT COMPLETED|Overall Study||0
8302109|NCT01540825|20469063|P2|NOT COMPLETED|Overall Study||0
8302110|NCT01540825|20469064|P1|NOT COMPLETED|Overall Study||0
8302111|NCT01540825|20469054|P11|COMPLETED|Overall Study||6
8302112|NCT01540825|20469055|P10|COMPLETED|Overall Study||6
8302113|NCT01540825|20469056|P9|COMPLETED|Overall Study||6
8302114|NCT01540825|20469057|P8|COMPLETED|Overall Study||6
8302115|NCT01540825|20469058|P7|COMPLETED|Overall Study||6
8302116|NCT01540825|20469059|P6|COMPLETED|Overall Study||6
8302117|NCT01540825|20469060|P5|COMPLETED|Overall Study||6
8302118|NCT01540825|20469061|P4|COMPLETED|Overall Study||6
8302119|NCT01540825|20469062|P3|COMPLETED|Overall Study||6
8302120|NCT01540825|20469063|P2|COMPLETED|Overall Study||6
8302121|NCT01540825|20469064|P1|COMPLETED|Overall Study||20
8302122|NCT01540825|20469054|P11|STARTED|Overall Study||6
8302123|NCT01540825|20469055|P10|STARTED|Overall Study||6
8302124|NCT01540825|20469056|P9|STARTED|Overall Study||6
8302125|NCT01540825|20469057|P8|STARTED|Overall Study||6
8302126|NCT01540825|20469058|P7|STARTED|Overall Study||6
8302127|NCT01540825|20469059|P6|STARTED|Overall Study||6
8302128|NCT01540825|20469060|P5|STARTED|Overall Study||6
8302129|NCT01540825|20469061|P4|STARTED|Overall Study||6
8302130|NCT01540825|20469062|P3|STARTED|Overall Study||6
8302131|NCT01540825|20469063|P2|STARTED|Overall Study||6
8302132|NCT01540825|20469064|P1|STARTED|Overall Study||20
8302133|NCT01540773|20469160|P2|NOT COMPLETED|Second Intervention||0
8302134|NCT01540773|20469161|P1|NOT COMPLETED|Second Intervention||0
8302135|NCT01540773|20469160|P2|COMPLETED|Second Intervention||8
8302136|NCT01540773|20469161|P1|COMPLETED|Second Intervention||8
8302137|NCT01540773|20469160|P2|STARTED|Second Intervention||8
8302138|NCT01540773|20469161|P1|STARTED|Second Intervention||8
8302139|NCT01540773|20469160|P2|NOT COMPLETED|Wash Out Period of 1 Week||0
8302140|NCT01540773|20469161|P1|NOT COMPLETED|Wash Out Period of 1 Week||0
8302141|NCT01540773|20469160|P2|COMPLETED|Wash Out Period of 1 Week||8
8302142|NCT01540773|20469161|P1|COMPLETED|Wash Out Period of 1 Week||8
8302143|NCT01540773|20469160|P2|STARTED|Wash Out Period of 1 Week||8
8302144|NCT01540773|20469161|P1|STARTED|Wash Out Period of 1 Week||8
8302145|NCT01540773|20469160|P2|NOT COMPLETED|First Intervention||0
8302146|NCT01540773|20469161|P1|NOT COMPLETED|First Intervention||0
8302147|NCT01540773|20469160|P2|COMPLETED|First Intervention||8
8302148|NCT01540773|20469161|P1|COMPLETED|First Intervention||8
8302149|NCT01540773|20469160|P2|STARTED|First Intervention||8
8302150|NCT01540773|20469161|P1|STARTED|First Intervention||8
8302151|NCT01540565|20469171|P1|NOT COMPLETED|Overall Study||2
8302152|NCT01540565|20469171|P1|COMPLETED|Overall Study||50
8302153|NCT01540565|20469171|P1|STARTED|Overall Study||52
8302154|NCT01540513|20469181|P1|NOT COMPLETED|Overall Study||0
8302155|NCT01540513|20469181|P1|COMPLETED|Overall Study||12
8302156|NCT01540513|20469181|P1|STARTED|Overall Study||12
8302157|NCT01540487|20469190|P2|NOT COMPLETED|Overall Study||0
8302158|NCT01540487|20469191|P1|NOT COMPLETED|Overall Study||1
8302159|NCT01540487|20469190|P2|COMPLETED|Overall Study||24
8302160|NCT01540487|20469191|P1|COMPLETED|Overall Study||23
8302161|NCT01540487|20469190|P2|STARTED|Overall Study||24
8302162|NCT01540487|20469191|P1|STARTED|Overall Study||24
8302163|NCT01540409|20469227|P2|NOT COMPLETED|Overall Study||0
8302164|NCT01540409|20469228|P1|NOT COMPLETED|Overall Study||0
8302165|NCT01540409|20469227|P2|COMPLETED|Overall Study||6
8302166|NCT01540409|20469228|P1|COMPLETED|Overall Study||6
8302167|NCT01540409|20469227|P2|STARTED|Overall Study||6
8302168|NCT01540409|20469228|P1|STARTED|Overall Study||6
8302169|NCT01540370|20469237|P1|NOT COMPLETED|Overall Study||2
8302170|NCT01540370|20469237|P1|COMPLETED|Overall Study||100
8302171|NCT01540370|20469237|P1|STARTED|Overall Study||102
8302172|NCT01540266|20469248|P6|NOT COMPLETED|Overall Study||0
8302173|NCT01540266|20469249|P5|NOT COMPLETED|Overall Study||0
8302174|NCT01540266|20469250|P4|NOT COMPLETED|Overall Study||0
8302175|NCT01540266|20469251|P3|NOT COMPLETED|Overall Study||1
8302176|NCT01540266|20469252|P2|NOT COMPLETED|Overall Study||1
8302177|NCT01540266|20469253|P1|NOT COMPLETED|Overall Study||6
8302178|NCT01540266|20469248|P6|COMPLETED|Overall Study||19
8302179|NCT01540266|20469249|P5|COMPLETED|Overall Study||20
8302180|NCT01540266|20469250|P4|COMPLETED|Overall Study||38
8302181|NCT01540266|20469251|P3|COMPLETED|Overall Study||59
8302182|NCT01540266|20469252|P2|COMPLETED|Overall Study||41
8302183|NCT01540266|20469253|P1|COMPLETED|Overall Study||57
8302184|NCT01540266|20469248|P6|STARTED|Overall Study||19
8302185|NCT01540266|20469249|P5|STARTED|Overall Study||20
8302186|NCT01540266|20469250|P4|STARTED|Overall Study||38
8302187|NCT01540266|20469251|P3|STARTED|Overall Study||60
8302188|NCT01540266|20469252|P2|STARTED|Overall Study||42
8302189|NCT01540266|20469253|P1|STARTED|Overall Study||63
8302190|NCT01540162|20469269|P2|NOT COMPLETED|Overall Study||0
8302191|NCT01540162|20469270|P1|NOT COMPLETED|Overall Study||0
8302192|NCT01540162|20469269|P2|COMPLETED|Overall Study||32
8302193|NCT01540162|20469270|P1|COMPLETED|Overall Study||30
8302194|NCT01540162|20469269|P2|STARTED|Overall Study||32
8302195|NCT01540162|20469270|P1|STARTED|Overall Study||30
8302196|NCT01540045|20469280|P1|NOT COMPLETED|Overall Study||0
8302197|NCT01540045|20469280|P1|COMPLETED|Overall Study||40
8302198|NCT01540045|20469280|P1|STARTED|Overall Study||40
8302199|NCT01539980|20469319|P1|NOT COMPLETED|Overall Study||0
8302200|NCT01539980|20469319|P1|COMPLETED|Overall Study||30
8302201|NCT01539980|20469319|P1|STARTED|Overall Study||30
8302202|NCT01539837|20469330|P3|NOT COMPLETED|Overall Study||2
8302203|NCT01539837|20469331|P2|NOT COMPLETED|Overall Study||1
8302204|NCT01539837|20469332|P1|NOT COMPLETED|Overall Study||0
8302205|NCT01539837|20469330|P3|COMPLETED|Overall Study||5
8302206|NCT01539837|20469331|P2|COMPLETED|Overall Study||6
8302207|NCT01539837|20469332|P1|COMPLETED|Overall Study||8
8302208|NCT01539837|20469330|P3|STARTED|Overall Study||7
8302209|NCT01539837|20469331|P2|STARTED|Overall Study||7
8302210|NCT01539837|20469332|P1|STARTED|Overall Study||8
8302211|NCT01539811|20469345|P2|NOT COMPLETED|Overall Study||0
8302212|NCT01539811|20469346|P1|NOT COMPLETED|Overall Study||0
8302213|NCT01539811|20469345|P2|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
8302214|NCT01539811|20469346|P1|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
8302215|NCT01539811|20469345|P2|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
8302216|NCT01539811|20469346|P1|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
8302217|NCT01539759|20469354|P2|NOT COMPLETED|Overall Study||8
8302218|NCT01539759|20469355|P1|NOT COMPLETED|Overall Study||6
8302219|NCT01539759|20469354|P2|COMPLETED|Overall Study||48
8302220|NCT01539759|20469355|P1|COMPLETED|Overall Study||50
8302221|NCT01539759|20469354|P2|IUD in Place at 6 Months Posptartum|Overall Study||40
8302222|NCT01539759|20469355|P1|IUD in Place at 6 Months Posptartum|Overall Study||32
8302223|NCT01539759|20469354|P2|IUD Removal|Overall Study||7
8302224|NCT01539759|20469355|P1|IUD Removal|Overall Study||2
8302225|NCT01539759|20469354|P2|IUD Expulsion|Overall Study||4
8302226|NCT01539759|20469355|P1|IUD Expulsion|Overall Study||1
8302227|NCT01539759|20469354|P2|Had Successful IUD Placement|Overall Study||53
8302228|NCT01539759|20469355|P1|Had Successful IUD Placement|Overall Study||34
8302229|NCT01539759|20469354|P2|STARTED|Overall Study||56
8302230|NCT01539759|20469355|P1|STARTED|Overall Study||56
8302231|NCT01539694|20469365|P2|NOT COMPLETED|Overall Study||1
8302232|NCT01539694|20469366|P1|NOT COMPLETED|Overall Study||1
8302233|NCT01539694|20469365|P2|COMPLETED|Overall Study||62
8302234|NCT01539694|20469366|P1|COMPLETED|Overall Study||62
8302235|NCT01539694|20469365|P2|STARTED|Overall Study||63
8302236|NCT01539694|20469366|P1|STARTED|Overall Study||63
8302237|NCT01539642|20469376|P2|NOT COMPLETED|Overall Study||31
8302238|NCT01539642|20469377|P1|NOT COMPLETED|Overall Study||36
8302239|NCT01539642|20469376|P2|COMPLETED|Overall Study||27
8302240|NCT01539642|20469377|P1|COMPLETED|Overall Study||78
8302241|NCT01539642|20469376|P2|STARTED|Overall Study||58
8302242|NCT01539642|20469377|P1|STARTED|Overall Study||114
8302243|NCT01539590|20469385|P2|NOT COMPLETED|Overall Study||0
8302244|NCT01539590|20469386|P1|NOT COMPLETED|Overall Study||3
8302245|NCT01539590|20469385|P2|COMPLETED|Overall Study||2
8302246|NCT01539590|20469386|P1|COMPLETED|Overall Study||0
8302247|NCT01539590|20469385|P2|Complete Study Treatment|Overall Study||2
8302248|NCT01539590|20469386|P1|Complete Study Treatment|Overall Study||1
8302249|NCT01539590|20469385|P2|STARTED|Overall Study||2
8302250|NCT01539590|20469386|P1|STARTED|Overall Study||3
8302251|NCT01539538|20469394|P2|NOT COMPLETED|Overall Study||44
8302252|NCT01539538|20469395|P1|NOT COMPLETED|Overall Study||31
8302253|NCT01539538|20469394|P2|COMPLETED|Overall Study||136
8302254|NCT01539538|20469395|P1|COMPLETED|Overall Study||146
8302255|NCT01539538|20469394|P2|STARTED|Overall Study||180
8302256|NCT01539538|20469395|P1|STARTED|Overall Study||177
8302257|NCT01539525|20469404|P3|NOT COMPLETED|Overall Study||17
8302258|NCT01539525|20469405|P2|NOT COMPLETED|Overall Study||16
8302259|NCT01539525|20469406|P1|NOT COMPLETED|Overall Study||20
8302260|NCT01539525|20469404|P3|COMPLETED|Overall Study||134
8302261|NCT01539525|20469405|P2|COMPLETED|Overall Study||127
8302262|NCT01539525|20469406|P1|COMPLETED|Overall Study||125
8302263|NCT01539525|20469404|P3|STARTED|Overall Study||151
8302264|NCT01539525|20469405|P2|STARTED|Overall Study||143
8302265|NCT01539525|20469406|P1|STARTED|Overall Study||145
8302266|NCT01539512|20469425|P2|NOT COMPLETED|Overall Study||13
8302267|NCT01539512|20469426|P1|NOT COMPLETED|Overall Study||23
8302268|NCT01539512|20469425|P2|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
8302269|NCT01539512|20469426|P1|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
8302270|NCT01539512|20469425|P2|STARTED|Overall Study||110
8302271|NCT01539512|20469426|P1|STARTED|Overall Study||110
8302272|NCT01539317|20469442|P2|NOT COMPLETED|Overall Study||0
8302273|NCT01539317|20469443|P1|NOT COMPLETED|Overall Study||1
8302274|NCT01539317|20469442|P2|COMPLETED|Overall Study||25
8302275|NCT01539317|20469443|P1|COMPLETED|Overall Study||24
8302276|NCT01539317|20469442|P2|STARTED|Overall Study||25
8302277|NCT01539317|20469443|P1|STARTED|Overall Study||25
8302278|NCT01539291|20469461|P4|NOT COMPLETED|Study GS-US-312-0117||26
8302279|NCT01539291|20469462|P3|NOT COMPLETED|Study GS-US-312-0117||22
8302280|NCT01539291|20469463|P2|NOT COMPLETED|Study GS-US-312-0117||2
8302281|NCT01539291|20469464|P1|NOT COMPLETED|Study GS-US-312-0117||41
8302282|NCT01539291|20469461|P4|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18
8302283|NCT01539291|20469462|P3|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20
8302284|NCT01539291|20469463|P2|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2
8302285|NCT01539291|20469464|P1|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30
8302286|NCT01539291|20469461|P4|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44
8302287|NCT01539291|20469462|P3|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42
8302288|NCT01539291|20469463|P2|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4
8302289|NCT01539291|20469464|P1|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71
8302290|NCT01539291|20469461|P4|NOT COMPLETED|Study GS-US-312-0116||0
8302291|NCT01539291|20469462|P3|NOT COMPLETED|Study GS-US-312-0116||0
8302292|NCT01539291|20469463|P2|NOT COMPLETED|Study GS-US-312-0116||0
8302293|NCT01539291|20469464|P1|NOT COMPLETED|Study GS-US-312-0116||25
8302294|NCT01539291|20469461|P4|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44
8302295|NCT01539291|20469462|P3|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42
8302296|NCT01539291|20469463|P2|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4
8302297|NCT01539291|20469464|P1|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81
8302298|NCT01539291|20469461|P4|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44
8302299|NCT01539291|20469462|P3|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42
8302300|NCT01539291|20469463|P2|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4
8302301|NCT01539291|20469464|P1|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106
8302308|NCT01539135|20469547|P2|NOT COMPLETED|Overall Study||0
8302309|NCT01539135|20469548|P1|NOT COMPLETED|Overall Study||0
8302310|NCT01539135|20469547|P2|COMPLETED|Overall Study||37
8302311|NCT01539135|20469548|P1|COMPLETED|Overall Study||43
8302312|NCT01539135|20469547|P2|STARTED|Overall Study||37
8302313|NCT01539135|20469548|P1|STARTED|Overall Study||43
8302314|NCT01539083|20469560|P3|NOT COMPLETED|After Randomization (TP and VTP)||23
8302315|NCT01539083|20469561|P2|NOT COMPLETED|After Randomization (TP and VTP)||21
8302316|NCT01539083|20469562|P1|NOT COMPLETED|After Randomization (TP and VTP)||0
8302317|NCT01539083|20469560|P3|COMPLETED|After Randomization (TP and VTP)||80
8302318|NCT01539083|20469561|P2|COMPLETED|After Randomization (TP and VTP)||79
8302319|NCT01539083|20469562|P1|COMPLETED|After Randomization (TP and VTP)||0
8302320|NCT01539083|20469560|P3|Safety Population|After Randomization (TP and VTP)||103
8302321|NCT01539083|20469561|P2|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
8302322|NCT01539083|20469562|P1|Safety Population|After Randomization (TP and VTP)||0
8302323|NCT01539083|20469560|P3|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
8302324|NCT01539083|20469561|P2|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
8302325|NCT01539083|20469562|P1|STARTED|After Randomization (TP and VTP)||0
8302326|NCT01539083|20469560|P3|NOT COMPLETED|Before Randomization (VCD Induction)||0
8302327|NCT01539083|20469561|P2|NOT COMPLETED|Before Randomization (VCD Induction)||0
8302328|NCT01539083|20469562|P1|NOT COMPLETED|Before Randomization (VCD Induction)||53
8302329|NCT01539083|20469560|P3|COMPLETED|Before Randomization (VCD Induction)||0
8302330|NCT01539083|20469561|P2|COMPLETED|Before Randomization (VCD Induction)||0
8302331|NCT01539083|20469562|P1|COMPLETED|Before Randomization (VCD Induction)||203
8302332|NCT01539083|20469560|P3|Treated|Before Randomization (VCD Induction)||0
8302333|NCT01539083|20469561|P2|Treated|Before Randomization (VCD Induction)||0
8302334|NCT01539083|20469562|P1|Treated|Before Randomization (VCD Induction)||254
8302335|NCT01539083|20469560|P3|STARTED|Before Randomization (VCD Induction)||0
8302336|NCT01539083|20469561|P2|STARTED|Before Randomization (VCD Induction)||0
8302337|NCT01539083|20469562|P1|STARTED|Before Randomization (VCD Induction)||256
8302338|NCT01539070|20469585|P2|NOT COMPLETED|Overall Study||39
8302339|NCT01539070|20469586|P1|NOT COMPLETED|Overall Study||59
8302340|NCT01539070|20469585|P2|COMPLETED|Overall Study||99
8302341|NCT01539070|20469586|P1|COMPLETED|Overall Study||109
8302342|NCT01539070|20469585|P2|STARTED|Overall Study||138
8302343|NCT01539070|20469586|P1|STARTED|Overall Study||168
8302344|NCT01538862|20469598|P1|NOT COMPLETED|Overall Study||0
8302345|NCT01538862|20469598|P1|COMPLETED|Overall Study||7
8302346|NCT01538862|20469598|P1|STARTED|Overall Study||7
8302347|NCT01538719|20469606|P2|NOT COMPLETED|Overall Study||0
8302348|NCT01538719|20469607|P1|NOT COMPLETED|Overall Study||2
8302349|NCT01538719|20469606|P2|COMPLETED|Overall Study||12
8302350|NCT01538719|20469607|P1|COMPLETED|Overall Study||5
8302351|NCT01538719|20469606|P2|STARTED|Overall Study||12
8302352|NCT01538719|20469607|P1|STARTED|Overall Study||7
8302353|NCT01538615|20469617|P2|NOT COMPLETED|Overall Study||12
8302354|NCT01538615|20469618|P1|NOT COMPLETED|Overall Study||22
8302355|NCT01538615|20469617|P2|COMPLETED|Overall Study||146
8302356|NCT01538615|20469618|P1|COMPLETED|Overall Study||140
8302357|NCT01538615|20469617|P2|STARTED|Overall Study||158
8302358|NCT01538615|20469618|P1|STARTED|Overall Study||162
8302359|NCT01538472|20469630|P1|NOT COMPLETED|Overall Study||4
8302360|NCT01538472|20469630|P1|COMPLETED|Overall Study||36
8302361|NCT01538472|20469630|P1|STARTED|Overall Study||40
8302362|NCT01538199|20469641|P4|NOT COMPLETED|Overall Study||2
8302363|NCT01538199|20469642|P3|NOT COMPLETED|Overall Study||1
8302364|NCT01538199|20469643|P2|NOT COMPLETED|Overall Study||3
8302365|NCT01538199|20469644|P1|NOT COMPLETED|Overall Study||2
8302366|NCT01538199|20469641|P4|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
8302367|NCT01538199|20469642|P3|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
8302368|NCT01538199|20469643|P2|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
8302369|NCT01538199|20469644|P1|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
8302370|NCT01538199|20469641|P4|STARTED|Overall Study||3
8302371|NCT01538199|20469642|P3|STARTED|Overall Study||4
8302372|NCT01538199|20469643|P2|STARTED|Overall Study||11
8302373|NCT01538199|20469644|P1|STARTED|Overall Study||10
8302374|NCT01537900|20469667|P1|NOT COMPLETED|Overall Study||0
8302375|NCT01537900|20469667|P1|COMPLETED|Overall Study||4
8302376|NCT01537900|20469667|P1|STARTED|Overall Study||4
8302377|NCT01537887|20469678|P6|NOT COMPLETED|Period 3||0
8302378|NCT01537887|20469679|P5|NOT COMPLETED|Period 3||0
8302379|NCT01537887|20469680|P4|NOT COMPLETED|Period 3||0
8302380|NCT01537887|20469681|P3|NOT COMPLETED|Period 3||1
8302381|NCT01537887|20469682|P2|NOT COMPLETED|Period 3||1
8302382|NCT01537887|20469683|P1|NOT COMPLETED|Period 3||0
8302383|NCT01537887|20469678|P6|COMPLETED|Period 3||11
8302384|NCT01537887|20469679|P5|COMPLETED|Period 3||11
8302385|NCT01537887|20469680|P4|COMPLETED|Period 3||12
8302386|NCT01537887|20469681|P3|COMPLETED|Period 3||10
8302387|NCT01537887|20469682|P2|COMPLETED|Period 3||10
8302388|NCT01537887|20469683|P1|COMPLETED|Period 3||12
8302389|NCT01537887|20469678|P6|STARTED|Period 3||11
8302390|NCT01537887|20469679|P5|STARTED|Period 3||11
8302391|NCT01537887|20469680|P4|STARTED|Period 3||12
8302392|NCT01537887|20469681|P3|STARTED|Period 3||11
8302393|NCT01537887|20469682|P2|STARTED|Period 3||11
8302394|NCT01537887|20469683|P1|STARTED|Period 3||12
8302395|NCT01537887|20469678|P6|NOT COMPLETED|Period 2||0
8302396|NCT01537887|20469679|P5|NOT COMPLETED|Period 2||0
8302397|NCT01537887|20469680|P4|NOT COMPLETED|Period 2||0
8302398|NCT01537887|20469681|P3|NOT COMPLETED|Period 2||0
8302399|NCT01537887|20469682|P2|NOT COMPLETED|Period 2||1
8302400|NCT01537887|20469683|P1|NOT COMPLETED|Period 2||0
8302401|NCT01537887|20469678|P6|COMPLETED|Period 2||11
8302402|NCT01537887|20469679|P5|COMPLETED|Period 2||11
8302403|NCT01537887|20469680|P4|COMPLETED|Period 2||12
8302404|NCT01537887|20469681|P3|COMPLETED|Period 2||11
8302405|NCT01537887|20469682|P2|COMPLETED|Period 2||11
8302406|NCT01537887|20469683|P1|COMPLETED|Period 2||12
8302407|NCT01537887|20469678|P6|STARTED|Period 2||11
8302408|NCT01537887|20469679|P5|STARTED|Period 2||11
8302409|NCT01537887|20469680|P4|STARTED|Period 2||12
8302410|NCT01537887|20469681|P3|STARTED|Period 2||11
8302411|NCT01537887|20469682|P2|STARTED|Period 2||12
8302412|NCT01537887|20469683|P1|STARTED|Period 2||12
8302413|NCT01537887|20469678|P6|NOT COMPLETED|Period 1||1
8302414|NCT01537887|20469679|P5|NOT COMPLETED|Period 1||1
8302415|NCT01537887|20469680|P4|NOT COMPLETED|Period 1||0
8302416|NCT01537887|20469681|P3|NOT COMPLETED|Period 1||1
8302417|NCT01537887|20469682|P2|NOT COMPLETED|Period 1||0
8302418|NCT01537887|20469683|P1|NOT COMPLETED|Period 1||0
8302419|NCT01537887|20469678|P6|COMPLETED|Period 1||11
8302420|NCT01537887|20469679|P5|COMPLETED|Period 1||11
8302421|NCT01537887|20469680|P4|COMPLETED|Period 1||12
8302422|NCT01537887|20469681|P3|COMPLETED|Period 1||11
8302423|NCT01537887|20469682|P2|COMPLETED|Period 1||12
8302424|NCT01537887|20469683|P1|COMPLETED|Period 1||12
8302425|NCT01537887|20469678|P6|Received at Least 1 Dose of Study Drug|Period 1||12
8302426|NCT01537887|20469679|P5|Received at Least 1 Dose of Study Drug|Period 1||12
8302427|NCT01537887|20469680|P4|Received at Least 1 Dose of Study Drug|Period 1||12
8302428|NCT01537887|20469681|P3|Received at Least 1 Dose of Study Drug|Period 1||11
8302429|NCT01537887|20469682|P2|Received at Least 1 Dose of Study Drug|Period 1||12
8302430|NCT01537887|20469683|P1|Received at Least 1 Dose of Study Drug|Period 1||12
8302431|NCT01537887|20469678|P6|STARTED|Period 1||12
8302432|NCT01537887|20469679|P5|STARTED|Period 1||12
8302433|NCT01537887|20469680|P4|STARTED|Period 1||12
8302434|NCT01537887|20469681|P3|STARTED|Period 1||12
8302435|NCT01537887|20469682|P2|STARTED|Period 1||12
8302436|NCT01537887|20469683|P1|STARTED|Period 1||12
8302437|NCT01537835|20469697|P3|NOT COMPLETED|Overall Study||0
8302438|NCT01537835|20469698|P2|NOT COMPLETED|Overall Study||0
8302439|NCT01537835|20469699|P1|NOT COMPLETED|Overall Study||0
8302440|NCT01537835|20469697|P3|COMPLETED|Overall Study||35
8302441|NCT01537835|20469698|P2|COMPLETED|Overall Study||37
8302442|NCT01537835|20469699|P1|COMPLETED|Overall Study||37
8302443|NCT01537835|20469697|P3|STARTED|Overall Study||35
8302444|NCT01537835|20469698|P2|STARTED|Overall Study||37
8302445|NCT01537835|20469699|P1|STARTED|Overall Study||37
8302446|NCT01537783|20469712|P2|NOT COMPLETED|Overall Study||2
8302447|NCT01537783|20469713|P1|NOT COMPLETED|Overall Study||11
8302448|NCT01537783|20469712|P2|COMPLETED|Overall Study||23
8302449|NCT01537783|20469713|P1|COMPLETED|Overall Study||14
8302450|NCT01537783|20469712|P2|STARTED|Overall Study||25
8302451|NCT01537783|20469713|P1|STARTED|Overall Study||25
8302452|NCT01537666|20469723|P4|NOT COMPLETED|Overall Study||0
8302453|NCT01537666|20469724|P3|NOT COMPLETED|Overall Study||0
8302454|NCT01537666|20469725|P2|NOT COMPLETED|Overall Study||0
8302455|NCT01537666|20469726|P1|NOT COMPLETED|Overall Study||0
8302456|NCT01537666|20469723|P4|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
8302457|NCT01537666|20469724|P3|COMPLETED|Overall Study||6
8302458|NCT01537666|20469725|P2|COMPLETED|Overall Study||6
8302459|NCT01537666|20469726|P1|COMPLETED|Overall Study||6
8302460|NCT01537666|20469723|P4|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
8302461|NCT01537666|20469724|P3|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
8302462|NCT01537666|20469725|P2|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
8302463|NCT01537666|20469726|P1|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
8302464|NCT01537549|20469764|P1|NOT COMPLETED|Overall Study||3
8302465|NCT01537549|20469764|P1|COMPLETED|Overall Study||8
8302466|NCT01537549|20469764|P1|STARTED|Overall Study||11
8302467|NCT01537432|20469772|P2|NOT COMPLETED|Overall Study||2
8302468|NCT01537432|20469773|P1|NOT COMPLETED|Overall Study||6
8302469|NCT01537432|20469772|P2|COMPLETED|Overall Study||10
8302470|NCT01537432|20469773|P1|COMPLETED|Overall Study||18
8302471|NCT01537432|20469772|P2|STARTED|Overall Study||12
8302472|NCT01537432|20469773|P1|STARTED|Overall Study||24
8302473|NCT01537419|20469783|P2|NOT COMPLETED|Overall Study||12
8302474|NCT01537419|20469784|P1|NOT COMPLETED|Overall Study||11
8302475|NCT01537419|20469783|P2|COMPLETED|Overall Study||54
8302476|NCT01537419|20469784|P1|COMPLETED|Overall Study||52
8302477|NCT01537419|20469783|P2|STARTED|Overall Study||66
8302478|NCT01537419|20469784|P1|STARTED|Overall Study||63
8302479|NCT01537393|20469796|P2|NOT COMPLETED|Overall Study||191
8302480|NCT01537393|20469797|P1|NOT COMPLETED|Overall Study||154
8302481|NCT01537393|20469796|P2|COMPLETED|Overall Study||507
8302482|NCT01537393|20469797|P1|COMPLETED|Overall Study||553
8302483|NCT01537393|20469796|P2|STARTED|Overall Study||698
8302484|NCT01537393|20469797|P1|STARTED|Overall Study||707
8302485|NCT01537367|20469808|P3|NOT COMPLETED|Overall Study||0
8302486|NCT01537367|20469809|P2|NOT COMPLETED|Overall Study||0
8302487|NCT01537367|20469810|P1|NOT COMPLETED|Overall Study||0
8302488|NCT01537367|20469808|P3|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
8302489|NCT01537367|20469809|P2|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
8302490|NCT01537367|20469810|P1|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
8302491|NCT01537367|20469808|P3|STARTED|Overall Study||613
8302492|NCT01537367|20469809|P2|STARTED|Overall Study||610
8302493|NCT01537367|20469810|P1|STARTED|Overall Study||615
8302494|NCT01537315|20469826|P2|NOT COMPLETED|Overall Study||0
8302495|NCT01537315|20469827|P1|NOT COMPLETED|Overall Study||0
8302496|NCT01537315|20469826|P2|COMPLETED|Overall Study||7
8302497|NCT01537315|20469827|P1|COMPLETED|Overall Study||1
8302498|NCT01537315|20469826|P2|STARTED|Overall Study||7
8302499|NCT01537315|20469827|P1|STARTED|Overall Study||1
8302503|NCT01537211|20469842|P2|NOT COMPLETED|Overall Study||1
8302504|NCT01537211|20469843|P1|NOT COMPLETED|Overall Study||0
8302505|NCT01537211|20469842|P2|COMPLETED|Overall Study||5
8302506|NCT01537211|20469843|P1|COMPLETED|Overall Study||4
8302507|NCT01537211|20469842|P2|STARTED|Overall Study||6
8302508|NCT01537211|20469843|P1|STARTED|Overall Study||4
8302509|NCT01537198|20469877|P1|NOT COMPLETED|Overall Study||154
8302510|NCT01537198|20469877|P1|COMPLETED|Overall Study||463
8302511|NCT01537198|20469877|P1|STARTED|Overall Study||617
8302512|NCT01537185|20469885|P4|NOT COMPLETED|Overall Study||2
8302513|NCT01537185|20469886|P3|NOT COMPLETED|Overall Study||6
8302514|NCT01537185|20469887|P2|NOT COMPLETED|Overall Study||6
8302515|NCT01537185|20469888|P1|NOT COMPLETED|Overall Study||3
8302516|NCT01537185|20469885|P4|COMPLETED|Overall Study||8
8302517|NCT01537185|20469886|P3|COMPLETED|Overall Study||4
8302518|NCT01537185|20469887|P2|COMPLETED|Overall Study||6
8302519|NCT01537185|20469888|P1|COMPLETED|Overall Study||7
8302520|NCT01537185|20469885|P4|STARTED|Overall Study||10
8302521|NCT01537185|20469886|P3|STARTED|Overall Study||10
8302522|NCT01537185|20469887|P2|STARTED|Overall Study||12
8302523|NCT01537185|20469888|P1|STARTED|Overall Study||10
8302524|NCT01537133|20469906|P4|NOT COMPLETED|Overall Study||0
8302525|NCT01537133|20469907|P3|NOT COMPLETED|Overall Study||0
8302526|NCT01537133|20469908|P2|NOT COMPLETED|Overall Study||0
8302527|NCT01537133|20469909|P1|NOT COMPLETED|Overall Study||3
8302528|NCT01537133|20469906|P4|COMPLETED|Overall Study||21
8302529|NCT01537133|20469907|P3|COMPLETED|Overall Study||21
8302530|NCT01537133|20469908|P2|COMPLETED|Overall Study||14
8302531|NCT01537133|20469909|P1|COMPLETED|Overall Study||25
8302532|NCT01537133|20469906|P4|STARTED|Overall Study||21
8302533|NCT01537133|20469907|P3|STARTED|Overall Study||21
8302534|NCT01537133|20469908|P2|STARTED|Overall Study||14
8302535|NCT01537133|20469909|P1|STARTED|Overall Study||28
8302536|NCT01537120|20469925|P1|NOT COMPLETED|12 Weeks Vildagliptin||0
8302537|NCT01537120|20469925|P1|COMPLETED|12 Weeks Vildagliptin||23
8302538|NCT01537120|20469925|P1|STARTED|12 Weeks Vildagliptin||23
8302539|NCT01537120|20469925|P1|NOT COMPLETED|3 Weeks Placebo||1
8302540|NCT01537120|20469925|P1|COMPLETED|3 Weeks Placebo||23
8302541|NCT01537120|20469925|P1|STARTED|3 Weeks Placebo||24
8302542|NCT01537120|20469925|P1|NOT COMPLETED|8 Weeks Washout||1
8302543|NCT01537120|20469925|P1|COMPLETED|8 Weeks Washout||24
8302544|NCT01537120|20469925|P1|STARTED|8 Weeks Washout||25
8302545|NCT01537120|20469925|P1|NOT COMPLETED|Enrolled||0
8302546|NCT01537120|20469925|P1|COMPLETED|Enrolled||25
8302547|NCT01537120|20469925|P1|STARTED|Enrolled||25
8302548|NCT01537081|20469938|P3|NOT COMPLETED|Overall Study||16
8302549|NCT01537081|20469939|P2|NOT COMPLETED|Overall Study||38
8302550|NCT01537081|20469940|P1|NOT COMPLETED|Overall Study||39
8302551|NCT01537081|20469938|P3|COMPLETED|Overall Study||547
8302552|NCT01537081|20469939|P2|COMPLETED|Overall Study||1086
8302553|NCT01537081|20469940|P1|COMPLETED|Overall Study||1084
8302554|NCT01537081|20469938|P3|Modified Intent to Treat Population|Overall Study||556
8302555|NCT01537081|20469939|P2|Modified Intent to Treat Population|Overall Study||1109
8302556|NCT01537081|20469940|P1|Modified Intent to Treat Population|Overall Study||1106
8302557|NCT01537081|20469938|P3|Safety Population|Overall Study||561
8302558|NCT01537081|20469939|P2|Safety Population|Overall Study||1122
8302559|NCT01537081|20469940|P1|Safety Population|Overall Study||1122
8302560|NCT01537081|20469938|P3|STARTED|Overall Study||563
8302561|NCT01537081|20469939|P2|STARTED|Overall Study||1124
8302562|NCT01537081|20469940|P1|STARTED|Overall Study||1123
8302563|NCT01537068|20469953|P2|NOT COMPLETED|Overall Study||3
8302564|NCT01537068|20469954|P1|NOT COMPLETED|Overall Study||4
8302565|NCT01537068|20469953|P2|COMPLETED|Overall Study||26
8302566|NCT01537068|20469954|P1|COMPLETED|Overall Study||26
8302567|NCT01537068|20469953|P2|STARTED|Overall Study||29
8302568|NCT01537068|20469954|P1|STARTED|Overall Study||30
8302569|NCT01537042|20469966|P2|NOT COMPLETED|Overall Study||5
8302570|NCT01537042|20469967|P1|NOT COMPLETED|Overall Study||0
8302571|NCT01537042|20469966|P2|COMPLETED|Overall Study||15
8302572|NCT01537042|20469967|P1|COMPLETED|Overall Study||10
8302573|NCT01537042|20469966|P2|STARTED|Overall Study||20
8302574|NCT01537042|20469967|P1|STARTED|Overall Study||10
8302575|NCT01537029|20470003|P1|NOT COMPLETED|Overall Study||0
8302576|NCT01537029|20470003|P1|COMPLETED|Overall Study||15
8302577|NCT01537029|20470003|P1|STARTED|Overall Study||15
8302578|NCT01536951|20470009|P9|NOT COMPLETED|Third Intervention||0
8302579|NCT01536951|20470010|P8|NOT COMPLETED|Third Intervention||0
8302580|NCT01536951|20470011|P7|NOT COMPLETED|Third Intervention||0
8302581|NCT01536951|20470012|P6|NOT COMPLETED|Third Intervention||0
8302582|NCT01536951|20470013|P5|NOT COMPLETED|Third Intervention||0
8302583|NCT01536951|20470014|P4|NOT COMPLETED|Third Intervention||0
8302584|NCT01536951|20470015|P3|NOT COMPLETED|Third Intervention||0
8302585|NCT01536951|20470016|P2|NOT COMPLETED|Third Intervention||0
8302586|NCT01536951|20470017|P1|NOT COMPLETED|Third Intervention||0
8302587|NCT01536951|20470009|P9|COMPLETED|Third Intervention||9
8302588|NCT01536951|20470010|P8|COMPLETED|Third Intervention||8
8302589|NCT01536951|20470011|P7|COMPLETED|Third Intervention||9
8302590|NCT01536951|20470012|P6|COMPLETED|Third Intervention||9
8302591|NCT01536951|20470013|P5|COMPLETED|Third Intervention||9
8302592|NCT01536951|20470014|P4|COMPLETED|Third Intervention||8
8302593|NCT01536951|20470015|P3|COMPLETED|Third Intervention||2
8302594|NCT01536951|20470016|P2|COMPLETED|Third Intervention||3
8302595|NCT01536951|20470017|P1|COMPLETED|Third Intervention||3
8302596|NCT01536951|20470009|P9|STARTED|Third Intervention||9
8302597|NCT01536951|20470010|P8|STARTED|Third Intervention||8
8302598|NCT01536951|20470011|P7|STARTED|Third Intervention||9
8302599|NCT01536951|20470012|P6|STARTED|Third Intervention||9
8302600|NCT01536951|20470013|P5|STARTED|Third Intervention||9
8302601|NCT01536951|20470014|P4|STARTED|Third Intervention||8
8302602|NCT01536951|20470015|P3|STARTED|Third Intervention||2
8302603|NCT01536951|20470016|P2|STARTED|Third Intervention||3
8302604|NCT01536951|20470017|P1|STARTED|Third Intervention||3
8302605|NCT01536951|20470009|P9|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302606|NCT01536951|20470010|P8|NOT COMPLETED|Second Intervention and Washout Period 2||1
8302607|NCT01536951|20470011|P7|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302608|NCT01536951|20470012|P6|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302609|NCT01536951|20470013|P5|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302610|NCT01536951|20470014|P4|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302611|NCT01536951|20470015|P3|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302612|NCT01536951|20470016|P2|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302613|NCT01536951|20470017|P1|NOT COMPLETED|Second Intervention and Washout Period 2||0
8302614|NCT01536951|20470009|P9|COMPLETED|Second Intervention and Washout Period 2||9
8302615|NCT01536951|20470010|P8|COMPLETED|Second Intervention and Washout Period 2||8
8302616|NCT01536951|20470011|P7|COMPLETED|Second Intervention and Washout Period 2||9
8302617|NCT01536951|20470012|P6|COMPLETED|Second Intervention and Washout Period 2||9
8302618|NCT01536951|20470013|P5|COMPLETED|Second Intervention and Washout Period 2||9
8302619|NCT01536951|20470014|P4|COMPLETED|Second Intervention and Washout Period 2||8
8302620|NCT01536951|20470015|P3|COMPLETED|Second Intervention and Washout Period 2||2
8302621|NCT01536951|20470016|P2|COMPLETED|Second Intervention and Washout Period 2||3
8302622|NCT01536951|20470017|P1|COMPLETED|Second Intervention and Washout Period 2||3
8302623|NCT01536951|20470009|P9|STARTED|Second Intervention and Washout Period 2||9
8302624|NCT01536951|20470010|P8|STARTED|Second Intervention and Washout Period 2||9
8302625|NCT01536951|20470011|P7|STARTED|Second Intervention and Washout Period 2||9
8302626|NCT01536951|20470012|P6|STARTED|Second Intervention and Washout Period 2||9
8302627|NCT01536951|20470013|P5|STARTED|Second Intervention and Washout Period 2||9
8302628|NCT01536951|20470014|P4|STARTED|Second Intervention and Washout Period 2||8
8302629|NCT01536951|20470015|P3|STARTED|Second Intervention and Washout Period 2||2
8302630|NCT01536951|20470016|P2|STARTED|Second Intervention and Washout Period 2||3
8302631|NCT01536951|20470017|P1|STARTED|Second Intervention and Washout Period 2||3
8302632|NCT01536951|20470009|P9|NOT COMPLETED|First Intervention and Washout Period 1||0
8302633|NCT01536951|20470010|P8|NOT COMPLETED|First Intervention and Washout Period 1||0
8302634|NCT01536951|20470011|P7|NOT COMPLETED|First Intervention and Washout Period 1||0
8302635|NCT01536951|20470012|P6|NOT COMPLETED|First Intervention and Washout Period 1||0
8302636|NCT01536951|20470013|P5|NOT COMPLETED|First Intervention and Washout Period 1||0
8302637|NCT01536951|20470014|P4|NOT COMPLETED|First Intervention and Washout Period 1||0
8302638|NCT01536951|20470015|P3|NOT COMPLETED|First Intervention and Washout Period 1||1
8302639|NCT01536951|20470016|P2|NOT COMPLETED|First Intervention and Washout Period 1||0
8302640|NCT01536951|20470017|P1|NOT COMPLETED|First Intervention and Washout Period 1||0
8302641|NCT01536951|20470009|P9|COMPLETED|First Intervention and Washout Period 1||9
8302642|NCT01536951|20470010|P8|COMPLETED|First Intervention and Washout Period 1||9
8302643|NCT01536951|20470011|P7|COMPLETED|First Intervention and Washout Period 1||9
8302644|NCT01536951|20470012|P6|COMPLETED|First Intervention and Washout Period 1||9
8302645|NCT01536951|20470013|P5|COMPLETED|First Intervention and Washout Period 1||9
8302646|NCT01536951|20470014|P4|COMPLETED|First Intervention and Washout Period 1||8
8302647|NCT01536951|20470015|P3|COMPLETED|First Intervention and Washout Period 1||2
8302648|NCT01536951|20470016|P2|COMPLETED|First Intervention and Washout Period 1||3
8302649|NCT01536951|20470017|P1|COMPLETED|First Intervention and Washout Period 1||3
8302650|NCT01536951|20470009|P9|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8302651|NCT01536951|20470010|P8|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8302652|NCT01536951|20470011|P7|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8302653|NCT01536951|20470012|P6|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8302654|NCT01536951|20470013|P5|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
8302655|NCT01536951|20470014|P4|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
8302656|NCT01536951|20470015|P3|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
8302657|NCT01536951|20470016|P2|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
8302658|NCT01536951|20470017|P1|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
8302659|NCT01536951|20470009|P9|STARTED|First Intervention and Washout Period 1||9
8302660|NCT01536951|20470010|P8|STARTED|First Intervention and Washout Period 1||9
8302661|NCT01536951|20470011|P7|STARTED|First Intervention and Washout Period 1||9
8302662|NCT01536951|20470012|P6|STARTED|First Intervention and Washout Period 1||9
8302663|NCT01536951|20470013|P5|STARTED|First Intervention and Washout Period 1||9
8302664|NCT01536951|20470014|P4|STARTED|First Intervention and Washout Period 1||8
8302665|NCT01536951|20470015|P3|STARTED|First Intervention and Washout Period 1||3
8302666|NCT01536951|20470016|P2|STARTED|First Intervention and Washout Period 1||3
8302667|NCT01536951|20470017|P1|STARTED|First Intervention and Washout Period 1||3
8302668|NCT01536938|20470047|P3|NOT COMPLETED|Overall Study||8
8302669|NCT01536938|20470048|P2|NOT COMPLETED|Overall Study||7
8302670|NCT01536938|20470049|P1|NOT COMPLETED|Overall Study||6
8302671|NCT01536938|20470047|P3|COMPLETED|Overall Study||93
8302672|NCT01536938|20470048|P2|COMPLETED|Overall Study||94
8302673|NCT01536938|20470049|P1|COMPLETED|Overall Study||94
8302674|NCT01536938|20470047|P3|STARTED|Overall Study||101
8302675|NCT01536938|20470048|P2|STARTED|Overall Study||101
8302676|NCT01536938|20470049|P1|STARTED|Overall Study||100
8302677|NCT01536886|20470061|P4|NOT COMPLETED|Overall Study||3
8302678|NCT01536886|20470062|P3|NOT COMPLETED|Overall Study||2
8302679|NCT01536886|20470063|P2|NOT COMPLETED|Overall Study||8
8302680|NCT01536886|20470064|P1|NOT COMPLETED|Overall Study||5
8302681|NCT01536886|20470061|P4|COMPLETED|Overall Study||48
8302682|NCT01536886|20470062|P3|COMPLETED|Overall Study||47
8302683|NCT01536886|20470063|P2|COMPLETED|Overall Study||127
8302684|NCT01536886|20470064|P1|COMPLETED|Overall Study||136
8302685|NCT01536886|20470061|P4|STARTED|Overall Study||51
8302686|NCT01536886|20470062|P3|STARTED|Overall Study||49
8302687|NCT01536886|20470063|P2|STARTED|Overall Study||135
8302688|NCT01536886|20470064|P1|STARTED|Overall Study||141
8302689|NCT01536860|20470074|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8302690|NCT01536860|20470075|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8302691|NCT01536860|20470076|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8302692|NCT01536860|20470074|P3|COMPLETED|Third Intervention (1 Day)||4
8302693|NCT01536860|20470075|P2|COMPLETED|Third Intervention (1 Day)||4
8302694|NCT01536860|20470076|P1|COMPLETED|Third Intervention (1 Day)||3
8302695|NCT01536860|20470074|P3|STARTED|Third Intervention (1 Day)||4
8302696|NCT01536860|20470075|P2|STARTED|Third Intervention (1 Day)||4
8302697|NCT01536860|20470076|P1|STARTED|Third Intervention (1 Day)||3
8302698|NCT01536860|20470074|P3|NOT COMPLETED|Washout Period (3 Days)||0
8302699|NCT01536860|20470075|P2|NOT COMPLETED|Washout Period (3 Days)||0
8302700|NCT01536860|20470076|P1|NOT COMPLETED|Washout Period (3 Days)||1
8302701|NCT01536860|20470074|P3|COMPLETED|Washout Period (3 Days)||4
8302702|NCT01536860|20470075|P2|COMPLETED|Washout Period (3 Days)||4
8302703|NCT01536860|20470076|P1|COMPLETED|Washout Period (3 Days)||3
8302704|NCT01536860|20470074|P3|STARTED|Washout Period (3 Days)||4
8302705|NCT01536860|20470075|P2|STARTED|Washout Period (3 Days)||4
8302706|NCT01536860|20470076|P1|STARTED|Washout Period (3 Days)||4
8302707|NCT01536860|20470074|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8302708|NCT01536860|20470075|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8302709|NCT01536860|20470076|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8302710|NCT01536860|20470074|P3|COMPLETED|Second Intervention (1 Day)||4
8302711|NCT01536860|20470075|P2|COMPLETED|Second Intervention (1 Day)||4
8302712|NCT01536860|20470076|P1|COMPLETED|Second Intervention (1 Day)||4
8302713|NCT01536860|20470074|P3|STARTED|Second Intervention (1 Day)||4
8302714|NCT01536860|20470075|P2|STARTED|Second Intervention (1 Day)||4
8302715|NCT01536860|20470076|P1|STARTED|Second Intervention (1 Day)||4
8302716|NCT01536860|20470074|P3|NOT COMPLETED|Washout Period (3 Days)||0
8302717|NCT01536860|20470075|P2|NOT COMPLETED|Washout Period (3 Days)||0
8302718|NCT01536860|20470076|P1|NOT COMPLETED|Washout Period (3 Days)||0
8302719|NCT01536860|20470074|P3|COMPLETED|Washout Period (3 Days)||4
8302720|NCT01536860|20470075|P2|COMPLETED|Washout Period (3 Days)||4
8302721|NCT01536860|20470076|P1|COMPLETED|Washout Period (3 Days)||4
8302722|NCT01536860|20470074|P3|STARTED|Washout Period (3 Days)||4
8302723|NCT01536860|20470075|P2|STARTED|Washout Period (3 Days)||4
8302724|NCT01536860|20470076|P1|STARTED|Washout Period (3 Days)||4
8302725|NCT01536860|20470074|P3|NOT COMPLETED|First Intervention (1 Day)||0
8302726|NCT01536860|20470075|P2|NOT COMPLETED|First Intervention (1 Day)||0
8302727|NCT01536860|20470076|P1|NOT COMPLETED|First Intervention (1 Day)||0
8302728|NCT01536860|20470074|P3|COMPLETED|First Intervention (1 Day)||4
8302729|NCT01536860|20470075|P2|COMPLETED|First Intervention (1 Day)||4
8302730|NCT01536860|20470076|P1|COMPLETED|First Intervention (1 Day)||4
8302731|NCT01536860|20470074|P3|STARTED|First Intervention (1 Day)||4
8302732|NCT01536860|20470075|P2|STARTED|First Intervention (1 Day)||4
8302733|NCT01536860|20470076|P1|STARTED|First Intervention (1 Day)||4
8302740|NCT01536704|20470101|P4|NOT COMPLETED|Period 4||0
8302741|NCT01536704|20470102|P3|NOT COMPLETED|Period 4||0
8302742|NCT01536704|20470103|P2|NOT COMPLETED|Period 4||0
8302743|NCT01536704|20470104|P1|NOT COMPLETED|Period 4||0
8302744|NCT01536704|20470101|P4|COMPLETED|Period 4||10
8302745|NCT01536704|20470102|P3|COMPLETED|Period 4||10
8302746|NCT01536704|20470103|P2|COMPLETED|Period 4||11
8302747|NCT01536704|20470104|P1|COMPLETED|Period 4||12
8302748|NCT01536704|20470101|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
8302834|NCT01536561|20470192|P1|COMPLETED|Long-Term Follow-Up||13
8302749|NCT01536704|20470102|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
8302750|NCT01536704|20470103|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
8302751|NCT01536704|20470104|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
8302752|NCT01536704|20470101|P4|NOT COMPLETED|Washout Period 3||0
8302753|NCT01536704|20470102|P3|NOT COMPLETED|Washout Period 3||1
8302754|NCT01536704|20470103|P2|NOT COMPLETED|Washout Period 3||0
8302755|NCT01536704|20470104|P1|NOT COMPLETED|Washout Period 3||0
8302756|NCT01536704|20470101|P4|COMPLETED|Washout Period 3||10
8302757|NCT01536704|20470102|P3|COMPLETED|Washout Period 3||11
8302758|NCT01536704|20470103|P2|COMPLETED|Washout Period 3||12
8302759|NCT01536704|20470104|P1|COMPLETED|Washout Period 3||10
8302760|NCT01536704|20470101|P4|STARTED|Washout Period 3||10
8302761|NCT01536704|20470102|P3|STARTED|Washout Period 3||12
8302762|NCT01536704|20470103|P2|STARTED|Washout Period 3||12
8302763|NCT01536704|20470104|P1|STARTED|Washout Period 3||10
8302764|NCT01536704|20470101|P4|NOT COMPLETED|Period 3||1
8302765|NCT01536704|20470102|P3|NOT COMPLETED|Period 3||0
8302766|NCT01536704|20470103|P2|NOT COMPLETED|Period 3||0
8302767|NCT01536704|20470104|P1|NOT COMPLETED|Period 3||0
8302768|NCT01536704|20470101|P4|COMPLETED|Period 3||10
8302769|NCT01536704|20470102|P3|COMPLETED|Period 3||12
8302770|NCT01536704|20470103|P2|COMPLETED|Period 3||12
8302771|NCT01536704|20470104|P1|COMPLETED|Period 3||10
8302772|NCT01536704|20470101|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
8302773|NCT01536704|20470102|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8302774|NCT01536704|20470103|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8302775|NCT01536704|20470104|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
8302776|NCT01536704|20470101|P4|NOT COMPLETED|Washout Period 2||1
8302777|NCT01536704|20470102|P3|NOT COMPLETED|Washout Period 2||0
8302778|NCT01536704|20470103|P2|NOT COMPLETED|Washout Period 2||0
8302779|NCT01536704|20470104|P1|NOT COMPLETED|Washout Period 2||1
8302780|NCT01536704|20470101|P4|COMPLETED|Washout Period 2||12
8302781|NCT01536704|20470102|P3|COMPLETED|Washout Period 2||10
8302782|NCT01536704|20470103|P2|COMPLETED|Washout Period 2||11
8302783|NCT01536704|20470104|P1|COMPLETED|Washout Period 2||12
8302784|NCT01536704|20470101|P4|STARTED|Washout Period 2||13
8302785|NCT01536704|20470102|P3|STARTED|Washout Period 2||10
8302786|NCT01536704|20470103|P2|STARTED|Washout Period 2||11
8302787|NCT01536704|20470104|P1|STARTED|Washout Period 2||13
8302788|NCT01536704|20470101|P4|NOT COMPLETED|Period 2||0
8302789|NCT01536704|20470102|P3|NOT COMPLETED|Period 2||0
8302790|NCT01536704|20470103|P2|NOT COMPLETED|Period 2||0
8302791|NCT01536704|20470104|P1|NOT COMPLETED|Period 2||0
8302792|NCT01536704|20470101|P4|COMPLETED|Period 2||13
8302793|NCT01536704|20470102|P3|COMPLETED|Period 2||10
8302794|NCT01536704|20470103|P2|COMPLETED|Period 2||11
8302795|NCT01536704|20470104|P1|COMPLETED|Period 2||13
8302796|NCT01536704|20470101|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
8302797|NCT01536704|20470102|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
8302798|NCT01536704|20470103|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
8302799|NCT01536704|20470104|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
8302800|NCT01536704|20470101|P4|NOT COMPLETED|Washout Period 1||0
8302801|NCT01536704|20470102|P3|NOT COMPLETED|Washout Period 1||0
8302802|NCT01536704|20470103|P2|NOT COMPLETED|Washout Period 1||2
8302803|NCT01536704|20470104|P1|NOT COMPLETED|Washout Period 1||1
8302804|NCT01536704|20470101|P4|COMPLETED|Washout Period 1||13
8302805|NCT01536704|20470102|P3|COMPLETED|Washout Period 1||13
8302806|NCT01536704|20470103|P2|COMPLETED|Washout Period 1||10
8302807|NCT01536704|20470104|P1|COMPLETED|Washout Period 1||11
8302808|NCT01536704|20470101|P4|STARTED|Washout Period 1||13
8302809|NCT01536704|20470102|P3|STARTED|Washout Period 1||13
8302810|NCT01536704|20470103|P2|STARTED|Washout Period 1||12
8302811|NCT01536704|20470104|P1|STARTED|Washout Period 1||12
8302812|NCT01536704|20470101|P4|NOT COMPLETED|Period 1||0
8302813|NCT01536704|20470102|P3|NOT COMPLETED|Period 1||0
8302814|NCT01536704|20470103|P2|NOT COMPLETED|Period 1||0
8302815|NCT01536704|20470104|P1|NOT COMPLETED|Period 1||0
8302816|NCT01536704|20470101|P4|COMPLETED|Period 1||13
8302817|NCT01536704|20470102|P3|COMPLETED|Period 1||13
8302818|NCT01536704|20470103|P2|COMPLETED|Period 1||12
8302819|NCT01536704|20470104|P1|COMPLETED|Period 1||12
8302820|NCT01536704|20470101|P4|STARTED|Period 1||13
8302821|NCT01536704|20470102|P3|STARTED|Period 1||13
8302822|NCT01536704|20470103|P2|STARTED|Period 1||12
8302823|NCT01536704|20470104|P1|STARTED|Period 1||12
8302824|NCT01536587|20470134|P1|NOT COMPLETED|Overall Study||2
8302825|NCT01536587|20470134|P1|COMPLETED|Overall Study||30
8302826|NCT01536587|20470134|P1|STARTED|Overall Study||32
8302827|NCT01536574|20470173|P2|NOT COMPLETED|Overall Study||7
8302828|NCT01536574|20470174|P1|NOT COMPLETED|Overall Study||6
8302829|NCT01536574|20470173|P2|COMPLETED|Overall Study||126
8302830|NCT01536574|20470174|P1|COMPLETED|Overall Study||156
8302831|NCT01536574|20470173|P2|STARTED|Overall Study||133
8302832|NCT01536574|20470174|P1|STARTED|Overall Study||162
8302833|NCT01536561|20470192|P1|NOT COMPLETED|Long-Term Follow-Up||0
8302835|NCT01536561|20470192|P1|STARTED|Long-Term Follow-Up||13
8302836|NCT01536561|20470192|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
8302837|NCT01536561|20470192|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
8302838|NCT01536561|20470192|P1|STARTED|Dosimetric and Therapeutic Treatment||59
8302839|NCT01536535|20470232|P2|NOT COMPLETED|Overall Study||13
8302840|NCT01536535|20470233|P1|NOT COMPLETED|Overall Study||15
8302841|NCT01536535|20470232|P2|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237
8302842|NCT01536535|20470233|P1|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163
8302843|NCT01536535|20470232|P2|STARTED|Overall Study||250
8302844|NCT01536535|20470233|P1|STARTED|Overall Study||178
8302845|NCT01536496|20470245|P2|NOT COMPLETED|Overall Study||1
8302846|NCT01536496|20470246|P1|NOT COMPLETED|Overall Study||2
8302847|NCT01536496|20470245|P2|COMPLETED|Overall Study||56
8302848|NCT01536496|20470246|P1|COMPLETED|Overall Study||55
8302849|NCT01536496|20470245|P2|STARTED|Overall Study||57
8302850|NCT01536496|20470246|P1|STARTED|Overall Study||57
8302851|NCT01536418|20470282|P2|NOT COMPLETED|Overall Study||66
8302852|NCT01536418|20470283|P1|NOT COMPLETED|Overall Study||69
8302853|NCT01536418|20470282|P2|COMPLETED|Overall Study||60
8302854|NCT01536418|20470283|P1|COMPLETED|Overall Study||58
8302855|NCT01536418|20470282|P2|STARTED|Overall Study||126
8302856|NCT01536418|20470283|P1|STARTED|Overall Study||127
8302857|NCT01536405|20470303|P2|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
8302858|NCT01536405|20470304|P1|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
8302859|NCT01536405|20470303|P2|COMPLETED|Visit 4 to Extended Study Follow-up||595
8302860|NCT01536405|20470304|P1|COMPLETED|Visit 4 to Extended Study Follow-up||595
8302861|NCT01536405|20470303|P2|STARTED|Visit 4 to Extended Study Follow-up||618
8302862|NCT01536405|20470304|P1|STARTED|Visit 4 to Extended Study Follow-up||615
8302863|NCT01536405|20470303|P2|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
8302864|NCT01536405|20470304|P1|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
8302865|NCT01536405|20470303|P2|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
8302866|NCT01536405|20470304|P1|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
8302867|NCT01536405|20470303|P2|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
8302868|NCT01536405|20470304|P1|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
8302869|NCT01536405|20470303|P2|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
8302870|NCT01536405|20470304|P1|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
8302871|NCT01536405|20470303|P2|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
8302872|NCT01536405|20470304|P1|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
8302873|NCT01536405|20470303|P2|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
8302874|NCT01536405|20470304|P1|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
8302875|NCT01536405|20470303|P2|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
8302876|NCT01536405|20470304|P1|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
8302877|NCT01536405|20470303|P2|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
8302878|NCT01536405|20470304|P1|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
8302879|NCT01536405|20470303|P2|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
8302880|NCT01536405|20470304|P1|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
8302881|NCT01536405|20470303|P2|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
8302882|NCT01536405|20470304|P1|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
8302883|NCT01536405|20470303|P2|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
8302884|NCT01536405|20470304|P1|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
8302885|NCT01536405|20470303|P2|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
8302886|NCT01536405|20470304|P1|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
8302887|NCT01536405|20470303|P2|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
8302888|NCT01536405|20470304|P1|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
8302889|NCT01536405|20470303|P2|STARTED|Randomization to Visit 1 (Vaccination 1)||706
8302890|NCT01536405|20470304|P1|STARTED|Randomization to Visit 1 (Vaccination 1)||706
8302891|NCT01536379|20470342|P2|NOT COMPLETED|Overall Study||3
8302892|NCT01536379|20470343|P1|NOT COMPLETED|Overall Study||2
8302893|NCT01536379|20470342|P2|COMPLETED|Overall Study||9
8302894|NCT01536379|20470343|P1|COMPLETED|Overall Study||11
8302895|NCT01536379|20470342|P2|STARTED|Overall Study||12
8302896|NCT01536379|20470343|P1|STARTED|Overall Study||13
8302897|NCT01536366|20470419|P2|NOT COMPLETED|Overall Study||4
8302898|NCT01536366|20470420|P1|NOT COMPLETED|Overall Study||13
8302899|NCT01536366|20470419|P2|COMPLETED|Overall Study||9
8302900|NCT01536366|20470420|P1|COMPLETED|Overall Study||1
8302901|NCT01536366|20470419|P2|Follow-up|Overall Study||9
8302902|NCT01536366|20470420|P1|Follow-up|Overall Study||13
8302903|NCT01536366|20470419|P2|Repaglinide|Overall Study||13
8302904|NCT01536366|20470420|P1|Repaglinide|Overall Study||14
8302905|NCT01536366|20470419|P2|BIA 9-1067 + Repaglinide|Overall Study||10
8302906|NCT01536366|20470420|P1|BIA 9-1067 + Repaglinide|Overall Study||14
8302907|NCT01536366|20470419|P2|STARTED|Overall Study||13
8302908|NCT01536366|20470420|P1|STARTED|Overall Study||14
8302909|NCT01536262|20470435|P3|NOT COMPLETED|Overall Study||2
8302910|NCT01536262|20470436|P2|NOT COMPLETED|Overall Study||2
8302911|NCT01536262|20470437|P1|NOT COMPLETED|Overall Study||8
8302912|NCT01536262|20470435|P3|COMPLETED|Overall Study||39
8302913|NCT01536262|20470436|P2|COMPLETED|Overall Study||38
8302914|NCT01536262|20470437|P1|COMPLETED|Overall Study||33
8302915|NCT01536262|20470435|P3|STARTED|Overall Study||41
8302916|NCT01536262|20470436|P2|STARTED|Overall Study||40
8302917|NCT01536262|20470437|P1|STARTED|Overall Study||41
8302918|NCT01536197|20470453|P2|NOT COMPLETED|Overall Study||0
8302919|NCT01536197|20470454|P1|NOT COMPLETED|Overall Study||0
8302920|NCT01536197|20470453|P2|COMPLETED|Overall Study||10
8302921|NCT01536197|20470454|P1|COMPLETED|Overall Study||23
8302922|NCT01536197|20470453|P2|STARTED|Overall Study||10
8302923|NCT01536197|20470454|P1|STARTED|Overall Study||23
8302924|NCT01536184|20470464|P2|NOT COMPLETED|Overall Study||0
8302925|NCT01536184|20470465|P1|NOT COMPLETED|Overall Study||0
8302926|NCT01536184|20470464|P2|COMPLETED|Overall Study||4
8302927|NCT01536184|20470465|P1|COMPLETED|Overall Study||8
8302928|NCT01536184|20470464|P2|STARTED|Overall Study||4
8302929|NCT01536184|20470465|P1|STARTED|Overall Study||8
8302930|NCT01536171|20470479|P1|NOT COMPLETED|Overall Study||1
8302931|NCT01536171|20470479|P1|COMPLETED|Overall Study||21
8302932|NCT01536171|20470479|P1|STARTED|Overall Study||22
8302933|NCT01536145|20470484|P11|NOT COMPLETED|Overall Study||10
8302934|NCT01536145|20470485|P10|NOT COMPLETED|Overall Study||6
8302935|NCT01536145|20470486|P9|NOT COMPLETED|Overall Study||3
8302936|NCT01536145|20470487|P8|NOT COMPLETED|Overall Study||4
8302937|NCT01536145|20470488|P7|NOT COMPLETED|Overall Study||2
8302938|NCT01536145|20470489|P6|NOT COMPLETED|Overall Study||3
8302939|NCT01536145|20470490|P5|NOT COMPLETED|Overall Study||2
8302940|NCT01536145|20470491|P4|NOT COMPLETED|Overall Study||2
8302941|NCT01536145|20470492|P3|NOT COMPLETED|Overall Study||2
8302942|NCT01536145|20470493|P2|NOT COMPLETED|Overall Study||4
8302943|NCT01536145|20470494|P1|NOT COMPLETED|Overall Study||3
8302944|NCT01536145|20470484|P11|COMPLETED|Overall Study||0
8302945|NCT01536145|20470485|P10|COMPLETED|Overall Study||1
8302946|NCT01536145|20470486|P9|COMPLETED|Overall Study||0
8302947|NCT01536145|20470487|P8|COMPLETED|Overall Study||0
8302948|NCT01536145|20470488|P7|COMPLETED|Overall Study||1
8302949|NCT01536145|20470489|P6|COMPLETED|Overall Study||0
8302950|NCT01536145|20470490|P5|COMPLETED|Overall Study||2
8302951|NCT01536145|20470491|P4|COMPLETED|Overall Study||1
8302952|NCT01536145|20470492|P3|COMPLETED|Overall Study||1
8302953|NCT01536145|20470493|P2|COMPLETED|Overall Study||0
8302954|NCT01536145|20470494|P1|COMPLETED|Overall Study||0
8302955|NCT01536145|20470484|P11|STARTED|Overall Study||10
8302956|NCT01536145|20470485|P10|STARTED|Overall Study||7
8302957|NCT01536145|20470486|P9|STARTED|Overall Study||3
8302958|NCT01536145|20470487|P8|STARTED|Overall Study||4
8302959|NCT01536145|20470488|P7|STARTED|Overall Study||3
8302960|NCT01536145|20470489|P6|STARTED|Overall Study||3
8302961|NCT01536145|20470490|P5|STARTED|Overall Study||4
8302962|NCT01536145|20470491|P4|STARTED|Overall Study||3
8302963|NCT01536145|20470492|P3|STARTED|Overall Study||3
8302964|NCT01536145|20470493|P2|STARTED|Overall Study||4
8302965|NCT01536145|20470494|P1|STARTED|Overall Study||3
8302966|NCT01536119|20470601|P2|NOT COMPLETED|Overall Study||14
8302967|NCT01536119|20470602|P1|NOT COMPLETED|Overall Study||17
8302968|NCT01536119|20470601|P2|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
8302969|NCT01536119|20470602|P1|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
8302970|NCT01536119|20470601|P2|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
8302971|NCT01536119|20470602|P1|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
8302972|NCT01536093|20470628|P2|NOT COMPLETED|Overall Study||3
8302973|NCT01536093|20470629|P1|NOT COMPLETED|Overall Study||3
8302974|NCT01536093|20470628|P2|COMPLETED|Overall Study||21
8302975|NCT01536093|20470629|P1|COMPLETED|Overall Study||21
8302976|NCT01536093|20470628|P2|STARTED|Overall Study||24
8302977|NCT01536093|20470629|P1|STARTED|Overall Study||24
8302978|NCT01536067|20470645|P1|NOT COMPLETED|Overall Study||1
8302979|NCT01536067|20470645|P1|COMPLETED|Overall Study||2
8302980|NCT01536067|20470645|P1|STARTED|Overall Study||3
8302981|NCT01536015|20470658|P2|NOT COMPLETED|Overall Study||10
8302982|NCT01536015|20470659|P1|NOT COMPLETED|Overall Study||8
8302983|NCT01536015|20470658|P2|COMPLETED|Overall Study||3
8302984|NCT01536015|20470659|P1|COMPLETED|Overall Study||4
8302985|NCT01536015|20470658|P2|STARTED|Overall Study||13
8302986|NCT01536015|20470659|P1|STARTED|Overall Study||12
8302987|NCT01535976|20470677|P2|NOT COMPLETED|Overall Study||1
8302988|NCT01535976|20470678|P1|NOT COMPLETED|Overall Study||1
8302989|NCT01535976|20470677|P2|COMPLETED|Overall Study||26
8302990|NCT01535976|20470678|P1|COMPLETED|Overall Study||26
8302991|NCT01535976|20470677|P2|STARTED|Overall Study||27
8302992|NCT01535976|20470678|P1|STARTED|Overall Study||27
8302993|NCT01535937|20470686|P2|NOT COMPLETED|Overall Study||0
8302994|NCT01535937|20470687|P1|NOT COMPLETED|Overall Study||0
8302995|NCT01535937|20470686|P2|COMPLETED|Overall Study||28
8302996|NCT01535937|20470687|P1|COMPLETED|Overall Study||27
8302997|NCT01535937|20470686|P2|STARTED|Overall Study||28
8302998|NCT01535937|20470687|P1|STARTED|Overall Study||27
8302999|NCT01535807|20470697|P2|NOT COMPLETED|Overall Study||2
8303000|NCT01535807|20470698|P1|NOT COMPLETED|Overall Study||2
8303001|NCT01535807|20470697|P2|COMPLETED|Overall Study||20
8303002|NCT01535807|20470698|P1|COMPLETED|Overall Study||20
8303003|NCT01535807|20470697|P2|STARTED|Overall Study||22
8303004|NCT01535807|20470698|P1|STARTED|Overall Study||22
8303005|NCT01535729|20470704|P1|NOT COMPLETED|Overall Study||416
8303006|NCT01535729|20470704|P1|COMPLETED|Overall Study||49
8303007|NCT01535729|20470704|P1|Treated|Overall Study||385
8303008|NCT01535729|20470704|P1|STARTED|Overall Study||465
8303009|NCT01535664|20470731|P1|NOT COMPLETED|Overall Study||0
8303010|NCT01535664|20470731|P1|COMPLETED|Overall Study||20
8303011|NCT01535664|20470731|P1|STARTED|Overall Study||20
8303012|NCT01535638|20470745|P6|NOT COMPLETED|Treatment 3 (Single Dose)||0
8303013|NCT01535638|20470746|P5|NOT COMPLETED|Treatment 3 (Single Dose)||0
8303014|NCT01535638|20470747|P4|NOT COMPLETED|Treatment 3 (Single Dose)||1
8303015|NCT01535638|20470748|P3|NOT COMPLETED|Treatment 3 (Single Dose)||0
8303016|NCT01535638|20470749|P2|NOT COMPLETED|Treatment 3 (Single Dose)||0
8303017|NCT01535638|20470750|P1|NOT COMPLETED|Treatment 3 (Single Dose)||0
8303018|NCT01535638|20470745|P6|COMPLETED|Treatment 3 (Single Dose)||2
8303019|NCT01535638|20470746|P5|COMPLETED|Treatment 3 (Single Dose)||3
8303020|NCT01535638|20470747|P4|COMPLETED|Treatment 3 (Single Dose)||2
8303021|NCT01535638|20470748|P3|COMPLETED|Treatment 3 (Single Dose)||3
8303022|NCT01535638|20470749|P2|COMPLETED|Treatment 3 (Single Dose)||3
8303023|NCT01535638|20470750|P1|COMPLETED|Treatment 3 (Single Dose)||3
8303024|NCT01535638|20470745|P6|STARTED|Treatment 3 (Single Dose)||2
8303025|NCT01535638|20470746|P5|STARTED|Treatment 3 (Single Dose)||3
8303026|NCT01535638|20470747|P4|STARTED|Treatment 3 (Single Dose)||3
8303027|NCT01535638|20470748|P3|STARTED|Treatment 3 (Single Dose)||3
8303028|NCT01535638|20470749|P2|STARTED|Treatment 3 (Single Dose)||3
8303029|NCT01535638|20470750|P1|STARTED|Treatment 3 (Single Dose)||3
8303030|NCT01535638|20470745|P6|NOT COMPLETED|Treatment 2 (Single Dose)||0
8303031|NCT01535638|20470746|P5|NOT COMPLETED|Treatment 2 (Single Dose)||0
8303032|NCT01535638|20470747|P4|NOT COMPLETED|Treatment 2 (Single Dose)||0
8303033|NCT01535638|20470748|P3|NOT COMPLETED|Treatment 2 (Single Dose)||0
8303034|NCT01535638|20470749|P2|NOT COMPLETED|Treatment 2 (Single Dose)||0
8303035|NCT01535638|20470750|P1|NOT COMPLETED|Treatment 2 (Single Dose)||0
8303036|NCT01535638|20470745|P6|COMPLETED|Treatment 2 (Single Dose)||2
8303037|NCT01535638|20470746|P5|COMPLETED|Treatment 2 (Single Dose)||3
8303038|NCT01535638|20470747|P4|COMPLETED|Treatment 2 (Single Dose)||3
8303039|NCT01535638|20470748|P3|COMPLETED|Treatment 2 (Single Dose)||3
8303040|NCT01535638|20470749|P2|COMPLETED|Treatment 2 (Single Dose)||3
8303041|NCT01535638|20470750|P1|COMPLETED|Treatment 2 (Single Dose)||3
8303042|NCT01535638|20470745|P6|STARTED|Treatment 2 (Single Dose)||2
8303043|NCT01535638|20470746|P5|STARTED|Treatment 2 (Single Dose)||3
8303044|NCT01535638|20470747|P4|STARTED|Treatment 2 (Single Dose)||3
8303045|NCT01535638|20470748|P3|STARTED|Treatment 2 (Single Dose)||3
8303046|NCT01535638|20470749|P2|STARTED|Treatment 2 (Single Dose)||3
8303047|NCT01535638|20470750|P1|STARTED|Treatment 2 (Single Dose)||3
8303048|NCT01535638|20470745|P6|NOT COMPLETED|Treatment 1 (Single Dose)||1
8303049|NCT01535638|20470746|P5|NOT COMPLETED|Treatment 1 (Single Dose)||0
8303050|NCT01535638|20470747|P4|NOT COMPLETED|Treatment 1 (Single Dose)||0
8303051|NCT01535638|20470748|P3|NOT COMPLETED|Treatment 1 (Single Dose)||0
8303052|NCT01535638|20470749|P2|NOT COMPLETED|Treatment 1 (Single Dose)||0
8303053|NCT01535638|20470750|P1|NOT COMPLETED|Treatment 1 (Single Dose)||0
8303054|NCT01535638|20470745|P6|COMPLETED|Treatment 1 (Single Dose)||2
8303055|NCT01535638|20470746|P5|COMPLETED|Treatment 1 (Single Dose)||3
8303056|NCT01535638|20470747|P4|COMPLETED|Treatment 1 (Single Dose)||3
8303057|NCT01535638|20470748|P3|COMPLETED|Treatment 1 (Single Dose)||3
8303058|NCT01535638|20470749|P2|COMPLETED|Treatment 1 (Single Dose)||3
8303059|NCT01535638|20470750|P1|COMPLETED|Treatment 1 (Single Dose)||3
8303060|NCT01535638|20470745|P6|STARTED|Treatment 1 (Single Dose)||3
8303061|NCT01535638|20470746|P5|STARTED|Treatment 1 (Single Dose)||3
8303062|NCT01535638|20470747|P4|STARTED|Treatment 1 (Single Dose)||3
8303063|NCT01535638|20470748|P3|STARTED|Treatment 1 (Single Dose)||3
8303064|NCT01535638|20470749|P2|STARTED|Treatment 1 (Single Dose)||3
8303065|NCT01535638|20470750|P1|STARTED|Treatment 1 (Single Dose)||3
8303066|NCT01535599|20470764|P2|NOT COMPLETED|Overall Study||96
8303067|NCT01535599|20470765|P1|NOT COMPLETED|Overall Study||50
8303068|NCT01535599|20470764|P2|COMPLETED|Overall Study||250
8303069|NCT01535599|20470765|P1|COMPLETED|Overall Study||297
8303070|NCT01535599|20470764|P2|STARTED|Overall Study||346
8303071|NCT01535599|20470765|P1|STARTED|Overall Study||347
8303072|NCT01535573|20470778|P3|NOT COMPLETED|Overall Study||19
8303073|NCT01535573|20470779|P2|NOT COMPLETED|Overall Study||21
8303074|NCT01535573|20470780|P1|NOT COMPLETED|Overall Study||8
8303075|NCT01535573|20470778|P3|COMPLETED|Overall Study||24
8303076|NCT01535573|20470779|P2|COMPLETED|Overall Study||23
8303077|NCT01535573|20470780|P1|COMPLETED|Overall Study||13
8303078|NCT01535573|20470778|P3|STARTED|Overall Study||43
8303079|NCT01535573|20470779|P2|STARTED|Overall Study||44
8303080|NCT01535573|20470780|P1|STARTED|Overall Study||21
8303081|NCT01535560|20470799|P2|NOT COMPLETED|Overall Study||96
8303082|NCT01535560|20470800|P1|NOT COMPLETED|Overall Study||37
8303083|NCT01535560|20470799|P2|COMPLETED|Overall Study||179
8303084|NCT01535560|20470800|P1|COMPLETED|Overall Study||237
8303085|NCT01535560|20470799|P2|STARTED|Overall Study||275
8303086|NCT01535560|20470800|P1|STARTED|Overall Study||274
8303087|NCT01535443|20470810|P1|NOT COMPLETED|Overall Study||3
8303088|NCT01535443|20470810|P1|COMPLETED|Overall Study||32
8303089|NCT01535443|20470810|P1|STARTED|Overall Study||35
8303090|NCT01535365|20470827|P2|NOT COMPLETED|Overall Study||0
8303091|NCT01535365|20470828|P1|NOT COMPLETED|Overall Study||0
8303092|NCT01535365|20470827|P2|COMPLETED|Overall Study||29
8303093|NCT01535365|20470828|P1|COMPLETED|Overall Study||31
8303094|NCT01535365|20470827|P2|STARTED|Overall Study||29
8303095|NCT01535365|20470828|P1|STARTED|Overall Study||31
8303096|NCT01535326|20470839|P3|NOT COMPLETED|Overall Study||0
8303097|NCT01535326|20470840|P2|NOT COMPLETED|Overall Study||0
8303098|NCT01535326|20470841|P1|NOT COMPLETED|Overall Study||0
8303099|NCT01535326|20470839|P3|COMPLETED|Overall Study||90
8303100|NCT01535326|20470840|P2|COMPLETED|Overall Study||90
8303101|NCT01535326|20470841|P1|COMPLETED|Overall Study||90
8303102|NCT01535326|20470839|P3|STARTED|Overall Study||90
8303103|NCT01535326|20470840|P2|STARTED|Overall Study||90
8303104|NCT01535326|20470841|P1|STARTED|Overall Study||90
8303105|NCT01535287|20470860|P2|NOT COMPLETED|Overall Study||6
8303106|NCT01535287|20470861|P1|NOT COMPLETED|Overall Study||5
8303107|NCT01535287|20470860|P2|COMPLETED|Overall Study||64
8303108|NCT01535287|20470861|P1|COMPLETED|Overall Study||65
8303109|NCT01535287|20470860|P2|STARTED|Overall Study||70
8303110|NCT01535287|20470861|P1|STARTED|Overall Study||70
8303111|NCT01535261|20470877|P1|NOT COMPLETED|Overall Study||50
8303112|NCT01535261|20470877|P1|COMPLETED|Overall Study||307
8303113|NCT01535261|20470877|P1|STARTED|Overall Study||357
8303114|NCT01535235|20470890|P2|NOT COMPLETED|Overall Study||0
8303115|NCT01535235|20470891|P1|NOT COMPLETED|Overall Study||1
8303116|NCT01535235|20470890|P2|COMPLETED|Overall Study||15
8303117|NCT01535235|20470891|P1|COMPLETED|Overall Study||15
8303118|NCT01535235|20470890|P2|STARTED|Overall Study||15
8303119|NCT01535235|20470891|P1|STARTED|Overall Study||16
8303120|NCT01535222|20470905|P6|NOT COMPLETED|Overall Study||0
8303121|NCT01535222|20470906|P5|NOT COMPLETED|Overall Study||0
8303122|NCT01535222|20470907|P4|NOT COMPLETED|Overall Study||0
8303123|NCT01535222|20470908|P3|NOT COMPLETED|Overall Study||1
8303124|NCT01535222|20470909|P2|NOT COMPLETED|Overall Study||0
8303125|NCT01535222|20470910|P1|NOT COMPLETED|Overall Study||0
8303126|NCT01535222|20470905|P6|COMPLETED|Overall Study||8
8303127|NCT01535222|20470906|P5|COMPLETED|Overall Study||6
8303128|NCT01535222|20470907|P4|COMPLETED|Overall Study||6
8303129|NCT01535222|20470908|P3|COMPLETED|Overall Study||6
8303130|NCT01535222|20470909|P2|COMPLETED|Overall Study||3
8303131|NCT01535222|20470910|P1|COMPLETED|Overall Study||3
8303132|NCT01535222|20470905|P6|STARTED|Overall Study||8
8303133|NCT01535222|20470906|P5|STARTED|Overall Study||6
8303134|NCT01535222|20470907|P4|STARTED|Overall Study||6
8303135|NCT01535222|20470908|P3|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
8303136|NCT01535222|20470909|P2|STARTED|Overall Study||3
8303137|NCT01535222|20470910|P1|STARTED|Overall Study||3
8303138|NCT01535118|20470930|P1|NOT COMPLETED|Overall Study||0
8303139|NCT01535118|20470930|P1|COMPLETED|Overall Study||2765
8303140|NCT01535118|20470930|P1|STARTED|Overall Study||2765
8303141|NCT01535053|20470941|P2|NOT COMPLETED|Overall Study||2
8303142|NCT01535053|20470942|P1|NOT COMPLETED|Overall Study||1
8303143|NCT01535053|20470941|P2|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26
8303144|NCT01535053|20470942|P1|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28
8303145|NCT01535053|20470941|P2|STARTED|Overall Study||28
8303146|NCT01535053|20470942|P1|STARTED|Overall Study||29
8303147|NCT01535040|20470960|P2|NOT COMPLETED|Overall Study||21
8303148|NCT01535040|20470961|P1|NOT COMPLETED|Overall Study||30
8303149|NCT01535040|20470960|P2|COMPLETED|Overall Study||44
8303150|NCT01535040|20470961|P1|COMPLETED|Overall Study||35
8303151|NCT01535040|20470960|P2|STARTED|Overall Study||65
8303152|NCT01535040|20470961|P1|STARTED|Overall Study||65
8303153|NCT01535014|20470977|P4|NOT COMPLETED|Overall Study||0
8303154|NCT01535014|20470978|P3|NOT COMPLETED|Overall Study||1
8303155|NCT01535014|20470979|P2|NOT COMPLETED|Overall Study||6
8303156|NCT01535014|20470980|P1|NOT COMPLETED|Overall Study||2
8303157|NCT01535014|20470977|P4|COMPLETED|Overall Study||33
8303158|NCT01535014|20470978|P3|COMPLETED|Overall Study||49
8303159|NCT01535014|20470979|P2|COMPLETED|Overall Study||194
8303160|NCT01535014|20470980|P1|COMPLETED|Overall Study||208
8303161|NCT01535014|20470977|P4|STARTED|Overall Study||33
8303162|NCT01535014|20470978|P3|STARTED|Overall Study||50
8303163|NCT01535014|20470979|P2|STARTED|Overall Study||200
8303164|NCT01535014|20470980|P1|STARTED|Overall Study||210
8303165|NCT01535001|20471014|P2|NOT COMPLETED|Overall Study||6
8303166|NCT01535001|20471015|P1|NOT COMPLETED|Overall Study||3
8303167|NCT01535001|20471014|P2|COMPLETED|Overall Study||44
8303168|NCT01535001|20471015|P1|COMPLETED|Overall Study||47
8303169|NCT01535001|20471014|P2|STARTED|Overall Study||50
8303170|NCT01535001|20471015|P1|STARTED|Overall Study||50
8303171|NCT01534975|20471041|P4|NOT COMPLETED|Overall Study||0
8303172|NCT01534975|20471042|P3|NOT COMPLETED|Overall Study||0
8303173|NCT01534975|20471043|P2|NOT COMPLETED|Overall Study||0
8303174|NCT01534975|20471044|P1|NOT COMPLETED|Overall Study||0
8303175|NCT01534975|20471041|P4|COMPLETED|Overall Study||84
8303176|NCT01534975|20471042|P3|COMPLETED|Overall Study||160
8303177|NCT01534975|20471043|P2|COMPLETED|Overall Study||133
8303178|NCT01534975|20471044|P1|COMPLETED|Overall Study||136
8303179|NCT01534975|20471041|P4|STARTED|Overall Study||84
8303180|NCT01534975|20471042|P3|STARTED|Overall Study||160
8303181|NCT01534975|20471043|P2|STARTED|Overall Study||133
8303182|NCT01534975|20471044|P1|STARTED|Overall Study||136
8303183|NCT01534962|20471058|P4|NOT COMPLETED|Overall Study||32
8303184|NCT01534962|20471059|P3|NOT COMPLETED|Overall Study||24
8303185|NCT01534962|20471060|P2|NOT COMPLETED|Overall Study||26
8303186|NCT01534962|20471061|P1|NOT COMPLETED|Overall Study||37
8303187|NCT01534962|20471058|P4|COMPLETED|Overall Study||24
8303188|NCT01534962|20471059|P3|COMPLETED|Overall Study||34
8303189|NCT01534962|20471060|P2|COMPLETED|Overall Study||34
8303190|NCT01534962|20471061|P1|COMPLETED|Overall Study||30
8303191|NCT01534962|20471058|P4|STARTED|Overall Study||56
8303192|NCT01534962|20471059|P3|STARTED|Overall Study||58
8303193|NCT01534962|20471060|P2|STARTED|Overall Study||60
8303194|NCT01534962|20471061|P1|STARTED|Overall Study||67
8303195|NCT01534910|20471093|P2|NOT COMPLETED|Overall Study||4
8303196|NCT01534910|20471094|P1|NOT COMPLETED|Overall Study||4
8303197|NCT01534910|20471093|P2|COMPLETED|Overall Study||28
8303198|NCT01534910|20471094|P1|COMPLETED|Overall Study||29
8303199|NCT01534910|20471093|P2|STARTED|Overall Study||32
8303200|NCT01534910|20471094|P1|STARTED|Overall Study||33
8303201|NCT01534897|20471102|P1|NOT COMPLETED|Overall Study||0
8303202|NCT01534897|20471102|P1|COMPLETED|Overall Study||10
8303203|NCT01534897|20471102|P1|Day 37 Iodine-131 Treatment|Overall Study||6
8303204|NCT01534897|20471102|P1|Day 25 Iodine-131 Scan|Overall Study||10
8303205|NCT01534897|20471102|P1|STARTED|Overall Study||10
8303206|NCT01534689|20471110|P1|NOT COMPLETED|Overall Study||0
8303207|NCT01534689|20471110|P1|COMPLETED|Overall Study||105
8303208|NCT01534689|20471110|P1|STARTED|Overall Study||105
8303209|NCT01534676|20471118|P2|NOT COMPLETED|Overall Study||1
8303210|NCT01534676|20471119|P1|NOT COMPLETED|Overall Study||2
8303211|NCT01534676|20471118|P2|COMPLETED|Overall Study||0
8303212|NCT01534676|20471119|P1|COMPLETED|Overall Study||0
8303213|NCT01534676|20471118|P2|STARTED|Overall Study||1
8303214|NCT01534676|20471119|P1|STARTED|Overall Study||2
8303215|NCT01534663|20471127|P2|NOT COMPLETED|Overall Study||3
8303216|NCT01534663|20471128|P1|NOT COMPLETED|Overall Study||2
8303217|NCT01534663|20471127|P2|COMPLETED|Overall Study||14
8303218|NCT01534663|20471128|P1|COMPLETED|Overall Study||12
8303219|NCT01534663|20471127|P2|STARTED|Overall Study||17
8303220|NCT01534663|20471128|P1|STARTED|Overall Study||14
8303221|NCT01534637|20471162|P1|NOT COMPLETED|Overall Study||9
8303222|NCT01534637|20471162|P1|COMPLETED|Overall Study||13
8303223|NCT01534637|20471162|P1|STARTED|Overall Study||22
8303224|NCT01534533|20471172|P4|NOT COMPLETED|Overall Study||4
8303225|NCT01534533|20471173|P3|NOT COMPLETED|Overall Study||8
8303226|NCT01534533|20471174|P2|NOT COMPLETED|Overall Study||3
8303227|NCT01534533|20471175|P1|NOT COMPLETED|Overall Study||8
8303228|NCT01534533|20471172|P4|COMPLETED|Overall Study||44
8303229|NCT01534533|20471173|P3|COMPLETED|Overall Study||40
8303230|NCT01534533|20471174|P2|COMPLETED|Overall Study||45
8303231|NCT01534533|20471175|P1|COMPLETED|Overall Study||40
8303232|NCT01534533|20471172|P4|STARTED|Overall Study||48
8303233|NCT01534533|20471173|P3|STARTED|Overall Study||48
8303234|NCT01534533|20471174|P2|STARTED|Overall Study||48
8303235|NCT01534533|20471175|P1|STARTED|Overall Study||48
8303236|NCT01534520|20471203|P2|NOT COMPLETED|Overall Study||1
8303237|NCT01534520|20471204|P1|NOT COMPLETED|Overall Study||0
8303238|NCT01534520|20471203|P2|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
8303239|NCT01534520|20471204|P1|COMPLETED|Overall Study||30
8303240|NCT01534520|20471203|P2|STARTED|Overall Study||29
8303241|NCT01534520|20471204|P1|STARTED|Overall Study||30
8303242|NCT01534416|20471218|P2|NOT COMPLETED|Overall Study||0
8303243|NCT01534416|20471219|P1|NOT COMPLETED|Overall Study||0
8303244|NCT01534416|20471218|P2|COMPLETED|Overall Study||64
8303245|NCT01534416|20471219|P1|COMPLETED|Overall Study||68
8303246|NCT01534416|20471218|P2|STARTED|Overall Study||64
8303247|NCT01534416|20471219|P1|STARTED|Overall Study||68
8303248|NCT01534351|20471238|P3|NOT COMPLETED|Overall Study||0
8303249|NCT01534351|20471239|P2|NOT COMPLETED|Overall Study||0
8303250|NCT01534351|20471240|P1|NOT COMPLETED|Overall Study||1
8303251|NCT01534351|20471238|P3|COMPLETED|Overall Study||0
8303252|NCT01534351|20471239|P2|COMPLETED|Overall Study||0
8303253|NCT01534351|20471240|P1|COMPLETED|Overall Study||0
8303254|NCT01534351|20471238|P3|STARTED|Overall Study||0
8303255|NCT01534351|20471239|P2|STARTED|Overall Study||0
8303256|NCT01534351|20471240|P1|STARTED|Overall Study||1
8303257|NCT01534273|20471261|P7|NOT COMPLETED|Period 2||0
8303258|NCT01534273|20471262|P6|NOT COMPLETED|Period 2||0
8303259|NCT01534273|20471263|P5|NOT COMPLETED|Period 2||0
8303260|NCT01534273|20471264|P4|NOT COMPLETED|Period 2||0
8303261|NCT01534273|20471265|P3|NOT COMPLETED|Period 2||0
8303262|NCT01534273|20471266|P2|NOT COMPLETED|Period 2||0
8303263|NCT01534273|20471267|P1|NOT COMPLETED|Period 2||0
8303264|NCT01534273|20471261|P7|COMPLETED|Period 2||0
8303265|NCT01534273|20471262|P6|COMPLETED|Period 2||0
8303266|NCT01534273|20471263|P5|COMPLETED|Period 2||0
8303267|NCT01534273|20471264|P4|COMPLETED|Period 2||6
8303268|NCT01534273|20471265|P3|COMPLETED|Period 2||2
8303269|NCT01534273|20471266|P2|COMPLETED|Period 2||0
8303270|NCT01534273|20471267|P1|COMPLETED|Period 2||0
8303271|NCT01534273|20471261|P7|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
8303272|NCT01534273|20471262|P6|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
8303273|NCT01534273|20471263|P5|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
8303274|NCT01534273|20471264|P4|STARTED|Period 2||6
8303275|NCT01534273|20471265|P3|STARTED|Period 2||2
8303276|NCT01534273|20471266|P2|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
8303277|NCT01534273|20471267|P1|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
8303278|NCT01534273|20471261|P7|NOT COMPLETED|Period 1||0
8303279|NCT01534273|20471262|P6|NOT COMPLETED|Period 1||0
8303280|NCT01534273|20471263|P5|NOT COMPLETED|Period 1||0
8303281|NCT01534273|20471264|P4|NOT COMPLETED|Period 1||1
8303282|NCT01534273|20471265|P3|NOT COMPLETED|Period 1||0
8303283|NCT01534273|20471266|P2|NOT COMPLETED|Period 1||0
8303284|NCT01534273|20471267|P1|NOT COMPLETED|Period 1||0
8303285|NCT01534273|20471261|P7|COMPLETED|Period 1||6
8303286|NCT01534273|20471262|P6|COMPLETED|Period 1||3
8303287|NCT01534273|20471263|P5|COMPLETED|Period 1||3
8303288|NCT01534273|20471264|P4|COMPLETED|Period 1||6
8303289|NCT01534273|20471265|P3|COMPLETED|Period 1||2
8303290|NCT01534273|20471266|P2|COMPLETED|Period 1||6
8303291|NCT01534273|20471267|P1|COMPLETED|Period 1||3
8303292|NCT01534273|20471261|P7|Received at Least 1 Dose of Study Drug|Period 1||6
8303293|NCT01534273|20471262|P6|Received at Least 1 Dose of Study Drug|Period 1||3
8303294|NCT01534273|20471263|P5|Received at Least 1 Dose of Study Drug|Period 1||3
8303295|NCT01534273|20471264|P4|Received at Least 1 Dose of Study Drug|Period 1||7
8303296|NCT01534273|20471265|P3|Received at Least 1 Dose of Study Drug|Period 1||2
8303297|NCT01534273|20471266|P2|Received at Least 1 Dose of Study Drug|Period 1||6
8303298|NCT01534273|20471267|P1|Received at Least 1 Dose of Study Drug|Period 1||3
8303299|NCT01534273|20471261|P7|STARTED|Period 1||6
8303300|NCT01534273|20471262|P6|STARTED|Period 1||3
8303301|NCT01534273|20471263|P5|STARTED|Period 1||3
8303302|NCT01534273|20471264|P4|STARTED|Period 1||7
8303303|NCT01534273|20471265|P3|STARTED|Period 1||2
8303304|NCT01534273|20471266|P2|STARTED|Period 1||6
8303305|NCT01534273|20471267|P1|STARTED|Period 1||3
8303306|NCT01534260|20471294|P2|NOT COMPLETED|Overall Study||20
8303307|NCT01534260|20471295|P1|NOT COMPLETED|Overall Study||16
8303308|NCT01534260|20471294|P2|COMPLETED|Overall Study||0
8303309|NCT01534260|20471295|P1|COMPLETED|Overall Study||1
8303310|NCT01534260|20471294|P2|STARTED|Overall Study||20
8303311|NCT01534260|20471295|P1|STARTED|Overall Study||17
8303312|NCT01534208|20471305|P2|NOT COMPLETED|Overall Study||49
8303313|NCT01534208|20471306|P1|NOT COMPLETED|Overall Study||57
8303314|NCT01534208|20471305|P2|COMPLETED|Overall Study||234
8303315|NCT01534208|20471306|P1|COMPLETED|Overall Study||159
8303316|NCT01534208|20471305|P2|STARTED|Overall Study||283
8303317|NCT01534208|20471306|P1|STARTED|Overall Study||216
8303318|NCT01534195|20471324|P2|NOT COMPLETED|Overall Study||1
8303319|NCT01534195|20471325|P1|NOT COMPLETED|Overall Study||1
8303320|NCT01534195|20471324|P2|COMPLETED|Overall Study||5
8303321|NCT01534195|20471325|P1|COMPLETED|Overall Study||4
8303322|NCT01534195|20471324|P2|STARTED|Overall Study||6
8303323|NCT01534195|20471325|P1|STARTED|Overall Study||5
8303324|NCT01534182|20471339|P2|NOT COMPLETED|Overall Study||10
8303325|NCT01534182|20471340|P1|NOT COMPLETED|Overall Study||12
8303326|NCT01534182|20471339|P2|COMPLETED|Overall Study||58
8303327|NCT01534182|20471340|P1|COMPLETED|Overall Study||218
8303328|NCT01534182|20471339|P2|Full Analysis Set|Overall Study||62
8303329|NCT01534182|20471340|P1|Full Analysis Set|Overall Study||229
8303330|NCT01534182|20471339|P2|Safety Set|Overall Study||64
8303331|NCT01534182|20471340|P1|Safety Set|Overall Study||230
8303332|NCT01534182|20471339|P2|STARTED|Overall Study||68
8303333|NCT01534182|20471340|P1|STARTED|Overall Study||230
8303334|NCT01534143|20471355|P1|NOT COMPLETED|Overall Study||0
8303335|NCT01534143|20471355|P1|COMPLETED|Overall Study||1
8303336|NCT01534143|20471355|P1|STARTED|Overall Study||1
8303337|NCT01534078|20471371|P1|NOT COMPLETED|Overall Study||2
8303338|NCT01534078|20471371|P1|COMPLETED|Overall Study||32
8303339|NCT01534078|20471371|P1|STARTED|Overall Study||34
8303340|NCT01534052|20471378|P1|NOT COMPLETED|Overall Study||0
8303341|NCT01534052|20471378|P1|COMPLETED|Overall Study||52
8303342|NCT01534052|20471378|P1|Treatment Received|Overall Study||52
8303343|NCT01534052|20471378|P1|STARTED|Overall Study||52
8303344|NCT01534013|20471384|P2|NOT COMPLETED|Overall Study||0
8303345|NCT01534013|20471385|P1|NOT COMPLETED|Overall Study||2
8303346|NCT01534013|20471384|P2|COMPLETED|Overall Study||6
8303347|NCT01534013|20471385|P1|COMPLETED|Overall Study||6
8303348|NCT01534013|20471384|P2|STARTED|Overall Study||6
8303349|NCT01534013|20471385|P1|STARTED|Overall Study||8
8303350|NCT01533974|20471393|P2|NOT COMPLETED|Overall Study||50
8303351|NCT01533974|20471394|P1|NOT COMPLETED|Overall Study||51
8303352|NCT01533974|20471393|P2|COMPLETED|Overall Study||176
8303353|NCT01533974|20471394|P1|COMPLETED|Overall Study||173
8303354|NCT01533974|20471393|P2|STARTED|Overall Study||226
8303355|NCT01533974|20471394|P1|STARTED|Overall Study||224
8303356|NCT01533948|20471400|P1|NOT COMPLETED|Overall Study||0
8303357|NCT01533948|20471400|P1|COMPLETED|Overall Study||25
8303358|NCT01533948|20471400|P1|STARTED|Overall Study||25
8303359|NCT01533935|20471408|P5|NOT COMPLETED|Overall Study||8
8303360|NCT01533935|20471409|P4|NOT COMPLETED|Overall Study||7
8303361|NCT01533935|20471410|P3|NOT COMPLETED|Overall Study||8
8303362|NCT01533935|20471411|P2|NOT COMPLETED|Overall Study||13
8303363|NCT01533935|20471412|P1|NOT COMPLETED|Overall Study||6
8303364|NCT01533935|20471408|P5|COMPLETED|Overall Study|All treatment periods|50
8303365|NCT01533935|20471409|P4|COMPLETED|Overall Study|All treatment periods|52
8303366|NCT01533935|20471410|P3|COMPLETED|Overall Study|All treatment periods|50
8303367|NCT01533935|20471411|P2|COMPLETED|Overall Study|All treatment periods|45
8303368|NCT01533935|20471412|P1|COMPLETED|Overall Study|All treatment periods|52
8303369|NCT01533935|20471408|P5|Received Tio+Olo 5/5|Overall Study||55
8303370|NCT01533935|20471409|P4|Received Tio+Olo 5/5|Overall Study||54
8303371|NCT01533935|20471410|P3|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
8303372|NCT01533935|20471411|P2|Received Tio+Olo 5/5|Overall Study||58
8303373|NCT01533935|20471412|P1|Received Tio+Olo 5/5|Overall Study||56
8303374|NCT01533935|20471408|P5|Received Tio+Olo 2.5/5|Overall Study||56
8303375|NCT01533935|20471409|P4|Received Tio+Olo 2.5/5|Overall Study||56
8303376|NCT01533935|20471410|P3|Received Tio+Olo 2.5/5|Overall Study||49
8303377|NCT01533935|20471411|P2|Received Tio+Olo 2.5/5|Overall Study||0
8303378|NCT01533935|20471412|P1|Received Tio+Olo 2.5/5|Overall Study||58
8303379|NCT01533935|20471408|P5|Received Tio 5|Overall Study||52
8303380|NCT01533935|20471409|P4|Received Tio 5|Overall Study||0
8303381|NCT01533935|20471410|P3|Received Tio 5|Overall Study||58
8303382|NCT01533935|20471411|P2|Received Tio 5|Overall Study||54
8303383|NCT01533935|20471412|P1|Received Tio 5|Overall Study||54
8303384|NCT01533935|20471408|P5|Received Olo 5|Overall Study||0
8303385|NCT01533935|20471409|P4|Received Olo 5|Overall Study||59
8303386|NCT01533935|20471410|P3|Received Olo 5|Overall Study||55
8303387|NCT01533935|20471411|P2|Received Olo 5|Overall Study||52
8303388|NCT01533935|20471412|P1|Received Olo 5|Overall Study||52
8303389|NCT01533935|20471408|P5|Received Placebo|Overall Study||58
8303390|NCT01533935|20471409|P4|Received Placebo|Overall Study||57
8303391|NCT01533935|20471410|P3|Received Placebo|Overall Study||52
8303392|NCT01533935|20471411|P2|Received Placebo|Overall Study||47
8303393|NCT01533935|20471412|P1|Received Placebo|Overall Study||0
8303394|NCT01533935|20471408|P5|STARTED|Overall Study||58
8303395|NCT01533935|20471409|P4|STARTED|Overall Study||59
8303396|NCT01533935|20471410|P3|STARTED|Overall Study||58
8303397|NCT01533935|20471411|P2|STARTED|Overall Study||58
8303398|NCT01533935|20471412|P1|STARTED|Overall Study||58
8303399|NCT01533922|20471439|P5|NOT COMPLETED|Overall Study||6
8303400|NCT01533922|20471440|P4|NOT COMPLETED|Overall Study||5
8303401|NCT01533922|20471441|P3|NOT COMPLETED|Overall Study||10
8303402|NCT01533922|20471442|P2|NOT COMPLETED|Overall Study||12
8303403|NCT01533922|20471443|P1|NOT COMPLETED|Overall Study||10
8303404|NCT01533922|20471439|P5|COMPLETED|Overall Study|Completed all treatment arms|53
8303405|NCT01533922|20471440|P4|COMPLETED|Overall Study|Completed all treatment arms|53
8303406|NCT01533922|20471441|P3|COMPLETED|Overall Study|Completed all treatment arms|50
8303407|NCT01533922|20471442|P2|COMPLETED|Overall Study|Completed all treatment arms|47
8303408|NCT01533922|20471443|P1|COMPLETED|Overall Study|Completed all treatment arms|49
8303409|NCT01533922|20471439|P5|Received Tio+Olo 5/5|Overall Study||56
8303410|NCT01533922|20471440|P4|Received Tio+Olo 5/5|Overall Study||53
8303411|NCT01533922|20471441|P3|Received Tio+Olo 5/5|Overall Study||0
8303412|NCT01533922|20471442|P2|Received Tio+Olo 5/5|Overall Study||59
8303413|NCT01533922|20471443|P1|Received Tio+Olo 5/5|Overall Study||58
8303414|NCT01533922|20471439|P5|Received Tio+Olo 2.5/5|Overall Study||56
8303415|NCT01533922|20471440|P4|Received Tio+Olo 2.5/5|Overall Study||55
8303416|NCT01533922|20471441|P3|Received Tio+Olo 2.5/5|Overall Study||52
8303417|NCT01533922|20471442|P2|Received Tio+Olo 2.5/5|Overall Study||0
8303418|NCT01533922|20471443|P1|Received Tio+Olo 2.5/5|Overall Study||59
8303419|NCT01533922|20471439|P5|Received Tio 5|Overall Study||54
8303420|NCT01533922|20471440|P4|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
8303421|NCT01533922|20471441|P3|Received Tio 5|Overall Study||59
8303422|NCT01533922|20471442|P2|Received Tio 5|Overall Study||58
8303423|NCT01533922|20471443|P1|Received Tio 5|Overall Study||54
8303424|NCT01533922|20471439|P5|Received Olo 5|Overall Study||0
8303425|NCT01533922|20471440|P4|Received Olo 5|Overall Study||57
8303426|NCT01533922|20471441|P3|Received Olo 5|Overall Study||57
8303427|NCT01533922|20471442|P2|Received Olo 5|Overall Study||52
8303428|NCT01533922|20471443|P1|Received Olo 5|Overall Study||51
8303429|NCT01533922|20471439|P5|Received Placebo|Overall Study||59
8303430|NCT01533922|20471440|P4|Received Placebo|Overall Study||57
8303431|NCT01533922|20471441|P3|Received Placebo|Overall Study||57
8303432|NCT01533922|20471442|P2|Received Placebo|Overall Study||49
8303433|NCT01533922|20471443|P1|Received Placebo|Overall Study||0
8303434|NCT01533922|20471439|P5|STARTED|Overall Study||59
8303435|NCT01533922|20471440|P4|STARTED|Overall Study||58
8303436|NCT01533922|20471441|P3|STARTED|Overall Study||60
8303437|NCT01533922|20471442|P2|STARTED|Overall Study||59
8303438|NCT01533922|20471443|P1|STARTED|Overall Study||59
8303439|NCT01533753|20471472|P2|NOT COMPLETED|Overall Study||0
8303440|NCT01533753|20471473|P1|NOT COMPLETED|Overall Study||0
8303441|NCT01533753|20471472|P2|COMPLETED|Overall Study||3
8303442|NCT01533753|20471473|P1|COMPLETED|Overall Study||2
8303443|NCT01533753|20471472|P2|STARTED|Overall Study||3
8303444|NCT01533753|20471473|P1|STARTED|Overall Study||2
8303445|NCT01533688|20471488|P3|NOT COMPLETED|Overall Study||8
8303446|NCT01533688|20471489|P2|NOT COMPLETED|Overall Study||10
8303447|NCT01533688|20471490|P1|NOT COMPLETED|Overall Study||8
8303448|NCT01533688|20471488|P3|COMPLETED|Overall Study||63
8303449|NCT01533688|20471489|P2|COMPLETED|Overall Study||60
8303450|NCT01533688|20471490|P1|COMPLETED|Overall Study||63
8303451|NCT01533688|20471488|P3|STARTED|Overall Study||71
8303452|NCT01533688|20471489|P2|STARTED|Overall Study||70
8303453|NCT01533688|20471490|P1|STARTED|Overall Study||71
8303454|NCT01533597|20471503|P2|NOT COMPLETED|Overall Study||10
8303455|NCT01533597|20471504|P1|NOT COMPLETED|Overall Study||6
8303456|NCT01533597|20471503|P2|COMPLETED|Overall Study||25
8303457|NCT01533597|20471504|P1|COMPLETED|Overall Study||29
8303458|NCT01533597|20471503|P2|STARTED|Overall Study||35
8303459|NCT01533597|20471504|P1|STARTED|Overall Study||35
8303460|NCT01533493|20471522|P2|NOT COMPLETED|Overall Study||3
8303461|NCT01533493|20471523|P1|NOT COMPLETED|Overall Study||5
8303462|NCT01533493|20471522|P2|COMPLETED|Overall Study||11
8303463|NCT01533493|20471523|P1|COMPLETED|Overall Study||7
8303464|NCT01533493|20471522|P2|STARTED|Overall Study||14
8303465|NCT01533493|20471523|P1|STARTED|Overall Study||12
8303466|NCT01533428|20471531|P2|NOT COMPLETED|Overall Study||8
8303467|NCT01533428|20471532|P1|NOT COMPLETED|Overall Study||9
8303468|NCT01533428|20471531|P2|COMPLETED|Overall Study||175
8303469|NCT01533428|20471532|P1|COMPLETED|Overall Study||177
8303470|NCT01533428|20471531|P2|STARTED|Overall Study||183
8303471|NCT01533428|20471532|P1|STARTED|Overall Study||186
8303472|NCT01533259|20471572|P1|NOT COMPLETED|Overall Study||0
8303473|NCT01533259|20471572|P1|COMPLETED|Overall Study||48
8303474|NCT01533259|20471572|P1|STARTED|Overall Study||48
8303475|NCT01533246|20471578|P1|NOT COMPLETED|Overall Study||2
8303476|NCT01533246|20471578|P1|COMPLETED|Overall Study||15
8303477|NCT01533246|20471578|P1|STARTED|Overall Study||17
8303478|NCT01533207|20471589|P2|NOT COMPLETED|Overall Study||0
8303479|NCT01533207|20471590|P1|NOT COMPLETED|Overall Study||0
8303480|NCT01533207|20471589|P2|COMPLETED|Overall Study||18
8303481|NCT01533207|20471590|P1|COMPLETED|Overall Study||20
8303482|NCT01533207|20471589|P2|STARTED|Overall Study||18
8303483|NCT01533207|20471590|P1|STARTED|Overall Study||20
8303484|NCT01533181|20471602|P2|NOT COMPLETED|Overall Study||1
8303485|NCT01533181|20471603|P1|NOT COMPLETED|Overall Study||1
8303486|NCT01533181|20471602|P2|COMPLETED|Overall Study||28
8303487|NCT01533181|20471603|P1|COMPLETED|Overall Study||14
8303488|NCT01533181|20471602|P2|STARTED|Overall Study||29
8303489|NCT01533181|20471603|P1|STARTED|Overall Study||15
8303490|NCT01533116|20471619|P4|NOT COMPLETED|Overall Study||0
8303491|NCT01533116|20471620|P3|NOT COMPLETED|Overall Study||1
8303492|NCT01533116|20471621|P2|NOT COMPLETED|Overall Study||1
8303493|NCT01533116|20471622|P1|NOT COMPLETED|Overall Study||2
8303494|NCT01533116|20471619|P4|COMPLETED|Overall Study||12
8303495|NCT01533116|20471620|P3|COMPLETED|Overall Study||12
8303496|NCT01533116|20471621|P2|COMPLETED|Overall Study||12
8303497|NCT01533116|20471622|P1|COMPLETED|Overall Study||12
8303498|NCT01533116|20471619|P4|STARTED|Overall Study||12
8303499|NCT01533116|20471620|P3|STARTED|Overall Study||13
8303500|NCT01533116|20471621|P2|STARTED|Overall Study||13
8303501|NCT01533116|20471622|P1|STARTED|Overall Study||14
8303502|NCT01533077|20471652|P4|NOT COMPLETED|Overall Study||0
8303503|NCT01533077|20471653|P3|NOT COMPLETED|Overall Study||0
8303504|NCT01533077|20471654|P2|NOT COMPLETED|Overall Study||1
8303505|NCT01533077|20471655|P1|NOT COMPLETED|Overall Study||1
8303506|NCT01533077|20471652|P4|COMPLETED|Overall Study||4
8303507|NCT01533077|20471653|P3|COMPLETED|Overall Study||4
8303508|NCT01533077|20471654|P2|COMPLETED|Overall Study||4
8303509|NCT01533077|20471655|P1|COMPLETED|Overall Study||4
8303510|NCT01533077|20471652|P4|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
8303511|NCT01533077|20471653|P3|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
8303512|NCT01533077|20471654|P2|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
8303513|NCT01533077|20471655|P1|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
8303514|NCT01533077|20471652|P4|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
8303515|NCT01533077|20471653|P3|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
8303516|NCT01533077|20471654|P2|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
8303517|NCT01533077|20471655|P1|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
8303518|NCT01533077|20471652|P4|Sinemet® 100/25|Overall Study||4
8303519|NCT01533077|20471653|P3|Sinemet® 100/25|Overall Study||4
8303520|NCT01533077|20471654|P2|Sinemet® 100/25|Overall Study||5
8303521|NCT01533077|20471655|P1|Sinemet® 100/25|Overall Study||4
8303522|NCT01533077|20471652|P4|BIA 9-1067 50 mg|Overall Study||4
8303523|NCT01533077|20471653|P3|BIA 9-1067 50 mg|Overall Study||4
8303524|NCT01533077|20471654|P2|BIA 9-1067 50 mg|Overall Study||5
8303525|NCT01533077|20471655|P1|BIA 9-1067 50 mg|Overall Study||5
8303526|NCT01533077|20471652|P4|STARTED|Overall Study||4
8303527|NCT01533077|20471653|P3|STARTED|Overall Study||4
8303528|NCT01533077|20471654|P2|STARTED|Overall Study||5
8303529|NCT01533077|20471655|P1|STARTED|Overall Study||5
8303530|NCT01533038|20471711|P2|NOT COMPLETED|Overall Study||1
8303531|NCT01533038|20471712|P1|NOT COMPLETED|Overall Study||0
8303532|NCT01533038|20471711|P2|COMPLETED|Overall Study||34
8303533|NCT01533038|20471712|P1|COMPLETED|Overall Study||45
8303534|NCT01533038|20471711|P2|STARTED|Overall Study||35
8303535|NCT01533038|20471712|P1|STARTED|Overall Study||45
8303536|NCT01532999|20471720|P2|NOT COMPLETED|Overall Study||18
8303537|NCT01532999|20471721|P1|NOT COMPLETED|Overall Study||31
8303538|NCT01532999|20471720|P2|COMPLETED|Overall Study||77
8303539|NCT01532999|20471721|P1|COMPLETED|Overall Study||65
8303540|NCT01532999|20471720|P2|STARTED|Overall Study||95
8303541|NCT01532999|20471721|P1|STARTED|Overall Study||96
8303542|NCT01532986|20471745|P2|NOT COMPLETED|Overall Study||24
8303543|NCT01532986|20471746|P1|NOT COMPLETED|Overall Study||23
8303544|NCT01532986|20471745|P2|COMPLETED|Overall Study||138
8303545|NCT01532986|20471746|P1|COMPLETED|Overall Study||143
8303546|NCT01532986|20471745|P2|STARTED|Overall Study||162
8303547|NCT01532986|20471746|P1|STARTED|Overall Study||166
8303548|NCT01532973|20471779|P10|NOT COMPLETED|Part 3||0
8303549|NCT01532973|20471780|P9|NOT COMPLETED|Part 3||0
8303550|NCT01532973|20471781|P8|NOT COMPLETED|Part 3||0
8303551|NCT01532973|20471782|P7|NOT COMPLETED|Part 3||0
8303552|NCT01532973|20471783|P6|NOT COMPLETED|Part 3||0
8303553|NCT01532973|20471784|P5|NOT COMPLETED|Part 3||0
8303554|NCT01532973|20471785|P4|NOT COMPLETED|Part 3||0
8303555|NCT01532973|20471786|P3|NOT COMPLETED|Part 3||0
8303556|NCT01532973|20471787|P2|NOT COMPLETED|Part 3||0
8303557|NCT01532973|20471788|P1|NOT COMPLETED|Part 3||0
8303558|NCT01532973|20471779|P10|COMPLETED|Part 3||6
8303559|NCT01532973|20471780|P9|COMPLETED|Part 3||6
8303560|NCT01532973|20471781|P8|COMPLETED|Part 3||0
8303561|NCT01532973|20471782|P7|COMPLETED|Part 3||0
8303562|NCT01532973|20471783|P6|COMPLETED|Part 3||0
8303563|NCT01532973|20471784|P5|COMPLETED|Part 3||0
8303564|NCT01532973|20471785|P4|COMPLETED|Part 3||0
8303565|NCT01532973|20471786|P3|COMPLETED|Part 3||0
8303566|NCT01532973|20471787|P2|COMPLETED|Part 3||0
8303567|NCT01532973|20471788|P1|COMPLETED|Part 3||0
8303568|NCT01532973|20471779|P10|STARTED|Part 3||6
8303569|NCT01532973|20471780|P9|STARTED|Part 3||6
8303570|NCT01532973|20471781|P8|STARTED|Part 3||0
8303571|NCT01532973|20471782|P7|STARTED|Part 3||0
8303572|NCT01532973|20471783|P6|STARTED|Part 3||0
8303573|NCT01532973|20471784|P5|STARTED|Part 3||0
8303574|NCT01532973|20471785|P4|STARTED|Part 3||0
8303575|NCT01532973|20471786|P3|STARTED|Part 3||0
8303576|NCT01532973|20471787|P2|STARTED|Part 3||0
8303577|NCT01532973|20471788|P1|STARTED|Part 3||0
8303578|NCT01532973|20471779|P10|NOT COMPLETED|Part 2||0
8303579|NCT01532973|20471780|P9|NOT COMPLETED|Part 2||0
8303580|NCT01532973|20471781|P8|NOT COMPLETED|Part 2||0
8303581|NCT01532973|20471782|P7|NOT COMPLETED|Part 2||0
8303582|NCT01532973|20471783|P6|NOT COMPLETED|Part 2||0
8303583|NCT01532973|20471784|P5|NOT COMPLETED|Part 2||0
8303584|NCT01532973|20471785|P4|NOT COMPLETED|Part 2||0
8303585|NCT01532973|20471786|P3|NOT COMPLETED|Part 2||0
8303586|NCT01532973|20471787|P2|NOT COMPLETED|Part 2||0
8303587|NCT01532973|20471788|P1|NOT COMPLETED|Part 2||0
8303588|NCT01532973|20471779|P10|COMPLETED|Part 2||0
8303589|NCT01532973|20471780|P9|COMPLETED|Part 2||0
8303590|NCT01532973|20471781|P8|COMPLETED|Part 2||0
8303591|NCT01532973|20471782|P7|COMPLETED|Part 2||6
8303592|NCT01532973|20471783|P6|COMPLETED|Part 2||6
8303593|NCT01532973|20471784|P5|COMPLETED|Part 2||6
8303594|NCT01532973|20471785|P4|COMPLETED|Part 2||0
8303595|NCT01532973|20471786|P3|COMPLETED|Part 2||0
8303596|NCT01532973|20471787|P2|COMPLETED|Part 2||0
8303597|NCT01532973|20471788|P1|COMPLETED|Part 2||0
8303598|NCT01532973|20471779|P10|STARTED|Part 2||0
8303599|NCT01532973|20471780|P9|STARTED|Part 2||0
8303600|NCT01532973|20471781|P8|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
8303601|NCT01532973|20471782|P7|STARTED|Part 2||6
8303602|NCT01532973|20471783|P6|STARTED|Part 2||6
8303603|NCT01532973|20471784|P5|STARTED|Part 2||6
8303604|NCT01532973|20471785|P4|STARTED|Part 2||0
8303605|NCT01532973|20471786|P3|STARTED|Part 2||0
8303606|NCT01532973|20471787|P2|STARTED|Part 2||0
8303607|NCT01532973|20471788|P1|STARTED|Part 2||0
8303608|NCT01532973|20471779|P10|NOT COMPLETED|Part 1||0
8303609|NCT01532973|20471780|P9|NOT COMPLETED|Part 1||0
8303610|NCT01532973|20471781|P8|NOT COMPLETED|Part 1||0
8303611|NCT01532973|20471782|P7|NOT COMPLETED|Part 1||0
8303612|NCT01532973|20471783|P6|NOT COMPLETED|Part 1||0
8303613|NCT01532973|20471784|P5|NOT COMPLETED|Part 1||0
8303614|NCT01532973|20471785|P4|NOT COMPLETED|Part 1||0
8303615|NCT01532973|20471786|P3|NOT COMPLETED|Part 1||0
8303616|NCT01532973|20471787|P2|NOT COMPLETED|Part 1||0
8303617|NCT01532973|20471788|P1|NOT COMPLETED|Part 1||0
8303618|NCT01532973|20471779|P10|COMPLETED|Part 1||0
8303619|NCT01532973|20471780|P9|COMPLETED|Part 1||0
8303620|NCT01532973|20471781|P8|COMPLETED|Part 1||0
8303621|NCT01532973|20471782|P7|COMPLETED|Part 1||0
8303622|NCT01532973|20471783|P6|COMPLETED|Part 1||0
8303623|NCT01532973|20471784|P5|COMPLETED|Part 1||0
8303624|NCT01532973|20471785|P4|COMPLETED|Part 1||0
8303625|NCT01532973|20471786|P3|COMPLETED|Part 1||6
8303626|NCT01532973|20471787|P2|COMPLETED|Part 1||6
8303627|NCT01532973|20471788|P1|COMPLETED|Part 1||6
8303628|NCT01532973|20471779|P10|STARTED|Part 1||0
8303629|NCT01532973|20471780|P9|STARTED|Part 1||0
8303630|NCT01532973|20471781|P8|STARTED|Part 1||0
8303631|NCT01532973|20471782|P7|STARTED|Part 1||0
8303632|NCT01532973|20471783|P6|STARTED|Part 1||0
8303633|NCT01532973|20471784|P5|STARTED|Part 1||0
8303634|NCT01532973|20471785|P4|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
8303635|NCT01532973|20471786|P3|STARTED|Part 1||6
8303636|NCT01532973|20471787|P2|STARTED|Part 1||6
8303637|NCT01532973|20471788|P1|STARTED|Part 1||6
8303638|NCT01532934|20471830|P2|NOT COMPLETED|Overall Study||13
8303639|NCT01532934|20471831|P1|NOT COMPLETED|Overall Study||14
8303640|NCT01532934|20471830|P2|COMPLETED|Overall Study||39
8303641|NCT01532934|20471831|P1|COMPLETED|Overall Study||39
8303642|NCT01532934|20471830|P2|STARTED|Overall Study||52
8303643|NCT01532934|20471831|P1|STARTED|Overall Study||53
8303644|NCT01532921|20471841|P1|NOT COMPLETED|Overall Study||16
8303645|NCT01532921|20471841|P1|COMPLETED|Overall Study||69
8303646|NCT01532921|20471841|P1|6 Months Follow Up|Overall Study||68
8303647|NCT01532921|20471841|P1|Discharge|Overall Study||75
8303648|NCT01532921|20471841|P1|Implantation Procedure|Overall Study||76
8303649|NCT01532921|20471841|P1|STARTED|Overall Study||85
8303650|NCT01532869|20471863|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
8303651|NCT01532869|20471864|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
8303652|NCT01532869|20471863|P2|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
8303653|NCT01532869|20471864|P1|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
8303654|NCT01532869|20471863|P2|STARTED|Open-label Period (Week 48 to Week 96)||30
8303655|NCT01532869|20471864|P1|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
8303656|NCT01532869|20471863|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
8303657|NCT01532869|20471864|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
8303658|NCT01532869|20471863|P2|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
8303659|NCT01532869|20471864|P1|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
8303660|NCT01532869|20471863|P2|STARTED|Blinded-Treatment Period (Up to Week 48)||43
8303661|NCT01532869|20471864|P1|STARTED|Blinded-Treatment Period (Up to Week 48)||44
8303662|NCT01532869|20471863|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
8303663|NCT01532869|20471864|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
8303664|NCT01532869|20471863|P2|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
8303665|NCT01532869|20471864|P1|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
8303666|NCT01532869|20471863|P2|STARTED|Blinded-Treatment Period (Up to Week 24)||43
8303667|NCT01532869|20471864|P1|STARTED|Blinded-Treatment Period (Up to Week 24)||44
8303668|NCT01532830|20471901|P1|NOT COMPLETED|Overall Study||4
8303669|NCT01532830|20471901|P1|COMPLETED|Overall Study||26
8303670|NCT01532830|20471901|P1|STARTED|Overall Study||30
8303671|NCT01532817|20471910|P1|NOT COMPLETED|Overall Study||0
8303672|NCT01532817|20471910|P1|COMPLETED|Overall Study||30
8303673|NCT01532817|20471910|P1|STARTED|Overall Study||30
8303674|NCT01532700|20471914|P1|NOT COMPLETED|Overall Study||0
8303675|NCT01532700|20471914|P1|COMPLETED|Overall Study||28
8303676|NCT01532700|20471914|P1|STARTED|Overall Study||28
8303677|NCT01532648|20471923|P2|NOT COMPLETED|Overall Study||17
8303678|NCT01532648|20471924|P1|NOT COMPLETED|Overall Study||36
8303679|NCT01532648|20471923|P2|COMPLETED|Overall Study||238
8303680|NCT01532648|20471924|P1|COMPLETED|Overall Study||219
8303681|NCT01532648|20471923|P2|Intent-To-Treat Population|Overall Study||228
8303682|NCT01532648|20471924|P1|Intent-To-Treat Population|Overall Study||230
8303683|NCT01532648|20471923|P2|Safety Population|Overall Study||255
8303684|NCT01532648|20471924|P1|Safety Population|Overall Study||255
8303685|NCT01532648|20471923|P2|STARTED|Overall Study||255
8303686|NCT01532648|20471924|P1|STARTED|Overall Study||255
8303687|NCT01532635|20471942|P1|NOT COMPLETED|Overall Study||0
8303688|NCT01532635|20471942|P1|COMPLETED|Overall Study||4
8303689|NCT01532635|20471942|P1|STARTED|Overall Study||4
8303690|NCT01532570|20471958|P4|NOT COMPLETED|Overall Study||0
8303691|NCT01532570|20471959|P3|NOT COMPLETED|Overall Study||0
8303692|NCT01532570|20471960|P2|NOT COMPLETED|Overall Study||1
8303693|NCT01532570|20471961|P1|NOT COMPLETED|Overall Study||1
8303694|NCT01532570|20471958|P4|COMPLETED|Overall Study||4
8303695|NCT01532570|20471959|P3|COMPLETED|Overall Study||1
8303696|NCT01532570|20471960|P2|COMPLETED|Overall Study||1
8303697|NCT01532570|20471961|P1|COMPLETED|Overall Study||10
8303698|NCT01532570|20471958|P4|STARTED|Overall Study||4
8303699|NCT01532570|20471959|P3|STARTED|Overall Study||1
8303700|NCT01532570|20471960|P2|STARTED|Overall Study||2
8303701|NCT01532570|20471961|P1|STARTED|Overall Study||11
8303702|NCT01532453|20471994|P2|NOT COMPLETED|Overall Study||70
8303703|NCT01532453|20471995|P1|NOT COMPLETED|Overall Study||27
8303704|NCT01532453|20471994|P2|COMPLETED|Overall Study||90
8303705|NCT01532453|20471995|P1|COMPLETED|Overall Study||54
8303706|NCT01532453|20471994|P2|STARTED|Overall Study||160
8303707|NCT01532453|20471995|P1|STARTED|Overall Study||81
8303708|NCT01532414|20472006|P3|NOT COMPLETED|Overall Study||3
8303709|NCT01532414|20472007|P2|NOT COMPLETED|Overall Study||2
8303710|NCT01532414|20472008|P1|NOT COMPLETED|Overall Study||7
8303711|NCT01532414|20472006|P3|COMPLETED|Overall Study||35
8303712|NCT01532414|20472007|P2|COMPLETED|Overall Study||19
8303713|NCT01532414|20472008|P1|COMPLETED|Overall Study||85
8303714|NCT01532414|20472006|P3|STARTED|Overall Study||38
8303715|NCT01532414|20472007|P2|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
8303716|NCT01532414|20472008|P1|STARTED|Overall Study||92
8303717|NCT01532388|20472018|P2|NOT COMPLETED|12-month Follow-up||67
8303718|NCT01532388|20472019|P1|NOT COMPLETED|12-month Follow-up||69
8303719|NCT01532388|20472018|P2|COMPLETED|12-month Follow-up||34
8303720|NCT01532388|20472019|P1|COMPLETED|12-month Follow-up||32
8303721|NCT01532388|20472018|P2|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
8303722|NCT01532388|20472019|P1|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
8303723|NCT01532388|20472018|P2|NOT COMPLETED|6-month Follow-up||66
8303724|NCT01532388|20472019|P1|NOT COMPLETED|6-month Follow-up||74
8303725|NCT01532388|20472018|P2|COMPLETED|6-month Follow-up||35
8303726|NCT01532388|20472019|P1|COMPLETED|6-month Follow-up||27
8303727|NCT01532388|20472018|P2|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
8303728|NCT01532388|20472019|P1|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
8303729|NCT01532388|20472018|P2|NOT COMPLETED|3-month Follow-up||68
8303730|NCT01532388|20472019|P1|NOT COMPLETED|3-month Follow-up||68
8303731|NCT01532388|20472018|P2|COMPLETED|3-month Follow-up||33
8303732|NCT01532388|20472019|P1|COMPLETED|3-month Follow-up||33
8303733|NCT01532388|20472018|P2|STARTED|3-month Follow-up||101
8303734|NCT01532388|20472019|P1|STARTED|3-month Follow-up||101
8303735|NCT01532362|20472049|P2|NOT COMPLETED|Overall Study||0
8303736|NCT01532362|20472050|P1|NOT COMPLETED|Overall Study||0
8303737|NCT01532362|20472049|P2|COMPLETED|Overall Study||0
8303738|NCT01532362|20472050|P1|COMPLETED|Overall Study||1
8303739|NCT01532362|20472049|P2|STARTED|Overall Study||0
8303740|NCT01532362|20472050|P1|STARTED|Overall Study||1
8303741|NCT01532349|20472060|P2|NOT COMPLETED|Overall Study||5
8303742|NCT01532349|20472061|P1|NOT COMPLETED|Overall Study||2
8303743|NCT01532349|20472060|P2|COMPLETED|Overall Study||12
8303744|NCT01532349|20472061|P1|COMPLETED|Overall Study||15
8303745|NCT01532349|20472060|P2|STARTED|Overall Study||17
8303746|NCT01532349|20472061|P1|STARTED|Overall Study||17
8303747|NCT01532141|20472070|P3|NOT COMPLETED|Overall Study||0
8303748|NCT01532141|20472071|P2|NOT COMPLETED|Overall Study||0
8303749|NCT01532141|20472072|P1|NOT COMPLETED|Overall Study||1
8303750|NCT01532141|20472070|P3|COMPLETED|Overall Study||8
8303751|NCT01532141|20472071|P2|COMPLETED|Overall Study||8
8303752|NCT01532141|20472072|P1|COMPLETED|Overall Study||8
8303753|NCT01532141|20472070|P3|Period 3|Overall Study||8
8303754|NCT01532141|20472071|P2|Period 3|Overall Study||8
8303755|NCT01532141|20472072|P1|Period 3|Overall Study||8
8303756|NCT01532141|20472070|P3|Period 2|Overall Study||8
8303757|NCT01532141|20472071|P2|Period 2|Overall Study||8
8303758|NCT01532141|20472072|P1|Period 2|Overall Study||8
8303759|NCT01532141|20472070|P3|Period 1|Overall Study||8
8303760|NCT01532141|20472071|P2|Period 1|Overall Study||8
8303761|NCT01532141|20472072|P1|Period 1|Overall Study||9
8303762|NCT01532141|20472070|P3|STARTED|Overall Study||8
8303763|NCT01532141|20472071|P2|STARTED|Overall Study||8
8303764|NCT01532141|20472072|P1|STARTED|Overall Study||9
8303765|NCT01532128|20472090|P3|NOT COMPLETED|Overall Study||0
8303766|NCT01532128|20472091|P2|NOT COMPLETED|Overall Study||0
8303767|NCT01532128|20472092|P1|NOT COMPLETED|Overall Study||0
8303768|NCT01532128|20472090|P3|COMPLETED|Overall Study||8
8303769|NCT01532128|20472091|P2|COMPLETED|Overall Study||8
8303770|NCT01532128|20472092|P1|COMPLETED|Overall Study||8
8303771|NCT01532128|20472090|P3|STARTED|Overall Study||8
8303772|NCT01532128|20472091|P2|STARTED|Overall Study||8
8303773|NCT01532128|20472092|P1|STARTED|Overall Study||8
8303774|NCT01532089|20472109|P2|NOT COMPLETED|Overall Study||0
8303775|NCT01532089|20472110|P1|NOT COMPLETED|Overall Study||0
8303776|NCT01532089|20472109|P2|COMPLETED|Overall Study||43
8303777|NCT01532089|20472110|P1|COMPLETED|Overall Study||45
8303778|NCT01532089|20472109|P2|STARTED|Overall Study||43
8303779|NCT01532089|20472110|P1|STARTED|Overall Study||45
8303780|NCT01531998|20472124|P1|NOT COMPLETED|Overall Study||3
8303781|NCT01531998|20472124|P1|COMPLETED|Overall Study||8
8303782|NCT01531998|20472124|P1|STARTED|Overall Study||11
8303783|NCT01531959|20472131|P2|NOT COMPLETED|Overall Study||2
8303784|NCT01531959|20472132|P1|NOT COMPLETED|Overall Study||2
8303785|NCT01531959|20472131|P2|COMPLETED|Overall Study||66
8303786|NCT01531959|20472132|P1|COMPLETED|Overall Study||66
8303787|NCT01531959|20472131|P2|STARTED|Overall Study||68
8303788|NCT01531959|20472132|P1|STARTED|Overall Study||68
8303789|NCT01531894|20472146|P1|NOT COMPLETED|Overall Study||9
8303790|NCT01531894|20472146|P1|COMPLETED|Overall Study||2
8303791|NCT01531894|20472146|P1|STARTED|Overall Study||11
8303792|NCT01531738|20472152|P2|NOT COMPLETED|Overall Study||0
8303793|NCT01531738|20472153|P1|NOT COMPLETED|Overall Study||0
8303794|NCT01531738|20472152|P2|COMPLETED|Overall Study||11
8303795|NCT01531738|20472153|P1|COMPLETED|Overall Study||11
8303796|NCT01531738|20472152|P2|STARTED|Overall Study||11
8303797|NCT01531738|20472153|P1|STARTED|Overall Study||11
8303798|NCT01531725|20472163|P1|NOT COMPLETED|Overall Study||5
8303799|NCT01531725|20472163|P1|COMPLETED|Overall Study||197
8303800|NCT01531725|20472163|P1|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
8303801|NCT01531673|20472181|P13|NOT COMPLETED|Overall Study||0
8303802|NCT01531673|20472182|P12|NOT COMPLETED|Overall Study||0
8303803|NCT01531673|20472183|P11|NOT COMPLETED|Overall Study||0
8303804|NCT01531673|20472184|P10|NOT COMPLETED|Overall Study||1
8303805|NCT01531673|20472185|P9|NOT COMPLETED|Overall Study||0
8303806|NCT01531673|20472186|P8|NOT COMPLETED|Overall Study||0
8303807|NCT01531673|20472187|P7|NOT COMPLETED|Overall Study||0
8303808|NCT01531673|20472188|P6|NOT COMPLETED|Overall Study||1
8303809|NCT01531673|20472189|P5|NOT COMPLETED|Overall Study||1
8303810|NCT01531673|20472190|P4|NOT COMPLETED|Overall Study||1
8303811|NCT01531673|20472191|P3|NOT COMPLETED|Overall Study||0
8303812|NCT01531673|20472192|P2|NOT COMPLETED|Overall Study||1
8303813|NCT01531673|20472193|P1|NOT COMPLETED|Overall Study||0
8303814|NCT01531673|20472181|P13|COMPLETED|Overall Study||14
8303815|NCT01531673|20472182|P12|COMPLETED|Overall Study||4
8303816|NCT01531673|20472183|P11|COMPLETED|Overall Study||16
8303817|NCT01531673|20472184|P10|COMPLETED|Overall Study||18
8303818|NCT01531673|20472185|P9|COMPLETED|Overall Study||17
8303819|NCT01531673|20472186|P8|COMPLETED|Overall Study||9
8303820|NCT01531673|20472187|P7|COMPLETED|Overall Study||17
8303821|NCT01531673|20472188|P6|COMPLETED|Overall Study||18
8303822|NCT01531673|20472189|P5|COMPLETED|Overall Study||7
8303823|NCT01531673|20472190|P4|COMPLETED|Overall Study||17
8303824|NCT01531673|20472191|P3|COMPLETED|Overall Study||8
8303825|NCT01531673|20472192|P2|COMPLETED|Overall Study||7
8303826|NCT01531673|20472193|P1|COMPLETED|Overall Study||33
8303827|NCT01531673|20472181|P13|STARTED|Overall Study||14
8303828|NCT01531673|20472182|P12|STARTED|Overall Study||4
8303829|NCT01531673|20472183|P11|STARTED|Overall Study||16
8303830|NCT01531673|20472184|P10|STARTED|Overall Study||19
8303831|NCT01531673|20472185|P9|STARTED|Overall Study||17
8303832|NCT01531673|20472186|P8|STARTED|Overall Study||9
8303833|NCT01531673|20472187|P7|STARTED|Overall Study||17
8303834|NCT01531673|20472188|P6|STARTED|Overall Study||19
8303835|NCT01531673|20472189|P5|STARTED|Overall Study||8
8303836|NCT01531673|20472190|P4|STARTED|Overall Study||18
8303837|NCT01531673|20472191|P3|STARTED|Overall Study||8
8303838|NCT01531673|20472192|P2|STARTED|Overall Study||8
8303839|NCT01531673|20472193|P1|STARTED|Overall Study||33
8303840|NCT01531439|20472304|P2|NOT COMPLETED|Overall Study||1
8303841|NCT01531439|20472305|P1|NOT COMPLETED|Overall Study||4
8303842|NCT01531439|20472304|P2|COMPLETED|Overall Study||42
8303843|NCT01531439|20472305|P1|COMPLETED|Overall Study||37
8303844|NCT01531439|20472304|P2|STARTED|Overall Study||43
8303845|NCT01531439|20472305|P1|STARTED|Overall Study||41
8303846|NCT01531387|20472319|P2|NOT COMPLETED|Overall Study||11
8303847|NCT01531387|20472320|P1|NOT COMPLETED|Overall Study||11
8303848|NCT01531387|20472319|P2|COMPLETED|Overall Study||0
8303849|NCT01531387|20472320|P1|COMPLETED|Overall Study||0
8303850|NCT01531387|20472319|P2|STARTED|Overall Study||11
8303851|NCT01531387|20472320|P1|STARTED|Overall Study||11
8303861|NCT01531335|20472403|P2|NOT COMPLETED|Overall Study||0
8303862|NCT01531335|20472404|P1|NOT COMPLETED|Overall Study||0
8303863|NCT01531335|20472403|P2|COMPLETED|Overall Study||40
8303864|NCT01531335|20472404|P1|COMPLETED|Overall Study||40
8303865|NCT01531335|20472403|P2|STARTED|Overall Study||40
8303866|NCT01531335|20472404|P1|STARTED|Overall Study||40
8303867|NCT01531205|20472412|P1|NOT COMPLETED|Overall Study||1
8303868|NCT01531205|20472412|P1|COMPLETED|Overall Study||1
8303869|NCT01531205|20472412|P1|STARTED|Overall Study||2
8303870|NCT01531153|20472424|P3|NOT COMPLETED|Overall Study||15
8303871|NCT01531153|20472425|P2|NOT COMPLETED|Overall Study||9
8303872|NCT01531153|20472426|P1|NOT COMPLETED|Overall Study||10
8303873|NCT01531153|20472424|P3|COMPLETED|Overall Study||15
8303874|NCT01531153|20472425|P2|COMPLETED|Overall Study||22
8303875|NCT01531153|20472426|P1|COMPLETED|Overall Study||22
8303876|NCT01531153|20472424|P3|STARTED|Overall Study||30
8303877|NCT01531153|20472425|P2|STARTED|Overall Study||31
8303878|NCT01531153|20472426|P1|STARTED|Overall Study||32
8303882|NCT01530880|20472502|P1|NOT COMPLETED|Overall Study||0
8303883|NCT01530880|20472502|P1|COMPLETED|Overall Study||35
8303884|NCT01530880|20472502|P1|STARTED|Overall Study||35
8303885|NCT01530477|20472516|P3|NOT COMPLETED|Overall Study||0
8303886|NCT01530477|20472517|P2|NOT COMPLETED|Overall Study||0
8303887|NCT01530477|20472518|P1|NOT COMPLETED|Overall Study||0
8303888|NCT01530477|20472516|P3|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
8303889|NCT01530477|20472517|P2|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
8303890|NCT01530477|20472518|P1|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
8303891|NCT01530477|20472516|P3|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
8303892|NCT01530477|20472517|P2|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
8303893|NCT01530477|20472518|P1|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
8303894|NCT01530464|20472526|P2|NOT COMPLETED|Washout (24h)||1
8303895|NCT01530464|20472527|P1|NOT COMPLETED|Washout (24h)||0
8303896|NCT01530464|20472526|P2|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
8303897|NCT01530464|20472527|P1|COMPLETED|Washout (24h)||9
8303898|NCT01530464|20472526|P2|STARTED|Washout (24h)||8
8303899|NCT01530464|20472527|P1|STARTED|Washout (24h)||9
8303900|NCT01530464|20472526|P2|NOT COMPLETED|Third Intervention (24h)||0
8303901|NCT01530464|20472527|P1|NOT COMPLETED|Third Intervention (24h)||0
8303902|NCT01530464|20472526|P2|COMPLETED|Third Intervention (24h)||8
8303903|NCT01530464|20472527|P1|COMPLETED|Third Intervention (24h)||9
8303904|NCT01530464|20472526|P2|STARTED|Third Intervention (24h)||8
8303905|NCT01530464|20472527|P1|STARTED|Third Intervention (24h)||9
8303906|NCT01530464|20472526|P2|NOT COMPLETED|Washout (24h)||0
8303907|NCT01530464|20472527|P1|NOT COMPLETED|Washout (24h)||1
8303908|NCT01530464|20472526|P2|COMPLETED|Washout (24h)||8
8303909|NCT01530464|20472527|P1|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
8303910|NCT01530464|20472526|P2|STARTED|Washout (24h)||8
8303911|NCT01530464|20472527|P1|STARTED|Washout (24h)||10
8303912|NCT01530464|20472526|P2|NOT COMPLETED|Second Intervention (24h)||0
8303913|NCT01530464|20472527|P1|NOT COMPLETED|Second Intervention (24h)||0
8303914|NCT01530464|20472526|P2|COMPLETED|Second Intervention (24h)||8
8303915|NCT01530464|20472527|P1|COMPLETED|Second Intervention (24h)||10
8303916|NCT01530464|20472526|P2|STARTED|Second Intervention (24h)||8
8303917|NCT01530464|20472527|P1|STARTED|Second Intervention (24h)||10
8303918|NCT01530464|20472526|P2|NOT COMPLETED|Washout (24h)||0
8303919|NCT01530464|20472527|P1|NOT COMPLETED|Washout (24h)||0
8303920|NCT01530464|20472526|P2|COMPLETED|Washout (24h)||8
8303921|NCT01530464|20472527|P1|COMPLETED|Washout (24h)||10
8303922|NCT01530464|20472526|P2|STARTED|Washout (24h)||8
8303923|NCT01530464|20472527|P1|STARTED|Washout (24h)||10
8303924|NCT01530464|20472526|P2|NOT COMPLETED|First Intervention (24h)||0
8303925|NCT01530464|20472527|P1|NOT COMPLETED|First Intervention (24h)||0
8303926|NCT01530464|20472526|P2|COMPLETED|First Intervention (24h)||8
8303927|NCT01530464|20472527|P1|COMPLETED|First Intervention (24h)||10
8303928|NCT01530464|20472526|P2|STARTED|First Intervention (24h)||8
8303929|NCT01530464|20472527|P1|STARTED|First Intervention (24h)||10
8303930|NCT01530399|20472560|P6|NOT COMPLETED|Overall Study||1
8303931|NCT01530399|20472561|P5|NOT COMPLETED|Overall Study||0
8303932|NCT01530399|20472562|P4|NOT COMPLETED|Overall Study||0
8303933|NCT01530399|20472563|P3|NOT COMPLETED|Overall Study||1
8303934|NCT01530399|20472564|P2|NOT COMPLETED|Overall Study||2
8303935|NCT01530399|20472565|P1|NOT COMPLETED|Overall Study||1
8303936|NCT01530399|20472560|P6|COMPLETED|Overall Study||6
8303937|NCT01530399|20472561|P5|COMPLETED|Overall Study||6
8303938|NCT01530399|20472562|P4|COMPLETED|Overall Study||10
8303939|NCT01530399|20472563|P3|COMPLETED|Overall Study||7
8303940|NCT01530399|20472564|P2|COMPLETED|Overall Study||8
8303941|NCT01530399|20472565|P1|COMPLETED|Overall Study||7
8303942|NCT01530399|20472560|P6|STARTED|Overall Study||7
8303943|NCT01530399|20472561|P5|STARTED|Overall Study||6
8303944|NCT01530399|20472562|P4|STARTED|Overall Study||10
8303945|NCT01530399|20472563|P3|STARTED|Overall Study||8
8303946|NCT01530399|20472564|P2|STARTED|Overall Study||10
8303947|NCT01530399|20472565|P1|STARTED|Overall Study||8
8303948|NCT01530334|20472579|P1|NOT COMPLETED|Overall Study||51
8303949|NCT01530334|20472579|P1|COMPLETED|Overall Study||10
8303950|NCT01530334|20472579|P1|STARTED|Overall Study||61
8303951|NCT01530243|20472592|P4|NOT COMPLETED|Overall Study||2
8303952|NCT01530243|20472593|P3|NOT COMPLETED|Overall Study||3
8303953|NCT01530243|20472594|P2|NOT COMPLETED|Overall Study||3
8303954|NCT01530243|20472595|P1|NOT COMPLETED|Overall Study||2
8303955|NCT01530243|20472592|P4|COMPLETED|Overall Study||24
8303956|NCT01530243|20472593|P3|COMPLETED|Overall Study||23
8303957|NCT01530243|20472594|P2|COMPLETED|Overall Study||23
8303958|NCT01530243|20472595|P1|COMPLETED|Overall Study||24
8303959|NCT01530243|20472592|P4|STARTED|Overall Study||26
8303960|NCT01530243|20472593|P3|STARTED|Overall Study||26
8303961|NCT01530243|20472594|P2|STARTED|Overall Study||26
8303962|NCT01530243|20472595|P1|STARTED|Overall Study||26
8303963|NCT01530178|20472615|P2|NOT COMPLETED|Overall Study||0
8303964|NCT01530178|20472616|P1|NOT COMPLETED|Overall Study||0
8303965|NCT01530178|20472615|P2|COMPLETED|Overall Study||6
8303966|NCT01530178|20472616|P1|COMPLETED|Overall Study||2
8303967|NCT01530178|20472615|P2|STARTED|Overall Study||6
8303968|NCT01530178|20472616|P1|STARTED|Overall Study||2
8303969|NCT01530087|20472626|P1|NOT COMPLETED|Overall Study||2
8303970|NCT01530087|20472626|P1|COMPLETED|Overall Study||1
8303971|NCT01530087|20472626|P1|STARTED|Overall Study||3
8303972|NCT01529827|20472631|P1|NOT COMPLETED|Overall Study||0
8303973|NCT01529827|20472631|P1|COMPLETED|Overall Study||94
8303974|NCT01529827|20472631|P1|STARTED|Overall Study||94
8303975|NCT01529749|20472642|P4|NOT COMPLETED|Overall Study||2
8303976|NCT01529749|20472643|P3|NOT COMPLETED|Overall Study||2
8303977|NCT01529749|20472644|P2|NOT COMPLETED|Overall Study||2
8303978|NCT01529749|20472645|P1|NOT COMPLETED|Overall Study||0
8303979|NCT01529749|20472642|P4|COMPLETED|Overall Study||10
8303980|NCT01529749|20472643|P3|COMPLETED|Overall Study||10
8303981|NCT01529749|20472644|P2|COMPLETED|Overall Study||10
8303982|NCT01529749|20472645|P1|COMPLETED|Overall Study||12
8303983|NCT01529749|20472642|P4|STARTED|Overall Study||12
8303984|NCT01529749|20472643|P3|STARTED|Overall Study||12
8303985|NCT01529749|20472644|P2|STARTED|Overall Study||12
8303986|NCT01529749|20472645|P1|STARTED|Overall Study||12
8303987|NCT01529645|20472729|P10|NOT COMPLETED|Overall Study||0
8303988|NCT01529645|20472730|P9|NOT COMPLETED|Overall Study||1
8303989|NCT01529645|20472731|P8|NOT COMPLETED|Overall Study||0
8303990|NCT01529645|20472732|P7|NOT COMPLETED|Overall Study||2
8303991|NCT01529645|20472733|P6|NOT COMPLETED|Overall Study||1
8303992|NCT01529645|20472734|P5|NOT COMPLETED|Overall Study||2
8303993|NCT01529645|20472735|P4|NOT COMPLETED|Overall Study||2
8303994|NCT01529645|20472736|P3|NOT COMPLETED|Overall Study||2
8303995|NCT01529645|20472737|P2|NOT COMPLETED|Overall Study||1
8303996|NCT01529645|20472738|P1|NOT COMPLETED|Overall Study||2
8303997|NCT01529645|20472729|P10|COMPLETED|Overall Study||42
8303998|NCT01529645|20472730|P9|COMPLETED|Overall Study||41
8303999|NCT01529645|20472731|P8|COMPLETED|Overall Study||42
8304000|NCT01529645|20472732|P7|COMPLETED|Overall Study||40
8304001|NCT01529645|20472733|P6|COMPLETED|Overall Study||41
8304002|NCT01529645|20472734|P5|COMPLETED|Overall Study||40
8304003|NCT01529645|20472735|P4|COMPLETED|Overall Study||40
8304004|NCT01529645|20472736|P3|COMPLETED|Overall Study||40
8304005|NCT01529645|20472737|P2|COMPLETED|Overall Study||41
8304006|NCT01529645|20472738|P1|COMPLETED|Overall Study||40
8304007|NCT01529645|20472729|P10|STARTED|Overall Study||42
8304008|NCT01529645|20472730|P9|STARTED|Overall Study||42
8304009|NCT01529645|20472731|P8|STARTED|Overall Study||42
8304010|NCT01529645|20472732|P7|STARTED|Overall Study||42
8304011|NCT01529645|20472733|P6|STARTED|Overall Study||42
8304012|NCT01529645|20472734|P5|STARTED|Overall Study||42
8304013|NCT01529645|20472735|P4|STARTED|Overall Study||42
8304014|NCT01529645|20472736|P3|STARTED|Overall Study||42
8304015|NCT01529645|20472737|P2|STARTED|Overall Study||42
8304016|NCT01529645|20472738|P1|STARTED|Overall Study||42
8304017|NCT01529632|20472836|P2|NOT COMPLETED|Overall Study||3
8304018|NCT01529632|20472837|P1|NOT COMPLETED|Overall Study||3
8304019|NCT01529632|20472836|P2|COMPLETED|Overall Study||100
8304020|NCT01529632|20472837|P1|COMPLETED|Overall Study||87
8304021|NCT01529632|20472836|P2|STARTED|Overall Study||103
8304022|NCT01529632|20472837|P1|STARTED|Overall Study||90
8304023|NCT01529606|20472857|P2|NOT COMPLETED|Overall Study||18
8304024|NCT01529606|20472858|P1|NOT COMPLETED|Overall Study||21
8304025|NCT01529606|20472857|P2|COMPLETED|Overall Study||29
8304026|NCT01529606|20472858|P1|COMPLETED|Overall Study||34
8304027|NCT01529606|20472857|P2|STARTED|Overall Study||47
8304028|NCT01529606|20472858|P1|STARTED|Overall Study||55
8304029|NCT01529515|20472870|P4|NOT COMPLETED|DOUBLE BLIND PHASE||12
8304030|NCT01529515|20472871|P3|NOT COMPLETED|DOUBLE BLIND PHASE||23
8304031|NCT01529515|20472872|P2|NOT COMPLETED|DOUBLE BLIND PHASE||0
8304032|NCT01529515|20472873|P1|NOT COMPLETED|DOUBLE BLIND PHASE||0
8304033|NCT01529515|20472870|P4|COMPLETED|DOUBLE BLIND PHASE||148
8304034|NCT01529515|20472871|P3|COMPLETED|DOUBLE BLIND PHASE||122
8304035|NCT01529515|20472872|P2|COMPLETED|DOUBLE BLIND PHASE||0
8304036|NCT01529515|20472873|P1|COMPLETED|DOUBLE BLIND PHASE||0
8304037|NCT01529515|20472870|P4|STARTED|DOUBLE BLIND PHASE||160
8304038|NCT01529515|20472871|P3|STARTED|DOUBLE BLIND PHASE||145
8304039|NCT01529515|20472872|P2|STARTED|DOUBLE BLIND PHASE||0
8304040|NCT01529515|20472873|P1|STARTED|DOUBLE BLIND PHASE||0
8304041|NCT01529515|20472870|P4|NOT COMPLETED|MAINTENANCE PHASE||0
8304042|NCT01529515|20472871|P3|NOT COMPLETED|MAINTENANCE PHASE||0
8304043|NCT01529515|20472872|P2|NOT COMPLETED|MAINTENANCE PHASE||74
8304044|NCT01529515|20472873|P1|NOT COMPLETED|MAINTENANCE PHASE||0
8304045|NCT01529515|20472870|P4|COMPLETED|MAINTENANCE PHASE||0
8304046|NCT01529515|20472871|P3|COMPLETED|MAINTENANCE PHASE||0
8304047|NCT01529515|20472872|P2|COMPLETED|MAINTENANCE PHASE||305
8304048|NCT01529515|20472873|P1|COMPLETED|MAINTENANCE PHASE||0
8304049|NCT01529515|20472870|P4|STARTED|MAINTENANCE PHASE||0
8304050|NCT01529515|20472871|P3|STARTED|MAINTENANCE PHASE||0
8304051|NCT01529515|20472872|P2|STARTED|MAINTENANCE PHASE||379
8304052|NCT01529515|20472873|P1|STARTED|MAINTENANCE PHASE||0
8304053|NCT01529515|20472870|P4|NOT COMPLETED|TRANSITION PHASE||0
8304054|NCT01529515|20472871|P3|NOT COMPLETED|TRANSITION PHASE||0
8304055|NCT01529515|20472872|P2|NOT COMPLETED|TRANSITION PHASE||0
8304056|NCT01529515|20472873|P1|NOT COMPLETED|TRANSITION PHASE||127
8304057|NCT01529515|20472870|P4|COMPLETED|TRANSITION PHASE||0
8304058|NCT01529515|20472871|P3|COMPLETED|TRANSITION PHASE||0
8304059|NCT01529515|20472872|P2|COMPLETED|TRANSITION PHASE||0
8304060|NCT01529515|20472873|P1|COMPLETED|TRANSITION PHASE||379
8304061|NCT01529515|20472870|P4|STARTED|TRANSITION PHASE||0
8304062|NCT01529515|20472871|P3|STARTED|TRANSITION PHASE||0
8304063|NCT01529515|20472872|P2|STARTED|TRANSITION PHASE||0
8304064|NCT01529515|20472873|P1|STARTED|TRANSITION PHASE||506
8304065|NCT01529502|20472892|P6|NOT COMPLETED|Overall Study||0
8304066|NCT01529502|20472893|P5|NOT COMPLETED|Overall Study||0
8304067|NCT01529502|20472894|P4|NOT COMPLETED|Overall Study||2
8304068|NCT01529502|20472895|P3|NOT COMPLETED|Overall Study||0
8304069|NCT01529502|20472896|P2|NOT COMPLETED|Overall Study||0
8304070|NCT01529502|20472897|P1|NOT COMPLETED|Overall Study||0
8304071|NCT01529502|20472892|P6|COMPLETED|Overall Study||2
8304072|NCT01529502|20472893|P5|COMPLETED|Overall Study||2
8304073|NCT01529502|20472894|P4|COMPLETED|Overall Study||1
8304074|NCT01529502|20472895|P3|COMPLETED|Overall Study||2
8304075|NCT01529502|20472896|P2|COMPLETED|Overall Study||3
8304076|NCT01529502|20472897|P1|COMPLETED|Overall Study||2
8304077|NCT01529502|20472892|P6|STARTED|Overall Study||2
8304078|NCT01529502|20472893|P5|STARTED|Overall Study||2
8304079|NCT01529502|20472894|P4|STARTED|Overall Study||3
8304080|NCT01529502|20472895|P3|STARTED|Overall Study||2
8304081|NCT01529502|20472896|P2|STARTED|Overall Study||3
8304082|NCT01529502|20472897|P1|STARTED|Overall Study||2
8304083|NCT01529450|20472910|P2|NOT COMPLETED|Overall Study||2
8304084|NCT01529450|20472911|P1|NOT COMPLETED|Overall Study||0
8304085|NCT01529450|20472910|P2|COMPLETED|Overall Study||6
8304086|NCT01529450|20472911|P1|COMPLETED|Overall Study||3
8304087|NCT01529450|20472910|P2|STARTED|Overall Study||8
8304088|NCT01529450|20472911|P1|STARTED|Overall Study||3
8304089|NCT01529385|20472920|P2|NOT COMPLETED|Overall Study||1
8304090|NCT01529385|20472921|P1|NOT COMPLETED|Overall Study||2
8304091|NCT01529385|20472920|P2|COMPLETED|Overall Study||39
8304092|NCT01529385|20472921|P1|COMPLETED|Overall Study||38
8304093|NCT01529385|20472920|P2|Received Intervention|Overall Study||40
8304094|NCT01529385|20472921|P1|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
8304095|NCT01529385|20472920|P2|STARTED|Overall Study||40
8304096|NCT01529385|20472921|P1|STARTED|Overall Study||40
8304097|NCT01529346|20472950|P5|NOT COMPLETED|Overall Study||0
8304098|NCT01529346|20472951|P4|NOT COMPLETED|Overall Study||0
8304099|NCT01529346|20472952|P3|NOT COMPLETED|Overall Study||2
8304100|NCT01529346|20472953|P2|NOT COMPLETED|Overall Study||1
8304101|NCT01529346|20472954|P1|NOT COMPLETED|Overall Study||2
8304102|NCT01529346|20472950|P5|COMPLETED|Overall Study||36
8304103|NCT01529346|20472951|P4|COMPLETED|Overall Study||36
8304104|NCT01529346|20472952|P3|COMPLETED|Overall Study||52
8304105|NCT01529346|20472953|P2|COMPLETED|Overall Study||53
8304106|NCT01529346|20472954|P1|COMPLETED|Overall Study||53
8304107|NCT01529346|20472950|P5|STARTED|Overall Study||36
8304108|NCT01529346|20472951|P4|STARTED|Overall Study||36
8304109|NCT01529346|20472952|P3|STARTED|Overall Study||54
8304110|NCT01529346|20472953|P2|STARTED|Overall Study||54
8304111|NCT01529346|20472954|P1|STARTED|Overall Study||55
8304123|NCT01529112|20473105|P2|NOT COMPLETED|Overall Study||41
8304124|NCT01529112|20473106|P1|NOT COMPLETED|Overall Study||69
8304125|NCT01529112|20473105|P2|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
8304126|NCT01529112|20473106|P1|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
8304127|NCT01529112|20473105|P2|STARTED|Overall Study||46
8304128|NCT01529112|20473106|P1|STARTED|Overall Study||89
8304129|NCT01529060|20473133|P2|NOT COMPLETED|Overall Study||0
8304130|NCT01529060|20473134|P1|NOT COMPLETED|Overall Study||0
8304131|NCT01529060|20473133|P2|COMPLETED|Overall Study||10
8304132|NCT01529060|20473134|P1|COMPLETED|Overall Study||10
8304133|NCT01529060|20473133|P2|STARTED|Overall Study||10
8304134|NCT01529060|20473134|P1|STARTED|Overall Study||10
8304135|NCT01529034|20473142|P1|NOT COMPLETED|Overall Study||174
8304136|NCT01529034|20473142|P1|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1
8304137|NCT01529034|20473142|P1|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161
8304138|NCT01529034|20473142|P1|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175
8304139|NCT01528969|20473157|P2|NOT COMPLETED|Overall Study||0
8304140|NCT01528969|20473158|P1|NOT COMPLETED|Overall Study||2
8304141|NCT01528969|20473157|P2|COMPLETED|Overall Study||38
8304142|NCT01528969|20473158|P1|COMPLETED|Overall Study||35
8304143|NCT01528969|20473157|P2|STARTED|Overall Study||38
8304144|NCT01528969|20473158|P1|STARTED|Overall Study||37
8304145|NCT01528891|20473166|P2|NOT COMPLETED|Overall Study||0
8304146|NCT01528891|20473167|P1|NOT COMPLETED|Overall Study||0
8304147|NCT01528891|20473166|P2|COMPLETED|Overall Study||200
8304148|NCT01528891|20473167|P1|COMPLETED|Overall Study||200
8304149|NCT01528891|20473166|P2|STARTED|Overall Study||200
8304150|NCT01528891|20473167|P1|STARTED|Overall Study||200
8304151|NCT01528878|20473179|P1|NOT COMPLETED|Overall Study||0
8304152|NCT01528878|20473179|P1|COMPLETED|Overall Study||30
8304153|NCT01528878|20473179|P1|STARTED|Overall Study||30
8304154|NCT01528787|20473191|P4|NOT COMPLETED|Overall Study||1
8304155|NCT01528787|20473192|P3|NOT COMPLETED|Overall Study||1
8304156|NCT01528787|20473193|P2|NOT COMPLETED|Overall Study||0
8304157|NCT01528787|20473194|P1|NOT COMPLETED|Overall Study||0
8304158|NCT01528787|20473191|P4|COMPLETED|Overall Study||22
8304159|NCT01528787|20473192|P3|COMPLETED|Overall Study||18
8304160|NCT01528787|20473193|P2|COMPLETED|Overall Study||21
8304161|NCT01528787|20473194|P1|COMPLETED|Overall Study||22
8304162|NCT01528787|20473191|P4|STARTED|Overall Study||23
8304163|NCT01528787|20473192|P3|STARTED|Overall Study||19
8304164|NCT01528787|20473193|P2|STARTED|Overall Study||21
8304165|NCT01528787|20473194|P1|STARTED|Overall Study||22
8304166|NCT01528735|20473206|P2|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
8304167|NCT01528735|20473207|P1|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
8304168|NCT01528735|20473206|P2|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
8304169|NCT01528735|20473207|P1|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
8304170|NCT01528735|20473206|P2|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
8304171|NCT01528735|20473207|P1|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
8304172|NCT01528735|20473206|P2|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
8304173|NCT01528735|20473207|P1|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
8304174|NCT01528735|20473206|P2|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
8304175|NCT01528735|20473207|P1|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
8304176|NCT01528735|20473206|P2|STARTED|Treatment Period 1: Faldap/Del/RBV||13
8304177|NCT01528735|20473207|P1|STARTED|Treatment Period 1: Faldap/Del/RBV||12
8304178|NCT01528709|20473309|P2|NOT COMPLETED|Overall Study||15
8304179|NCT01528709|20473310|P1|NOT COMPLETED|Overall Study||13
8304180|NCT01528709|20473309|P2|COMPLETED|Overall Study||72
8304181|NCT01528709|20473310|P1|COMPLETED|Overall Study||73
8304182|NCT01528709|20473309|P2|STARTED|Overall Study||87
8304183|NCT01528709|20473310|P1|STARTED|Overall Study||86
8304184|NCT01528696|20473320|P2|NOT COMPLETED|Overall Study||19
8304185|NCT01528696|20473321|P1|NOT COMPLETED|Overall Study||18
8304186|NCT01528696|20473320|P2|COMPLETED|Overall Study||0
8304187|NCT01528696|20473321|P1|COMPLETED|Overall Study||0
8304188|NCT01528696|20473320|P2|Hospital Stay (2-5 Days)|Overall Study||19
8304189|NCT01528696|20473321|P1|Hospital Stay (2-5 Days)|Overall Study||18
8304190|NCT01528696|20473320|P2|STARTED|Overall Study||19
8304191|NCT01528696|20473321|P1|STARTED|Overall Study||18
8304192|NCT01528605|20473337|P6|NOT COMPLETED|Overall Study||0
8304193|NCT01528605|20473338|P5|NOT COMPLETED|Overall Study||0
8304194|NCT01528605|20473339|P4|NOT COMPLETED|Overall Study||1
8304195|NCT01528605|20473340|P3|NOT COMPLETED|Overall Study||1
8304196|NCT01528605|20473341|P2|NOT COMPLETED|Overall Study||0
8304197|NCT01528605|20473342|P1|NOT COMPLETED|Overall Study||2
8304198|NCT01528605|20473337|P6|COMPLETED|Overall Study||28
8304199|NCT01528605|20473338|P5|COMPLETED|Overall Study||28
8304200|NCT01528605|20473339|P4|COMPLETED|Overall Study||27
8304201|NCT01528605|20473340|P3|COMPLETED|Overall Study||27
8304202|NCT01528605|20473341|P2|COMPLETED|Overall Study||28
8304203|NCT01528605|20473342|P1|COMPLETED|Overall Study||26
8304204|NCT01528605|20473337|P6|STARTED|Overall Study||28
8304205|NCT01528605|20473338|P5|STARTED|Overall Study||28
8304206|NCT01528605|20473339|P4|STARTED|Overall Study||28
8304207|NCT01528605|20473340|P3|STARTED|Overall Study||28
8304208|NCT01528605|20473341|P2|STARTED|Overall Study||28
8304209|NCT01528605|20473342|P1|STARTED|Overall Study||28
8304210|NCT01528592|20473366|P1|NOT COMPLETED|Overall Study||0
8304211|NCT01528592|20473366|P1|COMPLETED|Overall Study||18
8304212|NCT01528592|20473366|P1|STARTED|Overall Study||18
8304213|NCT01528345|20473372|P2|NOT COMPLETED|Overall Study||50
8304214|NCT01528345|20473373|P1|NOT COMPLETED|Overall Study||47
8304215|NCT01528345|20473372|P2|COMPLETED|Overall Study||0
8304216|NCT01528345|20473373|P1|COMPLETED|Overall Study||0
8304217|NCT01528345|20473372|P2|STARTED|Overall Study||50
8304218|NCT01528345|20473373|P1|STARTED|Overall Study||47
8304219|NCT01528332|20473391|P2|NOT COMPLETED|Overall Study||2
8304220|NCT01528332|20473392|P1|NOT COMPLETED|Overall Study||4
8304221|NCT01528332|20473391|P2|COMPLETED|Overall Study||84
8304222|NCT01528332|20473392|P1|COMPLETED|Overall Study||81
8304223|NCT01528332|20473391|P2|STARTED|Overall Study||86
8304224|NCT01528332|20473392|P1|STARTED|Overall Study||85
8304225|NCT01528319|20473398|P1|NOT COMPLETED|Overall Study||1
8304226|NCT01528319|20473398|P1|COMPLETED|Overall Study||23
8304227|NCT01528319|20473398|P1|12 Weeks After Surgery|Overall Study||24
8304228|NCT01528319|20473398|P1|STARTED|Overall Study||24
8304229|NCT01528293|20473409|P2|NOT COMPLETED|Overall Study||0
8304230|NCT01528293|20473410|P1|NOT COMPLETED|Overall Study||1
8304231|NCT01528293|20473409|P2|COMPLETED|Overall Study||1
8304232|NCT01528293|20473410|P1|COMPLETED|Overall Study||0
8304233|NCT01528293|20473409|P2|STARTED|Overall Study||1
8304234|NCT01528293|20473410|P1|STARTED|Overall Study||1
8304235|NCT01528254|20473424|P2|NOT COMPLETED|Overall Study||216
8304236|NCT01528254|20473425|P1|NOT COMPLETED|Overall Study||187
8304237|NCT01528254|20473424|P2|COMPLETED|Overall Study||787
8304238|NCT01528254|20473425|P1|COMPLETED|Overall Study||811
8304239|NCT01528254|20473424|P2|Completed Treatment Period 3|Overall Study||115
8304240|NCT01528254|20473425|P1|Completed Treatment Period 3|Overall Study||109
8304241|NCT01528254|20473424|P2|Completed Treatment Period 2|Overall Study||399
8304242|NCT01528254|20473425|P1|Completed Treatment Period 2|Overall Study||244
8304243|NCT01528254|20473424|P2|Completed Treatment Period 1|Overall Study||273
8304244|NCT01528254|20473425|P1|Completed Treatment Period 1|Overall Study||458
8304245|NCT01528254|20473424|P2|Full Analysis Set (FAS)|Overall Study||989
8304246|NCT01528254|20473425|P1|Full Analysis Set (FAS)|Overall Study||983
8304247|NCT01528254|20473424|P2|Safety Set|Overall Study||1001
8304248|NCT01528254|20473425|P1|Safety Set|Overall Study||998
8304249|NCT01528254|20473424|P2|STARTED|Overall Study||1003
8304250|NCT01528254|20473425|P1|STARTED|Overall Study||998
8304251|NCT01528228|20473448|P2|NOT COMPLETED|Overall Study||1
8304252|NCT01528228|20473449|P1|NOT COMPLETED|Overall Study||1
8304253|NCT01528228|20473448|P2|COMPLETED|Overall Study||9
8304254|NCT01528228|20473449|P1|COMPLETED|Overall Study||9
8304255|NCT01528228|20473448|P2|STARTED|Overall Study||10
8304256|NCT01528228|20473449|P1|STARTED|Overall Study||10
8304257|NCT01528215|20473457|P2|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
8304258|NCT01528215|20473458|P1|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
8304259|NCT01528215|20473457|P2|COMPLETED|1 Year Follow-up to 5 Year Follow-up||45
8304260|NCT01528215|20473458|P1|COMPLETED|1 Year Follow-up to 5 Year Follow-up||40
8304261|NCT01528215|20473457|P2|STARTED|1 Year Follow-up to 5 Year Follow-up||60
8304262|NCT01528215|20473458|P1|STARTED|1 Year Follow-up to 5 Year Follow-up||55
8304263|NCT01528215|20473457|P2|NOT COMPLETED|Enrollment to 1 Year Follow-up||1
8304264|NCT01528215|20473458|P1|NOT COMPLETED|Enrollment to 1 Year Follow-up||4
8304265|NCT01528215|20473457|P2|COMPLETED|Enrollment to 1 Year Follow-up||60
8304266|NCT01528215|20473458|P1|COMPLETED|Enrollment to 1 Year Follow-up||55
8304267|NCT01528215|20473457|P2|STARTED|Enrollment to 1 Year Follow-up||61
8304268|NCT01528215|20473458|P1|STARTED|Enrollment to 1 Year Follow-up||59
8304269|NCT01528150|20473466|P1|NOT COMPLETED|Overall Study||44
8304270|NCT01528150|20473466|P1|COMPLETED|Overall Study||422
8304271|NCT01528150|20473466|P1|STARTED|Overall Study||466
8304272|NCT01528124|20473477|P7|NOT COMPLETED|Overall Study||0
8304273|NCT01528124|20473478|P6|NOT COMPLETED|Overall Study||0
8304274|NCT01528124|20473479|P5|NOT COMPLETED|Overall Study||0
8304275|NCT01528124|20473480|P4|NOT COMPLETED|Overall Study||0
8304276|NCT01528124|20473481|P3|NOT COMPLETED|Overall Study||0
8304277|NCT01528124|20473482|P2|NOT COMPLETED|Overall Study||0
8304278|NCT01528124|20473483|P1|NOT COMPLETED|Overall Study||0
8304279|NCT01528124|20473477|P7|COMPLETED|Overall Study||6
8304280|NCT01528124|20473478|P6|COMPLETED|Overall Study||6
8304281|NCT01528124|20473479|P5|COMPLETED|Overall Study||5
8304282|NCT01528124|20473480|P4|COMPLETED|Overall Study||6
8304283|NCT01528124|20473481|P3|COMPLETED|Overall Study||6
8304284|NCT01528124|20473482|P2|COMPLETED|Overall Study||6
8304285|NCT01528124|20473483|P1|COMPLETED|Overall Study||6
8304286|NCT01528124|20473477|P7|Received Study Drug|Overall Study||6
8304287|NCT01528124|20473478|P6|Received Study Drug|Overall Study||6
8304288|NCT01528124|20473479|P5|Received Study Drug|Overall Study||5
8304289|NCT01528124|20473480|P4|Received Study Drug|Overall Study||6
8304290|NCT01528124|20473481|P3|Received Study Drug|Overall Study||6
8304291|NCT01528124|20473482|P2|Received Study Drug|Overall Study||6
8304292|NCT01528124|20473483|P1|Received Study Drug|Overall Study||6
8304293|NCT01528124|20473477|P7|STARTED|Overall Study||6
8304294|NCT01528124|20473478|P6|STARTED|Overall Study||6
8304295|NCT01528124|20473479|P5|STARTED|Overall Study||5
8304296|NCT01528124|20473480|P4|STARTED|Overall Study||6
8304297|NCT01528124|20473481|P3|STARTED|Overall Study||6
8304298|NCT01528124|20473482|P2|STARTED|Overall Study||6
8304299|NCT01528124|20473483|P1|STARTED|Overall Study||6
8304300|NCT01528072|20473517|P1|NOT COMPLETED|Overall Study||74
8304301|NCT01528072|20473517|P1|COMPLETED|Overall Study||66
8304302|NCT01528072|20473517|P1|STARTED|Overall Study||140
8304303|NCT01528033|20473523|P2|NOT COMPLETED|Follow Up||44
8304304|NCT01528033|20473524|P1|NOT COMPLETED|Follow Up||46
8304305|NCT01528033|20473523|P2|COMPLETED|Follow Up||207
8304306|NCT01528033|20473524|P1|COMPLETED|Follow Up||210
8304307|NCT01528033|20473523|P2|STARTED|Follow Up||251
8304308|NCT01528033|20473524|P1|STARTED|Follow Up||256
8304309|NCT01528033|20473523|P2|NOT COMPLETED|Primary Endpoint Assessment ITT||15
8304310|NCT01528033|20473524|P1|NOT COMPLETED|Primary Endpoint Assessment ITT||17
8304311|NCT01528033|20473523|P2|COMPLETED|Primary Endpoint Assessment ITT||251
8304312|NCT01528033|20473524|P1|COMPLETED|Primary Endpoint Assessment ITT||256
8304313|NCT01528033|20473523|P2|STARTED|Primary Endpoint Assessment ITT||266
8304314|NCT01528033|20473524|P1|STARTED|Primary Endpoint Assessment ITT||273
8304315|NCT01527942|20473536|P2|NOT COMPLETED|Overall Study||0
8304316|NCT01527942|20473537|P1|NOT COMPLETED|Overall Study||0
8304317|NCT01527942|20473536|P2|COMPLETED|Overall Study||18
8304318|NCT01527942|20473537|P1|COMPLETED|Overall Study||16
8304319|NCT01527942|20473536|P2|STARTED|Overall Study||18
8304320|NCT01527942|20473537|P1|STARTED|Overall Study||16
8304321|NCT01527682|20473547|P1|NOT COMPLETED|Overall Study||8
8304322|NCT01527682|20473547|P1|COMPLETED|Overall Study||29
8304323|NCT01527682|20473547|P1|STARTED|Overall Study||37
8304324|NCT01527513|20473555|P2|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
8304325|NCT01527513|20473556|P1|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
8304326|NCT01527513|20473555|P2|COMPLETED|Eligible for 1-Year Open Label Period||95
8304327|NCT01527513|20473556|P1|COMPLETED|Eligible for 1-Year Open Label Period||0
8304328|NCT01527513|20473555|P2|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
8304329|NCT01527513|20473556|P1|STARTED|Eligible for 1-Year Open Label Period||0
8304330|NCT01527513|20473555|P2|NOT COMPLETED|Double Blind Period (DB) - Part I||8
8304331|NCT01527513|20473556|P1|NOT COMPLETED|Double Blind Period (DB) - Part I||3
8304332|NCT01527513|20473555|P2|COMPLETED|Double Blind Period (DB) - Part I||75
8304333|NCT01527513|20473556|P1|COMPLETED|Double Blind Period (DB) - Part I||37
8304334|NCT01527513|20473555|P2|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
8304335|NCT01527513|20473556|P1|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
8304336|NCT01527513|20473555|P2|Efficacy PP Population|Double Blind Period (DB) - Part I||67
8304337|NCT01527513|20473556|P1|Efficacy PP Population|Double Blind Period (DB) - Part I||37
8304338|NCT01527513|20473555|P2|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
8304339|NCT01527513|20473556|P1|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
8304340|NCT01527513|20473555|P2|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
8304341|NCT01527513|20473556|P1|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
8304342|NCT01527513|20473555|P2|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
8304343|NCT01527513|20473556|P1|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
8304344|NCT01527513|20473555|P2|Safety Population|Double Blind Period (DB) - Part I||83
8304345|NCT01527513|20473556|P1|Safety Population|Double Blind Period (DB) - Part I||40
8304346|NCT01527513|20473555|P2|Randomized|Double Blind Period (DB) - Part I||83
8304347|NCT01527513|20473556|P1|Randomized|Double Blind Period (DB) - Part I||40
8304348|NCT01527513|20473555|P2|STARTED|Double Blind Period (DB) - Part I||83
8304349|NCT01527513|20473556|P1|STARTED|Double Blind Period (DB) - Part I||40
8304350|NCT01527500|20473570|P2|NOT COMPLETED|Part B||0
8304351|NCT01527500|20473571|P1|NOT COMPLETED|Part B||1
8304352|NCT01527500|20473570|P2|COMPLETED|Part B||1
8304353|NCT01527500|20473571|P1|COMPLETED|Part B||6
8304354|NCT01527500|20473570|P2|STARTED|Part B||1
8304355|NCT01527500|20473571|P1|STARTED|Part B||7
8304356|NCT01527500|20473570|P2|NOT COMPLETED|Part A||13
8304357|NCT01527500|20473571|P1|NOT COMPLETED|Part A||30
8304358|NCT01527500|20473570|P2|COMPLETED|Part A||38
8304359|NCT01527500|20473571|P1|COMPLETED|Part A||69
8304360|NCT01527500|20473570|P2|STARTED|Part A||51
8304361|NCT01527500|20473571|P1|STARTED|Part A||99
8304362|NCT01527487|20473601|P2|NOT COMPLETED|Overall Study||7
8304363|NCT01527487|20473602|P1|NOT COMPLETED|Overall Study||8
8304364|NCT01527487|20473601|P2|COMPLETED|Overall Study||15
8304365|NCT01527487|20473602|P1|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
8304366|NCT01527487|20473601|P2|STARTED|Overall Study||22
8304367|NCT01527487|20473602|P1|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
8304368|NCT01527383|20473616|P2|NOT COMPLETED|Overall Study||4
8304369|NCT01527383|20473617|P1|NOT COMPLETED|Overall Study||15
8304370|NCT01527383|20473616|P2|COMPLETED|Overall Study||58
8304371|NCT01527383|20473617|P1|COMPLETED|Overall Study||277
8304372|NCT01527383|20473616|P2|Vaccination 4 (~Day 90)|Overall Study||58
8304373|NCT01527383|20473617|P1|Vaccination 4 (~Day 90)|Overall Study||277
8304374|NCT01527383|20473616|P2|Vaccination 3 (~Day 60)|Overall Study||58
8304375|NCT01527383|20473617|P1|Vaccination 3 (~Day 60)|Overall Study||278
8304376|NCT01527383|20473616|P2|Vaccination 2 (~Day 30)|Overall Study||61
8304377|NCT01527383|20473617|P1|Vaccination 2 (~Day 30)|Overall Study||283
8304378|NCT01527383|20473616|P2|Vaccination 1 (Day 1)|Overall Study||62
8304379|NCT01527383|20473617|P1|Vaccination 1 (Day 1)|Overall Study||291
8304380|NCT01527383|20473616|P2|STARTED|Overall Study||62
8304381|NCT01527383|20473617|P1|STARTED|Overall Study||292
8304382|NCT01527370|20473631|P1|NOT COMPLETED|Overall Study||6
8304383|NCT01527370|20473631|P1|COMPLETED|Overall Study||244
8304384|NCT01527370|20473631|P1|STARTED|Overall Study||250
8304385|NCT01527357|20473639|P2|NOT COMPLETED|Overall Study||9
8304386|NCT01527357|20473640|P1|NOT COMPLETED|Overall Study||17
8304387|NCT01527357|20473639|P2|COMPLETED|Overall Study||230
8304388|NCT01527357|20473640|P1|COMPLETED|Overall Study||465
8304389|NCT01527357|20473639|P2|Efficacy Population|Overall Study||239
8304390|NCT01527357|20473640|P1|Efficacy Population|Overall Study|Two participants did not receive study treatment.|480
8304391|NCT01527357|20473639|P2|STARTED|Overall Study||239
8304392|NCT01527357|20473640|P1|STARTED|Overall Study||482
8304393|NCT01527292|20473662|P2|NOT COMPLETED|Overall Study||3
8304394|NCT01527292|20473663|P1|NOT COMPLETED|Overall Study||0
8304395|NCT01527292|20473662|P2|COMPLETED|Overall Study||0
8304396|NCT01527292|20473663|P1|COMPLETED|Overall Study||0
8304397|NCT01527292|20473662|P2|STARTED|Overall Study||3
8304398|NCT01527292|20473663|P1|STARTED|Overall Study||0
8304408|NCT01527110|20473705|P1|NOT COMPLETED|Overall Study||1
8304409|NCT01527110|20473705|P1|COMPLETED|Overall Study||20
8304410|NCT01527110|20473705|P1|STARTED|Overall Study||21
8304411|NCT01527045|20473753|P3|NOT COMPLETED|Overall Study||0
8304412|NCT01527045|20473754|P2|NOT COMPLETED|Overall Study||0
8304413|NCT01527045|20473755|P1|NOT COMPLETED|Overall Study||1
8304414|NCT01527045|20473753|P3|COMPLETED|Overall Study||12
8304415|NCT01527045|20473754|P2|COMPLETED|Overall Study||5
8304416|NCT01527045|20473755|P1|COMPLETED|Overall Study||29
8304417|NCT01527045|20473753|P3|STARTED|Overall Study||12
8304418|NCT01527045|20473754|P2|STARTED|Overall Study||5
8304419|NCT01527045|20473755|P1|STARTED|Overall Study||30
8304420|NCT01527006|20473786|P2|NOT COMPLETED|Extension Phase||8
8304421|NCT01527006|20473787|P1|NOT COMPLETED|Extension Phase||6
8304422|NCT01527006|20473786|P2|COMPLETED|Extension Phase||14
8304423|NCT01527006|20473787|P1|COMPLETED|Extension Phase||13
8304424|NCT01527006|20473786|P2|STARTED|Extension Phase||22
8304425|NCT01527006|20473787|P1|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
8304426|NCT01527006|20473786|P2|NOT COMPLETED|Core Study||6
8304427|NCT01527006|20473787|P1|NOT COMPLETED|Core Study||2
8304428|NCT01527006|20473786|P2|COMPLETED|Core Study||22
8304429|NCT01527006|20473787|P1|COMPLETED|Core Study||20
8304430|NCT01527006|20473786|P2|STARTED|Core Study||28
8304431|NCT01527006|20473787|P1|STARTED|Core Study||22
8304432|NCT01526928|20473843|P6|NOT COMPLETED|Overall Study||6
8304433|NCT01526928|20473844|P5|NOT COMPLETED|Overall Study||95
8304434|NCT01526928|20473845|P4|NOT COMPLETED|Overall Study||245
8304435|NCT01526928|20473846|P3|NOT COMPLETED|Overall Study||209
8304436|NCT01526928|20473847|P2|NOT COMPLETED|Overall Study||19
8304437|NCT01526928|20473848|P1|NOT COMPLETED|Overall Study||38
8304438|NCT01526928|20473843|P6|COMPLETED|Overall Study||0
8304439|NCT01526928|20473844|P5|COMPLETED|Overall Study||0
8304440|NCT01526928|20473845|P4|COMPLETED|Overall Study||0
8304441|NCT01526928|20473846|P3|COMPLETED|Overall Study||0
8304442|NCT01526928|20473847|P2|COMPLETED|Overall Study||0
8304443|NCT01526928|20473848|P1|COMPLETED|Overall Study||0
8304444|NCT01526928|20473843|P6|Started Phase 2|Overall Study||0
8304445|NCT01526928|20473844|P5|Started Phase 2|Overall Study||82
8304446|NCT01526928|20473845|P4|Started Phase 2|Overall Study||228
8304447|NCT01526928|20473846|P3|Started Phase 2|Overall Study||191
8304448|NCT01526928|20473847|P2|Started Phase 2|Overall Study||0
8304449|NCT01526928|20473848|P1|Started Phase 2|Overall Study||0
8304450|NCT01526928|20473843|P6|Started Phase 1|Overall Study||6
8304451|NCT01526928|20473844|P5|Started Phase 1|Overall Study||13
8304452|NCT01526928|20473845|P4|Started Phase 1|Overall Study||17
8304453|NCT01526928|20473846|P3|Started Phase 1|Overall Study||18
8304454|NCT01526928|20473847|P2|Started Phase 1|Overall Study||19
8304455|NCT01526928|20473848|P1|Started Phase 1|Overall Study||38
8304456|NCT01526928|20473843|P6|STARTED|Overall Study||6
8304457|NCT01526928|20473844|P5|STARTED|Overall Study||95
8304458|NCT01526928|20473845|P4|STARTED|Overall Study||245
8304459|NCT01526928|20473846|P3|STARTED|Overall Study||209
8304460|NCT01526928|20473847|P2|STARTED|Overall Study||19
8304461|NCT01526928|20473848|P1|STARTED|Overall Study||38
8304462|NCT01526902|20473967|P2|NOT COMPLETED|Overall Study||0
8304463|NCT01526902|20473968|P1|NOT COMPLETED|Overall Study||0
8304464|NCT01526902|20473967|P2|COMPLETED|Overall Study||24
8304465|NCT01526902|20473968|P1|COMPLETED|Overall Study||25
8304466|NCT01526902|20473967|P2|STARTED|Overall Study||24
8304467|NCT01526902|20473968|P1|STARTED|Overall Study||25
8304468|NCT01526889|20473986|P2|NOT COMPLETED|Treatment Extension Period||0
8304469|NCT01526889|20473987|P1|NOT COMPLETED|Treatment Extension Period||1
8304470|NCT01526889|20473986|P2|COMPLETED|Treatment Extension Period||0
8304471|NCT01526889|20473987|P1|COMPLETED|Treatment Extension Period||4
8304472|NCT01526889|20473986|P2|STARTED|Treatment Extension Period||0
8304473|NCT01526889|20473987|P1|STARTED|Treatment Extension Period||5
8304474|NCT01526889|20473986|P2|NOT COMPLETED|Treatment Period||0
8304475|NCT01526889|20473987|P1|NOT COMPLETED|Treatment Period||2
8304476|NCT01526889|20473986|P2|COMPLETED|Treatment Period||7
8304477|NCT01526889|20473987|P1|COMPLETED|Treatment Period||16
8304478|NCT01526889|20473986|P2|STARTED|Treatment Period||7
8304479|NCT01526889|20473987|P1|STARTED|Treatment Period||18
8304480|NCT01526785|20474008|P1|NOT COMPLETED|Overall Study||13
8304481|NCT01526785|20474008|P1|COMPLETED|Overall Study||100
8304482|NCT01526785|20474008|P1|STARTED|Overall Study||113
8304483|NCT01526733|20474018|P2|NOT COMPLETED|Phase 2||0
8304484|NCT01526733|20474019|P1|NOT COMPLETED|Phase 2||0
8304485|NCT01526733|20474018|P2|COMPLETED|Phase 2||12
8304486|NCT01526733|20474019|P1|COMPLETED|Phase 2||10
8304487|NCT01526733|20474018|P2|STARTED|Phase 2||12
8304488|NCT01526733|20474019|P1|STARTED|Phase 2||10
8304489|NCT01526733|20474018|P2|NOT COMPLETED|Washout Period of 5 to 21 Days||0
8304490|NCT01526733|20474019|P1|NOT COMPLETED|Washout Period of 5 to 21 Days||0
8304491|NCT01526733|20474018|P2|COMPLETED|Washout Period of 5 to 21 Days||12
8304492|NCT01526733|20474019|P1|COMPLETED|Washout Period of 5 to 21 Days||10
8304493|NCT01526733|20474018|P2|STARTED|Washout Period of 5 to 21 Days||12
8304494|NCT01526733|20474019|P1|STARTED|Washout Period of 5 to 21 Days||10
8304495|NCT01526733|20474018|P2|NOT COMPLETED|Phase 1||1
8304496|NCT01526733|20474019|P1|NOT COMPLETED|Phase 1||2
8304497|NCT01526733|20474018|P2|COMPLETED|Phase 1||12
8304498|NCT01526733|20474019|P1|COMPLETED|Phase 1||10
8304499|NCT01526733|20474018|P2|Received at Least 1 Dose of Study Drug|Phase 1||13
8304500|NCT01526733|20474019|P1|Received at Least 1 Dose of Study Drug|Phase 1||12
8304501|NCT01526733|20474018|P2|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
8304502|NCT01526733|20474019|P1|STARTED|Phase 1||12
8304503|NCT01526629|20474037|P1|NOT COMPLETED|Overall Study||46
8304504|NCT01526629|20474037|P1|COMPLETED|Overall Study||308
8304505|NCT01526629|20474037|P1|STARTED|Overall Study||354
8304506|NCT01526577|20474046|P5|NOT COMPLETED|Overall Study||2
8304507|NCT01526577|20474047|P4|NOT COMPLETED|Overall Study||1
8304508|NCT01526577|20474048|P3|NOT COMPLETED|Overall Study||1
8304509|NCT01526577|20474049|P2|NOT COMPLETED|Overall Study||0
8304510|NCT01526577|20474050|P1|NOT COMPLETED|Overall Study||1
8304511|NCT01526577|20474046|P5|COMPLETED|Overall Study||8
8304512|NCT01526577|20474047|P4|COMPLETED|Overall Study||8
8304513|NCT01526577|20474048|P3|COMPLETED|Overall Study||32
8304514|NCT01526577|20474049|P2|COMPLETED|Overall Study||12
8304515|NCT01526577|20474050|P1|COMPLETED|Overall Study||48
8304516|NCT01526577|20474046|P5|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
8304517|NCT01526577|20474047|P4|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
8304518|NCT01526577|20474048|P3|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
8304519|NCT01526577|20474049|P2|STARTED|Overall Study||12
8304520|NCT01526577|20474050|P1|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
8304521|NCT01526551|20474058|P1|NOT COMPLETED|Overall Study||424
8304522|NCT01526551|20474058|P1|COMPLETED|Overall Study||511
8304523|NCT01526551|20474058|P1|STARTED|Overall Study||935
8304524|NCT01526538|20474065|P2|NOT COMPLETED|Overall Study||4
8304525|NCT01526538|20474066|P1|NOT COMPLETED|Overall Study||9
8304526|NCT01526538|20474065|P2|COMPLETED|Overall Study||18
8304527|NCT01526538|20474066|P1|COMPLETED|Overall Study||21
8304528|NCT01526538|20474065|P2|STARTED|Overall Study||22
8304529|NCT01526538|20474066|P1|STARTED|Overall Study||30
8304530|NCT01526356|20474079|P3|NOT COMPLETED|Overall Study||12
8304531|NCT01526356|20474080|P2|NOT COMPLETED|Overall Study||10
8304532|NCT01526356|20474081|P1|NOT COMPLETED|Overall Study||8
8304533|NCT01526356|20474079|P3|COMPLETED|Overall Study||45
8304534|NCT01526356|20474080|P2|COMPLETED|Overall Study||53
8304535|NCT01526356|20474081|P1|COMPLETED|Overall Study||51
8304536|NCT01526356|20474079|P3|STARTED|Overall Study||57
8304537|NCT01526356|20474080|P2|STARTED|Overall Study||63
8304538|NCT01526356|20474081|P1|STARTED|Overall Study||59
8304539|NCT01526343|20474107|P1|NOT COMPLETED|Overall Study||0
8304540|NCT01526343|20474107|P1|COMPLETED|Overall Study||47
8304541|NCT01526343|20474107|P1|STARTED|Overall Study||47
8304542|NCT01526213|20474118|P6|NOT COMPLETED|Period 3 (5 Days)||0
8304543|NCT01526213|20474119|P5|NOT COMPLETED|Period 3 (5 Days)||0
8304544|NCT01526213|20474120|P4|NOT COMPLETED|Period 3 (5 Days)||0
8304545|NCT01526213|20474121|P3|NOT COMPLETED|Period 3 (5 Days)||0
8304546|NCT01526213|20474122|P2|NOT COMPLETED|Period 3 (5 Days)||0
8304547|NCT01526213|20474123|P1|NOT COMPLETED|Period 3 (5 Days)||0
8304548|NCT01526213|20474118|P6|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304549|NCT01526213|20474119|P5|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304550|NCT01526213|20474120|P4|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304551|NCT01526213|20474121|P3|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304552|NCT01526213|20474122|P2|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304553|NCT01526213|20474123|P1|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304554|NCT01526213|20474118|P6|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304714|NCT01525615|20474415|P3|STARTED|Overall Study||139
8304555|NCT01526213|20474119|P5|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304556|NCT01526213|20474120|P4|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304557|NCT01526213|20474121|P3|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304558|NCT01526213|20474122|P2|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304559|NCT01526213|20474123|P1|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304560|NCT01526213|20474118|P6|NOT COMPLETED|Washout 2 (10 Days)||0
8304561|NCT01526213|20474119|P5|NOT COMPLETED|Washout 2 (10 Days)||0
8304562|NCT01526213|20474120|P4|NOT COMPLETED|Washout 2 (10 Days)||0
8304563|NCT01526213|20474121|P3|NOT COMPLETED|Washout 2 (10 Days)||0
8304564|NCT01526213|20474122|P2|NOT COMPLETED|Washout 2 (10 Days)||0
8304565|NCT01526213|20474123|P1|NOT COMPLETED|Washout 2 (10 Days)||0
8304566|NCT01526213|20474118|P6|COMPLETED|Washout 2 (10 Days)||3
8304567|NCT01526213|20474119|P5|COMPLETED|Washout 2 (10 Days)||3
8304568|NCT01526213|20474120|P4|COMPLETED|Washout 2 (10 Days)||3
8304569|NCT01526213|20474121|P3|COMPLETED|Washout 2 (10 Days)||3
8304570|NCT01526213|20474122|P2|COMPLETED|Washout 2 (10 Days)||3
8304571|NCT01526213|20474123|P1|COMPLETED|Washout 2 (10 Days)||3
8304572|NCT01526213|20474118|P6|STARTED|Washout 2 (10 Days)||3
8304573|NCT01526213|20474119|P5|STARTED|Washout 2 (10 Days)||3
8304574|NCT01526213|20474120|P4|STARTED|Washout 2 (10 Days)||3
8304575|NCT01526213|20474121|P3|STARTED|Washout 2 (10 Days)||3
8304576|NCT01526213|20474122|P2|STARTED|Washout 2 (10 Days)||3
8304577|NCT01526213|20474123|P1|STARTED|Washout 2 (10 Days)||3
8304578|NCT01526213|20474118|P6|NOT COMPLETED|Period 2 (5 Days)||0
8304579|NCT01526213|20474119|P5|NOT COMPLETED|Period 2 (5 Days)||0
8304580|NCT01526213|20474120|P4|NOT COMPLETED|Period 2 (5 Days)||0
8304581|NCT01526213|20474121|P3|NOT COMPLETED|Period 2 (5 Days)||0
8304582|NCT01526213|20474122|P2|NOT COMPLETED|Period 2 (5 Days)||0
8304583|NCT01526213|20474123|P1|NOT COMPLETED|Period 2 (5 Days)||0
8304584|NCT01526213|20474118|P6|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
8304585|NCT01526213|20474119|P5|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
8304586|NCT01526213|20474120|P4|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
8304587|NCT01526213|20474121|P3|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
8304588|NCT01526213|20474122|P2|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304589|NCT01526213|20474123|P1|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304590|NCT01526213|20474118|P6|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304591|NCT01526213|20474119|P5|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304592|NCT01526213|20474120|P4|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304593|NCT01526213|20474121|P3|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304594|NCT01526213|20474122|P2|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304595|NCT01526213|20474123|P1|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304596|NCT01526213|20474118|P6|NOT COMPLETED|Washout 1 (10 Days)||0
8304597|NCT01526213|20474119|P5|NOT COMPLETED|Washout 1 (10 Days)||0
8304598|NCT01526213|20474120|P4|NOT COMPLETED|Washout 1 (10 Days)||0
8304599|NCT01526213|20474121|P3|NOT COMPLETED|Washout 1 (10 Days)||0
8304600|NCT01526213|20474122|P2|NOT COMPLETED|Washout 1 (10 Days)||0
8304601|NCT01526213|20474123|P1|NOT COMPLETED|Washout 1 (10 Days)||0
8304602|NCT01526213|20474118|P6|COMPLETED|Washout 1 (10 Days)||3
8304603|NCT01526213|20474119|P5|COMPLETED|Washout 1 (10 Days)||3
8304604|NCT01526213|20474120|P4|COMPLETED|Washout 1 (10 Days)||3
8304605|NCT01526213|20474121|P3|COMPLETED|Washout 1 (10 Days)||3
8304606|NCT01526213|20474122|P2|COMPLETED|Washout 1 (10 Days)||3
8304607|NCT01526213|20474123|P1|COMPLETED|Washout 1 (10 Days)||3
8304608|NCT01526213|20474118|P6|STARTED|Washout 1 (10 Days)||3
8304609|NCT01526213|20474119|P5|STARTED|Washout 1 (10 Days)||3
8304610|NCT01526213|20474120|P4|STARTED|Washout 1 (10 Days)||3
8304611|NCT01526213|20474121|P3|STARTED|Washout 1 (10 Days)||3
8304612|NCT01526213|20474122|P2|STARTED|Washout 1 (10 Days)||3
8304613|NCT01526213|20474123|P1|STARTED|Washout 1 (10 Days)||3
8304614|NCT01526213|20474118|P6|NOT COMPLETED|Period 1 (5 Days)||0
8304615|NCT01526213|20474119|P5|NOT COMPLETED|Period 1 (5 Days)||0
8304616|NCT01526213|20474120|P4|NOT COMPLETED|Period 1 (5 Days)||0
8304617|NCT01526213|20474121|P3|NOT COMPLETED|Period 1 (5 Days)||0
8304618|NCT01526213|20474122|P2|NOT COMPLETED|Period 1 (5 Days)||0
8304619|NCT01526213|20474123|P1|NOT COMPLETED|Period 1 (5 Days)||0
8304620|NCT01526213|20474118|P6|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304621|NCT01526213|20474119|P5|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304622|NCT01526213|20474120|P4|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304623|NCT01526213|20474121|P3|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304624|NCT01526213|20474122|P2|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304625|NCT01526213|20474123|P1|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
8304715|NCT01525615|20474416|P2|STARTED|Overall Study||133
8304626|NCT01526213|20474118|P6|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
8304627|NCT01526213|20474119|P5|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304628|NCT01526213|20474120|P4|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304629|NCT01526213|20474121|P3|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304630|NCT01526213|20474122|P2|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304631|NCT01526213|20474123|P1|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
8304632|NCT01526148|20474136|P2|NOT COMPLETED|Overall Study||13
8304633|NCT01526148|20474137|P1|NOT COMPLETED|Overall Study||14
8304634|NCT01526148|20474136|P2|COMPLETED|Overall Study||11
8304635|NCT01526148|20474137|P1|COMPLETED|Overall Study||4
8304636|NCT01526148|20474136|P2|STARTED|Overall Study||24
8304637|NCT01526148|20474137|P1|STARTED|Overall Study||18
8304638|NCT01526057|20474148|P3|NOT COMPLETED|Overall Study||6
8304639|NCT01526057|20474149|P2|NOT COMPLETED|Overall Study||3
8304640|NCT01526057|20474150|P1|NOT COMPLETED|Overall Study||9
8304641|NCT01526057|20474148|P3|COMPLETED|Overall Study||67
8304642|NCT01526057|20474149|P2|COMPLETED|Overall Study||71
8304643|NCT01526057|20474150|P1|COMPLETED|Overall Study||64
8304644|NCT01526057|20474148|P3|STARTED|Overall Study||73
8304645|NCT01526057|20474149|P2|STARTED|Overall Study||74
8304646|NCT01526057|20474150|P1|STARTED|Overall Study||73
8304647|NCT01525927|20474235|P1|NOT COMPLETED|Overall Study||0
8304648|NCT01525927|20474235|P1|COMPLETED|Overall Study||0
8304649|NCT01525927|20474235|P1|STARTED|Overall Study||0
8304662|NCT01525862|20474264|P1|NOT COMPLETED|Overall Study||0
8304663|NCT01525862|20474264|P1|COMPLETED|Overall Study||21
8304664|NCT01525862|20474264|P1|STARTED|Overall Study||21
8304665|NCT01525849|20474273|P2|NOT COMPLETED|Overall Study||16
8304666|NCT01525849|20474274|P1|NOT COMPLETED|Overall Study||5
8304667|NCT01525849|20474273|P2|COMPLETED|Overall Study||59
8304668|NCT01525849|20474274|P1|COMPLETED|Overall Study||71
8304669|NCT01525849|20474273|P2|6-Months|Overall Study||60
8304670|NCT01525849|20474274|P1|6-Months|Overall Study||73
8304671|NCT01525849|20474273|P2|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
8304672|NCT01525849|20474274|P1|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
8304673|NCT01525849|20474273|P2|STARTED|Overall Study||75
8304674|NCT01525849|20474274|P1|STARTED|Overall Study||76
8304675|NCT01525745|20474290|P2|NOT COMPLETED|Overall Study||1
8304676|NCT01525745|20474291|P1|NOT COMPLETED|Overall Study||1
8304677|NCT01525745|20474290|P2|COMPLETED|Overall Study||1
8304678|NCT01525745|20474291|P1|COMPLETED|Overall Study||3
8304679|NCT01525745|20474290|P2|STARTED|Overall Study||2
8304680|NCT01525745|20474291|P1|STARTED|Overall Study||4
8304681|NCT01525667|20474308|P3|NOT COMPLETED|Overall Study||0
8304682|NCT01525667|20474309|P2|NOT COMPLETED|Overall Study||0
8304683|NCT01525667|20474310|P1|NOT COMPLETED|Overall Study||0
8304684|NCT01525667|20474308|P3|COMPLETED|Overall Study||7
8304685|NCT01525667|20474309|P2|COMPLETED|Overall Study||6
8304686|NCT01525667|20474310|P1|COMPLETED|Overall Study||7
8304687|NCT01525667|20474308|P3|STARTED|Overall Study||7
8304688|NCT01525667|20474309|P2|STARTED|Overall Study||6
8304689|NCT01525667|20474310|P1|STARTED|Overall Study||7
8304690|NCT01525641|20474330|P1|NOT COMPLETED|Overall Study||180
8304691|NCT01525641|20474330|P1|COMPLETED|Overall Study||435
8304692|NCT01525641|20474330|P1|STARTED|Overall Study||615
8304693|NCT01525628|20474344|P5|NOT COMPLETED|Overall Study||3
8304694|NCT01525628|20474345|P4|NOT COMPLETED|Overall Study||4
8304695|NCT01525628|20474346|P3|NOT COMPLETED|Overall Study||5
8304696|NCT01525628|20474347|P2|NOT COMPLETED|Overall Study||5
8304697|NCT01525628|20474348|P1|NOT COMPLETED|Overall Study||2
8304698|NCT01525628|20474344|P5|COMPLETED|Overall Study||4
8304699|NCT01525628|20474345|P4|COMPLETED|Overall Study||10
8304700|NCT01525628|20474346|P3|COMPLETED|Overall Study||11
8304701|NCT01525628|20474347|P2|COMPLETED|Overall Study||14
8304702|NCT01525628|20474348|P1|COMPLETED|Overall Study||14
8304703|NCT01525628|20474344|P5|STARTED|Overall Study||7
8304704|NCT01525628|20474345|P4|STARTED|Overall Study||14
8304705|NCT01525628|20474346|P3|STARTED|Overall Study||16
8304706|NCT01525628|20474347|P2|STARTED|Overall Study||19
8304707|NCT01525628|20474348|P1|STARTED|Overall Study||16
8304708|NCT01525615|20474415|P3|NOT COMPLETED|Overall Study||6
8304709|NCT01525615|20474416|P2|NOT COMPLETED|Overall Study||7
8304710|NCT01525615|20474417|P1|NOT COMPLETED|Overall Study||14
8304711|NCT01525615|20474415|P3|COMPLETED|Overall Study||133
8304712|NCT01525615|20474416|P2|COMPLETED|Overall Study||126
8304713|NCT01525615|20474417|P1|COMPLETED|Overall Study||118
8304716|NCT01525615|20474417|P1|STARTED|Overall Study||132
8304717|NCT01525602|20474469|P8|NOT COMPLETED|Overall Study||7
8304718|NCT01525602|20474470|P7|NOT COMPLETED|Overall Study||6
8304719|NCT01525602|20474471|P6|NOT COMPLETED|Overall Study||7
8304720|NCT01525602|20474472|P5|NOT COMPLETED|Overall Study||33
8304721|NCT01525602|20474473|P4|NOT COMPLETED|Overall Study||6
8304722|NCT01525602|20474474|P3|NOT COMPLETED|Overall Study||3
8304723|NCT01525602|20474475|P2|NOT COMPLETED|Overall Study||3
8304724|NCT01525602|20474476|P1|NOT COMPLETED|Overall Study||9
8304725|NCT01525602|20474469|P8|COMPLETED|Overall Study||0
8304726|NCT01525602|20474470|P7|COMPLETED|Overall Study||0
8304727|NCT01525602|20474471|P6|COMPLETED|Overall Study||0
8304728|NCT01525602|20474472|P5|COMPLETED|Overall Study||0
8304729|NCT01525602|20474473|P4|COMPLETED|Overall Study||0
8304730|NCT01525602|20474474|P3|COMPLETED|Overall Study||0
8304731|NCT01525602|20474475|P2|COMPLETED|Overall Study||0
8304732|NCT01525602|20474476|P1|COMPLETED|Overall Study||0
8304733|NCT01525602|20474469|P8|STARTED|Overall Study||7
8304734|NCT01525602|20474470|P7|STARTED|Overall Study||6
8304735|NCT01525602|20474471|P6|STARTED|Overall Study||7
8304736|NCT01525602|20474472|P5|STARTED|Overall Study||33
8304737|NCT01525602|20474473|P4|STARTED|Overall Study||6
8304738|NCT01525602|20474474|P3|STARTED|Overall Study||3
8304739|NCT01525602|20474475|P2|STARTED|Overall Study||3
8304740|NCT01525602|20474476|P1|STARTED|Overall Study||9
8304741|NCT01525589|20474547|P3|NOT COMPLETED|Overall Study||35
8304742|NCT01525589|20474548|P2|NOT COMPLETED|Overall Study||20
8304743|NCT01525589|20474549|P1|NOT COMPLETED|Overall Study||56
8304744|NCT01525589|20474547|P3|COMPLETED|Overall Study||0
8304745|NCT01525589|20474548|P2|COMPLETED|Overall Study||0
8304746|NCT01525589|20474549|P1|COMPLETED|Overall Study||0
8304747|NCT01525589|20474547|P3|STARTED|Overall Study||35
8304748|NCT01525589|20474548|P2|STARTED|Overall Study||20
8304749|NCT01525589|20474549|P1|STARTED|Overall Study||56
8304750|NCT01525563|20474593|P1|NOT COMPLETED|Overall Study||212
8304751|NCT01525563|20474593|P1|COMPLETED|Overall Study|6 Months Follow-up|788
8304752|NCT01525563|20474593|P1|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
8304753|NCT01525563|20474593|P1|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
8304754|NCT01525563|20474593|P1|STARTED|Overall Study||1000
8304755|NCT01525550|20474605|P2|NOT COMPLETED|Overall Study||45
8304756|NCT01525550|20474606|P1|NOT COMPLETED|Overall Study||61
8304757|NCT01525550|20474605|P2|COMPLETED|Overall Study||0
8304758|NCT01525550|20474606|P1|COMPLETED|Overall Study||0
8304759|NCT01525550|20474605|P2|STARTED|Overall Study||45
8304760|NCT01525550|20474606|P1|STARTED|Overall Study||61
8304761|NCT01525420|20474668|P2|NOT COMPLETED|Overall Study||24
8304762|NCT01525420|20474669|P1|NOT COMPLETED|Overall Study||16
8304763|NCT01525420|20474668|P2|COMPLETED|Overall Study||38
8304764|NCT01525420|20474669|P1|COMPLETED|Overall Study||43
8304765|NCT01525420|20474668|P2|STARTED|Overall Study||62
8304766|NCT01525420|20474669|P1|STARTED|Overall Study||59
8304767|NCT01525407|20474677|P2|NOT COMPLETED|Overall Study||4
8304768|NCT01525407|20474678|P1|NOT COMPLETED|Overall Study||3
8304769|NCT01525407|20474677|P2|COMPLETED|Overall Study||38
8304770|NCT01525407|20474678|P1|COMPLETED|Overall Study||38
8304771|NCT01525407|20474677|P2|STARTED|Overall Study||42
8304772|NCT01525407|20474678|P1|STARTED|Overall Study||41
8304773|NCT01525329|20474694|P2|NOT COMPLETED|Overall Study||0
8304774|NCT01525329|20474695|P1|NOT COMPLETED|Overall Study||0
8304775|NCT01525329|20474694|P2|COMPLETED|Overall Study||14
8304776|NCT01525329|20474695|P1|COMPLETED|Overall Study||4
8304777|NCT01525329|20474694|P2|STARTED|Overall Study||14
8304778|NCT01525329|20474695|P1|STARTED|Overall Study||4
8304779|NCT01525238|20474712|P3|NOT COMPLETED|Overall Study||0
8304780|NCT01525238|20474713|P2|NOT COMPLETED|Overall Study||0
8304781|NCT01525238|20474714|P1|NOT COMPLETED|Overall Study||1
8304782|NCT01525238|20474712|P3|COMPLETED|Overall Study||8
8304783|NCT01525238|20474713|P2|COMPLETED|Overall Study||8
8304784|NCT01525238|20474714|P1|COMPLETED|Overall Study||7
8304785|NCT01525238|20474712|P3|STARTED|Overall Study||8
8304786|NCT01525238|20474713|P2|STARTED|Overall Study||8
8304787|NCT01525238|20474714|P1|STARTED|Overall Study||8
8304788|NCT01525225|20474779|P1|NOT COMPLETED|Treated||0
8304789|NCT01525225|20474779|P1|COMPLETED|Treated||2
8304790|NCT01525225|20474779|P1|STARTED|Treated||2
8304791|NCT01525225|20474779|P1|NOT COMPLETED|Enrollment||2
8304792|NCT01525225|20474779|P1|COMPLETED|Enrollment||2
8304793|NCT01525225|20474779|P1|STARTED|Enrollment||4
8304794|NCT01525173|20474786|P2|NOT COMPLETED|Overall Study||5
8304795|NCT01525173|20474787|P1|NOT COMPLETED|Overall Study||7
8304796|NCT01525173|20474786|P2|COMPLETED|Overall Study||62
8304797|NCT01525173|20474787|P1|COMPLETED|Overall Study||63
8304798|NCT01525173|20474786|P2|STARTED|Overall Study||67
8304799|NCT01525173|20474787|P1|STARTED|Overall Study||70
8304803|NCT01524991|20474804|P1|NOT COMPLETED|Overall Study||34
8304804|NCT01524991|20474804|P1|COMPLETED|Overall Study||2
8304805|NCT01524991|20474804|P1|STARTED|Overall Study||36
8304806|NCT01524978|20474822|P11|NOT COMPLETED|Overall Study||28
8304807|NCT01524978|20474823|P10|NOT COMPLETED|Overall Study||9
8304808|NCT01524978|20474824|P9|NOT COMPLETED|Overall Study||12
8304809|NCT01524978|20474825|P8|NOT COMPLETED|Overall Study||12
8304810|NCT01524978|20474826|P7|NOT COMPLETED|Overall Study||26
8304811|NCT01524978|20474827|P6|NOT COMPLETED|Overall Study||9
8304812|NCT01524978|20474828|P5|NOT COMPLETED|Overall Study||9
8304813|NCT01524978|20474829|P4|NOT COMPLETED|Overall Study||27
8304814|NCT01524978|20474830|P3|NOT COMPLETED|Overall Study||10
8304815|NCT01524978|20474831|P2|NOT COMPLETED|Overall Study||4
8304816|NCT01524978|20474832|P1|NOT COMPLETED|Overall Study||62
8304817|NCT01524978|20474822|P11|COMPLETED|Overall Study||0
8304818|NCT01524978|20474823|P10|COMPLETED|Overall Study||0
8304819|NCT01524978|20474824|P9|COMPLETED|Overall Study||0
8304820|NCT01524978|20474825|P8|COMPLETED|Overall Study||0
8304821|NCT01524978|20474826|P7|COMPLETED|Overall Study||0
8304822|NCT01524978|20474827|P6|COMPLETED|Overall Study||0
8304823|NCT01524978|20474828|P5|COMPLETED|Overall Study||0
8304824|NCT01524978|20474829|P4|COMPLETED|Overall Study||0
8304825|NCT01524978|20474830|P3|COMPLETED|Overall Study||0
8304826|NCT01524978|20474831|P2|COMPLETED|Overall Study||0
8304827|NCT01524978|20474832|P1|COMPLETED|Overall Study||0
8304828|NCT01524978|20474822|P11|STARTED|Overall Study||28
8304829|NCT01524978|20474823|P10|STARTED|Overall Study||9
8304830|NCT01524978|20474824|P9|STARTED|Overall Study||12
8304831|NCT01524978|20474825|P8|STARTED|Overall Study||12
8304832|NCT01524978|20474826|P7|STARTED|Overall Study||26
8304833|NCT01524978|20474827|P6|STARTED|Overall Study||9
8304834|NCT01524978|20474828|P5|STARTED|Overall Study||9
8304835|NCT01524978|20474829|P4|STARTED|Overall Study||27
8304836|NCT01524978|20474830|P3|STARTED|Overall Study||10
8304837|NCT01524978|20474831|P2|STARTED|Overall Study||4
8304838|NCT01524978|20474832|P1|STARTED|Overall Study||62
8304839|NCT01524913|20474960|P3|NOT COMPLETED|Overall Study||0
8304840|NCT01524913|20474961|P2|NOT COMPLETED|Overall Study||0
8304841|NCT01524913|20474962|P1|NOT COMPLETED|Overall Study||4
8304842|NCT01524913|20474960|P3|COMPLETED|Overall Study||31
8304843|NCT01524913|20474961|P2|COMPLETED|Overall Study||36
8304844|NCT01524913|20474962|P1|COMPLETED|Overall Study||31
8304845|NCT01524913|20474960|P3|STARTED|Overall Study||31
8304846|NCT01524913|20474961|P2|STARTED|Overall Study||36
8304847|NCT01524913|20474962|P1|STARTED|Overall Study||35
8304848|NCT01524900|20474984|P5|NOT COMPLETED|Overall Study||0
8304849|NCT01524900|20474985|P4|NOT COMPLETED|Overall Study||1
8304850|NCT01524900|20474986|P3|NOT COMPLETED|Overall Study||1
8304851|NCT01524900|20474987|P2|NOT COMPLETED|Overall Study||14
8304852|NCT01524900|20474988|P1|NOT COMPLETED|Overall Study||6
8304853|NCT01524900|20474984|P5|COMPLETED|Overall Study||40
8304854|NCT01524900|20474985|P4|COMPLETED|Overall Study||21
8304855|NCT01524900|20474986|P3|COMPLETED|Overall Study||29
8304856|NCT01524900|20474987|P2|COMPLETED|Overall Study||232
8304857|NCT01524900|20474988|P1|COMPLETED|Overall Study||43
8304858|NCT01524900|20474984|P5|STARTED|Overall Study||40
8304859|NCT01524900|20474985|P4|STARTED|Overall Study||22
8304860|NCT01524900|20474986|P3|STARTED|Overall Study||30
8304861|NCT01524900|20474987|P2|STARTED|Overall Study||246
8304862|NCT01524900|20474988|P1|STARTED|Overall Study||49
8304887|NCT01524770|20475090|P2|NOT COMPLETED|Second Intervention||0
8304888|NCT01524770|20475091|P1|NOT COMPLETED|Second Intervention||0
8304889|NCT01524770|20475090|P2|COMPLETED|Second Intervention||23
8304890|NCT01524770|20475091|P1|COMPLETED|Second Intervention||23
8304891|NCT01524770|20475090|P2|STARTED|Second Intervention||23
8304892|NCT01524770|20475091|P1|STARTED|Second Intervention||23
8304893|NCT01524770|20475090|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
8304894|NCT01524770|20475091|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
8304895|NCT01524770|20475090|P2|COMPLETED|Washout Period of at Least 28 Days||23
8304896|NCT01524770|20475091|P1|COMPLETED|Washout Period of at Least 28 Days||23
8304897|NCT01524770|20475090|P2|STARTED|Washout Period of at Least 28 Days||23
8304898|NCT01524770|20475091|P1|STARTED|Washout Period of at Least 28 Days||23
8304899|NCT01524770|20475090|P2|NOT COMPLETED|First Intervention||1
8304900|NCT01524770|20475091|P1|NOT COMPLETED|First Intervention||3
8304901|NCT01524770|20475090|P2|COMPLETED|First Intervention||23
8304902|NCT01524770|20475091|P1|COMPLETED|First Intervention||23
8304903|NCT01524770|20475090|P2|Received at Least 1 Dose of Study Drug|First Intervention||24
8304904|NCT01524770|20475091|P1|Received at Least 1 Dose of Study Drug|First Intervention||26
8304905|NCT01524770|20475090|P2|STARTED|First Intervention||24
8304906|NCT01524770|20475091|P1|STARTED|First Intervention||26
8304907|NCT01524692|20475101|P1|NOT COMPLETED|Overall Study||3
8304908|NCT01524692|20475101|P1|COMPLETED|Overall Study||32
8304909|NCT01524692|20475101|P1|STARTED|Overall Study||35
8304910|NCT01524679|20475111|P2|NOT COMPLETED|Overall Study||9
8304911|NCT01524679|20475112|P1|NOT COMPLETED|Overall Study||23
8304912|NCT01524679|20475111|P2|COMPLETED|Overall Study||49
8304913|NCT01524679|20475112|P1|COMPLETED|Overall Study||89
8304914|NCT01524679|20475111|P2|STARTED|Overall Study||58
8304915|NCT01524679|20475112|P1|STARTED|Overall Study||112
8304916|NCT01524627|20475124|P2|NOT COMPLETED|Overall Study||2
8304917|NCT01524627|20475125|P1|NOT COMPLETED|Overall Study||1
8304918|NCT01524627|20475124|P2|COMPLETED|Overall Study||19
8304919|NCT01524627|20475125|P1|COMPLETED|Overall Study||21
8304920|NCT01524627|20475124|P2|STARTED|Overall Study||21
8304921|NCT01524627|20475125|P1|STARTED|Overall Study||22
8304922|NCT01524302|20475133|P2|NOT COMPLETED|Overall Study||0
8304923|NCT01524302|20475134|P1|NOT COMPLETED|Overall Study||0
8304924|NCT01524302|20475133|P2|COMPLETED|Overall Study||6
8304925|NCT01524302|20475134|P1|COMPLETED|Overall Study||6
8304926|NCT01524302|20475133|P2|STARTED|Overall Study||6
8304927|NCT01524302|20475134|P1|STARTED|Overall Study||6
8304928|NCT01524289|20475152|P2|NOT COMPLETED|Overall Study||14
8304929|NCT01524289|20475153|P1|NOT COMPLETED|Overall Study||30
8304930|NCT01524289|20475152|P2|COMPLETED|Overall Study||88
8304931|NCT01524289|20475153|P1|COMPLETED|Overall Study||174
8304932|NCT01524289|20475152|P2|Treated|Overall Study||102
8304933|NCT01524289|20475153|P1|Treated|Overall Study||203
8304934|NCT01524289|20475152|P2|STARTED|Overall Study||102
8304935|NCT01524289|20475153|P1|STARTED|Overall Study||204
8304936|NCT01524224|20475211|P8|NOT COMPLETED|Overall Study||6
8304937|NCT01524224|20475212|P7|NOT COMPLETED|Overall Study||3
8304938|NCT01524224|20475213|P6|NOT COMPLETED|Overall Study||2
8304939|NCT01524224|20475214|P5|NOT COMPLETED|Overall Study||4
8304940|NCT01524224|20475215|P4|NOT COMPLETED|Overall Study||2
8304941|NCT01524224|20475216|P3|NOT COMPLETED|Overall Study||2
8304942|NCT01524224|20475217|P2|NOT COMPLETED|Overall Study||1
8304943|NCT01524224|20475218|P1|NOT COMPLETED|Overall Study||3
8304944|NCT01524224|20475211|P8|COMPLETED|Overall Study||0
8304945|NCT01524224|20475212|P7|COMPLETED|Overall Study||0
8304946|NCT01524224|20475213|P6|COMPLETED|Overall Study||1
8304947|NCT01524224|20475214|P5|COMPLETED|Overall Study||0
8304948|NCT01524224|20475215|P4|COMPLETED|Overall Study||1
8304949|NCT01524224|20475216|P3|COMPLETED|Overall Study||1
8304950|NCT01524224|20475217|P2|COMPLETED|Overall Study||2
8304951|NCT01524224|20475218|P1|COMPLETED|Overall Study||1
8304952|NCT01524224|20475211|P8|Received at Least One Dose of Study Drug|Overall Study||6
8304953|NCT01524224|20475212|P7|Received at Least One Dose of Study Drug|Overall Study||3
8304954|NCT01524224|20475213|P6|Received at Least One Dose of Study Drug|Overall Study||3
8304955|NCT01524224|20475214|P5|Received at Least One Dose of Study Drug|Overall Study||4
8304956|NCT01524224|20475215|P4|Received at Least One Dose of Study Drug|Overall Study||3
8304957|NCT01524224|20475216|P3|Received at Least One Dose of Study Drug|Overall Study||3
8304958|NCT01524224|20475217|P2|Received at Least One Dose of Study Drug|Overall Study||3
8304959|NCT01524224|20475218|P1|Received at Least One Dose of Study Drug|Overall Study||4
8304960|NCT01524224|20475211|P8|STARTED|Overall Study||6
8304961|NCT01524224|20475212|P7|STARTED|Overall Study||3
8304962|NCT01524224|20475213|P6|STARTED|Overall Study||3
8304963|NCT01524224|20475214|P5|STARTED|Overall Study||4
8304964|NCT01524224|20475215|P4|STARTED|Overall Study||3
8304965|NCT01524224|20475216|P3|STARTED|Overall Study||3
8304966|NCT01524224|20475217|P2|STARTED|Overall Study||3
8304967|NCT01524224|20475218|P1|STARTED|Overall Study||4
8304968|NCT01524198|20475254|P2|NOT COMPLETED|Overall Study||16
8304969|NCT01524198|20475255|P1|NOT COMPLETED|Overall Study||23
8304970|NCT01524198|20475254|P2|COMPLETED|Overall Study||458
8304971|NCT01524198|20475255|P1|COMPLETED|Overall Study||448
8304972|NCT01524198|20475254|P2|STARTED|Overall Study||474
8304973|NCT01524198|20475255|P1|STARTED|Overall Study||471
8304974|NCT01524133|20475266|P3|NOT COMPLETED|Overall Study 52 Weeks||27
8304975|NCT01524133|20475267|P2|NOT COMPLETED|Overall Study 52 Weeks||20
8304976|NCT01524133|20475268|P1|NOT COMPLETED|Overall Study 52 Weeks||21
8304977|NCT01524133|20475266|P3|COMPLETED|Overall Study 52 Weeks||40
8304978|NCT01524133|20475267|P2|COMPLETED|Overall Study 52 Weeks||49
8304979|NCT01524133|20475268|P1|COMPLETED|Overall Study 52 Weeks||50
8304980|NCT01524133|20475266|P3|STARTED|Overall Study 52 Weeks||67
8304981|NCT01524133|20475267|P2|STARTED|Overall Study 52 Weeks||69
8304982|NCT01524133|20475268|P1|STARTED|Overall Study 52 Weeks||71
8304983|NCT01524133|20475266|P3|NOT COMPLETED|Treatment Phase||36
8304984|NCT01524133|20475267|P2|NOT COMPLETED|Treatment Phase||32
8304985|NCT01524133|20475268|P1|NOT COMPLETED|Treatment Phase||19
8304986|NCT01524133|20475266|P3|COMPLETED|Treatment Phase|Completed both assigned treatments|31
8304987|NCT01524133|20475267|P2|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
8304988|NCT01524133|20475268|P1|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
8304989|NCT01524133|20475266|P3|STARTED|Treatment Phase||67
8304990|NCT01524133|20475267|P2|STARTED|Treatment Phase||69
8304991|NCT01524133|20475268|P1|STARTED|Treatment Phase||71
8304992|NCT01523964|20475283|P4|NOT COMPLETED|Overall Study||0
8304993|NCT01523964|20475284|P3|NOT COMPLETED|Overall Study||0
8304994|NCT01523964|20475285|P2|NOT COMPLETED|Overall Study||0
8304995|NCT01523964|20475286|P1|NOT COMPLETED|Overall Study||0
8304996|NCT01523964|20475283|P4|COMPLETED|Overall Study||15
8304997|NCT01523964|20475284|P3|COMPLETED|Overall Study||16
8304998|NCT01523964|20475285|P2|COMPLETED|Overall Study||30
8304999|NCT01523964|20475286|P1|COMPLETED|Overall Study||31
8305000|NCT01523964|20475283|P4|STARTED|Overall Study||15
8305001|NCT01523964|20475284|P3|STARTED|Overall Study||16
8305002|NCT01523964|20475285|P2|STARTED|Overall Study||30
8305003|NCT01523964|20475286|P1|STARTED|Overall Study||31
8305004|NCT01523899|20475298|P2|NOT COMPLETED|Overall Study||0
8305005|NCT01523899|20475299|P1|NOT COMPLETED|Overall Study||0
8305006|NCT01523899|20475298|P2|COMPLETED|Overall Study||126
8305007|NCT01523899|20475299|P1|COMPLETED|Overall Study||126
8305008|NCT01523899|20475298|P2|STARTED|Overall Study||126
8305009|NCT01523899|20475299|P1|STARTED|Overall Study||126
8305010|NCT01523886|20475311|P2|NOT COMPLETED|Overall Study||1
8305011|NCT01523886|20475312|P1|NOT COMPLETED|Overall Study||0
8305012|NCT01523886|20475311|P2|COMPLETED|Overall Study||23
8305013|NCT01523886|20475312|P1|COMPLETED|Overall Study||25
8305014|NCT01523886|20475311|P2|STARTED|Overall Study||24
8305015|NCT01523886|20475312|P1|STARTED|Overall Study||25
8305016|NCT01523873|20475318|P1|NOT COMPLETED|Overall Study||422
8305017|NCT01523873|20475318|P1|COMPLETED|Overall Study||35499
8305018|NCT01523873|20475318|P1|Administered With Dotarem|Overall Study||35474
8305019|NCT01523873|20475318|P1|STARTED|Overall Study||35921
8305020|NCT01523834|20475325|P1|NOT COMPLETED|Overall Study||31
8305021|NCT01523834|20475325|P1|COMPLETED|Overall Study||4
8305022|NCT01523834|20475325|P1|Maintenance Phase|Overall Study|Started Maintenance Phase|6
8305023|NCT01523834|20475325|P1|Consolidation Phase|Overall Study|Started Consolidation Phase|7
8305024|NCT01523834|20475325|P1|STARTED|Overall Study|Started Induction Phase|35
8305025|NCT01523821|20475336|P3|NOT COMPLETED|Overall Study||0
8305026|NCT01523821|20475337|P2|NOT COMPLETED|Overall Study||0
8305027|NCT01523821|20475338|P1|NOT COMPLETED|Overall Study||0
8305028|NCT01523821|20475336|P3|COMPLETED|Overall Study||6
8305029|NCT01523821|20475337|P2|COMPLETED|Overall Study||6
8305030|NCT01523821|20475338|P1|COMPLETED|Overall Study||8
8305031|NCT01523821|20475336|P3|STARTED|Overall Study||6
8305032|NCT01523821|20475337|P2|STARTED|Overall Study||6
8305033|NCT01523821|20475338|P1|STARTED|Overall Study||8
8305034|NCT01523782|20475364|P3|NOT COMPLETED|Overall Study||5
8305035|NCT01523782|20475365|P2|NOT COMPLETED|Overall Study||0
8305036|NCT01523782|20475366|P1|NOT COMPLETED|Overall Study||1
8305037|NCT01523782|20475364|P3|COMPLETED|Overall Study||9
8305038|NCT01523782|20475365|P2|COMPLETED|Overall Study||13
8305039|NCT01523782|20475366|P1|COMPLETED|Overall Study||2
8305040|NCT01523782|20475364|P3|STARTED|Overall Study||14
8305041|NCT01523782|20475365|P2|STARTED|Overall Study||13
8305042|NCT01523782|20475366|P1|STARTED|Overall Study||3
8305043|NCT01523756|20475413|P2|NOT COMPLETED|Test Period 2||1
8305044|NCT01523756|20475414|P1|NOT COMPLETED|Test Period 2||0
8305045|NCT01523756|20475413|P2|COMPLETED|Test Period 2||7
8305046|NCT01523756|20475414|P1|COMPLETED|Test Period 2||10
8305047|NCT01523756|20475413|P2|STARTED|Test Period 2||8
8305048|NCT01523756|20475414|P1|STARTED|Test Period 2||10
8305049|NCT01523756|20475413|P2|NOT COMPLETED|Test Period 1||0
8305050|NCT01523756|20475414|P1|NOT COMPLETED|Test Period 1||1
8305051|NCT01523756|20475413|P2|COMPLETED|Test Period 1||8
8305052|NCT01523756|20475414|P1|COMPLETED|Test Period 1||10
8305053|NCT01523756|20475413|P2|STARTED|Test Period 1||8
8305054|NCT01523756|20475414|P1|STARTED|Test Period 1||11
8305055|NCT01523756|20475413|P2|NOT COMPLETED|Baseline Period||1
8305056|NCT01523756|20475414|P1|NOT COMPLETED|Baseline Period||0
8305057|NCT01523756|20475413|P2|COMPLETED|Baseline Period||8
8305058|NCT01523756|20475414|P1|COMPLETED|Baseline Period||11
8305059|NCT01523756|20475413|P2|STARTED|Baseline Period||9
8305060|NCT01523756|20475414|P1|STARTED|Baseline Period||11
8305061|NCT01523743|20475422|P2|NOT COMPLETED|Period 2||2
8305062|NCT01523743|20475423|P1|NOT COMPLETED|Period 2||1
8305063|NCT01523743|20475422|P2|COMPLETED|Period 2||58
8305064|NCT01523743|20475423|P1|COMPLETED|Period 2||52
8305065|NCT01523743|20475422|P2|STARTED|Period 2||60
8305066|NCT01523743|20475423|P1|STARTED|Period 2||53
8305067|NCT01523743|20475422|P2|NOT COMPLETED|Period 1||2
8305068|NCT01523743|20475423|P1|NOT COMPLETED|Period 1||10
8305069|NCT01523743|20475422|P2|COMPLETED|Period 1||60
8305070|NCT01523743|20475423|P1|COMPLETED|Period 1||53
8305071|NCT01523743|20475422|P2|STARTED|Period 1||62
8305072|NCT01523743|20475423|P1|STARTED|Period 1||63
8305073|NCT01523704|20475431|P2|NOT COMPLETED|Overall Study||88
8305074|NCT01523704|20475432|P1|NOT COMPLETED|Overall Study||78
8305075|NCT01523704|20475431|P2|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|550
8305076|NCT01523704|20475432|P1|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|558
8305077|NCT01523704|20475431|P2|STARTED|Overall Study|January 2012|638
8305078|NCT01523704|20475432|P1|STARTED|Overall Study|January 2012|636
8305079|NCT01523613|20475445|P3|NOT COMPLETED|Overall Study||12
8305080|NCT01523613|20475446|P2|NOT COMPLETED|Overall Study||5
8305081|NCT01523613|20475447|P1|NOT COMPLETED|Overall Study||7
8305082|NCT01523613|20475445|P3|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
8305083|NCT01523613|20475446|P2|COMPLETED|Overall Study|- 25 single restorations (25F)|25
8305084|NCT01523613|20475447|P1|COMPLETED|Overall Study|- 23 single restorations (23R)|23
8305085|NCT01523613|20475445|P3|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
8305086|NCT01523613|20475446|P2|STARTED|Overall Study|- 30 single restorations (30 F)|30
8305087|NCT01523613|20475447|P1|STARTED|Overall Study|- 30 single restorations (30 R)|30
8305088|NCT01523587|20475459|P2|NOT COMPLETED|Overall Study||397
8305089|NCT01523587|20475460|P1|NOT COMPLETED|Overall Study||398
8305090|NCT01523587|20475459|P2|COMPLETED|Overall Study||0
8305091|NCT01523587|20475460|P1|COMPLETED|Overall Study||0
8305092|NCT01523587|20475459|P2|Treated|Overall Study||395
8305093|NCT01523587|20475460|P1|Treated|Overall Study||392
8305094|NCT01523587|20475459|P2|STARTED|Overall Study||397
8305095|NCT01523587|20475460|P1|STARTED|Overall Study||398
8305096|NCT01523496|20475484|P4|NOT COMPLETED|Overall Study||3
8305097|NCT01523496|20475485|P3|NOT COMPLETED|Overall Study||12
8305098|NCT01523496|20475486|P2|NOT COMPLETED|Overall Study||4
8305099|NCT01523496|20475487|P1|NOT COMPLETED|Overall Study||10
8305100|NCT01523496|20475484|P4|COMPLETED|Overall Study||27
8305101|NCT01523496|20475485|P3|COMPLETED|Overall Study||46
8305102|NCT01523496|20475486|P2|COMPLETED|Overall Study||32
8305103|NCT01523496|20475487|P1|COMPLETED|Overall Study||56
8305104|NCT01523496|20475484|P4|STARTED|Overall Study||30
8305105|NCT01523496|20475485|P3|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
8305106|NCT01523496|20475486|P2|STARTED|Overall Study||36
8305107|NCT01523496|20475487|P1|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
8305108|NCT01523457|20475503|P2|NOT COMPLETED|Overall Study||2
8305109|NCT01523457|20475504|P1|NOT COMPLETED|Overall Study||7
8305110|NCT01523457|20475503|P2|COMPLETED|Overall Study||29
8305111|NCT01523457|20475504|P1|COMPLETED|Overall Study||37
8305112|NCT01523457|20475503|P2|STARTED|Overall Study||31
8305113|NCT01523457|20475504|P1|STARTED|Overall Study||44
8305114|NCT01523392|20475522|P2|NOT COMPLETED|Treatment Period 2||0
8305115|NCT01523392|20475523|P1|NOT COMPLETED|Treatment Period 2||0
8305116|NCT01523392|20475522|P2|COMPLETED|Treatment Period 2||14
8305117|NCT01523392|20475523|P1|COMPLETED|Treatment Period 2||17
8305118|NCT01523392|20475522|P2|STARTED|Treatment Period 2||14
8305119|NCT01523392|20475523|P1|STARTED|Treatment Period 2||17
8305120|NCT01523392|20475522|P2|NOT COMPLETED|Washout Period - 10 to 14 Days||0
8305121|NCT01523392|20475523|P1|NOT COMPLETED|Washout Period - 10 to 14 Days||1
8305122|NCT01523392|20475522|P2|COMPLETED|Washout Period - 10 to 14 Days||14
8305123|NCT01523392|20475523|P1|COMPLETED|Washout Period - 10 to 14 Days||17
8305124|NCT01523392|20475522|P2|STARTED|Washout Period - 10 to 14 Days||14
8305125|NCT01523392|20475523|P1|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
8305126|NCT01523392|20475522|P2|NOT COMPLETED|Treatment Period 1||0
8305127|NCT01523392|20475523|P1|NOT COMPLETED|Treatment Period 1||3
8305128|NCT01523392|20475522|P2|COMPLETED|Treatment Period 1||14
8305129|NCT01523392|20475523|P1|COMPLETED|Treatment Period 1||17
8305130|NCT01523392|20475522|P2|STARTED|Treatment Period 1||14
8305131|NCT01523392|20475523|P1|STARTED|Treatment Period 1||20
8305132|NCT01523366|20475539|P2|NOT COMPLETED|Treatment Period 2||0
8305133|NCT01523366|20475540|P1|NOT COMPLETED|Treatment Period 2||1
8305134|NCT01523366|20475539|P2|COMPLETED|Treatment Period 2||20
8305135|NCT01523366|20475540|P1|COMPLETED|Treatment Period 2||18
8305136|NCT01523366|20475539|P2|STARTED|Treatment Period 2||20
8305137|NCT01523366|20475540|P1|STARTED|Treatment Period 2||19
8305138|NCT01523366|20475539|P2|NOT COMPLETED|Washout Period - 10-14 Days||0
8305139|NCT01523366|20475540|P1|NOT COMPLETED|Washout Period - 10-14 Days||0
8305140|NCT01523366|20475539|P2|COMPLETED|Washout Period - 10-14 Days||20
8305141|NCT01523366|20475540|P1|COMPLETED|Washout Period - 10-14 Days||19
8305142|NCT01523366|20475539|P2|STARTED|Washout Period - 10-14 Days||20
8305143|NCT01523366|20475540|P1|STARTED|Washout Period - 10-14 Days||19
8305144|NCT01523366|20475539|P2|NOT COMPLETED|Treatment Period 1||0
8305145|NCT01523366|20475540|P1|NOT COMPLETED|Treatment Period 1||1
8305146|NCT01523366|20475539|P2|COMPLETED|Treatment Period 1||20
8305147|NCT01523366|20475540|P1|COMPLETED|Treatment Period 1||19
8305148|NCT01523366|20475539|P2|STARTED|Treatment Period 1||20
8305149|NCT01523366|20475540|P1|STARTED|Treatment Period 1||20
8305150|NCT01523301|20475556|P2|NOT COMPLETED|Overall Study||32
8305151|NCT01523301|20475557|P1|NOT COMPLETED|Overall Study||35
8305152|NCT01523301|20475556|P2|COMPLETED|Overall Study||164
8305153|NCT01523301|20475557|P1|COMPLETED|Overall Study||149
8305154|NCT01523301|20475556|P2|STARTED|Overall Study||196
8305155|NCT01523301|20475557|P1|STARTED|Overall Study||184
8305156|NCT01523275|20475577|P2|NOT COMPLETED|Overall Study||2
8305157|NCT01523275|20475578|P1|NOT COMPLETED|Overall Study||2
8305158|NCT01523275|20475577|P2|COMPLETED|Overall Study||7
8305159|NCT01523275|20475578|P1|COMPLETED|Overall Study||4
8305160|NCT01523275|20475577|P2|STARTED|Overall Study||9
8305161|NCT01523275|20475578|P1|STARTED|Overall Study||6
8305171|NCT01522963|20475620|P4|NOT COMPLETED|Overall Study||6
8305172|NCT01522963|20475621|P3|NOT COMPLETED|Overall Study||3
8305173|NCT01522963|20475622|P2|NOT COMPLETED|Overall Study||3
8305174|NCT01522963|20475623|P1|NOT COMPLETED|Overall Study||2
8305175|NCT01522963|20475620|P4|COMPLETED|Overall Study||18
8305176|NCT01522963|20475621|P3|COMPLETED|Overall Study||22
8305177|NCT01522963|20475622|P2|COMPLETED|Overall Study||22
8305178|NCT01522963|20475623|P1|COMPLETED|Overall Study||22
8305179|NCT01522963|20475620|P4|STARTED|Overall Study||24
8305180|NCT01522963|20475621|P3|STARTED|Overall Study||25
8305181|NCT01522963|20475622|P2|STARTED|Overall Study||25
8305182|NCT01522963|20475623|P1|STARTED|Overall Study||24
8305183|NCT01522950|20475638|P3|NOT COMPLETED|Overall Study||5
8305184|NCT01522950|20475639|P2|NOT COMPLETED|Overall Study||5
8305185|NCT01522950|20475640|P1|NOT COMPLETED|Overall Study||6
8305186|NCT01522950|20475638|P3|COMPLETED|Overall Study||22
8305187|NCT01522950|20475639|P2|COMPLETED|Overall Study||18
8305188|NCT01522950|20475640|P1|COMPLETED|Overall Study||20
8305189|NCT01522950|20475638|P3|STARTED|Overall Study||27
8305190|NCT01522950|20475639|P2|STARTED|Overall Study||23
8305191|NCT01522950|20475640|P1|STARTED|Overall Study||26
8305192|NCT01522937|20475657|P1|NOT COMPLETED|Overall Study||0
8305193|NCT01522937|20475657|P1|COMPLETED|Overall Study||146
8305194|NCT01522937|20475657|P1|STARTED|Overall Study||146
8305195|NCT01522924|20475667|P2|NOT COMPLETED|Overall Study||0
8305196|NCT01522924|20475668|P1|NOT COMPLETED|Overall Study||0
8305197|NCT01522924|20475667|P2|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
8305198|NCT01522924|20475668|P1|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
8305199|NCT01522924|20475667|P2|STARTED|Overall Study|There were 52 dental students in the control group.|52
8305200|NCT01522924|20475668|P1|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
8305201|NCT01522755|20475686|P1|NOT COMPLETED|Overall Study||0
8305202|NCT01522755|20475686|P1|COMPLETED|Overall Study||409
8305203|NCT01522755|20475686|P1|STARTED|Overall Study||409
8305204|NCT01522703|20475696|P2|NOT COMPLETED|Overall Study||6
8305205|NCT01522703|20475697|P1|NOT COMPLETED|Overall Study||5
8305206|NCT01522703|20475696|P2|COMPLETED|Overall Study||20
8305207|NCT01522703|20475697|P1|COMPLETED|Overall Study||20
8305208|NCT01522703|20475696|P2|STARTED|Overall Study||26
8305209|NCT01522703|20475697|P1|STARTED|Overall Study||25
8305210|NCT01522651|20475708|P5|NOT COMPLETED|Overall Study||6
8305211|NCT01522651|20475709|P4|NOT COMPLETED|Overall Study||8
8305212|NCT01522651|20475710|P3|NOT COMPLETED|Overall Study||4
8305213|NCT01522651|20475711|P2|NOT COMPLETED|Overall Study||8
8305214|NCT01522651|20475712|P1|NOT COMPLETED|Overall Study||9
8305215|NCT01522651|20475708|P5|COMPLETED|Overall Study||21
8305216|NCT01522651|20475709|P4|COMPLETED|Overall Study||20
8305217|NCT01522651|20475710|P3|COMPLETED|Overall Study||22
8305218|NCT01522651|20475711|P2|COMPLETED|Overall Study||19
8305219|NCT01522651|20475712|P1|COMPLETED|Overall Study||17
8305220|NCT01522651|20475708|P5|STARTED|Overall Study||27
8305221|NCT01522651|20475709|P4|STARTED|Overall Study||28
8305222|NCT01522651|20475710|P3|STARTED|Overall Study||26
8305223|NCT01522651|20475711|P2|STARTED|Overall Study||27
8305224|NCT01522651|20475712|P1|STARTED|Overall Study||26
8305225|NCT01522456|20475739|P1|NOT COMPLETED|Overall Study||8
8305226|NCT01522456|20475739|P1|COMPLETED|Overall Study||65
8305227|NCT01522456|20475739|P1|STARTED|Overall Study||73
8305228|NCT01522443|20475802|P2|NOT COMPLETED|Overall Study||55
8305229|NCT01522443|20475803|P1|NOT COMPLETED|Overall Study||53
8305230|NCT01522443|20475802|P2|COMPLETED|Overall Study||3
8305231|NCT01522443|20475803|P1|COMPLETED|Overall Study||8
8305232|NCT01522443|20475802|P2|STARTED|Overall Study||58
8305233|NCT01522443|20475803|P1|STARTED|Overall Study||61
8305234|NCT01522404|20475815|P2|NOT COMPLETED|Second Intervention (up to Week 58)||0
8305235|NCT01522404|20475816|P1|NOT COMPLETED|Second Intervention (up to Week 58)||1
8305236|NCT01522404|20475815|P2|COMPLETED|Second Intervention (up to Week 58)||19
8305237|NCT01522404|20475816|P1|COMPLETED|Second Intervention (up to Week 58)||17
8305238|NCT01522404|20475815|P2|STARTED|Second Intervention (up to Week 58)||19
8305239|NCT01522404|20475816|P1|STARTED|Second Intervention (up to Week 58)||18
8305240|NCT01522404|20475815|P2|NOT COMPLETED|First Intervention (up to Week 29)||0
8305241|NCT01522404|20475816|P1|NOT COMPLETED|First Intervention (up to Week 29)||2
8305242|NCT01522404|20475815|P2|COMPLETED|First Intervention (up to Week 29)||19
8305243|NCT01522404|20475816|P1|COMPLETED|First Intervention (up to Week 29)||18
8305244|NCT01522404|20475815|P2|STARTED|First Intervention (up to Week 29)||19
8305245|NCT01522404|20475816|P1|STARTED|First Intervention (up to Week 29)||20
8305246|NCT01522391|20475834|P2|NOT COMPLETED|Overall Study||1
8305247|NCT01522391|20475835|P1|NOT COMPLETED|Overall Study||1
8305248|NCT01522391|20475834|P2|COMPLETED|Overall Study||20
8305249|NCT01522391|20475835|P1|COMPLETED|Overall Study||19
8305250|NCT01522391|20475834|P2|STARTED|Overall Study||21
8305251|NCT01522391|20475835|P1|STARTED|Overall Study||20
8305252|NCT01522339|20475895|P1|NOT COMPLETED|Overall Study||0
8305253|NCT01522339|20475895|P1|COMPLETED|Overall Study||15
8305254|NCT01522339|20475895|P1|STARTED|Overall Study||15
8305255|NCT01522248|20475902|P2|NOT COMPLETED|Overall Study||0
8305256|NCT01522248|20475903|P1|NOT COMPLETED|Overall Study||1
8305257|NCT01522248|20475902|P2|COMPLETED|Overall Study||10
8305258|NCT01522248|20475903|P1|COMPLETED|Overall Study||9
8305259|NCT01522248|20475902|P2|STARTED|Overall Study||10
8305260|NCT01522248|20475903|P1|STARTED|Overall Study||10
8305261|NCT01522235|20475918|P2|NOT COMPLETED|Overall Study||1
8305262|NCT01522235|20475919|P1|NOT COMPLETED|Overall Study||1
8305263|NCT01522235|20475918|P2|COMPLETED|Overall Study||2
8305264|NCT01522235|20475919|P1|COMPLETED|Overall Study||2
8305265|NCT01522235|20475918|P2|Randomized|Overall Study||3
8305266|NCT01522235|20475919|P1|Randomized|Overall Study||2
8305267|NCT01522235|20475918|P2|STARTED|Overall Study||3
8305268|NCT01522235|20475919|P1|STARTED|Overall Study||3
8305269|NCT01522131|20475937|P2|NOT COMPLETED|Overall Study||0
8305270|NCT01522131|20475938|P1|NOT COMPLETED|Overall Study||2
8305271|NCT01522131|20475937|P2|COMPLETED|Overall Study||17
8305272|NCT01522131|20475938|P1|COMPLETED|Overall Study||14
8305273|NCT01522131|20475937|P2|STARTED|Overall Study||17
8305274|NCT01522131|20475938|P1|STARTED|Overall Study||16
8305275|NCT01521949|20475946|P1|NOT COMPLETED|Overall Study||0
8305276|NCT01521949|20475946|P1|COMPLETED|Overall Study||21
8305277|NCT01521949|20475946|P1|STARTED|Overall Study||21
8305278|NCT01521923|20475955|P4|NOT COMPLETED|Overall Study||13
8305279|NCT01521923|20475956|P3|NOT COMPLETED|Overall Study||15
8305280|NCT01521923|20475957|P2|NOT COMPLETED|Overall Study||9
8305281|NCT01521923|20475958|P1|NOT COMPLETED|Overall Study||7
8305282|NCT01521923|20475955|P4|COMPLETED|Overall Study||70
8305283|NCT01521923|20475956|P3|COMPLETED|Overall Study||112
8305284|NCT01521923|20475957|P2|COMPLETED|Overall Study||72
8305285|NCT01521923|20475958|P1|COMPLETED|Overall Study||59
8305286|NCT01521923|20475955|P4|STARTED|Overall Study||83
8305287|NCT01521923|20475956|P3|STARTED|Overall Study||127
8305288|NCT01521923|20475957|P2|STARTED|Overall Study||81
8305289|NCT01521923|20475958|P1|STARTED|Overall Study||66
8305290|NCT01521897|20476078|P1|NOT COMPLETED|Overall Study||23
8305291|NCT01521897|20476078|P1|COMPLETED|Overall Study||1120
8305292|NCT01521897|20476078|P1|STARTED|Overall Study||1143
8305293|NCT01521884|20476090|P1|NOT COMPLETED|Overall Study||27
8305294|NCT01521884|20476090|P1|COMPLETED|Overall Study||35
8305295|NCT01521884|20476090|P1|STARTED|Overall Study||62
8305296|NCT01521871|20476109|P2|NOT COMPLETED|Overall Study||0
8305297|NCT01521871|20476110|P1|NOT COMPLETED|Overall Study||0
8305298|NCT01521871|20476109|P2|COMPLETED|Overall Study||32
8305299|NCT01521871|20476110|P1|COMPLETED|Overall Study||32
8305300|NCT01521871|20476109|P2|STARTED|Overall Study||32
8305301|NCT01521871|20476110|P1|STARTED|Overall Study||32
8305302|NCT01521845|20476150|P2|NOT COMPLETED|Overall Study||5
8305303|NCT01521845|20476151|P1|NOT COMPLETED|Overall Study||9
8305304|NCT01521845|20476150|P2|COMPLETED|Overall Study||47
8305305|NCT01521845|20476151|P1|COMPLETED|Overall Study||43
8305306|NCT01521845|20476150|P2|STARTED|Overall Study||52
8305307|NCT01521845|20476151|P1|STARTED|Overall Study||52
8305308|NCT01521780|20476161|P3|NOT COMPLETED|Overall Study||0
8305309|NCT01521780|20476162|P2|NOT COMPLETED|Overall Study||0
8305310|NCT01521780|20476163|P1|NOT COMPLETED|Overall Study||0
8305311|NCT01521780|20476161|P3|COMPLETED|Overall Study||2
8305312|NCT01521780|20476162|P2|COMPLETED|Overall Study||1
8305313|NCT01521780|20476163|P1|COMPLETED|Overall Study||9
8305314|NCT01521780|20476161|P3|STARTED|Overall Study||2
8305315|NCT01521780|20476162|P2|STARTED|Overall Study||1
8305316|NCT01521780|20476163|P1|STARTED|Overall Study||9
8305317|NCT01521559|20476187|P2|NOT COMPLETED|Overall Study||18
8305318|NCT01521559|20476188|P1|NOT COMPLETED|Overall Study||15
8305319|NCT01521559|20476187|P2|COMPLETED|Overall Study||73
8305320|NCT01521559|20476188|P1|COMPLETED|Overall Study||77
8305321|NCT01521559|20476187|P2|Completed Week 52|Overall Study||73
8305322|NCT01521559|20476188|P1|Completed Week 52|Overall Study||77
8305323|NCT01521559|20476187|P2|Completed Week 24|Overall Study||85
8305324|NCT01521559|20476188|P1|Completed Week 24|Overall Study||83
8305325|NCT01521559|20476187|P2|STARTED|Overall Study||91
8305326|NCT01521559|20476188|P1|STARTED|Overall Study||92
8305327|NCT01521546|20476202|P2|NOT COMPLETED|Overall Study||0
8305328|NCT01521546|20476203|P1|NOT COMPLETED|Overall Study||2
8305329|NCT01521546|20476202|P2|COMPLETED|Overall Study||20
8305330|NCT01521546|20476203|P1|COMPLETED|Overall Study||20
8305331|NCT01521546|20476202|P2|STARTED|Overall Study||20
8305332|NCT01521546|20476203|P1|STARTED|Overall Study||22
8305333|NCT01521507|20476211|P2|NOT COMPLETED|Stage 2: Observational Design||2
8305334|NCT01521507|20476212|P1|NOT COMPLETED|Stage 2: Observational Design||4
8305335|NCT01521507|20476211|P2|COMPLETED|Stage 2: Observational Design||92
8305336|NCT01521507|20476212|P1|COMPLETED|Stage 2: Observational Design||94
8305337|NCT01521507|20476211|P2|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
8305338|NCT01521507|20476212|P1|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
8305339|NCT01521507|20476211|P2|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
8305340|NCT01521507|20476212|P1|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
8305341|NCT01521507|20476211|P2|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
8305342|NCT01521507|20476212|P1|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
8305343|NCT01521507|20476211|P2|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
8305344|NCT01521507|20476212|P1|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
8305345|NCT01521507|20476211|P2|STARTED|Stage 2: Observational Design||94
8305346|NCT01521507|20476212|P1|STARTED|Stage 2: Observational Design||98
8305347|NCT01521507|20476211|P2|NOT COMPLETED|Stage 1: Randomized Design||5
8305348|NCT01521507|20476212|P1|NOT COMPLETED|Stage 1: Randomized Design||3
8305349|NCT01521507|20476211|P2|COMPLETED|Stage 1: Randomized Design||94
8305350|NCT01521507|20476212|P1|COMPLETED|Stage 1: Randomized Design||98
8305351|NCT01521507|20476211|P2|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
8305352|NCT01521507|20476212|P1|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
8305353|NCT01521507|20476211|P2|STARTED|Stage 1: Randomized Design||99
8305354|NCT01521507|20476212|P1|STARTED|Stage 1: Randomized Design||101
8305355|NCT01521494|20476234|P5|NOT COMPLETED|Overall Study||7
8305356|NCT01521494|20476235|P4|NOT COMPLETED|Overall Study||21
8305357|NCT01521494|20476236|P3|NOT COMPLETED|Overall Study||12
8305358|NCT01521494|20476237|P2|NOT COMPLETED|Overall Study||5
8305359|NCT01521494|20476238|P1|NOT COMPLETED|Overall Study||2
8305360|NCT01521494|20476234|P5|COMPLETED|Overall Study||30
8305361|NCT01521494|20476235|P4|COMPLETED|Overall Study||15
8305362|NCT01521494|20476236|P3|COMPLETED|Overall Study||23
8305363|NCT01521494|20476237|P2|COMPLETED|Overall Study||31
8305364|NCT01521494|20476238|P1|COMPLETED|Overall Study||37
8305365|NCT01521494|20476234|P5|STARTED|Overall Study||37
8305366|NCT01521494|20476235|P4|STARTED|Overall Study||36
8305367|NCT01521494|20476236|P3|STARTED|Overall Study||35
8305368|NCT01521494|20476237|P2|STARTED|Overall Study||36
8305369|NCT01521494|20476238|P1|STARTED|Overall Study||39
8305370|NCT01521364|20476260|P1|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
8305371|NCT01521364|20476260|P1|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
8305372|NCT01521364|20476260|P1|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
8305373|NCT01521364|20476260|P1|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
8305374|NCT01521364|20476260|P1|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
8305375|NCT01521364|20476260|P1|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
8305376|NCT01521364|20476260|P1|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
8305377|NCT01521364|20476260|P1|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
8305378|NCT01521364|20476260|P1|STARTED|Linezolid Without Clarithromycin (1 wk)||7
8305379|NCT01521260|20476273|P2|NOT COMPLETED|Overall Study||0
8305380|NCT01521260|20476274|P1|NOT COMPLETED|Overall Study||0
8305381|NCT01521260|20476273|P2|COMPLETED|Overall Study||15
8305382|NCT01521260|20476274|P1|COMPLETED|Overall Study||15
8305383|NCT01521260|20476273|P2|STARTED|Overall Study||15
8305384|NCT01521260|20476274|P1|STARTED|Overall Study||15
8305385|NCT01521143|20476284|P4|NOT COMPLETED|Overall Study||7
8305386|NCT01521143|20476285|P3|NOT COMPLETED|Overall Study||8
8305387|NCT01521143|20476286|P2|NOT COMPLETED|Overall Study||26
8305388|NCT01521143|20476287|P1|NOT COMPLETED|Overall Study||29
8305389|NCT01521143|20476284|P4|COMPLETED|Overall Study||0
8305390|NCT01521143|20476285|P3|COMPLETED|Overall Study||0
8305391|NCT01521143|20476286|P2|COMPLETED|Overall Study||10
8305392|NCT01521143|20476287|P1|COMPLETED|Overall Study||11
8305393|NCT01521143|20476284|P4|Received Treatment|Overall Study||4
8305394|NCT01521143|20476285|P3|Received Treatment|Overall Study||3
8305395|NCT01521143|20476286|P2|Received Treatment|Overall Study||20
8305396|NCT01521143|20476287|P1|Received Treatment|Overall Study||20
8305397|NCT01521143|20476284|P4|STARTED|Overall Study||7
8305398|NCT01521143|20476285|P3|STARTED|Overall Study||8
8305399|NCT01521143|20476286|P2|STARTED|Overall Study||36
8305400|NCT01521143|20476287|P1|STARTED|Overall Study||40
8305401|NCT01521026|20476319|P2|NOT COMPLETED|Overall Study||3
8305402|NCT01521026|20476320|P1|NOT COMPLETED|Overall Study||15
8305403|NCT01521026|20476319|P2|COMPLETED|Overall Study||28
8305404|NCT01521026|20476320|P1|COMPLETED|Overall Study||23
8305405|NCT01521026|20476319|P2|STARTED|Overall Study||31
8305406|NCT01521026|20476320|P1|STARTED|Overall Study||38
8305407|NCT01520987|20476336|P8|NOT COMPLETED|Overall Study||0
8305408|NCT01520987|20476337|P7|NOT COMPLETED|Overall Study||0
8305409|NCT01520987|20476338|P6|NOT COMPLETED|Overall Study||1
8305410|NCT01520987|20476339|P5|NOT COMPLETED|Overall Study||0
8305411|NCT01520987|20476340|P4|NOT COMPLETED|Overall Study||0
8305412|NCT01520987|20476341|P3|NOT COMPLETED|Overall Study||0
8305413|NCT01520987|20476342|P2|NOT COMPLETED|Overall Study||0
8305414|NCT01520987|20476343|P1|NOT COMPLETED|Overall Study||1
8305415|NCT01520987|20476336|P8|COMPLETED|Overall Study||14
8305416|NCT01520987|20476337|P7|COMPLETED|Overall Study||12
8305417|NCT01520987|20476338|P6|COMPLETED|Overall Study||13
8305418|NCT01520987|20476339|P5|COMPLETED|Overall Study||14
8305419|NCT01520987|20476340|P4|COMPLETED|Overall Study||15
8305420|NCT01520987|20476341|P3|COMPLETED|Overall Study||11
8305421|NCT01520987|20476342|P2|COMPLETED|Overall Study||12
8305422|NCT01520987|20476343|P1|COMPLETED|Overall Study||12
8305423|NCT01520987|20476336|P8|Dosed|Overall Study||14
8305424|NCT01520987|20476337|P7|Dosed|Overall Study||12
8305425|NCT01520987|20476338|P6|Dosed|Overall Study||14
8305426|NCT01520987|20476339|P5|Dosed|Overall Study||14
8305427|NCT01520987|20476340|P4|Dosed|Overall Study||15
8305428|NCT01520987|20476341|P3|Dosed|Overall Study||11
8305429|NCT01520987|20476342|P2|Dosed|Overall Study||12
8305430|NCT01520987|20476343|P1|Dosed|Overall Study||13
8305431|NCT01520987|20476336|P8|STARTED|Overall Study||14
8305432|NCT01520987|20476337|P7|STARTED|Overall Study||12
8305433|NCT01520987|20476338|P6|STARTED|Overall Study||14
8305434|NCT01520987|20476339|P5|STARTED|Overall Study||14
8305435|NCT01520987|20476340|P4|STARTED|Overall Study||15
8305436|NCT01520987|20476341|P3|STARTED|Overall Study||11
8305437|NCT01520987|20476342|P2|STARTED|Overall Study||12
8305438|NCT01520987|20476343|P1|STARTED|Overall Study||13
8305439|NCT01520922|20476403|P2|NOT COMPLETED|Survival Follow-up||0
8305440|NCT01520922|20476404|P1|NOT COMPLETED|Survival Follow-up||1
8305441|NCT01520922|20476403|P2|COMPLETED|Survival Follow-up||40
8305442|NCT01520922|20476404|P1|COMPLETED|Survival Follow-up||20
8305443|NCT01520922|20476403|P2|STARTED|Survival Follow-up||40
8305444|NCT01520922|20476404|P1|STARTED|Survival Follow-up||21
8305445|NCT01520922|20476403|P2|NOT COMPLETED|Follow up||1
8305446|NCT01520922|20476404|P1|NOT COMPLETED|Follow up||0
8305447|NCT01520922|20476403|P2|COMPLETED|Follow up||44
8305448|NCT01520922|20476404|P1|COMPLETED|Follow up||44
8305449|NCT01520922|20476403|P2|STARTED|Follow up||45
8305450|NCT01520922|20476404|P1|STARTED|Follow up||44
8305451|NCT01520922|20476403|P2|NOT COMPLETED|Treatment Phase||8
8305452|NCT01520922|20476404|P1|NOT COMPLETED|Treatment Phase||5
8305453|NCT01520922|20476403|P2|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
8305454|NCT01520922|20476404|P1|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
8305455|NCT01520922|20476403|P2|STARTED|Treatment Phase||53
8305456|NCT01520922|20476404|P1|STARTED|Treatment Phase||44
8305457|NCT01520909|20476466|P3|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
8305458|NCT01520909|20476467|P2|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
8305459|NCT01520909|20476468|P1|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
8305460|NCT01520909|20476466|P3|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
8305461|NCT01520909|20476467|P2|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
8305462|NCT01520909|20476468|P1|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
8305463|NCT01520909|20476466|P3|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
8305464|NCT01520909|20476467|P2|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
8305465|NCT01520909|20476468|P1|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
8305466|NCT01520909|20476466|P3|NOT COMPLETED|Part 1 (Randomized Period)||0
8305467|NCT01520909|20476467|P2|NOT COMPLETED|Part 1 (Randomized Period)||2
8305468|NCT01520909|20476468|P1|NOT COMPLETED|Part 1 (Randomized Period)||1
8305469|NCT01520909|20476466|P3|COMPLETED|Part 1 (Randomized Period)||0
8305470|NCT01520909|20476467|P2|COMPLETED|Part 1 (Randomized Period)||61
8305471|NCT01520909|20476468|P1|COMPLETED|Part 1 (Randomized Period)||28
8305472|NCT01520909|20476466|P3|STARTED|Part 1 (Randomized Period)||0
8305473|NCT01520909|20476467|P2|STARTED|Part 1 (Randomized Period)||63
8305474|NCT01520909|20476468|P1|STARTED|Part 1 (Randomized Period)||29
8305475|NCT01520727|20476539|P9|NOT COMPLETED|Overall Study||0
8305476|NCT01520727|20476540|P8|NOT COMPLETED|Overall Study||0
8305477|NCT01520727|20476541|P7|NOT COMPLETED|Overall Study||0
8305478|NCT01520727|20476542|P6|NOT COMPLETED|Overall Study||0
8305479|NCT01520727|20476543|P5|NOT COMPLETED|Overall Study||0
8305480|NCT01520727|20476544|P4|NOT COMPLETED|Overall Study||0
8305481|NCT01520727|20476545|P3|NOT COMPLETED|Overall Study||0
8305482|NCT01520727|20476546|P2|NOT COMPLETED|Overall Study||0
8305483|NCT01520727|20476547|P1|NOT COMPLETED|Overall Study||0
8305484|NCT01520727|20476539|P9|COMPLETED|Overall Study||16
8305485|NCT01520727|20476540|P8|COMPLETED|Overall Study||6
8305486|NCT01520727|20476541|P7|COMPLETED|Overall Study||6
8305487|NCT01520727|20476542|P6|COMPLETED|Overall Study||6
8305488|NCT01520727|20476543|P5|COMPLETED|Overall Study||6
8305489|NCT01520727|20476544|P4|COMPLETED|Overall Study||6
8305490|NCT01520727|20476545|P3|COMPLETED|Overall Study||6
8305491|NCT01520727|20476546|P2|COMPLETED|Overall Study||6
8305492|NCT01520727|20476547|P1|COMPLETED|Overall Study||6
8305493|NCT01520727|20476539|P9|STARTED|Overall Study||16
8305494|NCT01520727|20476540|P8|STARTED|Overall Study||6
8305495|NCT01520727|20476541|P7|STARTED|Overall Study||6
8305496|NCT01520727|20476542|P6|STARTED|Overall Study||6
8305497|NCT01520727|20476543|P5|STARTED|Overall Study||6
8305498|NCT01520727|20476544|P4|STARTED|Overall Study||6
8305499|NCT01520727|20476545|P3|STARTED|Overall Study||6
8305500|NCT01520727|20476546|P2|STARTED|Overall Study||6
8305501|NCT01520727|20476547|P1|STARTED|Overall Study||6
8305502|NCT01520714|20476585|P2|NOT COMPLETED|Overall Study||6
8305503|NCT01520714|20476586|P1|NOT COMPLETED|Overall Study||0
8305504|NCT01520714|20476585|P2|COMPLETED|Overall Study||5
8305505|NCT01520714|20476586|P1|COMPLETED|Overall Study||0
8305506|NCT01520714|20476585|P2|STARTED|Overall Study||11
8305507|NCT01520714|20476586|P1|STARTED|Overall Study||0
8305508|NCT01520688|20476592|P7|NOT COMPLETED|Overall Study||5
8305509|NCT01520688|20476593|P6|NOT COMPLETED|Overall Study||0
8305510|NCT01520688|20476594|P5|NOT COMPLETED|Overall Study||1
8305511|NCT01520688|20476595|P4|NOT COMPLETED|Overall Study||1
8305512|NCT01520688|20476596|P3|NOT COMPLETED|Overall Study||0
8305513|NCT01520688|20476597|P2|NOT COMPLETED|Overall Study||2
8305514|NCT01520688|20476598|P1|NOT COMPLETED|Overall Study||0
8305515|NCT01520688|20476592|P7|COMPLETED|Overall Study||0
8305516|NCT01520688|20476593|P6|COMPLETED|Overall Study||5
8305517|NCT01520688|20476594|P5|COMPLETED|Overall Study||4
8305518|NCT01520688|20476595|P4|COMPLETED|Overall Study||4
8305519|NCT01520688|20476596|P3|COMPLETED|Overall Study||4
8305520|NCT01520688|20476597|P2|COMPLETED|Overall Study||2
8305521|NCT01520688|20476598|P1|COMPLETED|Overall Study||4
8305522|NCT01520688|20476592|P7|STARTED|Overall Study||5
8305523|NCT01520688|20476593|P6|STARTED|Overall Study||5
8305524|NCT01520688|20476594|P5|STARTED|Overall Study||5
8305525|NCT01520688|20476595|P4|STARTED|Overall Study||5
8305526|NCT01520688|20476596|P3|STARTED|Overall Study||4
8305527|NCT01520688|20476597|P2|STARTED|Overall Study||4
8305528|NCT01520688|20476598|P1|STARTED|Overall Study||4
8305529|NCT01520558|20476610|P3|NOT COMPLETED|Overall Study||3
8305530|NCT01520558|20476611|P2|NOT COMPLETED|Overall Study||2
8305531|NCT01520558|20476612|P1|NOT COMPLETED|Overall Study||2
8305532|NCT01520558|20476610|P3|COMPLETED|Overall Study||3
8305533|NCT01520558|20476611|P2|COMPLETED|Overall Study||1
8305534|NCT01520558|20476612|P1|COMPLETED|Overall Study||1
8305535|NCT01520558|20476610|P3|STARTED|Overall Study||6
8305536|NCT01520558|20476611|P2|STARTED|Overall Study||3
8305537|NCT01520558|20476612|P1|STARTED|Overall Study||3
8305538|NCT01520532|20476620|P1|NOT COMPLETED|Overall Study||0
8305539|NCT01520532|20476620|P1|COMPLETED|Overall Study||60
8305540|NCT01520532|20476620|P1|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
8305541|NCT01520519|20476626|P1|NOT COMPLETED|Overall Study||0
8305542|NCT01520519|20476626|P1|COMPLETED|Overall Study||40
8305543|NCT01520519|20476626|P1|STARTED|Overall Study||40
8305544|NCT01520506|20476631|P1|NOT COMPLETED|Overall Study||6
8305545|NCT01520506|20476631|P1|COMPLETED|Overall Study||44
8305546|NCT01520506|20476631|P1|STARTED|Overall Study||50
8305547|NCT01520454|20476641|P4|NOT COMPLETED|Overall Study||0
8305548|NCT01520454|20476642|P3|NOT COMPLETED|Overall Study||0
8305549|NCT01520454|20476643|P2|NOT COMPLETED|Overall Study||0
8305550|NCT01520454|20476644|P1|NOT COMPLETED|Overall Study||0
8305551|NCT01520454|20476641|P4|COMPLETED|Overall Study||6
8305552|NCT01520454|20476642|P3|COMPLETED|Overall Study||5
8305553|NCT01520454|20476643|P2|COMPLETED|Overall Study||6
8305554|NCT01520454|20476644|P1|COMPLETED|Overall Study||9
8305555|NCT01520454|20476641|P4|STARTED|Overall Study||6
8305556|NCT01520454|20476642|P3|STARTED|Overall Study||5
8305557|NCT01520454|20476643|P2|STARTED|Overall Study||6
8305558|NCT01520454|20476644|P1|STARTED|Overall Study||9
8305559|NCT01520402|20476686|P1|NOT COMPLETED|Overall Study||5
8305560|NCT01520402|20476686|P1|COMPLETED|Overall Study||30
8305561|NCT01520402|20476686|P1|STARTED|Overall Study||35
8305562|NCT01520363|20476699|P2|NOT COMPLETED|Overall Study||0
8305563|NCT01520363|20476700|P1|NOT COMPLETED|Overall Study||2
8305564|NCT01520363|20476699|P2|COMPLETED|Overall Study||26
8305565|NCT01520363|20476700|P1|COMPLETED|Overall Study||24
8305566|NCT01520363|20476699|P2|STARTED|Overall Study||26
8305567|NCT01520363|20476700|P1|STARTED|Overall Study||26
8305568|NCT01520324|20476774|P1|NOT COMPLETED|Overall Study||1
8305569|NCT01520324|20476774|P1|COMPLETED|Overall Study||52
8305570|NCT01520324|20476774|P1|STARTED|Overall Study||53
8305571|NCT01520207|20476787|P2|NOT COMPLETED|Overall Study||0
8305572|NCT01520207|20476788|P1|NOT COMPLETED|Overall Study||2
8305573|NCT01520207|20476787|P2|COMPLETED|Overall Study||25
8305574|NCT01520207|20476788|P1|COMPLETED|Overall Study||25
8305575|NCT01520207|20476787|P2|STARTED|Overall Study||25
8305576|NCT01520207|20476788|P1|STARTED|Overall Study||27
8305577|NCT01520038|20476794|P1|NOT COMPLETED|Overall Study||1
8305578|NCT01520038|20476794|P1|COMPLETED|Overall Study||1
8305579|NCT01520038|20476794|P1|STARTED|Overall Study||2
8305598|NCT01519947|20476915|P4|NOT COMPLETED|Overall Study||8
8305599|NCT01519947|20476916|P3|NOT COMPLETED|Overall Study||7
8305600|NCT01519947|20476917|P2|NOT COMPLETED|Overall Study||4
8305601|NCT01519947|20476918|P1|NOT COMPLETED|Overall Study||2
8305602|NCT01519947|20476915|P4|COMPLETED|Overall Study||34
8305603|NCT01519947|20476916|P3|COMPLETED|Overall Study||8
8305604|NCT01519947|20476917|P2|COMPLETED|Overall Study||7
8305605|NCT01519947|20476918|P1|COMPLETED|Overall Study||17
8305606|NCT01519947|20476915|P4|STARTED|Overall Study||42
8305607|NCT01519947|20476916|P3|STARTED|Overall Study||15
8305608|NCT01519947|20476917|P2|STARTED|Overall Study||11
8305609|NCT01519947|20476918|P1|STARTED|Overall Study||19
8305610|NCT01519934|20476948|P1|NOT COMPLETED|Overall Study||3
8305611|NCT01519934|20476948|P1|COMPLETED|Overall Study||45
8305612|NCT01519934|20476948|P1|STARTED|Overall Study||48
8305613|NCT01519921|20476957|P2|NOT COMPLETED|Overall Study||15
8305614|NCT01519921|20476958|P1|NOT COMPLETED|Overall Study||21
8305615|NCT01519921|20476957|P2|COMPLETED|Overall Study||49
8305616|NCT01519921|20476958|P1|COMPLETED|Overall Study||65
8305617|NCT01519921|20476957|P2|STARTED|Overall Study||64
8305618|NCT01519921|20476958|P1|STARTED|Overall Study||86
8305619|NCT01519882|20476982|P2|NOT COMPLETED|Overall Study||0
8305620|NCT01519882|20476983|P1|NOT COMPLETED|Overall Study||0
8305621|NCT01519882|20476982|P2|COMPLETED|Overall Study||0
8305622|NCT01519882|20476983|P1|COMPLETED|Overall Study||1
8305623|NCT01519882|20476982|P2|STARTED|Overall Study||0
8305624|NCT01519882|20476983|P1|STARTED|Overall Study||1
8305625|NCT01519869|20477007|P1|NOT COMPLETED|Overall Study||1
8305626|NCT01519869|20477007|P1|COMPLETED|Overall Study||27
8305627|NCT01519869|20477007|P1|STARTED|Overall Study||28
8305628|NCT01519817|20477011|P4|NOT COMPLETED|Overall Study||1
8305629|NCT01519817|20477012|P3|NOT COMPLETED|Overall Study||0
8305630|NCT01519817|20477013|P2|NOT COMPLETED|Overall Study||0
8305631|NCT01519817|20477014|P1|NOT COMPLETED|Overall Study||1
8305632|NCT01519817|20477011|P4|COMPLETED|Overall Study||10
8305633|NCT01519817|20477012|P3|COMPLETED|Overall Study||16
8305634|NCT01519817|20477013|P2|COMPLETED|Overall Study||3
8305635|NCT01519817|20477014|P1|COMPLETED|Overall Study||3
8305636|NCT01519817|20477011|P4|STARTED|Overall Study||11
8305637|NCT01519817|20477012|P3|STARTED|Overall Study||16
8305638|NCT01519817|20477013|P2|STARTED|Overall Study||3
8305639|NCT01519817|20477014|P1|STARTED|Overall Study||4
8305640|NCT01519791|20477054|P2|NOT COMPLETED|Overall Study||368
8305641|NCT01519791|20477055|P1|NOT COMPLETED|Overall Study||152
8305642|NCT01519791|20477054|P2|COMPLETED|Overall Study||292
8305643|NCT01519791|20477055|P1|COMPLETED|Overall Study||67
8305644|NCT01519791|20477054|P2|Completed Week 52|Overall Study||500
8305645|NCT01519791|20477055|P1|Completed Week 52|Overall Study||143
8305646|NCT01519791|20477054|P2|STARTED|Overall Study||660
8305647|NCT01519791|20477055|P1|STARTED|Overall Study||219
8305648|NCT01519778|20477119|P1|NOT COMPLETED|Overall Study||14
8305649|NCT01519778|20477119|P1|COMPLETED|Overall Study||186
8305650|NCT01519778|20477119|P1|STARTED|Overall Study||200
8305651|NCT01519765|20477125|P2|NOT COMPLETED|Overall Study||2
8305652|NCT01519765|20477126|P1|NOT COMPLETED|Overall Study||3
8305653|NCT01519765|20477125|P2|COMPLETED|Overall Study||34
8305654|NCT01519765|20477126|P1|COMPLETED|Overall Study||34
8305655|NCT01519765|20477125|P2|STARTED|Overall Study||36
8305656|NCT01519765|20477126|P1|STARTED|Overall Study||37
8305657|NCT01519713|20477175|P3|NOT COMPLETED|Overall Study||0
8305658|NCT01519713|20477176|P2|NOT COMPLETED|Overall Study||0
8305659|NCT01519713|20477177|P1|NOT COMPLETED|Overall Study||0
8305660|NCT01519713|20477175|P3|COMPLETED|Overall Study||4
8305661|NCT01519713|20477176|P2|COMPLETED|Overall Study||2
8305662|NCT01519713|20477177|P1|COMPLETED|Overall Study||194
8305663|NCT01519713|20477175|P3|STARTED|Overall Study||4
8305664|NCT01519713|20477176|P2|STARTED|Overall Study||2
8305665|NCT01519713|20477177|P1|STARTED|Overall Study||194
8305666|NCT01519700|20477204|P4|NOT COMPLETED|Overall Study||7
8305667|NCT01519700|20477205|P3|NOT COMPLETED|Overall Study||7
8305668|NCT01519700|20477206|P2|NOT COMPLETED|Overall Study||6
8305669|NCT01519700|20477207|P1|NOT COMPLETED|Overall Study||9
8305670|NCT01519700|20477204|P4|COMPLETED|Overall Study||47
8305671|NCT01519700|20477205|P3|COMPLETED|Overall Study||48
8305672|NCT01519700|20477206|P2|COMPLETED|Overall Study||49
8305673|NCT01519700|20477207|P1|COMPLETED|Overall Study||45
8305674|NCT01519700|20477204|P4|Treated Cycle 6 Neupogen|Overall Study||49
8305675|NCT01519700|20477205|P3|Treated Cycle 6 Neupogen|Overall Study||0
8305676|NCT01519700|20477206|P2|Treated Cycle 6 Neupogen|Overall Study||49
8305677|NCT01519700|20477207|P1|Treated Cycle 6 Neupogen|Overall Study||0
8305678|NCT01519700|20477204|P4|Treated Cycle 6 EP2006|Overall Study||0
8305679|NCT01519700|20477205|P3|Treated Cycle 6 EP2006|Overall Study||48
8305680|NCT01519700|20477206|P2|Treated Cycle 6 EP2006|Overall Study||0
8305681|NCT01519700|20477207|P1|Treated Cycle 6 EP2006|Overall Study||45
8305682|NCT01519700|20477204|P4|Treated Cycle 5 Neupogen|Overall Study||50
8305683|NCT01519700|20477205|P3|Treated Cycle 5 Neupogen|Overall Study||48
8305684|NCT01519700|20477206|P2|Treated Cycle 5 Neupogen|Overall Study||0
8305685|NCT01519700|20477207|P1|Treated Cycle 5 Neupogen|Overall Study||0
8305686|NCT01519700|20477204|P4|Treated Cycle 5 EP2006|Overall Study||0
8305687|NCT01519700|20477205|P3|Treated Cycle 5 EP2006|Overall Study||0
8305688|NCT01519700|20477206|P2|Treated Cycle 5 EP2006|Overall Study||49
8305689|NCT01519700|20477207|P1|Treated Cycle 5 EP2006|Overall Study||46
8305690|NCT01519700|20477204|P4|Treated Cycle 4 Neupogen|Overall Study||50
8305691|NCT01519700|20477205|P3|Treated Cycle 4 Neupogen|Overall Study||0
8305692|NCT01519700|20477206|P2|Treated Cycle 4 Neupogen|Overall Study||51
8305693|NCT01519700|20477207|P1|Treated Cycle 4 Neupogen|Overall Study||0
8305694|NCT01519700|20477204|P4|Treated Cycle 4 EP2006|Overall Study||0
8305695|NCT01519700|20477205|P3|Treated Cycle 4 EP2006|Overall Study||50
8305696|NCT01519700|20477206|P2|Treated Cycle 4 EP2006|Overall Study||0
8305697|NCT01519700|20477207|P1|Treated Cycle 4 EP2006|Overall Study||51
8305698|NCT01519700|20477204|P4|Treated Cycle 3 Neupogen|Overall Study||51
8305699|NCT01519700|20477205|P3|Treated Cycle 3 Neupogen|Overall Study||54
8305700|NCT01519700|20477206|P2|Treated Cycle 3 Neupogen|Overall Study||0
8305701|NCT01519700|20477207|P1|Treated Cycle 3 Neupogen|Overall Study||0
8305702|NCT01519700|20477204|P4|Treated Cycle 3 EP2006|Overall Study||0
8305703|NCT01519700|20477205|P3|Treated Cycle 3 EP2006|Overall Study||0
8305704|NCT01519700|20477206|P2|Treated Cycle 3 EP2006|Overall Study||51
8305705|NCT01519700|20477207|P1|Treated Cycle 3 EP2006|Overall Study||51
8305706|NCT01519700|20477204|P4|Treated Cycle 2 Neupogen|Overall Study||51
8305707|NCT01519700|20477205|P3|Treated Cycle 2 Neupogen|Overall Study||0
8305708|NCT01519700|20477206|P2|Treated Cycle 2 Neupogen|Overall Study||52
8305709|NCT01519700|20477207|P1|Treated Cycle 2 Neupogen|Overall Study||0
8305710|NCT01519700|20477204|P4|Treated Cycle 2 EP2006|Overall Study||0
8305711|NCT01519700|20477205|P3|Treated Cycle 2 EP2006|Overall Study||55
8305712|NCT01519700|20477206|P2|Treated Cycle 2 EP2006|Overall Study||0
8305713|NCT01519700|20477207|P1|Treated Cycle 2 EP2006|Overall Study||52
8305714|NCT01519700|20477204|P4|Treated Cycle 1 Neupogen|Overall Study||52
8305715|NCT01519700|20477205|P3|Treated Cycle 1 Neupogen|Overall Study||55
8305716|NCT01519700|20477206|P2|Treated Cycle 1 Neupogen|Overall Study||0
8305717|NCT01519700|20477207|P1|Treated Cycle 1 Neupogen|Overall Study||0
8305718|NCT01519700|20477204|P4|Treated Cycle 1 EP2006|Overall Study||0
8305719|NCT01519700|20477205|P3|Treated Cycle 1 EP2006|Overall Study||0
8305720|NCT01519700|20477206|P2|Treated Cycle 1 EP2006|Overall Study||54
8305721|NCT01519700|20477207|P1|Treated Cycle 1 EP2006|Overall Study||53
8305722|NCT01519700|20477204|P4|STARTED|Overall Study||54
8305723|NCT01519700|20477205|P3|STARTED|Overall Study||55
8305724|NCT01519700|20477206|P2|STARTED|Overall Study||55
8305725|NCT01519700|20477207|P1|STARTED|Overall Study||54
8305726|NCT01519674|20477242|P3|NOT COMPLETED|Overall Study||12
8305727|NCT01519674|20477243|P2|NOT COMPLETED|Overall Study||13
8305728|NCT01519674|20477244|P1|NOT COMPLETED|Overall Study||21
8305729|NCT01519674|20477242|P3|COMPLETED|Overall Study||181
8305730|NCT01519674|20477243|P2|COMPLETED|Overall Study||182
8305731|NCT01519674|20477244|P1|COMPLETED|Overall Study||173
8305732|NCT01519674|20477242|P3|Exposed|Overall Study||190
8305733|NCT01519674|20477243|P2|Exposed|Overall Study||193
8305734|NCT01519674|20477244|P1|Exposed|Overall Study||192
8305735|NCT01519674|20477242|P3|STARTED|Overall Study||193
8305736|NCT01519674|20477243|P2|STARTED|Overall Study||195
8305737|NCT01519674|20477244|P1|STARTED|Overall Study||194
8305738|NCT01519661|20477282|P1|NOT COMPLETED|Overall Study||61
8305739|NCT01519661|20477282|P1|COMPLETED|Overall Study||96
8305740|NCT01519661|20477282|P1|STARTED|Overall Study||157
8305741|NCT01519648|20477299|P2|NOT COMPLETED|Overall Study||0
8305742|NCT01519648|20477300|P1|NOT COMPLETED|Overall Study||0
8305743|NCT01519648|20477299|P2|COMPLETED|Overall Study||306
8305744|NCT01519648|20477300|P1|COMPLETED|Overall Study||502
8305745|NCT01519648|20477299|P2|STARTED|Overall Study||306
8305746|NCT01519648|20477300|P1|STARTED|Overall Study||502
8305747|NCT01519635|20477308|P2|NOT COMPLETED|Overall Study||3
8305748|NCT01519635|20477309|P1|NOT COMPLETED|Overall Study||1
8305749|NCT01519635|20477308|P2|COMPLETED|Overall Study||9
8305750|NCT01519635|20477309|P1|COMPLETED|Overall Study||11
8305751|NCT01519635|20477308|P2|STARTED|Overall Study||12
8305752|NCT01519635|20477309|P1|STARTED|Overall Study||12
8305753|NCT01519570|20477317|P2|NOT COMPLETED|Overall Study||0
8305754|NCT01519570|20477318|P1|NOT COMPLETED|Overall Study||0
8305755|NCT01519570|20477317|P2|COMPLETED|Overall Study||2089
8305756|NCT01519570|20477318|P1|COMPLETED|Overall Study||500
8305757|NCT01519570|20477317|P2|STARTED|Overall Study||2089
8305758|NCT01519570|20477318|P1|STARTED|Overall Study||500
8305759|NCT01519518|20477326|P2|NOT COMPLETED|Overall Study||10
8305760|NCT01519518|20477327|P1|NOT COMPLETED|Overall Study||7
8305761|NCT01519518|20477326|P2|COMPLETED|Overall Study||905
8305762|NCT01519518|20477327|P1|COMPLETED|Overall Study||907
8305763|NCT01519518|20477326|P2|STARTED|Overall Study||915
8305764|NCT01519518|20477327|P1|STARTED|Overall Study||914
8305765|NCT01519466|20477341|P2|NOT COMPLETED|Overall Study||0
8305766|NCT01519466|20477342|P1|NOT COMPLETED|Overall Study||0
8305767|NCT01519466|20477341|P2|COMPLETED|Overall Study||16
8305768|NCT01519466|20477342|P1|COMPLETED|Overall Study||33
8305769|NCT01519466|20477341|P2|STARTED|Overall Study||16
8305770|NCT01519466|20477342|P1|STARTED|Overall Study||33
8305771|NCT01519427|20477352|P1|NOT COMPLETED|Overall Study||2
8305772|NCT01519427|20477352|P1|COMPLETED|Overall Study||0
8305773|NCT01519427|20477352|P1|STARTED|Overall Study||2
8305774|NCT01519414|20477361|P3|NOT COMPLETED|Post Cross-over||0
8305775|NCT01519414|20477362|P2|NOT COMPLETED|Post Cross-over||0
8305776|NCT01519414|20477363|P1|NOT COMPLETED|Post Cross-over||0
8305777|NCT01519414|20477361|P3|COMPLETED|Post Cross-over||12
8305778|NCT01519414|20477362|P2|COMPLETED|Post Cross-over||14
8305779|NCT01519414|20477363|P1|COMPLETED|Post Cross-over||52
8305780|NCT01519414|20477361|P3|STARTED|Post Cross-over||12
8305781|NCT01519414|20477362|P2|STARTED|Post Cross-over||14
8305782|NCT01519414|20477363|P1|STARTED|Post Cross-over||52
8305783|NCT01519414|20477361|P3|NOT COMPLETED|Pre Cross-over||0
8305784|NCT01519414|20477362|P2|NOT COMPLETED|Pre Cross-over||0
8305785|NCT01519414|20477363|P1|NOT COMPLETED|Pre Cross-over||0
8305786|NCT01519414|20477361|P3|COMPLETED|Pre Cross-over||0
8305787|NCT01519414|20477362|P2|COMPLETED|Pre Cross-over||26
8305788|NCT01519414|20477363|P1|COMPLETED|Pre Cross-over||52
8305789|NCT01519414|20477361|P3|STARTED|Pre Cross-over||0
8305790|NCT01519414|20477362|P2|STARTED|Pre Cross-over||26
8305791|NCT01519414|20477363|P1|STARTED|Pre Cross-over||52
8305792|NCT01519323|20477384|P2|NOT COMPLETED|Overall Study||3
8305793|NCT01519323|20477385|P1|NOT COMPLETED|Overall Study||3
8305794|NCT01519323|20477384|P2|COMPLETED|Overall Study||0
8305795|NCT01519323|20477385|P1|COMPLETED|Overall Study||0
8305796|NCT01519323|20477384|P2|STARTED|Overall Study||3
8305797|NCT01519323|20477385|P1|STARTED|Overall Study||3
8305798|NCT01519284|20477401|P5|NOT COMPLETED|Overall Study||0
8305799|NCT01519284|20477402|P4|NOT COMPLETED|Overall Study||0
8305800|NCT01519284|20477403|P3|NOT COMPLETED|Overall Study||2
8305801|NCT01519284|20477404|P2|NOT COMPLETED|Overall Study||0
8305802|NCT01519284|20477405|P1|NOT COMPLETED|Overall Study||0
8305803|NCT01519284|20477401|P5|COMPLETED|Overall Study||16
8305804|NCT01519284|20477402|P4|COMPLETED|Overall Study||16
8305805|NCT01519284|20477403|P3|COMPLETED|Overall Study||16
8305806|NCT01519284|20477404|P2|COMPLETED|Overall Study||16
8305807|NCT01519284|20477405|P1|COMPLETED|Overall Study||16
8305808|NCT01519284|20477401|P5|STARTED|Overall Study||16
8305809|NCT01519284|20477402|P4|STARTED|Overall Study||16
8305810|NCT01519284|20477403|P3|STARTED|Overall Study||18
8305811|NCT01519284|20477404|P2|STARTED|Overall Study||16
8305812|NCT01519284|20477405|P1|STARTED|Overall Study||16
8305813|NCT01519271|20477434|P2|NOT COMPLETED|Phase 2||0
8305814|NCT01519271|20477435|P1|NOT COMPLETED|Phase 2||0
8305815|NCT01519271|20477434|P2|COMPLETED|Phase 2||14
8305816|NCT01519271|20477435|P1|COMPLETED|Phase 2||12
8305817|NCT01519271|20477434|P2|STARTED|Phase 2||14
8305818|NCT01519271|20477435|P1|STARTED|Phase 2|2 participants discontinued after Phase 1|12
8305819|NCT01519271|20477434|P2|NOT COMPLETED|Phase 1||1
8305820|NCT01519271|20477435|P1|NOT COMPLETED|Phase 1||0
8305821|NCT01519271|20477434|P2|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
8305822|NCT01519271|20477435|P1|COMPLETED|Phase 1||14
8305823|NCT01519271|20477434|P2|STARTED|Phase 1||14
8305824|NCT01519271|20477435|P1|STARTED|Phase 1||14
8305825|NCT01519245|20477445|P2|NOT COMPLETED|Overall Study||2
8305826|NCT01519245|20477446|P1|NOT COMPLETED|Overall Study||1
8305827|NCT01519245|20477445|P2|COMPLETED|Overall Study||18
8305828|NCT01519245|20477446|P1|COMPLETED|Overall Study||23
8305829|NCT01519245|20477445|P2|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
8305830|NCT01519245|20477446|P1|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
8305831|NCT01519245|20477445|P2|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
8305832|NCT01519245|20477446|P1|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
8305833|NCT01519245|20477445|P2|STARTED|Overall Study||20
8305834|NCT01519245|20477446|P1|STARTED|Overall Study||24
8305835|NCT01519206|20477458|P1|NOT COMPLETED|Overall Study||5
8305836|NCT01519206|20477458|P1|COMPLETED|Overall Study||27
8305837|NCT01519206|20477458|P1|STARTED|Overall Study||32
8305838|NCT01519167|20477472|P2|NOT COMPLETED|Overall Study||8
8305839|NCT01519167|20477473|P1|NOT COMPLETED|Overall Study||0
8305840|NCT01519167|20477472|P2|COMPLETED|Overall Study||81
8305841|NCT01519167|20477473|P1|COMPLETED|Overall Study||1
8305842|NCT01519167|20477472|P2|STARTED|Overall Study||89
8305843|NCT01519167|20477473|P1|STARTED|Overall Study||1
8305844|NCT01519089|20477499|P2|NOT COMPLETED|Overall Study||15
8305845|NCT01519089|20477500|P1|NOT COMPLETED|Overall Study||7
8305846|NCT01519089|20477499|P2|COMPLETED|Overall Study||33
8305847|NCT01519089|20477500|P1|COMPLETED|Overall Study||40
8305848|NCT01519089|20477499|P2|Received Treatment|Overall Study||47
8305849|NCT01519089|20477500|P1|Received Treatment|Overall Study||47
8305850|NCT01519089|20477499|P2|STARTED|Overall Study||48
8305851|NCT01519089|20477500|P1|STARTED|Overall Study||47
8305852|NCT01519063|20477621|P2|NOT COMPLETED|Overall Study||5
8305853|NCT01519063|20477622|P1|NOT COMPLETED|Overall Study||7
8305854|NCT01519063|20477621|P2|COMPLETED|Overall Study||25
8305855|NCT01519063|20477622|P1|COMPLETED|Overall Study||19
8305856|NCT01519063|20477621|P2|STARTED|Overall Study||30
8305857|NCT01519063|20477622|P1|STARTED|Overall Study||26
8305858|NCT01518972|20477642|P2|NOT COMPLETED|Overall Study||4
8305859|NCT01518972|20477643|P1|NOT COMPLETED|Overall Study||6
8305860|NCT01518972|20477642|P2|COMPLETED|Overall Study||11
8305861|NCT01518972|20477643|P1|COMPLETED|Overall Study||9
8305862|NCT01518972|20477642|P2|STARTED|Overall Study||15
8305863|NCT01518972|20477643|P1|STARTED|Overall Study||15
8305891|NCT01518868|20477666|P2|NOT COMPLETED|Overall Study||4
8305892|NCT01518868|20477667|P1|NOT COMPLETED|Overall Study||4
8305893|NCT01518868|20477666|P2|COMPLETED|Overall Study||59
8305894|NCT01518868|20477667|P1|COMPLETED|Overall Study||59
8305895|NCT01518868|20477666|P2|STARTED|Overall Study||63
8305896|NCT01518868|20477667|P1|STARTED|Overall Study||63
8305897|NCT01518530|20477675|P1|NOT COMPLETED|Post-Treatment Follow-up||0
8305898|NCT01518530|20477675|P1|COMPLETED|Post-Treatment Follow-up||9
8305899|NCT01518530|20477675|P1|STARTED|Post-Treatment Follow-up||9
8305900|NCT01518530|20477675|P1|NOT COMPLETED|Active Treatment Period||1
8305901|NCT01518530|20477675|P1|COMPLETED|Active Treatment Period||9
8305902|NCT01518530|20477675|P1|STARTED|Active Treatment Period||10
8305903|NCT01518374|20477679|P1|NOT COMPLETED|Overall Study||7
8305904|NCT01518374|20477679|P1|COMPLETED|Overall Study||1761
8305905|NCT01518374|20477679|P1|STARTED|Overall Study||1768
8305906|NCT01518322|20477683|P1|NOT COMPLETED|Overall Study||13
8305907|NCT01518322|20477683|P1|COMPLETED|Overall Study||222
8305908|NCT01518322|20477683|P1|STARTED|Overall Study||235
8305909|NCT01518309|20477696|P1|NOT COMPLETED|Overall Study||39
8305910|NCT01518309|20477696|P1|COMPLETED|Overall Study||0
8305911|NCT01518309|20477696|P1|STARTED|Overall Study||39
8305912|NCT01518270|20477700|P1|NOT COMPLETED|Overall Study||0
8305913|NCT01518270|20477700|P1|COMPLETED|Overall Study||179
8305914|NCT01518270|20477700|P1|STARTED|Overall Study||179
8305915|NCT01518257|20477708|P2|NOT COMPLETED|Overall Study||0
8305916|NCT01518257|20477709|P1|NOT COMPLETED|Overall Study||2
8305917|NCT01518257|20477708|P2|COMPLETED|Overall Study||60
8305918|NCT01518257|20477709|P1|COMPLETED|Overall Study||59
8305919|NCT01518257|20477708|P2|STARTED|Overall Study||60
8305920|NCT01518257|20477709|P1|STARTED|Overall Study||61
8305921|NCT01518244|20477731|P1|NOT COMPLETED|Overall Study||3
8305922|NCT01518244|20477731|P1|COMPLETED|Overall Study||47
8305923|NCT01518244|20477731|P1|STARTED|Overall Study||50
8305924|NCT01518192|20477739|P3|NOT COMPLETED|Overall Study||35
8305925|NCT01518192|20477740|P2|NOT COMPLETED|Overall Study||26
8305926|NCT01518192|20477741|P1|NOT COMPLETED|Overall Study||29
8305927|NCT01518192|20477739|P3|COMPLETED|Overall Study||224
8305928|NCT01518192|20477740|P2|COMPLETED|Overall Study||114
8305929|NCT01518192|20477741|P1|COMPLETED|Overall Study||116
8305930|NCT01518192|20477739|P3|STARTED|Overall Study||259
8305931|NCT01518192|20477740|P2|STARTED|Overall Study||140
8305932|NCT01518192|20477741|P1|STARTED|Overall Study||145
8305933|NCT01518153|20477762|P3|NOT COMPLETED|Donor Lymphocyte Infusion||1
8305934|NCT01518153|20477763|P2|NOT COMPLETED|Donor Lymphocyte Infusion||2
8305935|NCT01518153|20477764|P1|NOT COMPLETED|Donor Lymphocyte Infusion||0
8305936|NCT01518153|20477762|P3|COMPLETED|Donor Lymphocyte Infusion||3
8305937|NCT01518153|20477763|P2|COMPLETED|Donor Lymphocyte Infusion||1
8305938|NCT01518153|20477764|P1|COMPLETED|Donor Lymphocyte Infusion||0
8305939|NCT01518153|20477762|P3|STARTED|Donor Lymphocyte Infusion||4
8305940|NCT01518153|20477763|P2|STARTED|Donor Lymphocyte Infusion||3
8305941|NCT01518153|20477764|P1|STARTED|Donor Lymphocyte Infusion||0
8305942|NCT01518153|20477762|P3|NOT COMPLETED|Stem Cell Transplant||0
8305943|NCT01518153|20477763|P2|NOT COMPLETED|Stem Cell Transplant||0
8305944|NCT01518153|20477764|P1|NOT COMPLETED|Stem Cell Transplant||9
8305945|NCT01518153|20477762|P3|COMPLETED|Stem Cell Transplant||0
8305946|NCT01518153|20477763|P2|COMPLETED|Stem Cell Transplant||0
8305947|NCT01518153|20477764|P1|COMPLETED|Stem Cell Transplant||7
8305948|NCT01518153|20477762|P3|STARTED|Stem Cell Transplant||0
8305949|NCT01518153|20477763|P2|STARTED|Stem Cell Transplant||0
8305950|NCT01518153|20477764|P1|STARTED|Stem Cell Transplant||16
8305951|NCT01517984|20477775|P4|NOT COMPLETED|Overall Study||1
8305952|NCT01517984|20477776|P3|NOT COMPLETED|Overall Study||4
8305953|NCT01517984|20477777|P2|NOT COMPLETED|Overall Study||23
8305954|NCT01517984|20477778|P1|NOT COMPLETED|Overall Study||5
8305955|NCT01517984|20477775|P4|COMPLETED|Overall Study||6
8305956|NCT01517984|20477776|P3|COMPLETED|Overall Study||10
8305957|NCT01517984|20477777|P2|COMPLETED|Overall Study||3
8305958|NCT01517984|20477778|P1|COMPLETED|Overall Study||0
8305959|NCT01517984|20477775|P4|STARTED|Overall Study||7
8305960|NCT01517984|20477776|P3|STARTED|Overall Study||14
8305961|NCT01517984|20477777|P2|STARTED|Overall Study||26
8305962|NCT01517984|20477778|P1|STARTED|Overall Study||5
8305963|NCT01517893|20477804|P2|NOT COMPLETED|Overall Study||0
8305964|NCT01517893|20477805|P1|NOT COMPLETED|Overall Study||3
8305965|NCT01517893|20477804|P2|COMPLETED|Overall Study||7
8305966|NCT01517893|20477805|P1|COMPLETED|Overall Study||5
8305967|NCT01517893|20477804|P2|STARTED|Overall Study||7
8305968|NCT01517893|20477805|P1|STARTED|Overall Study||8
8305969|NCT01517867|20477827|P2|NOT COMPLETED|Overall Study||65
8305970|NCT01517867|20477828|P1|NOT COMPLETED|Overall Study||63
8305971|NCT01517867|20477827|P2|COMPLETED|Overall Study||15
8305972|NCT01517867|20477828|P1|COMPLETED|Overall Study||18
8305973|NCT01517867|20477827|P2|STARTED|Overall Study||80
8305974|NCT01517867|20477828|P1|STARTED|Overall Study||81
8305975|NCT01517763|20477839|P3|NOT COMPLETED|Overall Study||0
8305976|NCT01517763|20477840|P2|NOT COMPLETED|Overall Study||0
8305977|NCT01517763|20477841|P1|NOT COMPLETED|Overall Study||0
8305978|NCT01517763|20477839|P3|COMPLETED|Overall Study||0
8305979|NCT01517763|20477840|P2|COMPLETED|Overall Study||0
8305980|NCT01517763|20477841|P1|COMPLETED|Overall Study||0
8305981|NCT01517763|20477839|P3|STARTED|Overall Study||0
8305982|NCT01517763|20477840|P2|STARTED|Overall Study||0
8305983|NCT01517763|20477841|P1|STARTED|Overall Study||0
8305984|NCT01517750|20477856|P4|NOT COMPLETED|Overall Study||1
8305985|NCT01517750|20477857|P3|NOT COMPLETED|Overall Study||4
8305986|NCT01517750|20477858|P2|NOT COMPLETED|Overall Study||2
8305987|NCT01517750|20477859|P1|NOT COMPLETED|Overall Study||1
8305988|NCT01517750|20477856|P4|COMPLETED|Overall Study||18
8305989|NCT01517750|20477857|P3|COMPLETED|Overall Study||17
8305990|NCT01517750|20477858|P2|COMPLETED|Overall Study||17
8305991|NCT01517750|20477859|P1|COMPLETED|Overall Study||20
8305992|NCT01517750|20477856|P4|STARTED|Overall Study||19
8305993|NCT01517750|20477857|P3|STARTED|Overall Study||21
8305994|NCT01517750|20477858|P2|STARTED|Overall Study||19
8305995|NCT01517750|20477859|P1|STARTED|Overall Study||21
8305996|NCT01517659|20477889|P1|NOT COMPLETED|Overall Study||0
8305997|NCT01517659|20477889|P1|COMPLETED|Overall Study||45
8305998|NCT01517659|20477889|P1|STARTED|Overall Study||45
8305999|NCT01517529|20477896|P1|NOT COMPLETED|Overall Study||0
8306000|NCT01517529|20477896|P1|COMPLETED|Overall Study||10
8306001|NCT01517529|20477896|P1|STARTED|Overall Study||10
8306002|NCT01517412|20477903|P2|NOT COMPLETED|Overall Study||24
8306003|NCT01517412|20477904|P1|NOT COMPLETED|Overall Study||36
8306004|NCT01517412|20477903|P2|COMPLETED|Overall Study||202
8306005|NCT01517412|20477904|P1|COMPLETED|Overall Study||189
8306006|NCT01517412|20477903|P2|STARTED|Overall Study||226
8306007|NCT01517412|20477904|P1|STARTED|Overall Study||225
8306008|NCT01517373|20477933|P6|NOT COMPLETED|Treatment Period||7
8306009|NCT01517373|20477934|P5|NOT COMPLETED|Treatment Period||6
8306010|NCT01517373|20477935|P4|NOT COMPLETED|Treatment Period||7
8306011|NCT01517373|20477936|P3|NOT COMPLETED|Treatment Period||6
8306012|NCT01517373|20477937|P2|NOT COMPLETED|Treatment Period||4
8306013|NCT01517373|20477938|P1|NOT COMPLETED|Treatment Period||0
8306014|NCT01517373|20477933|P6|COMPLETED|Treatment Period||54
8306015|NCT01517373|20477934|P5|COMPLETED|Treatment Period||55
8306016|NCT01517373|20477935|P4|COMPLETED|Treatment Period||54
8306017|NCT01517373|20477936|P3|COMPLETED|Treatment Period||54
8306018|NCT01517373|20477937|P2|COMPLETED|Treatment Period||57
8306019|NCT01517373|20477938|P1|COMPLETED|Treatment Period||0
8306020|NCT01517373|20477933|P6|STARTED|Treatment Period||61
8306021|NCT01517373|20477934|P5|STARTED|Treatment Period||61
8306022|NCT01517373|20477935|P4|STARTED|Treatment Period||61
8306023|NCT01517373|20477936|P3|STARTED|Treatment Period||60
8306024|NCT01517373|20477937|P2|STARTED|Treatment Period||61
8306025|NCT01517373|20477938|P1|STARTED|Treatment Period||0
8306026|NCT01517373|20477933|P6|NOT COMPLETED|Run-in Period||0
8306027|NCT01517373|20477934|P5|NOT COMPLETED|Run-in Period||0
8306028|NCT01517373|20477935|P4|NOT COMPLETED|Run-in Period||0
8306029|NCT01517373|20477936|P3|NOT COMPLETED|Run-in Period||0
8306030|NCT01517373|20477937|P2|NOT COMPLETED|Run-in Period||0
8306031|NCT01517373|20477938|P1|NOT COMPLETED|Run-in Period||57
8306032|NCT01517373|20477933|P6|COMPLETED|Run-in Period||0
8306033|NCT01517373|20477934|P5|COMPLETED|Run-in Period||0
8306034|NCT01517373|20477935|P4|COMPLETED|Run-in Period||0
8306035|NCT01517373|20477936|P3|COMPLETED|Run-in Period||0
8306036|NCT01517373|20477937|P2|COMPLETED|Run-in Period||0
8306037|NCT01517373|20477938|P1|COMPLETED|Run-in Period||304
8306038|NCT01517373|20477933|P6|STARTED|Run-in Period||0
8306039|NCT01517373|20477934|P5|STARTED|Run-in Period||0
8306040|NCT01517373|20477935|P4|STARTED|Run-in Period||0
8306041|NCT01517373|20477936|P3|STARTED|Run-in Period||0
8306042|NCT01517373|20477937|P2|STARTED|Run-in Period||0
8306043|NCT01517373|20477938|P1|STARTED|Run-in Period||361
8306044|NCT01517295|20478008|P2|NOT COMPLETED|Overall Study||0
8306045|NCT01517295|20478009|P1|NOT COMPLETED|Overall Study||1
8306046|NCT01517295|20478008|P2|COMPLETED|Overall Study||14
8306047|NCT01517295|20478009|P1|COMPLETED|Overall Study||15
8306048|NCT01517295|20478008|P2|STARTED|Overall Study||14
8306049|NCT01517295|20478009|P1|STARTED|Overall Study||16
8306050|NCT01517282|20478023|P4|NOT COMPLETED|Overall Study||1
8306051|NCT01517282|20478024|P3|NOT COMPLETED|Overall Study||1
8306052|NCT01517282|20478025|P2|NOT COMPLETED|Overall Study||1
8306053|NCT01517282|20478026|P1|NOT COMPLETED|Overall Study||1
8306054|NCT01517282|20478023|P4|COMPLETED|Overall Study||5
8306055|NCT01517282|20478024|P3|COMPLETED|Overall Study||8
8306056|NCT01517282|20478025|P2|COMPLETED|Overall Study||7
8306057|NCT01517282|20478026|P1|COMPLETED|Overall Study||8
8306058|NCT01517282|20478023|P4|STARTED|Overall Study||6
8306059|NCT01517282|20478024|P3|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
8306060|NCT01517282|20478025|P2|STARTED|Overall Study||8
8306061|NCT01517282|20478026|P1|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
8306062|NCT01517178|20478060|P2|NOT COMPLETED|Period 2||2
8306063|NCT01517178|20478061|P1|NOT COMPLETED|Period 2||6
8306064|NCT01517178|20478060|P2|COMPLETED|Period 2||4
8306065|NCT01517178|20478061|P1|COMPLETED|Period 2||5
8306066|NCT01517178|20478060|P2|STARTED|Period 2||6
8306067|NCT01517178|20478061|P1|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
8306068|NCT01517178|20478060|P2|NOT COMPLETED|Period 1||5
8306069|NCT01517178|20478061|P1|NOT COMPLETED|Period 1||4
8306070|NCT01517178|20478060|P2|COMPLETED|Period 1||6
8306071|NCT01517178|20478061|P1|COMPLETED|Period 1||12
8306072|NCT01517178|20478060|P2|STARTED|Period 1||11
8306073|NCT01517178|20478061|P1|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
8306074|NCT01517074|20478067|P1|NOT COMPLETED|Overall Study||0
8306075|NCT01517074|20478067|P1|COMPLETED|Overall Study||5
8306076|NCT01517074|20478067|P1|STARTED|Overall Study||5
8306077|NCT01516970|20478089|P2|NOT COMPLETED|Overall Study||21
8306078|NCT01516970|20478090|P1|NOT COMPLETED|Overall Study||18
8306079|NCT01516970|20478089|P2|COMPLETED|Overall Study||132
8306080|NCT01516970|20478090|P1|COMPLETED|Overall Study||141
8306081|NCT01516970|20478089|P2|STARTED|Overall Study||153
8306082|NCT01516970|20478090|P1|STARTED|Overall Study||159
8306083|NCT01516957|20478105|P4|NOT COMPLETED|Open-label Phase||156
8306084|NCT01516957|20478106|P3|NOT COMPLETED|Open-label Phase||0
8306085|NCT01516957|20478107|P2|NOT COMPLETED|Open-label Phase||0
8306086|NCT01516957|20478108|P1|NOT COMPLETED|Open-label Phase||0
8306087|NCT01516957|20478105|P4|COMPLETED|Open-label Phase||0
8306088|NCT01516957|20478106|P3|COMPLETED|Open-label Phase||0
8306089|NCT01516957|20478107|P2|COMPLETED|Open-label Phase||0
8306090|NCT01516957|20478108|P1|COMPLETED|Open-label Phase||0
8306091|NCT01516957|20478105|P4|STARTED|Open-label Phase||156
8306092|NCT01516957|20478106|P3|STARTED|Open-label Phase||0
8306093|NCT01516957|20478107|P2|STARTED|Open-label Phase||0
8306094|NCT01516957|20478108|P1|STARTED|Open-label Phase||0
8306095|NCT01516957|20478105|P4|NOT COMPLETED|Placebo-controlled Phase||0
8306096|NCT01516957|20478106|P3|NOT COMPLETED|Placebo-controlled Phase||5
8306097|NCT01516957|20478107|P2|NOT COMPLETED|Placebo-controlled Phase||4
8306098|NCT01516957|20478108|P1|NOT COMPLETED|Placebo-controlled Phase||3
8306099|NCT01516957|20478105|P4|COMPLETED|Placebo-controlled Phase||0
8306100|NCT01516957|20478106|P3|COMPLETED|Placebo-controlled Phase||51
8306101|NCT01516957|20478107|P2|COMPLETED|Placebo-controlled Phase||53
8306102|NCT01516957|20478108|P1|COMPLETED|Placebo-controlled Phase||52
8306103|NCT01516957|20478105|P4|STARTED|Placebo-controlled Phase||0
8306104|NCT01516957|20478106|P3|STARTED|Placebo-controlled Phase||56
8306105|NCT01516957|20478107|P2|STARTED|Placebo-controlled Phase||57
8306106|NCT01516957|20478108|P1|STARTED|Placebo-controlled Phase||55
8306107|NCT01516892|20478129|P1|NOT COMPLETED|Overall Study||343
8306108|NCT01516892|20478129|P1|COMPLETED|Overall Study||373
8306109|NCT01516892|20478129|P1|STARTED|Overall Study||716
8306110|NCT01516879|20478137|P2|NOT COMPLETED|Overall Study||34
8306111|NCT01516879|20478138|P1|NOT COMPLETED|Overall Study||16
8306112|NCT01516879|20478137|P2|COMPLETED|Overall Study||568
8306113|NCT01516879|20478138|P1|COMPLETED|Overall Study||287
8306114|NCT01516879|20478137|P2|Received Treatment|Overall Study||599
8306115|NCT01516879|20478138|P1|Received Treatment|Overall Study||302
8306116|NCT01516879|20478137|P2|STARTED|Overall Study||602
8306117|NCT01516879|20478138|P1|STARTED|Overall Study||303
8306118|NCT01516749|20478172|P1|NOT COMPLETED|Follow-up Off Therapy||1
8306119|NCT01516749|20478172|P1|COMPLETED|Follow-up Off Therapy||4
8306120|NCT01516749|20478172|P1|STARTED|Follow-up Off Therapy||5
8306121|NCT01516749|20478172|P1|NOT COMPLETED|Active Therapy||1
8306122|NCT01516749|20478172|P1|COMPLETED|Active Therapy||5
8306123|NCT01516749|20478172|P1|STARTED|Active Therapy||6
8306124|NCT01516736|20478181|P2|NOT COMPLETED|Overall Study||13
8306125|NCT01516736|20478182|P1|NOT COMPLETED|Overall Study||20
8306126|NCT01516736|20478181|P2|COMPLETED|Overall Study||140
8306127|NCT01516736|20478182|P1|COMPLETED|Overall Study||135
8306128|NCT01516736|20478181|P2|STARTED|Overall Study||153
8306129|NCT01516736|20478182|P1|STARTED|Overall Study||155
8306130|NCT01516684|20478204|P2|NOT COMPLETED|Overall Study||0
8306131|NCT01516684|20478205|P1|NOT COMPLETED|Overall Study||0
8306132|NCT01516684|20478204|P2|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152
~Trials were randomized for each arm, not participants"|0
8306133|NCT01516684|20478205|P1|COMPLETED|Overall Study|Trials were randomized for each arm, not participants|0
8306134|NCT01516684|20478204|P2|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.
~Trials were randomized for each arm, not participants"|0
8306135|NCT01516684|20478205|P1|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.
~Trials were randomized for each arm, not participants"|0
8306136|NCT01516632|20478221|P2|NOT COMPLETED|Overall Study||15
8306137|NCT01516632|20478222|P1|NOT COMPLETED|Overall Study||24
8306138|NCT01516632|20478221|P2|COMPLETED|Overall Study||48
8306139|NCT01516632|20478222|P1|COMPLETED|Overall Study||77
8306140|NCT01516632|20478221|P2|STARTED|Overall Study||63
8306141|NCT01516632|20478222|P1|STARTED|Overall Study||101
8306142|NCT01516437|20478236|P4|NOT COMPLETED|Overall Study||1
8306143|NCT01516437|20478237|P3|NOT COMPLETED|Overall Study||1
8306144|NCT01516437|20478238|P2|NOT COMPLETED|Overall Study||0
8306145|NCT01516437|20478239|P1|NOT COMPLETED|Overall Study||0
8306146|NCT01516437|20478236|P4|COMPLETED|Overall Study||6
8306147|NCT01516437|20478237|P3|COMPLETED|Overall Study||14
8306148|NCT01516437|20478238|P2|COMPLETED|Overall Study||24
8306149|NCT01516437|20478239|P1|COMPLETED|Overall Study||24
8306150|NCT01516437|20478236|P4|STARTED|Overall Study||7
8306151|NCT01516437|20478237|P3|STARTED|Overall Study||15
8306152|NCT01516437|20478238|P2|STARTED|Overall Study||24
8306153|NCT01516437|20478239|P1|STARTED|Overall Study||24
8306154|NCT01516424|20478295|P2|NOT COMPLETED|Overall Study||22
8306155|NCT01516424|20478296|P1|NOT COMPLETED|Overall Study||35
8306156|NCT01516424|20478295|P2|COMPLETED|Overall Study||114
8306157|NCT01516424|20478296|P1|COMPLETED|Overall Study||96
8306158|NCT01516424|20478295|P2|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
8306159|NCT01516424|20478296|P1|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
8306160|NCT01516268|20478304|P2|NOT COMPLETED|Overall Study||0
8306161|NCT01516268|20478305|P1|NOT COMPLETED|Overall Study||0
8306162|NCT01516268|20478304|P2|COMPLETED|Overall Study||25
8306163|NCT01516268|20478305|P1|COMPLETED|Overall Study||25
8306164|NCT01516268|20478304|P2|STARTED|Overall Study||25
8306165|NCT01516268|20478305|P1|STARTED|Overall Study||25
8306166|NCT01516034|20478311|P1|NOT COMPLETED|Overall Study||8
8306167|NCT01516034|20478311|P1|COMPLETED|Overall Study||0
8306168|NCT01516034|20478311|P1|STARTED|Overall Study||8
8306169|NCT01516008|20478318|P3|NOT COMPLETED|Overall Study||18
8306170|NCT01516008|20478319|P2|NOT COMPLETED|Overall Study||16
8306171|NCT01516008|20478320|P1|NOT COMPLETED|Overall Study||45
8306172|NCT01516008|20478318|P3|COMPLETED|Overall Study||99
8306173|NCT01516008|20478319|P2|COMPLETED|Overall Study||105
8306174|NCT01516008|20478320|P1|COMPLETED|Overall Study||69
8306175|NCT01516008|20478318|P3|STARTED|Overall Study||117
8306176|NCT01516008|20478319|P2|STARTED|Overall Study||121
8306177|NCT01516008|20478320|P1|STARTED|Overall Study||114
8306178|NCT01515995|20478354|P2|NOT COMPLETED|Overall Study||4
8306179|NCT01515995|20478355|P1|NOT COMPLETED|Overall Study||3
8306180|NCT01515995|20478354|P2|COMPLETED|Overall Study||21
8306181|NCT01515995|20478355|P1|COMPLETED|Overall Study||22
8306182|NCT01515995|20478354|P2|STARTED|Overall Study||25
8306183|NCT01515995|20478355|P1|STARTED|Overall Study||25
8306184|NCT01515956|20478361|P1|NOT COMPLETED|Overall Study||0
8306185|NCT01515956|20478361|P1|COMPLETED|Overall Study||15
8306186|NCT01515956|20478361|P1|STARTED|Overall Study||15
8306187|NCT01515943|20478370|P3|NOT COMPLETED|Overall Study||13
8306188|NCT01515943|20478371|P2|NOT COMPLETED|Overall Study||16
8306189|NCT01515943|20478372|P1|NOT COMPLETED|Overall Study||6
8306190|NCT01515943|20478370|P3|COMPLETED|Overall Study||31
8306191|NCT01515943|20478371|P2|COMPLETED|Overall Study||69
8306192|NCT01515943|20478372|P1|COMPLETED|Overall Study||69
8306193|NCT01515943|20478370|P3|STARTED|Overall Study||44
8306194|NCT01515943|20478371|P2|STARTED|Overall Study||85
8306195|NCT01515943|20478372|P1|STARTED|Overall Study||75
8306196|NCT01515891|20478418|P1|NOT COMPLETED|Overall Study||0
8306197|NCT01515891|20478418|P1|COMPLETED|Overall Study||4
8306198|NCT01515891|20478418|P1|STARTED|Overall Study||4
8306226|NCT01515748|20478437|P2|NOT COMPLETED|Overall Study||135
8306227|NCT01515748|20478438|P1|NOT COMPLETED|Overall Study||120
8306228|NCT01515748|20478437|P2|COMPLETED|Overall Study||131
8306229|NCT01515748|20478438|P1|COMPLETED|Overall Study||144
8306230|NCT01515748|20478437|P2|Treated|Overall Study||241
8306231|NCT01515748|20478438|P1|Treated|Overall Study||195
8306232|NCT01515748|20478437|P2|STARTED|Overall Study||266
8306233|NCT01515748|20478438|P1|STARTED|Overall Study||264
8306234|NCT01515696|20478461|P2|NOT COMPLETED|Overall Study||10
8306235|NCT01515696|20478462|P1|NOT COMPLETED|Overall Study||8
8306236|NCT01515696|20478461|P2|COMPLETED|Overall Study||39
8306237|NCT01515696|20478462|P1|COMPLETED|Overall Study||39
8306238|NCT01515696|20478461|P2|STARTED|Overall Study||49
8306239|NCT01515696|20478462|P1|STARTED|Overall Study||47
8306240|NCT01515657|20478472|P3|NOT COMPLETED|Third Intervention||0
8306241|NCT01515657|20478473|P2|NOT COMPLETED|Third Intervention||0
8306242|NCT01515657|20478474|P1|NOT COMPLETED|Third Intervention||1
8306243|NCT01515657|20478472|P3|COMPLETED|Third Intervention||13
8306244|NCT01515657|20478473|P2|COMPLETED|Third Intervention||11
8306245|NCT01515657|20478474|P1|COMPLETED|Third Intervention||13
8306246|NCT01515657|20478472|P3|STARTED|Third Intervention||13
8306247|NCT01515657|20478473|P2|STARTED|Third Intervention||11
8306248|NCT01515657|20478474|P1|STARTED|Third Intervention||14
8306249|NCT01515657|20478472|P3|NOT COMPLETED|Second Intervention||0
8306250|NCT01515657|20478473|P2|NOT COMPLETED|Second Intervention||1
8306251|NCT01515657|20478474|P1|NOT COMPLETED|Second Intervention||0
8306252|NCT01515657|20478472|P3|COMPLETED|Second Intervention||13
8306253|NCT01515657|20478473|P2|COMPLETED|Second Intervention||11
8306254|NCT01515657|20478474|P1|COMPLETED|Second Intervention||14
8306255|NCT01515657|20478472|P3|STARTED|Second Intervention||13
8306256|NCT01515657|20478473|P2|STARTED|Second Intervention||12
8306257|NCT01515657|20478474|P1|STARTED|Second Intervention||14
8306258|NCT01515657|20478472|P3|NOT COMPLETED|First Intervention||0
8306259|NCT01515657|20478473|P2|NOT COMPLETED|First Intervention||1
8306260|NCT01515657|20478474|P1|NOT COMPLETED|First Intervention||0
8306261|NCT01515657|20478472|P3|COMPLETED|First Intervention||13
8306262|NCT01515657|20478473|P2|COMPLETED|First Intervention||12
8306263|NCT01515657|20478474|P1|COMPLETED|First Intervention||14
8306264|NCT01515657|20478472|P3|STARTED|First Intervention||13
8306265|NCT01515657|20478473|P2|STARTED|First Intervention||13
8306266|NCT01515657|20478474|P1|STARTED|First Intervention||14
8306267|NCT01515566|20478484|P2|NOT COMPLETED|Overall Study||0
8306268|NCT01515566|20478485|P1|NOT COMPLETED|Overall Study||0
8306269|NCT01515566|20478484|P2|COMPLETED|Overall Study||10
8306270|NCT01515566|20478485|P1|COMPLETED|Overall Study||10
8306271|NCT01515566|20478484|P2|STARTED|Overall Study||10
8306272|NCT01515566|20478485|P1|STARTED|Overall Study||10
8306273|NCT01515540|20478497|P2|NOT COMPLETED|Overall Study||3
8306274|NCT01515540|20478498|P1|NOT COMPLETED|Overall Study||5
8306275|NCT01515540|20478497|P2|COMPLETED|Overall Study||15
8306276|NCT01515540|20478498|P1|COMPLETED|Overall Study||15
8306277|NCT01515540|20478497|P2|STARTED|Overall Study||18
8306278|NCT01515540|20478498|P1|STARTED|Overall Study||20
8306279|NCT01515488|20478506|P2|NOT COMPLETED|Overall Study||0
8306280|NCT01515488|20478507|P1|NOT COMPLETED|Overall Study||0
8306281|NCT01515488|20478506|P2|COMPLETED|Overall Study||200
8306282|NCT01515488|20478507|P1|COMPLETED|Overall Study||200
8306283|NCT01515488|20478506|P2|STARTED|Overall Study||200
8306284|NCT01515488|20478507|P1|STARTED|Overall Study||200
8306285|NCT01515475|20478521|P4|NOT COMPLETED|Overall Study||12
8306286|NCT01515475|20478522|P3|NOT COMPLETED|Overall Study||12
8306287|NCT01515475|20478523|P2|NOT COMPLETED|Overall Study||15
8306288|NCT01515475|20478524|P1|NOT COMPLETED|Overall Study||20
8306289|NCT01515475|20478521|P4|COMPLETED|Overall Study||53
8306290|NCT01515475|20478522|P3|COMPLETED|Overall Study||53
8306291|NCT01515475|20478523|P2|COMPLETED|Overall Study||43
8306292|NCT01515475|20478524|P1|COMPLETED|Overall Study||41
8306293|NCT01515475|20478521|P4|STARTED|Overall Study||65
8306294|NCT01515475|20478522|P3|STARTED|Overall Study||65
8306295|NCT01515475|20478523|P2|STARTED|Overall Study||58
8306296|NCT01515475|20478524|P1|STARTED|Overall Study||61
8306297|NCT01515423|20478598|P3|NOT COMPLETED|DOUBLE BLIND||92
8306298|NCT01515423|20478599|P2|NOT COMPLETED|DOUBLE BLIND||82
8306299|NCT01515423|20478600|P1|NOT COMPLETED|DOUBLE BLIND||0
8306300|NCT01515423|20478598|P3|COMPLETED|DOUBLE BLIND||420
8306301|NCT01515423|20478599|P2|COMPLETED|DOUBLE BLIND||422
8306302|NCT01515423|20478600|P1|COMPLETED|DOUBLE BLIND||0
8306303|NCT01515423|20478598|P3|STARTED|DOUBLE BLIND||512
8306304|NCT01515423|20478599|P2|STARTED|DOUBLE BLIND||504
8306305|NCT01515423|20478600|P1|STARTED|DOUBLE BLIND||0
8306306|NCT01515423|20478598|P3|NOT COMPLETED|Open Label Phase||0
8306307|NCT01515423|20478599|P2|NOT COMPLETED|Open Label Phase||0
8306308|NCT01515423|20478600|P1|NOT COMPLETED|Open Label Phase||413
8306309|NCT01515423|20478598|P3|COMPLETED|Open Label Phase||0
8306310|NCT01515423|20478599|P2|COMPLETED|Open Label Phase||0
8306311|NCT01515423|20478600|P1|COMPLETED|Open Label Phase||1016
8306312|NCT01515423|20478598|P3|STARTED|Open Label Phase||0
8306313|NCT01515423|20478599|P2|STARTED|Open Label Phase||0
8306314|NCT01515423|20478600|P1|STARTED|Open Label Phase||1429
8306315|NCT01515410|20478619|P2|NOT COMPLETED|Overall Study||0
8306316|NCT01515410|20478620|P1|NOT COMPLETED|Overall Study||0
8306317|NCT01515410|20478619|P2|COMPLETED|Overall Study||15
8306318|NCT01515410|20478620|P1|COMPLETED|Overall Study||19
8306319|NCT01515410|20478619|P2|STARTED|Overall Study||15
8306320|NCT01515410|20478620|P1|STARTED|Overall Study||19
8306321|NCT01515345|20478628|P2|NOT COMPLETED|Overall Study||0
8306322|NCT01515345|20478629|P1|NOT COMPLETED|Overall Study||1
8306323|NCT01515345|20478628|P2|COMPLETED|Overall Study||343
8306324|NCT01515345|20478629|P1|COMPLETED|Overall Study||664
8306325|NCT01515345|20478628|P2|STARTED|Overall Study||343
8306326|NCT01515345|20478629|P1|STARTED|Overall Study||665
8306337|NCT01515189|20478655|P2|NOT COMPLETED|First Re-Induction Phase||15
8306338|NCT01515189|20478656|P1|NOT COMPLETED|First Re-Induction Phase||14
8306339|NCT01515189|20478655|P2|COMPLETED|First Re-Induction Phase||17
8306340|NCT01515189|20478656|P1|COMPLETED|First Re-Induction Phase||9
8306341|NCT01515189|20478655|P2|STARTED|First Re-Induction Phase||32
8306342|NCT01515189|20478656|P1|STARTED|First Re-Induction Phase||23
8306343|NCT01515189|20478655|P2|NOT COMPLETED|Induction||232
8306344|NCT01515189|20478656|P1|NOT COMPLETED|Induction||237
8306345|NCT01515189|20478655|P2|COMPLETED|Induction||130
8306346|NCT01515189|20478656|P1|COMPLETED|Induction||128
8306347|NCT01515189|20478655|P2|STARTED|Induction||362
8306348|NCT01515189|20478656|P1|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
8306349|NCT01515176|20478678|P2|NOT COMPLETED|Overall Study||0
8306350|NCT01515176|20478679|P1|NOT COMPLETED|Overall Study||0
8306351|NCT01515176|20478678|P2|COMPLETED|Overall Study||32
8306352|NCT01515176|20478679|P1|COMPLETED|Overall Study||4
8306353|NCT01515176|20478678|P2|STARTED|Overall Study||32
8306354|NCT01515176|20478679|P1|STARTED|Overall Study||4
8306355|NCT01515072|20478693|P2|NOT COMPLETED|Overall Study||0
8306356|NCT01515072|20478694|P1|NOT COMPLETED|Overall Study||0
8306357|NCT01515072|20478693|P2|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
8306358|NCT01515072|20478694|P1|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
8306359|NCT01515072|20478693|P2|STARTED|Overall Study||155
8306360|NCT01515072|20478694|P1|STARTED|Overall Study||166
8306361|NCT01515046|20478734|P1|NOT COMPLETED|Overall Study||0
8306362|NCT01515046|20478734|P1|COMPLETED|Overall Study||1
8306363|NCT01515046|20478734|P1|STARTED|Overall Study||1
8306364|NCT01514864|20478744|P2|NOT COMPLETED|Overall Study||5
8306365|NCT01514864|20478745|P1|NOT COMPLETED|Overall Study||9
8306366|NCT01514864|20478744|P2|COMPLETED|Overall Study||0
8306367|NCT01514864|20478745|P1|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
8306368|NCT01514864|20478744|P2|STARTED|Overall Study||5
8306369|NCT01514864|20478745|P1|STARTED|Overall Study||9
8306370|NCT01514786|20478763|P2|NOT COMPLETED|Overall Study||0
8306371|NCT01514786|20478764|P1|NOT COMPLETED|Overall Study||0
8306372|NCT01514786|20478763|P2|COMPLETED|Overall Study||284
8306373|NCT01514786|20478764|P1|COMPLETED|Overall Study||286
8306374|NCT01514786|20478763|P2|STARTED|Overall Study||284
8306375|NCT01514786|20478764|P1|STARTED|Overall Study||286
8306376|NCT01514760|20478770|P1|NOT COMPLETED|Overall Study||2
8306377|NCT01514760|20478770|P1|COMPLETED|Overall Study||20
8306378|NCT01514760|20478770|P1|STARTED|Overall Study||22
8306379|NCT01514734|20478777|P1|NOT COMPLETED|Overall Study||0
8306380|NCT01514734|20478777|P1|COMPLETED|Overall Study||9
8306381|NCT01514734|20478777|P1|STARTED|Overall Study||9
8306382|NCT01514682|20478783|P2|NOT COMPLETED|Overall Study||6
8306383|NCT01514682|20478784|P1|NOT COMPLETED|Overall Study||6
8306384|NCT01514682|20478783|P2|COMPLETED|Overall Study||14
8306385|NCT01514682|20478784|P1|COMPLETED|Overall Study||13
8306386|NCT01514682|20478783|P2|STARTED|Overall Study||20
8306387|NCT01514682|20478784|P1|STARTED|Overall Study||19
8306388|NCT01514630|20478800|P1|NOT COMPLETED|Overall Study||3
8306389|NCT01514630|20478800|P1|COMPLETED|Overall Study||11
8306390|NCT01514630|20478800|P1|STARTED|Overall Study||14
8306391|NCT01514513|20478806|P2|NOT COMPLETED|Overall Study||1
8306392|NCT01514513|20478807|P1|NOT COMPLETED|Overall Study||1
8306393|NCT01514513|20478806|P2|COMPLETED|Overall Study||20
8306394|NCT01514513|20478807|P1|COMPLETED|Overall Study||20
8306395|NCT01514513|20478806|P2|STARTED|Overall Study||21
8306396|NCT01514513|20478807|P1|STARTED|Overall Study||21
8306397|NCT01514461|20478818|P3|NOT COMPLETED|Overall Study||4
8306398|NCT01514461|20478819|P2|NOT COMPLETED|Overall Study||3
8306399|NCT01514461|20478820|P1|NOT COMPLETED|Overall Study||5
8306400|NCT01514461|20478818|P3|COMPLETED|Overall Study||11
8306401|NCT01514461|20478819|P2|COMPLETED|Overall Study||12
8306402|NCT01514461|20478820|P1|COMPLETED|Overall Study||10
8306403|NCT01514461|20478818|P3|STARTED|Overall Study||15
8306404|NCT01514461|20478819|P2|STARTED|Overall Study||15
8306405|NCT01514461|20478820|P1|STARTED|Overall Study||15
8306406|NCT01514448|20478859|P2|NOT COMPLETED|Overall Study||8
8306407|NCT01514448|20478860|P1|NOT COMPLETED|Overall Study||12
8306408|NCT01514448|20478859|P2|COMPLETED|Overall Study||5
8306409|NCT01514448|20478860|P1|COMPLETED|Overall Study||4
8306410|NCT01514448|20478859|P2|Full Analysis Set (FAS)|Overall Study||13
8306411|NCT01514448|20478860|P1|Full Analysis Set (FAS)|Overall Study||12
8306412|NCT01514448|20478859|P2|STARTED|Overall Study||13
8306413|NCT01514448|20478860|P1|STARTED|Overall Study||16
8306414|NCT01514422|20478875|P1|NOT COMPLETED|Overall Study||1
8306415|NCT01514422|20478875|P1|COMPLETED|Overall Study||19
8306416|NCT01514422|20478875|P1|STARTED|Overall Study||20
8306417|NCT01514396|20478881|P1|NOT COMPLETED|Overall Study||0
8306418|NCT01514396|20478881|P1|COMPLETED|Overall Study||8
8306419|NCT01514396|20478881|P1|STARTED|Overall Study||8
8306420|NCT01514383|20478886|P1|NOT COMPLETED|Overall Study||0
8306421|NCT01514383|20478886|P1|COMPLETED|Overall Study||34
8306422|NCT01514383|20478886|P1|STARTED|Overall Study||34
8306423|NCT01514370|20478893|P2|NOT COMPLETED|Overall Study||16
8306424|NCT01514370|20478894|P1|NOT COMPLETED|Overall Study||11
8306425|NCT01514370|20478893|P2|COMPLETED|Overall Study||24
8306426|NCT01514370|20478894|P1|COMPLETED|Overall Study||29
8306427|NCT01514370|20478893|P2|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40
8306428|NCT01514370|20478894|P1|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38
8306429|NCT01514370|20478893|P2|STARTED|Overall Study||40
8306430|NCT01514370|20478894|P1|STARTED|Overall Study||40
8306431|NCT01514357|20478940|P2|NOT COMPLETED|Overall Study||0
8306432|NCT01514357|20478941|P1|NOT COMPLETED|Overall Study||4
8306433|NCT01514357|20478940|P2|COMPLETED|Overall Study||0
8306434|NCT01514357|20478941|P1|COMPLETED|Overall Study||8
8306435|NCT01514357|20478940|P2|STARTED|Overall Study||0
8306436|NCT01514357|20478941|P1|STARTED|Overall Study||12
8306437|NCT01514318|20478947|P1|NOT COMPLETED|Overall Study||0
8306438|NCT01514318|20478947|P1|COMPLETED|Overall Study||8
8306439|NCT01514318|20478947|P1|STARTED|Overall Study||8
8306440|NCT01514292|20478953|P1|NOT COMPLETED|Overall Study||0
8306441|NCT01514292|20478953|P1|COMPLETED|Overall Study||72
8306442|NCT01514292|20478953|P1|STARTED|Overall Study||72
8306443|NCT01514279|20478960|P3|NOT COMPLETED|Overall Study||5
8306444|NCT01514279|20478961|P2|NOT COMPLETED|Overall Study||13
8306445|NCT01514279|20478962|P1|NOT COMPLETED|Overall Study||11
8306446|NCT01514279|20478960|P3|COMPLETED|Overall Study||114
8306447|NCT01514279|20478961|P2|COMPLETED|Overall Study||110
8306448|NCT01514279|20478962|P1|COMPLETED|Overall Study||107
8306449|NCT01514279|20478960|P3|STARTED|Overall Study||119
8306450|NCT01514279|20478961|P2|STARTED|Overall Study||123
8306451|NCT01514279|20478962|P1|STARTED|Overall Study||118
8306452|NCT01514240|20479026|P2|NOT COMPLETED|Overall Study||11
8306453|NCT01514240|20479027|P1|NOT COMPLETED|Overall Study||6
8306454|NCT01514240|20479026|P2|COMPLETED|Overall Study||45
8306455|NCT01514240|20479027|P1|COMPLETED|Overall Study||50
8306456|NCT01514240|20479026|P2|STARTED|Overall Study||56
8306457|NCT01514240|20479027|P1|STARTED|Overall Study||56
8306458|NCT01514201|20479105|P4|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33
8306459|NCT01514201|20479106|P3|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8306460|NCT01514201|20479107|P2|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8306461|NCT01514201|20479108|P1|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8306462|NCT01514201|20479105|P4|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2
8306463|NCT01514201|20479106|P3|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8306464|NCT01514201|20479107|P2|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8306465|NCT01514201|20479108|P1|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
8306466|NCT01514201|20479105|P4|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35
8306467|NCT01514201|20479106|P3|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
8306468|NCT01514201|20479107|P2|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
8306469|NCT01514201|20479108|P1|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
8306470|NCT01514201|20479105|P4|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12
8306471|NCT01514201|20479106|P3|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8306472|NCT01514201|20479107|P2|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8306473|NCT01514201|20479108|P1|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8306474|NCT01514201|20479105|P4|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35
8306475|NCT01514201|20479106|P3|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8306476|NCT01514201|20479107|P2|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8306477|NCT01514201|20479108|P1|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
8306478|NCT01514201|20479105|P4|STARTED|PHASE II: Veliparib + Radiation Therapy||47
8306479|NCT01514201|20479106|P3|STARTED|PHASE II: Veliparib + Radiation Therapy||0
8306480|NCT01514201|20479107|P2|STARTED|PHASE II: Veliparib + Radiation Therapy||0
8306481|NCT01514201|20479108|P1|STARTED|PHASE II: Veliparib + Radiation Therapy||0
8306482|NCT01514201|20479105|P4|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8306483|NCT01514201|20479106|P3|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
8306484|NCT01514201|20479107|P2|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
8306485|NCT01514201|20479108|P1|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5
8306486|NCT01514201|20479105|P4|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8306487|NCT01514201|20479106|P3|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8306488|NCT01514201|20479107|P2|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8306489|NCT01514201|20479108|P1|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
8306490|NCT01514201|20479105|P4|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0
8306491|NCT01514201|20479106|P3|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
8306492|NCT01514201|20479107|P2|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
8306493|NCT01514201|20479108|P1|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5
8306494|NCT01514201|20479105|P4|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
8306495|NCT01514201|20479106|P3|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
8306496|NCT01514201|20479107|P2|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
8306497|NCT01514201|20479108|P1|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1
8306498|NCT01514201|20479105|P4|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
8306499|NCT01514201|20479106|P3|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
8306500|NCT01514201|20479107|P2|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
8306501|NCT01514201|20479108|P1|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5
8306502|NCT01514201|20479105|P4|STARTED|PHASE I: Veliparib + Radiation Therapy||0
8306503|NCT01514201|20479106|P3|STARTED|PHASE I: Veliparib + Radiation Therapy||6
8306504|NCT01514201|20479107|P2|STARTED|PHASE I: Veliparib + Radiation Therapy||6
8306505|NCT01514201|20479108|P1|STARTED|PHASE I: Veliparib + Radiation Therapy||6
8306506|NCT01514162|20479167|P1|NOT COMPLETED|Overall Study||85
8306507|NCT01514162|20479167|P1|COMPLETED|Overall Study||160
8306508|NCT01514162|20479167|P1|STARTED|Overall Study||245
8306509|NCT01514149|20479178|P5|NOT COMPLETED|Overall Study||1
8306510|NCT01514149|20479179|P4|NOT COMPLETED|Overall Study||1
8306511|NCT01514149|20479180|P3|NOT COMPLETED|Overall Study||3
8306512|NCT01514149|20479181|P2|NOT COMPLETED|Overall Study||1
8306513|NCT01514149|20479182|P1|NOT COMPLETED|Overall Study||3
8306514|NCT01514149|20479178|P5|COMPLETED|Overall Study||14
8306515|NCT01514149|20479179|P4|COMPLETED|Overall Study||13
8306516|NCT01514149|20479180|P3|COMPLETED|Overall Study||11
8306517|NCT01514149|20479181|P2|COMPLETED|Overall Study||14
8306518|NCT01514149|20479182|P1|COMPLETED|Overall Study||12
8306519|NCT01514149|20479178|P5|STARTED|Overall Study||15
8306520|NCT01514149|20479179|P4|STARTED|Overall Study||14
8306521|NCT01514149|20479180|P3|STARTED|Overall Study||14
8306522|NCT01514149|20479181|P2|STARTED|Overall Study||15
8306523|NCT01514149|20479182|P1|STARTED|Overall Study||15
8306524|NCT01514136|20479206|P8|NOT COMPLETED|Test Period; Test D*||0
8306525|NCT01514136|20479207|P7|NOT COMPLETED|Test Period; Test D*||0
8306526|NCT01514136|20479208|P6|NOT COMPLETED|Test Period; Test D*||0
8306527|NCT01514136|20479209|P5|NOT COMPLETED|Test Period; Test D*||0
8306528|NCT01514136|20479210|P4|NOT COMPLETED|Test Period; Test D*||0
8306529|NCT01514136|20479211|P3|NOT COMPLETED|Test Period; Test D*||0
8306530|NCT01514136|20479212|P2|NOT COMPLETED|Test Period; Test D*||0
8306531|NCT01514136|20479213|P1|NOT COMPLETED|Test Period; Test D*||0
8306532|NCT01514136|20479206|P8|COMPLETED|Test Period; Test D*||23
8306533|NCT01514136|20479207|P7|COMPLETED|Test Period; Test D*||0
8306534|NCT01514136|20479208|P6|COMPLETED|Test Period; Test D*||0
8306535|NCT01514136|20479209|P5|COMPLETED|Test Period; Test D*||0
8306536|NCT01514136|20479210|P4|COMPLETED|Test Period; Test D*||0
8306537|NCT01514136|20479211|P3|COMPLETED|Test Period; Test D*||0
8306538|NCT01514136|20479212|P2|COMPLETED|Test Period; Test D*||0
8306539|NCT01514136|20479213|P1|COMPLETED|Test Period; Test D*||0
8306540|NCT01514136|20479206|P8|STARTED|Test Period; Test D*||23
8306541|NCT01514136|20479207|P7|STARTED|Test Period; Test D*||0
8306542|NCT01514136|20479208|P6|STARTED|Test Period; Test D*||0
8306543|NCT01514136|20479209|P5|STARTED|Test Period; Test D*||0
8306544|NCT01514136|20479210|P4|STARTED|Test Period; Test D*||0
8306545|NCT01514136|20479211|P3|STARTED|Test Period; Test D*||0
8306546|NCT01514136|20479212|P2|STARTED|Test Period; Test D*||0
8306547|NCT01514136|20479213|P1|STARTED|Test Period; Test D*||0
8306548|NCT01514136|20479206|P8|NOT COMPLETED|Test Period 2; Test C*||0
8306549|NCT01514136|20479207|P7|NOT COMPLETED|Test Period 2; Test C*||3
8306550|NCT01514136|20479208|P6|NOT COMPLETED|Test Period 2; Test C*||0
8306551|NCT01514136|20479209|P5|NOT COMPLETED|Test Period 2; Test C*||0
8306552|NCT01514136|20479210|P4|NOT COMPLETED|Test Period 2; Test C*||0
8306553|NCT01514136|20479211|P3|NOT COMPLETED|Test Period 2; Test C*||0
8306554|NCT01514136|20479212|P2|NOT COMPLETED|Test Period 2; Test C*||0
8306555|NCT01514136|20479213|P1|NOT COMPLETED|Test Period 2; Test C*||0
8306556|NCT01514136|20479206|P8|COMPLETED|Test Period 2; Test C*||0
8306557|NCT01514136|20479207|P7|COMPLETED|Test Period 2; Test C*||23
8306558|NCT01514136|20479208|P6|COMPLETED|Test Period 2; Test C*||0
8306559|NCT01514136|20479209|P5|COMPLETED|Test Period 2; Test C*||0
8306560|NCT01514136|20479210|P4|COMPLETED|Test Period 2; Test C*||0
8306561|NCT01514136|20479211|P3|COMPLETED|Test Period 2; Test C*||0
8306562|NCT01514136|20479212|P2|COMPLETED|Test Period 2; Test C*||0
8306563|NCT01514136|20479213|P1|COMPLETED|Test Period 2; Test C*||0
8306564|NCT01514136|20479206|P8|STARTED|Test Period 2; Test C*||0
8306565|NCT01514136|20479207|P7|STARTED|Test Period 2; Test C*||26
8306566|NCT01514136|20479208|P6|STARTED|Test Period 2; Test C*||0
8306567|NCT01514136|20479209|P5|STARTED|Test Period 2; Test C*||0
8306568|NCT01514136|20479210|P4|STARTED|Test Period 2; Test C*||0
8306569|NCT01514136|20479211|P3|STARTED|Test Period 2; Test C*||0
8306570|NCT01514136|20479212|P2|STARTED|Test Period 2; Test C*||0
8306571|NCT01514136|20479213|P1|STARTED|Test Period 2; Test C*||0
8306572|NCT01514136|20479206|P8|NOT COMPLETED|Test Period 2; Test B*||0
8306573|NCT01514136|20479207|P7|NOT COMPLETED|Test Period 2; Test B*||0
8306574|NCT01514136|20479208|P6|NOT COMPLETED|Test Period 2; Test B*||2
8306575|NCT01514136|20479209|P5|NOT COMPLETED|Test Period 2; Test B*||0
8306576|NCT01514136|20479210|P4|NOT COMPLETED|Test Period 2; Test B*||0
8306577|NCT01514136|20479211|P3|NOT COMPLETED|Test Period 2; Test B*||0
8306578|NCT01514136|20479212|P2|NOT COMPLETED|Test Period 2; Test B*||0
8306579|NCT01514136|20479213|P1|NOT COMPLETED|Test Period 2; Test B*||0
8306580|NCT01514136|20479206|P8|COMPLETED|Test Period 2; Test B*||0
8306581|NCT01514136|20479207|P7|COMPLETED|Test Period 2; Test B*||0
8306582|NCT01514136|20479208|P6|COMPLETED|Test Period 2; Test B*||26
8306583|NCT01514136|20479209|P5|COMPLETED|Test Period 2; Test B*||0
8306584|NCT01514136|20479210|P4|COMPLETED|Test Period 2; Test B*||0
8306585|NCT01514136|20479211|P3|COMPLETED|Test Period 2; Test B*||0
8306586|NCT01514136|20479212|P2|COMPLETED|Test Period 2; Test B*||0
8306587|NCT01514136|20479213|P1|COMPLETED|Test Period 2; Test B*||0
8306588|NCT01514136|20479206|P8|STARTED|Test Period 2; Test B*||0
8306589|NCT01514136|20479207|P7|STARTED|Test Period 2; Test B*||0
8306590|NCT01514136|20479208|P6|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
8306591|NCT01514136|20479209|P5|STARTED|Test Period 2; Test B*||0
8306592|NCT01514136|20479210|P4|STARTED|Test Period 2; Test B*||0
8306593|NCT01514136|20479211|P3|STARTED|Test Period 2; Test B*||0
8306594|NCT01514136|20479212|P2|STARTED|Test Period 2; Test B*||0
8306595|NCT01514136|20479213|P1|STARTED|Test Period 2; Test B*||0
8306596|NCT01514136|20479206|P8|NOT COMPLETED|Test Period 2; Test A*||0
8306597|NCT01514136|20479207|P7|NOT COMPLETED|Test Period 2; Test A*||0
8306598|NCT01514136|20479208|P6|NOT COMPLETED|Test Period 2; Test A*||0
8306599|NCT01514136|20479209|P5|NOT COMPLETED|Test Period 2; Test A*||2
8306600|NCT01514136|20479210|P4|NOT COMPLETED|Test Period 2; Test A*||0
8306601|NCT01514136|20479211|P3|NOT COMPLETED|Test Period 2; Test A*||0
8306602|NCT01514136|20479212|P2|NOT COMPLETED|Test Period 2; Test A*||0
8306603|NCT01514136|20479213|P1|NOT COMPLETED|Test Period 2; Test A*||0
8306604|NCT01514136|20479206|P8|COMPLETED|Test Period 2; Test A*||0
8306605|NCT01514136|20479207|P7|COMPLETED|Test Period 2; Test A*||0
8306606|NCT01514136|20479208|P6|COMPLETED|Test Period 2; Test A*||0
8306607|NCT01514136|20479209|P5|COMPLETED|Test Period 2; Test A*||26
8306608|NCT01514136|20479210|P4|COMPLETED|Test Period 2; Test A*||0
8306609|NCT01514136|20479211|P3|COMPLETED|Test Period 2; Test A*||0
8306610|NCT01514136|20479212|P2|COMPLETED|Test Period 2; Test A*||0
8306611|NCT01514136|20479213|P1|COMPLETED|Test Period 2; Test A*||0
8306612|NCT01514136|20479206|P8|STARTED|Test Period 2; Test A*||0
8306613|NCT01514136|20479207|P7|STARTED|Test Period 2; Test A*||0
8306614|NCT01514136|20479208|P6|STARTED|Test Period 2; Test A*||0
8306615|NCT01514136|20479209|P5|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
8306616|NCT01514136|20479210|P4|STARTED|Test Period 2; Test A*||0
8306617|NCT01514136|20479211|P3|STARTED|Test Period 2; Test A*||0
8306618|NCT01514136|20479212|P2|STARTED|Test Period 2; Test A*||0
8306619|NCT01514136|20479213|P1|STARTED|Test Period 2; Test A*||0
8306620|NCT01514136|20479206|P8|NOT COMPLETED|Test Period 1; Test D||0
8306621|NCT01514136|20479207|P7|NOT COMPLETED|Test Period 1; Test D||0
8306622|NCT01514136|20479208|P6|NOT COMPLETED|Test Period 1; Test D||0
8306623|NCT01514136|20479209|P5|NOT COMPLETED|Test Period 1; Test D||0
8306624|NCT01514136|20479210|P4|NOT COMPLETED|Test Period 1; Test D||2
8306625|NCT01514136|20479211|P3|NOT COMPLETED|Test Period 1; Test D||0
8306626|NCT01514136|20479212|P2|NOT COMPLETED|Test Period 1; Test D||0
8306627|NCT01514136|20479213|P1|NOT COMPLETED|Test Period 1; Test D||0
8306628|NCT01514136|20479206|P8|COMPLETED|Test Period 1; Test D||0
8306629|NCT01514136|20479207|P7|COMPLETED|Test Period 1; Test D||0
8306630|NCT01514136|20479208|P6|COMPLETED|Test Period 1; Test D||0
8306631|NCT01514136|20479209|P5|COMPLETED|Test Period 1; Test D||0
8306632|NCT01514136|20479210|P4|COMPLETED|Test Period 1; Test D||24
8306633|NCT01514136|20479211|P3|COMPLETED|Test Period 1; Test D||0
8306634|NCT01514136|20479212|P2|COMPLETED|Test Period 1; Test D||0
8306635|NCT01514136|20479213|P1|COMPLETED|Test Period 1; Test D||0
8306636|NCT01514136|20479206|P8|STARTED|Test Period 1; Test D||0
8306637|NCT01514136|20479207|P7|STARTED|Test Period 1; Test D||0
8306638|NCT01514136|20479208|P6|STARTED|Test Period 1; Test D||0
8306639|NCT01514136|20479209|P5|STARTED|Test Period 1; Test D||0
8306640|NCT01514136|20479210|P4|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
8306641|NCT01514136|20479211|P3|STARTED|Test Period 1; Test D||0
8306642|NCT01514136|20479212|P2|STARTED|Test Period 1; Test D||0
8306643|NCT01514136|20479213|P1|STARTED|Test Period 1; Test D||0
8306644|NCT01514136|20479206|P8|NOT COMPLETED|Test Period 1; Test C||0
8306645|NCT01514136|20479207|P7|NOT COMPLETED|Test Period 1; Test C||0
8306646|NCT01514136|20479208|P6|NOT COMPLETED|Test Period 1; Test C||0
8306647|NCT01514136|20479209|P5|NOT COMPLETED|Test Period 1; Test C||0
8306648|NCT01514136|20479210|P4|NOT COMPLETED|Test Period 1; Test C||0
8306649|NCT01514136|20479211|P3|NOT COMPLETED|Test Period 1; Test C||0
8306650|NCT01514136|20479212|P2|NOT COMPLETED|Test Period 1; Test C||0
8306651|NCT01514136|20479213|P1|NOT COMPLETED|Test Period 1; Test C||0
8306652|NCT01514136|20479206|P8|COMPLETED|Test Period 1; Test C||0
8306653|NCT01514136|20479207|P7|COMPLETED|Test Period 1; Test C||0
8306654|NCT01514136|20479208|P6|COMPLETED|Test Period 1; Test C||0
8306655|NCT01514136|20479209|P5|COMPLETED|Test Period 1; Test C||0
8306656|NCT01514136|20479210|P4|COMPLETED|Test Period 1; Test C||0
8306657|NCT01514136|20479211|P3|COMPLETED|Test Period 1; Test C||24
8306658|NCT01514136|20479212|P2|COMPLETED|Test Period 1; Test C||0
8306659|NCT01514136|20479213|P1|COMPLETED|Test Period 1; Test C||0
8306660|NCT01514136|20479206|P8|STARTED|Test Period 1; Test C||0
8306661|NCT01514136|20479207|P7|STARTED|Test Period 1; Test C||0
8306662|NCT01514136|20479208|P6|STARTED|Test Period 1; Test C||0
8306663|NCT01514136|20479209|P5|STARTED|Test Period 1; Test C||0
8306664|NCT01514136|20479210|P4|STARTED|Test Period 1; Test C||0
8306665|NCT01514136|20479211|P3|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
8306666|NCT01514136|20479212|P2|STARTED|Test Period 1; Test C||0
8306667|NCT01514136|20479213|P1|STARTED|Test Period 1; Test C||0
8306668|NCT01514136|20479206|P8|NOT COMPLETED|Test Period 1; Test B||0
8306669|NCT01514136|20479207|P7|NOT COMPLETED|Test Period 1; Test B||0
8306670|NCT01514136|20479208|P6|NOT COMPLETED|Test Period 1; Test B||0
8306671|NCT01514136|20479209|P5|NOT COMPLETED|Test Period 1; Test B||0
8306672|NCT01514136|20479210|P4|NOT COMPLETED|Test Period 1; Test B||0
8306673|NCT01514136|20479211|P3|NOT COMPLETED|Test Period 1; Test B||0
8306674|NCT01514136|20479212|P2|NOT COMPLETED|Test Period 1; Test B||1
8306675|NCT01514136|20479213|P1|NOT COMPLETED|Test Period 1; Test B||0
8306676|NCT01514136|20479206|P8|COMPLETED|Test Period 1; Test B||0
8306677|NCT01514136|20479207|P7|COMPLETED|Test Period 1; Test B||0
8306678|NCT01514136|20479208|P6|COMPLETED|Test Period 1; Test B||0
8306679|NCT01514136|20479209|P5|COMPLETED|Test Period 1; Test B||0
8306680|NCT01514136|20479210|P4|COMPLETED|Test Period 1; Test B||0
8306681|NCT01514136|20479211|P3|COMPLETED|Test Period 1; Test B||0
8306682|NCT01514136|20479212|P2|COMPLETED|Test Period 1; Test B||23
8306683|NCT01514136|20479213|P1|COMPLETED|Test Period 1; Test B||0
8306684|NCT01514136|20479206|P8|STARTED|Test Period 1; Test B||0
8306685|NCT01514136|20479207|P7|STARTED|Test Period 1; Test B||0
8306686|NCT01514136|20479208|P6|STARTED|Test Period 1; Test B||0
8306687|NCT01514136|20479209|P5|STARTED|Test Period 1; Test B||0
8306688|NCT01514136|20479210|P4|STARTED|Test Period 1; Test B||0
8306689|NCT01514136|20479211|P3|STARTED|Test Period 1; Test B||0
8306690|NCT01514136|20479212|P2|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
8306691|NCT01514136|20479213|P1|STARTED|Test Period 1; Test B||0
8306692|NCT01514136|20479206|P8|NOT COMPLETED|Test Period 1; Test A||0
8306693|NCT01514136|20479207|P7|NOT COMPLETED|Test Period 1; Test A||0
8306694|NCT01514136|20479208|P6|NOT COMPLETED|Test Period 1; Test A||0
8306695|NCT01514136|20479209|P5|NOT COMPLETED|Test Period 1; Test A||0
8306696|NCT01514136|20479210|P4|NOT COMPLETED|Test Period 1; Test A||0
8306697|NCT01514136|20479211|P3|NOT COMPLETED|Test Period 1; Test A||0
8306698|NCT01514136|20479212|P2|NOT COMPLETED|Test Period 1; Test A||0
8306699|NCT01514136|20479213|P1|NOT COMPLETED|Test Period 1; Test A||3
8306700|NCT01514136|20479206|P8|COMPLETED|Test Period 1; Test A||0
8306701|NCT01514136|20479207|P7|COMPLETED|Test Period 1; Test A||0
8306702|NCT01514136|20479208|P6|COMPLETED|Test Period 1; Test A||0
8306703|NCT01514136|20479209|P5|COMPLETED|Test Period 1; Test A||0
8306704|NCT01514136|20479210|P4|COMPLETED|Test Period 1; Test A||0
8306705|NCT01514136|20479211|P3|COMPLETED|Test Period 1; Test A||0
8306706|NCT01514136|20479212|P2|COMPLETED|Test Period 1; Test A||0
8306707|NCT01514136|20479213|P1|COMPLETED|Test Period 1; Test A||22
8306708|NCT01514136|20479206|P8|STARTED|Test Period 1; Test A||0
8306709|NCT01514136|20479207|P7|STARTED|Test Period 1; Test A||0
8306710|NCT01514136|20479208|P6|STARTED|Test Period 1; Test A||0
8306711|NCT01514136|20479209|P5|STARTED|Test Period 1; Test A||0
8306712|NCT01514136|20479210|P4|STARTED|Test Period 1; Test A||0
8306713|NCT01514136|20479211|P3|STARTED|Test Period 1; Test A||0
8306714|NCT01514136|20479212|P2|STARTED|Test Period 1; Test A||0
8306715|NCT01514136|20479213|P1|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
8306716|NCT01513967|20479247|P8|NOT COMPLETED|Overall Study||2
8306717|NCT01513967|20479248|P7|NOT COMPLETED|Overall Study||2
8306718|NCT01513967|20479249|P6|NOT COMPLETED|Overall Study||1
8306719|NCT01513967|20479250|P5|NOT COMPLETED|Overall Study||0
8306720|NCT01513967|20479251|P4|NOT COMPLETED|Overall Study||0
8306721|NCT01513967|20479252|P3|NOT COMPLETED|Overall Study||0
8306722|NCT01513967|20479253|P2|NOT COMPLETED|Overall Study||0
8306723|NCT01513967|20479254|P1|NOT COMPLETED|Overall Study||0
8306724|NCT01513967|20479247|P8|COMPLETED|Overall Study||6
8306725|NCT01513967|20479248|P7|COMPLETED|Overall Study||3
8306726|NCT01513967|20479249|P6|COMPLETED|Overall Study||3
8306727|NCT01513967|20479250|P5|COMPLETED|Overall Study||4
8306728|NCT01513967|20479251|P4|COMPLETED|Overall Study||6
8306729|NCT01513967|20479252|P3|COMPLETED|Overall Study||4
8306730|NCT01513967|20479253|P2|COMPLETED|Overall Study||4
8306731|NCT01513967|20479254|P1|COMPLETED|Overall Study||4
8306732|NCT01513967|20479247|P8|STARTED|Overall Study||8
8306733|NCT01513967|20479248|P7|STARTED|Overall Study||5
8306734|NCT01513967|20479249|P6|STARTED|Overall Study||4
8306735|NCT01513967|20479250|P5|STARTED|Overall Study||4
8306736|NCT01513967|20479251|P4|STARTED|Overall Study||6
8306737|NCT01513967|20479252|P3|STARTED|Overall Study||4
8306738|NCT01513967|20479253|P2|STARTED|Overall Study||4
8306739|NCT01513967|20479254|P1|STARTED|Overall Study||4
8306740|NCT01513902|20479275|P3|NOT COMPLETED|Overall Study||0
8306741|NCT01513902|20479276|P2|NOT COMPLETED|Overall Study||0
8306742|NCT01513902|20479277|P1|NOT COMPLETED|Overall Study||0
8306743|NCT01513902|20479275|P3|COMPLETED|Overall Study||9
8306744|NCT01513902|20479276|P2|COMPLETED|Overall Study||9
8306745|NCT01513902|20479277|P1|COMPLETED|Overall Study||8
8306746|NCT01513902|20479275|P3|STARTED|Overall Study||9
8306747|NCT01513902|20479276|P2|STARTED|Overall Study||9
8306748|NCT01513902|20479277|P1|STARTED|Overall Study||8
8306753|NCT01513590|20479323|P2|NOT COMPLETED|Overall Study||13
8306754|NCT01513590|20479324|P1|NOT COMPLETED|Overall Study||10
8306755|NCT01513590|20479323|P2|COMPLETED|Overall Study||184
8306756|NCT01513590|20479324|P1|COMPLETED|Overall Study||187
8306757|NCT01513590|20479323|P2|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
8306758|NCT01513590|20479324|P1|Exposed|Overall Study|"One (1) subject was withdrawn prior to exposure due to non fulfilment of inclusion criteria"|196
8306759|NCT01513590|20479323|P2|STARTED|Overall Study||197
8306760|NCT01513590|20479324|P1|STARTED|Overall Study||197
8306761|NCT01513551|20479345|P3|NOT COMPLETED|Overall Study||5
8306762|NCT01513551|20479346|P2|NOT COMPLETED|Overall Study||6
8306763|NCT01513551|20479347|P1|NOT COMPLETED|Overall Study||4
8306764|NCT01513551|20479345|P3|COMPLETED|Overall Study||226
8306765|NCT01513551|20479346|P2|COMPLETED|Overall Study||225
8306766|NCT01513551|20479347|P1|COMPLETED|Overall Study||226
8306767|NCT01513551|20479345|P3|Vaccinated|Overall Study||230
8306768|NCT01513551|20479346|P2|Vaccinated|Overall Study||231
8306769|NCT01513551|20479347|P1|Vaccinated|Overall Study||230
8306770|NCT01513551|20479345|P3|STARTED|Overall Study||231
8306771|NCT01513551|20479346|P2|STARTED|Overall Study||231
8306772|NCT01513551|20479347|P1|STARTED|Overall Study||230
8306773|NCT01513538|20479373|P1|NOT COMPLETED|Overall Study||5
8306774|NCT01513538|20479373|P1|COMPLETED|Overall Study||573
8306775|NCT01513538|20479373|P1|STARTED|Overall Study||578
8306776|NCT01513473|20479379|P2|NOT COMPLETED|Extension Trial (26 Weeks)||6
8306777|NCT01513473|20479380|P1|NOT COMPLETED|Extension Trial (26 Weeks)||1
8306778|NCT01513473|20479379|P2|COMPLETED|Extension Trial (26 Weeks)||122
8306779|NCT01513473|20479380|P1|COMPLETED|Extension Trial (26 Weeks)||151
8306780|NCT01513473|20479379|P2|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
8306781|NCT01513473|20479380|P1|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
8306782|NCT01513473|20479379|P2|NOT COMPLETED|Main Trial (26 Weeks)||11
8306783|NCT01513473|20479380|P1|NOT COMPLETED|Main Trial (26 Weeks)||4
8306784|NCT01513473|20479379|P2|COMPLETED|Main Trial (26 Weeks)||165
8306785|NCT01513473|20479380|P1|COMPLETED|Main Trial (26 Weeks)||170
8306786|NCT01513473|20479379|P2|Exposed|Main Trial (26 Weeks)||175
8306787|NCT01513473|20479380|P1|Exposed|Main Trial (26 Weeks)||174
8306788|NCT01513473|20479379|P2|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
8306789|NCT01513473|20479380|P1|STARTED|Main Trial (26 Weeks)||174
8306790|NCT01513460|20479407|P3|NOT COMPLETED|Overall Study||56
8306791|NCT01513460|20479408|P2|NOT COMPLETED|Overall Study||32
8306792|NCT01513460|20479409|P1|NOT COMPLETED|Overall Study||29
8306793|NCT01513460|20479407|P3|COMPLETED|Overall Study||201
8306794|NCT01513460|20479408|P2|COMPLETED|Overall Study||226
8306795|NCT01513460|20479409|P1|COMPLETED|Overall Study||229
8306796|NCT01513460|20479407|P3|Per-protocol Set|Overall Study||166
8306797|NCT01513460|20479408|P2|Per-protocol Set|Overall Study||186
8306798|NCT01513460|20479409|P1|Per-protocol Set|Overall Study||196
8306799|NCT01513460|20479407|P3|Full Analysis Set|Overall Study||257
8306800|NCT01513460|20479408|P2|Full Analysis Set|Overall Study||258
8306801|NCT01513460|20479409|P1|Full Analysis Set|Overall Study||257
8306802|NCT01513460|20479407|P3|STARTED|Overall Study||257
8306803|NCT01513460|20479408|P2|STARTED|Overall Study||258
8306804|NCT01513460|20479409|P1|STARTED|Overall Study||258
8306805|NCT01513447|20479435|P2|NOT COMPLETED|Overall Study||0
8306806|NCT01513447|20479436|P1|NOT COMPLETED|Overall Study||0
8306807|NCT01513447|20479435|P2|COMPLETED|Overall Study||5
8306808|NCT01513447|20479436|P1|COMPLETED|Overall Study||3
8306809|NCT01513447|20479435|P2|STARTED|Overall Study||5
8306810|NCT01513447|20479436|P1|STARTED|Overall Study||3
8306811|NCT01513330|20479444|P2|NOT COMPLETED|Standard Care First,||4
8306812|NCT01513330|20479445|P1|NOT COMPLETED|Standard Care First,||4
8306813|NCT01513330|20479444|P2|COMPLETED|Standard Care First,||52
8306814|NCT01513330|20479445|P1|COMPLETED|Standard Care First,||56
8306815|NCT01513330|20479444|P2|STARTED|Standard Care First,||56
8306816|NCT01513330|20479445|P1|STARTED|Standard Care First,||60
8306817|NCT01513330|20479444|P2|NOT COMPLETED|SenSura Mio First,||2
8306818|NCT01513330|20479445|P1|NOT COMPLETED|SenSura Mio First,||4
8306819|NCT01513330|20479444|P2|COMPLETED|SenSura Mio First,||56
8306820|NCT01513330|20479445|P1|COMPLETED|SenSura Mio First,||60
8306821|NCT01513330|20479444|P2|STARTED|SenSura Mio First,||58
8306822|NCT01513330|20479445|P1|STARTED|SenSura Mio First,||64
8306823|NCT01513317|20479453|P2|NOT COMPLETED|Overall Study||24
8306824|NCT01513317|20479454|P1|NOT COMPLETED|Overall Study||34
8306825|NCT01513317|20479453|P2|COMPLETED|Overall Study||2
8306826|NCT01513317|20479454|P1|COMPLETED|Overall Study||16
8306827|NCT01513317|20479453|P2|STARTED|Overall Study||26
8306828|NCT01513317|20479454|P1|STARTED|Overall Study||50
8306829|NCT01513291|20479472|P5|NOT COMPLETED|Run-out Period||0
8306830|NCT01513291|20479473|P4|NOT COMPLETED|Run-out Period||2
8306831|NCT01513291|20479474|P3|NOT COMPLETED|Run-out Period||0
8306832|NCT01513291|20479475|P2|NOT COMPLETED|Run-out Period||0
8306833|NCT01513291|20479476|P1|NOT COMPLETED|Run-out Period||0
8306834|NCT01513291|20479472|P5|COMPLETED|Run-out Period||101
8306835|NCT01513291|20479473|P4|COMPLETED|Run-out Period||45
8306836|NCT01513291|20479474|P3|COMPLETED|Run-out Period||50
8306837|NCT01513291|20479475|P2|COMPLETED|Run-out Period||0
8306838|NCT01513291|20479476|P1|COMPLETED|Run-out Period||0
8306839|NCT01513291|20479472|P5|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
8306840|NCT01513291|20479473|P4|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
8306841|NCT01513291|20479474|P3|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
8306842|NCT01513291|20479475|P2|STARTED|Run-out Period||0
8306843|NCT01513291|20479476|P1|STARTED|Run-out Period||0
8306844|NCT01513291|20479472|P5|NOT COMPLETED|Treatment Period||0
8306845|NCT01513291|20479473|P4|NOT COMPLETED|Treatment Period||0
8306846|NCT01513291|20479474|P3|NOT COMPLETED|Treatment Period||0
8306847|NCT01513291|20479475|P2|NOT COMPLETED|Treatment Period||16
8306848|NCT01513291|20479476|P1|NOT COMPLETED|Treatment Period||23
8306849|NCT01513291|20479472|P5|COMPLETED|Treatment Period||0
8306850|NCT01513291|20479473|P4|COMPLETED|Treatment Period||0
8306851|NCT01513291|20479474|P3|COMPLETED|Treatment Period||0
8306852|NCT01513291|20479475|P2|COMPLETED|Treatment Period||101
8306853|NCT01513291|20479476|P1|COMPLETED|Treatment Period||97
8306854|NCT01513291|20479472|P5|Treated|Treatment Period||0
8306855|NCT01513291|20479473|P4|Treated|Treatment Period||0
8306856|NCT01513291|20479474|P3|Treated|Treatment Period||0
8306857|NCT01513291|20479475|P2|Treated|Treatment Period||115
8306858|NCT01513291|20479476|P1|Treated|Treatment Period||120
8306859|NCT01513291|20479472|P5|STARTED|Treatment Period||0
8306860|NCT01513291|20479473|P4|STARTED|Treatment Period||0
8306861|NCT01513291|20479474|P3|STARTED|Treatment Period||0
8306862|NCT01513291|20479475|P2|STARTED|Treatment Period||117
8306863|NCT01513291|20479476|P1|STARTED|Treatment Period||120
8306864|NCT01513239|20479504|P6|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
8306865|NCT01513239|20479505|P5|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
8306866|NCT01513239|20479506|P4|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
8306867|NCT01513239|20479507|P3|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
8306868|NCT01513239|20479508|P2|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
8306869|NCT01513239|20479509|P1|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
8306870|NCT01513239|20479504|P6|COMPLETED|Period 2: 9 Month Extension Phase||78
8306871|NCT01513239|20479505|P5|COMPLETED|Period 2: 9 Month Extension Phase||90
8306872|NCT01513239|20479506|P4|COMPLETED|Period 2: 9 Month Extension Phase||102
8306873|NCT01513239|20479507|P3|COMPLETED|Period 2: 9 Month Extension Phase||0
8306874|NCT01513239|20479508|P2|COMPLETED|Period 2: 9 Month Extension Phase||0
8306875|NCT01513239|20479509|P1|COMPLETED|Period 2: 9 Month Extension Phase||0
8306876|NCT01513239|20479504|P6|STARTED|Period 2: 9 Month Extension Phase||83
8306877|NCT01513239|20479505|P5|STARTED|Period 2: 9 Month Extension Phase||100
8306878|NCT01513239|20479506|P4|STARTED|Period 2: 9 Month Extension Phase||112
8306879|NCT01513239|20479507|P3|STARTED|Period 2: 9 Month Extension Phase||0
8306880|NCT01513239|20479508|P2|STARTED|Period 2: 9 Month Extension Phase||0
8306881|NCT01513239|20479509|P1|STARTED|Period 2: 9 Month Extension Phase||0
8306882|NCT01513239|20479504|P6|NOT COMPLETED|Period 1: Main Phase||0
8306883|NCT01513239|20479505|P5|NOT COMPLETED|Period 1: Main Phase||0
8306884|NCT01513239|20479506|P4|NOT COMPLETED|Period 1: Main Phase||0
8306885|NCT01513239|20479507|P3|NOT COMPLETED|Period 1: Main Phase||88
8306886|NCT01513239|20479508|P2|NOT COMPLETED|Period 1: Main Phase||70
8306887|NCT01513239|20479509|P1|NOT COMPLETED|Period 1: Main Phase||75
8306888|NCT01513239|20479504|P6|COMPLETED|Period 1: Main Phase||0
8306889|NCT01513239|20479505|P5|COMPLETED|Period 1: Main Phase||0
8306890|NCT01513239|20479506|P4|COMPLETED|Period 1: Main Phase||0
8306891|NCT01513239|20479507|P3|COMPLETED|Period 1: Main Phase||311
8306892|NCT01513239|20479508|P2|COMPLETED|Period 1: Main Phase||337
8306893|NCT01513239|20479509|P1|COMPLETED|Period 1: Main Phase||322
8306894|NCT01513239|20479504|P6|All Participants as Treated|Period 1: Main Phase||0
8306895|NCT01513239|20479505|P5|All Participants as Treated|Period 1: Main Phase||0
8306896|NCT01513239|20479506|P4|All Participants as Treated|Period 1: Main Phase||0
8306897|NCT01513239|20479507|P3|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
8306898|NCT01513239|20479508|P2|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
8306899|NCT01513239|20479509|P1|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
8306900|NCT01513239|20479504|P6|Treated|Period 1: Main Phase||0
8306901|NCT01513239|20479505|P5|Treated|Period 1: Main Phase||0
8306902|NCT01513239|20479506|P4|Treated|Period 1: Main Phase||0
8306903|NCT01513239|20479507|P3|Treated|Period 1: Main Phase|Treated participants|381
8306904|NCT01513239|20479508|P2|Treated|Period 1: Main Phase|Treated participants|396
8306905|NCT01513239|20479509|P1|Treated|Period 1: Main Phase|Treated participants|391
8306906|NCT01513239|20479504|P6|STARTED|Period 1: Main Phase||0
8306907|NCT01513239|20479505|P5|STARTED|Period 1: Main Phase||0
8306908|NCT01513239|20479506|P4|STARTED|Period 1: Main Phase||0
8306909|NCT01513239|20479507|P3|STARTED|Period 1: Main Phase|Randomized participants|399
8306910|NCT01513239|20479508|P2|STARTED|Period 1: Main Phase|Randomized participants|407
8306911|NCT01513239|20479509|P1|STARTED|Period 1: Main Phase|Randomized participants|397
8306912|NCT01513148|20479562|P2|NOT COMPLETED|Overall Study||2
8306913|NCT01513148|20479563|P1|NOT COMPLETED|Overall Study||2
8306914|NCT01513148|20479562|P2|COMPLETED|Overall Study||14
8306915|NCT01513148|20479563|P1|COMPLETED|Overall Study||14
8306916|NCT01513148|20479562|P2|STARTED|Overall Study||16
8306917|NCT01513148|20479563|P1|STARTED|Overall Study||16
8306918|NCT01513122|20479611|P2|NOT COMPLETED|Overall Study||3
8306919|NCT01513122|20479612|P1|NOT COMPLETED|Overall Study||11
8306920|NCT01513122|20479611|P2|COMPLETED|Overall Study||105
8306921|NCT01513122|20479612|P1|COMPLETED|Overall Study||91
8306922|NCT01513122|20479611|P2|STARTED|Overall Study||108
8306923|NCT01513122|20479612|P1|STARTED|Overall Study||102
8306924|NCT01512979|20479630|P2|NOT COMPLETED|Overall Study||22
8306925|NCT01512979|20479631|P1|NOT COMPLETED|Overall Study||19
8306926|NCT01512979|20479630|P2|COMPLETED|Overall Study||135
8306927|NCT01512979|20479631|P1|COMPLETED|Overall Study||140
8306928|NCT01512979|20479630|P2|STARTED|Overall Study|Randomised and treated|157
8306929|NCT01512979|20479631|P1|STARTED|Overall Study|Randomised and treated|159
8306930|NCT01512849|20479651|P4|NOT COMPLETED|Crossover Period 2||0
8306931|NCT01512849|20479652|P3|NOT COMPLETED|Crossover Period 2||0
8306932|NCT01512849|20479653|P2|NOT COMPLETED|Crossover Period 2||0
8306933|NCT01512849|20479654|P1|NOT COMPLETED|Crossover Period 2||0
8306934|NCT01512849|20479651|P4|COMPLETED|Crossover Period 2||6
8306935|NCT01512849|20479652|P3|COMPLETED|Crossover Period 2||6
8306936|NCT01512849|20479653|P2|COMPLETED|Crossover Period 2||6
8306937|NCT01512849|20479654|P1|COMPLETED|Crossover Period 2||6
8306938|NCT01512849|20479651|P4|STARTED|Crossover Period 2||6
8306939|NCT01512849|20479652|P3|STARTED|Crossover Period 2||6
8306940|NCT01512849|20479653|P2|STARTED|Crossover Period 2||6
8306941|NCT01512849|20479654|P1|STARTED|Crossover Period 2||6
8306942|NCT01512849|20479651|P4|NOT COMPLETED|Crossover Period 1||0
8306943|NCT01512849|20479652|P3|NOT COMPLETED|Crossover Period 1||0
8306944|NCT01512849|20479653|P2|NOT COMPLETED|Crossover Period 1||0
8306945|NCT01512849|20479654|P1|NOT COMPLETED|Crossover Period 1||0
8306946|NCT01512849|20479651|P4|COMPLETED|Crossover Period 1||6
8306947|NCT01512849|20479652|P3|COMPLETED|Crossover Period 1||6
8306948|NCT01512849|20479653|P2|COMPLETED|Crossover Period 1||6
8306949|NCT01512849|20479654|P1|COMPLETED|Crossover Period 1||6
8306950|NCT01512849|20479651|P4|STARTED|Crossover Period 1||6
8306951|NCT01512849|20479652|P3|STARTED|Crossover Period 1||6
8306952|NCT01512849|20479653|P2|STARTED|Crossover Period 1||6
8306953|NCT01512849|20479654|P1|STARTED|Crossover Period 1||6
8306954|NCT01512797|20479678|P2|NOT COMPLETED|Overall Study||0
8306955|NCT01512797|20479679|P1|NOT COMPLETED|Overall Study||0
8306956|NCT01512797|20479678|P2|COMPLETED|Overall Study||16
8306957|NCT01512797|20479679|P1|COMPLETED|Overall Study||16
8306958|NCT01512797|20479678|P2|STARTED|Overall Study||16
8306959|NCT01512797|20479679|P1|STARTED|Overall Study||16
8306960|NCT01512758|20479695|P2|NOT COMPLETED|Overall Study||0
8306961|NCT01512758|20479696|P1|NOT COMPLETED|Overall Study||0
8306962|NCT01512758|20479695|P2|COMPLETED|Overall Study||6
8306963|NCT01512758|20479696|P1|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30
8306964|NCT01512758|20479695|P2|STARTED|Overall Study||6
8306965|NCT01512758|20479696|P1|STARTED|Overall Study||30
8306966|NCT01512745|20479731|P2|NOT COMPLETED|Overall Study||20
8306967|NCT01512745|20479732|P1|NOT COMPLETED|Overall Study||40
8306968|NCT01512745|20479731|P2|COMPLETED|Overall Study||71
8306969|NCT01512745|20479732|P1|COMPLETED|Overall Study||136
8306970|NCT01512745|20479731|P2|STARTED|Overall Study||91
8306971|NCT01512745|20479732|P1|STARTED|Overall Study||176
8306972|NCT01512693|20479748|P2|NOT COMPLETED|Overall Study||1
8306973|NCT01512693|20479749|P1|NOT COMPLETED|Overall Study||0
8306974|NCT01512693|20479748|P2|COMPLETED|Overall Study||8
8306975|NCT01512693|20479749|P1|COMPLETED|Overall Study||8
8306976|NCT01512693|20479748|P2|STARTED|Overall Study||9
8306977|NCT01512693|20479749|P1|STARTED|Overall Study||8
8306978|NCT01512667|20479763|P2|NOT COMPLETED|Overall Study||0
8306979|NCT01512667|20479764|P1|NOT COMPLETED|Overall Study||0
8306980|NCT01512667|20479763|P2|COMPLETED|Overall Study||12
8306981|NCT01512667|20479764|P1|COMPLETED|Overall Study||13
8306982|NCT01512667|20479763|P2|Unmatched Participants|Overall Study||0
8306983|NCT01512667|20479764|P1|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
8306984|NCT01512667|20479763|P2|Matched Participants|Overall Study||12
8306985|NCT01512667|20479764|P1|Matched Participants|Overall Study||12
8306986|NCT01512667|20479763|P2|STARTED|Overall Study||12
8306987|NCT01512667|20479764|P1|STARTED|Overall Study||13
8306988|NCT01512446|20479778|P2|NOT COMPLETED|Overall Study||215
8306989|NCT01512446|20479779|P1|NOT COMPLETED|Overall Study||221
8306990|NCT01512446|20479778|P2|COMPLETED|Overall Study||0
8306991|NCT01512446|20479779|P1|COMPLETED|Overall Study||0
8306992|NCT01512446|20479778|P2|Safety Analysis Set|Overall Study||188
8306993|NCT01512446|20479779|P1|Safety Analysis Set|Overall Study||197
8306994|NCT01512446|20479778|P2|STARTED|Overall Study||215
8306995|NCT01512446|20479779|P1|STARTED|Overall Study||221
8306996|NCT01512368|20479789|P1|NOT COMPLETED|Overall Study||3
8306997|NCT01512368|20479789|P1|COMPLETED|Overall Study||60
8306998|NCT01512368|20479789|P1|STARTED|Overall Study||63
8306999|NCT01512264|20479802|P4|NOT COMPLETED|Overall Study||1
8307000|NCT01512264|20479803|P3|NOT COMPLETED|Overall Study||0
8307001|NCT01512264|20479804|P2|NOT COMPLETED|Overall Study||0
8307002|NCT01512264|20479805|P1|NOT COMPLETED|Overall Study||0
8307003|NCT01512264|20479802|P4|COMPLETED|Overall Study||6
8307004|NCT01512264|20479803|P3|COMPLETED|Overall Study||7
8307005|NCT01512264|20479804|P2|COMPLETED|Overall Study||7
8307006|NCT01512264|20479805|P1|COMPLETED|Overall Study||7
8307007|NCT01512264|20479802|P4|STARTED|Overall Study||7
8307008|NCT01512264|20479803|P3|STARTED|Overall Study||7
8307009|NCT01512264|20479804|P2|STARTED|Overall Study||7
8307010|NCT01512264|20479805|P1|STARTED|Overall Study||7
8307011|NCT01512251|20479897|P2|NOT COMPLETED|Phase II||0
8307012|NCT01512251|20479898|P1|NOT COMPLETED|Phase II||0
8307013|NCT01512251|20479897|P2|COMPLETED|Phase II||0
8307014|NCT01512251|20479898|P1|COMPLETED|Phase II||0
8307015|NCT01512251|20479897|P2|STARTED|Phase II||0
8307016|NCT01512251|20479898|P1|STARTED|Phase II||0
8307017|NCT01512251|20479897|P2|NOT COMPLETED|Phase I, Dose 4||0
8307018|NCT01512251|20479898|P1|NOT COMPLETED|Phase I, Dose 4||0
8307019|NCT01512251|20479897|P2|COMPLETED|Phase I, Dose 4||0
8307020|NCT01512251|20479898|P1|COMPLETED|Phase I, Dose 4||0
8307021|NCT01512251|20479897|P2|STARTED|Phase I, Dose 4||0
8307022|NCT01512251|20479898|P1|STARTED|Phase I, Dose 4||0
8307023|NCT01512251|20479897|P2|NOT COMPLETED|Phase I, Dose 3||0
8307024|NCT01512251|20479898|P1|NOT COMPLETED|Phase I, Dose 3||0
8307025|NCT01512251|20479897|P2|COMPLETED|Phase I, Dose 3||0
8307026|NCT01512251|20479898|P1|COMPLETED|Phase I, Dose 3||0
8307027|NCT01512251|20479897|P2|STARTED|Phase I, Dose 3||0
8307028|NCT01512251|20479898|P1|STARTED|Phase I, Dose 3||0
8307029|NCT01512251|20479897|P2|NOT COMPLETED|Phase I, Dose 2||0
8307030|NCT01512251|20479898|P1|NOT COMPLETED|Phase I, Dose 2||0
8307031|NCT01512251|20479897|P2|COMPLETED|Phase I, Dose 2||0
8307032|NCT01512251|20479898|P1|COMPLETED|Phase I, Dose 2||0
8307033|NCT01512251|20479897|P2|STARTED|Phase I, Dose 2||0
8307034|NCT01512251|20479898|P1|STARTED|Phase I, Dose 2||0
8307035|NCT01512251|20479897|P2|NOT COMPLETED|Phase I, Dose 1||5
8307036|NCT01512251|20479898|P1|NOT COMPLETED|Phase I, Dose 1||3
8307037|NCT01512251|20479897|P2|COMPLETED|Phase I, Dose 1||0
8307038|NCT01512251|20479898|P1|COMPLETED|Phase I, Dose 1||0
8307039|NCT01512251|20479897|P2|STARTED|Phase I, Dose 1||5
8307040|NCT01512251|20479898|P1|STARTED|Phase I, Dose 1||3
8307041|NCT01512251|20479897|P2|NOT COMPLETED|Dose Level -1||0
8307042|NCT01512251|20479898|P1|NOT COMPLETED|Dose Level -1||0
8307043|NCT01512251|20479897|P2|COMPLETED|Dose Level -1||5
8307044|NCT01512251|20479898|P1|COMPLETED|Dose Level -1||3
8307045|NCT01512251|20479897|P2|STARTED|Dose Level -1||5
8307046|NCT01512251|20479898|P1|STARTED|Dose Level -1||3
8307047|NCT01512225|20479919|P2|NOT COMPLETED|Overall Study||0
8307048|NCT01512225|20479920|P1|NOT COMPLETED|Overall Study||0
8307049|NCT01512225|20479919|P2|COMPLETED|Overall Study||45
8307050|NCT01512225|20479920|P1|COMPLETED|Overall Study||45
8307051|NCT01512225|20479919|P2|Provided Day 14 Volume|Overall Study||40
8307052|NCT01512225|20479920|P1|Provided Day 14 Volume|Overall Study||45
8307053|NCT01512225|20479919|P2|STARTED|Overall Study||45
8307054|NCT01512225|20479920|P1|STARTED|Overall Study||45
8307055|NCT01512160|20479944|P4|NOT COMPLETED|Overall Study||1
8307056|NCT01512160|20479945|P3|NOT COMPLETED|Overall Study||0
8307057|NCT01512160|20479946|P2|NOT COMPLETED|Overall Study||0
8307058|NCT01512160|20479947|P1|NOT COMPLETED|Overall Study||2
8307059|NCT01512160|20479944|P4|COMPLETED|Overall Study||22
8307060|NCT01512160|20479945|P3|COMPLETED|Overall Study||22
8307061|NCT01512160|20479946|P2|COMPLETED|Overall Study||23
8307062|NCT01512160|20479947|P1|COMPLETED|Overall Study||20
8307063|NCT01512160|20479944|P4|STARTED|Overall Study||23
8307064|NCT01512160|20479945|P3|STARTED|Overall Study||22
8307065|NCT01512160|20479946|P2|STARTED|Overall Study||23
8307066|NCT01512160|20479947|P1|STARTED|Overall Study||22
8307067|NCT01512108|20480039|P2|NOT COMPLETED|Overall Study||9
8307068|NCT01512108|20480040|P1|NOT COMPLETED|Overall Study||22
8307069|NCT01512108|20480039|P2|COMPLETED|Overall Study||111
8307070|NCT01512108|20480040|P1|COMPLETED|Overall Study||221
8307071|NCT01512108|20480039|P2|Exposed|Overall Study||120
8307072|NCT01512108|20480040|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
8307073|NCT01512108|20480039|P2|STARTED|Overall Study||120
8307074|NCT01512108|20480040|P1|STARTED|Overall Study||243
8307075|NCT01511978|20480054|P2|NOT COMPLETED|Overall Study||0
8307076|NCT01511978|20480055|P1|NOT COMPLETED|Overall Study||0
8307077|NCT01511978|20480054|P2|COMPLETED|Overall Study||18
8307078|NCT01511978|20480055|P1|COMPLETED|Overall Study||14
8307079|NCT01511978|20480054|P2|STARTED|Overall Study||18
8307080|NCT01511978|20480055|P1|STARTED|Overall Study||14
8307081|NCT01511939|20480066|P3|NOT COMPLETED|Overall Study||0
8307082|NCT01511939|20480067|P2|NOT COMPLETED|Overall Study||1
8307083|NCT01511939|20480068|P1|NOT COMPLETED|Overall Study||2
8307084|NCT01511939|20480066|P3|COMPLETED|Overall Study||8
8307085|NCT01511939|20480067|P2|COMPLETED|Overall Study||4
8307086|NCT01511939|20480068|P1|COMPLETED|Overall Study||7
8307087|NCT01511939|20480066|P3|STARTED|Overall Study||8
8307088|NCT01511939|20480067|P2|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
8307089|NCT01511939|20480068|P1|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
8307090|NCT01511809|20480087|P2|NOT COMPLETED|Overall Study||7
8307091|NCT01511809|20480088|P1|NOT COMPLETED|Overall Study||7
8307092|NCT01511809|20480087|P2|COMPLETED|Overall Study||52
8307093|NCT01511809|20480088|P1|COMPLETED|Overall Study||51
8307094|NCT01511809|20480087|P2|STARTED|Overall Study||59
8307095|NCT01511809|20480088|P1|STARTED|Overall Study||58
8307096|NCT01511536|20480097|P3|NOT COMPLETED|Phase 2||9
8307097|NCT01511536|20480098|P2|NOT COMPLETED|Phase 2||0
8307098|NCT01511536|20480099|P1|NOT COMPLETED|Phase 2||0
8307099|NCT01511536|20480097|P3|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
8307100|NCT01511536|20480098|P2|COMPLETED|Phase 2||0
8307101|NCT01511536|20480099|P1|COMPLETED|Phase 2||0
8307102|NCT01511536|20480097|P3|STARTED|Phase 2||27
8307103|NCT01511536|20480098|P2|STARTED|Phase 2||0
8307104|NCT01511536|20480099|P1|STARTED|Phase 2||0
8307105|NCT01511536|20480097|P3|NOT COMPLETED|Phase 1||0
8307106|NCT01511536|20480098|P2|NOT COMPLETED|Phase 1||1
8307107|NCT01511536|20480099|P1|NOT COMPLETED|Phase 1||0
8307108|NCT01511536|20480097|P3|COMPLETED|Phase 1||0
8307109|NCT01511536|20480098|P2|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
8307110|NCT01511536|20480099|P1|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
8307111|NCT01511536|20480097|P3|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
8307112|NCT01511536|20480098|P2|STARTED|Phase 1||7
8307113|NCT01511536|20480099|P1|STARTED|Phase 1||3
8307114|NCT01511445|20480121|P2|NOT COMPLETED|Overall Study||4
8307115|NCT01511445|20480122|P1|NOT COMPLETED|Overall Study||5
8307116|NCT01511445|20480121|P2|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
8307117|NCT01511445|20480122|P1|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
8307118|NCT01511445|20480121|P2|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
8307119|NCT01511445|20480122|P1|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
8307120|NCT01511445|20480121|P2|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
8307121|NCT01511445|20480122|P1|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
8307122|NCT01511445|20480121|P2|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
8307123|NCT01511445|20480122|P1|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
8307124|NCT01511445|20480121|P2|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
8307125|NCT01511445|20480122|P1|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
8307126|NCT01511419|20480132|P2|NOT COMPLETED|Dose 2||0
8307127|NCT01511419|20480133|P1|NOT COMPLETED|Dose 2||1
8307128|NCT01511419|20480132|P2|COMPLETED|Dose 2||10
8307129|NCT01511419|20480133|P1|COMPLETED|Dose 2||29
8307130|NCT01511419|20480132|P2|STARTED|Dose 2||10
8307131|NCT01511419|20480133|P1|STARTED|Dose 2||30
8307132|NCT01511419|20480132|P2|NOT COMPLETED|Dose 1||0
8307133|NCT01511419|20480133|P1|NOT COMPLETED|Dose 1||0
8307134|NCT01511419|20480132|P2|COMPLETED|Dose 1||10
8307135|NCT01511419|20480133|P1|COMPLETED|Dose 1||30
8307136|NCT01511419|20480132|P2|STARTED|Dose 1||10
8307137|NCT01511419|20480133|P1|STARTED|Dose 1||30
8307138|NCT01511315|20480225|P1|NOT COMPLETED|Overall Study||4
8307139|NCT01511315|20480225|P1|COMPLETED|Overall Study||32
8307140|NCT01511315|20480225|P1|STARTED|Overall Study||36
8307141|NCT01511250|20480245|P10|NOT COMPLETED|Overall Study||5
8307142|NCT01511250|20480246|P9|NOT COMPLETED|Overall Study||14
8307143|NCT01511250|20480247|P8|NOT COMPLETED|Overall Study||4
8307144|NCT01511250|20480248|P7|NOT COMPLETED|Overall Study||2
8307145|NCT01511250|20480249|P6|NOT COMPLETED|Overall Study||0
8307146|NCT01511250|20480250|P5|NOT COMPLETED|Overall Study||0
8307147|NCT01511250|20480251|P4|NOT COMPLETED|Overall Study||3
8307148|NCT01511250|20480252|P3|NOT COMPLETED|Overall Study||4
8307149|NCT01511250|20480253|P2|NOT COMPLETED|Overall Study||5
8307150|NCT01511250|20480254|P1|NOT COMPLETED|Overall Study||9
8307151|NCT01511250|20480245|P10|COMPLETED|Overall Study||48
8307152|NCT01511250|20480246|P9|COMPLETED|Overall Study||145
8307153|NCT01511250|20480247|P8|COMPLETED|Overall Study||9
8307154|NCT01511250|20480248|P7|COMPLETED|Overall Study||21
8307155|NCT01511250|20480249|P6|COMPLETED|Overall Study||17
8307156|NCT01511250|20480250|P5|COMPLETED|Overall Study||21
8307157|NCT01511250|20480251|P4|COMPLETED|Overall Study||11
8307158|NCT01511250|20480252|P3|COMPLETED|Overall Study||18
8307159|NCT01511250|20480253|P2|COMPLETED|Overall Study||9
8307160|NCT01511250|20480254|P1|COMPLETED|Overall Study||15
8307161|NCT01511250|20480245|P10|STARTED|Overall Study||53
8307162|NCT01511250|20480246|P9|STARTED|Overall Study||159
8307163|NCT01511250|20480247|P8|STARTED|Overall Study||13
8307164|NCT01511250|20480248|P7|STARTED|Overall Study||23
8307165|NCT01511250|20480249|P6|STARTED|Overall Study||17
8307166|NCT01511250|20480250|P5|STARTED|Overall Study||21
8307167|NCT01511250|20480251|P4|STARTED|Overall Study||14
8307168|NCT01511250|20480252|P3|STARTED|Overall Study||22
8307169|NCT01511250|20480253|P2|STARTED|Overall Study||14
8307170|NCT01511250|20480254|P1|STARTED|Overall Study||24
8307171|NCT01511107|20480402|P2|NOT COMPLETED|Overall Study||41
8307172|NCT01511107|20480403|P1|NOT COMPLETED|Overall Study||22
8307173|NCT01511107|20480402|P2|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
8307174|NCT01511107|20480403|P1|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
8307175|NCT01511107|20480402|P2|STARTED|Overall Study|Randomized to the treatment group.|260
8307176|NCT01511107|20480403|P1|STARTED|Overall Study|Randomized to the treatment group.|260
8307177|NCT01511081|20480453|P2|NOT COMPLETED|Overall Study||0
8307178|NCT01511081|20480454|P1|NOT COMPLETED|Overall Study||0
8307179|NCT01511081|20480453|P2|COMPLETED|Overall Study||9
8307180|NCT01511081|20480454|P1|COMPLETED|Overall Study||8
8307181|NCT01511081|20480453|P2|STARTED|Overall Study||9
8307182|NCT01511081|20480454|P1|STARTED|Overall Study||8
8307183|NCT01511068|20480462|P1|NOT COMPLETED|Overall Study||0
8307184|NCT01511068|20480462|P1|COMPLETED|Overall Study||2
8307185|NCT01511068|20480462|P1|STARTED|Overall Study||2
8307186|NCT01511055|20480475|P1|NOT COMPLETED|Overall Study||6
8307187|NCT01511055|20480475|P1|COMPLETED|Overall Study||21
8307188|NCT01511055|20480475|P1|STARTED|Overall Study||27
8307189|NCT01511016|20480482|P2|NOT COMPLETED|Overall Study||2
8307190|NCT01511016|20480483|P1|NOT COMPLETED|Overall Study||2
8307191|NCT01511016|20480482|P2|COMPLETED|Overall Study||7
8307192|NCT01511016|20480483|P1|COMPLETED|Overall Study||6
8307193|NCT01511016|20480482|P2|STARTED|Overall Study||9
8307194|NCT01511016|20480483|P1|STARTED|Overall Study||8
8307195|NCT01510912|20480499|P1|NOT COMPLETED|Overall Study||242
8307196|NCT01510912|20480499|P1|COMPLETED|Overall Study||360
8307197|NCT01510912|20480499|P1|STARTED|Overall Study||602
8307198|NCT01510834|20480505|P1|NOT COMPLETED|Overall Study||33
8307199|NCT01510834|20480505|P1|COMPLETED|Overall Study||57
8307200|NCT01510834|20480505|P1|STARTED|Overall Study||90
8307201|NCT01510769|20480515|P3|NOT COMPLETED|Overall Study||22
8307202|NCT01510769|20480516|P2|NOT COMPLETED|Overall Study||25
8307203|NCT01510769|20480517|P1|NOT COMPLETED|Overall Study||27
8307204|NCT01510769|20480515|P3|COMPLETED|Overall Study||87
8307205|NCT01510769|20480516|P2|COMPLETED|Overall Study||84
8307206|NCT01510769|20480517|P1|COMPLETED|Overall Study||79
8307207|NCT01510769|20480515|P3|STARTED|Overall Study||109
8307208|NCT01510769|20480516|P2|STARTED|Overall Study||109
8307209|NCT01510769|20480517|P1|STARTED|Overall Study||106
8307210|NCT01510756|20480534|P1|NOT COMPLETED|Overall Study||4
8307211|NCT01510756|20480534|P1|COMPLETED|Overall Study||0
8307212|NCT01510756|20480534|P1|STARTED|Overall Study||4
8307213|NCT01510717|20480542|P2|NOT COMPLETED|Overall Study||5
8307214|NCT01510717|20480543|P1|NOT COMPLETED|Overall Study||2
8307215|NCT01510717|20480542|P2|COMPLETED|Overall Study||160
8307216|NCT01510717|20480543|P1|COMPLETED|Overall Study||153
8307217|NCT01510717|20480542|P2|STARTED|Overall Study||165
8307218|NCT01510717|20480543|P1|STARTED|Overall Study||155
8307219|NCT01510704|20480571|P4|NOT COMPLETED|Overall Study||0
8307220|NCT01510704|20480572|P3|NOT COMPLETED|Overall Study||0
8307221|NCT01510704|20480573|P2|NOT COMPLETED|Overall Study||0
8307222|NCT01510704|20480574|P1|NOT COMPLETED|Overall Study||0
8307223|NCT01510704|20480571|P4|COMPLETED|Overall Study||53
8307224|NCT01510704|20480572|P3|COMPLETED|Overall Study||50
8307225|NCT01510704|20480573|P2|COMPLETED|Overall Study||58
8307226|NCT01510704|20480574|P1|COMPLETED|Overall Study||54
8307227|NCT01510704|20480571|P4|STARTED|Overall Study||53
8307228|NCT01510704|20480572|P3|STARTED|Overall Study||50
8307229|NCT01510704|20480573|P2|STARTED|Overall Study||58
8307230|NCT01510704|20480574|P1|STARTED|Overall Study||54
8307231|NCT01510652|20480586|P2|NOT COMPLETED|Overall Study||67
8307232|NCT01510652|20480587|P1|NOT COMPLETED|Overall Study||92
8307233|NCT01510652|20480586|P2|COMPLETED|Overall Study||288
8307234|NCT01510652|20480587|P1|COMPLETED|Overall Study||627
8307235|NCT01510652|20480586|P2|Baseline|Overall Study||348
8307236|NCT01510652|20480587|P1|Baseline|Overall Study||718
8307237|NCT01510652|20480586|P2|STARTED|Overall Study||355
8307238|NCT01510652|20480587|P1|STARTED|Overall Study||719
8307239|NCT01510457|20480599|P2|NOT COMPLETED|Overall Study||3
8307240|NCT01510457|20480600|P1|NOT COMPLETED|Overall Study||5
8307241|NCT01510457|20480599|P2|COMPLETED|Overall Study||26
8307242|NCT01510457|20480600|P1|COMPLETED|Overall Study||12
8307243|NCT01510457|20480599|P2|STARTED|Overall Study||29
8307244|NCT01510457|20480600|P1|STARTED|Overall Study||17
8307245|NCT01510379|20480620|P2|NOT COMPLETED|Overall Study||0
8307246|NCT01510379|20480621|P1|NOT COMPLETED|Overall Study||0
8307247|NCT01510379|20480620|P2|COMPLETED|Overall Study||51
8307248|NCT01510379|20480621|P1|COMPLETED|Overall Study||49
8307249|NCT01510379|20480620|P2|STARTED|Overall Study||51
8307250|NCT01510379|20480621|P1|STARTED|Overall Study||49
8307251|NCT01510327|20480629|P1|NOT COMPLETED|Overall Study||0
8307252|NCT01510327|20480629|P1|COMPLETED|Overall Study||22
8307253|NCT01510327|20480629|P1|STARTED|Overall Study||22
8307254|NCT01510158|20480663|P3|NOT COMPLETED|Overall Study||50
8307255|NCT01510158|20480664|P2|NOT COMPLETED|Overall Study||53
8307256|NCT01510158|20480665|P1|NOT COMPLETED|Overall Study||51
8307257|NCT01510158|20480663|P3|COMPLETED|Overall Study||152
8307258|NCT01510158|20480664|P2|COMPLETED|Overall Study||150
8307259|NCT01510158|20480665|P1|COMPLETED|Overall Study||151
8307260|NCT01510158|20480663|P3|STARTED|Overall Study||202
8307261|NCT01510158|20480664|P2|STARTED|Overall Study||203
8307262|NCT01510158|20480665|P1|STARTED|Overall Study||202
8307263|NCT01510145|20480679|P1|NOT COMPLETED|Overall Study||18
8307264|NCT01510145|20480679|P1|COMPLETED|Overall Study||173
8307265|NCT01510145|20480679|P1|STARTED|Overall Study||191
8307278|NCT01509950|20480807|P3|NOT COMPLETED|Overall Study||0
8307279|NCT01509950|20480808|P2|NOT COMPLETED|Overall Study||0
8307280|NCT01509950|20480809|P1|NOT COMPLETED|Overall Study||0
8307281|NCT01509950|20480807|P3|COMPLETED|Overall Study||0
8307282|NCT01509950|20480808|P2|COMPLETED|Overall Study||8
8307283|NCT01509950|20480809|P1|COMPLETED|Overall Study||7
8307284|NCT01509950|20480807|P3|STARTED|Overall Study||0
8307285|NCT01509950|20480808|P2|STARTED|Overall Study||8
8307286|NCT01509950|20480809|P1|STARTED|Overall Study||7
8307287|NCT01509872|20480837|P2|NOT COMPLETED|Overall Study||0
8307288|NCT01509872|20480838|P1|NOT COMPLETED|Overall Study||1
8307289|NCT01509872|20480837|P2|COMPLETED|Overall Study||24
8307290|NCT01509872|20480838|P1|COMPLETED|Overall Study||25
8307291|NCT01509872|20480837|P2|Post-Intervention Assessment|Overall Study||24
8307292|NCT01509872|20480838|P1|Post-Intervention Assessment|Overall Study||26
8307293|NCT01509872|20480837|P2|STARTED|Overall Study||24
8307294|NCT01509872|20480838|P1|STARTED|Overall Study||26
8307295|NCT01509807|20480852|P2|NOT COMPLETED|Overall Study||1
8307296|NCT01509807|20480853|P1|NOT COMPLETED|Overall Study||1
8307297|NCT01509807|20480852|P2|COMPLETED|Overall Study||16
8307298|NCT01509807|20480853|P1|COMPLETED|Overall Study||15
8307299|NCT01509807|20480852|P2|STARTED|Overall Study||17
8307300|NCT01509807|20480853|P1|STARTED|Overall Study||16
8307301|NCT01509677|20480879|P2|NOT COMPLETED|Overall Study||6
8307302|NCT01509677|20480880|P1|NOT COMPLETED|Overall Study||3
8307303|NCT01509677|20480879|P2|COMPLETED|Overall Study||73
8307304|NCT01509677|20480880|P1|COMPLETED|Overall Study||76
8307305|NCT01509677|20480879|P2|STARTED|Overall Study||79
8307306|NCT01509677|20480880|P1|STARTED|Overall Study||79
8307307|NCT01509664|20480952|P2|NOT COMPLETED|Overall Study||21
8307308|NCT01509664|20480953|P1|NOT COMPLETED|Overall Study||15
8307309|NCT01509664|20480952|P2|COMPLETED|Overall Study||28
8307310|NCT01509664|20480953|P1|COMPLETED|Overall Study||34
8307311|NCT01509664|20480952|P2|T3 Follow-up|Overall Study||33
8307312|NCT01509664|20480953|P1|T3 Follow-up|Overall Study||40
8307313|NCT01509664|20480952|P2|T2 Follow-up|Overall Study||38
8307314|NCT01509664|20480953|P1|T2 Follow-up|Overall Study||45
8307315|NCT01509664|20480952|P2|STARTED|Overall Study||49
8307316|NCT01509664|20480953|P1|STARTED|Overall Study||49
8307317|NCT01509638|20480961|P2|NOT COMPLETED|Overall Study||2
8307318|NCT01509638|20480962|P1|NOT COMPLETED|Overall Study||3
8307319|NCT01509638|20480961|P2|COMPLETED|Overall Study||24
8307320|NCT01509638|20480962|P1|COMPLETED|Overall Study||20
8307321|NCT01509638|20480961|P2|STARTED|Overall Study||26
8307322|NCT01509638|20480962|P1|STARTED|Overall Study||23
8307323|NCT01509625|20480986|P1|NOT COMPLETED|Overall Study||9
8307324|NCT01509625|20480986|P1|COMPLETED|Overall Study||263
8307325|NCT01509625|20480986|P1|STARTED|Overall Study||272
8307335|NCT01509586|20481020|P2|NOT COMPLETED|Overall Study||0
8307336|NCT01509586|20481021|P1|NOT COMPLETED|Overall Study||0
8307337|NCT01509586|20481020|P2|COMPLETED|Overall Study|final intent to treat sample|610
8307338|NCT01509586|20481021|P1|COMPLETED|Overall Study|final intent to treat sample|626
8307339|NCT01509586|20481020|P2|Week 58 (Month 12)|Overall Study||499
8307340|NCT01509586|20481021|P1|Week 58 (Month 12)|Overall Study||492
8307341|NCT01509586|20481020|P2|Week 46|Overall Study||494
8307342|NCT01509586|20481021|P1|Week 46|Overall Study||483
8307343|NCT01509586|20481020|P2|Week 32 (Month 6)|Overall Study||523
8307344|NCT01509586|20481021|P1|Week 32 (Month 6)|Overall Study||504
8307345|NCT01509586|20481020|P2|Week18|Overall Study||555
8307346|NCT01509586|20481021|P1|Week18|Overall Study||529
8307347|NCT01509586|20481020|P2|Week 14|Overall Study||566
8307348|NCT01509586|20481021|P1|Week 14|Overall Study||528
8307349|NCT01509586|20481020|P2|Week 10|Overall Study||574
8307350|NCT01509586|20481021|P1|Week 10|Overall Study||537
8307351|NCT01509586|20481020|P2|Week 6|Overall Study||585
8307352|NCT01509586|20481021|P1|Week 6|Overall Study||551
8307353|NCT01509586|20481020|P2|Week 3|Overall Study||585
8307354|NCT01509586|20481021|P1|Week 3|Overall Study||574
8307355|NCT01509586|20481020|P2|STARTED|Overall Study|Week 0|610
8307356|NCT01509586|20481021|P1|STARTED|Overall Study|Week 0|626
8307357|NCT01509547|20481029|P2|NOT COMPLETED|Overall Study||39
8307358|NCT01509547|20481030|P1|NOT COMPLETED|Overall Study||35
8307359|NCT01509547|20481029|P2|COMPLETED|Overall Study||41
8307360|NCT01509547|20481030|P1|COMPLETED|Overall Study||42
8307361|NCT01509547|20481029|P2|STARTED|Overall Study||80
8307362|NCT01509547|20481030|P1|STARTED|Overall Study||77
8307363|NCT01509404|20481048|P2|NOT COMPLETED|Overall Study||0
8307364|NCT01509404|20481049|P1|NOT COMPLETED|Overall Study||0
8307365|NCT01509404|20481048|P2|COMPLETED|Overall Study||20
8307366|NCT01509404|20481049|P1|COMPLETED|Overall Study||20
8307367|NCT01509404|20481048|P2|STARTED|Overall Study||20
8307368|NCT01509404|20481049|P1|STARTED|Overall Study||20
8307375|NCT01509105|20481080|P1|NOT COMPLETED|Overall Study||0
8307376|NCT01509105|20481080|P1|COMPLETED|Overall Study||649
8307377|NCT01509105|20481080|P1|STARTED|Overall Study||649
8307378|NCT01509079|20481097|P2|NOT COMPLETED|Overall Study||3
8307379|NCT01509079|20481098|P1|NOT COMPLETED|Overall Study||0
8307380|NCT01509079|20481097|P2|COMPLETED|Overall Study||56
8307381|NCT01509079|20481098|P1|COMPLETED|Overall Study||57
8307382|NCT01509079|20481097|P2|STARTED|Overall Study||59
8307383|NCT01509079|20481098|P1|STARTED|Overall Study||57
8307384|NCT01509053|20481118|P1|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
8307385|NCT01509053|20481118|P1|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
8307386|NCT01509053|20481118|P1|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
8307387|NCT01509053|20481118|P1|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
8307388|NCT01509053|20481118|P1|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
8307389|NCT01509053|20481118|P1|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
8307390|NCT01509053|20481118|P1|NOT COMPLETED|Oral Aripirazole (Phase A)||11
8307391|NCT01509053|20481118|P1|COMPLETED|Oral Aripirazole (Phase A)||8
8307392|NCT01509053|20481118|P1|STARTED|Oral Aripirazole (Phase A)||19
8307393|NCT01509040|20481132|P3|NOT COMPLETED|Overall Study||0
8307394|NCT01509040|20481133|P2|NOT COMPLETED|Overall Study||1
8307395|NCT01509040|20481134|P1|NOT COMPLETED|Overall Study||0
8307396|NCT01509040|20481132|P3|COMPLETED|Overall Study||0
8307397|NCT01509040|20481133|P2|COMPLETED|Overall Study||1
8307398|NCT01509040|20481134|P1|COMPLETED|Overall Study||0
8307399|NCT01509040|20481132|P3|STARTED|Overall Study||0
8307400|NCT01509040|20481133|P2|STARTED|Overall Study||2
8307401|NCT01509040|20481134|P1|STARTED|Overall Study||0
8307402|NCT01508936|20481180|P2|NOT COMPLETED|Overall Study||79
8307403|NCT01508936|20481181|P1|NOT COMPLETED|Overall Study||23
8307404|NCT01508936|20481180|P2|COMPLETED|Overall Study||330
8307405|NCT01508936|20481181|P1|COMPLETED|Overall Study||79
8307406|NCT01508936|20481180|P2|FEV1 Subpopulation Analysis Set|Overall Study||346
8307407|NCT01508936|20481181|P1|FEV1 Subpopulation Analysis Set|Overall Study||91
8307408|NCT01508936|20481180|P2|Full Analysis Set|Overall Study||395
8307409|NCT01508936|20481181|P1|Full Analysis Set|Overall Study||97
8307410|NCT01508936|20481180|P2|Safety Analysis Set|Overall Study||395
8307411|NCT01508936|20481181|P1|Safety Analysis Set|Overall Study||97
8307412|NCT01508936|20481180|P2|Randomized, Not Treated|Overall Study||3
8307413|NCT01508936|20481181|P1|Randomized, Not Treated|Overall Study||1
8307414|NCT01508936|20481180|P2|Randomized|Overall Study||398
8307415|NCT01508936|20481181|P1|Randomized|Overall Study||98
8307416|NCT01508936|20481180|P2|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
8307417|NCT01508936|20481181|P1|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
8307418|NCT01508936|20481180|P2|STARTED|Overall Study||409
8307419|NCT01508936|20481181|P1|STARTED|Overall Study||102
8307420|NCT01508910|20481220|P4|NOT COMPLETED|Treatment||3
8307421|NCT01508910|20481221|P3|NOT COMPLETED|Treatment||10
8307422|NCT01508910|20481222|P2|NOT COMPLETED|Treatment||4
8307423|NCT01508910|20481223|P1|NOT COMPLETED|Treatment||2
8307424|NCT01508910|20481220|P4|COMPLETED|Treatment||3
8307425|NCT01508910|20481221|P3|COMPLETED|Treatment||18
8307426|NCT01508910|20481222|P2|COMPLETED|Treatment||24
8307427|NCT01508910|20481223|P1|COMPLETED|Treatment||48
8307428|NCT01508910|20481220|P4|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
8307429|NCT01508910|20481221|P3|STARTED|Treatment||28
8307430|NCT01508910|20481222|P2|STARTED|Treatment||28
8307431|NCT01508910|20481223|P1|STARTED|Treatment||50
8307432|NCT01508910|20481220|P4|NOT COMPLETED|Randomization||0
8307433|NCT01508910|20481221|P3|NOT COMPLETED|Randomization||0
8307434|NCT01508910|20481222|P2|NOT COMPLETED|Randomization||0
8307435|NCT01508910|20481223|P1|NOT COMPLETED|Randomization||0
8307436|NCT01508910|20481220|P4|COMPLETED|Randomization||0
8307437|NCT01508910|20481221|P3|COMPLETED|Randomization||28
8307438|NCT01508910|20481222|P2|COMPLETED|Randomization||27
8307439|NCT01508910|20481223|P1|COMPLETED|Randomization||57
8307440|NCT01508910|20481220|P4|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
8307441|NCT01508910|20481221|P3|STARTED|Randomization||28
8307442|NCT01508910|20481222|P2|STARTED|Randomization||27
8307443|NCT01508910|20481223|P1|STARTED|Randomization||57
8307444|NCT01508832|20481247|P2|NOT COMPLETED|Overall Study||0
8307445|NCT01508832|20481248|P1|NOT COMPLETED|Overall Study||0
8307446|NCT01508832|20481247|P2|COMPLETED|Overall Study||6
8307447|NCT01508832|20481248|P1|COMPLETED|Overall Study||6
8307448|NCT01508832|20481247|P2|STARTED|Overall Study||6
8307449|NCT01508832|20481248|P1|STARTED|Overall Study||6
8307450|NCT01508702|20481256|P2|NOT COMPLETED|Overall Study||13
8307451|NCT01508702|20481257|P1|NOT COMPLETED|Overall Study||23
8307452|NCT01508702|20481256|P2|COMPLETED|Overall Study||94
8307453|NCT01508702|20481257|P1|COMPLETED|Overall Study||84
8307454|NCT01508702|20481256|P2|STARTED|Overall Study||107
8307455|NCT01508702|20481257|P1|STARTED|Overall Study||107
8307456|NCT01508676|20481265|P2|NOT COMPLETED|Phase II (2 Weeks)||1
8307457|NCT01508676|20481266|P1|NOT COMPLETED|Phase II (2 Weeks)||1
8307458|NCT01508676|20481265|P2|COMPLETED|Phase II (2 Weeks)||13
8307459|NCT01508676|20481266|P1|COMPLETED|Phase II (2 Weeks)||15
8307460|NCT01508676|20481265|P2|STARTED|Phase II (2 Weeks)||14
8307461|NCT01508676|20481266|P1|STARTED|Phase II (2 Weeks)||16
8307462|NCT01508676|20481265|P2|NOT COMPLETED|Washout Period (1 Week)||0
8307463|NCT01508676|20481266|P1|NOT COMPLETED|Washout Period (1 Week)||0
8307464|NCT01508676|20481265|P2|COMPLETED|Washout Period (1 Week)||14
8307465|NCT01508676|20481266|P1|COMPLETED|Washout Period (1 Week)||16
8307466|NCT01508676|20481265|P2|STARTED|Washout Period (1 Week)||14
8307467|NCT01508676|20481266|P1|STARTED|Washout Period (1 Week)||16
8307468|NCT01508676|20481265|P2|NOT COMPLETED|Phase I (2 Weeks)||3
8307469|NCT01508676|20481266|P1|NOT COMPLETED|Phase I (2 Weeks)||2
8307470|NCT01508676|20481265|P2|COMPLETED|Phase I (2 Weeks)||14
8307471|NCT01508676|20481266|P1|COMPLETED|Phase I (2 Weeks)||16
8307472|NCT01508676|20481265|P2|STARTED|Phase I (2 Weeks)||17
8307473|NCT01508676|20481266|P1|STARTED|Phase I (2 Weeks)||18
8307474|NCT01508650|20481278|P2|NOT COMPLETED|Overall Study||3
8307475|NCT01508650|20481279|P1|NOT COMPLETED|Overall Study||0
8307476|NCT01508650|20481278|P2|COMPLETED|Overall Study||12
8307477|NCT01508650|20481279|P1|COMPLETED|Overall Study||12
8307478|NCT01508650|20481278|P2|STARTED|Overall Study||15
8307479|NCT01508650|20481279|P1|STARTED|Overall Study||12
8307480|NCT01508455|20481287|P1|NOT COMPLETED|Overall Study||0
8307481|NCT01508455|20481287|P1|COMPLETED|Overall Study||6
8307482|NCT01508455|20481287|P1|STARTED|Overall Study||6
8307483|NCT01508325|20481298|P2|NOT COMPLETED|Overall Study||21
8307484|NCT01508325|20481299|P1|NOT COMPLETED|Overall Study||18
8307485|NCT01508325|20481298|P2|COMPLETED|Overall Study||72
8307486|NCT01508325|20481299|P1|COMPLETED|Overall Study||75
8307487|NCT01508325|20481298|P2|STARTED|Overall Study||93
8307488|NCT01508325|20481299|P1|STARTED|Overall Study||93
8307489|NCT01508169|20481329|P2|NOT COMPLETED|Overall Study||2
8307490|NCT01508169|20481330|P1|NOT COMPLETED|Overall Study||3
8307491|NCT01508169|20481329|P2|COMPLETED|Overall Study||45
8307492|NCT01508169|20481330|P1|COMPLETED|Overall Study||44
8307493|NCT01508169|20481329|P2|STARTED|Overall Study||47
8307494|NCT01508169|20481330|P1|STARTED|Overall Study||47
8307495|NCT01508130|20481344|P2|NOT COMPLETED|Overall Study||69
8307496|NCT01508130|20481345|P1|NOT COMPLETED|Overall Study||227
8307497|NCT01508130|20481344|P2|COMPLETED|Overall Study||73
8307498|NCT01508130|20481345|P1|COMPLETED|Overall Study||266
8307499|NCT01508130|20481344|P2|mTRT|Overall Study||142
8307500|NCT01508130|20481345|P1|mTRT|Overall Study||493
8307501|NCT01508130|20481344|P2|STARTED|Overall Study||142
8307502|NCT01508130|20481345|P1|STARTED|Overall Study||493
8307503|NCT01508117|20481387|P1|NOT COMPLETED|Overall Study||0
8307504|NCT01508117|20481387|P1|COMPLETED|Overall Study||1
8307505|NCT01508117|20481387|P1|STARTED|Overall Study||1
8307506|NCT01508052|20481393|P2|NOT COMPLETED|Overall Study||0
8307507|NCT01508052|20481394|P1|NOT COMPLETED|Overall Study||0
8307508|NCT01508052|20481393|P2|COMPLETED|Overall Study||20
8307509|NCT01508052|20481394|P1|COMPLETED|Overall Study||20
8307510|NCT01508052|20481393|P2|STARTED|Overall Study||20
8307511|NCT01508052|20481394|P1|STARTED|Overall Study||20
8307512|NCT01508013|20481402|P2|NOT COMPLETED|Overall Study||23
8307513|NCT01508013|20481403|P1|NOT COMPLETED|Overall Study||32
8307514|NCT01508013|20481402|P2|COMPLETED|Overall Study||206
8307515|NCT01508013|20481403|P1|COMPLETED|Overall Study||182
8307516|NCT01508013|20481402|P2|STARTED|Overall Study||229
8307517|NCT01508013|20481403|P1|STARTED|Overall Study||214
8307521|NCT01507831|20481456|P2|NOT COMPLETED|Overall Study||440
8307522|NCT01507831|20481457|P1|NOT COMPLETED|Overall Study||193
8307523|NCT01507831|20481456|P2|COMPLETED|Overall Study||1113
8307524|NCT01507831|20481457|P1|COMPLETED|Overall Study||595
8307525|NCT01507831|20481456|P2|Treated|Overall Study||1550
8307526|NCT01507831|20481457|P1|Treated|Overall Study||788
8307527|NCT01507831|20481456|P2|STARTED|Overall Study|Randomized|1553
8307528|NCT01507831|20481457|P1|STARTED|Overall Study|Randomized|788
8307529|NCT01507779|20481527|P2|NOT COMPLETED|Overall Study||0
8307530|NCT01507779|20481528|P1|NOT COMPLETED|Overall Study||0
8307531|NCT01507779|20481527|P2|COMPLETED|Overall Study||25
8307532|NCT01507779|20481528|P1|COMPLETED|Overall Study||23
8307533|NCT01507779|20481527|P2|STARTED|Overall Study||25
8307534|NCT01507779|20481528|P1|STARTED|Overall Study||23
8307535|NCT01507688|20481568|P2|NOT COMPLETED|6 Month to 12 Month Assessment||3
8307536|NCT01507688|20481569|P1|NOT COMPLETED|6 Month to 12 Month Assessment||5
8307537|NCT01507688|20481568|P2|COMPLETED|6 Month to 12 Month Assessment||116
8307538|NCT01507688|20481569|P1|COMPLETED|6 Month to 12 Month Assessment||108
8307539|NCT01507688|20481568|P2|STARTED|6 Month to 12 Month Assessment||119
8307540|NCT01507688|20481569|P1|STARTED|6 Month to 12 Month Assessment||113
8307541|NCT01507688|20481568|P2|NOT COMPLETED|Baseline to 6 Month Assessment||10
8307542|NCT01507688|20481569|P1|NOT COMPLETED|Baseline to 6 Month Assessment||16
8307543|NCT01507688|20481568|P2|COMPLETED|Baseline to 6 Month Assessment||119
8307544|NCT01507688|20481569|P1|COMPLETED|Baseline to 6 Month Assessment||113
8307545|NCT01507688|20481568|P2|STARTED|Baseline to 6 Month Assessment||129
8307546|NCT01507688|20481569|P1|STARTED|Baseline to 6 Month Assessment||129
8307547|NCT01507662|20481577|P2|NOT COMPLETED|Overall Study||831
8307548|NCT01507662|20481578|P1|NOT COMPLETED|Overall Study||816
8307549|NCT01507662|20481577|P2|COMPLETED|Overall Study||3020
8307550|NCT01507662|20481578|P1|COMPLETED|Overall Study||3082
8307551|NCT01507662|20481577|P2|STARTED|Overall Study||3851
8307552|NCT01507662|20481578|P1|STARTED|Overall Study||3898
8307553|NCT01507584|20481584|P1|NOT COMPLETED|Overall Study||0
8307554|NCT01507584|20481584|P1|COMPLETED|Overall Study||0
8307555|NCT01507584|20481584|P1|STARTED|Overall Study||0
8307556|NCT01507493|20481592|P2|NOT COMPLETED|Overall Study||0
8307557|NCT01507493|20481593|P1|NOT COMPLETED|Overall Study||0
8307558|NCT01507493|20481592|P2|COMPLETED|Overall Study||178
8307559|NCT01507493|20481593|P1|COMPLETED|Overall Study||22
8307560|NCT01507493|20481592|P2|STARTED|Overall Study||178
8307561|NCT01507493|20481593|P1|STARTED|Overall Study||22
8307562|NCT01507350|20481607|P1|NOT COMPLETED|Overall Study||0
8307563|NCT01507350|20481607|P1|COMPLETED|Overall Study||9
8307564|NCT01507350|20481607|P1|STARTED|Overall Study||9
8307565|NCT01507298|20481613|P2|NOT COMPLETED|Overall Study||6
8307566|NCT01507298|20481614|P1|NOT COMPLETED|Overall Study||0
8307567|NCT01507298|20481613|P2|COMPLETED|Overall Study||14
8307568|NCT01507298|20481614|P1|COMPLETED|Overall Study||1
8307569|NCT01507298|20481613|P2|STARTED|Overall Study||20
8307570|NCT01507298|20481614|P1|STARTED|Overall Study||1
8307571|NCT01507246|20481624|P2|NOT COMPLETED|Overall Study||1
8307572|NCT01507246|20481625|P1|NOT COMPLETED|Overall Study||2
8307573|NCT01507246|20481624|P2|COMPLETED|Overall Study||21
8307574|NCT01507246|20481625|P1|COMPLETED|Overall Study||18
8307575|NCT01507246|20481624|P2|STARTED|Overall Study||22
8307576|NCT01507246|20481625|P1|STARTED|Overall Study||20
8307577|NCT01507233|20481639|P2|NOT COMPLETED|Overall Study||0
8307578|NCT01507233|20481640|P1|NOT COMPLETED|Overall Study||0
8307579|NCT01507233|20481639|P2|COMPLETED|Overall Study||0
8307580|NCT01507233|20481640|P1|COMPLETED|Overall Study||5
8307581|NCT01507233|20481639|P2|STARTED|Overall Study||0
8307582|NCT01507233|20481640|P1|STARTED|Overall Study||5
8307583|NCT01507220|20481652|P2|NOT COMPLETED|Overall Study||0
8307584|NCT01507220|20481653|P1|NOT COMPLETED|Overall Study||0
8307585|NCT01507220|20481652|P2|COMPLETED|Overall Study||0
8307586|NCT01507220|20481653|P1|COMPLETED|Overall Study||2
8307587|NCT01507220|20481652|P2|STARTED|Overall Study||0
8307588|NCT01507220|20481653|P1|STARTED|Overall Study||2
8307589|NCT01507181|20481667|P2|NOT COMPLETED|Overall Study||0
8307590|NCT01507181|20481668|P1|NOT COMPLETED|Overall Study||0
8307591|NCT01507181|20481667|P2|COMPLETED|Overall Study||12
8307592|NCT01507181|20481668|P1|COMPLETED|Overall Study||12
8307593|NCT01507181|20481667|P2|STARTED|Overall Study||12
8307594|NCT01507181|20481668|P1|STARTED|Overall Study||12
8307595|NCT01507155|20481688|P2|NOT COMPLETED|Overall Study||0
8307596|NCT01507155|20481689|P1|NOT COMPLETED|Overall Study||0
8307597|NCT01507155|20481688|P2|COMPLETED|Overall Study||60
8307598|NCT01507155|20481689|P1|COMPLETED|Overall Study||625
8307599|NCT01507155|20481688|P2|STARTED|Overall Study||60
8307600|NCT01507155|20481689|P1|STARTED|Overall Study||625
8307601|NCT01507103|20481698|P3|NOT COMPLETED|Overall Study||0
8307602|NCT01507103|20481699|P2|NOT COMPLETED|Overall Study||0
8307603|NCT01507103|20481700|P1|NOT COMPLETED|Overall Study||0
8307604|NCT01507103|20481698|P3|COMPLETED|Overall Study||42
8307605|NCT01507103|20481699|P2|COMPLETED|Overall Study||41
8307606|NCT01507103|20481700|P1|COMPLETED|Overall Study||41
8307607|NCT01507103|20481698|P3|STARTED|Overall Study||42
8307608|NCT01507103|20481699|P2|STARTED|Overall Study||41
8307609|NCT01507103|20481700|P1|STARTED|Overall Study||41
8307610|NCT01507090|20481723|P1|NOT COMPLETED|Overall Study||18
8307611|NCT01507090|20481723|P1|COMPLETED|Overall Study||624
8307612|NCT01507090|20481723|P1|STARTED|Overall Study||642
8307613|NCT01507051|20481762|P4|NOT COMPLETED|Overall Study||7
8307614|NCT01507051|20481763|P3|NOT COMPLETED|Overall Study||1
8307615|NCT01507051|20481764|P2|NOT COMPLETED|Overall Study||3
8307616|NCT01507051|20481765|P1|NOT COMPLETED|Overall Study||2
8307617|NCT01507051|20481762|P4|COMPLETED|Overall Study||0
8307618|NCT01507051|20481763|P3|COMPLETED|Overall Study||28
8307619|NCT01507051|20481764|P2|COMPLETED|Overall Study||28
8307620|NCT01507051|20481765|P1|COMPLETED|Overall Study||27
8307621|NCT01507051|20481762|P4|Received Placebo or Rivaroxaban|Overall Study||0
8307622|NCT01507051|20481763|P3|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
8307623|NCT01507051|20481764|P2|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
8307624|NCT01507051|20481765|P1|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
8307625|NCT01507051|20481762|P4|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
8307626|NCT01507051|20481763|P3|Warfarin run-in Phase|Overall Study||0
8307627|NCT01507051|20481764|P2|Warfarin run-in Phase|Overall Study||28
8307628|NCT01507051|20481765|P1|Warfarin run-in Phase|Overall Study||28
8307629|NCT01507051|20481762|P4|STARTED|Overall Study||7
8307630|NCT01507051|20481763|P3|STARTED|Overall Study||29
8307631|NCT01507051|20481764|P2|STARTED|Overall Study||31
8307632|NCT01507051|20481765|P1|STARTED|Overall Study||29
8307633|NCT01506960|20481883|P1|NOT COMPLETED|Overall Study||47
8307634|NCT01506960|20481883|P1|COMPLETED|Overall Study||17
8307635|NCT01506960|20481883|P1|STARTED|Overall Study||64
8307639|NCT01506908|20481907|P2|NOT COMPLETED|Overall Study||0
8307640|NCT01506908|20481908|P1|NOT COMPLETED|Overall Study||1
8307641|NCT01506908|20481907|P2|COMPLETED|Overall Study||161
8307642|NCT01506908|20481908|P1|COMPLETED|Overall Study||161
8307643|NCT01506908|20481907|P2|STARTED|Overall Study||161
8307644|NCT01506908|20481908|P1|STARTED|Overall Study||162
8307645|NCT01506882|20481926|P2|NOT COMPLETED|Overall Study||7
8307646|NCT01506882|20481927|P1|NOT COMPLETED|Overall Study||22
8307647|NCT01506882|20481926|P2|COMPLETED|Overall Study||3
8307648|NCT01506882|20481927|P1|COMPLETED|Overall Study||39
8307649|NCT01506882|20481926|P2|STARTED|Overall Study||10
8307650|NCT01506882|20481927|P1|STARTED|Overall Study||61
8307651|NCT01506726|20481941|P2|NOT COMPLETED|Overall Study||2
8307652|NCT01506726|20481942|P1|NOT COMPLETED|Overall Study||1
8307653|NCT01506726|20481941|P2|COMPLETED|Overall Study||3
8307654|NCT01506726|20481942|P1|COMPLETED|Overall Study||5
8307655|NCT01506726|20481941|P2|STARTED|Overall Study||5
8307656|NCT01506726|20481942|P1|STARTED|Overall Study||6
8307657|NCT01506596|20481982|P1|NOT COMPLETED|Overall Study||1
8307658|NCT01506596|20481982|P1|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
8307659|NCT01506596|20481982|P1|STARTED|Overall Study||42
8307660|NCT01506479|20481993|P3|NOT COMPLETED|Overall Study||3
8307661|NCT01506479|20481994|P2|NOT COMPLETED|Overall Study||5
8307662|NCT01506479|20481995|P1|NOT COMPLETED|Overall Study||3
8307663|NCT01506479|20481993|P3|COMPLETED|Overall Study||42
8307664|NCT01506479|20481994|P2|COMPLETED|Overall Study||38
8307665|NCT01506479|20481995|P1|COMPLETED|Overall Study||37
8307666|NCT01506479|20481993|P3|STARTED|Overall Study||45
8307667|NCT01506479|20481994|P2|STARTED|Overall Study||43
8307668|NCT01506479|20481995|P1|STARTED|Overall Study||40
8307669|NCT01506453|20482009|P2|NOT COMPLETED|Overall Study||2
8307670|NCT01506453|20482010|P1|NOT COMPLETED|Overall Study||0
8307671|NCT01506453|20482009|P2|COMPLETED|Overall Study||24
8307672|NCT01506453|20482010|P1|COMPLETED|Overall Study||25
8307673|NCT01506453|20482009|P2|STARTED|Overall Study||26
8307674|NCT01506453|20482010|P1|STARTED|Overall Study||25
8307675|NCT01506362|20482020|P1|NOT COMPLETED|Overall Study||6
8307676|NCT01506362|20482020|P1|COMPLETED|Overall Study||16
8307677|NCT01506362|20482020|P1|STARTED|Overall Study||22
8307678|NCT01506323|20482026|P2|NOT COMPLETED|Overall Study||13
8307679|NCT01506323|20482027|P1|NOT COMPLETED|Overall Study||24
8307680|NCT01506323|20482026|P2|COMPLETED|Overall Study||71
8307681|NCT01506323|20482027|P1|COMPLETED|Overall Study||65
8307682|NCT01506323|20482026|P2|Post-treatment Completed CAPS|Overall Study||72
8307683|NCT01506323|20482027|P1|Post-treatment Completed CAPS|Overall Study||68
8307684|NCT01506323|20482026|P2|Post-treatment Completers|Overall Study||72
8307685|NCT01506323|20482027|P1|Post-treatment Completers|Overall Study||69
8307686|NCT01506323|20482026|P2|STARTED|Overall Study||84
8307687|NCT01506323|20482027|P1|STARTED|Overall Study||89
8307688|NCT01506271|20482056|P3|NOT COMPLETED|Overall Study||3
8307689|NCT01506271|20482057|P2|NOT COMPLETED|Overall Study||7
8307690|NCT01506271|20482058|P1|NOT COMPLETED|Overall Study||4
8307691|NCT01506271|20482056|P3|COMPLETED|Overall Study||114
8307692|NCT01506271|20482057|P2|COMPLETED|Overall Study||109
8307693|NCT01506271|20482058|P1|COMPLETED|Overall Study||114
8307694|NCT01506271|20482056|P3|Treated|Overall Study||114
8307695|NCT01506271|20482057|P2|Treated|Overall Study||116
8307696|NCT01506271|20482058|P1|Treated|Overall Study||117
8307697|NCT01506271|20482056|P3|STARTED|Overall Study||117
8307698|NCT01506271|20482057|P2|STARTED|Overall Study||116
8307699|NCT01506271|20482058|P1|STARTED|Overall Study||118
8307700|NCT01506193|20482120|P3|NOT COMPLETED|Overall Study||14
8307701|NCT01506193|20482121|P2|NOT COMPLETED|Overall Study||4
8307702|NCT01506193|20482122|P1|NOT COMPLETED|Overall Study||14
8307703|NCT01506193|20482120|P3|COMPLETED|Overall Study||168
8307704|NCT01506193|20482121|P2|COMPLETED|Overall Study||179
8307705|NCT01506193|20482122|P1|COMPLETED|Overall Study||337
8307706|NCT01506193|20482120|P3|STARTED|Overall Study||182
8307707|NCT01506193|20482121|P2|STARTED|Overall Study||183
8307708|NCT01506193|20482122|P1|STARTED|Overall Study||351
8307709|NCT01505933|20482155|P2|NOT COMPLETED|Overall Study||0
8307710|NCT01505933|20482156|P1|NOT COMPLETED|Overall Study||0
8307711|NCT01505933|20482155|P2|COMPLETED|Overall Study||14
8307712|NCT01505933|20482156|P1|COMPLETED|Overall Study||10
8307713|NCT01505933|20482155|P2|STARTED|Overall Study||14
8307714|NCT01505933|20482156|P1|STARTED|Overall Study||10
8307715|NCT01505881|20482168|P2|NOT COMPLETED|Overall Study||1
8307716|NCT01505881|20482169|P1|NOT COMPLETED|Overall Study||4
8307717|NCT01505881|20482168|P2|COMPLETED|Overall Study||58
8307718|NCT01505881|20482169|P1|COMPLETED|Overall Study||95
8307719|NCT01505881|20482168|P2|STARTED|Overall Study||59
8307720|NCT01505881|20482169|P1|STARTED|Overall Study||99
8307721|NCT01505764|20482183|P2|NOT COMPLETED|Overall Study||1
8307722|NCT01505764|20482184|P1|NOT COMPLETED|Overall Study||3
8307723|NCT01505764|20482183|P2|COMPLETED|Overall Study||2
8307724|NCT01505764|20482184|P1|COMPLETED|Overall Study||3
8307725|NCT01505764|20482183|P2|STARTED|Overall Study||3
8307726|NCT01505764|20482184|P1|STARTED|Overall Study||6
8307727|NCT01505673|20482214|P2|NOT COMPLETED|Overall Study||2
8307728|NCT01505673|20482215|P1|NOT COMPLETED|Overall Study||3
8307729|NCT01505673|20482214|P2|COMPLETED|Overall Study||34
8307730|NCT01505673|20482215|P1|COMPLETED|Overall Study||32
8307731|NCT01505673|20482214|P2|STARTED|Overall Study||36
8307732|NCT01505673|20482215|P1|STARTED|Overall Study||35
8307733|NCT01505647|20482275|P2|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
8307734|NCT01505647|20482276|P1|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
8307735|NCT01505647|20482275|P2|COMPLETED|Day 43 Through Day 182 Follow-up||163
8307736|NCT01505647|20482276|P1|COMPLETED|Day 43 Through Day 182 Follow-up||328
8307737|NCT01505647|20482275|P2|STARTED|Day 43 Through Day 182 Follow-up||166
8307738|NCT01505647|20482276|P1|STARTED|Day 43 Through Day 182 Follow-up||329
8307739|NCT01505647|20482275|P2|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
8307740|NCT01505647|20482276|P1|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
8307741|NCT01505647|20482275|P2|COMPLETED|Day 1 Through Day 42 Follow-up||166
8307742|NCT01505647|20482276|P1|COMPLETED|Day 1 Through Day 42 Follow-up||329
8307743|NCT01505647|20482275|P2|Vaccinated|Day 1 Through Day 42 Follow-up||166
8307744|NCT01505647|20482276|P1|Vaccinated|Day 1 Through Day 42 Follow-up||331
8307745|NCT01505647|20482275|P2|STARTED|Day 1 Through Day 42 Follow-up||166
8307746|NCT01505647|20482276|P1|STARTED|Day 1 Through Day 42 Follow-up||332
8307747|NCT01505634|20482293|P3|NOT COMPLETED|Overall Study||6
8307748|NCT01505634|20482294|P2|NOT COMPLETED|Overall Study||10
8307749|NCT01505634|20482295|P1|NOT COMPLETED|Overall Study||9
8307750|NCT01505634|20482293|P3|COMPLETED|Overall Study||94
8307751|NCT01505634|20482294|P2|COMPLETED|Overall Study||91
8307752|NCT01505634|20482295|P1|COMPLETED|Overall Study||92
8307753|NCT01505634|20482293|P3|Treated|Overall Study||100
8307754|NCT01505634|20482294|P2|Treated|Overall Study||99
8307755|NCT01505634|20482295|P1|Treated|Overall Study||99
8307756|NCT01505634|20482293|P3|STARTED|Overall Study||100
8307757|NCT01505634|20482294|P2|STARTED|Overall Study||101
8307758|NCT01505634|20482295|P1|STARTED|Overall Study||101
8307759|NCT01505608|20482350|P2|NOT COMPLETED|Phase II||2
8307760|NCT01505608|20482351|P1|NOT COMPLETED|Phase II||2
8307761|NCT01505608|20482350|P2|COMPLETED|Phase II||2
8307762|NCT01505608|20482351|P1|COMPLETED|Phase II||0
8307763|NCT01505608|20482350|P2|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
8307764|NCT01505608|20482351|P1|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
8307765|NCT01505608|20482350|P2|NOT COMPLETED|Phase I||6
8307766|NCT01505608|20482351|P1|NOT COMPLETED|Phase I||0
8307767|NCT01505608|20482350|P2|COMPLETED|Phase I||2
8307768|NCT01505608|20482351|P1|COMPLETED|Phase I||0
8307769|NCT01505608|20482350|P2|STARTED|Phase I||8
8307770|NCT01505608|20482351|P1|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
8307771|NCT01505530|20482370|P3|NOT COMPLETED|Overall Study||41
8307772|NCT01505530|20482371|P2|NOT COMPLETED|Overall Study||43
8307773|NCT01505530|20482372|P1|NOT COMPLETED|Overall Study||41
8307774|NCT01505530|20482370|P3|COMPLETED|Overall Study||0
8307775|NCT01505530|20482371|P2|COMPLETED|Overall Study||0
8307776|NCT01505530|20482372|P1|COMPLETED|Overall Study||0
8307777|NCT01505530|20482370|P3|Completed One Cycle of Study Drug|Overall Study||31
8307778|NCT01505530|20482371|P2|Completed One Cycle of Study Drug|Overall Study||27
8307779|NCT01505530|20482372|P1|Completed One Cycle of Study Drug|Overall Study||29
8307780|NCT01505530|20482370|P3|Received At Least One Dose of Study Drug|Overall Study||41
8307781|NCT01505530|20482371|P2|Received At Least One Dose of Study Drug|Overall Study||42
8307782|NCT01505530|20482372|P1|Received At Least One Dose of Study Drug|Overall Study||41
8307783|NCT01505530|20482370|P3|STARTED|Overall Study||41
8307784|NCT01505530|20482371|P2|STARTED|Overall Study||43
8307785|NCT01505530|20482372|P1|STARTED|Overall Study||41
8307786|NCT01505491|20482416|P3|NOT COMPLETED|Overall Study||5
8307787|NCT01505491|20482417|P2|NOT COMPLETED|Overall Study||1
8307788|NCT01505491|20482418|P1|NOT COMPLETED|Overall Study||2
8307789|NCT01505491|20482416|P3|COMPLETED|Overall Study||59
8307790|NCT01505491|20482417|P2|COMPLETED|Overall Study||61
8307791|NCT01505491|20482418|P1|COMPLETED|Overall Study||65
8307792|NCT01505491|20482416|P3|STARTED|Overall Study||64
8307793|NCT01505491|20482417|P2|STARTED|Overall Study||62
8307794|NCT01505491|20482418|P1|STARTED|Overall Study||67
8307795|NCT01505465|20482440|P2|NOT COMPLETED|Overall Study||7
8307796|NCT01505465|20482441|P1|NOT COMPLETED|Overall Study||6
8307797|NCT01505465|20482440|P2|COMPLETED|Overall Study||18
8307798|NCT01505465|20482441|P1|COMPLETED|Overall Study||19
8307799|NCT01505465|20482440|P2|STARTED|Overall Study||25
8307800|NCT01505465|20482441|P1|STARTED|Overall Study||25
8307801|NCT01505387|20482457|P2|NOT COMPLETED|Overall Study||1
8307802|NCT01505387|20482458|P1|NOT COMPLETED|Overall Study||2
8307803|NCT01505387|20482457|P2|COMPLETED|Overall Study||24
8307804|NCT01505387|20482458|P1|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
8307805|NCT01505387|20482457|P2|Treated|Overall Study||24
8307806|NCT01505387|20482458|P1|Treated|Overall Study||24
8307807|NCT01505387|20482457|P2|STARTED|Overall Study||25
8307808|NCT01505387|20482458|P1|STARTED|Overall Study||25
8307809|NCT01505374|20482464|P2|NOT COMPLETED|Overall Study||0
8307810|NCT01505374|20482465|P1|NOT COMPLETED|Overall Study||1
8307811|NCT01505374|20482464|P2|COMPLETED|Overall Study||30
8307812|NCT01505374|20482465|P1|COMPLETED|Overall Study||29
8307813|NCT01505374|20482464|P2|STARTED|Overall Study||30
8307814|NCT01505374|20482465|P1|STARTED|Overall Study||30
8307815|NCT01505179|20482481|P2|NOT COMPLETED|Overall Study||0
8307816|NCT01505179|20482482|P1|NOT COMPLETED|Overall Study||0
8307817|NCT01505179|20482481|P2|COMPLETED|Overall Study||4
8307818|NCT01505179|20482482|P1|COMPLETED|Overall Study||6
8307819|NCT01505179|20482481|P2|STARTED|Overall Study||4
8307820|NCT01505179|20482482|P1|STARTED|Overall Study||6
8307842|NCT01505062|20482531|P3|NOT COMPLETED|Overall Study||0
8307843|NCT01505062|20482532|P2|NOT COMPLETED|Overall Study||0
8307844|NCT01505062|20482533|P1|NOT COMPLETED|Overall Study||0
8307845|NCT01505062|20482531|P3|COMPLETED|Overall Study||3
8307846|NCT01505062|20482532|P2|COMPLETED|Overall Study||3
8307847|NCT01505062|20482533|P1|COMPLETED|Overall Study||3
8307848|NCT01505062|20482531|P3|STARTED|Overall Study||3
8307849|NCT01505062|20482532|P2|STARTED|Overall Study||3
8307850|NCT01505062|20482533|P1|STARTED|Overall Study||3
8307851|NCT01505010|20482546|P2|NOT COMPLETED|Overall Study||2
8307852|NCT01505010|20482547|P1|NOT COMPLETED|Overall Study||0
8307853|NCT01505010|20482546|P2|COMPLETED|Overall Study||6
8307854|NCT01505010|20482547|P1|COMPLETED|Overall Study||9
8307855|NCT01505010|20482546|P2|STARTED|Overall Study||8
8307856|NCT01505010|20482547|P1|STARTED|Overall Study||9
8307857|NCT01504997|20482557|P1|NOT COMPLETED|Overall Study||0
8307858|NCT01504997|20482557|P1|COMPLETED|Overall Study||18
8307859|NCT01504997|20482557|P1|STARTED|Overall Study||18
8307860|NCT01504971|20482561|P1|NOT COMPLETED|Overall Study||13
8307861|NCT01504971|20482561|P1|COMPLETED|Overall Study||82
8307862|NCT01504971|20482561|P1|STARTED|Overall Study||95
8307863|NCT01504958|20482572|P3|NOT COMPLETED|Overall Study||0
8307864|NCT01504958|20482573|P2|NOT COMPLETED|Overall Study||0
8307865|NCT01504958|20482574|P1|NOT COMPLETED|Overall Study||0
8307866|NCT01504958|20482572|P3|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
8307867|NCT01504958|20482573|P2|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
8307868|NCT01504958|20482574|P1|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
8307869|NCT01504958|20482572|P3|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
8307870|NCT01504958|20482573|P2|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
8307871|NCT01504958|20482574|P1|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
8307872|NCT01504867|20482590|P2|NOT COMPLETED|Overall Study||3
8307873|NCT01504867|20482591|P1|NOT COMPLETED|Overall Study||7
8307874|NCT01504867|20482590|P2|COMPLETED|Overall Study||195
8307875|NCT01504867|20482591|P1|COMPLETED|Overall Study||195
8307876|NCT01504867|20482590|P2|STARTED|Overall Study||198
8307877|NCT01504867|20482591|P1|STARTED|Overall Study||202
8307878|NCT01504854|20482611|P2|NOT COMPLETED|Overall Study||7
8307879|NCT01504854|20482612|P1|NOT COMPLETED|Overall Study||8
8307880|NCT01504854|20482611|P2|COMPLETED|Overall Study||48
8307881|NCT01504854|20482612|P1|COMPLETED|Overall Study||56
8307882|NCT01504854|20482611|P2|STARTED|Overall Study||55
8307883|NCT01504854|20482612|P1|STARTED|Overall Study||64
8307896|NCT01504477|20482671|P1|NOT COMPLETED|Overall Study||0
8307897|NCT01504477|20482671|P1|COMPLETED|Overall Study||6
8307898|NCT01504477|20482671|P1|STARTED|Overall Study||6
8307899|NCT01504412|20482684|P5|NOT COMPLETED|Overall Study||13
8307900|NCT01504412|20482685|P4|NOT COMPLETED|Overall Study||19
8307901|NCT01504412|20482686|P3|NOT COMPLETED|Overall Study||4
8307902|NCT01504412|20482687|P2|NOT COMPLETED|Overall Study||12
8307903|NCT01504412|20482688|P1|NOT COMPLETED|Overall Study||5
8307904|NCT01504412|20482684|P5|COMPLETED|Overall Study||77
8307905|NCT01504412|20482685|P4|COMPLETED|Overall Study||75
8307906|NCT01504412|20482686|P3|COMPLETED|Overall Study||86
8307907|NCT01504412|20482687|P2|COMPLETED|Overall Study||75
8307908|NCT01504412|20482688|P1|COMPLETED|Overall Study||84
8307909|NCT01504412|20482684|P5|STARTED|Overall Study||90
8307910|NCT01504412|20482685|P4|STARTED|Overall Study||94
8307911|NCT01504412|20482686|P3|STARTED|Overall Study||90
8307912|NCT01504412|20482687|P2|STARTED|Overall Study||87
8307913|NCT01504412|20482688|P1|STARTED|Overall Study||89
8307914|NCT01504204|20482707|P2|NOT COMPLETED|Overall Study||1
8307915|NCT01504204|20482708|P1|NOT COMPLETED|Overall Study||1
8307916|NCT01504204|20482707|P2|COMPLETED|Overall Study||9
8307917|NCT01504204|20482708|P1|COMPLETED|Overall Study||9
8307918|NCT01504204|20482707|P2|STARTED|Overall Study||10
8307919|NCT01504204|20482708|P1|STARTED|Overall Study||10
8307920|NCT01503749|20482721|P3|NOT COMPLETED|Overall Study||0
8307921|NCT01503749|20482722|P2|NOT COMPLETED|Overall Study||0
8307922|NCT01503749|20482723|P1|NOT COMPLETED|Overall Study||0
8307923|NCT01503749|20482721|P3|COMPLETED|Overall Study||3
8307924|NCT01503749|20482722|P2|COMPLETED|Overall Study||3
8307925|NCT01503749|20482723|P1|COMPLETED|Overall Study||3
8307926|NCT01503749|20482721|P3|STARTED|Overall Study||3
8307927|NCT01503749|20482722|P2|STARTED|Overall Study||3
8307928|NCT01503749|20482723|P1|STARTED|Overall Study||3
8307929|NCT01503515|20482736|P2|NOT COMPLETED|Overall Study||35
8307930|NCT01503515|20482737|P1|NOT COMPLETED|Overall Study||21
8307931|NCT01503515|20482736|P2|COMPLETED|Overall Study||112
8307932|NCT01503515|20482737|P1|COMPLETED|Overall Study||124
8307933|NCT01503515|20482736|P2|STARTED|Overall Study||147
8307934|NCT01503515|20482737|P1|STARTED|Overall Study||145
8307935|NCT01503333|20482745|P2|NOT COMPLETED|Overall Study||305
8307936|NCT01503333|20482746|P1|NOT COMPLETED|Overall Study||340
8307937|NCT01503333|20482745|P2|COMPLETED|Overall Study||461
8307938|NCT01503333|20482746|P1|COMPLETED|Overall Study||437
8307939|NCT01503333|20482745|P2|Completed Post-intervention|Overall Study||706
8307940|NCT01503333|20482746|P1|Completed Post-intervention|Overall Study||680
8307941|NCT01503333|20482745|P2|Completed Baseline|Overall Study||753
8307942|NCT01503333|20482746|P1|Completed Baseline|Overall Study||766
8307943|NCT01503333|20482745|P2|STARTED|Overall Study||766
8307944|NCT01503333|20482746|P1|STARTED|Overall Study||777
8307945|NCT01503164|20482774|P2|NOT COMPLETED|Overall Study||1
8307946|NCT01503164|20482775|P1|NOT COMPLETED|Overall Study||2
8307947|NCT01503164|20482774|P2|COMPLETED|Overall Study||55
8307948|NCT01503164|20482775|P1|COMPLETED|Overall Study||53
8307949|NCT01503164|20482774|P2|STARTED|Overall Study||56
8307950|NCT01503164|20482775|P1|STARTED|Overall Study||55
8307951|NCT01503021|20482805|P2|NOT COMPLETED|Overall Study||26
8307952|NCT01503021|20482806|P1|NOT COMPLETED|Overall Study||27
8307953|NCT01503021|20482805|P2|COMPLETED|Overall Study||332
8307954|NCT01503021|20482806|P1|COMPLETED|Overall Study||333
8307955|NCT01503021|20482805|P2|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
8307956|NCT01503021|20482806|P1|Completed Treatment|Overall Study||333
8307957|NCT01503021|20482805|P2|Dosed|Overall Study||352
8307958|NCT01503021|20482806|P1|Dosed|Overall Study||351
8307959|NCT01503021|20482805|P2|STARTED|Overall Study||358
8307960|NCT01503021|20482806|P1|STARTED|Overall Study||360
8307961|NCT01502956|20482855|P2|NOT COMPLETED|Overall Study||26
8307962|NCT01502956|20482856|P1|NOT COMPLETED|Overall Study||24
8307963|NCT01502956|20482855|P2|COMPLETED|Overall Study||168
8307964|NCT01502956|20482856|P1|COMPLETED|Overall Study||168
8307965|NCT01502956|20482855|P2|STARTED|Overall Study||194
8307966|NCT01502956|20482856|P1|STARTED|Overall Study||192
8307967|NCT01502787|20482880|P2|NOT COMPLETED|Overall Study||0
8307968|NCT01502787|20482881|P1|NOT COMPLETED|Overall Study||0
8307969|NCT01502787|20482880|P2|COMPLETED|Overall Study||10
8307970|NCT01502787|20482881|P1|COMPLETED|Overall Study||11
8307971|NCT01502787|20482880|P2|STARTED|Overall Study||10
8307972|NCT01502787|20482881|P1|STARTED|Overall Study||11
8307973|NCT01502761|20482895|P4|NOT COMPLETED|Overall Study||0
8307974|NCT01502761|20482896|P3|NOT COMPLETED|Overall Study||0
8307975|NCT01502761|20482897|P2|NOT COMPLETED|Overall Study||0
8307976|NCT01502761|20482898|P1|NOT COMPLETED|Overall Study||0
8307977|NCT01502761|20482895|P4|COMPLETED|Overall Study||0
8307978|NCT01502761|20482896|P3|COMPLETED|Overall Study||0
8307979|NCT01502761|20482897|P2|COMPLETED|Overall Study||0
8307980|NCT01502761|20482898|P1|COMPLETED|Overall Study||4
8307981|NCT01502761|20482895|P4|STARTED|Overall Study||0
8307982|NCT01502761|20482896|P3|STARTED|Overall Study||0
8307983|NCT01502761|20482897|P2|STARTED|Overall Study||0
8307984|NCT01502761|20482898|P1|STARTED|Overall Study||4
8307985|NCT01502709|20482914|P2|NOT COMPLETED|Overall Study||0
8307986|NCT01502709|20482915|P1|NOT COMPLETED|Overall Study||4
8307987|NCT01502709|20482914|P2|COMPLETED|Overall Study||0
8307988|NCT01502709|20482915|P1|COMPLETED|Overall Study||1
8307989|NCT01502709|20482914|P2|STARTED|Overall Study||0
8307990|NCT01502709|20482915|P1|STARTED|Overall Study||5
8307991|NCT01502644|20482928|P4|NOT COMPLETED|Assigned to NA Groups||8
8307992|NCT01502644|20482929|P3|NOT COMPLETED|Assigned to NA Groups||3
8307993|NCT01502644|20482930|P2|NOT COMPLETED|Assigned to NA Groups||6
8307994|NCT01502644|20482931|P1|NOT COMPLETED|Assigned to NA Groups||0
8307995|NCT01502644|20482928|P4|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
8307996|NCT01502644|20482929|P3|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
8307997|NCT01502644|20482930|P2|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
8307998|NCT01502644|20482931|P1|COMPLETED|Assigned to NA Groups||0
8307999|NCT01502644|20482928|P4|STARTED|Assigned to NA Groups||32
8308000|NCT01502644|20482929|P3|STARTED|Assigned to NA Groups||10
8308001|NCT01502644|20482930|P2|STARTED|Assigned to NA Groups||30
8308002|NCT01502644|20482931|P1|STARTED|Assigned to NA Groups||0
8308003|NCT01502644|20482928|P4|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8308004|NCT01502644|20482929|P3|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8308005|NCT01502644|20482930|P2|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8308006|NCT01502644|20482931|P1|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
8308007|NCT01502644|20482928|P4|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8308008|NCT01502644|20482929|P3|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8308009|NCT01502644|20482930|P2|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
8308010|NCT01502644|20482931|P1|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
8308011|NCT01502644|20482928|P4|STARTED|Enrolled at Visit 1 After Pre-screening||0
8308012|NCT01502644|20482929|P3|STARTED|Enrolled at Visit 1 After Pre-screening||0
8308013|NCT01502644|20482930|P2|STARTED|Enrolled at Visit 1 After Pre-screening||0
8308014|NCT01502644|20482931|P1|STARTED|Enrolled at Visit 1 After Pre-screening||81
8308015|NCT01502631|20482941|P2|NOT COMPLETED|Overall Study||20
8308016|NCT01502631|20482942|P1|NOT COMPLETED|Overall Study||20
8308017|NCT01502631|20482941|P2|COMPLETED|Overall Study||11
8308018|NCT01502631|20482942|P1|COMPLETED|Overall Study||10
8308019|NCT01502631|20482941|P2|STARTED|Overall Study||31
8308020|NCT01502631|20482942|P1|STARTED|Overall Study||30
8308021|NCT01502423|20482962|P2|NOT COMPLETED|Overall Study||1
8308022|NCT01502423|20482963|P1|NOT COMPLETED|Overall Study||0
8308023|NCT01502423|20482962|P2|COMPLETED|Overall Study||29
8308024|NCT01502423|20482963|P1|COMPLETED|Overall Study||31
8308025|NCT01502423|20482962|P2|STARTED|Overall Study||30
8308026|NCT01502423|20482963|P1|STARTED|Overall Study||31
8308027|NCT01502410|20482985|P4|NOT COMPLETED|Overall Study||0
8308028|NCT01502410|20482986|P3|NOT COMPLETED|Overall Study||0
8308029|NCT01502410|20482987|P2|NOT COMPLETED|Overall Study||10
8308030|NCT01502410|20482988|P1|NOT COMPLETED|Overall Study||10
8308031|NCT01502410|20482985|P4|COMPLETED|Overall Study||0
8308032|NCT01502410|20482986|P3|COMPLETED|Overall Study||0
8308033|NCT01502410|20482987|P2|COMPLETED|Overall Study||0
8308034|NCT01502410|20482988|P1|COMPLETED|Overall Study||0
8308035|NCT01502410|20482985|P4|STARTED|Overall Study||0
8308036|NCT01502410|20482986|P3|STARTED|Overall Study||0
8308037|NCT01502410|20482987|P2|STARTED|Overall Study||10
8308038|NCT01502410|20482988|P1|STARTED|Overall Study||10
8308039|NCT01502371|20483006|P5|NOT COMPLETED|Overall Study||52
8308040|NCT01502371|20483007|P4|NOT COMPLETED|Overall Study||37
8308041|NCT01502371|20483008|P3|NOT COMPLETED|Overall Study||25
8308042|NCT01502371|20483009|P2|NOT COMPLETED|Overall Study||32
8308043|NCT01502371|20483010|P1|NOT COMPLETED|Overall Study||41
8308044|NCT01502371|20483006|P5|COMPLETED|Overall Study||60
8308045|NCT01502371|20483007|P4|COMPLETED|Overall Study||88
8308046|NCT01502371|20483008|P3|COMPLETED|Overall Study||83
8308047|NCT01502371|20483009|P2|COMPLETED|Overall Study||81
8308048|NCT01502371|20483010|P1|COMPLETED|Overall Study||79
8308049|NCT01502371|20483006|P5|STARTED|Overall Study||112
8308050|NCT01502371|20483007|P4|STARTED|Overall Study||125
8308051|NCT01502371|20483008|P3|STARTED|Overall Study||108
8308052|NCT01502371|20483009|P2|STARTED|Overall Study||113
8308053|NCT01502371|20483010|P1|STARTED|Overall Study||120
8308054|NCT01502332|20483035|P2|NOT COMPLETED|Overall Study||0
8308055|NCT01502332|20483036|P1|NOT COMPLETED|Overall Study||0
8308056|NCT01502332|20483035|P2|COMPLETED|Overall Study||163
8308057|NCT01502332|20483036|P1|COMPLETED|Overall Study||157
8308058|NCT01502332|20483035|P2|STARTED|Overall Study||163
8308059|NCT01502332|20483036|P1|STARTED|Overall Study||157
8308060|NCT01502306|20483053|P3|NOT COMPLETED|Overall Study||0
8308061|NCT01502306|20483054|P2|NOT COMPLETED|Overall Study||0
8308062|NCT01502306|20483055|P1|NOT COMPLETED|Overall Study||0
8308063|NCT01502306|20483053|P3|COMPLETED|Overall Study||1407
8308064|NCT01502306|20483054|P2|COMPLETED|Overall Study||1405
8308065|NCT01502306|20483055|P1|COMPLETED|Overall Study||1004
8308066|NCT01502306|20483053|P3|STARTED|Overall Study||1407
8308067|NCT01502306|20483054|P2|STARTED|Overall Study||1405
8308068|NCT01502306|20483055|P1|STARTED|Overall Study||1004
8308069|NCT01502293|20483075|P3|NOT COMPLETED|Overall Study||4
8308070|NCT01502293|20483076|P2|NOT COMPLETED|Overall Study||17
8308071|NCT01502293|20483077|P1|NOT COMPLETED|Overall Study||25
8308072|NCT01502293|20483075|P3|COMPLETED|Overall Study||0
8308073|NCT01502293|20483076|P2|COMPLETED|Overall Study||0
8308074|NCT01502293|20483077|P1|COMPLETED|Overall Study||5
8308075|NCT01502293|20483075|P3|STARTED|Overall Study||4
8308076|NCT01502293|20483076|P2|STARTED|Overall Study||17
8308077|NCT01502293|20483077|P1|STARTED|Overall Study||30
8308078|NCT01502228|20483106|P1|NOT COMPLETED|Overall Study||1
8308079|NCT01502228|20483106|P1|COMPLETED|Overall Study||13
8308080|NCT01502228|20483106|P1|STARTED|Overall Study||14
8308081|NCT01502033|20483111|P1|NOT COMPLETED|Overall Study||3
8308082|NCT01502033|20483111|P1|COMPLETED|Overall Study|Milestone (10 participants) met|7
8308083|NCT01502033|20483111|P1|STARTED|Overall Study|Milestone (10 participants) met.|10
8308098|NCT01501929|20483162|P2|NOT COMPLETED|Second Intervention||0
8308099|NCT01501929|20483163|P1|NOT COMPLETED|Second Intervention||0
8308100|NCT01501929|20483162|P2|COMPLETED|Second Intervention||17
8308101|NCT01501929|20483163|P1|COMPLETED|Second Intervention||8
8308102|NCT01501929|20483162|P2|STARTED|Second Intervention||17
8308103|NCT01501929|20483163|P1|STARTED|Second Intervention||8
8308104|NCT01501929|20483162|P2|NOT COMPLETED|First Intervention||0
8308105|NCT01501929|20483163|P1|NOT COMPLETED|First Intervention||0
8308106|NCT01501929|20483162|P2|COMPLETED|First Intervention||17
8308107|NCT01501929|20483163|P1|COMPLETED|First Intervention||8
8308108|NCT01501929|20483162|P2|STARTED|First Intervention||17
8308109|NCT01501929|20483163|P1|STARTED|First Intervention||8
8308110|NCT01501162|20483173|P2|NOT COMPLETED|Overall Study||5
8308111|NCT01501162|20483174|P1|NOT COMPLETED|Overall Study||8
8308112|NCT01501162|20483173|P2|COMPLETED|Overall Study||60
8308113|NCT01501162|20483174|P1|COMPLETED|Overall Study||57
8308114|NCT01501162|20483173|P2|STARTED|Overall Study||65
8308115|NCT01501162|20483174|P1|STARTED|Overall Study||65
8308116|NCT01501110|20483184|P2|NOT COMPLETED|Overall Study||1
8308117|NCT01501110|20483185|P1|NOT COMPLETED|Overall Study||0
8308118|NCT01501110|20483184|P2|COMPLETED|Overall Study||33
8308119|NCT01501110|20483185|P1|COMPLETED|Overall Study||34
8308120|NCT01501110|20483184|P2|STARTED|Overall Study||34
8308121|NCT01501110|20483185|P1|STARTED|Overall Study||34
8308122|NCT01500772|20483191|P1|NOT COMPLETED|Overall Study||6
8308123|NCT01500772|20483191|P1|COMPLETED|Overall Study||0
8308124|NCT01500772|20483191|P1|STARTED|Overall Study||6
8308125|NCT01500759|20483200|P2|NOT COMPLETED|Overall Study||0
8308126|NCT01500759|20483201|P1|NOT COMPLETED|Overall Study||0
8308127|NCT01500759|20483200|P2|COMPLETED|Overall Study||3190
8308128|NCT01500759|20483201|P1|COMPLETED|Overall Study||3686
8308129|NCT01500759|20483200|P2|STARTED|Overall Study||3190
8308130|NCT01500759|20483201|P1|STARTED|Overall Study||3686
8308131|NCT01500746|20483252|P2|NOT COMPLETED|Overall Study||0
8308132|NCT01500746|20483253|P1|NOT COMPLETED|Overall Study||0
8308133|NCT01500746|20483252|P2|COMPLETED|Overall Study||4
8308134|NCT01500746|20483253|P1|COMPLETED|Overall Study||4
8308135|NCT01500746|20483252|P2|STARTED|Overall Study||4
8308136|NCT01500746|20483253|P1|STARTED|Overall Study||4
8308143|NCT01500720|20483270|P2|NOT COMPLETED|Overall Study||9
8308144|NCT01500720|20483271|P1|NOT COMPLETED|Overall Study||5
8308145|NCT01500720|20483270|P2|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
8308146|NCT01500720|20483271|P1|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
8308147|NCT01500720|20483270|P2|Treated|Overall Study||88
8308148|NCT01500720|20483271|P1|Treated|Overall Study||89
8308149|NCT01500720|20483270|P2|STARTED|Overall Study|Randomized|89
8308150|NCT01500720|20483271|P1|STARTED|Overall Study|Randomized|90
8308157|NCT01500629|20483312|P2|NOT COMPLETED|Period 2 (Single Dose)||0
8308158|NCT01500629|20483313|P1|NOT COMPLETED|Period 2 (Single Dose)||0
8308159|NCT01500629|20483312|P2|COMPLETED|Period 2 (Single Dose)||10
8308160|NCT01500629|20483313|P1|COMPLETED|Period 2 (Single Dose)||10
8308161|NCT01500629|20483312|P2|STARTED|Period 2 (Single Dose)||10
8308162|NCT01500629|20483313|P1|STARTED|Period 2 (Single Dose)||10
8308163|NCT01500629|20483312|P2|NOT COMPLETED|Washout Period of 14 to 30 Days||0
8308164|NCT01500629|20483313|P1|NOT COMPLETED|Washout Period of 14 to 30 Days||1
8308165|NCT01500629|20483312|P2|COMPLETED|Washout Period of 14 to 30 Days||10
8308166|NCT01500629|20483313|P1|COMPLETED|Washout Period of 14 to 30 Days||10
8308167|NCT01500629|20483312|P2|STARTED|Washout Period of 14 to 30 Days||10
8308168|NCT01500629|20483313|P1|STARTED|Washout Period of 14 to 30 Days||11
8308169|NCT01500629|20483312|P2|NOT COMPLETED|Period 1 (Single Dose)||0
8308170|NCT01500629|20483313|P1|NOT COMPLETED|Period 1 (Single Dose)||0
8308171|NCT01500629|20483312|P2|COMPLETED|Period 1 (Single Dose)||10
8308172|NCT01500629|20483313|P1|COMPLETED|Period 1 (Single Dose)||11
8308173|NCT01500629|20483312|P2|STARTED|Period 1 (Single Dose)||10
8308174|NCT01500629|20483313|P1|STARTED|Period 1 (Single Dose)||11
8308175|NCT01500434|20483397|P1|NOT COMPLETED|Overall Study||7
8308176|NCT01500434|20483397|P1|COMPLETED|Overall Study||95
8308177|NCT01500434|20483397|P1|STARTED|Overall Study||102
8308178|NCT01500382|20483430|P4|NOT COMPLETED|Treatment Period 2||0
8308179|NCT01500382|20483431|P3|NOT COMPLETED|Treatment Period 2||0
8308180|NCT01500382|20483432|P2|NOT COMPLETED|Treatment Period 2||0
8308181|NCT01500382|20483433|P1|NOT COMPLETED|Treatment Period 2||0
8308182|NCT01500382|20483430|P4|COMPLETED|Treatment Period 2||1
8308183|NCT01500382|20483431|P3|COMPLETED|Treatment Period 2||0
8308184|NCT01500382|20483432|P2|COMPLETED|Treatment Period 2||1
8308185|NCT01500382|20483433|P1|COMPLETED|Treatment Period 2||1
8308186|NCT01500382|20483430|P4|STARTED|Treatment Period 2||1
8308187|NCT01500382|20483431|P3|STARTED|Treatment Period 2||0
8308188|NCT01500382|20483432|P2|STARTED|Treatment Period 2||1
8308189|NCT01500382|20483433|P1|STARTED|Treatment Period 2||1
8308190|NCT01500382|20483430|P4|NOT COMPLETED|Washout Period||0
8308191|NCT01500382|20483431|P3|NOT COMPLETED|Washout Period||1
8308192|NCT01500382|20483432|P2|NOT COMPLETED|Washout Period||0
8308193|NCT01500382|20483433|P1|NOT COMPLETED|Washout Period||0
8308194|NCT01500382|20483430|P4|COMPLETED|Washout Period||1
8308195|NCT01500382|20483431|P3|COMPLETED|Washout Period||0
8308196|NCT01500382|20483432|P2|COMPLETED|Washout Period||1
8308197|NCT01500382|20483433|P1|COMPLETED|Washout Period||1
8308198|NCT01500382|20483430|P4|STARTED|Washout Period||1
8308199|NCT01500382|20483431|P3|STARTED|Washout Period||1
8308200|NCT01500382|20483432|P2|STARTED|Washout Period||1
8308201|NCT01500382|20483433|P1|STARTED|Washout Period||1
8308202|NCT01500382|20483430|P4|NOT COMPLETED|Treatment Period 1||0
8308203|NCT01500382|20483431|P3|NOT COMPLETED|Treatment Period 1||0
8308204|NCT01500382|20483432|P2|NOT COMPLETED|Treatment Period 1||0
8308205|NCT01500382|20483433|P1|NOT COMPLETED|Treatment Period 1||0
8308206|NCT01500382|20483430|P4|COMPLETED|Treatment Period 1||1
8308207|NCT01500382|20483431|P3|COMPLETED|Treatment Period 1||1
8308208|NCT01500382|20483432|P2|COMPLETED|Treatment Period 1||1
8308209|NCT01500382|20483433|P1|COMPLETED|Treatment Period 1||1
8308210|NCT01500382|20483430|P4|STARTED|Treatment Period 1||1
8308211|NCT01500382|20483431|P3|STARTED|Treatment Period 1||1
8308212|NCT01500382|20483432|P2|STARTED|Treatment Period 1||1
8308213|NCT01500382|20483433|P1|STARTED|Treatment Period 1||1
8308214|NCT01500317|20483458|P3|NOT COMPLETED|Overall Study||0
8308215|NCT01500317|20483459|P2|NOT COMPLETED|Overall Study||2
8308216|NCT01500317|20483460|P1|NOT COMPLETED|Overall Study||3
8308217|NCT01500317|20483458|P3|COMPLETED|Overall Study||13
8308218|NCT01500317|20483459|P2|COMPLETED|Overall Study||10
8308219|NCT01500317|20483460|P1|COMPLETED|Overall Study||10
8308220|NCT01500317|20483458|P3|STARTED|Overall Study||13
8308221|NCT01500317|20483459|P2|STARTED|Overall Study||12
8308222|NCT01500317|20483460|P1|STARTED|Overall Study||13
8308223|NCT01500278|20483482|P2|NOT COMPLETED|Week 13 - Week 104||126
8308224|NCT01500278|20483483|P1|NOT COMPLETED|Week 13 - Week 104||139
8308225|NCT01500278|20483482|P2|COMPLETED|Week 13 - Week 104||302
8308226|NCT01500278|20483483|P1|COMPLETED|Week 13 - Week 104||287
8308227|NCT01500278|20483482|P2|STARTED|Week 13 - Week 104||428
8308228|NCT01500278|20483483|P1|STARTED|Week 13 - Week 104||426
8308229|NCT01500278|20483482|P2|NOT COMPLETED|Week 0 - Week 12||30
8308230|NCT01500278|20483483|P1|NOT COMPLETED|Week 0 - Week 12||31
8308231|NCT01500278|20483482|P2|COMPLETED|Week 0 - Week 12||428
8308232|NCT01500278|20483483|P1|COMPLETED|Week 0 - Week 12||426
8308233|NCT01500278|20483482|P2|STARTED|Week 0 - Week 12||458
8308234|NCT01500278|20483483|P1|STARTED|Week 0 - Week 12||457
8308247|NCT01500226|20483534|P2|NOT COMPLETED|Overall Study||494
8308248|NCT01500226|20483535|P1|NOT COMPLETED|Overall Study||499
8308249|NCT01500226|20483534|P2|COMPLETED|Overall Study||191
8308250|NCT01500226|20483535|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
8308251|NCT01500226|20483534|P2|STARTED|Overall Study||685
8308252|NCT01500226|20483535|P1|STARTED|Overall Study|Number of randomized patients|684
8308253|NCT01500213|20483547|P2|NOT COMPLETED|Overall Study||224
8308254|NCT01500213|20483548|P1|NOT COMPLETED|Overall Study||217
8308255|NCT01500213|20483547|P2|COMPLETED|Overall Study||53
8308256|NCT01500213|20483548|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
8308257|NCT01500213|20483547|P2|STARTED|Overall Study||277
8308258|NCT01500213|20483548|P1|STARTED|Overall Study|Number of randomized patients|278
8308259|NCT01500200|20483561|P6|NOT COMPLETED|Stage 2||4
8308260|NCT01500200|20483562|P5|NOT COMPLETED|Stage 2||5
8308261|NCT01500200|20483563|P4|NOT COMPLETED|Stage 2||0
8308262|NCT01500200|20483564|P3|NOT COMPLETED|Stage 2||0
8308263|NCT01500200|20483565|P2|NOT COMPLETED|Stage 2||0
8308264|NCT01500200|20483566|P1|NOT COMPLETED|Stage 2||0
8308265|NCT01500200|20483561|P6|COMPLETED|Stage 2||18
8308266|NCT01500200|20483562|P5|COMPLETED|Stage 2||18
8308267|NCT01500200|20483563|P4|COMPLETED|Stage 2||20
8308268|NCT01500200|20483564|P3|COMPLETED|Stage 2||0
8308269|NCT01500200|20483565|P2|COMPLETED|Stage 2||0
8308270|NCT01500200|20483566|P1|COMPLETED|Stage 2||0
8308271|NCT01500200|20483561|P6|STARTED|Stage 2||22
8308272|NCT01500200|20483562|P5|STARTED|Stage 2||23
8308273|NCT01500200|20483563|P4|STARTED|Stage 2||20
8308274|NCT01500200|20483564|P3|STARTED|Stage 2||0
8308275|NCT01500200|20483565|P2|STARTED|Stage 2||0
8308276|NCT01500200|20483566|P1|STARTED|Stage 2||0
8308277|NCT01500200|20483561|P6|NOT COMPLETED|Stage 1||0
8308278|NCT01500200|20483562|P5|NOT COMPLETED|Stage 1||0
8308279|NCT01500200|20483563|P4|NOT COMPLETED|Stage 1||0
8308280|NCT01500200|20483564|P3|NOT COMPLETED|Stage 1||6
8308281|NCT01500200|20483565|P2|NOT COMPLETED|Stage 1||6
8308282|NCT01500200|20483566|P1|NOT COMPLETED|Stage 1||8
8308283|NCT01500200|20483561|P6|COMPLETED|Stage 1||0
8308284|NCT01500200|20483562|P5|COMPLETED|Stage 1||0
8308285|NCT01500200|20483563|P4|COMPLETED|Stage 1||0
8308286|NCT01500200|20483564|P3|COMPLETED|Stage 1||13
8308287|NCT01500200|20483565|P2|COMPLETED|Stage 1||18
8308288|NCT01500200|20483566|P1|COMPLETED|Stage 1||90
8308289|NCT01500200|20483561|P6|STARTED|Stage 1||0
8308290|NCT01500200|20483562|P5|STARTED|Stage 1||0
8308291|NCT01500200|20483563|P4|STARTED|Stage 1||0
8308292|NCT01500200|20483564|P3|STARTED|Stage 1||19
8308293|NCT01500200|20483565|P2|STARTED|Stage 1||24
8308294|NCT01500200|20483566|P1|STARTED|Stage 1||98
8308295|NCT01500187|20483600|P2|NOT COMPLETED|Overall Study||0
8308296|NCT01500187|20483601|P1|NOT COMPLETED|Overall Study||6
8308297|NCT01500187|20483600|P2|COMPLETED|Overall Study||15
8308298|NCT01500187|20483601|P1|COMPLETED|Overall Study||17
8308299|NCT01500187|20483600|P2|STARTED|Overall Study||15
8308300|NCT01500187|20483601|P1|STARTED|Overall Study||23
8308301|NCT01500135|20483609|P2|NOT COMPLETED|Overall Study||11
8308302|NCT01500135|20483610|P1|NOT COMPLETED|Overall Study||17
8308303|NCT01500135|20483609|P2|COMPLETED|Overall Study||39
8308304|NCT01500135|20483610|P1|COMPLETED|Overall Study||83
8308305|NCT01500135|20483609|P2|STARTED|Overall Study||50
8308306|NCT01500135|20483610|P1|STARTED|Overall Study||100
8308316|NCT01500096|20483637|P4|NOT COMPLETED|Overall Study||2
8308317|NCT01500096|20483638|P3|NOT COMPLETED|Overall Study||0
8308318|NCT01500096|20483639|P2|NOT COMPLETED|Overall Study||0
8308319|NCT01500096|20483640|P1|NOT COMPLETED|Overall Study||1
8308320|NCT01500096|20483637|P4|COMPLETED|Overall Study||14
8308321|NCT01500096|20483638|P3|COMPLETED|Overall Study||31
8308322|NCT01500096|20483639|P2|COMPLETED|Overall Study||17
8308323|NCT01500096|20483640|P1|COMPLETED|Overall Study||31
8308324|NCT01500096|20483637|P4|STARTED|Overall Study||16
8308325|NCT01500096|20483638|P3|STARTED|Overall Study||31
8308326|NCT01500096|20483639|P2|STARTED|Overall Study||17
8308327|NCT01500096|20483640|P1|STARTED|Overall Study||32
8308328|NCT01500083|20483696|P2|NOT COMPLETED|Overall Study||43
8308329|NCT01500083|20483697|P1|NOT COMPLETED|Overall Study||12
8308330|NCT01500083|20483696|P2|COMPLETED|Overall Study||31
8308331|NCT01500083|20483697|P1|COMPLETED|Overall Study||4
8308332|NCT01500083|20483696|P2|STARTED|Overall Study||74
8308333|NCT01500083|20483697|P1|STARTED|Overall Study||16
8308334|NCT01500057|20483705|P2|NOT COMPLETED|Overall Study||4
8308335|NCT01500057|20483706|P1|NOT COMPLETED|Overall Study||6
8308336|NCT01500057|20483705|P2|COMPLETED|Overall Study||31
8308337|NCT01500057|20483706|P1|COMPLETED|Overall Study||25
8308338|NCT01500057|20483705|P2|STARTED|Overall Study||35
8308339|NCT01500057|20483706|P1|STARTED|Overall Study||31
8308340|NCT01500031|20483716|P1|NOT COMPLETED|Overall Study||5
8308341|NCT01500031|20483716|P1|COMPLETED|Overall Study||87
8308342|NCT01500031|20483716|P1|STARTED|Overall Study||92
8308343|NCT01499862|20483731|P1|NOT COMPLETED|Overall Study||0
8308344|NCT01499862|20483731|P1|COMPLETED|Overall Study||3
8308345|NCT01499862|20483731|P1|STARTED|Overall Study||3
8308346|NCT01499849|20483751|P2|NOT COMPLETED|Overall Study||226
8308347|NCT01499849|20483752|P1|NOT COMPLETED|Overall Study||224
8308348|NCT01499849|20483751|P2|COMPLETED|Overall Study||40
8308349|NCT01499849|20483752|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
8308350|NCT01499849|20483751|P2|STARTED|Overall Study||266
8308351|NCT01499849|20483752|P1|STARTED|Overall Study|Number of randomized patients|266
8308352|NCT01499810|20483762|P1|NOT COMPLETED|Overall Study||12
8308353|NCT01499810|20483762|P1|COMPLETED|Overall Study||41
8308354|NCT01499810|20483762|P1|STARTED|Overall Study||53
8308355|NCT01499667|20483812|P3|NOT COMPLETED|Overall Study||10
8308356|NCT01499667|20483813|P2|NOT COMPLETED|Overall Study||11
8308357|NCT01499667|20483814|P1|NOT COMPLETED|Overall Study||9
8308358|NCT01499667|20483812|P3|COMPLETED|Overall Study||40
8308359|NCT01499667|20483813|P2|COMPLETED|Overall Study||31
8308360|NCT01499667|20483814|P1|COMPLETED|Overall Study||41
8308361|NCT01499667|20483812|P3|Modified Full Analysis Set|Overall Study||39
8308362|NCT01499667|20483813|P2|Modified Full Analysis Set|Overall Study||29
8308363|NCT01499667|20483814|P1|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
8308364|NCT01499667|20483812|P3|Full Analysis Set (FAS)|Overall Study||50
8308365|NCT01499667|20483813|P2|Full Analysis Set (FAS)|Overall Study||42
8308366|NCT01499667|20483814|P1|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
8308367|NCT01499667|20483812|P3|STARTED|Overall Study||50
8308368|NCT01499667|20483813|P2|STARTED|Overall Study||42
8308369|NCT01499667|20483814|P1|STARTED|Overall Study|"Started indicates randomized as well as safety population."|50
8308370|NCT01499654|20483843|P1|NOT COMPLETED|Overall Study||0
8308371|NCT01499654|20483843|P1|COMPLETED|Overall Study||64
8308372|NCT01499654|20483843|P1|STARTED|Overall Study||64
8308373|NCT01499576|20483862|P1|NOT COMPLETED|Overall Study||21
8308374|NCT01499576|20483862|P1|COMPLETED|Overall Study||105
8308375|NCT01499576|20483862|P1|STARTED|Overall Study||126
8308376|NCT01499511|20483870|P2|NOT COMPLETED|Overall Study||0
8308377|NCT01499511|20483871|P1|NOT COMPLETED|Overall Study||1
8308378|NCT01499511|20483870|P2|COMPLETED|Overall Study||833
8308379|NCT01499511|20483871|P1|COMPLETED|Overall Study||884
8308380|NCT01499511|20483870|P2|STARTED|Overall Study||833
8308381|NCT01499511|20483871|P1|STARTED|Overall Study||885
8308382|NCT01499498|20483888|P1|NOT COMPLETED|Overall Study||0
8308383|NCT01499498|20483888|P1|COMPLETED|Overall Study||13
8308384|NCT01499498|20483888|P1|STARTED|Overall Study||13
8308385|NCT01499368|20483899|P3|NOT COMPLETED|Overall Study||21
8308386|NCT01499368|20483900|P2|NOT COMPLETED|Overall Study||18
8308387|NCT01499368|20483901|P1|NOT COMPLETED|Overall Study||27
8308388|NCT01499368|20483899|P3|COMPLETED|Overall Study||146
8308389|NCT01499368|20483900|P2|COMPLETED|Overall Study||145
8308390|NCT01499368|20483901|P1|COMPLETED|Overall Study||138
8308391|NCT01499368|20483899|P3|STARTED|Overall Study||167
8308392|NCT01499368|20483900|P2|STARTED|Overall Study||163
8308393|NCT01499368|20483901|P1|STARTED|Overall Study||165
8308394|NCT01499355|20483918|P4|NOT COMPLETED|Double-Blind Period||23
8308395|NCT01499355|20483919|P3|NOT COMPLETED|Double-Blind Period||25
8308396|NCT01499355|20483920|P2|NOT COMPLETED|Double-Blind Period||23
8308397|NCT01499355|20483921|P1|NOT COMPLETED|Double-Blind Period||0
8308398|NCT01499355|20483918|P4|COMPLETED|Double-Blind Period||39
8308399|NCT01499355|20483919|P3|COMPLETED|Double-Blind Period||38
8308400|NCT01499355|20483920|P2|COMPLETED|Double-Blind Period||40
8308401|NCT01499355|20483921|P1|COMPLETED|Double-Blind Period||0
8308402|NCT01499355|20483918|P4|STARTED|Double-Blind Period||62
8308403|NCT01499355|20483919|P3|STARTED|Double-Blind Period||63
8308404|NCT01499355|20483920|P2|STARTED|Double-Blind Period||63
8308405|NCT01499355|20483921|P1|STARTED|Double-Blind Period||0
8308406|NCT01499355|20483918|P4|NOT COMPLETED|Run-In Period||0
8308407|NCT01499355|20483919|P3|NOT COMPLETED|Run-In Period||0
8308408|NCT01499355|20483920|P2|NOT COMPLETED|Run-In Period||0
8308409|NCT01499355|20483921|P1|NOT COMPLETED|Run-In Period||31
8308410|NCT01499355|20483918|P4|COMPLETED|Run-In Period||0
8308411|NCT01499355|20483919|P3|COMPLETED|Run-In Period||0
8308412|NCT01499355|20483920|P2|COMPLETED|Run-In Period||0
8308413|NCT01499355|20483921|P1|COMPLETED|Run-In Period||245
8308414|NCT01499355|20483918|P4|STARTED|Run-In Period||0
8308415|NCT01499355|20483919|P3|STARTED|Run-In Period||0
8308416|NCT01499355|20483920|P2|STARTED|Run-In Period||0
8308417|NCT01499355|20483921|P1|STARTED|Run-In Period||276
8308418|NCT01499303|20483954|P2|NOT COMPLETED|Overall Study||7
8308419|NCT01499303|20483955|P1|NOT COMPLETED|Overall Study||3
8308420|NCT01499303|20483954|P2|COMPLETED|Overall Study||40
8308421|NCT01499303|20483955|P1|COMPLETED|Overall Study||18
8308422|NCT01499303|20483954|P2|STARTED|Overall Study||47
8308423|NCT01499303|20483955|P1|STARTED|Overall Study||21
8308424|NCT01499290|20483963|P2|NOT COMPLETED|Overall Study||35
8308425|NCT01499290|20483964|P1|NOT COMPLETED|Overall Study||55
8308426|NCT01499290|20483963|P2|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
8308427|NCT01499290|20483964|P1|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
8308428|NCT01499290|20483963|P2|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
8308429|NCT01499290|20483964|P1|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
8308430|NCT01499277|20484014|P2|NOT COMPLETED|Overall Study||32
8308431|NCT01499277|20484015|P1|NOT COMPLETED|Overall Study||47
8308432|NCT01499277|20484014|P2|COMPLETED|Overall Study||223
8308433|NCT01499277|20484015|P1|COMPLETED|Overall Study||459
8308434|NCT01499277|20484014|P2|STARTED|Overall Study||255
8308435|NCT01499277|20484015|P1|STARTED|Overall Study||506
8308436|NCT01499199|20484037|P1|NOT COMPLETED|Overall Study||2
8308437|NCT01499199|20484037|P1|COMPLETED|Overall Study||11
8308438|NCT01499199|20484037|P1|STARTED|Overall Study||13
8308439|NCT01499173|20484056|P1|NOT COMPLETED|Overall Study||37
8308440|NCT01499173|20484056|P1|COMPLETED|Overall Study||64
8308441|NCT01499173|20484056|P1|STARTED|Overall Study||101
8308442|NCT01499160|20484066|P1|NOT COMPLETED|Overall Study||2
8308443|NCT01499160|20484066|P1|COMPLETED|Overall Study|"1 pt-withdrew consent
~1pt-had cardiac toxicity"|5
8308444|NCT01499160|20484066|P1|STARTED|Overall Study||7
8308445|NCT01499147|20484073|P2|NOT COMPLETED|Overall Study||5
8308446|NCT01499147|20484074|P1|NOT COMPLETED|Overall Study||15
8308447|NCT01499147|20484073|P2|COMPLETED|Overall Study||12
8308448|NCT01499147|20484074|P1|COMPLETED|Overall Study||18
8308449|NCT01499147|20484073|P2|STARTED|Overall Study||17
8308450|NCT01499147|20484074|P1|STARTED|Overall Study||33
8308451|NCT01499134|20484089|P2|NOT COMPLETED|Overall Study||1
8308452|NCT01499134|20484090|P1|NOT COMPLETED|Overall Study||0
8308453|NCT01499134|20484089|P2|COMPLETED|Overall Study||7
8308454|NCT01499134|20484090|P1|COMPLETED|Overall Study||9
8308455|NCT01499134|20484089|P2|STARTED|Overall Study||8
8308456|NCT01499134|20484090|P1|STARTED|Overall Study||9
8308457|NCT01499095|20484112|P2|NOT COMPLETED|Overall Study||93
8308458|NCT01499095|20484113|P1|NOT COMPLETED|Overall Study||89
8308459|NCT01499095|20484112|P2|COMPLETED|Overall Study||314
8308460|NCT01499095|20484113|P1|COMPLETED|Overall Study||315
8308461|NCT01499095|20484112|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
8308462|NCT01499095|20484113|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
8308463|NCT01499095|20484112|P2|Participated in Substudy|Overall Study||0
8308464|NCT01499095|20484113|P1|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
8308465|NCT01499095|20484112|P2|Treated|Overall Study||406
8308466|NCT01499095|20484113|P1|Treated|Overall Study||403
8308467|NCT01499095|20484112|P2|STARTED|Overall Study||407
8308468|NCT01499095|20484113|P1|STARTED|Overall Study||404
8308469|NCT01499082|20484143|P2|NOT COMPLETED|Overall Study||48
8308470|NCT01499082|20484144|P1|NOT COMPLETED|Overall Study||45
8308471|NCT01499082|20484143|P2|COMPLETED|Overall Study||355
8308472|NCT01499082|20484144|P1|COMPLETED|Overall Study||359
8308473|NCT01499082|20484143|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
8308474|NCT01499082|20484144|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
8308475|NCT01499082|20484143|P2|Participated in Substudy|Overall Study||0
8308476|NCT01499082|20484144|P1|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
8308477|NCT01499082|20484143|P2|Treated|Overall Study||402
8308478|NCT01499082|20484144|P1|Treated|Overall Study||404
8308479|NCT01499082|20484143|P2|STARTED|Overall Study||403
8308480|NCT01499082|20484144|P1|STARTED|Overall Study||404
8308481|NCT01499043|20484172|P1|NOT COMPLETED|Overall Study||6
8308482|NCT01499043|20484172|P1|COMPLETED|Overall Study||0
8308483|NCT01499043|20484172|P1|STARTED|Overall Study||6
8308484|NCT01498991|20484182|P1|NOT COMPLETED|Overall Study||0
8308485|NCT01498991|20484182|P1|COMPLETED|Overall Study||2
8308486|NCT01498991|20484182|P1|STARTED|Overall Study||2
8308487|NCT01498978|20484193|P1|NOT COMPLETED|Overall Study||2
8308488|NCT01498978|20484193|P1|COMPLETED|Overall Study||8
8308489|NCT01498978|20484193|P1|STARTED|Overall Study||10
8308490|NCT01498952|20484215|P5|NOT COMPLETED|Overall Study||0
8308491|NCT01498952|20484216|P4|NOT COMPLETED|Overall Study||0
8308492|NCT01498952|20484217|P3|NOT COMPLETED|Overall Study||0
8308493|NCT01498952|20484218|P2|NOT COMPLETED|Overall Study||2
8308494|NCT01498952|20484219|P1|NOT COMPLETED|Overall Study||2
8308495|NCT01498952|20484215|P5|COMPLETED|Overall Study||0
8308496|NCT01498952|20484216|P4|COMPLETED|Overall Study||0
8308497|NCT01498952|20484217|P3|COMPLETED|Overall Study||0
8308498|NCT01498952|20484218|P2|COMPLETED|Overall Study||1
8308499|NCT01498952|20484219|P1|COMPLETED|Overall Study||1
8308500|NCT01498952|20484215|P5|STARTED|Overall Study||0
8308501|NCT01498952|20484216|P4|STARTED|Overall Study||0
8308502|NCT01498952|20484217|P3|STARTED|Overall Study||0
8308503|NCT01498952|20484218|P2|STARTED|Overall Study||3
8308504|NCT01498952|20484219|P1|STARTED|Overall Study||3
8308505|NCT01498887|20484261|P2|NOT COMPLETED|Overall Study||11
8308506|NCT01498887|20484262|P1|NOT COMPLETED|Overall Study||16
8308507|NCT01498887|20484261|P2|COMPLETED|Overall Study||136
8308508|NCT01498887|20484262|P1|COMPLETED|Overall Study||184
8308509|NCT01498887|20484261|P2|Intent-to-treat|Overall Study||135
8308510|NCT01498887|20484262|P1|Intent-to-treat|Overall Study||185
8308511|NCT01498887|20484261|P2|Safety Set|Overall Study||147
8308512|NCT01498887|20484262|P1|Safety Set|Overall Study||200
8308513|NCT01498887|20484261|P2|STARTED|Overall Study||147
8308514|NCT01498887|20484262|P1|STARTED|Overall Study||200
8308515|NCT01498822|20484283|P2|NOT COMPLETED|Overall Study||56
8308516|NCT01498822|20484284|P1|NOT COMPLETED|Overall Study||54
8308517|NCT01498822|20484283|P2|COMPLETED|Overall Study||122
8308518|NCT01498822|20484284|P1|COMPLETED|Overall Study||121
8308519|NCT01498822|20484283|P2|STARTED|Overall Study||178
8308520|NCT01498822|20484284|P1|STARTED|Overall Study||175
8308521|NCT01498744|20484298|P2|NOT COMPLETED|Overall Study||0
8308522|NCT01498744|20484299|P1|NOT COMPLETED|Overall Study||0
8308523|NCT01498744|20484298|P2|COMPLETED|Overall Study||31
8308524|NCT01498744|20484299|P1|COMPLETED|Overall Study||22
8308525|NCT01498744|20484298|P2|STARTED|Overall Study||31
8308526|NCT01498744|20484299|P1|STARTED|Overall Study||22
8308527|NCT01498692|20484311|P1|NOT COMPLETED|Overall Study||8
8308528|NCT01498692|20484311|P1|COMPLETED|Overall Study||86
8308529|NCT01498692|20484311|P1|STARTED|Overall Study||94
8308530|NCT01498679|20484342|P2|NOT COMPLETED|Overall Study||22
8308531|NCT01498679|20484343|P1|NOT COMPLETED|Overall Study||89
8308532|NCT01498679|20484342|P2|COMPLETED|Overall Study||131
8308533|NCT01498679|20484343|P1|COMPLETED|Overall Study||65
8308534|NCT01498679|20484342|P2|STARTED|Overall Study||153
8308535|NCT01498679|20484343|P1|STARTED|Overall Study||154
8308536|NCT01498653|20484359|P2|NOT COMPLETED|Overall Study||35
8308537|NCT01498653|20484360|P1|NOT COMPLETED|Overall Study||19
8308538|NCT01498653|20484359|P2|COMPLETED|Overall Study||119
8308539|NCT01498653|20484360|P1|COMPLETED|Overall Study||136
8308540|NCT01498653|20484359|P2|STARTED|Overall Study||154
8308541|NCT01498653|20484360|P1|STARTED|Overall Study||155
8308542|NCT01498640|20484374|P1|NOT COMPLETED|Overall Study||5
8308543|NCT01498640|20484374|P1|COMPLETED|Overall Study||47
8308544|NCT01498640|20484374|P1|STARTED|Overall Study||52
8308545|NCT01498601|20484390|P2|NOT COMPLETED|Overall Study||0
8308546|NCT01498601|20484391|P1|NOT COMPLETED|Overall Study||0
8308547|NCT01498601|20484390|P2|COMPLETED|Overall Study||32
8308548|NCT01498601|20484391|P1|COMPLETED|Overall Study||51
8308549|NCT01498601|20484390|P2|STARTED|Overall Study||32
8308550|NCT01498601|20484391|P1|STARTED|Overall Study||51
8308551|NCT01498588|20484397|P1|NOT COMPLETED|Overall Study||0
8308552|NCT01498588|20484397|P1|COMPLETED|Overall Study||7
8308553|NCT01498588|20484397|P1|STARTED|Overall Study||7
8308554|NCT01498575|20484404|P2|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
8308555|NCT01498575|20484405|P1|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
8308556|NCT01498575|20484404|P2|COMPLETED|On the Road Driving Assessment (ODA)||65
8308557|NCT01498575|20484405|P1|COMPLETED|On the Road Driving Assessment (ODA)||86
8308558|NCT01498575|20484404|P2|STARTED|On the Road Driving Assessment (ODA)||89
8308559|NCT01498575|20484405|P1|STARTED|On the Road Driving Assessment (ODA)||128
8308560|NCT01498575|20484404|P2|NOT COMPLETED|Overall Sample||14
8308561|NCT01498575|20484405|P1|NOT COMPLETED|Overall Sample||60
8308562|NCT01498575|20484404|P2|COMPLETED|Overall Sample||400
8308563|NCT01498575|20484405|P1|COMPLETED|Overall Sample||550
8308564|NCT01498575|20484404|P2|STARTED|Overall Sample||414
8308565|NCT01498575|20484405|P1|STARTED|Overall Sample||610
8308566|NCT01498549|20484411|P1|NOT COMPLETED|Overall Study||4
8308567|NCT01498549|20484411|P1|COMPLETED|Overall Study||35
8308568|NCT01498549|20484411|P1|Sugar Pill 0 mg|Overall Study||36
8308569|NCT01498549|20484411|P1|Atomoxetine 80 mg|Overall Study||37
8308570|NCT01498549|20484411|P1|Atomoxetine 40 mg|Overall Study||39
8308571|NCT01498549|20484411|P1|STARTED|Overall Study||39
8308572|NCT01498458|20484422|P1|NOT COMPLETED|Overall Study||7
8308573|NCT01498458|20484422|P1|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
8308574|NCT01498458|20484422|P1|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
8308575|NCT01498445|20484437|P6|NOT COMPLETED|Overall Study||1
8308576|NCT01498445|20484438|P5|NOT COMPLETED|Overall Study||1
8308577|NCT01498445|20484439|P4|NOT COMPLETED|Overall Study||2
8308578|NCT01498445|20484440|P3|NOT COMPLETED|Overall Study||1
8308579|NCT01498445|20484441|P2|NOT COMPLETED|Overall Study||0
8308580|NCT01498445|20484442|P1|NOT COMPLETED|Overall Study||0
8308581|NCT01498445|20484437|P6|COMPLETED|Overall Study||4
8308582|NCT01498445|20484438|P5|COMPLETED|Overall Study||3
8308583|NCT01498445|20484439|P4|COMPLETED|Overall Study||6
8308584|NCT01498445|20484440|P3|COMPLETED|Overall Study||7
8308585|NCT01498445|20484441|P2|COMPLETED|Overall Study||3
8308586|NCT01498445|20484442|P1|COMPLETED|Overall Study||4
8308587|NCT01498445|20484437|P6|STARTED|Overall Study||5
8308588|NCT01498445|20484438|P5|STARTED|Overall Study||4
8308589|NCT01498445|20484439|P4|STARTED|Overall Study||8
8308590|NCT01498445|20484440|P3|STARTED|Overall Study||8
8308591|NCT01498445|20484441|P2|STARTED|Overall Study||3
8308592|NCT01498445|20484442|P1|STARTED|Overall Study||4
8308593|NCT01498419|20484478|P4|NOT COMPLETED|Overall Study||19
8308594|NCT01498419|20484479|P3|NOT COMPLETED|Overall Study||18
8308595|NCT01498419|20484480|P2|NOT COMPLETED|Overall Study||23
8308596|NCT01498419|20484481|P1|NOT COMPLETED|Overall Study||18
8308597|NCT01498419|20484478|P4|COMPLETED|Overall Study||7
8308598|NCT01498419|20484479|P3|COMPLETED|Overall Study||41
8308599|NCT01498419|20484480|P2|COMPLETED|Overall Study||39
8308600|NCT01498419|20484481|P1|COMPLETED|Overall Study||42
8308601|NCT01498419|20484478|P4|STARTED|Overall Study||26
8308602|NCT01498419|20484479|P3|STARTED|Overall Study||59
8308603|NCT01498419|20484480|P2|STARTED|Overall Study||62
8308604|NCT01498419|20484481|P1|STARTED|Overall Study||60
8308605|NCT01498289|20484517|P2|NOT COMPLETED|Overall Study||104
8308606|NCT01498289|20484518|P1|NOT COMPLETED|Overall Study||98
8308607|NCT01498289|20484517|P2|COMPLETED|Overall Study||0
8308608|NCT01498289|20484518|P1|COMPLETED|Overall Study||0
8308609|NCT01498289|20484517|P2|Participants Assessed for AEs|Overall Study||98
8308610|NCT01498289|20484518|P1|Participants Assessed for AEs|Overall Study||91
8308611|NCT01498289|20484517|P2|STARTED|Overall Study||104
8308612|NCT01498289|20484518|P1|STARTED|Overall Study||98
8308613|NCT01498185|20484539|P5|NOT COMPLETED|Overall Study||3
8308614|NCT01498185|20484540|P4|NOT COMPLETED|Overall Study||3
8308615|NCT01498185|20484541|P3|NOT COMPLETED|Overall Study||0
8308616|NCT01498185|20484542|P2|NOT COMPLETED|Overall Study||1
8308617|NCT01498185|20484543|P1|NOT COMPLETED|Overall Study||1
8308618|NCT01498185|20484539|P5|COMPLETED|Overall Study||12
8308619|NCT01498185|20484540|P4|COMPLETED|Overall Study||11
8308620|NCT01498185|20484541|P3|COMPLETED|Overall Study||15
8308621|NCT01498185|20484542|P2|COMPLETED|Overall Study||12
8308622|NCT01498185|20484543|P1|COMPLETED|Overall Study||12
8308623|NCT01498185|20484539|P5|STARTED|Overall Study||15
8308624|NCT01498185|20484540|P4|STARTED|Overall Study||14
8308625|NCT01498185|20484541|P3|STARTED|Overall Study||15
8308626|NCT01498185|20484542|P2|STARTED|Overall Study||13
8308627|NCT01498185|20484543|P1|STARTED|Overall Study||13
8308628|NCT01498120|20484583|P1|NOT COMPLETED|Overall Study||13
8308629|NCT01498120|20484583|P1|COMPLETED|Overall Study||1
8308630|NCT01498120|20484583|P1|STARTED|Overall Study||14
8308631|NCT01498068|20484590|P2|NOT COMPLETED|Overall Study||1
8308632|NCT01498068|20484591|P1|NOT COMPLETED|Overall Study||1
8308633|NCT01498068|20484590|P2|COMPLETED|Overall Study||19
8308634|NCT01498068|20484591|P1|COMPLETED|Overall Study||15
8308635|NCT01498068|20484590|P2|STARTED|Overall Study||20
8308636|NCT01498068|20484591|P1|STARTED|Overall Study||16
8308637|NCT01497938|20484609|P2|NOT COMPLETED|Overall Study||2
8308638|NCT01497938|20484610|P1|NOT COMPLETED|Overall Study||5
8308639|NCT01497938|20484609|P2|COMPLETED|Overall Study||124
8308640|NCT01497938|20484610|P1|COMPLETED|Overall Study||116
8308641|NCT01497938|20484609|P2|STARTED|Overall Study||126
8308642|NCT01497938|20484610|P1|STARTED|Overall Study||121
8308643|NCT01497899|20484622|P4|NOT COMPLETED|Open-Label Extension Phase||5
8308644|NCT01497899|20484623|P3|NOT COMPLETED|Open-Label Extension Phase||9
8308645|NCT01497899|20484624|P2|NOT COMPLETED|Open-Label Extension Phase||7
8308646|NCT01497899|20484625|P1|NOT COMPLETED|Open-Label Extension Phase||19
8308647|NCT01497899|20484622|P4|COMPLETED|Open-Label Extension Phase||33
8308648|NCT01497899|20484623|P3|COMPLETED|Open-Label Extension Phase||61
8308649|NCT01497899|20484624|P2|COMPLETED|Open-Label Extension Phase||46
8308650|NCT01497899|20484625|P1|COMPLETED|Open-Label Extension Phase||86
8308651|NCT01497899|20484622|P4|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
8308652|NCT01497899|20484623|P3|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
8308653|NCT01497899|20484624|P2|STARTED|Open-Label Extension Phase||53
8308654|NCT01497899|20484625|P1|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
8308655|NCT01497899|20484622|P4|NOT COMPLETED|Double-Blind Phase||0
8308656|NCT01497899|20484623|P3|NOT COMPLETED|Double-Blind Phase||0
8308657|NCT01497899|20484624|P2|NOT COMPLETED|Double-Blind Phase||5
8308658|NCT01497899|20484625|P1|NOT COMPLETED|Double-Blind Phase||6
8308659|NCT01497899|20484622|P4|COMPLETED|Double-Blind Phase||0
8308660|NCT01497899|20484623|P3|COMPLETED|Double-Blind Phase||0
8308661|NCT01497899|20484624|P2|COMPLETED|Double-Blind Phase||53
8308662|NCT01497899|20484625|P1|COMPLETED|Double-Blind Phase||107
8308663|NCT01497899|20484622|P4|STARTED|Double-Blind Phase||0
8308664|NCT01497899|20484623|P3|STARTED|Double-Blind Phase||0
8308665|NCT01497899|20484624|P2|STARTED|Double-Blind Phase||58
8308666|NCT01497899|20484625|P1|STARTED|Double-Blind Phase||113
8308667|NCT01497860|20484638|P1|NOT COMPLETED|Overall Study||0
8308668|NCT01497860|20484638|P1|COMPLETED|Overall Study||12
8308669|NCT01497860|20484638|P1|STARTED|Overall Study||12
8308670|NCT01497756|20484642|P1|NOT COMPLETED|Overall Study||0
8308671|NCT01497756|20484642|P1|COMPLETED|Overall Study||10
8308672|NCT01497756|20484642|P1|STARTED|Overall Study||10
8308673|NCT01497665|20484647|P1|NOT COMPLETED|Overall Study||0
8308674|NCT01497665|20484647|P1|COMPLETED|Overall Study||16
8308675|NCT01497665|20484647|P1|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
8308676|NCT01497665|20484647|P1|STARTED|Overall Study||16
8308677|NCT01497613|20484657|P2|NOT COMPLETED|Overall Study||19
8308678|NCT01497613|20484658|P1|NOT COMPLETED|Overall Study||37
8308679|NCT01497613|20484657|P2|COMPLETED|Overall Study||131
8308680|NCT01497613|20484658|P1|COMPLETED|Overall Study||113
8308681|NCT01497613|20484657|P2|STARTED|Overall Study||150
8308682|NCT01497613|20484658|P1|STARTED|Overall Study||150
8308686|NCT01497366|20484702|P2|NOT COMPLETED|Overall Study||88
8308687|NCT01497366|20484703|P1|NOT COMPLETED|Overall Study||39
8308688|NCT01497366|20484702|P2|COMPLETED|Overall Study||176
8308689|NCT01497366|20484703|P1|COMPLETED|Overall Study||224
8308690|NCT01497366|20484702|P2|Randomized But Not Treated|Overall Study||21
8308691|NCT01497366|20484703|P1|Randomized But Not Treated|Overall Study||7
8308692|NCT01497366|20484702|P2|STARTED|Overall Study||264
8308693|NCT01497366|20484703|P1|STARTED|Overall Study||263
8308694|NCT01497275|20484721|P1|NOT COMPLETED|Overall Study||2
8308695|NCT01497275|20484721|P1|COMPLETED|Overall Study||3
8308696|NCT01497275|20484721|P1|STARTED|Overall Study||5
8308697|NCT01497262|20484728|P1|NOT COMPLETED|Overall Study||11
8308698|NCT01497262|20484728|P1|COMPLETED|Overall Study||151
8308699|NCT01497262|20484728|P1|STARTED|Overall Study||162
8308700|NCT01497197|20484735|P2|NOT COMPLETED|Overall Study||15
8308701|NCT01497197|20484736|P1|NOT COMPLETED|Overall Study||17
8308702|NCT01497197|20484735|P2|COMPLETED|Overall Study||70
8308703|NCT01497197|20484736|P1|COMPLETED|Overall Study||72
8308704|NCT01497197|20484735|P2|STARTED|Overall Study||85
8308705|NCT01497197|20484736|P1|STARTED|Overall Study||89
8308706|NCT01497171|20484764|P2|NOT COMPLETED|Overall Study||0
8308707|NCT01497171|20484765|P1|NOT COMPLETED|Overall Study||0
8308708|NCT01497171|20484764|P2|COMPLETED|Overall Study||3
8308709|NCT01497171|20484765|P1|COMPLETED|Overall Study||2
8308710|NCT01497171|20484764|P2|STARTED|Overall Study||3
8308711|NCT01497171|20484765|P1|STARTED|Overall Study||2
8308712|NCT01497067|20484771|P1|NOT COMPLETED|Overall Study||82
8308713|NCT01497067|20484771|P1|COMPLETED|Overall Study||575
8308714|NCT01497067|20484771|P1|STARTED|Overall Study||657
8308715|NCT01496846|20484782|P6|NOT COMPLETED|Supplemental Buccal Infiltration||0
8308716|NCT01496846|20484783|P5|NOT COMPLETED|Supplemental Buccal Infiltration||0
8308717|NCT01496846|20484784|P4|NOT COMPLETED|Supplemental Buccal Infiltration||0
8308718|NCT01496846|20484785|P3|NOT COMPLETED|Supplemental Buccal Infiltration||0
8308719|NCT01496846|20484786|P2|NOT COMPLETED|Supplemental Buccal Infiltration||0
8308720|NCT01496846|20484787|P1|NOT COMPLETED|Supplemental Buccal Infiltration||0
8308721|NCT01496846|20484782|P6|COMPLETED|Supplemental Buccal Infiltration||38
8308722|NCT01496846|20484783|P5|COMPLETED|Supplemental Buccal Infiltration||35
8308723|NCT01496846|20484784|P4|COMPLETED|Supplemental Buccal Infiltration||40
8308724|NCT01496846|20484785|P3|COMPLETED|Supplemental Buccal Infiltration||36
8308725|NCT01496846|20484786|P2|COMPLETED|Supplemental Buccal Infiltration||0
8308726|NCT01496846|20484787|P1|COMPLETED|Supplemental Buccal Infiltration||0
8308727|NCT01496846|20484782|P6|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
8308728|NCT01496846|20484783|P5|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
8308729|NCT01496846|20484784|P4|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
8308730|NCT01496846|20484785|P3|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
8308731|NCT01496846|20484786|P2|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
8308732|NCT01496846|20484787|P1|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
8308733|NCT01496846|20484782|P6|NOT COMPLETED|IANB Articaine (All Participants)||0
8308734|NCT01496846|20484783|P5|NOT COMPLETED|IANB Articaine (All Participants)||0
8308735|NCT01496846|20484784|P4|NOT COMPLETED|IANB Articaine (All Participants)||0
8308736|NCT01496846|20484785|P3|NOT COMPLETED|IANB Articaine (All Participants)||0
8308737|NCT01496846|20484786|P2|NOT COMPLETED|IANB Articaine (All Participants)||1
8308738|NCT01496846|20484787|P1|NOT COMPLETED|IANB Articaine (All Participants)||1
8308739|NCT01496846|20484782|P6|COMPLETED|IANB Articaine (All Participants)||38
8308740|NCT01496846|20484783|P5|COMPLETED|IANB Articaine (All Participants)||35
8308741|NCT01496846|20484784|P4|COMPLETED|IANB Articaine (All Participants)||40
8308742|NCT01496846|20484785|P3|COMPLETED|IANB Articaine (All Participants)||36
8308743|NCT01496846|20484786|P2|COMPLETED|IANB Articaine (All Participants)||23
8308744|NCT01496846|20484787|P1|COMPLETED|IANB Articaine (All Participants)||27
8308745|NCT01496846|20484782|P6|STARTED|IANB Articaine (All Participants)||38
8308746|NCT01496846|20484783|P5|STARTED|IANB Articaine (All Participants)||35
8308747|NCT01496846|20484784|P4|STARTED|IANB Articaine (All Participants)||40
8308748|NCT01496846|20484785|P3|STARTED|IANB Articaine (All Participants)||36
8308749|NCT01496846|20484786|P2|STARTED|IANB Articaine (All Participants)||24
8308750|NCT01496846|20484787|P1|STARTED|IANB Articaine (All Participants)||28
8308751|NCT01496807|20484798|P1|NOT COMPLETED|Overall Study||30
8308752|NCT01496807|20484798|P1|COMPLETED|Overall Study||1
8308753|NCT01496807|20484798|P1|STARTED|Overall Study||31
8308754|NCT01496469|20484810|P2|NOT COMPLETED|Overall Study||8
8308755|NCT01496469|20484811|P1|NOT COMPLETED|Overall Study||10
8308756|NCT01496469|20484810|P2|COMPLETED|Overall Study||53
8308757|NCT01496469|20484811|P1|COMPLETED|Overall Study||50
8308758|NCT01496469|20484810|P2|STARTED|Overall Study||61
8308759|NCT01496469|20484811|P1|STARTED|Overall Study||60
8308760|NCT01496456|20484821|P1|NOT COMPLETED|Overall Study||8
8308761|NCT01496456|20484821|P1|COMPLETED|Overall Study||9
8308762|NCT01496456|20484821|P1|3-yr Final Recall|Overall Study||9
8308763|NCT01496456|20484821|P1|2-yr Recall|Overall Study||10
8308764|NCT01496456|20484821|P1|1-yr Recall|Overall Study||12
8308765|NCT01496456|20484821|P1|Baseline|Overall Study|Baseline group started with 16 patients.|16
8308766|NCT01496456|20484821|P1|STARTED|Overall Study||17
8308767|NCT01496430|20484834|P3|NOT COMPLETED|Overall Study||10
8308768|NCT01496430|20484835|P2|NOT COMPLETED|Overall Study||5
8308769|NCT01496430|20484836|P1|NOT COMPLETED|Overall Study||6
8308770|NCT01496430|20484834|P3|COMPLETED|Overall Study||25
8308771|NCT01496430|20484835|P2|COMPLETED|Overall Study||30
8308772|NCT01496430|20484836|P1|COMPLETED|Overall Study||29
8308773|NCT01496430|20484834|P3|STARTED|Overall Study||35
8308774|NCT01496430|20484835|P2|STARTED|Overall Study||35
8308775|NCT01496430|20484836|P1|STARTED|Overall Study||35
8308776|NCT01496365|20484917|P7|NOT COMPLETED|Overall Study||6
8308777|NCT01496365|20484918|P6|NOT COMPLETED|Overall Study||10
8308778|NCT01496365|20484919|P5|NOT COMPLETED|Overall Study||13
8308779|NCT01496365|20484920|P4|NOT COMPLETED|Overall Study||4
8308780|NCT01496365|20484921|P3|NOT COMPLETED|Overall Study||6
8308781|NCT01496365|20484922|P2|NOT COMPLETED|Overall Study||15
8308782|NCT01496365|20484923|P1|NOT COMPLETED|Overall Study||15
8308783|NCT01496365|20484917|P7|COMPLETED|Overall Study||51
8308784|NCT01496365|20484918|P6|COMPLETED|Overall Study||46
8308785|NCT01496365|20484919|P5|COMPLETED|Overall Study||44
8308786|NCT01496365|20484920|P4|COMPLETED|Overall Study||53
8308787|NCT01496365|20484921|P3|COMPLETED|Overall Study||51
8308788|NCT01496365|20484922|P2|COMPLETED|Overall Study||41
8308789|NCT01496365|20484923|P1|COMPLETED|Overall Study||97
8308790|NCT01496365|20484917|P7|STARTED|Overall Study||57
8308791|NCT01496365|20484918|P6|STARTED|Overall Study||56
8308792|NCT01496365|20484919|P5|STARTED|Overall Study||57
8308793|NCT01496365|20484920|P4|STARTED|Overall Study||57
8308794|NCT01496365|20484921|P3|STARTED|Overall Study||57
8308795|NCT01496365|20484922|P2|STARTED|Overall Study||56
8308796|NCT01496365|20484923|P1|STARTED|Overall Study||112
8308797|NCT01496352|20485025|P2|NOT COMPLETED|Overall Study||0
8308798|NCT01496352|20485026|P1|NOT COMPLETED|Overall Study||0
8308799|NCT01496352|20485025|P2|COMPLETED|Overall Study||6
8308800|NCT01496352|20485026|P1|COMPLETED|Overall Study||24
8308801|NCT01496352|20485025|P2|STARTED|Overall Study||6
8308802|NCT01496352|20485026|P1|STARTED|Overall Study||24
8308803|NCT01496313|20485044|P2|NOT COMPLETED|Overall Study||15
8308804|NCT01496313|20485045|P1|NOT COMPLETED|Overall Study||5
8308805|NCT01496313|20485044|P2|COMPLETED|Overall Study||26
8308806|NCT01496313|20485045|P1|COMPLETED|Overall Study||35
8308807|NCT01496313|20485044|P2|STARTED|Overall Study||41
8308808|NCT01496313|20485045|P1|STARTED|Overall Study||40
8308809|NCT01496287|20485061|P1|NOT COMPLETED|Overall Study||6
8308810|NCT01496287|20485061|P1|COMPLETED|Overall Study||64
8308811|NCT01496287|20485061|P1|STARTED|Overall Study||70
8308812|NCT01496274|20485071|P2|NOT COMPLETED|Overall Study||5
8308813|NCT01496274|20485072|P1|NOT COMPLETED|Overall Study||3
8308814|NCT01496274|20485071|P2|COMPLETED|Overall Study||18
8308815|NCT01496274|20485072|P1|COMPLETED|Overall Study||37
8308816|NCT01496274|20485071|P2|STARTED|Overall Study||23
8308817|NCT01496274|20485072|P1|STARTED|Overall Study||40
8308818|NCT01496248|20485104|P1|NOT COMPLETED|Overall Study||10
8308819|NCT01496248|20485104|P1|COMPLETED|Overall Study||25
8308820|NCT01496248|20485104|P1|STARTED|Overall Study||35
8308821|NCT01496183|20485117|P2|NOT COMPLETED|Overall Study||2
8308822|NCT01496183|20485118|P1|NOT COMPLETED|Overall Study||3
8308823|NCT01496183|20485117|P2|COMPLETED|Overall Study||13
8308824|NCT01496183|20485118|P1|COMPLETED|Overall Study||6
8308825|NCT01496183|20485117|P2|STARTED|Overall Study||15
8308826|NCT01496183|20485118|P1|STARTED|Overall Study||9
8308827|NCT01496157|20485148|P1|NOT COMPLETED|Overall Study||0
8308828|NCT01496157|20485148|P1|COMPLETED|Overall Study||13
8308829|NCT01496157|20485148|P1|STARTED|Overall Study||13
8308830|NCT01496131|20485155|P2|NOT COMPLETED|Overall Study||0
8308831|NCT01496131|20485156|P1|NOT COMPLETED|Overall Study||0
8308832|NCT01496131|20485155|P2|COMPLETED|Overall Study||14
8308833|NCT01496131|20485156|P1|COMPLETED|Overall Study||14
8308834|NCT01496131|20485155|P2|STARTED|Overall Study||14
8308835|NCT01496131|20485156|P1|STARTED|Overall Study||14
8308836|NCT01496066|20485170|P2|NOT COMPLETED|Overall Study||9
8308837|NCT01496066|20485171|P1|NOT COMPLETED|Overall Study||12
8308838|NCT01496066|20485170|P2|COMPLETED|Overall Study||188
8308839|NCT01496066|20485171|P1|COMPLETED|Overall Study||391
8308840|NCT01496066|20485170|P2|STARTED|Overall Study||197
8308841|NCT01496066|20485171|P1|STARTED|Overall Study||403
8308842|NCT01495988|20485194|P4|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308843|NCT01495988|20485195|P3|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308844|NCT01495988|20485196|P2|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308845|NCT01495988|20485197|P1|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308846|NCT01495988|20485194|P4|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308847|NCT01495988|20485195|P3|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308848|NCT01495988|20485196|P2|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
8308849|NCT01495988|20485197|P1|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308850|NCT01495988|20485194|P4|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308851|NCT01495988|20485195|P3|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308852|NCT01495988|20485196|P2|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
8308853|NCT01495988|20485197|P1|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
8308854|NCT01495988|20485194|P4|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
8308855|NCT01495988|20485195|P3|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
8308856|NCT01495988|20485196|P2|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
8308857|NCT01495988|20485197|P1|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
8308858|NCT01495988|20485194|P4|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
8308859|NCT01495988|20485195|P3|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
8308860|NCT01495988|20485196|P2|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
8308861|NCT01495988|20485197|P1|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
8308862|NCT01495988|20485194|P4|STARTED|Vem +/- Bev (Protocol v2.0)||3
8308863|NCT01495988|20485195|P3|STARTED|Vem +/- Bev (Protocol v2.0)||5
8308864|NCT01495988|20485196|P2|STARTED|Vem +/- Bev (Protocol v2.0)||0
8308865|NCT01495988|20485197|P1|STARTED|Vem +/- Bev (Protocol v2.0)||0
8308866|NCT01495975|20485233|P2|NOT COMPLETED|Overall Study||0
8308867|NCT01495975|20485234|P1|NOT COMPLETED|Overall Study||1
8308868|NCT01495975|20485233|P2|COMPLETED|Overall Study||14
8308869|NCT01495975|20485234|P1|COMPLETED|Overall Study||14
8308870|NCT01495975|20485233|P2|STARTED|Overall Study||14
8308871|NCT01495975|20485234|P1|STARTED|Overall Study||15
8308872|NCT01495923|20485242|P2|NOT COMPLETED|Overall Study||0
8308873|NCT01495923|20485243|P1|NOT COMPLETED|Overall Study||0
8308874|NCT01495923|20485242|P2|COMPLETED|Overall Study||72
8308875|NCT01495923|20485243|P1|COMPLETED|Overall Study||73
8308876|NCT01495923|20485242|P2|STARTED|Overall Study||72
8308877|NCT01495923|20485243|P1|STARTED|Overall Study||73
8308878|NCT01495858|20485276|P3|NOT COMPLETED|Overall Study||0
8308879|NCT01495858|20485277|P2|NOT COMPLETED|Overall Study||0
8308880|NCT01495858|20485278|P1|NOT COMPLETED|Overall Study||0
8308881|NCT01495858|20485276|P3|COMPLETED|Overall Study||54
8308882|NCT01495858|20485277|P2|COMPLETED|Overall Study||106
8308883|NCT01495858|20485278|P1|COMPLETED|Overall Study||107
8308884|NCT01495858|20485276|P3|STARTED|Overall Study||54
8308885|NCT01495858|20485277|P2|STARTED|Overall Study||106
8308886|NCT01495858|20485278|P1|STARTED|Overall Study||107
8308887|NCT01495793|20485358|P1|NOT COMPLETED|Overall Study||2
8308888|NCT01495793|20485358|P1|COMPLETED|Overall Study||22
8308889|NCT01495793|20485358|P1|STARTED|Overall Study||24
8308890|NCT01495702|20485371|P2|NOT COMPLETED|Extension Phase||0
8308891|NCT01495702|20485372|P1|NOT COMPLETED|Extension Phase||0
8308892|NCT01495702|20485371|P2|COMPLETED|Extension Phase||2
8308893|NCT01495702|20485372|P1|COMPLETED|Extension Phase||26
8308894|NCT01495702|20485371|P2|STARTED|Extension Phase||2
8308895|NCT01495702|20485372|P1|STARTED|Extension Phase||26
8308896|NCT01495702|20485371|P2|NOT COMPLETED|Randomized Phase||28
8308897|NCT01495702|20485372|P1|NOT COMPLETED|Randomized Phase||26
8308898|NCT01495702|20485371|P2|COMPLETED|Randomized Phase||119
8308899|NCT01495702|20485372|P1|COMPLETED|Randomized Phase||266
8308900|NCT01495702|20485371|P2|STARTED|Randomized Phase||147
8308901|NCT01495702|20485372|P1|STARTED|Randomized Phase||292
8308902|NCT01495689|20485387|P2|NOT COMPLETED|Overall Study||7
8308903|NCT01495689|20485388|P1|NOT COMPLETED|Overall Study||10
8308904|NCT01495689|20485387|P2|COMPLETED|Overall Study||16
8308905|NCT01495689|20485388|P1|COMPLETED|Overall Study||16
8308906|NCT01495689|20485387|P2|STARTED|Overall Study||23
8308907|NCT01495689|20485388|P1|STARTED|Overall Study||26
8308908|NCT01495585|20485397|P3|NOT COMPLETED|Overall Study||0
8308909|NCT01495585|20485398|P2|NOT COMPLETED|Overall Study||0
8308910|NCT01495585|20485399|P1|NOT COMPLETED|Overall Study||0
8308911|NCT01495585|20485397|P3|COMPLETED|Overall Study||4
8308912|NCT01495585|20485398|P2|COMPLETED|Overall Study||6
8308913|NCT01495585|20485399|P1|COMPLETED|Overall Study||4
8308914|NCT01495585|20485397|P3|Open Label Lonafarnib 200 mg|Overall Study||0
8308915|NCT01495585|20485398|P2|Open Label Lonafarnib 200 mg|Overall Study||0
8308916|NCT01495585|20485399|P1|Open Label Lonafarnib 200 mg|Overall Study||2
8308917|NCT01495585|20485397|P3|STARTED|Overall Study||4
8308918|NCT01495585|20485398|P2|STARTED|Overall Study||6
8308919|NCT01495585|20485399|P1|STARTED|Overall Study||4
8308920|NCT01495572|20485412|P2|NOT COMPLETED|Overall Study||0
8308921|NCT01495572|20485413|P1|NOT COMPLETED|Overall Study||0
8308922|NCT01495572|20485412|P2|COMPLETED|Overall Study||5
8308923|NCT01495572|20485413|P1|COMPLETED|Overall Study||0
8308924|NCT01495572|20485412|P2|STARTED|Overall Study||5
8308925|NCT01495572|20485413|P1|STARTED|Overall Study||0
8308926|NCT01495481|20485421|P1|NOT COMPLETED|Dexmedetomidine||0
8308927|NCT01495481|20485421|P1|COMPLETED|Dexmedetomidine||22
8308928|NCT01495481|20485421|P1|STARTED|Dexmedetomidine||22
8308929|NCT01495481|20485421|P1|NOT COMPLETED|Washout||0
8308930|NCT01495481|20485421|P1|COMPLETED|Washout||22
8308931|NCT01495481|20485421|P1|STARTED|Washout||22
8308932|NCT01495481|20485421|P1|NOT COMPLETED|Adenosine||0
8308933|NCT01495481|20485421|P1|COMPLETED|Adenosine||22
8308934|NCT01495481|20485421|P1|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
8308935|NCT01495286|20485433|P1|NOT COMPLETED|Overall Study||0
8308936|NCT01495286|20485433|P1|COMPLETED|Overall Study||30
8308937|NCT01495286|20485433|P1|STARTED|Overall Study||30
8308938|NCT01495221|20485441|P1|NOT COMPLETED|Overall Study||0
8308939|NCT01495221|20485441|P1|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
8308940|NCT01495221|20485441|P1|STARTED|Overall Study|First Patient enrolled December 2011.|9
8308941|NCT01495000|20485450|P2|NOT COMPLETED|Overall Study||12
8308942|NCT01495000|20485451|P1|NOT COMPLETED|Overall Study||13
8308943|NCT01495000|20485450|P2|COMPLETED|Overall Study||114
8308944|NCT01495000|20485451|P1|COMPLETED|Overall Study||111
8308945|NCT01495000|20485450|P2|STARTED|Overall Study||126
8308946|NCT01495000|20485451|P1|STARTED|Overall Study||124
8308947|NCT01494987|20485493|P2|NOT COMPLETED|Overall Study||28
8308948|NCT01494987|20485494|P1|NOT COMPLETED|Overall Study||28
8308949|NCT01494987|20485493|P2|COMPLETED|Overall Study||187
8308950|NCT01494987|20485494|P1|COMPLETED|Overall Study||188
8308951|NCT01494987|20485493|P2|STARTED|Overall Study||215
8308952|NCT01494987|20485494|P1|STARTED|Overall Study||216
8308953|NCT01494818|20485508|P2|NOT COMPLETED|Overall Study||2
8308954|NCT01494818|20485509|P1|NOT COMPLETED|Overall Study||2
8308955|NCT01494818|20485508|P2|COMPLETED|Overall Study||37
8308956|NCT01494818|20485509|P1|COMPLETED|Overall Study||37
8308957|NCT01494818|20485508|P2|STARTED|Overall Study||39
8308958|NCT01494818|20485509|P1|STARTED|Overall Study||39
8308959|NCT01494753|20485531|P2|NOT COMPLETED|Day42-Day84||0
8308960|NCT01494753|20485532|P1|NOT COMPLETED|Day42-Day84||0
8308961|NCT01494753|20485531|P2|COMPLETED|Day42-Day84||15
8308962|NCT01494753|20485532|P1|COMPLETED|Day42-Day84||15
8308963|NCT01494753|20485531|P2|STARTED|Day42-Day84||15
8308964|NCT01494753|20485532|P1|STARTED|Day42-Day84||15
8308965|NCT01494753|20485531|P2|NOT COMPLETED|Day0-Day42||0
8308966|NCT01494753|20485532|P1|NOT COMPLETED|Day0-Day42||0
8308967|NCT01494753|20485531|P2|COMPLETED|Day0-Day42||15
8308968|NCT01494753|20485532|P1|COMPLETED|Day0-Day42||15
8308969|NCT01494753|20485531|P2|STARTED|Day0-Day42||15
8308970|NCT01494753|20485532|P1|STARTED|Day0-Day42||15
8308971|NCT01494649|20485540|P2|NOT COMPLETED|Overall Study||1
8308972|NCT01494649|20485541|P1|NOT COMPLETED|Overall Study||0
8308973|NCT01494649|20485540|P2|COMPLETED|Overall Study||58
8308974|NCT01494649|20485541|P1|COMPLETED|Overall Study||59
8308975|NCT01494649|20485540|P2|STARTED|Overall Study||59
8308976|NCT01494649|20485541|P1|STARTED|Overall Study||59
8308977|NCT01494610|20485557|P2|NOT COMPLETED|Period 4||0
8308978|NCT01494610|20485558|P1|NOT COMPLETED|Period 4||1
8308979|NCT01494610|20485557|P2|COMPLETED|Period 4||28
8308980|NCT01494610|20485558|P1|COMPLETED|Period 4||27
8308981|NCT01494610|20485557|P2|STARTED|Period 4||28
8308982|NCT01494610|20485558|P1|STARTED|Period 4||28
8308983|NCT01494610|20485557|P2|NOT COMPLETED|Period 3||0
8308984|NCT01494610|20485558|P1|NOT COMPLETED|Period 3||2
8308985|NCT01494610|20485557|P2|COMPLETED|Period 3||28
8308986|NCT01494610|20485558|P1|COMPLETED|Period 3||28
8308987|NCT01494610|20485557|P2|STARTED|Period 3||28
8308988|NCT01494610|20485558|P1|STARTED|Period 3||30
8308989|NCT01494610|20485557|P2|NOT COMPLETED|Period 2||0
8308990|NCT01494610|20485558|P1|NOT COMPLETED|Period 2||0
8308991|NCT01494610|20485557|P2|COMPLETED|Period 2||28
8308992|NCT01494610|20485558|P1|COMPLETED|Period 2||30
8308993|NCT01494610|20485557|P2|STARTED|Period 2||28
8308994|NCT01494610|20485558|P1|STARTED|Period 2||30
8308995|NCT01494610|20485557|P2|NOT COMPLETED|Period 1||1
8308996|NCT01494610|20485558|P1|NOT COMPLETED|Period 1||1
8308997|NCT01494610|20485557|P2|COMPLETED|Period 1||28
8308998|NCT01494610|20485558|P1|COMPLETED|Period 1||30
8308999|NCT01494610|20485557|P2|STARTED|Period 1||29
8309000|NCT01494610|20485558|P1|STARTED|Period 1||31
8309001|NCT01494584|20485626|P1|NOT COMPLETED|Overall Study||1
8309002|NCT01494584|20485626|P1|COMPLETED|Overall Study||4
8309003|NCT01494584|20485626|P1|STARTED|Overall Study||5
8309004|NCT01494545|20485715|P1|NOT COMPLETED|Overall Study||10
8309005|NCT01494545|20485715|P1|COMPLETED|Overall Study||92
8309006|NCT01494545|20485715|P1|STARTED|Overall Study||102
8309007|NCT01494532|20485758|P6|NOT COMPLETED|Overall Study||0
8309008|NCT01494532|20485759|P5|NOT COMPLETED|Overall Study||12
8309009|NCT01494532|20485760|P4|NOT COMPLETED|Overall Study||15
8309010|NCT01494532|20485761|P3|NOT COMPLETED|Overall Study||17
8309011|NCT01494532|20485762|P2|NOT COMPLETED|Overall Study||4
8309012|NCT01494532|20485763|P1|NOT COMPLETED|Overall Study||10
8309013|NCT01494532|20485758|P6|COMPLETED|Overall Study||25
8309014|NCT01494532|20485759|P5|COMPLETED|Overall Study||64
8309015|NCT01494532|20485760|P4|COMPLETED|Overall Study||60
8309016|NCT01494532|20485761|P3|COMPLETED|Overall Study||59
8309017|NCT01494532|20485762|P2|COMPLETED|Overall Study||21
8309018|NCT01494532|20485763|P1|COMPLETED|Overall Study||65
8309019|NCT01494532|20485758|P6|STARTED|Overall Study||25
8309020|NCT01494532|20485759|P5|STARTED|Overall Study||76
8309021|NCT01494532|20485760|P4|STARTED|Overall Study||75
8309022|NCT01494532|20485761|P3|STARTED|Overall Study||76
8309023|NCT01494532|20485762|P2|STARTED|Overall Study||25
8309024|NCT01494532|20485763|P1|STARTED|Overall Study||75
8309025|NCT01494506|20485918|P3|NOT COMPLETED|Overall Study||103
8309026|NCT01494506|20485919|P2|NOT COMPLETED|Overall Study||143
8309027|NCT01494506|20485920|P1|NOT COMPLETED|Overall Study||148
8309028|NCT01494506|20485918|P3|COMPLETED|Overall Study||14
8309029|NCT01494506|20485919|P2|COMPLETED|Overall Study||6
8309030|NCT01494506|20485920|P1|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
8309031|NCT01494506|20485918|P3|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
8309032|NCT01494506|20485919|P2|Treated Population|Overall Study||134
8309033|NCT01494506|20485920|P1|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
8309034|NCT01494506|20485918|P3|STARTED|Overall Study||117
8309035|NCT01494506|20485919|P2|STARTED|Overall Study||149
8309036|NCT01494506|20485920|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
8309055|NCT01494350|20485974|P1|NOT COMPLETED|Overall Study||1
8309056|NCT01494350|20485974|P1|COMPLETED|Overall Study||49
8309057|NCT01494350|20485974|P1|STARTED|Overall Study||50
8309058|NCT01494298|20485984|P2|NOT COMPLETED|Overall Study||8
8309059|NCT01494298|20485985|P1|NOT COMPLETED|Overall Study||2
8309060|NCT01494298|20485984|P2|COMPLETED|Overall Study||47
8309061|NCT01494298|20485985|P1|COMPLETED|Overall Study||54
8309062|NCT01494298|20485984|P2|STARTED|Overall Study||55
8309063|NCT01494298|20485985|P1|STARTED|Overall Study||56
8309064|NCT01494051|20485997|P2|NOT COMPLETED|Overall Study||0
8309065|NCT01494051|20485998|P1|NOT COMPLETED|Overall Study||0
8309066|NCT01494051|20485997|P2|COMPLETED|Overall Study||7
8309067|NCT01494051|20485998|P1|COMPLETED|Overall Study||6
8309068|NCT01494051|20485997|P2|STARTED|Overall Study||7
8309069|NCT01494051|20485998|P1|STARTED|Overall Study||6
8309070|NCT01494038|20486008|P2|NOT COMPLETED|Overall Study||83
8309071|NCT01494038|20486009|P1|NOT COMPLETED|Overall Study||88
8309072|NCT01494038|20486008|P2|COMPLETED|Overall Study||396
8309073|NCT01494038|20486009|P1|COMPLETED|Overall Study||389
8309074|NCT01494038|20486008|P2|STARTED|Overall Study||479
8309075|NCT01494038|20486009|P1|STARTED|Overall Study||477
8309076|NCT01493960|20486097|P2|NOT COMPLETED|Overall Study||18
8309077|NCT01493960|20486098|P1|NOT COMPLETED|Overall Study||32
8309078|NCT01493960|20486097|P2|COMPLETED|Overall Study||26
8309079|NCT01493960|20486098|P1|COMPLETED|Overall Study||55
8309080|NCT01493960|20486097|P2|Received Study Drug|Overall Study||43
8309081|NCT01493960|20486098|P1|Received Study Drug|Overall Study||87
8309082|NCT01493960|20486097|P2|STARTED|Overall Study||44
8309083|NCT01493960|20486098|P1|STARTED|Overall Study||87
8309084|NCT01493947|20486118|P2|NOT COMPLETED|Period B Extension Period||32
8309085|NCT01493947|20486119|P1|NOT COMPLETED|Period B Extension Period||33
8309086|NCT01493947|20486118|P2|COMPLETED|Period B Extension Period||326
8309087|NCT01493947|20486119|P1|COMPLETED|Period B Extension Period||366
8309088|NCT01493947|20486118|P2|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
8309089|NCT01493947|20486119|P1|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
8309090|NCT01493947|20486118|P2|NOT COMPLETED|Period A Efficacy and Safety Data||28
8309091|NCT01493947|20486119|P1|NOT COMPLETED|Period A Efficacy and Safety Data||32
8309092|NCT01493947|20486118|P2|COMPLETED|Period A Efficacy and Safety Data||456
8309093|NCT01493947|20486119|P1|COMPLETED|Period A Efficacy and Safety Data||446
8309094|NCT01493947|20486118|P2|STARTED|Period A Efficacy and Safety Data||484
8309095|NCT01493947|20486119|P1|STARTED|Period A Efficacy and Safety Data||478
8309096|NCT01493778|20486129|P1|NOT COMPLETED|Overall Study||8
8309097|NCT01493778|20486129|P1|COMPLETED|Overall Study||52
8309098|NCT01493778|20486129|P1|STARTED|Overall Study||60
8309117|NCT01493557|20486211|P3|NOT COMPLETED|Adding the Second Strategy||0
8309118|NCT01493557|20486212|P2|NOT COMPLETED|Adding the Second Strategy||4
8309119|NCT01493557|20486213|P1|NOT COMPLETED|Adding the Second Strategy||2
8309120|NCT01493557|20486211|P3|COMPLETED|Adding the Second Strategy||0
8309121|NCT01493557|20486212|P2|COMPLETED|Adding the Second Strategy||11
8309122|NCT01493557|20486213|P1|COMPLETED|Adding the Second Strategy||12
8309123|NCT01493557|20486211|P3|STARTED|Adding the Second Strategy||0
8309124|NCT01493557|20486212|P2|STARTED|Adding the Second Strategy||15
8309125|NCT01493557|20486213|P1|STARTED|Adding the Second Strategy||14
8309126|NCT01493557|20486211|P3|NOT COMPLETED|Randomized to Management Strategies||0
8309127|NCT01493557|20486212|P2|NOT COMPLETED|Randomized to Management Strategies||11
8309128|NCT01493557|20486213|P1|NOT COMPLETED|Randomized to Management Strategies||15
8309129|NCT01493557|20486211|P3|COMPLETED|Randomized to Management Strategies||0
8309130|NCT01493557|20486212|P2|COMPLETED|Randomized to Management Strategies||47
8309131|NCT01493557|20486213|P1|COMPLETED|Randomized to Management Strategies||44
8309132|NCT01493557|20486211|P3|STARTED|Randomized to Management Strategies||0
8309133|NCT01493557|20486212|P2|STARTED|Randomized to Management Strategies||58
8309134|NCT01493557|20486213|P1|STARTED|Randomized to Management Strategies||59
8309135|NCT01493557|20486211|P3|NOT COMPLETED|Not Randomized to Management Strategies||134
8309136|NCT01493557|20486212|P2|NOT COMPLETED|Not Randomized to Management Strategies||0
8309137|NCT01493557|20486213|P1|NOT COMPLETED|Not Randomized to Management Strategies||0
8309138|NCT01493557|20486211|P3|COMPLETED|Not Randomized to Management Strategies||816
8309139|NCT01493557|20486212|P2|COMPLETED|Not Randomized to Management Strategies||0
8309140|NCT01493557|20486213|P1|COMPLETED|Not Randomized to Management Strategies||0
8309141|NCT01493557|20486211|P3|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
8309142|NCT01493557|20486212|P2|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
8309143|NCT01493557|20486213|P1|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
8309144|NCT01493557|20486211|P3|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
8309145|NCT01493557|20486212|P2|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
8309146|NCT01493557|20486213|P1|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
8309147|NCT01493557|20486211|P3|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
8309148|NCT01493557|20486212|P2|Without Experiencing GIS|Not Randomized to Management Strategies||0
8309149|NCT01493557|20486213|P1|Without Experiencing GIS|Not Randomized to Management Strategies||0
8309150|NCT01493557|20486211|P3|STARTED|Not Randomized to Management Strategies||950
8309151|NCT01493557|20486212|P2|STARTED|Not Randomized to Management Strategies||0
8309152|NCT01493557|20486213|P1|STARTED|Not Randomized to Management Strategies||0
8309153|NCT01493531|20486241|P3|NOT COMPLETED|Overall Study||48
8309154|NCT01493531|20486242|P2|NOT COMPLETED|Overall Study||50
8309155|NCT01493531|20486243|P1|NOT COMPLETED|Overall Study||41
8309156|NCT01493531|20486241|P3|COMPLETED|Overall Study||158
8309157|NCT01493531|20486242|P2|COMPLETED|Overall Study||150
8309158|NCT01493531|20486243|P1|COMPLETED|Overall Study||163
8309159|NCT01493531|20486241|P3|STARTED|Overall Study||206
8309160|NCT01493531|20486242|P2|STARTED|Overall Study||200
8309161|NCT01493531|20486243|P1|STARTED|Overall Study||204
8309162|NCT01493427|20486257|P1|NOT COMPLETED|Overall Study||20
8309163|NCT01493427|20486257|P1|COMPLETED|Overall Study||179
8309164|NCT01493427|20486257|P1|STARTED|Overall Study||199
8309165|NCT01493414|20486262|P1|NOT COMPLETED|Overall Study||950
8309166|NCT01493414|20486262|P1|COMPLETED|Overall Study||1283
8309167|NCT01493414|20486262|P1|STARTED|Overall Study||2233
8309168|NCT01493284|20486275|P1|NOT COMPLETED|Overall Study||61
8309169|NCT01493284|20486275|P1|COMPLETED|Overall Study||161
8309170|NCT01493284|20486275|P1|STARTED|Overall Study||222
8309171|NCT01493180|20486284|P2|NOT COMPLETED|Overall Study||2
8309172|NCT01493180|20486285|P1|NOT COMPLETED|Overall Study||3
8309173|NCT01493180|20486284|P2|COMPLETED|Overall Study||49
8309174|NCT01493180|20486285|P1|COMPLETED|Overall Study||48
8309175|NCT01493180|20486284|P2|STARTED|Overall Study||51
8309176|NCT01493180|20486285|P1|STARTED|Overall Study||51
8309177|NCT01493167|20486291|P1|NOT COMPLETED|Overall Study||0
8309178|NCT01493167|20486291|P1|COMPLETED|Overall Study||97
8309179|NCT01493167|20486291|P1|STARTED|Overall Study||97
8309180|NCT01493089|20486297|P2|NOT COMPLETED|Overall Study||3
8309181|NCT01493089|20486298|P1|NOT COMPLETED|Overall Study||3
8309182|NCT01493089|20486297|P2|COMPLETED|Overall Study||114
8309183|NCT01493089|20486298|P1|COMPLETED|Overall Study||119
8309184|NCT01493089|20486297|P2|STARTED|Overall Study||117
8309185|NCT01493089|20486298|P1|STARTED|Overall Study||122
8309186|NCT01493024|20486318|P4|NOT COMPLETED|Overall Study||0
8309187|NCT01493024|20486319|P3|NOT COMPLETED|Overall Study||0
8309188|NCT01493024|20486320|P2|NOT COMPLETED|Overall Study||0
8309189|NCT01493024|20486321|P1|NOT COMPLETED|Overall Study||0
8309190|NCT01493024|20486318|P4|COMPLETED|Overall Study||24
8309191|NCT01493024|20486319|P3|COMPLETED|Overall Study||24
8309192|NCT01493024|20486320|P2|COMPLETED|Overall Study||12
8309193|NCT01493024|20486321|P1|COMPLETED|Overall Study||30
8309194|NCT01493024|20486318|P4|STARTED|Overall Study||24
8309195|NCT01493024|20486319|P3|STARTED|Overall Study||24
8309196|NCT01493024|20486320|P2|STARTED|Overall Study||12
8309197|NCT01493024|20486321|P1|STARTED|Overall Study||30
8309198|NCT01492686|20486397|P2|NOT COMPLETED|Open-label Phase||18
8309199|NCT01492686|20486398|P1|NOT COMPLETED|Open-label Phase||12
8309200|NCT01492686|20486397|P2|COMPLETED|Open-label Phase||40
8309201|NCT01492686|20486398|P1|COMPLETED|Open-label Phase||53
8309202|NCT01492686|20486397|P2|STARTED|Open-label Phase||58
8309203|NCT01492686|20486398|P1|STARTED|Open-label Phase||65
8309204|NCT01492686|20486397|P2|NOT COMPLETED|Double-blind Phase||8
8309205|NCT01492686|20486398|P1|NOT COMPLETED|Double-blind Phase||2
8309206|NCT01492686|20486397|P2|COMPLETED|Double-blind Phase||60
8309207|NCT01492686|20486398|P1|COMPLETED|Double-blind Phase||67
8309208|NCT01492686|20486397|P2|STARTED|Double-blind Phase||68
8309209|NCT01492686|20486398|P1|STARTED|Double-blind Phase||69
8309210|NCT01492673|20486422|P1|NOT COMPLETED|Overall Study||0
8309211|NCT01492673|20486422|P1|COMPLETED|Overall Study||9
8309212|NCT01492673|20486422|P1|STARTED|Overall Study||9
8309213|NCT01492582|20486429|P2|NOT COMPLETED|Overall Study||64
8309214|NCT01492582|20486430|P1|NOT COMPLETED|Overall Study||69
8309215|NCT01492582|20486429|P2|COMPLETED|Overall Study|Returned evaluable survey|982
8309216|NCT01492582|20486430|P1|COMPLETED|Overall Study|Received 3 vaccine doses and completed Month 7 blood draw (224 quadrivalent; 160 nonavalent)|384
8309217|NCT01492582|20486429|P2|Received First Nonavalent Vaccine Dose|Overall Study||0
8309218|NCT01492582|20486430|P1|Received First Nonavalent Vaccine Dose|Overall Study||182
8309219|NCT01492582|20486429|P2|Received First Quadrivalent Vaccine Dose|Overall Study|Does not apply|0
8309220|NCT01492582|20486430|P1|Received First Quadrivalent Vaccine Dose|Overall Study||254
8309221|NCT01492582|20486429|P2|STARTED|Overall Study|Consented to the survey arm of the study|1046
8309222|NCT01492582|20486430|P1|STARTED|Overall Study|Consented to the vaccine arm (265 quadrivalent vaccine; 188 nonavalent vaccine)|453
8309223|NCT01492439|20486455|P2|NOT COMPLETED|Overall Study||9
8309224|NCT01492439|20486456|P1|NOT COMPLETED|Overall Study||4
8309225|NCT01492439|20486455|P2|COMPLETED|Overall Study||9
8309226|NCT01492439|20486456|P1|COMPLETED|Overall Study||15
8309227|NCT01492439|20486455|P2|Post-intervention|Overall Study||13
8309228|NCT01492439|20486456|P1|Post-intervention|Overall Study||18
8309229|NCT01492439|20486455|P2|STARTED|Overall Study||18
8309230|NCT01492439|20486456|P1|STARTED|Overall Study||19
8309231|NCT01492426|20486504|P2|NOT COMPLETED|Follow-Up||10
8309232|NCT01492426|20486505|P1|NOT COMPLETED|Follow-Up||25
8309233|NCT01492426|20486504|P2|COMPLETED|Follow-Up||181
8309234|NCT01492426|20486505|P1|COMPLETED|Follow-Up||359
8309235|NCT01492426|20486504|P2|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
8309236|NCT01492426|20486505|P1|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
8309237|NCT01492426|20486504|P2|NOT COMPLETED|Treatment||40
8309238|NCT01492426|20486505|P1|NOT COMPLETED|Treatment||83
8309239|NCT01492426|20486504|P2|COMPLETED|Treatment||160
8309240|NCT01492426|20486505|P1|COMPLETED|Treatment||319
8309241|NCT01492426|20486504|P2|STARTED|Treatment||200
8309242|NCT01492426|20486505|P1|STARTED|Treatment||402
8309243|NCT01492400|20486523|P2|NOT COMPLETED|Overall Study||16
8309244|NCT01492400|20486524|P1|NOT COMPLETED|Overall Study||16
8309245|NCT01492400|20486523|P2|COMPLETED|Overall Study||166
8309246|NCT01492400|20486524|P1|COMPLETED|Overall Study||165
8309247|NCT01492400|20486523|P2|STARTED|Overall Study||182
8309248|NCT01492400|20486524|P1|STARTED|Overall Study||181
8309249|NCT01492309|20486536|P2|NOT COMPLETED|Overall Study||0
8309250|NCT01492309|20486537|P1|NOT COMPLETED|Overall Study||0
8309251|NCT01492309|20486536|P2|COMPLETED|Overall Study||11
8309252|NCT01492309|20486537|P1|COMPLETED|Overall Study||11
8309253|NCT01492309|20486536|P2|STARTED|Overall Study||11
8309254|NCT01492309|20486537|P1|STARTED|Overall Study||11
8309255|NCT01492088|20486548|P3|NOT COMPLETED|Overall Study||14
8309256|NCT01492088|20486549|P2|NOT COMPLETED|Overall Study||14
8309257|NCT01492088|20486550|P1|NOT COMPLETED|Overall Study||3
8309258|NCT01492088|20486548|P3|COMPLETED|Overall Study||3
8309259|NCT01492088|20486549|P2|COMPLETED|Overall Study||2
8309260|NCT01492088|20486550|P1|COMPLETED|Overall Study||0
8309261|NCT01492088|20486548|P3|STARTED|Overall Study||17
8309262|NCT01492088|20486549|P2|STARTED|Overall Study||16
8309263|NCT01492088|20486550|P1|STARTED|Overall Study||3
8309264|NCT01491984|20486610|P2|NOT COMPLETED|Overall Study||1
8309265|NCT01491984|20486611|P1|NOT COMPLETED|Overall Study||2
8309266|NCT01491984|20486610|P2|COMPLETED|Overall Study||44
8309267|NCT01491984|20486611|P1|COMPLETED|Overall Study||47
8309268|NCT01491984|20486610|P2|STARTED|Overall Study||45
8309269|NCT01491984|20486611|P1|STARTED|Overall Study||49
8309270|NCT01491958|20486619|P2|NOT COMPLETED|Overall Study||0
8309271|NCT01491958|20486620|P1|NOT COMPLETED|Overall Study||0
8309272|NCT01491958|20486619|P2|COMPLETED|Overall Study||40
8309273|NCT01491958|20486620|P1|COMPLETED|Overall Study||40
8309274|NCT01491958|20486619|P2|STARTED|Overall Study||40
8309275|NCT01491958|20486620|P1|STARTED|Overall Study||40
8309276|NCT01491919|20486631|P3|NOT COMPLETED|Overall Study||1
8309277|NCT01491919|20486632|P2|NOT COMPLETED|Overall Study||2
8309278|NCT01491919|20486633|P1|NOT COMPLETED|Overall Study||1
8309279|NCT01491919|20486631|P3|COMPLETED|Overall Study||2
8309280|NCT01491919|20486632|P2|COMPLETED|Overall Study||8
8309281|NCT01491919|20486633|P1|COMPLETED|Overall Study||12
8309282|NCT01491919|20486631|P3|STARTED|Overall Study||3
8309283|NCT01491919|20486632|P2|STARTED|Overall Study||10
8309284|NCT01491919|20486633|P1|STARTED|Overall Study||13
8309285|NCT01491893|20486679|P10|NOT COMPLETED|Overall Study||0
8309286|NCT01491893|20486680|P9|NOT COMPLETED|Overall Study||0
8309287|NCT01491893|20486681|P8|NOT COMPLETED|Overall Study||0
8309288|NCT01491893|20486682|P7|NOT COMPLETED|Overall Study||0
8309289|NCT01491893|20486683|P6|NOT COMPLETED|Overall Study||0
8309290|NCT01491893|20486684|P5|NOT COMPLETED|Overall Study||0
8309291|NCT01491893|20486685|P4|NOT COMPLETED|Overall Study||0
8309292|NCT01491893|20486686|P3|NOT COMPLETED|Overall Study||0
8309293|NCT01491893|20486687|P2|NOT COMPLETED|Overall Study||0
8309294|NCT01491893|20486688|P1|NOT COMPLETED|Overall Study||0
8309295|NCT01491893|20486679|P10|COMPLETED|Overall Study||7
8309296|NCT01491893|20486680|P9|COMPLETED|Overall Study||15
8309297|NCT01491893|20486681|P8|COMPLETED|Overall Study||24
8309298|NCT01491893|20486682|P7|COMPLETED|Overall Study||6
8309299|NCT01491893|20486683|P6|COMPLETED|Overall Study||1
8309300|NCT01491893|20486684|P5|COMPLETED|Overall Study||4
8309301|NCT01491893|20486685|P4|COMPLETED|Overall Study||1
8309302|NCT01491893|20486686|P3|COMPLETED|Overall Study||1
8309303|NCT01491893|20486687|P2|COMPLETED|Overall Study||1
8309304|NCT01491893|20486688|P1|COMPLETED|Overall Study||1
8309305|NCT01491893|20486679|P10|STARTED|Overall Study||7
8309306|NCT01491893|20486680|P9|STARTED|Overall Study||15
8309307|NCT01491893|20486681|P8|STARTED|Overall Study||24
8309308|NCT01491893|20486682|P7|STARTED|Overall Study||6
8309309|NCT01491893|20486683|P6|STARTED|Overall Study||1
8309310|NCT01491893|20486684|P5|STARTED|Overall Study||4
8309311|NCT01491893|20486685|P4|STARTED|Overall Study||1
8309312|NCT01491893|20486686|P3|STARTED|Overall Study||1
8309313|NCT01491893|20486687|P2|STARTED|Overall Study||1
8309314|NCT01491893|20486688|P1|STARTED|Overall Study||1
8309315|NCT01491854|20486704|P1|NOT COMPLETED|Overall Study||130
8309316|NCT01491854|20486704|P1|COMPLETED|Overall Study||0
8309317|NCT01491854|20486704|P1|STARTED|Overall Study||130
8309318|NCT01491841|20486715|P1|NOT COMPLETED|Overall Study||11
8309319|NCT01491841|20486715|P1|COMPLETED|Overall Study||22
8309320|NCT01491841|20486715|P1|STARTED|Overall Study||33
8309321|NCT01491802|20486729|P2|NOT COMPLETED|Overall Study||2
8309322|NCT01491802|20486730|P1|NOT COMPLETED|Overall Study||1
8309323|NCT01491802|20486729|P2|COMPLETED|Overall Study||6
8309324|NCT01491802|20486730|P1|COMPLETED|Overall Study||8
8309325|NCT01491802|20486729|P2|STARTED|Overall Study||8
8309326|NCT01491802|20486730|P1|STARTED|Overall Study||9
8309327|NCT01491737|20486757|P2|NOT COMPLETED|Overall Study||129
8309328|NCT01491737|20486758|P1|NOT COMPLETED|Overall Study||129
8309329|NCT01491737|20486757|P2|COMPLETED|Overall Study||0
8309330|NCT01491737|20486758|P1|COMPLETED|Overall Study||0
8309331|NCT01491737|20486757|P2|Entered Follow-Up (Post-Treatment)|Overall Study||116
8309332|NCT01491737|20486758|P1|Entered Follow-Up (Post-Treatment)|Overall Study||120
8309333|NCT01491737|20486757|P2|Received at Least One Dose of Study Drug|Overall Study||124
8309334|NCT01491737|20486758|P1|Received at Least One Dose of Study Drug|Overall Study||127
8309335|NCT01491737|20486757|P2|STARTED|Overall Study||129
8309336|NCT01491737|20486758|P1|STARTED|Overall Study||129
8309337|NCT01491672|20486785|P3|NOT COMPLETED|Overall Study||11
8309338|NCT01491672|20486786|P2|NOT COMPLETED|Overall Study||60
8309339|NCT01491672|20486787|P1|NOT COMPLETED|Overall Study||56
8309340|NCT01491672|20486785|P3|COMPLETED|Overall Study||3
8309341|NCT01491672|20486786|P2|COMPLETED|Overall Study||2
8309342|NCT01491672|20486787|P1|COMPLETED|Overall Study||2
8309343|NCT01491672|20486785|P3|Safety Set|Overall Study||14
8309344|NCT01491672|20486786|P2|Safety Set|Overall Study||61
8309345|NCT01491672|20486787|P1|Safety Set|Overall Study||58
8309346|NCT01491672|20486785|P3|STARTED|Overall Study||14
8309347|NCT01491672|20486786|P2|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
8309348|NCT01491672|20486787|P1|STARTED|Overall Study||58
8309349|NCT01491633|20486812|P1|NOT COMPLETED|Overall Study||5
8309350|NCT01491633|20486812|P1|COMPLETED|Overall Study||0
8309351|NCT01491633|20486812|P1|STARTED|Overall Study||5
8309352|NCT01491607|20486824|P1|NOT COMPLETED|Overall Study||10
8309353|NCT01491607|20486824|P1|COMPLETED|Overall Study||190
8309354|NCT01491607|20486824|P1|STARTED|Overall Study||200
8309355|NCT01491490|20486922|P2|NOT COMPLETED|Overall Study||0
8309356|NCT01491490|20486923|P1|NOT COMPLETED|Overall Study||0
8309357|NCT01491490|20486922|P2|COMPLETED|Overall Study||1
8309358|NCT01491490|20486923|P1|COMPLETED|Overall Study||1
8309359|NCT01491490|20486922|P2|STARTED|Overall Study||1
8309360|NCT01491490|20486923|P1|STARTED|Overall Study||1
8309361|NCT01491178|20486929|P1|NOT COMPLETED|Overall Study||2794
8309362|NCT01491178|20486929|P1|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
8309363|NCT01491178|20486929|P1|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
8309364|NCT01491113|20486939|P5|NOT COMPLETED|Overall Study||0
8309365|NCT01491113|20486940|P4|NOT COMPLETED|Overall Study||0
8309366|NCT01491113|20486941|P3|NOT COMPLETED|Overall Study||0
8309367|NCT01491113|20486942|P2|NOT COMPLETED|Overall Study||0
8309368|NCT01491113|20486943|P1|NOT COMPLETED|Overall Study||0
8309369|NCT01491113|20486939|P5|COMPLETED|Overall Study||6
8309370|NCT01491113|20486940|P4|COMPLETED|Overall Study||6
8309371|NCT01491113|20486941|P3|COMPLETED|Overall Study||6
8309372|NCT01491113|20486942|P2|COMPLETED|Overall Study||6
8309373|NCT01491113|20486943|P1|COMPLETED|Overall Study||6
8309374|NCT01491113|20486939|P5|STARTED|Overall Study||6
8309375|NCT01491113|20486940|P4|STARTED|Overall Study||6
8309376|NCT01491113|20486941|P3|STARTED|Overall Study||6
8309377|NCT01491113|20486942|P2|STARTED|Overall Study||6
8309378|NCT01491113|20486943|P1|STARTED|Overall Study||6
8309379|NCT01491035|20487038|P8|NOT COMPLETED|Overall Study||0
8309380|NCT01491035|20487039|P7|NOT COMPLETED|Overall Study||0
8309381|NCT01491035|20487040|P6|NOT COMPLETED|Overall Study||0
8309382|NCT01491035|20487041|P5|NOT COMPLETED|Overall Study||1
8309383|NCT01491035|20487042|P4|NOT COMPLETED|Overall Study||0
8309384|NCT01491035|20487043|P3|NOT COMPLETED|Overall Study||0
8309385|NCT01491035|20487044|P2|NOT COMPLETED|Overall Study||0
8309386|NCT01491035|20487045|P1|NOT COMPLETED|Overall Study||0
8309387|NCT01491035|20487038|P8|COMPLETED|Overall Study||6
8309388|NCT01491035|20487039|P7|COMPLETED|Overall Study||6
8309389|NCT01491035|20487040|P6|COMPLETED|Overall Study||6
8309390|NCT01491035|20487041|P5|COMPLETED|Overall Study||5
8309391|NCT01491035|20487042|P4|COMPLETED|Overall Study||6
8309392|NCT01491035|20487043|P3|COMPLETED|Overall Study||6
8309393|NCT01491035|20487044|P2|COMPLETED|Overall Study||6
8309394|NCT01491035|20487045|P1|COMPLETED|Overall Study||6
8309395|NCT01491035|20487038|P8|STARTED|Overall Study||6
8309396|NCT01491035|20487039|P7|STARTED|Overall Study||6
8309397|NCT01491035|20487040|P6|STARTED|Overall Study||6
8309398|NCT01491035|20487041|P5|STARTED|Overall Study||6
8309399|NCT01491035|20487042|P4|STARTED|Overall Study||6
8309400|NCT01491035|20487043|P3|STARTED|Overall Study||6
8309401|NCT01491035|20487044|P2|STARTED|Overall Study||6
8309402|NCT01491035|20487045|P1|STARTED|Overall Study||6
8309403|NCT01491022|20487113|P2|NOT COMPLETED|Intervention 2||0
8309404|NCT01491022|20487114|P1|NOT COMPLETED|Intervention 2||1
8309405|NCT01491022|20487113|P2|COMPLETED|Intervention 2||11
8309406|NCT01491022|20487114|P1|COMPLETED|Intervention 2||8
8309407|NCT01491022|20487113|P2|STARTED|Intervention 2||11
8309408|NCT01491022|20487114|P1|STARTED|Intervention 2||9
8309409|NCT01491022|20487113|P2|NOT COMPLETED|2 Week Washout||0
8309410|NCT01491022|20487114|P1|NOT COMPLETED|2 Week Washout||0
8309411|NCT01491022|20487113|P2|COMPLETED|2 Week Washout||11
8309412|NCT01491022|20487114|P1|COMPLETED|2 Week Washout||9
8309413|NCT01491022|20487113|P2|STARTED|2 Week Washout||11
8309414|NCT01491022|20487114|P1|STARTED|2 Week Washout||9
8309415|NCT01491022|20487113|P2|NOT COMPLETED|Intervention 1||1
8309416|NCT01491022|20487114|P1|NOT COMPLETED|Intervention 1||1
8309417|NCT01491022|20487113|P2|COMPLETED|Intervention 1||11
8309418|NCT01491022|20487114|P1|COMPLETED|Intervention 1||9
8309419|NCT01491022|20487113|P2|STARTED|Intervention 1||12
8309420|NCT01491022|20487114|P1|STARTED|Intervention 1||10
8309421|NCT01490931|20487130|P1|NOT COMPLETED|Overall Study||0
8309422|NCT01490931|20487130|P1|COMPLETED|Overall Study||25
8309423|NCT01490931|20487130|P1|STARTED|Overall Study||25
8309424|NCT01490918|20487149|P3|NOT COMPLETED|Overall Study||12
8309425|NCT01490918|20487150|P2|NOT COMPLETED|Overall Study||14
8309426|NCT01490918|20487151|P1|NOT COMPLETED|Overall Study||13
8309427|NCT01490918|20487149|P3|COMPLETED|Overall Study||22
8309428|NCT01490918|20487150|P2|COMPLETED|Overall Study||52
8309429|NCT01490918|20487151|P1|COMPLETED|Overall Study||52
8309430|NCT01490918|20487149|P3|STARTED|Overall Study||34
8309431|NCT01490918|20487150|P2|STARTED|Overall Study||66
8309432|NCT01490918|20487151|P1|STARTED|Overall Study||65
8309433|NCT01490892|20487184|P1|NOT COMPLETED|Overall Study||0
8309434|NCT01490892|20487184|P1|COMPLETED|Overall Study||219
8309435|NCT01490892|20487184|P1|STARTED|Overall Study||219
8309436|NCT01490866|20487189|P1|NOT COMPLETED|Axitinib Maintenance Therapy||49
8309437|NCT01490866|20487189|P1|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
8309438|NCT01490866|20487189|P1|STARTED|Axitinib Maintenance Therapy||49
8309439|NCT01490866|20487189|P1|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
8309440|NCT01490866|20487189|P1|COMPLETED|FOLFOX/Bevacizumab Treatment||49
8309441|NCT01490866|20487189|P1|STARTED|FOLFOX/Bevacizumab Treatment||70
8309442|NCT01490840|20487200|P2|NOT COMPLETED|Phase 2||6
8309443|NCT01490840|20487201|P1|NOT COMPLETED|Phase 2||6
8309444|NCT01490840|20487200|P2|COMPLETED|Phase 2||68
8309445|NCT01490840|20487201|P1|COMPLETED|Phase 2||75
8309446|NCT01490840|20487200|P2|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
8309447|NCT01490840|20487201|P1|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
8309448|NCT01490840|20487200|P2|NOT COMPLETED|Phase 1||6
8309449|NCT01490840|20487201|P1|NOT COMPLETED|Phase 1||10
8309450|NCT01490840|20487200|P2|COMPLETED|Phase 1||78
8309451|NCT01490840|20487201|P1|COMPLETED|Phase 1||84
8309452|NCT01490840|20487200|P2|Modified Full Analysis Set|Phase 1||83
8309453|NCT01490840|20487201|P1|Modified Full Analysis Set|Phase 1||56
8309454|NCT01490840|20487200|P2|STARTED|Phase 1||84
8309455|NCT01490840|20487201|P1|STARTED|Phase 1||94
8309456|NCT01490814|20487225|P2|NOT COMPLETED|Overall Study||8
8309457|NCT01490814|20487226|P1|NOT COMPLETED|Overall Study||4
8309458|NCT01490814|20487225|P2|COMPLETED|Overall Study|376 received ablation|376
8309459|NCT01490814|20487226|P1|COMPLETED|Overall Study|374 received ablation|374
8309460|NCT01490814|20487225|P2|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
8309461|NCT01490814|20487226|P1|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
8309462|NCT01490788|20487246|P6|NOT COMPLETED|Overall Study||0
8309463|NCT01490788|20487247|P5|NOT COMPLETED|Overall Study||0
8309464|NCT01490788|20487248|P4|NOT COMPLETED|Overall Study||0
8309465|NCT01490788|20487249|P3|NOT COMPLETED|Overall Study||0
8309466|NCT01490788|20487250|P2|NOT COMPLETED|Overall Study||0
8309467|NCT01490788|20487251|P1|NOT COMPLETED|Overall Study||1
8309468|NCT01490788|20487246|P6|COMPLETED|Overall Study||5
8309469|NCT01490788|20487247|P5|COMPLETED|Overall Study||5
8309470|NCT01490788|20487248|P4|COMPLETED|Overall Study||5
8309471|NCT01490788|20487249|P3|COMPLETED|Overall Study||5
8309472|NCT01490788|20487250|P2|COMPLETED|Overall Study||5
8309473|NCT01490788|20487251|P1|COMPLETED|Overall Study||4
8309474|NCT01490788|20487246|P6|STARTED|Overall Study||5
8309475|NCT01490788|20487247|P5|STARTED|Overall Study||5
8309476|NCT01490788|20487248|P4|STARTED|Overall Study||5
8309477|NCT01490788|20487249|P3|STARTED|Overall Study||5
8309478|NCT01490788|20487250|P2|STARTED|Overall Study||5
8309479|NCT01490788|20487251|P1|STARTED|Overall Study||5
8309480|NCT01490723|20487262|P1|NOT COMPLETED|Overall Study||0
8309481|NCT01490723|20487262|P1|COMPLETED|Overall Study||20
8309482|NCT01490723|20487262|P1|STARTED|Overall Study||20
8309483|NCT01490697|20487269|P2|NOT COMPLETED|Overall Study||2
8309484|NCT01490697|20487270|P1|NOT COMPLETED|Overall Study||1
8309485|NCT01490697|20487269|P2|COMPLETED|Overall Study||16
8309486|NCT01490697|20487270|P1|COMPLETED|Overall Study||15
8309487|NCT01490697|20487269|P2|STARTED|Overall Study||18
8309488|NCT01490697|20487270|P1|STARTED|Overall Study||16
8309489|NCT01490684|20487278|P1|NOT COMPLETED|Overall Study||0
8309490|NCT01490684|20487278|P1|COMPLETED|Overall Study||162
8309491|NCT01490684|20487278|P1|STARTED|Overall Study||162
8309492|NCT01490632|20487290|P20|NOT COMPLETED|Part D: Re-Treatment Period||7
8309493|NCT01490632|20487291|P19|NOT COMPLETED|Part D: Re-Treatment Period||7
8309494|NCT01490632|20487292|P18|NOT COMPLETED|Part D: Re-Treatment Period||5
8309495|NCT01490632|20487293|P17|NOT COMPLETED|Part D: Re-Treatment Period||0
8309496|NCT01490632|20487294|P16|NOT COMPLETED|Part D: Re-Treatment Period||0
8309497|NCT01490632|20487295|P15|NOT COMPLETED|Part D: Re-Treatment Period||0
8309498|NCT01490632|20487296|P14|NOT COMPLETED|Part D: Re-Treatment Period||0
8309499|NCT01490632|20487297|P13|NOT COMPLETED|Part D: Re-Treatment Period||0
8309500|NCT01490632|20487298|P12|NOT COMPLETED|Part D: Re-Treatment Period||0
8309501|NCT01490632|20487299|P11|NOT COMPLETED|Part D: Re-Treatment Period||0
8309502|NCT01490632|20487300|P10|NOT COMPLETED|Part D: Re-Treatment Period||0
8309503|NCT01490632|20487301|P9|NOT COMPLETED|Part D: Re-Treatment Period||0
8309504|NCT01490632|20487302|P8|NOT COMPLETED|Part D: Re-Treatment Period||0
8309505|NCT01490632|20487303|P7|NOT COMPLETED|Part D: Re-Treatment Period||0
8309506|NCT01490632|20487304|P6|NOT COMPLETED|Part D: Re-Treatment Period||0
8309507|NCT01490632|20487305|P5|NOT COMPLETED|Part D: Re-Treatment Period||0
8309508|NCT01490632|20487306|P4|NOT COMPLETED|Part D: Re-Treatment Period||0
8309509|NCT01490632|20487307|P3|NOT COMPLETED|Part D: Re-Treatment Period||0
8309510|NCT01490632|20487308|P2|NOT COMPLETED|Part D: Re-Treatment Period||0
8309511|NCT01490632|20487309|P1|NOT COMPLETED|Part D: Re-Treatment Period||0
8309512|NCT01490632|20487290|P20|COMPLETED|Part D: Re-Treatment Period||30
8309513|NCT01490632|20487291|P19|COMPLETED|Part D: Re-Treatment Period||12
8309514|NCT01490632|20487292|P18|COMPLETED|Part D: Re-Treatment Period||8
8309515|NCT01490632|20487293|P17|COMPLETED|Part D: Re-Treatment Period||3
8309516|NCT01490632|20487294|P16|COMPLETED|Part D: Re-Treatment Period||0
8309517|NCT01490632|20487295|P15|COMPLETED|Part D: Re-Treatment Period||0
8309518|NCT01490632|20487296|P14|COMPLETED|Part D: Re-Treatment Period||0
8309519|NCT01490632|20487297|P13|COMPLETED|Part D: Re-Treatment Period||0
8309520|NCT01490632|20487298|P12|COMPLETED|Part D: Re-Treatment Period||0
8309521|NCT01490632|20487299|P11|COMPLETED|Part D: Re-Treatment Period||0
8309522|NCT01490632|20487300|P10|COMPLETED|Part D: Re-Treatment Period||0
8309523|NCT01490632|20487301|P9|COMPLETED|Part D: Re-Treatment Period||0
8309524|NCT01490632|20487302|P8|COMPLETED|Part D: Re-Treatment Period||0
8309525|NCT01490632|20487303|P7|COMPLETED|Part D: Re-Treatment Period||0
8309526|NCT01490632|20487304|P6|COMPLETED|Part D: Re-Treatment Period||0
8309527|NCT01490632|20487305|P5|COMPLETED|Part D: Re-Treatment Period||0
8309528|NCT01490632|20487306|P4|COMPLETED|Part D: Re-Treatment Period||0
8309529|NCT01490632|20487307|P3|COMPLETED|Part D: Re-Treatment Period||0
8309530|NCT01490632|20487308|P2|COMPLETED|Part D: Re-Treatment Period||0
8309531|NCT01490632|20487309|P1|COMPLETED|Part D: Re-Treatment Period||0
8309532|NCT01490632|20487290|P20|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
8309533|NCT01490632|20487291|P19|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
8309534|NCT01490632|20487292|P18|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
8309535|NCT01490632|20487293|P17|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
8309536|NCT01490632|20487294|P16|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
8309537|NCT01490632|20487295|P15|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
8309538|NCT01490632|20487296|P14|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
8309539|NCT01490632|20487297|P13|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
8309540|NCT01490632|20487298|P12|STARTED|Part D: Re-Treatment Period||0
8309541|NCT01490632|20487299|P11|STARTED|Part D: Re-Treatment Period||0
8309542|NCT01490632|20487300|P10|STARTED|Part D: Re-Treatment Period||0
8309543|NCT01490632|20487301|P9|STARTED|Part D: Re-Treatment Period||0
8309544|NCT01490632|20487302|P8|STARTED|Part D: Re-Treatment Period||0
8309545|NCT01490632|20487303|P7|STARTED|Part D: Re-Treatment Period||0
8309546|NCT01490632|20487304|P6|STARTED|Part D: Re-Treatment Period||0
8309547|NCT01490632|20487305|P5|STARTED|Part D: Re-Treatment Period||0
8309548|NCT01490632|20487306|P4|STARTED|Part D: Re-Treatment Period||0
8309549|NCT01490632|20487307|P3|STARTED|Part D: Re-Treatment Period||0
8309550|NCT01490632|20487308|P2|STARTED|Part D: Re-Treatment Period||0
8309551|NCT01490632|20487309|P1|STARTED|Part D: Re-Treatment Period||0
8309552|NCT01490632|20487290|P20|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309553|NCT01490632|20487291|P19|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309554|NCT01490632|20487292|P18|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309555|NCT01490632|20487293|P17|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309556|NCT01490632|20487294|P16|NOT COMPLETED|Part C: Washout or Step-Down Period||37
8309557|NCT01490632|20487295|P15|NOT COMPLETED|Part C: Washout or Step-Down Period||18
8309558|NCT01490632|20487296|P14|NOT COMPLETED|Part C: Washout or Step-Down Period||10
8309559|NCT01490632|20487297|P13|NOT COMPLETED|Part C: Washout or Step-Down Period||5
8309560|NCT01490632|20487298|P12|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309561|NCT01490632|20487299|P11|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309562|NCT01490632|20487300|P10|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309563|NCT01490632|20487301|P9|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309564|NCT01490632|20487302|P8|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309565|NCT01490632|20487303|P7|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309566|NCT01490632|20487304|P6|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309567|NCT01490632|20487305|P5|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309568|NCT01490632|20487306|P4|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309569|NCT01490632|20487307|P3|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309570|NCT01490632|20487308|P2|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309571|NCT01490632|20487309|P1|NOT COMPLETED|Part C: Washout or Step-Down Period||0
8309572|NCT01490632|20487290|P20|COMPLETED|Part C: Washout or Step-Down Period||0
8309573|NCT01490632|20487291|P19|COMPLETED|Part C: Washout or Step-Down Period||0
8309574|NCT01490632|20487292|P18|COMPLETED|Part C: Washout or Step-Down Period||0
8309575|NCT01490632|20487293|P17|COMPLETED|Part C: Washout or Step-Down Period||0
8309576|NCT01490632|20487294|P16|COMPLETED|Part C: Washout or Step-Down Period||18
8309577|NCT01490632|20487295|P15|COMPLETED|Part C: Washout or Step-Down Period||37
8309578|NCT01490632|20487296|P14|COMPLETED|Part C: Washout or Step-Down Period||6
8309579|NCT01490632|20487297|P13|COMPLETED|Part C: Washout or Step-Down Period||10
8309580|NCT01490632|20487298|P12|COMPLETED|Part C: Washout or Step-Down Period||0
8309581|NCT01490632|20487299|P11|COMPLETED|Part C: Washout or Step-Down Period||0
8309582|NCT01490632|20487300|P10|COMPLETED|Part C: Washout or Step-Down Period||0
8309583|NCT01490632|20487301|P9|COMPLETED|Part C: Washout or Step-Down Period||0
8309584|NCT01490632|20487302|P8|COMPLETED|Part C: Washout or Step-Down Period||0
8309585|NCT01490632|20487303|P7|COMPLETED|Part C: Washout or Step-Down Period||0
8309586|NCT01490632|20487304|P6|COMPLETED|Part C: Washout or Step-Down Period||0
8309587|NCT01490632|20487305|P5|COMPLETED|Part C: Washout or Step-Down Period||0
8309588|NCT01490632|20487306|P4|COMPLETED|Part C: Washout or Step-Down Period||0
8309589|NCT01490632|20487307|P3|COMPLETED|Part C: Washout or Step-Down Period||0
8309590|NCT01490632|20487308|P2|COMPLETED|Part C: Washout or Step-Down Period||0
8309591|NCT01490632|20487309|P1|COMPLETED|Part C: Washout or Step-Down Period||0
8309592|NCT01490632|20487290|P20|STARTED|Part C: Washout or Step-Down Period||0
8309593|NCT01490632|20487291|P19|STARTED|Part C: Washout or Step-Down Period||0
8309594|NCT01490632|20487292|P18|STARTED|Part C: Washout or Step-Down Period||0
8309595|NCT01490632|20487293|P17|STARTED|Part C: Washout or Step-Down Period||0
8309596|NCT01490632|20487294|P16|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
8309597|NCT01490632|20487295|P15|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
8309598|NCT01490632|20487296|P14|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
8309599|NCT01490632|20487297|P13|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
8309600|NCT01490632|20487298|P12|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
8309601|NCT01490632|20487299|P11|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
8309602|NCT01490632|20487300|P10|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
8309603|NCT01490632|20487301|P9|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
8309604|NCT01490632|20487302|P8|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
8309605|NCT01490632|20487303|P7|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
8309606|NCT01490632|20487304|P6|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
8309607|NCT01490632|20487305|P5|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
8309608|NCT01490632|20487306|P4|STARTED|Part C: Washout or Step-Down Period||0
8309609|NCT01490632|20487307|P3|STARTED|Part C: Washout or Step-Down Period||0
8309610|NCT01490632|20487308|P2|STARTED|Part C: Washout or Step-Down Period||0
8309611|NCT01490632|20487309|P1|STARTED|Part C: Washout or Step-Down Period||0
8309612|NCT01490632|20487290|P20|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309613|NCT01490632|20487291|P19|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309614|NCT01490632|20487292|P18|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309615|NCT01490632|20487293|P17|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309616|NCT01490632|20487294|P16|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309617|NCT01490632|20487295|P15|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309618|NCT01490632|20487296|P14|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309619|NCT01490632|20487297|P13|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309620|NCT01490632|20487298|P12|NOT COMPLETED|Part B: Extension or Step-Up Period||8
8309621|NCT01490632|20487299|P11|NOT COMPLETED|Part B: Extension or Step-Up Period||21
8309622|NCT01490632|20487300|P10|NOT COMPLETED|Part B: Extension or Step-Up Period||25
8309623|NCT01490632|20487301|P9|NOT COMPLETED|Part B: Extension or Step-Up Period||10
8309624|NCT01490632|20487302|P8|NOT COMPLETED|Part B: Extension or Step-Up Period||6
8309625|NCT01490632|20487303|P7|NOT COMPLETED|Part B: Extension or Step-Up Period||13
8309626|NCT01490632|20487304|P6|NOT COMPLETED|Part B: Extension or Step-Up Period||4
8309627|NCT01490632|20487305|P5|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309628|NCT01490632|20487306|P4|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309629|NCT01490632|20487307|P3|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309630|NCT01490632|20487308|P2|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309631|NCT01490632|20487309|P1|NOT COMPLETED|Part B: Extension or Step-Up Period||0
8309632|NCT01490632|20487290|P20|COMPLETED|Part B: Extension or Step-Up Period||0
8309633|NCT01490632|20487291|P19|COMPLETED|Part B: Extension or Step-Up Period||0
8309634|NCT01490632|20487292|P18|COMPLETED|Part B: Extension or Step-Up Period||0
8309635|NCT01490632|20487293|P17|COMPLETED|Part B: Extension or Step-Up Period||0
8309636|NCT01490632|20487294|P16|COMPLETED|Part B: Extension or Step-Up Period||0
8309637|NCT01490632|20487295|P15|COMPLETED|Part B: Extension or Step-Up Period||0
8309638|NCT01490632|20487296|P14|COMPLETED|Part B: Extension or Step-Up Period||0
8309639|NCT01490632|20487297|P13|COMPLETED|Part B: Extension or Step-Up Period||0
8309640|NCT01490632|20487298|P12|COMPLETED|Part B: Extension or Step-Up Period||0
8309641|NCT01490632|20487299|P11|COMPLETED|Part B: Extension or Step-Up Period||22
8309642|NCT01490632|20487300|P10|COMPLETED|Part B: Extension or Step-Up Period||25
8309643|NCT01490632|20487301|P9|COMPLETED|Part B: Extension or Step-Up Period||6
8309644|NCT01490632|20487302|P8|COMPLETED|Part B: Extension or Step-Up Period||13
8309645|NCT01490632|20487303|P7|COMPLETED|Part B: Extension or Step-Up Period||51
8309646|NCT01490632|20487304|P6|COMPLETED|Part B: Extension or Step-Up Period||25
8309647|NCT01490632|20487305|P5|COMPLETED|Part B: Extension or Step-Up Period||0
8309648|NCT01490632|20487306|P4|COMPLETED|Part B: Extension or Step-Up Period||0
8309649|NCT01490632|20487307|P3|COMPLETED|Part B: Extension or Step-Up Period||0
8309650|NCT01490632|20487308|P2|COMPLETED|Part B: Extension or Step-Up Period||0
8309651|NCT01490632|20487309|P1|COMPLETED|Part B: Extension or Step-Up Period||0
8309652|NCT01490632|20487290|P20|STARTED|Part B: Extension or Step-Up Period||0
8309653|NCT01490632|20487291|P19|STARTED|Part B: Extension or Step-Up Period||0
8309654|NCT01490632|20487292|P18|STARTED|Part B: Extension or Step-Up Period||0
8309655|NCT01490632|20487293|P17|STARTED|Part B: Extension or Step-Up Period||0
8309656|NCT01490632|20487294|P16|STARTED|Part B: Extension or Step-Up Period||0
8309657|NCT01490632|20487295|P15|STARTED|Part B: Extension or Step-Up Period||0
8309658|NCT01490632|20487296|P14|STARTED|Part B: Extension or Step-Up Period||0
8309659|NCT01490632|20487297|P13|STARTED|Part B: Extension or Step-Up Period||0
8309660|NCT01490632|20487298|P12|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
8309661|NCT01490632|20487299|P11|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
8309662|NCT01490632|20487300|P10|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
8309663|NCT01490632|20487301|P9|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
8309664|NCT01490632|20487302|P8|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
8309665|NCT01490632|20487303|P7|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
8309666|NCT01490632|20487304|P6|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
8309667|NCT01490632|20487305|P5|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8309668|NCT01490632|20487306|P4|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8309669|NCT01490632|20487307|P3|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8309670|NCT01490632|20487308|P2|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8309671|NCT01490632|20487309|P1|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
8309672|NCT01490632|20487290|P20|NOT COMPLETED|Part A: Initial Treatment Period||0
8309673|NCT01490632|20487291|P19|NOT COMPLETED|Part A: Initial Treatment Period||0
8309674|NCT01490632|20487292|P18|NOT COMPLETED|Part A: Initial Treatment Period||0
8309675|NCT01490632|20487293|P17|NOT COMPLETED|Part A: Initial Treatment Period||0
8309676|NCT01490632|20487294|P16|NOT COMPLETED|Part A: Initial Treatment Period||0
8309677|NCT01490632|20487295|P15|NOT COMPLETED|Part A: Initial Treatment Period||0
8309678|NCT01490632|20487296|P14|NOT COMPLETED|Part A: Initial Treatment Period||0
8309679|NCT01490632|20487297|P13|NOT COMPLETED|Part A: Initial Treatment Period||0
8309680|NCT01490632|20487298|P12|NOT COMPLETED|Part A: Initial Treatment Period||0
8309681|NCT01490632|20487299|P11|NOT COMPLETED|Part A: Initial Treatment Period||0
8309682|NCT01490632|20487300|P10|NOT COMPLETED|Part A: Initial Treatment Period||0
8309683|NCT01490632|20487301|P9|NOT COMPLETED|Part A: Initial Treatment Period||0
8309684|NCT01490632|20487302|P8|NOT COMPLETED|Part A: Initial Treatment Period||0
8309685|NCT01490632|20487303|P7|NOT COMPLETED|Part A: Initial Treatment Period||0
8309686|NCT01490632|20487304|P6|NOT COMPLETED|Part A: Initial Treatment Period||0
8309687|NCT01490632|20487305|P5|NOT COMPLETED|Part A: Initial Treatment Period||17
8309688|NCT01490632|20487306|P4|NOT COMPLETED|Part A: Initial Treatment Period||9
8309689|NCT01490632|20487307|P3|NOT COMPLETED|Part A: Initial Treatment Period||5
8309690|NCT01490632|20487308|P2|NOT COMPLETED|Part A: Initial Treatment Period||4
8309691|NCT01490632|20487309|P1|NOT COMPLETED|Part A: Initial Treatment Period||7
8309692|NCT01490632|20487290|P20|COMPLETED|Part A: Initial Treatment Period||0
8309693|NCT01490632|20487291|P19|COMPLETED|Part A: Initial Treatment Period||0
8309694|NCT01490632|20487292|P18|COMPLETED|Part A: Initial Treatment Period||0
8309695|NCT01490632|20487293|P17|COMPLETED|Part A: Initial Treatment Period||0
8309696|NCT01490632|20487294|P16|COMPLETED|Part A: Initial Treatment Period||0
8309697|NCT01490632|20487295|P15|COMPLETED|Part A: Initial Treatment Period||0
8309698|NCT01490632|20487296|P14|COMPLETED|Part A: Initial Treatment Period||0
8309699|NCT01490632|20487297|P13|COMPLETED|Part A: Initial Treatment Period||0
8309700|NCT01490632|20487298|P12|COMPLETED|Part A: Initial Treatment Period||0
8309701|NCT01490632|20487299|P11|COMPLETED|Part A: Initial Treatment Period||0
8309702|NCT01490632|20487300|P10|COMPLETED|Part A: Initial Treatment Period||0
8309703|NCT01490632|20487301|P9|COMPLETED|Part A: Initial Treatment Period||0
8309704|NCT01490632|20487302|P8|COMPLETED|Part A: Initial Treatment Period||0
8309705|NCT01490632|20487303|P7|COMPLETED|Part A: Initial Treatment Period||0
8309706|NCT01490632|20487304|P6|COMPLETED|Part A: Initial Treatment Period||0
8309707|NCT01490632|20487305|P5|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
8309708|NCT01490632|20487306|P4|COMPLETED|Part A: Initial Treatment Period||55
8309709|NCT01490632|20487307|P3|COMPLETED|Part A: Initial Treatment Period||67
8309710|NCT01490632|20487308|P2|COMPLETED|Part A: Initial Treatment Period||28
8309711|NCT01490632|20487309|P1|COMPLETED|Part A: Initial Treatment Period||27
8309712|NCT01490632|20487290|P20|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309713|NCT01490632|20487291|P19|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309714|NCT01490632|20487292|P18|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309715|NCT01490632|20487293|P17|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309716|NCT01490632|20487294|P16|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309717|NCT01490632|20487295|P15|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309718|NCT01490632|20487296|P14|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309719|NCT01490632|20487297|P13|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309720|NCT01490632|20487298|P12|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309721|NCT01490632|20487299|P11|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309722|NCT01490632|20487300|P10|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309723|NCT01490632|20487301|P9|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309724|NCT01490632|20487302|P8|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309725|NCT01490632|20487303|P7|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309726|NCT01490632|20487304|P6|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
8309727|NCT01490632|20487305|P5|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
8309728|NCT01490632|20487306|P4|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
8309729|NCT01490632|20487307|P3|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
8309730|NCT01490632|20487308|P2|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
8309731|NCT01490632|20487309|P1|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
8309732|NCT01490632|20487290|P20|STARTED|Part A: Initial Treatment Period||0
8309733|NCT01490632|20487291|P19|STARTED|Part A: Initial Treatment Period||0
8309734|NCT01490632|20487292|P18|STARTED|Part A: Initial Treatment Period||0
8309735|NCT01490632|20487293|P17|STARTED|Part A: Initial Treatment Period||0
8309736|NCT01490632|20487294|P16|STARTED|Part A: Initial Treatment Period||0
8309737|NCT01490632|20487295|P15|STARTED|Part A: Initial Treatment Period||0
8309738|NCT01490632|20487296|P14|STARTED|Part A: Initial Treatment Period||0
8309739|NCT01490632|20487297|P13|STARTED|Part A: Initial Treatment Period||0
8309740|NCT01490632|20487298|P12|STARTED|Part A: Initial Treatment Period||0
8309741|NCT01490632|20487299|P11|STARTED|Part A: Initial Treatment Period||0
8309742|NCT01490632|20487300|P10|STARTED|Part A: Initial Treatment Period||0
8309743|NCT01490632|20487301|P9|STARTED|Part A: Initial Treatment Period||0
8309744|NCT01490632|20487302|P8|STARTED|Part A: Initial Treatment Period||0
8309745|NCT01490632|20487303|P7|STARTED|Part A: Initial Treatment Period||0
8309746|NCT01490632|20487304|P6|STARTED|Part A: Initial Treatment Period||0
8309747|NCT01490632|20487305|P5|STARTED|Part A: Initial Treatment Period||69
8309748|NCT01490632|20487306|P4|STARTED|Part A: Initial Treatment Period||64
8309749|NCT01490632|20487307|P3|STARTED|Part A: Initial Treatment Period||72
8309750|NCT01490632|20487308|P2|STARTED|Part A: Initial Treatment Period||32
8309751|NCT01490632|20487309|P1|STARTED|Part A: Initial Treatment Period||34
8309758|NCT01490359|20487462|P2|NOT COMPLETED|Overall Study||17
8309759|NCT01490359|20487463|P1|NOT COMPLETED|Overall Study||24
8309760|NCT01490359|20487462|P2|COMPLETED|Overall Study||555
8309761|NCT01490359|20487463|P1|COMPLETED|Overall Study||585
8309762|NCT01490359|20487462|P2|Followed-up at 12 mo|Overall Study||537
8309763|NCT01490359|20487463|P1|Followed-up at 12 mo|Overall Study||569
8309764|NCT01490359|20487462|P2|Followed-up at 6 mo|Overall Study||535
8309765|NCT01490359|20487463|P1|Followed-up at 6 mo|Overall Study||558
8309766|NCT01490359|20487462|P2|STARTED|Overall Study||572
8309767|NCT01490359|20487463|P1|STARTED|Overall Study||609
8309768|NCT01490294|20487487|P4|NOT COMPLETED|Overall Study||1
8309769|NCT01490294|20487488|P3|NOT COMPLETED|Overall Study||1
8309770|NCT01490294|20487489|P2|NOT COMPLETED|Overall Study||0
8309771|NCT01490294|20487490|P1|NOT COMPLETED|Overall Study||5
8309772|NCT01490294|20487487|P4|COMPLETED|Overall Study||54
8309773|NCT01490294|20487488|P3|COMPLETED|Overall Study||58
8309774|NCT01490294|20487489|P2|COMPLETED|Overall Study||60
8309775|NCT01490294|20487490|P1|COMPLETED|Overall Study||53
8309776|NCT01490294|20487487|P4|Participant Received Treatment|Overall Study||54
8309777|NCT01490294|20487488|P3|Participant Received Treatment|Overall Study||58
8309778|NCT01490294|20487489|P2|Participant Received Treatment|Overall Study||60
8309779|NCT01490294|20487490|P1|Participant Received Treatment|Overall Study||54
8309780|NCT01490294|20487487|P4|STARTED|Overall Study||55
8309781|NCT01490294|20487488|P3|STARTED|Overall Study||59
8309782|NCT01490294|20487489|P2|STARTED|Overall Study||60
8309783|NCT01490294|20487490|P1|STARTED|Overall Study||58
8309784|NCT01490190|20487724|P1|NOT COMPLETED|Overall Study||48
8309785|NCT01490190|20487724|P1|COMPLETED|Overall Study||204
8309786|NCT01490190|20487724|P1|STARTED|Overall Study||252
8309787|NCT01490151|20487745|P1|NOT COMPLETED|Overall Study||0
8309788|NCT01490151|20487745|P1|COMPLETED|Overall Study||22
8309789|NCT01490151|20487745|P1|STARTED|Overall Study||22
8309790|NCT01490125|20487751|P6|NOT COMPLETED|Period III||0
8309791|NCT01490125|20487752|P5|NOT COMPLETED|Period III||1
8309792|NCT01490125|20487753|P4|NOT COMPLETED|Period III||2
8309793|NCT01490125|20487754|P3|NOT COMPLETED|Period III||0
8309794|NCT01490125|20487755|P2|NOT COMPLETED|Period III||1
8309795|NCT01490125|20487756|P1|NOT COMPLETED|Period III||3
8309796|NCT01490125|20487751|P6|COMPLETED|Period III||35
8309797|NCT01490125|20487752|P5|COMPLETED|Period III||31
8309798|NCT01490125|20487753|P4|COMPLETED|Period III||28
8309799|NCT01490125|20487754|P3|COMPLETED|Period III||34
8309800|NCT01490125|20487755|P2|COMPLETED|Period III||32
8309801|NCT01490125|20487756|P1|COMPLETED|Period III||31
8309802|NCT01490125|20487751|P6|STARTED|Period III||35
8309803|NCT01490125|20487752|P5|STARTED|Period III||32
8309804|NCT01490125|20487753|P4|STARTED|Period III||30
8309805|NCT01490125|20487754|P3|STARTED|Period III||34
8309806|NCT01490125|20487755|P2|STARTED|Period III||33
8309807|NCT01490125|20487756|P1|STARTED|Period III||34
8309808|NCT01490125|20487751|P6|NOT COMPLETED|Period II||2
8309809|NCT01490125|20487752|P5|NOT COMPLETED|Period II||4
8309810|NCT01490125|20487753|P4|NOT COMPLETED|Period II||3
8309811|NCT01490125|20487754|P3|NOT COMPLETED|Period II||3
8309812|NCT01490125|20487755|P2|NOT COMPLETED|Period II||4
8309813|NCT01490125|20487756|P1|NOT COMPLETED|Period II||3
8309814|NCT01490125|20487751|P6|COMPLETED|Period II||35
8309815|NCT01490125|20487752|P5|COMPLETED|Period II||32
8309816|NCT01490125|20487753|P4|COMPLETED|Period II||30
8309817|NCT01490125|20487754|P3|COMPLETED|Period II||34
8309818|NCT01490125|20487755|P2|COMPLETED|Period II||33
8309819|NCT01490125|20487756|P1|COMPLETED|Period II||34
8309820|NCT01490125|20487751|P6|STARTED|Period II||37
8309821|NCT01490125|20487752|P5|STARTED|Period II||36
8309822|NCT01490125|20487753|P4|STARTED|Period II||33
8309823|NCT01490125|20487754|P3|STARTED|Period II||37
8309824|NCT01490125|20487755|P2|STARTED|Period II||37
8309825|NCT01490125|20487756|P1|STARTED|Period II||37
8309826|NCT01490125|20487751|P6|NOT COMPLETED|Period I||5
8309827|NCT01490125|20487752|P5|NOT COMPLETED|Period I||4
8309828|NCT01490125|20487753|P4|NOT COMPLETED|Period I||5
8309829|NCT01490125|20487754|P3|NOT COMPLETED|Period I||4
8309830|NCT01490125|20487755|P2|NOT COMPLETED|Period I||5
8309831|NCT01490125|20487756|P1|NOT COMPLETED|Period I||6
8309832|NCT01490125|20487751|P6|COMPLETED|Period I||37
8309833|NCT01490125|20487752|P5|COMPLETED|Period I||36
8309834|NCT01490125|20487753|P4|COMPLETED|Period I||33
8309835|NCT01490125|20487754|P3|COMPLETED|Period I||37
8309836|NCT01490125|20487755|P2|COMPLETED|Period I||37
8309837|NCT01490125|20487756|P1|COMPLETED|Period I||37
8309838|NCT01490125|20487751|P6|STARTED|Period I||42
8309839|NCT01490125|20487752|P5|STARTED|Period I||40
8309840|NCT01490125|20487753|P4|STARTED|Period I||38
8309841|NCT01490125|20487754|P3|STARTED|Period I||41
8309842|NCT01490125|20487755|P2|STARTED|Period I||42
8309843|NCT01490125|20487756|P1|STARTED|Period I||43
8309844|NCT01490086|20487784|P5|NOT COMPLETED|Overall Study||11
8309845|NCT01490086|20487785|P4|NOT COMPLETED|Overall Study||7
8309846|NCT01490086|20487786|P3|NOT COMPLETED|Overall Study||7
8309847|NCT01490086|20487787|P2|NOT COMPLETED|Overall Study||15
8309848|NCT01490086|20487788|P1|NOT COMPLETED|Overall Study||8
8309849|NCT01490086|20487784|P5|COMPLETED|Overall Study||28
8309850|NCT01490086|20487785|P4|COMPLETED|Overall Study||13
8309851|NCT01490086|20487786|P3|COMPLETED|Overall Study||51
8309852|NCT01490086|20487787|P2|COMPLETED|Overall Study||44
8309853|NCT01490086|20487788|P1|COMPLETED|Overall Study||50
8309854|NCT01490086|20487784|P5|STARTED|Overall Study||39
8309855|NCT01490086|20487785|P4|STARTED|Overall Study||20
8309856|NCT01490086|20487786|P3|STARTED|Overall Study||58
8309857|NCT01490086|20487787|P2|STARTED|Overall Study||59
8309858|NCT01490086|20487788|P1|STARTED|Overall Study||58
8309859|NCT01490073|20487822|P2|NOT COMPLETED|Overall Study||0
8309860|NCT01490073|20487823|P1|NOT COMPLETED|Overall Study||0
8309861|NCT01490073|20487822|P2|COMPLETED|Overall Study||12
8309862|NCT01490073|20487823|P1|COMPLETED|Overall Study||12
8309863|NCT01490073|20487822|P2|STARTED|Overall Study||12
8309864|NCT01490073|20487823|P1|STARTED|Overall Study||12
8309865|NCT01490060|20487833|P4|NOT COMPLETED|Cycle 2||0
8309866|NCT01490060|20487834|P3|NOT COMPLETED|Cycle 2||1
8309867|NCT01490060|20487835|P2|NOT COMPLETED|Cycle 2||1
8309868|NCT01490060|20487836|P1|NOT COMPLETED|Cycle 2||2
8309869|NCT01490060|20487833|P4|COMPLETED|Cycle 2||8
8309870|NCT01490060|20487834|P3|COMPLETED|Cycle 2||8
8309871|NCT01490060|20487835|P2|COMPLETED|Cycle 2||11
8309872|NCT01490060|20487836|P1|COMPLETED|Cycle 2||9
8309873|NCT01490060|20487833|P4|STARTED|Cycle 2||8
8309874|NCT01490060|20487834|P3|STARTED|Cycle 2||9
8309875|NCT01490060|20487835|P2|STARTED|Cycle 2||12
8309876|NCT01490060|20487836|P1|STARTED|Cycle 2||11
8309877|NCT01490060|20487833|P4|NOT COMPLETED|Cycle 1||3
8309878|NCT01490060|20487834|P3|NOT COMPLETED|Cycle 1||3
8309879|NCT01490060|20487835|P2|NOT COMPLETED|Cycle 1||1
8309880|NCT01490060|20487836|P1|NOT COMPLETED|Cycle 1||0
8309881|NCT01490060|20487833|P4|COMPLETED|Cycle 1||8
8309882|NCT01490060|20487834|P3|COMPLETED|Cycle 1||9
8309883|NCT01490060|20487835|P2|COMPLETED|Cycle 1||12
8309884|NCT01490060|20487836|P1|COMPLETED|Cycle 1||11
8309885|NCT01490060|20487833|P4|STARTED|Cycle 1||11
8309886|NCT01490060|20487834|P3|STARTED|Cycle 1||12
8309887|NCT01490060|20487835|P2|STARTED|Cycle 1||13
8309888|NCT01490060|20487836|P1|STARTED|Cycle 1||11
8309889|NCT01489969|20487847|P3|NOT COMPLETED|Overall Study||1
8309890|NCT01489969|20487848|P2|NOT COMPLETED|Overall Study||4
8309891|NCT01489969|20487849|P1|NOT COMPLETED|Overall Study||5
8309892|NCT01489969|20487847|P3|COMPLETED|Overall Study||44
8309893|NCT01489969|20487848|P2|COMPLETED|Overall Study||43
8309894|NCT01489969|20487849|P1|COMPLETED|Overall Study||40
8309895|NCT01489969|20487847|P3|STARTED|Overall Study||45
8309896|NCT01489969|20487848|P2|STARTED|Overall Study||47
8309897|NCT01489969|20487849|P1|STARTED|Overall Study||45
8309898|NCT01489956|20487865|P3|NOT COMPLETED|Overall Study||1
8309899|NCT01489956|20487866|P2|NOT COMPLETED|Overall Study||0
8309900|NCT01489956|20487867|P1|NOT COMPLETED|Overall Study||1
8309901|NCT01489956|20487865|P3|COMPLETED|Overall Study||5
8309902|NCT01489956|20487866|P2|COMPLETED|Overall Study||0
8309903|NCT01489956|20487867|P1|COMPLETED|Overall Study||12
8309904|NCT01489956|20487865|P3|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
8309905|NCT01489956|20487866|P2|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
8309906|NCT01489956|20487867|P1|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
8309907|NCT01489891|20487904|P2|NOT COMPLETED|Overall Study||0
8309908|NCT01489891|20487905|P1|NOT COMPLETED|Overall Study||1
8309909|NCT01489891|20487904|P2|COMPLETED|Overall Study||60
8309910|NCT01489891|20487905|P1|COMPLETED|Overall Study||59
8309911|NCT01489891|20487904|P2|STARTED|Overall Study||60
8309912|NCT01489891|20487905|P1|STARTED|Overall Study||60
8309913|NCT01489826|20487926|P9|NOT COMPLETED|Overall Study||0
8309914|NCT01489826|20487927|P8|NOT COMPLETED|Overall Study||0
8309915|NCT01489826|20487928|P7|NOT COMPLETED|Overall Study||0
8309916|NCT01489826|20487929|P6|NOT COMPLETED|Overall Study||0
8309917|NCT01489826|20487930|P5|NOT COMPLETED|Overall Study||0
8309918|NCT01489826|20487931|P4|NOT COMPLETED|Overall Study||0
8309919|NCT01489826|20487932|P3|NOT COMPLETED|Overall Study||0
8309920|NCT01489826|20487933|P2|NOT COMPLETED|Overall Study||0
8309921|NCT01489826|20487934|P1|NOT COMPLETED|Overall Study||0
8309922|NCT01489826|20487926|P9|COMPLETED|Overall Study||6
8309923|NCT01489826|20487927|P8|COMPLETED|Overall Study||3
8309924|NCT01489826|20487928|P7|COMPLETED|Overall Study||9
8309925|NCT01489826|20487929|P6|COMPLETED|Overall Study||3
8309926|NCT01489826|20487930|P5|COMPLETED|Overall Study||3
8309927|NCT01489826|20487931|P4|COMPLETED|Overall Study||7
8309928|NCT01489826|20487932|P3|COMPLETED|Overall Study||3
8309929|NCT01489826|20487933|P2|COMPLETED|Overall Study||3
8309930|NCT01489826|20487934|P1|COMPLETED|Overall Study||3
8309931|NCT01489826|20487926|P9|STARTED|Overall Study||6
8309932|NCT01489826|20487927|P8|STARTED|Overall Study||3
8309933|NCT01489826|20487928|P7|STARTED|Overall Study||9
8309934|NCT01489826|20487929|P6|STARTED|Overall Study||3
8309935|NCT01489826|20487930|P5|STARTED|Overall Study||3
8309936|NCT01489826|20487931|P4|STARTED|Overall Study||7
8309937|NCT01489826|20487932|P3|STARTED|Overall Study||3
8309938|NCT01489826|20487933|P2|STARTED|Overall Study||3
8309939|NCT01489826|20487934|P1|STARTED|Overall Study||3
8309940|NCT01489670|20488031|P1|NOT COMPLETED|Overall Study||53
8309941|NCT01489670|20488031|P1|COMPLETED|Overall Study||334
8309942|NCT01489670|20488031|P1|STARTED|Overall Study||387
8309943|NCT01489579|20488043|P2|NOT COMPLETED|Overall Study||7
8309944|NCT01489579|20488044|P1|NOT COMPLETED|Overall Study||9
8309945|NCT01489579|20488043|P2|COMPLETED|Overall Study||57
8309946|NCT01489579|20488044|P1|COMPLETED|Overall Study||47
8309947|NCT01489579|20488043|P2|STARTED|Overall Study||64
8309948|NCT01489579|20488044|P1|STARTED|Overall Study||56
8309949|NCT01489527|20488060|P2|NOT COMPLETED|Overall Study||26
8309950|NCT01489527|20488061|P1|NOT COMPLETED|Overall Study||22
8309951|NCT01489527|20488060|P2|COMPLETED|Overall Study||175
8309952|NCT01489527|20488061|P1|COMPLETED|Overall Study||183
8309953|NCT01489527|20488060|P2|STARTED|Overall Study||201
8309954|NCT01489527|20488061|P1|STARTED|Overall Study||205
8309955|NCT01489358|20488078|P3|NOT COMPLETED|Overall Study||2
8309956|NCT01489358|20488079|P2|NOT COMPLETED|Overall Study||0
8309957|NCT01489358|20488080|P1|NOT COMPLETED|Overall Study||0
8309958|NCT01489358|20488078|P3|COMPLETED|Overall Study||8
8309959|NCT01489358|20488079|P2|COMPLETED|Overall Study||10
8309960|NCT01489358|20488080|P1|COMPLETED|Overall Study||5
8309961|NCT01489358|20488078|P3|STARTED|Overall Study||10
8309962|NCT01489358|20488079|P2|STARTED|Overall Study||10
8309963|NCT01489358|20488080|P1|STARTED|Overall Study||5
8309964|NCT01489254|20488130|P4|NOT COMPLETED|Open-label Extension Part||58
8309965|NCT01489254|20488131|P3|NOT COMPLETED|Open-label Extension Part||0
8309966|NCT01489254|20488132|P2|NOT COMPLETED|Open-label Extension Part||0
8309967|NCT01489254|20488133|P1|NOT COMPLETED|Open-label Extension Part||0
8309968|NCT01489254|20488130|P4|COMPLETED|Open-label Extension Part||670
8309969|NCT01489254|20488131|P3|COMPLETED|Open-label Extension Part||0
8309970|NCT01489254|20488132|P2|COMPLETED|Open-label Extension Part||0
8309971|NCT01489254|20488133|P1|COMPLETED|Open-label Extension Part||0
8309972|NCT01489254|20488130|P4|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
8309973|NCT01489254|20488131|P3|STARTED|Open-label Extension Part||0
8309974|NCT01489254|20488132|P2|STARTED|Open-label Extension Part||0
8309975|NCT01489254|20488133|P1|STARTED|Open-label Extension Part||0
8309976|NCT01489254|20488130|P4|NOT COMPLETED|Double-blind Part||0
8309977|NCT01489254|20488131|P3|NOT COMPLETED|Double-blind Part||3
8309978|NCT01489254|20488132|P2|NOT COMPLETED|Double-blind Part||33
8309979|NCT01489254|20488133|P1|NOT COMPLETED|Double-blind Part||25
8309980|NCT01489254|20488130|P4|COMPLETED|Double-blind Part||0
8309981|NCT01489254|20488131|P3|COMPLETED|Double-blind Part||81
8309982|NCT01489254|20488132|P2|COMPLETED|Double-blind Part||324
8309983|NCT01489254|20488133|P1|COMPLETED|Double-blind Part||330
8309984|NCT01489254|20488130|P4|STARTED|Double-blind Part||0
8309985|NCT01489254|20488131|P3|STARTED|Double-blind Part||84
8309986|NCT01489254|20488132|P2|STARTED|Double-blind Part||357
8309987|NCT01489254|20488133|P1|STARTED|Double-blind Part||355
8309988|NCT01489189|20488144|P2|NOT COMPLETED|Overall Study||35
8309989|NCT01489189|20488145|P1|NOT COMPLETED|Overall Study||31
8309990|NCT01489189|20488144|P2|COMPLETED|Overall Study|Number of Eyes|168
8309991|NCT01489189|20488145|P1|COMPLETED|Overall Study|Number of Eyes|160
8309992|NCT01489189|20488144|P2|STARTED|Overall Study|Number of Eyes|203
8309993|NCT01489189|20488145|P1|STARTED|Overall Study|Number of Eyes|191
8309994|NCT01489111|20488170|P1|NOT COMPLETED|Overall Study||1
8309995|NCT01489111|20488170|P1|COMPLETED|Overall Study||35
8309996|NCT01489111|20488170|P1|STARTED|Overall Study||36
8309997|NCT01489020|20488191|P6|NOT COMPLETED|Overall Study||0
8309998|NCT01489020|20488192|P5|NOT COMPLETED|Overall Study||6
8309999|NCT01489020|20488193|P4|NOT COMPLETED|Overall Study||0
8310000|NCT01489020|20488194|P3|NOT COMPLETED|Overall Study||3
8310001|NCT01489020|20488195|P2|NOT COMPLETED|Overall Study||0
8310002|NCT01489020|20488196|P1|NOT COMPLETED|Overall Study||1
8310003|NCT01489020|20488191|P6|COMPLETED|Overall Study||4
8310004|NCT01489020|20488192|P5|COMPLETED|Overall Study||6
8310005|NCT01489020|20488193|P4|COMPLETED|Overall Study||4
8310006|NCT01489020|20488194|P3|COMPLETED|Overall Study||9
8310007|NCT01489020|20488195|P2|COMPLETED|Overall Study||4
8310008|NCT01489020|20488196|P1|COMPLETED|Overall Study||11
8310009|NCT01489020|20488191|P6|STARTED|Overall Study||4
8310010|NCT01489020|20488192|P5|STARTED|Overall Study||12
8310011|NCT01489020|20488193|P4|STARTED|Overall Study||4
8310012|NCT01489020|20488194|P3|STARTED|Overall Study||12
8310013|NCT01489020|20488195|P2|STARTED|Overall Study||4
8310014|NCT01489020|20488196|P1|STARTED|Overall Study||12
8310021|NCT01488890|20488322|P4|NOT COMPLETED|Overall Study||5
8310022|NCT01488890|20488323|P3|NOT COMPLETED|Overall Study||35
8310023|NCT01488890|20488324|P2|NOT COMPLETED|Overall Study||20
8310024|NCT01488890|20488325|P1|NOT COMPLETED|Overall Study||32
8310025|NCT01488890|20488322|P4|COMPLETED|Overall Study||25
8310026|NCT01488890|20488323|P3|COMPLETED|Overall Study||85
8310027|NCT01488890|20488324|P2|COMPLETED|Overall Study||100
8310028|NCT01488890|20488325|P1|COMPLETED|Overall Study||88
8310029|NCT01488890|20488322|P4|Treated|Overall Study||30
8310030|NCT01488890|20488323|P3|Treated|Overall Study||119
8310031|NCT01488890|20488324|P2|Treated|Overall Study||120
8310032|NCT01488890|20488325|P1|Treated|Overall Study||120
8310033|NCT01488890|20488322|P4|STARTED|Overall Study||30
8310034|NCT01488890|20488323|P3|STARTED|Overall Study||120
8310035|NCT01488890|20488324|P2|STARTED|Overall Study||120
8310036|NCT01488890|20488325|P1|STARTED|Overall Study||120
8310037|NCT01488877|20488363|P3|NOT COMPLETED|Re-randomization||0
8310038|NCT01488877|20488364|P2|NOT COMPLETED|Re-randomization||0
8310039|NCT01488877|20488365|P1|NOT COMPLETED|Re-randomization||0
8310040|NCT01488877|20488363|P3|COMPLETED|Re-randomization||3
8310041|NCT01488877|20488364|P2|COMPLETED|Re-randomization||0
8310042|NCT01488877|20488365|P1|COMPLETED|Re-randomization||0
8310043|NCT01488877|20488363|P3|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
8310044|NCT01488877|20488364|P2|STARTED|Re-randomization||0
8310045|NCT01488877|20488365|P1|STARTED|Re-randomization||0
8310046|NCT01488877|20488363|P3|NOT COMPLETED|Initial Randomization||0
8310047|NCT01488877|20488364|P2|NOT COMPLETED|Initial Randomization||0
8310048|NCT01488877|20488365|P1|NOT COMPLETED|Initial Randomization||0
8310049|NCT01488877|20488363|P3|COMPLETED|Initial Randomization||0
8310050|NCT01488877|20488364|P2|COMPLETED|Initial Randomization||5
8310051|NCT01488877|20488365|P1|COMPLETED|Initial Randomization||1
8310052|NCT01488877|20488363|P3|STARTED|Initial Randomization||0
8310053|NCT01488877|20488364|P2|STARTED|Initial Randomization||5
8310054|NCT01488877|20488365|P1|STARTED|Initial Randomization||1
8310055|NCT01488708|20488382|P2|NOT COMPLETED|Overall Study||578
8310056|NCT01488708|20488383|P1|NOT COMPLETED|Overall Study||940
8310057|NCT01488708|20488382|P2|COMPLETED|Overall Study||0
8310058|NCT01488708|20488383|P1|COMPLETED|Overall Study||0
8310059|NCT01488708|20488382|P2|Participated in Follow Up|Overall Study||526
8310060|NCT01488708|20488383|P1|Participated in Follow Up|Overall Study||810
8310061|NCT01488708|20488382|P2|Received at Least 1 Dose of Study Drug|Overall Study||578
8310062|NCT01488708|20488383|P1|Received at Least 1 Dose of Study Drug|Overall Study||937
8310063|NCT01488708|20488382|P2|STARTED|Overall Study||578
8310064|NCT01488708|20488383|P1|STARTED|Overall Study||940
8310065|NCT01488487|20488403|P1|NOT COMPLETED|Overall Study||9
8310066|NCT01488487|20488403|P1|COMPLETED|Overall Study||15
8310067|NCT01488487|20488403|P1|Received Treatment|Overall Study||24
8310068|NCT01488487|20488403|P1|STARTED|Overall Study||24
8310069|NCT01488448|20488412|P2|NOT COMPLETED|Overall Study||17
8310070|NCT01488448|20488413|P1|NOT COMPLETED|Overall Study||20
8310071|NCT01488448|20488412|P2|COMPLETED|Overall Study||97
8310072|NCT01488448|20488413|P1|COMPLETED|Overall Study||93
8310073|NCT01488448|20488412|P2|STARTED|Overall Study||114
8310074|NCT01488448|20488413|P1|STARTED|Overall Study||113
8310075|NCT01488409|20488437|P2|NOT COMPLETED|Overall Study||4
8310076|NCT01488409|20488438|P1|NOT COMPLETED|Overall Study||4
8310077|NCT01488409|20488437|P2|COMPLETED|Overall Study||15
8310078|NCT01488409|20488438|P1|COMPLETED|Overall Study||16
8310079|NCT01488409|20488437|P2|STARTED|Overall Study||19
8310080|NCT01488409|20488438|P1|STARTED|Overall Study||20
8310081|NCT01488370|20488455|P3|NOT COMPLETED|Overall Study||1
8310082|NCT01488370|20488456|P2|NOT COMPLETED|Overall Study||1
8310083|NCT01488370|20488457|P1|NOT COMPLETED|Overall Study||0
8310084|NCT01488370|20488455|P3|COMPLETED|Overall Study||19
8310085|NCT01488370|20488456|P2|COMPLETED|Overall Study||22
8310086|NCT01488370|20488457|P1|COMPLETED|Overall Study||22
8310087|NCT01488370|20488455|P3|STARTED|Overall Study||20
8310088|NCT01488370|20488456|P2|STARTED|Overall Study||23
8310089|NCT01488370|20488457|P1|STARTED|Overall Study||22
8310090|NCT01488318|20488477|P1|NOT COMPLETED|Overall Study||0
8310091|NCT01488318|20488477|P1|COMPLETED|Overall Study||14
8310092|NCT01488318|20488477|P1|STARTED|Overall Study||14
8310093|NCT01488279|20488486|P2|NOT COMPLETED|Overall Study||0
8310094|NCT01488279|20488487|P1|NOT COMPLETED|Overall Study||0
8310095|NCT01488279|20488486|P2|COMPLETED|Overall Study||5
8310096|NCT01488279|20488487|P1|COMPLETED|Overall Study||5
8310097|NCT01488279|20488486|P2|STARTED|Overall Study||5
8310098|NCT01488279|20488487|P1|STARTED|Overall Study||5
8310099|NCT01488188|20488503|P2|NOT COMPLETED|Overall Study||0
8310100|NCT01488188|20488504|P1|NOT COMPLETED|Overall Study||0
8310101|NCT01488188|20488503|P2|COMPLETED|Overall Study||20
8310102|NCT01488188|20488504|P1|COMPLETED|Overall Study||20
8310103|NCT01488188|20488503|P2|STARTED|Overall Study||20
8310104|NCT01488188|20488504|P1|STARTED|Overall Study||20
8310105|NCT01488097|20488516|P1|NOT COMPLETED|Overall Study||1
8310106|NCT01488097|20488516|P1|COMPLETED|Overall Study||7
8310107|NCT01488097|20488516|P1|Received Study Drug in Extension Study|Overall Study||8
8310108|NCT01488097|20488516|P1|STARTED|Overall Study||8
8310109|NCT01488071|20488529|P2|NOT COMPLETED|Overall Study||63
8310110|NCT01488071|20488530|P1|NOT COMPLETED|Overall Study||53
8310111|NCT01488071|20488529|P2|COMPLETED|Overall Study||179
8310112|NCT01488071|20488530|P1|COMPLETED|Overall Study||200
8310113|NCT01488071|20488529|P2|STARTED|Overall Study|APTS|242
8310114|NCT01488071|20488530|P1|STARTED|Overall Study|all-patients-treated set (APTS)|253
8310115|NCT01488019|20488564|P2|NOT COMPLETED|Overall Study||304
8310116|NCT01488019|20488565|P1|NOT COMPLETED|Overall Study||247
8310117|NCT01488019|20488564|P2|COMPLETED|Overall Study||226
8310118|NCT01488019|20488565|P1|COMPLETED|Overall Study||294
8310119|NCT01488019|20488564|P2|STARTED|Overall Study||530
8310120|NCT01488019|20488565|P1|STARTED|Overall Study||541
8310121|NCT01487954|20488599|P2|NOT COMPLETED|Overall Study||0
8310122|NCT01487954|20488600|P1|NOT COMPLETED|Overall Study||0
8310123|NCT01487954|20488599|P2|COMPLETED|Overall Study||16
8310124|NCT01487954|20488600|P1|COMPLETED|Overall Study||29
8310125|NCT01487954|20488599|P2|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
8310126|NCT01487954|20488600|P1|Safety lead-in|Overall Study||10
8310127|NCT01487954|20488599|P2|STARTED|Overall Study||16
8310128|NCT01487954|20488600|P1|STARTED|Overall Study||29
8310129|NCT01487863|20488610|P2|NOT COMPLETED|Overall Study||19
8310130|NCT01487863|20488611|P1|NOT COMPLETED|Overall Study||19
8310131|NCT01487863|20488610|P2|COMPLETED|Overall Study||15
8310132|NCT01487863|20488611|P1|COMPLETED|Overall Study||16
8310133|NCT01487863|20488610|P2|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
8310134|NCT01487863|20488611|P1|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
8310135|NCT01487863|20488610|P2|Subjects Randomized (Efficacy Analysis)|Overall Study||34
8310136|NCT01487863|20488611|P1|Subjects Randomized (Efficacy Analysis)|Overall Study||35
8310137|NCT01487863|20488610|P2|STARTED|Overall Study||34
8310138|NCT01487863|20488611|P1|STARTED|Overall Study||35
8310139|NCT01487668|20488619|P2|NOT COMPLETED|Overall Study||17
8310140|NCT01487668|20488620|P1|NOT COMPLETED|Overall Study||25
8310141|NCT01487668|20488619|P2|COMPLETED|Overall Study||124
8310142|NCT01487668|20488620|P1|COMPLETED|Overall Study||121
8310143|NCT01487668|20488619|P2|STARTED|Overall Study||141
8310144|NCT01487668|20488620|P1|STARTED|Overall Study||146
8310145|NCT01487577|20488628|P1|NOT COMPLETED|Overall Study||1
8310146|NCT01487577|20488628|P1|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
8310147|NCT01487577|20488628|P1|STARTED|Overall Study||19
8310148|NCT01487525|20488642|P2|NOT COMPLETED|Overall Study||1
8310149|NCT01487525|20488643|P1|NOT COMPLETED|Overall Study||0
8310150|NCT01487525|20488642|P2|COMPLETED|Overall Study||19
8310151|NCT01487525|20488643|P1|COMPLETED|Overall Study||22
8310152|NCT01487525|20488642|P2|STARTED|Overall Study||20
8310153|NCT01487525|20488643|P1|STARTED|Overall Study||22
8310154|NCT01487499|20488653|P1|NOT COMPLETED|Overall Study||0
8310155|NCT01487499|20488653|P1|COMPLETED|Overall Study||4
8310156|NCT01487499|20488653|P1|STARTED|Overall Study||4
8310157|NCT01487265|20488659|P1|NOT COMPLETED|Overall Study||37
8310158|NCT01487265|20488659|P1|COMPLETED|Overall Study||0
8310159|NCT01487265|20488659|P1|STARTED|Overall Study||37
8310160|NCT01487200|20488671|P4|NOT COMPLETED|Overall Study||0
8310161|NCT01487200|20488672|P3|NOT COMPLETED|Overall Study||0
8310162|NCT01487200|20488673|P2|NOT COMPLETED|Overall Study||1
8310163|NCT01487200|20488674|P1|NOT COMPLETED|Overall Study||0
8310164|NCT01487200|20488671|P4|COMPLETED|Overall Study||5
8310165|NCT01487200|20488672|P3|COMPLETED|Overall Study||7
8310166|NCT01487200|20488673|P2|COMPLETED|Overall Study||6
8310167|NCT01487200|20488674|P1|COMPLETED|Overall Study||5
8310168|NCT01487200|20488671|P4|STARTED|Overall Study||5
8310169|NCT01487200|20488672|P3|STARTED|Overall Study||7
8310170|NCT01487200|20488673|P2|STARTED|Overall Study||7
8310171|NCT01487200|20488674|P1|STARTED|Overall Study||5
8310172|NCT01487161|20488704|P4|NOT COMPLETED|Overall Study||2
8310173|NCT01487161|20488705|P3|NOT COMPLETED|Overall Study||1
8310174|NCT01487161|20488706|P2|NOT COMPLETED|Overall Study||2
8310175|NCT01487161|20488707|P1|NOT COMPLETED|Overall Study||2
8310176|NCT01487161|20488704|P4|COMPLETED|Overall Study||50
8310177|NCT01487161|20488705|P3|COMPLETED|Overall Study||59
8310178|NCT01487161|20488706|P2|COMPLETED|Overall Study||57
8310179|NCT01487161|20488707|P1|COMPLETED|Overall Study||56
8310180|NCT01487161|20488704|P4|STARTED|Overall Study||52
8310181|NCT01487161|20488705|P3|STARTED|Overall Study||60
8310182|NCT01487161|20488706|P2|STARTED|Overall Study||59
8310183|NCT01487161|20488707|P1|STARTED|Overall Study||58
8310184|NCT01486966|20488772|P2|NOT COMPLETED|Overall Study||2
8310185|NCT01486966|20488773|P1|NOT COMPLETED|Overall Study||0
8310186|NCT01486966|20488772|P2|COMPLETED|Overall Study||27
8310187|NCT01486966|20488773|P1|COMPLETED|Overall Study||29
8310188|NCT01486966|20488772|P2|STARTED|Overall Study||29
8310189|NCT01486966|20488773|P1|STARTED|Overall Study||29
8310190|NCT01486927|20488797|P1|NOT COMPLETED|Overall Study||13
8310191|NCT01486927|20488797|P1|COMPLETED|Overall Study||161
8310192|NCT01486927|20488797|P1|STARTED|Overall Study||174
8310193|NCT01486810|20488828|P1|NOT COMPLETED|Overall Study||8
8310194|NCT01486810|20488828|P1|COMPLETED|Overall Study||9
8310195|NCT01486810|20488828|P1|STARTED|Overall Study||17
8310196|NCT01486758|20488835|P2|NOT COMPLETED|Overall Study||1
8310197|NCT01486758|20488836|P1|NOT COMPLETED|Overall Study||0
8310198|NCT01486758|20488835|P2|COMPLETED|Overall Study||19
8310199|NCT01486758|20488836|P1|COMPLETED|Overall Study||20
8310200|NCT01486758|20488835|P2|STARTED|Overall Study||20
8310201|NCT01486758|20488836|P1|STARTED|Overall Study||20
8310202|NCT01486615|20488860|P4|NOT COMPLETED|Overall Study||2
8310203|NCT01486615|20488861|P3|NOT COMPLETED|Overall Study||2
8310204|NCT01486615|20488862|P2|NOT COMPLETED|Overall Study||1
8310205|NCT01486615|20488863|P1|NOT COMPLETED|Overall Study||0
8310206|NCT01486615|20488860|P4|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
8310207|NCT01486615|20488861|P3|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
8310208|NCT01486615|20488862|P2|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
8310209|NCT01486615|20488863|P1|COMPLETED|Overall Study||20
8310210|NCT01486615|20488860|P4|STARTED|Overall Study||20
8310211|NCT01486615|20488861|P3|STARTED|Overall Study||20
8310212|NCT01486615|20488862|P2|STARTED|Overall Study||20
8310213|NCT01486615|20488863|P1|STARTED|Overall Study||20
8310214|NCT01486446|20488903|P2|NOT COMPLETED|Overall Study||0
8310215|NCT01486446|20488904|P1|NOT COMPLETED|Overall Study||1
8310216|NCT01486446|20488903|P2|COMPLETED|Overall Study||1
8310217|NCT01486446|20488904|P1|COMPLETED|Overall Study||6
8310218|NCT01486446|20488903|P2|STARTED|Overall Study||1
8310219|NCT01486446|20488904|P1|STARTED|Overall Study||7
8310220|NCT01486316|20488927|P4|NOT COMPLETED|Overall Study||2
8310221|NCT01486316|20488928|P3|NOT COMPLETED|Overall Study||5
8310222|NCT01486316|20488929|P2|NOT COMPLETED|Overall Study||3
8310223|NCT01486316|20488930|P1|NOT COMPLETED|Overall Study||4
8310224|NCT01486316|20488927|P4|COMPLETED|Overall Study||0
8310225|NCT01486316|20488928|P3|COMPLETED|Overall Study||0
8310226|NCT01486316|20488929|P2|COMPLETED|Overall Study||7
8310227|NCT01486316|20488930|P1|COMPLETED|Overall Study||3
8310228|NCT01486316|20488927|P4|STARTED|Overall Study|Exited prior to 6 month visit|2
8310229|NCT01486316|20488928|P3|STARTED|Overall Study|Exited prior to implant|5
8310230|NCT01486316|20488929|P2|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
8310231|NCT01486316|20488930|P1|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
8310232|NCT01486264|20488942|P2|NOT COMPLETED|Overall Study||47
8310233|NCT01486264|20488943|P1|NOT COMPLETED|Overall Study||29
8310234|NCT01486264|20488942|P2|COMPLETED|Overall Study||94
8310235|NCT01486264|20488943|P1|COMPLETED|Overall Study||113
8310236|NCT01486264|20488942|P2|Treated|Overall Study||140
8310237|NCT01486264|20488943|P1|Treated|Overall Study||142
8310238|NCT01486264|20488942|P2|STARTED|Overall Study||141
8310239|NCT01486264|20488943|P1|STARTED|Overall Study||142
8310240|NCT01486238|20488975|P2|NOT COMPLETED|Overall Study||6
8310241|NCT01486238|20488976|P1|NOT COMPLETED|Overall Study||2
8310242|NCT01486238|20488975|P2|COMPLETED|Overall Study||43
8310243|NCT01486238|20488976|P1|COMPLETED|Overall Study||21
8310244|NCT01486238|20488975|P2|STARTED|Overall Study||49
8310245|NCT01486238|20488976|P1|STARTED|Overall Study||23
8310246|NCT01486199|20488984|P2|NOT COMPLETED|Study Day at t= 2 Years||0
8310247|NCT01486199|20488985|P1|NOT COMPLETED|Study Day at t= 2 Years||0
8310248|NCT01486199|20488984|P2|COMPLETED|Study Day at t= 2 Years||0
8310249|NCT01486199|20488985|P1|COMPLETED|Study Day at t= 2 Years||9
8310250|NCT01486199|20488984|P2|STARTED|Study Day at t= 2 Years||0
8310251|NCT01486199|20488985|P1|STARTED|Study Day at t= 2 Years||9
8310252|NCT01486199|20488984|P2|NOT COMPLETED|Two Year Period Between Study Days||0
8310253|NCT01486199|20488985|P1|NOT COMPLETED|Two Year Period Between Study Days||1
8310254|NCT01486199|20488984|P2|COMPLETED|Two Year Period Between Study Days||0
8310255|NCT01486199|20488985|P1|COMPLETED|Two Year Period Between Study Days||9
8310256|NCT01486199|20488984|P2|STARTED|Two Year Period Between Study Days||0
8310257|NCT01486199|20488985|P1|STARTED|Two Year Period Between Study Days||10
8310258|NCT01486199|20488984|P2|NOT COMPLETED|Baseline Study Day||1
8310259|NCT01486199|20488985|P1|NOT COMPLETED|Baseline Study Day||0
8310260|NCT01486199|20488984|P2|COMPLETED|Baseline Study Day||9
8310261|NCT01486199|20488985|P1|COMPLETED|Baseline Study Day||10
8310262|NCT01486199|20488984|P2|STARTED|Baseline Study Day||10
8310263|NCT01486199|20488985|P1|STARTED|Baseline Study Day||10
8310264|NCT01486043|20488997|P1|NOT COMPLETED|Overall Study||2
8310265|NCT01486043|20488997|P1|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
8310266|NCT01486043|20488997|P1|STARTED|Overall Study||4
8310267|NCT01485991|20489005|P2|NOT COMPLETED|Overall Study||36
8310268|NCT01485991|20489006|P1|NOT COMPLETED|Overall Study||32
8310269|NCT01485991|20489005|P2|COMPLETED|Overall Study||350
8310270|NCT01485991|20489006|P1|COMPLETED|Overall Study||353
8310271|NCT01485991|20489005|P2|Treated|Overall Study||384
8310272|NCT01485991|20489006|P1|Treated|Overall Study||379
8310273|NCT01485991|20489005|P2|STARTED|Overall Study||386
8310274|NCT01485991|20489006|P1|STARTED|Overall Study||385
8310293|NCT01485640|20489038|P1|NOT COMPLETED|Overall Study||122
8310294|NCT01485640|20489038|P1|COMPLETED|Overall Study||40
8310295|NCT01485640|20489038|P1|STARTED|Overall Study||162
8310296|NCT01485627|20489045|P2|NOT COMPLETED|Overall Study||57
8310297|NCT01485627|20489046|P1|NOT COMPLETED|Overall Study||66
8310298|NCT01485627|20489045|P2|COMPLETED|Overall Study|135 patients and 49 caregivers|184
8310299|NCT01485627|20489046|P1|COMPLETED|Overall Study|130 patients and 48 caregivers|178
8310300|NCT01485627|20489045|P2|Bereaved Caregivers: 7 Month Completed|Overall Study||49
8310301|NCT01485627|20489046|P1|Bereaved Caregivers: 7 Month Completed|Overall Study||48
8310302|NCT01485627|20489045|P2|Bereaved Caregivers: 2 Month Completed|Overall Study||52
8310303|NCT01485627|20489046|P1|Bereaved Caregivers: 2 Month Completed|Overall Study||49
8310304|NCT01485627|20489045|P2|Bereaved Caregivers: 1 Month|Overall Study||51
8310305|NCT01485627|20489046|P1|Bereaved Caregivers: 1 Month|Overall Study||51
8310306|NCT01485627|20489045|P2|Bereaved Caregivers: Total|Overall Study||64
8310307|NCT01485627|20489046|P1|Bereaved Caregivers: Total|Overall Study||63
8310308|NCT01485627|20489045|P2|Allocated Caregivers: Total|Overall Study||99
8310309|NCT01485627|20489046|P1|Allocated Caregivers: Total|Overall Study||105
8310310|NCT01485627|20489045|P2|STARTED|Overall Study|142 patients and 99 caregivers|241
8310311|NCT01485627|20489046|P1|STARTED|Overall Study|139 patients and 105 caregivers|244
8310352|NCT01485588|20489430|P3|NOT COMPLETED|Overall Study||0
8310353|NCT01485588|20489431|P2|NOT COMPLETED|Overall Study||0
8310354|NCT01485588|20489432|P1|NOT COMPLETED|Overall Study||0
8310355|NCT01485588|20489430|P3|COMPLETED|Overall Study||6
8310356|NCT01485588|20489431|P2|COMPLETED|Overall Study||6
8310357|NCT01485588|20489432|P1|COMPLETED|Overall Study||6
8310358|NCT01485588|20489430|P3|STARTED|Overall Study||6
8310359|NCT01485588|20489431|P2|STARTED|Overall Study||6
8310360|NCT01485588|20489432|P1|STARTED|Overall Study||6
8310361|NCT01485536|20489443|P1|NOT COMPLETED|Overall Study||4
8310362|NCT01485536|20489443|P1|COMPLETED|Overall Study||17
8310363|NCT01485536|20489443|P1|STARTED|Overall Study||21
8310364|NCT01485393|20489448|P2|NOT COMPLETED|Overall Study||0
8310365|NCT01485393|20489449|P1|NOT COMPLETED|Overall Study||0
8310366|NCT01485393|20489448|P2|COMPLETED|Overall Study||5
8310367|NCT01485393|20489449|P1|COMPLETED|Overall Study||5
8310368|NCT01485393|20489448|P2|STARTED|Overall Study||5
8310369|NCT01485393|20489449|P1|STARTED|Overall Study||5
8310370|NCT01485380|20489457|P1|NOT COMPLETED|Overall Study||3
8310371|NCT01485380|20489457|P1|COMPLETED|Overall Study||17
8310372|NCT01485380|20489457|P1|STARTED|Overall Study||20
8310373|NCT01485354|20489461|P1|NOT COMPLETED|Overall Study||5
8310374|NCT01485354|20489461|P1|COMPLETED|Overall Study||12
8310375|NCT01485354|20489461|P1|STARTED|Overall Study||17
8310376|NCT01485172|20489475|P6|NOT COMPLETED|Overall Study||4
8310377|NCT01485172|20489476|P5|NOT COMPLETED|Overall Study||5
8310378|NCT01485172|20489477|P4|NOT COMPLETED|Overall Study||8
8310379|NCT01485172|20489478|P3|NOT COMPLETED|Overall Study||7
8310380|NCT01485172|20489479|P2|NOT COMPLETED|Overall Study||1
8310381|NCT01485172|20489480|P1|NOT COMPLETED|Overall Study||7
8310382|NCT01485172|20489475|P6|COMPLETED|Overall Study||9
8310383|NCT01485172|20489476|P5|COMPLETED|Overall Study||34
8310384|NCT01485172|20489477|P4|COMPLETED|Overall Study||32
8310385|NCT01485172|20489478|P3|COMPLETED|Overall Study||34
8310386|NCT01485172|20489479|P2|COMPLETED|Overall Study||12
8310387|NCT01485172|20489480|P1|COMPLETED|Overall Study||33
8310388|NCT01485172|20489475|P6|STARTED|Overall Study||13
8310389|NCT01485172|20489476|P5|STARTED|Overall Study||39
8310390|NCT01485172|20489477|P4|STARTED|Overall Study||40
8310391|NCT01485172|20489478|P3|STARTED|Overall Study||41
8310392|NCT01485172|20489479|P2|STARTED|Overall Study||13
8310393|NCT01485172|20489480|P1|STARTED|Overall Study||40
8310394|NCT01485120|20489554|P1|NOT COMPLETED|Overall Study||2
8310395|NCT01485120|20489554|P1|COMPLETED|Overall Study||32
8310396|NCT01485120|20489554|P1|STARTED|Overall Study||34
8310397|NCT01485094|20489562|P3|NOT COMPLETED|Overall Study||1
8310398|NCT01485094|20489563|P2|NOT COMPLETED|Overall Study||2
8310399|NCT01485094|20489564|P1|NOT COMPLETED|Overall Study||3
8310400|NCT01485094|20489562|P3|COMPLETED|Overall Study||18
8310401|NCT01485094|20489563|P2|COMPLETED|Overall Study||18
8310402|NCT01485094|20489564|P1|COMPLETED|Overall Study||17
8310403|NCT01485094|20489562|P3|STARTED|Overall Study||19
8310404|NCT01485094|20489563|P2|STARTED|Overall Study||20
8310405|NCT01485094|20489564|P1|STARTED|Overall Study||20
8310406|NCT01485055|20489605|P1|NOT COMPLETED|Overall Study||0
8310407|NCT01485055|20489605|P1|COMPLETED|Overall Study||11
8310408|NCT01485055|20489605|P1|STARTED|Overall Study||11
8310409|NCT01484977|20489609|P1|NOT COMPLETED|Overall Study||27
8310410|NCT01484977|20489609|P1|COMPLETED|Overall Study||93
8310411|NCT01484977|20489609|P1|STARTED|Overall Study||120
8310412|NCT01484951|20489613|P1|NOT COMPLETED|Overall Study||5
8310413|NCT01484951|20489613|P1|COMPLETED|Overall Study||69
8310414|NCT01484951|20489613|P1|STARTED|Overall Study||74
8310415|NCT01484938|20489618|P1|NOT COMPLETED|Overall Study||4
8310416|NCT01484938|20489618|P1|COMPLETED|Overall Study||171
8310417|NCT01484938|20489618|P1|STARTED|Overall Study||175
8310418|NCT01484912|20489625|P2|NOT COMPLETED|Overall Study||1
8310419|NCT01484912|20489626|P1|NOT COMPLETED|Overall Study||1
8310420|NCT01484912|20489625|P2|COMPLETED|Overall Study||39
8310421|NCT01484912|20489626|P1|COMPLETED|Overall Study||38
8310422|NCT01484912|20489625|P2|STARTED|Overall Study||40
8310423|NCT01484912|20489626|P1|STARTED|Overall Study||39
8310424|NCT01484873|20489636|P1|NOT COMPLETED|Overall Study||2
8310425|NCT01484873|20489636|P1|COMPLETED|Overall Study||8
8310426|NCT01484873|20489636|P1|STARTED|Overall Study||10
8310427|NCT01484834|20489648|P4|NOT COMPLETED|Overall Study||4
8310428|NCT01484834|20489649|P3|NOT COMPLETED|Overall Study||1
8310429|NCT01484834|20489650|P2|NOT COMPLETED|Overall Study||8
8310430|NCT01484834|20489651|P1|NOT COMPLETED|Overall Study||5
8310431|NCT01484834|20489648|P4|COMPLETED|Overall Study||20
8310432|NCT01484834|20489649|P3|COMPLETED|Overall Study||38
8310433|NCT01484834|20489650|P2|COMPLETED|Overall Study||54
8310434|NCT01484834|20489651|P1|COMPLETED|Overall Study||60
8310435|NCT01484834|20489648|P4|STARTED|Overall Study||24
8310436|NCT01484834|20489649|P3|STARTED|Overall Study||39
8310437|NCT01484834|20489650|P2|STARTED|Overall Study||62
8310438|NCT01484834|20489651|P1|STARTED|Overall Study||65
8310439|NCT01484652|20489679|P2|NOT COMPLETED|Overall Study||21
8310440|NCT01484652|20489680|P1|NOT COMPLETED|Overall Study||15
8310441|NCT01484652|20489679|P2|COMPLETED|Overall Study||142
8310442|NCT01484652|20489680|P1|COMPLETED|Overall Study||151
8310443|NCT01484652|20489679|P2|STARTED|Overall Study||163
8310444|NCT01484652|20489680|P1|STARTED|Overall Study||166
8310445|NCT01484626|20489686|P1|NOT COMPLETED|Overall Study||0
8310446|NCT01484626|20489686|P1|COMPLETED|Overall Study||3
8310447|NCT01484626|20489686|P1|STARTED|Overall Study||3
8310448|NCT01484561|20489692|P2|NOT COMPLETED|Overall Study||6
8310449|NCT01484561|20489693|P1|NOT COMPLETED|Overall Study||9
8310450|NCT01484561|20489692|P2|COMPLETED|Overall Study||45
8310451|NCT01484561|20489693|P1|COMPLETED|Overall Study||88
8310452|NCT01484561|20489692|P2|STARTED|Overall Study||51
8310453|NCT01484561|20489693|P1|STARTED|Overall Study||97
8310454|NCT01484496|20489783|P4|NOT COMPLETED|Period 2||22
8310455|NCT01484496|20489784|P3|NOT COMPLETED|Period 2||15
8310456|NCT01484496|20489785|P2|NOT COMPLETED|Period 2||0
8310457|NCT01484496|20489786|P1|NOT COMPLETED|Period 2||0
8310458|NCT01484496|20489783|P4|COMPLETED|Period 2||434
8310459|NCT01484496|20489784|P3|COMPLETED|Period 2||191
8310460|NCT01484496|20489785|P2|COMPLETED|Period 2||0
8310461|NCT01484496|20489786|P1|COMPLETED|Period 2||0
8310462|NCT01484496|20489783|P4|STARTED|Period 2||456
8310463|NCT01484496|20489784|P3|STARTED|Period 2||206
8310464|NCT01484496|20489785|P2|STARTED|Period 2||0
8310465|NCT01484496|20489786|P1|STARTED|Period 2||0
8310466|NCT01484496|20489783|P4|NOT COMPLETED|Period 1||0
8310467|NCT01484496|20489784|P3|NOT COMPLETED|Period 1||0
8310468|NCT01484496|20489785|P2|NOT COMPLETED|Period 1||93
8310469|NCT01484496|20489786|P1|NOT COMPLETED|Period 1||66
8310470|NCT01484496|20489783|P4|COMPLETED|Period 1||0
8310471|NCT01484496|20489784|P3|COMPLETED|Period 1||0
8310472|NCT01484496|20489785|P2|COMPLETED|Period 1||463
8310473|NCT01484496|20489786|P1|COMPLETED|Period 1||214
8310474|NCT01484496|20489783|P4|STARTED|Period 1||0
8310475|NCT01484496|20489784|P3|STARTED|Period 1||0
8310476|NCT01484496|20489785|P2|STARTED|Period 1||556
8310477|NCT01484496|20489786|P1|STARTED|Period 1||280
8310478|NCT01484431|20489801|P3|NOT COMPLETED|Period 2||2
8310479|NCT01484431|20489802|P2|NOT COMPLETED|Period 2||1
8310480|NCT01484431|20489803|P1|NOT COMPLETED|Period 2||1
8310481|NCT01484431|20489801|P3|COMPLETED|Period 2||4
8310482|NCT01484431|20489802|P2|COMPLETED|Period 2||5
8310483|NCT01484431|20489803|P1|COMPLETED|Period 2||5
8310484|NCT01484431|20489801|P3|Received 40 mg|Period 2||1
8310485|NCT01484431|20489802|P2|Received 40 mg|Period 2||0
8310486|NCT01484431|20489803|P1|Received 40 mg|Period 2||0
8310487|NCT01484431|20489801|P3|Received 20 mg|Period 2||4
8310488|NCT01484431|20489802|P2|Received 20 mg|Period 2||1
8310489|NCT01484431|20489803|P1|Received 20 mg|Period 2||3
8310490|NCT01484431|20489801|P3|Received 15 mg|Period 2||1
8310491|NCT01484431|20489802|P2|Received 15 mg|Period 2||2
8310492|NCT01484431|20489803|P1|Received 15 mg|Period 2||1
8310493|NCT01484431|20489801|P3|Received 10 mg|Period 2||0
8310494|NCT01484431|20489802|P2|Received 10 mg|Period 2||1
8310495|NCT01484431|20489803|P1|Received 10 mg|Period 2||0
8310496|NCT01484431|20489801|P3|Received 8 mg|Period 2||0
8310497|NCT01484431|20489802|P2|Received 8 mg|Period 2||0
8310498|NCT01484431|20489803|P1|Received 8 mg|Period 2||1
8310499|NCT01484431|20489801|P3|Received 7.5 mg|Period 2||0
8310500|NCT01484431|20489802|P2|Received 7.5 mg|Period 2||2
8310501|NCT01484431|20489803|P1|Received 7.5 mg|Period 2||0
8310502|NCT01484431|20489801|P3|Received 7 mg|Period 2||0
8310503|NCT01484431|20489802|P2|Received 7 mg|Period 2||0
8310504|NCT01484431|20489803|P1|Received 7 mg|Period 2||1
8310505|NCT01484431|20489801|P3|STARTED|Period 2||6
8310506|NCT01484431|20489802|P2|STARTED|Period 2||6
8310507|NCT01484431|20489803|P1|STARTED|Period 2||6
8310508|NCT01484431|20489801|P3|NOT COMPLETED|Period 1: High Dose||0
8310509|NCT01484431|20489802|P2|NOT COMPLETED|Period 1: High Dose||1
8310510|NCT01484431|20489803|P1|NOT COMPLETED|Period 1: High Dose||0
8310511|NCT01484431|20489801|P3|COMPLETED|Period 1: High Dose||6
8310512|NCT01484431|20489802|P2|COMPLETED|Period 1: High Dose||6
8310513|NCT01484431|20489803|P1|COMPLETED|Period 1: High Dose||6
8310514|NCT01484431|20489801|P3|Received 40 mg|Period 1: High Dose||5
8310515|NCT01484431|20489802|P2|Received 40 mg|Period 1: High Dose||0
8310516|NCT01484431|20489803|P1|Received 40 mg|Period 1: High Dose||0
8310517|NCT01484431|20489801|P3|Received 20 mg|Period 1: High Dose||1
8310518|NCT01484431|20489802|P2|Received 20 mg|Period 1: High Dose||5
8310519|NCT01484431|20489803|P1|Received 20 mg|Period 1: High Dose||3
8310520|NCT01484431|20489801|P3|Received 15 mg|Period 1: High Dose||0
8310521|NCT01484431|20489802|P2|Received 15 mg|Period 1: High Dose||1
8310522|NCT01484431|20489803|P1|Received 15 mg|Period 1: High Dose||1
8310523|NCT01484431|20489801|P3|Received 10 mg|Period 1: High Dose||0
8310524|NCT01484431|20489802|P2|Received 10 mg|Period 1: High Dose||1
8310525|NCT01484431|20489803|P1|Received 10 mg|Period 1: High Dose||1
8310526|NCT01484431|20489801|P3|Received 8 mg|Period 1: High Dose||0
8310527|NCT01484431|20489802|P2|Received 8 mg|Period 1: High Dose||0
8310528|NCT01484431|20489803|P1|Received 8 mg|Period 1: High Dose||1
8310529|NCT01484431|20489801|P3|STARTED|Period 1: High Dose||6
8310530|NCT01484431|20489802|P2|STARTED|Period 1: High Dose||7
8310531|NCT01484431|20489803|P1|STARTED|Period 1: High Dose||6
8310532|NCT01484431|20489801|P3|NOT COMPLETED|Period 1: Low Dose||0
8310533|NCT01484431|20489802|P2|NOT COMPLETED|Period 1: Low Dose||0
8310534|NCT01484431|20489803|P1|NOT COMPLETED|Period 1: Low Dose||0
8310535|NCT01484431|20489801|P3|COMPLETED|Period 1: Low Dose||6
8310536|NCT01484431|20489802|P2|COMPLETED|Period 1: Low Dose||7
8310537|NCT01484431|20489803|P1|COMPLETED|Period 1: Low Dose||6
8310538|NCT01484431|20489801|P3|Received 10 mg|Period 1: Low Dose||6
8310539|NCT01484431|20489802|P2|Received 10 mg|Period 1: Low Dose||0
8310540|NCT01484431|20489803|P1|Received 10 mg|Period 1: Low Dose||0
8310541|NCT01484431|20489801|P3|Received 5 mg|Period 1: Low Dose||0
8310542|NCT01484431|20489802|P2|Received 5 mg|Period 1: Low Dose||7
8310543|NCT01484431|20489803|P1|Received 5 mg|Period 1: Low Dose||0
8310544|NCT01484431|20489801|P3|Received 4 mg|Period 1: Low Dose||0
8310545|NCT01484431|20489802|P2|Received 4 mg|Period 1: Low Dose||0
8310546|NCT01484431|20489803|P1|Received 4 mg|Period 1: Low Dose||5
8310547|NCT01484431|20489801|P3|Received 2 mg|Period 1: Low Dose||0
8310548|NCT01484431|20489802|P2|Received 2 mg|Period 1: Low Dose||0
8310549|NCT01484431|20489803|P1|Received 2 mg|Period 1: Low Dose||1
8310550|NCT01484431|20489801|P3|STARTED|Period 1: Low Dose||6
8310551|NCT01484431|20489802|P2|STARTED|Period 1: Low Dose||7
8310552|NCT01484431|20489803|P1|STARTED|Period 1: Low Dose||6
8310553|NCT01484340|20489820|P2|NOT COMPLETED|Overall Study||0
8310554|NCT01484340|20489821|P1|NOT COMPLETED|Overall Study||0
8310555|NCT01484340|20489820|P2|COMPLETED|Overall Study||279
8310556|NCT01484340|20489821|P1|COMPLETED|Overall Study||281
8310557|NCT01484340|20489820|P2|STARTED|Overall Study||279
8310558|NCT01484340|20489821|P1|STARTED|Overall Study||281
8310559|NCT01484314|20489833|P1|NOT COMPLETED|Overall Study||0
8310560|NCT01484314|20489833|P1|COMPLETED|Overall Study||1
8310561|NCT01484314|20489833|P1|STARTED|Overall Study||1
8310562|NCT01484275|20489841|P2|NOT COMPLETED|Overall Study||42
8310563|NCT01484275|20489842|P1|NOT COMPLETED|Overall Study||43
8310564|NCT01484275|20489841|P2|COMPLETED|Overall Study||0
8310565|NCT01484275|20489842|P1|COMPLETED|Overall Study||0
8310566|NCT01484275|20489841|P2|STARTED|Overall Study||42
8310567|NCT01484275|20489842|P1|STARTED|Overall Study||43
8310568|NCT01484197|20489864|P4|NOT COMPLETED|Treatment Period 4||0
8310569|NCT01484197|20489865|P3|NOT COMPLETED|Treatment Period 4||0
8310570|NCT01484197|20489866|P2|NOT COMPLETED|Treatment Period 4||0
8310571|NCT01484197|20489867|P1|NOT COMPLETED|Treatment Period 4||0
8310572|NCT01484197|20489864|P4|COMPLETED|Treatment Period 4||6
8310573|NCT01484197|20489865|P3|COMPLETED|Treatment Period 4||9
8310574|NCT01484197|20489866|P2|COMPLETED|Treatment Period 4||8
8310575|NCT01484197|20489867|P1|COMPLETED|Treatment Period 4||7
8310576|NCT01484197|20489864|P4|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
8310577|NCT01484197|20489865|P3|STARTED|Treatment Period 4||9
8310578|NCT01484197|20489866|P2|STARTED|Treatment Period 4||8
8310579|NCT01484197|20489867|P1|STARTED|Treatment Period 4||7
8310580|NCT01484197|20489864|P4|NOT COMPLETED|Treatment Period 3||0
8310581|NCT01484197|20489865|P3|NOT COMPLETED|Treatment Period 3||0
8310582|NCT01484197|20489866|P2|NOT COMPLETED|Treatment Period 3||0
8310583|NCT01484197|20489867|P1|NOT COMPLETED|Treatment Period 3||0
8310584|NCT01484197|20489864|P4|COMPLETED|Treatment Period 3||8
8310585|NCT01484197|20489865|P3|COMPLETED|Treatment Period 3||9
8310586|NCT01484197|20489866|P2|COMPLETED|Treatment Period 3||8
8310587|NCT01484197|20489867|P1|COMPLETED|Treatment Period 3||7
8310588|NCT01484197|20489864|P4|STARTED|Treatment Period 3||8
8310589|NCT01484197|20489865|P3|STARTED|Treatment Period 3||9
8310590|NCT01484197|20489866|P2|STARTED|Treatment Period 3||8
8310591|NCT01484197|20489867|P1|STARTED|Treatment Period 3||7
8310592|NCT01484197|20489864|P4|NOT COMPLETED|Treatment Period 2||1
8310593|NCT01484197|20489865|P3|NOT COMPLETED|Treatment Period 2||0
8310594|NCT01484197|20489866|P2|NOT COMPLETED|Treatment Period 2||0
8310595|NCT01484197|20489867|P1|NOT COMPLETED|Treatment Period 2||0
8310596|NCT01484197|20489864|P4|COMPLETED|Treatment Period 2||8
8310597|NCT01484197|20489865|P3|COMPLETED|Treatment Period 2||9
8310598|NCT01484197|20489866|P2|COMPLETED|Treatment Period 2||8
8310599|NCT01484197|20489867|P1|COMPLETED|Treatment Period 2||7
8310600|NCT01484197|20489864|P4|STARTED|Treatment Period 2||9
8310601|NCT01484197|20489865|P3|STARTED|Treatment Period 2||9
8310602|NCT01484197|20489866|P2|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
8310603|NCT01484197|20489867|P1|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
8310604|NCT01484197|20489864|P4|NOT COMPLETED|Treatment Period 1||0
8310605|NCT01484197|20489865|P3|NOT COMPLETED|Treatment Period 1||0
8310606|NCT01484197|20489866|P2|NOT COMPLETED|Treatment Period 1||0
8310607|NCT01484197|20489867|P1|NOT COMPLETED|Treatment Period 1||1
8310608|NCT01484197|20489864|P4|COMPLETED|Treatment Period 1||9
8310609|NCT01484197|20489865|P3|COMPLETED|Treatment Period 1||9
8310610|NCT01484197|20489866|P2|COMPLETED|Treatment Period 1||9
8310611|NCT01484197|20489867|P1|COMPLETED|Treatment Period 1||8
8310612|NCT01484197|20489864|P4|STARTED|Treatment Period 1||9
8310613|NCT01484197|20489865|P3|STARTED|Treatment Period 1||9
8310614|NCT01484197|20489866|P2|STARTED|Treatment Period 1||9
8310615|NCT01484197|20489867|P1|STARTED|Treatment Period 1||9
8310616|NCT01484132|20489950|P1|NOT COMPLETED|Overall Study||22
8310617|NCT01484132|20489950|P1|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
8310618|NCT01484132|20489950|P1|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
8310619|NCT01484132|20489950|P1|STARTED|Overall Study||113
8310620|NCT01484054|20489958|P2|NOT COMPLETED|Period 2||0
8310621|NCT01484054|20489959|P1|NOT COMPLETED|Period 2||0
8310622|NCT01484054|20489958|P2|COMPLETED|Period 2||49
8310623|NCT01484054|20489959|P1|COMPLETED|Period 2||50
8310624|NCT01484054|20489958|P2|STARTED|Period 2||49
8310625|NCT01484054|20489959|P1|STARTED|Period 2||50
8310626|NCT01484054|20489958|P2|NOT COMPLETED|Period 1||1
8310627|NCT01484054|20489959|P1|NOT COMPLETED|Period 1||0
8310628|NCT01484054|20489958|P2|COMPLETED|Period 1||49
8310629|NCT01484054|20489959|P1|COMPLETED|Period 1||50
8310630|NCT01484054|20489958|P2|STARTED|Period 1||50
8310631|NCT01484054|20489959|P1|STARTED|Period 1||50
8310632|NCT01484041|20489969|P1|NOT COMPLETED|Overall Study||0
8310633|NCT01484041|20489969|P1|COMPLETED|Overall Study||12
8310634|NCT01484041|20489969|P1|STARTED|Overall Study||12
8310635|NCT01484028|20489977|P4|NOT COMPLETED|Period 2||0
8310636|NCT01484028|20489978|P3|NOT COMPLETED|Period 2||0
8310637|NCT01484028|20489979|P2|NOT COMPLETED|Period 2||0
8310638|NCT01484028|20489980|P1|NOT COMPLETED|Period 2||0
8310639|NCT01484028|20489977|P4|COMPLETED|Period 2||66
8310640|NCT01484028|20489978|P3|COMPLETED|Period 2||64
8310641|NCT01484028|20489979|P2|COMPLETED|Period 2||67
8310642|NCT01484028|20489980|P1|COMPLETED|Period 2||66
8310643|NCT01484028|20489977|P4|STARTED|Period 2||66
8310644|NCT01484028|20489978|P3|STARTED|Period 2||64
8310645|NCT01484028|20489979|P2|STARTED|Period 2||67
8310646|NCT01484028|20489980|P1|STARTED|Period 2||66
8310647|NCT01484028|20489977|P4|NOT COMPLETED|Period 1||1
8310648|NCT01484028|20489978|P3|NOT COMPLETED|Period 1||0
8310649|NCT01484028|20489979|P2|NOT COMPLETED|Period 1||3
8310650|NCT01484028|20489980|P1|NOT COMPLETED|Period 1||0
8310651|NCT01484028|20489977|P4|COMPLETED|Period 1||66
8310652|NCT01484028|20489978|P3|COMPLETED|Period 1||64
8310653|NCT01484028|20489979|P2|COMPLETED|Period 1||67
8310654|NCT01484028|20489980|P1|COMPLETED|Period 1||66
8310655|NCT01484028|20489977|P4|STARTED|Period 1||67
8310656|NCT01484028|20489978|P3|STARTED|Period 1||64
8310657|NCT01484028|20489979|P2|STARTED|Period 1||70
8310658|NCT01484028|20489980|P1|STARTED|Period 1||66
8310659|NCT01483963|20489995|P5|NOT COMPLETED|Overall Study||0
8310660|NCT01483963|20489996|P4|NOT COMPLETED|Overall Study||0
8310661|NCT01483963|20489997|P3|NOT COMPLETED|Overall Study||0
8310662|NCT01483963|20489998|P2|NOT COMPLETED|Overall Study||0
8310663|NCT01483963|20489999|P1|NOT COMPLETED|Overall Study||0
8310664|NCT01483963|20489995|P5|COMPLETED|Overall Study||10
8310665|NCT01483963|20489996|P4|COMPLETED|Overall Study||10
8310666|NCT01483963|20489997|P3|COMPLETED|Overall Study||10
8310667|NCT01483963|20489998|P2|COMPLETED|Overall Study||10
8310668|NCT01483963|20489999|P1|COMPLETED|Overall Study||10
8310669|NCT01483963|20489995|P5|STARTED|Overall Study||10
8310670|NCT01483963|20489996|P4|STARTED|Overall Study||10
8310671|NCT01483963|20489997|P3|STARTED|Overall Study||10
8310672|NCT01483963|20489998|P2|STARTED|Overall Study||10
8310673|NCT01483963|20489999|P1|STARTED|Overall Study||10
8310674|NCT01483937|20490073|P2|NOT COMPLETED|Overall Study||3
8310675|NCT01483937|20490074|P1|NOT COMPLETED|Overall Study||4
8310676|NCT01483937|20490073|P2|COMPLETED|Overall Study||14
8310677|NCT01483937|20490074|P1|COMPLETED|Overall Study||11
8310678|NCT01483937|20490073|P2|STARTED|Overall Study||17
8310679|NCT01483937|20490074|P1|STARTED|Overall Study||15
8310680|NCT01483924|20490101|P5|NOT COMPLETED|Overall Study||2
8310681|NCT01483924|20490102|P4|NOT COMPLETED|Overall Study||4
8310682|NCT01483924|20490103|P3|NOT COMPLETED|Overall Study||1
8310683|NCT01483924|20490104|P2|NOT COMPLETED|Overall Study||0
8310684|NCT01483924|20490105|P1|NOT COMPLETED|Overall Study||2
8310685|NCT01483924|20490101|P5|COMPLETED|Overall Study||10
8310686|NCT01483924|20490102|P4|COMPLETED|Overall Study||8
8310687|NCT01483924|20490103|P3|COMPLETED|Overall Study||11
8310688|NCT01483924|20490104|P2|COMPLETED|Overall Study||12
8310689|NCT01483924|20490105|P1|COMPLETED|Overall Study||10
8310690|NCT01483924|20490101|P5|STARTED|Overall Study||12
8310691|NCT01483924|20490102|P4|STARTED|Overall Study||12
8310692|NCT01483924|20490103|P3|STARTED|Overall Study||12
8310693|NCT01483924|20490104|P2|STARTED|Overall Study||12
8310694|NCT01483924|20490105|P1|STARTED|Overall Study||12
8310695|NCT01483872|20490153|P2|NOT COMPLETED|Overall Study||0
8310696|NCT01483872|20490154|P1|NOT COMPLETED|Overall Study||0
8310697|NCT01483872|20490153|P2|COMPLETED|Overall Study||1
8310698|NCT01483872|20490154|P1|COMPLETED|Overall Study||0
8310699|NCT01483872|20490153|P2|STARTED|Overall Study||1
8310700|NCT01483872|20490154|P1|STARTED|Overall Study||0
8310701|NCT01483820|20490158|P1|NOT COMPLETED|Overall Study||8
8310702|NCT01483820|20490158|P1|COMPLETED|Overall Study||0
8310703|NCT01483820|20490158|P1|STARTED|Overall Study||8
8310704|NCT01483807|20490167|P2|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
8310705|NCT01483807|20490168|P1|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
8310706|NCT01483807|20490167|P2|COMPLETED|Second Treatment Phase (7 Weeks)||10
8310707|NCT01483807|20490168|P1|COMPLETED|Second Treatment Phase (7 Weeks)||10
8310708|NCT01483807|20490167|P2|STARTED|Second Treatment Phase (7 Weeks)||10
8310709|NCT01483807|20490168|P1|STARTED|Second Treatment Phase (7 Weeks)||10
8310710|NCT01483807|20490167|P2|NOT COMPLETED|Washout (2 Weeks)||0
8310711|NCT01483807|20490168|P1|NOT COMPLETED|Washout (2 Weeks)||0
8310712|NCT01483807|20490167|P2|COMPLETED|Washout (2 Weeks)||10
8310713|NCT01483807|20490168|P1|COMPLETED|Washout (2 Weeks)||10
8310714|NCT01483807|20490167|P2|STARTED|Washout (2 Weeks)||10
8310715|NCT01483807|20490168|P1|STARTED|Washout (2 Weeks)||10
8310716|NCT01483807|20490167|P2|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
8310717|NCT01483807|20490168|P1|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
8310718|NCT01483807|20490167|P2|COMPLETED|First Treatment Phase (7 Weeks)||10
8310719|NCT01483807|20490168|P1|COMPLETED|First Treatment Phase (7 Weeks)||10
8310720|NCT01483807|20490167|P2|STARTED|First Treatment Phase (7 Weeks)||10
8310721|NCT01483807|20490168|P1|STARTED|First Treatment Phase (7 Weeks)||10
8310722|NCT01483690|20490181|P2|NOT COMPLETED|Overall Study||5
8310723|NCT01483690|20490182|P1|NOT COMPLETED|Overall Study||2
8310724|NCT01483690|20490181|P2|COMPLETED|Overall Study||13
8310725|NCT01483690|20490182|P1|COMPLETED|Overall Study||3
8310726|NCT01483690|20490181|P2|STARTED|Overall Study||18
8310727|NCT01483690|20490182|P1|STARTED|Overall Study||5
8310728|NCT01483651|20490190|P6|NOT COMPLETED|Overall Study||1
8310729|NCT01483651|20490191|P5|NOT COMPLETED|Overall Study||0
8310730|NCT01483651|20490192|P4|NOT COMPLETED|Overall Study||0
8310731|NCT01483651|20490193|P3|NOT COMPLETED|Overall Study||1
8310732|NCT01483651|20490194|P2|NOT COMPLETED|Overall Study||1
8310733|NCT01483651|20490195|P1|NOT COMPLETED|Overall Study||0
8310734|NCT01483651|20490190|P6|COMPLETED|Overall Study||1
8310735|NCT01483651|20490191|P5|COMPLETED|Overall Study||2
8310736|NCT01483651|20490192|P4|COMPLETED|Overall Study||1
8310737|NCT01483651|20490193|P3|COMPLETED|Overall Study||1
8310738|NCT01483651|20490194|P2|COMPLETED|Overall Study||2
8310739|NCT01483651|20490195|P1|COMPLETED|Overall Study||1
8310740|NCT01483651|20490190|P6|STARTED|Overall Study||2
8310741|NCT01483651|20490191|P5|STARTED|Overall Study||2
8310742|NCT01483651|20490192|P4|STARTED|Overall Study||1
8310743|NCT01483651|20490193|P3|STARTED|Overall Study||2
8310744|NCT01483651|20490194|P2|STARTED|Overall Study||3
8310745|NCT01483651|20490195|P1|STARTED|Overall Study||1
8310746|NCT01483625|20490205|P2|NOT COMPLETED|Overall Study||2
8310747|NCT01483625|20490206|P1|NOT COMPLETED|Overall Study||4
8310748|NCT01483625|20490205|P2|COMPLETED|Overall Study||66
8310749|NCT01483625|20490206|P1|COMPLETED|Overall Study||68
8310750|NCT01483625|20490205|P2|STARTED|Overall Study||68
8310751|NCT01483625|20490206|P1|STARTED|Overall Study||72
8310752|NCT01483599|20490229|P14|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
8310753|NCT01483599|20490230|P13|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
8310754|NCT01483599|20490231|P12|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
8310755|NCT01483599|20490232|P11|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
8310756|NCT01483599|20490233|P10|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
8310757|NCT01483599|20490234|P9|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
8310758|NCT01483599|20490235|P8|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
8310759|NCT01483599|20490236|P7|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310760|NCT01483599|20490237|P6|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310761|NCT01483599|20490238|P5|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310762|NCT01483599|20490239|P4|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310763|NCT01483599|20490240|P3|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310764|NCT01483599|20490241|P2|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310765|NCT01483599|20490242|P1|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310766|NCT01483599|20490229|P14|COMPLETED|After Controlled Period(Week 16-Week 40)||32
8310767|NCT01483599|20490230|P13|COMPLETED|After Controlled Period(Week 16-Week 40)||35
8310768|NCT01483599|20490231|P12|COMPLETED|After Controlled Period(Week 16-Week 40)||39
8310769|NCT01483599|20490232|P11|COMPLETED|After Controlled Period(Week 16-Week 40)||37
8310770|NCT01483599|20490233|P10|COMPLETED|After Controlled Period(Week 16-Week 40)||37
8310771|NCT01483599|20490234|P9|COMPLETED|After Controlled Period(Week 16-Week 40)||29
8310772|NCT01483599|20490235|P8|COMPLETED|After Controlled Period(Week 16-Week 40)||37
8310773|NCT01483599|20490236|P7|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310774|NCT01483599|20490237|P6|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310775|NCT01483599|20490238|P5|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310776|NCT01483599|20490239|P4|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310777|NCT01483599|20490240|P3|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310778|NCT01483599|20490241|P2|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310779|NCT01483599|20490242|P1|COMPLETED|After Controlled Period(Week 16-Week 40)||0
8310780|NCT01483599|20490229|P14|STARTED|After Controlled Period(Week 16-Week 40)||39
8310781|NCT01483599|20490230|P13|STARTED|After Controlled Period(Week 16-Week 40)||38
8310782|NCT01483599|20490231|P12|STARTED|After Controlled Period(Week 16-Week 40)||40
8310783|NCT01483599|20490232|P11|STARTED|After Controlled Period(Week 16-Week 40)||39
8310784|NCT01483599|20490233|P10|STARTED|After Controlled Period(Week 16-Week 40)||41
8310785|NCT01483599|20490234|P9|STARTED|After Controlled Period(Week 16-Week 40)||38
8310786|NCT01483599|20490235|P8|STARTED|After Controlled Period(Week 16-Week 40)||39
8310787|NCT01483599|20490236|P7|STARTED|After Controlled Period(Week 16-Week 40)||0
8310788|NCT01483599|20490237|P6|STARTED|After Controlled Period(Week 16-Week 40)||0
8310789|NCT01483599|20490238|P5|STARTED|After Controlled Period(Week 16-Week 40)||0
8310790|NCT01483599|20490239|P4|STARTED|After Controlled Period(Week 16-Week 40)||0
8310791|NCT01483599|20490240|P3|STARTED|After Controlled Period(Week 16-Week 40)||0
8310792|NCT01483599|20490241|P2|STARTED|After Controlled Period(Week 16-Week 40)||0
8310793|NCT01483599|20490242|P1|STARTED|After Controlled Period(Week 16-Week 40)||0
8310794|NCT01483599|20490229|P14|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310795|NCT01483599|20490230|P13|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310796|NCT01483599|20490231|P12|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310797|NCT01483599|20490232|P11|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310798|NCT01483599|20490233|P10|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310799|NCT01483599|20490234|P9|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310800|NCT01483599|20490235|P8|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310801|NCT01483599|20490236|P7|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
8310802|NCT01483599|20490237|P6|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
8310803|NCT01483599|20490238|P5|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
8310804|NCT01483599|20490239|P4|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
8310805|NCT01483599|20490240|P3|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310806|NCT01483599|20490241|P2|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
8310807|NCT01483599|20490242|P1|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
8310808|NCT01483599|20490229|P14|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310809|NCT01483599|20490230|P13|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310810|NCT01483599|20490231|P12|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310811|NCT01483599|20490232|P11|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310812|NCT01483599|20490233|P10|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310813|NCT01483599|20490234|P9|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310814|NCT01483599|20490235|P8|COMPLETED|Controlled Period (CP) (up to Week 16)||0
8310815|NCT01483599|20490236|P7|COMPLETED|Controlled Period (CP) (up to Week 16)||39
8310816|NCT01483599|20490237|P6|COMPLETED|Controlled Period (CP) (up to Week 16)||38
8310817|NCT01483599|20490238|P5|COMPLETED|Controlled Period (CP) (up to Week 16)||40
8310818|NCT01483599|20490239|P4|COMPLETED|Controlled Period (CP) (up to Week 16)||39
8310819|NCT01483599|20490240|P3|COMPLETED|Controlled Period (CP) (up to Week 16)||41
8310820|NCT01483599|20490241|P2|COMPLETED|Controlled Period (CP) (up to Week 16)||38
8310821|NCT01483599|20490242|P1|COMPLETED|Controlled Period (CP) (up to Week 16)||39
8310822|NCT01483599|20490229|P14|Treated|Controlled Period (CP) (up to Week 16)||0
8310823|NCT01483599|20490230|P13|Treated|Controlled Period (CP) (up to Week 16)||0
8310824|NCT01483599|20490231|P12|Treated|Controlled Period (CP) (up to Week 16)||0
8310825|NCT01483599|20490232|P11|Treated|Controlled Period (CP) (up to Week 16)||0
8310826|NCT01483599|20490233|P10|Treated|Controlled Period (CP) (up to Week 16)||0
8310827|NCT01483599|20490234|P9|Treated|Controlled Period (CP) (up to Week 16)||0
8310828|NCT01483599|20490235|P8|Treated|Controlled Period (CP) (up to Week 16)||0
8310829|NCT01483599|20490236|P7|Treated|Controlled Period (CP) (up to Week 16)||43
8310830|NCT01483599|20490237|P6|Treated|Controlled Period (CP) (up to Week 16)||41
8310831|NCT01483599|20490238|P5|Treated|Controlled Period (CP) (up to Week 16)||42
8310832|NCT01483599|20490239|P4|Treated|Controlled Period (CP) (up to Week 16)||42
8310833|NCT01483599|20490240|P3|Treated|Controlled Period (CP) (up to Week 16)||41
8310834|NCT01483599|20490241|P2|Treated|Controlled Period (CP) (up to Week 16)||41
8310835|NCT01483599|20490242|P1|Treated|Controlled Period (CP) (up to Week 16)||42
8310836|NCT01483599|20490229|P14|STARTED|Controlled Period (CP) (up to Week 16)||0
8310837|NCT01483599|20490230|P13|STARTED|Controlled Period (CP) (up to Week 16)||0
8310838|NCT01483599|20490231|P12|STARTED|Controlled Period (CP) (up to Week 16)||0
8310839|NCT01483599|20490232|P11|STARTED|Controlled Period (CP) (up to Week 16)||0
8310840|NCT01483599|20490233|P10|STARTED|Controlled Period (CP) (up to Week 16)||0
8310841|NCT01483599|20490234|P9|STARTED|Controlled Period (CP) (up to Week 16)||0
8310842|NCT01483599|20490235|P8|STARTED|Controlled Period (CP) (up to Week 16)||0
8310843|NCT01483599|20490236|P7|STARTED|Controlled Period (CP) (up to Week 16)||43
8310844|NCT01483599|20490237|P6|STARTED|Controlled Period (CP) (up to Week 16)||42
8310845|NCT01483599|20490238|P5|STARTED|Controlled Period (CP) (up to Week 16)||42
8310846|NCT01483599|20490239|P4|STARTED|Controlled Period (CP) (up to Week 16)||42
8310847|NCT01483599|20490240|P3|STARTED|Controlled Period (CP) (up to Week 16)||41
8310848|NCT01483599|20490241|P2|STARTED|Controlled Period (CP) (up to Week 16)||41
8310849|NCT01483599|20490242|P1|STARTED|Controlled Period (CP) (up to Week 16)||42
8310850|NCT01483560|20490293|P2|NOT COMPLETED|Overall Study||15
8310851|NCT01483560|20490294|P1|NOT COMPLETED|Overall Study||26
8310852|NCT01483560|20490293|P2|COMPLETED|Overall Study||194
8310853|NCT01483560|20490294|P1|COMPLETED|Overall Study||193
8310854|NCT01483560|20490293|P2|STARTED|Overall Study||209
8310855|NCT01483560|20490294|P1|STARTED|Overall Study||219
8310856|NCT01483378|20490314|P2|NOT COMPLETED|Overall Study||0
8310857|NCT01483378|20490315|P1|NOT COMPLETED|Overall Study||0
8310858|NCT01483378|20490314|P2|COMPLETED|Overall Study||66
8310859|NCT01483378|20490315|P1|COMPLETED|Overall Study||100
8310860|NCT01483378|20490314|P2|STARTED|Overall Study||66
8310861|NCT01483378|20490315|P1|STARTED|Overall Study||100
8310862|NCT01483352|20490321|P1|NOT COMPLETED|Overall Study||0
8310863|NCT01483352|20490321|P1|COMPLETED|Overall Study||12
8310864|NCT01483352|20490321|P1|STARTED|Overall Study||12
8310865|NCT01483209|20490340|P1|NOT COMPLETED|Overall Study||1
8310866|NCT01483209|20490340|P1|COMPLETED|Overall Study||1
8310867|NCT01483209|20490340|P1|STARTED|Overall Study||2
8310868|NCT01483183|20490355|P10|NOT COMPLETED|Overall Study||1
8310869|NCT01483183|20490356|P9|NOT COMPLETED|Overall Study||0
8310870|NCT01483183|20490357|P8|NOT COMPLETED|Overall Study||0
8310871|NCT01483183|20490358|P7|NOT COMPLETED|Overall Study||2
8310872|NCT01483183|20490359|P6|NOT COMPLETED|Overall Study||0
8310873|NCT01483183|20490360|P5|NOT COMPLETED|Overall Study||0
8310874|NCT01483183|20490361|P4|NOT COMPLETED|Overall Study||0
8310875|NCT01483183|20490362|P3|NOT COMPLETED|Overall Study||0
8310876|NCT01483183|20490363|P2|NOT COMPLETED|Overall Study||0
8310877|NCT01483183|20490364|P1|NOT COMPLETED|Overall Study||0
8310878|NCT01483183|20490355|P10|COMPLETED|Overall Study||4
8310879|NCT01483183|20490356|P9|COMPLETED|Overall Study||4
8310880|NCT01483183|20490357|P8|COMPLETED|Overall Study||4
8310881|NCT01483183|20490358|P7|COMPLETED|Overall Study||4
8310882|NCT01483183|20490359|P6|COMPLETED|Overall Study||4
8310883|NCT01483183|20490360|P5|COMPLETED|Overall Study||4
8310884|NCT01483183|20490361|P4|COMPLETED|Overall Study||3
8310885|NCT01483183|20490362|P3|COMPLETED|Overall Study||5
8310886|NCT01483183|20490363|P2|COMPLETED|Overall Study||1
8310887|NCT01483183|20490364|P1|COMPLETED|Overall Study||4
8310888|NCT01483183|20490355|P10|STARTED|Overall Study||5
8310889|NCT01483183|20490356|P9|STARTED|Overall Study||4
8310890|NCT01483183|20490357|P8|STARTED|Overall Study||4
8310891|NCT01483183|20490358|P7|STARTED|Overall Study||6
8310892|NCT01483183|20490359|P6|STARTED|Overall Study||4
8310893|NCT01483183|20490360|P5|STARTED|Overall Study||4
8310894|NCT01483183|20490361|P4|STARTED|Overall Study||3
8310895|NCT01483183|20490362|P3|STARTED|Overall Study||5
8310896|NCT01483183|20490363|P2|STARTED|Overall Study||1
8310897|NCT01483183|20490364|P1|STARTED|Overall Study||4
8310898|NCT01483118|20490434|P2|NOT COMPLETED|Overall Study||16
8310899|NCT01483118|20490435|P1|NOT COMPLETED|Overall Study||12
8310900|NCT01483118|20490434|P2|COMPLETED|Overall Study||6
8310901|NCT01483118|20490435|P1|COMPLETED|Overall Study||11
8310902|NCT01483118|20490434|P2|Completed 3 Months|Overall Study||11
8310903|NCT01483118|20490435|P1|Completed 3 Months|Overall Study||15
8310904|NCT01483118|20490434|P2|STARTED|Overall Study||22
8310905|NCT01483118|20490435|P1|STARTED|Overall Study||23
8310906|NCT01482962|20490447|P2|NOT COMPLETED|Overall Study||133
8310907|NCT01482962|20490448|P1|NOT COMPLETED|Overall Study||138
8310908|NCT01482962|20490447|P2|COMPLETED|Overall Study||0
8310909|NCT01482962|20490448|P1|COMPLETED|Overall Study||0
8310910|NCT01482962|20490447|P2|Safety Population: Received Study Drug|Overall Study||127
8310911|NCT01482962|20490448|P1|Safety Population: Received Study Drug|Overall Study||137
8310912|NCT01482962|20490447|P2|STARTED|Overall Study||133
8310913|NCT01482962|20490448|P1|STARTED|Overall Study||138
8310914|NCT01482910|20490481|P2|NOT COMPLETED|Overall Study||9
8310915|NCT01482910|20490482|P1|NOT COMPLETED|Overall Study||15
8310916|NCT01482910|20490481|P2|COMPLETED|Overall Study||67
8310917|NCT01482910|20490482|P1|COMPLETED|Overall Study||213
8310918|NCT01482910|20490481|P2|Completed Week 28|Overall Study||71
8310919|NCT01482910|20490482|P1|Completed Week 28|Overall Study||216
8310920|NCT01482910|20490481|P2|STARTED|Overall Study||76
8310921|NCT01482910|20490482|P1|STARTED|Overall Study||228
8310922|NCT01482884|20490494|P2|NOT COMPLETED|Overall Study||18
8310923|NCT01482884|20490495|P1|NOT COMPLETED|Overall Study||13
8310924|NCT01482884|20490494|P2|COMPLETED|Overall Study||37
8310925|NCT01482884|20490495|P1|COMPLETED|Overall Study||43
8310926|NCT01482884|20490494|P2|STARTED|Overall Study||55
8310927|NCT01482884|20490495|P1|STARTED|Overall Study|One participant did not receive study treatment|56
8310928|NCT01482819|20490521|P1|NOT COMPLETED|Overall Study||2
8310929|NCT01482819|20490521|P1|COMPLETED|Overall Study||19
8310930|NCT01482819|20490521|P1|STARTED|Overall Study||21
8310931|NCT01482767|20490541|P2|NOT COMPLETED|Overall Study||49
8310932|NCT01482767|20490542|P1|NOT COMPLETED|Overall Study||54
8310933|NCT01482767|20490541|P2|COMPLETED|Overall Study||78
8310934|NCT01482767|20490542|P1|COMPLETED|Overall Study||81
8310935|NCT01482767|20490541|P2|STARTED|Overall Study||127
8310936|NCT01482767|20490542|P1|STARTED|Overall Study||135
8310937|NCT01482715|20490575|P13|NOT COMPLETED|Overall Study||0
8310938|NCT01482715|20490576|P12|NOT COMPLETED|Overall Study||0
8310939|NCT01482715|20490577|P11|NOT COMPLETED|Overall Study||0
8310940|NCT01482715|20490578|P10|NOT COMPLETED|Overall Study||0
8310941|NCT01482715|20490579|P9|NOT COMPLETED|Overall Study||0
8310942|NCT01482715|20490580|P8|NOT COMPLETED|Overall Study||0
8310943|NCT01482715|20490581|P7|NOT COMPLETED|Overall Study||0
8310944|NCT01482715|20490582|P6|NOT COMPLETED|Overall Study||0
8310945|NCT01482715|20490583|P5|NOT COMPLETED|Overall Study||0
8310946|NCT01482715|20490584|P4|NOT COMPLETED|Overall Study||0
8310947|NCT01482715|20490585|P3|NOT COMPLETED|Overall Study||0
8310948|NCT01482715|20490586|P2|NOT COMPLETED|Overall Study||0
8310949|NCT01482715|20490587|P1|NOT COMPLETED|Overall Study||0
8310950|NCT01482715|20490575|P13|COMPLETED|Overall Study||26
8310951|NCT01482715|20490576|P12|COMPLETED|Overall Study||12
8310952|NCT01482715|20490577|P11|COMPLETED|Overall Study||42
8310953|NCT01482715|20490578|P10|COMPLETED|Overall Study||3
8310954|NCT01482715|20490579|P9|COMPLETED|Overall Study||7
8310955|NCT01482715|20490580|P8|COMPLETED|Overall Study||9
8310956|NCT01482715|20490581|P7|COMPLETED|Overall Study||8
8310957|NCT01482715|20490582|P6|COMPLETED|Overall Study||3
8310958|NCT01482715|20490583|P5|COMPLETED|Overall Study||4
8310959|NCT01482715|20490584|P4|COMPLETED|Overall Study||9
8310960|NCT01482715|20490585|P3|COMPLETED|Overall Study||4
8310961|NCT01482715|20490586|P2|COMPLETED|Overall Study||3
8310962|NCT01482715|20490587|P1|COMPLETED|Overall Study||6
8310963|NCT01482715|20490575|P13|STARTED|Overall Study||26
8310964|NCT01482715|20490576|P12|STARTED|Overall Study||12
8310965|NCT01482715|20490577|P11|STARTED|Overall Study||42
8310966|NCT01482715|20490578|P10|STARTED|Overall Study||3
8310967|NCT01482715|20490579|P9|STARTED|Overall Study||7
8310968|NCT01482715|20490580|P8|STARTED|Overall Study||9
8310969|NCT01482715|20490581|P7|STARTED|Overall Study||8
8310970|NCT01482715|20490582|P6|STARTED|Overall Study||3
8310971|NCT01482715|20490583|P5|STARTED|Overall Study||4
8310972|NCT01482715|20490584|P4|STARTED|Overall Study||9
8310973|NCT01482715|20490585|P3|STARTED|Overall Study||4
8310974|NCT01482715|20490586|P2|STARTED|Overall Study||3
8310975|NCT01482715|20490587|P1|STARTED|Overall Study||6
8310976|NCT01482598|20490670|P2|NOT COMPLETED|Overall Study||22
8310977|NCT01482598|20490671|P1|NOT COMPLETED|Overall Study||16
8310978|NCT01482598|20490670|P2|COMPLETED|Overall Study||51
8310979|NCT01482598|20490671|P1|COMPLETED|Overall Study||50
8310980|NCT01482598|20490670|P2|STARTED|Overall Study||73
8310981|NCT01482598|20490671|P1|STARTED|Overall Study||66
8310982|NCT01482429|20490679|P2|NOT COMPLETED|Protocol||0
8310983|NCT01482429|20490680|P1|NOT COMPLETED|Protocol||275
8310984|NCT01482429|20490679|P2|COMPLETED|Protocol||0
8310985|NCT01482429|20490680|P1|COMPLETED|Protocol||139
8310986|NCT01482429|20490679|P2|STARTED|Protocol||0
8310987|NCT01482429|20490680|P1|STARTED|Protocol||414
8310988|NCT01482429|20490679|P2|NOT COMPLETED|Care Usual||173
8310989|NCT01482429|20490680|P1|NOT COMPLETED|Care Usual||0
8310990|NCT01482429|20490679|P2|COMPLETED|Care Usual||96
8310991|NCT01482429|20490680|P1|COMPLETED|Care Usual||0
8310992|NCT01482429|20490679|P2|STARTED|Care Usual||269
8310993|NCT01482429|20490680|P1|STARTED|Care Usual||0
8310994|NCT01482351|20490690|P1|NOT COMPLETED|Overall Study||14
8310995|NCT01482351|20490690|P1|COMPLETED|Overall Study||54
8310996|NCT01482351|20490690|P1|12 Months|Overall Study||54
8310997|NCT01482351|20490690|P1|6 Months|Overall Study|14 dropped out|54
8310998|NCT01482351|20490690|P1|STARTED|Overall Study||68
8310999|NCT01482325|20490712|P1|NOT COMPLETED|Overall Study||0
8311000|NCT01482325|20490712|P1|COMPLETED|Overall Study||31
8311001|NCT01482325|20490712|P1|STARTED|Overall Study||31
8311002|NCT01482312|20490716|P3|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
8311003|NCT01482312|20490717|P2|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
8311004|NCT01482312|20490718|P1|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
8311005|NCT01482312|20490716|P3|COMPLETED|Period 3, 90 Minutes of Wear||9
8311006|NCT01482312|20490717|P2|COMPLETED|Period 3, 90 Minutes of Wear||9
8311007|NCT01482312|20490718|P1|COMPLETED|Period 3, 90 Minutes of Wear||8
8311008|NCT01482312|20490716|P3|STARTED|Period 3, 90 Minutes of Wear||9
8311009|NCT01482312|20490717|P2|STARTED|Period 3, 90 Minutes of Wear||9
8311010|NCT01482312|20490718|P1|STARTED|Period 3, 90 Minutes of Wear||8
8311011|NCT01482312|20490716|P3|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
8311012|NCT01482312|20490717|P2|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
8311013|NCT01482312|20490718|P1|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
8311014|NCT01482312|20490716|P3|COMPLETED|Period 2, 90 Minutes of Wear||9
8311015|NCT01482312|20490717|P2|COMPLETED|Period 2, 90 Minutes of Wear||9
8311016|NCT01482312|20490718|P1|COMPLETED|Period 2, 90 Minutes of Wear||8
8311017|NCT01482312|20490716|P3|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
8311018|NCT01482312|20490717|P2|STARTED|Period 2, 90 Minutes of Wear||9
8311019|NCT01482312|20490718|P1|STARTED|Period 2, 90 Minutes of Wear||9
8311020|NCT01482312|20490716|P3|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
8311021|NCT01482312|20490717|P2|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
8311022|NCT01482312|20490718|P1|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
8311023|NCT01482312|20490716|P3|COMPLETED|Period 1, 90 Minutes of Wear||10
8311024|NCT01482312|20490717|P2|COMPLETED|Period 1, 90 Minutes of Wear||9
8311025|NCT01482312|20490718|P1|COMPLETED|Period 1, 90 Minutes of Wear||9
8311026|NCT01482312|20490716|P3|STARTED|Period 1, 90 Minutes of Wear||10
8311027|NCT01482312|20490717|P2|STARTED|Period 1, 90 Minutes of Wear||9
8311028|NCT01482312|20490718|P1|STARTED|Period 1, 90 Minutes of Wear||10
8311029|NCT01482221|20490732|P3|NOT COMPLETED|Overall Study||23
8311030|NCT01482221|20490733|P2|NOT COMPLETED|Overall Study||20
8311031|NCT01482221|20490734|P1|NOT COMPLETED|Overall Study||21
8311032|NCT01482221|20490732|P3|COMPLETED|Overall Study||77
8311033|NCT01482221|20490733|P2|COMPLETED|Overall Study||81
8311034|NCT01482221|20490734|P1|COMPLETED|Overall Study||80
8311035|NCT01482221|20490732|P3|STARTED|Overall Study||100
8311036|NCT01482221|20490733|P2|STARTED|Overall Study||101
8311037|NCT01482221|20490734|P1|STARTED|Overall Study||101
8311038|NCT01482169|20490775|P1|NOT COMPLETED|Overall Study||2
8311039|NCT01482169|20490775|P1|COMPLETED|Overall Study||46
8311040|NCT01482169|20490775|P1|STARTED|Overall Study||48
8311041|NCT01482091|20490784|P2|NOT COMPLETED|Overall Study||0
8311042|NCT01482091|20490785|P1|NOT COMPLETED|Overall Study||0
8311043|NCT01482091|20490784|P2|COMPLETED|Overall Study||24
8311044|NCT01482091|20490785|P1|COMPLETED|Overall Study||25
8311045|NCT01482091|20490784|P2|STARTED|Overall Study||24
8311046|NCT01482091|20490785|P1|STARTED|Overall Study||25
8311047|NCT01482065|20490817|P2|NOT COMPLETED|Overall Study||1
8311048|NCT01482065|20490818|P1|NOT COMPLETED|Overall Study||0
8311049|NCT01482065|20490817|P2|COMPLETED|Overall Study||4
8311050|NCT01482065|20490818|P1|COMPLETED|Overall Study||4
8311051|NCT01482065|20490817|P2|STARTED|Overall Study||5
8311052|NCT01482065|20490818|P1|STARTED|Overall Study||4
8311053|NCT01481935|20490832|P2|NOT COMPLETED|Overall Study||0
8311054|NCT01481935|20490833|P1|NOT COMPLETED|Overall Study||0
8311055|NCT01481935|20490832|P2|COMPLETED|Overall Study||93
8311056|NCT01481935|20490833|P1|COMPLETED|Overall Study||97
8311057|NCT01481935|20490832|P2|STARTED|Overall Study||93
8311058|NCT01481935|20490833|P1|STARTED|Overall Study||97
8311059|NCT01481896|20490839|P1|NOT COMPLETED|Overall Study||12
8311060|NCT01481896|20490839|P1|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
8311061|NCT01481896|20490839|P1|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
8311062|NCT01481896|20490839|P1|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
8311063|NCT01481779|20490855|P2|NOT COMPLETED|Overall Study||28
8311064|NCT01481779|20490856|P1|NOT COMPLETED|Overall Study||70
8311065|NCT01481779|20490855|P2|COMPLETED|Overall Study||132
8311066|NCT01481779|20490856|P1|COMPLETED|Overall Study||225
8311067|NCT01481779|20490855|P2|Received at Least 1 Dose of Study Drug|Overall Study||159
8311068|NCT01481779|20490856|P1|Received at Least 1 Dose of Study Drug|Overall Study||294
8311069|NCT01481779|20490855|P2|STARTED|Overall Study||160
8311070|NCT01481779|20490856|P1|STARTED|Overall Study||295
8311071|NCT01481740|20490904|P2|NOT COMPLETED|Overall Study||7
8311072|NCT01481740|20490905|P1|NOT COMPLETED|Overall Study||11
8311073|NCT01481740|20490904|P2|COMPLETED|Overall Study||81
8311074|NCT01481740|20490905|P1|COMPLETED|Overall Study||79
8311075|NCT01481740|20490904|P2|STARTED|Overall Study||88
8311076|NCT01481740|20490905|P1|STARTED|Overall Study||90
8311077|NCT01481558|20490923|P2|NOT COMPLETED|Overall Study||0
8311078|NCT01481558|20490924|P1|NOT COMPLETED|Overall Study||0
8311079|NCT01481558|20490923|P2|COMPLETED|Overall Study||20
8311080|NCT01481558|20490924|P1|COMPLETED|Overall Study||20
8311081|NCT01481558|20490923|P2|STARTED|Overall Study||20
8311082|NCT01481558|20490924|P1|STARTED|Overall Study||20
8311083|NCT01481376|20490930|P1|NOT COMPLETED|Overall Study||31
8311084|NCT01481376|20490930|P1|COMPLETED|Overall Study||169
8311085|NCT01481376|20490930|P1|STARTED|Overall Study||200
8311086|NCT01481324|20490941|P3|NOT COMPLETED|Overall Study||2
8311087|NCT01481324|20490942|P2|NOT COMPLETED|Overall Study||2
8311088|NCT01481324|20490943|P1|NOT COMPLETED|Overall Study||0
8311089|NCT01481324|20490941|P3|COMPLETED|Overall Study||20
8311090|NCT01481324|20490942|P2|COMPLETED|Overall Study||22
8311091|NCT01481324|20490943|P1|COMPLETED|Overall Study||21
8311092|NCT01481324|20490941|P3|Month 3-Wear Rate Data|Overall Study||6
8311093|NCT01481324|20490942|P2|Month 3-Wear Rate Data|Overall Study||11
8311094|NCT01481324|20490943|P1|Month 3-Wear Rate Data|Overall Study||7
8311095|NCT01481324|20490941|P3|Month 2-Wear Rate Data|Overall Study||7
8311096|NCT01481324|20490942|P2|Month 2-Wear Rate Data|Overall Study||13
8311097|NCT01481324|20490943|P1|Month 2-Wear Rate Data|Overall Study||9
8311098|NCT01481324|20490941|P3|Month 1-Wear Rate Data|Overall Study||8
8311099|NCT01481324|20490942|P2|Month 1-Wear Rate Data|Overall Study||16
8311100|NCT01481324|20490943|P1|Month 1-Wear Rate Data|Overall Study||15
8311101|NCT01481324|20490941|P3|STARTED|Overall Study||22
8311102|NCT01481324|20490942|P2|STARTED|Overall Study||24
8311103|NCT01481324|20490943|P1|STARTED|Overall Study||21
8311104|NCT01481129|20490951|P1|NOT COMPLETED|Overall Study||0
8311105|NCT01481129|20490951|P1|COMPLETED|Overall Study||22
8311106|NCT01481129|20490951|P1|STARTED|Overall Study||22
8311107|NCT01481116|20490962|P3|NOT COMPLETED|Overall Study||813
8311108|NCT01481116|20490963|P2|NOT COMPLETED|Overall Study||817
8311109|NCT01481116|20490964|P1|NOT COMPLETED|Overall Study||824
8311110|NCT01481116|20490962|P3|COMPLETED|Overall Study||0
8311111|NCT01481116|20490963|P2|COMPLETED|Overall Study||0
8311112|NCT01481116|20490964|P1|COMPLETED|Overall Study||0
8311113|NCT01481116|20490962|P3|Treated|Overall Study||813
8311114|NCT01481116|20490963|P2|Treated|Overall Study||816
8311115|NCT01481116|20490964|P1|Treated|Overall Study||822
8311116|NCT01481116|20490962|P3|STARTED|Overall Study||813
8311117|NCT01481116|20490963|P2|STARTED|Overall Study||817
8311118|NCT01481116|20490964|P1|STARTED|Overall Study||824
8311119|NCT01480843|20490990|P1|NOT COMPLETED|Overall Study||5
8311120|NCT01480843|20490990|P1|COMPLETED|Overall Study||60
8311121|NCT01480843|20490990|P1|STARTED|Overall Study||65
8311122|NCT01480674|20490995|P1|NOT COMPLETED|Overall Study||35
8311123|NCT01480674|20490995|P1|COMPLETED|Overall Study||125
8311124|NCT01480674|20490995|P1|Analysed Set|Overall Study||128
8311125|NCT01480674|20490995|P1|Safety Set|Overall Study||154
8311126|NCT01480674|20490995|P1|STARTED|Overall Study||160
8311127|NCT01480596|20491009|P2|NOT COMPLETED|Overall Study||2
8311128|NCT01480596|20491010|P1|NOT COMPLETED|Overall Study||5
8311129|NCT01480596|20491009|P2|COMPLETED|Overall Study||16
8311130|NCT01480596|20491010|P1|COMPLETED|Overall Study||17
8311131|NCT01480596|20491009|P2|STARTED|Overall Study||18
8311132|NCT01480596|20491010|P1|STARTED|Overall Study||22
8311133|NCT01480297|20491052|P1|NOT COMPLETED|Overall Study||0
8311134|NCT01480297|20491052|P1|COMPLETED|Overall Study||8
8311135|NCT01480297|20491052|P1|STARTED|Overall Study||8
8311136|NCT01480284|20491058|P2|NOT COMPLETED|Overall Study||0
8311137|NCT01480284|20491059|P1|NOT COMPLETED|Overall Study||8
8311138|NCT01480284|20491058|P2|COMPLETED|Overall Study||56
8311139|NCT01480284|20491059|P1|COMPLETED|Overall Study||102
8311140|NCT01480284|20491058|P2|STARTED|Overall Study||56
8311141|NCT01480284|20491059|P1|STARTED|Overall Study||110
8311142|NCT01480258|20491089|P2|NOT COMPLETED|Toddler Dose||0
8311143|NCT01480258|20491090|P1|NOT COMPLETED|Toddler Dose||0
8311144|NCT01480258|20491089|P2|COMPLETED|Toddler Dose||642
8311145|NCT01480258|20491090|P1|COMPLETED|Toddler Dose||639
8311146|NCT01480258|20491089|P2|STARTED|Toddler Dose||642
8311147|NCT01480258|20491090|P1|STARTED|Toddler Dose||639
8311148|NCT01480258|20491089|P2|NOT COMPLETED|Interim Period||9
8311149|NCT01480258|20491090|P1|NOT COMPLETED|Interim Period||10
8311150|NCT01480258|20491089|P2|COMPLETED|Interim Period||642
8311151|NCT01480258|20491090|P1|COMPLETED|Interim Period||639
8311152|NCT01480258|20491089|P2|STARTED|Interim Period||651
8311153|NCT01480258|20491090|P1|STARTED|Interim Period||649
8311154|NCT01480258|20491089|P2|NOT COMPLETED|Infant Series||8
8311155|NCT01480258|20491090|P1|NOT COMPLETED|Infant Series||7
8311156|NCT01480258|20491089|P2|COMPLETED|Infant Series||651
8311157|NCT01480258|20491090|P1|COMPLETED|Infant Series||649
8311158|NCT01480258|20491089|P2|Vaccinated|Infant Series||659
8311159|NCT01480258|20491090|P1|Vaccinated|Infant Series||653
8311160|NCT01480258|20491089|P2|STARTED|Infant Series||659
8311161|NCT01480258|20491090|P1|STARTED|Infant Series||656
8311162|NCT01480232|20491116|P4|NOT COMPLETED|Overall Study||19
8311163|NCT01480232|20491117|P3|NOT COMPLETED|Overall Study||17
8311164|NCT01480232|20491118|P2|NOT COMPLETED|Overall Study||22
8311165|NCT01480232|20491119|P1|NOT COMPLETED|Overall Study||18
8311166|NCT01480232|20491116|P4|COMPLETED|Overall Study||22
8311167|NCT01480232|20491117|P3|COMPLETED|Overall Study||21
8311168|NCT01480232|20491118|P2|COMPLETED|Overall Study||19
8311169|NCT01480232|20491119|P1|COMPLETED|Overall Study||22
8311170|NCT01480232|20491116|P4|STARTED|Overall Study||41
8311171|NCT01480232|20491117|P3|STARTED|Overall Study||38
8311172|NCT01480232|20491118|P2|STARTED|Overall Study||41
8311173|NCT01480232|20491119|P1|STARTED|Overall Study||40
8311174|NCT01480219|20491147|P2|NOT COMPLETED|Overall Study||0
8311175|NCT01480219|20491148|P1|NOT COMPLETED|Overall Study||0
8311176|NCT01480219|20491147|P2|COMPLETED|Overall Study||142
8311177|NCT01480219|20491148|P1|COMPLETED|Overall Study||325
8311178|NCT01480219|20491147|P2|STARTED|Overall Study||142
8311179|NCT01480219|20491148|P1|STARTED|Overall Study||325
8311180|NCT01480180|20491156|P6|NOT COMPLETED|Extension Phase, Part 2||0
8311181|NCT01480180|20491157|P5|NOT COMPLETED|Extension Phase, Part 2||2
8311182|NCT01480180|20491158|P4|NOT COMPLETED|Extension Phase, Part 2||7
8311183|NCT01480180|20491159|P3|NOT COMPLETED|Extension Phase, Part 2||17
8311184|NCT01480180|20491160|P2|NOT COMPLETED|Extension Phase, Part 2||0
8311185|NCT01480180|20491161|P1|NOT COMPLETED|Extension Phase, Part 2||0
8311186|NCT01480180|20491156|P6|COMPLETED|Extension Phase, Part 2||0
8311187|NCT01480180|20491157|P5|COMPLETED|Extension Phase, Part 2||3
8311188|NCT01480180|20491158|P4|COMPLETED|Extension Phase, Part 2||33
8311189|NCT01480180|20491159|P3|COMPLETED|Extension Phase, Part 2||77
8311190|NCT01480180|20491160|P2|COMPLETED|Extension Phase, Part 2||0
8311191|NCT01480180|20491161|P1|COMPLETED|Extension Phase, Part 2||0
8311192|NCT01480180|20491156|P6|STARTED|Extension Phase, Part 2||0
8311193|NCT01480180|20491157|P5|STARTED|Extension Phase, Part 2||5
8311194|NCT01480180|20491158|P4|STARTED|Extension Phase, Part 2||40
8311195|NCT01480180|20491159|P3|STARTED|Extension Phase, Part 2||94
8311196|NCT01480180|20491160|P2|STARTED|Extension Phase, Part 2||0
8311197|NCT01480180|20491161|P1|STARTED|Extension Phase, Part 2||0
8311198|NCT01480180|20491156|P6|NOT COMPLETED|Extension Phase, Part 1||0
8311199|NCT01480180|20491157|P5|NOT COMPLETED|Extension Phase, Part 1||0
8311200|NCT01480180|20491158|P4|NOT COMPLETED|Extension Phase, Part 1||10
8311201|NCT01480180|20491159|P3|NOT COMPLETED|Extension Phase, Part 1||10
8311202|NCT01480180|20491160|P2|NOT COMPLETED|Extension Phase, Part 1||0
8311203|NCT01480180|20491161|P1|NOT COMPLETED|Extension Phase, Part 1||0
8311204|NCT01480180|20491156|P6|COMPLETED|Extension Phase, Part 1||0
8311205|NCT01480180|20491157|P5|COMPLETED|Extension Phase, Part 1||7
8311206|NCT01480180|20491158|P4|COMPLETED|Extension Phase, Part 1||28
8311207|NCT01480180|20491159|P3|COMPLETED|Extension Phase, Part 1||95
8311208|NCT01480180|20491160|P2|COMPLETED|Extension Phase, Part 1||0
8311209|NCT01480180|20491161|P1|COMPLETED|Extension Phase, Part 1||0
8311210|NCT01480180|20491156|P6|STARTED|Extension Phase, Part 1||0
8311211|NCT01480180|20491157|P5|STARTED|Extension Phase, Part 1||7
8311212|NCT01480180|20491158|P4|STARTED|Extension Phase, Part 1||38
8311213|NCT01480180|20491159|P3|STARTED|Extension Phase, Part 1||105
8311214|NCT01480180|20491160|P2|STARTED|Extension Phase, Part 1||0
8311215|NCT01480180|20491161|P1|STARTED|Extension Phase, Part 1||0
8311216|NCT01480180|20491156|P6|NOT COMPLETED|Main Phase||0
8311217|NCT01480180|20491157|P5|NOT COMPLETED|Main Phase||0
8311218|NCT01480180|20491158|P4|NOT COMPLETED|Main Phase||0
8311219|NCT01480180|20491159|P3|NOT COMPLETED|Main Phase||0
8311220|NCT01480180|20491160|P2|NOT COMPLETED|Main Phase||1
8311221|NCT01480180|20491161|P1|NOT COMPLETED|Main Phase||19
8311222|NCT01480180|20491156|P6|COMPLETED|Main Phase|Not applicable for this phase|0
8311223|NCT01480180|20491157|P5|COMPLETED|Main Phase|Not applicable for this phase|0
8311224|NCT01480180|20491158|P4|COMPLETED|Main Phase|Not applicable for this phase|0
8311225|NCT01480180|20491159|P3|COMPLETED|Main Phase|Not applicable for this phase|0
8311226|NCT01480180|20491160|P2|COMPLETED|Main Phase||11
8311227|NCT01480180|20491161|P1|COMPLETED|Main Phase||155
8311228|NCT01480180|20491156|P6|Max. Participants After Switching|Main Phase||0
8311229|NCT01480180|20491157|P5|Max. Participants After Switching|Main Phase||0
8311230|NCT01480180|20491158|P4|Max. Participants After Switching|Main Phase||0
8311231|NCT01480180|20491159|P3|Max. Participants After Switching|Main Phase||0
8311232|NCT01480180|20491160|P2|Max. Participants After Switching|Main Phase||11
8311233|NCT01480180|20491161|P1|Max. Participants After Switching|Main Phase||175
8311234|NCT01480180|20491156|P6|STARTED|Main Phase|Not applicable for this phase|0
8311235|NCT01480180|20491157|P5|STARTED|Main Phase|Not applicable for this phase|0
8311236|NCT01480180|20491158|P4|STARTED|Main Phase|Not applicable for this phase|0
8311237|NCT01480180|20491159|P3|STARTED|Main Phase|Not applicable for this phase|0
8311238|NCT01480180|20491160|P2|STARTED|Main Phase||12
8311239|NCT01480180|20491161|P1|STARTED|Main Phase||174
8311240|NCT01480089|20491318|P2|NOT COMPLETED|Overall Study||0
8311241|NCT01480089|20491319|P1|NOT COMPLETED|Overall Study||0
8311242|NCT01480089|20491318|P2|COMPLETED|Overall Study||30
8311243|NCT01480089|20491319|P1|COMPLETED|Overall Study||25
8311244|NCT01480089|20491318|P2|STARTED|Overall Study||30
8311245|NCT01480089|20491319|P1|STARTED|Overall Study||25
8311246|NCT01480076|20491329|P1|NOT COMPLETED|Overall Study||290
8311247|NCT01480076|20491329|P1|COMPLETED|Overall Study||611
8311248|NCT01480076|20491329|P1|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
8311249|NCT01480076|20491329|P1|STARTED|Overall Study|enrolled and started run-in treatment|901
8311250|NCT01479985|20491450|P2|NOT COMPLETED|Overall Study||6
8311251|NCT01479985|20491451|P1|NOT COMPLETED|Overall Study||6
8311252|NCT01479985|20491450|P2|COMPLETED|Overall Study||80
8311253|NCT01479985|20491451|P1|COMPLETED|Overall Study||161
8311254|NCT01479985|20491450|P2|Baseline Survey|Overall Study||85
8311255|NCT01479985|20491451|P1|Baseline Survey|Overall Study||166
8311256|NCT01479985|20491450|P2|STARTED|Overall Study||86
8311257|NCT01479985|20491451|P1|STARTED|Overall Study||167
8311258|NCT01479868|20491459|P1|NOT COMPLETED|Overall Study||9
8311259|NCT01479868|20491459|P1|COMPLETED|Overall Study||97
8311260|NCT01479868|20491459|P1|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
8311261|NCT01479777|20491474|P1|NOT COMPLETED|Overall Study||2
8311262|NCT01479777|20491474|P1|COMPLETED|Overall Study||10
8311263|NCT01479777|20491474|P1|STARTED|Overall Study||12
8311264|NCT01479764|20491486|P2|NOT COMPLETED|Treated||2
8311265|NCT01479764|20491487|P1|NOT COMPLETED|Treated||0
8311266|NCT01479764|20491486|P2|COMPLETED|Treated||75
8311267|NCT01479764|20491487|P1|COMPLETED|Treated||74
8311268|NCT01479764|20491486|P2|STARTED|Treated||77
8311269|NCT01479764|20491487|P1|STARTED|Treated||74
8311270|NCT01479764|20491486|P2|NOT COMPLETED|Randomized||1
8311271|NCT01479764|20491487|P1|NOT COMPLETED|Randomized||2
8311272|NCT01479764|20491486|P2|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
8311273|NCT01479764|20491487|P1|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
8311274|NCT01479764|20491486|P2|STARTED|Randomized||78
8311275|NCT01479764|20491487|P1|STARTED|Randomized||76
8311276|NCT01479725|20491497|P2|NOT COMPLETED|Overall Study||1
8311277|NCT01479725|20491498|P1|NOT COMPLETED|Overall Study||2
8311278|NCT01479725|20491497|P2|COMPLETED|Overall Study||1
8311279|NCT01479725|20491498|P1|COMPLETED|Overall Study||4
8311280|NCT01479725|20491497|P2|STARTED|Overall Study||2
8311281|NCT01479725|20491498|P1|STARTED|Overall Study||6
8311282|NCT01479621|20491510|P7|NOT COMPLETED|Treatment Period||20
8311283|NCT01479621|20491511|P6|NOT COMPLETED|Treatment Period||41
8311284|NCT01479621|20491512|P5|NOT COMPLETED|Treatment Period||21
8311285|NCT01479621|20491513|P4|NOT COMPLETED|Treatment Period||12
8311286|NCT01479621|20491514|P3|NOT COMPLETED|Treatment Period||21
8311287|NCT01479621|20491515|P2|NOT COMPLETED|Treatment Period||24
8311288|NCT01479621|20491516|P1|NOT COMPLETED|Treatment Period||0
8311289|NCT01479621|20491510|P7|COMPLETED|Treatment Period||84
8311290|NCT01479621|20491511|P6|COMPLETED|Treatment Period||63
8311291|NCT01479621|20491512|P5|COMPLETED|Treatment Period||82
8311292|NCT01479621|20491513|P4|COMPLETED|Treatment Period||92
8311293|NCT01479621|20491514|P3|COMPLETED|Treatment Period||83
8311294|NCT01479621|20491515|P2|COMPLETED|Treatment Period||79
8311295|NCT01479621|20491516|P1|COMPLETED|Treatment Period||0
8311296|NCT01479621|20491510|P7|Full Analysis Set|Treatment Period||102
8311297|NCT01479621|20491511|P6|Full Analysis Set|Treatment Period||102
8311298|NCT01479621|20491512|P5|Full Analysis Set|Treatment Period||102
8311299|NCT01479621|20491513|P4|Full Analysis Set|Treatment Period||102
8311300|NCT01479621|20491514|P3|Full Analysis Set|Treatment Period||101
8311301|NCT01479621|20491515|P2|Full Analysis Set|Treatment Period||102
8311302|NCT01479621|20491516|P1|Full Analysis Set|Treatment Period||0
8311303|NCT01479621|20491510|P7|Safety Population|Treatment Period||104
8311304|NCT01479621|20491511|P6|Safety Population|Treatment Period||104
8311305|NCT01479621|20491512|P5|Safety Population|Treatment Period||103
8311306|NCT01479621|20491513|P4|Safety Population|Treatment Period||104
8311307|NCT01479621|20491514|P3|Safety Population|Treatment Period||104
8311308|NCT01479621|20491515|P2|Safety Population|Treatment Period||103
8311309|NCT01479621|20491516|P1|Safety Population|Treatment Period||0
8311310|NCT01479621|20491510|P7|STARTED|Treatment Period||104
8311311|NCT01479621|20491511|P6|STARTED|Treatment Period||104
8311312|NCT01479621|20491512|P5|STARTED|Treatment Period||103
8311313|NCT01479621|20491513|P4|STARTED|Treatment Period||104
8311314|NCT01479621|20491514|P3|STARTED|Treatment Period||104
8311315|NCT01479621|20491515|P2|STARTED|Treatment Period||103
8311316|NCT01479621|20491516|P1|STARTED|Treatment Period||0
8311317|NCT01479621|20491510|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311318|NCT01479621|20491511|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311319|NCT01479621|20491512|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311320|NCT01479621|20491513|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311321|NCT01479621|20491514|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311322|NCT01479621|20491515|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311323|NCT01479621|20491516|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
8311324|NCT01479621|20491510|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311325|NCT01479621|20491511|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311326|NCT01479621|20491512|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311327|NCT01479621|20491513|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311328|NCT01479621|20491514|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311329|NCT01479621|20491515|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
8311330|NCT01479621|20491516|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
8311331|NCT01479621|20491510|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8311332|NCT01479621|20491511|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8311333|NCT01479621|20491512|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8311334|NCT01479621|20491513|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8311335|NCT01479621|20491514|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8311336|NCT01479621|20491515|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
8311337|NCT01479621|20491516|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||909
8311338|NCT01479595|20491604|P2|NOT COMPLETED|Overall Study||2
8311339|NCT01479595|20491605|P1|NOT COMPLETED|Overall Study||2
8311340|NCT01479595|20491604|P2|COMPLETED|Overall Study||19
8311341|NCT01479595|20491605|P1|COMPLETED|Overall Study||42
8311342|NCT01479595|20491604|P2|Per Protocol Analysis Set|Overall Study||20
8311343|NCT01479595|20491605|P1|Per Protocol Analysis Set|Overall Study||41
8311344|NCT01479595|20491604|P2|PK Analysis Set|Overall Study||0
8311345|NCT01479595|20491605|P1|PK Analysis Set|Overall Study||42
8311346|NCT01479595|20491604|P2|STARTED|Overall Study||21
8311347|NCT01479595|20491605|P1|STARTED|Overall Study||44
8311348|NCT01479543|20491632|P5|NOT COMPLETED|Overall Study||1
8311349|NCT01479543|20491633|P4|NOT COMPLETED|Overall Study||0
8311350|NCT01479543|20491634|P3|NOT COMPLETED|Overall Study||1
8311351|NCT01479543|20491635|P2|NOT COMPLETED|Overall Study||0
8311352|NCT01479543|20491636|P1|NOT COMPLETED|Overall Study||1
8311353|NCT01479543|20491632|P5|COMPLETED|Overall Study||20
8311354|NCT01479543|20491633|P4|COMPLETED|Overall Study||20
8311355|NCT01479543|20491634|P3|COMPLETED|Overall Study||20
8311356|NCT01479543|20491635|P2|COMPLETED|Overall Study||20
8311357|NCT01479543|20491636|P1|COMPLETED|Overall Study||20
8311358|NCT01479543|20491632|P5|STARTED|Overall Study||21
8311359|NCT01479543|20491633|P4|STARTED|Overall Study||20
8311360|NCT01479543|20491634|P3|STARTED|Overall Study||21
8311361|NCT01479543|20491635|P2|STARTED|Overall Study||20
8311362|NCT01479543|20491636|P1|STARTED|Overall Study||21
8311363|NCT01479530|20491650|P2|NOT COMPLETED|Overall Study||12
8311364|NCT01479530|20491651|P1|NOT COMPLETED|Overall Study||10
8311365|NCT01479530|20491650|P2|COMPLETED|Overall Study||151
8311366|NCT01479530|20491651|P1|COMPLETED|Overall Study||148
8311367|NCT01479530|20491650|P2|STARTED|Overall Study||163
8311368|NCT01479530|20491651|P1|STARTED|Overall Study||158
8311369|NCT01479517|20491666|P3|NOT COMPLETED|Overall Study||0
8311370|NCT01479517|20491667|P2|NOT COMPLETED|Overall Study||0
8311371|NCT01479517|20491668|P1|NOT COMPLETED|Overall Study||0
8311372|NCT01479517|20491666|P3|COMPLETED|Overall Study||10
8311373|NCT01479517|20491667|P2|COMPLETED|Overall Study||10
8311374|NCT01479517|20491668|P1|COMPLETED|Overall Study||10
8311375|NCT01479517|20491666|P3|STARTED|Overall Study||10
8311376|NCT01479517|20491667|P2|STARTED|Overall Study||10
8311377|NCT01479517|20491668|P1|STARTED|Overall Study||10
8311378|NCT01479478|20491687|P2|NOT COMPLETED|Overall Study||0
8311379|NCT01479478|20491688|P1|NOT COMPLETED|Overall Study||0
8311380|NCT01479478|20491687|P2|COMPLETED|Overall Study||126
8311381|NCT01479478|20491688|P1|COMPLETED|Overall Study||125
8311382|NCT01479478|20491687|P2|STARTED|Overall Study||126
8311383|NCT01479478|20491688|P1|STARTED|Overall Study||125
8311384|NCT01479465|20491732|P4|NOT COMPLETED|Overall Study||85
8311385|NCT01479465|20491733|P3|NOT COMPLETED|Overall Study||86
8311386|NCT01479465|20491734|P2|NOT COMPLETED|Overall Study||84
8311387|NCT01479465|20491735|P1|NOT COMPLETED|Overall Study||11
8311388|NCT01479465|20491732|P4|COMPLETED|Overall Study||0
8311389|NCT01479465|20491733|P3|COMPLETED|Overall Study||0
8311390|NCT01479465|20491734|P2|COMPLETED|Overall Study||0
8311391|NCT01479465|20491735|P1|COMPLETED|Overall Study||0
8311392|NCT01479465|20491732|P4|STARTED|Overall Study||85
8311393|NCT01479465|20491733|P3|STARTED|Overall Study||86
8311394|NCT01479465|20491734|P2|STARTED|Overall Study||84
8311395|NCT01479465|20491735|P1|STARTED|Overall Study||11
8311396|NCT01479439|20491756|P3|NOT COMPLETED|Overall Study||2
8311397|NCT01479439|20491757|P2|NOT COMPLETED|Overall Study||1
8311398|NCT01479439|20491758|P1|NOT COMPLETED|Overall Study||1
8311399|NCT01479439|20491756|P3|COMPLETED|Overall Study||6
8311400|NCT01479439|20491757|P2|COMPLETED|Overall Study||12
8311401|NCT01479439|20491758|P1|COMPLETED|Overall Study||14
8311402|NCT01479439|20491756|P3|STARTED|Overall Study||8
8311403|NCT01479439|20491757|P2|STARTED|Overall Study||13
8311404|NCT01479439|20491758|P1|STARTED|Overall Study||15
8311405|NCT01479426|20491774|P2|NOT COMPLETED|Overall Study||3
8311406|NCT01479426|20491775|P1|NOT COMPLETED|Overall Study||4
8311407|NCT01479426|20491774|P2|COMPLETED|Overall Study||37
8311408|NCT01479426|20491775|P1|COMPLETED|Overall Study||36
8311409|NCT01479426|20491774|P2|STARTED|Overall Study||40
8311410|NCT01479426|20491775|P1|STARTED|Overall Study||40
8311411|NCT01479374|20491790|P3|NOT COMPLETED|Overall Study||5
8311412|NCT01479374|20491791|P2|NOT COMPLETED|Overall Study||8
8311413|NCT01479374|20491792|P1|NOT COMPLETED|Overall Study||3
8311414|NCT01479374|20491790|P3|COMPLETED|Overall Study||63
8311415|NCT01479374|20491791|P2|COMPLETED|Overall Study||60
8311416|NCT01479374|20491792|P1|COMPLETED|Overall Study||63
8311417|NCT01479374|20491790|P3|STARTED|Overall Study||68
8311418|NCT01479374|20491791|P2|STARTED|Overall Study||68
8311419|NCT01479374|20491792|P1|STARTED|Overall Study||66
8311420|NCT01479348|20491818|P2|NOT COMPLETED|Overall Study||0
8311421|NCT01479348|20491819|P1|NOT COMPLETED|Overall Study||0
8311422|NCT01479348|20491818|P2|COMPLETED|Overall Study||0
8311423|NCT01479348|20491819|P1|COMPLETED|Overall Study||5
8311424|NCT01479348|20491818|P2|STARTED|Overall Study||0
8311425|NCT01479348|20491819|P1|STARTED|Overall Study||5
8311426|NCT01479270|20491828|P2|NOT COMPLETED|Overall Study||0
8311427|NCT01479270|20491829|P1|NOT COMPLETED|Overall Study||0
8311428|NCT01479270|20491828|P2|COMPLETED|Overall Study||28
8311429|NCT01479270|20491829|P1|COMPLETED|Overall Study||28
8311430|NCT01479270|20491828|P2|STARTED|Overall Study||28
8311431|NCT01479270|20491829|P1|STARTED|Overall Study||28
8311432|NCT01479127|20491841|P1|NOT COMPLETED|Overall Study||3
8311433|NCT01479127|20491841|P1|COMPLETED|Overall Study||5
8311434|NCT01479127|20491841|P1|Started LCIG|Overall Study||6
8311435|NCT01479127|20491841|P1|STARTED|Overall Study|started oral study drug (full safety sample)|8
8311436|NCT01479010|20491875|P1|NOT COMPLETED|Overall Study||1
8311437|NCT01479010|20491875|P1|COMPLETED|Overall Study||1
8311438|NCT01479010|20491875|P1|STARTED|Overall Study||2
8311439|NCT01478971|20491886|P1|NOT COMPLETED|Peginesatide Treatment Period||14
8311440|NCT01478971|20491886|P1|COMPLETED|Peginesatide Treatment Period||143
8311441|NCT01478971|20491886|P1|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
8311442|NCT01478971|20491886|P1|NOT COMPLETED|Standard of Care Period||25
8311443|NCT01478971|20491886|P1|COMPLETED|Standard of Care Period||159
8311444|NCT01478971|20491886|P1|Received Treatment|Standard of Care Period||178
8311445|NCT01478971|20491886|P1|STARTED|Standard of Care Period||184
8311446|NCT01478958|20491903|P3|NOT COMPLETED|Overall Study||3
8311447|NCT01478958|20491904|P2|NOT COMPLETED|Overall Study||2
8311448|NCT01478958|20491905|P1|NOT COMPLETED|Overall Study||2
8311449|NCT01478958|20491903|P3|COMPLETED|Overall Study||66
8311450|NCT01478958|20491904|P2|COMPLETED|Overall Study||64
8311451|NCT01478958|20491905|P1|COMPLETED|Overall Study||65
8311452|NCT01478958|20491903|P3|STARTED|Overall Study||69
8311453|NCT01478958|20491904|P2|STARTED|Overall Study||66
8311454|NCT01478958|20491905|P1|STARTED|Overall Study||67
8311455|NCT01478854|20491913|P1|NOT COMPLETED|Overall Study||0
8311456|NCT01478854|20491913|P1|COMPLETED|Overall Study||30
8311457|NCT01478854|20491913|P1|STARTED|Overall Study||30
8311458|NCT01478828|20491925|P1|NOT COMPLETED|Overall Study||1
8311459|NCT01478828|20491925|P1|COMPLETED|Overall Study||1
8311460|NCT01478828|20491925|P1|STARTED|Overall Study||2
8311461|NCT01478620|20491936|P1|NOT COMPLETED|Overall Study||6
8311462|NCT01478620|20491936|P1|COMPLETED|Overall Study||119
8311463|NCT01478620|20491936|P1|STARTED|Overall Study||125
8311464|NCT01478594|20491942|P2|NOT COMPLETED|Overall Study||28
8311465|NCT01478594|20491943|P1|NOT COMPLETED|Overall Study||65
8311466|NCT01478594|20491942|P2|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
8311467|NCT01478594|20491943|P1|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
8311468|NCT01478594|20491942|P2|Treated|Overall Study||87
8311469|NCT01478594|20491943|P1|Treated|Overall Study||177
8311470|NCT01478594|20491942|P2|STARTED|Overall Study||88
8311471|NCT01478594|20491943|P1|STARTED|Overall Study||177
8311472|NCT01478581|20492019|P4|NOT COMPLETED|Overall Study||0
8311473|NCT01478581|20492020|P3|NOT COMPLETED|Overall Study||0
8311474|NCT01478581|20492021|P2|NOT COMPLETED|Overall Study||0
8311475|NCT01478581|20492022|P1|NOT COMPLETED|Overall Study||0
8311476|NCT01478581|20492019|P4|COMPLETED|Overall Study||43
8311477|NCT01478581|20492020|P3|COMPLETED|Overall Study||18
8311478|NCT01478581|20492021|P2|COMPLETED|Overall Study||18
8311479|NCT01478581|20492022|P1|COMPLETED|Overall Study||13
8311480|NCT01478581|20492019|P4|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
8311481|NCT01478581|20492020|P3|STARTED|Overall Study||18
8311482|NCT01478581|20492021|P2|STARTED|Overall Study||18
8311483|NCT01478581|20492022|P1|STARTED|Overall Study||13
8311484|NCT01478373|20492072|P1|NOT COMPLETED|Survival Phase||38
8311485|NCT01478373|20492072|P1|COMPLETED|Survival Phase||0
8311486|NCT01478373|20492072|P1|STARTED|Survival Phase||38
8311487|NCT01478373|20492072|P1|NOT COMPLETED|Treatment Phase||1
8311488|NCT01478373|20492072|P1|COMPLETED|Treatment Phase||38
8311489|NCT01478373|20492072|P1|STARTED|Treatment Phase||39
8311490|NCT01478360|20492085|P2|NOT COMPLETED|Overall Study||3
8311491|NCT01478360|20492086|P1|NOT COMPLETED|Overall Study||2
8311492|NCT01478360|20492085|P2|COMPLETED|Overall Study||12
8311493|NCT01478360|20492086|P1|COMPLETED|Overall Study||29
8311494|NCT01478360|20492085|P2|PK (Pharmacokinetics) Analysis Set|Overall Study||0
8311495|NCT01478360|20492086|P1|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
8311496|NCT01478360|20492085|P2|PD (Pharmacodynamic) Analysis Set|Overall Study||15
8311497|NCT01478360|20492086|P1|PD (Pharmacodynamic) Analysis Set|Overall Study||31
8311498|NCT01478360|20492085|P2|STARTED|Overall Study||15
8311499|NCT01478360|20492086|P1|STARTED|Overall Study||31
8311500|NCT01478347|20492092|P1|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
8311501|NCT01478347|20492092|P1|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
8311502|NCT01478347|20492092|P1|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
8311503|NCT01478347|20492092|P1|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
8311504|NCT01478347|20492092|P1|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
8311505|NCT01478347|20492092|P1|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
8311506|NCT01478321|20492097|P1|NOT COMPLETED|Follow-up Until Death or 12.31.18 Occurs||0
8311507|NCT01478321|20492097|P1|COMPLETED|Follow-up Until Death or 12.31.18 Occurs||54
8311508|NCT01478321|20492097|P1|STARTED|Follow-up Until Death or 12.31.18 Occurs||54
8311509|NCT01478321|20492097|P1|NOT COMPLETED|Adjuvant Therapy Until PD or Toxicity||10
8311510|NCT01478321|20492097|P1|COMPLETED|Adjuvant Therapy Until PD or Toxicity||27
8311511|NCT01478321|20492097|P1|Went on to Cycle 2 +|Adjuvant Therapy Until PD or Toxicity||27
8311512|NCT01478321|20492097|P1|STARTED|Adjuvant Therapy Until PD or Toxicity||37
8311513|NCT01478321|20492097|P1|NOT COMPLETED|Started Adjuvant Therapy||1
8311514|NCT01478321|20492097|P1|COMPLETED|Started Adjuvant Therapy||37
8311515|NCT01478321|20492097|P1|Completed First Cycle|Started Adjuvant Therapy||37
8311516|NCT01478321|20492097|P1|STARTED|Started Adjuvant Therapy||38
8311517|NCT01478321|20492097|P1|NOT COMPLETED|Concurrent Therapy (5 Weeks)||16
8311518|NCT01478321|20492097|P1|COMPLETED|Concurrent Therapy (5 Weeks)||38
8311519|NCT01478321|20492097|P1|STARTED|Concurrent Therapy (5 Weeks)||54
8311520|NCT01478256|20492109|P2|NOT COMPLETED|Overall Study||0
8311521|NCT01478256|20492110|P1|NOT COMPLETED|Overall Study||0
8311522|NCT01478256|20492109|P2|COMPLETED|Overall Study||15
8311523|NCT01478256|20492110|P1|COMPLETED|Overall Study||15
8311524|NCT01478256|20492109|P2|STARTED|Overall Study||15
8311525|NCT01478256|20492110|P1|STARTED|Overall Study||15
8311526|NCT01478113|20492120|P2|NOT COMPLETED|Overall Study||1
8311527|NCT01478113|20492121|P1|NOT COMPLETED|Overall Study||1
8311528|NCT01478113|20492120|P2|COMPLETED|Overall Study||1
8311529|NCT01478113|20492121|P1|COMPLETED|Overall Study||1
8311530|NCT01478113|20492120|P2|STARTED|Overall Study||2
8311531|NCT01478113|20492121|P1|STARTED|Overall Study||2
8311532|NCT01478087|20492139|P1|NOT COMPLETED|Overall Study||1
8311533|NCT01478087|20492139|P1|COMPLETED|Overall Study||2
8311534|NCT01478087|20492139|P1|STARTED|Overall Study||3
8311535|NCT01478048|20492146|P2|NOT COMPLETED|Overall Study||75
8311536|NCT01478048|20492147|P1|NOT COMPLETED|Overall Study||77
8311537|NCT01478048|20492146|P2|COMPLETED|Overall Study||0
8311538|NCT01478048|20492147|P1|COMPLETED|Overall Study||0
8311539|NCT01478048|20492146|P2|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
8311540|NCT01478048|20492147|P1|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
8311541|NCT01478048|20492146|P2|STARTED|Overall Study||75
8311542|NCT01478048|20492147|P1|STARTED|Overall Study||77
8311543|NCT01478009|20492165|P2|NOT COMPLETED|Overall Study||1
8311544|NCT01478009|20492166|P1|NOT COMPLETED|Overall Study||1
8311545|NCT01478009|20492165|P2|COMPLETED|Overall Study||49
8311546|NCT01478009|20492166|P1|COMPLETED|Overall Study||49
8311547|NCT01478009|20492165|P2|STARTED|Overall Study||50
8311548|NCT01478009|20492166|P1|STARTED|Overall Study||50
8311549|NCT01477892|20492176|P2|NOT COMPLETED|Overall Study||2
8311550|NCT01477892|20492177|P1|NOT COMPLETED|Overall Study||0
8311551|NCT01477892|20492176|P2|COMPLETED|Overall Study||5
8311552|NCT01477892|20492177|P1|COMPLETED|Overall Study||7
8311553|NCT01477892|20492176|P2|STARTED|Overall Study||7
8311554|NCT01477892|20492177|P1|STARTED|Overall Study||7
8311555|NCT01477853|20492188|P3|NOT COMPLETED|Phase B||11
8311556|NCT01477853|20492189|P2|NOT COMPLETED|Phase B||11
8311557|NCT01477853|20492190|P1|NOT COMPLETED|Phase B||12
8311558|NCT01477853|20492188|P3|COMPLETED|Phase B||0
8311559|NCT01477853|20492189|P2|COMPLETED|Phase B||0
8311560|NCT01477853|20492190|P1|COMPLETED|Phase B||0
8311561|NCT01477853|20492188|P3|STARTED|Phase B||11
8311562|NCT01477853|20492189|P2|STARTED|Phase B||11
8311563|NCT01477853|20492190|P1|STARTED|Phase B||12
8311564|NCT01477853|20492188|P3|NOT COMPLETED|Phase A||44
8311565|NCT01477853|20492189|P2|NOT COMPLETED|Phase A||45
8311566|NCT01477853|20492190|P1|NOT COMPLETED|Phase A||43
8311567|NCT01477853|20492188|P3|COMPLETED|Phase A||11
8311568|NCT01477853|20492189|P2|COMPLETED|Phase A||11
8311569|NCT01477853|20492190|P1|COMPLETED|Phase A||12
8311570|NCT01477853|20492188|P3|STARTED|Phase A||55
8311571|NCT01477853|20492189|P2|STARTED|Phase A||56
8311572|NCT01477853|20492190|P1|STARTED|Phase A||55
8311573|NCT01477762|20492232|P4|NOT COMPLETED|Overall Study||2
8311574|NCT01477762|20492233|P3|NOT COMPLETED|Overall Study||4
8311575|NCT01477762|20492234|P2|NOT COMPLETED|Overall Study||13
8311576|NCT01477762|20492235|P1|NOT COMPLETED|Overall Study||9
8311577|NCT01477762|20492232|P4|COMPLETED|Overall Study||11
8311578|NCT01477762|20492233|P3|COMPLETED|Overall Study||16
8311579|NCT01477762|20492234|P2|COMPLETED|Overall Study||20
8311580|NCT01477762|20492235|P1|COMPLETED|Overall Study||16
8311581|NCT01477762|20492232|P4|STARTED|Overall Study||13
8311582|NCT01477762|20492233|P3|STARTED|Overall Study||20
8311583|NCT01477762|20492234|P2|STARTED|Overall Study||33
8311584|NCT01477762|20492235|P1|STARTED|Overall Study||25
8311585|NCT01477749|20492257|P1|NOT COMPLETED|Overall Study||4
8311586|NCT01477749|20492257|P1|COMPLETED|Overall Study||43
8311587|NCT01477749|20492257|P1|STARTED|Overall Study||47
8311588|NCT01477710|20492264|P1|NOT COMPLETED|Overall Study||0
8311589|NCT01477710|20492264|P1|COMPLETED|Overall Study||30
8311590|NCT01477710|20492264|P1|STARTED|Overall Study||30
8311591|NCT01477567|20492279|P7|NOT COMPLETED|Overall Study||0
8311592|NCT01477567|20492280|P6|NOT COMPLETED|Overall Study||0
8311593|NCT01477567|20492281|P5|NOT COMPLETED|Overall Study||0
8311594|NCT01477567|20492282|P4|NOT COMPLETED|Overall Study||0
8311595|NCT01477567|20492283|P3|NOT COMPLETED|Overall Study||0
8311596|NCT01477567|20492284|P2|NOT COMPLETED|Overall Study||0
8311597|NCT01477567|20492285|P1|NOT COMPLETED|Overall Study||0
8311598|NCT01477567|20492279|P7|COMPLETED|Overall Study||6
8311599|NCT01477567|20492280|P6|COMPLETED|Overall Study||5
8311600|NCT01477567|20492281|P5|COMPLETED|Overall Study||6
8311601|NCT01477567|20492282|P4|COMPLETED|Overall Study||6
8311602|NCT01477567|20492283|P3|COMPLETED|Overall Study||6
8311603|NCT01477567|20492284|P2|COMPLETED|Overall Study||6
8311604|NCT01477567|20492285|P1|COMPLETED|Overall Study||5
8311605|NCT01477567|20492279|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
8311606|NCT01477567|20492280|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
8311607|NCT01477567|20492281|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8311608|NCT01477567|20492282|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8311609|NCT01477567|20492283|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8311610|NCT01477567|20492284|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8311611|NCT01477567|20492285|P1|Received at Least 1 Dose of Study Drug|Overall Study||5
8311612|NCT01477567|20492279|P7|STARTED|Overall Study||6
8311613|NCT01477567|20492280|P6|STARTED|Overall Study||5
8311614|NCT01477567|20492281|P5|STARTED|Overall Study||6
8311615|NCT01477567|20492282|P4|STARTED|Overall Study||6
8311616|NCT01477567|20492283|P3|STARTED|Overall Study||6
8311617|NCT01477567|20492284|P2|STARTED|Overall Study||6
8311618|NCT01477567|20492285|P1|STARTED|Overall Study||5
8311619|NCT01477463|20492341|P2|NOT COMPLETED|Overall Study||0
8311620|NCT01477463|20492342|P1|NOT COMPLETED|Overall Study||0
8311621|NCT01477463|20492341|P2|COMPLETED|Overall Study||6
8311622|NCT01477463|20492342|P1|COMPLETED|Overall Study||18
8311623|NCT01477463|20492341|P2|STARTED|Overall Study||6
8311624|NCT01477463|20492342|P1|STARTED|Overall Study||18
8311625|NCT01477450|20492355|P3|NOT COMPLETED|Overall Study||0
8311626|NCT01477450|20492356|P2|NOT COMPLETED|Overall Study||0
8311627|NCT01477450|20492357|P1|NOT COMPLETED|Overall Study||0
8311628|NCT01477450|20492355|P3|COMPLETED|Overall Study||10
8311629|NCT01477450|20492356|P2|COMPLETED|Overall Study||10
8311630|NCT01477450|20492357|P1|COMPLETED|Overall Study||10
8311631|NCT01477450|20492355|P3|STARTED|Overall Study||10
8311632|NCT01477450|20492356|P2|STARTED|Overall Study||10
8311633|NCT01477450|20492357|P1|STARTED|Overall Study||10
8311634|NCT01477333|20492365|P1|NOT COMPLETED|Overall Study||3
8311635|NCT01477333|20492365|P1|COMPLETED|Overall Study||15
8311636|NCT01477333|20492365|P1|STARTED|Overall Study||18
8311637|NCT01477320|20492383|P2|NOT COMPLETED|Overall Study||15
8311638|NCT01477320|20492384|P1|NOT COMPLETED|Overall Study||7
8311639|NCT01477320|20492383|P2|COMPLETED|Overall Study||47
8311640|NCT01477320|20492384|P1|COMPLETED|Overall Study||55
8311641|NCT01477320|20492383|P2|STARTED|Overall Study||62
8311642|NCT01477320|20492384|P1|STARTED|Overall Study||62
8311643|NCT01477177|20492392|P1|NOT COMPLETED|Overall Study||0
8311644|NCT01477177|20492392|P1|COMPLETED|Overall Study||4
8311645|NCT01477177|20492392|P1|STARTED|Overall Study||4
8311646|NCT01476748|20492403|P3|NOT COMPLETED|Overall Study||0
8311647|NCT01476748|20492404|P2|NOT COMPLETED|Overall Study||0
8311648|NCT01476748|20492405|P1|NOT COMPLETED|Overall Study||0
8311649|NCT01476748|20492403|P3|COMPLETED|Overall Study||5
8311650|NCT01476748|20492404|P2|COMPLETED|Overall Study||5
8311651|NCT01476748|20492405|P1|COMPLETED|Overall Study||5
8311652|NCT01476748|20492403|P3|STARTED|Overall Study||5
8311653|NCT01476748|20492404|P2|STARTED|Overall Study||5
8311654|NCT01476748|20492405|P1|STARTED|Overall Study||5
8311655|NCT01476722|20492416|P1|NOT COMPLETED|Overall Study||1
8311656|NCT01476722|20492416|P1|COMPLETED|Overall Study||124
8311657|NCT01476722|20492416|P1|STARTED|Overall Study||125
8311658|NCT01476696|20492423|P3|NOT COMPLETED|Overall Study||0
8311659|NCT01476696|20492424|P2|NOT COMPLETED|Overall Study||1
8311660|NCT01476696|20492425|P1|NOT COMPLETED|Overall Study||3
8311661|NCT01476696|20492423|P3|COMPLETED|Overall Study||9
8311662|NCT01476696|20492424|P2|COMPLETED|Overall Study||8
8311663|NCT01476696|20492425|P1|COMPLETED|Overall Study||12
8311664|NCT01476696|20492423|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
8311665|NCT01476696|20492424|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
8311666|NCT01476696|20492425|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
8311667|NCT01476696|20492423|P3|STARTED|Overall Study||9
8311668|NCT01476696|20492424|P2|STARTED|Overall Study||9
8311669|NCT01476696|20492425|P1|STARTED|Overall Study||15
8311670|NCT01476644|20492439|P1|NOT COMPLETED|Overall Study||39
8311671|NCT01476644|20492439|P1|COMPLETED|Overall Study||122
8311672|NCT01476644|20492439|P1|STARTED|Overall Study||161
8311673|NCT01476475|20492446|P2|NOT COMPLETED|Overall Study||3
8311674|NCT01476475|20492447|P1|NOT COMPLETED|Overall Study||11
8311675|NCT01476475|20492446|P2|COMPLETED|Overall Study||159
8311676|NCT01476475|20492447|P1|COMPLETED|Overall Study||150
8311677|NCT01476475|20492446|P2|STARTED|Overall Study||162
8311678|NCT01476475|20492447|P1|STARTED|Overall Study||161
8311679|NCT01476449|20492481|P2|NOT COMPLETED|Overall Study||2
8311680|NCT01476449|20492482|P1|NOT COMPLETED|Overall Study||2
8311681|NCT01476449|20492481|P2|COMPLETED|Overall Study||8
8311682|NCT01476449|20492482|P1|COMPLETED|Overall Study||8
8311683|NCT01476449|20492481|P2|STARTED|Overall Study||10
8311684|NCT01476449|20492482|P1|STARTED|Overall Study||10
8311685|NCT01476345|20492496|P2|NOT COMPLETED|Period 4||0
8311686|NCT01476345|20492497|P1|NOT COMPLETED|Period 4||0
8311687|NCT01476345|20492496|P2|COMPLETED|Period 4||39
8311688|NCT01476345|20492497|P1|COMPLETED|Period 4||39
8311689|NCT01476345|20492496|P2|STARTED|Period 4||39
8311690|NCT01476345|20492497|P1|STARTED|Period 4||39
8311691|NCT01476345|20492496|P2|NOT COMPLETED|Period 3||0
8311692|NCT01476345|20492497|P1|NOT COMPLETED|Period 3||0
8311693|NCT01476345|20492496|P2|COMPLETED|Period 3||39
8311694|NCT01476345|20492497|P1|COMPLETED|Period 3||39
8311695|NCT01476345|20492496|P2|STARTED|Period 3||39
8311696|NCT01476345|20492497|P1|STARTED|Period 3||39
8311697|NCT01476345|20492496|P2|NOT COMPLETED|Period 2||0
8311698|NCT01476345|20492497|P1|NOT COMPLETED|Period 2||0
8311699|NCT01476345|20492496|P2|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
8311700|NCT01476345|20492497|P1|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
8311701|NCT01476345|20492496|P2|STARTED|Period 2||40
8311702|NCT01476345|20492497|P1|STARTED|Period 2||40
8311703|NCT01476345|20492496|P2|NOT COMPLETED|Period 1||0
8311704|NCT01476345|20492497|P1|NOT COMPLETED|Period 1||0
8311705|NCT01476345|20492496|P2|COMPLETED|Period 1||40
8311706|NCT01476345|20492497|P1|COMPLETED|Period 1||40
8311707|NCT01476345|20492496|P2|Received at Least 1 Dose of Study Drug|Period 1||40
8311708|NCT01476345|20492497|P1|Received at Least 1 Dose of Study Drug|Period 1||40
8311709|NCT01476345|20492496|P2|STARTED|Period 1||40
8311710|NCT01476345|20492497|P1|STARTED|Period 1||40
8311711|NCT01476267|20492509|P1|NOT COMPLETED|Overall Study||0
8311712|NCT01476267|20492509|P1|COMPLETED|Overall Study||6
8311713|NCT01476267|20492509|P1|STARTED|Overall Study||6
8311714|NCT01476202|20492517|P3|NOT COMPLETED|Overall Study||0
8311715|NCT01476202|20492518|P2|NOT COMPLETED|Overall Study||0
8311716|NCT01476202|20492519|P1|NOT COMPLETED|Overall Study||0
8311717|NCT01476202|20492517|P3|COMPLETED|Overall Study||40
8311718|NCT01476202|20492518|P2|COMPLETED|Overall Study||40
8311719|NCT01476202|20492519|P1|COMPLETED|Overall Study||40
8311720|NCT01476202|20492517|P3|STARTED|Overall Study||40
8311721|NCT01476202|20492518|P2|STARTED|Overall Study||40
8311722|NCT01476202|20492519|P1|STARTED|Overall Study||40
8311723|NCT01475955|20492535|P5|NOT COMPLETED|Overall Study||0
8311724|NCT01475955|20492536|P4|NOT COMPLETED|Overall Study||0
8311725|NCT01475955|20492537|P3|NOT COMPLETED|Overall Study||3
8311726|NCT01475955|20492538|P2|NOT COMPLETED|Overall Study||0
8311727|NCT01475955|20492539|P1|NOT COMPLETED|Overall Study||1
8311728|NCT01475955|20492535|P5|COMPLETED|Overall Study||46
8311729|NCT01475955|20492536|P4|COMPLETED|Overall Study||46
8311730|NCT01475955|20492537|P3|COMPLETED|Overall Study||44
8311731|NCT01475955|20492538|P2|COMPLETED|Overall Study||48
8311732|NCT01475955|20492539|P1|COMPLETED|Overall Study||47
8311733|NCT01475955|20492535|P5|STARTED|Overall Study||46
8311734|NCT01475955|20492536|P4|STARTED|Overall Study||46
8311735|NCT01475955|20492537|P3|STARTED|Overall Study||47
8311736|NCT01475955|20492538|P2|STARTED|Overall Study||48
8311737|NCT01475955|20492539|P1|STARTED|Overall Study||48
8311738|NCT01475851|20492898|P2|NOT COMPLETED|Overall Study||0
8311739|NCT01475851|20492899|P1|NOT COMPLETED|Overall Study||1
8311740|NCT01475851|20492898|P2|COMPLETED|Overall Study||21
8311741|NCT01475851|20492899|P1|COMPLETED|Overall Study||12
8311742|NCT01475851|20492898|P2|STARTED|Overall Study||21
8311743|NCT01475851|20492899|P1|STARTED|Overall Study||13
8311744|NCT01475838|20492927|P2|NOT COMPLETED|Extension Phase||0
8311745|NCT01475838|20492928|P1|NOT COMPLETED|Extension Phase||1
8311746|NCT01475838|20492927|P2|COMPLETED|Extension Phase||20
8311747|NCT01475838|20492928|P1|COMPLETED|Extension Phase||41
8311748|NCT01475838|20492927|P2|STARTED|Extension Phase||20
8311749|NCT01475838|20492928|P1|STARTED|Extension Phase||42
8311750|NCT01475838|20492927|P2|NOT COMPLETED|Randomized Phase||36
8311751|NCT01475838|20492928|P1|NOT COMPLETED|Randomized Phase||30
8311752|NCT01475838|20492927|P2|COMPLETED|Randomized Phase||109
8311753|NCT01475838|20492928|P1|COMPLETED|Randomized Phase||263
8311754|NCT01475838|20492927|P2|STARTED|Randomized Phase||145
8311755|NCT01475838|20492928|P1|STARTED|Randomized Phase||293
8311756|NCT01475825|20492945|P4|NOT COMPLETED|Overall Study||30
8311757|NCT01475825|20492946|P3|NOT COMPLETED|Overall Study||64
8311758|NCT01475825|20492947|P2|NOT COMPLETED|Overall Study||32
8311759|NCT01475825|20492948|P1|NOT COMPLETED|Overall Study||67
8311760|NCT01475825|20492945|P4|COMPLETED|Overall Study||22
8311761|NCT01475825|20492946|P3|COMPLETED|Overall Study||38
8311762|NCT01475825|20492947|P2|COMPLETED|Overall Study||19
8311763|NCT01475825|20492948|P1|COMPLETED|Overall Study||37
8311764|NCT01475825|20492945|P4|Completed Open-Label Continuation|Overall Study||22
8311765|NCT01475825|20492946|P3|Completed Open-Label Continuation|Overall Study||38
8311766|NCT01475825|20492947|P2|Completed Open-Label Continuation|Overall Study||19
8311767|NCT01475825|20492948|P1|Completed Open-Label Continuation|Overall Study||37
8311768|NCT01475825|20492945|P4|Entered Open-Label Continuation|Overall Study||29
8311769|NCT01475825|20492946|P3|Entered Open-Label Continuation|Overall Study||44
8311770|NCT01475825|20492947|P2|Entered Open-Label Continuation|Overall Study||31
8311771|NCT01475825|20492948|P1|Entered Open-Label Continuation|Overall Study||45
8311772|NCT01475825|20492945|P4|Completed Blinded Treatment Period|Overall Study||40
8311773|NCT01475825|20492946|P3|Completed Blinded Treatment Period|Overall Study||59
8311774|NCT01475825|20492947|P2|Completed Blinded Treatment Period|Overall Study||42
8311775|NCT01475825|20492948|P1|Completed Blinded Treatment Period|Overall Study||60
8311776|NCT01475825|20492945|P4|Randomized and Treated|Overall Study||52
8311777|NCT01475825|20492946|P3|Randomized and Treated|Overall Study||102
8311778|NCT01475825|20492947|P2|Randomized and Treated|Overall Study||51
8311779|NCT01475825|20492948|P1|Randomized and Treated|Overall Study||104
8311780|NCT01475825|20492945|P4|STARTED|Overall Study||52
8311781|NCT01475825|20492946|P3|STARTED|Overall Study||102
8311782|NCT01475825|20492947|P2|STARTED|Overall Study||51
8311783|NCT01475825|20492948|P1|STARTED|Overall Study||104
8311784|NCT01475734|20492980|P2|NOT COMPLETED|Overall Study||1
8311785|NCT01475734|20492981|P1|NOT COMPLETED|Overall Study||2
8311786|NCT01475734|20492980|P2|COMPLETED|Overall Study||21
8311787|NCT01475734|20492981|P1|COMPLETED|Overall Study||20
8311788|NCT01475734|20492980|P2|STARTED|Overall Study||22
8311789|NCT01475734|20492981|P1|STARTED|Overall Study||22
8311790|NCT01475721|20493009|P2|NOT COMPLETED|Overall Study||14
8311791|NCT01475721|20493010|P1|NOT COMPLETED|Overall Study||11
8311792|NCT01475721|20493009|P2|COMPLETED|Overall Study||5831
8311793|NCT01475721|20493010|P1|COMPLETED|Overall Study||5823
8311794|NCT01475721|20493009|P2|STARTED|Overall Study||5845
8311795|NCT01475721|20493010|P1|STARTED|Overall Study||5834
8311796|NCT01475643|20493026|P2|NOT COMPLETED|Overall Study||10
8311797|NCT01475643|20493027|P1|NOT COMPLETED|Overall Study||14
8311798|NCT01475643|20493026|P2|COMPLETED|Overall Study||43
8311799|NCT01475643|20493027|P1|COMPLETED|Overall Study||40
8311800|NCT01475643|20493026|P2|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53
8311801|NCT01475643|20493027|P1|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54
8311802|NCT01475513|20493037|P2|NOT COMPLETED|Overall Study||10
8311803|NCT01475513|20493038|P1|NOT COMPLETED|Overall Study||3
8311804|NCT01475513|20493037|P2|COMPLETED|Overall Study||16
8311805|NCT01475513|20493038|P1|COMPLETED|Overall Study||17
8311806|NCT01475513|20493037|P2|STARTED|Overall Study||26
8311807|NCT01475513|20493038|P1|STARTED|Overall Study||20
8311808|NCT01475487|20493076|P2|NOT COMPLETED|Overall Study||1
8311809|NCT01475487|20493077|P1|NOT COMPLETED|Overall Study||2
8311810|NCT01475487|20493076|P2|COMPLETED|Overall Study||24
8311811|NCT01475487|20493077|P1|COMPLETED|Overall Study||23
8311812|NCT01475487|20493076|P2|STARTED|Overall Study||25
8311813|NCT01475487|20493077|P1|STARTED|Overall Study||25
8311814|NCT01475474|20493089|P1|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
8311815|NCT01475474|20493089|P1|COMPLETED|Return to Baseline Period - 4 Weeks||71
8311816|NCT01475474|20493089|P1|STARTED|Return to Baseline Period - 4 Weeks||73
8311817|NCT01475474|20493089|P1|NOT COMPLETED|Treatment Period - 12 Weeks||18
8311818|NCT01475474|20493089|P1|COMPLETED|Treatment Period - 12 Weeks||73
8311819|NCT01475474|20493089|P1|STARTED|Treatment Period - 12 Weeks||91
8311820|NCT01475474|20493089|P1|NOT COMPLETED|Baseline Period - 4 Weeks||6
8311821|NCT01475474|20493089|P1|COMPLETED|Baseline Period - 4 Weeks||91
8311822|NCT01475474|20493089|P1|STARTED|Baseline Period - 4 Weeks||97
8311823|NCT01475461|20493100|P7|NOT COMPLETED|Treatment Period||2
8311824|NCT01475461|20493101|P6|NOT COMPLETED|Treatment Period||5
8311825|NCT01475461|20493102|P5|NOT COMPLETED|Treatment Period||4
8311826|NCT01475461|20493103|P4|NOT COMPLETED|Treatment Period||8
8311827|NCT01475461|20493104|P3|NOT COMPLETED|Treatment Period||4
8311828|NCT01475461|20493105|P2|NOT COMPLETED|Treatment Period||9
8311829|NCT01475461|20493106|P1|NOT COMPLETED|Treatment Period||0
8311830|NCT01475461|20493100|P7|COMPLETED|Treatment Period||53
8311831|NCT01475461|20493101|P6|COMPLETED|Treatment Period||51
8311832|NCT01475461|20493102|P5|COMPLETED|Treatment Period||52
8311833|NCT01475461|20493103|P4|COMPLETED|Treatment Period||46
8311834|NCT01475461|20493104|P3|COMPLETED|Treatment Period||53
8311835|NCT01475461|20493105|P2|COMPLETED|Treatment Period||48
8311836|NCT01475461|20493106|P1|COMPLETED|Treatment Period||0
8311837|NCT01475461|20493100|P7|STARTED|Treatment Period||55
8311838|NCT01475461|20493101|P6|STARTED|Treatment Period||56
8311839|NCT01475461|20493102|P5|STARTED|Treatment Period||56
8311840|NCT01475461|20493103|P4|STARTED|Treatment Period||54
8311841|NCT01475461|20493104|P3|STARTED|Treatment Period||57
8311842|NCT01475461|20493105|P2|STARTED|Treatment Period||57
8311843|NCT01475461|20493106|P1|STARTED|Treatment Period||0
8311844|NCT01475461|20493100|P7|NOT COMPLETED|Run-in Period||0
8311845|NCT01475461|20493101|P6|NOT COMPLETED|Run-in Period||0
8311846|NCT01475461|20493102|P5|NOT COMPLETED|Run-in Period||0
8311847|NCT01475461|20493103|P4|NOT COMPLETED|Run-in Period||0
8311848|NCT01475461|20493104|P3|NOT COMPLETED|Run-in Period||0
8311849|NCT01475461|20493105|P2|NOT COMPLETED|Run-in Period||0
8311850|NCT01475461|20493106|P1|NOT COMPLETED|Run-in Period||41
8311851|NCT01475461|20493100|P7|COMPLETED|Run-in Period||0
8311852|NCT01475461|20493101|P6|COMPLETED|Run-in Period||0
8311853|NCT01475461|20493102|P5|COMPLETED|Run-in Period||0
8311854|NCT01475461|20493103|P4|COMPLETED|Run-in Period||0
8311855|NCT01475461|20493104|P3|COMPLETED|Run-in Period||0
8311856|NCT01475461|20493105|P2|COMPLETED|Run-in Period||0
8311857|NCT01475461|20493106|P1|COMPLETED|Run-in Period||335
8311858|NCT01475461|20493100|P7|STARTED|Run-in Period||0
8311859|NCT01475461|20493101|P6|STARTED|Run-in Period||0
8311860|NCT01475461|20493102|P5|STARTED|Run-in Period||0
8311861|NCT01475461|20493103|P4|STARTED|Run-in Period||0
8311862|NCT01475461|20493104|P3|STARTED|Run-in Period||0
8311863|NCT01475461|20493105|P2|STARTED|Run-in Period||0
8311864|NCT01475461|20493106|P1|STARTED|Run-in Period||376
8311865|NCT01475331|20493186|P2|NOT COMPLETED|Overall Study||2
8311866|NCT01475331|20493187|P1|NOT COMPLETED|Overall Study||5
8311867|NCT01475331|20493186|P2|COMPLETED|Overall Study||21
8311868|NCT01475331|20493187|P1|COMPLETED|Overall Study||18
8311869|NCT01475331|20493186|P2|STARTED|Overall Study||23
8311870|NCT01475331|20493187|P1|STARTED|Overall Study||23
8311871|NCT01475305|20493195|P2|NOT COMPLETED|Overall Study||0
8311872|NCT01475305|20493196|P1|NOT COMPLETED|Overall Study||0
8311873|NCT01475305|20493195|P2|COMPLETED|Overall Study||3
8311874|NCT01475305|20493196|P1|COMPLETED|Overall Study||4
8311875|NCT01475305|20493195|P2|End of Quarantine, Day 15|Overall Study||3
8311876|NCT01475305|20493196|P1|End of Quarantine, Day 15|Overall Study||4
8311877|NCT01475305|20493195|P2|STARTED|Overall Study||3
8311878|NCT01475305|20493196|P1|STARTED|Overall Study||4
8311879|NCT01475253|20493239|P4|NOT COMPLETED|Open Label Extension||0
8311880|NCT01475253|20493240|P3|NOT COMPLETED|Open Label Extension||0
8311881|NCT01475253|20493241|P2|NOT COMPLETED|Open Label Extension||0
8311882|NCT01475253|20493242|P1|NOT COMPLETED|Open Label Extension||0
8311883|NCT01475253|20493239|P4|COMPLETED|Open Label Extension||56
8311884|NCT01475253|20493240|P3|COMPLETED|Open Label Extension||0
8311885|NCT01475253|20493241|P2|COMPLETED|Open Label Extension||0
8311886|NCT01475253|20493242|P1|COMPLETED|Open Label Extension||0
8311887|NCT01475253|20493239|P4|STARTED|Open Label Extension||56
8311888|NCT01475253|20493240|P3|STARTED|Open Label Extension||0
8311889|NCT01475253|20493241|P2|STARTED|Open Label Extension||0
8311890|NCT01475253|20493242|P1|STARTED|Open Label Extension||0
8311891|NCT01475253|20493239|P4|NOT COMPLETED|Randomized, Blinded Study||0
8311892|NCT01475253|20493240|P3|NOT COMPLETED|Randomized, Blinded Study||0
8311893|NCT01475253|20493241|P2|NOT COMPLETED|Randomized, Blinded Study||1
8311894|NCT01475253|20493242|P1|NOT COMPLETED|Randomized, Blinded Study||2
8311895|NCT01475253|20493239|P4|COMPLETED|Randomized, Blinded Study||0
8311896|NCT01475253|20493240|P3|COMPLETED|Randomized, Blinded Study||11
8311897|NCT01475253|20493241|P2|COMPLETED|Randomized, Blinded Study||45
8311898|NCT01475253|20493242|P1|COMPLETED|Randomized, Blinded Study||45
8311899|NCT01475253|20493239|P4|STARTED|Randomized, Blinded Study||0
8311900|NCT01475253|20493240|P3|STARTED|Randomized, Blinded Study||11
8311901|NCT01475253|20493241|P2|STARTED|Randomized, Blinded Study||46
8311902|NCT01475253|20493242|P1|STARTED|Randomized, Blinded Study||47
8311903|NCT01475214|20493271|P3|NOT COMPLETED|Overall Study||2
8311904|NCT01475214|20493272|P2|NOT COMPLETED|Overall Study||4
8311905|NCT01475214|20493273|P1|NOT COMPLETED|Overall Study||5
8311906|NCT01475214|20493271|P3|COMPLETED|Overall Study||79
8311907|NCT01475214|20493272|P2|COMPLETED|Overall Study||75
8311908|NCT01475214|20493273|P1|COMPLETED|Overall Study||79
8311909|NCT01475214|20493271|P3|STARTED|Overall Study||81
8311910|NCT01475214|20493272|P2|STARTED|Overall Study||79
8311911|NCT01475214|20493273|P1|STARTED|Overall Study||84
8311912|NCT01475175|20493284|P1|NOT COMPLETED|Overall Study||0
8311913|NCT01475175|20493284|P1|COMPLETED|Overall Study||12
8311914|NCT01475175|20493284|P1|STARTED|Overall Study||12
8311915|NCT01475162|20493296|P1|NOT COMPLETED|Overall Study||14
8311916|NCT01475162|20493296|P1|COMPLETED|Overall Study||0
8311917|NCT01475162|20493296|P1|STARTED|Overall Study||14
8311918|NCT01475097|20493309|P2|NOT COMPLETED|Overall Study||1
8311919|NCT01475097|20493310|P1|NOT COMPLETED|Overall Study||1
8311920|NCT01475097|20493309|P2|COMPLETED|Overall Study||126
8311921|NCT01475097|20493310|P1|COMPLETED|Overall Study||127
8311922|NCT01475097|20493309|P2|STARTED|Overall Study||127
8311923|NCT01475097|20493310|P1|STARTED|Overall Study||128
8311927|NCT01474993|20493328|P2|NOT COMPLETED|Overall Study||3
8311928|NCT01474993|20493329|P1|NOT COMPLETED|Overall Study||1
8311929|NCT01474993|20493328|P2|COMPLETED|Overall Study||26
8311930|NCT01474993|20493329|P1|COMPLETED|Overall Study||14
8311931|NCT01474993|20493328|P2|STARTED|Overall Study||29
8311932|NCT01474993|20493329|P1|STARTED|Overall Study||15
8311933|NCT01474915|20493359|P2|NOT COMPLETED|Overall Study||10
8311934|NCT01474915|20493360|P1|NOT COMPLETED|Overall Study||10
8311935|NCT01474915|20493359|P2|COMPLETED|Overall Study||51
8311936|NCT01474915|20493360|P1|COMPLETED|Overall Study||50
8311937|NCT01474915|20493359|P2|STARTED|Overall Study||61
8311938|NCT01474915|20493360|P1|STARTED|Overall Study||60
8311939|NCT01474876|20493371|P3|NOT COMPLETED|Overall Study||0
8311940|NCT01474876|20493372|P2|NOT COMPLETED|Overall Study||23
8311941|NCT01474876|20493373|P1|NOT COMPLETED|Overall Study||66
8311942|NCT01474876|20493371|P3|COMPLETED|Overall Study||1
8311943|NCT01474876|20493372|P2|COMPLETED|Overall Study||128
8311944|NCT01474876|20493373|P1|COMPLETED|Overall Study||337
8311945|NCT01474876|20493371|P3|STARTED|Overall Study||1
8311946|NCT01474876|20493372|P2|STARTED|Overall Study||151
8311947|NCT01474876|20493373|P1|STARTED|Overall Study||403
8311948|NCT01474863|20493407|P3|NOT COMPLETED|Overall Study||0
8311949|NCT01474863|20493408|P2|NOT COMPLETED|Overall Study||0
8311950|NCT01474863|20493409|P1|NOT COMPLETED|Overall Study||0
8311951|NCT01474863|20493407|P3|COMPLETED|Overall Study||24
8311952|NCT01474863|20493408|P2|COMPLETED|Overall Study||22
8311953|NCT01474863|20493409|P1|COMPLETED|Overall Study||26
8311954|NCT01474863|20493407|P3|STARTED|Overall Study||24
8311955|NCT01474863|20493408|P2|STARTED|Overall Study||22
8311956|NCT01474863|20493409|P1|STARTED|Overall Study||26
8311957|NCT01474746|20493419|P2|NOT COMPLETED|Overall Study||2
8311958|NCT01474746|20493420|P1|NOT COMPLETED|Overall Study||3
8311959|NCT01474746|20493419|P2|COMPLETED|Overall Study||25
8311960|NCT01474746|20493420|P1|COMPLETED|Overall Study||27
8311961|NCT01474746|20493419|P2|STARTED|Overall Study||27
8311962|NCT01474746|20493420|P1|STARTED|Overall Study||30
8311963|NCT01474681|20493484|P4|NOT COMPLETED|Overall Study||6
8311964|NCT01474681|20493485|P3|NOT COMPLETED|Overall Study||2
8311965|NCT01474681|20493486|P2|NOT COMPLETED|Overall Study||3
8311966|NCT01474681|20493487|P1|NOT COMPLETED|Overall Study||0
8311967|NCT01474681|20493484|P4|COMPLETED|Overall Study||9
8311968|NCT01474681|20493485|P3|COMPLETED|Overall Study||1
8311969|NCT01474681|20493486|P2|COMPLETED|Overall Study||5
8311970|NCT01474681|20493487|P1|COMPLETED|Overall Study||1
8311971|NCT01474681|20493484|P4|STARTED|Overall Study||15
8311972|NCT01474681|20493485|P3|STARTED|Overall Study||3
8311973|NCT01474681|20493486|P2|STARTED|Overall Study||8
8311974|NCT01474681|20493487|P1|STARTED|Overall Study||1
8311981|NCT01474551|20493538|P1|NOT COMPLETED|Overall Study||1
8311982|NCT01474551|20493538|P1|COMPLETED|Overall Study||1
8311983|NCT01474551|20493538|P1|STARTED|Overall Study||2
8311984|NCT01474538|20493544|P2|NOT COMPLETED|Treatment Period 2||2
8311985|NCT01474538|20493545|P1|NOT COMPLETED|Treatment Period 2||6
8311986|NCT01474538|20493544|P2|COMPLETED|Treatment Period 2||56
8311987|NCT01474538|20493545|P1|COMPLETED|Treatment Period 2||51
8311988|NCT01474538|20493544|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
8311989|NCT01474538|20493545|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
8311990|NCT01474538|20493544|P2|STARTED|Treatment Period 2||58
8311991|NCT01474538|20493545|P1|STARTED|Treatment Period 2||57
8311992|NCT01474538|20493544|P2|NOT COMPLETED|Treatment Period 1||4
8311993|NCT01474538|20493545|P1|NOT COMPLETED|Treatment Period 1||3
8311994|NCT01474538|20493544|P2|COMPLETED|Treatment Period 1||58
8311995|NCT01474538|20493545|P1|COMPLETED|Treatment Period 1||57
8311996|NCT01474538|20493544|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
8311997|NCT01474538|20493545|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
8311998|NCT01474538|20493544|P2|STARTED|Treatment Period 1||62
8311999|NCT01474538|20493545|P1|STARTED|Treatment Period 1||60
8312000|NCT01474512|20493562|P18|NOT COMPLETED|Post-Treatment Follow-Up||46
8312001|NCT01474512|20493563|P17|NOT COMPLETED|Post-Treatment Follow-Up||156
8312002|NCT01474512|20493564|P16|NOT COMPLETED|Post-Treatment Follow-Up||8
8312003|NCT01474512|20493565|P15|NOT COMPLETED|Post-Treatment Follow-Up||18
8312004|NCT01474512|20493566|P14|NOT COMPLETED|Post-Treatment Follow-Up||0
8312005|NCT01474512|20493567|P13|NOT COMPLETED|Post-Treatment Follow-Up||0
8312006|NCT01474512|20493568|P12|NOT COMPLETED|Post-Treatment Follow-Up||0
8312007|NCT01474512|20493569|P11|NOT COMPLETED|Post-Treatment Follow-Up||0
8312008|NCT01474512|20493570|P10|NOT COMPLETED|Post-Treatment Follow-Up||0
8312009|NCT01474512|20493571|P9|NOT COMPLETED|Post-Treatment Follow-Up||0
8312010|NCT01474512|20493572|P8|NOT COMPLETED|Post-Treatment Follow-Up||0
8312011|NCT01474512|20493573|P7|NOT COMPLETED|Post-Treatment Follow-Up||0
8312012|NCT01474512|20493574|P6|NOT COMPLETED|Post-Treatment Follow-Up||0
8312013|NCT01474512|20493575|P5|NOT COMPLETED|Post-Treatment Follow-Up||0
8312014|NCT01474512|20493576|P4|NOT COMPLETED|Post-Treatment Follow-Up||0
8312015|NCT01474512|20493577|P3|NOT COMPLETED|Post-Treatment Follow-Up||0
8312016|NCT01474512|20493578|P2|NOT COMPLETED|Post-Treatment Follow-Up||0
8312017|NCT01474512|20493579|P1|NOT COMPLETED|Post-Treatment Follow-Up||0
8312018|NCT01474512|20493562|P18|COMPLETED|Post-Treatment Follow-Up||239
8312019|NCT01474512|20493563|P17|COMPLETED|Post-Treatment Follow-Up||544
8312020|NCT01474512|20493564|P16|COMPLETED|Post-Treatment Follow-Up||17
8312021|NCT01474512|20493565|P15|COMPLETED|Post-Treatment Follow-Up||0
8312022|NCT01474512|20493566|P14|COMPLETED|Post-Treatment Follow-Up||0
8312023|NCT01474512|20493567|P13|COMPLETED|Post-Treatment Follow-Up||0
8312024|NCT01474512|20493568|P12|COMPLETED|Post-Treatment Follow-Up||0
8312025|NCT01474512|20493569|P11|COMPLETED|Post-Treatment Follow-Up||0
8312026|NCT01474512|20493570|P10|COMPLETED|Post-Treatment Follow-Up||0
8312027|NCT01474512|20493571|P9|COMPLETED|Post-Treatment Follow-Up||0
8312028|NCT01474512|20493572|P8|COMPLETED|Post-Treatment Follow-Up||0
8312029|NCT01474512|20493573|P7|COMPLETED|Post-Treatment Follow-Up||0
8312030|NCT01474512|20493574|P6|COMPLETED|Post-Treatment Follow-Up||0
8312031|NCT01474512|20493575|P5|COMPLETED|Post-Treatment Follow-Up||0
8312032|NCT01474512|20493576|P4|COMPLETED|Post-Treatment Follow-Up||0
8312033|NCT01474512|20493577|P3|COMPLETED|Post-Treatment Follow-Up||0
8312034|NCT01474512|20493578|P2|COMPLETED|Post-Treatment Follow-Up||0
8312035|NCT01474512|20493579|P1|COMPLETED|Post-Treatment Follow-Up||0
8312036|NCT01474512|20493562|P18|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285
8312037|NCT01474512|20493563|P17|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700
8312038|NCT01474512|20493564|P16|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25
8312039|NCT01474512|20493565|P15|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18
8312040|NCT01474512|20493566|P14|STARTED|Post-Treatment Follow-Up||0
8312041|NCT01474512|20493567|P13|STARTED|Post-Treatment Follow-Up||0
8312042|NCT01474512|20493568|P12|STARTED|Post-Treatment Follow-Up||0
8312043|NCT01474512|20493569|P11|STARTED|Post-Treatment Follow-Up||0
8312044|NCT01474512|20493570|P10|STARTED|Post-Treatment Follow-Up||0
8312045|NCT01474512|20493571|P9|STARTED|Post-Treatment Follow-Up||0
8312046|NCT01474512|20493572|P8|STARTED|Post-Treatment Follow-Up||0
8312047|NCT01474512|20493573|P7|STARTED|Post-Treatment Follow-Up||0
8312048|NCT01474512|20493574|P6|STARTED|Post-Treatment Follow-Up||0
8312049|NCT01474512|20493575|P5|STARTED|Post-Treatment Follow-Up||0
8312050|NCT01474512|20493576|P4|STARTED|Post-Treatment Follow-Up||0
8312051|NCT01474512|20493577|P3|STARTED|Post-Treatment Follow-Up||0
8312052|NCT01474512|20493578|P2|STARTED|Post-Treatment Follow-Up||0
8312053|NCT01474512|20493579|P1|STARTED|Post-Treatment Follow-Up||0
8312054|NCT01474512|20493562|P18|NOT COMPLETED|Long-Term Extension Period||0
8312055|NCT01474512|20493563|P17|NOT COMPLETED|Long-Term Extension Period||0
8312056|NCT01474512|20493564|P16|NOT COMPLETED|Long-Term Extension Period||0
8312057|NCT01474512|20493565|P15|NOT COMPLETED|Long-Term Extension Period||0
8312058|NCT01474512|20493566|P14|NOT COMPLETED|Long-Term Extension Period||220
8312059|NCT01474512|20493567|P13|NOT COMPLETED|Long-Term Extension Period||218
8312060|NCT01474512|20493568|P12|NOT COMPLETED|Long-Term Extension Period||26
8312061|NCT01474512|20493569|P11|NOT COMPLETED|Long-Term Extension Period||0
8312062|NCT01474512|20493570|P10|NOT COMPLETED|Long-Term Extension Period||0
8312063|NCT01474512|20493571|P9|NOT COMPLETED|Long-Term Extension Period||0
8312064|NCT01474512|20493572|P8|NOT COMPLETED|Long-Term Extension Period||0
8312065|NCT01474512|20493573|P7|NOT COMPLETED|Long-Term Extension Period||0
8312066|NCT01474512|20493574|P6|NOT COMPLETED|Long-Term Extension Period||0
8312067|NCT01474512|20493575|P5|NOT COMPLETED|Long-Term Extension Period||0
8312068|NCT01474512|20493576|P4|NOT COMPLETED|Long-Term Extension Period||0
8312069|NCT01474512|20493577|P3|NOT COMPLETED|Long-Term Extension Period||0
8312070|NCT01474512|20493578|P2|NOT COMPLETED|Long-Term Extension Period||0
8312071|NCT01474512|20493579|P1|NOT COMPLETED|Long-Term Extension Period||0
8312072|NCT01474512|20493562|P18|COMPLETED|Long-Term Extension Period||0
8312073|NCT01474512|20493563|P17|COMPLETED|Long-Term Extension Period||0
8312074|NCT01474512|20493564|P16|COMPLETED|Long-Term Extension Period||0
8312075|NCT01474512|20493565|P15|COMPLETED|Long-Term Extension Period||0
8312076|NCT01474512|20493566|P14|COMPLETED|Long-Term Extension Period||855
8312077|NCT01474512|20493567|P13|COMPLETED|Long-Term Extension Period||836
8312078|NCT01474512|20493568|P12|COMPLETED|Long-Term Extension Period||0
8312079|NCT01474512|20493569|P11|COMPLETED|Long-Term Extension Period||0
8312080|NCT01474512|20493570|P10|COMPLETED|Long-Term Extension Period||0
8312081|NCT01474512|20493571|P9|COMPLETED|Long-Term Extension Period||0
8312082|NCT01474512|20493572|P8|COMPLETED|Long-Term Extension Period||0
8312083|NCT01474512|20493573|P7|COMPLETED|Long-Term Extension Period||0
8312084|NCT01474512|20493574|P6|COMPLETED|Long-Term Extension Period||0
8312085|NCT01474512|20493575|P5|COMPLETED|Long-Term Extension Period||0
8312086|NCT01474512|20493576|P4|COMPLETED|Long-Term Extension Period||0
8312087|NCT01474512|20493577|P3|COMPLETED|Long-Term Extension Period||0
8312088|NCT01474512|20493578|P2|COMPLETED|Long-Term Extension Period||0
8312089|NCT01474512|20493579|P1|COMPLETED|Long-Term Extension Period||0
8312090|NCT01474512|20493562|P18|STARTED|Long-Term Extension Period||0
8312091|NCT01474512|20493563|P17|STARTED|Long-Term Extension Period||0
8312092|NCT01474512|20493564|P16|STARTED|Long-Term Extension Period||0
8312093|NCT01474512|20493565|P15|STARTED|Long-Term Extension Period||0
8312094|NCT01474512|20493566|P14|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075
8312095|NCT01474512|20493567|P13|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054
8312096|NCT01474512|20493568|P12|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26
8312097|NCT01474512|20493569|P11|STARTED|Long-Term Extension Period||0
8312098|NCT01474512|20493570|P10|STARTED|Long-Term Extension Period||0
8312099|NCT01474512|20493571|P9|STARTED|Long-Term Extension Period||0
8312100|NCT01474512|20493572|P8|STARTED|Long-Term Extension Period||0
8312101|NCT01474512|20493573|P7|STARTED|Long-Term Extension Period||0
8312102|NCT01474512|20493574|P6|STARTED|Long-Term Extension Period||0
8312103|NCT01474512|20493575|P5|STARTED|Long-Term Extension Period||0
8312104|NCT01474512|20493576|P4|STARTED|Long-Term Extension Period||0
8312105|NCT01474512|20493577|P3|STARTED|Long-Term Extension Period||0
8312106|NCT01474512|20493578|P2|STARTED|Long-Term Extension Period||0
8312107|NCT01474512|20493579|P1|STARTED|Long-Term Extension Period||0
8312108|NCT01474512|20493562|P18|NOT COMPLETED|Maintenance Period||0
8312109|NCT01474512|20493563|P17|NOT COMPLETED|Maintenance Period||0
8312110|NCT01474512|20493564|P16|NOT COMPLETED|Maintenance Period||0
8312111|NCT01474512|20493565|P15|NOT COMPLETED|Maintenance Period||0
8312112|NCT01474512|20493566|P14|NOT COMPLETED|Maintenance Period||0
8312113|NCT01474512|20493567|P13|NOT COMPLETED|Maintenance Period||0
8312114|NCT01474512|20493568|P12|NOT COMPLETED|Maintenance Period||0
8312115|NCT01474512|20493569|P11|NOT COMPLETED|Maintenance Period||0
8312116|NCT01474512|20493570|P10|NOT COMPLETED|Maintenance Period||18
8312117|NCT01474512|20493571|P9|NOT COMPLETED|Maintenance Period||16
8312118|NCT01474512|20493572|P8|NOT COMPLETED|Maintenance Period||41
8312119|NCT01474512|20493573|P7|NOT COMPLETED|Maintenance Period||10
8312120|NCT01474512|20493574|P6|NOT COMPLETED|Maintenance Period||52
8312121|NCT01474512|20493575|P5|NOT COMPLETED|Maintenance Period||119
8312122|NCT01474512|20493576|P4|NOT COMPLETED|Maintenance Period||202
8312123|NCT01474512|20493577|P3|NOT COMPLETED|Maintenance Period||0
8312124|NCT01474512|20493578|P2|NOT COMPLETED|Maintenance Period||0
8312125|NCT01474512|20493579|P1|NOT COMPLETED|Maintenance Period||0
8312126|NCT01474512|20493562|P18|COMPLETED|Maintenance Period||0
8312127|NCT01474512|20493563|P17|COMPLETED|Maintenance Period||0
8312128|NCT01474512|20493564|P16|COMPLETED|Maintenance Period||0
8312129|NCT01474512|20493565|P15|COMPLETED|Maintenance Period||0
8312130|NCT01474512|20493566|P14|COMPLETED|Maintenance Period||0
8312131|NCT01474512|20493567|P13|COMPLETED|Maintenance Period||0
8312132|NCT01474512|20493568|P12|COMPLETED|Maintenance Period||0
8312133|NCT01474512|20493569|P11|COMPLETED|Maintenance Period||0
8312134|NCT01474512|20493570|P10|COMPLETED|Maintenance Period||44
8312135|NCT01474512|20493571|P9|COMPLETED|Maintenance Period||62
8312136|NCT01474512|20493572|P8|COMPLETED|Maintenance Period||350
8312137|NCT01474512|20493573|P7|COMPLETED|Maintenance Period||6
8312138|NCT01474512|20493574|P6|COMPLETED|Maintenance Period||177
8312139|NCT01474512|20493575|P5|COMPLETED|Maintenance Period||108
8312140|NCT01474512|20493576|P4|COMPLETED|Maintenance Period||24
8312141|NCT01474512|20493577|P3|COMPLETED|Maintenance Period||0
8312142|NCT01474512|20493578|P2|COMPLETED|Maintenance Period||0
8312143|NCT01474512|20493579|P1|COMPLETED|Maintenance Period||0
8312144|NCT01474512|20493562|P18|Relapsed Population Completers|Maintenance Period||0
8312145|NCT01474512|20493563|P17|Relapsed Population Completers|Maintenance Period||0
8312146|NCT01474512|20493564|P16|Relapsed Population Completers|Maintenance Period||0
8312147|NCT01474512|20493565|P15|Relapsed Population Completers|Maintenance Period||0
8312148|NCT01474512|20493566|P14|Relapsed Population Completers|Maintenance Period||0
8312149|NCT01474512|20493567|P13|Relapsed Population Completers|Maintenance Period||0
8312150|NCT01474512|20493568|P12|Relapsed Population Completers|Maintenance Period||0
8312151|NCT01474512|20493569|P11|Relapsed Population Completers|Maintenance Period||321
8312152|NCT01474512|20493570|P10|Relapsed Population Completers|Maintenance Period||0
8312153|NCT01474512|20493571|P9|Relapsed Population Completers|Maintenance Period||0
8312154|NCT01474512|20493572|P8|Relapsed Population Completers|Maintenance Period||0
8312155|NCT01474512|20493573|P7|Relapsed Population Completers|Maintenance Period||0
8312156|NCT01474512|20493574|P6|Relapsed Population Completers|Maintenance Period||0
8312157|NCT01474512|20493575|P5|Relapsed Population Completers|Maintenance Period||0
8312158|NCT01474512|20493576|P4|Relapsed Population Completers|Maintenance Period||0
8312159|NCT01474512|20493577|P3|Relapsed Population Completers|Maintenance Period||0
8312160|NCT01474512|20493578|P2|Relapsed Population Completers|Maintenance Period||0
8312161|NCT01474512|20493579|P1|Relapsed Population Completers|Maintenance Period||0
8312162|NCT01474512|20493562|P18|Relapsed Population Received Drug|Maintenance Period||0
8312163|NCT01474512|20493563|P17|Relapsed Population Received Drug|Maintenance Period||0
8312164|NCT01474512|20493564|P16|Relapsed Population Received Drug|Maintenance Period||0
8312165|NCT01474512|20493565|P15|Relapsed Population Received Drug|Maintenance Period||0
8312166|NCT01474512|20493566|P14|Relapsed Population Received Drug|Maintenance Period||0
8312167|NCT01474512|20493567|P13|Relapsed Population Received Drug|Maintenance Period||0
8312168|NCT01474512|20493568|P12|Relapsed Population Received Drug|Maintenance Period||0
8312169|NCT01474512|20493569|P11|Relapsed Population Received Drug|Maintenance Period||348
8312170|NCT01474512|20493570|P10|Relapsed Population Received Drug|Maintenance Period||0
8312171|NCT01474512|20493571|P9|Relapsed Population Received Drug|Maintenance Period||0
8312172|NCT01474512|20493572|P8|Relapsed Population Received Drug|Maintenance Period||0
8312173|NCT01474512|20493573|P7|Relapsed Population Received Drug|Maintenance Period||0
8312174|NCT01474512|20493574|P6|Relapsed Population Received Drug|Maintenance Period||0
8312175|NCT01474512|20493575|P5|Relapsed Population Received Drug|Maintenance Period||0
8312176|NCT01474512|20493576|P4|Relapsed Population Received Drug|Maintenance Period||0
8312177|NCT01474512|20493577|P3|Relapsed Population Received Drug|Maintenance Period||0
8312178|NCT01474512|20493578|P2|Relapsed Population Received Drug|Maintenance Period||0
8312179|NCT01474512|20493579|P1|Relapsed Population Received Drug|Maintenance Period||0
8312180|NCT01474512|20493562|P18|Received Study Drug|Maintenance Period||0
8312181|NCT01474512|20493563|P17|Received Study Drug|Maintenance Period||0
8312182|NCT01474512|20493564|P16|Received Study Drug|Maintenance Period||0
8312183|NCT01474512|20493565|P15|Received Study Drug|Maintenance Period||0
8312184|NCT01474512|20493566|P14|Received Study Drug|Maintenance Period||0
8312185|NCT01474512|20493567|P13|Received Study Drug|Maintenance Period||0
8312186|NCT01474512|20493568|P12|Received Study Drug|Maintenance Period||0
8312187|NCT01474512|20493569|P11|Received Study Drug|Maintenance Period||0
8312188|NCT01474512|20493570|P10|Received Study Drug|Maintenance Period||62
8312189|NCT01474512|20493571|P9|Received Study Drug|Maintenance Period||78
8312190|NCT01474512|20493572|P8|Received Study Drug|Maintenance Period||391
8312191|NCT01474512|20493573|P7|Received Study Drug|Maintenance Period||16
8312192|NCT01474512|20493574|P6|Received Study Drug|Maintenance Period||229
8312193|NCT01474512|20493575|P5|Received Study Drug|Maintenance Period||227
8312194|NCT01474512|20493576|P4|Received Study Drug|Maintenance Period||226
8312195|NCT01474512|20493577|P3|Received Study Drug|Maintenance Period||0
8312196|NCT01474512|20493578|P2|Received Study Drug|Maintenance Period||0
8312197|NCT01474512|20493579|P1|Received Study Drug|Maintenance Period||0
8312198|NCT01474512|20493562|P18|STARTED|Maintenance Period||0
8312199|NCT01474512|20493563|P17|STARTED|Maintenance Period||0
8312200|NCT01474512|20493564|P16|STARTED|Maintenance Period||0
8312201|NCT01474512|20493565|P15|STARTED|Maintenance Period||0
8312202|NCT01474512|20493566|P14|STARTED|Maintenance Period||0
8312203|NCT01474512|20493567|P13|STARTED|Maintenance Period||0
8312204|NCT01474512|20493568|P12|STARTED|Maintenance Period||0
8312205|NCT01474512|20493569|P11|STARTED|Maintenance Period||0
8312206|NCT01474512|20493570|P10|STARTED|Maintenance Period||62
8312207|NCT01474512|20493571|P9|STARTED|Maintenance Period||78
8312208|NCT01474512|20493572|P8|STARTED|Maintenance Period||391
8312209|NCT01474512|20493573|P7|STARTED|Maintenance Period||16
8312210|NCT01474512|20493574|P6|STARTED|Maintenance Period||229
8312298|NCT01474434|20493657|P2|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
8312211|NCT01474512|20493575|P5|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
8312212|NCT01474512|20493576|P4|STARTED|Maintenance Period||226
8312213|NCT01474512|20493577|P3|STARTED|Maintenance Period||0
8312214|NCT01474512|20493578|P2|STARTED|Maintenance Period||0
8312215|NCT01474512|20493579|P1|STARTED|Maintenance Period||0
8312216|NCT01474512|20493562|P18|NOT COMPLETED|Induction Period||0
8312217|NCT01474512|20493563|P17|NOT COMPLETED|Induction Period||0
8312218|NCT01474512|20493564|P16|NOT COMPLETED|Induction Period||0
8312219|NCT01474512|20493565|P15|NOT COMPLETED|Induction Period||0
8312220|NCT01474512|20493566|P14|NOT COMPLETED|Induction Period||0
8312221|NCT01474512|20493567|P13|NOT COMPLETED|Induction Period||0
8312222|NCT01474512|20493568|P12|NOT COMPLETED|Induction Period||0
8312223|NCT01474512|20493569|P11|NOT COMPLETED|Induction Period||0
8312224|NCT01474512|20493570|P10|NOT COMPLETED|Induction Period||0
8312225|NCT01474512|20493571|P9|NOT COMPLETED|Induction Period||0
8312226|NCT01474512|20493572|P8|NOT COMPLETED|Induction Period||0
8312227|NCT01474512|20493573|P7|NOT COMPLETED|Induction Period||0
8312228|NCT01474512|20493574|P6|NOT COMPLETED|Induction Period||0
8312229|NCT01474512|20493575|P5|NOT COMPLETED|Induction Period||0
8312230|NCT01474512|20493576|P4|NOT COMPLETED|Induction Period||0
8312231|NCT01474512|20493577|P3|NOT COMPLETED|Induction Period||18
8312232|NCT01474512|20493578|P2|NOT COMPLETED|Induction Period||24
8312233|NCT01474512|20493579|P1|NOT COMPLETED|Induction Period||24
8312234|NCT01474512|20493562|P18|COMPLETED|Induction Period||0
8312235|NCT01474512|20493563|P17|COMPLETED|Induction Period||0
8312236|NCT01474512|20493564|P16|COMPLETED|Induction Period||0
8312237|NCT01474512|20493565|P15|COMPLETED|Induction Period||0
8312238|NCT01474512|20493566|P14|COMPLETED|Induction Period||0
8312239|NCT01474512|20493567|P13|COMPLETED|Induction Period||0
8312240|NCT01474512|20493568|P12|COMPLETED|Induction Period||0
8312241|NCT01474512|20493569|P11|COMPLETED|Induction Period||0
8312242|NCT01474512|20493570|P10|COMPLETED|Induction Period||0
8312243|NCT01474512|20493571|P9|COMPLETED|Induction Period||0
8312244|NCT01474512|20493572|P8|COMPLETED|Induction Period||0
8312245|NCT01474512|20493573|P7|COMPLETED|Induction Period||0
8312246|NCT01474512|20493574|P6|COMPLETED|Induction Period||0
8312247|NCT01474512|20493575|P5|COMPLETED|Induction Period||0
8312248|NCT01474512|20493576|P4|COMPLETED|Induction Period||0
8312249|NCT01474512|20493577|P3|COMPLETED|Induction Period||415
8312250|NCT01474512|20493578|P2|COMPLETED|Induction Period||408
8312251|NCT01474512|20493579|P1|COMPLETED|Induction Period||407
8312252|NCT01474512|20493562|P18|Received Study Drug|Induction Period||0
8312253|NCT01474512|20493563|P17|Received Study Drug|Induction Period||0
8312254|NCT01474512|20493564|P16|Received Study Drug|Induction Period||0
8312255|NCT01474512|20493565|P15|Received Study Drug|Induction Period||0
8312256|NCT01474512|20493566|P14|Received Study Drug|Induction Period||0
8312257|NCT01474512|20493567|P13|Received Study Drug|Induction Period||0
8312258|NCT01474512|20493568|P12|Received Study Drug|Induction Period||0
8312259|NCT01474512|20493569|P11|Received Study Drug|Induction Period||0
8312260|NCT01474512|20493570|P10|Received Study Drug|Induction Period||0
8312261|NCT01474512|20493571|P9|Received Study Drug|Induction Period||0
8312262|NCT01474512|20493572|P8|Received Study Drug|Induction Period||0
8312263|NCT01474512|20493573|P7|Received Study Drug|Induction Period||0
8312264|NCT01474512|20493574|P6|Received Study Drug|Induction Period||0
8312265|NCT01474512|20493575|P5|Received Study Drug|Induction Period||0
8312266|NCT01474512|20493576|P4|Received Study Drug|Induction Period||0
8312267|NCT01474512|20493577|P3|Received Study Drug|Induction Period||433
8312268|NCT01474512|20493578|P2|Received Study Drug|Induction Period||432
8312269|NCT01474512|20493579|P1|Received Study Drug|Induction Period||431
8312270|NCT01474512|20493562|P18|STARTED|Induction Period||0
8312271|NCT01474512|20493563|P17|STARTED|Induction Period||0
8312272|NCT01474512|20493564|P16|STARTED|Induction Period||0
8312273|NCT01474512|20493565|P15|STARTED|Induction Period||0
8312274|NCT01474512|20493566|P14|STARTED|Induction Period||0
8312275|NCT01474512|20493567|P13|STARTED|Induction Period||0
8312276|NCT01474512|20493568|P12|STARTED|Induction Period||0
8312277|NCT01474512|20493569|P11|STARTED|Induction Period||0
8312278|NCT01474512|20493570|P10|STARTED|Induction Period||0
8312279|NCT01474512|20493571|P9|STARTED|Induction Period||0
8312280|NCT01474512|20493572|P8|STARTED|Induction Period||0
8312281|NCT01474512|20493573|P7|STARTED|Induction Period||0
8312282|NCT01474512|20493574|P6|STARTED|Induction Period||0
8312283|NCT01474512|20493575|P5|STARTED|Induction Period||0
8312284|NCT01474512|20493576|P4|STARTED|Induction Period||0
8312285|NCT01474512|20493577|P3|STARTED|Induction Period||433
8312286|NCT01474512|20493578|P2|STARTED|Induction Period||432
8312287|NCT01474512|20493579|P1|STARTED|Induction Period||431
8312288|NCT01474434|20493655|P4|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
8312289|NCT01474434|20493656|P3|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
8312290|NCT01474434|20493657|P2|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
8312291|NCT01474434|20493658|P1|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
8312292|NCT01474434|20493655|P4|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
8312293|NCT01474434|20493656|P3|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
8312294|NCT01474434|20493657|P2|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
8312295|NCT01474434|20493658|P1|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
8312296|NCT01474434|20493655|P4|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
8312297|NCT01474434|20493656|P3|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
8312299|NCT01474434|20493658|P1|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
8312300|NCT01474434|20493655|P4|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
8312301|NCT01474434|20493656|P3|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
8312302|NCT01474434|20493657|P2|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
8312303|NCT01474434|20493658|P1|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
8312304|NCT01474434|20493655|P4|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
8312305|NCT01474434|20493656|P3|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
8312306|NCT01474434|20493657|P2|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
8312307|NCT01474434|20493658|P1|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
8312308|NCT01474434|20493655|P4|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
8312309|NCT01474434|20493656|P3|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
8312310|NCT01474434|20493657|P2|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
8312311|NCT01474434|20493658|P1|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
8312312|NCT01474317|20493700|P1|NOT COMPLETED|Overall Study||2
8312313|NCT01474317|20493700|P1|COMPLETED|Overall Study||224
8312314|NCT01474317|20493700|P1|STARTED|Overall Study||226
8312315|NCT01474291|20493709|P1|NOT COMPLETED|Overall Study||220
8312316|NCT01474291|20493709|P1|COMPLETED|Overall Study||383
8312317|NCT01474291|20493709|P1|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
8312318|NCT01474291|20493709|P1|STARTED|Overall Study||603
8312319|NCT01474239|20493753|P2|NOT COMPLETED|Overall Study||32
8312320|NCT01474239|20493754|P1|NOT COMPLETED|Overall Study||59
8312321|NCT01474239|20493753|P2|COMPLETED|Overall Study||0
8312322|NCT01474239|20493754|P1|COMPLETED|Overall Study||0
8312323|NCT01474239|20493753|P2|STARTED|Overall Study||32
8312324|NCT01474239|20493754|P1|STARTED|Overall Study||59
8312325|NCT01474213|20493792|P2|NOT COMPLETED|Overall Study||0
8312326|NCT01474213|20493793|P1|NOT COMPLETED|Overall Study||0
8312327|NCT01474213|20493792|P2|COMPLETED|Overall Study||20
8312328|NCT01474213|20493793|P1|COMPLETED|Overall Study||20
8312329|NCT01474213|20493792|P2|STARTED|Overall Study||20
8312330|NCT01474213|20493793|P1|STARTED|Overall Study||20
8312337|NCT01474122|20493871|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||15
8312338|NCT01474122|20493872|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||13
8312339|NCT01474122|20493873|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||17
8312340|NCT01474122|20493871|P3|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
8312341|NCT01474122|20493872|P2|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
8312342|NCT01474122|20493873|P1|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
8312343|NCT01474122|20493871|P3|STARTED|Period 2: Week 16 to End of Study||88
8312344|NCT01474122|20493872|P2|STARTED|Period 2: Week 16 to End of Study||86
8312345|NCT01474122|20493873|P1|STARTED|Period 2: Week 16 to End of Study||87
8312346|NCT01474122|20493871|P3|NOT COMPLETED|Period 1: Baseline to Week 16||1
8312347|NCT01474122|20493872|P2|NOT COMPLETED|Period 1: Baseline to Week 16||2
8312348|NCT01474122|20493873|P1|NOT COMPLETED|Period 1: Baseline to Week 16||1
8312349|NCT01474122|20493871|P3|COMPLETED|Period 1: Baseline to Week 16||88
8312350|NCT01474122|20493872|P2|COMPLETED|Period 1: Baseline to Week 16||86
8312351|NCT01474122|20493873|P1|COMPLETED|Period 1: Baseline to Week 16||87
8312352|NCT01474122|20493871|P3|STARTED|Period 1: Baseline to Week 16||89
8312353|NCT01474122|20493872|P2|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
8312354|NCT01474122|20493873|P1|STARTED|Period 1: Baseline to Week 16||88
8312355|NCT01474109|20493899|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||12
8312356|NCT01474109|20493900|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||18
8312357|NCT01474109|20493901|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||18
8312358|NCT01474109|20493899|P3|COMPLETED|Period 2: Week 16 to End of Study||83
8312359|NCT01474109|20493900|P2|COMPLETED|Period 2: Week 16 to End of Study||73
8312360|NCT01474109|20493901|P1|COMPLETED|Period 2: Week 16 to End of Study||70
8312361|NCT01474109|20493899|P3|STARTED|Period 2: Week 16 to End of Study||95
8312362|NCT01474109|20493900|P2|STARTED|Period 2: Week 16 to End of Study||91
8312363|NCT01474109|20493901|P1|STARTED|Period 2: Week 16 to End of Study||88
8312364|NCT01474109|20493899|P3|NOT COMPLETED|Period 1: Baseline to Week 16||2
8312365|NCT01474109|20493900|P2|NOT COMPLETED|Period 1: Baseline to Week 16||6
8312366|NCT01474109|20493901|P1|NOT COMPLETED|Period 1: Baseline to Week 16||7
8312367|NCT01474109|20493899|P3|COMPLETED|Period 1: Baseline to Week 16||95
8312368|NCT01474109|20493900|P2|COMPLETED|Period 1: Baseline to Week 16||91
8312369|NCT01474109|20493901|P1|COMPLETED|Period 1: Baseline to Week 16||88
8312370|NCT01474109|20493899|P3|STARTED|Period 1: Baseline to Week 16||97
8312371|NCT01474109|20493900|P2|STARTED|Period 1: Baseline to Week 16||97
8312372|NCT01474109|20493901|P1|STARTED|Period 1: Baseline to Week 16||95
8312373|NCT01474018|20493926|P2|NOT COMPLETED|Overall Study||3
8312374|NCT01474018|20493927|P1|NOT COMPLETED|Overall Study||0
8312375|NCT01474018|20493926|P2|COMPLETED|Overall Study||7
8312376|NCT01474018|20493927|P1|COMPLETED|Overall Study|Writing paper|5
8312377|NCT01474018|20493926|P2|STARTED|Overall Study||10
8312378|NCT01474018|20493927|P1|STARTED|Overall Study||5
8312379|NCT01473992|20493937|P3|NOT COMPLETED|Overall Study||0
8312380|NCT01473992|20493938|P2|NOT COMPLETED|Overall Study||0
8312381|NCT01473992|20493939|P1|NOT COMPLETED|Overall Study||0
8312382|NCT01473992|20493937|P3|COMPLETED|Overall Study||5
8312383|NCT01473992|20493938|P2|COMPLETED|Overall Study||10
8312384|NCT01473992|20493939|P1|COMPLETED|Overall Study||10
8312385|NCT01473992|20493937|P3|STARTED|Overall Study||5
8312386|NCT01473992|20493938|P2|STARTED|Overall Study||10
8312387|NCT01473992|20493939|P1|STARTED|Overall Study||10
8312388|NCT01473953|20493959|P5|NOT COMPLETED|Overall Study||0
8312389|NCT01473953|20493960|P4|NOT COMPLETED|Overall Study||0
8312390|NCT01473953|20493961|P3|NOT COMPLETED|Overall Study||0
8312391|NCT01473953|20493962|P2|NOT COMPLETED|Overall Study||0
8312392|NCT01473953|20493963|P1|NOT COMPLETED|Overall Study||1
8312393|NCT01473953|20493959|P5|COMPLETED|Overall Study||8
8312394|NCT01473953|20493960|P4|COMPLETED|Overall Study||5
8312395|NCT01473953|20493961|P3|COMPLETED|Overall Study||6
8312396|NCT01473953|20493962|P2|COMPLETED|Overall Study||6
8312397|NCT01473953|20493963|P1|COMPLETED|Overall Study||5
8312398|NCT01473953|20493959|P5|STARTED|Overall Study||8
8312399|NCT01473953|20493960|P4|STARTED|Overall Study||5
8312400|NCT01473953|20493961|P3|STARTED|Overall Study||6
8312401|NCT01473953|20493962|P2|STARTED|Overall Study||6
8312402|NCT01473953|20493963|P1|STARTED|Overall Study||6
8312403|NCT01473940|20494009|P4|NOT COMPLETED|Follow-up Until Death||0
8312404|NCT01473940|20494010|P3|NOT COMPLETED|Follow-up Until Death||0
8312405|NCT01473940|20494011|P2|NOT COMPLETED|Follow-up Until Death||0
8312406|NCT01473940|20494012|P1|NOT COMPLETED|Follow-up Until Death||0
8312407|NCT01473940|20494009|P4|COMPLETED|Follow-up Until Death||7
8312408|NCT01473940|20494010|P3|COMPLETED|Follow-up Until Death||5
8312409|NCT01473940|20494011|P2|COMPLETED|Follow-up Until Death||4
8312410|NCT01473940|20494012|P1|COMPLETED|Follow-up Until Death||3
8312411|NCT01473940|20494009|P4|STARTED|Follow-up Until Death||7
8312412|NCT01473940|20494010|P3|STARTED|Follow-up Until Death||5
8312413|NCT01473940|20494011|P2|STARTED|Follow-up Until Death||4
8312414|NCT01473940|20494012|P1|STARTED|Follow-up Until Death||3
8312415|NCT01473940|20494009|P4|NOT COMPLETED|Maintenance Therapy||4
8312416|NCT01473940|20494010|P3|NOT COMPLETED|Maintenance Therapy||1
8312417|NCT01473940|20494011|P2|NOT COMPLETED|Maintenance Therapy||2
8312418|NCT01473940|20494012|P1|NOT COMPLETED|Maintenance Therapy||1
8312419|NCT01473940|20494009|P4|COMPLETED|Maintenance Therapy||3
8312420|NCT01473940|20494010|P3|COMPLETED|Maintenance Therapy||3
8312421|NCT01473940|20494011|P2|COMPLETED|Maintenance Therapy||1
8312422|NCT01473940|20494012|P1|COMPLETED|Maintenance Therapy||2
8312423|NCT01473940|20494009|P4|Went on to Start Maintenance Therapy|Maintenance Therapy||3
8312424|NCT01473940|20494010|P3|Went on to Start Maintenance Therapy|Maintenance Therapy||3
8312425|NCT01473940|20494011|P2|Went on to Start Maintenance Therapy|Maintenance Therapy||1
8312426|NCT01473940|20494012|P1|Went on to Start Maintenance Therapy|Maintenance Therapy||2
8312427|NCT01473940|20494009|P4|Evaluated for Response|Maintenance Therapy||7
8312428|NCT01473940|20494010|P3|Evaluated for Response|Maintenance Therapy||4
8312429|NCT01473940|20494011|P2|Evaluated for Response|Maintenance Therapy||3
8312430|NCT01473940|20494012|P1|Evaluated for Response|Maintenance Therapy||3
8312431|NCT01473940|20494009|P4|STARTED|Maintenance Therapy||7
8312432|NCT01473940|20494010|P3|STARTED|Maintenance Therapy||4
8312433|NCT01473940|20494011|P2|STARTED|Maintenance Therapy||3
8312434|NCT01473940|20494012|P1|STARTED|Maintenance Therapy||3
8312435|NCT01473940|20494009|P4|NOT COMPLETED|Induction Therapy||1
8312436|NCT01473940|20494010|P3|NOT COMPLETED|Induction Therapy||2
8312437|NCT01473940|20494011|P2|NOT COMPLETED|Induction Therapy||1
8312438|NCT01473940|20494012|P1|NOT COMPLETED|Induction Therapy||0
8312439|NCT01473940|20494009|P4|COMPLETED|Induction Therapy||7
8312440|NCT01473940|20494010|P3|COMPLETED|Induction Therapy||4
8312441|NCT01473940|20494011|P2|COMPLETED|Induction Therapy||3
8312442|NCT01473940|20494012|P1|COMPLETED|Induction Therapy||3
8312443|NCT01473940|20494009|P4|Completed Induction- 12 Weeks|Induction Therapy||7
8312444|NCT01473940|20494010|P3|Completed Induction- 12 Weeks|Induction Therapy||4
8312445|NCT01473940|20494011|P2|Completed Induction- 12 Weeks|Induction Therapy||3
8312446|NCT01473940|20494012|P1|Completed Induction- 12 Weeks|Induction Therapy||3
8312447|NCT01473940|20494009|P4|Started Treatment|Induction Therapy||8
8312448|NCT01473940|20494010|P3|Started Treatment|Induction Therapy||6
8312449|NCT01473940|20494011|P2|Started Treatment|Induction Therapy||4
8312450|NCT01473940|20494012|P1|Started Treatment|Induction Therapy||3
8312451|NCT01473940|20494009|P4|STARTED|Induction Therapy||8
8312452|NCT01473940|20494010|P3|STARTED|Induction Therapy||6
8312453|NCT01473940|20494011|P2|STARTED|Induction Therapy||4
8312454|NCT01473940|20494012|P1|STARTED|Induction Therapy||3
8312455|NCT01473836|20494042|P1|NOT COMPLETED|Overall Study||6
8312456|NCT01473836|20494042|P1|COMPLETED|Overall Study||32
8312457|NCT01473836|20494042|P1|STARTED|Overall Study||38
8312458|NCT01473758|20494053|P4|NOT COMPLETED|Cycle 2||0
8312459|NCT01473758|20494054|P3|NOT COMPLETED|Cycle 2||5
8312460|NCT01473758|20494055|P2|NOT COMPLETED|Cycle 2||0
8312461|NCT01473758|20494056|P1|NOT COMPLETED|Cycle 2||0
8312462|NCT01473758|20494053|P4|COMPLETED|Cycle 2||4
8312463|NCT01473758|20494054|P3|COMPLETED|Cycle 2||5
8312464|NCT01473758|20494055|P2|COMPLETED|Cycle 2||0
8312465|NCT01473758|20494056|P1|COMPLETED|Cycle 2||0
8312466|NCT01473758|20494053|P4|STARTED|Cycle 2||4
8312467|NCT01473758|20494054|P3|STARTED|Cycle 2||10
8312468|NCT01473758|20494055|P2|STARTED|Cycle 2||0
8312469|NCT01473758|20494056|P1|STARTED|Cycle 2||0
8312470|NCT01473758|20494053|P4|NOT COMPLETED|Cycle 1||0
8312471|NCT01473758|20494054|P3|NOT COMPLETED|Cycle 1||0
8312472|NCT01473758|20494055|P2|NOT COMPLETED|Cycle 1||3
8312473|NCT01473758|20494056|P1|NOT COMPLETED|Cycle 1||11
8312474|NCT01473758|20494053|P4|COMPLETED|Cycle 1||0
8312475|NCT01473758|20494054|P3|COMPLETED|Cycle 1||0
8312476|NCT01473758|20494055|P2|COMPLETED|Cycle 1||40
8312477|NCT01473758|20494056|P1|COMPLETED|Cycle 1||27
8312478|NCT01473758|20494053|P4|STARTED|Cycle 1||0
8312479|NCT01473758|20494054|P3|STARTED|Cycle 1||0
8312480|NCT01473758|20494055|P2|STARTED|Cycle 1||43
8312481|NCT01473758|20494056|P1|STARTED|Cycle 1||38
8312482|NCT01473745|20494180|P2|NOT COMPLETED|Overall Study||0
8312483|NCT01473745|20494181|P1|NOT COMPLETED|Overall Study||0
8312484|NCT01473745|20494180|P2|COMPLETED|Overall Study||24
8312485|NCT01473745|20494181|P1|COMPLETED|Overall Study||24
8312486|NCT01473745|20494180|P2|STARTED|Overall Study||24
8312487|NCT01473745|20494181|P1|STARTED|Overall Study||24
8312488|NCT01473732|20494193|P2|NOT COMPLETED|Overall Study||0
8312489|NCT01473732|20494194|P1|NOT COMPLETED|Overall Study||2
8312490|NCT01473732|20494193|P2|COMPLETED|Overall Study||0
8312491|NCT01473732|20494194|P1|COMPLETED|Overall Study||0
8312492|NCT01473732|20494193|P2|STARTED|Overall Study||0
8312493|NCT01473732|20494194|P1|STARTED|Overall Study||2
8312494|NCT01473602|20494202|P2|NOT COMPLETED|Overall Study||8
8312495|NCT01473602|20494203|P1|NOT COMPLETED|Overall Study||8
8312496|NCT01473602|20494202|P2|COMPLETED|Overall Study||13
8312497|NCT01473602|20494203|P1|COMPLETED|Overall Study||10
8312498|NCT01473602|20494202|P2|Completed 12 Months|Overall Study||13
8312499|NCT01473602|20494203|P1|Completed 12 Months|Overall Study||10
8312500|NCT01473602|20494202|P2|Completed 6 Months|Overall Study||15
8312501|NCT01473602|20494203|P1|Completed 6 Months|Overall Study||12
8312502|NCT01473602|20494202|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
8312503|NCT01473602|20494203|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
8312504|NCT01473602|20494202|P2|STARTED|Overall Study||21
8312505|NCT01473602|20494203|P1|STARTED|Overall Study||18
8312506|NCT01473589|20494239|P2|NOT COMPLETED|Overall Study||16
8312507|NCT01473589|20494240|P1|NOT COMPLETED|Overall Study||11
8312508|NCT01473589|20494239|P2|COMPLETED|Overall Study||46
8312509|NCT01473589|20494240|P1|COMPLETED|Overall Study||49
8312510|NCT01473589|20494239|P2|Completed 12 Months|Overall Study||48
8312511|NCT01473589|20494240|P1|Completed 12 Months|Overall Study||49
8312512|NCT01473589|20494239|P2|Completed 6 Months|Overall Study||54
8312513|NCT01473589|20494240|P1|Completed 6 Months|Overall Study||51
8312514|NCT01473589|20494239|P2|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
8312515|NCT01473589|20494240|P1|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
8312516|NCT01473589|20494239|P2|STARTED|Overall Study||62
8312517|NCT01473589|20494240|P1|STARTED|Overall Study||60
8312518|NCT01473563|20494274|P1|NOT COMPLETED|Overall Study||1
8312519|NCT01473563|20494274|P1|COMPLETED|Overall Study||51
8312520|NCT01473563|20494274|P1|Received at Least 1 Dose of Study Drug|Overall Study||52
8312521|NCT01473563|20494274|P1|STARTED|Overall Study||52
8312570|NCT01473420|20494350|P2|NOT COMPLETED|Maintenance Period (16 Weeks)||17
8312571|NCT01473420|20494351|P1|NOT COMPLETED|Maintenance Period (16 Weeks)||18
8312572|NCT01473420|20494350|P2|COMPLETED|Maintenance Period (16 Weeks)||105
8312573|NCT01473420|20494351|P1|COMPLETED|Maintenance Period (16 Weeks)||106
8312574|NCT01473420|20494350|P2|STARTED|Maintenance Period (16 Weeks)||122
8312575|NCT01473420|20494351|P1|STARTED|Maintenance Period (16 Weeks)||124
8312576|NCT01473420|20494350|P2|NOT COMPLETED|Titration Period (18 Weeks)||38
8312577|NCT01473420|20494351|P1|NOT COMPLETED|Titration Period (18 Weeks)||36
8312578|NCT01473420|20494350|P2|COMPLETED|Titration Period (18 Weeks)||122
8312579|NCT01473420|20494351|P1|COMPLETED|Titration Period (18 Weeks)||124
8312580|NCT01473420|20494350|P2|Treated|Titration Period (18 Weeks)||86
8312581|NCT01473420|20494351|P1|Treated|Titration Period (18 Weeks)||80
8312582|NCT01473420|20494350|P2|STARTED|Titration Period (18 Weeks)||160
8312583|NCT01473420|20494351|P1|STARTED|Titration Period (18 Weeks)||160
8312584|NCT01473407|20494435|P2|NOT COMPLETED|Overall Study||47
8312585|NCT01473407|20494436|P1|NOT COMPLETED|Overall Study||54
8312586|NCT01473407|20494435|P2|COMPLETED|Overall Study||259
8312587|NCT01473407|20494436|P1|COMPLETED|Overall Study||252
8312588|NCT01473407|20494435|P2|STARTED|Overall Study||306
8312589|NCT01473407|20494436|P1|STARTED|Overall Study||306
8312590|NCT01473394|20494490|P2|NOT COMPLETED|Overall Study||43
8312591|NCT01473394|20494491|P1|NOT COMPLETED|Overall Study||45
8312592|NCT01473394|20494490|P2|COMPLETED|Overall Study||212
8312593|NCT01473394|20494491|P1|COMPLETED|Overall Study||208
8312594|NCT01473394|20494490|P2|STARTED|Overall Study||255
8312595|NCT01473394|20494491|P1|STARTED|Overall Study||253
8312596|NCT01473381|20494505|P4|NOT COMPLETED|Overall Study||89
8312597|NCT01473381|20494506|P3|NOT COMPLETED|Overall Study||102
8312598|NCT01473381|20494507|P2|NOT COMPLETED|Overall Study||93
8312599|NCT01473381|20494508|P1|NOT COMPLETED|Overall Study||80
8312600|NCT01473381|20494505|P4|COMPLETED|Overall Study||200
8312601|NCT01473381|20494506|P3|COMPLETED|Overall Study||189
8312602|NCT01473381|20494507|P2|COMPLETED|Overall Study||199
8312603|NCT01473381|20494508|P1|COMPLETED|Overall Study||210
8312604|NCT01473381|20494505|P4|Safety Population|Overall Study||282
8312605|NCT01473381|20494506|P3|Safety Population|Overall Study||287
8312606|NCT01473381|20494507|P2|Safety Population|Overall Study||288
8312607|NCT01473381|20494508|P1|Safety Population|Overall Study||281
8312608|NCT01473381|20494505|P4|STARTED|Overall Study||289
8312609|NCT01473381|20494506|P3|STARTED|Overall Study||291
8312610|NCT01473381|20494507|P2|STARTED|Overall Study||292
8312611|NCT01473381|20494508|P1|STARTED|Overall Study||290
8312612|NCT01473368|20494530|P4|NOT COMPLETED|Overall Study||0
8312613|NCT01473368|20494531|P3|NOT COMPLETED|Overall Study||3
8312614|NCT01473368|20494532|P2|NOT COMPLETED|Overall Study||0
8312615|NCT01473368|20494533|P1|NOT COMPLETED|Overall Study||1
8312616|NCT01473368|20494530|P4|COMPLETED|Overall Study||12
8312617|NCT01473368|20494531|P3|COMPLETED|Overall Study||12
8312618|NCT01473368|20494532|P2|COMPLETED|Overall Study||12
8312619|NCT01473368|20494533|P1|COMPLETED|Overall Study||13
8312620|NCT01473368|20494530|P4|STARTED|Overall Study||12
8312621|NCT01473368|20494531|P3|STARTED|Overall Study||15
8312622|NCT01473368|20494532|P2|STARTED|Overall Study||12
8312623|NCT01473368|20494533|P1|STARTED|Overall Study||14
8312624|NCT01473355|20494570|P1|NOT COMPLETED|Overall Study||6
8312625|NCT01473355|20494570|P1|COMPLETED|Overall Study||39
8312626|NCT01473355|20494570|P1|STARTED|Overall Study||45
8312627|NCT01473160|20494579|P1|NOT COMPLETED|Overall Study||0
8312628|NCT01473160|20494579|P1|COMPLETED|Overall Study||9
8312629|NCT01473160|20494579|P1|STARTED|Overall Study||9
8312630|NCT01472965|20494599|P2|NOT COMPLETED|Overall Study||0
8312631|NCT01472965|20494600|P1|NOT COMPLETED|Overall Study||1
8312632|NCT01472965|20494599|P2|COMPLETED|Overall Study||46
8312633|NCT01472965|20494600|P1|COMPLETED|Overall Study||48
8312634|NCT01472965|20494599|P2|STARTED|Overall Study||46
8312635|NCT01472965|20494600|P1|STARTED|Overall Study||49
8312648|NCT01472874|20494650|P1|NOT COMPLETED|Overall Study||0
8312649|NCT01472874|20494650|P1|COMPLETED|Overall Study||8
8312650|NCT01472874|20494650|P1|STARTED|Overall Study||8
8312651|NCT01472835|20494667|P2|NOT COMPLETED|Overall Study||0
8312652|NCT01472835|20494668|P1|NOT COMPLETED|Overall Study||2
8312653|NCT01472835|20494667|P2|COMPLETED|Overall Study||36
8312654|NCT01472835|20494668|P1|COMPLETED|Overall Study||35
8312655|NCT01472835|20494667|P2|STARTED|Overall Study||36
8312656|NCT01472835|20494668|P1|STARTED|Overall Study||37
8312657|NCT01472822|20494684|P2|NOT COMPLETED|Overall Study||2
8312658|NCT01472822|20494685|P1|NOT COMPLETED|Overall Study||2
8312659|NCT01472822|20494684|P2|COMPLETED|Overall Study||28
8312660|NCT01472822|20494685|P1|COMPLETED|Overall Study||28
8312661|NCT01472822|20494684|P2|STARTED|Overall Study||30
8312662|NCT01472822|20494685|P1|STARTED|Overall Study||30
8312663|NCT01472757|20494703|P4|NOT COMPLETED|Overall Study||19
8312664|NCT01472757|20494704|P3|NOT COMPLETED|Overall Study||19
8312665|NCT01472757|20494705|P2|NOT COMPLETED|Overall Study||13
8312666|NCT01472757|20494706|P1|NOT COMPLETED|Overall Study||30
8312667|NCT01472757|20494703|P4|COMPLETED|Overall Study||75
8312668|NCT01472757|20494704|P3|COMPLETED|Overall Study||76
8312669|NCT01472757|20494705|P2|COMPLETED|Overall Study||80
8312670|NCT01472757|20494706|P1|COMPLETED|Overall Study||61
8312671|NCT01472757|20494703|P4|Full Analysis Set|Overall Study||92
8312672|NCT01472757|20494704|P3|Full Analysis Set|Overall Study||92
8312673|NCT01472757|20494705|P2|Full Analysis Set|Overall Study||93
8312674|NCT01472757|20494706|P1|Full Analysis Set|Overall Study||91
8312675|NCT01472757|20494703|P4|STARTED|Overall Study||94
8312676|NCT01472757|20494704|P3|STARTED|Overall Study||95
8312677|NCT01472757|20494705|P2|STARTED|Overall Study||93
8312678|NCT01472757|20494706|P1|STARTED|Overall Study||91
8312679|NCT01472718|20494730|P2|NOT COMPLETED|Overall Study||7
8312680|NCT01472718|20494731|P1|NOT COMPLETED|Overall Study||6
8312681|NCT01472718|20494730|P2|COMPLETED|Overall Study||97
8312682|NCT01472718|20494731|P1|COMPLETED|Overall Study||98
8312683|NCT01472718|20494730|P2|STARTED|Overall Study||104
8312684|NCT01472718|20494731|P1|STARTED|Overall Study||104
8312685|NCT01472692|20494741|P2|NOT COMPLETED|Overall Study||0
8312686|NCT01472692|20494742|P1|NOT COMPLETED|Overall Study||0
8312687|NCT01472692|20494741|P2|COMPLETED|Overall Study||0
8312688|NCT01472692|20494742|P1|COMPLETED|Overall Study||0
8312689|NCT01472692|20494741|P2|STARTED|Overall Study||0
8312690|NCT01472692|20494742|P1|STARTED|Overall Study||0
8312697|NCT01472549|20494756|P2|NOT COMPLETED|Overall Study||0
8312698|NCT01472549|20494757|P1|NOT COMPLETED|Overall Study||0
8312699|NCT01472549|20494756|P2|COMPLETED|Overall Study||575
8312700|NCT01472549|20494757|P1|COMPLETED|Overall Study||572
8312701|NCT01472549|20494756|P2|STARTED|Overall Study||575
8312702|NCT01472549|20494757|P1|STARTED|Overall Study||572
8312703|NCT01472445|20494779|P2|NOT COMPLETED|Overall Study||0
8312704|NCT01472445|20494780|P1|NOT COMPLETED|Overall Study||0
8312705|NCT01472445|20494779|P2|COMPLETED|Overall Study||16
8312706|NCT01472445|20494780|P1|COMPLETED|Overall Study||25
8312707|NCT01472445|20494779|P2|STARTED|Overall Study||16
8312708|NCT01472445|20494780|P1|STARTED|Overall Study||25
8312709|NCT01472432|20494804|P2|NOT COMPLETED|Overall Study||0
8312710|NCT01472432|20494805|P1|NOT COMPLETED|Overall Study||0
8312711|NCT01472432|20494804|P2|COMPLETED|Overall Study||53
8312712|NCT01472432|20494805|P1|COMPLETED|Overall Study||53
8312713|NCT01472432|20494804|P2|Ulcer Reduction|Overall Study||33
8312714|NCT01472432|20494805|P1|Ulcer Reduction|Overall Study||13
8312715|NCT01472432|20494804|P2|STARTED|Overall Study||53
8312716|NCT01472432|20494805|P1|STARTED|Overall Study||53
8312717|NCT01472380|20494821|P1|NOT COMPLETED|Efavirenz and FFA||0
8312718|NCT01472380|20494821|P1|COMPLETED|Efavirenz and FFA||28
8312719|NCT01472380|20494821|P1|STARTED|Efavirenz and FFA||28
8312720|NCT01472380|20494821|P1|NOT COMPLETED|1 Day Period Between Dosing||1
8312721|NCT01472380|20494821|P1|COMPLETED|1 Day Period Between Dosing||28
8312722|NCT01472380|20494821|P1|STARTED|1 Day Period Between Dosing||29
8312723|NCT01472380|20494821|P1|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
8312724|NCT01472380|20494821|P1|COMPLETED|Fenofibric Acid (FFA) Alone||29
8312725|NCT01472380|20494821|P1|STARTED|Fenofibric Acid (FFA) Alone||29
8312726|NCT01472380|20494821|P1|NOT COMPLETED|Efavirenz Alone||1
8312727|NCT01472380|20494821|P1|COMPLETED|Efavirenz Alone||29
8312728|NCT01472380|20494821|P1|STARTED|Efavirenz Alone||30
8312729|NCT01472341|20494832|P1|NOT COMPLETED|Overall Study||272
8312730|NCT01472341|20494832|P1|COMPLETED|Overall Study||235
8312731|NCT01472341|20494832|P1|STARTED|Overall Study||507
8312732|NCT01472289|20494838|P1|NOT COMPLETED|Overall Study||2
8312733|NCT01472289|20494838|P1|COMPLETED|Overall Study||15
8312734|NCT01472289|20494838|P1|STARTED|Overall Study||17
8312735|NCT01472185|20494850|P2|NOT COMPLETED|Overall Study||34
8312736|NCT01472185|20494851|P1|NOT COMPLETED|Overall Study||34
8312737|NCT01472185|20494850|P2|COMPLETED|Overall Study||199
8312738|NCT01472185|20494851|P1|COMPLETED|Overall Study||198
8312739|NCT01472185|20494850|P2|STARTED|Overall Study||233
8312740|NCT01472185|20494851|P1|STARTED|Overall Study||232
8312741|NCT01472081|20494871|P6|NOT COMPLETED|Overall Study||6
8312742|NCT01472081|20494872|P5|NOT COMPLETED|Overall Study||47
8312743|NCT01472081|20494873|P4|NOT COMPLETED|Overall Study||46
8312744|NCT01472081|20494874|P3|NOT COMPLETED|Overall Study||20
8312745|NCT01472081|20494875|P2|NOT COMPLETED|Overall Study||26
8312746|NCT01472081|20494876|P1|NOT COMPLETED|Overall Study||7
8312747|NCT01472081|20494871|P6|COMPLETED|Overall Study||0
8312748|NCT01472081|20494872|P5|COMPLETED|Overall Study||0
8312749|NCT01472081|20494873|P4|COMPLETED|Overall Study||1
8312750|NCT01472081|20494874|P3|COMPLETED|Overall Study||0
8312751|NCT01472081|20494875|P2|COMPLETED|Overall Study||0
8312752|NCT01472081|20494876|P1|COMPLETED|Overall Study||0
8312753|NCT01472081|20494871|P6|STARTED|Overall Study||6
8312754|NCT01472081|20494872|P5|STARTED|Overall Study||47
8312755|NCT01472081|20494873|P4|STARTED|Overall Study||47
8312756|NCT01472081|20494874|P3|STARTED|Overall Study||20
8312757|NCT01472081|20494875|P2|STARTED|Overall Study||26
8312758|NCT01472081|20494876|P1|STARTED|Overall Study||7
8312759|NCT01471782|20494925|P6|NOT COMPLETED|Overall Study||41
8312760|NCT01471782|20494926|P5|NOT COMPLETED|Overall Study||26
8312761|NCT01471782|20494927|P4|NOT COMPLETED|Overall Study||5
8312762|NCT01471782|20494928|P3|NOT COMPLETED|Overall Study||5
8312763|NCT01471782|20494929|P2|NOT COMPLETED|Overall Study||6
8312764|NCT01471782|20494930|P1|NOT COMPLETED|Overall Study||5
8312765|NCT01471782|20494925|P6|COMPLETED|Overall Study|Completed 5 cycles|3
8312766|NCT01471782|20494926|P5|COMPLETED|Overall Study|Completed 5 cycles|0
8312767|NCT01471782|20494927|P4|COMPLETED|Overall Study|Completed 5 cycles|1
8312768|NCT01471782|20494928|P3|COMPLETED|Overall Study|Completed 5 cycles|0
8312769|NCT01471782|20494929|P2|COMPLETED|Overall Study|Completed 5 cycles|1
8312770|NCT01471782|20494930|P1|COMPLETED|Overall Study|Completed 5 cycles|0
8312771|NCT01471782|20494925|P6|STARTED|Overall Study||44
8312772|NCT01471782|20494926|P5|STARTED|Overall Study||26
8312773|NCT01471782|20494927|P4|STARTED|Overall Study||6
8312774|NCT01471782|20494928|P3|STARTED|Overall Study||5
8312775|NCT01471782|20494929|P2|STARTED|Overall Study||7
8312776|NCT01471782|20494930|P1|STARTED|Overall Study||5
8312777|NCT01471691|20494984|P2|NOT COMPLETED|Overall Study||1
8312778|NCT01471691|20494985|P1|NOT COMPLETED|Overall Study||0
8312779|NCT01471691|20494984|P2|COMPLETED|Overall Study||5
8312780|NCT01471691|20494985|P1|COMPLETED|Overall Study||8
8312781|NCT01471691|20494984|P2|STARTED|Overall Study||6
8312782|NCT01471691|20494985|P1|STARTED|Overall Study||8
8312783|NCT01471379|20494994|P3|NOT COMPLETED|Overall Study||0
8312784|NCT01471379|20494995|P2|NOT COMPLETED|Overall Study||1
8312785|NCT01471379|20494996|P1|NOT COMPLETED|Overall Study||1
8312786|NCT01471379|20494994|P3|COMPLETED|Overall Study||0
8312787|NCT01471379|20494995|P2|COMPLETED|Overall Study||0
8312788|NCT01471379|20494996|P1|COMPLETED|Overall Study||0
8312789|NCT01471379|20494994|P3|STARTED|Overall Study||0
8312790|NCT01471379|20494995|P2|STARTED|Overall Study||1
8312791|NCT01471379|20494996|P1|STARTED|Overall Study||1
8312792|NCT01471353|20495016|P1|NOT COMPLETED|Overall Study||3
8312793|NCT01471353|20495016|P1|COMPLETED|Overall Study||39
8312794|NCT01471353|20495016|P1|STARTED|Overall Study||42
8312795|NCT01471340|20495027|P2|NOT COMPLETED|Overall Study||6
8312796|NCT01471340|20495028|P1|NOT COMPLETED|Overall Study||6
8312797|NCT01471340|20495027|P2|COMPLETED|Overall Study||5855
8312798|NCT01471340|20495028|P1|COMPLETED|Overall Study||5862
8312799|NCT01471340|20495027|P2|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
8312800|NCT01471340|20495028|P1|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
8312801|NCT01471639|20495038|P1|NOT COMPLETED|Overall Study||0
8312802|NCT01471639|20495038|P1|COMPLETED|Overall Study||37
8312803|NCT01471639|20495038|P1|STARTED|Overall Study||37
8312804|NCT01471626|20495043|P1|NOT COMPLETED|Overall Study||0
8312805|NCT01471626|20495043|P1|COMPLETED|Overall Study||21
8312806|NCT01471626|20495043|P1|STARTED|Overall Study||21
8312807|NCT01471574|20495051|P4|NOT COMPLETED|Follow-up Period||3
8312808|NCT01471574|20495052|P3|NOT COMPLETED|Follow-up Period||7
8312809|NCT01471574|20495053|P2|NOT COMPLETED|Follow-up Period||2
8312810|NCT01471574|20495054|P1|NOT COMPLETED|Follow-up Period||7
8312811|NCT01471574|20495051|P4|COMPLETED|Follow-up Period||21
8312812|NCT01471574|20495052|P3|COMPLETED|Follow-up Period||95
8312813|NCT01471574|20495053|P2|COMPLETED|Follow-up Period||32
8312814|NCT01471574|20495054|P1|COMPLETED|Follow-up Period||114
8312815|NCT01471574|20495051|P4|STARTED|Follow-up Period||24
8312816|NCT01471574|20495052|P3|STARTED|Follow-up Period||102
8312817|NCT01471574|20495053|P2|STARTED|Follow-up Period||34
8312818|NCT01471574|20495054|P1|STARTED|Follow-up Period||121
8312819|NCT01471574|20495051|P4|NOT COMPLETED|Treatment Period||3
8312820|NCT01471574|20495052|P3|NOT COMPLETED|Treatment Period||24
8312821|NCT01471574|20495053|P2|NOT COMPLETED|Treatment Period||10
8312822|NCT01471574|20495054|P1|NOT COMPLETED|Treatment Period||31
8312823|NCT01471574|20495051|P4|COMPLETED|Treatment Period||21
8312824|NCT01471574|20495052|P3|COMPLETED|Treatment Period||82
8312825|NCT01471574|20495053|P2|COMPLETED|Treatment Period||29
8312826|NCT01471574|20495054|P1|COMPLETED|Treatment Period||101
8312827|NCT01471574|20495051|P4|STARTED|Treatment Period||24
8312828|NCT01471574|20495052|P3|STARTED|Treatment Period||106
8312829|NCT01471574|20495053|P2|STARTED|Treatment Period||39
8312830|NCT01471574|20495054|P1|STARTED|Treatment Period||132
8312837|NCT01471457|20495112|P2|NOT COMPLETED|Overall Study||18
8312838|NCT01471457|20495113|P1|NOT COMPLETED|Overall Study||19
8312839|NCT01471457|20495112|P2|COMPLETED|Overall Study||74
8312840|NCT01471457|20495113|P1|COMPLETED|Overall Study||73
8312841|NCT01471457|20495112|P2|STARTED|Overall Study||92
8312842|NCT01471457|20495113|P1|STARTED|Overall Study||92
8312843|NCT01471197|20495123|P2|NOT COMPLETED|Overall Study||2
8312844|NCT01471197|20495124|P1|NOT COMPLETED|Overall Study||6
8312845|NCT01471197|20495123|P2|COMPLETED|Overall Study||0
8312846|NCT01471197|20495124|P1|COMPLETED|Overall Study||0
8312847|NCT01471197|20495123|P2|STARTED|Overall Study||2
8312848|NCT01471197|20495124|P1|STARTED|Overall Study||6
8312849|NCT01471171|20495134|P2|NOT COMPLETED|Treatment Period 2||0
8312850|NCT01471171|20495135|P1|NOT COMPLETED|Treatment Period 2||1
8312851|NCT01471171|20495134|P2|COMPLETED|Treatment Period 2||54
8312852|NCT01471171|20495135|P1|COMPLETED|Treatment Period 2||52
8312853|NCT01471171|20495134|P2|STARTED|Treatment Period 2||54
8312854|NCT01471171|20495135|P1|STARTED|Treatment Period 2||53
8312855|NCT01471171|20495134|P2|NOT COMPLETED|Treatment Period 1||1
8312856|NCT01471171|20495135|P1|NOT COMPLETED|Treatment Period 1||4
8312857|NCT01471171|20495134|P2|COMPLETED|Treatment Period 1||54
8312858|NCT01471171|20495135|P1|COMPLETED|Treatment Period 1||53
8312859|NCT01471171|20495134|P2|STARTED|Treatment Period 1||55
8312860|NCT01471171|20495135|P1|STARTED|Treatment Period 1||57
8312861|NCT01471054|20495147|P2|NOT COMPLETED|Overall Study||0
8312862|NCT01471054|20495148|P1|NOT COMPLETED|Overall Study||4
8312863|NCT01471054|20495147|P2|COMPLETED|Overall Study||1
8312864|NCT01471054|20495148|P1|COMPLETED|Overall Study||1
8312865|NCT01471054|20495147|P2|STARTED|Overall Study||1
8312866|NCT01471054|20495148|P1|STARTED|Overall Study||5
8312867|NCT01471041|20495164|P1|NOT COMPLETED|Overall Study||7
8312868|NCT01471041|20495164|P1|COMPLETED|Overall Study||47
8312869|NCT01471041|20495164|P1|STARTED|Overall Study||54
8312870|NCT01471028|20495171|P2|NOT COMPLETED|VTI-208E||12
8312871|NCT01471028|20495172|P1|NOT COMPLETED|VTI-208E||8
8312872|NCT01471028|20495171|P2|COMPLETED|VTI-208E||51
8312873|NCT01471028|20495172|P1|COMPLETED|VTI-208E||48
8312874|NCT01471028|20495171|P2|Database Lock, 31 July 2015|VTI-208E||63
8312875|NCT01471028|20495172|P1|Database Lock, 31 July 2015|VTI-208E||56
8312876|NCT01471028|20495171|P2|STARTED|VTI-208E||63
8312877|NCT01471028|20495172|P1|STARTED|VTI-208E||56
8312878|NCT01471028|20495171|P2|NOT COMPLETED|VTI-208||44
8312879|NCT01471028|20495172|P1|NOT COMPLETED|VTI-208||40
8312880|NCT01471028|20495171|P2|COMPLETED|VTI-208||63
8312881|NCT01471028|20495172|P1|COMPLETED|VTI-208||56
8312882|NCT01471028|20495171|P2|STARTED|VTI-208||107
8312883|NCT01471028|20495172|P1|STARTED|VTI-208||96
8312884|NCT01471015|20495187|P3|NOT COMPLETED|Overall Study||1
8312885|NCT01471015|20495188|P2|NOT COMPLETED|Overall Study||1
8312886|NCT01471015|20495189|P1|NOT COMPLETED|Overall Study||0
8312887|NCT01471015|20495187|P3|COMPLETED|Overall Study||9
8312888|NCT01471015|20495188|P2|COMPLETED|Overall Study||9
8312889|NCT01471015|20495189|P1|COMPLETED|Overall Study||10
8312890|NCT01471015|20495187|P3|STARTED|Overall Study||10
8312891|NCT01471015|20495188|P2|STARTED|Overall Study||10
8312892|NCT01471015|20495189|P1|STARTED|Overall Study||10
8312893|NCT01470859|20495203|P2|NOT COMPLETED|Overall Study||0
8312894|NCT01470859|20495204|P1|NOT COMPLETED|Overall Study||1
8312895|NCT01470859|20495203|P2|COMPLETED|Overall Study||15
8312896|NCT01470859|20495204|P1|COMPLETED|Overall Study||14
8312897|NCT01470859|20495203|P2|STARTED|Overall Study||15
8312898|NCT01470859|20495204|P1|STARTED|Overall Study||15
8312899|NCT01470781|20495220|P2|NOT COMPLETED|Overall Study||12
8312900|NCT01470781|20495221|P1|NOT COMPLETED|Overall Study||18
8312901|NCT01470781|20495220|P2|COMPLETED|Overall Study||21
8312902|NCT01470781|20495221|P1|COMPLETED|Overall Study||21
8312903|NCT01470781|20495220|P2|Post-Treatment Assessment|Overall Study||23
8312904|NCT01470781|20495221|P1|Post-Treatment Assessment|Overall Study||22
8312905|NCT01470781|20495220|P2|Midpoint Assessment|Overall Study||30
8312906|NCT01470781|20495221|P1|Midpoint Assessment|Overall Study||30
8312907|NCT01470781|20495220|P2|STARTED|Overall Study||33
8312908|NCT01470781|20495221|P1|STARTED|Overall Study||39
8312909|NCT01470651|20495239|P2|NOT COMPLETED|Overall Study||3
8312910|NCT01470651|20495240|P1|NOT COMPLETED|Overall Study||7
8312911|NCT01470651|20495239|P2|COMPLETED|Overall Study||10
8312912|NCT01470651|20495240|P1|COMPLETED|Overall Study||6
8312913|NCT01470651|20495239|P2|STARTED|Overall Study||13
8312914|NCT01470651|20495240|P1|STARTED|Overall Study||13
8312915|NCT01470599|20495250|P2|NOT COMPLETED|Overall Study||43
8312916|NCT01470599|20495251|P1|NOT COMPLETED|Overall Study||19
8312917|NCT01470599|20495250|P2|COMPLETED|Overall Study||45
8312918|NCT01470599|20495251|P1|COMPLETED|Overall Study||43
8312919|NCT01470599|20495250|P2|STARTED|Overall Study||88
8312920|NCT01470599|20495251|P1|STARTED|Overall Study||62
8312927|NCT01470417|20495336|P2|NOT COMPLETED|Overall Study||2
8312928|NCT01470417|20495337|P1|NOT COMPLETED|Overall Study||0
8312929|NCT01470417|20495336|P2|COMPLETED|Overall Study||5
8312930|NCT01470417|20495337|P1|COMPLETED|Overall Study||3
8312931|NCT01470417|20495336|P2|STARTED|Overall Study||7
8312932|NCT01470417|20495337|P1|STARTED|Overall Study||3
8312933|NCT01470326|20495349|P1|NOT COMPLETED|Overall Study||153
8312934|NCT01470326|20495349|P1|COMPLETED|Overall Study||3034
8312935|NCT01470326|20495349|P1|STARTED|Overall Study||3187
8312939|NCT01470196|20495367|P1|NOT COMPLETED|Overall Study||0
8312940|NCT01470196|20495367|P1|COMPLETED|Overall Study||31
8312941|NCT01470196|20495367|P1|STARTED|Overall Study||31
8312942|NCT01470170|20495380|P5|NOT COMPLETED|Overall Study||0
8312943|NCT01470170|20495381|P4|NOT COMPLETED|Overall Study||0
8312944|NCT01470170|20495382|P3|NOT COMPLETED|Overall Study||0
8312945|NCT01470170|20495383|P2|NOT COMPLETED|Overall Study||0
8312946|NCT01470170|20495384|P1|NOT COMPLETED|Overall Study||0
8312947|NCT01470170|20495380|P5|COMPLETED|Overall Study||34
8312948|NCT01470170|20495381|P4|COMPLETED|Overall Study||36
8312949|NCT01470170|20495382|P3|COMPLETED|Overall Study||34
8312950|NCT01470170|20495383|P2|COMPLETED|Overall Study||35
8312951|NCT01470170|20495384|P1|COMPLETED|Overall Study||34
8312952|NCT01470170|20495380|P5|STARTED|Overall Study||34
8312953|NCT01470170|20495381|P4|STARTED|Overall Study||36
8312954|NCT01470170|20495382|P3|STARTED|Overall Study||34
8312955|NCT01470170|20495383|P2|STARTED|Overall Study||35
8312956|NCT01470170|20495384|P1|STARTED|Overall Study||34
8312957|NCT01470144|20495416|P1|NOT COMPLETED|Overall Study||10
8312958|NCT01470144|20495416|P1|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
8312959|NCT01470144|20495416|P1|STARTED|Overall Study||41
8312960|NCT01470118|20495424|P3|NOT COMPLETED|Overall Study||2
8312961|NCT01470118|20495425|P2|NOT COMPLETED|Overall Study||5
8312962|NCT01470118|20495426|P1|NOT COMPLETED|Overall Study||5
8312963|NCT01470118|20495424|P3|COMPLETED|Overall Study||39
8312964|NCT01470118|20495425|P2|COMPLETED|Overall Study||38
8312965|NCT01470118|20495426|P1|COMPLETED|Overall Study||38
8312966|NCT01470118|20495424|P3|STARTED|Overall Study||41
8312967|NCT01470118|20495425|P2|STARTED|Overall Study||43
8312968|NCT01470118|20495426|P1|STARTED|Overall Study||43
8312969|NCT01470027|20495461|P3|NOT COMPLETED|Overall Study||1
8312970|NCT01470027|20495462|P2|NOT COMPLETED|Overall Study||1
8312971|NCT01470027|20495463|P1|NOT COMPLETED|Overall Study||1
8312972|NCT01470027|20495461|P3|COMPLETED|Overall Study||15
8312973|NCT01470027|20495462|P2|COMPLETED|Overall Study||14
8312974|NCT01470027|20495463|P1|COMPLETED|Overall Study||15
8312975|NCT01470027|20495461|P3|STARTED|Overall Study||16
8312976|NCT01470027|20495462|P2|STARTED|Overall Study||15
8312977|NCT01470027|20495463|P1|STARTED|Overall Study||16
8312978|NCT01470001|20495521|P2|NOT COMPLETED|Overall Study||2
8312979|NCT01470001|20495522|P1|NOT COMPLETED|Overall Study||5
8312980|NCT01470001|20495521|P2|COMPLETED|Overall Study||58
8312981|NCT01470001|20495522|P1|COMPLETED|Overall Study||53
8312982|NCT01470001|20495521|P2|STARTED|Overall Study||60
8312983|NCT01470001|20495522|P1|STARTED|Overall Study||58
8312984|NCT01469819|20495532|P1|NOT COMPLETED|Overall Study||8
8312985|NCT01469819|20495532|P1|COMPLETED|Overall Study||29
8312986|NCT01469819|20495532|P1|STARTED|Overall Study||37
8312987|NCT01469767|20495542|P1|NOT COMPLETED|Overall Study||0
8312988|NCT01469767|20495542|P1|COMPLETED|Overall Study||10
8312989|NCT01469767|20495542|P1|STARTED|Overall Study||10
8312990|NCT01469715|20495550|P1|NOT COMPLETED|Overall Study||0
8312991|NCT01469715|20495550|P1|COMPLETED|Overall Study||16
8312992|NCT01469715|20495550|P1|STARTED|Overall Study||16
8313005|NCT01469585|20495567|P2|NOT COMPLETED|Overall Study||3
8313006|NCT01469585|20495568|P1|NOT COMPLETED|Overall Study||7
8313007|NCT01469585|20495567|P2|COMPLETED|Overall Study||6
8313008|NCT01469585|20495568|P1|COMPLETED|Overall Study||4
8313009|NCT01469585|20495567|P2|STARTED|Overall Study||9
8313010|NCT01469585|20495568|P1|STARTED|Overall Study||11
8313011|NCT01469546|20495576|P1|NOT COMPLETED|Dose Escalation to 10 mg||0
8313012|NCT01469546|20495576|P1|COMPLETED|Dose Escalation to 10 mg||19
8313013|NCT01469546|20495576|P1|STARTED|Dose Escalation to 10 mg||19
8313014|NCT01469546|20495576|P1|NOT COMPLETED|Received 5 mg Dose||23
8313015|NCT01469546|20495576|P1|COMPLETED|Received 5 mg Dose||19
8313016|NCT01469546|20495576|P1|Completed First Cycle|Received 5 mg Dose||30
8313017|NCT01469546|20495576|P1|STARTED|Received 5 mg Dose||42
8313018|NCT01469377|20495586|P3|NOT COMPLETED|Overall Study||66
8313019|NCT01469377|20495587|P2|NOT COMPLETED|Overall Study||48
8313020|NCT01469377|20495588|P1|NOT COMPLETED|Overall Study||35
8313021|NCT01469377|20495586|P3|COMPLETED|Overall Study||210
8313022|NCT01469377|20495587|P2|COMPLETED|Overall Study||226
8313023|NCT01469377|20495588|P1|COMPLETED|Overall Study||234
8313024|NCT01469377|20495586|P3|STARTED|Overall Study||276
8313025|NCT01469377|20495587|P2|STARTED|Overall Study||274
8313026|NCT01469377|20495588|P1|STARTED|Overall Study||269
8313027|NCT01469364|20495599|P1|NOT COMPLETED|Overall Study||2
8313028|NCT01469364|20495599|P1|COMPLETED|Overall Study||28
8313029|NCT01469364|20495599|P1|STARTED|Overall Study||30
8313030|NCT01469234|20495617|P3|NOT COMPLETED|Overall Study||0
8313031|NCT01469234|20495618|P2|NOT COMPLETED|Overall Study||0
8313032|NCT01469234|20495619|P1|NOT COMPLETED|Overall Study||0
8313033|NCT01469234|20495617|P3|COMPLETED|Overall Study||85
8313034|NCT01469234|20495618|P2|COMPLETED|Overall Study||85
8313035|NCT01469234|20495619|P1|COMPLETED|Overall Study||85
8313036|NCT01469234|20495617|P3|STARTED|Overall Study||85
8313037|NCT01469234|20495618|P2|STARTED|Overall Study||85
8313038|NCT01469234|20495619|P1|STARTED|Overall Study||85
8313039|NCT01469221|20495650|P3|NOT COMPLETED|Double Blind Phase||0
8313040|NCT01469221|20495651|P2|NOT COMPLETED|Double Blind Phase||17
8313041|NCT01469221|20495652|P1|NOT COMPLETED|Double Blind Phase||14
8313042|NCT01469221|20495650|P3|COMPLETED|Double Blind Phase||0
8313043|NCT01469221|20495651|P2|COMPLETED|Double Blind Phase||0
8313044|NCT01469221|20495652|P1|COMPLETED|Double Blind Phase||0
8313045|NCT01469221|20495650|P3|STARTED|Double Blind Phase||0
8313046|NCT01469221|20495651|P2|STARTED|Double Blind Phase||17
8313047|NCT01469221|20495652|P1|STARTED|Double Blind Phase||14
8313048|NCT01469221|20495650|P3|NOT COMPLETED|Open Label Phase||3
8313049|NCT01469221|20495651|P2|NOT COMPLETED|Open Label Phase||0
8313050|NCT01469221|20495652|P1|NOT COMPLETED|Open Label Phase||0
8313051|NCT01469221|20495650|P3|COMPLETED|Open Label Phase||44
8313052|NCT01469221|20495651|P2|COMPLETED|Open Label Phase||0
8313053|NCT01469221|20495652|P1|COMPLETED|Open Label Phase||0
8313054|NCT01469221|20495650|P3|STARTED|Open Label Phase||47
8313055|NCT01469221|20495651|P2|STARTED|Open Label Phase||0
8313056|NCT01469221|20495652|P1|STARTED|Open Label Phase||0
8313057|NCT01469182|20495663|P2|NOT COMPLETED|Overall Study||6
8313058|NCT01469182|20495664|P1|NOT COMPLETED|Overall Study||35
8313059|NCT01469182|20495663|P2|COMPLETED|Overall Study||298
8313060|NCT01469182|20495664|P1|COMPLETED|Overall Study||575
8313061|NCT01469182|20495663|P2|Treated|Overall Study||304
8313062|NCT01469182|20495664|P1|Treated|Overall Study||609
8313063|NCT01469182|20495663|P2|STARTED|Overall Study||304
8313064|NCT01469182|20495664|P1|STARTED|Overall Study||610
8313065|NCT01469065|20495691|P5|NOT COMPLETED|Overall Study||1
8313066|NCT01469065|20495692|P4|NOT COMPLETED|Overall Study||0
8313067|NCT01469065|20495693|P3|NOT COMPLETED|Overall Study||0
8313068|NCT01469065|20495694|P2|NOT COMPLETED|Overall Study||1
8313069|NCT01469065|20495695|P1|NOT COMPLETED|Overall Study||0
8313070|NCT01469065|20495691|P5|COMPLETED|Overall Study||16
8313071|NCT01469065|20495692|P4|COMPLETED|Overall Study||16
8313072|NCT01469065|20495693|P3|COMPLETED|Overall Study||16
8313073|NCT01469065|20495694|P2|COMPLETED|Overall Study||16
8313074|NCT01469065|20495695|P1|COMPLETED|Overall Study||16
8313075|NCT01469065|20495691|P5|STARTED|Overall Study||17
8313076|NCT01469065|20495692|P4|STARTED|Overall Study||16
8313077|NCT01469065|20495693|P3|STARTED|Overall Study||16
8313078|NCT01469065|20495694|P2|STARTED|Overall Study||17
8313079|NCT01469065|20495695|P1|STARTED|Overall Study||16
8313080|NCT01469052|20495791|P6|NOT COMPLETED|Overall Study||6
8313081|NCT01469052|20495792|P5|NOT COMPLETED|Overall Study||8
8313082|NCT01469052|20495793|P4|NOT COMPLETED|Overall Study||5
8313083|NCT01469052|20495794|P3|NOT COMPLETED|Overall Study||6
8313084|NCT01469052|20495795|P2|NOT COMPLETED|Overall Study||4
8313085|NCT01469052|20495796|P1|NOT COMPLETED|Overall Study||6
8313086|NCT01469052|20495791|P6|COMPLETED|Overall Study||0
8313087|NCT01469052|20495792|P5|COMPLETED|Overall Study||0
8313088|NCT01469052|20495793|P4|COMPLETED|Overall Study||1
8313089|NCT01469052|20495794|P3|COMPLETED|Overall Study||0
8313090|NCT01469052|20495795|P2|COMPLETED|Overall Study||0
8313091|NCT01469052|20495796|P1|COMPLETED|Overall Study||0
8313092|NCT01469052|20495791|P6|STARTED|Overall Study||6
8313093|NCT01469052|20495792|P5|STARTED|Overall Study||8
8313094|NCT01469052|20495793|P4|STARTED|Overall Study||6
8313095|NCT01469052|20495794|P3|STARTED|Overall Study||6
8313096|NCT01469052|20495795|P2|STARTED|Overall Study||4
8313097|NCT01469052|20495796|P1|STARTED|Overall Study||6
8313098|NCT01469039|20495843|P3|NOT COMPLETED|Overall Study||113
8313099|NCT01469039|20495844|P2|NOT COMPLETED|Overall Study||73
8313100|NCT01469039|20495845|P1|NOT COMPLETED|Overall Study||77
8313101|NCT01469039|20495843|P3|COMPLETED|Overall Study||95
8313102|NCT01469039|20495844|P2|COMPLETED|Overall Study||135
8313103|NCT01469039|20495845|P1|COMPLETED|Overall Study||130
8313104|NCT01469039|20495843|P3|STARTED|Overall Study||208
8313105|NCT01469039|20495844|P2|STARTED|Overall Study||208
8313106|NCT01469039|20495845|P1|STARTED|Overall Study||207
8313107|NCT01469013|20495861|P13|NOT COMPLETED|Part B (Extension Period)||6
8313108|NCT01469013|20495862|P12|NOT COMPLETED|Part B (Extension Period)||6
8313109|NCT01469013|20495863|P11|NOT COMPLETED|Part B (Extension Period)||2
8313110|NCT01469013|20495864|P10|NOT COMPLETED|Part B (Extension Period)||3
8313111|NCT01469013|20495865|P9|NOT COMPLETED|Part B (Extension Period)||4
8313112|NCT01469013|20495866|P8|NOT COMPLETED|Part B (Extension Period)||5
8313113|NCT01469013|20495867|P7|NOT COMPLETED|Part B (Extension Period)||5
8313114|NCT01469013|20495868|P6|NOT COMPLETED|Part B (Extension Period)||2
8313115|NCT01469013|20495869|P5|NOT COMPLETED|Part B (Extension Period)||0
8313116|NCT01469013|20495870|P4|NOT COMPLETED|Part B (Extension Period)||0
8313117|NCT01469013|20495871|P3|NOT COMPLETED|Part B (Extension Period)||0
8313118|NCT01469013|20495872|P2|NOT COMPLETED|Part B (Extension Period)||0
8313119|NCT01469013|20495873|P1|NOT COMPLETED|Part B (Extension Period)||0
8313120|NCT01469013|20495861|P13|COMPLETED|Part B (Extension Period)||18
8313121|NCT01469013|20495862|P12|COMPLETED|Part B (Extension Period)||18
8313122|NCT01469013|20495863|P11|COMPLETED|Part B (Extension Period)||10
8313123|NCT01469013|20495864|P10|COMPLETED|Part B (Extension Period)||8
8313124|NCT01469013|20495865|P9|COMPLETED|Part B (Extension Period)||20
8313125|NCT01469013|20495866|P8|COMPLETED|Part B (Extension Period)||18
8313126|NCT01469013|20495867|P7|COMPLETED|Part B (Extension Period)||7
8313127|NCT01469013|20495868|P6|COMPLETED|Part B (Extension Period)||10
8313128|NCT01469013|20495869|P5|COMPLETED|Part B (Extension Period)||0
8313129|NCT01469013|20495870|P4|COMPLETED|Part B (Extension Period)||0
8313130|NCT01469013|20495871|P3|COMPLETED|Part B (Extension Period)||0
8313131|NCT01469013|20495872|P2|COMPLETED|Part B (Extension Period)||0
8313132|NCT01469013|20495873|P1|COMPLETED|Part B (Extension Period)||0
8313133|NCT01469013|20495861|P13|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
8313134|NCT01469013|20495862|P12|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
8313135|NCT01469013|20495863|P11|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
8313136|NCT01469013|20495864|P10|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
8313137|NCT01469013|20495865|P9|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
8313138|NCT01469013|20495866|P8|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
8313139|NCT01469013|20495867|P7|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
8313140|NCT01469013|20495868|P6|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
8313141|NCT01469013|20495869|P5|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8313142|NCT01469013|20495870|P4|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8313143|NCT01469013|20495871|P3|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8313144|NCT01469013|20495872|P2|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8313145|NCT01469013|20495873|P1|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
8313146|NCT01469013|20495861|P13|STARTED|Part B (Extension Period)||24
8313147|NCT01469013|20495862|P12|STARTED|Part B (Extension Period)||24
8313148|NCT01469013|20495863|P11|STARTED|Part B (Extension Period)||12
8313149|NCT01469013|20495864|P10|STARTED|Part B (Extension Period)||11
8313150|NCT01469013|20495865|P9|STARTED|Part B (Extension Period)||24
8313151|NCT01469013|20495866|P8|STARTED|Part B (Extension Period)||23
8313152|NCT01469013|20495867|P7|STARTED|Part B (Extension Period)||12
8313153|NCT01469013|20495868|P6|STARTED|Part B (Extension Period)||12
8313154|NCT01469013|20495869|P5|STARTED|Part B (Extension Period)||0
8313155|NCT01469013|20495870|P4|STARTED|Part B (Extension Period)||0
8313156|NCT01469013|20495871|P3|STARTED|Part B (Extension Period)||0
8313157|NCT01469013|20495872|P2|STARTED|Part B (Extension Period)||0
8313158|NCT01469013|20495873|P1|STARTED|Part B (Extension Period)||0
8313159|NCT01469013|20495861|P13|NOT COMPLETED|Part A (Treatment Period)||0
8313160|NCT01469013|20495862|P12|NOT COMPLETED|Part A (Treatment Period)||0
8313161|NCT01469013|20495863|P11|NOT COMPLETED|Part A (Treatment Period)||0
8313162|NCT01469013|20495864|P10|NOT COMPLETED|Part A (Treatment Period)||0
8313163|NCT01469013|20495865|P9|NOT COMPLETED|Part A (Treatment Period)||0
8313164|NCT01469013|20495866|P8|NOT COMPLETED|Part A (Treatment Period)||0
8313165|NCT01469013|20495867|P7|NOT COMPLETED|Part A (Treatment Period)||0
8313166|NCT01469013|20495868|P6|NOT COMPLETED|Part A (Treatment Period)||0
8313167|NCT01469013|20495869|P5|NOT COMPLETED|Part A (Treatment Period)||1
8313168|NCT01469013|20495870|P4|NOT COMPLETED|Part A (Treatment Period)||0
8313169|NCT01469013|20495871|P3|NOT COMPLETED|Part A (Treatment Period)||1
8313170|NCT01469013|20495872|P2|NOT COMPLETED|Part A (Treatment Period)||0
8313171|NCT01469013|20495873|P1|NOT COMPLETED|Part A (Treatment Period)||1
8313172|NCT01469013|20495861|P13|COMPLETED|Part A (Treatment Period)||0
8313173|NCT01469013|20495862|P12|COMPLETED|Part A (Treatment Period)||0
8313174|NCT01469013|20495863|P11|COMPLETED|Part A (Treatment Period)||0
8313175|NCT01469013|20495864|P10|COMPLETED|Part A (Treatment Period)||0
8313176|NCT01469013|20495865|P9|COMPLETED|Part A (Treatment Period)||0
8313177|NCT01469013|20495866|P8|COMPLETED|Part A (Treatment Period)||0
8313178|NCT01469013|20495867|P7|COMPLETED|Part A (Treatment Period)||0
8313179|NCT01469013|20495868|P6|COMPLETED|Part A (Treatment Period)||0
8313180|NCT01469013|20495869|P5|COMPLETED|Part A (Treatment Period)||48
8313181|NCT01469013|20495870|P4|COMPLETED|Part A (Treatment Period)||24
8313182|NCT01469013|20495871|P3|COMPLETED|Part A (Treatment Period)||23
8313183|NCT01469013|20495872|P2|COMPLETED|Part A (Treatment Period)||24
8313184|NCT01469013|20495873|P1|COMPLETED|Part A (Treatment Period)||23
8313185|NCT01469013|20495861|P13|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313186|NCT01469013|20495862|P12|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313187|NCT01469013|20495863|P11|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313188|NCT01469013|20495864|P10|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313189|NCT01469013|20495865|P9|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313190|NCT01469013|20495866|P8|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313191|NCT01469013|20495867|P7|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313192|NCT01469013|20495868|P6|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
8313193|NCT01469013|20495869|P5|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
8313194|NCT01469013|20495870|P4|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
8313195|NCT01469013|20495871|P3|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
8313196|NCT01469013|20495872|P2|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
8313197|NCT01469013|20495873|P1|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
8313198|NCT01469013|20495861|P13|STARTED|Part A (Treatment Period)||0
8313199|NCT01469013|20495862|P12|STARTED|Part A (Treatment Period)||0
8313200|NCT01469013|20495863|P11|STARTED|Part A (Treatment Period)||0
8313201|NCT01469013|20495864|P10|STARTED|Part A (Treatment Period)||0
8313202|NCT01469013|20495865|P9|STARTED|Part A (Treatment Period)||0
8313203|NCT01469013|20495866|P8|STARTED|Part A (Treatment Period)||0
8313204|NCT01469013|20495867|P7|STARTED|Part A (Treatment Period)||0
8313205|NCT01469013|20495868|P6|STARTED|Part A (Treatment Period)||0
8313206|NCT01469013|20495869|P5|STARTED|Part A (Treatment Period)||49
8313207|NCT01469013|20495870|P4|STARTED|Part A (Treatment Period)||24
8313208|NCT01469013|20495871|P3|STARTED|Part A (Treatment Period)||24
8313209|NCT01469013|20495872|P2|STARTED|Part A (Treatment Period)||24
8313210|NCT01469013|20495873|P1|STARTED|Part A (Treatment Period)||24
8313211|NCT01469000|20495958|P2|NOT COMPLETED|Overall Study||4
8313212|NCT01469000|20495959|P1|NOT COMPLETED|Overall Study||20
8313213|NCT01469000|20495958|P2|COMPLETED|Overall Study||62
8313214|NCT01469000|20495959|P1|COMPLETED|Overall Study||109
8313215|NCT01469000|20495958|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
8313216|NCT01469000|20495959|P1|Received at Least 1 Dose of Study Drug|Overall Study||126
8313217|NCT01469000|20495958|P2|STARTED|Overall Study||66
8313218|NCT01469000|20495959|P1|STARTED|Overall Study||129
8313219|NCT01468987|20495979|P2|NOT COMPLETED|Overall Study||60
8313220|NCT01468987|20495980|P1|NOT COMPLETED|Overall Study||71
8313221|NCT01468987|20495979|P2|COMPLETED|Overall Study||618
8313222|NCT01468987|20495980|P1|COMPLETED|Overall Study||620
8313223|NCT01468987|20495979|P2|Received at Least 1 Dose of Study Drug|Overall Study||677
8313224|NCT01468987|20495980|P1|Received at Least 1 Dose of Study Drug|Overall Study||691
8313225|NCT01468987|20495979|P2|STARTED|Overall Study||678
8313226|NCT01468987|20495980|P1|STARTED|Overall Study||691
8313227|NCT01468974|20496024|P1|NOT COMPLETED|3 Years Follow-up||6
8313228|NCT01468974|20496024|P1|COMPLETED|3 Years Follow-up||26
8313229|NCT01468974|20496024|P1|STARTED|3 Years Follow-up||32
8313230|NCT01468974|20496024|P1|NOT COMPLETED|2 Years Follow-up||2
8313231|NCT01468974|20496024|P1|COMPLETED|2 Years Follow-up||32
8313232|NCT01468974|20496024|P1|STARTED|2 Years Follow-up||34
8313233|NCT01468974|20496024|P1|NOT COMPLETED|1 Year Follow-up||0
8313234|NCT01468974|20496024|P1|COMPLETED|1 Year Follow-up||34
8313235|NCT01468974|20496024|P1|STARTED|1 Year Follow-up||34
8313236|NCT01468974|20496024|P1|NOT COMPLETED|6 Months Follow-up||0
8313237|NCT01468974|20496024|P1|COMPLETED|6 Months Follow-up||34
8313238|NCT01468974|20496024|P1|STARTED|6 Months Follow-up||34
8313239|NCT01468974|20496024|P1|NOT COMPLETED|1 Month Follow-up||1
8313240|NCT01468974|20496024|P1|COMPLETED|1 Month Follow-up||34
8313241|NCT01468974|20496024|P1|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35
8313242|NCT01468909|20496157|P2|NOT COMPLETED|Overall Study||2
8313243|NCT01468909|20496158|P1|NOT COMPLETED|Overall Study||2
8313244|NCT01468909|20496157|P2|COMPLETED|Overall Study||52
8313245|NCT01468909|20496158|P1|COMPLETED|Overall Study||50
8313246|NCT01468909|20496157|P2|STARTED|Overall Study||54
8313247|NCT01468909|20496158|P1|STARTED|Overall Study||52
8313254|NCT01468818|20496191|P1|NOT COMPLETED|Overall Study||2
8313255|NCT01468818|20496191|P1|COMPLETED|Overall Study||16
8313256|NCT01468818|20496191|P1|STARTED|Overall Study||18
8313257|NCT01468675|20496198|P2|NOT COMPLETED|Overall Study||1372
8313258|NCT01468675|20496199|P1|NOT COMPLETED|Overall Study||1000
8313259|NCT01468675|20496198|P2|COMPLETED|Overall Study||2004
8313260|NCT01468675|20496199|P1|COMPLETED|Overall Study||1699
8313261|NCT01468675|20496198|P2|STARTED|Overall Study||3376
8313262|NCT01468675|20496199|P1|STARTED|Overall Study||2699
8313263|NCT01468597|20496205|P1|NOT COMPLETED|Overall Study||35
8313264|NCT01468597|20496205|P1|COMPLETED|Overall Study||149
8313265|NCT01468597|20496205|P1|STARTED|Overall Study||184
8313266|NCT01468584|20496210|P1|NOT COMPLETED|Overall Study||0
8313267|NCT01468584|20496210|P1|COMPLETED|Overall Study||10
8313268|NCT01468584|20496210|P1|STARTED|Overall Study||10
8313269|NCT01468558|20496214|P1|NOT COMPLETED|Overall Study||2
8313270|NCT01468558|20496214|P1|COMPLETED|Overall Study||22
8313271|NCT01468558|20496214|P1|STARTED|Overall Study||24
8313272|NCT01468350|20496229|P4|NOT COMPLETED|(PART B) Day 1, Day 15||0
8313273|NCT01468350|20496230|P3|NOT COMPLETED|(PART B) Day 1, Day 15||0
8313274|NCT01468350|20496231|P2|NOT COMPLETED|(PART B) Day 1, Day 15||0
8313275|NCT01468350|20496232|P1|NOT COMPLETED|(PART B) Day 1, Day 15||0
8313276|NCT01468350|20496229|P4|COMPLETED|(PART B) Day 1, Day 15||12
8313277|NCT01468350|20496230|P3|COMPLETED|(PART B) Day 1, Day 15||12
8313278|NCT01468350|20496231|P2|COMPLETED|(PART B) Day 1, Day 15||0
8313279|NCT01468350|20496232|P1|COMPLETED|(PART B) Day 1, Day 15||0
8313280|NCT01468350|20496229|P4|STARTED|(PART B) Day 1, Day 15||12
8313281|NCT01468350|20496230|P3|STARTED|(PART B) Day 1, Day 15||12
8313282|NCT01468350|20496231|P2|STARTED|(PART B) Day 1, Day 15||0
8313283|NCT01468350|20496232|P1|STARTED|(PART B) Day 1, Day 15||0
8313284|NCT01468350|20496229|P4|NOT COMPLETED|(PART A) Day 1, Day 3||0
8313285|NCT01468350|20496230|P3|NOT COMPLETED|(PART A) Day 1, Day 3||0
8313286|NCT01468350|20496231|P2|NOT COMPLETED|(PART A) Day 1, Day 3||0
8313287|NCT01468350|20496232|P1|NOT COMPLETED|(PART A) Day 1, Day 3||0
8313288|NCT01468350|20496229|P4|COMPLETED|(PART A) Day 1, Day 3||0
8313289|NCT01468350|20496230|P3|COMPLETED|(PART A) Day 1, Day 3||0
8313290|NCT01468350|20496231|P2|COMPLETED|(PART A) Day 1, Day 3||5
8313291|NCT01468350|20496232|P1|COMPLETED|(PART A) Day 1, Day 3||6
8313292|NCT01468350|20496229|P4|STARTED|(PART A) Day 1, Day 3||0
8313293|NCT01468350|20496230|P3|STARTED|(PART A) Day 1, Day 3||0
8313294|NCT01468350|20496231|P2|STARTED|(PART A) Day 1, Day 3||5
8313295|NCT01468350|20496232|P1|STARTED|(PART A) Day 1, Day 3||6
8313296|NCT01468337|20496242|P1|NOT COMPLETED|Overall Study||0
8313297|NCT01468337|20496242|P1|COMPLETED|Overall Study||5
8313298|NCT01468337|20496242|P1|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
8313299|NCT01468337|20496242|P1|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
8313300|NCT01468337|20496242|P1|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
8313301|NCT01468337|20496242|P1|Week 2|Overall Study||5
8313302|NCT01468337|20496242|P1|STARTED|Overall Study||5
8313384|NCT01468181|20496323|P5|NOT COMPLETED|Overall Study||5
8313385|NCT01468181|20496324|P4|NOT COMPLETED|Overall Study||3
8313386|NCT01468181|20496325|P3|NOT COMPLETED|Overall Study||8
8313387|NCT01468181|20496326|P2|NOT COMPLETED|Overall Study||2
8313388|NCT01468181|20496327|P1|NOT COMPLETED|Overall Study||10
8313389|NCT01468181|20496323|P5|COMPLETED|Overall Study||66
8313390|NCT01468181|20496324|P4|COMPLETED|Overall Study||63
8313391|NCT01468181|20496325|P3|COMPLETED|Overall Study||57
8313392|NCT01468181|20496326|P2|COMPLETED|Overall Study||59
8313393|NCT01468181|20496327|P1|COMPLETED|Overall Study||121
8313394|NCT01468181|20496323|P5|Received at Least 1 Dose of Study Drug|Overall Study||71
8313395|NCT01468181|20496324|P4|Received at Least 1 Dose of Study Drug|Overall Study||66
8313396|NCT01468181|20496325|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
8313397|NCT01468181|20496326|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
8313398|NCT01468181|20496327|P1|Received at Least 1 Dose of Study Drug|Overall Study||131
8313399|NCT01468181|20496323|P5|STARTED|Overall Study||71
8313400|NCT01468181|20496324|P4|STARTED|Overall Study||66
8313401|NCT01468181|20496325|P3|STARTED|Overall Study||65
8313402|NCT01468181|20496326|P2|STARTED|Overall Study||61
8313403|NCT01468181|20496327|P1|STARTED|Overall Study||131
8313404|NCT01468077|20496376|P2|NOT COMPLETED|Overall Study||3
8313405|NCT01468077|20496377|P1|NOT COMPLETED|Overall Study||4
8313406|NCT01468077|20496376|P2|COMPLETED|Overall Study||22
8313407|NCT01468077|20496377|P1|COMPLETED|Overall Study||18
8313408|NCT01468077|20496376|P2|STARTED|Overall Study||25
8313409|NCT01468077|20496377|P1|STARTED|Overall Study||22
8313410|NCT01468012|20496416|P3|NOT COMPLETED|Overall Study||4
8313411|NCT01468012|20496417|P2|NOT COMPLETED|Overall Study||1
8313412|NCT01468012|20496418|P1|NOT COMPLETED|Overall Study||2
8313413|NCT01468012|20496416|P3|COMPLETED|Overall Study||0
8313414|NCT01468012|20496417|P2|COMPLETED|Overall Study||9
8313415|NCT01468012|20496418|P1|COMPLETED|Overall Study||7
8313416|NCT01468012|20496416|P3|STARTED|Overall Study||4
8313417|NCT01468012|20496417|P2|STARTED|Overall Study||10
8313418|NCT01468012|20496418|P1|STARTED|Overall Study||9
8313419|NCT01467999|20496429|P1|NOT COMPLETED|Overall Study||13
8313420|NCT01467999|20496429|P1|COMPLETED|Overall Study||9
8313421|NCT01467999|20496429|P1|STARTED|Overall Study||22
8313422|NCT01467960|20496439|P6|NOT COMPLETED|Overall Study||30
8313423|NCT01467960|20496440|P5|NOT COMPLETED|Overall Study||30
8313424|NCT01467960|20496441|P4|NOT COMPLETED|Overall Study||30
8313425|NCT01467960|20496442|P3|NOT COMPLETED|Overall Study||0
8313426|NCT01467960|20496443|P2|NOT COMPLETED|Overall Study||0
8313427|NCT01467960|20496444|P1|NOT COMPLETED|Overall Study||0
8313428|NCT01467960|20496439|P6|COMPLETED|Overall Study||0
8313429|NCT01467960|20496440|P5|COMPLETED|Overall Study||0
8313430|NCT01467960|20496441|P4|COMPLETED|Overall Study||0
8313431|NCT01467960|20496442|P3|COMPLETED|Overall Study||30
8313432|NCT01467960|20496443|P2|COMPLETED|Overall Study||30
8313433|NCT01467960|20496444|P1|COMPLETED|Overall Study||30
8313434|NCT01467960|20496439|P6|STARTED|Overall Study||30
8313435|NCT01467960|20496440|P5|STARTED|Overall Study||30
8313436|NCT01467960|20496441|P4|STARTED|Overall Study||30
8313437|NCT01467960|20496442|P3|STARTED|Overall Study||30
8313438|NCT01467960|20496443|P2|STARTED|Overall Study||30
8313439|NCT01467960|20496444|P1|STARTED|Overall Study||30
8313440|NCT01467947|20496458|P1|NOT COMPLETED|Overall Study||0
8313441|NCT01467947|20496458|P1|COMPLETED|Overall Study||46
8313442|NCT01467947|20496458|P1|STARTED|Overall Study||46
8313443|NCT01467934|20496466|P3|NOT COMPLETED|Overall Study||0
8313444|NCT01467934|20496467|P2|NOT COMPLETED|Overall Study||0
8313445|NCT01467934|20496468|P1|NOT COMPLETED|Overall Study||0
8313446|NCT01467934|20496466|P3|COMPLETED|Overall Study||110
8313447|NCT01467934|20496467|P2|COMPLETED|Overall Study||212
8313448|NCT01467934|20496468|P1|COMPLETED|Overall Study||208
8313449|NCT01467934|20496466|P3|STARTED|Overall Study||110
8313450|NCT01467934|20496467|P2|STARTED|Overall Study||212
8313451|NCT01467934|20496468|P1|STARTED|Overall Study||208
8313452|NCT01467882|20496476|P1|NOT COMPLETED|Overall Study||0
8313453|NCT01467882|20496476|P1|COMPLETED|Overall Study||44
8313454|NCT01467882|20496476|P1|STARTED|Overall Study||44
8313455|NCT01467713|20496503|P4|NOT COMPLETED|Overall Study||109
8313456|NCT01467713|20496504|P3|NOT COMPLETED|Overall Study||102
8313457|NCT01467713|20496505|P2|NOT COMPLETED|Overall Study||104
8313458|NCT01467713|20496506|P1|NOT COMPLETED|Overall Study||102
8313459|NCT01467713|20496503|P4|COMPLETED|Overall Study||45
8313460|NCT01467713|20496504|P3|COMPLETED|Overall Study||58
8313461|NCT01467713|20496505|P2|COMPLETED|Overall Study||60
8313462|NCT01467713|20496506|P1|COMPLETED|Overall Study||62
8313463|NCT01467713|20496503|P4|Safety Analysis Set: Received Treatment|Overall Study||154
8313464|NCT01467713|20496504|P3|Safety Analysis Set: Received Treatment|Overall Study||159
8313465|NCT01467713|20496505|P2|Safety Analysis Set: Received Treatment|Overall Study||164
8313466|NCT01467713|20496506|P1|Safety Analysis Set: Received Treatment|Overall Study||163
8313467|NCT01467713|20496503|P4|STARTED|Overall Study||154
8313468|NCT01467713|20496504|P3|STARTED|Overall Study||160
8313469|NCT01467713|20496505|P2|STARTED|Overall Study||164
8313470|NCT01467713|20496506|P1|STARTED|Overall Study||164
8313471|NCT01467700|20496560|P4|NOT COMPLETED|Overall Study||27
8313472|NCT01467700|20496561|P3|NOT COMPLETED|Overall Study||27
8313473|NCT01467700|20496562|P2|NOT COMPLETED|Overall Study||28
8313474|NCT01467700|20496563|P1|NOT COMPLETED|Overall Study||29
8313475|NCT01467700|20496560|P4|COMPLETED|Overall Study||96
8313476|NCT01467700|20496561|P3|COMPLETED|Overall Study||97
8313477|NCT01467700|20496562|P2|COMPLETED|Overall Study||100
8313478|NCT01467700|20496563|P1|COMPLETED|Overall Study||86
8313479|NCT01467700|20496560|P4|Safety Set - Received Treatment|Overall Study||123
8313480|NCT01467700|20496561|P3|Safety Set - Received Treatment|Overall Study||124
8313481|NCT01467700|20496562|P2|Safety Set - Received Treatment|Overall Study||127
8313482|NCT01467700|20496563|P1|Safety Set - Received Treatment|Overall Study||115
8313483|NCT01467700|20496560|P4|STARTED|Overall Study||123
8313484|NCT01467700|20496561|P3|STARTED|Overall Study||124
8313485|NCT01467700|20496562|P2|STARTED|Overall Study||128
8313486|NCT01467700|20496563|P1|STARTED|Overall Study||115
8313493|NCT01467583|20496625|P3|NOT COMPLETED|Overall Study||2
8313494|NCT01467583|20496626|P2|NOT COMPLETED|Overall Study||1
8313495|NCT01467583|20496627|P1|NOT COMPLETED|Overall Study||2
8313496|NCT01467583|20496625|P3|COMPLETED|Overall Study||10
8313497|NCT01467583|20496626|P2|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
8313498|NCT01467583|20496627|P1|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
8313499|NCT01467583|20496625|P3|STARTED|Overall Study||12
8313500|NCT01467583|20496626|P2|STARTED|Overall Study||4
8313501|NCT01467583|20496627|P1|STARTED|Overall Study||16
8313502|NCT01467570|20496640|P2|NOT COMPLETED|Overall Study||9
8313503|NCT01467570|20496641|P1|NOT COMPLETED|Overall Study||8
8313504|NCT01467570|20496640|P2|COMPLETED|Overall Study||63
8313505|NCT01467570|20496641|P1|COMPLETED|Overall Study||67
8313506|NCT01467570|20496640|P2|STARTED|Overall Study||72
8313507|NCT01467570|20496641|P1|STARTED|Overall Study||75
8313508|NCT01467557|20496667|P2|NOT COMPLETED|Overall Study||107
8313509|NCT01467557|20496668|P1|NOT COMPLETED|Overall Study||99
8313510|NCT01467557|20496667|P2|COMPLETED|Overall Study||463
8313511|NCT01467557|20496668|P1|COMPLETED|Overall Study||502
8313512|NCT01467557|20496667|P2|12 Month Survey Completed|Overall Study||463
8313513|NCT01467557|20496668|P1|12 Month Survey Completed|Overall Study||502
8313514|NCT01467557|20496667|P2|4 Month Survey Completed|Overall Study||493
8313515|NCT01467557|20496668|P1|4 Month Survey Completed|Overall Study||533
8313516|NCT01467557|20496667|P2|2 Week Survey Completed|Overall Study||522
8313517|NCT01467557|20496668|P1|2 Week Survey Completed|Overall Study||551
8313518|NCT01467557|20496667|P2|STARTED|Overall Study||570
8313519|NCT01467557|20496668|P1|STARTED|Overall Study||601
8313520|NCT01467505|20496678|P2|NOT COMPLETED|Overall Study||3
8313521|NCT01467505|20496679|P1|NOT COMPLETED|Overall Study||33
8313522|NCT01467505|20496678|P2|COMPLETED|Overall Study||7
8313523|NCT01467505|20496679|P1|COMPLETED|Overall Study||18
8313524|NCT01467505|20496678|P2|STARTED|Overall Study||10
8313525|NCT01467505|20496679|P1|STARTED|Overall Study||51
8313526|NCT01467492|20496711|P2|NOT COMPLETED|Overall Study||13
8313527|NCT01467492|20496712|P1|NOT COMPLETED|Overall Study||22
8313528|NCT01467492|20496711|P2|COMPLETED|Overall Study||25
8313529|NCT01467492|20496712|P1|COMPLETED|Overall Study||61
8313530|NCT01467492|20496711|P2|STARTED|Overall Study||38
8313531|NCT01467492|20496712|P1|STARTED|Overall Study||83
8313532|NCT01467479|20496736|P3|NOT COMPLETED|Overall Study||16
8313533|NCT01467479|20496737|P2|NOT COMPLETED|Overall Study||17
8313534|NCT01467479|20496738|P1|NOT COMPLETED|Overall Study||9
8313535|NCT01467479|20496736|P3|COMPLETED|Overall Study||45
8313536|NCT01467479|20496737|P2|COMPLETED|Overall Study||52
8313537|NCT01467479|20496738|P1|COMPLETED|Overall Study||46
8313538|NCT01467479|20496736|P3|Treated|Overall Study||59
8313539|NCT01467479|20496737|P2|Treated|Overall Study||69
8313540|NCT01467479|20496738|P1|Treated|Overall Study||54
8313541|NCT01467479|20496736|P3|STARTED|Overall Study||61
8313542|NCT01467479|20496737|P2|STARTED|Overall Study||69
8313543|NCT01467479|20496738|P1|STARTED|Overall Study||55
8313544|NCT01467466|20496769|P4|NOT COMPLETED|Overall Study||88
8313545|NCT01467466|20496770|P3|NOT COMPLETED|Overall Study||104
8313546|NCT01467466|20496771|P2|NOT COMPLETED|Overall Study||104
8313547|NCT01467466|20496772|P1|NOT COMPLETED|Overall Study||109
8313548|NCT01467466|20496769|P4|COMPLETED|Overall Study||1203
8313549|NCT01467466|20496770|P3|COMPLETED|Overall Study||1190
8313550|NCT01467466|20496771|P2|COMPLETED|Overall Study||1188
8313551|NCT01467466|20496772|P1|COMPLETED|Overall Study||1191
8313552|NCT01467466|20496769|P4|STARTED|Overall Study||1291
8313553|NCT01467466|20496770|P3|STARTED|Overall Study||1294
8313554|NCT01467466|20496771|P2|STARTED|Overall Study||1292
8313555|NCT01467466|20496772|P1|STARTED|Overall Study||1300
8313564|NCT01467271|20496803|P1|NOT COMPLETED|Overall Study||202
8313565|NCT01467271|20496803|P1|COMPLETED|Overall Study||338
8313566|NCT01467271|20496803|P1|STARTED|Overall Study||540
8313567|NCT01467076|20496810|P3|NOT COMPLETED|Overall Study||0
8313568|NCT01467076|20496811|P2|NOT COMPLETED|Overall Study||0
8313569|NCT01467076|20496812|P1|NOT COMPLETED|Overall Study||1
8313570|NCT01467076|20496810|P3|COMPLETED|Overall Study||2
8313571|NCT01467076|20496811|P2|COMPLETED|Overall Study||2
8313572|NCT01467076|20496812|P1|COMPLETED|Overall Study||2
8313573|NCT01467076|20496810|P3|STARTED|Overall Study||2
8313574|NCT01467076|20496811|P2|STARTED|Overall Study||2
8313575|NCT01467076|20496812|P1|STARTED|Overall Study||3
8313576|NCT01467037|20496849|P1|NOT COMPLETED|Overall Study||0
8313577|NCT01467037|20496849|P1|COMPLETED|Overall Study||374
8313578|NCT01467037|20496849|P1|STARTED|Overall Study||374
8313579|NCT01466985|20496859|P3|NOT COMPLETED|Overall Study||0
8313580|NCT01466985|20496860|P2|NOT COMPLETED|Overall Study||0
8313581|NCT01466985|20496861|P1|NOT COMPLETED|Overall Study||0
8313582|NCT01466985|20496859|P3|COMPLETED|Overall Study||6
8313583|NCT01466985|20496860|P2|COMPLETED|Overall Study||6
8313584|NCT01466985|20496861|P1|COMPLETED|Overall Study||6
8313585|NCT01466985|20496859|P3|STARTED|Overall Study||6
8313586|NCT01466985|20496860|P2|STARTED|Overall Study||6
8313587|NCT01466985|20496861|P1|STARTED|Overall Study||6
8313588|NCT01466972|20496878|P1|NOT COMPLETED|Overall Study||0
8313589|NCT01466972|20496878|P1|COMPLETED|Overall Study||30
8313590|NCT01466972|20496878|P1|STARTED|Overall Study||30
8313591|NCT01466881|20496884|P1|NOT COMPLETED|Overall Study||40
8313592|NCT01466881|20496884|P1|COMPLETED|Overall Study||2
8313593|NCT01466881|20496884|P1|Eligible and Treated|Overall Study||37
8313594|NCT01466881|20496884|P1|STARTED|Overall Study||42
8313595|NCT01466790|20496901|P8|NOT COMPLETED|Overall Study||1
8313596|NCT01466790|20496902|P7|NOT COMPLETED|Overall Study||1
8313597|NCT01466790|20496903|P6|NOT COMPLETED|Overall Study||0
8313598|NCT01466790|20496904|P5|NOT COMPLETED|Overall Study||3
8313599|NCT01466790|20496905|P4|NOT COMPLETED|Overall Study||0
8313600|NCT01466790|20496906|P3|NOT COMPLETED|Overall Study||0
8313601|NCT01466790|20496907|P2|NOT COMPLETED|Overall Study||1
8313602|NCT01466790|20496908|P1|NOT COMPLETED|Overall Study||4
8313603|NCT01466790|20496901|P8|COMPLETED|Overall Study||13
8313604|NCT01466790|20496902|P7|COMPLETED|Overall Study||26
8313605|NCT01466790|20496903|P6|COMPLETED|Overall Study||16
8313606|NCT01466790|20496904|P5|COMPLETED|Overall Study||27
8313607|NCT01466790|20496905|P4|COMPLETED|Overall Study||14
8313608|NCT01466790|20496906|P3|COMPLETED|Overall Study||27
8313609|NCT01466790|20496907|P2|COMPLETED|Overall Study||14
8313610|NCT01466790|20496908|P1|COMPLETED|Overall Study||20
8313611|NCT01466790|20496901|P8|STARTED|Overall Study||14
8313612|NCT01466790|20496902|P7|STARTED|Overall Study||27
8313613|NCT01466790|20496903|P6|STARTED|Overall Study||16
8313614|NCT01466790|20496904|P5|STARTED|Overall Study||30
8313615|NCT01466790|20496905|P4|STARTED|Overall Study||14
8313616|NCT01466790|20496906|P3|STARTED|Overall Study||27
8313617|NCT01466790|20496907|P2|STARTED|Overall Study||15
8313618|NCT01466790|20496908|P1|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
8313619|NCT01466764|20496972|P2|NOT COMPLETED|Overall Study||0
8313620|NCT01466764|20496973|P1|NOT COMPLETED|Overall Study||0
8313621|NCT01466764|20496972|P2|COMPLETED|Overall Study||5
8313622|NCT01466764|20496973|P1|COMPLETED|Overall Study||5
8313623|NCT01466764|20496972|P2|STARTED|Overall Study||5
8313624|NCT01466764|20496973|P1|STARTED|Overall Study||5
8313625|NCT01466751|20496993|P2|NOT COMPLETED|Overall Study||0
8313626|NCT01466751|20496994|P1|NOT COMPLETED|Overall Study||1
8313627|NCT01466751|20496993|P2|COMPLETED|Overall Study||14
8313628|NCT01466751|20496994|P1|COMPLETED|Overall Study||13
8313629|NCT01466751|20496993|P2|STARTED|Overall Study||14
8313630|NCT01466751|20496994|P1|STARTED|Overall Study||14
8313631|NCT01466673|20497004|P2|NOT COMPLETED|Overall Study||6
8313632|NCT01466673|20497005|P1|NOT COMPLETED|Overall Study||7
8313633|NCT01466673|20497004|P2|COMPLETED|Overall Study||95
8313634|NCT01466673|20497005|P1|COMPLETED|Overall Study||93
8313635|NCT01466673|20497004|P2|STARTED|Overall Study||101
8313636|NCT01466673|20497005|P1|STARTED|Overall Study||100
8313637|NCT01466660|20497031|P2|NOT COMPLETED|Overall Study||159
8313638|NCT01466660|20497032|P1|NOT COMPLETED|Overall Study||160
8313639|NCT01466660|20497031|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
8313640|NCT01466660|20497032|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
8313641|NCT01466660|20497031|P2|STARTED|Overall Study||159
8313642|NCT01466660|20497032|P1|STARTED|Overall Study||160
8313643|NCT01466595|20497058|P2|NOT COMPLETED|Overall Study||1
8313644|NCT01466595|20497059|P1|NOT COMPLETED|Overall Study||0
8313645|NCT01466595|20497058|P2|COMPLETED|Overall Study||23
8313646|NCT01466595|20497059|P1|COMPLETED|Overall Study||49
8313647|NCT01466595|20497058|P2|STARTED|Overall Study||24
8313648|NCT01466595|20497059|P1|STARTED|Overall Study||49
8313649|NCT01466491|20497153|P4|NOT COMPLETED|Overall Study||0
8313650|NCT01466491|20497154|P3|NOT COMPLETED|Overall Study||3
8313651|NCT01466491|20497155|P2|NOT COMPLETED|Overall Study||3
8313652|NCT01466491|20497156|P1|NOT COMPLETED|Overall Study||0
8313653|NCT01466491|20497153|P4|COMPLETED|Overall Study||83
8313654|NCT01466491|20497154|P3|COMPLETED|Overall Study||80
8313655|NCT01466491|20497155|P2|COMPLETED|Overall Study||80
8313656|NCT01466491|20497156|P1|COMPLETED|Overall Study||83
8313657|NCT01466491|20497153|P4|STARTED|Overall Study||83
8313658|NCT01466491|20497154|P3|STARTED|Overall Study||83
8313659|NCT01466491|20497155|P2|STARTED|Overall Study||83
8313660|NCT01466491|20497156|P1|STARTED|Overall Study||83
8313661|NCT01466387|20497176|P6|NOT COMPLETED|Overall Study||1
8313662|NCT01466387|20497177|P5|NOT COMPLETED|Overall Study||0
8313663|NCT01466387|20497178|P4|NOT COMPLETED|Overall Study||2
8313664|NCT01466387|20497179|P3|NOT COMPLETED|Overall Study||1
8313665|NCT01466387|20497180|P2|NOT COMPLETED|Overall Study||0
8313666|NCT01466387|20497181|P1|NOT COMPLETED|Overall Study||1
8313667|NCT01466387|20497176|P6|COMPLETED|Overall Study||99
8313668|NCT01466387|20497177|P5|COMPLETED|Overall Study||51
8313669|NCT01466387|20497178|P4|COMPLETED|Overall Study||99
8313670|NCT01466387|20497179|P3|COMPLETED|Overall Study||98
8313671|NCT01466387|20497180|P2|COMPLETED|Overall Study||100
8313672|NCT01466387|20497181|P1|COMPLETED|Overall Study||100
8313673|NCT01466387|20497176|P6|STARTED|Overall Study||100
8313674|NCT01466387|20497177|P5|STARTED|Overall Study||51
8313675|NCT01466387|20497178|P4|STARTED|Overall Study||101
8313676|NCT01466387|20497179|P3|STARTED|Overall Study||99
8313677|NCT01466387|20497180|P2|STARTED|Overall Study||100
8313678|NCT01466387|20497181|P1|STARTED|Overall Study||101
8313679|NCT01466361|20497223|P4|NOT COMPLETED|Overall Study||0
8313680|NCT01466361|20497224|P3|NOT COMPLETED|Overall Study||0
8313681|NCT01466361|20497225|P2|NOT COMPLETED|Overall Study||0
8313682|NCT01466361|20497226|P1|NOT COMPLETED|Overall Study||0
8313683|NCT01466361|20497223|P4|COMPLETED|Overall Study||41
8313684|NCT01466361|20497224|P3|COMPLETED|Overall Study||60
8313685|NCT01466361|20497225|P2|COMPLETED|Overall Study||34
8313686|NCT01466361|20497226|P1|COMPLETED|Overall Study||52
8313687|NCT01466361|20497223|P4|STARTED|Overall Study||41
8313688|NCT01466361|20497224|P3|STARTED|Overall Study||60
8313689|NCT01466361|20497225|P2|STARTED|Overall Study||34
8313690|NCT01466361|20497226|P1|STARTED|Overall Study||52
8313691|NCT01466348|20497242|P2|NOT COMPLETED|Period II - Second Intervention||0
8313692|NCT01466348|20497243|P1|NOT COMPLETED|Period II - Second Intervention||0
8313693|NCT01466348|20497242|P2|COMPLETED|Period II - Second Intervention||36
8313694|NCT01466348|20497243|P1|COMPLETED|Period II - Second Intervention||35
8313695|NCT01466348|20497242|P2|STARTED|Period II - Second Intervention||36
8313696|NCT01466348|20497243|P1|STARTED|Period II - Second Intervention||35
8313697|NCT01466348|20497242|P2|NOT COMPLETED|Period I - First Intervention||1
8313698|NCT01466348|20497243|P1|NOT COMPLETED|Period I - First Intervention||0
8313699|NCT01466348|20497242|P2|COMPLETED|Period I - First Intervention||35
8313700|NCT01466348|20497243|P1|COMPLETED|Period I - First Intervention||36
8313701|NCT01466348|20497242|P2|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
8313702|NCT01466348|20497243|P1|Intent To Treat (ITT) Population|Period I - First Intervention||36
8313703|NCT01466348|20497242|P2|STARTED|Period I - First Intervention||36
8313704|NCT01466348|20497243|P1|STARTED|Period I - First Intervention||36
8313705|NCT01466270|20497271|P2|NOT COMPLETED|Overall Study||6
8313706|NCT01466270|20497272|P1|NOT COMPLETED|Overall Study||12
8313707|NCT01466270|20497271|P2|COMPLETED|Overall Study||25
8313708|NCT01466270|20497272|P1|COMPLETED|Overall Study||19
8313709|NCT01466270|20497271|P2|STARTED|Overall Study||31
8313710|NCT01466270|20497272|P1|STARTED|Overall Study||31
8313711|NCT01466192|20497284|P1|NOT COMPLETED|Overall Study||4
8313712|NCT01466192|20497284|P1|COMPLETED|Overall Study||104
8313713|NCT01466192|20497284|P1|STARTED|Overall Study||108
8313714|NCT01466179|20497288|P1|NOT COMPLETED|Overall Study||179
8313715|NCT01466179|20497288|P1|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
8313716|NCT01466179|20497288|P1|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
8313717|NCT01466166|20497308|P1|NOT COMPLETED|Overall Study||163
8313718|NCT01466166|20497308|P1|COMPLETED|Overall Study||25
8313719|NCT01466166|20497308|P1|Completed 24 Weeks of Treatment|Overall Study||55
8313720|NCT01466166|20497308|P1|Received Treatment|Overall Study||188
8313721|NCT01466166|20497308|P1|STARTED|Overall Study||188
8313722|NCT01466153|20497322|P3|NOT COMPLETED|Overall Study||25
8313723|NCT01466153|20497323|P2|NOT COMPLETED|Overall Study||24
8313724|NCT01466153|20497324|P1|NOT COMPLETED|Overall Study||29
8313725|NCT01466153|20497322|P3|COMPLETED|Overall Study||36
8313726|NCT01466153|20497323|P2|COMPLETED|Overall Study||12
8313727|NCT01466153|20497324|P1|COMPLETED|Overall Study||33
8313728|NCT01466153|20497322|P3|STARTED|Overall Study||61
8313729|NCT01466153|20497323|P2|STARTED|Overall Study||36
8313730|NCT01466153|20497324|P1|STARTED|Overall Study||62
8313731|NCT01466127|20497365|P2|NOT COMPLETED|Overall Study||16
8313732|NCT01466127|20497366|P1|NOT COMPLETED|Overall Study||14
8313733|NCT01466127|20497365|P2|COMPLETED|Overall Study||14
8313734|NCT01466127|20497366|P1|COMPLETED|Overall Study||16
8313735|NCT01466127|20497365|P2|STARTED|Overall Study||30
8313736|NCT01466127|20497366|P1|STARTED|Overall Study||30
8313737|NCT01466075|20497372|P1|NOT COMPLETED|Overall Study||0
8313738|NCT01466075|20497372|P1|COMPLETED|Overall Study||207
8313739|NCT01466075|20497372|P1|STARTED|Overall Study||207
8313740|NCT01466062|20497379|P1|NOT COMPLETED|Overall Study||2
8313741|NCT01466062|20497379|P1|COMPLETED|Overall Study||26
8313742|NCT01466062|20497379|P1|STARTED|Overall Study||28
8313743|NCT01465997|20497402|P2|NOT COMPLETED|Overall Study||89
8313744|NCT01465997|20497403|P1|NOT COMPLETED|Overall Study||68
8313745|NCT01465997|20497402|P2|COMPLETED|Overall Study||180
8313746|NCT01465997|20497403|P1|COMPLETED|Overall Study||211
8313747|NCT01465997|20497402|P2|STARTED|Overall Study||269
8313748|NCT01465997|20497403|P1|STARTED|Overall Study||279
8313749|NCT01465958|20497413|P2|NOT COMPLETED|Subcutaneous (SC) Phase||1
8313750|NCT01465958|20497414|P1|NOT COMPLETED|Subcutaneous (SC) Phase||0
8313751|NCT01465958|20497413|P2|COMPLETED|Subcutaneous (SC) Phase||10
8313752|NCT01465958|20497414|P1|COMPLETED|Subcutaneous (SC) Phase||0
8313753|NCT01465958|20497413|P2|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
8313754|NCT01465958|20497414|P1|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
8313755|NCT01465958|20497413|P2|NOT COMPLETED|Intravenous (IV) Phase||0
8313756|NCT01465958|20497414|P1|NOT COMPLETED|Intravenous (IV) Phase||0
8313757|NCT01465958|20497413|P2|COMPLETED|Intravenous (IV) Phase||0
8313758|NCT01465958|20497414|P1|COMPLETED|Intravenous (IV) Phase||11
8313759|NCT01465958|20497413|P2|STARTED|Intravenous (IV) Phase||0
8313760|NCT01465958|20497414|P1|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
8313761|NCT01465958|20497413|P2|NOT COMPLETED|Run-in Phase||0
8313762|NCT01465958|20497414|P1|NOT COMPLETED|Run-in Phase||1
8313763|NCT01465958|20497413|P2|COMPLETED|Run-in Phase||0
8313764|NCT01465958|20497414|P1|COMPLETED|Run-in Phase||10
8313765|NCT01465958|20497413|P2|STARTED|Run-in Phase||0
8313766|NCT01465958|20497414|P1|STARTED|Run-in Phase||11
8313767|NCT01465841|20497422|P1|NOT COMPLETED|Overall Study||68
8313768|NCT01465841|20497422|P1|COMPLETED|Overall Study||449
8313769|NCT01465841|20497422|P1|STARTED|Overall Study||517
8313770|NCT01465802|20497435|P5|NOT COMPLETED|Overall Study||12
8313771|NCT01465802|20497436|P4|NOT COMPLETED|Overall Study||29
8313772|NCT01465802|20497437|P3|NOT COMPLETED|Overall Study||0
8313773|NCT01465802|20497438|P2|NOT COMPLETED|Overall Study||24
8313774|NCT01465802|20497439|P1|NOT COMPLETED|Overall Study||33
8313775|NCT01465802|20497435|P5|COMPLETED|Overall Study||13
8313776|NCT01465802|20497436|P4|COMPLETED|Overall Study||38
8313777|NCT01465802|20497437|P3|COMPLETED|Overall Study||7
8313778|NCT01465802|20497438|P2|COMPLETED|Overall Study||42
8313779|NCT01465802|20497439|P1|COMPLETED|Overall Study||33
8313780|NCT01465802|20497435|P5|STARTED|Overall Study||25
8313781|NCT01465802|20497436|P4|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
8313782|NCT01465802|20497437|P3|STARTED|Overall Study||7
8313783|NCT01465802|20497438|P2|STARTED|Overall Study||66
8313784|NCT01465802|20497439|P1|STARTED|Overall Study||66
8313785|NCT01465763|20497491|P3|NOT COMPLETED|Overall Study||4
8313786|NCT01465763|20497492|P2|NOT COMPLETED|Overall Study||1
8313787|NCT01465763|20497493|P1|NOT COMPLETED|Overall Study||31
8313788|NCT01465763|20497491|P3|COMPLETED|Overall Study||118
8313789|NCT01465763|20497492|P2|COMPLETED|Overall Study||15
8313790|NCT01465763|20497493|P1|COMPLETED|Overall Study||445
8313791|NCT01465763|20497491|P3|STARTED|Overall Study||122
8313792|NCT01465763|20497492|P2|STARTED|Overall Study||16
8313793|NCT01465763|20497493|P1|STARTED|Overall Study||476
8313858|NCT01465464|20497535|P2|NOT COMPLETED|Overall Study||444
8313859|NCT01465464|20497536|P1|NOT COMPLETED|Overall Study||444
8313860|NCT01465464|20497535|P2|COMPLETED|Overall Study||0
8313861|NCT01465464|20497536|P1|COMPLETED|Overall Study||0
8313862|NCT01465464|20497535|P2|STARTED|Overall Study||444
8313863|NCT01465464|20497536|P1|STARTED|Overall Study||444
8313864|NCT01465412|20497548|P4|NOT COMPLETED|Overall Study||0
8313865|NCT01465412|20497549|P3|NOT COMPLETED|Overall Study||0
8313866|NCT01465412|20497550|P2|NOT COMPLETED|Overall Study||0
8313867|NCT01465412|20497551|P1|NOT COMPLETED|Overall Study||0
8313868|NCT01465412|20497548|P4|COMPLETED|Overall Study||9
8313869|NCT01465412|20497549|P3|COMPLETED|Overall Study||9
8313870|NCT01465412|20497550|P2|COMPLETED|Overall Study||12
8313871|NCT01465412|20497551|P1|COMPLETED|Overall Study||12
8313872|NCT01465412|20497548|P4|STARTED|Overall Study||9
8313873|NCT01465412|20497549|P3|STARTED|Overall Study||9
8313874|NCT01465412|20497550|P2|STARTED|Overall Study||12
8313875|NCT01465412|20497551|P1|STARTED|Overall Study||12
8313876|NCT01465386|20497589|P1|NOT COMPLETED|Overall Study||4
8313877|NCT01465386|20497589|P1|COMPLETED|Overall Study||2
8313878|NCT01465386|20497589|P1|STARTED|Overall Study||6
8313879|NCT01465347|20497593|P2|NOT COMPLETED|Overall Study||3
8313880|NCT01465347|20497594|P1|NOT COMPLETED|Overall Study||1
8313881|NCT01465347|20497593|P2|COMPLETED|Overall Study||53
8313882|NCT01465347|20497594|P1|COMPLETED|Overall Study||2
8313883|NCT01465347|20497593|P2|STARTED|Overall Study||56
8313884|NCT01465347|20497594|P1|STARTED|Overall Study||3
8313885|NCT01465334|20497606|P2|NOT COMPLETED|Overall Study||6
8313886|NCT01465334|20497607|P1|NOT COMPLETED|Overall Study||2
8313887|NCT01465334|20497606|P2|COMPLETED|Overall Study||9
8313888|NCT01465334|20497607|P1|COMPLETED|Overall Study||13
8313889|NCT01465334|20497606|P2|Eligible for Allogeneic Transplant|Overall Study||9
8313890|NCT01465334|20497607|P1|Eligible for Allogeneic Transplant|Overall Study||9
8313891|NCT01465334|20497606|P2|Complete Part B Induction|Overall Study||15
8313892|NCT01465334|20497607|P1|Complete Part B Induction|Overall Study||7
8313893|NCT01465334|20497606|P2|Complete Part A Induction|Overall Study||15
8313894|NCT01465334|20497607|P1|Complete Part A Induction|Overall Study||12
8313895|NCT01465334|20497606|P2|STARTED|Overall Study||15
8313896|NCT01465334|20497607|P1|STARTED|Overall Study||15
8313897|NCT01465230|20497633|P1|NOT COMPLETED|Overall Study||2
8313898|NCT01465230|20497633|P1|COMPLETED|Overall Study||0
8313899|NCT01465230|20497633|P1|STARTED|Overall Study||2
8313900|NCT01465191|20497640|P3|NOT COMPLETED|Overall Study||7
8313901|NCT01465191|20497641|P2|NOT COMPLETED|Overall Study||9
8313902|NCT01465191|20497642|P1|NOT COMPLETED|Overall Study||9
8313903|NCT01465191|20497640|P3|COMPLETED|Overall Study||43
8313904|NCT01465191|20497641|P2|COMPLETED|Overall Study||54
8313905|NCT01465191|20497642|P1|COMPLETED|Overall Study||47
8313906|NCT01465191|20497640|P3|STARTED|Overall Study||50
8313907|NCT01465191|20497641|P2|STARTED|Overall Study||63
8313908|NCT01465191|20497642|P1|STARTED|Overall Study||56
8313909|NCT01465178|20497691|P2|NOT COMPLETED|Overall Study||0
8313910|NCT01465178|20497692|P1|NOT COMPLETED|Overall Study||1
8313911|NCT01465178|20497691|P2|COMPLETED|Overall Study||31
8313912|NCT01465178|20497692|P1|COMPLETED|Overall Study||30
8313913|NCT01465178|20497691|P2|STARTED|Overall Study||31
8313914|NCT01465178|20497692|P1|STARTED|Overall Study||31
8313915|NCT01465048|20497703|P3|NOT COMPLETED|Overall Study||0
8313916|NCT01465048|20497704|P2|NOT COMPLETED|Overall Study||0
8313917|NCT01465048|20497705|P1|NOT COMPLETED|Overall Study||0
8313918|NCT01465048|20497703|P3|COMPLETED|Overall Study||6
8313919|NCT01465048|20497704|P2|COMPLETED|Overall Study||6
8313920|NCT01465048|20497705|P1|COMPLETED|Overall Study||6
8313921|NCT01465048|20497703|P3|STARTED|Overall Study||6
8313922|NCT01465048|20497704|P2|STARTED|Overall Study||6
8313923|NCT01465048|20497705|P1|STARTED|Overall Study||6
8313924|NCT01465022|20497716|P3|NOT COMPLETED|Overall Study||70
8313925|NCT01465022|20497717|P2|NOT COMPLETED|Overall Study||23
8313926|NCT01465022|20497718|P1|NOT COMPLETED|Overall Study||23
8313927|NCT01465022|20497716|P3|COMPLETED|Overall Study||0
8313928|NCT01465022|20497717|P2|COMPLETED|Overall Study||40
8313929|NCT01465022|20497718|P1|COMPLETED|Overall Study||41
8313930|NCT01465022|20497716|P3|STARTED|Overall Study||70
8313931|NCT01465022|20497717|P2|STARTED|Overall Study||63
8313932|NCT01465022|20497718|P1|STARTED|Overall Study||64
8313933|NCT01464996|20497732|P1|NOT COMPLETED|Overall Study||0
8313934|NCT01464996|20497732|P1|COMPLETED|Overall Study||24
8313935|NCT01464996|20497732|P1|OptiBond FL|Overall Study||24
8313936|NCT01464996|20497732|P1|OptiBond XTR|Overall Study||23
8313937|NCT01464996|20497732|P1|STARTED|Overall Study||24
8313938|NCT01464931|20497752|P2|NOT COMPLETED|Overall Study||0
8313939|NCT01464931|20497753|P1|NOT COMPLETED|Overall Study||1
8313940|NCT01464931|20497752|P2|COMPLETED|Overall Study||16
8313941|NCT01464931|20497753|P1|COMPLETED|Overall Study||15
8313942|NCT01464931|20497752|P2|STARTED|Overall Study||16
8313943|NCT01464931|20497753|P1|STARTED|Overall Study||16
8313944|NCT01464879|20497790|P1|NOT COMPLETED|Overall Study||2
8313945|NCT01464879|20497790|P1|COMPLETED|Overall Study||18
8313946|NCT01464879|20497790|P1|Applicator Application (3.75 mL)|Overall Study||18
8313947|NCT01464879|20497790|P1|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
8313948|NCT01464879|20497790|P1|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
8313949|NCT01464879|20497790|P1|Washout Period|Overall Study||20
8313950|NCT01464879|20497790|P1|Hand Application (2.50 mL)|Overall Study||20
8313951|NCT01464879|20497790|P1|STARTED|Overall Study||20
8313952|NCT01464840|20497827|P3|NOT COMPLETED|Overall Study||0
8313953|NCT01464840|20497828|P2|NOT COMPLETED|Overall Study||0
8313954|NCT01464840|20497829|P1|NOT COMPLETED|Overall Study||0
8313955|NCT01464840|20497827|P3|COMPLETED|Overall Study||10
8313956|NCT01464840|20497828|P2|COMPLETED|Overall Study||10
8313957|NCT01464840|20497829|P1|COMPLETED|Overall Study||10
8313958|NCT01464840|20497827|P3|STARTED|Overall Study||10
8313959|NCT01464840|20497828|P2|STARTED|Overall Study||10
8313960|NCT01464840|20497829|P1|STARTED|Overall Study||10
8313961|NCT01464827|20497851|P14|NOT COMPLETED|Overall Study||3
8313962|NCT01464827|20497852|P13|NOT COMPLETED|Overall Study||2
8313963|NCT01464827|20497853|P12|NOT COMPLETED|Overall Study||2
8313964|NCT01464827|20497854|P11|NOT COMPLETED|Overall Study||2
8313965|NCT01464827|20497855|P10|NOT COMPLETED|Overall Study||3
8313966|NCT01464827|20497856|P9|NOT COMPLETED|Overall Study||3
8313967|NCT01464827|20497857|P8|NOT COMPLETED|Overall Study||3
8313968|NCT01464827|20497858|P7|NOT COMPLETED|Overall Study||4
8313969|NCT01464827|20497859|P6|NOT COMPLETED|Overall Study||1
8313970|NCT01464827|20497860|P5|NOT COMPLETED|Overall Study||8
8313971|NCT01464827|20497861|P4|NOT COMPLETED|Overall Study||4
8313972|NCT01464827|20497862|P3|NOT COMPLETED|Overall Study||0
8313973|NCT01464827|20497863|P2|NOT COMPLETED|Overall Study||7
8313974|NCT01464827|20497864|P1|NOT COMPLETED|Overall Study||3
8313975|NCT01464827|20497851|P14|COMPLETED|Overall Study||19
8313976|NCT01464827|20497852|P13|COMPLETED|Overall Study||21
8313977|NCT01464827|20497853|P12|COMPLETED|Overall Study||21
8313978|NCT01464827|20497854|P11|COMPLETED|Overall Study||21
8313979|NCT01464827|20497855|P10|COMPLETED|Overall Study||44
8313980|NCT01464827|20497856|P9|COMPLETED|Overall Study||37
8313981|NCT01464827|20497857|P8|COMPLETED|Overall Study||37
8313982|NCT01464827|20497858|P7|COMPLETED|Overall Study||37
8313983|NCT01464827|20497859|P6|COMPLETED|Overall Study||38
8313984|NCT01464827|20497860|P5|COMPLETED|Overall Study||72
8313985|NCT01464827|20497861|P4|COMPLETED|Overall Study||36
8313986|NCT01464827|20497862|P3|COMPLETED|Overall Study||39
8313987|NCT01464827|20497863|P2|COMPLETED|Overall Study||36
8313988|NCT01464827|20497864|P1|COMPLETED|Overall Study||77
8313989|NCT01464827|20497851|P14|Treated|Overall Study||20
8313990|NCT01464827|20497852|P13|Treated|Overall Study||23
8313991|NCT01464827|20497853|P12|Treated|Overall Study||22
8313992|NCT01464827|20497854|P11|Treated|Overall Study||23
8313993|NCT01464827|20497855|P10|Treated|Overall Study||45
8313994|NCT01464827|20497856|P9|Treated|Overall Study||40
8313995|NCT01464827|20497857|P8|Treated|Overall Study||40
8313996|NCT01464827|20497858|P7|Treated|Overall Study||40
8313997|NCT01464827|20497859|P6|Treated|Overall Study||39
8313998|NCT01464827|20497860|P5|Treated|Overall Study||79
8313999|NCT01464827|20497861|P4|Treated|Overall Study||40
8314000|NCT01464827|20497862|P3|Treated|Overall Study||39
8314001|NCT01464827|20497863|P2|Treated|Overall Study||41
8314002|NCT01464827|20497864|P1|Treated|Overall Study||80
8314003|NCT01464827|20497851|P14|STARTED|Overall Study||22
8314004|NCT01464827|20497852|P13|STARTED|Overall Study||23
8314005|NCT01464827|20497853|P12|STARTED|Overall Study||23
8314006|NCT01464827|20497854|P11|STARTED|Overall Study||23
8314007|NCT01464827|20497855|P10|STARTED|Overall Study||47
8314008|NCT01464827|20497856|P9|STARTED|Overall Study||40
8314009|NCT01464827|20497857|P8|STARTED|Overall Study||40
8314010|NCT01464827|20497858|P7|STARTED|Overall Study||41
8314011|NCT01464827|20497859|P6|STARTED|Overall Study||39
8314012|NCT01464827|20497860|P5|STARTED|Overall Study||80
8314013|NCT01464827|20497861|P4|STARTED|Overall Study||40
8314014|NCT01464827|20497862|P3|STARTED|Overall Study||39
8314015|NCT01464827|20497863|P2|STARTED|Overall Study||43
8314016|NCT01464827|20497864|P1|STARTED|Overall Study||80
8314017|NCT01464788|20497911|P3|NOT COMPLETED|Overall Study||0
8314018|NCT01464788|20497912|P2|NOT COMPLETED|Overall Study||2
8314019|NCT01464788|20497913|P1|NOT COMPLETED|Overall Study||0
8314020|NCT01464788|20497911|P3|COMPLETED|Overall Study||29
8314021|NCT01464788|20497912|P2|COMPLETED|Overall Study||29
8314022|NCT01464788|20497913|P1|COMPLETED|Overall Study||30
8314023|NCT01464788|20497911|P3|STARTED|Overall Study||29
8314024|NCT01464788|20497912|P2|STARTED|Overall Study||31
8314025|NCT01464788|20497913|P1|STARTED|Overall Study||30
8314026|NCT01464775|20497926|P2|NOT COMPLETED|Overall Study||6
8314027|NCT01464775|20497927|P1|NOT COMPLETED|Overall Study||11
8314028|NCT01464775|20497926|P2|COMPLETED|Overall Study||38
8314029|NCT01464775|20497927|P1|COMPLETED|Overall Study||112
8314030|NCT01464775|20497926|P2|STARTED|Overall Study||44
8314031|NCT01464775|20497927|P1|STARTED|Overall Study||123
8314032|NCT01464723|20497935|P1|NOT COMPLETED|Overall Study||0
8314033|NCT01464723|20497935|P1|COMPLETED|Overall Study||0
8314034|NCT01464723|20497935|P1|STARTED|Overall Study||0
8314035|NCT01464697|20497944|P2|NOT COMPLETED|Overall Study||10
8314036|NCT01464697|20497945|P1|NOT COMPLETED|Overall Study||3
8314037|NCT01464697|20497944|P2|COMPLETED|Overall Study||86
8314038|NCT01464697|20497945|P1|COMPLETED|Overall Study||90
8314039|NCT01464697|20497944|P2|STARTED|Overall Study||96
8314040|NCT01464697|20497945|P1|STARTED|Overall Study||93
8314041|NCT01464619|20497999|P2|NOT COMPLETED|Overall Study||4
8314042|NCT01464619|20498000|P1|NOT COMPLETED|Overall Study||3
8314043|NCT01464619|20497999|P2|COMPLETED|Overall Study||25
8314044|NCT01464619|20498000|P1|COMPLETED|Overall Study||29
8314045|NCT01464619|20497999|P2|STARTED|Overall Study||29
8314046|NCT01464619|20498000|P1|STARTED|Overall Study||32
8314047|NCT01464424|20498020|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
8314048|NCT01464424|20498021|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
8314049|NCT01464424|20498020|P2|COMPLETED|Period 2, Second 6 Weeks||41
8314050|NCT01464424|20498021|P1|COMPLETED|Period 2, Second 6 Weeks||42
8314051|NCT01464424|20498020|P2|STARTED|Period 2, Second 6 Weeks||41
8314052|NCT01464424|20498021|P1|STARTED|Period 2, Second 6 Weeks||42
8314053|NCT01464424|20498020|P2|NOT COMPLETED|Period 1, First 6 Weeks||1
8314054|NCT01464424|20498021|P1|NOT COMPLETED|Period 1, First 6 Weeks||0
8314055|NCT01464424|20498020|P2|COMPLETED|Period 1, First 6 Weeks||41
8314056|NCT01464424|20498021|P1|COMPLETED|Period 1, First 6 Weeks||42
8314057|NCT01464424|20498020|P2|STARTED|Period 1, First 6 Weeks||42
8314058|NCT01464424|20498021|P1|STARTED|Period 1, First 6 Weeks||42
8314059|NCT01464359|20498029|P1|NOT COMPLETED|Overall Study||0
8314060|NCT01464359|20498029|P1|COMPLETED|Overall Study||3
8314061|NCT01464359|20498029|P1|STARTED|Overall Study||3
8314062|NCT01464346|20498041|P3|NOT COMPLETED|Overall Study||1
8314063|NCT01464346|20498042|P2|NOT COMPLETED|Overall Study||0
8314064|NCT01464346|20498043|P1|NOT COMPLETED|Overall Study||0
8314065|NCT01464346|20498041|P3|COMPLETED|Overall Study||28
8314066|NCT01464346|20498042|P2|COMPLETED|Overall Study||32
8314067|NCT01464346|20498043|P1|COMPLETED|Overall Study||29
8314068|NCT01464346|20498041|P3|STARTED|Overall Study||29
8314069|NCT01464346|20498042|P2|STARTED|Overall Study||32
8314070|NCT01464346|20498043|P1|STARTED|Overall Study||29
8314071|NCT01464333|20498052|P1|NOT COMPLETED|Overall Study||163
8314072|NCT01464333|20498052|P1|COMPLETED|Overall Study||226
8314073|NCT01464333|20498052|P1|STARTED|Overall Study||389
8314074|NCT01464307|20498065|P2|NOT COMPLETED|Open-Label Extension Period||0
8314075|NCT01464307|20498066|P1|NOT COMPLETED|Open-Label Extension Period||51
8314076|NCT01464307|20498065|P2|COMPLETED|Open-Label Extension Period||0
8314077|NCT01464307|20498066|P1|COMPLETED|Open-Label Extension Period||218
8314078|NCT01464307|20498065|P2|Treated|Open-Label Extension Period||0
8314079|NCT01464307|20498066|P1|Treated|Open-Label Extension Period||269
8314080|NCT01464307|20498065|P2|STARTED|Open-Label Extension Period||0
8314081|NCT01464307|20498066|P1|STARTED|Open-Label Extension Period||269
8314082|NCT01464307|20498065|P2|NOT COMPLETED|Main Period||5
8314083|NCT01464307|20498066|P1|NOT COMPLETED|Main Period||15
8314084|NCT01464307|20498065|P2|COMPLETED|Main Period||140
8314085|NCT01464307|20498066|P1|COMPLETED|Main Period||129
8314086|NCT01464307|20498065|P2|Treated|Main Period||145
8314087|NCT01464307|20498066|P1|Treated|Main Period||144
8314088|NCT01464307|20498065|P2|STARTED|Main Period||145
8314089|NCT01464307|20498066|P1|STARTED|Main Period||144
8314090|NCT01464255|20498081|P2|NOT COMPLETED|Overall Study||1
8314091|NCT01464255|20498082|P1|NOT COMPLETED|Overall Study||0
8314092|NCT01464255|20498081|P2|COMPLETED|Overall Study||24
8314093|NCT01464255|20498082|P1|COMPLETED|Overall Study||25
8314094|NCT01464255|20498081|P2|STARTED|Overall Study||25
8314095|NCT01464255|20498082|P1|STARTED|Overall Study||25
8314096|NCT01464229|20498107|P2|NOT COMPLETED|Overall Study||2
8314097|NCT01464229|20498108|P1|NOT COMPLETED|Overall Study||5
8314098|NCT01464229|20498107|P2|COMPLETED|Overall Study||8
8314099|NCT01464229|20498108|P1|COMPLETED|Overall Study||5
8314100|NCT01464229|20498107|P2|STARTED|Overall Study||10
8314101|NCT01464229|20498108|P1|STARTED|Overall Study||10
8314102|NCT01464190|20498116|P2|NOT COMPLETED|Overall Study||41
8314103|NCT01464190|20498117|P1|NOT COMPLETED|Overall Study||69
8314104|NCT01464190|20498116|P2|COMPLETED|Overall Study||227
8314105|NCT01464190|20498117|P1|COMPLETED|Overall Study||322
8314106|NCT01464190|20498116|P2|STARTED|Overall Study||268
8314107|NCT01464190|20498117|P1|STARTED|Overall Study||391
8314108|NCT01464021|20498127|P1|NOT COMPLETED|Overall Study||26
8314109|NCT01464021|20498127|P1|COMPLETED|Overall Study||0
8314110|NCT01464021|20498127|P1|STARTED|Overall Study||26
8314111|NCT01463982|20498143|P4|NOT COMPLETED|Overall Study||0
8314112|NCT01463982|20498144|P3|NOT COMPLETED|Overall Study||2
8314113|NCT01463982|20498145|P2|NOT COMPLETED|Overall Study||1
8314114|NCT01463982|20498146|P1|NOT COMPLETED|Overall Study||0
8314115|NCT01463982|20498143|P4|COMPLETED|Overall Study||6
8314116|NCT01463982|20498144|P3|COMPLETED|Overall Study||2
8314117|NCT01463982|20498145|P2|COMPLETED|Overall Study||7
8314118|NCT01463982|20498146|P1|COMPLETED|Overall Study||3
8314119|NCT01463982|20498143|P4|STARTED|Overall Study||6
8314120|NCT01463982|20498144|P3|STARTED|Overall Study||4
8314121|NCT01463982|20498145|P2|STARTED|Overall Study||8
8314122|NCT01463982|20498146|P1|STARTED|Overall Study||3
8314123|NCT01463878|20498162|P2|NOT COMPLETED|Overall Study||2
8314124|NCT01463878|20498163|P1|NOT COMPLETED|Overall Study||2
8314125|NCT01463878|20498162|P2|COMPLETED|Overall Study||7
8314126|NCT01463878|20498163|P1|COMPLETED|Overall Study||7
8314127|NCT01463878|20498162|P2|STARTED|Overall Study||9
8314128|NCT01463878|20498163|P1|STARTED|Overall Study||9
8314129|NCT01463696|20498177|P8|NOT COMPLETED|Overall Study||4
8314130|NCT01463696|20498178|P7|NOT COMPLETED|Overall Study||10
8314131|NCT01463696|20498179|P6|NOT COMPLETED|Overall Study||3
8314132|NCT01463696|20498180|P5|NOT COMPLETED|Overall Study||1
8314133|NCT01463696|20498181|P4|NOT COMPLETED|Overall Study||4
8314134|NCT01463696|20498182|P3|NOT COMPLETED|Overall Study||1
8314135|NCT01463696|20498183|P2|NOT COMPLETED|Overall Study||2
8314136|NCT01463696|20498184|P1|NOT COMPLETED|Overall Study||0
8314137|NCT01463696|20498177|P8|COMPLETED|Overall Study||2
8314138|NCT01463696|20498178|P7|COMPLETED|Overall Study||6
8314139|NCT01463696|20498179|P6|COMPLETED|Overall Study||3
8314140|NCT01463696|20498180|P5|COMPLETED|Overall Study||2
8314141|NCT01463696|20498181|P4|COMPLETED|Overall Study||3
8314142|NCT01463696|20498182|P3|COMPLETED|Overall Study||2
8314143|NCT01463696|20498183|P2|COMPLETED|Overall Study||4
8314144|NCT01463696|20498184|P1|COMPLETED|Overall Study||1
8314145|NCT01463696|20498177|P8|Treated|Overall Study||6
8314146|NCT01463696|20498178|P7|Treated|Overall Study||15
8314147|NCT01463696|20498179|P6|Treated|Overall Study||6
8314148|NCT01463696|20498180|P5|Treated|Overall Study||3
8314149|NCT01463696|20498181|P4|Treated|Overall Study||7
8314150|NCT01463696|20498182|P3|Treated|Overall Study||3
8314151|NCT01463696|20498183|P2|Treated|Overall Study||6
8314152|NCT01463696|20498184|P1|Treated|Overall Study||1
8314153|NCT01463696|20498177|P8|STARTED|Overall Study||6
8314154|NCT01463696|20498178|P7|STARTED|Overall Study||16
8314155|NCT01463696|20498179|P6|STARTED|Overall Study||6
8314156|NCT01463696|20498180|P5|STARTED|Overall Study||3
8314157|NCT01463696|20498181|P4|STARTED|Overall Study||7
8314158|NCT01463696|20498182|P3|STARTED|Overall Study||3
8314159|NCT01463696|20498183|P2|STARTED|Overall Study||6
8314160|NCT01463696|20498184|P1|STARTED|Overall Study||1
8314161|NCT01463683|20498237|P3|NOT COMPLETED|Overall Study||11
8314162|NCT01463683|20498238|P2|NOT COMPLETED|Overall Study||31
8314163|NCT01463683|20498239|P1|NOT COMPLETED|Overall Study||19
8314164|NCT01463683|20498237|P3|COMPLETED|Overall Study||93
8314165|NCT01463683|20498238|P2|COMPLETED|Overall Study||278
8314166|NCT01463683|20498239|P1|COMPLETED|Overall Study||290
8314167|NCT01463683|20498237|P3|Received Vaccination 3 (Month 6)|Overall Study||93
8314168|NCT01463683|20498238|P2|Received Vaccination 3 (Month 6)|Overall Study||281
8314169|NCT01463683|20498239|P1|Received Vaccination 3 (Month 6)|Overall Study||290
8314170|NCT01463683|20498237|P3|Received Vaccination 2 (Month 1)|Overall Study||103
8314171|NCT01463683|20498238|P2|Received Vaccination 2 (Month 1)|Overall Study||300
8314172|NCT01463683|20498239|P1|Received Vaccination 2 (Month 1)|Overall Study||302
8314173|NCT01463683|20498237|P3|Received Vaccination 1 (Day 1)|Overall Study||104
8314174|NCT01463683|20498238|P2|Received Vaccination 1 (Day 1)|Overall Study||308
8314175|NCT01463683|20498239|P1|Received Vaccination 1 (Day 1)|Overall Study||309
8314176|NCT01463683|20498237|P3|STARTED|Overall Study||104
8314177|NCT01463683|20498238|P2|STARTED|Overall Study||309
8314178|NCT01463683|20498239|P1|STARTED|Overall Study||309
8314179|NCT01463631|20498256|P4|NOT COMPLETED|Overall Study||6
8314180|NCT01463631|20498257|P3|NOT COMPLETED|Overall Study||1
8314181|NCT01463631|20498258|P2|NOT COMPLETED|Overall Study||0
8314182|NCT01463631|20498259|P1|NOT COMPLETED|Overall Study||0
8314183|NCT01463631|20498256|P4|COMPLETED|Overall Study||9
8314184|NCT01463631|20498257|P3|COMPLETED|Overall Study||4
8314185|NCT01463631|20498258|P2|COMPLETED|Overall Study||4
8314186|NCT01463631|20498259|P1|COMPLETED|Overall Study||3
8314187|NCT01463631|20498256|P4|Received at Least One Dose of Study Drug|Overall Study||15
8314188|NCT01463631|20498257|P3|Received at Least One Dose of Study Drug|Overall Study||5
8314189|NCT01463631|20498258|P2|Received at Least One Dose of Study Drug|Overall Study||4
8314190|NCT01463631|20498259|P1|Received at Least One Dose of Study Drug|Overall Study||3
8314191|NCT01463631|20498256|P4|STARTED|Overall Study||15
8314192|NCT01463631|20498257|P3|STARTED|Overall Study||5
8314193|NCT01463631|20498258|P2|STARTED|Overall Study||4
8314194|NCT01463631|20498259|P1|STARTED|Overall Study||3
8314195|NCT01463527|20498281|P2|NOT COMPLETED|Overall Study||7
8314196|NCT01463527|20498282|P1|NOT COMPLETED|Overall Study||6
8314197|NCT01463527|20498281|P2|COMPLETED|Overall Study||77
8314198|NCT01463527|20498282|P1|COMPLETED|Overall Study||77
8314199|NCT01463527|20498281|P2|STARTED|Overall Study||84
8314200|NCT01463527|20498282|P1|STARTED|Overall Study||83
8314201|NCT01463384|20498290|P1|NOT COMPLETED|Overall Study||0
8314202|NCT01463384|20498290|P1|COMPLETED|Overall Study||13
8314203|NCT01463384|20498290|P1|STARTED|Overall Study||13
8314204|NCT01463306|20498305|P3|NOT COMPLETED|Overall Study||5
8314205|NCT01463306|20498306|P2|NOT COMPLETED|Overall Study||52
8314206|NCT01463306|20498307|P1|NOT COMPLETED|Overall Study||86
8314207|NCT01463306|20498305|P3|COMPLETED|Overall Study||6
8314208|NCT01463306|20498306|P2|COMPLETED|Overall Study||158
8314209|NCT01463306|20498307|P1|COMPLETED|Overall Study||298
8314210|NCT01463306|20498305|P3|STARTED|Overall Study||11
8314211|NCT01463306|20498306|P2|STARTED|Overall Study||210
8314212|NCT01463306|20498307|P1|STARTED|Overall Study||384
8314213|NCT01463293|20498378|P3|NOT COMPLETED|Overall Study||12
8314214|NCT01463293|20498379|P2|NOT COMPLETED|Overall Study||16
8314215|NCT01463293|20498380|P1|NOT COMPLETED|Overall Study||6
8314216|NCT01463293|20498378|P3|COMPLETED|Overall Study||59
8314217|NCT01463293|20498379|P2|COMPLETED|Overall Study||63
8314218|NCT01463293|20498380|P1|COMPLETED|Overall Study||68
8314219|NCT01463293|20498378|P3|STARTED|Overall Study||71
8314220|NCT01463293|20498379|P2|STARTED|Overall Study||79
8314221|NCT01463293|20498380|P1|STARTED|Overall Study||74
8314222|NCT01463267|20498392|P4|NOT COMPLETED|Overall Study||2
8314223|NCT01463267|20498393|P3|NOT COMPLETED|Overall Study||2
8314224|NCT01463267|20498394|P2|NOT COMPLETED|Overall Study||0
8314225|NCT01463267|20498395|P1|NOT COMPLETED|Overall Study||1
8314226|NCT01463267|20498392|P4|COMPLETED|Overall Study||13
8314227|NCT01463267|20498393|P3|COMPLETED|Overall Study||13
8314228|NCT01463267|20498394|P2|COMPLETED|Overall Study||15
8314229|NCT01463267|20498395|P1|COMPLETED|Overall Study||14
8314230|NCT01463267|20498392|P4|STARTED|Overall Study||15
8314231|NCT01463267|20498393|P3|STARTED|Overall Study||15
8314232|NCT01463267|20498394|P2|STARTED|Overall Study||15
8314233|NCT01463267|20498395|P1|STARTED|Overall Study||15
8314234|NCT01463202|20498411|P2|NOT COMPLETED|Overall Study||0
8314235|NCT01463202|20498412|P1|NOT COMPLETED|Overall Study||0
8314236|NCT01463202|20498411|P2|COMPLETED|Overall Study||78
8314237|NCT01463202|20498412|P1|COMPLETED|Overall Study||79
8314238|NCT01463202|20498411|P2|STARTED|Overall Study||78
8314239|NCT01463202|20498412|P1|STARTED|Overall Study||79
8314240|NCT01463111|20498424|P1|NOT COMPLETED|Overall Study||9
8314241|NCT01463111|20498424|P1|COMPLETED|Overall Study||17
8314242|NCT01463111|20498424|P1|STARTED|Overall Study||26
8314243|NCT01463098|20498446|P14|NOT COMPLETED|Part B (11 Days)||0
8314244|NCT01463098|20498447|P13|NOT COMPLETED|Part B (11 Days)||0
8314245|NCT01463098|20498448|P12|NOT COMPLETED|Part B (11 Days)||1
8314246|NCT01463098|20498449|P11|NOT COMPLETED|Part B (11 Days)||0
8314247|NCT01463098|20498450|P10|NOT COMPLETED|Part B (11 Days)||0
8314248|NCT01463098|20498451|P9|NOT COMPLETED|Part B (11 Days)||0
8314249|NCT01463098|20498452|P8|NOT COMPLETED|Part B (11 Days)||0
8314250|NCT01463098|20498453|P7|NOT COMPLETED|Part B (11 Days)||0
8314251|NCT01463098|20498454|P6|NOT COMPLETED|Part B (11 Days)||0
8314252|NCT01463098|20498455|P5|NOT COMPLETED|Part B (11 Days)||0
8314253|NCT01463098|20498456|P4|NOT COMPLETED|Part B (11 Days)||0
8314254|NCT01463098|20498457|P3|NOT COMPLETED|Part B (11 Days)||0
8314255|NCT01463098|20498458|P2|NOT COMPLETED|Part B (11 Days)||0
8314256|NCT01463098|20498459|P1|NOT COMPLETED|Part B (11 Days)||0
8314257|NCT01463098|20498446|P14|COMPLETED|Part B (11 Days)||12
8314258|NCT01463098|20498447|P13|COMPLETED|Part B (11 Days)||10
8314259|NCT01463098|20498448|P12|COMPLETED|Part B (11 Days)||12
8314260|NCT01463098|20498449|P11|COMPLETED|Part B (11 Days)||11
8314261|NCT01463098|20498450|P10|COMPLETED|Part B (11 Days)||12
8314262|NCT01463098|20498451|P9|COMPLETED|Part B (11 Days)||0
8314263|NCT01463098|20498452|P8|COMPLETED|Part B (11 Days)||0
8314264|NCT01463098|20498453|P7|COMPLETED|Part B (11 Days)||0
8314265|NCT01463098|20498454|P6|COMPLETED|Part B (11 Days)||0
8314266|NCT01463098|20498455|P5|COMPLETED|Part B (11 Days)||0
8314267|NCT01463098|20498456|P4|COMPLETED|Part B (11 Days)||0
8314268|NCT01463098|20498457|P3|COMPLETED|Part B (11 Days)||0
8314269|NCT01463098|20498458|P2|COMPLETED|Part B (11 Days)||0
8314270|NCT01463098|20498459|P1|COMPLETED|Part B (11 Days)||0
8314271|NCT01463098|20498446|P14|STARTED|Part B (11 Days)||12
8314272|NCT01463098|20498447|P13|STARTED|Part B (11 Days)||10
8314273|NCT01463098|20498448|P12|STARTED|Part B (11 Days)||13
8314274|NCT01463098|20498449|P11|STARTED|Part B (11 Days)||11
8314275|NCT01463098|20498450|P10|STARTED|Part B (11 Days)||12
8314276|NCT01463098|20498451|P9|STARTED|Part B (11 Days)||0
8314277|NCT01463098|20498452|P8|STARTED|Part B (11 Days)||0
8314278|NCT01463098|20498453|P7|STARTED|Part B (11 Days)||0
8314279|NCT01463098|20498454|P6|STARTED|Part B (11 Days)||0
8314280|NCT01463098|20498455|P5|STARTED|Part B (11 Days)||0
8314281|NCT01463098|20498456|P4|STARTED|Part B (11 Days)||0
8314282|NCT01463098|20498457|P3|STARTED|Part B (11 Days)||0
8314283|NCT01463098|20498458|P2|STARTED|Part B (11 Days)||0
8314284|NCT01463098|20498459|P1|STARTED|Part B (11 Days)||0
8314285|NCT01463098|20498446|P14|NOT COMPLETED|Part A (11 Days)||0
8314286|NCT01463098|20498447|P13|NOT COMPLETED|Part A (11 Days)||0
8314287|NCT01463098|20498448|P12|NOT COMPLETED|Part A (11 Days)||0
8314288|NCT01463098|20498449|P11|NOT COMPLETED|Part A (11 Days)||0
8314289|NCT01463098|20498450|P10|NOT COMPLETED|Part A (11 Days)||0
8314290|NCT01463098|20498451|P9|NOT COMPLETED|Part A (11 Days)||1
8314291|NCT01463098|20498452|P8|NOT COMPLETED|Part A (11 Days)||0
8314292|NCT01463098|20498453|P7|NOT COMPLETED|Part A (11 Days)||0
8314293|NCT01463098|20498454|P6|NOT COMPLETED|Part A (11 Days)||0
8314294|NCT01463098|20498455|P5|NOT COMPLETED|Part A (11 Days)||1
8314295|NCT01463098|20498456|P4|NOT COMPLETED|Part A (11 Days)||0
8314296|NCT01463098|20498457|P3|NOT COMPLETED|Part A (11 Days)||0
8314297|NCT01463098|20498458|P2|NOT COMPLETED|Part A (11 Days)||0
8314298|NCT01463098|20498459|P1|NOT COMPLETED|Part A (11 Days)||2
8314299|NCT01463098|20498446|P14|COMPLETED|Part A (11 Days)||0
8314300|NCT01463098|20498447|P13|COMPLETED|Part A (11 Days)||0
8314301|NCT01463098|20498448|P12|COMPLETED|Part A (11 Days)||0
8314302|NCT01463098|20498449|P11|COMPLETED|Part A (11 Days)||0
8314303|NCT01463098|20498450|P10|COMPLETED|Part A (11 Days)||0
8314304|NCT01463098|20498451|P9|COMPLETED|Part A (11 Days)||5
8314305|NCT01463098|20498452|P8|COMPLETED|Part A (11 Days)||6
8314306|NCT01463098|20498453|P7|COMPLETED|Part A (11 Days)||6
8314307|NCT01463098|20498454|P6|COMPLETED|Part A (11 Days)||6
8314308|NCT01463098|20498455|P5|COMPLETED|Part A (11 Days)||5
8314309|NCT01463098|20498456|P4|COMPLETED|Part A (11 Days)||6
8314310|NCT01463098|20498457|P3|COMPLETED|Part A (11 Days)||6
8314311|NCT01463098|20498458|P2|COMPLETED|Part A (11 Days)||6
8314312|NCT01463098|20498459|P1|COMPLETED|Part A (11 Days)||14
8314313|NCT01463098|20498446|P14|STARTED|Part A (11 Days)||0
8314314|NCT01463098|20498447|P13|STARTED|Part A (11 Days)||0
8314315|NCT01463098|20498448|P12|STARTED|Part A (11 Days)||0
8314316|NCT01463098|20498449|P11|STARTED|Part A (11 Days)||0
8314317|NCT01463098|20498450|P10|STARTED|Part A (11 Days)||0
8314318|NCT01463098|20498451|P9|STARTED|Part A (11 Days)||6
8314319|NCT01463098|20498452|P8|STARTED|Part A (11 Days)||6
8314320|NCT01463098|20498453|P7|STARTED|Part A (11 Days)||6
8314321|NCT01463098|20498454|P6|STARTED|Part A (11 Days)||6
8314322|NCT01463098|20498455|P5|STARTED|Part A (11 Days)||6
8314323|NCT01463098|20498456|P4|STARTED|Part A (11 Days)||6
8314324|NCT01463098|20498457|P3|STARTED|Part A (11 Days)||6
8314325|NCT01463098|20498458|P2|STARTED|Part A (11 Days)||6
8314326|NCT01463098|20498459|P1|STARTED|Part A (11 Days)||16
8314327|NCT01463033|20498782|P2|NOT COMPLETED|Overall Study||6
8314328|NCT01463033|20498783|P1|NOT COMPLETED|Overall Study||7
8314329|NCT01463033|20498782|P2|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
8314330|NCT01463033|20498783|P1|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
8314331|NCT01463033|20498782|P2|STARTED|Overall Study||60
8314332|NCT01463033|20498783|P1|STARTED|Overall Study||66
8314336|NCT01462942|20498801|P5|NOT COMPLETED|Overall Study||45
8314337|NCT01462942|20498802|P4|NOT COMPLETED|Overall Study||50
8314338|NCT01462942|20498803|P3|NOT COMPLETED|Overall Study||40
8314339|NCT01462942|20498804|P2|NOT COMPLETED|Overall Study||34
8314340|NCT01462942|20498805|P1|NOT COMPLETED|Overall Study||34
8314341|NCT01462942|20498801|P5|COMPLETED|Overall Study||339
8314342|NCT01462942|20498802|P4|COMPLETED|Overall Study||335
8314343|NCT01462942|20498803|P3|COMPLETED|Overall Study||341
8314344|NCT01462942|20498804|P2|COMPLETED|Overall Study||351
8314345|NCT01462942|20498805|P1|COMPLETED|Overall Study||160
8314346|NCT01462942|20498801|P5|STARTED|Overall Study||384
8314347|NCT01462942|20498802|P4|STARTED|Overall Study||385
8314348|NCT01462942|20498803|P3|STARTED|Overall Study||381
8314349|NCT01462942|20498804|P2|STARTED|Overall Study||385
8314350|NCT01462942|20498805|P1|STARTED|Overall Study||194
8314351|NCT01462929|20498835|P3|NOT COMPLETED|Overall Study||5
8314352|NCT01462929|20498836|P2|NOT COMPLETED|Overall Study||4
8314353|NCT01462929|20498837|P1|NOT COMPLETED|Overall Study||5
8314354|NCT01462929|20498835|P3|COMPLETED|Overall Study||80
8314355|NCT01462929|20498836|P2|COMPLETED|Overall Study||154
8314356|NCT01462929|20498837|P1|COMPLETED|Overall Study||166
8314357|NCT01462929|20498835|P3|STARTED|Overall Study||85
8314358|NCT01462929|20498836|P2|STARTED|Overall Study||158
8314359|NCT01462929|20498837|P1|STARTED|Overall Study||171
8314360|NCT01462877|20498848|P1|NOT COMPLETED|Overall Study||71
8314361|NCT01462877|20498848|P1|COMPLETED|Overall Study||435
8314362|NCT01462877|20498848|P1|Per-protocol Set|Overall Study||364
8314363|NCT01462877|20498848|P1|Full Analysis Set|Overall Study||468
8314364|NCT01462877|20498848|P1|Safety Set|Overall Study||492
8314365|NCT01462877|20498848|P1|STARTED|Overall Study||506
8314366|NCT01462812|20498864|P2|NOT COMPLETED|Overall Study||1
8314367|NCT01462812|20498865|P1|NOT COMPLETED|Overall Study||0
8314368|NCT01462812|20498864|P2|COMPLETED|Overall Study||111
8314369|NCT01462812|20498865|P1|COMPLETED|Overall Study||111
8314370|NCT01462812|20498864|P2|STARTED|Overall Study||112
8314371|NCT01462812|20498865|P1|STARTED|Overall Study||111
8314372|NCT01462773|20498871|P1|NOT COMPLETED|Overall Study||0
8314373|NCT01462773|20498871|P1|COMPLETED|Overall Study||16
8314374|NCT01462773|20498871|P1|STARTED|Overall Study||16
8314375|NCT01462695|20498878|P2|NOT COMPLETED|Overall Study||13
8314376|NCT01462695|20498879|P1|NOT COMPLETED|Overall Study||17
8314377|NCT01462695|20498878|P2|COMPLETED|Overall Study||0
8314378|NCT01462695|20498879|P1|COMPLETED|Overall Study||0
8314379|NCT01462695|20498878|P2|STARTED|Overall Study||13
8314380|NCT01462695|20498879|P1|STARTED|Overall Study||17
8314381|NCT01462565|20498885|P1|NOT COMPLETED|Overall Study||0
8314382|NCT01462565|20498885|P1|COMPLETED|Overall Study||16
8314383|NCT01462565|20498885|P1|STARTED|Overall Study||16
8314384|NCT01462435|20498907|P4|NOT COMPLETED|Overall Study||5
8314385|NCT01462435|20498908|P3|NOT COMPLETED|Overall Study||1
8314386|NCT01462435|20498909|P2|NOT COMPLETED|Overall Study||0
8314387|NCT01462435|20498910|P1|NOT COMPLETED|Overall Study||1
8314388|NCT01462435|20498907|P4|COMPLETED|Overall Study||101
8314389|NCT01462435|20498908|P3|COMPLETED|Overall Study||106
8314390|NCT01462435|20498909|P2|COMPLETED|Overall Study||109
8314391|NCT01462435|20498910|P1|COMPLETED|Overall Study||105
8314392|NCT01462435|20498907|P4|STARTED|Overall Study||106
8314393|NCT01462435|20498908|P3|STARTED|Overall Study||107
8314394|NCT01462435|20498909|P2|STARTED|Overall Study||109
8314395|NCT01462435|20498910|P1|STARTED|Overall Study||106
8314396|NCT01462370|20498948|P2|NOT COMPLETED|Overall Study||5
8314397|NCT01462370|20498949|P1|NOT COMPLETED|Overall Study||1
8314398|NCT01462370|20498948|P2|COMPLETED|Overall Study||65
8314399|NCT01462370|20498949|P1|COMPLETED|Overall Study||68
8314400|NCT01462370|20498948|P2|STARTED|Overall Study||70
8314401|NCT01462370|20498949|P1|STARTED|Overall Study||69
8314402|NCT01462357|20498984|P3|NOT COMPLETED|Overall Study||12
8314403|NCT01462357|20498985|P2|NOT COMPLETED|Overall Study||19
8314404|NCT01462357|20498986|P1|NOT COMPLETED|Overall Study||8
8314405|NCT01462357|20498984|P3|COMPLETED|Overall Study||346
8314406|NCT01462357|20498985|P2|COMPLETED|Overall Study||339
8314407|NCT01462357|20498986|P1|COMPLETED|Overall Study||351
8314408|NCT01462357|20498984|P3|STARTED|Overall Study||358
8314409|NCT01462357|20498985|P2|STARTED|Overall Study||358
8314410|NCT01462357|20498986|P1|STARTED|Overall Study||359
8314411|NCT01462344|20499059|P2|NOT COMPLETED|Overall Study||350
8314412|NCT01462344|20499060|P1|NOT COMPLETED|Overall Study||383
8314413|NCT01462344|20499059|P2|COMPLETED|Overall Study||2751
8314414|NCT01462344|20499060|P1|COMPLETED|Overall Study||2724
8314415|NCT01462344|20499059|P2|STARTED|Overall Study||3101
8314416|NCT01462344|20499060|P1|STARTED|Overall Study||3107
8314417|NCT01462318|20499082|P3|NOT COMPLETED|Extension Phase||45
8314418|NCT01462318|20499083|P2|NOT COMPLETED|Extension Phase||0
8314419|NCT01462318|20499084|P1|NOT COMPLETED|Extension Phase||0
8314420|NCT01462318|20499082|P3|COMPLETED|Extension Phase||70
8314421|NCT01462318|20499083|P2|COMPLETED|Extension Phase||0
8314422|NCT01462318|20499084|P1|COMPLETED|Extension Phase||0
8314423|NCT01462318|20499082|P3|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
8314424|NCT01462318|20499083|P2|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
8314425|NCT01462318|20499084|P1|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
8314426|NCT01462318|20499082|P3|NOT COMPLETED|Main Study / TP-DI Study||0
8314427|NCT01462318|20499083|P2|NOT COMPLETED|Main Study / TP-DI Study||0
8314428|NCT01462318|20499084|P1|NOT COMPLETED|Main Study / TP-DI Study||8
8314429|NCT01462318|20499082|P3|COMPLETED|Main Study / TP-DI Study||0
8314430|NCT01462318|20499083|P2|COMPLETED|Main Study / TP-DI Study||20
8314431|NCT01462318|20499084|P1|COMPLETED|Main Study / TP-DI Study||105
8314432|NCT01462318|20499082|P3|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
8314433|NCT01462318|20499083|P2|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
8314434|NCT01462318|20499084|P1|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
8314435|NCT01462318|20499082|P3|STARTED|Main Study / TP-DI Study||0
8314436|NCT01462318|20499083|P2|STARTED|Main Study / TP-DI Study||20
8314437|NCT01462318|20499084|P1|STARTED|Main Study / TP-DI Study||113
8314438|NCT01462305|20499103|P2|NOT COMPLETED|Overall Study||4
8314439|NCT01462305|20499104|P1|NOT COMPLETED|Overall Study||2
8314440|NCT01462305|20499103|P2|COMPLETED|Overall Study||13
8314441|NCT01462305|20499104|P1|COMPLETED|Overall Study||16
8314442|NCT01462305|20499103|P2|STARTED|Overall Study||17
8314443|NCT01462305|20499104|P1|STARTED|Overall Study||18
8314444|NCT01462292|20499117|P3|NOT COMPLETED|Overall Study||0
8314445|NCT01462292|20499118|P2|NOT COMPLETED|Overall Study||0
8314446|NCT01462292|20499119|P1|NOT COMPLETED|Overall Study||0
8314447|NCT01462292|20499117|P3|COMPLETED|Overall Study||18
8314448|NCT01462292|20499118|P2|COMPLETED|Overall Study||17
8314449|NCT01462292|20499119|P1|COMPLETED|Overall Study||16
8314450|NCT01462292|20499117|P3|STARTED|Overall Study||18
8314451|NCT01462292|20499118|P2|STARTED|Overall Study||17
8314452|NCT01462292|20499119|P1|STARTED|Overall Study||16
8314453|NCT01462279|20499178|P1|NOT COMPLETED|Overall Study||3
8314454|NCT01462279|20499178|P1|COMPLETED|Overall Study||17
8314455|NCT01462279|20499178|P1|STARTED|Overall Study||20
8314456|NCT01462266|20499185|P2|NOT COMPLETED|Overall Study||27
8314457|NCT01462266|20499186|P1|NOT COMPLETED|Overall Study||35
8314458|NCT01462266|20499185|P2|COMPLETED|Overall Study||303
8314459|NCT01462266|20499186|P1|COMPLETED|Overall Study||295
8314460|NCT01462266|20499185|P2|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
8314461|NCT01462266|20499186|P1|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
8314462|NCT01462266|20499185|P2|STARTED|Overall Study||330
8314463|NCT01462266|20499186|P1|STARTED|Overall Study||330
8314464|NCT01462253|20499200|P1|NOT COMPLETED|Overall Study||8
8314465|NCT01462253|20499200|P1|COMPLETED|Overall Study||27
8314466|NCT01462253|20499200|P1|STARTED|Overall Study||35
8314467|NCT01462227|20499211|P4|NOT COMPLETED|Second Assignment||0
8314468|NCT01462227|20499212|P3|NOT COMPLETED|Second Assignment||1
8314469|NCT01462227|20499213|P2|NOT COMPLETED|Second Assignment||1
8314470|NCT01462227|20499214|P1|NOT COMPLETED|Second Assignment||1
8314471|NCT01462227|20499211|P4|COMPLETED|Second Assignment||5
8314472|NCT01462227|20499212|P3|COMPLETED|Second Assignment||5
8314473|NCT01462227|20499213|P2|COMPLETED|Second Assignment||1
8314474|NCT01462227|20499214|P1|COMPLETED|Second Assignment||3
8314475|NCT01462227|20499211|P4|STARTED|Second Assignment||5
8314476|NCT01462227|20499212|P3|STARTED|Second Assignment||6
8314477|NCT01462227|20499213|P2|STARTED|Second Assignment||2
8314478|NCT01462227|20499214|P1|STARTED|Second Assignment||4
8314479|NCT01462227|20499211|P4|NOT COMPLETED|First Assignment||0
8314480|NCT01462227|20499212|P3|NOT COMPLETED|First Assignment||0
8314481|NCT01462227|20499213|P2|NOT COMPLETED|First Assignment||0
8314482|NCT01462227|20499214|P1|NOT COMPLETED|First Assignment||0
8314483|NCT01462227|20499211|P4|COMPLETED|First Assignment||5
8314484|NCT01462227|20499212|P3|COMPLETED|First Assignment||6
8314485|NCT01462227|20499213|P2|COMPLETED|First Assignment||2
8314486|NCT01462227|20499214|P1|COMPLETED|First Assignment||4
8314487|NCT01462227|20499211|P4|STARTED|First Assignment||5
8314488|NCT01462227|20499212|P3|STARTED|First Assignment||6
8314489|NCT01462227|20499213|P2|STARTED|First Assignment||2
8314490|NCT01462227|20499214|P1|STARTED|First Assignment||4
8314491|NCT01462162|20499232|P1|NOT COMPLETED|Overall Study||12
8314492|NCT01462162|20499232|P1|COMPLETED|Overall Study||108
8314493|NCT01462162|20499232|P1|STARTED|Overall Study||120
8314494|NCT01462110|20499259|P2|NOT COMPLETED|Overall Study||0
8314495|NCT01462110|20499260|P1|NOT COMPLETED|Overall Study||1
8314496|NCT01462110|20499259|P2|COMPLETED|Overall Study||43
8314497|NCT01462110|20499260|P1|COMPLETED|Overall Study||43
8314498|NCT01462110|20499259|P2|STARTED|Overall Study||43
8314499|NCT01462110|20499260|P1|STARTED|Overall Study||44
8314500|NCT01462084|20499280|P2|NOT COMPLETED|Overall Study||1
8314501|NCT01462084|20499281|P1|NOT COMPLETED|Overall Study||2
8314502|NCT01462084|20499280|P2|COMPLETED|Overall Study||9
8314503|NCT01462084|20499281|P1|COMPLETED|Overall Study||9
8314504|NCT01462084|20499280|P2|Included for Analysis|Overall Study||9
8314505|NCT01462084|20499281|P1|Included for Analysis|Overall Study||9
8314506|NCT01462084|20499280|P2|STARTED|Overall Study||10
8314507|NCT01462084|20499281|P1|STARTED|Overall Study||11
8314508|NCT01462045|20499292|P3|NOT COMPLETED|Overall Study||0
8314509|NCT01462045|20499293|P2|NOT COMPLETED|Overall Study||1
8314510|NCT01462045|20499294|P1|NOT COMPLETED|Overall Study||0
8314511|NCT01462045|20499292|P3|COMPLETED|Overall Study||7
8314512|NCT01462045|20499293|P2|COMPLETED|Overall Study||10
8314513|NCT01462045|20499294|P1|COMPLETED|Overall Study||11
8314514|NCT01462045|20499292|P3|STARTED|Overall Study||7
8314515|NCT01462045|20499293|P2|STARTED|Overall Study||11
8314516|NCT01462045|20499294|P1|STARTED|Overall Study||11
8314517|NCT01461993|20499308|P3|NOT COMPLETED|Overall Study||64
8314518|NCT01461993|20499309|P2|NOT COMPLETED|Overall Study||157
8314519|NCT01461993|20499310|P1|NOT COMPLETED|Overall Study||151
8314520|NCT01461993|20499308|P3|COMPLETED|Overall Study||438
8314521|NCT01461993|20499309|P2|COMPLETED|Overall Study||841
8314522|NCT01461993|20499310|P1|COMPLETED|Overall Study||848
8314523|NCT01461993|20499308|P3|STARTED|Overall Study||502
8314524|NCT01461993|20499309|P2|STARTED|Overall Study||998
8314525|NCT01461993|20499310|P1|STARTED|Overall Study||999
8314526|NCT01461980|20499335|P3|NOT COMPLETED|Overall Study||165
8314527|NCT01461980|20499336|P2|NOT COMPLETED|Overall Study||145
8314528|NCT01461980|20499337|P1|NOT COMPLETED|Overall Study||166
8314529|NCT01461980|20499335|P3|COMPLETED|Overall Study||717
8314530|NCT01461980|20499336|P2|COMPLETED|Overall Study||733
8314531|NCT01461980|20499337|P1|COMPLETED|Overall Study||722
8314532|NCT01461980|20499335|P3|Vaccination 3|Overall Study||748
8314533|NCT01461980|20499336|P2|Vaccination 3|Overall Study||777
8314534|NCT01461980|20499337|P1|Vaccination 3|Overall Study||757
8314535|NCT01461980|20499335|P3|Vaccination 2|Overall Study||799
8314536|NCT01461980|20499336|P2|Vaccination 2|Overall Study||819
8314537|NCT01461980|20499337|P1|Vaccination 2|Overall Study||802
8314538|NCT01461980|20499335|P3|Vaccination 1|Overall Study||875
8314539|NCT01461980|20499336|P2|Vaccination 1|Overall Study||870
8314540|NCT01461980|20499337|P1|Vaccination 1|Overall Study||884
8314541|NCT01461980|20499335|P3|STARTED|Overall Study||882
8314542|NCT01461980|20499336|P2|STARTED|Overall Study||878
8314543|NCT01461980|20499337|P1|STARTED|Overall Study||888
8314544|NCT01461928|20499367|P3|NOT COMPLETED|Maintenance II (15 Months)||27
8314545|NCT01461928|20499368|P2|NOT COMPLETED|Maintenance II (15 Months)||23
8314546|NCT01461928|20499369|P1|NOT COMPLETED|Maintenance II (15 Months)||0
8314547|NCT01461928|20499367|P3|COMPLETED|Maintenance II (15 Months)||111
8314548|NCT01461928|20499368|P2|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115
8314549|NCT01461928|20499369|P1|COMPLETED|Maintenance II (15 Months)||0
8314550|NCT01461928|20499367|P3|STARTED|Maintenance II (15 Months)||138
8314551|NCT01461928|20499368|P2|STARTED|Maintenance II (15 Months)||138
8314552|NCT01461928|20499369|P1|STARTED|Maintenance II (15 Months)||0
8314553|NCT01461928|20499367|P3|NOT COMPLETED|Maintenance I (24 Months)||0
8314554|NCT01461928|20499368|P2|NOT COMPLETED|Maintenance I (24 Months)||0
8314555|NCT01461928|20499369|P1|NOT COMPLETED|Maintenance I (24 Months)||218
8314556|NCT01461928|20499367|P3|COMPLETED|Maintenance I (24 Months)||0
8314557|NCT01461928|20499368|P2|COMPLETED|Maintenance I (24 Months)||0
8314558|NCT01461928|20499369|P1|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276
8314559|NCT01461928|20499367|P3|STARTED|Maintenance I (24 Months)||0
8314560|NCT01461928|20499368|P2|STARTED|Maintenance I (24 Months)||0
8314561|NCT01461928|20499369|P1|STARTED|Maintenance I (24 Months)||494
8314562|NCT01461928|20499367|P3|NOT COMPLETED|Induction (up to 8 Months)||0
8314563|NCT01461928|20499368|P2|NOT COMPLETED|Induction (up to 8 Months)||0
8314564|NCT01461928|20499369|P1|NOT COMPLETED|Induction (up to 8 Months)||198
8314565|NCT01461928|20499367|P3|COMPLETED|Induction (up to 8 Months)||0
8314566|NCT01461928|20499368|P2|COMPLETED|Induction (up to 8 Months)||0
8314567|NCT01461928|20499369|P1|COMPLETED|Induction (up to 8 Months)||494
8314568|NCT01461928|20499367|P3|STARTED|Induction (up to 8 Months)||0
8314569|NCT01461928|20499368|P2|STARTED|Induction (up to 8 Months)||0
8314570|NCT01461928|20499369|P1|STARTED|Induction (up to 8 Months)||692
8314571|NCT01461863|20499390|P2|NOT COMPLETED|Overall Study||0
8314572|NCT01461863|20499391|P1|NOT COMPLETED|Overall Study||0
8314573|NCT01461863|20499390|P2|COMPLETED|Overall Study||48
8314574|NCT01461863|20499391|P1|COMPLETED|Overall Study||48
8314575|NCT01461863|20499390|P2|STARTED|Overall Study||48
8314576|NCT01461863|20499391|P1|STARTED|Overall Study||48
8314577|NCT01461824|20499402|P3|NOT COMPLETED|Overall Study||3
8314578|NCT01461824|20499403|P2|NOT COMPLETED|Overall Study||4
8314579|NCT01461824|20499404|P1|NOT COMPLETED|Overall Study||2
8314580|NCT01461824|20499402|P3|COMPLETED|Overall Study||8
8314581|NCT01461824|20499403|P2|COMPLETED|Overall Study||7
8314582|NCT01461824|20499404|P1|COMPLETED|Overall Study||10
8314583|NCT01461824|20499402|P3|STARTED|Overall Study||11
8314584|NCT01461824|20499403|P2|STARTED|Overall Study||11
8314585|NCT01461824|20499404|P1|STARTED|Overall Study||12
8314586|NCT01461811|20499420|P2|NOT COMPLETED|Overall Study||3
8314587|NCT01461811|20499421|P1|NOT COMPLETED|Overall Study||4
8314588|NCT01461811|20499420|P2|COMPLETED|Overall Study||46
8314589|NCT01461811|20499421|P1|COMPLETED|Overall Study||91
8314590|NCT01461811|20499420|P2|STARTED|Overall Study||49
8314591|NCT01461811|20499421|P1|STARTED|Overall Study||95
8314592|NCT01461733|20499451|P2|NOT COMPLETED|Overall Study||4
8314593|NCT01461733|20499452|P1|NOT COMPLETED|Overall Study||4
8314594|NCT01461733|20499451|P2|COMPLETED|Overall Study||8
8314595|NCT01461733|20499452|P1|COMPLETED|Overall Study||8
8314596|NCT01461733|20499451|P2|STARTED|Overall Study||12
8314597|NCT01461733|20499452|P1|STARTED|Overall Study||12
8314598|NCT01461707|20499460|P2|NOT COMPLETED|Overall Study||0
8314599|NCT01461707|20499461|P1|NOT COMPLETED|Overall Study||1
8314600|NCT01461707|20499460|P2|COMPLETED|Overall Study||15
8314601|NCT01461707|20499461|P1|COMPLETED|Overall Study||14
8314602|NCT01461707|20499460|P2|STARTED|Overall Study||15
8314603|NCT01461707|20499461|P1|STARTED|Overall Study||15
8314604|NCT01461668|20499471|P2|NOT COMPLETED|Overall Study||1
8314605|NCT01461668|20499472|P1|NOT COMPLETED|Overall Study||2
8314606|NCT01461668|20499471|P2|COMPLETED|Overall Study||25
8314607|NCT01461668|20499472|P1|COMPLETED|Overall Study||25
8314608|NCT01461668|20499471|P2|STARTED|Overall Study||26
8314609|NCT01461668|20499472|P1|STARTED|Overall Study||27
8314610|NCT01461655|20499478|P1|NOT COMPLETED|Overall Study||0
8314611|NCT01461655|20499478|P1|COMPLETED|Overall Study||40
8314612|NCT01461655|20499478|P1|STARTED|Overall Study||40
8314613|NCT01461551|20499498|P3|NOT COMPLETED|Overall Study||2
8314614|NCT01461551|20499499|P2|NOT COMPLETED|Overall Study||1
8314615|NCT01461551|20499500|P1|NOT COMPLETED|Overall Study||2
8314616|NCT01461551|20499498|P3|COMPLETED|Overall Study||33
8314617|NCT01461551|20499499|P2|COMPLETED|Overall Study||34
8314618|NCT01461551|20499500|P1|COMPLETED|Overall Study||33
8314619|NCT01461551|20499498|P3|STARTED|Overall Study||35
8314620|NCT01461551|20499499|P2|STARTED|Overall Study||35
8314621|NCT01461551|20499500|P1|STARTED|Overall Study||35
8314622|NCT01461538|20499511|P3|NOT COMPLETED|Overall Study||2
8314623|NCT01461538|20499512|P2|NOT COMPLETED|Overall Study||8
8314624|NCT01461538|20499513|P1|NOT COMPLETED|Overall Study||18
8314625|NCT01461538|20499511|P3|COMPLETED|Overall Study||7
8314626|NCT01461538|20499512|P2|COMPLETED|Overall Study||20
8314627|NCT01461538|20499513|P1|COMPLETED|Overall Study||28
8314628|NCT01461538|20499511|P3|STARTED|Overall Study||9
8314629|NCT01461538|20499512|P2|STARTED|Overall Study||28
8314630|NCT01461538|20499513|P1|STARTED|Overall Study||46
8314631|NCT01461499|20499551|P2|NOT COMPLETED|Overall Study||4
8314632|NCT01461499|20499552|P1|NOT COMPLETED|Overall Study||8
8314633|NCT01461499|20499551|P2|COMPLETED|Overall Study||114
8314634|NCT01461499|20499552|P1|COMPLETED|Overall Study||111
8314635|NCT01461499|20499551|P2|STARTED|Overall Study||118
8314636|NCT01461499|20499552|P1|STARTED|Overall Study||119
8314637|NCT01461473|20499562|P2|NOT COMPLETED|Overall Study||4
8314638|NCT01461473|20499563|P1|NOT COMPLETED|Overall Study||5
8314639|NCT01461473|20499562|P2|COMPLETED|Overall Study||55
8314640|NCT01461473|20499563|P1|COMPLETED|Overall Study||67
8314641|NCT01461473|20499562|P2|STARTED|Overall Study||59
8314642|NCT01461473|20499563|P1|STARTED|Overall Study||72
8314643|NCT01461369|20499582|P3|NOT COMPLETED|Overall Study||17
8314644|NCT01461369|20499583|P2|NOT COMPLETED|Overall Study||17
8314645|NCT01461369|20499584|P1|NOT COMPLETED|Overall Study||13
8314646|NCT01461369|20499582|P3|COMPLETED|Overall Study||86
8314647|NCT01461369|20499583|P2|COMPLETED|Overall Study||81
8314648|NCT01461369|20499584|P1|COMPLETED|Overall Study||91
8314649|NCT01461369|20499582|P3|STARTED|Overall Study||103
8314650|NCT01461369|20499583|P2|STARTED|Overall Study||98
8314651|NCT01461369|20499584|P1|STARTED|Overall Study||104
8314652|NCT01461096|20499609|P2|NOT COMPLETED|Overall Study||61
8314653|NCT01461096|20499610|P1|NOT COMPLETED|Overall Study||62
8314654|NCT01461096|20499609|P2|COMPLETED|Overall Study||226
8314655|NCT01461096|20499610|P1|COMPLETED|Overall Study||226
8314656|NCT01461096|20499609|P2|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
8314657|NCT01461096|20499610|P1|Did Not Start Treatment|Overall Study||0
8314658|NCT01461096|20499609|P2|STARTED|Overall Study||287
8314659|NCT01461096|20499610|P1|STARTED|Overall Study||288
8314660|NCT01461057|20499626|P2|NOT COMPLETED|Overall Study||15
8314661|NCT01461057|20499627|P1|NOT COMPLETED|Overall Study||15
8314662|NCT01461057|20499626|P2|COMPLETED|Overall Study||0
8314663|NCT01461057|20499627|P1|COMPLETED|Overall Study||0
8314664|NCT01461057|20499626|P2|STARTED|Overall Study||15
8314665|NCT01461057|20499627|P1|STARTED|Overall Study||15
8314666|NCT01461044|20499637|P2|NOT COMPLETED|Overall Study||40
8314667|NCT01461044|20499638|P1|NOT COMPLETED|Overall Study||70
8314668|NCT01461044|20499637|P2|COMPLETED|Overall Study||37
8314669|NCT01461044|20499638|P1|COMPLETED|Overall Study||80
8314670|NCT01461044|20499637|P2|Participants Alive at Inclusion|Overall Study||58
8314671|NCT01461044|20499638|P1|Participants Alive at Inclusion|Overall Study||127
8314672|NCT01461044|20499637|P2|STARTED|Overall Study||77
8314673|NCT01461044|20499638|P1|STARTED|Overall Study||150
8314674|NCT01461005|20499711|P1|NOT COMPLETED|Overall Study||1
8314675|NCT01461005|20499711|P1|COMPLETED|Overall Study||0
8314676|NCT01461005|20499711|P1|STARTED|Overall Study||1
8314677|NCT01460940|20499720|P1|NOT COMPLETED|Overall Study||0
8314678|NCT01460940|20499720|P1|COMPLETED|Overall Study||24
8314679|NCT01460940|20499720|P1|STARTED|Overall Study||24
8314680|NCT01460927|20499726|P1|NOT COMPLETED|Overall Study||0
8314681|NCT01460927|20499726|P1|COMPLETED|Overall Study||25
8314682|NCT01460927|20499726|P1|STARTED|Overall Study||25
8314683|NCT01460901|20499734|P1|NOT COMPLETED|Overall Study||2
8314684|NCT01460901|20499734|P1|COMPLETED|Overall Study|Follow-up completed|3
8314685|NCT01460901|20499734|P1|tV-CTL Infusion|Overall Study||3
8314686|NCT01460901|20499734|P1|STARTED|Overall Study|First enrollment|5
8314687|NCT01460875|20499742|P1|NOT COMPLETED|Overall Study||0
8314688|NCT01460875|20499742|P1|COMPLETED|Overall Study||34
8314689|NCT01460875|20499742|P1|STARTED|Overall Study||34
8314690|NCT01460732|20499753|P1|NOT COMPLETED|Overall Study||0
8314691|NCT01460732|20499753|P1|COMPLETED|Overall Study||81
8314692|NCT01460732|20499753|P1|STARTED|Overall Study||81
8314693|NCT01460719|20499766|P1|NOT COMPLETED|Overall Study||2
8314694|NCT01460719|20499766|P1|COMPLETED|Overall Study||78
8314695|NCT01460719|20499766|P1|Vaccination 4 (~Day 90)|Overall Study||78
8314696|NCT01460719|20499766|P1|Vaccination 3 (~Day 60)|Overall Study||78
8314697|NCT01460719|20499766|P1|Vaccination 2 (~Day 30)|Overall Study||78
8314698|NCT01460719|20499766|P1|Vaccination 1 (Day 1)|Overall Study||80
8314699|NCT01460719|20499766|P1|STARTED|Overall Study||80
8314700|NCT01460628|20499776|P1|NOT COMPLETED|Overall Study||5
8314701|NCT01460628|20499776|P1|COMPLETED|Overall Study||20
8314702|NCT01460628|20499776|P1|STARTED|Overall Study||25
8314703|NCT01460446|20499788|P2|NOT COMPLETED|Overall Study||20
8314704|NCT01460446|20499789|P1|NOT COMPLETED|Overall Study||5
8314705|NCT01460446|20499788|P2|COMPLETED|Overall Study||93
8314706|NCT01460446|20499789|P1|COMPLETED|Overall Study||100
8314707|NCT01460446|20499788|P2|STARTED|Overall Study||113
8314708|NCT01460446|20499789|P1|STARTED|Overall Study||105
8314709|NCT01460407|20499816|P2|NOT COMPLETED|Period 2: Day 6 to Day 14||1
8314710|NCT01460407|20499817|P1|NOT COMPLETED|Period 2: Day 6 to Day 14||0
8314711|NCT01460407|20499816|P2|COMPLETED|Period 2: Day 6 to Day 14||13
8314712|NCT01460407|20499817|P1|COMPLETED|Period 2: Day 6 to Day 14||0
8314713|NCT01460407|20499816|P2|STARTED|Period 2: Day 6 to Day 14||14
8314714|NCT01460407|20499817|P1|STARTED|Period 2: Day 6 to Day 14||0
8314715|NCT01460407|20499816|P2|NOT COMPLETED|Period 1: Day 1 to Day 5||0
8314716|NCT01460407|20499817|P1|NOT COMPLETED|Period 1: Day 1 to Day 5||0
8314717|NCT01460407|20499816|P2|COMPLETED|Period 1: Day 1 to Day 5||0
8314718|NCT01460407|20499817|P1|COMPLETED|Period 1: Day 1 to Day 5||14
8314719|NCT01460407|20499816|P2|STARTED|Period 1: Day 1 to Day 5||0
8314720|NCT01460407|20499817|P1|STARTED|Period 1: Day 1 to Day 5||14
8314721|NCT01460381|20499830|P2|NOT COMPLETED|Period 2 (Days 8-15)||0
8314722|NCT01460381|20499831|P1|NOT COMPLETED|Period 2 (Days 8-15)||1
8314723|NCT01460381|20499830|P2|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
8314724|NCT01460381|20499831|P1|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
8314725|NCT01460381|20499830|P2|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
8314726|NCT01460381|20499831|P1|STARTED|Period 2 (Days 8-15)||7
8314727|NCT01460381|20499830|P2|NOT COMPLETED|Period 1 (Days 1-7)||0
8314728|NCT01460381|20499831|P1|NOT COMPLETED|Period 1 (Days 1-7)||0
8314729|NCT01460381|20499830|P2|COMPLETED|Period 1 (Days 1-7)||11
8314730|NCT01460381|20499831|P1|COMPLETED|Period 1 (Days 1-7)||7
8314731|NCT01460381|20499830|P2|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
8314732|NCT01460381|20499831|P1|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
8314733|NCT01460381|20499830|P2|STARTED|Period 1 (Days 1-7)||11
8314734|NCT01460381|20499831|P1|STARTED|Period 1 (Days 1-7)||7
8314735|NCT01460368|20499847|P7|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
8314736|NCT01460368|20499848|P6|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
8314737|NCT01460368|20499849|P5|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
8314738|NCT01460368|20499850|P4|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
8314739|NCT01460368|20499851|P3|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
8314740|NCT01460368|20499852|P2|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
8314741|NCT01460368|20499853|P1|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
8314742|NCT01460368|20499847|P7|COMPLETED|Part B: Third Interventions (Period 3)||9
8314743|NCT01460368|20499848|P6|COMPLETED|Part B: Third Interventions (Period 3)||9
8314744|NCT01460368|20499849|P5|COMPLETED|Part B: Third Interventions (Period 3)||9
8314745|NCT01460368|20499850|P4|COMPLETED|Part B: Third Interventions (Period 3)||9
8314746|NCT01460368|20499851|P3|COMPLETED|Part B: Third Interventions (Period 3)||8
8314747|NCT01460368|20499852|P2|COMPLETED|Part B: Third Interventions (Period 3)||8
8314748|NCT01460368|20499853|P1|COMPLETED|Part B: Third Interventions (Period 3)||0
8314749|NCT01460368|20499847|P7|STARTED|Part B: Third Interventions (Period 3)||9
8314750|NCT01460368|20499848|P6|STARTED|Part B: Third Interventions (Period 3)||10
8314751|NCT01460368|20499849|P5|STARTED|Part B: Third Interventions (Period 3)||9
8314752|NCT01460368|20499850|P4|STARTED|Part B: Third Interventions (Period 3)||10
8314753|NCT01460368|20499851|P3|STARTED|Part B: Third Interventions (Period 3)||9
8314754|NCT01460368|20499852|P2|STARTED|Part B: Third Interventions (Period 3)||8
8314755|NCT01460368|20499853|P1|STARTED|Part B: Third Interventions (Period 3)||0
8314756|NCT01460368|20499847|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314757|NCT01460368|20499848|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314758|NCT01460368|20499849|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314759|NCT01460368|20499850|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314760|NCT01460368|20499851|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
8314761|NCT01460368|20499852|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314762|NCT01460368|20499853|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314763|NCT01460368|20499847|P7|COMPLETED|Part B: Washout (up to 15 Days)||9
8314764|NCT01460368|20499848|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
8314765|NCT01460368|20499849|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
8314766|NCT01460368|20499850|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
8314767|NCT01460368|20499851|P3|COMPLETED|Part B: Washout (up to 15 Days)||9
8314768|NCT01460368|20499852|P2|COMPLETED|Part B: Washout (up to 15 Days)||8
8314769|NCT01460368|20499853|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
8314770|NCT01460368|20499847|P7|STARTED|Part B: Washout (up to 15 Days)||9
8314771|NCT01460368|20499848|P6|STARTED|Part B: Washout (up to 15 Days)||10
8314772|NCT01460368|20499849|P5|STARTED|Part B: Washout (up to 15 Days)||9
8314773|NCT01460368|20499850|P4|STARTED|Part B: Washout (up to 15 Days)||10
8314774|NCT01460368|20499851|P3|STARTED|Part B: Washout (up to 15 Days)||10
8314775|NCT01460368|20499852|P2|STARTED|Part B: Washout (up to 15 Days)||8
8314776|NCT01460368|20499853|P1|STARTED|Part B: Washout (up to 15 Days)||0
8314777|NCT01460368|20499847|P7|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
8314778|NCT01460368|20499848|P6|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8314779|NCT01460368|20499849|P5|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8314780|NCT01460368|20499850|P4|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8314781|NCT01460368|20499851|P3|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8314782|NCT01460368|20499852|P2|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
8314783|NCT01460368|20499853|P1|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
8314784|NCT01460368|20499847|P7|COMPLETED|Part B: Second Intervention (Period 2)||9
8314785|NCT01460368|20499848|P6|COMPLETED|Part B: Second Intervention (Period 2)||10
8314786|NCT01460368|20499849|P5|COMPLETED|Part B: Second Intervention (Period 2)||9
8314787|NCT01460368|20499850|P4|COMPLETED|Part B: Second Intervention (Period 2)||10
8314788|NCT01460368|20499851|P3|COMPLETED|Part B: Second Intervention (Period 2)||10
8314789|NCT01460368|20499852|P2|COMPLETED|Part B: Second Intervention (Period 2)||8
8314790|NCT01460368|20499853|P1|COMPLETED|Part B: Second Intervention (Period 2)||0
8314791|NCT01460368|20499847|P7|STARTED|Part B: Second Intervention (Period 2)||10
8314792|NCT01460368|20499848|P6|STARTED|Part B: Second Intervention (Period 2)||10
8314793|NCT01460368|20499849|P5|STARTED|Part B: Second Intervention (Period 2)||9
8314794|NCT01460368|20499850|P4|STARTED|Part B: Second Intervention (Period 2)||10
8314795|NCT01460368|20499851|P3|STARTED|Part B: Second Intervention (Period 2)||10
8314796|NCT01460368|20499852|P2|STARTED|Part B: Second Intervention (Period 2)||10
8314797|NCT01460368|20499853|P1|STARTED|Part B: Second Intervention (Period 2)||0
8314798|NCT01460368|20499847|P7|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314799|NCT01460368|20499848|P6|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314800|NCT01460368|20499849|P5|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314801|NCT01460368|20499850|P4|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314802|NCT01460368|20499851|P3|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314803|NCT01460368|20499852|P2|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314804|NCT01460368|20499853|P1|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
8314805|NCT01460368|20499847|P7|COMPLETED|Part B: Washout (up to 15 Days)||10
8314806|NCT01460368|20499848|P6|COMPLETED|Part B: Washout (up to 15 Days)||10
8314807|NCT01460368|20499849|P5|COMPLETED|Part B: Washout (up to 15 Days)||9
8314808|NCT01460368|20499850|P4|COMPLETED|Part B: Washout (up to 15 Days)||10
8314809|NCT01460368|20499851|P3|COMPLETED|Part B: Washout (up to 15 Days)||10
8314810|NCT01460368|20499852|P2|COMPLETED|Part B: Washout (up to 15 Days)||10
8314811|NCT01460368|20499853|P1|COMPLETED|Part B: Washout (up to 15 Days)||0
8314812|NCT01460368|20499847|P7|STARTED|Part B: Washout (up to 15 Days)||10
8314813|NCT01460368|20499848|P6|STARTED|Part B: Washout (up to 15 Days)||10
8314814|NCT01460368|20499849|P5|STARTED|Part B: Washout (up to 15 Days)||9
8314815|NCT01460368|20499850|P4|STARTED|Part B: Washout (up to 15 Days)||10
8314816|NCT01460368|20499851|P3|STARTED|Part B: Washout (up to 15 Days)||10
8314817|NCT01460368|20499852|P2|STARTED|Part B: Washout (up to 15 Days)||10
8314818|NCT01460368|20499853|P1|STARTED|Part B: Washout (up to 15 Days)||0
8314819|NCT01460368|20499847|P7|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8314820|NCT01460368|20499848|P6|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8314821|NCT01460368|20499849|P5|NOT COMPLETED|Part B: First Intervention (Period 1)||1
8314822|NCT01460368|20499850|P4|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8314823|NCT01460368|20499851|P3|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8314824|NCT01460368|20499852|P2|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8314825|NCT01460368|20499853|P1|NOT COMPLETED|Part B: First Intervention (Period 1)||0
8314826|NCT01460368|20499847|P7|COMPLETED|Part B: First Intervention (Period 1)||10
8314827|NCT01460368|20499848|P6|COMPLETED|Part B: First Intervention (Period 1)||10
8314828|NCT01460368|20499849|P5|COMPLETED|Part B: First Intervention (Period 1)||9
8314829|NCT01460368|20499850|P4|COMPLETED|Part B: First Intervention (Period 1)||10
8314830|NCT01460368|20499851|P3|COMPLETED|Part B: First Intervention (Period 1)||10
8314831|NCT01460368|20499852|P2|COMPLETED|Part B: First Intervention (Period 1)||10
8314832|NCT01460368|20499853|P1|COMPLETED|Part B: First Intervention (Period 1)||0
8314833|NCT01460368|20499847|P7|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8314834|NCT01460368|20499848|P6|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8314835|NCT01460368|20499849|P5|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8314836|NCT01460368|20499850|P4|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8314837|NCT01460368|20499851|P3|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8314838|NCT01460368|20499852|P2|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
8314839|NCT01460368|20499853|P1|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
8314840|NCT01460368|20499847|P7|STARTED|Part B: First Intervention (Period 1)||10
8314841|NCT01460368|20499848|P6|STARTED|Part B: First Intervention (Period 1)||10
8314842|NCT01460368|20499849|P5|STARTED|Part B: First Intervention (Period 1)||10
8314843|NCT01460368|20499850|P4|STARTED|Part B: First Intervention (Period 1)||10
8314844|NCT01460368|20499851|P3|STARTED|Part B: First Intervention (Period 1)||10
8314845|NCT01460368|20499852|P2|STARTED|Part B: First Intervention (Period 1)||10
8314846|NCT01460368|20499853|P1|STARTED|Part B: First Intervention (Period 1)||0
8314847|NCT01460368|20499847|P7|NOT COMPLETED|Part A||0
8314848|NCT01460368|20499848|P6|NOT COMPLETED|Part A||0
8314849|NCT01460368|20499849|P5|NOT COMPLETED|Part A||0
8314850|NCT01460368|20499850|P4|NOT COMPLETED|Part A||0
8314851|NCT01460368|20499851|P3|NOT COMPLETED|Part A||0
8314852|NCT01460368|20499852|P2|NOT COMPLETED|Part A||0
8314853|NCT01460368|20499853|P1|NOT COMPLETED|Part A||0
8314854|NCT01460368|20499847|P7|COMPLETED|Part A||0
8314855|NCT01460368|20499848|P6|COMPLETED|Part A||0
8314856|NCT01460368|20499849|P5|COMPLETED|Part A||0
8314857|NCT01460368|20499850|P4|COMPLETED|Part A||0
8314858|NCT01460368|20499851|P3|COMPLETED|Part A||0
8314859|NCT01460368|20499852|P2|COMPLETED|Part A||0
8314860|NCT01460368|20499853|P1|COMPLETED|Part A||7
8314861|NCT01460368|20499847|P7|Received at Least One Dose of Study Drug|Part A||0
8314862|NCT01460368|20499848|P6|Received at Least One Dose of Study Drug|Part A||0
8314863|NCT01460368|20499849|P5|Received at Least One Dose of Study Drug|Part A||0
8314864|NCT01460368|20499850|P4|Received at Least One Dose of Study Drug|Part A||0
8314865|NCT01460368|20499851|P3|Received at Least One Dose of Study Drug|Part A||0
8314866|NCT01460368|20499852|P2|Received at Least One Dose of Study Drug|Part A||0
8314867|NCT01460368|20499853|P1|Received at Least One Dose of Study Drug|Part A||7
8314868|NCT01460368|20499847|P7|STARTED|Part A||0
8314869|NCT01460368|20499848|P6|STARTED|Part A||0
8314870|NCT01460368|20499849|P5|STARTED|Part A||0
8314871|NCT01460368|20499850|P4|STARTED|Part A||0
8314872|NCT01460368|20499851|P3|STARTED|Part A||0
8314873|NCT01460368|20499852|P2|STARTED|Part A||0
8314874|NCT01460368|20499853|P1|STARTED|Part A||7
8314875|NCT01460342|20499865|P2|NOT COMPLETED|Overall Study||14
8314876|NCT01460342|20499866|P1|NOT COMPLETED|Overall Study||11
8314877|NCT01460342|20499865|P2|COMPLETED|Overall Study||292
8314878|NCT01460342|20499866|P1|COMPLETED|Overall Study||293
8314879|NCT01460342|20499865|P2|Received at Least 1 Dose of Study Drug|Overall Study||306
8314880|NCT01460342|20499866|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
8314881|NCT01460342|20499865|P2|STARTED|Overall Study||306
8314882|NCT01460342|20499866|P1|STARTED|Overall Study||304
8314883|NCT01460303|20499888|P2|NOT COMPLETED|Overall Study||0
8314884|NCT01460303|20499889|P1|NOT COMPLETED|Overall Study||0
8314885|NCT01460303|20499888|P2|COMPLETED|Overall Study||24
8314886|NCT01460303|20499889|P1|COMPLETED|Overall Study||25
8314887|NCT01460303|20499888|P2|STARTED|Overall Study||24
8314888|NCT01460303|20499889|P1|STARTED|Overall Study||25
8314889|NCT01460290|20499897|P1|NOT COMPLETED|Overall Study||4
8314890|NCT01460290|20499897|P1|COMPLETED|Overall Study||11
8314891|NCT01460290|20499897|P1|STARTED|Overall Study||15
8314892|NCT01460225|20499917|P1|NOT COMPLETED|Overall Study||0
8314893|NCT01460225|20499917|P1|COMPLETED|Overall Study|November 2010|19
8314894|NCT01460225|20499917|P1|STARTED|Overall Study|January 2009.|19
8314895|NCT01460160|20499924|P2|NOT COMPLETED|Follow-up||2
8314896|NCT01460160|20499925|P1|NOT COMPLETED|Follow-up||11
8314897|NCT01460160|20499924|P2|COMPLETED|Follow-up||20
8314898|NCT01460160|20499925|P1|COMPLETED|Follow-up||67
8314899|NCT01460160|20499924|P2|STARTED|Follow-up||22
8314900|NCT01460160|20499925|P1|STARTED|Follow-up||78
8314901|NCT01460160|20499924|P2|NOT COMPLETED|Treatment||5
8314902|NCT01460160|20499925|P1|NOT COMPLETED|Treatment||23
8314903|NCT01460160|20499924|P2|COMPLETED|Treatment||19
8314904|NCT01460160|20499925|P1|COMPLETED|Treatment||59
8314905|NCT01460160|20499924|P2|STARTED|Treatment||24
8314906|NCT01460160|20499925|P1|STARTED|Treatment||82
8314907|NCT01459913|20499966|P4|NOT COMPLETED|Overall Study||33
8314908|NCT01459913|20499967|P3|NOT COMPLETED|Overall Study||13
8314909|NCT01459913|20499968|P2|NOT COMPLETED|Overall Study||20
8314910|NCT01459913|20499969|P1|NOT COMPLETED|Overall Study||41
8314911|NCT01459913|20499966|P4|COMPLETED|Overall Study||29
8314912|NCT01459913|20499967|P3|COMPLETED|Overall Study||6
8314913|NCT01459913|20499968|P2|COMPLETED|Overall Study||32
8314914|NCT01459913|20499969|P1|COMPLETED|Overall Study||65
8314915|NCT01459913|20499966|P4|STARTED|Overall Study||62
8314916|NCT01459913|20499967|P3|STARTED|Overall Study||19
8314917|NCT01459913|20499968|P2|STARTED|Overall Study||52
8314918|NCT01459913|20499969|P1|STARTED|Overall Study||106
8314919|NCT01459796|20500000|P2|NOT COMPLETED|Overall Study||126
8314920|NCT01459796|20500001|P1|NOT COMPLETED|Overall Study||94
8314921|NCT01459796|20500000|P2|COMPLETED|Overall Study||0
8314922|NCT01459796|20500001|P1|COMPLETED|Overall Study||0
8314923|NCT01459796|20500000|P2|STARTED|Overall Study||126
8314924|NCT01459796|20500001|P1|STARTED|Overall Study||94
8314925|NCT01459783|20500019|P2|NOT COMPLETED|6 Months to 12 Months||30
8314926|NCT01459783|20500020|P1|NOT COMPLETED|6 Months to 12 Months||19
8314927|NCT01459783|20500019|P2|COMPLETED|6 Months to 12 Months||23
8314928|NCT01459783|20500020|P1|COMPLETED|6 Months to 12 Months||20
8314929|NCT01459783|20500019|P2|STARTED|6 Months to 12 Months||53
8314930|NCT01459783|20500020|P1|STARTED|6 Months to 12 Months||39
8314931|NCT01459783|20500019|P2|NOT COMPLETED|Baseline to 6 Months||20
8314932|NCT01459783|20500020|P1|NOT COMPLETED|Baseline to 6 Months||32
8314933|NCT01459783|20500019|P2|COMPLETED|Baseline to 6 Months||53
8314934|NCT01459783|20500020|P1|COMPLETED|Baseline to 6 Months||39
8314935|NCT01459783|20500019|P2|STARTED|Baseline to 6 Months||73
8314936|NCT01459783|20500020|P1|STARTED|Baseline to 6 Months||71
8314937|NCT01459718|20500028|P1|NOT COMPLETED|Overall Study||3
8314938|NCT01459718|20500028|P1|COMPLETED|Overall Study||10
8314939|NCT01459718|20500028|P1|Safety Analysis Set|Overall Study||13
8314940|NCT01459718|20500028|P1|STARTED|Overall Study||13
8314941|NCT01459705|20500042|P3|NOT COMPLETED|Overall Study||7
8314942|NCT01459705|20500043|P2|NOT COMPLETED|Overall Study||24
8314943|NCT01459705|20500044|P1|NOT COMPLETED|Overall Study||22
8314944|NCT01459705|20500042|P3|COMPLETED|Overall Study||47
8314945|NCT01459705|20500043|P2|COMPLETED|Overall Study||30
8314946|NCT01459705|20500044|P1|COMPLETED|Overall Study||32
8314947|NCT01459705|20500042|P3|STARTED|Overall Study||54
8314948|NCT01459705|20500043|P2|STARTED|Overall Study||54
8314949|NCT01459705|20500044|P1|STARTED|Overall Study||54
8314950|NCT01459653|20500062|P1|NOT COMPLETED|Overall Study||668
8314951|NCT01459653|20500062|P1|COMPLETED|Overall Study||828
8314952|NCT01459653|20500062|P1|STARTED|Overall Study||1496
8314959|NCT01459588|20500227|P4|NOT COMPLETED|Overall Study||1
8314960|NCT01459588|20500228|P3|NOT COMPLETED|Overall Study||1
8314961|NCT01459588|20500229|P2|NOT COMPLETED|Overall Study||2
8314962|NCT01459588|20500230|P1|NOT COMPLETED|Overall Study||1
8314963|NCT01459588|20500227|P4|COMPLETED|Overall Study||55
8314964|NCT01459588|20500228|P3|COMPLETED|Overall Study||102
8314965|NCT01459588|20500229|P2|COMPLETED|Overall Study||49
8314966|NCT01459588|20500230|P1|COMPLETED|Overall Study||104
8314967|NCT01459588|20500227|P4|STARTED|Overall Study||56
8314968|NCT01459588|20500228|P3|STARTED|Overall Study||103
8314969|NCT01459588|20500229|P2|STARTED|Overall Study||51
8314970|NCT01459588|20500230|P1|STARTED|Overall Study||105
8314971|NCT01459068|20500258|P2|NOT COMPLETED|Overall Study||34
8314972|NCT01459068|20500259|P1|NOT COMPLETED|Overall Study||39
8314973|NCT01459068|20500258|P2|COMPLETED|Overall Study||148
8314974|NCT01459068|20500259|P1|COMPLETED|Overall Study||126
8314975|NCT01459068|20500258|P2|STARTED|Overall Study||182
8314976|NCT01459068|20500259|P1|STARTED|Overall Study||165
8314977|NCT01459016|20500275|P1|NOT COMPLETED|Overall Study||15
8314978|NCT01459016|20500275|P1|COMPLETED|Overall Study||41
8314979|NCT01459016|20500275|P1|STARTED|Overall Study||56
8314980|NCT01458990|20500291|P2|NOT COMPLETED|Overall Study||0
8314981|NCT01458990|20500292|P1|NOT COMPLETED|Overall Study||0
8314982|NCT01458990|20500291|P2|COMPLETED|Overall Study||15
8314983|NCT01458990|20500292|P1|COMPLETED|Overall Study||45
8314984|NCT01458990|20500291|P2|STARTED|Overall Study||15
8314985|NCT01458990|20500292|P1|STARTED|Overall Study||45
8314986|NCT01458951|20500303|P3|NOT COMPLETED|Overall Study||15
8314987|NCT01458951|20500304|P2|NOT COMPLETED|Overall Study||1
8314988|NCT01458951|20500305|P1|NOT COMPLETED|Overall Study||32
8314989|NCT01458951|20500303|P3|COMPLETED|Overall Study||97
8314990|NCT01458951|20500304|P2|COMPLETED|Overall Study||5
8314991|NCT01458951|20500305|P1|COMPLETED|Overall Study||397
8314992|NCT01458951|20500303|P3|STARTED|Overall Study||112
8314993|NCT01458951|20500304|P2|STARTED|Overall Study||6
8314994|NCT01458951|20500305|P1|STARTED|Overall Study||429
8314995|NCT01458639|20500330|P1|NOT COMPLETED|Overall Study||6
8314996|NCT01458639|20500330|P1|COMPLETED|Overall Study||12
8314997|NCT01458639|20500330|P1|STARTED|Overall Study||18
8314998|NCT01458587|20500342|P2|NOT COMPLETED|Overall Study||0
8314999|NCT01458587|20500343|P1|NOT COMPLETED|Overall Study||1
8315000|NCT01458587|20500342|P2|COMPLETED|Overall Study||35
8315001|NCT01458587|20500343|P1|COMPLETED|Overall Study||34
8315002|NCT01458587|20500342|P2|STARTED|Overall Study||35
8315003|NCT01458587|20500343|P1|STARTED|Overall Study||35
8315004|NCT01458574|20500506|P3|NOT COMPLETED|Overall Study||145
8315005|NCT01458574|20500507|P2|NOT COMPLETED|Overall Study||71
8315006|NCT01458574|20500508|P1|NOT COMPLETED|Overall Study||87
8315007|NCT01458574|20500506|P3|COMPLETED|Overall Study||53
8315008|NCT01458574|20500507|P2|COMPLETED|Overall Study||126
8315009|NCT01458574|20500508|P1|COMPLETED|Overall Study||111
8315010|NCT01458574|20500506|P3|Treated|Overall Study||198
8315011|NCT01458574|20500507|P2|Treated|Overall Study||196
8315012|NCT01458574|20500508|P1|Treated|Overall Study||198
8315013|NCT01458574|20500506|P3|STARTED|Overall Study||198
8315014|NCT01458574|20500507|P2|STARTED|Overall Study||197
8315015|NCT01458574|20500508|P1|STARTED|Overall Study||198
8315016|NCT01458561|20500593|P2|NOT COMPLETED|Overall Study||0
8315017|NCT01458561|20500594|P1|NOT COMPLETED|Overall Study||0
8315018|NCT01458561|20500593|P2|COMPLETED|Overall Study||1
8315019|NCT01458561|20500594|P1|COMPLETED|Overall Study||0
8315020|NCT01458561|20500593|P2|STARTED|Overall Study||1
8315021|NCT01458561|20500594|P1|STARTED|Overall Study||0
8315022|NCT01458535|20500638|P6|NOT COMPLETED|Overall Study||4
8315023|NCT01458535|20500639|P5|NOT COMPLETED|Overall Study||4
8315024|NCT01458535|20500640|P4|NOT COMPLETED|Overall Study||4
8315025|NCT01458535|20500641|P3|NOT COMPLETED|Overall Study||2
8315026|NCT01458535|20500642|P2|NOT COMPLETED|Overall Study||2
8315027|NCT01458535|20500643|P1|NOT COMPLETED|Overall Study||0
8315028|NCT01458535|20500638|P6|COMPLETED|Overall Study||7
8315029|NCT01458535|20500639|P5|COMPLETED|Overall Study||6
8315030|NCT01458535|20500640|P4|COMPLETED|Overall Study||6
8315031|NCT01458535|20500641|P3|COMPLETED|Overall Study||8
8315032|NCT01458535|20500642|P2|COMPLETED|Overall Study||8
8315033|NCT01458535|20500643|P1|COMPLETED|Overall Study||10
8315034|NCT01458535|20500638|P6|STARTED|Overall Study||11
8315035|NCT01458535|20500639|P5|STARTED|Overall Study||10
8315036|NCT01458535|20500640|P4|STARTED|Overall Study||10
8315037|NCT01458535|20500641|P3|STARTED|Overall Study||10
8315038|NCT01458535|20500642|P2|STARTED|Overall Study||10
8315039|NCT01458535|20500643|P1|STARTED|Overall Study||10
8315040|NCT01458522|20500695|P2|NOT COMPLETED|Overall Study||11
8315041|NCT01458522|20500696|P1|NOT COMPLETED|Overall Study||3
8315042|NCT01458522|20500695|P2|COMPLETED|Overall Study||26
8315043|NCT01458522|20500696|P1|COMPLETED|Overall Study||34
8315044|NCT01458522|20500695|P2|Crossover to Second Drug|Overall Study||10
8315045|NCT01458522|20500696|P1|Crossover to Second Drug|Overall Study||15
8315046|NCT01458522|20500695|P2|Received First Drug|Overall Study||35
8315047|NCT01458522|20500696|P1|Received First Drug|Overall Study||35
8315048|NCT01458522|20500695|P2|STARTED|Overall Study||37
8315049|NCT01458522|20500696|P1|STARTED|Overall Study||37
8315050|NCT01458418|20500726|P4|NOT COMPLETED|Overall Study||0
8315051|NCT01458418|20500727|P3|NOT COMPLETED|Overall Study||0
8315052|NCT01458418|20500728|P2|NOT COMPLETED|Overall Study||0
8315053|NCT01458418|20500729|P1|NOT COMPLETED|Overall Study||0
8315054|NCT01458418|20500726|P4|COMPLETED|Overall Study||4
8315055|NCT01458418|20500727|P3|COMPLETED|Overall Study||0
8315056|NCT01458418|20500728|P2|COMPLETED|Overall Study||0
8315057|NCT01458418|20500729|P1|COMPLETED|Overall Study||0
8315058|NCT01458418|20500726|P4|STARTED|Overall Study||4
8315059|NCT01458418|20500727|P3|STARTED|Overall Study||0
8315060|NCT01458418|20500728|P2|STARTED|Overall Study||0
8315061|NCT01458418|20500729|P1|STARTED|Overall Study||0
8315062|NCT01458392|20500742|P3|NOT COMPLETED|Overall Study||31
8315063|NCT01458392|20500743|P2|NOT COMPLETED|Overall Study||13
8315064|NCT01458392|20500744|P1|NOT COMPLETED|Overall Study||2
8315065|NCT01458392|20500742|P3|COMPLETED|Overall Study||0
8315066|NCT01458392|20500743|P2|COMPLETED|Overall Study||0
8315067|NCT01458392|20500744|P1|COMPLETED|Overall Study||0
8315068|NCT01458392|20500742|P3|STARTED|Overall Study||31
8315069|NCT01458392|20500743|P2|STARTED|Overall Study||13
8315070|NCT01458392|20500744|P1|STARTED|Overall Study||2
8315149|NCT01458275|20500800|P3|NOT COMPLETED|Overall Study||9
8315150|NCT01458275|20500801|P2|NOT COMPLETED|Overall Study||13
8315151|NCT01458275|20500802|P1|NOT COMPLETED|Overall Study||14
8315152|NCT01458275|20500800|P3|COMPLETED|Overall Study||273
8315153|NCT01458275|20500801|P2|COMPLETED|Overall Study||269
8315154|NCT01458275|20500802|P1|COMPLETED|Overall Study||269
8315155|NCT01458275|20500800|P3|STARTED|Overall Study||282
8315156|NCT01458275|20500801|P2|STARTED|Overall Study||282
8315157|NCT01458275|20500802|P1|STARTED|Overall Study||283
8315158|NCT01458249|20500844|P1|NOT COMPLETED|Overall Study||8
8315159|NCT01458249|20500844|P1|COMPLETED|Overall Study||44
8315160|NCT01458249|20500844|P1|Participants Treated|Overall Study||51
8315161|NCT01458249|20500844|P1|STARTED|Overall Study||52
8315162|NCT01458210|20500863|P1|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
8315163|NCT01458210|20500863|P1|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
8315164|NCT01458210|20500863|P1|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
8315165|NCT01458210|20500863|P1|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
8315166|NCT01458210|20500863|P1|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
8315167|NCT01458210|20500863|P1|STARTED|Ortho-Cyclen Alone (Period 1)||22
8315168|NCT01458210|20500863|P1|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
8315169|NCT01458210|20500863|P1|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
8315170|NCT01458210|20500863|P1|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
8315171|NCT01458210|20500863|P1|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
8315172|NCT01458171|20500880|P1|NOT COMPLETED|Overall Study||1
8315173|NCT01458171|20500880|P1|COMPLETED|Overall Study||22
8315174|NCT01458171|20500880|P1|STARTED|Overall Study||23
8315175|NCT01458132|20500903|P2|NOT COMPLETED|Overall Study||3
8315176|NCT01458132|20500904|P1|NOT COMPLETED|Overall Study||15
8315177|NCT01458132|20500903|P2|COMPLETED|Overall Study||1
8315178|NCT01458132|20500904|P1|COMPLETED|Overall Study||0
8315179|NCT01458132|20500903|P2|STARTED|Overall Study||4
8315180|NCT01458132|20500904|P1|STARTED|Overall Study||15
8315181|NCT01458119|20500912|P1|NOT COMPLETED|Overall Study||20
8315182|NCT01458119|20500912|P1|COMPLETED|Overall Study||65
8315183|NCT01458119|20500912|P1|ITT-Amenable Population|Overall Study||68
8315184|NCT01458119|20500912|P1|Intent to Treat (ITT) Population|Overall Study||85
8315185|NCT01458119|20500912|P1|Safety Population|Overall Study||85
8315186|NCT01458119|20500912|P1|Received at Least 1 Dose of Study Drug|Overall Study||85
8315187|NCT01458119|20500912|P1|STARTED|Overall Study||85
8315188|NCT01458106|20500919|P2|NOT COMPLETED|Overall Study||1
8315189|NCT01458106|20500920|P1|NOT COMPLETED|Overall Study||3
8315190|NCT01458106|20500919|P2|COMPLETED|Overall Study||34
8315191|NCT01458106|20500920|P1|COMPLETED|Overall Study||33
8315192|NCT01458106|20500919|P2|Non-PK Subgroup|Overall Study||0
8315193|NCT01458106|20500920|P1|Non-PK Subgroup|Overall Study||11
8315194|NCT01458106|20500919|P2|PK Subgroup|Overall Study||35
8315195|NCT01458106|20500920|P1|PK Subgroup|Overall Study||25
8315196|NCT01458106|20500919|P2|STARTED|Overall Study||35
8315197|NCT01458106|20500920|P1|STARTED|Overall Study||36
8315198|NCT01457950|20500997|P4|NOT COMPLETED|Open-Label Phase||2
8315199|NCT01457950|20500998|P3|NOT COMPLETED|Open-Label Phase||2
8315200|NCT01457950|20500999|P2|NOT COMPLETED|Open-Label Phase||0
8315201|NCT01457950|20501000|P1|NOT COMPLETED|Open-Label Phase||0
8315202|NCT01457950|20500997|P4|COMPLETED|Open-Label Phase||61
8315203|NCT01457950|20500998|P3|COMPLETED|Open-Label Phase||58
8315204|NCT01457950|20500999|P2|COMPLETED|Open-Label Phase||0
8315205|NCT01457950|20501000|P1|COMPLETED|Open-Label Phase||0
8315206|NCT01457950|20500997|P4|STARTED|Open-Label Phase||63
8315207|NCT01457950|20500998|P3|STARTED|Open-Label Phase||60
8315208|NCT01457950|20500999|P2|STARTED|Open-Label Phase||0
8315209|NCT01457950|20501000|P1|STARTED|Open-Label Phase||0
8315210|NCT01457950|20500997|P4|NOT COMPLETED|Double-Blind Phase||0
8315211|NCT01457950|20500998|P3|NOT COMPLETED|Double-Blind Phase||0
8315212|NCT01457950|20500999|P2|NOT COMPLETED|Double-Blind Phase||3
8315213|NCT01457950|20501000|P1|NOT COMPLETED|Double-Blind Phase||9
8315214|NCT01457950|20500997|P4|COMPLETED|Double-Blind Phase||0
8315215|NCT01457950|20500998|P3|COMPLETED|Double-Blind Phase||0
8315216|NCT01457950|20500999|P2|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|63
8315217|NCT01457950|20501000|P1|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|60
8315218|NCT01457950|20500997|P4|Completed the 6 Month Assessment|Double-Blind Phase||0
8315219|NCT01457950|20500998|P3|Completed the 6 Month Assessment|Double-Blind Phase||0
8315220|NCT01457950|20500999|P2|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|64
8315221|NCT01457950|20501000|P1|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|62
8315222|NCT01457950|20500997|P4|STARTED|Double-Blind Phase||0
8315223|NCT01457950|20500998|P3|STARTED|Double-Blind Phase||0
8315224|NCT01457950|20500999|P2|STARTED|Double-Blind Phase||66
8315225|NCT01457950|20501000|P1|STARTED|Double-Blind Phase||69
8315226|NCT01457924|20501079|P5|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
8315227|NCT01457924|20501080|P4|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
8315228|NCT01457924|20501081|P3|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
8315229|NCT01457924|20501082|P2|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
8315230|NCT01457924|20501083|P1|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
8315231|NCT01457924|20501079|P5|COMPLETED|Individualized FUP (Weeks 48+)||36
8315232|NCT01457924|20501080|P4|COMPLETED|Individualized FUP (Weeks 48+)||15
8315233|NCT01457924|20501081|P3|COMPLETED|Individualized FUP (Weeks 48+)||12
8315234|NCT01457924|20501082|P2|COMPLETED|Individualized FUP (Weeks 48+)||14
8315235|NCT01457924|20501083|P1|COMPLETED|Individualized FUP (Weeks 48+)||11
8315236|NCT01457924|20501079|P5|STARTED|Individualized FUP (Weeks 48+)||42
8315237|NCT01457924|20501080|P4|STARTED|Individualized FUP (Weeks 48+)||20
8315238|NCT01457924|20501081|P3|STARTED|Individualized FUP (Weeks 48+)||16
8315239|NCT01457924|20501082|P2|STARTED|Individualized FUP (Weeks 48+)||18
8315240|NCT01457924|20501083|P1|STARTED|Individualized FUP (Weeks 48+)||16
8315241|NCT01457924|20501079|P5|NOT COMPLETED|FUP (Weeks 24-48)||2
8315242|NCT01457924|20501080|P4|NOT COMPLETED|FUP (Weeks 24-48)||1
8315243|NCT01457924|20501081|P3|NOT COMPLETED|FUP (Weeks 24-48)||2
8315244|NCT01457924|20501082|P2|NOT COMPLETED|FUP (Weeks 24-48)||1
8315245|NCT01457924|20501083|P1|NOT COMPLETED|FUP (Weeks 24-48)||3
8315246|NCT01457924|20501079|P5|COMPLETED|FUP (Weeks 24-48)||57
8315247|NCT01457924|20501080|P4|COMPLETED|FUP (Weeks 24-48)||32
8315248|NCT01457924|20501081|P3|COMPLETED|FUP (Weeks 24-48)||30
8315249|NCT01457924|20501082|P2|COMPLETED|FUP (Weeks 24-48)||30
8315250|NCT01457924|20501083|P1|COMPLETED|FUP (Weeks 24-48)||63
8315251|NCT01457924|20501079|P5|STARTED|FUP (Weeks 24-48)||59
8315252|NCT01457924|20501080|P4|STARTED|FUP (Weeks 24-48)||33
8315253|NCT01457924|20501081|P3|STARTED|FUP (Weeks 24-48)||32
8315254|NCT01457924|20501082|P2|STARTED|FUP (Weeks 24-48)||31
8315255|NCT01457924|20501083|P1|STARTED|FUP (Weeks 24-48)||66
8315256|NCT01457924|20501079|P5|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
8315257|NCT01457924|20501080|P4|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
8315258|NCT01457924|20501081|P3|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
8315259|NCT01457924|20501082|P2|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
8315260|NCT01457924|20501083|P1|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
8315261|NCT01457924|20501079|P5|COMPLETED|Treatment Phase (Weeks 0-24)||58
8315262|NCT01457924|20501080|P4|COMPLETED|Treatment Phase (Weeks 0-24)||33
8315263|NCT01457924|20501081|P3|COMPLETED|Treatment Phase (Weeks 0-24)||30
8315264|NCT01457924|20501082|P2|COMPLETED|Treatment Phase (Weeks 0-24)||29
8315265|NCT01457924|20501083|P1|COMPLETED|Treatment Phase (Weeks 0-24)||64
8315266|NCT01457924|20501079|P5|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
8315267|NCT01457924|20501080|P4|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
8315268|NCT01457924|20501081|P3|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
8315269|NCT01457924|20501082|P2|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
8315270|NCT01457924|20501083|P1|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
8315271|NCT01457924|20501079|P5|STARTED|Treatment Phase (Weeks 0-24)||64
8315272|NCT01457924|20501080|P4|STARTED|Treatment Phase (Weeks 0-24)||34
8315273|NCT01457924|20501081|P3|STARTED|Treatment Phase (Weeks 0-24)||32
8315274|NCT01457924|20501082|P2|STARTED|Treatment Phase (Weeks 0-24)||34
8315275|NCT01457924|20501083|P1|STARTED|Treatment Phase (Weeks 0-24)||67
8315276|NCT01457885|20501145|P1|NOT COMPLETED|Overall Study||0
8315277|NCT01457885|20501145|P1|COMPLETED|Overall Study||74
8315278|NCT01457885|20501145|P1|STARTED|Overall Study||74
8315279|NCT01457846|20501153|P2|NOT COMPLETED|Overall Study||30
8315280|NCT01457846|20501154|P1|NOT COMPLETED|Overall Study||41
8315281|NCT01457846|20501153|P2|COMPLETED|Overall Study||0
8315282|NCT01457846|20501154|P1|COMPLETED|Overall Study||0
8315283|NCT01457846|20501153|P2|Ongoing Treatment at Data Cut-off|Overall Study||1
8315284|NCT01457846|20501154|P1|Ongoing Treatment at Data Cut-off|Overall Study||1
8315285|NCT01457846|20501153|P2|Did Not Receive Treatment|Overall Study||3
8315286|NCT01457846|20501154|P1|Did Not Receive Treatment|Overall Study||1
8315287|NCT01457846|20501153|P2|Received Treatment|Overall Study||27
8315288|NCT01457846|20501154|P1|Received Treatment|Overall Study||40
8315289|NCT01457846|20501153|P2|STARTED|Overall Study||30
8315290|NCT01457846|20501154|P1|STARTED|Overall Study||41
8315291|NCT01457703|20501170|P2|NOT COMPLETED|Overall Study||11
8315292|NCT01457703|20501171|P1|NOT COMPLETED|Overall Study||6
8315293|NCT01457703|20501170|P2|COMPLETED|Overall Study||22
8315294|NCT01457703|20501171|P1|COMPLETED|Overall Study||23
8315295|NCT01457703|20501170|P2|STARTED|Overall Study||33
8315296|NCT01457703|20501171|P1|STARTED|Overall Study||29
8315297|NCT01457573|20501185|P1|NOT COMPLETED|Overall Study||0
8315298|NCT01457573|20501185|P1|COMPLETED|Overall Study||10
8315299|NCT01457573|20501185|P1|STARTED|Overall Study||10
8315300|NCT01457521|20501201|P2|NOT COMPLETED|Overall Study||10
8315301|NCT01457521|20501202|P1|NOT COMPLETED|Overall Study||12
8315302|NCT01457521|20501201|P2|COMPLETED|Overall Study||117
8315303|NCT01457521|20501202|P1|COMPLETED|Overall Study||111
8315304|NCT01457521|20501201|P2|STARTED|Overall Study||127
8315305|NCT01457521|20501202|P1|STARTED|Overall Study||123
8315306|NCT01457430|20501208|P1|NOT COMPLETED|Overall Study||0
8315307|NCT01457430|20501208|P1|COMPLETED|Overall Study||19
8315308|NCT01457430|20501208|P1|STARTED|Overall Study||19
8315309|NCT01457417|20501220|P5|NOT COMPLETED|Overall Study||0
8315310|NCT01457417|20501221|P4|NOT COMPLETED|Overall Study||0
8315311|NCT01457417|20501222|P3|NOT COMPLETED|Overall Study||0
8315312|NCT01457417|20501223|P2|NOT COMPLETED|Overall Study||0
8315313|NCT01457417|20501224|P1|NOT COMPLETED|Overall Study||0
8315314|NCT01457417|20501220|P5|COMPLETED|Overall Study||19
8315315|NCT01457417|20501221|P4|COMPLETED|Overall Study||3
8315316|NCT01457417|20501222|P3|COMPLETED|Overall Study||4
8315317|NCT01457417|20501223|P2|COMPLETED|Overall Study||3
8315318|NCT01457417|20501224|P1|COMPLETED|Overall Study||3
8315319|NCT01457417|20501220|P5|STARTED|Overall Study||19
8315320|NCT01457417|20501221|P4|STARTED|Overall Study||3
8315321|NCT01457417|20501222|P3|STARTED|Overall Study||4
8315322|NCT01457417|20501223|P2|STARTED|Overall Study||3
8315323|NCT01457417|20501224|P1|STARTED|Overall Study||3
8315324|NCT01457352|20501282|P2|NOT COMPLETED|Period 3||5
8315325|NCT01457352|20501283|P1|NOT COMPLETED|Period 3||1
8315326|NCT01457352|20501282|P2|COMPLETED|Period 3||144
8315327|NCT01457352|20501283|P1|COMPLETED|Period 3||146
8315328|NCT01457352|20501282|P2|Randomization|Period 3||149
8315329|NCT01457352|20501283|P1|Randomization|Period 3||147
8315330|NCT01457352|20501282|P2|STARTED|Period 3||149
8315331|NCT01457352|20501283|P1|STARTED|Period 3||147
8315332|NCT01457352|20501282|P2|NOT COMPLETED|Period 2||0
8315333|NCT01457352|20501283|P1|NOT COMPLETED|Period 2||80
8315334|NCT01457352|20501282|P2|COMPLETED|Period 2||0
8315335|NCT01457352|20501283|P1|COMPLETED|Period 2||296
8315336|NCT01457352|20501282|P2|STARTED|Period 2||0
8315337|NCT01457352|20501283|P1|STARTED|Period 2||376
8315338|NCT01457352|20501282|P2|NOT COMPLETED|Period 1||0
8315339|NCT01457352|20501283|P1|NOT COMPLETED|Period 1||16
8315340|NCT01457352|20501282|P2|COMPLETED|Period 1||0
8315341|NCT01457352|20501283|P1|COMPLETED|Period 1||376
8315342|NCT01457352|20501282|P2|STARTED|Period 1||0
8315343|NCT01457352|20501283|P1|STARTED|Period 1||392
8315380|NCT01457196|20501462|P1|NOT COMPLETED|Overall Study||0
8315381|NCT01457196|20501462|P1|COMPLETED|Overall Study||2074
8315382|NCT01457196|20501462|P1|STARTED|Overall Study||2074
8315383|NCT01457053|20501468|P2|NOT COMPLETED|Overall Study||1
8315384|NCT01457053|20501469|P1|NOT COMPLETED|Overall Study||1
8315385|NCT01457053|20501468|P2|COMPLETED|Overall Study||1
8315386|NCT01457053|20501469|P1|COMPLETED|Overall Study||1
8315387|NCT01457053|20501468|P2|STARTED|Overall Study||2
8315388|NCT01457053|20501469|P1|STARTED|Overall Study||2
8315389|NCT01457014|20501475|P4|NOT COMPLETED|Fourth Night||0
8315390|NCT01457014|20501476|P3|NOT COMPLETED|Fourth Night||0
8315391|NCT01457014|20501477|P2|NOT COMPLETED|Fourth Night||0
8315392|NCT01457014|20501478|P1|NOT COMPLETED|Fourth Night||0
8315393|NCT01457014|20501475|P4|COMPLETED|Fourth Night||11
8315394|NCT01457014|20501476|P3|COMPLETED|Fourth Night||12
8315395|NCT01457014|20501477|P2|COMPLETED|Fourth Night||11
8315396|NCT01457014|20501478|P1|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
8315397|NCT01457014|20501475|P4|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8315398|NCT01457014|20501476|P3|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
8315399|NCT01457014|20501477|P2|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8315400|NCT01457014|20501478|P1|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
8315401|NCT01457014|20501475|P4|NOT COMPLETED|Third Night||0
8315402|NCT01457014|20501476|P3|NOT COMPLETED|Third Night||0
8315403|NCT01457014|20501477|P2|NOT COMPLETED|Third Night||0
8315404|NCT01457014|20501478|P1|NOT COMPLETED|Third Night||0
8315405|NCT01457014|20501475|P4|COMPLETED|Third Night||12
8315406|NCT01457014|20501476|P3|COMPLETED|Third Night||11
8315407|NCT01457014|20501477|P2|COMPLETED|Third Night||11
8315408|NCT01457014|20501478|P1|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
8315409|NCT01457014|20501475|P4|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
8315410|NCT01457014|20501476|P3|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8315411|NCT01457014|20501477|P2|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8315412|NCT01457014|20501478|P1|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
8315413|NCT01457014|20501475|P4|NOT COMPLETED|Second Night||0
8315414|NCT01457014|20501476|P3|NOT COMPLETED|Second Night||0
8315415|NCT01457014|20501477|P2|NOT COMPLETED|Second Night||0
8315416|NCT01457014|20501478|P1|NOT COMPLETED|Second Night||0
8315417|NCT01457014|20501475|P4|COMPLETED|Second Night||11
8315418|NCT01457014|20501476|P3|COMPLETED|Second Night||11
8315419|NCT01457014|20501477|P2|COMPLETED|Second Night||12
8315420|NCT01457014|20501478|P1|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
8315421|NCT01457014|20501475|P4|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8315422|NCT01457014|20501476|P3|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
8315423|NCT01457014|20501477|P2|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
8315424|NCT01457014|20501478|P1|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
8315425|NCT01457014|20501475|P4|NOT COMPLETED|First Night||0
8315426|NCT01457014|20501476|P3|NOT COMPLETED|First Night||0
8315427|NCT01457014|20501477|P2|NOT COMPLETED|First Night||0
8315428|NCT01457014|20501478|P1|NOT COMPLETED|First Night||40
8315429|NCT01457014|20501475|P4|COMPLETED|First Night||0
8315430|NCT01457014|20501476|P3|COMPLETED|First Night||0
8315431|NCT01457014|20501477|P2|COMPLETED|First Night||0
8315432|NCT01457014|20501478|P1|COMPLETED|First Night||34
8315433|NCT01457014|20501475|P4|STARTED|First Night||0
8315434|NCT01457014|20501476|P3|STARTED|First Night||0
8315435|NCT01457014|20501477|P2|STARTED|First Night||0
8315436|NCT01457014|20501478|P1|STARTED|First Night||74
8315437|NCT01456962|20501495|P2|NOT COMPLETED|Overall Study||1
8315438|NCT01456962|20501496|P1|NOT COMPLETED|Overall Study||2
8315439|NCT01456962|20501495|P2|COMPLETED|Overall Study||19
8315440|NCT01456962|20501496|P1|COMPLETED|Overall Study||14
8315441|NCT01456962|20501495|P2|STARTED|Overall Study||20
8315442|NCT01456962|20501496|P1|STARTED|Overall Study||16
8315443|NCT01456949|20501502|P1|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62
8315444|NCT01456949|20501502|P1|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303
8315445|NCT01456949|20501502|P1|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298
8315446|NCT01456949|20501502|P1|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309
8315447|NCT01456949|20501502|P1|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325
8315448|NCT01456949|20501502|P1|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342
8315449|NCT01456949|20501502|P1|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344
8315450|NCT01456949|20501502|P1|STARTED|Study Cryoablation Procedure & Follow-up||365
8315451|NCT01456949|20501502|P1|NOT COMPLETED|Enrollment||37
8315452|NCT01456949|20501502|P1|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365
8315453|NCT01456949|20501502|P1|Modified Intent to Treat Group (mITT)|Enrollment||354
8315454|NCT01456949|20501502|P1|Treated|Enrollment||359
8315455|NCT01456949|20501502|P1|STARTED|Enrollment||402
8315456|NCT01456936|20501513|P4|NOT COMPLETED|Overall Study||483
8315457|NCT01456936|20501514|P3|NOT COMPLETED|Overall Study||481
8315458|NCT01456936|20501515|P2|NOT COMPLETED|Overall Study||448
8315459|NCT01456936|20501516|P1|NOT COMPLETED|Overall Study||439
8315460|NCT01456936|20501513|P4|COMPLETED|Overall Study||1552
8315461|NCT01456936|20501514|P3|COMPLETED|Overall Study||1557
8315462|NCT01456936|20501515|P2|COMPLETED|Overall Study||1586
8315463|NCT01456936|20501516|P1|COMPLETED|Overall Study||1598
8315464|NCT01456936|20501513|P4|Randomized and Treated|Overall Study||2014
8315465|NCT01456936|20501514|P3|Randomized and Treated|Overall Study||2022
8315466|NCT01456936|20501515|P2|Randomized and Treated|Overall Study||2006
8315467|NCT01456936|20501516|P1|Randomized and Treated|Overall Study||2016
8315468|NCT01456936|20501513|P4|STARTED|Overall Study||2035
8315469|NCT01456936|20501514|P3|STARTED|Overall Study||2038
8315470|NCT01456936|20501515|P2|STARTED|Overall Study||2034
8315471|NCT01456936|20501516|P1|STARTED|Overall Study||2037
8315472|NCT01456897|20501624|P2|NOT COMPLETED|Overall Study||57
8315473|NCT01456897|20501625|P1|NOT COMPLETED|Overall Study||75
8315474|NCT01456897|20501624|P2|COMPLETED|Overall Study||41
8315475|NCT01456897|20501625|P1|COMPLETED|Overall Study||109
8315476|NCT01456897|20501624|P2|STARTED|Overall Study||98
8315477|NCT01456897|20501625|P1|STARTED|Overall Study||184
8315478|NCT01456780|20501644|P3|NOT COMPLETED|Overall Study||0
8315479|NCT01456780|20501645|P2|NOT COMPLETED|Overall Study||3
8315480|NCT01456780|20501646|P1|NOT COMPLETED|Overall Study||3
8315481|NCT01456780|20501644|P3|COMPLETED|Overall Study||20
8315482|NCT01456780|20501645|P2|COMPLETED|Overall Study||17
8315483|NCT01456780|20501646|P1|COMPLETED|Overall Study||17
8315484|NCT01456780|20501644|P3|STARTED|Overall Study||20
8315485|NCT01456780|20501645|P2|STARTED|Overall Study||20
8315486|NCT01456780|20501646|P1|STARTED|Overall Study||20
8315487|NCT01456494|20501665|P2|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6
8315488|NCT01456494|20501666|P1|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5
8315489|NCT01456494|20501665|P2|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20
8315490|NCT01456494|20501666|P1|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19
8315491|NCT01456494|20501665|P2|STARTED|Follow-Up Visit (Post 30-day Discharge)||26
8315492|NCT01456494|20501666|P1|STARTED|Follow-Up Visit (Post 30-day Discharge)||24
8315493|NCT01456494|20501665|P2|NOT COMPLETED|Initial Inpatient Visit||0
8315494|NCT01456494|20501666|P1|NOT COMPLETED|Initial Inpatient Visit||0
8315495|NCT01456494|20501665|P2|COMPLETED|Initial Inpatient Visit||26
8315496|NCT01456494|20501666|P1|COMPLETED|Initial Inpatient Visit||24
8315497|NCT01456494|20501665|P2|STARTED|Initial Inpatient Visit||26
8315498|NCT01456494|20501666|P1|STARTED|Initial Inpatient Visit||24
8315499|NCT01456299|20501683|P3|NOT COMPLETED|Overall Study||1
8315500|NCT01456299|20501684|P2|NOT COMPLETED|Overall Study||1
8315501|NCT01456299|20501685|P1|NOT COMPLETED|Overall Study||0
8315502|NCT01456299|20501683|P3|COMPLETED|Overall Study||33
8315503|NCT01456299|20501684|P2|COMPLETED|Overall Study||33
8315504|NCT01456299|20501685|P1|COMPLETED|Overall Study||34
8315505|NCT01456299|20501683|P3|STARTED|Overall Study||34
8315506|NCT01456299|20501684|P2|STARTED|Overall Study||34
8315507|NCT01456299|20501685|P1|STARTED|Overall Study||34
8315508|NCT01456221|20501695|P2|NOT COMPLETED|Overall Study||57
8315509|NCT01456221|20501696|P1|NOT COMPLETED|Overall Study||64
8315510|NCT01456221|20501695|P2|COMPLETED|Overall Study||126
8315511|NCT01456221|20501696|P1|COMPLETED|Overall Study||119
8315512|NCT01456221|20501695|P2|STARTED|Overall Study||183
8315513|NCT01456221|20501696|P1|STARTED|Overall Study||183
8315514|NCT01456195|20501711|P3|NOT COMPLETED|Overall Study||14
8315515|NCT01456195|20501712|P2|NOT COMPLETED|Overall Study||10
8315516|NCT01456195|20501713|P1|NOT COMPLETED|Overall Study||11
8315517|NCT01456195|20501711|P3|COMPLETED|Overall Study||127
8315518|NCT01456195|20501712|P2|COMPLETED|Overall Study||127
8315519|NCT01456195|20501713|P1|COMPLETED|Overall Study||132
8315520|NCT01456195|20501711|P3|STARTED|Overall Study||141
8315521|NCT01456195|20501712|P2|STARTED|Overall Study||137
8315522|NCT01456195|20501713|P1|STARTED|Overall Study||143
8315523|NCT01456169|20501733|P3|NOT COMPLETED|Overall Study||12
8315524|NCT01456169|20501734|P2|NOT COMPLETED|Overall Study||5
8315525|NCT01456169|20501735|P1|NOT COMPLETED|Overall Study||10
8315526|NCT01456169|20501733|P3|COMPLETED|Overall Study||123
8315527|NCT01456169|20501734|P2|COMPLETED|Overall Study||122
8315528|NCT01456169|20501735|P1|COMPLETED|Overall Study||123
8315529|NCT01456169|20501733|P3|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
8315530|NCT01456169|20501734|P2|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
8315623|NCT01454947|20502092|P3|COMPLETED|Overall Study||32
8315531|NCT01456169|20501735|P1|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
8315532|NCT01456143|20501786|P1|NOT COMPLETED|Overall Study||0
8315533|NCT01456143|20501786|P1|COMPLETED|Overall Study||33
8315534|NCT01456143|20501786|P1|STARTED|Overall Study||33
8315535|NCT01456130|20501795|P1|NOT COMPLETED|Overall Study||10
8315536|NCT01456130|20501795|P1|COMPLETED|Overall Study||57
8315537|NCT01456130|20501795|P1|STARTED|Overall Study||67
8315538|NCT01456052|20501805|P3|NOT COMPLETED|Overall Study||5
8315539|NCT01456052|20501806|P2|NOT COMPLETED|Overall Study||5
8315540|NCT01456052|20501807|P1|NOT COMPLETED|Overall Study||2
8315541|NCT01456052|20501805|P3|COMPLETED|Overall Study||19
8315542|NCT01456052|20501806|P2|COMPLETED|Overall Study||20
8315543|NCT01456052|20501807|P1|COMPLETED|Overall Study||8
8315544|NCT01456052|20501805|P3|STARTED|Overall Study||24
8315545|NCT01456052|20501806|P2|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
8315546|NCT01456052|20501807|P1|STARTED|Overall Study||10
8315547|NCT01456039|20501827|P3|NOT COMPLETED|Phase 2 (Second Step)||33
8315548|NCT01456039|20501828|P2|NOT COMPLETED|Phase 2 (Second Step)||0
8315549|NCT01456039|20501829|P1|NOT COMPLETED|Phase 2 (Second Step)||0
8315550|NCT01456039|20501827|P3|COMPLETED|Phase 2 (Second Step)||7
8315551|NCT01456039|20501828|P2|COMPLETED|Phase 2 (Second Step)||0
8315552|NCT01456039|20501829|P1|COMPLETED|Phase 2 (Second Step)||0
8315553|NCT01456039|20501827|P3|STARTED|Phase 2 (Second Step)||40
8315554|NCT01456039|20501828|P2|STARTED|Phase 2 (Second Step)||0
8315555|NCT01456039|20501829|P1|STARTED|Phase 2 (Second Step)||0
8315556|NCT01456039|20501827|P3|NOT COMPLETED|Phase 1 (First Step)||0
8315557|NCT01456039|20501828|P2|NOT COMPLETED|Phase 1 (First Step)||7
8315558|NCT01456039|20501829|P1|NOT COMPLETED|Phase 1 (First Step)||2
8315559|NCT01456039|20501827|P3|COMPLETED|Phase 1 (First Step)||0
8315560|NCT01456039|20501828|P2|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
8315561|NCT01456039|20501829|P1|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
8315562|NCT01456039|20501827|P3|STARTED|Phase 1 (First Step)||0
8315563|NCT01456039|20501828|P2|STARTED|Phase 1 (First Step)||8
8315564|NCT01456039|20501829|P1|STARTED|Phase 1 (First Step)||3
8315565|NCT01456000|20501901|P2|NOT COMPLETED|Overall Study||3
8315566|NCT01456000|20501902|P1|NOT COMPLETED|Overall Study||8
8315567|NCT01456000|20501901|P2|COMPLETED|Overall Study||172
8315568|NCT01456000|20501902|P1|COMPLETED|Overall Study||170
8315569|NCT01456000|20501901|P2|STARTED|Overall Study||175
8315570|NCT01456000|20501902|P1|STARTED|Overall Study||178
8315571|NCT01455545|20501908|P2|NOT COMPLETED|Overall Study||0
8315572|NCT01455545|20501909|P1|NOT COMPLETED|Overall Study||0
8315573|NCT01455545|20501908|P2|COMPLETED|Overall Study||45
8315574|NCT01455545|20501909|P1|COMPLETED|Overall Study||55
8315575|NCT01455545|20501908|P2|STARTED|Overall Study||45
8315576|NCT01455545|20501909|P1|STARTED|Overall Study||55
8315577|NCT01455519|20501939|P2|NOT COMPLETED|Overall Study||5
8315578|NCT01455519|20501940|P1|NOT COMPLETED|Overall Study||4
8315579|NCT01455519|20501939|P2|COMPLETED|Overall Study||18
8315580|NCT01455519|20501940|P1|COMPLETED|Overall Study||8
8315581|NCT01455519|20501939|P2|STARTED|Overall Study||23
8315582|NCT01455519|20501940|P1|STARTED|Overall Study||12
8315583|NCT01455220|20501970|P1|NOT COMPLETED|Overall Study||30
8315584|NCT01455220|20501970|P1|COMPLETED|Overall Study||15
8315585|NCT01455220|20501970|P1|STARTED|Overall Study||45
8315586|NCT01455194|20501980|P4|NOT COMPLETED|Overall Study||28
8315587|NCT01455194|20501981|P3|NOT COMPLETED|Overall Study||30
8315588|NCT01455194|20501982|P2|NOT COMPLETED|Overall Study||31
8315589|NCT01455194|20501983|P1|NOT COMPLETED|Overall Study||153
8315590|NCT01455194|20501980|P4|COMPLETED|Overall Study||97
8315591|NCT01455194|20501981|P3|COMPLETED|Overall Study||92
8315592|NCT01455194|20501982|P2|COMPLETED|Overall Study||89
8315593|NCT01455194|20501983|P1|COMPLETED|Overall Study||0
8315594|NCT01455194|20501980|P4|STARTED|Overall Study||125
8315595|NCT01455194|20501981|P3|STARTED|Overall Study||122
8315596|NCT01455194|20501982|P2|STARTED|Overall Study||120
8315597|NCT01455194|20501983|P1|STARTED|Overall Study||153
8315601|NCT01455064|20502040|P1|NOT COMPLETED|Overall Study||1
8315602|NCT01455064|20502040|P1|COMPLETED|Overall Study||30
8315603|NCT01455064|20502040|P1|STARTED|Overall Study||31
8315604|NCT01455012|20502046|P2|NOT COMPLETED|Overall Study||4
8315605|NCT01455012|20502047|P1|NOT COMPLETED|Overall Study||11
8315606|NCT01455012|20502046|P2|COMPLETED|Overall Study||36
8315607|NCT01455012|20502047|P1|COMPLETED|Overall Study||30
8315608|NCT01455012|20502046|P2|STARTED|Overall Study||40
8315609|NCT01455012|20502047|P1|STARTED|Overall Study||41
8315610|NCT01454947|20502087|P8|NOT COMPLETED|Overall Study||5
8315611|NCT01454947|20502088|P7|NOT COMPLETED|Overall Study||1
8315612|NCT01454947|20502089|P6|NOT COMPLETED|Overall Study||3
8315613|NCT01454947|20502090|P5|NOT COMPLETED|Overall Study||1
8315614|NCT01454947|20502091|P4|NOT COMPLETED|Overall Study||1
8315615|NCT01454947|20502092|P3|NOT COMPLETED|Overall Study||3
8315616|NCT01454947|20502093|P2|NOT COMPLETED|Overall Study||4
8315617|NCT01454947|20502094|P1|NOT COMPLETED|Overall Study||3
8315618|NCT01454947|20502087|P8|COMPLETED|Overall Study||23
8315619|NCT01454947|20502088|P7|COMPLETED|Overall Study||26
8315620|NCT01454947|20502089|P6|COMPLETED|Overall Study||32
8315621|NCT01454947|20502090|P5|COMPLETED|Overall Study||33
8315622|NCT01454947|20502091|P4|COMPLETED|Overall Study||19
8315624|NCT01454947|20502093|P2|COMPLETED|Overall Study||38
8315625|NCT01454947|20502094|P1|COMPLETED|Overall Study||24
8315626|NCT01454947|20502087|P8|STARTED|Overall Study||28
8315627|NCT01454947|20502088|P7|STARTED|Overall Study||27
8315628|NCT01454947|20502089|P6|STARTED|Overall Study||35
8315629|NCT01454947|20502090|P5|STARTED|Overall Study||34
8315630|NCT01454947|20502091|P4|STARTED|Overall Study||20
8315631|NCT01454947|20502092|P3|STARTED|Overall Study||35
8315632|NCT01454947|20502093|P2|STARTED|Overall Study||42
8315633|NCT01454947|20502094|P1|STARTED|Overall Study||27
8315634|NCT01454934|20502114|P2|NOT COMPLETED|Overall Study||270
8315635|NCT01454934|20502115|P1|NOT COMPLETED|Overall Study||270
8315636|NCT01454934|20502114|P2|COMPLETED|Overall Study||0
8315637|NCT01454934|20502115|P1|COMPLETED|Overall Study||0
8315638|NCT01454934|20502114|P2|STARTED|Overall Study||270
8315639|NCT01454934|20502115|P1|STARTED|Overall Study||270
8315640|NCT01454830|20502127|P2|NOT COMPLETED|Overall Study||27
8315641|NCT01454830|20502128|P1|NOT COMPLETED|Overall Study||31
8315642|NCT01454830|20502127|P2|COMPLETED|Overall Study||30
8315643|NCT01454830|20502128|P1|COMPLETED|Overall Study||30
8315644|NCT01454830|20502127|P2|STARTED|Overall Study||57
8315645|NCT01454830|20502128|P1|STARTED|Overall Study||61
8315646|NCT01454791|20502148|P2|NOT COMPLETED|Overall Study||0
8315647|NCT01454791|20502149|P1|NOT COMPLETED|Overall Study||0
8315648|NCT01454791|20502148|P2|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
8315649|NCT01454791|20502149|P1|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
8315650|NCT01454791|20502148|P2|STARTED|Overall Study||20
8315651|NCT01454791|20502149|P1|STARTED|Overall Study||20
8315652|NCT01454778|20502159|P1|NOT COMPLETED|Overall Study||3
8315653|NCT01454778|20502159|P1|COMPLETED|Overall Study||47
8315654|NCT01454778|20502159|P1|STARTED|Overall Study||50
8315655|NCT01454739|20502170|P2|NOT COMPLETED|Overall Study||21
8315656|NCT01454739|20502171|P1|NOT COMPLETED|Overall Study||7
8315657|NCT01454739|20502170|P2|COMPLETED|Overall Study||158
8315658|NCT01454739|20502171|P1|COMPLETED|Overall Study||54
8315659|NCT01454739|20502170|P2|Surgery Subgroup|Overall Study||26
8315660|NCT01454739|20502171|P1|Surgery Subgroup|Overall Study||2
8315661|NCT01454739|20502170|P2|Episodic|Overall Study||13
8315662|NCT01454739|20502171|P1|Episodic|Overall Study||0
8315663|NCT01454739|20502170|P2|Personalized Prophylaxis|Overall Study||23
8315664|NCT01454739|20502171|P1|Personalized Prophylaxis|Overall Study||3
8315665|NCT01454739|20502170|P2|Weekly Prophylaxis|Overall Study||34
8315666|NCT01454739|20502171|P1|Weekly Prophylaxis|Overall Study||0
8315667|NCT01454739|20502170|P2|Tailored Prophylaxis|Overall Study||131
8315668|NCT01454739|20502171|P1|Tailored Prophylaxis|Overall Study||59
8315669|NCT01454739|20502170|P2|STARTED|Overall Study||179
8315670|NCT01454739|20502171|P1|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
8315671|NCT01454726|20502200|P2|NOT COMPLETED|Overall Study||1
8315672|NCT01454726|20502201|P1|NOT COMPLETED|Overall Study||0
8315673|NCT01454726|20502200|P2|COMPLETED|Overall Study||10
8315674|NCT01454726|20502201|P1|COMPLETED|Overall Study||16
8315675|NCT01454726|20502200|P2|STARTED|Overall Study||11
8315676|NCT01454726|20502201|P1|STARTED|Overall Study||16
8315677|NCT01454596|20502219|P12|NOT COMPLETED|Overall Study||0
8315678|NCT01454596|20502220|P11|NOT COMPLETED|Overall Study||1
8315679|NCT01454596|20502221|P10|NOT COMPLETED|Overall Study||1
8315680|NCT01454596|20502222|P9|NOT COMPLETED|Overall Study||0
8315681|NCT01454596|20502223|P8|NOT COMPLETED|Overall Study||0
8315682|NCT01454596|20502224|P7|NOT COMPLETED|Overall Study||0
8315683|NCT01454596|20502225|P6|NOT COMPLETED|Overall Study||0
8315684|NCT01454596|20502226|P5|NOT COMPLETED|Overall Study||0
8315685|NCT01454596|20502227|P4|NOT COMPLETED|Overall Study||0
8315686|NCT01454596|20502228|P3|NOT COMPLETED|Overall Study||0
8315687|NCT01454596|20502229|P2|NOT COMPLETED|Overall Study||0
8315688|NCT01454596|20502230|P1|NOT COMPLETED|Overall Study||0
8315689|NCT01454596|20502219|P12|COMPLETED|Overall Study||1
8315690|NCT01454596|20502220|P11|COMPLETED|Overall Study||0
8315691|NCT01454596|20502221|P10|COMPLETED|Overall Study||2
8315692|NCT01454596|20502222|P9|COMPLETED|Overall Study||3
8315693|NCT01454596|20502223|P8|COMPLETED|Overall Study||3
8315694|NCT01454596|20502224|P7|COMPLETED|Overall Study||1
8315695|NCT01454596|20502225|P6|COMPLETED|Overall Study||1
8315696|NCT01454596|20502226|P5|COMPLETED|Overall Study||1
8315697|NCT01454596|20502227|P4|COMPLETED|Overall Study||1
8315698|NCT01454596|20502228|P3|COMPLETED|Overall Study||1
8315699|NCT01454596|20502229|P2|COMPLETED|Overall Study||1
8315700|NCT01454596|20502230|P1|COMPLETED|Overall Study||1
8315701|NCT01454596|20502219|P12|STARTED|Overall Study||1
8315702|NCT01454596|20502220|P11|STARTED|Overall Study||1
8315703|NCT01454596|20502221|P10|STARTED|Overall Study||3
8315704|NCT01454596|20502222|P9|STARTED|Overall Study||3
8315705|NCT01454596|20502223|P8|STARTED|Overall Study||3
8315706|NCT01454596|20502224|P7|STARTED|Overall Study||1
8315707|NCT01454596|20502225|P6|STARTED|Overall Study||1
8315708|NCT01454596|20502226|P5|STARTED|Overall Study||1
8315709|NCT01454596|20502227|P4|STARTED|Overall Study||1
8315710|NCT01454596|20502228|P3|STARTED|Overall Study||1
8315711|NCT01454596|20502229|P2|STARTED|Overall Study||1
8315712|NCT01454596|20502230|P1|STARTED|Overall Study||1
8315713|NCT01454583|20502307|P3|NOT COMPLETED|3rd Year||297
8315714|NCT01454583|20502308|P2|NOT COMPLETED|3rd Year||512
8315715|NCT01454583|20502309|P1|NOT COMPLETED|3rd Year||1959
8315716|NCT01454583|20502307|P3|COMPLETED|3rd Year||285
8315717|NCT01454583|20502308|P2|COMPLETED|3rd Year||470
8315718|NCT01454583|20502309|P1|COMPLETED|3rd Year||1832
8315719|NCT01454583|20502307|P3|STARTED|3rd Year||582
8315720|NCT01454583|20502308|P2|STARTED|3rd Year||982
8315721|NCT01454583|20502309|P1|STARTED|3rd Year||3791
8315722|NCT01454583|20502307|P3|NOT COMPLETED|2nd Year||737
8315723|NCT01454583|20502308|P2|NOT COMPLETED|2nd Year||1049
8315724|NCT01454583|20502309|P1|NOT COMPLETED|2nd Year||3965
8315725|NCT01454583|20502307|P3|COMPLETED|2nd Year||1376
8315726|NCT01454583|20502308|P2|COMPLETED|2nd Year||1647
8315727|NCT01454583|20502309|P1|COMPLETED|2nd Year||6212
8315728|NCT01454583|20502307|P3|STARTED|2nd Year||2113
8315729|NCT01454583|20502308|P2|STARTED|2nd Year||2696
8315730|NCT01454583|20502309|P1|STARTED|2nd Year||10177
8315731|NCT01454583|20502307|P3|NOT COMPLETED|1st Year||180
8315732|NCT01454583|20502308|P2|NOT COMPLETED|1st Year||318
8315733|NCT01454583|20502309|P1|NOT COMPLETED|1st Year||1057
8315734|NCT01454583|20502307|P3|COMPLETED|1st Year||1933
8315735|NCT01454583|20502308|P2|COMPLETED|1st Year||2378
8315736|NCT01454583|20502309|P1|COMPLETED|1st Year||9120
8315737|NCT01454583|20502307|P3|STARTED|1st Year||2113
8315738|NCT01454583|20502308|P2|STARTED|1st Year||2696
8315739|NCT01454583|20502309|P1|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
8315740|NCT01454570|20502377|P1|NOT COMPLETED|Overall Study||9
8315741|NCT01454570|20502377|P1|COMPLETED|Overall Study||10
8315742|NCT01454570|20502377|P1|STARTED|Overall Study||19
8315743|NCT01454531|20502381|P1|NOT COMPLETED|Overall Study||23
8315744|NCT01454531|20502381|P1|COMPLETED|Overall Study||173
8315745|NCT01454531|20502381|P1|Subjects Treated|Overall Study||192
8315746|NCT01454531|20502381|P1|STARTED|Overall Study||196
8315747|NCT01454505|20502393|P4|NOT COMPLETED|Overall Study||0
8315748|NCT01454505|20502394|P3|NOT COMPLETED|Overall Study||0
8315749|NCT01454505|20502395|P2|NOT COMPLETED|Overall Study||0
8315750|NCT01454505|20502396|P1|NOT COMPLETED|Overall Study||0
8315751|NCT01454505|20502393|P4|COMPLETED|Overall Study||20
8315752|NCT01454505|20502394|P3|COMPLETED|Overall Study||40
8315753|NCT01454505|20502395|P2|COMPLETED|Overall Study||15
8315754|NCT01454505|20502396|P1|COMPLETED|Overall Study||35
8315755|NCT01454505|20502393|P4|STARTED|Overall Study||20
8315756|NCT01454505|20502394|P3|STARTED|Overall Study||40
8315757|NCT01454505|20502395|P2|STARTED|Overall Study||15
8315758|NCT01454505|20502396|P1|STARTED|Overall Study||35
8315767|NCT01454401|20502417|P1|NOT COMPLETED|Overall Study||5
8315768|NCT01454401|20502417|P1|COMPLETED|Overall Study|Per Protocol (PP)|39
8315769|NCT01454401|20502417|P1|STARTED|Overall Study|ITT|44
8315770|NCT01454362|20502424|P2|NOT COMPLETED|Overall Study||0
8315771|NCT01454362|20502425|P1|NOT COMPLETED|Overall Study||0
8315772|NCT01454362|20502424|P2|COMPLETED|Overall Study||23
8315773|NCT01454362|20502425|P1|COMPLETED|Overall Study||28
8315774|NCT01454362|20502424|P2|STARTED|Overall Study||23
8315775|NCT01454362|20502425|P1|STARTED|Overall Study||28
8315776|NCT01454284|20502441|P2|NOT COMPLETED|Overall Study||73
8315777|NCT01454284|20502442|P1|NOT COMPLETED|Overall Study||116
8315778|NCT01454284|20502441|P2|COMPLETED|Overall Study||377
8315779|NCT01454284|20502442|P1|COMPLETED|Overall Study||548
8315780|NCT01454284|20502441|P2|Received at Least 1 Dose of Study Drug|Overall Study||449
8315781|NCT01454284|20502442|P1|Received at Least 1 Dose of Study Drug|Overall Study||663
8315782|NCT01454284|20502441|P2|STARTED|Overall Study||450
8315783|NCT01454284|20502442|P1|STARTED|Overall Study||664
8315784|NCT01454258|20502490|P1|NOT COMPLETED|Overall Study||997
8315785|NCT01454258|20502490|P1|COMPLETED|Overall Study||9103
8315786|NCT01454258|20502490|P1|STARTED|Overall Study||10100
8315787|NCT01454102|20502512|P16|NOT COMPLETED|Overall Study||1
8315788|NCT01454102|20502513|P15|NOT COMPLETED|Overall Study||3
8315789|NCT01454102|20502514|P14|NOT COMPLETED|Overall Study||4
8315790|NCT01454102|20502515|P13|NOT COMPLETED|Overall Study||7
8315791|NCT01454102|20502516|P12|NOT COMPLETED|Overall Study||4
8315792|NCT01454102|20502517|P11|NOT COMPLETED|Overall Study||0
8315793|NCT01454102|20502518|P10|NOT COMPLETED|Overall Study||0
8315794|NCT01454102|20502519|P9|NOT COMPLETED|Overall Study||1
8315795|NCT01454102|20502520|P8|NOT COMPLETED|Overall Study||0
8315796|NCT01454102|20502521|P7|NOT COMPLETED|Overall Study||2
8315797|NCT01454102|20502522|P6|NOT COMPLETED|Overall Study||3
8315798|NCT01454102|20502523|P5|NOT COMPLETED|Overall Study||3
8315799|NCT01454102|20502524|P4|NOT COMPLETED|Overall Study||0
8315800|NCT01454102|20502525|P3|NOT COMPLETED|Overall Study||0
8315801|NCT01454102|20502526|P2|NOT COMPLETED|Overall Study||0
8315802|NCT01454102|20502527|P1|NOT COMPLETED|Overall Study||0
8315803|NCT01454102|20502512|P16|COMPLETED|Overall Study||13
8315804|NCT01454102|20502513|P15|COMPLETED|Overall Study||36
8315805|NCT01454102|20502514|P14|COMPLETED|Overall Study||34
8315806|NCT01454102|20502515|P13|COMPLETED|Overall Study||33
8315807|NCT01454102|20502516|P12|COMPLETED|Overall Study||27
8315808|NCT01454102|20502517|P11|COMPLETED|Overall Study||12
8315809|NCT01454102|20502518|P10|COMPLETED|Overall Study||13
8315810|NCT01454102|20502519|P9|COMPLETED|Overall Study||12
8315811|NCT01454102|20502520|P8|COMPLETED|Overall Study||25
8315812|NCT01454102|20502521|P7|COMPLETED|Overall Study||22
8315813|NCT01454102|20502522|P6|COMPLETED|Overall Study||49
8315814|NCT01454102|20502523|P5|COMPLETED|Overall Study||18
8315815|NCT01454102|20502524|P4|COMPLETED|Overall Study||12
8315816|NCT01454102|20502525|P3|COMPLETED|Overall Study||15
8315817|NCT01454102|20502526|P2|COMPLETED|Overall Study||15
8315818|NCT01454102|20502527|P1|COMPLETED|Overall Study||12
8315819|NCT01454102|20502512|P16|STARTED|Overall Study||14
8315820|NCT01454102|20502513|P15|STARTED|Overall Study||39
8315821|NCT01454102|20502514|P14|STARTED|Overall Study||38
8315822|NCT01454102|20502515|P13|STARTED|Overall Study||40
8315823|NCT01454102|20502516|P12|STARTED|Overall Study||31
8315824|NCT01454102|20502517|P11|STARTED|Overall Study||12
8315825|NCT01454102|20502518|P10|STARTED|Overall Study||13
8315826|NCT01454102|20502519|P9|STARTED|Overall Study||13
8315827|NCT01454102|20502520|P8|STARTED|Overall Study||25
8315828|NCT01454102|20502521|P7|STARTED|Overall Study||24
8315829|NCT01454102|20502522|P6|STARTED|Overall Study||52
8315830|NCT01454102|20502523|P5|STARTED|Overall Study||21
8315831|NCT01454102|20502524|P4|STARTED|Overall Study||12
8315832|NCT01454102|20502525|P3|STARTED|Overall Study||15
8315833|NCT01454102|20502526|P2|STARTED|Overall Study||15
8315834|NCT01454102|20502527|P1|STARTED|Overall Study||12
8315835|NCT01454076|20502647|P5|NOT COMPLETED|Overall Study||6
8315836|NCT01454076|20502648|P4|NOT COMPLETED|Overall Study||2
8315837|NCT01454076|20502649|P3|NOT COMPLETED|Overall Study||9
8315838|NCT01454076|20502650|P2|NOT COMPLETED|Overall Study||6
8315839|NCT01454076|20502651|P1|NOT COMPLETED|Overall Study||13
8315840|NCT01454076|20502647|P5|COMPLETED|Overall Study||15
8315841|NCT01454076|20502648|P4|COMPLETED|Overall Study||16
8315842|NCT01454076|20502649|P3|COMPLETED|Overall Study||15
8315843|NCT01454076|20502650|P2|COMPLETED|Overall Study||14
8315844|NCT01454076|20502651|P1|COMPLETED|Overall Study||16
8315845|NCT01454076|20502647|P5|STARTED|Overall Study||21
8315846|NCT01454076|20502648|P4|STARTED|Overall Study||18
8315847|NCT01454076|20502649|P3|STARTED|Overall Study||24
8315848|NCT01454076|20502650|P2|STARTED|Overall Study||20
8315849|NCT01454076|20502651|P1|STARTED|Overall Study||29
8315850|NCT01454063|20502704|P2|NOT COMPLETED|Treated||0
8315851|NCT01454063|20502705|P1|NOT COMPLETED|Treated||2
8315852|NCT01454063|20502704|P2|COMPLETED|Treated||201
8315853|NCT01454063|20502705|P1|COMPLETED|Treated||199
8315854|NCT01454063|20502704|P2|STARTED|Treated||201
8315855|NCT01454063|20502705|P1|STARTED|Treated||201
8315856|NCT01454063|20502704|P2|NOT COMPLETED|Randomized||2
8315857|NCT01454063|20502705|P1|NOT COMPLETED|Randomized||1
8315858|NCT01454063|20502704|P2|COMPLETED|Randomized||201
8315859|NCT01454063|20502705|P1|COMPLETED|Randomized||201
8315860|NCT01454063|20502704|P2|STARTED|Randomized||203
8315861|NCT01454063|20502705|P1|STARTED|Randomized||202
8315862|NCT01453998|20502726|P3|NOT COMPLETED|After Protocol Amendment 2.||0
8315863|NCT01453998|20502727|P2|NOT COMPLETED|After Protocol Amendment 2.||0
8315864|NCT01453998|20502728|P1|NOT COMPLETED|After Protocol Amendment 2.||1
8315865|NCT01453998|20502726|P3|COMPLETED|After Protocol Amendment 2.||124
8315866|NCT01453998|20502727|P2|COMPLETED|After Protocol Amendment 2.||130
8315867|NCT01453998|20502728|P1|COMPLETED|After Protocol Amendment 2.||130
8315868|NCT01453998|20502726|P3|STARTED|After Protocol Amendment 2.||124
8315869|NCT01453998|20502727|P2|STARTED|After Protocol Amendment 2.||130
8315870|NCT01453998|20502728|P1|STARTED|After Protocol Amendment 2.||131
8315871|NCT01453998|20502726|P3|NOT COMPLETED|Before Protocol Amendment 2||0
8315872|NCT01453998|20502727|P2|NOT COMPLETED|Before Protocol Amendment 2||0
8315873|NCT01453998|20502728|P1|NOT COMPLETED|Before Protocol Amendment 2||0
8315874|NCT01453998|20502726|P3|COMPLETED|Before Protocol Amendment 2||99
8315875|NCT01453998|20502727|P2|COMPLETED|Before Protocol Amendment 2||88
8315876|NCT01453998|20502728|P1|COMPLETED|Before Protocol Amendment 2||85
8315877|NCT01453998|20502726|P3|STARTED|Before Protocol Amendment 2||99
8315878|NCT01453998|20502727|P2|STARTED|Before Protocol Amendment 2||88
8315879|NCT01453998|20502728|P1|STARTED|Before Protocol Amendment 2||85
8315880|NCT01453946|20502892|P1|NOT COMPLETED|Overall Study||9
8315881|NCT01453946|20502892|P1|COMPLETED|Overall Study||41
8315882|NCT01453946|20502892|P1|STARTED|Overall Study||50
8315883|NCT01453894|20502900|P2|NOT COMPLETED|Overall Study||0
8315884|NCT01453894|20502901|P1|NOT COMPLETED|Overall Study||0
8315885|NCT01453894|20502900|P2|COMPLETED|Overall Study||225
8315886|NCT01453894|20502901|P1|COMPLETED|Overall Study||225
8315887|NCT01453894|20502900|P2|STARTED|Overall Study||225
8315888|NCT01453894|20502901|P1|STARTED|Overall Study||225
8315889|NCT01453855|20502909|P2|NOT COMPLETED|Overall Study||14
8315890|NCT01453855|20502910|P1|NOT COMPLETED|Overall Study||10
8315891|NCT01453855|20502909|P2|COMPLETED|Overall Study||408
8315892|NCT01453855|20502910|P1|COMPLETED|Overall Study||432
8315893|NCT01453855|20502909|P2|STARTED|Overall Study||422
8315894|NCT01453855|20502910|P1|STARTED|Overall Study||442
8315895|NCT01453725|20502918|P2|NOT COMPLETED|Overall Study||11
8315896|NCT01453725|20502919|P1|NOT COMPLETED|Overall Study||13
8315897|NCT01453725|20502918|P2|COMPLETED|Overall Study||89
8315898|NCT01453725|20502919|P1|COMPLETED|Overall Study||85
8315899|NCT01453725|20502918|P2|STARTED|Overall Study||100
8315900|NCT01453725|20502919|P1|STARTED|Overall Study||98
8315901|NCT01453595|20502942|P3|NOT COMPLETED|Overall Study||2
8315902|NCT01453595|20502943|P2|NOT COMPLETED|Overall Study||1
8315903|NCT01453595|20502944|P1|NOT COMPLETED|Overall Study||2
8315904|NCT01453595|20502942|P3|COMPLETED|Overall Study||0
8315905|NCT01453595|20502943|P2|COMPLETED|Overall Study||5
8315906|NCT01453595|20502944|P1|COMPLETED|Overall Study||0
8315907|NCT01453595|20502942|P3|STARTED|Overall Study||2
8315908|NCT01453595|20502943|P2|STARTED|Overall Study||6
8315909|NCT01453595|20502944|P1|STARTED|Overall Study||2
8315910|NCT01453569|20502953|P3|NOT COMPLETED|Overall Study||7
8315911|NCT01453569|20502954|P2|NOT COMPLETED|Overall Study||14
8315912|NCT01453569|20502955|P1|NOT COMPLETED|Overall Study||11
8315913|NCT01453569|20502953|P3|COMPLETED|Overall Study||78
8315914|NCT01453569|20502954|P2|COMPLETED|Overall Study||70
8315915|NCT01453569|20502955|P1|COMPLETED|Overall Study||75
8315916|NCT01453569|20502953|P3|STARTED|Overall Study||85
8315917|NCT01453569|20502954|P2|STARTED|Overall Study||84
8315918|NCT01453569|20502955|P1|STARTED|Overall Study||86
8315919|NCT01453439|20502974|P2|NOT COMPLETED|Follow-up||11
8315920|NCT01453439|20502975|P1|NOT COMPLETED|Follow-up||5
8315921|NCT01453439|20502974|P2|COMPLETED|Follow-up||37
8315922|NCT01453439|20502975|P1|COMPLETED|Follow-up||39
8315923|NCT01453439|20502974|P2|STARTED|Follow-up||48
8315924|NCT01453439|20502975|P1|STARTED|Follow-up||44
8315925|NCT01453439|20502974|P2|NOT COMPLETED|Treatment Phase||11
8315926|NCT01453439|20502975|P1|NOT COMPLETED|Treatment Phase||17
8315927|NCT01453439|20502974|P2|COMPLETED|Treatment Phase||48
8315928|NCT01453439|20502975|P1|COMPLETED|Treatment Phase||44
8315929|NCT01453439|20502974|P2|STARTED|Treatment Phase||59
8315930|NCT01453439|20502975|P1|STARTED|Treatment Phase||61
8315931|NCT01453413|20502995|P1|NOT COMPLETED|Overall Study||0
8315932|NCT01453413|20502995|P1|COMPLETED|Overall Study||297
8315933|NCT01453413|20502995|P1|STARTED|Overall Study||297
8315934|NCT01453387|20503002|P2|NOT COMPLETED|Overall Study||0
8315935|NCT01453387|20503003|P1|NOT COMPLETED|Overall Study||0
8315936|NCT01453387|20503002|P2|COMPLETED|Overall Study||7
8315937|NCT01453387|20503003|P1|COMPLETED|Overall Study||21
8315938|NCT01453387|20503002|P2|STARTED|Overall Study||7
8315939|NCT01453387|20503003|P1|STARTED|Overall Study||21
8315940|NCT01453374|20503086|P1|NOT COMPLETED|Overall Study||18
8315941|NCT01453374|20503086|P1|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
8315942|NCT01453374|20503086|P1|STARTED|Overall Study||27
8315943|NCT01453361|20503102|P1|NOT COMPLETED|Overall Study||16
8315944|NCT01453361|20503102|P1|COMPLETED|Overall Study||2
8315945|NCT01453361|20503102|P1|STARTED|Overall Study||18
8315946|NCT01453348|20503110|P3|NOT COMPLETED|Overall Study||1
8315947|NCT01453348|20503111|P2|NOT COMPLETED|Overall Study||1
8315948|NCT01453348|20503112|P1|NOT COMPLETED|Overall Study||1
8315949|NCT01453348|20503110|P3|COMPLETED|Overall Study||83
8315950|NCT01453348|20503111|P2|COMPLETED|Overall Study||83
8315951|NCT01453348|20503112|P1|COMPLETED|Overall Study||83
8315952|NCT01453348|20503110|P3|STARTED|Overall Study||84
8315953|NCT01453348|20503111|P2|STARTED|Overall Study||84
8315954|NCT01453348|20503112|P1|STARTED|Overall Study||84
8315955|NCT01453296|20503128|P2|NOT COMPLETED|Treatment Period 2||0
8315956|NCT01453296|20503129|P1|NOT COMPLETED|Treatment Period 2||2
8315957|NCT01453296|20503128|P2|COMPLETED|Treatment Period 2||13
8315958|NCT01453296|20503129|P1|COMPLETED|Treatment Period 2||11
8315959|NCT01453296|20503128|P2|STARTED|Treatment Period 2||13
8315960|NCT01453296|20503129|P1|STARTED|Treatment Period 2||13
8315961|NCT01453296|20503128|P2|NOT COMPLETED|Washout Period||0
8315962|NCT01453296|20503129|P1|NOT COMPLETED|Washout Period||0
8315963|NCT01453296|20503128|P2|COMPLETED|Washout Period||13
8315964|NCT01453296|20503129|P1|COMPLETED|Washout Period||13
8315965|NCT01453296|20503128|P2|STARTED|Washout Period||13
8315966|NCT01453296|20503129|P1|STARTED|Washout Period||13
8315967|NCT01453296|20503128|P2|NOT COMPLETED|Treatment Period 1||1
8315968|NCT01453296|20503129|P1|NOT COMPLETED|Treatment Period 1||1
8315969|NCT01453296|20503128|P2|COMPLETED|Treatment Period 1||13
8315970|NCT01453296|20503129|P1|COMPLETED|Treatment Period 1||13
8315971|NCT01453296|20503128|P2|STARTED|Treatment Period 1||14
8315972|NCT01453296|20503129|P1|STARTED|Treatment Period 1||14
8315973|NCT01453205|20503196|P3|NOT COMPLETED|Overall Study||54
8315974|NCT01453205|20503197|P2|NOT COMPLETED|Overall Study||52
8315975|NCT01453205|20503198|P1|NOT COMPLETED|Overall Study||80
8315976|NCT01453205|20503196|P3|COMPLETED|Overall Study||1
8315977|NCT01453205|20503197|P2|COMPLETED|Overall Study||0
8315978|NCT01453205|20503198|P1|COMPLETED|Overall Study||0
8315979|NCT01453205|20503196|P3|STARTED|Overall Study||55
8315980|NCT01453205|20503197|P2|STARTED|Overall Study||52
8315981|NCT01453205|20503198|P1|STARTED|Overall Study||80
8315982|NCT01453166|20503249|P3|NOT COMPLETED|Overall Study||1
8315983|NCT01453166|20503250|P2|NOT COMPLETED|Overall Study||2
8315984|NCT01453166|20503251|P1|NOT COMPLETED|Overall Study||2
8315985|NCT01453166|20503249|P3|COMPLETED|Overall Study||38
8315986|NCT01453166|20503250|P2|COMPLETED|Overall Study||39
8315987|NCT01453166|20503251|P1|COMPLETED|Overall Study||40
8315988|NCT01453166|20503249|P3|STARTED|Overall Study||39
8315989|NCT01453166|20503250|P2|STARTED|Overall Study||41
8315990|NCT01453166|20503251|P1|STARTED|Overall Study||42
8315991|NCT01453153|20503274|P3|NOT COMPLETED|Overall Study||20
8315992|NCT01453153|20503275|P2|NOT COMPLETED|Overall Study||4
8315993|NCT01453153|20503276|P1|NOT COMPLETED|Overall Study||4
8315994|NCT01453153|20503274|P3|COMPLETED|Overall Study||0
8315995|NCT01453153|20503275|P2|COMPLETED|Overall Study||0
8315996|NCT01453153|20503276|P1|COMPLETED|Overall Study||0
8315997|NCT01453153|20503274|P3|STARTED|Overall Study||20
8315998|NCT01453153|20503275|P2|STARTED|Overall Study||4
8315999|NCT01453153|20503276|P1|STARTED|Overall Study||4
8316000|NCT01453075|20503349|P2|NOT COMPLETED|Overall Study||1
8316001|NCT01453075|20503350|P1|NOT COMPLETED|Overall Study||5
8316002|NCT01453075|20503349|P2|COMPLETED|Overall Study||14
8316003|NCT01453075|20503350|P1|COMPLETED|Overall Study||11
8316004|NCT01453075|20503349|P2|STARTED|Overall Study||15
8316005|NCT01453075|20503350|P1|STARTED|Overall Study||16
8316006|NCT01453049|20503358|P2|NOT COMPLETED|Overall Study||42
8316007|NCT01453049|20503359|P1|NOT COMPLETED|Overall Study||41
8316008|NCT01453049|20503358|P2|COMPLETED|Overall Study||2
8316009|NCT01453049|20503359|P1|COMPLETED|Overall Study||1
8316010|NCT01453049|20503358|P2|STARTED|Overall Study||44
8316011|NCT01453049|20503359|P1|STARTED|Overall Study||42
8316012|NCT01453036|20503432|P3|NOT COMPLETED|Overall Study||31
8316013|NCT01453036|20503433|P2|NOT COMPLETED|Overall Study||115
8316014|NCT01453036|20503434|P1|NOT COMPLETED|Overall Study||26
8316015|NCT01453036|20503432|P3|COMPLETED|Overall Study||277
8316016|NCT01453036|20503433|P2|COMPLETED|Overall Study||193
8316017|NCT01453036|20503434|P1|COMPLETED|Overall Study||282
8316018|NCT01453036|20503432|P3|STARTED|Overall Study||308
8316019|NCT01453036|20503433|P2|STARTED|Overall Study||308
8316020|NCT01453036|20503434|P1|STARTED|Overall Study||308
8316021|NCT01453023|20503442|P2|NOT COMPLETED|Treatment Period 2||1
8316022|NCT01453023|20503443|P1|NOT COMPLETED|Treatment Period 2||0
8316023|NCT01453023|20503442|P2|COMPLETED|Treatment Period 2||11
8316024|NCT01453023|20503443|P1|COMPLETED|Treatment Period 2||12
8316025|NCT01453023|20503442|P2|STARTED|Treatment Period 2||12
8316026|NCT01453023|20503443|P1|STARTED|Treatment Period 2||12
8316027|NCT01453023|20503442|P2|NOT COMPLETED|Washout Period||0
8316028|NCT01453023|20503443|P1|NOT COMPLETED|Washout Period||0
8316029|NCT01453023|20503442|P2|COMPLETED|Washout Period||12
8316030|NCT01453023|20503443|P1|COMPLETED|Washout Period||12
8316031|NCT01453023|20503442|P2|STARTED|Washout Period||12
8316032|NCT01453023|20503443|P1|STARTED|Washout Period||12
8316033|NCT01453023|20503442|P2|NOT COMPLETED|Treatment Period (TP) 1||1
8316034|NCT01453023|20503443|P1|NOT COMPLETED|Treatment Period (TP) 1||1
8316035|NCT01453023|20503442|P2|COMPLETED|Treatment Period (TP) 1||12
8316036|NCT01453023|20503443|P1|COMPLETED|Treatment Period (TP) 1||12
8316037|NCT01453023|20503442|P2|STARTED|Treatment Period (TP) 1||13
8316038|NCT01453023|20503443|P1|STARTED|Treatment Period (TP) 1||13
8316039|NCT01452854|20503511|P1|NOT COMPLETED|Overall Study||0
8316040|NCT01452854|20503511|P1|COMPLETED|Overall Study||2
8316041|NCT01452854|20503511|P1|STARTED|Overall Study||2
8316042|NCT01452789|20503517|P2|NOT COMPLETED|Overall Study||2
8316043|NCT01452789|20503518|P1|NOT COMPLETED|Overall Study||3
8316044|NCT01452789|20503517|P2|COMPLETED|Overall Study||28
8316045|NCT01452789|20503518|P1|COMPLETED|Overall Study||30
8316046|NCT01452789|20503517|P2|STARTED|Overall Study||30
8316047|NCT01452789|20503518|P1|STARTED|Overall Study||33
8316048|NCT01452529|20503532|P3|NOT COMPLETED|Double-blind (DB) Period||82
8316049|NCT01452529|20503533|P2|NOT COMPLETED|Double-blind (DB) Period||67
8316050|NCT01452529|20503534|P1|NOT COMPLETED|Double-blind (DB) Period||0
8316051|NCT01452529|20503532|P3|COMPLETED|Double-blind (DB) Period||210
8316052|NCT01452529|20503533|P2|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
8316053|NCT01452529|20503534|P1|COMPLETED|Double-blind (DB) Period||0
8316054|NCT01452529|20503532|P3|STARTED|Double-blind (DB) Period||292
8316055|NCT01452529|20503533|P2|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
8316056|NCT01452529|20503534|P1|STARTED|Double-blind (DB) Period||0
8316057|NCT01452529|20503532|P3|NOT COMPLETED|Run-in Period||0
8316058|NCT01452529|20503533|P2|NOT COMPLETED|Run-in Period||0
8316059|NCT01452529|20503534|P1|NOT COMPLETED|Run-in Period||313
8316060|NCT01452529|20503532|P3|COMPLETED|Run-in Period||0
8316061|NCT01452529|20503533|P2|COMPLETED|Run-in Period||0
8316062|NCT01452529|20503534|P1|COMPLETED|Run-in Period||592
8316063|NCT01452529|20503532|P3|STARTED|Run-in Period||0
8316064|NCT01452529|20503533|P2|STARTED|Run-in Period||0
8316065|NCT01452529|20503534|P1|STARTED|Run-in Period||905
8316066|NCT01452425|20503549|P1|NOT COMPLETED|Overall Study||0
8316067|NCT01452425|20503549|P1|COMPLETED|Overall Study||10
8316068|NCT01452425|20503549|P1|STARTED|Overall Study||10
8316069|NCT01452412|20503556|P2|NOT COMPLETED|Overall Study||17
8316070|NCT01452412|20503557|P1|NOT COMPLETED|Overall Study||28
8316071|NCT01452412|20503556|P2|COMPLETED|Overall Study||58
8316072|NCT01452412|20503557|P1|COMPLETED|Overall Study||46
8316073|NCT01452412|20503556|P2|STARTED|Overall Study||75
8316074|NCT01452412|20503557|P1|STARTED|Overall Study||74
8316075|NCT01452347|20503573|P2|NOT COMPLETED|Overall Study||7
8316076|NCT01452347|20503574|P1|NOT COMPLETED|Overall Study||17
8316077|NCT01452347|20503573|P2|COMPLETED|Overall Study||77
8316078|NCT01452347|20503574|P1|COMPLETED|Overall Study||151
8316079|NCT01452347|20503573|P2|STARTED|Overall Study||84
8316080|NCT01452347|20503574|P1|STARTED|Overall Study||168
8316081|NCT01452269|20503592|P2|NOT COMPLETED|Overall Study||5
8316082|NCT01452269|20503593|P1|NOT COMPLETED|Overall Study||1
8316083|NCT01452269|20503592|P2|COMPLETED|Overall Study||51
8316084|NCT01452269|20503593|P1|COMPLETED|Overall Study||47
8316085|NCT01452269|20503592|P2|STARTED|Overall Study||56
8316086|NCT01452269|20503593|P1|STARTED|Overall Study||48
8316087|NCT01452191|20503606|P3|NOT COMPLETED|Overall Study||112
8316088|NCT01452191|20503607|P2|NOT COMPLETED|Overall Study||117
8316089|NCT01452191|20503608|P1|NOT COMPLETED|Overall Study||132
8316090|NCT01452191|20503606|P3|COMPLETED|Overall Study||258
8316091|NCT01452191|20503607|P2|COMPLETED|Overall Study||252
8316092|NCT01452191|20503608|P1|COMPLETED|Overall Study||241
8316093|NCT01452191|20503606|P3|STARTED|Overall Study||370
8316094|NCT01452191|20503607|P2|STARTED|Overall Study||369
8316095|NCT01452191|20503608|P1|STARTED|Overall Study||373
8316096|NCT01452152|20503634|P3|NOT COMPLETED|Overall Study||4
8316097|NCT01452152|20503635|P2|NOT COMPLETED|Overall Study||0
8316098|NCT01452152|20503636|P1|NOT COMPLETED|Overall Study||5
8316099|NCT01452152|20503634|P3|COMPLETED|Overall Study||0
8316100|NCT01452152|20503635|P2|COMPLETED|Overall Study||0
8316101|NCT01452152|20503636|P1|COMPLETED|Overall Study||0
8316102|NCT01452152|20503634|P3|STARTED|Overall Study||4
8316103|NCT01452152|20503635|P2|STARTED|Overall Study||0
8316104|NCT01452152|20503636|P1|STARTED|Overall Study||5
8316105|NCT01452126|20503659|P1|NOT COMPLETED|Overall Study||0
8316106|NCT01452126|20503659|P1|COMPLETED|Overall Study||49
8316107|NCT01452126|20503659|P1|STARTED|Overall Study||49
8316108|NCT01451996|20503671|P4|NOT COMPLETED|Overall Study||0
8316109|NCT01451996|20503672|P3|NOT COMPLETED|Overall Study||0
8316110|NCT01451996|20503673|P2|NOT COMPLETED|Overall Study||0
8316111|NCT01451996|20503674|P1|NOT COMPLETED|Overall Study||0
8316112|NCT01451996|20503671|P4|COMPLETED|Overall Study||85
8316113|NCT01451996|20503672|P3|COMPLETED|Overall Study||85
8316114|NCT01451996|20503673|P2|COMPLETED|Overall Study||87
8316115|NCT01451996|20503674|P1|COMPLETED|Overall Study||83
8316116|NCT01451996|20503671|P4|STARTED|Overall Study||85
8316117|NCT01451996|20503672|P3|STARTED|Overall Study||85
8316118|NCT01451996|20503673|P2|STARTED|Overall Study||87
8316119|NCT01451996|20503674|P1|STARTED|Overall Study||83
8316120|NCT01451983|20503692|P4|NOT COMPLETED|Overall Study||0
8316121|NCT01451983|20503693|P3|NOT COMPLETED|Overall Study||0
8316122|NCT01451983|20503694|P2|NOT COMPLETED|Overall Study||0
8316123|NCT01451983|20503695|P1|NOT COMPLETED|Overall Study||0
8316124|NCT01451983|20503692|P4|COMPLETED|Overall Study||24
8316125|NCT01451983|20503693|P3|COMPLETED|Overall Study||61
8316126|NCT01451983|20503694|P2|COMPLETED|Overall Study||27
8316127|NCT01451983|20503695|P1|COMPLETED|Overall Study||26
8316128|NCT01451983|20503692|P4|STARTED|Overall Study||24
8316129|NCT01451983|20503693|P3|STARTED|Overall Study||61
8316130|NCT01451983|20503694|P2|STARTED|Overall Study||27
8316131|NCT01451983|20503695|P1|STARTED|Overall Study||26
8316132|NCT01451931|20503708|P3|NOT COMPLETED|Overall Study||43
8316133|NCT01451931|20503709|P2|NOT COMPLETED|Overall Study||58
8316134|NCT01451931|20503710|P1|NOT COMPLETED|Overall Study||33
8316135|NCT01451931|20503708|P3|COMPLETED|Overall Study||923
8316136|NCT01451931|20503709|P2|COMPLETED|Overall Study||843
8316137|NCT01451931|20503710|P1|COMPLETED|Overall Study||876
8316138|NCT01451931|20503708|P3|6-month Follow up|Overall Study||923
8316139|NCT01451931|20503709|P2|6-month Follow up|Overall Study||843
8316140|NCT01451931|20503710|P1|6-month Follow up|Overall Study||876
8316141|NCT01451931|20503708|P3|Baseline Data Collection|Overall Study||958
8316142|NCT01451931|20503709|P2|Baseline Data Collection|Overall Study||893
8316143|NCT01451931|20503710|P1|Baseline Data Collection|Overall Study||908
8316144|NCT01451931|20503708|P3|STARTED|Overall Study||966
8316145|NCT01451931|20503709|P2|STARTED|Overall Study||901
8316146|NCT01451931|20503710|P1|STARTED|Overall Study||909
8316147|NCT01451827|20503734|P4|NOT COMPLETED|Overall Study||4
8316148|NCT01451827|20503735|P3|NOT COMPLETED|Overall Study||2
8316149|NCT01451827|20503736|P2|NOT COMPLETED|Overall Study||5
8316150|NCT01451827|20503737|P1|NOT COMPLETED|Overall Study||3
8316151|NCT01451827|20503734|P4|COMPLETED|Overall Study||39
8316152|NCT01451827|20503735|P3|COMPLETED|Overall Study||42
8316153|NCT01451827|20503736|P2|COMPLETED|Overall Study||40
8316154|NCT01451827|20503737|P1|COMPLETED|Overall Study||42
8316155|NCT01451827|20503734|P4|STARTED|Overall Study||43
8316156|NCT01451827|20503735|P3|STARTED|Overall Study||44
8316157|NCT01451827|20503736|P2|STARTED|Overall Study||45
8316158|NCT01451827|20503737|P1|STARTED|Overall Study||45
8316159|NCT01451814|20503757|P2|NOT COMPLETED|Overall Study||5
8316160|NCT01451814|20503758|P1|NOT COMPLETED|Overall Study||6
8316161|NCT01451814|20503757|P2|COMPLETED|Overall Study||26
8316162|NCT01451814|20503758|P1|COMPLETED|Overall Study||29
8316163|NCT01451814|20503757|P2|Attended a Session|Overall Study||31
8316164|NCT01451814|20503758|P1|Attended a Session|Overall Study||35
8316165|NCT01451814|20503757|P2|STARTED|Overall Study||31
8316166|NCT01451814|20503758|P1|STARTED|Overall Study||35
8316167|NCT01451775|20503768|P6|NOT COMPLETED|Overall Study||0
8316168|NCT01451775|20503769|P5|NOT COMPLETED|Overall Study||0
8316169|NCT01451775|20503770|P4|NOT COMPLETED|Overall Study||0
8316170|NCT01451775|20503771|P3|NOT COMPLETED|Overall Study||0
8316171|NCT01451775|20503772|P2|NOT COMPLETED|Overall Study||0
8316172|NCT01451775|20503773|P1|NOT COMPLETED|Overall Study||0
8316173|NCT01451775|20503768|P6|COMPLETED|Overall Study||3
8316174|NCT01451775|20503769|P5|COMPLETED|Overall Study||3
8316175|NCT01451775|20503770|P4|COMPLETED|Overall Study||3
8316176|NCT01451775|20503771|P3|COMPLETED|Overall Study||3
8316177|NCT01451775|20503772|P2|COMPLETED|Overall Study||3
8316178|NCT01451775|20503773|P1|COMPLETED|Overall Study||3
8316179|NCT01451775|20503768|P6|STARTED|Overall Study||3
8316180|NCT01451775|20503769|P5|STARTED|Overall Study||3
8316181|NCT01451775|20503770|P4|STARTED|Overall Study||3
8316182|NCT01451775|20503771|P3|STARTED|Overall Study||3
8316183|NCT01451775|20503772|P2|STARTED|Overall Study||3
8316184|NCT01451775|20503773|P1|STARTED|Overall Study||3
8316185|NCT01451762|20503790|P3|NOT COMPLETED|Overall Study||6
8316186|NCT01451762|20503791|P2|NOT COMPLETED|Overall Study||6
8316187|NCT01451762|20503792|P1|NOT COMPLETED|Overall Study||3
8316188|NCT01451762|20503790|P3|COMPLETED|Overall Study||24
8316189|NCT01451762|20503791|P2|COMPLETED|Overall Study||24
8316190|NCT01451762|20503792|P1|COMPLETED|Overall Study||27
8316191|NCT01451762|20503790|P3|STARTED|Overall Study||30
8316192|NCT01451762|20503791|P2|STARTED|Overall Study||30
8316193|NCT01451762|20503792|P1|STARTED|Overall Study||30
8316194|NCT01451749|20503802|P2|NOT COMPLETED|Overall Study||14
8316195|NCT01451749|20503803|P1|NOT COMPLETED|Overall Study||32
8316196|NCT01451749|20503802|P2|COMPLETED|Overall Study||94
8316197|NCT01451749|20503803|P1|COMPLETED|Overall Study||184
8316198|NCT01451749|20503802|P2|STARTED|Overall Study||108
8316199|NCT01451749|20503803|P1|STARTED|Overall Study||216
8316200|NCT01451723|20503815|P2|NOT COMPLETED|Overall Study||5
8316201|NCT01451723|20503816|P1|NOT COMPLETED|Overall Study||6
8316202|NCT01451723|20503815|P2|COMPLETED|Overall Study||0
8316203|NCT01451723|20503816|P1|COMPLETED|Overall Study||0
8316204|NCT01451723|20503815|P2|STARTED|Overall Study||5
8316205|NCT01451723|20503816|P1|STARTED|Overall Study||6
8316206|NCT01451645|20503826|P2|NOT COMPLETED|Overall Study||8
8316207|NCT01451645|20503827|P1|NOT COMPLETED|Overall Study||9
8316208|NCT01451645|20503826|P2|COMPLETED|Overall Study||33
8316209|NCT01451645|20503827|P1|COMPLETED|Overall Study||32
8316210|NCT01451645|20503826|P2|STARTED|Overall Study||41
8316211|NCT01451645|20503827|P1|STARTED|Overall Study||41
8316212|NCT01451632|20503841|P10|NOT COMPLETED|Overall Study||0
8316213|NCT01451632|20503842|P9|NOT COMPLETED|Overall Study||0
8316214|NCT01451632|20503843|P8|NOT COMPLETED|Overall Study||0
8316215|NCT01451632|20503844|P7|NOT COMPLETED|Overall Study||0
8316216|NCT01451632|20503845|P6|NOT COMPLETED|Overall Study||0
8316217|NCT01451632|20503846|P5|NOT COMPLETED|Overall Study||0
8316218|NCT01451632|20503847|P4|NOT COMPLETED|Overall Study||0
8316219|NCT01451632|20503848|P3|NOT COMPLETED|Overall Study||0
8316220|NCT01451632|20503849|P2|NOT COMPLETED|Overall Study||0
8316221|NCT01451632|20503850|P1|NOT COMPLETED|Overall Study||0
8316222|NCT01451632|20503841|P10|COMPLETED|Overall Study||4
8316223|NCT01451632|20503842|P9|COMPLETED|Overall Study||4
8316224|NCT01451632|20503843|P8|COMPLETED|Overall Study||6
8316225|NCT01451632|20503844|P7|COMPLETED|Overall Study||8
8316226|NCT01451632|20503845|P6|COMPLETED|Overall Study||4
8316227|NCT01451632|20503846|P5|COMPLETED|Overall Study||4
8316228|NCT01451632|20503847|P4|COMPLETED|Overall Study||3
8316229|NCT01451632|20503848|P3|COMPLETED|Overall Study||3
8316230|NCT01451632|20503849|P2|COMPLETED|Overall Study||4
8316231|NCT01451632|20503850|P1|COMPLETED|Overall Study||8
8316232|NCT01451632|20503841|P10|STARTED|Overall Study||4
8316233|NCT01451632|20503842|P9|STARTED|Overall Study||4
8316234|NCT01451632|20503843|P8|STARTED|Overall Study||6
8316235|NCT01451632|20503844|P7|STARTED|Overall Study||8
8316236|NCT01451632|20503845|P6|STARTED|Overall Study||4
8316237|NCT01451632|20503846|P5|STARTED|Overall Study||4
8316238|NCT01451632|20503847|P4|STARTED|Overall Study||3
8316239|NCT01451632|20503848|P3|STARTED|Overall Study||3
8316240|NCT01451632|20503849|P2|STARTED|Overall Study||4
8316241|NCT01451632|20503850|P1|STARTED|Overall Study||8
8316242|NCT01451606|20503898|P2|NOT COMPLETED|Overall Study||3
8316243|NCT01451606|20503899|P1|NOT COMPLETED|Overall Study||4
8316244|NCT01451606|20503898|P2|COMPLETED|Overall Study||15
8316245|NCT01451606|20503899|P1|COMPLETED|Overall Study||12
8316246|NCT01451606|20503898|P2|STARTED|Overall Study||18
8316247|NCT01451606|20503899|P1|STARTED|Overall Study||16
8316248|NCT01451554|20503909|P2|NOT COMPLETED|Overall Study||9
8316249|NCT01451554|20503910|P1|NOT COMPLETED|Overall Study||14
8316250|NCT01451554|20503909|P2|COMPLETED|Overall Study||23
8316251|NCT01451554|20503910|P1|COMPLETED|Overall Study||19
8316252|NCT01451554|20503909|P2|STARTED|Overall Study||32
8316253|NCT01451554|20503910|P1|STARTED|Overall Study||33
8316254|NCT01451541|20503921|P3|NOT COMPLETED|Overall Study||27
8316255|NCT01451541|20503922|P2|NOT COMPLETED|Overall Study||25
8316256|NCT01451541|20503923|P1|NOT COMPLETED|Overall Study||36
8316257|NCT01451541|20503921|P3|COMPLETED|Overall Study||254
8316258|NCT01451541|20503922|P2|COMPLETED|Overall Study||257
8316259|NCT01451541|20503923|P1|COMPLETED|Overall Study||247
8316260|NCT01451541|20503921|P3|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
8316261|NCT01451541|20503922|P2|STARTED|Overall Study||282
8316262|NCT01451541|20503923|P1|STARTED|Overall Study||283
8316263|NCT01451463|20503963|P1|NOT COMPLETED|Overall Study||0
8316264|NCT01451463|20503963|P1|COMPLETED|Overall Study||11
8316265|NCT01451463|20503963|P1|STARTED|Overall Study||11
8316266|NCT01451437|20503981|P9|NOT COMPLETED|Overall Study||4
8316267|NCT01451437|20503982|P8|NOT COMPLETED|Overall Study||3
8316268|NCT01451437|20503983|P7|NOT COMPLETED|Overall Study||6
8316269|NCT01451437|20503984|P6|NOT COMPLETED|Overall Study||3
8316270|NCT01451437|20503985|P5|NOT COMPLETED|Overall Study||4
8316271|NCT01451437|20503986|P4|NOT COMPLETED|Overall Study||1
8316272|NCT01451437|20503987|P3|NOT COMPLETED|Overall Study||3
8316273|NCT01451437|20503988|P2|NOT COMPLETED|Overall Study||1
8316274|NCT01451437|20503989|P1|NOT COMPLETED|Overall Study||1
8316275|NCT01451437|20503981|P9|COMPLETED|Overall Study||0
8316276|NCT01451437|20503982|P8|COMPLETED|Overall Study||0
8316277|NCT01451437|20503983|P7|COMPLETED|Overall Study||0
8316278|NCT01451437|20503984|P6|COMPLETED|Overall Study||0
8316279|NCT01451437|20503985|P5|COMPLETED|Overall Study||0
8316280|NCT01451437|20503986|P4|COMPLETED|Overall Study||0
8316281|NCT01451437|20503987|P3|COMPLETED|Overall Study||0
8316282|NCT01451437|20503988|P2|COMPLETED|Overall Study||0
8316283|NCT01451437|20503989|P1|COMPLETED|Overall Study||0
8316284|NCT01451437|20503981|P9|STARTED|Overall Study||4
8316285|NCT01451437|20503982|P8|STARTED|Overall Study||3
8316286|NCT01451437|20503983|P7|STARTED|Overall Study||6
8316287|NCT01451437|20503984|P6|STARTED|Overall Study||3
8316288|NCT01451437|20503985|P5|STARTED|Overall Study||4
8316289|NCT01451437|20503986|P4|STARTED|Overall Study||1
8316290|NCT01451437|20503987|P3|STARTED|Overall Study||3
8316291|NCT01451437|20503988|P2|STARTED|Overall Study||1
8316292|NCT01451437|20503989|P1|STARTED|Overall Study||1
8316293|NCT01451424|20504121|P4|NOT COMPLETED|Overall Study||5
8316294|NCT01451424|20504122|P3|NOT COMPLETED|Overall Study||1
8316295|NCT01451424|20504123|P2|NOT COMPLETED|Overall Study||2
8316296|NCT01451424|20504124|P1|NOT COMPLETED|Overall Study||1
8316297|NCT01451424|20504121|P4|COMPLETED|Overall Study||5
8316298|NCT01451424|20504122|P3|COMPLETED|Overall Study||11
8316299|NCT01451424|20504123|P2|COMPLETED|Overall Study||7
8316300|NCT01451424|20504124|P1|COMPLETED|Overall Study||8
8316301|NCT01451424|20504121|P4|STARTED|Overall Study||10
8316302|NCT01451424|20504122|P3|STARTED|Overall Study||12
8316303|NCT01451424|20504123|P2|STARTED|Overall Study||9
8316304|NCT01451424|20504124|P1|STARTED|Overall Study||9
8316305|NCT01451411|20504157|P2|NOT COMPLETED|Overall Study||0
8316306|NCT01451411|20504158|P1|NOT COMPLETED|Overall Study||0
8316307|NCT01451411|20504157|P2|COMPLETED|Overall Study||1
8316308|NCT01451411|20504158|P1|COMPLETED|Overall Study||3
8316309|NCT01451411|20504157|P2|STARTED|Overall Study||1
8316310|NCT01451411|20504158|P1|STARTED|Overall Study||3
8316311|NCT01451398|20504182|P2|NOT COMPLETED|Overall Study||37
8316312|NCT01451398|20504183|P1|NOT COMPLETED|Overall Study||27
8316313|NCT01451398|20504182|P2|COMPLETED|Overall Study||139
8316314|NCT01451398|20504183|P1|COMPLETED|Overall Study||150
8316315|NCT01451398|20504182|P2|STARTED|Overall Study||176
8316316|NCT01451398|20504183|P1|STARTED|Overall Study||177
8316317|NCT01451385|20504215|P1|NOT COMPLETED|Overall Study||91
8316318|NCT01451385|20504215|P1|COMPLETED|Overall Study||285
8316319|NCT01451385|20504215|P1|STARTED|Overall Study||376
8316320|NCT01451372|20504227|P1|NOT COMPLETED|Overall Study||0
8316321|NCT01451372|20504227|P1|COMPLETED|Overall Study||69
8316322|NCT01451372|20504227|P1|STARTED|Overall Study||69
8316323|NCT01451203|20504234|P2|NOT COMPLETED|Post-treatment Period||34
8316324|NCT01451203|20504235|P1|NOT COMPLETED|Post-treatment Period||14
8316325|NCT01451203|20504234|P2|COMPLETED|Post-treatment Period||74
8316326|NCT01451203|20504235|P1|COMPLETED|Post-treatment Period||57
8316327|NCT01451203|20504234|P2|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
8316328|NCT01451203|20504235|P1|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
8316329|NCT01451203|20504234|P2|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
8316330|NCT01451203|20504235|P1|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
8316331|NCT01451203|20504234|P2|NOT COMPLETED|Double-blind Treatment Period||50
8316332|NCT01451203|20504235|P1|NOT COMPLETED|Double-blind Treatment Period||85
8316333|NCT01451203|20504234|P2|COMPLETED|Double-blind Treatment Period||111
8316334|NCT01451203|20504235|P1|COMPLETED|Double-blind Treatment Period||73
8316335|NCT01451203|20504234|P2|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
8316336|NCT01451203|20504235|P1|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
8316337|NCT01451203|20504234|P2|Received Treatment|Double-blind Treatment Period||159
8316338|NCT01451203|20504235|P1|Received Treatment|Double-blind Treatment Period||157
8316339|NCT01451203|20504234|P2|STARTED|Double-blind Treatment Period||161
8316340|NCT01451203|20504235|P1|STARTED|Double-blind Treatment Period||158
8316341|NCT01451164|20504253|P4|NOT COMPLETED|Overall Study||46
8316342|NCT01451164|20504254|P3|NOT COMPLETED|Overall Study||45
8316343|NCT01451164|20504255|P2|NOT COMPLETED|Overall Study||34
8316344|NCT01451164|20504256|P1|NOT COMPLETED|Overall Study||43
8316345|NCT01451164|20504253|P4|COMPLETED|Overall Study||70
8316346|NCT01451164|20504254|P3|COMPLETED|Overall Study||68
8316347|NCT01451164|20504255|P2|COMPLETED|Overall Study||81
8316348|NCT01451164|20504256|P1|COMPLETED|Overall Study||72
8316349|NCT01451164|20504253|P4|STARTED|Overall Study||116
8316350|NCT01451164|20504254|P3|STARTED|Overall Study||113
8316351|NCT01451164|20504255|P2|STARTED|Overall Study||115
8316352|NCT01451164|20504256|P1|STARTED|Overall Study||115
8316353|NCT01450943|20504285|P3|NOT COMPLETED|Overall Study||6
8316354|NCT01450943|20504286|P2|NOT COMPLETED|Overall Study||7
8316355|NCT01450943|20504287|P1|NOT COMPLETED|Overall Study||2
8316356|NCT01450943|20504285|P3|COMPLETED|Overall Study||42
8316357|NCT01450943|20504286|P2|COMPLETED|Overall Study||35
8316358|NCT01450943|20504287|P1|COMPLETED|Overall Study||26
8316359|NCT01450943|20504285|P3|STARTED|Overall Study||48
8316360|NCT01450943|20504286|P2|STARTED|Overall Study||42
8316361|NCT01450943|20504287|P1|STARTED|Overall Study||28
8316362|NCT01450826|20504303|P2|NOT COMPLETED|Overall Study||0
8316363|NCT01450826|20504304|P1|NOT COMPLETED|Overall Study||0
8316364|NCT01450826|20504303|P2|COMPLETED|Overall Study||66
8316365|NCT01450826|20504304|P1|COMPLETED|Overall Study||70
8316366|NCT01450826|20504303|P2|STARTED|Overall Study||66
8316367|NCT01450826|20504304|P1|STARTED|Overall Study||70
8316368|NCT01450813|20504320|P4|NOT COMPLETED|Overall Study||3
8316369|NCT01450813|20504321|P3|NOT COMPLETED|Overall Study||0
8316370|NCT01450813|20504322|P2|NOT COMPLETED|Overall Study||1
8316371|NCT01450813|20504323|P1|NOT COMPLETED|Overall Study||1
8316372|NCT01450813|20504320|P4|COMPLETED|Overall Study||17
8316373|NCT01450813|20504321|P3|COMPLETED|Overall Study||20
8316374|NCT01450813|20504322|P2|COMPLETED|Overall Study||19
8316375|NCT01450813|20504323|P1|COMPLETED|Overall Study||19
8316376|NCT01450813|20504320|P4|STARTED|Overall Study||20
8316377|NCT01450813|20504321|P3|STARTED|Overall Study||20
8316378|NCT01450813|20504322|P2|STARTED|Overall Study||20
8316379|NCT01450813|20504323|P1|STARTED|Overall Study||20
8316380|NCT01450800|20504337|P2|NOT COMPLETED|Overall Study||3
8316381|NCT01450800|20504338|P1|NOT COMPLETED|Overall Study||1
8316382|NCT01450800|20504337|P2|COMPLETED|Overall Study||78
8316383|NCT01450800|20504338|P1|COMPLETED|Overall Study||81
8316384|NCT01450800|20504337|P2|STARTED|Overall Study|81 participants were randomized to placebo|81
8316385|NCT01450800|20504338|P1|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
8316386|NCT01450787|20504354|P2|NOT COMPLETED|Overall Study||0
8316387|NCT01450787|20504355|P1|NOT COMPLETED|Overall Study||0
8316388|NCT01450787|20504354|P2|COMPLETED|Overall Study||25
8316389|NCT01450787|20504355|P1|COMPLETED|Overall Study||38
8316390|NCT01450787|20504354|P2|STARTED|Overall Study||25
8316391|NCT01450787|20504355|P1|STARTED|Overall Study||38
8316392|NCT01450761|20504373|P2|NOT COMPLETED|Treatment With Blinded Study Therapy||476
8316393|NCT01450761|20504374|P1|NOT COMPLETED|Treatment With Blinded Study Therapy||478
8316394|NCT01450761|20504373|P2|COMPLETED|Treatment With Blinded Study Therapy||0
8316395|NCT01450761|20504374|P1|COMPLETED|Treatment With Blinded Study Therapy||0
8316396|NCT01450761|20504373|P2|STARTED|Treatment With Blinded Study Therapy||476
8316397|NCT01450761|20504374|P1|STARTED|Treatment With Blinded Study Therapy||478
8316398|NCT01450761|20504373|P2|NOT COMPLETED|Lead-in Chemotherapy||85
8316399|NCT01450761|20504374|P1|NOT COMPLETED|Lead-in Chemotherapy||84
8316400|NCT01450761|20504373|P2|COMPLETED|Lead-in Chemotherapy||476
8316401|NCT01450761|20504374|P1|COMPLETED|Lead-in Chemotherapy||478
8316402|NCT01450761|20504373|P2|STARTED|Lead-in Chemotherapy||561
8316403|NCT01450761|20504374|P1|STARTED|Lead-in Chemotherapy||562
8316404|NCT01450761|20504373|P2|NOT COMPLETED|Randomization||5
8316405|NCT01450761|20504374|P1|NOT COMPLETED|Randomization||4
8316406|NCT01450761|20504373|P2|COMPLETED|Randomization||561
8316407|NCT01450761|20504374|P1|COMPLETED|Randomization||562
8316408|NCT01450761|20504373|P2|STARTED|Randomization||566
8316409|NCT01450761|20504374|P1|STARTED|Randomization||566
8316410|NCT01450696|20504386|P2|NOT COMPLETED|Overall Study||148
8316411|NCT01450696|20504387|P1|NOT COMPLETED|Overall Study||148
8316412|NCT01450696|20504386|P2|COMPLETED|Overall Study||0
8316413|NCT01450696|20504387|P1|COMPLETED|Overall Study||0
8316414|NCT01450696|20504386|P2|Treated (Safety Population)|Overall Study||147
8316415|NCT01450696|20504387|P1|Treated (Safety Population)|Overall Study||147
8316416|NCT01450696|20504386|P2|STARTED|Overall Study||148
8316417|NCT01450696|20504387|P1|STARTED|Overall Study||148
8316418|NCT01450683|20504409|P1|NOT COMPLETED|Overall Study||2
8316419|NCT01450683|20504409|P1|COMPLETED|Overall Study||2
8316420|NCT01450683|20504409|P1|STARTED|Overall Study||4
8316421|NCT01450631|20504415|P2|NOT COMPLETED|Overall Study||4
8316422|NCT01450631|20504416|P1|NOT COMPLETED|Overall Study||3
8316423|NCT01450631|20504415|P2|COMPLETED|Overall Study||42
8316424|NCT01450631|20504416|P1|COMPLETED|Overall Study||43
8316425|NCT01450631|20504415|P2|STARTED|Overall Study||46
8316426|NCT01450631|20504416|P1|STARTED|Overall Study||46
8316427|NCT01450397|20504424|P1|NOT COMPLETED|Overall Study||0
8316428|NCT01450397|20504424|P1|COMPLETED|Overall Study||5
8316429|NCT01450397|20504424|P1|STARTED|Overall Study||5
8316430|NCT01450319|20504428|P1|NOT COMPLETED|Overall Study||0
8316431|NCT01450319|20504428|P1|COMPLETED|Overall Study||70
8316432|NCT01450319|20504428|P1|STARTED|Overall Study||70
8316433|NCT01450306|20504441|P2|NOT COMPLETED|Overall Study||0
8316434|NCT01450306|20504442|P1|NOT COMPLETED|Overall Study||0
8316435|NCT01450306|20504441|P2|COMPLETED|Overall Study||10
8316436|NCT01450306|20504442|P1|COMPLETED|Overall Study||10
8316437|NCT01450306|20504441|P2|STARTED|Overall Study||10
8316438|NCT01450306|20504442|P1|STARTED|Overall Study||10
8316439|NCT01450189|20504455|P3|NOT COMPLETED|Overall Study||0
8316440|NCT01450189|20504456|P2|NOT COMPLETED|Overall Study||0
8316441|NCT01450189|20504457|P1|NOT COMPLETED|Overall Study||0
8316442|NCT01450189|20504455|P3|COMPLETED|Overall Study||19
8316443|NCT01450189|20504456|P2|COMPLETED|Overall Study||18
8316444|NCT01450189|20504457|P1|COMPLETED|Overall Study||9
8316445|NCT01450189|20504455|P3|STARTED|Overall Study||19
8316446|NCT01450189|20504456|P2|STARTED|Overall Study||18
8316447|NCT01450189|20504457|P1|STARTED|Overall Study||9
8316448|NCT01450137|20504546|P2|NOT COMPLETED|Week 12 to Study End||2
8316449|NCT01450137|20504547|P1|NOT COMPLETED|Week 12 to Study End||0
8316450|NCT01450137|20504546|P2|COMPLETED|Week 12 to Study End||5
8316451|NCT01450137|20504547|P1|COMPLETED|Week 12 to Study End||18
8316452|NCT01450137|20504546|P2|STARTED|Week 12 to Study End||7
8316453|NCT01450137|20504547|P1|STARTED|Week 12 to Study End||18
8316454|NCT01450137|20504546|P2|NOT COMPLETED|Up to Week 12||3
8316455|NCT01450137|20504547|P1|NOT COMPLETED|Up to Week 12||2
8316456|NCT01450137|20504546|P2|COMPLETED|Up to Week 12||7
8316457|NCT01450137|20504547|P1|COMPLETED|Up to Week 12||18
8316458|NCT01450137|20504546|P2|STARTED|Up to Week 12||10
8316459|NCT01450137|20504547|P1|STARTED|Up to Week 12||20
8316460|NCT01450098|20504561|P2|NOT COMPLETED|Period 3||3
8316461|NCT01450098|20504562|P1|NOT COMPLETED|Period 3||0
8316462|NCT01450098|20504561|P2|COMPLETED|Period 3||28
8316463|NCT01450098|20504562|P1|COMPLETED|Period 3||8
8316464|NCT01450098|20504561|P2|Received at Least 1 Dose of Study Drug|Period 3||30
8316465|NCT01450098|20504562|P1|Received at Least 1 Dose of Study Drug|Period 3||8
8316466|NCT01450098|20504561|P2|STARTED|Period 3||31
8316467|NCT01450098|20504562|P1|STARTED|Period 3||8
8316468|NCT01450098|20504561|P2|NOT COMPLETED|Washout of at Least 14 Days||0
8316469|NCT01450098|20504562|P1|NOT COMPLETED|Washout of at Least 14 Days||0
8316470|NCT01450098|20504561|P2|COMPLETED|Washout of at Least 14 Days||31
8316471|NCT01450098|20504562|P1|COMPLETED|Washout of at Least 14 Days||8
8316472|NCT01450098|20504561|P2|STARTED|Washout of at Least 14 Days||31
8316473|NCT01450098|20504562|P1|STARTED|Washout of at Least 14 Days||8
8316474|NCT01450098|20504561|P2|NOT COMPLETED|Period 2||0
8316475|NCT01450098|20504562|P1|NOT COMPLETED|Period 2||0
8316476|NCT01450098|20504561|P2|COMPLETED|Period 2||31
8316477|NCT01450098|20504562|P1|COMPLETED|Period 2||8
8316478|NCT01450098|20504561|P2|Received at Least 1 Dose of Study Drug|Period 2||31
8316479|NCT01450098|20504562|P1|Received at Least 1 Dose of Study Drug|Period 2||8
8316480|NCT01450098|20504561|P2|STARTED|Period 2||31
8316481|NCT01450098|20504562|P1|STARTED|Period 2||8
8316482|NCT01450098|20504561|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
8316483|NCT01450098|20504562|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
8316484|NCT01450098|20504561|P2|COMPLETED|Washout Period of at Least 14 Days||31
8316485|NCT01450098|20504562|P1|COMPLETED|Washout Period of at Least 14 Days||8
8316486|NCT01450098|20504561|P2|STARTED|Washout Period of at Least 14 Days||31
8316487|NCT01450098|20504562|P1|STARTED|Washout Period of at Least 14 Days||8
8316488|NCT01450098|20504561|P2|NOT COMPLETED|Period 1||0
8316489|NCT01450098|20504562|P1|NOT COMPLETED|Period 1||0
8316490|NCT01450098|20504561|P2|COMPLETED|Period 1||31
8316491|NCT01450098|20504562|P1|COMPLETED|Period 1||8
8316492|NCT01450098|20504561|P2|Received at Least 1 Dose of Study Drug|Period 1||31
8316493|NCT01450098|20504562|P1|Received at Least 1 Dose of Study Drug|Period 1||8
8316494|NCT01450098|20504561|P2|STARTED|Period 1||31
8316495|NCT01450098|20504562|P1|STARTED|Period 1||8
8316496|NCT01450007|20504581|P3|NOT COMPLETED|Overall Study||3
8316497|NCT01450007|20504582|P2|NOT COMPLETED|Overall Study||5
8316498|NCT01450007|20504583|P1|NOT COMPLETED|Overall Study||2
8316499|NCT01450007|20504581|P3|COMPLETED|Overall Study||41
8316500|NCT01450007|20504582|P2|COMPLETED|Overall Study||37
8316501|NCT01450007|20504583|P1|COMPLETED|Overall Study||42
8316502|NCT01450007|20504581|P3|STARTED|Overall Study||44
8316503|NCT01450007|20504582|P2|STARTED|Overall Study||42
8316504|NCT01450007|20504583|P1|STARTED|Overall Study||44
8316505|NCT01449955|20504602|P2|NOT COMPLETED|Overall Study||2
8316506|NCT01449955|20504603|P1|NOT COMPLETED|Overall Study||1
8316507|NCT01449955|20504602|P2|COMPLETED|Overall Study||24
8316508|NCT01449955|20504603|P1|COMPLETED|Overall Study||27
8316509|NCT01449955|20504602|P2|STARTED|Overall Study||26
8316510|NCT01449955|20504603|P1|STARTED|Overall Study||28
8316511|NCT01449929|20504631|P3|NOT COMPLETED|Extension Phase Approximately 3 Years||8
8316512|NCT01449929|20504632|P2|NOT COMPLETED|Extension Phase Approximately 3 Years||0
8316513|NCT01449929|20504633|P1|NOT COMPLETED|Extension Phase Approximately 3 Years||0
8316514|NCT01449929|20504631|P3|COMPLETED|Extension Phase Approximately 3 Years||115
8316515|NCT01449929|20504632|P2|COMPLETED|Extension Phase Approximately 3 Years||0
8316516|NCT01449929|20504633|P1|COMPLETED|Extension Phase Approximately 3 Years||0
8316517|NCT01449929|20504631|P3|STARTED|Extension Phase Approximately 3 Years||123
8316518|NCT01449929|20504632|P2|STARTED|Extension Phase Approximately 3 Years||0
8316519|NCT01449929|20504633|P1|STARTED|Extension Phase Approximately 3 Years||0
8316520|NCT01449929|20504631|P3|NOT COMPLETED|Randomization Phase 96 Week||0
8316521|NCT01449929|20504632|P2|NOT COMPLETED|Randomization Phase 96 Week||53
8316522|NCT01449929|20504633|P1|NOT COMPLETED|Randomization Phase 96 Week||33
8316523|NCT01449929|20504631|P3|COMPLETED|Randomization Phase 96 Week||0
8316524|NCT01449929|20504632|P2|COMPLETED|Randomization Phase 96 Week||189
8316525|NCT01449929|20504633|P1|COMPLETED|Randomization Phase 96 Week||209
8316526|NCT01449929|20504631|P3|STARTED|Randomization Phase 96 Week||0
8316527|NCT01449929|20504632|P2|STARTED|Randomization Phase 96 Week||242
8316528|NCT01449929|20504633|P1|STARTED|Randomization Phase 96 Week||242
8316529|NCT01449864|20504670|P1|NOT COMPLETED|Overall Study||5
8316530|NCT01449864|20504670|P1|COMPLETED|Overall Study||17
8316531|NCT01449864|20504670|P1|STARTED|Overall Study||22
8316532|NCT01449812|20504678|P3|NOT COMPLETED|Overall Study||1
8316533|NCT01449812|20504679|P2|NOT COMPLETED|Overall Study||0
8316534|NCT01449812|20504680|P1|NOT COMPLETED|Overall Study||2
8316535|NCT01449812|20504678|P3|COMPLETED|Overall Study||279
8316536|NCT01449812|20504679|P2|COMPLETED|Overall Study||273
8316537|NCT01449812|20504680|P1|COMPLETED|Overall Study||270
8316538|NCT01449812|20504678|P3|STARTED|Overall Study||280
8316539|NCT01449812|20504679|P2|STARTED|Overall Study||273
8316540|NCT01449812|20504680|P1|STARTED|Overall Study||272
8316541|NCT01449747|20504774|P2|NOT COMPLETED|Overall Study||0
8316542|NCT01449747|20504775|P1|NOT COMPLETED|Overall Study||0
8316543|NCT01449747|20504774|P2|COMPLETED|Overall Study||12
8316544|NCT01449747|20504775|P1|COMPLETED|Overall Study||12
8316545|NCT01449747|20504774|P2|STARTED|Overall Study||12
8316546|NCT01449747|20504775|P1|STARTED|Overall Study||12
8316547|NCT01449734|20504789|P1|NOT COMPLETED|Overall Study||0
8316548|NCT01449734|20504789|P1|COMPLETED|Overall Study||215
8316549|NCT01449734|20504789|P1|STARTED|Overall Study||215
8316550|NCT01449721|20504795|P2|NOT COMPLETED|Overall Study||2
8316551|NCT01449721|20504796|P1|NOT COMPLETED|Overall Study||0
8316552|NCT01449721|20504795|P2|COMPLETED|Overall Study||28
8316553|NCT01449721|20504796|P1|COMPLETED|Overall Study||112
8316554|NCT01449721|20504795|P2|STARTED|Overall Study||30
8316555|NCT01449721|20504796|P1|STARTED|Overall Study||112
8316556|NCT01449708|20504808|P2|NOT COMPLETED|Overall Study||3
8316557|NCT01449708|20504809|P1|NOT COMPLETED|Overall Study||2
8316558|NCT01449708|20504808|P2|COMPLETED|Overall Study||60
8316559|NCT01449708|20504809|P1|COMPLETED|Overall Study||59
8316560|NCT01449708|20504808|P2|STARTED|Overall Study||63
8316561|NCT01449708|20504809|P1|STARTED|Overall Study||61
8316562|NCT01449682|20504820|P2|NOT COMPLETED|Overall Study||1
8316563|NCT01449682|20504821|P1|NOT COMPLETED|Overall Study||1
8316564|NCT01449682|20504820|P2|COMPLETED|Overall Study||4
8316565|NCT01449682|20504821|P1|COMPLETED|Overall Study||4
8316566|NCT01449682|20504820|P2|STARTED|Overall Study||5
8316567|NCT01449682|20504821|P1|STARTED|Overall Study||5
8316568|NCT01449630|20504842|P9|NOT COMPLETED|Period 3||0
8316569|NCT01449630|20504843|P8|NOT COMPLETED|Period 3||0
8316570|NCT01449630|20504844|P7|NOT COMPLETED|Period 3||0
8316571|NCT01449630|20504845|P6|NOT COMPLETED|Period 3||0
8316572|NCT01449630|20504846|P5|NOT COMPLETED|Period 3||0
8316573|NCT01449630|20504847|P4|NOT COMPLETED|Period 3||0
8316574|NCT01449630|20504848|P3|NOT COMPLETED|Period 3||0
8316575|NCT01449630|20504849|P2|NOT COMPLETED|Period 3||0
8316576|NCT01449630|20504850|P1|NOT COMPLETED|Period 3||0
8316577|NCT01449630|20504842|P9|COMPLETED|Period 3||2
8316578|NCT01449630|20504843|P8|COMPLETED|Period 3||6
8316579|NCT01449630|20504844|P7|COMPLETED|Period 3||1
8316580|NCT01449630|20504845|P6|COMPLETED|Period 3||1
8316581|NCT01449630|20504846|P5|COMPLETED|Period 3||5
8316582|NCT01449630|20504847|P4|COMPLETED|Period 3||1
8316583|NCT01449630|20504848|P3|COMPLETED|Period 3||2
8316584|NCT01449630|20504849|P2|COMPLETED|Period 3||6
8316585|NCT01449630|20504850|P1|COMPLETED|Period 3||1
8316586|NCT01449630|20504842|P9|STARTED|Period 3||2
8316587|NCT01449630|20504843|P8|STARTED|Period 3||6
8316588|NCT01449630|20504844|P7|STARTED|Period 3||1
8316589|NCT01449630|20504845|P6|STARTED|Period 3||1
8316590|NCT01449630|20504846|P5|STARTED|Period 3||5
8316591|NCT01449630|20504847|P4|STARTED|Period 3||1
8316592|NCT01449630|20504848|P3|STARTED|Period 3||2
8316593|NCT01449630|20504849|P2|STARTED|Period 3||6
8316594|NCT01449630|20504850|P1|STARTED|Period 3||1
8316595|NCT01449630|20504842|P9|NOT COMPLETED|Period 2||0
8316596|NCT01449630|20504843|P8|NOT COMPLETED|Period 2||0
8316597|NCT01449630|20504844|P7|NOT COMPLETED|Period 2||1
8316598|NCT01449630|20504845|P6|NOT COMPLETED|Period 2||0
8316599|NCT01449630|20504846|P5|NOT COMPLETED|Period 2||0
8316600|NCT01449630|20504847|P4|NOT COMPLETED|Period 2||0
8316601|NCT01449630|20504848|P3|NOT COMPLETED|Period 2||0
8316602|NCT01449630|20504849|P2|NOT COMPLETED|Period 2||0
8316603|NCT01449630|20504850|P1|NOT COMPLETED|Period 2||0
8316604|NCT01449630|20504842|P9|COMPLETED|Period 2||2
8316605|NCT01449630|20504843|P8|COMPLETED|Period 2||6
8316606|NCT01449630|20504844|P7|COMPLETED|Period 2||1
8316607|NCT01449630|20504845|P6|COMPLETED|Period 2||1
8316608|NCT01449630|20504846|P5|COMPLETED|Period 2||5
8316609|NCT01449630|20504847|P4|COMPLETED|Period 2||1
8316610|NCT01449630|20504848|P3|COMPLETED|Period 2||2
8316611|NCT01449630|20504849|P2|COMPLETED|Period 2||6
8316612|NCT01449630|20504850|P1|COMPLETED|Period 2||1
8316613|NCT01449630|20504842|P9|STARTED|Period 2||2
8316614|NCT01449630|20504843|P8|STARTED|Period 2||6
8316615|NCT01449630|20504844|P7|STARTED|Period 2||2
8316616|NCT01449630|20504845|P6|STARTED|Period 2||1
8316617|NCT01449630|20504846|P5|STARTED|Period 2||5
8316618|NCT01449630|20504847|P4|STARTED|Period 2||1
8316619|NCT01449630|20504848|P3|STARTED|Period 2||2
8316620|NCT01449630|20504849|P2|STARTED|Period 2||6
8316621|NCT01449630|20504850|P1|STARTED|Period 2||1
8316622|NCT01449630|20504842|P9|NOT COMPLETED|Period 1||0
8316623|NCT01449630|20504843|P8|NOT COMPLETED|Period 1||0
8316624|NCT01449630|20504844|P7|NOT COMPLETED|Period 1||0
8316625|NCT01449630|20504845|P6|NOT COMPLETED|Period 1||1
8316626|NCT01449630|20504846|P5|NOT COMPLETED|Period 1||0
8316627|NCT01449630|20504847|P4|NOT COMPLETED|Period 1||1
8316628|NCT01449630|20504848|P3|NOT COMPLETED|Period 1||0
8316629|NCT01449630|20504849|P2|NOT COMPLETED|Period 1||0
8316630|NCT01449630|20504850|P1|NOT COMPLETED|Period 1||1
8316631|NCT01449630|20504842|P9|COMPLETED|Period 1||2
8316632|NCT01449630|20504843|P8|COMPLETED|Period 1||6
8316633|NCT01449630|20504844|P7|COMPLETED|Period 1||2
8316634|NCT01449630|20504845|P6|COMPLETED|Period 1||1
8316635|NCT01449630|20504846|P5|COMPLETED|Period 1||5
8316636|NCT01449630|20504847|P4|COMPLETED|Period 1||1
8316637|NCT01449630|20504848|P3|COMPLETED|Period 1||2
8316638|NCT01449630|20504849|P2|COMPLETED|Period 1||6
8316639|NCT01449630|20504850|P1|COMPLETED|Period 1||1
8316640|NCT01449630|20504842|P9|Received at Least 1 Dose|Period 1||2
8316641|NCT01449630|20504843|P8|Received at Least 1 Dose|Period 1||6
8316642|NCT01449630|20504844|P7|Received at Least 1 Dose|Period 1||2
8316643|NCT01449630|20504845|P6|Received at Least 1 Dose|Period 1||1
8316644|NCT01449630|20504846|P5|Received at Least 1 Dose|Period 1||5
8316645|NCT01449630|20504847|P4|Received at Least 1 Dose|Period 1||2
8316646|NCT01449630|20504848|P3|Received at Least 1 Dose|Period 1||2
8316647|NCT01449630|20504849|P2|Received at Least 1 Dose|Period 1||6
8316648|NCT01449630|20504850|P1|Received at Least 1 Dose|Period 1||2
8316649|NCT01449630|20504842|P9|STARTED|Period 1||2
8316650|NCT01449630|20504843|P8|STARTED|Period 1||6
8316651|NCT01449630|20504844|P7|STARTED|Period 1||2
8316652|NCT01449630|20504845|P6|STARTED|Period 1||2
8316653|NCT01449630|20504846|P5|STARTED|Period 1||5
8316654|NCT01449630|20504847|P4|STARTED|Period 1||2
8316655|NCT01449630|20504848|P3|STARTED|Period 1||2
8316656|NCT01449630|20504849|P2|STARTED|Period 1||6
8316657|NCT01449630|20504850|P1|STARTED|Period 1||2
8316658|NCT01449539|20504920|P1|NOT COMPLETED|Overall Study||4
8316659|NCT01449539|20504920|P1|COMPLETED|Overall Study||4
8316660|NCT01449539|20504920|P1|STARTED|Overall Study||8
8316661|NCT01449526|20504926|P2|NOT COMPLETED|Overall Study||6
8316662|NCT01449526|20504927|P1|NOT COMPLETED|Overall Study||2
8316663|NCT01449526|20504926|P2|COMPLETED|Overall Study||77
8316664|NCT01449526|20504927|P1|COMPLETED|Overall Study||81
8316665|NCT01449526|20504926|P2|STARTED|Overall Study||83
8316666|NCT01449526|20504927|P1|STARTED|Overall Study||83
8316667|NCT01449513|20504937|P2|NOT COMPLETED|Overall Study||0
8316668|NCT01449513|20504938|P1|NOT COMPLETED|Overall Study||0
8316669|NCT01449513|20504937|P2|COMPLETED|Overall Study||8
8316670|NCT01449513|20504938|P1|COMPLETED|Overall Study||16
8316671|NCT01449513|20504937|P2|STARTED|Overall Study||8
8316672|NCT01449513|20504938|P1|STARTED|Overall Study||16
8316691|NCT01449370|20505138|P25|NOT COMPLETED|Overall Study||8
8316692|NCT01449370|20505139|P24|NOT COMPLETED|Overall Study||10
8316693|NCT01449370|20505140|P23|NOT COMPLETED|Overall Study||4
8316694|NCT01449370|20505141|P22|NOT COMPLETED|Overall Study||4
8316695|NCT01449370|20505142|P21|NOT COMPLETED|Overall Study||6
8316696|NCT01449370|20505143|P20|NOT COMPLETED|Overall Study||3
8316697|NCT01449370|20505144|P19|NOT COMPLETED|Overall Study||3
8316698|NCT01449370|20505145|P18|NOT COMPLETED|Overall Study||3
8316699|NCT01449370|20505146|P17|NOT COMPLETED|Overall Study||7
8316700|NCT01449370|20505147|P16|NOT COMPLETED|Overall Study||3
8316701|NCT01449370|20505148|P15|NOT COMPLETED|Overall Study||3
8316702|NCT01449370|20505149|P14|NOT COMPLETED|Overall Study||11
8316703|NCT01449370|20505150|P13|NOT COMPLETED|Overall Study||3
8316704|NCT01449370|20505151|P12|NOT COMPLETED|Overall Study||3
8316705|NCT01449370|20505152|P11|NOT COMPLETED|Overall Study||3
8316706|NCT01449370|20505153|P10|NOT COMPLETED|Overall Study||3
8316707|NCT01449370|20505154|P9|NOT COMPLETED|Overall Study||12
8316708|NCT01449370|20505155|P8|NOT COMPLETED|Overall Study||3
8316709|NCT01449370|20505156|P7|NOT COMPLETED|Overall Study||3
8316710|NCT01449370|20505157|P6|NOT COMPLETED|Overall Study||3
8316711|NCT01449370|20505158|P5|NOT COMPLETED|Overall Study||3
8316712|NCT01449370|20505159|P4|NOT COMPLETED|Overall Study||4
8316713|NCT01449370|20505160|P3|NOT COMPLETED|Overall Study||8
8316714|NCT01449370|20505161|P2|NOT COMPLETED|Overall Study||6
8316715|NCT01449370|20505162|P1|NOT COMPLETED|Overall Study||6
8316716|NCT01449370|20505138|P25|COMPLETED|Overall Study||0
8316717|NCT01449370|20505139|P24|COMPLETED|Overall Study||0
8316718|NCT01449370|20505140|P23|COMPLETED|Overall Study||0
8316719|NCT01449370|20505141|P22|COMPLETED|Overall Study||0
8316720|NCT01449370|20505142|P21|COMPLETED|Overall Study||0
8316721|NCT01449370|20505143|P20|COMPLETED|Overall Study||0
8316722|NCT01449370|20505144|P19|COMPLETED|Overall Study||0
8316723|NCT01449370|20505145|P18|COMPLETED|Overall Study||0
8316724|NCT01449370|20505146|P17|COMPLETED|Overall Study||0
8316725|NCT01449370|20505147|P16|COMPLETED|Overall Study||0
8316726|NCT01449370|20505148|P15|COMPLETED|Overall Study||0
8316727|NCT01449370|20505149|P14|COMPLETED|Overall Study||0
8316728|NCT01449370|20505150|P13|COMPLETED|Overall Study||0
8316729|NCT01449370|20505151|P12|COMPLETED|Overall Study||0
8316730|NCT01449370|20505152|P11|COMPLETED|Overall Study||0
8316731|NCT01449370|20505153|P10|COMPLETED|Overall Study||0
8316732|NCT01449370|20505154|P9|COMPLETED|Overall Study||0
8316733|NCT01449370|20505155|P8|COMPLETED|Overall Study||0
8316734|NCT01449370|20505156|P7|COMPLETED|Overall Study||0
8316735|NCT01449370|20505157|P6|COMPLETED|Overall Study||0
8316736|NCT01449370|20505158|P5|COMPLETED|Overall Study||0
8316737|NCT01449370|20505159|P4|COMPLETED|Overall Study||0
8316738|NCT01449370|20505160|P3|COMPLETED|Overall Study||0
8316739|NCT01449370|20505161|P2|COMPLETED|Overall Study||0
8316740|NCT01449370|20505162|P1|COMPLETED|Overall Study||0
8316741|NCT01449370|20505138|P25|STARTED|Overall Study||8
8316742|NCT01449370|20505139|P24|STARTED|Overall Study||10
8316743|NCT01449370|20505140|P23|STARTED|Overall Study||4
8316744|NCT01449370|20505141|P22|STARTED|Overall Study||4
8316745|NCT01449370|20505142|P21|STARTED|Overall Study||6
8316746|NCT01449370|20505143|P20|STARTED|Overall Study||3
8316747|NCT01449370|20505144|P19|STARTED|Overall Study||3
8316748|NCT01449370|20505145|P18|STARTED|Overall Study||3
8316749|NCT01449370|20505146|P17|STARTED|Overall Study||7
8316750|NCT01449370|20505147|P16|STARTED|Overall Study||3
8316751|NCT01449370|20505148|P15|STARTED|Overall Study||3
8316752|NCT01449370|20505149|P14|STARTED|Overall Study||11
8316753|NCT01449370|20505150|P13|STARTED|Overall Study||3
8316754|NCT01449370|20505151|P12|STARTED|Overall Study||3
8316755|NCT01449370|20505152|P11|STARTED|Overall Study||3
8316756|NCT01449370|20505153|P10|STARTED|Overall Study||3
8316757|NCT01449370|20505154|P9|STARTED|Overall Study||12
8316758|NCT01449370|20505155|P8|STARTED|Overall Study||3
8316759|NCT01449370|20505156|P7|STARTED|Overall Study||3
8316760|NCT01449370|20505157|P6|STARTED|Overall Study||3
8316761|NCT01449370|20505158|P5|STARTED|Overall Study||3
8316762|NCT01449370|20505159|P4|STARTED|Overall Study||4
8316763|NCT01449370|20505160|P3|STARTED|Overall Study||8
8316764|NCT01449370|20505161|P2|STARTED|Overall Study||6
8316765|NCT01449370|20505162|P1|STARTED|Overall Study||6
8316766|NCT01449305|20505535|P1|NOT COMPLETED|Overall Study||2
8316767|NCT01449305|20505535|P1|COMPLETED|Overall Study||42
8316768|NCT01449305|20505535|P1|STARTED|Overall Study||44
8316769|NCT01449279|20505540|P1|NOT COMPLETED|Overall Study||7
8316770|NCT01449279|20505540|P1|COMPLETED|Overall Study||15
8316771|NCT01449279|20505540|P1|STARTED|Overall Study||22
8316772|NCT01449266|20505551|P1|NOT COMPLETED|Overall Study||0
8316773|NCT01449266|20505551|P1|COMPLETED|Overall Study||10
8316774|NCT01449266|20505551|P1|STARTED|Overall Study||10
8316778|NCT01449006|20505565|P2|NOT COMPLETED|Overall Study||0
8316779|NCT01449006|20505566|P1|NOT COMPLETED|Overall Study||3
8316780|NCT01449006|20505565|P2|COMPLETED|Overall Study||9
8316781|NCT01449006|20505566|P1|COMPLETED|Overall Study||5
8316782|NCT01449006|20505565|P2|STARTED|Overall Study||9
8316783|NCT01449006|20505566|P1|STARTED|Overall Study||8
8316784|NCT01448850|20505580|P2|NOT COMPLETED|Overall Study||40
8316785|NCT01448850|20505581|P1|NOT COMPLETED|Overall Study||34
8316786|NCT01448850|20505580|P2|COMPLETED|Overall Study||120
8316787|NCT01448850|20505581|P1|COMPLETED|Overall Study||130
8316788|NCT01448850|20505580|P2|STARTED|Overall Study||160
8316789|NCT01448850|20505581|P1|STARTED|Overall Study||164
8316790|NCT01448824|20505612|P8|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3
8316791|NCT01448824|20505613|P7|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316792|NCT01448824|20505614|P6|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316793|NCT01448824|20505615|P5|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316794|NCT01448824|20505616|P4|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316795|NCT01448824|20505617|P3|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316796|NCT01448824|20505618|P2|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316797|NCT01448824|20505619|P1|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316798|NCT01448824|20505612|P8|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8
8316799|NCT01448824|20505613|P7|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316800|NCT01448824|20505614|P6|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316801|NCT01448824|20505615|P5|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316802|NCT01448824|20505616|P4|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316803|NCT01448824|20505617|P3|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316804|NCT01448824|20505618|P2|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316805|NCT01448824|20505619|P1|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
8316806|NCT01448824|20505612|P8|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10
8316807|NCT01448824|20505613|P7|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8316808|NCT01448824|20505614|P6|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8316809|NCT01448824|20505615|P5|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8316810|NCT01448824|20505616|P4|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8316811|NCT01448824|20505617|P3|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8316812|NCT01448824|20505618|P2|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8316813|NCT01448824|20505619|P1|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
8316814|NCT01448824|20505612|P8|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11
8316815|NCT01448824|20505613|P7|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8316816|NCT01448824|20505614|P6|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8316817|NCT01448824|20505615|P5|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8316818|NCT01448824|20505616|P4|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8316819|NCT01448824|20505617|P3|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8316820|NCT01448824|20505618|P2|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8316821|NCT01448824|20505619|P1|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
8316822|NCT01448824|20505612|P8|STARTED|Part 2 Period 2: Drug-drug Interaction||11
8316823|NCT01448824|20505613|P7|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8316824|NCT01448824|20505614|P6|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8316825|NCT01448824|20505615|P5|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8316826|NCT01448824|20505616|P4|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8316827|NCT01448824|20505617|P3|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8316828|NCT01448824|20505618|P2|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8316829|NCT01448824|20505619|P1|STARTED|Part 2 Period 2: Drug-drug Interaction||0
8316830|NCT01448824|20505612|P8|NOT COMPLETED|Part 2: Washout Period||0
8316831|NCT01448824|20505613|P7|NOT COMPLETED|Part 2: Washout Period||0
8316832|NCT01448824|20505614|P6|NOT COMPLETED|Part 2: Washout Period||0
8316833|NCT01448824|20505615|P5|NOT COMPLETED|Part 2: Washout Period||0
8316834|NCT01448824|20505616|P4|NOT COMPLETED|Part 2: Washout Period||0
8316835|NCT01448824|20505617|P3|NOT COMPLETED|Part 2: Washout Period||0
8316836|NCT01448824|20505618|P2|NOT COMPLETED|Part 2: Washout Period||0
8316837|NCT01448824|20505619|P1|NOT COMPLETED|Part 2: Washout Period||0
8316838|NCT01448824|20505612|P8|COMPLETED|Part 2: Washout Period||11
8316839|NCT01448824|20505613|P7|COMPLETED|Part 2: Washout Period||0
8316840|NCT01448824|20505614|P6|COMPLETED|Part 2: Washout Period||0
8316841|NCT01448824|20505615|P5|COMPLETED|Part 2: Washout Period||0
8316842|NCT01448824|20505616|P4|COMPLETED|Part 2: Washout Period||0
8316843|NCT01448824|20505617|P3|COMPLETED|Part 2: Washout Period||0
8316844|NCT01448824|20505618|P2|COMPLETED|Part 2: Washout Period||0
8316845|NCT01448824|20505619|P1|COMPLETED|Part 2: Washout Period||0
8316846|NCT01448824|20505612|P8|STARTED|Part 2: Washout Period||11
8316847|NCT01448824|20505613|P7|STARTED|Part 2: Washout Period||0
8316848|NCT01448824|20505614|P6|STARTED|Part 2: Washout Period||0
8316849|NCT01448824|20505615|P5|STARTED|Part 2: Washout Period||0
8316850|NCT01448824|20505616|P4|STARTED|Part 2: Washout Period||0
8316851|NCT01448824|20505617|P3|STARTED|Part 2: Washout Period||0
8316852|NCT01448824|20505618|P2|STARTED|Part 2: Washout Period||0
8316853|NCT01448824|20505619|P1|STARTED|Part 2: Washout Period||0
8316854|NCT01448824|20505612|P8|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1
8316855|NCT01448824|20505613|P7|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316856|NCT01448824|20505614|P6|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316857|NCT01448824|20505615|P5|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316858|NCT01448824|20505616|P4|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316859|NCT01448824|20505617|P3|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316860|NCT01448824|20505618|P2|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316861|NCT01448824|20505619|P1|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316862|NCT01448824|20505612|P8|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11
8316863|NCT01448824|20505613|P7|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316864|NCT01448824|20505614|P6|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316865|NCT01448824|20505615|P5|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316866|NCT01448824|20505616|P4|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316867|NCT01448824|20505617|P3|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316868|NCT01448824|20505618|P2|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316869|NCT01448824|20505619|P1|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
8316870|NCT01448824|20505612|P8|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12
8316871|NCT01448824|20505613|P7|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8316872|NCT01448824|20505614|P6|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8316873|NCT01448824|20505615|P5|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8316874|NCT01448824|20505616|P4|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8316875|NCT01448824|20505617|P3|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8316876|NCT01448824|20505618|P2|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8316877|NCT01448824|20505619|P1|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
8316878|NCT01448824|20505612|P8|STARTED|Part 2 Period 1: Drug-drug Interaction||12
8316879|NCT01448824|20505613|P7|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8316880|NCT01448824|20505614|P6|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8316881|NCT01448824|20505615|P5|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8316882|NCT01448824|20505616|P4|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8316883|NCT01448824|20505617|P3|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8316884|NCT01448824|20505618|P2|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8316885|NCT01448824|20505619|P1|STARTED|Part 2 Period 1: Drug-drug Interaction||0
8316886|NCT01448824|20505612|P8|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316887|NCT01448824|20505613|P7|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316888|NCT01448824|20505614|P6|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316889|NCT01448824|20505615|P5|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316890|NCT01448824|20505616|P4|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316891|NCT01448824|20505617|P3|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316892|NCT01448824|20505618|P2|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316893|NCT01448824|20505619|P1|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316894|NCT01448824|20505612|P8|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316895|NCT01448824|20505613|P7|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316896|NCT01448824|20505614|P6|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316897|NCT01448824|20505615|P5|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316898|NCT01448824|20505616|P4|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
8316899|NCT01448824|20505617|P3|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
8316900|NCT01448824|20505618|P2|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
8316901|NCT01448824|20505619|P1|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11
8316902|NCT01448824|20505612|P8|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8316903|NCT01448824|20505613|P7|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8316904|NCT01448824|20505614|P6|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8316905|NCT01448824|20505615|P5|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8316906|NCT01448824|20505616|P4|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
8316907|NCT01448824|20505617|P3|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
8316908|NCT01448824|20505618|P2|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
8316909|NCT01448824|20505619|P1|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11
8316910|NCT01448824|20505612|P8|STARTED|Part 1 Period 2: Multiple Ascending Dose||0
8316911|NCT01448824|20505613|P7|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0
8316912|NCT01448824|20505614|P6|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0
8316913|NCT01448824|20505615|P5|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0
8316914|NCT01448824|20505616|P4|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
8316915|NCT01448824|20505617|P3|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
8316916|NCT01448824|20505618|P2|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
8316917|NCT01448824|20505619|P1|STARTED|Part 1 Period 2: Multiple Ascending Dose||11
8316918|NCT01448824|20505612|P8|NOT COMPLETED|Part 1: Washout Period||0
8316919|NCT01448824|20505613|P7|NOT COMPLETED|Part 1: Washout Period||0
8316920|NCT01448824|20505614|P6|NOT COMPLETED|Part 1: Washout Period||0
8316921|NCT01448824|20505615|P5|NOT COMPLETED|Part 1: Washout Period||0
8316922|NCT01448824|20505616|P4|NOT COMPLETED|Part 1: Washout Period||0
8316923|NCT01448824|20505617|P3|NOT COMPLETED|Part 1: Washout Period||0
8316924|NCT01448824|20505618|P2|NOT COMPLETED|Part 1: Washout Period||0
8316925|NCT01448824|20505619|P1|NOT COMPLETED|Part 1: Washout Period||1
8316926|NCT01448824|20505612|P8|COMPLETED|Part 1: Washout Period||0
8316927|NCT01448824|20505613|P7|COMPLETED|Part 1: Washout Period||0
8316928|NCT01448824|20505614|P6|COMPLETED|Part 1: Washout Period||0
8316929|NCT01448824|20505615|P5|COMPLETED|Part 1: Washout Period||0
8316930|NCT01448824|20505616|P4|COMPLETED|Part 1: Washout Period||0
8316931|NCT01448824|20505617|P3|COMPLETED|Part 1: Washout Period||4
8316932|NCT01448824|20505618|P2|COMPLETED|Part 1: Washout Period||4
8316933|NCT01448824|20505619|P1|COMPLETED|Part 1: Washout Period||11
8316934|NCT01448824|20505612|P8|STARTED|Part 1: Washout Period||0
8316935|NCT01448824|20505613|P7|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0
8316936|NCT01448824|20505614|P6|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0
8316937|NCT01448824|20505615|P5|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0
8316938|NCT01448824|20505616|P4|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
8316939|NCT01448824|20505617|P3|STARTED|Part 1: Washout Period||4
8316940|NCT01448824|20505618|P2|STARTED|Part 1: Washout Period||4
8316941|NCT01448824|20505619|P1|STARTED|Part 1: Washout Period||12
8316942|NCT01448824|20505612|P8|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8316943|NCT01448824|20505613|P7|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
8316944|NCT01448824|20505614|P6|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
8316945|NCT01448824|20505615|P5|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
8316946|NCT01448824|20505616|P4|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
8316947|NCT01448824|20505617|P3|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8316948|NCT01448824|20505618|P2|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8316949|NCT01448824|20505619|P1|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8316950|NCT01448824|20505612|P8|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
8316951|NCT01448824|20505613|P7|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11
8316952|NCT01448824|20505614|P6|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10
8316953|NCT01448824|20505615|P5|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14
8316954|NCT01448824|20505616|P4|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9
8316955|NCT01448824|20505617|P3|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
8316956|NCT01448824|20505618|P2|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
8316957|NCT01448824|20505619|P1|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12
8316958|NCT01448824|20505612|P8|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0
8316959|NCT01448824|20505613|P7|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
8316960|NCT01448824|20505614|P6|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
8316961|NCT01448824|20505615|P5|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16
8316962|NCT01448824|20505616|P4|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10
8316963|NCT01448824|20505617|P3|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
8316964|NCT01448824|20505618|P2|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
8316965|NCT01448824|20505619|P1|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
8316966|NCT01448824|20505612|P8|STARTED|Part 1 Period 1: Multiple Ascending Dose||0
8316967|NCT01448824|20505613|P7|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
8316968|NCT01448824|20505614|P6|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
8316969|NCT01448824|20505615|P5|STARTED|Part 1 Period 1: Multiple Ascending Dose||16
8316970|NCT01448824|20505616|P4|STARTED|Part 1 Period 1: Multiple Ascending Dose||10
8316971|NCT01448824|20505617|P3|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
8316972|NCT01448824|20505618|P2|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
8316973|NCT01448824|20505619|P1|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
8316974|NCT01448707|20505670|P2|NOT COMPLETED|Overall Study||18
8316975|NCT01448707|20505671|P1|NOT COMPLETED|Overall Study||18
8316976|NCT01448707|20505670|P2|COMPLETED|Overall Study||118
8316977|NCT01448707|20505671|P1|COMPLETED|Overall Study||119
8316978|NCT01448707|20505670|P2|STARTED|Overall Study||136
8316979|NCT01448707|20505671|P1|STARTED|Overall Study||137
8316980|NCT01448616|20505692|P4|NOT COMPLETED|Study Drug (Treatment Phase)||4
8316981|NCT01448616|20505693|P3|NOT COMPLETED|Study Drug (Treatment Phase)||4
8316982|NCT01448616|20505694|P2|NOT COMPLETED|Study Drug (Treatment Phase)||2
8316983|NCT01448616|20505695|P1|NOT COMPLETED|Study Drug (Treatment Phase)||0
8316984|NCT01448616|20505692|P4|COMPLETED|Study Drug (Treatment Phase)||9
8316985|NCT01448616|20505693|P3|COMPLETED|Study Drug (Treatment Phase)||23
8316986|NCT01448616|20505694|P2|COMPLETED|Study Drug (Treatment Phase)||22
8316987|NCT01448616|20505695|P1|COMPLETED|Study Drug (Treatment Phase)||0
8316988|NCT01448616|20505692|P4|STARTED|Study Drug (Treatment Phase)||13
8316989|NCT01448616|20505693|P3|STARTED|Study Drug (Treatment Phase)||27
8316990|NCT01448616|20505694|P2|STARTED|Study Drug (Treatment Phase)||24
8316991|NCT01448616|20505695|P1|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
8316992|NCT01448616|20505692|P4|NOT COMPLETED|Lead-In (Observational Phase)||0
8316993|NCT01448616|20505693|P3|NOT COMPLETED|Lead-In (Observational Phase)||0
8316994|NCT01448616|20505694|P2|NOT COMPLETED|Lead-In (Observational Phase)||0
8316995|NCT01448616|20505695|P1|NOT COMPLETED|Lead-In (Observational Phase)||9
8316996|NCT01448616|20505692|P4|COMPLETED|Lead-In (Observational Phase)||0
8316997|NCT01448616|20505693|P3|COMPLETED|Lead-In (Observational Phase)||0
8316998|NCT01448616|20505694|P2|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
8316999|NCT01448616|20505695|P1|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
8317000|NCT01448616|20505692|P4|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
8317001|NCT01448616|20505693|P3|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
8317002|NCT01448616|20505694|P2|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
8317003|NCT01448616|20505695|P1|STARTED|Lead-In (Observational Phase)||73
8317004|NCT01448525|20505715|P2|NOT COMPLETED|Overall Study||2
8317005|NCT01448525|20505716|P1|NOT COMPLETED|Overall Study||1
8317006|NCT01448525|20505715|P2|COMPLETED|Overall Study||42
8317007|NCT01448525|20505716|P1|COMPLETED|Overall Study||43
8317008|NCT01448525|20505715|P2|STARTED|Overall Study||44
8317009|NCT01448525|20505716|P1|STARTED|Overall Study||44
8317010|NCT01448486|20505726|P2|NOT COMPLETED|Overall Study||0
8317011|NCT01448486|20505727|P1|NOT COMPLETED|Overall Study||0
8317012|NCT01448486|20505726|P2|COMPLETED|Overall Study||3
8317013|NCT01448486|20505727|P1|COMPLETED|Overall Study||3
8317014|NCT01448486|20505726|P2|STARTED|Overall Study||3
8317015|NCT01448486|20505727|P1|STARTED|Overall Study||3
8317016|NCT01448421|20505735|P1|NOT COMPLETED|Overall Study||0
8317017|NCT01448421|20505735|P1|COMPLETED|Overall Study||37
8317018|NCT01448421|20505735|P1|STARTED|Overall Study||37
8317019|NCT01448356|20505740|P1|NOT COMPLETED|Overall Study||0
8317020|NCT01448356|20505740|P1|COMPLETED|Overall Study|cross-over|10
8317021|NCT01448356|20505740|P1|STARTED|Overall Study||10
8317022|NCT01448213|20505747|P2|NOT COMPLETED|Overall Study||22
8317023|NCT01448213|20505748|P1|NOT COMPLETED|Overall Study||17
8317024|NCT01448213|20505747|P2|COMPLETED|Overall Study||112
8317025|NCT01448213|20505748|P1|COMPLETED|Overall Study||113
8317026|NCT01448213|20505747|P2|STARTED|Overall Study||134
8317027|NCT01448213|20505748|P1|STARTED|Overall Study||130
8317028|NCT01448057|20505758|P2|NOT COMPLETED|Overall Study||4
8317029|NCT01448057|20505759|P1|NOT COMPLETED|Overall Study||8
8317030|NCT01448057|20505758|P2|COMPLETED|Overall Study||167
8317031|NCT01448057|20505759|P1|COMPLETED|Overall Study||162
8317032|NCT01448057|20505758|P2|STARTED|Overall Study||171
8317033|NCT01448057|20505759|P1|STARTED|Overall Study||170
8317034|NCT01448044|20505769|P2|NOT COMPLETED|Follow Up Period||14
8317035|NCT01448044|20505770|P1|NOT COMPLETED|Follow Up Period||12
8317036|NCT01448044|20505769|P2|COMPLETED|Follow Up Period||26
8317037|NCT01448044|20505770|P1|COMPLETED|Follow Up Period||65
8317038|NCT01448044|20505769|P2|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
8317039|NCT01448044|20505770|P1|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
8317040|NCT01448044|20505769|P2|NOT COMPLETED|Treatment Period||16
8317041|NCT01448044|20505770|P1|NOT COMPLETED|Treatment Period||23
8317042|NCT01448044|20505769|P2|COMPLETED|Treatment Period||26
8317043|NCT01448044|20505770|P1|COMPLETED|Treatment Period||59
8317044|NCT01448044|20505769|P2|STARTED|Treatment Period||42
8317045|NCT01448044|20505770|P1|STARTED|Treatment Period||82
8317046|NCT01447927|20505786|P2|NOT COMPLETED|Overall Study||3
8317047|NCT01447927|20505787|P1|NOT COMPLETED|Overall Study||5
8317048|NCT01447927|20505786|P2|COMPLETED|Overall Study||33
8317049|NCT01447927|20505787|P1|COMPLETED|Overall Study||33
8317050|NCT01447927|20505786|P2|STARTED|Overall Study||36
8317051|NCT01447927|20505787|P1|STARTED|Overall Study||38
8317052|NCT01447914|20505795|P1|NOT COMPLETED|Overall Study||0
8317053|NCT01447914|20505795|P1|COMPLETED|Overall Study||16
8317054|NCT01447914|20505795|P1|STARTED|Overall Study||16
8317055|NCT01447888|20505806|P2|NOT COMPLETED|Overall Study||0
8317056|NCT01447888|20505807|P1|NOT COMPLETED|Overall Study||0
8317057|NCT01447888|20505806|P2|COMPLETED|Overall Study||55
8317058|NCT01447888|20505807|P1|COMPLETED|Overall Study||45
8317059|NCT01447888|20505806|P2|STARTED|Overall Study||55
8317060|NCT01447888|20505807|P1|STARTED|Overall Study||45
8317061|NCT01447849|20505819|P4|NOT COMPLETED|Second Intervention||0
8317062|NCT01447849|20505820|P3|NOT COMPLETED|Second Intervention||0
8317063|NCT01447849|20505821|P2|NOT COMPLETED|Second Intervention||0
8317064|NCT01447849|20505822|P1|NOT COMPLETED|Second Intervention||0
8317065|NCT01447849|20505819|P4|COMPLETED|Second Intervention||10
8317066|NCT01447849|20505820|P3|COMPLETED|Second Intervention||10
8317067|NCT01447849|20505821|P2|COMPLETED|Second Intervention||10
8317068|NCT01447849|20505822|P1|COMPLETED|Second Intervention||10
8317069|NCT01447849|20505819|P4|STARTED|Second Intervention||10
8317070|NCT01447849|20505820|P3|STARTED|Second Intervention||10
8317071|NCT01447849|20505821|P2|STARTED|Second Intervention||10
8317072|NCT01447849|20505822|P1|STARTED|Second Intervention||10
8317073|NCT01447849|20505819|P4|NOT COMPLETED|Washout Period for 1 Week||0
8317074|NCT01447849|20505820|P3|NOT COMPLETED|Washout Period for 1 Week||0
8317075|NCT01447849|20505821|P2|NOT COMPLETED|Washout Period for 1 Week||0
8317076|NCT01447849|20505822|P1|NOT COMPLETED|Washout Period for 1 Week||0
8317077|NCT01447849|20505819|P4|COMPLETED|Washout Period for 1 Week||10
8317078|NCT01447849|20505820|P3|COMPLETED|Washout Period for 1 Week||10
8317079|NCT01447849|20505821|P2|COMPLETED|Washout Period for 1 Week||10
8317080|NCT01447849|20505822|P1|COMPLETED|Washout Period for 1 Week||10
8317081|NCT01447849|20505819|P4|STARTED|Washout Period for 1 Week||10
8317082|NCT01447849|20505820|P3|STARTED|Washout Period for 1 Week||10
8317083|NCT01447849|20505821|P2|STARTED|Washout Period for 1 Week||10
8317084|NCT01447849|20505822|P1|STARTED|Washout Period for 1 Week||10
8317085|NCT01447849|20505819|P4|NOT COMPLETED|First Intervention||0
8317086|NCT01447849|20505820|P3|NOT COMPLETED|First Intervention||0
8317087|NCT01447849|20505821|P2|NOT COMPLETED|First Intervention||0
8317088|NCT01447849|20505822|P1|NOT COMPLETED|First Intervention||0
8317089|NCT01447849|20505819|P4|COMPLETED|First Intervention||10
8317090|NCT01447849|20505820|P3|COMPLETED|First Intervention||10
8317091|NCT01447849|20505821|P2|COMPLETED|First Intervention||10
8317092|NCT01447849|20505822|P1|COMPLETED|First Intervention||10
8317093|NCT01447849|20505819|P4|STARTED|First Intervention||10
8317094|NCT01447849|20505820|P3|STARTED|First Intervention||10
8317095|NCT01447849|20505821|P2|STARTED|First Intervention||10
8317096|NCT01447849|20505822|P1|STARTED|First Intervention||10
8317097|NCT01447719|20505832|P1|NOT COMPLETED|Overall Study||93
8317098|NCT01447719|20505832|P1|COMPLETED|Overall Study||59
8317099|NCT01447719|20505832|P1|Deceased <2 Years After AV-45 Scan|Overall Study||66
8317100|NCT01447719|20505832|P1|Valid AV-45 Scan Acquired|Overall Study||147
8317101|NCT01447719|20505832|P1|STARTED|Overall Study||152
8317102|NCT01447706|20505845|P2|NOT COMPLETED|Overall Study||3
8317103|NCT01447706|20505846|P1|NOT COMPLETED|Overall Study||0
8317104|NCT01447706|20505845|P2|COMPLETED|Overall Study||80
8317105|NCT01447706|20505846|P1|COMPLETED|Overall Study||140
8317106|NCT01447706|20505845|P2|STARTED|Overall Study|3 patients enrolled but not dosed|83
8317107|NCT01447706|20505846|P1|STARTED|Overall Study||140
8317108|NCT01447576|20505858|P1|NOT COMPLETED|Overall Study||476
8317109|NCT01447576|20505858|P1|COMPLETED|Overall Study||560
8317110|NCT01447576|20505858|P1|STARTED|Overall Study||1036
8317111|NCT01447511|20505869|P5|NOT COMPLETED|Rifampin Period||0
8317112|NCT01447511|20505870|P4|NOT COMPLETED|Rifampin Period||1
8317113|NCT01447511|20505871|P3|NOT COMPLETED|Rifampin Period||0
8317114|NCT01447511|20505872|P2|NOT COMPLETED|Rifampin Period||0
8317115|NCT01447511|20505873|P1|NOT COMPLETED|Rifampin Period||0
8317116|NCT01447511|20505869|P5|COMPLETED|Rifampin Period||4
8317117|NCT01447511|20505870|P4|COMPLETED|Rifampin Period||2
8317118|NCT01447511|20505871|P3|COMPLETED|Rifampin Period||8
8317119|NCT01447511|20505872|P2|COMPLETED|Rifampin Period||5
8317120|NCT01447511|20505873|P1|COMPLETED|Rifampin Period||8
8317121|NCT01447511|20505869|P5|STARTED|Rifampin Period||4
8317122|NCT01447511|20505870|P4|STARTED|Rifampin Period||3
8317123|NCT01447511|20505871|P3|STARTED|Rifampin Period||8
8317124|NCT01447511|20505872|P2|STARTED|Rifampin Period||5
8317125|NCT01447511|20505873|P1|STARTED|Rifampin Period||8
8317126|NCT01447511|20505869|P5|NOT COMPLETED|Fluconazole Period||0
8317127|NCT01447511|20505870|P4|NOT COMPLETED|Fluconazole Period||0
8317128|NCT01447511|20505871|P3|NOT COMPLETED|Fluconazole Period||1
8317129|NCT01447511|20505872|P2|NOT COMPLETED|Fluconazole Period||0
8317130|NCT01447511|20505873|P1|NOT COMPLETED|Fluconazole Period||0
8317131|NCT01447511|20505869|P5|COMPLETED|Fluconazole Period||4
8317132|NCT01447511|20505870|P4|COMPLETED|Fluconazole Period||3
8317133|NCT01447511|20505871|P3|COMPLETED|Fluconazole Period||8
8317134|NCT01447511|20505872|P2|COMPLETED|Fluconazole Period||0
8317135|NCT01447511|20505873|P1|COMPLETED|Fluconazole Period||8
8317136|NCT01447511|20505869|P5|STARTED|Fluconazole Period||4
8317137|NCT01447511|20505870|P4|STARTED|Fluconazole Period||3
8317138|NCT01447511|20505871|P3|STARTED|Fluconazole Period||9
8317139|NCT01447511|20505872|P2|STARTED|Fluconazole Period||0
8317140|NCT01447511|20505873|P1|STARTED|Fluconazole Period||8
8317141|NCT01447511|20505869|P5|NOT COMPLETED|Control Period||0
8317142|NCT01447511|20505870|P4|NOT COMPLETED|Control Period||0
8317143|NCT01447511|20505871|P3|NOT COMPLETED|Control Period||0
8317144|NCT01447511|20505872|P2|NOT COMPLETED|Control Period||0
8317145|NCT01447511|20505873|P1|NOT COMPLETED|Control Period||0
8317146|NCT01447511|20505869|P5|COMPLETED|Control Period||4
8317147|NCT01447511|20505870|P4|COMPLETED|Control Period||3
8317148|NCT01447511|20505871|P3|COMPLETED|Control Period||9
8317149|NCT01447511|20505872|P2|COMPLETED|Control Period||5
8317150|NCT01447511|20505873|P1|COMPLETED|Control Period||8
8317151|NCT01447511|20505869|P5|STARTED|Control Period||4
8317152|NCT01447511|20505870|P4|STARTED|Control Period||3
8317153|NCT01447511|20505871|P3|STARTED|Control Period||9
8317154|NCT01447511|20505872|P2|STARTED|Control Period||5
8317155|NCT01447511|20505873|P1|STARTED|Control Period||8
8317156|NCT01447446|20505891|P6|NOT COMPLETED|Overall Study||32
8317157|NCT01447446|20505892|P5|NOT COMPLETED|Overall Study||211
8317158|NCT01447446|20505893|P4|NOT COMPLETED|Overall Study||33
8317159|NCT01447446|20505894|P3|NOT COMPLETED|Overall Study||100
8317160|NCT01447446|20505895|P2|NOT COMPLETED|Overall Study||165
8317161|NCT01447446|20505896|P1|NOT COMPLETED|Overall Study||722
8317162|NCT01447446|20505891|P6|COMPLETED|Overall Study||54
8317163|NCT01447446|20505892|P5|COMPLETED|Overall Study||610
8317164|NCT01447446|20505893|P4|COMPLETED|Overall Study||60
8317165|NCT01447446|20505894|P3|COMPLETED|Overall Study||192
8317166|NCT01447446|20505895|P2|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
8317167|NCT01447446|20505896|P1|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
8317168|NCT01447446|20505891|P6|STARTED|Overall Study||86
8317169|NCT01447446|20505892|P5|STARTED|Overall Study||821
8317170|NCT01447446|20505893|P4|STARTED|Overall Study||93
8317171|NCT01447446|20505894|P3|STARTED|Overall Study||292
8317172|NCT01447446|20505895|P2|STARTED|Overall Study||496
8317173|NCT01447446|20505896|P1|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
8317174|NCT01447433|20505986|P2|NOT COMPLETED|Overall Study||6
8317175|NCT01447433|20505987|P1|NOT COMPLETED|Overall Study||4
8317176|NCT01447433|20505986|P2|COMPLETED|Overall Study||21
8317177|NCT01447433|20505987|P1|COMPLETED|Overall Study||22
8317178|NCT01447433|20505986|P2|STARTED|Overall Study||27
8317179|NCT01447433|20505987|P1|STARTED|Overall Study||26
8317180|NCT01447420|20506014|P3|NOT COMPLETED|Overall Study||10
8317181|NCT01447420|20506015|P2|NOT COMPLETED|Overall Study||27
8317182|NCT01447420|20506016|P1|NOT COMPLETED|Overall Study||10
8317183|NCT01447420|20506014|P3|COMPLETED|Overall Study||8
8317184|NCT01447420|20506015|P2|COMPLETED|Overall Study||45
8317185|NCT01447420|20506016|P1|COMPLETED|Overall Study||29
8317186|NCT01447420|20506014|P3|STARTED|Overall Study||18
8317187|NCT01447420|20506015|P2|STARTED|Overall Study||72
8317188|NCT01447420|20506016|P1|STARTED|Overall Study||39
8317189|NCT01447407|20506036|P4|NOT COMPLETED|Overall Study||2
8317190|NCT01447407|20506037|P3|NOT COMPLETED|Overall Study||1
8317191|NCT01447407|20506038|P2|NOT COMPLETED|Overall Study||0
8317192|NCT01447407|20506039|P1|NOT COMPLETED|Overall Study||2
8317193|NCT01447407|20506036|P4|COMPLETED|Overall Study||40
8317194|NCT01447407|20506037|P3|COMPLETED|Overall Study||40
8317195|NCT01447407|20506038|P2|COMPLETED|Overall Study||40
8317196|NCT01447407|20506039|P1|COMPLETED|Overall Study||39
8317197|NCT01447407|20506036|P4|STARTED|Overall Study||42
8317198|NCT01447407|20506037|P3|STARTED|Overall Study||41
8317199|NCT01447407|20506038|P2|STARTED|Overall Study||40
8317200|NCT01447407|20506039|P1|STARTED|Overall Study||41
8317201|NCT01447225|20506077|P10|NOT COMPLETED|Overall Study||0
8317202|NCT01447225|20506078|P9|NOT COMPLETED|Overall Study||0
8317203|NCT01447225|20506079|P8|NOT COMPLETED|Overall Study||0
8317204|NCT01447225|20506080|P7|NOT COMPLETED|Overall Study||0
8317205|NCT01447225|20506081|P6|NOT COMPLETED|Overall Study||0
8317206|NCT01447225|20506082|P5|NOT COMPLETED|Overall Study||0
8317207|NCT01447225|20506083|P4|NOT COMPLETED|Overall Study||0
8317208|NCT01447225|20506084|P3|NOT COMPLETED|Overall Study||0
8317209|NCT01447225|20506085|P2|NOT COMPLETED|Overall Study||0
8317210|NCT01447225|20506086|P1|NOT COMPLETED|Overall Study||0
8317211|NCT01447225|20506077|P10|COMPLETED|Overall Study||4
8317212|NCT01447225|20506078|P9|COMPLETED|Overall Study||3
8317213|NCT01447225|20506079|P8|COMPLETED|Overall Study||4
8317214|NCT01447225|20506080|P7|COMPLETED|Overall Study||7
8317215|NCT01447225|20506081|P6|COMPLETED|Overall Study||3
8317216|NCT01447225|20506082|P5|COMPLETED|Overall Study||3
8317217|NCT01447225|20506083|P4|COMPLETED|Overall Study||3
8317218|NCT01447225|20506084|P3|COMPLETED|Overall Study||5
8317219|NCT01447225|20506085|P2|COMPLETED|Overall Study||8
8317220|NCT01447225|20506086|P1|COMPLETED|Overall Study||3
8317221|NCT01447225|20506077|P10|STARTED|Overall Study||4
8317222|NCT01447225|20506078|P9|STARTED|Overall Study||3
8317223|NCT01447225|20506079|P8|STARTED|Overall Study||4
8317224|NCT01447225|20506080|P7|STARTED|Overall Study||7
8317225|NCT01447225|20506081|P6|STARTED|Overall Study||3
8317226|NCT01447225|20506082|P5|STARTED|Overall Study||3
8317227|NCT01447225|20506083|P4|STARTED|Overall Study||3
8317228|NCT01447225|20506084|P3|STARTED|Overall Study||5
8317229|NCT01447225|20506085|P2|STARTED|Overall Study||8
8317230|NCT01447225|20506086|P1|STARTED|Overall Study||3
8317231|NCT01447121|20506156|P1|NOT COMPLETED|Overall Study||0
8317232|NCT01447121|20506156|P1|COMPLETED|Overall Study||118
8317233|NCT01447121|20506156|P1|STARTED|Overall Study||118
8317234|NCT01447017|20506163|P2|NOT COMPLETED|Overall Study||10
8317235|NCT01447017|20506164|P1|NOT COMPLETED|Overall Study||10
8317236|NCT01447017|20506163|P2|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
8317237|NCT01447017|20506164|P1|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
8317238|NCT01447017|20506163|P2|Performed Visit 2|Overall Study||24
8317239|NCT01447017|20506164|P1|Performed Visit 2|Overall Study||43
8317240|NCT01447017|20506163|P2|STARTED|Overall Study||24
8317241|NCT01447017|20506164|P1|STARTED|Overall Study||45
8317242|NCT01446965|20506172|P2|NOT COMPLETED|Participants Followed and Analyzed||12
8317243|NCT01446965|20506173|P1|NOT COMPLETED|Participants Followed and Analyzed||10
8317244|NCT01446965|20506172|P2|COMPLETED|Participants Followed and Analyzed||766
8317245|NCT01446965|20506173|P1|COMPLETED|Participants Followed and Analyzed||1514
8317246|NCT01446965|20506172|P2|Given WCD Out of Protocol|Participants Followed and Analyzed||20
8317247|NCT01446965|20506173|P1|Given WCD Out of Protocol|Participants Followed and Analyzed||0
8317248|NCT01446965|20506172|P2|Never Given WCD|Participants Followed and Analyzed||758
8317249|NCT01446965|20506173|P1|Never Given WCD|Participants Followed and Analyzed||0
8317250|NCT01446965|20506172|P2|Never Wore WCD|Participants Followed and Analyzed||0
8317251|NCT01446965|20506173|P1|Never Wore WCD|Participants Followed and Analyzed||43
8317252|NCT01446965|20506172|P2|Received WCD|Participants Followed and Analyzed||0
8317253|NCT01446965|20506173|P1|Received WCD|Participants Followed and Analyzed||1481
8317254|NCT01446965|20506172|P2|STARTED|Participants Followed and Analyzed||778
8317255|NCT01446965|20506173|P1|STARTED|Participants Followed and Analyzed||1524
8317256|NCT01446965|20506172|P2|NOT COMPLETED|Randominization||16
8317257|NCT01446965|20506173|P1|NOT COMPLETED|Randominization||30
8317258|NCT01446965|20506172|P2|COMPLETED|Randominization||778
8317259|NCT01446965|20506173|P1|COMPLETED|Randominization||1524
8317260|NCT01446965|20506172|P2|STARTED|Randominization||794
8317261|NCT01446965|20506173|P1|STARTED|Randominization||1554
8317262|NCT01446913|20506186|P3|NOT COMPLETED|Overall Study||11
8317263|NCT01446913|20506187|P2|NOT COMPLETED|Overall Study||9
8317264|NCT01446913|20506188|P1|NOT COMPLETED|Overall Study||9
8317265|NCT01446913|20506186|P3|COMPLETED|Overall Study||73
8317266|NCT01446913|20506187|P2|COMPLETED|Overall Study||73
8317267|NCT01446913|20506188|P1|COMPLETED|Overall Study||77
8317268|NCT01446913|20506186|P3|Patients With Sleep Apnea|Overall Study||21
8317269|NCT01446913|20506187|P2|Patients With Sleep Apnea|Overall Study||45
8317270|NCT01446913|20506188|P1|Patients With Sleep Apnea|Overall Study||39
8317271|NCT01446913|20506186|P3|Patients With Sleep Study|Overall Study||29
8317272|NCT01446913|20506187|P2|Patients With Sleep Study|Overall Study||56
8317273|NCT01446913|20506188|P1|Patients With Sleep Study|Overall Study||53
8317274|NCT01446913|20506186|P3|STARTED|Overall Study||84
8317275|NCT01446913|20506187|P2|STARTED|Overall Study||82
8317276|NCT01446913|20506188|P1|STARTED|Overall Study||86
8317277|NCT01446874|20506249|P3|NOT COMPLETED|Overall Study||18
8317278|NCT01446874|20506250|P2|NOT COMPLETED|Overall Study||4
8317279|NCT01446874|20506251|P1|NOT COMPLETED|Overall Study||2
8317280|NCT01446874|20506249|P3|COMPLETED|Overall Study||62
8317281|NCT01446874|20506250|P2|COMPLETED|Overall Study||46
8317282|NCT01446874|20506251|P1|COMPLETED|Overall Study||18
8317283|NCT01446874|20506249|P3|STARTED|Overall Study||80
8317284|NCT01446874|20506250|P2|STARTED|Overall Study||50
8317285|NCT01446874|20506251|P1|STARTED|Overall Study||20
8317286|NCT01446809|20506279|P3|NOT COMPLETED|Overall Study||2
8317287|NCT01446809|20506280|P2|NOT COMPLETED|Overall Study||0
8317288|NCT01446809|20506281|P1|NOT COMPLETED|Overall Study||0
8317289|NCT01446809|20506279|P3|COMPLETED|Overall Study||0
8317290|NCT01446809|20506280|P2|COMPLETED|Overall Study||7
8317291|NCT01446809|20506281|P1|COMPLETED|Overall Study||14
8317292|NCT01446809|20506279|P3|STARTED|Overall Study||2
8317293|NCT01446809|20506280|P2|STARTED|Overall Study||7
8317294|NCT01446809|20506281|P1|STARTED|Overall Study||14
8317295|NCT01446796|20506304|P2|NOT COMPLETED|Overall Study||0
8317296|NCT01446796|20506305|P1|NOT COMPLETED|Overall Study||1
8317297|NCT01446796|20506304|P2|COMPLETED|Overall Study|Study terminated early|0
8317298|NCT01446796|20506305|P1|COMPLETED|Overall Study|"Study terminated early
~One subject of three withdrew prior to randomization and did not start"|2
8317299|NCT01446796|20506304|P2|STARTED|Overall Study||0
8317300|NCT01446796|20506305|P1|STARTED|Overall Study||3
8317301|NCT01446705|20506319|P2|NOT COMPLETED|Overall Study||0
8317302|NCT01446705|20506320|P1|NOT COMPLETED|Overall Study||0
8317303|NCT01446705|20506319|P2|COMPLETED|Overall Study||6627
8317304|NCT01446705|20506320|P1|COMPLETED|Overall Study||50446
8317305|NCT01446705|20506319|P2|STARTED|Overall Study||6627
8317306|NCT01446705|20506320|P1|STARTED|Overall Study||50446
8317307|NCT01446666|20506336|P1|NOT COMPLETED|Overall Study||81
8317308|NCT01446666|20506336|P1|COMPLETED|Overall Study||326
8317309|NCT01446666|20506336|P1|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407
8317310|NCT01446419|20506351|P2|NOT COMPLETED|Overall Study||1
8317311|NCT01446419|20506352|P1|NOT COMPLETED|Overall Study||5
8317312|NCT01446419|20506351|P2|COMPLETED|Overall Study||77
8317313|NCT01446419|20506352|P1|COMPLETED|Overall Study||142
8317314|NCT01446419|20506351|P2|12 Month Follow-up|Overall Study||77
8317315|NCT01446419|20506352|P1|12 Month Follow-up|Overall Study||142
8317316|NCT01446419|20506351|P2|6 Month Follow-up|Overall Study||77
8317317|NCT01446419|20506352|P1|6 Month Follow-up|Overall Study||144
8317318|NCT01446419|20506351|P2|3 Month Follow-up|Overall Study||77
8317319|NCT01446419|20506352|P1|3 Month Follow-up|Overall Study||146
8317320|NCT01446419|20506351|P2|STARTED|Overall Study||78
8317321|NCT01446419|20506352|P1|STARTED|Overall Study||147
8317322|NCT01446289|20506366|P4|NOT COMPLETED|Overall Study||0
8317323|NCT01446289|20506367|P3|NOT COMPLETED|Overall Study||1
8317324|NCT01446289|20506368|P2|NOT COMPLETED|Overall Study||0
8317325|NCT01446289|20506369|P1|NOT COMPLETED|Overall Study||1
8317326|NCT01446289|20506366|P4|COMPLETED|Overall Study||35
8317327|NCT01446289|20506367|P3|COMPLETED|Overall Study||50
8317328|NCT01446289|20506368|P2|COMPLETED|Overall Study||35
8317329|NCT01446289|20506369|P1|COMPLETED|Overall Study||50
8317330|NCT01446289|20506366|P4|STARTED|Overall Study||35
8317331|NCT01446289|20506367|P3|STARTED|Overall Study||51
8317332|NCT01446289|20506368|P2|STARTED|Overall Study||35
8317333|NCT01446289|20506369|P1|STARTED|Overall Study||51
8317334|NCT01446250|20506397|P4|NOT COMPLETED|Follow-up||6
8317335|NCT01446250|20506398|P3|NOT COMPLETED|Follow-up||0
8317336|NCT01446250|20506399|P2|NOT COMPLETED|Follow-up||0
8317337|NCT01446250|20506400|P1|NOT COMPLETED|Follow-up||0
8317338|NCT01446250|20506397|P4|COMPLETED|Follow-up||0
8317339|NCT01446250|20506398|P3|COMPLETED|Follow-up||0
8317340|NCT01446250|20506399|P2|COMPLETED|Follow-up||0
8317341|NCT01446250|20506400|P1|COMPLETED|Follow-up||0
8317342|NCT01446250|20506397|P4|STARTED|Follow-up||6
8317343|NCT01446250|20506398|P3|STARTED|Follow-up||0
8317344|NCT01446250|20506399|P2|STARTED|Follow-up||0
8317345|NCT01446250|20506400|P1|STARTED|Follow-up||0
8317346|NCT01446250|20506397|P4|NOT COMPLETED|Treatment Period 2||0
8317347|NCT01446250|20506398|P3|NOT COMPLETED|Treatment Period 2||0
8317348|NCT01446250|20506399|P2|NOT COMPLETED|Treatment Period 2||1
8317349|NCT01446250|20506400|P1|NOT COMPLETED|Treatment Period 2||0
8317350|NCT01446250|20506397|P4|COMPLETED|Treatment Period 2||0
8317351|NCT01446250|20506398|P3|COMPLETED|Treatment Period 2||0
8317352|NCT01446250|20506399|P2|COMPLETED|Treatment Period 2||6
8317353|NCT01446250|20506400|P1|COMPLETED|Treatment Period 2||0
8317354|NCT01446250|20506397|P4|STARTED|Treatment Period 2||0
8317355|NCT01446250|20506398|P3|STARTED|Treatment Period 2||0
8317356|NCT01446250|20506399|P2|STARTED|Treatment Period 2||7
8317357|NCT01446250|20506400|P1|STARTED|Treatment Period 2||0
8317358|NCT01446250|20506397|P4|NOT COMPLETED|Clinical Hold||0
8317359|NCT01446250|20506398|P3|NOT COMPLETED|Clinical Hold||0
8317360|NCT01446250|20506399|P2|NOT COMPLETED|Clinical Hold||0
8317361|NCT01446250|20506400|P1|NOT COMPLETED|Clinical Hold||0
8317362|NCT01446250|20506397|P4|COMPLETED|Clinical Hold||0
8317363|NCT01446250|20506398|P3|COMPLETED|Clinical Hold||5
8317364|NCT01446250|20506399|P2|COMPLETED|Clinical Hold||2
8317365|NCT01446250|20506400|P1|COMPLETED|Clinical Hold||0
8317366|NCT01446250|20506397|P4|STARTED|Clinical Hold||0
8317367|NCT01446250|20506398|P3|STARTED|Clinical Hold||5
8317368|NCT01446250|20506399|P2|STARTED|Clinical Hold||2
8317369|NCT01446250|20506400|P1|STARTED|Clinical Hold||0
8317370|NCT01446250|20506397|P4|NOT COMPLETED|Treatment Period 1||0
8317371|NCT01446250|20506398|P3|NOT COMPLETED|Treatment Period 1||0
8317372|NCT01446250|20506399|P2|NOT COMPLETED|Treatment Period 1||1
8317373|NCT01446250|20506400|P1|NOT COMPLETED|Treatment Period 1||0
8317374|NCT01446250|20506397|P4|COMPLETED|Treatment Period 1||0
8317375|NCT01446250|20506398|P3|COMPLETED|Treatment Period 1||0
8317376|NCT01446250|20506399|P2|COMPLETED|Treatment Period 1||2
8317377|NCT01446250|20506400|P1|COMPLETED|Treatment Period 1||5
8317378|NCT01446250|20506397|P4|STARTED|Treatment Period 1||0
8317379|NCT01446250|20506398|P3|STARTED|Treatment Period 1||0
8317380|NCT01446250|20506399|P2|STARTED|Treatment Period 1||3
8317381|NCT01446250|20506400|P1|STARTED|Treatment Period 1||5
8317382|NCT01446237|20506412|P1|NOT COMPLETED|Overall Study||10
8317383|NCT01446237|20506412|P1|COMPLETED|Overall Study||115
8317384|NCT01446237|20506412|P1|STARTED|Overall Study||125
8317385|NCT01446159|20506424|P4|NOT COMPLETED|Overall Study||62
8317386|NCT01446159|20506425|P3|NOT COMPLETED|Overall Study||71
8317387|NCT01446159|20506426|P2|NOT COMPLETED|Overall Study||3
8317388|NCT01446159|20506427|P1|NOT COMPLETED|Overall Study||3
8317389|NCT01446159|20506424|P4|COMPLETED|Overall Study||23
8317390|NCT01446159|20506425|P3|COMPLETED|Overall Study||21
8317391|NCT01446159|20506426|P2|COMPLETED|Overall Study||0
8317392|NCT01446159|20506427|P1|COMPLETED|Overall Study||0
8317393|NCT01446159|20506424|P4|STARTED|Overall Study||85
8317394|NCT01446159|20506425|P3|STARTED|Overall Study||92
8317395|NCT01446159|20506426|P2|STARTED|Overall Study||3
8317396|NCT01446159|20506427|P1|STARTED|Overall Study||3
8317397|NCT01446042|20506502|P3|NOT COMPLETED|Overall Study||9
8317398|NCT01446042|20506503|P2|NOT COMPLETED|Overall Study||3
8317399|NCT01446042|20506504|P1|NOT COMPLETED|Overall Study||20
8317400|NCT01446042|20506502|P3|COMPLETED|Overall Study||69
8317401|NCT01446042|20506503|P2|COMPLETED|Overall Study||83
8317402|NCT01446042|20506504|P1|COMPLETED|Overall Study||122
8317403|NCT01446042|20506502|P3|STARTED|Overall Study||78
8317404|NCT01446042|20506503|P2|STARTED|Overall Study||86
8317405|NCT01446042|20506504|P1|STARTED|Overall Study||142
8317406|NCT01446003|20506515|P2|NOT COMPLETED|Period 2||0
8317407|NCT01446003|20506516|P1|NOT COMPLETED|Period 2||1
8317408|NCT01446003|20506515|P2|COMPLETED|Period 2||15
8317409|NCT01446003|20506516|P1|COMPLETED|Period 2||13
8317410|NCT01446003|20506515|P2|STARTED|Period 2||15
8317411|NCT01446003|20506516|P1|STARTED|Period 2||14
8317412|NCT01446003|20506515|P2|NOT COMPLETED|Period 1||0
8317413|NCT01446003|20506516|P1|NOT COMPLETED|Period 1||2
8317414|NCT01446003|20506515|P2|COMPLETED|Period 1||15
8317415|NCT01446003|20506516|P1|COMPLETED|Period 1||14
8317416|NCT01446003|20506515|P2|STARTED|Period 1||15
8317417|NCT01446003|20506516|P1|STARTED|Period 1||16
8317418|NCT01445951|20506537|P3|NOT COMPLETED|Overall Study||19
8317419|NCT01445951|20506538|P2|NOT COMPLETED|Overall Study||36
8317420|NCT01445951|20506539|P1|NOT COMPLETED|Overall Study||44
8317421|NCT01445951|20506537|P3|COMPLETED|Overall Study||151
8317422|NCT01445951|20506538|P2|COMPLETED|Overall Study||138
8317423|NCT01445951|20506539|P1|COMPLETED|Overall Study||130
8317424|NCT01445951|20506537|P3|STARTED|Overall Study||170
8317425|NCT01445951|20506538|P2|STARTED|Overall Study||174
8317426|NCT01445951|20506539|P1|STARTED|Overall Study||174
8317427|NCT01445886|20506577|P1|NOT COMPLETED|Overall Study||5
8317428|NCT01445886|20506577|P1|COMPLETED|Overall Study||28
8317429|NCT01445886|20506577|P1|STARTED|Overall Study||33
8317430|NCT01445873|20506587|P1|NOT COMPLETED|Overall Study||0
8317431|NCT01445873|20506587|P1|COMPLETED|Overall Study||36
8317432|NCT01445873|20506587|P1|STARTED|Overall Study||36
8317433|NCT01445847|20506617|P2|NOT COMPLETED|Overall Study||14
8317434|NCT01445847|20506618|P1|NOT COMPLETED|Overall Study||14
8317435|NCT01445847|20506617|P2|COMPLETED|Overall Study||36
8317436|NCT01445847|20506618|P1|COMPLETED|Overall Study||36
8317437|NCT01445847|20506617|P2|STARTED|Overall Study||50
8317438|NCT01445847|20506618|P1|STARTED|Overall Study||50
8317439|NCT01445821|20506626|P2|NOT COMPLETED|Overall Study||0
8317440|NCT01445821|20506627|P1|NOT COMPLETED|Overall Study||0
8317441|NCT01445821|20506626|P2|COMPLETED|Overall Study||22
8317442|NCT01445821|20506627|P1|COMPLETED|Overall Study||22
8317443|NCT01445821|20506626|P2|STARTED|Overall Study||22
8317444|NCT01445821|20506627|P1|STARTED|Overall Study||22
8317445|NCT01445769|20506635|P1|NOT COMPLETED|Overall Study||8
8317446|NCT01445769|20506635|P1|COMPLETED|Overall Study||37
8317447|NCT01445769|20506635|P1|STARTED|Overall Study||45
8317448|NCT01445678|20506655|P2|NOT COMPLETED|Overall Study||21
8317449|NCT01445678|20506656|P1|NOT COMPLETED|Overall Study||30
8317450|NCT01445678|20506655|P2|COMPLETED|Overall Study||476
8317451|NCT01445678|20506656|P1|COMPLETED|Overall Study||452
8317452|NCT01445678|20506655|P2|STARTED|Overall Study||497
8317453|NCT01445678|20506656|P1|STARTED|Overall Study||482
8317454|NCT01445652|20506674|P2|NOT COMPLETED|Overall Study||3
8317455|NCT01445652|20506675|P1|NOT COMPLETED|Overall Study||10
8317456|NCT01445652|20506674|P2|COMPLETED|Overall Study||50
8317457|NCT01445652|20506675|P1|COMPLETED|Overall Study||47
8317458|NCT01445652|20506674|P2|STARTED|Overall Study||53
8317459|NCT01445652|20506675|P1|STARTED|Overall Study||57
8317460|NCT01445626|20506683|P1|NOT COMPLETED|Overall Study||0
8317461|NCT01445626|20506683|P1|COMPLETED|Overall Study||87
8317462|NCT01445626|20506683|P1|STARTED|Overall Study||87
8317463|NCT01445613|20506693|P1|NOT COMPLETED|1-year Follow-up||77
8317464|NCT01445613|20506693|P1|COMPLETED|1-year Follow-up||1088
8317465|NCT01445613|20506693|P1|STARTED|1-year Follow-up||1165
8317466|NCT01445613|20506693|P1|NOT COMPLETED|30-day Follow-up||35
8317467|NCT01445613|20506693|P1|COMPLETED|30-day Follow-up||1165
8317468|NCT01445613|20506693|P1|STARTED|30-day Follow-up||1200
8317472|NCT01445535|20506737|P4|NOT COMPLETED|Overall Study||2
8317473|NCT01445535|20506738|P3|NOT COMPLETED|Overall Study||1
8317474|NCT01445535|20506739|P2|NOT COMPLETED|Overall Study||0
8317475|NCT01445535|20506740|P1|NOT COMPLETED|Overall Study||1
8317476|NCT01445535|20506737|P4|COMPLETED|Overall Study||4
8317477|NCT01445535|20506738|P3|COMPLETED|Overall Study||2
8317478|NCT01445535|20506739|P2|COMPLETED|Overall Study||3
8317479|NCT01445535|20506740|P1|COMPLETED|Overall Study||2
8317480|NCT01445535|20506737|P4|STARTED|Overall Study||6
8317481|NCT01445535|20506738|P3|STARTED|Overall Study||3
8317482|NCT01445535|20506739|P2|STARTED|Overall Study||3
8317483|NCT01445535|20506740|P1|STARTED|Overall Study||3
8317484|NCT01445301|20506764|P3|NOT COMPLETED|Overall Study||9
8317485|NCT01445301|20506765|P2|NOT COMPLETED|Overall Study||35
8317486|NCT01445301|20506766|P1|NOT COMPLETED|Overall Study||21
8317487|NCT01445301|20506764|P3|COMPLETED|Overall Study||290
8317488|NCT01445301|20506765|P2|COMPLETED|Overall Study||262
8317489|NCT01445301|20506766|P1|COMPLETED|Overall Study||183
8317490|NCT01445301|20506764|P3|STARTED|Overall Study||299
8317491|NCT01445301|20506765|P2|STARTED|Overall Study||297
8317492|NCT01445301|20506766|P1|STARTED|Overall Study||204
8317493|NCT01445171|20506801|P1|NOT COMPLETED|Overall Study||95
8317494|NCT01445171|20506801|P1|COMPLETED|Overall Study||200
8317495|NCT01445171|20506801|P1|Implanted With Study Device|Overall Study||287
8317496|NCT01445171|20506801|P1|STARTED|Overall Study||295
8317497|NCT01445028|20506824|P2|NOT COMPLETED|Overall Study||3
8317498|NCT01445028|20506825|P1|NOT COMPLETED|Overall Study||0
8317499|NCT01445028|20506824|P2|COMPLETED|Overall Study||51
8317500|NCT01445028|20506825|P1|COMPLETED|Overall Study||58
8317501|NCT01445028|20506824|P2|STARTED|Overall Study||54
8317502|NCT01445028|20506825|P1|STARTED|Overall Study||58
8317503|NCT01444924|20506833|P2|NOT COMPLETED|Overall Study||0
8317504|NCT01444924|20506834|P1|NOT COMPLETED|Overall Study||0
8317505|NCT01444924|20506833|P2|COMPLETED|Overall Study||33
8317506|NCT01444924|20506834|P1|COMPLETED|Overall Study||31
8317507|NCT01444924|20506833|P2|STARTED|Overall Study||33
8317508|NCT01444924|20506834|P1|STARTED|Overall Study||31
8317509|NCT01444911|20506844|P2|NOT COMPLETED|Overall Study||0
8317510|NCT01444911|20506845|P1|NOT COMPLETED|Overall Study||8
8317511|NCT01444911|20506844|P2|COMPLETED|Overall Study||13
8317512|NCT01444911|20506845|P1|COMPLETED|Overall Study||8
8317513|NCT01444911|20506844|P2|STARTED|Overall Study||13
8317514|NCT01444911|20506845|P1|STARTED|Overall Study||16
8317515|NCT01444898|20506857|P1|NOT COMPLETED|Overall Study||1
8317516|NCT01444898|20506857|P1|COMPLETED|Overall Study||9
8317517|NCT01444898|20506857|P1|STARTED|Overall Study||10
8317518|NCT01444781|20506872|P3|NOT COMPLETED|Overall Study||3
8317519|NCT01444781|20506873|P2|NOT COMPLETED|Overall Study||4
8317520|NCT01444781|20506874|P1|NOT COMPLETED|Overall Study||3
8317521|NCT01444781|20506872|P3|COMPLETED|Overall Study||272
8317522|NCT01444781|20506873|P2|COMPLETED|Overall Study||411
8317523|NCT01444781|20506874|P1|COMPLETED|Overall Study||413
8317524|NCT01444781|20506872|P3|STARTED|Overall Study||275
8317525|NCT01444781|20506873|P2|STARTED|Overall Study||415
8317526|NCT01444781|20506874|P1|STARTED|Overall Study||416
8317527|NCT01444742|20506912|P1|NOT COMPLETED|Overall Study||1
8317528|NCT01444742|20506912|P1|COMPLETED|Overall Study||80
8317529|NCT01444742|20506912|P1|STARTED|Overall Study||81
8317530|NCT01444651|20506919|P2|NOT COMPLETED|Overall Study||9
8317531|NCT01444651|20506920|P1|NOT COMPLETED|Overall Study||11
8317532|NCT01444651|20506919|P2|COMPLETED|Overall Study||28
8317533|NCT01444651|20506920|P1|COMPLETED|Overall Study||25
8317534|NCT01444651|20506919|P2|STARTED|Overall Study||37
8317535|NCT01444651|20506920|P1|STARTED|Overall Study||36
8317536|NCT01444456|20506936|P1|NOT COMPLETED|Overall Study||285
8317537|NCT01444456|20506936|P1|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
8317538|NCT01444456|20506936|P1|Received Darbepoetin Alfa|Overall Study||1134
8317539|NCT01444456|20506936|P1|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
8317540|NCT01444456|20506936|P1|STARTED|Overall Study||1262
8317541|NCT01444430|20506947|P2|NOT COMPLETED|Overall Study||81
8317542|NCT01444430|20506948|P1|NOT COMPLETED|Overall Study||61
8317543|NCT01444430|20506947|P2|COMPLETED|Overall Study||5766
8317544|NCT01444430|20506948|P1|COMPLETED|Overall Study||5785
8317545|NCT01444430|20506947|P2|STARTED|Overall Study||5847
8317546|NCT01444430|20506948|P1|STARTED|Overall Study||5846
8317547|NCT01444417|20506970|P2|NOT COMPLETED|Overall Study||1
8317548|NCT01444417|20506971|P1|NOT COMPLETED|Overall Study||2
8317549|NCT01444417|20506970|P2|COMPLETED|Overall Study||41
8317550|NCT01444417|20506971|P1|COMPLETED|Overall Study||18
8317551|NCT01444417|20506970|P2|Received Treatment|Overall Study||42
8317552|NCT01444417|20506971|P1|Received Treatment|Overall Study||19
8317553|NCT01444417|20506970|P2|STARTED|Overall Study||42
8317554|NCT01444417|20506971|P1|STARTED|Overall Study||20
8317555|NCT01444391|20506987|P1|NOT COMPLETED|Overall Study||1
8317556|NCT01444391|20506987|P1|COMPLETED|Overall Study||41
8317557|NCT01444391|20506987|P1|STARTED|Overall Study||42
8317558|NCT01444378|20506995|P1|NOT COMPLETED|Overall Study||17
8317559|NCT01444378|20506995|P1|COMPLETED|Overall Study||124
8317560|NCT01444378|20506995|P1|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
8317561|NCT01444300|20507107|P2|NOT COMPLETED|Overall Study||0
8317562|NCT01444300|20507108|P1|NOT COMPLETED|Overall Study||4
8317563|NCT01444300|20507107|P2|COMPLETED|Overall Study||12
8317564|NCT01444300|20507108|P1|COMPLETED|Overall Study||8
8317565|NCT01444300|20507107|P2|STARTED|Overall Study||12
8317566|NCT01444300|20507108|P1|STARTED|Overall Study||12
8317567|NCT01444287|20507118|P1|NOT COMPLETED|Period 4||0
8317568|NCT01444287|20507118|P1|COMPLETED|Period 4||22
8317569|NCT01444287|20507118|P1|STARTED|Period 4||22
8317570|NCT01444287|20507118|P1|NOT COMPLETED|Period 3||0
8317571|NCT01444287|20507118|P1|COMPLETED|Period 3||22
8317572|NCT01444287|20507118|P1|STARTED|Period 3||22
8317573|NCT01444287|20507118|P1|NOT COMPLETED|Period 2||0
8317574|NCT01444287|20507118|P1|COMPLETED|Period 2||22
8317575|NCT01444287|20507118|P1|STARTED|Period 2||22
8317576|NCT01444287|20507118|P1|NOT COMPLETED|Period 1||0
8317577|NCT01444287|20507118|P1|COMPLETED|Period 1||22
8317578|NCT01444287|20507118|P1|STARTED|Period 1||22
8317579|NCT01444092|20507140|P1|NOT COMPLETED|Overall Study||17
8317580|NCT01444092|20507140|P1|COMPLETED|Overall Study||91
8317581|NCT01444092|20507140|P1|INFORMED CONSENT OBTAINED|Overall Study||108
8317582|NCT01444092|20507140|P1|STARTED|Overall Study||108
8317583|NCT01444027|20507149|P3|NOT COMPLETED|Overall Study||38
8317584|NCT01444027|20507150|P2|NOT COMPLETED|Overall Study||30
8317585|NCT01444027|20507151|P1|NOT COMPLETED|Overall Study||30
8317586|NCT01444027|20507149|P3|COMPLETED|Overall Study||133
8317587|NCT01444027|20507150|P2|COMPLETED|Overall Study||141
8317588|NCT01444027|20507151|P1|COMPLETED|Overall Study||142
8317589|NCT01444027|20507149|P3|3 Month Follow-up|Overall Study||133
8317590|NCT01444027|20507150|P2|3 Month Follow-up|Overall Study||141
8317591|NCT01444027|20507151|P1|3 Month Follow-up|Overall Study||142
8317592|NCT01444027|20507149|P3|1 Month Follow-up|Overall Study||141
8317593|NCT01444027|20507150|P2|1 Month Follow-up|Overall Study||159
8317594|NCT01444027|20507151|P1|1 Month Follow-up|Overall Study||160
8317595|NCT01444027|20507149|P3|Received Intervention as Assigned|Overall Study||147
8317596|NCT01444027|20507150|P2|Received Intervention as Assigned|Overall Study||161
8317597|NCT01444027|20507151|P1|Received Intervention as Assigned|Overall Study||168
8317598|NCT01444027|20507149|P3|STARTED|Overall Study||171
8317599|NCT01444027|20507150|P2|STARTED|Overall Study||171
8317600|NCT01444027|20507151|P1|STARTED|Overall Study||172
8317601|NCT01443923|20507173|P2|NOT COMPLETED|Overall Study||0
8317602|NCT01443923|20507174|P1|NOT COMPLETED|Overall Study||1
8317603|NCT01443923|20507173|P2|COMPLETED|Overall Study||1
8317604|NCT01443923|20507174|P1|COMPLETED|Overall Study||2
8317605|NCT01443923|20507173|P2|STARTED|Overall Study||1
8317606|NCT01443923|20507174|P1|STARTED|Overall Study||3
8317607|NCT01443858|20507191|P3|NOT COMPLETED|Overall Study||7
8317608|NCT01443858|20507192|P2|NOT COMPLETED|Overall Study||13
8317609|NCT01443858|20507193|P1|NOT COMPLETED|Overall Study||15
8317610|NCT01443858|20507191|P3|COMPLETED|Overall Study||18
8317611|NCT01443858|20507192|P2|COMPLETED|Overall Study||12
8317612|NCT01443858|20507193|P1|COMPLETED|Overall Study||10
8317613|NCT01443858|20507191|P3|STARTED|Overall Study||25
8317614|NCT01443858|20507192|P2|STARTED|Overall Study||25
8317615|NCT01443858|20507193|P1|STARTED|Overall Study||25
8317616|NCT01443845|20507215|P2|NOT COMPLETED|Overall Study||337
8317617|NCT01443845|20507216|P1|NOT COMPLETED|Overall Study||254
8317618|NCT01443845|20507215|P2|COMPLETED|Overall Study||841
8317619|NCT01443845|20507216|P1|COMPLETED|Overall Study||922
8317620|NCT01443845|20507215|P2|STARTED|Overall Study||1178
8317621|NCT01443845|20507216|P1|STARTED|Overall Study||1176
8317622|NCT01443546|20507231|P3|NOT COMPLETED|Overall Study||0
8317623|NCT01443546|20507232|P2|NOT COMPLETED|Overall Study||0
8317624|NCT01443546|20507233|P1|NOT COMPLETED|Overall Study||0
8317625|NCT01443546|20507231|P3|COMPLETED|Overall Study||8
8317626|NCT01443546|20507232|P2|COMPLETED|Overall Study||9
8317627|NCT01443546|20507233|P1|COMPLETED|Overall Study||9
8317628|NCT01443546|20507231|P3|STARTED|Overall Study||8
8317629|NCT01443546|20507232|P2|STARTED|Overall Study||9
8317630|NCT01443546|20507233|P1|STARTED|Overall Study||9
8317631|NCT01443494|20507253|P1|NOT COMPLETED|Overall Study||0
8317632|NCT01443494|20507253|P1|COMPLETED|Overall Study||19
8317633|NCT01443494|20507253|P1|STARTED|Overall Study||19
8317634|NCT01443442|20507260|P2|NOT COMPLETED|Overall Study||0
8317635|NCT01443442|20507261|P1|NOT COMPLETED|Overall Study||0
8317636|NCT01443442|20507260|P2|COMPLETED|Overall Study||11
8317637|NCT01443442|20507261|P1|COMPLETED|Overall Study||12
8317638|NCT01443442|20507260|P2|STARTED|Overall Study||11
8317639|NCT01443442|20507261|P1|STARTED|Overall Study||12
8317640|NCT01443403|20507271|P4|NOT COMPLETED|Overall Study||9
8317641|NCT01443403|20507272|P3|NOT COMPLETED|Overall Study||7
8317642|NCT01443403|20507273|P2|NOT COMPLETED|Overall Study||6
8317643|NCT01443403|20507274|P1|NOT COMPLETED|Overall Study||6
8317644|NCT01443403|20507271|P4|COMPLETED|Overall Study||52
8317645|NCT01443403|20507272|P3|COMPLETED|Overall Study||54
8317646|NCT01443403|20507273|P2|COMPLETED|Overall Study||55
8317647|NCT01443403|20507274|P1|COMPLETED|Overall Study||55
8317648|NCT01443403|20507271|P4|Received Treatment|Overall Study||61
8317649|NCT01443403|20507272|P3|Received Treatment|Overall Study||60
8317650|NCT01443403|20507273|P2|Received Treatment|Overall Study||61
8317651|NCT01443403|20507274|P1|Received Treatment|Overall Study||61
8317652|NCT01443403|20507271|P4|STARTED|Overall Study||61
8317653|NCT01443403|20507272|P3|STARTED|Overall Study||61
8317654|NCT01443403|20507273|P2|STARTED|Overall Study||61
8317655|NCT01443403|20507274|P1|STARTED|Overall Study||61
8317656|NCT01443364|20507421|P1|NOT COMPLETED|Overall Study||41
8317657|NCT01443364|20507421|P1|COMPLETED|Overall Study||91
8317658|NCT01443364|20507421|P1|STARTED|Overall Study||132
8317659|NCT01443130|20507550|P6|NOT COMPLETED|Overall Study||34
8317660|NCT01443130|20507551|P5|NOT COMPLETED|Overall Study||44
8317661|NCT01443130|20507552|P4|NOT COMPLETED|Overall Study||39
8317662|NCT01443130|20507553|P3|NOT COMPLETED|Overall Study||77
8317663|NCT01443130|20507554|P2|NOT COMPLETED|Overall Study||69
8317664|NCT01443130|20507555|P1|NOT COMPLETED|Overall Study||68
8317665|NCT01443130|20507550|P6|COMPLETED|Overall Study||225
8317666|NCT01443130|20507551|P5|COMPLETED|Overall Study||230
8317667|NCT01443130|20507552|P4|COMPLETED|Overall Study||231
8317668|NCT01443130|20507553|P3|COMPLETED|Overall Study||223
8317669|NCT01443130|20507554|P2|COMPLETED|Overall Study||231
8317670|NCT01443130|20507555|P1|COMPLETED|Overall Study||232
8317671|NCT01443130|20507550|P6|STARTED|Overall Study||259
8317672|NCT01443130|20507551|P5|STARTED|Overall Study||274
8317673|NCT01443130|20507552|P4|STARTED|Overall Study||270
8317674|NCT01443130|20507553|P3|STARTED|Overall Study||300
8317675|NCT01443130|20507554|P2|STARTED|Overall Study||300
8317676|NCT01443130|20507555|P1|STARTED|Overall Study||300
8317677|NCT01443078|20507605|P1|NOT COMPLETED|Overall Study||29
8317678|NCT01443078|20507605|P1|COMPLETED|Overall Study||13
8317679|NCT01443078|20507605|P1|STARTED|Overall Study||42
8317680|NCT01443026|20507612|P2|NOT COMPLETED|Overall Study||5
8317681|NCT01443026|20507613|P1|NOT COMPLETED|Overall Study||3
8317682|NCT01443026|20507612|P2|COMPLETED|Overall Study||32
8317683|NCT01443026|20507613|P1|COMPLETED|Overall Study||26
8317684|NCT01443026|20507612|P2|STARTED|Overall Study||37
8317685|NCT01443026|20507613|P1|STARTED|Overall Study||29
8317686|NCT01442844|20507621|P2|NOT COMPLETED|Overall Study||0
8317687|NCT01442844|20507622|P1|NOT COMPLETED|Overall Study||0
8317688|NCT01442844|20507621|P2|COMPLETED|Overall Study||2
8317689|NCT01442844|20507622|P1|COMPLETED|Overall Study||1
8317690|NCT01442844|20507621|P2|STARTED|Overall Study||2
8317691|NCT01442844|20507622|P1|STARTED|Overall Study||1
8317692|NCT01442779|20507628|P1|NOT COMPLETED|Overall Study||7
8317693|NCT01442779|20507628|P1|COMPLETED|Overall Study||11
8317694|NCT01442779|20507628|P1|STARTED|Overall Study||18
8317695|NCT01442714|20507634|P1|NOT COMPLETED|Overall Study||12
8317696|NCT01442714|20507634|P1|COMPLETED|Overall Study||21
8317697|NCT01442714|20507634|P1|STARTED|Overall Study||33
8317710|NCT01442675|20507651|P1|NOT COMPLETED|Overall Study||12
8317711|NCT01442675|20507651|P1|COMPLETED|Overall Study||822
8317712|NCT01442675|20507651|P1|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
8317713|NCT01442675|20507651|P1|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
8317714|NCT01442675|20507651|P1|STARTED|Overall Study||834
8317715|NCT01442493|20507663|P2|NOT COMPLETED|Overall Study||2
8317716|NCT01442493|20507664|P1|NOT COMPLETED|Overall Study||3
8317717|NCT01442493|20507663|P2|COMPLETED|Overall Study||149
8317718|NCT01442493|20507664|P1|COMPLETED|Overall Study||146
8317719|NCT01442493|20507663|P2|STARTED|Overall Study||151
8317720|NCT01442493|20507664|P1|STARTED|Overall Study||149
8317721|NCT01442376|20507685|P3|NOT COMPLETED|Overall Study||5
8317722|NCT01442376|20507686|P2|NOT COMPLETED|Overall Study||9
8317723|NCT01442376|20507687|P1|NOT COMPLETED|Overall Study||3
8317724|NCT01442376|20507685|P3|COMPLETED|Overall Study||159
8317725|NCT01442376|20507686|P2|COMPLETED|Overall Study||160
8317726|NCT01442376|20507687|P1|COMPLETED|Overall Study||166
8317727|NCT01442376|20507685|P3|STARTED|Overall Study|Randomized patients|164
8317728|NCT01442376|20507686|P2|STARTED|Overall Study|Randomized patients|169
8317729|NCT01442376|20507687|P1|STARTED|Overall Study|Randomized patients|169
8317730|NCT01442181|20507700|P2|NOT COMPLETED|Overall Study||3
8317731|NCT01442181|20507701|P1|NOT COMPLETED|Overall Study||4
8317732|NCT01442181|20507700|P2|COMPLETED|Overall Study||8
8317733|NCT01442181|20507701|P1|COMPLETED|Overall Study||10
8317734|NCT01442181|20507700|P2|STARTED|Overall Study||11
8317735|NCT01442181|20507701|P1|STARTED|Overall Study||14
8317736|NCT01442155|20507725|P1|NOT COMPLETED|Overall Study||65
8317737|NCT01442155|20507725|P1|COMPLETED|Overall Study||9
8317738|NCT01442155|20507725|P1|STARTED|Overall Study||74
8317739|NCT01442129|20507732|P2|NOT COMPLETED|Overall Study||0
8317740|NCT01442129|20507733|P1|NOT COMPLETED|Overall Study||0
8317741|NCT01442129|20507732|P2|COMPLETED|Overall Study||10
8317742|NCT01442129|20507733|P1|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
8317743|NCT01442129|20507732|P2|STARTED|Overall Study||10
8317744|NCT01442129|20507733|P1|STARTED|Overall Study||20
8317745|NCT01442103|20507741|P1|NOT COMPLETED|Overall Study||2
8317746|NCT01442103|20507741|P1|COMPLETED|Overall Study||8
8317747|NCT01442103|20507741|P1|STARTED|Overall Study||10
8317748|NCT01442064|20507751|P6|NOT COMPLETED|Overall Study||99
8317749|NCT01442064|20507752|P5|NOT COMPLETED|Overall Study||106
8317750|NCT01442064|20507753|P4|NOT COMPLETED|Overall Study||98
8317751|NCT01442064|20507754|P3|NOT COMPLETED|Overall Study||104
8317752|NCT01442064|20507755|P2|NOT COMPLETED|Overall Study||101
8317753|NCT01442064|20507756|P1|NOT COMPLETED|Overall Study||97
8317754|NCT01442064|20507751|P6|COMPLETED|Overall Study||0
8317755|NCT01442064|20507752|P5|COMPLETED|Overall Study||1
8317756|NCT01442064|20507753|P4|COMPLETED|Overall Study||0
8317757|NCT01442064|20507754|P3|COMPLETED|Overall Study||0
8317758|NCT01442064|20507755|P2|COMPLETED|Overall Study||2
8317759|NCT01442064|20507756|P1|COMPLETED|Overall Study||0
8317760|NCT01442064|20507751|P6|Received Study Drug in Extension Study|Overall Study||81
8317761|NCT01442064|20507752|P5|Received Study Drug in Extension Study|Overall Study||89
8317762|NCT01442064|20507753|P4|Received Study Drug in Extension Study|Overall Study||70
8317763|NCT01442064|20507754|P3|Received Study Drug in Extension Study|Overall Study||60
8317764|NCT01442064|20507755|P2|Received Study Drug in Extension Study|Overall Study||70
8317765|NCT01442064|20507756|P1|Received Study Drug in Extension Study|Overall Study||61
8317766|NCT01442064|20507751|P6|Ranibizumab-Treated Subjects|Overall Study||99
8317767|NCT01442064|20507752|P5|Ranibizumab-Treated Subjects|Overall Study||107
8317768|NCT01442064|20507753|P4|Ranibizumab-Treated Subjects|Overall Study||96
8317769|NCT01442064|20507754|P3|Ranibizumab-Treated Subjects|Overall Study||104
8317770|NCT01442064|20507755|P2|Ranibizumab-Treated Subjects|Overall Study||103
8317771|NCT01442064|20507756|P1|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
8317772|NCT01442064|20507751|P6|STARTED|Overall Study||99
8317773|NCT01442064|20507752|P5|STARTED|Overall Study||107
8317774|NCT01442064|20507753|P4|STARTED|Overall Study||98
8317775|NCT01442064|20507754|P3|STARTED|Overall Study||104
8317776|NCT01442064|20507755|P2|STARTED|Overall Study||103
8317777|NCT01442064|20507756|P1|STARTED|Overall Study||97
8317778|NCT01442038|20507793|P2|NOT COMPLETED|Overall Study||279
8317779|NCT01442038|20507794|P1|NOT COMPLETED|Overall Study||303
8317780|NCT01442038|20507793|P2|COMPLETED|Overall Study||1040
8317781|NCT01442038|20507794|P1|COMPLETED|Overall Study||1029
8317782|NCT01442038|20507793|P2|STARTED|Overall Study||1319
8317783|NCT01442038|20507794|P1|STARTED|Overall Study||1332
8317784|NCT01441973|20507808|P2|NOT COMPLETED|Overall Study||16
8317785|NCT01441973|20507809|P1|NOT COMPLETED|Overall Study||15
8317786|NCT01441973|20507808|P2|COMPLETED|Overall Study|Still receiving treatment|0
8317787|NCT01441973|20507809|P1|COMPLETED|Overall Study|Still receiving treatment|0
8317788|NCT01441973|20507808|P2|STARTED|Overall Study||16
8317789|NCT01441973|20507809|P1|STARTED|Overall Study||15
8317790|NCT01441960|20507831|P2|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
8317791|NCT01441960|20507832|P1|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
8317792|NCT01441960|20507831|P2|COMPLETED|Second Neuromuscular Blocking Agent||13
8317793|NCT01441960|20507832|P1|COMPLETED|Second Neuromuscular Blocking Agent||18
8317794|NCT01441960|20507831|P2|STARTED|Second Neuromuscular Blocking Agent||13
8317795|NCT01441960|20507832|P1|STARTED|Second Neuromuscular Blocking Agent||18
8317796|NCT01441960|20507831|P2|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
8317891|NCT01441180|20508260|P1|COMPLETED|Overall Study||9
8317797|NCT01441960|20507832|P1|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
8317798|NCT01441960|20507831|P2|COMPLETED|First Neuromuscular Blocking Agent:||13
8317799|NCT01441960|20507832|P1|COMPLETED|First Neuromuscular Blocking Agent:||18
8317800|NCT01441960|20507831|P2|STARTED|First Neuromuscular Blocking Agent:||19
8317801|NCT01441960|20507832|P1|STARTED|First Neuromuscular Blocking Agent:||26
8317805|NCT01441843|20507848|P2|NOT COMPLETED|Overall Study||5
8317806|NCT01441843|20507849|P1|NOT COMPLETED|Overall Study||12
8317807|NCT01441843|20507848|P2|COMPLETED|Overall Study||195
8317808|NCT01441843|20507849|P1|COMPLETED|Overall Study||188
8317809|NCT01441843|20507848|P2|STARTED|Overall Study||200
8317810|NCT01441843|20507849|P1|STARTED|Overall Study||200
8317811|NCT01441765|20507857|P2|NOT COMPLETED|Overall Study||0
8317812|NCT01441765|20507858|P1|NOT COMPLETED|Overall Study||1
8317813|NCT01441765|20507857|P2|COMPLETED|Overall Study|not opened|0
8317814|NCT01441765|20507858|P1|COMPLETED|Overall Study||10
8317815|NCT01441765|20507857|P2|STARTED|Overall Study|not opened|0
8317816|NCT01441765|20507858|P1|STARTED|Overall Study||11
8317847|NCT01441596|20508106|P3|NOT COMPLETED|Overall Study||4
8317848|NCT01441596|20508107|P2|NOT COMPLETED|Overall Study||3
8317849|NCT01441596|20508108|P1|NOT COMPLETED|Overall Study||4
8317850|NCT01441596|20508106|P3|COMPLETED|Overall Study||39
8317851|NCT01441596|20508107|P2|COMPLETED|Overall Study||35
8317852|NCT01441596|20508108|P1|COMPLETED|Overall Study||36
8317853|NCT01441596|20508106|P3|STARTED|Overall Study||43
8317854|NCT01441596|20508107|P2|STARTED|Overall Study||38
8317855|NCT01441596|20508108|P1|STARTED|Overall Study||40
8317856|NCT01441570|20508124|P2|NOT COMPLETED|Overall Study||0
8317857|NCT01441570|20508125|P1|NOT COMPLETED|Overall Study||0
8317858|NCT01441570|20508124|P2|COMPLETED|Overall Study||5
8317859|NCT01441570|20508125|P1|COMPLETED|Overall Study||6
8317860|NCT01441570|20508124|P2|STARTED|Overall Study||5
8317861|NCT01441570|20508125|P1|STARTED|Overall Study||6
8317862|NCT01441492|20508135|P2|NOT COMPLETED|Overall Study||28
8317863|NCT01441492|20508136|P1|NOT COMPLETED|Overall Study||27
8317864|NCT01441492|20508135|P2|COMPLETED|Overall Study||174
8317865|NCT01441492|20508136|P1|COMPLETED|Overall Study||170
8317866|NCT01441492|20508135|P2|STARTED|Overall Study||202
8317867|NCT01441492|20508136|P1|STARTED|Overall Study||197
8317868|NCT01441466|20508162|P2|NOT COMPLETED|Overall Study||0
8317869|NCT01441466|20508163|P1|NOT COMPLETED|Overall Study||0
8317870|NCT01441466|20508162|P2|COMPLETED|Overall Study||11
8317871|NCT01441466|20508163|P1|COMPLETED|Overall Study||37
8317872|NCT01441466|20508162|P2|STARTED|Overall Study||11
8317873|NCT01441466|20508163|P1|STARTED|Overall Study||37
8317874|NCT01441414|20508179|P1|NOT COMPLETED|Overall Study||15
8317875|NCT01441414|20508179|P1|COMPLETED|Overall Study||3
8317876|NCT01441414|20508179|P1|STARTED|Overall Study||18
8317880|NCT01441245|20508232|P2|NOT COMPLETED|Overall Study||0
8317881|NCT01441245|20508233|P1|NOT COMPLETED|Overall Study||0
8317882|NCT01441245|20508232|P2|COMPLETED|Overall Study||27
8317883|NCT01441245|20508233|P1|COMPLETED|Overall Study||30
8317884|NCT01441245|20508232|P2|STARTED|Overall Study||27
8317885|NCT01441245|20508233|P1|STARTED|Overall Study||30
8317886|NCT01441180|20508258|P3|NOT COMPLETED|Overall Study||3
8317887|NCT01441180|20508259|P2|NOT COMPLETED|Overall Study||1
8317888|NCT01441180|20508260|P1|NOT COMPLETED|Overall Study||1
8317889|NCT01441180|20508258|P3|COMPLETED|Overall Study||22
8317890|NCT01441180|20508259|P2|COMPLETED|Overall Study||24
8317892|NCT01441180|20508258|P3|STARTED|Overall Study||25
8317893|NCT01441180|20508259|P2|STARTED|Overall Study||25
8317894|NCT01441180|20508260|P1|STARTED|Overall Study||10
8317895|NCT01441102|20508271|P1|NOT COMPLETED|Overall Study||3
8317896|NCT01441102|20508271|P1|COMPLETED|Overall Study||4
8317897|NCT01441102|20508271|P1|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
8317898|NCT01441076|20508291|P1|NOT COMPLETED|Overall Study||2
8317899|NCT01441076|20508291|P1|COMPLETED|Overall Study||4
8317900|NCT01441076|20508291|P1|STARTED|Overall Study||6
8317901|NCT01441063|20508309|P1|NOT COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||1
8317902|NCT01441063|20508309|P1|COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||2
8317903|NCT01441063|20508309|P1|STARTED|Tocilizumab + Zidovudine /Valganciclovir||3
8317904|NCT01441063|20508309|P1|NOT COMPLETED|Tocilizumab Alone||3
8317905|NCT01441063|20508309|P1|COMPLETED|Tocilizumab Alone||5
8317906|NCT01441063|20508309|P1|STARTED|Tocilizumab Alone||8
8317907|NCT01441037|20508338|P1|NOT COMPLETED|Overall Study||0
8317908|NCT01441037|20508338|P1|COMPLETED|Overall Study||27
8317909|NCT01441037|20508338|P1|STARTED|Overall Study||27
8317910|NCT01440972|20508344|P2|NOT COMPLETED|Overall Study||2
8317911|NCT01440972|20508345|P1|NOT COMPLETED|Overall Study||3
8317912|NCT01440972|20508344|P2|COMPLETED|Overall Study||19
8317913|NCT01440972|20508345|P1|COMPLETED|Overall Study||21
8317914|NCT01440972|20508344|P2|STARTED|Overall Study||21
8317915|NCT01440972|20508345|P1|STARTED|Overall Study||24
8317916|NCT01440959|20508359|P1|NOT COMPLETED|Overall Study||0
8317917|NCT01440959|20508359|P1|COMPLETED|Overall Study||30
8317918|NCT01440959|20508359|P1|STARTED|Overall Study||30
8317919|NCT01440946|20508369|P2|NOT COMPLETED|Overall Study||1
8317920|NCT01440946|20508370|P1|NOT COMPLETED|Overall Study||2
8317921|NCT01440946|20508369|P2|COMPLETED|Overall Study||14
8317922|NCT01440946|20508370|P1|COMPLETED|Overall Study||13
8317923|NCT01440946|20508369|P2|STARTED|Overall Study||15
8317924|NCT01440946|20508370|P1|STARTED|Overall Study||15
8317925|NCT01440881|20508409|P2|NOT COMPLETED|Overall Study||1
8317926|NCT01440881|20508410|P1|NOT COMPLETED|Overall Study||0
8317927|NCT01440881|20508409|P2|COMPLETED|Overall Study||14
8317928|NCT01440881|20508410|P1|COMPLETED|Overall Study||14
8317929|NCT01440881|20508409|P2|STARTED|Overall Study||15
8317930|NCT01440881|20508410|P1|STARTED|Overall Study||14
8317931|NCT01440816|20508424|P2|NOT COMPLETED|Overall Study||11
8317932|NCT01440816|20508425|P1|NOT COMPLETED|Overall Study||1
8317933|NCT01440816|20508424|P2|COMPLETED|Overall Study||1
8317934|NCT01440816|20508425|P1|COMPLETED|Overall Study||2
8317935|NCT01440816|20508424|P2|STARTED|Overall Study||12
8317936|NCT01440816|20508425|P1|STARTED|Overall Study||3
8317937|NCT01440803|20508441|P2|NOT COMPLETED|Overall Study||4
8317938|NCT01440803|20508442|P1|NOT COMPLETED|Overall Study||2
8317939|NCT01440803|20508441|P2|COMPLETED|Overall Study||24
8317940|NCT01440803|20508442|P1|COMPLETED|Overall Study||11
8317941|NCT01440803|20508441|P2|Period 3 - Forteo Open Label|Overall Study||27
8317942|NCT01440803|20508442|P1|Period 3 - Forteo Open Label|Overall Study||13
8317943|NCT01440803|20508441|P2|Period 2 - Forteo/Forteo|Overall Study||28
8317944|NCT01440803|20508442|P1|Period 2 - Forteo/Forteo|Overall Study||13
8317945|NCT01440803|20508441|P2|Period 1 - Forteo/Placebo|Overall Study||28
8317946|NCT01440803|20508442|P1|Period 1 - Forteo/Placebo|Overall Study||13
8317947|NCT01440803|20508441|P2|STARTED|Overall Study||28
8317948|NCT01440803|20508442|P1|STARTED|Overall Study||13
8317949|NCT01440764|20508451|P7|NOT COMPLETED|Test Day 3||0
8317950|NCT01440764|20508452|P6|NOT COMPLETED|Test Day 3||0
8317951|NCT01440764|20508453|P5|NOT COMPLETED|Test Day 3||0
8317952|NCT01440764|20508454|P4|NOT COMPLETED|Test Day 3||0
8317953|NCT01440764|20508455|P3|NOT COMPLETED|Test Day 3||0
8317954|NCT01440764|20508456|P2|NOT COMPLETED|Test Day 3||0
8317955|NCT01440764|20508457|P1|NOT COMPLETED|Test Day 3||0
8317956|NCT01440764|20508451|P7|COMPLETED|Test Day 3||3
8317957|NCT01440764|20508452|P6|COMPLETED|Test Day 3||5
8317958|NCT01440764|20508453|P5|COMPLETED|Test Day 3||3
8317959|NCT01440764|20508454|P4|COMPLETED|Test Day 3||1
8317960|NCT01440764|20508455|P3|COMPLETED|Test Day 3||6
8317961|NCT01440764|20508456|P2|COMPLETED|Test Day 3||2
8317962|NCT01440764|20508457|P1|COMPLETED|Test Day 3||3
8317963|NCT01440764|20508451|P7|STARTED|Test Day 3||3
8317964|NCT01440764|20508452|P6|STARTED|Test Day 3||5
8317965|NCT01440764|20508453|P5|STARTED|Test Day 3||3
8317966|NCT01440764|20508454|P4|STARTED|Test Day 3||1
8317967|NCT01440764|20508455|P3|STARTED|Test Day 3||6
8317968|NCT01440764|20508456|P2|STARTED|Test Day 3||2
8317969|NCT01440764|20508457|P1|STARTED|Test Day 3||3
8317970|NCT01440764|20508451|P7|NOT COMPLETED|Test Day 2||0
8317971|NCT01440764|20508452|P6|NOT COMPLETED|Test Day 2||0
8317972|NCT01440764|20508453|P5|NOT COMPLETED|Test Day 2||0
8317973|NCT01440764|20508454|P4|NOT COMPLETED|Test Day 2||0
8317974|NCT01440764|20508455|P3|NOT COMPLETED|Test Day 2||0
8317975|NCT01440764|20508456|P2|NOT COMPLETED|Test Day 2||0
8317976|NCT01440764|20508457|P1|NOT COMPLETED|Test Day 2||0
8317977|NCT01440764|20508451|P7|COMPLETED|Test Day 2||3
8317978|NCT01440764|20508452|P6|COMPLETED|Test Day 2||5
8317979|NCT01440764|20508453|P5|COMPLETED|Test Day 2||3
8317980|NCT01440764|20508454|P4|COMPLETED|Test Day 2||1
8317981|NCT01440764|20508455|P3|COMPLETED|Test Day 2||6
8317982|NCT01440764|20508456|P2|COMPLETED|Test Day 2||2
8317983|NCT01440764|20508457|P1|COMPLETED|Test Day 2||3
8317984|NCT01440764|20508451|P7|STARTED|Test Day 2||3
8317985|NCT01440764|20508452|P6|STARTED|Test Day 2||5
8317986|NCT01440764|20508453|P5|STARTED|Test Day 2||3
8317987|NCT01440764|20508454|P4|STARTED|Test Day 2||1
8317988|NCT01440764|20508455|P3|STARTED|Test Day 2||6
8317989|NCT01440764|20508456|P2|STARTED|Test Day 2||2
8317990|NCT01440764|20508457|P1|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
8317991|NCT01440764|20508451|P7|NOT COMPLETED|Test Day 1||0
8317992|NCT01440764|20508452|P6|NOT COMPLETED|Test Day 1||0
8317993|NCT01440764|20508453|P5|NOT COMPLETED|Test Day 1||0
8317994|NCT01440764|20508454|P4|NOT COMPLETED|Test Day 1||0
8317995|NCT01440764|20508455|P3|NOT COMPLETED|Test Day 1||0
8317996|NCT01440764|20508456|P2|NOT COMPLETED|Test Day 1||0
8317997|NCT01440764|20508457|P1|NOT COMPLETED|Test Day 1||0
8317998|NCT01440764|20508451|P7|COMPLETED|Test Day 1||3
8317999|NCT01440764|20508452|P6|COMPLETED|Test Day 1||5
8318000|NCT01440764|20508453|P5|COMPLETED|Test Day 1||3
8318001|NCT01440764|20508454|P4|COMPLETED|Test Day 1||1
8318002|NCT01440764|20508455|P3|COMPLETED|Test Day 1||6
8318003|NCT01440764|20508456|P2|COMPLETED|Test Day 1||2
8318004|NCT01440764|20508457|P1|COMPLETED|Test Day 1||4
8318005|NCT01440764|20508451|P7|STARTED|Test Day 1||3
8318006|NCT01440764|20508452|P6|STARTED|Test Day 1||5
8318007|NCT01440764|20508453|P5|STARTED|Test Day 1||3
8318008|NCT01440764|20508454|P4|STARTED|Test Day 1||1
8318009|NCT01440764|20508455|P3|STARTED|Test Day 1||6
8318010|NCT01440764|20508456|P2|STARTED|Test Day 1||2
8318011|NCT01440764|20508457|P1|STARTED|Test Day 1||4
8318012|NCT01440647|20508478|P2|NOT COMPLETED|Overall Study||3
8318013|NCT01440647|20508479|P1|NOT COMPLETED|Overall Study||2
8318014|NCT01440647|20508478|P2|COMPLETED|Overall Study||15
8318015|NCT01440647|20508479|P1|COMPLETED|Overall Study||14
8318016|NCT01440647|20508478|P2|STARTED|Overall Study||18
8318017|NCT01440647|20508479|P1|STARTED|Overall Study||16
8318018|NCT01440634|20508489|P2|NOT COMPLETED|Randomization Phase||10
8318019|NCT01440634|20508490|P1|NOT COMPLETED|Randomization Phase||6
8318020|NCT01440634|20508489|P2|COMPLETED|Randomization Phase||14
8318021|NCT01440634|20508490|P1|COMPLETED|Randomization Phase||24
8318022|NCT01440634|20508489|P2|STARTED|Randomization Phase||24
8318023|NCT01440634|20508490|P1|STARTED|Randomization Phase||30
8318024|NCT01440634|20508489|P2|NOT COMPLETED|Cross Sectional Phase||0
8318025|NCT01440634|20508490|P1|NOT COMPLETED|Cross Sectional Phase||0
8318026|NCT01440634|20508489|P2|COMPLETED|Cross Sectional Phase||347
8318027|NCT01440634|20508490|P1|COMPLETED|Cross Sectional Phase||0
8318028|NCT01440634|20508489|P2|STARTED|Cross Sectional Phase||347
8318029|NCT01440634|20508490|P1|STARTED|Cross Sectional Phase||0
8318030|NCT01440595|20508498|P3|NOT COMPLETED|Overall Study||1
8318031|NCT01440595|20508499|P2|NOT COMPLETED|Overall Study||3
8318032|NCT01440595|20508500|P1|NOT COMPLETED|Overall Study||1
8318033|NCT01440595|20508498|P3|COMPLETED|Overall Study||0
8318034|NCT01440595|20508499|P2|COMPLETED|Overall Study||0
8318035|NCT01440595|20508500|P1|COMPLETED|Overall Study||0
8318036|NCT01440595|20508498|P3|STARTED|Overall Study||1
8318037|NCT01440595|20508499|P2|STARTED|Overall Study||3
8318038|NCT01440595|20508500|P1|STARTED|Overall Study||1
8318039|NCT01440569|20508520|P2|NOT COMPLETED|Open-Label Rollover Phase||6
8318040|NCT01440569|20508521|P1|NOT COMPLETED|Open-Label Rollover Phase||47
8318041|NCT01440569|20508520|P2|COMPLETED|Open-Label Rollover Phase||7
8318042|NCT01440569|20508521|P1|COMPLETED|Open-Label Rollover Phase||204
8318043|NCT01440569|20508520|P2|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
8318044|NCT01440569|20508521|P1|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
8318045|NCT01440569|20508520|P2|NOT COMPLETED|Main Study||4
8318046|NCT01440569|20508521|P1|NOT COMPLETED|Main Study||36
8318047|NCT01440569|20508520|P2|COMPLETED|Main Study||14
8318048|NCT01440569|20508521|P1|COMPLETED|Main Study||260
8318049|NCT01440569|20508520|P2|Enrolled and Treated|Main Study||18
8318050|NCT01440569|20508521|P1|Enrolled and Treated|Main Study||295
8318051|NCT01440569|20508520|P2|STARTED|Main Study||18
8318052|NCT01440569|20508521|P1|STARTED|Main Study||296
8318053|NCT01440543|20508543|P4|NOT COMPLETED|Overall Study||6
8318054|NCT01440543|20508544|P3|NOT COMPLETED|Overall Study||2
8318055|NCT01440543|20508545|P2|NOT COMPLETED|Overall Study||4
8318056|NCT01440543|20508546|P1|NOT COMPLETED|Overall Study||4
8318057|NCT01440543|20508543|P4|COMPLETED|Overall Study||101
8318058|NCT01440543|20508544|P3|COMPLETED|Overall Study||100
8318059|NCT01440543|20508545|P2|COMPLETED|Overall Study||101
8318060|NCT01440543|20508546|P1|COMPLETED|Overall Study||102
8318061|NCT01440543|20508543|P4|STARTED|Overall Study||107
8318062|NCT01440543|20508544|P3|STARTED|Overall Study||102
8318063|NCT01440543|20508545|P2|STARTED|Overall Study||105
8318064|NCT01440543|20508546|P1|STARTED|Overall Study||106
8318065|NCT01440517|20508556|P1|NOT COMPLETED|Overall Study||1
8318066|NCT01440517|20508556|P1|COMPLETED|Overall Study||4
8318067|NCT01440517|20508556|P1|STARTED|Overall Study||5
8318068|NCT01440452|20508565|P4|NOT COMPLETED|Overall Study||0
8318069|NCT01440452|20508566|P3|NOT COMPLETED|Overall Study||0
8318070|NCT01440452|20508567|P2|NOT COMPLETED|Overall Study||0
8318071|NCT01440452|20508568|P1|NOT COMPLETED|Overall Study||0
8318072|NCT01440452|20508565|P4|COMPLETED|Overall Study||4
8318073|NCT01440452|20508566|P3|COMPLETED|Overall Study||8
8318074|NCT01440452|20508567|P2|COMPLETED|Overall Study||7
8318075|NCT01440452|20508568|P1|COMPLETED|Overall Study||6
8318076|NCT01440452|20508565|P4|STARTED|Overall Study||4
8318077|NCT01440452|20508566|P3|STARTED|Overall Study||8
8318078|NCT01440452|20508567|P2|STARTED|Overall Study||7
8318079|NCT01440452|20508568|P1|STARTED|Overall Study||6
8318080|NCT01440387|20508608|P2|NOT COMPLETED|Overall Study||0
8318081|NCT01440387|20508609|P1|NOT COMPLETED|Overall Study||0
8318082|NCT01440387|20508608|P2|COMPLETED|Overall Study||56
8318083|NCT01440387|20508609|P1|COMPLETED|Overall Study||56
8318084|NCT01440387|20508608|P2|STARTED|Overall Study||56
8318085|NCT01440387|20508609|P1|STARTED|Overall Study||56
8318086|NCT01440374|20508632|P4|NOT COMPLETED|Part 3: Extension||32
8318087|NCT01440374|20508633|P3|NOT COMPLETED|Part 3: Extension||0
8318088|NCT01440374|20508634|P2|NOT COMPLETED|Part 3: Extension||0
8318089|NCT01440374|20508635|P1|NOT COMPLETED|Part 3: Extension||0
8318090|NCT01440374|20508632|P4|COMPLETED|Part 3: Extension||27
8318091|NCT01440374|20508633|P3|COMPLETED|Part 3: Extension||0
8318092|NCT01440374|20508634|P2|COMPLETED|Part 3: Extension||0
8318093|NCT01440374|20508635|P1|COMPLETED|Part 3: Extension||0
8318094|NCT01440374|20508632|P4|STARTED|Part 3: Extension||59
8318095|NCT01440374|20508633|P3|STARTED|Part 3: Extension||0
8318096|NCT01440374|20508634|P2|STARTED|Part 3: Extension||0
8318097|NCT01440374|20508635|P1|STARTED|Part 3: Extension||0
8318098|NCT01440374|20508632|P4|NOT COMPLETED|Part 2; Double-blind Phase||0
8318099|NCT01440374|20508633|P3|NOT COMPLETED|Part 2; Double-blind Phase||55
8318100|NCT01440374|20508634|P2|NOT COMPLETED|Part 2; Double-blind Phase||20
8318101|NCT01440374|20508635|P1|NOT COMPLETED|Part 2; Double-blind Phase||0
8318102|NCT01440374|20508632|P4|COMPLETED|Part 2; Double-blind Phase||0
8318103|NCT01440374|20508633|P3|COMPLETED|Part 2; Double-blind Phase||43
8318104|NCT01440374|20508634|P2|COMPLETED|Part 2; Double-blind Phase||27
8318105|NCT01440374|20508635|P1|COMPLETED|Part 2; Double-blind Phase||0
8318106|NCT01440374|20508632|P4|STARTED|Part 2; Double-blind Phase||0
8318107|NCT01440374|20508633|P3|STARTED|Part 2; Double-blind Phase||98
8318108|NCT01440374|20508634|P2|STARTED|Part 2; Double-blind Phase||47
8318109|NCT01440374|20508635|P1|STARTED|Part 2; Double-blind Phase||0
8318110|NCT01440374|20508632|P4|NOT COMPLETED|Part 1: Open-label Phase||0
8318111|NCT01440374|20508633|P3|NOT COMPLETED|Part 1: Open-label Phase||0
8318112|NCT01440374|20508634|P2|NOT COMPLETED|Part 1: Open-label Phase||0
8318113|NCT01440374|20508635|P1|NOT COMPLETED|Part 1: Open-label Phase||6
8318114|NCT01440374|20508632|P4|COMPLETED|Part 1: Open-label Phase||0
8318115|NCT01440374|20508633|P3|COMPLETED|Part 1: Open-label Phase||0
8318116|NCT01440374|20508634|P2|COMPLETED|Part 1: Open-label Phase||0
8318117|NCT01440374|20508635|P1|COMPLETED|Part 1: Open-label Phase||11
8318118|NCT01440374|20508632|P4|STARTED|Part 1: Open-label Phase||0
8318119|NCT01440374|20508633|P3|STARTED|Part 1: Open-label Phase||0
8318120|NCT01440374|20508634|P2|STARTED|Part 1: Open-label Phase||0
8318121|NCT01440374|20508635|P1|STARTED|Part 1: Open-label Phase||17
8318122|NCT01440322|20508670|P2|NOT COMPLETED|Overall Study||1
8318123|NCT01440322|20508671|P1|NOT COMPLETED|Overall Study||7
8318124|NCT01440322|20508670|P2|COMPLETED|Overall Study||49
8318125|NCT01440322|20508671|P1|COMPLETED|Overall Study||90
8318126|NCT01440322|20508670|P2|STARTED|Overall Study||50
8318127|NCT01440322|20508671|P1|STARTED|Overall Study||97
8318128|NCT01440283|20508693|P1|NOT COMPLETED|Overall Study||10
8318129|NCT01440283|20508693|P1|COMPLETED|Overall Study||4
8318130|NCT01440283|20508693|P1|STARTED|Overall Study||14
8318131|NCT01440101|20508708|P3|NOT COMPLETED|Overall Study||1
8318132|NCT01440101|20508709|P2|NOT COMPLETED|Overall Study||4
8318133|NCT01440101|20508710|P1|NOT COMPLETED|Overall Study||2
8318134|NCT01440101|20508708|P3|COMPLETED|Overall Study||46
8318135|NCT01440101|20508709|P2|COMPLETED|Overall Study||43
8318136|NCT01440101|20508710|P1|COMPLETED|Overall Study||10
8318137|NCT01440101|20508708|P3|STARTED|Overall Study||47
8318138|NCT01440101|20508709|P2|STARTED|Overall Study||47
8318139|NCT01440101|20508710|P1|STARTED|Overall Study||12
8318140|NCT01440049|20508743|P1|NOT COMPLETED|Overall Study||5
8318141|NCT01440049|20508743|P1|COMPLETED|Overall Study||155
8318142|NCT01440049|20508743|P1|STARTED|Overall Study||160
8318143|NCT01439971|20508775|P5|NOT COMPLETED|Overall Study||1
8318144|NCT01439971|20508776|P4|NOT COMPLETED|Overall Study||0
8318145|NCT01439971|20508777|P3|NOT COMPLETED|Overall Study||2
8318146|NCT01439971|20508778|P2|NOT COMPLETED|Overall Study||1
8318147|NCT01439971|20508779|P1|NOT COMPLETED|Overall Study||0
8318148|NCT01439971|20508775|P5|COMPLETED|Overall Study||6
8318149|NCT01439971|20508776|P4|COMPLETED|Overall Study||6
8318150|NCT01439971|20508777|P3|COMPLETED|Overall Study||6
8318151|NCT01439971|20508778|P2|COMPLETED|Overall Study||6
8318152|NCT01439971|20508779|P1|COMPLETED|Overall Study||1
8318153|NCT01439971|20508775|P5|Received Treatment|Overall Study||6
8318154|NCT01439971|20508776|P4|Received Treatment|Overall Study||6
8318155|NCT01439971|20508777|P3|Received Treatment|Overall Study||6
8318156|NCT01439971|20508778|P2|Received Treatment|Overall Study||6
8318157|NCT01439971|20508779|P1|Received Treatment|Overall Study||1
8318158|NCT01439971|20508775|P5|STARTED|Overall Study||7
8318159|NCT01439971|20508776|P4|STARTED|Overall Study||6
8318160|NCT01439971|20508777|P3|STARTED|Overall Study||8
8318161|NCT01439971|20508778|P2|STARTED|Overall Study||7
8318162|NCT01439971|20508779|P1|STARTED|Overall Study||1
8318163|NCT01439945|20508959|P4|NOT COMPLETED|Optional Continuation Phase||0
8318164|NCT01439945|20508960|P3|NOT COMPLETED|Optional Continuation Phase||0
8318165|NCT01439945|20508961|P2|NOT COMPLETED|Optional Continuation Phase||0
8318166|NCT01439945|20508962|P1|NOT COMPLETED|Optional Continuation Phase||0
8318167|NCT01439945|20508959|P4|COMPLETED|Optional Continuation Phase||0
8318168|NCT01439945|20508960|P3|COMPLETED|Optional Continuation Phase||0
8318169|NCT01439945|20508961|P2|COMPLETED|Optional Continuation Phase||44
8318170|NCT01439945|20508962|P1|COMPLETED|Optional Continuation Phase||72
8318171|NCT01439945|20508959|P4|STARTED|Optional Continuation Phase||0
8318172|NCT01439945|20508960|P3|STARTED|Optional Continuation Phase||0
8318173|NCT01439945|20508961|P2|STARTED|Optional Continuation Phase||44
8318174|NCT01439945|20508962|P1|STARTED|Optional Continuation Phase||72
8318175|NCT01439945|20508959|P4|NOT COMPLETED|Double-Blind Treatment Phase||2
8318176|NCT01439945|20508960|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
8318177|NCT01439945|20508961|P2|NOT COMPLETED|Double-Blind Treatment Phase||5
8318178|NCT01439945|20508962|P1|NOT COMPLETED|Double-Blind Treatment Phase||4
8318179|NCT01439945|20508959|P4|COMPLETED|Double-Blind Treatment Phase||46
8318180|NCT01439945|20508960|P3|COMPLETED|Double-Blind Treatment Phase||45
8318181|NCT01439945|20508961|P2|COMPLETED|Double-Blind Treatment Phase||91
8318182|NCT01439945|20508962|P1|COMPLETED|Double-Blind Treatment Phase||93
8318183|NCT01439945|20508959|P4|STARTED|Double-Blind Treatment Phase||48
8318184|NCT01439945|20508960|P3|STARTED|Double-Blind Treatment Phase||48
8318185|NCT01439945|20508961|P2|STARTED|Double-Blind Treatment Phase||96
8318186|NCT01439945|20508962|P1|STARTED|Double-Blind Treatment Phase||97
8318187|NCT01439880|20508987|P2|NOT COMPLETED|All-IP Period (Years 2 to 5)||140
8318188|NCT01439880|20508988|P1|NOT COMPLETED|All-IP Period (Years 2 to 5)||70
8318189|NCT01439880|20508987|P2|COMPLETED|All-IP Period (Years 2 to 5)||682
8318190|NCT01439880|20508988|P1|COMPLETED|All-IP Period (Years 2 to 5)||328
8318191|NCT01439880|20508987|P2|Received Evolocumab|All-IP Period (Years 2 to 5)||777
8318192|NCT01439880|20508988|P1|Received Evolocumab|All-IP Period (Years 2 to 5)||374
8318193|NCT01439880|20508987|P2|STARTED|All-IP Period (Years 2 to 5)||822
8318194|NCT01439880|20508988|P1|STARTED|All-IP Period (Years 2 to 5)||398
8318195|NCT01439880|20508987|P2|NOT COMPLETED|SOC-controlled Period (Year 1)||60
8318196|NCT01439880|20508988|P1|NOT COMPLETED|SOC-controlled Period (Year 1)||44
8318197|NCT01439880|20508987|P2|COMPLETED|SOC-controlled Period (Year 1)||822
8318198|NCT01439880|20508988|P1|COMPLETED|SOC-controlled Period (Year 1)||398
8318199|NCT01439880|20508987|P2|Received Evolocumab|SOC-controlled Period (Year 1)||881
8318200|NCT01439880|20508988|P1|Received Evolocumab|SOC-controlled Period (Year 1)||0
8318201|NCT01439880|20508987|P2|STARTED|SOC-controlled Period (Year 1)||882
8318202|NCT01439880|20508988|P1|STARTED|SOC-controlled Period (Year 1)||442
8318203|NCT01439867|20509031|P2|NOT COMPLETED|Overall Study||8
8318204|NCT01439867|20509032|P1|NOT COMPLETED|Overall Study||6
8318205|NCT01439867|20509031|P2|COMPLETED|Overall Study||2
8318206|NCT01439867|20509032|P1|COMPLETED|Overall Study||2
8318207|NCT01439867|20509031|P2|Received Treatment|Overall Study||10
8318208|NCT01439867|20509032|P1|Received Treatment|Overall Study||7
8318209|NCT01439867|20509031|P2|STARTED|Overall Study||10
8318210|NCT01439867|20509032|P1|STARTED|Overall Study||8
8318211|NCT01439854|20509073|P2|NOT COMPLETED|Overall Study||0
8318212|NCT01439854|20509074|P1|NOT COMPLETED|Overall Study||0
8318213|NCT01439854|20509073|P2|COMPLETED|Overall Study||10
8318214|NCT01439854|20509074|P1|COMPLETED|Overall Study||8
8318215|NCT01439854|20509073|P2|STARTED|Overall Study||10
8318216|NCT01439854|20509074|P1|STARTED|Overall Study||8
8318217|NCT01439724|20509084|P2|NOT COMPLETED|Overall Study||8
8318218|NCT01439724|20509085|P1|NOT COMPLETED|Overall Study||9
8318219|NCT01439724|20509084|P2|COMPLETED|Overall Study||39
8318220|NCT01439724|20509085|P1|COMPLETED|Overall Study||38
8318221|NCT01439724|20509084|P2|STARTED|Overall Study||47
8318222|NCT01439724|20509085|P1|STARTED|Overall Study||47
8318223|NCT01439711|20509091|P1|NOT COMPLETED|Overall Study||40
8318224|NCT01439711|20509091|P1|COMPLETED|Overall Study||68
8318225|NCT01439711|20509091|P1|STARTED|Overall Study||108
8318226|NCT01439672|20509102|P1|NOT COMPLETED|Overall Study||24
8318227|NCT01439672|20509102|P1|COMPLETED|Overall Study||11
8318228|NCT01439672|20509102|P1|STARTED|Overall Study||35
8318229|NCT01439633|20509106|P1|NOT COMPLETED|Overall Study||0
8318230|NCT01439633|20509106|P1|COMPLETED|Overall Study||22
8318231|NCT01439633|20509106|P1|STARTED|Overall Study||22
8318232|NCT01439620|20509110|P1|NOT COMPLETED|Overall Study||0
8318233|NCT01439620|20509110|P1|COMPLETED|Overall Study||7
8318234|NCT01439620|20509110|P1|STARTED|Overall Study||7
8318235|NCT01439594|20509114|P1|NOT COMPLETED|Overall Study||0
8318236|NCT01439594|20509114|P1|COMPLETED|Overall Study||17
8318237|NCT01439594|20509114|P1|STARTED|Overall Study||17
8318238|NCT01439581|20509120|P2|NOT COMPLETED|Overall Study||0
8318239|NCT01439581|20509121|P1|NOT COMPLETED|Overall Study||0
8318240|NCT01439581|20509120|P2|COMPLETED|Overall Study||212
8318241|NCT01439581|20509121|P1|COMPLETED|Overall Study||216
8318242|NCT01439581|20509120|P2|STARTED|Overall Study||212
8318243|NCT01439581|20509121|P1|STARTED|Overall Study||216
8318244|NCT01439568|20509129|P2|NOT COMPLETED|Overall Study||2
8318245|NCT01439568|20509130|P1|NOT COMPLETED|Overall Study||3
8318246|NCT01439568|20509129|P2|COMPLETED|Overall Study||41
8318247|NCT01439568|20509130|P1|COMPLETED|Overall Study||44
8318248|NCT01439568|20509129|P2|Received at Least One Dose of Study Drug|Overall Study||43
8318249|NCT01439568|20509130|P1|Received at Least One Dose of Study Drug|Overall Study||47
8318250|NCT01439568|20509129|P2|STARTED|Overall Study||43
8318251|NCT01439568|20509130|P1|STARTED|Overall Study||47
8318252|NCT01439555|20509142|P1|NOT COMPLETED|Overall Study||1
8318253|NCT01439555|20509142|P1|COMPLETED|Overall Study||10
8318254|NCT01439555|20509142|P1|STARTED|Overall Study||11
8318255|NCT01439373|20509154|P2|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
8318256|NCT01439373|20509155|P1|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
8318257|NCT01439373|20509154|P2|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
8318258|NCT01439373|20509155|P1|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
8318259|NCT01439373|20509154|P2|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
8318260|NCT01439373|20509155|P1|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
8318261|NCT01439373|20509154|P2|NOT COMPLETED|Monotherapy (Day 1)||1
8318262|NCT01439373|20509155|P1|NOT COMPLETED|Monotherapy (Day 1)||0
8318263|NCT01439373|20509154|P2|COMPLETED|Monotherapy (Day 1)||4
8318264|NCT01439373|20509155|P1|COMPLETED|Monotherapy (Day 1)||11
8318265|NCT01439373|20509154|P2|STARTED|Monotherapy (Day 1)||5
8318266|NCT01439373|20509155|P1|STARTED|Monotherapy (Day 1)||11
8318267|NCT01439360|20509198|P2|NOT COMPLETED|Overall Study||208
8318268|NCT01439360|20509199|P1|NOT COMPLETED|Overall Study||198
8318269|NCT01439360|20509198|P2|COMPLETED|Overall Study||5804
8318270|NCT01439360|20509199|P1|COMPLETED|Overall Study||5808
8318271|NCT01439360|20509198|P2|STARTED|Overall Study||6012
8318272|NCT01439360|20509199|P1|STARTED|Overall Study||6006
8318273|NCT01439282|20509249|P2|NOT COMPLETED|Overall Study||1
8318274|NCT01439282|20509250|P1|NOT COMPLETED|Overall Study||8
8318275|NCT01439282|20509249|P2|COMPLETED|Overall Study||9
8318276|NCT01439282|20509250|P1|COMPLETED|Overall Study||59
8318277|NCT01439282|20509249|P2|STARTED|Overall Study||10
8318278|NCT01439282|20509250|P1|STARTED|Overall Study||67
8318279|NCT01439204|20509262|P2|NOT COMPLETED|Overall Study||3
8318280|NCT01439204|20509263|P1|NOT COMPLETED|Overall Study||4
8318281|NCT01439204|20509262|P2|COMPLETED|Overall Study||33
8318282|NCT01439204|20509263|P1|COMPLETED|Overall Study||32
8318283|NCT01439204|20509262|P2|STARTED|Overall Study||36
8318284|NCT01439204|20509263|P1|STARTED|Overall Study||36
8318285|NCT01439165|20509297|P2|NOT COMPLETED|Overall Study||2
8318286|NCT01439165|20509298|P1|NOT COMPLETED|Overall Study||21
8318287|NCT01439165|20509297|P2|COMPLETED|Overall Study||326
8318288|NCT01439165|20509298|P1|COMPLETED|Overall Study||981
8318289|NCT01439165|20509297|P2|STARTED|Overall Study||328
8318290|NCT01439165|20509298|P1|STARTED|Overall Study||1002
8318291|NCT01439126|20509312|P2|NOT COMPLETED|Overall Study||42
8318292|NCT01439126|20509313|P1|NOT COMPLETED|Overall Study||31
8318293|NCT01439126|20509312|P2|COMPLETED|Overall Study||25
8318294|NCT01439126|20509313|P1|COMPLETED|Overall Study||37
8318295|NCT01439126|20509312|P2|STARTED|Overall Study||67
8318296|NCT01439126|20509313|P1|STARTED|Overall Study||68
8318297|NCT01439087|20509333|P1|NOT COMPLETED|Overall Study||0
8318298|NCT01439087|20509333|P1|COMPLETED|Overall Study||2
8318299|NCT01439087|20509333|P1|STARTED|Overall Study||2
8318300|NCT01439074|20509339|P2|NOT COMPLETED|Overall Study||13
8318301|NCT01439074|20509340|P1|NOT COMPLETED|Overall Study||9
8318302|NCT01439074|20509339|P2|COMPLETED|Overall Study||74
8318303|NCT01439074|20509340|P1|COMPLETED|Overall Study||66
8318304|NCT01439074|20509339|P2|STARTED|Overall Study||87
8318305|NCT01439074|20509340|P1|STARTED|Overall Study||75
8318306|NCT01439035|20509352|P1|NOT COMPLETED|Overall Study||0
8318307|NCT01439035|20509352|P1|COMPLETED|Overall Study||6
8318308|NCT01439035|20509352|P1|STARTED|Overall Study||6
8318309|NCT01439009|20509358|P2|NOT COMPLETED|Overall Study||3
8318310|NCT01439009|20509359|P1|NOT COMPLETED|Overall Study||8
8318311|NCT01439009|20509358|P2|COMPLETED|Overall Study||47
8318312|NCT01439009|20509359|P1|COMPLETED|Overall Study||42
8318313|NCT01439009|20509358|P2|STARTED|Overall Study||50
8318314|NCT01439009|20509359|P1|STARTED|Overall Study||50
8318315|NCT01438996|20509392|P3|NOT COMPLETED|Overall Study||0
8318316|NCT01438996|20509393|P2|NOT COMPLETED|Overall Study||1
8318317|NCT01438996|20509394|P1|NOT COMPLETED|Overall Study||4
8318318|NCT01438996|20509392|P3|COMPLETED|Overall Study||20
8318319|NCT01438996|20509393|P2|COMPLETED|Overall Study||12
8318320|NCT01438996|20509394|P1|COMPLETED|Overall Study||14
8318321|NCT01438996|20509392|P3|STARTED|Overall Study||20
8318322|NCT01438996|20509393|P2|STARTED|Overall Study||13
8318323|NCT01438996|20509394|P1|STARTED|Overall Study||18
8318324|NCT01438840|20509428|P3|NOT COMPLETED|Extension Phase||10
8318325|NCT01438840|20509429|P2|NOT COMPLETED|Extension Phase||0
8318326|NCT01438840|20509430|P1|NOT COMPLETED|Extension Phase||0
8318327|NCT01438840|20509428|P3|COMPLETED|Extension Phase||29
8318328|NCT01438840|20509429|P2|COMPLETED|Extension Phase||0
8318329|NCT01438840|20509430|P1|COMPLETED|Extension Phase||0
8318330|NCT01438840|20509428|P3|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
8318331|NCT01438840|20509429|P2|STARTED|Extension Phase||0
8318332|NCT01438840|20509430|P1|STARTED|Extension Phase||0
8318333|NCT01438840|20509428|P3|NOT COMPLETED|Core Study||0
8318334|NCT01438840|20509429|P2|NOT COMPLETED|Core Study||10
8318335|NCT01438840|20509430|P1|NOT COMPLETED|Core Study||16
8318336|NCT01438840|20509428|P3|COMPLETED|Core Study||0
8318337|NCT01438840|20509429|P2|COMPLETED|Core Study||22
8318338|NCT01438840|20509430|P1|COMPLETED|Core Study||1
8318339|NCT01438840|20509428|P3|STARTED|Core Study||0
8318340|NCT01438840|20509429|P2|STARTED|Core Study||32
8318341|NCT01438840|20509430|P1|STARTED|Core Study||17
8318342|NCT01438814|20509443|P2|NOT COMPLETED|Overall Study||14
8318343|NCT01438814|20509444|P1|NOT COMPLETED|Overall Study||14
8318344|NCT01438814|20509443|P2|COMPLETED|Overall Study||331
8318345|NCT01438814|20509444|P1|COMPLETED|Overall Study||330
8318346|NCT01438814|20509443|P2|STARTED|Overall Study||345
8318347|NCT01438814|20509444|P1|STARTED|Overall Study||344
8318348|NCT01438710|20509474|P2|NOT COMPLETED|Second Week of Treatment||0
8318349|NCT01438710|20509475|P1|NOT COMPLETED|Second Week of Treatment||1
8318350|NCT01438710|20509474|P2|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
8318351|NCT01438710|20509475|P1|COMPLETED|Second Week of Treatment||40
8318352|NCT01438710|20509474|P2|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
8318353|NCT01438710|20509475|P1|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
8318354|NCT01438710|20509474|P2|NOT COMPLETED|First Week of Treatment||3
8318355|NCT01438710|20509475|P1|NOT COMPLETED|First Week of Treatment||0
8318356|NCT01438710|20509474|P2|COMPLETED|First Week of Treatment||41
8318357|NCT01438710|20509475|P1|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
8318358|NCT01438710|20509474|P2|STARTED|First Week of Treatment||44
8318359|NCT01438710|20509475|P1|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
8318360|NCT01438541|20509480|P1|NOT COMPLETED|Overall Study||7
8318361|NCT01438541|20509480|P1|COMPLETED|Overall Study||22
8318362|NCT01438541|20509480|P1|STARTED|Overall Study||29
8318363|NCT01438489|20509489|P3|NOT COMPLETED|Overall Study||19
8318364|NCT01438489|20509490|P2|NOT COMPLETED|Overall Study||16
8318365|NCT01438489|20509491|P1|NOT COMPLETED|Overall Study||26
8318366|NCT01438489|20509489|P3|COMPLETED|Overall Study||85
8318367|NCT01438489|20509490|P2|COMPLETED|Overall Study||84
8318368|NCT01438489|20509491|P1|COMPLETED|Overall Study||77
8318369|NCT01438489|20509489|P3|STARTED|Overall Study||104
8318370|NCT01438489|20509490|P2|STARTED|Overall Study||100
8318371|NCT01438489|20509491|P1|STARTED|Overall Study||103
8318372|NCT01438476|20509536|P2|NOT COMPLETED|Overall Study||11
8318373|NCT01438476|20509537|P1|NOT COMPLETED|Overall Study||10
8318374|NCT01438476|20509536|P2|COMPLETED|Overall Study||34
8318375|NCT01438476|20509537|P1|COMPLETED|Overall Study||106
8318376|NCT01438476|20509536|P2|STARTED|Overall Study||45
8318377|NCT01438476|20509537|P1|STARTED|Overall Study||116
8318378|NCT01438424|20509543|P1|NOT COMPLETED|Overall Study||417
8318379|NCT01438424|20509543|P1|COMPLETED|Overall Study|Completed treatment|634
8318380|NCT01438424|20509543|P1|STARTED|Overall Study|Received treatment|1051
8318381|NCT01438411|20509579|P1|NOT COMPLETED|Overall Study||13
8318382|NCT01438411|20509579|P1|COMPLETED|Overall Study||40
8318383|NCT01438411|20509579|P1|STARTED|Overall Study||53
8318384|NCT01438307|20509594|P2|NOT COMPLETED|Overall Study||1
8318385|NCT01438307|20509595|P1|NOT COMPLETED|Overall Study||1
8318386|NCT01438307|20509594|P2|COMPLETED|Overall Study||13
8318387|NCT01438307|20509595|P1|COMPLETED|Overall Study||13
8318388|NCT01438307|20509594|P2|STARTED|Overall Study||14
8318389|NCT01438307|20509595|P1|STARTED|Overall Study||14
8318390|NCT01438294|20509609|P2|NOT COMPLETED|Overall Study||7
8318391|NCT01438294|20509610|P1|NOT COMPLETED|Overall Study||3
8318392|NCT01438294|20509609|P2|COMPLETED|Overall Study||13
8318393|NCT01438294|20509610|P1|COMPLETED|Overall Study||13
8318394|NCT01438294|20509609|P2|STARTED|Overall Study||20
8318395|NCT01438294|20509610|P1|STARTED|Overall Study||16
8318396|NCT01438229|20509620|P1|NOT COMPLETED|Overall Study||3
8318397|NCT01438229|20509620|P1|COMPLETED|Overall Study||44
8318398|NCT01438229|20509620|P1|Underwent Procedure|Overall Study||46
8318399|NCT01438229|20509620|P1|Excluded Due to Renal Artery Anatomy|Overall Study||1
8318400|NCT01438229|20509620|P1|STARTED|Overall Study||47
8318401|NCT01438177|20509653|P1|NOT COMPLETED|Overall Study||2
8318402|NCT01438177|20509653|P1|COMPLETED|Overall Study|Patients who were off due to disease progression|9
8318403|NCT01438177|20509653|P1|STARTED|Overall Study||11
8318404|NCT01438151|20509660|P1|NOT COMPLETED|Overall Study||8
8318405|NCT01438151|20509660|P1|COMPLETED|Overall Study||3
8318406|NCT01438151|20509660|P1|STARTED|Overall Study||11
8318407|NCT01438060|20509666|P2|NOT COMPLETED|On Study Beyond Week 140||8
8318408|NCT01438060|20509667|P1|NOT COMPLETED|On Study Beyond Week 140||0
8318409|NCT01438060|20509666|P2|COMPLETED|On Study Beyond Week 140||1
8318410|NCT01438060|20509667|P1|COMPLETED|On Study Beyond Week 140||0
8318411|NCT01438060|20509666|P2|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
8318412|NCT01438060|20509667|P1|STARTED|On Study Beyond Week 140||0
8318413|NCT01438060|20509666|P2|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
8318414|NCT01438060|20509667|P1|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
8318415|NCT01438060|20509666|P2|COMPLETED|Extension Phase: Week 10 to Week 130||25
8318416|NCT01438060|20509667|P1|COMPLETED|Extension Phase: Week 10 to Week 130||22
8318417|NCT01438060|20509666|P2|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
8318418|NCT01438060|20509667|P1|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
8318419|NCT01438060|20509666|P2|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
8318420|NCT01438060|20509667|P1|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
8318421|NCT01438060|20509666|P2|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
8318422|NCT01438060|20509667|P1|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
8318423|NCT01438060|20509666|P2|STARTED|Acute Phase: Double-blind, 10 Weeks||106
8318424|NCT01438060|20509667|P1|STARTED|Acute Phase: Double-blind, 10 Weeks||102
8318425|NCT01438008|20509747|P2|NOT COMPLETED|Overall Study||0
8318426|NCT01438008|20509748|P1|NOT COMPLETED|Overall Study||0
8318427|NCT01438008|20509747|P2|COMPLETED|Overall Study||5
8318428|NCT01438008|20509748|P1|COMPLETED|Overall Study||4
8318429|NCT01438008|20509747|P2|STARTED|Overall Study||5
8318430|NCT01438008|20509748|P1|STARTED|Overall Study||4
8318431|NCT01437995|20509759|P3|NOT COMPLETED|Overall Study||20
8318432|NCT01437995|20509760|P2|NOT COMPLETED|Overall Study||18
8318433|NCT01437995|20509761|P1|NOT COMPLETED|Overall Study||11
8318434|NCT01437995|20509759|P3|COMPLETED|Overall Study||135
8318435|NCT01437995|20509760|P2|COMPLETED|Overall Study||131
8318436|NCT01437995|20509761|P1|COMPLETED|Overall Study||140
8318437|NCT01437995|20509759|P3|Included in Treatment Failure Analysis|Overall Study||151
8318438|NCT01437995|20509760|P2|Included in Treatment Failure Analysis|Overall Study||146
8318439|NCT01437995|20509761|P1|Included in Treatment Failure Analysis|Overall Study||150
8318440|NCT01437995|20509759|P3|STARTED|Overall Study||155
8318441|NCT01437995|20509760|P2|STARTED|Overall Study||149
8318442|NCT01437995|20509761|P1|STARTED|Overall Study||151
8318443|NCT01437943|20509783|P2|NOT COMPLETED|Overall Study||2
8318444|NCT01437943|20509784|P1|NOT COMPLETED|Overall Study||7
8318445|NCT01437943|20509783|P2|COMPLETED|Overall Study||1
8318446|NCT01437943|20509784|P1|COMPLETED|Overall Study||0
8318447|NCT01437943|20509783|P2|STARTED|Overall Study||3
8318448|NCT01437943|20509784|P1|STARTED|Overall Study||7
8318449|NCT01437878|20509792|P2|NOT COMPLETED|Overall Study||0
8318450|NCT01437878|20509793|P1|NOT COMPLETED|Overall Study||1
8318451|NCT01437878|20509792|P2|COMPLETED|Overall Study||1
8318452|NCT01437878|20509793|P1|COMPLETED|Overall Study||0
8318453|NCT01437878|20509792|P2|STARTED|Overall Study||1
8318454|NCT01437878|20509793|P1|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
8318455|NCT01437852|20509833|P1|NOT COMPLETED|Overall Study||0
8318456|NCT01437852|20509833|P1|COMPLETED|Overall Study||30
8318457|NCT01437852|20509833|P1|Received Autograft|Overall Study||30
8318458|NCT01437852|20509833|P1|Received StrataGraft Skin Tissue|Overall Study||30
8318459|NCT01437852|20509833|P1|STARTED|Overall Study||30
8318460|NCT01437605|20509841|P2|NOT COMPLETED|Overall Study||0
8318461|NCT01437605|20509842|P1|NOT COMPLETED|Overall Study||0
8318462|NCT01437605|20509841|P2|COMPLETED|Overall Study||5
8318463|NCT01437605|20509842|P1|COMPLETED|Overall Study||9
8318464|NCT01437605|20509841|P2|STARTED|Overall Study||5
8318465|NCT01437605|20509842|P1|STARTED|Overall Study||9
8318466|NCT01437540|20509860|P2|NOT COMPLETED|Overall Study||65
8318467|NCT01437540|20509861|P1|NOT COMPLETED|Overall Study||127
8318468|NCT01437540|20509860|P2|COMPLETED|Overall Study||133
8318469|NCT01437540|20509861|P1|COMPLETED|Overall Study||265
8318470|NCT01437540|20509860|P2|STARTED|Overall Study||198
8318471|NCT01437540|20509861|P1|STARTED|Overall Study||392
8318472|NCT01437501|20509875|P2|NOT COMPLETED|Overall Study||11
8318473|NCT01437501|20509876|P1|NOT COMPLETED|Overall Study||13
8318474|NCT01437501|20509875|P2|COMPLETED|Overall Study||132
8318475|NCT01437501|20509876|P1|COMPLETED|Overall Study||135
8318476|NCT01437501|20509875|P2|STARTED|Overall Study||143
8318477|NCT01437501|20509876|P1|STARTED|Overall Study||148
8318478|NCT01437488|20509884|P1|NOT COMPLETED|Overall Study||0
8318479|NCT01437488|20509884|P1|COMPLETED|Overall Study||14
8318480|NCT01437488|20509884|P1|STARTED|Overall Study||14
8318481|NCT01437449|20509891|P1|NOT COMPLETED|Overall Study||0
8318482|NCT01437449|20509891|P1|COMPLETED|Overall Study||27
8318483|NCT01437449|20509891|P1|STARTED|Overall Study||27
8318484|NCT01437423|20509898|P1|NOT COMPLETED|Overall Study||15
8318485|NCT01437423|20509898|P1|COMPLETED|Overall Study||647
8318486|NCT01437423|20509898|P1|STARTED|Overall Study||662
8318487|NCT01437397|20509910|P5|NOT COMPLETED|Overall Study||101
8318488|NCT01437397|20509911|P4|NOT COMPLETED|Overall Study||69
8318489|NCT01437397|20509912|P3|NOT COMPLETED|Overall Study||72
8318490|NCT01437397|20509913|P2|NOT COMPLETED|Overall Study||62
8318491|NCT01437397|20509914|P1|NOT COMPLETED|Overall Study||66
8318492|NCT01437397|20509910|P5|COMPLETED|Overall Study||236
8318493|NCT01437397|20509911|P4|COMPLETED|Overall Study||270
8318494|NCT01437397|20509912|P3|COMPLETED|Overall Study||268
8318495|NCT01437397|20509913|P2|COMPLETED|Overall Study||276
8318496|NCT01437397|20509914|P1|COMPLETED|Overall Study||272
8318497|NCT01437397|20509910|P5|STARTED|Overall Study||337
8318498|NCT01437397|20509911|P4|STARTED|Overall Study||339
8318499|NCT01437397|20509912|P3|STARTED|Overall Study||340
8318500|NCT01437397|20509913|P2|STARTED|Overall Study||338
8318501|NCT01437397|20509914|P1|STARTED|Overall Study||338
8318502|NCT01437319|20509941|P3|NOT COMPLETED|Phase II||37
8318503|NCT01437319|20509942|P2|NOT COMPLETED|Phase II||44
8318504|NCT01437319|20509943|P1|NOT COMPLETED|Phase II||0
8318505|NCT01437319|20509941|P3|COMPLETED|Phase II||75
8318506|NCT01437319|20509942|P2|COMPLETED|Phase II||71
8318507|NCT01437319|20509943|P1|COMPLETED|Phase II||0
8318508|NCT01437319|20509941|P3|STARTED|Phase II||112
8318509|NCT01437319|20509942|P2|STARTED|Phase II||115
8318510|NCT01437319|20509943|P1|STARTED|Phase II||0
8318511|NCT01437319|20509941|P3|NOT COMPLETED|Phase I||0
8318512|NCT01437319|20509942|P2|NOT COMPLETED|Phase I||0
8318513|NCT01437319|20509943|P1|NOT COMPLETED|Phase I||55
8318514|NCT01437319|20509941|P3|COMPLETED|Phase I||0
8318515|NCT01437319|20509942|P2|COMPLETED|Phase I||0
8318516|NCT01437319|20509943|P1|COMPLETED|Phase I||227
8318517|NCT01437319|20509941|P3|STARTED|Phase I||0
8318518|NCT01437319|20509942|P2|STARTED|Phase I||0
8318519|NCT01437319|20509943|P1|STARTED|Phase I||282
8318520|NCT01437267|20509958|P6|NOT COMPLETED|Overall Study||0
8318521|NCT01437267|20509959|P5|NOT COMPLETED|Overall Study||0
8318522|NCT01437267|20509960|P4|NOT COMPLETED|Overall Study||1
8318523|NCT01437267|20509961|P3|NOT COMPLETED|Overall Study||0
8318524|NCT01437267|20509962|P2|NOT COMPLETED|Overall Study||1
8318525|NCT01437267|20509963|P1|NOT COMPLETED|Overall Study||0
8318526|NCT01437267|20509958|P6|COMPLETED|Overall Study||20
8318527|NCT01437267|20509959|P5|COMPLETED|Overall Study||20
8318528|NCT01437267|20509960|P4|COMPLETED|Overall Study||19
8318529|NCT01437267|20509961|P3|COMPLETED|Overall Study||20
8318530|NCT01437267|20509962|P2|COMPLETED|Overall Study||19
8318531|NCT01437267|20509963|P1|COMPLETED|Overall Study||20
8318532|NCT01437267|20509958|P6|STARTED|Overall Study||20
8318533|NCT01437267|20509959|P5|STARTED|Overall Study||20
8318534|NCT01437267|20509960|P4|STARTED|Overall Study||20
8318535|NCT01437267|20509961|P3|STARTED|Overall Study||20
8318536|NCT01437267|20509962|P2|STARTED|Overall Study||20
8318537|NCT01437267|20509963|P1|STARTED|Overall Study||20
8318538|NCT01437124|20510001|P1|NOT COMPLETED|Overall Study||0
8318539|NCT01437124|20510001|P1|COMPLETED|Overall Study||83
8318540|NCT01437124|20510001|P1|STARTED|Overall Study||83
8318541|NCT01437111|20510006|P1|NOT COMPLETED|Overall Study||18
8318542|NCT01437111|20510006|P1|COMPLETED|Overall Study||182
8318543|NCT01437111|20510006|P1|Treated Participants|Overall Study||198
8318544|NCT01437111|20510006|P1|STARTED|Overall Study||200
8318545|NCT01437098|20510017|P1|NOT COMPLETED|Overall Study||13
8318546|NCT01437098|20510017|P1|COMPLETED|Overall Study||42
8318547|NCT01437098|20510017|P1|36 Months|Overall Study||36
8318548|NCT01437098|20510017|P1|24 Months|Overall Study||42
8318549|NCT01437098|20510017|P1|12 Months|Overall Study||45
8318550|NCT01437098|20510017|P1|6 Months|Overall Study||47
8318551|NCT01437098|20510017|P1|30 Days|Overall Study||51
8318552|NCT01437098|20510017|P1|STARTED|Overall Study||55
8318553|NCT01436799|20510074|P2|NOT COMPLETED|Overall Study||0
8318554|NCT01436799|20510075|P1|NOT COMPLETED|Overall Study||0
8318555|NCT01436799|20510074|P2|COMPLETED|Overall Study||20
8318556|NCT01436799|20510075|P1|COMPLETED|Overall Study||20
8318557|NCT01436799|20510074|P2|STARTED|Overall Study||20
8318558|NCT01436799|20510075|P1|STARTED|Overall Study||20
8318559|NCT01436643|20510084|P4|NOT COMPLETED|Core Phase (16 Weeks)||0
8318560|NCT01436643|20510085|P3|NOT COMPLETED|Core Phase (16 Weeks)||3
8318561|NCT01436643|20510086|P2|NOT COMPLETED|Core Phase (16 Weeks)||4
8318562|NCT01436643|20510087|P1|NOT COMPLETED|Core Phase (16 Weeks)||1
8318563|NCT01436643|20510084|P4|COMPLETED|Core Phase (16 Weeks)||0
8318564|NCT01436643|20510085|P3|COMPLETED|Core Phase (16 Weeks)||17
8318565|NCT01436643|20510086|P2|COMPLETED|Core Phase (16 Weeks)||11
8318566|NCT01436643|20510087|P1|COMPLETED|Core Phase (16 Weeks)||16
8318567|NCT01436643|20510084|P4|STARTED|Core Phase (16 Weeks)||0
8318568|NCT01436643|20510085|P3|STARTED|Core Phase (16 Weeks)||20
8318569|NCT01436643|20510086|P2|STARTED|Core Phase (16 Weeks)||15
8318570|NCT01436643|20510087|P1|STARTED|Core Phase (16 Weeks)||17
8318571|NCT01436643|20510084|P4|NOT COMPLETED|2-week Pre-treatment||10
8318572|NCT01436643|20510085|P3|NOT COMPLETED|2-week Pre-treatment||0
8318573|NCT01436643|20510086|P2|NOT COMPLETED|2-week Pre-treatment||0
8318574|NCT01436643|20510087|P1|NOT COMPLETED|2-week Pre-treatment||0
8318575|NCT01436643|20510084|P4|COMPLETED|2-week Pre-treatment||44
8318576|NCT01436643|20510085|P3|COMPLETED|2-week Pre-treatment||0
8318577|NCT01436643|20510086|P2|COMPLETED|2-week Pre-treatment||0
8318578|NCT01436643|20510087|P1|COMPLETED|2-week Pre-treatment||0
8318579|NCT01436643|20510084|P4|STARTED|2-week Pre-treatment||54
8318580|NCT01436643|20510085|P3|STARTED|2-week Pre-treatment||0
8318581|NCT01436643|20510086|P2|STARTED|2-week Pre-treatment||0
8318582|NCT01436643|20510087|P1|STARTED|2-week Pre-treatment||0
8318583|NCT01436526|20510099|P2|NOT COMPLETED|Period 2||0
8318584|NCT01436526|20510100|P1|NOT COMPLETED|Period 2||0
8318585|NCT01436526|20510099|P2|COMPLETED|Period 2||13
8318586|NCT01436526|20510100|P1|COMPLETED|Period 2||13
8318587|NCT01436526|20510099|P2|Participants Received Treatment|Period 2||13
8318588|NCT01436526|20510100|P1|Participants Received Treatment|Period 2||13
8318589|NCT01436526|20510099|P2|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
8318590|NCT01436526|20510100|P1|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
8318591|NCT01436526|20510099|P2|NOT COMPLETED|Period 1||0
8318592|NCT01436526|20510100|P1|NOT COMPLETED|Period 1||0
8318593|NCT01436526|20510099|P2|COMPLETED|Period 1||14
8318594|NCT01436526|20510100|P1|COMPLETED|Period 1||14
8318595|NCT01436526|20510099|P2|Participants Received Treatment|Period 1||14
8318596|NCT01436526|20510100|P1|Participants Received Treatment|Period 1||14
8318597|NCT01436526|20510099|P2|STARTED|Period 1||14
8318598|NCT01436526|20510100|P1|STARTED|Period 1||14
8318599|NCT01436500|20510122|P5|NOT COMPLETED|Overall Study||4
8318600|NCT01436500|20510123|P4|NOT COMPLETED|Overall Study||1
8318601|NCT01436500|20510124|P3|NOT COMPLETED|Overall Study||5
8318602|NCT01436500|20510125|P2|NOT COMPLETED|Overall Study||3
8318603|NCT01436500|20510126|P1|NOT COMPLETED|Overall Study||3
8318604|NCT01436500|20510122|P5|COMPLETED|Overall Study||9
8318605|NCT01436500|20510123|P4|COMPLETED|Overall Study||5
8318606|NCT01436500|20510124|P3|COMPLETED|Overall Study||7
8318607|NCT01436500|20510125|P2|COMPLETED|Overall Study||9
8318608|NCT01436500|20510126|P1|COMPLETED|Overall Study||9
8318609|NCT01436500|20510122|P5|STARTED|Overall Study||13
8318610|NCT01436500|20510123|P4|STARTED|Overall Study||6
8318611|NCT01436500|20510124|P3|STARTED|Overall Study||12
8318612|NCT01436500|20510125|P2|STARTED|Overall Study||12
8318613|NCT01436500|20510126|P1|STARTED|Overall Study||12
8318614|NCT01436435|20510159|P1|NOT COMPLETED|Overall Study||64
8318615|NCT01436435|20510159|P1|COMPLETED|Overall Study||177
8318616|NCT01436435|20510159|P1|STARTED|Overall Study||241
8318617|NCT01436396|20510170|P2|NOT COMPLETED|Overall Study||42
8318618|NCT01436396|20510171|P1|NOT COMPLETED|Overall Study||32
8318619|NCT01436396|20510170|P2|COMPLETED|Overall Study||354
8318620|NCT01436396|20510171|P1|COMPLETED|Overall Study||364
8318621|NCT01436396|20510170|P2|Vaccinated|Overall Study||393
8318622|NCT01436396|20510171|P1|Vaccinated|Overall Study||394
8318623|NCT01436396|20510170|P2|STARTED|Overall Study||396
8318624|NCT01436396|20510171|P1|STARTED|Overall Study||396
8318625|NCT01436370|20510211|P8|NOT COMPLETED|Overall Study||0
8318626|NCT01436370|20510212|P7|NOT COMPLETED|Overall Study||0
8318627|NCT01436370|20510213|P6|NOT COMPLETED|Overall Study||0
8318628|NCT01436370|20510214|P5|NOT COMPLETED|Overall Study||1
8318629|NCT01436370|20510215|P4|NOT COMPLETED|Overall Study||0
8318630|NCT01436370|20510216|P3|NOT COMPLETED|Overall Study||0
8318631|NCT01436370|20510217|P2|NOT COMPLETED|Overall Study||0
8318632|NCT01436370|20510218|P1|NOT COMPLETED|Overall Study||0
8318633|NCT01436370|20510211|P8|COMPLETED|Overall Study||16
8318634|NCT01436370|20510212|P7|COMPLETED|Overall Study||16
8318635|NCT01436370|20510213|P6|COMPLETED|Overall Study||19
8318636|NCT01436370|20510214|P5|COMPLETED|Overall Study||18
8318637|NCT01436370|20510215|P4|COMPLETED|Overall Study||10
8318638|NCT01436370|20510216|P3|COMPLETED|Overall Study||10
8318639|NCT01436370|20510217|P2|COMPLETED|Overall Study||6
8318640|NCT01436370|20510218|P1|COMPLETED|Overall Study||6
8318641|NCT01436370|20510211|P8|STARTED|Overall Study||16
8318642|NCT01436370|20510212|P7|STARTED|Overall Study||16
8318643|NCT01436370|20510213|P6|STARTED|Overall Study||19
8318644|NCT01436370|20510214|P5|STARTED|Overall Study||19
8318645|NCT01436370|20510215|P4|STARTED|Overall Study||10
8318646|NCT01436370|20510216|P3|STARTED|Overall Study||10
8318647|NCT01436370|20510217|P2|STARTED|Overall Study||6
8318648|NCT01436370|20510218|P1|STARTED|Overall Study||6
8318649|NCT01436357|20510298|P2|NOT COMPLETED|Overall Study||128
8318650|NCT01436357|20510299|P1|NOT COMPLETED|Overall Study||122
8318651|NCT01436357|20510298|P2|COMPLETED|Overall Study||146
8318652|NCT01436357|20510299|P1|COMPLETED|Overall Study||152
8318653|NCT01436357|20510298|P2|Stage 2|Overall Study||226
8318654|NCT01436357|20510299|P1|Stage 2|Overall Study||225
8318655|NCT01436357|20510298|P2|Stage 1|Overall Study||48
8318656|NCT01436357|20510299|P1|Stage 1|Overall Study||49
8318657|NCT01436357|20510298|P2|STARTED|Overall Study||274
8318658|NCT01436357|20510299|P1|STARTED|Overall Study||274
8318659|NCT01436305|20510320|P3|NOT COMPLETED|Overall Study||0
8318660|NCT01436305|20510321|P2|NOT COMPLETED|Overall Study||4
8318661|NCT01436305|20510322|P1|NOT COMPLETED|Overall Study||2
8318662|NCT01436305|20510320|P3|COMPLETED|Overall Study||7
8318663|NCT01436305|20510321|P2|COMPLETED|Overall Study||2
8318664|NCT01436305|20510322|P1|COMPLETED|Overall Study||4
8318665|NCT01436305|20510320|P3|STARTED|Overall Study||7
8318666|NCT01436305|20510321|P2|STARTED|Overall Study||6
8318667|NCT01436305|20510322|P1|STARTED|Overall Study||6
8318668|NCT01436279|20510419|P2|NOT COMPLETED|Overall Study||0
8318669|NCT01436279|20510420|P1|NOT COMPLETED|Overall Study||0
8318670|NCT01436279|20510419|P2|COMPLETED|Overall Study||20
8318671|NCT01436279|20510420|P1|COMPLETED|Overall Study||30
8318672|NCT01436279|20510419|P2|STARTED|Overall Study||20
8318673|NCT01436279|20510420|P1|STARTED|Overall Study||30
8318674|NCT01436266|20510442|P2|NOT COMPLETED|Overall Study||0
8318675|NCT01436266|20510443|P1|NOT COMPLETED|Overall Study||0
8318676|NCT01436266|20510442|P2|COMPLETED|Overall Study||1
8318677|NCT01436266|20510443|P1|COMPLETED|Overall Study||1
8318678|NCT01436266|20510442|P2|STARTED|Overall Study||1
8318679|NCT01436266|20510443|P1|STARTED|Overall Study||1
8318680|NCT01436253|20510449|P1|NOT COMPLETED|Overall Study||299
8318681|NCT01436253|20510449|P1|COMPLETED|Overall Study||1897
8318682|NCT01436253|20510449|P1|STARTED|Overall Study||2196
8318683|NCT01436201|20510454|P1|NOT COMPLETED|Overall Study||4
8318684|NCT01436201|20510454|P1|COMPLETED|Overall Study||20
8318685|NCT01436201|20510454|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
8318686|NCT01436201|20510454|P1|STARTED|Overall Study||24
8318726|NCT01436110|20510560|P3|NOT COMPLETED|Overall Study||23
8318727|NCT01436110|20510561|P2|NOT COMPLETED|Overall Study||26
8318728|NCT01436110|20510562|P1|NOT COMPLETED|Overall Study||39
8318729|NCT01436110|20510560|P3|COMPLETED|Overall Study||95
8318730|NCT01436110|20510561|P2|COMPLETED|Overall Study||91
8318731|NCT01436110|20510562|P1|COMPLETED|Overall Study||77
8318732|NCT01436110|20510560|P3|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
8318733|NCT01436110|20510561|P2|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
8318734|NCT01436110|20510562|P1|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
8318735|NCT01436110|20510560|P3|STARTED|Overall Study|These participants were randomized to trial medication.|118
8318736|NCT01436110|20510561|P2|STARTED|Overall Study|These participants were randomized to trial medication.|117
8318737|NCT01436110|20510562|P1|STARTED|Overall Study|These participants were randomized to trial medication.|116
8318738|NCT01436084|20510585|P1|NOT COMPLETED|Overall Study||4
8318739|NCT01436084|20510585|P1|COMPLETED|Overall Study||0
8318740|NCT01436084|20510585|P1|STARTED|Overall Study||4
8318741|NCT01436071|20510591|P2|NOT COMPLETED|Overall Study||14
8318742|NCT01436071|20510592|P1|NOT COMPLETED|Overall Study||26
8318743|NCT01436071|20510591|P2|COMPLETED|Overall Study||110
8318744|NCT01436071|20510592|P1|COMPLETED|Overall Study||98
8318745|NCT01436071|20510591|P2|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
8318746|NCT01436071|20510592|P1|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
8318747|NCT01436071|20510591|P2|STARTED|Overall Study|These participants were randomized to trial medication.|124
8318748|NCT01436071|20510592|P1|STARTED|Overall Study|These participants were randomized to trial medication.|124
8318749|NCT01436045|20510608|P2|NOT COMPLETED|Overall Study||0
8318750|NCT01436045|20510609|P1|NOT COMPLETED|Overall Study||0
8318751|NCT01436045|20510608|P2|COMPLETED|Overall Study||6
8318752|NCT01436045|20510609|P1|COMPLETED|Overall Study||6
8318753|NCT01436045|20510608|P2|STARTED|Overall Study||6
8318754|NCT01436045|20510609|P1|STARTED|Overall Study||6
8318755|NCT01436006|20510620|P1|NOT COMPLETED|Overall Study||37
8318756|NCT01436006|20510620|P1|COMPLETED|Overall Study||6663
8318757|NCT01436006|20510620|P1|STARTED|Overall Study||6700
8318758|NCT01435928|20510634|P3|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
8318759|NCT01435928|20510635|P2|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
8318760|NCT01435928|20510636|P1|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
8318761|NCT01435928|20510634|P3|COMPLETED|Double Blind Phase - 28 Weeks||20
8318762|NCT01435928|20510635|P2|COMPLETED|Double Blind Phase - 28 Weeks||28
8318763|NCT01435928|20510636|P1|COMPLETED|Double Blind Phase - 28 Weeks||0
8318764|NCT01435928|20510634|P3|STARTED|Double Blind Phase - 28 Weeks||141
8318765|NCT01435928|20510635|P2|STARTED|Double Blind Phase - 28 Weeks||144
8318766|NCT01435928|20510636|P1|STARTED|Double Blind Phase - 28 Weeks||0
8318767|NCT01435928|20510634|P3|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
8318768|NCT01435928|20510635|P2|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
8318769|NCT01435928|20510636|P1|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
8318770|NCT01435928|20510634|P3|COMPLETED|Open Label Phase - up to 24 Weeks||0
8318771|NCT01435928|20510635|P2|COMPLETED|Open Label Phase - up to 24 Weeks||0
8318772|NCT01435928|20510636|P1|COMPLETED|Open Label Phase - up to 24 Weeks||287
8318773|NCT01435928|20510634|P3|STARTED|Open Label Phase - up to 24 Weeks||0
8318774|NCT01435928|20510635|P2|STARTED|Open Label Phase - up to 24 Weeks||0
8318775|NCT01435928|20510636|P1|STARTED|Open Label Phase - up to 24 Weeks||676
8318776|NCT01435824|20510663|P2|NOT COMPLETED|Second Intervention||0
8318777|NCT01435824|20510664|P1|NOT COMPLETED|Second Intervention||0
8318778|NCT01435824|20510663|P2|COMPLETED|Second Intervention||8
8318779|NCT01435824|20510664|P1|COMPLETED|Second Intervention||8
8318780|NCT01435824|20510663|P2|STARTED|Second Intervention||8
8318781|NCT01435824|20510664|P1|STARTED|Second Intervention||8
8318782|NCT01435824|20510663|P2|NOT COMPLETED|Washout of 1-2 Weeks||0
8318783|NCT01435824|20510664|P1|NOT COMPLETED|Washout of 1-2 Weeks||0
8318784|NCT01435824|20510663|P2|COMPLETED|Washout of 1-2 Weeks||8
8318785|NCT01435824|20510664|P1|COMPLETED|Washout of 1-2 Weeks||8
8318786|NCT01435824|20510663|P2|STARTED|Washout of 1-2 Weeks||8
8318787|NCT01435824|20510664|P1|STARTED|Washout of 1-2 Weeks||8
8318788|NCT01435824|20510663|P2|NOT COMPLETED|First Intervention||0
8318789|NCT01435824|20510664|P1|NOT COMPLETED|First Intervention||0
8318790|NCT01435824|20510663|P2|COMPLETED|First Intervention||8
8318791|NCT01435824|20510664|P1|COMPLETED|First Intervention||8
8318792|NCT01435824|20510663|P2|STARTED|First Intervention||8
8318793|NCT01435824|20510664|P1|STARTED|First Intervention||8
8318794|NCT01435798|20510682|P1|NOT COMPLETED|Overall Study||1
8318795|NCT01435798|20510682|P1|COMPLETED|Overall Study|Crossover design|25
8318796|NCT01435798|20510682|P1|100% MTD|Overall Study||25
8318797|NCT01435798|20510682|P1|50% MTD|Overall Study||25
8318798|NCT01435798|20510682|P1|25% MTD|Overall Study||26
8318799|NCT01435798|20510682|P1|0% MTD|Overall Study||25
8318800|NCT01435798|20510682|P1|STARTED|Overall Study|Crossover design|26
8318801|NCT01435772|20510699|P3|NOT COMPLETED|Overall Study||15
8318802|NCT01435772|20510700|P2|NOT COMPLETED|Overall Study||3
8318803|NCT01435772|20510701|P1|NOT COMPLETED|Overall Study||3
8318804|NCT01435772|20510699|P3|COMPLETED|Overall Study||0
8318805|NCT01435772|20510700|P2|COMPLETED|Overall Study||0
8318806|NCT01435772|20510701|P1|COMPLETED|Overall Study||0
8318807|NCT01435772|20510699|P3|STARTED|Overall Study||15
8318808|NCT01435772|20510700|P2|STARTED|Overall Study||3
8318809|NCT01435772|20510701|P1|STARTED|Overall Study||3
8318846|NCT01435655|20510783|P1|NOT COMPLETED|Overall Study||3
8318847|NCT01435655|20510783|P1|COMPLETED|Overall Study||7
8318848|NCT01435655|20510783|P1|STARTED|Overall Study||10
8318849|NCT01435616|20510797|P2|NOT COMPLETED|Overall Study||80
8318850|NCT01435616|20510798|P1|NOT COMPLETED|Overall Study||171
8318851|NCT01435616|20510797|P2|COMPLETED|Overall Study||455
8318852|NCT01435616|20510798|P1|COMPLETED|Overall Study||832
8318853|NCT01435616|20510797|P2|Received at Least 1 Dose of Study Drug|Overall Study||535
8318854|NCT01435616|20510798|P1|Received at Least 1 Dose of Study Drug|Overall Study||1003
8318855|NCT01435616|20510797|P2|STARTED|Overall Study||535
8318856|NCT01435616|20510798|P1|STARTED|Overall Study||1003
8318857|NCT01435603|20510844|P2|NOT COMPLETED|Overall Study||35
8318858|NCT01435603|20510845|P1|NOT COMPLETED|Overall Study||39
8318859|NCT01435603|20510844|P2|COMPLETED|Overall Study||129
8318860|NCT01435603|20510845|P1|COMPLETED|Overall Study||128
8318861|NCT01435603|20510844|P2|STARTED|Overall Study||164
8318862|NCT01435603|20510845|P1|STARTED|Overall Study||167
8318863|NCT01435577|20510853|P2|NOT COMPLETED|Overall Study||52
8318864|NCT01435577|20510854|P1|NOT COMPLETED|Overall Study||17
8318865|NCT01435577|20510853|P2|COMPLETED|Overall Study||13
8318866|NCT01435577|20510854|P1|COMPLETED|Overall Study||47
8318867|NCT01435577|20510853|P2|STARTED|Overall Study||65
8318868|NCT01435577|20510854|P1|STARTED|Overall Study||64
8318869|NCT01435512|20510904|P2|NOT COMPLETED|Overall Study||0
8318870|NCT01435512|20510905|P1|NOT COMPLETED|Overall Study||0
8318871|NCT01435512|20510904|P2|COMPLETED|Overall Study||68
8318872|NCT01435512|20510905|P1|COMPLETED|Overall Study||67
8318873|NCT01435512|20510904|P2|STARTED|Overall Study||68
8318874|NCT01435512|20510905|P1|STARTED|Overall Study||67
8318875|NCT01435460|20510915|P2|NOT COMPLETED|Overall Study||6
8318876|NCT01435460|20510916|P1|NOT COMPLETED|Overall Study||11
8318877|NCT01435460|20510915|P2|COMPLETED|Overall Study||143
8318878|NCT01435460|20510916|P1|COMPLETED|Overall Study||140
8318879|NCT01435460|20510915|P2|STARTED|Overall Study||149
8318880|NCT01435460|20510916|P1|STARTED|Overall Study||151
8318881|NCT01435382|20510932|P4|NOT COMPLETED|Overall Study||1
8318882|NCT01435382|20510933|P3|NOT COMPLETED|Overall Study||1
8318883|NCT01435382|20510934|P2|NOT COMPLETED|Overall Study||2
8318884|NCT01435382|20510935|P1|NOT COMPLETED|Overall Study||1
8318885|NCT01435382|20510932|P4|COMPLETED|Overall Study||10
8318886|NCT01435382|20510933|P3|COMPLETED|Overall Study||12
8318887|NCT01435382|20510934|P2|COMPLETED|Overall Study||11
8318888|NCT01435382|20510935|P1|COMPLETED|Overall Study||11
8318889|NCT01435382|20510932|P4|STARTED|Overall Study||11
8318890|NCT01435382|20510933|P3|STARTED|Overall Study||13
8318891|NCT01435382|20510934|P2|STARTED|Overall Study||13
8318892|NCT01435382|20510935|P1|STARTED|Overall Study||12
8318893|NCT01435356|20511024|P2|NOT COMPLETED|Overall Study||24
8318894|NCT01435356|20511025|P1|NOT COMPLETED|Overall Study||32
8318895|NCT01435356|20511024|P2|COMPLETED|Overall Study||5
8318896|NCT01435356|20511025|P1|COMPLETED|Overall Study||16
8318897|NCT01435356|20511024|P2|STARTED|Overall Study||29
8318898|NCT01435356|20511025|P1|STARTED|Overall Study||48
8318899|NCT01435304|20511039|P2|NOT COMPLETED|Overall Study||0
8318900|NCT01435304|20511040|P1|NOT COMPLETED|Overall Study||0
8318901|NCT01435304|20511039|P2|COMPLETED|Overall Study||50
8318902|NCT01435304|20511040|P1|COMPLETED|Overall Study||50
8318903|NCT01435304|20511039|P2|STARTED|Overall Study||50
8318904|NCT01435304|20511040|P1|STARTED|Overall Study||50
8318905|NCT01435265|20511058|P2|NOT COMPLETED|Overall Study||1
8318906|NCT01435265|20511059|P1|NOT COMPLETED|Overall Study||0
8318907|NCT01435265|20511058|P2|COMPLETED|Overall Study||3
8318908|NCT01435265|20511059|P1|COMPLETED|Overall Study||3
8318909|NCT01435265|20511058|P2|STARTED|Overall Study||4
8318910|NCT01435265|20511059|P1|STARTED|Overall Study||3
8318911|NCT01435174|20511069|P1|NOT COMPLETED|Overall Study||9
8318912|NCT01435174|20511069|P1|COMPLETED|Overall Study||8
8318913|NCT01435174|20511069|P1|STARTED|Overall Study||17
8318914|NCT01435122|20511073|P1|NOT COMPLETED|Overall Study||8
8318915|NCT01435122|20511073|P1|COMPLETED|Overall Study||22
8318916|NCT01435122|20511073|P1|STARTED|Overall Study||30
8318917|NCT01435031|20511082|P1|NOT COMPLETED|ITT at 4 Years||7
8318918|NCT01435031|20511082|P1|COMPLETED|ITT at 4 Years||171
8318919|NCT01435031|20511082|P1|STARTED|ITT at 4 Years||178
8318920|NCT01435031|20511082|P1|NOT COMPLETED|ITT at 3 Years||11
8318921|NCT01435031|20511082|P1|COMPLETED|ITT at 3 Years||178
8318922|NCT01435031|20511082|P1|STARTED|ITT at 3 Years||189
8318923|NCT01435031|20511082|P1|NOT COMPLETED|ITT at 2 Years||13
8318924|NCT01435031|20511082|P1|COMPLETED|ITT at 2 Years||189
8318925|NCT01435031|20511082|P1|STARTED|ITT at 2 Years||202
8318926|NCT01435031|20511082|P1|NOT COMPLETED|ITT at 1 Year||9
8318927|NCT01435031|20511082|P1|COMPLETED|ITT at 1 Year||202
8318928|NCT01435031|20511082|P1|STARTED|ITT at 1 Year||211
8318929|NCT01435031|20511082|P1|NOT COMPLETED|ITT at 6 Months||5
8318930|NCT01435031|20511082|P1|COMPLETED|ITT at 6 Months||211
8318931|NCT01435031|20511082|P1|STARTED|ITT at 6 Months||216
8318932|NCT01435031|20511082|P1|NOT COMPLETED|ITT at 1 Month||6
8318933|NCT01435031|20511082|P1|COMPLETED|ITT at 1 Month||216
8318934|NCT01435031|20511082|P1|STARTED|ITT at 1 Month|ITT population|222
8318935|NCT01435018|20511183|P3|NOT COMPLETED|Overall Study||41
8318936|NCT01435018|20511184|P2|NOT COMPLETED|Overall Study||34
8318937|NCT01435018|20511185|P1|NOT COMPLETED|Overall Study||47
8318938|NCT01435018|20511183|P3|COMPLETED|Overall Study||98
8318939|NCT01435018|20511184|P2|COMPLETED|Overall Study||26
8318940|NCT01435018|20511185|P1|COMPLETED|Overall Study||88
8318941|NCT01435018|20511183|P3|STARTED|Overall Study||139
8318942|NCT01435018|20511184|P2|STARTED|Overall Study||60
8318943|NCT01435018|20511185|P1|STARTED|Overall Study||135
8318944|NCT01434823|20511278|P2|NOT COMPLETED|Overall Study||7
8318945|NCT01434823|20511279|P1|NOT COMPLETED|Overall Study||4
8318946|NCT01434823|20511278|P2|COMPLETED|Overall Study||778
8318947|NCT01434823|20511279|P1|COMPLETED|Overall Study||820
8318948|NCT01434823|20511278|P2|STARTED|Overall Study||785
8318949|NCT01434823|20511279|P1|STARTED|Overall Study||824
8318950|NCT01434810|20511297|P2|NOT COMPLETED|Overall Study||10
8318951|NCT01434810|20511298|P1|NOT COMPLETED|Overall Study||23
8318952|NCT01434810|20511297|P2|COMPLETED|Overall Study||213
8318953|NCT01434810|20511298|P1|COMPLETED|Overall Study||201
8318954|NCT01434810|20511297|P2|STARTED|Overall Study||223
8318955|NCT01434810|20511298|P1|STARTED|Overall Study||224
8318956|NCT01434745|20511310|P2|NOT COMPLETED|Overall Study||0
8318957|NCT01434745|20511311|P1|NOT COMPLETED|Overall Study||0
8318958|NCT01434745|20511310|P2|COMPLETED|Overall Study||0
8318959|NCT01434745|20511311|P1|COMPLETED|Overall Study||0
8318960|NCT01434745|20511310|P2|STARTED|Overall Study||0
8318961|NCT01434745|20511311|P1|STARTED|Overall Study||0
8318962|NCT01434693|20511333|P4|NOT COMPLETED|Overall Study||1
8318963|NCT01434693|20511334|P3|NOT COMPLETED|Overall Study||1
8318964|NCT01434693|20511335|P2|NOT COMPLETED|Overall Study||0
8318965|NCT01434693|20511336|P1|NOT COMPLETED|Overall Study||3
8318966|NCT01434693|20511333|P4|COMPLETED|Overall Study||8
8318967|NCT01434693|20511334|P3|COMPLETED|Overall Study||8
8318968|NCT01434693|20511335|P2|COMPLETED|Overall Study||9
8318969|NCT01434693|20511336|P1|COMPLETED|Overall Study||6
8318970|NCT01434693|20511333|P4|STARTED|Overall Study||9
8318971|NCT01434693|20511334|P3|STARTED|Overall Study||9
8318972|NCT01434693|20511335|P2|STARTED|Overall Study||9
8318973|NCT01434693|20511336|P1|STARTED|Overall Study||9
8318974|NCT01434680|20511350|P4|NOT COMPLETED|Overall Study||0
8318975|NCT01434680|20511351|P3|NOT COMPLETED|Overall Study||2
8318976|NCT01434680|20511352|P2|NOT COMPLETED|Overall Study||2
8318977|NCT01434680|20511353|P1|NOT COMPLETED|Overall Study||3
8318978|NCT01434680|20511350|P4|COMPLETED|Overall Study||119
8318979|NCT01434680|20511351|P3|COMPLETED|Overall Study||304
8318980|NCT01434680|20511352|P2|COMPLETED|Overall Study||266
8318981|NCT01434680|20511353|P1|COMPLETED|Overall Study||296
8318982|NCT01434680|20511350|P4|STARTED|Overall Study||119
8318983|NCT01434680|20511351|P3|STARTED|Overall Study||306
8318984|NCT01434680|20511352|P2|STARTED|Overall Study||268
8318985|NCT01434680|20511353|P1|STARTED|Overall Study||299
8318986|NCT01434667|20511370|P2|NOT COMPLETED|Overall Study||10
8318987|NCT01434667|20511371|P1|NOT COMPLETED|Overall Study||5
8318988|NCT01434667|20511370|P2|COMPLETED|Overall Study||65
8318989|NCT01434667|20511371|P1|COMPLETED|Overall Study||34
8318990|NCT01434667|20511370|P2|STARTED|Overall Study||75
8318991|NCT01434667|20511371|P1|STARTED|Overall Study||39
8318992|NCT01434654|20511397|P2|NOT COMPLETED|Overall Study||0
8318993|NCT01434654|20511398|P1|NOT COMPLETED|Overall Study||2
8318994|NCT01434654|20511397|P2|COMPLETED|Overall Study||12
8318995|NCT01434654|20511398|P1|COMPLETED|Overall Study||5
8318996|NCT01434654|20511397|P2|STARTED|Overall Study||12
8318997|NCT01434654|20511398|P1|STARTED|Overall Study||7
8318998|NCT01434641|20511410|P1|NOT COMPLETED|Overall Study||0
8318999|NCT01434641|20511410|P1|COMPLETED|Overall Study||102
8319000|NCT01434641|20511410|P1|STARTED|Overall Study||102
8319004|NCT01434342|20511434|P2|NOT COMPLETED|Overall Study||17
8319005|NCT01434342|20511435|P1|NOT COMPLETED|Overall Study||48
8319006|NCT01434342|20511434|P2|COMPLETED|Overall Study||31
8319007|NCT01434342|20511435|P1|COMPLETED|Overall Study||50
8319008|NCT01434342|20511434|P2|STARTED|Overall Study||48
8319009|NCT01434342|20511435|P1|STARTED|Overall Study||98
8319016|NCT01434186|20511474|P2|NOT COMPLETED|Overall Study||0
8319017|NCT01434186|20511475|P1|NOT COMPLETED|Overall Study||0
8319018|NCT01434186|20511474|P2|COMPLETED|Overall Study||4
8319019|NCT01434186|20511475|P1|COMPLETED|Overall Study||2
8319020|NCT01434186|20511474|P2|STARTED|Overall Study||4
8319021|NCT01434186|20511475|P1|STARTED|Overall Study||2
8319022|NCT01434121|20511484|P3|NOT COMPLETED|Overall Study||0
8319023|NCT01434121|20511485|P2|NOT COMPLETED|Overall Study||0
8319024|NCT01434121|20511486|P1|NOT COMPLETED|Overall Study||0
8319025|NCT01434121|20511484|P3|COMPLETED|Overall Study||8
8319026|NCT01434121|20511485|P2|COMPLETED|Overall Study||8
8319027|NCT01434121|20511486|P1|COMPLETED|Overall Study||8
8319028|NCT01434121|20511484|P3|STARTED|Overall Study||8
8319029|NCT01434121|20511485|P2|STARTED|Overall Study||8
8319030|NCT01434121|20511486|P1|STARTED|Overall Study||8
8319031|NCT01434030|20511512|P1|NOT COMPLETED|Overall Study||1
8319032|NCT01434030|20511512|P1|COMPLETED|Overall Study||56
8319033|NCT01434030|20511512|P1|STARTED|Overall Study||57
8319034|NCT01433978|20511519|P3|NOT COMPLETED|Extension Phase||6
8319035|NCT01433978|20511520|P2|NOT COMPLETED|Extension Phase||0
8319036|NCT01433978|20511521|P1|NOT COMPLETED|Extension Phase||0
8319037|NCT01433978|20511519|P3|COMPLETED|Extension Phase||0
8319038|NCT01433978|20511520|P2|COMPLETED|Extension Phase||0
8319039|NCT01433978|20511521|P1|COMPLETED|Extension Phase||0
8319040|NCT01433978|20511519|P3|STARTED|Extension Phase||6
8319041|NCT01433978|20511520|P2|STARTED|Extension Phase||0
8319042|NCT01433978|20511521|P1|STARTED|Extension Phase||0
8319043|NCT01433978|20511519|P3|NOT COMPLETED|Core Study||0
8319044|NCT01433978|20511520|P2|NOT COMPLETED|Core Study||11
8319045|NCT01433978|20511521|P1|NOT COMPLETED|Core Study||11
8319046|NCT01433978|20511519|P3|COMPLETED|Core Study||0
8319047|NCT01433978|20511520|P2|COMPLETED|Core Study||1
8319048|NCT01433978|20511521|P1|COMPLETED|Core Study||0
8319049|NCT01433978|20511519|P3|STARTED|Core Study||0
8319050|NCT01433978|20511520|P2|STARTED|Core Study||12
8319051|NCT01433978|20511521|P1|STARTED|Core Study||11
8319052|NCT01433913|20511530|P2|NOT COMPLETED|Overall Study||0
8319053|NCT01433913|20511531|P1|NOT COMPLETED|Overall Study||1
8319054|NCT01433913|20511530|P2|COMPLETED|Overall Study||10
8319055|NCT01433913|20511531|P1|COMPLETED|Overall Study||9
8319056|NCT01433913|20511530|P2|STARTED|Overall Study||10
8319057|NCT01433913|20511531|P1|STARTED|Overall Study||10
8319058|NCT01433731|20511567|P4|NOT COMPLETED|Overall Study||0
8319059|NCT01433731|20511568|P3|NOT COMPLETED|Overall Study||0
8319060|NCT01433731|20511569|P2|NOT COMPLETED|Overall Study||0
8319061|NCT01433731|20511570|P1|NOT COMPLETED|Overall Study||0
8319062|NCT01433731|20511567|P4|COMPLETED|Overall Study||5
8319063|NCT01433731|20511568|P3|COMPLETED|Overall Study||5
8319064|NCT01433731|20511569|P2|COMPLETED|Overall Study||5
8319065|NCT01433731|20511570|P1|COMPLETED|Overall Study||3
8319066|NCT01433731|20511567|P4|STARTED|Overall Study||5
8319067|NCT01433731|20511568|P3|STARTED|Overall Study||5
8319068|NCT01433731|20511569|P2|STARTED|Overall Study||5
8319069|NCT01433731|20511570|P1|STARTED|Overall Study||3
8319070|NCT01433549|20511578|P2|NOT COMPLETED|Phase 2: Second Study Product||1
8319071|NCT01433549|20511579|P1|NOT COMPLETED|Phase 2: Second Study Product||0
8319072|NCT01433549|20511578|P2|COMPLETED|Phase 2: Second Study Product||12
8319073|NCT01433549|20511579|P1|COMPLETED|Phase 2: Second Study Product||12
8319074|NCT01433549|20511578|P2|STARTED|Phase 2: Second Study Product||13
8319075|NCT01433549|20511579|P1|STARTED|Phase 2: Second Study Product||12
8319076|NCT01433549|20511578|P2|NOT COMPLETED|Phase 1: First Study Product||0
8319077|NCT01433549|20511579|P1|NOT COMPLETED|Phase 1: First Study Product||0
8319078|NCT01433549|20511578|P2|COMPLETED|Phase 1: First Study Product||13
8319079|NCT01433549|20511579|P1|COMPLETED|Phase 1: First Study Product||12
8319080|NCT01433549|20511578|P2|STARTED|Phase 1: First Study Product||13
8319081|NCT01433549|20511579|P1|STARTED|Phase 1: First Study Product||12
8319082|NCT01433471|20511589|P2|NOT COMPLETED|Overall Study||1
8319083|NCT01433471|20511590|P1|NOT COMPLETED|Overall Study||0
8319084|NCT01433471|20511589|P2|COMPLETED|Overall Study||1
8319085|NCT01433471|20511590|P1|COMPLETED|Overall Study||2
8319086|NCT01433471|20511589|P2|STARTED|Overall Study||2
8319087|NCT01433471|20511590|P1|STARTED|Overall Study||2
8319088|NCT01433354|20511606|P1|NOT COMPLETED|Overall Study||119
8319089|NCT01433354|20511606|P1|COMPLETED|Overall Study||0
8319090|NCT01433354|20511606|P1|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
8319091|NCT01433263|20511622|P2|NOT COMPLETED|Overall Study||12
8319092|NCT01433263|20511623|P1|NOT COMPLETED|Overall Study||19
8319093|NCT01433263|20511622|P2|COMPLETED|Overall Study||16
8319094|NCT01433263|20511623|P1|COMPLETED|Overall Study||10
8319095|NCT01433263|20511622|P2|STARTED|Overall Study||28
8319096|NCT01433263|20511623|P1|STARTED|Overall Study||29
8319097|NCT01433250|20511652|P2|NOT COMPLETED|Overall Study||3
8319098|NCT01433250|20511653|P1|NOT COMPLETED|Overall Study||3
8319099|NCT01433250|20511652|P2|COMPLETED|Overall Study||14
8319100|NCT01433250|20511653|P1|COMPLETED|Overall Study||19
8319101|NCT01433250|20511652|P2|STARTED|Overall Study||17
8319102|NCT01433250|20511653|P1|STARTED|Overall Study||22
8319103|NCT01433172|20511672|P3|NOT COMPLETED|Overall Study||1
8319104|NCT01433172|20511673|P2|NOT COMPLETED|Overall Study||3
8319105|NCT01433172|20511674|P1|NOT COMPLETED|Overall Study||0
8319106|NCT01433172|20511672|P3|COMPLETED|Overall Study||32
8319107|NCT01433172|20511673|P2|COMPLETED|Overall Study||34
8319108|NCT01433172|20511674|P1|COMPLETED|Overall Study||3
8319109|NCT01433172|20511672|P3|STARTED|Overall Study||33
8319110|NCT01433172|20511673|P2|STARTED|Overall Study||37
8319111|NCT01433172|20511674|P1|STARTED|Overall Study||3
8319112|NCT01433159|20511686|P2|NOT COMPLETED|Overall Study||1
8319113|NCT01433159|20511687|P1|NOT COMPLETED|Overall Study||2
8319114|NCT01433159|20511686|P2|COMPLETED|Overall Study||9
8319115|NCT01433159|20511687|P1|COMPLETED|Overall Study||7
8319116|NCT01433159|20511686|P2|STARTED|Overall Study||10
8319117|NCT01433159|20511687|P1|STARTED|Overall Study||9
8319118|NCT01433107|20511695|P2|NOT COMPLETED|Overall Study||17
8319119|NCT01433107|20511696|P1|NOT COMPLETED|Overall Study||27
8319120|NCT01433107|20511695|P2|COMPLETED|Overall Study||128
8319121|NCT01433107|20511696|P1|COMPLETED|Overall Study||118
8319122|NCT01433107|20511695|P2|STARTED|Overall Study||145
8319123|NCT01433107|20511696|P1|STARTED|Overall Study||145
8319124|NCT01433081|20511708|P2|NOT COMPLETED|Overall Study||2
8319125|NCT01433081|20511709|P1|NOT COMPLETED|Overall Study||2
8319126|NCT01433081|20511708|P2|COMPLETED|Overall Study||23
8319127|NCT01433081|20511709|P1|COMPLETED|Overall Study||23
8319128|NCT01433081|20511708|P2|STARTED|Overall Study||25
8319129|NCT01433081|20511709|P1|STARTED|Overall Study||25
8319130|NCT01433055|20511719|P2|NOT COMPLETED|Overall Study||0
8319131|NCT01433055|20511720|P1|NOT COMPLETED|Overall Study||2
8319132|NCT01433055|20511719|P2|COMPLETED|Overall Study||23
8319133|NCT01433055|20511720|P1|COMPLETED|Overall Study||27
8319134|NCT01433055|20511719|P2|STARTED|Overall Study||23
8319135|NCT01433055|20511720|P1|STARTED|Overall Study||29
8319136|NCT01433042|20511734|P1|NOT COMPLETED|Overall Study||1
8319137|NCT01433042|20511734|P1|COMPLETED|Overall Study||224
8319138|NCT01433042|20511734|P1|STARTED|Overall Study||225
8319139|NCT01433016|20511738|P1|NOT COMPLETED|Overall Study||0
8319140|NCT01433016|20511738|P1|COMPLETED|Overall Study||20
8319141|NCT01433016|20511738|P1|STARTED|Overall Study||20
8319142|NCT01432951|20511742|P1|NOT COMPLETED|Safety Extension Day 30 to End of Study||0
8319143|NCT01432951|20511742|P1|COMPLETED|Safety Extension Day 30 to End of Study||15
8319144|NCT01432951|20511742|P1|STARTED|Safety Extension Day 30 to End of Study|Participants had the option to continue on to safety extension period.|15
8319145|NCT01432951|20511742|P1|NOT COMPLETED|Treatment Phase (Day 1 to 30)||1
8319146|NCT01432951|20511742|P1|COMPLETED|Treatment Phase (Day 1 to 30)||25
8319147|NCT01432951|20511742|P1|Progressive Disease|Treatment Phase (Day 1 to 30)||10
8319148|NCT01432951|20511742|P1|PK Sampling (no Dosing) Days 15-17|Treatment Phase (Day 1 to 30)||23
8319149|NCT01432951|20511742|P1|Received at Least One Dose of Study Drug|Treatment Phase (Day 1 to 30)||25
8319150|NCT01432951|20511742|P1|STARTED|Treatment Phase (Day 1 to 30)||26
8319151|NCT01432938|20511751|P2|NOT COMPLETED|Second Intervention||0
8319152|NCT01432938|20511752|P1|NOT COMPLETED|Second Intervention||1
8319153|NCT01432938|20511751|P2|COMPLETED|Second Intervention||14
8319154|NCT01432938|20511752|P1|COMPLETED|Second Intervention||11
8319155|NCT01432938|20511751|P2|STARTED|Second Intervention||14
8319156|NCT01432938|20511752|P1|STARTED|Second Intervention||12
8319157|NCT01432938|20511751|P2|NOT COMPLETED|Washout Period of at Least 24 Days||0
8319158|NCT01432938|20511752|P1|NOT COMPLETED|Washout Period of at Least 24 Days||0
8319159|NCT01432938|20511751|P2|COMPLETED|Washout Period of at Least 24 Days||14
8319160|NCT01432938|20511752|P1|COMPLETED|Washout Period of at Least 24 Days||12
8319161|NCT01432938|20511751|P2|STARTED|Washout Period of at Least 24 Days||14
8319162|NCT01432938|20511752|P1|STARTED|Washout Period of at Least 24 Days||12
8319163|NCT01432938|20511751|P2|NOT COMPLETED|First Intervention||0
8319164|NCT01432938|20511752|P1|NOT COMPLETED|First Intervention||2
8319165|NCT01432938|20511751|P2|COMPLETED|First Intervention||14
8319166|NCT01432938|20511752|P1|COMPLETED|First Intervention||12
8319167|NCT01432938|20511751|P2|Received at Least 1 Dose of Study Drug|First Intervention||14
8319168|NCT01432938|20511752|P1|Received at Least 1 Dose of Study Drug|First Intervention||14
8319169|NCT01432938|20511751|P2|STARTED|First Intervention||14
8319170|NCT01432938|20511752|P1|STARTED|First Intervention||14
8319171|NCT01432886|20511769|P2|NOT COMPLETED|Overall Study||0
8319172|NCT01432886|20511770|P1|NOT COMPLETED|Overall Study||0
8319173|NCT01432886|20511769|P2|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
8319174|NCT01432886|20511770|P1|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
8319175|NCT01432886|20511769|P2|STARTED|Overall Study||6
8319176|NCT01432886|20511770|P1|STARTED|Overall Study||6
8319177|NCT01432756|20511782|P4|NOT COMPLETED|Overall Study||1
8319178|NCT01432756|20511783|P3|NOT COMPLETED|Overall Study||2
8319179|NCT01432756|20511784|P2|NOT COMPLETED|Overall Study||0
8319180|NCT01432756|20511785|P1|NOT COMPLETED|Overall Study||1
8319181|NCT01432756|20511782|P4|COMPLETED|Overall Study||33
8319182|NCT01432756|20511783|P3|COMPLETED|Overall Study||30
8319183|NCT01432756|20511784|P2|COMPLETED|Overall Study||34
8319184|NCT01432756|20511785|P1|COMPLETED|Overall Study||31
8319185|NCT01432756|20511782|P4|STARTED|Overall Study||34
8319186|NCT01432756|20511783|P3|STARTED|Overall Study||32
8319187|NCT01432756|20511784|P2|STARTED|Overall Study||34
8319188|NCT01432756|20511785|P1|STARTED|Overall Study||32
8319189|NCT01432730|20511793|P2|NOT COMPLETED|Period 2||4
8319190|NCT01432730|20511794|P1|NOT COMPLETED|Period 2||0
8319191|NCT01432730|20511793|P2|COMPLETED|Period 2||8
8319192|NCT01432730|20511794|P1|COMPLETED|Period 2||10
8319193|NCT01432730|20511793|P2|STARTED|Period 2||12
8319194|NCT01432730|20511794|P1|STARTED|Period 2||10
8319195|NCT01432730|20511793|P2|NOT COMPLETED|Period 1||0
8319196|NCT01432730|20511794|P1|NOT COMPLETED|Period 1||2
8319197|NCT01432730|20511793|P2|COMPLETED|Period 1||12
8319198|NCT01432730|20511794|P1|COMPLETED|Period 1||10
8319199|NCT01432730|20511793|P2|STARTED|Period 1||12
8319200|NCT01432730|20511794|P1|STARTED|Period 1||12
8319201|NCT01432626|20511830|P1|NOT COMPLETED|Overall Study||7
8319202|NCT01432626|20511830|P1|COMPLETED|Overall Study|Completed both images|3
8319203|NCT01432626|20511830|P1|STARTED|Overall Study||10
8319204|NCT01432600|20511837|P3|NOT COMPLETED|Overall Study||1
8319205|NCT01432600|20511838|P2|NOT COMPLETED|Overall Study||1
8319206|NCT01432600|20511839|P1|NOT COMPLETED|Overall Study||0
8319207|NCT01432600|20511837|P3|COMPLETED|Overall Study||33
8319208|NCT01432600|20511838|P2|COMPLETED|Overall Study||35
8319209|NCT01432600|20511839|P1|COMPLETED|Overall Study||10
8319210|NCT01432600|20511837|P3|STARTED|Overall Study||34
8319211|NCT01432600|20511838|P2|STARTED|Overall Study||36
8319212|NCT01432600|20511839|P1|STARTED|Overall Study||10
8319216|NCT01432561|20511861|P1|NOT COMPLETED|Overall Study||0
8319217|NCT01432561|20511861|P1|COMPLETED|Overall Study||8
8319218|NCT01432561|20511861|P1|STARTED|Overall Study||8
8319219|NCT01432535|20511870|P3|NOT COMPLETED|Overall Study||0
8319220|NCT01432535|20511871|P2|NOT COMPLETED|Overall Study||0
8319221|NCT01432535|20511872|P1|NOT COMPLETED|Overall Study||0
8319222|NCT01432535|20511870|P3|COMPLETED|Overall Study||6
8319223|NCT01432535|20511871|P2|COMPLETED|Overall Study||7
8319224|NCT01432535|20511872|P1|COMPLETED|Overall Study||12
8319225|NCT01432535|20511870|P3|STARTED|Overall Study||6
8319226|NCT01432535|20511871|P2|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
8319227|NCT01432535|20511872|P1|STARTED|Overall Study||12
8319228|NCT01432457|20511901|P3|NOT COMPLETED|Overall Study||59
8319229|NCT01432457|20511902|P2|NOT COMPLETED|Overall Study||48
8319230|NCT01432457|20511903|P1|NOT COMPLETED|Overall Study||37
8319231|NCT01432457|20511901|P3|COMPLETED|Overall Study||253
8319232|NCT01432457|20511902|P2|COMPLETED|Overall Study||258
8319233|NCT01432457|20511903|P1|COMPLETED|Overall Study||269
8319234|NCT01432457|20511901|P3|STARTED|Overall Study||312
8319235|NCT01432457|20511902|P2|STARTED|Overall Study||306
8319236|NCT01432457|20511903|P1|STARTED|Overall Study||306
8319237|NCT01432444|20511932|P3|NOT COMPLETED|Extension Phase||192
8319238|NCT01432444|20511933|P2|NOT COMPLETED|Extension Phase||0
8319239|NCT01432444|20511934|P1|NOT COMPLETED|Extension Phase||0
8319240|NCT01432444|20511932|P3|COMPLETED|Extension Phase||0
8319241|NCT01432444|20511933|P2|COMPLETED|Extension Phase||0
8319242|NCT01432444|20511934|P1|COMPLETED|Extension Phase||0
8319243|NCT01432444|20511932|P3|STARTED|Extension Phase||192
8319244|NCT01432444|20511933|P2|STARTED|Extension Phase||0
8319245|NCT01432444|20511934|P1|STARTED|Extension Phase||0
8319246|NCT01432444|20511932|P3|NOT COMPLETED|Treatment Phase||0
8319247|NCT01432444|20511933|P2|NOT COMPLETED|Treatment Phase||140
8319248|NCT01432444|20511934|P1|NOT COMPLETED|Treatment Phase||0
8319249|NCT01432444|20511932|P3|COMPLETED|Treatment Phase||0
8319250|NCT01432444|20511933|P2|COMPLETED|Treatment Phase||293
8319251|NCT01432444|20511934|P1|COMPLETED|Treatment Phase||0
8319252|NCT01432444|20511932|P3|STARTED|Treatment Phase||0
8319253|NCT01432444|20511933|P2|STARTED|Treatment Phase||433
8319254|NCT01432444|20511934|P1|STARTED|Treatment Phase||0
8319255|NCT01432444|20511932|P3|NOT COMPLETED|Tolerability/Cross-titration Phase||0
8319256|NCT01432444|20511933|P2|NOT COMPLETED|Tolerability/Cross-titration Phase||0
8319257|NCT01432444|20511934|P1|NOT COMPLETED|Tolerability/Cross-titration Phase||60
8319258|NCT01432444|20511932|P3|COMPLETED|Tolerability/Cross-titration Phase||0
8319259|NCT01432444|20511933|P2|COMPLETED|Tolerability/Cross-titration Phase||0
8319260|NCT01432444|20511934|P1|COMPLETED|Tolerability/Cross-titration Phase||265
8319261|NCT01432444|20511932|P3|STARTED|Tolerability/Cross-titration Phase||0
8319262|NCT01432444|20511933|P2|STARTED|Tolerability/Cross-titration Phase||0
8319263|NCT01432444|20511934|P1|STARTED|Tolerability/Cross-titration Phase||325
8319264|NCT01432405|20511946|P2|NOT COMPLETED|Overall Study||2
8319265|NCT01432405|20511947|P1|NOT COMPLETED|Overall Study||1
8319266|NCT01432405|20511946|P2|COMPLETED|Overall Study||10
8319267|NCT01432405|20511947|P1|COMPLETED|Overall Study||11
8319268|NCT01432405|20511946|P2|STARTED|Overall Study||12
8319269|NCT01432405|20511947|P1|STARTED|Overall Study||12
8319270|NCT01432379|20511955|P1|NOT COMPLETED|Overall Study||385
8319271|NCT01432379|20511955|P1|COMPLETED|Overall Study||783
8319272|NCT01432379|20511955|P1|STARTED|Overall Study||1168
8319273|NCT01432366|20511960|P1|NOT COMPLETED|Overall Study||68
8319274|NCT01432366|20511960|P1|COMPLETED|Overall Study||392
8319275|NCT01432366|20511960|P1|STARTED|Overall Study||460
8319276|NCT01432327|20511982|P4|NOT COMPLETED|Posttest 1 Year||23
8319277|NCT01432327|20511983|P3|NOT COMPLETED|Posttest 1 Year||20
8319278|NCT01432327|20511984|P2|NOT COMPLETED|Posttest 1 Year||28
8319279|NCT01432327|20511985|P1|NOT COMPLETED|Posttest 1 Year||24
8319280|NCT01432327|20511982|P4|COMPLETED|Posttest 1 Year||31
8319281|NCT01432327|20511983|P3|COMPLETED|Posttest 1 Year||30
8319282|NCT01432327|20511984|P2|COMPLETED|Posttest 1 Year||27
8319283|NCT01432327|20511985|P1|COMPLETED|Posttest 1 Year||28
8319284|NCT01432327|20511982|P4|STARTED|Posttest 1 Year||54
8319285|NCT01432327|20511983|P3|STARTED|Posttest 1 Year||50
8319286|NCT01432327|20511984|P2|STARTED|Posttest 1 Year||55
8319287|NCT01432327|20511985|P1|STARTED|Posttest 1 Year||52
8319288|NCT01432327|20511982|P4|NOT COMPLETED|Posttest 6 Months||2
8319289|NCT01432327|20511983|P3|NOT COMPLETED|Posttest 6 Months||5
8319290|NCT01432327|20511984|P2|NOT COMPLETED|Posttest 6 Months||0
8319291|NCT01432327|20511985|P1|NOT COMPLETED|Posttest 6 Months||0
8319292|NCT01432327|20511982|P4|COMPLETED|Posttest 6 Months||54
8319293|NCT01432327|20511983|P3|COMPLETED|Posttest 6 Months||50
8319294|NCT01432327|20511984|P2|COMPLETED|Posttest 6 Months||55
8319295|NCT01432327|20511985|P1|COMPLETED|Posttest 6 Months||52
8319296|NCT01432327|20511982|P4|STARTED|Posttest 6 Months||56
8319297|NCT01432327|20511983|P3|STARTED|Posttest 6 Months||55
8319298|NCT01432327|20511984|P2|STARTED|Posttest 6 Months||55
8319299|NCT01432327|20511985|P1|STARTED|Posttest 6 Months||52
8319300|NCT01432327|20511982|P4|NOT COMPLETED|Posttest 3 Months||1
8319301|NCT01432327|20511983|P3|NOT COMPLETED|Posttest 3 Months||2
8319302|NCT01432327|20511984|P2|NOT COMPLETED|Posttest 3 Months||2
8319303|NCT01432327|20511985|P1|NOT COMPLETED|Posttest 3 Months||4
8319304|NCT01432327|20511982|P4|COMPLETED|Posttest 3 Months||56
8319305|NCT01432327|20511983|P3|COMPLETED|Posttest 3 Months||55
8319306|NCT01432327|20511984|P2|COMPLETED|Posttest 3 Months||55
8319307|NCT01432327|20511985|P1|COMPLETED|Posttest 3 Months||52
8319308|NCT01432327|20511982|P4|STARTED|Posttest 3 Months||57
8319309|NCT01432327|20511983|P3|STARTED|Posttest 3 Months||57
8319310|NCT01432327|20511984|P2|STARTED|Posttest 3 Months||57
8319311|NCT01432327|20511985|P1|STARTED|Posttest 3 Months||56
8319312|NCT01432327|20511982|P4|NOT COMPLETED|Baseline||0
8319313|NCT01432327|20511983|P3|NOT COMPLETED|Baseline||0
8319314|NCT01432327|20511984|P2|NOT COMPLETED|Baseline||0
8319315|NCT01432327|20511985|P1|NOT COMPLETED|Baseline||0
8319316|NCT01432327|20511982|P4|COMPLETED|Baseline||57
8319317|NCT01432327|20511983|P3|COMPLETED|Baseline||57
8319318|NCT01432327|20511984|P2|COMPLETED|Baseline||57
8319319|NCT01432327|20511985|P1|COMPLETED|Baseline||56
8319320|NCT01432327|20511982|P4|STARTED|Baseline||57
8319321|NCT01432327|20511983|P3|STARTED|Baseline||57
8319322|NCT01432327|20511984|P2|STARTED|Baseline||57
8319323|NCT01432327|20511985|P1|STARTED|Baseline||56
8319324|NCT01432275|20511995|P2|NOT COMPLETED|ADC With Calculator (10 Days)||2
8319325|NCT01432275|20511996|P1|NOT COMPLETED|ADC With Calculator (10 Days)||3
8319326|NCT01432275|20511995|P2|COMPLETED|ADC With Calculator (10 Days)||79
8319327|NCT01432275|20511996|P1|COMPLETED|ADC With Calculator (10 Days)||85
8319328|NCT01432275|20511995|P2|STARTED|ADC With Calculator (10 Days)||81
8319329|NCT01432275|20511996|P1|STARTED|ADC With Calculator (10 Days)||88
8319330|NCT01432275|20511995|P2|NOT COMPLETED|Second BG Meter System (7 Days)||3
8319331|NCT01432275|20511996|P1|NOT COMPLETED|Second BG Meter System (7 Days)||2
8319332|NCT01432275|20511995|P2|COMPLETED|Second BG Meter System (7 Days)||81
8319333|NCT01432275|20511996|P1|COMPLETED|Second BG Meter System (7 Days)||88
8319334|NCT01432275|20511995|P2|STARTED|Second BG Meter System (7 Days)||84
8319335|NCT01432275|20511996|P1|STARTED|Second BG Meter System (7 Days)||90
8319336|NCT01432275|20511995|P2|NOT COMPLETED|First BG Meter System (7 Days)||3
8319337|NCT01432275|20511996|P1|NOT COMPLETED|First BG Meter System (7 Days)||0
8319338|NCT01432275|20511995|P2|COMPLETED|First BG Meter System (7 Days)||84
8319339|NCT01432275|20511996|P1|COMPLETED|First BG Meter System (7 Days)||90
8319340|NCT01432275|20511995|P2|STARTED|First BG Meter System (7 Days)||87
8319341|NCT01432275|20511996|P1|STARTED|First BG Meter System (7 Days)||90
8319342|NCT01432262|20512005|P2|NOT COMPLETED|Overall Study||1
8319343|NCT01432262|20512006|P1|NOT COMPLETED|Overall Study||2
8319344|NCT01432262|20512005|P2|COMPLETED|Overall Study||161
8319345|NCT01432262|20512006|P1|COMPLETED|Overall Study||160
8319346|NCT01432262|20512005|P2|Vaccinated|Overall Study||161
8319347|NCT01432262|20512006|P1|Vaccinated|Overall Study||162
8319348|NCT01432262|20512005|P2|STARTED|Overall Study||162
8319349|NCT01432262|20512006|P1|STARTED|Overall Study||162
8319350|NCT01432236|20512024|P2|NOT COMPLETED|Overall Study||18
8319351|NCT01432236|20512025|P1|NOT COMPLETED|Overall Study||26
8319352|NCT01432236|20512024|P2|COMPLETED|Overall Study||79
8319353|NCT01432236|20512025|P1|COMPLETED|Overall Study||70
8319354|NCT01432236|20512024|P2|STARTED|Overall Study||97
8319355|NCT01432236|20512025|P1|STARTED|Overall Study||96
8319356|NCT01432171|20512072|P2|NOT COMPLETED|Overall Study||11
8319357|NCT01432171|20512073|P1|NOT COMPLETED|Overall Study||14
8319358|NCT01432171|20512072|P2|COMPLETED|Overall Study||8
8319359|NCT01432171|20512073|P1|COMPLETED|Overall Study||4
8319360|NCT01432171|20512072|P2|STARTED|Overall Study||19
8319361|NCT01432171|20512073|P1|STARTED|Overall Study||18
8319362|NCT01432145|20512079|P1|NOT COMPLETED|Overall Study||7
8319363|NCT01432145|20512079|P1|COMPLETED|Overall Study||67
8319364|NCT01432145|20512079|P1|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74
8319365|NCT01432015|20512086|P2|NOT COMPLETED|Overall Study||0
8319366|NCT01432015|20512087|P1|NOT COMPLETED|Overall Study||0
8319367|NCT01432015|20512086|P2|COMPLETED|Overall Study||10
8319368|NCT01432015|20512087|P1|COMPLETED|Overall Study||10
8319369|NCT01432015|20512086|P2|STARTED|Overall Study||10
8319370|NCT01432015|20512087|P1|STARTED|Overall Study||10
8319371|NCT01431989|20512095|P2|NOT COMPLETED|Period 2||0
8319372|NCT01431989|20512096|P1|NOT COMPLETED|Period 2||0
8319373|NCT01431989|20512095|P2|COMPLETED|Period 2||14
8319374|NCT01431989|20512096|P1|COMPLETED|Period 2||14
8319375|NCT01431989|20512095|P2|STARTED|Period 2||14
8319376|NCT01431989|20512096|P1|STARTED|Period 2||14
8319377|NCT01431989|20512095|P2|NOT COMPLETED|14-Day Washout Period||0
8319378|NCT01431989|20512096|P1|NOT COMPLETED|14-Day Washout Period||0
8319379|NCT01431989|20512095|P2|COMPLETED|14-Day Washout Period||14
8319380|NCT01431989|20512096|P1|COMPLETED|14-Day Washout Period||14
8319381|NCT01431989|20512095|P2|STARTED|14-Day Washout Period||14
8319382|NCT01431989|20512096|P1|STARTED|14-Day Washout Period||14
8319383|NCT01431989|20512095|P2|NOT COMPLETED|Period 1||0
8319384|NCT01431989|20512096|P1|NOT COMPLETED|Period 1||0
8319385|NCT01431989|20512095|P2|COMPLETED|Period 1||14
8319386|NCT01431989|20512096|P1|COMPLETED|Period 1||14
8319387|NCT01431989|20512095|P2|STARTED|Period 1||14
8319388|NCT01431989|20512096|P1|STARTED|Period 1||14
8319389|NCT01431976|20512114|P1|NOT COMPLETED|Overall Study||14
8319390|NCT01431976|20512114|P1|COMPLETED|Overall Study||6
8319391|NCT01431976|20512114|P1|STARTED|Overall Study||20
8319392|NCT01431963|20512125|P1|NOT COMPLETED|Overall Study||35
8319393|NCT01431963|20512125|P1|COMPLETED|Overall Study||32
8319394|NCT01431963|20512125|P1|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
8319395|NCT01431963|20512125|P1|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
8319396|NCT01431963|20512125|P1|Complete MP (24 Weeks)|Overall Study||42
8319397|NCT01431963|20512125|P1|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
8319398|NCT01431963|20512125|P1|Complete EP (6 Weeks)|Overall Study||52
8319399|NCT01431963|20512125|P1|Received Treatment|Overall Study||65
8319400|NCT01431963|20512125|P1|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
8319401|NCT01431963|20512125|P1|STARTED|Overall Study||67
8319402|NCT01431950|20512133|P2|NOT COMPLETED|Overall Study||15
8319403|NCT01431950|20512134|P1|NOT COMPLETED|Overall Study||19
8319404|NCT01431950|20512133|P2|COMPLETED|Overall Study||104
8319405|NCT01431950|20512134|P1|COMPLETED|Overall Study||100
8319406|NCT01431950|20512133|P2|STARTED|Overall Study||119
8319407|NCT01431950|20512134|P1|STARTED|Overall Study||119
8319408|NCT01431846|20512151|P3|NOT COMPLETED|Overall Study||0
8319409|NCT01431846|20512152|P2|NOT COMPLETED|Overall Study||0
8319410|NCT01431846|20512153|P1|NOT COMPLETED|Overall Study||0
8319411|NCT01431846|20512151|P3|COMPLETED|Overall Study||8
8319412|NCT01431846|20512152|P2|COMPLETED|Overall Study||3
8319413|NCT01431846|20512153|P1|COMPLETED|Overall Study||8
8319414|NCT01431846|20512151|P3|STARTED|Overall Study||8
8319415|NCT01431846|20512152|P2|STARTED|Overall Study||3
8319416|NCT01431846|20512153|P1|STARTED|Overall Study||8
8319417|NCT01431794|20512166|P5|NOT COMPLETED|Overall Study||0
8319418|NCT01431794|20512167|P4|NOT COMPLETED|Overall Study||0
8319419|NCT01431794|20512168|P3|NOT COMPLETED|Overall Study||0
8319420|NCT01431794|20512169|P2|NOT COMPLETED|Overall Study||0
8319421|NCT01431794|20512170|P1|NOT COMPLETED|Overall Study||0
8319422|NCT01431794|20512166|P5|COMPLETED|Overall Study|not started due to early study's termination|0
8319423|NCT01431794|20512167|P4|COMPLETED|Overall Study|not started due to early study's termination|0
8319424|NCT01431794|20512168|P3|COMPLETED|Overall Study|not started due to early study's termination|0
8319425|NCT01431794|20512169|P2|COMPLETED|Overall Study|not started due to early study's termination|0
8319426|NCT01431794|20512170|P1|COMPLETED|Overall Study||13
8319427|NCT01431794|20512166|P5|STARTED|Overall Study|not started due to early study's termination|0
8319428|NCT01431794|20512167|P4|STARTED|Overall Study|not started due to early study's termination|0
8319429|NCT01431794|20512168|P3|STARTED|Overall Study|not started due to early study's termination|0
8319430|NCT01431794|20512169|P2|STARTED|Overall Study|not started due to early study's termination|0
8319431|NCT01431794|20512170|P1|STARTED|Overall Study||13
8319432|NCT01431755|20512188|P1|NOT COMPLETED|Overall Study||5
8319433|NCT01431755|20512188|P1|COMPLETED|Overall Study||49
8319434|NCT01431755|20512188|P1|STARTED|Overall Study||54
8319435|NCT01431716|20512199|P1|NOT COMPLETED|Overall Study||1
8319436|NCT01431716|20512199|P1|COMPLETED|Overall Study||41
8319437|NCT01431716|20512199|P1|STARTED|Overall Study||42
8319438|NCT01431703|20512216|P1|NOT COMPLETED|Overall Study||0
8319439|NCT01431703|20512216|P1|COMPLETED|Overall Study||326
8319440|NCT01431703|20512216|P1|STARTED|Overall Study||326
8319441|NCT01431534|20512223|P3|NOT COMPLETED|Extension Phase||0
8319442|NCT01431534|20512224|P2|NOT COMPLETED|Extension Phase||0
8319443|NCT01431534|20512225|P1|NOT COMPLETED|Extension Phase||0
8319444|NCT01431534|20512223|P3|COMPLETED|Extension Phase||2
8319445|NCT01431534|20512224|P2|COMPLETED|Extension Phase||0
8319446|NCT01431534|20512225|P1|COMPLETED|Extension Phase||0
8319447|NCT01431534|20512223|P3|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2
8319448|NCT01431534|20512224|P2|STARTED|Extension Phase|No participants continued in Extension Phase.|0
8319449|NCT01431534|20512225|P1|STARTED|Extension Phase|No participants continued in Extension Phase.|0
8319450|NCT01431534|20512223|P3|NOT COMPLETED|Treatment Phase||11
8319451|NCT01431534|20512224|P2|NOT COMPLETED|Treatment Phase||3
8319452|NCT01431534|20512225|P1|NOT COMPLETED|Treatment Phase||4
8319453|NCT01431534|20512223|P3|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2
8319454|NCT01431534|20512224|P2|COMPLETED|Treatment Phase||0
8319455|NCT01431534|20512225|P1|COMPLETED|Treatment Phase||0
8319456|NCT01431534|20512223|P3|STARTED|Treatment Phase||13
8319457|NCT01431534|20512224|P2|STARTED|Treatment Phase||3
8319458|NCT01431534|20512225|P1|STARTED|Treatment Phase||4
8319459|NCT01431521|20512240|P4|NOT COMPLETED|Overall Study||0
8319460|NCT01431521|20512241|P3|NOT COMPLETED|Overall Study||1
8319461|NCT01431521|20512242|P2|NOT COMPLETED|Overall Study||0
8319462|NCT01431521|20512243|P1|NOT COMPLETED|Overall Study||0
8319463|NCT01431521|20512240|P4|COMPLETED|Overall Study||5
8319464|NCT01431521|20512241|P3|COMPLETED|Overall Study||10
8319465|NCT01431521|20512242|P2|COMPLETED|Overall Study||5
8319466|NCT01431521|20512243|P1|COMPLETED|Overall Study||10
8319467|NCT01431521|20512240|P4|Treated|Overall Study||5
8319468|NCT01431521|20512241|P3|Treated|Overall Study||10
8319469|NCT01431521|20512242|P2|Treated|Overall Study||5
8319470|NCT01431521|20512243|P1|Treated|Overall Study||10
8319471|NCT01431521|20512240|P4|STARTED|Overall Study||5
8319472|NCT01431521|20512241|P3|STARTED|Overall Study||11
8319473|NCT01431521|20512242|P2|STARTED|Overall Study||5
8319474|NCT01431521|20512243|P1|STARTED|Overall Study||10
8319475|NCT01431508|20512264|P1|NOT COMPLETED|Overall Study||2
8319476|NCT01431508|20512264|P1|COMPLETED|Overall Study||13
8319477|NCT01431508|20512264|P1|STARTED|Overall Study||15
8319478|NCT01431391|20512270|P2|NOT COMPLETED|Overall Study||4
8319479|NCT01431391|20512271|P1|NOT COMPLETED|Overall Study||8
8319480|NCT01431391|20512270|P2|COMPLETED|Overall Study||30
8319481|NCT01431391|20512271|P1|COMPLETED|Overall Study||26
8319482|NCT01431391|20512270|P2|Received ≥1 Leaukapheresis|Overall Study||34
8319483|NCT01431391|20512271|P1|Received ≥1 Leaukapheresis|Overall Study||34
8319484|NCT01431391|20512270|P2|STARTED|Overall Study||34
8319485|NCT01431391|20512271|P1|STARTED|Overall Study||34
8319486|NCT01431339|20512281|P2|NOT COMPLETED|Overall Study||35
8319487|NCT01431339|20512282|P1|NOT COMPLETED|Overall Study||39
8319488|NCT01431339|20512281|P2|COMPLETED|Overall Study||333
8319489|NCT01431339|20512282|P1|COMPLETED|Overall Study||332
8319490|NCT01431339|20512281|P2|Safety Population|Overall Study||367
8319491|NCT01431339|20512282|P1|Safety Population|Overall Study||368
8319492|NCT01431339|20512281|P2|STARTED|Overall Study||368
8319493|NCT01431339|20512282|P1|STARTED|Overall Study||371
8319494|NCT01431313|20512297|P3|NOT COMPLETED|Overall Study||0
8319495|NCT01431313|20512298|P2|NOT COMPLETED|Overall Study||0
8319496|NCT01431313|20512299|P1|NOT COMPLETED|Overall Study||0
8319497|NCT01431313|20512297|P3|COMPLETED|Overall Study||8
8319498|NCT01431313|20512298|P2|COMPLETED|Overall Study||20
8319499|NCT01431313|20512299|P1|COMPLETED|Overall Study||20
8319500|NCT01431313|20512297|P3|STARTED|Overall Study||8
8319501|NCT01431313|20512298|P2|STARTED|Overall Study||20
8319502|NCT01431313|20512299|P1|STARTED|Overall Study||20
8319503|NCT01431300|20512331|P3|NOT COMPLETED|Overall Study||0
8319504|NCT01431300|20512332|P2|NOT COMPLETED|Overall Study||0
8319505|NCT01431300|20512333|P1|NOT COMPLETED|Overall Study||1
8319506|NCT01431300|20512331|P3|COMPLETED|Overall Study||10
8319507|NCT01431300|20512332|P2|COMPLETED|Overall Study||10
8319508|NCT01431300|20512333|P1|COMPLETED|Overall Study||10
8319509|NCT01431300|20512331|P3|STARTED|Overall Study||10
8319510|NCT01431300|20512332|P2|STARTED|Overall Study||10
8319511|NCT01431300|20512333|P1|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
8319512|NCT01431287|20512349|P5|NOT COMPLETED|Overall Study||77
8319513|NCT01431287|20512350|P4|NOT COMPLETED|Overall Study||63
8319514|NCT01431287|20512351|P3|NOT COMPLETED|Overall Study||97
8319515|NCT01431287|20512352|P2|NOT COMPLETED|Overall Study||98
8319516|NCT01431287|20512353|P1|NOT COMPLETED|Overall Study||98
8319517|NCT01431287|20512349|P5|COMPLETED|Overall Study||430
8319518|NCT01431287|20512350|P4|COMPLETED|Overall Study||445
8319519|NCT01431287|20512351|P3|COMPLETED|Overall Study||410
8319520|NCT01431287|20512352|P2|COMPLETED|Overall Study||409
8319521|NCT01431287|20512353|P1|COMPLETED|Overall Study||412
8319522|NCT01431287|20512349|P5|STARTED|Overall Study||507
8319523|NCT01431287|20512350|P4|STARTED|Overall Study||508
8319524|NCT01431287|20512351|P3|STARTED|Overall Study||507
8319525|NCT01431287|20512352|P2|STARTED|Overall Study||507
8319526|NCT01431287|20512353|P1|STARTED|Overall Study|started are actually the randomized|510
8319527|NCT01431274|20512515|P5|NOT COMPLETED|Overall Study||56
8319528|NCT01431274|20512516|P4|NOT COMPLETED|Overall Study||60
8319529|NCT01431274|20512517|P3|NOT COMPLETED|Overall Study||72
8319530|NCT01431274|20512518|P2|NOT COMPLETED|Overall Study||77
8319531|NCT01431274|20512519|P1|NOT COMPLETED|Overall Study||97
8319532|NCT01431274|20512515|P5|COMPLETED|Overall Study||466
8319533|NCT01431274|20512516|P4|COMPLETED|Overall Study||462
8319534|NCT01431274|20512517|P3|COMPLETED|Overall Study||455
8319535|NCT01431274|20512518|P2|COMPLETED|Overall Study||448
8319536|NCT01431274|20512519|P1|COMPLETED|Overall Study||431
8319537|NCT01431274|20512515|P5|STARTED|Overall Study||522
8319538|NCT01431274|20512516|P4|STARTED|Overall Study||522
8319539|NCT01431274|20512517|P3|STARTED|Overall Study||527
8319540|NCT01431274|20512518|P2|STARTED|Overall Study||525
8319541|NCT01431274|20512519|P1|STARTED|Overall Study||528
8319542|NCT01431170|20512678|P2|NOT COMPLETED|Overall Study||1
8319543|NCT01431170|20512679|P1|NOT COMPLETED|Overall Study||3
8319544|NCT01431170|20512678|P2|COMPLETED|Overall Study||11
8319545|NCT01431170|20512679|P1|COMPLETED|Overall Study||9
8319546|NCT01431170|20512678|P2|STARTED|Overall Study||12
8319547|NCT01431170|20512679|P1|STARTED|Overall Study||12
8319548|NCT01431144|20512697|P2|NOT COMPLETED|Overall Study||0
8319549|NCT01431144|20512698|P1|NOT COMPLETED|Overall Study||2
8319550|NCT01431144|20512697|P2|COMPLETED|Overall Study||14
8319551|NCT01431144|20512698|P1|COMPLETED|Overall Study||11
8319552|NCT01431144|20512697|P2|STARTED|Overall Study||14
8319553|NCT01431144|20512698|P1|STARTED|Overall Study||13
8319554|NCT01431131|20512706|P2|NOT COMPLETED|Overall Study||0
8319555|NCT01431131|20512707|P1|NOT COMPLETED|Overall Study||0
8319556|NCT01431131|20512706|P2|COMPLETED|Overall Study||12
8319557|NCT01431131|20512707|P1|COMPLETED|Overall Study||12
8319558|NCT01431131|20512706|P2|STARTED|Overall Study||12
8319559|NCT01431131|20512707|P1|STARTED|Overall Study||12
8319560|NCT01431105|20512715|P1|NOT COMPLETED|Overall Study||0
8319561|NCT01431105|20512715|P1|COMPLETED|Overall Study||34
8319562|NCT01431105|20512715|P1|STARTED|Overall Study||34
8319563|NCT01431079|20512721|P2|NOT COMPLETED|Overall Study||39
8319564|NCT01431079|20512722|P1|NOT COMPLETED|Overall Study||35
8319565|NCT01431079|20512721|P2|COMPLETED|Overall Study||6
8319566|NCT01431079|20512722|P1|COMPLETED|Overall Study||10
8319567|NCT01431079|20512721|P2|Post-test|Overall Study||45
8319568|NCT01431079|20512722|P1|Post-test|Overall Study||45
8319569|NCT01431079|20512721|P2|STARTED|Overall Study||45
8319570|NCT01431079|20512722|P1|STARTED|Overall Study||45
8319571|NCT01431014|20512776|P2|NOT COMPLETED|Overall Study||9
8319572|NCT01431014|20512777|P1|NOT COMPLETED|Overall Study||3
8319573|NCT01431014|20512776|P2|COMPLETED|Overall Study||25
8319574|NCT01431014|20512777|P1|COMPLETED|Overall Study||31
8319575|NCT01431014|20512776|P2|STARTED|Overall Study||34
8319576|NCT01431014|20512777|P1|STARTED|Overall Study||34
8319577|NCT01430819|20512785|P2|NOT COMPLETED|Overall Study||0
8319578|NCT01430819|20512786|P1|NOT COMPLETED|Overall Study||0
8319579|NCT01430819|20512785|P2|COMPLETED|Overall Study||150
8319580|NCT01430819|20512786|P1|COMPLETED|Overall Study||150
8319581|NCT01430819|20512785|P2|STARTED|Overall Study||150
8319582|NCT01430819|20512786|P1|STARTED|Overall Study||150
8319583|NCT01430754|20512801|P2|NOT COMPLETED|Randomized Phase||0
8319584|NCT01430754|20512802|P1|NOT COMPLETED|Randomized Phase||0
8319585|NCT01430754|20512801|P2|COMPLETED|Randomized Phase||10
8319586|NCT01430754|20512802|P1|COMPLETED|Randomized Phase||10
8319587|NCT01430754|20512801|P2|STARTED|Randomized Phase||10
8319588|NCT01430754|20512802|P1|STARTED|Randomized Phase||10
8319589|NCT01430754|20512801|P2|NOT COMPLETED|Run-In Phase||0
8319590|NCT01430754|20512802|P1|NOT COMPLETED|Run-In Phase||37
8319591|NCT01430754|20512801|P2|COMPLETED|Run-In Phase||0
8319592|NCT01430754|20512802|P1|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
8319593|NCT01430754|20512801|P2|Entrained - After Run-In Phase|Run-In Phase||0
8319594|NCT01430754|20512802|P1|Entrained - After Run-In Phase|Run-In Phase||24
8319595|NCT01430754|20512801|P2|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
8319596|NCT01430754|20512802|P1|STARTED|Run-In Phase||57
8319597|NCT01430741|20512824|P4|NOT COMPLETED|Overall Study||0
8319598|NCT01430741|20512825|P3|NOT COMPLETED|Overall Study||10
8319599|NCT01430741|20512826|P2|NOT COMPLETED|Overall Study||0
8319600|NCT01430741|20512827|P1|NOT COMPLETED|Overall Study||0
8319601|NCT01430741|20512824|P4|COMPLETED|Overall Study||81
8319602|NCT01430741|20512825|P3|COMPLETED|Overall Study||37
8319603|NCT01430741|20512826|P2|COMPLETED|Overall Study||87
8319604|NCT01430741|20512827|P1|COMPLETED|Overall Study||22
8319605|NCT01430741|20512824|P4|STARTED|Overall Study||81
8319606|NCT01430741|20512825|P3|STARTED|Overall Study||47
8319607|NCT01430741|20512826|P2|STARTED|Overall Study||87
8319608|NCT01430741|20512827|P1|STARTED|Overall Study||22
8319609|NCT01430624|20512860|P3|NOT COMPLETED|Overall Study||29
8319610|NCT01430624|20512861|P2|NOT COMPLETED|Overall Study||34
8319611|NCT01430624|20512862|P1|NOT COMPLETED|Overall Study||28
8319612|NCT01430624|20512860|P3|COMPLETED|Overall Study|Completed one or more follow-ups|52
8319613|NCT01430624|20512861|P2|COMPLETED|Overall Study|Completed one or more follow-ups|48
8319614|NCT01430624|20512862|P1|COMPLETED|Overall Study|Completed one or more follow-ups|54
8319615|NCT01430624|20512860|P3|Eligible Baseline Completes|Overall Study||79
8319616|NCT01430624|20512861|P2|Eligible Baseline Completes|Overall Study||77
8319617|NCT01430624|20512862|P1|Eligible Baseline Completes|Overall Study||77
8319618|NCT01430624|20512860|P3|STARTED|Overall Study||81
8319619|NCT01430624|20512861|P2|STARTED|Overall Study||82
8319620|NCT01430624|20512862|P1|STARTED|Overall Study|Initial potential eligible screened enrolled|82
8319621|NCT01430611|20512893|P2|NOT COMPLETED|Overall Study||15
8319622|NCT01430611|20512894|P1|NOT COMPLETED|Overall Study||17
8319623|NCT01430611|20512893|P2|COMPLETED|Overall Study||318
8319624|NCT01430611|20512894|P1|COMPLETED|Overall Study||315
8319625|NCT01430611|20512893|P2|STARTED|Overall Study||333
8319626|NCT01430611|20512894|P1|STARTED|Overall Study||332
8319627|NCT01430585|20512912|P1|NOT COMPLETED|Overall Study||14
8319628|NCT01430585|20512912|P1|COMPLETED|Overall Study||0
8319629|NCT01430585|20512912|P1|STARTED|Overall Study||14
8319630|NCT01430559|20512947|P2|NOT COMPLETED|Overall Study||12
8319631|NCT01430559|20512948|P1|NOT COMPLETED|Overall Study||20
8319632|NCT01430559|20512947|P2|COMPLETED|Overall Study||135
8319633|NCT01430559|20512948|P1|COMPLETED|Overall Study||126
8319634|NCT01430559|20512947|P2|Treated|Overall Study||144
8319635|NCT01430559|20512948|P1|Treated|Overall Study||143
8319636|NCT01430559|20512947|P2|STARTED|Overall Study||147
8319637|NCT01430559|20512948|P1|STARTED|Overall Study||146
8319638|NCT01430468|20512984|P2|NOT COMPLETED|Overall Study||6
8319639|NCT01430468|20512985|P1|NOT COMPLETED|Overall Study||7
8319640|NCT01430468|20512984|P2|COMPLETED|Overall Study||16
8319641|NCT01430468|20512985|P1|COMPLETED|Overall Study||15
8319642|NCT01430468|20512984|P2|STARTED|Overall Study||22
8319643|NCT01430468|20512985|P1|STARTED|Overall Study||22
8319644|NCT01430455|20512993|P1|NOT COMPLETED|Overall Study||2
8319645|NCT01430455|20512993|P1|COMPLETED|Overall Study||5
8319646|NCT01430455|20512993|P1|STARTED|Overall Study||7
8319647|NCT01430442|20513005|P8|NOT COMPLETED|Overall Study||9
8319648|NCT01430442|20513006|P7|NOT COMPLETED|Overall Study||19
8319649|NCT01430442|20513007|P6|NOT COMPLETED|Overall Study||8
8319650|NCT01430442|20513008|P5|NOT COMPLETED|Overall Study||9
8319651|NCT01430442|20513009|P4|NOT COMPLETED|Overall Study||4
8319652|NCT01430442|20513010|P3|NOT COMPLETED|Overall Study||5
8319653|NCT01430442|20513011|P2|NOT COMPLETED|Overall Study||6
8319654|NCT01430442|20513012|P1|NOT COMPLETED|Overall Study||13
8319655|NCT01430442|20513005|P8|COMPLETED|Overall Study||100
8319656|NCT01430442|20513006|P7|COMPLETED|Overall Study||210
8319657|NCT01430442|20513007|P6|COMPLETED|Overall Study||84
8319658|NCT01430442|20513008|P5|COMPLETED|Overall Study||112
8319659|NCT01430442|20513009|P4|COMPLETED|Overall Study||86
8319660|NCT01430442|20513010|P3|COMPLETED|Overall Study||86
8319661|NCT01430442|20513011|P2|COMPLETED|Overall Study||62
8319662|NCT01430442|20513012|P1|COMPLETED|Overall Study||72
8319663|NCT01430442|20513005|P8|STARTED|Overall Study||109
8319664|NCT01430442|20513006|P7|STARTED|Overall Study||229
8319665|NCT01430442|20513007|P6|STARTED|Overall Study||92
8319666|NCT01430442|20513008|P5|STARTED|Overall Study||121
8319667|NCT01430442|20513009|P4|STARTED|Overall Study||90
8319668|NCT01430442|20513010|P3|STARTED|Overall Study||91
8319669|NCT01430442|20513011|P2|STARTED|Overall Study||68
8319670|NCT01430442|20513012|P1|STARTED|Overall Study||85
8319671|NCT01430403|20513065|P3|NOT COMPLETED|Overall Study||8
8319672|NCT01430403|20513066|P2|NOT COMPLETED|Overall Study||9
8319673|NCT01430403|20513067|P1|NOT COMPLETED|Overall Study||17
8319674|NCT01430403|20513065|P3|COMPLETED|Overall Study||81
8319675|NCT01430403|20513066|P2|COMPLETED|Overall Study||121
8319676|NCT01430403|20513067|P1|COMPLETED|Overall Study||242
8319677|NCT01430403|20513065|P3|STARTED|Overall Study|Intent-to-treat|89
8319678|NCT01430403|20513066|P2|STARTED|Overall Study|Intent-to-treat|130
8319679|NCT01430403|20513067|P1|STARTED|Overall Study|Intent-to-treat|259
8319680|NCT01430325|20513120|P4|NOT COMPLETED|Overall Study||0
8319681|NCT01430325|20513121|P3|NOT COMPLETED|Overall Study||0
8319682|NCT01430325|20513122|P2|NOT COMPLETED|Overall Study||0
8319683|NCT01430325|20513123|P1|NOT COMPLETED|Overall Study||0
8319684|NCT01430325|20513120|P4|COMPLETED|Overall Study||12
8319685|NCT01430325|20513121|P3|COMPLETED|Overall Study||8
8319686|NCT01430325|20513122|P2|COMPLETED|Overall Study||12
8319687|NCT01430325|20513123|P1|COMPLETED|Overall Study||10
8319688|NCT01430325|20513120|P4|STARTED|Overall Study||12
8319689|NCT01430325|20513121|P3|STARTED|Overall Study||8
8319690|NCT01430325|20513122|P2|STARTED|Overall Study||12
8319691|NCT01430325|20513123|P1|STARTED|Overall Study||10
8319692|NCT01430299|20513143|P2|NOT COMPLETED|Overall Study||2
8319693|NCT01430299|20513144|P1|NOT COMPLETED|Overall Study||4
8319694|NCT01430299|20513143|P2|COMPLETED|Overall Study||21
8319695|NCT01430299|20513144|P1|COMPLETED|Overall Study||16
8319696|NCT01430299|20513143|P2|STARTED|Overall Study||23
8319697|NCT01430299|20513144|P1|STARTED|Overall Study||20
8319698|NCT01430182|20513152|P2|NOT COMPLETED|Overall Study||0
8319699|NCT01430182|20513153|P1|NOT COMPLETED|Overall Study||0
8319700|NCT01430182|20513152|P2|COMPLETED|Overall Study||8
8319701|NCT01430182|20513153|P1|COMPLETED|Overall Study||9
8319702|NCT01430182|20513152|P2|STARTED|Overall Study||8
8319703|NCT01430182|20513153|P1|STARTED|Overall Study||9
8319704|NCT01430169|20513159|P1|NOT COMPLETED|Overall Study||0
8319705|NCT01430169|20513159|P1|COMPLETED|Overall Study||20
8319706|NCT01430169|20513159|P1|STARTED|Overall Study||20
8319707|NCT01430130|20513174|P1|NOT COMPLETED|Overall Study||2
8319708|NCT01430130|20513174|P1|COMPLETED|Overall Study||10
8319709|NCT01430130|20513174|P1|STARTED|Overall Study||12
8319710|NCT01430104|20513180|P1|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
8319711|NCT01430104|20513180|P1|COMPLETED|28-Day Teriparatide Treatment Period||28
8319712|NCT01430104|20513180|P1|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
8319713|NCT01430104|20513180|P1|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
8319714|NCT01430104|20513180|P1|NOT COMPLETED|14-Day Lead-In Period||0
8319715|NCT01430104|20513180|P1|COMPLETED|14-Day Lead-In Period||30
8319716|NCT01430104|20513180|P1|STARTED|14-Day Lead-In Period||30
8319717|NCT01430091|20513192|P1|NOT COMPLETED|Overall Study||0
8319718|NCT01430091|20513192|P1|COMPLETED|Overall Study||18
8319719|NCT01430091|20513192|P1|STARTED|Overall Study||18
8319720|NCT01429987|20513218|P4|NOT COMPLETED|Overall Study||66
8319721|NCT01429987|20513219|P3|NOT COMPLETED|Overall Study||36
8319722|NCT01429987|20513220|P2|NOT COMPLETED|Overall Study||62
8319723|NCT01429987|20513221|P1|NOT COMPLETED|Overall Study||49
8319724|NCT01429987|20513218|P4|COMPLETED|Overall Study||171
8319725|NCT01429987|20513219|P3|COMPLETED|Overall Study||202
8319726|NCT01429987|20513220|P2|COMPLETED|Overall Study||176
8319727|NCT01429987|20513221|P1|COMPLETED|Overall Study||189
8319728|NCT01429987|20513218|P4|STARTED|Overall Study||237
8319729|NCT01429987|20513219|P3|STARTED|Overall Study||238
8319730|NCT01429987|20513220|P2|STARTED|Overall Study||238
8319731|NCT01429987|20513221|P1|STARTED|Overall Study||238
8319732|NCT01429792|20513247|P1|NOT COMPLETED|Overall Study||406
8319733|NCT01429792|20513247|P1|COMPLETED|Overall Study||607
8319734|NCT01429792|20513247|P1|Genotype 4|Overall Study||5
8319735|NCT01429792|20513247|P1|Genotype 2 & 3|Overall Study||305
8319736|NCT01429792|20513247|P1|Genotype 1|Overall Study||687
8319737|NCT01429792|20513247|P1|STARTED|Overall Study||1013
8319738|NCT01429623|20513261|P2|NOT COMPLETED|Overall Study||59
8319739|NCT01429623|20513262|P1|NOT COMPLETED|Overall Study||51
8319740|NCT01429623|20513261|P2|COMPLETED|Overall Study||48
8319741|NCT01429623|20513262|P1|COMPLETED|Overall Study||51
8319742|NCT01429623|20513261|P2|Converted to Alzheimer's|Overall Study|21 of 103|21
8319743|NCT01429623|20513262|P1|Converted to Alzheimer's|Overall Study|14 of 99|14
8319744|NCT01429623|20513261|P2|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
8319745|NCT01429623|20513262|P1|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
8319746|NCT01429584|20513276|P2|NOT COMPLETED|Overall Study||1
8319747|NCT01429584|20513277|P1|NOT COMPLETED|Overall Study||1
8319748|NCT01429584|20513276|P2|COMPLETED|Overall Study||14
8319749|NCT01429584|20513277|P1|COMPLETED|Overall Study||14
8319750|NCT01429584|20513276|P2|STARTED|Overall Study||15
8319751|NCT01429584|20513277|P1|STARTED|Overall Study||15
8319752|NCT01429532|20513290|P3|NOT COMPLETED|Overall Study||0
8319753|NCT01429532|20513291|P2|NOT COMPLETED|Overall Study||0
8319754|NCT01429532|20513292|P1|NOT COMPLETED|Overall Study||0
8319755|NCT01429532|20513290|P3|COMPLETED|Overall Study||40
8319756|NCT01429532|20513291|P2|COMPLETED|Overall Study||40
8319757|NCT01429532|20513292|P1|COMPLETED|Overall Study||40
8319758|NCT01429532|20513290|P3|STARTED|Overall Study||40
8319759|NCT01429532|20513291|P2|STARTED|Overall Study||40
8319760|NCT01429532|20513292|P1|STARTED|Overall Study||40
8319767|NCT01429441|20513319|P2|NOT COMPLETED|Overall Study||23
8319768|NCT01429441|20513320|P1|NOT COMPLETED|Overall Study||38
8319769|NCT01429441|20513319|P2|COMPLETED|Overall Study||51
8319770|NCT01429441|20513320|P1|COMPLETED|Overall Study||108
8319771|NCT01429441|20513319|P2|STARTED|Overall Study||74
8319772|NCT01429441|20513320|P1|STARTED|Overall Study||146
8319773|NCT01429350|20513330|P2|NOT COMPLETED|Overall Study||5
8319774|NCT01429350|20513331|P1|NOT COMPLETED|Overall Study||7
8319775|NCT01429350|20513330|P2|COMPLETED|Overall Study||50
8319776|NCT01429350|20513331|P1|COMPLETED|Overall Study||46
8319777|NCT01429350|20513330|P2|90 Day|Overall Study||50
8319778|NCT01429350|20513331|P1|90 Day|Overall Study||46
8319779|NCT01429350|20513330|P2|Per Protocol|Overall Study||37
8319780|NCT01429350|20513331|P1|Per Protocol|Overall Study||41
8319781|NCT01429350|20513330|P2|As-Treated|Overall Study||43
8319782|NCT01429350|20513331|P1|As-Treated|Overall Study||62
8319783|NCT01429350|20513330|P2|STARTED|Overall Study||55
8319784|NCT01429350|20513331|P1|STARTED|Overall Study||53
8319785|NCT01429298|20513345|P2|NOT COMPLETED|Overall Study||6
8319786|NCT01429298|20513346|P1|NOT COMPLETED|Overall Study||4
8319787|NCT01429298|20513345|P2|COMPLETED|Overall Study||169
8319788|NCT01429298|20513346|P1|COMPLETED|Overall Study||171
8319789|NCT01429298|20513345|P2|Given IV Opioids|Overall Study|6 never given IV opioids|169
8319790|NCT01429298|20513346|P1|Given IV Opioids|Overall Study|4 never given IV opioids|171
8319791|NCT01429298|20513345|P2|STARTED|Overall Study||175
8319792|NCT01429298|20513346|P1|STARTED|Overall Study||175
8319793|NCT01429285|20513362|P2|NOT COMPLETED|Overall Study||9
8319794|NCT01429285|20513363|P1|NOT COMPLETED|Overall Study||22
8319795|NCT01429285|20513362|P2|COMPLETED|Overall Study||166
8319796|NCT01429285|20513363|P1|COMPLETED|Overall Study||153
8319797|NCT01429285|20513362|P2|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
8319886|NCT01428453|20513525|P1|NOT COMPLETED|Overall Study||6
8319887|NCT01428453|20513524|P2|COMPLETED|Overall Study||52
8319798|NCT01429285|20513363|P1|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
8319799|NCT01429285|20513362|P2|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
8319800|NCT01429285|20513363|P1|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
8319801|NCT01429285|20513362|P2|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
8319802|NCT01429285|20513363|P1|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
8319803|NCT01429285|20513362|P2|STARTED|Overall Study||175
8319804|NCT01429285|20513363|P1|STARTED|Overall Study||175
8319805|NCT01429272|20513385|P4|NOT COMPLETED|Overall Study||5
8319806|NCT01429272|20513386|P3|NOT COMPLETED|Overall Study||4
8319807|NCT01429272|20513387|P2|NOT COMPLETED|Overall Study||9
8319808|NCT01429272|20513388|P1|NOT COMPLETED|Overall Study||6
8319809|NCT01429272|20513385|P4|COMPLETED|Overall Study||14
8319810|NCT01429272|20513386|P3|COMPLETED|Overall Study||15
8319811|NCT01429272|20513387|P2|COMPLETED|Overall Study||22
8319812|NCT01429272|20513388|P1|COMPLETED|Overall Study||24
8319813|NCT01429272|20513385|P4|STARTED|Overall Study||19
8319814|NCT01429272|20513386|P3|STARTED|Overall Study||19
8319815|NCT01429272|20513387|P2|STARTED|Overall Study||31
8319816|NCT01429272|20513388|P1|STARTED|Overall Study||30
8319817|NCT01429259|20513402|P1|NOT COMPLETED|Overall Study||0
8319818|NCT01429259|20513402|P1|COMPLETED|Overall Study||30
8319819|NCT01429259|20513402|P1|STARTED|Overall Study||30
8319820|NCT01429077|20513409|P2|NOT COMPLETED|Overall Study||3
8319821|NCT01429077|20513410|P1|NOT COMPLETED|Overall Study||0
8319822|NCT01429077|20513409|P2|COMPLETED|Overall Study||14
8319823|NCT01429077|20513410|P1|COMPLETED|Overall Study||19
8319824|NCT01429077|20513409|P2|Completed 6-week Intervention|Overall Study||17
8319825|NCT01429077|20513410|P1|Completed 6-week Intervention|Overall Study||19
8319826|NCT01429077|20513409|P2|STARTED|Overall Study||17
8319827|NCT01429077|20513410|P1|STARTED|Overall Study||19
8319828|NCT01429064|20513420|P4|NOT COMPLETED|Overall Study||0
8319829|NCT01429064|20513421|P3|NOT COMPLETED|Overall Study||0
8319830|NCT01429064|20513422|P2|NOT COMPLETED|Overall Study||0
8319831|NCT01429064|20513423|P1|NOT COMPLETED|Overall Study||0
8319832|NCT01429064|20513420|P4|COMPLETED|Overall Study||16
8319833|NCT01429064|20513421|P3|COMPLETED|Overall Study||19
8319834|NCT01429064|20513422|P2|COMPLETED|Overall Study||22
8319835|NCT01429064|20513423|P1|COMPLETED|Overall Study||19
8319836|NCT01429064|20513420|P4|STARTED|Overall Study||16
8319837|NCT01429064|20513421|P3|STARTED|Overall Study||19
8319838|NCT01429064|20513422|P2|STARTED|Overall Study||22
8319839|NCT01429064|20513423|P1|STARTED|Overall Study||19
8319840|NCT01429051|20513433|P1|NOT COMPLETED|Tolerability Phase||15
8319841|NCT01429051|20513433|P1|COMPLETED|Tolerability Phase||16
8319842|NCT01429051|20513433|P1|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
8319843|NCT01429051|20513433|P1|NOT COMPLETED|Efficacy Phase||2
8319844|NCT01429051|20513433|P1|COMPLETED|Efficacy Phase||13
8319845|NCT01429051|20513433|P1|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
8319846|NCT01429051|20513433|P1|NOT COMPLETED|Titration Phase||12
8319847|NCT01429051|20513433|P1|COMPLETED|Titration Phase||33
8319848|NCT01429051|20513433|P1|STARTED|Titration Phase||45
8319849|NCT01428882|20513456|P2|NOT COMPLETED|Overall Study||10
8319850|NCT01428882|20513457|P1|NOT COMPLETED|Overall Study||6
8319851|NCT01428882|20513456|P2|COMPLETED|Overall Study||58
8319852|NCT01428882|20513457|P1|COMPLETED|Overall Study||61
8319853|NCT01428882|20513456|P2|STARTED|Overall Study||68
8319854|NCT01428882|20513457|P1|STARTED|Overall Study||67
8319855|NCT01428765|20513469|P1|NOT COMPLETED|Overall Study||0
8319856|NCT01428765|20513469|P1|COMPLETED|Overall Study||1063
8319857|NCT01428765|20513469|P1|STARTED|Overall Study||1063
8319858|NCT01428713|20513480|P2|NOT COMPLETED|Overall Study||5
8319859|NCT01428713|20513481|P1|NOT COMPLETED|Overall Study||3
8319860|NCT01428713|20513480|P2|COMPLETED|Overall Study||3
8319861|NCT01428713|20513481|P1|COMPLETED|Overall Study||6
8319862|NCT01428713|20513480|P2|STARTED|Overall Study||8
8319863|NCT01428713|20513481|P1|STARTED|Overall Study||9
8319864|NCT01428661|20513490|P3|NOT COMPLETED|Open Label Extension||320
8319865|NCT01428661|20513491|P2|NOT COMPLETED|Open Label Extension||0
8319866|NCT01428661|20513492|P1|NOT COMPLETED|Open Label Extension||0
8319867|NCT01428661|20513490|P3|COMPLETED|Open Label Extension||19
8319868|NCT01428661|20513491|P2|COMPLETED|Open Label Extension|Does not apply.|0
8319869|NCT01428661|20513492|P1|COMPLETED|Open Label Extension|Does not apply.|0
8319870|NCT01428661|20513490|P3|STARTED|Open Label Extension||339
8319871|NCT01428661|20513491|P2|STARTED|Open Label Extension|Does not apply.|0
8319872|NCT01428661|20513492|P1|STARTED|Open Label Extension|Does not apply.|0
8319873|NCT01428661|20513490|P3|NOT COMPLETED|Double-Masked Phase||0
8319874|NCT01428661|20513491|P2|NOT COMPLETED|Double-Masked Phase||49
8319875|NCT01428661|20513492|P1|NOT COMPLETED|Double-Masked Phase||57
8319876|NCT01428661|20513490|P3|COMPLETED|Double-Masked Phase|Does not apply.|0
8319877|NCT01428661|20513491|P2|COMPLETED|Double-Masked Phase||204
8319878|NCT01428661|20513492|P1|COMPLETED|Double-Masked Phase||197
8319879|NCT01428661|20513490|P3|STARTED|Double-Masked Phase|Does not apply.|0
8319880|NCT01428661|20513491|P2|STARTED|Double-Masked Phase||253
8319881|NCT01428661|20513492|P1|STARTED|Double-Masked Phase||254
8319882|NCT01428583|20513500|P1|NOT COMPLETED|Overall Study||237
8319883|NCT01428583|20513500|P1|COMPLETED|Overall Study||158
8319884|NCT01428583|20513500|P1|STARTED|Overall Study||395
8319885|NCT01428453|20513524|P2|NOT COMPLETED|Overall Study||9
8319888|NCT01428453|20513525|P1|COMPLETED|Overall Study||56
8319889|NCT01428453|20513524|P2|STARTED|Overall Study||61
8319890|NCT01428453|20513525|P1|STARTED|Overall Study||62
8319891|NCT01428336|20513551|P2|NOT COMPLETED|Overall Study||0
8319892|NCT01428336|20513552|P1|NOT COMPLETED|Overall Study||0
8319893|NCT01428336|20513551|P2|COMPLETED|Overall Study||12
8319894|NCT01428336|20513552|P1|COMPLETED|Overall Study||10
8319895|NCT01428336|20513551|P2|STARTED|Overall Study||12
8319896|NCT01428336|20513552|P1|STARTED|Overall Study||10
8319897|NCT01428258|20513564|P2|NOT COMPLETED|Intervention 2||0
8319898|NCT01428258|20513565|P1|NOT COMPLETED|Intervention 2||0
8319899|NCT01428258|20513564|P2|COMPLETED|Intervention 2||15
8319900|NCT01428258|20513565|P1|COMPLETED|Intervention 2||15
8319901|NCT01428258|20513564|P2|STARTED|Intervention 2||15
8319902|NCT01428258|20513565|P1|STARTED|Intervention 2||15
8319903|NCT01428258|20513564|P2|NOT COMPLETED|Intervention 1||0
8319904|NCT01428258|20513565|P1|NOT COMPLETED|Intervention 1||2
8319905|NCT01428258|20513564|P2|COMPLETED|Intervention 1||15
8319906|NCT01428258|20513565|P1|COMPLETED|Intervention 1||15
8319907|NCT01428258|20513564|P2|STARTED|Intervention 1||15
8319908|NCT01428258|20513565|P1|STARTED|Intervention 1||17
8319909|NCT01428245|20513583|P1|NOT COMPLETED|Overall Study||0
8319910|NCT01428245|20513583|P1|COMPLETED|Overall Study||1
8319911|NCT01428245|20513583|P1|STARTED|Overall Study||1
8319912|NCT01428219|20513587|P1|NOT COMPLETED|Overall Study||3
8319913|NCT01428219|20513587|P1|COMPLETED|Overall Study||22
8319914|NCT01428219|20513587|P1|STARTED|Overall Study||25
8319915|NCT01428193|20513598|P1|NOT COMPLETED|Overall Study||2
8319916|NCT01428193|20513598|P1|COMPLETED|Overall Study||2
8319917|NCT01428193|20513598|P1|STARTED|Overall Study||4
8319918|NCT01428128|20513602|P1|NOT COMPLETED|Overall Study||17
8319919|NCT01428128|20513602|P1|COMPLETED|Overall Study||33
8319920|NCT01428128|20513602|P1|STARTED|Overall Study||50
8319921|NCT01428115|20513607|P1|NOT COMPLETED|Overall Study||21
8319922|NCT01428115|20513607|P1|COMPLETED|Overall Study||62
8319923|NCT01428115|20513607|P1|STARTED|Overall Study||83
8319930|NCT01428063|20513634|P3|NOT COMPLETED|Overall Study||1
8319931|NCT01428063|20513635|P2|NOT COMPLETED|Overall Study||10
8319932|NCT01428063|20513636|P1|NOT COMPLETED|Overall Study||10
8319933|NCT01428063|20513634|P3|COMPLETED|Overall Study||5
8319934|NCT01428063|20513635|P2|COMPLETED|Overall Study||112
8319935|NCT01428063|20513636|P1|COMPLETED|Overall Study||89
8319936|NCT01428063|20513634|P3|STARTED|Overall Study||6
8319937|NCT01428063|20513635|P2|STARTED|Overall Study||122
8319938|NCT01428063|20513636|P1|STARTED|Overall Study||99
8319939|NCT01428024|20513707|P2|NOT COMPLETED|Overall Study||1
8319940|NCT01428024|20513708|P1|NOT COMPLETED|Overall Study||1
8319941|NCT01428024|20513707|P2|COMPLETED|Overall Study||29
8319942|NCT01428024|20513708|P1|COMPLETED|Overall Study||29
8319943|NCT01428024|20513707|P2|STARTED|Overall Study||30
8319944|NCT01428024|20513708|P1|STARTED|Overall Study||30
8319945|NCT01427972|20513737|P12|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319946|NCT01427972|20513738|P11|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319947|NCT01427972|20513739|P10|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319948|NCT01427972|20513740|P9|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319949|NCT01427972|20513741|P8|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319950|NCT01427972|20513742|P7|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319951|NCT01427972|20513743|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319952|NCT01427972|20513744|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319953|NCT01427972|20513745|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319954|NCT01427972|20513746|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319955|NCT01427972|20513747|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||1
8319956|NCT01427972|20513748|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
8319957|NCT01427972|20513737|P12|COMPLETED|Treatment Period 2 (21 Days)||4
8319958|NCT01427972|20513738|P11|COMPLETED|Treatment Period 2 (21 Days)||3
8319959|NCT01427972|20513739|P10|COMPLETED|Treatment Period 2 (21 Days)||3
8319960|NCT01427972|20513740|P9|COMPLETED|Treatment Period 2 (21 Days)||3
8319961|NCT01427972|20513741|P8|COMPLETED|Treatment Period 2 (21 Days)||4
8319962|NCT01427972|20513742|P7|COMPLETED|Treatment Period 2 (21 Days)||3
8319963|NCT01427972|20513743|P6|COMPLETED|Treatment Period 2 (21 Days)||1
8319964|NCT01427972|20513744|P5|COMPLETED|Treatment Period 2 (21 Days)||4
8319965|NCT01427972|20513745|P4|COMPLETED|Treatment Period 2 (21 Days)||3
8319966|NCT01427972|20513746|P3|COMPLETED|Treatment Period 2 (21 Days)||4
8319967|NCT01427972|20513747|P2|COMPLETED|Treatment Period 2 (21 Days)||3
8319968|NCT01427972|20513748|P1|COMPLETED|Treatment Period 2 (21 Days)||3
8319969|NCT01427972|20513737|P12|STARTED|Treatment Period 2 (21 Days)||4
8319970|NCT01427972|20513738|P11|STARTED|Treatment Period 2 (21 Days)||3
8319971|NCT01427972|20513739|P10|STARTED|Treatment Period 2 (21 Days)||3
8319972|NCT01427972|20513740|P9|STARTED|Treatment Period 2 (21 Days)||3
8319973|NCT01427972|20513741|P8|STARTED|Treatment Period 2 (21 Days)||4
8319974|NCT01427972|20513742|P7|STARTED|Treatment Period 2 (21 Days)||3
8319975|NCT01427972|20513743|P6|STARTED|Treatment Period 2 (21 Days)||1
8319976|NCT01427972|20513744|P5|STARTED|Treatment Period 2 (21 Days)||4
8319977|NCT01427972|20513745|P4|STARTED|Treatment Period 2 (21 Days)||3
8319978|NCT01427972|20513746|P3|STARTED|Treatment Period 2 (21 Days)||4
8319979|NCT01427972|20513747|P2|STARTED|Treatment Period 2 (21 Days)||4
8319980|NCT01427972|20513748|P1|STARTED|Treatment Period 2 (21 Days)||3
8319981|NCT01427972|20513737|P12|NOT COMPLETED|Washout (at Least 28 Days)||0
8319982|NCT01427972|20513738|P11|NOT COMPLETED|Washout (at Least 28 Days)||0
8319983|NCT01427972|20513739|P10|NOT COMPLETED|Washout (at Least 28 Days)||0
8319984|NCT01427972|20513740|P9|NOT COMPLETED|Washout (at Least 28 Days)||0
8319985|NCT01427972|20513741|P8|NOT COMPLETED|Washout (at Least 28 Days)||0
8319986|NCT01427972|20513742|P7|NOT COMPLETED|Washout (at Least 28 Days)||0
8319987|NCT01427972|20513743|P6|NOT COMPLETED|Washout (at Least 28 Days)||2
8319988|NCT01427972|20513744|P5|NOT COMPLETED|Washout (at Least 28 Days)||0
8319989|NCT01427972|20513745|P4|NOT COMPLETED|Washout (at Least 28 Days)||0
8319990|NCT01427972|20513746|P3|NOT COMPLETED|Washout (at Least 28 Days)||0
8319991|NCT01427972|20513747|P2|NOT COMPLETED|Washout (at Least 28 Days)||0
8319992|NCT01427972|20513748|P1|NOT COMPLETED|Washout (at Least 28 Days)||0
8319993|NCT01427972|20513737|P12|COMPLETED|Washout (at Least 28 Days)||4
8319994|NCT01427972|20513738|P11|COMPLETED|Washout (at Least 28 Days)||3
8319995|NCT01427972|20513739|P10|COMPLETED|Washout (at Least 28 Days)||3
8319996|NCT01427972|20513740|P9|COMPLETED|Washout (at Least 28 Days)||3
8319997|NCT01427972|20513741|P8|COMPLETED|Washout (at Least 28 Days)||4
8319998|NCT01427972|20513742|P7|COMPLETED|Washout (at Least 28 Days)||3
8319999|NCT01427972|20513743|P6|COMPLETED|Washout (at Least 28 Days)||1
8320000|NCT01427972|20513744|P5|COMPLETED|Washout (at Least 28 Days)||4
8320001|NCT01427972|20513745|P4|COMPLETED|Washout (at Least 28 Days)||3
8320002|NCT01427972|20513746|P3|COMPLETED|Washout (at Least 28 Days)||4
8320003|NCT01427972|20513747|P2|COMPLETED|Washout (at Least 28 Days)||4
8320004|NCT01427972|20513748|P1|COMPLETED|Washout (at Least 28 Days)||3
8320005|NCT01427972|20513737|P12|STARTED|Washout (at Least 28 Days)||4
8320006|NCT01427972|20513738|P11|STARTED|Washout (at Least 28 Days)||3
8320007|NCT01427972|20513739|P10|STARTED|Washout (at Least 28 Days)||3
8320008|NCT01427972|20513740|P9|STARTED|Washout (at Least 28 Days)||3
8320009|NCT01427972|20513741|P8|STARTED|Washout (at Least 28 Days)||4
8320010|NCT01427972|20513742|P7|STARTED|Washout (at Least 28 Days)||3
8320011|NCT01427972|20513743|P6|STARTED|Washout (at Least 28 Days)||3
8320012|NCT01427972|20513744|P5|STARTED|Washout (at Least 28 Days)||4
8320013|NCT01427972|20513745|P4|STARTED|Washout (at Least 28 Days)||3
8320014|NCT01427972|20513746|P3|STARTED|Washout (at Least 28 Days)||4
8320015|NCT01427972|20513747|P2|STARTED|Washout (at Least 28 Days)||4
8320016|NCT01427972|20513748|P1|STARTED|Washout (at Least 28 Days)||3
8320017|NCT01427972|20513737|P12|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320018|NCT01427972|20513738|P11|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320019|NCT01427972|20513739|P10|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320020|NCT01427972|20513740|P9|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320021|NCT01427972|20513741|P8|NOT COMPLETED|Treatment Period 1 (21 Days)||1
8320022|NCT01427972|20513742|P7|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320023|NCT01427972|20513743|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320024|NCT01427972|20513744|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320025|NCT01427972|20513745|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320026|NCT01427972|20513746|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320027|NCT01427972|20513747|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320028|NCT01427972|20513748|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
8320029|NCT01427972|20513737|P12|COMPLETED|Treatment Period 1 (21 Days)||4
8320030|NCT01427972|20513738|P11|COMPLETED|Treatment Period 1 (21 Days)||3
8320031|NCT01427972|20513739|P10|COMPLETED|Treatment Period 1 (21 Days)||3
8320032|NCT01427972|20513740|P9|COMPLETED|Treatment Period 1 (21 Days)||3
8320033|NCT01427972|20513741|P8|COMPLETED|Treatment Period 1 (21 Days)||4
8320034|NCT01427972|20513742|P7|COMPLETED|Treatment Period 1 (21 Days)||3
8320035|NCT01427972|20513743|P6|COMPLETED|Treatment Period 1 (21 Days)||3
8320036|NCT01427972|20513744|P5|COMPLETED|Treatment Period 1 (21 Days)||4
8320037|NCT01427972|20513745|P4|COMPLETED|Treatment Period 1 (21 Days)||3
8320038|NCT01427972|20513746|P3|COMPLETED|Treatment Period 1 (21 Days)||4
8320039|NCT01427972|20513747|P2|COMPLETED|Treatment Period 1 (21 Days)||4
8320040|NCT01427972|20513748|P1|COMPLETED|Treatment Period 1 (21 Days)||3
8320041|NCT01427972|20513737|P12|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
8320042|NCT01427972|20513738|P11|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8320043|NCT01427972|20513739|P10|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8320044|NCT01427972|20513740|P9|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8320045|NCT01427972|20513741|P8|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5
8320046|NCT01427972|20513742|P7|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8320047|NCT01427972|20513743|P6|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8320048|NCT01427972|20513744|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
8320049|NCT01427972|20513745|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8320050|NCT01427972|20513746|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
8320051|NCT01427972|20513747|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
8320052|NCT01427972|20513748|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
8320053|NCT01427972|20513737|P12|STARTED|Treatment Period 1 (21 Days)||4
8320054|NCT01427972|20513738|P11|STARTED|Treatment Period 1 (21 Days)||3
8320055|NCT01427972|20513739|P10|STARTED|Treatment Period 1 (21 Days)||3
8320056|NCT01427972|20513740|P9|STARTED|Treatment Period 1 (21 Days)||3
8320057|NCT01427972|20513741|P8|STARTED|Treatment Period 1 (21 Days)||5
8320058|NCT01427972|20513742|P7|STARTED|Treatment Period 1 (21 Days)||3
8320059|NCT01427972|20513743|P6|STARTED|Treatment Period 1 (21 Days)||3
8320060|NCT01427972|20513744|P5|STARTED|Treatment Period 1 (21 Days)||4
8320061|NCT01427972|20513745|P4|STARTED|Treatment Period 1 (21 Days)||3
8320062|NCT01427972|20513746|P3|STARTED|Treatment Period 1 (21 Days)||4
8320063|NCT01427972|20513747|P2|STARTED|Treatment Period 1 (21 Days)||4
8320064|NCT01427972|20513748|P1|STARTED|Treatment Period 1 (21 Days)||3
8320065|NCT01427933|20513774|P2|NOT COMPLETED|Overall Study||13
8320066|NCT01427933|20513775|P1|NOT COMPLETED|Overall Study||8
8320067|NCT01427933|20513774|P2|COMPLETED|Overall Study||57
8320068|NCT01427933|20513775|P1|COMPLETED|Overall Study||63
8320069|NCT01427933|20513774|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
8320070|NCT01427933|20513775|P1|Received at Least 1 Dose of Study Drug|Overall Study||69
8320071|NCT01427933|20513774|P2|STARTED|Overall Study||70
8320072|NCT01427933|20513775|P1|STARTED|Overall Study||71
8320073|NCT01427920|20513795|P2|NOT COMPLETED|Overall Study||17
8320074|NCT01427920|20513796|P1|NOT COMPLETED|Overall Study||9
8320075|NCT01427920|20513795|P2|COMPLETED|Overall Study||157
8320076|NCT01427920|20513796|P1|COMPLETED|Overall Study||165
8320077|NCT01427920|20513795|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
8320078|NCT01427920|20513796|P1|Exposed|Overall Study||174
8320079|NCT01427920|20513795|P2|STARTED|Overall Study||174
8320080|NCT01427920|20513796|P1|STARTED|Overall Study||174
8320081|NCT01427907|20513816|P2|NOT COMPLETED|Overall Study||4
8320082|NCT01427907|20513817|P1|NOT COMPLETED|Overall Study||3
8320083|NCT01427907|20513816|P2|COMPLETED|Overall Study|Completed study|14
8320084|NCT01427907|20513817|P1|COMPLETED|Overall Study|Completed study|17
8320085|NCT01427907|20513816|P2|STARTED|Overall Study|Randomized|18
8320086|NCT01427907|20513817|P1|STARTED|Overall Study|Randomized|20
8320087|NCT01427881|20513823|P1|NOT COMPLETED|Overall Study||0
8320088|NCT01427881|20513823|P1|COMPLETED|Overall Study||43
8320089|NCT01427881|20513823|P1|STARTED|Overall Study||43
8320090|NCT01427803|20513838|P2|NOT COMPLETED|Overall Study||26
8320091|NCT01427803|20513839|P1|NOT COMPLETED|Overall Study||63
8320092|NCT01427803|20513838|P2|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
8320093|NCT01427803|20513839|P1|COMPLETED|Overall Study||463
8320094|NCT01427803|20513838|P2|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
8320095|NCT01427803|20513839|P1|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
8320096|NCT01427803|20513838|P2|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
8320097|NCT01427803|20513839|P1|Baseline Assessment|Overall Study||516
8320098|NCT01427803|20513838|P2|Purchased Product|Overall Study||252
8320099|NCT01427803|20513839|P1|Purchased Product|Overall Study|Only 516 participants used e-diary|525
8320100|NCT01427803|20513838|P2|STARTED|Overall Study||252
8320101|NCT01427803|20513839|P1|STARTED|Overall Study||526
8320102|NCT01427751|20513853|P2|NOT COMPLETED|Overall Study||14
8320103|NCT01427751|20513854|P1|NOT COMPLETED|Overall Study||42
8320104|NCT01427751|20513853|P2|COMPLETED|Overall Study||139
8320105|NCT01427751|20513854|P1|COMPLETED|Overall Study||112
8320106|NCT01427751|20513853|P2|STARTED|Overall Study||153
8320107|NCT01427751|20513854|P1|STARTED|Overall Study||154
8320108|NCT01427738|20513874|P2|NOT COMPLETED|Overall Study||21
8320109|NCT01427738|20513875|P1|NOT COMPLETED|Overall Study||19
8320110|NCT01427738|20513874|P2|COMPLETED|Overall Study||90
8320111|NCT01427738|20513875|P1|COMPLETED|Overall Study||91
8320112|NCT01427738|20513874|P2|STARTED|Overall Study||111
8320113|NCT01427738|20513875|P1|STARTED|Overall Study||110
8320114|NCT01427608|20513895|P2|NOT COMPLETED|Overall Study||38
8320115|NCT01427608|20513896|P1|NOT COMPLETED|Overall Study||21
8320116|NCT01427608|20513895|P2|COMPLETED|Overall Study||24
8320117|NCT01427608|20513896|P1|COMPLETED|Overall Study||43
8320118|NCT01427608|20513895|P2|STARTED|Overall Study||62
8320119|NCT01427608|20513896|P1|STARTED|Overall Study||64
8320120|NCT01427595|20513908|P1|NOT COMPLETED|Overall Study||13
8320121|NCT01427595|20513908|P1|COMPLETED|Overall Study||12
8320122|NCT01427595|20513908|P1|STARTED|Overall Study||25
8320123|NCT01427517|20513915|P3|NOT COMPLETED|Overall Study||0
8320124|NCT01427517|20513916|P2|NOT COMPLETED|Overall Study||0
8320125|NCT01427517|20513917|P1|NOT COMPLETED|Overall Study||0
8320126|NCT01427517|20513915|P3|COMPLETED|Overall Study||3
8320127|NCT01427517|20513916|P2|COMPLETED|Overall Study||3
8320128|NCT01427517|20513917|P1|COMPLETED|Overall Study||3
8320129|NCT01427517|20513915|P3|STARTED|Overall Study||3
8320130|NCT01427517|20513916|P2|STARTED|Overall Study||3
8320131|NCT01427517|20513917|P1|STARTED|Overall Study||3
8320132|NCT01427504|20513931|P6|NOT COMPLETED|Overall Study||2
8320133|NCT01427504|20513932|P5|NOT COMPLETED|Overall Study||1
8320134|NCT01427504|20513933|P4|NOT COMPLETED|Overall Study||1
8320135|NCT01427504|20513934|P3|NOT COMPLETED|Overall Study||1
8320136|NCT01427504|20513935|P2|NOT COMPLETED|Overall Study||1
8320137|NCT01427504|20513936|P1|NOT COMPLETED|Overall Study||0
8320138|NCT01427504|20513931|P6|COMPLETED|Overall Study||4
8320139|NCT01427504|20513932|P5|COMPLETED|Overall Study||2
8320140|NCT01427504|20513933|P4|COMPLETED|Overall Study||5
8320141|NCT01427504|20513934|P3|COMPLETED|Overall Study||3
8320142|NCT01427504|20513935|P2|COMPLETED|Overall Study||2
8320143|NCT01427504|20513936|P1|COMPLETED|Overall Study||4
8320144|NCT01427504|20513931|P6|Received Combination|Overall Study||6
8320145|NCT01427504|20513932|P5|Received Combination|Overall Study||3
8320146|NCT01427504|20513933|P4|Received Combination|Overall Study||6
8320147|NCT01427504|20513934|P3|Received Combination|Overall Study||3
8320148|NCT01427504|20513935|P2|Received Combination|Overall Study||3
8320149|NCT01427504|20513936|P1|Received Combination|Overall Study||4
8320150|NCT01427504|20513931|P6|Received Etravirine|Overall Study||4
8320151|NCT01427504|20513932|P5|Received Etravirine|Overall Study||2
8320152|NCT01427504|20513933|P4|Received Etravirine|Overall Study||6
8320153|NCT01427504|20513934|P3|Received Etravirine|Overall Study||4
8320154|NCT01427504|20513935|P2|Received Etravirine|Overall Study||2
8320155|NCT01427504|20513936|P1|Received Etravirine|Overall Study||4
8320156|NCT01427504|20513931|P6|Received Boceprevir|Overall Study||4
8320157|NCT01427504|20513932|P5|Received Boceprevir|Overall Study||2
8320158|NCT01427504|20513933|P4|Received Boceprevir|Overall Study||5
8320159|NCT01427504|20513934|P3|Received Boceprevir|Overall Study||3
8320160|NCT01427504|20513935|P2|Received Boceprevir|Overall Study||3
8320161|NCT01427504|20513936|P1|Received Boceprevir|Overall Study||4
8320162|NCT01427504|20513931|P6|STARTED|Overall Study||6
8320163|NCT01427504|20513932|P5|STARTED|Overall Study||3
8320164|NCT01427504|20513933|P4|STARTED|Overall Study||6
8320165|NCT01427504|20513934|P3|STARTED|Overall Study||4
8320166|NCT01427504|20513935|P2|STARTED|Overall Study||3
8320167|NCT01427504|20513936|P1|STARTED|Overall Study||4
8320168|NCT01427309|20513957|P4|NOT COMPLETED|Overall Study||376
8320169|NCT01427309|20513958|P3|NOT COMPLETED|Overall Study||361
8320170|NCT01427309|20513959|P2|NOT COMPLETED|Overall Study||407
8320171|NCT01427309|20513960|P1|NOT COMPLETED|Overall Study||372
8320172|NCT01427309|20513957|P4|COMPLETED|Overall Study||8373
8320173|NCT01427309|20513958|P3|COMPLETED|Overall Study||8376
8320174|NCT01427309|20513959|P2|COMPLETED|Overall Study||6837
8320175|NCT01427309|20513960|P1|COMPLETED|Overall Study||6881
8320176|NCT01427309|20513957|P4|STARTED|Overall Study||8749
8320177|NCT01427309|20513958|P3|STARTED|Overall Study||8737
8320178|NCT01427309|20513959|P2|STARTED|Overall Study||7244
8320179|NCT01427309|20513960|P1|STARTED|Overall Study||7253
8320180|NCT01427296|20514000|P2|NOT COMPLETED|Overall Study||0
8320181|NCT01427296|20514001|P1|NOT COMPLETED|Overall Study||0
8320182|NCT01427296|20514000|P2|COMPLETED|Overall Study||1051
8320183|NCT01427296|20514001|P1|COMPLETED|Overall Study||1041
8320184|NCT01427296|20514000|P2|STARTED|Overall Study||1051
8320185|NCT01427296|20514001|P1|STARTED|Overall Study||1041
8320186|NCT01426958|20514007|P1|NOT COMPLETED|Overall Study||2
8320187|NCT01426958|20514007|P1|COMPLETED|Overall Study||22
8320188|NCT01426958|20514007|P1|STARTED|Overall Study||24
8320189|NCT01426867|20514024|P3|NOT COMPLETED|Overall Study||0
8320190|NCT01426867|20514025|P2|NOT COMPLETED|Overall Study||0
8320191|NCT01426867|20514026|P1|NOT COMPLETED|Overall Study||0
8320192|NCT01426867|20514024|P3|COMPLETED|Overall Study||34
8320193|NCT01426867|20514025|P2|COMPLETED|Overall Study||34
8320194|NCT01426867|20514026|P1|COMPLETED|Overall Study||33
8320195|NCT01426867|20514024|P3|STARTED|Overall Study||34
8320196|NCT01426867|20514025|P2|STARTED|Overall Study||34
8320197|NCT01426867|20514026|P1|STARTED|Overall Study||33
8320198|NCT01426854|20514036|P2|NOT COMPLETED|Overall Study||31
8320199|NCT01426854|20514037|P1|NOT COMPLETED|Overall Study||12
8320200|NCT01426854|20514036|P2|COMPLETED|Overall Study||98
8320201|NCT01426854|20514037|P1|COMPLETED|Overall Study||119
8320202|NCT01426854|20514036|P2|STARTED|Overall Study||129
8320203|NCT01426854|20514037|P1|STARTED|Overall Study||131
8320204|NCT01426828|20514047|P2|NOT COMPLETED|Immune Response Analysis||7
8320205|NCT01426828|20514048|P1|NOT COMPLETED|Immune Response Analysis||9
8320206|NCT01426828|20514047|P2|COMPLETED|Immune Response Analysis||8
8320207|NCT01426828|20514048|P1|COMPLETED|Immune Response Analysis||8
8320208|NCT01426828|20514047|P2|STARTED|Immune Response Analysis||15
8320209|NCT01426828|20514048|P1|STARTED|Immune Response Analysis||17
8320210|NCT01426828|20514047|P2|NOT COMPLETED|Overall Study Evaluations||3
8320211|NCT01426828|20514048|P1|NOT COMPLETED|Overall Study Evaluations||5
8320212|NCT01426828|20514047|P2|COMPLETED|Overall Study Evaluations||15
8320213|NCT01426828|20514048|P1|COMPLETED|Overall Study Evaluations||17
8320214|NCT01426828|20514047|P2|STARTED|Overall Study Evaluations||18
8320215|NCT01426828|20514048|P1|STARTED|Overall Study Evaluations||22
8320216|NCT01426789|20514056|P6|NOT COMPLETED|Part 2||0
8320217|NCT01426789|20514057|P5|NOT COMPLETED|Part 2||8
8320218|NCT01426789|20514058|P4|NOT COMPLETED|Part 2||1
8320219|NCT01426789|20514059|P3|NOT COMPLETED|Part 2||15
8320220|NCT01426789|20514060|P2|NOT COMPLETED|Part 2||0
8320221|NCT01426789|20514061|P1|NOT COMPLETED|Part 2||0
8320222|NCT01426789|20514056|P6|COMPLETED|Part 2||1
8320223|NCT01426789|20514057|P5|COMPLETED|Part 2||19
8320224|NCT01426789|20514058|P4|COMPLETED|Part 2||12
8320225|NCT01426789|20514059|P3|COMPLETED|Part 2||34
8320226|NCT01426789|20514060|P2|COMPLETED|Part 2||0
8320227|NCT01426789|20514061|P1|COMPLETED|Part 2||0
8320228|NCT01426789|20514056|P6|STARTED|Part 2||1
8320229|NCT01426789|20514057|P5|STARTED|Part 2||27
8320230|NCT01426789|20514058|P4|STARTED|Part 2||13
8320231|NCT01426789|20514059|P3|STARTED|Part 2||49
8320232|NCT01426789|20514060|P2|STARTED|Part 2||0
8320233|NCT01426789|20514061|P1|STARTED|Part 2||0
8320234|NCT01426789|20514056|P6|NOT COMPLETED|Part 1||0
8320235|NCT01426789|20514057|P5|NOT COMPLETED|Part 1||0
8320236|NCT01426789|20514058|P4|NOT COMPLETED|Part 1||0
8320237|NCT01426789|20514059|P3|NOT COMPLETED|Part 1||0
8320238|NCT01426789|20514060|P2|NOT COMPLETED|Part 1||4
8320239|NCT01426789|20514061|P1|NOT COMPLETED|Part 1||6
8320240|NCT01426789|20514056|P6|COMPLETED|Part 1||0
8320241|NCT01426789|20514057|P5|COMPLETED|Part 1||0
8320242|NCT01426789|20514058|P4|COMPLETED|Part 1||0
8320243|NCT01426789|20514059|P3|COMPLETED|Part 1||0
8320244|NCT01426789|20514060|P2|COMPLETED|Part 1||28
8320245|NCT01426789|20514061|P1|COMPLETED|Part 1||62
8320246|NCT01426789|20514056|P6|STARTED|Part 1||0
8320247|NCT01426789|20514057|P5|STARTED|Part 1||0
8320248|NCT01426789|20514058|P4|STARTED|Part 1||0
8320249|NCT01426789|20514059|P3|STARTED|Part 1||0
8320250|NCT01426789|20514060|P2|STARTED|Part 1||32
8320251|NCT01426789|20514061|P1|STARTED|Part 1||68
8320258|NCT01426581|20514086|P2|NOT COMPLETED|Overall Study||0
8320259|NCT01426581|20514087|P1|NOT COMPLETED|Overall Study||0
8320260|NCT01426581|20514086|P2|COMPLETED|Overall Study||58
8320261|NCT01426581|20514087|P1|COMPLETED|Overall Study||62
8320262|NCT01426581|20514086|P2|STARTED|Overall Study||58
8320263|NCT01426581|20514087|P1|STARTED|Overall Study||62
8320264|NCT01426555|20514103|P2|NOT COMPLETED|Overall Study||15
8320265|NCT01426555|20514104|P1|NOT COMPLETED|Overall Study||18
8320266|NCT01426555|20514103|P2|COMPLETED|Overall Study||20
8320267|NCT01426555|20514104|P1|COMPLETED|Overall Study||17
8320268|NCT01426555|20514103|P2|STARTED|Overall Study||35
8320269|NCT01426555|20514104|P1|STARTED|Overall Study||35
8320270|NCT01426516|20514114|P2|NOT COMPLETED|Overall Study||0
8320271|NCT01426516|20514115|P1|NOT COMPLETED|Overall Study||0
8320272|NCT01426516|20514114|P2|COMPLETED|Overall Study||17
8320273|NCT01426516|20514115|P1|COMPLETED|Overall Study||12
8320274|NCT01426516|20514114|P2|STARTED|Overall Study||17
8320275|NCT01426516|20514115|P1|STARTED|Overall Study||12
8320276|NCT01426438|20514123|P2|NOT COMPLETED|Overall Study||10
8320277|NCT01426438|20514124|P1|NOT COMPLETED|Overall Study||15
8320278|NCT01426438|20514123|P2|COMPLETED|Overall Study||39
8320279|NCT01426438|20514124|P1|COMPLETED|Overall Study||35
8320280|NCT01426438|20514123|P2|STARTED|Overall Study||49
8320281|NCT01426438|20514124|P1|STARTED|Overall Study||50
8320282|NCT01426425|20514156|P1|NOT COMPLETED|Overall Study||175
8320283|NCT01426425|20514156|P1|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
8320284|NCT01426425|20514156|P1|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
8320285|NCT01426425|20514156|P1|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
8320286|NCT01426425|20514156|P1|STARTED|Overall Study||572
8320287|NCT01426412|20514171|P9|NOT COMPLETED|Overall Study||1
8320288|NCT01426412|20514172|P8|NOT COMPLETED|Overall Study||3
8320289|NCT01426412|20514173|P7|NOT COMPLETED|Overall Study||0
8320290|NCT01426412|20514174|P6|NOT COMPLETED|Overall Study||0
8320291|NCT01426412|20514175|P5|NOT COMPLETED|Overall Study||1
8320292|NCT01426412|20514176|P4|NOT COMPLETED|Overall Study||0
8320293|NCT01426412|20514177|P3|NOT COMPLETED|Overall Study||0
8320294|NCT01426412|20514178|P2|NOT COMPLETED|Overall Study||0
8320295|NCT01426412|20514179|P1|NOT COMPLETED|Overall Study||1
8320296|NCT01426412|20514171|P9|COMPLETED|Overall Study||16
8320297|NCT01426412|20514172|P8|COMPLETED|Overall Study||7
8320298|NCT01426412|20514173|P7|COMPLETED|Overall Study||6
8320299|NCT01426412|20514174|P6|COMPLETED|Overall Study||6
8320300|NCT01426412|20514175|P5|COMPLETED|Overall Study||5
8320301|NCT01426412|20514176|P4|COMPLETED|Overall Study||6
8320302|NCT01426412|20514177|P3|COMPLETED|Overall Study||6
8320303|NCT01426412|20514178|P2|COMPLETED|Overall Study||6
8320304|NCT01426412|20514179|P1|COMPLETED|Overall Study||5
8320305|NCT01426412|20514171|P9|Received at Least 1 Dose of Study Drug|Overall Study||17
8320306|NCT01426412|20514172|P8|Received at Least 1 Dose of Study Drug|Overall Study||10
8320307|NCT01426412|20514173|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
8320308|NCT01426412|20514174|P6|Received at Least 1 Dose of Study Drug|Overall Study||6
8320309|NCT01426412|20514175|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8320310|NCT01426412|20514176|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8320311|NCT01426412|20514177|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8320312|NCT01426412|20514178|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8320313|NCT01426412|20514179|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8320314|NCT01426412|20514171|P9|STARTED|Overall Study||17
8320315|NCT01426412|20514172|P8|STARTED|Overall Study||10
8320316|NCT01426412|20514173|P7|STARTED|Overall Study||6
8320317|NCT01426412|20514174|P6|STARTED|Overall Study||6
8320318|NCT01426412|20514175|P5|STARTED|Overall Study||6
8320319|NCT01426412|20514176|P4|STARTED|Overall Study||6
8320320|NCT01426412|20514177|P3|STARTED|Overall Study||6
8320321|NCT01426412|20514178|P2|STARTED|Overall Study||6
8320322|NCT01426412|20514179|P1|STARTED|Overall Study||6
8320323|NCT01426386|20514242|P6|NOT COMPLETED|Overall Study||1
8320324|NCT01426386|20514243|P5|NOT COMPLETED|Overall Study||4
8320325|NCT01426386|20514244|P4|NOT COMPLETED|Overall Study||0
8320326|NCT01426386|20514245|P3|NOT COMPLETED|Overall Study||2
8320327|NCT01426386|20514246|P2|NOT COMPLETED|Overall Study||6
8320328|NCT01426386|20514247|P1|NOT COMPLETED|Overall Study||3
8320329|NCT01426386|20514242|P6|COMPLETED|Overall Study||42
8320330|NCT01426386|20514243|P5|COMPLETED|Overall Study||43
8320331|NCT01426386|20514244|P4|COMPLETED|Overall Study||44
8320332|NCT01426386|20514245|P3|COMPLETED|Overall Study||42
8320333|NCT01426386|20514246|P2|COMPLETED|Overall Study||39
8320334|NCT01426386|20514247|P1|COMPLETED|Overall Study||39
8320335|NCT01426386|20514242|P6|STARTED|Overall Study||43
8320336|NCT01426386|20514243|P5|STARTED|Overall Study||47
8320337|NCT01426386|20514244|P4|STARTED|Overall Study||44
8320338|NCT01426386|20514245|P3|STARTED|Overall Study||44
8320339|NCT01426386|20514246|P2|STARTED|Overall Study||45
8320340|NCT01426386|20514247|P1|STARTED|Overall Study||42
8320341|NCT01426373|20514303|P1|NOT COMPLETED|Overall Study||34
8320342|NCT01426373|20514303|P1|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
8320343|NCT01426373|20514303|P1|STARTED|Overall Study||165
8320344|NCT01426360|20514321|P2|NOT COMPLETED|Overall Study||0
8320345|NCT01426360|20514322|P1|NOT COMPLETED|Overall Study||0
8320346|NCT01426360|20514321|P2|COMPLETED|Overall Study||41
8320347|NCT01426360|20514322|P1|COMPLETED|Overall Study||38
8320348|NCT01426360|20514321|P2|STARTED|Overall Study||41
8320349|NCT01426360|20514322|P1|STARTED|Overall Study||38
8320350|NCT01426347|20514336|P2|NOT COMPLETED|Overall Study||3
8320351|NCT01426347|20514337|P1|NOT COMPLETED|Overall Study||7
8320352|NCT01426347|20514336|P2|COMPLETED|Overall Study||39
8320353|NCT01426347|20514337|P1|COMPLETED|Overall Study||34
8320354|NCT01426347|20514336|P2|STARTED|Overall Study||42
8320355|NCT01426347|20514337|P1|STARTED|Overall Study||41
8320356|NCT01426269|20514345|P3|NOT COMPLETED|Period 2: 40 Weeks||47
8320357|NCT01426269|20514346|P2|NOT COMPLETED|Period 2: 40 Weeks||38
8320358|NCT01426269|20514347|P1|NOT COMPLETED|Period 2: 40 Weeks||0
8320359|NCT01426269|20514345|P3|COMPLETED|Period 2: 40 Weeks||18
8320360|NCT01426269|20514346|P2|COMPLETED|Period 2: 40 Weeks||27
8320361|NCT01426269|20514347|P1|COMPLETED|Period 2: 40 Weeks||0
8320362|NCT01426269|20514345|P3|STARTED|Period 2: 40 Weeks||65
8320363|NCT01426269|20514346|P2|STARTED|Period 2: 40 Weeks||65
8320364|NCT01426269|20514347|P1|STARTED|Period 2: 40 Weeks||0
8320365|NCT01426269|20514345|P3|NOT COMPLETED|Eligibility for Period 2, Randomization||0
8320366|NCT01426269|20514346|P2|NOT COMPLETED|Eligibility for Period 2, Randomization||0
8320367|NCT01426269|20514347|P1|NOT COMPLETED|Eligibility for Period 2, Randomization||50
8320368|NCT01426269|20514345|P3|COMPLETED|Eligibility for Period 2, Randomization||0
8320369|NCT01426269|20514346|P2|COMPLETED|Eligibility for Period 2, Randomization||0
8320370|NCT01426269|20514347|P1|COMPLETED|Eligibility for Period 2, Randomization||130
8320371|NCT01426269|20514345|P3|STARTED|Eligibility for Period 2, Randomization||0
8320372|NCT01426269|20514346|P2|STARTED|Eligibility for Period 2, Randomization||0
8320373|NCT01426269|20514347|P1|STARTED|Eligibility for Period 2, Randomization||180
8320374|NCT01426269|20514345|P3|NOT COMPLETED|Period 1: 12 Weeks||0
8320375|NCT01426269|20514346|P2|NOT COMPLETED|Period 1: 12 Weeks||0
8320376|NCT01426269|20514347|P1|NOT COMPLETED|Period 1: 12 Weeks||55
8320377|NCT01426269|20514345|P3|COMPLETED|Period 1: 12 Weeks||0
8320378|NCT01426269|20514346|P2|COMPLETED|Period 1: 12 Weeks||0
8320379|NCT01426269|20514347|P1|COMPLETED|Period 1: 12 Weeks||180
8320380|NCT01426269|20514345|P3|STARTED|Period 1: 12 Weeks||0
8320381|NCT01426269|20514346|P2|STARTED|Period 1: 12 Weeks||0
8320382|NCT01426269|20514347|P1|STARTED|Period 1: 12 Weeks||235
8320383|NCT01426230|20514374|P2|NOT COMPLETED|Overall Study||27
8320384|NCT01426230|20514375|P1|NOT COMPLETED|Overall Study||31
8320385|NCT01426230|20514374|P2|COMPLETED|Overall Study||84
8320386|NCT01426230|20514375|P1|COMPLETED|Overall Study||55
8320387|NCT01426230|20514374|P2|STARTED|Overall Study||111
8320388|NCT01426230|20514375|P1|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
8320389|NCT01426217|20514382|P2|NOT COMPLETED|Overall Study||14
8320390|NCT01426217|20514383|P1|NOT COMPLETED|Overall Study||8
8320391|NCT01426217|20514382|P2|COMPLETED|Overall Study||266
8320392|NCT01426217|20514383|P1|COMPLETED|Overall Study||306
8320393|NCT01426217|20514382|P2|STARTED|Overall Study||280
8320394|NCT01426217|20514383|P1|STARTED|Overall Study||314
8320395|NCT01426191|20514389|P1|NOT COMPLETED|Overall Study||0
8320396|NCT01426191|20514389|P1|COMPLETED|Overall Study||2032
8320397|NCT01426191|20514389|P1|STARTED|Overall Study||2032
8320398|NCT01426113|20514396|P2|NOT COMPLETED|Overall Study||2
8320399|NCT01426113|20514397|P1|NOT COMPLETED|Overall Study||1
8320400|NCT01426113|20514396|P2|COMPLETED|Overall Study||1
8320401|NCT01426113|20514397|P1|COMPLETED|Overall Study||2
8320402|NCT01426113|20514396|P2|STARTED|Overall Study||3
8320403|NCT01426113|20514397|P1|STARTED|Overall Study||3
8320404|NCT01426009|20514403|P1|NOT COMPLETED|Washout 4||1
8320405|NCT01426009|20514403|P1|COMPLETED|Washout 4||126
8320406|NCT01426009|20514403|P1|STARTED|Washout 4||127
8320407|NCT01426009|20514403|P1|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
8320408|NCT01426009|20514403|P1|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
8320409|NCT01426009|20514403|P1|Placebo|Period 4-Fourth Intervention (7 Days)||10
8320410|NCT01426009|20514403|P1|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
8320411|NCT01426009|20514403|P1|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
8320412|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
8320413|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
8320414|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
8320415|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
8320416|NCT01426009|20514403|P1|STARTED|Period 4-Fourth Intervention (7 Days)||128
8320417|NCT01426009|20514403|P1|NOT COMPLETED|Washout 3||1
8320418|NCT01426009|20514403|P1|COMPLETED|Washout 3||128
8320419|NCT01426009|20514403|P1|STARTED|Washout 3||129
8320420|NCT01426009|20514403|P1|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
8320421|NCT01426009|20514403|P1|COMPLETED|Period 3-Third Intervention (7 Days)||129
8320422|NCT01426009|20514403|P1|Placebo|Period 3-Third Intervention (7 Days)||22
8320423|NCT01426009|20514403|P1|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
8320424|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
8320425|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
8320426|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
8320427|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
8320428|NCT01426009|20514403|P1|STARTED|Period 3-Third Intervention (7 Days)||129
8320429|NCT01426009|20514403|P1|NOT COMPLETED|Washout 2||1
8320430|NCT01426009|20514403|P1|COMPLETED|Washout 2||129
8320431|NCT01426009|20514403|P1|STARTED|Washout 2||130
8320432|NCT01426009|20514403|P1|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
8320433|NCT01426009|20514403|P1|COMPLETED|Period 2-Second Intervention (7 Days)||130
8320434|NCT01426009|20514403|P1|Placebo|Period 2-Second Intervention (7 Days)||21
8320435|NCT01426009|20514403|P1|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
8320436|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
8320437|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
8320438|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
8320439|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
8320440|NCT01426009|20514403|P1|STARTED|Period 2-Second Intervention (7 Days)||135
8320441|NCT01426009|20514403|P1|NOT COMPLETED|Washout 1||2
8320442|NCT01426009|20514403|P1|COMPLETED|Washout 1||135
8320443|NCT01426009|20514403|P1|STARTED|Washout 1||137
8320444|NCT01426009|20514403|P1|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
8320445|NCT01426009|20514403|P1|COMPLETED|Period 1-First Intervention (7 Days)||137
8320446|NCT01426009|20514403|P1|Placebo|Period 1-First Intervention (7 Days)||24
8320447|NCT01426009|20514403|P1|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
8320448|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
8320449|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
8320450|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
8320451|NCT01426009|20514403|P1|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
8320452|NCT01426009|20514403|P1|STARTED|Period 1-First Intervention (7 Days)||139
8320453|NCT01425879|20514459|P1|NOT COMPLETED|Overall Study||0
8320454|NCT01425879|20514459|P1|COMPLETED|Overall Study||8
8320455|NCT01425879|20514459|P1|STARTED|Overall Study||8
8320456|NCT01425853|20514468|P2|NOT COMPLETED|Overall Study||77
8320457|NCT01425853|20514469|P1|NOT COMPLETED|Overall Study||64
8320458|NCT01425853|20514468|P2|COMPLETED|Overall Study||225
8320459|NCT01425853|20514469|P1|COMPLETED|Overall Study||240
8320460|NCT01425853|20514468|P2|Per Protocol (PP)|Overall Study||258
8320461|NCT01425853|20514469|P1|Per Protocol (PP)|Overall Study||264
8320462|NCT01425853|20514468|P2|Safety Population|Overall Study||299
8320463|NCT01425853|20514469|P1|Safety Population|Overall Study||304
8320464|NCT01425853|20514468|P2|STARTED|Overall Study||302
8320465|NCT01425853|20514469|P1|STARTED|Overall Study||304
8320466|NCT01425814|20514499|P6|NOT COMPLETED|Period 5||1
8320467|NCT01425814|20514500|P5|NOT COMPLETED|Period 5||0
8320468|NCT01425814|20514501|P4|NOT COMPLETED|Period 5||0
8320469|NCT01425814|20514502|P3|NOT COMPLETED|Period 5||1
8320470|NCT01425814|20514503|P2|NOT COMPLETED|Period 5||0
8320471|NCT01425814|20514504|P1|NOT COMPLETED|Period 5||0
8320472|NCT01425814|20514499|P6|COMPLETED|Period 5||11
8320473|NCT01425814|20514500|P5|COMPLETED|Period 5||12
8320474|NCT01425814|20514501|P4|COMPLETED|Period 5||10
8320475|NCT01425814|20514502|P3|COMPLETED|Period 5||10
8320476|NCT01425814|20514503|P2|COMPLETED|Period 5||9
8320477|NCT01425814|20514504|P1|COMPLETED|Period 5||11
8320478|NCT01425814|20514499|P6|STARTED|Period 5||12
8320479|NCT01425814|20514500|P5|STARTED|Period 5||12
8320480|NCT01425814|20514501|P4|STARTED|Period 5||10
8320481|NCT01425814|20514502|P3|STARTED|Period 5||11
8320482|NCT01425814|20514503|P2|STARTED|Period 5||9
8320483|NCT01425814|20514504|P1|STARTED|Period 5||11
8320484|NCT01425814|20514499|P6|NOT COMPLETED|Period 4||0
8320485|NCT01425814|20514500|P5|NOT COMPLETED|Period 4||0
8320486|NCT01425814|20514501|P4|NOT COMPLETED|Period 4||0
8320487|NCT01425814|20514502|P3|NOT COMPLETED|Period 4||1
8320488|NCT01425814|20514503|P2|NOT COMPLETED|Period 4||0
8320489|NCT01425814|20514504|P1|NOT COMPLETED|Period 4||1
8320490|NCT01425814|20514499|P6|COMPLETED|Period 4||12
8320491|NCT01425814|20514500|P5|COMPLETED|Period 4||12
8320492|NCT01425814|20514501|P4|COMPLETED|Period 4||10
8320493|NCT01425814|20514502|P3|COMPLETED|Period 4||11
8320494|NCT01425814|20514503|P2|COMPLETED|Period 4||9
8320495|NCT01425814|20514504|P1|COMPLETED|Period 4||11
8320496|NCT01425814|20514499|P6|STARTED|Period 4||12
8320497|NCT01425814|20514500|P5|STARTED|Period 4||12
8320498|NCT01425814|20514501|P4|STARTED|Period 4||10
8320499|NCT01425814|20514502|P3|STARTED|Period 4||12
8320500|NCT01425814|20514503|P2|STARTED|Period 4||9
8320501|NCT01425814|20514504|P1|STARTED|Period 4||12
8320502|NCT01425814|20514499|P6|NOT COMPLETED|Period 3||1
8320503|NCT01425814|20514500|P5|NOT COMPLETED|Period 3||0
8320504|NCT01425814|20514501|P4|NOT COMPLETED|Period 3||0
8320505|NCT01425814|20514502|P3|NOT COMPLETED|Period 3||0
8320506|NCT01425814|20514503|P2|NOT COMPLETED|Period 3||0
8320507|NCT01425814|20514504|P1|NOT COMPLETED|Period 3||0
8320508|NCT01425814|20514499|P6|COMPLETED|Period 3||12
8320509|NCT01425814|20514500|P5|COMPLETED|Period 3||12
8320510|NCT01425814|20514501|P4|COMPLETED|Period 3||10
8320511|NCT01425814|20514502|P3|COMPLETED|Period 3||12
8320512|NCT01425814|20514503|P2|COMPLETED|Period 3||9
8320513|NCT01425814|20514504|P1|COMPLETED|Period 3||12
8320514|NCT01425814|20514499|P6|STARTED|Period 3||13
8320515|NCT01425814|20514500|P5|STARTED|Period 3||12
8320516|NCT01425814|20514501|P4|STARTED|Period 3||10
8320517|NCT01425814|20514502|P3|STARTED|Period 3||12
8320518|NCT01425814|20514503|P2|STARTED|Period 3||9
8320519|NCT01425814|20514504|P1|STARTED|Period 3||12
8320520|NCT01425814|20514499|P6|NOT COMPLETED|Period 2||0
8320521|NCT01425814|20514500|P5|NOT COMPLETED|Period 2||0
8320522|NCT01425814|20514501|P4|NOT COMPLETED|Period 2||0
8320523|NCT01425814|20514502|P3|NOT COMPLETED|Period 2||0
8320524|NCT01425814|20514503|P2|NOT COMPLETED|Period 2||1
8320525|NCT01425814|20514504|P1|NOT COMPLETED|Period 2||0
8320526|NCT01425814|20514499|P6|COMPLETED|Period 2||13
8320527|NCT01425814|20514500|P5|COMPLETED|Period 2||12
8320528|NCT01425814|20514501|P4|COMPLETED|Period 2||10
8320529|NCT01425814|20514502|P3|COMPLETED|Period 2||12
8320530|NCT01425814|20514503|P2|COMPLETED|Period 2||9
8320531|NCT01425814|20514504|P1|COMPLETED|Period 2||12
8320532|NCT01425814|20514499|P6|STARTED|Period 2||13
8320533|NCT01425814|20514500|P5|STARTED|Period 2||12
8320534|NCT01425814|20514501|P4|STARTED|Period 2||10
8320535|NCT01425814|20514502|P3|STARTED|Period 2||12
8320536|NCT01425814|20514503|P2|STARTED|Period 2||10
8320537|NCT01425814|20514504|P1|STARTED|Period 2||12
8320538|NCT01425814|20514499|P6|NOT COMPLETED|Period 1||0
8320539|NCT01425814|20514500|P5|NOT COMPLETED|Period 1||0
8320540|NCT01425814|20514501|P4|NOT COMPLETED|Period 1||0
8320541|NCT01425814|20514502|P3|NOT COMPLETED|Period 1||0
8320542|NCT01425814|20514503|P2|NOT COMPLETED|Period 1||1
8320543|NCT01425814|20514504|P1|NOT COMPLETED|Period 1||0
8320544|NCT01425814|20514499|P6|COMPLETED|Period 1||13
8320545|NCT01425814|20514500|P5|COMPLETED|Period 1||12
8320546|NCT01425814|20514501|P4|COMPLETED|Period 1||10
8320547|NCT01425814|20514502|P3|COMPLETED|Period 1||12
8320548|NCT01425814|20514503|P2|COMPLETED|Period 1||10
8320549|NCT01425814|20514504|P1|COMPLETED|Period 1||12
8320550|NCT01425814|20514499|P6|STARTED|Period 1||13
8320551|NCT01425814|20514500|P5|STARTED|Period 1||12
8320552|NCT01425814|20514501|P4|STARTED|Period 1||10
8320553|NCT01425814|20514502|P3|STARTED|Period 1||12
8320554|NCT01425814|20514503|P2|STARTED|Period 1||11
8320555|NCT01425814|20514504|P1|STARTED|Period 1||12
8320556|NCT01425801|20514596|P6|NOT COMPLETED|Period 6||0
8320557|NCT01425801|20514597|P5|NOT COMPLETED|Period 6||0
8320558|NCT01425801|20514598|P4|NOT COMPLETED|Period 6||0
8320559|NCT01425801|20514599|P3|NOT COMPLETED|Period 6||0
8320560|NCT01425801|20514600|P2|NOT COMPLETED|Period 6||0
8320561|NCT01425801|20514601|P1|NOT COMPLETED|Period 6||0
8320562|NCT01425801|20514596|P6|COMPLETED|Period 6||10
8320563|NCT01425801|20514597|P5|COMPLETED|Period 6||11
8320564|NCT01425801|20514598|P4|COMPLETED|Period 6||12
8320565|NCT01425801|20514599|P3|COMPLETED|Period 6||7
8320566|NCT01425801|20514600|P2|COMPLETED|Period 6||9
8320567|NCT01425801|20514601|P1|COMPLETED|Period 6||9
8320568|NCT01425801|20514596|P6|STARTED|Period 6||10
8320569|NCT01425801|20514597|P5|STARTED|Period 6||11
8320570|NCT01425801|20514598|P4|STARTED|Period 6||12
8320571|NCT01425801|20514599|P3|STARTED|Period 6||7
8320572|NCT01425801|20514600|P2|STARTED|Period 6||9
8320573|NCT01425801|20514601|P1|STARTED|Period 6||9
8320574|NCT01425801|20514596|P6|NOT COMPLETED|Period 5||0
8320575|NCT01425801|20514597|P5|NOT COMPLETED|Period 5||0
8320576|NCT01425801|20514598|P4|NOT COMPLETED|Period 5||0
8320577|NCT01425801|20514599|P3|NOT COMPLETED|Period 5||0
8320578|NCT01425801|20514600|P2|NOT COMPLETED|Period 5||0
8320579|NCT01425801|20514601|P1|NOT COMPLETED|Period 5||0
8320580|NCT01425801|20514596|P6|COMPLETED|Period 5||10
8320581|NCT01425801|20514597|P5|COMPLETED|Period 5||11
8320582|NCT01425801|20514598|P4|COMPLETED|Period 5||12
8320583|NCT01425801|20514599|P3|COMPLETED|Period 5||7
8320584|NCT01425801|20514600|P2|COMPLETED|Period 5||9
8320585|NCT01425801|20514601|P1|COMPLETED|Period 5||9
8320586|NCT01425801|20514596|P6|STARTED|Period 5||10
8320587|NCT01425801|20514597|P5|STARTED|Period 5||11
8320588|NCT01425801|20514598|P4|STARTED|Period 5||12
8320589|NCT01425801|20514599|P3|STARTED|Period 5||7
8320590|NCT01425801|20514600|P2|STARTED|Period 5||9
8320591|NCT01425801|20514601|P1|STARTED|Period 5||9
8320592|NCT01425801|20514596|P6|NOT COMPLETED|Period 4||0
8320593|NCT01425801|20514597|P5|NOT COMPLETED|Period 4||0
8320594|NCT01425801|20514598|P4|NOT COMPLETED|Period 4||0
8320595|NCT01425801|20514599|P3|NOT COMPLETED|Period 4||1
8320596|NCT01425801|20514600|P2|NOT COMPLETED|Period 4||0
8320597|NCT01425801|20514601|P1|NOT COMPLETED|Period 4||0
8320598|NCT01425801|20514596|P6|COMPLETED|Period 4||10
8320599|NCT01425801|20514597|P5|COMPLETED|Period 4||11
8320600|NCT01425801|20514598|P4|COMPLETED|Period 4||12
8320601|NCT01425801|20514599|P3|COMPLETED|Period 4||7
8320602|NCT01425801|20514600|P2|COMPLETED|Period 4||9
8320603|NCT01425801|20514601|P1|COMPLETED|Period 4||9
8320604|NCT01425801|20514596|P6|STARTED|Period 4||10
8320605|NCT01425801|20514597|P5|STARTED|Period 4||11
8320606|NCT01425801|20514598|P4|STARTED|Period 4||12
8320607|NCT01425801|20514599|P3|STARTED|Period 4||8
8320608|NCT01425801|20514600|P2|STARTED|Period 4||9
8320609|NCT01425801|20514601|P1|STARTED|Period 4||9
8320610|NCT01425801|20514596|P6|NOT COMPLETED|Period 3||0
8320611|NCT01425801|20514597|P5|NOT COMPLETED|Period 3||0
8320612|NCT01425801|20514598|P4|NOT COMPLETED|Period 3||0
8320613|NCT01425801|20514599|P3|NOT COMPLETED|Period 3||1
8320614|NCT01425801|20514600|P2|NOT COMPLETED|Period 3||0
8320615|NCT01425801|20514601|P1|NOT COMPLETED|Period 3||0
8320616|NCT01425801|20514596|P6|COMPLETED|Period 3||10
8320617|NCT01425801|20514597|P5|COMPLETED|Period 3||11
8320618|NCT01425801|20514598|P4|COMPLETED|Period 3||12
8320619|NCT01425801|20514599|P3|COMPLETED|Period 3||8
8320620|NCT01425801|20514600|P2|COMPLETED|Period 3||9
8320621|NCT01425801|20514601|P1|COMPLETED|Period 3||9
8320622|NCT01425801|20514596|P6|STARTED|Period 3||10
8320623|NCT01425801|20514597|P5|STARTED|Period 3||11
8320624|NCT01425801|20514598|P4|STARTED|Period 3||12
8320625|NCT01425801|20514599|P3|STARTED|Period 3||9
8320626|NCT01425801|20514600|P2|STARTED|Period 3||9
8320627|NCT01425801|20514601|P1|STARTED|Period 3||9
8320628|NCT01425801|20514596|P6|NOT COMPLETED|Period 2||0
8320629|NCT01425801|20514597|P5|NOT COMPLETED|Period 2||1
8320630|NCT01425801|20514598|P4|NOT COMPLETED|Period 2||0
8320631|NCT01425801|20514599|P3|NOT COMPLETED|Period 2||0
8320632|NCT01425801|20514600|P2|NOT COMPLETED|Period 2||0
8320633|NCT01425801|20514601|P1|NOT COMPLETED|Period 2||0
8320634|NCT01425801|20514596|P6|COMPLETED|Period 2||10
8320635|NCT01425801|20514597|P5|COMPLETED|Period 2||11
8320636|NCT01425801|20514598|P4|COMPLETED|Period 2||12
8320637|NCT01425801|20514599|P3|COMPLETED|Period 2||9
8320638|NCT01425801|20514600|P2|COMPLETED|Period 2||9
8320639|NCT01425801|20514601|P1|COMPLETED|Period 2||9
8320640|NCT01425801|20514596|P6|STARTED|Period 2||10
8320641|NCT01425801|20514597|P5|STARTED|Period 2||12
8320642|NCT01425801|20514598|P4|STARTED|Period 2||12
8320643|NCT01425801|20514599|P3|STARTED|Period 2||9
8320644|NCT01425801|20514600|P2|STARTED|Period 2||9
8320645|NCT01425801|20514601|P1|STARTED|Period 2||9
8320646|NCT01425801|20514596|P6|NOT COMPLETED|Period 1||0
8320647|NCT01425801|20514597|P5|NOT COMPLETED|Period 1||1
8320648|NCT01425801|20514598|P4|NOT COMPLETED|Period 1||0
8320649|NCT01425801|20514599|P3|NOT COMPLETED|Period 1||0
8320650|NCT01425801|20514600|P2|NOT COMPLETED|Period 1||0
8320651|NCT01425801|20514601|P1|NOT COMPLETED|Period 1||0
8320652|NCT01425801|20514596|P6|COMPLETED|Period 1||10
8320653|NCT01425801|20514597|P5|COMPLETED|Period 1||12
8320654|NCT01425801|20514598|P4|COMPLETED|Period 1||12
8320655|NCT01425801|20514599|P3|COMPLETED|Period 1||9
8320656|NCT01425801|20514600|P2|COMPLETED|Period 1||9
8320657|NCT01425801|20514601|P1|COMPLETED|Period 1||9
8320658|NCT01425801|20514596|P6|STARTED|Period 1||10
8320659|NCT01425801|20514597|P5|STARTED|Period 1||13
8320660|NCT01425801|20514598|P4|STARTED|Period 1||12
8320661|NCT01425801|20514599|P3|STARTED|Period 1||9
8320662|NCT01425801|20514600|P2|STARTED|Period 1||9
8320663|NCT01425801|20514601|P1|STARTED|Period 1||9
8320664|NCT01425749|20514707|P2|NOT COMPLETED|Overall Study||1
8320665|NCT01425749|20514708|P1|NOT COMPLETED|Overall Study||0
8320666|NCT01425749|20514707|P2|COMPLETED|Overall Study||11
8320667|NCT01425749|20514708|P1|COMPLETED|Overall Study||13
8320668|NCT01425749|20514707|P2|STARTED|Overall Study||12
8320669|NCT01425749|20514708|P1|STARTED|Overall Study||13
8320670|NCT01425723|20514725|P2|NOT COMPLETED|Overall Study||18
8320671|NCT01425723|20514726|P1|NOT COMPLETED|Overall Study||4
8320672|NCT01425723|20514725|P2|COMPLETED|Overall Study||75
8320673|NCT01425723|20514726|P1|COMPLETED|Overall Study||23
8320674|NCT01425723|20514725|P2|Surgery Subgroup|Overall Study||15
8320675|NCT01425723|20514726|P1|Surgery Subgroup|Overall Study||1
8320676|NCT01425723|20514725|P2|Episodic|Overall Study||15
8320677|NCT01425723|20514726|P1|Episodic|Overall Study||0
8320678|NCT01425723|20514725|P2|Personalized Prophylaxis|Overall Study||17
8320679|NCT01425723|20514726|P1|Personalized Prophylaxis|Overall Study||2
8320680|NCT01425723|20514725|P2|Individualized Prophylaxis|Overall Study||31
8320681|NCT01425723|20514726|P1|Individualized Prophylaxis|Overall Study||5
8320682|NCT01425723|20514725|P2|Weekly Prophylaxis|Overall Study||51
8320683|NCT01425723|20514726|P1|Weekly Prophylaxis|Overall Study||23
8320684|NCT01425723|20514725|P2|STARTED|Overall Study||93
8320685|NCT01425723|20514726|P1|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
8320686|NCT01425632|20514756|P3|NOT COMPLETED|Overall Study||4
8320687|NCT01425632|20514757|P2|NOT COMPLETED|Overall Study||1
8320688|NCT01425632|20514758|P1|NOT COMPLETED|Overall Study||1
8320689|NCT01425632|20514756|P3|COMPLETED|Overall Study||159
8320690|NCT01425632|20514757|P2|COMPLETED|Overall Study||165
8320691|NCT01425632|20514758|P1|COMPLETED|Overall Study||160
8320692|NCT01425632|20514756|P3|STARTED|Overall Study||163
8320693|NCT01425632|20514757|P2|STARTED|Overall Study||166
8320694|NCT01425632|20514758|P1|STARTED|Overall Study||161
8320695|NCT01425528|20514768|P2|NOT COMPLETED|Overall Study||1
8320696|NCT01425528|20514769|P1|NOT COMPLETED|Overall Study||1
8320697|NCT01425528|20514768|P2|COMPLETED|Overall Study||5
8320698|NCT01425528|20514769|P1|COMPLETED|Overall Study||5
8320699|NCT01425528|20514768|P2|STARTED|Overall Study||6
8320700|NCT01425528|20514769|P1|STARTED|Overall Study||6
8320701|NCT01425463|20514777|P2|NOT COMPLETED|Overall Study||24
8320702|NCT01425463|20514778|P1|NOT COMPLETED|Overall Study||24
8320703|NCT01425463|20514777|P2|COMPLETED|Overall Study||102
8320704|NCT01425463|20514778|P1|COMPLETED|Overall Study||106
8320705|NCT01425463|20514777|P2|Full Analysis Set|Overall Study||116
8320706|NCT01425463|20514778|P1|Full Analysis Set|Overall Study||122
8320707|NCT01425463|20514777|P2|Safety Set|Overall Study||122
8320708|NCT01425463|20514778|P1|Safety Set|Overall Study||126
8320709|NCT01425463|20514777|P2|STARTED|Overall Study||126
8320710|NCT01425463|20514778|P1|STARTED|Overall Study||130
8320711|NCT01425359|20514794|P2|NOT COMPLETED|Overall Study||22
8320712|NCT01425359|20514795|P1|NOT COMPLETED|Overall Study||19
8320713|NCT01425359|20514794|P2|COMPLETED|Overall Study||451
8320714|NCT01425359|20514795|P1|COMPLETED|Overall Study||457
8320715|NCT01425359|20514794|P2|STARTED|Overall Study||473
8320716|NCT01425359|20514795|P1|STARTED|Overall Study||476
8320717|NCT01425307|20514813|P2|NOT COMPLETED|Overall Study||19
8320718|NCT01425307|20514814|P1|NOT COMPLETED|Overall Study||19
8320719|NCT01425307|20514813|P2|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
8320720|NCT01425307|20514814|P1|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
8320721|NCT01425307|20514813|P2|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
8320722|NCT01425307|20514814|P1|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
8320723|NCT01425281|20514826|P2|NOT COMPLETED|At 5-year Clinical Follow-up||11
8320724|NCT01425281|20514827|P1|NOT COMPLETED|At 5-year Clinical Follow-up||32
8320725|NCT01425281|20514826|P2|COMPLETED|At 5-year Clinical Follow-up||125
8320726|NCT01425281|20514827|P1|COMPLETED|At 5-year Clinical Follow-up||256
8320727|NCT01425281|20514826|P2|STARTED|At 5-year Clinical Follow-up||136
8320728|NCT01425281|20514827|P1|STARTED|At 5-year Clinical Follow-up||288
8320729|NCT01425281|20514826|P2|NOT COMPLETED|At 4-year Clinical Follow-up||21
8320730|NCT01425281|20514827|P1|NOT COMPLETED|At 4-year Clinical Follow-up||30
8320731|NCT01425281|20514826|P2|COMPLETED|At 4-year Clinical Follow-up||136
8320732|NCT01425281|20514827|P1|COMPLETED|At 4-year Clinical Follow-up||288
8320733|NCT01425281|20514826|P2|STARTED|At 4-year Clinical Follow-up||157
8320734|NCT01425281|20514827|P1|STARTED|At 4-year Clinical Follow-up||318
8320735|NCT01425281|20514826|P2|NOT COMPLETED|At 3-year Clinical Follow-up||6
8320736|NCT01425281|20514827|P1|NOT COMPLETED|At 3-year Clinical Follow-up||5
8320737|NCT01425281|20514826|P2|COMPLETED|At 3-year Clinical Follow-up||157
8320738|NCT01425281|20514827|P1|COMPLETED|At 3-year Clinical Follow-up||318
8320739|NCT01425281|20514826|P2|STARTED|At 3-year Clinical Follow-up||163
8320740|NCT01425281|20514827|P1|STARTED|At 3-year Clinical Follow-up||323
8320741|NCT01425281|20514826|P2|NOT COMPLETED|At 2-year Clinical Follow-up||1
8320742|NCT01425281|20514827|P1|NOT COMPLETED|At 2-year Clinical Follow-up||6
8320743|NCT01425281|20514826|P2|COMPLETED|At 2-year Clinical Follow-up||163
8320744|NCT01425281|20514827|P1|COMPLETED|At 2-year Clinical Follow-up||323
8320745|NCT01425281|20514826|P2|STARTED|At 2-year Clinical Follow-up||164
8320746|NCT01425281|20514827|P1|STARTED|At 2-year Clinical Follow-up||329
8320747|NCT01425281|20514826|P2|NOT COMPLETED|At 1-year Clinical Follow-up||1
8320748|NCT01425281|20514827|P1|NOT COMPLETED|At 1-year Clinical Follow-up||2
8320749|NCT01425281|20514826|P2|COMPLETED|At 1-year Clinical Follow-up||164
8320750|NCT01425281|20514827|P1|COMPLETED|At 1-year Clinical Follow-up||329
8320751|NCT01425281|20514826|P2|STARTED|At 1-year Clinical Follow-up||165
8320752|NCT01425281|20514827|P1|STARTED|At 1-year Clinical Follow-up||331
8320753|NCT01425281|20514826|P2|NOT COMPLETED|At 180-day Clinical Follow-up||1
8320754|NCT01425281|20514827|P1|NOT COMPLETED|At 180-day Clinical Follow-up||3
8320755|NCT01425281|20514826|P2|COMPLETED|At 180-day Clinical Follow-up||165
8320756|NCT01425281|20514827|P1|COMPLETED|At 180-day Clinical Follow-up||331
8320757|NCT01425281|20514826|P2|STARTED|At 180-day Clinical Follow-up||166
8320758|NCT01425281|20514827|P1|STARTED|At 180-day Clinical Follow-up||334
8320759|NCT01425281|20514826|P2|NOT COMPLETED|At 30-day Clinical Follow-up||0
8320760|NCT01425281|20514827|P1|NOT COMPLETED|At 30-day Clinical Follow-up||1
8320761|NCT01425281|20514826|P2|COMPLETED|At 30-day Clinical Follow-up||166
8320762|NCT01425281|20514827|P1|COMPLETED|At 30-day Clinical Follow-up||334
8320763|NCT01425281|20514826|P2|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166
8320764|NCT01425281|20514827|P1|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335
8320765|NCT01425268|20515045|P2|NOT COMPLETED|Overall Study||0
8320766|NCT01425268|20515046|P1|NOT COMPLETED|Overall Study||8
8320767|NCT01425268|20515045|P2|COMPLETED|Overall Study||52
8320768|NCT01425268|20515046|P1|COMPLETED|Overall Study||98
8320769|NCT01425268|20515045|P2|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
8320770|NCT01425268|20515046|P1|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
8320771|NCT01425229|20515054|P1|NOT COMPLETED|Bosentan During Clarithromycin||0
8320772|NCT01425229|20515054|P1|COMPLETED|Bosentan During Clarithromycin||16
8320773|NCT01425229|20515054|P1|STARTED|Bosentan During Clarithromycin||16
8320774|NCT01425229|20515054|P1|NOT COMPLETED|Bosentan Steady-state||0
8320775|NCT01425229|20515054|P1|COMPLETED|Bosentan Steady-state||16
8320776|NCT01425229|20515054|P1|STARTED|Bosentan Steady-state||16
8320777|NCT01425229|20515054|P1|NOT COMPLETED|Bosentan Single Dose||0
8320778|NCT01425229|20515054|P1|COMPLETED|Bosentan Single Dose||16
8320779|NCT01425229|20515054|P1|STARTED|Bosentan Single Dose||16
8320810|NCT01425190|20515086|P3|NOT COMPLETED|Overall Study||0
8320811|NCT01425190|20515087|P2|NOT COMPLETED|Overall Study||0
8320812|NCT01425190|20515088|P1|NOT COMPLETED|Overall Study||1
8320813|NCT01425190|20515086|P3|COMPLETED|Overall Study||0
8320814|NCT01425190|20515087|P2|COMPLETED|Overall Study||0
8320815|NCT01425190|20515088|P1|COMPLETED|Overall Study||15
8320816|NCT01425190|20515086|P3|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
8320817|NCT01425190|20515087|P2|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
8320818|NCT01425190|20515088|P1|STARTED|Overall Study||16
8320819|NCT01425008|20515124|P19|NOT COMPLETED|Dose Expansion Phase||19
8320820|NCT01425008|20515125|P18|NOT COMPLETED|Dose Expansion Phase||2
8320821|NCT01425008|20515126|P17|NOT COMPLETED|Dose Expansion Phase||20
8320822|NCT01425008|20515127|P16|NOT COMPLETED|Dose Expansion Phase||11
8320823|NCT01425008|20515128|P15|NOT COMPLETED|Dose Expansion Phase||6
8320824|NCT01425008|20515129|P14|NOT COMPLETED|Dose Expansion Phase||1
8320825|NCT01425008|20515130|P13|NOT COMPLETED|Dose Expansion Phase||16
8320826|NCT01425008|20515131|P12|NOT COMPLETED|Dose Expansion Phase||8
8320827|NCT01425008|20515132|P11|NOT COMPLETED|Dose Expansion Phase||15
8320828|NCT01425008|20515133|P10|NOT COMPLETED|Dose Expansion Phase||0
8320829|NCT01425008|20515134|P9|NOT COMPLETED|Dose Expansion Phase||0
8320830|NCT01425008|20515135|P8|NOT COMPLETED|Dose Expansion Phase||0
8320831|NCT01425008|20515136|P7|NOT COMPLETED|Dose Expansion Phase||0
8320832|NCT01425008|20515137|P6|NOT COMPLETED|Dose Expansion Phase||0
8320833|NCT01425008|20515138|P5|NOT COMPLETED|Dose Expansion Phase||0
8320834|NCT01425008|20515139|P4|NOT COMPLETED|Dose Expansion Phase||0
8320835|NCT01425008|20515140|P3|NOT COMPLETED|Dose Expansion Phase||0
8320836|NCT01425008|20515141|P2|NOT COMPLETED|Dose Expansion Phase||0
8320837|NCT01425008|20515142|P1|NOT COMPLETED|Dose Expansion Phase||0
8320838|NCT01425008|20515124|P19|COMPLETED|Dose Expansion Phase||0
8320839|NCT01425008|20515125|P18|COMPLETED|Dose Expansion Phase||0
8320840|NCT01425008|20515126|P17|COMPLETED|Dose Expansion Phase||0
8320841|NCT01425008|20515127|P16|COMPLETED|Dose Expansion Phase||0
8320842|NCT01425008|20515128|P15|COMPLETED|Dose Expansion Phase||0
8320843|NCT01425008|20515129|P14|COMPLETED|Dose Expansion Phase||0
8320844|NCT01425008|20515130|P13|COMPLETED|Dose Expansion Phase||0
8320845|NCT01425008|20515131|P12|COMPLETED|Dose Expansion Phase||0
8320846|NCT01425008|20515132|P11|COMPLETED|Dose Expansion Phase||1
8320847|NCT01425008|20515133|P10|COMPLETED|Dose Expansion Phase||0
8320848|NCT01425008|20515134|P9|COMPLETED|Dose Expansion Phase||0
8320849|NCT01425008|20515135|P8|COMPLETED|Dose Expansion Phase||0
8320850|NCT01425008|20515136|P7|COMPLETED|Dose Expansion Phase||0
8320851|NCT01425008|20515137|P6|COMPLETED|Dose Expansion Phase||0
8320852|NCT01425008|20515138|P5|COMPLETED|Dose Expansion Phase||0
8320853|NCT01425008|20515139|P4|COMPLETED|Dose Expansion Phase||0
8320854|NCT01425008|20515140|P3|COMPLETED|Dose Expansion Phase||0
8320855|NCT01425008|20515141|P2|COMPLETED|Dose Expansion Phase||0
8320856|NCT01425008|20515142|P1|COMPLETED|Dose Expansion Phase||0
8320857|NCT01425008|20515124|P19|STARTED|Dose Expansion Phase||19
8320858|NCT01425008|20515125|P18|STARTED|Dose Expansion Phase||2
8320859|NCT01425008|20515126|P17|STARTED|Dose Expansion Phase||20
8320860|NCT01425008|20515127|P16|STARTED|Dose Expansion Phase||11
8320861|NCT01425008|20515128|P15|STARTED|Dose Expansion Phase||6
8320862|NCT01425008|20515129|P14|STARTED|Dose Expansion Phase||1
8320863|NCT01425008|20515130|P13|STARTED|Dose Expansion Phase||16
8320864|NCT01425008|20515131|P12|STARTED|Dose Expansion Phase||8
8320865|NCT01425008|20515132|P11|STARTED|Dose Expansion Phase||16
8320866|NCT01425008|20515133|P10|STARTED|Dose Expansion Phase||0
8320867|NCT01425008|20515134|P9|STARTED|Dose Expansion Phase||0
8320868|NCT01425008|20515135|P8|STARTED|Dose Expansion Phase||0
8320869|NCT01425008|20515136|P7|STARTED|Dose Expansion Phase||0
8320870|NCT01425008|20515137|P6|STARTED|Dose Expansion Phase||0
8320871|NCT01425008|20515138|P5|STARTED|Dose Expansion Phase||0
8320872|NCT01425008|20515139|P4|STARTED|Dose Expansion Phase||0
8320873|NCT01425008|20515140|P3|STARTED|Dose Expansion Phase||0
8320874|NCT01425008|20515141|P2|STARTED|Dose Expansion Phase||0
8320875|NCT01425008|20515142|P1|STARTED|Dose Expansion Phase||0
8320876|NCT01425008|20515124|P19|NOT COMPLETED|Dose Escalation Phase||0
8320877|NCT01425008|20515125|P18|NOT COMPLETED|Dose Escalation Phase||0
8320878|NCT01425008|20515126|P17|NOT COMPLETED|Dose Escalation Phase||0
8320879|NCT01425008|20515127|P16|NOT COMPLETED|Dose Escalation Phase||0
8320880|NCT01425008|20515128|P15|NOT COMPLETED|Dose Escalation Phase||0
8320881|NCT01425008|20515129|P14|NOT COMPLETED|Dose Escalation Phase||0
8320882|NCT01425008|20515130|P13|NOT COMPLETED|Dose Escalation Phase||0
8320883|NCT01425008|20515131|P12|NOT COMPLETED|Dose Escalation Phase||0
8320884|NCT01425008|20515132|P11|NOT COMPLETED|Dose Escalation Phase||0
8320885|NCT01425008|20515133|P10|NOT COMPLETED|Dose Escalation Phase||4
8320886|NCT01425008|20515134|P9|NOT COMPLETED|Dose Escalation Phase||13
8320887|NCT01425008|20515135|P8|NOT COMPLETED|Dose Escalation Phase||3
8320888|NCT01425008|20515136|P7|NOT COMPLETED|Dose Escalation Phase||3
8320889|NCT01425008|20515137|P6|NOT COMPLETED|Dose Escalation Phase||7
8320890|NCT01425008|20515138|P5|NOT COMPLETED|Dose Escalation Phase||7
8320891|NCT01425008|20515139|P4|NOT COMPLETED|Dose Escalation Phase||3
8320892|NCT01425008|20515140|P3|NOT COMPLETED|Dose Escalation Phase||3
8320893|NCT01425008|20515141|P2|NOT COMPLETED|Dose Escalation Phase||3
8320894|NCT01425008|20515142|P1|NOT COMPLETED|Dose Escalation Phase||4
8320895|NCT01425008|20515124|P19|COMPLETED|Dose Escalation Phase||0
8320896|NCT01425008|20515125|P18|COMPLETED|Dose Escalation Phase||0
8320897|NCT01425008|20515126|P17|COMPLETED|Dose Escalation Phase||0
8320898|NCT01425008|20515127|P16|COMPLETED|Dose Escalation Phase||0
8320899|NCT01425008|20515128|P15|COMPLETED|Dose Escalation Phase||0
8320900|NCT01425008|20515129|P14|COMPLETED|Dose Escalation Phase||0
8320901|NCT01425008|20515130|P13|COMPLETED|Dose Escalation Phase||0
8320902|NCT01425008|20515131|P12|COMPLETED|Dose Escalation Phase||0
8320903|NCT01425008|20515132|P11|COMPLETED|Dose Escalation Phase||0
8320904|NCT01425008|20515133|P10|COMPLETED|Dose Escalation Phase||0
8320905|NCT01425008|20515134|P9|COMPLETED|Dose Escalation Phase||0
8320906|NCT01425008|20515135|P8|COMPLETED|Dose Escalation Phase||0
8320907|NCT01425008|20515136|P7|COMPLETED|Dose Escalation Phase||0
8320908|NCT01425008|20515137|P6|COMPLETED|Dose Escalation Phase||0
8320909|NCT01425008|20515138|P5|COMPLETED|Dose Escalation Phase||0
8320910|NCT01425008|20515139|P4|COMPLETED|Dose Escalation Phase||0
8320911|NCT01425008|20515140|P3|COMPLETED|Dose Escalation Phase||0
8320912|NCT01425008|20515141|P2|COMPLETED|Dose Escalation Phase||0
8320913|NCT01425008|20515142|P1|COMPLETED|Dose Escalation Phase||0
8320914|NCT01425008|20515124|P19|STARTED|Dose Escalation Phase||0
8320915|NCT01425008|20515125|P18|STARTED|Dose Escalation Phase||0
8320916|NCT01425008|20515126|P17|STARTED|Dose Escalation Phase||0
8320917|NCT01425008|20515127|P16|STARTED|Dose Escalation Phase||0
8320918|NCT01425008|20515128|P15|STARTED|Dose Escalation Phase||0
8320919|NCT01425008|20515129|P14|STARTED|Dose Escalation Phase||0
8320920|NCT01425008|20515130|P13|STARTED|Dose Escalation Phase||0
8320921|NCT01425008|20515131|P12|STARTED|Dose Escalation Phase||0
8320922|NCT01425008|20515132|P11|STARTED|Dose Escalation Phase||0
8320923|NCT01425008|20515133|P10|STARTED|Dose Escalation Phase||4
8320924|NCT01425008|20515134|P9|STARTED|Dose Escalation Phase||13
8320925|NCT01425008|20515135|P8|STARTED|Dose Escalation Phase||3
8320926|NCT01425008|20515136|P7|STARTED|Dose Escalation Phase||3
8320927|NCT01425008|20515137|P6|STARTED|Dose Escalation Phase||7
8320928|NCT01425008|20515138|P5|STARTED|Dose Escalation Phase||7
8320929|NCT01425008|20515139|P4|STARTED|Dose Escalation Phase||3
8320930|NCT01425008|20515140|P3|STARTED|Dose Escalation Phase||3
8320931|NCT01425008|20515141|P2|STARTED|Dose Escalation Phase||3
8320932|NCT01425008|20515142|P1|STARTED|Dose Escalation Phase||4
8320933|NCT01424943|20515428|P2|NOT COMPLETED|Overall Study||1
8320934|NCT01424943|20515429|P1|NOT COMPLETED|Overall Study||13
8320935|NCT01424943|20515428|P2|COMPLETED|Overall Study||23
8320936|NCT01424943|20515429|P1|COMPLETED|Overall Study||12
8320937|NCT01424943|20515428|P2|STARTED|Overall Study||24
8320938|NCT01424943|20515429|P1|STARTED|Overall Study||25
8320939|NCT01424930|20515445|P2|NOT COMPLETED|Overall Study||14
8320940|NCT01424930|20515446|P1|NOT COMPLETED|Overall Study||4
8320941|NCT01424930|20515445|P2|COMPLETED|Overall Study||4
8320942|NCT01424930|20515446|P1|COMPLETED|Overall Study||3
8320943|NCT01424930|20515445|P2|Completed Food Safety Evaluation|Overall Study||18
8320944|NCT01424930|20515446|P1|Completed Food Safety Evaluation|Overall Study||6
8320945|NCT01424930|20515445|P2|STARTED|Overall Study||18
8320946|NCT01424930|20515446|P1|STARTED|Overall Study||7
8320947|NCT01424813|20515460|P2|NOT COMPLETED|Overall Study||2
8320948|NCT01424813|20515461|P1|NOT COMPLETED|Overall Study||5
8320949|NCT01424813|20515460|P2|COMPLETED|Overall Study||77
8320950|NCT01424813|20515461|P1|COMPLETED|Overall Study||74
8320951|NCT01424813|20515460|P2|Treated|Overall Study|Safety set and full analysis set|78
8320952|NCT01424813|20515461|P1|Treated|Overall Study|Safety set and full analysis set|79
8320953|NCT01424813|20515460|P2|STARTED|Overall Study||79
8320954|NCT01424813|20515461|P1|STARTED|Overall Study||79
8320955|NCT01424670|20515481|P2|NOT COMPLETED|Continuation Period||14
8320956|NCT01424670|20515482|P1|NOT COMPLETED|Continuation Period||34
8320957|NCT01424670|20515481|P2|COMPLETED|Continuation Period||142
8320958|NCT01424670|20515482|P1|COMPLETED|Continuation Period||288
8320959|NCT01424670|20515481|P2|STARTED|Continuation Period||156
8320960|NCT01424670|20515482|P1|STARTED|Continuation Period||322
8320961|NCT01424670|20515481|P2|NOT COMPLETED|6-Month Intensive Period (182 Days)||14
8320962|NCT01424670|20515482|P1|NOT COMPLETED|6-Month Intensive Period (182 Days)||19
8320963|NCT01424670|20515481|P2|COMPLETED|6-Month Intensive Period (182 Days)||156
8320964|NCT01424670|20515482|P1|COMPLETED|6-Month Intensive Period (182 Days)||322
8320965|NCT01424670|20515481|P2|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170
8320966|NCT01424670|20515482|P1|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341
8320967|NCT01424670|20515481|P2|STARTED|6-Month Intensive Period (182 Days)||170
8320968|NCT01424670|20515482|P1|STARTED|6-Month Intensive Period (182 Days)||341
8320969|NCT01424644|20515504|P2|NOT COMPLETED|Overall Study||27
8320970|NCT01424644|20515505|P1|NOT COMPLETED|Overall Study||33
8320971|NCT01424644|20515504|P2|COMPLETED|Overall Study||372
8320972|NCT01424644|20515505|P1|COMPLETED|Overall Study||369
8320973|NCT01424644|20515504|P2|STARTED|Overall Study||399
8320974|NCT01424644|20515505|P1|STARTED|Overall Study||402
8320975|NCT01424566|20515519|P3|NOT COMPLETED|Double-blind Treatment||15
8320976|NCT01424566|20515520|P2|NOT COMPLETED|Double-blind Treatment||25
8320977|NCT01424566|20515521|P1|NOT COMPLETED|Double-blind Treatment||0
8320978|NCT01424566|20515519|P3|COMPLETED|Double-blind Treatment||88
8320979|NCT01424566|20515520|P2|COMPLETED|Double-blind Treatment||78
8320980|NCT01424566|20515521|P1|COMPLETED|Double-blind Treatment||0
8320981|NCT01424566|20515519|P3|ITT Population|Double-blind Treatment||103
8320982|NCT01424566|20515520|P2|ITT Population|Double-blind Treatment||103
8320983|NCT01424566|20515521|P1|ITT Population|Double-blind Treatment||0
8320984|NCT01424566|20515519|P3|Randomized Safety Population|Double-blind Treatment||103
8320985|NCT01424566|20515520|P2|Randomized Safety Population|Double-blind Treatment||103
8320986|NCT01424566|20515521|P1|Randomized Safety Population|Double-blind Treatment||0
8320987|NCT01424566|20515519|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
8320988|NCT01424566|20515520|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
8320989|NCT01424566|20515521|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
8320990|NCT01424566|20515519|P3|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
8320991|NCT01424566|20515520|P2|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
8320992|NCT01424566|20515521|P1|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
8320993|NCT01424566|20515519|P3|NOT COMPLETED|Single-blind Treatment||0
8320994|NCT01424566|20515520|P2|NOT COMPLETED|Single-blind Treatment||0
8320995|NCT01424566|20515521|P1|NOT COMPLETED|Single-blind Treatment||200
8320996|NCT01424566|20515519|P3|COMPLETED|Single-blind Treatment||0
8320997|NCT01424566|20515520|P2|COMPLETED|Single-blind Treatment||0
8320998|NCT01424566|20515521|P1|COMPLETED|Single-blind Treatment||206
8320999|NCT01424566|20515519|P3|Met Randomization Criteria|Single-blind Treatment||0
8321000|NCT01424566|20515520|P2|Met Randomization Criteria|Single-blind Treatment||0
8321001|NCT01424566|20515521|P1|Met Randomization Criteria|Single-blind Treatment||206
8321002|NCT01424566|20515519|P3|Single-blind Safety Population|Single-blind Treatment||0
8321003|NCT01424566|20515520|P2|Single-blind Safety Population|Single-blind Treatment||0
8321004|NCT01424566|20515521|P1|Single-blind Safety Population|Single-blind Treatment||404
8321005|NCT01424566|20515519|P3|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
8321006|NCT01424566|20515520|P2|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
8321007|NCT01424566|20515521|P1|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
8321008|NCT01424566|20515519|P3|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
8321009|NCT01424566|20515520|P2|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
8321010|NCT01424566|20515521|P1|STARTED|Single-blind Treatment||406
8321011|NCT01424514|20515548|P2|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
8321012|NCT01424514|20515549|P1|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
8321013|NCT01424514|20515548|P2|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
8321014|NCT01424514|20515549|P1|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
8321015|NCT01424514|20515548|P2|STARTED|Period 3:Intervention Period 2 (14 Days)||19
8321016|NCT01424514|20515549|P1|STARTED|Period 3:Intervention Period 2 (14 Days)||19
8321017|NCT01424514|20515548|P2|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
8321018|NCT01424514|20515549|P1|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
8321019|NCT01424514|20515548|P2|COMPLETED|Period 2:Washout Period (4 Weeks)||19
8321020|NCT01424514|20515549|P1|COMPLETED|Period 2:Washout Period (4 Weeks)||19
8321021|NCT01424514|20515548|P2|STARTED|Period 2:Washout Period (4 Weeks)||19
8321022|NCT01424514|20515549|P1|STARTED|Period 2:Washout Period (4 Weeks)||19
8321023|NCT01424514|20515548|P2|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
8321024|NCT01424514|20515549|P1|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
8321025|NCT01424514|20515548|P2|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
8321026|NCT01424514|20515549|P1|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
8321027|NCT01424514|20515548|P2|STARTED|Period 1:Intervention Period 1 (14 Days)||20
8321028|NCT01424514|20515549|P1|STARTED|Period 1:Intervention Period 1 (14 Days)||20
8321029|NCT01424501|20515594|P6|NOT COMPLETED|Overall Study||0
8321030|NCT01424501|20515595|P5|NOT COMPLETED|Overall Study||0
8321031|NCT01424501|20515596|P4|NOT COMPLETED|Overall Study||0
8321032|NCT01424501|20515597|P3|NOT COMPLETED|Overall Study||2
8321033|NCT01424501|20515598|P2|NOT COMPLETED|Overall Study||1
8321034|NCT01424501|20515599|P1|NOT COMPLETED|Overall Study||1
8321035|NCT01424501|20515594|P6|COMPLETED|Overall Study||40
8321036|NCT01424501|20515595|P5|COMPLETED|Overall Study||40
8321037|NCT01424501|20515596|P4|COMPLETED|Overall Study||25
8321038|NCT01424501|20515597|P3|COMPLETED|Overall Study||22
8321039|NCT01424501|20515598|P2|COMPLETED|Overall Study||5
8321040|NCT01424501|20515599|P1|COMPLETED|Overall Study||6
8321041|NCT01424501|20515594|P6|STARTED|Overall Study||40
8321042|NCT01424501|20515595|P5|STARTED|Overall Study||40
8321043|NCT01424501|20515596|P4|STARTED|Overall Study||25
8321044|NCT01424501|20515597|P3|STARTED|Overall Study||24
8321045|NCT01424501|20515598|P2|STARTED|Overall Study||6
8321046|NCT01424501|20515599|P1|STARTED|Overall Study||7
8321047|NCT01424397|20515775|P12|NOT COMPLETED|Period-3 (8 Days)||0
8321048|NCT01424397|20515776|P11|NOT COMPLETED|Period-3 (8 Days)||0
8321049|NCT01424397|20515777|P10|NOT COMPLETED|Period-3 (8 Days)||0
8321050|NCT01424397|20515778|P9|NOT COMPLETED|Period-3 (8 Days)||0
8321051|NCT01424397|20515779|P8|NOT COMPLETED|Period-3 (8 Days)||0
8321052|NCT01424397|20515780|P7|NOT COMPLETED|Period-3 (8 Days)||0
8321053|NCT01424397|20515781|P6|NOT COMPLETED|Period-3 (8 Days)||0
8321054|NCT01424397|20515782|P5|NOT COMPLETED|Period-3 (8 Days)||0
8321055|NCT01424397|20515783|P4|NOT COMPLETED|Period-3 (8 Days)||0
8321056|NCT01424397|20515784|P3|NOT COMPLETED|Period-3 (8 Days)||0
8321057|NCT01424397|20515785|P2|NOT COMPLETED|Period-3 (8 Days)||0
8321058|NCT01424397|20515786|P1|NOT COMPLETED|Period-3 (8 Days)||0
8321059|NCT01424397|20515775|P12|COMPLETED|Period-3 (8 Days)||4
8321060|NCT01424397|20515776|P11|COMPLETED|Period-3 (8 Days)||4
8321061|NCT01424397|20515777|P10|COMPLETED|Period-3 (8 Days)||3
8321062|NCT01424397|20515778|P9|COMPLETED|Period-3 (8 Days)||4
8321063|NCT01424397|20515779|P8|COMPLETED|Period-3 (8 Days)||4
8321064|NCT01424397|20515780|P7|COMPLETED|Period-3 (8 Days)||4
8321065|NCT01424397|20515781|P6|COMPLETED|Period-3 (8 Days)||8
8321066|NCT01424397|20515782|P5|COMPLETED|Period-3 (8 Days)||8
8321067|NCT01424397|20515783|P4|COMPLETED|Period-3 (8 Days)||8
8321068|NCT01424397|20515784|P3|COMPLETED|Period-3 (8 Days)||7
8321069|NCT01424397|20515785|P2|COMPLETED|Period-3 (8 Days)||8
8321070|NCT01424397|20515786|P1|COMPLETED|Period-3 (8 Days)||7
8321071|NCT01424397|20515775|P12|STARTED|Period-3 (8 Days)||4
8321072|NCT01424397|20515776|P11|STARTED|Period-3 (8 Days)||4
8321073|NCT01424397|20515777|P10|STARTED|Period-3 (8 Days)||3
8321074|NCT01424397|20515778|P9|STARTED|Period-3 (8 Days)||4
8321075|NCT01424397|20515779|P8|STARTED|Period-3 (8 Days)||4
8321076|NCT01424397|20515780|P7|STARTED|Period-3 (8 Days)||4
8321077|NCT01424397|20515781|P6|STARTED|Period-3 (8 Days)||8
8321078|NCT01424397|20515782|P5|STARTED|Period-3 (8 Days)||8
8321079|NCT01424397|20515783|P4|STARTED|Period-3 (8 Days)||8
8321080|NCT01424397|20515784|P3|STARTED|Period-3 (8 Days)||7
8321081|NCT01424397|20515785|P2|STARTED|Period-3 (8 Days)||8
8321082|NCT01424397|20515786|P1|STARTED|Period-3 (8 Days)||7
8321083|NCT01424397|20515775|P12|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321084|NCT01424397|20515776|P11|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321085|NCT01424397|20515777|P10|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321086|NCT01424397|20515778|P9|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321087|NCT01424397|20515779|P8|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321088|NCT01424397|20515780|P7|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321089|NCT01424397|20515781|P6|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321090|NCT01424397|20515782|P5|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321091|NCT01424397|20515783|P4|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321092|NCT01424397|20515784|P3|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321093|NCT01424397|20515785|P2|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321094|NCT01424397|20515786|P1|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
8321095|NCT01424397|20515775|P12|COMPLETED|Washout Period-2 (14-20 Days)||4
8321096|NCT01424397|20515776|P11|COMPLETED|Washout Period-2 (14-20 Days)||4
8321097|NCT01424397|20515777|P10|COMPLETED|Washout Period-2 (14-20 Days)||3
8321098|NCT01424397|20515778|P9|COMPLETED|Washout Period-2 (14-20 Days)||4
8321099|NCT01424397|20515779|P8|COMPLETED|Washout Period-2 (14-20 Days)||4
8321100|NCT01424397|20515780|P7|COMPLETED|Washout Period-2 (14-20 Days)||4
8321101|NCT01424397|20515781|P6|COMPLETED|Washout Period-2 (14-20 Days)||8
8321102|NCT01424397|20515782|P5|COMPLETED|Washout Period-2 (14-20 Days)||8
8321103|NCT01424397|20515783|P4|COMPLETED|Washout Period-2 (14-20 Days)||8
8321104|NCT01424397|20515784|P3|COMPLETED|Washout Period-2 (14-20 Days)||7
8321105|NCT01424397|20515785|P2|COMPLETED|Washout Period-2 (14-20 Days)||8
8321106|NCT01424397|20515786|P1|COMPLETED|Washout Period-2 (14-20 Days)||7
8321107|NCT01424397|20515775|P12|STARTED|Washout Period-2 (14-20 Days)||4
8321108|NCT01424397|20515776|P11|STARTED|Washout Period-2 (14-20 Days)||4
8321109|NCT01424397|20515777|P10|STARTED|Washout Period-2 (14-20 Days)||3
8321110|NCT01424397|20515778|P9|STARTED|Washout Period-2 (14-20 Days)||4
8321111|NCT01424397|20515779|P8|STARTED|Washout Period-2 (14-20 Days)||4
8321112|NCT01424397|20515780|P7|STARTED|Washout Period-2 (14-20 Days)||4
8321113|NCT01424397|20515781|P6|STARTED|Washout Period-2 (14-20 Days)||8
8321114|NCT01424397|20515782|P5|STARTED|Washout Period-2 (14-20 Days)||8
8321115|NCT01424397|20515783|P4|STARTED|Washout Period-2 (14-20 Days)||8
8321116|NCT01424397|20515784|P3|STARTED|Washout Period-2 (14-20 Days)||7
8321117|NCT01424397|20515785|P2|STARTED|Washout Period-2 (14-20 Days)||8
8321118|NCT01424397|20515786|P1|STARTED|Washout Period-2 (14-20 Days)||7
8321119|NCT01424397|20515775|P12|NOT COMPLETED|Period-2 (8 Days)||0
8321120|NCT01424397|20515776|P11|NOT COMPLETED|Period-2 (8 Days)||0
8321121|NCT01424397|20515777|P10|NOT COMPLETED|Period-2 (8 Days)||0
8321122|NCT01424397|20515778|P9|NOT COMPLETED|Period-2 (8 Days)||0
8321123|NCT01424397|20515779|P8|NOT COMPLETED|Period-2 (8 Days)||0
8321124|NCT01424397|20515780|P7|NOT COMPLETED|Period-2 (8 Days)||0
8321125|NCT01424397|20515781|P6|NOT COMPLETED|Period-2 (8 Days)||0
8321126|NCT01424397|20515782|P5|NOT COMPLETED|Period-2 (8 Days)||0
8321127|NCT01424397|20515783|P4|NOT COMPLETED|Period-2 (8 Days)||0
8321128|NCT01424397|20515784|P3|NOT COMPLETED|Period-2 (8 Days)||1
8321129|NCT01424397|20515785|P2|NOT COMPLETED|Period-2 (8 Days)||0
8321130|NCT01424397|20515786|P1|NOT COMPLETED|Period-2 (8 Days)||0
8321131|NCT01424397|20515775|P12|COMPLETED|Period-2 (8 Days)||4
8321132|NCT01424397|20515776|P11|COMPLETED|Period-2 (8 Days)||4
8321133|NCT01424397|20515777|P10|COMPLETED|Period-2 (8 Days)||3
8321134|NCT01424397|20515778|P9|COMPLETED|Period-2 (8 Days)||4
8321135|NCT01424397|20515779|P8|COMPLETED|Period-2 (8 Days)||4
8321136|NCT01424397|20515780|P7|COMPLETED|Period-2 (8 Days)||4
8321137|NCT01424397|20515781|P6|COMPLETED|Period-2 (8 Days)||8
8321138|NCT01424397|20515782|P5|COMPLETED|Period-2 (8 Days)||8
8321139|NCT01424397|20515783|P4|COMPLETED|Period-2 (8 Days)||8
8321140|NCT01424397|20515784|P3|COMPLETED|Period-2 (8 Days)||7
8321141|NCT01424397|20515785|P2|COMPLETED|Period-2 (8 Days)||8
8321142|NCT01424397|20515786|P1|COMPLETED|Period-2 (8 Days)||7
8321143|NCT01424397|20515775|P12|STARTED|Period-2 (8 Days)||4
8321144|NCT01424397|20515776|P11|STARTED|Period-2 (8 Days)||4
8321145|NCT01424397|20515777|P10|STARTED|Period-2 (8 Days)||3
8321146|NCT01424397|20515778|P9|STARTED|Period-2 (8 Days)||4
8321147|NCT01424397|20515779|P8|STARTED|Period-2 (8 Days)||4
8321148|NCT01424397|20515780|P7|STARTED|Period-2 (8 Days)||4
8321149|NCT01424397|20515781|P6|STARTED|Period-2 (8 Days)||8
8321150|NCT01424397|20515782|P5|STARTED|Period-2 (8 Days)||8
8321151|NCT01424397|20515783|P4|STARTED|Period-2 (8 Days)||8
8321152|NCT01424397|20515784|P3|STARTED|Period-2 (8 Days)||8
8321153|NCT01424397|20515785|P2|STARTED|Period-2 (8 Days)||8
8321154|NCT01424397|20515786|P1|STARTED|Period-2 (8 Days)||7
8321155|NCT01424397|20515775|P12|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321156|NCT01424397|20515776|P11|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321157|NCT01424397|20515777|P10|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321158|NCT01424397|20515778|P9|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321159|NCT01424397|20515779|P8|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321160|NCT01424397|20515780|P7|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321161|NCT01424397|20515781|P6|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321162|NCT01424397|20515782|P5|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321163|NCT01424397|20515783|P4|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321164|NCT01424397|20515784|P3|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321165|NCT01424397|20515785|P2|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321166|NCT01424397|20515786|P1|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
8321167|NCT01424397|20515775|P12|COMPLETED|Washout Period-1 (14-20 Days)||4
8321168|NCT01424397|20515776|P11|COMPLETED|Washout Period-1 (14-20 Days)||4
8321169|NCT01424397|20515777|P10|COMPLETED|Washout Period-1 (14-20 Days)||3
8321170|NCT01424397|20515778|P9|COMPLETED|Washout Period-1 (14-20 Days)||4
8321171|NCT01424397|20515779|P8|COMPLETED|Washout Period-1 (14-20 Days)||4
8321172|NCT01424397|20515780|P7|COMPLETED|Washout Period-1 (14-20 Days)||4
8321173|NCT01424397|20515781|P6|COMPLETED|Washout Period-1 (14-20 Days)||8
8321174|NCT01424397|20515782|P5|COMPLETED|Washout Period-1 (14-20 Days)||8
8321175|NCT01424397|20515783|P4|COMPLETED|Washout Period-1 (14-20 Days)||8
8321176|NCT01424397|20515784|P3|COMPLETED|Washout Period-1 (14-20 Days)||8
8321177|NCT01424397|20515785|P2|COMPLETED|Washout Period-1 (14-20 Days)||8
8321178|NCT01424397|20515786|P1|COMPLETED|Washout Period-1 (14-20 Days)||7
8321179|NCT01424397|20515775|P12|STARTED|Washout Period-1 (14-20 Days)||4
8321180|NCT01424397|20515776|P11|STARTED|Washout Period-1 (14-20 Days)||4
8321181|NCT01424397|20515777|P10|STARTED|Washout Period-1 (14-20 Days)||3
8321182|NCT01424397|20515778|P9|STARTED|Washout Period-1 (14-20 Days)||4
8321183|NCT01424397|20515779|P8|STARTED|Washout Period-1 (14-20 Days)||4
8321184|NCT01424397|20515780|P7|STARTED|Washout Period-1 (14-20 Days)||4
8321185|NCT01424397|20515781|P6|STARTED|Washout Period-1 (14-20 Days)||8
8321186|NCT01424397|20515782|P5|STARTED|Washout Period-1 (14-20 Days)||8
8321187|NCT01424397|20515783|P4|STARTED|Washout Period-1 (14-20 Days)||8
8321188|NCT01424397|20515784|P3|STARTED|Washout Period-1 (14-20 Days)||8
8321189|NCT01424397|20515785|P2|STARTED|Washout Period-1 (14-20 Days)||8
8321190|NCT01424397|20515786|P1|STARTED|Washout Period-1 (14-20 Days)||7
8321191|NCT01424397|20515775|P12|NOT COMPLETED|Period-1 (8 Days)||0
8321192|NCT01424397|20515776|P11|NOT COMPLETED|Period-1 (8 Days)||0
8321193|NCT01424397|20515777|P10|NOT COMPLETED|Period-1 (8 Days)||0
8321194|NCT01424397|20515778|P9|NOT COMPLETED|Period-1 (8 Days)||0
8321195|NCT01424397|20515779|P8|NOT COMPLETED|Period-1 (8 Days)||0
8321196|NCT01424397|20515780|P7|NOT COMPLETED|Period-1 (8 Days)||0
8321197|NCT01424397|20515781|P6|NOT COMPLETED|Period-1 (8 Days)||0
8321198|NCT01424397|20515782|P5|NOT COMPLETED|Period-1 (8 Days)||0
8321199|NCT01424397|20515783|P4|NOT COMPLETED|Period-1 (8 Days)||0
8321200|NCT01424397|20515784|P3|NOT COMPLETED|Period-1 (8 Days)||0
8321201|NCT01424397|20515785|P2|NOT COMPLETED|Period-1 (8 Days)||0
8321202|NCT01424397|20515786|P1|NOT COMPLETED|Period-1 (8 Days)||0
8321203|NCT01424397|20515775|P12|COMPLETED|Period-1 (8 Days)||4
8321204|NCT01424397|20515776|P11|COMPLETED|Period-1 (8 Days)||4
8321205|NCT01424397|20515777|P10|COMPLETED|Period-1 (8 Days)||3
8321206|NCT01424397|20515778|P9|COMPLETED|Period-1 (8 Days)||4
8321207|NCT01424397|20515779|P8|COMPLETED|Period-1 (8 Days)||4
8321208|NCT01424397|20515780|P7|COMPLETED|Period-1 (8 Days)||4
8321209|NCT01424397|20515781|P6|COMPLETED|Period-1 (8 Days)||8
8321210|NCT01424397|20515782|P5|COMPLETED|Period-1 (8 Days)||8
8321211|NCT01424397|20515783|P4|COMPLETED|Period-1 (8 Days)||8
8321212|NCT01424397|20515784|P3|COMPLETED|Period-1 (8 Days)||8
8321213|NCT01424397|20515785|P2|COMPLETED|Period-1 (8 Days)||8
8321214|NCT01424397|20515786|P1|COMPLETED|Period-1 (8 Days)||7
8321215|NCT01424397|20515775|P12|STARTED|Period-1 (8 Days)||4
8321216|NCT01424397|20515776|P11|STARTED|Period-1 (8 Days)||4
8321217|NCT01424397|20515777|P10|STARTED|Period-1 (8 Days)||3
8321218|NCT01424397|20515778|P9|STARTED|Period-1 (8 Days)||4
8321219|NCT01424397|20515779|P8|STARTED|Period-1 (8 Days)||4
8321220|NCT01424397|20515780|P7|STARTED|Period-1 (8 Days)||4
8321221|NCT01424397|20515781|P6|STARTED|Period-1 (8 Days)||8
8321222|NCT01424397|20515782|P5|STARTED|Period-1 (8 Days)||8
8321223|NCT01424397|20515783|P4|STARTED|Period-1 (8 Days)||8
8321224|NCT01424397|20515784|P3|STARTED|Period-1 (8 Days)||8
8321225|NCT01424397|20515785|P2|STARTED|Period-1 (8 Days)||8
8321226|NCT01424397|20515786|P1|STARTED|Period-1 (8 Days)||7
8321227|NCT01424306|20515832|P6|NOT COMPLETED|Overall Study||0
8321228|NCT01424306|20515833|P5|NOT COMPLETED|Overall Study||1
8321229|NCT01424306|20515834|P4|NOT COMPLETED|Overall Study||0
8321230|NCT01424306|20515835|P3|NOT COMPLETED|Overall Study||0
8321231|NCT01424306|20515836|P2|NOT COMPLETED|Overall Study||0
8321232|NCT01424306|20515837|P1|NOT COMPLETED|Overall Study||0
8321233|NCT01424306|20515832|P6|COMPLETED|Overall Study||6
8321234|NCT01424306|20515833|P5|COMPLETED|Overall Study||4
8321235|NCT01424306|20515834|P4|COMPLETED|Overall Study||3
8321236|NCT01424306|20515835|P3|COMPLETED|Overall Study||3
8321237|NCT01424306|20515836|P2|COMPLETED|Overall Study||4
8321238|NCT01424306|20515837|P1|COMPLETED|Overall Study||4
8321239|NCT01424306|20515832|P6|STARTED|Overall Study||6
8321240|NCT01424306|20515833|P5|STARTED|Overall Study||5
8321241|NCT01424306|20515834|P4|STARTED|Overall Study||3
8321242|NCT01424306|20515835|P3|STARTED|Overall Study||3
8321243|NCT01424306|20515836|P2|STARTED|Overall Study||4
8321244|NCT01424306|20515837|P1|STARTED|Overall Study||4
8321251|NCT01424215|20515927|P2|NOT COMPLETED|Overall Study||0
8321252|NCT01424215|20515928|P1|NOT COMPLETED|Overall Study||0
8321253|NCT01424215|20515927|P2|COMPLETED|Overall Study||50
8321254|NCT01424215|20515928|P1|COMPLETED|Overall Study||50
8321255|NCT01424215|20515927|P2|STARTED|Overall Study||50
8321256|NCT01424215|20515928|P1|STARTED|Overall Study||50
8321257|NCT01424189|20515938|P2|NOT COMPLETED|Overall Study||6
8321258|NCT01424189|20515939|P1|NOT COMPLETED|Overall Study||13
8321259|NCT01424189|20515938|P2|COMPLETED|Overall Study||182
8321260|NCT01424189|20515939|P1|COMPLETED|Overall Study||373
8321261|NCT01424189|20515938|P2|STARTED|Overall Study||188
8321262|NCT01424189|20515939|P1|STARTED|Overall Study||386
8321263|NCT01424072|20515954|P3|NOT COMPLETED|Overall Study||0
8321264|NCT01424072|20515955|P2|NOT COMPLETED|Overall Study||0
8321265|NCT01424072|20515956|P1|NOT COMPLETED|Overall Study||0
8321266|NCT01424072|20515954|P3|COMPLETED|Overall Study||22
8321267|NCT01424072|20515955|P2|COMPLETED|Overall Study||26
8321268|NCT01424072|20515956|P1|COMPLETED|Overall Study||27
8321269|NCT01424072|20515954|P3|STARTED|Overall Study||22
8321270|NCT01424072|20515955|P2|STARTED|Overall Study||26
8321271|NCT01424072|20515956|P1|STARTED|Overall Study||27
8321272|NCT01424033|20515973|P1|NOT COMPLETED|Overall Study||5
8321273|NCT01424033|20515973|P1|COMPLETED|Overall Study||0
8321274|NCT01424033|20515973|P1|STARTED|Overall Study||5
8321275|NCT01423916|20515980|P3|NOT COMPLETED|Overall Study||7
8321276|NCT01423916|20515981|P2|NOT COMPLETED|Overall Study||20
8321277|NCT01423916|20515982|P1|NOT COMPLETED|Overall Study||11
8321278|NCT01423916|20515980|P3|COMPLETED|Overall Study||64
8321279|NCT01423916|20515981|P2|COMPLETED|Overall Study||53
8321280|NCT01423916|20515982|P1|COMPLETED|Overall Study||63
8321281|NCT01423916|20515980|P3|STARTED|Overall Study||71
8321282|NCT01423916|20515981|P2|STARTED|Overall Study||73
8321283|NCT01423916|20515982|P1|STARTED|Overall Study||74
8321284|NCT01423812|20516038|P2|NOT COMPLETED|Overall Study||4
8321285|NCT01423812|20516039|P1|NOT COMPLETED|Overall Study||3
8321286|NCT01423812|20516038|P2|COMPLETED|Overall Study||26
8321287|NCT01423812|20516039|P1|COMPLETED|Overall Study||27
8321288|NCT01423812|20516038|P2|STARTED|Overall Study||30
8321289|NCT01423812|20516039|P1|STARTED|Overall Study||30
8321290|NCT01423773|20516047|P2|NOT COMPLETED|Period 2, 2 Days||0
8321291|NCT01423773|20516048|P1|NOT COMPLETED|Period 2, 2 Days||0
8321292|NCT01423773|20516047|P2|COMPLETED|Period 2, 2 Days||10
8321293|NCT01423773|20516048|P1|COMPLETED|Period 2, 2 Days||10
8321294|NCT01423773|20516047|P2|STARTED|Period 2, 2 Days||10
8321295|NCT01423773|20516048|P1|STARTED|Period 2, 2 Days||10
8321296|NCT01423773|20516047|P2|NOT COMPLETED|Period One, 2 Days||0
8321297|NCT01423773|20516048|P1|NOT COMPLETED|Period One, 2 Days||0
8321298|NCT01423773|20516047|P2|COMPLETED|Period One, 2 Days||10
8321299|NCT01423773|20516048|P1|COMPLETED|Period One, 2 Days||10
8321300|NCT01423773|20516047|P2|STARTED|Period One, 2 Days||10
8321301|NCT01423773|20516048|P1|STARTED|Period One, 2 Days||10
8321302|NCT01423760|20516056|P2|NOT COMPLETED|Overall Study||0
8321303|NCT01423760|20516057|P1|NOT COMPLETED|Overall Study||0
8321304|NCT01423760|20516056|P2|COMPLETED|Overall Study||13
8321305|NCT01423760|20516057|P1|COMPLETED|Overall Study||14
8321306|NCT01423760|20516056|P2|Safety Analysis Set|Overall Study||8
8321307|NCT01423760|20516057|P1|Safety Analysis Set|Overall Study||12
8321308|NCT01423760|20516056|P2|Number of Non-treatment Subjects|Overall Study||5
8321309|NCT01423760|20516057|P1|Number of Non-treatment Subjects|Overall Study||2
8321310|NCT01423760|20516056|P2|Number of Tecemotide Subjects|Overall Study||8
8321311|NCT01423760|20516057|P1|Number of Tecemotide Subjects|Overall Study||12
8321312|NCT01423760|20516056|P2|STARTED|Overall Study||13
8321313|NCT01423760|20516057|P1|STARTED|Overall Study||14
8321314|NCT01423617|20516067|P2|NOT COMPLETED|Overall Study||1
8321315|NCT01423617|20516068|P1|NOT COMPLETED|Overall Study||0
8321316|NCT01423617|20516067|P2|COMPLETED|Overall Study||45
8321317|NCT01423617|20516068|P1|COMPLETED|Overall Study||46
8321318|NCT01423617|20516067|P2|STARTED|Overall Study||46
8321319|NCT01423617|20516068|P1|STARTED|Overall Study||46
8321320|NCT01423604|20516085|P2|NOT COMPLETED|Randomized||63
8321321|NCT01423604|20516086|P1|NOT COMPLETED|Randomized||63
8321322|NCT01423604|20516085|P2|COMPLETED|Randomized||0
8321323|NCT01423604|20516086|P1|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
8321324|NCT01423604|20516085|P2|STARTED|Randomized||63
8321325|NCT01423604|20516086|P1|STARTED|Randomized||64
8321326|NCT01423604|20516085|P2|NOT COMPLETED|Safety Run-In||0
8321327|NCT01423604|20516086|P1|NOT COMPLETED|Safety Run-In||9
8321328|NCT01423604|20516085|P2|COMPLETED|Safety Run-In||0
8321329|NCT01423604|20516086|P1|COMPLETED|Safety Run-In||0
8321330|NCT01423604|20516085|P2|STARTED|Safety Run-In||0
8321331|NCT01423604|20516086|P1|STARTED|Safety Run-In||9
8321332|NCT01423253|20516101|P1|NOT COMPLETED|Overall Study||9
8321333|NCT01423253|20516101|P1|COMPLETED|Overall Study||39
8321334|NCT01423253|20516101|P1|STARTED|Overall Study||48
8321335|NCT01423162|20516114|P2|NOT COMPLETED|Overall Study||0
8321336|NCT01423162|20516115|P1|NOT COMPLETED|Overall Study||0
8321337|NCT01423162|20516114|P2|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
8321338|NCT01423162|20516115|P1|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
8321339|NCT01423162|20516114|P2|STARTED|Overall Study||9
8321340|NCT01423162|20516115|P1|STARTED|Overall Study||11
8321341|NCT01423084|20516123|P2|NOT COMPLETED|Overall Study||4
8321342|NCT01423084|20516124|P1|NOT COMPLETED|Overall Study||2
8321343|NCT01423084|20516123|P2|COMPLETED|Overall Study||170
8321344|NCT01423084|20516124|P1|COMPLETED|Overall Study||168
8321345|NCT01423084|20516123|P2|STARTED|Overall Study||174
8321346|NCT01423084|20516124|P1|STARTED|Overall Study||170
8321347|NCT01422915|20516154|P1|NOT COMPLETED|Overall Study||1
8321348|NCT01422915|20516154|P1|COMPLETED|Overall Study||3
8321349|NCT01422915|20516154|P1|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
8321350|NCT01422889|20516159|P1|NOT COMPLETED|Overall Study||9
8321351|NCT01422889|20516159|P1|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
8321352|NCT01422889|20516159|P1|STARTED|Overall Study||1120
8321353|NCT01422876|20516174|P10|NOT COMPLETED|Week 52||17
8321354|NCT01422876|20516175|P9|NOT COMPLETED|Week 52||21
8321355|NCT01422876|20516176|P8|NOT COMPLETED|Week 52||23
8321356|NCT01422876|20516177|P7|NOT COMPLETED|Week 52||16
8321357|NCT01422876|20516178|P6|NOT COMPLETED|Week 52||17
8321358|NCT01422876|20516179|P5|NOT COMPLETED|Week 52||15
8321359|NCT01422876|20516180|P4|NOT COMPLETED|Week 52||18
8321360|NCT01422876|20516181|P3|NOT COMPLETED|Week 52||13
8321361|NCT01422876|20516182|P2|NOT COMPLETED|Week 52||10
8321362|NCT01422876|20516183|P1|NOT COMPLETED|Week 52||12
8321363|NCT01422876|20516174|P10|COMPLETED|Week 52||118
8321364|NCT01422876|20516175|P9|COMPLETED|Week 52||113
8321365|NCT01422876|20516176|P8|COMPLETED|Week 52||112
8321366|NCT01422876|20516177|P7|COMPLETED|Week 52||120
8321367|NCT01422876|20516178|P6|COMPLETED|Week 52||120
8321368|NCT01422876|20516179|P5|COMPLETED|Week 52||117
8321369|NCT01422876|20516180|P4|COMPLETED|Week 52||122
8321370|NCT01422876|20516181|P3|COMPLETED|Week 52||128
8321371|NCT01422876|20516182|P2|COMPLETED|Week 52||126
8321372|NCT01422876|20516183|P1|COMPLETED|Week 52||125
8321373|NCT01422876|20516174|P10|STARTED|Week 52||135
8321374|NCT01422876|20516175|P9|STARTED|Week 52||134
8321375|NCT01422876|20516176|P8|STARTED|Week 52||135
8321376|NCT01422876|20516177|P7|STARTED|Week 52||136
8321377|NCT01422876|20516178|P6|STARTED|Week 52||137
8321378|NCT01422876|20516179|P5|STARTED|Week 52||132
8321379|NCT01422876|20516180|P4|STARTED|Week 52||140
8321380|NCT01422876|20516181|P3|STARTED|Week 52||141
8321381|NCT01422876|20516182|P2|STARTED|Week 52||136
8321382|NCT01422876|20516183|P1|STARTED|Week 52||137
8321383|NCT01422876|20516174|P10|NOT COMPLETED|Week 24||10
8321384|NCT01422876|20516175|P9|NOT COMPLETED|Week 24||6
8321385|NCT01422876|20516176|P8|NOT COMPLETED|Week 24||7
8321386|NCT01422876|20516177|P7|NOT COMPLETED|Week 24||6
8321387|NCT01422876|20516178|P6|NOT COMPLETED|Week 24||6
8321388|NCT01422876|20516179|P5|NOT COMPLETED|Week 24||7
8321389|NCT01422876|20516180|P4|NOT COMPLETED|Week 24||8
8321390|NCT01422876|20516181|P3|NOT COMPLETED|Week 24||5
8321391|NCT01422876|20516182|P2|NOT COMPLETED|Week 24||3
8321392|NCT01422876|20516183|P1|NOT COMPLETED|Week 24||6
8321393|NCT01422876|20516174|P10|COMPLETED|Week 24||125
8321394|NCT01422876|20516175|P9|COMPLETED|Week 24||128
8321395|NCT01422876|20516176|P8|COMPLETED|Week 24||128
8321396|NCT01422876|20516177|P7|COMPLETED|Week 24||130
8321397|NCT01422876|20516178|P6|COMPLETED|Week 24||131
8321398|NCT01422876|20516179|P5|COMPLETED|Week 24||125
8321399|NCT01422876|20516180|P4|COMPLETED|Week 24||132
8321400|NCT01422876|20516181|P3|COMPLETED|Week 24||136
8321401|NCT01422876|20516182|P2|COMPLETED|Week 24||133
8321402|NCT01422876|20516183|P1|COMPLETED|Week 24||131
8321403|NCT01422876|20516174|P10|STARTED|Week 24||135
8321404|NCT01422876|20516175|P9|STARTED|Week 24||134
8321405|NCT01422876|20516176|P8|STARTED|Week 24||135
8321406|NCT01422876|20516177|P7|STARTED|Week 24||136
8321407|NCT01422876|20516178|P6|STARTED|Week 24||137
8321408|NCT01422876|20516179|P5|STARTED|Week 24||132
8321409|NCT01422876|20516180|P4|STARTED|Week 24||140
8321410|NCT01422876|20516181|P3|STARTED|Week 24||141
8321411|NCT01422876|20516182|P2|STARTED|Week 24||136
8321412|NCT01422876|20516183|P1|STARTED|Week 24||137
8321413|NCT01422850|20516230|P1|NOT COMPLETED|Overall Study||3
8321414|NCT01422850|20516230|P1|COMPLETED|Overall Study||18
8321415|NCT01422850|20516230|P1|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
8321416|NCT01422850|20516230|P1|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
8321417|NCT01422850|20516230|P1|Week 9 - Second Treatment|Overall Study||20
8321418|NCT01422850|20516230|P1|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
8321419|NCT01422850|20516230|P1|Week 4 - First Treatment|Overall Study||21
8321420|NCT01422850|20516230|P1|STARTED|Overall Study||21
8321421|NCT01422824|20516236|P1|NOT COMPLETED|Overall Study||38
8321422|NCT01422824|20516236|P1|COMPLETED|Overall Study||147
8321423|NCT01422824|20516236|P1|Treated|Overall Study||184
8321424|NCT01422824|20516236|P1|STARTED|Overall Study||185
8321425|NCT01422720|20516241|P1|NOT COMPLETED|Overall Study||22
8321426|NCT01422720|20516241|P1|COMPLETED|Overall Study||50
8321427|NCT01422720|20516241|P1|Per-Protocol Set (PPS)|Overall Study||55
8321428|NCT01422720|20516241|P1|Full Analysis Set (FAS)|Overall Study||71
8321429|NCT01422720|20516241|P1|Safety Set|Overall Study||72
8321430|NCT01422720|20516241|P1|STARTED|Overall Study||72
8321431|NCT01422538|20516252|P3|NOT COMPLETED|Overall Study||2
8321432|NCT01422538|20516253|P2|NOT COMPLETED|Overall Study||2
8321433|NCT01422538|20516254|P1|NOT COMPLETED|Overall Study||0
8321434|NCT01422538|20516252|P3|COMPLETED|Overall Study||8
8321435|NCT01422538|20516253|P2|COMPLETED|Overall Study||8
8321436|NCT01422538|20516254|P1|COMPLETED|Overall Study||10
8321437|NCT01422538|20516252|P3|STARTED|Overall Study||10
8321438|NCT01422538|20516253|P2|STARTED|Overall Study||10
8321439|NCT01422538|20516254|P1|STARTED|Overall Study||10
8321440|NCT01422434|20516279|P3|NOT COMPLETED|Overall Study||6
8321441|NCT01422434|20516280|P2|NOT COMPLETED|Overall Study||5
8321442|NCT01422434|20516281|P1|NOT COMPLETED|Overall Study||11
8321443|NCT01422434|20516279|P3|COMPLETED|Overall Study||217
8321444|NCT01422434|20516280|P2|COMPLETED|Overall Study||221
8321445|NCT01422434|20516281|P1|COMPLETED|Overall Study||216
8321446|NCT01422434|20516279|P3|STARTED|Overall Study||223
8321447|NCT01422434|20516280|P2|STARTED|Overall Study||226
8321448|NCT01422434|20516281|P1|STARTED|Overall Study||227
8321449|NCT01422408|20516298|P1|NOT COMPLETED|Overall Study||4
8321450|NCT01422408|20516298|P1|COMPLETED|Overall Study||30
8321451|NCT01422408|20516298|P1|STARTED|Overall Study||34
8321452|NCT01422382|20516327|P1|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
8321453|NCT01422382|20516327|P1|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
8321454|NCT01422382|20516327|P1|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
8321455|NCT01422382|20516327|P1|NOT COMPLETED|Diltiazem 240 mg QD||0
8321456|NCT01422382|20516327|P1|COMPLETED|Diltiazem 240 mg QD||28
8321457|NCT01422382|20516327|P1|STARTED|Diltiazem 240 mg QD||28
8321458|NCT01422382|20516327|P1|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
8321459|NCT01422382|20516327|P1|COMPLETED|NK-104 4mg Once Daily (QD)||28
8321460|NCT01422382|20516327|P1|STARTED|NK-104 4mg Once Daily (QD)||28
8321461|NCT01422369|20516332|P1|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
8321462|NCT01422369|20516332|P1|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
8321463|NCT01422369|20516332|P1|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
8321464|NCT01422369|20516332|P1|NOT COMPLETED|Prezista 800mg/100mg QD||0
8321465|NCT01422369|20516332|P1|COMPLETED|Prezista 800mg/100mg QD||28
8321466|NCT01422369|20516332|P1|STARTED|Prezista 800mg/100mg QD||28
8321467|NCT01422369|20516332|P1|NOT COMPLETED|NK-104 4mg QD||0
8321468|NCT01422369|20516332|P1|COMPLETED|NK-104 4mg QD||28
8321469|NCT01422369|20516332|P1|STARTED|NK-104 4mg QD||28
8321470|NCT01422356|20516337|P1|NOT COMPLETED|Overall Study||31
8321471|NCT01422356|20516337|P1|COMPLETED|Overall Study||169
8321472|NCT01422356|20516337|P1|STARTED|Overall Study||200
8321481|NCT01422239|20516376|P2|NOT COMPLETED|Overall Study||3
8321482|NCT01422239|20516377|P1|NOT COMPLETED|Overall Study||4
8321483|NCT01422239|20516376|P2|COMPLETED|Overall Study||3
8321484|NCT01422239|20516377|P1|COMPLETED|Overall Study||10
8321485|NCT01422239|20516376|P2|STARTED|Overall Study||6
8321486|NCT01422239|20516377|P1|STARTED|Overall Study||14
8321487|NCT01422226|20516389|P2|NOT COMPLETED|Overall Study||0
8321488|NCT01422226|20516390|P1|NOT COMPLETED|Overall Study||0
8321489|NCT01422226|20516389|P2|COMPLETED|Overall Study||2
8321490|NCT01422226|20516390|P1|COMPLETED|Overall Study||1
8321491|NCT01422226|20516389|P2|STARTED|Overall Study||2
8321492|NCT01422226|20516390|P1|STARTED|Overall Study||1
8321493|NCT01422213|20516399|P3|NOT COMPLETED|Overall Study||29
8321494|NCT01422213|20516400|P2|NOT COMPLETED|Overall Study||22
8321495|NCT01422213|20516401|P1|NOT COMPLETED|Overall Study||33
8321496|NCT01422213|20516399|P3|COMPLETED|Overall Study||178
8321497|NCT01422213|20516400|P2|COMPLETED|Overall Study||173
8321498|NCT01422213|20516401|P1|COMPLETED|Overall Study||163
8321499|NCT01422213|20516399|P3|STARTED|Overall Study||207
8321500|NCT01422213|20516400|P2|STARTED|Overall Study||195
8321501|NCT01422213|20516401|P1|STARTED|Overall Study||196
8321502|NCT01422200|20516461|P2|NOT COMPLETED|Overall Study||0
8321503|NCT01422200|20516462|P1|NOT COMPLETED|Overall Study||0
8321504|NCT01422200|20516461|P2|COMPLETED|Overall Study||11
8321505|NCT01422200|20516462|P1|COMPLETED|Overall Study||11
8321506|NCT01422200|20516461|P2|STARTED|Overall Study||11
8321507|NCT01422200|20516462|P1|STARTED|Overall Study||11
8321508|NCT01422187|20516473|P3|NOT COMPLETED|Overall Study||0
8321509|NCT01422187|20516474|P2|NOT COMPLETED|Overall Study||1
8321510|NCT01422187|20516475|P1|NOT COMPLETED|Overall Study||1
8321511|NCT01422187|20516473|P3|COMPLETED|Overall Study||2
8321512|NCT01422187|20516474|P2|COMPLETED|Overall Study||8
8321513|NCT01422187|20516475|P1|COMPLETED|Overall Study||7
8321514|NCT01422187|20516473|P3|STARTED|Overall Study||2
8321515|NCT01422187|20516474|P2|STARTED|Overall Study||9
8321516|NCT01422187|20516475|P1|STARTED|Overall Study||8
8321517|NCT01422161|20516494|P2|NOT COMPLETED|Overall Study||0
8321518|NCT01422161|20516495|P1|NOT COMPLETED|Overall Study||0
8321519|NCT01422161|20516494|P2|COMPLETED|Overall Study||6
8321520|NCT01422161|20516495|P1|COMPLETED|Overall Study||10
8321521|NCT01422161|20516494|P2|STARTED|Overall Study||6
8321522|NCT01422161|20516495|P1|STARTED|Overall Study||10
8321523|NCT01422135|20516511|P6|NOT COMPLETED|Overall Study||1
8321524|NCT01422135|20516512|P5|NOT COMPLETED|Overall Study||0
8321525|NCT01422135|20516513|P4|NOT COMPLETED|Overall Study||0
8321526|NCT01422135|20516514|P3|NOT COMPLETED|Overall Study||1
8321527|NCT01422135|20516515|P2|NOT COMPLETED|Overall Study||0
8321528|NCT01422135|20516516|P1|NOT COMPLETED|Overall Study||0
8321529|NCT01422135|20516511|P6|COMPLETED|Overall Study||3
8321530|NCT01422135|20516512|P5|COMPLETED|Overall Study||4
8321531|NCT01422135|20516513|P4|COMPLETED|Overall Study||4
8321532|NCT01422135|20516514|P3|COMPLETED|Overall Study||3
8321533|NCT01422135|20516515|P2|COMPLETED|Overall Study||4
8321534|NCT01422135|20516516|P1|COMPLETED|Overall Study||4
8321535|NCT01422135|20516511|P6|STARTED|Overall Study||4
8321536|NCT01422135|20516512|P5|STARTED|Overall Study||4
8321537|NCT01422135|20516513|P4|STARTED|Overall Study||4
8321538|NCT01422135|20516514|P3|STARTED|Overall Study||4
8321539|NCT01422135|20516515|P2|STARTED|Overall Study||4
8321540|NCT01422135|20516516|P1|STARTED|Overall Study||4
8321541|NCT01422070|20516527|P2|NOT COMPLETED|Overall Study||0
8321542|NCT01422070|20516528|P1|NOT COMPLETED|Overall Study||0
8321543|NCT01422070|20516527|P2|COMPLETED|Overall Study||803
8321544|NCT01422070|20516528|P1|COMPLETED|Overall Study||5031
8321545|NCT01422070|20516527|P2|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
8321546|NCT01422070|20516528|P1|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
8321547|NCT01421719|20516539|P1|NOT COMPLETED|Overall Study||4
8321548|NCT01421719|20516539|P1|COMPLETED|Overall Study||16
8321549|NCT01421719|20516539|P1|STARTED|Overall Study||20
8321550|NCT01421667|20516548|P4|NOT COMPLETED|Overall Study||1
8321551|NCT01421667|20516549|P3|NOT COMPLETED|Overall Study||2
8321552|NCT01421667|20516550|P2|NOT COMPLETED|Overall Study||2
8321553|NCT01421667|20516551|P1|NOT COMPLETED|Overall Study||0
8321554|NCT01421667|20516548|P4|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
8321555|NCT01421667|20516549|P3|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
8321556|NCT01421667|20516550|P2|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
8321557|NCT01421667|20516551|P1|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
8321558|NCT01421667|20516548|P4|STARTED|Overall Study||16
8321559|NCT01421667|20516549|P3|STARTED|Overall Study||53
8321560|NCT01421667|20516550|P2|STARTED|Overall Study||68
8321561|NCT01421667|20516551|P1|STARTED|Overall Study||35
8321562|NCT01421654|20516603|P2|NOT COMPLETED|Overall Study||0
8321563|NCT01421654|20516604|P1|NOT COMPLETED|Overall Study||0
8321564|NCT01421654|20516603|P2|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
8321565|NCT01421654|20516604|P1|COMPLETED|Overall Study||11
8321566|NCT01421654|20516603|P2|STARTED|Overall Study||9
8321567|NCT01421654|20516604|P1|STARTED|Overall Study||11
8321568|NCT01421641|20516612|P2|NOT COMPLETED|Overall Study||2
8321569|NCT01421641|20516613|P1|NOT COMPLETED|Overall Study||2
8321570|NCT01421641|20516612|P2|COMPLETED|Overall Study||35
8321571|NCT01421641|20516613|P1|COMPLETED|Overall Study||35
8321572|NCT01421641|20516612|P2|STARTED|Overall Study||37
8321573|NCT01421641|20516613|P1|STARTED|Overall Study||37
8321574|NCT01421589|20516623|P1|NOT COMPLETED|Overall Study||0
8321575|NCT01421589|20516623|P1|COMPLETED|Overall Study||15
8321576|NCT01421589|20516623|P1|STARTED|Overall Study||15
8321577|NCT01421511|20516635|P2|NOT COMPLETED|Overall Study||28
8321578|NCT01421511|20516636|P1|NOT COMPLETED|Overall Study||19
8321579|NCT01421511|20516635|P2|COMPLETED|Overall Study||306
8321580|NCT01421511|20516636|P1|COMPLETED|Overall Study||313
8321581|NCT01421511|20516635|P2|STARTED|Overall Study||334
8321582|NCT01421511|20516636|P1|STARTED|Overall Study||332
8321589|NCT01421472|20516671|P4|NOT COMPLETED|Overall Study||0
8321590|NCT01421472|20516672|P3|NOT COMPLETED|Overall Study||0
8321591|NCT01421472|20516673|P2|NOT COMPLETED|Overall Study||0
8321592|NCT01421472|20516674|P1|NOT COMPLETED|Overall Study||0
8321593|NCT01421472|20516671|P4|COMPLETED|Overall Study||32
8321594|NCT01421472|20516672|P3|COMPLETED|Overall Study||64
8321595|NCT01421472|20516673|P2|COMPLETED|Overall Study||33
8321596|NCT01421472|20516674|P1|COMPLETED|Overall Study||67
8321597|NCT01421472|20516671|P4|STARTED|Overall Study||32
8321598|NCT01421472|20516672|P3|STARTED|Overall Study||64
8321599|NCT01421472|20516673|P2|STARTED|Overall Study||33
8321600|NCT01421472|20516674|P1|STARTED|Overall Study||67
8321601|NCT01421459|20516686|P2|NOT COMPLETED|Overall Study||52
8321602|NCT01421459|20516687|P1|NOT COMPLETED|Overall Study||45
8321603|NCT01421459|20516686|P2|COMPLETED|Overall Study||328
8321604|NCT01421459|20516687|P1|COMPLETED|Overall Study||334
8321605|NCT01421459|20516686|P2|Received at Least 1 Dose of Study Drug|Overall Study||380
8321606|NCT01421459|20516687|P1|Received at Least 1 Dose of Study Drug|Overall Study||376
8321607|NCT01421459|20516686|P2|STARTED|Overall Study||380
8321608|NCT01421459|20516687|P1|STARTED|Overall Study||379
8321609|NCT01421355|20516721|P1|NOT COMPLETED|Overall Study||6
8321610|NCT01421355|20516721|P1|COMPLETED|Overall Study||15
8321611|NCT01421355|20516721|P1|STARTED|Overall Study||21
8321612|NCT01421342|20516728|P3|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
8321613|NCT01421342|20516729|P2|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
8321614|NCT01421342|20516730|P1|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
8321615|NCT01421342|20516728|P3|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
8321616|NCT01421342|20516729|P2|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
8321617|NCT01421342|20516730|P1|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
8321618|NCT01421342|20516728|P3|STARTED|Continuation of Treatment (Week 12 - 36)||268
8321619|NCT01421342|20516729|P2|STARTED|Continuation of Treatment (Week 12 - 36)||253
8321620|NCT01421342|20516730|P1|STARTED|Continuation of Treatment (Week 12 - 36)||204
8321621|NCT01421342|20516728|P3|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
8321622|NCT01421342|20516729|P2|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
8321623|NCT01421342|20516730|P1|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
8321624|NCT01421342|20516728|P3|COMPLETED|Completed to Week 12 But Then Withdrawn||268
8321625|NCT01421342|20516729|P2|COMPLETED|Completed to Week 12 But Then Withdrawn||253
8321626|NCT01421342|20516730|P1|COMPLETED|Completed to Week 12 But Then Withdrawn||204
8321627|NCT01421342|20516728|P3|STARTED|Completed to Week 12 But Then Withdrawn||406
8321628|NCT01421342|20516729|P2|STARTED|Completed to Week 12 But Then Withdrawn||378
8321629|NCT01421342|20516730|P1|STARTED|Completed to Week 12 But Then Withdrawn||353
8321630|NCT01421342|20516728|P3|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
8321631|NCT01421342|20516729|P2|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
8321632|NCT01421342|20516730|P1|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
8321633|NCT01421342|20516728|P3|COMPLETED|Acute Treatment Phase (12 Weeks)||406
8321634|NCT01421342|20516729|P2|COMPLETED|Acute Treatment Phase (12 Weeks)||378
8321635|NCT01421342|20516730|P1|COMPLETED|Acute Treatment Phase (12 Weeks)||353
8321636|NCT01421342|20516728|P3|STARTED|Acute Treatment Phase (12 Weeks)||505
8321637|NCT01421342|20516729|P2|STARTED|Acute Treatment Phase (12 Weeks)||506
8321638|NCT01421342|20516730|P1|STARTED|Acute Treatment Phase (12 Weeks)||511
8321639|NCT01421303|20516747|P1|NOT COMPLETED|Overall Study||22
8321640|NCT01421303|20516747|P1|COMPLETED|Overall Study||58
8321641|NCT01421303|20516747|P1|STARTED|Overall Study||80
8321642|NCT01421277|20516774|P2|NOT COMPLETED|Overall Study||92
8321643|NCT01421277|20516775|P1|NOT COMPLETED|Overall Study||0
8321644|NCT01421277|20516774|P2|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
8321645|NCT01421277|20516775|P1|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
8321646|NCT01421277|20516774|P2|STARTED|Overall Study||191
8321647|NCT01421277|20516775|P1|STARTED|Overall Study||25
8321648|NCT01421225|20516787|P2|NOT COMPLETED|Overall Study||1
8321649|NCT01421225|20516788|P1|NOT COMPLETED|Overall Study||0
8321650|NCT01421225|20516787|P2|COMPLETED|Overall Study||5
8321651|NCT01421225|20516788|P1|COMPLETED|Overall Study||4
8321652|NCT01421225|20516787|P2|STARTED|Overall Study||6
8321653|NCT01421225|20516788|P1|STARTED|Overall Study||4
8321654|NCT01421147|20516802|P2|NOT COMPLETED|Extension Period||11
8321655|NCT01421147|20516803|P1|NOT COMPLETED|Extension Period||8
8321656|NCT01421147|20516802|P2|COMPLETED|Extension Period||245
8321657|NCT01421147|20516803|P1|COMPLETED|Extension Period||245
8321658|NCT01421147|20516802|P2|STARTED|Extension Period||256
8321659|NCT01421147|20516803|P1|STARTED|Extension Period||253
8321660|NCT01421147|20516802|P2|NOT COMPLETED|Treatment Period||11
8321661|NCT01421147|20516803|P1|NOT COMPLETED|Treatment Period||16
8321662|NCT01421147|20516802|P2|COMPLETED|Treatment Period||256
8321663|NCT01421147|20516803|P1|COMPLETED|Treatment Period||253
8321664|NCT01421147|20516802|P2|Received at Least 1 Dose of Study Drug|Treatment Period||267
8321665|NCT01421147|20516803|P1|Received at Least 1 Dose of Study Drug|Treatment Period||268
8321666|NCT01421147|20516802|P2|STARTED|Treatment Period||267
8321667|NCT01421147|20516803|P1|STARTED|Treatment Period||269
8321668|NCT01421134|20516835|P2|NOT COMPLETED|Overall Study||15
8321669|NCT01421134|20516836|P1|NOT COMPLETED|Overall Study||7
8321670|NCT01421134|20516835|P2|COMPLETED|Overall Study||87
8321671|NCT01421134|20516836|P1|COMPLETED|Overall Study||102
8321672|NCT01421134|20516835|P2|STARTED|Overall Study||102
8321673|NCT01421134|20516836|P1|STARTED|Overall Study||109
8321674|NCT01420965|20516857|P3|NOT COMPLETED|Overall Study||0
8321675|NCT01420965|20516858|P2|NOT COMPLETED|Overall Study||1
8321676|NCT01420965|20516859|P1|NOT COMPLETED|Overall Study||1
8321677|NCT01420965|20516857|P3|COMPLETED|Overall Study||3
8321678|NCT01420965|20516858|P2|COMPLETED|Overall Study||1
8321679|NCT01420965|20516859|P1|COMPLETED|Overall Study||1
8321680|NCT01420965|20516857|P3|STARTED|Overall Study||3
8321681|NCT01420965|20516858|P2|STARTED|Overall Study||2
8321682|NCT01420965|20516859|P1|STARTED|Overall Study||2
8321689|NCT01420848|20516890|P3|NOT COMPLETED|Overall Study||0
8321690|NCT01420848|20516891|P2|NOT COMPLETED|Overall Study||0
8321691|NCT01420848|20516892|P1|NOT COMPLETED|Overall Study||0
8321692|NCT01420848|20516890|P3|COMPLETED|Overall Study||22
8321693|NCT01420848|20516891|P2|COMPLETED|Overall Study||25
8321694|NCT01420848|20516892|P1|COMPLETED|Overall Study||24
8321695|NCT01420848|20516890|P3|STARTED|Overall Study||22
8321696|NCT01420848|20516891|P2|STARTED|Overall Study||25
8321697|NCT01420848|20516892|P1|STARTED|Overall Study||24
8321698|NCT01420653|20516907|P4|NOT COMPLETED|Overall Study||7
8321699|NCT01420653|20516908|P3|NOT COMPLETED|Overall Study||4
8321700|NCT01420653|20516909|P2|NOT COMPLETED|Overall Study||3
8321701|NCT01420653|20516910|P1|NOT COMPLETED|Overall Study||3
8321702|NCT01420653|20516907|P4|COMPLETED|Overall Study||68
8321703|NCT01420653|20516908|P3|COMPLETED|Overall Study||108
8321704|NCT01420653|20516909|P2|COMPLETED|Overall Study||108
8321705|NCT01420653|20516910|P1|COMPLETED|Overall Study||107
8321706|NCT01420653|20516907|P4|STARTED|Overall Study||75
8321707|NCT01420653|20516908|P3|STARTED|Overall Study||112
8321708|NCT01420653|20516909|P2|STARTED|Overall Study||111
8321709|NCT01420653|20516910|P1|STARTED|Overall Study||110
8321710|NCT01420627|20516920|P1|NOT COMPLETED|EZN-2279 Maintenance Period||0
8321711|NCT01420627|20516920|P1|COMPLETED|EZN-2279 Maintenance Period||6
8321712|NCT01420627|20516920|P1|STARTED|EZN-2279 Maintenance Period||6
8321713|NCT01420627|20516920|P1|NOT COMPLETED|EZN-2279 Treatment Period||1
8321714|NCT01420627|20516920|P1|COMPLETED|EZN-2279 Treatment Period||6
8321715|NCT01420627|20516920|P1|STARTED|EZN-2279 Treatment Period||7
8321716|NCT01420627|20516920|P1|NOT COMPLETED|Adagen Lead-in Period||0
8321717|NCT01420627|20516920|P1|COMPLETED|Adagen Lead-in Period||7
8321718|NCT01420627|20516920|P1|STARTED|Adagen Lead-in Period||7
8321719|NCT01420549|20516936|P2|NOT COMPLETED|Overall Study||5
8321720|NCT01420549|20516937|P1|NOT COMPLETED|Overall Study||7
8321721|NCT01420549|20516936|P2|COMPLETED|Overall Study||58
8321722|NCT01420549|20516937|P1|COMPLETED|Overall Study||59
8321723|NCT01420549|20516936|P2|STARTED|Overall Study||63
8321724|NCT01420549|20516937|P1|STARTED|Overall Study||66
8321725|NCT01420536|20516945|P2|NOT COMPLETED|Period 2 (30 Days)||0
8321726|NCT01420536|20516946|P1|NOT COMPLETED|Period 2 (30 Days)||0
8321727|NCT01420536|20516945|P2|COMPLETED|Period 2 (30 Days)||22
8321728|NCT01420536|20516946|P1|COMPLETED|Period 2 (30 Days)||19
8321729|NCT01420536|20516945|P2|STARTED|Period 2 (30 Days)||22
8321730|NCT01420536|20516946|P1|STARTED|Period 2 (30 Days)||19
8321731|NCT01420536|20516945|P2|NOT COMPLETED|Period 1 (30 Days)||0
8321732|NCT01420536|20516946|P1|NOT COMPLETED|Period 1 (30 Days)||3
8321733|NCT01420536|20516945|P2|COMPLETED|Period 1 (30 Days)||22
8321734|NCT01420536|20516946|P1|COMPLETED|Period 1 (30 Days)|Participants declined to participate further before changing interventions.|19
8321735|NCT01420536|20516945|P2|STARTED|Period 1 (30 Days)||22
8321736|NCT01420536|20516946|P1|STARTED|Period 1 (30 Days)||22
8321737|NCT01420289|20516978|P2|NOT COMPLETED|Overall Study||0
8321738|NCT01420289|20516979|P1|NOT COMPLETED|Overall Study||0
8321739|NCT01420289|20516978|P2|COMPLETED|Overall Study||16
8321740|NCT01420289|20516979|P1|COMPLETED|Overall Study||18
8321741|NCT01420289|20516978|P2|STARTED|Overall Study||16
8321742|NCT01420289|20516979|P1|STARTED|Overall Study||18
8321743|NCT01420146|20516991|P1|NOT COMPLETED|Overall Study||0
8321744|NCT01420146|20516991|P1|COMPLETED|Overall Study||20
8321745|NCT01420146|20516991|P1|STARTED|Overall Study||20
8321746|NCT01420081|20517004|P9|NOT COMPLETED|Overall Study||3
8321747|NCT01420081|20517005|P8|NOT COMPLETED|Overall Study||3
8321748|NCT01420081|20517006|P7|NOT COMPLETED|Overall Study||3
8321749|NCT01420081|20517007|P6|NOT COMPLETED|Overall Study||20
8321750|NCT01420081|20517008|P5|NOT COMPLETED|Overall Study||20
8321751|NCT01420081|20517009|P4|NOT COMPLETED|Overall Study||3
8321752|NCT01420081|20517010|P3|NOT COMPLETED|Overall Study||11
8321753|NCT01420081|20517011|P2|NOT COMPLETED|Overall Study||1
8321754|NCT01420081|20517012|P1|NOT COMPLETED|Overall Study||3
8321755|NCT01420081|20517004|P9|COMPLETED|Overall Study||0
8321756|NCT01420081|20517005|P8|COMPLETED|Overall Study||0
8321757|NCT01420081|20517006|P7|COMPLETED|Overall Study||0
8321758|NCT01420081|20517007|P6|COMPLETED|Overall Study||0
8321759|NCT01420081|20517008|P5|COMPLETED|Overall Study||0
8321760|NCT01420081|20517009|P4|COMPLETED|Overall Study||0
8321761|NCT01420081|20517010|P3|COMPLETED|Overall Study||0
8321762|NCT01420081|20517011|P2|COMPLETED|Overall Study||0
8321763|NCT01420081|20517012|P1|COMPLETED|Overall Study||0
8321764|NCT01420081|20517004|P9|STARTED|Overall Study||3
8321765|NCT01420081|20517005|P8|STARTED|Overall Study||3
8321766|NCT01420081|20517006|P7|STARTED|Overall Study||3
8321767|NCT01420081|20517007|P6|STARTED|Overall Study||20
8321768|NCT01420081|20517008|P5|STARTED|Overall Study||20
8321769|NCT01420081|20517009|P4|STARTED|Overall Study||3
8321770|NCT01420081|20517010|P3|STARTED|Overall Study||11
8321771|NCT01420081|20517011|P2|STARTED|Overall Study||1
8321772|NCT01420081|20517012|P1|STARTED|Overall Study||3
8321773|NCT01420068|20517093|P2|NOT COMPLETED|Overall Study||5
8321774|NCT01420068|20517094|P1|NOT COMPLETED|Overall Study||2
8321775|NCT01420068|20517093|P2|COMPLETED|Overall Study||50
8321776|NCT01420068|20517094|P1|COMPLETED|Overall Study||49
8321777|NCT01420068|20517093|P2|STARTED|Overall Study||55
8321778|NCT01420068|20517094|P1|STARTED|Overall Study||51
8321779|NCT01420016|20517116|P4|NOT COMPLETED|Safety Analysis||0
8321780|NCT01420016|20517117|P3|NOT COMPLETED|Safety Analysis||0
8321781|NCT01420016|20517118|P2|NOT COMPLETED|Safety Analysis||0
8321782|NCT01420016|20517119|P1|NOT COMPLETED|Safety Analysis||0
8321783|NCT01420016|20517116|P4|COMPLETED|Safety Analysis||5159
8321784|NCT01420016|20517117|P3|COMPLETED|Safety Analysis||6392
8321785|NCT01420016|20517118|P2|COMPLETED|Safety Analysis||0
8321786|NCT01420016|20517119|P1|COMPLETED|Safety Analysis||0
8321787|NCT01420016|20517116|P4|STARTED|Safety Analysis||5159
8321788|NCT01420016|20517117|P3|STARTED|Safety Analysis||6392
8321789|NCT01420016|20517118|P2|STARTED|Safety Analysis||0
8321790|NCT01420016|20517119|P1|STARTED|Safety Analysis||0
8321791|NCT01420016|20517116|P4|NOT COMPLETED|Primary Analysis||0
8321792|NCT01420016|20517117|P3|NOT COMPLETED|Primary Analysis||0
8321793|NCT01420016|20517118|P2|NOT COMPLETED|Primary Analysis||2540
8321794|NCT01420016|20517119|P1|NOT COMPLETED|Primary Analysis||2927
8321795|NCT01420016|20517116|P4|COMPLETED|Primary Analysis||0
8321796|NCT01420016|20517117|P3|COMPLETED|Primary Analysis||0
8321797|NCT01420016|20517118|P2|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
8321798|NCT01420016|20517119|P1|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
8321799|NCT01420016|20517116|P4|STARTED|Primary Analysis||0
8321800|NCT01420016|20517117|P3|STARTED|Primary Analysis||0
8321801|NCT01420016|20517118|P2|STARTED|Primary Analysis||6411
8321802|NCT01420016|20517119|P1|STARTED|Primary Analysis||6970
8321803|NCT01419977|20517127|P2|NOT COMPLETED|Overall Study||0
8321804|NCT01419977|20517128|P1|NOT COMPLETED|Overall Study||0
8321805|NCT01419977|20517127|P2|COMPLETED|Overall Study||13
8321806|NCT01419977|20517128|P1|COMPLETED|Overall Study||16
8321807|NCT01419977|20517127|P2|STARTED|Overall Study||13
8321808|NCT01419977|20517128|P1|STARTED|Overall Study||16
8321809|NCT01419795|20517142|P2|NOT COMPLETED|Overall Study||0
8321810|NCT01419795|20517143|P1|NOT COMPLETED|Overall Study||0
8321811|NCT01419795|20517142|P2|COMPLETED|Overall Study||0
8321812|NCT01419795|20517143|P1|COMPLETED|Overall Study||3
8321813|NCT01419795|20517142|P2|STARTED|Overall Study||0
8321814|NCT01419795|20517143|P1|STARTED|Overall Study||3
8321815|NCT01419769|20517165|P1|NOT COMPLETED|Overall Study||4
8321816|NCT01419769|20517165|P1|COMPLETED|Overall Study||29
8321817|NCT01419769|20517165|P1|STARTED|Overall Study||33
8321818|NCT01419717|20517178|P1|NOT COMPLETED|Overall Study||125
8321819|NCT01419717|20517178|P1|COMPLETED|Overall Study||4
8321820|NCT01419717|20517178|P1|Received Denosumab|Overall Study||128
8321821|NCT01419717|20517178|P1|STARTED|Overall Study||129
8321822|NCT01419639|20517183|P1|NOT COMPLETED|Overall Study||1
8321823|NCT01419639|20517183|P1|COMPLETED|Overall Study||9
8321824|NCT01419639|20517183|P1|STARTED|Overall Study||10
8321825|NCT01419626|20517192|P3|NOT COMPLETED|Overall Study||3
8321826|NCT01419626|20517193|P2|NOT COMPLETED|Overall Study||3
8321827|NCT01419626|20517194|P1|NOT COMPLETED|Overall Study||4
8321828|NCT01419626|20517192|P3|COMPLETED|Overall Study||44
8321829|NCT01419626|20517193|P2|COMPLETED|Overall Study||44
8321830|NCT01419626|20517194|P1|COMPLETED|Overall Study||42
8321831|NCT01419626|20517192|P3|STARTED|Overall Study||47
8321832|NCT01419626|20517193|P2|STARTED|Overall Study||47
8321833|NCT01419626|20517194|P1|STARTED|Overall Study||46
8321834|NCT01419314|20517225|P2|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
8321835|NCT01419314|20517226|P1|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
8321836|NCT01419314|20517225|P2|COMPLETED|Follow-up at Week 6 of the Trial||19
8321837|NCT01419314|20517226|P1|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
8321838|NCT01419314|20517225|P2|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
8321839|NCT01419314|20517226|P1|STARTED|Follow-up at Week 6 of the Trial||17
8321840|NCT01419314|20517225|P2|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
8321841|NCT01419314|20517226|P1|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
8321842|NCT01419314|20517225|P2|COMPLETED|Follow-up at Week 3 of the Trial||21
8321843|NCT01419314|20517226|P1|COMPLETED|Follow-up at Week 3 of the Trial||17
8321844|NCT01419314|20517225|P2|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
8321845|NCT01419314|20517226|P1|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
8321846|NCT01419314|20517225|P2|NOT COMPLETED|Start of Study||0
8321847|NCT01419314|20517226|P1|NOT COMPLETED|Start of Study||0
8321848|NCT01419314|20517225|P2|COMPLETED|Start of Study||22
8321849|NCT01419314|20517226|P1|COMPLETED|Start of Study||23
8321850|NCT01419314|20517225|P2|STARTED|Start of Study|No comfort issues reported.|22
8321851|NCT01419314|20517226|P1|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
8321852|NCT01419275|20517246|P1|NOT COMPLETED|Overall Study||0
8321853|NCT01419275|20517246|P1|COMPLETED|Overall Study||126
8321854|NCT01419275|20517246|P1|STARTED|Overall Study||126
8321855|NCT01419249|20517252|P2|NOT COMPLETED|Overall Study||0
8321856|NCT01419249|20517253|P1|NOT COMPLETED|Overall Study||0
8321857|NCT01419249|20517252|P2|COMPLETED|Overall Study||140
8321858|NCT01419249|20517253|P1|COMPLETED|Overall Study||318
8321859|NCT01419249|20517252|P2|STARTED|Overall Study||140
8321860|NCT01419249|20517253|P1|STARTED|Overall Study||318
8321861|NCT01419236|20517267|P2|NOT COMPLETED|Overall Study||5
8321862|NCT01419236|20517268|P1|NOT COMPLETED|Overall Study||5
8321863|NCT01419236|20517267|P2|COMPLETED|Overall Study||35
8321864|NCT01419236|20517268|P1|COMPLETED|Overall Study||31
8321865|NCT01419236|20517267|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
8321866|NCT01419236|20517268|P1|Received at Least 1 Dose of Study Drug|Overall Study||35
8321867|NCT01419236|20517267|P2|STARTED|Overall Study||40
8321868|NCT01419236|20517268|P1|STARTED|Overall Study||36
8321869|NCT01419197|20517292|P2|NOT COMPLETED|Overall Study||198
8321870|NCT01419197|20517293|P1|NOT COMPLETED|Overall Study||404
8321871|NCT01419197|20517292|P2|COMPLETED|Overall Study||0
8321872|NCT01419197|20517293|P1|COMPLETED|Overall Study||0
8321873|NCT01419197|20517292|P2|Switched to Trastuzumab Emtansine|Overall Study||94
8321874|NCT01419197|20517293|P1|Switched to Trastuzumab Emtansine|Overall Study||0
8321875|NCT01419197|20517292|P2|STARTED|Overall Study||198
8321876|NCT01419197|20517293|P1|STARTED|Overall Study||404
8321877|NCT01419184|20517318|P2|NOT COMPLETED|Overall Study||15
8321878|NCT01419184|20517319|P1|NOT COMPLETED|Overall Study||10
8321879|NCT01419184|20517318|P2|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
8321880|NCT01419184|20517319|P1|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
8321881|NCT01419184|20517318|P2|Received at Least 1 Dose of Study Drug|Overall Study||106
8321882|NCT01419184|20517319|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
8321883|NCT01419184|20517318|P2|STARTED|Overall Study||121
8321884|NCT01419184|20517319|P1|STARTED|Overall Study||128
8321885|NCT01419171|20517335|P1|NOT COMPLETED|Overall Study||0
8321886|NCT01419171|20517335|P1|COMPLETED|Overall Study||328
8321887|NCT01419171|20517335|P1|STARTED|Overall Study||328
8321888|NCT01419080|20517352|P1|NOT COMPLETED|Overall Study||131
8321889|NCT01419080|20517352|P1|COMPLETED|Overall Study||666
8321890|NCT01419080|20517352|P1|STARTED|Overall Study||797
8321891|NCT01419028|20517358|P1|NOT COMPLETED|Overall Study||0
8321892|NCT01419028|20517358|P1|COMPLETED|Overall Study||48
8321893|NCT01419028|20517358|P1|STARTED|Overall Study||48
8321894|NCT01419015|20517363|P1|NOT COMPLETED|Overall Study||2
8321895|NCT01419015|20517363|P1|COMPLETED|Overall Study||15
8321896|NCT01419015|20517363|P1|STARTED|Overall Study||17
8321897|NCT01418937|20517367|P1|NOT COMPLETED|Overall Study||8
8321898|NCT01418937|20517367|P1|COMPLETED|Overall Study||156
8321899|NCT01418937|20517367|P1|STARTED|Overall Study||164
8321900|NCT01418703|20517376|P4|NOT COMPLETED|Overall Study||0
8321901|NCT01418703|20517377|P3|NOT COMPLETED|Overall Study||0
8321902|NCT01418703|20517378|P2|NOT COMPLETED|Overall Study||0
8321903|NCT01418703|20517379|P1|NOT COMPLETED|Overall Study||0
8321904|NCT01418703|20517376|P4|COMPLETED|Overall Study||6
8321905|NCT01418703|20517377|P3|COMPLETED|Overall Study||6
8321906|NCT01418703|20517378|P2|COMPLETED|Overall Study||13
8321907|NCT01418703|20517379|P1|COMPLETED|Overall Study||13
8321908|NCT01418703|20517376|P4|STARTED|Overall Study||6
8321909|NCT01418703|20517377|P3|STARTED|Overall Study||6
8321910|NCT01418703|20517378|P2|STARTED|Overall Study||13
8321911|NCT01418703|20517379|P1|STARTED|Overall Study||13
8321912|NCT01418482|20517390|P1|NOT COMPLETED|Overall Study||0
8321913|NCT01418482|20517390|P1|COMPLETED|Overall Study||15
8321914|NCT01418482|20517390|P1|STARTED|Overall Study||15
8321915|NCT01418378|20517398|P2|NOT COMPLETED|Overall Study||5
8321916|NCT01418378|20517399|P1|NOT COMPLETED|Overall Study||1
8321917|NCT01418378|20517398|P2|COMPLETED|Overall Study||83
8321918|NCT01418378|20517399|P1|COMPLETED|Overall Study||89
8321919|NCT01418378|20517398|P2|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88
8321920|NCT01418378|20517399|P1|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90
8321921|NCT01418378|20517398|P2|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88
8321922|NCT01418378|20517399|P1|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90
8321935|NCT01418209|20517485|P3|NOT COMPLETED|Overall Study||4
8321936|NCT01418209|20517486|P2|NOT COMPLETED|Overall Study||3
8321937|NCT01418209|20517487|P1|NOT COMPLETED|Overall Study||2
8321938|NCT01418209|20517485|P3|COMPLETED|Overall Study||142
8321939|NCT01418209|20517486|P2|COMPLETED|Overall Study||93
8321940|NCT01418209|20517487|P1|COMPLETED|Overall Study||95
8321941|NCT01418209|20517485|P3|STARTED|Overall Study||146
8321942|NCT01418209|20517486|P2|STARTED|Overall Study||96
8321943|NCT01418209|20517487|P1|STARTED|Overall Study||97
8321944|NCT01418001|20517516|P1|NOT COMPLETED|Overall Study||0
8321945|NCT01418001|20517516|P1|COMPLETED|Overall Study||5
8321946|NCT01418001|20517516|P1|STARTED|Overall Study||5
8321947|NCT01417936|20517521|P1|NOT COMPLETED|Overall Study||0
8321948|NCT01417936|20517521|P1|COMPLETED|Overall Study||26
8321949|NCT01417936|20517521|P1|STARTED|Overall Study||26
8321950|NCT01417741|20517542|P2|NOT COMPLETED|Overall Study||0
8321951|NCT01417741|20517543|P1|NOT COMPLETED|Overall Study||0
8321952|NCT01417741|20517542|P2|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86
8321953|NCT01417741|20517543|P1|COMPLETED|Overall Study||75
8321954|NCT01417741|20517542|P2|STARTED|Overall Study||86
8321955|NCT01417741|20517543|P1|STARTED|Overall Study||75
8321956|NCT01417481|20517551|P2|NOT COMPLETED|Second Period (8 Weeks)||0
8321957|NCT01417481|20517552|P1|NOT COMPLETED|Second Period (8 Weeks)||0
8321958|NCT01417481|20517551|P2|COMPLETED|Second Period (8 Weeks)||5
8321959|NCT01417481|20517552|P1|COMPLETED|Second Period (8 Weeks)||8
8321960|NCT01417481|20517551|P2|STARTED|Second Period (8 Weeks)||5
8321961|NCT01417481|20517552|P1|STARTED|Second Period (8 Weeks)||8
8321962|NCT01417481|20517551|P2|NOT COMPLETED|Washout (2 Weeks)||0
8321963|NCT01417481|20517552|P1|NOT COMPLETED|Washout (2 Weeks)||0
8321964|NCT01417481|20517551|P2|COMPLETED|Washout (2 Weeks)||5
8321965|NCT01417481|20517552|P1|COMPLETED|Washout (2 Weeks)||8
8321966|NCT01417481|20517551|P2|STARTED|Washout (2 Weeks)||5
8321967|NCT01417481|20517552|P1|STARTED|Washout (2 Weeks)||8
8321968|NCT01417481|20517551|P2|NOT COMPLETED|First Intervention (8 Weeks)||2
8321969|NCT01417481|20517552|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
8321970|NCT01417481|20517551|P2|COMPLETED|First Intervention (8 Weeks)||5
8321971|NCT01417481|20517552|P1|COMPLETED|First Intervention (8 Weeks)||8
8321972|NCT01417481|20517551|P2|STARTED|First Intervention (8 Weeks)||7
8321973|NCT01417481|20517552|P1|STARTED|First Intervention (8 Weeks)||8
8321974|NCT01417455|20517584|P8|NOT COMPLETED|Overall Study||0
8321975|NCT01417455|20517585|P7|NOT COMPLETED|Overall Study||0
8321976|NCT01417455|20517586|P6|NOT COMPLETED|Overall Study||0
8321977|NCT01417455|20517587|P5|NOT COMPLETED|Overall Study||0
8321978|NCT01417455|20517588|P4|NOT COMPLETED|Overall Study||0
8321979|NCT01417455|20517589|P3|NOT COMPLETED|Overall Study||0
8321980|NCT01417455|20517590|P2|NOT COMPLETED|Overall Study||0
8321981|NCT01417455|20517591|P1|NOT COMPLETED|Overall Study||0
8321982|NCT01417455|20517584|P8|COMPLETED|Overall Study||25
8321983|NCT01417455|20517585|P7|COMPLETED|Overall Study||13
8321984|NCT01417455|20517586|P6|COMPLETED|Overall Study||13
8321985|NCT01417455|20517587|P5|COMPLETED|Overall Study||30
8321986|NCT01417455|20517588|P4|COMPLETED|Overall Study||17
8321987|NCT01417455|20517589|P3|COMPLETED|Overall Study||17
8321988|NCT01417455|20517590|P2|COMPLETED|Overall Study||16
8321989|NCT01417455|20517591|P1|COMPLETED|Overall Study||16
8321990|NCT01417455|20517584|P8|STARTED|Overall Study||25
8321991|NCT01417455|20517585|P7|STARTED|Overall Study||13
8321992|NCT01417455|20517586|P6|STARTED|Overall Study||13
8321993|NCT01417455|20517587|P5|STARTED|Overall Study||30
8321994|NCT01417455|20517588|P4|STARTED|Overall Study||17
8321995|NCT01417455|20517589|P3|STARTED|Overall Study||17
8321996|NCT01417455|20517590|P2|STARTED|Overall Study||16
8321997|NCT01417455|20517591|P1|STARTED|Overall Study||16
8321998|NCT01417377|20517617|P1|NOT COMPLETED|Overall Study||13
8321999|NCT01417377|20517617|P1|COMPLETED|Overall Study||9
8322000|NCT01417377|20517617|P1|Treated|Overall Study||21
8322001|NCT01417377|20517617|P1|STARTED|Overall Study||22
8322002|NCT01417234|20517624|P1|NOT COMPLETED|Overall Study||3
8322003|NCT01417234|20517624|P1|COMPLETED|Overall Study||27
8322004|NCT01417234|20517624|P1|STARTED|Overall Study||30
8322005|NCT01417195|20517633|P2|NOT COMPLETED|Overall Study||1
8322006|NCT01417195|20517634|P1|NOT COMPLETED|Overall Study||3
8322007|NCT01417195|20517633|P2|COMPLETED|Overall Study||61
8322008|NCT01417195|20517634|P1|COMPLETED|Overall Study||57
8322009|NCT01417195|20517633|P2|STARTED|Overall Study||62
8322010|NCT01417195|20517634|P1|STARTED|Overall Study||60
8322011|NCT01417156|20517650|P1|NOT COMPLETED|Overall Study||14
8322012|NCT01417156|20517650|P1|COMPLETED|Overall Study||6
8322013|NCT01417156|20517650|P1|STARTED|Overall Study||20
8322014|NCT01417104|20517660|P2|NOT COMPLETED|Overall Study||2
8322015|NCT01417104|20517661|P1|NOT COMPLETED|Overall Study||6
8322016|NCT01417104|20517660|P2|COMPLETED|Overall Study||35
8322017|NCT01417104|20517661|P1|COMPLETED|Overall Study||28
8322018|NCT01417104|20517660|P2|STARTED|Overall Study||37
8322019|NCT01417104|20517661|P1|STARTED|Overall Study||34
8322020|NCT01417078|20517671|P1|NOT COMPLETED|Overall Study||1
8322021|NCT01417078|20517671|P1|COMPLETED|Overall Study||30
8322022|NCT01417078|20517671|P1|STARTED|Overall Study||31
8322023|NCT01417026|20517683|P2|NOT COMPLETED|Overall Study||0
8322024|NCT01417026|20517684|P1|NOT COMPLETED|Overall Study||2
8322025|NCT01417026|20517683|P2|COMPLETED|Overall Study||13
8322026|NCT01417026|20517684|P1|COMPLETED|Overall Study||14
8322027|NCT01417026|20517683|P2|STARTED|Overall Study||13
8322028|NCT01417026|20517684|P1|STARTED|Overall Study||16
8322029|NCT01417000|20517696|P2|NOT COMPLETED|Overall Study||29
8322030|NCT01417000|20517697|P1|NOT COMPLETED|Overall Study||61
8322031|NCT01417000|20517696|P2|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
8322032|NCT01417000|20517697|P1|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
8322033|NCT01417000|20517696|P2|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
8322034|NCT01417000|20517697|P1|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
8322035|NCT01416987|20517705|P1|NOT COMPLETED|Overall Study||0
8322036|NCT01416987|20517705|P1|COMPLETED|Overall Study||600
8322037|NCT01416987|20517705|P1|STARTED|Overall Study||600
8322038|NCT01416805|20517714|P2|NOT COMPLETED|Overall Study||4
8322039|NCT01416805|20517715|P1|NOT COMPLETED|Overall Study||4
8322040|NCT01416805|20517714|P2|COMPLETED|Overall Study||47
8322041|NCT01416805|20517715|P1|COMPLETED|Overall Study||45
8322042|NCT01416805|20517714|P2|STARTED|Overall Study||51
8322043|NCT01416805|20517715|P1|STARTED|Overall Study||49
8322044|NCT01416636|20517725|P2|NOT COMPLETED|Overall Study||6
8322045|NCT01416636|20517726|P1|NOT COMPLETED|Overall Study||8
8322046|NCT01416636|20517725|P2|COMPLETED|Overall Study||46
8322047|NCT01416636|20517726|P1|COMPLETED|Overall Study||45
8322048|NCT01416636|20517725|P2|STARTED|Overall Study||52
8322049|NCT01416636|20517726|P1|STARTED|Overall Study||53
8322050|NCT01416610|20517754|P1|NOT COMPLETED|Overall Study||43
8322051|NCT01416610|20517754|P1|COMPLETED|Overall Study||45
8322052|NCT01416610|20517754|P1|Completed Follow-up|Overall Study||45
8322053|NCT01416610|20517754|P1|Completed Treatment|Overall Study||47
8322054|NCT01416610|20517754|P1|Per Protocol|Overall Study||83
8322055|NCT01416610|20517754|P1|Safety Population|Overall Study||86
8322056|NCT01416610|20517754|P1|Intention to Treat|Overall Study||88
8322057|NCT01416610|20517754|P1|STARTED|Overall Study||88
8322058|NCT01416584|20517771|P3|NOT COMPLETED|Overall Study||1
8322059|NCT01416584|20517772|P2|NOT COMPLETED|Overall Study||2
8322060|NCT01416584|20517773|P1|NOT COMPLETED|Overall Study||3
8322061|NCT01416584|20517771|P3|COMPLETED|Overall Study||32
8322062|NCT01416584|20517772|P2|COMPLETED|Overall Study||33
8322063|NCT01416584|20517773|P1|COMPLETED|Overall Study||27
8322064|NCT01416584|20517771|P3|STARTED|Overall Study||33
8322065|NCT01416584|20517772|P2|STARTED|Overall Study||35
8322066|NCT01416584|20517773|P1|STARTED|Overall Study||30
8322067|NCT01416571|20517808|P1|NOT COMPLETED|Overall Study||2
8322068|NCT01416571|20517808|P1|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
8322069|NCT01416571|20517808|P1|STARTED|Overall Study||78
8322070|NCT01416389|20517837|P2|NOT COMPLETED|Overall Study||0
8322071|NCT01416389|20517838|P1|NOT COMPLETED|Overall Study||3
8322072|NCT01416389|20517837|P2|COMPLETED|Overall Study||13
8322073|NCT01416389|20517838|P1|COMPLETED|Overall Study||23
8322074|NCT01416389|20517837|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
8322075|NCT01416389|20517838|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
8322076|NCT01416389|20517837|P2|STARTED|Overall Study||13
8322077|NCT01416389|20517838|P1|STARTED|Overall Study||26
8322078|NCT01416272|20517855|P1|NOT COMPLETED|Overall Study||4
8322079|NCT01416272|20517855|P1|COMPLETED|Overall Study||8
8322080|NCT01416272|20517855|P1|STARTED|Overall Study||12
8322081|NCT01416194|20517864|P3|NOT COMPLETED|Overall Study||0
8322082|NCT01416194|20517865|P2|NOT COMPLETED|Overall Study||0
8322083|NCT01416194|20517866|P1|NOT COMPLETED|Overall Study||0
8322084|NCT01416194|20517864|P3|COMPLETED|Overall Study||6666
8322085|NCT01416194|20517865|P2|COMPLETED|Overall Study||2720
8322086|NCT01416194|20517866|P1|COMPLETED|Overall Study||1111
8322087|NCT01416194|20517864|P3|STARTED|Overall Study||6666
8322088|NCT01416194|20517865|P2|STARTED|Overall Study||2720
8322089|NCT01416194|20517866|P1|STARTED|Overall Study||1111
8322090|NCT01416181|20517912|P2|NOT COMPLETED|Part 2||286
8322091|NCT01416181|20517913|P1|NOT COMPLETED|Part 2||271
8322092|NCT01416181|20517912|P2|COMPLETED|Part 2||6
8322093|NCT01416181|20517913|P1|COMPLETED|Part 2||3
8322094|NCT01416181|20517912|P2|Completed Treatment for > 96 Weeks|Part 2||0
8322095|NCT01416181|20517913|P1|Completed Treatment for > 96 Weeks|Part 2||1
8322096|NCT01416181|20517912|P2|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
8322097|NCT01416181|20517913|P1|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
8322098|NCT01416181|20517912|P2|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
8322099|NCT01416181|20517913|P1|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
8322100|NCT01416181|20517912|P2|STARTED|Part 2||292
8322101|NCT01416181|20517913|P1|STARTED|Part 2||274
8322102|NCT01416181|20517912|P2|NOT COMPLETED|Part 1||114
8322103|NCT01416181|20517913|P1|NOT COMPLETED|Part 1||137
8322104|NCT01416181|20517912|P2|COMPLETED|Part 1|Completed Study through Week 108|326
8322105|NCT01416181|20517913|P1|COMPLETED|Part 1|Completed Study through Week 108|312
8322106|NCT01416181|20517912|P2|Withdrew Prior to Dosing|Part 1||1
8322107|NCT01416181|20517913|P1|Withdrew Prior to Dosing|Part 1||0
8322108|NCT01416181|20517912|P2|STARTED|Part 1||440
8322109|NCT01416181|20517913|P1|STARTED|Part 1||449
8322110|NCT01416155|20517975|P1|NOT COMPLETED|Overall Study||58
8322111|NCT01416155|20517975|P1|COMPLETED|Overall Study||39
8322112|NCT01416155|20517975|P1|STARTED|Overall Study||97
8322113|NCT01416142|20517982|P3|NOT COMPLETED|PureVision2 HD||1
8322114|NCT01416142|20517983|P2|NOT COMPLETED|PureVision2 HD||0
8322115|NCT01416142|20517984|P1|NOT COMPLETED|PureVision2 HD||0
8322116|NCT01416142|20517982|P3|COMPLETED|PureVision2 HD||62
8322117|NCT01416142|20517983|P2|COMPLETED|PureVision2 HD||0
8322118|NCT01416142|20517984|P1|COMPLETED|PureVision2 HD||0
8322119|NCT01416142|20517982|P3|STARTED|PureVision2 HD||63
8322120|NCT01416142|20517983|P2|STARTED|PureVision2 HD||0
8322121|NCT01416142|20517984|P1|STARTED|PureVision2 HD||0
8322122|NCT01416142|20517982|P3|NOT COMPLETED|Cross Over at Movie Intermission||0
8322123|NCT01416142|20517983|P2|NOT COMPLETED|Cross Over at Movie Intermission||0
8322124|NCT01416142|20517984|P1|NOT COMPLETED|Cross Over at Movie Intermission||0
8322125|NCT01416142|20517982|P3|COMPLETED|Cross Over at Movie Intermission||0
8322126|NCT01416142|20517983|P2|COMPLETED|Cross Over at Movie Intermission||31
8322127|NCT01416142|20517984|P1|COMPLETED|Cross Over at Movie Intermission||32
8322128|NCT01416142|20517982|P3|STARTED|Cross Over at Movie Intermission||0
8322129|NCT01416142|20517983|P2|STARTED|Cross Over at Movie Intermission||31
8322130|NCT01416142|20517984|P1|STARTED|Cross Over at Movie Intermission||32
8322131|NCT01416129|20517995|P2|NOT COMPLETED|Experimental Condition: Brimless||0
8322132|NCT01416129|20517996|P1|NOT COMPLETED|Experimental Condition: Brimless||0
8322133|NCT01416129|20517995|P2|COMPLETED|Experimental Condition: Brimless||5
8322134|NCT01416129|20517996|P1|COMPLETED|Experimental Condition: Brimless||5
8322135|NCT01416129|20517995|P2|STARTED|Experimental Condition: Brimless||5
8322136|NCT01416129|20517996|P1|STARTED|Experimental Condition: Brimless||5
8322137|NCT01416129|20517995|P2|NOT COMPLETED|Control Condition: Ischial Containment||0
8322138|NCT01416129|20517996|P1|NOT COMPLETED|Control Condition: Ischial Containment||0
8322139|NCT01416129|20517995|P2|COMPLETED|Control Condition: Ischial Containment||5
8322140|NCT01416129|20517996|P1|COMPLETED|Control Condition: Ischial Containment||5
8322141|NCT01416129|20517995|P2|STARTED|Control Condition: Ischial Containment||5
8322142|NCT01416129|20517996|P1|STARTED|Control Condition: Ischial Containment||5
8322143|NCT01416025|20518004|P2|NOT COMPLETED|Overall Study||0
8322144|NCT01416025|20518005|P1|NOT COMPLETED|Overall Study||0
8322145|NCT01416025|20518004|P2|COMPLETED|Overall Study||15
8322146|NCT01416025|20518005|P1|COMPLETED|Overall Study||14
8322147|NCT01416025|20518004|P2|STARTED|Overall Study||15
8322148|NCT01416025|20518005|P1|STARTED|Overall Study||14
8322149|NCT01415986|20518011|P1|NOT COMPLETED|Overall Study||1
8322150|NCT01415986|20518011|P1|COMPLETED|Overall Study|Study terminated|0
8322151|NCT01415986|20518011|P1|STARTED|Overall Study||1
8322152|NCT01415960|20518016|P1|NOT COMPLETED|Overall Study||12
8322153|NCT01415960|20518016|P1|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
8322154|NCT01415960|20518016|P1|PK Subgroup|Overall Study||30
8322155|NCT01415960|20518016|P1|ITT|Overall Study||161
8322156|NCT01415960|20518016|P1|STARTED|Overall Study||163
8322157|NCT01415934|20518028|P2|NOT COMPLETED|Overall Study||7
8322158|NCT01415934|20518029|P1|NOT COMPLETED|Overall Study||3
8322159|NCT01415934|20518028|P2|COMPLETED|Overall Study||182
8322160|NCT01415934|20518029|P1|COMPLETED|Overall Study||189
8322161|NCT01415934|20518028|P2|STARTED|Overall Study||189
8322162|NCT01415934|20518029|P1|STARTED|Overall Study||192
8322163|NCT01415921|20518037|P2|NOT COMPLETED|Overall Study||3
8322164|NCT01415921|20518038|P1|NOT COMPLETED|Overall Study||3
8322165|NCT01415921|20518037|P2|COMPLETED|Overall Study||14
8322166|NCT01415921|20518038|P1|COMPLETED|Overall Study||13
8322167|NCT01415921|20518037|P2|STARTED|Overall Study||17
8322168|NCT01415921|20518038|P1|STARTED|Overall Study||16
8322169|NCT01415908|20518048|P2|NOT COMPLETED|Overall Study||0
8322170|NCT01415908|20518049|P1|NOT COMPLETED|Overall Study||1
8322171|NCT01415908|20518048|P2|COMPLETED|Overall Study||4
8322172|NCT01415908|20518049|P1|COMPLETED|Overall Study||10
8322173|NCT01415908|20518048|P2|STARTED|Overall Study||4
8322174|NCT01415908|20518049|P1|STARTED|Overall Study||11
8322175|NCT01415583|20518077|P2|NOT COMPLETED|Overall Study||0
8322176|NCT01415583|20518078|P1|NOT COMPLETED|Overall Study||0
8322177|NCT01415583|20518077|P2|COMPLETED|Overall Study||157
8322178|NCT01415583|20518078|P1|COMPLETED|Overall Study||157
8322179|NCT01415583|20518077|P2|STARTED|Overall Study||157
8322180|NCT01415583|20518078|P1|STARTED|Overall Study||157
8322181|NCT01415531|20518086|P2|NOT COMPLETED|Overall Study||37
8322182|NCT01415531|20518087|P1|NOT COMPLETED|Overall Study||25
8322183|NCT01415531|20518086|P2|COMPLETED|Overall Study||390
8322184|NCT01415531|20518087|P1|COMPLETED|Overall Study||189
8322185|NCT01415531|20518086|P2|STARTED|Overall Study||427
8322186|NCT01415531|20518087|P1|STARTED|Overall Study||214
8322187|NCT01415518|20518097|P2|NOT COMPLETED|Overall Study||31
8322188|NCT01415518|20518098|P1|NOT COMPLETED|Overall Study||16
8322189|NCT01415518|20518097|P2|COMPLETED|Overall Study||261
8322190|NCT01415518|20518098|P1|COMPLETED|Overall Study||276
8322191|NCT01415518|20518097|P2|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
8322192|NCT01415518|20518098|P1|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
8322193|NCT01415518|20518097|P2|Patients Who Received Study Treatment|Overall Study||292
8322194|NCT01415518|20518098|P1|Patients Who Received Study Treatment|Overall Study||290
8322195|NCT01415518|20518097|P2|STARTED|Overall Study||292
8322196|NCT01415518|20518098|P1|STARTED|Overall Study||292
8322197|NCT01415453|20518150|P1|NOT COMPLETED|Overall Study||0
8322198|NCT01415453|20518150|P1|COMPLETED|Overall Study||1
8322199|NCT01415453|20518150|P1|Imaging Study|Overall Study||1
8322200|NCT01415453|20518150|P1|STARTED|Overall Study||1
8322201|NCT01415440|20518157|P3|NOT COMPLETED|Overall Study||2
8322202|NCT01415440|20518158|P2|NOT COMPLETED|Overall Study||1
8322203|NCT01415440|20518159|P1|NOT COMPLETED|Overall Study||4
8322204|NCT01415440|20518157|P3|COMPLETED|Overall Study||27
8322205|NCT01415440|20518158|P2|COMPLETED|Overall Study||28
8322206|NCT01415440|20518159|P1|COMPLETED|Overall Study||37
8322207|NCT01415440|20518157|P3|STARTED|Overall Study||29
8322208|NCT01415440|20518158|P2|STARTED|Overall Study||29
8322209|NCT01415440|20518159|P1|STARTED|Overall Study||41
8322222|NCT01415401|20518210|P1|NOT COMPLETED|Overall Study||7
8322223|NCT01415401|20518210|P1|COMPLETED|Overall Study||47
8322224|NCT01415401|20518210|P1|STARTED|Overall Study||54
8322237|NCT01415232|20518224|P1|NOT COMPLETED|Overall Study||0
8322238|NCT01415232|20518224|P1|COMPLETED|Overall Study||160
8322239|NCT01415232|20518224|P1|STARTED|Overall Study||160
8322240|NCT01414855|20518228|P1|NOT COMPLETED|Overall Study||29
8322241|NCT01414855|20518228|P1|COMPLETED|Overall Study||71
8322242|NCT01414855|20518228|P1|STARTED|Overall Study||100
8322243|NCT01414738|20518244|P1|NOT COMPLETED|Overall Study||44
8322244|NCT01414738|20518244|P1|COMPLETED|Overall Study||5
8322245|NCT01414738|20518244|P1|Follow-up (9 Months)|Overall Study||5
8322246|NCT01414738|20518244|P1|Follow-up (6 Months)|Overall Study||8
8322247|NCT01414738|20518244|P1|Follow-up (3 Months)|Overall Study||18
8322248|NCT01414738|20518244|P1|STARTED|Overall Study||49
8322249|NCT01414634|20518265|P8|NOT COMPLETED|Overall Study||0
8322250|NCT01414634|20518266|P7|NOT COMPLETED|Overall Study||0
8322251|NCT01414634|20518267|P6|NOT COMPLETED|Overall Study||0
8322252|NCT01414634|20518268|P5|NOT COMPLETED|Overall Study||0
8322253|NCT01414634|20518269|P4|NOT COMPLETED|Overall Study||0
8322254|NCT01414634|20518270|P3|NOT COMPLETED|Overall Study||0
8322255|NCT01414634|20518271|P2|NOT COMPLETED|Overall Study||0
8322256|NCT01414634|20518272|P1|NOT COMPLETED|Overall Study||0
8322257|NCT01414634|20518265|P8|COMPLETED|Overall Study||1
8322258|NCT01414634|20518266|P7|COMPLETED|Overall Study||1
8322259|NCT01414634|20518267|P6|COMPLETED|Overall Study||2
8322260|NCT01414634|20518268|P5|COMPLETED|Overall Study||1
8322261|NCT01414634|20518269|P4|COMPLETED|Overall Study||1
8322262|NCT01414634|20518270|P3|COMPLETED|Overall Study||1
8322263|NCT01414634|20518271|P2|COMPLETED|Overall Study||1
8322264|NCT01414634|20518272|P1|COMPLETED|Overall Study||1
8322265|NCT01414634|20518265|P8|STARTED|Overall Study||1
8322266|NCT01414634|20518266|P7|STARTED|Overall Study||1
8322267|NCT01414634|20518267|P6|STARTED|Overall Study||2
8322268|NCT01414634|20518268|P5|STARTED|Overall Study||1
8322269|NCT01414634|20518269|P4|STARTED|Overall Study||1
8322270|NCT01414634|20518270|P3|STARTED|Overall Study||1
8322271|NCT01414634|20518271|P2|STARTED|Overall Study||1
8322272|NCT01414634|20518272|P1|STARTED|Overall Study||1
8322273|NCT01414426|20518285|P2|NOT COMPLETED|Overall Study||2
8322274|NCT01414426|20518286|P1|NOT COMPLETED|Overall Study||1
8322275|NCT01414426|20518285|P2|COMPLETED|Overall Study||8
8322276|NCT01414426|20518286|P1|COMPLETED|Overall Study||9
8322277|NCT01414426|20518285|P2|STARTED|Overall Study||10
8322278|NCT01414426|20518286|P1|STARTED|Overall Study||10
8322279|NCT01414413|20518302|P2|NOT COMPLETED|Overall Study||0
8322280|NCT01414413|20518303|P1|NOT COMPLETED|Overall Study||0
8322281|NCT01414413|20518302|P2|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
8322282|NCT01414413|20518303|P1|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
8322283|NCT01414413|20518302|P2|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
8322284|NCT01414413|20518303|P1|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
8322285|NCT01414257|20518315|P1|NOT COMPLETED|Overall Study||22
8322286|NCT01414257|20518315|P1|COMPLETED|Overall Study||2838
8322287|NCT01414257|20518315|P1|STARTED|Overall Study||2860
8322288|NCT01414244|20518328|P2|NOT COMPLETED|Overall Study||0
8322289|NCT01414244|20518329|P1|NOT COMPLETED|Overall Study||0
8322290|NCT01414244|20518328|P2|COMPLETED|Overall Study||52
8322291|NCT01414244|20518329|P1|COMPLETED|Overall Study||54
8322292|NCT01414244|20518328|P2|STARTED|Overall Study||52
8322293|NCT01414244|20518329|P1|STARTED|Overall Study||54
8322294|NCT01414205|20518343|P2|NOT COMPLETED|Overall Study||7
8322295|NCT01414205|20518344|P1|NOT COMPLETED|Overall Study||7
8322296|NCT01414205|20518343|P2|COMPLETED|Overall Study||32
8322297|NCT01414205|20518344|P1|COMPLETED|Overall Study||34
8322298|NCT01414205|20518343|P2|Received Study Drug|Overall Study||38
8322299|NCT01414205|20518344|P1|Received Study Drug|Overall Study||40
8322300|NCT01414205|20518343|P2|STARTED|Overall Study||39
8322301|NCT01414205|20518344|P1|STARTED|Overall Study||41
8322302|NCT01414192|20518380|P4|NOT COMPLETED|Overall Study||0
8322303|NCT01414192|20518381|P3|NOT COMPLETED|Overall Study||0
8322304|NCT01414192|20518382|P2|NOT COMPLETED|Overall Study||0
8322305|NCT01414192|20518383|P1|NOT COMPLETED|Overall Study||0
8322306|NCT01414192|20518380|P4|COMPLETED|Overall Study||1726
8322307|NCT01414192|20518381|P3|COMPLETED|Overall Study||424
8322308|NCT01414192|20518382|P2|COMPLETED|Overall Study||575
8322309|NCT01414192|20518383|P1|COMPLETED|Overall Study||490
8322310|NCT01414192|20518380|P4|STARTED|Overall Study||1726
8322311|NCT01414192|20518381|P3|STARTED|Overall Study||424
8322312|NCT01414192|20518382|P2|STARTED|Overall Study||575
8322313|NCT01414192|20518383|P1|STARTED|Overall Study||490
8322314|NCT01414166|20518413|P2|NOT COMPLETED|Overall Study||83
8322315|NCT01414166|20518414|P1|NOT COMPLETED|Overall Study||91
8322316|NCT01414166|20518413|P2|COMPLETED|Overall Study||39
8322317|NCT01414166|20518414|P1|COMPLETED|Overall Study||31
8322318|NCT01414166|20518413|P2|Treated|Overall Study||121
8322319|NCT01414166|20518414|P1|Treated|Overall Study||120
8322320|NCT01414166|20518413|P2|STARTED|Overall Study||122
8322321|NCT01414166|20518414|P1|STARTED|Overall Study||122
8322322|NCT01414153|20518440|P4|NOT COMPLETED|Overall Study||4
8322323|NCT01414153|20518441|P3|NOT COMPLETED|Overall Study||4
8322324|NCT01414153|20518442|P2|NOT COMPLETED|Overall Study||2
8322325|NCT01414153|20518443|P1|NOT COMPLETED|Overall Study||8
8322326|NCT01414153|20518440|P4|COMPLETED|Overall Study||37
8322327|NCT01414153|20518441|P3|COMPLETED|Overall Study||35
8322328|NCT01414153|20518442|P2|COMPLETED|Overall Study||38
8322329|NCT01414153|20518443|P1|COMPLETED|Overall Study||30
8322330|NCT01414153|20518440|P4|STARTED|Overall Study||41
8322331|NCT01414153|20518441|P3|STARTED|Overall Study||39
8322332|NCT01414153|20518442|P2|STARTED|Overall Study||40
8322333|NCT01414153|20518443|P1|STARTED|Overall Study||38
8322334|NCT01414114|20518477|P1|NOT COMPLETED|Overall Study||5
8322335|NCT01414114|20518477|P1|COMPLETED|Overall Study|Completed 12-week treatment period|32
8322336|NCT01414114|20518477|P1|STARTED|Overall Study||37
8322337|NCT01414036|20518497|P2|NOT COMPLETED|Completed 3 Month Survey||5
8322338|NCT01414036|20518498|P1|NOT COMPLETED|Completed 3 Month Survey||9
8322339|NCT01414036|20518497|P2|COMPLETED|Completed 3 Month Survey||19
8322340|NCT01414036|20518498|P1|COMPLETED|Completed 3 Month Survey||14
8322341|NCT01414036|20518497|P2|STARTED|Completed 3 Month Survey||24
8322342|NCT01414036|20518498|P1|STARTED|Completed 3 Month Survey||23
8322343|NCT01414036|20518497|P2|NOT COMPLETED|Received Allocated Intervention||13
8322344|NCT01414036|20518498|P1|NOT COMPLETED|Received Allocated Intervention||0
8322345|NCT01414036|20518497|P2|COMPLETED|Received Allocated Intervention||11
8322346|NCT01414036|20518498|P1|COMPLETED|Received Allocated Intervention||23
8322347|NCT01414036|20518497|P2|STARTED|Received Allocated Intervention||24
8322348|NCT01414036|20518498|P1|STARTED|Received Allocated Intervention||23
8322349|NCT01414010|20518512|P4|NOT COMPLETED|Overall Study||0
8322350|NCT01414010|20518513|P3|NOT COMPLETED|Overall Study||0
8322351|NCT01414010|20518514|P2|NOT COMPLETED|Overall Study||0
8322352|NCT01414010|20518515|P1|NOT COMPLETED|Overall Study||2
8322353|NCT01414010|20518512|P4|COMPLETED|Overall Study||8
8322354|NCT01414010|20518513|P3|COMPLETED|Overall Study||8
8322355|NCT01414010|20518514|P2|COMPLETED|Overall Study||8
8322356|NCT01414010|20518515|P1|COMPLETED|Overall Study||6
8322357|NCT01414010|20518512|P4|STARTED|Overall Study||8
8322358|NCT01414010|20518513|P3|STARTED|Overall Study||8
8322359|NCT01414010|20518514|P2|STARTED|Overall Study||8
8322360|NCT01414010|20518515|P1|STARTED|Overall Study||8
8322361|NCT01413958|20518533|P2|NOT COMPLETED|Overall Study||1
8322362|NCT01413958|20518534|P1|NOT COMPLETED|Overall Study||0
8322363|NCT01413958|20518533|P2|COMPLETED|Overall Study||286
8322364|NCT01413958|20518534|P1|COMPLETED|Overall Study||288
8322365|NCT01413958|20518533|P2|STARTED|Overall Study||287
8322366|NCT01413958|20518534|P1|STARTED|Overall Study||288
8322367|NCT01413750|20518569|P4|NOT COMPLETED|Overall Study||0
8322368|NCT01413750|20518570|P3|NOT COMPLETED|Overall Study||0
8322369|NCT01413750|20518571|P2|NOT COMPLETED|Overall Study||0
8322370|NCT01413750|20518572|P1|NOT COMPLETED|Overall Study||0
8322371|NCT01413750|20518569|P4|COMPLETED|Overall Study||7
8322372|NCT01413750|20518570|P3|COMPLETED|Overall Study||4
8322373|NCT01413750|20518571|P2|COMPLETED|Overall Study||6
8322374|NCT01413750|20518572|P1|COMPLETED|Overall Study||6
8322375|NCT01413750|20518569|P4|STARTED|Overall Study||7
8322376|NCT01413750|20518570|P3|STARTED|Overall Study||4
8322377|NCT01413750|20518571|P2|STARTED|Overall Study||6
8322378|NCT01413750|20518572|P1|STARTED|Overall Study||6
8322379|NCT01413542|20518585|P4|NOT COMPLETED|Overall Study||1
8322380|NCT01413542|20518586|P3|NOT COMPLETED|Overall Study||3
8322381|NCT01413542|20518587|P2|NOT COMPLETED|Overall Study||0
8322382|NCT01413542|20518588|P1|NOT COMPLETED|Overall Study||1
8322383|NCT01413542|20518585|P4|COMPLETED|Overall Study||7
8322384|NCT01413542|20518586|P3|COMPLETED|Overall Study||6
8322385|NCT01413542|20518587|P2|COMPLETED|Overall Study||6
8322386|NCT01413542|20518588|P1|COMPLETED|Overall Study||5
8322387|NCT01413542|20518585|P4|STARTED|Overall Study||8
8322388|NCT01413542|20518586|P3|STARTED|Overall Study||9
8322389|NCT01413542|20518587|P2|STARTED|Overall Study||6
8322390|NCT01413542|20518588|P1|STARTED|Overall Study||6
8322391|NCT01413516|20518603|P2|NOT COMPLETED|Overall Study||0
8322392|NCT01413516|20518604|P1|NOT COMPLETED|Overall Study||0
8322393|NCT01413516|20518603|P2|COMPLETED|Overall Study||9
8322394|NCT01413516|20518604|P1|COMPLETED|Overall Study||8
8322395|NCT01413516|20518603|P2|STARTED|Overall Study||9
8322396|NCT01413516|20518604|P1|STARTED|Overall Study||8
8322397|NCT01413503|20518610|P1|NOT COMPLETED|Overall Study||1
8322398|NCT01413503|20518610|P1|COMPLETED|Overall Study||49
8322399|NCT01413503|20518610|P1|STARTED|Overall Study||50
8322400|NCT01413360|20518614|P1|NOT COMPLETED|Overall Study||3
8322401|NCT01413360|20518614|P1|COMPLETED|Overall Study||7
8322402|NCT01413360|20518614|P1|STARTED|Overall Study||10
8322403|NCT01413204|20518622|P3|NOT COMPLETED|Overall Study||19
8322404|NCT01413204|20518623|P2|NOT COMPLETED|Overall Study||6
8322405|NCT01413204|20518624|P1|NOT COMPLETED|Overall Study||6
8322406|NCT01413204|20518622|P3|COMPLETED|Overall Study||74
8322407|NCT01413204|20518623|P2|COMPLETED|Overall Study||83
8322408|NCT01413204|20518624|P1|COMPLETED|Overall Study||84
8322409|NCT01413204|20518622|P3|STARTED|Overall Study||93
8322410|NCT01413204|20518623|P2|STARTED|Overall Study||89
8322411|NCT01413204|20518624|P1|STARTED|Overall Study||90
8322412|NCT01413191|20518632|P1|NOT COMPLETED|Overall Study||11
8322413|NCT01413191|20518632|P1|COMPLETED|Overall Study||7
8322414|NCT01413191|20518632|P1|STARTED|Overall Study||18
8322415|NCT01413178|20518644|P2|NOT COMPLETED|Overall Study||2
8322416|NCT01413178|20518645|P1|NOT COMPLETED|Overall Study||1
8322417|NCT01413178|20518644|P2|COMPLETED|Overall Study||98
8322418|NCT01413178|20518645|P1|COMPLETED|Overall Study||104
8322419|NCT01413178|20518644|P2|STARTED|Overall Study||100
8322420|NCT01413178|20518645|P1|STARTED|Overall Study||105
8322421|NCT01413087|20518661|P2|NOT COMPLETED|Overall Study||0
8322422|NCT01413087|20518662|P1|NOT COMPLETED|Overall Study||0
8322423|NCT01413087|20518661|P2|COMPLETED|Overall Study||6
8322424|NCT01413087|20518662|P1|COMPLETED|Overall Study||6
8322425|NCT01413087|20518661|P2|STARTED|Overall Study||6
8322426|NCT01413087|20518662|P1|STARTED|Overall Study||6
8322427|NCT01412983|20518688|P2|NOT COMPLETED|2nd Period||0
8322428|NCT01412983|20518689|P1|NOT COMPLETED|2nd Period||0
8322429|NCT01412983|20518688|P2|COMPLETED|2nd Period||46
8322430|NCT01412983|20518689|P1|COMPLETED|2nd Period||50
8322431|NCT01412983|20518688|P2|STARTED|2nd Period||46
8322432|NCT01412983|20518689|P1|STARTED|2nd Period||50
8322433|NCT01412983|20518688|P2|NOT COMPLETED|1st Period||4
8322434|NCT01412983|20518689|P1|NOT COMPLETED|1st Period||0
8322435|NCT01412983|20518688|P2|COMPLETED|1st Period||46
8322436|NCT01412983|20518689|P1|COMPLETED|1st Period||50
8322437|NCT01412983|20518688|P2|STARTED|1st Period||50
8322438|NCT01412983|20518689|P1|STARTED|1st Period||50
8322439|NCT01412957|20518699|P2|NOT COMPLETED|Overall Study||157
8322440|NCT01412957|20518700|P1|NOT COMPLETED|Overall Study||149
8322441|NCT01412957|20518699|P2|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
8322442|NCT01412957|20518700|P1|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
8322443|NCT01412957|20518699|P2|STARTED|Overall Study||188
8322444|NCT01412957|20518700|P1|STARTED|Overall Study||189
8322445|NCT01412944|20518722|P6|NOT COMPLETED|Follow-up||0
8322446|NCT01412944|20518723|P5|NOT COMPLETED|Follow-up||0
8322447|NCT01412944|20518724|P4|NOT COMPLETED|Follow-up||0
8322448|NCT01412944|20518725|P3|NOT COMPLETED|Follow-up||0
8322449|NCT01412944|20518726|P2|NOT COMPLETED|Follow-up||0
8322450|NCT01412944|20518727|P1|NOT COMPLETED|Follow-up||0
8322451|NCT01412944|20518722|P6|COMPLETED|Follow-up||0
8322452|NCT01412944|20518723|P5|COMPLETED|Follow-up||2
8322453|NCT01412944|20518724|P4|COMPLETED|Follow-up||1
8322454|NCT01412944|20518725|P3|COMPLETED|Follow-up||2
8322455|NCT01412944|20518726|P2|COMPLETED|Follow-up||0
8322456|NCT01412944|20518727|P1|COMPLETED|Follow-up||0
8322457|NCT01412944|20518722|P6|STARTED|Follow-up||0
8322458|NCT01412944|20518723|P5|STARTED|Follow-up||2
8322459|NCT01412944|20518724|P4|STARTED|Follow-up||1
8322460|NCT01412944|20518725|P3|STARTED|Follow-up||2
8322461|NCT01412944|20518726|P2|STARTED|Follow-up||0
8322462|NCT01412944|20518727|P1|STARTED|Follow-up||0
8322463|NCT01412944|20518722|P6|NOT COMPLETED|Entire: IV + Maintenance||0
8322464|NCT01412944|20518723|P5|NOT COMPLETED|Entire: IV + Maintenance||0
8322465|NCT01412944|20518724|P4|NOT COMPLETED|Entire: IV + Maintenance||0
8322466|NCT01412944|20518725|P3|NOT COMPLETED|Entire: IV + Maintenance||0
8322467|NCT01412944|20518726|P2|NOT COMPLETED|Entire: IV + Maintenance||5
8322468|NCT01412944|20518727|P1|NOT COMPLETED|Entire: IV + Maintenance||2
8322469|NCT01412944|20518722|P6|COMPLETED|Entire: IV + Maintenance||0
8322470|NCT01412944|20518723|P5|COMPLETED|Entire: IV + Maintenance||0
8322471|NCT01412944|20518724|P4|COMPLETED|Entire: IV + Maintenance||0
8322472|NCT01412944|20518725|P3|COMPLETED|Entire: IV + Maintenance||0
8322473|NCT01412944|20518726|P2|COMPLETED|Entire: IV + Maintenance||17
8322474|NCT01412944|20518727|P1|COMPLETED|Entire: IV + Maintenance||19
8322475|NCT01412944|20518722|P6|STARTED|Entire: IV + Maintenance||0
8322476|NCT01412944|20518723|P5|STARTED|Entire: IV + Maintenance||0
8322477|NCT01412944|20518724|P4|STARTED|Entire: IV + Maintenance||0
8322478|NCT01412944|20518725|P3|STARTED|Entire: IV + Maintenance||0
8322479|NCT01412944|20518726|P2|STARTED|Entire: IV + Maintenance||22
8322480|NCT01412944|20518727|P1|STARTED|Entire: IV + Maintenance||21
8322481|NCT01412944|20518722|P6|NOT COMPLETED|Entire: IV + Maintenance||2
8322482|NCT01412944|20518723|P5|NOT COMPLETED|Entire: IV + Maintenance||3
8322483|NCT01412944|20518724|P4|NOT COMPLETED|Entire: IV + Maintenance||1
8322484|NCT01412944|20518725|P3|NOT COMPLETED|Entire: IV + Maintenance||1
8322485|NCT01412944|20518726|P2|NOT COMPLETED|Entire: IV + Maintenance||0
8322486|NCT01412944|20518727|P1|NOT COMPLETED|Entire: IV + Maintenance||0
8322487|NCT01412944|20518722|P6|COMPLETED|Entire: IV + Maintenance||6
8322488|NCT01412944|20518723|P5|COMPLETED|Entire: IV + Maintenance||11
8322489|NCT01412944|20518724|P4|COMPLETED|Entire: IV + Maintenance||5
8322490|NCT01412944|20518725|P3|COMPLETED|Entire: IV + Maintenance||14
8322491|NCT01412944|20518726|P2|COMPLETED|Entire: IV + Maintenance||0
8322492|NCT01412944|20518727|P1|COMPLETED|Entire: IV + Maintenance||0
8322493|NCT01412944|20518722|P6|STARTED|Entire: IV + Maintenance||8
8322494|NCT01412944|20518723|P5|STARTED|Entire: IV + Maintenance||14
8322495|NCT01412944|20518724|P4|STARTED|Entire: IV + Maintenance||6
8322496|NCT01412944|20518725|P3|STARTED|Entire: IV + Maintenance||15
8322497|NCT01412944|20518726|P2|STARTED|Entire: IV + Maintenance||0
8322498|NCT01412944|20518727|P1|STARTED|Entire: IV + Maintenance||0
8322499|NCT01412944|20518722|P6|NOT COMPLETED|IV: Per CAIN457A2307||0
8322500|NCT01412944|20518723|P5|NOT COMPLETED|IV: Per CAIN457A2307||0
8322501|NCT01412944|20518724|P4|NOT COMPLETED|IV: Per CAIN457A2307||0
8322502|NCT01412944|20518725|P3|NOT COMPLETED|IV: Per CAIN457A2307||0
8322503|NCT01412944|20518726|P2|NOT COMPLETED|IV: Per CAIN457A2307||2
8322504|NCT01412944|20518727|P1|NOT COMPLETED|IV: Per CAIN457A2307||1
8322505|NCT01412944|20518722|P6|COMPLETED|IV: Per CAIN457A2307||0
8322506|NCT01412944|20518723|P5|COMPLETED|IV: Per CAIN457A2307||0
8322507|NCT01412944|20518724|P4|COMPLETED|IV: Per CAIN457A2307||0
8322508|NCT01412944|20518725|P3|COMPLETED|IV: Per CAIN457A2307||0
8322509|NCT01412944|20518726|P2|COMPLETED|IV: Per CAIN457A2307||20
8322510|NCT01412944|20518727|P1|COMPLETED|IV: Per CAIN457A2307||20
8322511|NCT01412944|20518722|P6|STARTED|IV: Per CAIN457A2307||0
8322512|NCT01412944|20518723|P5|STARTED|IV: Per CAIN457A2307||0
8322513|NCT01412944|20518724|P4|STARTED|IV: Per CAIN457A2307||0
8322514|NCT01412944|20518725|P3|STARTED|IV: Per CAIN457A2307||0
8322515|NCT01412944|20518726|P2|STARTED|IV: Per CAIN457A2307||22
8322516|NCT01412944|20518727|P1|STARTED|IV: Per CAIN457A2307||21
8322517|NCT01412944|20518722|P6|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
8322518|NCT01412944|20518723|P5|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8322519|NCT01412944|20518724|P4|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8322520|NCT01412944|20518725|P3|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
8322521|NCT01412944|20518726|P2|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8322522|NCT01412944|20518727|P1|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8322523|NCT01412944|20518722|P6|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
8322524|NCT01412944|20518723|P5|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
8322525|NCT01412944|20518724|P4|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
8322526|NCT01412944|20518725|P3|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
8322527|NCT01412944|20518726|P2|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8322528|NCT01412944|20518727|P1|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
8322529|NCT01412944|20518722|P6|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
8322530|NCT01412944|20518723|P5|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
8322531|NCT01412944|20518724|P4|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
8322532|NCT01412944|20518725|P3|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
8322533|NCT01412944|20518726|P2|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
8322534|NCT01412944|20518727|P1|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
8322535|NCT01412918|20518763|P2|NOT COMPLETED|Overall Study||0
8322536|NCT01412918|20518764|P1|NOT COMPLETED|Overall Study||0
8322537|NCT01412918|20518763|P2|COMPLETED|Overall Study||1
8322538|NCT01412918|20518764|P1|COMPLETED|Overall Study||20
8322539|NCT01412918|20518763|P2|STARTED|Overall Study||1
8322540|NCT01412918|20518764|P1|STARTED|Overall Study||20
8322562|NCT01412866|20518791|P2|NOT COMPLETED|Overall Study||2
8322563|NCT01412866|20518792|P1|NOT COMPLETED|Overall Study||1
8322564|NCT01412866|20518791|P2|COMPLETED|Overall Study||64
8322565|NCT01412866|20518792|P1|COMPLETED|Overall Study||57
8322566|NCT01412866|20518791|P2|STARTED|Overall Study||66
8322567|NCT01412866|20518792|P1|STARTED|Overall Study||58
8322568|NCT01412801|20518804|P6|NOT COMPLETED|Overall Study||3
8322569|NCT01412801|20518805|P5|NOT COMPLETED|Overall Study||3
8322570|NCT01412801|20518806|P4|NOT COMPLETED|Overall Study||4
8322571|NCT01412801|20518807|P3|NOT COMPLETED|Overall Study||7
8322572|NCT01412801|20518808|P2|NOT COMPLETED|Overall Study||5
8322573|NCT01412801|20518809|P1|NOT COMPLETED|Overall Study||4
8322574|NCT01412801|20518804|P6|COMPLETED|Overall Study||84
8322575|NCT01412801|20518805|P5|COMPLETED|Overall Study||85
8322576|NCT01412801|20518806|P4|COMPLETED|Overall Study||87
8322577|NCT01412801|20518807|P3|COMPLETED|Overall Study||83
8322578|NCT01412801|20518808|P2|COMPLETED|Overall Study||84
8322579|NCT01412801|20518809|P1|COMPLETED|Overall Study||87
8322580|NCT01412801|20518804|P6|STARTED|Overall Study||87
8322581|NCT01412801|20518805|P5|STARTED|Overall Study||88
8322582|NCT01412801|20518806|P4|STARTED|Overall Study||91
8322583|NCT01412801|20518807|P3|STARTED|Overall Study||90
8322584|NCT01412801|20518808|P2|STARTED|Overall Study||89
8322585|NCT01412801|20518809|P1|STARTED|Overall Study||91
8322586|NCT01412710|20518848|P2|NOT COMPLETED|Overall Study||5
8322587|NCT01412710|20518849|P1|NOT COMPLETED|Overall Study||4
8322588|NCT01412710|20518848|P2|COMPLETED|Overall Study||22
8322589|NCT01412710|20518849|P1|COMPLETED|Overall Study||46
8322590|NCT01412710|20518848|P2|STARTED|Overall Study||27
8322591|NCT01412710|20518849|P1|STARTED|Overall Study||50
8322592|NCT01412554|20518857|P1|NOT COMPLETED|Overall Study||0
8322593|NCT01412554|20518857|P1|COMPLETED|Overall Study||103
8322594|NCT01412554|20518857|P1|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103
8322595|NCT01412541|20518863|P2|NOT COMPLETED|Overall Study||43
8322596|NCT01412541|20518864|P1|NOT COMPLETED|Overall Study||126
8322597|NCT01412541|20518863|P2|COMPLETED|Overall Study||117
8322598|NCT01412541|20518864|P1|COMPLETED|Overall Study||246
8322599|NCT01412541|20518863|P2|STARTED|Overall Study||160
8322600|NCT01412541|20518864|P1|STARTED|Overall Study||372
8322601|NCT01412424|20518904|P1|NOT COMPLETED|Extension Treatment Period||6
8322602|NCT01412424|20518904|P1|COMPLETED|Extension Treatment Period||82
8322603|NCT01412424|20518904|P1|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
8322604|NCT01412424|20518904|P1|NOT COMPLETED|Core Treatment Period||53
8322605|NCT01412424|20518904|P1|COMPLETED|Core Treatment Period||102
8322606|NCT01412424|20518904|P1|STARTED|Core Treatment Period||155
8322607|NCT01412372|20518922|P2|NOT COMPLETED|Overall Study||3
8322608|NCT01412372|20518923|P1|NOT COMPLETED|Overall Study||4
8322609|NCT01412372|20518922|P2|COMPLETED|Overall Study||28
8322610|NCT01412372|20518923|P1|COMPLETED|Overall Study||26
8322611|NCT01412372|20518922|P2|STARTED|Overall Study||31
8322612|NCT01412372|20518923|P1|STARTED|Overall Study||30
8322613|NCT01412333|20518941|P2|NOT COMPLETED|Overall Study||57
8322614|NCT01412333|20518942|P1|NOT COMPLETED|Overall Study||98
8322615|NCT01412333|20518941|P2|COMPLETED|Overall Study||360
8322616|NCT01412333|20518942|P1|COMPLETED|Overall Study||320
8322617|NCT01412333|20518941|P2|STARTED|Overall Study||417
8322618|NCT01412333|20518942|P1|STARTED|Overall Study||418
8322619|NCT01412281|20518977|P4|NOT COMPLETED|Overall Study||0
8322620|NCT01412281|20518978|P3|NOT COMPLETED|Overall Study||0
8322621|NCT01412281|20518979|P2|NOT COMPLETED|Overall Study||0
8322622|NCT01412281|20518980|P1|NOT COMPLETED|Overall Study||0
8322623|NCT01412281|20518977|P4|COMPLETED|Overall Study||110
8322624|NCT01412281|20518978|P3|COMPLETED|Overall Study||110
8322625|NCT01412281|20518979|P2|COMPLETED|Overall Study||110
8322626|NCT01412281|20518980|P1|COMPLETED|Overall Study||110
8322627|NCT01412281|20518977|P4|STARTED|Overall Study||110
8322628|NCT01412281|20518978|P3|STARTED|Overall Study||110
8322629|NCT01412281|20518979|P2|STARTED|Overall Study||110
8322630|NCT01412281|20518980|P1|STARTED|Overall Study||110
8322631|NCT01412229|20519002|P1|NOT COMPLETED|Overall Study||1
8322632|NCT01412229|20519002|P1|COMPLETED|Overall Study||38
8322633|NCT01412229|20519002|P1|STARTED|Overall Study||39
8322634|NCT01412164|20519014|P1|NOT COMPLETED|Overall Study||47
8322635|NCT01412164|20519014|P1|COMPLETED|Overall Study||683
8322636|NCT01412164|20519014|P1|STARTED|Overall Study||730
8322637|NCT01412151|20519025|P1|NOT COMPLETED|Week 306 - 310 - Washout Period||2
8322638|NCT01412151|20519025|P1|COMPLETED|Week 306 - 310 - Washout Period||3
8322639|NCT01412151|20519025|P1|STARTED|Week 306 - 310 - Washout Period||5
8322640|NCT01412151|20519025|P1|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
8322641|NCT01412151|20519025|P1|COMPLETED|Week 0 - 306 - Treatment Period||5
8322642|NCT01412151|20519025|P1|STARTED|Week 0 - 306 - Treatment Period||10
8322643|NCT01412086|20519031|P1|NOT COMPLETED|Overall Study||0
8322644|NCT01412086|20519031|P1|COMPLETED|Overall Study||112
8322645|NCT01412086|20519031|P1|STARTED|Overall Study||112
8322646|NCT01412060|20519036|P3|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
8322647|NCT01412060|20519037|P2|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
8322648|NCT01412060|20519038|P1|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
8322649|NCT01412060|20519036|P3|COMPLETED|Double-blind Treatment Phase (DBP)||18
8322650|NCT01412060|20519037|P2|COMPLETED|Double-blind Treatment Phase (DBP)||16
8322651|NCT01412060|20519038|P1|COMPLETED|Double-blind Treatment Phase (DBP)||0
8322652|NCT01412060|20519036|P3|STARTED|Double-blind Treatment Phase (DBP)||101
8322653|NCT01412060|20519037|P2|STARTED|Double-blind Treatment Phase (DBP)||99
8322654|NCT01412060|20519038|P1|STARTED|Double-blind Treatment Phase (DBP)||0
8322655|NCT01412060|20519036|P3|NOT COMPLETED|Period Between SP and DBP||0
8322656|NCT01412060|20519037|P2|NOT COMPLETED|Period Between SP and DBP||0
8322657|NCT01412060|20519038|P1|NOT COMPLETED|Period Between SP and DBP||64
8322658|NCT01412060|20519036|P3|COMPLETED|Period Between SP and DBP||0
8322659|NCT01412060|20519037|P2|COMPLETED|Period Between SP and DBP||0
8322660|NCT01412060|20519038|P1|COMPLETED|Period Between SP and DBP||200
8322661|NCT01412060|20519036|P3|STARTED|Period Between SP and DBP||0
8322662|NCT01412060|20519037|P2|STARTED|Period Between SP and DBP||0
8322663|NCT01412060|20519038|P1|STARTED|Period Between SP and DBP||264
8322664|NCT01412060|20519036|P3|NOT COMPLETED|Open-label Stabilization Period (SP)||0
8322665|NCT01412060|20519037|P2|NOT COMPLETED|Open-label Stabilization Period (SP)||0
8322666|NCT01412060|20519038|P1|NOT COMPLETED|Open-label Stabilization Period (SP)||100
8322667|NCT01412060|20519036|P3|COMPLETED|Open-label Stabilization Period (SP)||0
8322668|NCT01412060|20519037|P2|COMPLETED|Open-label Stabilization Period (SP)||0
8322669|NCT01412060|20519038|P1|COMPLETED|Open-label Stabilization Period (SP)||264
8322670|NCT01412060|20519036|P3|STARTED|Open-label Stabilization Period (SP)||0
8322671|NCT01412060|20519037|P2|STARTED|Open-label Stabilization Period (SP)||0
8322672|NCT01412060|20519038|P1|STARTED|Open-label Stabilization Period (SP)||364
8322673|NCT01412060|20519036|P3|NOT COMPLETED|Period Between RIP and SP||0
8322674|NCT01412060|20519037|P2|NOT COMPLETED|Period Between RIP and SP||0
8322675|NCT01412060|20519038|P1|NOT COMPLETED|Period Between RIP and SP||54
8322676|NCT01412060|20519036|P3|COMPLETED|Period Between RIP and SP||0
8322677|NCT01412060|20519037|P2|COMPLETED|Period Between RIP and SP||0
8322678|NCT01412060|20519038|P1|COMPLETED|Period Between RIP and SP||364
8322679|NCT01412060|20519036|P3|STARTED|Period Between RIP and SP||0
8322680|NCT01412060|20519037|P2|STARTED|Period Between RIP and SP||0
8322681|NCT01412060|20519038|P1|STARTED|Period Between RIP and SP||418
8322682|NCT01412060|20519036|P3|NOT COMPLETED|Open-label Run-in Period (RIP)||0
8322683|NCT01412060|20519037|P2|NOT COMPLETED|Open-label Run-in Period (RIP)||0
8322684|NCT01412060|20519038|P1|NOT COMPLETED|Open-label Run-in Period (RIP)||347
8322685|NCT01412060|20519036|P3|COMPLETED|Open-label Run-in Period (RIP)||0
8322686|NCT01412060|20519037|P2|COMPLETED|Open-label Run-in Period (RIP)||0
8322687|NCT01412060|20519038|P1|COMPLETED|Open-label Run-in Period (RIP)||418
8322688|NCT01412060|20519036|P3|STARTED|Open-label Run-in Period (RIP)||0
8322689|NCT01412060|20519037|P2|STARTED|Open-label Run-in Period (RIP)||0
8322690|NCT01412060|20519038|P1|STARTED|Open-label Run-in Period (RIP)||765
8322691|NCT01412021|20519048|P1|NOT COMPLETED|Overall Study||19
8322692|NCT01412021|20519048|P1|COMPLETED|Overall Study||356
8322693|NCT01412021|20519048|P1|Case Report Forms Locked|Overall Study||368
8322694|NCT01412021|20519048|P1|STARTED|Overall Study||375
8322695|NCT01411995|20519085|P2|NOT COMPLETED|Overall Study||1
8322696|NCT01411995|20519086|P1|NOT COMPLETED|Overall Study||0
8322697|NCT01411995|20519085|P2|COMPLETED|Overall Study||99
8322698|NCT01411995|20519086|P1|COMPLETED|Overall Study||100
8322699|NCT01411995|20519085|P2|STARTED|Overall Study||100
8322700|NCT01411995|20519086|P1|STARTED|Overall Study||100
8322701|NCT01411917|20519094|P2|NOT COMPLETED|Overall Study||1
8322702|NCT01411917|20519095|P1|NOT COMPLETED|Overall Study||0
8322703|NCT01411917|20519094|P2|COMPLETED|Overall Study||36
8322704|NCT01411917|20519095|P1|COMPLETED|Overall Study||32
8322705|NCT01411917|20519094|P2|STARTED|Overall Study||37
8322706|NCT01411917|20519095|P1|STARTED|Overall Study||32
8322707|NCT01411891|20519117|P2|NOT COMPLETED|Overall Study||2
8322708|NCT01411891|20519118|P1|NOT COMPLETED|Overall Study||3
8322709|NCT01411891|20519117|P2|COMPLETED|Overall Study||48
8322710|NCT01411891|20519118|P1|COMPLETED|Overall Study||47
8322711|NCT01411891|20519117|P2|STARTED|Overall Study||50
8322712|NCT01411891|20519118|P1|STARTED|Overall Study||50
8322713|NCT01411852|20519128|P2|NOT COMPLETED|Hospital Intervention Phase||18
8322714|NCT01411852|20519129|P1|NOT COMPLETED|Hospital Intervention Phase||24
8322715|NCT01411852|20519128|P2|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
8322716|NCT01411852|20519129|P1|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
8322717|NCT01411852|20519128|P2|STARTED|Hospital Intervention Phase||89
8322718|NCT01411852|20519129|P1|STARTED|Hospital Intervention Phase||83
8322719|NCT01411852|20519128|P2|NOT COMPLETED|Prehospital Intervention Phase||7
8322720|NCT01411852|20519129|P1|NOT COMPLETED|Prehospital Intervention Phase||12
8322721|NCT01411852|20519128|P2|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
8322722|NCT01411852|20519129|P1|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
8322723|NCT01411852|20519128|P2|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
8322724|NCT01411852|20519129|P1|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
8322725|NCT01411839|20519174|P2|NOT COMPLETED|Overall Study||3
8322726|NCT01411839|20519175|P1|NOT COMPLETED|Overall Study||4
8322727|NCT01411839|20519174|P2|COMPLETED|Overall Study||17
8322728|NCT01411839|20519175|P1|COMPLETED|Overall Study||16
8322729|NCT01411839|20519174|P2|STARTED|Overall Study||20
8322730|NCT01411839|20519175|P1|STARTED|Overall Study||20
8322731|NCT01411774|20519187|P2|NOT COMPLETED|Overall Study||3
8322732|NCT01411774|20519188|P1|NOT COMPLETED|Overall Study||0
8322733|NCT01411774|20519187|P2|COMPLETED|Overall Study||67
8322734|NCT01411774|20519188|P1|COMPLETED|Overall Study||72
8322735|NCT01411774|20519187|P2|STARTED|Overall Study||70
8322736|NCT01411774|20519188|P1|STARTED|Overall Study||72
8322737|NCT01411696|20519196|P1|NOT COMPLETED|Overall Study||0
8322738|NCT01411696|20519196|P1|COMPLETED|Overall Study||289
8322739|NCT01411696|20519196|P1|STARTED|Overall Study||289
8322740|NCT01411592|20519205|P2|NOT COMPLETED|Overall Study||0
8322741|NCT01411592|20519206|P1|NOT COMPLETED|Overall Study||0
8322742|NCT01411592|20519205|P2|COMPLETED|Overall Study||16
8322743|NCT01411592|20519206|P1|COMPLETED|Overall Study||14
8322744|NCT01411592|20519205|P2|5-Year Time Frame|Overall Study||16
8322745|NCT01411592|20519206|P1|5-Year Time Frame|Overall Study||14
8322746|NCT01411592|20519205|P2|STARTED|Overall Study||16
8322747|NCT01411592|20519206|P1|STARTED|Overall Study||14
8322748|NCT01411527|20519216|P2|NOT COMPLETED|Overall Study||0
8322749|NCT01411527|20519217|P1|NOT COMPLETED|Overall Study||0
8322750|NCT01411527|20519216|P2|COMPLETED|Overall Study||93
8322751|NCT01411527|20519217|P1|COMPLETED|Overall Study||1864
8322752|NCT01411527|20519216|P2|STARTED|Overall Study||93
8322753|NCT01411527|20519217|P1|STARTED|Overall Study||1864
8322754|NCT01411501|20519226|P4|NOT COMPLETED|Overall Study||7
8322755|NCT01411501|20519227|P3|NOT COMPLETED|Overall Study||6
8322756|NCT01411501|20519228|P2|NOT COMPLETED|Overall Study||6
8322757|NCT01411501|20519229|P1|NOT COMPLETED|Overall Study||10
8322758|NCT01411501|20519226|P4|COMPLETED|Overall Study||163
8322759|NCT01411501|20519227|P3|COMPLETED|Overall Study||159
8322760|NCT01411501|20519228|P2|COMPLETED|Overall Study||166
8322761|NCT01411501|20519229|P1|COMPLETED|Overall Study||158
8322762|NCT01411501|20519226|P4|STARTED|Overall Study||170
8322763|NCT01411501|20519227|P3|STARTED|Overall Study||165
8322764|NCT01411501|20519228|P2|STARTED|Overall Study||172
8322765|NCT01411501|20519229|P1|STARTED|Overall Study||168
8322766|NCT01411488|20519261|P2|NOT COMPLETED|Overall Study||0
8322767|NCT01411488|20519262|P1|NOT COMPLETED|Overall Study||0
8322768|NCT01411488|20519261|P2|COMPLETED|Overall Study||38
8322769|NCT01411488|20519262|P1|COMPLETED|Overall Study||41
8322770|NCT01411488|20519261|P2|STARTED|Overall Study||38
8322771|NCT01411488|20519262|P1|STARTED|Overall Study||41
8322772|NCT01411267|20519274|P10|NOT COMPLETED|Overall Study||0
8322773|NCT01411267|20519275|P9|NOT COMPLETED|Overall Study||0
8322774|NCT01411267|20519276|P8|NOT COMPLETED|Overall Study||0
8322775|NCT01411267|20519277|P7|NOT COMPLETED|Overall Study||0
8322776|NCT01411267|20519278|P6|NOT COMPLETED|Overall Study||2
8322777|NCT01411267|20519279|P5|NOT COMPLETED|Overall Study||2
8322778|NCT01411267|20519280|P4|NOT COMPLETED|Overall Study||1
8322779|NCT01411267|20519281|P3|NOT COMPLETED|Overall Study||0
8322780|NCT01411267|20519282|P2|NOT COMPLETED|Overall Study||0
8322781|NCT01411267|20519283|P1|NOT COMPLETED|Overall Study||0
8322782|NCT01411267|20519274|P10|COMPLETED|Overall Study||0
8322783|NCT01411267|20519275|P9|COMPLETED|Overall Study||0
8322784|NCT01411267|20519276|P8|COMPLETED|Overall Study||0
8322785|NCT01411267|20519277|P7|COMPLETED|Overall Study||0
8322786|NCT01411267|20519278|P6|COMPLETED|Overall Study||10
8322787|NCT01411267|20519279|P5|COMPLETED|Overall Study||0
8322788|NCT01411267|20519280|P4|COMPLETED|Overall Study||4
8322789|NCT01411267|20519281|P3|COMPLETED|Overall Study||2
8322790|NCT01411267|20519282|P2|COMPLETED|Overall Study||3
8322791|NCT01411267|20519283|P1|COMPLETED|Overall Study||0
8322792|NCT01411267|20519274|P10|STARTED|Overall Study||0
8322793|NCT01411267|20519275|P9|STARTED|Overall Study||0
8322794|NCT01411267|20519276|P8|STARTED|Overall Study||0
8322795|NCT01411267|20519277|P7|STARTED|Overall Study||0
8322796|NCT01411267|20519278|P6|STARTED|Overall Study||12
8322797|NCT01411267|20519279|P5|STARTED|Overall Study||2
8322798|NCT01411267|20519280|P4|STARTED|Overall Study||5
8322799|NCT01411267|20519281|P3|STARTED|Overall Study||2
8322800|NCT01411267|20519282|P2|STARTED|Overall Study||3
8322801|NCT01411267|20519283|P1|STARTED|Overall Study||0
8322802|NCT01411241|20519303|P2|NOT COMPLETED|Overall Study||22
8322803|NCT01411241|20519304|P1|NOT COMPLETED|Overall Study||11
8322804|NCT01411241|20519303|P2|COMPLETED|Overall Study||293
8322805|NCT01411241|20519304|P1|COMPLETED|Overall Study||298
8322806|NCT01411241|20519303|P2|STARTED|Overall Study||315
8322807|NCT01411241|20519304|P1|STARTED|Overall Study||309
8322808|NCT01411228|20519329|P3|NOT COMPLETED|Overall Study||1
8322809|NCT01411228|20519330|P2|NOT COMPLETED|Overall Study||0
8322810|NCT01411228|20519331|P1|NOT COMPLETED|Overall Study||1
8322811|NCT01411228|20519329|P3|COMPLETED|Overall Study||4
8322812|NCT01411228|20519330|P2|COMPLETED|Overall Study||5
8322813|NCT01411228|20519331|P1|COMPLETED|Overall Study||4
8322814|NCT01411228|20519329|P3|STARTED|Overall Study||5
8322815|NCT01411228|20519330|P2|STARTED|Overall Study||5
8322816|NCT01411228|20519331|P1|STARTED|Overall Study||5
8322817|NCT01411215|20519353|P2|NOT COMPLETED|Overall Study||84
8322818|NCT01411215|20519354|P1|NOT COMPLETED|Overall Study||66
8322819|NCT01411215|20519353|P2|COMPLETED|Overall Study||7
8322820|NCT01411215|20519354|P1|COMPLETED|Overall Study||3
8322821|NCT01411215|20519353|P2|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
8322822|NCT01411215|20519354|P1|Treated|Overall Study||69
8322823|NCT01411215|20519353|P2|STARTED|Overall Study||91
8322824|NCT01411215|20519354|P1|STARTED|Overall Study||69
8322825|NCT01411137|20519387|P1|NOT COMPLETED|Part 3: Open-Label Extension||0
8322826|NCT01411137|20519387|P1|COMPLETED|Part 3: Open-Label Extension||12
8322827|NCT01411137|20519387|P1|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
8322828|NCT01411137|20519387|P1|NOT COMPLETED|Part 2: Open-Label Extension||7
8322829|NCT01411137|20519387|P1|COMPLETED|Part 2: Open-Label Extension||25
8322830|NCT01411137|20519387|P1|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
8322831|NCT01411137|20519387|P1|NOT COMPLETED|Part 1: Dose Conversion||10
8322832|NCT01411137|20519387|P1|COMPLETED|Part 1: Dose Conversion||33
8322833|NCT01411137|20519387|P1|STARTED|Part 1: Dose Conversion||43
8322834|NCT01411085|20519406|P1|NOT COMPLETED|Overall Study||3
8322835|NCT01411085|20519406|P1|COMPLETED|Overall Study||7
8322836|NCT01411085|20519406|P1|STARTED|Overall Study||10
8322837|NCT01410812|20519413|P3|NOT COMPLETED|Overall Study||0
8322838|NCT01410812|20519414|P2|NOT COMPLETED|Overall Study||0
8322839|NCT01410812|20519415|P1|NOT COMPLETED|Overall Study||0
8322840|NCT01410812|20519413|P3|COMPLETED|Overall Study||76
8322841|NCT01410812|20519414|P2|COMPLETED|Overall Study||75
8322842|NCT01410812|20519415|P1|COMPLETED|Overall Study||75
8322843|NCT01410812|20519413|P3|STARTED|Overall Study||76
8322844|NCT01410812|20519414|P2|STARTED|Overall Study||75
8322845|NCT01410812|20519415|P1|STARTED|Overall Study||75
8322846|NCT01410799|20519426|P1|NOT COMPLETED|Overall Study||13
8322847|NCT01410799|20519426|P1|COMPLETED|Overall Study||0
8322848|NCT01410799|20519426|P1|STARTED|Overall Study||13
8322849|NCT01410773|20519435|P1|NOT COMPLETED|Overall Study||0
8322850|NCT01410773|20519435|P1|COMPLETED|Overall Study||110
8322851|NCT01410773|20519435|P1|STARTED|Overall Study||110
8322852|NCT01410604|20519442|P2|NOT COMPLETED|Overall Study||2
8322853|NCT01410604|20519443|P1|NOT COMPLETED|Overall Study||3
8322854|NCT01410604|20519442|P2|COMPLETED|Overall Study||14
8322855|NCT01410604|20519443|P1|COMPLETED|Overall Study||12
8322856|NCT01410604|20519442|P2|STARTED|Overall Study||16
8322857|NCT01410604|20519443|P1|STARTED|Overall Study||15
8322858|NCT01410565|20519465|P3|NOT COMPLETED|Double Blind Phase||0
8322859|NCT01410565|20519466|P2|NOT COMPLETED|Double Blind Phase||15
8322860|NCT01410565|20519467|P1|NOT COMPLETED|Double Blind Phase||13
8322861|NCT01410565|20519465|P3|COMPLETED|Double Blind Phase||0
8322862|NCT01410565|20519466|P2|COMPLETED|Double Blind Phase||0
8322863|NCT01410565|20519467|P1|COMPLETED|Double Blind Phase||0
8322864|NCT01410565|20519465|P3|STARTED|Double Blind Phase||0
8322865|NCT01410565|20519466|P2|STARTED|Double Blind Phase||15
8322866|NCT01410565|20519467|P1|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
8322867|NCT01410565|20519465|P3|NOT COMPLETED|Open Label Phase Apaziquone||8
8322868|NCT01410565|20519466|P2|NOT COMPLETED|Open Label Phase Apaziquone||0
8322869|NCT01410565|20519467|P1|NOT COMPLETED|Open Label Phase Apaziquone||0
8322870|NCT01410565|20519465|P3|COMPLETED|Open Label Phase Apaziquone||58
8322871|NCT01410565|20519466|P2|COMPLETED|Open Label Phase Apaziquone||0
8322872|NCT01410565|20519467|P1|COMPLETED|Open Label Phase Apaziquone||0
8322873|NCT01410565|20519465|P3|STARTED|Open Label Phase Apaziquone||66
8322874|NCT01410565|20519466|P2|STARTED|Open Label Phase Apaziquone||0
8322875|NCT01410565|20519467|P1|STARTED|Open Label Phase Apaziquone||0
8322876|NCT01410552|20519477|P1|NOT COMPLETED|Overall Study||136
8322877|NCT01410552|20519477|P1|COMPLETED|Overall Study||877
8322878|NCT01410552|20519477|P1|STARTED|Overall Study||1013
8322879|NCT01410474|20519484|P2|NOT COMPLETED|Overall Study||1
8322880|NCT01410474|20519485|P1|NOT COMPLETED|Overall Study||0
8322881|NCT01410474|20519484|P2|COMPLETED|Overall Study||167
8322882|NCT01410474|20519485|P1|COMPLETED|Overall Study||173
8322883|NCT01410474|20519484|P2|STARTED|Overall Study||168
8322884|NCT01410474|20519485|P1|STARTED|Overall Study||173
8322885|NCT01410448|20519508|P2|NOT COMPLETED|Overall Study||35
8322886|NCT01410448|20519509|P1|NOT COMPLETED|Overall Study||12
8322887|NCT01410448|20519508|P2|COMPLETED|Overall Study||155
8322888|NCT01410448|20519509|P1|COMPLETED|Overall Study||181
8322889|NCT01410448|20519508|P2|Modified ITT Analysis Set|Overall Study||149
8322890|NCT01410448|20519509|P1|Modified ITT Analysis Set|Overall Study||161
8322891|NCT01410448|20519508|P2|Intent-to Treat (ITT) Analysis Set|Overall Study||190
8322892|NCT01410448|20519509|P1|Intent-to Treat (ITT) Analysis Set|Overall Study||193
8322893|NCT01410448|20519508|P2|STARTED|Overall Study||190
8322894|NCT01410448|20519509|P1|STARTED|Overall Study||193
8322895|NCT01410409|20519549|P2|NOT COMPLETED|Overall Study||4
8322896|NCT01410409|20519550|P1|NOT COMPLETED|Overall Study||1
8322897|NCT01410409|20519549|P2|COMPLETED|Overall Study||46
8322898|NCT01410409|20519550|P1|COMPLETED|Overall Study||49
8322899|NCT01410409|20519549|P2|STARTED|Overall Study||50
8322900|NCT01410409|20519550|P1|STARTED|Overall Study||50
8322901|NCT01410357|20519574|P2|NOT COMPLETED|Overall Study||24
8322902|NCT01410357|20519575|P1|NOT COMPLETED|Overall Study||26
8322903|NCT01410357|20519574|P2|COMPLETED|Overall Study||76
8322904|NCT01410357|20519575|P1|COMPLETED|Overall Study||74
8322905|NCT01410357|20519574|P2|STARTED|Overall Study||100
8322906|NCT01410357|20519575|P1|STARTED|Overall Study||100
8322907|NCT01410344|20519629|P1|NOT COMPLETED|Overall Study||3
8322908|NCT01410344|20519629|P1|COMPLETED|Overall Study||17
8322909|NCT01410344|20519629|P1|STARTED|Overall Study||20
8322910|NCT01410240|20519646|P3|NOT COMPLETED|Overall Study||2
8322911|NCT01410240|20519647|P2|NOT COMPLETED|Overall Study||1
8322912|NCT01410240|20519648|P1|NOT COMPLETED|Overall Study||1
8322913|NCT01410240|20519646|P3|COMPLETED|Overall Study||10
8322914|NCT01410240|20519647|P2|COMPLETED|Overall Study||52
8322915|NCT01410240|20519648|P1|COMPLETED|Overall Study||52
8322916|NCT01410240|20519646|P3|STARTED|Overall Study||12
8322917|NCT01410240|20519647|P2|STARTED|Overall Study||53
8322918|NCT01410240|20519648|P1|STARTED|Overall Study||53
8322931|NCT01410110|20519794|P2|NOT COMPLETED|Overall Study||2
8322932|NCT01410110|20519795|P1|NOT COMPLETED|Overall Study||4
8322933|NCT01410110|20519794|P2|COMPLETED|Overall Study||22
8322934|NCT01410110|20519795|P1|COMPLETED|Overall Study||20
8322935|NCT01410110|20519794|P2|6 Month Follow-up|Overall Study||22
8322936|NCT01410110|20519795|P1|6 Month Follow-up|Overall Study||20
8322937|NCT01410110|20519794|P2|3 Months (End of Intervention)|Overall Study||22
8322938|NCT01410110|20519795|P1|3 Months (End of Intervention)|Overall Study||20
8322939|NCT01410110|20519794|P2|Randomization|Overall Study||24
8322940|NCT01410110|20519795|P1|Randomization|Overall Study||24
8322941|NCT01410110|20519794|P2|STARTED|Overall Study||24
8322942|NCT01410110|20519795|P1|STARTED|Overall Study||24
8322943|NCT01410097|20519819|P2|NOT COMPLETED|Overall Study||3
8322944|NCT01410097|20519820|P1|NOT COMPLETED|Overall Study||5
8322945|NCT01410097|20519819|P2|COMPLETED|Overall Study||530
8322946|NCT01410097|20519820|P1|COMPLETED|Overall Study||551
8322947|NCT01410097|20519819|P2|STARTED|Overall Study||533
8322948|NCT01410097|20519820|P1|STARTED|Overall Study||556
8322949|NCT01410084|20519844|P2|NOT COMPLETED|Overall Study||3
8322950|NCT01410084|20519845|P1|NOT COMPLETED|Overall Study||1
8322951|NCT01410084|20519844|P2|COMPLETED|Overall Study||27
8322952|NCT01410084|20519845|P1|COMPLETED|Overall Study||37
8322953|NCT01410084|20519844|P2|STARTED|Overall Study||30
8322954|NCT01410084|20519845|P1|STARTED|Overall Study||38
8322955|NCT01410058|20519857|P2|NOT COMPLETED|Day 35||0
8322956|NCT01410058|20519858|P1|NOT COMPLETED|Day 35||0
8322957|NCT01410058|20519857|P2|COMPLETED|Day 35||6
8322958|NCT01410058|20519858|P1|COMPLETED|Day 35||13
8322959|NCT01410058|20519857|P2|STARTED|Day 35||6
8322960|NCT01410058|20519858|P1|STARTED|Day 35||13
8322961|NCT01410058|20519857|P2|NOT COMPLETED|Baseline Day 22||0
8322962|NCT01410058|20519858|P1|NOT COMPLETED|Baseline Day 22||0
8322963|NCT01410058|20519857|P2|COMPLETED|Baseline Day 22||6
8322964|NCT01410058|20519858|P1|COMPLETED|Baseline Day 22||13
8322965|NCT01410058|20519857|P2|STARTED|Baseline Day 22||6
8322966|NCT01410058|20519858|P1|STARTED|Baseline Day 22||13
8322967|NCT01410058|20519857|P2|NOT COMPLETED|Washout Day 0||0
8322968|NCT01410058|20519858|P1|NOT COMPLETED|Washout Day 0||0
8322969|NCT01410058|20519857|P2|COMPLETED|Washout Day 0||6
8322970|NCT01410058|20519858|P1|COMPLETED|Washout Day 0||13
8322971|NCT01410058|20519857|P2|STARTED|Washout Day 0||6
8322972|NCT01410058|20519858|P1|STARTED|Washout Day 0||13
8322973|NCT01409993|20519870|P4|NOT COMPLETED|Overall Study||5
8322974|NCT01409993|20519871|P3|NOT COMPLETED|Overall Study||3
8322975|NCT01409993|20519872|P2|NOT COMPLETED|Overall Study||5
8322976|NCT01409993|20519873|P1|NOT COMPLETED|Overall Study||4
8322977|NCT01409993|20519870|P4|COMPLETED|Overall Study||8
8322978|NCT01409993|20519871|P3|COMPLETED|Overall Study||11
8322979|NCT01409993|20519872|P2|COMPLETED|Overall Study||21
8322980|NCT01409993|20519873|P1|COMPLETED|Overall Study||21
8322981|NCT01409993|20519870|P4|STARTED|Overall Study||13
8322982|NCT01409993|20519871|P3|STARTED|Overall Study||14
8322983|NCT01409993|20519872|P2|STARTED|Overall Study||26
8322984|NCT01409993|20519873|P1|STARTED|Overall Study||25
8322985|NCT01409928|20519891|P1|NOT COMPLETED|Overall Study||12
8322986|NCT01409928|20519891|P1|COMPLETED|Overall Study||4
8322987|NCT01409928|20519891|P1|STARTED|Overall Study||16
8322988|NCT01409837|20519897|P2|NOT COMPLETED|Overall Study||2
8322989|NCT01409837|20519898|P1|NOT COMPLETED|Overall Study||3
8322990|NCT01409837|20519897|P2|COMPLETED|Overall Study||14
8322991|NCT01409837|20519898|P1|COMPLETED|Overall Study||14
8322992|NCT01409837|20519897|P2|282nd Week|Overall Study||14
8322993|NCT01409837|20519898|P1|282nd Week|Overall Study||14
8322994|NCT01409837|20519897|P2|186th Week|Overall Study||14
8322995|NCT01409837|20519898|P1|186th Week|Overall Study|Moved away to another location|14
8322996|NCT01409837|20519897|P2|138th Week|Overall Study||14
8322997|NCT01409837|20519898|P1|138th Week|Overall Study||15
8322998|NCT01409837|20519897|P2|114th Week|Overall Study||14
8322999|NCT01409837|20519898|P1|114th Week|Overall Study||15
8323000|NCT01409837|20519897|P2|102nd Week|Overall Study|Married another wife|14
8323001|NCT01409837|20519898|P1|102nd Week|Overall Study||15
8323002|NCT01409837|20519897|P2|96th Week|Overall Study||15
8323003|NCT01409837|20519898|P1|96th Week|Overall Study||15
8323004|NCT01409837|20519897|P2|48th Week|Overall Study||15
8323005|NCT01409837|20519898|P1|48th Week|Overall Study|Lost to follow-up|15
8323006|NCT01409837|20519897|P2|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
8323007|NCT01409837|20519898|P1|24th Week|Overall Study||16
8323008|NCT01409837|20519897|P2|12th Week|Overall Study||16
8323009|NCT01409837|20519898|P1|12th Week|Overall Study|Moved away to another location|16
8323010|NCT01409837|20519897|P2|6th Week|Overall Study||16
8323011|NCT01409837|20519898|P1|6th Week|Overall Study||17
8323012|NCT01409837|20519897|P2|STARTED|Overall Study||16
8323013|NCT01409837|20519898|P1|STARTED|Overall Study||17
8323014|NCT01409811|20519920|P1|NOT COMPLETED|Overall Study||1
8323015|NCT01409811|20519920|P1|COMPLETED|Overall Study||8
8323016|NCT01409811|20519920|P1|STARTED|Overall Study||9
8323017|NCT01409707|20519927|P3|NOT COMPLETED|Overall Study||16
8323018|NCT01409707|20519928|P2|NOT COMPLETED|Overall Study||17
8323019|NCT01409707|20519929|P1|NOT COMPLETED|Overall Study||5
8323020|NCT01409707|20519927|P3|COMPLETED|Overall Study||24
8323021|NCT01409707|20519928|P2|COMPLETED|Overall Study||28
8323022|NCT01409707|20519929|P1|COMPLETED|Overall Study||36
8323023|NCT01409707|20519927|P3|STARTED|Overall Study||40
8323024|NCT01409707|20519928|P2|STARTED|Overall Study||45
8323025|NCT01409707|20519929|P1|STARTED|Overall Study||41
8323026|NCT01409564|20519941|P2|NOT COMPLETED|Overall Study||5
8323027|NCT01409564|20519942|P1|NOT COMPLETED|Overall Study||5
8323028|NCT01409564|20519941|P2|COMPLETED|Overall Study||18
8323029|NCT01409564|20519942|P1|COMPLETED|Overall Study||18
8323030|NCT01409564|20519941|P2|STARTED|Overall Study||23
8323031|NCT01409564|20519942|P1|STARTED|Overall Study||23
8323032|NCT01409434|20519960|P1|NOT COMPLETED|Overall Study||4
8323033|NCT01409434|20519960|P1|COMPLETED|Overall Study||40
8323034|NCT01409434|20519960|P1|STARTED|Overall Study||44
8323035|NCT01409382|20519970|P2|NOT COMPLETED|Overall Study||80
8323036|NCT01409382|20519971|P1|NOT COMPLETED|Overall Study||81
8323037|NCT01409382|20519970|P2|COMPLETED|Overall Study||160
8323038|NCT01409382|20519971|P1|COMPLETED|Overall Study||159
8323039|NCT01409382|20519970|P2|STARTED|Overall Study||240
8323040|NCT01409382|20519971|P1|STARTED|Overall Study||240
8323041|NCT01409291|20519985|P2|NOT COMPLETED|Overall Study||9
8323042|NCT01409291|20519986|P1|NOT COMPLETED|Overall Study||7
8323043|NCT01409291|20519985|P2|COMPLETED|Overall Study||19
8323044|NCT01409291|20519986|P1|COMPLETED|Overall Study||29
8323045|NCT01409291|20519985|P2|STARTED|Overall Study||28
8323046|NCT01409291|20519986|P1|STARTED|Overall Study||36
8323047|NCT01409239|20519996|P2|NOT COMPLETED|Overall Study||0
8323048|NCT01409239|20519997|P1|NOT COMPLETED|Overall Study||0
8323049|NCT01409239|20519996|P2|COMPLETED|Overall Study||17
8323050|NCT01409239|20519997|P1|COMPLETED|Overall Study||16
8323051|NCT01409239|20519996|P2|STARTED|Overall Study||17
8323052|NCT01409239|20519997|P1|STARTED|Overall Study||16
8323053|NCT01409213|20520003|P1|NOT COMPLETED|Overall Study||0
8323054|NCT01409213|20520003|P1|COMPLETED|Overall Study||1523
8323055|NCT01409213|20520003|P1|STARTED|Overall Study||1523
8323056|NCT01409096|20520010|P2|NOT COMPLETED|Overall Study||5
8323057|NCT01409096|20520011|P1|NOT COMPLETED|Overall Study||2
8323058|NCT01409096|20520010|P2|COMPLETED|Overall Study||35
8323059|NCT01409096|20520011|P1|COMPLETED|Overall Study||38
8323060|NCT01409096|20520010|P2|STARTED|Overall Study||40
8323061|NCT01409096|20520011|P1|STARTED|Overall Study||40
8323062|NCT01409031|20520025|P2|NOT COMPLETED|Overall Study||0
8323063|NCT01409031|20520026|P1|NOT COMPLETED|Overall Study||1
8323064|NCT01409031|20520025|P2|COMPLETED|Overall Study||2
8323065|NCT01409031|20520026|P1|COMPLETED|Overall Study||0
8323066|NCT01409031|20520025|P2|STARTED|Overall Study||2
8323067|NCT01409031|20520026|P1|STARTED|Overall Study||1
8323068|NCT01408992|20520042|P1|NOT COMPLETED|Overall Study||0
8323069|NCT01408992|20520042|P1|COMPLETED|Overall Study||558
8323070|NCT01408992|20520042|P1|STARTED|Overall Study||558
8323071|NCT01408914|20520057|P3|NOT COMPLETED|Overall Study||13
8323072|NCT01408914|20520058|P2|NOT COMPLETED|Overall Study||12
8323073|NCT01408914|20520059|P1|NOT COMPLETED|Overall Study||12
8323074|NCT01408914|20520057|P3|COMPLETED|Overall Study||47
8323075|NCT01408914|20520058|P2|COMPLETED|Overall Study||48
8323076|NCT01408914|20520059|P1|COMPLETED|Overall Study||48
8323077|NCT01408914|20520057|P3|STARTED|Overall Study||60
8323078|NCT01408914|20520058|P2|STARTED|Overall Study||60
8323079|NCT01408914|20520059|P1|STARTED|Overall Study||60
8323080|NCT01408901|20520077|P4|NOT COMPLETED|26-Week Follow-Up||1
8323081|NCT01408901|20520078|P3|NOT COMPLETED|26-Week Follow-Up||0
8323082|NCT01408901|20520079|P2|NOT COMPLETED|26-Week Follow-Up||2
8323083|NCT01408901|20520080|P1|NOT COMPLETED|26-Week Follow-Up||1
8323084|NCT01408901|20520077|P4|COMPLETED|26-Week Follow-Up||46
8323085|NCT01408901|20520078|P3|COMPLETED|26-Week Follow-Up||50
8323086|NCT01408901|20520079|P2|COMPLETED|26-Week Follow-Up||50
8323087|NCT01408901|20520080|P1|COMPLETED|26-Week Follow-Up||48
8323088|NCT01408901|20520077|P4|STARTED|26-Week Follow-Up||47
8323089|NCT01408901|20520078|P3|STARTED|26-Week Follow-Up||50
8323090|NCT01408901|20520079|P2|STARTED|26-Week Follow-Up||52
8323091|NCT01408901|20520080|P1|STARTED|26-Week Follow-Up||49
8323092|NCT01408901|20520077|P4|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3
8323093|NCT01408901|20520078|P3|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0
8323094|NCT01408901|20520079|P2|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2
8323095|NCT01408901|20520080|P1|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1
8323096|NCT01408901|20520077|P4|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46
8323097|NCT01408901|20520078|P3|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
8323098|NCT01408901|20520079|P2|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
8323099|NCT01408901|20520080|P1|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49
8323100|NCT01408901|20520077|P4|STARTED|12-Week Follow-Up (Primary Endpoint)||49
8323101|NCT01408901|20520078|P3|STARTED|12-Week Follow-Up (Primary Endpoint)||50
8323102|NCT01408901|20520079|P2|STARTED|12-Week Follow-Up (Primary Endpoint)||52
8323103|NCT01408901|20520080|P1|STARTED|12-Week Follow-Up (Primary Endpoint)||50
8323104|NCT01408901|20520077|P4|NOT COMPLETED|6-Week Follow-Up||4
8323105|NCT01408901|20520078|P3|NOT COMPLETED|6-Week Follow-Up||3
8323106|NCT01408901|20520079|P2|NOT COMPLETED|6-Week Follow-Up||2
8323107|NCT01408901|20520080|P1|NOT COMPLETED|6-Week Follow-Up||3
8323108|NCT01408901|20520077|P4|COMPLETED|6-Week Follow-Up||47
8323109|NCT01408901|20520078|P3|COMPLETED|6-Week Follow-Up||50
8323110|NCT01408901|20520079|P2|COMPLETED|6-Week Follow-Up||51
8323111|NCT01408901|20520080|P1|COMPLETED|6-Week Follow-Up||50
8323112|NCT01408901|20520077|P4|STARTED|6-Week Follow-Up||51
8323113|NCT01408901|20520078|P3|STARTED|6-Week Follow-Up||53
8323114|NCT01408901|20520079|P2|STARTED|6-Week Follow-Up||53
8323115|NCT01408901|20520080|P1|STARTED|6-Week Follow-Up||53
8323116|NCT01408888|20520106|P2|NOT COMPLETED|Second Intervention||0
8323117|NCT01408888|20520107|P1|NOT COMPLETED|Second Intervention||2
8323118|NCT01408888|20520106|P2|COMPLETED|Second Intervention||8
8323119|NCT01408888|20520107|P1|COMPLETED|Second Intervention||16
8323120|NCT01408888|20520106|P2|STARTED|Second Intervention||8
8323121|NCT01408888|20520107|P1|STARTED|Second Intervention||18
8323122|NCT01408888|20520106|P2|NOT COMPLETED|Washout of at Least 21 Days||0
8323123|NCT01408888|20520107|P1|NOT COMPLETED|Washout of at Least 21 Days||0
8323124|NCT01408888|20520106|P2|COMPLETED|Washout of at Least 21 Days||8
8323125|NCT01408888|20520107|P1|COMPLETED|Washout of at Least 21 Days||18
8323126|NCT01408888|20520106|P2|STARTED|Washout of at Least 21 Days||8
8323127|NCT01408888|20520107|P1|STARTED|Washout of at Least 21 Days||18
8323128|NCT01408888|20520106|P2|NOT COMPLETED|First Intervention||3
8323129|NCT01408888|20520107|P1|NOT COMPLETED|First Intervention||0
8323130|NCT01408888|20520106|P2|COMPLETED|First Intervention||8
8323131|NCT01408888|20520107|P1|COMPLETED|First Intervention||18
8323132|NCT01408888|20520106|P2|Received at Least 1 Dose of Drug|First Intervention||11
8323133|NCT01408888|20520107|P1|Received at Least 1 Dose of Drug|First Intervention||18
8323134|NCT01408888|20520106|P2|STARTED|First Intervention||11
8323135|NCT01408888|20520107|P1|STARTED|First Intervention||18
8323136|NCT01408862|20520130|P1|NOT COMPLETED|Overall Study||0
8323137|NCT01408862|20520130|P1|COMPLETED|Overall Study||20
8323138|NCT01408862|20520130|P1|STARTED|Overall Study||20
8323139|NCT01408732|20520135|P2|NOT COMPLETED|Overall Study||2
8323140|NCT01408732|20520136|P1|NOT COMPLETED|Overall Study||2
8323141|NCT01408732|20520135|P2|COMPLETED|Overall Study||7
8323142|NCT01408732|20520136|P1|COMPLETED|Overall Study||7
8323143|NCT01408732|20520135|P2|STARTED|Overall Study||9
8323144|NCT01408732|20520136|P1|STARTED|Overall Study||9
8323145|NCT01408719|20520162|P20|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323146|NCT01408719|20520163|P19|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323147|NCT01408719|20520164|P18|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323148|NCT01408719|20520165|P17|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323149|NCT01408719|20520166|P16|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323150|NCT01408719|20520167|P15|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323151|NCT01408719|20520168|P14|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323152|NCT01408719|20520169|P13|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323153|NCT01408719|20520170|P12|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323154|NCT01408719|20520171|P11|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323155|NCT01408719|20520172|P10|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323156|NCT01408719|20520173|P9|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323157|NCT01408719|20520174|P8|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323158|NCT01408719|20520175|P7|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323159|NCT01408719|20520176|P6|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323160|NCT01408719|20520177|P5|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323161|NCT01408719|20520178|P4|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323162|NCT01408719|20520179|P3|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323163|NCT01408719|20520180|P2|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323164|NCT01408719|20520181|P1|NOT COMPLETED|Fourth Intervention (35 Days)||0
8323165|NCT01408719|20520162|P20|COMPLETED|Fourth Intervention (35 Days)||1
8323166|NCT01408719|20520163|P19|COMPLETED|Fourth Intervention (35 Days)||0
8323167|NCT01408719|20520164|P18|COMPLETED|Fourth Intervention (35 Days)||2
8323168|NCT01408719|20520165|P17|COMPLETED|Fourth Intervention (35 Days)||2
8323169|NCT01408719|20520166|P16|COMPLETED|Fourth Intervention (35 Days)||1
8323170|NCT01408719|20520167|P15|COMPLETED|Fourth Intervention (35 Days)||1
8323171|NCT01408719|20520168|P14|COMPLETED|Fourth Intervention (35 Days)||3
8323172|NCT01408719|20520169|P13|COMPLETED|Fourth Intervention (35 Days)||1
8323173|NCT01408719|20520170|P12|COMPLETED|Fourth Intervention (35 Days)||2
8323174|NCT01408719|20520171|P11|COMPLETED|Fourth Intervention (35 Days)||2
8323175|NCT01408719|20520172|P10|COMPLETED|Fourth Intervention (35 Days)||1
8323176|NCT01408719|20520173|P9|COMPLETED|Fourth Intervention (35 Days)||1
8323177|NCT01408719|20520174|P8|COMPLETED|Fourth Intervention (35 Days)||2
8323178|NCT01408719|20520175|P7|COMPLETED|Fourth Intervention (35 Days)||2
8323179|NCT01408719|20520176|P6|COMPLETED|Fourth Intervention (35 Days)||3
8323180|NCT01408719|20520177|P5|COMPLETED|Fourth Intervention (35 Days)||3
8323181|NCT01408719|20520178|P4|COMPLETED|Fourth Intervention (35 Days)||2
8323182|NCT01408719|20520179|P3|COMPLETED|Fourth Intervention (35 Days)||1
8323183|NCT01408719|20520180|P2|COMPLETED|Fourth Intervention (35 Days)||3
8323184|NCT01408719|20520181|P1|COMPLETED|Fourth Intervention (35 Days)||2
8323185|NCT01408719|20520162|P20|STARTED|Fourth Intervention (35 Days)||1
8323186|NCT01408719|20520163|P19|STARTED|Fourth Intervention (35 Days)||0
8323187|NCT01408719|20520164|P18|STARTED|Fourth Intervention (35 Days)||2
8323188|NCT01408719|20520165|P17|STARTED|Fourth Intervention (35 Days)||2
8323189|NCT01408719|20520166|P16|STARTED|Fourth Intervention (35 Days)||1
8323190|NCT01408719|20520167|P15|STARTED|Fourth Intervention (35 Days)||1
8323191|NCT01408719|20520168|P14|STARTED|Fourth Intervention (35 Days)||3
8323192|NCT01408719|20520169|P13|STARTED|Fourth Intervention (35 Days)||1
8323193|NCT01408719|20520170|P12|STARTED|Fourth Intervention (35 Days)||2
8323194|NCT01408719|20520171|P11|STARTED|Fourth Intervention (35 Days)||2
8323195|NCT01408719|20520172|P10|STARTED|Fourth Intervention (35 Days)||1
8323196|NCT01408719|20520173|P9|STARTED|Fourth Intervention (35 Days)||1
8323197|NCT01408719|20520174|P8|STARTED|Fourth Intervention (35 Days)||2
8323198|NCT01408719|20520175|P7|STARTED|Fourth Intervention (35 Days)||2
8323199|NCT01408719|20520176|P6|STARTED|Fourth Intervention (35 Days)||3
8323200|NCT01408719|20520177|P5|STARTED|Fourth Intervention (35 Days)||3
8323201|NCT01408719|20520178|P4|STARTED|Fourth Intervention (35 Days)||2
8323202|NCT01408719|20520179|P3|STARTED|Fourth Intervention (35 Days)||1
8323203|NCT01408719|20520180|P2|STARTED|Fourth Intervention (35 Days)||3
8323204|NCT01408719|20520181|P1|STARTED|Fourth Intervention (35 Days)||2
8323205|NCT01408719|20520162|P20|NOT COMPLETED|Washout Period (28 Days)||0
8323206|NCT01408719|20520163|P19|NOT COMPLETED|Washout Period (28 Days)||0
8323207|NCT01408719|20520164|P18|NOT COMPLETED|Washout Period (28 Days)||0
8323208|NCT01408719|20520165|P17|NOT COMPLETED|Washout Period (28 Days)||0
8323209|NCT01408719|20520166|P16|NOT COMPLETED|Washout Period (28 Days)||0
8323210|NCT01408719|20520167|P15|NOT COMPLETED|Washout Period (28 Days)||0
8323211|NCT01408719|20520168|P14|NOT COMPLETED|Washout Period (28 Days)||0
8323212|NCT01408719|20520169|P13|NOT COMPLETED|Washout Period (28 Days)||0
8323213|NCT01408719|20520170|P12|NOT COMPLETED|Washout Period (28 Days)||0
8323214|NCT01408719|20520171|P11|NOT COMPLETED|Washout Period (28 Days)||0
8323215|NCT01408719|20520172|P10|NOT COMPLETED|Washout Period (28 Days)||0
8323216|NCT01408719|20520173|P9|NOT COMPLETED|Washout Period (28 Days)||0
8323217|NCT01408719|20520174|P8|NOT COMPLETED|Washout Period (28 Days)||0
8323218|NCT01408719|20520175|P7|NOT COMPLETED|Washout Period (28 Days)||0
8323219|NCT01408719|20520176|P6|NOT COMPLETED|Washout Period (28 Days)||0
8323220|NCT01408719|20520177|P5|NOT COMPLETED|Washout Period (28 Days)||0
8323221|NCT01408719|20520178|P4|NOT COMPLETED|Washout Period (28 Days)||0
8323222|NCT01408719|20520179|P3|NOT COMPLETED|Washout Period (28 Days)||0
8323223|NCT01408719|20520180|P2|NOT COMPLETED|Washout Period (28 Days)||0
8323224|NCT01408719|20520181|P1|NOT COMPLETED|Washout Period (28 Days)||0
8323225|NCT01408719|20520162|P20|COMPLETED|Washout Period (28 Days)||1
8323226|NCT01408719|20520163|P19|COMPLETED|Washout Period (28 Days)||0
8323227|NCT01408719|20520164|P18|COMPLETED|Washout Period (28 Days)||2
8323228|NCT01408719|20520165|P17|COMPLETED|Washout Period (28 Days)||2
8323229|NCT01408719|20520166|P16|COMPLETED|Washout Period (28 Days)||1
8323230|NCT01408719|20520167|P15|COMPLETED|Washout Period (28 Days)||1
8323231|NCT01408719|20520168|P14|COMPLETED|Washout Period (28 Days)||3
8323232|NCT01408719|20520169|P13|COMPLETED|Washout Period (28 Days)||1
8323233|NCT01408719|20520170|P12|COMPLETED|Washout Period (28 Days)||2
8323234|NCT01408719|20520171|P11|COMPLETED|Washout Period (28 Days)||2
8323235|NCT01408719|20520172|P10|COMPLETED|Washout Period (28 Days)||1
8323236|NCT01408719|20520173|P9|COMPLETED|Washout Period (28 Days)||1
8323237|NCT01408719|20520174|P8|COMPLETED|Washout Period (28 Days)||2
8323238|NCT01408719|20520175|P7|COMPLETED|Washout Period (28 Days)||2
8323239|NCT01408719|20520176|P6|COMPLETED|Washout Period (28 Days)||3
8323240|NCT01408719|20520177|P5|COMPLETED|Washout Period (28 Days)||3
8323241|NCT01408719|20520178|P4|COMPLETED|Washout Period (28 Days)||2
8323242|NCT01408719|20520179|P3|COMPLETED|Washout Period (28 Days)||1
8323243|NCT01408719|20520180|P2|COMPLETED|Washout Period (28 Days)||3
8323244|NCT01408719|20520181|P1|COMPLETED|Washout Period (28 Days)||2
8323245|NCT01408719|20520162|P20|STARTED|Washout Period (28 Days)||1
8323246|NCT01408719|20520163|P19|STARTED|Washout Period (28 Days)||0
8323247|NCT01408719|20520164|P18|STARTED|Washout Period (28 Days)||2
8323248|NCT01408719|20520165|P17|STARTED|Washout Period (28 Days)||2
8323249|NCT01408719|20520166|P16|STARTED|Washout Period (28 Days)||1
8323250|NCT01408719|20520167|P15|STARTED|Washout Period (28 Days)||1
8323251|NCT01408719|20520168|P14|STARTED|Washout Period (28 Days)||3
8323252|NCT01408719|20520169|P13|STARTED|Washout Period (28 Days)||1
8323253|NCT01408719|20520170|P12|STARTED|Washout Period (28 Days)||2
8323254|NCT01408719|20520171|P11|STARTED|Washout Period (28 Days)||2
8323255|NCT01408719|20520172|P10|STARTED|Washout Period (28 Days)||1
8323256|NCT01408719|20520173|P9|STARTED|Washout Period (28 Days)||1
8323257|NCT01408719|20520174|P8|STARTED|Washout Period (28 Days)||2
8323258|NCT01408719|20520175|P7|STARTED|Washout Period (28 Days)||2
8323259|NCT01408719|20520176|P6|STARTED|Washout Period (28 Days)||3
8323260|NCT01408719|20520177|P5|STARTED|Washout Period (28 Days)||3
8323261|NCT01408719|20520178|P4|STARTED|Washout Period (28 Days)||2
8323262|NCT01408719|20520179|P3|STARTED|Washout Period (28 Days)||1
8323263|NCT01408719|20520180|P2|STARTED|Washout Period (28 Days)||3
8323264|NCT01408719|20520181|P1|STARTED|Washout Period (28 Days)||2
8323265|NCT01408719|20520162|P20|NOT COMPLETED|Third Intervention (35 Days)||0
8323266|NCT01408719|20520163|P19|NOT COMPLETED|Third Intervention (35 Days)||0
8323267|NCT01408719|20520164|P18|NOT COMPLETED|Third Intervention (35 Days)||0
8323268|NCT01408719|20520165|P17|NOT COMPLETED|Third Intervention (35 Days)||0
8323269|NCT01408719|20520166|P16|NOT COMPLETED|Third Intervention (35 Days)||0
8323270|NCT01408719|20520167|P15|NOT COMPLETED|Third Intervention (35 Days)||0
8323271|NCT01408719|20520168|P14|NOT COMPLETED|Third Intervention (35 Days)||0
8323272|NCT01408719|20520169|P13|NOT COMPLETED|Third Intervention (35 Days)||0
8323273|NCT01408719|20520170|P12|NOT COMPLETED|Third Intervention (35 Days)||0
8323274|NCT01408719|20520171|P11|NOT COMPLETED|Third Intervention (35 Days)||0
8323275|NCT01408719|20520172|P10|NOT COMPLETED|Third Intervention (35 Days)||0
8323276|NCT01408719|20520173|P9|NOT COMPLETED|Third Intervention (35 Days)||0
8323277|NCT01408719|20520174|P8|NOT COMPLETED|Third Intervention (35 Days)||1
8323278|NCT01408719|20520175|P7|NOT COMPLETED|Third Intervention (35 Days)||0
8323279|NCT01408719|20520176|P6|NOT COMPLETED|Third Intervention (35 Days)||0
8323280|NCT01408719|20520177|P5|NOT COMPLETED|Third Intervention (35 Days)||0
8323281|NCT01408719|20520178|P4|NOT COMPLETED|Third Intervention (35 Days)||0
8323282|NCT01408719|20520179|P3|NOT COMPLETED|Third Intervention (35 Days)||0
8323283|NCT01408719|20520180|P2|NOT COMPLETED|Third Intervention (35 Days)||0
8323284|NCT01408719|20520181|P1|NOT COMPLETED|Third Intervention (35 Days)||0
8323285|NCT01408719|20520162|P20|COMPLETED|Third Intervention (35 Days)||1
8323286|NCT01408719|20520163|P19|COMPLETED|Third Intervention (35 Days)||0
8323287|NCT01408719|20520164|P18|COMPLETED|Third Intervention (35 Days)||2
8323288|NCT01408719|20520165|P17|COMPLETED|Third Intervention (35 Days)||2
8323289|NCT01408719|20520166|P16|COMPLETED|Third Intervention (35 Days)||1
8323290|NCT01408719|20520167|P15|COMPLETED|Third Intervention (35 Days)||1
8323291|NCT01408719|20520168|P14|COMPLETED|Third Intervention (35 Days)||3
8323292|NCT01408719|20520169|P13|COMPLETED|Third Intervention (35 Days)||2
8323293|NCT01408719|20520170|P12|COMPLETED|Third Intervention (35 Days)||2
8323294|NCT01408719|20520171|P11|COMPLETED|Third Intervention (35 Days)||2
8323295|NCT01408719|20520172|P10|COMPLETED|Third Intervention (35 Days)||1
8323296|NCT01408719|20520173|P9|COMPLETED|Third Intervention (35 Days)||1
8323297|NCT01408719|20520174|P8|COMPLETED|Third Intervention (35 Days)||2
8323298|NCT01408719|20520175|P7|COMPLETED|Third Intervention (35 Days)||2
8323299|NCT01408719|20520176|P6|COMPLETED|Third Intervention (35 Days)||3
8323300|NCT01408719|20520177|P5|COMPLETED|Third Intervention (35 Days)||3
8323301|NCT01408719|20520178|P4|COMPLETED|Third Intervention (35 Days)||2
8323302|NCT01408719|20520179|P3|COMPLETED|Third Intervention (35 Days)||1
8323303|NCT01408719|20520180|P2|COMPLETED|Third Intervention (35 Days)||3
8323304|NCT01408719|20520181|P1|COMPLETED|Third Intervention (35 Days)||2
8323305|NCT01408719|20520162|P20|STARTED|Third Intervention (35 Days)||1
8323306|NCT01408719|20520163|P19|STARTED|Third Intervention (35 Days)||0
8323307|NCT01408719|20520164|P18|STARTED|Third Intervention (35 Days)||2
8323308|NCT01408719|20520165|P17|STARTED|Third Intervention (35 Days)||2
8323309|NCT01408719|20520166|P16|STARTED|Third Intervention (35 Days)||1
8323310|NCT01408719|20520167|P15|STARTED|Third Intervention (35 Days)||1
8323311|NCT01408719|20520168|P14|STARTED|Third Intervention (35 Days)||3
8323312|NCT01408719|20520169|P13|STARTED|Third Intervention (35 Days)||2
8323313|NCT01408719|20520170|P12|STARTED|Third Intervention (35 Days)||2
8323314|NCT01408719|20520171|P11|STARTED|Third Intervention (35 Days)||2
8323315|NCT01408719|20520172|P10|STARTED|Third Intervention (35 Days)||1
8323316|NCT01408719|20520173|P9|STARTED|Third Intervention (35 Days)||1
8323317|NCT01408719|20520174|P8|STARTED|Third Intervention (35 Days)||3
8323318|NCT01408719|20520175|P7|STARTED|Third Intervention (35 Days)||2
8323319|NCT01408719|20520176|P6|STARTED|Third Intervention (35 Days)||3
8323320|NCT01408719|20520177|P5|STARTED|Third Intervention (35 Days)||3
8323321|NCT01408719|20520178|P4|STARTED|Third Intervention (35 Days)||2
8323322|NCT01408719|20520179|P3|STARTED|Third Intervention (35 Days)||1
8323323|NCT01408719|20520180|P2|STARTED|Third Intervention (35 Days)||3
8323324|NCT01408719|20520181|P1|STARTED|Third Intervention (35 Days)||2
8323325|NCT01408719|20520162|P20|NOT COMPLETED|Washout Period (28 Days)||0
8323326|NCT01408719|20520163|P19|NOT COMPLETED|Washout Period (28 Days)||0
8323327|NCT01408719|20520164|P18|NOT COMPLETED|Washout Period (28 Days)||0
8323328|NCT01408719|20520165|P17|NOT COMPLETED|Washout Period (28 Days)||0
8323329|NCT01408719|20520166|P16|NOT COMPLETED|Washout Period (28 Days)||0
8323330|NCT01408719|20520167|P15|NOT COMPLETED|Washout Period (28 Days)||0
8323331|NCT01408719|20520168|P14|NOT COMPLETED|Washout Period (28 Days)||0
8323332|NCT01408719|20520169|P13|NOT COMPLETED|Washout Period (28 Days)||0
8323333|NCT01408719|20520170|P12|NOT COMPLETED|Washout Period (28 Days)||0
8323334|NCT01408719|20520171|P11|NOT COMPLETED|Washout Period (28 Days)||0
8323335|NCT01408719|20520172|P10|NOT COMPLETED|Washout Period (28 Days)||0
8323336|NCT01408719|20520173|P9|NOT COMPLETED|Washout Period (28 Days)||0
8323337|NCT01408719|20520174|P8|NOT COMPLETED|Washout Period (28 Days)||0
8323338|NCT01408719|20520175|P7|NOT COMPLETED|Washout Period (28 Days)||0
8323339|NCT01408719|20520176|P6|NOT COMPLETED|Washout Period (28 Days)||0
8323340|NCT01408719|20520177|P5|NOT COMPLETED|Washout Period (28 Days)||0
8323341|NCT01408719|20520178|P4|NOT COMPLETED|Washout Period (28 Days)||0
8323342|NCT01408719|20520179|P3|NOT COMPLETED|Washout Period (28 Days)||0
8323343|NCT01408719|20520180|P2|NOT COMPLETED|Washout Period (28 Days)||0
8323344|NCT01408719|20520181|P1|NOT COMPLETED|Washout Period (28 Days)||0
8323345|NCT01408719|20520162|P20|COMPLETED|Washout Period (28 Days)||1
8323346|NCT01408719|20520163|P19|COMPLETED|Washout Period (28 Days)||0
8323347|NCT01408719|20520164|P18|COMPLETED|Washout Period (28 Days)||2
8323348|NCT01408719|20520165|P17|COMPLETED|Washout Period (28 Days)||2
8323349|NCT01408719|20520166|P16|COMPLETED|Washout Period (28 Days)||1
8323350|NCT01408719|20520167|P15|COMPLETED|Washout Period (28 Days)||1
8323351|NCT01408719|20520168|P14|COMPLETED|Washout Period (28 Days)||3
8323352|NCT01408719|20520169|P13|COMPLETED|Washout Period (28 Days)||2
8323353|NCT01408719|20520170|P12|COMPLETED|Washout Period (28 Days)||2
8323354|NCT01408719|20520171|P11|COMPLETED|Washout Period (28 Days)||2
8323355|NCT01408719|20520172|P10|COMPLETED|Washout Period (28 Days)||1
8323356|NCT01408719|20520173|P9|COMPLETED|Washout Period (28 Days)||1
8323357|NCT01408719|20520174|P8|COMPLETED|Washout Period (28 Days)||3
8323358|NCT01408719|20520175|P7|COMPLETED|Washout Period (28 Days)||2
8323359|NCT01408719|20520176|P6|COMPLETED|Washout Period (28 Days)||3
8323360|NCT01408719|20520177|P5|COMPLETED|Washout Period (28 Days)||3
8323361|NCT01408719|20520178|P4|COMPLETED|Washout Period (28 Days)||2
8323362|NCT01408719|20520179|P3|COMPLETED|Washout Period (28 Days)||1
8323363|NCT01408719|20520180|P2|COMPLETED|Washout Period (28 Days)||3
8323364|NCT01408719|20520181|P1|COMPLETED|Washout Period (28 Days)||2
8323365|NCT01408719|20520162|P20|STARTED|Washout Period (28 Days)||1
8323366|NCT01408719|20520163|P19|STARTED|Washout Period (28 Days)||0
8323367|NCT01408719|20520164|P18|STARTED|Washout Period (28 Days)||2
8323368|NCT01408719|20520165|P17|STARTED|Washout Period (28 Days)||2
8323369|NCT01408719|20520166|P16|STARTED|Washout Period (28 Days)||1
8323370|NCT01408719|20520167|P15|STARTED|Washout Period (28 Days)||1
8323371|NCT01408719|20520168|P14|STARTED|Washout Period (28 Days)||3
8323372|NCT01408719|20520169|P13|STARTED|Washout Period (28 Days)||2
8323373|NCT01408719|20520170|P12|STARTED|Washout Period (28 Days)||2
8323374|NCT01408719|20520171|P11|STARTED|Washout Period (28 Days)||2
8323375|NCT01408719|20520172|P10|STARTED|Washout Period (28 Days)||1
8323376|NCT01408719|20520173|P9|STARTED|Washout Period (28 Days)||1
8323377|NCT01408719|20520174|P8|STARTED|Washout Period (28 Days)||3
8323378|NCT01408719|20520175|P7|STARTED|Washout Period (28 Days)||2
8323379|NCT01408719|20520176|P6|STARTED|Washout Period (28 Days)||3
8323380|NCT01408719|20520177|P5|STARTED|Washout Period (28 Days)||3
8323381|NCT01408719|20520178|P4|STARTED|Washout Period (28 Days)||2
8323382|NCT01408719|20520179|P3|STARTED|Washout Period (28 Days)||1
8323383|NCT01408719|20520180|P2|STARTED|Washout Period (28 Days)||3
8323384|NCT01408719|20520181|P1|STARTED|Washout Period (28 Days)||2
8323385|NCT01408719|20520162|P20|NOT COMPLETED|Second Intervention (35 Days)||0
8323386|NCT01408719|20520163|P19|NOT COMPLETED|Second Intervention (35 Days)||0
8323387|NCT01408719|20520164|P18|NOT COMPLETED|Second Intervention (35 Days)||0
8323388|NCT01408719|20520165|P17|NOT COMPLETED|Second Intervention (35 Days)||0
8323389|NCT01408719|20520166|P16|NOT COMPLETED|Second Intervention (35 Days)||0
8323390|NCT01408719|20520167|P15|NOT COMPLETED|Second Intervention (35 Days)||0
8323391|NCT01408719|20520168|P14|NOT COMPLETED|Second Intervention (35 Days)||1
8323392|NCT01408719|20520169|P13|NOT COMPLETED|Second Intervention (35 Days)||0
8323393|NCT01408719|20520170|P12|NOT COMPLETED|Second Intervention (35 Days)||0
8323394|NCT01408719|20520171|P11|NOT COMPLETED|Second Intervention (35 Days)||0
8323395|NCT01408719|20520172|P10|NOT COMPLETED|Second Intervention (35 Days)||0
8323396|NCT01408719|20520173|P9|NOT COMPLETED|Second Intervention (35 Days)||0
8323397|NCT01408719|20520174|P8|NOT COMPLETED|Second Intervention (35 Days)||0
8323398|NCT01408719|20520175|P7|NOT COMPLETED|Second Intervention (35 Days)||0
8323399|NCT01408719|20520176|P6|NOT COMPLETED|Second Intervention (35 Days)||0
8323400|NCT01408719|20520177|P5|NOT COMPLETED|Second Intervention (35 Days)||0
8323401|NCT01408719|20520178|P4|NOT COMPLETED|Second Intervention (35 Days)||0
8323402|NCT01408719|20520179|P3|NOT COMPLETED|Second Intervention (35 Days)||0
8323403|NCT01408719|20520180|P2|NOT COMPLETED|Second Intervention (35 Days)||0
8323404|NCT01408719|20520181|P1|NOT COMPLETED|Second Intervention (35 Days)||0
8323405|NCT01408719|20520162|P20|COMPLETED|Second Intervention (35 Days)||1
8323406|NCT01408719|20520163|P19|COMPLETED|Second Intervention (35 Days)||0
8323407|NCT01408719|20520164|P18|COMPLETED|Second Intervention (35 Days)||2
8323408|NCT01408719|20520165|P17|COMPLETED|Second Intervention (35 Days)||2
8323409|NCT01408719|20520166|P16|COMPLETED|Second Intervention (35 Days)||2
8323410|NCT01408719|20520167|P15|COMPLETED|Second Intervention (35 Days)||1
8323411|NCT01408719|20520168|P14|COMPLETED|Second Intervention (35 Days)||3
8323412|NCT01408719|20520169|P13|COMPLETED|Second Intervention (35 Days)||2
8323413|NCT01408719|20520170|P12|COMPLETED|Second Intervention (35 Days)||2
8323414|NCT01408719|20520171|P11|COMPLETED|Second Intervention (35 Days)||2
8323415|NCT01408719|20520172|P10|COMPLETED|Second Intervention (35 Days)||1
8323416|NCT01408719|20520173|P9|COMPLETED|Second Intervention (35 Days)||1
8323417|NCT01408719|20520174|P8|COMPLETED|Second Intervention (35 Days)||3
8323418|NCT01408719|20520175|P7|COMPLETED|Second Intervention (35 Days)||2
8323419|NCT01408719|20520176|P6|COMPLETED|Second Intervention (35 Days)||3
8323420|NCT01408719|20520177|P5|COMPLETED|Second Intervention (35 Days)||3
8323421|NCT01408719|20520178|P4|COMPLETED|Second Intervention (35 Days)||2
8323422|NCT01408719|20520179|P3|COMPLETED|Second Intervention (35 Days)||1
8323423|NCT01408719|20520180|P2|COMPLETED|Second Intervention (35 Days)||3
8323424|NCT01408719|20520181|P1|COMPLETED|Second Intervention (35 Days)||2
8323425|NCT01408719|20520162|P20|STARTED|Second Intervention (35 Days)||1
8323426|NCT01408719|20520163|P19|STARTED|Second Intervention (35 Days)||0
8323427|NCT01408719|20520164|P18|STARTED|Second Intervention (35 Days)||2
8323428|NCT01408719|20520165|P17|STARTED|Second Intervention (35 Days)||2
8323429|NCT01408719|20520166|P16|STARTED|Second Intervention (35 Days)||2
8323430|NCT01408719|20520167|P15|STARTED|Second Intervention (35 Days)||1
8323431|NCT01408719|20520168|P14|STARTED|Second Intervention (35 Days)||4
8323432|NCT01408719|20520169|P13|STARTED|Second Intervention (35 Days)||2
8323433|NCT01408719|20520170|P12|STARTED|Second Intervention (35 Days)||2
8323434|NCT01408719|20520171|P11|STARTED|Second Intervention (35 Days)||2
8323435|NCT01408719|20520172|P10|STARTED|Second Intervention (35 Days)||1
8323436|NCT01408719|20520173|P9|STARTED|Second Intervention (35 Days)||1
8323437|NCT01408719|20520174|P8|STARTED|Second Intervention (35 Days)||3
8323438|NCT01408719|20520175|P7|STARTED|Second Intervention (35 Days)||2
8323439|NCT01408719|20520176|P6|STARTED|Second Intervention (35 Days)||3
8323440|NCT01408719|20520177|P5|STARTED|Second Intervention (35 Days)||3
8323441|NCT01408719|20520178|P4|STARTED|Second Intervention (35 Days)||2
8323442|NCT01408719|20520179|P3|STARTED|Second Intervention (35 Days)||1
8323443|NCT01408719|20520180|P2|STARTED|Second Intervention (35 Days)||3
8323444|NCT01408719|20520181|P1|STARTED|Second Intervention (35 Days)||2
8323445|NCT01408719|20520162|P20|NOT COMPLETED|Washout Period (28 Days)||0
8323446|NCT01408719|20520163|P19|NOT COMPLETED|Washout Period (28 Days)||0
8323447|NCT01408719|20520164|P18|NOT COMPLETED|Washout Period (28 Days)||0
8323448|NCT01408719|20520165|P17|NOT COMPLETED|Washout Period (28 Days)||0
8323449|NCT01408719|20520166|P16|NOT COMPLETED|Washout Period (28 Days)||0
8323450|NCT01408719|20520167|P15|NOT COMPLETED|Washout Period (28 Days)||0
8323451|NCT01408719|20520168|P14|NOT COMPLETED|Washout Period (28 Days)||0
8323452|NCT01408719|20520169|P13|NOT COMPLETED|Washout Period (28 Days)||0
8323453|NCT01408719|20520170|P12|NOT COMPLETED|Washout Period (28 Days)||0
8323454|NCT01408719|20520171|P11|NOT COMPLETED|Washout Period (28 Days)||0
8323455|NCT01408719|20520172|P10|NOT COMPLETED|Washout Period (28 Days)||0
8323456|NCT01408719|20520173|P9|NOT COMPLETED|Washout Period (28 Days)||0
8323457|NCT01408719|20520174|P8|NOT COMPLETED|Washout Period (28 Days)||0
8323458|NCT01408719|20520175|P7|NOT COMPLETED|Washout Period (28 Days)||0
8323459|NCT01408719|20520176|P6|NOT COMPLETED|Washout Period (28 Days)||0
8323460|NCT01408719|20520177|P5|NOT COMPLETED|Washout Period (28 Days)||0
8323461|NCT01408719|20520178|P4|NOT COMPLETED|Washout Period (28 Days)||0
8323462|NCT01408719|20520179|P3|NOT COMPLETED|Washout Period (28 Days)||0
8323463|NCT01408719|20520180|P2|NOT COMPLETED|Washout Period (28 Days)||0
8323464|NCT01408719|20520181|P1|NOT COMPLETED|Washout Period (28 Days)||0
8323465|NCT01408719|20520162|P20|COMPLETED|Washout Period (28 Days)||1
8323466|NCT01408719|20520163|P19|COMPLETED|Washout Period (28 Days)||0
8323467|NCT01408719|20520164|P18|COMPLETED|Washout Period (28 Days)||2
8323468|NCT01408719|20520165|P17|COMPLETED|Washout Period (28 Days)||2
8323469|NCT01408719|20520166|P16|COMPLETED|Washout Period (28 Days)||2
8323470|NCT01408719|20520167|P15|COMPLETED|Washout Period (28 Days)||1
8323471|NCT01408719|20520168|P14|COMPLETED|Washout Period (28 Days)||4
8323472|NCT01408719|20520169|P13|COMPLETED|Washout Period (28 Days)||2
8323473|NCT01408719|20520170|P12|COMPLETED|Washout Period (28 Days)||2
8323474|NCT01408719|20520171|P11|COMPLETED|Washout Period (28 Days)||2
8323475|NCT01408719|20520172|P10|COMPLETED|Washout Period (28 Days)||1
8323476|NCT01408719|20520173|P9|COMPLETED|Washout Period (28 Days)||1
8323477|NCT01408719|20520174|P8|COMPLETED|Washout Period (28 Days)||3
8323478|NCT01408719|20520175|P7|COMPLETED|Washout Period (28 Days)||2
8323479|NCT01408719|20520176|P6|COMPLETED|Washout Period (28 Days)||3
8323480|NCT01408719|20520177|P5|COMPLETED|Washout Period (28 Days)||3
8323481|NCT01408719|20520178|P4|COMPLETED|Washout Period (28 Days)||2
8323482|NCT01408719|20520179|P3|COMPLETED|Washout Period (28 Days)||1
8323483|NCT01408719|20520180|P2|COMPLETED|Washout Period (28 Days)||3
8323484|NCT01408719|20520181|P1|COMPLETED|Washout Period (28 Days)||2
8323485|NCT01408719|20520162|P20|STARTED|Washout Period (28 Days)||1
8323486|NCT01408719|20520163|P19|STARTED|Washout Period (28 Days)||0
8323487|NCT01408719|20520164|P18|STARTED|Washout Period (28 Days)||2
8323488|NCT01408719|20520165|P17|STARTED|Washout Period (28 Days)||2
8323489|NCT01408719|20520166|P16|STARTED|Washout Period (28 Days)||2
8323490|NCT01408719|20520167|P15|STARTED|Washout Period (28 Days)||1
8323491|NCT01408719|20520168|P14|STARTED|Washout Period (28 Days)||4
8323492|NCT01408719|20520169|P13|STARTED|Washout Period (28 Days)||2
8323493|NCT01408719|20520170|P12|STARTED|Washout Period (28 Days)||2
8323494|NCT01408719|20520171|P11|STARTED|Washout Period (28 Days)||2
8323495|NCT01408719|20520172|P10|STARTED|Washout Period (28 Days)||1
8323496|NCT01408719|20520173|P9|STARTED|Washout Period (28 Days)||1
8323497|NCT01408719|20520174|P8|STARTED|Washout Period (28 Days)||3
8323498|NCT01408719|20520175|P7|STARTED|Washout Period (28 Days)||2
8323499|NCT01408719|20520176|P6|STARTED|Washout Period (28 Days)||3
8323500|NCT01408719|20520177|P5|STARTED|Washout Period (28 Days)||3
8323501|NCT01408719|20520178|P4|STARTED|Washout Period (28 Days)||2
8323502|NCT01408719|20520179|P3|STARTED|Washout Period (28 Days)||1
8323503|NCT01408719|20520180|P2|STARTED|Washout Period (28 Days)||3
8323504|NCT01408719|20520181|P1|STARTED|Washout Period (28 Days)||2
8323505|NCT01408719|20520162|P20|NOT COMPLETED|First Intervention (35 Days)||0
8323506|NCT01408719|20520163|P19|NOT COMPLETED|First Intervention (35 Days)||1
8323507|NCT01408719|20520164|P18|NOT COMPLETED|First Intervention (35 Days)||0
8323508|NCT01408719|20520165|P17|NOT COMPLETED|First Intervention (35 Days)||1
8323509|NCT01408719|20520166|P16|NOT COMPLETED|First Intervention (35 Days)||0
8323510|NCT01408719|20520167|P15|NOT COMPLETED|First Intervention (35 Days)||0
8323511|NCT01408719|20520168|P14|NOT COMPLETED|First Intervention (35 Days)||1
8323512|NCT01408719|20520169|P13|NOT COMPLETED|First Intervention (35 Days)||0
8323513|NCT01408719|20520170|P12|NOT COMPLETED|First Intervention (35 Days)||0
8323514|NCT01408719|20520171|P11|NOT COMPLETED|First Intervention (35 Days)||0
8323515|NCT01408719|20520172|P10|NOT COMPLETED|First Intervention (35 Days)||0
8323516|NCT01408719|20520173|P9|NOT COMPLETED|First Intervention (35 Days)||1
8323517|NCT01408719|20520174|P8|NOT COMPLETED|First Intervention (35 Days)||0
8323518|NCT01408719|20520175|P7|NOT COMPLETED|First Intervention (35 Days)||0
8323519|NCT01408719|20520176|P6|NOT COMPLETED|First Intervention (35 Days)||0
8323520|NCT01408719|20520177|P5|NOT COMPLETED|First Intervention (35 Days)||1
8323521|NCT01408719|20520178|P4|NOT COMPLETED|First Intervention (35 Days)||0
8323522|NCT01408719|20520179|P3|NOT COMPLETED|First Intervention (35 Days)||1
8323523|NCT01408719|20520180|P2|NOT COMPLETED|First Intervention (35 Days)||0
8323524|NCT01408719|20520181|P1|NOT COMPLETED|First Intervention (35 Days)||0
8323525|NCT01408719|20520162|P20|COMPLETED|First Intervention (35 Days)||1
8323526|NCT01408719|20520163|P19|COMPLETED|First Intervention (35 Days)||0
8323527|NCT01408719|20520164|P18|COMPLETED|First Intervention (35 Days)||2
8323528|NCT01408719|20520165|P17|COMPLETED|First Intervention (35 Days)||2
8323529|NCT01408719|20520166|P16|COMPLETED|First Intervention (35 Days)||2
8323530|NCT01408719|20520167|P15|COMPLETED|First Intervention (35 Days)||1
8323531|NCT01408719|20520168|P14|COMPLETED|First Intervention (35 Days)||4
8323532|NCT01408719|20520169|P13|COMPLETED|First Intervention (35 Days)||2
8323533|NCT01408719|20520170|P12|COMPLETED|First Intervention (35 Days)||2
8323534|NCT01408719|20520171|P11|COMPLETED|First Intervention (35 Days)||2
8323535|NCT01408719|20520172|P10|COMPLETED|First Intervention (35 Days)||1
8323536|NCT01408719|20520173|P9|COMPLETED|First Intervention (35 Days)||1
8323537|NCT01408719|20520174|P8|COMPLETED|First Intervention (35 Days)||3
8323538|NCT01408719|20520175|P7|COMPLETED|First Intervention (35 Days)||2
8323539|NCT01408719|20520176|P6|COMPLETED|First Intervention (35 Days)||3
8323540|NCT01408719|20520177|P5|COMPLETED|First Intervention (35 Days)||3
8323541|NCT01408719|20520178|P4|COMPLETED|First Intervention (35 Days)||2
8323542|NCT01408719|20520179|P3|COMPLETED|First Intervention (35 Days)||1
8323543|NCT01408719|20520180|P2|COMPLETED|First Intervention (35 Days)||3
8323544|NCT01408719|20520181|P1|COMPLETED|First Intervention (35 Days)||2
8323545|NCT01408719|20520162|P20|STARTED|First Intervention (35 Days)||1
8323546|NCT01408719|20520163|P19|STARTED|First Intervention (35 Days)||1
8323547|NCT01408719|20520164|P18|STARTED|First Intervention (35 Days)||2
8323548|NCT01408719|20520165|P17|STARTED|First Intervention (35 Days)||3
8323549|NCT01408719|20520166|P16|STARTED|First Intervention (35 Days)||2
8323550|NCT01408719|20520167|P15|STARTED|First Intervention (35 Days)||1
8323551|NCT01408719|20520168|P14|STARTED|First Intervention (35 Days)||5
8323552|NCT01408719|20520169|P13|STARTED|First Intervention (35 Days)||2
8323553|NCT01408719|20520170|P12|STARTED|First Intervention (35 Days)||2
8323554|NCT01408719|20520171|P11|STARTED|First Intervention (35 Days)||2
8323555|NCT01408719|20520172|P10|STARTED|First Intervention (35 Days)||1
8323556|NCT01408719|20520173|P9|STARTED|First Intervention (35 Days)||2
8323557|NCT01408719|20520174|P8|STARTED|First Intervention (35 Days)||3
8323558|NCT01408719|20520175|P7|STARTED|First Intervention (35 Days)||2
8323559|NCT01408719|20520176|P6|STARTED|First Intervention (35 Days)||3
8323560|NCT01408719|20520177|P5|STARTED|First Intervention (35 Days)||4
8323561|NCT01408719|20520178|P4|STARTED|First Intervention (35 Days)||2
8323562|NCT01408719|20520179|P3|STARTED|First Intervention (35 Days)||2
8323563|NCT01408719|20520180|P2|STARTED|First Intervention (35 Days)||3
8323564|NCT01408719|20520181|P1|STARTED|First Intervention (35 Days)||2
8323565|NCT01408706|20520193|P2|NOT COMPLETED|Overall Study||0
8323566|NCT01408706|20520194|P1|NOT COMPLETED|Overall Study||1
8323567|NCT01408706|20520193|P2|COMPLETED|Overall Study||30
8323568|NCT01408706|20520194|P1|COMPLETED|Overall Study||29
8323569|NCT01408706|20520193|P2|STARTED|Overall Study||30
8323570|NCT01408706|20520194|P1|STARTED|Overall Study||30
8323571|NCT01408641|20520206|P2|NOT COMPLETED|Overall Study||0
8323572|NCT01408641|20520207|P1|NOT COMPLETED|Overall Study||1
8323573|NCT01408641|20520206|P2|COMPLETED|Overall Study||0
8323574|NCT01408641|20520207|P1|COMPLETED|Overall Study||0
8323575|NCT01408641|20520206|P2|STARTED|Overall Study||0
8323576|NCT01408641|20520207|P1|STARTED|Overall Study||1
8323577|NCT01408628|20520215|P1|NOT COMPLETED|Completed 6 Month Follow-Up||14
8323578|NCT01408628|20520215|P1|COMPLETED|Completed 6 Month Follow-Up||25
8323579|NCT01408628|20520215|P1|STARTED|Completed 6 Month Follow-Up||39
8323580|NCT01408628|20520215|P1|NOT COMPLETED|Started Classes/Intervention||0
8323581|NCT01408628|20520215|P1|COMPLETED|Started Classes/Intervention||39
8323582|NCT01408628|20520215|P1|STARTED|Started Classes/Intervention||39
8323583|NCT01408628|20520215|P1|NOT COMPLETED|Consented||12
8323584|NCT01408628|20520215|P1|COMPLETED|Consented||39
8323585|NCT01408628|20520215|P1|STARTED|Consented||51
8323586|NCT01408576|20520224|P3|NOT COMPLETED|Overall Study||508
8323587|NCT01408576|20520225|P2|NOT COMPLETED|Overall Study||498
8323588|NCT01408576|20520226|P1|NOT COMPLETED|Overall Study||188
8323589|NCT01408576|20520224|P3|COMPLETED|Overall Study||0
8323590|NCT01408576|20520225|P2|COMPLETED|Overall Study||0
8323591|NCT01408576|20520226|P1|COMPLETED|Overall Study||56
8323592|NCT01408576|20520224|P3|STARTED|Overall Study||508
8323593|NCT01408576|20520225|P2|STARTED|Overall Study||498
8323594|NCT01408576|20520226|P1|STARTED|Overall Study||244
8323595|NCT01408563|20520273|P1|NOT COMPLETED|Overall Study||2
8323596|NCT01408563|20520273|P1|COMPLETED|Overall Study||31
8323597|NCT01408563|20520273|P1|Received Transplant|Overall Study||31
8323598|NCT01408563|20520273|P1|STARTED|Overall Study||33
8323599|NCT01408537|20520289|P1|NOT COMPLETED|Overall Study||8
8323600|NCT01408537|20520289|P1|COMPLETED|Overall Study||144
8323601|NCT01408537|20520289|P1|STARTED|Overall Study||152
8323602|NCT01408485|20520305|P1|NOT COMPLETED|Overall Study||21
8323603|NCT01408485|20520305|P1|COMPLETED|Overall Study||179
8323604|NCT01408485|20520305|P1|STARTED|Overall Study||200
8323605|NCT01408329|20520313|P2|NOT COMPLETED|Overall Study||4
8323606|NCT01408329|20520314|P1|NOT COMPLETED|Overall Study||3
8323607|NCT01408329|20520313|P2|COMPLETED|Overall Study||11
8323608|NCT01408329|20520314|P1|COMPLETED|Overall Study||10
8323609|NCT01408329|20520313|P2|STARTED|Overall Study||15
8323610|NCT01408329|20520314|P1|STARTED|Overall Study||13
8323611|NCT01408303|20520323|P3|NOT COMPLETED|Overall Study||6
8323612|NCT01408303|20520324|P2|NOT COMPLETED|Overall Study||12
8323613|NCT01408303|20520325|P1|NOT COMPLETED|Overall Study||6
8323614|NCT01408303|20520323|P3|COMPLETED|Overall Study||210
8323615|NCT01408303|20520324|P2|COMPLETED|Overall Study||204
8323616|NCT01408303|20520325|P1|COMPLETED|Overall Study||209
8323617|NCT01408303|20520323|P3|STARTED|Overall Study||216
8323618|NCT01408303|20520324|P2|STARTED|Overall Study||216
8323619|NCT01408303|20520325|P1|STARTED|Overall Study||215
8323620|NCT01408277|20520335|P2|NOT COMPLETED|Overall Study||4
8323621|NCT01408277|20520336|P1|NOT COMPLETED|Overall Study||8
8323622|NCT01408277|20520335|P2|COMPLETED|Overall Study||23
8323623|NCT01408277|20520336|P1|COMPLETED|Overall Study||20
8323624|NCT01408277|20520335|P2|STARTED|Overall Study||27
8323625|NCT01408277|20520336|P1|STARTED|Overall Study||28
8323626|NCT01408147|20520344|P2|NOT COMPLETED|Overall Study||1
8323627|NCT01408147|20520345|P1|NOT COMPLETED|Overall Study||0
8323628|NCT01408147|20520344|P2|COMPLETED|Overall Study||196
8323629|NCT01408147|20520345|P1|COMPLETED|Overall Study|1 clinic withdrew due to low census|174
8323630|NCT01408147|20520344|P2|STARTED|Overall Study|197 participants|197
8323631|NCT01408147|20520345|P1|STARTED|Overall Study|174 participants|174
8323632|NCT01408043|20520353|P1|NOT COMPLETED|Overall Study||1
8323633|NCT01408043|20520353|P1|COMPLETED|Overall Study||24
8323634|NCT01408043|20520353|P1|STARTED|Overall Study||25
8323635|NCT01408030|20520372|P4|NOT COMPLETED|Observation Phase (Off Drug)||4
8323636|NCT01408030|20520373|P3|NOT COMPLETED|Observation Phase (Off Drug)||6
8323637|NCT01408030|20520374|P2|NOT COMPLETED|Observation Phase (Off Drug)||6
8323638|NCT01408030|20520375|P1|NOT COMPLETED|Observation Phase (Off Drug)||4
8323639|NCT01408030|20520372|P4|COMPLETED|Observation Phase (Off Drug)||21
8323640|NCT01408030|20520373|P3|COMPLETED|Observation Phase (Off Drug)||26
8323641|NCT01408030|20520374|P2|COMPLETED|Observation Phase (Off Drug)||18
8323642|NCT01408030|20520375|P1|COMPLETED|Observation Phase (Off Drug)||22
8323643|NCT01408030|20520372|P4|STARTED|Observation Phase (Off Drug)||25
8323644|NCT01408030|20520373|P3|STARTED|Observation Phase (Off Drug)||32
8323645|NCT01408030|20520374|P2|STARTED|Observation Phase (Off Drug)||24
8323646|NCT01408030|20520375|P1|STARTED|Observation Phase (Off Drug)||26
8323647|NCT01408030|20520372|P4|NOT COMPLETED|Treatment Phase (on Drug)||3
8323648|NCT01408030|20520373|P3|NOT COMPLETED|Treatment Phase (on Drug)||1
8323649|NCT01408030|20520374|P2|NOT COMPLETED|Treatment Phase (on Drug)||7
8323650|NCT01408030|20520375|P1|NOT COMPLETED|Treatment Phase (on Drug)||3
8323651|NCT01408030|20520372|P4|COMPLETED|Treatment Phase (on Drug)||25
8323652|NCT01408030|20520373|P3|COMPLETED|Treatment Phase (on Drug)||32
8323653|NCT01408030|20520374|P2|COMPLETED|Treatment Phase (on Drug)||24
8323654|NCT01408030|20520375|P1|COMPLETED|Treatment Phase (on Drug)||26
8323655|NCT01408030|20520372|P4|STARTED|Treatment Phase (on Drug)||28
8323656|NCT01408030|20520373|P3|STARTED|Treatment Phase (on Drug)||33
8323657|NCT01408030|20520374|P2|STARTED|Treatment Phase (on Drug)||31
8323658|NCT01408030|20520375|P1|STARTED|Treatment Phase (on Drug)||29
8323659|NCT01407952|20520407|P2|NOT COMPLETED|Overall Study||37
8323660|NCT01407952|20520408|P1|NOT COMPLETED|Overall Study||46
8323661|NCT01407952|20520407|P2|COMPLETED|Overall Study||266
8323662|NCT01407952|20520408|P1|COMPLETED|Overall Study||251
8323663|NCT01407952|20520407|P2|STARTED|Overall Study||303
8323664|NCT01407952|20520408|P1|STARTED|Overall Study||297
8323665|NCT01407926|20520434|P1|NOT COMPLETED|Overall Study||55
8323666|NCT01407926|20520434|P1|COMPLETED|Overall Study||87
8323667|NCT01407926|20520434|P1|STARTED|Overall Study||142
8323668|NCT01407575|20520451|P2|NOT COMPLETED|Overall Study||1
8323669|NCT01407575|20520452|P1|NOT COMPLETED|Overall Study||2
8323670|NCT01407575|20520451|P2|COMPLETED|Overall Study||5
8323671|NCT01407575|20520452|P1|COMPLETED|Overall Study||5
8323672|NCT01407575|20520451|P2|STARTED|Overall Study||6
8323673|NCT01407575|20520452|P1|STARTED|Overall Study||7
8323674|NCT01407523|20520470|P1|NOT COMPLETED|Overall Study||0
8323675|NCT01407523|20520470|P1|COMPLETED|Overall Study||16
8323676|NCT01407523|20520470|P1|STARTED|Overall Study||16
8323677|NCT01407367|20520482|P2|NOT COMPLETED|Overall Study||78
8323678|NCT01407367|20520483|P1|NOT COMPLETED|Overall Study||40
8323679|NCT01407367|20520482|P2|COMPLETED|Overall Study||164
8323680|NCT01407367|20520483|P1|COMPLETED|Overall Study||68
8323681|NCT01407367|20520482|P2|STARTED|Overall Study||242
8323682|NCT01407367|20520483|P1|STARTED|Overall Study||108
8323695|NCT01407276|20520514|P8|NOT COMPLETED|Overall Study||1
8323696|NCT01407276|20520515|P7|NOT COMPLETED|Overall Study||0
8323697|NCT01407276|20520516|P6|NOT COMPLETED|Overall Study||0
8323698|NCT01407276|20520517|P5|NOT COMPLETED|Overall Study||0
8323699|NCT01407276|20520518|P4|NOT COMPLETED|Overall Study||0
8323700|NCT01407276|20520519|P3|NOT COMPLETED|Overall Study||0
8323701|NCT01407276|20520520|P2|NOT COMPLETED|Overall Study||0
8323702|NCT01407276|20520521|P1|NOT COMPLETED|Overall Study||0
8323703|NCT01407276|20520514|P8|COMPLETED|Overall Study||6
8323704|NCT01407276|20520515|P7|COMPLETED|Overall Study||6
8323705|NCT01407276|20520516|P6|COMPLETED|Overall Study||6
8323706|NCT01407276|20520517|P5|COMPLETED|Overall Study||6
8323707|NCT01407276|20520518|P4|COMPLETED|Overall Study||6
8323708|NCT01407276|20520519|P3|COMPLETED|Overall Study||6
8323709|NCT01407276|20520520|P2|COMPLETED|Overall Study||6
8323710|NCT01407276|20520521|P1|COMPLETED|Overall Study||6
8323711|NCT01407276|20520514|P8|STARTED|Overall Study||7
8323712|NCT01407276|20520515|P7|STARTED|Overall Study||6
8323713|NCT01407276|20520516|P6|STARTED|Overall Study||6
8323714|NCT01407276|20520517|P5|STARTED|Overall Study||6
8323715|NCT01407276|20520518|P4|STARTED|Overall Study||6
8323716|NCT01407276|20520519|P3|STARTED|Overall Study||6
8323717|NCT01407276|20520520|P2|STARTED|Overall Study||6
8323718|NCT01407276|20520521|P1|STARTED|Overall Study||6
8323719|NCT01407107|20520648|P3|NOT COMPLETED|Overall Study||0
8323720|NCT01407107|20520649|P2|NOT COMPLETED|Overall Study||0
8323721|NCT01407107|20520650|P1|NOT COMPLETED|Overall Study||0
8323722|NCT01407107|20520648|P3|COMPLETED|Overall Study||3
8323723|NCT01407107|20520649|P2|COMPLETED|Overall Study||3
8323724|NCT01407107|20520650|P1|COMPLETED|Overall Study||7
8323725|NCT01407107|20520648|P3|STARTED|Overall Study||3
8323726|NCT01407107|20520649|P2|STARTED|Overall Study||3
8323727|NCT01407107|20520650|P1|STARTED|Overall Study||7
8323728|NCT01407094|20520664|P3|NOT COMPLETED|Stage 2||15
8323729|NCT01407094|20520665|P2|NOT COMPLETED|Stage 2||11
8323730|NCT01407094|20520666|P1|NOT COMPLETED|Stage 2||21
8323731|NCT01407094|20520664|P3|COMPLETED|Stage 2||38
8323732|NCT01407094|20520665|P2|COMPLETED|Stage 2||35
8323733|NCT01407094|20520666|P1|COMPLETED|Stage 2||113
8323734|NCT01407094|20520664|P3|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
8323735|NCT01407094|20520665|P2|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
8323736|NCT01407094|20520666|P1|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
8323737|NCT01407094|20520664|P3|NOT COMPLETED|Stage 1||0
8323738|NCT01407094|20520665|P2|NOT COMPLETED|Stage 1||27
8323739|NCT01407094|20520666|P1|NOT COMPLETED|Stage 1||34
8323740|NCT01407094|20520664|P3|COMPLETED|Stage 1||0
8323741|NCT01407094|20520665|P2|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
8323742|NCT01407094|20520666|P1|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
8323743|NCT01407094|20520664|P3|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
8323744|NCT01407094|20520665|P2|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
8323745|NCT01407094|20520666|P1|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
8323746|NCT01407068|20520674|P1|NOT COMPLETED|Overall Study||0
8323747|NCT01407068|20520674|P1|COMPLETED|Overall Study||60
8323748|NCT01407068|20520674|P1|STARTED|Overall Study||60
8323749|NCT01406990|20520683|P1|NOT COMPLETED|Overall Study||0
8323750|NCT01406990|20520683|P1|COMPLETED|Overall Study||15
8323751|NCT01406990|20520683|P1|STARTED|Overall Study||15
8323752|NCT01406938|20520689|P6|NOT COMPLETED|Follow up||3
8323753|NCT01406938|20520690|P5|NOT COMPLETED|Follow up||9
8323754|NCT01406938|20520691|P4|NOT COMPLETED|Follow up||3
8323755|NCT01406938|20520692|P3|NOT COMPLETED|Follow up||8
8323756|NCT01406938|20520693|P2|NOT COMPLETED|Follow up||5
8323757|NCT01406938|20520694|P1|NOT COMPLETED|Follow up||8
8323758|NCT01406938|20520689|P6|COMPLETED|Follow up||32
8323759|NCT01406938|20520690|P5|COMPLETED|Follow up||31
8323760|NCT01406938|20520691|P4|COMPLETED|Follow up||36
8323761|NCT01406938|20520692|P3|COMPLETED|Follow up||32
8323762|NCT01406938|20520693|P2|COMPLETED|Follow up||18
8323763|NCT01406938|20520694|P1|COMPLETED|Follow up||18
8323764|NCT01406938|20520689|P6|STARTED|Follow up||35
8323765|NCT01406938|20520690|P5|STARTED|Follow up||40
8323766|NCT01406938|20520691|P4|STARTED|Follow up||39
8323767|NCT01406938|20520692|P3|STARTED|Follow up||40
8323768|NCT01406938|20520693|P2|STARTED|Follow up||23
8323769|NCT01406938|20520694|P1|STARTED|Follow up||26
8323770|NCT01406938|20520689|P6|NOT COMPLETED|Maintenance Period||16
8323771|NCT01406938|20520690|P5|NOT COMPLETED|Maintenance Period||25
8323772|NCT01406938|20520691|P4|NOT COMPLETED|Maintenance Period||18
8323773|NCT01406938|20520692|P3|NOT COMPLETED|Maintenance Period||17
8323774|NCT01406938|20520693|P2|NOT COMPLETED|Maintenance Period||0
8323775|NCT01406938|20520694|P1|NOT COMPLETED|Maintenance Period||0
8323776|NCT01406938|20520689|P6|COMPLETED|Maintenance Period||201
8323777|NCT01406938|20520690|P5|COMPLETED|Maintenance Period||181
8323778|NCT01406938|20520691|P4|COMPLETED|Maintenance Period||199
8323779|NCT01406938|20520692|P3|COMPLETED|Maintenance Period||186
8323780|NCT01406938|20520693|P2|COMPLETED|Maintenance Period||0
8323781|NCT01406938|20520694|P1|COMPLETED|Maintenance Period||0
8323782|NCT01406938|20520689|P6|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
8323783|NCT01406938|20520690|P5|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
8323784|NCT01406938|20520691|P4|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
8323785|NCT01406938|20520692|P3|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
8323786|NCT01406938|20520693|P2|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
8323787|NCT01406938|20520694|P1|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
8323788|NCT01406938|20520689|P6|STARTED|Maintenance Period||217
8323789|NCT01406938|20520690|P5|STARTED|Maintenance Period||206
8323790|NCT01406938|20520691|P4|STARTED|Maintenance Period||217
8323791|NCT01406938|20520692|P3|STARTED|Maintenance Period||203
8323792|NCT01406938|20520693|P2|STARTED|Maintenance Period||0
8323793|NCT01406938|20520694|P1|STARTED|Maintenance Period||0
8323794|NCT01406938|20520689|P6|NOT COMPLETED|Induction Period||0
8323795|NCT01406938|20520690|P5|NOT COMPLETED|Induction Period||0
8323796|NCT01406938|20520691|P4|NOT COMPLETED|Induction Period||0
8323797|NCT01406938|20520692|P3|NOT COMPLETED|Induction Period||0
8323798|NCT01406938|20520693|P2|NOT COMPLETED|Induction Period||20
8323799|NCT01406938|20520694|P1|NOT COMPLETED|Induction Period||18
8323800|NCT01406938|20520689|P6|COMPLETED|Induction Period||0
8323801|NCT01406938|20520690|P5|COMPLETED|Induction Period||0
8323802|NCT01406938|20520691|P4|COMPLETED|Induction Period||0
8323803|NCT01406938|20520692|P3|COMPLETED|Induction Period||0
8323804|NCT01406938|20520693|P2|COMPLETED|Induction Period||464
8323805|NCT01406938|20520694|P1|COMPLETED|Induction Period||464
8323806|NCT01406938|20520689|P6|FAS:Patients Assigned Study Treatment|Induction Period||0
8323807|NCT01406938|20520690|P5|FAS:Patients Assigned Study Treatment|Induction Period||0
8323808|NCT01406938|20520691|P4|FAS:Patients Assigned Study Treatment|Induction Period||0
8323809|NCT01406938|20520692|P3|FAS:Patients Assigned Study Treatment|Induction Period||0
8323810|NCT01406938|20520693|P2|FAS:Patients Assigned Study Treatment|Induction Period||483
8323811|NCT01406938|20520694|P1|FAS:Patients Assigned Study Treatment|Induction Period||482
8323812|NCT01406938|20520689|P6|STARTED|Induction Period||0
8323813|NCT01406938|20520690|P5|STARTED|Induction Period||0
8323814|NCT01406938|20520691|P4|STARTED|Induction Period||0
8323815|NCT01406938|20520692|P3|STARTED|Induction Period||0
8323816|NCT01406938|20520693|P2|STARTED|Induction Period||484
8323817|NCT01406938|20520694|P1|STARTED|Induction Period||482
8323818|NCT01406873|20520812|P2|NOT COMPLETED|Overall Study||1
8323819|NCT01406873|20520813|P1|NOT COMPLETED|Overall Study||1
8323820|NCT01406873|20520812|P2|COMPLETED|Overall Study||20
8323821|NCT01406873|20520813|P1|COMPLETED|Overall Study||20
8323822|NCT01406873|20520812|P2|STARTED|Overall Study||21
8323823|NCT01406873|20520813|P1|STARTED|Overall Study||21
8323824|NCT01406860|20520831|P2|NOT COMPLETED|Overall Study||0
8323825|NCT01406860|20520832|P1|NOT COMPLETED|Overall Study||0
8323826|NCT01406860|20520831|P2|COMPLETED|Overall Study||8
8323827|NCT01406860|20520832|P1|COMPLETED|Overall Study||11
8323828|NCT01406860|20520831|P2|STARTED|Overall Study||8
8323829|NCT01406860|20520832|P1|STARTED|Overall Study||11
8323830|NCT01406795|20520844|P1|NOT COMPLETED|Overall Study||1
8323831|NCT01406795|20520844|P1|COMPLETED|Overall Study||0
8323832|NCT01406795|20520844|P1|STARTED|Overall Study||1
8323833|NCT01406717|20520860|P2|NOT COMPLETED|Overall Study||31
8323834|NCT01406717|20520861|P1|NOT COMPLETED|Overall Study||43
8323835|NCT01406717|20520860|P2|COMPLETED|Overall Study||149
8323836|NCT01406717|20520861|P1|COMPLETED|Overall Study||137
8323837|NCT01406717|20520860|P2|STARTED|Overall Study||180
8323838|NCT01406717|20520861|P1|STARTED|Overall Study||180
8323839|NCT01406652|20520891|P2|NOT COMPLETED|Overall Study||20
8323840|NCT01406652|20520892|P1|NOT COMPLETED|Overall Study||20
8323841|NCT01406652|20520891|P2|COMPLETED|Overall Study||95
8323842|NCT01406652|20520892|P1|COMPLETED|Overall Study||89
8323843|NCT01406652|20520891|P2|STARTED|Overall Study||115
8323844|NCT01406652|20520892|P1|STARTED|Overall Study||109
8323845|NCT01406574|20520900|P4|NOT COMPLETED|Overall Study||4
8323846|NCT01406574|20520901|P3|NOT COMPLETED|Overall Study||1
8323847|NCT01406574|20520902|P2|NOT COMPLETED|Overall Study||1
8323848|NCT01406574|20520903|P1|NOT COMPLETED|Overall Study||1
8323849|NCT01406574|20520900|P4|COMPLETED|Overall Study||1
8323850|NCT01406574|20520901|P3|COMPLETED|Overall Study||6
8323851|NCT01406574|20520902|P2|COMPLETED|Overall Study||3
8323852|NCT01406574|20520903|P1|COMPLETED|Overall Study||6
8323853|NCT01406574|20520900|P4|STARTED|Overall Study||5
8323854|NCT01406574|20520901|P3|STARTED|Overall Study||7
8323855|NCT01406574|20520902|P2|STARTED|Overall Study||4
8323856|NCT01406574|20520903|P1|STARTED|Overall Study||7
8323857|NCT01406444|20520918|P3|NOT COMPLETED|Overall Study||2
8323858|NCT01406444|20520919|P2|NOT COMPLETED|Overall Study||9
8323859|NCT01406444|20520920|P1|NOT COMPLETED|Overall Study||10
8323860|NCT01406444|20520918|P3|COMPLETED|Overall Study||14
8323861|NCT01406444|20520919|P2|COMPLETED|Overall Study||24
8323862|NCT01406444|20520920|P1|COMPLETED|Overall Study||23
8323863|NCT01406444|20520918|P3|STARTED|Overall Study||16
8323864|NCT01406444|20520919|P2|STARTED|Overall Study||33
8323865|NCT01406444|20520920|P1|STARTED|Overall Study||33
8323866|NCT01406223|20520935|P4|NOT COMPLETED|Overall Study||16
8323867|NCT01406223|20520936|P3|NOT COMPLETED|Overall Study||18
8323868|NCT01406223|20520937|P2|NOT COMPLETED|Overall Study||12
8323869|NCT01406223|20520938|P1|NOT COMPLETED|Overall Study||12
8323870|NCT01406223|20520935|P4|COMPLETED|Overall Study||3
8323871|NCT01406223|20520936|P3|COMPLETED|Overall Study||2
8323872|NCT01406223|20520937|P2|COMPLETED|Overall Study||7
8323873|NCT01406223|20520938|P1|COMPLETED|Overall Study||6
8323874|NCT01406223|20520935|P4|STARTED|Overall Study||19
8323875|NCT01406223|20520936|P3|STARTED|Overall Study||20
8323876|NCT01406223|20520937|P2|STARTED|Overall Study||19
8323877|NCT01406223|20520938|P1|STARTED|Overall Study||18
8323878|NCT01406015|20520954|P2|NOT COMPLETED|Overall Study||3
8323879|NCT01406015|20520955|P1|NOT COMPLETED|Overall Study||3
8323880|NCT01406015|20520954|P2|COMPLETED|Overall Study||16
8323881|NCT01406015|20520955|P1|COMPLETED|Overall Study||16
8323882|NCT01406015|20520954|P2|STARTED|Overall Study||19
8323883|NCT01406015|20520955|P1|STARTED|Overall Study||19
8323884|NCT01405950|20520971|P4|NOT COMPLETED|Overall Study||0
8323885|NCT01405950|20520972|P3|NOT COMPLETED|Overall Study||0
8323886|NCT01405950|20520973|P2|NOT COMPLETED|Overall Study||0
8323887|NCT01405950|20520974|P1|NOT COMPLETED|Overall Study||1
8323888|NCT01405950|20520971|P4|COMPLETED|Overall Study||0
8323889|NCT01405950|20520972|P3|COMPLETED|Overall Study||0
8323890|NCT01405950|20520973|P2|COMPLETED|Overall Study||2
8323891|NCT01405950|20520974|P1|COMPLETED|Overall Study||7
8323892|NCT01405950|20520971|P4|STARTED|Overall Study||0
8323893|NCT01405950|20520972|P3|STARTED|Overall Study||0
8323894|NCT01405950|20520973|P2|STARTED|Overall Study||2
8323895|NCT01405950|20520974|P1|STARTED|Overall Study||8
8323896|NCT01405937|20520988|P2|NOT COMPLETED|Overall Study||0
8323897|NCT01405937|20520989|P1|NOT COMPLETED|Overall Study||0
8323898|NCT01405937|20520988|P2|COMPLETED|Overall Study||26
8323899|NCT01405937|20520989|P1|COMPLETED|Overall Study||25
8323900|NCT01405937|20520988|P2|STARTED|Overall Study||26
8323901|NCT01405937|20520989|P1|STARTED|Overall Study||25
8323902|NCT01405924|20521009|P1|NOT COMPLETED|Overall Study||10
8323903|NCT01405924|20521009|P1|COMPLETED|Overall Study||101
8323904|NCT01405924|20521009|P1|STARTED|Overall Study||111
8323905|NCT01405911|20521022|P3|NOT COMPLETED|Overall Study||1
8323906|NCT01405911|20521023|P2|NOT COMPLETED|Overall Study||3
8323907|NCT01405911|20521024|P1|NOT COMPLETED|Overall Study||4
8323908|NCT01405911|20521022|P3|COMPLETED|Overall Study||76
8323909|NCT01405911|20521023|P2|COMPLETED|Overall Study||79
8323910|NCT01405911|20521024|P1|COMPLETED|Overall Study||79
8323911|NCT01405911|20521022|P3|Treated|Overall Study||77
8323912|NCT01405911|20521023|P2|Treated|Overall Study|1 participant received study drug but was discontinued due to pre-treatment lab AE.|82
8323913|NCT01405911|20521024|P1|Treated|Overall Study||82
8323914|NCT01405911|20521022|P3|STARTED|Overall Study||77
8323915|NCT01405911|20521023|P2|STARTED|Overall Study||82
8323916|NCT01405911|20521024|P1|STARTED|Overall Study||83
8323917|NCT01405898|20521043|P2|NOT COMPLETED|Overall Study||2
8323918|NCT01405898|20521044|P1|NOT COMPLETED|Overall Study||2
8323919|NCT01405898|20521043|P2|COMPLETED|Overall Study||32
8323920|NCT01405898|20521044|P1|COMPLETED|Overall Study||32
8323921|NCT01405898|20521043|P2|STARTED|Overall Study||34
8323922|NCT01405898|20521044|P1|STARTED|Overall Study||34
8323923|NCT01405820|20521068|P6|NOT COMPLETED|Open-Label Treatment Period||2
8323924|NCT01405820|20521069|P5|NOT COMPLETED|Open-Label Treatment Period||2
8323925|NCT01405820|20521070|P4|NOT COMPLETED|Open-Label Treatment Period||5
8323926|NCT01405820|20521071|P3|NOT COMPLETED|Open-Label Treatment Period||3
8323927|NCT01405820|20521072|P2|NOT COMPLETED|Open-Label Treatment Period||2
8323928|NCT01405820|20521073|P1|NOT COMPLETED|Open-Label Treatment Period||4
8323929|NCT01405820|20521068|P6|COMPLETED|Open-Label Treatment Period||30
8323930|NCT01405820|20521069|P5|COMPLETED|Open-Label Treatment Period||40
8323931|NCT01405820|20521070|P4|COMPLETED|Open-Label Treatment Period||37
8323932|NCT01405820|20521071|P3|COMPLETED|Open-Label Treatment Period||39
8323933|NCT01405820|20521072|P2|COMPLETED|Open-Label Treatment Period||33
8323934|NCT01405820|20521073|P1|COMPLETED|Open-Label Treatment Period||40
8323935|NCT01405820|20521068|P6|STARTED|Open-Label Treatment Period||32
8323936|NCT01405820|20521069|P5|STARTED|Open-Label Treatment Period||42
8323937|NCT01405820|20521070|P4|STARTED|Open-Label Treatment Period||42
8323938|NCT01405820|20521071|P3|STARTED|Open-Label Treatment Period||42
8323939|NCT01405820|20521072|P2|STARTED|Open-Label Treatment Period||35
8323940|NCT01405820|20521073|P1|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
8323941|NCT01405820|20521068|P6|NOT COMPLETED|Randomized Treatment Period||37
8323942|NCT01405820|20521069|P5|NOT COMPLETED|Randomized Treatment Period||45
8323943|NCT01405820|20521070|P4|NOT COMPLETED|Randomized Treatment Period||51
8323944|NCT01405820|20521071|P3|NOT COMPLETED|Randomized Treatment Period||43
8323945|NCT01405820|20521072|P2|NOT COMPLETED|Randomized Treatment Period||10
8323946|NCT01405820|20521073|P1|NOT COMPLETED|Randomized Treatment Period||11
8323947|NCT01405820|20521068|P6|COMPLETED|Randomized Treatment Period||1
8323948|NCT01405820|20521069|P5|COMPLETED|Randomized Treatment Period||2
8323949|NCT01405820|20521070|P4|COMPLETED|Randomized Treatment Period||3
8323950|NCT01405820|20521071|P3|COMPLETED|Randomized Treatment Period||9
8323951|NCT01405820|20521072|P2|COMPLETED|Randomized Treatment Period||35
8323952|NCT01405820|20521073|P1|COMPLETED|Randomized Treatment Period||43
8323953|NCT01405820|20521068|P6|Safety Population|Randomized Treatment Period||38
8323954|NCT01405820|20521069|P5|Safety Population|Randomized Treatment Period||47
8323955|NCT01405820|20521070|P4|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
8323956|NCT01405820|20521071|P3|Safety Population|Randomized Treatment Period||52
8323957|NCT01405820|20521072|P2|Safety Population|Randomized Treatment Period||45
8323958|NCT01405820|20521073|P1|Safety Population|Randomized Treatment Period||54
8323959|NCT01405820|20521068|P6|STARTED|Randomized Treatment Period||38
8323960|NCT01405820|20521069|P5|STARTED|Randomized Treatment Period||47
8323961|NCT01405820|20521070|P4|STARTED|Randomized Treatment Period||54
8323962|NCT01405820|20521071|P3|STARTED|Randomized Treatment Period||52
8323963|NCT01405820|20521072|P2|STARTED|Randomized Treatment Period||45
8323964|NCT01405820|20521073|P1|STARTED|Randomized Treatment Period||54
8323965|NCT01405794|20521093|P1|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
8323966|NCT01405794|20521093|P1|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
8323967|NCT01405794|20521093|P1|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
8323968|NCT01405794|20521093|P1|NOT COMPLETED|72 hr Washout||0
8323969|NCT01405794|20521093|P1|COMPLETED|72 hr Washout||12
8323970|NCT01405794|20521093|P1|STARTED|72 hr Washout||12
8323971|NCT01405794|20521093|P1|NOT COMPLETED|First Dose Placebo (14 Days)||0
8323972|NCT01405794|20521093|P1|COMPLETED|First Dose Placebo (14 Days)||12
8323973|NCT01405794|20521093|P1|STARTED|First Dose Placebo (14 Days)||12
8323974|NCT01405768|20521169|P2|NOT COMPLETED|Overall Study||0
8323975|NCT01405768|20521170|P1|NOT COMPLETED|Overall Study||4
8323976|NCT01405768|20521169|P2|COMPLETED|Overall Study||28
8323977|NCT01405768|20521170|P1|COMPLETED|Overall Study||24
8323978|NCT01405768|20521169|P2|STARTED|Overall Study||28
8323979|NCT01405768|20521170|P1|STARTED|Overall Study||28
8323980|NCT01405742|20521182|P2|NOT COMPLETED|Overall Study||0
8323981|NCT01405742|20521183|P1|NOT COMPLETED|Overall Study||1
8323982|NCT01405742|20521182|P2|COMPLETED|Overall Study||2
8323983|NCT01405742|20521183|P1|COMPLETED|Overall Study||1
8323984|NCT01405742|20521182|P2|STARTED|Overall Study||2
8323985|NCT01405742|20521183|P1|STARTED|Overall Study||2
8323986|NCT01405560|20521193|P1|NOT COMPLETED|Overall Study||1
8323987|NCT01405560|20521193|P1|COMPLETED|Overall Study||41
8323988|NCT01405560|20521193|P1|STARTED|Overall Study||42
8323989|NCT01405508|20521208|P4|NOT COMPLETED|Overall Study||0
8323990|NCT01405508|20521209|P3|NOT COMPLETED|Overall Study||0
8323991|NCT01405508|20521210|P2|NOT COMPLETED|Overall Study||1
8323992|NCT01405508|20521211|P1|NOT COMPLETED|Overall Study||1
8323993|NCT01405508|20521208|P4|COMPLETED|Overall Study||26
8323994|NCT01405508|20521209|P3|COMPLETED|Overall Study||27
8323995|NCT01405508|20521210|P2|COMPLETED|Overall Study||25
8323996|NCT01405508|20521211|P1|COMPLETED|Overall Study||25
8323997|NCT01405508|20521208|P4|STARTED|Overall Study||26
8323998|NCT01405508|20521209|P3|STARTED|Overall Study||27
8323999|NCT01405508|20521210|P2|STARTED|Overall Study||26
8324000|NCT01405508|20521211|P1|STARTED|Overall Study||26
8324001|NCT01405469|20521229|P1|NOT COMPLETED|Overall Study||0
8324002|NCT01405469|20521229|P1|COMPLETED|Overall Study||16
8324003|NCT01405469|20521229|P1|STARTED|Overall Study||16
8324004|NCT01405456|20521243|P2|NOT COMPLETED|Overall Study||1
8324005|NCT01405456|20521244|P1|NOT COMPLETED|Overall Study||3
8324006|NCT01405456|20521243|P2|COMPLETED|Overall Study||20
8324007|NCT01405456|20521244|P1|COMPLETED|Overall Study||22
8324008|NCT01405456|20521243|P2|STARTED|Overall Study||21
8324009|NCT01405456|20521244|P1|STARTED|Overall Study||25
8324010|NCT01405313|20521272|P1|NOT COMPLETED|Overall Study||0
8324011|NCT01405313|20521272|P1|COMPLETED|Overall Study||21
8324012|NCT01405313|20521272|P1|STARTED|Overall Study||21
8324013|NCT01405196|20521284|P4|NOT COMPLETED|Overall Study||9
8324014|NCT01405196|20521285|P3|NOT COMPLETED|Overall Study||23
8324015|NCT01405196|20521286|P2|NOT COMPLETED|Overall Study||12
8324016|NCT01405196|20521287|P1|NOT COMPLETED|Overall Study||11
8324017|NCT01405196|20521284|P4|COMPLETED|Overall Study||36
8324018|NCT01405196|20521285|P3|COMPLETED|Overall Study||23
8324019|NCT01405196|20521286|P2|COMPLETED|Overall Study||35
8324020|NCT01405196|20521287|P1|COMPLETED|Overall Study||34
8324021|NCT01405196|20521284|P4|STARTED|Overall Study||45
8324022|NCT01405196|20521285|P3|STARTED|Overall Study||46
8324023|NCT01405196|20521286|P2|STARTED|Overall Study||47
8324024|NCT01405196|20521287|P1|STARTED|Overall Study||45
8324025|NCT01405053|20521374|P2|NOT COMPLETED|Overall Study||8
8324026|NCT01405053|20521375|P1|NOT COMPLETED|Overall Study||10
8324027|NCT01405053|20521374|P2|COMPLETED|Overall Study||4
8324028|NCT01405053|20521375|P1|COMPLETED|Overall Study||15
8324029|NCT01405053|20521374|P2|STARTED|Overall Study||12
8324030|NCT01405053|20521375|P1|STARTED|Overall Study||25
8324031|NCT01405027|20521401|P2|NOT COMPLETED|Overall Study||51
8324032|NCT01405027|20521402|P1|NOT COMPLETED|Overall Study||32
8324033|NCT01405027|20521401|P2|COMPLETED|Overall Study||62
8324034|NCT01405027|20521402|P1|COMPLETED|Overall Study||52
8324035|NCT01405027|20521401|P2|STARTED|Overall Study||113
8324036|NCT01405027|20521402|P1|STARTED|Overall Study||84
8324037|NCT01404988|20521419|P3|NOT COMPLETED|Overall Study||3
8324038|NCT01404988|20521420|P2|NOT COMPLETED|Overall Study||4
8324039|NCT01404988|20521421|P1|NOT COMPLETED|Overall Study||6
8324040|NCT01404988|20521419|P3|COMPLETED|Overall Study||30
8324041|NCT01404988|20521420|P2|COMPLETED|Overall Study||29
8324042|NCT01404988|20521421|P1|COMPLETED|Overall Study||27
8324043|NCT01404988|20521419|P3|STARTED|Overall Study||33
8324044|NCT01404988|20521420|P2|STARTED|Overall Study||33
8324045|NCT01404988|20521421|P1|STARTED|Overall Study||33
8324046|NCT01404936|20521438|P1|NOT COMPLETED|Overall Study||0
8324047|NCT01404936|20521438|P1|COMPLETED|Overall Study||30
8324048|NCT01404936|20521438|P1|STARTED|Overall Study||30
8324049|NCT01404923|20521444|P2|NOT COMPLETED|Overall Study||17
8324050|NCT01404923|20521445|P1|NOT COMPLETED|Overall Study||23
8324051|NCT01404923|20521444|P2|COMPLETED|Overall Study||197
8324052|NCT01404923|20521445|P1|COMPLETED|Overall Study||199
8324053|NCT01404923|20521444|P2|STARTED|Overall Study||214
8324054|NCT01404923|20521445|P1|STARTED|Overall Study||222
8324055|NCT01404832|20521453|P1|NOT COMPLETED|Overall Study||0
8324056|NCT01404832|20521453|P1|COMPLETED|Overall Study||21
8324057|NCT01404832|20521453|P1|STARTED|Overall Study||21
8324058|NCT01404650|20521458|P1|NOT COMPLETED|Overall Study||0
8324059|NCT01404650|20521458|P1|COMPLETED|Overall Study||25
8324060|NCT01404650|20521458|P1|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
8324061|NCT01404611|20521468|P3|NOT COMPLETED|Overall Study||5
8324062|NCT01404611|20521469|P2|NOT COMPLETED|Overall Study||19
8324063|NCT01404611|20521470|P1|NOT COMPLETED|Overall Study||8
8324064|NCT01404611|20521468|P3|COMPLETED|Overall Study||106
8324065|NCT01404611|20521469|P2|COMPLETED|Overall Study||89
8324066|NCT01404611|20521470|P1|COMPLETED|Overall Study||104
8324067|NCT01404611|20521468|P3|STARTED|Overall Study||111
8324068|NCT01404611|20521469|P2|STARTED|Overall Study||108
8324069|NCT01404611|20521470|P1|STARTED|Overall Study||112
8324070|NCT01404572|20521478|P3|NOT COMPLETED|Overall Study||0
8324071|NCT01404572|20521479|P2|NOT COMPLETED|Overall Study||0
8324072|NCT01404572|20521480|P1|NOT COMPLETED|Overall Study||0
8324073|NCT01404572|20521478|P3|COMPLETED|Overall Study||4
8324074|NCT01404572|20521479|P2|COMPLETED|Overall Study||4
8324075|NCT01404572|20521480|P1|COMPLETED|Overall Study||4
8324076|NCT01404572|20521478|P3|STARTED|Overall Study||4
8324077|NCT01404572|20521479|P2|STARTED|Overall Study||4
8324078|NCT01404572|20521480|P1|STARTED|Overall Study||4
8324079|NCT01404559|20521511|P4|NOT COMPLETED|Overall Study||0
8324080|NCT01404559|20521512|P3|NOT COMPLETED|Overall Study||0
8324081|NCT01404559|20521513|P2|NOT COMPLETED|Overall Study||0
8324082|NCT01404559|20521514|P1|NOT COMPLETED|Overall Study||0
8324083|NCT01404559|20521511|P4|COMPLETED|Overall Study||14
8324084|NCT01404559|20521512|P3|COMPLETED|Overall Study||4
8324085|NCT01404559|20521513|P2|COMPLETED|Overall Study||5
8324086|NCT01404559|20521514|P1|COMPLETED|Overall Study||5
8324087|NCT01404559|20521511|P4|STARTED|Overall Study||14
8324088|NCT01404559|20521512|P3|STARTED|Overall Study||4
8324089|NCT01404559|20521513|P2|STARTED|Overall Study||5
8324090|NCT01404559|20521514|P1|STARTED|Overall Study||5
8324091|NCT01404429|20521527|P2|NOT COMPLETED|Overall Study||7
8324092|NCT01404429|20521528|P1|NOT COMPLETED|Overall Study||9
8324093|NCT01404429|20521527|P2|COMPLETED|Overall Study||46
8324094|NCT01404429|20521528|P1|COMPLETED|Overall Study||38
8324095|NCT01404429|20521527|P2|STARTED|Overall Study||53
8324096|NCT01404429|20521528|P1|STARTED|Overall Study||47
8324097|NCT01404325|20521542|P2|NOT COMPLETED|Overall Study||2
8324098|NCT01404325|20521543|P1|NOT COMPLETED|Overall Study||4
8324099|NCT01404325|20521542|P2|COMPLETED|Overall Study||61
8324100|NCT01404325|20521543|P1|COMPLETED|Overall Study||63
8324101|NCT01404325|20521542|P2|STARTED|Overall Study||63
8324102|NCT01404325|20521543|P1|STARTED|Overall Study||67
8324109|NCT01404260|20521625|P2|NOT COMPLETED|Overall Study||9
8324110|NCT01404260|20521626|P1|NOT COMPLETED|Overall Study||3
8324111|NCT01404260|20521625|P2|COMPLETED|Overall Study||101
8324112|NCT01404260|20521626|P1|COMPLETED|Overall Study||106
8324113|NCT01404260|20521625|P2|STARTED|Overall Study||110
8324114|NCT01404260|20521626|P1|STARTED|Overall Study||109
8324115|NCT01404234|20521632|P1|NOT COMPLETED|Overall Study||2
8324116|NCT01404234|20521632|P1|COMPLETED|Overall Study||59
8324117|NCT01404234|20521632|P1|STARTED|Overall Study||61
8324118|NCT01404208|20521648|P2|NOT COMPLETED|Overall Study||0
8324119|NCT01404208|20521649|P1|NOT COMPLETED|Overall Study||3
8324120|NCT01404208|20521648|P2|COMPLETED|Overall Study||72
8324121|NCT01404208|20521649|P1|COMPLETED|Overall Study||67
8324122|NCT01404208|20521648|P2|STARTED|Overall Study||72
8324123|NCT01404208|20521649|P1|STARTED|Overall Study||70
8324124|NCT01404078|20521659|P2|NOT COMPLETED|Overall Study||20
8324125|NCT01404078|20521660|P1|NOT COMPLETED|Overall Study||18
8324126|NCT01404078|20521659|P2|COMPLETED|Overall Study||237
8324127|NCT01404078|20521660|P1|COMPLETED|Overall Study||243
8324128|NCT01404078|20521659|P2|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
8324129|NCT01404078|20521660|P1|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
8324130|NCT01404039|20521675|P13|NOT COMPLETED|Overall Study||0
8324131|NCT01404039|20521676|P12|NOT COMPLETED|Overall Study||0
8324132|NCT01404039|20521677|P11|NOT COMPLETED|Overall Study||1
8324133|NCT01404039|20521678|P10|NOT COMPLETED|Overall Study||1
8324134|NCT01404039|20521679|P9|NOT COMPLETED|Overall Study||0
8324135|NCT01404039|20521680|P8|NOT COMPLETED|Overall Study||0
8324136|NCT01404039|20521681|P7|NOT COMPLETED|Overall Study||0
8324137|NCT01404039|20521682|P6|NOT COMPLETED|Overall Study||0
8324138|NCT01404039|20521683|P5|NOT COMPLETED|Overall Study||0
8324139|NCT01404039|20521684|P4|NOT COMPLETED|Overall Study||0
8324140|NCT01404039|20521685|P3|NOT COMPLETED|Overall Study||0
8324141|NCT01404039|20521686|P2|NOT COMPLETED|Overall Study||0
8324142|NCT01404039|20521687|P1|NOT COMPLETED|Overall Study||1
8324143|NCT01404039|20521675|P13|COMPLETED|Overall Study||0
8324144|NCT01404039|20521676|P12|COMPLETED|Overall Study||0
8324145|NCT01404039|20521677|P11|COMPLETED|Overall Study||14
8324146|NCT01404039|20521678|P10|COMPLETED|Overall Study||14
8324147|NCT01404039|20521679|P9|COMPLETED|Overall Study||15
8324148|NCT01404039|20521680|P8|COMPLETED|Overall Study||15
8324149|NCT01404039|20521681|P7|COMPLETED|Overall Study||10
8324150|NCT01404039|20521682|P6|COMPLETED|Overall Study||10
8324151|NCT01404039|20521683|P5|COMPLETED|Overall Study||10
8324152|NCT01404039|20521684|P4|COMPLETED|Overall Study||10
8324153|NCT01404039|20521685|P3|COMPLETED|Overall Study||5
8324154|NCT01404039|20521686|P2|COMPLETED|Overall Study||5
8324155|NCT01404039|20521687|P1|COMPLETED|Overall Study||4
8324156|NCT01404039|20521675|P13|STARTED|Overall Study||0
8324157|NCT01404039|20521676|P12|STARTED|Overall Study||0
8324158|NCT01404039|20521677|P11|STARTED|Overall Study||15
8324159|NCT01404039|20521678|P10|STARTED|Overall Study||15
8324160|NCT01404039|20521679|P9|STARTED|Overall Study||15
8324161|NCT01404039|20521680|P8|STARTED|Overall Study||15
8324162|NCT01404039|20521681|P7|STARTED|Overall Study||10
8324163|NCT01404039|20521682|P6|STARTED|Overall Study||10
8324164|NCT01404039|20521683|P5|STARTED|Overall Study||10
8324165|NCT01404039|20521684|P4|STARTED|Overall Study||10
8324166|NCT01404039|20521685|P3|STARTED|Overall Study||5
8324167|NCT01404039|20521686|P2|STARTED|Overall Study||5
8324168|NCT01404039|20521687|P1|STARTED|Overall Study||5
8324169|NCT01403987|20521714|P3|NOT COMPLETED|Overall Study||18
8324170|NCT01403987|20521715|P2|NOT COMPLETED|Overall Study||17
8324171|NCT01403987|20521716|P1|NOT COMPLETED|Overall Study||18
8324172|NCT01403987|20521714|P3|COMPLETED|Overall Study||50
8324173|NCT01403987|20521715|P2|COMPLETED|Overall Study||17
8324174|NCT01403987|20521716|P1|COMPLETED|Overall Study||16
8324175|NCT01403987|20521714|P3|STARTED|Overall Study||68
8324176|NCT01403987|20521715|P2|STARTED|Overall Study||34
8324177|NCT01403987|20521716|P1|STARTED|Overall Study||34
8324178|NCT01403948|20521740|P10|NOT COMPLETED|Overall Study||7
8324179|NCT01403948|20521741|P9|NOT COMPLETED|Overall Study||6
8324180|NCT01403948|20521742|P8|NOT COMPLETED|Overall Study||4
8324181|NCT01403948|20521743|P7|NOT COMPLETED|Overall Study||6
8324182|NCT01403948|20521744|P6|NOT COMPLETED|Overall Study||7
8324183|NCT01403948|20521745|P5|NOT COMPLETED|Overall Study||6
8324184|NCT01403948|20521746|P4|NOT COMPLETED|Overall Study||4
8324185|NCT01403948|20521747|P3|NOT COMPLETED|Overall Study||3
8324186|NCT01403948|20521748|P2|NOT COMPLETED|Overall Study||4
8324187|NCT01403948|20521749|P1|NOT COMPLETED|Overall Study||1
8324188|NCT01403948|20521740|P10|COMPLETED|Overall Study||0
8324189|NCT01403948|20521741|P9|COMPLETED|Overall Study||0
8324190|NCT01403948|20521742|P8|COMPLETED|Overall Study||0
8324191|NCT01403948|20521743|P7|COMPLETED|Overall Study||0
8324192|NCT01403948|20521744|P6|COMPLETED|Overall Study||0
8324193|NCT01403948|20521745|P5|COMPLETED|Overall Study||0
8324194|NCT01403948|20521746|P4|COMPLETED|Overall Study||0
8324195|NCT01403948|20521747|P3|COMPLETED|Overall Study||0
8324196|NCT01403948|20521748|P2|COMPLETED|Overall Study||0
8324197|NCT01403948|20521749|P1|COMPLETED|Overall Study||0
8324198|NCT01403948|20521740|P10|STARTED|Overall Study||7
8324199|NCT01403948|20521741|P9|STARTED|Overall Study||6
8324200|NCT01403948|20521742|P8|STARTED|Overall Study||4
8324201|NCT01403948|20521743|P7|STARTED|Overall Study||6
8324202|NCT01403948|20521744|P6|STARTED|Overall Study||7
8324203|NCT01403948|20521745|P5|STARTED|Overall Study||6
8324204|NCT01403948|20521746|P4|STARTED|Overall Study||4
8324205|NCT01403948|20521747|P3|STARTED|Overall Study||3
8324206|NCT01403948|20521748|P2|STARTED|Overall Study||4
8324207|NCT01403948|20521749|P1|STARTED|Overall Study||1
8324208|NCT01403805|20521822|P2|NOT COMPLETED|Overall Study||7
8324209|NCT01403805|20521823|P1|NOT COMPLETED|Overall Study||0
8324210|NCT01403805|20521822|P2|COMPLETED|Overall Study||98
8324211|NCT01403805|20521823|P1|COMPLETED|Overall Study||94
8324212|NCT01403805|20521822|P2|Pneumonia Diagnosis|Overall Study||2
8324213|NCT01403805|20521823|P1|Pneumonia Diagnosis|Overall Study||21
8324214|NCT01403805|20521822|P2|STARTED|Overall Study||105
8324215|NCT01403805|20521823|P1|STARTED|Overall Study||94
8324216|NCT01403610|20521839|P4|NOT COMPLETED|Overall Study||0
8324217|NCT01403610|20521840|P3|NOT COMPLETED|Overall Study||0
8324218|NCT01403610|20521841|P2|NOT COMPLETED|Overall Study||3
8324219|NCT01403610|20521842|P1|NOT COMPLETED|Overall Study||2
8324220|NCT01403610|20521839|P4|COMPLETED|Overall Study||13
8324221|NCT01403610|20521840|P3|COMPLETED|Overall Study||4
8324222|NCT01403610|20521841|P2|COMPLETED|Overall Study||3
8324223|NCT01403610|20521842|P1|COMPLETED|Overall Study||3
8324224|NCT01403610|20521839|P4|STARTED|Overall Study||13
8324225|NCT01403610|20521840|P3|STARTED|Overall Study||4
8324226|NCT01403610|20521841|P2|STARTED|Overall Study||6
8324227|NCT01403610|20521842|P1|STARTED|Overall Study||5
8324228|NCT01403441|20521852|P1|NOT COMPLETED|Overall Study||0
8324229|NCT01403441|20521852|P1|COMPLETED|Overall Study||3
8324230|NCT01403441|20521852|P1|STARTED|Overall Study||3
8324231|NCT01403376|20521862|P3|NOT COMPLETED|Overall Study||0
8324232|NCT01403376|20521863|P2|NOT COMPLETED|Overall Study||0
8324233|NCT01403376|20521864|P1|NOT COMPLETED|Overall Study||0
8324234|NCT01403376|20521862|P3|COMPLETED|Overall Study||46
8324235|NCT01403376|20521863|P2|COMPLETED|Overall Study||41
8324236|NCT01403376|20521864|P1|COMPLETED|Overall Study||41
8324237|NCT01403376|20521862|P3|STARTED|Overall Study||46
8324238|NCT01403376|20521863|P2|STARTED|Overall Study||41
8324239|NCT01403376|20521864|P1|STARTED|Overall Study||41
8324240|NCT01403246|20521884|P1|NOT COMPLETED|Overall Study||0
8324241|NCT01403246|20521884|P1|COMPLETED|Overall Study||9
8324242|NCT01403246|20521884|P1|STARTED|Overall Study||9
8324243|NCT01403194|20521888|P1|NOT COMPLETED|Overall Study||10
8324244|NCT01403194|20521888|P1|COMPLETED|Overall Study||1
8324245|NCT01403194|20521888|P1|STARTED|Overall Study||11
8324246|NCT01403116|20521896|P2|NOT COMPLETED|Overall Study||27
8324247|NCT01403116|20521897|P1|NOT COMPLETED|Overall Study||32
8324248|NCT01403116|20521896|P2|COMPLETED|Overall Study||133
8324249|NCT01403116|20521897|P1|COMPLETED|Overall Study||129
8324250|NCT01403116|20521896|P2|Randomized in Error/ No Treatment Recvd|Overall Study||3
8324251|NCT01403116|20521897|P1|Randomized in Error/ No Treatment Recvd|Overall Study||1
8324252|NCT01403116|20521896|P2|Randomized|Overall Study||163
8324253|NCT01403116|20521897|P1|Randomized|Overall Study||162
8324254|NCT01403116|20521896|P2|STARTED|Overall Study||160
8324255|NCT01403116|20521897|P1|STARTED|Overall Study||161
8324256|NCT01403090|20521904|P1|NOT COMPLETED|Overall Study||0
8324257|NCT01403090|20521904|P1|COMPLETED|Overall Study||8
8324258|NCT01403090|20521904|P1|STARTED|Overall Study||8
8324259|NCT01403051|20521910|P2|NOT COMPLETED|Overall Study||6
8324260|NCT01403051|20521911|P1|NOT COMPLETED|Overall Study||10
8324261|NCT01403051|20521910|P2|COMPLETED|Overall Study||80
8324262|NCT01403051|20521911|P1|COMPLETED|Overall Study||71
8324263|NCT01403051|20521910|P2|Initiated Study Treatment|Overall Study||86
8324264|NCT01403051|20521911|P1|Initiated Study Treatment|Overall Study||81
8324265|NCT01403051|20521910|P2|STARTED|Overall Study||86
8324266|NCT01403051|20521911|P1|STARTED|Overall Study||81
8324267|NCT01402986|20521947|P4|NOT COMPLETED|Overall Study||22
8324268|NCT01402986|20521948|P3|NOT COMPLETED|Overall Study||8
8324269|NCT01402986|20521949|P2|NOT COMPLETED|Overall Study||15
8324270|NCT01402986|20521950|P1|NOT COMPLETED|Overall Study||9
8324271|NCT01402986|20521947|P4|COMPLETED|Overall Study||129
8324272|NCT01402986|20521948|P3|COMPLETED|Overall Study||67
8324273|NCT01402986|20521949|P2|COMPLETED|Overall Study||135
8324274|NCT01402986|20521950|P1|COMPLETED|Overall Study||67
8324275|NCT01402986|20521947|P4|STARTED|Overall Study||151
8324276|NCT01402986|20521948|P3|STARTED|Overall Study||75
8324277|NCT01402986|20521949|P2|STARTED|Overall Study||150
8324278|NCT01402986|20521950|P1|STARTED|Overall Study||76
8324291|NCT01402908|20522096|P2|NOT COMPLETED|Overall Study||18
8324292|NCT01402908|20522097|P1|NOT COMPLETED|Overall Study||34
8324293|NCT01402908|20522096|P2|COMPLETED|Overall Study||243
8324294|NCT01402908|20522097|P1|COMPLETED|Overall Study||224
8324295|NCT01402908|20522096|P2|STARTED|Overall Study||261
8324296|NCT01402908|20522097|P1|STARTED|Overall Study||258
8324297|NCT01402869|20522112|P3|NOT COMPLETED|Overall Study||1
8324298|NCT01402869|20522113|P2|NOT COMPLETED|Overall Study||0
8324299|NCT01402869|20522114|P1|NOT COMPLETED|Overall Study||0
8324300|NCT01402869|20522112|P3|COMPLETED|Overall Study||30
8324301|NCT01402869|20522113|P2|COMPLETED|Overall Study||30
8324302|NCT01402869|20522114|P1|COMPLETED|Overall Study||30
8324303|NCT01402869|20522112|P3|STARTED|Overall Study||31
8324304|NCT01402869|20522113|P2|STARTED|Overall Study||30
8324305|NCT01402869|20522114|P1|STARTED|Overall Study||30
8324306|NCT01402817|20522128|P1|NOT COMPLETED|Overall Study||11
8324307|NCT01402817|20522128|P1|COMPLETED|Overall Study||8
8324308|NCT01402817|20522128|P1|STARTED|Overall Study||19
8324309|NCT01402700|20522133|P1|NOT COMPLETED|Overall Study||7
8324310|NCT01402700|20522133|P1|COMPLETED|Overall Study||68
8324311|NCT01402700|20522133|P1|STARTED|Overall Study||75
8324312|NCT01402570|20522137|P1|NOT COMPLETED|Overall Study||1
8324313|NCT01402570|20522137|P1|COMPLETED|Overall Study||19
8324314|NCT01402570|20522137|P1|STARTED|Overall Study||20
8324315|NCT01402544|20522144|P1|NOT COMPLETED|Overall Study||6
8324316|NCT01402544|20522144|P1|COMPLETED|Overall Study||6
8324317|NCT01402544|20522144|P1|STARTED|Overall Study||12
8324318|NCT01402531|20522150|P1|NOT COMPLETED|Overall Study||0
8324319|NCT01402531|20522150|P1|COMPLETED|Overall Study||0
8324320|NCT01402531|20522150|P1|STARTED|Overall Study||0
8324321|NCT01402427|20522156|P2|NOT COMPLETED|Overall Study||0
8324322|NCT01402427|20522157|P1|NOT COMPLETED|Overall Study||0
8324323|NCT01402427|20522156|P2|COMPLETED|Overall Study||294
8324324|NCT01402427|20522157|P1|COMPLETED|Overall Study||297
8324325|NCT01402427|20522156|P2|STARTED|Overall Study||294
8324326|NCT01402427|20522157|P1|STARTED|Overall Study||297
8324327|NCT01402375|20522181|P6|NOT COMPLETED|Overall Study||0
8324328|NCT01402375|20522182|P5|NOT COMPLETED|Overall Study||0
8324329|NCT01402375|20522183|P4|NOT COMPLETED|Overall Study||0
8324330|NCT01402375|20522184|P3|NOT COMPLETED|Overall Study||0
8324331|NCT01402375|20522185|P2|NOT COMPLETED|Overall Study||0
8324332|NCT01402375|20522186|P1|NOT COMPLETED|Overall Study||0
8324333|NCT01402375|20522181|P6|COMPLETED|Overall Study||120
8324334|NCT01402375|20522182|P5|COMPLETED|Overall Study||120
8324335|NCT01402375|20522183|P4|COMPLETED|Overall Study||120
8324336|NCT01402375|20522184|P3|COMPLETED|Overall Study||120
8324337|NCT01402375|20522185|P2|COMPLETED|Overall Study||120
8324338|NCT01402375|20522186|P1|COMPLETED|Overall Study||120
8324339|NCT01402375|20522181|P6|STARTED|Overall Study||120
8324340|NCT01402375|20522182|P5|STARTED|Overall Study||120
8324341|NCT01402375|20522183|P4|STARTED|Overall Study||120
8324342|NCT01402375|20522184|P3|STARTED|Overall Study||120
8324343|NCT01402375|20522185|P2|STARTED|Overall Study||120
8324344|NCT01402375|20522186|P1|STARTED|Overall Study||120
8324348|NCT01402141|20522231|P2|NOT COMPLETED|Overall Study||2
8324349|NCT01402141|20522232|P1|NOT COMPLETED|Overall Study||1
8324350|NCT01402141|20522231|P2|COMPLETED|Overall Study||28
8324351|NCT01402141|20522232|P1|COMPLETED|Overall Study||29
8324352|NCT01402141|20522231|P2|STARTED|Overall Study||30
8324353|NCT01402141|20522232|P1|STARTED|Overall Study||30
8324354|NCT01402128|20522254|P2|NOT COMPLETED|Overall Study||0
8324355|NCT01402128|20522255|P1|NOT COMPLETED|Overall Study||1
8324356|NCT01402128|20522254|P2|COMPLETED|Overall Study||40
8324357|NCT01402128|20522255|P1|COMPLETED|Overall Study||39
8324358|NCT01402128|20522254|P2|STARTED|Overall Study||40
8324359|NCT01402128|20522255|P1|STARTED|Overall Study||40
8324360|NCT01402115|20522283|P2|NOT COMPLETED|Overall Study||1
8324361|NCT01402115|20522284|P1|NOT COMPLETED|Overall Study||1
8324362|NCT01402115|20522283|P2|COMPLETED|Overall Study||29
8324363|NCT01402115|20522284|P1|COMPLETED|Overall Study||29
8324364|NCT01402115|20522283|P2|STARTED|Overall Study||30
8324365|NCT01402115|20522284|P1|STARTED|Overall Study||30
8324366|NCT01402102|20522300|P2|NOT COMPLETED|Overall Study||3
8324367|NCT01402102|20522301|P1|NOT COMPLETED|Overall Study||2
8324368|NCT01402102|20522300|P2|COMPLETED|Overall Study||27
8324369|NCT01402102|20522301|P1|COMPLETED|Overall Study||28
8324370|NCT01402102|20522300|P2|STARTED|Overall Study||30
8324371|NCT01402102|20522301|P1|STARTED|Overall Study||30
8324372|NCT01402063|20522321|P2|NOT COMPLETED|Overall Study||3
8324373|NCT01402063|20522322|P1|NOT COMPLETED|Overall Study||3
8324374|NCT01402063|20522321|P2|COMPLETED|Overall Study||18
8324375|NCT01402063|20522322|P1|COMPLETED|Overall Study||39
8324376|NCT01402063|20522321|P2|STARTED|Overall Study||21
8324377|NCT01402063|20522322|P1|STARTED|Overall Study||42
8324378|NCT01402050|20522330|P2|NOT COMPLETED|Overall Study||0
8324379|NCT01402050|20522331|P1|NOT COMPLETED|Overall Study||0
8324380|NCT01402050|20522330|P2|COMPLETED|Overall Study||191
8324381|NCT01402050|20522331|P1|COMPLETED|Overall Study||185
8324382|NCT01402050|20522330|P2|STARTED|Overall Study||191
8324383|NCT01402050|20522331|P1|STARTED|Overall Study||185
8324384|NCT01402011|20522340|P3|NOT COMPLETED|Nine Month Follow-up||0
8324385|NCT01402011|20522341|P2|NOT COMPLETED|Nine Month Follow-up||1
8324386|NCT01402011|20522342|P1|NOT COMPLETED|Nine Month Follow-up||0
8324387|NCT01402011|20522340|P3|COMPLETED|Nine Month Follow-up||26
8324388|NCT01402011|20522341|P2|COMPLETED|Nine Month Follow-up||19
8324389|NCT01402011|20522342|P1|COMPLETED|Nine Month Follow-up||27
8324390|NCT01402011|20522340|P3|STARTED|Nine Month Follow-up||26
8324391|NCT01402011|20522341|P2|STARTED|Nine Month Follow-up||20
8324392|NCT01402011|20522342|P1|STARTED|Nine Month Follow-up||27
8324393|NCT01402011|20522340|P3|NOT COMPLETED|Active Treatment Period||0
8324394|NCT01402011|20522341|P2|NOT COMPLETED|Active Treatment Period||3
8324395|NCT01402011|20522342|P1|NOT COMPLETED|Active Treatment Period||1
8324396|NCT01402011|20522340|P3|COMPLETED|Active Treatment Period||26
8324397|NCT01402011|20522341|P2|COMPLETED|Active Treatment Period||20
8324398|NCT01402011|20522342|P1|COMPLETED|Active Treatment Period||27
8324399|NCT01402011|20522340|P3|STARTED|Active Treatment Period||26
8324400|NCT01402011|20522341|P2|STARTED|Active Treatment Period||23
8324401|NCT01402011|20522342|P1|STARTED|Active Treatment Period||28
8324402|NCT01402011|20522340|P3|NOT COMPLETED|Delayed Treatment Period||0
8324403|NCT01402011|20522341|P2|NOT COMPLETED|Delayed Treatment Period||0
8324404|NCT01402011|20522342|P1|NOT COMPLETED|Delayed Treatment Period||1
8324405|NCT01402011|20522340|P3|COMPLETED|Delayed Treatment Period||26
8324406|NCT01402011|20522341|P2|COMPLETED|Delayed Treatment Period||23
8324407|NCT01402011|20522342|P1|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
8324408|NCT01402011|20522340|P3|STARTED|Delayed Treatment Period||26
8324409|NCT01402011|20522341|P2|STARTED|Delayed Treatment Period||23
8324410|NCT01402011|20522342|P1|STARTED|Delayed Treatment Period||29
8324411|NCT01401959|20522371|P3|NOT COMPLETED|Treated||5
8324412|NCT01401959|20522372|P2|NOT COMPLETED|Treated||8
8324413|NCT01401959|20522373|P1|NOT COMPLETED|Treated||7
8324414|NCT01401959|20522371|P3|COMPLETED|Treated||26
8324415|NCT01401959|20522372|P2|COMPLETED|Treated||34
8324416|NCT01401959|20522373|P1|COMPLETED|Treated||46
8324417|NCT01401959|20522371|P3|STARTED|Treated||31
8324418|NCT01401959|20522372|P2|STARTED|Treated||42
8324419|NCT01401959|20522373|P1|STARTED|Treated||53
8324420|NCT01401959|20522371|P3|NOT COMPLETED|Enrolled||0
8324421|NCT01401959|20522372|P2|NOT COMPLETED|Enrolled||0
8324422|NCT01401959|20522373|P1|NOT COMPLETED|Enrolled||1
8324423|NCT01401959|20522371|P3|COMPLETED|Enrolled||31
8324424|NCT01401959|20522372|P2|COMPLETED|Enrolled||42
8324425|NCT01401959|20522373|P1|COMPLETED|Enrolled||53
8324426|NCT01401959|20522371|P3|STARTED|Enrolled||31
8324427|NCT01401959|20522372|P2|STARTED|Enrolled||42
8324428|NCT01401959|20522373|P1|STARTED|Enrolled||54
8324429|NCT01401907|20522389|P2|NOT COMPLETED|Overall Study||51
8324430|NCT01401907|20522390|P1|NOT COMPLETED|Overall Study||57
8324431|NCT01401907|20522389|P2|COMPLETED|Overall Study||124
8324432|NCT01401907|20522390|P1|COMPLETED|Overall Study||118
8324433|NCT01401907|20522389|P2|12 Week Outcomes|Overall Study||153
8324434|NCT01401907|20522390|P1|12 Week Outcomes|Overall Study||148
8324435|NCT01401907|20522389|P2|STARTED|Overall Study||175
8324436|NCT01401907|20522390|P1|STARTED|Overall Study||175
8324437|NCT01401842|20522412|P2|NOT COMPLETED|Overall Study||67
8324438|NCT01401842|20522413|P1|NOT COMPLETED|Overall Study||68
8324439|NCT01401842|20522412|P2|COMPLETED|Overall Study||217
8324440|NCT01401842|20522413|P1|COMPLETED|Overall Study||230
8324441|NCT01401842|20522412|P2|STARTED|Overall Study||284
8324442|NCT01401842|20522413|P1|STARTED|Overall Study||298
8324443|NCT01401699|20522423|P1|NOT COMPLETED|Overall Study||0
8324444|NCT01401699|20522423|P1|COMPLETED|Overall Study||109
8324445|NCT01401699|20522423|P1|STARTED|Overall Study||109
8324446|NCT01401647|20522430|P3|NOT COMPLETED|Overall Study||3
8324447|NCT01401647|20522431|P2|NOT COMPLETED|Overall Study||8
8324448|NCT01401647|20522432|P1|NOT COMPLETED|Overall Study||4
8324449|NCT01401647|20522430|P3|COMPLETED|Overall Study||1056
8324450|NCT01401647|20522431|P2|COMPLETED|Overall Study||985
8324451|NCT01401647|20522432|P1|COMPLETED|Overall Study||968
8324452|NCT01401647|20522430|P3|STARTED|Overall Study||1059
8324453|NCT01401647|20522431|P2|STARTED|Overall Study||993
8324454|NCT01401647|20522432|P1|STARTED|Overall Study||972
8324455|NCT01401595|20522445|P2|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
8324456|NCT01401595|20522446|P1|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
8324457|NCT01401595|20522445|P2|COMPLETED|Imaging and Treatment (for NE Arm)||10
8324458|NCT01401595|20522446|P1|COMPLETED|Imaging and Treatment (for NE Arm)||18
8324459|NCT01401595|20522445|P2|STARTED|Imaging and Treatment (for NE Arm)||10
8324460|NCT01401595|20522446|P1|STARTED|Imaging and Treatment (for NE Arm)||32
8324461|NCT01401595|20522445|P2|NOT COMPLETED|Recruitment and Screening||2
8324462|NCT01401595|20522446|P1|NOT COMPLETED|Recruitment and Screening||43
8324463|NCT01401595|20522445|P2|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
8324464|NCT01401595|20522446|P1|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
8324465|NCT01401595|20522445|P2|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
8324466|NCT01401595|20522446|P1|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
8324475|NCT01401543|20522474|P4|NOT COMPLETED|Fourth Intervention||0
8324476|NCT01401543|20522475|P3|NOT COMPLETED|Fourth Intervention||0
8324477|NCT01401543|20522476|P2|NOT COMPLETED|Fourth Intervention||0
8324478|NCT01401543|20522477|P1|NOT COMPLETED|Fourth Intervention||0
8324479|NCT01401543|20522474|P4|COMPLETED|Fourth Intervention||6
8324480|NCT01401543|20522475|P3|COMPLETED|Fourth Intervention||6
8324481|NCT01401543|20522476|P2|COMPLETED|Fourth Intervention||6
8324482|NCT01401543|20522477|P1|COMPLETED|Fourth Intervention||6
8324483|NCT01401543|20522474|P4|STARTED|Fourth Intervention||6
8324484|NCT01401543|20522475|P3|STARTED|Fourth Intervention||6
8324485|NCT01401543|20522476|P2|STARTED|Fourth Intervention||6
8324486|NCT01401543|20522477|P1|STARTED|Fourth Intervention||6
8324487|NCT01401543|20522474|P4|NOT COMPLETED|Third Washout Period of 1 Week||0
8324488|NCT01401543|20522475|P3|NOT COMPLETED|Third Washout Period of 1 Week||0
8324489|NCT01401543|20522476|P2|NOT COMPLETED|Third Washout Period of 1 Week||0
8324490|NCT01401543|20522477|P1|NOT COMPLETED|Third Washout Period of 1 Week||0
8324491|NCT01401543|20522474|P4|COMPLETED|Third Washout Period of 1 Week||6
8324492|NCT01401543|20522475|P3|COMPLETED|Third Washout Period of 1 Week||6
8324493|NCT01401543|20522476|P2|COMPLETED|Third Washout Period of 1 Week||6
8324494|NCT01401543|20522477|P1|COMPLETED|Third Washout Period of 1 Week||6
8324495|NCT01401543|20522474|P4|STARTED|Third Washout Period of 1 Week||6
8324496|NCT01401543|20522475|P3|STARTED|Third Washout Period of 1 Week||6
8324497|NCT01401543|20522476|P2|STARTED|Third Washout Period of 1 Week||6
8324498|NCT01401543|20522477|P1|STARTED|Third Washout Period of 1 Week||6
8324499|NCT01401543|20522474|P4|NOT COMPLETED|Third Intervention||0
8324500|NCT01401543|20522475|P3|NOT COMPLETED|Third Intervention||0
8324501|NCT01401543|20522476|P2|NOT COMPLETED|Third Intervention||0
8324502|NCT01401543|20522477|P1|NOT COMPLETED|Third Intervention||0
8324503|NCT01401543|20522474|P4|COMPLETED|Third Intervention||6
8324504|NCT01401543|20522475|P3|COMPLETED|Third Intervention||6
8324505|NCT01401543|20522476|P2|COMPLETED|Third Intervention||6
8324506|NCT01401543|20522477|P1|COMPLETED|Third Intervention||6
8324507|NCT01401543|20522474|P4|STARTED|Third Intervention||6
8324508|NCT01401543|20522475|P3|STARTED|Third Intervention||6
8324509|NCT01401543|20522476|P2|STARTED|Third Intervention||6
8324510|NCT01401543|20522477|P1|STARTED|Third Intervention||6
8324511|NCT01401543|20522474|P4|NOT COMPLETED|Second Washout Period of 1 Week||0
8324512|NCT01401543|20522475|P3|NOT COMPLETED|Second Washout Period of 1 Week||0
8324513|NCT01401543|20522476|P2|NOT COMPLETED|Second Washout Period of 1 Week||0
8324514|NCT01401543|20522477|P1|NOT COMPLETED|Second Washout Period of 1 Week||0
8324515|NCT01401543|20522474|P4|COMPLETED|Second Washout Period of 1 Week||6
8324516|NCT01401543|20522475|P3|COMPLETED|Second Washout Period of 1 Week||6
8324517|NCT01401543|20522476|P2|COMPLETED|Second Washout Period of 1 Week||6
8324518|NCT01401543|20522477|P1|COMPLETED|Second Washout Period of 1 Week||6
8324519|NCT01401543|20522474|P4|STARTED|Second Washout Period of 1 Week||6
8324520|NCT01401543|20522475|P3|STARTED|Second Washout Period of 1 Week||6
8324521|NCT01401543|20522476|P2|STARTED|Second Washout Period of 1 Week||6
8324522|NCT01401543|20522477|P1|STARTED|Second Washout Period of 1 Week||6
8324523|NCT01401543|20522474|P4|NOT COMPLETED|Second Intervention||0
8324524|NCT01401543|20522475|P3|NOT COMPLETED|Second Intervention||0
8324525|NCT01401543|20522476|P2|NOT COMPLETED|Second Intervention||0
8324526|NCT01401543|20522477|P1|NOT COMPLETED|Second Intervention||0
8324527|NCT01401543|20522474|P4|COMPLETED|Second Intervention||6
8324528|NCT01401543|20522475|P3|COMPLETED|Second Intervention||6
8324529|NCT01401543|20522476|P2|COMPLETED|Second Intervention||6
8324530|NCT01401543|20522477|P1|COMPLETED|Second Intervention||6
8324531|NCT01401543|20522474|P4|STARTED|Second Intervention||6
8324532|NCT01401543|20522475|P3|STARTED|Second Intervention||6
8324533|NCT01401543|20522476|P2|STARTED|Second Intervention||6
8324534|NCT01401543|20522477|P1|STARTED|Second Intervention||6
8324535|NCT01401543|20522474|P4|NOT COMPLETED|First Washout Period of 1 Week||0
8324536|NCT01401543|20522475|P3|NOT COMPLETED|First Washout Period of 1 Week||0
8324537|NCT01401543|20522476|P2|NOT COMPLETED|First Washout Period of 1 Week||0
8324538|NCT01401543|20522477|P1|NOT COMPLETED|First Washout Period of 1 Week||0
8324539|NCT01401543|20522474|P4|COMPLETED|First Washout Period of 1 Week||6
8324540|NCT01401543|20522475|P3|COMPLETED|First Washout Period of 1 Week||6
8324541|NCT01401543|20522476|P2|COMPLETED|First Washout Period of 1 Week||6
8324542|NCT01401543|20522477|P1|COMPLETED|First Washout Period of 1 Week||6
8324543|NCT01401543|20522474|P4|STARTED|First Washout Period of 1 Week||6
8324544|NCT01401543|20522475|P3|STARTED|First Washout Period of 1 Week||6
8324545|NCT01401543|20522476|P2|STARTED|First Washout Period of 1 Week||6
8324546|NCT01401543|20522477|P1|STARTED|First Washout Period of 1 Week||6
8324547|NCT01401543|20522474|P4|NOT COMPLETED|First Intervention||0
8324548|NCT01401543|20522475|P3|NOT COMPLETED|First Intervention||0
8324549|NCT01401543|20522476|P2|NOT COMPLETED|First Intervention||0
8324550|NCT01401543|20522477|P1|NOT COMPLETED|First Intervention||0
8324551|NCT01401543|20522474|P4|COMPLETED|First Intervention||6
8324552|NCT01401543|20522475|P3|COMPLETED|First Intervention||6
8324553|NCT01401543|20522476|P2|COMPLETED|First Intervention||6
8324554|NCT01401543|20522477|P1|COMPLETED|First Intervention||6
8324555|NCT01401543|20522474|P4|STARTED|First Intervention||6
8324556|NCT01401543|20522475|P3|STARTED|First Intervention||6
8324557|NCT01401543|20522476|P2|STARTED|First Intervention||6
8324558|NCT01401543|20522477|P1|STARTED|First Intervention||6
8324559|NCT01401530|20522502|P3|NOT COMPLETED|Overall Study||3
8324560|NCT01401530|20522503|P2|NOT COMPLETED|Overall Study||6
8324561|NCT01401530|20522504|P1|NOT COMPLETED|Overall Study||3
8324562|NCT01401530|20522502|P3|COMPLETED|Overall Study||0
8324563|NCT01401530|20522503|P2|COMPLETED|Overall Study||1
8324564|NCT01401530|20522504|P1|COMPLETED|Overall Study||0
8324565|NCT01401530|20522502|P3|STARTED|Overall Study||3
8324566|NCT01401530|20522503|P2|STARTED|Overall Study||7
8324567|NCT01401530|20522504|P1|STARTED|Overall Study||3
8324568|NCT01401517|20522544|P3|NOT COMPLETED|Overall Study||3
8324569|NCT01401517|20522545|P2|NOT COMPLETED|Overall Study||2
8324570|NCT01401517|20522546|P1|NOT COMPLETED|Overall Study||3
8324571|NCT01401517|20522544|P3|COMPLETED|Overall Study||15
8324572|NCT01401517|20522545|P2|COMPLETED|Overall Study||17
8324573|NCT01401517|20522546|P1|COMPLETED|Overall Study||15
8324574|NCT01401517|20522544|P3|STARTED|Overall Study||18
8324575|NCT01401517|20522545|P2|STARTED|Overall Study||19
8324576|NCT01401517|20522546|P1|STARTED|Overall Study||18
8324577|NCT01401478|20522563|P1|NOT COMPLETED|Overall Study||31
8324578|NCT01401478|20522563|P1|COMPLETED|Overall Study||55
8324579|NCT01401478|20522563|P1|STARTED|Overall Study||86
8324580|NCT01401465|20522576|P2|NOT COMPLETED|Treatment Period 2||2
8324581|NCT01401465|20522577|P1|NOT COMPLETED|Treatment Period 2||0
8324582|NCT01401465|20522576|P2|COMPLETED|Treatment Period 2||144
8324583|NCT01401465|20522577|P1|COMPLETED|Treatment Period 2||150
8324584|NCT01401465|20522576|P2|STARTED|Treatment Period 2||146
8324585|NCT01401465|20522577|P1|STARTED|Treatment Period 2||150
8324586|NCT01401465|20522576|P2|NOT COMPLETED|Washout||0
8324587|NCT01401465|20522577|P1|NOT COMPLETED|Washout||0
8324588|NCT01401465|20522576|P2|COMPLETED|Washout||146
8324589|NCT01401465|20522577|P1|COMPLETED|Washout||150
8324590|NCT01401465|20522576|P2|STARTED|Washout||146
8324591|NCT01401465|20522577|P1|STARTED|Washout||150
8324592|NCT01401465|20522576|P2|NOT COMPLETED|Treatment Period 1||16
8324593|NCT01401465|20522577|P1|NOT COMPLETED|Treatment Period 1||15
8324594|NCT01401465|20522576|P2|COMPLETED|Treatment Period 1||146
8324595|NCT01401465|20522577|P1|COMPLETED|Treatment Period 1||150
8324596|NCT01401465|20522576|P2|STARTED|Treatment Period 1||162
8324597|NCT01401465|20522577|P1|STARTED|Treatment Period 1||165
8324598|NCT01401452|20522640|P1|NOT COMPLETED|Overall Study||72
8324599|NCT01401452|20522640|P1|COMPLETED|Overall Study||174
8324600|NCT01401452|20522640|P1|Visit 5 (9 Months)|Overall Study||175
8324601|NCT01401452|20522640|P1|Visit 4 (6 Months)|Overall Study||172
8324602|NCT01401452|20522640|P1|Visit 3 (3 Months)|Overall Study||217
8324603|NCT01401452|20522640|P1|Visit 2 (1 Month)|Overall Study||225
8324604|NCT01401452|20522640|P1|Visit 1 (Baseline)|Overall Study||246
8324605|NCT01401452|20522640|P1|STARTED|Overall Study||246
8324606|NCT01401361|20522652|P1|NOT COMPLETED|Overall Study||28
8324607|NCT01401361|20522652|P1|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
8324608|NCT01401361|20522652|P1|STARTED|Overall Study||150
8324609|NCT01401322|20522658|P1|NOT COMPLETED|Overall Study||2
8324610|NCT01401322|20522658|P1|COMPLETED|Overall Study||3
8324611|NCT01401322|20522658|P1|STARTED|Overall Study||5
8324612|NCT01401283|20522664|P2|NOT COMPLETED|Overall Study||10
8324613|NCT01401283|20522665|P1|NOT COMPLETED|Overall Study||10
8324614|NCT01401283|20522664|P2|COMPLETED|Overall Study||81
8324615|NCT01401283|20522665|P1|COMPLETED|Overall Study||79
8324616|NCT01401283|20522664|P2|STARTED|Overall Study||91
8324617|NCT01401283|20522665|P1|STARTED|Overall Study||89
8324618|NCT01401257|20522677|P4|NOT COMPLETED|Overall Study||2
8324619|NCT01401257|20522678|P3|NOT COMPLETED|Overall Study||3
8324620|NCT01401257|20522679|P2|NOT COMPLETED|Overall Study||2
8324621|NCT01401257|20522680|P1|NOT COMPLETED|Overall Study||0
8324622|NCT01401257|20522677|P4|COMPLETED|Overall Study||17
8324623|NCT01401257|20522678|P3|COMPLETED|Overall Study||16
8324624|NCT01401257|20522679|P2|COMPLETED|Overall Study||19
8324625|NCT01401257|20522680|P1|COMPLETED|Overall Study||21
8324626|NCT01401257|20522677|P4|STARTED|Overall Study||19
8324627|NCT01401257|20522678|P3|STARTED|Overall Study||19
8324628|NCT01401257|20522679|P2|STARTED|Overall Study||21
8324629|NCT01401257|20522680|P1|STARTED|Overall Study||21
8324630|NCT01401166|20522692|P4|NOT COMPLETED|Safety Follow-Up Period||19
8324631|NCT01401166|20522693|P3|NOT COMPLETED|Safety Follow-Up Period||17
8324632|NCT01401166|20522694|P2|NOT COMPLETED|Safety Follow-Up Period||18
8324633|NCT01401166|20522695|P1|NOT COMPLETED|Safety Follow-Up Period||25
8324634|NCT01401166|20522692|P4|COMPLETED|Safety Follow-Up Period||100
8324635|NCT01401166|20522693|P3|COMPLETED|Safety Follow-Up Period||104
8324636|NCT01401166|20522694|P2|COMPLETED|Safety Follow-Up Period||106
8324637|NCT01401166|20522695|P1|COMPLETED|Safety Follow-Up Period||99
8324638|NCT01401166|20522692|P4|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
8324639|NCT01401166|20522693|P3|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
8324640|NCT01401166|20522694|P2|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
8324641|NCT01401166|20522695|P1|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
8324642|NCT01401166|20522692|P4|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
8324643|NCT01401166|20522693|P3|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
8324644|NCT01401166|20522694|P2|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
8324645|NCT01401166|20522695|P1|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
8324646|NCT01401166|20522692|P4|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
8324647|NCT01401166|20522693|P3|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
8324648|NCT01401166|20522694|P2|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
8324649|NCT01401166|20522695|P1|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
8324650|NCT01401166|20522692|P4|STARTED|Continuation Treatment (Cycles 9 to 18)||105
8324651|NCT01401166|20522693|P3|STARTED|Continuation Treatment (Cycles 9 to 18)||107
8324652|NCT01401166|20522694|P2|STARTED|Continuation Treatment (Cycles 9 to 18)||116
8324653|NCT01401166|20522695|P1|STARTED|Continuation Treatment (Cycles 9 to 18)||113
8324654|NCT01401166|20522692|P4|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
8324655|NCT01401166|20522693|P3|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
8324656|NCT01401166|20522694|P2|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
8324657|NCT01401166|20522695|P1|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
8324658|NCT01401166|20522692|P4|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
8324659|NCT01401166|20522693|P3|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
8324660|NCT01401166|20522694|P2|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
8324661|NCT01401166|20522695|P1|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
8324662|NCT01401166|20522692|P4|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
8324663|NCT01401166|20522693|P3|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
8324664|NCT01401166|20522694|P2|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
8324665|NCT01401166|20522695|P1|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
8324666|NCT01401166|20522692|P4|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
8324667|NCT01401166|20522693|P3|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
8324668|NCT01401166|20522694|P2|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
8324669|NCT01401166|20522695|P1|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
8324670|NCT01401166|20522692|P4|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
8324671|NCT01401166|20522693|P3|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
8324672|NCT01401166|20522694|P2|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
8324673|NCT01401166|20522695|P1|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
8324674|NCT01401166|20522692|P4|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
8324675|NCT01401166|20522693|P3|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
8324676|NCT01401166|20522694|P2|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
8324677|NCT01401166|20522695|P1|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
8324678|NCT01401153|20522731|P2|NOT COMPLETED|Second Test Day||5
8324679|NCT01401153|20522732|P1|NOT COMPLETED|Second Test Day||0
8324680|NCT01401153|20522731|P2|COMPLETED|Second Test Day||60
8324681|NCT01401153|20522732|P1|COMPLETED|Second Test Day||45
8324682|NCT01401153|20522731|P2|STARTED|Second Test Day||65
8324683|NCT01401153|20522732|P1|STARTED|Second Test Day||45
8324684|NCT01401153|20522731|P2|NOT COMPLETED|First Test Day||10
8324685|NCT01401153|20522732|P1|NOT COMPLETED|First Test Day||1
8324686|NCT01401153|20522731|P2|COMPLETED|First Test Day||45
8324687|NCT01401153|20522732|P1|COMPLETED|First Test Day||65
8324688|NCT01401153|20522731|P2|STARTED|First Test Day||55
8324689|NCT01401153|20522732|P1|STARTED|First Test Day||66
8324690|NCT01401101|20522766|P2|NOT COMPLETED|Overall Study||27
8324691|NCT01401101|20522767|P1|NOT COMPLETED|Overall Study||22
8324692|NCT01401101|20522766|P2|COMPLETED|Overall Study||171
8324693|NCT01401101|20522767|P1|COMPLETED|Overall Study||184
8324694|NCT01401101|20522766|P2|STARTED|Overall Study||198
8324695|NCT01401101|20522767|P1|STARTED|Overall Study||206
8324696|NCT01401062|20522779|P2|NOT COMPLETED|Overall Study||8
8324697|NCT01401062|20522780|P1|NOT COMPLETED|Overall Study||11
8324698|NCT01401062|20522779|P2|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
8324699|NCT01401062|20522780|P1|COMPLETED|Overall Study||0
8324700|NCT01401062|20522779|P2|STARTED|Overall Study||12
8324701|NCT01401062|20522780|P1|STARTED|Overall Study||11
8324702|NCT01401049|20522788|P2|NOT COMPLETED|Overall Study||0
8324703|NCT01401049|20522789|P1|NOT COMPLETED|Overall Study||0
8324704|NCT01401049|20522788|P2|COMPLETED|Overall Study||0
8324705|NCT01401049|20522789|P1|COMPLETED|Overall Study||0
8324706|NCT01401049|20522788|P2|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
8324707|NCT01401049|20522789|P1|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
8324708|NCT01401023|20522797|P1|NOT COMPLETED|Overall Study||0
8324709|NCT01401023|20522797|P1|COMPLETED|Overall Study||10
8324710|NCT01401023|20522797|P1|STARTED|Overall Study||10
8324711|NCT01401010|20522807|P2|NOT COMPLETED|Overall Study||0
8324712|NCT01401010|20522808|P1|NOT COMPLETED|Overall Study||1
8324713|NCT01401010|20522807|P2|COMPLETED|Overall Study||6
8324714|NCT01401010|20522808|P1|COMPLETED|Overall Study||5
8324715|NCT01401010|20522807|P2|STARTED|Overall Study||6
8324716|NCT01401010|20522808|P1|STARTED|Overall Study||6
8324717|NCT01400971|20522831|P1|NOT COMPLETED|Overall Study||917
8324718|NCT01400971|20522831|P1|COMPLETED|Overall Study||3382
8324719|NCT01400971|20522831|P1|Complete Treatment Data|Overall Study||2528
8324720|NCT01400971|20522831|P1|STARTED|Overall Study||4299
8324721|NCT01400958|20522840|P2|NOT COMPLETED|Overall Study||2
8324722|NCT01400958|20522841|P1|NOT COMPLETED|Overall Study||1
8324723|NCT01400958|20522840|P2|COMPLETED|Overall Study||1
8324724|NCT01400958|20522841|P1|COMPLETED|Overall Study||2
8324725|NCT01400958|20522840|P2|STARTED|Overall Study||3
8324726|NCT01400958|20522841|P1|STARTED|Overall Study||3
8324727|NCT01400932|20522851|P2|NOT COMPLETED|Overall Study||15
8324728|NCT01400932|20522852|P1|NOT COMPLETED|Overall Study||14
8324729|NCT01400932|20522851|P2|COMPLETED|Overall Study||167
8324730|NCT01400932|20522852|P1|COMPLETED|Overall Study||164
8324731|NCT01400932|20522851|P2|STARTED|Overall Study||182
8324732|NCT01400932|20522852|P1|STARTED|Overall Study||178
8324733|NCT01400919|20522874|P1|NOT COMPLETED|Overall Study||8
8324734|NCT01400919|20522874|P1|COMPLETED|Overall Study||67
8324735|NCT01400919|20522874|P1|STARTED|Overall Study||75
8324736|NCT01400906|20522878|P6|NOT COMPLETED|Treatment Period 3||0
8324737|NCT01400906|20522879|P5|NOT COMPLETED|Treatment Period 3||0
8324738|NCT01400906|20522880|P4|NOT COMPLETED|Treatment Period 3||0
8324739|NCT01400906|20522881|P3|NOT COMPLETED|Treatment Period 3||0
8324740|NCT01400906|20522882|P2|NOT COMPLETED|Treatment Period 3||0
8324741|NCT01400906|20522883|P1|NOT COMPLETED|Treatment Period 3||0
8324742|NCT01400906|20522878|P6|COMPLETED|Treatment Period 3||5
8324743|NCT01400906|20522879|P5|COMPLETED|Treatment Period 3||6
8324744|NCT01400906|20522880|P4|COMPLETED|Treatment Period 3||6
8324745|NCT01400906|20522881|P3|COMPLETED|Treatment Period 3||6
8324746|NCT01400906|20522882|P2|COMPLETED|Treatment Period 3||6
8324747|NCT01400906|20522883|P1|COMPLETED|Treatment Period 3||6
8324748|NCT01400906|20522878|P6|STARTED|Treatment Period 3||5
8324749|NCT01400906|20522879|P5|STARTED|Treatment Period 3||6
8324750|NCT01400906|20522880|P4|STARTED|Treatment Period 3||6
8324751|NCT01400906|20522881|P3|STARTED|Treatment Period 3||6
8324752|NCT01400906|20522882|P2|STARTED|Treatment Period 3||6
8324753|NCT01400906|20522883|P1|STARTED|Treatment Period 3||6
8324754|NCT01400906|20522878|P6|NOT COMPLETED|Washout Period 2||0
8324755|NCT01400906|20522879|P5|NOT COMPLETED|Washout Period 2||0
8324756|NCT01400906|20522880|P4|NOT COMPLETED|Washout Period 2||0
8324757|NCT01400906|20522881|P3|NOT COMPLETED|Washout Period 2||0
8324758|NCT01400906|20522882|P2|NOT COMPLETED|Washout Period 2||0
8324759|NCT01400906|20522883|P1|NOT COMPLETED|Washout Period 2||0
8324760|NCT01400906|20522878|P6|COMPLETED|Washout Period 2||5
8324761|NCT01400906|20522879|P5|COMPLETED|Washout Period 2||6
8324762|NCT01400906|20522880|P4|COMPLETED|Washout Period 2||6
8324763|NCT01400906|20522881|P3|COMPLETED|Washout Period 2||6
8324764|NCT01400906|20522882|P2|COMPLETED|Washout Period 2||6
8324765|NCT01400906|20522883|P1|COMPLETED|Washout Period 2||6
8324766|NCT01400906|20522878|P6|STARTED|Washout Period 2||5
8324767|NCT01400906|20522879|P5|STARTED|Washout Period 2||6
8324768|NCT01400906|20522880|P4|STARTED|Washout Period 2||6
8324769|NCT01400906|20522881|P3|STARTED|Washout Period 2||6
8324770|NCT01400906|20522882|P2|STARTED|Washout Period 2||6
8324771|NCT01400906|20522883|P1|STARTED|Washout Period 2||6
8324772|NCT01400906|20522878|P6|NOT COMPLETED|Treatment Period 2||0
8324773|NCT01400906|20522879|P5|NOT COMPLETED|Treatment Period 2||0
8324774|NCT01400906|20522880|P4|NOT COMPLETED|Treatment Period 2||0
8324775|NCT01400906|20522881|P3|NOT COMPLETED|Treatment Period 2||0
8324776|NCT01400906|20522882|P2|NOT COMPLETED|Treatment Period 2||0
8324777|NCT01400906|20522883|P1|NOT COMPLETED|Treatment Period 2||0
8324778|NCT01400906|20522878|P6|COMPLETED|Treatment Period 2||5
8324779|NCT01400906|20522879|P5|COMPLETED|Treatment Period 2||6
8324780|NCT01400906|20522880|P4|COMPLETED|Treatment Period 2||6
8324781|NCT01400906|20522881|P3|COMPLETED|Treatment Period 2||6
8324782|NCT01400906|20522882|P2|COMPLETED|Treatment Period 2||6
8324783|NCT01400906|20522883|P1|COMPLETED|Treatment Period 2||6
8324784|NCT01400906|20522878|P6|STARTED|Treatment Period 2||5
8324785|NCT01400906|20522879|P5|STARTED|Treatment Period 2||6
8324786|NCT01400906|20522880|P4|STARTED|Treatment Period 2||6
8324787|NCT01400906|20522881|P3|STARTED|Treatment Period 2||6
8324788|NCT01400906|20522882|P2|STARTED|Treatment Period 2||6
8324789|NCT01400906|20522883|P1|STARTED|Treatment Period 2||6
8324790|NCT01400906|20522878|P6|NOT COMPLETED|Washout Period 1||0
8324791|NCT01400906|20522879|P5|NOT COMPLETED|Washout Period 1||0
8324792|NCT01400906|20522880|P4|NOT COMPLETED|Washout Period 1||0
8324793|NCT01400906|20522881|P3|NOT COMPLETED|Washout Period 1||0
8324794|NCT01400906|20522882|P2|NOT COMPLETED|Washout Period 1||0
8324795|NCT01400906|20522883|P1|NOT COMPLETED|Washout Period 1||0
8324796|NCT01400906|20522878|P6|COMPLETED|Washout Period 1||5
8324797|NCT01400906|20522879|P5|COMPLETED|Washout Period 1||6
8324798|NCT01400906|20522880|P4|COMPLETED|Washout Period 1||6
8324799|NCT01400906|20522881|P3|COMPLETED|Washout Period 1||6
8324800|NCT01400906|20522882|P2|COMPLETED|Washout Period 1||6
8324801|NCT01400906|20522883|P1|COMPLETED|Washout Period 1||6
8324802|NCT01400906|20522878|P6|STARTED|Washout Period 1||5
8324803|NCT01400906|20522879|P5|STARTED|Washout Period 1||6
8324804|NCT01400906|20522880|P4|STARTED|Washout Period 1||6
8324805|NCT01400906|20522881|P3|STARTED|Washout Period 1||6
8324806|NCT01400906|20522882|P2|STARTED|Washout Period 1||6
8324807|NCT01400906|20522883|P1|STARTED|Washout Period 1||6
8324808|NCT01400906|20522878|P6|NOT COMPLETED|Treatment Period 1||0
8324809|NCT01400906|20522879|P5|NOT COMPLETED|Treatment Period 1||0
8324810|NCT01400906|20522880|P4|NOT COMPLETED|Treatment Period 1||0
8324811|NCT01400906|20522881|P3|NOT COMPLETED|Treatment Period 1||0
8324812|NCT01400906|20522882|P2|NOT COMPLETED|Treatment Period 1||0
8324813|NCT01400906|20522883|P1|NOT COMPLETED|Treatment Period 1||0
8324814|NCT01400906|20522878|P6|COMPLETED|Treatment Period 1||5
8324815|NCT01400906|20522879|P5|COMPLETED|Treatment Period 1||6
8324816|NCT01400906|20522880|P4|COMPLETED|Treatment Period 1||6
8324817|NCT01400906|20522881|P3|COMPLETED|Treatment Period 1||6
8324818|NCT01400906|20522882|P2|COMPLETED|Treatment Period 1||6
8324819|NCT01400906|20522883|P1|COMPLETED|Treatment Period 1||6
8324820|NCT01400906|20522878|P6|STARTED|Treatment Period 1||5
8324821|NCT01400906|20522879|P5|STARTED|Treatment Period 1||6
8324822|NCT01400906|20522880|P4|STARTED|Treatment Period 1||6
8324823|NCT01400906|20522881|P3|STARTED|Treatment Period 1||6
8324824|NCT01400906|20522882|P2|STARTED|Treatment Period 1||6
8324825|NCT01400906|20522883|P1|STARTED|Treatment Period 1||6
8324832|NCT01400880|20522926|P1|NOT COMPLETED|Overall Study||2
8324833|NCT01400880|20522926|P1|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
8324834|NCT01400880|20522926|P1|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
8324835|NCT01400841|20522930|P1|NOT COMPLETED|Extended Study Phase (2 Years)||2
8324836|NCT01400841|20522930|P1|COMPLETED|Extended Study Phase (2 Years)||11
8324837|NCT01400841|20522930|P1|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation
~1 subject death prior to agreeing to extended follow-up"|13
8324838|NCT01400841|20522930|P1|NOT COMPLETED|Initial Study Phase (6 Months)||1
8324839|NCT01400841|20522930|P1|COMPLETED|Initial Study Phase (6 Months)||15
8324840|NCT01400841|20522930|P1|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
8324841|NCT01400698|20522968|P6|NOT COMPLETED|Overall Study||6
8324842|NCT01400698|20522969|P5|NOT COMPLETED|Overall Study||7
8324843|NCT01400698|20522970|P4|NOT COMPLETED|Overall Study||8
8324844|NCT01400698|20522971|P3|NOT COMPLETED|Overall Study||2
8324845|NCT01400698|20522972|P2|NOT COMPLETED|Overall Study||11
8324846|NCT01400698|20522973|P1|NOT COMPLETED|Overall Study||15
8324847|NCT01400698|20522968|P6|COMPLETED|Overall Study||9
8324848|NCT01400698|20522969|P5|COMPLETED|Overall Study||7
8324849|NCT01400698|20522970|P4|COMPLETED|Overall Study||6
8324850|NCT01400698|20522971|P3|COMPLETED|Overall Study||0
8324851|NCT01400698|20522972|P2|COMPLETED|Overall Study||12
8324852|NCT01400698|20522973|P1|COMPLETED|Overall Study||8
8324853|NCT01400698|20522968|P6|STARTED|Overall Study||15
8324854|NCT01400698|20522969|P5|STARTED|Overall Study||14
8324855|NCT01400698|20522970|P4|STARTED|Overall Study||14
8324856|NCT01400698|20522971|P3|STARTED|Overall Study||2
8324857|NCT01400698|20522972|P2|STARTED|Overall Study||23
8324858|NCT01400698|20522973|P1|STARTED|Overall Study||23
8324859|NCT01400516|20522997|P2|NOT COMPLETED|Extension Trial||0
8324860|NCT01400516|20522998|P1|NOT COMPLETED|Extension Trial||0
8324861|NCT01400516|20522997|P2|COMPLETED|Extension Trial||7
8324862|NCT01400516|20522998|P1|COMPLETED|Extension Trial||6
8324863|NCT01400516|20522997|P2|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
8324864|NCT01400516|20522998|P1|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
8324865|NCT01400516|20522997|P2|NOT COMPLETED|Primary Trial||2
8324866|NCT01400516|20522998|P1|NOT COMPLETED|Primary Trial||0
8324867|NCT01400516|20522997|P2|COMPLETED|Primary Trial||12
8324868|NCT01400516|20522998|P1|COMPLETED|Primary Trial||12
8324869|NCT01400516|20522997|P2|STARTED|Primary Trial||14
8324870|NCT01400516|20522998|P1|STARTED|Primary Trial||12
8324871|NCT01400503|20523008|P1|NOT COMPLETED|Overall Study||60
8324872|NCT01400503|20523008|P1|COMPLETED|Overall Study||0
8324873|NCT01400503|20523008|P1|STARTED|Overall Study||60
8324874|NCT01400477|20523019|P2|NOT COMPLETED|Overall Study||0
8324875|NCT01400477|20523020|P1|NOT COMPLETED|Overall Study||2
8324876|NCT01400477|20523019|P2|COMPLETED|Overall Study||40
8324877|NCT01400477|20523020|P1|COMPLETED|Overall Study||38
8324878|NCT01400477|20523019|P2|STARTED|Overall Study||40
8324879|NCT01400477|20523020|P1|STARTED|Overall Study||40
8324880|NCT01400451|20523031|P3|NOT COMPLETED|Combination Treatment (or Intended)||2
8324881|NCT01400451|20523032|P2|NOT COMPLETED|Combination Treatment (or Intended)||4
8324882|NCT01400451|20523033|P1|NOT COMPLETED|Combination Treatment (or Intended)||6
8324883|NCT01400451|20523031|P3|COMPLETED|Combination Treatment (or Intended)||0
8324884|NCT01400451|20523032|P2|COMPLETED|Combination Treatment (or Intended)||0
8324885|NCT01400451|20523033|P1|COMPLETED|Combination Treatment (or Intended)||0
8324886|NCT01400451|20523031|P3|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
8324887|NCT01400451|20523032|P2|STARTED|Combination Treatment (or Intended)||4
8324888|NCT01400451|20523033|P1|STARTED|Combination Treatment (or Intended)||6
8324889|NCT01400451|20523031|P3|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
8324890|NCT01400451|20523032|P2|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
8324891|NCT01400451|20523033|P1|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
8324892|NCT01400451|20523031|P3|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
8324893|NCT01400451|20523032|P2|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
8324894|NCT01400451|20523033|P1|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
8324895|NCT01400451|20523031|P3|STARTED|28 Day Lead In With Vemurafenib Alone||2
8324896|NCT01400451|20523032|P2|STARTED|28 Day Lead In With Vemurafenib Alone||4
8324897|NCT01400451|20523033|P1|STARTED|28 Day Lead In With Vemurafenib Alone||6
8324898|NCT01400425|20523047|P1|NOT COMPLETED|Overall Study||10
8324899|NCT01400425|20523047|P1|COMPLETED|Overall Study||229
8324900|NCT01400425|20523047|P1|STARTED|Overall Study||239
8324907|NCT01400243|20523107|P2|NOT COMPLETED|Overall Study||11
8324908|NCT01400243|20523108|P1|NOT COMPLETED|Overall Study||8
8324909|NCT01400243|20523107|P2|COMPLETED|Overall Study||52
8324910|NCT01400243|20523108|P1|COMPLETED|Overall Study||56
8324911|NCT01400243|20523107|P2|STARTED|Overall Study||63
8324912|NCT01400243|20523108|P1|STARTED|Overall Study||64
8324913|NCT01400139|20523130|P1|NOT COMPLETED|HYD Extension Period||23
8324914|NCT01400139|20523130|P1|COMPLETED|HYD Extension Period||83
8324915|NCT01400139|20523130|P1|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
8324916|NCT01400139|20523130|P1|NOT COMPLETED|HYD Core Study||512
8324917|NCT01400139|20523130|P1|COMPLETED|HYD Core Study||410
8324918|NCT01400139|20523130|P1|STARTED|HYD Core Study||922
8324919|NCT01400113|20523153|P2|NOT COMPLETED|Overall Study||1
8324920|NCT01400113|20523154|P1|NOT COMPLETED|Overall Study||1
8324921|NCT01400113|20523153|P2|COMPLETED|Overall Study||59
8324922|NCT01400113|20523154|P1|COMPLETED|Overall Study||59
8324923|NCT01400113|20523153|P2|STARTED|Overall Study||60
8324924|NCT01400113|20523154|P1|STARTED|Overall Study||60
8324925|NCT01399905|20523162|P2|NOT COMPLETED|Overall Study||1
8324926|NCT01399905|20523163|P1|NOT COMPLETED|Overall Study||1
8324927|NCT01399905|20523162|P2|COMPLETED|Overall Study|Subject was treated at least one dose of carbidopa before withdrawing from the study.|6
8324928|NCT01399905|20523163|P1|COMPLETED|Overall Study|Subject withdrew from the study before receiving treatment.|6
8324929|NCT01399905|20523162|P2|STARTED|Overall Study||7
8324930|NCT01399905|20523163|P1|STARTED|Overall Study||7
8324931|NCT01399866|20523177|P2|NOT COMPLETED|Overall Study||2
8324932|NCT01399866|20523178|P1|NOT COMPLETED|Overall Study||4
8324933|NCT01399866|20523177|P2|COMPLETED|Overall Study||28
8324934|NCT01399866|20523178|P1|COMPLETED|Overall Study||28
8324935|NCT01399866|20523177|P2|STARTED|Overall Study||30
8324936|NCT01399866|20523178|P1|STARTED|Overall Study||32
8324937|NCT01399827|20523196|P2|NOT COMPLETED|Overall Study||0
8324938|NCT01399827|20523197|P1|NOT COMPLETED|Overall Study||0
8324939|NCT01399827|20523196|P2|COMPLETED|Overall Study||1
8324940|NCT01399827|20523197|P1|COMPLETED|Overall Study||1
8324941|NCT01399827|20523196|P2|STARTED|Overall Study||1
8324942|NCT01399827|20523197|P1|STARTED|Overall Study||1
8324943|NCT01399788|20523211|P2|NOT COMPLETED|Second Intervention Period||0
8324944|NCT01399788|20523212|P1|NOT COMPLETED|Second Intervention Period||0
8324945|NCT01399788|20523211|P2|COMPLETED|Second Intervention Period||18
8324946|NCT01399788|20523212|P1|COMPLETED|Second Intervention Period||17
8324947|NCT01399788|20523211|P2|STARTED|Second Intervention Period||18
8324948|NCT01399788|20523212|P1|STARTED|Second Intervention Period||17
8324949|NCT01399788|20523211|P2|NOT COMPLETED|Washout Period (at Least 1 Week)||0
8324950|NCT01399788|20523212|P1|NOT COMPLETED|Washout Period (at Least 1 Week)||0
8324951|NCT01399788|20523211|P2|COMPLETED|Washout Period (at Least 1 Week)||18
8324952|NCT01399788|20523212|P1|COMPLETED|Washout Period (at Least 1 Week)||17
8324953|NCT01399788|20523211|P2|STARTED|Washout Period (at Least 1 Week)||18
8324954|NCT01399788|20523212|P1|STARTED|Washout Period (at Least 1 Week)||17
8324955|NCT01399788|20523211|P2|NOT COMPLETED|First Intervention Period||0
8324956|NCT01399788|20523212|P1|NOT COMPLETED|First Intervention Period||1
8324957|NCT01399788|20523211|P2|COMPLETED|First Intervention Period||18
8324958|NCT01399788|20523212|P1|COMPLETED|First Intervention Period||17
8324959|NCT01399788|20523211|P2|STARTED|First Intervention Period||18
8324960|NCT01399788|20523212|P1|STARTED|First Intervention Period||18
8324961|NCT01399736|20523234|P2|NOT COMPLETED|Overall Study||4
8324962|NCT01399736|20523235|P1|NOT COMPLETED|Overall Study||4
8324963|NCT01399736|20523234|P2|COMPLETED|Overall Study||586
8324964|NCT01399736|20523235|P1|COMPLETED|Overall Study||291
8324965|NCT01399736|20523234|P2|STARTED|Overall Study||590
8324966|NCT01399736|20523235|P1|STARTED|Overall Study||295
8324967|NCT01399723|20523311|P2|NOT COMPLETED|Overall Study||1
8324968|NCT01399723|20523312|P1|NOT COMPLETED|Overall Study||0
8324969|NCT01399723|20523311|P2|COMPLETED|Overall Study||263
8324970|NCT01399723|20523312|P1|COMPLETED|Overall Study||263
8324971|NCT01399723|20523311|P2|STARTED|Overall Study||264
8324972|NCT01399723|20523312|P1|STARTED|Overall Study||263
8324973|NCT01399697|20523325|P3|NOT COMPLETED|Overall Study||4
8324974|NCT01399697|20523326|P2|NOT COMPLETED|Overall Study||3
8324975|NCT01399697|20523327|P1|NOT COMPLETED|Overall Study||41
8324976|NCT01399697|20523325|P3|COMPLETED|Overall Study||78
8324977|NCT01399697|20523326|P2|COMPLETED|Overall Study||80
8324978|NCT01399697|20523327|P1|COMPLETED|Overall Study||55
8324979|NCT01399697|20523325|P3|STARTED|Overall Study||82
8324980|NCT01399697|20523326|P2|STARTED|Overall Study||83
8324981|NCT01399697|20523327|P1|STARTED|Overall Study||96
8324982|NCT01399619|20523354|P4|NOT COMPLETED|Overall Study||17
8324983|NCT01399619|20523355|P3|NOT COMPLETED|Overall Study||12
8324984|NCT01399619|20523356|P2|NOT COMPLETED|Overall Study||0
8324985|NCT01399619|20523357|P1|NOT COMPLETED|Overall Study||25
8324986|NCT01399619|20523354|P4|COMPLETED|Overall Study||0
8324987|NCT01399619|20523355|P3|COMPLETED|Overall Study||74
8324988|NCT01399619|20523356|P2|COMPLETED|Overall Study||84
8324989|NCT01399619|20523357|P1|COMPLETED|Overall Study||98
8324990|NCT01399619|20523354|P4|STARTED|Overall Study||17
8324991|NCT01399619|20523355|P3|STARTED|Overall Study||86
8324992|NCT01399619|20523356|P2|STARTED|Overall Study||84
8324993|NCT01399619|20523357|P1|STARTED|Overall Study||123
8324994|NCT01399593|20523420|P2|NOT COMPLETED|Overall Study||2
8324995|NCT01399593|20523421|P1|NOT COMPLETED|Overall Study||3
8324996|NCT01399593|20523420|P2|COMPLETED|Overall Study||49
8324997|NCT01399593|20523421|P1|COMPLETED|Overall Study||48
8324998|NCT01399593|20523420|P2|STARTED|Overall Study||51
8324999|NCT01399593|20523421|P1|STARTED|Overall Study||51
8325000|NCT01399268|20523429|P2|NOT COMPLETED|Overall Study||0
8325001|NCT01399268|20523430|P1|NOT COMPLETED|Overall Study||0
8325002|NCT01399268|20523429|P2|COMPLETED|Overall Study||15
8325003|NCT01399268|20523430|P1|COMPLETED|Overall Study||15
8325004|NCT01399268|20523429|P2|STARTED|Overall Study||15
8325005|NCT01399268|20523430|P1|STARTED|Overall Study||15
8325006|NCT01399229|20523448|P3|NOT COMPLETED|Overall Study||0
8325007|NCT01399229|20523449|P2|NOT COMPLETED|Overall Study||0
8325008|NCT01399229|20523450|P1|NOT COMPLETED|Overall Study||0
8325009|NCT01399229|20523448|P3|COMPLETED|Overall Study||5
8325010|NCT01399229|20523449|P2|COMPLETED|Overall Study||5
8325011|NCT01399229|20523450|P1|COMPLETED|Overall Study||20
8325012|NCT01399229|20523448|P3|STARTED|Overall Study||5
8325013|NCT01399229|20523449|P2|STARTED|Overall Study||5
8325014|NCT01399229|20523450|P1|STARTED|Overall Study||20
8325015|NCT01399190|20523454|P1|NOT COMPLETED|Overall Study||20
8325016|NCT01399190|20523454|P1|COMPLETED|Overall Study||48
8325017|NCT01399190|20523454|P1|Evaluable for Primary Endpoint Analysis|Overall Study||60
8325018|NCT01399190|20523454|P1|Included in Final Analysis|Overall Study||63
8325019|NCT01399190|20523454|P1|STARTED|Overall Study||68
8325020|NCT01399125|20523462|P2|NOT COMPLETED|Overall Study||60
8325021|NCT01399125|20523463|P1|NOT COMPLETED|Overall Study||51
8325022|NCT01399125|20523462|P2|COMPLETED|Overall Study||193
8325023|NCT01399125|20523463|P1|COMPLETED|Overall Study||197
8325024|NCT01399125|20523462|P2|Per Protocol (PP) Population|Overall Study||188
8325025|NCT01399125|20523463|P1|Per Protocol (PP) Population|Overall Study||192
8325026|NCT01399125|20523462|P2|STARTED|Overall Study||253
8325027|NCT01399125|20523463|P1|STARTED|Overall Study||248
8325028|NCT01399099|20523477|P1|NOT COMPLETED|Overall Study||31
8325029|NCT01399099|20523477|P1|COMPLETED|Overall Study||36
8325030|NCT01399099|20523477|P1|6 Months|Overall Study||47
8325031|NCT01399099|20523477|P1|STARTED|Overall Study||67
8325032|NCT01399047|20523484|P2|NOT COMPLETED|Overall Study||1
8325033|NCT01399047|20523485|P1|NOT COMPLETED|Overall Study||0
8325034|NCT01399047|20523484|P2|COMPLETED|Overall Study||8
8325035|NCT01399047|20523485|P1|COMPLETED|Overall Study||10
8325036|NCT01399047|20523484|P2|STARTED|Overall Study||9
8325037|NCT01399047|20523485|P1|STARTED|Overall Study||10
8325038|NCT01399008|20523502|P3|NOT COMPLETED|Overall Study||2
8325039|NCT01399008|20523503|P2|NOT COMPLETED|Overall Study||5
8325040|NCT01399008|20523504|P1|NOT COMPLETED|Overall Study||3
8325041|NCT01399008|20523502|P3|COMPLETED|Overall Study||31
8325042|NCT01399008|20523503|P2|COMPLETED|Overall Study||27
8325043|NCT01399008|20523504|P1|COMPLETED|Overall Study||32
8325044|NCT01399008|20523502|P3|STARTED|Overall Study||33
8325045|NCT01399008|20523503|P2|STARTED|Overall Study||32
8325046|NCT01399008|20523504|P1|STARTED|Overall Study||35
8325047|NCT01398982|20523514|P2|NOT COMPLETED|Overall Study||2
8325048|NCT01398982|20523515|P1|NOT COMPLETED|Overall Study||6
8325049|NCT01398982|20523514|P2|COMPLETED|Overall Study||47
8325050|NCT01398982|20523515|P1|COMPLETED|Overall Study||38
8325051|NCT01398982|20523514|P2|STARTED|Overall Study||49
8325052|NCT01398982|20523515|P1|STARTED|Overall Study||44
8325053|NCT01398956|20523521|P1|NOT COMPLETED|Overall Study||10
8325054|NCT01398956|20523521|P1|COMPLETED|Overall Study||34
8325055|NCT01398956|20523521|P1|STARTED|Overall Study||44
8325056|NCT01398943|20523529|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8325057|NCT01398943|20523530|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8325058|NCT01398943|20523531|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8325059|NCT01398943|20523532|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8325060|NCT01398943|20523529|P4|COMPLETED|Second Intervention (1 Day)||15
8325061|NCT01398943|20523530|P3|COMPLETED|Second Intervention (1 Day)||15
8325062|NCT01398943|20523531|P2|COMPLETED|Second Intervention (1 Day)||15
8325063|NCT01398943|20523532|P1|COMPLETED|Second Intervention (1 Day)||15
8325064|NCT01398943|20523529|P4|STARTED|Second Intervention (1 Day)||15
8325065|NCT01398943|20523530|P3|STARTED|Second Intervention (1 Day)||15
8325066|NCT01398943|20523531|P2|STARTED|Second Intervention (1 Day)||15
8325067|NCT01398943|20523532|P1|STARTED|Second Intervention (1 Day)||15
8325068|NCT01398943|20523529|P4|NOT COMPLETED|Washout (2-7 Days)||0
8325069|NCT01398943|20523530|P3|NOT COMPLETED|Washout (2-7 Days)||0
8325070|NCT01398943|20523531|P2|NOT COMPLETED|Washout (2-7 Days)||0
8325071|NCT01398943|20523532|P1|NOT COMPLETED|Washout (2-7 Days)||0
8325072|NCT01398943|20523529|P4|COMPLETED|Washout (2-7 Days)||15
8325073|NCT01398943|20523530|P3|COMPLETED|Washout (2-7 Days)||15
8325074|NCT01398943|20523531|P2|COMPLETED|Washout (2-7 Days)||15
8325075|NCT01398943|20523532|P1|COMPLETED|Washout (2-7 Days)||15
8325076|NCT01398943|20523529|P4|STARTED|Washout (2-7 Days)||15
8325077|NCT01398943|20523530|P3|STARTED|Washout (2-7 Days)||15
8325078|NCT01398943|20523531|P2|STARTED|Washout (2-7 Days)||15
8325079|NCT01398943|20523532|P1|STARTED|Washout (2-7 Days)||15
8325080|NCT01398943|20523529|P4|NOT COMPLETED|First Intervention (1 Day)||0
8325081|NCT01398943|20523530|P3|NOT COMPLETED|First Intervention (1 Day)||0
8325082|NCT01398943|20523531|P2|NOT COMPLETED|First Intervention (1 Day)||0
8325083|NCT01398943|20523532|P1|NOT COMPLETED|First Intervention (1 Day)||0
8325084|NCT01398943|20523529|P4|COMPLETED|First Intervention (1 Day)||15
8325085|NCT01398943|20523530|P3|COMPLETED|First Intervention (1 Day)||15
8325086|NCT01398943|20523531|P2|COMPLETED|First Intervention (1 Day)||15
8325087|NCT01398943|20523532|P1|COMPLETED|First Intervention (1 Day)||15
8325088|NCT01398943|20523529|P4|STARTED|First Intervention (1 Day)||15
8325089|NCT01398943|20523530|P3|STARTED|First Intervention (1 Day)||15
8325090|NCT01398943|20523531|P2|STARTED|First Intervention (1 Day)||15
8325091|NCT01398943|20523532|P1|STARTED|First Intervention (1 Day)||15
8325092|NCT01398852|20523540|P1|NOT COMPLETED|Overall Study||372
8325093|NCT01398852|20523540|P1|COMPLETED|Overall Study||0
8325094|NCT01398852|20523540|P1|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
8325095|NCT01398839|20523546|P2|NOT COMPLETED|Overall Study||0
8325096|NCT01398839|20523547|P1|NOT COMPLETED|Overall Study||0
8325097|NCT01398839|20523546|P2|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
8325098|NCT01398839|20523547|P1|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
8325099|NCT01398839|20523546|P2|STARTED|Overall Study||37
8325100|NCT01398839|20523547|P1|STARTED|Overall Study||35
8325101|NCT01398787|20523553|P1|NOT COMPLETED|Overall Study||1
8325102|NCT01398787|20523553|P1|COMPLETED|Overall Study||197
8325103|NCT01398787|20523553|P1|STARTED|Overall Study||198
8325104|NCT01398514|20523571|P2|NOT COMPLETED|Overall Study||6
8325105|NCT01398514|20523572|P1|NOT COMPLETED|Overall Study||8
8325106|NCT01398514|20523571|P2|COMPLETED|Overall Study||20
8325107|NCT01398514|20523572|P1|COMPLETED|Overall Study||18
8325108|NCT01398514|20523571|P2|STARTED|Overall Study||26
8325109|NCT01398514|20523572|P1|STARTED|Overall Study||26
8325110|NCT01398475|20523584|P4|NOT COMPLETED|Overall Study||0
8325111|NCT01398475|20523585|P3|NOT COMPLETED|Overall Study||0
8325112|NCT01398475|20523586|P2|NOT COMPLETED|Overall Study||0
8325113|NCT01398475|20523587|P1|NOT COMPLETED|Overall Study||0
8325114|NCT01398475|20523584|P4|COMPLETED|Overall Study||4
8325115|NCT01398475|20523585|P3|COMPLETED|Overall Study||4
8325116|NCT01398475|20523586|P2|COMPLETED|Overall Study||3
8325117|NCT01398475|20523587|P1|COMPLETED|Overall Study||4
8325118|NCT01398475|20523584|P4|Received Fourth Intervention|Overall Study||4
8325119|NCT01398475|20523585|P3|Received Fourth Intervention|Overall Study||4
8325120|NCT01398475|20523586|P2|Received Fourth Intervention|Overall Study||3
8325121|NCT01398475|20523587|P1|Received Fourth Intervention|Overall Study||4
8325122|NCT01398475|20523584|P4|Received Third Intervention|Overall Study||4
8325123|NCT01398475|20523585|P3|Received Third Intervention|Overall Study||4
8325124|NCT01398475|20523586|P2|Received Third Intervention|Overall Study||3
8325125|NCT01398475|20523587|P1|Received Third Intervention|Overall Study||4
8325126|NCT01398475|20523584|P4|Received Second Intervention|Overall Study||4
8325127|NCT01398475|20523585|P3|Received Second Intervention|Overall Study||4
8325128|NCT01398475|20523586|P2|Received Second Intervention|Overall Study||3
8325129|NCT01398475|20523587|P1|Received Second Intervention|Overall Study||4
8325130|NCT01398475|20523584|P4|Received First Intervention|Overall Study||4
8325131|NCT01398475|20523585|P3|Received First Intervention|Overall Study||4
8325132|NCT01398475|20523586|P2|Received First Intervention|Overall Study||3
8325133|NCT01398475|20523587|P1|Received First Intervention|Overall Study||4
8325134|NCT01398475|20523584|P4|STARTED|Overall Study||4
8325135|NCT01398475|20523585|P3|STARTED|Overall Study||4
8325136|NCT01398475|20523586|P2|STARTED|Overall Study||3
8325137|NCT01398475|20523587|P1|STARTED|Overall Study||4
8325138|NCT01398410|20523607|P2|NOT COMPLETED|Overall Study||56
8325139|NCT01398410|20523608|P1|NOT COMPLETED|Overall Study||58
8325140|NCT01398410|20523607|P2|COMPLETED|Overall Study||148
8325141|NCT01398410|20523608|P1|COMPLETED|Overall Study||143
8325142|NCT01398410|20523607|P2|STARTED|Overall Study||204
8325143|NCT01398410|20523608|P1|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
8325144|NCT01398358|20523619|P3|NOT COMPLETED|Overall Study||21
8325145|NCT01398358|20523620|P2|NOT COMPLETED|Overall Study||23
8325146|NCT01398358|20523621|P1|NOT COMPLETED|Overall Study||15
8325147|NCT01398358|20523619|P3|COMPLETED|Overall Study||234
8325148|NCT01398358|20523620|P2|COMPLETED|Overall Study||201
8325149|NCT01398358|20523621|P1|COMPLETED|Overall Study||203
8325150|NCT01398358|20523619|P3|STARTED|Overall Study||255
8325151|NCT01398358|20523620|P2|STARTED|Overall Study||224
8325152|NCT01398358|20523621|P1|STARTED|Overall Study||218
8325153|NCT01398280|20523634|P2|NOT COMPLETED|Overall Study||0
8325154|NCT01398280|20523635|P1|NOT COMPLETED|Overall Study||4
8325155|NCT01398280|20523634|P2|COMPLETED|Overall Study||4
8325156|NCT01398280|20523635|P1|COMPLETED|Overall Study||7
8325157|NCT01398280|20523634|P2|STARTED|Overall Study||4
8325158|NCT01398280|20523635|P1|STARTED|Overall Study||11
8325159|NCT01398176|20523643|P2|NOT COMPLETED|Overall Study||6
8325160|NCT01398176|20523644|P1|NOT COMPLETED|Overall Study||3
8325161|NCT01398176|20523643|P2|COMPLETED|Overall Study||19
8325162|NCT01398176|20523644|P1|COMPLETED|Overall Study||23
8325163|NCT01398176|20523643|P2|STARTED|Overall Study||25
8325164|NCT01398176|20523644|P1|STARTED|Overall Study||26
8325165|NCT01398059|20523650|P6|NOT COMPLETED|Overall Study||0
8325166|NCT01398059|20523651|P5|NOT COMPLETED|Overall Study||0
8325167|NCT01398059|20523652|P4|NOT COMPLETED|Overall Study||0
8325168|NCT01398059|20523653|P3|NOT COMPLETED|Overall Study||0
8325169|NCT01398059|20523654|P2|NOT COMPLETED|Overall Study||0
8325170|NCT01398059|20523655|P1|NOT COMPLETED|Overall Study||0
8325171|NCT01398059|20523650|P6|COMPLETED|Overall Study||2
8325172|NCT01398059|20523651|P5|COMPLETED|Overall Study||4
8325173|NCT01398059|20523652|P4|COMPLETED|Overall Study||2
8325174|NCT01398059|20523653|P3|COMPLETED|Overall Study||4
8325175|NCT01398059|20523654|P2|COMPLETED|Overall Study||3
8325176|NCT01398059|20523655|P1|COMPLETED|Overall Study||4
8325177|NCT01398059|20523650|P6|STARTED|Overall Study||2
8325178|NCT01398059|20523651|P5|STARTED|Overall Study||4
8325179|NCT01398059|20523652|P4|STARTED|Overall Study||2
8325180|NCT01398059|20523653|P3|STARTED|Overall Study||4
8325181|NCT01398059|20523654|P2|STARTED|Overall Study||3
8325182|NCT01398059|20523655|P1|STARTED|Overall Study||4
8325183|NCT01397890|20523677|P2|NOT COMPLETED|Overall Study||31
8325184|NCT01397890|20523678|P1|NOT COMPLETED|Overall Study||23
8325185|NCT01397890|20523677|P2|COMPLETED|Overall Study||260
8325186|NCT01397890|20523678|P1|COMPLETED|Overall Study||264
8325187|NCT01397890|20523677|P2|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
8325188|NCT01397890|20523678|P1|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
8325189|NCT01397890|20523677|P2|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
8325190|NCT01397890|20523678|P1|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
8325191|NCT01397890|20523677|P2|STARTED|Overall Study||291
8325192|NCT01397890|20523678|P1|STARTED|Overall Study||287
8325193|NCT01397851|20523732|P2|NOT COMPLETED|Overall Study||46
8325194|NCT01397851|20523733|P1|NOT COMPLETED|Overall Study||79
8325195|NCT01397851|20523732|P2|COMPLETED|Overall Study||39917
8325196|NCT01397851|20523733|P1|COMPLETED|Overall Study||41555
8325197|NCT01397851|20523732|P2|STARTED|Overall Study||39963
8325198|NCT01397851|20523733|P1|STARTED|Overall Study||41634
8325199|NCT01397825|20523749|P5|NOT COMPLETED|Overall Study||0
8325200|NCT01397825|20523750|P4|NOT COMPLETED|Overall Study||3
8325201|NCT01397825|20523751|P3|NOT COMPLETED|Overall Study||25
8325202|NCT01397825|20523752|P2|NOT COMPLETED|Overall Study||4
8325203|NCT01397825|20523753|P1|NOT COMPLETED|Overall Study||13
8325204|NCT01397825|20523749|P5|COMPLETED|Overall Study||0
8325205|NCT01397825|20523750|P4|COMPLETED|Overall Study||0
8325206|NCT01397825|20523751|P3|COMPLETED|Overall Study||0
8325207|NCT01397825|20523752|P2|COMPLETED|Overall Study||0
8325208|NCT01397825|20523753|P1|COMPLETED|Overall Study||0
8325209|NCT01397825|20523749|P5|STARTED|Overall Study||0
8325210|NCT01397825|20523750|P4|STARTED|Overall Study||3
8325211|NCT01397825|20523751|P3|STARTED|Overall Study||25
8325212|NCT01397825|20523752|P2|STARTED|Overall Study||4
8325213|NCT01397825|20523753|P1|STARTED|Overall Study||13
8325214|NCT01397786|20523823|P3|NOT COMPLETED|Phase B||138
8325215|NCT01397786|20523824|P2|NOT COMPLETED|Phase B||95
8325216|NCT01397786|20523825|P1|NOT COMPLETED|Phase B||303
8325217|NCT01397786|20523823|P3|COMPLETED|Phase B||91
8325218|NCT01397786|20523824|P2|COMPLETED|Phase B||109
8325219|NCT01397786|20523825|P1|COMPLETED|Phase B||308
8325220|NCT01397786|20523823|P3|STARTED|Phase B||229
8325221|NCT01397786|20523824|P2|STARTED|Phase B||204
8325222|NCT01397786|20523825|P1|STARTED|Phase B||611
8325223|NCT01397786|20523823|P3|NOT COMPLETED|Phase A||28
8325224|NCT01397786|20523824|P2|NOT COMPLETED|Phase A||0
8325225|NCT01397786|20523825|P1|NOT COMPLETED|Phase A||0
8325226|NCT01397786|20523823|P3|COMPLETED|Phase A||199
8325227|NCT01397786|20523824|P2|COMPLETED|Phase A||0
8325228|NCT01397786|20523825|P1|COMPLETED|Phase A||12
8325229|NCT01397786|20523823|P3|STARTED|Phase A||227
8325230|NCT01397786|20523824|P2|STARTED|Phase A||0
8325231|NCT01397786|20523825|P1|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
8325232|NCT01397747|20523891|P1|NOT COMPLETED|Overall Study||1027
8325233|NCT01397747|20523891|P1|COMPLETED|Overall Study||9989
8325234|NCT01397747|20523891|P1|STARTED|Overall Study||11016
8325235|NCT01397695|20523896|P1|NOT COMPLETED|Overall Study||0
8325236|NCT01397695|20523896|P1|COMPLETED|Overall Study||0
8325237|NCT01397695|20523896|P1|STARTED|Overall Study||0
8325238|NCT01397656|20523902|P2|NOT COMPLETED|Overall Study||0
8325239|NCT01397656|20523903|P1|NOT COMPLETED|Overall Study||0
8325240|NCT01397656|20523902|P2|COMPLETED|Overall Study||30
8325241|NCT01397656|20523903|P1|COMPLETED|Overall Study||33
8325242|NCT01397656|20523902|P2|STARTED|Overall Study||30
8325243|NCT01397656|20523903|P1|STARTED|Overall Study||33
8325244|NCT01397617|20523918|P3|NOT COMPLETED|Overall Study||29
8325245|NCT01397617|20523919|P2|NOT COMPLETED|Overall Study||23
8325246|NCT01397617|20523920|P1|NOT COMPLETED|Overall Study||31
8325247|NCT01397617|20523918|P3|COMPLETED|Overall Study||31
8325248|NCT01397617|20523919|P2|COMPLETED|Overall Study||30
8325249|NCT01397617|20523920|P1|COMPLETED|Overall Study||33
8325250|NCT01397617|20523918|P3|STARTED|Overall Study||60
8325251|NCT01397617|20523919|P2|STARTED|Overall Study||53
8325252|NCT01397617|20523920|P1|STARTED|Overall Study||64
8325253|NCT01397591|20523931|P1|NOT COMPLETED|Overall Study||0
8325254|NCT01397591|20523931|P1|COMPLETED|Overall Study||2
8325255|NCT01397591|20523931|P1|STARTED|Overall Study||2
8325256|NCT01397552|20523941|P2|NOT COMPLETED|Overall Study||1
8325257|NCT01397552|20523942|P1|NOT COMPLETED|Overall Study||3
8325258|NCT01397552|20523941|P2|COMPLETED|Overall Study||3
8325259|NCT01397552|20523942|P1|COMPLETED|Overall Study||1
8325260|NCT01397552|20523941|P2|STARTED|Overall Study||4
8325261|NCT01397552|20523942|P1|STARTED|Overall Study||4
8325262|NCT01397461|20523951|P3|NOT COMPLETED|Overall Study||2
8325263|NCT01397461|20523952|P2|NOT COMPLETED|Overall Study||6
8325264|NCT01397461|20523953|P1|NOT COMPLETED|Overall Study||2
8325265|NCT01397461|20523951|P3|COMPLETED|Overall Study||152
8325266|NCT01397461|20523952|P2|COMPLETED|Overall Study||150
8325267|NCT01397461|20523953|P1|COMPLETED|Overall Study||153
8325268|NCT01397461|20523951|P3|STARTED|Overall Study||154
8325269|NCT01397461|20523952|P2|STARTED|Overall Study||156
8325270|NCT01397461|20523953|P1|STARTED|Overall Study||155
8325271|NCT01397448|20523964|P3|NOT COMPLETED|Overall Study||18
8325272|NCT01397448|20523965|P2|NOT COMPLETED|Overall Study||15
8325273|NCT01397448|20523966|P1|NOT COMPLETED|Overall Study||18
8325274|NCT01397448|20523964|P3|COMPLETED|Overall Study||140
8325275|NCT01397448|20523965|P2|COMPLETED|Overall Study||142
8325276|NCT01397448|20523966|P1|COMPLETED|Overall Study||138
8325277|NCT01397448|20523964|P3|STARTED|Overall Study||158
8325278|NCT01397448|20523965|P2|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
8325279|NCT01397448|20523966|P1|STARTED|Overall Study||156
8325280|NCT01397422|20523981|P4|NOT COMPLETED|Overall Study||8
8325281|NCT01397422|20523982|P3|NOT COMPLETED|Overall Study||3
8325282|NCT01397422|20523983|P2|NOT COMPLETED|Overall Study||3
8325283|NCT01397422|20523984|P1|NOT COMPLETED|Overall Study||2
8325284|NCT01397422|20523981|P4|COMPLETED|Overall Study||12
8325285|NCT01397422|20523982|P3|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
8325286|NCT01397422|20523983|P2|COMPLETED|Overall Study||17
8325287|NCT01397422|20523984|P1|COMPLETED|Overall Study||20
8325288|NCT01397422|20523981|P4|STARTED|Overall Study||20
8325289|NCT01397422|20523982|P3|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
8325290|NCT01397422|20523983|P2|STARTED|Overall Study||20
8325291|NCT01397422|20523984|P1|STARTED|Overall Study||22
8325292|NCT01397409|20524024|P10|NOT COMPLETED|Stage 3||0
8325293|NCT01397409|20524025|P9|NOT COMPLETED|Stage 3||0
8325294|NCT01397409|20524026|P8|NOT COMPLETED|Stage 3||2
8325295|NCT01397409|20524027|P7|NOT COMPLETED|Stage 3||0
8325296|NCT01397409|20524028|P6|NOT COMPLETED|Stage 3||0
8325297|NCT01397409|20524029|P5|NOT COMPLETED|Stage 3||0
8325298|NCT01397409|20524030|P4|NOT COMPLETED|Stage 3||0
8325299|NCT01397409|20524031|P3|NOT COMPLETED|Stage 3||0
8325300|NCT01397409|20524032|P2|NOT COMPLETED|Stage 3||0
8325301|NCT01397409|20524033|P1|NOT COMPLETED|Stage 3||0
8325302|NCT01397409|20524024|P10|COMPLETED|Stage 3||16
8325303|NCT01397409|20524025|P9|COMPLETED|Stage 3||25
8325304|NCT01397409|20524026|P8|COMPLETED|Stage 3||21
8325305|NCT01397409|20524027|P7|COMPLETED|Stage 3||0
8325306|NCT01397409|20524028|P6|COMPLETED|Stage 3||0
8325307|NCT01397409|20524029|P5|COMPLETED|Stage 3||0
8325308|NCT01397409|20524030|P4|COMPLETED|Stage 3||0
8325309|NCT01397409|20524031|P3|COMPLETED|Stage 3||0
8325310|NCT01397409|20524032|P2|COMPLETED|Stage 3||0
8325311|NCT01397409|20524033|P1|COMPLETED|Stage 3||0
8325312|NCT01397409|20524024|P10|STARTED|Stage 3||16
8325313|NCT01397409|20524025|P9|STARTED|Stage 3||25
8325314|NCT01397409|20524026|P8|STARTED|Stage 3||23
8325315|NCT01397409|20524027|P7|STARTED|Stage 3||0
8325316|NCT01397409|20524028|P6|STARTED|Stage 3||0
8325317|NCT01397409|20524029|P5|STARTED|Stage 3||0
8325318|NCT01397409|20524030|P4|STARTED|Stage 3||0
8325319|NCT01397409|20524031|P3|STARTED|Stage 3||0
8325320|NCT01397409|20524032|P2|STARTED|Stage 3||0
8325321|NCT01397409|20524033|P1|STARTED|Stage 3||0
8325322|NCT01397409|20524024|P10|NOT COMPLETED|Stage 2||0
8325323|NCT01397409|20524025|P9|NOT COMPLETED|Stage 2||0
8325324|NCT01397409|20524026|P8|NOT COMPLETED|Stage 2||0
8325325|NCT01397409|20524027|P7|NOT COMPLETED|Stage 2||0
8325326|NCT01397409|20524028|P6|NOT COMPLETED|Stage 2||4
8325327|NCT01397409|20524029|P5|NOT COMPLETED|Stage 2||8
8325328|NCT01397409|20524030|P4|NOT COMPLETED|Stage 2||0
8325329|NCT01397409|20524031|P3|NOT COMPLETED|Stage 2||0
8325330|NCT01397409|20524032|P2|NOT COMPLETED|Stage 2||0
8325331|NCT01397409|20524033|P1|NOT COMPLETED|Stage 2||0
8325332|NCT01397409|20524024|P10|COMPLETED|Stage 2||0
8325333|NCT01397409|20524025|P9|COMPLETED|Stage 2||0
8325334|NCT01397409|20524026|P8|COMPLETED|Stage 2||0
8325335|NCT01397409|20524027|P7|COMPLETED|Stage 2||58
8325336|NCT01397409|20524028|P6|COMPLETED|Stage 2||54
8325337|NCT01397409|20524029|P5|COMPLETED|Stage 2||59
8325338|NCT01397409|20524030|P4|COMPLETED|Stage 2||0
8325339|NCT01397409|20524031|P3|COMPLETED|Stage 2||0
8325340|NCT01397409|20524032|P2|COMPLETED|Stage 2||0
8325341|NCT01397409|20524033|P1|COMPLETED|Stage 2||0
8325342|NCT01397409|20524024|P10|STARTED|Stage 2||0
8325343|NCT01397409|20524025|P9|STARTED|Stage 2||0
8325344|NCT01397409|20524026|P8|STARTED|Stage 2||0
8325345|NCT01397409|20524027|P7|STARTED|Stage 2||58
8325346|NCT01397409|20524028|P6|STARTED|Stage 2||58
8325347|NCT01397409|20524029|P5|STARTED|Stage 2||67
8325348|NCT01397409|20524030|P4|STARTED|Stage 2||0
8325349|NCT01397409|20524031|P3|STARTED|Stage 2||0
8325350|NCT01397409|20524032|P2|STARTED|Stage 2||0
8325351|NCT01397409|20524033|P1|STARTED|Stage 2||0
8325352|NCT01397409|20524024|P10|NOT COMPLETED|Stage 1||0
8325353|NCT01397409|20524025|P9|NOT COMPLETED|Stage 1||0
8325354|NCT01397409|20524026|P8|NOT COMPLETED|Stage 1||0
8325355|NCT01397409|20524027|P7|NOT COMPLETED|Stage 1||0
8325356|NCT01397409|20524028|P6|NOT COMPLETED|Stage 1||0
8325357|NCT01397409|20524029|P5|NOT COMPLETED|Stage 1||0
8325358|NCT01397409|20524030|P4|NOT COMPLETED|Stage 1||0
8325359|NCT01397409|20524031|P3|NOT COMPLETED|Stage 1||0
8325360|NCT01397409|20524032|P2|NOT COMPLETED|Stage 1||0
8325361|NCT01397409|20524033|P1|NOT COMPLETED|Stage 1||0
8325362|NCT01397409|20524024|P10|COMPLETED|Stage 1||0
8325363|NCT01397409|20524025|P9|COMPLETED|Stage 1||0
8325364|NCT01397409|20524026|P8|COMPLETED|Stage 1||0
8325365|NCT01397409|20524027|P7|COMPLETED|Stage 1||0
8325366|NCT01397409|20524028|P6|COMPLETED|Stage 1||0
8325367|NCT01397409|20524029|P5|COMPLETED|Stage 1||0
8325368|NCT01397409|20524030|P4|COMPLETED|Stage 1||3
8325369|NCT01397409|20524031|P3|COMPLETED|Stage 1||6
8325370|NCT01397409|20524032|P2|COMPLETED|Stage 1||6
8325371|NCT01397409|20524033|P1|COMPLETED|Stage 1||9
8325372|NCT01397409|20524024|P10|STARTED|Stage 1||0
8325373|NCT01397409|20524025|P9|STARTED|Stage 1||0
8325374|NCT01397409|20524026|P8|STARTED|Stage 1||0
8325375|NCT01397409|20524027|P7|STARTED|Stage 1||0
8325376|NCT01397409|20524028|P6|STARTED|Stage 1||0
8325377|NCT01397409|20524029|P5|STARTED|Stage 1||0
8325378|NCT01397409|20524030|P4|STARTED|Stage 1||3
8325379|NCT01397409|20524031|P3|STARTED|Stage 1||6
8325380|NCT01397409|20524032|P2|STARTED|Stage 1||6
8325381|NCT01397409|20524033|P1|STARTED|Stage 1||9
8325382|NCT01397253|20524073|P2|NOT COMPLETED|Overall Study||149
8325383|NCT01397253|20524074|P1|NOT COMPLETED|Overall Study||126
8325384|NCT01397253|20524073|P2|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
8325385|NCT01397253|20524074|P1|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
8325386|NCT01397253|20524073|P2|STARTED|Overall Study||392
8325387|NCT01397253|20524074|P1|STARTED|Overall Study||443
8325388|NCT01397084|20524080|P1|NOT COMPLETED|Overall Study||8
8325389|NCT01397084|20524080|P1|COMPLETED|Overall Study||100
8325390|NCT01397084|20524080|P1|STARTED|Overall Study||108
8325391|NCT01397071|20524087|P1|NOT COMPLETED|Consumption of Beef Patty With Avocado||0
8325392|NCT01397071|20524087|P1|COMPLETED|Consumption of Beef Patty With Avocado||11
8325393|NCT01397071|20524087|P1|STARTED|Consumption of Beef Patty With Avocado||11
8325394|NCT01397071|20524087|P1|NOT COMPLETED|Consumption of Beef Patty Alone||0
8325395|NCT01397071|20524087|P1|COMPLETED|Consumption of Beef Patty Alone||11
8325396|NCT01397071|20524087|P1|STARTED|Consumption of Beef Patty Alone||11
8325397|NCT01396837|20524095|P1|NOT COMPLETED|Overall Study||4
8325398|NCT01396837|20524095|P1|COMPLETED|Overall Study||16
8325399|NCT01396837|20524095|P1|STARTED|Overall Study||20
8325400|NCT01396551|20524102|P1|NOT COMPLETED|Overall Study||0
8325401|NCT01396551|20524102|P1|COMPLETED|Overall Study||69
8325402|NCT01396551|20524102|P1|STARTED|Overall Study||69
8325403|NCT01396525|20524106|P1|NOT COMPLETED|Overall Study||26
8325404|NCT01396525|20524106|P1|COMPLETED|Overall Study||127
8325405|NCT01396525|20524106|P1|STARTED|Overall Study||153
8325406|NCT01396512|20524206|P2|NOT COMPLETED|Overall Study||1
8325407|NCT01396512|20524207|P1|NOT COMPLETED|Overall Study||0
8325408|NCT01396512|20524206|P2|COMPLETED|Overall Study||136
8325409|NCT01396512|20524207|P1|COMPLETED|Overall Study||137
8325410|NCT01396512|20524206|P2|STARTED|Overall Study||137
8325411|NCT01396512|20524207|P1|STARTED|Overall Study||137
8325412|NCT01396486|20524222|P3|NOT COMPLETED|Overall Study||12
8325413|NCT01396486|20524223|P2|NOT COMPLETED|Overall Study||12
8325414|NCT01396486|20524224|P1|NOT COMPLETED|Overall Study||10
8325415|NCT01396486|20524222|P3|COMPLETED|Overall Study||10
8325416|NCT01396486|20524223|P2|COMPLETED|Overall Study||7
8325417|NCT01396486|20524224|P1|COMPLETED|Overall Study||10
8325418|NCT01396486|20524222|P3|Exposed|Overall Study||17
8325419|NCT01396486|20524223|P2|Exposed|Overall Study||16
8325420|NCT01396486|20524224|P1|Exposed|Overall Study||19
8325421|NCT01396486|20524222|P3|STARTED|Overall Study||22
8325422|NCT01396486|20524223|P2|STARTED|Overall Study||19
8325423|NCT01396486|20524224|P1|STARTED|Overall Study||20
8325424|NCT01396447|20524239|P4|NOT COMPLETED|Overall Study||52
8325425|NCT01396447|20524240|P3|NOT COMPLETED|Overall Study||30
8325426|NCT01396447|20524241|P2|NOT COMPLETED|Overall Study||40
8325427|NCT01396447|20524242|P1|NOT COMPLETED|Overall Study||43
8325428|NCT01396447|20524239|P4|COMPLETED|Overall Study||94
8325429|NCT01396447|20524240|P3|COMPLETED|Overall Study||117
8325430|NCT01396447|20524241|P2|COMPLETED|Overall Study||103
8325431|NCT01396447|20524242|P1|COMPLETED|Overall Study||105
8325432|NCT01396447|20524239|P4|Received Treatment|Overall Study||146
8325433|NCT01396447|20524240|P3|Received Treatment|Overall Study||146
8325434|NCT01396447|20524241|P2|Received Treatment|Overall Study||141
8325435|NCT01396447|20524242|P1|Received Treatment|Overall Study||145
8325436|NCT01396447|20524239|P4|STARTED|Overall Study||146
8325437|NCT01396447|20524240|P3|STARTED|Overall Study||147
8325438|NCT01396447|20524241|P2|STARTED|Overall Study||143
8325439|NCT01396447|20524242|P1|STARTED|Overall Study||148
8325440|NCT01396434|20524259|P3|NOT COMPLETED|Overall Study||0
8325441|NCT01396434|20524260|P2|NOT COMPLETED|Overall Study||0
8325442|NCT01396434|20524261|P1|NOT COMPLETED|Overall Study||11
8325443|NCT01396434|20524259|P3|COMPLETED|Overall Study||14
8325444|NCT01396434|20524260|P2|COMPLETED|Overall Study||175
8325445|NCT01396434|20524261|P1|COMPLETED|Overall Study||2806
8325446|NCT01396434|20524259|P3|STARTED|Overall Study||14
8325447|NCT01396434|20524260|P2|STARTED|Overall Study||175
8325448|NCT01396434|20524261|P1|STARTED|Overall Study||2817
8325449|NCT01396421|20524273|P4|NOT COMPLETED|Overall Study||75
8325450|NCT01396421|20524274|P3|NOT COMPLETED|Overall Study||34
8325451|NCT01396421|20524275|P2|NOT COMPLETED|Overall Study||58
8325452|NCT01396421|20524276|P1|NOT COMPLETED|Overall Study||59
8325453|NCT01396421|20524273|P4|COMPLETED|Overall Study||109
8325454|NCT01396421|20524274|P3|COMPLETED|Overall Study||56
8325455|NCT01396421|20524275|P2|COMPLETED|Overall Study||124
8325456|NCT01396421|20524276|P1|COMPLETED|Overall Study||121
8325457|NCT01396421|20524273|P4|STARTED|Overall Study||184
8325458|NCT01396421|20524274|P3|STARTED|Overall Study||90
8325459|NCT01396421|20524275|P2|STARTED|Overall Study||182
8325460|NCT01396421|20524276|P1|STARTED|Overall Study||180
8325461|NCT01396395|20524348|P2|NOT COMPLETED|Overall Study||27
8325462|NCT01396395|20524349|P1|NOT COMPLETED|Overall Study||40
8325463|NCT01396395|20524348|P2|COMPLETED|Overall Study||175
8325464|NCT01396395|20524349|P1|COMPLETED|Overall Study||160
8325465|NCT01396395|20524348|P2|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
8325466|NCT01396395|20524349|P1|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
8325467|NCT01396395|20524348|P2|STARTED|Overall Study||202
8325468|NCT01396395|20524349|P1|STARTED|Overall Study||200
8325469|NCT01396382|20524384|P1|NOT COMPLETED|Overall Study||0
8325470|NCT01396382|20524384|P1|COMPLETED|Overall Study||97
8325471|NCT01396382|20524384|P1|STARTED|Overall Study||97
8325472|NCT01396317|20524391|P2|NOT COMPLETED|Overall Study||0
8325473|NCT01396317|20524392|P1|NOT COMPLETED|Overall Study||1
8325474|NCT01396317|20524391|P2|COMPLETED|Overall Study||10
8325475|NCT01396317|20524392|P1|COMPLETED|Overall Study||9
8325476|NCT01396317|20524391|P2|STARTED|Overall Study||10
8325477|NCT01396317|20524392|P1|STARTED|Overall Study||10
8325478|NCT01396265|20524406|P1|NOT COMPLETED|Rifa+Afatinib||1
8325479|NCT01396265|20524406|P1|COMPLETED|Rifa+Afatinib||21
8325480|NCT01396265|20524406|P1|STARTED|Rifa+Afatinib||22
8325481|NCT01396265|20524406|P1|NOT COMPLETED|Washout||0
8325482|NCT01396265|20524406|P1|COMPLETED|Washout||22
8325483|NCT01396265|20524406|P1|STARTED|Washout||22
8325484|NCT01396265|20524406|P1|NOT COMPLETED|Afatinib||0
8325485|NCT01396265|20524406|P1|COMPLETED|Afatinib||22
8325486|NCT01396265|20524406|P1|STARTED|Afatinib||22
8325487|NCT01396239|20524433|P4|NOT COMPLETED|Overall Study||0
8325488|NCT01396239|20524434|P3|NOT COMPLETED|Overall Study||0
8325489|NCT01396239|20524435|P2|NOT COMPLETED|Overall Study||0
8325490|NCT01396239|20524436|P1|NOT COMPLETED|Overall Study||0
8325491|NCT01396239|20524433|P4|COMPLETED|Overall Study||2
8325492|NCT01396239|20524434|P3|COMPLETED|Overall Study||4
8325493|NCT01396239|20524435|P2|COMPLETED|Overall Study||2
8325494|NCT01396239|20524436|P1|COMPLETED|Overall Study||4
8325495|NCT01396239|20524433|P4|STARTED|Overall Study||2
8325496|NCT01396239|20524434|P3|STARTED|Overall Study||4
8325497|NCT01396239|20524435|P2|STARTED|Overall Study||2
8325498|NCT01396239|20524436|P1|STARTED|Overall Study||4
8325499|NCT01396226|20524459|P2|NOT COMPLETED|Overall Study||0
8325500|NCT01396226|20524460|P1|NOT COMPLETED|Overall Study||0
8325501|NCT01396226|20524459|P2|COMPLETED|Overall Study||6
8325502|NCT01396226|20524460|P1|COMPLETED|Overall Study||12
8325503|NCT01396226|20524459|P2|Patients Who Completed Treatment|Overall Study||6
8325504|NCT01396226|20524460|P1|Patients Who Completed Treatment|Overall Study||12
8325505|NCT01396226|20524459|P2|Patients Who Received Treatment|Overall Study||6
8325506|NCT01396226|20524460|P1|Patients Who Received Treatment|Overall Study||12
8325507|NCT01396226|20524459|P2|STARTED|Overall Study||6
8325508|NCT01396226|20524460|P1|STARTED|Overall Study||12
8325509|NCT01396187|20524495|P5|NOT COMPLETED|Overall Study||1
8325510|NCT01396187|20524496|P4|NOT COMPLETED|Overall Study||0
8325511|NCT01396187|20524497|P3|NOT COMPLETED|Overall Study||1
8325512|NCT01396187|20524498|P2|NOT COMPLETED|Overall Study||3
8325513|NCT01396187|20524499|P1|NOT COMPLETED|Overall Study||1
8325514|NCT01396187|20524495|P5|COMPLETED|Overall Study||9
8325515|NCT01396187|20524496|P4|COMPLETED|Overall Study||10
8325516|NCT01396187|20524497|P3|COMPLETED|Overall Study||9
8325517|NCT01396187|20524498|P2|COMPLETED|Overall Study||9
8325518|NCT01396187|20524499|P1|COMPLETED|Overall Study||7
8325519|NCT01396187|20524495|P5|STARTED|Overall Study||10
8325520|NCT01396187|20524496|P4|STARTED|Overall Study||10
8325521|NCT01396187|20524497|P3|STARTED|Overall Study||10
8325522|NCT01396187|20524498|P2|STARTED|Overall Study||12
8325523|NCT01396187|20524499|P1|STARTED|Overall Study||8
8325524|NCT01396161|20524599|P7|NOT COMPLETED|Overall Study||1
8325525|NCT01396161|20524600|P6|NOT COMPLETED|Overall Study||0
8325526|NCT01396161|20524601|P5|NOT COMPLETED|Overall Study||1
8325527|NCT01396161|20524602|P4|NOT COMPLETED|Overall Study||0
8325528|NCT01396161|20524603|P3|NOT COMPLETED|Overall Study||0
8325529|NCT01396161|20524604|P2|NOT COMPLETED|Overall Study||0
8325530|NCT01396161|20524605|P1|NOT COMPLETED|Overall Study||0
8325531|NCT01396161|20524599|P7|COMPLETED|Overall Study||10
8325532|NCT01396161|20524600|P6|COMPLETED|Overall Study||9
8325533|NCT01396161|20524601|P5|COMPLETED|Overall Study||8
8325534|NCT01396161|20524602|P4|COMPLETED|Overall Study||9
8325535|NCT01396161|20524603|P3|COMPLETED|Overall Study||9
8325536|NCT01396161|20524604|P2|COMPLETED|Overall Study||5
8325537|NCT01396161|20524605|P1|COMPLETED|Overall Study||12
8325538|NCT01396161|20524599|P7|STARTED|Overall Study||11
8325539|NCT01396161|20524600|P6|STARTED|Overall Study||9
8325540|NCT01396161|20524601|P5|STARTED|Overall Study||9
8325541|NCT01396161|20524602|P4|STARTED|Overall Study||9
8325542|NCT01396161|20524603|P3|STARTED|Overall Study||9
8325543|NCT01396161|20524604|P2|STARTED|Overall Study||5
8325544|NCT01396161|20524605|P1|STARTED|Overall Study||12
8325545|NCT01396148|20524658|P1|NOT COMPLETED|Overall Study||1
8325546|NCT01396148|20524658|P1|COMPLETED|Overall Study||5
8325547|NCT01396148|20524658|P1|STARTED|Overall Study||6
8325548|NCT01396083|20524688|P2|NOT COMPLETED|Overall Study||47
8325549|NCT01396083|20524689|P1|NOT COMPLETED|Overall Study||11
8325550|NCT01396083|20524688|P2|COMPLETED|Overall Study||72
8325551|NCT01396083|20524689|P1|COMPLETED|Overall Study||113
8325552|NCT01396083|20524688|P2|STARTED|Overall Study||119
8325553|NCT01396083|20524689|P1|STARTED|Overall Study||124
8325554|NCT01396070|20524713|P1|NOT COMPLETED|Overall Study||19
8325555|NCT01396070|20524713|P1|COMPLETED|Overall Study||17
8325556|NCT01396070|20524713|P1|STARTED|Overall Study||36
8325557|NCT01396057|20524722|P2|NOT COMPLETED|Overall Study||18
8325558|NCT01396057|20524723|P1|NOT COMPLETED|Overall Study||11
8325559|NCT01396057|20524722|P2|COMPLETED|Overall Study||100
8325560|NCT01396057|20524723|P1|COMPLETED|Overall Study||115
8325561|NCT01396057|20524722|P2|STARTED|Overall Study||118
8325562|NCT01396057|20524723|P1|STARTED|Overall Study||126
8325563|NCT01396044|20524749|P2|NOT COMPLETED|Overall Study||0
8325564|NCT01396044|20524750|P1|NOT COMPLETED|Overall Study||0
8325565|NCT01396044|20524749|P2|COMPLETED|Overall Study||171
8325566|NCT01396044|20524750|P1|COMPLETED|Overall Study||125
8325567|NCT01396044|20524749|P2|STARTED|Overall Study||171
8325568|NCT01396044|20524750|P1|STARTED|Overall Study||125
8325569|NCT01396005|20524772|P2|NOT COMPLETED|Overall Study||2
8325570|NCT01396005|20524773|P1|NOT COMPLETED|Overall Study||0
8325571|NCT01396005|20524772|P2|COMPLETED|Overall Study||9
8325572|NCT01396005|20524773|P1|COMPLETED|Overall Study||10
8325573|NCT01396005|20524772|P2|STARTED|Overall Study||11
8325574|NCT01396005|20524773|P1|STARTED|Overall Study||10
8325575|NCT01395966|20524792|P3|NOT COMPLETED|Overall Study||8
8325576|NCT01395966|20524793|P2|NOT COMPLETED|Overall Study||19
8325577|NCT01395966|20524794|P1|NOT COMPLETED|Overall Study||10
8325578|NCT01395966|20524792|P3|COMPLETED|Overall Study||104
8325579|NCT01395966|20524793|P2|COMPLETED|Overall Study||91
8325580|NCT01395966|20524794|P1|COMPLETED|Overall Study||99
8325581|NCT01395966|20524792|P3|STARTED|Overall Study||112
8325582|NCT01395966|20524793|P2|STARTED|Overall Study||110
8325583|NCT01395966|20524794|P1|STARTED|Overall Study||109
8325584|NCT01395914|20524804|P2|NOT COMPLETED|Overall Study||37
8325585|NCT01395914|20524805|P1|NOT COMPLETED|Overall Study||72
8325586|NCT01395914|20524804|P2|COMPLETED|Overall Study||131
8325587|NCT01395914|20524805|P1|COMPLETED|Overall Study||273
8325588|NCT01395914|20524804|P2|Safety Population|Overall Study||167
8325589|NCT01395914|20524805|P1|Safety Population|Overall Study||343
8325590|NCT01395914|20524804|P2|ITT Population|Overall Study||168
8325591|NCT01395914|20524805|P1|ITT Population|Overall Study||345
8325592|NCT01395914|20524804|P2|STARTED|Overall Study||168
8325593|NCT01395914|20524805|P1|STARTED|Overall Study||345
8325594|NCT01395901|20524819|P2|NOT COMPLETED|Overall Study||5
8325595|NCT01395901|20524820|P1|NOT COMPLETED|Overall Study||10
8325596|NCT01395901|20524819|P2|COMPLETED|Overall Study|Treated patients completing the study|329
8325597|NCT01395901|20524820|P1|COMPLETED|Overall Study|Treated patients completing the study|326
8325598|NCT01395901|20524819|P2|STARTED|Overall Study|Randomized Population|334
8325599|NCT01395901|20524820|P1|STARTED|Overall Study|Randomized Population|336
8325600|NCT01395888|20524836|P3|NOT COMPLETED|Treatment Period (TP)||17
8325601|NCT01395888|20524837|P2|NOT COMPLETED|Treatment Period (TP)||15
8325602|NCT01395888|20524838|P1|NOT COMPLETED|Treatment Period (TP)||0
8325603|NCT01395888|20524836|P3|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
8325604|NCT01395888|20524837|P2|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
8325605|NCT01395888|20524838|P1|COMPLETED|Treatment Period (TP)||0
8325606|NCT01395888|20524836|P3|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
8325607|NCT01395888|20524837|P2|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
8325608|NCT01395888|20524838|P1|Completed the Treatment Period|Treatment Period (TP)||0
8325609|NCT01395888|20524836|P3|STARTED|Treatment Period (TP)||130
8325610|NCT01395888|20524837|P2|STARTED|Treatment Period (TP)||127
8325611|NCT01395888|20524838|P1|STARTED|Treatment Period (TP)||0
8325612|NCT01395888|20524836|P3|NOT COMPLETED|2-week Run-in Period||0
8325613|NCT01395888|20524837|P2|NOT COMPLETED|2-week Run-in Period||0
8325614|NCT01395888|20524838|P1|NOT COMPLETED|2-week Run-in Period||22
8325615|NCT01395888|20524836|P3|COMPLETED|2-week Run-in Period||0
8325616|NCT01395888|20524837|P2|COMPLETED|2-week Run-in Period||0
8325617|NCT01395888|20524838|P1|COMPLETED|2-week Run-in Period||257
8325618|NCT01395888|20524836|P3|STARTED|2-week Run-in Period||0
8325619|NCT01395888|20524837|P2|STARTED|2-week Run-in Period||0
8325620|NCT01395888|20524838|P1|STARTED|2-week Run-in Period||279
8325621|NCT01395823|20524846|P2|NOT COMPLETED|Overall Study||9
8325622|NCT01395823|20524847|P1|NOT COMPLETED|Overall Study||15
8325623|NCT01395823|20524846|P2|COMPLETED|Overall Study||130
8325624|NCT01395823|20524847|P1|COMPLETED|Overall Study||122
8325625|NCT01395823|20524846|P2|STARTED|Overall Study||139
8325626|NCT01395823|20524847|P1|STARTED|Overall Study||137
8325627|NCT01395810|20524857|P4|NOT COMPLETED|Overall Study||0
8325628|NCT01395810|20524858|P3|NOT COMPLETED|Overall Study||0
8325629|NCT01395810|20524859|P2|NOT COMPLETED|Overall Study||4
8325630|NCT01395810|20524860|P1|NOT COMPLETED|Overall Study||2
8325631|NCT01395810|20524857|P4|COMPLETED|Overall Study||5
8325632|NCT01395810|20524858|P3|COMPLETED|Overall Study||0
8325633|NCT01395810|20524859|P2|COMPLETED|Overall Study||44
8325634|NCT01395810|20524860|P1|COMPLETED|Overall Study||16
8325635|NCT01395810|20524857|P4|After Switching the Arms|Overall Study||5
8325636|NCT01395810|20524858|P3|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
8325637|NCT01395810|20524859|P2|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
8325638|NCT01395810|20524860|P1|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
8325639|NCT01395810|20524857|P4|STARTED|Overall Study||5
8325640|NCT01395810|20524858|P3|STARTED|Overall Study||0
8325641|NCT01395810|20524859|P2|STARTED|Overall Study||48
8325642|NCT01395810|20524860|P1|STARTED|Overall Study||18
8325643|NCT01395797|20524894|P6|NOT COMPLETED|Overall Study||3
8325644|NCT01395797|20524895|P5|NOT COMPLETED|Overall Study||2
8325645|NCT01395797|20524896|P4|NOT COMPLETED|Overall Study||2
8325646|NCT01395797|20524897|P3|NOT COMPLETED|Overall Study||4
8325647|NCT01395797|20524898|P2|NOT COMPLETED|Overall Study||1
8325648|NCT01395797|20524899|P1|NOT COMPLETED|Overall Study||3
8325649|NCT01395797|20524894|P6|COMPLETED|Overall Study||14
8325650|NCT01395797|20524895|P5|COMPLETED|Overall Study||7
8325651|NCT01395797|20524896|P4|COMPLETED|Overall Study||13
8325652|NCT01395797|20524897|P3|COMPLETED|Overall Study||14
8325653|NCT01395797|20524898|P2|COMPLETED|Overall Study||3
8325654|NCT01395797|20524899|P1|COMPLETED|Overall Study||16
8325655|NCT01395797|20524894|P6|STARTED|Overall Study||17
8325656|NCT01395797|20524895|P5|STARTED|Overall Study||9
8325657|NCT01395797|20524896|P4|STARTED|Overall Study||15
8325658|NCT01395797|20524897|P3|STARTED|Overall Study||18
8325659|NCT01395797|20524898|P2|STARTED|Overall Study||4
8325660|NCT01395797|20524899|P1|STARTED|Overall Study||19
8325661|NCT01395784|20524919|P1|NOT COMPLETED|Overall Study||15
8325662|NCT01395784|20524919|P1|COMPLETED|Overall Study||17
8325663|NCT01395784|20524919|P1|STARTED|Overall Study||32
8325664|NCT01395758|20524926|P3|NOT COMPLETED|Crossover Period||0
8325665|NCT01395758|20524927|P2|NOT COMPLETED|Crossover Period||0
8325666|NCT01395758|20524928|P1|NOT COMPLETED|Crossover Period||0
8325667|NCT01395758|20524926|P3|COMPLETED|Crossover Period||26
8325668|NCT01395758|20524927|P2|COMPLETED|Crossover Period||0
8325669|NCT01395758|20524928|P1|COMPLETED|Crossover Period||0
8325670|NCT01395758|20524926|P3|STARTED|Crossover Period||26
8325671|NCT01395758|20524927|P2|STARTED|Crossover Period||0
8325672|NCT01395758|20524928|P1|STARTED|Crossover Period||0
8325673|NCT01395758|20524926|P3|NOT COMPLETED|Open-label Treatment Period||0
8325674|NCT01395758|20524927|P2|NOT COMPLETED|Open-label Treatment Period||0
8325675|NCT01395758|20524928|P1|NOT COMPLETED|Open-label Treatment Period||4
8325676|NCT01395758|20524926|P3|COMPLETED|Open-label Treatment Period||0
8325677|NCT01395758|20524927|P2|COMPLETED|Open-label Treatment Period||45
8325678|NCT01395758|20524928|P1|COMPLETED|Open-label Treatment Period||47
8325679|NCT01395758|20524926|P3|STARTED|Open-label Treatment Period||0
8325680|NCT01395758|20524927|P2|STARTED|Open-label Treatment Period||45
8325681|NCT01395758|20524928|P1|STARTED|Open-label Treatment Period||51
8325682|NCT01395537|20524939|P1|NOT COMPLETED|Phase II||0
8325683|NCT01395537|20524939|P1|COMPLETED|Phase II||1
8325684|NCT01395537|20524939|P1|STARTED|Phase II||1
8325685|NCT01395537|20524939|P1|NOT COMPLETED|Phase I||0
8325686|NCT01395537|20524939|P1|COMPLETED|Phase I||13
8325687|NCT01395537|20524939|P1|STARTED|Phase I||13
8325688|NCT01395524|20524948|P3|NOT COMPLETED|Overall Study||17
8325689|NCT01395524|20524949|P2|NOT COMPLETED|Overall Study||16
8325690|NCT01395524|20524950|P1|NOT COMPLETED|Overall Study||18
8325691|NCT01395524|20524948|P3|COMPLETED|Overall Study||89
8325692|NCT01395524|20524949|P2|COMPLETED|Overall Study||83
8325693|NCT01395524|20524950|P1|COMPLETED|Overall Study||79
8325694|NCT01395524|20524948|P3|STARTED|Overall Study||106
8325695|NCT01395524|20524949|P2|STARTED|Overall Study||99
8325696|NCT01395524|20524950|P1|STARTED|Overall Study||97
8325697|NCT01395394|20524973|P3|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
8325698|NCT01395394|20524974|P2|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
8325699|NCT01395394|20524975|P1|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
8325700|NCT01395394|20524973|P3|COMPLETED|Study Visit 2 (Non-responders Only)||0
8325701|NCT01395394|20524974|P2|COMPLETED|Study Visit 2 (Non-responders Only)||0
8325702|NCT01395394|20524975|P1|COMPLETED|Study Visit 2 (Non-responders Only)||3
8325703|NCT01395394|20524973|P3|STARTED|Study Visit 2 (Non-responders Only)||0
8325704|NCT01395394|20524974|P2|STARTED|Study Visit 2 (Non-responders Only)||0
8325705|NCT01395394|20524975|P1|STARTED|Study Visit 2 (Non-responders Only)||3
8325706|NCT01395394|20524973|P3|NOT COMPLETED|Baseline Study Visit||0
8325707|NCT01395394|20524974|P2|NOT COMPLETED|Baseline Study Visit||0
8325708|NCT01395394|20524975|P1|NOT COMPLETED|Baseline Study Visit||1
8325709|NCT01395394|20524973|P3|COMPLETED|Baseline Study Visit||5
8325710|NCT01395394|20524974|P2|COMPLETED|Baseline Study Visit||3
8325711|NCT01395394|20524975|P1|COMPLETED|Baseline Study Visit||3
8325712|NCT01395394|20524973|P3|STARTED|Baseline Study Visit||5
8325713|NCT01395394|20524974|P2|STARTED|Baseline Study Visit||3
8325714|NCT01395394|20524975|P1|STARTED|Baseline Study Visit||4
8325715|NCT01395368|20524986|P1|NOT COMPLETED|Overall Study||16
8325716|NCT01395368|20524986|P1|COMPLETED|Overall Study||92
8325717|NCT01395368|20524986|P1|STARTED|Overall Study||108
8325718|NCT01395329|20524993|P3|NOT COMPLETED|Overall Study||0
8325719|NCT01395329|20524994|P2|NOT COMPLETED|Overall Study||0
8325720|NCT01395329|20524995|P1|NOT COMPLETED|Overall Study||0
8325721|NCT01395329|20524993|P3|COMPLETED|Overall Study||14
8325722|NCT01395329|20524994|P2|COMPLETED|Overall Study||14
8325723|NCT01395329|20524995|P1|COMPLETED|Overall Study||14
8325724|NCT01395329|20524993|P3|STARTED|Overall Study||14
8325725|NCT01395329|20524994|P2|STARTED|Overall Study||14
8325726|NCT01395329|20524995|P1|STARTED|Overall Study||14
8325727|NCT01395316|20525042|P1|NOT COMPLETED|Overall Study||3
8325728|NCT01395316|20525042|P1|COMPLETED|Overall Study||5
8325729|NCT01395316|20525042|P1|STARTED|Overall Study||8
8325730|NCT01395277|20525048|P2|NOT COMPLETED|Overall Study||0
8325731|NCT01395277|20525049|P1|NOT COMPLETED|Overall Study||0
8325732|NCT01395277|20525048|P2|COMPLETED|Overall Study||15
8325733|NCT01395277|20525049|P1|COMPLETED|Overall Study||15
8325734|NCT01395277|20525048|P2|STARTED|Overall Study||15
8325735|NCT01395277|20525049|P1|STARTED|Overall Study||15
8325736|NCT01395043|20525057|P1|NOT COMPLETED|Overall Study||0
8325737|NCT01395043|20525057|P1|COMPLETED|Overall Study||15
8325738|NCT01395043|20525057|P1|STARTED|Overall Study||15
8325739|NCT01395030|20525062|P1|NOT COMPLETED|Overall Study||7
8325740|NCT01395030|20525062|P1|COMPLETED|Overall Study||57
8325741|NCT01395030|20525062|P1|Adequate Tissue for Analysis|Overall Study||50
8325742|NCT01395030|20525062|P1|Complete FCH PET/CT|Overall Study||57
8325743|NCT01395030|20525062|P1|STARTED|Overall Study||64
8325744|NCT01395017|20525072|P2|NOT COMPLETED|Overall Study||102
8325745|NCT01395017|20525073|P1|NOT COMPLETED|Overall Study||100
8325746|NCT01395017|20525072|P2|COMPLETED|Overall Study||0
8325747|NCT01395017|20525073|P1|COMPLETED|Overall Study||0
8325748|NCT01395017|20525072|P2|Treated|Overall Study||101
8325749|NCT01395017|20525073|P1|Treated|Overall Study||98
8325750|NCT01395017|20525072|P2|STARTED|Overall Study||102
8325751|NCT01395017|20525073|P1|STARTED|Overall Study||100
8325752|NCT01394991|20525083|P2|NOT COMPLETED|Overall Study||72
8325753|NCT01394991|20525084|P1|NOT COMPLETED|Overall Study||59
8325754|NCT01394991|20525083|P2|COMPLETED|Overall Study||190
8325755|NCT01394991|20525084|P1|COMPLETED|Overall Study||183
8325756|NCT01394991|20525083|P2|STARTED|Overall Study||262
8325757|NCT01394991|20525084|P1|STARTED|Overall Study||242
8325764|NCT01394952|20525115|P2|NOT COMPLETED|Overall Study||17
8325765|NCT01394952|20525116|P1|NOT COMPLETED|Overall Study||17
8325766|NCT01394952|20525115|P2|COMPLETED|Overall Study||4932
8325767|NCT01394952|20525116|P1|COMPLETED|Overall Study||4935
8325768|NCT01394952|20525115|P2|Received at Least One Dose of Study Drug|Overall Study||4943
8325769|NCT01394952|20525116|P1|Received at Least One Dose of Study Drug|Overall Study||4949
8325770|NCT01394952|20525115|P2|STARTED|Overall Study||4949
8325771|NCT01394952|20525116|P1|STARTED|Overall Study||4952
8325772|NCT01394939|20525136|P4|NOT COMPLETED|Overall Study||7
8325773|NCT01394939|20525137|P3|NOT COMPLETED|Overall Study||0
8325774|NCT01394939|20525138|P2|NOT COMPLETED|Overall Study||10
8325775|NCT01394939|20525139|P1|NOT COMPLETED|Overall Study||1
8325776|NCT01394939|20525136|P4|COMPLETED|Overall Study||10
8325777|NCT01394939|20525137|P3|COMPLETED|Overall Study||4
8325778|NCT01394939|20525138|P2|COMPLETED|Overall Study||15
8325779|NCT01394939|20525139|P1|COMPLETED|Overall Study||3
8325780|NCT01394939|20525136|P4|STARTED|Overall Study||17
8325781|NCT01394939|20525137|P3|STARTED|Overall Study||4
8325782|NCT01394939|20525138|P2|STARTED|Overall Study||25
8325783|NCT01394939|20525139|P1|STARTED|Overall Study||4
8325784|NCT01394926|20525149|P1|NOT COMPLETED|Overall Study||0
8325785|NCT01394926|20525149|P1|COMPLETED|Overall Study||21
8325786|NCT01394926|20525149|P1|STARTED|Overall Study||21
8325787|NCT01394718|20525160|P2|NOT COMPLETED|Overall Study||1
8325788|NCT01394718|20525161|P1|NOT COMPLETED|Overall Study||2
8325789|NCT01394718|20525160|P2|COMPLETED|Overall Study||29
8325790|NCT01394718|20525161|P1|COMPLETED|Overall Study||28
8325791|NCT01394718|20525160|P2|STARTED|Overall Study||30
8325792|NCT01394718|20525161|P1|STARTED|Overall Study||30
8325793|NCT01394705|20525175|P2|NOT COMPLETED|Overall Study||2
8325794|NCT01394705|20525176|P1|NOT COMPLETED|Overall Study||2
8325795|NCT01394705|20525175|P2|COMPLETED|Overall Study||19
8325796|NCT01394705|20525176|P1|COMPLETED|Overall Study||19
8325797|NCT01394705|20525175|P2|STARTED|Overall Study||21
8325798|NCT01394705|20525176|P1|STARTED|Overall Study||21
8325799|NCT01394692|20525186|P2|NOT COMPLETED|Overall Study||0
8325800|NCT01394692|20525187|P1|NOT COMPLETED|Overall Study||0
8325801|NCT01394692|20525186|P2|COMPLETED|Overall Study||29
8325802|NCT01394692|20525187|P1|COMPLETED|Overall Study||29
8325803|NCT01394692|20525186|P2|STARTED|Overall Study||29
8325804|NCT01394692|20525187|P1|STARTED|Overall Study||29
8325805|NCT01394627|20525193|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8325806|NCT01394627|20525194|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8325807|NCT01394627|20525193|P2|COMPLETED|Second Intervention (1 Day)||12
8325808|NCT01394627|20525194|P1|COMPLETED|Second Intervention (1 Day)||7
8325809|NCT01394627|20525193|P2|STARTED|Second Intervention (1 Day)||12
8325810|NCT01394627|20525194|P1|STARTED|Second Intervention (1 Day)||7
8325811|NCT01394627|20525193|P2|NOT COMPLETED|Washout (1-3 Months)||0
8325812|NCT01394627|20525194|P1|NOT COMPLETED|Washout (1-3 Months)||1
8325813|NCT01394627|20525193|P2|COMPLETED|Washout (1-3 Months)||12
8325814|NCT01394627|20525194|P1|COMPLETED|Washout (1-3 Months)||7
8325815|NCT01394627|20525193|P2|STARTED|Washout (1-3 Months)||12
8325816|NCT01394627|20525194|P1|STARTED|Washout (1-3 Months)||8
8325817|NCT01394627|20525193|P2|NOT COMPLETED|First Intervention (1 Day)||1
8325818|NCT01394627|20525194|P1|NOT COMPLETED|First Intervention (1 Day)||0
8325819|NCT01394627|20525193|P2|COMPLETED|First Intervention (1 Day)||12
8325820|NCT01394627|20525194|P1|COMPLETED|First Intervention (1 Day)||8
8325821|NCT01394627|20525193|P2|STARTED|First Intervention (1 Day)||13
8325822|NCT01394627|20525194|P1|STARTED|First Intervention (1 Day)||8
8325823|NCT01394614|20525204|P2|NOT COMPLETED|Overall Study||0
8325824|NCT01394614|20525205|P1|NOT COMPLETED|Overall Study||0
8325825|NCT01394614|20525204|P2|COMPLETED|Overall Study||16
8325826|NCT01394614|20525205|P1|COMPLETED|Overall Study||8
8325827|NCT01394614|20525204|P2|STARTED|Overall Study||16
8325828|NCT01394614|20525205|P1|STARTED|Overall Study||8
8325829|NCT01394523|20525214|P3|NOT COMPLETED|Overall Study||0
8325830|NCT01394523|20525215|P2|NOT COMPLETED|Overall Study||0
8325831|NCT01394523|20525216|P1|NOT COMPLETED|Overall Study||1
8325832|NCT01394523|20525214|P3|COMPLETED|Overall Study||13
8325833|NCT01394523|20525215|P2|COMPLETED|Overall Study||13
8325834|NCT01394523|20525216|P1|COMPLETED|Overall Study||12
8325835|NCT01394523|20525214|P3|STARTED|Overall Study||13
8325836|NCT01394523|20525215|P2|STARTED|Overall Study||13
8325837|NCT01394523|20525216|P1|STARTED|Overall Study||13
8325838|NCT01394510|20525224|P1|NOT COMPLETED|Overall Study||0
8325839|NCT01394510|20525224|P1|COMPLETED|Overall Study||13
8325840|NCT01394510|20525224|P1|STARTED|Overall Study||13
8325841|NCT01394276|20525230|P1|NOT COMPLETED|Overall Study||62
8325842|NCT01394276|20525230|P1|COMPLETED|Overall Study||260
8325843|NCT01394276|20525230|P1|STARTED|Overall Study||322
8325844|NCT01394250|20525254|P2|NOT COMPLETED|Successful IV Placement & Follow-Up||11
8325845|NCT01394250|20525255|P1|NOT COMPLETED|Successful IV Placement & Follow-Up||6
8325846|NCT01394250|20525254|P2|COMPLETED|Successful IV Placement & Follow-Up||110
8325847|NCT01394250|20525255|P1|COMPLETED|Successful IV Placement & Follow-Up||114
8325848|NCT01394250|20525254|P2|STARTED|Successful IV Placement & Follow-Up||121
8325849|NCT01394250|20525255|P1|STARTED|Successful IV Placement & Follow-Up||120
8325850|NCT01394250|20525254|P2|NOT COMPLETED|Randomization and IV Placement Attempt||13
8325851|NCT01394250|20525255|P1|NOT COMPLETED|Randomization and IV Placement Attempt||14
8325852|NCT01394250|20525254|P2|COMPLETED|Randomization and IV Placement Attempt||121
8325853|NCT01394250|20525255|P1|COMPLETED|Randomization and IV Placement Attempt||120
8325854|NCT01394250|20525254|P2|STARTED|Randomization and IV Placement Attempt||134
8325855|NCT01394250|20525255|P1|STARTED|Randomization and IV Placement Attempt||134
8325856|NCT01394211|20525263|P1|NOT COMPLETED|Overall Study||2
8325857|NCT01394211|20525263|P1|COMPLETED|Overall Study||0
8325858|NCT01394211|20525263|P1|STARTED|Overall Study||2
8325859|NCT01394185|20525269|P6|NOT COMPLETED|Overall Study||1
8325860|NCT01394185|20525270|P5|NOT COMPLETED|Overall Study||4
8325861|NCT01394185|20525271|P4|NOT COMPLETED|Overall Study||1
8325862|NCT01394185|20525272|P3|NOT COMPLETED|Overall Study||0
8325863|NCT01394185|20525273|P2|NOT COMPLETED|Overall Study||0
8325864|NCT01394185|20525274|P1|NOT COMPLETED|Overall Study||6
8325865|NCT01394185|20525269|P6|COMPLETED|Overall Study||2
8325866|NCT01394185|20525270|P5|COMPLETED|Overall Study||2
8325867|NCT01394185|20525271|P4|COMPLETED|Overall Study||3
8325868|NCT01394185|20525272|P3|COMPLETED|Overall Study||2
8325869|NCT01394185|20525273|P2|COMPLETED|Overall Study||2
8325870|NCT01394185|20525274|P1|COMPLETED|Overall Study||2
8325871|NCT01394185|20525269|P6|STARTED|Overall Study||3
8325872|NCT01394185|20525270|P5|STARTED|Overall Study||6
8325873|NCT01394185|20525271|P4|STARTED|Overall Study||4
8325874|NCT01394185|20525272|P3|STARTED|Overall Study||2
8325875|NCT01394185|20525273|P2|STARTED|Overall Study||2
8325876|NCT01394185|20525274|P1|STARTED|Overall Study||8
8325877|NCT01394159|20525287|P2|NOT COMPLETED|Overall Study||0
8325878|NCT01394159|20525288|P1|NOT COMPLETED|Overall Study||0
8325879|NCT01394159|20525287|P2|COMPLETED|Overall Study||28
8325880|NCT01394159|20525288|P1|COMPLETED|Overall Study||28
8325881|NCT01394159|20525287|P2|STARTED|Overall Study||28
8325882|NCT01394159|20525288|P1|STARTED|Overall Study||28
8325883|NCT01394081|20525300|P2|NOT COMPLETED|Overall Study||0
8325884|NCT01394081|20525301|P1|NOT COMPLETED|Overall Study||0
8325885|NCT01394081|20525300|P2|COMPLETED|Overall Study||102
8325886|NCT01394081|20525301|P1|COMPLETED|Overall Study||101
8325887|NCT01394081|20525300|P2|STARTED|Overall Study||102
8325888|NCT01394081|20525301|P1|STARTED|Overall Study||101
8325889|NCT01394003|20525317|P8|NOT COMPLETED|Overall Study||0
8325890|NCT01394003|20525318|P7|NOT COMPLETED|Overall Study||0
8325891|NCT01394003|20525319|P6|NOT COMPLETED|Overall Study||0
8325892|NCT01394003|20525320|P5|NOT COMPLETED|Overall Study||0
8325893|NCT01394003|20525321|P4|NOT COMPLETED|Overall Study||0
8325894|NCT01394003|20525322|P3|NOT COMPLETED|Overall Study||0
8325895|NCT01394003|20525323|P2|NOT COMPLETED|Overall Study||0
8325896|NCT01394003|20525324|P1|NOT COMPLETED|Overall Study||0
8325897|NCT01394003|20525317|P8|COMPLETED|Overall Study||2
8325898|NCT01394003|20525318|P7|COMPLETED|Overall Study||6
8325899|NCT01394003|20525319|P6|COMPLETED|Overall Study||3
8325900|NCT01394003|20525320|P5|COMPLETED|Overall Study||3
8325901|NCT01394003|20525321|P4|COMPLETED|Overall Study||6
8325902|NCT01394003|20525322|P3|COMPLETED|Overall Study||3
8325903|NCT01394003|20525323|P2|COMPLETED|Overall Study||8
8325904|NCT01394003|20525324|P1|COMPLETED|Overall Study||3
8325905|NCT01394003|20525317|P8|Received at Least 1 Dose of Study Drug|Overall Study||2
8325906|NCT01394003|20525318|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
8325907|NCT01394003|20525319|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
8325908|NCT01394003|20525320|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
8325909|NCT01394003|20525321|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8325910|NCT01394003|20525322|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8325911|NCT01394003|20525323|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8325912|NCT01394003|20525324|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8325913|NCT01394003|20525317|P8|STARTED|Overall Study||2
8325914|NCT01394003|20525318|P7|STARTED|Overall Study||6
8325915|NCT01394003|20525319|P6|STARTED|Overall Study||3
8325916|NCT01394003|20525320|P5|STARTED|Overall Study||3
8325917|NCT01394003|20525321|P4|STARTED|Overall Study||6
8325918|NCT01394003|20525322|P3|STARTED|Overall Study||3
8325919|NCT01394003|20525323|P2|STARTED|Overall Study||8
8325920|NCT01394003|20525324|P1|STARTED|Overall Study||3
8325921|NCT01393990|20525378|P18|NOT COMPLETED|Overall Study||0
8325922|NCT01393990|20525379|P17|NOT COMPLETED|Overall Study||0
8325923|NCT01393990|20525380|P16|NOT COMPLETED|Overall Study||3
8325924|NCT01393990|20525381|P15|NOT COMPLETED|Overall Study||9
8325925|NCT01393990|20525382|P14|NOT COMPLETED|Overall Study||2
8325926|NCT01393990|20525383|P13|NOT COMPLETED|Overall Study||0
8325927|NCT01393990|20525384|P12|NOT COMPLETED|Overall Study||0
8325928|NCT01393990|20525385|P11|NOT COMPLETED|Overall Study||0
8325929|NCT01393990|20525386|P10|NOT COMPLETED|Overall Study||1
8325930|NCT01393990|20525387|P9|NOT COMPLETED|Overall Study||3
8325931|NCT01393990|20525388|P8|NOT COMPLETED|Overall Study||1
8325932|NCT01393990|20525389|P7|NOT COMPLETED|Overall Study||1
8325933|NCT01393990|20525390|P6|NOT COMPLETED|Overall Study||1
8325934|NCT01393990|20525391|P5|NOT COMPLETED|Overall Study||2
8325935|NCT01393990|20525392|P4|NOT COMPLETED|Overall Study||1
8325936|NCT01393990|20525393|P3|NOT COMPLETED|Overall Study||0
8325937|NCT01393990|20525394|P2|NOT COMPLETED|Overall Study||0
8325938|NCT01393990|20525395|P1|NOT COMPLETED|Overall Study||1
8325939|NCT01393990|20525378|P18|COMPLETED|Overall Study||6
8325940|NCT01393990|20525379|P17|COMPLETED|Overall Study||3
8325941|NCT01393990|20525380|P16|COMPLETED|Overall Study||5
8325942|NCT01393990|20525381|P15|COMPLETED|Overall Study||9
8325943|NCT01393990|20525382|P14|COMPLETED|Overall Study||3
8325944|NCT01393990|20525383|P13|COMPLETED|Overall Study||3
8325945|NCT01393990|20525384|P12|COMPLETED|Overall Study||3
8325946|NCT01393990|20525385|P11|COMPLETED|Overall Study||3
8325947|NCT01393990|20525386|P10|COMPLETED|Overall Study||2
8325948|NCT01393990|20525387|P9|COMPLETED|Overall Study||3
8325949|NCT01393990|20525388|P8|COMPLETED|Overall Study||6
8325950|NCT01393990|20525389|P7|COMPLETED|Overall Study||2
8325951|NCT01393990|20525390|P6|COMPLETED|Overall Study||2
8325952|NCT01393990|20525391|P5|COMPLETED|Overall Study||3
8325953|NCT01393990|20525392|P4|COMPLETED|Overall Study||2
8325954|NCT01393990|20525393|P3|COMPLETED|Overall Study||3
8325955|NCT01393990|20525394|P2|COMPLETED|Overall Study||3
8325956|NCT01393990|20525395|P1|COMPLETED|Overall Study||3
8325957|NCT01393990|20525378|P18|Received at Least 1 Dose of Study Drug|Overall Study||6
8325958|NCT01393990|20525379|P17|Received at Least 1 Dose of Study Drug|Overall Study||3
8325959|NCT01393990|20525380|P16|Received at Least 1 Dose of Study Drug|Overall Study||8
8325960|NCT01393990|20525381|P15|Received at Least 1 Dose of Study Drug|Overall Study||18
8325961|NCT01393990|20525382|P14|Received at Least 1 Dose of Study Drug|Overall Study||5
8325962|NCT01393990|20525383|P13|Received at Least 1 Dose of Study Drug|Overall Study||3
8325963|NCT01393990|20525384|P12|Received at Least 1 Dose of Study Drug|Overall Study||3
8325964|NCT01393990|20525385|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
8325965|NCT01393990|20525386|P10|Received at Least 1 Dose of Study Drug|Overall Study||3
8325966|NCT01393990|20525387|P9|Received at Least 1 Dose of Study Drug|Overall Study||6
8325967|NCT01393990|20525388|P8|Received at Least 1 Dose of Study Drug|Overall Study||7
8325968|NCT01393990|20525389|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
8325969|NCT01393990|20525390|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
8325970|NCT01393990|20525391|P5|Received at Least 1 Dose of Study Drug|Overall Study||5
8325971|NCT01393990|20525392|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8325972|NCT01393990|20525393|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8325973|NCT01393990|20525394|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8325974|NCT01393990|20525395|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
8325975|NCT01393990|20525378|P18|STARTED|Overall Study||6
8325976|NCT01393990|20525379|P17|STARTED|Overall Study||3
8325977|NCT01393990|20525380|P16|STARTED|Overall Study||8
8325978|NCT01393990|20525381|P15|STARTED|Overall Study||18
8325979|NCT01393990|20525382|P14|STARTED|Overall Study||5
8325980|NCT01393990|20525383|P13|STARTED|Overall Study||3
8325981|NCT01393990|20525384|P12|STARTED|Overall Study||3
8325982|NCT01393990|20525385|P11|STARTED|Overall Study||3
8325983|NCT01393990|20525386|P10|STARTED|Overall Study||3
8325984|NCT01393990|20525387|P9|STARTED|Overall Study||6
8325985|NCT01393990|20525388|P8|STARTED|Overall Study||7
8325986|NCT01393990|20525389|P7|STARTED|Overall Study||3
8325987|NCT01393990|20525390|P6|STARTED|Overall Study||3
8325988|NCT01393990|20525391|P5|STARTED|Overall Study||5
8325989|NCT01393990|20525392|P4|STARTED|Overall Study||3
8325990|NCT01393990|20525393|P3|STARTED|Overall Study||3
8325991|NCT01393990|20525394|P2|STARTED|Overall Study||3
8325992|NCT01393990|20525395|P1|STARTED|Overall Study||4
8325993|NCT01393964|20525486|P3|NOT COMPLETED|Overall Study||9
8325994|NCT01393964|20525487|P2|NOT COMPLETED|Overall Study||9
8325995|NCT01393964|20525488|P1|NOT COMPLETED|Overall Study||8
8325996|NCT01393964|20525486|P3|COMPLETED|Overall Study|Completed=treatment on-going|0
8325997|NCT01393964|20525487|P2|COMPLETED|Overall Study|Completed=treatment on-going|0
8325998|NCT01393964|20525488|P1|COMPLETED|Overall Study|Completed=treatment on-going|0
8325999|NCT01393964|20525486|P3|STARTED|Overall Study||9
8326000|NCT01393964|20525487|P2|STARTED|Overall Study||9
8326001|NCT01393964|20525488|P1|STARTED|Overall Study||8
8326002|NCT01393899|20525529|P3|NOT COMPLETED|Overall Study||23
8326003|NCT01393899|20525530|P2|NOT COMPLETED|Overall Study||28
8326004|NCT01393899|20525531|P1|NOT COMPLETED|Overall Study||32
8326005|NCT01393899|20525529|P3|COMPLETED|Overall Study||38
8326006|NCT01393899|20525530|P2|COMPLETED|Overall Study||32
8326007|NCT01393899|20525531|P1|COMPLETED|Overall Study||27
8326008|NCT01393899|20525529|P3|STARTED|Overall Study||61
8326009|NCT01393899|20525530|P2|STARTED|Overall Study||60
8326010|NCT01393899|20525531|P1|STARTED|Overall Study||59
8326011|NCT01393821|20525585|P2|NOT COMPLETED|Overall Study||3
8326012|NCT01393821|20525586|P1|NOT COMPLETED|Overall Study||5
8326013|NCT01393821|20525585|P2|COMPLETED|Overall Study||10
8326014|NCT01393821|20525586|P1|COMPLETED|Overall Study||9
8326015|NCT01393821|20525585|P2|STARTED|Overall Study||13
8326016|NCT01393821|20525586|P1|STARTED|Overall Study||14
8326017|NCT01393743|20525600|P3|NOT COMPLETED|Extension Phase||60
8326018|NCT01393743|20525601|P2|NOT COMPLETED|Extension Phase||0
8326019|NCT01393743|20525602|P1|NOT COMPLETED|Extension Phase||0
8326020|NCT01393743|20525600|P3|COMPLETED|Extension Phase||78
8326021|NCT01393743|20525601|P2|COMPLETED|Extension Phase||0
8326022|NCT01393743|20525602|P1|COMPLETED|Extension Phase||0
8326023|NCT01393743|20525600|P3|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
8326024|NCT01393743|20525601|P2|STARTED|Extension Phase||0
8326025|NCT01393743|20525602|P1|STARTED|Extension Phase||0
8326026|NCT01393743|20525600|P3|NOT COMPLETED|Core Study||0
8326027|NCT01393743|20525601|P2|NOT COMPLETED|Core Study||13
8326028|NCT01393743|20525602|P1|NOT COMPLETED|Core Study||10
8326029|NCT01393743|20525600|P3|COMPLETED|Core Study||0
8326030|NCT01393743|20525601|P2|COMPLETED|Core Study||68
8326031|NCT01393743|20525602|P1|COMPLETED|Core Study||72
8326032|NCT01393743|20525600|P3|STARTED|Core Study||0
8326033|NCT01393743|20525601|P2|STARTED|Core Study|Treated|81
8326034|NCT01393743|20525602|P1|STARTED|Core Study|Treated|82
8326035|NCT01393730|20525625|P1|NOT COMPLETED|Overall Study||6
8326036|NCT01393730|20525625|P1|COMPLETED|Overall Study||34
8326037|NCT01393730|20525625|P1|Evaluable AR Mutation|Overall Study||14
8326038|NCT01393730|20525625|P1|Evaluable AR Amplification|Overall Study||21
8326039|NCT01393730|20525625|P1|Treated|Overall Study||38
8326040|NCT01393730|20525625|P1|STARTED|Overall Study||40
8326041|NCT01393717|20525637|P2|NOT COMPLETED|Overall Study||0
8326042|NCT01393717|20525638|P1|NOT COMPLETED|Overall Study||0
8326043|NCT01393717|20525637|P2|COMPLETED|Overall Study||20
8326044|NCT01393717|20525638|P1|COMPLETED|Overall Study||37
8326045|NCT01393717|20525637|P2|STARTED|Overall Study||20
8326046|NCT01393717|20525638|P1|STARTED|Overall Study||37
8326047|NCT01393704|20525652|P2|NOT COMPLETED|Overall Study||0
8326048|NCT01393704|20525653|P1|NOT COMPLETED|Overall Study||0
8326049|NCT01393704|20525652|P2|COMPLETED|Overall Study||76
8326050|NCT01393704|20525653|P1|COMPLETED|Overall Study||76
8326051|NCT01393704|20525652|P2|STARTED|Overall Study||76
8326052|NCT01393704|20525653|P1|STARTED|Overall Study||76
8326053|NCT01393626|20525671|P4|NOT COMPLETED|Overall Study||1
8326054|NCT01393626|20525672|P3|NOT COMPLETED|Overall Study||12
8326055|NCT01393626|20525673|P2|NOT COMPLETED|Overall Study||12
8326056|NCT01393626|20525674|P1|NOT COMPLETED|Overall Study||18
8326057|NCT01393626|20525671|P4|COMPLETED|Overall Study||15
8326058|NCT01393626|20525672|P3|COMPLETED|Overall Study||74
8326059|NCT01393626|20525673|P2|COMPLETED|Overall Study||74
8326060|NCT01393626|20525674|P1|COMPLETED|Overall Study||73
8326061|NCT01393626|20525671|P4|STARTED|Overall Study||16
8326062|NCT01393626|20525672|P3|STARTED|Overall Study||86
8326063|NCT01393626|20525673|P2|STARTED|Overall Study||86
8326064|NCT01393626|20525674|P1|STARTED|Overall Study||91
8326065|NCT01393613|20525754|P4|NOT COMPLETED|Overall Study||66
8326066|NCT01393613|20525755|P3|NOT COMPLETED|Overall Study||54
8326067|NCT01393613|20525756|P2|NOT COMPLETED|Overall Study||57
8326068|NCT01393613|20525757|P1|NOT COMPLETED|Overall Study||39
8326069|NCT01393613|20525754|P4|COMPLETED|Overall Study||118
8326070|NCT01393613|20525755|P3|COMPLETED|Overall Study||130
8326071|NCT01393613|20525756|P2|COMPLETED|Overall Study||129
8326072|NCT01393613|20525757|P1|COMPLETED|Overall Study||81
8326073|NCT01393613|20525754|P4|STARTED|Overall Study||184
8326074|NCT01393613|20525755|P3|STARTED|Overall Study||184
8326075|NCT01393613|20525756|P2|STARTED|Overall Study||186
8326076|NCT01393613|20525757|P1|STARTED|Overall Study||120
8326077|NCT01393600|20525819|P4|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
8326078|NCT01393600|20525820|P3|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
8326079|NCT01393600|20525821|P2|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
8326080|NCT01393600|20525822|P1|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
8326081|NCT01393600|20525819|P4|COMPLETED|Follow-up Period (Day 29 to 35)||8
8326082|NCT01393600|20525820|P3|COMPLETED|Follow-up Period (Day 29 to 35)||6
8326083|NCT01393600|20525821|P2|COMPLETED|Follow-up Period (Day 29 to 35)||7
8326084|NCT01393600|20525822|P1|COMPLETED|Follow-up Period (Day 29 to 35)||9
8326085|NCT01393600|20525819|P4|STARTED|Follow-up Period (Day 29 to 35)||8
8326086|NCT01393600|20525820|P3|STARTED|Follow-up Period (Day 29 to 35)||7
8326087|NCT01393600|20525821|P2|STARTED|Follow-up Period (Day 29 to 35)||7
8326088|NCT01393600|20525822|P1|STARTED|Follow-up Period (Day 29 to 35)||9
8326089|NCT01393600|20525819|P4|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
8326090|NCT01393600|20525820|P3|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
8326091|NCT01393600|20525821|P2|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
8326092|NCT01393600|20525822|P1|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
8326093|NCT01393600|20525819|P4|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
8326094|NCT01393600|20525820|P3|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
8326095|NCT01393600|20525821|P2|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
8326096|NCT01393600|20525822|P1|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
8326097|NCT01393600|20525819|P4|STARTED|Treatment Period 2 (Day 15 to 28)||9
8326098|NCT01393600|20525820|P3|STARTED|Treatment Period 2 (Day 15 to 28)||9
8326099|NCT01393600|20525821|P2|STARTED|Treatment Period 2 (Day 15 to 28)||7
8326100|NCT01393600|20525822|P1|STARTED|Treatment Period 2 (Day 15 to 28)||9
8326101|NCT01393600|20525819|P4|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
8326102|NCT01393600|20525820|P3|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
8326103|NCT01393600|20525821|P2|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
8326104|NCT01393600|20525822|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
8326105|NCT01393600|20525819|P4|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
8326106|NCT01393600|20525820|P3|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
8326107|NCT01393600|20525821|P2|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
8326108|NCT01393600|20525822|P1|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
8326109|NCT01393600|20525819|P4|STARTED|Treatment Period 1 (Day 1 to 14)||10
8326110|NCT01393600|20525820|P3|STARTED|Treatment Period 1 (Day 1 to 14)||10
8326111|NCT01393600|20525821|P2|STARTED|Treatment Period 1 (Day 1 to 14)||8
8326112|NCT01393600|20525822|P1|STARTED|Treatment Period 1 (Day 1 to 14)||9
8326113|NCT01393457|20525841|P4|NOT COMPLETED|Overall Study||12
8326114|NCT01393457|20525842|P3|NOT COMPLETED|Overall Study||15
8326115|NCT01393457|20525843|P2|NOT COMPLETED|Overall Study||12
8326116|NCT01393457|20525844|P1|NOT COMPLETED|Overall Study||12
8326117|NCT01393457|20525841|P4|COMPLETED|Overall Study||15
8326118|NCT01393457|20525842|P3|COMPLETED|Overall Study||16
8326119|NCT01393457|20525843|P2|COMPLETED|Overall Study||14
8326120|NCT01393457|20525844|P1|COMPLETED|Overall Study||14
8326121|NCT01393457|20525841|P4|STARTED|Overall Study||27
8326122|NCT01393457|20525842|P3|STARTED|Overall Study||31
8326123|NCT01393457|20525843|P2|STARTED|Overall Study||26
8326124|NCT01393457|20525844|P1|STARTED|Overall Study||26
8326125|NCT01393444|20525858|P1|NOT COMPLETED|Overall Study||3
8326126|NCT01393444|20525858|P1|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
8326127|NCT01393444|20525858|P1|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
8326128|NCT01393444|20525858|P1|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
8326129|NCT01393444|20525858|P1|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
8326130|NCT01393444|20525858|P1|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
8326131|NCT01393444|20525858|P1|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
8326132|NCT01393444|20525858|P1|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
8326133|NCT01393444|20525858|P1|STARTED|Overall Study||6
8326134|NCT01393405|20525863|P3|NOT COMPLETED|Maintenance Period Week||24
8326135|NCT01393405|20525864|P2|NOT COMPLETED|Maintenance Period Week||29
8326136|NCT01393405|20525865|P1|NOT COMPLETED|Maintenance Period Week||0
8326137|NCT01393405|20525863|P3|COMPLETED|Maintenance Period Week||16
8326138|NCT01393405|20525864|P2|COMPLETED|Maintenance Period Week||15
8326139|NCT01393405|20525865|P1|COMPLETED|Maintenance Period Week||0
8326140|NCT01393405|20525863|P3|STARTED|Maintenance Period Week||40
8326141|NCT01393405|20525864|P2|STARTED|Maintenance Period Week||44
8326142|NCT01393405|20525865|P1|STARTED|Maintenance Period Week||0
8326143|NCT01393405|20525863|P3|NOT COMPLETED|Induction Period (week1-16)||0
8326144|NCT01393405|20525864|P2|NOT COMPLETED|Induction Period (week1-16)||0
8326145|NCT01393405|20525865|P1|NOT COMPLETED|Induction Period (week1-16)||95
8326146|NCT01393405|20525863|P3|COMPLETED|Induction Period (week1-16)||0
8326147|NCT01393405|20525864|P2|COMPLETED|Induction Period (week1-16)||0
8326148|NCT01393405|20525865|P1|COMPLETED|Induction Period (week1-16)||84
8326149|NCT01393405|20525863|P3|STARTED|Induction Period (week1-16)||0
8326150|NCT01393405|20525864|P2|STARTED|Induction Period (week1-16)||0
8326151|NCT01393405|20525865|P1|STARTED|Induction Period (week1-16)||179
8326152|NCT01393392|20525884|P2|NOT COMPLETED|Overall Study||19
8326153|NCT01393392|20525885|P1|NOT COMPLETED|Overall Study||11
8326154|NCT01393392|20525884|P2|COMPLETED|Overall Study||24
8326155|NCT01393392|20525885|P1|COMPLETED|Overall Study||33
8326156|NCT01393392|20525884|P2|STARTED|Overall Study||43
8326157|NCT01393392|20525885|P1|STARTED|Overall Study||44
8326158|NCT01393301|20525903|P2|NOT COMPLETED|Overall Study||3
8326159|NCT01393301|20525904|P1|NOT COMPLETED|Overall Study||9
8326160|NCT01393301|20525903|P2|COMPLETED|Overall Study||24
8326161|NCT01393301|20525904|P1|COMPLETED|Overall Study||17
8326162|NCT01393301|20525903|P2|STARTED|Overall Study||27
8326163|NCT01393301|20525904|P1|STARTED|Overall Study||26
8326164|NCT01393158|20525917|P2|NOT COMPLETED|Overall Study||0
8326165|NCT01393158|20525918|P1|NOT COMPLETED|Overall Study||1
8326166|NCT01393158|20525917|P2|COMPLETED|Overall Study||10
8326167|NCT01393158|20525918|P1|COMPLETED|Overall Study||5
8326168|NCT01393158|20525917|P2|STARTED|Overall Study||10
8326169|NCT01393158|20525918|P1|STARTED|Overall Study||6
8326170|NCT01393132|20525932|P2|NOT COMPLETED|Overall Study||0
8326171|NCT01393132|20525933|P1|NOT COMPLETED|Overall Study||0
8326172|NCT01393132|20525932|P2|COMPLETED|Overall Study||3
8326173|NCT01393132|20525933|P1|COMPLETED|Overall Study||6
8326174|NCT01393132|20525932|P2|STARTED|Overall Study||3
8326175|NCT01393132|20525933|P1|STARTED|Overall Study||6
8326176|NCT01393106|20525945|P1|NOT COMPLETED|Overall Study||5
8326177|NCT01393106|20525945|P1|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
8326178|NCT01393106|20525945|P1|STARTED|Overall Study||25
8326179|NCT01392989|20525962|P1|NOT COMPLETED|CIK Cell Infusion||0
8326180|NCT01392989|20525962|P1|COMPLETED|CIK Cell Infusion||31
8326181|NCT01392989|20525962|P1|STARTED|CIK Cell Infusion||31
8326182|NCT01392989|20525962|P1|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0
8326183|NCT01392989|20525962|P1|COMPLETED|Total Lymphoid Irradiation (TLI)||44
8326184|NCT01392989|20525962|P1|STARTED|Total Lymphoid Irradiation (TLI)||44
8326185|NCT01392963|20525972|P2|NOT COMPLETED|Week 24 Follow-up||0
8326186|NCT01392963|20525973|P1|NOT COMPLETED|Week 24 Follow-up||2
8326187|NCT01392963|20525972|P2|COMPLETED|Week 24 Follow-up||17
8326188|NCT01392963|20525973|P1|COMPLETED|Week 24 Follow-up||9
8326189|NCT01392963|20525972|P2|STARTED|Week 24 Follow-up||17
8326190|NCT01392963|20525973|P1|STARTED|Week 24 Follow-up||11
8326191|NCT01392963|20525972|P2|NOT COMPLETED|Week 12 (Second Intervention)||0
8326192|NCT01392963|20525973|P1|NOT COMPLETED|Week 12 (Second Intervention)||0
8326193|NCT01392963|20525972|P2|COMPLETED|Week 12 (Second Intervention)||17
8326194|NCT01392963|20525973|P1|COMPLETED|Week 12 (Second Intervention)||11
8326195|NCT01392963|20525972|P2|STARTED|Week 12 (Second Intervention)||17
8326196|NCT01392963|20525973|P1|STARTED|Week 12 (Second Intervention)||11
8326197|NCT01392963|20525972|P2|NOT COMPLETED|Week 0 (First Intervention)||2
8326198|NCT01392963|20525973|P1|NOT COMPLETED|Week 0 (First Intervention)||0
8326199|NCT01392963|20525972|P2|COMPLETED|Week 0 (First Intervention)||17
8326200|NCT01392963|20525973|P1|COMPLETED|Week 0 (First Intervention)||11
8326201|NCT01392963|20525972|P2|STARTED|Week 0 (First Intervention)||19
8326202|NCT01392963|20525973|P1|STARTED|Week 0 (First Intervention)||11
8326203|NCT01392742|20525981|P1|NOT COMPLETED|Overall Study||201
8326204|NCT01392742|20525981|P1|COMPLETED|Overall Study||242
8326205|NCT01392742|20525981|P1|STARTED|Overall Study||443
8326206|NCT01392703|20525996|P3|NOT COMPLETED|Day 9||0
8326207|NCT01392703|20525997|P2|NOT COMPLETED|Day 9||0
8326208|NCT01392703|20525998|P1|NOT COMPLETED|Day 9||0
8326209|NCT01392703|20525996|P3|COMPLETED|Day 9||25
8326210|NCT01392703|20525997|P2|COMPLETED|Day 9||26
8326211|NCT01392703|20525998|P1|COMPLETED|Day 9||26
8326212|NCT01392703|20525996|P3|STARTED|Day 9||25
8326213|NCT01392703|20525997|P2|STARTED|Day 9||26
8326214|NCT01392703|20525998|P1|STARTED|Day 9||26
8326215|NCT01392703|20525996|P3|NOT COMPLETED|Day 5||0
8326216|NCT01392703|20525997|P2|NOT COMPLETED|Day 5||0
8326217|NCT01392703|20525998|P1|NOT COMPLETED|Day 5||0
8326218|NCT01392703|20525996|P3|COMPLETED|Day 5||26
8326219|NCT01392703|20525997|P2|COMPLETED|Day 5||25
8326220|NCT01392703|20525998|P1|COMPLETED|Day 5||26
8326221|NCT01392703|20525996|P3|STARTED|Day 5||26
8326222|NCT01392703|20525997|P2|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
8326223|NCT01392703|20525998|P1|STARTED|Day 5||26
8326224|NCT01392703|20525996|P3|NOT COMPLETED|Day 1||0
8326225|NCT01392703|20525997|P2|NOT COMPLETED|Day 1||0
8326226|NCT01392703|20525998|P1|NOT COMPLETED|Day 1||0
8326227|NCT01392703|20525996|P3|COMPLETED|Day 1||26
8326228|NCT01392703|20525997|P2|COMPLETED|Day 1||26
8326229|NCT01392703|20525998|P1|COMPLETED|Day 1||26
8326230|NCT01392703|20525996|P3|STARTED|Day 1||26
8326231|NCT01392703|20525997|P2|STARTED|Day 1||26
8326232|NCT01392703|20525998|P1|STARTED|Day 1||26
8326233|NCT01392677|20526027|P2|NOT COMPLETED|Overall Study||8
8326234|NCT01392677|20526028|P1|NOT COMPLETED|Overall Study||8
8326235|NCT01392677|20526027|P2|COMPLETED|Overall Study||101
8326236|NCT01392677|20526028|P1|COMPLETED|Overall Study||101
8326237|NCT01392677|20526027|P2|STARTED|Overall Study||109
8326238|NCT01392677|20526028|P1|STARTED|Overall Study||109
8326239|NCT01392625|20526044|P2|NOT COMPLETED|Overall Study||1
8326240|NCT01392625|20526045|P1|NOT COMPLETED|Overall Study||2
8326241|NCT01392625|20526044|P2|COMPLETED|Overall Study||18
8326242|NCT01392625|20526045|P1|COMPLETED|Overall Study||16
8326243|NCT01392625|20526044|P2|STARTED|Overall Study||19
8326244|NCT01392625|20526045|P1|STARTED|Overall Study||18
8326245|NCT01392573|20526063|P2|NOT COMPLETED|Overall Study||35
8326246|NCT01392573|20526064|P1|NOT COMPLETED|Overall Study||32
8326247|NCT01392573|20526063|P2|COMPLETED|Overall Study||171
8326248|NCT01392573|20526064|P1|COMPLETED|Overall Study||175
8326249|NCT01392573|20526063|P2|Exposed|Overall Study||206
8326250|NCT01392573|20526064|P1|Exposed|Overall Study||207
8326251|NCT01392573|20526063|P2|STARTED|Overall Study||206
8326252|NCT01392573|20526064|P1|STARTED|Overall Study||207
8326253|NCT01392560|20526072|P1|NOT COMPLETED|Overall Study||12
8326254|NCT01392560|20526072|P1|COMPLETED|Overall Study||40
8326255|NCT01392560|20526072|P1|STARTED|Overall Study||52
8326256|NCT01392547|20526078|P1|NOT COMPLETED|Overall Study||8
8326257|NCT01392547|20526078|P1|COMPLETED|Overall Study||64
8326258|NCT01392547|20526078|P1|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
8326259|NCT01392495|20526092|P1|NOT COMPLETED|Overall Study||16
8326260|NCT01392495|20526092|P1|COMPLETED|Overall Study||1
8326261|NCT01392495|20526092|P1|Received 400 mg|Overall Study||13
8326262|NCT01392495|20526092|P1|Received 200 mg|Overall Study||4
8326263|NCT01392495|20526092|P1|STARTED|Overall Study||17
8326264|NCT01392443|20526104|P1|NOT COMPLETED|Overall Study||68
8326265|NCT01392443|20526104|P1|COMPLETED|Overall Study||52
8326266|NCT01392443|20526104|P1|STARTED|Overall Study||120
8326267|NCT01392378|20526117|P5|NOT COMPLETED|Toddler Dose||1
8326268|NCT01392378|20526118|P4|NOT COMPLETED|Toddler Dose||2
8326269|NCT01392378|20526119|P3|NOT COMPLETED|Toddler Dose||0
8326270|NCT01392378|20526120|P2|NOT COMPLETED|Toddler Dose||1
8326271|NCT01392378|20526121|P1|NOT COMPLETED|Toddler Dose||0
8326272|NCT01392378|20526117|P5|COMPLETED|Toddler Dose||208
8326273|NCT01392378|20526118|P4|COMPLETED|Toddler Dose||173
8326274|NCT01392378|20526119|P3|COMPLETED|Toddler Dose||170
8326275|NCT01392378|20526120|P2|COMPLETED|Toddler Dose||172
8326276|NCT01392378|20526121|P1|COMPLETED|Toddler Dose||169
8326277|NCT01392378|20526117|P5|STARTED|Toddler Dose||209
8326278|NCT01392378|20526118|P4|STARTED|Toddler Dose||175
8326279|NCT01392378|20526119|P3|STARTED|Toddler Dose||170
8326280|NCT01392378|20526120|P2|STARTED|Toddler Dose||173
8326281|NCT01392378|20526121|P1|STARTED|Toddler Dose||169
8326282|NCT01392378|20526117|P5|NOT COMPLETED|After Infant Series||1
8326283|NCT01392378|20526118|P4|NOT COMPLETED|After Infant Series||0
8326284|NCT01392378|20526119|P3|NOT COMPLETED|After Infant Series||2
8326285|NCT01392378|20526120|P2|NOT COMPLETED|After Infant Series||1
8326286|NCT01392378|20526121|P1|NOT COMPLETED|After Infant Series||0
8326287|NCT01392378|20526117|P5|COMPLETED|After Infant Series||209
8326288|NCT01392378|20526118|P4|COMPLETED|After Infant Series||175
8326289|NCT01392378|20526119|P3|COMPLETED|After Infant Series||170
8326290|NCT01392378|20526120|P2|COMPLETED|After Infant Series||173
8326291|NCT01392378|20526121|P1|COMPLETED|After Infant Series||169
8326292|NCT01392378|20526117|P5|STARTED|After Infant Series||210
8326293|NCT01392378|20526118|P4|STARTED|After Infant Series||175
8326294|NCT01392378|20526119|P3|STARTED|After Infant Series||172
8326295|NCT01392378|20526120|P2|STARTED|After Infant Series||174
8326296|NCT01392378|20526121|P1|STARTED|After Infant Series||169
8326297|NCT01392378|20526117|P5|NOT COMPLETED|Infant Series||0
8326298|NCT01392378|20526118|P4|NOT COMPLETED|Infant Series||2
8326299|NCT01392378|20526119|P3|NOT COMPLETED|Infant Series||0
8326300|NCT01392378|20526120|P2|NOT COMPLETED|Infant Series||2
8326301|NCT01392378|20526121|P1|NOT COMPLETED|Infant Series||4
8326302|NCT01392378|20526117|P5|COMPLETED|Infant Series||210
8326303|NCT01392378|20526118|P4|COMPLETED|Infant Series||175
8326304|NCT01392378|20526119|P3|COMPLETED|Infant Series||172
8326305|NCT01392378|20526120|P2|COMPLETED|Infant Series||174
8326306|NCT01392378|20526121|P1|COMPLETED|Infant Series||169
8326307|NCT01392378|20526117|P5|Vaccinated Dose 3|Infant Series||210
8326308|NCT01392378|20526118|P4|Vaccinated Dose 3|Infant Series||176
8326309|NCT01392378|20526119|P3|Vaccinated Dose 3|Infant Series||172
8326310|NCT01392378|20526120|P2|Vaccinated Dose 3|Infant Series||174
8326311|NCT01392378|20526121|P1|Vaccinated Dose 3|Infant Series||170
8326312|NCT01392378|20526117|P5|Vaccinated Dose 2|Infant Series||210
8326313|NCT01392378|20526118|P4|Vaccinated Dose 2|Infant Series||177
8326314|NCT01392378|20526119|P3|Vaccinated Dose 2|Infant Series||172
8326315|NCT01392378|20526120|P2|Vaccinated Dose 2|Infant Series||174
8326316|NCT01392378|20526121|P1|Vaccinated Dose 2|Infant Series||171
8326317|NCT01392378|20526117|P5|Vaccinated Dose 1|Infant Series||210
8326318|NCT01392378|20526118|P4|Vaccinated Dose 1|Infant Series||177
8326319|NCT01392378|20526119|P3|Vaccinated Dose 1|Infant Series||172
8326320|NCT01392378|20526120|P2|Vaccinated Dose 1|Infant Series||176
8326321|NCT01392378|20526121|P1|Vaccinated Dose 1|Infant Series||173
8326322|NCT01392378|20526117|P5|STARTED|Infant Series||210
8326323|NCT01392378|20526118|P4|STARTED|Infant Series||177
8326324|NCT01392378|20526119|P3|STARTED|Infant Series||172
8326325|NCT01392378|20526120|P2|STARTED|Infant Series||176
8326326|NCT01392378|20526121|P1|STARTED|Infant Series||173
8326327|NCT01392326|20526261|P3|NOT COMPLETED|Overall Study||48
8326328|NCT01392326|20526262|P2|NOT COMPLETED|Overall Study||35
8326329|NCT01392326|20526263|P1|NOT COMPLETED|Overall Study||47
8326330|NCT01392326|20526261|P3|COMPLETED|Overall Study||154
8326331|NCT01392326|20526262|P2|COMPLETED|Overall Study||167
8326332|NCT01392326|20526263|P1|COMPLETED|Overall Study||155
8326333|NCT01392326|20526261|P3|STARTED|Overall Study||202
8326334|NCT01392326|20526262|P2|STARTED|Overall Study||202
8326335|NCT01392326|20526263|P1|STARTED|Overall Study||202
8326336|NCT01392300|20526300|P3|NOT COMPLETED|Open Label Extension (OLEX) Period||51
8326337|NCT01392300|20526301|P2|NOT COMPLETED|Open Label Extension (OLEX) Period||0
8326338|NCT01392300|20526302|P1|NOT COMPLETED|Open Label Extension (OLEX) Period||0
8326339|NCT01392300|20526300|P3|COMPLETED|Open Label Extension (OLEX) Period||248
8326340|NCT01392300|20526301|P2|COMPLETED|Open Label Extension (OLEX) Period||0
8326341|NCT01392300|20526302|P1|COMPLETED|Open Label Extension (OLEX) Period||0
8326342|NCT01392300|20526300|P3|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
8326343|NCT01392300|20526301|P2|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
8326344|NCT01392300|20526302|P1|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
8326345|NCT01392300|20526300|P3|NOT COMPLETED|Main Period (MP)||0
8326346|NCT01392300|20526301|P2|NOT COMPLETED|Main Period (MP)||7
8326347|NCT01392300|20526302|P1|NOT COMPLETED|Main Period (MP)||11
8326348|NCT01392300|20526300|P3|COMPLETED|Main Period (MP)||0
8326349|NCT01392300|20526301|P2|COMPLETED|Main Period (MP)||100
8326350|NCT01392300|20526302|P1|COMPLETED|Main Period (MP)||199
8326351|NCT01392300|20526300|P3|STARTED|Main Period (MP)||0
8326352|NCT01392300|20526301|P2|STARTED|Main Period (MP)||107
8326353|NCT01392300|20526302|P1|STARTED|Main Period (MP)||210
8326354|NCT01392170|20526407|P1|NOT COMPLETED|Overall Study||2
8326355|NCT01392170|20526407|P1|COMPLETED|Overall Study||0
8326356|NCT01392170|20526407|P1|STARTED|Overall Study||2
8326357|NCT01392053|20526413|P2|NOT COMPLETED|Overall Study||0
8326358|NCT01392053|20526414|P1|NOT COMPLETED|Overall Study||0
8326359|NCT01392053|20526413|P2|COMPLETED|Overall Study||23
8326360|NCT01392053|20526414|P1|COMPLETED|Overall Study||23
8326361|NCT01392053|20526413|P2|STARTED|Overall Study||23
8326362|NCT01392053|20526414|P1|STARTED|Overall Study||23
8326363|NCT01391858|20526434|P2|NOT COMPLETED|Overall Study||0
8326364|NCT01391858|20526435|P1|NOT COMPLETED|Overall Study||2
8326365|NCT01391858|20526434|P2|COMPLETED|Overall Study||24
8326366|NCT01391858|20526435|P1|COMPLETED|Overall Study||23
8326367|NCT01391858|20526434|P2|STARTED|Overall Study||24
8326368|NCT01391858|20526435|P1|STARTED|Overall Study||25
8326369|NCT01391832|20526457|P2|NOT COMPLETED|Overall Study||23
8326370|NCT01391832|20526458|P1|NOT COMPLETED|Overall Study||21
8326371|NCT01391832|20526457|P2|COMPLETED|Overall Study||31
8326372|NCT01391832|20526458|P1|COMPLETED|Overall Study||28
8326373|NCT01391832|20526457|P2|3 Month Follow-Up|Overall Study||29
8326374|NCT01391832|20526458|P1|3 Month Follow-Up|Overall Study||28
8326375|NCT01391832|20526457|P2|1 Month Follow-Up|Overall Study||31
8326376|NCT01391832|20526458|P1|1 Month Follow-Up|Overall Study||30
8326377|NCT01391832|20526457|P2|STARTED|Overall Study||54
8326378|NCT01391832|20526458|P1|STARTED|Overall Study||49
8326379|NCT01391819|20526466|P1|NOT COMPLETED|Overall Study||402
8326380|NCT01391819|20526466|P1|COMPLETED|Overall Study||1714
8326381|NCT01391819|20526466|P1|STARTED|Overall Study||2116
8326382|NCT01391793|20526510|P2|NOT COMPLETED|Overall Study||144
8326383|NCT01391793|20526511|P1|NOT COMPLETED|Overall Study||147
8326384|NCT01391793|20526510|P2|COMPLETED|Overall Study||131
8326385|NCT01391793|20526511|P1|COMPLETED|Overall Study||124
8326386|NCT01391793|20526510|P2|Had a Positive Urine Culture|Overall Study||188
8326387|NCT01391793|20526511|P1|Had a Positive Urine Culture|Overall Study||197
8326388|NCT01391793|20526510|P2|STARTED|Overall Study||275
8326389|NCT01391793|20526511|P1|STARTED|Overall Study||271
8326390|NCT01391663|20526525|P4|NOT COMPLETED|Overall Study||0
8326391|NCT01391663|20526526|P3|NOT COMPLETED|Overall Study||1
8326392|NCT01391663|20526527|P2|NOT COMPLETED|Overall Study||0
8326393|NCT01391663|20526528|P1|NOT COMPLETED|Overall Study||0
8326394|NCT01391663|20526525|P4|COMPLETED|Overall Study||12
8326395|NCT01391663|20526526|P3|COMPLETED|Overall Study||11
8326396|NCT01391663|20526527|P2|COMPLETED|Overall Study||12
8326397|NCT01391663|20526528|P1|COMPLETED|Overall Study||12
8326398|NCT01391663|20526525|P4|STARTED|Overall Study||12
8326399|NCT01391663|20526526|P3|STARTED|Overall Study||12
8326400|NCT01391663|20526527|P2|STARTED|Overall Study||12
8326401|NCT01391663|20526528|P1|STARTED|Overall Study||12
8326402|NCT01391611|20526558|P1|NOT COMPLETED|Overall Study||22
8326403|NCT01391611|20526558|P1|COMPLETED|Overall Study||3
8326404|NCT01391611|20526558|P1|STARTED|Overall Study||25
8326405|NCT01391559|20526563|P2|NOT COMPLETED|Second Intervention||0
8326406|NCT01391559|20526564|P1|NOT COMPLETED|Second Intervention||0
8326407|NCT01391559|20526563|P2|COMPLETED|Second Intervention||10
8326408|NCT01391559|20526564|P1|COMPLETED|Second Intervention||10
8326409|NCT01391559|20526563|P2|STARTED|Second Intervention||10
8326410|NCT01391559|20526564|P1|STARTED|Second Intervention||10
8326411|NCT01391559|20526563|P2|NOT COMPLETED|First Intervention||0
8326412|NCT01391559|20526564|P1|NOT COMPLETED|First Intervention||0
8326413|NCT01391559|20526563|P2|COMPLETED|First Intervention||10
8326414|NCT01391559|20526564|P1|COMPLETED|First Intervention||10
8326415|NCT01391559|20526563|P2|STARTED|First Intervention||10
8326416|NCT01391559|20526564|P1|STARTED|First Intervention||10
8326417|NCT01391546|20526572|P2|NOT COMPLETED|Overall Study||0
8326418|NCT01391546|20526573|P1|NOT COMPLETED|Overall Study||1
8326419|NCT01391546|20526572|P2|COMPLETED|Overall Study||177
8326420|NCT01391546|20526573|P1|COMPLETED|Overall Study||176
8326421|NCT01391546|20526572|P2|Vaccinated|Overall Study||177
8326422|NCT01391546|20526573|P1|Vaccinated|Overall Study||176
8326423|NCT01391546|20526572|P2|STARTED|Overall Study||177
8326424|NCT01391546|20526573|P1|STARTED|Overall Study||177
8326425|NCT01391507|20526595|P4|NOT COMPLETED|Overall Study||7
8326426|NCT01391507|20526596|P3|NOT COMPLETED|Overall Study||4
8326427|NCT01391507|20526597|P2|NOT COMPLETED|Overall Study||4
8326428|NCT01391507|20526598|P1|NOT COMPLETED|Overall Study||4
8326429|NCT01391507|20526595|P4|COMPLETED|Overall Study||5
8326430|NCT01391507|20526596|P3|COMPLETED|Overall Study||2
8326431|NCT01391507|20526597|P2|COMPLETED|Overall Study||4
8326432|NCT01391507|20526598|P1|COMPLETED|Overall Study||6
8326433|NCT01391507|20526595|P4|STARTED|Overall Study||12
8326434|NCT01391507|20526596|P3|STARTED|Overall Study||6
8326435|NCT01391507|20526597|P2|STARTED|Overall Study||8
8326436|NCT01391507|20526598|P1|STARTED|Overall Study||10
8326437|NCT01391468|20526646|P2|NOT COMPLETED|Overall Study||2
8326438|NCT01391468|20526647|P1|NOT COMPLETED|Overall Study||6
8326439|NCT01391468|20526646|P2|COMPLETED|Overall Study||21
8326440|NCT01391468|20526647|P1|COMPLETED|Overall Study||18
8326441|NCT01391468|20526646|P2|STARTED|Overall Study||23
8326442|NCT01391468|20526647|P1|STARTED|Overall Study||24
8326443|NCT01391364|20526661|P2|NOT COMPLETED|Overall Study||2
8326444|NCT01391364|20526662|P1|NOT COMPLETED|Overall Study||5
8326445|NCT01391364|20526661|P2|COMPLETED|Overall Study||214
8326446|NCT01391364|20526662|P1|COMPLETED|Overall Study||217
8326447|NCT01391364|20526661|P2|STARTED|Overall Study||216
8326448|NCT01391364|20526662|P1|STARTED|Overall Study||222
8326449|NCT01391325|20526672|P1|NOT COMPLETED|Overall Study||494
8326450|NCT01391325|20526672|P1|COMPLETED|Overall Study||1238
8326451|NCT01391325|20526672|P1|STARTED|Overall Study||1732
8326452|NCT01391312|20526681|P2|NOT COMPLETED|Overall Study||1
8326453|NCT01391312|20526682|P1|NOT COMPLETED|Overall Study||2
8326454|NCT01391312|20526681|P2|COMPLETED|Overall Study||19
8326455|NCT01391312|20526682|P1|COMPLETED|Overall Study||18
8326456|NCT01391312|20526681|P2|STARTED|Overall Study||20
8326457|NCT01391312|20526682|P1|STARTED|Overall Study||20
8326458|NCT01391299|20526695|P3|NOT COMPLETED|Overall Study||2
8326459|NCT01391299|20526696|P2|NOT COMPLETED|Overall Study||1
8326460|NCT01391299|20526697|P1|NOT COMPLETED|Overall Study||0
8326461|NCT01391299|20526695|P3|COMPLETED|Overall Study||56
8326462|NCT01391299|20526696|P2|COMPLETED|Overall Study||59
8326463|NCT01391299|20526697|P1|COMPLETED|Overall Study||57
8326464|NCT01391299|20526695|P3|STARTED|Overall Study||58
8326465|NCT01391299|20526696|P2|STARTED|Overall Study||60
8326466|NCT01391299|20526697|P1|STARTED|Overall Study||57
8326467|NCT01391286|20526719|P2|NOT COMPLETED|Overall Study||0
8326468|NCT01391286|20526720|P1|NOT COMPLETED|Overall Study||0
8326469|NCT01391286|20526719|P2|COMPLETED|Overall Study||18
8326470|NCT01391286|20526720|P1|COMPLETED|Overall Study||18
8326471|NCT01391286|20526719|P2|STARTED|Overall Study||18
8326472|NCT01391286|20526720|P1|STARTED|Overall Study||18
8326473|NCT01391273|20526734|P2|NOT COMPLETED|Overall Study||2
8326474|NCT01391273|20526735|P1|NOT COMPLETED|Overall Study||4
8326475|NCT01391273|20526734|P2|COMPLETED|Overall Study||83
8326476|NCT01391273|20526735|P1|COMPLETED|Overall Study||84
8326477|NCT01391273|20526734|P2|STARTED|Overall Study||85
8326478|NCT01391273|20526735|P1|STARTED|Overall Study||88
8326479|NCT01391130|20526749|P2|NOT COMPLETED|Overall Study||6
8326480|NCT01391130|20526750|P1|NOT COMPLETED|Overall Study||6
8326481|NCT01391130|20526749|P2|COMPLETED|Overall Study||31
8326482|NCT01391130|20526750|P1|COMPLETED|Overall Study||67
8326483|NCT01391130|20526749|P2|Received At Least One Dose of Study Drug|Overall Study||36
8326484|NCT01391130|20526750|P1|Received At Least One Dose of Study Drug|Overall Study||72
8326485|NCT01391130|20526749|P2|STARTED|Overall Study||37
8326486|NCT01391130|20526750|P1|STARTED|Overall Study||73
8326487|NCT01391013|20526766|P2|NOT COMPLETED|Overall Study||0
8326488|NCT01391013|20526767|P1|NOT COMPLETED|Overall Study||0
8326489|NCT01391013|20526766|P2|COMPLETED|Overall Study||15
8326490|NCT01391013|20526767|P1|COMPLETED|Overall Study||15
8326491|NCT01391013|20526766|P2|STARTED|Overall Study||15
8326492|NCT01391013|20526767|P1|STARTED|Overall Study||15
8326493|NCT01391000|20526807|P2|NOT COMPLETED|Overall Study||0
8326494|NCT01391000|20526808|P1|NOT COMPLETED|Overall Study||2
8326495|NCT01391000|20526807|P2|COMPLETED|Overall Study||35
8326496|NCT01391000|20526808|P1|COMPLETED|Overall Study||33
8326497|NCT01391000|20526807|P2|STARTED|Overall Study||35
8326498|NCT01391000|20526808|P1|STARTED|Overall Study||35
8326499|NCT01390948|20526821|P3|NOT COMPLETED|Overall Study||1
8326500|NCT01390948|20526822|P2|NOT COMPLETED|Overall Study||18
8326501|NCT01390948|20526823|P1|NOT COMPLETED|Overall Study||15
8326502|NCT01390948|20526821|P3|COMPLETED|Overall Study||2
8326503|NCT01390948|20526822|P2|COMPLETED|Overall Study||44
8326504|NCT01390948|20526823|P1|COMPLETED|Overall Study||44
8326505|NCT01390948|20526821|P3|Treated|Overall Study||3
8326506|NCT01390948|20526822|P2|Treated|Overall Study||60
8326507|NCT01390948|20526823|P1|Treated|Overall Study||56
8326508|NCT01390948|20526821|P3|STARTED|Overall Study||3
8326509|NCT01390948|20526822|P2|STARTED|Overall Study||62
8326510|NCT01390948|20526823|P1|STARTED|Overall Study||59
8326511|NCT01390909|20526864|P6|NOT COMPLETED|Overall Study||0
8326512|NCT01390909|20526865|P5|NOT COMPLETED|Overall Study||0
8326513|NCT01390909|20526866|P4|NOT COMPLETED|Overall Study||0
8326514|NCT01390909|20526867|P3|NOT COMPLETED|Overall Study||0
8326515|NCT01390909|20526868|P2|NOT COMPLETED|Overall Study||0
8326516|NCT01390909|20526869|P1|NOT COMPLETED|Overall Study||0
8326517|NCT01390909|20526864|P6|COMPLETED|Overall Study||613
8326518|NCT01390909|20526865|P5|COMPLETED|Overall Study||613
8326519|NCT01390909|20526866|P4|COMPLETED|Overall Study||602
8326520|NCT01390909|20526867|P3|COMPLETED|Overall Study||3552
8326521|NCT01390909|20526868|P2|COMPLETED|Overall Study||3552
8326522|NCT01390909|20526869|P1|COMPLETED|Overall Study||3454
8326523|NCT01390909|20526864|P6|Participants in Subgroup|Overall Study||0
8326524|NCT01390909|20526865|P5|Participants in Subgroup|Overall Study||602
8326525|NCT01390909|20526866|P4|Participants in Subgroup|Overall Study||0
8326526|NCT01390909|20526867|P3|Participants in Subgroup|Overall Study||0
8326527|NCT01390909|20526868|P2|Participants in Subgroup|Overall Study||3454
8326528|NCT01390909|20526869|P1|Participants in Subgroup|Overall Study||0
8326529|NCT01390909|20526864|P6|STARTED|Overall Study||613
8326530|NCT01390909|20526865|P5|STARTED|Overall Study||613
8326531|NCT01390909|20526866|P4|STARTED|Overall Study||602
8326532|NCT01390909|20526867|P3|STARTED|Overall Study||3552
8326533|NCT01390909|20526868|P2|STARTED|Overall Study||3552
8326534|NCT01390909|20526869|P1|STARTED|Overall Study||3454
8326535|NCT01390870|20526887|P1|NOT COMPLETED|Overall Study||0
8326536|NCT01390870|20526887|P1|COMPLETED|Overall Study||400
8326537|NCT01390870|20526887|P1|STARTED|Overall Study||400
8326538|NCT01390857|20526891|P1|NOT COMPLETED|Overall Study||10
8326539|NCT01390857|20526891|P1|COMPLETED|Overall Study||369
8326540|NCT01390857|20526891|P1|STARTED|Overall Study||379
8326541|NCT01390844|20526902|P4|NOT COMPLETED|Follow-Up Phase||0
8326542|NCT01390844|20526903|P3|NOT COMPLETED|Follow-Up Phase||1
8326543|NCT01390844|20526904|P2|NOT COMPLETED|Follow-Up Phase||1
8326544|NCT01390844|20526905|P1|NOT COMPLETED|Follow-Up Phase||1
8326545|NCT01390844|20526902|P4|COMPLETED|Follow-Up Phase||8
8326546|NCT01390844|20526903|P3|COMPLETED|Follow-Up Phase||25
8326547|NCT01390844|20526904|P2|COMPLETED|Follow-Up Phase||36
8326548|NCT01390844|20526905|P1|COMPLETED|Follow-Up Phase||92
8326549|NCT01390844|20526902|P4|STARTED|Follow-Up Phase||8
8326550|NCT01390844|20526903|P3|STARTED|Follow-Up Phase||26
8326551|NCT01390844|20526904|P2|STARTED|Follow-Up Phase||37
8326552|NCT01390844|20526905|P1|STARTED|Follow-Up Phase||93
8326553|NCT01390844|20526902|P4|NOT COMPLETED|Treatment Phase||19
8326554|NCT01390844|20526903|P3|NOT COMPLETED|Treatment Phase||31
8326555|NCT01390844|20526904|P2|NOT COMPLETED|Treatment Phase||28
8326556|NCT01390844|20526905|P1|NOT COMPLETED|Treatment Phase||40
8326557|NCT01390844|20526902|P4|COMPLETED|Treatment Phase||8
8326558|NCT01390844|20526903|P3|COMPLETED|Treatment Phase||26
8326559|NCT01390844|20526904|P2|COMPLETED|Treatment Phase||37
8326560|NCT01390844|20526905|P1|COMPLETED|Treatment Phase||93
8326561|NCT01390844|20526902|P4|Followed Good Clinical Practice (GCP)|Treatment Phase||24
8326562|NCT01390844|20526903|P3|Followed Good Clinical Practice (GCP)|Treatment Phase||47
8326563|NCT01390844|20526904|P2|Followed Good Clinical Practice (GCP)|Treatment Phase||65
8326564|NCT01390844|20526905|P1|Followed Good Clinical Practice (GCP)|Treatment Phase||133
8326565|NCT01390844|20526902|P4|STARTED|Treatment Phase||27
8326566|NCT01390844|20526903|P3|STARTED|Treatment Phase||57
8326567|NCT01390844|20526904|P2|STARTED|Treatment Phase||65
8326568|NCT01390844|20526905|P1|STARTED|Treatment Phase||133
8326569|NCT01390818|20526946|P15|NOT COMPLETED|Overall Study||0
8326570|NCT01390818|20526947|P14|NOT COMPLETED|Overall Study||0
8326571|NCT01390818|20526948|P13|NOT COMPLETED|Overall Study||0
8326572|NCT01390818|20526949|P12|NOT COMPLETED|Overall Study||0
8326573|NCT01390818|20526950|P11|NOT COMPLETED|Overall Study||0
8326574|NCT01390818|20526951|P10|NOT COMPLETED|Overall Study||0
8326575|NCT01390818|20526952|P9|NOT COMPLETED|Overall Study||0
8326576|NCT01390818|20526953|P8|NOT COMPLETED|Overall Study||0
8326577|NCT01390818|20526954|P7|NOT COMPLETED|Overall Study||0
8326578|NCT01390818|20526955|P6|NOT COMPLETED|Overall Study||0
8326579|NCT01390818|20526956|P5|NOT COMPLETED|Overall Study||0
8326580|NCT01390818|20526957|P4|NOT COMPLETED|Overall Study||0
8326581|NCT01390818|20526958|P3|NOT COMPLETED|Overall Study||0
8326582|NCT01390818|20526959|P2|NOT COMPLETED|Overall Study||0
8326583|NCT01390818|20526960|P1|NOT COMPLETED|Overall Study||0
8326584|NCT01390818|20526946|P15|COMPLETED|Overall Study||15
8326585|NCT01390818|20526947|P14|COMPLETED|Overall Study||18
8326586|NCT01390818|20526948|P13|COMPLETED|Overall Study||24
8326587|NCT01390818|20526949|P12|COMPLETED|Overall Study||26
8326588|NCT01390818|20526950|P11|COMPLETED|Overall Study||4
8326589|NCT01390818|20526951|P10|COMPLETED|Overall Study||3
8326590|NCT01390818|20526952|P9|COMPLETED|Overall Study||3
8326591|NCT01390818|20526953|P8|COMPLETED|Overall Study||14
8326592|NCT01390818|20526954|P7|COMPLETED|Overall Study||19
8326593|NCT01390818|20526955|P6|COMPLETED|Overall Study||3
8326594|NCT01390818|20526956|P5|COMPLETED|Overall Study||4
8326595|NCT01390818|20526957|P4|COMPLETED|Overall Study||4
8326596|NCT01390818|20526958|P3|COMPLETED|Overall Study||3
8326597|NCT01390818|20526959|P2|COMPLETED|Overall Study||3
8326598|NCT01390818|20526960|P1|COMPLETED|Overall Study||3
8326599|NCT01390818|20526946|P15|STARTED|Overall Study||15
8326600|NCT01390818|20526947|P14|STARTED|Overall Study||18
8326601|NCT01390818|20526948|P13|STARTED|Overall Study||24
8326602|NCT01390818|20526949|P12|STARTED|Overall Study||26
8326603|NCT01390818|20526950|P11|STARTED|Overall Study||4
8326604|NCT01390818|20526951|P10|STARTED|Overall Study||3
8326605|NCT01390818|20526952|P9|STARTED|Overall Study||3
8326606|NCT01390818|20526953|P8|STARTED|Overall Study||14
8326607|NCT01390818|20526954|P7|STARTED|Overall Study||19
8326608|NCT01390818|20526955|P6|STARTED|Overall Study||3
8326609|NCT01390818|20526956|P5|STARTED|Overall Study||4
8326610|NCT01390818|20526957|P4|STARTED|Overall Study||4
8326611|NCT01390818|20526958|P3|STARTED|Overall Study||3
8326612|NCT01390818|20526959|P2|STARTED|Overall Study||3
8326613|NCT01390818|20526960|P1|STARTED|Overall Study||3
8326614|NCT01390779|20527232|P1|NOT COMPLETED|Overall Study||1
8326615|NCT01390779|20527232|P1|COMPLETED|Overall Study||32
8326616|NCT01390779|20527232|P1|STARTED|Overall Study||33
8326617|NCT01390649|20527237|P1|NOT COMPLETED|Overall Study||1
8326618|NCT01390649|20527237|P1|COMPLETED|Overall Study||56
8326619|NCT01390649|20527237|P1|STARTED|Overall Study|Subjects treated with Privigen|57
8326620|NCT01390584|20527244|P3|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
8326621|NCT01390584|20527245|P2|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
8326622|NCT01390584|20527246|P1|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
8326623|NCT01390584|20527244|P3|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
8326624|NCT01390584|20527245|P2|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||1
8326625|NCT01390584|20527246|P1|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||4
8326626|NCT01390584|20527244|P3|STARTED|Step 2: ABVD or BEACOPP Then INRT||0
8326627|NCT01390584|20527245|P2|STARTED|Step 2: ABVD or BEACOPP Then INRT||1
8326628|NCT01390584|20527246|P1|STARTED|Step 2: ABVD or BEACOPP Then INRT||4
8326629|NCT01390584|20527244|P3|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
8326630|NCT01390584|20527245|P2|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
8326631|NCT01390584|20527246|P1|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
8326632|NCT01390584|20527244|P3|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
8326633|NCT01390584|20527245|P2|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
8326634|NCT01390584|20527246|P1|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||4
8326635|NCT01390584|20527244|P3|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
8326636|NCT01390584|20527245|P2|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
8326637|NCT01390584|20527246|P1|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||4
8326638|NCT01390441|20527268|P5|NOT COMPLETED|Extension Period||0
8326639|NCT01390441|20527269|P4|NOT COMPLETED|Extension Period||1
8326640|NCT01390441|20527270|P3|NOT COMPLETED|Extension Period||0
8326641|NCT01390441|20527271|P2|NOT COMPLETED|Extension Period||1
8326642|NCT01390441|20527272|P1|NOT COMPLETED|Extension Period||3
8326643|NCT01390441|20527268|P5|COMPLETED|Extension Period||3
8326644|NCT01390441|20527269|P4|COMPLETED|Extension Period||0
8326645|NCT01390441|20527270|P3|COMPLETED|Extension Period||1
8326646|NCT01390441|20527271|P2|COMPLETED|Extension Period||12
8326647|NCT01390441|20527272|P1|COMPLETED|Extension Period||12
8326648|NCT01390441|20527268|P5|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
8326649|NCT01390441|20527269|P4|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
8326650|NCT01390441|20527270|P3|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
8326651|NCT01390441|20527271|P2|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
8326652|NCT01390441|20527272|P1|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
8326653|NCT01390441|20527268|P5|NOT COMPLETED|Treatment Period||11
8326654|NCT01390441|20527269|P4|NOT COMPLETED|Treatment Period||13
8326655|NCT01390441|20527270|P3|NOT COMPLETED|Treatment Period||10
8326656|NCT01390441|20527271|P2|NOT COMPLETED|Treatment Period||1
8326657|NCT01390441|20527272|P1|NOT COMPLETED|Treatment Period||1
8326658|NCT01390441|20527268|P5|COMPLETED|Treatment Period||7
8326659|NCT01390441|20527269|P4|COMPLETED|Treatment Period||6
8326660|NCT01390441|20527270|P3|COMPLETED|Treatment Period||8
8326661|NCT01390441|20527271|P2|COMPLETED|Treatment Period||21
8326662|NCT01390441|20527272|P1|COMPLETED|Treatment Period||22
8326663|NCT01390441|20527268|P5|STARTED|Treatment Period||18
8326664|NCT01390441|20527269|P4|STARTED|Treatment Period||19
8326665|NCT01390441|20527270|P3|STARTED|Treatment Period||18
8326666|NCT01390441|20527271|P2|STARTED|Treatment Period||22
8326667|NCT01390441|20527272|P1|STARTED|Treatment Period||23
8326668|NCT01390428|20527337|P6|NOT COMPLETED|Overall Study||0
8326669|NCT01390428|20527338|P5|NOT COMPLETED|Overall Study||1
8326670|NCT01390428|20527339|P4|NOT COMPLETED|Overall Study||0
8326671|NCT01390428|20527340|P3|NOT COMPLETED|Overall Study||1
8326672|NCT01390428|20527341|P2|NOT COMPLETED|Overall Study||0
8326673|NCT01390428|20527342|P1|NOT COMPLETED|Overall Study||0
8326674|NCT01390428|20527337|P6|COMPLETED|Overall Study||8
8326675|NCT01390428|20527338|P5|COMPLETED|Overall Study||7
8326676|NCT01390428|20527339|P4|COMPLETED|Overall Study||9
8326677|NCT01390428|20527340|P3|COMPLETED|Overall Study||8
8326678|NCT01390428|20527341|P2|COMPLETED|Overall Study||8
8326679|NCT01390428|20527342|P1|COMPLETED|Overall Study||8
8326680|NCT01390428|20527337|P6|STARTED|Overall Study||8
8326681|NCT01390428|20527338|P5|STARTED|Overall Study||8
8326682|NCT01390428|20527339|P4|STARTED|Overall Study||9
8326683|NCT01390428|20527340|P3|STARTED|Overall Study||9
8326684|NCT01390428|20527341|P2|STARTED|Overall Study||8
8326685|NCT01390428|20527342|P1|STARTED|Overall Study||8
8326686|NCT01390415|20527394|P2|NOT COMPLETED|Overall Study||0
8326687|NCT01390415|20527395|P1|NOT COMPLETED|Overall Study||0
8326688|NCT01390415|20527394|P2|COMPLETED|Overall Study||37
8326689|NCT01390415|20527395|P1|COMPLETED|Overall Study||99
8326690|NCT01390415|20527394|P2|STARTED|Overall Study||37
8326691|NCT01390415|20527395|P1|STARTED|Overall Study||99
8326692|NCT01390402|20527405|P1|NOT COMPLETED|Overall Study||5
8326693|NCT01390402|20527405|P1|COMPLETED|Overall Study||1
8326694|NCT01390402|20527405|P1|STARTED|Overall Study||6
8326695|NCT01390389|20527411|P2|NOT COMPLETED|Overall Study||1
8326696|NCT01390389|20527412|P1|NOT COMPLETED|Overall Study||4
8326697|NCT01390389|20527411|P2|COMPLETED|Overall Study||8
8326698|NCT01390389|20527412|P1|COMPLETED|Overall Study||6
8326699|NCT01390389|20527411|P2|STARTED|Overall Study||9
8326700|NCT01390389|20527412|P1|STARTED|Overall Study||10
8326701|NCT01390298|20527422|P1|NOT COMPLETED|Overall Study||24
8326702|NCT01390298|20527422|P1|COMPLETED|Overall Study||31
8326703|NCT01390298|20527422|P1|STARTED|Overall Study||55
8326704|NCT01390272|20527428|P2|NOT COMPLETED|Overall Study||15
8326705|NCT01390272|20527429|P1|NOT COMPLETED|Overall Study||17
8326706|NCT01390272|20527428|P2|COMPLETED|Overall Study||178
8326707|NCT01390272|20527429|P1|COMPLETED|Overall Study||175
8326708|NCT01390272|20527428|P2|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160
8326709|NCT01390272|20527429|P1|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155
8326710|NCT01390272|20527428|P2|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159
8326711|NCT01390272|20527429|P1|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139
8326712|NCT01390272|20527428|P2|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171
8326713|NCT01390272|20527429|P1|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162
8326714|NCT01390272|20527428|P2|STARTED|Overall Study||193
8326715|NCT01390272|20527429|P1|STARTED|Overall Study||192
8326716|NCT01390259|20527459|P2|NOT COMPLETED|Overall Study||0
8326717|NCT01390259|20527460|P1|NOT COMPLETED|Overall Study||0
8326718|NCT01390259|20527459|P2|COMPLETED|Overall Study||6
8326719|NCT01390259|20527460|P1|COMPLETED|Overall Study||5
8326720|NCT01390259|20527459|P2|STARTED|Overall Study||6
8326721|NCT01390259|20527460|P1|STARTED|Overall Study||5
8326722|NCT01390246|20527471|P2|NOT COMPLETED|Overall Study||25
8326723|NCT01390246|20527472|P1|NOT COMPLETED|Overall Study||20
8326724|NCT01390246|20527471|P2|COMPLETED|Overall Study||10
8326725|NCT01390246|20527472|P1|COMPLETED|Overall Study||10
8326726|NCT01390246|20527471|P2|Visit 7: 36-38 Weeks Gestation|Overall Study||10
8326727|NCT01390246|20527472|P1|Visit 7: 36-38 Weeks Gestation|Overall Study||10
8326728|NCT01390246|20527471|P2|Visit 6: End of Treatment|Overall Study||15
8326729|NCT01390246|20527472|P1|Visit 6: End of Treatment|Overall Study||15
8326730|NCT01390246|20527471|P2|Visit 2: Quit Day|Overall Study||24
8326731|NCT01390246|20527472|P1|Visit 2: Quit Day|Overall Study||24
8326732|NCT01390246|20527471|P2|STARTED|Overall Study||35
8326733|NCT01390246|20527472|P1|STARTED|Overall Study||30
8326734|NCT01390233|20527487|P3|NOT COMPLETED|Overall Study||6
8326735|NCT01390233|20527488|P2|NOT COMPLETED|Overall Study||2
8326736|NCT01390233|20527489|P1|NOT COMPLETED|Overall Study||5
8326737|NCT01390233|20527487|P3|COMPLETED|Overall Study||30
8326738|NCT01390233|20527488|P2|COMPLETED|Overall Study||29
8326739|NCT01390233|20527489|P1|COMPLETED|Overall Study||30
8326740|NCT01390233|20527487|P3|STARTED|Overall Study||36
8326741|NCT01390233|20527488|P2|STARTED|Overall Study||31
8326742|NCT01390233|20527489|P1|STARTED|Overall Study||35
8326743|NCT01390220|20527497|P3|NOT COMPLETED|Comparative Phase||0
8326744|NCT01390220|20527498|P2|NOT COMPLETED|Comparative Phase||1
8326745|NCT01390220|20527499|P1|NOT COMPLETED|Comparative Phase||0
8326746|NCT01390220|20527497|P3|COMPLETED|Comparative Phase||67
8326747|NCT01390220|20527498|P2|COMPLETED|Comparative Phase||133
8326748|NCT01390220|20527499|P1|COMPLETED|Comparative Phase|This arm not applicable in CP|0
8326749|NCT01390220|20527497|P3|STARTED|Comparative Phase||67
8326750|NCT01390220|20527498|P2|STARTED|Comparative Phase||134
8326751|NCT01390220|20527499|P1|STARTED|Comparative Phase|This arm not applicable in CP|0
8326752|NCT01390220|20527497|P3|NOT COMPLETED|Test Dose Phase||0
8326753|NCT01390220|20527498|P2|NOT COMPLETED|Test Dose Phase||0
8326754|NCT01390220|20527499|P1|NOT COMPLETED|Test Dose Phase||91
8326755|NCT01390220|20527497|P3|COMPLETED|Test Dose Phase||0
8326756|NCT01390220|20527498|P2|COMPLETED|Test Dose Phase||0
8326757|NCT01390220|20527499|P1|COMPLETED|Test Dose Phase||201
8326758|NCT01390220|20527497|P3|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
8326759|NCT01390220|20527498|P2|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
8326760|NCT01390220|20527499|P1|STARTED|Test Dose Phase||292
8326761|NCT01390181|20527514|P1|NOT COMPLETED|Overall Study||4
8326762|NCT01390181|20527514|P1|COMPLETED|Overall Study||0
8326763|NCT01390181|20527514|P1|STARTED|Overall Study||4
8326764|NCT01390064|20527520|P2|NOT COMPLETED|Overall Study||0
8326765|NCT01390064|20527521|P1|NOT COMPLETED|Overall Study||0
8326766|NCT01390064|20527520|P2|COMPLETED|Overall Study||3
8326767|NCT01390064|20527521|P1|COMPLETED|Overall Study||3
8326768|NCT01390064|20527520|P2|STARTED|Overall Study||3
8326769|NCT01390064|20527521|P1|STARTED|Overall Study||3
8326770|NCT01390038|20527527|P1|NOT COMPLETED|Overall Study||8
8326771|NCT01390038|20527527|P1|COMPLETED|Overall Study||149
8326772|NCT01390038|20527527|P1|STARTED|Overall Study||157
8326773|NCT01389973|20527537|P1|NOT COMPLETED|Overall Study||20
8326774|NCT01389973|20527537|P1|COMPLETED|Overall Study||0
8326775|NCT01389973|20527537|P1|STARTED|Overall Study||20
8326776|NCT01389882|20527547|P2|NOT COMPLETED|Overall Study||4
8326777|NCT01389882|20527548|P1|NOT COMPLETED|Overall Study||1
8326778|NCT01389882|20527547|P2|COMPLETED|Overall Study||7
8326779|NCT01389882|20527548|P1|COMPLETED|Overall Study||12
8326780|NCT01389882|20527547|P2|STARTED|Overall Study||11
8326781|NCT01389882|20527548|P1|STARTED|Overall Study||13
8326782|NCT01389856|20527578|P2|NOT COMPLETED|Overall Study||0
8326783|NCT01389856|20527579|P1|NOT COMPLETED|Overall Study||0
8326784|NCT01389856|20527578|P2|COMPLETED|Overall Study||8
8326785|NCT01389856|20527579|P1|COMPLETED|Overall Study||13
8326786|NCT01389856|20527578|P2|STARTED|Overall Study|Randomized and treated.|8
8326787|NCT01389856|20527579|P1|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
8326788|NCT01389817|20527636|P2|NOT COMPLETED|Overall Study||0
8326789|NCT01389817|20527637|P1|NOT COMPLETED|Overall Study||4
8326790|NCT01389817|20527636|P2|COMPLETED|Overall Study||0
8326791|NCT01389817|20527637|P1|COMPLETED|Overall Study||0
8326792|NCT01389817|20527636|P2|STARTED|Overall Study||0
8326793|NCT01389817|20527637|P1|STARTED|Overall Study||4
8326794|NCT01389765|20527643|P2|NOT COMPLETED|Second Intervention (Day 1)||0
8326795|NCT01389765|20527644|P1|NOT COMPLETED|Second Intervention (Day 1)||0
8326796|NCT01389765|20527643|P2|COMPLETED|Second Intervention (Day 1)||12
8326797|NCT01389765|20527644|P1|COMPLETED|Second Intervention (Day 1)||12
8326798|NCT01389765|20527643|P2|STARTED|Second Intervention (Day 1)||12
8326799|NCT01389765|20527644|P1|STARTED|Second Intervention (Day 1)||12
8326800|NCT01389765|20527643|P2|NOT COMPLETED|Washout Period (7 Days)||0
8326801|NCT01389765|20527644|P1|NOT COMPLETED|Washout Period (7 Days)||0
8326802|NCT01389765|20527643|P2|COMPLETED|Washout Period (7 Days)||12
8326803|NCT01389765|20527644|P1|COMPLETED|Washout Period (7 Days)||12
8326804|NCT01389765|20527643|P2|STARTED|Washout Period (7 Days)||12
8326805|NCT01389765|20527644|P1|STARTED|Washout Period (7 Days)||12
8326806|NCT01389765|20527643|P2|NOT COMPLETED|First Intervention (Day 1)||0
8326807|NCT01389765|20527644|P1|NOT COMPLETED|First Intervention (Day 1)||0
8326808|NCT01389765|20527643|P2|COMPLETED|First Intervention (Day 1)||12
8326809|NCT01389765|20527644|P1|COMPLETED|First Intervention (Day 1)||12
8326810|NCT01389765|20527643|P2|STARTED|First Intervention (Day 1)||12
8326811|NCT01389765|20527644|P1|STARTED|First Intervention (Day 1)||12
8326812|NCT01389752|20527654|P2|NOT COMPLETED|Study Period 2||0
8326813|NCT01389752|20527655|P1|NOT COMPLETED|Study Period 2||1
8326814|NCT01389752|20527654|P2|COMPLETED|Study Period 2||9
8326815|NCT01389752|20527655|P1|COMPLETED|Study Period 2||10
8326816|NCT01389752|20527654|P2|STARTED|Study Period 2||9
8326817|NCT01389752|20527655|P1|STARTED|Study Period 2||11
8326818|NCT01389752|20527654|P2|NOT COMPLETED|Study Period 1||2
8326819|NCT01389752|20527655|P1|NOT COMPLETED|Study Period 1||0
8326820|NCT01389752|20527654|P2|COMPLETED|Study Period 1||9
8326821|NCT01389752|20527655|P1|COMPLETED|Study Period 1||11
8326822|NCT01389752|20527654|P2|STARTED|Study Period 1||11
8326823|NCT01389752|20527655|P1|STARTED|Study Period 1||11
8326824|NCT01389596|20527668|P3|NOT COMPLETED|Overall Study||10
8326825|NCT01389596|20527669|P2|NOT COMPLETED|Overall Study||16
8326826|NCT01389596|20527670|P1|NOT COMPLETED|Overall Study||10
8326827|NCT01389596|20527668|P3|COMPLETED|Overall Study||84
8326828|NCT01389596|20527669|P2|COMPLETED|Overall Study||81
8326829|NCT01389596|20527670|P1|COMPLETED|Overall Study||94
8326830|NCT01389596|20527668|P3|STARTED|Overall Study||94
8326831|NCT01389596|20527669|P2|STARTED|Overall Study||97
8326832|NCT01389596|20527670|P1|STARTED|Overall Study||104
8326833|NCT01389323|20527729|P1|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
8326834|NCT01389323|20527729|P1|COMPLETED|Follow-up Period (up to 48 Weeks)||184
8326835|NCT01389323|20527729|P1|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
8326836|NCT01389323|20527729|P1|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
8326837|NCT01389323|20527729|P1|COMPLETED|Treatment Period (up to 48 Weeks)||151
8326838|NCT01389323|20527729|P1|STARTED|Treatment Period (up to 48 Weeks)||246
8326839|NCT01389284|20527752|P3|NOT COMPLETED|Overall Study||0
8326840|NCT01389284|20527753|P2|NOT COMPLETED|Overall Study||0
8326841|NCT01389284|20527754|P1|NOT COMPLETED|Overall Study||0
8326842|NCT01389284|20527752|P3|COMPLETED|Overall Study||60
8326843|NCT01389284|20527753|P2|COMPLETED|Overall Study||120
8326844|NCT01389284|20527754|P1|COMPLETED|Overall Study||120
8326845|NCT01389284|20527752|P3|STARTED|Overall Study||60
8326846|NCT01389284|20527753|P2|STARTED|Overall Study||120
8326847|NCT01389284|20527754|P1|STARTED|Overall Study||120
8326848|NCT01389258|20527786|P1|NOT COMPLETED|Overall Study||5
8326849|NCT01389258|20527786|P1|COMPLETED|Overall Study||40
8326850|NCT01389258|20527786|P1|STARTED|Overall Study||45
8326851|NCT01389245|20527796|P1|NOT COMPLETED|Overall Study||15
8326852|NCT01389245|20527796|P1|COMPLETED|Overall Study||27
8326853|NCT01389245|20527796|P1|STARTED|Overall Study||42
8326854|NCT01389128|20527806|P2|NOT COMPLETED|Overall Study||6
8326855|NCT01389128|20527807|P1|NOT COMPLETED|Overall Study||5
8326856|NCT01389128|20527806|P2|COMPLETED|Overall Study||34
8326857|NCT01389128|20527807|P1|COMPLETED|Overall Study||35
8326858|NCT01389128|20527806|P2|STARTED|Overall Study||40
8326859|NCT01389128|20527807|P1|STARTED|Overall Study||40
8326860|NCT01389102|20527831|P6|NOT COMPLETED|Overall Study||8
8326861|NCT01389102|20527832|P5|NOT COMPLETED|Overall Study||13
8326862|NCT01389102|20527833|P4|NOT COMPLETED|Overall Study||7
8326863|NCT01389102|20527834|P3|NOT COMPLETED|Overall Study||19
8326864|NCT01389102|20527835|P2|NOT COMPLETED|Overall Study||12
8326865|NCT01389102|20527836|P1|NOT COMPLETED|Overall Study||18
8326866|NCT01389102|20527831|P6|COMPLETED|Overall Study||68
8326867|NCT01389102|20527832|P5|COMPLETED|Overall Study||61
8326868|NCT01389102|20527833|P4|COMPLETED|Overall Study||69
8326869|NCT01389102|20527834|P3|COMPLETED|Overall Study||58
8326870|NCT01389102|20527835|P2|COMPLETED|Overall Study||64
8326871|NCT01389102|20527836|P1|COMPLETED|Overall Study||57
8326872|NCT01389102|20527831|P6|STARTED|Overall Study||76
8326873|NCT01389102|20527832|P5|STARTED|Overall Study||74
8326874|NCT01389102|20527833|P4|STARTED|Overall Study||76
8326875|NCT01389102|20527834|P3|STARTED|Overall Study||77
8326876|NCT01389102|20527835|P2|STARTED|Overall Study||76
8326877|NCT01389102|20527836|P1|STARTED|Overall Study||75
8326878|NCT01389076|20527856|P1|NOT COMPLETED|Overall Study||0
8326879|NCT01389076|20527856|P1|COMPLETED|Overall Study||22
8326880|NCT01389076|20527856|P1|STARTED|Overall Study||22
8326881|NCT01388985|20527866|P2|NOT COMPLETED|Overall Study||38
8326882|NCT01388985|20527867|P1|NOT COMPLETED|Overall Study||49
8326883|NCT01388985|20527866|P2|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211
8326884|NCT01388985|20527867|P1|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200
8326885|NCT01388985|20527866|P2|Primary Vaccination Period|Overall Study||238
8326886|NCT01388985|20527867|P1|Primary Vaccination Period|Overall Study||231
8326887|NCT01388985|20527866|P2|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
8326888|NCT01388985|20527867|P1|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
8326889|NCT01388946|20527883|P2|NOT COMPLETED|Overall Study||3
8326890|NCT01388946|20527884|P1|NOT COMPLETED|Overall Study||6
8326891|NCT01388946|20527883|P2|COMPLETED|Overall Study||52
8326892|NCT01388946|20527884|P1|COMPLETED|Overall Study||49
8326893|NCT01388946|20527883|P2|STARTED|Overall Study||55
8326894|NCT01388946|20527884|P1|STARTED|Overall Study||55
8326895|NCT01388920|20527919|P3|NOT COMPLETED|Overall Study||0
8326896|NCT01388920|20527920|P2|NOT COMPLETED|Overall Study||0
8326897|NCT01388920|20527921|P1|NOT COMPLETED|Overall Study||0
8326898|NCT01388920|20527919|P3|COMPLETED|Overall Study||0
8326899|NCT01388920|20527920|P2|COMPLETED|Overall Study||1
8326900|NCT01388920|20527921|P1|COMPLETED|Overall Study||1
8326901|NCT01388920|20527919|P3|STARTED|Overall Study||0
8326902|NCT01388920|20527920|P2|STARTED|Overall Study||1
8326903|NCT01388920|20527921|P1|STARTED|Overall Study||1
8326904|NCT01388907|20527931|P2|NOT COMPLETED|Overall Study||0
8326905|NCT01388907|20527932|P1|NOT COMPLETED|Overall Study||2
8326906|NCT01388907|20527931|P2|COMPLETED|Overall Study||28
8326907|NCT01388907|20527932|P1|COMPLETED|Overall Study||31
8326908|NCT01388907|20527931|P2|STARTED|Overall Study||28
8326909|NCT01388907|20527932|P1|STARTED|Overall Study||33
8326910|NCT01388816|20527948|P4|NOT COMPLETED|Overall Study||0
8326911|NCT01388816|20527949|P3|NOT COMPLETED|Overall Study||3
8326912|NCT01388816|20527950|P2|NOT COMPLETED|Overall Study||4
8326913|NCT01388816|20527951|P1|NOT COMPLETED|Overall Study||2
8326914|NCT01388816|20527948|P4|COMPLETED|Overall Study||44
8326915|NCT01388816|20527949|P3|COMPLETED|Overall Study||41
8326916|NCT01388816|20527950|P2|COMPLETED|Overall Study||39
8326917|NCT01388816|20527951|P1|COMPLETED|Overall Study||43
8326918|NCT01388816|20527948|P4|STARTED|Overall Study||44
8326919|NCT01388816|20527949|P3|STARTED|Overall Study||44
8326920|NCT01388816|20527950|P2|STARTED|Overall Study||43
8326921|NCT01388816|20527951|P1|STARTED|Overall Study||45
8326922|NCT01388790|20527980|P1|NOT COMPLETED|Overall Study||8
8326923|NCT01388790|20527980|P1|COMPLETED|Overall Study||32
8326924|NCT01388790|20527980|P1|STARTED|Overall Study||40
8326925|NCT01388777|20527985|P1|NOT COMPLETED|Overall Study||0
8326926|NCT01388777|20527985|P1|COMPLETED|Overall Study||1
8326927|NCT01388777|20527985|P1|Cryoablation|Overall Study||1
8326928|NCT01388777|20527985|P1|STARTED|Overall Study||1
8326929|NCT01388647|20527991|P2|NOT COMPLETED|Overall Study||2
8326930|NCT01388647|20527992|P1|NOT COMPLETED|Overall Study||1
8326931|NCT01388647|20527991|P2|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
8326932|NCT01388647|20527992|P1|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
8326933|NCT01388647|20527991|P2|STARTED|Overall Study||6
8326934|NCT01388647|20527992|P1|STARTED|Overall Study||6
8326935|NCT01388543|20528005|P2|NOT COMPLETED|Day 14||4
8326936|NCT01388543|20528006|P1|NOT COMPLETED|Day 14||1
8326937|NCT01388543|20528005|P2|COMPLETED|Day 14||12
8326938|NCT01388543|20528006|P1|COMPLETED|Day 14||14
8326939|NCT01388543|20528005|P2|STARTED|Day 14||16
8326940|NCT01388543|20528006|P1|STARTED|Day 14||15
8326941|NCT01388543|20528005|P2|NOT COMPLETED|Day 7, Primary End Point||0
8326942|NCT01388543|20528006|P1|NOT COMPLETED|Day 7, Primary End Point||0
8326943|NCT01388543|20528005|P2|COMPLETED|Day 7, Primary End Point||16
8326944|NCT01388543|20528006|P1|COMPLETED|Day 7, Primary End Point||15
8326945|NCT01388543|20528005|P2|STARTED|Day 7, Primary End Point||16
8326946|NCT01388543|20528006|P1|STARTED|Day 7, Primary End Point||15
8326947|NCT01388530|20528012|P1|NOT COMPLETED|Overall Study||5
8326948|NCT01388530|20528012|P1|COMPLETED|Overall Study||20
8326949|NCT01388530|20528012|P1|STARTED|Overall Study||25
8326950|NCT01388491|20528021|P2|NOT COMPLETED|Overall Study||29
8326951|NCT01388491|20528022|P1|NOT COMPLETED|Overall Study||34
8326952|NCT01388491|20528021|P2|COMPLETED|Overall Study||114
8326953|NCT01388491|20528022|P1|COMPLETED|Overall Study||116
8326954|NCT01388491|20528021|P2|Per Protocol (PP) Population|Overall Study||121
8326955|NCT01388491|20528022|P1|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
8326956|NCT01388491|20528021|P2|Intent-to-Treat (ITT) Population|Overall Study||136
8326957|NCT01388491|20528022|P1|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
8326958|NCT01388491|20528021|P2|Safety Population|Overall Study||142
8326959|NCT01388491|20528022|P1|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
8326960|NCT01388491|20528021|P2|STARTED|Overall Study||143
8326961|NCT01388491|20528022|P1|STARTED|Overall Study|number randomized|150
8326962|NCT01388361|20528057|P3|NOT COMPLETED|Overall Study||14
8326963|NCT01388361|20528058|P2|NOT COMPLETED|Overall Study||12
8326964|NCT01388361|20528059|P1|NOT COMPLETED|Overall Study||12
8326965|NCT01388361|20528057|P3|COMPLETED|Overall Study||75
8326966|NCT01388361|20528058|P2|COMPLETED|Overall Study||76
8326967|NCT01388361|20528059|P1|COMPLETED|Overall Study||224
8326968|NCT01388361|20528057|P3|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
8326969|NCT01388361|20528058|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
8326970|NCT01388361|20528059|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
8326971|NCT01388361|20528057|P3|STARTED|Overall Study||89
8326972|NCT01388361|20528058|P2|STARTED|Overall Study||88
8326973|NCT01388361|20528059|P1|STARTED|Overall Study||236
8326974|NCT01388335|20528076|P1|NOT COMPLETED|Safety Extension||7
8326975|NCT01388335|20528076|P1|COMPLETED|Safety Extension||0
8326976|NCT01388335|20528076|P1|STARTED|Safety Extension|Six completed Period 2 and 1 participant who discontinued Period 2 entered Safety Extension.|7
8326977|NCT01388335|20528076|P1|NOT COMPLETED|Period 2||3
8326978|NCT01388335|20528076|P1|COMPLETED|Period 2|Only 6 participants who completed Period 2 entered Safety Extension.|9
8326979|NCT01388335|20528076|P1|Received at Least 1 Dose of Study Drug|Period 2||12
8326980|NCT01388335|20528076|P1|STARTED|Period 2||12
8326981|NCT01388335|20528076|P1|NOT COMPLETED|Period 1||1
8326982|NCT01388335|20528076|P1|COMPLETED|Period 1||12
8326983|NCT01388335|20528076|P1|Received at Least 1 Dose of Study Drug|Period 1||13
8326984|NCT01388335|20528076|P1|STARTED|Period 1||13
8326985|NCT01388166|20528103|P1|NOT COMPLETED|Overall Study||59
8326986|NCT01388166|20528103|P1|COMPLETED|Overall Study||1194
8326987|NCT01388166|20528103|P1|STARTED|Overall Study||1253
8326988|NCT01387815|20528111|P2|NOT COMPLETED|Overall Study||104
8326989|NCT01387815|20528112|P1|NOT COMPLETED|Overall Study||140
8326990|NCT01387815|20528111|P2|COMPLETED|Overall Study||189
8326991|NCT01387815|20528112|P1|COMPLETED|Overall Study||162
8326992|NCT01387815|20528111|P2|STARTED|Overall Study||293
8326993|NCT01387815|20528112|P1|STARTED|Overall Study||302
8326994|NCT01387789|20528406|P1|NOT COMPLETED|Overall Study||8
8326995|NCT01387789|20528406|P1|COMPLETED|Overall Study||63
8326996|NCT01387789|20528406|P1|STARTED|Overall Study||71
8326997|NCT01387737|20528420|P2|NOT COMPLETED|Overall Study||74
8326998|NCT01387737|20528421|P1|NOT COMPLETED|Overall Study||52
8326999|NCT01387737|20528420|P2|COMPLETED|Overall Study||641
8327000|NCT01387737|20528421|P1|COMPLETED|Overall Study||532
8327001|NCT01387737|20528420|P2|STARTED|Overall Study||715
8327002|NCT01387737|20528421|P1|STARTED|Overall Study||584
8327003|NCT01387672|20528433|P6|NOT COMPLETED|Overall Study||0
8327004|NCT01387672|20528434|P5|NOT COMPLETED|Overall Study||4
8327005|NCT01387672|20528435|P4|NOT COMPLETED|Overall Study||4
8327006|NCT01387672|20528436|P3|NOT COMPLETED|Overall Study||5
8327007|NCT01387672|20528437|P2|NOT COMPLETED|Overall Study||7
8327008|NCT01387672|20528438|P1|NOT COMPLETED|Overall Study||7
8327009|NCT01387672|20528433|P6|COMPLETED|Overall Study||37
8327010|NCT01387672|20528434|P5|COMPLETED|Overall Study||34
8327011|NCT01387672|20528435|P4|COMPLETED|Overall Study||35
8327012|NCT01387672|20528436|P3|COMPLETED|Overall Study||33
8327013|NCT01387672|20528437|P2|COMPLETED|Overall Study||31
8327014|NCT01387672|20528438|P1|COMPLETED|Overall Study||32
8327015|NCT01387672|20528433|P6|STARTED|Overall Study||37
8327016|NCT01387672|20528434|P5|STARTED|Overall Study||38
8327017|NCT01387672|20528435|P4|STARTED|Overall Study||39
8327018|NCT01387672|20528436|P3|STARTED|Overall Study||38
8327019|NCT01387672|20528437|P2|STARTED|Overall Study||38
8327020|NCT01387672|20528438|P1|STARTED|Overall Study||39
8327027|NCT01387581|20528471|P3|NOT COMPLETED|Overall Study||3
8327028|NCT01387581|20528472|P2|NOT COMPLETED|Overall Study||6
8327029|NCT01387581|20528473|P1|NOT COMPLETED|Overall Study||7
8327030|NCT01387581|20528471|P3|COMPLETED|Overall Study||9
8327031|NCT01387581|20528472|P2|COMPLETED|Overall Study||101
8327032|NCT01387581|20528473|P1|COMPLETED|Overall Study||101
8327033|NCT01387581|20528471|P3|STARTED|Overall Study||12
8327034|NCT01387581|20528472|P2|STARTED|Overall Study||107
8327035|NCT01387581|20528473|P1|STARTED|Overall Study||108
8327036|NCT01387542|20528484|P1|NOT COMPLETED|Overall Study||8
8327037|NCT01387542|20528484|P1|COMPLETED|Overall Study||32
8327038|NCT01387542|20528484|P1|Treated|Overall Study||38
8327039|NCT01387542|20528484|P1|STARTED|Overall Study||40
8327040|NCT01387516|20528495|P4|NOT COMPLETED|Overall Study||4
8327041|NCT01387516|20528496|P3|NOT COMPLETED|Overall Study||4
8327042|NCT01387516|20528497|P2|NOT COMPLETED|Overall Study||5
8327043|NCT01387516|20528498|P1|NOT COMPLETED|Overall Study||5
8327044|NCT01387516|20528495|P4|COMPLETED|Overall Study||65
8327045|NCT01387516|20528496|P3|COMPLETED|Overall Study||75
8327046|NCT01387516|20528497|P2|COMPLETED|Overall Study||63
8327047|NCT01387516|20528498|P1|COMPLETED|Overall Study||75
8327048|NCT01387516|20528495|P4|STARTED|Overall Study||69
8327049|NCT01387516|20528496|P3|STARTED|Overall Study||79
8327050|NCT01387516|20528497|P2|STARTED|Overall Study||68
8327051|NCT01387516|20528498|P1|STARTED|Overall Study||80
8327062|NCT01387347|20528531|P2|NOT COMPLETED|Overall Study||1
8327063|NCT01387347|20528532|P1|NOT COMPLETED|Overall Study||2
8327064|NCT01387347|20528531|P2|COMPLETED|Overall Study||35
8327065|NCT01387347|20528532|P1|COMPLETED|Overall Study||34
8327066|NCT01387347|20528531|P2|STARTED|Overall Study||36
8327067|NCT01387347|20528532|P1|STARTED|Overall Study||36
8327068|NCT01387282|20528544|P2|NOT COMPLETED|Overall Study||47
8327069|NCT01387282|20528545|P1|NOT COMPLETED|Overall Study||97
8327070|NCT01387282|20528544|P2|COMPLETED|Overall Study||118
8327071|NCT01387282|20528545|P1|COMPLETED|Overall Study||233
8327072|NCT01387282|20528544|P2|Safety Population|Overall Study||161
8327073|NCT01387282|20528545|P1|Safety Population|Overall Study||330
8327074|NCT01387282|20528544|P2|MITT Population|Overall Study||136
8327075|NCT01387282|20528545|P1|MITT Population|Overall Study||268
8327076|NCT01387282|20528544|P2|ITT Population|Overall Study||165
8327077|NCT01387282|20528545|P1|ITT Population|Overall Study||330
8327078|NCT01387282|20528544|P2|STARTED|Overall Study||165
8327079|NCT01387282|20528545|P1|STARTED|Overall Study||330
8327080|NCT01387269|20528561|P2|NOT COMPLETED|Overall Study||40
8327081|NCT01387269|20528562|P1|NOT COMPLETED|Overall Study||92
8327082|NCT01387269|20528561|P2|COMPLETED|Overall Study||121
8327083|NCT01387269|20528562|P1|COMPLETED|Overall Study||231
8327084|NCT01387269|20528561|P2|Safety Population|Overall Study||161
8327085|NCT01387269|20528562|P1|Safety Population|Overall Study||320
8327086|NCT01387269|20528561|P2|MITT Population|Overall Study||141
8327087|NCT01387269|20528562|P1|MITT Population|Overall Study||284
8327088|NCT01387269|20528561|P2|ITT Population|Overall Study||161
8327089|NCT01387269|20528562|P1|ITT Population|Overall Study||323
8327090|NCT01387269|20528561|P2|STARTED|Overall Study||161
8327091|NCT01387269|20528562|P1|STARTED|Overall Study||323
8327092|NCT01387230|20528579|P3|NOT COMPLETED|Overall Study||13
8327093|NCT01387230|20528580|P2|NOT COMPLETED|Overall Study||7
8327094|NCT01387230|20528581|P1|NOT COMPLETED|Overall Study||18
8327095|NCT01387230|20528579|P3|COMPLETED|Overall Study||56
8327096|NCT01387230|20528580|P2|COMPLETED|Overall Study||62
8327097|NCT01387230|20528581|P1|COMPLETED|Overall Study||50
8327098|NCT01387230|20528579|P3|STARTED|Overall Study||69
8327099|NCT01387230|20528580|P2|STARTED|Overall Study||69
8327100|NCT01387230|20528581|P1|STARTED|Overall Study||68
8327101|NCT01387178|20528597|P2|NOT COMPLETED|Overall Study||0
8327102|NCT01387178|20528598|P1|NOT COMPLETED|Overall Study||0
8327103|NCT01387178|20528597|P2|COMPLETED|Overall Study||10641
8327104|NCT01387178|20528598|P1|COMPLETED|Overall Study||11582
8327105|NCT01387178|20528597|P2|STARTED|Overall Study||10641
8327106|NCT01387178|20528598|P1|STARTED|Overall Study||11582
8327107|NCT01387139|20528610|P2|NOT COMPLETED|Overall Study||0
8327108|NCT01387139|20528611|P1|NOT COMPLETED|Overall Study||0
8327109|NCT01387139|20528610|P2|COMPLETED|Overall Study||84
8327110|NCT01387139|20528611|P1|COMPLETED|Overall Study||99
8327111|NCT01387139|20528610|P2|STARTED|Overall Study||84
8327112|NCT01387139|20528611|P1|STARTED|Overall Study||99
8327113|NCT01387074|20528627|P1|NOT COMPLETED|Overall Study||8
8327114|NCT01387074|20528627|P1|COMPLETED|Overall Study||100
8327115|NCT01387074|20528627|P1|STARTED|Overall Study||108
8327116|NCT01387022|20528640|P2|NOT COMPLETED|Overall Study||4
8327117|NCT01387022|20528641|P1|NOT COMPLETED|Overall Study||1
8327118|NCT01387022|20528640|P2|COMPLETED|Overall Study||26
8327119|NCT01387022|20528641|P1|COMPLETED|Overall Study||28
8327120|NCT01387022|20528640|P2|STARTED|Overall Study||30
8327121|NCT01387022|20528641|P1|STARTED|Overall Study||29
8327122|NCT01386983|20528659|P2|NOT COMPLETED|Overall Study||0
8327123|NCT01386983|20528660|P1|NOT COMPLETED|Overall Study||0
8327124|NCT01386983|20528659|P2|COMPLETED|Overall Study||68
8327125|NCT01386983|20528660|P1|COMPLETED|Overall Study||264
8327126|NCT01386983|20528659|P2|STARTED|Overall Study||68
8327127|NCT01386983|20528660|P1|STARTED|Overall Study||264
8327128|NCT01386970|20528670|P2|NOT COMPLETED|Overall Study||2
8327129|NCT01386970|20528671|P1|NOT COMPLETED|Overall Study||4
8327130|NCT01386970|20528670|P2|COMPLETED|Overall Study||21
8327131|NCT01386970|20528671|P1|COMPLETED|Overall Study||16
8327132|NCT01386970|20528670|P2|STARTED|Overall Study||23
8327133|NCT01386970|20528671|P1|STARTED|Overall Study||20
8327134|NCT01386944|20528679|P1|NOT COMPLETED|Overall Study||56
8327135|NCT01386944|20528679|P1|COMPLETED|Overall Study||46
8327136|NCT01386944|20528679|P1|STARTED|Overall Study||102
8327137|NCT01386788|20528689|P1|NOT COMPLETED|Overall Study||2
8327138|NCT01386788|20528689|P1|COMPLETED|Overall Study||100
8327139|NCT01386788|20528689|P1|STARTED|Overall Study||102
8327140|NCT01386684|20528694|P1|NOT COMPLETED|Overall Study||293
8327141|NCT01386684|20528694|P1|COMPLETED|Overall Study||259
8327142|NCT01386684|20528694|P1|STARTED|Overall Study||552
8327161|NCT01386645|20528802|P3|NOT COMPLETED|Overall Study||2
8327162|NCT01386645|20528803|P2|NOT COMPLETED|Overall Study||1
8327163|NCT01386645|20528804|P1|NOT COMPLETED|Overall Study||0
8327164|NCT01386645|20528802|P3|COMPLETED|Overall Study||17
8327165|NCT01386645|20528803|P2|COMPLETED|Overall Study||18
8327166|NCT01386645|20528804|P1|COMPLETED|Overall Study||18
8327167|NCT01386645|20528802|P3|STARTED|Overall Study||19
8327168|NCT01386645|20528803|P2|STARTED|Overall Study||19
8327169|NCT01386645|20528804|P1|STARTED|Overall Study||18
8327170|NCT01386632|20528820|P2|NOT COMPLETED|Overall Study||4
8327171|NCT01386632|20528821|P1|NOT COMPLETED|Overall Study||5
8327172|NCT01386632|20528820|P2|COMPLETED|Overall Study||21
8327173|NCT01386632|20528821|P1|COMPLETED|Overall Study||20
8327174|NCT01386632|20528820|P2|STARTED|Overall Study||25
8327175|NCT01386632|20528821|P1|STARTED|Overall Study||25
8327176|NCT01386606|20528833|P4|NOT COMPLETED|Overall Study||1
8327177|NCT01386606|20528834|P3|NOT COMPLETED|Overall Study||3
8327178|NCT01386606|20528835|P2|NOT COMPLETED|Overall Study||4
8327179|NCT01386606|20528836|P1|NOT COMPLETED|Overall Study||4
8327180|NCT01386606|20528833|P4|COMPLETED|Overall Study||13
8327181|NCT01386606|20528834|P3|COMPLETED|Overall Study||13
8327182|NCT01386606|20528835|P2|COMPLETED|Overall Study||10
8327183|NCT01386606|20528836|P1|COMPLETED|Overall Study||12
8327184|NCT01386606|20528833|P4|STARTED|Overall Study||14
8327185|NCT01386606|20528834|P3|STARTED|Overall Study||16
8327186|NCT01386606|20528835|P2|STARTED|Overall Study||14
8327187|NCT01386606|20528836|P1|STARTED|Overall Study||16
8327188|NCT01386554|20528867|P3|NOT COMPLETED|Overall Study||6
8327189|NCT01386554|20528868|P2|NOT COMPLETED|Overall Study||9
8327190|NCT01386554|20528869|P1|NOT COMPLETED|Overall Study||3
8327191|NCT01386554|20528867|P3|COMPLETED|Overall Study||15
8327192|NCT01386554|20528868|P2|COMPLETED|Overall Study||26
8327193|NCT01386554|20528869|P1|COMPLETED|Overall Study||1
8327194|NCT01386554|20528867|P3|STARTED|Overall Study||21
8327195|NCT01386554|20528868|P2|STARTED|Overall Study||35
8327196|NCT01386554|20528869|P1|STARTED|Overall Study||4
8327197|NCT01386528|20528880|P1|NOT COMPLETED|Overall Study||0
8327198|NCT01386528|20528880|P1|COMPLETED|Overall Study||13
8327199|NCT01386528|20528880|P1|STARTED|Overall Study||13
8327200|NCT01386125|20528892|P2|NOT COMPLETED|Overall Study||37
8327201|NCT01386125|20528893|P1|NOT COMPLETED|Overall Study||25
8327202|NCT01386125|20528892|P2|COMPLETED|Overall Study||336
8327203|NCT01386125|20528893|P1|COMPLETED|Overall Study||350
8327204|NCT01386125|20528892|P2|STARTED|Overall Study||373
8327205|NCT01386125|20528893|P1|STARTED|Overall Study||375
8327206|NCT01386008|20528901|P1|NOT COMPLETED|Overall Study||20
8327207|NCT01386008|20528901|P1|COMPLETED|Overall Study||0
8327208|NCT01386008|20528901|P1|STARTED|Overall Study||20
8327209|NCT01385995|20528910|P2|NOT COMPLETED|Period 2, 2 Months||0
8327210|NCT01385995|20528911|P1|NOT COMPLETED|Period 2, 2 Months||0
8327211|NCT01385995|20528910|P2|COMPLETED|Period 2, 2 Months||25
8327212|NCT01385995|20528911|P1|COMPLETED|Period 2, 2 Months||24
8327213|NCT01385995|20528910|P2|STARTED|Period 2, 2 Months||25
8327214|NCT01385995|20528911|P1|STARTED|Period 2, 2 Months||24
8327215|NCT01385995|20528910|P2|NOT COMPLETED|Washout Period, 1 Month||0
8327216|NCT01385995|20528911|P1|NOT COMPLETED|Washout Period, 1 Month||0
8327217|NCT01385995|20528910|P2|COMPLETED|Washout Period, 1 Month||25
8327218|NCT01385995|20528911|P1|COMPLETED|Washout Period, 1 Month||24
8327219|NCT01385995|20528910|P2|STARTED|Washout Period, 1 Month||25
8327220|NCT01385995|20528911|P1|STARTED|Washout Period, 1 Month||24
8327221|NCT01385995|20528910|P2|NOT COMPLETED|Period 1, 2 Months||0
8327222|NCT01385995|20528911|P1|NOT COMPLETED|Period 1, 2 Months||1
8327223|NCT01385995|20528910|P2|COMPLETED|Period 1, 2 Months||25
8327224|NCT01385995|20528911|P1|COMPLETED|Period 1, 2 Months||24
8327225|NCT01385995|20528910|P2|STARTED|Period 1, 2 Months||25
8327226|NCT01385995|20528911|P1|STARTED|Period 1, 2 Months||25
8327227|NCT01385748|20528928|P3|NOT COMPLETED|Overall Study||13
8327228|NCT01385748|20528929|P2|NOT COMPLETED|Overall Study||14
8327229|NCT01385748|20528930|P1|NOT COMPLETED|Overall Study||15
8327230|NCT01385748|20528928|P3|COMPLETED|Overall Study||49
8327231|NCT01385748|20528929|P2|COMPLETED|Overall Study||51
8327232|NCT01385748|20528930|P1|COMPLETED|Overall Study||41
8327233|NCT01385748|20528928|P3|STARTED|Overall Study||62
8327234|NCT01385748|20528929|P2|STARTED|Overall Study||65
8327235|NCT01385748|20528930|P1|STARTED|Overall Study||56
8327236|NCT01385696|20528975|P2|NOT COMPLETED|Overall Study||0
8327237|NCT01385696|20528976|P1|NOT COMPLETED|Overall Study||0
8327238|NCT01385696|20528975|P2|COMPLETED|Overall Study||64
8327239|NCT01385696|20528976|P1|COMPLETED|Overall Study||66
8327240|NCT01385696|20528975|P2|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
8327241|NCT01385696|20528976|P1|STARTED|Overall Study||66
8327242|NCT01385644|20528987|P2|NOT COMPLETED|Overall Study||0
8327243|NCT01385644|20528988|P1|NOT COMPLETED|Overall Study||0
8327244|NCT01385644|20528987|P2|COMPLETED|Overall Study||4
8327245|NCT01385644|20528988|P1|COMPLETED|Overall Study||4
8327246|NCT01385644|20528987|P2|STARTED|Overall Study||4
8327247|NCT01385644|20528988|P1|STARTED|Overall Study||4
8327248|NCT01385579|20529002|P2|NOT COMPLETED|Overall Study||0
8327249|NCT01385579|20529003|P1|NOT COMPLETED|Overall Study||0
8327250|NCT01385579|20529002|P2|COMPLETED|Overall Study||104
8327251|NCT01385579|20529003|P1|COMPLETED|Overall Study||98
8327252|NCT01385579|20529002|P2|STARTED|Overall Study||104
8327253|NCT01385579|20529003|P1|STARTED|Overall Study||98
8327254|NCT01385566|20529015|P6|NOT COMPLETED|Overall Study||0
8327255|NCT01385566|20529016|P5|NOT COMPLETED|Overall Study||0
8327256|NCT01385566|20529017|P4|NOT COMPLETED|Overall Study||1
8327257|NCT01385566|20529018|P3|NOT COMPLETED|Overall Study||0
8327258|NCT01385566|20529019|P2|NOT COMPLETED|Overall Study||0
8327259|NCT01385566|20529020|P1|NOT COMPLETED|Overall Study||1
8327260|NCT01385566|20529015|P6|COMPLETED|Overall Study||34
8327261|NCT01385566|20529016|P5|COMPLETED|Overall Study||34
8327262|NCT01385566|20529017|P4|COMPLETED|Overall Study||34
8327263|NCT01385566|20529018|P3|COMPLETED|Overall Study||34
8327264|NCT01385566|20529019|P2|COMPLETED|Overall Study||34
8327265|NCT01385566|20529020|P1|COMPLETED|Overall Study||51
8327266|NCT01385566|20529015|P6|STARTED|Overall Study||34
8327267|NCT01385566|20529016|P5|STARTED|Overall Study||34
8327268|NCT01385566|20529017|P4|STARTED|Overall Study||35
8327269|NCT01385566|20529018|P3|STARTED|Overall Study||34
8327270|NCT01385566|20529019|P2|STARTED|Overall Study||34
8327271|NCT01385566|20529020|P1|STARTED|Overall Study||52
8327272|NCT01385371|20529074|P2|NOT COMPLETED|Overall Study||97
8327273|NCT01385371|20529075|P1|NOT COMPLETED|Overall Study||149
8327274|NCT01385371|20529074|P2|COMPLETED|Overall Study||652
8327275|NCT01385371|20529075|P1|COMPLETED|Overall Study||603
8327276|NCT01385371|20529074|P2|STARTED|Overall Study||749
8327277|NCT01385371|20529075|P1|STARTED|Overall Study||752
8327278|NCT01385306|20529095|P1|NOT COMPLETED|Overall Study||0
8327279|NCT01385306|20529095|P1|COMPLETED|Overall Study||6
8327280|NCT01385306|20529095|P1|STARTED|Overall Study||6
8327281|NCT01385293|20529103|P1|NOT COMPLETED|Overall Study||0
8327282|NCT01385293|20529103|P1|COMPLETED|Overall Study||30
8327283|NCT01385293|20529103|P1|STARTED|Overall Study||30
8327284|NCT01385280|20529113|P1|NOT COMPLETED|Overall Study||0
8327285|NCT01385280|20529113|P1|COMPLETED|Overall Study||13
8327286|NCT01385280|20529113|P1|STARTED|Overall Study||13
8327287|NCT01385202|20529123|P1|NOT COMPLETED|Overall Study||18
8327288|NCT01385202|20529123|P1|COMPLETED|Overall Study||154
8327289|NCT01385202|20529123|P1|Undergoing Ablation|Overall Study||160
8327290|NCT01385202|20529123|P1|Study Catheter Inserted|Overall Study||161
8327291|NCT01385202|20529123|P1|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
8327292|NCT01385189|20529135|P5|NOT COMPLETED|Overall Study||2
8327293|NCT01385189|20529136|P4|NOT COMPLETED|Overall Study||1
8327294|NCT01385189|20529137|P3|NOT COMPLETED|Overall Study||0
8327295|NCT01385189|20529138|P2|NOT COMPLETED|Overall Study||1
8327296|NCT01385189|20529139|P1|NOT COMPLETED|Overall Study||1
8327297|NCT01385189|20529135|P5|COMPLETED|Overall Study||6
8327298|NCT01385189|20529136|P4|COMPLETED|Overall Study||3
8327299|NCT01385189|20529137|P3|COMPLETED|Overall Study||4
8327300|NCT01385189|20529138|P2|COMPLETED|Overall Study||11
8327301|NCT01385189|20529139|P1|COMPLETED|Overall Study||11
8327302|NCT01385189|20529135|P5|STARTED|Overall Study||8
8327303|NCT01385189|20529136|P4|STARTED|Overall Study||4
8327304|NCT01385189|20529137|P3|STARTED|Overall Study||4
8327305|NCT01385189|20529138|P2|STARTED|Overall Study||12
8327306|NCT01385189|20529139|P1|STARTED|Overall Study||12
8327307|NCT01385176|20529160|P2|NOT COMPLETED|6-18 Month All VNS Active||3
8327308|NCT01385176|20529161|P1|NOT COMPLETED|6-18 Month All VNS Active||4
8327309|NCT01385176|20529160|P2|COMPLETED|6-18 Month All VNS Active||27
8327310|NCT01385176|20529161|P1|COMPLETED|6-18 Month All VNS Active||58
8327311|NCT01385176|20529160|P2|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|30
8327312|NCT01385176|20529161|P1|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|62
8327313|NCT01385176|20529160|P2|NOT COMPLETED|Randomization Phase||2
8327314|NCT01385176|20529161|P1|NOT COMPLETED|Randomization Phase||1
8327315|NCT01385176|20529160|P2|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|30
8327316|NCT01385176|20529161|P1|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|62
8327317|NCT01385176|20529160|P2|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|32
8327318|NCT01385176|20529161|P1|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|63
8327319|NCT01385137|20529177|P2|NOT COMPLETED|Evaluable for Primary Endpoint||24
8327320|NCT01385137|20529178|P1|NOT COMPLETED|Evaluable for Primary Endpoint||29
8327321|NCT01385137|20529177|P2|COMPLETED|Evaluable for Primary Endpoint||107
8327322|NCT01385137|20529178|P1|COMPLETED|Evaluable for Primary Endpoint||102
8327323|NCT01385137|20529177|P2|STARTED|Evaluable for Primary Endpoint||131
8327324|NCT01385137|20529178|P1|STARTED|Evaluable for Primary Endpoint||131
8327325|NCT01385137|20529177|P2|NOT COMPLETED|Evaluable at Baseline||4
8327326|NCT01385137|20529178|P1|NOT COMPLETED|Evaluable at Baseline||9
8327327|NCT01385137|20529177|P2|COMPLETED|Evaluable at Baseline||127
8327328|NCT01385137|20529178|P1|COMPLETED|Evaluable at Baseline||122
8327329|NCT01385137|20529177|P2|STARTED|Evaluable at Baseline||131
8327330|NCT01385137|20529178|P1|STARTED|Evaluable at Baseline||131
8327331|NCT01385098|20529192|P1|NOT COMPLETED|Overall Study||14
8327332|NCT01385098|20529192|P1|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
8327333|NCT01385098|20529192|P1|STARTED|Overall Study||37
8327334|NCT01385033|20529200|P6|NOT COMPLETED|Part III||0
8327335|NCT01385033|20529201|P5|NOT COMPLETED|Part III||0
8327336|NCT01385033|20529202|P4|NOT COMPLETED|Part III||0
8327337|NCT01385033|20529203|P3|NOT COMPLETED|Part III||0
8327338|NCT01385033|20529204|P2|NOT COMPLETED|Part III||0
8327339|NCT01385033|20529205|P1|NOT COMPLETED|Part III||0
8327340|NCT01385033|20529200|P6|COMPLETED|Part III||0
8327341|NCT01385033|20529201|P5|COMPLETED|Part III||0
8327342|NCT01385033|20529202|P4|COMPLETED|Part III||0
8327343|NCT01385033|20529203|P3|COMPLETED|Part III||0
8327344|NCT01385033|20529204|P2|COMPLETED|Part III||0
8327345|NCT01385033|20529205|P1|COMPLETED|Part III||0
8327346|NCT01385033|20529200|P6|STARTED|Part III||0
8327347|NCT01385033|20529201|P5|STARTED|Part III||0
8327348|NCT01385033|20529202|P4|STARTED|Part III||0
8327349|NCT01385033|20529203|P3|STARTED|Part III||0
8327350|NCT01385033|20529204|P2|STARTED|Part III||0
8327351|NCT01385033|20529205|P1|STARTED|Part III||0
8327352|NCT01385033|20529200|P6|NOT COMPLETED|Part II||0
8327353|NCT01385033|20529201|P5|NOT COMPLETED|Part II||0
8327354|NCT01385033|20529202|P4|NOT COMPLETED|Part II||0
8327355|NCT01385033|20529203|P3|NOT COMPLETED|Part II||0
8327356|NCT01385033|20529204|P2|NOT COMPLETED|Part II||0
8327357|NCT01385033|20529205|P1|NOT COMPLETED|Part II||0
8327358|NCT01385033|20529200|P6|COMPLETED|Part II||0
8327359|NCT01385033|20529201|P5|COMPLETED|Part II||0
8327360|NCT01385033|20529202|P4|COMPLETED|Part II||0
8327361|NCT01385033|20529203|P3|COMPLETED|Part II||0
8327362|NCT01385033|20529204|P2|COMPLETED|Part II||0
8327363|NCT01385033|20529205|P1|COMPLETED|Part II||0
8327364|NCT01385033|20529200|P6|STARTED|Part II||0
8327365|NCT01385033|20529201|P5|STARTED|Part II||0
8327366|NCT01385033|20529202|P4|STARTED|Part II||0
8327367|NCT01385033|20529203|P3|STARTED|Part II||0
8327368|NCT01385033|20529204|P2|STARTED|Part II||0
8327369|NCT01385033|20529205|P1|STARTED|Part II||0
8327370|NCT01385033|20529200|P6|NOT COMPLETED|Part I||0
8327371|NCT01385033|20529201|P5|NOT COMPLETED|Part I||0
8327372|NCT01385033|20529202|P4|NOT COMPLETED|Part I||0
8327373|NCT01385033|20529203|P3|NOT COMPLETED|Part I||0
8327374|NCT01385033|20529204|P2|NOT COMPLETED|Part I||0
8327375|NCT01385033|20529205|P1|NOT COMPLETED|Part I||0
8327376|NCT01385033|20529200|P6|COMPLETED|Part I||0
8327377|NCT01385033|20529201|P5|COMPLETED|Part I||0
8327378|NCT01385033|20529202|P4|COMPLETED|Part I||0
8327379|NCT01385033|20529203|P3|COMPLETED|Part I||0
8327380|NCT01385033|20529204|P2|COMPLETED|Part I||14
8327381|NCT01385033|20529205|P1|COMPLETED|Part I||6
8327382|NCT01385033|20529200|P6|STARTED|Part I||0
8327383|NCT01385033|20529201|P5|STARTED|Part I||0
8327384|NCT01385033|20529202|P4|STARTED|Part I||0
8327385|NCT01385033|20529203|P3|STARTED|Part I||0
8327386|NCT01385033|20529204|P2|STARTED|Part I|These subjects did not participate in Part II or III|14
8327387|NCT01385033|20529205|P1|STARTED|Part I|These subjects did not participate in Part II or III|6
8327388|NCT01384877|20529214|P2|NOT COMPLETED|Treatment 2||2
8327389|NCT01384877|20529215|P1|NOT COMPLETED|Treatment 2||2
8327390|NCT01384877|20529214|P2|COMPLETED|Treatment 2||11
8327391|NCT01384877|20529215|P1|COMPLETED|Treatment 2||14
8327392|NCT01384877|20529214|P2|STARTED|Treatment 2|2 Patients died between treatment periods|13
8327393|NCT01384877|20529215|P1|STARTED|Treatment 2|1 Patient died between treatment periods|16
8327394|NCT01384877|20529214|P2|NOT COMPLETED|Treatment 1||0
8327395|NCT01384877|20529215|P1|NOT COMPLETED|Treatment 1||0
8327396|NCT01384877|20529214|P2|COMPLETED|Treatment 1||15
8327397|NCT01384877|20529215|P1|COMPLETED|Treatment 1||17
8327398|NCT01384877|20529214|P2|STARTED|Treatment 1||15
8327399|NCT01384877|20529215|P1|STARTED|Treatment 1||17
8327400|NCT01384760|20529241|P2|NOT COMPLETED|Overall Study||6
8327401|NCT01384760|20529242|P1|NOT COMPLETED|Overall Study||16
8327402|NCT01384760|20529241|P2|COMPLETED|Overall Study||37
8327403|NCT01384760|20529242|P1|COMPLETED|Overall Study||45
8327404|NCT01384760|20529241|P2|Randomized|Overall Study||43
8327405|NCT01384760|20529242|P1|Randomized|Overall Study||61
8327406|NCT01384760|20529241|P2|STARTED|Overall Study||43
8327407|NCT01384760|20529242|P1|STARTED|Overall Study||61
8327408|NCT01384734|20529255|P5|NOT COMPLETED|Overall Study||29
8327409|NCT01384734|20529256|P4|NOT COMPLETED|Overall Study||28
8327410|NCT01384734|20529257|P3|NOT COMPLETED|Overall Study||23
8327411|NCT01384734|20529258|P2|NOT COMPLETED|Overall Study||24
8327412|NCT01384734|20529259|P1|NOT COMPLETED|Overall Study||17
8327413|NCT01384734|20529255|P5|COMPLETED|Overall Study||22
8327414|NCT01384734|20529256|P4|COMPLETED|Overall Study||22
8327415|NCT01384734|20529257|P3|COMPLETED|Overall Study||28
8327416|NCT01384734|20529258|P2|COMPLETED|Overall Study||25
8327417|NCT01384734|20529259|P1|COMPLETED|Overall Study||33
8327418|NCT01384734|20529255|P5|STARTED|Overall Study||51
8327419|NCT01384734|20529256|P4|STARTED|Overall Study||50
8327420|NCT01384734|20529257|P3|STARTED|Overall Study||51
8327421|NCT01384734|20529258|P2|STARTED|Overall Study||49
8327422|NCT01384734|20529259|P1|STARTED|Overall Study||50
8327423|NCT01384591|20529342|P3|NOT COMPLETED|Overall Study||0
8327424|NCT01384591|20529343|P2|NOT COMPLETED|Overall Study||0
8327425|NCT01384591|20529344|P1|NOT COMPLETED|Overall Study||0
8327426|NCT01384591|20529342|P3|COMPLETED|Overall Study||2
8327427|NCT01384591|20529343|P2|COMPLETED|Overall Study||2
8327428|NCT01384591|20529344|P1|COMPLETED|Overall Study||2
8327429|NCT01384591|20529342|P3|STARTED|Overall Study||2
8327430|NCT01384591|20529343|P2|STARTED|Overall Study||2
8327431|NCT01384591|20529344|P1|STARTED|Overall Study||2
8327432|NCT01384539|20529474|P2|NOT COMPLETED|Overall Study||7
8327433|NCT01384539|20529475|P1|NOT COMPLETED|Overall Study||6
8327434|NCT01384539|20529474|P2|COMPLETED|Overall Study||57
8327435|NCT01384539|20529475|P1|COMPLETED|Overall Study||58
8327436|NCT01384539|20529474|P2|STARTED|Overall Study||64
8327437|NCT01384539|20529475|P1|STARTED|Overall Study||64
8327438|NCT01384292|20529488|P3|NOT COMPLETED|Part B||0
8327439|NCT01384292|20529489|P2|NOT COMPLETED|Part B||0
8327440|NCT01384292|20529490|P1|NOT COMPLETED|Part B||1
8327441|NCT01384292|20529488|P3|COMPLETED|Part B||0
8327442|NCT01384292|20529489|P2|COMPLETED|Part B||6
8327443|NCT01384292|20529490|P1|COMPLETED|Part B||2
8327444|NCT01384292|20529488|P3|STARTED|Part B||0
8327445|NCT01384292|20529489|P2|STARTED|Part B||6
8327446|NCT01384292|20529490|P1|STARTED|Part B||3
8327447|NCT01384292|20529488|P3|NOT COMPLETED|Part A||0
8327448|NCT01384292|20529489|P2|NOT COMPLETED|Part A||0
8327449|NCT01384292|20529490|P1|NOT COMPLETED|Part A||0
8327450|NCT01384292|20529488|P3|COMPLETED|Part A||4
8327451|NCT01384292|20529489|P2|COMPLETED|Part A||5
8327452|NCT01384292|20529490|P1|COMPLETED|Part A||5
8327453|NCT01384292|20529488|P3|STARTED|Part A||4
8327454|NCT01384292|20529489|P2|STARTED|Part A||5
8327455|NCT01384292|20529490|P1|STARTED|Part A||5
8327456|NCT01384019|20529502|P2|NOT COMPLETED|Overall Study||6
8327457|NCT01384019|20529503|P1|NOT COMPLETED|Overall Study||10
8327458|NCT01384019|20529502|P2|COMPLETED|Overall Study||55
8327459|NCT01384019|20529503|P1|COMPLETED|Overall Study||55
8327460|NCT01384019|20529502|P2|STARTED|Overall Study||61
8327461|NCT01384019|20529503|P1|STARTED|Overall Study||65
8327462|NCT01383993|20529512|P3|NOT COMPLETED|Overall Study||1
8327463|NCT01383993|20529513|P2|NOT COMPLETED|Overall Study||1
8327464|NCT01383993|20529514|P1|NOT COMPLETED|Overall Study||3
8327465|NCT01383993|20529512|P3|COMPLETED|Overall Study||1
8327466|NCT01383993|20529513|P2|COMPLETED|Overall Study||3
8327467|NCT01383993|20529514|P1|COMPLETED|Overall Study||12
8327468|NCT01383993|20529512|P3|STARTED|Overall Study||2
8327469|NCT01383993|20529513|P2|STARTED|Overall Study||4
8327470|NCT01383993|20529514|P1|STARTED|Overall Study||15
8327471|NCT01383954|20529561|P1|NOT COMPLETED|Overall Study||14
8327472|NCT01383954|20529561|P1|COMPLETED|Overall Study||38
8327473|NCT01383954|20529561|P1|Safety Population: Received Treatment|Overall Study||48
8327474|NCT01383954|20529561|P1|STARTED|Overall Study||52
8327475|NCT01383928|20529569|P3|NOT COMPLETED|Overall Study||40
8327476|NCT01383928|20529570|P2|NOT COMPLETED|Overall Study||7
8327477|NCT01383928|20529571|P1|NOT COMPLETED|Overall Study||5
8327478|NCT01383928|20529569|P3|COMPLETED|Overall Study||10
8327479|NCT01383928|20529570|P2|COMPLETED|Overall Study||0
8327480|NCT01383928|20529571|P1|COMPLETED|Overall Study||2
8327481|NCT01383928|20529569|P3|STARTED|Overall Study||50
8327482|NCT01383928|20529570|P2|STARTED|Overall Study||7
8327483|NCT01383928|20529571|P1|STARTED|Overall Study||7
8327484|NCT01383759|20529615|P2|NOT COMPLETED|Overall Study||0
8327485|NCT01383759|20529616|P1|NOT COMPLETED|Overall Study||0
8327486|NCT01383759|20529615|P2|COMPLETED|Overall Study||1
8327487|NCT01383759|20529616|P1|COMPLETED|Overall Study||19
8327488|NCT01383759|20529615|P2|STARTED|Overall Study||1
8327489|NCT01383759|20529616|P1|STARTED|Overall Study||19
8327490|NCT01383720|20529630|P1|NOT COMPLETED|Overall Study||0
8327491|NCT01383720|20529630|P1|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
8327492|NCT01383720|20529630|P1|Primary Endpoint (Discharge/7 Days)|Overall Study||11
8327493|NCT01383720|20529630|P1|STARTED|Overall Study||11
8327494|NCT01383707|20529652|P1|NOT COMPLETED|Overall Study||72
8327495|NCT01383707|20529652|P1|COMPLETED|Overall Study||5
8327496|NCT01383707|20529652|P1|STARTED|Overall Study||77
8327497|NCT01383681|20529661|P1|NOT COMPLETED|Overall Study||46
8327498|NCT01383681|20529661|P1|COMPLETED|Overall Study||189
8327499|NCT01383681|20529661|P1|STARTED|Overall Study||235
8327500|NCT01383616|20529668|P2|NOT COMPLETED|Overall Study||23
8327501|NCT01383616|20529669|P1|NOT COMPLETED|Overall Study||17
8327502|NCT01383616|20529668|P2|COMPLETED|Overall Study||21
8327503|NCT01383616|20529669|P1|COMPLETED|Overall Study||23
8327504|NCT01383616|20529668|P2|STARTED|Overall Study||44
8327505|NCT01383616|20529669|P1|STARTED|Overall Study||40
8327506|NCT01383499|20529692|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
8327507|NCT01383499|20529693|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
8327508|NCT01383499|20529694|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
8327509|NCT01383499|20529695|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
8327510|NCT01383499|20529692|P4|COMPLETED|Period 3 (4 Weeks)||25
8327511|NCT01383499|20529693|P3|COMPLETED|Period 3 (4 Weeks)||25
8327512|NCT01383499|20529694|P2|COMPLETED|Period 3 (4 Weeks)||24
8327513|NCT01383499|20529695|P1|COMPLETED|Period 3 (4 Weeks)||26
8327514|NCT01383499|20529692|P4|STARTED|Period 3 (4 Weeks)||25
8327515|NCT01383499|20529693|P3|STARTED|Period 3 (4 Weeks)||25
8327516|NCT01383499|20529694|P2|STARTED|Period 3 (4 Weeks)||24
8327517|NCT01383499|20529695|P1|STARTED|Period 3 (4 Weeks)||26
8327518|NCT01383499|20529692|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
8327519|NCT01383499|20529693|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
8327520|NCT01383499|20529694|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
8327521|NCT01383499|20529695|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
8327522|NCT01383499|20529692|P4|COMPLETED|Period 2 (4 Weeks)||25
8327523|NCT01383499|20529693|P3|COMPLETED|Period 2 (4 Weeks)||25
8327524|NCT01383499|20529694|P2|COMPLETED|Period 2 (4 Weeks)||24
8327525|NCT01383499|20529695|P1|COMPLETED|Period 2 (4 Weeks)||26
8327526|NCT01383499|20529692|P4|STARTED|Period 2 (4 Weeks)||25
8327527|NCT01383499|20529693|P3|STARTED|Period 2 (4 Weeks)||25
8327528|NCT01383499|20529694|P2|STARTED|Period 2 (4 Weeks)||24
8327529|NCT01383499|20529695|P1|STARTED|Period 2 (4 Weeks)||26
8327530|NCT01383499|20529692|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
8327531|NCT01383499|20529693|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
8327532|NCT01383499|20529694|P2|NOT COMPLETED|Period 1 (4 Weeks)||0
8327533|NCT01383499|20529695|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
8327534|NCT01383499|20529692|P4|COMPLETED|Period 1 (4 Weeks)||25
8327535|NCT01383499|20529693|P3|COMPLETED|Period 1 (4 Weeks)||25
8327536|NCT01383499|20529694|P2|COMPLETED|Period 1 (4 Weeks)||24
8327537|NCT01383499|20529695|P1|COMPLETED|Period 1 (4 Weeks)||26
8327538|NCT01383499|20529692|P4|STARTED|Period 1 (4 Weeks)||25
8327539|NCT01383499|20529693|P3|STARTED|Period 1 (4 Weeks)||25
8327540|NCT01383499|20529694|P2|STARTED|Period 1 (4 Weeks)||24
8327541|NCT01383499|20529695|P1|STARTED|Period 1 (4 Weeks)||27
8327542|NCT01383486|20529745|P1|NOT COMPLETED|Overall Study||18
8327543|NCT01383486|20529745|P1|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
8327544|NCT01383486|20529745|P1|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
8327545|NCT01383486|20529745|P1|STARTED|Overall Study|Number of participants who were provided with investigational products|253
8327546|NCT01383447|20529751|P1|NOT COMPLETED|Overall Study||2
8327547|NCT01383447|20529751|P1|COMPLETED|Overall Study||0
8327548|NCT01383447|20529751|P1|STARTED|Overall Study||2
8327549|NCT01383421|20529759|P1|NOT COMPLETED|Overall Study||346
8327550|NCT01383421|20529759|P1|COMPLETED|Overall Study||679
8327551|NCT01383421|20529759|P1|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
8327552|NCT01383356|20529822|P2|NOT COMPLETED|Period 2||0
8327553|NCT01383356|20529823|P1|NOT COMPLETED|Period 2||0
8327554|NCT01383356|20529822|P2|COMPLETED|Period 2|Completed period 2.|23
8327555|NCT01383356|20529823|P1|COMPLETED|Period 2|Completed period 2.|21
8327556|NCT01383356|20529822|P2|STARTED|Period 2|Entered and treated.|23
8327557|NCT01383356|20529823|P1|STARTED|Period 2|Entered and treated.|21
8327558|NCT01383356|20529822|P2|NOT COMPLETED|Washout Period (at Least 35 Days)||0
8327559|NCT01383356|20529823|P1|NOT COMPLETED|Washout Period (at Least 35 Days)||0
8327560|NCT01383356|20529822|P2|COMPLETED|Washout Period (at Least 35 Days)||23
8327561|NCT01383356|20529823|P1|COMPLETED|Washout Period (at Least 35 Days)||21
8327562|NCT01383356|20529822|P2|STARTED|Washout Period (at Least 35 Days)||23
8327563|NCT01383356|20529823|P1|STARTED|Washout Period (at Least 35 Days)||21
8327564|NCT01383356|20529822|P2|NOT COMPLETED|Period 1||6
8327565|NCT01383356|20529823|P1|NOT COMPLETED|Period 1||8
8327566|NCT01383356|20529822|P2|COMPLETED|Period 1|Completed period 1.|23
8327567|NCT01383356|20529823|P1|COMPLETED|Period 1|Completed period 1.|21
8327568|NCT01383356|20529822|P2|STARTED|Period 1|Entered and treated.|29
8327569|NCT01383356|20529823|P1|STARTED|Period 1|Entered and treated.|29
8327570|NCT01383317|20529835|P2|NOT COMPLETED|Overall Study||2
8327571|NCT01383317|20529836|P1|NOT COMPLETED|Overall Study||3
8327572|NCT01383317|20529835|P2|COMPLETED|Overall Study||33
8327573|NCT01383317|20529836|P1|COMPLETED|Overall Study||26
8327574|NCT01383317|20529835|P2|STARTED|Overall Study||35
8327575|NCT01383317|20529836|P1|STARTED|Overall Study||29
8327576|NCT01383213|20529860|P2|NOT COMPLETED|Overall Study||0
8327577|NCT01383213|20529861|P1|NOT COMPLETED|Overall Study||0
8327578|NCT01383213|20529860|P2|COMPLETED|Overall Study||41
8327579|NCT01383213|20529861|P1|COMPLETED|Overall Study||40
8327580|NCT01383213|20529860|P2|STARTED|Overall Study||41
8327581|NCT01383213|20529861|P1|STARTED|Overall Study||40
8327582|NCT01383200|20529869|P2|NOT COMPLETED|Overall Study||0
8327583|NCT01383200|20529870|P1|NOT COMPLETED|Overall Study||0
8327584|NCT01383200|20529869|P2|COMPLETED|Overall Study||6
8327585|NCT01383200|20529870|P1|COMPLETED|Overall Study||5
8327586|NCT01383200|20529869|P2|STARTED|Overall Study||6
8327587|NCT01383200|20529870|P1|STARTED|Overall Study||5
8327588|NCT01383174|20529878|P2|NOT COMPLETED|6 Month Assessment||1
8327589|NCT01383174|20529879|P1|NOT COMPLETED|6 Month Assessment||5
8327590|NCT01383174|20529878|P2|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
8327591|NCT01383174|20529879|P1|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
8327592|NCT01383174|20529878|P2|STARTED|6 Month Assessment||74
8327593|NCT01383174|20529879|P1|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
8327594|NCT01383174|20529878|P2|NOT COMPLETED|3 Month Assessment||1
8327595|NCT01383174|20529879|P1|NOT COMPLETED|3 Month Assessment||6
8327596|NCT01383174|20529878|P2|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
8327597|NCT01383174|20529879|P1|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
8327598|NCT01383174|20529878|P2|STARTED|3 Month Assessment||75
8327599|NCT01383174|20529879|P1|STARTED|3 Month Assessment||76
8327600|NCT01383174|20529878|P2|NOT COMPLETED|Baseline Assessment||0
8327601|NCT01383174|20529879|P1|NOT COMPLETED|Baseline Assessment||0
8327602|NCT01383174|20529878|P2|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
8327603|NCT01383174|20529879|P1|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
8327604|NCT01383174|20529878|P2|STARTED|Baseline Assessment||75
8327605|NCT01383174|20529879|P1|STARTED|Baseline Assessment||76
8327606|NCT01383161|20529905|P2|NOT COMPLETED|Overall Study||4
8327607|NCT01383161|20529906|P1|NOT COMPLETED|Overall Study||5
8327608|NCT01383161|20529905|P2|COMPLETED|Overall Study||17
8327609|NCT01383161|20529906|P1|COMPLETED|Overall Study||20
8327610|NCT01383161|20529905|P2|STARTED|Overall Study||21
8327611|NCT01383161|20529906|P1|STARTED|Overall Study||25
8327612|NCT01383096|20529925|P3|NOT COMPLETED|Fifth Intervention (8 Days)||0
8327613|NCT01383096|20529926|P2|NOT COMPLETED|Fifth Intervention (8 Days)||0
8327614|NCT01383096|20529927|P1|NOT COMPLETED|Fifth Intervention (8 Days)||2
8327615|NCT01383096|20529925|P3|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8327616|NCT01383096|20529926|P2|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
8327617|NCT01383096|20529927|P1|COMPLETED|Fifth Intervention (8 Days)||11
8327618|NCT01383096|20529925|P3|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8327619|NCT01383096|20529926|P2|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
8327620|NCT01383096|20529927|P1|STARTED|Fifth Intervention (8 Days)||13
8327621|NCT01383096|20529925|P3|NOT COMPLETED|Fourth Intervention (8 Days)||0
8327622|NCT01383096|20529926|P2|NOT COMPLETED|Fourth Intervention (8 Days)||0
8327623|NCT01383096|20529927|P1|NOT COMPLETED|Fourth Intervention (8 Days)||2
8327624|NCT01383096|20529925|P3|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8327625|NCT01383096|20529926|P2|COMPLETED|Fourth Intervention (8 Days)||12
8327626|NCT01383096|20529927|P1|COMPLETED|Fourth Intervention (8 Days)||13
8327627|NCT01383096|20529925|P3|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8327628|NCT01383096|20529926|P2|STARTED|Fourth Intervention (8 Days)||12
8327629|NCT01383096|20529927|P1|STARTED|Fourth Intervention (8 Days)||15
8327630|NCT01383096|20529925|P3|NOT COMPLETED|Third Intervention (8 Days)||0
8327631|NCT01383096|20529926|P2|NOT COMPLETED|Third Intervention (8 Days)||4
8327632|NCT01383096|20529927|P1|NOT COMPLETED|Third Intervention (8 Days)||4
8327633|NCT01383096|20529925|P3|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8327634|NCT01383096|20529926|P2|COMPLETED|Third Intervention (8 Days)||12
8327635|NCT01383096|20529927|P1|COMPLETED|Third Intervention (8 Days)||15
8327636|NCT01383096|20529925|P3|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
8327637|NCT01383096|20529926|P2|STARTED|Third Intervention (8 Days)||16
8327638|NCT01383096|20529927|P1|STARTED|Third Intervention (8 Days)||19
8327639|NCT01383096|20529925|P3|NOT COMPLETED|Second Intervention (8 Days)||2
8327640|NCT01383096|20529926|P2|NOT COMPLETED|Second Intervention (8 Days)||1
8327641|NCT01383096|20529927|P1|NOT COMPLETED|Second Intervention (8 Days)||0
8327642|NCT01383096|20529925|P3|COMPLETED|Second Intervention (8 Days)||14
8327643|NCT01383096|20529926|P2|COMPLETED|Second Intervention (8 Days)||16
8327644|NCT01383096|20529927|P1|COMPLETED|Second Intervention (8 Days)||19
8327645|NCT01383096|20529925|P3|STARTED|Second Intervention (8 Days)||16
8327646|NCT01383096|20529926|P2|STARTED|Second Intervention (8 Days)||17
8327647|NCT01383096|20529927|P1|STARTED|Second Intervention (8 Days)||19
8327648|NCT01383096|20529925|P3|NOT COMPLETED|First Intervention (8 Days)||0
8327649|NCT01383096|20529926|P2|NOT COMPLETED|First Intervention (8 Days)||0
8327650|NCT01383096|20529927|P1|NOT COMPLETED|First Intervention (8 Days)||0
8327651|NCT01383096|20529925|P3|COMPLETED|First Intervention (8 Days)||16
8327652|NCT01383096|20529926|P2|COMPLETED|First Intervention (8 Days)||17
8327653|NCT01383096|20529927|P1|COMPLETED|First Intervention (8 Days)||19
8327654|NCT01383096|20529925|P3|STARTED|First Intervention (8 Days)||16
8327655|NCT01383096|20529926|P2|STARTED|First Intervention (8 Days)||17
8327656|NCT01383096|20529927|P1|STARTED|First Intervention (8 Days)||19
8327660|NCT01383005|20530015|P2|NOT COMPLETED|Overall Study||0
8327661|NCT01383005|20530016|P1|NOT COMPLETED|Overall Study||0
8327662|NCT01383005|20530015|P2|COMPLETED|Overall Study||60
8327663|NCT01383005|20530016|P1|COMPLETED|Overall Study||34
8327664|NCT01383005|20530015|P2|STARTED|Overall Study||60
8327665|NCT01383005|20530016|P1|STARTED|Overall Study||34
8327666|NCT01382940|20530035|P1|NOT COMPLETED|Overall Study||73
8327667|NCT01382940|20530035|P1|COMPLETED|Overall Study||278
8327668|NCT01382940|20530035|P1|Received Day 182 Infusion|Overall Study||278
8327669|NCT01382940|20530035|P1|Received Day 168 Infusion|Overall Study||290
8327670|NCT01382940|20530035|P1|Received Day 15 Infusions|Overall Study||341
8327671|NCT01382940|20530035|P1|Received Day 1 Infusion|Overall Study||351
8327672|NCT01382940|20530035|P1|STARTED|Overall Study||351
8327673|NCT01382901|20530047|P2|NOT COMPLETED|Overall Study||14
8327674|NCT01382901|20530048|P1|NOT COMPLETED|Overall Study||17
8327675|NCT01382901|20530047|P2|COMPLETED|Overall Study||7
8327676|NCT01382901|20530048|P1|COMPLETED|Overall Study||7
8327677|NCT01382901|20530047|P2|STARTED|Overall Study||21
8327678|NCT01382901|20530048|P1|STARTED|Overall Study||24
8327679|NCT01382719|20530058|P4|NOT COMPLETED|Overall Study||33
8327680|NCT01382719|20530059|P3|NOT COMPLETED|Overall Study||34
8327681|NCT01382719|20530060|P2|NOT COMPLETED|Overall Study||19
8327682|NCT01382719|20530061|P1|NOT COMPLETED|Overall Study||18
8327683|NCT01382719|20530058|P4|COMPLETED|Overall Study||66
8327684|NCT01382719|20530059|P3|COMPLETED|Overall Study||66
8327685|NCT01382719|20530060|P2|COMPLETED|Overall Study||81
8327686|NCT01382719|20530061|P1|COMPLETED|Overall Study||80
8327687|NCT01382719|20530058|P4|Subjects Not Dosed|Overall Study||1
8327688|NCT01382719|20530059|P3|Subjects Not Dosed|Overall Study||1
8327689|NCT01382719|20530060|P2|Subjects Not Dosed|Overall Study||0
8327690|NCT01382719|20530061|P1|Subjects Not Dosed|Overall Study||1
8327691|NCT01382719|20530058|P4|STARTED|Overall Study||99
8327692|NCT01382719|20530059|P3|STARTED|Overall Study||100
8327693|NCT01382719|20530060|P2|STARTED|Overall Study||100
8327694|NCT01382719|20530061|P1|STARTED|Overall Study||98
8327695|NCT01382602|20530097|P2|NOT COMPLETED|Overall Study||4
8327696|NCT01382602|20530098|P1|NOT COMPLETED|Overall Study||0
8327697|NCT01382602|20530097|P2|COMPLETED|Overall Study||46
8327698|NCT01382602|20530098|P1|COMPLETED|Overall Study||93
8327699|NCT01382602|20530097|P2|STARTED|Overall Study||50
8327700|NCT01382602|20530098|P1|STARTED|Overall Study||93
8327701|NCT01382446|20530106|P2|NOT COMPLETED|Overall Study||4
8327702|NCT01382446|20530107|P1|NOT COMPLETED|Overall Study||3
8327703|NCT01382446|20530106|P2|COMPLETED|Overall Study||29
8327704|NCT01382446|20530107|P1|COMPLETED|Overall Study||30
8327705|NCT01382446|20530106|P2|STARTED|Overall Study||33
8327706|NCT01382446|20530107|P1|STARTED|Overall Study||33
8327707|NCT01382303|20530115|P2|NOT COMPLETED|Overall Study||17
8327708|NCT01382303|20530116|P1|NOT COMPLETED|Overall Study||35
8327709|NCT01382303|20530115|P2|COMPLETED|Overall Study||70
8327710|NCT01382303|20530116|P1|COMPLETED|Overall Study||52
8327711|NCT01382303|20530115|P2|STARTED|Overall Study||87
8327712|NCT01382303|20530116|P1|STARTED|Overall Study||87
8327713|NCT01382251|20530134|P2|NOT COMPLETED|Overall Study||21
8327714|NCT01382251|20530135|P1|NOT COMPLETED|Overall Study||21
8327715|NCT01382251|20530134|P2|COMPLETED|Overall Study||102
8327716|NCT01382251|20530135|P1|COMPLETED|Overall Study||102
8327717|NCT01382251|20530134|P2|STARTED|Overall Study||123
8327718|NCT01382251|20530135|P1|STARTED|Overall Study||123
8327719|NCT01382225|20530148|P2|NOT COMPLETED|Overall Study||7
8327720|NCT01382225|20530149|P1|NOT COMPLETED|Overall Study||14
8327721|NCT01382225|20530148|P2|COMPLETED|Overall Study||722
8327722|NCT01382225|20530149|P1|COMPLETED|Overall Study||711
8327723|NCT01382225|20530148|P2|STARTED|Overall Study||729
8327724|NCT01382225|20530149|P1|STARTED|Overall Study||725
8327725|NCT01382212|20530171|P1|NOT COMPLETED|Overall Study||2
8327726|NCT01382212|20530171|P1|COMPLETED|Overall Study||11
8327727|NCT01382212|20530171|P1|STARTED|Overall Study||13
8327728|NCT01382186|20530197|P2|NOT COMPLETED|Overall Study||0
8327729|NCT01382186|20530198|P1|NOT COMPLETED|Overall Study||1
8327730|NCT01382186|20530197|P2|COMPLETED|Overall Study||819
8327731|NCT01382186|20530198|P1|COMPLETED|Overall Study||32
8327732|NCT01382186|20530197|P2|STARTED|Overall Study||819
8327733|NCT01382186|20530198|P1|STARTED|Overall Study||33
8327734|NCT01382108|20530214|P2|NOT COMPLETED|Overall Study||0
8327735|NCT01382108|20530215|P1|NOT COMPLETED|Overall Study||0
8327736|NCT01382108|20530214|P2|COMPLETED|Overall Study||19
8327737|NCT01382108|20530215|P1|COMPLETED|Overall Study||20
8327738|NCT01382108|20530214|P2|STARTED|Overall Study||19
8327739|NCT01382108|20530215|P1|STARTED|Overall Study||20
8327740|NCT01381952|20530225|P1|NOT COMPLETED|Overall Study||0
8327741|NCT01381952|20530225|P1|COMPLETED|Overall Study||20
8327742|NCT01381952|20530225|P1|Collected Dose and Image Information|Overall Study||20
8327743|NCT01381952|20530225|P1|STARTED|Overall Study||20
8327744|NCT01381926|20530234|P2|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
8327745|NCT01381926|20530235|P1|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
8327746|NCT01381926|20530234|P2|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
8327747|NCT01381926|20530235|P1|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
8327748|NCT01381926|20530234|P2|STARTED|Low/High Dose of 2nd Treatment (2months)||4
8327749|NCT01381926|20530235|P1|STARTED|Low/High Dose of 2nd Treatment (2months)||3
8327750|NCT01381926|20530234|P2|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
8327751|NCT01381926|20530235|P1|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
8327752|NCT01381926|20530234|P2|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
8327753|NCT01381926|20530235|P1|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
8327754|NCT01381926|20530234|P2|STARTED|Low/High Dose of 1st Treatment (2months)||5
8327755|NCT01381926|20530235|P1|STARTED|Low/High Dose of 1st Treatment (2months)||5
8327756|NCT01381900|20530248|P3|NOT COMPLETED|Overall Study||12
8327757|NCT01381900|20530249|P2|NOT COMPLETED|Overall Study||9
8327758|NCT01381900|20530250|P1|NOT COMPLETED|Overall Study||9
8327759|NCT01381900|20530248|P3|COMPLETED|Overall Study||215
8327760|NCT01381900|20530249|P2|COMPLETED|Overall Study||214
8327761|NCT01381900|20530250|P1|COMPLETED|Overall Study||217
8327762|NCT01381900|20530248|P3|STARTED|Overall Study||227
8327763|NCT01381900|20530249|P2|STARTED|Overall Study||223
8327764|NCT01381900|20530250|P1|STARTED|Overall Study||226
8327765|NCT01381874|20530273|P3|NOT COMPLETED|Overall Study||76
8327766|NCT01381874|20530274|P2|NOT COMPLETED|Overall Study||63
8327767|NCT01381874|20530275|P1|NOT COMPLETED|Overall Study||77
8327768|NCT01381874|20530273|P3|COMPLETED|Overall Study||30
8327769|NCT01381874|20530274|P2|COMPLETED|Overall Study||26
8327770|NCT01381874|20530275|P1|COMPLETED|Overall Study||25
8327771|NCT01381874|20530273|P3|Treated|Overall Study||104
8327772|NCT01381874|20530274|P2|Treated|Overall Study||87
8327773|NCT01381874|20530275|P1|Treated|Overall Study||102
8327774|NCT01381874|20530273|P3|STARTED|Overall Study||106
8327775|NCT01381874|20530274|P2|STARTED|Overall Study||89
8327776|NCT01381874|20530275|P1|STARTED|Overall Study||102
8327777|NCT01381861|20530301|P1|NOT COMPLETED|Overall Study||0
8327778|NCT01381861|20530301|P1|COMPLETED|Overall Study||23
8327779|NCT01381861|20530301|P1|STARTED|Overall Study||23
8327780|NCT01381679|20530312|P1|NOT COMPLETED|Overall Study||888
8327781|NCT01381679|20530312|P1|COMPLETED|Overall Study||794
8327782|NCT01381679|20530312|P1|STARTED|Overall Study||1682
8327783|NCT01381575|20530327|P3|NOT COMPLETED|Overall Study||20
8327784|NCT01381575|20530328|P2|NOT COMPLETED|Overall Study||39
8327785|NCT01381575|20530329|P1|NOT COMPLETED|Overall Study||26
8327786|NCT01381575|20530327|P3|COMPLETED|Overall Study||395
8327787|NCT01381575|20530328|P2|COMPLETED|Overall Study||443
8327788|NCT01381575|20530329|P1|COMPLETED|Overall Study||524
8327789|NCT01381575|20530327|P3|STARTED|Overall Study||415
8327790|NCT01381575|20530328|P2|STARTED|Overall Study||482
8327791|NCT01381575|20530329|P1|STARTED|Overall Study||550
8327792|NCT01381562|20530386|P3|NOT COMPLETED|Overall Study||0
8327793|NCT01381562|20530387|P2|NOT COMPLETED|Overall Study||1
8327794|NCT01381562|20530388|P1|NOT COMPLETED|Overall Study||0
8327795|NCT01381562|20530386|P3|COMPLETED|Overall Study||5
8327796|NCT01381562|20530387|P2|COMPLETED|Overall Study||3
8327797|NCT01381562|20530388|P1|COMPLETED|Overall Study||5
8327798|NCT01381562|20530386|P3|STARTED|Overall Study||5
8327799|NCT01381562|20530387|P2|STARTED|Overall Study||4
8327800|NCT01381562|20530388|P1|STARTED|Overall Study||5
8327801|NCT01381549|20530456|P3|NOT COMPLETED|Overall Study||1
8327802|NCT01381549|20530457|P2|NOT COMPLETED|Overall Study||0
8327803|NCT01381549|20530458|P1|NOT COMPLETED|Overall Study||0
8327804|NCT01381549|20530456|P3|COMPLETED|Overall Study||5
8327805|NCT01381549|20530457|P2|COMPLETED|Overall Study||8
8327806|NCT01381549|20530458|P1|COMPLETED|Overall Study||6
8327807|NCT01381549|20530456|P3|STARTED|Overall Study||6
8327808|NCT01381549|20530457|P2|STARTED|Overall Study||8
8327809|NCT01381549|20530458|P1|STARTED|Overall Study||6
8327810|NCT01381471|20530553|P1|NOT COMPLETED|Overall Study||0
8327811|NCT01381471|20530553|P1|COMPLETED|Overall Study||11060
8327812|NCT01381471|20530553|P1|STARTED|Overall Study||11060
8327813|NCT01381406|20530560|P2|NOT COMPLETED|Overall Study||0
8327814|NCT01381406|20530561|P1|NOT COMPLETED|Overall Study||0
8327815|NCT01381406|20530560|P2|COMPLETED|Overall Study||852
8327816|NCT01381406|20530561|P1|COMPLETED|Overall Study||2481
8327817|NCT01381406|20530560|P2|STARTED|Overall Study||852
8327818|NCT01381406|20530561|P1|STARTED|Overall Study||2481
8327819|NCT01381120|20530573|P2|NOT COMPLETED|Overall Study||9
8327820|NCT01381120|20530574|P1|NOT COMPLETED|Overall Study||11
8327821|NCT01381120|20530573|P2|COMPLETED|Overall Study||18
8327822|NCT01381120|20530574|P1|COMPLETED|Overall Study||39
8327823|NCT01381120|20530573|P2|STARTED|Overall Study||27
8327824|NCT01381120|20530574|P1|STARTED|Overall Study||50
8327825|NCT01381068|20530584|P2|NOT COMPLETED|Overall Study||0
8327826|NCT01381068|20530585|P1|NOT COMPLETED|Overall Study||1
8327827|NCT01381068|20530584|P2|COMPLETED|Overall Study||24
8327828|NCT01381068|20530585|P1|COMPLETED|Overall Study||24
8327829|NCT01381068|20530584|P2|STARTED|Overall Study||24
8327830|NCT01381068|20530585|P1|STARTED|Overall Study||25
8327831|NCT01381016|20530605|P2|NOT COMPLETED|Overall Study||6
8327832|NCT01381016|20530606|P1|NOT COMPLETED|Overall Study||3
8327833|NCT01381016|20530605|P2|COMPLETED|Overall Study||11
8327834|NCT01381016|20530606|P1|COMPLETED|Overall Study||10
8327835|NCT01381016|20530605|P2|STARTED|Overall Study||17
8327836|NCT01381016|20530606|P1|STARTED|Overall Study||13
8327837|NCT01380834|20530616|P2|NOT COMPLETED|Overall Study||0
8327838|NCT01380834|20530617|P1|NOT COMPLETED|Overall Study||1
8327839|NCT01380834|20530616|P2|COMPLETED|Overall Study||42
8327840|NCT01380834|20530617|P1|COMPLETED|Overall Study||41
8327841|NCT01380834|20530616|P2|STARTED|Overall Study||42
8327842|NCT01380834|20530617|P1|STARTED|Overall Study||42
8327843|NCT01380782|20530629|P4|NOT COMPLETED|Overall Study||4
8327844|NCT01380782|20530630|P3|NOT COMPLETED|Overall Study||11
8327845|NCT01380782|20530631|P2|NOT COMPLETED|Overall Study||10
8327846|NCT01380782|20530632|P1|NOT COMPLETED|Overall Study||12
8327847|NCT01380782|20530629|P4|COMPLETED|Overall Study||0
8327848|NCT01380782|20530630|P3|COMPLETED|Overall Study||0
8327849|NCT01380782|20530631|P2|COMPLETED|Overall Study||0
8327850|NCT01380782|20530632|P1|COMPLETED|Overall Study||0
8327851|NCT01380782|20530629|P4|STARTED|Overall Study||4
8327852|NCT01380782|20530630|P3|STARTED|Overall Study||11
8327853|NCT01380782|20530631|P2|STARTED|Overall Study||10
8327854|NCT01380782|20530632|P1|STARTED|Overall Study||12
8327855|NCT01380769|20530655|P2|NOT COMPLETED|Overall Study||14
8327856|NCT01380769|20530656|P1|NOT COMPLETED|Overall Study||9
8327857|NCT01380769|20530655|P2|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
8327858|NCT01380769|20530656|P1|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
8327859|NCT01380769|20530655|P2|STARTED|Overall Study||57
8327860|NCT01380769|20530656|P1|STARTED|Overall Study||100
8327861|NCT01380743|20530668|P4|NOT COMPLETED|Overall Study||0
8327862|NCT01380743|20530669|P3|NOT COMPLETED|Overall Study||0
8327863|NCT01380743|20530670|P2|NOT COMPLETED|Overall Study||0
8327864|NCT01380743|20530671|P1|NOT COMPLETED|Overall Study||0
8327865|NCT01380743|20530668|P4|COMPLETED|Overall Study||7
8327866|NCT01380743|20530669|P3|COMPLETED|Overall Study||6
8327867|NCT01380743|20530670|P2|COMPLETED|Overall Study||6
8327868|NCT01380743|20530671|P1|COMPLETED|Overall Study||6
8327869|NCT01380743|20530668|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
8327870|NCT01380743|20530669|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8327871|NCT01380743|20530670|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8327872|NCT01380743|20530671|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8327873|NCT01380743|20530668|P4|STARTED|Overall Study||7
8327874|NCT01380743|20530669|P3|STARTED|Overall Study||6
8327875|NCT01380743|20530670|P2|STARTED|Overall Study||6
8327876|NCT01380743|20530671|P1|STARTED|Overall Study||6
8327877|NCT01380730|20530717|P8|NOT COMPLETED|Overall Study||0
8327878|NCT01380730|20530718|P7|NOT COMPLETED|Overall Study||0
8327879|NCT01380730|20530719|P6|NOT COMPLETED|Overall Study||0
8327880|NCT01380730|20530720|P5|NOT COMPLETED|Overall Study||1
8327881|NCT01380730|20530721|P4|NOT COMPLETED|Overall Study||0
8327882|NCT01380730|20530722|P3|NOT COMPLETED|Overall Study||0
8327883|NCT01380730|20530723|P2|NOT COMPLETED|Overall Study||0
8327884|NCT01380730|20530724|P1|NOT COMPLETED|Overall Study||0
8327885|NCT01380730|20530717|P8|COMPLETED|Overall Study||80
8327886|NCT01380730|20530718|P7|COMPLETED|Overall Study||79
8327887|NCT01380730|20530719|P6|COMPLETED|Overall Study||79
8327888|NCT01380730|20530720|P5|COMPLETED|Overall Study||77
8327889|NCT01380730|20530721|P4|COMPLETED|Overall Study||79
8327890|NCT01380730|20530722|P3|COMPLETED|Overall Study||79
8327891|NCT01380730|20530723|P2|COMPLETED|Overall Study||79
8327892|NCT01380730|20530724|P1|COMPLETED|Overall Study||78
8327893|NCT01380730|20530717|P8|Received Treatment|Overall Study||80
8327894|NCT01380730|20530718|P7|Received Treatment|Overall Study||79
8327895|NCT01380730|20530719|P6|Received Treatment|Overall Study||79
8327896|NCT01380730|20530720|P5|Received Treatment|Overall Study||78
8327897|NCT01380730|20530721|P4|Received Treatment|Overall Study||79
8327898|NCT01380730|20530722|P3|Received Treatment|Overall Study||79
8327899|NCT01380730|20530723|P2|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
8327900|NCT01380730|20530724|P1|Received Treatment|Overall Study||78
8327901|NCT01380730|20530717|P8|STARTED|Overall Study||80
8327902|NCT01380730|20530718|P7|STARTED|Overall Study||79
8327903|NCT01380730|20530719|P6|STARTED|Overall Study||79
8327904|NCT01380730|20530720|P5|STARTED|Overall Study||78
8327905|NCT01380730|20530721|P4|STARTED|Overall Study||79
8327906|NCT01380730|20530722|P3|STARTED|Overall Study||79
8327907|NCT01380730|20530723|P2|STARTED|Overall Study||79
8327908|NCT01380730|20530724|P1|STARTED|Overall Study||78
8327909|NCT01380691|20530782|P4|NOT COMPLETED|Period 2||0
8327910|NCT01380691|20530783|P3|NOT COMPLETED|Period 2||0
8327911|NCT01380691|20530784|P2|NOT COMPLETED|Period 2||0
8327912|NCT01380691|20530785|P1|NOT COMPLETED|Period 2||0
8327913|NCT01380691|20530782|P4|COMPLETED|Period 2||6
8327914|NCT01380691|20530783|P3|COMPLETED|Period 2||6
8327915|NCT01380691|20530784|P2|COMPLETED|Period 2||7
8327916|NCT01380691|20530785|P1|COMPLETED|Period 2||7
8327917|NCT01380691|20530782|P4|STARTED|Period 2||6
8327918|NCT01380691|20530783|P3|STARTED|Period 2||6
8327919|NCT01380691|20530784|P2|STARTED|Period 2||7
8327920|NCT01380691|20530785|P1|STARTED|Period 2||7
8327921|NCT01380691|20530782|P4|NOT COMPLETED|Washout (7 Days)||1
8327922|NCT01380691|20530783|P3|NOT COMPLETED|Washout (7 Days)||1
8327923|NCT01380691|20530784|P2|NOT COMPLETED|Washout (7 Days)||0
8327924|NCT01380691|20530785|P1|NOT COMPLETED|Washout (7 Days)||0
8327925|NCT01380691|20530782|P4|COMPLETED|Washout (7 Days)||6
8327926|NCT01380691|20530783|P3|COMPLETED|Washout (7 Days)||6
8327927|NCT01380691|20530784|P2|COMPLETED|Washout (7 Days)||7
8327928|NCT01380691|20530785|P1|COMPLETED|Washout (7 Days)||7
8327929|NCT01380691|20530782|P4|STARTED|Washout (7 Days)||7
8327930|NCT01380691|20530783|P3|STARTED|Washout (7 Days)||7
8327931|NCT01380691|20530784|P2|STARTED|Washout (7 Days)||7
8327932|NCT01380691|20530785|P1|STARTED|Washout (7 Days)||7
8327933|NCT01380691|20530782|P4|NOT COMPLETED|Period 1||0
8327934|NCT01380691|20530783|P3|NOT COMPLETED|Period 1||0
8327935|NCT01380691|20530784|P2|NOT COMPLETED|Period 1||0
8327936|NCT01380691|20530785|P1|NOT COMPLETED|Period 1||0
8327937|NCT01380691|20530782|P4|COMPLETED|Period 1||7
8327938|NCT01380691|20530783|P3|COMPLETED|Period 1||7
8327939|NCT01380691|20530784|P2|COMPLETED|Period 1||7
8327940|NCT01380691|20530785|P1|COMPLETED|Period 1||7
8327941|NCT01380691|20530782|P4|STARTED|Period 1||7
8327942|NCT01380691|20530783|P3|STARTED|Period 1||7
8327943|NCT01380691|20530784|P2|STARTED|Period 1||7
8327944|NCT01380691|20530785|P1|STARTED|Period 1||7
8327945|NCT01380639|20530837|P2|NOT COMPLETED|Overall Study||4
8327946|NCT01380639|20530838|P1|NOT COMPLETED|Overall Study||6
8327947|NCT01380639|20530837|P2|COMPLETED|Overall Study||36
8327948|NCT01380639|20530838|P1|COMPLETED|Overall Study||36
8327949|NCT01380639|20530837|P2|STARTED|Overall Study||40
8327950|NCT01380639|20530838|P1|STARTED|Overall Study||42
8327951|NCT01380535|20530846|P2|NOT COMPLETED|Overall Study||15
8327952|NCT01380535|20530847|P1|NOT COMPLETED|Overall Study||7
8327953|NCT01380535|20530846|P2|COMPLETED|Overall Study||16
8327954|NCT01380535|20530847|P1|COMPLETED|Overall Study||22
8327955|NCT01380535|20530846|P2|Intent-to-treat Population|Overall Study||24
8327956|NCT01380535|20530847|P1|Intent-to-treat Population|Overall Study||29
8327957|NCT01380535|20530846|P2|Safety Population|Overall Study||28
8327958|NCT01380535|20530847|P1|Safety Population|Overall Study||28
8327959|NCT01380535|20530846|P2|Baseline Population|Overall Study||31
8327960|NCT01380535|20530847|P1|Baseline Population|Overall Study||29
8327961|NCT01380535|20530846|P2|STARTED|Overall Study||31
8327962|NCT01380535|20530847|P1|STARTED|Overall Study||29
8327963|NCT01380379|20530853|P1|NOT COMPLETED|Overall Study||1
8327964|NCT01380379|20530853|P1|COMPLETED|Overall Study||8
8327965|NCT01380379|20530853|P1|STARTED|Overall Study||9
8327966|NCT01380366|20530858|P1|NOT COMPLETED|Overall Study||0
8327967|NCT01380366|20530858|P1|COMPLETED|Overall Study||15
8327968|NCT01380366|20530858|P1|STARTED|Overall Study||15
8327969|NCT01380327|20530866|P3|NOT COMPLETED|Overall Study||7
8327970|NCT01380327|20530867|P2|NOT COMPLETED|Overall Study||3
8327971|NCT01380327|20530868|P1|NOT COMPLETED|Overall Study||3
8327972|NCT01380327|20530866|P3|COMPLETED|Overall Study||21
8327973|NCT01380327|20530867|P2|COMPLETED|Overall Study||28
8327974|NCT01380327|20530868|P1|COMPLETED|Overall Study||27
8327975|NCT01380327|20530866|P3|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
8327976|NCT01380327|20530867|P2|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
8327977|NCT01380327|20530868|P1|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
8327978|NCT01380197|20530890|P2|NOT COMPLETED|Overall Study||0
8327979|NCT01380197|20530891|P1|NOT COMPLETED|Overall Study||0
8327980|NCT01380197|20530890|P2|COMPLETED|Overall Study||20
8327981|NCT01380197|20530891|P1|COMPLETED|Overall Study||20
8327982|NCT01380197|20530890|P2|STARTED|Overall Study||20
8327983|NCT01380197|20530891|P1|STARTED|Overall Study||20
8327984|NCT01380184|20530899|P1|NOT COMPLETED|Part 2||14
8327985|NCT01380184|20530899|P1|COMPLETED|Part 2||0
8327986|NCT01380184|20530899|P1|STARTED|Part 2||14
8327987|NCT01380184|20530899|P1|NOT COMPLETED|Washout Period (≥2 Days)||0
8327988|NCT01380184|20530899|P1|COMPLETED|Washout Period (≥2 Days)||14
8327989|NCT01380184|20530899|P1|STARTED|Washout Period (≥2 Days)||14
8327990|NCT01380184|20530899|P1|NOT COMPLETED|Part 1 (19 Days)||1
8327991|NCT01380184|20530899|P1|COMPLETED|Part 1 (19 Days)||14
8327992|NCT01380184|20530899|P1|STARTED|Part 1 (19 Days)||15
8327993|NCT01380145|20530910|P1|NOT COMPLETED|Overall Study||4
8327994|NCT01380145|20530910|P1|COMPLETED|Overall Study||9
8327995|NCT01380145|20530910|P1|STARTED|Overall Study||13
8327996|NCT01380106|20530920|P2|NOT COMPLETED|Overall Study||0
8327997|NCT01380106|20530921|P1|NOT COMPLETED|Overall Study||0
8327998|NCT01380106|20530920|P2|COMPLETED|Overall Study||17
8327999|NCT01380106|20530921|P1|COMPLETED|Overall Study||16
8328000|NCT01380106|20530920|P2|STARTED|Overall Study||17
8328001|NCT01380106|20530921|P1|STARTED|Overall Study||16
8328002|NCT01380093|20530929|P9|NOT COMPLETED|Treatment Phase: Third Intervention||2
8328003|NCT01380093|20530930|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328004|NCT01380093|20530931|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328005|NCT01380093|20530932|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328006|NCT01380093|20530933|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328007|NCT01380093|20530934|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328008|NCT01380093|20530935|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328009|NCT01380093|20530936|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328010|NCT01380093|20530937|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
8328011|NCT01380093|20530929|P9|COMPLETED|Treatment Phase: Third Intervention||4
8328012|NCT01380093|20530930|P8|COMPLETED|Treatment Phase: Third Intervention||6
8328013|NCT01380093|20530931|P7|COMPLETED|Treatment Phase: Third Intervention||6
8328014|NCT01380093|20530932|P6|COMPLETED|Treatment Phase: Third Intervention||6
8328015|NCT01380093|20530933|P5|COMPLETED|Treatment Phase: Third Intervention||6
8328016|NCT01380093|20530934|P4|COMPLETED|Treatment Phase: Third Intervention||5
8328017|NCT01380093|20530935|P3|COMPLETED|Treatment Phase: Third Intervention||0
8328018|NCT01380093|20530936|P2|COMPLETED|Treatment Phase: Third Intervention||0
8328019|NCT01380093|20530937|P1|COMPLETED|Treatment Phase: Third Intervention||0
8328020|NCT01380093|20530929|P9|STARTED|Treatment Phase: Third Intervention||6
8328021|NCT01380093|20530930|P8|STARTED|Treatment Phase: Third Intervention||6
8328022|NCT01380093|20530931|P7|STARTED|Treatment Phase: Third Intervention||6
8328023|NCT01380093|20530932|P6|STARTED|Treatment Phase: Third Intervention||6
8328024|NCT01380093|20530933|P5|STARTED|Treatment Phase: Third Intervention||6
8328025|NCT01380093|20530934|P4|STARTED|Treatment Phase: Third Intervention||5
8328026|NCT01380093|20530935|P3|STARTED|Treatment Phase: Third Intervention||0
8328027|NCT01380093|20530936|P2|STARTED|Treatment Phase: Third Intervention||0
8328028|NCT01380093|20530937|P1|STARTED|Treatment Phase: Third Intervention||0
8328029|NCT01380093|20530929|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
8328030|NCT01380093|20530930|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
8328031|NCT01380093|20530931|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
8328032|NCT01380093|20530932|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
8328033|NCT01380093|20530933|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
8328034|NCT01380093|20530934|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
8328035|NCT01380093|20530935|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
8328036|NCT01380093|20530936|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
8328037|NCT01380093|20530937|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
8328038|NCT01380093|20530929|P9|COMPLETED|Treatment Phase: Washout Period||6
8328039|NCT01380093|20530930|P8|COMPLETED|Treatment Phase: Washout Period||6
8328040|NCT01380093|20530931|P7|COMPLETED|Treatment Phase: Washout Period||6
8328041|NCT01380093|20530932|P6|COMPLETED|Treatment Phase: Washout Period||6
8328042|NCT01380093|20530933|P5|COMPLETED|Treatment Phase: Washout Period||6
8328043|NCT01380093|20530934|P4|COMPLETED|Treatment Phase: Washout Period||5
8328044|NCT01380093|20530935|P3|COMPLETED|Treatment Phase: Washout Period||0
8328045|NCT01380093|20530936|P2|COMPLETED|Treatment Phase: Washout Period||0
8328046|NCT01380093|20530937|P1|COMPLETED|Treatment Phase: Washout Period||0
8328047|NCT01380093|20530929|P9|STARTED|Treatment Phase: Washout Period||6
8328048|NCT01380093|20530930|P8|STARTED|Treatment Phase: Washout Period||6
8328049|NCT01380093|20530931|P7|STARTED|Treatment Phase: Washout Period||6
8328050|NCT01380093|20530932|P6|STARTED|Treatment Phase: Washout Period||6
8328051|NCT01380093|20530933|P5|STARTED|Treatment Phase: Washout Period||6
8328052|NCT01380093|20530934|P4|STARTED|Treatment Phase: Washout Period||5
8328053|NCT01380093|20530935|P3|STARTED|Treatment Phase: Washout Period||0
8328054|NCT01380093|20530936|P2|STARTED|Treatment Phase: Washout Period||0
8328055|NCT01380093|20530937|P1|STARTED|Treatment Phase: Washout Period||0
8328056|NCT01380093|20530929|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328057|NCT01380093|20530930|P8|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328058|NCT01380093|20530931|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328059|NCT01380093|20530932|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328060|NCT01380093|20530933|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328061|NCT01380093|20530934|P4|NOT COMPLETED|Treatment Phase: Second Intervention||1
8328062|NCT01380093|20530935|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328063|NCT01380093|20530936|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328064|NCT01380093|20530937|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
8328065|NCT01380093|20530929|P9|COMPLETED|Treatment Phase: Second Intervention||6
8328066|NCT01380093|20530930|P8|COMPLETED|Treatment Phase: Second Intervention||6
8328067|NCT01380093|20530931|P7|COMPLETED|Treatment Phase: Second Intervention||6
8328068|NCT01380093|20530932|P6|COMPLETED|Treatment Phase: Second Intervention||6
8328069|NCT01380093|20530933|P5|COMPLETED|Treatment Phase: Second Intervention||6
8328070|NCT01380093|20530934|P4|COMPLETED|Treatment Phase: Second Intervention||5
8328071|NCT01380093|20530935|P3|COMPLETED|Treatment Phase: Second Intervention||0
8328072|NCT01380093|20530936|P2|COMPLETED|Treatment Phase: Second Intervention||0
8328073|NCT01380093|20530937|P1|COMPLETED|Treatment Phase: Second Intervention||0
8328074|NCT01380093|20530929|P9|STARTED|Treatment Phase: Second Intervention||6
8328075|NCT01380093|20530930|P8|STARTED|Treatment Phase: Second Intervention||6
8328076|NCT01380093|20530931|P7|STARTED|Treatment Phase: Second Intervention||6
8328077|NCT01380093|20530932|P6|STARTED|Treatment Phase: Second Intervention||6
8328078|NCT01380093|20530933|P5|STARTED|Treatment Phase: Second Intervention||6
8328079|NCT01380093|20530934|P4|STARTED|Treatment Phase: Second Intervention||6
8328080|NCT01380093|20530935|P3|STARTED|Treatment Phase: Second Intervention||0
8328081|NCT01380093|20530936|P2|STARTED|Treatment Phase: Second Intervention||0
8328082|NCT01380093|20530937|P1|STARTED|Treatment Phase: Second Intervention||0
8328083|NCT01380093|20530929|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
8328084|NCT01380093|20530930|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
8328085|NCT01380093|20530931|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
8328086|NCT01380093|20530932|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
8328087|NCT01380093|20530933|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
8328088|NCT01380093|20530934|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
8328089|NCT01380093|20530935|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
8328090|NCT01380093|20530936|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
8328091|NCT01380093|20530937|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
8328092|NCT01380093|20530929|P9|COMPLETED|Treatment Phase: Washout Period||6
8328093|NCT01380093|20530930|P8|COMPLETED|Treatment Phase: Washout Period||6
8328094|NCT01380093|20530931|P7|COMPLETED|Treatment Phase: Washout Period||6
8328095|NCT01380093|20530932|P6|COMPLETED|Treatment Phase: Washout Period||6
8328096|NCT01380093|20530933|P5|COMPLETED|Treatment Phase: Washout Period||6
8328097|NCT01380093|20530934|P4|COMPLETED|Treatment Phase: Washout Period||6
8328098|NCT01380093|20530935|P3|COMPLETED|Treatment Phase: Washout Period||0
8328099|NCT01380093|20530936|P2|COMPLETED|Treatment Phase: Washout Period||0
8328100|NCT01380093|20530937|P1|COMPLETED|Treatment Phase: Washout Period||0
8328101|NCT01380093|20530929|P9|STARTED|Treatment Phase: Washout Period||6
8328102|NCT01380093|20530930|P8|STARTED|Treatment Phase: Washout Period||6
8328103|NCT01380093|20530931|P7|STARTED|Treatment Phase: Washout Period||6
8328104|NCT01380093|20530932|P6|STARTED|Treatment Phase: Washout Period||6
8328105|NCT01380093|20530933|P5|STARTED|Treatment Phase: Washout Period||6
8328106|NCT01380093|20530934|P4|STARTED|Treatment Phase: Washout Period||6
8328107|NCT01380093|20530935|P3|STARTED|Treatment Phase: Washout Period||0
8328108|NCT01380093|20530936|P2|STARTED|Treatment Phase: Washout Period||0
8328109|NCT01380093|20530937|P1|STARTED|Treatment Phase: Washout Period||0
8328110|NCT01380093|20530929|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
8328111|NCT01380093|20530930|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
8328112|NCT01380093|20530931|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
8328113|NCT01380093|20530932|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
8328114|NCT01380093|20530933|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
8328115|NCT01380093|20530934|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
8328116|NCT01380093|20530935|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
8328117|NCT01380093|20530936|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
8328118|NCT01380093|20530937|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
8328119|NCT01380093|20530929|P9|COMPLETED|Treatment Phase: First Intervention||6
8328120|NCT01380093|20530930|P8|COMPLETED|Treatment Phase: First Intervention||6
8328121|NCT01380093|20530931|P7|COMPLETED|Treatment Phase: First Intervention||6
8328122|NCT01380093|20530932|P6|COMPLETED|Treatment Phase: First Intervention||6
8328123|NCT01380093|20530933|P5|COMPLETED|Treatment Phase: First Intervention||6
8328124|NCT01380093|20530934|P4|COMPLETED|Treatment Phase: First Intervention||6
8328125|NCT01380093|20530935|P3|COMPLETED|Treatment Phase: First Intervention||0
8328126|NCT01380093|20530936|P2|COMPLETED|Treatment Phase: First Intervention||0
8328127|NCT01380093|20530937|P1|COMPLETED|Treatment Phase: First Intervention||0
8328128|NCT01380093|20530929|P9|STARTED|Treatment Phase: First Intervention||6
8328129|NCT01380093|20530930|P8|STARTED|Treatment Phase: First Intervention||6
8328130|NCT01380093|20530931|P7|STARTED|Treatment Phase: First Intervention||6
8328131|NCT01380093|20530932|P6|STARTED|Treatment Phase: First Intervention||6
8328132|NCT01380093|20530933|P5|STARTED|Treatment Phase: First Intervention||6
8328133|NCT01380093|20530934|P4|STARTED|Treatment Phase: First Intervention||6
8328134|NCT01380093|20530935|P3|STARTED|Treatment Phase: First Intervention||0
8328135|NCT01380093|20530936|P2|STARTED|Treatment Phase: First Intervention||0
8328136|NCT01380093|20530937|P1|STARTED|Treatment Phase: First Intervention||0
8328137|NCT01380093|20530929|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8328138|NCT01380093|20530930|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8328139|NCT01380093|20530931|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8328140|NCT01380093|20530932|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8328141|NCT01380093|20530933|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8328142|NCT01380093|20530934|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8328143|NCT01380093|20530935|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
8328144|NCT01380093|20530936|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
8328145|NCT01380093|20530937|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
8328146|NCT01380093|20530929|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
8328147|NCT01380093|20530930|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
8328148|NCT01380093|20530931|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
8328149|NCT01380093|20530932|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
8328150|NCT01380093|20530933|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
8328151|NCT01380093|20530934|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
8328152|NCT01380093|20530935|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
8328153|NCT01380093|20530936|P2|COMPLETED|Drug Discrimination Phase: Day 2||20
8328154|NCT01380093|20530937|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
8328155|NCT01380093|20530929|P9|STARTED|Drug Discrimination Phase: Day 2||0
8328156|NCT01380093|20530930|P8|STARTED|Drug Discrimination Phase: Day 2||0
8328157|NCT01380093|20530931|P7|STARTED|Drug Discrimination Phase: Day 2||0
8328158|NCT01380093|20530932|P6|STARTED|Drug Discrimination Phase: Day 2||0
8328159|NCT01380093|20530933|P5|STARTED|Drug Discrimination Phase: Day 2||0
8328160|NCT01380093|20530934|P4|STARTED|Drug Discrimination Phase: Day 2||0
8328161|NCT01380093|20530935|P3|STARTED|Drug Discrimination Phase: Day 2||29
8328162|NCT01380093|20530936|P2|STARTED|Drug Discrimination Phase: Day 2||29
8328163|NCT01380093|20530937|P1|STARTED|Drug Discrimination Phase: Day 2||0
8328164|NCT01380093|20530929|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328165|NCT01380093|20530930|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328166|NCT01380093|20530931|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328167|NCT01380093|20530932|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328168|NCT01380093|20530933|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328169|NCT01380093|20530934|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328170|NCT01380093|20530935|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328171|NCT01380093|20530936|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
8328172|NCT01380093|20530937|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
8328173|NCT01380093|20530929|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
8328174|NCT01380093|20530930|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
8328175|NCT01380093|20530931|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
8328176|NCT01380093|20530932|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
8328177|NCT01380093|20530933|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
8328178|NCT01380093|20530934|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
8328179|NCT01380093|20530935|P3|COMPLETED|Drug Discrimination Phase: Day 1||29
8328180|NCT01380093|20530936|P2|COMPLETED|Drug Discrimination Phase: Day 1||29
8328181|NCT01380093|20530937|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
8328182|NCT01380093|20530929|P9|STARTED|Drug Discrimination Phase: Day 1||0
8328183|NCT01380093|20530930|P8|STARTED|Drug Discrimination Phase: Day 1||0
8328184|NCT01380093|20530931|P7|STARTED|Drug Discrimination Phase: Day 1||0
8328185|NCT01380093|20530932|P6|STARTED|Drug Discrimination Phase: Day 1||0
8328186|NCT01380093|20530933|P5|STARTED|Drug Discrimination Phase: Day 1||0
8328187|NCT01380093|20530934|P4|STARTED|Drug Discrimination Phase: Day 1||0
8328188|NCT01380093|20530935|P3|STARTED|Drug Discrimination Phase: Day 1||29
8328189|NCT01380093|20530936|P2|STARTED|Drug Discrimination Phase: Day 1||30
8328190|NCT01380093|20530937|P1|STARTED|Drug Discrimination Phase: Day 1||0
8328191|NCT01380093|20530929|P9|NOT COMPLETED|Naloxone Challenge Phase||0
8328192|NCT01380093|20530930|P8|NOT COMPLETED|Naloxone Challenge Phase||0
8328193|NCT01380093|20530931|P7|NOT COMPLETED|Naloxone Challenge Phase||0
8328194|NCT01380093|20530932|P6|NOT COMPLETED|Naloxone Challenge Phase||0
8328195|NCT01380093|20530933|P5|NOT COMPLETED|Naloxone Challenge Phase||0
8328196|NCT01380093|20530934|P4|NOT COMPLETED|Naloxone Challenge Phase||0
8328197|NCT01380093|20530935|P3|NOT COMPLETED|Naloxone Challenge Phase||0
8328198|NCT01380093|20530936|P2|NOT COMPLETED|Naloxone Challenge Phase||0
8328199|NCT01380093|20530937|P1|NOT COMPLETED|Naloxone Challenge Phase||21
8328200|NCT01380093|20530929|P9|COMPLETED|Naloxone Challenge Phase||0
8328201|NCT01380093|20530930|P8|COMPLETED|Naloxone Challenge Phase||0
8328202|NCT01380093|20530931|P7|COMPLETED|Naloxone Challenge Phase||0
8328203|NCT01380093|20530932|P6|COMPLETED|Naloxone Challenge Phase||0
8328204|NCT01380093|20530933|P5|COMPLETED|Naloxone Challenge Phase||0
8328205|NCT01380093|20530934|P4|COMPLETED|Naloxone Challenge Phase||0
8328206|NCT01380093|20530935|P3|COMPLETED|Naloxone Challenge Phase||0
8328207|NCT01380093|20530936|P2|COMPLETED|Naloxone Challenge Phase||0
8328208|NCT01380093|20530937|P1|COMPLETED|Naloxone Challenge Phase||59
8328209|NCT01380093|20530929|P9|TREATED|Naloxone Challenge Phase||0
8328210|NCT01380093|20530930|P8|TREATED|Naloxone Challenge Phase||0
8328211|NCT01380093|20530931|P7|TREATED|Naloxone Challenge Phase||0
8328212|NCT01380093|20530932|P6|TREATED|Naloxone Challenge Phase||0
8328213|NCT01380093|20530933|P5|TREATED|Naloxone Challenge Phase||0
8328214|NCT01380093|20530934|P4|TREATED|Naloxone Challenge Phase||0
8328215|NCT01380093|20530935|P3|TREATED|Naloxone Challenge Phase||0
8328216|NCT01380093|20530936|P2|TREATED|Naloxone Challenge Phase||0
8328217|NCT01380093|20530937|P1|TREATED|Naloxone Challenge Phase||59
8328218|NCT01380093|20530929|P9|STARTED|Naloxone Challenge Phase||0
8328219|NCT01380093|20530930|P8|STARTED|Naloxone Challenge Phase||0
8328220|NCT01380093|20530931|P7|STARTED|Naloxone Challenge Phase||0
8328221|NCT01380093|20530932|P6|STARTED|Naloxone Challenge Phase||0
8328222|NCT01380093|20530933|P5|STARTED|Naloxone Challenge Phase||0
8328223|NCT01380093|20530934|P4|STARTED|Naloxone Challenge Phase||0
8328224|NCT01380093|20530935|P3|STARTED|Naloxone Challenge Phase||0
8328225|NCT01380093|20530936|P2|STARTED|Naloxone Challenge Phase||0
8328226|NCT01380093|20530937|P1|STARTED|Naloxone Challenge Phase||80
8328227|NCT01379963|20531227|P1|NOT COMPLETED|Overall Study||0
8328228|NCT01379963|20531227|P1|COMPLETED|Overall Study||780
8328229|NCT01379963|20531227|P1|STARTED|Overall Study||780
8328230|NCT01379937|20531236|P4|NOT COMPLETED|Overall Study||1
8328231|NCT01379937|20531237|P3|NOT COMPLETED|Overall Study||2
8328232|NCT01379937|20531238|P2|NOT COMPLETED|Overall Study||3
8328233|NCT01379937|20531239|P1|NOT COMPLETED|Overall Study||1
8328234|NCT01379937|20531236|P4|COMPLETED|Overall Study||103
8328235|NCT01379937|20531237|P3|COMPLETED|Overall Study||102
8328236|NCT01379937|20531238|P2|COMPLETED|Overall Study||153
8328237|NCT01379937|20531239|P1|COMPLETED|Overall Study||155
8328238|NCT01379937|20531236|P4|STARTED|Overall Study||104
8328239|NCT01379937|20531237|P3|STARTED|Overall Study||104
8328240|NCT01379937|20531238|P2|STARTED|Overall Study||156
8328241|NCT01379937|20531239|P1|STARTED|Overall Study||156
8328242|NCT01379924|20531321|P2|NOT COMPLETED|36-month Assessment||4
8328243|NCT01379924|20531322|P1|NOT COMPLETED|36-month Assessment||3
8328244|NCT01379924|20531321|P2|COMPLETED|36-month Assessment||48
8328245|NCT01379924|20531322|P1|COMPLETED|36-month Assessment||52
8328246|NCT01379924|20531321|P2|STARTED|36-month Assessment||52
8328247|NCT01379924|20531322|P1|STARTED|36-month Assessment||55
8328248|NCT01379924|20531321|P2|NOT COMPLETED|24-month Assessment||3
8328249|NCT01379924|20531322|P1|NOT COMPLETED|24-month Assessment||7
8328250|NCT01379924|20531321|P2|COMPLETED|24-month Assessment||52
8328251|NCT01379924|20531322|P1|COMPLETED|24-month Assessment||55
8328252|NCT01379924|20531321|P2|STARTED|24-month Assessment||55
8328253|NCT01379924|20531322|P1|STARTED|24-month Assessment||62
8328254|NCT01379924|20531321|P2|NOT COMPLETED|12-month Assessment||13
8328255|NCT01379924|20531322|P1|NOT COMPLETED|12-month Assessment||10
8328256|NCT01379924|20531321|P2|COMPLETED|12-month Assessment||55
8328257|NCT01379924|20531322|P1|COMPLETED|12-month Assessment||62
8328258|NCT01379924|20531321|P2|STARTED|12-month Assessment||68
8328259|NCT01379924|20531322|P1|STARTED|12-month Assessment||72
8328260|NCT01379924|20531321|P2|NOT COMPLETED|Baseline||0
8328261|NCT01379924|20531322|P1|NOT COMPLETED|Baseline||0
8328262|NCT01379924|20531321|P2|COMPLETED|Baseline||68
8328263|NCT01379924|20531322|P1|COMPLETED|Baseline||72
8328264|NCT01379924|20531321|P2|STARTED|Baseline||68
8328265|NCT01379924|20531322|P1|STARTED|Baseline||72
8328266|NCT01379781|20531359|P2|NOT COMPLETED|Overall Study||8
8328267|NCT01379781|20531360|P1|NOT COMPLETED|Overall Study||11
8328268|NCT01379781|20531359|P2|COMPLETED|Overall Study||19
8328269|NCT01379781|20531360|P1|COMPLETED|Overall Study||16
8328270|NCT01379781|20531359|P2|STARTED|Overall Study||27
8328271|NCT01379781|20531360|P1|STARTED|Overall Study||27
8328272|NCT01379768|20531369|P3|NOT COMPLETED|Overall Study||0
8328273|NCT01379768|20531370|P2|NOT COMPLETED|Overall Study||1
8328274|NCT01379768|20531371|P1|NOT COMPLETED|Overall Study||3
8328275|NCT01379768|20531369|P3|COMPLETED|Overall Study||20
8328276|NCT01379768|20531370|P2|COMPLETED|Overall Study||21
8328277|NCT01379768|20531371|P1|COMPLETED|Overall Study||20
8328278|NCT01379768|20531369|P3|STARTED|Overall Study||20
8328279|NCT01379768|20531370|P2|STARTED|Overall Study||22
8328280|NCT01379768|20531371|P1|STARTED|Overall Study||23
8328281|NCT01379703|20531394|P3|NOT COMPLETED|9 Months Through 18 Months||0
8328282|NCT01379703|20531395|P2|NOT COMPLETED|9 Months Through 18 Months||230
8328283|NCT01379703|20531396|P1|NOT COMPLETED|9 Months Through 18 Months||0
8328284|NCT01379703|20531394|P3|COMPLETED|9 Months Through 18 Months||0
8328285|NCT01379703|20531395|P2|COMPLETED|9 Months Through 18 Months||854
8328286|NCT01379703|20531396|P1|COMPLETED|9 Months Through 18 Months||0
8328287|NCT01379703|20531394|P3|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
8328288|NCT01379703|20531395|P2|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
8328289|NCT01379703|20531396|P1|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
8328290|NCT01379703|20531394|P3|NOT COMPLETED|Study Start Through 9 Months||143
8328291|NCT01379703|20531395|P2|NOT COMPLETED|Study Start Through 9 Months||122
8328292|NCT01379703|20531396|P1|NOT COMPLETED|Study Start Through 9 Months||4
8328293|NCT01379703|20531394|P3|COMPLETED|Study Start Through 9 Months||873
8328294|NCT01379703|20531395|P2|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
8328295|NCT01379703|20531396|P1|COMPLETED|Study Start Through 9 Months||62
8328296|NCT01379703|20531394|P3|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
8328297|NCT01379703|20531395|P2|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
8328298|NCT01379703|20531396|P1|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
8328299|NCT01379664|20531459|P2|NOT COMPLETED|Overall Study||0
8328300|NCT01379664|20531460|P1|NOT COMPLETED|Overall Study||0
8328301|NCT01379664|20531459|P2|COMPLETED|Overall Study||870
8328302|NCT01379664|20531460|P1|COMPLETED|Overall Study||714
8328303|NCT01379664|20531459|P2|STARTED|Overall Study||870
8328304|NCT01379664|20531460|P1|STARTED|Overall Study||714
8328305|NCT01379651|20531472|P2|NOT COMPLETED|Overall Study||0
8328306|NCT01379651|20531473|P1|NOT COMPLETED|Overall Study||0
8328307|NCT01379651|20531472|P2|COMPLETED|Overall Study||10
8328308|NCT01379651|20531473|P1|COMPLETED|Overall Study||10
8328309|NCT01379651|20531472|P2|STARTED|Overall Study||10
8328310|NCT01379651|20531473|P1|STARTED|Overall Study||10
8328311|NCT01379625|20531483|P2|NOT COMPLETED|Overall Study||0
8328312|NCT01379625|20531484|P1|NOT COMPLETED|Overall Study||0
8328313|NCT01379625|20531483|P2|COMPLETED|Overall Study||16
8328314|NCT01379625|20531484|P1|COMPLETED|Overall Study||16
8328315|NCT01379625|20531483|P2|STARTED|Overall Study||16
8328316|NCT01379625|20531484|P1|STARTED|Overall Study||16
8328320|NCT01379534|20531508|P2|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
8328321|NCT01379534|20531509|P1|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
8328322|NCT01379534|20531508|P2|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
8328323|NCT01379534|20531509|P1|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
8328324|NCT01379534|20531508|P2|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
8328325|NCT01379534|20531509|P1|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
8328326|NCT01379534|20531508|P2|NOT COMPLETED|Treatment Phase||31
8328327|NCT01379534|20531509|P1|NOT COMPLETED|Treatment Phase||22
8328328|NCT01379534|20531508|P2|COMPLETED|Treatment Phase||0
8328329|NCT01379534|20531509|P1|COMPLETED|Treatment Phase||0
8328330|NCT01379534|20531508|P2|STARTED|Treatment Phase||31
8328331|NCT01379534|20531509|P1|STARTED|Treatment Phase||22
8328332|NCT01379521|20531529|P2|NOT COMPLETED|Post-Treatment Evaluations||21
8328333|NCT01379521|20531530|P1|NOT COMPLETED|Post-Treatment Evaluations||25
8328334|NCT01379521|20531529|P2|COMPLETED|Post-Treatment Evaluations||0
8328335|NCT01379521|20531530|P1|COMPLETED|Post-Treatment Evaluations||0
8328336|NCT01379521|20531529|P2|STARTED|Post-Treatment Evaluations||21
8328337|NCT01379521|20531530|P1|STARTED|Post-Treatment Evaluations||25
8328338|NCT01379521|20531529|P2|NOT COMPLETED|Overall Study -Treatment Period||26
8328339|NCT01379521|20531530|P1|NOT COMPLETED|Overall Study -Treatment Period||33
8328340|NCT01379521|20531529|P2|COMPLETED|Overall Study -Treatment Period||0
8328341|NCT01379521|20531530|P1|COMPLETED|Overall Study -Treatment Period||0
8328342|NCT01379521|20531529|P2|STARTED|Overall Study -Treatment Period||26
8328343|NCT01379521|20531530|P1|STARTED|Overall Study -Treatment Period||33
8328344|NCT01379508|20531552|P4|NOT COMPLETED|Extension Period Weeks 109-156||0
8328345|NCT01379508|20531553|P3|NOT COMPLETED|Extension Period Weeks 109-156||14
8328346|NCT01379508|20531554|P2|NOT COMPLETED|Extension Period Weeks 109-156||3
8328347|NCT01379508|20531555|P1|NOT COMPLETED|Extension Period Weeks 109-156||19
8328348|NCT01379508|20531552|P4|COMPLETED|Extension Period Weeks 109-156||10
8328349|NCT01379508|20531553|P3|COMPLETED|Extension Period Weeks 109-156||65
8328350|NCT01379508|20531554|P2|COMPLETED|Extension Period Weeks 109-156||14
8328351|NCT01379508|20531555|P1|COMPLETED|Extension Period Weeks 109-156||45
8328352|NCT01379508|20531552|P4|STARTED|Extension Period Weeks 109-156||10
8328353|NCT01379508|20531553|P3|STARTED|Extension Period Weeks 109-156||79
8328354|NCT01379508|20531554|P2|STARTED|Extension Period Weeks 109-156||17
8328355|NCT01379508|20531555|P1|STARTED|Extension Period Weeks 109-156||64
8328356|NCT01379508|20531552|P4|NOT COMPLETED|Treatment to Week 104||0
8328357|NCT01379508|20531553|P3|NOT COMPLETED|Treatment to Week 104||13
8328358|NCT01379508|20531554|P2|NOT COMPLETED|Treatment to Week 104||3
8328359|NCT01379508|20531555|P1|NOT COMPLETED|Treatment to Week 104||19
8328360|NCT01379508|20531552|P4|COMPLETED|Treatment to Week 104||11
8328361|NCT01379508|20531553|P3|COMPLETED|Treatment to Week 104||96
8328362|NCT01379508|20531554|P2|COMPLETED|Treatment to Week 104||19
8328363|NCT01379508|20531555|P1|COMPLETED|Treatment to Week 104||80
8328364|NCT01379508|20531552|P4|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
8328365|NCT01379508|20531553|P3|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
8328366|NCT01379508|20531554|P2|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
8328367|NCT01379508|20531555|P1|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
8328368|NCT01379508|20531552|P4|Completed Wk 24|Treatment to Week 104||11
8328369|NCT01379508|20531553|P3|Completed Wk 24|Treatment to Week 104||107
8328370|NCT01379508|20531554|P2|Completed Wk 24|Treatment to Week 104||22
8328371|NCT01379508|20531555|P1|Completed Wk 24|Treatment to Week 104||93
8328372|NCT01379508|20531552|P4|STARTED|Treatment to Week 104||11
8328373|NCT01379508|20531553|P3|STARTED|Treatment to Week 104||109
8328374|NCT01379508|20531554|P2|STARTED|Treatment to Week 104||22
8328375|NCT01379508|20531555|P1|STARTED|Treatment to Week 104||99
8328376|NCT01379274|20531581|P1|NOT COMPLETED|Overall Study||1
8328377|NCT01379274|20531581|P1|COMPLETED|Overall Study||1
8328378|NCT01379274|20531581|P1|STARTED|Overall Study||2
8328379|NCT01379222|20531585|P1|NOT COMPLETED|Overall Study||73
8328380|NCT01379222|20531585|P1|COMPLETED|Overall Study||105
8328381|NCT01379222|20531585|P1|STARTED|Overall Study||178
8328382|NCT01379183|20531591|P2|NOT COMPLETED|Overall Study||0
8328383|NCT01379183|20531592|P1|NOT COMPLETED|Overall Study||0
8328384|NCT01379183|20531591|P2|COMPLETED|Overall Study||21
8328385|NCT01379183|20531592|P1|COMPLETED|Overall Study||19
8328386|NCT01379183|20531591|P2|STARTED|Overall Study||21
8328387|NCT01379183|20531592|P1|STARTED|Overall Study||19
8328388|NCT01378988|20531610|P2|NOT COMPLETED|Overall Study||0
8328389|NCT01378988|20531611|P1|NOT COMPLETED|Overall Study||0
8328390|NCT01378988|20531610|P2|COMPLETED|Overall Study||3
8328391|NCT01378988|20531611|P1|COMPLETED|Overall Study||2
8328392|NCT01378988|20531610|P2|STARTED|Overall Study||3
8328393|NCT01378988|20531611|P1|STARTED|Overall Study||2
8328394|NCT01378975|20531641|P2|NOT COMPLETED|Overall Study||50
8328395|NCT01378975|20531642|P1|NOT COMPLETED|Overall Study||86
8328396|NCT01378975|20531641|P2|COMPLETED|Overall Study||6
8328397|NCT01378975|20531642|P1|COMPLETED|Overall Study||4
8328398|NCT01378975|20531641|P2|STARTED|Overall Study||56
8328399|NCT01378975|20531642|P1|STARTED|Overall Study||90
8328400|NCT01378962|20531668|P1|NOT COMPLETED|Overall Study||17
8328401|NCT01378962|20531668|P1|COMPLETED|Overall Study||33
8328402|NCT01378962|20531668|P1|STARTED|Overall Study||50
8328403|NCT01378520|20531681|P2|NOT COMPLETED|Second Intervention (Day 4-6)||0
8328404|NCT01378520|20531682|P1|NOT COMPLETED|Second Intervention (Day 4-6)||0
8328405|NCT01378520|20531681|P2|COMPLETED|Second Intervention (Day 4-6)||10
8328406|NCT01378520|20531682|P1|COMPLETED|Second Intervention (Day 4-6)||10
8328407|NCT01378520|20531681|P2|STARTED|Second Intervention (Day 4-6)||10
8328408|NCT01378520|20531682|P1|STARTED|Second Intervention (Day 4-6)||10
8328409|NCT01378520|20531681|P2|NOT COMPLETED|First Intervention (Day 2-3)||0
8328410|NCT01378520|20531682|P1|NOT COMPLETED|First Intervention (Day 2-3)||0
8328411|NCT01378520|20531681|P2|COMPLETED|First Intervention (Day 2-3)||10
8328412|NCT01378520|20531682|P1|COMPLETED|First Intervention (Day 2-3)||10
8328413|NCT01378520|20531681|P2|STARTED|First Intervention (Day 2-3)||10
8328414|NCT01378520|20531682|P1|STARTED|First Intervention (Day 2-3)||10
8328415|NCT01378429|20531694|P2|NOT COMPLETED|Overall Study||0
8328416|NCT01378429|20531695|P1|NOT COMPLETED|Overall Study||1
8328417|NCT01378429|20531694|P2|COMPLETED|Overall Study||47
8328418|NCT01378429|20531695|P1|COMPLETED|Overall Study||41
8328419|NCT01378429|20531694|P2|STARTED|Overall Study||47
8328420|NCT01378429|20531695|P1|STARTED|Overall Study||42
8328421|NCT01378416|20531727|P1|NOT COMPLETED|Overall Study||0
8328422|NCT01378416|20531727|P1|COMPLETED|Overall Study||16
8328423|NCT01378416|20531727|P1|STARTED|Overall Study||16
8328424|NCT01378377|20531738|P3|NOT COMPLETED|Overall Study||0
8328425|NCT01378377|20531739|P2|NOT COMPLETED|Overall Study||0
8328426|NCT01378377|20531740|P1|NOT COMPLETED|Overall Study||0
8328427|NCT01378377|20531738|P3|COMPLETED|Overall Study||6
8328428|NCT01378377|20531739|P2|COMPLETED|Overall Study||23
8328429|NCT01378377|20531740|P1|COMPLETED|Overall Study||4
8328430|NCT01378377|20531738|P3|STARTED|Overall Study||6
8328431|NCT01378377|20531739|P2|STARTED|Overall Study||23
8328432|NCT01378377|20531740|P1|STARTED|Overall Study||4
8328433|NCT01378325|20531808|P2|NOT COMPLETED|Overall Study||1
8328434|NCT01378325|20531809|P1|NOT COMPLETED|Overall Study||0
8328435|NCT01378325|20531808|P2|COMPLETED|Overall Study||39
8328436|NCT01378325|20531809|P1|COMPLETED|Overall Study||40
8328437|NCT01378325|20531808|P2|STARTED|Overall Study||40
8328438|NCT01378325|20531809|P1|STARTED|Overall Study||40
8328439|NCT01378299|20531815|P1|NOT COMPLETED|Overall Study||31
8328440|NCT01378299|20531815|P1|COMPLETED|Overall Study||74
8328441|NCT01378299|20531815|P1|BMI Group 3|Overall Study||27
8328442|NCT01378299|20531815|P1|BMI Group 2|Overall Study||40
8328443|NCT01378299|20531815|P1|BMI group1|Overall Study||38
8328444|NCT01378299|20531815|P1|STARTED|Overall Study||105
8328445|NCT01378273|20531854|P2|NOT COMPLETED|Overall Study||1
8328446|NCT01378273|20531855|P1|NOT COMPLETED|Overall Study||4
8328447|NCT01378273|20531854|P2|COMPLETED|Overall Study||476
8328448|NCT01378273|20531855|P1|COMPLETED|Overall Study||460
8328449|NCT01378273|20531854|P2|STARTED|Overall Study||477
8328450|NCT01378273|20531855|P1|STARTED|Overall Study||464
8328451|NCT01378221|20531869|P2|NOT COMPLETED|Overall Study||9
8328452|NCT01378221|20531870|P1|NOT COMPLETED|Overall Study||7
8328453|NCT01378221|20531869|P2|COMPLETED|Overall Study||30
8328454|NCT01378221|20531870|P1|COMPLETED|Overall Study||29
8328455|NCT01378221|20531869|P2|STARTED|Overall Study||39
8328456|NCT01378221|20531870|P1|STARTED|Overall Study||36
8328457|NCT01378195|20531878|P2|NOT COMPLETED|Overall Study||18
8328458|NCT01378195|20531879|P1|NOT COMPLETED|Overall Study||29
8328459|NCT01378195|20531878|P2|COMPLETED|Overall Study||57
8328460|NCT01378195|20531879|P1|COMPLETED|Overall Study||46
8328461|NCT01378195|20531878|P2|STARTED|Overall Study||75
8328462|NCT01378195|20531879|P1|STARTED|Overall Study||75
8328463|NCT01378117|20531892|P3|NOT COMPLETED|Overall Study||3
8328464|NCT01378117|20531893|P2|NOT COMPLETED|Overall Study||1
8328465|NCT01378117|20531894|P1|NOT COMPLETED|Overall Study||4
8328466|NCT01378117|20531892|P3|COMPLETED|Overall Study||26
8328467|NCT01378117|20531893|P2|COMPLETED|Overall Study||29
8328468|NCT01378117|20531894|P1|COMPLETED|Overall Study||27
8328469|NCT01378117|20531892|P3|STARTED|Overall Study||29
8328470|NCT01378117|20531893|P2|STARTED|Overall Study||30
8328471|NCT01378117|20531894|P1|STARTED|Overall Study||31
8328472|NCT01378104|20531928|P2|NOT COMPLETED|Overall Study||26
8328473|NCT01378104|20531929|P1|NOT COMPLETED|Overall Study||27
8328474|NCT01378104|20531928|P2|COMPLETED|Overall Study||60
8328475|NCT01378104|20531929|P1|COMPLETED|Overall Study||65
8328476|NCT01378104|20531928|P2|STARTED|Overall Study||86
8328477|NCT01378104|20531929|P1|STARTED|Overall Study||92
8328478|NCT01378065|20531937|P1|NOT COMPLETED|Overall Study||0
8328479|NCT01378065|20531937|P1|COMPLETED|Overall Study||30
8328480|NCT01378065|20531937|P1|12 Months|Overall Study||30
8328481|NCT01378065|20531937|P1|6 Months|Overall Study||30
8328482|NCT01378065|20531937|P1|3 Months|Overall Study||30
8328483|NCT01378065|20531937|P1|6 Week|Overall Study||30
8328484|NCT01378065|20531937|P1|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
8328485|NCT01377987|20531974|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8328486|NCT01377987|20531975|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8328487|NCT01377987|20531974|P2|COMPLETED|Second Intervention (7 Days)||14
8328488|NCT01377987|20531975|P1|COMPLETED|Second Intervention (7 Days)||13
8328489|NCT01377987|20531974|P2|STARTED|Second Intervention (7 Days)||14
8328490|NCT01377987|20531975|P1|STARTED|Second Intervention (7 Days)||13
8328491|NCT01377987|20531974|P2|NOT COMPLETED|Washout (7 Days)||1
8328492|NCT01377987|20531975|P1|NOT COMPLETED|Washout (7 Days)||1
8328493|NCT01377987|20531974|P2|COMPLETED|Washout (7 Days)||14
8328494|NCT01377987|20531975|P1|COMPLETED|Washout (7 Days)||13
8328495|NCT01377987|20531974|P2|STARTED|Washout (7 Days)||15
8328496|NCT01377987|20531975|P1|STARTED|Washout (7 Days)||14
8328497|NCT01377987|20531974|P2|NOT COMPLETED|First Intervention (7 Days)||0
8328498|NCT01377987|20531975|P1|NOT COMPLETED|First Intervention (7 Days)||0
8328499|NCT01377987|20531974|P2|COMPLETED|First Intervention (7 Days)||15
8328500|NCT01377987|20531975|P1|COMPLETED|First Intervention (7 Days)||14
8328501|NCT01377987|20531974|P2|STARTED|First Intervention (7 Days)||15
8328502|NCT01377987|20531975|P1|STARTED|First Intervention (7 Days)||14
8328503|NCT01377922|20531993|P2|NOT COMPLETED|Overall Study||0
8328504|NCT01377922|20531994|P1|NOT COMPLETED|Overall Study||1
8328505|NCT01377922|20531993|P2|COMPLETED|Overall Study||16
8328506|NCT01377922|20531994|P1|COMPLETED|Overall Study||21
8328507|NCT01377922|20531993|P2|STARTED|Overall Study||16
8328508|NCT01377922|20531994|P1|STARTED|Overall Study||22
8328509|NCT01377636|20532006|P1|NOT COMPLETED|Overall Study||0
8328510|NCT01377636|20532006|P1|COMPLETED|Overall Study||20
8328511|NCT01377636|20532006|P1|STARTED|Overall Study||20
8328512|NCT01377623|20532020|P2|NOT COMPLETED|Overall Study||5
8328513|NCT01377623|20532021|P1|NOT COMPLETED|Overall Study||7
8328514|NCT01377623|20532020|P2|COMPLETED|Overall Study||28
8328515|NCT01377623|20532021|P1|COMPLETED|Overall Study||26
8328516|NCT01377623|20532020|P2|STARTED|Overall Study||33
8328517|NCT01377623|20532021|P1|STARTED|Overall Study||33
8328518|NCT01377584|20532041|P6|NOT COMPLETED|Overall Study||3
8328519|NCT01377584|20532042|P5|NOT COMPLETED|Overall Study||3
8328520|NCT01377584|20532043|P4|NOT COMPLETED|Overall Study||4
8328521|NCT01377584|20532044|P3|NOT COMPLETED|Overall Study||4
8328522|NCT01377584|20532045|P2|NOT COMPLETED|Overall Study||3
8328523|NCT01377584|20532046|P1|NOT COMPLETED|Overall Study||3
8328524|NCT01377584|20532041|P6|COMPLETED|Overall Study||9
8328525|NCT01377584|20532042|P5|COMPLETED|Overall Study||9
8328526|NCT01377584|20532043|P4|COMPLETED|Overall Study||6
8328527|NCT01377584|20532044|P3|COMPLETED|Overall Study||6
8328528|NCT01377584|20532045|P2|COMPLETED|Overall Study||5
8328529|NCT01377584|20532046|P1|COMPLETED|Overall Study||5
8328530|NCT01377584|20532041|P6|STARTED|Overall Study||12
8328531|NCT01377584|20532042|P5|STARTED|Overall Study||12
8328532|NCT01377584|20532043|P4|STARTED|Overall Study||10
8328533|NCT01377584|20532044|P3|STARTED|Overall Study||10
8328534|NCT01377584|20532045|P2|STARTED|Overall Study||8
8328535|NCT01377584|20532046|P1|STARTED|Overall Study||8
8328536|NCT01377480|20532079|P4|NOT COMPLETED|Overall Study||11
8328537|NCT01377480|20532080|P3|NOT COMPLETED|Overall Study||10
8328538|NCT01377480|20532081|P2|NOT COMPLETED|Overall Study||1
8328539|NCT01377480|20532082|P1|NOT COMPLETED|Overall Study||0
8328540|NCT01377480|20532079|P4|COMPLETED|Overall Study||19
8328541|NCT01377480|20532080|P3|COMPLETED|Overall Study||18
8328542|NCT01377480|20532081|P2|COMPLETED|Overall Study||29
8328543|NCT01377480|20532082|P1|COMPLETED|Overall Study||32
8328544|NCT01377480|20532079|P4|STARTED|Overall Study||30
8328545|NCT01377480|20532080|P3|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
8328546|NCT01377480|20532081|P2|STARTED|Overall Study||30
8328547|NCT01377480|20532082|P1|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
8328548|NCT01377467|20532094|P2|NOT COMPLETED|Overall Study||0
8328549|NCT01377467|20532095|P1|NOT COMPLETED|Overall Study||0
8328550|NCT01377467|20532094|P2|COMPLETED|Overall Study||44
8328551|NCT01377467|20532095|P1|COMPLETED|Overall Study||46
8328552|NCT01377467|20532094|P2|STARTED|Overall Study||44
8328553|NCT01377467|20532095|P1|STARTED|Overall Study||46
8328554|NCT01377441|20532143|P2|NOT COMPLETED|Overall Study||0
8328555|NCT01377441|20532144|P1|NOT COMPLETED|Overall Study||0
8328556|NCT01377441|20532143|P2|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
8328557|NCT01377441|20532144|P1|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
8328558|NCT01377441|20532143|P2|STARTED|Overall Study||0
8328559|NCT01377441|20532144|P1|STARTED|Overall Study||0
8328560|NCT01377402|20532152|P1|NOT COMPLETED|Overall Study||0
8328561|NCT01377402|20532152|P1|COMPLETED|Overall Study||982
8328562|NCT01377402|20532152|P1|STARTED|Overall Study||982
8328563|NCT01377389|20532158|P1|NOT COMPLETED|Overall Study||3
8328564|NCT01377389|20532158|P1|COMPLETED|Overall Study||27
8328565|NCT01377389|20532158|P1|STARTED|Overall Study||30
8328566|NCT01377233|20532172|P5|NOT COMPLETED|Double-blind||2
8328567|NCT01377233|20532173|P4|NOT COMPLETED|Double-blind||4
8328568|NCT01377233|20532174|P3|NOT COMPLETED|Double-blind||2
8328569|NCT01377233|20532175|P2|NOT COMPLETED|Double-blind||1
8328570|NCT01377233|20532176|P1|NOT COMPLETED|Double-blind||0
8328571|NCT01377233|20532172|P5|COMPLETED|Double-blind||8
8328572|NCT01377233|20532173|P4|COMPLETED|Double-blind||7
8328573|NCT01377233|20532174|P3|COMPLETED|Double-blind||8
8328574|NCT01377233|20532175|P2|COMPLETED|Double-blind||10
8328575|NCT01377233|20532176|P1|COMPLETED|Double-blind||0
8328576|NCT01377233|20532172|P5|STARTED|Double-blind||10
8328577|NCT01377233|20532173|P4|STARTED|Double-blind||11
8328578|NCT01377233|20532174|P3|STARTED|Double-blind||10
8328579|NCT01377233|20532175|P2|STARTED|Double-blind||11
8328580|NCT01377233|20532176|P1|STARTED|Double-blind||0
8328581|NCT01377233|20532172|P5|NOT COMPLETED|Open-label||0
8328582|NCT01377233|20532173|P4|NOT COMPLETED|Open-label||0
8328583|NCT01377233|20532174|P3|NOT COMPLETED|Open-label||0
8328584|NCT01377233|20532175|P2|NOT COMPLETED|Open-label||0
8328585|NCT01377233|20532176|P1|NOT COMPLETED|Open-label||4
8328586|NCT01377233|20532172|P5|COMPLETED|Open-label||0
8328587|NCT01377233|20532173|P4|COMPLETED|Open-label||0
8328588|NCT01377233|20532174|P3|COMPLETED|Open-label||0
8328589|NCT01377233|20532175|P2|COMPLETED|Open-label||0
8328590|NCT01377233|20532176|P1|COMPLETED|Open-label||42
8328591|NCT01377233|20532172|P5|STARTED|Open-label||0
8328592|NCT01377233|20532173|P4|STARTED|Open-label||0
8328593|NCT01377233|20532174|P3|STARTED|Open-label||0
8328594|NCT01377233|20532175|P2|STARTED|Open-label||0
8328595|NCT01377233|20532176|P1|STARTED|Open-label||46
8328596|NCT01377194|20532203|P3|NOT COMPLETED|Overall Study||46
8328597|NCT01377194|20532204|P2|NOT COMPLETED|Overall Study||43
8328598|NCT01377194|20532205|P1|NOT COMPLETED|Overall Study||32
8328599|NCT01377194|20532203|P3|COMPLETED|Overall Study||142
8328600|NCT01377194|20532204|P2|COMPLETED|Overall Study||145
8328601|NCT01377194|20532205|P1|COMPLETED|Overall Study||154
8328602|NCT01377194|20532203|P3|STARTED|Overall Study||188
8328603|NCT01377194|20532204|P2|STARTED|Overall Study||188
8328604|NCT01377194|20532205|P1|STARTED|Overall Study||186
8328605|NCT01377012|20532219|P3|NOT COMPLETED|Extension Study, Weeks 104-260||68
8328606|NCT01377012|20532220|P2|NOT COMPLETED|Extension Study, Weeks 104-260||71
8328607|NCT01377012|20532221|P1|NOT COMPLETED|Extension Study, Weeks 104-260||57
8328608|NCT01377012|20532219|P3|COMPLETED|Extension Study, Weeks 104-260||0
8328609|NCT01377012|20532220|P2|COMPLETED|Extension Study, Weeks 104-260||0
8328610|NCT01377012|20532221|P1|COMPLETED|Extension Study, Weeks 104-260||0
8328611|NCT01377012|20532219|P3|STARTED|Extension Study, Weeks 104-260||68
8328612|NCT01377012|20532220|P2|STARTED|Extension Study, Weeks 104-260||71
8328613|NCT01377012|20532221|P1|STARTED|Extension Study, Weeks 104-260||57
8328614|NCT01377012|20532219|P3|NOT COMPLETED|Core Study||134
8328615|NCT01377012|20532220|P2|NOT COMPLETED|Core Study||132
8328616|NCT01377012|20532221|P1|NOT COMPLETED|Core Study||134
8328617|NCT01377012|20532219|P3|COMPLETED|Core Study||80
8328618|NCT01377012|20532220|P2|COMPLETED|Core Study||81
8328619|NCT01377012|20532221|P1|COMPLETED|Core Study||76
8328620|NCT01377012|20532219|P3|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
8328621|NCT01377012|20532220|P2|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
8328622|NCT01377012|20532221|P1|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
8328623|NCT01377012|20532219|P3|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
8328624|NCT01377012|20532220|P2|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
8328625|NCT01377012|20532221|P1|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
8328626|NCT01377012|20532219|P3|wk16 Re-randomized to AIN 150mg NR|Core Study||53
8328627|NCT01377012|20532220|P2|wk16 Re-randomized to AIN 150mg NR|Core Study||0
8328628|NCT01377012|20532221|P1|wk16 Re-randomized to AIN 150mg NR|Core Study||0
8328629|NCT01377012|20532219|P3|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
8328630|NCT01377012|20532220|P2|wk16 Re-randomized to AIN 75mg NR|Core Study||0
8328631|NCT01377012|20532221|P1|wk16 Re-randomized to AIN 75mg NR|Core Study||0
8328632|NCT01377012|20532219|P3|STARTED|Core Study||214
8328633|NCT01377012|20532220|P2|STARTED|Core Study||213
8328634|NCT01377012|20532221|P1|STARTED|Core Study||210
8328635|NCT01376908|20532258|P2|NOT COMPLETED|Overall Study||3
8328636|NCT01376908|20532259|P1|NOT COMPLETED|Overall Study||2
8328637|NCT01376908|20532258|P2|COMPLETED|Overall Study||26
8328638|NCT01376908|20532259|P1|COMPLETED|Overall Study||25
8328639|NCT01376908|20532258|P2|STARTED|Overall Study||29
8328640|NCT01376908|20532259|P1|STARTED|Overall Study||27
8328641|NCT01376804|20532292|P1|NOT COMPLETED|Follow-up Period||0
8328642|NCT01376804|20532292|P1|COMPLETED|Follow-up Period||55
8328643|NCT01376804|20532292|P1|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
8328644|NCT01376804|20532292|P1|NOT COMPLETED|Treatment Period||8
8328645|NCT01376804|20532292|P1|COMPLETED|Treatment Period||49
8328646|NCT01376804|20532292|P1|Received Study Drug|Treatment Period||56
8328647|NCT01376804|20532292|P1|STARTED|Treatment Period||57
8328651|NCT01376557|20532324|P5|NOT COMPLETED|Overall Study||7
8328652|NCT01376557|20532325|P4|NOT COMPLETED|Overall Study||6
8328653|NCT01376557|20532326|P3|NOT COMPLETED|Overall Study||5
8328654|NCT01376557|20532327|P2|NOT COMPLETED|Overall Study||6
8328655|NCT01376557|20532328|P1|NOT COMPLETED|Overall Study||8
8328656|NCT01376557|20532324|P5|COMPLETED|Overall Study||53
8328657|NCT01376557|20532325|P4|COMPLETED|Overall Study||54
8328658|NCT01376557|20532326|P3|COMPLETED|Overall Study||55
8328659|NCT01376557|20532327|P2|COMPLETED|Overall Study||54
8328660|NCT01376557|20532328|P1|COMPLETED|Overall Study||51
8328661|NCT01376557|20532324|P5|STARTED|Overall Study||60
8328662|NCT01376557|20532325|P4|STARTED|Overall Study||60
8328663|NCT01376557|20532326|P3|STARTED|Overall Study||60
8328664|NCT01376557|20532327|P2|STARTED|Overall Study||60
8328665|NCT01376557|20532328|P1|STARTED|Overall Study||59
8328666|NCT01376388|20532365|P1|NOT COMPLETED|Overall Study||18
8328667|NCT01376388|20532365|P1|COMPLETED|Overall Study||112
8328668|NCT01376388|20532365|P1|STARTED|Overall Study||130
8328669|NCT01376362|20532380|P1|NOT COMPLETED|Overall Study||0
8328670|NCT01376362|20532380|P1|COMPLETED|Overall Study||5
8328671|NCT01376362|20532380|P1|STARTED|Overall Study||5
8328672|NCT01376349|20532403|P3|NOT COMPLETED|Optional Continuation Phase||0
8328673|NCT01376349|20532404|P2|NOT COMPLETED|Optional Continuation Phase||0
8328674|NCT01376349|20532405|P1|NOT COMPLETED|Optional Continuation Phase||0
8328675|NCT01376349|20532403|P3|COMPLETED|Optional Continuation Phase||94
8328676|NCT01376349|20532404|P2|COMPLETED|Optional Continuation Phase||0
8328677|NCT01376349|20532405|P1|COMPLETED|Optional Continuation Phase||0
8328678|NCT01376349|20532403|P3|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
8328679|NCT01376349|20532404|P2|STARTED|Optional Continuation Phase||0
8328680|NCT01376349|20532405|P1|STARTED|Optional Continuation Phase||0
8328681|NCT01376349|20532403|P3|NOT COMPLETED|Raondomized Treatment||29
8328682|NCT01376349|20532404|P2|NOT COMPLETED|Raondomized Treatment||35
8328683|NCT01376349|20532405|P1|NOT COMPLETED|Raondomized Treatment||24
8328684|NCT01376349|20532403|P3|COMPLETED|Raondomized Treatment||118
8328685|NCT01376349|20532404|P2|COMPLETED|Raondomized Treatment||114
8328686|NCT01376349|20532405|P1|COMPLETED|Raondomized Treatment||123
8328687|NCT01376349|20532403|P3|STARTED|Raondomized Treatment||147
8328688|NCT01376349|20532404|P2|STARTED|Raondomized Treatment||149
8328689|NCT01376349|20532405|P1|STARTED|Raondomized Treatment||147
8328690|NCT01376323|20532419|P5|NOT COMPLETED|Overall Study||1
8328691|NCT01376323|20532420|P4|NOT COMPLETED|Overall Study||5
8328692|NCT01376323|20532421|P3|NOT COMPLETED|Overall Study||3
8328693|NCT01376323|20532422|P2|NOT COMPLETED|Overall Study||1
8328694|NCT01376323|20532423|P1|NOT COMPLETED|Overall Study||2
8328695|NCT01376323|20532419|P5|COMPLETED|Overall Study||17
8328696|NCT01376323|20532420|P4|COMPLETED|Overall Study||14
8328697|NCT01376323|20532421|P3|COMPLETED|Overall Study||16
8328698|NCT01376323|20532422|P2|COMPLETED|Overall Study||17
8328699|NCT01376323|20532423|P1|COMPLETED|Overall Study||18
8328700|NCT01376323|20532419|P5|STARTED|Overall Study||18
8328701|NCT01376323|20532420|P4|STARTED|Overall Study||19
8328702|NCT01376323|20532421|P3|STARTED|Overall Study||19
8328703|NCT01376323|20532422|P2|STARTED|Overall Study||18
8328704|NCT01376323|20532423|P1|STARTED|Overall Study||20
8328705|NCT01376310|20532507|P2|NOT COMPLETED|Overall Study||11
8328706|NCT01376310|20532508|P1|NOT COMPLETED|Overall Study||36
8328707|NCT01376310|20532507|P2|COMPLETED|Overall Study||22
8328708|NCT01376310|20532508|P1|COMPLETED|Overall Study||90
8328709|NCT01376310|20532507|P2|STARTED|Overall Study||33
8328710|NCT01376310|20532508|P1|STARTED|Overall Study||126
8328711|NCT01376297|20532516|P2|NOT COMPLETED|Overall Study||49
8328712|NCT01376297|20532517|P1|NOT COMPLETED|Overall Study||128
8328713|NCT01376297|20532516|P2|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
8328714|NCT01376297|20532517|P1|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
8328715|NCT01376297|20532516|P2|STARTED|Overall Study|number of randomised patients|104
8328716|NCT01376297|20532517|P1|STARTED|Overall Study|number of randomised patients|309
8328717|NCT01376245|20532527|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||26
8328718|NCT01376245|20532528|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||23
8328719|NCT01376245|20532529|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||25
8328720|NCT01376245|20532530|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||32
8328721|NCT01376245|20532531|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
8328722|NCT01376245|20532527|P5|COMPLETED|24-week, Double-blind Treatment Period||134
8328723|NCT01376245|20532528|P4|COMPLETED|24-week, Double-blind Treatment Period||138
8328724|NCT01376245|20532529|P3|COMPLETED|24-week, Double-blind Treatment Period||135
8328725|NCT01376245|20532530|P2|COMPLETED|24-week, Double-blind Treatment Period||130
8328726|NCT01376245|20532531|P1|COMPLETED|24-week, Double-blind Treatment Period||0
8328727|NCT01376245|20532527|P5|STARTED|24-week, Double-blind Treatment Period||160
8328728|NCT01376245|20532528|P4|STARTED|24-week, Double-blind Treatment Period||161
8328729|NCT01376245|20532529|P3|STARTED|24-week, Double-blind Treatment Period||160
8328730|NCT01376245|20532530|P2|STARTED|24-week, Double-blind Treatment Period||162
8328731|NCT01376245|20532531|P1|STARTED|24-week, Double-blind Treatment Period||0
8328732|NCT01376245|20532527|P5|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328733|NCT01376245|20532528|P4|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328734|NCT01376245|20532529|P3|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328735|NCT01376245|20532530|P2|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328736|NCT01376245|20532531|P1|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
8328737|NCT01376245|20532527|P5|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328738|NCT01376245|20532528|P4|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328739|NCT01376245|20532529|P3|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328740|NCT01376245|20532530|P2|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
8328741|NCT01376245|20532531|P1|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
8328742|NCT01376245|20532527|P5|STARTED|2-wk Single-blind Placebo Run-in Period||0
8328743|NCT01376245|20532528|P4|STARTED|2-wk Single-blind Placebo Run-in Period||0
8328744|NCT01376245|20532529|P3|STARTED|2-wk Single-blind Placebo Run-in Period||0
8328745|NCT01376245|20532530|P2|STARTED|2-wk Single-blind Placebo Run-in Period||0
8328746|NCT01376245|20532531|P1|STARTED|2-wk Single-blind Placebo Run-in Period||744
8328747|NCT01376167|20532548|P3|NOT COMPLETED|Overall Study||6
8328748|NCT01376167|20532549|P2|NOT COMPLETED|Overall Study||10
8328749|NCT01376167|20532550|P1|NOT COMPLETED|Overall Study||4
8328750|NCT01376167|20532548|P3|COMPLETED|Overall Study||123
8328751|NCT01376167|20532549|P2|COMPLETED|Overall Study||250
8328752|NCT01376167|20532550|P1|COMPLETED|Overall Study||129
8328753|NCT01376167|20532548|P3|STARTED|Overall Study||129
8328754|NCT01376167|20532549|P2|STARTED|Overall Study||260
8328755|NCT01376167|20532550|P1|STARTED|Overall Study||133
8328756|NCT01376089|20532621|P2|NOT COMPLETED|Overall Study||4
8328757|NCT01376089|20532622|P1|NOT COMPLETED|Overall Study||3
8328758|NCT01376089|20532621|P2|COMPLETED|Overall Study||144
8328759|NCT01376089|20532622|P1|COMPLETED|Overall Study||148
8328760|NCT01376089|20532621|P2|STARTED|Overall Study||148
8328761|NCT01376089|20532622|P1|STARTED|Overall Study||151
8328762|NCT01376050|20532634|P2|NOT COMPLETED|Overall Study||0
8328763|NCT01376050|20532635|P1|NOT COMPLETED|Overall Study||0
8328764|NCT01376050|20532634|P2|COMPLETED|Overall Study||11
8328765|NCT01376050|20532635|P1|COMPLETED|Overall Study||13
8328766|NCT01376050|20532634|P2|STARTED|Overall Study||11
8328767|NCT01376050|20532635|P1|STARTED|Overall Study||13
8328768|NCT01376037|20532645|P2|NOT COMPLETED|Overall Study||2
8328769|NCT01376037|20532646|P1|NOT COMPLETED|Overall Study||0
8328770|NCT01376037|20532645|P2|COMPLETED|Overall Study||29
8328771|NCT01376037|20532646|P1|COMPLETED|Overall Study||31
8328772|NCT01376037|20532645|P2|STARTED|Overall Study||31
8328773|NCT01376037|20532646|P1|STARTED|Overall Study||31
8328794|NCT01375946|20532661|P6|NOT COMPLETED|Overall Study||0
8328795|NCT01375946|20532662|P5|NOT COMPLETED|Overall Study||0
8328796|NCT01375946|20532663|P4|NOT COMPLETED|Overall Study||0
8328797|NCT01375946|20532664|P3|NOT COMPLETED|Overall Study||0
8328798|NCT01375946|20532665|P2|NOT COMPLETED|Overall Study||0
8328799|NCT01375946|20532666|P1|NOT COMPLETED|Overall Study||0
8328800|NCT01375946|20532661|P6|COMPLETED|Overall Study||4
8328801|NCT01375946|20532662|P5|COMPLETED|Overall Study||4
8328802|NCT01375946|20532663|P4|COMPLETED|Overall Study||4
8328803|NCT01375946|20532664|P3|COMPLETED|Overall Study||4
8328804|NCT01375946|20532665|P2|COMPLETED|Overall Study||4
8328805|NCT01375946|20532666|P1|COMPLETED|Overall Study||4
8328806|NCT01375946|20532661|P6|STARTED|Overall Study||4
8328807|NCT01375946|20532662|P5|STARTED|Overall Study||4
8328808|NCT01375946|20532663|P4|STARTED|Overall Study||4
8328809|NCT01375946|20532664|P3|STARTED|Overall Study||4
8328810|NCT01375946|20532665|P2|STARTED|Overall Study||4
8328811|NCT01375946|20532666|P1|STARTED|Overall Study||4
8328812|NCT01375777|20532683|P9|NOT COMPLETED|Overall Study||2
8328813|NCT01375777|20532684|P8|NOT COMPLETED|Overall Study||2
8328814|NCT01375777|20532685|P7|NOT COMPLETED|Overall Study||2
8328815|NCT01375777|20532686|P6|NOT COMPLETED|Overall Study||1
8328816|NCT01375777|20532687|P5|NOT COMPLETED|Overall Study||1
8328817|NCT01375777|20532688|P4|NOT COMPLETED|Overall Study||0
8328818|NCT01375777|20532689|P3|NOT COMPLETED|Overall Study||1
8328819|NCT01375777|20532690|P2|NOT COMPLETED|Overall Study||3
8328820|NCT01375777|20532691|P1|NOT COMPLETED|Overall Study||2
8328821|NCT01375777|20532683|P9|COMPLETED|Overall Study||44
8328822|NCT01375777|20532684|P8|COMPLETED|Overall Study||44
8328823|NCT01375777|20532685|P7|COMPLETED|Overall Study||44
8328824|NCT01375777|20532686|P6|COMPLETED|Overall Study||44
8328825|NCT01375777|20532687|P5|COMPLETED|Overall Study||45
8328826|NCT01375777|20532688|P4|COMPLETED|Overall Study||45
8328827|NCT01375777|20532689|P3|COMPLETED|Overall Study||45
8328828|NCT01375777|20532690|P2|COMPLETED|Overall Study||42
8328829|NCT01375777|20532691|P1|COMPLETED|Overall Study||44
8328830|NCT01375777|20532683|P9|Received Treatment|Overall Study||45
8328831|NCT01375777|20532684|P8|Received Treatment|Overall Study||45
8328832|NCT01375777|20532685|P7|Received Treatment|Overall Study||45
8328833|NCT01375777|20532686|P6|Received Treatment|Overall Study||45
8328834|NCT01375777|20532687|P5|Received Treatment|Overall Study||46
8328835|NCT01375777|20532688|P4|Received Treatment|Overall Study||45
8328836|NCT01375777|20532689|P3|Received Treatment|Overall Study||45
8328837|NCT01375777|20532690|P2|Received Treatment|Overall Study||45
8328838|NCT01375777|20532691|P1|Received Treatment|Overall Study||45
8328839|NCT01375777|20532683|P9|STARTED|Overall Study||46
8328840|NCT01375777|20532684|P8|STARTED|Overall Study||46
8328841|NCT01375777|20532685|P7|STARTED|Overall Study||46
8328842|NCT01375777|20532686|P6|STARTED|Overall Study||45
8328843|NCT01375777|20532687|P5|STARTED|Overall Study||46
8328844|NCT01375777|20532688|P4|STARTED|Overall Study||45
8328845|NCT01375777|20532689|P3|STARTED|Overall Study||46
8328846|NCT01375777|20532690|P2|STARTED|Overall Study||45
8328847|NCT01375777|20532691|P1|STARTED|Overall Study||46
8328848|NCT01375764|20532761|P5|NOT COMPLETED|Overall Study||1
8328849|NCT01375764|20532762|P4|NOT COMPLETED|Overall Study||1
8328850|NCT01375764|20532763|P3|NOT COMPLETED|Overall Study||0
8328851|NCT01375764|20532764|P2|NOT COMPLETED|Overall Study||1
8328852|NCT01375764|20532765|P1|NOT COMPLETED|Overall Study||2
8328853|NCT01375764|20532761|P5|COMPLETED|Overall Study||31
8328854|NCT01375764|20532762|P4|COMPLETED|Overall Study||31
8328855|NCT01375764|20532763|P3|COMPLETED|Overall Study||32
8328856|NCT01375764|20532764|P2|COMPLETED|Overall Study||30
8328857|NCT01375764|20532765|P1|COMPLETED|Overall Study||31
8328858|NCT01375764|20532761|P5|Received Treatment|Overall Study||32
8328859|NCT01375764|20532762|P4|Received Treatment|Overall Study||31
8328860|NCT01375764|20532763|P3|Received Treatment|Overall Study||32
8328861|NCT01375764|20532764|P2|Received Treatment|Overall Study||30
8328862|NCT01375764|20532765|P1|Received Treatment|Overall Study||32
8328863|NCT01375764|20532761|P5|STARTED|Overall Study||32
8328864|NCT01375764|20532762|P4|STARTED|Overall Study||32
8328865|NCT01375764|20532763|P3|STARTED|Overall Study||32
8328866|NCT01375764|20532764|P2|STARTED|Overall Study||31
8328867|NCT01375764|20532765|P1|STARTED|Overall Study||33
8328868|NCT01375751|20532811|P3|NOT COMPLETED|Overall Study||0
8328869|NCT01375751|20532812|P2|NOT COMPLETED|Overall Study||1
8328870|NCT01375751|20532813|P1|NOT COMPLETED|Overall Study||0
8328871|NCT01375751|20532811|P3|COMPLETED|Overall Study||56
8328872|NCT01375751|20532812|P2|COMPLETED|Overall Study||55
8328873|NCT01375751|20532813|P1|COMPLETED|Overall Study||56
8328874|NCT01375751|20532811|P3|Received Treatment|Overall Study||56
8328875|NCT01375751|20532812|P2|Received Treatment|Overall Study||55
8328876|NCT01375751|20532813|P1|Received Treatment|Overall Study||56
8328877|NCT01375751|20532811|P3|STARTED|Overall Study||56
8328878|NCT01375751|20532812|P2|STARTED|Overall Study||56
8328879|NCT01375751|20532813|P1|STARTED|Overall Study||56
8328880|NCT01375673|20532838|P2|NOT COMPLETED|Overall Study||1
8328881|NCT01375673|20532839|P1|NOT COMPLETED|Overall Study||0
8328882|NCT01375673|20532838|P2|COMPLETED|Overall Study||6
8328883|NCT01375673|20532839|P1|COMPLETED|Overall Study||7
8328884|NCT01375673|20532838|P2|STARTED|Overall Study||7
8328885|NCT01375673|20532839|P1|STARTED|Overall Study||7
8328886|NCT01375660|20532851|P2|NOT COMPLETED|Overall Study||16
8328887|NCT01375660|20532852|P1|NOT COMPLETED|Overall Study||16
8328888|NCT01375660|20532851|P2|COMPLETED|Overall Study||87
8328889|NCT01375660|20532852|P1|COMPLETED|Overall Study||86
8328890|NCT01375660|20532851|P2|STARTED|Overall Study||103
8328891|NCT01375660|20532852|P1|STARTED|Overall Study||102
8328892|NCT01375608|20532870|P1|NOT COMPLETED|Overall Study||2
8328893|NCT01375608|20532870|P1|COMPLETED|Overall Study||8
8328894|NCT01375608|20532870|P1|STARTED|Overall Study||10
8328895|NCT01375569|20532874|P1|NOT COMPLETED|Overall Study||0
8328896|NCT01375569|20532874|P1|COMPLETED|Overall Study||11
8328897|NCT01375569|20532874|P1|STARTED|Overall Study||11
8328898|NCT01375491|20532882|P3|NOT COMPLETED|Overall Study||0
8328899|NCT01375491|20532883|P2|NOT COMPLETED|Overall Study||1
8328900|NCT01375491|20532884|P1|NOT COMPLETED|Overall Study||2
8328901|NCT01375491|20532882|P3|COMPLETED|Overall Study||15
8328902|NCT01375491|20532883|P2|COMPLETED|Overall Study||12
8328903|NCT01375491|20532884|P1|COMPLETED|Overall Study||9
8328904|NCT01375491|20532882|P3|STARTED|Overall Study||15
8328905|NCT01375491|20532883|P2|STARTED|Overall Study||13
8328906|NCT01375491|20532884|P1|STARTED|Overall Study||11
8328907|NCT01375374|20532898|P1|NOT COMPLETED|Overall Study||1
8328908|NCT01375374|20532898|P1|COMPLETED|Overall Study||10
8328909|NCT01375374|20532898|P1|STARTED|Overall Study||11
8328910|NCT01375205|20532907|P2|NOT COMPLETED|Overall Study||13
8328911|NCT01375205|20532908|P1|NOT COMPLETED|Overall Study||21
8328912|NCT01375205|20532907|P2|COMPLETED|Overall Study||33
8328913|NCT01375205|20532908|P1|COMPLETED|Overall Study||33
8328914|NCT01375205|20532907|P2|STARTED|Overall Study||46
8328915|NCT01375205|20532908|P1|STARTED|Overall Study||54
8328916|NCT01375140|20532928|P1|NOT COMPLETED|Overall Study||0
8328917|NCT01375140|20532928|P1|COMPLETED|Overall Study||31
8328918|NCT01375140|20532928|P1|STARTED|Overall Study||31
8328919|NCT01375127|20532938|P6|NOT COMPLETED|Overall Study||0
8328920|NCT01375127|20532939|P5|NOT COMPLETED|Overall Study||0
8328921|NCT01375127|20532940|P4|NOT COMPLETED|Overall Study||0
8328922|NCT01375127|20532941|P3|NOT COMPLETED|Overall Study||0
8328923|NCT01375127|20532942|P2|NOT COMPLETED|Overall Study||0
8328924|NCT01375127|20532943|P1|NOT COMPLETED|Overall Study||0
8328925|NCT01375127|20532938|P6|COMPLETED|Overall Study||3
8328926|NCT01375127|20532939|P5|COMPLETED|Overall Study||5
8328927|NCT01375127|20532940|P4|COMPLETED|Overall Study||33
8328928|NCT01375127|20532941|P3|COMPLETED|Overall Study||40
8328929|NCT01375127|20532942|P2|COMPLETED|Overall Study||1
8328930|NCT01375127|20532943|P1|COMPLETED|Overall Study||1
8328931|NCT01375127|20532938|P6|STARTED|Overall Study||3
8328932|NCT01375127|20532939|P5|STARTED|Overall Study||5
8328933|NCT01375127|20532940|P4|STARTED|Overall Study||33
8328934|NCT01375127|20532941|P3|STARTED|Overall Study||40
8328935|NCT01375127|20532942|P2|STARTED|Overall Study||1
8328936|NCT01375127|20532943|P1|STARTED|Overall Study||1
8328937|NCT01375075|20532981|P6|NOT COMPLETED|Overall Study||3
8328938|NCT01375075|20532982|P5|NOT COMPLETED|Overall Study||0
8328939|NCT01375075|20532983|P4|NOT COMPLETED|Overall Study||1
8328940|NCT01375075|20532984|P3|NOT COMPLETED|Overall Study||3
8328941|NCT01375075|20532985|P2|NOT COMPLETED|Overall Study||1
8328942|NCT01375075|20532986|P1|NOT COMPLETED|Overall Study||1
8328943|NCT01375075|20532981|P6|COMPLETED|Overall Study||25
8328944|NCT01375075|20532982|P5|COMPLETED|Overall Study||27
8328945|NCT01375075|20532983|P4|COMPLETED|Overall Study||27
8328946|NCT01375075|20532984|P3|COMPLETED|Overall Study||24
8328947|NCT01375075|20532985|P2|COMPLETED|Overall Study||27
8328948|NCT01375075|20532986|P1|COMPLETED|Overall Study||26
8328949|NCT01375075|20532981|P6|Received at Least One Dose of Study Drug|Overall Study||28
8328950|NCT01375075|20532982|P5|Received at Least One Dose of Study Drug|Overall Study||27
8328951|NCT01375075|20532983|P4|Received at Least One Dose of Study Drug|Overall Study||28
8328952|NCT01375075|20532984|P3|Received at Least One Dose of Study Drug|Overall Study||27
8328953|NCT01375075|20532985|P2|Received at Least One Dose of Study Drug|Overall Study||28
8328954|NCT01375075|20532986|P1|Received at Least One Dose of Study Drug|Overall Study||27
8328955|NCT01375075|20532981|P6|STARTED|Overall Study||28
8328956|NCT01375075|20532982|P5|STARTED|Overall Study||27
8328957|NCT01375075|20532983|P4|STARTED|Overall Study||28
8328958|NCT01375075|20532984|P3|STARTED|Overall Study||27
8328959|NCT01375075|20532985|P2|STARTED|Overall Study||28
8328960|NCT01375075|20532986|P1|STARTED|Overall Study||27
8328961|NCT01375049|20533070|P1|NOT COMPLETED|Overall Study||50
8328962|NCT01375049|20533070|P1|COMPLETED|Overall Study||55
8328963|NCT01375049|20533070|P1|STARTED|Overall Study||105
8328964|NCT01375010|20533087|P2|NOT COMPLETED|Overall Study||4
8328965|NCT01375010|20533088|P1|NOT COMPLETED|Overall Study||12
8328966|NCT01375010|20533087|P2|COMPLETED|Overall Study||38
8328967|NCT01375010|20533088|P1|COMPLETED|Overall Study||31
8328968|NCT01375010|20533087|P2|STARTED|Overall Study||42
8328969|NCT01375010|20533088|P1|STARTED|Overall Study||43
8328970|NCT01374971|20533102|P1|NOT COMPLETED|Overall Study||1
8328971|NCT01374971|20533102|P1|COMPLETED|Overall Study||11
8328972|NCT01374971|20533102|P1|STARTED|Overall Study||12
8328973|NCT01374919|20533107|P1|NOT COMPLETED|Overall Study||2
8328974|NCT01374919|20533107|P1|COMPLETED|Overall Study||58
8328975|NCT01374919|20533107|P1|STARTED|Overall Study||60
8328976|NCT01374906|20533114|P2|NOT COMPLETED|Overall Study||48
8328977|NCT01374906|20533115|P1|NOT COMPLETED|Overall Study||40
8328978|NCT01374906|20533114|P2|COMPLETED|Overall Study||28
8328979|NCT01374906|20533115|P1|COMPLETED|Overall Study||34
8328980|NCT01374906|20533114|P2|Completed Extension Phase|Overall Study||15
8328981|NCT01374906|20533115|P1|Completed Extension Phase|Overall Study||24
8328982|NCT01374906|20533114|P2|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
8328983|NCT01374906|20533115|P1|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
8328984|NCT01374906|20533114|P2|Completed Core Phase/Entered Ext. Phase|Overall Study||41
8328985|NCT01374906|20533115|P1|Completed Core Phase/Entered Ext. Phase|Overall Study||40
8328986|NCT01374906|20533114|P2|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
8328987|NCT01374906|20533115|P1|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
8328988|NCT01374906|20533114|P2|Completed Core Phase|Overall Study||54
8328989|NCT01374906|20533115|P1|Completed Core Phase|Overall Study||50
8328990|NCT01374906|20533114|P2|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
8328991|NCT01374906|20533115|P1|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
8328992|NCT01374906|20533114|P2|STARTED|Overall Study||76
8328993|NCT01374906|20533115|P1|STARTED|Overall Study||74
8328994|NCT01374802|20533182|P1|NOT COMPLETED|Overall Study||0
8328995|NCT01374802|20533182|P1|COMPLETED|Overall Study||14
8328996|NCT01374802|20533182|P1|STARTED|Overall Study||14
8328997|NCT01374568|20533196|P2|NOT COMPLETED|Overall Study||2
8328998|NCT01374568|20533197|P1|NOT COMPLETED|Overall Study||0
8328999|NCT01374568|20533196|P2|COMPLETED|Overall Study||1
8329000|NCT01374568|20533197|P1|COMPLETED|Overall Study||2
8329001|NCT01374568|20533196|P2|STARTED|Overall Study||3
8329002|NCT01374568|20533197|P1|STARTED|Overall Study||2
8329003|NCT01374516|20533207|P2|NOT COMPLETED|Surveillance Expansion Period||1253
8329004|NCT01374516|20533208|P1|NOT COMPLETED|Surveillance Expansion Period||2349
8329005|NCT01374516|20533207|P2|COMPLETED|Surveillance Expansion Period||5387
8329006|NCT01374516|20533208|P1|COMPLETED|Surveillance Expansion Period||10932
8329007|NCT01374516|20533207|P2|STARTED|Surveillance Expansion Period||6640
8329008|NCT01374516|20533208|P1|STARTED|Surveillance Expansion Period||13281
8329009|NCT01374516|20533207|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309
8329010|NCT01374516|20533208|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639
8329011|NCT01374516|20533207|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||6640
8329012|NCT01374516|20533208|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||13281
8329013|NCT01374516|20533207|P2|STARTED|Vaccination Phase (Up to 25 Months)||6949
8329014|NCT01374516|20533208|P1|STARTED|Vaccination Phase (Up to 25 Months)||13920
8329015|NCT01374490|20533240|P1|NOT COMPLETED|Overall Study||60
8329016|NCT01374490|20533240|P1|COMPLETED|Overall Study||190
8329017|NCT01374490|20533240|P1|STARTED|Overall Study||250
8329018|NCT01374451|20533246|P2|NOT COMPLETED|Overall Study||0
8329019|NCT01374451|20533247|P1|NOT COMPLETED|Overall Study||1
8329020|NCT01374451|20533246|P2|COMPLETED|Overall Study||81
8329021|NCT01374451|20533247|P1|COMPLETED|Overall Study||78
8329022|NCT01374451|20533246|P2|STARTED|Overall Study||81
8329023|NCT01374451|20533247|P1|STARTED|Overall Study||79
8329024|NCT01374438|20533276|P2|NOT COMPLETED|Overall Study||0
8329025|NCT01374438|20533277|P1|NOT COMPLETED|Overall Study||0
8329026|NCT01374438|20533276|P2|COMPLETED|Overall Study||13
8329027|NCT01374438|20533277|P1|COMPLETED|Overall Study||16
8329028|NCT01374438|20533276|P2|STARTED|Overall Study||13
8329029|NCT01374438|20533277|P1|STARTED|Overall Study||16
8329030|NCT01374425|20533293|P2|NOT COMPLETED|Overall Study||188
8329031|NCT01374425|20533294|P1|NOT COMPLETED|Overall Study||188
8329032|NCT01374425|20533293|P2|COMPLETED|Overall Study||0
8329033|NCT01374425|20533294|P1|COMPLETED|Overall Study||0
8329034|NCT01374425|20533293|P2|STARTED|Overall Study||188
8329035|NCT01374425|20533294|P1|STARTED|Overall Study||188
8329036|NCT01374269|20533374|P2|NOT COMPLETED|Overall Study||5
8329037|NCT01374269|20533375|P1|NOT COMPLETED|Overall Study||6
8329038|NCT01374269|20533374|P2|COMPLETED|Overall Study||39
8329039|NCT01374269|20533375|P1|COMPLETED|Overall Study||40
8329040|NCT01374269|20533374|P2|STARTED|Overall Study||44
8329041|NCT01374269|20533375|P1|STARTED|Overall Study||46
8329042|NCT01374217|20533503|P1|NOT COMPLETED|Overall Study||13
8329043|NCT01374217|20533503|P1|COMPLETED|Overall Study||0
8329044|NCT01374217|20533503|P1|STARTED|Overall Study||13
8329045|NCT01374178|20533511|P2|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
8329046|NCT01374178|20533512|P1|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
8329047|NCT01374178|20533511|P2|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
8329048|NCT01374178|20533512|P1|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
8329049|NCT01374178|20533511|P2|STARTED|Period 2 (up to 24 Hours After Dosing)||5
8329050|NCT01374178|20533512|P1|STARTED|Period 2 (up to 24 Hours After Dosing)||10
8329051|NCT01374178|20533511|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
8329052|NCT01374178|20533512|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
8329053|NCT01374178|20533511|P2|COMPLETED|Washout Period of at Least 7 Days||5
8329054|NCT01374178|20533512|P1|COMPLETED|Washout Period of at Least 7 Days||10
8329055|NCT01374178|20533511|P2|STARTED|Washout Period of at Least 7 Days||5
8329056|NCT01374178|20533512|P1|STARTED|Washout Period of at Least 7 Days||11
8329057|NCT01374178|20533511|P2|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
8329058|NCT01374178|20533512|P1|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
8329059|NCT01374178|20533511|P2|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
8329060|NCT01374178|20533512|P1|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
8329061|NCT01374178|20533511|P2|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
8329062|NCT01374178|20533512|P1|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
8329063|NCT01374178|20533511|P2|STARTED|Period 1 (up to 24 Hours After Dosing)||5
8329064|NCT01374178|20533512|P1|STARTED|Period 1 (up to 24 Hours After Dosing)||11
8329065|NCT01374087|20533530|P2|NOT COMPLETED|Overall Study||15
8329066|NCT01374087|20533531|P1|NOT COMPLETED|Overall Study||16
8329067|NCT01374087|20533530|P2|COMPLETED|Overall Study||0
8329068|NCT01374087|20533531|P1|COMPLETED|Overall Study||0
8329069|NCT01374087|20533530|P2|STARTED|Overall Study||15
8329070|NCT01374087|20533531|P1|STARTED|Overall Study||16
8329071|NCT01373931|20533551|P2|NOT COMPLETED|Period 2||0
8329072|NCT01373931|20533552|P1|NOT COMPLETED|Period 2||0
8329073|NCT01373931|20533551|P2|COMPLETED|Period 2||8
8329074|NCT01373931|20533552|P1|COMPLETED|Period 2||6
8329075|NCT01373931|20533551|P2|STARTED|Period 2||8
8329076|NCT01373931|20533552|P1|STARTED|Period 2||6
8329077|NCT01373931|20533551|P2|NOT COMPLETED|Period 1||2
8329078|NCT01373931|20533552|P1|NOT COMPLETED|Period 1||2
8329079|NCT01373931|20533551|P2|COMPLETED|Period 1||8
8329080|NCT01373931|20533552|P1|COMPLETED|Period 1||6
8329081|NCT01373931|20533551|P2|STARTED|Period 1||10
8329082|NCT01373931|20533552|P1|STARTED|Period 1||8
8329083|NCT01373931|20533551|P2|NOT COMPLETED|Lead-in Period||0
8329084|NCT01373931|20533552|P1|NOT COMPLETED|Lead-in Period||2
8329085|NCT01373931|20533551|P2|COMPLETED|Lead-in Period||10
8329086|NCT01373931|20533552|P1|COMPLETED|Lead-in Period||8
8329087|NCT01373931|20533551|P2|Received at Least 1 Dose of Study Drug|Lead-in Period||10
8329088|NCT01373931|20533552|P1|Received at Least 1 Dose of Study Drug|Lead-in Period||8
8329089|NCT01373931|20533551|P2|STARTED|Lead-in Period||10
8329090|NCT01373931|20533552|P1|STARTED|Lead-in Period||10
8329091|NCT01373918|20533565|P2|NOT COMPLETED|Overall Study||1
8329092|NCT01373918|20533566|P1|NOT COMPLETED|Overall Study||0
8329093|NCT01373918|20533565|P2|COMPLETED|Overall Study||15
8329094|NCT01373918|20533566|P1|COMPLETED|Overall Study||20
8329095|NCT01373918|20533565|P2|STARTED|Overall Study||16
8329096|NCT01373918|20533566|P1|STARTED|Overall Study||20
8329097|NCT01373671|20533578|P1|NOT COMPLETED|Overall Study||92
8329098|NCT01373671|20533578|P1|COMPLETED|Overall Study||672
8329099|NCT01373671|20533578|P1|STARTED|Overall Study||764
8329100|NCT01373580|20533583|P1|NOT COMPLETED|Overall Study||56
8329101|NCT01373580|20533583|P1|COMPLETED|Overall Study||317
8329102|NCT01373580|20533583|P1|STARTED|Overall Study||373
8329109|NCT01373450|20533598|P6|NOT COMPLETED|Crossover Period 4||0
8329110|NCT01373450|20533599|P5|NOT COMPLETED|Crossover Period 4||0
8329111|NCT01373450|20533600|P4|NOT COMPLETED|Crossover Period 4||0
8329112|NCT01373450|20533601|P3|NOT COMPLETED|Crossover Period 4||0
8329113|NCT01373450|20533602|P2|NOT COMPLETED|Crossover Period 4||0
8329114|NCT01373450|20533603|P1|NOT COMPLETED|Crossover Period 4||0
8329115|NCT01373450|20533598|P6|COMPLETED|Crossover Period 4||2
8329116|NCT01373450|20533599|P5|COMPLETED|Crossover Period 4||2
8329117|NCT01373450|20533600|P4|COMPLETED|Crossover Period 4||2
8329118|NCT01373450|20533601|P3|COMPLETED|Crossover Period 4||2
8329119|NCT01373450|20533602|P2|COMPLETED|Crossover Period 4||2
8329120|NCT01373450|20533603|P1|COMPLETED|Crossover Period 4||2
8329121|NCT01373450|20533598|P6|STARTED|Crossover Period 4||2
8329122|NCT01373450|20533599|P5|STARTED|Crossover Period 4||2
8329123|NCT01373450|20533600|P4|STARTED|Crossover Period 4||2
8329124|NCT01373450|20533601|P3|STARTED|Crossover Period 4||2
8329125|NCT01373450|20533602|P2|STARTED|Crossover Period 4||2
8329126|NCT01373450|20533603|P1|STARTED|Crossover Period 4||2
8329127|NCT01373450|20533598|P6|NOT COMPLETED|7 Day Wash-out||0
8329128|NCT01373450|20533599|P5|NOT COMPLETED|7 Day Wash-out||0
8329129|NCT01373450|20533600|P4|NOT COMPLETED|7 Day Wash-out||0
8329130|NCT01373450|20533601|P3|NOT COMPLETED|7 Day Wash-out||0
8329131|NCT01373450|20533602|P2|NOT COMPLETED|7 Day Wash-out||0
8329132|NCT01373450|20533603|P1|NOT COMPLETED|7 Day Wash-out||0
8329133|NCT01373450|20533598|P6|COMPLETED|7 Day Wash-out||2
8329134|NCT01373450|20533599|P5|COMPLETED|7 Day Wash-out||2
8329135|NCT01373450|20533600|P4|COMPLETED|7 Day Wash-out||2
8329136|NCT01373450|20533601|P3|COMPLETED|7 Day Wash-out||2
8329137|NCT01373450|20533602|P2|COMPLETED|7 Day Wash-out||2
8329138|NCT01373450|20533603|P1|COMPLETED|7 Day Wash-out||2
8329139|NCT01373450|20533598|P6|STARTED|7 Day Wash-out||2
8329140|NCT01373450|20533599|P5|STARTED|7 Day Wash-out||2
8329141|NCT01373450|20533600|P4|STARTED|7 Day Wash-out||2
8329142|NCT01373450|20533601|P3|STARTED|7 Day Wash-out||2
8329143|NCT01373450|20533602|P2|STARTED|7 Day Wash-out||2
8329144|NCT01373450|20533603|P1|STARTED|7 Day Wash-out||2
8329145|NCT01373450|20533598|P6|NOT COMPLETED|Crossover Period 3||0
8329146|NCT01373450|20533599|P5|NOT COMPLETED|Crossover Period 3||0
8329147|NCT01373450|20533600|P4|NOT COMPLETED|Crossover Period 3||0
8329148|NCT01373450|20533601|P3|NOT COMPLETED|Crossover Period 3||0
8329149|NCT01373450|20533602|P2|NOT COMPLETED|Crossover Period 3||0
8329150|NCT01373450|20533603|P1|NOT COMPLETED|Crossover Period 3||0
8329151|NCT01373450|20533598|P6|COMPLETED|Crossover Period 3||2
8329152|NCT01373450|20533599|P5|COMPLETED|Crossover Period 3||2
8329153|NCT01373450|20533600|P4|COMPLETED|Crossover Period 3||2
8329154|NCT01373450|20533601|P3|COMPLETED|Crossover Period 3||2
8329155|NCT01373450|20533602|P2|COMPLETED|Crossover Period 3||2
8329156|NCT01373450|20533603|P1|COMPLETED|Crossover Period 3||2
8329157|NCT01373450|20533598|P6|STARTED|Crossover Period 3||2
8329158|NCT01373450|20533599|P5|STARTED|Crossover Period 3||2
8329159|NCT01373450|20533600|P4|STARTED|Crossover Period 3||2
8329160|NCT01373450|20533601|P3|STARTED|Crossover Period 3||2
8329161|NCT01373450|20533602|P2|STARTED|Crossover Period 3||2
8329162|NCT01373450|20533603|P1|STARTED|Crossover Period 3||2
8329163|NCT01373450|20533598|P6|NOT COMPLETED|7 Day Wash-out||0
8329164|NCT01373450|20533599|P5|NOT COMPLETED|7 Day Wash-out||0
8329165|NCT01373450|20533600|P4|NOT COMPLETED|7 Day Wash-out||0
8329166|NCT01373450|20533601|P3|NOT COMPLETED|7 Day Wash-out||0
8329167|NCT01373450|20533602|P2|NOT COMPLETED|7 Day Wash-out||0
8329168|NCT01373450|20533603|P1|NOT COMPLETED|7 Day Wash-out||0
8329169|NCT01373450|20533598|P6|COMPLETED|7 Day Wash-out||2
8329170|NCT01373450|20533599|P5|COMPLETED|7 Day Wash-out||2
8329171|NCT01373450|20533600|P4|COMPLETED|7 Day Wash-out||2
8329172|NCT01373450|20533601|P3|COMPLETED|7 Day Wash-out||2
8329173|NCT01373450|20533602|P2|COMPLETED|7 Day Wash-out||2
8329174|NCT01373450|20533603|P1|COMPLETED|7 Day Wash-out||2
8329175|NCT01373450|20533598|P6|STARTED|7 Day Wash-out||2
8329176|NCT01373450|20533599|P5|STARTED|7 Day Wash-out||2
8329177|NCT01373450|20533600|P4|STARTED|7 Day Wash-out||2
8329178|NCT01373450|20533601|P3|STARTED|7 Day Wash-out||2
8329179|NCT01373450|20533602|P2|STARTED|7 Day Wash-out||2
8329180|NCT01373450|20533603|P1|STARTED|7 Day Wash-out||2
8329181|NCT01373450|20533598|P6|NOT COMPLETED|Crossover Period 2||0
8329182|NCT01373450|20533599|P5|NOT COMPLETED|Crossover Period 2||0
8329183|NCT01373450|20533600|P4|NOT COMPLETED|Crossover Period 2||0
8329184|NCT01373450|20533601|P3|NOT COMPLETED|Crossover Period 2||0
8329185|NCT01373450|20533602|P2|NOT COMPLETED|Crossover Period 2||0
8329186|NCT01373450|20533603|P1|NOT COMPLETED|Crossover Period 2||0
8329187|NCT01373450|20533598|P6|COMPLETED|Crossover Period 2||2
8329188|NCT01373450|20533599|P5|COMPLETED|Crossover Period 2||2
8329189|NCT01373450|20533600|P4|COMPLETED|Crossover Period 2||2
8329190|NCT01373450|20533601|P3|COMPLETED|Crossover Period 2||2
8329191|NCT01373450|20533602|P2|COMPLETED|Crossover Period 2||2
8329192|NCT01373450|20533603|P1|COMPLETED|Crossover Period 2||2
8329193|NCT01373450|20533598|P6|STARTED|Crossover Period 2||2
8329194|NCT01373450|20533599|P5|STARTED|Crossover Period 2||2
8329195|NCT01373450|20533600|P4|STARTED|Crossover Period 2||2
8329196|NCT01373450|20533601|P3|STARTED|Crossover Period 2||2
8329197|NCT01373450|20533602|P2|STARTED|Crossover Period 2||2
8329198|NCT01373450|20533603|P1|STARTED|Crossover Period 2||2
8329199|NCT01373450|20533598|P6|NOT COMPLETED|7 Day Wash-out||0
8329200|NCT01373450|20533599|P5|NOT COMPLETED|7 Day Wash-out||0
8329201|NCT01373450|20533600|P4|NOT COMPLETED|7 Day Wash-out||0
8329202|NCT01373450|20533601|P3|NOT COMPLETED|7 Day Wash-out||0
8329203|NCT01373450|20533602|P2|NOT COMPLETED|7 Day Wash-out||0
8329204|NCT01373450|20533603|P1|NOT COMPLETED|7 Day Wash-out||0
8329205|NCT01373450|20533598|P6|COMPLETED|7 Day Wash-out||2
8329206|NCT01373450|20533599|P5|COMPLETED|7 Day Wash-out||2
8329207|NCT01373450|20533600|P4|COMPLETED|7 Day Wash-out||2
8329208|NCT01373450|20533601|P3|COMPLETED|7 Day Wash-out||2
8329209|NCT01373450|20533602|P2|COMPLETED|7 Day Wash-out||2
8329210|NCT01373450|20533603|P1|COMPLETED|7 Day Wash-out||2
8329211|NCT01373450|20533598|P6|STARTED|7 Day Wash-out||2
8329212|NCT01373450|20533599|P5|STARTED|7 Day Wash-out||2
8329213|NCT01373450|20533600|P4|STARTED|7 Day Wash-out||2
8329214|NCT01373450|20533601|P3|STARTED|7 Day Wash-out||2
8329215|NCT01373450|20533602|P2|STARTED|7 Day Wash-out||2
8329216|NCT01373450|20533603|P1|STARTED|7 Day Wash-out||2
8329217|NCT01373450|20533598|P6|NOT COMPLETED|Crossover Period 1||0
8329218|NCT01373450|20533599|P5|NOT COMPLETED|Crossover Period 1||0
8329219|NCT01373450|20533600|P4|NOT COMPLETED|Crossover Period 1||0
8329220|NCT01373450|20533601|P3|NOT COMPLETED|Crossover Period 1||0
8329221|NCT01373450|20533602|P2|NOT COMPLETED|Crossover Period 1||0
8329222|NCT01373450|20533603|P1|NOT COMPLETED|Crossover Period 1||0
8329223|NCT01373450|20533598|P6|COMPLETED|Crossover Period 1||2
8329224|NCT01373450|20533599|P5|COMPLETED|Crossover Period 1||2
8329225|NCT01373450|20533600|P4|COMPLETED|Crossover Period 1||2
8329226|NCT01373450|20533601|P3|COMPLETED|Crossover Period 1||2
8329227|NCT01373450|20533602|P2|COMPLETED|Crossover Period 1||2
8329228|NCT01373450|20533603|P1|COMPLETED|Crossover Period 1||2
8329229|NCT01373450|20533598|P6|STARTED|Crossover Period 1||2
8329230|NCT01373450|20533599|P5|STARTED|Crossover Period 1||2
8329231|NCT01373450|20533600|P4|STARTED|Crossover Period 1||2
8329232|NCT01373450|20533601|P3|STARTED|Crossover Period 1||2
8329233|NCT01373450|20533602|P2|STARTED|Crossover Period 1||2
8329234|NCT01373450|20533603|P1|STARTED|Crossover Period 1||2
8329235|NCT01373346|20533625|P1|NOT COMPLETED|Overall Study||1
8329236|NCT01373346|20533625|P1|COMPLETED|Overall Study||14
8329237|NCT01373346|20533625|P1|STARTED|Overall Study||15
8329238|NCT01373294|20533648|P2|NOT COMPLETED|Overall Study||0
8329239|NCT01373294|20533649|P1|NOT COMPLETED|Overall Study||1
8329240|NCT01373294|20533648|P2|COMPLETED|Overall Study||2
8329241|NCT01373294|20533649|P1|COMPLETED|Overall Study||14
8329242|NCT01373294|20533648|P2|STARTED|Overall Study||2
8329243|NCT01373294|20533649|P1|STARTED|Overall Study||15
8329244|NCT01373281|20533658|P2|NOT COMPLETED|Surveillance Expansion Period||118
8329245|NCT01373281|20533659|P1|NOT COMPLETED|Surveillance Expansion Period||202
8329246|NCT01373281|20533658|P2|COMPLETED|Surveillance Expansion Period||3279
8329247|NCT01373281|20533659|P1|COMPLETED|Surveillance Expansion Period||6595
8329248|NCT01373281|20533658|P2|STARTED|Surveillance Expansion Period||3397
8329249|NCT01373281|20533659|P1|STARTED|Surveillance Expansion Period||6797
8329250|NCT01373281|20533658|P2|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
8329251|NCT01373281|20533659|P1|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
8329252|NCT01373281|20533658|P2|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
8329253|NCT01373281|20533659|P1|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
8329254|NCT01373281|20533658|P2|STARTED|Vaccination Phase (Up to 25 Months)||3424
8329255|NCT01373281|20533659|P1|STARTED|Vaccination Phase (Up to 25 Months)||6851
8329256|NCT01373242|20533691|P1|NOT COMPLETED|Overall Study||16
8329257|NCT01373242|20533691|P1|COMPLETED|Overall Study||38
8329258|NCT01373242|20533691|P1|STARTED|Overall Study||54
8329259|NCT01373229|20533707|P1|NOT COMPLETED|Overall Study||6
8329260|NCT01373229|20533707|P1|COMPLETED|Overall Study||9
8329261|NCT01373229|20533707|P1|STARTED|Overall Study||15
8329262|NCT01373164|20533721|P5|NOT COMPLETED|Overall Study||2
8329263|NCT01373164|20533722|P4|NOT COMPLETED|Overall Study||12
8329264|NCT01373164|20533723|P3|NOT COMPLETED|Overall Study||1
8329265|NCT01373164|20533724|P2|NOT COMPLETED|Overall Study||1
8329266|NCT01373164|20533725|P1|NOT COMPLETED|Overall Study||0
8329267|NCT01373164|20533721|P5|COMPLETED|Overall Study||50
8329268|NCT01373164|20533722|P4|COMPLETED|Overall Study||92
8329269|NCT01373164|20533723|P3|COMPLETED|Overall Study||4
8329270|NCT01373164|20533724|P2|COMPLETED|Overall Study||3
8329271|NCT01373164|20533725|P1|COMPLETED|Overall Study||5
8329272|NCT01373164|20533721|P5|Received at Least One Dose|Overall Study||52
8329273|NCT01373164|20533722|P4|Received at Least One Dose|Overall Study||103
8329274|NCT01373164|20533723|P3|Received at Least One Dose|Overall Study||5
8329275|NCT01373164|20533724|P2|Received at Least One Dose|Overall Study||4
8329276|NCT01373164|20533725|P1|Received at Least One Dose|Overall Study||5
8329277|NCT01373164|20533721|P5|STARTED|Overall Study||52
8329278|NCT01373164|20533722|P4|STARTED|Overall Study||104
8329279|NCT01373164|20533723|P3|STARTED|Overall Study||5
8329280|NCT01373164|20533724|P2|STARTED|Overall Study||4
8329281|NCT01373164|20533725|P1|STARTED|Overall Study||5
8329282|NCT01372995|20533759|P3|NOT COMPLETED|Overall Study||1
8329283|NCT01372995|20533760|P2|NOT COMPLETED|Overall Study||1
8329284|NCT01372995|20533761|P1|NOT COMPLETED|Overall Study||0
8329285|NCT01372995|20533759|P3|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
8329286|NCT01372995|20533760|P2|COMPLETED|Overall Study||9
8329287|NCT01372995|20533761|P1|COMPLETED|Overall Study||10
8329288|NCT01372995|20533759|P3|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
8329289|NCT01372995|20533760|P2|STARTED|Overall Study||10
8329290|NCT01372995|20533761|P1|STARTED|Overall Study||10
8329291|NCT01372878|20533808|P1|NOT COMPLETED|Overall Study||184
8329292|NCT01372878|20533808|P1|COMPLETED|Overall Study||700
8329293|NCT01372878|20533808|P1|STARTED|Overall Study||884
8329294|NCT01372813|20533813|P1|NOT COMPLETED|Overall Study||0
8329295|NCT01372813|20533813|P1|COMPLETED|Overall Study||3
8329296|NCT01372813|20533813|P1|STARTED|Overall Study||3
8329297|NCT01372774|20533828|P2|NOT COMPLETED|Overall Study||5
8329298|NCT01372774|20533829|P1|NOT COMPLETED|Overall Study||4
8329299|NCT01372774|20533828|P2|COMPLETED|Overall Study||93
8329300|NCT01372774|20533829|P1|COMPLETED|Overall Study||92
8329301|NCT01372774|20533828|P2|STARTED|Overall Study||98
8329302|NCT01372774|20533829|P1|STARTED|Overall Study||96
8329303|NCT01372748|20533845|P2|NOT COMPLETED|Overall Study||39
8329304|NCT01372748|20533846|P1|NOT COMPLETED|Overall Study||23
8329305|NCT01372748|20533845|P2|COMPLETED|Overall Study|defined as having vital status|12603
8329306|NCT01372748|20533846|P1|COMPLETED|Overall Study|defined as having vital status|11022
8329307|NCT01372748|20533845|P2|STARTED|Overall Study||12642
8329308|NCT01372748|20533846|P1|STARTED|Overall Study||11045
8329309|NCT01372618|20533854|P1|NOT COMPLETED|Overall Study||9
8329310|NCT01372618|20533854|P1|COMPLETED|Overall Study||0
8329311|NCT01372618|20533854|P1|STARTED|Overall Study||9
8329312|NCT01372605|20533862|P2|NOT COMPLETED|Overall Study||10
8329313|NCT01372605|20533863|P1|NOT COMPLETED|Overall Study||12
8329314|NCT01372605|20533862|P2|COMPLETED|Overall Study||145
8329315|NCT01372605|20533863|P1|COMPLETED|Overall Study||137
8329316|NCT01372605|20533862|P2|STARTED|Overall Study||155
8329317|NCT01372605|20533863|P1|STARTED|Overall Study||149
8329318|NCT01372501|20533889|P1|NOT COMPLETED|Overall Study||5
8329319|NCT01372501|20533889|P1|COMPLETED|Overall Study||14
8329320|NCT01372501|20533889|P1|STARTED|Overall Study||19
8329321|NCT01372462|20533894|P1|NOT COMPLETED|No Treatment Control||0
8329322|NCT01372462|20533894|P1|COMPLETED|No Treatment Control||15
8329323|NCT01372462|20533894|P1|STARTED|No Treatment Control||15
8329324|NCT01372462|20533894|P1|NOT COMPLETED|Oxygen Nasal Cannula||0
8329325|NCT01372462|20533894|P1|COMPLETED|Oxygen Nasal Cannula||15
8329326|NCT01372462|20533894|P1|STARTED|Oxygen Nasal Cannula||15
8329327|NCT01372462|20533894|P1|NOT COMPLETED|NIOV - Oxygen||0
8329328|NCT01372462|20533894|P1|COMPLETED|NIOV - Oxygen||15
8329329|NCT01372462|20533894|P1|STARTED|NIOV - Oxygen||15
8329330|NCT01372462|20533894|P1|NOT COMPLETED|NIOV - Room Air||0
8329331|NCT01372462|20533894|P1|COMPLETED|NIOV - Room Air||15
8329332|NCT01372462|20533894|P1|STARTED|NIOV - Room Air||15
8329333|NCT01372410|20533912|P8|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8329334|NCT01372410|20533913|P7|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8329335|NCT01372410|20533914|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||1
8329336|NCT01372410|20533915|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8329337|NCT01372410|20533916|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8329338|NCT01372410|20533917|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||1
8329339|NCT01372410|20533918|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8329340|NCT01372410|20533919|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
8329341|NCT01372410|20533912|P8|COMPLETED|Treatment Period 3 (7 Days)||18
8329342|NCT01372410|20533913|P7|COMPLETED|Treatment Period 3 (7 Days)||15
8329343|NCT01372410|20533914|P6|COMPLETED|Treatment Period 3 (7 Days)||18
8329344|NCT01372410|20533915|P5|COMPLETED|Treatment Period 3 (7 Days)||20
8329345|NCT01372410|20533916|P4|COMPLETED|Treatment Period 3 (7 Days)||22
8329346|NCT01372410|20533917|P3|COMPLETED|Treatment Period 3 (7 Days)||15
8329347|NCT01372410|20533918|P2|COMPLETED|Treatment Period 3 (7 Days)||18
8329348|NCT01372410|20533919|P1|COMPLETED|Treatment Period 3 (7 Days)||21
8329349|NCT01372410|20533912|P8|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
8329350|NCT01372410|20533913|P7|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
8329351|NCT01372410|20533914|P6|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
8329352|NCT01372410|20533915|P5|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
8329353|NCT01372410|20533916|P4|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
8329354|NCT01372410|20533917|P3|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
8329355|NCT01372410|20533918|P2|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
8329356|NCT01372410|20533919|P1|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
8329357|NCT01372410|20533912|P8|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
8329358|NCT01372410|20533913|P7|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
8329359|NCT01372410|20533914|P6|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8329360|NCT01372410|20533915|P5|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
8329361|NCT01372410|20533916|P4|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8329362|NCT01372410|20533917|P3|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8329363|NCT01372410|20533918|P2|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8329364|NCT01372410|20533919|P1|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
8329365|NCT01372410|20533912|P8|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
8329366|NCT01372410|20533913|P7|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
8329367|NCT01372410|20533914|P6|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
8329368|NCT01372410|20533915|P5|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
8329369|NCT01372410|20533916|P4|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
8329370|NCT01372410|20533917|P3|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
8329371|NCT01372410|20533918|P2|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
8329372|NCT01372410|20533919|P1|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
8329373|NCT01372410|20533912|P8|STARTED|Washout Period 2 (10-14 Days)||19
8329374|NCT01372410|20533913|P7|STARTED|Washout Period 2 (10-14 Days)||21
8329375|NCT01372410|20533914|P6|STARTED|Washout Period 2 (10-14 Days)||16
8329376|NCT01372410|20533915|P5|STARTED|Washout Period 2 (10-14 Days)||19
8329377|NCT01372410|20533916|P4|STARTED|Washout Period 2 (10-14 Days)||17
8329378|NCT01372410|20533917|P3|STARTED|Washout Period 2 (10-14 Days)||22
8329379|NCT01372410|20533918|P2|STARTED|Washout Period 2 (10-14 Days)||21
8329380|NCT01372410|20533919|P1|STARTED|Washout Period 2 (10-14 Days)||19
8329381|NCT01372410|20533912|P8|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329382|NCT01372410|20533913|P7|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329383|NCT01372410|20533914|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329384|NCT01372410|20533915|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329385|NCT01372410|20533916|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329386|NCT01372410|20533917|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329387|NCT01372410|20533918|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329388|NCT01372410|20533919|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
8329389|NCT01372410|20533912|P8|COMPLETED|Treatment Period 2 (7 Days)||19
8329390|NCT01372410|20533913|P7|COMPLETED|Treatment Period 2 (7 Days)||21
8329391|NCT01372410|20533914|P6|COMPLETED|Treatment Period 2 (7 Days)||16
8329392|NCT01372410|20533915|P5|COMPLETED|Treatment Period 2 (7 Days)||19
8329393|NCT01372410|20533916|P4|COMPLETED|Treatment Period 2 (7 Days)||17
8329394|NCT01372410|20533917|P3|COMPLETED|Treatment Period 2 (7 Days)||22
8329395|NCT01372410|20533918|P2|COMPLETED|Treatment Period 2 (7 Days)||21
8329396|NCT01372410|20533919|P1|COMPLETED|Treatment Period 2 (7 Days)||19
8329397|NCT01372410|20533912|P8|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
8329398|NCT01372410|20533913|P7|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
8329399|NCT01372410|20533914|P6|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
8329400|NCT01372410|20533915|P5|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
8329401|NCT01372410|20533916|P4|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
8329402|NCT01372410|20533917|P3|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
8329403|NCT01372410|20533918|P2|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
8329404|NCT01372410|20533919|P1|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
8329405|NCT01372410|20533912|P8|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
8329406|NCT01372410|20533913|P7|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8329407|NCT01372410|20533914|P6|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8329408|NCT01372410|20533915|P5|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8329409|NCT01372410|20533916|P4|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8329410|NCT01372410|20533917|P3|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8329411|NCT01372410|20533918|P2|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
8329412|NCT01372410|20533919|P1|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
8329413|NCT01372410|20533912|P8|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
8329414|NCT01372410|20533913|P7|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
8329415|NCT01372410|20533914|P6|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
8329416|NCT01372410|20533915|P5|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
8329417|NCT01372410|20533916|P4|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
8329418|NCT01372410|20533917|P3|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
8329419|NCT01372410|20533918|P2|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
8329420|NCT01372410|20533919|P1|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
8329421|NCT01372410|20533912|P8|STARTED|Washout Period 1 (10-14 Days)||19
8329422|NCT01372410|20533913|P7|STARTED|Washout Period 1 (10-14 Days)||20
8329423|NCT01372410|20533914|P6|STARTED|Washout Period 1 (10-14 Days)||21
8329424|NCT01372410|20533915|P5|STARTED|Washout Period 1 (10-14 Days)||19
8329425|NCT01372410|20533916|P4|STARTED|Washout Period 1 (10-14 Days)||20
8329426|NCT01372410|20533917|P3|STARTED|Washout Period 1 (10-14 Days)||19
8329427|NCT01372410|20533918|P2|STARTED|Washout Period 1 (10-14 Days)||19
8329428|NCT01372410|20533919|P1|STARTED|Washout Period 1 (10-14 Days)||19
8329429|NCT01372410|20533912|P8|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8329430|NCT01372410|20533913|P7|NOT COMPLETED|Treatment Period 1 (7 Days)||2
8329431|NCT01372410|20533914|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8329432|NCT01372410|20533915|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||2
8329433|NCT01372410|20533916|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8329434|NCT01372410|20533917|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
8329435|NCT01372410|20533918|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||2
8329436|NCT01372410|20533919|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||1
8329437|NCT01372410|20533912|P8|COMPLETED|Treatment Period 1 (7 Days)||19
8329438|NCT01372410|20533913|P7|COMPLETED|Treatment Period 1 (7 Days)||20
8329439|NCT01372410|20533914|P6|COMPLETED|Treatment Period 1 (7 Days)||21
8329440|NCT01372410|20533915|P5|COMPLETED|Treatment Period 1 (7 Days)||19
8329441|NCT01372410|20533916|P4|COMPLETED|Treatment Period 1 (7 Days)||20
8329442|NCT01372410|20533917|P3|COMPLETED|Treatment Period 1 (7 Days)||19
8329443|NCT01372410|20533918|P2|COMPLETED|Treatment Period 1 (7 Days)||19
8329444|NCT01372410|20533919|P1|COMPLETED|Treatment Period 1 (7 Days)||19
8329445|NCT01372410|20533912|P8|STARTED|Treatment Period 1 (7 Days)||19
8329446|NCT01372410|20533913|P7|STARTED|Treatment Period 1 (7 Days)||22
8329447|NCT01372410|20533914|P6|STARTED|Treatment Period 1 (7 Days)||21
8329448|NCT01372410|20533915|P5|STARTED|Treatment Period 1 (7 Days)||21
8329449|NCT01372410|20533916|P4|STARTED|Treatment Period 1 (7 Days)||20
8329450|NCT01372410|20533917|P3|STARTED|Treatment Period 1 (7 Days)||19
8329451|NCT01372410|20533918|P2|STARTED|Treatment Period 1 (7 Days)||21
8329452|NCT01372410|20533919|P1|STARTED|Treatment Period 1 (7 Days)||20
8329453|NCT01372384|20533956|P1|NOT COMPLETED|Overall Study||3
8329454|NCT01372384|20533956|P1|COMPLETED|Overall Study||3
8329455|NCT01372384|20533956|P1|STARTED|Overall Study||6
8329456|NCT01372254|20533965|P2|NOT COMPLETED|Overall Study||3
8329457|NCT01372254|20533966|P1|NOT COMPLETED|Overall Study||4
8329458|NCT01372254|20533965|P2|COMPLETED|Overall Study||46
8329459|NCT01372254|20533966|P1|COMPLETED|Overall Study||43
8329460|NCT01372254|20533965|P2|STARTED|Overall Study||49
8329461|NCT01372254|20533966|P1|STARTED|Overall Study||47
8329462|NCT01372202|20533975|P3|NOT COMPLETED|Overall Study||0
8329463|NCT01372202|20533976|P2|NOT COMPLETED|Overall Study||0
8329464|NCT01372202|20533977|P1|NOT COMPLETED|Overall Study||0
8329465|NCT01372202|20533975|P3|COMPLETED|Overall Study||9
8329466|NCT01372202|20533976|P2|COMPLETED|Overall Study||9
8329467|NCT01372202|20533977|P1|COMPLETED|Overall Study||13
8329468|NCT01372202|20533975|P3|STARTED|Overall Study||9
8329469|NCT01372202|20533976|P2|STARTED|Overall Study||9
8329470|NCT01372202|20533977|P1|STARTED|Overall Study||13
8329471|NCT01372150|20533997|P3|NOT COMPLETED|Overall Study||16
8329472|NCT01372150|20533998|P2|NOT COMPLETED|Overall Study||14
8329473|NCT01372150|20533999|P1|NOT COMPLETED|Overall Study||13
8329474|NCT01372150|20533997|P3|COMPLETED|Overall Study||99
8329475|NCT01372150|20533998|P2|COMPLETED|Overall Study||99
8329476|NCT01372150|20533999|P1|COMPLETED|Overall Study||99
8329477|NCT01372150|20533997|P3|Treated|Overall Study||115
8329478|NCT01372150|20533998|P2|Treated|Overall Study||112
8329479|NCT01372150|20533999|P1|Treated|Overall Study||112
8329480|NCT01372150|20533997|P3|STARTED|Overall Study||115
8329481|NCT01372150|20533998|P2|STARTED|Overall Study||113
8329482|NCT01372150|20533999|P1|STARTED|Overall Study||112
8329483|NCT01372085|20534026|P10|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329484|NCT01372085|20534027|P9|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329485|NCT01372085|20534028|P8|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329486|NCT01372085|20534029|P7|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329487|NCT01372085|20534030|P6|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329488|NCT01372085|20534031|P5|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329489|NCT01372085|20534032|P4|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329490|NCT01372085|20534033|P3|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329491|NCT01372085|20534034|P2|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329492|NCT01372085|20534035|P1|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
8329493|NCT01372085|20534026|P10|COMPLETED|Forth Intervention (Period 4a/4b)||1
8329494|NCT01372085|20534027|P9|COMPLETED|Forth Intervention (Period 4a/4b)||1
8329495|NCT01372085|20534028|P8|COMPLETED|Forth Intervention (Period 4a/4b)||1
8329496|NCT01372085|20534029|P7|COMPLETED|Forth Intervention (Period 4a/4b)||3
8329497|NCT01372085|20534030|P6|COMPLETED|Forth Intervention (Period 4a/4b)||5
8329498|NCT01372085|20534031|P5|COMPLETED|Forth Intervention (Period 4a/4b)||2
8329499|NCT01372085|20534032|P4|COMPLETED|Forth Intervention (Period 4a/4b)||1
8329500|NCT01372085|20534033|P3|COMPLETED|Forth Intervention (Period 4a/4b)||2
8329501|NCT01372085|20534034|P2|COMPLETED|Forth Intervention (Period 4a/4b)||0
8329502|NCT01372085|20534035|P1|COMPLETED|Forth Intervention (Period 4a/4b)||0
8329503|NCT01372085|20534026|P10|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1
8329504|NCT01372085|20534027|P9|STARTED|Forth Intervention (Period 4a/4b)||1
8329505|NCT01372085|20534028|P8|STARTED|Forth Intervention (Period 4a/4b)||1
8329506|NCT01372085|20534029|P7|STARTED|Forth Intervention (Period 4a/4b)||3
8329507|NCT01372085|20534030|P6|STARTED|Forth Intervention (Period 4a/4b)||5
8329508|NCT01372085|20534031|P5|STARTED|Forth Intervention (Period 4a/4b)||2
8329509|NCT01372085|20534032|P4|STARTED|Forth Intervention (Period 4a/4b)||1
8329510|NCT01372085|20534033|P3|STARTED|Forth Intervention (Period 4a/4b)||2
8329511|NCT01372085|20534034|P2|STARTED|Forth Intervention (Period 4a/4b)||0
8329512|NCT01372085|20534035|P1|STARTED|Forth Intervention (Period 4a/4b)||0
8329513|NCT01372085|20534026|P10|NOT COMPLETED|Washout Period 3||0
8329514|NCT01372085|20534027|P9|NOT COMPLETED|Washout Period 3||0
8329515|NCT01372085|20534028|P8|NOT COMPLETED|Washout Period 3||0
8329516|NCT01372085|20534029|P7|NOT COMPLETED|Washout Period 3||0
8329517|NCT01372085|20534030|P6|NOT COMPLETED|Washout Period 3||2
8329518|NCT01372085|20534031|P5|NOT COMPLETED|Washout Period 3||0
8329519|NCT01372085|20534032|P4|NOT COMPLETED|Washout Period 3||0
8329520|NCT01372085|20534033|P3|NOT COMPLETED|Washout Period 3||0
8329521|NCT01372085|20534034|P2|NOT COMPLETED|Washout Period 3||0
8329522|NCT01372085|20534035|P1|NOT COMPLETED|Washout Period 3||0
8329523|NCT01372085|20534026|P10|COMPLETED|Washout Period 3||0
8329524|NCT01372085|20534027|P9|COMPLETED|Washout Period 3||1
8329525|NCT01372085|20534028|P8|COMPLETED|Washout Period 3||1
8329526|NCT01372085|20534029|P7|COMPLETED|Washout Period 3||3
8329527|NCT01372085|20534030|P6|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5
8329528|NCT01372085|20534031|P5|COMPLETED|Washout Period 3||2
8329529|NCT01372085|20534032|P4|COMPLETED|Washout Period 3||1
8329530|NCT01372085|20534033|P3|COMPLETED|Washout Period 3||2
8329531|NCT01372085|20534034|P2|COMPLETED|Washout Period 3||0
8329532|NCT01372085|20534035|P1|COMPLETED|Washout Period 3||0
8329533|NCT01372085|20534026|P10|STARTED|Washout Period 3||0
8329534|NCT01372085|20534027|P9|STARTED|Washout Period 3||1
8329535|NCT01372085|20534028|P8|STARTED|Washout Period 3||1
8329536|NCT01372085|20534029|P7|STARTED|Washout Period 3||3
8329537|NCT01372085|20534030|P6|STARTED|Washout Period 3||7
8329538|NCT01372085|20534031|P5|STARTED|Washout Period 3||2
8329539|NCT01372085|20534032|P4|STARTED|Washout Period 3||1
8329540|NCT01372085|20534033|P3|STARTED|Washout Period 3||2
8329541|NCT01372085|20534034|P2|STARTED|Washout Period 3||0
8329542|NCT01372085|20534035|P1|STARTED|Washout Period 3||0
8329543|NCT01372085|20534026|P10|NOT COMPLETED|Third Intervention (Period 3)||0
8329544|NCT01372085|20534027|P9|NOT COMPLETED|Third Intervention (Period 3)||0
8329545|NCT01372085|20534028|P8|NOT COMPLETED|Third Intervention (Period 3)||0
8329546|NCT01372085|20534029|P7|NOT COMPLETED|Third Intervention (Period 3)||0
8329547|NCT01372085|20534030|P6|NOT COMPLETED|Third Intervention (Period 3)||0
8329548|NCT01372085|20534031|P5|NOT COMPLETED|Third Intervention (Period 3)||0
8329549|NCT01372085|20534032|P4|NOT COMPLETED|Third Intervention (Period 3)||0
8329550|NCT01372085|20534033|P3|NOT COMPLETED|Third Intervention (Period 3)||0
8329551|NCT01372085|20534034|P2|NOT COMPLETED|Third Intervention (Period 3)||0
8329552|NCT01372085|20534035|P1|NOT COMPLETED|Third Intervention (Period 3)||0
8329553|NCT01372085|20534026|P10|COMPLETED|Third Intervention (Period 3)||0
8329554|NCT01372085|20534027|P9|COMPLETED|Third Intervention (Period 3)||1
8329555|NCT01372085|20534028|P8|COMPLETED|Third Intervention (Period 3)||1
8329556|NCT01372085|20534029|P7|COMPLETED|Third Intervention (Period 3)||3
8329557|NCT01372085|20534030|P6|COMPLETED|Third Intervention (Period 3)||7
8329558|NCT01372085|20534031|P5|COMPLETED|Third Intervention (Period 3)||2
8329559|NCT01372085|20534032|P4|COMPLETED|Third Intervention (Period 3)||1
8329560|NCT01372085|20534033|P3|COMPLETED|Third Intervention (Period 3)||2
8329561|NCT01372085|20534034|P2|COMPLETED|Third Intervention (Period 3)||0
8329562|NCT01372085|20534035|P1|COMPLETED|Third Intervention (Period 3)||0
8329563|NCT01372085|20534026|P10|STARTED|Third Intervention (Period 3)||0
8329564|NCT01372085|20534027|P9|STARTED|Third Intervention (Period 3)||1
8329565|NCT01372085|20534028|P8|STARTED|Third Intervention (Period 3)||1
8329566|NCT01372085|20534029|P7|STARTED|Third Intervention (Period 3)||3
8329567|NCT01372085|20534030|P6|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7
8329568|NCT01372085|20534031|P5|STARTED|Third Intervention (Period 3)||2
8329569|NCT01372085|20534032|P4|STARTED|Third Intervention (Period 3)||1
8329570|NCT01372085|20534033|P3|STARTED|Third Intervention (Period 3)||2
8329571|NCT01372085|20534034|P2|STARTED|Third Intervention (Period 3)||0
8329572|NCT01372085|20534035|P1|STARTED|Third Intervention (Period 3)||0
8329573|NCT01372085|20534026|P10|NOT COMPLETED|Washout Period 2||0
8329574|NCT01372085|20534027|P9|NOT COMPLETED|Washout Period 2||0
8329575|NCT01372085|20534028|P8|NOT COMPLETED|Washout Period 2||0
8329576|NCT01372085|20534029|P7|NOT COMPLETED|Washout Period 2||0
8329577|NCT01372085|20534030|P6|NOT COMPLETED|Washout Period 2||0
8329578|NCT01372085|20534031|P5|NOT COMPLETED|Washout Period 2||1
8329579|NCT01372085|20534032|P4|NOT COMPLETED|Washout Period 2||0
8329580|NCT01372085|20534033|P3|NOT COMPLETED|Washout Period 2||0
8329581|NCT01372085|20534034|P2|NOT COMPLETED|Washout Period 2||0
8329582|NCT01372085|20534035|P1|NOT COMPLETED|Washout Period 2||0
8329583|NCT01372085|20534026|P10|COMPLETED|Washout Period 2||0
8329584|NCT01372085|20534027|P9|COMPLETED|Washout Period 2||1
8329585|NCT01372085|20534028|P8|COMPLETED|Washout Period 2||1
8329586|NCT01372085|20534029|P7|COMPLETED|Washout Period 2||3
8329587|NCT01372085|20534030|P6|COMPLETED|Washout Period 2||5
8329588|NCT01372085|20534031|P5|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2
8329589|NCT01372085|20534032|P4|COMPLETED|Washout Period 2||1
8329590|NCT01372085|20534033|P3|COMPLETED|Washout Period 2||2
8329591|NCT01372085|20534034|P2|COMPLETED|Washout Period 2||0
8329592|NCT01372085|20534035|P1|COMPLETED|Washout Period 2||0
8329593|NCT01372085|20534026|P10|STARTED|Washout Period 2||0
8329594|NCT01372085|20534027|P9|STARTED|Washout Period 2||1
8329595|NCT01372085|20534028|P8|STARTED|Washout Period 2||1
8329596|NCT01372085|20534029|P7|STARTED|Washout Period 2||3
8329597|NCT01372085|20534030|P6|STARTED|Washout Period 2||5
8329598|NCT01372085|20534031|P5|STARTED|Washout Period 2||3
8329599|NCT01372085|20534032|P4|STARTED|Washout Period 2||1
8329600|NCT01372085|20534033|P3|STARTED|Washout Period 2||2
8329601|NCT01372085|20534034|P2|STARTED|Washout Period 2||0
8329602|NCT01372085|20534035|P1|STARTED|Washout Period 2||0
8329603|NCT01372085|20534026|P10|NOT COMPLETED|Second Intervention (Period 2)||0
8329604|NCT01372085|20534027|P9|NOT COMPLETED|Second Intervention (Period 2)||0
8329605|NCT01372085|20534028|P8|NOT COMPLETED|Second Intervention (Period 2)||0
8329606|NCT01372085|20534029|P7|NOT COMPLETED|Second Intervention (Period 2)||0
8329607|NCT01372085|20534030|P6|NOT COMPLETED|Second Intervention (Period 2)||0
8329608|NCT01372085|20534031|P5|NOT COMPLETED|Second Intervention (Period 2)||0
8329609|NCT01372085|20534032|P4|NOT COMPLETED|Second Intervention (Period 2)||0
8329610|NCT01372085|20534033|P3|NOT COMPLETED|Second Intervention (Period 2)||0
8329611|NCT01372085|20534034|P2|NOT COMPLETED|Second Intervention (Period 2)||0
8329612|NCT01372085|20534035|P1|NOT COMPLETED|Second Intervention (Period 2)||0
8329613|NCT01372085|20534026|P10|COMPLETED|Second Intervention (Period 2)||0
8329614|NCT01372085|20534027|P9|COMPLETED|Second Intervention (Period 2)||1
8329615|NCT01372085|20534028|P8|COMPLETED|Second Intervention (Period 2)||1
8329616|NCT01372085|20534029|P7|COMPLETED|Second Intervention (Period 2)||3
8329617|NCT01372085|20534030|P6|COMPLETED|Second Intervention (Period 2)||5
8329618|NCT01372085|20534031|P5|COMPLETED|Second Intervention (Period 2)||3
8329619|NCT01372085|20534032|P4|COMPLETED|Second Intervention (Period 2)||1
8329620|NCT01372085|20534033|P3|COMPLETED|Second Intervention (Period 2)||2
8329621|NCT01372085|20534034|P2|COMPLETED|Second Intervention (Period 2)||0
8329622|NCT01372085|20534035|P1|COMPLETED|Second Intervention (Period 2)||0
8329623|NCT01372085|20534026|P10|STARTED|Second Intervention (Period 2)||0
8329624|NCT01372085|20534027|P9|STARTED|Second Intervention (Period 2)||1
8329625|NCT01372085|20534028|P8|STARTED|Second Intervention (Period 2)||1
8329626|NCT01372085|20534029|P7|STARTED|Second Intervention (Period 2)||3
8329627|NCT01372085|20534030|P6|STARTED|Second Intervention (Period 2)||5
8329628|NCT01372085|20534031|P5|STARTED|Second Intervention (Period 2)||3
8329629|NCT01372085|20534032|P4|STARTED|Second Intervention (Period 2)||1
8329630|NCT01372085|20534033|P3|STARTED|Second Intervention (Period 2)||2
8329631|NCT01372085|20534034|P2|STARTED|Second Intervention (Period 2)||0
8329632|NCT01372085|20534035|P1|STARTED|Second Intervention (Period 2)||0
8329633|NCT01372085|20534026|P10|NOT COMPLETED|Washout Period 1||0
8329634|NCT01372085|20534027|P9|NOT COMPLETED|Washout Period 1||0
8329635|NCT01372085|20534028|P8|NOT COMPLETED|Washout Period 1||0
8329636|NCT01372085|20534029|P7|NOT COMPLETED|Washout Period 1||0
8329637|NCT01372085|20534030|P6|NOT COMPLETED|Washout Period 1||0
8329638|NCT01372085|20534031|P5|NOT COMPLETED|Washout Period 1||0
8329639|NCT01372085|20534032|P4|NOT COMPLETED|Washout Period 1||0
8329640|NCT01372085|20534033|P3|NOT COMPLETED|Washout Period 1||0
8329641|NCT01372085|20534034|P2|NOT COMPLETED|Washout Period 1||0
8329642|NCT01372085|20534035|P1|NOT COMPLETED|Washout Period 1||0
8329643|NCT01372085|20534026|P10|COMPLETED|Washout Period 1||0
8329644|NCT01372085|20534027|P9|COMPLETED|Washout Period 1||1
8329645|NCT01372085|20534028|P8|COMPLETED|Washout Period 1||1
8329646|NCT01372085|20534029|P7|COMPLETED|Washout Period 1||3
8329647|NCT01372085|20534030|P6|COMPLETED|Washout Period 1||5
8329648|NCT01372085|20534031|P5|COMPLETED|Washout Period 1||3
8329649|NCT01372085|20534032|P4|COMPLETED|Washout Period 1||1
8329650|NCT01372085|20534033|P3|COMPLETED|Washout Period 1||2
8329651|NCT01372085|20534034|P2|COMPLETED|Washout Period 1||0
8329652|NCT01372085|20534035|P1|COMPLETED|Washout Period 1||0
8329653|NCT01372085|20534026|P10|STARTED|Washout Period 1||0
8329654|NCT01372085|20534027|P9|STARTED|Washout Period 1||1
8329655|NCT01372085|20534028|P8|STARTED|Washout Period 1||1
8329656|NCT01372085|20534029|P7|STARTED|Washout Period 1||3
8329657|NCT01372085|20534030|P6|STARTED|Washout Period 1||5
8329658|NCT01372085|20534031|P5|STARTED|Washout Period 1||3
8329659|NCT01372085|20534032|P4|STARTED|Washout Period 1||1
8329660|NCT01372085|20534033|P3|STARTED|Washout Period 1||2
8329661|NCT01372085|20534034|P2|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
8329662|NCT01372085|20534035|P1|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
8329663|NCT01372085|20534026|P10|NOT COMPLETED|First Intervention (Period 1)||0
8329664|NCT01372085|20534027|P9|NOT COMPLETED|First Intervention (Period 1)||0
8329665|NCT01372085|20534028|P8|NOT COMPLETED|First Intervention (Period 1)||0
8329666|NCT01372085|20534029|P7|NOT COMPLETED|First Intervention (Period 1)||0
8329667|NCT01372085|20534030|P6|NOT COMPLETED|First Intervention (Period 1)||0
8329668|NCT01372085|20534031|P5|NOT COMPLETED|First Intervention (Period 1)||0
8329669|NCT01372085|20534032|P4|NOT COMPLETED|First Intervention (Period 1)||0
8329670|NCT01372085|20534033|P3|NOT COMPLETED|First Intervention (Period 1)||0
8329671|NCT01372085|20534034|P2|NOT COMPLETED|First Intervention (Period 1)||0
8329672|NCT01372085|20534035|P1|NOT COMPLETED|First Intervention (Period 1)||0
8329673|NCT01372085|20534026|P10|COMPLETED|First Intervention (Period 1)||0
8329674|NCT01372085|20534027|P9|COMPLETED|First Intervention (Period 1)||1
8329675|NCT01372085|20534028|P8|COMPLETED|First Intervention (Period 1)||1
8329676|NCT01372085|20534029|P7|COMPLETED|First Intervention (Period 1)||3
8329677|NCT01372085|20534030|P6|COMPLETED|First Intervention (Period 1)||5
8329678|NCT01372085|20534031|P5|COMPLETED|First Intervention (Period 1)||3
8329679|NCT01372085|20534032|P4|COMPLETED|First Intervention (Period 1)||1
8329680|NCT01372085|20534033|P3|COMPLETED|First Intervention (Period 1)||2
8329681|NCT01372085|20534034|P2|COMPLETED|First Intervention (Period 1)||2
8329682|NCT01372085|20534035|P1|COMPLETED|First Intervention (Period 1)||8
8329683|NCT01372085|20534026|P10|STARTED|First Intervention (Period 1)||0
8329684|NCT01372085|20534027|P9|STARTED|First Intervention (Period 1)||1
8329685|NCT01372085|20534028|P8|STARTED|First Intervention (Period 1)||1
8329686|NCT01372085|20534029|P7|STARTED|First Intervention (Period 1)||3
8329687|NCT01372085|20534030|P6|STARTED|First Intervention (Period 1)||5
8329688|NCT01372085|20534031|P5|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3
8329689|NCT01372085|20534032|P4|STARTED|First Intervention (Period 1)||1
8329690|NCT01372085|20534033|P3|STARTED|First Intervention (Period 1)||2
8329691|NCT01372085|20534034|P2|STARTED|First Intervention (Period 1)||2
8329692|NCT01372085|20534035|P1|STARTED|First Intervention (Period 1)||8
8329693|NCT01371994|20534067|P2|NOT COMPLETED|Overall Study||42
8329694|NCT01371994|20534068|P1|NOT COMPLETED|Overall Study||57
8329695|NCT01371994|20534067|P2|COMPLETED|Overall Study||278
8329696|NCT01371994|20534068|P1|COMPLETED|Overall Study||263
8329697|NCT01371994|20534067|P2|Received Treatment|Overall Study||313
8329698|NCT01371994|20534068|P1|Received Treatment|Overall Study||310
8329699|NCT01371994|20534067|P2|STARTED|Overall Study||320
8329700|NCT01371994|20534068|P1|STARTED|Overall Study||320
8329719|NCT01371877|20534180|P2|NOT COMPLETED|Overall Study||4
8329720|NCT01371877|20534181|P1|NOT COMPLETED|Overall Study||0
8329721|NCT01371877|20534180|P2|COMPLETED|Overall Study||17
8329722|NCT01371877|20534181|P1|COMPLETED|Overall Study||21
8329723|NCT01371877|20534180|P2|STARTED|Overall Study||21
8329724|NCT01371877|20534181|P1|STARTED|Overall Study||21
8329725|NCT01371851|20534193|P2|NOT COMPLETED|Overall Study||9
8329726|NCT01371851|20534194|P1|NOT COMPLETED|Overall Study||8
8329727|NCT01371851|20534193|P2|COMPLETED|Overall Study||2
8329728|NCT01371851|20534194|P1|COMPLETED|Overall Study||3
8329729|NCT01371851|20534193|P2|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
8329730|NCT01371851|20534194|P1|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
8329731|NCT01371838|20534202|P2|NOT COMPLETED|Overall Study||66
8329732|NCT01371838|20534203|P1|NOT COMPLETED|Overall Study||49
8329733|NCT01371838|20534202|P2|COMPLETED|Overall Study||317
8329734|NCT01371838|20534203|P1|COMPLETED|Overall Study||332
8329735|NCT01371838|20534202|P2|STARTED|Overall Study||383
8329736|NCT01371838|20534203|P1|STARTED|Overall Study||381
8329737|NCT01371825|20534239|P1|NOT COMPLETED|Overall Study||4
8329738|NCT01371825|20534239|P1|COMPLETED|Overall Study||5
8329739|NCT01371825|20534239|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
8329740|NCT01371825|20534239|P1|STARTED|Overall Study||9
8329741|NCT01371786|20534252|P2|NOT COMPLETED|Overall Study||0
8329742|NCT01371786|20534253|P1|NOT COMPLETED|Overall Study||0
8329743|NCT01371786|20534252|P2|COMPLETED|Overall Study||7
8329744|NCT01371786|20534253|P1|COMPLETED|Overall Study||7
8329745|NCT01371786|20534252|P2|STARTED|Overall Study||7
8329746|NCT01371786|20534253|P1|STARTED|Overall Study||7
8329765|NCT01371734|20534343|P3|NOT COMPLETED|Overall Study||17
8329766|NCT01371734|20534344|P2|NOT COMPLETED|Overall Study||19
8329767|NCT01371734|20534345|P1|NOT COMPLETED|Overall Study||23
8329768|NCT01371734|20534343|P3|COMPLETED|Overall Study||104
8329769|NCT01371734|20534344|P2|COMPLETED|Overall Study||103
8329770|NCT01371734|20534345|P1|COMPLETED|Overall Study||97
8329771|NCT01371734|20534343|P3|STARTED|Overall Study||121
8329772|NCT01371734|20534344|P2|STARTED|Overall Study||122
8329773|NCT01371734|20534345|P1|STARTED|Overall Study||120
8329774|NCT01371721|20534365|P3|NOT COMPLETED|Overall Study||30
8329775|NCT01371721|20534366|P2|NOT COMPLETED|Overall Study||24
8329776|NCT01371721|20534367|P1|NOT COMPLETED|Overall Study||29
8329777|NCT01371721|20534365|P3|COMPLETED|Overall Study||62
8329778|NCT01371721|20534366|P2|COMPLETED|Overall Study||65
8329779|NCT01371721|20534367|P1|COMPLETED|Overall Study||59
8329780|NCT01371721|20534365|P3|Treated|Overall Study||92
8329781|NCT01371721|20534366|P2|Treated|Overall Study||89
8329782|NCT01371721|20534367|P1|Treated|Overall Study||87
8329783|NCT01371721|20534365|P3|STARTED|Overall Study||92
8329784|NCT01371721|20534366|P2|STARTED|Overall Study||89
8329785|NCT01371721|20534367|P1|STARTED|Overall Study||88
8329786|NCT01371708|20534400|P3|NOT COMPLETED|Overall Study||39
8329787|NCT01371708|20534401|P2|NOT COMPLETED|Overall Study||30
8329788|NCT01371708|20534402|P1|NOT COMPLETED|Overall Study||26
8329789|NCT01371708|20534400|P3|COMPLETED|Overall Study||59
8329790|NCT01371708|20534401|P2|COMPLETED|Overall Study||63
8329791|NCT01371708|20534402|P1|COMPLETED|Overall Study||66
8329792|NCT01371708|20534400|P3|Received Treatment|Overall Study||97
8329793|NCT01371708|20534401|P2|Received Treatment|Overall Study||93
8329794|NCT01371708|20534402|P1|Received Treatment|Overall Study||91
8329795|NCT01371708|20534400|P3|STARTED|Overall Study||98
8329796|NCT01371708|20534401|P2|STARTED|Overall Study||93
8329797|NCT01371708|20534402|P1|STARTED|Overall Study||92
8329798|NCT01371656|20534434|P2|NOT COMPLETED|Overall Study||14
8329799|NCT01371656|20534435|P1|NOT COMPLETED|Overall Study||64
8329800|NCT01371656|20534434|P2|COMPLETED|Overall Study||296
8329801|NCT01371656|20534435|P1|COMPLETED|Overall Study||250
8329802|NCT01371656|20534434|P2|STARTED|Overall Study||310
8329803|NCT01371656|20534435|P1|STARTED|Overall Study||314
8329804|NCT01371643|20534455|P2|NOT COMPLETED|Overall Study||0
8329805|NCT01371643|20534456|P1|NOT COMPLETED|Overall Study||3
8329806|NCT01371643|20534455|P2|COMPLETED|Overall Study||26
8329807|NCT01371643|20534456|P1|COMPLETED|Overall Study||12
8329808|NCT01371643|20534455|P2|STARTED|Overall Study||26
8329809|NCT01371643|20534456|P1|STARTED|Overall Study||15
8329810|NCT01371565|20534466|P1|NOT COMPLETED|Overall Study||3
8329811|NCT01371565|20534466|P1|COMPLETED|Overall Study||1
8329812|NCT01371565|20534466|P1|STARTED|Overall Study||4
8329813|NCT01371552|20534470|P6|NOT COMPLETED|Part 2, One Week||0
8329814|NCT01371552|20534471|P5|NOT COMPLETED|Part 2, One Week||0
8329815|NCT01371552|20534472|P4|NOT COMPLETED|Part 2, One Week||0
8329816|NCT01371552|20534473|P3|NOT COMPLETED|Part 2, One Week||0
8329817|NCT01371552|20534474|P2|NOT COMPLETED|Part 2, One Week||0
8329818|NCT01371552|20534475|P1|NOT COMPLETED|Part 2, One Week||0
8329819|NCT01371552|20534470|P6|COMPLETED|Part 2, One Week||18
8329820|NCT01371552|20534471|P5|COMPLETED|Part 2, One Week||15
8329821|NCT01371552|20534472|P4|COMPLETED|Part 2, One Week||20
8329822|NCT01371552|20534473|P3|COMPLETED|Part 2, One Week||18
8329823|NCT01371552|20534474|P2|COMPLETED|Part 2, One Week||17
8329824|NCT01371552|20534475|P1|COMPLETED|Part 2, One Week||18
8329825|NCT01371552|20534470|P6|STARTED|Part 2, One Week||18
8329826|NCT01371552|20534471|P5|STARTED|Part 2, One Week||15
8329827|NCT01371552|20534472|P4|STARTED|Part 2, One Week||20
8329828|NCT01371552|20534473|P3|STARTED|Part 2, One Week||18
8329829|NCT01371552|20534474|P2|STARTED|Part 2, One Week||17
8329830|NCT01371552|20534475|P1|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
8329831|NCT01371552|20534470|P6|NOT COMPLETED|Part 1, Third 3 Days||1
8329832|NCT01371552|20534471|P5|NOT COMPLETED|Part 1, Third 3 Days||1
8329833|NCT01371552|20534472|P4|NOT COMPLETED|Part 1, Third 3 Days||0
8329834|NCT01371552|20534473|P3|NOT COMPLETED|Part 1, Third 3 Days||0
8329835|NCT01371552|20534474|P2|NOT COMPLETED|Part 1, Third 3 Days||0
8329836|NCT01371552|20534475|P1|NOT COMPLETED|Part 1, Third 3 Days||0
8329837|NCT01371552|20534470|P6|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
8329838|NCT01371552|20534471|P5|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
8329839|NCT01371552|20534472|P4|COMPLETED|Part 1, Third 3 Days||20
8329840|NCT01371552|20534473|P3|COMPLETED|Part 1, Third 3 Days||18
8329841|NCT01371552|20534474|P2|COMPLETED|Part 1, Third 3 Days||17
8329842|NCT01371552|20534475|P1|COMPLETED|Part 1, Third 3 Days||19
8329843|NCT01371552|20534470|P6|STARTED|Part 1, Third 3 Days||18
8329844|NCT01371552|20534471|P5|STARTED|Part 1, Third 3 Days||15
8329845|NCT01371552|20534472|P4|STARTED|Part 1, Third 3 Days||20
8329846|NCT01371552|20534473|P3|STARTED|Part 1, Third 3 Days||18
8329847|NCT01371552|20534474|P2|STARTED|Part 1, Third 3 Days||17
8329848|NCT01371552|20534475|P1|STARTED|Part 1, Third 3 Days||19
8329849|NCT01371552|20534470|P6|NOT COMPLETED|Part 1, Second 3 Days||0
8329850|NCT01371552|20534471|P5|NOT COMPLETED|Part 1, Second 3 Days||0
8329851|NCT01371552|20534472|P4|NOT COMPLETED|Part 1, Second 3 Days||0
8329852|NCT01371552|20534473|P3|NOT COMPLETED|Part 1, Second 3 Days||0
8329853|NCT01371552|20534474|P2|NOT COMPLETED|Part 1, Second 3 Days||0
8329854|NCT01371552|20534475|P1|NOT COMPLETED|Part 1, Second 3 Days||1
8329855|NCT01371552|20534470|P6|COMPLETED|Part 1, Second 3 Days||18
8329856|NCT01371552|20534471|P5|COMPLETED|Part 1, Second 3 Days||15
8329857|NCT01371552|20534472|P4|COMPLETED|Part 1, Second 3 Days||20
8329858|NCT01371552|20534473|P3|COMPLETED|Part 1, Second 3 Days||18
8329859|NCT01371552|20534474|P2|COMPLETED|Part 1, Second 3 Days||17
8329860|NCT01371552|20534475|P1|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
8329861|NCT01371552|20534470|P6|STARTED|Part 1, Second 3 Days||18
8329862|NCT01371552|20534471|P5|STARTED|Part 1, Second 3 Days||15
8329863|NCT01371552|20534472|P4|STARTED|Part 1, Second 3 Days||20
8329864|NCT01371552|20534473|P3|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
8329865|NCT01371552|20534474|P2|STARTED|Part 1, Second 3 Days||17
8329866|NCT01371552|20534475|P1|STARTED|Part 1, Second 3 Days||19
8329867|NCT01371552|20534470|P6|NOT COMPLETED|Part 1, First 3 Days||0
8329868|NCT01371552|20534471|P5|NOT COMPLETED|Part 1, First 3 Days||0
8329869|NCT01371552|20534472|P4|NOT COMPLETED|Part 1, First 3 Days||0
8329870|NCT01371552|20534473|P3|NOT COMPLETED|Part 1, First 3 Days||1
8329871|NCT01371552|20534474|P2|NOT COMPLETED|Part 1, First 3 Days||0
8329872|NCT01371552|20534475|P1|NOT COMPLETED|Part 1, First 3 Days||0
8329873|NCT01371552|20534470|P6|COMPLETED|Part 1, First 3 Days||18
8329874|NCT01371552|20534471|P5|COMPLETED|Part 1, First 3 Days||15
8329875|NCT01371552|20534472|P4|COMPLETED|Part 1, First 3 Days||20
8329876|NCT01371552|20534473|P3|COMPLETED|Part 1, First 3 Days||19
8329877|NCT01371552|20534474|P2|COMPLETED|Part 1, First 3 Days||17
8329878|NCT01371552|20534475|P1|COMPLETED|Part 1, First 3 Days||19
8329879|NCT01371552|20534470|P6|STARTED|Part 1, First 3 Days||18
8329880|NCT01371552|20534471|P5|STARTED|Part 1, First 3 Days||15
8329881|NCT01371552|20534472|P4|STARTED|Part 1, First 3 Days||20
8329882|NCT01371552|20534473|P3|STARTED|Part 1, First 3 Days||20
8329883|NCT01371552|20534474|P2|STARTED|Part 1, First 3 Days||17
8329884|NCT01371552|20534475|P1|STARTED|Part 1, First 3 Days||19
8329885|NCT01371539|20534502|P2|NOT COMPLETED|Period Two: One Week||3
8329886|NCT01371539|20534503|P1|NOT COMPLETED|Period Two: One Week||0
8329887|NCT01371539|20534502|P2|COMPLETED|Period Two: One Week||47
8329888|NCT01371539|20534503|P1|COMPLETED|Period Two: One Week||53
8329889|NCT01371539|20534502|P2|STARTED|Period Two: One Week||50
8329890|NCT01371539|20534503|P1|STARTED|Period Two: One Week||53
8329891|NCT01371539|20534502|P2|NOT COMPLETED|Period One: One Week||1
8329892|NCT01371539|20534503|P1|NOT COMPLETED|Period One: One Week||0
8329893|NCT01371539|20534502|P2|COMPLETED|Period One: One Week||50
8329894|NCT01371539|20534503|P1|COMPLETED|Period One: One Week||53
8329895|NCT01371539|20534502|P2|STARTED|Period One: One Week||51
8329896|NCT01371539|20534503|P1|STARTED|Period One: One Week||53
8329897|NCT01371305|20534517|P6|NOT COMPLETED|Overall Study||2
8329898|NCT01371305|20534518|P5|NOT COMPLETED|Overall Study||4
8329899|NCT01371305|20534519|P4|NOT COMPLETED|Overall Study||2
8329900|NCT01371305|20534520|P3|NOT COMPLETED|Overall Study||0
8329901|NCT01371305|20534521|P2|NOT COMPLETED|Overall Study||0
8329902|NCT01371305|20534522|P1|NOT COMPLETED|Overall Study||0
8329903|NCT01371305|20534517|P6|COMPLETED|Overall Study||8
8329904|NCT01371305|20534518|P5|COMPLETED|Overall Study||2
8329905|NCT01371305|20534519|P4|COMPLETED|Overall Study||5
8329906|NCT01371305|20534520|P3|COMPLETED|Overall Study||6
8329907|NCT01371305|20534521|P2|COMPLETED|Overall Study||6
8329908|NCT01371305|20534522|P1|COMPLETED|Overall Study||6
8329909|NCT01371305|20534517|P6|STARTED|Overall Study||10
8329910|NCT01371305|20534518|P5|STARTED|Overall Study||6
8329911|NCT01371305|20534519|P4|STARTED|Overall Study||7
8329912|NCT01371305|20534520|P3|STARTED|Overall Study||6
8329913|NCT01371305|20534521|P2|STARTED|Overall Study||6
8329914|NCT01371305|20534522|P1|STARTED|Overall Study||6
8329915|NCT01371110|20534595|P2|NOT COMPLETED|Overall Study||0
8329916|NCT01371110|20534596|P1|NOT COMPLETED|Overall Study||0
8329917|NCT01371110|20534595|P2|COMPLETED|Overall Study||2
8329918|NCT01371110|20534596|P1|COMPLETED|Overall Study||1
8329919|NCT01371110|20534595|P2|STARTED|Overall Study||2
8329920|NCT01371110|20534596|P1|STARTED|Overall Study||1
8329921|NCT01371006|20534606|P2|NOT COMPLETED|Overall Study||0
8329922|NCT01371006|20534607|P1|NOT COMPLETED|Overall Study||1
8329923|NCT01371006|20534606|P2|COMPLETED|Overall Study||15
8329924|NCT01371006|20534607|P1|COMPLETED|Overall Study||13
8329925|NCT01371006|20534606|P2|STARTED|Overall Study||15
8329926|NCT01371006|20534607|P1|STARTED|Overall Study||14
8329933|NCT01370837|20534662|P3|NOT COMPLETED|Overall Study||0
8329934|NCT01370837|20534663|P2|NOT COMPLETED|Overall Study||0
8329935|NCT01370837|20534664|P1|NOT COMPLETED|Overall Study||0
8329936|NCT01370837|20534662|P3|COMPLETED|Overall Study||17
8329937|NCT01370837|20534663|P2|COMPLETED|Overall Study||12
8329938|NCT01370837|20534664|P1|COMPLETED|Overall Study||12
8329939|NCT01370837|20534662|P3|STARTED|Overall Study||17
8329940|NCT01370837|20534663|P2|STARTED|Overall Study||12
8329941|NCT01370837|20534664|P1|STARTED|Overall Study||12
8329942|NCT01370733|20534674|P2|NOT COMPLETED|Overall Study||22
8329943|NCT01370733|20534675|P1|NOT COMPLETED|Overall Study||17
8329944|NCT01370733|20534674|P2|COMPLETED|Overall Study||77
8329945|NCT01370733|20534675|P1|COMPLETED|Overall Study||86
8329946|NCT01370733|20534674|P2|STARTED|Overall Study||99
8329947|NCT01370733|20534675|P1|STARTED|Overall Study||103
8329948|NCT01370694|20534697|P1|NOT COMPLETED|Overall Study||6
8329949|NCT01370694|20534697|P1|COMPLETED|Overall Study||1
8329950|NCT01370694|20534697|P1|STARTED|Overall Study||7
8329951|NCT01370655|20534719|P12|NOT COMPLETED|Period 2||0
8329952|NCT01370655|20534720|P11|NOT COMPLETED|Period 2||1
8329953|NCT01370655|20534721|P10|NOT COMPLETED|Period 2||0
8329954|NCT01370655|20534722|P9|NOT COMPLETED|Period 2||2
8329955|NCT01370655|20534723|P8|NOT COMPLETED|Period 2||1
8329956|NCT01370655|20534724|P7|NOT COMPLETED|Period 2||1
8329957|NCT01370655|20534725|P6|NOT COMPLETED|Period 2||0
8329958|NCT01370655|20534726|P5|NOT COMPLETED|Period 2||1
8329959|NCT01370655|20534727|P4|NOT COMPLETED|Period 2||0
8329960|NCT01370655|20534728|P3|NOT COMPLETED|Period 2||2
8329961|NCT01370655|20534729|P2|NOT COMPLETED|Period 2||0
8329962|NCT01370655|20534730|P1|NOT COMPLETED|Period 2||0
8329963|NCT01370655|20534719|P12|COMPLETED|Period 2||3
8329964|NCT01370655|20534720|P11|COMPLETED|Period 2||2
8329965|NCT01370655|20534721|P10|COMPLETED|Period 2||2
8329966|NCT01370655|20534722|P9|COMPLETED|Period 2||1
8329967|NCT01370655|20534723|P8|COMPLETED|Period 2||3
8329968|NCT01370655|20534724|P7|COMPLETED|Period 2||2
8329969|NCT01370655|20534725|P6|COMPLETED|Period 2||4
8329970|NCT01370655|20534726|P5|COMPLETED|Period 2||2
8329971|NCT01370655|20534727|P4|COMPLETED|Period 2||3
8329972|NCT01370655|20534728|P3|COMPLETED|Period 2||1
8329973|NCT01370655|20534729|P2|COMPLETED|Period 2||7
8329974|NCT01370655|20534730|P1|COMPLETED|Period 2||5
8329975|NCT01370655|20534719|P12|STARTED|Period 2||3
8329976|NCT01370655|20534720|P11|STARTED|Period 2||3
8329977|NCT01370655|20534721|P10|STARTED|Period 2||2
8329978|NCT01370655|20534722|P9|STARTED|Period 2||3
8329979|NCT01370655|20534723|P8|STARTED|Period 2||4
8329980|NCT01370655|20534724|P7|STARTED|Period 2||3
8329981|NCT01370655|20534725|P6|STARTED|Period 2||4
8329982|NCT01370655|20534726|P5|STARTED|Period 2||3
8329983|NCT01370655|20534727|P4|STARTED|Period 2||3
8329984|NCT01370655|20534728|P3|STARTED|Period 2||3
8329985|NCT01370655|20534729|P2|STARTED|Period 2||7
8329986|NCT01370655|20534730|P1|STARTED|Period 2||5
8329987|NCT01370655|20534719|P12|NOT COMPLETED|Period 1||0
8329988|NCT01370655|20534720|P11|NOT COMPLETED|Period 1||0
8329989|NCT01370655|20534721|P10|NOT COMPLETED|Period 1||0
8329990|NCT01370655|20534722|P9|NOT COMPLETED|Period 1||0
8329991|NCT01370655|20534723|P8|NOT COMPLETED|Period 1||0
8329992|NCT01370655|20534724|P7|NOT COMPLETED|Period 1||1
8329993|NCT01370655|20534725|P6|NOT COMPLETED|Period 1||0
8329994|NCT01370655|20534726|P5|NOT COMPLETED|Period 1||0
8329995|NCT01370655|20534727|P4|NOT COMPLETED|Period 1||0
8329996|NCT01370655|20534728|P3|NOT COMPLETED|Period 1||0
8329997|NCT01370655|20534729|P2|NOT COMPLETED|Period 1||0
8329998|NCT01370655|20534730|P1|NOT COMPLETED|Period 1||2
8329999|NCT01370655|20534719|P12|COMPLETED|Period 1||3
8330000|NCT01370655|20534720|P11|COMPLETED|Period 1||3
8330001|NCT01370655|20534721|P10|COMPLETED|Period 1||2
8330002|NCT01370655|20534722|P9|COMPLETED|Period 1||3
8330003|NCT01370655|20534723|P8|COMPLETED|Period 1||4
8330004|NCT01370655|20534724|P7|COMPLETED|Period 1||3
8330005|NCT01370655|20534725|P6|COMPLETED|Period 1||4
8330006|NCT01370655|20534726|P5|COMPLETED|Period 1||3
8330007|NCT01370655|20534727|P4|COMPLETED|Period 1||3
8330008|NCT01370655|20534728|P3|COMPLETED|Period 1||3
8330009|NCT01370655|20534729|P2|COMPLETED|Period 1||7
8330010|NCT01370655|20534730|P1|COMPLETED|Period 1||5
8330011|NCT01370655|20534719|P12|STARTED|Period 1||3
8330012|NCT01370655|20534720|P11|STARTED|Period 1||3
8330013|NCT01370655|20534721|P10|STARTED|Period 1||2
8330014|NCT01370655|20534722|P9|STARTED|Period 1||3
8330015|NCT01370655|20534723|P8|STARTED|Period 1||4
8330016|NCT01370655|20534724|P7|STARTED|Period 1||4
8330017|NCT01370655|20534725|P6|STARTED|Period 1||4
8330018|NCT01370655|20534726|P5|STARTED|Period 1||3
8330019|NCT01370655|20534727|P4|STARTED|Period 1||3
8330020|NCT01370655|20534728|P3|STARTED|Period 1||3
8330021|NCT01370655|20534729|P2|STARTED|Period 1||7
8330022|NCT01370655|20534730|P1|STARTED|Period 1||7
8330023|NCT01370642|20534767|P3|NOT COMPLETED|Overall Study||29
8330024|NCT01370642|20534768|P2|NOT COMPLETED|Overall Study||6
8330025|NCT01370642|20534769|P1|NOT COMPLETED|Overall Study||8
8330026|NCT01370642|20534767|P3|COMPLETED|Overall Study||69
8330027|NCT01370642|20534768|P2|COMPLETED|Overall Study||92
8330028|NCT01370642|20534769|P1|COMPLETED|Overall Study||90
8330029|NCT01370642|20534767|P3|FAS Population|Overall Study||98
8330030|NCT01370642|20534768|P2|FAS Population|Overall Study||97
8330031|NCT01370642|20534769|P1|FAS Population|Overall Study||98
8330032|NCT01370642|20534767|P3|STARTED|Overall Study||98
8330033|NCT01370642|20534768|P2|STARTED|Overall Study||98
8330034|NCT01370642|20534769|P1|STARTED|Overall Study||98
8330035|NCT01370629|20534798|P1|NOT COMPLETED|Overall Study||6
8330036|NCT01370629|20534798|P1|COMPLETED|Overall Study||2009
8330037|NCT01370629|20534798|P1|STARTED|Overall Study||2015
8330038|NCT01370616|20534808|P2|NOT COMPLETED|Overall Study||67
8330039|NCT01370616|20534809|P1|NOT COMPLETED|Overall Study||62
8330040|NCT01370616|20534808|P2|COMPLETED|Overall Study||216
8330041|NCT01370616|20534809|P1|COMPLETED|Overall Study||220
8330042|NCT01370616|20534808|P2|Treated|Overall Study||275
8330043|NCT01370616|20534809|P1|Treated|Overall Study||275
8330044|NCT01370616|20534808|P2|STARTED|Overall Study|Participants randomized|283
8330045|NCT01370616|20534809|P1|STARTED|Overall Study|Participants randomized|282
8330046|NCT01370603|20534833|P2|NOT COMPLETED|Period 2||4
8330047|NCT01370603|20534834|P1|NOT COMPLETED|Period 2||3
8330048|NCT01370603|20534833|P2|COMPLETED|Period 2||146
8330049|NCT01370603|20534834|P1|COMPLETED|Period 2||138
8330050|NCT01370603|20534833|P2|STARTED|Period 2||150
8330051|NCT01370603|20534834|P1|STARTED|Period 2||141
8330052|NCT01370603|20534833|P2|NOT COMPLETED|Crossover Washout||4
8330053|NCT01370603|20534834|P1|NOT COMPLETED|Crossover Washout||9
8330054|NCT01370603|20534833|P2|COMPLETED|Crossover Washout||150
8330055|NCT01370603|20534834|P1|COMPLETED|Crossover Washout||141
8330056|NCT01370603|20534833|P2|STARTED|Crossover Washout||154
8330057|NCT01370603|20534834|P1|STARTED|Crossover Washout||150
8330058|NCT01370603|20534833|P2|NOT COMPLETED|Period 1||10
8330059|NCT01370603|20534834|P1|NOT COMPLETED|Period 1||14
8330060|NCT01370603|20534833|P2|COMPLETED|Period 1||154
8330061|NCT01370603|20534834|P1|COMPLETED|Period 1||150
8330062|NCT01370603|20534833|P2|STARTED|Period 1||164
8330063|NCT01370603|20534834|P1|STARTED|Period 1||164
8330064|NCT01370590|20534852|P2|NOT COMPLETED|Period 2||2
8330065|NCT01370590|20534853|P1|NOT COMPLETED|Period 2||1
8330066|NCT01370590|20534852|P2|COMPLETED|Period 2||184
8330067|NCT01370590|20534853|P1|COMPLETED|Period 2||180
8330068|NCT01370590|20534852|P2|STARTED|Period 2||186
8330069|NCT01370590|20534853|P1|STARTED|Period 2||181
8330070|NCT01370590|20534852|P2|NOT COMPLETED|Crossover Washout Period||6
8330071|NCT01370590|20534853|P1|NOT COMPLETED|Crossover Washout Period||6
8330072|NCT01370590|20534852|P2|COMPLETED|Crossover Washout Period||186
8330073|NCT01370590|20534853|P1|COMPLETED|Crossover Washout Period||181
8330074|NCT01370590|20534852|P2|STARTED|Crossover Washout Period||192
8330075|NCT01370590|20534853|P1|STARTED|Crossover Washout Period||187
8330076|NCT01370590|20534852|P2|NOT COMPLETED|Period 1||11
8330077|NCT01370590|20534853|P1|NOT COMPLETED|Period 1||16
8330078|NCT01370590|20534852|P2|COMPLETED|Period 1||192
8330079|NCT01370590|20534853|P1|COMPLETED|Period 1||187
8330080|NCT01370590|20534852|P2|STARTED|Period 1||203
8330081|NCT01370590|20534853|P1|STARTED|Period 1||203
8330082|NCT01370564|20534869|P1|NOT COMPLETED|Overall Study||0
8330083|NCT01370564|20534869|P1|COMPLETED|Overall Study||21
8330084|NCT01370564|20534869|P1|STARTED|Overall Study||21
8330085|NCT01370538|20534881|P2|NOT COMPLETED|Overall Study||19
8330086|NCT01370538|20534882|P1|NOT COMPLETED|Overall Study||19
8330087|NCT01370538|20534881|P2|COMPLETED|Overall Study||152
8330088|NCT01370538|20534882|P1|COMPLETED|Overall Study||151
8330089|NCT01370538|20534881|P2|Patients Who Completed Treatment|Overall Study||152
8330090|NCT01370538|20534882|P1|Patients Who Completed Treatment|Overall Study||151
8330091|NCT01370538|20534881|P2|Patients Who Received Treatment|Overall Study||161
8330092|NCT01370538|20534882|P1|Patients Who Received Treatment|Overall Study||165
8330093|NCT01370538|20534881|P2|STARTED|Overall Study||171
8330094|NCT01370538|20534882|P1|STARTED|Overall Study||170
8330095|NCT01370525|20534898|P2|NOT COMPLETED|Overall Study||11
8330096|NCT01370525|20534899|P1|NOT COMPLETED|Overall Study||8
8330097|NCT01370525|20534898|P2|COMPLETED|Overall Study||158
8330098|NCT01370525|20534899|P1|COMPLETED|Overall Study||163
8330099|NCT01370525|20534898|P2|Patients Who Completed Treatment|Overall Study||158
8330100|NCT01370525|20534899|P1|Patients Who Completed Treatment|Overall Study||163
8330101|NCT01370525|20534898|P2|Patients Who Received Treatment|Overall Study||163
8330102|NCT01370525|20534899|P1|Patients Who Received Treatment|Overall Study||168
8330103|NCT01370525|20534898|P2|STARTED|Overall Study||169
8330104|NCT01370525|20534899|P1|STARTED|Overall Study||171
8330105|NCT01370499|20534915|P2|NOT COMPLETED|Overall Study||44
8330106|NCT01370499|20534916|P1|NOT COMPLETED|Overall Study||111
8330107|NCT01370499|20534915|P2|COMPLETED|Overall Study||49
8330108|NCT01370499|20534916|P1|COMPLETED|Overall Study||84
8330109|NCT01370499|20534915|P2|Received at Least 1 Dose of Study Drug|Overall Study||92
8330110|NCT01370499|20534916|P1|Received at Least 1 Dose of Study Drug|Overall Study||195
8330111|NCT01370499|20534915|P2|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
8330112|NCT01370499|20534916|P1|Entered Abrupt Discontinuation Phase|Overall Study||188
8330113|NCT01370499|20534915|P2|STARTED|Overall Study||93
8330114|NCT01370499|20534916|P1|STARTED|Overall Study||195
8330115|NCT01370460|20534950|P2|NOT COMPLETED|Overall Study||0
8330116|NCT01370460|20534951|P1|NOT COMPLETED|Overall Study||0
8330117|NCT01370460|20534950|P2|COMPLETED|Overall Study||51
8330118|NCT01370460|20534951|P1|COMPLETED|Overall Study||50
8330119|NCT01370460|20534950|P2|STARTED|Overall Study||51
8330120|NCT01370460|20534951|P1|STARTED|Overall Study||50
8330121|NCT01370408|20534958|P1|NOT COMPLETED|Overall Study||9
8330122|NCT01370408|20534958|P1|COMPLETED|Overall Study||76
8330123|NCT01370408|20534958|P1|STARTED|Overall Study||85
8330124|NCT01370369|20534969|P1|NOT COMPLETED|Overall Study||0
8330125|NCT01370369|20534969|P1|COMPLETED|Overall Study||20
8330126|NCT01370369|20534969|P1|STARTED|Overall Study||20
8330127|NCT01370356|20535018|P2|NOT COMPLETED|Overall Study||227
8330128|NCT01370356|20535019|P1|NOT COMPLETED|Overall Study||192
8330129|NCT01370356|20535018|P2|COMPLETED|Overall Study||515
8330130|NCT01370356|20535019|P1|COMPLETED|Overall Study||559
8330131|NCT01370356|20535018|P2|STARTED|Overall Study||742
8330132|NCT01370356|20535019|P1|STARTED|Overall Study||751
8330133|NCT01370317|20535035|P2|NOT COMPLETED|Overall Study||1
8330134|NCT01370317|20535036|P1|NOT COMPLETED|Overall Study||1
8330135|NCT01370317|20535035|P2|COMPLETED|Overall Study||8
8330136|NCT01370317|20535036|P1|COMPLETED|Overall Study||17
8330137|NCT01370317|20535035|P2|STARTED|Overall Study||9
8330138|NCT01370317|20535036|P1|STARTED|Overall Study||18
8330139|NCT01370265|20535047|P2|NOT COMPLETED|Second Intervention||0
8330140|NCT01370265|20535048|P1|NOT COMPLETED|Second Intervention||0
8330141|NCT01370265|20535047|P2|COMPLETED|Second Intervention||5
8330142|NCT01370265|20535048|P1|COMPLETED|Second Intervention||5
8330143|NCT01370265|20535047|P2|STARTED|Second Intervention||5
8330144|NCT01370265|20535048|P1|STARTED|Second Intervention||5
8330145|NCT01370265|20535047|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
8330146|NCT01370265|20535048|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
8330147|NCT01370265|20535047|P2|COMPLETED|Washout Period (50-minute Period Decay)||5
8330148|NCT01370265|20535048|P1|COMPLETED|Washout Period (50-minute Period Decay)||5
8330149|NCT01370265|20535047|P2|STARTED|Washout Period (50-minute Period Decay)||5
8330150|NCT01370265|20535048|P1|STARTED|Washout Period (50-minute Period Decay)||5
8330151|NCT01370265|20535047|P2|NOT COMPLETED|First Intervention||1
8330152|NCT01370265|20535048|P1|NOT COMPLETED|First Intervention||1
8330153|NCT01370265|20535047|P2|COMPLETED|First Intervention||5
8330154|NCT01370265|20535048|P1|COMPLETED|First Intervention||5
8330155|NCT01370265|20535047|P2|STARTED|First Intervention||6
8330156|NCT01370265|20535048|P1|STARTED|First Intervention||6
8330157|NCT01370265|20535047|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
8330158|NCT01370265|20535048|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
8330159|NCT01370265|20535047|P2|COMPLETED|Washout Period (50-minute Period Decay)||6
8330160|NCT01370265|20535048|P1|COMPLETED|Washout Period (50-minute Period Decay)||6
8330161|NCT01370265|20535047|P2|STARTED|Washout Period (50-minute Period Decay)||6
8330162|NCT01370265|20535048|P1|STARTED|Washout Period (50-minute Period Decay)||6
8330163|NCT01370265|20535047|P2|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
8330164|NCT01370265|20535048|P1|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
8330165|NCT01370265|20535047|P2|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
8330166|NCT01370265|20535048|P1|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
8330167|NCT01370265|20535047|P2|STARTED|Resting Myocardial Blood Flow (MBF)||6
8330168|NCT01370265|20535048|P1|STARTED|Resting Myocardial Blood Flow (MBF)||6
8330169|NCT01370213|20535068|P3|NOT COMPLETED|Overall Study||0
8330170|NCT01370213|20535069|P2|NOT COMPLETED|Overall Study||2
8330171|NCT01370213|20535070|P1|NOT COMPLETED|Overall Study||1
8330172|NCT01370213|20535068|P3|COMPLETED|Overall Study||1
8330173|NCT01370213|20535069|P2|COMPLETED|Overall Study||15
8330174|NCT01370213|20535070|P1|COMPLETED|Overall Study||6
8330175|NCT01370213|20535068|P3|STARTED|Overall Study||1
8330176|NCT01370213|20535069|P2|STARTED|Overall Study||17
8330177|NCT01370213|20535070|P1|STARTED|Overall Study||7
8330178|NCT01370083|20535090|P2|NOT COMPLETED|Overall Study||1
8330179|NCT01370083|20535091|P1|NOT COMPLETED|Overall Study||2
8330180|NCT01370083|20535090|P2|COMPLETED|Overall Study||6
8330181|NCT01370083|20535091|P1|COMPLETED|Overall Study||5
8330182|NCT01370083|20535090|P2|STARTED|Overall Study||7
8330183|NCT01370083|20535091|P1|STARTED|Overall Study||7
8330184|NCT01370005|20535104|P3|NOT COMPLETED|Overall Study||11
8330185|NCT01370005|20535105|P2|NOT COMPLETED|Overall Study||11
8330186|NCT01370005|20535106|P1|NOT COMPLETED|Overall Study||16
8330187|NCT01370005|20535104|P3|COMPLETED|Overall Study||266
8330188|NCT01370005|20535105|P2|COMPLETED|Overall Study||265
8330189|NCT01370005|20535106|P1|COMPLETED|Overall Study||256
8330190|NCT01370005|20535104|P3|STARTED|Overall Study||277
8330191|NCT01370005|20535105|P2|STARTED|Overall Study||276
8330192|NCT01370005|20535106|P1|STARTED|Overall Study||272
8330193|NCT01369888|20535163|P4|NOT COMPLETED|Overall Study||0
8330194|NCT01369888|20535164|P3|NOT COMPLETED|Overall Study||0
8330195|NCT01369888|20535165|P2|NOT COMPLETED|Overall Study||0
8330196|NCT01369888|20535166|P1|NOT COMPLETED|Overall Study||0
8330197|NCT01369888|20535163|P4|COMPLETED|Overall Study||0
8330198|NCT01369888|20535164|P3|COMPLETED|Overall Study||0
8330199|NCT01369888|20535165|P2|COMPLETED|Overall Study||2
8330200|NCT01369888|20535166|P1|COMPLETED|Overall Study||1
8330201|NCT01369888|20535163|P4|STARTED|Overall Study||0
8330202|NCT01369888|20535164|P3|STARTED|Overall Study||0
8330203|NCT01369888|20535165|P2|STARTED|Overall Study||2
8330204|NCT01369888|20535166|P1|STARTED|Overall Study||1
8330205|NCT01369875|20535176|P2|NOT COMPLETED|Overall Study||0
8330206|NCT01369875|20535177|P1|NOT COMPLETED|Overall Study||0
8330207|NCT01369875|20535176|P2|COMPLETED|Overall Study||1
8330208|NCT01369875|20535177|P1|COMPLETED|Overall Study||1
8330209|NCT01369875|20535176|P2|STARTED|Overall Study||1
8330210|NCT01369875|20535177|P1|STARTED|Overall Study||1
8330211|NCT01369849|20535188|P3|NOT COMPLETED|Overall Study||1
8330212|NCT01369849|20535189|P2|NOT COMPLETED|Overall Study||1
8330213|NCT01369849|20535190|P1|NOT COMPLETED|Overall Study||0
8330214|NCT01369849|20535188|P3|COMPLETED|Overall Study||4
8330215|NCT01369849|20535189|P2|COMPLETED|Overall Study||3
8330216|NCT01369849|20535190|P1|COMPLETED|Overall Study||6
8330217|NCT01369849|20535188|P3|STARTED|Overall Study||5
8330218|NCT01369849|20535189|P2|STARTED|Overall Study||4
8330219|NCT01369849|20535190|P1|STARTED|Overall Study||6
8330220|NCT01369784|20535212|P1|NOT COMPLETED|Overall Study||12
8330221|NCT01369784|20535212|P1|COMPLETED|Overall Study||146
8330222|NCT01369784|20535212|P1|STARTED|Overall Study||158
8330223|NCT01369758|20535237|P1|NOT COMPLETED|Overall Study||0
8330224|NCT01369758|20535237|P1|COMPLETED|Overall Study||290
8330225|NCT01369758|20535237|P1|STARTED|Overall Study||290
8330226|NCT01369745|20535247|P5|NOT COMPLETED|Overall Study||18
8330227|NCT01369745|20535248|P4|NOT COMPLETED|Overall Study||20
8330228|NCT01369745|20535249|P3|NOT COMPLETED|Overall Study||2
8330229|NCT01369745|20535250|P2|NOT COMPLETED|Overall Study||13
8330230|NCT01369745|20535251|P1|NOT COMPLETED|Overall Study||7
8330231|NCT01369745|20535247|P5|COMPLETED|Overall Study||65
8330232|NCT01369745|20535248|P4|COMPLETED|Overall Study||64
8330233|NCT01369745|20535249|P3|COMPLETED|Overall Study||16
8330234|NCT01369745|20535250|P2|COMPLETED|Overall Study||28
8330235|NCT01369745|20535251|P1|COMPLETED|Overall Study||25
8330236|NCT01369745|20535247|P5|STARTED|Overall Study||83
8330237|NCT01369745|20535248|P4|STARTED|Overall Study||84
8330238|NCT01369745|20535249|P3|STARTED|Overall Study||18
8330239|NCT01369745|20535250|P2|STARTED|Overall Study||41
8330240|NCT01369745|20535251|P1|STARTED|Overall Study||32
8330241|NCT01369732|20535285|P2|NOT COMPLETED|Overall Study||2
8330242|NCT01369732|20535286|P1|NOT COMPLETED|Overall Study||4
8330243|NCT01369732|20535285|P2|COMPLETED|Overall Study||31
8330244|NCT01369732|20535286|P1|COMPLETED|Overall Study||29
8330245|NCT01369732|20535285|P2|STARTED|Overall Study||33
8330246|NCT01369732|20535286|P1|STARTED|Overall Study||33
8330247|NCT01369706|20535292|P1|NOT COMPLETED|Overall Study||0
8330248|NCT01369706|20535292|P1|COMPLETED|Overall Study||388
8330249|NCT01369706|20535292|P1|STARTED|Overall Study||388
8330250|NCT01369680|20535300|P4|NOT COMPLETED|Overall Study||2
8330251|NCT01369680|20535301|P3|NOT COMPLETED|Overall Study||1
8330252|NCT01369680|20535302|P2|NOT COMPLETED|Overall Study||0
8330253|NCT01369680|20535303|P1|NOT COMPLETED|Overall Study||0
8330254|NCT01369680|20535300|P4|COMPLETED|Overall Study||1
8330255|NCT01369680|20535301|P3|COMPLETED|Overall Study||2
8330256|NCT01369680|20535302|P2|COMPLETED|Overall Study||3
8330257|NCT01369680|20535303|P1|COMPLETED|Overall Study||3
8330258|NCT01369680|20535300|P4|STARTED|Overall Study||3
8330259|NCT01369680|20535301|P3|STARTED|Overall Study||3
8330260|NCT01369680|20535302|P2|STARTED|Overall Study||3
8330261|NCT01369680|20535303|P1|STARTED|Overall Study||3
8330262|NCT01369641|20535324|P1|NOT COMPLETED|Overall Study||1
8330263|NCT01369641|20535324|P1|COMPLETED|Overall Study||0
8330264|NCT01369641|20535324|P1|STARTED|Overall Study||1
8330265|NCT01369615|20535330|P2|NOT COMPLETED|Overall Study||2
8330266|NCT01369615|20535331|P1|NOT COMPLETED|Overall Study||0
8330267|NCT01369615|20535330|P2|COMPLETED|Overall Study||12
8330268|NCT01369615|20535331|P1|COMPLETED|Overall Study||9
8330269|NCT01369615|20535330|P2|STARTED|Overall Study||14
8330270|NCT01369615|20535331|P1|STARTED|Overall Study||9
8330271|NCT01369511|20535341|P4|NOT COMPLETED|Overall Study||11
8330272|NCT01369511|20535342|P3|NOT COMPLETED|Overall Study||11
8330273|NCT01369511|20535343|P2|NOT COMPLETED|Overall Study||13
8330274|NCT01369511|20535344|P1|NOT COMPLETED|Overall Study||13
8330275|NCT01369511|20535341|P4|COMPLETED|Overall Study||89
8330276|NCT01369511|20535342|P3|COMPLETED|Overall Study||87
8330277|NCT01369511|20535343|P2|COMPLETED|Overall Study||91
8330278|NCT01369511|20535344|P1|COMPLETED|Overall Study||85
8330279|NCT01369511|20535341|P4|Received at Least 1 Dose of Study Drug|Overall Study||100
8330280|NCT01369511|20535342|P3|Received at Least 1 Dose of Study Drug|Overall Study||98
8330281|NCT01369511|20535343|P2|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
8330282|NCT01369511|20535344|P1|Received at Least 1 Dose of Study Drug|Overall Study||98
8330283|NCT01369511|20535341|P4|STARTED|Overall Study||100
8330284|NCT01369511|20535342|P3|STARTED|Overall Study||98
8330285|NCT01369511|20535343|P2|STARTED|Overall Study||104
8330286|NCT01369511|20535344|P1|STARTED|Overall Study||98
8330287|NCT01369498|20535362|P4|NOT COMPLETED|Overall Study||15
8330288|NCT01369498|20535363|P3|NOT COMPLETED|Overall Study||15
8330289|NCT01369498|20535364|P2|NOT COMPLETED|Overall Study||12
8330290|NCT01369498|20535365|P1|NOT COMPLETED|Overall Study||12
8330291|NCT01369498|20535362|P4|COMPLETED|Overall Study||0
8330292|NCT01369498|20535363|P3|COMPLETED|Overall Study||0
8330293|NCT01369498|20535364|P2|COMPLETED|Overall Study||0
8330294|NCT01369498|20535365|P1|COMPLETED|Overall Study||0
8330295|NCT01369498|20535362|P4|STARTED|Overall Study||15
8330296|NCT01369498|20535363|P3|STARTED|Overall Study||15
8330297|NCT01369498|20535364|P2|STARTED|Overall Study||12
8330298|NCT01369498|20535365|P1|STARTED|Overall Study||12
8330299|NCT01369485|20535397|P2|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
8330300|NCT01369485|20535398|P1|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
8330301|NCT01369485|20535397|P2|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
8330302|NCT01369485|20535398|P1|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
8330303|NCT01369485|20535397|P2|STARTED|Open Label Phase (Week 12 to Month 12)||66
8330304|NCT01369485|20535398|P1|STARTED|Open Label Phase (Week 12 to Month 12)||57
8330305|NCT01369485|20535397|P2|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
8330306|NCT01369485|20535398|P1|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
8330307|NCT01369485|20535397|P2|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
8330308|NCT01369485|20535398|P1|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
8330309|NCT01369485|20535397|P2|STARTED|Randomized Phase (Day 0 to Week 12)||83
8330310|NCT01369485|20535398|P1|STARTED|Randomized Phase (Day 0 to Week 12)||80
8330311|NCT01369433|20535440|P2|NOT COMPLETED|Overall Study||16
8330312|NCT01369433|20535441|P1|NOT COMPLETED|Overall Study||209
8330313|NCT01369433|20535440|P2|COMPLETED|Overall Study||0
8330314|NCT01369433|20535441|P1|COMPLETED|Overall Study||0
8330315|NCT01369433|20535440|P2|STARTED|Overall Study||16
8330316|NCT01369433|20535441|P1|STARTED|Overall Study||209
8330317|NCT01369355|20535453|P9|NOT COMPLETED|Long-term Extension (Week 44-272)||171
8330318|NCT01369355|20535454|P8|NOT COMPLETED|Long-term Extension (Week 44-272)||106
8330319|NCT01369355|20535455|P7|NOT COMPLETED|Long-term Extension (Week 44-272)||151
8330320|NCT01369355|20535456|P6|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8330321|NCT01369355|20535457|P5|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8330322|NCT01369355|20535458|P4|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8330323|NCT01369355|20535459|P3|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8330324|NCT01369355|20535460|P2|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8330325|NCT01369355|20535461|P1|NOT COMPLETED|Long-term Extension (Week 44-272)||0
8330326|NCT01369355|20535453|P9|COMPLETED|Long-term Extension (Week 44-272)||183
8330327|NCT01369355|20535454|P8|COMPLETED|Long-term Extension (Week 44-272)||107
8330328|NCT01369355|20535455|P7|COMPLETED|Long-term Extension (Week 44-272)||0
8330329|NCT01369355|20535456|P6|COMPLETED|Long-term Extension (Week 44-272)||0
8330330|NCT01369355|20535457|P5|COMPLETED|Long-term Extension (Week 44-272)||0
8330331|NCT01369355|20535458|P4|COMPLETED|Long-term Extension (Week 44-272)||0
8330332|NCT01369355|20535459|P3|COMPLETED|Long-term Extension (Week 44-272)||0
8330333|NCT01369355|20535460|P2|COMPLETED|Long-term Extension (Week 44-272)||0
8330334|NCT01369355|20535461|P1|COMPLETED|Long-term Extension (Week 44-272)||0
8330335|NCT01369355|20535453|P9|STARTED|Long-term Extension (Week 44-272)||354
8330336|NCT01369355|20535454|P8|STARTED|Long-term Extension (Week 44-272)||213
8330337|NCT01369355|20535455|P7|STARTED|Long-term Extension (Week 44-272)||151
8330338|NCT01369355|20535456|P6|STARTED|Long-term Extension (Week 44-272)||0
8330339|NCT01369355|20535457|P5|STARTED|Long-term Extension (Week 44-272)||0
8330340|NCT01369355|20535458|P4|STARTED|Long-term Extension (Week 44-272)||0
8330341|NCT01369355|20535459|P3|STARTED|Long-term Extension (Week 44-272)||0
8330342|NCT01369355|20535460|P2|STARTED|Long-term Extension (Week 44-272)||0
8330343|NCT01369355|20535461|P1|STARTED|Long-term Extension (Week 44-272)||0
8330344|NCT01369355|20535453|P9|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
8330345|NCT01369355|20535454|P8|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
8330346|NCT01369355|20535455|P7|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
8330347|NCT01369355|20535456|P6|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||272
8330348|NCT01369355|20535457|P5|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||154
8330349|NCT01369355|20535458|P4|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||30
8330350|NCT01369355|20535459|P3|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
8330351|NCT01369355|20535460|P2|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||29
8330352|NCT01369355|20535461|P1|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
8330353|NCT01369355|20535453|P9|COMPLETED|Week 0 - Week 44 (Maintenance)||0
8330354|NCT01369355|20535454|P8|COMPLETED|Week 0 - Week 44 (Maintenance)||0
8330355|NCT01369355|20535455|P7|COMPLETED|Week 0 - Week 44 (Maintenance)||0
8330356|NCT01369355|20535456|P6|COMPLETED|Week 0 - Week 44 (Maintenance)||204
8330357|NCT01369355|20535457|P5|COMPLETED|Week 0 - Week 44 (Maintenance)||131
8330358|NCT01369355|20535458|P4|COMPLETED|Week 0 - Week 44 (Maintenance)||93
8330359|NCT01369355|20535459|P3|COMPLETED|Week 0 - Week 44 (Maintenance)||101
8330360|NCT01369355|20535460|P2|COMPLETED|Week 0 - Week 44 (Maintenance)||103
8330361|NCT01369355|20535461|P1|COMPLETED|Week 0 - Week 44 (Maintenance)||102
8330362|NCT01369355|20535453|P9|STARTED|Week 0 - Week 44 (Maintenance)||0
8330363|NCT01369355|20535454|P8|STARTED|Week 0 - Week 44 (Maintenance)||0
8330364|NCT01369355|20535455|P7|STARTED|Week 0 - Week 44 (Maintenance)||0
8330365|NCT01369355|20535456|P6|STARTED|Week 0 - Week 44 (Maintenance)||476
8330366|NCT01369355|20535457|P5|STARTED|Week 0 - Week 44 (Maintenance)||285
8330367|NCT01369355|20535458|P4|STARTED|Week 0 - Week 44 (Maintenance)||123
8330368|NCT01369355|20535459|P3|STARTED|Week 0 - Week 44 (Maintenance)||132
8330369|NCT01369355|20535460|P2|STARTED|Week 0 - Week 44 (Maintenance)||132
8330370|NCT01369355|20535461|P1|STARTED|Week 0 - Week 44 (Maintenance)||133
8330371|NCT01369342|20535493|P3|NOT COMPLETED|Overall Study||3
8330372|NCT01369342|20535494|P2|NOT COMPLETED|Overall Study||9
8330373|NCT01369342|20535495|P1|NOT COMPLETED|Overall Study||13
8330374|NCT01369342|20535493|P3|COMPLETED|Overall Study||210
8330375|NCT01369342|20535494|P2|COMPLETED|Overall Study||204
8330376|NCT01369342|20535495|P1|COMPLETED|Overall Study||201
8330377|NCT01369342|20535493|P3|STARTED|Overall Study||213
8330378|NCT01369342|20535494|P2|STARTED|Overall Study||213
8330379|NCT01369342|20535495|P1|STARTED|Overall Study||214
8330380|NCT01369329|20535518|P3|NOT COMPLETED|Overall Study||14
8330381|NCT01369329|20535519|P2|NOT COMPLETED|Overall Study||11
8330382|NCT01369329|20535520|P1|NOT COMPLETED|Overall Study||12
8330383|NCT01369329|20535518|P3|COMPLETED|Overall Study||245
8330384|NCT01369329|20535519|P2|COMPLETED|Overall Study||243
8330385|NCT01369329|20535520|P1|COMPLETED|Overall Study||244
8330386|NCT01369329|20535518|P3|STARTED|Overall Study||259
8330387|NCT01369329|20535519|P2|STARTED|Overall Study||254
8330388|NCT01369329|20535520|P1|STARTED|Overall Study||256
8330389|NCT01369225|20535546|P6|NOT COMPLETED|Overall Study||0
8330390|NCT01369225|20535547|P5|NOT COMPLETED|Overall Study||2
8330391|NCT01369225|20535548|P4|NOT COMPLETED|Overall Study||2
8330392|NCT01369225|20535549|P3|NOT COMPLETED|Overall Study||3
8330393|NCT01369225|20535550|P2|NOT COMPLETED|Overall Study||0
8330394|NCT01369225|20535551|P1|NOT COMPLETED|Overall Study||2
8330395|NCT01369225|20535546|P6|COMPLETED|Overall Study||9
8330396|NCT01369225|20535547|P5|COMPLETED|Overall Study||10
8330397|NCT01369225|20535548|P4|COMPLETED|Overall Study||8
8330398|NCT01369225|20535549|P3|COMPLETED|Overall Study||9
8330399|NCT01369225|20535550|P2|COMPLETED|Overall Study||3
8330400|NCT01369225|20535551|P1|COMPLETED|Overall Study||4
8330401|NCT01369225|20535546|P6|STARTED|Overall Study||9
8330402|NCT01369225|20535547|P5|STARTED|Overall Study||12
8330403|NCT01369225|20535548|P4|STARTED|Overall Study||10
8330404|NCT01369225|20535549|P3|STARTED|Overall Study||12
8330405|NCT01369225|20535550|P2|STARTED|Overall Study||3
8330406|NCT01369225|20535551|P1|STARTED|Overall Study||6
8330407|NCT01369199|20535643|P1|NOT COMPLETED|Overall Study||3
8330408|NCT01369199|20535643|P1|COMPLETED|Overall Study||25
8330409|NCT01369199|20535643|P1|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
8330410|NCT01369199|20535643|P1|STARTED|Overall Study||28
8330411|NCT01369108|20535666|P1|NOT COMPLETED|Overall Study||11
8330412|NCT01369108|20535666|P1|COMPLETED|Overall Study||49
8330413|NCT01369108|20535666|P1|STARTED|Overall Study|120 teeth|60
8330414|NCT01369069|20535675|P2|NOT COMPLETED|Overall Study||16
8330415|NCT01369069|20535676|P1|NOT COMPLETED|Overall Study||17
8330416|NCT01369069|20535675|P2|COMPLETED|Overall Study||554
8330417|NCT01369069|20535676|P1|COMPLETED|Overall Study||564
8330418|NCT01369069|20535675|P2|STARTED|Overall Study||570
8330419|NCT01369069|20535676|P1|STARTED|Overall Study||581
8330420|NCT01369030|20535692|P1|NOT COMPLETED|Overall Study||40
8330421|NCT01369030|20535692|P1|COMPLETED|Overall Study||554
8330422|NCT01369030|20535692|P1|STARTED|Overall Study||594
8330423|NCT01368965|20535698|P1|NOT COMPLETED|Overall Study||12
8330424|NCT01368965|20535698|P1|COMPLETED|Overall Study||40
8330425|NCT01368965|20535698|P1|Subject Withdrawal Prior to Treatment|Overall Study||2
8330426|NCT01368965|20535698|P1|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
8330427|NCT01368900|20535707|P1|NOT COMPLETED|Overall Study||7
8330428|NCT01368900|20535707|P1|COMPLETED|Overall Study||61
8330429|NCT01368900|20535707|P1|STARTED|Overall Study||68
8330430|NCT01368874|20535720|P3|NOT COMPLETED|Overall Study||1
8330431|NCT01368874|20535721|P2|NOT COMPLETED|Overall Study||0
8330432|NCT01368874|20535722|P1|NOT COMPLETED|Overall Study||3
8330433|NCT01368874|20535720|P3|COMPLETED|Overall Study||24
8330434|NCT01368874|20535721|P2|COMPLETED|Overall Study||5
8330435|NCT01368874|20535722|P1|COMPLETED|Overall Study||31
8330436|NCT01368874|20535720|P3|STARTED|Overall Study||25
8330437|NCT01368874|20535721|P2|STARTED|Overall Study||5
8330438|NCT01368874|20535722|P1|STARTED|Overall Study||34
8330439|NCT01368835|20535782|P1|NOT COMPLETED|Overall Study||33
8330440|NCT01368835|20535782|P1|COMPLETED|Overall Study||70
8330441|NCT01368835|20535782|P1|STARTED|Overall Study|103 Subjects Enrolled|103
8330442|NCT01368809|20535791|P2|NOT COMPLETED|Overall Study||0
8330443|NCT01368809|20535792|P1|NOT COMPLETED|Overall Study||0
8330444|NCT01368809|20535791|P2|COMPLETED|Overall Study||50
8330445|NCT01368809|20535792|P1|COMPLETED|Overall Study||50
8330446|NCT01368809|20535791|P2|STARTED|Overall Study||50
8330447|NCT01368809|20535792|P1|STARTED|Overall Study||50
8330448|NCT01368653|20535804|P2|NOT COMPLETED|Overall Study||9
8330449|NCT01368653|20535805|P1|NOT COMPLETED|Overall Study||6
8330450|NCT01368653|20535804|P2|COMPLETED|Overall Study||37
8330451|NCT01368653|20535805|P1|COMPLETED|Overall Study||41
8330452|NCT01368653|20535804|P2|Randomized to Advice Only in Phase 2|Overall Study||10
8330453|NCT01368653|20535805|P1|Randomized to Advice Only in Phase 2|Overall Study||10
8330454|NCT01368653|20535804|P2|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
8330455|NCT01368653|20535805|P1|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
8330456|NCT01368653|20535804|P2|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
8330457|NCT01368653|20535805|P1|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
8330458|NCT01368653|20535804|P2|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
8330459|NCT01368653|20535805|P1|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
8330460|NCT01368653|20535804|P2|Completed 4-week Follow-up|Overall Study||37
8330461|NCT01368653|20535805|P1|Completed 4-week Follow-up|Overall Study||44
8330462|NCT01368653|20535804|P2|STARTED|Overall Study||46
8330463|NCT01368653|20535805|P1|STARTED|Overall Study||47
8330464|NCT01368614|20535821|P4|NOT COMPLETED|Study Period||3
8330465|NCT01368614|20535822|P3|NOT COMPLETED|Study Period||2
8330466|NCT01368614|20535823|P2|NOT COMPLETED|Study Period||1
8330467|NCT01368614|20535824|P1|NOT COMPLETED|Study Period||0
8330468|NCT01368614|20535821|P4|COMPLETED|Study Period||8
8330469|NCT01368614|20535822|P3|COMPLETED|Study Period||8
8330470|NCT01368614|20535823|P2|COMPLETED|Study Period||10
8330471|NCT01368614|20535824|P1|COMPLETED|Study Period||0
8330472|NCT01368614|20535821|P4|STARTED|Study Period||11
8330473|NCT01368614|20535822|P3|STARTED|Study Period||10
8330474|NCT01368614|20535823|P2|STARTED|Study Period||11
8330475|NCT01368614|20535824|P1|STARTED|Study Period||0
8330476|NCT01368614|20535821|P4|NOT COMPLETED|Screening Period||0
8330477|NCT01368614|20535822|P3|NOT COMPLETED|Screening Period||0
8330478|NCT01368614|20535823|P2|NOT COMPLETED|Screening Period||0
8330479|NCT01368614|20535824|P1|NOT COMPLETED|Screening Period||58
8330480|NCT01368614|20535821|P4|COMPLETED|Screening Period||0
8330481|NCT01368614|20535822|P3|COMPLETED|Screening Period||0
8330482|NCT01368614|20535823|P2|COMPLETED|Screening Period||0
8330483|NCT01368614|20535824|P1|COMPLETED|Screening Period||32
8330484|NCT01368614|20535821|P4|STARTED|Screening Period||0
8330485|NCT01368614|20535822|P3|STARTED|Screening Period||0
8330486|NCT01368614|20535823|P2|STARTED|Screening Period||0
8330487|NCT01368614|20535824|P1|STARTED|Screening Period||90
8330488|NCT01368562|20535877|P1|NOT COMPLETED|Overall Study||19
8330489|NCT01368562|20535877|P1|COMPLETED|Overall Study||7
8330490|NCT01368562|20535877|P1|Received at Least 1 Dose of Study Drug|Overall Study||25
8330491|NCT01368562|20535877|P1|STARTED|Overall Study||26
8330492|NCT01368536|20535884|P3|NOT COMPLETED|Overall Study||59
8330493|NCT01368536|20535885|P2|NOT COMPLETED|Overall Study||59
8330494|NCT01368536|20535886|P1|NOT COMPLETED|Overall Study||51
8330495|NCT01368536|20535884|P3|COMPLETED|Overall Study||83
8330496|NCT01368536|20535885|P2|COMPLETED|Overall Study||78
8330497|NCT01368536|20535886|P1|COMPLETED|Overall Study||87
8330498|NCT01368536|20535884|P3|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
8330499|NCT01368536|20535885|P2|Full Analysis Set|Overall Study||137
8330500|NCT01368536|20535886|P1|Full Analysis Set|Overall Study||138
8330501|NCT01368536|20535884|P3|STARTED|Overall Study||142
8330502|NCT01368536|20535885|P2|STARTED|Overall Study||137
8330503|NCT01368536|20535886|P1|STARTED|Overall Study||138
8330504|NCT01368497|20535907|P1|NOT COMPLETED|Overall Study||2
8330505|NCT01368497|20535907|P1|COMPLETED|Overall Study||58
8330506|NCT01368497|20535907|P1|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
8330507|NCT01368497|20535907|P1|STARTED|Overall Study||60
8330508|NCT01368432|20535936|P2|NOT COMPLETED|Overall Study||1
8330509|NCT01368432|20535937|P1|NOT COMPLETED|Overall Study||0
8330510|NCT01368432|20535936|P2|COMPLETED|Overall Study||7
8330511|NCT01368432|20535937|P1|COMPLETED|Overall Study||6
8330512|NCT01368432|20535936|P2|STARTED|Overall Study||8
8330513|NCT01368432|20535937|P1|STARTED|Overall Study||6
8330514|NCT01368406|20535971|P2|NOT COMPLETED|Overall Study||13
8330515|NCT01368406|20535972|P1|NOT COMPLETED|Overall Study||21
8330516|NCT01368406|20535971|P2|COMPLETED|Overall Study||66
8330517|NCT01368406|20535972|P1|COMPLETED|Overall Study||60
8330518|NCT01368406|20535971|P2|STARTED|Overall Study||79
8330519|NCT01368406|20535972|P1|STARTED|Overall Study||81
8330520|NCT01368276|20535980|P2|NOT COMPLETED|Overall Study||10
8330521|NCT01368276|20535981|P1|NOT COMPLETED|Overall Study||1
8330522|NCT01368276|20535980|P2|COMPLETED|Overall Study||18
8330523|NCT01368276|20535981|P1|COMPLETED|Overall Study||2
8330524|NCT01368276|20535980|P2|STARTED|Overall Study||28
8330525|NCT01368276|20535981|P1|STARTED|Overall Study||3
8330526|NCT01368263|20535994|P3|NOT COMPLETED|Overall Study||0
8330527|NCT01368263|20535995|P2|NOT COMPLETED|Overall Study||0
8330528|NCT01368263|20535996|P1|NOT COMPLETED|Overall Study||0
8330529|NCT01368263|20535994|P3|COMPLETED|Overall Study||1
8330530|NCT01368263|20535995|P2|COMPLETED|Overall Study||1
8330531|NCT01368263|20535996|P1|COMPLETED|Overall Study||6
8330532|NCT01368263|20535994|P3|STARTED|Overall Study||1
8330533|NCT01368263|20535995|P2|STARTED|Overall Study||1
8330534|NCT01368263|20535996|P1|STARTED|Overall Study||6
8330535|NCT01368211|20536018|P2|NOT COMPLETED|Second Platelets Transfusion||2
8330536|NCT01368211|20536019|P1|NOT COMPLETED|Second Platelets Transfusion||1
8330537|NCT01368211|20536018|P2|COMPLETED|Second Platelets Transfusion||5
8330538|NCT01368211|20536019|P1|COMPLETED|Second Platelets Transfusion||7
8330539|NCT01368211|20536018|P2|STARTED|Second Platelets Transfusion||7
8330540|NCT01368211|20536019|P1|STARTED|Second Platelets Transfusion||8
8330541|NCT01368211|20536018|P2|NOT COMPLETED|First Platelets Transfusion||0
8330542|NCT01368211|20536019|P1|NOT COMPLETED|First Platelets Transfusion||0
8330543|NCT01368211|20536018|P2|COMPLETED|First Platelets Transfusion||7
8330544|NCT01368211|20536019|P1|COMPLETED|First Platelets Transfusion||8
8330545|NCT01368211|20536018|P2|STARTED|First Platelets Transfusion||7
8330546|NCT01368211|20536019|P1|STARTED|First Platelets Transfusion||8
8330547|NCT01368185|20536027|P1|NOT COMPLETED|Overall Study||0
8330548|NCT01368185|20536027|P1|COMPLETED|Overall Study||1705
8330549|NCT01368185|20536027|P1|STARTED|Overall Study||1705
8330550|NCT01368081|20536047|P13|NOT COMPLETED|Overall Study||7
8330551|NCT01368081|20536048|P12|NOT COMPLETED|Overall Study||3
8330552|NCT01368081|20536049|P11|NOT COMPLETED|Overall Study||9
8330553|NCT01368081|20536050|P10|NOT COMPLETED|Overall Study||10
8330554|NCT01368081|20536051|P9|NOT COMPLETED|Overall Study||8
8330555|NCT01368081|20536052|P8|NOT COMPLETED|Overall Study||7
8330556|NCT01368081|20536053|P7|NOT COMPLETED|Overall Study||12
8330557|NCT01368081|20536054|P6|NOT COMPLETED|Overall Study||10
8330558|NCT01368081|20536055|P5|NOT COMPLETED|Overall Study||2
8330559|NCT01368081|20536056|P4|NOT COMPLETED|Overall Study||5
8330560|NCT01368081|20536057|P3|NOT COMPLETED|Overall Study||4
8330561|NCT01368081|20536058|P2|NOT COMPLETED|Overall Study||9
8330562|NCT01368081|20536059|P1|NOT COMPLETED|Overall Study||10
8330563|NCT01368081|20536047|P13|COMPLETED|Overall Study||63
8330564|NCT01368081|20536048|P12|COMPLETED|Overall Study||67
8330565|NCT01368081|20536049|P11|COMPLETED|Overall Study||62
8330566|NCT01368081|20536050|P10|COMPLETED|Overall Study||58
8330567|NCT01368081|20536051|P9|COMPLETED|Overall Study||62
8330568|NCT01368081|20536052|P8|COMPLETED|Overall Study||62
8330569|NCT01368081|20536053|P7|COMPLETED|Overall Study||124
8330570|NCT01368081|20536054|P6|COMPLETED|Overall Study||127
8330571|NCT01368081|20536055|P5|COMPLETED|Overall Study||63
8330572|NCT01368081|20536056|P4|COMPLETED|Overall Study||63
8330573|NCT01368081|20536057|P3|COMPLETED|Overall Study||59
8330574|NCT01368081|20536058|P2|COMPLETED|Overall Study||128
8330575|NCT01368081|20536059|P1|COMPLETED|Overall Study||126
8330576|NCT01368081|20536047|P13|STARTED|Overall Study||70
8330577|NCT01368081|20536048|P12|STARTED|Overall Study||70
8330578|NCT01368081|20536049|P11|STARTED|Overall Study||71
8330579|NCT01368081|20536050|P10|STARTED|Overall Study||68
8330580|NCT01368081|20536051|P9|STARTED|Overall Study||70
8330581|NCT01368081|20536052|P8|STARTED|Overall Study||69
8330582|NCT01368081|20536053|P7|STARTED|Overall Study||136
8330583|NCT01368081|20536054|P6|STARTED|Overall Study||137
8330584|NCT01368081|20536055|P5|STARTED|Overall Study||65
8330585|NCT01368081|20536056|P4|STARTED|Overall Study||68
8330586|NCT01368081|20536057|P3|STARTED|Overall Study||63
8330587|NCT01368081|20536058|P2|STARTED|Overall Study||137
8330588|NCT01368081|20536059|P1|STARTED|Overall Study||136
8330589|NCT01368042|20536113|P1|NOT COMPLETED|Overall Study||30
8330590|NCT01368042|20536113|P1|COMPLETED|Overall Study||235
8330591|NCT01368042|20536113|P1|STARTED|Overall Study||265
8330592|NCT01367886|20536133|P1|NOT COMPLETED|Overall Study||7
8330593|NCT01367886|20536133|P1|COMPLETED|Overall Study||14
8330594|NCT01367886|20536133|P1|STARTED|Overall Study||21
8330595|NCT01367860|20536142|P2|NOT COMPLETED|Overall Study||0
8330596|NCT01367860|20536143|P1|NOT COMPLETED|Overall Study||0
8330597|NCT01367860|20536142|P2|COMPLETED|Overall Study||20
8330598|NCT01367860|20536143|P1|COMPLETED|Overall Study||20
8330599|NCT01367860|20536142|P2|STARTED|Overall Study||20
8330600|NCT01367860|20536143|P1|STARTED|Overall Study||20
8330601|NCT01367847|20536183|P2|NOT COMPLETED|Overall Study||2
8330602|NCT01367847|20536184|P1|NOT COMPLETED|Overall Study||2
8330603|NCT01367847|20536183|P2|COMPLETED|Overall Study||7
8330604|NCT01367847|20536184|P1|COMPLETED|Overall Study||8
8330605|NCT01367847|20536183|P2|STARTED|Overall Study||9
8330606|NCT01367847|20536184|P1|STARTED|Overall Study||10
8330607|NCT01367834|20536200|P2|NOT COMPLETED|Overall Study||3
8330608|NCT01367834|20536201|P1|NOT COMPLETED|Overall Study||2
8330609|NCT01367834|20536200|P2|COMPLETED|Overall Study||3
8330610|NCT01367834|20536201|P1|COMPLETED|Overall Study||9
8330611|NCT01367834|20536200|P2|STARTED|Overall Study||6
8330612|NCT01367834|20536201|P1|STARTED|Overall Study||11
8330613|NCT01367704|20536225|P2|NOT COMPLETED|Overall Study||161
8330614|NCT01367704|20536226|P1|NOT COMPLETED|Overall Study||47
8330615|NCT01367704|20536225|P2|COMPLETED|Overall Study||847
8330616|NCT01367704|20536226|P1|COMPLETED|Overall Study||951
8330617|NCT01367704|20536225|P2|STARTED|Overall Study||1008
8330618|NCT01367704|20536226|P1|STARTED|Overall Study||998
8330619|NCT01367665|20536238|P2|NOT COMPLETED|Overall Study||55
8330620|NCT01367665|20536239|P1|NOT COMPLETED|Overall Study||442
8330621|NCT01367665|20536238|P2|COMPLETED|Overall Study||41
8330622|NCT01367665|20536239|P1|COMPLETED|Overall Study||677
8330623|NCT01367665|20536238|P2|STARTED|Overall Study||96
8330624|NCT01367665|20536239|P1|STARTED|Overall Study||1119
8330625|NCT01367457|20536270|P3|NOT COMPLETED|Overall Study||0
8330626|NCT01367457|20536271|P2|NOT COMPLETED|Overall Study||0
8330627|NCT01367457|20536272|P1|NOT COMPLETED|Overall Study||188
8330628|NCT01367457|20536270|P3|COMPLETED|Overall Study||26
8330629|NCT01367457|20536271|P2|COMPLETED|Overall Study||23
8330630|NCT01367457|20536272|P1|COMPLETED|Overall Study||5
8330631|NCT01367457|20536270|P3|STARTED|Overall Study||26
8330632|NCT01367457|20536271|P2|STARTED|Overall Study||23
8330633|NCT01367457|20536272|P1|STARTED|Overall Study||193
8330634|NCT01367444|20536299|P7|NOT COMPLETED|Overall Study||0
8330635|NCT01367444|20536300|P6|NOT COMPLETED|Overall Study||0
8330636|NCT01367444|20536301|P5|NOT COMPLETED|Overall Study||0
8330637|NCT01367444|20536302|P4|NOT COMPLETED|Overall Study||0
8330638|NCT01367444|20536303|P3|NOT COMPLETED|Overall Study||0
8330639|NCT01367444|20536304|P2|NOT COMPLETED|Overall Study||0
8330640|NCT01367444|20536305|P1|NOT COMPLETED|Overall Study||0
8330641|NCT01367444|20536299|P7|COMPLETED|Overall Study||1
8330642|NCT01367444|20536300|P6|COMPLETED|Overall Study||4
8330643|NCT01367444|20536301|P5|COMPLETED|Overall Study||6
8330644|NCT01367444|20536302|P4|COMPLETED|Overall Study||4
8330645|NCT01367444|20536303|P3|COMPLETED|Overall Study||4
8330646|NCT01367444|20536304|P2|COMPLETED|Overall Study||4
8330647|NCT01367444|20536305|P1|COMPLETED|Overall Study||4
8330648|NCT01367444|20536299|P7|STARTED|Overall Study||1
8330649|NCT01367444|20536300|P6|STARTED|Overall Study||4
8330650|NCT01367444|20536301|P5|STARTED|Overall Study||6
8330651|NCT01367444|20536302|P4|STARTED|Overall Study||4
8330652|NCT01367444|20536303|P3|STARTED|Overall Study||4
8330653|NCT01367444|20536304|P2|STARTED|Overall Study||4
8330654|NCT01367444|20536305|P1|STARTED|Overall Study||4
8330655|NCT01367275|20536328|P1|NOT COMPLETED|Overall Study||3
8330656|NCT01367275|20536328|P1|COMPLETED|Overall Study||5
8330657|NCT01367275|20536328|P1|STARTED|Overall Study||8
8330658|NCT01367262|20536332|P1|NOT COMPLETED|Overall Study||0
8330659|NCT01367262|20536332|P1|COMPLETED|Overall Study||6
8330660|NCT01367262|20536332|P1|STARTED|Overall Study||6
8330661|NCT01367249|20536345|P2|NOT COMPLETED|Overall Study||16
8330662|NCT01367249|20536346|P1|NOT COMPLETED|Overall Study||9
8330663|NCT01367249|20536345|P2|COMPLETED|Overall Study||202
8330664|NCT01367249|20536346|P1|COMPLETED|Overall Study||213
8330665|NCT01367249|20536345|P2|STARTED|Overall Study||218
8330666|NCT01367249|20536346|P1|STARTED|Overall Study||222
8330667|NCT01367236|20536356|P2|NOT COMPLETED|Overall Study||1
8330668|NCT01367236|20536357|P1|NOT COMPLETED|Overall Study||3
8330669|NCT01367236|20536356|P2|COMPLETED|Overall Study||29
8330670|NCT01367236|20536357|P1|COMPLETED|Overall Study||27
8330671|NCT01367236|20536356|P2|STARTED|Overall Study||30
8330672|NCT01367236|20536357|P1|STARTED|Overall Study||30
8330673|NCT01367158|20536376|P11|NOT COMPLETED|Overall Study||1
8330674|NCT01367158|20536377|P10|NOT COMPLETED|Overall Study||0
8330675|NCT01367158|20536378|P9|NOT COMPLETED|Overall Study||0
8330676|NCT01367158|20536379|P8|NOT COMPLETED|Overall Study||2
8330677|NCT01367158|20536380|P7|NOT COMPLETED|Overall Study||0
8330678|NCT01367158|20536381|P6|NOT COMPLETED|Overall Study||2
8330679|NCT01367158|20536382|P5|NOT COMPLETED|Overall Study||2
8330680|NCT01367158|20536383|P4|NOT COMPLETED|Overall Study||1
8330681|NCT01367158|20536384|P3|NOT COMPLETED|Overall Study||1
8330682|NCT01367158|20536385|P2|NOT COMPLETED|Overall Study||3
8330683|NCT01367158|20536386|P1|NOT COMPLETED|Overall Study||0
8330684|NCT01367158|20536376|P11|COMPLETED|Overall Study||72
8330685|NCT01367158|20536377|P10|COMPLETED|Overall Study||50
8330686|NCT01367158|20536378|P9|COMPLETED|Overall Study||23
8330687|NCT01367158|20536379|P8|COMPLETED|Overall Study||47
8330688|NCT01367158|20536380|P7|COMPLETED|Overall Study||25
8330689|NCT01367158|20536381|P6|COMPLETED|Overall Study||46
8330690|NCT01367158|20536382|P5|COMPLETED|Overall Study||23
8330691|NCT01367158|20536383|P4|COMPLETED|Overall Study||48
8330692|NCT01367158|20536384|P3|COMPLETED|Overall Study||23
8330693|NCT01367158|20536385|P2|COMPLETED|Overall Study||46
8330694|NCT01367158|20536386|P1|COMPLETED|Overall Study||25
8330695|NCT01367158|20536376|P11|STARTED|Overall Study||73
8330696|NCT01367158|20536377|P10|STARTED|Overall Study||50
8330697|NCT01367158|20536378|P9|STARTED|Overall Study||23
8330698|NCT01367158|20536379|P8|STARTED|Overall Study||49
8330699|NCT01367158|20536380|P7|STARTED|Overall Study||25
8330700|NCT01367158|20536381|P6|STARTED|Overall Study||48
8330701|NCT01367158|20536382|P5|STARTED|Overall Study||25
8330702|NCT01367158|20536383|P4|STARTED|Overall Study||49
8330703|NCT01367158|20536384|P3|STARTED|Overall Study||24
8330704|NCT01367158|20536385|P2|STARTED|Overall Study||49
8330705|NCT01367158|20536386|P1|STARTED|Overall Study||25
8330706|NCT01367119|20536530|P2|NOT COMPLETED|Overall Study||1
8330707|NCT01367119|20536531|P1|NOT COMPLETED|Overall Study||2
8330708|NCT01367119|20536530|P2|COMPLETED|Overall Study||16
8330709|NCT01367119|20536531|P1|COMPLETED|Overall Study||19
8330710|NCT01367119|20536530|P2|STARTED|Overall Study||17
8330711|NCT01367119|20536531|P1|STARTED|Overall Study||21
8330712|NCT01367080|20536543|P2|NOT COMPLETED|2nd Administration||0
8330713|NCT01367080|20536544|P1|NOT COMPLETED|2nd Administration||0
8330714|NCT01367080|20536543|P2|COMPLETED|2nd Administration||6
8330715|NCT01367080|20536544|P1|COMPLETED|2nd Administration||6
8330716|NCT01367080|20536543|P2|STARTED|2nd Administration||6
8330717|NCT01367080|20536544|P1|STARTED|2nd Administration||6
8330718|NCT01367080|20536543|P2|NOT COMPLETED|1st Administration||0
8330719|NCT01367080|20536544|P1|NOT COMPLETED|1st Administration||0
8330720|NCT01367080|20536543|P2|COMPLETED|1st Administration||6
8330721|NCT01367080|20536544|P1|COMPLETED|1st Administration||6
8330722|NCT01367080|20536543|P2|STARTED|1st Administration||6
8330723|NCT01367080|20536544|P1|STARTED|1st Administration||6
8330724|NCT01366976|20536558|P2|NOT COMPLETED|Overall Study||0
8330725|NCT01366976|20536559|P1|NOT COMPLETED|Overall Study||0
8330726|NCT01366976|20536558|P2|COMPLETED|Overall Study||30
8330727|NCT01366976|20536559|P1|COMPLETED|Overall Study||30
8330728|NCT01366976|20536558|P2|STARTED|Overall Study||30
8330729|NCT01366976|20536559|P1|STARTED|Overall Study||30
8330730|NCT01366885|20536571|P1|NOT COMPLETED|Overall Study||1
8330731|NCT01366885|20536571|P1|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
8330732|NCT01366885|20536571|P1|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
8330733|NCT01366872|20536576|P1|NOT COMPLETED|Overall Study||0
8330734|NCT01366872|20536576|P1|COMPLETED|Overall Study||50
8330735|NCT01366872|20536576|P1|STARTED|Overall Study||50
8330736|NCT01366846|20536586|P4|NOT COMPLETED|Overall Study||1
8330737|NCT01366846|20536587|P3|NOT COMPLETED|Overall Study||1
8330738|NCT01366846|20536588|P2|NOT COMPLETED|Overall Study||4
8330739|NCT01366846|20536589|P1|NOT COMPLETED|Overall Study||3
8330740|NCT01366846|20536586|P4|COMPLETED|Overall Study||45
8330741|NCT01366846|20536587|P3|COMPLETED|Overall Study||46
8330742|NCT01366846|20536588|P2|COMPLETED|Overall Study||224
8330743|NCT01366846|20536589|P1|COMPLETED|Overall Study||232
8330744|NCT01366846|20536586|P4|STARTED|Overall Study||46
8330745|NCT01366846|20536587|P3|STARTED|Overall Study||47
8330746|NCT01366846|20536588|P2|STARTED|Overall Study||228
8330747|NCT01366846|20536589|P1|STARTED|Overall Study||235
8330748|NCT01366638|20536612|P3|NOT COMPLETED|Overall Study||6
8330749|NCT01366638|20536613|P2|NOT COMPLETED|Overall Study||0
8330750|NCT01366638|20536614|P1|NOT COMPLETED|Overall Study||1
8330751|NCT01366638|20536612|P3|COMPLETED|Overall Study||20
8330752|NCT01366638|20536613|P2|COMPLETED|Overall Study||29
8330753|NCT01366638|20536614|P1|COMPLETED|Overall Study||23
8330754|NCT01366638|20536612|P3|STARTED|Overall Study||26
8330755|NCT01366638|20536613|P2|STARTED|Overall Study||29
8330756|NCT01366638|20536614|P1|STARTED|Overall Study||24
8330757|NCT01366534|20536651|P3|NOT COMPLETED|Overall Study||0
8330758|NCT01366534|20536652|P2|NOT COMPLETED|Overall Study||2
8330759|NCT01366534|20536653|P1|NOT COMPLETED|Overall Study||2
8330760|NCT01366534|20536651|P3|COMPLETED|Overall Study||12
8330761|NCT01366534|20536652|P2|COMPLETED|Overall Study||25
8330762|NCT01366534|20536653|P1|COMPLETED|Overall Study||26
8330763|NCT01366534|20536651|P3|STARTED|Overall Study||12
8330764|NCT01366534|20536652|P2|STARTED|Overall Study||27
8330765|NCT01366534|20536653|P1|STARTED|Overall Study||28
8330766|NCT01366521|20536703|P4|NOT COMPLETED|Overall Study||0
8330767|NCT01366521|20536704|P3|NOT COMPLETED|Overall Study||2
8330768|NCT01366521|20536705|P2|NOT COMPLETED|Overall Study||1
8330769|NCT01366521|20536706|P1|NOT COMPLETED|Overall Study||1
8330770|NCT01366521|20536703|P4|COMPLETED|Overall Study||11
8330771|NCT01366521|20536704|P3|COMPLETED|Overall Study||21
8330772|NCT01366521|20536705|P2|COMPLETED|Overall Study||14
8330773|NCT01366521|20536706|P1|COMPLETED|Overall Study||20
8330774|NCT01366521|20536703|P4|STARTED|Overall Study||11
8330775|NCT01366521|20536704|P3|STARTED|Overall Study||23
8330776|NCT01366521|20536705|P2|STARTED|Overall Study||15
8330777|NCT01366521|20536706|P1|STARTED|Overall Study||21
8330778|NCT01366495|20536785|P4|NOT COMPLETED|HIV Study||0
8330779|NCT01366495|20536786|P3|NOT COMPLETED|HIV Study||0
8330780|NCT01366495|20536787|P2|NOT COMPLETED|HIV Study||0
8330781|NCT01366495|20536788|P1|NOT COMPLETED|HIV Study||1
8330782|NCT01366495|20536785|P4|COMPLETED|HIV Study||0
8330783|NCT01366495|20536786|P3|COMPLETED|HIV Study||0
8330784|NCT01366495|20536787|P2|COMPLETED|HIV Study||50
8330785|NCT01366495|20536788|P1|COMPLETED|HIV Study||49
8330786|NCT01366495|20536785|P4|STARTED|HIV Study||0
8330787|NCT01366495|20536786|P3|STARTED|HIV Study||0
8330788|NCT01366495|20536787|P2|STARTED|HIV Study||50
8330789|NCT01366495|20536788|P1|STARTED|HIV Study||50
8330790|NCT01366495|20536785|P4|NOT COMPLETED|Testing Study||0
8330791|NCT01366495|20536786|P3|NOT COMPLETED|Testing Study||0
8330792|NCT01366495|20536787|P2|NOT COMPLETED|Testing Study||0
8330793|NCT01366495|20536788|P1|NOT COMPLETED|Testing Study||0
8330794|NCT01366495|20536785|P4|COMPLETED|Testing Study||348
8330795|NCT01366495|20536786|P3|COMPLETED|Testing Study||349
8330796|NCT01366495|20536787|P2|COMPLETED|Testing Study||0
8330797|NCT01366495|20536788|P1|COMPLETED|Testing Study||0
8330798|NCT01366495|20536785|P4|STARTED|Testing Study||348
8330799|NCT01366495|20536786|P3|STARTED|Testing Study||349
8330800|NCT01366495|20536787|P2|STARTED|Testing Study||0
8330801|NCT01366495|20536788|P1|STARTED|Testing Study||0
8330802|NCT01366443|20536802|P1|NOT COMPLETED|Overall Study||3
8330803|NCT01366443|20536802|P1|COMPLETED|Overall Study||285
8330804|NCT01366443|20536802|P1|STARTED|Overall Study||288
8330805|NCT01366417|20536807|P1|NOT COMPLETED|Overall Study||18
8330806|NCT01366417|20536807|P1|COMPLETED|Overall Study|25 subjects included in the analysis|25
8330807|NCT01366417|20536807|P1|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
8330808|NCT01366417|20536807|P1|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
8330809|NCT01366417|20536807|P1|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
8330810|NCT01366417|20536807|P1|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
8330811|NCT01366417|20536807|P1|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
8330812|NCT01366417|20536807|P1|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
8330813|NCT01366417|20536807|P1|STARTED|Overall Study||43
8330814|NCT01366209|20536816|P2|NOT COMPLETED|Overall Study||36
8330815|NCT01366209|20536817|P1|NOT COMPLETED|Overall Study||35
8330816|NCT01366209|20536816|P2|COMPLETED|Overall Study||241
8330817|NCT01366209|20536817|P1|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
8330818|NCT01366209|20536816|P2|STARTED|Overall Study||277
8330819|NCT01366209|20536817|P1|STARTED|Overall Study||278
8330820|NCT01366196|20536825|P2|NOT COMPLETED|Overall Study||0
8330821|NCT01366196|20536826|P1|NOT COMPLETED|Overall Study||0
8330822|NCT01366196|20536825|P2|COMPLETED|Overall Study||43
8330823|NCT01366196|20536826|P1|COMPLETED|Overall Study||43
8330824|NCT01366196|20536825|P2|STARTED|Overall Study||43
8330825|NCT01366196|20536826|P1|STARTED|Overall Study||43
8330826|NCT01365910|20536840|P1|NOT COMPLETED|Overall Study||30
8330827|NCT01365910|20536840|P1|COMPLETED|Overall Study||0
8330828|NCT01365910|20536840|P1|STARTED|Overall Study||30
8330829|NCT01365845|20536847|P3|NOT COMPLETED|Treatment Phase||0
8330830|NCT01365845|20536848|P2|NOT COMPLETED|Treatment Phase||0
8330831|NCT01365845|20536849|P1|NOT COMPLETED|Treatment Phase||0
8330832|NCT01365845|20536847|P3|COMPLETED|Treatment Phase||18
8330833|NCT01365845|20536848|P2|COMPLETED|Treatment Phase||0
8330834|NCT01365845|20536849|P1|COMPLETED|Treatment Phase||0
8330835|NCT01365845|20536847|P3|STARTED|Treatment Phase||18
8330836|NCT01365845|20536848|P2|STARTED|Treatment Phase||0
8330837|NCT01365845|20536849|P1|STARTED|Treatment Phase||0
8330838|NCT01365845|20536847|P3|NOT COMPLETED|Induction Phase||0
8330839|NCT01365845|20536848|P2|NOT COMPLETED|Induction Phase||0
8330840|NCT01365845|20536849|P1|NOT COMPLETED|Induction Phase||0
8330841|NCT01365845|20536847|P3|COMPLETED|Induction Phase||0
8330842|NCT01365845|20536848|P2|COMPLETED|Induction Phase||0
8330843|NCT01365845|20536849|P1|COMPLETED|Induction Phase||18
8330844|NCT01365845|20536847|P3|STARTED|Induction Phase||0
8330845|NCT01365845|20536848|P2|STARTED|Induction Phase||0
8330846|NCT01365845|20536849|P1|STARTED|Induction Phase||18
8330847|NCT01365819|20536856|P2|NOT COMPLETED|Overall Study||13
8330848|NCT01365819|20536857|P1|NOT COMPLETED|Overall Study||13
8330849|NCT01365819|20536856|P2|COMPLETED|Overall Study||14
8330850|NCT01365819|20536857|P1|COMPLETED|Overall Study||12
8330851|NCT01365819|20536856|P2|STARTED|Overall Study||27
8330852|NCT01365819|20536857|P1|STARTED|Overall Study||25
8330853|NCT01365793|20536875|P4|NOT COMPLETED|Overall Study||2
8330854|NCT01365793|20536876|P3|NOT COMPLETED|Overall Study||7
8330855|NCT01365793|20536877|P2|NOT COMPLETED|Overall Study||7
8330856|NCT01365793|20536878|P1|NOT COMPLETED|Overall Study||2
8330857|NCT01365793|20536875|P4|COMPLETED|Overall Study||347
8330858|NCT01365793|20536876|P3|COMPLETED|Overall Study||338
8330859|NCT01365793|20536877|P2|COMPLETED|Overall Study||344
8330860|NCT01365793|20536878|P1|COMPLETED|Overall Study||342
8330861|NCT01365793|20536875|P4|STARTED|Overall Study||349
8330862|NCT01365793|20536876|P3|STARTED|Overall Study||345
8330863|NCT01365793|20536877|P2|STARTED|Overall Study||351
8330864|NCT01365793|20536878|P1|STARTED|Overall Study||344
8330865|NCT01365650|20536904|P1|NOT COMPLETED|Treatment C||0
8330866|NCT01365650|20536904|P1|COMPLETED|Treatment C||24
8330867|NCT01365650|20536904|P1|STARTED|Treatment C||24
8330868|NCT01365650|20536904|P1|NOT COMPLETED|Treatment B||0
8330869|NCT01365650|20536904|P1|COMPLETED|Treatment B||24
8330870|NCT01365650|20536904|P1|STARTED|Treatment B||24
8330871|NCT01365650|20536904|P1|NOT COMPLETED|Treatment A||0
8330872|NCT01365650|20536904|P1|COMPLETED|Treatment A||24
8330873|NCT01365650|20536904|P1|STARTED|Treatment A||24
8330874|NCT01365624|20536929|P2|NOT COMPLETED|Overall Study||0
8330875|NCT01365624|20536930|P1|NOT COMPLETED|Overall Study||0
8330876|NCT01365624|20536929|P2|COMPLETED|Overall Study||15
8330877|NCT01365624|20536930|P1|COMPLETED|Overall Study||15
8330878|NCT01365624|20536929|P2|STARTED|Overall Study||15
8330879|NCT01365624|20536930|P1|STARTED|Overall Study||15
8330880|NCT01365611|20536946|P1|NOT COMPLETED|Overall Study||0
8330881|NCT01365611|20536946|P1|COMPLETED|Overall Study||36
8330882|NCT01365611|20536946|P1|STARTED|Overall Study||36
8330886|NCT01365546|20536976|P1|NOT COMPLETED|Overall Study||11
8330887|NCT01365546|20536976|P1|COMPLETED|Overall Study||30
8330888|NCT01365546|20536976|P1|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
8330889|NCT01365507|20536986|P2|NOT COMPLETED|Overall Study||9
8330890|NCT01365507|20536987|P1|NOT COMPLETED|Overall Study||9
8330891|NCT01365507|20536986|P2|COMPLETED|Overall Study||131
8330892|NCT01365507|20536987|P1|COMPLETED|Overall Study||127
8330893|NCT01365507|20536986|P2|Exposed|Overall Study||140
8330894|NCT01365507|20536987|P1|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
8330895|NCT01365507|20536986|P2|STARTED|Overall Study||140
8330896|NCT01365507|20536987|P1|STARTED|Overall Study||136
8330897|NCT01365494|20537003|P2|NOT COMPLETED|Overall Study||3
8330898|NCT01365494|20537004|P1|NOT COMPLETED|Overall Study||2
8330899|NCT01365494|20537003|P2|COMPLETED|Overall Study||121
8330900|NCT01365494|20537004|P1|COMPLETED|Overall Study||124
8330901|NCT01365494|20537003|P2|STARTED|Overall Study||124
8330902|NCT01365494|20537004|P1|STARTED|Overall Study||126
8330903|NCT01365481|20537020|P4|NOT COMPLETED|Overall Study||7
8330904|NCT01365481|20537021|P3|NOT COMPLETED|Overall Study||4
8330905|NCT01365481|20537022|P2|NOT COMPLETED|Overall Study||15
8330906|NCT01365481|20537023|P1|NOT COMPLETED|Overall Study||7
8330907|NCT01365481|20537020|P4|COMPLETED|Overall Study||50
8330908|NCT01365481|20537021|P3|COMPLETED|Overall Study||14
8330909|NCT01365481|20537022|P2|COMPLETED|Overall Study||37
8330910|NCT01365481|20537023|P1|COMPLETED|Overall Study||16
8330911|NCT01365481|20537020|P4|STARTED|Overall Study||57
8330912|NCT01365481|20537021|P3|STARTED|Overall Study||18
8330913|NCT01365481|20537022|P2|STARTED|Overall Study||52
8330914|NCT01365481|20537023|P1|STARTED|Overall Study||23
8330915|NCT01365468|20537043|P2|NOT COMPLETED|Overall Study||0
8330916|NCT01365468|20537044|P1|NOT COMPLETED|Overall Study||4
8330917|NCT01365468|20537043|P2|COMPLETED|Overall Study||5
8330918|NCT01365468|20537044|P1|COMPLETED|Overall Study||0
8330919|NCT01365468|20537043|P2|STARTED|Overall Study||5
8330920|NCT01365468|20537044|P1|STARTED|Overall Study||4
8330921|NCT01365455|20537059|P5|NOT COMPLETED|Follow-up Period||0
8330922|NCT01365455|20537060|P4|NOT COMPLETED|Follow-up Period||0
8330923|NCT01365455|20537061|P3|NOT COMPLETED|Follow-up Period||0
8330924|NCT01365455|20537062|P2|NOT COMPLETED|Follow-up Period||0
8330925|NCT01365455|20537063|P1|NOT COMPLETED|Follow-up Period||0
8330926|NCT01365455|20537059|P5|COMPLETED|Follow-up Period||0
8330927|NCT01365455|20537060|P4|COMPLETED|Follow-up Period||0
8330928|NCT01365455|20537061|P3|COMPLETED|Follow-up Period||18
8330929|NCT01365455|20537062|P2|COMPLETED|Follow-up Period||47
8330930|NCT01365455|20537063|P1|COMPLETED|Follow-up Period||58
8330931|NCT01365455|20537059|P5|STARTED|Follow-up Period||0
8330932|NCT01365455|20537060|P4|STARTED|Follow-up Period||0
8330933|NCT01365455|20537061|P3|STARTED|Follow-up Period||18
8330934|NCT01365455|20537062|P2|STARTED|Follow-up Period||47
8330935|NCT01365455|20537063|P1|STARTED|Follow-up Period||58
8330936|NCT01365455|20537059|P5|NOT COMPLETED|Maintenance Period||13
8330937|NCT01365455|20537060|P4|NOT COMPLETED|Maintenance Period||9
8330938|NCT01365455|20537061|P3|NOT COMPLETED|Maintenance Period||3
8330939|NCT01365455|20537062|P2|NOT COMPLETED|Maintenance Period||23
8330940|NCT01365455|20537063|P1|NOT COMPLETED|Maintenance Period||29
8330941|NCT01365455|20537059|P5|COMPLETED|Maintenance Period||92
8330942|NCT01365455|20537060|P4|COMPLETED|Maintenance Period||100
8330943|NCT01365455|20537061|P3|COMPLETED|Maintenance Period||15
8330944|NCT01365455|20537062|P2|COMPLETED|Maintenance Period||215
8330945|NCT01365455|20537063|P1|COMPLETED|Maintenance Period||201
8330946|NCT01365455|20537059|P5|STARTED|Maintenance Period||105
8330947|NCT01365455|20537060|P4|STARTED|Maintenance Period||109
8330948|NCT01365455|20537061|P3|STARTED|Maintenance Period||18
8330949|NCT01365455|20537062|P2|STARTED|Maintenance Period||238
8330950|NCT01365455|20537063|P1|STARTED|Maintenance Period||230
8330951|NCT01365455|20537059|P5|NOT COMPLETED|Induction Period||0
8330952|NCT01365455|20537060|P4|NOT COMPLETED|Induction Period||0
8330953|NCT01365455|20537061|P3|NOT COMPLETED|Induction Period||16
8330954|NCT01365455|20537062|P2|NOT COMPLETED|Induction Period||7
8330955|NCT01365455|20537063|P1|NOT COMPLETED|Induction Period||15
8330956|NCT01365455|20537059|P5|COMPLETED|Induction Period||0
8330957|NCT01365455|20537060|P4|COMPLETED|Induction Period||0
8330958|NCT01365455|20537061|P3|COMPLETED|Induction Period||232
8330959|NCT01365455|20537062|P2|COMPLETED|Induction Period||238
8330960|NCT01365455|20537063|P1|COMPLETED|Induction Period||230
8330961|NCT01365455|20537059|P5|STARTED|Induction Period||0
8330962|NCT01365455|20537060|P4|STARTED|Induction Period||0
8330963|NCT01365455|20537061|P3|STARTED|Induction Period||248
8330964|NCT01365455|20537062|P2|STARTED|Induction Period||245
8330965|NCT01365455|20537063|P1|STARTED|Induction Period||245
8330966|NCT01365273|20537153|P2|NOT COMPLETED|Overall Study||1
8330967|NCT01365273|20537154|P1|NOT COMPLETED|Overall Study||2
8330968|NCT01365273|20537153|P2|COMPLETED|Overall Study||20
8330969|NCT01365273|20537154|P1|COMPLETED|Overall Study||20
8330970|NCT01365273|20537153|P2|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
8330971|NCT01365273|20537154|P1|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
8330972|NCT01365273|20537153|P2|STARTED|Overall Study||21
8330973|NCT01365273|20537154|P1|STARTED|Overall Study||22
8330974|NCT01365130|20537164|P1|NOT COMPLETED|Overall Study||2
8330975|NCT01365130|20537164|P1|COMPLETED|Overall Study||13
8330976|NCT01365130|20537164|P1|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
8330977|NCT01365091|20537173|P4|NOT COMPLETED|Period 2||0
8330978|NCT01365091|20537174|P3|NOT COMPLETED|Period 2||1
8330979|NCT01365091|20537175|P2|NOT COMPLETED|Period 2||0
8330980|NCT01365091|20537176|P1|NOT COMPLETED|Period 2||1
8330981|NCT01365091|20537173|P4|COMPLETED|Period 2||25
8330982|NCT01365091|20537174|P3|COMPLETED|Period 2||24
8330983|NCT01365091|20537175|P2|COMPLETED|Period 2||26
8330984|NCT01365091|20537176|P1|COMPLETED|Period 2||25
8330985|NCT01365091|20537173|P4|STARTED|Period 2||25
8330986|NCT01365091|20537174|P3|STARTED|Period 2||25
8330987|NCT01365091|20537175|P2|STARTED|Period 2||26
8330988|NCT01365091|20537176|P1|STARTED|Period 2||26
8330989|NCT01365091|20537173|P4|NOT COMPLETED|Period 1||3
8330990|NCT01365091|20537174|P3|NOT COMPLETED|Period 1||3
8330991|NCT01365091|20537175|P2|NOT COMPLETED|Period 1||2
8330992|NCT01365091|20537176|P1|NOT COMPLETED|Period 1||2
8330993|NCT01365091|20537173|P4|COMPLETED|Period 1||25
8330994|NCT01365091|20537174|P3|COMPLETED|Period 1||25
8330995|NCT01365091|20537175|P2|COMPLETED|Period 1||26
8330996|NCT01365091|20537176|P1|COMPLETED|Period 1||26
8330997|NCT01365091|20537173|P4|STARTED|Period 1||28
8330998|NCT01365091|20537174|P3|STARTED|Period 1||28
8330999|NCT01365091|20537175|P2|STARTED|Period 1||28
8331000|NCT01365091|20537176|P1|STARTED|Period 1||28
8331001|NCT01365052|20537204|P2|NOT COMPLETED|Overall Study||4
8331002|NCT01365052|20537205|P1|NOT COMPLETED|Overall Study||4
8331003|NCT01365052|20537204|P2|COMPLETED|Overall Study||105
8331004|NCT01365052|20537205|P1|COMPLETED|Overall Study||213
8331005|NCT01365052|20537204|P2|STARTED|Overall Study||109
8331006|NCT01365052|20537205|P1|STARTED|Overall Study||217
8331007|NCT01365039|20537221|P2|NOT COMPLETED|Overall Study||0
8331008|NCT01365039|20537222|P1|NOT COMPLETED|Overall Study||1
8331009|NCT01365039|20537221|P2|COMPLETED|Overall Study||87
8331010|NCT01365039|20537222|P1|COMPLETED|Overall Study||85
8331011|NCT01365039|20537221|P2|STARTED|Overall Study||87
8331012|NCT01365039|20537222|P1|STARTED|Overall Study||86
8331013|NCT01364922|20537233|P3|NOT COMPLETED|Double-Blind (DB) Period||5
8331014|NCT01364922|20537234|P2|NOT COMPLETED|Double-Blind (DB) Period||5
8331015|NCT01364922|20537235|P1|NOT COMPLETED|Double-Blind (DB) Period||0
8331016|NCT01364922|20537233|P3|COMPLETED|Double-Blind (DB) Period||42
8331017|NCT01364922|20537234|P2|COMPLETED|Double-Blind (DB) Period||94
8331018|NCT01364922|20537235|P1|COMPLETED|Double-Blind (DB) Period||0
8331019|NCT01364922|20537233|P3|STARTED|Double-Blind (DB) Period||47
8331020|NCT01364922|20537234|P2|STARTED|Double-Blind (DB) Period||99
8331021|NCT01364922|20537235|P1|STARTED|Double-Blind (DB) Period||0
8331022|NCT01364922|20537233|P3|NOT COMPLETED|Open-label (OL) Period||0
8331023|NCT01364922|20537234|P2|NOT COMPLETED|Open-label (OL) Period||0
8331024|NCT01364922|20537235|P1|NOT COMPLETED|Open-label (OL) Period||22
8331025|NCT01364922|20537233|P3|COMPLETED|Open-label (OL) Period||0
8331026|NCT01364922|20537234|P2|COMPLETED|Open-label (OL) Period||0
8331027|NCT01364922|20537235|P1|COMPLETED|Open-label (OL) Period||146
8331028|NCT01364922|20537233|P3|STARTED|Open-label (OL) Period||0
8331029|NCT01364922|20537234|P2|STARTED|Open-label (OL) Period||0
8331030|NCT01364922|20537235|P1|STARTED|Open-label (OL) Period||168
8331031|NCT01364896|20537246|P1|NOT COMPLETED|Overall Study||0
8331032|NCT01364896|20537246|P1|COMPLETED|Overall Study||46
8331033|NCT01364896|20537246|P1|STARTED|Overall Study||46
8331034|NCT01364870|20537257|P3|NOT COMPLETED|Overall Study||14
8331035|NCT01364870|20537258|P2|NOT COMPLETED|Overall Study||30
8331036|NCT01364870|20537259|P1|NOT COMPLETED|Overall Study||22
8331037|NCT01364870|20537257|P3|COMPLETED|Overall Study||58
8331038|NCT01364870|20537258|P2|COMPLETED|Overall Study||93
8331039|NCT01364870|20537259|P1|COMPLETED|Overall Study||100
8331040|NCT01364870|20537257|P3|STARTED|Overall Study||72
8331041|NCT01364870|20537258|P2|STARTED|Overall Study||123
8331042|NCT01364870|20537259|P1|STARTED|Overall Study||122
8331043|NCT01364740|20537270|P1|NOT COMPLETED|Overall Study||0
8331044|NCT01364740|20537270|P1|COMPLETED|Overall Study||10
8331045|NCT01364740|20537270|P1|STARTED|Overall Study||10
8331046|NCT01364727|20537278|P1|NOT COMPLETED|Overall Study||2
8331047|NCT01364727|20537278|P1|COMPLETED|Overall Study||33
8331048|NCT01364727|20537278|P1|STARTED|Overall Study||35
8331049|NCT01364649|20537286|P2|NOT COMPLETED|Overall Study||43
8331050|NCT01364649|20537287|P1|NOT COMPLETED|Overall Study||56
8331051|NCT01364649|20537286|P2|COMPLETED|Overall Study||179
8331052|NCT01364649|20537287|P1|COMPLETED|Overall Study||169
8331053|NCT01364649|20537286|P2|STARTED|Overall Study||222
8331054|NCT01364649|20537287|P1|STARTED|Overall Study||225
8331055|NCT01364623|20537300|P4|NOT COMPLETED|Multiple Dose||0
8331056|NCT01364623|20537301|P3|NOT COMPLETED|Multiple Dose||0
8331057|NCT01364623|20537302|P2|NOT COMPLETED|Multiple Dose||0
8331058|NCT01364623|20537303|P1|NOT COMPLETED|Multiple Dose||0
8331059|NCT01364623|20537300|P4|COMPLETED|Multiple Dose||8
8331060|NCT01364623|20537301|P3|COMPLETED|Multiple Dose||0
8331061|NCT01364623|20537302|P2|COMPLETED|Multiple Dose||0
8331062|NCT01364623|20537303|P1|COMPLETED|Multiple Dose||0
8331063|NCT01364623|20537300|P4|STARTED|Multiple Dose||8
8331064|NCT01364623|20537301|P3|STARTED|Multiple Dose||0
8331065|NCT01364623|20537302|P2|STARTED|Multiple Dose||0
8331066|NCT01364623|20537303|P1|STARTED|Multiple Dose||0
8331067|NCT01364623|20537300|P4|NOT COMPLETED|Single Dose||0
8331068|NCT01364623|20537301|P3|NOT COMPLETED|Single Dose||0
8331069|NCT01364623|20537302|P2|NOT COMPLETED|Single Dose||0
8331070|NCT01364623|20537303|P1|NOT COMPLETED|Single Dose||0
8331071|NCT01364623|20537300|P4|COMPLETED|Single Dose||0
8331072|NCT01364623|20537301|P3|COMPLETED|Single Dose||8
8331073|NCT01364623|20537302|P2|COMPLETED|Single Dose||8
8331074|NCT01364623|20537303|P1|COMPLETED|Single Dose||8
8331075|NCT01364623|20537300|P4|STARTED|Single Dose||0
8331076|NCT01364623|20537301|P3|STARTED|Single Dose||8
8331077|NCT01364623|20537302|P2|STARTED|Single Dose||8
8331078|NCT01364623|20537303|P1|STARTED|Single Dose||8
8331079|NCT01364584|20537328|P2|NOT COMPLETED|Overall Study||0
8331080|NCT01364584|20537329|P1|NOT COMPLETED|Overall Study||0
8331081|NCT01364584|20537328|P2|COMPLETED|Overall Study||12
8331082|NCT01364584|20537329|P1|COMPLETED|Overall Study||11
8331083|NCT01364584|20537328|P2|STARTED|Overall Study||12
8331084|NCT01364584|20537329|P1|STARTED|Overall Study||11
8331085|NCT01364558|20537363|P3|NOT COMPLETED|Dose Three||0
8331086|NCT01364558|20537364|P2|NOT COMPLETED|Dose Three||0
8331087|NCT01364558|20537365|P1|NOT COMPLETED|Dose Three||0
8331088|NCT01364558|20537363|P3|COMPLETED|Dose Three||8
8331089|NCT01364558|20537364|P2|COMPLETED|Dose Three||8
8331090|NCT01364558|20537365|P1|COMPLETED|Dose Three||8
8331091|NCT01364558|20537363|P3|STARTED|Dose Three||8
8331092|NCT01364558|20537364|P2|STARTED|Dose Three||8
8331093|NCT01364558|20537365|P1|STARTED|Dose Three||8
8331094|NCT01364558|20537363|P3|NOT COMPLETED|Dose Two||0
8331095|NCT01364558|20537364|P2|NOT COMPLETED|Dose Two||0
8331096|NCT01364558|20537365|P1|NOT COMPLETED|Dose Two||0
8331097|NCT01364558|20537363|P3|COMPLETED|Dose Two||8
8331098|NCT01364558|20537364|P2|COMPLETED|Dose Two||8
8331099|NCT01364558|20537365|P1|COMPLETED|Dose Two||8
8331100|NCT01364558|20537363|P3|STARTED|Dose Two||8
8331101|NCT01364558|20537364|P2|STARTED|Dose Two||8
8331102|NCT01364558|20537365|P1|STARTED|Dose Two||8
8331103|NCT01364558|20537363|P3|NOT COMPLETED|Dose One||0
8331104|NCT01364558|20537364|P2|NOT COMPLETED|Dose One||0
8331105|NCT01364558|20537365|P1|NOT COMPLETED|Dose One||0
8331106|NCT01364558|20537363|P3|COMPLETED|Dose One||8
8331107|NCT01364558|20537364|P2|COMPLETED|Dose One||8
8331108|NCT01364558|20537365|P1|COMPLETED|Dose One||8
8331109|NCT01364558|20537363|P3|STARTED|Dose One||8
8331110|NCT01364558|20537364|P2|STARTED|Dose One||8
8331111|NCT01364558|20537365|P1|STARTED|Dose One||8
8331112|NCT01364467|20537375|P2|NOT COMPLETED|Overall Study||2
8331113|NCT01364467|20537376|P1|NOT COMPLETED|Overall Study||1
8331114|NCT01364467|20537375|P2|COMPLETED|Overall Study||18
8331115|NCT01364467|20537376|P1|COMPLETED|Overall Study||9
8331116|NCT01364467|20537375|P2|STARTED|Overall Study||20
8331117|NCT01364467|20537376|P1|STARTED|Overall Study||10
8331118|NCT01364428|20537388|P2|NOT COMPLETED|Overall Study||15
8331119|NCT01364428|20537389|P1|NOT COMPLETED|Overall Study||20
8331120|NCT01364428|20537388|P2|COMPLETED|Overall Study||172
8331121|NCT01364428|20537389|P1|COMPLETED|Overall Study||166
8331122|NCT01364428|20537388|P2|Exposed|Overall Study||187
8331123|NCT01364428|20537389|P1|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
8331124|NCT01364428|20537388|P2|STARTED|Overall Study||187
8331125|NCT01364428|20537389|P1|STARTED|Overall Study||186
8331138|NCT01364298|20537427|P2|NOT COMPLETED|Overall Study||23
8331139|NCT01364298|20537428|P1|NOT COMPLETED|Overall Study||14
8331140|NCT01364298|20537427|P2|COMPLETED|Overall Study||154
8331141|NCT01364298|20537428|P1|COMPLETED|Overall Study||162
8331142|NCT01364298|20537427|P2|Treated|Overall Study||174
8331143|NCT01364298|20537428|P1|Treated|Overall Study||174
8331144|NCT01364298|20537427|P2|STARTED|Overall Study||177
8331145|NCT01364298|20537428|P1|STARTED|Overall Study||176
8331146|NCT01364259|20537452|P2|NOT COMPLETED|Overall Study||0
8331147|NCT01364259|20537453|P1|NOT COMPLETED|Overall Study||0
8331148|NCT01364259|20537452|P2|COMPLETED|Overall Study||8
8331149|NCT01364259|20537453|P1|COMPLETED|Overall Study||9
8331150|NCT01364259|20537452|P2|STARTED|Overall Study||8
8331151|NCT01364259|20537453|P1|STARTED|Overall Study||9
8331152|NCT01364233|20537461|P1|NOT COMPLETED|Overall Study||1
8331153|NCT01364233|20537461|P1|COMPLETED|Overall Study||9
8331154|NCT01364233|20537461|P1|STARTED|Overall Study||10
8331155|NCT01364207|20537465|P2|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
8331156|NCT01364207|20537466|P1|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
8331157|NCT01364207|20537465|P2|COMPLETED|Second Visit (~1.5-2 Hours)||54
8331158|NCT01364207|20537466|P1|COMPLETED|Second Visit (~1.5-2 Hours)||52
8331159|NCT01364207|20537465|P2|STARTED|Second Visit (~1.5-2 Hours)||54
8331160|NCT01364207|20537466|P1|STARTED|Second Visit (~1.5-2 Hours)||52
8331161|NCT01364207|20537465|P2|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
8331162|NCT01364207|20537466|P1|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
8331163|NCT01364207|20537465|P2|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
8331164|NCT01364207|20537466|P1|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
8331165|NCT01364207|20537465|P2|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
8331166|NCT01364207|20537466|P1|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
8331167|NCT01364207|20537465|P2|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
8331168|NCT01364207|20537466|P1|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
8331169|NCT01364207|20537465|P2|COMPLETED|First Visit (~1.5-2 Hours)||58
8331170|NCT01364207|20537466|P1|COMPLETED|First Visit (~1.5-2 Hours)||54
8331171|NCT01364207|20537465|P2|STARTED|First Visit (~1.5-2 Hours)||58
8331172|NCT01364207|20537466|P1|STARTED|First Visit (~1.5-2 Hours)||54
8331173|NCT01364090|20537477|P3|NOT COMPLETED|Overall Study||6
8331174|NCT01364090|20537478|P2|NOT COMPLETED|Overall Study||14
8331175|NCT01364090|20537479|P1|NOT COMPLETED|Overall Study||3
8331176|NCT01364090|20537477|P3|COMPLETED|Overall Study||0
8331177|NCT01364090|20537478|P2|COMPLETED|Overall Study||12
8331178|NCT01364090|20537479|P1|COMPLETED|Overall Study||58
8331179|NCT01364090|20537477|P3|STARTED|Overall Study||6
8331180|NCT01364090|20537478|P2|STARTED|Overall Study||26
8331181|NCT01364090|20537479|P1|STARTED|Overall Study||61
8331182|NCT01363999|20537487|P1|NOT COMPLETED|D: RO4607381/ F49 Tablet||0
8331183|NCT01363999|20537487|P1|COMPLETED|D: RO4607381/ F49 Tablet||24
8331184|NCT01363999|20537487|P1|STARTED|D: RO4607381/ F49 Tablet||24
8331185|NCT01363999|20537487|P1|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0
8331186|NCT01363999|20537487|P1|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24
8331187|NCT01363999|20537487|P1|STARTED|C: RO5317116/ F04 Active-coated Tablet||24
8331188|NCT01363999|20537487|P1|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0
8331189|NCT01363999|20537487|P1|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24
8331190|NCT01363999|20537487|P1|STARTED|B: RO5317116/F03 Bilayer Tablet||24
8331191|NCT01363999|20537487|P1|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0
8331192|NCT01363999|20537487|P1|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24
8331193|NCT01363999|20537487|P1|STARTED|A: RO5317116/F01 Bilayer Tablet||24
8331194|NCT01363986|20537506|P1|NOT COMPLETED|Overall Study||1
8331195|NCT01363986|20537506|P1|COMPLETED|Overall Study||2
8331196|NCT01363986|20537506|P1|STARTED|Overall Study||3
8331215|NCT01363843|20537547|P1|NOT COMPLETED|Overall Study||1
8331216|NCT01363843|20537547|P1|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
8331217|NCT01363843|20537547|P1|STARTED|Overall Study||39
8331218|NCT01363765|20537554|P2|NOT COMPLETED|Overall Study||4731
8331219|NCT01363765|20537555|P1|NOT COMPLETED|Overall Study||5800
8331220|NCT01363765|20537554|P2|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
8331221|NCT01363765|20537555|P1|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
8331222|NCT01363765|20537554|P2|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
8331223|NCT01363765|20537555|P1|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
8331224|NCT01363713|20537567|P1|NOT COMPLETED|Overall Study||6
8331225|NCT01363713|20537567|P1|COMPLETED|Overall Study|Analysed (n=130)|124
8331226|NCT01363713|20537567|P1|ALLOCATED|Overall Study||130
8331227|NCT01363713|20537567|P1|STARTED|Overall Study|Assessed for eligibility|130
8331228|NCT01363700|20537576|P5|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8331229|NCT01363700|20537577|P4|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8331230|NCT01363700|20537578|P3|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8331231|NCT01363700|20537579|P2|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8331232|NCT01363700|20537580|P1|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
8331233|NCT01363700|20537576|P5|COMPLETED|Epinastine vs Olopatadine Period2||43
8331234|NCT01363700|20537577|P4|COMPLETED|Epinastine vs Olopatadine Period2||43
8331235|NCT01363700|20537578|P3|COMPLETED|Epinastine vs Olopatadine Period2||0
8331236|NCT01363700|20537579|P2|COMPLETED|Epinastine vs Olopatadine Period2||0
8331237|NCT01363700|20537580|P1|COMPLETED|Epinastine vs Olopatadine Period2||0
8331238|NCT01363700|20537576|P5|STARTED|Epinastine vs Olopatadine Period2||43
8331239|NCT01363700|20537577|P4|STARTED|Epinastine vs Olopatadine Period2||43
8331240|NCT01363700|20537578|P3|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
8331241|NCT01363700|20537579|P2|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
8331242|NCT01363700|20537580|P1|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
8331243|NCT01363700|20537576|P5|NOT COMPLETED|Epinastine vs Placebo Period1||0
8331244|NCT01363700|20537577|P4|NOT COMPLETED|Epinastine vs Placebo Period1||0
8331245|NCT01363700|20537578|P3|NOT COMPLETED|Epinastine vs Placebo Period1||0
8331246|NCT01363700|20537579|P2|NOT COMPLETED|Epinastine vs Placebo Period1||1
8331247|NCT01363700|20537580|P1|NOT COMPLETED|Epinastine vs Placebo Period1||0
8331248|NCT01363700|20537576|P5|COMPLETED|Epinastine vs Placebo Period1||0
8331249|NCT01363700|20537577|P4|COMPLETED|Epinastine vs Placebo Period1||0
8331250|NCT01363700|20537578|P3|COMPLETED|Epinastine vs Placebo Period1||22
8331251|NCT01363700|20537579|P2|COMPLETED|Epinastine vs Placebo Period1||21
8331252|NCT01363700|20537580|P1|COMPLETED|Epinastine vs Placebo Period1||43
8331253|NCT01363700|20537576|P5|STARTED|Epinastine vs Placebo Period1|No Allocation|0
8331254|NCT01363700|20537577|P4|STARTED|Epinastine vs Placebo Period1|No Allocation|0
8331255|NCT01363700|20537578|P3|STARTED|Epinastine vs Placebo Period1||22
8331256|NCT01363700|20537579|P2|STARTED|Epinastine vs Placebo Period1||22
8331257|NCT01363700|20537580|P1|STARTED|Epinastine vs Placebo Period1||43
8331258|NCT01363661|20537599|P2|NOT COMPLETED|Overall Study||4
8331259|NCT01363661|20537600|P1|NOT COMPLETED|Overall Study||14
8331260|NCT01363661|20537599|P2|COMPLETED|Overall Study||28
8331261|NCT01363661|20537600|P1|COMPLETED|Overall Study||18
8331262|NCT01363661|20537599|P2|STARTED|Overall Study||32
8331263|NCT01363661|20537600|P1|STARTED|Overall Study||32
8331267|NCT01363479|20537631|P2|NOT COMPLETED|Overall Study||21
8331268|NCT01363479|20537632|P1|NOT COMPLETED|Overall Study||12
8331269|NCT01363479|20537631|P2|COMPLETED|Overall Study||351
8331270|NCT01363479|20537632|P1|COMPLETED|Overall Study||359
8331271|NCT01363479|20537631|P2|STARTED|Overall Study|number of randomised patients|372
8331272|NCT01363479|20537632|P1|STARTED|Overall Study|number of randomised patients|371
8331273|NCT01363440|20537641|P3|NOT COMPLETED|Overall Study||27
8331274|NCT01363440|20537642|P2|NOT COMPLETED|Overall Study||31
8331275|NCT01363440|20537643|P1|NOT COMPLETED|Overall Study||23
8331276|NCT01363440|20537641|P3|COMPLETED|Overall Study|Completed Week 100|127
8331277|NCT01363440|20537642|P2|COMPLETED|Overall Study|Completed Week 100|125
8331278|NCT01363440|20537643|P1|COMPLETED|Overall Study|Completed Week 100|133
8331279|NCT01363440|20537641|P3|Completed Week 100|Overall Study||127
8331280|NCT01363440|20537642|P2|Completed Week 100|Overall Study||125
8331281|NCT01363440|20537643|P1|Completed Week 100|Overall Study||133
8331282|NCT01363440|20537641|P3|Completed Week 52|Overall Study||144
8331283|NCT01363440|20537642|P2|Completed Week 52|Overall Study||146
8331284|NCT01363440|20537643|P1|Completed Week 52|Overall Study||145
8331285|NCT01363440|20537641|P3|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
8331286|NCT01363440|20537642|P2|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
8331287|NCT01363440|20537643|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
8331288|NCT01363440|20537641|P3|STARTED|Overall Study|randomized|154
8331289|NCT01363440|20537642|P2|STARTED|Overall Study|randomized|156
8331290|NCT01363440|20537643|P1|STARTED|Overall Study|randomized|156
8331291|NCT01363401|20537674|P2|NOT COMPLETED|Overall Study||4
8331292|NCT01363401|20537675|P1|NOT COMPLETED|Overall Study||2
8331293|NCT01363401|20537674|P2|COMPLETED|Overall Study||27
8331294|NCT01363401|20537675|P1|COMPLETED|Overall Study||39
8331295|NCT01363401|20537674|P2|STARTED|Overall Study||31
8331296|NCT01363401|20537675|P1|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
8331297|NCT01363388|20537690|P3|NOT COMPLETED|Overall Study||4
8331298|NCT01363388|20537691|P2|NOT COMPLETED|Overall Study||3
8331299|NCT01363388|20537692|P1|NOT COMPLETED|Overall Study||5
8331300|NCT01363388|20537690|P3|COMPLETED|Overall Study||18
8331301|NCT01363388|20537691|P2|COMPLETED|Overall Study||19
8331302|NCT01363388|20537692|P1|COMPLETED|Overall Study||18
8331303|NCT01363388|20537690|P3|STARTED|Overall Study||22
8331304|NCT01363388|20537691|P2|STARTED|Overall Study||22
8331305|NCT01363388|20537692|P1|STARTED|Overall Study||23
8331306|NCT01363349|20537702|P2|NOT COMPLETED|Overall Study||70
8331307|NCT01363349|20537703|P1|NOT COMPLETED|Overall Study||67
8331308|NCT01363349|20537702|P2|COMPLETED|Overall Study||66
8331309|NCT01363349|20537703|P1|COMPLETED|Overall Study||66
8331310|NCT01363349|20537702|P2|Randomized|Overall Study||136
8331311|NCT01363349|20537703|P1|Randomized|Overall Study||133
8331312|NCT01363349|20537702|P2|STARTED|Overall Study||136
8331313|NCT01363349|20537703|P1|STARTED|Overall Study||133
8331314|NCT01363297|20537714|P5|NOT COMPLETED|Overall Study||31
8331315|NCT01363297|20537715|P4|NOT COMPLETED|Overall Study||10
8331316|NCT01363297|20537716|P3|NOT COMPLETED|Overall Study||6
8331317|NCT01363297|20537717|P2|NOT COMPLETED|Overall Study||6
8331318|NCT01363297|20537718|P1|NOT COMPLETED|Overall Study||3
8331319|NCT01363297|20537714|P5|COMPLETED|Overall Study||4
8331320|NCT01363297|20537715|P4|COMPLETED|Overall Study||3
8331321|NCT01363297|20537716|P3|COMPLETED|Overall Study||3
8331322|NCT01363297|20537717|P2|COMPLETED|Overall Study||6
8331323|NCT01363297|20537718|P1|COMPLETED|Overall Study||0
8331324|NCT01363297|20537714|P5|STARTED|Overall Study||35
8331325|NCT01363297|20537715|P4|STARTED|Overall Study||13
8331326|NCT01363297|20537716|P3|STARTED|Overall Study||9
8331327|NCT01363297|20537717|P2|STARTED|Overall Study||12
8331328|NCT01363297|20537718|P1|STARTED|Overall Study||3
8331329|NCT01363258|20537810|P2|NOT COMPLETED|Overall Study||0
8331330|NCT01363258|20537811|P1|NOT COMPLETED|Overall Study||0
8331331|NCT01363258|20537810|P2|COMPLETED|Overall Study||46
8331332|NCT01363258|20537811|P1|COMPLETED|Overall Study||54
8331333|NCT01363258|20537810|P2|STARTED|Overall Study||46
8331334|NCT01363258|20537811|P1|STARTED|Overall Study||54
8331335|NCT01363076|20537821|P2|NOT COMPLETED|Overall Study||1
8331336|NCT01363076|20537822|P1|NOT COMPLETED|Overall Study||0
8331337|NCT01363076|20537821|P2|COMPLETED|Overall Study||12
8331338|NCT01363076|20537822|P1|COMPLETED|Overall Study||7
8331339|NCT01363076|20537821|P2|STARTED|Overall Study||13
8331340|NCT01363076|20537822|P1|STARTED|Overall Study||7
8331341|NCT01363050|20537840|P1|NOT COMPLETED|Overall Study||0
8331342|NCT01363050|20537840|P1|COMPLETED|Overall Study||15
8331343|NCT01363050|20537840|P1|STARTED|Overall Study||15
8331344|NCT01363011|20537854|P2|NOT COMPLETED|Extension Phase||8
8331345|NCT01363011|20537855|P1|NOT COMPLETED|Extension Phase||5
8331346|NCT01363011|20537854|P2|COMPLETED|Extension Phase||41
8331347|NCT01363011|20537855|P1|COMPLETED|Extension Phase||13
8331348|NCT01363011|20537854|P2|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
8331349|NCT01363011|20537855|P1|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
8331350|NCT01363011|20537854|P2|NOT COMPLETED|Main Study||9
8331351|NCT01363011|20537855|P1|NOT COMPLETED|Main Study||4
8331352|NCT01363011|20537854|P2|COMPLETED|Main Study||64
8331353|NCT01363011|20537855|P1|COMPLETED|Main Study||29
8331354|NCT01363011|20537854|P2|STARTED|Main Study||73
8331355|NCT01363011|20537855|P1|STARTED|Main Study||33
8331356|NCT01362959|20537897|P2|NOT COMPLETED|Overall Study||0
8331357|NCT01362959|20537898|P1|NOT COMPLETED|Overall Study||0
8331358|NCT01362959|20537897|P2|COMPLETED|Overall Study||26
8331359|NCT01362959|20537898|P1|COMPLETED|Overall Study||21
8331360|NCT01362959|20537897|P2|STARTED|Overall Study||26
8331361|NCT01362959|20537898|P1|STARTED|Overall Study||21
8331362|NCT01362946|20537912|P2|NOT COMPLETED|Second Behavior Modification Block||0
8331363|NCT01362946|20537913|P1|NOT COMPLETED|Second Behavior Modification Block||0
8331364|NCT01362946|20537912|P2|COMPLETED|Second Behavior Modification Block||24
8331365|NCT01362946|20537913|P1|COMPLETED|Second Behavior Modification Block||23
8331366|NCT01362946|20537912|P2|STARTED|Second Behavior Modification Block||24
8331367|NCT01362946|20537913|P1|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
8331368|NCT01362946|20537912|P2|NOT COMPLETED|First Behavior Modification Block||0
8331369|NCT01362946|20537913|P1|NOT COMPLETED|First Behavior Modification Block||0
8331370|NCT01362946|20537912|P2|COMPLETED|First Behavior Modification Block||24
8331371|NCT01362946|20537913|P1|COMPLETED|First Behavior Modification Block||24
8331372|NCT01362946|20537912|P2|STARTED|First Behavior Modification Block||24
8331373|NCT01362946|20537913|P1|STARTED|First Behavior Modification Block||24
8331374|NCT01362907|20537946|P2|NOT COMPLETED|Period 2, One Week||0
8331375|NCT01362907|20537947|P1|NOT COMPLETED|Period 2, One Week||0
8331376|NCT01362907|20537946|P2|COMPLETED|Period 2, One Week||20
8331377|NCT01362907|20537947|P1|COMPLETED|Period 2, One Week||20
8331378|NCT01362907|20537946|P2|STARTED|Period 2, One Week||20
8331379|NCT01362907|20537947|P1|STARTED|Period 2, One Week||20
8331380|NCT01362907|20537946|P2|NOT COMPLETED|Period 1, One Week||0
8331381|NCT01362907|20537947|P1|NOT COMPLETED|Period 1, One Week||0
8331382|NCT01362907|20537946|P2|COMPLETED|Period 1, One Week||20
8331383|NCT01362907|20537947|P1|COMPLETED|Period 1, One Week||20
8331384|NCT01362907|20537946|P2|STARTED|Period 1, One Week||20
8331385|NCT01362907|20537947|P1|STARTED|Period 1, One Week||20
8331386|NCT01362894|20537961|P2|NOT COMPLETED|Period Two, 1 Week||0
8331387|NCT01362894|20537962|P1|NOT COMPLETED|Period Two, 1 Week||0
8331388|NCT01362894|20537961|P2|COMPLETED|Period Two, 1 Week||115
8331389|NCT01362894|20537962|P1|COMPLETED|Period Two, 1 Week||118
8331390|NCT01362894|20537961|P2|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
8331391|NCT01362894|20537962|P1|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
8331392|NCT01362894|20537961|P2|NOT COMPLETED|Period One, 1 Week||0
8331393|NCT01362894|20537962|P1|NOT COMPLETED|Period One, 1 Week||0
8331394|NCT01362894|20537961|P2|COMPLETED|Period One, 1 Week||117
8331395|NCT01362894|20537962|P1|COMPLETED|Period One, 1 Week||119
8331396|NCT01362894|20537961|P2|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
8331397|NCT01362894|20537962|P1|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
8331398|NCT01362790|20537982|P7|NOT COMPLETED|Dose De-escalation of Regimen A||0
8331399|NCT01362790|20537983|P6|NOT COMPLETED|Dose De-escalation of Regimen A||0
8331400|NCT01362790|20537984|P5|NOT COMPLETED|Dose De-escalation of Regimen A||6
8331401|NCT01362790|20537985|P4|NOT COMPLETED|Dose De-escalation of Regimen A||0
8331402|NCT01362790|20537986|P3|NOT COMPLETED|Dose De-escalation of Regimen A||0
8331403|NCT01362790|20537987|P2|NOT COMPLETED|Dose De-escalation of Regimen A||0
8331404|NCT01362790|20537988|P1|NOT COMPLETED|Dose De-escalation of Regimen A||0
8331405|NCT01362790|20537982|P7|COMPLETED|Dose De-escalation of Regimen A||0
8331406|NCT01362790|20537983|P6|COMPLETED|Dose De-escalation of Regimen A||0
8331407|NCT01362790|20537984|P5|COMPLETED|Dose De-escalation of Regimen A||2
8331408|NCT01362790|20537985|P4|COMPLETED|Dose De-escalation of Regimen A||0
8331409|NCT01362790|20537986|P3|COMPLETED|Dose De-escalation of Regimen A||0
8331410|NCT01362790|20537987|P2|COMPLETED|Dose De-escalation of Regimen A||0
8331411|NCT01362790|20537988|P1|COMPLETED|Dose De-escalation of Regimen A||0
8331412|NCT01362790|20537982|P7|STARTED|Dose De-escalation of Regimen A||0
8331413|NCT01362790|20537983|P6|STARTED|Dose De-escalation of Regimen A||0
8331414|NCT01362790|20537984|P5|STARTED|Dose De-escalation of Regimen A||8
8331415|NCT01362790|20537985|P4|STARTED|Dose De-escalation of Regimen A||0
8331416|NCT01362790|20537986|P3|STARTED|Dose De-escalation of Regimen A||0
8331417|NCT01362790|20537987|P2|STARTED|Dose De-escalation of Regimen A||0
8331418|NCT01362790|20537988|P1|STARTED|Dose De-escalation of Regimen A||0
8331419|NCT01362790|20537982|P7|NOT COMPLETED|Pilot Phase & Phase 2||0
8331420|NCT01362790|20537983|P6|NOT COMPLETED|Pilot Phase & Phase 2||4
8331421|NCT01362790|20537984|P5|NOT COMPLETED|Pilot Phase & Phase 2||0
8331422|NCT01362790|20537985|P4|NOT COMPLETED|Pilot Phase & Phase 2||14
8331423|NCT01362790|20537986|P3|NOT COMPLETED|Pilot Phase & Phase 2||5
8331424|NCT01362790|20537987|P2|NOT COMPLETED|Pilot Phase & Phase 2||8
8331425|NCT01362790|20537988|P1|NOT COMPLETED|Pilot Phase & Phase 2||10
8331426|NCT01362790|20537982|P7|COMPLETED|Pilot Phase & Phase 2||0
8331427|NCT01362790|20537983|P6|COMPLETED|Pilot Phase & Phase 2||0
8331428|NCT01362790|20537984|P5|COMPLETED|Pilot Phase & Phase 2||0
8331429|NCT01362790|20537985|P4|COMPLETED|Pilot Phase & Phase 2||1
8331430|NCT01362790|20537986|P3|COMPLETED|Pilot Phase & Phase 2||2
8331431|NCT01362790|20537987|P2|COMPLETED|Pilot Phase & Phase 2||0
8331432|NCT01362790|20537988|P1|COMPLETED|Pilot Phase & Phase 2||1
8331433|NCT01362790|20537982|P7|STARTED|Pilot Phase & Phase 2||0
8331434|NCT01362790|20537983|P6|STARTED|Pilot Phase & Phase 2||4
8331435|NCT01362790|20537984|P5|STARTED|Pilot Phase & Phase 2||0
8331436|NCT01362790|20537985|P4|STARTED|Pilot Phase & Phase 2||15
8331437|NCT01362790|20537986|P3|STARTED|Pilot Phase & Phase 2||7
8331438|NCT01362790|20537987|P2|STARTED|Pilot Phase & Phase 2||8
8331439|NCT01362790|20537988|P1|STARTED|Pilot Phase & Phase 2||11
8331440|NCT01362686|20538038|P3|NOT COMPLETED|Overall Study||10
8331441|NCT01362686|20538039|P2|NOT COMPLETED|Overall Study||12
8331442|NCT01362686|20538040|P1|NOT COMPLETED|Overall Study||8
8331443|NCT01362686|20538038|P3|COMPLETED|Overall Study||53
8331444|NCT01362686|20538039|P2|COMPLETED|Overall Study||54
8331445|NCT01362686|20538040|P1|COMPLETED|Overall Study||59
8331446|NCT01362686|20538038|P3|STARTED|Overall Study||63
8331447|NCT01362686|20538039|P2|STARTED|Overall Study||66
8331448|NCT01362686|20538040|P1|STARTED|Overall Study||67
8331449|NCT01362608|20538056|P2|NOT COMPLETED|Overall Study||8
8331450|NCT01362608|20538057|P1|NOT COMPLETED|Overall Study||4
8331451|NCT01362608|20538056|P2|COMPLETED|Overall Study||61
8331452|NCT01362608|20538057|P1|COMPLETED|Overall Study||63
8331453|NCT01362608|20538056|P2|STARTED|Overall Study||69
8331454|NCT01362608|20538057|P1|STARTED|Overall Study||67
8331455|NCT01362530|20538095|P2|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
8331456|NCT01362530|20538096|P1|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
8331457|NCT01362530|20538095|P2|COMPLETED|Optional Extension (Cycles 2-6)||0
8331458|NCT01362530|20538096|P1|COMPLETED|Optional Extension (Cycles 2-6)||46
8331459|NCT01362530|20538095|P2|STARTED|Optional Extension (Cycles 2-6)||0
8331460|NCT01362530|20538096|P1|STARTED|Optional Extension (Cycles 2-6)||171
8331461|NCT01362530|20538095|P2|NOT COMPLETED|Base Study (Cycle 1)||3
8331462|NCT01362530|20538096|P1|NOT COMPLETED|Base Study (Cycle 1)||5
8331463|NCT01362530|20538095|P2|COMPLETED|Base Study (Cycle 1)||149
8331464|NCT01362530|20538096|P1|COMPLETED|Base Study (Cycle 1)||150
8331465|NCT01362530|20538095|P2|Received Study Treatment|Base Study (Cycle 1)||150
8331466|NCT01362530|20538096|P1|Received Study Treatment|Base Study (Cycle 1)||152
8331467|NCT01362530|20538095|P2|STARTED|Base Study (Cycle 1)||152
8331468|NCT01362530|20538096|P1|STARTED|Base Study (Cycle 1)||155
8331469|NCT01362517|20538109|P1|NOT COMPLETED|Overall Study||2
8331470|NCT01362517|20538109|P1|COMPLETED|Overall Study||129
8331471|NCT01362517|20538109|P1|STARTED|Overall Study||131
8331472|NCT01362491|20538120|P3|NOT COMPLETED|Overall Study||0
8331473|NCT01362491|20538121|P2|NOT COMPLETED|Overall Study||0
8331474|NCT01362491|20538122|P1|NOT COMPLETED|Overall Study||1
8331475|NCT01362491|20538120|P3|COMPLETED|Overall Study||46
8331476|NCT01362491|20538121|P2|COMPLETED|Overall Study||89
8331477|NCT01362491|20538122|P1|COMPLETED|Overall Study||90
8331478|NCT01362491|20538120|P3|STARTED|Overall Study||46
8331479|NCT01362491|20538121|P2|STARTED|Overall Study||89
8331480|NCT01362491|20538122|P1|STARTED|Overall Study||91
8331481|NCT01362439|20538170|P1|NOT COMPLETED|Overall Study||15
8331482|NCT01362439|20538170|P1|COMPLETED|Overall Study||118
8331483|NCT01362439|20538170|P1|STARTED|Overall Study||133
8331484|NCT01362348|20538185|P1|NOT COMPLETED|Overall Study||14
8331485|NCT01362348|20538185|P1|COMPLETED|Overall Study||5
8331486|NCT01362348|20538185|P1|STARTED|Overall Study||19
8331487|NCT01362322|20538204|P2|NOT COMPLETED|Overall Study||7
8331488|NCT01362322|20538205|P1|NOT COMPLETED|Overall Study||5
8331489|NCT01362322|20538204|P2|COMPLETED|Overall Study||329
8331490|NCT01362322|20538205|P1|COMPLETED|Overall Study||330
8331491|NCT01362322|20538204|P2|STARTED|Overall Study||336
8331492|NCT01362322|20538205|P1|STARTED|Overall Study||335
8331493|NCT01362296|20538237|P4|NOT COMPLETED|Crossover Phase||2
8331494|NCT01362296|20538238|P3|NOT COMPLETED|Crossover Phase||23
8331495|NCT01362296|20538239|P2|NOT COMPLETED|Crossover Phase||0
8331496|NCT01362296|20538240|P1|NOT COMPLETED|Crossover Phase||0
8331497|NCT01362296|20538237|P4|COMPLETED|Crossover Phase||0
8331498|NCT01362296|20538238|P3|COMPLETED|Crossover Phase||0
8331499|NCT01362296|20538239|P2|COMPLETED|Crossover Phase||0
8331500|NCT01362296|20538240|P1|COMPLETED|Crossover Phase||0
8331501|NCT01362296|20538237|P4|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
8331502|NCT01362296|20538238|P3|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
8331503|NCT01362296|20538239|P2|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
8331504|NCT01362296|20538240|P1|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
8331505|NCT01362296|20538237|P4|NOT COMPLETED|Randomized Phase (RP)||0
8331506|NCT01362296|20538238|P3|NOT COMPLETED|Randomized Phase (RP)||0
8331507|NCT01362296|20538239|P2|NOT COMPLETED|Randomized Phase (RP)||43
8331508|NCT01362296|20538240|P1|NOT COMPLETED|Randomized Phase (RP)||87
8331509|NCT01362296|20538237|P4|COMPLETED|Randomized Phase (RP)||0
8331510|NCT01362296|20538238|P3|COMPLETED|Randomized Phase (RP)||0
8331511|NCT01362296|20538239|P2|COMPLETED|Randomized Phase (RP)||0
8331512|NCT01362296|20538240|P1|COMPLETED|Randomized Phase (RP)||0
8331513|NCT01362296|20538237|P4|STARTED|Randomized Phase (RP)||0
8331514|NCT01362296|20538238|P3|STARTED|Randomized Phase (RP)||0
8331515|NCT01362296|20538239|P2|STARTED|Randomized Phase (RP)||43
8331516|NCT01362296|20538240|P1|STARTED|Randomized Phase (RP)||87
8331517|NCT01362270|20538288|P2|NOT COMPLETED|Overall Study||2
8331518|NCT01362270|20538289|P1|NOT COMPLETED|Overall Study||2
8331519|NCT01362270|20538288|P2|COMPLETED|Overall Study||6
8331520|NCT01362270|20538289|P1|COMPLETED|Overall Study||5
8331521|NCT01362270|20538288|P2|STARTED|Overall Study||8
8331522|NCT01362270|20538289|P1|STARTED|Overall Study||7
8331529|NCT01362205|20538375|P2|NOT COMPLETED|Overall Study||0
8331530|NCT01362205|20538376|P1|NOT COMPLETED|Overall Study||0
8331531|NCT01362205|20538375|P2|COMPLETED|Overall Study||27
8331532|NCT01362205|20538376|P1|COMPLETED|Overall Study||22
8331533|NCT01362205|20538375|P2|STARTED|Overall Study||27
8331534|NCT01362205|20538376|P1|STARTED|Overall Study||22
8331535|NCT01362192|20538402|P1|NOT COMPLETED|Overall Study||4
8331536|NCT01362192|20538402|P1|COMPLETED|Overall Study||16
8331537|NCT01362192|20538402|P1|STARTED|Overall Study||20
8331538|NCT01362140|20538414|P2|NOT COMPLETED|Overall Study||11
8331539|NCT01362140|20538415|P1|NOT COMPLETED|Overall Study||10
8331540|NCT01362140|20538414|P2|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
8331541|NCT01362140|20538415|P1|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
8331542|NCT01362140|20538414|P2|Received Treatment|Overall Study||97
8331543|NCT01362140|20538415|P1|Received Treatment|Overall Study||49
8331544|NCT01362140|20538414|P2|STARTED|Overall Study||98
8331545|NCT01362140|20538415|P1|STARTED|Overall Study||49
8331546|NCT01362127|20538439|P2|NOT COMPLETED|Overall Study||0
8331547|NCT01362127|20538440|P1|NOT COMPLETED|Overall Study||0
8331548|NCT01362127|20538439|P2|COMPLETED|Overall Study||91
8331549|NCT01362127|20538440|P1|COMPLETED|Overall Study||90
8331550|NCT01362127|20538439|P2|STARTED|Overall Study||91
8331551|NCT01362127|20538440|P1|STARTED|Overall Study||90
8331552|NCT01362062|20538452|P2|NOT COMPLETED|Overall Study||0
8331553|NCT01362062|20538453|P1|NOT COMPLETED|Overall Study||26
8331554|NCT01362062|20538452|P2|COMPLETED|Overall Study||62
8331555|NCT01362062|20538453|P1|COMPLETED|Overall Study||22
8331556|NCT01362062|20538452|P2|STARTED|Overall Study||62
8331557|NCT01362062|20538453|P1|STARTED|Overall Study||48
8331558|NCT01362049|20538474|P4|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
8331559|NCT01362049|20538475|P3|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
8331560|NCT01362049|20538476|P2|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
8331561|NCT01362049|20538477|P1|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
8331562|NCT01362049|20538474|P4|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
8331563|NCT01362049|20538475|P3|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
8331564|NCT01362049|20538476|P2|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
8331565|NCT01362049|20538477|P1|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
8331566|NCT01362049|20538474|P4|STARTED|Follow-Up at 52 Weeks (12 Months)||24
8331567|NCT01362049|20538475|P3|STARTED|Follow-Up at 52 Weeks (12 Months)||30
8331568|NCT01362049|20538476|P2|STARTED|Follow-Up at 52 Weeks (12 Months)||16
8331569|NCT01362049|20538477|P1|STARTED|Follow-Up at 52 Weeks (12 Months)||23
8331570|NCT01362049|20538474|P4|NOT COMPLETED|Follow-Up at 7 Weeks||1
8331571|NCT01362049|20538475|P3|NOT COMPLETED|Follow-Up at 7 Weeks||2
8331572|NCT01362049|20538476|P2|NOT COMPLETED|Follow-Up at 7 Weeks||3
8331573|NCT01362049|20538477|P1|NOT COMPLETED|Follow-Up at 7 Weeks||3
8331574|NCT01362049|20538474|P4|COMPLETED|Follow-Up at 7 Weeks||24
8331575|NCT01362049|20538475|P3|COMPLETED|Follow-Up at 7 Weeks||30
8331576|NCT01362049|20538476|P2|COMPLETED|Follow-Up at 7 Weeks||16
8331577|NCT01362049|20538477|P1|COMPLETED|Follow-Up at 7 Weeks||23
8331578|NCT01362049|20538474|P4|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
8331579|NCT01362049|20538475|P3|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
8331580|NCT01362049|20538476|P2|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
8331581|NCT01362049|20538477|P1|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
8331582|NCT01362049|20538474|P4|STARTED|Follow-Up at 7 Weeks||25
8331583|NCT01362049|20538475|P3|STARTED|Follow-Up at 7 Weeks||32
8331584|NCT01362049|20538476|P2|STARTED|Follow-Up at 7 Weeks||19
8331585|NCT01362049|20538477|P1|STARTED|Follow-Up at 7 Weeks||26
8331586|NCT01361919|20538518|P3|NOT COMPLETED|Overall Study||10
8331587|NCT01361919|20538519|P2|NOT COMPLETED|Overall Study||12
8331588|NCT01361919|20538520|P1|NOT COMPLETED|Overall Study||10
8331589|NCT01361919|20538518|P3|COMPLETED|Overall Study||88
8331590|NCT01361919|20538519|P2|COMPLETED|Overall Study||88
8331591|NCT01361919|20538520|P1|COMPLETED|Overall Study||90
8331592|NCT01361919|20538518|P3|STARTED|Overall Study||98
8331593|NCT01361919|20538519|P2|STARTED|Overall Study||100
8331594|NCT01361919|20538520|P1|STARTED|Overall Study||100
8331595|NCT01361867|20538534|P1|NOT COMPLETED|Overall Study||0
8331596|NCT01361867|20538534|P1|COMPLETED|Overall Study||15
8331597|NCT01361867|20538534|P1|STARTED|Overall Study||15
8331598|NCT01361854|20538539|P2|NOT COMPLETED|Second Intervention||0
8331599|NCT01361854|20538540|P1|NOT COMPLETED|Second Intervention||0
8331600|NCT01361854|20538539|P2|COMPLETED|Second Intervention||48
8331601|NCT01361854|20538540|P1|COMPLETED|Second Intervention||47
8331602|NCT01361854|20538539|P2|STARTED|Second Intervention||48
8331603|NCT01361854|20538540|P1|STARTED|Second Intervention||47
8331604|NCT01361854|20538539|P2|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
8331605|NCT01361854|20538540|P1|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
8331606|NCT01361854|20538539|P2|COMPLETED|Wash-out, Maximum 2 Weeks||48
8331607|NCT01361854|20538540|P1|COMPLETED|Wash-out, Maximum 2 Weeks||47
8331608|NCT01361854|20538539|P2|STARTED|Wash-out, Maximum 2 Weeks||48
8331609|NCT01361854|20538540|P1|STARTED|Wash-out, Maximum 2 Weeks||47
8331610|NCT01361854|20538539|P2|NOT COMPLETED|Day 1||3
8331611|NCT01361854|20538540|P1|NOT COMPLETED|Day 1||4
8331612|NCT01361854|20538539|P2|COMPLETED|Day 1||48
8331613|NCT01361854|20538540|P1|COMPLETED|Day 1||47
8331614|NCT01361854|20538539|P2|STARTED|Day 1||51
8331615|NCT01361854|20538540|P1|STARTED|Day 1||51
8331616|NCT01361711|20538546|P1|NOT COMPLETED|10 Year Follow-up||50
8331617|NCT01361711|20538546|P1|COMPLETED|10 Year Follow-up||2
8331618|NCT01361711|20538546|P1|STARTED|10 Year Follow-up|All patients who receive at least one dose of study drug go into follow-up.|52
8331619|NCT01361711|20538546|P1|NOT COMPLETED|Completed Week 18 of Treatment||11
8331620|NCT01361711|20538546|P1|COMPLETED|Completed Week 18 of Treatment||30
8331621|NCT01361711|20538546|P1|STARTED|Completed Week 18 of Treatment||41
8331622|NCT01361711|20538546|P1|NOT COMPLETED|Continued Treatment After 12 Weeks||3
8331623|NCT01361711|20538546|P1|COMPLETED|Continued Treatment After 12 Weeks||41
8331624|NCT01361711|20538546|P1|STARTED|Continued Treatment After 12 Weeks||44
8331625|NCT01361711|20538546|P1|NOT COMPLETED|Continued Treatment After 9 Weeks||7
8331626|NCT01361711|20538546|P1|COMPLETED|Continued Treatment After 9 Weeks||44
8331627|NCT01361711|20538546|P1|STARTED|Continued Treatment After 9 Weeks||51
8331628|NCT01361711|20538546|P1|NOT COMPLETED|Week 9 Bone Marrow Response Assessment||1
8331629|NCT01361711|20538546|P1|COMPLETED|Week 9 Bone Marrow Response Assessment||51
8331630|NCT01361711|20538546|P1|STARTED|Week 9 Bone Marrow Response Assessment||52
8331631|NCT01361711|20538546|P1|NOT COMPLETED|Trial Entry (Registration)||1
8331632|NCT01361711|20538546|P1|COMPLETED|Trial Entry (Registration)||52
8331633|NCT01361711|20538546|P1|Received Dose of Study Drug|Trial Entry (Registration)||52
8331634|NCT01361711|20538546|P1|STARTED|Trial Entry (Registration)||53
8331641|NCT01361620|20538559|P1|NOT COMPLETED|Overall Study||0
8331642|NCT01361620|20538559|P1|COMPLETED|Overall Study||132
8331643|NCT01361620|20538559|P1|STARTED|Overall Study||132
8331644|NCT01361607|20538565|P2|NOT COMPLETED|Overall Study||41
8331645|NCT01361607|20538566|P1|NOT COMPLETED|Overall Study||64
8331646|NCT01361607|20538565|P2|COMPLETED|Overall Study||158
8331647|NCT01361607|20538566|P1|COMPLETED|Overall Study||136
8331648|NCT01361607|20538565|P2|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
8331649|NCT01361607|20538566|P1|ITT Population|Overall Study||198
8331650|NCT01361607|20538565|P2|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
8331651|NCT01361607|20538566|P1|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
8331652|NCT01361607|20538565|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
8331653|NCT01361607|20538566|P1|Received at Least 1 Dose of Study Drug|Overall Study||198
8331654|NCT01361607|20538565|P2|STARTED|Overall Study||199
8331655|NCT01361607|20538566|P1|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
8331656|NCT01361594|20538594|P2|NOT COMPLETED|Overall Study||2
8331657|NCT01361594|20538595|P1|NOT COMPLETED|Overall Study||1
8331658|NCT01361594|20538594|P2|COMPLETED|Overall Study||151
8331659|NCT01361594|20538595|P1|COMPLETED|Overall Study||151
8331660|NCT01361594|20538594|P2|STARTED|Overall Study||153
8331661|NCT01361594|20538595|P1|STARTED|Overall Study||152
8331662|NCT01361568|20538609|P6|NOT COMPLETED|Overall Study||2
8331663|NCT01361568|20538610|P5|NOT COMPLETED|Overall Study||1
8331664|NCT01361568|20538611|P4|NOT COMPLETED|Overall Study||0
8331665|NCT01361568|20538612|P3|NOT COMPLETED|Overall Study||0
8331666|NCT01361568|20538613|P2|NOT COMPLETED|Overall Study||1
8331667|NCT01361568|20538614|P1|NOT COMPLETED|Overall Study||2
8331668|NCT01361568|20538609|P6|COMPLETED|Overall Study||11
8331669|NCT01361568|20538610|P5|COMPLETED|Overall Study||6
8331670|NCT01361568|20538611|P4|COMPLETED|Overall Study||21
8331671|NCT01361568|20538612|P3|COMPLETED|Overall Study||20
8331672|NCT01361568|20538613|P2|COMPLETED|Overall Study||70
8331673|NCT01361568|20538614|P1|COMPLETED|Overall Study||69
8331674|NCT01361568|20538609|P6|STARTED|Overall Study||13
8331675|NCT01361568|20538610|P5|STARTED|Overall Study||7
8331676|NCT01361568|20538611|P4|STARTED|Overall Study||21
8331677|NCT01361568|20538612|P3|STARTED|Overall Study||20
8331678|NCT01361568|20538613|P2|STARTED|Overall Study||71
8331679|NCT01361568|20538614|P1|STARTED|Overall Study||71
8331680|NCT01361464|20538644|P1|NOT COMPLETED|Overall Study||3
8331681|NCT01361464|20538644|P1|COMPLETED|Overall Study||18
8331682|NCT01361464|20538644|P1|STARTED|Overall Study||21
8331683|NCT01361308|20538653|P2|NOT COMPLETED|Overall Study||30
8331684|NCT01361308|20538654|P1|NOT COMPLETED|Overall Study||35
8331685|NCT01361308|20538653|P2|COMPLETED|Overall Study||278
8331686|NCT01361308|20538654|P1|COMPLETED|Overall Study||271
8331687|NCT01361308|20538653|P2|STARTED|Overall Study||308
8331688|NCT01361308|20538654|P1|STARTED|Overall Study||306
8331689|NCT01361217|20538694|P1|NOT COMPLETED|Overall Study||0
8331690|NCT01361217|20538694|P1|COMPLETED|Overall Study||10
8331691|NCT01361217|20538694|P1|STARTED|Overall Study||10
8331692|NCT01361178|20538702|P2|NOT COMPLETED|Overall Study||0
8331693|NCT01361178|20538703|P1|NOT COMPLETED|Overall Study||13
8331694|NCT01361178|20538702|P2|COMPLETED|Overall Study||11
8331695|NCT01361178|20538703|P1|COMPLETED|Overall Study||109
8331696|NCT01361178|20538702|P2|STARTED|Overall Study||11
8331697|NCT01361178|20538703|P1|STARTED|Overall Study||122
8331698|NCT01361126|20538711|P2|NOT COMPLETED|Overall Study||2
8331699|NCT01361126|20538712|P1|NOT COMPLETED|Overall Study||0
8331700|NCT01361126|20538711|P2|COMPLETED|Overall Study||2
8331701|NCT01361126|20538712|P1|COMPLETED|Overall Study||13
8331702|NCT01361126|20538711|P2|STARTED|Overall Study||4
8331703|NCT01361126|20538712|P1|STARTED|Overall Study||13
8331704|NCT01361113|20538727|P1|NOT COMPLETED|Overall Study||0
8331705|NCT01361113|20538727|P1|COMPLETED|Overall Study||21
8331706|NCT01361113|20538727|P1|STARTED|Overall Study||21
8331707|NCT01361048|20538738|P3|NOT COMPLETED|Overall Study||1
8331708|NCT01361048|20538739|P2|NOT COMPLETED|Overall Study||0
8331709|NCT01361048|20538740|P1|NOT COMPLETED|Overall Study||0
8331710|NCT01361048|20538738|P3|COMPLETED|Overall Study||9
8331711|NCT01361048|20538739|P2|COMPLETED|Overall Study||10
8331712|NCT01361048|20538740|P1|COMPLETED|Overall Study||20
8331713|NCT01361048|20538738|P3|STARTED|Overall Study||10
8331714|NCT01361048|20538739|P2|STARTED|Overall Study||10
8331715|NCT01361048|20538740|P1|STARTED|Overall Study||20
8331716|NCT01361009|20538751|P1|NOT COMPLETED|Overall Study||116
8331717|NCT01361009|20538751|P1|COMPLETED|Overall Study||1901
8331718|NCT01361009|20538751|P1|STARTED|Overall Study||2017
8331719|NCT01360996|20538761|P3|NOT COMPLETED|Overall Study||2
8331720|NCT01360996|20538762|P2|NOT COMPLETED|Overall Study||3
8331721|NCT01360996|20538763|P1|NOT COMPLETED|Overall Study||6
8331722|NCT01360996|20538761|P3|COMPLETED|Overall Study||21
8331723|NCT01360996|20538762|P2|COMPLETED|Overall Study||18
8331724|NCT01360996|20538763|P1|COMPLETED|Overall Study||14
8331725|NCT01360996|20538761|P3|STARTED|Overall Study||23
8331726|NCT01360996|20538762|P2|STARTED|Overall Study||21
8331727|NCT01360996|20538763|P1|STARTED|Overall Study||20
8331728|NCT01360866|20538786|P4|NOT COMPLETED|Overall Study||22
8331729|NCT01360866|20538787|P3|NOT COMPLETED|Overall Study||519
8331730|NCT01360866|20538788|P2|NOT COMPLETED|Overall Study||287
8331731|NCT01360866|20538789|P1|NOT COMPLETED|Overall Study||221
8331732|NCT01360866|20538786|P4|COMPLETED|Overall Study||54
8331733|NCT01360866|20538787|P3|COMPLETED|Overall Study||1126
8331734|NCT01360866|20538788|P2|COMPLETED|Overall Study||420
8331735|NCT01360866|20538789|P1|COMPLETED|Overall Study||295
8331736|NCT01360866|20538786|P4|STARTED|Overall Study||76
8331737|NCT01360866|20538787|P3|STARTED|Overall Study||1645
8331738|NCT01360866|20538788|P2|STARTED|Overall Study||707
8331739|NCT01360866|20538789|P1|STARTED|Overall Study||516
8331740|NCT01360840|20538818|P3|NOT COMPLETED|Overall Study||9
8331741|NCT01360840|20538819|P2|NOT COMPLETED|Overall Study||10
8331742|NCT01360840|20538820|P1|NOT COMPLETED|Overall Study||10
8331743|NCT01360840|20538818|P3|COMPLETED|Overall Study||51
8331744|NCT01360840|20538819|P2|COMPLETED|Overall Study||50
8331745|NCT01360840|20538820|P1|COMPLETED|Overall Study||50
8331746|NCT01360840|20538818|P3|STARTED|Overall Study||60
8331747|NCT01360840|20538819|P2|STARTED|Overall Study||60
8331748|NCT01360840|20538820|P1|STARTED|Overall Study||60
8331749|NCT01360762|20538870|P1|NOT COMPLETED|Whole Study Period||36
8331750|NCT01360762|20538870|P1|COMPLETED|Whole Study Period||38
8331751|NCT01360762|20538870|P1|STARTED|Whole Study Period||74
8331752|NCT01360762|20538870|P1|NOT COMPLETED|Main Study Period (12-month Treatment)||29
8331753|NCT01360762|20538870|P1|COMPLETED|Main Study Period (12-month Treatment)||45
8331754|NCT01360762|20538870|P1|STARTED|Main Study Period (12-month Treatment)||74
8331755|NCT01360645|20538880|P4|NOT COMPLETED|Phase A+||24
8331756|NCT01360645|20538881|P3|NOT COMPLETED|Phase A+||0
8331757|NCT01360645|20538882|P2|NOT COMPLETED|Phase A+||0
8331758|NCT01360645|20538883|P1|NOT COMPLETED|Phase A+||0
8331759|NCT01360645|20538880|P4|COMPLETED|Phase A+||307
8331760|NCT01360645|20538881|P3|COMPLETED|Phase A+||0
8331761|NCT01360645|20538882|P2|COMPLETED|Phase A+||0
8331762|NCT01360645|20538883|P1|COMPLETED|Phase A+||0
8331763|NCT01360645|20538880|P4|STARTED|Phase A+||331
8331764|NCT01360645|20538881|P3|STARTED|Phase A+||0
8331765|NCT01360645|20538882|P2|STARTED|Phase A+||0
8331766|NCT01360645|20538883|P1|STARTED|Phase A+||0
8331767|NCT01360645|20538880|P4|NOT COMPLETED|Phase B (6 Weeks)||0
8331768|NCT01360645|20538881|P3|NOT COMPLETED|Phase B (6 Weeks)||13
8331769|NCT01360645|20538882|P2|NOT COMPLETED|Phase B (6 Weeks)||14
8331770|NCT01360645|20538883|P1|NOT COMPLETED|Phase B (6 Weeks)||0
8331771|NCT01360645|20538880|P4|COMPLETED|Phase B (6 Weeks)||0
8331772|NCT01360645|20538881|P3|COMPLETED|Phase B (6 Weeks)||178
8331773|NCT01360645|20538882|P2|COMPLETED|Phase B (6 Weeks)||174
8331774|NCT01360645|20538883|P1|COMPLETED|Phase B (6 Weeks)||0
8331775|NCT01360645|20538880|P4|STARTED|Phase B (6 Weeks)||0
8331776|NCT01360645|20538881|P3|STARTED|Phase B (6 Weeks)||191
8331777|NCT01360645|20538882|P2|STARTED|Phase B (6 Weeks)||188
8331778|NCT01360645|20538883|P1|STARTED|Phase B (6 Weeks)||0
8331779|NCT01360645|20538880|P4|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331780|NCT01360645|20538881|P3|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331781|NCT01360645|20538882|P2|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331782|NCT01360645|20538883|P1|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
8331783|NCT01360645|20538880|P4|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331784|NCT01360645|20538881|P3|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331785|NCT01360645|20538882|P2|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331786|NCT01360645|20538883|P1|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
8331787|NCT01360645|20538880|P4|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331788|NCT01360645|20538881|P3|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331789|NCT01360645|20538882|P2|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
8331790|NCT01360645|20538883|P1|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
8331791|NCT01360632|20538938|P5|NOT COMPLETED|Phase A+||25
8331792|NCT01360632|20538939|P4|NOT COMPLETED|Phase A+||0
8331793|NCT01360632|20538940|P3|NOT COMPLETED|Phase A+||0
8331794|NCT01360632|20538941|P2|NOT COMPLETED|Phase A+||0
8331795|NCT01360632|20538942|P1|NOT COMPLETED|Phase A+||0
8331796|NCT01360632|20538938|P5|COMPLETED|Phase A+||575
8331797|NCT01360632|20538939|P4|COMPLETED|Phase A+||0
8331798|NCT01360632|20538940|P3|COMPLETED|Phase A+||0
8331799|NCT01360632|20538941|P2|COMPLETED|Phase A+||0
8331800|NCT01360632|20538942|P1|COMPLETED|Phase A+||0
8331801|NCT01360632|20538938|P5|STARTED|Phase A+||600
8331802|NCT01360632|20538939|P4|STARTED|Phase A+||0
8331803|NCT01360632|20538940|P3|STARTED|Phase A+||0
8331804|NCT01360632|20538941|P2|STARTED|Phase A+||0
8331805|NCT01360632|20538942|P1|STARTED|Phase A+||0
8331806|NCT01360632|20538938|P5|NOT COMPLETED|Phase B (6 Weeks)||0
8331807|NCT01360632|20538939|P4|NOT COMPLETED|Phase B (6 Weeks)||13
8331808|NCT01360632|20538940|P3|NOT COMPLETED|Phase B (6 Weeks)||20
8331809|NCT01360632|20538941|P2|NOT COMPLETED|Phase B (6 Weeks)||10
8331810|NCT01360632|20538942|P1|NOT COMPLETED|Phase B (6 Weeks)||0
8331811|NCT01360632|20538938|P5|COMPLETED|Phase B (6 Weeks)||0
8331812|NCT01360632|20538939|P4|COMPLETED|Phase B (6 Weeks)||208
8331813|NCT01360632|20538940|P3|COMPLETED|Phase B (6 Weeks)||210
8331814|NCT01360632|20538941|P2|COMPLETED|Phase B (6 Weeks)||216
8331815|NCT01360632|20538942|P1|COMPLETED|Phase B (6 Weeks)||0
8331816|NCT01360632|20538938|P5|STARTED|Phase B (6 Weeks)||0
8331817|NCT01360632|20538939|P4|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
8331818|NCT01360632|20538940|P3|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
8331819|NCT01360632|20538941|P2|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
8331820|NCT01360632|20538942|P1|STARTED|Phase B (6 Weeks)||0
8331821|NCT01360632|20538938|P5|NOT COMPLETED|Phase A (8 Weeks)||0
8331822|NCT01360632|20538939|P4|NOT COMPLETED|Phase A (8 Weeks)||0
8331823|NCT01360632|20538940|P3|NOT COMPLETED|Phase A (8 Weeks)||0
8331824|NCT01360632|20538941|P2|NOT COMPLETED|Phase A (8 Weeks)||0
8331825|NCT01360632|20538942|P1|NOT COMPLETED|Phase A (8 Weeks)||255
8331826|NCT01360632|20538938|P5|COMPLETED|Phase A (8 Weeks)||0
8331827|NCT01360632|20538939|P4|COMPLETED|Phase A (8 Weeks)||0
8331828|NCT01360632|20538940|P3|COMPLETED|Phase A (8 Weeks)||0
8331829|NCT01360632|20538941|P2|COMPLETED|Phase A (8 Weeks)||0
8331830|NCT01360632|20538942|P1|COMPLETED|Phase A (8 Weeks)||1277
8331831|NCT01360632|20538938|P5|STARTED|Phase A (8 Weeks)||0
8331832|NCT01360632|20538939|P4|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
8331833|NCT01360632|20538940|P3|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
8331834|NCT01360632|20538941|P2|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
8331921|NCT01359748|20539231|P2|COMPLETED|Overall Study||20
8331835|NCT01360632|20538942|P1|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
8331836|NCT01360554|20539021|P2|NOT COMPLETED|Overall Study||439
8331837|NCT01360554|20539022|P1|NOT COMPLETED|Overall Study||439
8331838|NCT01360554|20539021|P2|COMPLETED|Overall Study||0
8331839|NCT01360554|20539022|P1|COMPLETED|Overall Study||0
8331840|NCT01360554|20539021|P2|Treated|Overall Study||436
8331841|NCT01360554|20539022|P1|Treated|Overall Study||436
8331842|NCT01360554|20539021|P2|STARTED|Overall Study|Three participants were randomized but not treated.|439
8331843|NCT01360554|20539022|P1|STARTED|Overall Study|Three participants were randomized but not treated.|439
8331844|NCT01360450|20539060|P2|NOT COMPLETED|Overall Study||0
8331845|NCT01360450|20539061|P1|NOT COMPLETED|Overall Study||0
8331846|NCT01360450|20539060|P2|COMPLETED|Overall Study||6
8331847|NCT01360450|20539061|P1|COMPLETED|Overall Study||6
8331848|NCT01360450|20539060|P2|Completed Treatment|Overall Study||6
8331849|NCT01360450|20539061|P1|Completed Treatment|Overall Study||6
8331850|NCT01360450|20539060|P2|STARTED|Overall Study||6
8331851|NCT01360450|20539061|P1|STARTED|Overall Study||6
8331852|NCT01360398|20539071|P1|NOT COMPLETED|Overall Study||22
8331853|NCT01360398|20539071|P1|COMPLETED|Overall Study||105
8331854|NCT01360398|20539071|P1|STARTED|Overall Study||127
8331855|NCT01360229|20539095|P2|NOT COMPLETED|Overall Study||2
8331856|NCT01360229|20539096|P1|NOT COMPLETED|Overall Study||3
8331857|NCT01360229|20539095|P2|COMPLETED|Overall Study||45
8331858|NCT01360229|20539096|P1|COMPLETED|Overall Study||44
8331859|NCT01360229|20539095|P2|STARTED|Overall Study||47
8331860|NCT01360229|20539096|P1|STARTED|Overall Study||47
8331861|NCT01360021|20539105|P3|NOT COMPLETED|Overall Study||7
8331862|NCT01360021|20539106|P2|NOT COMPLETED|Overall Study||4
8331863|NCT01360021|20539107|P1|NOT COMPLETED|Overall Study||8
8331864|NCT01360021|20539105|P3|COMPLETED|Overall Study|Patients who completed study|65
8331865|NCT01360021|20539106|P2|COMPLETED|Overall Study|Patients who completed study|67
8331866|NCT01360021|20539107|P1|COMPLETED|Overall Study|Patients who completed study|63
8331867|NCT01360021|20539105|P3|STARTED|Overall Study|Patients randomized|72
8331868|NCT01360021|20539106|P2|STARTED|Overall Study|Patients randomized|71
8331869|NCT01360021|20539107|P1|STARTED|Overall Study|Patients randomized|71
8331870|NCT01359956|20539134|P4|NOT COMPLETED|Overall Study||58
8331871|NCT01359956|20539135|P3|NOT COMPLETED|Overall Study||67
8331872|NCT01359956|20539136|P2|NOT COMPLETED|Overall Study||64
8331873|NCT01359956|20539137|P1|NOT COMPLETED|Overall Study||61
8331874|NCT01359956|20539134|P4|COMPLETED|Overall Study||4
8331875|NCT01359956|20539135|P3|COMPLETED|Overall Study||4
8331876|NCT01359956|20539136|P2|COMPLETED|Overall Study||5
8331877|NCT01359956|20539137|P1|COMPLETED|Overall Study||6
8331878|NCT01359956|20539134|P4|STARTED|Overall Study||62
8331879|NCT01359956|20539135|P3|STARTED|Overall Study||71
8331880|NCT01359956|20539136|P2|STARTED|Overall Study||69
8331881|NCT01359956|20539137|P1|STARTED|Overall Study||67
8331882|NCT01359943|20539162|P3|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
8331883|NCT01359943|20539163|P2|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
8331884|NCT01359943|20539164|P1|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
8331885|NCT01359943|20539162|P3|COMPLETED|Follow-up (Weeks 52 - 60)||36
8331886|NCT01359943|20539163|P2|COMPLETED|Follow-up (Weeks 52 - 60)||69
8331887|NCT01359943|20539164|P1|COMPLETED|Follow-up (Weeks 52 - 60)||78
8331888|NCT01359943|20539162|P3|STARTED|Follow-up (Weeks 52 - 60)||44
8331889|NCT01359943|20539163|P2|STARTED|Follow-up (Weeks 52 - 60)||84
8331890|NCT01359943|20539164|P1|STARTED|Follow-up (Weeks 52 - 60)||86
8331891|NCT01359943|20539162|P3|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
8331892|NCT01359943|20539163|P2|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
8331893|NCT01359943|20539164|P1|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
8331894|NCT01359943|20539162|P3|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
8331895|NCT01359943|20539163|P2|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
8331896|NCT01359943|20539164|P1|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
8331897|NCT01359943|20539162|P3|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
8331898|NCT01359943|20539163|P2|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
8331899|NCT01359943|20539164|P1|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
8331900|NCT01359943|20539162|P3|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
8331901|NCT01359943|20539163|P2|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
8331902|NCT01359943|20539164|P1|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
8331903|NCT01359943|20539162|P3|COMPLETED|Double-blind (Weeks 0 - 16)||44
8331904|NCT01359943|20539163|P2|COMPLETED|Double-blind (Weeks 0 - 16)||85
8331905|NCT01359943|20539164|P1|COMPLETED|Double-blind (Weeks 0 - 16)||86
8331906|NCT01359943|20539162|P3|STARTED|Double-blind (Weeks 0 - 16)||44
8331907|NCT01359943|20539163|P2|STARTED|Double-blind (Weeks 0 - 16)||89
8331908|NCT01359943|20539164|P1|STARTED|Double-blind (Weeks 0 - 16)||88
8331909|NCT01359904|20539212|P2|NOT COMPLETED|Overall Study||0
8331910|NCT01359904|20539213|P1|NOT COMPLETED|Overall Study||1
8331911|NCT01359904|20539212|P2|COMPLETED|Overall Study||19
8331912|NCT01359904|20539213|P1|COMPLETED|Overall Study||14
8331913|NCT01359904|20539212|P2|STARTED|Overall Study||19
8331914|NCT01359904|20539213|P1|STARTED|Overall Study||15
8331915|NCT01359748|20539229|P4|NOT COMPLETED|Overall Study||0
8331916|NCT01359748|20539230|P3|NOT COMPLETED|Overall Study||0
8331917|NCT01359748|20539231|P2|NOT COMPLETED|Overall Study||0
8331918|NCT01359748|20539232|P1|NOT COMPLETED|Overall Study||0
8331919|NCT01359748|20539229|P4|COMPLETED|Overall Study||11
8331920|NCT01359748|20539230|P3|COMPLETED|Overall Study||10
8331922|NCT01359748|20539232|P1|COMPLETED|Overall Study||48
8331923|NCT01359748|20539229|P4|STARTED|Overall Study||11
8331924|NCT01359748|20539230|P3|STARTED|Overall Study||10
8331925|NCT01359748|20539231|P2|STARTED|Overall Study||20
8331926|NCT01359748|20539232|P1|STARTED|Overall Study||48
8331927|NCT01359735|20539242|P2|NOT COMPLETED|Overall Study||0
8331928|NCT01359735|20539243|P1|NOT COMPLETED|Overall Study||0
8331929|NCT01359735|20539242|P2|COMPLETED|Overall Study||4
8331930|NCT01359735|20539243|P1|COMPLETED|Overall Study||4
8331931|NCT01359735|20539242|P2|STARTED|Overall Study||4
8331932|NCT01359735|20539243|P1|STARTED|Overall Study||4
8331933|NCT01359644|20539267|P10|NOT COMPLETED|Follow-up Period||0
8331934|NCT01359644|20539268|P9|NOT COMPLETED|Follow-up Period||0
8331935|NCT01359644|20539269|P8|NOT COMPLETED|Follow-up Period||2
8331936|NCT01359644|20539270|P7|NOT COMPLETED|Follow-up Period||1
8331937|NCT01359644|20539271|P6|NOT COMPLETED|Follow-up Period||1
8331938|NCT01359644|20539272|P5|NOT COMPLETED|Follow-up Period||0
8331939|NCT01359644|20539273|P4|NOT COMPLETED|Follow-up Period||0
8331940|NCT01359644|20539274|P3|NOT COMPLETED|Follow-up Period||0
8331941|NCT01359644|20539275|P2|NOT COMPLETED|Follow-up Period||0
8331942|NCT01359644|20539276|P1|NOT COMPLETED|Follow-up Period||0
8331943|NCT01359644|20539267|P10|COMPLETED|Follow-up Period||20
8331944|NCT01359644|20539268|P9|COMPLETED|Follow-up Period||21
8331945|NCT01359644|20539269|P8|COMPLETED|Follow-up Period||39
8331946|NCT01359644|20539270|P7|COMPLETED|Follow-up Period||40
8331947|NCT01359644|20539271|P6|COMPLETED|Follow-up Period||12
8331948|NCT01359644|20539272|P5|COMPLETED|Follow-up Period||15
8331949|NCT01359644|20539273|P4|COMPLETED|Follow-up Period||14
8331950|NCT01359644|20539274|P3|COMPLETED|Follow-up Period||14
8331951|NCT01359644|20539275|P2|COMPLETED|Follow-up Period||16
8331952|NCT01359644|20539276|P1|COMPLETED|Follow-up Period||15
8331953|NCT01359644|20539267|P10|STARTED|Follow-up Period||20
8331954|NCT01359644|20539268|P9|STARTED|Follow-up Period||21
8331955|NCT01359644|20539269|P8|STARTED|Follow-up Period||41
8331956|NCT01359644|20539270|P7|STARTED|Follow-up Period||41
8331957|NCT01359644|20539271|P6|STARTED|Follow-up Period||13
8331958|NCT01359644|20539272|P5|STARTED|Follow-up Period||15
8331959|NCT01359644|20539273|P4|STARTED|Follow-up Period||14
8331960|NCT01359644|20539274|P3|STARTED|Follow-up Period||14
8331961|NCT01359644|20539275|P2|STARTED|Follow-up Period||16
8331962|NCT01359644|20539276|P1|STARTED|Follow-up Period||15
8331963|NCT01359644|20539267|P10|NOT COMPLETED|Treatment Period||0
8331964|NCT01359644|20539268|P9|NOT COMPLETED|Treatment Period||0
8331965|NCT01359644|20539269|P8|NOT COMPLETED|Treatment Period||0
8331966|NCT01359644|20539270|P7|NOT COMPLETED|Treatment Period||0
8331967|NCT01359644|20539271|P6|NOT COMPLETED|Treatment Period||2
8331968|NCT01359644|20539272|P5|NOT COMPLETED|Treatment Period||0
8331969|NCT01359644|20539273|P4|NOT COMPLETED|Treatment Period||0
8331970|NCT01359644|20539274|P3|NOT COMPLETED|Treatment Period||1
8331971|NCT01359644|20539275|P2|NOT COMPLETED|Treatment Period||1
8331972|NCT01359644|20539276|P1|NOT COMPLETED|Treatment Period||0
8331973|NCT01359644|20539267|P10|COMPLETED|Treatment Period||20
8331974|NCT01359644|20539268|P9|COMPLETED|Treatment Period||21
8331975|NCT01359644|20539269|P8|COMPLETED|Treatment Period||41
8331976|NCT01359644|20539270|P7|COMPLETED|Treatment Period||41
8331977|NCT01359644|20539271|P6|COMPLETED|Treatment Period||12
8331978|NCT01359644|20539272|P5|COMPLETED|Treatment Period||15
8331979|NCT01359644|20539273|P4|COMPLETED|Treatment Period||14
8331980|NCT01359644|20539274|P3|COMPLETED|Treatment Period||13
8331981|NCT01359644|20539275|P2|COMPLETED|Treatment Period||15
8331982|NCT01359644|20539276|P1|COMPLETED|Treatment Period||15
8331983|NCT01359644|20539267|P10|STARTED|Treatment Period||20
8331984|NCT01359644|20539268|P9|STARTED|Treatment Period||21
8331985|NCT01359644|20539269|P8|STARTED|Treatment Period||41
8331986|NCT01359644|20539270|P7|STARTED|Treatment Period||41
8331987|NCT01359644|20539271|P6|STARTED|Treatment Period||14
8331988|NCT01359644|20539272|P5|STARTED|Treatment Period||15
8331989|NCT01359644|20539273|P4|STARTED|Treatment Period||14
8331990|NCT01359644|20539274|P3|STARTED|Treatment Period||14
8331991|NCT01359644|20539275|P2|STARTED|Treatment Period||16
8331992|NCT01359644|20539276|P1|STARTED|Treatment Period||15
8331993|NCT01359449|20539320|P2|NOT COMPLETED|Overall Study||4
8331994|NCT01359449|20539321|P1|NOT COMPLETED|Overall Study||4
8331995|NCT01359449|20539320|P2|COMPLETED|Overall Study||58
8331996|NCT01359449|20539321|P1|COMPLETED|Overall Study||57
8331997|NCT01359449|20539320|P2|STARTED|Overall Study||62
8331998|NCT01359449|20539321|P1|STARTED|Overall Study||61
8331999|NCT01359410|20539345|P2|NOT COMPLETED|Overall Study||0
8332000|NCT01359410|20539346|P1|NOT COMPLETED|Overall Study||0
8332001|NCT01359410|20539345|P2|COMPLETED|Overall Study||46
8332002|NCT01359410|20539346|P1|COMPLETED|Overall Study||54
8332003|NCT01359410|20539345|P2|STARTED|Overall Study||46
8332004|NCT01359410|20539346|P1|STARTED|Overall Study||54
8332005|NCT01359371|20539360|P1|NOT COMPLETED|Overall Study||0
8332006|NCT01359371|20539360|P1|COMPLETED|Overall Study||131
8332007|NCT01359371|20539360|P1|STARTED|Overall Study||131
8332008|NCT01359254|20539371|P2|NOT COMPLETED|Overall Study||0
8332009|NCT01359254|20539372|P1|NOT COMPLETED|Overall Study||1
8332010|NCT01359254|20539371|P2|COMPLETED|Overall Study||0
8332011|NCT01359254|20539372|P1|COMPLETED|Overall Study||0
8332012|NCT01359254|20539371|P2|STARTED|Overall Study||0
8332013|NCT01359254|20539372|P1|STARTED|Overall Study||1
8332014|NCT01359150|20539382|P2|NOT COMPLETED|Overall Study||5
8332015|NCT01359150|20539383|P1|NOT COMPLETED|Overall Study||7
8332016|NCT01359150|20539382|P2|COMPLETED|Overall Study||106
8332017|NCT01359150|20539383|P1|COMPLETED|Overall Study||105
8332018|NCT01359150|20539382|P2|STARTED|Overall Study||111
8332019|NCT01359150|20539383|P1|STARTED|Overall Study||112
8332020|NCT01359111|20539405|P1|NOT COMPLETED|Overall Study||0
8332021|NCT01359111|20539405|P1|COMPLETED|Overall Study||20
8332022|NCT01359111|20539405|P1|STARTED|Overall Study||20
8332023|NCT01359046|20539414|P2|NOT COMPLETED|Overall Study||17
8332024|NCT01359046|20539415|P1|NOT COMPLETED|Overall Study||7
8332025|NCT01359046|20539414|P2|COMPLETED|Overall Study||127
8332026|NCT01359046|20539415|P1|COMPLETED|Overall Study||137
8332027|NCT01359046|20539414|P2|STARTED|Overall Study||144
8332028|NCT01359046|20539415|P1|STARTED|Overall Study||144
8332029|NCT01359007|20539423|P1|NOT COMPLETED|Overall Study||2
8332030|NCT01359007|20539423|P1|COMPLETED|Overall Study||3
8332031|NCT01359007|20539423|P1|STARTED|Overall Study||5
8332032|NCT01358981|20539438|P7|NOT COMPLETED|Period 4||0
8332033|NCT01358981|20539439|P6|NOT COMPLETED|Period 4||0
8332034|NCT01358981|20539440|P5|NOT COMPLETED|Period 4||0
8332035|NCT01358981|20539441|P4|NOT COMPLETED|Period 4||0
8332036|NCT01358981|20539442|P3|NOT COMPLETED|Period 4||0
8332037|NCT01358981|20539443|P2|NOT COMPLETED|Period 4||0
8332038|NCT01358981|20539444|P1|NOT COMPLETED|Period 4||0
8332039|NCT01358981|20539438|P7|COMPLETED|Period 4||0
8332040|NCT01358981|20539439|P6|COMPLETED|Period 4||0
8332041|NCT01358981|20539440|P5|COMPLETED|Period 4||0
8332042|NCT01358981|20539441|P4|COMPLETED|Period 4||2
8332043|NCT01358981|20539442|P3|COMPLETED|Period 4||2
8332044|NCT01358981|20539443|P2|COMPLETED|Period 4||2
8332045|NCT01358981|20539444|P1|COMPLETED|Period 4||2
8332046|NCT01358981|20539438|P7|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
8332047|NCT01358981|20539439|P6|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
8332048|NCT01358981|20539440|P5|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
8332049|NCT01358981|20539441|P4|STARTED|Period 4||2
8332050|NCT01358981|20539442|P3|STARTED|Period 4||2
8332051|NCT01358981|20539443|P2|STARTED|Period 4||2
8332052|NCT01358981|20539444|P1|STARTED|Period 4||2
8332053|NCT01358981|20539438|P7|NOT COMPLETED|Period 3||0
8332054|NCT01358981|20539439|P6|NOT COMPLETED|Period 3||0
8332055|NCT01358981|20539440|P5|NOT COMPLETED|Period 3||0
8332056|NCT01358981|20539441|P4|NOT COMPLETED|Period 3||0
8332057|NCT01358981|20539442|P3|NOT COMPLETED|Period 3||0
8332058|NCT01358981|20539443|P2|NOT COMPLETED|Period 3||0
8332059|NCT01358981|20539444|P1|NOT COMPLETED|Period 3||0
8332060|NCT01358981|20539438|P7|COMPLETED|Period 3||3
8332061|NCT01358981|20539439|P6|COMPLETED|Period 3||3
8332062|NCT01358981|20539440|P5|COMPLETED|Period 3||3
8332063|NCT01358981|20539441|P4|COMPLETED|Period 3||2
8332064|NCT01358981|20539442|P3|COMPLETED|Period 3||2
8332065|NCT01358981|20539443|P2|COMPLETED|Period 3||2
8332066|NCT01358981|20539444|P1|COMPLETED|Period 3||2
8332067|NCT01358981|20539438|P7|STARTED|Period 3||3
8332068|NCT01358981|20539439|P6|STARTED|Period 3||3
8332069|NCT01358981|20539440|P5|STARTED|Period 3||3
8332070|NCT01358981|20539441|P4|STARTED|Period 3||2
8332071|NCT01358981|20539442|P3|STARTED|Period 3||2
8332072|NCT01358981|20539443|P2|STARTED|Period 3||2
8332073|NCT01358981|20539444|P1|STARTED|Period 3||2
8332074|NCT01358981|20539438|P7|NOT COMPLETED|Period 2||0
8332075|NCT01358981|20539439|P6|NOT COMPLETED|Period 2||0
8332076|NCT01358981|20539440|P5|NOT COMPLETED|Period 2||0
8332077|NCT01358981|20539441|P4|NOT COMPLETED|Period 2||0
8332078|NCT01358981|20539442|P3|NOT COMPLETED|Period 2||0
8332079|NCT01358981|20539443|P2|NOT COMPLETED|Period 2||0
8332080|NCT01358981|20539444|P1|NOT COMPLETED|Period 2||0
8332081|NCT01358981|20539438|P7|COMPLETED|Period 2||3
8332082|NCT01358981|20539439|P6|COMPLETED|Period 2||3
8332083|NCT01358981|20539440|P5|COMPLETED|Period 2||3
8332084|NCT01358981|20539441|P4|COMPLETED|Period 2||2
8332085|NCT01358981|20539442|P3|COMPLETED|Period 2||2
8332086|NCT01358981|20539443|P2|COMPLETED|Period 2||2
8332087|NCT01358981|20539444|P1|COMPLETED|Period 2||2
8332088|NCT01358981|20539438|P7|STARTED|Period 2||3
8332089|NCT01358981|20539439|P6|STARTED|Period 2||3
8332090|NCT01358981|20539440|P5|STARTED|Period 2||3
8332091|NCT01358981|20539441|P4|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2
8332092|NCT01358981|20539442|P3|STARTED|Period 2||2
8332093|NCT01358981|20539443|P2|STARTED|Period 2||2
8332094|NCT01358981|20539444|P1|STARTED|Period 2||2
8332095|NCT01358981|20539438|P7|NOT COMPLETED|Period 1||0
8332096|NCT01358981|20539439|P6|NOT COMPLETED|Period 1||0
8332097|NCT01358981|20539440|P5|NOT COMPLETED|Period 1||0
8332098|NCT01358981|20539441|P4|NOT COMPLETED|Period 1||1
8332099|NCT01358981|20539442|P3|NOT COMPLETED|Period 1||0
8332100|NCT01358981|20539443|P2|NOT COMPLETED|Period 1||0
8332101|NCT01358981|20539444|P1|NOT COMPLETED|Period 1||0
8332102|NCT01358981|20539438|P7|COMPLETED|Period 1||3
8332103|NCT01358981|20539439|P6|COMPLETED|Period 1||3
8332104|NCT01358981|20539440|P5|COMPLETED|Period 1||3
8332105|NCT01358981|20539441|P4|COMPLETED|Period 1||1
8332106|NCT01358981|20539442|P3|COMPLETED|Period 1||2
8332107|NCT01358981|20539443|P2|COMPLETED|Period 1||2
8332108|NCT01358981|20539444|P1|COMPLETED|Period 1||2
8332109|NCT01358981|20539438|P7|Received at Least 1dose of Study Drug|Period 1||3
8332110|NCT01358981|20539439|P6|Received at Least 1dose of Study Drug|Period 1||3
8332111|NCT01358981|20539440|P5|Received at Least 1dose of Study Drug|Period 1||3
8332112|NCT01358981|20539441|P4|Received at Least 1dose of Study Drug|Period 1||2
8332113|NCT01358981|20539442|P3|Received at Least 1dose of Study Drug|Period 1||2
8332114|NCT01358981|20539443|P2|Received at Least 1dose of Study Drug|Period 1||2
8332115|NCT01358981|20539444|P1|Received at Least 1dose of Study Drug|Period 1||2
8332116|NCT01358981|20539438|P7|STARTED|Period 1||3
8332117|NCT01358981|20539439|P6|STARTED|Period 1||3
8332118|NCT01358981|20539440|P5|STARTED|Period 1||3
8332119|NCT01358981|20539441|P4|STARTED|Period 1||2
8332120|NCT01358981|20539442|P3|STARTED|Period 1||2
8332121|NCT01358981|20539443|P2|STARTED|Period 1||2
8332122|NCT01358981|20539444|P1|STARTED|Period 1||2
8332123|NCT01358968|20539505|P4|NOT COMPLETED|Continued Access Phase||7
8332124|NCT01358968|20539506|P3|NOT COMPLETED|Continued Access Phase||12
8332125|NCT01358968|20539507|P2|NOT COMPLETED|Continued Access Phase||0
8332126|NCT01358968|20539508|P1|NOT COMPLETED|Continued Access Phase||0
8332127|NCT01358968|20539505|P4|COMPLETED|Continued Access Phase||0
8332128|NCT01358968|20539506|P3|COMPLETED|Continued Access Phase||0
8332129|NCT01358968|20539507|P2|COMPLETED|Continued Access Phase||0
8332130|NCT01358968|20539508|P1|COMPLETED|Continued Access Phase||0
8332131|NCT01358968|20539505|P4|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
8332132|NCT01358968|20539506|P3|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
8332133|NCT01358968|20539507|P2|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
8332134|NCT01358968|20539508|P1|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
8332135|NCT01358968|20539505|P4|STARTED|Continued Access Phase||7
8332136|NCT01358968|20539506|P3|STARTED|Continued Access Phase||12
8332137|NCT01358968|20539507|P2|STARTED|Continued Access Phase||0
8332138|NCT01358968|20539508|P1|STARTED|Continued Access Phase||0
8332139|NCT01358968|20539505|P4|NOT COMPLETED|Period 2||0
8332140|NCT01358968|20539506|P3|NOT COMPLETED|Period 2||0
8332141|NCT01358968|20539507|P2|NOT COMPLETED|Period 2||1
8332142|NCT01358968|20539508|P1|NOT COMPLETED|Period 2||0
8332143|NCT01358968|20539505|P4|COMPLETED|Period 2||0
8332144|NCT01358968|20539506|P3|COMPLETED|Period 2||0
8332145|NCT01358968|20539507|P2|COMPLETED|Period 2||19
8332146|NCT01358968|20539508|P1|COMPLETED|Period 2||0
8332147|NCT01358968|20539505|P4|Received at Least 1 Dose of Study Drug|Period 2||0
8332148|NCT01358968|20539506|P3|Received at Least 1 Dose of Study Drug|Period 2||0
8332149|NCT01358968|20539507|P2|Received at Least 1 Dose of Study Drug|Period 2||19
8332150|NCT01358968|20539508|P1|Received at Least 1 Dose of Study Drug|Period 2||0
8332151|NCT01358968|20539505|P4|STARTED|Period 2||0
8332152|NCT01358968|20539506|P3|STARTED|Period 2||0
8332153|NCT01358968|20539507|P2|STARTED|Period 2||20
8332154|NCT01358968|20539508|P1|STARTED|Period 2||0
8332155|NCT01358968|20539505|P4|NOT COMPLETED|Period 1||0
8332156|NCT01358968|20539506|P3|NOT COMPLETED|Period 1||0
8332157|NCT01358968|20539507|P2|NOT COMPLETED|Period 1||0
8332158|NCT01358968|20539508|P1|NOT COMPLETED|Period 1||0
8332159|NCT01358968|20539505|P4|COMPLETED|Period 1||0
8332160|NCT01358968|20539506|P3|COMPLETED|Period 1||0
8332161|NCT01358968|20539507|P2|COMPLETED|Period 1||0
8332162|NCT01358968|20539508|P1|COMPLETED|Period 1||20
8332163|NCT01358968|20539505|P4|Received at Least 1 Dose of Study Drug|Period 1||0
8332164|NCT01358968|20539506|P3|Received at Least 1 Dose of Study Drug|Period 1||0
8332165|NCT01358968|20539507|P2|Received at Least 1 Dose of Study Drug|Period 1||0
8332166|NCT01358968|20539508|P1|Received at Least 1 Dose of Study Drug|Period 1||20
8332167|NCT01358968|20539505|P4|STARTED|Period 1||0
8332168|NCT01358968|20539506|P3|STARTED|Period 1||0
8332169|NCT01358968|20539507|P2|STARTED|Period 1||0
8332170|NCT01358968|20539508|P1|STARTED|Period 1||20
8332181|NCT01358864|20539595|P8|NOT COMPLETED|Overall Study||55
8332182|NCT01358864|20539596|P7|NOT COMPLETED|Overall Study||65
8332183|NCT01358864|20539597|P6|NOT COMPLETED|Overall Study||13
8332184|NCT01358864|20539598|P5|NOT COMPLETED|Overall Study||11
8332185|NCT01358864|20539599|P4|NOT COMPLETED|Overall Study||19
8332186|NCT01358864|20539600|P3|NOT COMPLETED|Overall Study||16
8332187|NCT01358864|20539601|P2|NOT COMPLETED|Overall Study||13
8332188|NCT01358864|20539602|P1|NOT COMPLETED|Overall Study||31
8332189|NCT01358864|20539595|P8|COMPLETED|Overall Study||85
8332190|NCT01358864|20539596|P7|COMPLETED|Overall Study||81
8332191|NCT01358864|20539597|P6|COMPLETED|Overall Study||42
8332192|NCT01358864|20539598|P5|COMPLETED|Overall Study||46
8332193|NCT01358864|20539599|P4|COMPLETED|Overall Study||10
8332194|NCT01358864|20539600|P3|COMPLETED|Overall Study||87
8332195|NCT01358864|20539601|P2|COMPLETED|Overall Study||86
8332196|NCT01358864|20539602|P1|COMPLETED|Overall Study||18
8332197|NCT01358864|20539595|P8|STARTED|Overall Study||140
8332198|NCT01358864|20539596|P7|STARTED|Overall Study||146
8332199|NCT01358864|20539597|P6|STARTED|Overall Study||55
8332200|NCT01358864|20539598|P5|STARTED|Overall Study||57
8332201|NCT01358864|20539599|P4|STARTED|Overall Study||29
8332202|NCT01358864|20539600|P3|STARTED|Overall Study||103
8332203|NCT01358864|20539601|P2|STARTED|Overall Study||99
8332204|NCT01358864|20539602|P1|STARTED|Overall Study||49
8332205|NCT01358825|20539693|P2|NOT COMPLETED|Overall Study||1
8332206|NCT01358825|20539694|P1|NOT COMPLETED|Overall Study||0
8332207|NCT01358825|20539693|P2|COMPLETED|Overall Study||45
8332208|NCT01358825|20539694|P1|COMPLETED|Overall Study||12
8332209|NCT01358825|20539693|P2|STARTED|Overall Study||46
8332210|NCT01358825|20539694|P1|STARTED|Overall Study||12
8332211|NCT01358760|20539718|P3|NOT COMPLETED|Overall Study||25
8332212|NCT01358760|20539719|P2|NOT COMPLETED|Overall Study||20
8332213|NCT01358760|20539720|P1|NOT COMPLETED|Overall Study||22
8332214|NCT01358760|20539718|P3|COMPLETED|Overall Study||125
8332215|NCT01358760|20539719|P2|COMPLETED|Overall Study||128
8332216|NCT01358760|20539720|P1|COMPLETED|Overall Study||130
8332217|NCT01358760|20539718|P3|ITT Population|Overall Study||134
8332218|NCT01358760|20539719|P2|ITT Population|Overall Study||134
8332219|NCT01358760|20539720|P1|ITT Population|Overall Study||139
8332220|NCT01358760|20539718|P3|Safety Population|Overall Study||148
8332221|NCT01358760|20539719|P2|Safety Population|Overall Study||143
8332222|NCT01358760|20539720|P1|Safety Population|Overall Study||150
8332223|NCT01358760|20539718|P3|STARTED|Overall Study||150
8332224|NCT01358760|20539719|P2|STARTED|Overall Study||148
8332225|NCT01358760|20539720|P1|STARTED|Overall Study||152
8332226|NCT01358734|20539755|P3|NOT COMPLETED|Overall Study||34
8332227|NCT01358734|20539756|P2|NOT COMPLETED|Overall Study||39
8332228|NCT01358734|20539757|P1|NOT COMPLETED|Overall Study||15
8332229|NCT01358734|20539755|P3|COMPLETED|Overall Study||0
8332230|NCT01358734|20539756|P2|COMPLETED|Overall Study||0
8332231|NCT01358734|20539757|P1|COMPLETED|Overall Study||0
8332232|NCT01358734|20539755|P3|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
8332233|NCT01358734|20539756|P2|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
8332234|NCT01358734|20539757|P1|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
8332235|NCT01358734|20539755|P3|STARTED|Overall Study||34
8332236|NCT01358734|20539756|P2|STARTED|Overall Study||39
8332237|NCT01358734|20539757|P1|STARTED|Overall Study||15
8332238|NCT01358721|20539805|P4|NOT COMPLETED|Overall Study||24
8332239|NCT01358721|20539806|P3|NOT COMPLETED|Overall Study||22
8332240|NCT01358721|20539807|P2|NOT COMPLETED|Overall Study||22
8332241|NCT01358721|20539808|P1|NOT COMPLETED|Overall Study||21
8332242|NCT01358721|20539805|P4|COMPLETED|Overall Study||0
8332243|NCT01358721|20539806|P3|COMPLETED|Overall Study||1
8332244|NCT01358721|20539807|P2|COMPLETED|Overall Study||0
8332245|NCT01358721|20539808|P1|COMPLETED|Overall Study||1
8332246|NCT01358721|20539805|P4|STARTED|Overall Study||24
8332247|NCT01358721|20539806|P3|STARTED|Overall Study||23
8332248|NCT01358721|20539807|P2|STARTED|Overall Study||22
8332249|NCT01358721|20539808|P1|STARTED|Overall Study||22
8332250|NCT01358708|20539860|P2|NOT COMPLETED|Open-Label Treatment Phase||0
8332251|NCT01358708|20539861|P1|NOT COMPLETED|Open-Label Treatment Phase||0
8332252|NCT01358708|20539860|P2|COMPLETED|Open-Label Treatment Phase||12
8332253|NCT01358708|20539861|P1|COMPLETED|Open-Label Treatment Phase||5
8332254|NCT01358708|20539860|P2|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
8332255|NCT01358708|20539861|P1|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
8332256|NCT01358708|20539860|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
8332257|NCT01358708|20539861|P1|NOT COMPLETED|Double-Blind Treatment Phase||3
8332258|NCT01358708|20539860|P2|COMPLETED|Double-Blind Treatment Phase||13
8332259|NCT01358708|20539861|P1|COMPLETED|Double-Blind Treatment Phase||10
8332260|NCT01358708|20539860|P2|Received Study Medication|Double-Blind Treatment Phase||13
8332261|NCT01358708|20539861|P1|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
8332262|NCT01358708|20539860|P2|Randomized|Double-Blind Treatment Phase||13
8332263|NCT01358708|20539861|P1|Randomized|Double-Blind Treatment Phase||13
8332264|NCT01358708|20539860|P2|STARTED|Double-Blind Treatment Phase||13
8332265|NCT01358708|20539861|P1|STARTED|Double-Blind Treatment Phase||13
8332266|NCT01358578|20539884|P6|NOT COMPLETED|Follow-up Period||0
8332267|NCT01358578|20539885|P5|NOT COMPLETED|Follow-up Period||0
8332268|NCT01358578|20539886|P4|NOT COMPLETED|Follow-up Period||19
8332269|NCT01358578|20539887|P3|NOT COMPLETED|Follow-up Period||5
8332270|NCT01358578|20539888|P2|NOT COMPLETED|Follow-up Period||6
8332271|NCT01358578|20539889|P1|NOT COMPLETED|Follow-up Period||10
8332272|NCT01358578|20539884|P6|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
8332273|NCT01358578|20539885|P5|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
8332274|NCT01358578|20539886|P4|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
8332275|NCT01358578|20539887|P3|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
8332276|NCT01358578|20539888|P2|COMPLETED|Follow-up Period||119
8332277|NCT01358578|20539889|P1|COMPLETED|Follow-up Period||138
8332278|NCT01358578|20539884|P6|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
8332279|NCT01358578|20539885|P5|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
8332280|NCT01358578|20539886|P4|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
8332281|NCT01358578|20539887|P3|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
8332282|NCT01358578|20539888|P2|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
8332283|NCT01358578|20539889|P1|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
8332284|NCT01358578|20539884|P6|NOT COMPLETED|Maintenance Period||11
8332285|NCT01358578|20539885|P5|NOT COMPLETED|Maintenance Period||17
8332286|NCT01358578|20539886|P4|NOT COMPLETED|Maintenance Period||42
8332287|NCT01358578|20539887|P3|NOT COMPLETED|Maintenance Period||2
8332288|NCT01358578|20539888|P2|NOT COMPLETED|Maintenance Period||22
8332289|NCT01358578|20539889|P1|NOT COMPLETED|Maintenance Period||39
8332290|NCT01358578|20539884|P6|COMPLETED|Maintenance Period||131
8332291|NCT01358578|20539885|P5|COMPLETED|Maintenance Period||125
8332292|NCT01358578|20539886|P4|COMPLETED|Maintenance Period||263
8332293|NCT01358578|20539887|P3|COMPLETED|Maintenance Period||15
8332294|NCT01358578|20539888|P2|COMPLETED|Maintenance Period||290
8332295|NCT01358578|20539889|P1|COMPLETED|Maintenance Period||276
8332296|NCT01358578|20539884|P6|STARTED|Maintenance Period||142
8332297|NCT01358578|20539885|P5|STARTED|Maintenance Period||142
8332298|NCT01358578|20539886|P4|STARTED|Maintenance Period||305
8332299|NCT01358578|20539887|P3|STARTED|Maintenance Period||17
8332300|NCT01358578|20539888|P2|STARTED|Maintenance Period||312
8332301|NCT01358578|20539889|P1|STARTED|Maintenance Period||315
8332302|NCT01358578|20539884|P6|NOT COMPLETED|Induction Period||0
8332303|NCT01358578|20539885|P5|NOT COMPLETED|Induction Period||0
8332304|NCT01358578|20539886|P4|NOT COMPLETED|Induction Period||21
8332305|NCT01358578|20539887|P3|NOT COMPLETED|Induction Period||25
8332306|NCT01358578|20539888|P2|NOT COMPLETED|Induction Period||15
8332307|NCT01358578|20539889|P1|NOT COMPLETED|Induction Period||12
8332308|NCT01358578|20539884|P6|COMPLETED|Induction Period|These groups are populated after the induction period|0
8332309|NCT01358578|20539885|P5|COMPLETED|Induction Period|These groups are populated after the induction period|0
8332310|NCT01358578|20539886|P4|COMPLETED|Induction Period||305
8332311|NCT01358578|20539887|P3|COMPLETED|Induction Period||301
8332312|NCT01358578|20539888|P2|COMPLETED|Induction Period||312
8332313|NCT01358578|20539889|P1|COMPLETED|Induction Period||315
8332314|NCT01358578|20539884|P6|STARTED|Induction Period|These groups are populated after the induction period|0
8332315|NCT01358578|20539885|P5|STARTED|Induction Period|These groups are populated after the induction period|0
8332316|NCT01358578|20539886|P4|STARTED|Induction Period||326
8332317|NCT01358578|20539887|P3|STARTED|Induction Period||326
8332318|NCT01358578|20539888|P2|STARTED|Induction Period||327
8332319|NCT01358578|20539889|P1|STARTED|Induction Period||327
8332320|NCT01358526|20539941|P3|NOT COMPLETED|Double-blind Phase||121
8332321|NCT01358526|20539942|P2|NOT COMPLETED|Double-blind Phase||80
8332322|NCT01358526|20539943|P1|NOT COMPLETED|Double-blind Phase||0
8332323|NCT01358526|20539941|P3|COMPLETED|Double-blind Phase||181
8332324|NCT01358526|20539942|P2|COMPLETED|Double-blind Phase||218
8332325|NCT01358526|20539943|P1|COMPLETED|Double-blind Phase||0
8332326|NCT01358526|20539941|P3|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
8332327|NCT01358526|20539942|P2|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
8332328|NCT01358526|20539943|P1|STARTED|Double-blind Phase||0
8332329|NCT01358526|20539941|P3|NOT COMPLETED|Open-label Titration Period||0
8332330|NCT01358526|20539942|P2|NOT COMPLETED|Open-label Titration Period||0
8332331|NCT01358526|20539943|P1|NOT COMPLETED|Open-label Titration Period||494
8332332|NCT01358526|20539941|P3|COMPLETED|Open-label Titration Period||0
8332333|NCT01358526|20539942|P2|COMPLETED|Open-label Titration Period||0
8332334|NCT01358526|20539943|P1|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
8332335|NCT01358526|20539941|P3|STARTED|Open-label Titration Period||0
8332336|NCT01358526|20539942|P2|STARTED|Open-label Titration Period||0
8332337|NCT01358526|20539943|P1|STARTED|Open-label Titration Period||1095
8332338|NCT01358357|20539960|P3|NOT COMPLETED|Double-Blind Phase||0
8332339|NCT01358357|20539961|P2|NOT COMPLETED|Double-Blind Phase||100
8332340|NCT01358357|20539962|P1|NOT COMPLETED|Double-Blind Phase||80
8332341|NCT01358357|20539960|P3|COMPLETED|Double-Blind Phase||0
8332342|NCT01358357|20539961|P2|COMPLETED|Double-Blind Phase||150
8332343|NCT01358357|20539962|P1|COMPLETED|Double-Blind Phase||166
8332344|NCT01358357|20539960|P3|STARTED|Double-Blind Phase||0
8332345|NCT01358357|20539961|P2|STARTED|Double-Blind Phase||250
8332346|NCT01358357|20539962|P1|STARTED|Double-Blind Phase||246
8332347|NCT01358357|20539960|P3|NOT COMPLETED|Open Label Phase||462
8332348|NCT01358357|20539961|P2|NOT COMPLETED|Open Label Phase||0
8332349|NCT01358357|20539962|P1|NOT COMPLETED|Open Label Phase||0
8332350|NCT01358357|20539960|P3|COMPLETED|Open Label Phase||503
8332351|NCT01358357|20539961|P2|COMPLETED|Open Label Phase||0
8332352|NCT01358357|20539962|P1|COMPLETED|Open Label Phase||0
8332353|NCT01358357|20539960|P3|STARTED|Open Label Phase||965
8332354|NCT01358357|20539961|P2|STARTED|Open Label Phase||0
8332355|NCT01358357|20539962|P1|STARTED|Open Label Phase||0
8332356|NCT01358331|20540001|P6|NOT COMPLETED|Overall Study||6
8332357|NCT01358331|20540002|P5|NOT COMPLETED|Overall Study||7
8332358|NCT01358331|20540003|P4|NOT COMPLETED|Overall Study||3
8332359|NCT01358331|20540004|P3|NOT COMPLETED|Overall Study||4
8332360|NCT01358331|20540005|P2|NOT COMPLETED|Overall Study||3
8332361|NCT01358331|20540006|P1|NOT COMPLETED|Overall Study||2
8332362|NCT01358331|20540001|P6|COMPLETED|Overall Study||0
8332363|NCT01358331|20540002|P5|COMPLETED|Overall Study||0
8332364|NCT01358331|20540003|P4|COMPLETED|Overall Study||0
8332365|NCT01358331|20540004|P3|COMPLETED|Overall Study||0
8332366|NCT01358331|20540005|P2|COMPLETED|Overall Study||0
8332367|NCT01358331|20540006|P1|COMPLETED|Overall Study||0
8332368|NCT01358331|20540001|P6|STARTED|Overall Study||6
8332369|NCT01358331|20540002|P5|STARTED|Overall Study||7
8332370|NCT01358331|20540003|P4|STARTED|Overall Study||3
8332371|NCT01358331|20540004|P3|STARTED|Overall Study||4
8332372|NCT01358331|20540005|P2|STARTED|Overall Study||3
8332373|NCT01358331|20540006|P1|STARTED|Overall Study||2
8332374|NCT01358266|20540029|P3|NOT COMPLETED|Open-Label Period||70
8332375|NCT01358266|20540030|P2|NOT COMPLETED|Open-Label Period||44
8332376|NCT01358266|20540031|P1|NOT COMPLETED|Open-Label Period||56
8332377|NCT01358266|20540029|P3|COMPLETED|Open-Label Period||44
8332378|NCT01358266|20540030|P2|COMPLETED|Open-Label Period||58
8332379|NCT01358266|20540031|P1|COMPLETED|Open-Label Period||63
8332380|NCT01358266|20540029|P3|STARTED|Open-Label Period||114
8332381|NCT01358266|20540030|P2|STARTED|Open-Label Period||102
8332382|NCT01358266|20540031|P1|STARTED|Open-Label Period||119
8332383|NCT01358266|20540029|P3|NOT COMPLETED|Double-Masked Period||39
8332384|NCT01358266|20540030|P2|NOT COMPLETED|Double-Masked Period||46
8332385|NCT01358266|20540031|P1|NOT COMPLETED|Double-Masked Period||33
8332386|NCT01358266|20540029|P3|COMPLETED|Double-Masked Period||137
8332387|NCT01358266|20540030|P2|COMPLETED|Double-Masked Period||162
8332388|NCT01358266|20540031|P1|COMPLETED|Double-Masked Period||175
8332389|NCT01358266|20540029|P3|STARTED|Double-Masked Period||176
8332390|NCT01358266|20540030|P2|STARTED|Double-Masked Period||208
8332391|NCT01358266|20540031|P1|STARTED|Double-Masked Period||208
8332392|NCT01358175|20540058|P3|NOT COMPLETED|Overall Study||32
8332393|NCT01358175|20540059|P2|NOT COMPLETED|Overall Study||28
8332394|NCT01358175|20540060|P1|NOT COMPLETED|Overall Study||21
8332395|NCT01358175|20540058|P3|COMPLETED|Overall Study||90
8332396|NCT01358175|20540059|P2|COMPLETED|Overall Study||97
8332397|NCT01358175|20540060|P1|COMPLETED|Overall Study||103
8332398|NCT01358175|20540058|P3|STARTED|Overall Study||122
8332399|NCT01358175|20540059|P2|STARTED|Overall Study||125
8332400|NCT01358175|20540060|P1|STARTED|Overall Study||124
8332401|NCT01357980|20540097|P4|NOT COMPLETED|Overall Study||0
8332402|NCT01357980|20540098|P3|NOT COMPLETED|Overall Study||1
8332403|NCT01357980|20540099|P2|NOT COMPLETED|Overall Study||1
8332404|NCT01357980|20540100|P1|NOT COMPLETED|Overall Study||0
8332405|NCT01357980|20540097|P4|COMPLETED|Overall Study||7
8332406|NCT01357980|20540098|P3|COMPLETED|Overall Study||16
8332407|NCT01357980|20540099|P2|COMPLETED|Overall Study||6
8332408|NCT01357980|20540100|P1|COMPLETED|Overall Study||16
8332409|NCT01357980|20540097|P4|STARTED|Overall Study||7
8332410|NCT01357980|20540098|P3|STARTED|Overall Study||17
8332411|NCT01357980|20540099|P2|STARTED|Overall Study||7
8332412|NCT01357980|20540100|P1|STARTED|Overall Study||16
8332413|NCT01357915|20540144|P2|NOT COMPLETED|Overall Study||0
8332414|NCT01357915|20540145|P1|NOT COMPLETED|Overall Study||3
8332415|NCT01357915|20540144|P2|COMPLETED|Overall Study||17
8332416|NCT01357915|20540145|P1|COMPLETED|Overall Study||27
8332417|NCT01357915|20540144|P2|STARTED|Overall Study||17
8332418|NCT01357915|20540145|P1|STARTED|Overall Study||30
8332419|NCT01357889|20540163|P2|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
8332420|NCT01357889|20540164|P1|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
8332421|NCT01357889|20540163|P2|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
8332422|NCT01357889|20540164|P1|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
8332423|NCT01357889|20540163|P2|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
8332424|NCT01357889|20540164|P1|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
8332425|NCT01357889|20540163|P2|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
8332426|NCT01357889|20540164|P1|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
8332427|NCT01357889|20540163|P2|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
8332428|NCT01357889|20540164|P1|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
8332429|NCT01357889|20540163|P2|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
8332430|NCT01357889|20540164|P1|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
8332431|NCT01357889|20540163|P2|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
8332432|NCT01357889|20540164|P1|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
8332433|NCT01357889|20540163|P2|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
8332434|NCT01357889|20540164|P1|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
8332435|NCT01357889|20540163|P2|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
8332436|NCT01357889|20540164|P1|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
8332437|NCT01357850|20540208|P4|NOT COMPLETED|Overall Study||0
8332438|NCT01357850|20540209|P3|NOT COMPLETED|Overall Study||0
8332439|NCT01357850|20540210|P2|NOT COMPLETED|Overall Study||0
8332440|NCT01357850|20540211|P1|NOT COMPLETED|Overall Study||1
8332441|NCT01357850|20540208|P4|COMPLETED|Overall Study||27
8332442|NCT01357850|20540209|P3|COMPLETED|Overall Study||13
8332443|NCT01357850|20540210|P2|COMPLETED|Overall Study||12
8332444|NCT01357850|20540211|P1|COMPLETED|Overall Study||29
8332445|NCT01357850|20540208|P4|STARTED|Overall Study||27
8332446|NCT01357850|20540209|P3|STARTED|Overall Study||13
8332447|NCT01357850|20540210|P2|STARTED|Overall Study||12
8332448|NCT01357850|20540211|P1|STARTED|Overall Study||30
8332449|NCT01357720|20540285|P2|NOT COMPLETED|Overall Study||5
8332450|NCT01357720|20540286|P1|NOT COMPLETED|Overall Study||2
8332451|NCT01357720|20540285|P2|COMPLETED|Overall Study||195
8332452|NCT01357720|20540286|P1|COMPLETED|Overall Study||198
8332453|NCT01357720|20540285|P2|STARTED|Overall Study||200
8332454|NCT01357720|20540286|P1|STARTED|Overall Study||200
8332455|NCT01357655|20540302|P2|NOT COMPLETED|Overall Study||0
8332456|NCT01357655|20540303|P1|NOT COMPLETED|Overall Study||66
8332457|NCT01357655|20540302|P2|COMPLETED|Overall Study||0
8332458|NCT01357655|20540303|P1|COMPLETED|Overall Study||0
8332459|NCT01357655|20540302|P2|STARTED|Overall Study||0
8332460|NCT01357655|20540303|P1|STARTED|Overall Study||66
8332461|NCT01357616|20540320|P2|NOT COMPLETED|Overall Study||9
8332462|NCT01357616|20540321|P1|NOT COMPLETED|Overall Study||10
8332463|NCT01357616|20540320|P2|COMPLETED|Overall Study||153
8332464|NCT01357616|20540321|P1|COMPLETED|Overall Study||156
8332465|NCT01357616|20540320|P2|STARTED|Overall Study||162
8332466|NCT01357616|20540321|P1|STARTED|Overall Study||166
8332467|NCT01357577|20540335|P2|NOT COMPLETED|Overall Study||26
8332468|NCT01357577|20540336|P1|NOT COMPLETED|Overall Study||37
8332469|NCT01357577|20540335|P2|COMPLETED|Overall Study||39
8332470|NCT01357577|20540336|P1|COMPLETED|Overall Study||27
8332471|NCT01357577|20540335|P2|Post-Treatment Assessment Completed|Overall Study||39
8332472|NCT01357577|20540336|P1|Post-Treatment Assessment Completed|Overall Study||24
8332473|NCT01357577|20540335|P2|STARTED|Overall Study||65
8332474|NCT01357577|20540336|P1|STARTED|Overall Study||64
8332475|NCT01357564|20540352|P2|NOT COMPLETED|Long-term (8-month) Follow-up||16
8332476|NCT01357564|20540353|P1|NOT COMPLETED|Long-term (8-month) Follow-up||2
8332477|NCT01357564|20540352|P2|COMPLETED|Long-term (8-month) Follow-up||102
8332478|NCT01357564|20540353|P1|COMPLETED|Long-term (8-month) Follow-up||104
8332479|NCT01357564|20540352|P2|STARTED|Long-term (8-month) Follow-up||118
8332480|NCT01357564|20540353|P1|STARTED|Long-term (8-month) Follow-up||106
8332481|NCT01357564|20540352|P2|NOT COMPLETED|Short-term (4-month) Follow up||50
8332482|NCT01357564|20540353|P1|NOT COMPLETED|Short-term (4-month) Follow up||48
8332483|NCT01357564|20540352|P2|COMPLETED|Short-term (4-month) Follow up||118
8332484|NCT01357564|20540353|P1|COMPLETED|Short-term (4-month) Follow up||106
8332485|NCT01357564|20540352|P2|STARTED|Short-term (4-month) Follow up||168
8332486|NCT01357564|20540353|P1|STARTED|Short-term (4-month) Follow up||154
8332487|NCT01357551|20540363|P2|NOT COMPLETED|Overall Study||11
8332488|NCT01357551|20540364|P1|NOT COMPLETED|Overall Study||22
8332489|NCT01357551|20540363|P2|COMPLETED|Overall Study||101
8332490|NCT01357551|20540364|P1|COMPLETED|Overall Study||88
8332491|NCT01357551|20540363|P2|STARTED|Overall Study||112
8332492|NCT01357551|20540364|P1|STARTED|Overall Study||110
8332493|NCT01357512|20540378|P2|NOT COMPLETED|Overall Study||5
8332494|NCT01357512|20540379|P1|NOT COMPLETED|Overall Study||12
8332495|NCT01357512|20540378|P2|COMPLETED|Overall Study||60
8332496|NCT01357512|20540379|P1|COMPLETED|Overall Study||53
8332497|NCT01357512|20540378|P2|STARTED|Overall Study||65
8332498|NCT01357512|20540379|P1|STARTED|Overall Study||65
8332499|NCT01357356|20540391|P4|NOT COMPLETED|Overall Study||17
8332500|NCT01357356|20540392|P3|NOT COMPLETED|Overall Study||28
8332501|NCT01357356|20540393|P2|NOT COMPLETED|Overall Study||25
8332502|NCT01357356|20540394|P1|NOT COMPLETED|Overall Study||22
8332503|NCT01357356|20540391|P4|COMPLETED|Overall Study||171
8332504|NCT01357356|20540392|P3|COMPLETED|Overall Study||158
8332505|NCT01357356|20540393|P2|COMPLETED|Overall Study||163
8332506|NCT01357356|20540394|P1|COMPLETED|Overall Study||166
8332507|NCT01357356|20540391|P4|STARTED|Overall Study||188
8332508|NCT01357356|20540392|P3|STARTED|Overall Study||186
8332509|NCT01357356|20540393|P2|STARTED|Overall Study||188
8332510|NCT01357356|20540394|P1|STARTED|Overall Study||188
8332511|NCT01357239|20540412|P4|NOT COMPLETED|Stratum II: Partially-Methylated||2
8332512|NCT01357239|20540413|P3|NOT COMPLETED|Stratum II: Partially-Methylated||1
8332513|NCT01357239|20540414|P2|NOT COMPLETED|Stratum II: Partially-Methylated||0
8332514|NCT01357239|20540415|P1|NOT COMPLETED|Stratum II: Partially-Methylated||0
8332515|NCT01357239|20540412|P4|COMPLETED|Stratum II: Partially-Methylated||18
8332516|NCT01357239|20540413|P3|COMPLETED|Stratum II: Partially-Methylated||21
8332517|NCT01357239|20540414|P2|COMPLETED|Stratum II: Partially-Methylated||21
8332518|NCT01357239|20540415|P1|COMPLETED|Stratum II: Partially-Methylated||23
8332519|NCT01357239|20540412|P4|STARTED|Stratum II: Partially-Methylated||20
8332520|NCT01357239|20540413|P3|STARTED|Stratum II: Partially-Methylated||22
8332521|NCT01357239|20540414|P2|STARTED|Stratum II: Partially-Methylated||21
8332522|NCT01357239|20540415|P1|STARTED|Stratum II: Partially-Methylated||23
8332523|NCT01357239|20540412|P4|NOT COMPLETED|Stratum I: Fully-Methylated||0
8332524|NCT01357239|20540413|P3|NOT COMPLETED|Stratum I: Fully-Methylated||1
8332525|NCT01357239|20540414|P2|NOT COMPLETED|Stratum I: Fully-Methylated||0
8332526|NCT01357239|20540415|P1|NOT COMPLETED|Stratum I: Fully-Methylated||0
8332527|NCT01357239|20540412|P4|COMPLETED|Stratum I: Fully-Methylated||22
8332528|NCT01357239|20540413|P3|COMPLETED|Stratum I: Fully-Methylated||16
8332529|NCT01357239|20540414|P2|COMPLETED|Stratum I: Fully-Methylated||6
8332530|NCT01357239|20540415|P1|COMPLETED|Stratum I: Fully-Methylated||8
8332531|NCT01357239|20540412|P4|STARTED|Stratum I: Fully-Methylated||22
8332532|NCT01357239|20540413|P3|STARTED|Stratum I: Fully-Methylated||17
8332533|NCT01357239|20540414|P2|STARTED|Stratum I: Fully-Methylated||6
8332534|NCT01357239|20540415|P1|STARTED|Stratum I: Fully-Methylated||8
8332535|NCT01357239|20540412|P4|NOT COMPLETED|Stratum: All Patients||2
8332536|NCT01357239|20540413|P3|NOT COMPLETED|Stratum: All Patients||2
8332537|NCT01357239|20540414|P2|NOT COMPLETED|Stratum: All Patients||0
8332538|NCT01357239|20540415|P1|NOT COMPLETED|Stratum: All Patients||0
8332539|NCT01357239|20540412|P4|COMPLETED|Stratum: All Patients||40
8332540|NCT01357239|20540413|P3|COMPLETED|Stratum: All Patients||37
8332541|NCT01357239|20540414|P2|COMPLETED|Stratum: All Patients||27
8332542|NCT01357239|20540415|P1|COMPLETED|Stratum: All Patients||31
8332543|NCT01357239|20540412|P4|STARTED|Stratum: All Patients||42
8332544|NCT01357239|20540413|P3|STARTED|Stratum: All Patients||39
8332545|NCT01357239|20540414|P2|STARTED|Stratum: All Patients||27
8332546|NCT01357239|20540415|P1|STARTED|Stratum: All Patients||31
8332547|NCT01357161|20540473|P3|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
8332548|NCT01357161|20540474|P2|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
8332549|NCT01357161|20540475|P1|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
8332550|NCT01357161|20540473|P3|COMPLETED|Part 2 (Double-Blind Comparison)||0
8332551|NCT01357161|20540474|P2|COMPLETED|Part 2 (Double-Blind Comparison)||0
8332552|NCT01357161|20540475|P1|COMPLETED|Part 2 (Double-Blind Comparison)||0
8332553|NCT01357161|20540473|P3|Treated|Part 2 (Double-Blind Comparison)||60
8332554|NCT01357161|20540474|P2|Treated|Part 2 (Double-Blind Comparison)||59
8332555|NCT01357161|20540475|P1|Treated|Part 2 (Double-Blind Comparison)||0
8332556|NCT01357161|20540473|P3|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
8332557|NCT01357161|20540474|P2|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
8332558|NCT01357161|20540475|P1|STARTED|Part 2 (Double-Blind Comparison)||0
8332559|NCT01357161|20540473|P3|NOT COMPLETED|Part 1 (Open Label Run-in)||0
8332560|NCT01357161|20540474|P2|NOT COMPLETED|Part 1 (Open Label Run-in)||0
8332561|NCT01357161|20540475|P1|NOT COMPLETED|Part 1 (Open Label Run-in)||15
8332562|NCT01357161|20540473|P3|COMPLETED|Part 1 (Open Label Run-in)||0
8332563|NCT01357161|20540474|P2|COMPLETED|Part 1 (Open Label Run-in)||0
8332564|NCT01357161|20540475|P1|COMPLETED|Part 1 (Open Label Run-in)||0
8332565|NCT01357161|20540473|P3|STARTED|Part 1 (Open Label Run-in)||0
8332566|NCT01357161|20540474|P2|STARTED|Part 1 (Open Label Run-in)||0
8332567|NCT01357161|20540475|P1|STARTED|Part 1 (Open Label Run-in)||15
8332568|NCT01357148|20540504|P1|NOT COMPLETED|Overall Study||0
8332569|NCT01357148|20540504|P1|COMPLETED|Overall Study||143
8332570|NCT01357148|20540504|P1|STARTED|Overall Study||143
8332571|NCT01357135|20540514|P3|NOT COMPLETED|Overall Study||263
8332572|NCT01357135|20540515|P2|NOT COMPLETED|Overall Study||223
8332573|NCT01357135|20540516|P1|NOT COMPLETED|Overall Study||598
8332574|NCT01357135|20540514|P3|COMPLETED|Overall Study||583
8332575|NCT01357135|20540515|P2|COMPLETED|Overall Study||510
8332576|NCT01357135|20540516|P1|COMPLETED|Overall Study||1276
8332577|NCT01357135|20540514|P3|STARTED|Overall Study||846
8332578|NCT01357135|20540515|P2|STARTED|Overall Study||733
8332579|NCT01357135|20540516|P1|STARTED|Overall Study||1874
8332580|NCT01356966|20540527|P2|NOT COMPLETED|Overall Study||2
8332581|NCT01356966|20540528|P1|NOT COMPLETED|Overall Study||2
8332582|NCT01356966|20540527|P2|COMPLETED|Overall Study||12
8332583|NCT01356966|20540528|P1|COMPLETED|Overall Study||16
8332584|NCT01356966|20540527|P2|STARTED|Overall Study||14
8332585|NCT01356966|20540528|P1|STARTED|Overall Study||18
8332586|NCT01356940|20540540|P2|NOT COMPLETED|Second Intervention (28 Days)||0
8332587|NCT01356940|20540541|P1|NOT COMPLETED|Second Intervention (28 Days)||1
8332588|NCT01356940|20540540|P2|COMPLETED|Second Intervention (28 Days)||21
8332589|NCT01356940|20540541|P1|COMPLETED|Second Intervention (28 Days)||20
8332590|NCT01356940|20540540|P2|STARTED|Second Intervention (28 Days)||21
8332591|NCT01356940|20540541|P1|STARTED|Second Intervention (28 Days)||21
8332592|NCT01356940|20540540|P2|NOT COMPLETED|Washout (14 Days)||0
8332593|NCT01356940|20540541|P1|NOT COMPLETED|Washout (14 Days)||0
8332594|NCT01356940|20540540|P2|COMPLETED|Washout (14 Days)||21
8332595|NCT01356940|20540541|P1|COMPLETED|Washout (14 Days)||21
8332596|NCT01356940|20540540|P2|STARTED|Washout (14 Days)||21
8332597|NCT01356940|20540541|P1|STARTED|Washout (14 Days)||21
8332598|NCT01356940|20540540|P2|NOT COMPLETED|First Intervention (28 Days)||0
8332599|NCT01356940|20540541|P1|NOT COMPLETED|First Intervention (28 Days)||1
8332600|NCT01356940|20540540|P2|COMPLETED|First Intervention (28 Days)||21
8332601|NCT01356940|20540541|P1|COMPLETED|First Intervention (28 Days)||21
8332602|NCT01356940|20540540|P2|STARTED|First Intervention (28 Days)||21
8332603|NCT01356940|20540541|P1|STARTED|First Intervention (28 Days)||22
8332604|NCT01356667|20540551|P2|NOT COMPLETED|Overall Study||6
8332605|NCT01356667|20540552|P1|NOT COMPLETED|Overall Study||4
8332606|NCT01356667|20540551|P2|COMPLETED|Overall Study||0
8332607|NCT01356667|20540552|P1|COMPLETED|Overall Study||0
8332608|NCT01356667|20540551|P2|STARTED|Overall Study||6
8332609|NCT01356667|20540552|P1|STARTED|Overall Study||4
8332613|NCT01356602|20540570|P3|NOT COMPLETED|Overall Study||24
8332614|NCT01356602|20540571|P2|NOT COMPLETED|Overall Study||15
8332615|NCT01356602|20540572|P1|NOT COMPLETED|Overall Study||9
8332616|NCT01356602|20540570|P3|COMPLETED|Overall Study||108
8332617|NCT01356602|20540571|P2|COMPLETED|Overall Study||117
8332618|NCT01356602|20540572|P1|COMPLETED|Overall Study||124
8332619|NCT01356602|20540570|P3|Full Analysis Set|Overall Study||129
8332620|NCT01356602|20540571|P2|Full Analysis Set|Overall Study||129
8332621|NCT01356602|20540572|P1|Full Analysis Set|Overall Study||131
8332622|NCT01356602|20540570|P3|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
8332623|NCT01356602|20540571|P2|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
8332624|NCT01356602|20540572|P1|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
8332625|NCT01356602|20540570|P3|STARTED|Overall Study||132
8332626|NCT01356602|20540571|P2|STARTED|Overall Study||132
8332627|NCT01356602|20540572|P1|STARTED|Overall Study||133
8332628|NCT01356589|20540631|P1|NOT COMPLETED|Overall Study||5
8332629|NCT01356589|20540631|P1|COMPLETED|Overall Study||1283
8332630|NCT01356589|20540631|P1|Treated|Overall Study||1285
8332631|NCT01356589|20540631|P1|STARTED|Overall Study||1288
8332632|NCT01356498|20540643|P6|NOT COMPLETED|Overall Study||14
8332633|NCT01356498|20540644|P5|NOT COMPLETED|Overall Study||20
8332634|NCT01356498|20540645|P4|NOT COMPLETED|Overall Study||14
8332635|NCT01356498|20540646|P3|NOT COMPLETED|Overall Study||12
8332636|NCT01356498|20540647|P2|NOT COMPLETED|Overall Study||8
8332637|NCT01356498|20540648|P1|NOT COMPLETED|Overall Study||11
8332638|NCT01356498|20540643|P6|COMPLETED|Overall Study||2
8332639|NCT01356498|20540644|P5|COMPLETED|Overall Study||8
8332640|NCT01356498|20540645|P4|COMPLETED|Overall Study||8
8332641|NCT01356498|20540646|P3|COMPLETED|Overall Study||11
8332642|NCT01356498|20540647|P2|COMPLETED|Overall Study||17
8332643|NCT01356498|20540648|P1|COMPLETED|Overall Study||24
8332644|NCT01356498|20540643|P6|STARTED|Overall Study||16
8332645|NCT01356498|20540644|P5|STARTED|Overall Study||28
8332646|NCT01356498|20540645|P4|STARTED|Overall Study||22
8332647|NCT01356498|20540646|P3|STARTED|Overall Study||23
8332648|NCT01356498|20540647|P2|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
8332649|NCT01356498|20540648|P1|STARTED|Overall Study||35
8332650|NCT01356407|20540688|P2|NOT COMPLETED|Overall Study||4
8332651|NCT01356407|20540689|P1|NOT COMPLETED|Overall Study||6
8332652|NCT01356407|20540688|P2|COMPLETED|Overall Study||146
8332653|NCT01356407|20540689|P1|COMPLETED|Overall Study||144
8332654|NCT01356407|20540688|P2|STARTED|Overall Study||150
8332655|NCT01356407|20540689|P1|STARTED|Overall Study||150
8332656|NCT01356277|20540707|P2|NOT COMPLETED|Intervention Interval||7
8332657|NCT01356277|20540708|P1|NOT COMPLETED|Intervention Interval||10
8332658|NCT01356277|20540707|P2|COMPLETED|Intervention Interval||81
8332659|NCT01356277|20540708|P1|COMPLETED|Intervention Interval||66
8332660|NCT01356277|20540707|P2|STARTED|Intervention Interval||88
8332661|NCT01356277|20540708|P1|STARTED|Intervention Interval||76
8332662|NCT01356277|20540707|P2|NOT COMPLETED|Run-in||0
8332663|NCT01356277|20540708|P1|NOT COMPLETED|Run-in||5
8332664|NCT01356277|20540707|P2|COMPLETED|Run-in||88
8332665|NCT01356277|20540708|P1|COMPLETED|Run-in||76
8332666|NCT01356277|20540707|P2|STARTED|Run-in||88
8332667|NCT01356277|20540708|P1|STARTED|Run-in||81
8332668|NCT01356147|20540728|P2|NOT COMPLETED|Overall Study||0
8332669|NCT01356147|20540729|P1|NOT COMPLETED|Overall Study||0
8332670|NCT01356147|20540728|P2|COMPLETED|Overall Study||6
8332671|NCT01356147|20540729|P1|COMPLETED|Overall Study||5
8332672|NCT01356147|20540728|P2|STARTED|Overall Study||6
8332673|NCT01356147|20540729|P1|STARTED|Overall Study||5
8332674|NCT01355978|20540739|P1|NOT COMPLETED|Overall Study||4
8332675|NCT01355978|20540739|P1|COMPLETED|Overall Study||18
8332676|NCT01355978|20540739|P1|STARTED|Overall Study||22
8332677|NCT01355796|20540745|P2|NOT COMPLETED|Overall Study||0
8332678|NCT01355796|20540746|P1|NOT COMPLETED|Overall Study||0
8332679|NCT01355796|20540745|P2|COMPLETED|Overall Study||15
8332680|NCT01355796|20540746|P1|COMPLETED|Overall Study||15
8332681|NCT01355796|20540745|P2|Second Intervention for 14 Days|Overall Study||15
8332682|NCT01355796|20540746|P1|Second Intervention for 14 Days|Overall Study||15
8332683|NCT01355796|20540745|P2|Washout Period for 7 Days|Overall Study||15
8332684|NCT01355796|20540746|P1|Washout Period for 7 Days|Overall Study||15
8332685|NCT01355796|20540745|P2|First Intervention for 14 Days|Overall Study||15
8332686|NCT01355796|20540746|P1|First Intervention for 14 Days|Overall Study||15
8332687|NCT01355796|20540745|P2|STARTED|Overall Study||15
8332688|NCT01355796|20540746|P1|STARTED|Overall Study||15
8332689|NCT01355705|20540754|P1|NOT COMPLETED|Overall Study||0
8332690|NCT01355705|20540754|P1|COMPLETED|Overall Study||14
8332691|NCT01355705|20540754|P1|STARTED|Overall Study||14
8332692|NCT01355679|20540761|P1|NOT COMPLETED|Overall Study||2
8332693|NCT01355679|20540761|P1|COMPLETED|Overall Study||14
8332694|NCT01355679|20540761|P1|STARTED|Overall Study||16
8332695|NCT01355627|20540770|P2|NOT COMPLETED|Overall Study||38
8332696|NCT01355627|20540771|P1|NOT COMPLETED|Overall Study||33
8332697|NCT01355627|20540770|P2|COMPLETED|Overall Study||326
8332698|NCT01355627|20540771|P1|COMPLETED|Overall Study||329
8332699|NCT01355627|20540770|P2|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
8332700|NCT01355627|20540771|P1|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
8332701|NCT01355627|20540770|P2|Safety Analysis Set|Overall Study||364
8332702|NCT01355627|20540771|P1|Safety Analysis Set|Overall Study||362
8332703|NCT01355627|20540770|P2|STARTED|Overall Study||364
8332704|NCT01355627|20540771|P1|STARTED|Overall Study||362
8332705|NCT01355588|20540783|P4|NOT COMPLETED|Fourth Intervention (After Washout)||0
8332706|NCT01355588|20540784|P3|NOT COMPLETED|Fourth Intervention (After Washout)||0
8332707|NCT01355588|20540785|P2|NOT COMPLETED|Fourth Intervention (After Washout)||0
8332708|NCT01355588|20540786|P1|NOT COMPLETED|Fourth Intervention (After Washout)||0
8332709|NCT01355588|20540783|P4|COMPLETED|Fourth Intervention (After Washout)||4
8332710|NCT01355588|20540784|P3|COMPLETED|Fourth Intervention (After Washout)||4
8332711|NCT01355588|20540785|P2|COMPLETED|Fourth Intervention (After Washout)||4
8332712|NCT01355588|20540786|P1|COMPLETED|Fourth Intervention (After Washout)||4
8332713|NCT01355588|20540783|P4|STARTED|Fourth Intervention (After Washout)||4
8332714|NCT01355588|20540784|P3|STARTED|Fourth Intervention (After Washout)||4
8332715|NCT01355588|20540785|P2|STARTED|Fourth Intervention (After Washout)||4
8332716|NCT01355588|20540786|P1|STARTED|Fourth Intervention (After Washout)||4
8332717|NCT01355588|20540783|P4|NOT COMPLETED|Washout (3-7 Days)||0
8332718|NCT01355588|20540784|P3|NOT COMPLETED|Washout (3-7 Days)||0
8332719|NCT01355588|20540785|P2|NOT COMPLETED|Washout (3-7 Days)||0
8332720|NCT01355588|20540786|P1|NOT COMPLETED|Washout (3-7 Days)||0
8332721|NCT01355588|20540783|P4|COMPLETED|Washout (3-7 Days)||4
8332722|NCT01355588|20540784|P3|COMPLETED|Washout (3-7 Days)||4
8332723|NCT01355588|20540785|P2|COMPLETED|Washout (3-7 Days)||4
8332724|NCT01355588|20540786|P1|COMPLETED|Washout (3-7 Days)||4
8332725|NCT01355588|20540783|P4|STARTED|Washout (3-7 Days)||4
8332726|NCT01355588|20540784|P3|STARTED|Washout (3-7 Days)||4
8332727|NCT01355588|20540785|P2|STARTED|Washout (3-7 Days)||4
8332728|NCT01355588|20540786|P1|STARTED|Washout (3-7 Days)||4
8332729|NCT01355588|20540783|P4|NOT COMPLETED|Third Intervention (After Washout)||0
8332730|NCT01355588|20540784|P3|NOT COMPLETED|Third Intervention (After Washout)||0
8332731|NCT01355588|20540785|P2|NOT COMPLETED|Third Intervention (After Washout)||0
8332732|NCT01355588|20540786|P1|NOT COMPLETED|Third Intervention (After Washout)||0
8332733|NCT01355588|20540783|P4|COMPLETED|Third Intervention (After Washout)||4
8332734|NCT01355588|20540784|P3|COMPLETED|Third Intervention (After Washout)||4
8332735|NCT01355588|20540785|P2|COMPLETED|Third Intervention (After Washout)||4
8332736|NCT01355588|20540786|P1|COMPLETED|Third Intervention (After Washout)||4
8332737|NCT01355588|20540783|P4|STARTED|Third Intervention (After Washout)||4
8332738|NCT01355588|20540784|P3|STARTED|Third Intervention (After Washout)||4
8332739|NCT01355588|20540785|P2|STARTED|Third Intervention (After Washout)||4
8332740|NCT01355588|20540786|P1|STARTED|Third Intervention (After Washout)||4
8332741|NCT01355588|20540783|P4|NOT COMPLETED|Washout (3-7 Days)||0
8332742|NCT01355588|20540784|P3|NOT COMPLETED|Washout (3-7 Days)||0
8332743|NCT01355588|20540785|P2|NOT COMPLETED|Washout (3-7 Days)||0
8332744|NCT01355588|20540786|P1|NOT COMPLETED|Washout (3-7 Days)||0
8332745|NCT01355588|20540783|P4|COMPLETED|Washout (3-7 Days)||4
8332746|NCT01355588|20540784|P3|COMPLETED|Washout (3-7 Days)||4
8332747|NCT01355588|20540785|P2|COMPLETED|Washout (3-7 Days)||4
8332748|NCT01355588|20540786|P1|COMPLETED|Washout (3-7 Days)||4
8332749|NCT01355588|20540783|P4|STARTED|Washout (3-7 Days)||4
8332750|NCT01355588|20540784|P3|STARTED|Washout (3-7 Days)||4
8332751|NCT01355588|20540785|P2|STARTED|Washout (3-7 Days)||4
8332752|NCT01355588|20540786|P1|STARTED|Washout (3-7 Days)||4
8332753|NCT01355588|20540783|P4|NOT COMPLETED|Second Intervention (After Washout)||0
8332754|NCT01355588|20540784|P3|NOT COMPLETED|Second Intervention (After Washout)||0
8332755|NCT01355588|20540785|P2|NOT COMPLETED|Second Intervention (After Washout)||0
8332756|NCT01355588|20540786|P1|NOT COMPLETED|Second Intervention (After Washout)||0
8332757|NCT01355588|20540783|P4|COMPLETED|Second Intervention (After Washout)||4
8332758|NCT01355588|20540784|P3|COMPLETED|Second Intervention (After Washout)||4
8332759|NCT01355588|20540785|P2|COMPLETED|Second Intervention (After Washout)||4
8332760|NCT01355588|20540786|P1|COMPLETED|Second Intervention (After Washout)||4
8332761|NCT01355588|20540783|P4|STARTED|Second Intervention (After Washout)||4
8332762|NCT01355588|20540784|P3|STARTED|Second Intervention (After Washout)||4
8332763|NCT01355588|20540785|P2|STARTED|Second Intervention (After Washout)||4
8332764|NCT01355588|20540786|P1|STARTED|Second Intervention (After Washout)||4
8332765|NCT01355588|20540783|P4|NOT COMPLETED|Washout (3-7 Days)||0
8332766|NCT01355588|20540784|P3|NOT COMPLETED|Washout (3-7 Days)||0
8332767|NCT01355588|20540785|P2|NOT COMPLETED|Washout (3-7 Days)||0
8332768|NCT01355588|20540786|P1|NOT COMPLETED|Washout (3-7 Days)||0
8332769|NCT01355588|20540783|P4|COMPLETED|Washout (3-7 Days)||4
8332770|NCT01355588|20540784|P3|COMPLETED|Washout (3-7 Days)||4
8332771|NCT01355588|20540785|P2|COMPLETED|Washout (3-7 Days)||4
8332772|NCT01355588|20540786|P1|COMPLETED|Washout (3-7 Days)||4
8332773|NCT01355588|20540783|P4|STARTED|Washout (3-7 Days)||4
8332774|NCT01355588|20540784|P3|STARTED|Washout (3-7 Days)||4
8332775|NCT01355588|20540785|P2|STARTED|Washout (3-7 Days)||4
8332776|NCT01355588|20540786|P1|STARTED|Washout (3-7 Days)||4
8332777|NCT01355588|20540783|P4|NOT COMPLETED|First Intervention (Day 1)||0
8332778|NCT01355588|20540784|P3|NOT COMPLETED|First Intervention (Day 1)||0
8332779|NCT01355588|20540785|P2|NOT COMPLETED|First Intervention (Day 1)||0
8332780|NCT01355588|20540786|P1|NOT COMPLETED|First Intervention (Day 1)||0
8332781|NCT01355588|20540783|P4|COMPLETED|First Intervention (Day 1)||4
8332782|NCT01355588|20540784|P3|COMPLETED|First Intervention (Day 1)||4
8332783|NCT01355588|20540785|P2|COMPLETED|First Intervention (Day 1)||4
8332784|NCT01355588|20540786|P1|COMPLETED|First Intervention (Day 1)||4
8332785|NCT01355588|20540783|P4|STARTED|First Intervention (Day 1)||4
8332786|NCT01355588|20540784|P3|STARTED|First Intervention (Day 1)||4
8332787|NCT01355588|20540785|P2|STARTED|First Intervention (Day 1)||4
8332788|NCT01355588|20540786|P1|STARTED|First Intervention (Day 1)||4
8332789|NCT01355575|20540808|P1|NOT COMPLETED|Overall Study||2
8332790|NCT01355575|20540808|P1|COMPLETED|Overall Study||13
8332791|NCT01355575|20540808|P1|STARTED|Overall Study||15
8332792|NCT01355523|20540820|P2|NOT COMPLETED|Overall Study||10
8332793|NCT01355523|20540821|P1|NOT COMPLETED|Overall Study||1
8332794|NCT01355523|20540820|P2|COMPLETED|Overall Study||16
8332795|NCT01355523|20540821|P1|COMPLETED|Overall Study||27
8332796|NCT01355523|20540820|P2|STARTED|Overall Study||26
8332797|NCT01355523|20540821|P1|STARTED|Overall Study||28
8332798|NCT01355497|20540865|P2|NOT COMPLETED|Overall Study||63
8332799|NCT01355497|20540866|P1|NOT COMPLETED|Overall Study||66
8332800|NCT01355497|20540865|P2|COMPLETED|Overall Study||102
8332801|NCT01355497|20540866|P1|COMPLETED|Overall Study||99
8332802|NCT01355497|20540865|P2|STARTED|Overall Study||165
8332803|NCT01355497|20540866|P1|STARTED|Overall Study||165
8332804|NCT01355484|20540876|P2|NOT COMPLETED|Overall Study||54
8332805|NCT01355484|20540877|P1|NOT COMPLETED|Overall Study||51
8332806|NCT01355484|20540876|P2|COMPLETED|Overall Study||107
8332807|NCT01355484|20540877|P1|COMPLETED|Overall Study||109
8332808|NCT01355484|20540876|P2|STARTED|Overall Study||161
8332809|NCT01355484|20540877|P1|STARTED|Overall Study||160
8332822|NCT01355419|20540903|P1|NOT COMPLETED|Overall Study||8
8332823|NCT01355419|20540903|P1|COMPLETED|Overall Study||142
8332824|NCT01355419|20540903|P1|STARTED|Overall Study||150
8332825|NCT01355302|20540908|P3|NOT COMPLETED|Phase 2||0
8332826|NCT01355302|20540909|P2|NOT COMPLETED|Phase 2||0
8332827|NCT01355302|20540910|P1|NOT COMPLETED|Phase 2||0
8332828|NCT01355302|20540908|P3|COMPLETED|Phase 2||0
8332829|NCT01355302|20540909|P2|COMPLETED|Phase 2||0
8332830|NCT01355302|20540910|P1|COMPLETED|Phase 2||0
8332831|NCT01355302|20540908|P3|STARTED|Phase 2|The study was terminated prior to enrollment|0
8332832|NCT01355302|20540909|P2|STARTED|Phase 2|The study was terminated prior to enrollment|0
8332833|NCT01355302|20540910|P1|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
8332834|NCT01355302|20540908|P3|NOT COMPLETED|Phase 1b||0
8332835|NCT01355302|20540909|P2|NOT COMPLETED|Phase 1b||0
8332836|NCT01355302|20540910|P1|NOT COMPLETED|Phase 1b||6
8332837|NCT01355302|20540908|P3|COMPLETED|Phase 1b||0
8332838|NCT01355302|20540909|P2|COMPLETED|Phase 1b||0
8332839|NCT01355302|20540910|P1|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
8332840|NCT01355302|20540908|P3|STARTED|Phase 1b||0
8332841|NCT01355302|20540909|P2|STARTED|Phase 1b||0
8332842|NCT01355302|20540910|P1|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
8332843|NCT01355289|20540925|P5|NOT COMPLETED|Open Label Extension||34
8332844|NCT01355289|20540926|P4|NOT COMPLETED|Open Label Extension||0
8332845|NCT01355289|20540927|P3|NOT COMPLETED|Open Label Extension||0
8332846|NCT01355289|20540928|P2|NOT COMPLETED|Open Label Extension||0
8332847|NCT01355289|20540929|P1|NOT COMPLETED|Open Label Extension||0
8332848|NCT01355289|20540925|P5|COMPLETED|Open Label Extension||28
8332849|NCT01355289|20540926|P4|COMPLETED|Open Label Extension||0
8332850|NCT01355289|20540927|P3|COMPLETED|Open Label Extension||0
8332851|NCT01355289|20540928|P2|COMPLETED|Open Label Extension||0
8332852|NCT01355289|20540929|P1|COMPLETED|Open Label Extension||0
8332853|NCT01355289|20540925|P5|STARTED|Open Label Extension||62
8332854|NCT01355289|20540926|P4|STARTED|Open Label Extension||0
8332855|NCT01355289|20540927|P3|STARTED|Open Label Extension||0
8332856|NCT01355289|20540928|P2|STARTED|Open Label Extension||0
8332857|NCT01355289|20540929|P1|STARTED|Open Label Extension||0
8332858|NCT01355289|20540925|P5|NOT COMPLETED|Core Study||0
8332859|NCT01355289|20540926|P4|NOT COMPLETED|Core Study||2
8332860|NCT01355289|20540927|P3|NOT COMPLETED|Core Study||0
8332861|NCT01355289|20540928|P2|NOT COMPLETED|Core Study||0
8332862|NCT01355289|20540929|P1|NOT COMPLETED|Core Study||1
8332863|NCT01355289|20540925|P5|COMPLETED|Core Study||0
8332864|NCT01355289|20540926|P4|COMPLETED|Core Study||12
8332865|NCT01355289|20540927|P3|COMPLETED|Core Study||18
8332866|NCT01355289|20540928|P2|COMPLETED|Core Study||16
8332867|NCT01355289|20540929|P1|COMPLETED|Core Study||16
8332868|NCT01355289|20540925|P5|STARTED|Core Study||0
8332869|NCT01355289|20540926|P4|STARTED|Core Study||14
8332870|NCT01355289|20540927|P3|STARTED|Core Study||18
8332871|NCT01355289|20540928|P2|STARTED|Core Study||16
8332872|NCT01355289|20540929|P1|STARTED|Core Study||17
8332873|NCT01355224|20540956|P4|NOT COMPLETED|Overall Study||29
8332874|NCT01355224|20540957|P3|NOT COMPLETED|Overall Study||19
8332875|NCT01355224|20540958|P2|NOT COMPLETED|Overall Study||23
8332876|NCT01355224|20540959|P1|NOT COMPLETED|Overall Study||31
8332877|NCT01355224|20540956|P4|COMPLETED|Overall Study||172
8332878|NCT01355224|20540957|P3|COMPLETED|Overall Study||177
8332879|NCT01355224|20540958|P2|COMPLETED|Overall Study||180
8332880|NCT01355224|20540959|P1|COMPLETED|Overall Study||167
8332881|NCT01355224|20540956|P4|Competed Baseline|Overall Study||193
8332882|NCT01355224|20540957|P3|Competed Baseline|Overall Study||193
8332883|NCT01355224|20540958|P2|Competed Baseline|Overall Study||200
8332884|NCT01355224|20540959|P1|Competed Baseline|Overall Study||191
8332885|NCT01355224|20540956|P4|STARTED|Overall Study||201
8332886|NCT01355224|20540957|P3|STARTED|Overall Study||196
8332887|NCT01355224|20540958|P2|STARTED|Overall Study||203
8332888|NCT01355224|20540959|P1|STARTED|Overall Study||198
8332889|NCT01355159|20540981|P2|NOT COMPLETED|Overall Study||79
8332890|NCT01355159|20540982|P1|NOT COMPLETED|Overall Study||84
8332891|NCT01355159|20540981|P2|COMPLETED|Overall Study||1157
8332892|NCT01355159|20540982|P1|COMPLETED|Overall Study||1144
8332893|NCT01355159|20540981|P2|STARTED|Overall Study||1236
8332894|NCT01355159|20540982|P1|STARTED|Overall Study||1228
8332895|NCT01355081|20541039|P3|NOT COMPLETED|Overall Study||11
8332896|NCT01355081|20541040|P2|NOT COMPLETED|Overall Study||10
8332897|NCT01355081|20541041|P1|NOT COMPLETED|Overall Study||7
8332898|NCT01355081|20541039|P3|COMPLETED|Overall Study||113
8332899|NCT01355081|20541040|P2|COMPLETED|Overall Study||113
8332900|NCT01355081|20541041|P1|COMPLETED|Overall Study||112
8332901|NCT01355081|20541039|P3|STARTED|Overall Study||124
8332902|NCT01355081|20541040|P2|STARTED|Overall Study||123
8332903|NCT01355081|20541041|P1|STARTED|Overall Study||119
8332904|NCT01354990|20541064|P1|NOT COMPLETED|Overall Study||0
8332905|NCT01354990|20541064|P1|COMPLETED|Overall Study||2974
8332906|NCT01354990|20541064|P1|STARTED|Overall Study||2974
8332907|NCT01354964|20541073|P2|NOT COMPLETED|Overall Study||1
8332908|NCT01354964|20541074|P1|NOT COMPLETED|Overall Study||4
8332909|NCT01354964|20541073|P2|COMPLETED|Overall Study||7
8332910|NCT01354964|20541074|P1|COMPLETED|Overall Study||7
8332911|NCT01354964|20541073|P2|STARTED|Overall Study||8
8332912|NCT01354964|20541074|P1|STARTED|Overall Study||11
8332913|NCT01354951|20541090|P1|NOT COMPLETED|Overall Study||2
8332914|NCT01354951|20541090|P1|COMPLETED|Overall Study||1
8332915|NCT01354951|20541090|P1|STARTED|Overall Study||3
8332916|NCT01354938|20541097|P1|NOT COMPLETED|Overall Study||1
8332917|NCT01354938|20541097|P1|COMPLETED|Overall Study||219
8332918|NCT01354938|20541097|P1|STARTED|Overall Study||220
8332919|NCT01354899|20541103|P1|NOT COMPLETED|Overall Study||3
8332920|NCT01354899|20541103|P1|COMPLETED|Overall Study||21
8332921|NCT01354899|20541103|P1|STARTED|Overall Study||24
8332922|NCT01354691|20541110|P2|NOT COMPLETED|Overall Study||22
8332923|NCT01354691|20541111|P1|NOT COMPLETED|Overall Study||21
8332924|NCT01354691|20541110|P2|COMPLETED|Overall Study||77
8332925|NCT01354691|20541111|P1|COMPLETED|Overall Study||80
8332926|NCT01354691|20541110|P2|PP|Overall Study||75
8332927|NCT01354691|20541111|P1|PP|Overall Study||79
8332928|NCT01354691|20541110|P2|ITT|Overall Study||96
8332929|NCT01354691|20541111|P1|ITT|Overall Study||99
8332930|NCT01354691|20541110|P2|STARTED|Overall Study||99
8332931|NCT01354691|20541111|P1|STARTED|Overall Study||101
8332932|NCT01354652|20541128|P3|NOT COMPLETED|Overall Study||0
8332933|NCT01354652|20541129|P2|NOT COMPLETED|Overall Study||2
8332934|NCT01354652|20541130|P1|NOT COMPLETED|Overall Study||3
8332935|NCT01354652|20541128|P3|COMPLETED|Overall Study||0
8332936|NCT01354652|20541129|P2|COMPLETED|Overall Study||0
8332937|NCT01354652|20541130|P1|COMPLETED|Overall Study||0
8332938|NCT01354652|20541128|P3|STARTED|Overall Study||0
8332939|NCT01354652|20541129|P2|STARTED|Overall Study||2
8332940|NCT01354652|20541130|P1|STARTED|Overall Study||3
8332941|NCT01354496|20541155|P6|NOT COMPLETED|Period 3||0
8332942|NCT01354496|20541156|P5|NOT COMPLETED|Period 3||0
8332943|NCT01354496|20541157|P4|NOT COMPLETED|Period 3||0
8332944|NCT01354496|20541158|P3|NOT COMPLETED|Period 3||0
8332945|NCT01354496|20541159|P2|NOT COMPLETED|Period 3||0
8332946|NCT01354496|20541160|P1|NOT COMPLETED|Period 3||0
8332947|NCT01354496|20541155|P6|COMPLETED|Period 3||6
8332948|NCT01354496|20541156|P5|COMPLETED|Period 3||5
8332949|NCT01354496|20541157|P4|COMPLETED|Period 3||4
8332950|NCT01354496|20541158|P3|COMPLETED|Period 3||4
8332951|NCT01354496|20541159|P2|COMPLETED|Period 3||5
8332952|NCT01354496|20541160|P1|COMPLETED|Period 3||6
8332953|NCT01354496|20541155|P6|STARTED|Period 3||6
8332954|NCT01354496|20541156|P5|STARTED|Period 3||5
8332955|NCT01354496|20541157|P4|STARTED|Period 3||4
8332956|NCT01354496|20541158|P3|STARTED|Period 3||4
8332957|NCT01354496|20541159|P2|STARTED|Period 3||5
8332958|NCT01354496|20541160|P1|STARTED|Period 3||6
8332959|NCT01354496|20541155|P6|NOT COMPLETED|Washout (at Least 14 Days)||0
8332960|NCT01354496|20541156|P5|NOT COMPLETED|Washout (at Least 14 Days)||0
8332961|NCT01354496|20541157|P4|NOT COMPLETED|Washout (at Least 14 Days)||1
8332962|NCT01354496|20541158|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
8332963|NCT01354496|20541159|P2|NOT COMPLETED|Washout (at Least 14 Days)||1
8332964|NCT01354496|20541160|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
8332965|NCT01354496|20541155|P6|COMPLETED|Washout (at Least 14 Days)||6
8332966|NCT01354496|20541156|P5|COMPLETED|Washout (at Least 14 Days)||5
8332967|NCT01354496|20541157|P4|COMPLETED|Washout (at Least 14 Days)||4
8332968|NCT01354496|20541158|P3|COMPLETED|Washout (at Least 14 Days)||4
8332969|NCT01354496|20541159|P2|COMPLETED|Washout (at Least 14 Days)||5
8332970|NCT01354496|20541160|P1|COMPLETED|Washout (at Least 14 Days)||6
8332971|NCT01354496|20541155|P6|STARTED|Washout (at Least 14 Days)||6
8332972|NCT01354496|20541156|P5|STARTED|Washout (at Least 14 Days)||5
8332973|NCT01354496|20541157|P4|STARTED|Washout (at Least 14 Days)||5
8332974|NCT01354496|20541158|P3|STARTED|Washout (at Least 14 Days)||4
8332975|NCT01354496|20541159|P2|STARTED|Washout (at Least 14 Days)||6
8332976|NCT01354496|20541160|P1|STARTED|Washout (at Least 14 Days)||6
8332977|NCT01354496|20541155|P6|NOT COMPLETED|Period 2||0
8332978|NCT01354496|20541156|P5|NOT COMPLETED|Period 2||0
8332979|NCT01354496|20541157|P4|NOT COMPLETED|Period 2||1
8332980|NCT01354496|20541158|P3|NOT COMPLETED|Period 2||0
8332981|NCT01354496|20541159|P2|NOT COMPLETED|Period 2||0
8332982|NCT01354496|20541160|P1|NOT COMPLETED|Period 2||0
8332983|NCT01354496|20541155|P6|COMPLETED|Period 2||6
8332984|NCT01354496|20541156|P5|COMPLETED|Period 2||5
8332985|NCT01354496|20541157|P4|COMPLETED|Period 2||5
8332986|NCT01354496|20541158|P3|COMPLETED|Period 2||4
8332987|NCT01354496|20541159|P2|COMPLETED|Period 2||6
8332988|NCT01354496|20541160|P1|COMPLETED|Period 2||6
8332989|NCT01354496|20541155|P6|STARTED|Period 2||6
8332990|NCT01354496|20541156|P5|STARTED|Period 2||5
8332991|NCT01354496|20541157|P4|STARTED|Period 2||6
8332992|NCT01354496|20541158|P3|STARTED|Period 2||4
8332993|NCT01354496|20541159|P2|STARTED|Period 2||6
8332994|NCT01354496|20541160|P1|STARTED|Period 2||6
8332995|NCT01354496|20541155|P6|NOT COMPLETED|Washout (at Least 14 Days)||0
8332996|NCT01354496|20541156|P5|NOT COMPLETED|Washout (at Least 14 Days)||0
8332997|NCT01354496|20541157|P4|NOT COMPLETED|Washout (at Least 14 Days)||0
8332998|NCT01354496|20541158|P3|NOT COMPLETED|Washout (at Least 14 Days)||0
8332999|NCT01354496|20541159|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
8333000|NCT01354496|20541160|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
8333001|NCT01354496|20541155|P6|COMPLETED|Washout (at Least 14 Days)||6
8333002|NCT01354496|20541156|P5|COMPLETED|Washout (at Least 14 Days)||5
8333003|NCT01354496|20541157|P4|COMPLETED|Washout (at Least 14 Days)||6
8333004|NCT01354496|20541158|P3|COMPLETED|Washout (at Least 14 Days)||4
8333005|NCT01354496|20541159|P2|COMPLETED|Washout (at Least 14 Days)||6
8333006|NCT01354496|20541160|P1|COMPLETED|Washout (at Least 14 Days)||6
8333007|NCT01354496|20541155|P6|STARTED|Washout (at Least 14 Days)||6
8333008|NCT01354496|20541156|P5|STARTED|Washout (at Least 14 Days)||5
8333009|NCT01354496|20541157|P4|STARTED|Washout (at Least 14 Days)||6
8333010|NCT01354496|20541158|P3|STARTED|Washout (at Least 14 Days)||4
8333011|NCT01354496|20541159|P2|STARTED|Washout (at Least 14 Days)||6
8333012|NCT01354496|20541160|P1|STARTED|Washout (at Least 14 Days)||6
8333013|NCT01354496|20541155|P6|NOT COMPLETED|Period 1||0
8333014|NCT01354496|20541156|P5|NOT COMPLETED|Period 1||0
8333015|NCT01354496|20541157|P4|NOT COMPLETED|Period 1||0
8333016|NCT01354496|20541158|P3|NOT COMPLETED|Period 1||2
8333017|NCT01354496|20541159|P2|NOT COMPLETED|Period 1||0
8333018|NCT01354496|20541160|P1|NOT COMPLETED|Period 1||0
8333019|NCT01354496|20541155|P6|COMPLETED|Period 1||6
8333020|NCT01354496|20541156|P5|COMPLETED|Period 1||5
8333021|NCT01354496|20541157|P4|COMPLETED|Period 1||6
8333022|NCT01354496|20541158|P3|COMPLETED|Period 1||4
8333023|NCT01354496|20541159|P2|COMPLETED|Period 1||6
8333024|NCT01354496|20541160|P1|COMPLETED|Period 1||6
8333025|NCT01354496|20541155|P6|Received at Least 1 Dose of Study Drug|Period 1||6
8333026|NCT01354496|20541156|P5|Received at Least 1 Dose of Study Drug|Period 1||5
8333027|NCT01354496|20541157|P4|Received at Least 1 Dose of Study Drug|Period 1||6
8333028|NCT01354496|20541158|P3|Received at Least 1 Dose of Study Drug|Period 1||6
8333029|NCT01354496|20541159|P2|Received at Least 1 Dose of Study Drug|Period 1||6
8333030|NCT01354496|20541160|P1|Received at Least 1 Dose of Study Drug|Period 1||6
8333031|NCT01354496|20541155|P6|STARTED|Period 1||6
8333032|NCT01354496|20541156|P5|STARTED|Period 1||5
8333033|NCT01354496|20541157|P4|STARTED|Period 1||6
8333034|NCT01354496|20541158|P3|STARTED|Period 1||6
8333035|NCT01354496|20541159|P2|STARTED|Period 1||6
8333036|NCT01354496|20541160|P1|STARTED|Period 1||6
8333037|NCT01354444|20541189|P2|NOT COMPLETED|Overall Study||4
8333038|NCT01354444|20541190|P1|NOT COMPLETED|Overall Study||8
8333039|NCT01354444|20541189|P2|COMPLETED|Overall Study||11
8333040|NCT01354444|20541190|P1|COMPLETED|Overall Study||6
8333041|NCT01354444|20541189|P2|STARTED|Overall Study||15
8333042|NCT01354444|20541190|P1|STARTED|Overall Study||14
8333043|NCT01354431|20541203|P3|NOT COMPLETED|Participants Treated||54
8333044|NCT01354431|20541204|P2|NOT COMPLETED|Participants Treated||54
8333045|NCT01354431|20541205|P1|NOT COMPLETED|Participants Treated||59
8333046|NCT01354431|20541203|P3|COMPLETED|Participants Treated||0
8333047|NCT01354431|20541204|P2|COMPLETED|Participants Treated||0
8333048|NCT01354431|20541205|P1|COMPLETED|Participants Treated||0
8333049|NCT01354431|20541203|P3|STARTED|Participants Treated||54
8333050|NCT01354431|20541204|P2|STARTED|Participants Treated||54
8333051|NCT01354431|20541205|P1|STARTED|Participants Treated||59
8333052|NCT01354431|20541203|P3|NOT COMPLETED|Randomized to Enter Treatment Period||0
8333053|NCT01354431|20541204|P2|NOT COMPLETED|Randomized to Enter Treatment Period||0
8333054|NCT01354431|20541205|P1|NOT COMPLETED|Randomized to Enter Treatment Period||1
8333055|NCT01354431|20541203|P3|COMPLETED|Randomized to Enter Treatment Period||54
8333056|NCT01354431|20541204|P2|COMPLETED|Randomized to Enter Treatment Period||54
8333057|NCT01354431|20541205|P1|COMPLETED|Randomized to Enter Treatment Period||59
8333058|NCT01354431|20541203|P3|STARTED|Randomized to Enter Treatment Period||54
8333059|NCT01354431|20541204|P2|STARTED|Randomized to Enter Treatment Period||54
8333060|NCT01354431|20541205|P1|STARTED|Randomized to Enter Treatment Period||60
8333061|NCT01354314|20541229|P4|NOT COMPLETED|Overall Study||6
8333062|NCT01354314|20541230|P3|NOT COMPLETED|Overall Study||8
8333063|NCT01354314|20541231|P2|NOT COMPLETED|Overall Study||3
8333064|NCT01354314|20541232|P1|NOT COMPLETED|Overall Study||6
8333065|NCT01354314|20541229|P4|COMPLETED|Overall Study||5
8333066|NCT01354314|20541230|P3|COMPLETED|Overall Study||3
8333067|NCT01354314|20541231|P2|COMPLETED|Overall Study||8
8333068|NCT01354314|20541232|P1|COMPLETED|Overall Study||6
8333069|NCT01354314|20541229|P4|Completed (ITT)|Overall Study||10
8333070|NCT01354314|20541230|P3|Completed (ITT)|Overall Study||9
8333071|NCT01354314|20541231|P2|Completed (ITT)|Overall Study||11
8333072|NCT01354314|20541232|P1|Completed (ITT)|Overall Study||11
8333073|NCT01354314|20541229|P4|STARTED|Overall Study||11
8333074|NCT01354314|20541230|P3|STARTED|Overall Study||11
8333075|NCT01354314|20541231|P2|STARTED|Overall Study||11
8333076|NCT01354314|20541232|P1|STARTED|Overall Study||12
8333077|NCT01354223|20541368|P2|NOT COMPLETED|Overall Study||1
8333078|NCT01354223|20541369|P1|NOT COMPLETED|Overall Study||3
8333079|NCT01354223|20541368|P2|COMPLETED|Overall Study||29
8333080|NCT01354223|20541369|P1|COMPLETED|Overall Study||57
8333081|NCT01354223|20541368|P2|STARTED|Overall Study||30
8333082|NCT01354223|20541369|P1|STARTED|Overall Study||60
8333083|NCT01354197|20541385|P1|NOT COMPLETED|Overall Study||0
8333084|NCT01354197|20541385|P1|COMPLETED|Overall Study||4652
8333085|NCT01354197|20541385|P1|STARTED|Overall Study||4652
8333086|NCT01354145|20541393|P2|NOT COMPLETED|Overall Study||34
8333087|NCT01354145|20541394|P1|NOT COMPLETED|Overall Study||39
8333088|NCT01354145|20541393|P2|COMPLETED|Overall Study||63
8333089|NCT01354145|20541394|P1|COMPLETED|Overall Study||58
8333090|NCT01354145|20541393|P2|STARTED|Overall Study||97
8333091|NCT01354145|20541394|P1|STARTED|Overall Study||97
8333092|NCT01354132|20541428|P2|NOT COMPLETED|1 Month Post Study Medication||3
8333093|NCT01354132|20541429|P1|NOT COMPLETED|1 Month Post Study Medication||1
8333094|NCT01354132|20541428|P2|COMPLETED|1 Month Post Study Medication||16
8333095|NCT01354132|20541429|P1|COMPLETED|1 Month Post Study Medication||21
8333096|NCT01354132|20541428|P2|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
8333097|NCT01354132|20541429|P1|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
8333098|NCT01354132|20541428|P2|STARTED|1 Month Post Study Medication||19
8333099|NCT01354132|20541429|P1|STARTED|1 Month Post Study Medication||22
8333100|NCT01354132|20541428|P2|NOT COMPLETED|Double Blind (Visits 1-7)||11
8333101|NCT01354132|20541429|P1|NOT COMPLETED|Double Blind (Visits 1-7)||9
8333102|NCT01354132|20541428|P2|COMPLETED|Double Blind (Visits 1-7)||19
8333103|NCT01354132|20541429|P1|COMPLETED|Double Blind (Visits 1-7)||22
8333104|NCT01354132|20541428|P2|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
8333105|NCT01354132|20541429|P1|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
8333106|NCT01354132|20541428|P2|Stopped After First Visit|Double Blind (Visits 1-7)||2
8333107|NCT01354132|20541429|P1|Stopped After First Visit|Double Blind (Visits 1-7)||3
8333108|NCT01354132|20541428|P2|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
8333109|NCT01354132|20541429|P1|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
8333110|NCT01354132|20541428|P2|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
8333111|NCT01354132|20541429|P1|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
8333112|NCT01354132|20541428|P2|NOT COMPLETED|Randomization||1
8333113|NCT01354132|20541429|P1|NOT COMPLETED|Randomization||1
8333114|NCT01354132|20541428|P2|COMPLETED|Randomization||30
8333115|NCT01354132|20541429|P1|COMPLETED|Randomization||31
8333116|NCT01354132|20541428|P2|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
8333117|NCT01354132|20541429|P1|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
8333118|NCT01354106|20541467|P1|NOT COMPLETED|Overall Study||2
8333119|NCT01354106|20541467|P1|COMPLETED|Overall Study||24
8333120|NCT01354106|20541467|P1|STARTED|Overall Study||26
8333121|NCT01354028|20541473|P2|NOT COMPLETED|Overall Study||5
8333122|NCT01354028|20541474|P1|NOT COMPLETED|Overall Study||2
8333123|NCT01354028|20541473|P2|COMPLETED|Overall Study||10
8333124|NCT01354028|20541474|P1|COMPLETED|Overall Study||13
8333125|NCT01354028|20541473|P2|STARTED|Overall Study||15
8333126|NCT01354028|20541474|P1|STARTED|Overall Study||15
8333127|NCT01354015|20541488|P2|NOT COMPLETED|Overall Study||5
8333128|NCT01354015|20541489|P1|NOT COMPLETED|Overall Study||6
8333129|NCT01354015|20541488|P2|COMPLETED|Overall Study||43
8333130|NCT01354015|20541489|P1|COMPLETED|Overall Study||44
8333131|NCT01354015|20541488|P2|STARTED|Overall Study||48
8333132|NCT01354015|20541489|P1|STARTED|Overall Study||50
8333133|NCT01353976|20541499|P2|NOT COMPLETED|Overall Study||51
8333134|NCT01353976|20541500|P1|NOT COMPLETED|Overall Study||48
8333135|NCT01353976|20541499|P2|COMPLETED|Overall Study||83
8333136|NCT01353976|20541500|P1|COMPLETED|Overall Study||82
8333137|NCT01353976|20541499|P2|STARTED|Overall Study||134
8333138|NCT01353976|20541500|P1|STARTED|Overall Study||130
8333139|NCT01353963|20541510|P1|NOT COMPLETED|Overall Study||2
8333140|NCT01353963|20541510|P1|COMPLETED|Overall Study||11
8333141|NCT01353963|20541510|P1|STARTED|Overall Study||13
8333142|NCT01353911|20541528|P8|NOT COMPLETED|Overall Study||15
8333143|NCT01353911|20541529|P7|NOT COMPLETED|Overall Study||6
8333144|NCT01353911|20541530|P6|NOT COMPLETED|Overall Study||7
8333145|NCT01353911|20541531|P5|NOT COMPLETED|Overall Study||6
8333146|NCT01353911|20541532|P4|NOT COMPLETED|Overall Study||2
8333147|NCT01353911|20541533|P3|NOT COMPLETED|Overall Study||9
8333148|NCT01353911|20541534|P2|NOT COMPLETED|Overall Study||9
8333149|NCT01353911|20541535|P1|NOT COMPLETED|Overall Study||8
8333150|NCT01353911|20541528|P8|COMPLETED|Overall Study||51
8333151|NCT01353911|20541529|P7|COMPLETED|Overall Study||30
8333152|NCT01353911|20541530|P6|COMPLETED|Overall Study||36
8333153|NCT01353911|20541531|P5|COMPLETED|Overall Study||23
8333154|NCT01353911|20541532|P4|COMPLETED|Overall Study||22
8333155|NCT01353911|20541533|P3|COMPLETED|Overall Study||59
8333156|NCT01353911|20541534|P2|COMPLETED|Overall Study||57
8333157|NCT01353911|20541535|P1|COMPLETED|Overall Study||28
8333158|NCT01353911|20541528|P8|STARTED|Overall Study||66
8333159|NCT01353911|20541529|P7|STARTED|Overall Study||36
8333160|NCT01353911|20541530|P6|STARTED|Overall Study||43
8333161|NCT01353911|20541531|P5|STARTED|Overall Study||29
8333162|NCT01353911|20541532|P4|STARTED|Overall Study||24
8333163|NCT01353911|20541533|P3|STARTED|Overall Study||68
8333164|NCT01353911|20541534|P2|STARTED|Overall Study||66
8333165|NCT01353911|20541535|P1|STARTED|Overall Study||36
8333166|NCT01353898|20541615|P6|NOT COMPLETED|Overall Study||1
8333167|NCT01353898|20541616|P5|NOT COMPLETED|Overall Study||0
8333168|NCT01353898|20541617|P4|NOT COMPLETED|Overall Study||0
8333169|NCT01353898|20541618|P3|NOT COMPLETED|Overall Study||0
8333170|NCT01353898|20541619|P2|NOT COMPLETED|Overall Study||0
8333171|NCT01353898|20541620|P1|NOT COMPLETED|Overall Study||0
8333172|NCT01353898|20541615|P6|COMPLETED|Overall Study||1
8333173|NCT01353898|20541616|P5|COMPLETED|Overall Study||2
8333174|NCT01353898|20541617|P4|COMPLETED|Overall Study||2
8333175|NCT01353898|20541618|P3|COMPLETED|Overall Study||2
8333176|NCT01353898|20541619|P2|COMPLETED|Overall Study||2
8333177|NCT01353898|20541620|P1|COMPLETED|Overall Study||2
8333178|NCT01353898|20541615|P6|STARTED|Overall Study||2
8333179|NCT01353898|20541616|P5|STARTED|Overall Study||2
8333180|NCT01353898|20541617|P4|STARTED|Overall Study||2
8333181|NCT01353898|20541618|P3|STARTED|Overall Study||2
8333182|NCT01353898|20541619|P2|STARTED|Overall Study||2
8333183|NCT01353898|20541620|P1|STARTED|Overall Study||2
8333184|NCT01353859|20541646|P1|NOT COMPLETED|Overall Study||4
8333185|NCT01353859|20541646|P1|COMPLETED|Overall Study||35
8333186|NCT01353859|20541646|P1|STARTED|Overall Study||39
8333187|NCT01353703|20541661|P2|NOT COMPLETED|Overall Study||0
8333188|NCT01353703|20541662|P1|NOT COMPLETED|Overall Study||1
8333189|NCT01353703|20541661|P2|COMPLETED|Overall Study||112
8333190|NCT01353703|20541662|P1|COMPLETED|Overall Study||111
8333191|NCT01353703|20541661|P2|STARTED|Overall Study||112
8333192|NCT01353703|20541662|P1|STARTED|Overall Study||112
8333193|NCT01353664|20541708|P1|NOT COMPLETED|Overall Study||19
8333194|NCT01353664|20541708|P1|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
8333195|NCT01353664|20541708|P1|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
8333196|NCT01353586|20541714|P2|NOT COMPLETED|Overall Study||2
8333197|NCT01353586|20541715|P1|NOT COMPLETED|Overall Study||7
8333198|NCT01353586|20541714|P2|COMPLETED|Overall Study||17
8333199|NCT01353586|20541715|P1|COMPLETED|Overall Study||160
8333200|NCT01353586|20541714|P2|Participated in SNA Substudy|Overall Study||19
8333201|NCT01353586|20541715|P1|Participated in SNA Substudy|Overall Study||19
8333202|NCT01353586|20541714|P2|Participated in Roll-in Phase|Overall Study||0
8333203|NCT01353586|20541715|P1|Participated in Roll-in Phase|Overall Study||22
8333204|NCT01353586|20541714|P2|Participated in Workflow Phase|Overall Study||0
8333205|NCT01353586|20541715|P1|Participated in Workflow Phase|Overall Study||20
8333206|NCT01353586|20541714|P2|STARTED|Overall Study||19
8333207|NCT01353586|20541715|P1|STARTED|Overall Study||167
8333208|NCT01353508|20541733|P4|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
8333209|NCT01353508|20541734|P3|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
8333210|NCT01353508|20541735|P2|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
8333211|NCT01353508|20541736|P1|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
8333212|NCT01353508|20541733|P4|COMPLETED|Period 2 - Second Intervention (7 Days)||7
8333213|NCT01353508|20541734|P3|COMPLETED|Period 2 - Second Intervention (7 Days)||8
8333214|NCT01353508|20541735|P2|COMPLETED|Period 2 - Second Intervention (7 Days)||8
8333215|NCT01353508|20541736|P1|COMPLETED|Period 2 - Second Intervention (7 Days)||7
8333216|NCT01353508|20541733|P4|STARTED|Period 2 - Second Intervention (7 Days)||7
8333217|NCT01353508|20541734|P3|STARTED|Period 2 - Second Intervention (7 Days)||8
8333218|NCT01353508|20541735|P2|STARTED|Period 2 - Second Intervention (7 Days)||8
8333219|NCT01353508|20541736|P1|STARTED|Period 2 - Second Intervention (7 Days)||8
8333220|NCT01353508|20541733|P4|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
8333221|NCT01353508|20541734|P3|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
8333222|NCT01353508|20541735|P2|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
8333223|NCT01353508|20541736|P1|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
8333224|NCT01353508|20541733|P4|COMPLETED|Period 1 - First Intervention (7 Days)||7
8333225|NCT01353508|20541734|P3|COMPLETED|Period 1 - First Intervention (7 Days)||8
8333226|NCT01353508|20541735|P2|COMPLETED|Period 1 - First Intervention (7 Days)||8
8333227|NCT01353508|20541736|P1|COMPLETED|Period 1 - First Intervention (7 Days)||8
8333228|NCT01353508|20541733|P4|STARTED|Period 1 - First Intervention (7 Days)||8
8333229|NCT01353508|20541734|P3|STARTED|Period 1 - First Intervention (7 Days)||8
8333230|NCT01353508|20541735|P2|STARTED|Period 1 - First Intervention (7 Days)||8
8333231|NCT01353508|20541736|P1|STARTED|Period 1 - First Intervention (7 Days)||8
8333232|NCT01353274|20541814|P1|NOT COMPLETED|Overall Study||28
8333233|NCT01353274|20541814|P1|COMPLETED|Overall Study||1129
8333234|NCT01353274|20541814|P1|STARTED|Overall Study||1157
8333235|NCT01353222|20541824|P2|NOT COMPLETED|Overall Study||72
8333236|NCT01353222|20541825|P1|NOT COMPLETED|Overall Study||70
8333237|NCT01353222|20541824|P2|COMPLETED|Overall Study||0
8333238|NCT01353222|20541825|P1|COMPLETED|Overall Study||0
8333239|NCT01353222|20541824|P2|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
8333240|NCT01353222|20541825|P1|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
8333241|NCT01353222|20541824|P2|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
8333242|NCT01353222|20541825|P1|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
8333243|NCT01353222|20541824|P2|STARTED|Overall Study||72
8333244|NCT01353222|20541825|P1|STARTED|Overall Study||70
8333245|NCT01353196|20541833|P2|NOT COMPLETED|Overall Study||11
8333246|NCT01353196|20541834|P1|NOT COMPLETED|Overall Study||29
8333247|NCT01353196|20541833|P2|COMPLETED|Overall Study||59
8333248|NCT01353196|20541834|P1|COMPLETED|Overall Study||71
8333249|NCT01353196|20541833|P2|STARTED|Overall Study||70
8333250|NCT01353196|20541834|P1|STARTED|Overall Study||100
8333251|NCT01353144|20541842|P2|NOT COMPLETED|Overall Study||8
8333252|NCT01353144|20541843|P1|NOT COMPLETED|Overall Study||9
8333253|NCT01353144|20541842|P2|COMPLETED|Overall Study||81
8333254|NCT01353144|20541843|P1|COMPLETED|Overall Study||80
8333255|NCT01353144|20541842|P2|STARTED|Overall Study||89
8333256|NCT01353144|20541843|P1|STARTED|Overall Study||89
8333257|NCT01353079|20541853|P2|NOT COMPLETED|Overall Study||21
8333258|NCT01353079|20541854|P1|NOT COMPLETED|Overall Study||27
8333259|NCT01353079|20541853|P2|COMPLETED|Overall Study||190
8333260|NCT01353079|20541854|P1|COMPLETED|Overall Study||191
8333261|NCT01353079|20541853|P2|STARTED|Overall Study||211
8333262|NCT01353079|20541854|P1|STARTED|Overall Study||218
8333263|NCT01352845|20541868|P2|NOT COMPLETED|Overall Study||203
8333264|NCT01352845|20541869|P1|NOT COMPLETED|Overall Study||671
8333265|NCT01352845|20541868|P2|COMPLETED|Overall Study||619
8333266|NCT01352845|20541869|P1|COMPLETED|Overall Study||1800
8333267|NCT01352845|20541868|P2|STARTED|Overall Study||822
8333268|NCT01352845|20541869|P1|STARTED|Overall Study||2471
8333269|NCT01352793|20541958|P2|NOT COMPLETED|Overall Study||245
8333270|NCT01352793|20541959|P1|NOT COMPLETED|Overall Study||585
8333271|NCT01352793|20541958|P2|COMPLETED|Overall Study||1663
8333272|NCT01352793|20541959|P1|COMPLETED|Overall Study||3219
8333273|NCT01352793|20541958|P2|Vaccination 3|Overall Study||1710
8333274|NCT01352793|20541959|P1|Vaccination 3|Overall Study||3314
8333275|NCT01352793|20541958|P2|Vaccination 2|Overall Study||1806
8333276|NCT01352793|20541959|P1|Vaccination 2|Overall Study||3530
8333277|NCT01352793|20541958|P2|Vaccination 1|Overall Study||1908
8333278|NCT01352793|20541959|P1|Vaccination 1|Overall Study||3796
8333279|NCT01352793|20541958|P2|STARTED|Overall Study||1908
8333280|NCT01352793|20541959|P1|STARTED|Overall Study||3804
8333281|NCT01352741|20541983|P2|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
8333282|NCT01352741|20541984|P1|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
8333283|NCT01352741|20541983|P2|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
8333284|NCT01352741|20541984|P1|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
8333285|NCT01352741|20541983|P2|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
8333286|NCT01352741|20541984|P1|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
8333287|NCT01352741|20541983|P2|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
8333288|NCT01352741|20541984|P1|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
8333289|NCT01352741|20541983|P2|COMPLETED|Open-Label Tapentadol Continuation Arm||0
8333290|NCT01352741|20541984|P1|COMPLETED|Open-Label Tapentadol Continuation Arm||51
8333291|NCT01352741|20541983|P2|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
8333292|NCT01352741|20541984|P1|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
8333293|NCT01352741|20541983|P2|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
8333294|NCT01352741|20541984|P1|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
8333295|NCT01352741|20541983|P2|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
8333296|NCT01352741|20541984|P1|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
8333297|NCT01352741|20541983|P2|NOT COMPLETED|Double-blind Comparative Period||26
8333298|NCT01352741|20541984|P1|NOT COMPLETED|Double-blind Comparative Period||28
8333299|NCT01352741|20541983|P2|COMPLETED|Double-blind Comparative Period||133
8333300|NCT01352741|20541984|P1|COMPLETED|Double-blind Comparative Period||126
8333301|NCT01352741|20541983|P2|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
8333302|NCT01352741|20541984|P1|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
8333303|NCT01352741|20541983|P2|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
8333304|NCT01352741|20541984|P1|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
8333305|NCT01352741|20541983|P2|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
8333306|NCT01352741|20541984|P1|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
8333307|NCT01352741|20541983|P2|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
8333308|NCT01352741|20541984|P1|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
8333309|NCT01352741|20541983|P2|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
8333310|NCT01352741|20541984|P1|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
8333311|NCT01352741|20541983|P2|SF-12 Per Protocol Set|Double-blind Comparative Period||143
8333312|NCT01352741|20541984|P1|SF-12 Per Protocol Set|Double-blind Comparative Period||131
8333313|NCT01352741|20541983|P2|painDetect Per Protocol Set|Double-blind Comparative Period||127
8333314|NCT01352741|20541984|P1|painDetect Per Protocol Set|Double-blind Comparative Period||109
8333315|NCT01352741|20541983|P2|Per Protocol Set|Double-blind Comparative Period||149
8333316|NCT01352741|20541984|P1|Per Protocol Set|Double-blind Comparative Period||139
8333317|NCT01352741|20541983|P2|Major Protocol Deviations|Double-blind Comparative Period||8
8333318|NCT01352741|20541984|P1|Major Protocol Deviations|Double-blind Comparative Period||13
8333319|NCT01352741|20541983|P2|Full Analysis Set|Double-blind Comparative Period||157
8333320|NCT01352741|20541984|P1|Full Analysis Set|Double-blind Comparative Period||152
8333321|NCT01352741|20541983|P2|No Pain Assessments Available|Double-blind Comparative Period||2
8333322|NCT01352741|20541984|P1|No Pain Assessments Available|Double-blind Comparative Period||2
8333323|NCT01352741|20541983|P2|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
8333324|NCT01352741|20541984|P1|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
8333325|NCT01352741|20541983|P2|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
8333326|NCT01352741|20541984|P1|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
8333327|NCT01352741|20541983|P2|NOT COMPLETED|Open-label Tapentadol Titration Period||0
8333328|NCT01352741|20541984|P1|NOT COMPLETED|Open-label Tapentadol Titration Period||73
8333329|NCT01352741|20541983|P2|COMPLETED|Open-label Tapentadol Titration Period||0
8333330|NCT01352741|20541984|P1|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
8333331|NCT01352741|20541983|P2|Full Analysis Set|Open-label Tapentadol Titration Period||0
8333332|NCT01352741|20541984|P1|Full Analysis Set|Open-label Tapentadol Titration Period||436
8333333|NCT01352741|20541983|P2|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
8333334|NCT01352741|20541984|P1|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
8333335|NCT01352741|20541983|P2|STARTED|Open-label Tapentadol Titration Period||0
8333336|NCT01352741|20541984|P1|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
8333343|NCT01352637|20542105|P4|NOT COMPLETED|Drug||35
8333344|NCT01352637|20542106|P3|NOT COMPLETED|Drug||25
8333345|NCT01352637|20542107|P2|NOT COMPLETED|Drug||0
8333346|NCT01352637|20542108|P1|NOT COMPLETED|Drug||0
8333347|NCT01352637|20542105|P4|COMPLETED|Drug||62
8333348|NCT01352637|20542106|P3|COMPLETED|Drug||70
8333349|NCT01352637|20542107|P2|COMPLETED|Drug||0
8333350|NCT01352637|20542108|P1|COMPLETED|Drug||0
8333351|NCT01352637|20542105|P4|STARTED|Drug||97
8333352|NCT01352637|20542106|P3|STARTED|Drug||95
8333353|NCT01352637|20542107|P2|STARTED|Drug||0
8333354|NCT01352637|20542108|P1|STARTED|Drug||0
8333355|NCT01352637|20542105|P4|NOT COMPLETED|Exposure Therapy||0
8333356|NCT01352637|20542106|P3|NOT COMPLETED|Exposure Therapy||0
8333357|NCT01352637|20542107|P2|NOT COMPLETED|Exposure Therapy||33
8333358|NCT01352637|20542108|P1|NOT COMPLETED|Exposure Therapy||27
8333359|NCT01352637|20542105|P4|COMPLETED|Exposure Therapy||0
8333360|NCT01352637|20542106|P3|COMPLETED|Exposure Therapy||0
8333361|NCT01352637|20542107|P2|COMPLETED|Exposure Therapy||62
8333362|NCT01352637|20542108|P1|COMPLETED|Exposure Therapy||70
8333363|NCT01352637|20542105|P4|STARTED|Exposure Therapy||0
8333364|NCT01352637|20542106|P3|STARTED|Exposure Therapy||0
8333365|NCT01352637|20542107|P2|STARTED|Exposure Therapy||95
8333366|NCT01352637|20542108|P1|STARTED|Exposure Therapy||97
8333367|NCT01352598|20542118|P1|NOT COMPLETED|Overall Study||12
8333368|NCT01352598|20542118|P1|COMPLETED|Overall Study||72
8333369|NCT01352598|20542118|P1|STARTED|Overall Study||84
8333373|NCT01352546|20542134|P1|NOT COMPLETED|Overall Study||0
8333374|NCT01352546|20542134|P1|COMPLETED|Overall Study||31
8333375|NCT01352546|20542134|P1|STARTED|Overall Study||31
8333376|NCT01352507|20542140|P2|NOT COMPLETED|Extension Phase||0
8333377|NCT01352507|20542141|P1|NOT COMPLETED|Extension Phase||0
8333378|NCT01352507|20542140|P2|COMPLETED|Extension Phase||173
8333379|NCT01352507|20542141|P1|COMPLETED|Extension Phase||164
8333380|NCT01352507|20542140|P2|STARTED|Extension Phase||173
8333381|NCT01352507|20542141|P1|STARTED|Extension Phase||164
8333382|NCT01352507|20542140|P2|NOT COMPLETED|Treatment Period 2||3
8333383|NCT01352507|20542141|P1|NOT COMPLETED|Treatment Period 2||6
8333384|NCT01352507|20542140|P2|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
8333385|NCT01352507|20542141|P1|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
8333386|NCT01352507|20542140|P2|Received Treatment|Treatment Period 2||181
8333387|NCT01352507|20542141|P1|Received Treatment|Treatment Period 2||173
8333388|NCT01352507|20542140|P2|STARTED|Treatment Period 2||183
8333389|NCT01352507|20542141|P1|STARTED|Treatment Period 2||176
8333390|NCT01352507|20542140|P2|NOT COMPLETED|Washout Period||1
8333391|NCT01352507|20542141|P1|NOT COMPLETED|Washout Period||0
8333392|NCT01352507|20542140|P2|COMPLETED|Washout Period||183
8333393|NCT01352507|20542141|P1|COMPLETED|Washout Period||176
8333394|NCT01352507|20542140|P2|STARTED|Washout Period||184
8333395|NCT01352507|20542141|P1|STARTED|Washout Period||176
8333396|NCT01352507|20542140|P2|NOT COMPLETED|Treatment Period 1||9
8333397|NCT01352507|20542141|P1|NOT COMPLETED|Treatment Period 1||14
8333398|NCT01352507|20542140|P2|COMPLETED|Treatment Period 1||184
8333399|NCT01352507|20542141|P1|COMPLETED|Treatment Period 1||176
8333400|NCT01352507|20542140|P2|Received Treatment|Treatment Period 1||188
8333401|NCT01352507|20542141|P1|Received Treatment|Treatment Period 1||182
8333402|NCT01352507|20542140|P2|STARTED|Treatment Period 1||193
8333403|NCT01352507|20542141|P1|STARTED|Treatment Period 1||190
8333404|NCT01352468|20542174|P2|NOT COMPLETED|Overall Study||4
8333405|NCT01352468|20542175|P1|NOT COMPLETED|Overall Study||5
8333406|NCT01352468|20542174|P2|COMPLETED|Overall Study||18
8333407|NCT01352468|20542175|P1|COMPLETED|Overall Study||17
8333408|NCT01352468|20542174|P2|STARTED|Overall Study||22
8333409|NCT01352468|20542175|P1|STARTED|Overall Study||22
8333410|NCT01352442|20542185|P1|NOT COMPLETED|Overall Study||12
8333411|NCT01352442|20542185|P1|COMPLETED|Overall Study||139
8333412|NCT01352442|20542185|P1|STARTED|Overall Study||151
8333413|NCT01352416|20542194|P4|NOT COMPLETED|Overall Study||1
8333414|NCT01352416|20542195|P3|NOT COMPLETED|Overall Study||2
8333415|NCT01352416|20542196|P2|NOT COMPLETED|Overall Study||2
8333416|NCT01352416|20542197|P1|NOT COMPLETED|Overall Study||1
8333417|NCT01352416|20542194|P4|COMPLETED|Overall Study||1
8333418|NCT01352416|20542195|P3|COMPLETED|Overall Study||0
8333419|NCT01352416|20542196|P2|COMPLETED|Overall Study||5
8333420|NCT01352416|20542197|P1|COMPLETED|Overall Study||3
8333421|NCT01352416|20542194|P4|STARTED|Overall Study||2
8333422|NCT01352416|20542195|P3|STARTED|Overall Study||2
8333423|NCT01352416|20542196|P2|STARTED|Overall Study||7
8333424|NCT01352416|20542197|P1|STARTED|Overall Study||4
8333425|NCT01352286|20542207|P1|NOT COMPLETED|Overall Study||0
8333426|NCT01352286|20542207|P1|COMPLETED|Overall Study||25
8333427|NCT01352286|20542207|P1|Received T-cells|Overall Study||25
8333428|NCT01352286|20542207|P1|STARTED|Overall Study||25
8333429|NCT01352221|20542219|P4|NOT COMPLETED|Open-label Phase||11
8333430|NCT01352221|20542220|P3|NOT COMPLETED|Open-label Phase||13
8333431|NCT01352221|20542221|P2|NOT COMPLETED|Open-label Phase||0
8333432|NCT01352221|20542222|P1|NOT COMPLETED|Open-label Phase||0
8333433|NCT01352221|20542219|P4|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
8333434|NCT01352221|20542220|P3|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
8333435|NCT01352221|20542221|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
8333436|NCT01352221|20542222|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
8333437|NCT01352221|20542219|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
8333438|NCT01352221|20542220|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
8333439|NCT01352221|20542221|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
8333440|NCT01352221|20542222|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
8333441|NCT01352221|20542219|P4|NOT COMPLETED|Double-blind Phase||0
8333442|NCT01352221|20542220|P3|NOT COMPLETED|Double-blind Phase||0
8333443|NCT01352221|20542221|P2|NOT COMPLETED|Double-blind Phase||11
8333444|NCT01352221|20542222|P1|NOT COMPLETED|Double-blind Phase||9
8333445|NCT01352221|20542219|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
8333446|NCT01352221|20542220|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
8333447|NCT01352221|20542221|P2|COMPLETED|Double-blind Phase||53
8333448|NCT01352221|20542222|P1|COMPLETED|Double-blind Phase||55
8333449|NCT01352221|20542219|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
8333450|NCT01352221|20542220|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
8333451|NCT01352221|20542221|P2|STARTED|Double-blind Phase||64
8333452|NCT01352221|20542222|P1|STARTED|Double-blind Phase||64
8333453|NCT01352182|20542282|P2|NOT COMPLETED|Overall Study||0
8333454|NCT01352182|20542283|P1|NOT COMPLETED|Overall Study||0
8333455|NCT01352182|20542282|P2|COMPLETED|Overall Study||4
8333456|NCT01352182|20542283|P1|COMPLETED|Overall Study||8
8333457|NCT01352182|20542282|P2|STARTED|Overall Study||4
8333458|NCT01352182|20542283|P1|STARTED|Overall Study||8
8333459|NCT01352117|20542301|P2|NOT COMPLETED|Overall Study||24
8333460|NCT01352117|20542302|P1|NOT COMPLETED|Overall Study||21
8333461|NCT01352117|20542301|P2|COMPLETED|Overall Study||72
8333462|NCT01352117|20542302|P1|COMPLETED|Overall Study||75
8333463|NCT01352117|20542301|P2|Study Week 96 Data Potential|Overall Study||61
8333464|NCT01352117|20542302|P1|Study Week 96 Data Potential|Overall Study||58
8333465|NCT01352117|20542301|P2|Study Week 48 Data Potential|Overall Study||83
8333466|NCT01352117|20542302|P1|Study Week 48 Data Potential|Overall Study||80
8333467|NCT01352117|20542301|P2|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
8333468|NCT01352117|20542302|P1|Entered Step 2 to Initiate Delayed ET|Overall Study||32
8333469|NCT01352117|20542301|P2|STARTED|Overall Study||96
8333470|NCT01352117|20542302|P1|STARTED|Overall Study||96
8333491|NCT01351766|20542383|P1|NOT COMPLETED|Overall Study||3
8333492|NCT01351766|20542383|P1|COMPLETED|Overall Study||36
8333493|NCT01351766|20542383|P1|STARTED|Overall Study||39
8333494|NCT01351740|20542389|P2|NOT COMPLETED|Overall Study||6
8333495|NCT01351740|20542390|P1|NOT COMPLETED|Overall Study||2
8333496|NCT01351740|20542389|P2|COMPLETED|Overall Study||19
8333497|NCT01351740|20542390|P1|COMPLETED|Overall Study||23
8333498|NCT01351740|20542389|P2|STARTED|Overall Study||25
8333499|NCT01351740|20542390|P1|STARTED|Overall Study||25
8333500|NCT01351623|20542398|P1|NOT COMPLETED|Overall Study||9
8333501|NCT01351623|20542398|P1|COMPLETED|Overall Study||35
8333502|NCT01351623|20542398|P1|STARTED|Overall Study||44
8333503|NCT01351506|20542404|P1|NOT COMPLETED|Overall Study||137
8333504|NCT01351506|20542404|P1|COMPLETED|Overall Study||465
8333505|NCT01351506|20542404|P1|STARTED|Overall Study||602
8333506|NCT01351480|20542414|P1|NOT COMPLETED|Overall Study||8
8333507|NCT01351480|20542414|P1|COMPLETED|Overall Study||26
8333508|NCT01351480|20542414|P1|STARTED|Overall Study||34
8333509|NCT01351415|20542424|P2|NOT COMPLETED|Overall Study||240
8333510|NCT01351415|20542425|P1|NOT COMPLETED|Overall Study||245
8333511|NCT01351415|20542424|P2|COMPLETED|Overall Study||0
8333512|NCT01351415|20542425|P1|COMPLETED|Overall Study||0
8333513|NCT01351415|20542424|P2|Treated Participants|Overall Study||232
8333514|NCT01351415|20542425|P1|Treated Participants|Overall Study||243
8333515|NCT01351415|20542424|P2|STARTED|Overall Study||240
8333516|NCT01351415|20542425|P1|STARTED|Overall Study||245
8333517|NCT01351376|20542447|P2|NOT COMPLETED|Overall Study||0
8333518|NCT01351376|20542448|P1|NOT COMPLETED|Overall Study||0
8333519|NCT01351376|20542447|P2|COMPLETED|Overall Study||11
8333520|NCT01351376|20542448|P1|COMPLETED|Overall Study||10
8333521|NCT01351376|20542447|P2|STARTED|Overall Study||11
8333522|NCT01351376|20542448|P1|STARTED|Overall Study||10
8333523|NCT01351350|20542461|P5|NOT COMPLETED|Overall Study||7
8333524|NCT01351350|20542462|P4|NOT COMPLETED|Overall Study||13
8333525|NCT01351350|20542463|P3|NOT COMPLETED|Overall Study||11
8333526|NCT01351350|20542464|P2|NOT COMPLETED|Overall Study||29
8333527|NCT01351350|20542465|P1|NOT COMPLETED|Overall Study||8
8333528|NCT01351350|20542461|P5|COMPLETED|Overall Study||0
8333529|NCT01351350|20542462|P4|COMPLETED|Overall Study||0
8333530|NCT01351350|20542463|P3|COMPLETED|Overall Study||0
8333531|NCT01351350|20542464|P2|COMPLETED|Overall Study||0
8333532|NCT01351350|20542465|P1|COMPLETED|Overall Study||0
8333533|NCT01351350|20542461|P5|Dose-escalation Evaluable|Overall Study||0
8333534|NCT01351350|20542462|P4|Dose-escalation Evaluable|Overall Study||0
8333535|NCT01351350|20542463|P3|Dose-escalation Evaluable|Overall Study||10
8333536|NCT01351350|20542464|P2|Dose-escalation Evaluable|Overall Study||23
8333537|NCT01351350|20542465|P1|Dose-escalation Evaluable|Overall Study||7
8333538|NCT01351350|20542461|P5|Treated|Overall Study||7
8333539|NCT01351350|20542462|P4|Treated|Overall Study||13
8333540|NCT01351350|20542463|P3|Treated|Overall Study||10
8333541|NCT01351350|20542464|P2|Treated|Overall Study||29
8333542|NCT01351350|20542465|P1|Treated|Overall Study||8
8333543|NCT01351350|20542461|P5|STARTED|Overall Study||7
8333544|NCT01351350|20542462|P4|STARTED|Overall Study||13
8333545|NCT01351350|20542463|P3|STARTED|Overall Study||11
8333546|NCT01351350|20542464|P2|STARTED|Overall Study||29
8333547|NCT01351350|20542465|P1|STARTED|Overall Study||8
8333548|NCT01351337|20542578|P1|NOT COMPLETED|Overall Study||0
8333549|NCT01351337|20542578|P1|COMPLETED|Overall Study||58
8333550|NCT01351337|20542578|P1|STARTED|Overall Study||58
8333551|NCT01351090|20542587|P3|NOT COMPLETED|Overall Study||6
8333552|NCT01351090|20542588|P2|NOT COMPLETED|Overall Study||11
8333553|NCT01351090|20542589|P1|NOT COMPLETED|Overall Study||11
8333554|NCT01351090|20542587|P3|COMPLETED|Overall Study||36
8333555|NCT01351090|20542588|P2|COMPLETED|Overall Study||31
8333556|NCT01351090|20542589|P1|COMPLETED|Overall Study||32
8333557|NCT01351090|20542587|P3|STARTED|Overall Study||42
8333558|NCT01351090|20542588|P2|STARTED|Overall Study||42
8333559|NCT01351090|20542589|P1|STARTED|Overall Study||43
8333560|NCT01351077|20542608|P2|NOT COMPLETED|Overall Study||0
8333561|NCT01351077|20542609|P1|NOT COMPLETED|Overall Study||0
8333562|NCT01351077|20542608|P2|COMPLETED|Overall Study||180
8333563|NCT01351077|20542609|P1|COMPLETED|Overall Study||180
8333564|NCT01351077|20542608|P2|STARTED|Overall Study||180
8333565|NCT01351077|20542609|P1|STARTED|Overall Study||180
8333566|NCT01351064|20542625|P2|NOT COMPLETED|Overall Study||0
8333567|NCT01351064|20542626|P1|NOT COMPLETED|Overall Study||0
8333568|NCT01351064|20542625|P2|COMPLETED|Overall Study||42
8333569|NCT01351064|20542626|P1|COMPLETED|Overall Study||42
8333570|NCT01351064|20542625|P2|STARTED|Overall Study||42
8333571|NCT01351064|20542626|P1|STARTED|Overall Study||42
8333596|NCT01350999|20542670|P3|NOT COMPLETED|Overall Study||21
8333597|NCT01350999|20542671|P2|NOT COMPLETED|Overall Study||14
8333598|NCT01350999|20542672|P1|NOT COMPLETED|Overall Study||8
8333599|NCT01350999|20542670|P3|COMPLETED|Overall Study||146
8333600|NCT01350999|20542671|P2|COMPLETED|Overall Study||157
8333601|NCT01350999|20542672|P1|COMPLETED|Overall Study||157
8333602|NCT01350999|20542670|P3|Treated|Overall Study||167
8333603|NCT01350999|20542671|P2|Treated|Overall Study||171
8333604|NCT01350999|20542672|P1|Treated|Overall Study||165
8333605|NCT01350999|20542670|P3|STARTED|Overall Study||167
8333606|NCT01350999|20542671|P2|STARTED|Overall Study||171
8333607|NCT01350999|20542672|P1|STARTED|Overall Study||165
8333608|NCT01350973|20542710|P3|NOT COMPLETED|Overall Study||8
8333609|NCT01350973|20542711|P2|NOT COMPLETED|Overall Study||8
8333610|NCT01350973|20542712|P1|NOT COMPLETED|Overall Study||6
8333611|NCT01350973|20542710|P3|COMPLETED|Overall Study||187
8333612|NCT01350973|20542711|P2|COMPLETED|Overall Study||202
8333613|NCT01350973|20542712|P1|COMPLETED|Overall Study||200
8333614|NCT01350973|20542710|P3|Received Treatment|Overall Study||195
8333615|NCT01350973|20542711|P2|Received Treatment|Overall Study||210
8333616|NCT01350973|20542712|P1|Received Treatment|Overall Study||205
8333617|NCT01350973|20542710|P3|STARTED|Overall Study||195
8333618|NCT01350973|20542711|P2|STARTED|Overall Study||210
8333619|NCT01350973|20542712|P1|STARTED|Overall Study||206
8333620|NCT01350947|20542747|P1|NOT COMPLETED|Overall Study||0
8333621|NCT01350947|20542747|P1|COMPLETED|Overall Study||11
8333622|NCT01350947|20542747|P1|STARTED|Overall Study||11
8333623|NCT01350934|20542753|P2|NOT COMPLETED|Extension Study||4
8333624|NCT01350934|20542754|P1|NOT COMPLETED|Extension Study||5
8333625|NCT01350934|20542753|P2|COMPLETED|Extension Study||101
8333626|NCT01350934|20542754|P1|COMPLETED|Extension Study||95
8333627|NCT01350934|20542753|P2|STARTED|Extension Study||105
8333628|NCT01350934|20542754|P1|STARTED|Extension Study||100
8333629|NCT01350934|20542753|P2|NOT COMPLETED|Base Study||3
8333630|NCT01350934|20542754|P1|NOT COMPLETED|Base Study||11
8333631|NCT01350934|20542753|P2|COMPLETED|Base Study||105
8333632|NCT01350934|20542754|P1|COMPLETED|Base Study||100
8333633|NCT01350934|20542753|P2|STARTED|Base Study||108
8333634|NCT01350934|20542754|P1|STARTED|Base Study||111
8333635|NCT01350804|20542776|P4|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
8333636|NCT01350804|20542777|P3|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
8333637|NCT01350804|20542778|P2|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
8333638|NCT01350804|20542779|P1|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
8333639|NCT01350804|20542776|P4|COMPLETED|Extension Study, Weeks 52 - 260||0
8333640|NCT01350804|20542777|P3|COMPLETED|Extension Study, Weeks 52 - 260||0
8333641|NCT01350804|20542778|P2|COMPLETED|Extension Study, Weeks 52 - 260||0
8333642|NCT01350804|20542779|P1|COMPLETED|Extension Study, Weeks 52 - 260||0
8333643|NCT01350804|20542776|P4|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
8333644|NCT01350804|20542777|P3|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
8333645|NCT01350804|20542778|P2|STARTED|Extension Study, Weeks 52 - 260||79
8333646|NCT01350804|20542779|P1|STARTED|Extension Study, Weeks 52 - 260||80
8333647|NCT01350804|20542776|P4|NOT COMPLETED|Core Study||26
8333648|NCT01350804|20542777|P3|NOT COMPLETED|Core Study||47
8333649|NCT01350804|20542778|P2|NOT COMPLETED|Core Study||47
8333650|NCT01350804|20542779|P1|NOT COMPLETED|Core Study||41
8333651|NCT01350804|20542776|P4|COMPLETED|Core Study||112
8333652|NCT01350804|20542777|P3|COMPLETED|Core Study||91
8333653|NCT01350804|20542778|P2|COMPLETED|Core Study||90
8333654|NCT01350804|20542779|P1|COMPLETED|Core Study||97
8333655|NCT01350804|20542776|P4|Full Analysis Set|Core Study||138
8333656|NCT01350804|20542777|P3|Full Analysis Set|Core Study||138
8333657|NCT01350804|20542778|P2|Full Analysis Set|Core Study||137
8333658|NCT01350804|20542779|P1|Full Analysis Set|Core Study||138
8333659|NCT01350804|20542776|P4|Treatment Switch to AIN457 at Week 24|Core Study||37
8333660|NCT01350804|20542777|P3|Treatment Switch to AIN457 at Week 24|Core Study||45
8333661|NCT01350804|20542778|P2|Treatment Switch to AIN457 at Week 24|Core Study||0
8333662|NCT01350804|20542779|P1|Treatment Switch to AIN457 at Week 24|Core Study||0
8333663|NCT01350804|20542776|P4|Tratment Switch to AIN457 at Week 16|Core Study||0
8333664|NCT01350804|20542777|P3|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
8333665|NCT01350804|20542778|P2|Tratment Switch to AIN457 at Week 16|Core Study||0
8333666|NCT01350804|20542779|P1|Tratment Switch to AIN457 at Week 16|Core Study||0
8333667|NCT01350804|20542776|P4|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
8333668|NCT01350804|20542777|P3|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
8333669|NCT01350804|20542778|P2|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
8333670|NCT01350804|20542779|P1|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
8333671|NCT01350804|20542776|P4|STARTED|Core Study||138
8333672|NCT01350804|20542777|P3|STARTED|Core Study||138
8333673|NCT01350804|20542778|P2|STARTED|Core Study||137
8333674|NCT01350804|20542779|P1|STARTED|Core Study||138
8333675|NCT01350583|20542868|P1|NOT COMPLETED|Overall Study||0
8333676|NCT01350583|20542868|P1|COMPLETED|Overall Study||2
8333677|NCT01350583|20542868|P1|STARTED|Overall Study||2
8333678|NCT01350544|20542876|P2|NOT COMPLETED|Overall Study||22
8333679|NCT01350544|20542877|P1|NOT COMPLETED|Overall Study||23
8333680|NCT01350544|20542876|P2|COMPLETED|Overall Study||86
8333681|NCT01350544|20542877|P1|COMPLETED|Overall Study||85
8333682|NCT01350544|20542876|P2|STARTED|Overall Study||108
8333683|NCT01350544|20542877|P1|STARTED|Overall Study||108
8333684|NCT01350505|20542883|P1|NOT COMPLETED|Overall Study||4
8333685|NCT01350505|20542883|P1|COMPLETED|Overall Study||17
8333686|NCT01350505|20542883|P1|STARTED|Overall Study||21
8333687|NCT01350492|20542889|P2|NOT COMPLETED|Post Intervention Follow-Up||2
8333688|NCT01350492|20542890|P1|NOT COMPLETED|Post Intervention Follow-Up||6
8333689|NCT01350492|20542889|P2|COMPLETED|Post Intervention Follow-Up||18
8333690|NCT01350492|20542890|P1|COMPLETED|Post Intervention Follow-Up||17
8333691|NCT01350492|20542889|P2|6-month MRI Scan|Post Intervention Follow-Up||20
8333692|NCT01350492|20542890|P1|6-month MRI Scan|Post Intervention Follow-Up||20
8333693|NCT01350492|20542889|P2|STARTED|Post Intervention Follow-Up||20
8333694|NCT01350492|20542890|P1|STARTED|Post Intervention Follow-Up||23
8333695|NCT01350492|20542889|P2|NOT COMPLETED|Intervention||6
8333696|NCT01350492|20542890|P1|NOT COMPLETED|Intervention||5
8333697|NCT01350492|20542889|P2|COMPLETED|Intervention||20
8333698|NCT01350492|20542890|P1|COMPLETED|Intervention||23
8333699|NCT01350492|20542889|P2|11-week MRI Scan|Intervention||21
8333700|NCT01350492|20542890|P1|11-week MRI Scan|Intervention||23
8333701|NCT01350492|20542889|P2|6-week MRI Scan|Intervention||22
8333702|NCT01350492|20542890|P1|6-week MRI Scan|Intervention||24
8333703|NCT01350492|20542889|P2|STARTED|Intervention||26
8333704|NCT01350492|20542890|P1|STARTED|Intervention||28
8333705|NCT01350479|20542908|P2|NOT COMPLETED|Overall Study||0
8333706|NCT01350479|20542909|P1|NOT COMPLETED|Overall Study||0
8333707|NCT01350479|20542908|P2|COMPLETED|Overall Study||106
8333708|NCT01350479|20542909|P1|COMPLETED|Overall Study||94
8333709|NCT01350479|20542908|P2|STARTED|Overall Study||106
8333710|NCT01350479|20542909|P1|STARTED|Overall Study||94
8333711|NCT01350453|20542917|P2|NOT COMPLETED|Overall Study||1
8333712|NCT01350453|20542918|P1|NOT COMPLETED|Overall Study||2
8333713|NCT01350453|20542917|P2|COMPLETED|Overall Study||7
8333714|NCT01350453|20542918|P1|COMPLETED|Overall Study||9
8333715|NCT01350453|20542917|P2|STARTED|Overall Study||8
8333716|NCT01350453|20542918|P1|STARTED|Overall Study||11
8333717|NCT01350414|20542932|P1|NOT COMPLETED|Overall Study||19
8333718|NCT01350414|20542932|P1|COMPLETED|Overall Study||162
8333719|NCT01350414|20542932|P1|Year 5|Overall Study||162
8333720|NCT01350414|20542932|P1|Year 4|Overall Study||159
8333721|NCT01350414|20542932|P1|Year 3|Overall Study||162
8333722|NCT01350414|20542932|P1|Year 2|Overall Study||165
8333723|NCT01350414|20542932|P1|STARTED|Overall Study||181
8333724|NCT01350401|20542949|P1|NOT COMPLETED|Overall Study||0
8333725|NCT01350401|20542949|P1|COMPLETED|Overall Study||4
8333726|NCT01350401|20542949|P1|STARTED|Overall Study||4
8333727|NCT01350388|20542961|P2|NOT COMPLETED|Overall Study||1
8333728|NCT01350388|20542962|P1|NOT COMPLETED|Overall Study||3
8333729|NCT01350388|20542961|P2|COMPLETED|Overall Study||39
8333730|NCT01350388|20542962|P1|COMPLETED|Overall Study||37
8333731|NCT01350388|20542961|P2|STARTED|Overall Study||40
8333732|NCT01350388|20542962|P1|STARTED|Overall Study||40
8333733|NCT01350271|20542981|P3|NOT COMPLETED|Overall Study||26
8333734|NCT01350271|20542982|P2|NOT COMPLETED|Overall Study||17
8333735|NCT01350271|20542983|P1|NOT COMPLETED|Overall Study||21
8333736|NCT01350271|20542981|P3|COMPLETED|Overall Study||48
8333737|NCT01350271|20542982|P2|COMPLETED|Overall Study||53
8333738|NCT01350271|20542983|P1|COMPLETED|Overall Study||49
8333739|NCT01350271|20542981|P3|STARTED|Overall Study||74
8333740|NCT01350271|20542982|P2|STARTED|Overall Study||70
8333741|NCT01350271|20542983|P1|STARTED|Overall Study||70
8333742|NCT01350258|20542997|P1|NOT COMPLETED|Overall Study||0
8333743|NCT01350258|20542997|P1|COMPLETED|Overall Study||8
8333744|NCT01350258|20542997|P1|STARTED|Overall Study||8
8333745|NCT01350245|20543006|P1|NOT COMPLETED|Overall Study||0
8333746|NCT01350245|20543006|P1|COMPLETED|Overall Study||28
8333747|NCT01350245|20543006|P1|STARTED|Overall Study||28
8333748|NCT01350232|20543011|P1|NOT COMPLETED|Overall Study||0
8333749|NCT01350232|20543011|P1|COMPLETED|Overall Study||2
8333750|NCT01350232|20543011|P1|STARTED|Overall Study||2
8333751|NCT01350141|20543025|P3|NOT COMPLETED|Overall Study||1
8333752|NCT01350141|20543026|P2|NOT COMPLETED|Overall Study||0
8333753|NCT01350141|20543027|P1|NOT COMPLETED|Overall Study||3
8333754|NCT01350141|20543025|P3|COMPLETED|Overall Study||15
8333755|NCT01350141|20543026|P2|COMPLETED|Overall Study||15
8333756|NCT01350141|20543027|P1|COMPLETED|Overall Study||12
8333757|NCT01350141|20543025|P3|Treated|Overall Study||16
8333758|NCT01350141|20543026|P2|Treated|Overall Study||15
8333759|NCT01350141|20543027|P1|Treated|Overall Study||14
8333760|NCT01350141|20543025|P3|STARTED|Overall Study||16
8333761|NCT01350141|20543026|P2|STARTED|Overall Study||15
8333762|NCT01350141|20543027|P1|STARTED|Overall Study||15
8333763|NCT01350128|20543061|P1|NOT COMPLETED|Overall Study||14
8333764|NCT01350128|20543061|P1|COMPLETED|Overall Study||89
8333765|NCT01350128|20543061|P1|Atrovent HFA 34 µg BID|Overall Study||48
8333766|NCT01350128|20543061|P1|Placebo MDI BID|Overall Study||48
8333767|NCT01350128|20543061|P1|GP MDI 4.6 µg BID|Overall Study||45
8333768|NCT01350128|20543061|P1|GP MDI 9 µg BID|Overall Study||49
8333769|NCT01350128|20543061|P1|GP MDI 18 µg BID|Overall Study||49
8333770|NCT01350128|20543061|P1|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
8333771|NCT01350128|20543061|P1|STARTED|Overall Study||103
8333772|NCT01350115|20543125|P2|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
8333773|NCT01350115|20543126|P1|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
8333774|NCT01350115|20543125|P2|COMPLETED|Long Term Follow-Up (All Patients)||0
8333775|NCT01350115|20543126|P1|COMPLETED|Long Term Follow-Up (All Patients)||7
8333776|NCT01350115|20543125|P2|STARTED|Long Term Follow-Up (All Patients)||2
8333777|NCT01350115|20543126|P1|STARTED|Long Term Follow-Up (All Patients)||8
8333778|NCT01350115|20543125|P2|NOT COMPLETED|Core Study (All Patients)||0
8333779|NCT01350115|20543126|P1|NOT COMPLETED|Core Study (All Patients)||0
8333780|NCT01350115|20543125|P2|COMPLETED|Core Study (All Patients)||2
8333781|NCT01350115|20543126|P1|COMPLETED|Core Study (All Patients)||8
8333782|NCT01350115|20543125|P2|Pharmacodynamic Set|Core Study (All Patients)||2
8333783|NCT01350115|20543126|P1|Pharmacodynamic Set|Core Study (All Patients)||7
8333784|NCT01350115|20543125|P2|Safety Anlysis Set|Core Study (All Patients)||2
8333785|NCT01350115|20543126|P1|Safety Anlysis Set|Core Study (All Patients)||8
8333786|NCT01350115|20543125|P2|STARTED|Core Study (All Patients)||2
8333787|NCT01350115|20543126|P1|STARTED|Core Study (All Patients)||8
8333788|NCT01350102|20543142|P4|NOT COMPLETED|Overall Study||0
8333789|NCT01350102|20543143|P3|NOT COMPLETED|Overall Study||1
8333790|NCT01350102|20543144|P2|NOT COMPLETED|Overall Study||0
8333791|NCT01350102|20543145|P1|NOT COMPLETED|Overall Study||0
8333792|NCT01350102|20543142|P4|COMPLETED|Overall Study||0
8333793|NCT01350102|20543143|P3|COMPLETED|Overall Study||0
8333794|NCT01350102|20543144|P2|COMPLETED|Overall Study||1
8333795|NCT01350102|20543145|P1|COMPLETED|Overall Study||0
8333796|NCT01350102|20543142|P4|STARTED|Overall Study||0
8333797|NCT01350102|20543143|P3|STARTED|Overall Study||1
8333798|NCT01350102|20543144|P2|STARTED|Overall Study||1
8333799|NCT01350102|20543145|P1|STARTED|Overall Study||0
8333800|NCT01349972|20543165|P2|NOT COMPLETED|Overall Study||2
8333801|NCT01349972|20543166|P1|NOT COMPLETED|Overall Study||5
8333802|NCT01349972|20543165|P2|COMPLETED|Overall Study||56
8333803|NCT01349972|20543166|P1|COMPLETED|Overall Study||109
8333804|NCT01349972|20543165|P2|STARTED|Overall Study||58
8333805|NCT01349972|20543166|P1|STARTED|Overall Study||114
8333809|NCT01349933|20543193|P1|NOT COMPLETED|Overall Study||0
8333810|NCT01349933|20543193|P1|COMPLETED|Overall Study||21
8333811|NCT01349933|20543193|P1|STARTED|Overall Study||21
8333812|NCT01349920|20543203|P1|NOT COMPLETED|Overall Study||0
8333813|NCT01349920|20543203|P1|COMPLETED|Overall Study||15
8333814|NCT01349920|20543203|P1|STARTED|Overall Study||15
8333821|NCT01349829|20543262|P2|NOT COMPLETED|Overall Study||23
8333822|NCT01349829|20543263|P1|NOT COMPLETED|Overall Study||9
8333823|NCT01349829|20543262|P2|COMPLETED|Overall Study||102
8333824|NCT01349829|20543263|P1|COMPLETED|Overall Study||117
8333825|NCT01349829|20543262|P2|STARTED|Overall Study||125
8333826|NCT01349829|20543263|P1|STARTED|Overall Study||126
8333827|NCT01349816|20543281|P1|NOT COMPLETED|Overall Study||30
8333828|NCT01349816|20543281|P1|COMPLETED|Overall Study||155
8333829|NCT01349816|20543281|P1|FF MDI 9.6 µg|Overall Study||61
8333830|NCT01349816|20543281|P1|GFF MDI 9/9.6 µg|Overall Study||57
8333831|NCT01349816|20543281|P1|GFF MDI 18/9.6 µg|Overall Study||57
8333832|NCT01349816|20543281|P1|GFF MDI 36/9.6 µg|Overall Study||56
8333833|NCT01349816|20543281|P1|GFF MDI 36/7.2 µg|Overall Study||58
8333834|NCT01349816|20543281|P1|GP MDI 36 µg|Overall Study||61
8333835|NCT01349816|20543281|P1|STARTED|Overall Study||185
8333836|NCT01349803|20543347|P4|NOT COMPLETED|Overall Study||2
8333837|NCT01349803|20543348|P3|NOT COMPLETED|Overall Study||3
8333838|NCT01349803|20543349|P2|NOT COMPLETED|Overall Study||1
8333839|NCT01349803|20543350|P1|NOT COMPLETED|Overall Study||1
8333840|NCT01349803|20543347|P4|COMPLETED|Overall Study||57
8333841|NCT01349803|20543348|P3|COMPLETED|Overall Study||57
8333842|NCT01349803|20543349|P2|COMPLETED|Overall Study||57
8333843|NCT01349803|20543350|P1|COMPLETED|Overall Study||59
8333844|NCT01349803|20543347|P4|STARTED|Overall Study||59
8333845|NCT01349803|20543348|P3|STARTED|Overall Study||60
8333846|NCT01349803|20543349|P2|STARTED|Overall Study||58
8333847|NCT01349803|20543350|P1|STARTED|Overall Study||60
8333848|NCT01349790|20543420|P1|NOT COMPLETED|Overall Study||9
8333849|NCT01349790|20543420|P1|COMPLETED|Overall Study||31
8333850|NCT01349790|20543420|P1|STARTED|Overall Study||40
8333851|NCT01349673|20543439|P1|NOT COMPLETED|Overall Study||114
8333852|NCT01349673|20543439|P1|COMPLETED|Overall Study||0
8333853|NCT01349673|20543439|P1|Received At Least 1 Dose Of Study Drug|Overall Study||114
8333854|NCT01349673|20543439|P1|Participants Entered Cycle 8|Overall Study||1
8333855|NCT01349673|20543439|P1|Participants Entered Cycle 7|Overall Study||3
8333856|NCT01349673|20543439|P1|Participants Entered Cycle 6|Overall Study||5
8333857|NCT01349673|20543439|P1|Participants Entered Cycle 5|Overall Study||12
8333858|NCT01349673|20543439|P1|Participants Entered Cycle 4|Overall Study||22
8333859|NCT01349673|20543439|P1|Participants Entered Cycle 3|Overall Study||41
8333860|NCT01349673|20543439|P1|Participants Entered Cycle 2|Overall Study||65
8333861|NCT01349673|20543439|P1|Participants Entered Cycle 1|Overall Study||114
8333862|NCT01349673|20543439|P1|STARTED|Overall Study||114
8333863|NCT01349660|20543449|P3|NOT COMPLETED|Overall Study||76
8333864|NCT01349660|20543450|P2|NOT COMPLETED|Overall Study||6
8333865|NCT01349660|20543451|P1|NOT COMPLETED|Overall Study||6
8333866|NCT01349660|20543449|P3|COMPLETED|Overall Study||0
8333867|NCT01349660|20543450|P2|COMPLETED|Overall Study||0
8333868|NCT01349660|20543451|P1|COMPLETED|Overall Study||0
8333869|NCT01349660|20543449|P3|STARTED|Overall Study||76
8333870|NCT01349660|20543450|P2|STARTED|Overall Study||6
8333871|NCT01349660|20543451|P1|STARTED|Overall Study||6
8333872|NCT01349595|20543469|P2|NOT COMPLETED|Overall Study||2
8333873|NCT01349595|20543470|P1|NOT COMPLETED|Overall Study||2
8333874|NCT01349595|20543469|P2|COMPLETED|Overall Study||0
8333875|NCT01349595|20543470|P1|COMPLETED|Overall Study||0
8333876|NCT01349595|20543469|P2|STARTED|Overall Study||2
8333877|NCT01349595|20543470|P1|STARTED|Overall Study||2
8333878|NCT01349569|20543476|P1|NOT COMPLETED|Overall Study||4
8333879|NCT01349569|20543476|P1|COMPLETED|Overall Study||12
8333880|NCT01349569|20543476|P1|STARTED|Overall Study||16
8333881|NCT01349491|20543488|P2|NOT COMPLETED|Overall Study||0
8333882|NCT01349491|20543489|P1|NOT COMPLETED|Overall Study||0
8333883|NCT01349491|20543488|P2|COMPLETED|Overall Study||5
8333884|NCT01349491|20543489|P1|COMPLETED|Overall Study||5
8333885|NCT01349491|20543488|P2|STARTED|Overall Study||5
8333886|NCT01349491|20543489|P1|STARTED|Overall Study||5
8333887|NCT01349465|20543497|P2|NOT COMPLETED|Overall Study||22
8333888|NCT01349465|20543498|P1|NOT COMPLETED|Overall Study||18
8333889|NCT01349465|20543497|P2|COMPLETED|Overall Study||27
8333890|NCT01349465|20543498|P1|COMPLETED|Overall Study||182
8333891|NCT01349465|20543497|P2|STARTED|Overall Study||49
8333892|NCT01349465|20543498|P1|STARTED|Overall Study||200
8333893|NCT01349231|20543510|P1|NOT COMPLETED|Overall Study||0
8333894|NCT01349231|20543510|P1|COMPLETED|Overall Study||10
8333895|NCT01349231|20543510|P1|STARTED|Overall Study||10
8333896|NCT01349192|20543519|P2|NOT COMPLETED|Overall Study||6
8333897|NCT01349192|20543520|P1|NOT COMPLETED|Overall Study||3
8333898|NCT01349192|20543519|P2|COMPLETED|Overall Study||17
8333899|NCT01349192|20543520|P1|COMPLETED|Overall Study||21
8333900|NCT01349192|20543519|P2|Withdrawals|Overall Study||6
8333901|NCT01349192|20543520|P1|Withdrawals|Overall Study||3
8333902|NCT01349192|20543519|P2|Evaluable for Primary Endpoint|Overall Study||19
8333903|NCT01349192|20543520|P1|Evaluable for Primary Endpoint|Overall Study||22
8333904|NCT01349192|20543519|P2|STARTED|Overall Study||23
8333905|NCT01349192|20543520|P1|STARTED|Overall Study||24
8333906|NCT01349114|20543534|P2|NOT COMPLETED|Overall Study||0
8333907|NCT01349114|20543535|P1|NOT COMPLETED|Overall Study||0
8333908|NCT01349114|20543534|P2|COMPLETED|Overall Study||11
8333909|NCT01349114|20543535|P1|COMPLETED|Overall Study||10
8333910|NCT01349114|20543534|P2|STARTED|Overall Study||11
8333911|NCT01349114|20543535|P1|STARTED|Overall Study||10
8333912|NCT01349049|20543552|P9|NOT COMPLETED|Overall Study||55
8333913|NCT01349049|20543553|P8|NOT COMPLETED|Overall Study||4
8333914|NCT01349049|20543554|P7|NOT COMPLETED|Overall Study||5
8333915|NCT01349049|20543555|P6|NOT COMPLETED|Overall Study||6
8333916|NCT01349049|20543556|P5|NOT COMPLETED|Overall Study||3
8333917|NCT01349049|20543557|P4|NOT COMPLETED|Overall Study||3
8333918|NCT01349049|20543558|P3|NOT COMPLETED|Overall Study||3
8333919|NCT01349049|20543559|P2|NOT COMPLETED|Overall Study||7
8333920|NCT01349049|20543560|P1|NOT COMPLETED|Overall Study||3
8333921|NCT01349049|20543552|P9|COMPLETED|Overall Study||1
8333922|NCT01349049|20543553|P8|COMPLETED|Overall Study||0
8333923|NCT01349049|20543554|P7|COMPLETED|Overall Study||0
8333924|NCT01349049|20543555|P6|COMPLETED|Overall Study||0
8333925|NCT01349049|20543556|P5|COMPLETED|Overall Study||0
8333926|NCT01349049|20543557|P4|COMPLETED|Overall Study||0
8333927|NCT01349049|20543558|P3|COMPLETED|Overall Study||0
8333928|NCT01349049|20543559|P2|COMPLETED|Overall Study||0
8333929|NCT01349049|20543560|P1|COMPLETED|Overall Study||0
8333930|NCT01349049|20543552|P9|STARTED|Overall Study||56
8333931|NCT01349049|20543553|P8|STARTED|Overall Study||4
8333932|NCT01349049|20543554|P7|STARTED|Overall Study||5
8333933|NCT01349049|20543555|P6|STARTED|Overall Study||6
8333934|NCT01349049|20543556|P5|STARTED|Overall Study||3
8333935|NCT01349049|20543557|P4|STARTED|Overall Study||3
8333936|NCT01349049|20543558|P3|STARTED|Overall Study||3
8333937|NCT01349049|20543559|P2|STARTED|Overall Study||7
8333938|NCT01349049|20543560|P1|STARTED|Overall Study||3
8333939|NCT01349036|20543614|P2|NOT COMPLETED|Overall Study||24
8333940|NCT01349036|20543615|P1|NOT COMPLETED|Overall Study||14
8333941|NCT01349036|20543614|P2|COMPLETED|Overall Study||0
8333942|NCT01349036|20543615|P1|COMPLETED|Overall Study||0
8333943|NCT01349036|20543614|P2|STARTED|Overall Study||24
8333944|NCT01349036|20543615|P1|STARTED|Overall Study||14
8333945|NCT01348854|20543633|P2|NOT COMPLETED|Overall Study||1
8333946|NCT01348854|20543634|P1|NOT COMPLETED|Overall Study||3
8333947|NCT01348854|20543633|P2|COMPLETED|Overall Study|9 eyes of 5 participants|5
8333948|NCT01348854|20543634|P1|COMPLETED|Overall Study|47 eyes of 31 participants|31
8333949|NCT01348854|20543633|P2|STARTED|Overall Study|10 eyes of 6 participants|6
8333950|NCT01348854|20543634|P1|STARTED|Overall Study|53 eyes of 34 participants|34
8333951|NCT01348789|20543642|P1|NOT COMPLETED|Overall Study||4
8333952|NCT01348789|20543642|P1|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
8333953|NCT01348789|20543642|P1|STARTED|Overall Study||37
8333954|NCT01348776|20543653|P1|NOT COMPLETED|Overall Study||3
8333955|NCT01348776|20543653|P1|COMPLETED|Overall Study||84
8333956|NCT01348776|20543653|P1|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
8333957|NCT01348763|20543666|P1|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0
8333958|NCT01348763|20543666|P1|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11
8333959|NCT01348763|20543666|P1|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11
8333960|NCT01348763|20543666|P1|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2
8333961|NCT01348763|20543666|P1|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11
8333962|NCT01348763|20543666|P1|STARTED|With Tenofovir/Emtricitabine (10 Days)||13
8333963|NCT01348698|20543671|P1|NOT COMPLETED|Overall Study||72
8333964|NCT01348698|20543671|P1|COMPLETED|Overall Study||2
8333965|NCT01348698|20543671|P1|STARTED|Overall Study||74
8333966|NCT01348607|20543681|P3|NOT COMPLETED|Overall Study||0
8333967|NCT01348607|20543682|P2|NOT COMPLETED|Overall Study||0
8333968|NCT01348607|20543683|P1|NOT COMPLETED|Overall Study||0
8333969|NCT01348607|20543681|P3|COMPLETED|Overall Study||0
8333970|NCT01348607|20543682|P2|COMPLETED|Overall Study||0
8333971|NCT01348607|20543683|P1|COMPLETED|Overall Study||1
8333972|NCT01348607|20543681|P3|STARTED|Overall Study||0
8333973|NCT01348607|20543682|P2|STARTED|Overall Study||0
8333974|NCT01348607|20543683|P1|STARTED|Overall Study||1
8333975|NCT01348542|20543696|P2|NOT COMPLETED|Overall Study||0
8333976|NCT01348542|20543697|P1|NOT COMPLETED|Overall Study||3
8333977|NCT01348542|20543696|P2|COMPLETED|Overall Study||11
8333978|NCT01348542|20543697|P1|COMPLETED|Overall Study||10
8333979|NCT01348542|20543696|P2|STARTED|Overall Study||11
8333980|NCT01348542|20543697|P1|STARTED|Overall Study||13
8333981|NCT01348490|20543713|P1|NOT COMPLETED|Overall Study||24
8333982|NCT01348490|20543713|P1|COMPLETED|Overall Study||42
8333983|NCT01348490|20543713|P1|STARTED|Overall Study||66
8333984|NCT01348425|20543771|P2|NOT COMPLETED|Overall Study||1
8333985|NCT01348425|20543772|P1|NOT COMPLETED|Overall Study||1
8333986|NCT01348425|20543771|P2|COMPLETED|Overall Study||13
8333987|NCT01348425|20543772|P1|COMPLETED|Overall Study||30
8333988|NCT01348425|20543771|P2|STARTED|Overall Study||14
8333989|NCT01348425|20543772|P1|STARTED|Overall Study||31
8333990|NCT01348347|20543780|P3|NOT COMPLETED|Overall Study||6
8333991|NCT01348347|20543781|P2|NOT COMPLETED|Overall Study||6
8333992|NCT01348347|20543782|P1|NOT COMPLETED|Overall Study||3
8333993|NCT01348347|20543780|P3|COMPLETED|Overall Study||0
8333994|NCT01348347|20543781|P2|COMPLETED|Overall Study||0
8333995|NCT01348347|20543782|P1|COMPLETED|Overall Study||0
8333996|NCT01348347|20543780|P3|STARTED|Overall Study||6
8333997|NCT01348347|20543781|P2|STARTED|Overall Study||6
8333998|NCT01348347|20543782|P1|STARTED|Overall Study||3
8333999|NCT01348165|20543813|P7|NOT COMPLETED|Overall Study||1
8334000|NCT01348165|20543814|P6|NOT COMPLETED|Overall Study||0
8334001|NCT01348165|20543815|P5|NOT COMPLETED|Overall Study||0
8334002|NCT01348165|20543816|P4|NOT COMPLETED|Overall Study||0
8334003|NCT01348165|20543817|P3|NOT COMPLETED|Overall Study||0
8334004|NCT01348165|20543818|P2|NOT COMPLETED|Overall Study||0
8334005|NCT01348165|20543819|P1|NOT COMPLETED|Overall Study||0
8334006|NCT01348165|20543813|P7|COMPLETED|Overall Study||5
8334007|NCT01348165|20543814|P6|COMPLETED|Overall Study||1
8334008|NCT01348165|20543815|P5|COMPLETED|Overall Study||6
8334009|NCT01348165|20543816|P4|COMPLETED|Overall Study||6
8334010|NCT01348165|20543817|P3|COMPLETED|Overall Study||6
8334011|NCT01348165|20543818|P2|COMPLETED|Overall Study||5
8334012|NCT01348165|20543819|P1|COMPLETED|Overall Study||10
8334013|NCT01348165|20543813|P7|STARTED|Overall Study||6
8334014|NCT01348165|20543814|P6|STARTED|Overall Study||1
8334015|NCT01348165|20543815|P5|STARTED|Overall Study||6
8334016|NCT01348165|20543816|P4|STARTED|Overall Study||6
8334017|NCT01348165|20543817|P3|STARTED|Overall Study||6
8334018|NCT01348165|20543818|P2|STARTED|Overall Study||5
8334019|NCT01348165|20543819|P1|STARTED|Overall Study||10
8334020|NCT01348139|20543948|P6|NOT COMPLETED|Period 6||0
8334021|NCT01348139|20543949|P5|NOT COMPLETED|Period 6||0
8334022|NCT01348139|20543950|P4|NOT COMPLETED|Period 6||0
8334023|NCT01348139|20543951|P3|NOT COMPLETED|Period 6||0
8334024|NCT01348139|20543952|P2|NOT COMPLETED|Period 6||0
8334025|NCT01348139|20543953|P1|NOT COMPLETED|Period 6||0
8334026|NCT01348139|20543948|P6|COMPLETED|Period 6||4
8334027|NCT01348139|20543949|P5|COMPLETED|Period 6||5
8334028|NCT01348139|20543950|P4|COMPLETED|Period 6||4
8334029|NCT01348139|20543951|P3|COMPLETED|Period 6||4
8334030|NCT01348139|20543952|P2|COMPLETED|Period 6||4
8334031|NCT01348139|20543953|P1|COMPLETED|Period 6||4
8334032|NCT01348139|20543948|P6|STARTED|Period 6||4
8334033|NCT01348139|20543949|P5|STARTED|Period 6||5
8334034|NCT01348139|20543950|P4|STARTED|Period 6||4
8334035|NCT01348139|20543951|P3|STARTED|Period 6||4
8334036|NCT01348139|20543952|P2|STARTED|Period 6||4
8334037|NCT01348139|20543953|P1|STARTED|Period 6||4
8334038|NCT01348139|20543948|P6|NOT COMPLETED|Period 5||0
8334039|NCT01348139|20543949|P5|NOT COMPLETED|Period 5||0
8334040|NCT01348139|20543950|P4|NOT COMPLETED|Period 5||0
8334041|NCT01348139|20543951|P3|NOT COMPLETED|Period 5||0
8334042|NCT01348139|20543952|P2|NOT COMPLETED|Period 5||0
8334043|NCT01348139|20543953|P1|NOT COMPLETED|Period 5||0
8334044|NCT01348139|20543948|P6|COMPLETED|Period 5||4
8334045|NCT01348139|20543949|P5|COMPLETED|Period 5||5
8334046|NCT01348139|20543950|P4|COMPLETED|Period 5||4
8334047|NCT01348139|20543951|P3|COMPLETED|Period 5||4
8334048|NCT01348139|20543952|P2|COMPLETED|Period 5||4
8334049|NCT01348139|20543953|P1|COMPLETED|Period 5||4
8334050|NCT01348139|20543948|P6|STARTED|Period 5||4
8334051|NCT01348139|20543949|P5|STARTED|Period 5||5
8334052|NCT01348139|20543950|P4|STARTED|Period 5||4
8334053|NCT01348139|20543951|P3|STARTED|Period 5||4
8334054|NCT01348139|20543952|P2|STARTED|Period 5||4
8334055|NCT01348139|20543953|P1|STARTED|Period 5||4
8334056|NCT01348139|20543948|P6|NOT COMPLETED|Period 4||0
8334057|NCT01348139|20543949|P5|NOT COMPLETED|Period 4||0
8334058|NCT01348139|20543950|P4|NOT COMPLETED|Period 4||0
8334059|NCT01348139|20543951|P3|NOT COMPLETED|Period 4||0
8334060|NCT01348139|20543952|P2|NOT COMPLETED|Period 4||0
8334061|NCT01348139|20543953|P1|NOT COMPLETED|Period 4||0
8334062|NCT01348139|20543948|P6|COMPLETED|Period 4||4
8334063|NCT01348139|20543949|P5|COMPLETED|Period 4||5
8334064|NCT01348139|20543950|P4|COMPLETED|Period 4||4
8334065|NCT01348139|20543951|P3|COMPLETED|Period 4||4
8334066|NCT01348139|20543952|P2|COMPLETED|Period 4||4
8334067|NCT01348139|20543953|P1|COMPLETED|Period 4||4
8334068|NCT01348139|20543948|P6|STARTED|Period 4||4
8334069|NCT01348139|20543949|P5|STARTED|Period 4||5
8334070|NCT01348139|20543950|P4|STARTED|Period 4||4
8334071|NCT01348139|20543951|P3|STARTED|Period 4||4
8334072|NCT01348139|20543952|P2|STARTED|Period 4||4
8334073|NCT01348139|20543953|P1|STARTED|Period 4||4
8334074|NCT01348139|20543948|P6|NOT COMPLETED|Period 3||0
8334075|NCT01348139|20543949|P5|NOT COMPLETED|Period 3||0
8334076|NCT01348139|20543950|P4|NOT COMPLETED|Period 3||0
8334077|NCT01348139|20543951|P3|NOT COMPLETED|Period 3||0
8334078|NCT01348139|20543952|P2|NOT COMPLETED|Period 3||0
8334079|NCT01348139|20543953|P1|NOT COMPLETED|Period 3||0
8334080|NCT01348139|20543948|P6|COMPLETED|Period 3||4
8334081|NCT01348139|20543949|P5|COMPLETED|Period 3||5
8334082|NCT01348139|20543950|P4|COMPLETED|Period 3||4
8334083|NCT01348139|20543951|P3|COMPLETED|Period 3||4
8334084|NCT01348139|20543952|P2|COMPLETED|Period 3||4
8334085|NCT01348139|20543953|P1|COMPLETED|Period 3||4
8334086|NCT01348139|20543948|P6|STARTED|Period 3||4
8334087|NCT01348139|20543949|P5|STARTED|Period 3||5
8334088|NCT01348139|20543950|P4|STARTED|Period 3||4
8334089|NCT01348139|20543951|P3|STARTED|Period 3||4
8334090|NCT01348139|20543952|P2|STARTED|Period 3||4
8334091|NCT01348139|20543953|P1|STARTED|Period 3||4
8334092|NCT01348139|20543948|P6|NOT COMPLETED|Period 2||0
8334093|NCT01348139|20543949|P5|NOT COMPLETED|Period 2||0
8334094|NCT01348139|20543950|P4|NOT COMPLETED|Period 2||0
8334095|NCT01348139|20543951|P3|NOT COMPLETED|Period 2||0
8334096|NCT01348139|20543952|P2|NOT COMPLETED|Period 2||0
8334097|NCT01348139|20543953|P1|NOT COMPLETED|Period 2||0
8334098|NCT01348139|20543948|P6|COMPLETED|Period 2||4
8334099|NCT01348139|20543949|P5|COMPLETED|Period 2||5
8334100|NCT01348139|20543950|P4|COMPLETED|Period 2||4
8334101|NCT01348139|20543951|P3|COMPLETED|Period 2||4
8334102|NCT01348139|20543952|P2|COMPLETED|Period 2||4
8334103|NCT01348139|20543953|P1|COMPLETED|Period 2||4
8334104|NCT01348139|20543948|P6|STARTED|Period 2||4
8334105|NCT01348139|20543949|P5|STARTED|Period 2||5
8334106|NCT01348139|20543950|P4|STARTED|Period 2||4
8334107|NCT01348139|20543951|P3|STARTED|Period 2||4
8334108|NCT01348139|20543952|P2|STARTED|Period 2||4
8334109|NCT01348139|20543953|P1|STARTED|Period 2||4
8334110|NCT01348139|20543948|P6|NOT COMPLETED|Period 1||0
8334111|NCT01348139|20543949|P5|NOT COMPLETED|Period 1||0
8334112|NCT01348139|20543950|P4|NOT COMPLETED|Period 1||0
8334113|NCT01348139|20543951|P3|NOT COMPLETED|Period 1||0
8334114|NCT01348139|20543952|P2|NOT COMPLETED|Period 1||0
8334115|NCT01348139|20543953|P1|NOT COMPLETED|Period 1||1
8334116|NCT01348139|20543948|P6|COMPLETED|Period 1||4
8334117|NCT01348139|20543949|P5|COMPLETED|Period 1||5
8334118|NCT01348139|20543950|P4|COMPLETED|Period 1||4
8334119|NCT01348139|20543951|P3|COMPLETED|Period 1||4
8334120|NCT01348139|20543952|P2|COMPLETED|Period 1||4
8334121|NCT01348139|20543953|P1|COMPLETED|Period 1||4
8334122|NCT01348139|20543948|P6|STARTED|Period 1||4
8334123|NCT01348139|20543949|P5|STARTED|Period 1||5
8334124|NCT01348139|20543950|P4|STARTED|Period 1||4
8334125|NCT01348139|20543951|P3|STARTED|Period 1||4
8334126|NCT01348139|20543952|P2|STARTED|Period 1||4
8334127|NCT01348139|20543953|P1|STARTED|Period 1||5
8334128|NCT01348100|20544034|P7|NOT COMPLETED|Overall Study||3
8334129|NCT01348100|20544035|P6|NOT COMPLETED|Overall Study||2
8334130|NCT01348100|20544036|P5|NOT COMPLETED|Overall Study||1
8334131|NCT01348100|20544037|P4|NOT COMPLETED|Overall Study||1
8334132|NCT01348100|20544038|P3|NOT COMPLETED|Overall Study||2
8334133|NCT01348100|20544039|P2|NOT COMPLETED|Overall Study||0
8334134|NCT01348100|20544040|P1|NOT COMPLETED|Overall Study||0
8334135|NCT01348100|20544034|P7|COMPLETED|Overall Study||13
8334136|NCT01348100|20544035|P6|COMPLETED|Overall Study||14
8334137|NCT01348100|20544036|P5|COMPLETED|Overall Study||14
8334138|NCT01348100|20544037|P4|COMPLETED|Overall Study||14
8334139|NCT01348100|20544038|P3|COMPLETED|Overall Study||13
8334140|NCT01348100|20544039|P2|COMPLETED|Overall Study||2
8334141|NCT01348100|20544040|P1|COMPLETED|Overall Study||2
8334142|NCT01348100|20544034|P7|STARTED|Overall Study||16
8334143|NCT01348100|20544035|P6|STARTED|Overall Study||16
8334144|NCT01348100|20544036|P5|STARTED|Overall Study||15
8334145|NCT01348100|20544037|P4|STARTED|Overall Study||15
8334146|NCT01348100|20544038|P3|STARTED|Overall Study||15
8334147|NCT01348100|20544039|P2|STARTED|Overall Study||2
8334148|NCT01348100|20544040|P1|STARTED|Overall Study||2
8334149|NCT01348087|20544085|P1|NOT COMPLETED|Overall Study||148
8334150|NCT01348087|20544085|P1|COMPLETED|Overall Study||0
8334151|NCT01348087|20544085|P1|STARTED|Overall Study||148
8334152|NCT01347931|20544099|P1|NOT COMPLETED|NIOV System||0
8334153|NCT01347931|20544099|P1|COMPLETED|NIOV System||29
8334154|NCT01347931|20544099|P1|STARTED|NIOV System||29
8334155|NCT01347931|20544099|P1|NOT COMPLETED|Standard Oxygen Therapy||1
8334156|NCT01347931|20544099|P1|COMPLETED|Standard Oxygen Therapy||29
8334157|NCT01347931|20544099|P1|STARTED|Standard Oxygen Therapy||30
8334158|NCT01347879|20544111|P2|NOT COMPLETED|Overall Study||17
8334159|NCT01347879|20544112|P1|NOT COMPLETED|Overall Study||7
8334160|NCT01347879|20544111|P2|COMPLETED|Overall Study||83
8334161|NCT01347879|20544112|P1|COMPLETED|Overall Study||46
8334162|NCT01347879|20544111|P2|STARTED|Overall Study||100
8334163|NCT01347879|20544112|P1|STARTED|Overall Study||53
8334164|NCT01347866|20544161|P17|NOT COMPLETED|Overall Study||2
8334165|NCT01347866|20544162|P16|NOT COMPLETED|Overall Study||4
8334166|NCT01347866|20544163|P15|NOT COMPLETED|Overall Study||3
8334167|NCT01347866|20544164|P14|NOT COMPLETED|Overall Study||7
8334168|NCT01347866|20544165|P13|NOT COMPLETED|Overall Study||7
8334169|NCT01347866|20544166|P12|NOT COMPLETED|Overall Study||4
8334170|NCT01347866|20544167|P11|NOT COMPLETED|Overall Study||3
8334171|NCT01347866|20544168|P10|NOT COMPLETED|Overall Study||7
8334172|NCT01347866|20544169|P9|NOT COMPLETED|Overall Study||31
8334173|NCT01347866|20544170|P8|NOT COMPLETED|Overall Study||4
8334174|NCT01347866|20544171|P7|NOT COMPLETED|Overall Study||6
8334175|NCT01347866|20544172|P6|NOT COMPLETED|Overall Study||3
8334176|NCT01347866|20544173|P5|NOT COMPLETED|Overall Study||7
8334177|NCT01347866|20544174|P4|NOT COMPLETED|Overall Study||7
8334178|NCT01347866|20544175|P3|NOT COMPLETED|Overall Study||1
8334179|NCT01347866|20544176|P2|NOT COMPLETED|Overall Study||1
8334180|NCT01347866|20544177|P1|NOT COMPLETED|Overall Study||5
8334181|NCT01347866|20544161|P17|COMPLETED|Overall Study||0
8334182|NCT01347866|20544162|P16|COMPLETED|Overall Study||0
8334183|NCT01347866|20544163|P15|COMPLETED|Overall Study||0
8334184|NCT01347866|20544164|P14|COMPLETED|Overall Study||0
8334185|NCT01347866|20544165|P13|COMPLETED|Overall Study||0
8334186|NCT01347866|20544166|P12|COMPLETED|Overall Study||0
8334187|NCT01347866|20544167|P11|COMPLETED|Overall Study||0
8334188|NCT01347866|20544168|P10|COMPLETED|Overall Study||0
8334189|NCT01347866|20544169|P9|COMPLETED|Overall Study||0
8334190|NCT01347866|20544170|P8|COMPLETED|Overall Study||0
8334191|NCT01347866|20544171|P7|COMPLETED|Overall Study||0
8334192|NCT01347866|20544172|P6|COMPLETED|Overall Study||0
8334193|NCT01347866|20544173|P5|COMPLETED|Overall Study||0
8334194|NCT01347866|20544174|P4|COMPLETED|Overall Study||0
8334195|NCT01347866|20544175|P3|COMPLETED|Overall Study||0
8334196|NCT01347866|20544176|P2|COMPLETED|Overall Study||0
8334197|NCT01347866|20544177|P1|COMPLETED|Overall Study||0
8334198|NCT01347866|20544161|P17|STARTED|Overall Study||2
8334199|NCT01347866|20544162|P16|STARTED|Overall Study||4
8334200|NCT01347866|20544163|P15|STARTED|Overall Study||3
8334201|NCT01347866|20544164|P14|STARTED|Overall Study||7
8334202|NCT01347866|20544165|P13|STARTED|Overall Study||7
8334203|NCT01347866|20544166|P12|STARTED|Overall Study||4
8334204|NCT01347866|20544167|P11|STARTED|Overall Study||3
8334205|NCT01347866|20544168|P10|STARTED|Overall Study||7
8334206|NCT01347866|20544169|P9|STARTED|Overall Study||31
8334207|NCT01347866|20544170|P8|STARTED|Overall Study||4
8334208|NCT01347866|20544171|P7|STARTED|Overall Study||6
8334209|NCT01347866|20544172|P6|STARTED|Overall Study||3
8334210|NCT01347866|20544173|P5|STARTED|Overall Study||7
8334211|NCT01347866|20544174|P4|STARTED|Overall Study||7
8334212|NCT01347866|20544175|P3|STARTED|Overall Study||1
8334213|NCT01347866|20544176|P2|STARTED|Overall Study||1
8334214|NCT01347866|20544177|P1|STARTED|Overall Study||5
8334215|NCT01347840|20544551|P1|NOT COMPLETED|Overall Study||1
8334216|NCT01347840|20544551|P1|COMPLETED|Overall Study||0
8334217|NCT01347840|20544551|P1|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
8334218|NCT01347788|20544564|P3|NOT COMPLETED|Overall Study||0
8334219|NCT01347788|20544565|P2|NOT COMPLETED|Overall Study||0
8334220|NCT01347788|20544566|P1|NOT COMPLETED|Overall Study||0
8334221|NCT01347788|20544564|P3|COMPLETED|Overall Study||13
8334222|NCT01347788|20544565|P2|COMPLETED|Overall Study||10
8334223|NCT01347788|20544566|P1|COMPLETED|Overall Study||11
8334224|NCT01347788|20544564|P3|STARTED|Overall Study||13
8334225|NCT01347788|20544565|P2|STARTED|Overall Study||10
8334226|NCT01347788|20544566|P1|STARTED|Overall Study||11
8334227|NCT01347762|20544578|P4|NOT COMPLETED|Overall Study||8
8334228|NCT01347762|20544579|P3|NOT COMPLETED|Overall Study||9
8334229|NCT01347762|20544580|P2|NOT COMPLETED|Overall Study||2
8334230|NCT01347762|20544581|P1|NOT COMPLETED|Overall Study||4
8334231|NCT01347762|20544578|P4|COMPLETED|Overall Study||10
8334232|NCT01347762|20544579|P3|COMPLETED|Overall Study||7
8334233|NCT01347762|20544580|P2|COMPLETED|Overall Study||6
8334234|NCT01347762|20544581|P1|COMPLETED|Overall Study||6
8334235|NCT01347762|20544578|P4|STARTED|Overall Study||18
8334236|NCT01347762|20544579|P3|STARTED|Overall Study||16
8334237|NCT01347762|20544580|P2|STARTED|Overall Study||8
8334238|NCT01347762|20544581|P1|STARTED|Overall Study||10
8334239|NCT01347710|20544607|P1|NOT COMPLETED|Overall Study||31
8334240|NCT01347710|20544607|P1|COMPLETED|Overall Study||764
8334241|NCT01347710|20544607|P1|STARTED|Overall Study||795
8334242|NCT01347632|20544622|P1|NOT COMPLETED|Overall Study||2
8334243|NCT01347632|20544622|P1|COMPLETED|Overall Study||33
8334244|NCT01347632|20544622|P1|STARTED|Overall Study||35
8334245|NCT01347580|20544629|P2|NOT COMPLETED|Overall Study||56
8334246|NCT01347580|20544630|P1|NOT COMPLETED|Overall Study||65
8334247|NCT01347580|20544629|P2|COMPLETED|Overall Study|based on randomized treatment|897
8334248|NCT01347580|20544630|P1|COMPLETED|Overall Study|based on randomized treatment|844
8334249|NCT01347580|20544629|P2|Safety Population|Overall Study|based on actual treatment|950
8334250|NCT01347580|20544630|P1|Safety Population|Overall Study|based on actual treatment|908
8334251|NCT01347580|20544629|P2|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
8334252|NCT01347580|20544630|P1|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
8334253|NCT01347580|20544629|P2|STARTED|Overall Study|based on randomized treatment|953
8334254|NCT01347580|20544630|P1|STARTED|Overall Study|based on randomized treatment|909
8334255|NCT01347554|20544660|P2|NOT COMPLETED|Overall Study||11
8334256|NCT01347554|20544661|P1|NOT COMPLETED|Overall Study||7
8334257|NCT01347554|20544660|P2|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
8334258|NCT01347554|20544661|P1|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
8334259|NCT01347554|20544660|P2|STARTED|Overall Study||242
8334260|NCT01347554|20544661|P1|STARTED|Overall Study||237
8334261|NCT01347333|20544675|P2|NOT COMPLETED|Overall Study||0
8334262|NCT01347333|20544676|P1|NOT COMPLETED|Overall Study||0
8334263|NCT01347333|20544675|P2|COMPLETED|Overall Study||0
8334264|NCT01347333|20544676|P1|COMPLETED|Overall Study||23
8334265|NCT01347333|20544675|P2|STARTED|Overall Study|No participants were enrolled in the Primary Liver Tumor arm.|0
8334266|NCT01347333|20544676|P1|STARTED|Overall Study||23
8334267|NCT01347307|20544686|P2|NOT COMPLETED|Overall Study||5
8334268|NCT01347307|20544687|P1|NOT COMPLETED|Overall Study||0
8334269|NCT01347307|20544686|P2|COMPLETED|Overall Study||28
8334270|NCT01347307|20544687|P1|COMPLETED|Overall Study||3
8334271|NCT01347307|20544686|P2|STARTED|Overall Study||33
8334272|NCT01347307|20544687|P1|STARTED|Overall Study||3
8334273|NCT01347255|20544697|P1|NOT COMPLETED|Overall Study||0
8334274|NCT01347255|20544697|P1|COMPLETED|Overall Study||24
8334275|NCT01347255|20544697|P1|STARTED|Overall Study||24
8334276|NCT01347112|20544722|P2|NOT COMPLETED|Overall Study||12
8334277|NCT01347112|20544723|P1|NOT COMPLETED|Overall Study||4
8334278|NCT01347112|20544722|P2|COMPLETED|Overall Study||5
8334279|NCT01347112|20544723|P1|COMPLETED|Overall Study||12
8334280|NCT01347112|20544722|P2|STARTED|Overall Study||17
8334281|NCT01347112|20544723|P1|STARTED|Overall Study||16
8334282|NCT01347086|20544743|P10|NOT COMPLETED|Overall Study||1
8334283|NCT01347086|20544744|P9|NOT COMPLETED|Overall Study||0
8334284|NCT01347086|20544745|P8|NOT COMPLETED|Overall Study||1
8334285|NCT01347086|20544746|P7|NOT COMPLETED|Overall Study||1
8334286|NCT01347086|20544747|P6|NOT COMPLETED|Overall Study||0
8334287|NCT01347086|20544748|P5|NOT COMPLETED|Overall Study||0
8334288|NCT01347086|20544749|P4|NOT COMPLETED|Overall Study||0
8334289|NCT01347086|20544750|P3|NOT COMPLETED|Overall Study||1
8334290|NCT01347086|20544751|P2|NOT COMPLETED|Overall Study||0
8334291|NCT01347086|20544752|P1|NOT COMPLETED|Overall Study||0
8334292|NCT01347086|20544743|P10|COMPLETED|Overall Study||6
8334293|NCT01347086|20544744|P9|COMPLETED|Overall Study||6
8334294|NCT01347086|20544745|P8|COMPLETED|Overall Study||6
8334295|NCT01347086|20544746|P7|COMPLETED|Overall Study||6
8334296|NCT01347086|20544747|P6|COMPLETED|Overall Study||6
8334297|NCT01347086|20544748|P5|COMPLETED|Overall Study||6
8334298|NCT01347086|20544749|P4|COMPLETED|Overall Study||6
8334299|NCT01347086|20544750|P3|COMPLETED|Overall Study||6
8334300|NCT01347086|20544751|P2|COMPLETED|Overall Study||6
8334301|NCT01347086|20544752|P1|COMPLETED|Overall Study||2
8334302|NCT01347086|20544743|P10|STARTED|Overall Study|One subject was not treated.|7
8334303|NCT01347086|20544744|P9|STARTED|Overall Study||6
8334304|NCT01347086|20544745|P8|STARTED|Overall Study|One subject was not treated.|7
8334305|NCT01347086|20544746|P7|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.
~1 subject was not treated."|7
8334306|NCT01347086|20544747|P6|STARTED|Overall Study||6
8334307|NCT01347086|20544748|P5|STARTED|Overall Study||6
8334308|NCT01347086|20544749|P4|STARTED|Overall Study||6
8334309|NCT01347086|20544750|P3|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.
~1 subject was not treated."|7
8334310|NCT01347086|20544751|P2|STARTED|Overall Study||6
8334311|NCT01347086|20544752|P1|STARTED|Overall Study||2
8334312|NCT01347073|20544851|P1|NOT COMPLETED|Overall Study||2
8334313|NCT01347073|20544851|P1|COMPLETED|Overall Study||21
8334314|NCT01347073|20544851|P1|STARTED|Overall Study||23
8334315|NCT01347060|20544865|P2|NOT COMPLETED|Overall Study||0
8334316|NCT01347060|20544866|P1|NOT COMPLETED|Overall Study||0
8334317|NCT01347060|20544865|P2|COMPLETED|Overall Study||7580
8334318|NCT01347060|20544866|P1|COMPLETED|Overall Study||9868
8334319|NCT01347060|20544865|P2|STARTED|Overall Study||7580
8334320|NCT01347060|20544866|P1|STARTED|Overall Study||9868
8334321|NCT01347034|20544878|P2|NOT COMPLETED|Overall Study||0
8334322|NCT01347034|20544879|P1|NOT COMPLETED|Overall Study||0
8334323|NCT01347034|20544878|P2|COMPLETED|Overall Study||14
8334324|NCT01347034|20544879|P1|COMPLETED|Overall Study||6
8334325|NCT01347034|20544878|P2|STARTED|Overall Study||14
8334326|NCT01347034|20544879|P1|STARTED|Overall Study||6
8334327|NCT01347008|20544889|P2|NOT COMPLETED|Overall Study||0
8334328|NCT01347008|20544890|P1|NOT COMPLETED|Overall Study||0
8334329|NCT01347008|20544889|P2|COMPLETED|Overall Study||20
8334330|NCT01347008|20544890|P1|COMPLETED|Overall Study||21
8334331|NCT01347008|20544889|P2|STARTED|Overall Study||20
8334332|NCT01347008|20544890|P1|STARTED|Overall Study||21
8334333|NCT01346852|20544902|P2|NOT COMPLETED|Overall Study||0
8334334|NCT01346852|20544903|P1|NOT COMPLETED|Overall Study||0
8334335|NCT01346852|20544902|P2|COMPLETED|Overall Study||59684
8334336|NCT01346852|20544903|P1|COMPLETED|Overall Study||41753
8334337|NCT01346852|20544902|P2|STARTED|Overall Study||59684
8334338|NCT01346852|20544903|P1|STARTED|Overall Study||41753
8334339|NCT01346839|20544913|P2|NOT COMPLETED|Overall Study||209
8334340|NCT01346839|20544914|P1|NOT COMPLETED|Overall Study||314
8334341|NCT01346839|20544913|P2|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
8334342|NCT01346839|20544914|P1|COMPLETED|Overall Study||369
8334343|NCT01346839|20544913|P2|STARTED|Overall Study||573
8334344|NCT01346839|20544914|P1|STARTED|Overall Study||683
8334345|NCT01346774|20544930|P2|NOT COMPLETED|Overall Study||17
8334346|NCT01346774|20544931|P1|NOT COMPLETED|Overall Study||13
8334347|NCT01346774|20544930|P2|COMPLETED|Overall Study||63
8334348|NCT01346774|20544931|P1|COMPLETED|Overall Study||67
8334349|NCT01346774|20544930|P2|STARTED|Overall Study||80
8334350|NCT01346774|20544931|P1|STARTED|Overall Study||80
8334351|NCT01346696|20544937|P1|NOT COMPLETED|Overall Study||1
8334352|NCT01346696|20544937|P1|COMPLETED|Overall Study||44
8334353|NCT01346696|20544937|P1|STARTED|Overall Study||45
8334354|NCT01346683|20544948|P1|NOT COMPLETED|Overall Study||0
8334355|NCT01346683|20544948|P1|COMPLETED|Overall Study||45
8334356|NCT01346683|20544948|P1|STARTED|Overall Study||45
8334357|NCT01346592|20544959|P3|NOT COMPLETED|Overall Study||78
8334358|NCT01346592|20544960|P2|NOT COMPLETED|Overall Study||89
8334359|NCT01346592|20544961|P1|NOT COMPLETED|Overall Study||153
8334360|NCT01346592|20544959|P3|COMPLETED|Overall Study||1408
8334361|NCT01346592|20544960|P2|COMPLETED|Overall Study||1389
8334362|NCT01346592|20544961|P1|COMPLETED|Overall Study||2983
8334363|NCT01346592|20544959|P3|STARTED|Overall Study||1486
8334364|NCT01346592|20544960|P2|STARTED|Overall Study||1478
8334365|NCT01346592|20544961|P1|STARTED|Overall Study||3136
8334366|NCT01346540|20545053|P2|NOT COMPLETED|Overall Study||12
8334367|NCT01346540|20545054|P1|NOT COMPLETED|Overall Study||3
8334368|NCT01346540|20545053|P2|COMPLETED|Overall Study||0
8334369|NCT01346540|20545054|P1|COMPLETED|Overall Study||1
8334370|NCT01346540|20545053|P2|STARTED|Overall Study||12
8334371|NCT01346540|20545054|P1|STARTED|Overall Study||4
8334372|NCT01346514|20545065|P2|NOT COMPLETED|Overall Study||37
8334373|NCT01346514|20545066|P1|NOT COMPLETED|Overall Study||29
8334374|NCT01346514|20545065|P2|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
8334375|NCT01346514|20545066|P1|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
8334376|NCT01346514|20545065|P2|12 Month Assessment|Overall Study||53
8334377|NCT01346514|20545066|P1|12 Month Assessment|Overall Study||62
8334378|NCT01346514|20545065|P2|9 Month Assessment|Overall Study||59
8334379|NCT01346514|20545066|P1|9 Month Assessment|Overall Study||67
8334380|NCT01346514|20545065|P2|6 Month Assessment|Overall Study||61
8334381|NCT01346514|20545066|P1|6 Month Assessment|Overall Study||74
8334382|NCT01346514|20545065|P2|3 Month Assessment|Overall Study||68
8334383|NCT01346514|20545066|P1|3 Month Assessment|Overall Study||83
8334384|NCT01346514|20545065|P2|STARTED|Overall Study||90
8334385|NCT01346514|20545066|P1|STARTED|Overall Study||91
8334386|NCT01346501|20545086|P2|NOT COMPLETED|Overall Study||13
8334387|NCT01346501|20545087|P1|NOT COMPLETED|Overall Study||11
8334388|NCT01346501|20545086|P2|COMPLETED|Overall Study||80
8334389|NCT01346501|20545087|P1|COMPLETED|Overall Study||68
8334390|NCT01346501|20545086|P2|STARTED|Overall Study||93
8334391|NCT01346501|20545087|P1|STARTED|Overall Study||79
8334392|NCT01346488|20545100|P1|NOT COMPLETED|Overall Study||706
8334393|NCT01346488|20545100|P1|COMPLETED|Overall Study||1262
8334394|NCT01346488|20545100|P1|STARTED|Overall Study||1968
8334395|NCT01346475|20545120|P2|NOT COMPLETED|Second Intervention||0
8334396|NCT01346475|20545121|P1|NOT COMPLETED|Second Intervention||0
8334397|NCT01346475|20545120|P2|COMPLETED|Second Intervention||25
8334398|NCT01346475|20545121|P1|COMPLETED|Second Intervention||18
8334399|NCT01346475|20545120|P2|STARTED|Second Intervention||25
8334400|NCT01346475|20545121|P1|STARTED|Second Intervention||18
8334401|NCT01346475|20545120|P2|NOT COMPLETED|First Intervention||3
8334402|NCT01346475|20545121|P1|NOT COMPLETED|First Intervention||4
8334403|NCT01346475|20545120|P2|COMPLETED|First Intervention||25
8334404|NCT01346475|20545121|P1|COMPLETED|First Intervention||18
8334405|NCT01346475|20545120|P2|STARTED|First Intervention||28
8334406|NCT01346475|20545121|P1|STARTED|First Intervention||22
8334407|NCT01346410|20545133|P1|NOT COMPLETED|Overall Study||1
8334408|NCT01346410|20545133|P1|COMPLETED|Overall Study||0
8334409|NCT01346410|20545133|P1|STARTED|Overall Study||1
8334410|NCT01346397|20545140|P2|NOT COMPLETED|Overall Study||0
8334411|NCT01346397|20545141|P1|NOT COMPLETED|Overall Study||0
8334412|NCT01346397|20545140|P2|COMPLETED|Overall Study||85
8334413|NCT01346397|20545141|P1|COMPLETED|Overall Study||85
8334414|NCT01346397|20545140|P2|STARTED|Overall Study||85
8334415|NCT01346397|20545141|P1|STARTED|Overall Study||85
8334416|NCT01346371|20545151|P2|NOT COMPLETED|Overall Study||0
8334417|NCT01346371|20545152|P1|NOT COMPLETED|Overall Study||2
8334418|NCT01346371|20545151|P2|COMPLETED|Overall Study||20
8334419|NCT01346371|20545152|P1|COMPLETED|Overall Study||18
8334420|NCT01346371|20545151|P2|STARTED|Overall Study||20
8334421|NCT01346371|20545152|P1|STARTED|Overall Study||20
8334422|NCT01346293|20545160|P2|NOT COMPLETED|Overall Study||21
8334423|NCT01346293|20545161|P1|NOT COMPLETED|Overall Study||67
8334424|NCT01346293|20545160|P2|COMPLETED|Overall Study||608
8334425|NCT01346293|20545161|P1|COMPLETED|Overall Study||2676
8334426|NCT01346293|20545160|P2|STARTED|Overall Study||629
8334427|NCT01346293|20545161|P1|STARTED|Overall Study||2743
8334428|NCT01346189|20545191|P4|NOT COMPLETED|Overall Study||11
8334429|NCT01346189|20545192|P3|NOT COMPLETED|Overall Study||14
8334430|NCT01346189|20545193|P2|NOT COMPLETED|Overall Study||17
8334431|NCT01346189|20545194|P1|NOT COMPLETED|Overall Study||16
8334432|NCT01346189|20545191|P4|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
8334433|NCT01346189|20545192|P3|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
8334434|NCT01346189|20545193|P2|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
8334435|NCT01346189|20545194|P1|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
8334436|NCT01346189|20545191|P4|STARTED|Overall Study||366
8334437|NCT01346189|20545192|P3|STARTED|Overall Study||346
8334438|NCT01346189|20545193|P2|STARTED|Overall Study||358
8334439|NCT01346189|20545194|P1|STARTED|Overall Study||433
8334440|NCT01346176|20545211|P3|NOT COMPLETED|Completed Satisfaction Survey||6
8334441|NCT01346176|20545212|P2|NOT COMPLETED|Completed Satisfaction Survey||4
8334442|NCT01346176|20545213|P1|NOT COMPLETED|Completed Satisfaction Survey||6
8334443|NCT01346176|20545211|P3|COMPLETED|Completed Satisfaction Survey||27
8334444|NCT01346176|20545212|P2|COMPLETED|Completed Satisfaction Survey||22
8334445|NCT01346176|20545213|P1|COMPLETED|Completed Satisfaction Survey||29
8334446|NCT01346176|20545211|P3|STARTED|Completed Satisfaction Survey||33
8334447|NCT01346176|20545212|P2|STARTED|Completed Satisfaction Survey||26
8334448|NCT01346176|20545213|P1|STARTED|Completed Satisfaction Survey||35
8334449|NCT01346176|20545211|P3|NOT COMPLETED|Completed Advance Directive||10
8334450|NCT01346176|20545212|P2|NOT COMPLETED|Completed Advance Directive||14
8334451|NCT01346176|20545213|P1|NOT COMPLETED|Completed Advance Directive||13
8334452|NCT01346176|20545211|P3|COMPLETED|Completed Advance Directive||33
8334453|NCT01346176|20545212|P2|COMPLETED|Completed Advance Directive||26
8334454|NCT01346176|20545213|P1|COMPLETED|Completed Advance Directive||35
8334455|NCT01346176|20545211|P3|STARTED|Completed Advance Directive||43
8334456|NCT01346176|20545212|P2|STARTED|Completed Advance Directive||40
8334457|NCT01346176|20545213|P1|STARTED|Completed Advance Directive||48
8334458|NCT01346176|20545211|P3|NOT COMPLETED|Recruited||0
8334459|NCT01346176|20545212|P2|NOT COMPLETED|Recruited||0
8334460|NCT01346176|20545213|P1|NOT COMPLETED|Recruited||1
8334461|NCT01346176|20545211|P3|COMPLETED|Recruited||43
8334462|NCT01346176|20545212|P2|COMPLETED|Recruited||40
8334463|NCT01346176|20545213|P1|COMPLETED|Recruited||48
8334464|NCT01346176|20545211|P3|STARTED|Recruited||43
8334465|NCT01346176|20545212|P2|STARTED|Recruited||40
8334466|NCT01346176|20545213|P1|STARTED|Recruited||49
8334467|NCT01346085|20545224|P1|NOT COMPLETED|Overall Study||0
8334468|NCT01346085|20545224|P1|COMPLETED|Overall Study||10
8334469|NCT01346085|20545224|P1|STARTED|Overall Study||10
8334470|NCT01346072|20545231|P2|NOT COMPLETED|Overall Study||0
8334471|NCT01346072|20545232|P1|NOT COMPLETED|Overall Study||0
8334472|NCT01346072|20545231|P2|COMPLETED|Overall Study||10
8334473|NCT01346072|20545232|P1|COMPLETED|Overall Study||11
8334474|NCT01346072|20545231|P2|STARTED|Overall Study||10
8334475|NCT01346072|20545232|P1|STARTED|Overall Study||11
8334476|NCT01346059|20545242|P2|NOT COMPLETED|Overall Study||0
8334477|NCT01346059|20545243|P1|NOT COMPLETED|Overall Study||1
8334478|NCT01346059|20545242|P2|COMPLETED|Overall Study||1
8334479|NCT01346059|20545243|P1|COMPLETED|Overall Study||0
8334480|NCT01346059|20545242|P2|STARTED|Overall Study||1
8334481|NCT01346059|20545243|P1|STARTED|Overall Study||1
8334482|NCT01345929|20545255|P2|NOT COMPLETED|Overall Study||19
8334483|NCT01345929|20545256|P1|NOT COMPLETED|Overall Study||21
8334484|NCT01345929|20545255|P2|COMPLETED|Overall Study||516
8334485|NCT01345929|20545256|P1|COMPLETED|Overall Study||512
8334486|NCT01345929|20545255|P2|STARTED|Overall Study||535
8334487|NCT01345929|20545256|P1|STARTED|Overall Study||533
8334488|NCT01345786|20545268|P4|NOT COMPLETED|Overall Study||3
8334489|NCT01345786|20545269|P3|NOT COMPLETED|Overall Study||5
8334490|NCT01345786|20545270|P2|NOT COMPLETED|Overall Study||8
8334491|NCT01345786|20545271|P1|NOT COMPLETED|Overall Study||6
8334492|NCT01345786|20545268|P4|COMPLETED|Overall Study||35
8334493|NCT01345786|20545269|P3|COMPLETED|Overall Study||33
8334494|NCT01345786|20545270|P2|COMPLETED|Overall Study||33
8334495|NCT01345786|20545271|P1|COMPLETED|Overall Study||35
8334496|NCT01345786|20545268|P4|Treated|Overall Study||37
8334497|NCT01345786|20545269|P3|Treated|Overall Study||37
8334498|NCT01345786|20545270|P2|Treated|Overall Study||41
8334499|NCT01345786|20545271|P1|Treated|Overall Study||41
8334500|NCT01345786|20545268|P4|STARTED|Overall Study|Number randomized|38
8334501|NCT01345786|20545269|P3|STARTED|Overall Study|Number randomized|38
8334502|NCT01345786|20545270|P2|STARTED|Overall Study|Number randomized|41
8334503|NCT01345786|20545271|P1|STARTED|Overall Study|Number randomized|41
8334504|NCT01345721|20545320|P3|NOT COMPLETED|Overall Study||0
8334505|NCT01345721|20545321|P2|NOT COMPLETED|Overall Study||0
8334506|NCT01345721|20545322|P1|NOT COMPLETED|Overall Study||0
8334507|NCT01345721|20545320|P3|COMPLETED|Overall Study||65
8334508|NCT01345721|20545321|P2|COMPLETED|Overall Study||66
8334509|NCT01345721|20545322|P1|COMPLETED|Overall Study||74
8334510|NCT01345721|20545320|P3|STARTED|Overall Study||65
8334511|NCT01345721|20545321|P2|STARTED|Overall Study||66
8334512|NCT01345721|20545322|P1|STARTED|Overall Study||74
8334513|NCT01345682|20545351|P2|NOT COMPLETED|Overall Study||161
8334514|NCT01345682|20545352|P1|NOT COMPLETED|Overall Study||322
8334515|NCT01345682|20545351|P2|COMPLETED|Overall Study||0
8334516|NCT01345682|20545352|P1|COMPLETED|Overall Study||0
8334517|NCT01345682|20545351|P2|STARTED|Overall Study|Randomised|161
8334518|NCT01345682|20545352|P1|STARTED|Overall Study|Randomised|322
8334519|NCT01345669|20545386|P2|NOT COMPLETED|Overall Study||119
8334520|NCT01345669|20545387|P1|NOT COMPLETED|Overall Study||287
8334521|NCT01345669|20545386|P2|COMPLETED|Overall Study||87
8334522|NCT01345669|20545387|P1|COMPLETED|Overall Study||124
8334523|NCT01345669|20545386|P2|STARTED|Overall Study||206
8334524|NCT01345669|20545387|P1|STARTED|Overall Study||411
8334525|NCT01345630|20545405|P2|NOT COMPLETED|Overall Study||359
8334526|NCT01345630|20545406|P1|NOT COMPLETED|Overall Study||361
8334527|NCT01345630|20545405|P2|COMPLETED|Overall Study||42
8334528|NCT01345630|20545406|P1|COMPLETED|Overall Study||35
8334529|NCT01345630|20545405|P2|STARTED|Overall Study||401
8334530|NCT01345630|20545406|P1|STARTED|Overall Study||396
8334531|NCT01345591|20545462|P1|NOT COMPLETED|Overall Study||1
8334532|NCT01345591|20545462|P1|COMPLETED|Overall Study||19
8334533|NCT01345591|20545462|P1|STARTED|Overall Study||20
8334534|NCT01345513|20545471|P1|NOT COMPLETED|Overall Study||0
8334535|NCT01345513|20545471|P1|COMPLETED|Overall Study||50
8334536|NCT01345513|20545471|P1|STARTED|Overall Study||50
8334537|NCT01345318|20545478|P1|NOT COMPLETED|Overall Study||80
8334538|NCT01345318|20545478|P1|COMPLETED|Overall Study||111
8334539|NCT01345318|20545478|P1|STARTED|Overall Study||191
8334540|NCT01345292|20545486|P3|NOT COMPLETED|Overall Study||1
8334541|NCT01345292|20545487|P2|NOT COMPLETED|Overall Study||0
8334542|NCT01345292|20545488|P1|NOT COMPLETED|Overall Study||2
8334543|NCT01345292|20545486|P3|COMPLETED|Overall Study||74
8334544|NCT01345292|20545487|P2|COMPLETED|Overall Study||76
8334545|NCT01345292|20545488|P1|COMPLETED|Overall Study||73
8334546|NCT01345292|20545486|P3|STARTED|Overall Study||75
8334547|NCT01345292|20545487|P2|STARTED|Overall Study||76
8334548|NCT01345292|20545488|P1|STARTED|Overall Study||75
8334549|NCT01345253|20545519|P2|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144
8334550|NCT01345253|20545520|P1|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65
8334551|NCT01345253|20545519|P2|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146
8334552|NCT01345253|20545520|P1|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69
8334553|NCT01345253|20545519|P2|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290
8334554|NCT01345253|20545520|P1|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134
8334555|NCT01345253|20545519|P2|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79
8334556|NCT01345253|20545520|P1|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56
8334557|NCT01345253|20545519|P2|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372
8334558|NCT01345253|20545520|P1|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170
8334559|NCT01345253|20545519|P2|STARTED|Double-blind (DB) Phase (52 Weeks)||451
8334560|NCT01345253|20545520|P1|STARTED|Double-blind (DB) Phase (52 Weeks)||226
8334561|NCT01345240|20545541|P5|NOT COMPLETED|Overall Study||10
8334562|NCT01345240|20545542|P4|NOT COMPLETED|Overall Study||9
8334563|NCT01345240|20545543|P3|NOT COMPLETED|Overall Study||18
8334564|NCT01345240|20545544|P2|NOT COMPLETED|Overall Study||14
8334565|NCT01345240|20545545|P1|NOT COMPLETED|Overall Study||11
8334566|NCT01345240|20545541|P5|COMPLETED|Overall Study||129
8334567|NCT01345240|20545542|P4|COMPLETED|Overall Study||132
8334568|NCT01345240|20545543|P3|COMPLETED|Overall Study||123
8334569|NCT01345240|20545544|P2|COMPLETED|Overall Study||128
8334570|NCT01345240|20545545|P1|COMPLETED|Overall Study||131
8334571|NCT01345240|20545541|P5|STARTED|Overall Study||139
8334572|NCT01345240|20545542|P4|STARTED|Overall Study||141
8334573|NCT01345240|20545543|P3|STARTED|Overall Study||141
8334574|NCT01345240|20545544|P2|STARTED|Overall Study||142
8334575|NCT01345240|20545545|P1|STARTED|Overall Study||142
8334576|NCT01345188|20545665|P1|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
8334577|NCT01345188|20545665|P1|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
8334578|NCT01345188|20545665|P1|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
8334579|NCT01345188|20545665|P1|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
8334580|NCT01345188|20545665|P1|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
8334581|NCT01345188|20545665|P1|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
8334582|NCT01345162|20545677|P2|NOT COMPLETED|Overall Study||4
8334583|NCT01345162|20545678|P1|NOT COMPLETED|Overall Study||2
8334584|NCT01345162|20545677|P2|COMPLETED|Overall Study||96
8334585|NCT01345162|20545678|P1|COMPLETED|Overall Study||98
8334586|NCT01345162|20545677|P2|STARTED|Overall Study||100
8334587|NCT01345162|20545678|P1|STARTED|Overall Study||100
8334588|NCT01345123|20545687|P3|NOT COMPLETED|Overall Study||88
8334589|NCT01345123|20545688|P2|NOT COMPLETED|Overall Study||85
8334590|NCT01345123|20545689|P1|NOT COMPLETED|Overall Study||79
8334591|NCT01345123|20545687|P3|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
8334592|NCT01345123|20545688|P2|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
8334593|NCT01345123|20545689|P1|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
8334594|NCT01345123|20545687|P3|STARTED|Overall Study||3291
8334595|NCT01345123|20545688|P2|STARTED|Overall Study||3311
8334596|NCT01345123|20545689|P1|STARTED|Overall Study||3323
8334597|NCT01345058|20545711|P2|NOT COMPLETED|Overall Study||0
8334598|NCT01345058|20545712|P1|NOT COMPLETED|Overall Study||5
8334599|NCT01345058|20545711|P2|COMPLETED|Overall Study||36
8334600|NCT01345058|20545712|P1|COMPLETED|Overall Study||15
8334601|NCT01345058|20545711|P2|Received Lacosamide|Overall Study||0
8334602|NCT01345058|20545712|P1|Received Lacosamide|Overall Study||19
8334603|NCT01345058|20545711|P2|STARTED|Overall Study||36
8334604|NCT01345058|20545712|P1|STARTED|Overall Study||20
8334605|NCT01345019|20545728|P2|NOT COMPLETED|Open Label Treatment Phase||193
8334606|NCT01345019|20545729|P1|NOT COMPLETED|Open Label Treatment Phase||191
8334607|NCT01345019|20545728|P2|COMPLETED|Open Label Treatment Phase||233
8334608|NCT01345019|20545729|P1|COMPLETED|Open Label Treatment Phase||227
8334609|NCT01345019|20545728|P2|STARTED|Open Label Treatment Phase||426
8334610|NCT01345019|20545729|P1|STARTED|Open Label Treatment Phase||418
8334611|NCT01345019|20545728|P2|NOT COMPLETED|Blinded Treatment Phase||304
8334612|NCT01345019|20545729|P1|NOT COMPLETED|Blinded Treatment Phase||318
8334613|NCT01345019|20545728|P2|COMPLETED|Blinded Treatment Phase||555
8334614|NCT01345019|20545729|P1|COMPLETED|Blinded Treatment Phase||541
8334615|NCT01345019|20545728|P2|Received Treatment|Blinded Treatment Phase||850
8334616|NCT01345019|20545729|P1|Received Treatment|Blinded Treatment Phase||852
8334617|NCT01345019|20545728|P2|STARTED|Blinded Treatment Phase||859
8334618|NCT01345019|20545729|P1|STARTED|Blinded Treatment Phase||859
8334619|NCT01344876|20545751|P5|NOT COMPLETED|Overall Study||1
8334620|NCT01344876|20545752|P4|NOT COMPLETED|Overall Study||3
8334621|NCT01344876|20545753|P3|NOT COMPLETED|Overall Study||1
8334622|NCT01344876|20545754|P2|NOT COMPLETED|Overall Study||0
8334623|NCT01344876|20545755|P1|NOT COMPLETED|Overall Study||1
8334624|NCT01344876|20545751|P5|COMPLETED|Overall Study||2
8334625|NCT01344876|20545752|P4|COMPLETED|Overall Study||3
8334626|NCT01344876|20545753|P3|COMPLETED|Overall Study||3
8334627|NCT01344876|20545754|P2|COMPLETED|Overall Study||3
8334628|NCT01344876|20545755|P1|COMPLETED|Overall Study||3
8334629|NCT01344876|20545751|P5|STARTED|Overall Study||3
8334630|NCT01344876|20545752|P4|STARTED|Overall Study||6
8334631|NCT01344876|20545753|P3|STARTED|Overall Study||4
8334632|NCT01344876|20545754|P2|STARTED|Overall Study||3
8334633|NCT01344876|20545755|P1|STARTED|Overall Study||4
8334634|NCT01344824|20545769|P1|NOT COMPLETED|Overall Study||37
8334635|NCT01344824|20545769|P1|COMPLETED|Overall Study||1
8334636|NCT01344824|20545769|P1|STARTED|Overall Study||38
8334637|NCT01344759|20545777|P2|NOT COMPLETED|Overall Study||2
8334638|NCT01344759|20545778|P1|NOT COMPLETED|Overall Study||0
8334639|NCT01344759|20545777|P2|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
8334640|NCT01344759|20545778|P1|COMPLETED|Overall Study||30
8334641|NCT01344759|20545777|P2|STARTED|Overall Study||30
8334642|NCT01344759|20545778|P1|STARTED|Overall Study||30
8334643|NCT01344629|20545810|P2|NOT COMPLETED|Crossover Period 4||0
8334644|NCT01344629|20545811|P1|NOT COMPLETED|Crossover Period 4||0
8334645|NCT01344629|20545810|P2|COMPLETED|Crossover Period 4||31
8334646|NCT01344629|20545811|P1|COMPLETED|Crossover Period 4||32
8334647|NCT01344629|20545810|P2|STARTED|Crossover Period 4||31
8334648|NCT01344629|20545811|P1|STARTED|Crossover Period 4||32
8334649|NCT01344629|20545810|P2|NOT COMPLETED|Crossover Period 3||0
8334650|NCT01344629|20545811|P1|NOT COMPLETED|Crossover Period 3||0
8334651|NCT01344629|20545810|P2|COMPLETED|Crossover Period 3||31
8334652|NCT01344629|20545811|P1|COMPLETED|Crossover Period 3||32
8334653|NCT01344629|20545810|P2|STARTED|Crossover Period 3||31
8334654|NCT01344629|20545811|P1|STARTED|Crossover Period 3||32
8334655|NCT01344629|20545810|P2|NOT COMPLETED|Crossover Period 2||1
8334656|NCT01344629|20545811|P1|NOT COMPLETED|Crossover Period 2||0
8334657|NCT01344629|20545810|P2|COMPLETED|Crossover Period 2||31
8334658|NCT01344629|20545811|P1|COMPLETED|Crossover Period 2||32
8334659|NCT01344629|20545810|P2|STARTED|Crossover Period 2||32
8334660|NCT01344629|20545811|P1|STARTED|Crossover Period 2||32
8334661|NCT01344629|20545810|P2|NOT COMPLETED|Crossover Period 1||0
8334662|NCT01344629|20545811|P1|NOT COMPLETED|Crossover Period 1||0
8334663|NCT01344629|20545810|P2|COMPLETED|Crossover Period 1||32
8334664|NCT01344629|20545811|P1|COMPLETED|Crossover Period 1||32
8334665|NCT01344629|20545810|P2|STARTED|Crossover Period 1||32
8334666|NCT01344629|20545811|P1|STARTED|Crossover Period 1||32
8334667|NCT01344616|20545831|P2|NOT COMPLETED|Overall Study||44
8334668|NCT01344616|20545832|P1|NOT COMPLETED|Overall Study||35
8334669|NCT01344616|20545831|P2|COMPLETED|Overall Study||194
8334670|NCT01344616|20545832|P1|COMPLETED|Overall Study||209
8334671|NCT01344616|20545831|P2|STARTED|Overall Study||238
8334672|NCT01344616|20545832|P1|STARTED|Overall Study||244
8334673|NCT01344538|20545840|P2|NOT COMPLETED|Overall Study||1
8334674|NCT01344538|20545841|P1|NOT COMPLETED|Overall Study||2
8334675|NCT01344538|20545840|P2|COMPLETED|Overall Study||16
8334676|NCT01344538|20545841|P1|COMPLETED|Overall Study||14
8334677|NCT01344538|20545840|P2|STARTED|Overall Study||17
8334678|NCT01344538|20545841|P1|STARTED|Overall Study||16
8334679|NCT01344460|20545847|P1|NOT COMPLETED|Overall Study||3
8334680|NCT01344460|20545847|P1|COMPLETED|Overall Study||312
8334681|NCT01344460|20545847|P1|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
8334682|NCT01344460|20545847|P1|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
8334683|NCT01344447|20545892|P1|NOT COMPLETED|Overall Study||8
8334684|NCT01344447|20545892|P1|COMPLETED|Overall Study||471
8334685|NCT01344447|20545892|P1|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
8334686|NCT01344447|20545892|P1|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
8334687|NCT01344369|20545936|P2|NOT COMPLETED|Second Intervention||1
8334688|NCT01344369|20545937|P1|NOT COMPLETED|Second Intervention||0
8334689|NCT01344369|20545936|P2|COMPLETED|Second Intervention||16
8334690|NCT01344369|20545937|P1|COMPLETED|Second Intervention||17
8334691|NCT01344369|20545936|P2|STARTED|Second Intervention||17
8334692|NCT01344369|20545937|P1|STARTED|Second Intervention||17
8334693|NCT01344369|20545936|P2|NOT COMPLETED|Washout of 28 Days||1
8334694|NCT01344369|20545937|P1|NOT COMPLETED|Washout of 28 Days||1
8334695|NCT01344369|20545936|P2|COMPLETED|Washout of 28 Days||17
8334696|NCT01344369|20545937|P1|COMPLETED|Washout of 28 Days||17
8334697|NCT01344369|20545936|P2|STARTED|Washout of 28 Days||18
8334698|NCT01344369|20545937|P1|STARTED|Washout of 28 Days||18
8334699|NCT01344369|20545936|P2|NOT COMPLETED|First Intervention||0
8334700|NCT01344369|20545937|P1|NOT COMPLETED|First Intervention||0
8334701|NCT01344369|20545936|P2|COMPLETED|First Intervention||18
8334702|NCT01344369|20545937|P1|COMPLETED|First Intervention||18
8334703|NCT01344369|20545936|P2|STARTED|First Intervention||18
8334704|NCT01344369|20545937|P1|STARTED|First Intervention||18
8334705|NCT01344356|20545955|P2|NOT COMPLETED|Overall Study||9
8334706|NCT01344356|20545956|P1|NOT COMPLETED|Overall Study||0
8334707|NCT01344356|20545955|P2|COMPLETED|Overall Study||9
8334708|NCT01344356|20545956|P1|COMPLETED|Overall Study||1
8334709|NCT01344356|20545955|P2|STARTED|Overall Study||18
8334710|NCT01344356|20545956|P1|STARTED|Overall Study||1
8334711|NCT01344226|20545968|P1|NOT COMPLETED|Overall Study||8
8334712|NCT01344226|20545968|P1|COMPLETED|Overall Study||41
8334713|NCT01344226|20545968|P1|STARTED|Overall Study||49
8334714|NCT01344161|20545977|P2|NOT COMPLETED|Overall Study||3
8334715|NCT01344161|20545978|P1|NOT COMPLETED|Overall Study||5
8334716|NCT01344161|20545977|P2|COMPLETED|Overall Study||39
8334717|NCT01344161|20545978|P1|COMPLETED|Overall Study||38
8334718|NCT01344161|20545977|P2|STARTED|Overall Study||42
8334719|NCT01344161|20545978|P1|STARTED|Overall Study||43
8334720|NCT01344057|20545990|P1|NOT COMPLETED|Overall Study||1
8334721|NCT01344057|20545990|P1|COMPLETED|Overall Study||62
8334722|NCT01344057|20545990|P1|STARTED|Overall Study||63
8334723|NCT01343901|20545997|P1|NOT COMPLETED|Overall Study||113
8334724|NCT01343901|20545997|P1|COMPLETED|Overall Study||97
8334725|NCT01343901|20545997|P1|Efficacy Population|Overall Study||205
8334726|NCT01343901|20545997|P1|STARTED|Overall Study||210
8334727|NCT01343888|20546021|P3|NOT COMPLETED|Overall Study||22
8334728|NCT01343888|20546022|P2|NOT COMPLETED|Overall Study||39
8334729|NCT01343888|20546023|P1|NOT COMPLETED|Overall Study||25
8334730|NCT01343888|20546021|P3|COMPLETED|Overall Study||110
8334731|NCT01343888|20546022|P2|COMPLETED|Overall Study||222
8334732|NCT01343888|20546023|P1|COMPLETED|Overall Study||234
8334733|NCT01343888|20546021|P3|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
8334734|NCT01343888|20546022|P2|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
8334735|NCT01343888|20546023|P1|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
8334748|NCT01343693|20546082|P1|NOT COMPLETED|Overall Study||9
8334749|NCT01343693|20546082|P1|COMPLETED|Overall Study||110
8334750|NCT01343693|20546082|P1|STARTED|Overall Study||119
8334751|NCT01343667|20546089|P2|NOT COMPLETED|Overall Study||56
8334752|NCT01343667|20546090|P1|NOT COMPLETED|Overall Study||12
8334753|NCT01343667|20546089|P2|COMPLETED|Overall Study||916
8334754|NCT01343667|20546090|P1|COMPLETED|Overall Study||413
8334755|NCT01343667|20546089|P2|STARTED|Overall Study||972
8334756|NCT01343667|20546090|P1|STARTED|Overall Study||425
8334757|NCT01343485|20546098|P2|NOT COMPLETED|Overall Study||134
8334758|NCT01343485|20546099|P1|NOT COMPLETED|Overall Study||149
8334759|NCT01343485|20546098|P2|COMPLETED|Overall Study||46
8334760|NCT01343485|20546099|P1|COMPLETED|Overall Study||36
8334761|NCT01343485|20546098|P2|STARTED|Overall Study||180
8334762|NCT01343485|20546099|P1|STARTED|Overall Study||185
8334763|NCT01343407|20546105|P6|NOT COMPLETED|Third Treatment Period (Part 2)||0
8334764|NCT01343407|20546106|P5|NOT COMPLETED|Third Treatment Period (Part 2)||0
8334765|NCT01343407|20546107|P4|NOT COMPLETED|Third Treatment Period (Part 2)||0
8334766|NCT01343407|20546108|P3|NOT COMPLETED|Third Treatment Period (Part 2)||0
8334767|NCT01343407|20546109|P2|NOT COMPLETED|Third Treatment Period (Part 2)||0
8334768|NCT01343407|20546110|P1|NOT COMPLETED|Third Treatment Period (Part 2)||0
8334769|NCT01343407|20546105|P6|COMPLETED|Third Treatment Period (Part 2)||3
8334770|NCT01343407|20546106|P5|COMPLETED|Third Treatment Period (Part 2)||3
8334771|NCT01343407|20546107|P4|COMPLETED|Third Treatment Period (Part 2)||3
8334772|NCT01343407|20546108|P3|COMPLETED|Third Treatment Period (Part 2)||1
8334773|NCT01343407|20546109|P2|COMPLETED|Third Treatment Period (Part 2)||2
8334774|NCT01343407|20546110|P1|COMPLETED|Third Treatment Period (Part 2)||2
8334775|NCT01343407|20546105|P6|STARTED|Third Treatment Period (Part 2)||3
8334776|NCT01343407|20546106|P5|STARTED|Third Treatment Period (Part 2)||3
8334777|NCT01343407|20546107|P4|STARTED|Third Treatment Period (Part 2)||3
8334778|NCT01343407|20546108|P3|STARTED|Third Treatment Period (Part 2)||1
8334779|NCT01343407|20546109|P2|STARTED|Third Treatment Period (Part 2)||2
8334780|NCT01343407|20546110|P1|STARTED|Third Treatment Period (Part 2)||2
8334781|NCT01343407|20546105|P6|NOT COMPLETED|Second Washout (Part 2)||0
8334782|NCT01343407|20546106|P5|NOT COMPLETED|Second Washout (Part 2)||0
8334783|NCT01343407|20546107|P4|NOT COMPLETED|Second Washout (Part 2)||0
8334784|NCT01343407|20546108|P3|NOT COMPLETED|Second Washout (Part 2)||1
8334785|NCT01343407|20546109|P2|NOT COMPLETED|Second Washout (Part 2)||0
8334786|NCT01343407|20546110|P1|NOT COMPLETED|Second Washout (Part 2)||0
8334787|NCT01343407|20546105|P6|COMPLETED|Second Washout (Part 2)||3
8334788|NCT01343407|20546106|P5|COMPLETED|Second Washout (Part 2)||3
8334789|NCT01343407|20546107|P4|COMPLETED|Second Washout (Part 2)||3
8334790|NCT01343407|20546108|P3|COMPLETED|Second Washout (Part 2)||1
8334791|NCT01343407|20546109|P2|COMPLETED|Second Washout (Part 2)||2
8334792|NCT01343407|20546110|P1|COMPLETED|Second Washout (Part 2)||2
8334793|NCT01343407|20546105|P6|STARTED|Second Washout (Part 2)||3
8334794|NCT01343407|20546106|P5|STARTED|Second Washout (Part 2)||3
8334795|NCT01343407|20546107|P4|STARTED|Second Washout (Part 2)||3
8334796|NCT01343407|20546108|P3|STARTED|Second Washout (Part 2)||2
8334797|NCT01343407|20546109|P2|STARTED|Second Washout (Part 2)||2
8334798|NCT01343407|20546110|P1|STARTED|Second Washout (Part 2)||2
8334799|NCT01343407|20546105|P6|NOT COMPLETED|Second Treatment Period (Part 2)||0
8334800|NCT01343407|20546106|P5|NOT COMPLETED|Second Treatment Period (Part 2)||0
8334801|NCT01343407|20546107|P4|NOT COMPLETED|Second Treatment Period (Part 2)||0
8334802|NCT01343407|20546108|P3|NOT COMPLETED|Second Treatment Period (Part 2)||1
8334803|NCT01343407|20546109|P2|NOT COMPLETED|Second Treatment Period (Part 2)||0
8334804|NCT01343407|20546110|P1|NOT COMPLETED|Second Treatment Period (Part 2)||0
8334805|NCT01343407|20546105|P6|COMPLETED|Second Treatment Period (Part 2)||3
8334806|NCT01343407|20546106|P5|COMPLETED|Second Treatment Period (Part 2)||3
8334807|NCT01343407|20546107|P4|COMPLETED|Second Treatment Period (Part 2)||3
8334808|NCT01343407|20546108|P3|COMPLETED|Second Treatment Period (Part 2)||2
8334809|NCT01343407|20546109|P2|COMPLETED|Second Treatment Period (Part 2)||2
8334810|NCT01343407|20546110|P1|COMPLETED|Second Treatment Period (Part 2)||2
8334811|NCT01343407|20546105|P6|STARTED|Second Treatment Period (Part 2)||3
8334812|NCT01343407|20546106|P5|STARTED|Second Treatment Period (Part 2)||3
8334813|NCT01343407|20546107|P4|STARTED|Second Treatment Period (Part 2)||3
8334814|NCT01343407|20546108|P3|STARTED|Second Treatment Period (Part 2)||3
8334815|NCT01343407|20546109|P2|STARTED|Second Treatment Period (Part 2)||2
8334816|NCT01343407|20546110|P1|STARTED|Second Treatment Period (Part 2)||2
8334817|NCT01343407|20546105|P6|NOT COMPLETED|First Washout (Part 2)||0
8334818|NCT01343407|20546106|P5|NOT COMPLETED|First Washout (Part 2)||0
8334819|NCT01343407|20546107|P4|NOT COMPLETED|First Washout (Part 2)||0
8334820|NCT01343407|20546108|P3|NOT COMPLETED|First Washout (Part 2)||0
8334821|NCT01343407|20546109|P2|NOT COMPLETED|First Washout (Part 2)||0
8334822|NCT01343407|20546110|P1|NOT COMPLETED|First Washout (Part 2)||0
8334823|NCT01343407|20546105|P6|COMPLETED|First Washout (Part 2)||3
8334824|NCT01343407|20546106|P5|COMPLETED|First Washout (Part 2)||3
8334825|NCT01343407|20546107|P4|COMPLETED|First Washout (Part 2)||3
8334826|NCT01343407|20546108|P3|COMPLETED|First Washout (Part 2)||3
8334827|NCT01343407|20546109|P2|COMPLETED|First Washout (Part 2)||2
8334828|NCT01343407|20546110|P1|COMPLETED|First Washout (Part 2)||2
8334829|NCT01343407|20546105|P6|STARTED|First Washout (Part 2)||3
8334830|NCT01343407|20546106|P5|STARTED|First Washout (Part 2)||3
8334831|NCT01343407|20546107|P4|STARTED|First Washout (Part 2)||3
8334832|NCT01343407|20546108|P3|STARTED|First Washout (Part 2)||3
8334833|NCT01343407|20546109|P2|STARTED|First Washout (Part 2)||2
8334834|NCT01343407|20546110|P1|STARTED|First Washout (Part 2)||2
8334835|NCT01343407|20546105|P6|NOT COMPLETED|First Treatment Period (Part 2)||0
8334836|NCT01343407|20546106|P5|NOT COMPLETED|First Treatment Period (Part 2)||0
8334837|NCT01343407|20546107|P4|NOT COMPLETED|First Treatment Period (Part 2)||0
8334838|NCT01343407|20546108|P3|NOT COMPLETED|First Treatment Period (Part 2)||0
8334839|NCT01343407|20546109|P2|NOT COMPLETED|First Treatment Period (Part 2)||0
8334840|NCT01343407|20546110|P1|NOT COMPLETED|First Treatment Period (Part 2)||0
8334841|NCT01343407|20546105|P6|COMPLETED|First Treatment Period (Part 2)||3
8334842|NCT01343407|20546106|P5|COMPLETED|First Treatment Period (Part 2)||3
8334843|NCT01343407|20546107|P4|COMPLETED|First Treatment Period (Part 2)||3
8334844|NCT01343407|20546108|P3|COMPLETED|First Treatment Period (Part 2)||3
8334845|NCT01343407|20546109|P2|COMPLETED|First Treatment Period (Part 2)||2
8334846|NCT01343407|20546110|P1|COMPLETED|First Treatment Period (Part 2)||2
8334847|NCT01343407|20546105|P6|STARTED|First Treatment Period (Part 2)||3
8334848|NCT01343407|20546106|P5|STARTED|First Treatment Period (Part 2)||3
8334849|NCT01343407|20546107|P4|STARTED|First Treatment Period (Part 2)||3
8334850|NCT01343407|20546108|P3|STARTED|First Treatment Period (Part 2)||3
8334851|NCT01343407|20546109|P2|STARTED|First Treatment Period (Part 2)||2
8334852|NCT01343407|20546110|P1|STARTED|First Treatment Period (Part 2)||2
8334853|NCT01343368|20546138|P2|NOT COMPLETED|Overall Study||0
8334854|NCT01343368|20546139|P1|NOT COMPLETED|Overall Study||2
8334855|NCT01343368|20546138|P2|COMPLETED|Overall Study||10
8334856|NCT01343368|20546139|P1|COMPLETED|Overall Study||7
8334857|NCT01343368|20546138|P2|STARTED|Overall Study||10
8334858|NCT01343368|20546139|P1|STARTED|Overall Study||9
8334859|NCT01343277|20546175|P2|NOT COMPLETED|Overall Study||193
8334860|NCT01343277|20546176|P1|NOT COMPLETED|Overall Study||384
8334861|NCT01343277|20546175|P2|COMPLETED|Overall Study||0
8334862|NCT01343277|20546176|P1|COMPLETED|Overall Study||0
8334863|NCT01343277|20546175|P2|Treated|Overall Study||172
8334864|NCT01343277|20546176|P1|Treated|Overall Study||378
8334865|NCT01343277|20546175|P2|STARTED|Overall Study||193
8334866|NCT01343277|20546176|P1|STARTED|Overall Study||384
8334867|NCT01343251|20546194|P2|NOT COMPLETED|Overall Study||0
8334868|NCT01343251|20546195|P1|NOT COMPLETED|Overall Study||0
8334869|NCT01343251|20546194|P2|COMPLETED|Overall Study||17
8334870|NCT01343251|20546195|P1|COMPLETED|Overall Study||16
8334871|NCT01343251|20546194|P2|STARTED|Overall Study||17
8334872|NCT01343251|20546195|P1|STARTED|Overall Study||16
8334873|NCT01343095|20546212|P3|NOT COMPLETED|Overall Study||0
8334874|NCT01343095|20546213|P2|NOT COMPLETED|Overall Study||0
8334875|NCT01343095|20546214|P1|NOT COMPLETED|Overall Study||0
8334876|NCT01343095|20546212|P3|COMPLETED|Overall Study||3
8334877|NCT01343095|20546213|P2|COMPLETED|Overall Study||3
8334878|NCT01343095|20546214|P1|COMPLETED|Overall Study||2
8334879|NCT01343095|20546212|P3|STARTED|Overall Study||3
8334880|NCT01343095|20546213|P2|STARTED|Overall Study||3
8334881|NCT01343095|20546214|P1|STARTED|Overall Study||2
8334882|NCT01343082|20546237|P3|NOT COMPLETED|Treatment Period , Switched to DE-111||12
8334883|NCT01343082|20546238|P2|NOT COMPLETED|Treatment Period , Switched to DE-111||9
8334884|NCT01343082|20546239|P1|NOT COMPLETED|Treatment Period , Switched to DE-111||5
8334885|NCT01343082|20546237|P3|COMPLETED|Treatment Period , Switched to DE-111||31
8334886|NCT01343082|20546238|P2|COMPLETED|Treatment Period , Switched to DE-111||36
8334887|NCT01343082|20546239|P1|COMPLETED|Treatment Period , Switched to DE-111||43
8334888|NCT01343082|20546237|P3|STARTED|Treatment Period , Switched to DE-111||43
8334889|NCT01343082|20546238|P2|STARTED|Treatment Period , Switched to DE-111||45
8334890|NCT01343082|20546239|P1|STARTED|Treatment Period , Switched to DE-111||48
8334891|NCT01343082|20546237|P3|NOT COMPLETED|The run-in Period||5
8334892|NCT01343082|20546238|P2|NOT COMPLETED|The run-in Period||4
8334893|NCT01343082|20546239|P1|NOT COMPLETED|The run-in Period||3
8334894|NCT01343082|20546237|P3|COMPLETED|The run-in Period||43
8334895|NCT01343082|20546238|P2|COMPLETED|The run-in Period||45
8334896|NCT01343082|20546239|P1|COMPLETED|The run-in Period||48
8334897|NCT01343082|20546237|P3|STARTED|The run-in Period||48
8334898|NCT01343082|20546238|P2|STARTED|The run-in Period||49
8334899|NCT01343082|20546239|P1|STARTED|The run-in Period||51
8334900|NCT01343056|20546247|P4|NOT COMPLETED|Overall Study||9
8334901|NCT01343056|20546248|P3|NOT COMPLETED|Overall Study||3
8334902|NCT01343056|20546249|P2|NOT COMPLETED|Overall Study||5
8334903|NCT01343056|20546250|P1|NOT COMPLETED|Overall Study||7
8334904|NCT01343056|20546247|P4|COMPLETED|Overall Study||29
8334905|NCT01343056|20546248|P3|COMPLETED|Overall Study||29
8334906|NCT01343056|20546249|P2|COMPLETED|Overall Study||31
8334907|NCT01343056|20546250|P1|COMPLETED|Overall Study||28
8334908|NCT01343056|20546247|P4|STARTED|Overall Study||38
8334909|NCT01343056|20546248|P3|STARTED|Overall Study||32
8334910|NCT01343056|20546249|P2|STARTED|Overall Study||36
8334911|NCT01343056|20546250|P1|STARTED|Overall Study||35
8334928|NCT01343004|20546356|P3|NOT COMPLETED|Overall Study||160
8334929|NCT01343004|20546357|P2|NOT COMPLETED|Overall Study||218
8334930|NCT01343004|20546358|P1|NOT COMPLETED|Overall Study||184
8334931|NCT01343004|20546356|P3|COMPLETED|Overall Study||658
8334932|NCT01343004|20546357|P2|COMPLETED|Overall Study||606
8334933|NCT01343004|20546358|P1|COMPLETED|Overall Study||637
8334934|NCT01343004|20546356|P3|STARTED|Overall Study||818
8334935|NCT01343004|20546357|P2|STARTED|Overall Study||824
8334936|NCT01343004|20546358|P1|STARTED|Overall Study||821
8334937|NCT01342965|20546383|P2|NOT COMPLETED|Overall Study||107
8334938|NCT01342965|20546384|P1|NOT COMPLETED|Overall Study||109
8334939|NCT01342965|20546383|P2|COMPLETED|Overall Study||0
8334940|NCT01342965|20546384|P1|COMPLETED|Overall Study||1
8334941|NCT01342965|20546383|P2|Received Treatment|Overall Study||104
8334942|NCT01342965|20546384|P1|Received Treatment|Overall Study||110
8334943|NCT01342965|20546383|P2|STARTED|Overall Study||107
8334944|NCT01342965|20546384|P1|STARTED|Overall Study||110
8334945|NCT01342926|20546402|P4|NOT COMPLETED|Overall Study||12
8334946|NCT01342926|20546403|P3|NOT COMPLETED|Overall Study||14
8334947|NCT01342926|20546404|P2|NOT COMPLETED|Overall Study||15
8334948|NCT01342926|20546405|P1|NOT COMPLETED|Overall Study||9
8334949|NCT01342926|20546402|P4|COMPLETED|Overall Study||39
8334950|NCT01342926|20546403|P3|COMPLETED|Overall Study||34
8334951|NCT01342926|20546404|P2|COMPLETED|Overall Study||31
8334952|NCT01342926|20546405|P1|COMPLETED|Overall Study||37
8334953|NCT01342926|20546402|P4|STARTED|Overall Study||51
8334954|NCT01342926|20546403|P3|STARTED|Overall Study||48
8334955|NCT01342926|20546404|P2|STARTED|Overall Study||46
8334956|NCT01342926|20546405|P1|STARTED|Overall Study||46
8334957|NCT01342913|20546485|P3|NOT COMPLETED|Double-Blind Treatment Period||23
8334958|NCT01342913|20546486|P2|NOT COMPLETED|Double-Blind Treatment Period||16
8334959|NCT01342913|20546487|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8334960|NCT01342913|20546485|P3|COMPLETED|Double-Blind Treatment Period||243
8334961|NCT01342913|20546486|P2|COMPLETED|Double-Blind Treatment Period||246
8334962|NCT01342913|20546487|P1|COMPLETED|Double-Blind Treatment Period||0
8334963|NCT01342913|20546485|P3|STARTED|Double-Blind Treatment Period||266
8334964|NCT01342913|20546486|P2|STARTED|Double-Blind Treatment Period||262
8334965|NCT01342913|20546487|P1|STARTED|Double-Blind Treatment Period||0
8334966|NCT01342913|20546485|P3|NOT COMPLETED|2-week Run-in Period||0
8334967|NCT01342913|20546486|P2|NOT COMPLETED|2-week Run-in Period||0
8334968|NCT01342913|20546487|P1|NOT COMPLETED|2-week Run-in Period||174
8334969|NCT01342913|20546485|P3|COMPLETED|2-week Run-in Period||0
8334970|NCT01342913|20546486|P2|COMPLETED|2-week Run-in Period||0
8334971|NCT01342913|20546487|P1|COMPLETED|2-week Run-in Period||528
8334972|NCT01342913|20546485|P3|STARTED|2-week Run-in Period||0
8334973|NCT01342913|20546486|P2|STARTED|2-week Run-in Period||0
8334974|NCT01342913|20546487|P1|STARTED|2-week Run-in Period||702
8334975|NCT01342887|20546497|P1|NOT COMPLETED|Overall Study||2
8334976|NCT01342887|20546497|P1|COMPLETED|Overall Study||4
8334977|NCT01342887|20546497|P1|STARTED|Overall Study||6
8334978|NCT01342770|20546504|P1|NOT COMPLETED|Overall Study||0
8334979|NCT01342770|20546504|P1|COMPLETED|Overall Study||6
8334980|NCT01342770|20546504|P1|STARTED|Overall Study||6
8334981|NCT01342757|20546522|P1|NOT COMPLETED|Overall Study||0
8334982|NCT01342757|20546522|P1|COMPLETED|Overall Study||12
8334983|NCT01342757|20546522|P1|STARTED|Overall Study||12
8334984|NCT01342666|20546531|P2|NOT COMPLETED|Overall Study||0
8334985|NCT01342666|20546532|P1|NOT COMPLETED|Overall Study||0
8334986|NCT01342666|20546531|P2|COMPLETED|Overall Study||24
8334987|NCT01342666|20546532|P1|COMPLETED|Overall Study||26
8334988|NCT01342666|20546531|P2|STARTED|Overall Study||24
8334989|NCT01342666|20546532|P1|STARTED|Overall Study||26
8334990|NCT01342640|20546538|P1|NOT COMPLETED|Overall Study||41
8334991|NCT01342640|20546538|P1|COMPLETED|Overall Study||29
8334992|NCT01342640|20546538|P1|STARTED|Overall Study||70
8334993|NCT01342549|20546546|P2|NOT COMPLETED|Overall Study||0
8334994|NCT01342549|20546547|P1|NOT COMPLETED|Overall Study||0
8334995|NCT01342549|20546546|P2|COMPLETED|Overall Study||31
8334996|NCT01342549|20546547|P1|COMPLETED|Overall Study||31
8334997|NCT01342549|20546546|P2|STARTED|Overall Study||31
8334998|NCT01342549|20546547|P1|STARTED|Overall Study||31
8334999|NCT01342523|20546585|P32|NOT COMPLETED|Overall Study||1
8335000|NCT01342523|20546586|P31|NOT COMPLETED|Overall Study||1
8335001|NCT01342523|20546587|P30|NOT COMPLETED|Overall Study||1
8335002|NCT01342523|20546588|P29|NOT COMPLETED|Overall Study||1
8335003|NCT01342523|20546589|P28|NOT COMPLETED|Overall Study||1
8335004|NCT01342523|20546590|P27|NOT COMPLETED|Overall Study||1
8335005|NCT01342523|20546591|P26|NOT COMPLETED|Overall Study||2
8335006|NCT01342523|20546592|P25|NOT COMPLETED|Overall Study||1
8335007|NCT01342523|20546593|P24|NOT COMPLETED|Overall Study||1
8335008|NCT01342523|20546594|P23|NOT COMPLETED|Overall Study||0
8335009|NCT01342523|20546595|P22|NOT COMPLETED|Overall Study||0
8335010|NCT01342523|20546596|P21|NOT COMPLETED|Overall Study||0
8335011|NCT01342523|20546597|P20|NOT COMPLETED|Overall Study||0
8335012|NCT01342523|20546598|P19|NOT COMPLETED|Overall Study||0
8335013|NCT01342523|20546599|P18|NOT COMPLETED|Overall Study||0
8335014|NCT01342523|20546600|P17|NOT COMPLETED|Overall Study||1
8335015|NCT01342523|20546601|P16|NOT COMPLETED|Overall Study||0
8335016|NCT01342523|20546602|P15|NOT COMPLETED|Overall Study||1
8335017|NCT01342523|20546603|P14|NOT COMPLETED|Overall Study||2
8335018|NCT01342523|20546604|P13|NOT COMPLETED|Overall Study||0
8335019|NCT01342523|20546605|P12|NOT COMPLETED|Overall Study||2
8335020|NCT01342523|20546606|P11|NOT COMPLETED|Overall Study||0
8335021|NCT01342523|20546607|P10|NOT COMPLETED|Overall Study||0
8335022|NCT01342523|20546608|P9|NOT COMPLETED|Overall Study||0
8335023|NCT01342523|20546609|P8|NOT COMPLETED|Overall Study||0
8335024|NCT01342523|20546610|P7|NOT COMPLETED|Overall Study||0
8335025|NCT01342523|20546611|P6|NOT COMPLETED|Overall Study||0
8335026|NCT01342523|20546612|P5|NOT COMPLETED|Overall Study||0
8335027|NCT01342523|20546613|P4|NOT COMPLETED|Overall Study||1
8335028|NCT01342523|20546614|P3|NOT COMPLETED|Overall Study||0
8335029|NCT01342523|20546615|P2|NOT COMPLETED|Overall Study||0
8335030|NCT01342523|20546616|P1|NOT COMPLETED|Overall Study||1
8335031|NCT01342523|20546585|P32|COMPLETED|Overall Study||27
8335032|NCT01342523|20546586|P31|COMPLETED|Overall Study||30
8335033|NCT01342523|20546587|P30|COMPLETED|Overall Study||28
8335034|NCT01342523|20546588|P29|COMPLETED|Overall Study||34
8335035|NCT01342523|20546589|P28|COMPLETED|Overall Study||30
8335036|NCT01342523|20546590|P27|COMPLETED|Overall Study||33
8335037|NCT01342523|20546591|P26|COMPLETED|Overall Study||36
8335038|NCT01342523|20546592|P25|COMPLETED|Overall Study||36
8335039|NCT01342523|20546593|P24|COMPLETED|Overall Study||35
8335040|NCT01342523|20546594|P23|COMPLETED|Overall Study||36
8335041|NCT01342523|20546595|P22|COMPLETED|Overall Study||30
8335042|NCT01342523|20546596|P21|COMPLETED|Overall Study||29
8335043|NCT01342523|20546597|P20|COMPLETED|Overall Study||27
8335044|NCT01342523|20546598|P19|COMPLETED|Overall Study||21
8335045|NCT01342523|20546599|P18|COMPLETED|Overall Study||27
8335046|NCT01342523|20546600|P17|COMPLETED|Overall Study||28
8335047|NCT01342523|20546601|P16|COMPLETED|Overall Study||32
8335048|NCT01342523|20546602|P15|COMPLETED|Overall Study||37
8335049|NCT01342523|20546603|P14|COMPLETED|Overall Study||36
8335050|NCT01342523|20546604|P13|COMPLETED|Overall Study||39
8335051|NCT01342523|20546605|P12|COMPLETED|Overall Study||36
8335052|NCT01342523|20546606|P11|COMPLETED|Overall Study||38
8335053|NCT01342523|20546607|P10|COMPLETED|Overall Study||28
8335054|NCT01342523|20546608|P9|COMPLETED|Overall Study||28
8335055|NCT01342523|20546609|P8|COMPLETED|Overall Study||27
8335056|NCT01342523|20546610|P7|COMPLETED|Overall Study||22
8335057|NCT01342523|20546611|P6|COMPLETED|Overall Study||36
8335058|NCT01342523|20546612|P5|COMPLETED|Overall Study||36
8335059|NCT01342523|20546613|P4|COMPLETED|Overall Study||32
8335060|NCT01342523|20546614|P3|COMPLETED|Overall Study||36
8335061|NCT01342523|20546615|P2|COMPLETED|Overall Study||32
8335062|NCT01342523|20546616|P1|COMPLETED|Overall Study||34
8335063|NCT01342523|20546585|P32|STARTED|Overall Study||28
8335064|NCT01342523|20546586|P31|STARTED|Overall Study||31
8335065|NCT01342523|20546587|P30|STARTED|Overall Study||29
8335066|NCT01342523|20546588|P29|STARTED|Overall Study||35
8335067|NCT01342523|20546589|P28|STARTED|Overall Study||31
8335068|NCT01342523|20546590|P27|STARTED|Overall Study||34
8335069|NCT01342523|20546591|P26|STARTED|Overall Study||38
8335070|NCT01342523|20546592|P25|STARTED|Overall Study||37
8335071|NCT01342523|20546593|P24|STARTED|Overall Study||36
8335072|NCT01342523|20546594|P23|STARTED|Overall Study||36
8335073|NCT01342523|20546595|P22|STARTED|Overall Study||30
8335074|NCT01342523|20546596|P21|STARTED|Overall Study||29
8335075|NCT01342523|20546597|P20|STARTED|Overall Study||27
8335076|NCT01342523|20546598|P19|STARTED|Overall Study||21
8335077|NCT01342523|20546599|P18|STARTED|Overall Study||27
8335078|NCT01342523|20546600|P17|STARTED|Overall Study||29
8335079|NCT01342523|20546601|P16|STARTED|Overall Study||32
8335080|NCT01342523|20546602|P15|STARTED|Overall Study||38
8335081|NCT01342523|20546603|P14|STARTED|Overall Study||38
8335082|NCT01342523|20546604|P13|STARTED|Overall Study||39
8335083|NCT01342523|20546605|P12|STARTED|Overall Study||38
8335084|NCT01342523|20546606|P11|STARTED|Overall Study||38
8335085|NCT01342523|20546607|P10|STARTED|Overall Study||28
8335086|NCT01342523|20546608|P9|STARTED|Overall Study||28
8335087|NCT01342523|20546609|P8|STARTED|Overall Study||27
8335088|NCT01342523|20546610|P7|STARTED|Overall Study||22
8335089|NCT01342523|20546611|P6|STARTED|Overall Study||36
8335090|NCT01342523|20546612|P5|STARTED|Overall Study||36
8335091|NCT01342523|20546613|P4|STARTED|Overall Study||33
8335092|NCT01342523|20546614|P3|STARTED|Overall Study||36
8335093|NCT01342523|20546615|P2|STARTED|Overall Study||32
8335094|NCT01342523|20546616|P1|STARTED|Overall Study||35
8335095|NCT01342510|20546633|P4|NOT COMPLETED|Overall Study||11
8335096|NCT01342510|20546634|P3|NOT COMPLETED|Overall Study||13
8335097|NCT01342510|20546635|P2|NOT COMPLETED|Overall Study||6
8335098|NCT01342510|20546636|P1|NOT COMPLETED|Overall Study||12
8335099|NCT01342510|20546633|P4|COMPLETED|Overall Study||39
8335100|NCT01342510|20546634|P3|COMPLETED|Overall Study||37
8335101|NCT01342510|20546635|P2|COMPLETED|Overall Study||44
8335102|NCT01342510|20546636|P1|COMPLETED|Overall Study||38
8335103|NCT01342510|20546633|P4|STARTED|Overall Study||50
8335104|NCT01342510|20546634|P3|STARTED|Overall Study||50
8335105|NCT01342510|20546635|P2|STARTED|Overall Study||50
8335106|NCT01342510|20546636|P1|STARTED|Overall Study||50
8335107|NCT01342484|20546653|P3|NOT COMPLETED|Overall Study||1
8335108|NCT01342484|20546654|P2|NOT COMPLETED|Overall Study||0
8335109|NCT01342484|20546655|P1|NOT COMPLETED|Overall Study||2
8335110|NCT01342484|20546653|P3|COMPLETED|Overall Study||13
8335111|NCT01342484|20546654|P2|COMPLETED|Overall Study||10
8335112|NCT01342484|20546655|P1|COMPLETED|Overall Study||13
8335113|NCT01342484|20546653|P3|STARTED|Overall Study||14
8335114|NCT01342484|20546654|P2|STARTED|Overall Study||10
8335115|NCT01342484|20546655|P1|STARTED|Overall Study||15
8335116|NCT01342471|20546671|P2|NOT COMPLETED|Overall Study||6
8335117|NCT01342471|20546672|P1|NOT COMPLETED|Overall Study||5
8335118|NCT01342471|20546671|P2|COMPLETED|Overall Study||23
8335119|NCT01342471|20546672|P1|COMPLETED|Overall Study||24
8335120|NCT01342471|20546671|P2|STARTED|Overall Study||29
8335121|NCT01342471|20546672|P1|STARTED|Overall Study||29
8335122|NCT01342458|20546688|P2|NOT COMPLETED|Overall Study||4
8335123|NCT01342458|20546689|P1|NOT COMPLETED|Overall Study||2
8335124|NCT01342458|20546688|P2|COMPLETED|Overall Study||24
8335125|NCT01342458|20546689|P1|COMPLETED|Overall Study||26
8335126|NCT01342458|20546688|P2|STARTED|Overall Study||28
8335127|NCT01342458|20546689|P1|STARTED|Overall Study||28
8335128|NCT01342445|20546711|P2|NOT COMPLETED|Overall Study||2
8335129|NCT01342445|20546712|P1|NOT COMPLETED|Overall Study||0
8335130|NCT01342445|20546711|P2|COMPLETED|Overall Study||22
8335131|NCT01342445|20546712|P1|COMPLETED|Overall Study||26
8335132|NCT01342445|20546711|P2|STARTED|Overall Study||24
8335133|NCT01342445|20546712|P1|STARTED|Overall Study||26
8335134|NCT01342341|20546728|P2|NOT COMPLETED|Overall Study||4
8335135|NCT01342341|20546729|P1|NOT COMPLETED|Overall Study||4
8335136|NCT01342341|20546728|P2|COMPLETED|Overall Study||20
8335137|NCT01342341|20546729|P1|COMPLETED|Overall Study||20
8335138|NCT01342341|20546728|P2|STARTED|Overall Study||24
8335139|NCT01342341|20546729|P1|STARTED|Overall Study||24
8335140|NCT01342211|20546740|P5|NOT COMPLETED|Overall Study||2
8335141|NCT01342211|20546741|P4|NOT COMPLETED|Overall Study||2
8335142|NCT01342211|20546742|P3|NOT COMPLETED|Overall Study||0
8335143|NCT01342211|20546743|P2|NOT COMPLETED|Overall Study||2
8335144|NCT01342211|20546744|P1|NOT COMPLETED|Overall Study||0
8335145|NCT01342211|20546740|P5|COMPLETED|Overall Study||16
8335146|NCT01342211|20546741|P4|COMPLETED|Overall Study||17
8335147|NCT01342211|20546742|P3|COMPLETED|Overall Study||18
8335148|NCT01342211|20546743|P2|COMPLETED|Overall Study||17
8335149|NCT01342211|20546744|P1|COMPLETED|Overall Study||19
8335150|NCT01342211|20546740|P5|Treated|Overall Study||17
8335151|NCT01342211|20546741|P4|Treated|Overall Study||19
8335152|NCT01342211|20546742|P3|Treated|Overall Study||18
8335153|NCT01342211|20546743|P2|Treated|Overall Study||17
8335154|NCT01342211|20546744|P1|Treated|Overall Study||19
8335155|NCT01342211|20546740|P5|STARTED|Overall Study||18
8335156|NCT01342211|20546741|P4|STARTED|Overall Study||19
8335157|NCT01342211|20546742|P3|STARTED|Overall Study||18
8335158|NCT01342211|20546743|P2|STARTED|Overall Study||19
8335159|NCT01342211|20546744|P1|STARTED|Overall Study||19
8335160|NCT01342172|20546810|P1|NOT COMPLETED|Overall Study||0
8335161|NCT01342172|20546810|P1|COMPLETED|Overall Study||9
8335162|NCT01342172|20546810|P1|STARTED|Overall Study||9
8335163|NCT01342107|20546823|P2|NOT COMPLETED|Overall Study||0
8335164|NCT01342107|20546824|P1|NOT COMPLETED|Overall Study||0
8335165|NCT01342107|20546823|P2|COMPLETED|Overall Study||32
8335166|NCT01342107|20546824|P1|COMPLETED|Overall Study||34
8335167|NCT01342107|20546823|P2|STARTED|Overall Study||32
8335168|NCT01342107|20546824|P1|STARTED|Overall Study||34
8335169|NCT01342094|20546832|P2|NOT COMPLETED|Overall Study||3
8335170|NCT01342094|20546833|P1|NOT COMPLETED|Overall Study||5
8335171|NCT01342094|20546832|P2|COMPLETED|Overall Study||81
8335172|NCT01342094|20546833|P1|COMPLETED|Overall Study||77
8335173|NCT01342094|20546832|P2|STARTED|Overall Study||84
8335174|NCT01342094|20546833|P1|STARTED|Overall Study||82
8335175|NCT01342081|20546842|P3|NOT COMPLETED|Overall Study||1
8335176|NCT01342081|20546843|P2|NOT COMPLETED|Overall Study||2
8335177|NCT01342081|20546844|P1|NOT COMPLETED|Overall Study||2
8335178|NCT01342081|20546842|P3|COMPLETED|Overall Study||163
8335179|NCT01342081|20546843|P2|COMPLETED|Overall Study||162
8335180|NCT01342081|20546844|P1|COMPLETED|Overall Study||159
8335181|NCT01342081|20546842|P3|STARTED|Overall Study||164
8335182|NCT01342081|20546843|P2|STARTED|Overall Study||164
8335183|NCT01342081|20546844|P1|STARTED|Overall Study||161
8335184|NCT01342029|20546852|P2|NOT COMPLETED|Period 2||0
8335185|NCT01342029|20546853|P1|NOT COMPLETED|Period 2||2
8335186|NCT01342029|20546852|P2|COMPLETED|Period 2||67
8335187|NCT01342029|20546853|P1|COMPLETED|Period 2||65
8335188|NCT01342029|20546852|P2|Dropout|Period 2||0
8335189|NCT01342029|20546853|P1|Dropout|Period 2||2
8335190|NCT01342029|20546852|P2|STARTED|Period 2||67
8335191|NCT01342029|20546853|P1|STARTED|Period 2||67
8335192|NCT01342029|20546852|P2|NOT COMPLETED|Washout||4
8335193|NCT01342029|20546853|P1|NOT COMPLETED|Washout||0
8335194|NCT01342029|20546852|P2|COMPLETED|Washout||67
8335195|NCT01342029|20546853|P1|COMPLETED|Washout||67
8335196|NCT01342029|20546852|P2|STARTED|Washout||71
8335197|NCT01342029|20546853|P1|STARTED|Washout||67
8335198|NCT01342029|20546852|P2|NOT COMPLETED|Period 1||1
8335199|NCT01342029|20546853|P1|NOT COMPLETED|Period 1||3
8335200|NCT01342029|20546852|P2|COMPLETED|Period 1||71
8335201|NCT01342029|20546853|P1|COMPLETED|Period 1||67
8335202|NCT01342029|20546852|P2|Dropout|Period 1||1
8335203|NCT01342029|20546853|P1|Dropout|Period 1||3
8335204|NCT01342029|20546852|P2|STARTED|Period 1||72
8335205|NCT01342029|20546853|P1|STARTED|Period 1||70
8335206|NCT01341990|20546863|P2|NOT COMPLETED|Overall Study||1
8335207|NCT01341990|20546864|P1|NOT COMPLETED|Overall Study||3
8335208|NCT01341990|20546863|P2|COMPLETED|Overall Study||32
8335209|NCT01341990|20546864|P1|COMPLETED|Overall Study||32
8335210|NCT01341990|20546863|P2|STARTED|Overall Study||33
8335211|NCT01341990|20546864|P1|STARTED|Overall Study||35
8335212|NCT01341977|20546874|P2|NOT COMPLETED|Overall Study||15
8335213|NCT01341977|20546875|P1|NOT COMPLETED|Overall Study||14
8335214|NCT01341977|20546874|P2|COMPLETED|Overall Study||270
8335215|NCT01341977|20546875|P1|COMPLETED|Overall Study||274
8335216|NCT01341977|20546874|P2|STARTED|Overall Study||285
8335217|NCT01341977|20546875|P1|STARTED|Overall Study||288
8335218|NCT01341912|20546881|P1|NOT COMPLETED|Overall Study||0
8335219|NCT01341912|20546881|P1|COMPLETED|Overall Study||3
8335220|NCT01341912|20546881|P1|STARTED|Overall Study||3
8335221|NCT01341782|20546888|P2|NOT COMPLETED|Overall Study||14
8335222|NCT01341782|20546889|P1|NOT COMPLETED|Overall Study||15
8335223|NCT01341782|20546888|P2|COMPLETED|Overall Study||114
8335224|NCT01341782|20546889|P1|COMPLETED|Overall Study||112
8335225|NCT01341782|20546888|P2|STARTED|Overall Study||128
8335226|NCT01341782|20546889|P1|STARTED|Overall Study||127
8335227|NCT01341730|20546907|P2|NOT COMPLETED|Overall Study||4
8335228|NCT01341730|20546908|P1|NOT COMPLETED|Overall Study||4
8335229|NCT01341730|20546907|P2|COMPLETED|Overall Study||17
8335230|NCT01341730|20546908|P1|COMPLETED|Overall Study||16
8335231|NCT01341730|20546907|P2|STARTED|Overall Study||21
8335232|NCT01341730|20546908|P1|STARTED|Overall Study||20
8335233|NCT01341652|20546918|P2|NOT COMPLETED|Overall Study||2
8335234|NCT01341652|20546919|P1|NOT COMPLETED|Overall Study||0
8335235|NCT01341652|20546918|P2|COMPLETED|Overall Study||48
8335236|NCT01341652|20546919|P1|COMPLETED|Overall Study||49
8335237|NCT01341652|20546918|P2|STARTED|Overall Study||50
8335238|NCT01341652|20546919|P1|STARTED|Overall Study||49
8335239|NCT01341639|20546935|P2|NOT COMPLETED|Post-Treatment||3
8335240|NCT01341639|20546936|P1|NOT COMPLETED|Post-Treatment||0
8335241|NCT01341639|20546935|P2|COMPLETED|Post-Treatment||545
8335242|NCT01341639|20546936|P1|COMPLETED|Post-Treatment||539
8335243|NCT01341639|20546935|P2|STARTED|Post-Treatment||548
8335244|NCT01341639|20546936|P1|STARTED|Post-Treatment||539
8335245|NCT01341639|20546935|P2|NOT COMPLETED|Toddler Dose||34
8335246|NCT01341639|20546936|P1|NOT COMPLETED|Toddler Dose||51
8335247|NCT01341639|20546935|P2|COMPLETED|Toddler Dose||548
8335248|NCT01341639|20546936|P1|COMPLETED|Toddler Dose||539
8335249|NCT01341639|20546935|P2|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582
8335250|NCT01341639|20546936|P1|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590
8335251|NCT01341639|20546935|P2|NOT COMPLETED|Interim Period||9
8335252|NCT01341639|20546936|P1|NOT COMPLETED|Interim Period||8
8335253|NCT01341639|20546935|P2|COMPLETED|Interim Period||581
8335254|NCT01341639|20546936|P1|COMPLETED|Interim Period||591
8335255|NCT01341639|20546935|P2|STARTED|Interim Period||590
8335256|NCT01341639|20546936|P1|STARTED|Interim Period||599
8335257|NCT01341639|20546935|P2|NOT COMPLETED|Infant Series||32
8335258|NCT01341639|20546936|P1|NOT COMPLETED|Infant Series||29
8335259|NCT01341639|20546935|P2|COMPLETED|Infant Series||590
8335260|NCT01341639|20546936|P1|COMPLETED|Infant Series||599
8335261|NCT01341639|20546935|P2|Treated|Infant Series||605
8335262|NCT01341639|20546936|P1|Treated|Infant Series||610
8335263|NCT01341639|20546935|P2|Site 0048 Excluded|Infant Series||606
8335264|NCT01341639|20546936|P1|Site 0048 Excluded|Infant Series||611
8335265|NCT01341639|20546935|P2|STARTED|Infant Series||622
8335266|NCT01341639|20546936|P1|STARTED|Infant Series||628
8335267|NCT01341600|20546960|P3|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
8335268|NCT01341600|20546961|P2|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
8335269|NCT01341600|20546962|P1|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
8335270|NCT01341600|20546960|P3|COMPLETED|Clopidogrel Plus Omeprazole||4
8335271|NCT01341600|20546961|P2|COMPLETED|Clopidogrel Plus Omeprazole||5
8335272|NCT01341600|20546962|P1|COMPLETED|Clopidogrel Plus Omeprazole||5
8335273|NCT01341600|20546960|P3|STARTED|Clopidogrel Plus Omeprazole||4
8335274|NCT01341600|20546961|P2|STARTED|Clopidogrel Plus Omeprazole||5
8335275|NCT01341600|20546962|P1|STARTED|Clopidogrel Plus Omeprazole||5
8335276|NCT01341600|20546960|P3|NOT COMPLETED|Clopidogrel 225 mg||0
8335277|NCT01341600|20546961|P2|NOT COMPLETED|Clopidogrel 225 mg||0
8335278|NCT01341600|20546962|P1|NOT COMPLETED|Clopidogrel 225 mg||0
8335279|NCT01341600|20546960|P3|COMPLETED|Clopidogrel 225 mg||6
8335280|NCT01341600|20546961|P2|COMPLETED|Clopidogrel 225 mg||6
8335281|NCT01341600|20546962|P1|COMPLETED|Clopidogrel 225 mg||6
8335282|NCT01341600|20546960|P3|STARTED|Clopidogrel 225 mg||6
8335283|NCT01341600|20546961|P2|STARTED|Clopidogrel 225 mg||6
8335284|NCT01341600|20546962|P1|STARTED|Clopidogrel 225 mg||6
8335285|NCT01341600|20546960|P3|NOT COMPLETED|Clopidogrel 150 mg||0
8335286|NCT01341600|20546961|P2|NOT COMPLETED|Clopidogrel 150 mg||0
8335287|NCT01341600|20546962|P1|NOT COMPLETED|Clopidogrel 150 mg||0
8335288|NCT01341600|20546960|P3|COMPLETED|Clopidogrel 150 mg||6
8335289|NCT01341600|20546961|P2|COMPLETED|Clopidogrel 150 mg||6
8335290|NCT01341600|20546962|P1|COMPLETED|Clopidogrel 150 mg||6
8335291|NCT01341600|20546960|P3|STARTED|Clopidogrel 150 mg||6
8335292|NCT01341600|20546961|P2|STARTED|Clopidogrel 150 mg||6
8335293|NCT01341600|20546962|P1|STARTED|Clopidogrel 150 mg||6
8335294|NCT01341600|20546960|P3|NOT COMPLETED|Clopidogrel 75 mg||0
8335295|NCT01341600|20546961|P2|NOT COMPLETED|Clopidogrel 75 mg||0
8335296|NCT01341600|20546962|P1|NOT COMPLETED|Clopidogrel 75 mg||0
8335297|NCT01341600|20546960|P3|COMPLETED|Clopidogrel 75 mg||6
8335298|NCT01341600|20546961|P2|COMPLETED|Clopidogrel 75 mg||6
8335299|NCT01341600|20546962|P1|COMPLETED|Clopidogrel 75 mg||6
8335300|NCT01341600|20546960|P3|STARTED|Clopidogrel 75 mg||6
8335301|NCT01341600|20546961|P2|STARTED|Clopidogrel 75 mg||6
8335302|NCT01341600|20546962|P1|STARTED|Clopidogrel 75 mg||6
8335303|NCT01341587|20546981|P2|NOT COMPLETED|Overall Study||10
8335304|NCT01341587|20546982|P1|NOT COMPLETED|Overall Study||4
8335305|NCT01341587|20546981|P2|COMPLETED|Overall Study||0
8335306|NCT01341587|20546982|P1|COMPLETED|Overall Study||0
8335307|NCT01341587|20546981|P2|STARTED|Overall Study||10
8335308|NCT01341587|20546982|P1|STARTED|Overall Study||4
8335309|NCT01341470|20546994|P6|NOT COMPLETED|Overall Study||1
8335310|NCT01341470|20546995|P5|NOT COMPLETED|Overall Study||0
8335311|NCT01341470|20546996|P4|NOT COMPLETED|Overall Study||1
8335312|NCT01341470|20546997|P3|NOT COMPLETED|Overall Study||1
8335313|NCT01341470|20546998|P2|NOT COMPLETED|Overall Study||0
8335314|NCT01341470|20546999|P1|NOT COMPLETED|Overall Study||0
8335315|NCT01341470|20546994|P6|COMPLETED|Overall Study||9
8335316|NCT01341470|20546995|P5|COMPLETED|Overall Study||2
8335317|NCT01341470|20546996|P4|COMPLETED|Overall Study||9
8335318|NCT01341470|20546997|P3|COMPLETED|Overall Study||9
8335319|NCT01341470|20546998|P2|COMPLETED|Overall Study||9
8335320|NCT01341470|20546999|P1|COMPLETED|Overall Study||6
8335321|NCT01341470|20546994|P6|Received at Least 1 Dose of Study Drug|Overall Study||10
8335322|NCT01341470|20546995|P5|Received at Least 1 Dose of Study Drug|Overall Study||2
8335323|NCT01341470|20546996|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
8335324|NCT01341470|20546997|P3|Received at Least 1 Dose of Study Drug|Overall Study||10
8335325|NCT01341470|20546998|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
8335326|NCT01341470|20546999|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8335327|NCT01341470|20546994|P6|STARTED|Overall Study||10
8335328|NCT01341470|20546995|P5|STARTED|Overall Study||2
8335329|NCT01341470|20546996|P4|STARTED|Overall Study||10
8335330|NCT01341470|20546997|P3|STARTED|Overall Study||10
8335331|NCT01341470|20546998|P2|STARTED|Overall Study||9
8335332|NCT01341470|20546999|P1|STARTED|Overall Study||6
8335333|NCT01341457|20547033|P2|NOT COMPLETED|Overall Study||0
8335334|NCT01341457|20547034|P1|NOT COMPLETED|Overall Study||2
8335335|NCT01341457|20547033|P2|COMPLETED|Overall Study||10
8335336|NCT01341457|20547034|P1|COMPLETED|Overall Study||5
8335337|NCT01341457|20547033|P2|Received at Least One Dose of Study Drug|Overall Study||10
8335338|NCT01341457|20547034|P1|Received at Least One Dose of Study Drug|Overall Study||7
8335339|NCT01341457|20547033|P2|STARTED|Overall Study||10
8335340|NCT01341457|20547034|P1|STARTED|Overall Study||7
8335341|NCT01341444|20547052|P2|NOT COMPLETED|Overall Study||3
8335342|NCT01341444|20547053|P1|NOT COMPLETED|Overall Study||5
8335343|NCT01341444|20547052|P2|COMPLETED|Overall Study||29
8335344|NCT01341444|20547053|P1|COMPLETED|Overall Study||26
8335345|NCT01341444|20547052|P2|STARTED|Overall Study||32
8335346|NCT01341444|20547053|P1|STARTED|Overall Study||31
8335347|NCT01341301|20547059|P1|NOT COMPLETED|Overall Study||0
8335348|NCT01341301|20547059|P1|COMPLETED|Overall Study||25
8335349|NCT01341301|20547059|P1|STARTED|Overall Study||25
8335350|NCT01341067|20547066|P1|NOT COMPLETED|Overall Study||4
8335351|NCT01341067|20547066|P1|COMPLETED|Overall Study||26
8335352|NCT01341067|20547066|P1|STARTED|Overall Study||30
8335353|NCT01340976|20547079|P6|NOT COMPLETED|Overall Study||1
8335354|NCT01340976|20547080|P5|NOT COMPLETED|Overall Study||2
8335355|NCT01340976|20547081|P4|NOT COMPLETED|Overall Study||3
8335356|NCT01340976|20547082|P3|NOT COMPLETED|Overall Study||3
8335357|NCT01340976|20547083|P2|NOT COMPLETED|Overall Study||2
8335358|NCT01340976|20547084|P1|NOT COMPLETED|Overall Study||4
8335359|NCT01340976|20547079|P6|COMPLETED|Overall Study||6
8335360|NCT01340976|20547080|P5|COMPLETED|Overall Study||5
8335361|NCT01340976|20547081|P4|COMPLETED|Overall Study||2
8335362|NCT01340976|20547082|P3|COMPLETED|Overall Study||4
8335363|NCT01340976|20547083|P2|COMPLETED|Overall Study||1
8335364|NCT01340976|20547084|P1|COMPLETED|Overall Study||0
8335365|NCT01340976|20547079|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
8335366|NCT01340976|20547080|P5|Received at Least 1 Dose of Study Drug|Overall Study||7
8335367|NCT01340976|20547081|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
8335368|NCT01340976|20547082|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
8335369|NCT01340976|20547083|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8335370|NCT01340976|20547084|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
8335371|NCT01340976|20547079|P6|STARTED|Overall Study||7
8335372|NCT01340976|20547080|P5|STARTED|Overall Study||7
8335373|NCT01340976|20547081|P4|STARTED|Overall Study||5
8335374|NCT01340976|20547082|P3|STARTED|Overall Study||7
8335375|NCT01340976|20547083|P2|STARTED|Overall Study||3
8335376|NCT01340976|20547084|P1|STARTED|Overall Study||4
8335377|NCT01340937|20547122|P4|NOT COMPLETED|Period 3: Toddler Vaccinations||10
8335378|NCT01340937|20547123|P3|NOT COMPLETED|Period 3: Toddler Vaccinations||9
8335379|NCT01340937|20547124|P2|NOT COMPLETED|Period 3: Toddler Vaccinations||17
8335380|NCT01340937|20547125|P1|NOT COMPLETED|Period 3: Toddler Vaccinations||9
8335381|NCT01340937|20547122|P4|COMPLETED|Period 3: Toddler Vaccinations||319
8335382|NCT01340937|20547123|P3|COMPLETED|Period 3: Toddler Vaccinations||660
8335383|NCT01340937|20547124|P2|COMPLETED|Period 3: Toddler Vaccinations||641
8335384|NCT01340937|20547125|P1|COMPLETED|Period 3: Toddler Vaccinations||666
8335385|NCT01340937|20547122|P4|STARTED|Period 3: Toddler Vaccinations||329
8335386|NCT01340937|20547123|P3|STARTED|Period 3: Toddler Vaccinations||669
8335387|NCT01340937|20547124|P2|STARTED|Period 3: Toddler Vaccinations||658
8335388|NCT01340937|20547125|P1|STARTED|Period 3: Toddler Vaccinations||675
8335389|NCT01340937|20547122|P4|NOT COMPLETED|Period 2: Interim Period||41
8335390|NCT01340937|20547123|P3|NOT COMPLETED|Period 2: Interim Period||84
8335391|NCT01340937|20547124|P2|NOT COMPLETED|Period 2: Interim Period||79
8335392|NCT01340937|20547125|P1|NOT COMPLETED|Period 2: Interim Period||67
8335393|NCT01340937|20547122|P4|COMPLETED|Period 2: Interim Period||329
8335394|NCT01340937|20547123|P3|COMPLETED|Period 2: Interim Period||669
8335395|NCT01340937|20547124|P2|COMPLETED|Period 2: Interim Period||658
8335396|NCT01340937|20547125|P1|COMPLETED|Period 2: Interim Period||675
8335397|NCT01340937|20547122|P4|STARTED|Period 2: Interim Period||370
8335398|NCT01340937|20547123|P3|STARTED|Period 2: Interim Period||753
8335399|NCT01340937|20547124|P2|STARTED|Period 2: Interim Period||737
8335400|NCT01340937|20547125|P1|STARTED|Period 2: Interim Period||742
8335401|NCT01340937|20547122|P4|NOT COMPLETED|Period 1: Infant Series||32
8335402|NCT01340937|20547123|P3|NOT COMPLETED|Period 1: Infant Series||56
8335403|NCT01340937|20547124|P2|NOT COMPLETED|Period 1: Infant Series||60
8335404|NCT01340937|20547125|P1|NOT COMPLETED|Period 1: Infant Series||58
8335405|NCT01340937|20547122|P4|COMPLETED|Period 1: Infant Series||370
8335406|NCT01340937|20547123|P3|COMPLETED|Period 1: Infant Series||753
8335407|NCT01340937|20547124|P2|COMPLETED|Period 1: Infant Series||737
8335408|NCT01340937|20547125|P1|COMPLETED|Period 1: Infant Series||742
8335409|NCT01340937|20547122|P4|STARTED|Period 1: Infant Series||402
8335410|NCT01340937|20547123|P3|STARTED|Period 1: Infant Series||809
8335411|NCT01340937|20547124|P2|STARTED|Period 1: Infant Series||797
8335412|NCT01340937|20547125|P1|STARTED|Period 1: Infant Series||800
8335413|NCT01340898|20547285|P3|NOT COMPLETED|Booster Phase||7
8335414|NCT01340898|20547286|P2|NOT COMPLETED|Booster Phase||2
8335415|NCT01340898|20547287|P1|NOT COMPLETED|Booster Phase||10
8335416|NCT01340898|20547285|P3|COMPLETED|Booster Phase||163
8335417|NCT01340898|20547286|P2|COMPLETED|Booster Phase||164
8335418|NCT01340898|20547287|P1|COMPLETED|Booster Phase||332
8335419|NCT01340898|20547285|P3|STARTED|Booster Phase||170
8335420|NCT01340898|20547286|P2|STARTED|Booster Phase||166
8335421|NCT01340898|20547287|P1|STARTED|Booster Phase||342
8335422|NCT01340898|20547285|P3|NOT COMPLETED|Primary Phase||6
8335423|NCT01340898|20547286|P2|NOT COMPLETED|Primary Phase||9
8335424|NCT01340898|20547287|P1|NOT COMPLETED|Primary Phase||16
8335425|NCT01340898|20547285|P3|COMPLETED|Primary Phase||181
8335426|NCT01340898|20547286|P2|COMPLETED|Primary Phase||178
8335427|NCT01340898|20547287|P1|COMPLETED|Primary Phase||360
8335428|NCT01340898|20547285|P3|STARTED|Primary Phase||187
8335429|NCT01340898|20547286|P2|STARTED|Primary Phase||187
8335430|NCT01340898|20547287|P1|STARTED|Primary Phase||376
8335431|NCT01340885|20547390|P3|NOT COMPLETED|Overall Study||0
8335432|NCT01340885|20547391|P2|NOT COMPLETED|Overall Study||0
8335433|NCT01340885|20547392|P1|NOT COMPLETED|Overall Study||0
8335434|NCT01340885|20547390|P3|COMPLETED|Overall Study||0
8335435|NCT01340885|20547391|P2|COMPLETED|Overall Study||0
8335436|NCT01340885|20547392|P1|COMPLETED|Overall Study||0
8335437|NCT01340885|20547390|P3|STARTED|Overall Study||0
8335438|NCT01340885|20547391|P2|STARTED|Overall Study||0
8335439|NCT01340885|20547392|P1|STARTED|Overall Study||0
8335440|NCT01340872|20547417|P4|NOT COMPLETED|Open-label Phase||11
8335441|NCT01340872|20547418|P3|NOT COMPLETED|Open-label Phase||13
8335442|NCT01340872|20547419|P2|NOT COMPLETED|Open-label Phase||0
8335443|NCT01340872|20547420|P1|NOT COMPLETED|Open-label Phase||0
8335444|NCT01340872|20547417|P4|COMPLETED|Open-label Phase||36
8335445|NCT01340872|20547418|P3|COMPLETED|Open-label Phase||37
8335446|NCT01340872|20547419|P2|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
8335447|NCT01340872|20547420|P1|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
8335448|NCT01340872|20547417|P4|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
8335449|NCT01340872|20547418|P3|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
8335450|NCT01340872|20547419|P2|STARTED|Open-label Phase|Not Applicable to open-label phase|0
8335451|NCT01340872|20547420|P1|STARTED|Open-label Phase|Not Applicable to open-label phase|0
8335452|NCT01340872|20547417|P4|NOT COMPLETED|Double-blind Phase||0
8335453|NCT01340872|20547418|P3|NOT COMPLETED|Double-blind Phase||0
8335454|NCT01340872|20547419|P2|NOT COMPLETED|Double-blind Phase||11
8335455|NCT01340872|20547420|P1|NOT COMPLETED|Double-blind Phase||9
8335456|NCT01340872|20547417|P4|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
8335457|NCT01340872|20547418|P3|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
8335458|NCT01340872|20547419|P2|COMPLETED|Double-blind Phase||53
8335459|NCT01340872|20547420|P1|COMPLETED|Double-blind Phase||55
8335460|NCT01340872|20547417|P4|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
8335461|NCT01340872|20547418|P3|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
8335462|NCT01340872|20547419|P2|STARTED|Double-blind Phase||64
8335463|NCT01340872|20547420|P1|STARTED|Double-blind Phase||64
8335464|NCT01340794|20547480|P2|NOT COMPLETED|Overall Study||1
8335465|NCT01340794|20547481|P1|NOT COMPLETED|Overall Study||0
8335466|NCT01340794|20547480|P2|COMPLETED|Overall Study||4
8335467|NCT01340794|20547481|P1|COMPLETED|Overall Study||2
8335468|NCT01340794|20547480|P2|STARTED|Overall Study||5
8335469|NCT01340794|20547481|P1|STARTED|Overall Study||2
8335470|NCT01340768|20547497|P2|NOT COMPLETED|Overall Study||5
8335471|NCT01340768|20547498|P1|NOT COMPLETED|Overall Study||17
8335472|NCT01340768|20547497|P2|COMPLETED|Overall Study||429
8335473|NCT01340768|20547498|P1|COMPLETED|Overall Study||419
8335474|NCT01340768|20547497|P2|STARTED|Overall Study||434
8335475|NCT01340768|20547498|P1|STARTED|Overall Study||436
8335476|NCT01340664|20547509|P3|NOT COMPLETED|Overall Study||13
8335477|NCT01340664|20547510|P2|NOT COMPLETED|Overall Study||8
8335478|NCT01340664|20547511|P1|NOT COMPLETED|Overall Study||7
8335479|NCT01340664|20547509|P3|COMPLETED|Overall Study||80
8335480|NCT01340664|20547510|P2|COMPLETED|Overall Study||85
8335481|NCT01340664|20547511|P1|COMPLETED|Overall Study||86
8335482|NCT01340664|20547509|P3|STARTED|Overall Study||93
8335483|NCT01340664|20547510|P2|STARTED|Overall Study||93
8335484|NCT01340664|20547511|P1|STARTED|Overall Study||93
8335485|NCT01340651|20547528|P1|NOT COMPLETED|Overall Study||17
8335486|NCT01340651|20547528|P1|COMPLETED|Overall Study||24
8335487|NCT01340651|20547528|P1|STARTED|Overall Study||41
8335488|NCT01340625|20547544|P2|NOT COMPLETED|Second Intervention||0
8335489|NCT01340625|20547545|P1|NOT COMPLETED|Second Intervention||0
8335490|NCT01340625|20547544|P2|COMPLETED|Second Intervention||18
8335491|NCT01340625|20547545|P1|COMPLETED|Second Intervention||16
8335492|NCT01340625|20547544|P2|STARTED|Second Intervention||18
8335493|NCT01340625|20547545|P1|STARTED|Second Intervention||16
8335494|NCT01340625|20547544|P2|NOT COMPLETED|Washout Period of 28 Days||0
8335495|NCT01340625|20547545|P1|NOT COMPLETED|Washout Period of 28 Days||1
8335496|NCT01340625|20547544|P2|COMPLETED|Washout Period of 28 Days||18
8335497|NCT01340625|20547545|P1|COMPLETED|Washout Period of 28 Days||16
8335498|NCT01340625|20547544|P2|STARTED|Washout Period of 28 Days||18
8335499|NCT01340625|20547545|P1|STARTED|Washout Period of 28 Days||17
8335500|NCT01340625|20547544|P2|NOT COMPLETED|First Intervention||0
8335501|NCT01340625|20547545|P1|NOT COMPLETED|First Intervention||1
8335502|NCT01340625|20547544|P2|COMPLETED|First Intervention||18
8335503|NCT01340625|20547545|P1|COMPLETED|First Intervention||17
8335504|NCT01340625|20547544|P2|STARTED|First Intervention||18
8335505|NCT01340625|20547545|P1|STARTED|First Intervention||18
8335506|NCT01340586|20547563|P2|NOT COMPLETED|Overall Study||0
8335507|NCT01340586|20547564|P1|NOT COMPLETED|Overall Study||0
8335508|NCT01340586|20547563|P2|COMPLETED|Overall Study||8
8335509|NCT01340586|20547564|P1|COMPLETED|Overall Study||8
8335510|NCT01340586|20547563|P2|STARTED|Overall Study||8
8335511|NCT01340586|20547564|P1|STARTED|Overall Study||8
8335512|NCT01340573|20547629|P1|NOT COMPLETED|Overall Study||3
8335513|NCT01340573|20547629|P1|COMPLETED|Overall Study||0
8335514|NCT01340573|20547629|P1|STARTED|Overall Study||3
8335515|NCT01340495|20547650|P1|NOT COMPLETED|Overall Study||1
8335516|NCT01340495|20547650|P1|COMPLETED|Overall Study||69
8335517|NCT01340495|20547650|P1|STARTED|Overall Study||70
8335518|NCT01340482|20547660|P3|NOT COMPLETED|Overall Study||0
8335519|NCT01340482|20547661|P2|NOT COMPLETED|Overall Study||0
8335520|NCT01340482|20547662|P1|NOT COMPLETED|Overall Study||2
8335521|NCT01340482|20547660|P3|COMPLETED|Overall Study||1
8335522|NCT01340482|20547661|P2|COMPLETED|Overall Study||1
8335523|NCT01340482|20547662|P1|COMPLETED|Overall Study||25
8335524|NCT01340482|20547660|P3|STARTED|Overall Study||1
8335525|NCT01340482|20547661|P2|STARTED|Overall Study||1
8335526|NCT01340482|20547662|P1|STARTED|Overall Study||27
8335527|NCT01340300|20547677|P4|NOT COMPLETED|Overall Study||14
8335528|NCT01340300|20547678|P3|NOT COMPLETED|Overall Study||15
8335529|NCT01340300|20547679|P2|NOT COMPLETED|Overall Study||9
8335530|NCT01340300|20547680|P1|NOT COMPLETED|Overall Study||9
8335531|NCT01340300|20547677|P4|COMPLETED|Overall Study||20
8335532|NCT01340300|20547678|P3|COMPLETED|Overall Study||20
8335533|NCT01340300|20547679|P2|COMPLETED|Overall Study||26
8335534|NCT01340300|20547680|P1|COMPLETED|Overall Study||26
8335535|NCT01340300|20547677|P4|Follow-up Blood Sample|Overall Study||18
8335536|NCT01340300|20547678|P3|Follow-up Blood Sample|Overall Study||19
8335537|NCT01340300|20547679|P2|Follow-up Blood Sample|Overall Study||26
8335538|NCT01340300|20547680|P1|Follow-up Blood Sample|Overall Study||25
8335539|NCT01340300|20547677|P4|Baseline Blood Sample|Overall Study||29
8335540|NCT01340300|20547678|P3|Baseline Blood Sample|Overall Study||32
8335541|NCT01340300|20547679|P2|Baseline Blood Sample|Overall Study||34
8335542|NCT01340300|20547680|P1|Baseline Blood Sample|Overall Study||33
8335543|NCT01340300|20547677|P4|STARTED|Overall Study||34
8335544|NCT01340300|20547678|P3|STARTED|Overall Study||35
8335545|NCT01340300|20547679|P2|STARTED|Overall Study||35
8335546|NCT01340300|20547680|P1|STARTED|Overall Study||35
8335547|NCT01340209|20547713|P3|NOT COMPLETED|Overall Study||8
8335548|NCT01340209|20547714|P2|NOT COMPLETED|Overall Study||8
8335549|NCT01340209|20547715|P1|NOT COMPLETED|Overall Study||5
8335550|NCT01340209|20547713|P3|COMPLETED|Overall Study||106
8335551|NCT01340209|20547714|P2|COMPLETED|Overall Study||106
8335552|NCT01340209|20547715|P1|COMPLETED|Overall Study||52
8335553|NCT01340209|20547713|P3|STARTED|Overall Study||114
8335554|NCT01340209|20547714|P2|STARTED|Overall Study||114
8335555|NCT01340209|20547715|P1|STARTED|Overall Study||57
8335556|NCT01340196|20547750|P1|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
8335557|NCT01340196|20547750|P1|COMPLETED|Treat. Period 3 (Faldaprevir)||14
8335558|NCT01340196|20547750|P1|STARTED|Treat. Period 3 (Faldaprevir)||16
8335559|NCT01340196|20547750|P1|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
8335560|NCT01340196|20547750|P1|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
8335561|NCT01340196|20547750|P1|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
8335562|NCT01340196|20547750|P1|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
8335563|NCT01340196|20547750|P1|COMPLETED|Treat. Period 1 (Tenofovir)||16
8335564|NCT01340196|20547750|P1|STARTED|Treat. Period 1 (Tenofovir)||16
8335565|NCT01340144|20547781|P2|NOT COMPLETED|Overall Study||58
8335566|NCT01340144|20547782|P1|NOT COMPLETED|Overall Study||72
8335567|NCT01340144|20547781|P2|COMPLETED|Overall Study||567
8335568|NCT01340144|20547782|P1|COMPLETED|Overall Study||553
8335569|NCT01340144|20547781|P2|STARTED|Overall Study||625
8335570|NCT01340144|20547782|P1|STARTED|Overall Study||625
8335571|NCT01340066|20547790|P3|NOT COMPLETED|5 Week Double Blind Randomization Period||3
8335572|NCT01340066|20547791|P2|NOT COMPLETED|5 Week Double Blind Randomization Period||5
8335573|NCT01340066|20547792|P1|NOT COMPLETED|5 Week Double Blind Randomization Period||0
8335574|NCT01340066|20547790|P3|COMPLETED|5 Week Double Blind Randomization Period||31
8335575|NCT01340066|20547791|P2|COMPLETED|5 Week Double Blind Randomization Period||28
8335576|NCT01340066|20547792|P1|COMPLETED|5 Week Double Blind Randomization Period||0
8335577|NCT01340066|20547790|P3|STARTED|5 Week Double Blind Randomization Period||34
8335578|NCT01340066|20547791|P2|STARTED|5 Week Double Blind Randomization Period||33
8335579|NCT01340066|20547792|P1|STARTED|5 Week Double Blind Randomization Period||0
8335580|NCT01340066|20547790|P3|NOT COMPLETED|Placebo Run in Period||0
8335581|NCT01340066|20547791|P2|NOT COMPLETED|Placebo Run in Period||0
8335582|NCT01340066|20547792|P1|NOT COMPLETED|Placebo Run in Period||27
8335583|NCT01340066|20547790|P3|COMPLETED|Placebo Run in Period||0
8335584|NCT01340066|20547791|P2|COMPLETED|Placebo Run in Period||0
8335585|NCT01340066|20547792|P1|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
8335586|NCT01340066|20547790|P3|STARTED|Placebo Run in Period||0
8335587|NCT01340066|20547791|P2|STARTED|Placebo Run in Period||0
8335588|NCT01340066|20547792|P1|STARTED|Placebo Run in Period||94
8335589|NCT01340053|20547803|P4|NOT COMPLETED|Overall Study||3
8335590|NCT01340053|20547804|P3|NOT COMPLETED|Overall Study||4
8335591|NCT01340053|20547805|P2|NOT COMPLETED|Overall Study||2
8335592|NCT01340053|20547806|P1|NOT COMPLETED|Overall Study||4
8335593|NCT01340053|20547803|P4|COMPLETED|Overall Study||43
8335594|NCT01340053|20547804|P3|COMPLETED|Overall Study||43
8335595|NCT01340053|20547805|P2|COMPLETED|Overall Study||44
8335596|NCT01340053|20547806|P1|COMPLETED|Overall Study||43
8335597|NCT01340053|20547803|P4|STARTED|Overall Study||46
8335598|NCT01340053|20547804|P3|STARTED|Overall Study||47
8335599|NCT01340053|20547805|P2|STARTED|Overall Study||46
8335600|NCT01340053|20547806|P1|STARTED|Overall Study||47
8335601|NCT01340027|20547832|P12|NOT COMPLETED|Overall Study||4
8335602|NCT01340027|20547833|P11|NOT COMPLETED|Overall Study||2
8335603|NCT01340027|20547834|P10|NOT COMPLETED|Overall Study||6
8335604|NCT01340027|20547835|P9|NOT COMPLETED|Overall Study||8
8335605|NCT01340027|20547836|P8|NOT COMPLETED|Overall Study||7
8335606|NCT01340027|20547837|P7|NOT COMPLETED|Overall Study||7
8335607|NCT01340027|20547838|P6|NOT COMPLETED|Overall Study||4
8335608|NCT01340027|20547839|P5|NOT COMPLETED|Overall Study||10
8335609|NCT01340027|20547840|P4|NOT COMPLETED|Overall Study||4
8335610|NCT01340027|20547841|P3|NOT COMPLETED|Overall Study||4
8335611|NCT01340027|20547842|P2|NOT COMPLETED|Overall Study||7
8335612|NCT01340027|20547843|P1|NOT COMPLETED|Overall Study||5
8335613|NCT01340027|20547832|P12|COMPLETED|Overall Study||77
8335614|NCT01340027|20547833|P11|COMPLETED|Overall Study||79
8335615|NCT01340027|20547834|P10|COMPLETED|Overall Study||146
8335616|NCT01340027|20547835|P9|COMPLETED|Overall Study||136
8335617|NCT01340027|20547836|P8|COMPLETED|Overall Study||142
8335618|NCT01340027|20547837|P7|COMPLETED|Overall Study||142
8335619|NCT01340027|20547838|P6|COMPLETED|Overall Study||74
8335620|NCT01340027|20547839|P5|COMPLETED|Overall Study||146
8335621|NCT01340027|20547840|P4|COMPLETED|Overall Study||75
8335622|NCT01340027|20547841|P3|COMPLETED|Overall Study||75
8335623|NCT01340027|20547842|P2|COMPLETED|Overall Study||71
8335624|NCT01340027|20547843|P1|COMPLETED|Overall Study||76
8335625|NCT01340027|20547832|P12|Received Treatment|Overall Study||81
8335626|NCT01340027|20547833|P11|Received Treatment|Overall Study||81
8335627|NCT01340027|20547834|P10|Received Treatment|Overall Study||152
8335628|NCT01340027|20547835|P9|Received Treatment|Overall Study||144
8335629|NCT01340027|20547836|P8|Received Treatment|Overall Study||149
8335630|NCT01340027|20547837|P7|Received Treatment|Overall Study||149
8335631|NCT01340027|20547838|P6|Received Treatment|Overall Study||78
8335632|NCT01340027|20547839|P5|Received Treatment|Overall Study||156
8335633|NCT01340027|20547840|P4|Received Treatment|Overall Study||79
8335634|NCT01340027|20547841|P3|Received Treatment|Overall Study||78
8335635|NCT01340027|20547842|P2|Received Treatment|Overall Study||78
8335636|NCT01340027|20547843|P1|Received Treatment|Overall Study||81
8335637|NCT01340027|20547832|P12|STARTED|Overall Study||81
8335638|NCT01340027|20547833|P11|STARTED|Overall Study||81
8335639|NCT01340027|20547834|P10|STARTED|Overall Study||152
8335640|NCT01340027|20547835|P9|STARTED|Overall Study||144
8335641|NCT01340027|20547836|P8|STARTED|Overall Study||149
8335642|NCT01340027|20547837|P7|STARTED|Overall Study||149
8335643|NCT01340027|20547838|P6|STARTED|Overall Study||78
8335644|NCT01340027|20547839|P5|STARTED|Overall Study||156
8335645|NCT01340027|20547840|P4|STARTED|Overall Study||79
8335646|NCT01340027|20547841|P3|STARTED|Overall Study||79
8335647|NCT01340027|20547842|P2|STARTED|Overall Study||78
8335648|NCT01340027|20547843|P1|STARTED|Overall Study||81
8335649|NCT01340014|20548219|P2|NOT COMPLETED|Period 2, Second 7 Days||1
8335650|NCT01340014|20548220|P1|NOT COMPLETED|Period 2, Second 7 Days||0
8335651|NCT01340014|20548219|P2|COMPLETED|Period 2, Second 7 Days||56
8335652|NCT01340014|20548220|P1|COMPLETED|Period 2, Second 7 Days||53
8335653|NCT01340014|20548219|P2|STARTED|Period 2, Second 7 Days||57
8335654|NCT01340014|20548220|P1|STARTED|Period 2, Second 7 Days||53
8335655|NCT01340014|20548219|P2|NOT COMPLETED|Period 1, First 7 Days||0
8335656|NCT01340014|20548220|P1|NOT COMPLETED|Period 1, First 7 Days||2
8335657|NCT01340014|20548219|P2|COMPLETED|Period 1, First 7 Days||57
8335658|NCT01340014|20548220|P1|COMPLETED|Period 1, First 7 Days||53
8335659|NCT01340014|20548219|P2|STARTED|Period 1, First 7 Days||57
8335660|NCT01340014|20548220|P1|STARTED|Period 1, First 7 Days||55
8335661|NCT01339936|20548228|P1|NOT COMPLETED|Overall Study||2
8335662|NCT01339936|20548228|P1|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
8335663|NCT01339936|20548228|P1|STARTED|Overall Study|plus 2 screen failures|38
8335664|NCT01339923|20548241|P7|NOT COMPLETED|Overall Study||14
8335665|NCT01339923|20548242|P6|NOT COMPLETED|Overall Study||9
8335666|NCT01339923|20548243|P5|NOT COMPLETED|Overall Study||5
8335667|NCT01339923|20548244|P4|NOT COMPLETED|Overall Study||4
8335668|NCT01339923|20548245|P3|NOT COMPLETED|Overall Study||8
8335669|NCT01339923|20548246|P2|NOT COMPLETED|Overall Study||16
8335670|NCT01339923|20548247|P1|NOT COMPLETED|Overall Study||14
8335671|NCT01339923|20548241|P7|COMPLETED|Overall Study||111
8335672|NCT01339923|20548242|P6|COMPLETED|Overall Study||117
8335673|NCT01339923|20548243|P5|COMPLETED|Overall Study||295
8335674|NCT01339923|20548244|P4|COMPLETED|Overall Study||100
8335675|NCT01339923|20548245|P3|COMPLETED|Overall Study||243
8335676|NCT01339923|20548246|P2|COMPLETED|Overall Study||234
8335677|NCT01339923|20548247|P1|COMPLETED|Overall Study||239
8335678|NCT01339923|20548241|P7|STARTED|Overall Study||125
8335679|NCT01339923|20548242|P6|STARTED|Overall Study||126
8335680|NCT01339923|20548243|P5|STARTED|Overall Study||300
8335681|NCT01339923|20548244|P4|STARTED|Overall Study||104
8335682|NCT01339923|20548245|P3|STARTED|Overall Study||251
8335683|NCT01339923|20548246|P2|STARTED|Overall Study||250
8335684|NCT01339923|20548247|P1|STARTED|Overall Study||253
8335685|NCT01339910|20548318|P2|NOT COMPLETED|Overall Study||4
8335686|NCT01339910|20548319|P1|NOT COMPLETED|Overall Study||3
8335687|NCT01339910|20548318|P2|COMPLETED|Overall Study||133
8335688|NCT01339910|20548319|P1|COMPLETED|Overall Study||132
8335689|NCT01339910|20548318|P2|STARTED|Overall Study||137
8335690|NCT01339910|20548319|P1|STARTED|Overall Study||135
8335691|NCT01339897|20548357|P4|NOT COMPLETED|Overall Study||1
8335692|NCT01339897|20548358|P3|NOT COMPLETED|Overall Study||0
8335693|NCT01339897|20548359|P2|NOT COMPLETED|Overall Study||0
8335694|NCT01339897|20548360|P1|NOT COMPLETED|Overall Study||1
8335695|NCT01339897|20548357|P4|COMPLETED|Overall Study||5
8335696|NCT01339897|20548358|P3|COMPLETED|Overall Study||6
8335697|NCT01339897|20548359|P2|COMPLETED|Overall Study||6
8335698|NCT01339897|20548360|P1|COMPLETED|Overall Study||6
8335699|NCT01339897|20548357|P4|STARTED|Overall Study||6
8335700|NCT01339897|20548358|P3|STARTED|Overall Study||6
8335701|NCT01339897|20548359|P2|STARTED|Overall Study||6
8335702|NCT01339897|20548360|P1|STARTED|Overall Study||7
8335703|NCT01339858|20548388|P2|NOT COMPLETED|Overall Study||12
8335704|NCT01339858|20548389|P1|NOT COMPLETED|Overall Study||16
8335705|NCT01339858|20548388|P2|COMPLETED|Overall Study||18
8335706|NCT01339858|20548389|P1|COMPLETED|Overall Study||14
8335707|NCT01339858|20548388|P2|STARTED|Overall Study||30
8335708|NCT01339858|20548389|P1|STARTED|Overall Study||30
8335709|NCT01339832|20548413|P1|NOT COMPLETED|Overall Study||14
8335710|NCT01339832|20548413|P1|COMPLETED|Overall Study||37
8335711|NCT01339832|20548413|P1|STARTED|Overall Study||51
8335715|NCT01339429|20548433|P1|NOT COMPLETED|Overall Study||4
8335716|NCT01339429|20548433|P1|COMPLETED|Overall Study||37
8335717|NCT01339429|20548433|P1|STARTED|Overall Study||41
8335718|NCT01339416|20548438|P1|NOT COMPLETED|Overall Study||0
8335719|NCT01339416|20548438|P1|COMPLETED|Overall Study||8202
8335720|NCT01339416|20548438|P1|STARTED|Overall Study||8202
8335721|NCT01339403|20548450|P2|NOT COMPLETED|Overall Study||0
8335722|NCT01339403|20548451|P1|NOT COMPLETED|Overall Study||0
8335723|NCT01339403|20548450|P2|COMPLETED|Overall Study||257600
8335724|NCT01339403|20548451|P1|COMPLETED|Overall Study||24768
8335725|NCT01339403|20548450|P2|STARTED|Overall Study||257600
8335726|NCT01339403|20548451|P1|STARTED|Overall Study||24768
8335727|NCT01339390|20548473|P2|NOT COMPLETED|Overall Study||156
8335728|NCT01339390|20548474|P1|NOT COMPLETED|Overall Study||157
8335729|NCT01339390|20548473|P2|COMPLETED|Overall Study||1442
8335730|NCT01339390|20548474|P1|COMPLETED|Overall Study||1414
8335731|NCT01339390|20548473|P2|STARTED|Overall Study||1598
8335732|NCT01339390|20548474|P1|STARTED|Overall Study||1571
8335733|NCT01339299|20548482|P2|NOT COMPLETED|Overall Study||0
8335734|NCT01339299|20548483|P1|NOT COMPLETED|Overall Study||0
8335735|NCT01339299|20548482|P2|COMPLETED|Overall Study||50
8335736|NCT01339299|20548483|P1|COMPLETED|Overall Study||50
8335737|NCT01339299|20548482|P2|STARTED|Overall Study||50
8335738|NCT01339299|20548483|P1|STARTED|Overall Study||50
8335739|NCT01339273|20548491|P2|NOT COMPLETED|Overall Study||8
8335740|NCT01339273|20548492|P1|NOT COMPLETED|Overall Study||8
8335741|NCT01339273|20548491|P2|COMPLETED|Overall Study||28
8335742|NCT01339273|20548492|P1|COMPLETED|Overall Study||28
8335743|NCT01339273|20548491|P2|STARTED|Overall Study||36
8335744|NCT01339273|20548492|P1|STARTED|Overall Study||36
8335745|NCT01339260|20548526|P2|NOT COMPLETED|Multi-cycle Extension||193
8335746|NCT01339260|20548527|P1|NOT COMPLETED|Multi-cycle Extension||186
8335747|NCT01339260|20548526|P2|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
8335748|NCT01339260|20548527|P1|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
8335749|NCT01339260|20548526|P2|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
8335750|NCT01339260|20548527|P1|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
8335751|NCT01339260|20548526|P2|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
8335752|NCT01339260|20548527|P1|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
8335753|NCT01339260|20548526|P2|NOT COMPLETED|Cycle 1||10
8335754|NCT01339260|20548527|P1|NOT COMPLETED|Cycle 1||7
8335755|NCT01339260|20548526|P2|COMPLETED|Cycle 1||719
8335756|NCT01339260|20548527|P1|COMPLETED|Cycle 1||719
8335757|NCT01339260|20548526|P2|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
8335758|NCT01339260|20548527|P1|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
8335759|NCT01339260|20548526|P2|Safety Population|Cycle 1|Patients receiving palonosetron|725
8335760|NCT01339260|20548527|P1|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
8335761|NCT01339260|20548526|P2|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
8335762|NCT01339260|20548527|P1|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
8335763|NCT01339247|20548539|P2|NOT COMPLETED|Period 2||0
8335764|NCT01339247|20548540|P1|NOT COMPLETED|Period 2||0
8335765|NCT01339247|20548539|P2|COMPLETED|Period 2||30
8335766|NCT01339247|20548540|P1|COMPLETED|Period 2||30
8335767|NCT01339247|20548539|P2|STARTED|Period 2||30
8335768|NCT01339247|20548540|P1|STARTED|Period 2||30
8335769|NCT01339247|20548539|P2|NOT COMPLETED|Period 1||0
8335770|NCT01339247|20548540|P1|NOT COMPLETED|Period 1||0
8335771|NCT01339247|20548539|P2|COMPLETED|Period 1||30
8335772|NCT01339247|20548540|P1|COMPLETED|Period 1||30
8335773|NCT01339247|20548539|P2|STARTED|Period 1||30
8335774|NCT01339247|20548540|P1|STARTED|Period 1||30
8335775|NCT01339091|20548552|P2|NOT COMPLETED|Overall Study||28
8335776|NCT01339091|20548553|P1|NOT COMPLETED|Overall Study||27
8335777|NCT01339091|20548552|P2|COMPLETED|Overall Study||257
8335778|NCT01339091|20548553|P1|COMPLETED|Overall Study||261
8335779|NCT01339091|20548552|P2|Safety Population|Overall Study||284
8335780|NCT01339091|20548553|P1|Safety Population|Overall Study||284
8335781|NCT01339091|20548552|P2|STARTED|Overall Study||285
8335782|NCT01339091|20548553|P1|STARTED|Overall Study||288
8335783|NCT01339052|20548567|P2|NOT COMPLETED|Overall Study||50
8335784|NCT01339052|20548568|P1|NOT COMPLETED|Overall Study||15
8335785|NCT01339052|20548567|P2|COMPLETED|Overall Study||0
8335786|NCT01339052|20548568|P1|COMPLETED|Overall Study||0
8335787|NCT01339052|20548567|P2|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
8335788|NCT01339052|20548568|P1|Evaluable Plasma Sample at Surgery|Overall Study||13
8335789|NCT01339052|20548567|P2|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
8335790|NCT01339052|20548568|P1|Evaluable Tumor Sample at Surgery|Overall Study||14
8335791|NCT01339052|20548567|P2|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
8335792|NCT01339052|20548568|P1|Measurable Disease|Overall Study||11
8335793|NCT01339052|20548567|P2|STARTED|Overall Study||50
8335794|NCT01339052|20548568|P1|STARTED|Overall Study||15
8335795|NCT01339013|20548588|P1|NOT COMPLETED|Overall Study||0
8335796|NCT01339013|20548588|P1|COMPLETED|Overall Study||6
8335797|NCT01339013|20548588|P1|STARTED|Overall Study||6
8335798|NCT01339000|20548594|P2|NOT COMPLETED|Overall Study||0
8335799|NCT01339000|20548595|P1|NOT COMPLETED|Overall Study||1
8335800|NCT01339000|20548594|P2|COMPLETED|Overall Study||0
8335801|NCT01339000|20548595|P1|COMPLETED|Overall Study||0
8335802|NCT01339000|20548594|P2|STARTED|Overall Study||0
8335803|NCT01339000|20548595|P1|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
8335819|NCT01338870|20548639|P6|NOT COMPLETED|Overall Study||6
8335820|NCT01338870|20548640|P5|NOT COMPLETED|Overall Study||6
8335821|NCT01338870|20548641|P4|NOT COMPLETED|Overall Study||9
8335822|NCT01338870|20548642|P3|NOT COMPLETED|Overall Study||11
8335823|NCT01338870|20548643|P2|NOT COMPLETED|Overall Study||12
8335824|NCT01338870|20548644|P1|NOT COMPLETED|Overall Study||9
8335825|NCT01338870|20548639|P6|COMPLETED|Overall Study||44
8335826|NCT01338870|20548640|P5|COMPLETED|Overall Study||46
8335827|NCT01338870|20548641|P4|COMPLETED|Overall Study||41
8335828|NCT01338870|20548642|P3|COMPLETED|Overall Study||39
8335829|NCT01338870|20548643|P2|COMPLETED|Overall Study||37
8335830|NCT01338870|20548644|P1|COMPLETED|Overall Study||41
8335831|NCT01338870|20548639|P6|STARTED|Overall Study||50
8335832|NCT01338870|20548640|P5|STARTED|Overall Study||52
8335833|NCT01338870|20548641|P4|STARTED|Overall Study||50
8335834|NCT01338870|20548642|P3|STARTED|Overall Study||50
8335835|NCT01338870|20548643|P2|STARTED|Overall Study||49
8335836|NCT01338870|20548644|P1|STARTED|Overall Study||50
8335837|NCT01338857|20548694|P1|NOT COMPLETED|Overall Study||11
8335838|NCT01338857|20548694|P1|COMPLETED|Overall Study||1
8335839|NCT01338857|20548694|P1|STARTED|Overall Study||12
8335840|NCT01338818|20548699|P1|NOT COMPLETED|Overall Study||36
8335841|NCT01338818|20548699|P1|COMPLETED|Overall Study||262
8335842|NCT01338818|20548699|P1|STARTED|Overall Study||298
8335843|NCT01338792|20548705|P1|NOT COMPLETED|Overall Study||4
8335844|NCT01338792|20548705|P1|COMPLETED|Overall Study||43
8335845|NCT01338792|20548705|P1|STARTED|Overall Study||47
8335846|NCT01338649|20548713|P2|NOT COMPLETED|Overall Study||0
8335847|NCT01338649|20548714|P1|NOT COMPLETED|Overall Study||0
8335848|NCT01338649|20548713|P2|COMPLETED|Overall Study||14
8335849|NCT01338649|20548714|P1|COMPLETED|Overall Study||13
8335850|NCT01338649|20548713|P2|STARTED|Overall Study||14
8335851|NCT01338649|20548714|P1|STARTED|Overall Study||13
8335852|NCT01338636|20548720|P1|NOT COMPLETED|Overall Study||8
8335853|NCT01338636|20548720|P1|COMPLETED|Overall Study||22
8335854|NCT01338636|20548720|P1|STARTED|Overall Study||30
8335855|NCT01338610|20548734|P3|NOT COMPLETED|Overall Study||1
8335856|NCT01338610|20548735|P2|NOT COMPLETED|Overall Study||1
8335857|NCT01338610|20548736|P1|NOT COMPLETED|Overall Study||5
8335858|NCT01338610|20548734|P3|COMPLETED|Overall Study||28
8335859|NCT01338610|20548735|P2|COMPLETED|Overall Study||55
8335860|NCT01338610|20548736|P1|COMPLETED|Overall Study||34
8335861|NCT01338610|20548734|P3|STARTED|Overall Study||29
8335862|NCT01338610|20548735|P2|STARTED|Overall Study||56
8335863|NCT01338610|20548736|P1|STARTED|Overall Study||39
8335864|NCT01338506|20548745|P2|NOT COMPLETED|Overall Study||14
8335865|NCT01338506|20548746|P1|NOT COMPLETED|Overall Study||25
8335866|NCT01338506|20548745|P2|COMPLETED|Overall Study||13
8335867|NCT01338506|20548746|P1|COMPLETED|Overall Study||29
8335868|NCT01338506|20548745|P2|STARTED|Overall Study||27
8335869|NCT01338506|20548746|P1|STARTED|Overall Study||54
8335870|NCT01338493|20548762|P1|NOT COMPLETED|24 Months Follow up||0
8335871|NCT01338493|20548762|P1|COMPLETED|24 Months Follow up||104
8335872|NCT01338493|20548762|P1|STARTED|24 Months Follow up||104
8335873|NCT01338493|20548762|P1|NOT COMPLETED|12 Months Follow up||9
8335874|NCT01338493|20548762|P1|COMPLETED|12 Months Follow up||104
8335875|NCT01338493|20548762|P1|STARTED|12 Months Follow up||113
8335876|NCT01338493|20548762|P1|NOT COMPLETED|6 Months Follow up||19
8335877|NCT01338493|20548762|P1|COMPLETED|6 Months Follow up||113
8335878|NCT01338493|20548762|P1|STARTED|6 Months Follow up||132
8335879|NCT01338493|20548762|P1|NOT COMPLETED|Discharge||2
8335880|NCT01338493|20548762|P1|COMPLETED|Discharge||132
8335881|NCT01338493|20548762|P1|STARTED|Discharge||134
8335882|NCT01338493|20548762|P1|NOT COMPLETED|Implant||0
8335883|NCT01338493|20548762|P1|COMPLETED|Implant||134
8335884|NCT01338493|20548762|P1|STARTED|Implant||134
8335885|NCT01338493|20548762|P1|NOT COMPLETED|Enrolled||5
8335886|NCT01338493|20548762|P1|COMPLETED|Enrolled||134
8335887|NCT01338493|20548762|P1|STARTED|Enrolled||139
8335896|NCT01338298|20548792|P2|NOT COMPLETED|Overall Study||3
8335897|NCT01338298|20548793|P1|NOT COMPLETED|Overall Study||4
8335898|NCT01338298|20548792|P2|COMPLETED|Overall Study||15
8335899|NCT01338298|20548793|P1|COMPLETED|Overall Study||20
8335900|NCT01338298|20548792|P2|STARTED|Overall Study||18
8335901|NCT01338298|20548793|P1|STARTED|Overall Study||24
8335902|NCT01338025|20548803|P2|NOT COMPLETED|Overall Study||11
8335903|NCT01338025|20548804|P1|NOT COMPLETED|Overall Study||11
8335904|NCT01338025|20548803|P2|COMPLETED|Overall Study||6
8335905|NCT01338025|20548804|P1|COMPLETED|Overall Study||5
8335906|NCT01338025|20548803|P2|STARTED|Overall Study||17
8335907|NCT01338025|20548804|P1|STARTED|Overall Study||16
8335908|NCT01338012|20548816|P1|NOT COMPLETED|Overall Study||8
8335909|NCT01338012|20548816|P1|COMPLETED|Overall Study||0
8335910|NCT01338012|20548816|P1|STARTED|Overall Study||8
8335911|NCT01337986|20548822|P2|NOT COMPLETED|Overall Study||5
8335912|NCT01337986|20548823|P1|NOT COMPLETED|Overall Study||3
8335913|NCT01337986|20548822|P2|COMPLETED|Overall Study||18
8335914|NCT01337986|20548823|P1|COMPLETED|Overall Study||20
8335915|NCT01337986|20548822|P2|STARTED|Overall Study||23
8335916|NCT01337986|20548823|P1|STARTED|Overall Study||23
8335917|NCT01337973|20548860|P3|NOT COMPLETED|Overall Study||11
8335918|NCT01337973|20548861|P2|NOT COMPLETED|Overall Study||15
8335919|NCT01337973|20548862|P1|NOT COMPLETED|Overall Study||16
8335920|NCT01337973|20548860|P3|COMPLETED|Overall Study||49
8335921|NCT01337973|20548861|P2|COMPLETED|Overall Study||45
8335922|NCT01337973|20548862|P1|COMPLETED|Overall Study||44
8335923|NCT01337973|20548860|P3|STARTED|Overall Study||60
8335924|NCT01337973|20548861|P2|STARTED|Overall Study||60
8335925|NCT01337973|20548862|P1|STARTED|Overall Study||60
8335926|NCT01337960|20548876|P3|NOT COMPLETED|Overall Study||0
8335927|NCT01337960|20548877|P2|NOT COMPLETED|Overall Study||0
8335928|NCT01337960|20548878|P1|NOT COMPLETED|Overall Study||2
8335929|NCT01337960|20548876|P3|COMPLETED|Overall Study||6
8335930|NCT01337960|20548877|P2|COMPLETED|Overall Study||14
8335931|NCT01337960|20548878|P1|COMPLETED|Overall Study||12
8335932|NCT01337960|20548876|P3|STARTED|Overall Study||6
8335933|NCT01337960|20548877|P2|STARTED|Overall Study||14
8335934|NCT01337960|20548878|P1|STARTED|Overall Study||14
8335935|NCT01337739|20548900|P2|NOT COMPLETED|Overall Study||0
8335936|NCT01337739|20548901|P1|NOT COMPLETED|Overall Study||0
8335937|NCT01337739|20548900|P2|COMPLETED|Overall Study||4
8335938|NCT01337739|20548901|P1|COMPLETED|Overall Study||6
8335939|NCT01337739|20548900|P2|STARTED|Overall Study||4
8335940|NCT01337739|20548901|P1|STARTED|Overall Study||6
8335941|NCT01337700|20548911|P2|NOT COMPLETED|Overall Study||0
8335942|NCT01337700|20548912|P1|NOT COMPLETED|Overall Study||0
8335943|NCT01337700|20548911|P2|COMPLETED|Overall Study||5
8335944|NCT01337700|20548912|P1|COMPLETED|Overall Study||5
8335945|NCT01337700|20548911|P2|STARTED|Overall Study||5
8335946|NCT01337700|20548912|P1|STARTED|Overall Study||5
8335947|NCT01337687|20548928|P2|NOT COMPLETED|Overall Study||0
8335948|NCT01337687|20548929|P1|NOT COMPLETED|Overall Study||0
8335949|NCT01337687|20548928|P2|COMPLETED|Overall Study||9
8335950|NCT01337687|20548929|P1|COMPLETED|Overall Study||10
8335951|NCT01337687|20548928|P2|STARTED|Overall Study||9
8335952|NCT01337687|20548929|P1|STARTED|Overall Study||10
8335953|NCT01337674|20548943|P4|NOT COMPLETED|Treatment Period 2||0
8335954|NCT01337674|20548944|P3|NOT COMPLETED|Treatment Period 2||1
8335955|NCT01337674|20548945|P2|NOT COMPLETED|Treatment Period 2||0
8335956|NCT01337674|20548946|P1|NOT COMPLETED|Treatment Period 2||0
8335957|NCT01337674|20548943|P4|COMPLETED|Treatment Period 2||6
8335958|NCT01337674|20548944|P3|COMPLETED|Treatment Period 2||5
8335959|NCT01337674|20548945|P2|COMPLETED|Treatment Period 2||6
8335960|NCT01337674|20548946|P1|COMPLETED|Treatment Period 2||6
8335961|NCT01337674|20548943|P4|STARTED|Treatment Period 2||6
8335962|NCT01337674|20548944|P3|STARTED|Treatment Period 2||6
8335963|NCT01337674|20548945|P2|STARTED|Treatment Period 2||6
8335964|NCT01337674|20548946|P1|STARTED|Treatment Period 2||6
8335965|NCT01337674|20548943|P4|NOT COMPLETED|Two-week Washout Period||0
8335966|NCT01337674|20548944|P3|NOT COMPLETED|Two-week Washout Period||0
8335967|NCT01337674|20548945|P2|NOT COMPLETED|Two-week Washout Period||0
8335968|NCT01337674|20548946|P1|NOT COMPLETED|Two-week Washout Period||0
8335969|NCT01337674|20548943|P4|COMPLETED|Two-week Washout Period||6
8335970|NCT01337674|20548944|P3|COMPLETED|Two-week Washout Period||6
8335971|NCT01337674|20548945|P2|COMPLETED|Two-week Washout Period||6
8335972|NCT01337674|20548946|P1|COMPLETED|Two-week Washout Period||6
8335973|NCT01337674|20548943|P4|STARTED|Two-week Washout Period||6
8335974|NCT01337674|20548944|P3|STARTED|Two-week Washout Period||6
8335975|NCT01337674|20548945|P2|STARTED|Two-week Washout Period||6
8335976|NCT01337674|20548946|P1|STARTED|Two-week Washout Period||6
8335977|NCT01337674|20548943|P4|NOT COMPLETED|Treatment Period 1||1
8335978|NCT01337674|20548944|P3|NOT COMPLETED|Treatment Period 1||0
8335979|NCT01337674|20548945|P2|NOT COMPLETED|Treatment Period 1||1
8335980|NCT01337674|20548946|P1|NOT COMPLETED|Treatment Period 1||0
8335981|NCT01337674|20548943|P4|COMPLETED|Treatment Period 1||6
8335982|NCT01337674|20548944|P3|COMPLETED|Treatment Period 1||6
8335983|NCT01337674|20548945|P2|COMPLETED|Treatment Period 1||6
8335984|NCT01337674|20548946|P1|COMPLETED|Treatment Period 1||6
8335985|NCT01337674|20548943|P4|STARTED|Treatment Period 1|The discontinued participant was replaced|7
8335986|NCT01337674|20548944|P3|STARTED|Treatment Period 1||6
8335987|NCT01337674|20548945|P2|STARTED|Treatment Period 1|The discontinued participant was replaced|7
8335988|NCT01337674|20548946|P1|STARTED|Treatment Period 1||6
8335989|NCT01337635|20548964|P2|NOT COMPLETED|Overall Study||1
8335990|NCT01337635|20548965|P1|NOT COMPLETED|Overall Study||0
8335991|NCT01337635|20548964|P2|COMPLETED|Overall Study||3
8335992|NCT01337635|20548965|P1|COMPLETED|Overall Study||3
8335993|NCT01337635|20548964|P2|STARTED|Overall Study||4
8335994|NCT01337635|20548965|P1|STARTED|Overall Study||3
8335995|NCT01337609|20548976|P3|NOT COMPLETED|Overall Study||0
8335996|NCT01337609|20548977|P2|NOT COMPLETED|Overall Study||0
8335997|NCT01337609|20548978|P1|NOT COMPLETED|Overall Study||1
8335998|NCT01337609|20548976|P3|COMPLETED|Overall Study||2
8335999|NCT01337609|20548977|P2|COMPLETED|Overall Study||2
8336000|NCT01337609|20548978|P1|COMPLETED|Overall Study||0
8336001|NCT01337609|20548976|P3|STARTED|Overall Study||2
8336002|NCT01337609|20548977|P2|STARTED|Overall Study||2
8336003|NCT01337609|20548978|P1|STARTED|Overall Study||1
8336004|NCT01337596|20549007|P9|NOT COMPLETED|Overall Study||0
8336005|NCT01337596|20549008|P8|NOT COMPLETED|Overall Study||0
8336006|NCT01337596|20549009|P7|NOT COMPLETED|Overall Study||0
8336007|NCT01337596|20549010|P6|NOT COMPLETED|Overall Study||0
8336008|NCT01337596|20549011|P5|NOT COMPLETED|Overall Study||2
8336009|NCT01337596|20549012|P4|NOT COMPLETED|Overall Study||0
8336010|NCT01337596|20549013|P3|NOT COMPLETED|Overall Study||0
8336011|NCT01337596|20549014|P2|NOT COMPLETED|Overall Study||0
8336012|NCT01337596|20549015|P1|NOT COMPLETED|Overall Study||0
8336013|NCT01337596|20549007|P9|COMPLETED|Overall Study||7
8336014|NCT01337596|20549008|P8|COMPLETED|Overall Study||2
8336015|NCT01337596|20549009|P7|COMPLETED|Overall Study||12
8336016|NCT01337596|20549010|P6|COMPLETED|Overall Study||7
8336017|NCT01337596|20549011|P5|COMPLETED|Overall Study||5
8336018|NCT01337596|20549012|P4|COMPLETED|Overall Study||7
8336019|NCT01337596|20549013|P3|COMPLETED|Overall Study||7
8336020|NCT01337596|20549014|P2|COMPLETED|Overall Study||7
8336021|NCT01337596|20549015|P1|COMPLETED|Overall Study||7
8336022|NCT01337596|20549007|P9|Safety Population|Overall Study||7
8336023|NCT01337596|20549008|P8|Safety Population|Overall Study||2
8336024|NCT01337596|20549009|P7|Safety Population|Overall Study||12
8336025|NCT01337596|20549010|P6|Safety Population|Overall Study||7
8336026|NCT01337596|20549011|P5|Safety Population|Overall Study||7
8336027|NCT01337596|20549012|P4|Safety Population|Overall Study||7
8336028|NCT01337596|20549013|P3|Safety Population|Overall Study||7
8336029|NCT01337596|20549014|P2|Safety Population|Overall Study||7
8336030|NCT01337596|20549015|P1|Safety Population|Overall Study||7
8336031|NCT01337596|20549007|P9|STARTED|Overall Study||7
8336032|NCT01337596|20549008|P8|STARTED|Overall Study||2
8336033|NCT01337596|20549009|P7|STARTED|Overall Study||12
8336034|NCT01337596|20549010|P6|STARTED|Overall Study||7
8336035|NCT01337596|20549011|P5|STARTED|Overall Study||7
8336036|NCT01337596|20549012|P4|STARTED|Overall Study||7
8336037|NCT01337596|20549013|P3|STARTED|Overall Study||7
8336038|NCT01337596|20549014|P2|STARTED|Overall Study||7
8336039|NCT01337596|20549015|P1|STARTED|Overall Study||7
8336040|NCT01337336|20549051|P2|NOT COMPLETED|Overall Study||0
8336041|NCT01337336|20549052|P1|NOT COMPLETED|Overall Study||0
8336042|NCT01337336|20549051|P2|COMPLETED|Overall Study||2923
8336043|NCT01337336|20549052|P1|COMPLETED|Overall Study||1078
8336044|NCT01337336|20549051|P2|STARTED|Overall Study||2923
8336045|NCT01337336|20549052|P1|STARTED|Overall Study||1078
8336046|NCT01337297|20549066|P2|NOT COMPLETED|Overall Study||6
8336047|NCT01337297|20549067|P1|NOT COMPLETED|Overall Study||5
8336048|NCT01337297|20549066|P2|COMPLETED|Overall Study||3
8336049|NCT01337297|20549067|P1|COMPLETED|Overall Study||6
8336050|NCT01337297|20549066|P2|STARTED|Overall Study||9
8336051|NCT01337297|20549067|P1|STARTED|Overall Study||11
8336052|NCT01337167|20549075|P2|NOT COMPLETED|Toddler Vaccinations||13
8336053|NCT01337167|20549076|P1|NOT COMPLETED|Toddler Vaccinations||14
8336054|NCT01337167|20549075|P2|COMPLETED|Toddler Vaccinations||407
8336055|NCT01337167|20549076|P1|COMPLETED|Toddler Vaccinations||829
8336056|NCT01337167|20549075|P2|STARTED|Toddler Vaccinations||420
8336057|NCT01337167|20549076|P1|STARTED|Toddler Vaccinations||843
8336058|NCT01337167|20549075|P2|NOT COMPLETED|Interim Period||40
8336059|NCT01337167|20549076|P1|NOT COMPLETED|Interim Period||81
8336060|NCT01337167|20549075|P2|COMPLETED|Interim Period||420
8336061|NCT01337167|20549076|P1|COMPLETED|Interim Period||843
8336062|NCT01337167|20549075|P2|STARTED|Interim Period||460
8336063|NCT01337167|20549076|P1|STARTED|Interim Period||924
8336064|NCT01337167|20549075|P2|NOT COMPLETED|Infant Series||27
8336065|NCT01337167|20549076|P1|NOT COMPLETED|Infant Series||62
8336066|NCT01337167|20549075|P2|COMPLETED|Infant Series||460
8336067|NCT01337167|20549076|P1|COMPLETED|Infant Series||924
8336068|NCT01337167|20549075|P2|STARTED|Infant Series||487
8336069|NCT01337167|20549076|P1|STARTED|Infant Series||986
8336070|NCT01337115|20549144|P2|NOT COMPLETED|Overall Study||0
8336071|NCT01337115|20549145|P1|NOT COMPLETED|Overall Study||2
8336072|NCT01337115|20549144|P2|COMPLETED|Overall Study||25
8336073|NCT01337115|20549145|P1|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
8336074|NCT01337115|20549144|P2|STARTED|Overall Study||25
8336075|NCT01337115|20549145|P1|STARTED|Overall Study||25
8336076|NCT01337089|20549157|P1|NOT COMPLETED|Overall Study||404
8336077|NCT01337089|20549157|P1|COMPLETED|Overall Study||256
8336078|NCT01337089|20549157|P1|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
8336079|NCT01337089|20549157|P1|Safety Population|Overall Study||660
8336080|NCT01337089|20549157|P1|Received at Least 1 Dose of Study Drug|Overall Study||660
8336081|NCT01337089|20549157|P1|STARTED|Overall Study||660
8336082|NCT01337076|20549165|P1|NOT COMPLETED|Overall Study||2
8336083|NCT01337076|20549165|P1|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
8336084|NCT01337076|20549165|P1|STARTED|Overall Study|subjects implanted|21
8336085|NCT01337050|20549172|P3|NOT COMPLETED|Overall Study||19
8336086|NCT01337050|20549173|P2|NOT COMPLETED|Overall Study||13
8336087|NCT01337050|20549174|P1|NOT COMPLETED|Overall Study||4
8336088|NCT01337050|20549172|P3|COMPLETED|Overall Study||0
8336089|NCT01337050|20549173|P2|COMPLETED|Overall Study||0
8336090|NCT01337050|20549174|P1|COMPLETED|Overall Study||0
8336091|NCT01337050|20549172|P3|STARTED|Overall Study||19
8336092|NCT01337050|20549173|P2|STARTED|Overall Study||13
8336093|NCT01337050|20549174|P1|STARTED|Overall Study||4
8336094|NCT01336972|20549235|P3|NOT COMPLETED|Overall Study||0
8336095|NCT01336972|20549236|P2|NOT COMPLETED|Overall Study||1
8336096|NCT01336972|20549237|P1|NOT COMPLETED|Overall Study||1
8336097|NCT01336972|20549235|P3|COMPLETED|Overall Study||9
8336098|NCT01336972|20549236|P2|COMPLETED|Overall Study||9
8336099|NCT01336972|20549237|P1|COMPLETED|Overall Study||9
8336100|NCT01336972|20549235|P3|STARTED|Overall Study||9
8336101|NCT01336972|20549236|P2|STARTED|Overall Study||10
8336102|NCT01336972|20549237|P1|STARTED|Overall Study||10
8336103|NCT01336959|20549275|P3|NOT COMPLETED|Overall Study||1
8336104|NCT01336959|20549276|P2|NOT COMPLETED|Overall Study||5
8336105|NCT01336959|20549277|P1|NOT COMPLETED|Overall Study||0
8336106|NCT01336959|20549275|P3|COMPLETED|Overall Study||40
8336107|NCT01336959|20549276|P2|COMPLETED|Overall Study||37
8336108|NCT01336959|20549277|P1|COMPLETED|Overall Study||8
8336109|NCT01336959|20549275|P3|STARTED|Overall Study||41
8336110|NCT01336959|20549276|P2|STARTED|Overall Study||42
8336111|NCT01336959|20549277|P1|STARTED|Overall Study||8
8336112|NCT01336933|20549288|P1|NOT COMPLETED|Overall Study||1
8336113|NCT01336933|20549288|P1|COMPLETED|Overall Study||33
8336114|NCT01336933|20549288|P1|STARTED|Overall Study||34
8336115|NCT01336894|20549299|P2|NOT COMPLETED|Follow-up||7
8336116|NCT01336894|20549300|P1|NOT COMPLETED|Follow-up||2
8336117|NCT01336894|20549299|P2|COMPLETED|Follow-up||0
8336118|NCT01336894|20549300|P1|COMPLETED|Follow-up||2
8336119|NCT01336894|20549299|P2|STARTED|Follow-up||7
8336120|NCT01336894|20549300|P1|STARTED|Follow-up||4
8336121|NCT01336894|20549299|P2|NOT COMPLETED|Protocol Interventions||0
8336122|NCT01336894|20549300|P1|NOT COMPLETED|Protocol Interventions||0
8336123|NCT01336894|20549299|P2|COMPLETED|Protocol Interventions||7
8336124|NCT01336894|20549300|P1|COMPLETED|Protocol Interventions||4
8336125|NCT01336894|20549299|P2|STARTED|Protocol Interventions||7
8336126|NCT01336894|20549300|P1|STARTED|Protocol Interventions||4
8336127|NCT01336803|20549318|P1|NOT COMPLETED|Overall Study||0
8336128|NCT01336803|20549318|P1|COMPLETED|Overall Study||21
8336129|NCT01336803|20549318|P1|Lymphoma|Overall Study||7
8336130|NCT01336803|20549318|P1|Osteomyelitis|Overall Study||4
8336131|NCT01336803|20549318|P1|Bone Sarcoma|Overall Study||10
8336132|NCT01336803|20549318|P1|STARTED|Overall Study||21
8336133|NCT01336764|20549332|P2|NOT COMPLETED|Overall Study||5
8336134|NCT01336764|20549333|P1|NOT COMPLETED|Overall Study||5
8336135|NCT01336764|20549332|P2|COMPLETED|Overall Study||5
8336136|NCT01336764|20549333|P1|COMPLETED|Overall Study||7
8336137|NCT01336764|20549332|P2|STARTED|Overall Study||10
8336138|NCT01336764|20549333|P1|STARTED|Overall Study||12
8336139|NCT01336738|20549344|P5|NOT COMPLETED|Overall Study||10
8336140|NCT01336738|20549345|P4|NOT COMPLETED|Overall Study||7
8336141|NCT01336738|20549346|P3|NOT COMPLETED|Overall Study||8
8336142|NCT01336738|20549347|P2|NOT COMPLETED|Overall Study||9
8336143|NCT01336738|20549348|P1|NOT COMPLETED|Overall Study||7
8336144|NCT01336738|20549344|P5|COMPLETED|Overall Study||43
8336145|NCT01336738|20549345|P4|COMPLETED|Overall Study||47
8336146|NCT01336738|20549346|P3|COMPLETED|Overall Study||45
8336147|NCT01336738|20549347|P2|COMPLETED|Overall Study||45
8336148|NCT01336738|20549348|P1|COMPLETED|Overall Study||45
8336149|NCT01336738|20549344|P5|STARTED|Overall Study||53
8336150|NCT01336738|20549345|P4|STARTED|Overall Study||54
8336151|NCT01336738|20549346|P3|STARTED|Overall Study||53
8336152|NCT01336738|20549347|P2|STARTED|Overall Study||54
8336153|NCT01336738|20549348|P1|STARTED|Overall Study||52
8336154|NCT01336712|20549390|P1|NOT COMPLETED|Overall Study||3
8336155|NCT01336712|20549390|P1|COMPLETED|Overall Study||27
8336156|NCT01336712|20549390|P1|STARTED|Overall Study||30
8336157|NCT01336647|20549403|P3|NOT COMPLETED|Overall Study||3
8336158|NCT01336647|20549404|P2|NOT COMPLETED|Overall Study||1
8336159|NCT01336647|20549405|P1|NOT COMPLETED|Overall Study||4
8336160|NCT01336647|20549403|P3|COMPLETED|Overall Study||44
8336161|NCT01336647|20549404|P2|COMPLETED|Overall Study||48
8336162|NCT01336647|20549405|P1|COMPLETED|Overall Study||42
8336163|NCT01336647|20549403|P3|STARTED|Overall Study||47
8336164|NCT01336647|20549404|P2|STARTED|Overall Study||49
8336165|NCT01336647|20549405|P1|STARTED|Overall Study||46
8336166|NCT01336621|20549416|P1|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
8336167|NCT01336621|20549416|P1|COMPLETED|SFUCP (up to 2.6 Years)||0
8336168|NCT01336621|20549416|P1|STARTED|SFUCP (up to 2.6 Years)||9
8336169|NCT01336621|20549416|P1|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
8336170|NCT01336621|20549416|P1|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
8336171|NCT01336621|20549416|P1|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
8336172|NCT01336608|20549466|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||24
8336173|NCT01336608|20549467|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||30
8336174|NCT01336608|20549468|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||44
8336175|NCT01336608|20549469|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
8336176|NCT01336608|20549466|P4|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
8336177|NCT01336608|20549467|P3|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
8336178|NCT01336608|20549468|P2|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
8336179|NCT01336608|20549469|P1|COMPLETED|24-week, Double-blind Treatment Period||0
8336180|NCT01336608|20549466|P4|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
8336181|NCT01336608|20549467|P3|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
8336182|NCT01336608|20549468|P2|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
8336183|NCT01336608|20549469|P1|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
8336184|NCT01336608|20549466|P4|STARTED|24-week, Double-blind Treatment Period||135
8336185|NCT01336608|20549467|P3|STARTED|24-week, Double-blind Treatment Period||154
8336186|NCT01336608|20549468|P2|STARTED|24-week, Double-blind Treatment Period||141
8336187|NCT01336608|20549469|P1|STARTED|24-week, Double-blind Treatment Period||0
8336188|NCT01336608|20549466|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8336189|NCT01336608|20549467|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8336190|NCT01336608|20549468|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8336191|NCT01336608|20549469|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||115
8336192|NCT01336608|20549466|P4|COMPLETED|2-week, Single-blind Run-In Period||0
8336193|NCT01336608|20549467|P3|COMPLETED|2-week, Single-blind Run-In Period||0
8336194|NCT01336608|20549468|P2|COMPLETED|2-week, Single-blind Run-In Period||0
8336195|NCT01336608|20549469|P1|COMPLETED|2-week, Single-blind Run-In Period||444
8336196|NCT01336608|20549466|P4|STARTED|2-week, Single-blind Run-In Period||0
8336197|NCT01336608|20549467|P3|STARTED|2-week, Single-blind Run-In Period||0
8336198|NCT01336608|20549468|P2|STARTED|2-week, Single-blind Run-In Period||0
8336199|NCT01336608|20549469|P1|STARTED|2-week, Single-blind Run-In Period||559
8336200|NCT01336569|20549483|P1|NOT COMPLETED|Overall Study||4
8336201|NCT01336569|20549483|P1|COMPLETED|Overall Study||45
8336202|NCT01336569|20549483|P1|STARTED|Overall Study||49
8336203|NCT01336413|20549489|P2|NOT COMPLETED|Overall Study||8
8336204|NCT01336413|20549490|P1|NOT COMPLETED|Overall Study||1
8336205|NCT01336413|20549489|P2|COMPLETED|Overall Study||18
8336206|NCT01336413|20549490|P1|COMPLETED|Overall Study||26
8336207|NCT01336413|20549489|P2|STARTED|Overall Study||26
8336208|NCT01336413|20549490|P1|STARTED|Overall Study||27
8336209|NCT01336296|20549514|P2|NOT COMPLETED|Overall Study||4
8336210|NCT01336296|20549515|P1|NOT COMPLETED|Overall Study||5
8336211|NCT01336296|20549514|P2|COMPLETED|Overall Study||17
8336212|NCT01336296|20549515|P1|COMPLETED|Overall Study||35
8336213|NCT01336296|20549514|P2|STARTED|Overall Study||21
8336214|NCT01336296|20549515|P1|STARTED|Overall Study||40
8336215|NCT01336205|20549531|P2|NOT COMPLETED|Overall Study||89
8336216|NCT01336205|20549532|P1|NOT COMPLETED|Overall Study||233
8336217|NCT01336205|20549531|P2|COMPLETED|Overall Study||192
8336218|NCT01336205|20549532|P1|COMPLETED|Overall Study||330
8336219|NCT01336205|20549531|P2|STARTED|Overall Study||281
8336220|NCT01336205|20549532|P1|STARTED|Overall Study||563
8336221|NCT01336140|20549544|P2|NOT COMPLETED|Overall Study||0
8336222|NCT01336140|20549545|P1|NOT COMPLETED|Overall Study||0
8336223|NCT01336140|20549544|P2|COMPLETED|Overall Study||150
8336224|NCT01336140|20549545|P1|COMPLETED|Overall Study||150
8336225|NCT01336140|20549544|P2|STARTED|Overall Study||150
8336226|NCT01336140|20549545|P1|STARTED|Overall Study||150
8336227|NCT01336023|20549560|P3|NOT COMPLETED|Week 27 to 52||28
8336228|NCT01336023|20549561|P2|NOT COMPLETED|Week 27 to 52||44
8336229|NCT01336023|20549562|P1|NOT COMPLETED|Week 27 to 52||28
8336230|NCT01336023|20549560|P3|COMPLETED|Week 27 to 52||285
8336231|NCT01336023|20549561|P2|COMPLETED|Week 27 to 52||621
8336232|NCT01336023|20549562|P1|COMPLETED|Week 27 to 52||305
8336233|NCT01336023|20549560|P3|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
8336234|NCT01336023|20549561|P2|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
8336235|NCT01336023|20549562|P1|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
8336236|NCT01336023|20549560|P3|NOT COMPLETED|Week 0 to Week 26||73
8336237|NCT01336023|20549561|P2|NOT COMPLETED|Week 0 to Week 26||98
8336238|NCT01336023|20549562|P1|NOT COMPLETED|Week 0 to Week 26||48
8336239|NCT01336023|20549560|P3|COMPLETED|Week 0 to Week 26||342
8336240|NCT01336023|20549561|P2|COMPLETED|Week 0 to Week 26||736
8336241|NCT01336023|20549562|P1|COMPLETED|Week 0 to Week 26||366
8336242|NCT01336023|20549560|P3|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
8336243|NCT01336023|20549561|P2|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
8336244|NCT01336023|20549562|P1|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
8336245|NCT01336023|20549560|P3|STARTED|Week 0 to Week 26||415
8336246|NCT01336023|20549561|P2|STARTED|Week 0 to Week 26||834
8336247|NCT01336023|20549562|P1|STARTED|Week 0 to Week 26||414
8336248|NCT01335997|20549583|P2|NOT COMPLETED|Period III||79
8336249|NCT01335997|20549584|P1|NOT COMPLETED|Period III||78
8336250|NCT01335997|20549583|P2|COMPLETED|Period III||4
8336251|NCT01335997|20549584|P1|COMPLETED|Period III||6
8336252|NCT01335997|20549583|P2|STARTED|Period III||83
8336253|NCT01335997|20549584|P1|STARTED|Period III||84
8336254|NCT01335997|20549583|P2|NOT COMPLETED|Period I and II||479
8336255|NCT01335997|20549584|P1|NOT COMPLETED|Period I and II||493
8336256|NCT01335997|20549583|P2|COMPLETED|Period I and II||83
8336257|NCT01335997|20549584|P1|COMPLETED|Period I and II||84
8336258|NCT01335997|20549583|P2|STARTED|Period I and II||562
8336259|NCT01335997|20549584|P1|STARTED|Period I and II||577
8336260|NCT01335971|20549597|P3|NOT COMPLETED|Overall Study||1
8336261|NCT01335971|20549598|P2|NOT COMPLETED|Overall Study||1
8336262|NCT01335971|20549599|P1|NOT COMPLETED|Overall Study||2
8336263|NCT01335971|20549597|P3|COMPLETED|Overall Study||28
8336264|NCT01335971|20549598|P2|COMPLETED|Overall Study||28
8336265|NCT01335971|20549599|P1|COMPLETED|Overall Study||29
8336266|NCT01335971|20549597|P3|STARTED|Overall Study||29
8336267|NCT01335971|20549598|P2|STARTED|Overall Study||29
8336268|NCT01335971|20549599|P1|STARTED|Overall Study||31
8336269|NCT01335932|20549636|P2|NOT COMPLETED|Overall Study||4
8336270|NCT01335932|20549637|P1|NOT COMPLETED|Overall Study||0
8336271|NCT01335932|20549636|P2|COMPLETED|Overall Study||72
8336272|NCT01335932|20549637|P1|COMPLETED|Overall Study||84
8336273|NCT01335932|20549636|P2|STARTED|Overall Study||76
8336274|NCT01335932|20549637|P1|STARTED|Overall Study||84
8336275|NCT01335867|20549777|P2|NOT COMPLETED|Overall Study||4
8336276|NCT01335867|20549778|P1|NOT COMPLETED|Overall Study||7
8336277|NCT01335867|20549777|P2|COMPLETED|Overall Study||12
8336278|NCT01335867|20549778|P1|COMPLETED|Overall Study||9
8336279|NCT01335867|20549777|P2|STARTED|Overall Study||16
8336280|NCT01335867|20549778|P1|STARTED|Overall Study||16
8336281|NCT01335789|20549794|P2|NOT COMPLETED|Overall Study||0
8336282|NCT01335789|20549795|P1|NOT COMPLETED|Overall Study||0
8336283|NCT01335789|20549794|P2|COMPLETED|Overall Study||8
8336284|NCT01335789|20549795|P1|COMPLETED|Overall Study||8
8336285|NCT01335789|20549794|P2|STARTED|Overall Study||8
8336286|NCT01335789|20549795|P1|STARTED|Overall Study||8
8336287|NCT01335750|20549805|P1|NOT COMPLETED|Overall Study||0
8336288|NCT01335750|20549805|P1|COMPLETED|Overall Study||32
8336289|NCT01335750|20549805|P1|STARTED|Overall Study||32
8336290|NCT01335724|20549826|P2|NOT COMPLETED|Overall Study||0
8336291|NCT01335724|20549827|P1|NOT COMPLETED|Overall Study||0
8336292|NCT01335724|20549826|P2|COMPLETED|Overall Study||36
8336293|NCT01335724|20549827|P1|COMPLETED|Overall Study||36
8336294|NCT01335724|20549826|P2|STARTED|Overall Study||36
8336295|NCT01335724|20549827|P1|STARTED|Overall Study||36
8336296|NCT01335698|20549842|P5|NOT COMPLETED|Treatment Stage 2||1
8336297|NCT01335698|20549843|P4|NOT COMPLETED|Treatment Stage 2||8
8336298|NCT01335698|20549844|P3|NOT COMPLETED|Treatment Stage 2||5
8336299|NCT01335698|20549845|P2|NOT COMPLETED|Treatment Stage 2||3
8336300|NCT01335698|20549846|P1|NOT COMPLETED|Treatment Stage 2||11
8336301|NCT01335698|20549842|P5|COMPLETED|Treatment Stage 2||5
8336302|NCT01335698|20549843|P4|COMPLETED|Treatment Stage 2||18
8336303|NCT01335698|20549844|P3|COMPLETED|Treatment Stage 2||11
8336304|NCT01335698|20549845|P2|COMPLETED|Treatment Stage 2||1
8336305|NCT01335698|20549846|P1|COMPLETED|Treatment Stage 2||4
8336306|NCT01335698|20549842|P5|STARTED|Treatment Stage 2||6
8336307|NCT01335698|20549843|P4|STARTED|Treatment Stage 2||26
8336308|NCT01335698|20549844|P3|STARTED|Treatment Stage 2||16
8336309|NCT01335698|20549845|P2|STARTED|Treatment Stage 2||4
8336310|NCT01335698|20549846|P1|STARTED|Treatment Stage 2||15
8336311|NCT01335698|20549842|P5|NOT COMPLETED|Treatment Stage 1||2
8336312|NCT01335698|20549843|P4|NOT COMPLETED|Treatment Stage 1||9
8336313|NCT01335698|20549844|P3|NOT COMPLETED|Treatment Stage 1||5
8336314|NCT01335698|20549845|P2|NOT COMPLETED|Treatment Stage 1||8
8336315|NCT01335698|20549846|P1|NOT COMPLETED|Treatment Stage 1||8
8336316|NCT01335698|20549842|P5|COMPLETED|Treatment Stage 1||6
8336317|NCT01335698|20549843|P4|COMPLETED|Treatment Stage 1||26
8336318|NCT01335698|20549844|P3|COMPLETED|Treatment Stage 1||16
8336319|NCT01335698|20549845|P2|COMPLETED|Treatment Stage 1||4
8336320|NCT01335698|20549846|P1|COMPLETED|Treatment Stage 1||15
8336321|NCT01335698|20549842|P5|STARTED|Treatment Stage 1||8
8336322|NCT01335698|20549843|P4|STARTED|Treatment Stage 1||35
8336323|NCT01335698|20549844|P3|STARTED|Treatment Stage 1||21
8336324|NCT01335698|20549845|P2|STARTED|Treatment Stage 1||12
8336325|NCT01335698|20549846|P1|STARTED|Treatment Stage 1||23
8336326|NCT01335685|20549911|P8|NOT COMPLETED|Overall Study||3
8336327|NCT01335685|20549912|P7|NOT COMPLETED|Overall Study||2
8336328|NCT01335685|20549913|P6|NOT COMPLETED|Overall Study||5
8336329|NCT01335685|20549914|P5|NOT COMPLETED|Overall Study||0
8336330|NCT01335685|20549915|P4|NOT COMPLETED|Overall Study||11
8336331|NCT01335685|20549916|P3|NOT COMPLETED|Overall Study||2
8336332|NCT01335685|20549917|P2|NOT COMPLETED|Overall Study||1
8336333|NCT01335685|20549918|P1|NOT COMPLETED|Overall Study||3
8336334|NCT01335685|20549911|P8|COMPLETED|Overall Study||3
8336335|NCT01335685|20549912|P7|COMPLETED|Overall Study||2
8336336|NCT01335685|20549913|P6|COMPLETED|Overall Study||1
8336337|NCT01335685|20549914|P5|COMPLETED|Overall Study||5
8336338|NCT01335685|20549915|P4|COMPLETED|Overall Study||15
8336339|NCT01335685|20549916|P3|COMPLETED|Overall Study||1
8336340|NCT01335685|20549917|P2|COMPLETED|Overall Study||3
8336341|NCT01335685|20549918|P1|COMPLETED|Overall Study||4
8336342|NCT01335685|20549911|P8|STARTED|Overall Study||6
8336343|NCT01335685|20549912|P7|STARTED|Overall Study||4
8336344|NCT01335685|20549913|P6|STARTED|Overall Study||6
8336345|NCT01335685|20549914|P5|STARTED|Overall Study||5
8336346|NCT01335685|20549915|P4|STARTED|Overall Study||26
8336347|NCT01335685|20549916|P3|STARTED|Overall Study||3
8336348|NCT01335685|20549917|P2|STARTED|Overall Study||4
8336349|NCT01335685|20549918|P1|STARTED|Overall Study||7
8336350|NCT01335620|20550020|P1|NOT COMPLETED|Overall Study||0
8336351|NCT01335620|20550020|P1|COMPLETED|Overall Study||19
8336352|NCT01335620|20550020|P1|STARTED|Overall Study||19
8336353|NCT01335581|20550027|P1|NOT COMPLETED|Overall Study||10
8336354|NCT01335581|20550027|P1|COMPLETED|Overall Study||8
8336355|NCT01335581|20550027|P1|STARTED|Overall Study||18
8336356|NCT01335542|20550033|P2|NOT COMPLETED|Overall Study||0
8336357|NCT01335542|20550034|P1|NOT COMPLETED|Overall Study||0
8336358|NCT01335542|20550033|P2|COMPLETED|Overall Study||45
8336359|NCT01335542|20550034|P1|COMPLETED|Overall Study||45
8336360|NCT01335542|20550033|P2|STARTED|Overall Study||45
8336361|NCT01335542|20550034|P1|STARTED|Overall Study||45
8336362|NCT01335477|20550042|P2|NOT COMPLETED|Overall Study||59
8336363|NCT01335477|20550043|P1|NOT COMPLETED|Overall Study||41
8336364|NCT01335477|20550042|P2|COMPLETED|Overall Study||272
8336365|NCT01335477|20550043|P1|COMPLETED|Overall Study||179
8336366|NCT01335477|20550042|P2|STARTED|Overall Study||331
8336367|NCT01335477|20550043|P1|STARTED|Overall Study||220
8336368|NCT01335464|20550107|P2|NOT COMPLETED|Overall Study||49
8336369|NCT01335464|20550108|P1|NOT COMPLETED|Overall Study||32
8336370|NCT01335464|20550107|P2|COMPLETED|Overall Study||260
8336371|NCT01335464|20550108|P1|COMPLETED|Overall Study||174
8336372|NCT01335464|20550107|P2|STARTED|Overall Study||309
8336373|NCT01335464|20550108|P1|STARTED|Overall Study||206
8336374|NCT01335399|20550172|P2|NOT COMPLETED|Treatment Period||339
8336375|NCT01335399|20550173|P1|NOT COMPLETED|Treatment Period||333
8336376|NCT01335399|20550172|P2|COMPLETED|Treatment Period||32
8336377|NCT01335399|20550173|P1|COMPLETED|Treatment Period||38
8336378|NCT01335399|20550172|P2|STARTED|Treatment Period||371
8336379|NCT01335399|20550173|P1|STARTED|Treatment Period||371
8336380|NCT01335399|20550172|P2|NOT COMPLETED|Pre-treatment Period||3
8336381|NCT01335399|20550173|P1|NOT COMPLETED|Pre-treatment Period||3
8336382|NCT01335399|20550172|P2|COMPLETED|Pre-treatment Period||371
8336383|NCT01335399|20550173|P1|COMPLETED|Pre-treatment Period||371
8336384|NCT01335399|20550172|P2|STARTED|Pre-treatment Period||374
8336385|NCT01335399|20550173|P1|STARTED|Pre-treatment Period||374
8336386|NCT01335308|20550190|P3|NOT COMPLETED|Overall Study||81
8336387|NCT01335308|20550191|P2|NOT COMPLETED|Overall Study||67
8336388|NCT01335308|20550192|P1|NOT COMPLETED|Overall Study||40
8336389|NCT01335308|20550190|P3|COMPLETED|Overall Study||154
8336390|NCT01335308|20550191|P2|COMPLETED|Overall Study||145
8336391|NCT01335308|20550192|P1|COMPLETED|Overall Study||158
8336392|NCT01335308|20550190|P3|STARTED|Overall Study||235
8336393|NCT01335308|20550191|P2|STARTED|Overall Study||212
8336394|NCT01335308|20550192|P1|STARTED|Overall Study||198
8336395|NCT01335230|20550213|P4|NOT COMPLETED|Overall Study||0
8336396|NCT01335230|20550214|P3|NOT COMPLETED|Overall Study||0
8336397|NCT01335230|20550215|P2|NOT COMPLETED|Overall Study||0
8336398|NCT01335230|20550216|P1|NOT COMPLETED|Overall Study||0
8336399|NCT01335230|20550213|P4|COMPLETED|Overall Study|subjects|10
8336400|NCT01335230|20550214|P3|COMPLETED|Overall Study|subjects|10
8336401|NCT01335230|20550215|P2|COMPLETED|Overall Study|subjects|10
8336402|NCT01335230|20550216|P1|COMPLETED|Overall Study|subjects|10
8336403|NCT01335230|20550213|P4|STARTED|Overall Study|subjects|10
8336404|NCT01335230|20550214|P3|STARTED|Overall Study|subjects|10
8336405|NCT01335230|20550215|P2|STARTED|Overall Study|subjects|10
8336406|NCT01335230|20550216|P1|STARTED|Overall Study|subjects|10
8336407|NCT01335204|20550226|P1|NOT COMPLETED|Overall Study||0
8336408|NCT01335204|20550226|P1|COMPLETED|Overall Study||4
8336409|NCT01335204|20550226|P1|STARTED|Overall Study||4
8336410|NCT01335191|20550237|P2|NOT COMPLETED|Overall Study||0
8336411|NCT01335191|20550238|P1|NOT COMPLETED|Overall Study||0
8336412|NCT01335191|20550237|P2|COMPLETED|Overall Study||11
8336413|NCT01335191|20550238|P1|COMPLETED|Overall Study||16
8336414|NCT01335191|20550237|P2|STARTED|Overall Study||11
8336415|NCT01335191|20550238|P1|STARTED|Overall Study||16
8336416|NCT01335061|20550244|P1|NOT COMPLETED|Overall Study||0
8336417|NCT01335061|20550244|P1|COMPLETED|Overall Study||25
8336418|NCT01335061|20550244|P1|STARTED|Overall Study||25
8336419|NCT01334957|20550259|P1|NOT COMPLETED|Overall Study||0
8336420|NCT01334957|20550259|P1|COMPLETED|Overall Study||300
8336421|NCT01334957|20550259|P1|Received Multiple Doses|Overall Study||48
8336422|NCT01334957|20550259|P1|Received Single Dose|Overall Study||252
8336423|NCT01334957|20550259|P1|STARTED|Overall Study||300
8336424|NCT01334944|20550267|P2|NOT COMPLETED|Overall Study||0
8336425|NCT01334944|20550268|P1|NOT COMPLETED|Overall Study||0
8336426|NCT01334944|20550267|P2|COMPLETED|Overall Study||139
8336427|NCT01334944|20550268|P1|COMPLETED|Overall Study||11
8336428|NCT01334944|20550267|P2|Received Multiple Doses|Overall Study||43
8336429|NCT01334944|20550268|P1|Received Multiple Doses|Overall Study||10
8336430|NCT01334944|20550267|P2|Received Singel Dose|Overall Study||96
8336431|NCT01334944|20550268|P1|Received Singel Dose|Overall Study||1
8336432|NCT01334944|20550267|P2|STARTED|Overall Study||139
8336433|NCT01334944|20550268|P1|STARTED|Overall Study||11
8336434|NCT01334918|20550294|P2|NOT COMPLETED|Overall Study||1
8336435|NCT01334918|20550295|P1|NOT COMPLETED|Overall Study||8
8336436|NCT01334918|20550294|P2|COMPLETED|Overall Study||60
8336437|NCT01334918|20550295|P1|COMPLETED|Overall Study||55
8336438|NCT01334918|20550294|P2|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
8336439|NCT01334918|20550295|P1|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
8336440|NCT01334918|20550294|P2|STARTED|Overall Study||61
8336441|NCT01334918|20550295|P1|STARTED|Overall Study||63
8336442|NCT01334866|20550321|P1|NOT COMPLETED|Overall Study||19
8336443|NCT01334866|20550321|P1|COMPLETED|Overall Study||72
8336444|NCT01334866|20550321|P1|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
8336445|NCT01334827|20550331|P1|NOT COMPLETED|Overall Study||0
8336446|NCT01334827|20550331|P1|COMPLETED|Overall Study||48
8336447|NCT01334827|20550331|P1|STARTED|Overall Study||48
8336448|NCT01334723|20550339|P2|NOT COMPLETED|Overall Study||0
8336449|NCT01334723|20550340|P1|NOT COMPLETED|Overall Study||0
8336450|NCT01334723|20550339|P2|COMPLETED|Overall Study||17739
8336451|NCT01334723|20550340|P1|COMPLETED|Overall Study||17293
8336452|NCT01334723|20550339|P2|STARTED|Overall Study||17739
8336453|NCT01334723|20550340|P1|STARTED|Overall Study||17293
8336454|NCT01334710|20550366|P1|NOT COMPLETED|Overall Study||3
8336455|NCT01334710|20550366|P1|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
8336456|NCT01334710|20550366|P1|STARTED|Overall Study||3
8336457|NCT01334606|20550371|P1|NOT COMPLETED|Overall Study||18
8336458|NCT01334606|20550371|P1|COMPLETED|Overall Study||3
8336459|NCT01334606|20550371|P1|STARTED|Overall Study||21
8336460|NCT01334554|20550379|P2|NOT COMPLETED|Overall Study||2
8336461|NCT01334554|20550380|P1|NOT COMPLETED|Overall Study||4
8336462|NCT01334554|20550379|P2|COMPLETED|Overall Study||21
8336463|NCT01334554|20550380|P1|COMPLETED|Overall Study||19
8336464|NCT01334554|20550379|P2|STARTED|Overall Study||23
8336465|NCT01334554|20550380|P1|STARTED|Overall Study||23
8336466|NCT01334515|20550390|P2|NOT COMPLETED|Overall Study||29
8336467|NCT01334515|20550391|P1|NOT COMPLETED|Overall Study||12
8336468|NCT01334515|20550390|P2|COMPLETED|Overall Study||7
8336469|NCT01334515|20550391|P1|COMPLETED|Overall Study||4
8336470|NCT01334515|20550390|P2|STARTED|Overall Study||36
8336471|NCT01334515|20550391|P1|STARTED|Overall Study||16
8336472|NCT01334229|20550401|P2|NOT COMPLETED|Overall Study||0
8336473|NCT01334229|20550402|P1|NOT COMPLETED|Overall Study||0
8336474|NCT01334229|20550401|P2|COMPLETED|Overall Study||11
8336475|NCT01334229|20550402|P1|COMPLETED|Overall Study||11
8336476|NCT01334229|20550401|P2|STARTED|Overall Study||11
8336477|NCT01334229|20550402|P1|STARTED|Overall Study||11
8336478|NCT01334216|20550420|P2|NOT COMPLETED|Overall Study||0
8336479|NCT01334216|20550421|P1|NOT COMPLETED|Overall Study||0
8336480|NCT01334216|20550420|P2|COMPLETED|Overall Study||194
8336481|NCT01334216|20550421|P1|COMPLETED|Overall Study||168
8336482|NCT01334216|20550420|P2|STARTED|Overall Study||194
8336483|NCT01334216|20550421|P1|STARTED|Overall Study||168
8336484|NCT01334125|20550429|P2|NOT COMPLETED|Overall Study||3
8336485|NCT01334125|20550430|P1|NOT COMPLETED|Overall Study||3
8336486|NCT01334125|20550429|P2|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
8336487|NCT01334125|20550430|P1|COMPLETED|Overall Study|3 subjects move to another city|12
8336488|NCT01334125|20550429|P2|STARTED|Overall Study||13
8336489|NCT01334125|20550430|P1|STARTED|Overall Study||15
8336490|NCT01333956|20550446|P4|NOT COMPLETED|Overall Study||2
8336491|NCT01333956|20550447|P3|NOT COMPLETED|Overall Study||1
8336492|NCT01333956|20550448|P2|NOT COMPLETED|Overall Study||4
8336493|NCT01333956|20550449|P1|NOT COMPLETED|Overall Study||2
8336494|NCT01333956|20550446|P4|COMPLETED|Overall Study||28
8336495|NCT01333956|20550447|P3|COMPLETED|Overall Study||29
8336496|NCT01333956|20550448|P2|COMPLETED|Overall Study||26
8336497|NCT01333956|20550449|P1|COMPLETED|Overall Study||28
8336498|NCT01333956|20550446|P4|STARTED|Overall Study||30
8336499|NCT01333956|20550447|P3|STARTED|Overall Study||30
8336500|NCT01333956|20550448|P2|STARTED|Overall Study||30
8336501|NCT01333956|20550449|P1|STARTED|Overall Study||30
8336502|NCT01333943|20550485|P2|NOT COMPLETED|Overall Study||0
8336503|NCT01333943|20550486|P1|NOT COMPLETED|Overall Study||1
8336504|NCT01333943|20550485|P2|COMPLETED|Overall Study||47
8336505|NCT01333943|20550486|P1|COMPLETED|Overall Study||46
8336506|NCT01333943|20550485|P2|STARTED|Overall Study||47
8336507|NCT01333943|20550486|P1|STARTED|Overall Study||47
8336508|NCT01333865|20550502|P1|NOT COMPLETED|Overall Study||2
8336509|NCT01333865|20550502|P1|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
8336510|NCT01333865|20550502|P1|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
8336511|NCT01333813|20550507|P1|NOT COMPLETED|Overall Study||0
8336512|NCT01333813|20550507|P1|COMPLETED|Overall Study||297
8336513|NCT01333813|20550507|P1|STARTED|Overall Study||297
8336514|NCT01333722|20550522|P2|NOT COMPLETED|Overall Study||3
8336515|NCT01333722|20550523|P1|NOT COMPLETED|Overall Study||0
8336516|NCT01333722|20550522|P2|COMPLETED|Overall Study||46
8336517|NCT01333722|20550523|P1|COMPLETED|Overall Study||51
8336518|NCT01333722|20550522|P2|STARTED|Overall Study||49
8336519|NCT01333722|20550523|P1|STARTED|Overall Study||51
8336520|NCT01333592|20550537|P2|NOT COMPLETED|Overall Study||17
8336521|NCT01333592|20550538|P1|NOT COMPLETED|Overall Study||9
8336522|NCT01333592|20550537|P2|COMPLETED|Overall Study||52
8336523|NCT01333592|20550538|P1|COMPLETED|Overall Study||58
8336524|NCT01333592|20550537|P2|STARTED|Overall Study||69
8336525|NCT01333592|20550538|P1|STARTED|Overall Study||67
8336526|NCT01333501|20550548|P2|NOT COMPLETED|Overall Study||21
8336527|NCT01333501|20550549|P1|NOT COMPLETED|Overall Study||9
8336528|NCT01333501|20550548|P2|COMPLETED|Overall Study||30
8336529|NCT01333501|20550549|P1|COMPLETED|Overall Study||97
8336530|NCT01333501|20550548|P2|Safety Population|Overall Study||47
8336531|NCT01333501|20550549|P1|Safety Population|Overall Study||104
8336532|NCT01333501|20550548|P2|Full Analysis Set (FAS)|Overall Study||28
8336533|NCT01333501|20550549|P1|Full Analysis Set (FAS)|Overall Study||80
8336534|NCT01333501|20550548|P2|STARTED|Overall Study||51
8336535|NCT01333501|20550549|P1|STARTED|Overall Study||106
8336536|NCT01333488|20550598|P3|NOT COMPLETED|Overall Study||0
8336537|NCT01333488|20550599|P2|NOT COMPLETED|Overall Study||0
8336538|NCT01333488|20550600|P1|NOT COMPLETED|Overall Study||0
8336539|NCT01333488|20550598|P3|COMPLETED|Overall Study||3
8336540|NCT01333488|20550599|P2|COMPLETED|Overall Study||1
8336541|NCT01333488|20550600|P1|COMPLETED|Overall Study||2
8336542|NCT01333488|20550598|P3|STARTED|Overall Study||3
8336543|NCT01333488|20550599|P2|STARTED|Overall Study||1
8336544|NCT01333488|20550600|P1|STARTED|Overall Study||2
8336545|NCT01333475|20550616|P2|NOT COMPLETED|Overall Study||3
8336546|NCT01333475|20550617|P1|NOT COMPLETED|Overall Study||2
8336547|NCT01333475|20550616|P2|COMPLETED|Overall Study||6
8336548|NCT01333475|20550617|P1|COMPLETED|Overall Study||10
8336549|NCT01333475|20550616|P2|STARTED|Overall Study||9
8336550|NCT01333475|20550617|P1|STARTED|Overall Study||12
8336551|NCT01333436|20550627|P2|NOT COMPLETED|Overall Study||0
8336552|NCT01333436|20550628|P1|NOT COMPLETED|Overall Study||0
8336553|NCT01333436|20550627|P2|COMPLETED|Overall Study||50
8336554|NCT01333436|20550628|P1|COMPLETED|Overall Study||43
8336555|NCT01333436|20550627|P2|STARTED|Overall Study||50
8336556|NCT01333436|20550628|P1|STARTED|Overall Study||43
8336557|NCT01333397|20550643|P5|NOT COMPLETED|Overall Study||0
8336558|NCT01333397|20550644|P4|NOT COMPLETED|Overall Study||1
8336559|NCT01333397|20550645|P3|NOT COMPLETED|Overall Study||0
8336560|NCT01333397|20550646|P2|NOT COMPLETED|Overall Study||0
8336561|NCT01333397|20550647|P1|NOT COMPLETED|Overall Study||1
8336562|NCT01333397|20550643|P5|COMPLETED|Overall Study||35
8336563|NCT01333397|20550644|P4|COMPLETED|Overall Study||34
8336564|NCT01333397|20550645|P3|COMPLETED|Overall Study||35
8336565|NCT01333397|20550646|P2|COMPLETED|Overall Study||36
8336566|NCT01333397|20550647|P1|COMPLETED|Overall Study||34
8336567|NCT01333397|20550643|P5|STARTED|Overall Study||35
8336568|NCT01333397|20550644|P4|STARTED|Overall Study||35
8336569|NCT01333397|20550645|P3|STARTED|Overall Study||35
8336570|NCT01333397|20550646|P2|STARTED|Overall Study||36
8336571|NCT01333397|20550647|P1|STARTED|Overall Study||35
8336572|NCT01333189|20550721|P2|NOT COMPLETED|Overall Study||2
8336573|NCT01333189|20550722|P1|NOT COMPLETED|Overall Study||2
8336574|NCT01333189|20550721|P2|COMPLETED|Overall Study||11
8336575|NCT01333189|20550722|P1|COMPLETED|Overall Study||11
8336576|NCT01333189|20550721|P2|STARTED|Overall Study||13
8336577|NCT01333189|20550722|P1|STARTED|Overall Study||13
8336578|NCT01333111|20550753|P3|NOT COMPLETED|Overall Study||2
8336579|NCT01333111|20550754|P2|NOT COMPLETED|Overall Study||3
8336580|NCT01333111|20550755|P1|NOT COMPLETED|Overall Study||2
8336581|NCT01333111|20550753|P3|COMPLETED|Overall Study||13
8336582|NCT01333111|20550754|P2|COMPLETED|Overall Study||26
8336583|NCT01333111|20550755|P1|COMPLETED|Overall Study||28
8336584|NCT01333111|20550753|P3|STARTED|Overall Study||15
8336585|NCT01333111|20550754|P2|STARTED|Overall Study||29
8336586|NCT01333111|20550755|P1|STARTED|Overall Study||30
8336587|NCT01333098|20550779|P1|NOT COMPLETED|Overall Study||3
8336588|NCT01333098|20550779|P1|COMPLETED|Overall Study||12
8336589|NCT01333098|20550779|P1|STARTED|Overall Study||15
8336590|NCT01333072|20550790|P2|NOT COMPLETED|Overall Study||4
8336591|NCT01333072|20550791|P1|NOT COMPLETED|Overall Study||6
8336592|NCT01333072|20550790|P2|COMPLETED|Overall Study||27
8336593|NCT01333072|20550791|P1|COMPLETED|Overall Study||24
8336594|NCT01333072|20550790|P2|STARTED|Overall Study||31
8336595|NCT01333072|20550791|P1|STARTED|Overall Study||30
8336596|NCT01333059|20550799|P2|NOT COMPLETED|Overall Study||3
8336597|NCT01333059|20550800|P1|NOT COMPLETED|Overall Study||6
8336598|NCT01333059|20550799|P2|COMPLETED|Overall Study||8
8336599|NCT01333059|20550800|P1|COMPLETED|Overall Study||8
8336600|NCT01333059|20550799|P2|STARTED|Overall Study||11
8336601|NCT01333059|20550800|P1|STARTED|Overall Study||14
8336602|NCT01332994|20550810|P1|NOT COMPLETED|Overall Study||71
8336603|NCT01332994|20550810|P1|COMPLETED|Overall Study||448
8336604|NCT01332994|20550810|P1|Completed Week 66 (TCZ/RTX)|Overall Study||25
8336605|NCT01332994|20550810|P1|Completed Week 32 (TCZ/RTX)|Overall Study||26
8336606|NCT01332994|20550810|P1|Completed Week 32 (TCZ/TCZ)|Overall Study||200
8336607|NCT01332994|20550810|P1|Completed Week 16|Overall Study||463
8336608|NCT01332994|20550810|P1|STARTED|Overall Study||519
8336609|NCT01332981|20550866|P1|NOT COMPLETED|Overall Study||0
8336610|NCT01332981|20550866|P1|COMPLETED|Overall Study||220
8336611|NCT01332981|20550866|P1|STARTED|Overall Study||220
8336684|NCT01332851|20550952|P2|NOT COMPLETED|Overall Study||13
8336685|NCT01332851|20550953|P1|NOT COMPLETED|Overall Study||11
8336686|NCT01332851|20550952|P2|COMPLETED|Overall Study||110
8336687|NCT01332851|20550953|P1|COMPLETED|Overall Study||113
8336688|NCT01332851|20550952|P2|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
8336689|NCT01332851|20550953|P1|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
8336690|NCT01332851|20550952|P2|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
8336691|NCT01332851|20550953|P1|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
8336692|NCT01332851|20550952|P2|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
8336693|NCT01332851|20550953|P1|Completed Follow up 1|Overall Study||116
8336694|NCT01332851|20550952|P2|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
8336695|NCT01332851|20550953|P1|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
8336696|NCT01332851|20550952|P2|STARTED|Overall Study||123
8336697|NCT01332851|20550953|P1|STARTED|Overall Study||124
8336698|NCT01332799|20550987|P2|NOT COMPLETED|Overall Study||10
8336699|NCT01332799|20550988|P1|NOT COMPLETED|Overall Study||10
8336700|NCT01332799|20550987|P2|COMPLETED|Overall Study||0
8336701|NCT01332799|20550988|P1|COMPLETED|Overall Study||0
8336702|NCT01332799|20550987|P2|STARTED|Overall Study||10
8336703|NCT01332799|20550988|P1|STARTED|Overall Study||10
8336704|NCT01332721|20550998|P1|NOT COMPLETED|Overall Study||0
8336705|NCT01332721|20550998|P1|COMPLETED|Overall Study||38
8336706|NCT01332721|20550998|P1|STARTED|Overall Study||38
8336707|NCT01332630|20551004|P1|NOT COMPLETED|Overall Study||3
8336708|NCT01332630|20551004|P1|COMPLETED|Overall Study||21
8336709|NCT01332630|20551004|P1|STARTED|Overall Study||24
8336710|NCT01332578|20551008|P2|NOT COMPLETED|Period II||0
8336711|NCT01332578|20551009|P1|NOT COMPLETED|Period II||0
8336712|NCT01332578|20551008|P2|COMPLETED|Period II||13
8336713|NCT01332578|20551009|P1|COMPLETED|Period II||12
8336714|NCT01332578|20551008|P2|STARTED|Period II||13
8336715|NCT01332578|20551009|P1|STARTED|Period II||12
8336716|NCT01332578|20551008|P2|NOT COMPLETED|Washout Period||0
8336717|NCT01332578|20551009|P1|NOT COMPLETED|Washout Period||0
8336718|NCT01332578|20551008|P2|COMPLETED|Washout Period||13
8336719|NCT01332578|20551009|P1|COMPLETED|Washout Period||12
8336720|NCT01332578|20551008|P2|STARTED|Washout Period||13
8336721|NCT01332578|20551009|P1|STARTED|Washout Period||12
8336722|NCT01332578|20551008|P2|NOT COMPLETED|Period I||0
8336723|NCT01332578|20551009|P1|NOT COMPLETED|Period I||0
8336724|NCT01332578|20551008|P2|COMPLETED|Period I||13
8336725|NCT01332578|20551009|P1|COMPLETED|Period I||12
8336726|NCT01332578|20551008|P2|STARTED|Period I||13
8336727|NCT01332578|20551009|P1|STARTED|Period I||12
8336728|NCT01332500|20551032|P4|NOT COMPLETED|Overall Study||0
8336729|NCT01332500|20551033|P3|NOT COMPLETED|Overall Study||0
8336730|NCT01332500|20551034|P2|NOT COMPLETED|Overall Study||0
8336731|NCT01332500|20551035|P1|NOT COMPLETED|Overall Study||0
8336732|NCT01332500|20551032|P4|COMPLETED|Overall Study||5806
8336733|NCT01332500|20551033|P3|COMPLETED|Overall Study||2903
8336734|NCT01332500|20551034|P2|COMPLETED|Overall Study||39771
8336735|NCT01332500|20551035|P1|COMPLETED|Overall Study||13257
8336736|NCT01332500|20551032|P4|STARTED|Overall Study||5806
8336737|NCT01332500|20551033|P3|STARTED|Overall Study||2903
8336738|NCT01332500|20551034|P2|STARTED|Overall Study||39771
8336739|NCT01332500|20551035|P1|STARTED|Overall Study||13257
8336740|NCT01332487|20551055|P2|NOT COMPLETED|Overall Study||0
8336741|NCT01332487|20551056|P1|NOT COMPLETED|Overall Study||0
8336742|NCT01332487|20551055|P2|COMPLETED|Overall Study||3063
8336743|NCT01332487|20551056|P1|COMPLETED|Overall Study||5554
8336744|NCT01332487|20551055|P2|STARTED|Overall Study||3063
8336745|NCT01332487|20551056|P1|STARTED|Overall Study||5554
8336746|NCT01332461|20551066|P2|NOT COMPLETED|Overall Study||0
8336747|NCT01332461|20551067|P1|NOT COMPLETED|Overall Study||0
8336748|NCT01332461|20551066|P2|COMPLETED|Overall Study||4386
8336749|NCT01332461|20551067|P1|COMPLETED|Overall Study||1291
8336750|NCT01332461|20551066|P2|STARTED|Overall Study||4386
8336751|NCT01332461|20551067|P1|STARTED|Overall Study||1291
8336752|NCT01332435|20551081|P4|NOT COMPLETED|Overall Study||0
8336753|NCT01332435|20551082|P3|NOT COMPLETED|Overall Study||0
8336754|NCT01332435|20551083|P2|NOT COMPLETED|Overall Study||0
8336755|NCT01332435|20551084|P1|NOT COMPLETED|Overall Study||0
8336756|NCT01332435|20551081|P4|COMPLETED|Overall Study||1656
8336757|NCT01332435|20551082|P3|COMPLETED|Overall Study||2604
8336758|NCT01332435|20551083|P2|COMPLETED|Overall Study||1064
8336759|NCT01332435|20551084|P1|COMPLETED|Overall Study||1572
8336760|NCT01332435|20551081|P4|STARTED|Overall Study||1656
8336761|NCT01332435|20551082|P3|STARTED|Overall Study||2604
8336762|NCT01332435|20551083|P2|STARTED|Overall Study||1064
8336763|NCT01332435|20551084|P1|STARTED|Overall Study||1572
8336764|NCT01332357|20551114|P1|NOT COMPLETED|Overall Study||0
8336765|NCT01332357|20551114|P1|COMPLETED|Overall Study||6139
8336766|NCT01332357|20551114|P1|STARTED|Overall Study||6139
8336767|NCT01332331|20551120|P2|NOT COMPLETED|Overall Study||2
8336768|NCT01332331|20551121|P1|NOT COMPLETED|Overall Study||2
8336769|NCT01332331|20551120|P2|COMPLETED|Overall Study||18
8336770|NCT01332331|20551121|P1|COMPLETED|Overall Study||19
8336771|NCT01332331|20551120|P2|STARTED|Overall Study||20
8336772|NCT01332331|20551121|P1|STARTED|Overall Study||21
8336773|NCT01332318|20551173|P4|NOT COMPLETED|Overall Study||2
8336774|NCT01332318|20551174|P3|NOT COMPLETED|Overall Study||1
8336775|NCT01332318|20551175|P2|NOT COMPLETED|Overall Study||4
8336776|NCT01332318|20551176|P1|NOT COMPLETED|Overall Study||2
8336777|NCT01332318|20551173|P4|COMPLETED|Overall Study||28
8336778|NCT01332318|20551174|P3|COMPLETED|Overall Study||33
8336779|NCT01332318|20551175|P2|COMPLETED|Overall Study||28
8336780|NCT01332318|20551176|P1|COMPLETED|Overall Study||32
8336781|NCT01332318|20551173|P4|STARTED|Overall Study||30
8336782|NCT01332318|20551174|P3|STARTED|Overall Study||34
8336783|NCT01332318|20551175|P2|STARTED|Overall Study||32
8336784|NCT01332318|20551176|P1|STARTED|Overall Study||34
8336785|NCT01332305|20551287|P5|NOT COMPLETED|Overall Study||12
8336786|NCT01332305|20551288|P4|NOT COMPLETED|Overall Study||8
8336787|NCT01332305|20551289|P3|NOT COMPLETED|Overall Study||14
8336788|NCT01332305|20551290|P2|NOT COMPLETED|Overall Study||14
8336789|NCT01332305|20551291|P1|NOT COMPLETED|Overall Study||10
8336790|NCT01332305|20551287|P5|COMPLETED|Overall Study||33
8336791|NCT01332305|20551288|P4|COMPLETED|Overall Study||30
8336792|NCT01332305|20551289|P3|COMPLETED|Overall Study||31
8336793|NCT01332305|20551290|P2|COMPLETED|Overall Study||34
8336794|NCT01332305|20551291|P1|COMPLETED|Overall Study||31
8336795|NCT01332305|20551287|P5|STARTED|Overall Study||45
8336796|NCT01332305|20551288|P4|STARTED|Overall Study||38
8336797|NCT01332305|20551289|P3|STARTED|Overall Study||45
8336798|NCT01332305|20551290|P2|STARTED|Overall Study||48
8336799|NCT01332305|20551291|P1|STARTED|Overall Study||41
8336800|NCT01332292|20551313|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8336801|NCT01332292|20551314|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8336802|NCT01332292|20551313|P2|COMPLETED|Treatment Period 2 (14 Days)||11
8336803|NCT01332292|20551314|P1|COMPLETED|Treatment Period 2 (14 Days)||11
8336804|NCT01332292|20551313|P2|STARTED|Treatment Period 2 (14 Days)||12
8336805|NCT01332292|20551314|P1|STARTED|Treatment Period 2 (14 Days)||12
8336806|NCT01332292|20551313|P2|NOT COMPLETED|Washout Period (>=7 Days)||0
8336807|NCT01332292|20551314|P1|NOT COMPLETED|Washout Period (>=7 Days)||0
8336808|NCT01332292|20551313|P2|COMPLETED|Washout Period (>=7 Days)||12
8336809|NCT01332292|20551314|P1|COMPLETED|Washout Period (>=7 Days)||12
8336810|NCT01332292|20551313|P2|STARTED|Washout Period (>=7 Days)||12
8336811|NCT01332292|20551314|P1|STARTED|Washout Period (>=7 Days)||12
8336812|NCT01332292|20551313|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8336813|NCT01332292|20551314|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8336814|NCT01332292|20551313|P2|COMPLETED|Treatment Period 1 (14 Days)||12
8336815|NCT01332292|20551314|P1|COMPLETED|Treatment Period 1 (14 Days)||12
8336816|NCT01332292|20551313|P2|STARTED|Treatment Period 1 (14 Days)||13
8336817|NCT01332292|20551314|P1|STARTED|Treatment Period 1 (14 Days)||14
8336818|NCT01332253|20551376|P2|NOT COMPLETED|Overall Study||0
8336819|NCT01332253|20551377|P1|NOT COMPLETED|Overall Study||0
8336820|NCT01332253|20551376|P2|COMPLETED|Overall Study||79
8336821|NCT01332253|20551377|P1|COMPLETED|Overall Study||82
8336822|NCT01332253|20551376|P2|STARTED|Overall Study||79
8336823|NCT01332253|20551377|P1|STARTED|Overall Study||82
8336824|NCT01332227|20551405|P2|NOT COMPLETED|Overall Study||5
8336825|NCT01332227|20551406|P1|NOT COMPLETED|Overall Study||16
8336826|NCT01332227|20551405|P2|COMPLETED|Overall Study||32
8336827|NCT01332227|20551406|P1|COMPLETED|Overall Study||56
8336828|NCT01332227|20551405|P2|STARTED|Overall Study|Participants who received treatment|37
8336829|NCT01332227|20551406|P1|STARTED|Overall Study|Participants who received treatment|72
8336830|NCT01332188|20551428|P4|NOT COMPLETED|Overall Study||0
8336831|NCT01332188|20551429|P3|NOT COMPLETED|Overall Study||4
8336832|NCT01332188|20551430|P2|NOT COMPLETED|Overall Study||1
8336833|NCT01332188|20551431|P1|NOT COMPLETED|Overall Study||2
8336834|NCT01332188|20551428|P4|COMPLETED|Overall Study||25
8336835|NCT01332188|20551429|P3|COMPLETED|Overall Study||21
8336836|NCT01332188|20551430|P2|COMPLETED|Overall Study||25
8336837|NCT01332188|20551431|P1|COMPLETED|Overall Study||23
8336838|NCT01332188|20551428|P4|STARTED|Overall Study||25
8336839|NCT01332188|20551429|P3|STARTED|Overall Study||25
8336840|NCT01332188|20551430|P2|STARTED|Overall Study||26
8336841|NCT01332188|20551431|P1|STARTED|Overall Study||25
8336842|NCT01332123|20551585|P1|NOT COMPLETED|Overall Study||0
8336843|NCT01332123|20551585|P1|COMPLETED|Overall Study||10
8336844|NCT01332123|20551585|P1|STARTED|Overall Study||10
8336845|NCT01332071|20551590|P2|NOT COMPLETED|Period 2||0
8336846|NCT01332071|20551591|P1|NOT COMPLETED|Period 2||0
8336847|NCT01332071|20551590|P2|COMPLETED|Period 2||13
8336848|NCT01332071|20551591|P1|COMPLETED|Period 2||13
8336849|NCT01332071|20551590|P2|STARTED|Period 2||13
8336850|NCT01332071|20551591|P1|STARTED|Period 2||13
8336851|NCT01332071|20551590|P2|NOT COMPLETED|7-Day Washout Period||0
8336852|NCT01332071|20551591|P1|NOT COMPLETED|7-Day Washout Period||0
8336853|NCT01332071|20551590|P2|COMPLETED|7-Day Washout Period||13
8336854|NCT01332071|20551591|P1|COMPLETED|7-Day Washout Period||13
8336855|NCT01332071|20551590|P2|STARTED|7-Day Washout Period||13
8336856|NCT01332071|20551591|P1|STARTED|7-Day Washout Period||13
8336857|NCT01332071|20551590|P2|NOT COMPLETED|Period 1||0
8336858|NCT01332071|20551591|P1|NOT COMPLETED|Period 1||0
8336859|NCT01332071|20551590|P2|COMPLETED|Period 1||13
8336860|NCT01332071|20551591|P1|COMPLETED|Period 1||13
8336861|NCT01332071|20551590|P2|STARTED|Period 1||13
8336862|NCT01332071|20551591|P1|STARTED|Period 1||13
8336863|NCT01332019|20551609|P2|NOT COMPLETED|Overall Study||122
8336864|NCT01332019|20551610|P1|NOT COMPLETED|Overall Study||113
8336865|NCT01332019|20551609|P2|COMPLETED|Overall Study||425
8336866|NCT01332019|20551610|P1|COMPLETED|Overall Study||417
8336867|NCT01332019|20551609|P2|STARTED|Overall Study||547
8336868|NCT01332019|20551610|P1|STARTED|Overall Study||530
8336869|NCT01331837|20551694|P2|NOT COMPLETED|Overall Study||67
8336870|NCT01331837|20551695|P1|NOT COMPLETED|Overall Study||56
8336871|NCT01331837|20551694|P2|COMPLETED|Overall Study||1475
8336872|NCT01331837|20551695|P1|COMPLETED|Overall Study||1482
8336873|NCT01331837|20551694|P2|STARTED|Overall Study||1542
8336874|NCT01331837|20551695|P1|STARTED|Overall Study||1538
8336875|NCT01331824|20551735|P1|NOT COMPLETED|Overall Study||13
8336876|NCT01331824|20551735|P1|COMPLETED|Overall Study||9
8336877|NCT01331824|20551735|P1|STARTED|Overall Study||22
8336878|NCT01331694|20551748|P6|NOT COMPLETED|Overall Study||0
8336879|NCT01331694|20551749|P5|NOT COMPLETED|Overall Study||0
8336880|NCT01331694|20551750|P4|NOT COMPLETED|Overall Study||0
8336881|NCT01331694|20551751|P3|NOT COMPLETED|Overall Study||0
8336882|NCT01331694|20551752|P2|NOT COMPLETED|Overall Study||0
8336883|NCT01331694|20551753|P1|NOT COMPLETED|Overall Study||0
8336884|NCT01331694|20551748|P6|COMPLETED|Overall Study||9126
8336885|NCT01331694|20551749|P5|COMPLETED|Overall Study||10617
8336886|NCT01331694|20551750|P4|COMPLETED|Overall Study||12595
8336887|NCT01331694|20551751|P3|COMPLETED|Overall Study||12659
8336888|NCT01331694|20551752|P2|COMPLETED|Overall Study||14449
8336889|NCT01331694|20551753|P1|COMPLETED|Overall Study||16684
8336890|NCT01331694|20551748|P6|STARTED|Overall Study||9126
8336891|NCT01331694|20551749|P5|STARTED|Overall Study||10617
8336892|NCT01331694|20551750|P4|STARTED|Overall Study||12595
8336893|NCT01331694|20551751|P3|STARTED|Overall Study||12659
8336894|NCT01331694|20551752|P2|STARTED|Overall Study||14449
8336895|NCT01331694|20551753|P1|STARTED|Overall Study||16684
8336896|NCT01331681|20551770|P3|NOT COMPLETED|Overall Study||35
8336897|NCT01331681|20551771|P2|NOT COMPLETED|Overall Study||34
8336898|NCT01331681|20551772|P1|NOT COMPLETED|Overall Study||35
8336899|NCT01331681|20551770|P3|COMPLETED|Overall Study|Completed Week 148|100
8336900|NCT01331681|20551771|P2|COMPLETED|Overall Study|Completed Week 148|101
8336901|NCT01331681|20551772|P1|COMPLETED|Overall Study|Completed Week 148|101
8336902|NCT01331681|20551770|P3|Completed Week 148|Overall Study||100
8336903|NCT01331681|20551771|P2|Completed Week 148|Overall Study||101
8336904|NCT01331681|20551772|P1|Completed Week 148|Overall Study||101
8336905|NCT01331681|20551770|P3|Completed Week 100|Overall Study||105
8336906|NCT01331681|20551771|P2|Completed Week 100|Overall Study||110
8336907|NCT01331681|20551772|P1|Completed Week 100|Overall Study||115
8336908|NCT01331681|20551770|P3|Completed Week 52|Overall Study||115
8336909|NCT01331681|20551771|P2|Completed Week 52|Overall Study||121
8336910|NCT01331681|20551772|P1|Completed Week 52|Overall Study||125
8336911|NCT01331681|20551770|P3|Participants Received Treatment|Overall Study|safety population|133
8336912|NCT01331681|20551771|P2|Participants Received Treatment|Overall Study|safety population|135
8336913|NCT01331681|20551772|P1|Participants Received Treatment|Overall Study|safety population|136
8336914|NCT01331681|20551770|P3|STARTED|Overall Study|randomized|135
8336915|NCT01331681|20551771|P2|STARTED|Overall Study|randomized|135
8336916|NCT01331681|20551772|P1|STARTED|Overall Study|randomized|136
8336917|NCT01331408|20551798|P1|NOT COMPLETED|Overall Study||11
8336918|NCT01331408|20551798|P1|COMPLETED|Overall Study||50
8336919|NCT01331408|20551798|P1|STARTED|Overall Study||61
8336920|NCT01331304|20551806|P2|NOT COMPLETED|Overall Study||60
8336921|NCT01331304|20551807|P1|NOT COMPLETED|Overall Study||58
8336922|NCT01331304|20551806|P2|COMPLETED|Overall Study||182
8336923|NCT01331304|20551807|P1|COMPLETED|Overall Study||182
8336924|NCT01331304|20551806|P2|STARTED|Overall Study||242
8336925|NCT01331304|20551807|P1|STARTED|Overall Study||240
8336926|NCT01331291|20551821|P2|NOT COMPLETED|Overall Study||9
8336927|NCT01331291|20551822|P1|NOT COMPLETED|Overall Study||2
8336928|NCT01331291|20551821|P2|COMPLETED|Overall Study||0
8336929|NCT01331291|20551822|P1|COMPLETED|Overall Study||0
8336930|NCT01331291|20551821|P2|STARTED|Overall Study||9
8336931|NCT01331291|20551822|P1|STARTED|Overall Study||2
8336932|NCT01331239|20551835|P3|NOT COMPLETED|Part II: Core Study||1
8336933|NCT01331239|20551836|P2|NOT COMPLETED|Part II: Core Study||8
8336934|NCT01331239|20551837|P1|NOT COMPLETED|Part II: Core Study||0
8336935|NCT01331239|20551835|P3|COMPLETED|Part II: Core Study||3
8336936|NCT01331239|20551836|P2|COMPLETED|Part II: Core Study||7
8336937|NCT01331239|20551837|P1|COMPLETED|Part II: Core Study||0
8336938|NCT01331239|20551835|P3|STARTED|Part II: Core Study||4
8336939|NCT01331239|20551836|P2|STARTED|Part II: Core Study||15
8336940|NCT01331239|20551837|P1|STARTED|Part II: Core Study||0
8336941|NCT01331239|20551835|P3|NOT COMPLETED|Part I: Core Study||0
8336942|NCT01331239|20551836|P2|NOT COMPLETED|Part I: Core Study||0
8336943|NCT01331239|20551837|P1|NOT COMPLETED|Part I: Core Study||0
8336944|NCT01331239|20551835|P3|COMPLETED|Part I: Core Study||0
8336945|NCT01331239|20551836|P2|COMPLETED|Part I: Core Study||0
8336946|NCT01331239|20551837|P1|COMPLETED|Part I: Core Study||12
8336947|NCT01331239|20551835|P3|STARTED|Part I: Core Study||0
8336948|NCT01331239|20551836|P2|STARTED|Part I: Core Study||0
8336949|NCT01331239|20551837|P1|STARTED|Part I: Core Study||12
8336950|NCT01331213|20551909|P2|NOT COMPLETED|Overall Study||0
8336951|NCT01331213|20551910|P1|NOT COMPLETED|Overall Study||0
8336952|NCT01331213|20551909|P2|COMPLETED|Overall Study||10
8336953|NCT01331213|20551910|P1|COMPLETED|Overall Study||8
8336954|NCT01331213|20551909|P2|STARTED|Overall Study||10
8336955|NCT01331213|20551910|P1|STARTED|Overall Study||8
8336956|NCT01331161|20551930|P2|NOT COMPLETED|Overall Study||2
8336957|NCT01331161|20551931|P1|NOT COMPLETED|Overall Study||1
8336958|NCT01331161|20551930|P2|COMPLETED|Overall Study||31
8336959|NCT01331161|20551931|P1|COMPLETED|Overall Study||43
8336960|NCT01331161|20551930|P2|STARTED|Overall Study||33
8336961|NCT01331161|20551931|P1|STARTED|Overall Study||44
8336962|NCT01331109|20551939|P1|NOT COMPLETED|Overall Study||57
8336963|NCT01331109|20551939|P1|COMPLETED|Overall Study||0
8336964|NCT01331109|20551939|P1|STARTED|Overall Study||57
8336965|NCT01331083|20551951|P2|NOT COMPLETED|Overall Study||0
8336966|NCT01331083|20551952|P1|NOT COMPLETED|Overall Study||0
8336967|NCT01331083|20551951|P2|COMPLETED|Overall Study||25
8336968|NCT01331083|20551952|P1|COMPLETED|Overall Study||43
8336969|NCT01331083|20551951|P2|STARTED|Overall Study||25
8336970|NCT01331083|20551952|P1|STARTED|Overall Study||43
8336971|NCT01331005|20551966|P2|NOT COMPLETED|Overall Study||4
8336972|NCT01331005|20551967|P1|NOT COMPLETED|Overall Study||4
8336973|NCT01331005|20551966|P2|COMPLETED|Overall Study||57
8336974|NCT01331005|20551967|P1|COMPLETED|Overall Study||60
8336975|NCT01331005|20551966|P2|STARTED|Overall Study||61
8336976|NCT01331005|20551967|P1|STARTED|Overall Study||64
8336977|NCT01330966|20551977|P1|NOT COMPLETED|Overall Study||5
8336978|NCT01330966|20551977|P1|COMPLETED|Overall Study|Tumor responses evaluable in 42 of 47 pts; 5 pts discontinued prior to first tumor assessment.|42
8336979|NCT01330966|20551977|P1|STARTED|Overall Study||47
8336980|NCT01330953|20551988|P5|NOT COMPLETED|Overall Study||0
8336981|NCT01330953|20551989|P4|NOT COMPLETED|Overall Study||0
8336982|NCT01330953|20551990|P3|NOT COMPLETED|Overall Study||0
8336983|NCT01330953|20551991|P2|NOT COMPLETED|Overall Study||0
8336984|NCT01330953|20551992|P1|NOT COMPLETED|Overall Study||0
8336985|NCT01330953|20551988|P5|COMPLETED|Overall Study||6
8336986|NCT01330953|20551989|P4|COMPLETED|Overall Study||6
8336987|NCT01330953|20551990|P3|COMPLETED|Overall Study||6
8336988|NCT01330953|20551991|P2|COMPLETED|Overall Study||6
8336989|NCT01330953|20551992|P1|COMPLETED|Overall Study||8
8336990|NCT01330953|20551988|P5|STARTED|Overall Study||6
8336991|NCT01330953|20551989|P4|STARTED|Overall Study||6
8336992|NCT01330953|20551990|P3|STARTED|Overall Study||6
8336993|NCT01330953|20551991|P2|STARTED|Overall Study||6
8336994|NCT01330953|20551992|P1|STARTED|Overall Study||8
8336995|NCT01330914|20552038|P1|NOT COMPLETED|Overall Study||7
8336996|NCT01330914|20552038|P1|COMPLETED|Overall Study||48
8336997|NCT01330914|20552038|P1|STARTED|Overall Study||55
8336998|NCT01330628|20552046|P2|NOT COMPLETED|Overall Study||40
8336999|NCT01330628|20552047|P1|NOT COMPLETED|Overall Study||70
8337000|NCT01330628|20552046|P2|COMPLETED|Overall Study||42
8337001|NCT01330628|20552047|P1|COMPLETED|Overall Study||100
8337002|NCT01330628|20552046|P2|6 Month Follow-up|Overall Study||60
8337003|NCT01330628|20552047|P1|6 Month Follow-up|Overall Study||135
8337004|NCT01330628|20552046|P2|30 Day Follow-up|Overall Study||73
8337005|NCT01330628|20552047|P1|30 Day Follow-up|Overall Study||165
8337006|NCT01330628|20552046|P2|STARTED|Overall Study||82
8337007|NCT01330628|20552047|P1|STARTED|Overall Study||170
8337008|NCT01330459|20552057|P2|NOT COMPLETED|Overall Study||2
8337009|NCT01330459|20552058|P1|NOT COMPLETED|Overall Study||0
8337010|NCT01330459|20552057|P2|COMPLETED|Overall Study||58
8337011|NCT01330459|20552058|P1|COMPLETED|Overall Study||61
8337012|NCT01330459|20552057|P2|STARTED|Overall Study||60
8337013|NCT01330459|20552058|P1|STARTED|Overall Study||61
8337014|NCT01330433|20552074|P2|NOT COMPLETED|Overall Study||3
8337015|NCT01330433|20552075|P1|NOT COMPLETED|Overall Study||2
8337016|NCT01330433|20552074|P2|COMPLETED|Overall Study||16
8337017|NCT01330433|20552075|P1|COMPLETED|Overall Study||14
8337018|NCT01330433|20552074|P2|STARTED|Overall Study||19
8337019|NCT01330433|20552075|P1|STARTED|Overall Study||16
8337020|NCT01330420|20552095|P1|NOT COMPLETED|Overall Study||4
8337021|NCT01330420|20552095|P1|COMPLETED|Overall Study||24
8337022|NCT01330420|20552095|P1|STARTED|Overall Study||28
8337023|NCT01330394|20552105|P2|NOT COMPLETED|Overall Study||0
8337024|NCT01330394|20552106|P1|NOT COMPLETED|Overall Study||0
8337025|NCT01330394|20552105|P2|COMPLETED|Overall Study||16
8337026|NCT01330394|20552106|P1|COMPLETED|Overall Study||17
8337027|NCT01330394|20552105|P2|STARTED|Overall Study||16
8337028|NCT01330394|20552106|P1|STARTED|Overall Study||17
8337050|NCT01330355|20552162|P2|NOT COMPLETED|Overall Study||0
8337051|NCT01330355|20552163|P1|NOT COMPLETED|Overall Study||0
8337052|NCT01330355|20552162|P2|COMPLETED|Overall Study||17
8337053|NCT01330355|20552163|P1|COMPLETED|Overall Study||16
8337054|NCT01330355|20552162|P2|STARTED|Overall Study||17
8337055|NCT01330355|20552163|P1|STARTED|Overall Study||16
8337056|NCT01330316|20552177|P2|NOT COMPLETED|Overall Study||15
8337057|NCT01330316|20552178|P1|NOT COMPLETED|Overall Study||2
8337058|NCT01330316|20552177|P2|COMPLETED|Overall Study||60
8337059|NCT01330316|20552178|P1|COMPLETED|Overall Study||41
8337060|NCT01330316|20552177|P2|STARTED|Overall Study||75
8337061|NCT01330316|20552178|P1|STARTED|Overall Study||43
8337062|NCT01330303|20552214|P2|NOT COMPLETED|Period 2||0
8337063|NCT01330303|20552215|P1|NOT COMPLETED|Period 2||0
8337064|NCT01330303|20552214|P2|COMPLETED|Period 2||18
8337065|NCT01330303|20552215|P1|COMPLETED|Period 2||19
8337066|NCT01330303|20552214|P2|STARTED|Period 2||18
8337067|NCT01330303|20552215|P1|STARTED|Period 2||19
8337068|NCT01330303|20552214|P2|NOT COMPLETED|7-Day Washout Period||0
8337069|NCT01330303|20552215|P1|NOT COMPLETED|7-Day Washout Period||0
8337070|NCT01330303|20552214|P2|COMPLETED|7-Day Washout Period||18
8337071|NCT01330303|20552215|P1|COMPLETED|7-Day Washout Period||19
8337072|NCT01330303|20552214|P2|STARTED|7-Day Washout Period||18
8337073|NCT01330303|20552215|P1|STARTED|7-Day Washout Period||19
8337074|NCT01330303|20552214|P2|NOT COMPLETED|Period 1||2
8337075|NCT01330303|20552215|P1|NOT COMPLETED|Period 1||1
8337076|NCT01330303|20552214|P2|COMPLETED|Period 1||18
8337077|NCT01330303|20552215|P1|COMPLETED|Period 1||19
8337078|NCT01330303|20552214|P2|STARTED|Period 1||20
8337079|NCT01330303|20552215|P1|STARTED|Period 1||20
8337080|NCT01330290|20552225|P1|NOT COMPLETED|Overall Study||0
8337081|NCT01330290|20552225|P1|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
8337082|NCT01330290|20552225|P1|STARTED|Overall Study||148
8337083|NCT01330134|20552251|P2|NOT COMPLETED|Overall Study||0
8337084|NCT01330134|20552252|P1|NOT COMPLETED|Overall Study||0
8337085|NCT01330134|20552251|P2|COMPLETED|Overall Study||237
8337086|NCT01330134|20552252|P1|COMPLETED|Overall Study||244
8337087|NCT01330134|20552251|P2|STARTED|Overall Study||237
8337088|NCT01330134|20552252|P1|STARTED|Overall Study||244
8337089|NCT01330108|20552262|P1|NOT COMPLETED|Overall Study||4
8337090|NCT01330108|20552262|P1|COMPLETED|Overall Study||28
8337091|NCT01330108|20552262|P1|STARTED|Overall Study||32
8337092|NCT01330043|20552269|P2|NOT COMPLETED|Overall Study||4
8337093|NCT01330043|20552270|P1|NOT COMPLETED|Overall Study||0
8337094|NCT01330043|20552269|P2|COMPLETED|Overall Study||108
8337095|NCT01330043|20552270|P1|COMPLETED|Overall Study||111
8337096|NCT01330043|20552269|P2|STARTED|Overall Study||112
8337097|NCT01330043|20552270|P1|STARTED|Overall Study||111
8337098|NCT01330030|20552280|P2|NOT COMPLETED|Overall Study||17
8337099|NCT01330030|20552281|P1|NOT COMPLETED|Overall Study||16
8337100|NCT01330030|20552280|P2|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
8337101|NCT01330030|20552281|P1|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
8337102|NCT01330030|20552280|P2|STARTED|Overall Study||122
8337103|NCT01330030|20552281|P1|STARTED|Overall Study||121
8337104|NCT01330017|20552292|P5|NOT COMPLETED|Overall Study||3
8337105|NCT01330017|20552293|P4|NOT COMPLETED|Overall Study||12
8337106|NCT01330017|20552294|P3|NOT COMPLETED|Overall Study||8
8337107|NCT01330017|20552295|P2|NOT COMPLETED|Overall Study||4
8337108|NCT01330017|20552296|P1|NOT COMPLETED|Overall Study||5
8337109|NCT01330017|20552292|P5|COMPLETED|Overall Study||100
8337110|NCT01330017|20552293|P4|COMPLETED|Overall Study||100
8337111|NCT01330017|20552294|P3|COMPLETED|Overall Study||99
8337112|NCT01330017|20552295|P2|COMPLETED|Overall Study||104
8337113|NCT01330017|20552296|P1|COMPLETED|Overall Study||104
8337114|NCT01330017|20552292|P5|STARTED|Overall Study||103
8337115|NCT01330017|20552293|P4|STARTED|Overall Study||112
8337116|NCT01330017|20552294|P3|STARTED|Overall Study||107
8337117|NCT01330017|20552295|P2|STARTED|Overall Study||108
8337118|NCT01330017|20552296|P1|STARTED|Overall Study||109
8337119|NCT01329978|20552345|P5|NOT COMPLETED|Rerandomization Treatment Period||4
8337120|NCT01329978|20552346|P4|NOT COMPLETED|Rerandomization Treatment Period||5
8337121|NCT01329978|20552347|P3|NOT COMPLETED|Rerandomization Treatment Period||0
8337122|NCT01329978|20552348|P2|NOT COMPLETED|Rerandomization Treatment Period||0
8337123|NCT01329978|20552349|P1|NOT COMPLETED|Rerandomization Treatment Period||0
8337124|NCT01329978|20552345|P5|COMPLETED|Rerandomization Treatment Period||71
8337125|NCT01329978|20552346|P4|COMPLETED|Rerandomization Treatment Period||70
8337126|NCT01329978|20552347|P3|COMPLETED|Rerandomization Treatment Period||0
8337127|NCT01329978|20552348|P2|COMPLETED|Rerandomization Treatment Period||0
8337128|NCT01329978|20552349|P1|COMPLETED|Rerandomization Treatment Period||0
8337129|NCT01329978|20552345|P5|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
8337130|NCT01329978|20552346|P4|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
8337131|NCT01329978|20552347|P3|STARTED|Rerandomization Treatment Period||0
8337132|NCT01329978|20552348|P2|STARTED|Rerandomization Treatment Period||0
8337133|NCT01329978|20552349|P1|STARTED|Rerandomization Treatment Period||0
8337134|NCT01329978|20552345|P5|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
8337135|NCT01329978|20552346|P4|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
8337136|NCT01329978|20552347|P3|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
8337137|NCT01329978|20552348|P2|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
8337138|NCT01329978|20552349|P1|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
8337139|NCT01329978|20552345|P5|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
8337140|NCT01329978|20552346|P4|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
8337141|NCT01329978|20552347|P3|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
8337142|NCT01329978|20552348|P2|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
8337143|NCT01329978|20552349|P1|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
8337144|NCT01329978|20552345|P5|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
8337145|NCT01329978|20552346|P4|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
8337146|NCT01329978|20552347|P3|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
8337147|NCT01329978|20552348|P2|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
8337148|NCT01329978|20552349|P1|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
8337149|NCT01329939|20552423|P4|NOT COMPLETED|Overall Study||5
8337150|NCT01329939|20552424|P3|NOT COMPLETED|Overall Study||1
8337151|NCT01329939|20552425|P2|NOT COMPLETED|Overall Study||1
8337152|NCT01329939|20552426|P1|NOT COMPLETED|Overall Study||3
8337153|NCT01329939|20552423|P4|COMPLETED|Overall Study||4
8337154|NCT01329939|20552424|P3|COMPLETED|Overall Study||4
8337155|NCT01329939|20552425|P2|COMPLETED|Overall Study||4
8337156|NCT01329939|20552426|P1|COMPLETED|Overall Study||4
8337157|NCT01329939|20552423|P4|STARTED|Overall Study||9
8337158|NCT01329939|20552424|P3|STARTED|Overall Study||5
8337159|NCT01329939|20552425|P2|STARTED|Overall Study||5
8337160|NCT01329939|20552426|P1|STARTED|Overall Study||7
8337161|NCT01329900|20552464|P1|NOT COMPLETED|Overall Study||1
8337162|NCT01329900|20552464|P1|COMPLETED|Overall Study||49
8337163|NCT01329900|20552464|P1|STARTED|Overall Study||50
8337164|NCT01329848|20552468|P1|NOT COMPLETED|Overall Study||29
8337165|NCT01329848|20552468|P1|COMPLETED|Overall Study||54
8337166|NCT01329848|20552468|P1|STARTED|Overall Study||83
8337167|NCT01329679|20552473|P2|NOT COMPLETED|Overall Study||0
8337168|NCT01329679|20552474|P1|NOT COMPLETED|Overall Study||0
8337169|NCT01329679|20552473|P2|COMPLETED|Overall Study||13
8337170|NCT01329679|20552474|P1|COMPLETED|Overall Study||13
8337171|NCT01329679|20552473|P2|STARTED|Overall Study||13
8337172|NCT01329679|20552474|P1|STARTED|Overall Study||13
8337173|NCT01329562|20552494|P2|NOT COMPLETED|Overall Study||7
8337174|NCT01329562|20552495|P1|NOT COMPLETED|Overall Study||9
8337175|NCT01329562|20552494|P2|COMPLETED|Overall Study||14
8337176|NCT01329562|20552495|P1|COMPLETED|Overall Study||11
8337177|NCT01329562|20552494|P2|STARTED|Overall Study||21
8337178|NCT01329562|20552495|P1|STARTED|Overall Study||20
8337179|NCT01329549|20552544|P1|NOT COMPLETED|Overall Study||2
8337180|NCT01329549|20552544|P1|COMPLETED|Overall Study||0
8337181|NCT01329549|20552544|P1|STARTED|Overall Study||2
8337182|NCT01329419|20552555|P1|NOT COMPLETED|Overall Study||235
8337183|NCT01329419|20552555|P1|COMPLETED|Overall Study||4158
8337184|NCT01329419|20552555|P1|STARTED|Overall Study||4393
8337185|NCT01329380|20552561|P1|NOT COMPLETED|Overall Study||29
8337186|NCT01329380|20552561|P1|COMPLETED|Overall Study||374
8337187|NCT01329380|20552561|P1|Safety Population|Overall Study||396
8337188|NCT01329380|20552561|P1|STARTED|Overall Study||403
8337189|NCT01329328|20552574|P3|NOT COMPLETED|Overall Study||3
8337190|NCT01329328|20552575|P2|NOT COMPLETED|Overall Study||4
8337191|NCT01329328|20552576|P1|NOT COMPLETED|Overall Study||2
8337192|NCT01329328|20552574|P3|COMPLETED|Overall Study||15
8337193|NCT01329328|20552575|P2|COMPLETED|Overall Study||13
8337194|NCT01329328|20552576|P1|COMPLETED|Overall Study||13
8337195|NCT01329328|20552574|P3|STARTED|Overall Study||18
8337196|NCT01329328|20552575|P2|STARTED|Overall Study||17
8337197|NCT01329328|20552576|P1|STARTED|Overall Study||15
8337198|NCT01329263|20552589|P2|NOT COMPLETED|Overall Study||23
8337199|NCT01329263|20552590|P1|NOT COMPLETED|Overall Study||5
8337200|NCT01329263|20552589|P2|COMPLETED|Overall Study||22
8337201|NCT01329263|20552590|P1|COMPLETED|Overall Study||10
8337202|NCT01329263|20552589|P2|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
8337203|NCT01329263|20552590|P1|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
8337204|NCT01329263|20552589|P2|Completed Period 2 Own or CCrush Menthol|Overall Study||30
8337205|NCT01329263|20552590|P1|Completed Period 2 Own or CCrush Menthol|Overall Study||10
8337206|NCT01329263|20552589|P2|Completed Period 1 Own Menthol|Overall Study||45
8337207|NCT01329263|20552590|P1|Completed Period 1 Own Menthol|Overall Study||15
8337208|NCT01329263|20552589|P2|STARTED|Overall Study||45
8337209|NCT01329263|20552590|P1|STARTED|Overall Study||15
8337210|NCT01329198|20552604|P2|NOT COMPLETED|Overall Study||0
8337211|NCT01329198|20552605|P1|NOT COMPLETED|Overall Study||0
8337212|NCT01329198|20552604|P2|COMPLETED|Overall Study||2
8337213|NCT01329198|20552605|P1|COMPLETED|Overall Study||3
8337214|NCT01329198|20552604|P2|STARTED|Overall Study||2
8337215|NCT01329198|20552605|P1|STARTED|Overall Study||3
8337216|NCT01329185|20552618|P2|NOT COMPLETED|Overall Study||0
8337217|NCT01329185|20552619|P1|NOT COMPLETED|Overall Study||0
8337218|NCT01329185|20552618|P2|COMPLETED|Overall Study||7
8337219|NCT01329185|20552619|P1|COMPLETED|Overall Study||10
8337220|NCT01329185|20552618|P2|PTLD|Overall Study||0
8337221|NCT01329185|20552619|P1|PTLD|Overall Study||1
8337222|NCT01329185|20552618|P2|CMV Disease|Overall Study||0
8337223|NCT01329185|20552619|P1|CMV Disease|Overall Study||1
8337224|NCT01329185|20552618|P2|STARTED|Overall Study||7
8337225|NCT01329185|20552619|P1|STARTED|Overall Study||10
8337226|NCT01329029|20552627|P2|NOT COMPLETED|Overall Study||192
8337227|NCT01329029|20552628|P1|NOT COMPLETED|Overall Study||269
8337228|NCT01329029|20552627|P2|COMPLETED|Overall Study||780
8337229|NCT01329029|20552628|P1|COMPLETED|Overall Study||704
8337230|NCT01329029|20552627|P2|Safety Population|Overall Study||967
8337231|NCT01329029|20552628|P1|Safety Population|Overall Study||968
8337232|NCT01329029|20552627|P2|Full Analysis Set (FAS)|Overall Study||966
8337233|NCT01329029|20552628|P1|Full Analysis Set (FAS)|Overall Study||969
8337234|NCT01329029|20552627|P2|STARTED|Overall Study||972
8337235|NCT01329029|20552628|P1|STARTED|Overall Study||973
8337236|NCT01328964|20552701|P3|NOT COMPLETED|Overall Study||0
8337237|NCT01328964|20552702|P2|NOT COMPLETED|Overall Study||0
8337238|NCT01328964|20552703|P1|NOT COMPLETED|Overall Study||0
8337239|NCT01328964|20552701|P3|COMPLETED|Overall Study||4424
8337240|NCT01328964|20552702|P2|COMPLETED|Overall Study||3270
8337241|NCT01328964|20552703|P1|COMPLETED|Overall Study||2212
8337242|NCT01328964|20552701|P3|STARTED|Overall Study||4424
8337243|NCT01328964|20552702|P2|STARTED|Overall Study||3270
8337244|NCT01328964|20552703|P1|STARTED|Overall Study||2212
8337245|NCT01328951|20552718|P2|NOT COMPLETED|Overall Study||322
8337246|NCT01328951|20552719|P1|NOT COMPLETED|Overall Study||321
8337247|NCT01328951|20552718|P2|COMPLETED|Overall Study||0
8337248|NCT01328951|20552719|P1|COMPLETED|Overall Study||0
8337249|NCT01328951|20552718|P2|STARTED|Overall Study||322
8337250|NCT01328951|20552719|P1|STARTED|Overall Study||321
8337251|NCT01328873|20552743|P1|NOT COMPLETED|Overall Study||0
8337252|NCT01328873|20552743|P1|COMPLETED|Overall Study||49
8337253|NCT01328873|20552743|P1|STARTED|Overall Study||49
8337254|NCT01328782|20552755|P3|NOT COMPLETED|Overall Study||0
8337255|NCT01328782|20552756|P2|NOT COMPLETED|Overall Study||0
8337256|NCT01328782|20552757|P1|NOT COMPLETED|Overall Study||0
8337257|NCT01328782|20552755|P3|COMPLETED|Overall Study||39
8337258|NCT01328782|20552756|P2|COMPLETED|Overall Study||42
8337259|NCT01328782|20552757|P1|COMPLETED|Overall Study||43
8337260|NCT01328782|20552755|P3|STARTED|Overall Study||39
8337261|NCT01328782|20552756|P2|STARTED|Overall Study||42
8337262|NCT01328782|20552757|P1|STARTED|Overall Study||43
8337263|NCT01328769|20552779|P2|NOT COMPLETED|Overall Study||1
8337264|NCT01328769|20552780|P1|NOT COMPLETED|Overall Study||0
8337265|NCT01328769|20552779|P2|COMPLETED|Overall Study||23
8337266|NCT01328769|20552780|P1|COMPLETED|Overall Study||25
8337267|NCT01328769|20552779|P2|STARTED|Overall Study||24
8337268|NCT01328769|20552780|P1|STARTED|Overall Study||25
8337272|NCT01328743|20552807|P2|NOT COMPLETED|Overall Study||10
8337273|NCT01328743|20552808|P1|NOT COMPLETED|Overall Study||9
8337274|NCT01328743|20552807|P2|COMPLETED|Overall Study||79
8337275|NCT01328743|20552808|P1|COMPLETED|Overall Study||82
8337276|NCT01328743|20552807|P2|STARTED|Overall Study||89
8337277|NCT01328743|20552808|P1|STARTED|Overall Study||91
8337278|NCT01328717|20552824|P1|NOT COMPLETED|Overall Study||1
8337279|NCT01328717|20552824|P1|COMPLETED|Overall Study||77
8337280|NCT01328717|20552824|P1|STARTED|Overall Study||78
8337281|NCT01328587|20552829|P1|NOT COMPLETED|Overall Study||0
8337282|NCT01328587|20552829|P1|COMPLETED|Overall Study||34
8337283|NCT01328587|20552829|P1|STARTED|Overall Study||34
8337284|NCT01328574|20552833|P1|NOT COMPLETED|Overall Study||1
8337285|NCT01328574|20552833|P1|COMPLETED|Overall Study||12
8337286|NCT01328574|20552833|P1|STARTED|Overall Study||13
8337287|NCT01328548|20552847|P2|NOT COMPLETED|Overall Study||0
8337288|NCT01328548|20552848|P1|NOT COMPLETED|Overall Study||4
8337289|NCT01328548|20552847|P2|COMPLETED|Overall Study||50
8337290|NCT01328548|20552848|P1|COMPLETED|Overall Study||187
8337291|NCT01328548|20552847|P2|STARTED|Overall Study||50
8337292|NCT01328548|20552848|P1|STARTED|Overall Study||191
8337293|NCT01328535|20552866|P1|NOT COMPLETED|Overall Study||1
8337294|NCT01328535|20552866|P1|COMPLETED|Overall Study||24
8337295|NCT01328535|20552866|P1|STARTED|Overall Study||25
8337296|NCT01328496|20552877|P2|NOT COMPLETED|Overall Study||0
8337297|NCT01328496|20552878|P1|NOT COMPLETED|Overall Study||1
8337298|NCT01328496|20552877|P2|COMPLETED|Overall Study||4
8337299|NCT01328496|20552878|P1|COMPLETED|Overall Study||9
8337300|NCT01328496|20552877|P2|STARTED|Overall Study||4
8337301|NCT01328496|20552878|P1|STARTED|Overall Study||10
8337302|NCT01328444|20552896|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
8337303|NCT01328444|20552897|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
8337304|NCT01328444|20552898|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
8337305|NCT01328444|20552899|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
8337306|NCT01328444|20552900|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
8337307|NCT01328444|20552901|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
8337308|NCT01328444|20552896|P6|COMPLETED|Treatment Period 2 (12 Weeks)||59
8337309|NCT01328444|20552897|P5|COMPLETED|Treatment Period 2 (12 Weeks)||63
8337310|NCT01328444|20552898|P4|COMPLETED|Treatment Period 2 (12 Weeks)||30
8337311|NCT01328444|20552899|P3|COMPLETED|Treatment Period 2 (12 Weeks)||19
8337312|NCT01328444|20552900|P2|COMPLETED|Treatment Period 2 (12 Weeks)||22
8337313|NCT01328444|20552901|P1|COMPLETED|Treatment Period 2 (12 Weeks)||65
8337314|NCT01328444|20552896|P6|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
8337315|NCT01328444|20552897|P5|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
8337316|NCT01328444|20552898|P4|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
8337317|NCT01328444|20552899|P3|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
8337318|NCT01328444|20552900|P2|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
8337319|NCT01328444|20552901|P1|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
8337320|NCT01328444|20552896|P6|NOT COMPLETED|Washout Period (14 Days)||4
8337321|NCT01328444|20552897|P5|NOT COMPLETED|Washout Period (14 Days)||1
8337322|NCT01328444|20552898|P4|NOT COMPLETED|Washout Period (14 Days)||1
8337323|NCT01328444|20552899|P3|NOT COMPLETED|Washout Period (14 Days)||0
8337324|NCT01328444|20552900|P2|NOT COMPLETED|Washout Period (14 Days)||1
8337325|NCT01328444|20552901|P1|NOT COMPLETED|Washout Period (14 Days)||1
8337326|NCT01328444|20552896|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
8337327|NCT01328444|20552897|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
8337328|NCT01328444|20552898|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
8337329|NCT01328444|20552899|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
8337330|NCT01328444|20552900|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
8337331|NCT01328444|20552901|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
8337332|NCT01328444|20552896|P6|STARTED|Washout Period (14 Days)||72
8337333|NCT01328444|20552897|P5|STARTED|Washout Period (14 Days)||67
8337334|NCT01328444|20552898|P4|STARTED|Washout Period (14 Days)||33
8337335|NCT01328444|20552899|P3|STARTED|Washout Period (14 Days)||25
8337336|NCT01328444|20552900|P2|STARTED|Washout Period (14 Days)||21
8337337|NCT01328444|20552901|P1|STARTED|Washout Period (14 Days)||83
8337338|NCT01328444|20552896|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
8337339|NCT01328444|20552897|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
8337340|NCT01328444|20552898|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
8337341|NCT01328444|20552899|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
8337342|NCT01328444|20552900|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
8337343|NCT01328444|20552901|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
8337344|NCT01328444|20552896|P6|COMPLETED|Treatment Period 1 (12 Weeks)||72
8337345|NCT01328444|20552897|P5|COMPLETED|Treatment Period 1 (12 Weeks)||67
8337346|NCT01328444|20552898|P4|COMPLETED|Treatment Period 1 (12 Weeks)||33
8337347|NCT01328444|20552899|P3|COMPLETED|Treatment Period 1 (12 Weeks)||25
8337348|NCT01328444|20552900|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
8337349|NCT01328444|20552901|P1|COMPLETED|Treatment Period 1 (12 Weeks)||83
8337350|NCT01328444|20552896|P6|STARTED|Treatment Period 1 (12 Weeks)||78
8337351|NCT01328444|20552897|P5|STARTED|Treatment Period 1 (12 Weeks)||81
8337352|NCT01328444|20552898|P4|STARTED|Treatment Period 1 (12 Weeks)||41
8337353|NCT01328444|20552899|P3|STARTED|Treatment Period 1 (12 Weeks)||28
8337354|NCT01328444|20552900|P2|STARTED|Treatment Period 1 (12 Weeks)||26
8337355|NCT01328444|20552901|P1|STARTED|Treatment Period 1 (12 Weeks)||94
8337356|NCT01328431|20552947|P2|NOT COMPLETED|12 Month (12M)||97
8337357|NCT01328431|20552948|P1|NOT COMPLETED|12 Month (12M)||84
8337358|NCT01328431|20552947|P2|COMPLETED|12 Month (12M)||289
8337359|NCT01328431|20552948|P1|COMPLETED|12 Month (12M)||304
8337360|NCT01328431|20552947|P2|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
8337361|NCT01328431|20552948|P1|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
8337362|NCT01328431|20552947|P2|NOT COMPLETED|3 Month (3M)||72
8337363|NCT01328431|20552948|P1|NOT COMPLETED|3 Month (3M)||77
8337364|NCT01328431|20552947|P2|COMPLETED|3 Month (3M)||316
8337365|NCT01328431|20552948|P1|COMPLETED|3 Month (3M)||313
8337366|NCT01328431|20552947|P2|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
8337367|NCT01328431|20552948|P1|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
8337368|NCT01328431|20552947|P2|NOT COMPLETED|1 Month (1M)||58
8337369|NCT01328431|20552948|P1|NOT COMPLETED|1 Month (1M)||55
8337370|NCT01328431|20552947|P2|COMPLETED|1 Month (1M)||330
8337371|NCT01328431|20552948|P1|COMPLETED|1 Month (1M)||335
8337372|NCT01328431|20552947|P2|STARTED|1 Month (1M)||388
8337373|NCT01328431|20552948|P1|STARTED|1 Month (1M)||390
8337374|NCT01328431|20552947|P2|NOT COMPLETED|Baseline||2
8337375|NCT01328431|20552948|P1|NOT COMPLETED|Baseline||0
8337376|NCT01328431|20552947|P2|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
8337377|NCT01328431|20552948|P1|COMPLETED|Baseline||390
8337378|NCT01328431|20552947|P2|STARTED|Baseline||390
8337379|NCT01328431|20552948|P1|STARTED|Baseline||390
8337380|NCT01328405|20552958|P2|NOT COMPLETED|Overall Study||0
8337381|NCT01328405|20552959|P1|NOT COMPLETED|Overall Study||0
8337382|NCT01328405|20552958|P2|COMPLETED|Overall Study||48
8337383|NCT01328405|20552959|P1|COMPLETED|Overall Study||52
8337384|NCT01328405|20552958|P2|STARTED|Overall Study||48
8337385|NCT01328405|20552959|P1|STARTED|Overall Study||52
8337386|NCT01328379|20552976|P3|NOT COMPLETED|Overall Study||0
8337387|NCT01328379|20552977|P2|NOT COMPLETED|Overall Study||0
8337388|NCT01328379|20552978|P1|NOT COMPLETED|Overall Study||1
8337389|NCT01328379|20552976|P3|COMPLETED|Overall Study||143
8337390|NCT01328379|20552977|P2|COMPLETED|Overall Study||144
8337391|NCT01328379|20552978|P1|COMPLETED|Overall Study||142
8337392|NCT01328379|20552976|P3|STARTED|Overall Study||143
8337393|NCT01328379|20552977|P2|STARTED|Overall Study||144
8337394|NCT01328379|20552978|P1|STARTED|Overall Study||143
8337395|NCT01328366|20553004|P1|NOT COMPLETED|Overall Study||10
8337396|NCT01328366|20553004|P1|COMPLETED|Overall Study||143
8337397|NCT01328366|20553004|P1|STARTED|Overall Study||153
8337398|NCT01328249|20553024|P2|NOT COMPLETED|Overall Study||3
8337399|NCT01328249|20553025|P1|NOT COMPLETED|Overall Study||7
8337400|NCT01328249|20553024|P2|COMPLETED|Overall Study||23
8337401|NCT01328249|20553025|P1|COMPLETED|Overall Study||48
8337402|NCT01328249|20553024|P2|STARTED|Overall Study||26
8337403|NCT01328249|20553025|P1|STARTED|Overall Study||55
8337404|NCT01328184|20553033|P1|NOT COMPLETED|Overall Study||0
8337405|NCT01328184|20553033|P1|COMPLETED|Overall Study||18
8337406|NCT01328184|20553033|P1|STARTED|Overall Study||18
8337407|NCT01328158|20553073|P1|NOT COMPLETED|Overall Study||0
8337408|NCT01328158|20553073|P1|COMPLETED|Overall Study||220
8337409|NCT01328158|20553073|P1|STARTED|Overall Study||220
8337410|NCT01328080|20553111|P1|NOT COMPLETED|Overall Study||5
8337411|NCT01328080|20553111|P1|COMPLETED|Overall Study||6
8337412|NCT01328080|20553111|P1|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
8337413|NCT01328054|20553115|P2|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
8337414|NCT01328054|20553116|P1|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
8337415|NCT01328054|20553115|P2|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
8337416|NCT01328054|20553116|P1|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
8337417|NCT01328054|20553115|P2|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
8337418|NCT01328054|20553116|P1|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
8337419|NCT01328054|20553115|P2|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
8337420|NCT01328054|20553116|P1|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
8337421|NCT01328054|20553115|P2|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
8337422|NCT01328054|20553116|P1|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
8337423|NCT01328054|20553115|P2|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
8337424|NCT01328054|20553116|P1|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
8337425|NCT01328041|20553141|P1|NOT COMPLETED|Overall Study||57
8337426|NCT01328041|20553141|P1|COMPLETED|Overall Study||126
8337427|NCT01328041|20553141|P1|STARTED|Overall Study||183
8337428|NCT01328002|20553163|P2|NOT COMPLETED|Double-Blind Period||0
8337429|NCT01328002|20553164|P1|NOT COMPLETED|Double-Blind Period||2
8337430|NCT01328002|20553163|P2|COMPLETED|Double-Blind Period||6
8337431|NCT01328002|20553164|P1|COMPLETED|Double-Blind Period||12
8337432|NCT01328002|20553163|P2|STARTED|Double-Blind Period||6
8337433|NCT01328002|20553164|P1|STARTED|Double-Blind Period||14
8337434|NCT01328002|20553163|P2|NOT COMPLETED|Open-Label Period||0
8337435|NCT01328002|20553164|P1|NOT COMPLETED|Open-Label Period||96
8337436|NCT01328002|20553163|P2|COMPLETED|Open-Label Period||0
8337437|NCT01328002|20553164|P1|COMPLETED|Open-Label Period||20
8337438|NCT01328002|20553163|P2|STARTED|Open-Label Period||0
8337439|NCT01328002|20553164|P1|STARTED|Open-Label Period||116
8337440|NCT01327989|20553173|P1|NOT COMPLETED|Overall Study||14
8337441|NCT01327989|20553173|P1|COMPLETED|Overall Study||188
8337442|NCT01327989|20553173|P1|STARTED|Overall Study||202
8337443|NCT01327976|20553187|P2|NOT COMPLETED|Overall Study||7
8337444|NCT01327976|20553188|P1|NOT COMPLETED|Overall Study||8
8337445|NCT01327976|20553187|P2|COMPLETED|Overall Study||70
8337446|NCT01327976|20553188|P1|COMPLETED|Overall Study||154
8337447|NCT01327976|20553187|P2|STARTED|Overall Study||77
8337448|NCT01327976|20553188|P1|STARTED|Overall Study||162
8337449|NCT01327963|20553198|P1|NOT COMPLETED|Overall Study||0
8337450|NCT01327963|20553198|P1|COMPLETED|Overall Study|110 participants signed informed consent to be included in the study.|110
8337451|NCT01327963|20553198|P1|STARTED|Overall Study||110
8337452|NCT01327885|20553209|P2|NOT COMPLETED|Overall Study||224
8337453|NCT01327885|20553210|P1|NOT COMPLETED|Overall Study||228
8337454|NCT01327885|20553209|P2|COMPLETED|Overall Study||0
8337455|NCT01327885|20553210|P1|COMPLETED|Overall Study||0
8337456|NCT01327885|20553209|P2|STARTED|Overall Study||224
8337457|NCT01327885|20553210|P1|STARTED|Overall Study||228
8337458|NCT01327846|20553226|P4|NOT COMPLETED|Extension Phase||1706
8337459|NCT01327846|20553227|P3|NOT COMPLETED|Extension Phase||1092
8337460|NCT01327846|20553228|P2|NOT COMPLETED|Extension Phase||1144
8337461|NCT01327846|20553229|P1|NOT COMPLETED|Extension Phase||1099
8337462|NCT01327846|20553226|P4|COMPLETED|Extension Phase||238
8337463|NCT01327846|20553227|P3|COMPLETED|Extension Phase||187
8337464|NCT01327846|20553228|P2|COMPLETED|Extension Phase||143
8337465|NCT01327846|20553229|P1|COMPLETED|Extension Phase||168
8337466|NCT01327846|20553226|P4|Details Missing|Extension Phase||0
8337467|NCT01327846|20553227|P3|Details Missing|Extension Phase||1
8337468|NCT01327846|20553228|P2|Details Missing|Extension Phase||1
8337469|NCT01327846|20553229|P1|Details Missing|Extension Phase||0
8337470|NCT01327846|20553226|P4|Completed Treatment Period|Extension Phase||60
8337471|NCT01327846|20553227|P3|Completed Treatment Period|Extension Phase||49
8337472|NCT01327846|20553228|P2|Completed Treatment Period|Extension Phase||45
8337473|NCT01327846|20553229|P1|Completed Treatment Period|Extension Phase||41
8337474|NCT01327846|20553226|P4|Stopped/Discontinued Study at Washout|Extension Phase||178
8337475|NCT01327846|20553227|P3|Stopped/Discontinued Study at Washout|Extension Phase||137
8337476|NCT01327846|20553228|P2|Stopped/Discontinued Study at Washout|Extension Phase||97
8337477|NCT01327846|20553229|P1|Stopped/Discontinued Study at Washout|Extension Phase||127
8337478|NCT01327846|20553226|P4|STARTED|Extension Phase||1944
8337479|NCT01327846|20553227|P3|STARTED|Extension Phase||1279
8337480|NCT01327846|20553228|P2|STARTED|Extension Phase||1287
8337481|NCT01327846|20553229|P1|STARTED|Extension Phase||1267
8337482|NCT01327846|20553226|P4|NOT COMPLETED|Core Phase||33
8337483|NCT01327846|20553227|P3|NOT COMPLETED|Core Phase||26
8337484|NCT01327846|20553228|P2|NOT COMPLETED|Core Phase||32
8337485|NCT01327846|20553229|P1|NOT COMPLETED|Core Phase||28
8337486|NCT01327846|20553226|P4|COMPLETED|Core Phase||3311
8337487|NCT01327846|20553227|P3|COMPLETED|Core Phase||2144
8337488|NCT01327846|20553228|P2|COMPLETED|Core Phase||2252
8337489|NCT01327846|20553229|P1|COMPLETED|Core Phase||2235
8337490|NCT01327846|20553226|P4|STARTED|Core Phase||3344
8337491|NCT01327846|20553227|P3|STARTED|Core Phase||2170
8337492|NCT01327846|20553228|P2|STARTED|Core Phase||2284
8337493|NCT01327846|20553229|P1|STARTED|Core Phase||2263
8337494|NCT01327703|20553304|P2|NOT COMPLETED|Second Treatment Period||2
8337495|NCT01327703|20553305|P1|NOT COMPLETED|Second Treatment Period||1
8337496|NCT01327703|20553304|P2|COMPLETED|Second Treatment Period||42
8337497|NCT01327703|20553305|P1|COMPLETED|Second Treatment Period||39
8337498|NCT01327703|20553304|P2|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
8337499|NCT01327703|20553305|P1|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
8337500|NCT01327703|20553304|P2|NOT COMPLETED|First Treatment Period||0
8337501|NCT01327703|20553305|P1|NOT COMPLETED|First Treatment Period||0
8337502|NCT01327703|20553304|P2|COMPLETED|First Treatment Period||45
8337503|NCT01327703|20553305|P1|COMPLETED|First Treatment Period||42
8337504|NCT01327703|20553304|P2|STARTED|First Treatment Period||45
8337505|NCT01327703|20553305|P1|STARTED|First Treatment Period||42
8337506|NCT01327677|20553339|P2|NOT COMPLETED|Overall Study||13
8337507|NCT01327677|20553340|P1|NOT COMPLETED|Overall Study||20
8337508|NCT01327677|20553339|P2|COMPLETED|Overall Study||56
8337509|NCT01327677|20553340|P1|COMPLETED|Overall Study||48
8337510|NCT01327677|20553339|P2|STARTED|Overall Study||69
8337511|NCT01327677|20553340|P1|STARTED|Overall Study||68
8337512|NCT01327651|20553361|P9|NOT COMPLETED|Post Study Follow-up||2
8337513|NCT01327651|20553362|P8|NOT COMPLETED|Post Study Follow-up||1
8337514|NCT01327651|20553363|P7|NOT COMPLETED|Post Study Follow-up||4
8337515|NCT01327651|20553364|P6|NOT COMPLETED|Post Study Follow-up||0
8337516|NCT01327651|20553365|P5|NOT COMPLETED|Post Study Follow-up||0
8337517|NCT01327651|20553366|P4|NOT COMPLETED|Post Study Follow-up||0
8337518|NCT01327651|20553367|P3|NOT COMPLETED|Post Study Follow-up||1
8337519|NCT01327651|20553368|P2|NOT COMPLETED|Post Study Follow-up||1
8337520|NCT01327651|20553369|P1|NOT COMPLETED|Post Study Follow-up||0
8337521|NCT01327651|20553361|P9|COMPLETED|Post Study Follow-up||47
8337522|NCT01327651|20553362|P8|COMPLETED|Post Study Follow-up||49
8337523|NCT01327651|20553363|P7|COMPLETED|Post Study Follow-up||45
8337524|NCT01327651|20553364|P6|COMPLETED|Post Study Follow-up||59
8337525|NCT01327651|20553365|P5|COMPLETED|Post Study Follow-up||56
8337526|NCT01327651|20553366|P4|COMPLETED|Post Study Follow-up||57
8337527|NCT01327651|20553367|P3|COMPLETED|Post Study Follow-up||55
8337528|NCT01327651|20553368|P2|COMPLETED|Post Study Follow-up||55
8337529|NCT01327651|20553369|P1|COMPLETED|Post Study Follow-up||56
8337530|NCT01327651|20553361|P9|STARTED|Post Study Follow-up||49
8337531|NCT01327651|20553362|P8|STARTED|Post Study Follow-up||50
8337532|NCT01327651|20553363|P7|STARTED|Post Study Follow-up||49
8337533|NCT01327651|20553364|P6|STARTED|Post Study Follow-up||59
8337534|NCT01327651|20553365|P5|STARTED|Post Study Follow-up||56
8337535|NCT01327651|20553366|P4|STARTED|Post Study Follow-up||57
8337536|NCT01327651|20553367|P3|STARTED|Post Study Follow-up||56
8337537|NCT01327651|20553368|P2|STARTED|Post Study Follow-up||56
8337538|NCT01327651|20553369|P1|STARTED|Post Study Follow-up||56
8337539|NCT01327651|20553361|P9|NOT COMPLETED|Self-administered Dosing Period||11
8337540|NCT01327651|20553362|P8|NOT COMPLETED|Self-administered Dosing Period||10
8337541|NCT01327651|20553363|P7|NOT COMPLETED|Self-administered Dosing Period||10
8337542|NCT01327651|20553364|P6|NOT COMPLETED|Self-administered Dosing Period||0
8337543|NCT01327651|20553365|P5|NOT COMPLETED|Self-administered Dosing Period||3
8337544|NCT01327651|20553366|P4|NOT COMPLETED|Self-administered Dosing Period||3
8337545|NCT01327651|20553367|P3|NOT COMPLETED|Self-administered Dosing Period||4
8337546|NCT01327651|20553368|P2|NOT COMPLETED|Self-administered Dosing Period||3
8337547|NCT01327651|20553369|P1|NOT COMPLETED|Self-administered Dosing Period||4
8337548|NCT01327651|20553361|P9|COMPLETED|Self-administered Dosing Period||49
8337549|NCT01327651|20553362|P8|COMPLETED|Self-administered Dosing Period||50
8337550|NCT01327651|20553363|P7|COMPLETED|Self-administered Dosing Period||49
8337551|NCT01327651|20553364|P6|COMPLETED|Self-administered Dosing Period||59
8337552|NCT01327651|20553365|P5|COMPLETED|Self-administered Dosing Period||56
8337553|NCT01327651|20553366|P4|COMPLETED|Self-administered Dosing Period||57
8337554|NCT01327651|20553367|P3|COMPLETED|Self-administered Dosing Period||56
8337555|NCT01327651|20553368|P2|COMPLETED|Self-administered Dosing Period||56
8337556|NCT01327651|20553369|P1|COMPLETED|Self-administered Dosing Period||56
8337557|NCT01327651|20553361|P9|Week 26|Self-administered Dosing Period||49
8337558|NCT01327651|20553362|P8|Week 26|Self-administered Dosing Period||51
8337559|NCT01327651|20553363|P7|Week 26|Self-administered Dosing Period||50
8337560|NCT01327651|20553364|P6|Week 26|Self-administered Dosing Period||58
8337561|NCT01327651|20553365|P5|Week 26|Self-administered Dosing Period||56
8337562|NCT01327651|20553366|P4|Week 26|Self-administered Dosing Period||57
8337563|NCT01327651|20553367|P3|Week 26|Self-administered Dosing Period||53
8337564|NCT01327651|20553368|P2|Week 26|Self-administered Dosing Period||56
8337565|NCT01327651|20553369|P1|Week 26|Self-administered Dosing Period||58
8337566|NCT01327651|20553361|P9|Week 22|Self-administered Dosing Period||51
8337567|NCT01327651|20553362|P8|Week 22|Self-administered Dosing Period||50
8337568|NCT01327651|20553363|P7|Week 22|Self-administered Dosing Period||50
8337569|NCT01327651|20553364|P6|Week 22|Self-administered Dosing Period||59
8337570|NCT01327651|20553365|P5|Week 22|Self-administered Dosing Period||56
8337571|NCT01327651|20553366|P4|Week 22|Self-administered Dosing Period||58
8337572|NCT01327651|20553367|P3|Week 22|Self-administered Dosing Period||55
8337573|NCT01327651|20553368|P2|Week 22|Self-administered Dosing Period||56
8337574|NCT01327651|20553369|P1|Week 22|Self-administered Dosing Period||59
8337575|NCT01327651|20553361|P9|Week 18|Self-administered Dosing Period||53
8337576|NCT01327651|20553362|P8|Week 18|Self-administered Dosing Period||49
8337577|NCT01327651|20553363|P7|Week 18|Self-administered Dosing Period||53
8337578|NCT01327651|20553364|P6|Week 18|Self-administered Dosing Period||59
8337579|NCT01327651|20553365|P5|Week 18|Self-administered Dosing Period||57
8337580|NCT01327651|20553366|P4|Week 18|Self-administered Dosing Period||60
8337581|NCT01327651|20553367|P3|Week 18|Self-administered Dosing Period||56
8337582|NCT01327651|20553368|P2|Week 18|Self-administered Dosing Period||56
8337583|NCT01327651|20553369|P1|Week 18|Self-administered Dosing Period||57
8337584|NCT01327651|20553361|P9|Week 14|Self-administered Dosing Period||54
8337585|NCT01327651|20553362|P8|Week 14|Self-administered Dosing Period||51
8337586|NCT01327651|20553363|P7|Week 14|Self-administered Dosing Period||54
8337587|NCT01327651|20553364|P6|Week 14|Self-administered Dosing Period||59
8337588|NCT01327651|20553365|P5|Week 14|Self-administered Dosing Period||58
8337589|NCT01327651|20553366|P4|Week 14|Self-administered Dosing Period||60
8337590|NCT01327651|20553367|P3|Week 14|Self-administered Dosing Period||57
8337591|NCT01327651|20553368|P2|Week 14|Self-administered Dosing Period||55
8337592|NCT01327651|20553369|P1|Week 14|Self-administered Dosing Period||59
8337593|NCT01327651|20553361|P9|Week 10|Self-administered Dosing Period||56
8337594|NCT01327651|20553362|P8|Week 10|Self-administered Dosing Period||57
8337595|NCT01327651|20553363|P7|Week 10|Self-administered Dosing Period||57
8337596|NCT01327651|20553364|P6|Week 10|Self-administered Dosing Period||59
8337597|NCT01327651|20553365|P5|Week 10|Self-administered Dosing Period||59
8337598|NCT01327651|20553366|P4|Week 10|Self-administered Dosing Period||60
8337599|NCT01327651|20553367|P3|Week 10|Self-administered Dosing Period||60
8337600|NCT01327651|20553368|P2|Week 10|Self-administered Dosing Period||58
8337601|NCT01327651|20553369|P1|Week 10|Self-administered Dosing Period||59
8337602|NCT01327651|20553361|P9|STARTED|Self-administered Dosing Period||60
8337603|NCT01327651|20553362|P8|STARTED|Self-administered Dosing Period||60
8337604|NCT01327651|20553363|P7|STARTED|Self-administered Dosing Period||59
8337605|NCT01327651|20553364|P6|STARTED|Self-administered Dosing Period||59
8337606|NCT01327651|20553365|P5|STARTED|Self-administered Dosing Period||59
8337607|NCT01327651|20553366|P4|STARTED|Self-administered Dosing Period||60
8337608|NCT01327651|20553367|P3|STARTED|Self-administered Dosing Period||60
8337609|NCT01327651|20553368|P2|STARTED|Self-administered Dosing Period||59
8337610|NCT01327651|20553369|P1|STARTED|Self-administered Dosing Period||60
8337611|NCT01327599|20553488|P1|NOT COMPLETED|Overall Study||3
8337612|NCT01327599|20553488|P1|COMPLETED|Overall Study||57
8337613|NCT01327599|20553488|P1|STARTED|Overall Study||60
8337614|NCT01327573|20553498|P2|NOT COMPLETED|Overall Study||1
8337615|NCT01327573|20553499|P1|NOT COMPLETED|Overall Study||3
8337616|NCT01327573|20553498|P2|COMPLETED|Overall Study||4
8337617|NCT01327573|20553499|P1|COMPLETED|Overall Study||8
8337618|NCT01327573|20553498|P2|Received Treatment/Control as Allocated|Overall Study||5
8337619|NCT01327573|20553499|P1|Received Treatment/Control as Allocated|Overall Study||10
8337620|NCT01327573|20553498|P2|STARTED|Overall Study||5
8337621|NCT01327573|20553499|P1|STARTED|Overall Study||11
8337622|NCT01327547|20553510|P2|NOT COMPLETED|Overall Study||22
8337623|NCT01327547|20553511|P1|NOT COMPLETED|Overall Study||20
8337624|NCT01327547|20553510|P2|COMPLETED|Overall Study||45
8337625|NCT01327547|20553511|P1|COMPLETED|Overall Study||50
8337626|NCT01327547|20553510|P2|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
8337627|NCT01327547|20553511|P1|Randomized and Not Treated|Overall Study||0
8337628|NCT01327547|20553510|P2|STARTED|Overall Study||67
8337629|NCT01327547|20553511|P1|STARTED|Overall Study||70
8337630|NCT01327508|20553564|P2|NOT COMPLETED|Overall Study||0
8337631|NCT01327508|20553565|P1|NOT COMPLETED|Overall Study||0
8337632|NCT01327508|20553564|P2|COMPLETED|Overall Study||30
8337633|NCT01327508|20553565|P1|COMPLETED|Overall Study||30
8337634|NCT01327508|20553564|P2|STARTED|Overall Study||30
8337635|NCT01327508|20553565|P1|STARTED|Overall Study||30
8337636|NCT01327495|20553579|P6|NOT COMPLETED|Overall Study||2
8337637|NCT01327495|20553580|P5|NOT COMPLETED|Overall Study||3
8337638|NCT01327495|20553581|P4|NOT COMPLETED|Overall Study||0
8337639|NCT01327495|20553582|P3|NOT COMPLETED|Overall Study||2
8337640|NCT01327495|20553583|P2|NOT COMPLETED|Overall Study||2
8337641|NCT01327495|20553584|P1|NOT COMPLETED|Overall Study||2
8337642|NCT01327495|20553579|P6|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
8337643|NCT01327495|20553580|P5|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
8337644|NCT01327495|20553581|P4|COMPLETED|Overall Study||9
8337645|NCT01327495|20553582|P3|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
8337646|NCT01327495|20553583|P2|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
8337647|NCT01327495|20553584|P1|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
8337648|NCT01327495|20553579|P6|STARTED|Overall Study||11
8337649|NCT01327495|20553580|P5|STARTED|Overall Study||11
8337650|NCT01327495|20553581|P4|STARTED|Overall Study||9
8337651|NCT01327495|20553582|P3|STARTED|Overall Study||10
8337652|NCT01327495|20553583|P2|STARTED|Overall Study||11
8337653|NCT01327495|20553584|P1|STARTED|Overall Study||10
8337654|NCT01327482|20553676|P1|NOT COMPLETED|Overall Study||1
8337655|NCT01327482|20553676|P1|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
8337656|NCT01327482|20553676|P1|STARTED|Overall Study||10
8337657|NCT01327339|20553681|P1|NOT COMPLETED|Overall Study||8
8337658|NCT01327339|20553681|P1|COMPLETED|Overall Study||747
8337659|NCT01327339|20553681|P1|STARTED|Overall Study||755
8337660|NCT01327313|20553691|P4|NOT COMPLETED|Overall Study||0
8337661|NCT01327313|20553692|P3|NOT COMPLETED|Overall Study||0
8337662|NCT01327313|20553693|P2|NOT COMPLETED|Overall Study||0
8337663|NCT01327313|20553694|P1|NOT COMPLETED|Overall Study||0
8337664|NCT01327313|20553691|P4|COMPLETED|Overall Study||7
8337665|NCT01327313|20553692|P3|COMPLETED|Overall Study||6
8337666|NCT01327313|20553693|P2|COMPLETED|Overall Study||6
8337667|NCT01327313|20553694|P1|COMPLETED|Overall Study||8
8337668|NCT01327313|20553691|P4|STARTED|Overall Study||7
8337669|NCT01327313|20553692|P3|STARTED|Overall Study||6
8337670|NCT01327313|20553693|P2|STARTED|Overall Study||6
8337671|NCT01327313|20553694|P1|STARTED|Overall Study||8
8337672|NCT01327300|20553816|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
8337673|NCT01327300|20553817|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
8337674|NCT01327300|20553816|P2|COMPLETED|Second Intervention (12 Weeks)||2
8337675|NCT01327300|20553817|P1|COMPLETED|Second Intervention (12 Weeks)||4
8337676|NCT01327300|20553816|P2|STARTED|Second Intervention (12 Weeks)||2
8337677|NCT01327300|20553817|P1|STARTED|Second Intervention (12 Weeks)||4
8337678|NCT01327300|20553816|P2|NOT COMPLETED|Washout (3 Weeks)||0
8337679|NCT01327300|20553817|P1|NOT COMPLETED|Washout (3 Weeks)||1
8337680|NCT01327300|20553816|P2|COMPLETED|Washout (3 Weeks)||2
8337681|NCT01327300|20553817|P1|COMPLETED|Washout (3 Weeks)||4
8337682|NCT01327300|20553816|P2|STARTED|Washout (3 Weeks)||2
8337683|NCT01327300|20553817|P1|STARTED|Washout (3 Weeks)||5
8337684|NCT01327300|20553816|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
8337685|NCT01327300|20553817|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
8337686|NCT01327300|20553816|P2|COMPLETED|First Intervention (12 Weeks)||2
8337687|NCT01327300|20553817|P1|COMPLETED|First Intervention (12 Weeks)||5
8337688|NCT01327300|20553816|P2|STARTED|First Intervention (12 Weeks)||2
8337689|NCT01327300|20553817|P1|STARTED|First Intervention (12 Weeks)||5
8337690|NCT01327274|20553833|P1|NOT COMPLETED|Overall Study||0
8337691|NCT01327274|20553833|P1|COMPLETED|Overall Study||15
8337692|NCT01327274|20553833|P1|STARTED|Overall Study||15
8337693|NCT01327157|20553842|P2|NOT COMPLETED|91-180||0
8337694|NCT01327157|20553843|P1|NOT COMPLETED|91-180||0
8337695|NCT01327157|20553842|P2|COMPLETED|91-180||0
8337696|NCT01327157|20553843|P1|COMPLETED|91-180||7
8337697|NCT01327157|20553842|P2|STARTED|91-180||0
8337698|NCT01327157|20553843|P1|STARTED|91-180||7
8337699|NCT01327157|20553842|P2|NOT COMPLETED|01-90||0
8337700|NCT01327157|20553843|P1|NOT COMPLETED|01-90||0
8337701|NCT01327157|20553842|P2|COMPLETED|01-90||7
8337702|NCT01327157|20553843|P1|COMPLETED|01-90||7
8337703|NCT01327157|20553842|P2|STARTED|01-90||7
8337704|NCT01327157|20553843|P1|STARTED|01-90||7
8337705|NCT01327053|20553857|P2|NOT COMPLETED|Overall Study||151
8337706|NCT01327053|20553858|P1|NOT COMPLETED|Overall Study||79
8337707|NCT01327053|20553857|P2|COMPLETED|Overall Study||0
8337708|NCT01327053|20553858|P1|COMPLETED|Overall Study||0
8337709|NCT01327053|20553857|P2|Post-treatment Follow-up|Overall Study||40
8337710|NCT01327053|20553858|P1|Post-treatment Follow-up|Overall Study||19
8337711|NCT01327053|20553857|P2|Survival Follow-up|Overall Study||49
8337712|NCT01327053|20553858|P1|Survival Follow-up|Overall Study||33
8337713|NCT01327053|20553857|P2|Patients Cont. to Next Phase of Trial|Overall Study||89
8337714|NCT01327053|20553858|P1|Patients Cont. to Next Phase of Trial|Overall Study||52
8337715|NCT01327053|20553857|P2|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1
8337716|NCT01327053|20553858|P1|Untreated|Overall Study||0
8337717|NCT01327053|20553857|P2|STARTED|Overall Study||151
8337718|NCT01327053|20553858|P1|STARTED|Overall Study||79
8337719|NCT01326962|20553932|P1|NOT COMPLETED|Overall Study||7
8337720|NCT01326962|20553932|P1|COMPLETED|Overall Study||21
8337721|NCT01326962|20553932|P1|STARTED|Overall Study||28
8337722|NCT01326923|20553948|P1|NOT COMPLETED|Overall Study||0
8337723|NCT01326923|20553948|P1|COMPLETED|Overall Study||7
8337724|NCT01326923|20553948|P1|STARTED|Overall Study||7
8337725|NCT01326910|20553955|P2|NOT COMPLETED|Overall Study||3
8337726|NCT01326910|20553956|P1|NOT COMPLETED|Overall Study||4
8337727|NCT01326910|20553955|P2|COMPLETED|Overall Study||42
8337728|NCT01326910|20553956|P1|COMPLETED|Overall Study||41
8337729|NCT01326910|20553955|P2|STARTED|Overall Study||45
8337730|NCT01326910|20553956|P1|STARTED|Overall Study||45
8337731|NCT01326845|20553970|P2|NOT COMPLETED|Overall Study||5
8337732|NCT01326845|20553971|P1|NOT COMPLETED|Overall Study||7
8337733|NCT01326845|20553970|P2|COMPLETED|Overall Study|Study terminated early|0
8337734|NCT01326845|20553971|P1|COMPLETED|Overall Study|Study terminated early|0
8337735|NCT01326845|20553970|P2|STARTED|Overall Study||5
8337736|NCT01326845|20553971|P1|STARTED|Overall Study||7
8337737|NCT01326780|20553997|P4|NOT COMPLETED|Overall Study||13
8337738|NCT01326780|20553998|P3|NOT COMPLETED|Overall Study||6
8337739|NCT01326780|20553999|P2|NOT COMPLETED|Overall Study||9
8337740|NCT01326780|20554000|P1|NOT COMPLETED|Overall Study||13
8337741|NCT01326780|20553997|P4|COMPLETED|Overall Study||94
8337742|NCT01326780|20553998|P3|COMPLETED|Overall Study||103
8337743|NCT01326780|20553999|P2|COMPLETED|Overall Study||100
8337744|NCT01326780|20554000|P1|COMPLETED|Overall Study||93
8337745|NCT01326780|20553997|P4|STARTED|Overall Study||107
8337746|NCT01326780|20553998|P3|STARTED|Overall Study||109
8337747|NCT01326780|20553999|P2|STARTED|Overall Study||109
8337748|NCT01326780|20554000|P1|STARTED|Overall Study||106
8337749|NCT01326728|20554032|P2|NOT COMPLETED|Overall Study||9
8337750|NCT01326728|20554033|P1|NOT COMPLETED|Overall Study||47
8337751|NCT01326728|20554032|P2|COMPLETED|Overall Study||0
8337752|NCT01326728|20554033|P1|COMPLETED|Overall Study||0
8337753|NCT01326728|20554032|P2|STARTED|Overall Study||9
8337754|NCT01326728|20554033|P1|STARTED|Overall Study||47
8337755|NCT01326702|20554057|P7|NOT COMPLETED|Overall Study||7
8337756|NCT01326702|20554058|P6|NOT COMPLETED|Overall Study||8
8337757|NCT01326702|20554059|P5|NOT COMPLETED|Overall Study||4
8337758|NCT01326702|20554060|P4|NOT COMPLETED|Overall Study||3
8337759|NCT01326702|20554061|P3|NOT COMPLETED|Overall Study||5
8337760|NCT01326702|20554062|P2|NOT COMPLETED|Overall Study||2
8337761|NCT01326702|20554063|P1|NOT COMPLETED|Overall Study||2
8337762|NCT01326702|20554057|P7|COMPLETED|Overall Study||0
8337763|NCT01326702|20554058|P6|COMPLETED|Overall Study||7
8337764|NCT01326702|20554059|P5|COMPLETED|Overall Study||1
8337765|NCT01326702|20554060|P4|COMPLETED|Overall Study||1
8337766|NCT01326702|20554061|P3|COMPLETED|Overall Study||1
8337767|NCT01326702|20554062|P2|COMPLETED|Overall Study||1
8337768|NCT01326702|20554063|P1|COMPLETED|Overall Study||1
8337769|NCT01326702|20554057|P7|STARTED|Overall Study||7
8337770|NCT01326702|20554058|P6|STARTED|Overall Study||15
8337771|NCT01326702|20554059|P5|STARTED|Overall Study||5
8337772|NCT01326702|20554060|P4|STARTED|Overall Study||4
8337773|NCT01326702|20554061|P3|STARTED|Overall Study||6
8337774|NCT01326702|20554062|P2|STARTED|Overall Study||3
8337775|NCT01326702|20554063|P1|STARTED|Overall Study||3
8337776|NCT01326546|20554119|P2|NOT COMPLETED|Overall Study||13
8337777|NCT01326546|20554120|P1|NOT COMPLETED|Overall Study||17
8337778|NCT01326546|20554119|P2|COMPLETED|Overall Study||176
8337779|NCT01326546|20554120|P1|COMPLETED|Overall Study||172
8337780|NCT01326546|20554119|P2|STARTED|Overall Study||189
8337781|NCT01326546|20554120|P1|STARTED|Overall Study||189
8337782|NCT01326533|20554128|P2|NOT COMPLETED|Overall Study||0
8337783|NCT01326533|20554129|P1|NOT COMPLETED|Overall Study||4
8337784|NCT01326533|20554128|P2|COMPLETED|Overall Study||15
8337785|NCT01326533|20554129|P1|COMPLETED|Overall Study||13
8337786|NCT01326533|20554128|P2|STARTED|Overall Study||15
8337787|NCT01326533|20554129|P1|STARTED|Overall Study||17
8337788|NCT01326481|20554137|P1|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0
8337789|NCT01326481|20554137|P1|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
8337790|NCT01326481|20554137|P1|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
8337791|NCT01326481|20554137|P1|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1
8337792|NCT01326481|20554137|P1|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3
8337793|NCT01326481|20554137|P1|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4
8337794|NCT01326026|20554146|P2|NOT COMPLETED|Overall Study||13
8337795|NCT01326026|20554147|P1|NOT COMPLETED|Overall Study||12
8337796|NCT01326026|20554146|P2|COMPLETED|Overall Study||98
8337797|NCT01326026|20554147|P1|COMPLETED|Overall Study||99
8337798|NCT01326026|20554146|P2|Exposed|Overall Study||111
8337799|NCT01326026|20554147|P1|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
8337800|NCT01326026|20554146|P2|STARTED|Overall Study||111
8337801|NCT01326026|20554147|P1|STARTED|Overall Study||111
8337802|NCT01325870|20554164|P3|NOT COMPLETED|Overall Study||8
8337803|NCT01325870|20554165|P2|NOT COMPLETED|Overall Study||13
8337804|NCT01325870|20554166|P1|NOT COMPLETED|Overall Study||11
8337805|NCT01325870|20554164|P3|COMPLETED|Overall Study||6
8337806|NCT01325870|20554165|P2|COMPLETED|Overall Study||3
8337807|NCT01325870|20554166|P1|COMPLETED|Overall Study||7
8337808|NCT01325870|20554164|P3|STARTED|Overall Study||14
8337809|NCT01325870|20554165|P2|STARTED|Overall Study||16
8337810|NCT01325870|20554166|P1|STARTED|Overall Study||18
8337811|NCT01325792|20554180|P1|NOT COMPLETED|Overall Study||17
8337812|NCT01325792|20554180|P1|COMPLETED|Overall Study||87
8337813|NCT01325792|20554180|P1|STARTED|Overall Study||104
8337814|NCT01325714|20554187|P2|NOT COMPLETED|Overall Study||31
8337815|NCT01325714|20554188|P1|NOT COMPLETED|Overall Study||34
8337816|NCT01325714|20554187|P2|COMPLETED|Overall Study||71
8337817|NCT01325714|20554188|P1|COMPLETED|Overall Study||67
8337818|NCT01325714|20554187|P2|12 Month Assessment|Overall Study||71
8337819|NCT01325714|20554188|P1|12 Month Assessment|Overall Study||67
8337820|NCT01325714|20554187|P2|6 Month Asessment|Overall Study||82
8337821|NCT01325714|20554188|P1|6 Month Asessment|Overall Study||75
8337822|NCT01325714|20554187|P2|3 Month Assessment|Overall Study||86
8337823|NCT01325714|20554188|P1|3 Month Assessment|Overall Study||82
8337824|NCT01325714|20554187|P2|STARTED|Overall Study||102
8337825|NCT01325714|20554188|P1|STARTED|Overall Study||101
8337826|NCT01325701|20554212|P2|NOT COMPLETED|Overall Study||3
8337827|NCT01325701|20554213|P1|NOT COMPLETED|Overall Study||21
8337828|NCT01325701|20554212|P2|COMPLETED|Overall Study||5
8337829|NCT01325701|20554213|P1|COMPLETED|Overall Study||49
8337830|NCT01325701|20554212|P2|STARTED|Overall Study||8
8337831|NCT01325701|20554213|P1|STARTED|Overall Study||70
8337832|NCT01325623|20554223|P1|NOT COMPLETED|Overall Study||3
8337833|NCT01325623|20554223|P1|COMPLETED|Overall Study||28
8337834|NCT01325623|20554223|P1|STARTED|Overall Study||31
8337835|NCT01325584|20554265|P1|NOT COMPLETED|Overall Study||1
8337836|NCT01325584|20554265|P1|COMPLETED|Overall Study||11
8337837|NCT01325584|20554265|P1|STARTED|Overall Study||12
8337838|NCT01325532|20554275|P2|NOT COMPLETED|Overall Study||0
8337839|NCT01325532|20554276|P1|NOT COMPLETED|Overall Study||2
8337840|NCT01325532|20554275|P2|COMPLETED|Overall Study||13
8337841|NCT01325532|20554276|P1|COMPLETED|Overall Study||15
8337842|NCT01325532|20554275|P2|STARTED|Overall Study||13
8337843|NCT01325532|20554276|P1|STARTED|Overall Study||17
8337844|NCT01325493|20554288|P2|NOT COMPLETED|Overall Study||3
8337845|NCT01325493|20554289|P1|NOT COMPLETED|Overall Study||1
8337846|NCT01325493|20554288|P2|COMPLETED|Overall Study||21
8337847|NCT01325493|20554289|P1|COMPLETED|Overall Study||29
8337848|NCT01325493|20554288|P2|STARTED|Overall Study||24
8337849|NCT01325493|20554289|P1|STARTED|Overall Study||30
8337850|NCT01325428|20554301|P1|NOT COMPLETED|Part B||3
8337851|NCT01325428|20554301|P1|COMPLETED|Part B||7
8337852|NCT01325428|20554301|P1|STARTED|Part B||10
8337853|NCT01325428|20554301|P1|NOT COMPLETED|Part A||16
8337854|NCT01325428|20554301|P1|COMPLETED|Part A||10
8337855|NCT01325428|20554301|P1|STARTED|Part A||26
8337856|NCT01325350|20554321|P5|NOT COMPLETED|Overall Study||12
8337857|NCT01325350|20554322|P4|NOT COMPLETED|Overall Study||9
8337858|NCT01325350|20554323|P3|NOT COMPLETED|Overall Study||17
8337859|NCT01325350|20554324|P2|NOT COMPLETED|Overall Study||5
8337860|NCT01325350|20554325|P1|NOT COMPLETED|Overall Study||6
8337861|NCT01325350|20554321|P5|COMPLETED|Overall Study||50
8337862|NCT01325350|20554322|P4|COMPLETED|Overall Study||52
8337863|NCT01325350|20554323|P3|COMPLETED|Overall Study||44
8337864|NCT01325350|20554324|P2|COMPLETED|Overall Study||56
8337865|NCT01325350|20554325|P1|COMPLETED|Overall Study||55
8337866|NCT01325350|20554321|P5|STARTED|Overall Study||62
8337867|NCT01325350|20554322|P4|STARTED|Overall Study||61
8337868|NCT01325350|20554323|P3|STARTED|Overall Study||61
8337869|NCT01325350|20554324|P2|STARTED|Overall Study||61
8337870|NCT01325350|20554325|P1|STARTED|Overall Study||61
8337871|NCT01325337|20554367|P5|NOT COMPLETED|Overall Study||8
8337872|NCT01325337|20554368|P4|NOT COMPLETED|Overall Study||10
8337873|NCT01325337|20554369|P3|NOT COMPLETED|Overall Study||9
8337874|NCT01325337|20554370|P2|NOT COMPLETED|Overall Study||9
8337875|NCT01325337|20554371|P1|NOT COMPLETED|Overall Study||5
8337876|NCT01325337|20554367|P5|COMPLETED|Overall Study||53
8337877|NCT01325337|20554368|P4|COMPLETED|Overall Study||52
8337878|NCT01325337|20554369|P3|COMPLETED|Overall Study||53
8337879|NCT01325337|20554370|P2|COMPLETED|Overall Study||52
8337880|NCT01325337|20554371|P1|COMPLETED|Overall Study||56
8337881|NCT01325337|20554367|P5|STARTED|Overall Study||61
8337882|NCT01325337|20554368|P4|STARTED|Overall Study||62
8337883|NCT01325337|20554369|P3|STARTED|Overall Study||62
8337884|NCT01325337|20554370|P2|STARTED|Overall Study||61
8337885|NCT01325337|20554371|P1|STARTED|Overall Study||61
8337886|NCT01325311|20554410|P2|NOT COMPLETED|Overall Study||0
8337887|NCT01325311|20554411|P1|NOT COMPLETED|Overall Study||0
8337888|NCT01325311|20554410|P2|COMPLETED|Overall Study||7
8337889|NCT01325311|20554411|P1|COMPLETED|Overall Study||8
8337890|NCT01325311|20554410|P2|STARTED|Overall Study||7
8337891|NCT01325311|20554411|P1|STARTED|Overall Study||8
8337892|NCT01325207|20554451|P6|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
8337893|NCT01325207|20554452|P5|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
8337894|NCT01325207|20554453|P4|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
8337895|NCT01325207|20554454|P3|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
8337896|NCT01325207|20554455|P2|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
8337897|NCT01325207|20554456|P1|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
8337898|NCT01325207|20554451|P6|COMPLETED|Follow-up Every 3 Months Until Death||18
8337899|NCT01325207|20554452|P5|COMPLETED|Follow-up Every 3 Months Until Death||6
8337900|NCT01325207|20554453|P4|COMPLETED|Follow-up Every 3 Months Until Death||1
8337901|NCT01325207|20554454|P3|COMPLETED|Follow-up Every 3 Months Until Death||1
8337902|NCT01325207|20554455|P2|COMPLETED|Follow-up Every 3 Months Until Death||3
8337903|NCT01325207|20554456|P1|COMPLETED|Follow-up Every 3 Months Until Death||3
8337904|NCT01325207|20554451|P6|STARTED|Follow-up Every 3 Months Until Death||19
8337905|NCT01325207|20554452|P5|STARTED|Follow-up Every 3 Months Until Death||7
8337906|NCT01325207|20554453|P4|STARTED|Follow-up Every 3 Months Until Death||1
8337907|NCT01325207|20554454|P3|STARTED|Follow-up Every 3 Months Until Death||1
8337908|NCT01325207|20554455|P2|STARTED|Follow-up Every 3 Months Until Death||3
8337909|NCT01325207|20554456|P1|STARTED|Follow-up Every 3 Months Until Death||3
8337910|NCT01325207|20554451|P6|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5
8337911|NCT01325207|20554452|P5|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
8337912|NCT01325207|20554453|P4|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
8337913|NCT01325207|20554454|P3|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
8337914|NCT01325207|20554455|P2|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2
8337915|NCT01325207|20554456|P1|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
8337916|NCT01325207|20554451|P6|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9
8337917|NCT01325207|20554452|P5|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3
8337918|NCT01325207|20554453|P4|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
8337919|NCT01325207|20554454|P3|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
8337920|NCT01325207|20554455|P2|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
8337921|NCT01325207|20554456|P1|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
8337922|NCT01325207|20554451|P6|STARTED|Started 9th Week/Cycle 3 of Treatment||14
8337923|NCT01325207|20554452|P5|STARTED|Started 9th Week/Cycle 3 of Treatment||3
8337924|NCT01325207|20554453|P4|STARTED|Started 9th Week/Cycle 3 of Treatment||1
8337925|NCT01325207|20554454|P3|STARTED|Started 9th Week/Cycle 3 of Treatment||1
8337926|NCT01325207|20554455|P2|STARTED|Started 9th Week/Cycle 3 of Treatment||2
8337927|NCT01325207|20554456|P1|STARTED|Started 9th Week/Cycle 3 of Treatment||2
8337928|NCT01325207|20554451|P6|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5
8337929|NCT01325207|20554452|P5|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
8337930|NCT01325207|20554453|P4|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
8337931|NCT01325207|20554454|P3|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
8337932|NCT01325207|20554455|P2|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
8337933|NCT01325207|20554456|P1|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
8337934|NCT01325207|20554451|P6|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14
8337935|NCT01325207|20554452|P5|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3
8337936|NCT01325207|20554453|P4|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
8337937|NCT01325207|20554454|P3|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
8337938|NCT01325207|20554455|P2|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
8337939|NCT01325207|20554456|P1|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
8337940|NCT01325207|20554451|P6|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19
8337941|NCT01325207|20554452|P5|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5
8337942|NCT01325207|20554453|P4|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
8337943|NCT01325207|20554454|P3|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
8337944|NCT01325207|20554455|P2|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
8337945|NCT01325207|20554456|P1|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
8337946|NCT01325207|20554451|P6|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8337947|NCT01325207|20554452|P5|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2
8337948|NCT01325207|20554453|P4|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8337949|NCT01325207|20554454|P3|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8337950|NCT01325207|20554455|P2|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8337951|NCT01325207|20554456|P1|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
8337952|NCT01325207|20554451|P6|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19
8337953|NCT01325207|20554452|P5|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5
8337954|NCT01325207|20554453|P4|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
8337955|NCT01325207|20554454|P3|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
8337956|NCT01325207|20554455|P2|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
8337957|NCT01325207|20554456|P1|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
8337958|NCT01325207|20554451|P6|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19
8337959|NCT01325207|20554452|P5|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7
8337960|NCT01325207|20554453|P4|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
8337961|NCT01325207|20554454|P3|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
8337962|NCT01325207|20554455|P2|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
8337963|NCT01325207|20554456|P1|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
8337964|NCT01325181|20554481|P2|NOT COMPLETED|Overall Study||2
8337965|NCT01325181|20554482|P1|NOT COMPLETED|Overall Study||0
8337966|NCT01325181|20554481|P2|COMPLETED|Overall Study||14
8337967|NCT01325181|20554482|P1|COMPLETED|Overall Study||18
8337968|NCT01325181|20554481|P2|STARTED|Overall Study||16
8337969|NCT01325181|20554482|P1|STARTED|Overall Study||18
8337970|NCT01324999|20554488|P1|NOT COMPLETED|Overall Study||5
8337971|NCT01324999|20554488|P1|COMPLETED|Overall Study||7
8337972|NCT01324999|20554488|P1|STARTED|Overall Study||12
8337973|NCT01324947|20554499|P1|NOT COMPLETED|Overall Study||74
8337974|NCT01324947|20554499|P1|COMPLETED|Overall Study||0
8337975|NCT01324947|20554499|P1|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
8337976|NCT01324947|20554499|P1|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
8337977|NCT01324947|20554499|P1|STARTED|Overall Study||74
8337978|NCT01324882|20554512|P2|NOT COMPLETED|Overall Study||0
8337979|NCT01324882|20554513|P1|NOT COMPLETED|Overall Study||0
8337980|NCT01324882|20554512|P2|COMPLETED|Overall Study|30 patients had the colonoscopy|30
8337981|NCT01324882|20554513|P1|COMPLETED|Overall Study|27 patients had the colonoscopy|27
8337982|NCT01324882|20554512|P2|STARTED|Overall Study|30 patients were randomized to this arm|30
8337983|NCT01324882|20554513|P1|STARTED|Overall Study|27 patients were randomized to this arm.|27
8337984|NCT01324830|20554540|P19|NOT COMPLETED|Overall Study||6
8337985|NCT01324830|20554541|P18|NOT COMPLETED|Overall Study||6
8337986|NCT01324830|20554542|P17|NOT COMPLETED|Overall Study||3
8337987|NCT01324830|20554543|P16|NOT COMPLETED|Overall Study||3
8337988|NCT01324830|20554544|P15|NOT COMPLETED|Overall Study||1
8337989|NCT01324830|20554545|P14|NOT COMPLETED|Overall Study||1
8337990|NCT01324830|20554546|P13|NOT COMPLETED|Overall Study||1
8337991|NCT01324830|20554547|P12|NOT COMPLETED|Overall Study||1
8337992|NCT01324830|20554548|P11|NOT COMPLETED|Overall Study||4
8337993|NCT01324830|20554549|P10|NOT COMPLETED|Overall Study||6
8337994|NCT01324830|20554550|P9|NOT COMPLETED|Overall Study||5
8337995|NCT01324830|20554551|P8|NOT COMPLETED|Overall Study||3
8337996|NCT01324830|20554552|P7|NOT COMPLETED|Overall Study||3
8337997|NCT01324830|20554553|P6|NOT COMPLETED|Overall Study||7
8337998|NCT01324830|20554554|P5|NOT COMPLETED|Overall Study||7
8337999|NCT01324830|20554555|P4|NOT COMPLETED|Overall Study||3
8338000|NCT01324830|20554556|P3|NOT COMPLETED|Overall Study||3
8338001|NCT01324830|20554557|P2|NOT COMPLETED|Overall Study||3
8338002|NCT01324830|20554558|P1|NOT COMPLETED|Overall Study||3
8338003|NCT01324830|20554540|P19|COMPLETED|Overall Study||0
8338004|NCT01324830|20554541|P18|COMPLETED|Overall Study||0
8338005|NCT01324830|20554542|P17|COMPLETED|Overall Study||0
8338006|NCT01324830|20554543|P16|COMPLETED|Overall Study||0
8338007|NCT01324830|20554544|P15|COMPLETED|Overall Study||0
8338008|NCT01324830|20554545|P14|COMPLETED|Overall Study||0
8338009|NCT01324830|20554546|P13|COMPLETED|Overall Study||0
8338010|NCT01324830|20554547|P12|COMPLETED|Overall Study||0
8338011|NCT01324830|20554548|P11|COMPLETED|Overall Study||0
8338012|NCT01324830|20554549|P10|COMPLETED|Overall Study||0
8338013|NCT01324830|20554550|P9|COMPLETED|Overall Study||0
8338014|NCT01324830|20554551|P8|COMPLETED|Overall Study||0
8338015|NCT01324830|20554552|P7|COMPLETED|Overall Study||0
8338016|NCT01324830|20554553|P6|COMPLETED|Overall Study||0
8338017|NCT01324830|20554554|P5|COMPLETED|Overall Study||0
8338018|NCT01324830|20554555|P4|COMPLETED|Overall Study||0
8338019|NCT01324830|20554556|P3|COMPLETED|Overall Study||0
8338020|NCT01324830|20554557|P2|COMPLETED|Overall Study||0
8338021|NCT01324830|20554558|P1|COMPLETED|Overall Study||0
8338022|NCT01324830|20554540|P19|STARTED|Overall Study||6
8338023|NCT01324830|20554541|P18|STARTED|Overall Study||6
8338024|NCT01324830|20554542|P17|STARTED|Overall Study||3
8338025|NCT01324830|20554543|P16|STARTED|Overall Study||3
8338026|NCT01324830|20554544|P15|STARTED|Overall Study||1
8338027|NCT01324830|20554545|P14|STARTED|Overall Study||1
8338028|NCT01324830|20554546|P13|STARTED|Overall Study||1
8338029|NCT01324830|20554547|P12|STARTED|Overall Study||1
8338030|NCT01324830|20554548|P11|STARTED|Overall Study||4
8338031|NCT01324830|20554549|P10|STARTED|Overall Study||6
8338032|NCT01324830|20554550|P9|STARTED|Overall Study||5
8338033|NCT01324830|20554551|P8|STARTED|Overall Study||3
8338034|NCT01324830|20554552|P7|STARTED|Overall Study||3
8338035|NCT01324830|20554553|P6|STARTED|Overall Study||7
8338036|NCT01324830|20554554|P5|STARTED|Overall Study||7
8338037|NCT01324830|20554555|P4|STARTED|Overall Study||3
8338038|NCT01324830|20554556|P3|STARTED|Overall Study||3
8338039|NCT01324830|20554557|P2|STARTED|Overall Study||3
8338040|NCT01324830|20554558|P1|STARTED|Overall Study||3
8338041|NCT01324700|20554674|P4|NOT COMPLETED|Overall Study||11
8338042|NCT01324700|20554675|P3|NOT COMPLETED|Overall Study||16
8338043|NCT01324700|20554676|P2|NOT COMPLETED|Overall Study||4
8338044|NCT01324700|20554677|P1|NOT COMPLETED|Overall Study||9
8338045|NCT01324700|20554674|P4|COMPLETED|Overall Study||37
8338046|NCT01324700|20554675|P3|COMPLETED|Overall Study||33
8338047|NCT01324700|20554676|P2|COMPLETED|Overall Study||16
8338048|NCT01324700|20554677|P1|COMPLETED|Overall Study||13
8338049|NCT01324700|20554674|P4|STARTED|Overall Study||48
8338050|NCT01324700|20554675|P3|STARTED|Overall Study||49
8338051|NCT01324700|20554676|P2|STARTED|Overall Study||20
8338052|NCT01324700|20554677|P1|STARTED|Overall Study||22
8338053|NCT01324687|20554693|P2|NOT COMPLETED|Overall Study||15
8338054|NCT01324687|20554694|P1|NOT COMPLETED|Overall Study||0
8338055|NCT01324687|20554693|P2|COMPLETED|Overall Study||479
8338056|NCT01324687|20554694|P1|COMPLETED|Overall Study||1058
8338057|NCT01324687|20554693|P2|STARTED|Overall Study||494
8338058|NCT01324687|20554694|P1|STARTED|Overall Study||1058
8338059|NCT01324622|20554704|P2|NOT COMPLETED|Overall Study||7
8338060|NCT01324622|20554705|P1|NOT COMPLETED|Overall Study||9
8338061|NCT01324622|20554704|P2|COMPLETED|Overall Study||4
8338062|NCT01324622|20554705|P1|COMPLETED|Overall Study||4
8338063|NCT01324622|20554704|P2|STARTED|Overall Study||11
8338064|NCT01324622|20554705|P1|STARTED|Overall Study||13
8338065|NCT01324570|20554735|P2|NOT COMPLETED|Overall Study||14
8338066|NCT01324570|20554736|P1|NOT COMPLETED|Overall Study||4
8338067|NCT01324570|20554735|P2|COMPLETED|Overall Study||21
8338068|NCT01324570|20554736|P1|COMPLETED|Overall Study||2
8338069|NCT01324570|20554735|P2|STARTED|Overall Study||35
8338070|NCT01324570|20554736|P1|STARTED|Overall Study||6
8338071|NCT01324453|20554750|P2|NOT COMPLETED|Overall Study||0
8338072|NCT01324453|20554751|P1|NOT COMPLETED|Overall Study||0
8338073|NCT01324453|20554750|P2|COMPLETED|Overall Study||49
8338074|NCT01324453|20554751|P1|COMPLETED|Overall Study||54
8338075|NCT01324453|20554750|P2|STARTED|Overall Study||49
8338076|NCT01324453|20554751|P1|STARTED|Overall Study||54
8338077|NCT01324440|20554773|P2|NOT COMPLETED|Overall Study||1
8338078|NCT01324440|20554774|P1|NOT COMPLETED|Overall Study||0
8338079|NCT01324440|20554773|P2|COMPLETED|Overall Study||31
8338080|NCT01324440|20554774|P1|COMPLETED|Overall Study||32
8338081|NCT01324440|20554773|P2|STARTED|Overall Study||32
8338082|NCT01324440|20554774|P1|STARTED|Overall Study||32
8338083|NCT01324401|20554788|P2|NOT COMPLETED|Overall Study||6
8338084|NCT01324401|20554789|P1|NOT COMPLETED|Overall Study||1
8338085|NCT01324401|20554788|P2|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
8338086|NCT01324401|20554789|P1|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
8338087|NCT01324401|20554788|P2|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
8338088|NCT01324401|20554789|P1|STARTED|Overall Study||4
8338089|NCT01324388|20554800|P4|NOT COMPLETED|Part 2 of Study: Second Intervention||0
8338090|NCT01324388|20554801|P3|NOT COMPLETED|Part 2 of Study: Second Intervention||1
8338091|NCT01324388|20554802|P2|NOT COMPLETED|Part 2 of Study: Second Intervention||0
8338092|NCT01324388|20554803|P1|NOT COMPLETED|Part 2 of Study: Second Intervention||0
8338093|NCT01324388|20554800|P4|COMPLETED|Part 2 of Study: Second Intervention||9
8338094|NCT01324388|20554801|P3|COMPLETED|Part 2 of Study: Second Intervention||9
8338095|NCT01324388|20554802|P2|COMPLETED|Part 2 of Study: Second Intervention||0
8338096|NCT01324388|20554803|P1|COMPLETED|Part 2 of Study: Second Intervention||0
8338097|NCT01324388|20554800|P4|STARTED|Part 2 of Study: Second Intervention||9
8338098|NCT01324388|20554801|P3|STARTED|Part 2 of Study: Second Intervention||10
8338099|NCT01324388|20554802|P2|STARTED|Part 2 of Study: Second Intervention||0
8338100|NCT01324388|20554803|P1|STARTED|Part 2 of Study: Second Intervention||0
8338101|NCT01324388|20554800|P4|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
8338102|NCT01324388|20554801|P3|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
8338103|NCT01324388|20554802|P2|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
8338104|NCT01324388|20554803|P1|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
8338105|NCT01324388|20554800|P4|COMPLETED|Part 2: Washout of at Least 21 Days||9
8338106|NCT01324388|20554801|P3|COMPLETED|Part 2: Washout of at Least 21 Days||10
8338107|NCT01324388|20554802|P2|COMPLETED|Part 2: Washout of at Least 21 Days||0
8338108|NCT01324388|20554803|P1|COMPLETED|Part 2: Washout of at Least 21 Days||0
8338109|NCT01324388|20554800|P4|STARTED|Part 2: Washout of at Least 21 Days||9
8338110|NCT01324388|20554801|P3|STARTED|Part 2: Washout of at Least 21 Days||10
8338111|NCT01324388|20554802|P2|STARTED|Part 2: Washout of at Least 21 Days||0
8338112|NCT01324388|20554803|P1|STARTED|Part 2: Washout of at Least 21 Days||0
8338113|NCT01324388|20554800|P4|NOT COMPLETED|Part 2 of Study: First Intervention||1
8338114|NCT01324388|20554801|P3|NOT COMPLETED|Part 2 of Study: First Intervention||0
8338115|NCT01324388|20554802|P2|NOT COMPLETED|Part 2 of Study: First Intervention||0
8338116|NCT01324388|20554803|P1|NOT COMPLETED|Part 2 of Study: First Intervention||0
8338117|NCT01324388|20554800|P4|COMPLETED|Part 2 of Study: First Intervention||9
8338118|NCT01324388|20554801|P3|COMPLETED|Part 2 of Study: First Intervention||10
8338119|NCT01324388|20554802|P2|COMPLETED|Part 2 of Study: First Intervention||0
8338120|NCT01324388|20554803|P1|COMPLETED|Part 2 of Study: First Intervention||0
8338121|NCT01324388|20554800|P4|STARTED|Part 2 of Study: First Intervention||10
8338122|NCT01324388|20554801|P3|STARTED|Part 2 of Study: First Intervention||10
8338123|NCT01324388|20554802|P2|STARTED|Part 2 of Study: First Intervention||0
8338124|NCT01324388|20554803|P1|STARTED|Part 2 of Study: First Intervention||0
8338125|NCT01324388|20554800|P4|NOT COMPLETED|Part 1 of Study||0
8338126|NCT01324388|20554801|P3|NOT COMPLETED|Part 1 of Study||0
8338127|NCT01324388|20554802|P2|NOT COMPLETED|Part 1 of Study||2
8338128|NCT01324388|20554803|P1|NOT COMPLETED|Part 1 of Study||4
8338129|NCT01324388|20554800|P4|COMPLETED|Part 1 of Study||0
8338130|NCT01324388|20554801|P3|COMPLETED|Part 1 of Study||0
8338131|NCT01324388|20554802|P2|COMPLETED|Part 1 of Study||6
8338132|NCT01324388|20554803|P1|COMPLETED|Part 1 of Study||19
8338133|NCT01324388|20554800|P4|Received at Least 1 Dose|Part 1 of Study||0
8338134|NCT01324388|20554801|P3|Received at Least 1 Dose|Part 1 of Study||0
8338135|NCT01324388|20554802|P2|Received at Least 1 Dose|Part 1 of Study||8
8338136|NCT01324388|20554803|P1|Received at Least 1 Dose|Part 1 of Study||23
8338137|NCT01324388|20554800|P4|STARTED|Part 1 of Study||0
8338138|NCT01324388|20554801|P3|STARTED|Part 1 of Study||0
8338139|NCT01324388|20554802|P2|STARTED|Part 1 of Study||8
8338140|NCT01324388|20554803|P1|STARTED|Part 1 of Study||23
8338141|NCT01324349|20554824|P2|NOT COMPLETED|Overall Study||2
8338142|NCT01324349|20554825|P1|NOT COMPLETED|Overall Study||1
8338143|NCT01324349|20554824|P2|COMPLETED|Overall Study||16
8338144|NCT01324349|20554825|P1|COMPLETED|Overall Study||31
8338145|NCT01324349|20554824|P2|STARTED|Overall Study||18
8338146|NCT01324349|20554825|P1|STARTED|Overall Study||32
8338147|NCT01324323|20554835|P1|NOT COMPLETED|Overall Study||1
8338148|NCT01324323|20554835|P1|COMPLETED|Overall Study||13
8338149|NCT01324323|20554835|P1|STARTED|Overall Study||14
8338150|NCT01324310|20554855|P1|NOT COMPLETED|Overall Study||2
8338151|NCT01324310|20554855|P1|COMPLETED|Overall Study||13
8338152|NCT01324310|20554855|P1|STARTED|Overall Study||15
8338153|NCT01324271|20554875|P2|NOT COMPLETED|Overall Study||0
8338154|NCT01324271|20554876|P1|NOT COMPLETED|Overall Study||4
8338155|NCT01324271|20554875|P2|COMPLETED|Overall Study||28
8338156|NCT01324271|20554876|P1|COMPLETED|Overall Study||53
8338157|NCT01324271|20554875|P2|STARTED|Overall Study||28
8338158|NCT01324271|20554876|P1|STARTED|Overall Study||57
8338159|NCT01324128|20554884|P4|NOT COMPLETED|Stage 2||3
8338160|NCT01324128|20554885|P3|NOT COMPLETED|Stage 2||8
8338161|NCT01324128|20554886|P2|NOT COMPLETED|Stage 2||0
8338162|NCT01324128|20554887|P1|NOT COMPLETED|Stage 2||0
8338163|NCT01324128|20554884|P4|COMPLETED|Stage 2||46
8338164|NCT01324128|20554885|P3|COMPLETED|Stage 2||42
8338165|NCT01324128|20554886|P2|COMPLETED|Stage 2||0
8338166|NCT01324128|20554887|P1|COMPLETED|Stage 2||0
8338167|NCT01324128|20554884|P4|STARTED|Stage 2||49
8338168|NCT01324128|20554885|P3|STARTED|Stage 2||50
8338169|NCT01324128|20554886|P2|STARTED|Stage 2||0
8338170|NCT01324128|20554887|P1|STARTED|Stage 2||0
8338171|NCT01324128|20554884|P4|NOT COMPLETED|Stage 1||0
8338172|NCT01324128|20554885|P3|NOT COMPLETED|Stage 1||0
8338173|NCT01324128|20554886|P2|NOT COMPLETED|Stage 1||56
8338174|NCT01324128|20554887|P1|NOT COMPLETED|Stage 1||195
8338175|NCT01324128|20554884|P4|COMPLETED|Stage 1||0
8338176|NCT01324128|20554885|P3|COMPLETED|Stage 1||0
8338177|NCT01324128|20554886|P2|COMPLETED|Stage 1||293
8338178|NCT01324128|20554887|P1|COMPLETED|Stage 1||515
8338179|NCT01324128|20554884|P4|STARTED|Stage 1||0
8338180|NCT01324128|20554885|P3|STARTED|Stage 1||0
8338181|NCT01324128|20554886|P2|STARTED|Stage 1||349
8338182|NCT01324128|20554887|P1|STARTED|Stage 1||710
8338183|NCT01324102|20554899|P2|NOT COMPLETED|Overall Study||6
8338184|NCT01324102|20554900|P1|NOT COMPLETED|Overall Study||1
8338185|NCT01324102|20554899|P2|COMPLETED|Overall Study||6
8338186|NCT01324102|20554900|P1|COMPLETED|Overall Study||10
8338187|NCT01324102|20554899|P2|STARTED|Overall Study|Yoga group 4 and 6|12
8338188|NCT01324102|20554900|P1|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
8338189|NCT01324024|20554907|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
8338190|NCT01324024|20554908|P1|NOT COMPLETED|Second Intervention (4 Weeks)||2
8338191|NCT01324024|20554907|P2|COMPLETED|Second Intervention (4 Weeks)||16
8338192|NCT01324024|20554908|P1|COMPLETED|Second Intervention (4 Weeks)||16
8338193|NCT01324024|20554907|P2|STARTED|Second Intervention (4 Weeks)||17
8338194|NCT01324024|20554908|P1|STARTED|Second Intervention (4 Weeks)||18
8338195|NCT01324024|20554907|P2|NOT COMPLETED|Washout (2 Weeks)||0
8338196|NCT01324024|20554908|P1|NOT COMPLETED|Washout (2 Weeks)||0
8338197|NCT01324024|20554907|P2|COMPLETED|Washout (2 Weeks)||17
8338198|NCT01324024|20554908|P1|COMPLETED|Washout (2 Weeks)||18
8338199|NCT01324024|20554907|P2|STARTED|Washout (2 Weeks)||17
8338200|NCT01324024|20554908|P1|STARTED|Washout (2 Weeks)||18
8338201|NCT01324024|20554907|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8338202|NCT01324024|20554908|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8338203|NCT01324024|20554907|P2|COMPLETED|First Intervention (4 Weeks)||17
8338204|NCT01324024|20554908|P1|COMPLETED|First Intervention (4 Weeks)||18
8338205|NCT01324024|20554907|P2|STARTED|First Intervention (4 Weeks)||17
8338206|NCT01324024|20554908|P1|STARTED|First Intervention (4 Weeks)||18
8338207|NCT01323998|20554926|P5|NOT COMPLETED|Overall Study||0
8338208|NCT01323998|20554927|P4|NOT COMPLETED|Overall Study||0
8338209|NCT01323998|20554928|P3|NOT COMPLETED|Overall Study||0
8338210|NCT01323998|20554929|P2|NOT COMPLETED|Overall Study||0
8338211|NCT01323998|20554930|P1|NOT COMPLETED|Overall Study||0
8338212|NCT01323998|20554926|P5|COMPLETED|Overall Study||6735
8338213|NCT01323998|20554927|P4|COMPLETED|Overall Study||12052
8338214|NCT01323998|20554928|P3|COMPLETED|Overall Study||10294
8338215|NCT01323998|20554929|P2|COMPLETED|Overall Study||18681
8338216|NCT01323998|20554930|P1|COMPLETED|Overall Study||200631
8338217|NCT01323998|20554926|P5|STARTED|Overall Study||6735
8338218|NCT01323998|20554927|P4|STARTED|Overall Study||12052
8338219|NCT01323998|20554928|P3|STARTED|Overall Study||10294
8338220|NCT01323998|20554929|P2|STARTED|Overall Study||18681
8338221|NCT01323998|20554930|P1|STARTED|Overall Study||200631
8338222|NCT01323972|20554946|P4|NOT COMPLETED|Overall Study||1
8338223|NCT01323972|20554947|P3|NOT COMPLETED|Overall Study||2
8338224|NCT01323972|20554948|P2|NOT COMPLETED|Overall Study||3
8338225|NCT01323972|20554949|P1|NOT COMPLETED|Overall Study||2
8338226|NCT01323972|20554946|P4|COMPLETED|Overall Study||79
8338227|NCT01323972|20554947|P3|COMPLETED|Overall Study||78
8338228|NCT01323972|20554948|P2|COMPLETED|Overall Study||76
8338229|NCT01323972|20554949|P1|COMPLETED|Overall Study||79
8338230|NCT01323972|20554946|P4|STARTED|Overall Study||80
8338231|NCT01323972|20554947|P3|STARTED|Overall Study||80
8338232|NCT01323972|20554948|P2|STARTED|Overall Study||79
8338233|NCT01323972|20554949|P1|STARTED|Overall Study||81
8338234|NCT01323959|20554984|P3|NOT COMPLETED|Overall Study||0
8338235|NCT01323959|20554985|P2|NOT COMPLETED|Overall Study||0
8338236|NCT01323959|20554986|P1|NOT COMPLETED|Overall Study||0
8338237|NCT01323959|20554984|P3|COMPLETED|Overall Study||72
8338238|NCT01323959|20554985|P2|COMPLETED|Overall Study||72
8338239|NCT01323959|20554986|P1|COMPLETED|Overall Study||67
8338240|NCT01323959|20554984|P3|STARTED|Overall Study||72
8338241|NCT01323959|20554985|P2|STARTED|Overall Study||72
8338242|NCT01323959|20554986|P1|STARTED|Overall Study||67
8338243|NCT01323946|20555045|P3|NOT COMPLETED|Overall Study||0
8338244|NCT01323946|20555046|P2|NOT COMPLETED|Overall Study||3
8338245|NCT01323946|20555047|P1|NOT COMPLETED|Overall Study||3
8338246|NCT01323946|20555045|P3|COMPLETED|Overall Study||33
8338247|NCT01323946|20555046|P2|COMPLETED|Overall Study||31
8338248|NCT01323946|20555047|P1|COMPLETED|Overall Study||43
8338249|NCT01323946|20555045|P3|STARTED|Overall Study||33
8338250|NCT01323946|20555046|P2|STARTED|Overall Study||34
8338251|NCT01323946|20555047|P1|STARTED|Overall Study||46
8338252|NCT01323920|20555168|P1|NOT COMPLETED|Overall Study||6
8338253|NCT01323920|20555168|P1|COMPLETED|Overall Study||29
8338254|NCT01323920|20555168|P1|STARTED|Overall Study||35
8338255|NCT01323855|20555180|P5|NOT COMPLETED|Overall Study||0
8338256|NCT01323855|20555181|P4|NOT COMPLETED|Overall Study||0
8338257|NCT01323855|20555182|P3|NOT COMPLETED|Overall Study||0
8338258|NCT01323855|20555183|P2|NOT COMPLETED|Overall Study||0
8338259|NCT01323855|20555184|P1|NOT COMPLETED|Overall Study||0
8338260|NCT01323855|20555180|P5|COMPLETED|Overall Study||11
8338261|NCT01323855|20555181|P4|COMPLETED|Overall Study||9
8338262|NCT01323855|20555182|P3|COMPLETED|Overall Study||8
8338263|NCT01323855|20555183|P2|COMPLETED|Overall Study||9
8338264|NCT01323855|20555184|P1|COMPLETED|Overall Study||9
8338265|NCT01323855|20555180|P5|STARTED|Overall Study||11
8338266|NCT01323855|20555181|P4|STARTED|Overall Study||9
8338267|NCT01323855|20555182|P3|STARTED|Overall Study||8
8338268|NCT01323855|20555183|P2|STARTED|Overall Study||9
8338269|NCT01323855|20555184|P1|STARTED|Overall Study||9
8338270|NCT01323790|20555209|P3|NOT COMPLETED|Overall Study||45
8338271|NCT01323790|20555210|P2|NOT COMPLETED|Overall Study||60
8338272|NCT01323790|20555211|P1|NOT COMPLETED|Overall Study||55
8338273|NCT01323790|20555209|P3|COMPLETED|Overall Study||188
8338274|NCT01323790|20555210|P2|COMPLETED|Overall Study||174
8338275|NCT01323790|20555211|P1|COMPLETED|Overall Study||178
8338276|NCT01323790|20555209|P3|STARTED|Overall Study||233
8338277|NCT01323790|20555210|P2|STARTED|Overall Study||234
8338278|NCT01323790|20555211|P1|STARTED|Overall Study||233
8338279|NCT01323777|20555249|P1|NOT COMPLETED|Overall Study||0
8338280|NCT01323777|20555249|P1|COMPLETED|Overall Study||65
8338281|NCT01323777|20555249|P1|STARTED|Overall Study||65
8338282|NCT01323673|20555262|P2|NOT COMPLETED|Overall Study||5
8338283|NCT01323673|20555263|P1|NOT COMPLETED|Overall Study||3
8338284|NCT01323673|20555262|P2|COMPLETED|Overall Study||58
8338285|NCT01323673|20555263|P1|COMPLETED|Overall Study||59
8338286|NCT01323673|20555262|P2|STARTED|Overall Study||63
8338287|NCT01323673|20555263|P1|STARTED|Overall Study||62
8338288|NCT01323660|20555283|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
8338289|NCT01323660|20555284|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
8338290|NCT01323660|20555285|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
8338291|NCT01323660|20555286|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
8338292|NCT01323660|20555287|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
8338293|NCT01323660|20555288|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
8338294|NCT01323660|20555283|P6|COMPLETED|Treatment Period 2 (12 Weeks)||51
8338295|NCT01323660|20555284|P5|COMPLETED|Treatment Period 2 (12 Weeks)||55
8338296|NCT01323660|20555285|P4|COMPLETED|Treatment Period 2 (12 Weeks)||25
8338297|NCT01323660|20555286|P3|COMPLETED|Treatment Period 2 (12 Weeks)||14
8338298|NCT01323660|20555287|P2|COMPLETED|Treatment Period 2 (12 Weeks)||17
8338299|NCT01323660|20555288|P1|COMPLETED|Treatment Period 2 (12 Weeks)||55
8338300|NCT01323660|20555283|P6|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|58
8338301|NCT01323660|20555284|P5|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|59
8338302|NCT01323660|20555285|P4|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|28
8338303|NCT01323660|20555286|P3|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|17
8338304|NCT01323660|20555287|P2|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|18
8338305|NCT01323660|20555288|P1|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|67
8338306|NCT01323660|20555283|P6|NOT COMPLETED|Washout Period (14 Days)||2
8338307|NCT01323660|20555284|P5|NOT COMPLETED|Washout Period (14 Days)||3
8338308|NCT01323660|20555285|P4|NOT COMPLETED|Washout Period (14 Days)||3
8338309|NCT01323660|20555286|P3|NOT COMPLETED|Washout Period (14 Days)||1
8338310|NCT01323660|20555287|P2|NOT COMPLETED|Washout Period (14 Days)||0
8338311|NCT01323660|20555288|P1|NOT COMPLETED|Washout Period (14 Days)||0
8338312|NCT01323660|20555283|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
8338313|NCT01323660|20555284|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
8338314|NCT01323660|20555285|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
8338315|NCT01323660|20555286|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
8338316|NCT01323660|20555287|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
8338317|NCT01323660|20555288|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
8338318|NCT01323660|20555283|P6|STARTED|Washout Period (14 Days)||61
8338319|NCT01323660|20555284|P5|STARTED|Washout Period (14 Days)||61
8338320|NCT01323660|20555285|P4|STARTED|Washout Period (14 Days)||31
8338321|NCT01323660|20555286|P3|STARTED|Washout Period (14 Days)||19
8338322|NCT01323660|20555287|P2|STARTED|Washout Period (14 Days)||21
8338323|NCT01323660|20555288|P1|STARTED|Washout Period (14 Days)||65
8338324|NCT01323660|20555283|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
8338325|NCT01323660|20555284|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
8338326|NCT01323660|20555285|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
8338327|NCT01323660|20555286|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
8338328|NCT01323660|20555287|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
8338329|NCT01323660|20555288|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
8338330|NCT01323660|20555283|P6|COMPLETED|Treatment Period 1 (12 Weeks)||61
8338331|NCT01323660|20555284|P5|COMPLETED|Treatment Period 1 (12 Weeks)||61
8338332|NCT01323660|20555285|P4|COMPLETED|Treatment Period 1 (12 Weeks)||31
8338333|NCT01323660|20555286|P3|COMPLETED|Treatment Period 1 (12 Weeks)||19
8338334|NCT01323660|20555287|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
8338335|NCT01323660|20555288|P1|COMPLETED|Treatment Period 1 (12 Weeks)||65
8338336|NCT01323660|20555283|P6|STARTED|Treatment Period 1 (12 Weeks)||70
8338337|NCT01323660|20555284|P5|STARTED|Treatment Period 1 (12 Weeks)||71
8338338|NCT01323660|20555285|P4|STARTED|Treatment Period 1 (12 Weeks)||36
8338339|NCT01323660|20555286|P3|STARTED|Treatment Period 1 (12 Weeks)||24
8338340|NCT01323660|20555287|P2|STARTED|Treatment Period 1 (12 Weeks)||22
8338341|NCT01323660|20555288|P1|STARTED|Treatment Period 1 (12 Weeks)||84
8338342|NCT01323647|20555334|P2|NOT COMPLETED|Overall Study||0
8338343|NCT01323647|20555335|P1|NOT COMPLETED|Overall Study||9
8338344|NCT01323647|20555334|P2|COMPLETED|Overall Study||487
8338345|NCT01323647|20555335|P1|COMPLETED|Overall Study||461
8338346|NCT01323647|20555334|P2|STARTED|Overall Study||487
8338347|NCT01323647|20555335|P1|STARTED|Overall Study||470
8338348|NCT01323634|20555352|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
8338349|NCT01323634|20555353|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
8338350|NCT01323634|20555354|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
8338351|NCT01323634|20555352|P3|COMPLETED|Double-Blind (DB) Treatment Period||239
8338352|NCT01323634|20555353|P2|COMPLETED|Double-Blind (DB) Treatment Period||235
8338353|NCT01323634|20555354|P1|COMPLETED|Double-Blind (DB) Treatment Period||0
8338354|NCT01323634|20555352|P3|STARTED|Double-Blind (DB) Treatment Period||261
8338355|NCT01323634|20555353|P2|STARTED|Double-Blind (DB) Treatment Period||260
8338356|NCT01323634|20555354|P1|STARTED|Double-Blind (DB) Treatment Period||0
8338357|NCT01323634|20555352|P3|NOT COMPLETED|2-week Run-in Period||0
8338358|NCT01323634|20555353|P2|NOT COMPLETED|2-week Run-in Period||0
8338359|NCT01323634|20555354|P1|NOT COMPLETED|2-week Run-in Period||212
8338360|NCT01323634|20555352|P3|COMPLETED|2-week Run-in Period||0
8338361|NCT01323634|20555353|P2|COMPLETED|2-week Run-in Period||0
8338362|NCT01323634|20555354|P1|COMPLETED|2-week Run-in Period||521
8338363|NCT01323634|20555352|P3|STARTED|2-week Run-in Period||0
8338364|NCT01323634|20555353|P2|STARTED|2-week Run-in Period||0
8338365|NCT01323634|20555354|P1|STARTED|2-week Run-in Period||733
8338366|NCT01323621|20555364|P3|NOT COMPLETED|12-week, Double-blind Treatment Period||20
8338367|NCT01323621|20555365|P2|NOT COMPLETED|12-week, Double-blind Treatment Period||15
8338368|NCT01323621|20555366|P1|NOT COMPLETED|12-week, Double-blind Treatment Period||0
8338369|NCT01323621|20555364|P3|COMPLETED|12-week, Double-blind Treatment Period||239
8338370|NCT01323621|20555365|P2|COMPLETED|12-week, Double-blind Treatment Period||237
8338371|NCT01323621|20555366|P1|COMPLETED|12-week, Double-blind Treatment Period||0
8338372|NCT01323621|20555364|P3|STARTED|12-week, Double-blind Treatment Period||259
8338373|NCT01323621|20555365|P2|STARTED|12-week, Double-blind Treatment Period||252
8338374|NCT01323621|20555366|P1|STARTED|12-week, Double-blind Treatment Period||0
8338375|NCT01323621|20555364|P3|NOT COMPLETED|2-week, Single-blind Run In Period||0
8338376|NCT01323621|20555365|P2|NOT COMPLETED|2-week, Single-blind Run In Period||0
8338377|NCT01323621|20555366|P1|NOT COMPLETED|2-week, Single-blind Run In Period||228
8338378|NCT01323621|20555364|P3|COMPLETED|2-week, Single-blind Run In Period||0
8338379|NCT01323621|20555365|P2|COMPLETED|2-week, Single-blind Run In Period||0
8338380|NCT01323621|20555366|P1|COMPLETED|2-week, Single-blind Run In Period||511
8338381|NCT01323621|20555364|P3|STARTED|2-week, Single-blind Run In Period||0
8338382|NCT01323621|20555365|P2|STARTED|2-week, Single-blind Run In Period||0
8338383|NCT01323621|20555366|P1|STARTED|2-week, Single-blind Run In Period||739
8338384|NCT01323595|20555376|P2|NOT COMPLETED|Overall Study||21
8338385|NCT01323595|20555377|P1|NOT COMPLETED|Overall Study||23
8338386|NCT01323595|20555376|P2|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
8338387|NCT01323595|20555377|P1|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
8338388|NCT01323595|20555376|P2|STARTED|Overall Study||39
8338389|NCT01323595|20555377|P1|STARTED|Overall Study||39
8338390|NCT01323582|20555387|P2|NOT COMPLETED|Weeks 8-11 (Period 2)||1
8338391|NCT01323582|20555388|P1|NOT COMPLETED|Weeks 8-11 (Period 2)||0
8338392|NCT01323582|20555387|P2|COMPLETED|Weeks 8-11 (Period 2)||10
8338393|NCT01323582|20555388|P1|COMPLETED|Weeks 8-11 (Period 2)||10
8338394|NCT01323582|20555387|P2|STARTED|Weeks 8-11 (Period 2)||11
8338395|NCT01323582|20555388|P1|STARTED|Weeks 8-11 (Period 2)||10
8338396|NCT01323582|20555387|P2|NOT COMPLETED|Weeks 5-7 (Washout)||1
8338397|NCT01323582|20555388|P1|NOT COMPLETED|Weeks 5-7 (Washout)||0
8338398|NCT01323582|20555387|P2|COMPLETED|Weeks 5-7 (Washout)||11
8338399|NCT01323582|20555388|P1|COMPLETED|Weeks 5-7 (Washout)||10
8338400|NCT01323582|20555387|P2|STARTED|Weeks 5-7 (Washout)||12
8338401|NCT01323582|20555388|P1|STARTED|Weeks 5-7 (Washout)||10
8338402|NCT01323582|20555387|P2|NOT COMPLETED|Weeks 1-4 (First Period)||2
8338403|NCT01323582|20555388|P1|NOT COMPLETED|Weeks 1-4 (First Period)||2
8338404|NCT01323582|20555387|P2|COMPLETED|Weeks 1-4 (First Period)||12
8338405|NCT01323582|20555388|P1|COMPLETED|Weeks 1-4 (First Period)||10
8338406|NCT01323582|20555387|P2|STARTED|Weeks 1-4 (First Period)||14
8338407|NCT01323582|20555388|P1|STARTED|Weeks 1-4 (First Period)||12
8338408|NCT01323530|20555411|P7|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||17
8338409|NCT01323530|20555412|P6|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338410|NCT01323530|20555413|P5|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338411|NCT01323530|20555414|P4|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338412|NCT01323530|20555415|P3|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338413|NCT01323530|20555416|P2|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338414|NCT01323530|20555417|P1|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338415|NCT01323530|20555411|P7|COMPLETED|Phase 2 (Dose-confirmation Phase)||25
8338416|NCT01323530|20555412|P6|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338417|NCT01323530|20555413|P5|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338418|NCT01323530|20555414|P4|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338419|NCT01323530|20555415|P3|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338420|NCT01323530|20555416|P2|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338421|NCT01323530|20555417|P1|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
8338422|NCT01323530|20555411|P7|STARTED|Phase 2 (Dose-confirmation Phase)||42
8338423|NCT01323530|20555412|P6|STARTED|Phase 2 (Dose-confirmation Phase)||0
8338424|NCT01323530|20555413|P5|STARTED|Phase 2 (Dose-confirmation Phase)||0
8338425|NCT01323530|20555414|P4|STARTED|Phase 2 (Dose-confirmation Phase)||0
8338426|NCT01323530|20555415|P3|STARTED|Phase 2 (Dose-confirmation Phase)||0
8338427|NCT01323530|20555416|P2|STARTED|Phase 2 (Dose-confirmation Phase)||0
8338428|NCT01323530|20555417|P1|STARTED|Phase 2 (Dose-confirmation Phase)||0
8338429|NCT01323530|20555411|P7|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
8338430|NCT01323530|20555412|P6|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
8338431|NCT01323530|20555413|P5|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
8338432|NCT01323530|20555414|P4|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
8338433|NCT01323530|20555415|P3|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||1
8338434|NCT01323530|20555416|P2|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||2
8338435|NCT01323530|20555417|P1|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
8338436|NCT01323530|20555411|P7|COMPLETED|Phase 1b (Dose Escalation Phase)||0
8338437|NCT01323530|20555412|P6|COMPLETED|Phase 1b (Dose Escalation Phase)||3
8338438|NCT01323530|20555413|P5|COMPLETED|Phase 1b (Dose Escalation Phase)||3
8338439|NCT01323530|20555414|P4|COMPLETED|Phase 1b (Dose Escalation Phase)||3
8338440|NCT01323530|20555415|P3|COMPLETED|Phase 1b (Dose Escalation Phase)||4
8338441|NCT01323530|20555416|P2|COMPLETED|Phase 1b (Dose Escalation Phase)||4
8338442|NCT01323530|20555417|P1|COMPLETED|Phase 1b (Dose Escalation Phase)||5
8338443|NCT01323530|20555411|P7|STARTED|Phase 1b (Dose Escalation Phase)||0
8338444|NCT01323530|20555412|P6|STARTED|Phase 1b (Dose Escalation Phase)||6
8338445|NCT01323530|20555413|P5|STARTED|Phase 1b (Dose Escalation Phase)||6
8338446|NCT01323530|20555414|P4|STARTED|Phase 1b (Dose Escalation Phase)||3
8338447|NCT01323530|20555415|P3|STARTED|Phase 1b (Dose Escalation Phase)||5
8338448|NCT01323530|20555416|P2|STARTED|Phase 1b (Dose Escalation Phase)||6
8338449|NCT01323530|20555417|P1|STARTED|Phase 1b (Dose Escalation Phase)||8
8338450|NCT01323517|20555447|P1|NOT COMPLETED|Overall Study||0
8338451|NCT01323517|20555447|P1|COMPLETED|Overall Study||26
8338452|NCT01323517|20555447|P1|STARTED|Overall Study||26
8338453|NCT01323478|20555454|P1|NOT COMPLETED|Overall Study||24
8338454|NCT01323478|20555454|P1|COMPLETED|Overall Study||47
8338455|NCT01323478|20555454|P1|STARTED|Overall Study||71
8338456|NCT01323387|20555467|P1|NOT COMPLETED|Overall Study||84
8338457|NCT01323387|20555467|P1|COMPLETED|Overall Study||94
8338458|NCT01323387|20555467|P1|STARTED|Overall Study||178
8338459|NCT01323270|20555480|P2|NOT COMPLETED|Overall Study||29
8338460|NCT01323270|20555481|P1|NOT COMPLETED|Overall Study||43
8338461|NCT01323270|20555480|P2|COMPLETED|Overall Study||347
8338462|NCT01323270|20555481|P1|COMPLETED|Overall Study||330
8338463|NCT01323270|20555480|P2|STARTED|Overall Study||376
8338464|NCT01323270|20555481|P1|STARTED|Overall Study||373
8338465|NCT01323192|20555503|P2|NOT COMPLETED|Overall Study||6
8338466|NCT01323192|20555504|P1|NOT COMPLETED|Overall Study||9
8338467|NCT01323192|20555503|P2|COMPLETED|Overall Study||135
8338468|NCT01323192|20555504|P1|COMPLETED|Overall Study||134
8338469|NCT01323192|20555503|P2|STARTED|Overall Study||141
8338470|NCT01323192|20555504|P1|STARTED|Overall Study||143
8338471|NCT01323153|20555522|P2|NOT COMPLETED|Overall Study||8
8338472|NCT01323153|20555523|P1|NOT COMPLETED|Overall Study||17
8338473|NCT01323153|20555522|P2|COMPLETED|Overall Study||142
8338474|NCT01323153|20555523|P1|COMPLETED|Overall Study||133
8338475|NCT01323153|20555522|P2|STARTED|Overall Study||150
8338476|NCT01323153|20555523|P1|STARTED|Overall Study||150
8338477|NCT01323140|20555529|P1|NOT COMPLETED|Overall Study||2
8338478|NCT01323140|20555529|P1|COMPLETED|Overall Study||38
8338479|NCT01323140|20555529|P1|STARTED|Overall Study||40
8338480|NCT01323010|20555535|P2|NOT COMPLETED|Overall Study||0
8338481|NCT01323010|20555536|P1|NOT COMPLETED|Overall Study||0
8338482|NCT01323010|20555535|P2|COMPLETED|Overall Study||59
8338483|NCT01323010|20555536|P1|COMPLETED|Overall Study||60
8338484|NCT01323010|20555535|P2|STARTED|Overall Study||59
8338485|NCT01323010|20555536|P1|STARTED|Overall Study||60
8338486|NCT01322971|20555587|P2|NOT COMPLETED|Overall Study||1
8338487|NCT01322971|20555588|P1|NOT COMPLETED|Overall Study||1
8338488|NCT01322971|20555587|P2|COMPLETED|Overall Study||0
8338489|NCT01322971|20555588|P1|COMPLETED|Overall Study||0
8338490|NCT01322971|20555587|P2|STARTED|Overall Study||1
8338491|NCT01322971|20555588|P1|STARTED|Overall Study||1
8338492|NCT01322945|20555602|P2|NOT COMPLETED|Overall Study||0
8338493|NCT01322945|20555603|P1|NOT COMPLETED|Overall Study||0
8338494|NCT01322945|20555602|P2|COMPLETED|Overall Study||42
8338495|NCT01322945|20555603|P1|COMPLETED|Overall Study||52
8338496|NCT01322945|20555602|P2|STARTED|Overall Study||42
8338497|NCT01322945|20555603|P1|STARTED|Overall Study||52
8338498|NCT01322841|20555613|P2|NOT COMPLETED|Overall Study||0
8338499|NCT01322841|20555614|P1|NOT COMPLETED|Overall Study||0
8338500|NCT01322841|20555613|P2|COMPLETED|Overall Study||1123
8338501|NCT01322841|20555614|P1|COMPLETED|Overall Study||1116
8338502|NCT01322841|20555613|P2|STARTED|Overall Study||1123
8338503|NCT01322841|20555614|P1|STARTED|Overall Study||1116
8338504|NCT01322815|20555624|P2|NOT COMPLETED|Overall Study||0
8338505|NCT01322815|20555625|P1|NOT COMPLETED|Overall Study||0
8338506|NCT01322815|20555624|P2|COMPLETED|Overall Study||4
8338507|NCT01322815|20555625|P1|COMPLETED|Overall Study||7
8338508|NCT01322815|20555624|P2|STARTED|Overall Study||4
8338509|NCT01322815|20555625|P1|STARTED|Overall Study||7
8338510|NCT01322633|20555633|P2|NOT COMPLETED|Overall Study||0
8338511|NCT01322633|20555634|P1|NOT COMPLETED|Overall Study||0
8338512|NCT01322633|20555633|P2|COMPLETED|Overall Study||27686
8338513|NCT01322633|20555634|P1|COMPLETED|Overall Study||34178
8338514|NCT01322633|20555633|P2|STARTED|Overall Study||27686
8338515|NCT01322633|20555634|P1|STARTED|Overall Study||34178
8338516|NCT01322607|20555646|P2|NOT COMPLETED|Overall Study||0
8338517|NCT01322607|20555647|P1|NOT COMPLETED|Overall Study||1
8338518|NCT01322607|20555646|P2|COMPLETED|Overall Study||9
8338519|NCT01322607|20555647|P1|COMPLETED|Overall Study||10
8338520|NCT01322607|20555646|P2|STARTED|Overall Study||9
8338521|NCT01322607|20555647|P1|STARTED|Overall Study||11
8338522|NCT01322594|20555665|P6|NOT COMPLETED|Overall Study||0
8338523|NCT01322594|20555666|P5|NOT COMPLETED|Overall Study||0
8338524|NCT01322594|20555667|P4|NOT COMPLETED|Overall Study||0
8338525|NCT01322594|20555668|P3|NOT COMPLETED|Overall Study||0
8338526|NCT01322594|20555669|P2|NOT COMPLETED|Overall Study||0
8338527|NCT01322594|20555670|P1|NOT COMPLETED|Overall Study||0
8338528|NCT01322594|20555665|P6|COMPLETED|Overall Study||6
8338529|NCT01322594|20555666|P5|COMPLETED|Overall Study||7
8338530|NCT01322594|20555667|P4|COMPLETED|Overall Study||6
8338531|NCT01322594|20555668|P3|COMPLETED|Overall Study||3
8338532|NCT01322594|20555669|P2|COMPLETED|Overall Study||3
8338533|NCT01322594|20555670|P1|COMPLETED|Overall Study||6
8338534|NCT01322594|20555665|P6|STARTED|Overall Study||6
8338535|NCT01322594|20555666|P5|STARTED|Overall Study||7
8338536|NCT01322594|20555667|P4|STARTED|Overall Study||6
8338537|NCT01322594|20555668|P3|STARTED|Overall Study||3
8338538|NCT01322594|20555669|P2|STARTED|Overall Study||3
8338539|NCT01322594|20555670|P1|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
8338540|NCT01322490|20555753|P3|NOT COMPLETED|Long Term Follow-up Period||413
8338541|NCT01322490|20555754|P2|NOT COMPLETED|Long Term Follow-up Period||408
8338542|NCT01322490|20555755|P1|NOT COMPLETED|Long Term Follow-up Period||409
8338543|NCT01322490|20555753|P3|COMPLETED|Long Term Follow-up Period||0
8338544|NCT01322490|20555754|P2|COMPLETED|Long Term Follow-up Period||0
8338545|NCT01322490|20555755|P1|COMPLETED|Long Term Follow-up Period||0
8338546|NCT01322490|20555753|P3|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413
8338547|NCT01322490|20555754|P2|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408
8338548|NCT01322490|20555755|P1|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409
8338549|NCT01322490|20555753|P3|NOT COMPLETED|Treatment Period||153
8338550|NCT01322490|20555754|P2|NOT COMPLETED|Treatment Period||153
8338551|NCT01322490|20555755|P1|NOT COMPLETED|Treatment Period||132
8338552|NCT01322490|20555753|P3|COMPLETED|Treatment Period||280
8338553|NCT01322490|20555754|P2|COMPLETED|Treatment Period||279
8338554|NCT01322490|20555755|P1|COMPLETED|Treatment Period||300
8338555|NCT01322490|20555753|P3|Treated|Treatment Period||428
8338556|NCT01322490|20555754|P2|Treated|Treatment Period||429
8338557|NCT01322490|20555755|P1|Treated|Treatment Period||429
8338558|NCT01322490|20555753|P3|STARTED|Treatment Period||433
8338559|NCT01322490|20555754|P2|STARTED|Treatment Period||432
8338560|NCT01322490|20555755|P1|STARTED|Treatment Period||432
8338561|NCT01322386|20555768|P2|NOT COMPLETED|Overall Study||2
8338562|NCT01322386|20555769|P1|NOT COMPLETED|Overall Study||0
8338563|NCT01322386|20555768|P2|COMPLETED|Overall Study||9
8338564|NCT01322386|20555769|P1|COMPLETED|Overall Study||10
8338565|NCT01322386|20555768|P2|STARTED|Overall Study||11
8338566|NCT01322386|20555769|P1|STARTED|Overall Study||10
8338567|NCT01322360|20555777|P1|NOT COMPLETED|Overall Study||0
8338568|NCT01322360|20555777|P1|COMPLETED|Overall Study||50
8338569|NCT01322360|20555777|P1|STARTED|Overall Study||50
8338570|NCT01322347|20555784|P2|NOT COMPLETED|Overall Study||35
8338571|NCT01322347|20555785|P1|NOT COMPLETED|Overall Study||51
8338572|NCT01322347|20555784|P2|COMPLETED|Overall Study||112
8338573|NCT01322347|20555785|P1|COMPLETED|Overall Study||96
8338574|NCT01322347|20555784|P2|Completed St 3|Overall Study||86
8338575|NCT01322347|20555785|P1|Completed St 3|Overall Study||82
8338576|NCT01322347|20555784|P2|Enrolled in St 3|Overall Study||113
8338577|NCT01322347|20555785|P1|Enrolled in St 3|Overall Study||101
8338578|NCT01322347|20555784|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
8338579|NCT01322347|20555785|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
8338580|NCT01322347|20555784|P2|Completed 48 Wks in St 2|Overall Study||22
8338581|NCT01322347|20555785|P1|Completed 48 Wks in St 2|Overall Study||28
8338582|NCT01322347|20555784|P2|STARTED|Overall Study||147
8338583|NCT01322347|20555785|P1|STARTED|Overall Study||147
8338584|NCT01322048|20555822|P2|NOT COMPLETED|Overall Study||0
8338585|NCT01322048|20555823|P1|NOT COMPLETED|Overall Study||0
8338586|NCT01322048|20555822|P2|COMPLETED|Overall Study||26
8338587|NCT01322048|20555823|P1|COMPLETED|Overall Study||21
8338588|NCT01322048|20555822|P2|STARTED|Overall Study||26
8338589|NCT01322048|20555823|P1|STARTED|Overall Study||21
8338590|NCT01322022|20555833|P2|NOT COMPLETED|Overall Study||2
8338591|NCT01322022|20555834|P1|NOT COMPLETED|Overall Study||5
8338592|NCT01322022|20555833|P2|COMPLETED|Overall Study||18
8338593|NCT01322022|20555834|P1|COMPLETED|Overall Study||15
8338594|NCT01322022|20555833|P2|Week 4|Overall Study||18
8338595|NCT01322022|20555834|P1|Week 4|Overall Study||15
8338596|NCT01322022|20555833|P2|STARTED|Overall Study||20
8338597|NCT01322022|20555834|P1|STARTED|Overall Study||20
8338598|NCT01322009|20555848|P2|NOT COMPLETED|Overall Study||3
8338599|NCT01322009|20555849|P1|NOT COMPLETED|Overall Study||0
8338600|NCT01322009|20555848|P2|COMPLETED|Overall Study||4
8338601|NCT01322009|20555849|P1|COMPLETED|Overall Study||7
8338602|NCT01322009|20555848|P2|STARTED|Overall Study||7
8338603|NCT01322009|20555849|P1|STARTED|Overall Study||7
8338604|NCT01321879|20555857|P1|NOT COMPLETED|Overall Study||14
8338605|NCT01321879|20555857|P1|COMPLETED|Overall Study||25
8338606|NCT01321879|20555857|P1|STARTED|Overall Study||39
8338607|NCT01321749|20555863|P2|NOT COMPLETED|Overall Study||22
8338608|NCT01321749|20555864|P1|NOT COMPLETED|Overall Study||13
8338609|NCT01321749|20555863|P2|COMPLETED|Overall Study||30
8338610|NCT01321749|20555864|P1|COMPLETED|Overall Study||38
8338611|NCT01321749|20555863|P2|STARTED|Overall Study||52
8338612|NCT01321749|20555864|P1|STARTED|Overall Study||51
8338613|NCT01321723|20555873|P3|NOT COMPLETED|Overall Study||4
8338614|NCT01321723|20555874|P2|NOT COMPLETED|Overall Study||5
8338615|NCT01321723|20555875|P1|NOT COMPLETED|Overall Study||5
8338616|NCT01321723|20555873|P3|COMPLETED|Overall Study||28
8338617|NCT01321723|20555874|P2|COMPLETED|Overall Study||28
8338618|NCT01321723|20555875|P1|COMPLETED|Overall Study||27
8338619|NCT01321723|20555873|P3|STARTED|Overall Study||32
8338620|NCT01321723|20555874|P2|STARTED|Overall Study||33
8338621|NCT01321723|20555875|P1|STARTED|Overall Study||32
8338622|NCT01321710|20555897|P3|NOT COMPLETED|Overall Study||0
8338623|NCT01321710|20555898|P2|NOT COMPLETED|Overall Study||5
8338624|NCT01321710|20555899|P1|NOT COMPLETED|Overall Study||4
8338625|NCT01321710|20555897|P3|COMPLETED|Overall Study||44
8338626|NCT01321710|20555898|P2|COMPLETED|Overall Study||53
8338627|NCT01321710|20555899|P1|COMPLETED|Overall Study||46
8338628|NCT01321710|20555897|P3|STARTED|Overall Study||44
8338629|NCT01321710|20555898|P2|STARTED|Overall Study||58
8338630|NCT01321710|20555899|P1|STARTED|Overall Study||50
8338631|NCT01321697|20555914|P1|NOT COMPLETED|Overall Study||7
8338632|NCT01321697|20555914|P1|COMPLETED|Overall Study||0
8338633|NCT01321697|20555914|P1|STARTED|Overall Study||7
8338634|NCT01321606|20555920|P4|NOT COMPLETED|Overall Study||1
8338635|NCT01321606|20555921|P3|NOT COMPLETED|Overall Study||0
8338636|NCT01321606|20555922|P2|NOT COMPLETED|Overall Study||0
8338637|NCT01321606|20555923|P1|NOT COMPLETED|Overall Study||0
8338638|NCT01321606|20555920|P4|COMPLETED|Overall Study||28
8338639|NCT01321606|20555921|P3|COMPLETED|Overall Study||34
8338640|NCT01321606|20555922|P2|COMPLETED|Overall Study||32
8338641|NCT01321606|20555923|P1|COMPLETED|Overall Study||18
8338642|NCT01321606|20555920|P4|STARTED|Overall Study||29
8338643|NCT01321606|20555921|P3|STARTED|Overall Study||34
8338644|NCT01321606|20555922|P2|STARTED|Overall Study||32
8338645|NCT01321606|20555923|P1|STARTED|Overall Study||18
8338646|NCT01321554|20555943|P4|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
8338647|NCT01321554|20555944|P3|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
8338648|NCT01321554|20555945|P2|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
8338649|NCT01321554|20555946|P1|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
8338650|NCT01321554|20555943|P4|COMPLETED|OOL Lenvatinib Treatment Period||30
8338651|NCT01321554|20555944|P3|COMPLETED|OOL Lenvatinib Treatment Period||85
8338652|NCT01321554|20555945|P2|COMPLETED|OOL Lenvatinib Treatment Period||0
8338653|NCT01321554|20555946|P1|COMPLETED|OOL Lenvatinib Treatment Period||0
8338654|NCT01321554|20555943|P4|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|30
8338655|NCT01321554|20555944|P3|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|85
8338656|NCT01321554|20555945|P2|STARTED|OOL Lenvatinib Treatment Period||0
8338657|NCT01321554|20555946|P1|STARTED|OOL Lenvatinib Treatment Period||0
8338658|NCT01321554|20555943|P4|NOT COMPLETED|Randomization Phase||0
8338659|NCT01321554|20555944|P3|NOT COMPLETED|Randomization Phase||0
8338660|NCT01321554|20555945|P2|NOT COMPLETED|Randomization Phase||0
8338661|NCT01321554|20555946|P1|NOT COMPLETED|Randomization Phase||0
8338662|NCT01321554|20555943|P4|COMPLETED|Randomization Phase||0
8338663|NCT01321554|20555944|P3|COMPLETED|Randomization Phase||0
8338664|NCT01321554|20555945|P2|COMPLETED|Randomization Phase||131
8338665|NCT01321554|20555946|P1|COMPLETED|Randomization Phase||261
8338666|NCT01321554|20555943|P4|STARTED|Randomization Phase||0
8338667|NCT01321554|20555944|P3|STARTED|Randomization Phase||0
8338668|NCT01321554|20555945|P2|STARTED|Randomization Phase||131
8338669|NCT01321554|20555946|P1|STARTED|Randomization Phase||261
8338670|NCT01321437|20555959|P1|NOT COMPLETED|Overall Study||0
8338671|NCT01321437|20555959|P1|COMPLETED|Overall Study||11
8338672|NCT01321437|20555959|P1|STARTED|Overall Study||11
8338676|NCT01321008|20555971|P1|NOT COMPLETED|Overall Study||1
8338677|NCT01321008|20555971|P1|COMPLETED|Overall Study||0
8338678|NCT01321008|20555971|P1|STARTED|Overall Study||1
8338679|NCT01320943|20555977|P2|NOT COMPLETED|Overall Study||2
8338680|NCT01320943|20555978|P1|NOT COMPLETED|Overall Study||1
8338681|NCT01320943|20555977|P2|COMPLETED|Overall Study||20
8338682|NCT01320943|20555978|P1|COMPLETED|Overall Study||20
8338683|NCT01320943|20555977|P2|STARTED|Overall Study||22
8338684|NCT01320943|20555978|P1|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
8338685|NCT01320826|20555997|P1|NOT COMPLETED|Overall Study||0
8338686|NCT01320826|20555997|P1|COMPLETED|Overall Study||577
8338687|NCT01320826|20555997|P1|STARTED|Overall Study||577
8338688|NCT01320735|20556012|P1|NOT COMPLETED|Overall Study||106
8338689|NCT01320735|20556012|P1|COMPLETED|Overall Study||194
8338690|NCT01320735|20556012|P1|STARTED|Overall Study||300
8338691|NCT01320722|20556034|P5|NOT COMPLETED|Overall Study||8
8338692|NCT01320722|20556035|P4|NOT COMPLETED|Overall Study||14
8338693|NCT01320722|20556036|P3|NOT COMPLETED|Overall Study||7
8338694|NCT01320722|20556037|P2|NOT COMPLETED|Overall Study||6
8338695|NCT01320722|20556038|P1|NOT COMPLETED|Overall Study||3
8338696|NCT01320722|20556034|P5|COMPLETED|Overall Study||45
8338697|NCT01320722|20556035|P4|COMPLETED|Overall Study||35
8338698|NCT01320722|20556036|P3|COMPLETED|Overall Study||40
8338699|NCT01320722|20556037|P2|COMPLETED|Overall Study||41
8338700|NCT01320722|20556038|P1|COMPLETED|Overall Study||43
8338701|NCT01320722|20556034|P5|Received Intervention|Overall Study||51
8338702|NCT01320722|20556035|P4|Received Intervention|Overall Study||48
8338703|NCT01320722|20556036|P3|Received Intervention|Overall Study||46
8338704|NCT01320722|20556037|P2|Received Intervention|Overall Study||45
8338705|NCT01320722|20556038|P1|Received Intervention|Overall Study||43
8338706|NCT01320722|20556034|P5|STARTED|Overall Study||53
8338707|NCT01320722|20556035|P4|STARTED|Overall Study||49
8338708|NCT01320722|20556036|P3|STARTED|Overall Study||47
8338709|NCT01320722|20556037|P2|STARTED|Overall Study||47
8338710|NCT01320722|20556038|P1|STARTED|Overall Study||46
8338711|NCT01320683|20556075|P1|NOT COMPLETED|Overall Study||1
8338712|NCT01320683|20556075|P1|COMPLETED|Overall Study||0
8338713|NCT01320683|20556075|P1|STARTED|Overall Study||1
8338714|NCT01320553|20556084|P4|NOT COMPLETED|Overall Study||1
8338715|NCT01320553|20556085|P3|NOT COMPLETED|Overall Study||2
8338716|NCT01320553|20556086|P2|NOT COMPLETED|Overall Study||4
8338717|NCT01320553|20556087|P1|NOT COMPLETED|Overall Study||1
8338718|NCT01320553|20556084|P4|COMPLETED|Overall Study||29
8338719|NCT01320553|20556085|P3|COMPLETED|Overall Study||29
8338720|NCT01320553|20556086|P2|COMPLETED|Overall Study||26
8338721|NCT01320553|20556087|P1|COMPLETED|Overall Study||30
8338722|NCT01320553|20556084|P4|STARTED|Overall Study||30
8338723|NCT01320553|20556085|P3|STARTED|Overall Study||31
8338724|NCT01320553|20556086|P2|STARTED|Overall Study||30
8338725|NCT01320553|20556087|P1|STARTED|Overall Study||31
8338726|NCT01320293|20556101|P1|NOT COMPLETED|Overall Study||2
8338727|NCT01320293|20556101|P1|COMPLETED|Overall Study||16
8338728|NCT01320293|20556101|P1|STARTED|Overall Study||18
8338729|NCT01320202|20556109|P2|NOT COMPLETED|Overall Study||44
8338730|NCT01320202|20556110|P1|NOT COMPLETED|Overall Study||56
8338731|NCT01320202|20556109|P2|COMPLETED|Overall Study||109
8338732|NCT01320202|20556110|P1|COMPLETED|Overall Study||96
8338733|NCT01320202|20556109|P2|Completed St 3|Overall Study||82
8338734|NCT01320202|20556110|P1|Completed St 3|Overall Study||79
8338735|NCT01320202|20556109|P2|Enrolled in St 3|Overall Study||109
8338736|NCT01320202|20556110|P1|Enrolled in St 3|Overall Study||98
8338737|NCT01320202|20556109|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
8338738|NCT01320202|20556110|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
8338739|NCT01320202|20556109|P2|Comp 48 Wks in St 2|Overall Study||27
8338740|NCT01320202|20556110|P1|Comp 48 Wks in St 2|Overall Study||27
8338741|NCT01320202|20556109|P2|STARTED|Overall Study||153
8338742|NCT01320202|20556110|P1|STARTED|Overall Study||152
8338743|NCT01320150|20556147|P1|NOT COMPLETED|Overall Study||66
8338744|NCT01320150|20556147|P1|COMPLETED|Overall Study||245
8338745|NCT01320150|20556147|P1|Non-PPP|Overall Study||211
8338746|NCT01320150|20556147|P1|PPP|Overall Study||34
8338747|NCT01320150|20556147|P1|STARTED|Overall Study||311
8338748|NCT01320137|20556153|P2|NOT COMPLETED|Overall Study||0
8338749|NCT01320137|20556154|P1|NOT COMPLETED|Overall Study||0
8338750|NCT01320137|20556153|P2|COMPLETED|Overall Study||40
8338751|NCT01320137|20556154|P1|COMPLETED|Overall Study||40
8338752|NCT01320137|20556153|P2|STARTED|Overall Study||40
8338753|NCT01320137|20556154|P1|STARTED|Overall Study||40
8338763|NCT01320072|20556268|P2|NOT COMPLETED|Overall Study||0
8338764|NCT01320072|20556269|P1|NOT COMPLETED|Overall Study||0
8338765|NCT01320072|20556268|P2|COMPLETED|Overall Study||13
8338766|NCT01320072|20556269|P1|COMPLETED|Overall Study||16
8338767|NCT01320072|20556268|P2|STARTED|Overall Study||13
8338768|NCT01320072|20556269|P1|STARTED|Overall Study||16
8338778|NCT01319994|20556311|P2|NOT COMPLETED|Overall Study||6
8338779|NCT01319994|20556312|P1|NOT COMPLETED|Overall Study||7
8338780|NCT01319994|20556311|P2|COMPLETED|Overall Study||21
8338781|NCT01319994|20556312|P1|COMPLETED|Overall Study||19
8338782|NCT01319994|20556311|P2|Did Not Develop Overt Diabetes|Overall Study||21
8338783|NCT01319994|20556312|P1|Did Not Develop Overt Diabetes|Overall Study||19
8338784|NCT01319994|20556311|P2|Glucocorticoid Dose as Inc Cri|Overall Study||22
8338785|NCT01319994|20556312|P1|Glucocorticoid Dose as Inc Cri|Overall Study||19
8338786|NCT01319994|20556311|P2|Tolerated at Least 1.7g/Day Dose|Overall Study||24
8338787|NCT01319994|20556312|P1|Tolerated at Least 1.7g/Day Dose|Overall Study||19
8338788|NCT01319994|20556311|P2|Abto Keep Appoinment Shedule|Overall Study||24
8338789|NCT01319994|20556312|P1|Abto Keep Appoinment Shedule|Overall Study||23
8338790|NCT01319994|20556311|P2|STARTED|Overall Study||27
8338791|NCT01319994|20556312|P1|STARTED|Overall Study||26
8338792|NCT01319929|20556322|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
8338793|NCT01319929|20556323|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
8338794|NCT01319929|20556322|P2|COMPLETED|Second Treatment Period (4 Weeks)||16
8338795|NCT01319929|20556323|P1|COMPLETED|Second Treatment Period (4 Weeks)||16
8338796|NCT01319929|20556322|P2|STARTED|Second Treatment Period (4 Weeks)||17
8338797|NCT01319929|20556323|P1|STARTED|Second Treatment Period (4 Weeks)||17
8338798|NCT01319929|20556322|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
8338799|NCT01319929|20556323|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
8338800|NCT01319929|20556322|P2|COMPLETED|Washout Period (3 Weeks)||17
8338801|NCT01319929|20556323|P1|COMPLETED|Washout Period (3 Weeks)||17
8338802|NCT01319929|20556322|P2|STARTED|Washout Period (3 Weeks)||17
8338803|NCT01319929|20556323|P1|STARTED|Washout Period (3 Weeks)||17
8338804|NCT01319929|20556322|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||2
8338805|NCT01319929|20556323|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||3
8338806|NCT01319929|20556322|P2|COMPLETED|First Treatment Period (4 Weeks)||17
8338807|NCT01319929|20556323|P1|COMPLETED|First Treatment Period (4 Weeks)||17
8338808|NCT01319929|20556322|P2|STARTED|First Treatment Period (4 Weeks)||19
8338809|NCT01319929|20556323|P1|STARTED|First Treatment Period (4 Weeks)||20
8338810|NCT01319877|20556355|P2|NOT COMPLETED|Overall Study||45
8338811|NCT01319877|20556356|P1|NOT COMPLETED|Overall Study||108
8338812|NCT01319877|20556355|P2|COMPLETED|Overall Study||108
8338813|NCT01319877|20556356|P1|COMPLETED|Overall Study||345
8338814|NCT01319877|20556355|P2|STARTED|Overall Study||153
8338815|NCT01319877|20556356|P1|STARTED|Overall Study||453
8338816|NCT01319851|20556391|P1|NOT COMPLETED|Overall Study||0
8338817|NCT01319851|20556391|P1|COMPLETED|Overall Study||3
8338818|NCT01319851|20556391|P1|STARTED|Overall Study||3
8338819|NCT01319812|20556403|P2|NOT COMPLETED|Overall Study||22
8338820|NCT01319812|20556404|P1|NOT COMPLETED|Overall Study||16
8338821|NCT01319812|20556403|P2|COMPLETED|Overall Study||280
8338822|NCT01319812|20556404|P1|COMPLETED|Overall Study||145
8338823|NCT01319812|20556403|P2|STARTED|Overall Study||302
8338824|NCT01319812|20556404|P1|STARTED|Overall Study||161
8338825|NCT01319799|20556485|P1|NOT COMPLETED|Overall Study||0
8338826|NCT01319799|20556485|P1|COMPLETED|Overall Study||10
8338827|NCT01319799|20556485|P1|STARTED|Overall Study||10
8338828|NCT01319773|20556495|P5|NOT COMPLETED|Overall Study||0
8338829|NCT01319773|20556496|P4|NOT COMPLETED|Overall Study||0
8338830|NCT01319773|20556497|P3|NOT COMPLETED|Overall Study||0
8338831|NCT01319773|20556498|P2|NOT COMPLETED|Overall Study||0
8338832|NCT01319773|20556499|P1|NOT COMPLETED|Overall Study||0
8338833|NCT01319773|20556495|P5|COMPLETED|Overall Study||8
8338834|NCT01319773|20556496|P4|COMPLETED|Overall Study||8
8338835|NCT01319773|20556497|P3|COMPLETED|Overall Study||8
8338836|NCT01319773|20556498|P2|COMPLETED|Overall Study||10
8338837|NCT01319773|20556499|P1|COMPLETED|Overall Study||10
8338838|NCT01319773|20556495|P5|STARTED|Overall Study||8
8338839|NCT01319773|20556496|P4|STARTED|Overall Study||8
8338840|NCT01319773|20556497|P3|STARTED|Overall Study||8
8338841|NCT01319773|20556498|P2|STARTED|Overall Study||10
8338842|NCT01319773|20556499|P1|STARTED|Overall Study||10
8338843|NCT01319760|20556515|P2|NOT COMPLETED|Overall Study||0
8338844|NCT01319760|20556516|P1|NOT COMPLETED|Overall Study||0
8338845|NCT01319760|20556515|P2|COMPLETED|Overall Study||5
8338846|NCT01319760|20556516|P1|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
8338847|NCT01319760|20556515|P2|STARTED|Overall Study||5
8338848|NCT01319760|20556516|P1|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
8338849|NCT01319721|20556524|P2|NOT COMPLETED|Overall Study||6
8338850|NCT01319721|20556525|P1|NOT COMPLETED|Overall Study||1
8338851|NCT01319721|20556524|P2|COMPLETED|Overall Study|The unit of measure is eyes.|42
8338852|NCT01319721|20556525|P1|COMPLETED|Overall Study|The unit of measure is eyes.|47
8338853|NCT01319721|20556524|P2|STARTED|Overall Study|The unit of measure is eyes.|48
8338854|NCT01319721|20556525|P1|STARTED|Overall Study|The unit of measure is eyes.|48
8338855|NCT01319617|20556539|P1|NOT COMPLETED|Overall Study||1
8338856|NCT01319617|20556539|P1|COMPLETED|Overall Study||40
8338857|NCT01319617|20556539|P1|STARTED|Overall Study||41
8338858|NCT01319552|20556543|P1|NOT COMPLETED|Overall Study||0
8338859|NCT01319552|20556543|P1|COMPLETED|Overall Study||14
8338860|NCT01319552|20556543|P1|STARTED|Overall Study||14
8338861|NCT01319539|20556548|P1|NOT COMPLETED|Overall Study||0
8338862|NCT01319539|20556548|P1|COMPLETED|Overall Study||12
8338863|NCT01319539|20556548|P1|STARTED|Overall Study||12
8338864|NCT01319500|20556558|P2|NOT COMPLETED|Overall Study||0
8338865|NCT01319500|20556559|P1|NOT COMPLETED|Overall Study||0
8338866|NCT01319500|20556558|P2|COMPLETED|Overall Study||2589
8338867|NCT01319500|20556559|P1|COMPLETED|Overall Study||1187
8338868|NCT01319500|20556558|P2|STARTED|Overall Study||2589
8338869|NCT01319500|20556559|P1|STARTED|Overall Study||1187
8338870|NCT01319422|20556578|P2|NOT COMPLETED|Overall Study||0
8338871|NCT01319422|20556579|P1|NOT COMPLETED|Overall Study||1
8338872|NCT01319422|20556578|P2|COMPLETED|Overall Study||20
8338873|NCT01319422|20556579|P1|COMPLETED|Overall Study||19
8338874|NCT01319422|20556578|P2|STARTED|Overall Study||20
8338875|NCT01319422|20556579|P1|STARTED|Overall Study||20
8338879|NCT01319383|20556597|P2|NOT COMPLETED|Overall Study||10
8338880|NCT01319383|20556598|P1|NOT COMPLETED|Overall Study||12
8338881|NCT01319383|20556597|P2|COMPLETED|Overall Study||3
8338882|NCT01319383|20556598|P1|COMPLETED|Overall Study||0
8338883|NCT01319383|20556597|P2|Step 4|Overall Study|Only 3/6 completed the study.|3
8338884|NCT01319383|20556598|P1|Step 4|Overall Study|Arm 1 did not have a Step 4|0
8338885|NCT01319383|20556597|P2|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
8338886|NCT01319383|20556598|P1|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
8338887|NCT01319383|20556597|P2|Step 2|Overall Study||0
8338888|NCT01319383|20556598|P1|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
8338889|NCT01319383|20556597|P2|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
8338983|NCT01318512|20556885|P1|STARTED|Titration Period (4 Months)||340
8338890|NCT01319383|20556598|P1|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
8338891|NCT01319383|20556597|P2|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
8338892|NCT01319383|20556598|P1|Step 1|Overall Study||8
8338893|NCT01319383|20556597|P2|STARTED|Overall Study||13
8338894|NCT01319383|20556598|P1|STARTED|Overall Study||12
8338895|NCT01319318|20556615|P1|NOT COMPLETED|Overall Study||0
8338896|NCT01319318|20556615|P1|COMPLETED|Overall Study||25
8338897|NCT01319318|20556615|P1|STARTED|Overall Study||25
8338898|NCT01319110|20556621|P2|NOT COMPLETED|Overall Study||0
8338899|NCT01319110|20556622|P1|NOT COMPLETED|Overall Study||0
8338900|NCT01319110|20556621|P2|COMPLETED|Overall Study||5
8338901|NCT01319110|20556622|P1|COMPLETED|Overall Study||5
8338902|NCT01319110|20556621|P2|STARTED|Overall Study||5
8338903|NCT01319110|20556622|P1|STARTED|Overall Study||5
8338904|NCT01319045|20556630|P1|NOT COMPLETED|Overall Study||2
8338905|NCT01319045|20556630|P1|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
8338906|NCT01319045|20556630|P1|STARTED|Overall Study||5
8338907|NCT01318993|20556637|P1|NOT COMPLETED|Overall Study||398
8338908|NCT01318993|20556637|P1|COMPLETED|Overall Study||0
8338909|NCT01318993|20556637|P1|STARTED|Overall Study||398
8338910|NCT01318967|20556653|P1|NOT COMPLETED|Overall Study||0
8338911|NCT01318967|20556653|P1|COMPLETED|Overall Study||10
8338912|NCT01318967|20556653|P1|STARTED|Overall Study||10
8338913|NCT01318915|20556658|P1|NOT COMPLETED|Overall Study||1
8338914|NCT01318915|20556658|P1|COMPLETED|Overall Study||9
8338915|NCT01318915|20556658|P1|STARTED|Overall Study||10
8338916|NCT01318902|20556687|P4|NOT COMPLETED|Overall Study||6
8338917|NCT01318902|20556688|P3|NOT COMPLETED|Overall Study||2
8338918|NCT01318902|20556689|P2|NOT COMPLETED|Overall Study||3
8338919|NCT01318902|20556690|P1|NOT COMPLETED|Overall Study||1
8338920|NCT01318902|20556687|P4|COMPLETED|Overall Study||5
8338921|NCT01318902|20556688|P3|COMPLETED|Overall Study||3
8338922|NCT01318902|20556689|P2|COMPLETED|Overall Study||2
8338923|NCT01318902|20556690|P1|COMPLETED|Overall Study||5
8338924|NCT01318902|20556687|P4|STARTED|Overall Study||11
8338925|NCT01318902|20556688|P3|STARTED|Overall Study||5
8338926|NCT01318902|20556689|P2|STARTED|Overall Study||5
8338927|NCT01318902|20556690|P1|STARTED|Overall Study||6
8338928|NCT01318876|20556767|P1|NOT COMPLETED|Day 29 Survey||1825
8338929|NCT01318876|20556767|P1|COMPLETED|Day 29 Survey||5724
8338930|NCT01318876|20556767|P1|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
8338931|NCT01318876|20556767|P1|NOT COMPLETED|Day 8 Survey||1820
8338932|NCT01318876|20556767|P1|COMPLETED|Day 8 Survey||5825
8338933|NCT01318876|20556767|P1|STARTED|Day 8 Survey||7645
8338934|NCT01318811|20556774|P2|NOT COMPLETED|Overall Study||4
8338935|NCT01318811|20556775|P1|NOT COMPLETED|Overall Study||1
8338936|NCT01318811|20556774|P2|COMPLETED|Overall Study||4
8338937|NCT01318811|20556775|P1|COMPLETED|Overall Study||3
8338938|NCT01318811|20556774|P2|STARTED|Overall Study||8
8338939|NCT01318811|20556775|P1|STARTED|Overall Study||4
8338943|NCT01318694|20556791|P4|NOT COMPLETED|Overall Study||68
8338944|NCT01318694|20556792|P3|NOT COMPLETED|Overall Study||43
8338945|NCT01318694|20556793|P2|NOT COMPLETED|Overall Study||58
8338946|NCT01318694|20556794|P1|NOT COMPLETED|Overall Study||52
8338947|NCT01318694|20556791|P4|COMPLETED|Overall Study||200
8338948|NCT01318694|20556792|P3|COMPLETED|Overall Study||225
8338949|NCT01318694|20556793|P2|COMPLETED|Overall Study||212
8338950|NCT01318694|20556794|P1|COMPLETED|Overall Study||223
8338951|NCT01318694|20556791|P4|Safety Set|Overall Study||265
8338952|NCT01318694|20556792|P3|Safety Set|Overall Study||265
8338953|NCT01318694|20556793|P2|Safety Set|Overall Study||268
8338954|NCT01318694|20556794|P1|Safety Set|Overall Study||273
8338955|NCT01318694|20556791|P4|Full Analysis Set|Overall Study||268
8338956|NCT01318694|20556792|P3|Full Analysis Set|Overall Study||265
8338957|NCT01318694|20556793|P2|Full Analysis Set|Overall Study||270
8338958|NCT01318694|20556794|P1|Full Analysis Set|Overall Study||274
8338959|NCT01318694|20556791|P4|STARTED|Overall Study||268
8338960|NCT01318694|20556792|P3|STARTED|Overall Study||268
8338961|NCT01318694|20556793|P2|STARTED|Overall Study||270
8338962|NCT01318694|20556794|P1|STARTED|Overall Study||275
8338963|NCT01318577|20556850|P2|NOT COMPLETED|Overall Study||8
8338964|NCT01318577|20556851|P1|NOT COMPLETED|Overall Study||13
8338965|NCT01318577|20556850|P2|COMPLETED|Overall Study||212
8338966|NCT01318577|20556851|P1|COMPLETED|Overall Study||211
8338967|NCT01318577|20556850|P2|STARTED|Overall Study||220
8338968|NCT01318577|20556851|P1|STARTED|Overall Study||224
8338969|NCT01318538|20556859|P3|NOT COMPLETED|Overall Study||0
8338970|NCT01318538|20556860|P2|NOT COMPLETED|Overall Study||0
8338971|NCT01318538|20556861|P1|NOT COMPLETED|Overall Study||0
8338972|NCT01318538|20556859|P3|COMPLETED|Overall Study||8
8338973|NCT01318538|20556860|P2|COMPLETED|Overall Study||106
8338974|NCT01318538|20556861|P1|COMPLETED|Overall Study||52
8338975|NCT01318538|20556859|P3|STARTED|Overall Study||8
8338976|NCT01318538|20556860|P2|STARTED|Overall Study||106
8338977|NCT01318538|20556861|P1|STARTED|Overall Study||52
8338978|NCT01318512|20556885|P1|NOT COMPLETED|Maintenance Period (6 Months)||11
8338979|NCT01318512|20556885|P1|COMPLETED|Maintenance Period (6 Months)||329
8338980|NCT01318512|20556885|P1|STARTED|Maintenance Period (6 Months)||340
8338981|NCT01318512|20556885|P1|NOT COMPLETED|Titration Period (4 Months)||0
8338982|NCT01318512|20556885|P1|COMPLETED|Titration Period (4 Months)||340
8338984|NCT01318499|20556904|P3|NOT COMPLETED|Overall Study||147
8338985|NCT01318499|20556905|P2|NOT COMPLETED|Overall Study||76
8338986|NCT01318499|20556906|P1|NOT COMPLETED|Overall Study||65
8338987|NCT01318499|20556904|P3|COMPLETED|Overall Study||121
8338988|NCT01318499|20556905|P2|COMPLETED|Overall Study||458
8338989|NCT01318499|20556906|P1|COMPLETED|Overall Study||475
8338990|NCT01318499|20556904|P3|STARTED|Overall Study||268
8338991|NCT01318499|20556905|P2|STARTED|Overall Study||534
8338992|NCT01318499|20556906|P1|STARTED|Overall Study||540
8338993|NCT01318408|20556924|P1|NOT COMPLETED|Overall Study||8
8338994|NCT01318408|20556924|P1|COMPLETED|Overall Study||16
8338995|NCT01318408|20556924|P1|STARTED|Overall Study||24
8338996|NCT01318382|20556929|P1|NOT COMPLETED|Overall Study||13
8338997|NCT01318382|20556929|P1|COMPLETED|Overall Study||289
8338998|NCT01318382|20556929|P1|STARTED|Overall Study||302
8338999|NCT01318278|20556939|P3|NOT COMPLETED|Overall Study||0
8339000|NCT01318278|20556940|P2|NOT COMPLETED|Overall Study||0
8339001|NCT01318278|20556941|P1|NOT COMPLETED|Overall Study||0
8339002|NCT01318278|20556939|P3|COMPLETED|Overall Study||50
8339003|NCT01318278|20556940|P2|COMPLETED|Overall Study||10
8339004|NCT01318278|20556941|P1|COMPLETED|Overall Study||10
8339005|NCT01318278|20556939|P3|STARTED|Overall Study||50
8339006|NCT01318278|20556940|P2|STARTED|Overall Study||10
8339007|NCT01318278|20556941|P1|STARTED|Overall Study||10
8339008|NCT01318135|20556987|P8|NOT COMPLETED|Entered - Long-Term Extension Study||3
8339009|NCT01318135|20556988|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
8339010|NCT01318135|20556989|P6|NOT COMPLETED|Entered - Long-Term Extension Study||4
8339011|NCT01318135|20556990|P5|NOT COMPLETED|Entered - Long-Term Extension Study||9
8339012|NCT01318135|20556991|P4|NOT COMPLETED|Entered - Long-Term Extension Study||7
8339013|NCT01318135|20556992|P3|NOT COMPLETED|Entered - Long-Term Extension Study||8
8339014|NCT01318135|20556993|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
8339015|NCT01318135|20556994|P1|NOT COMPLETED|Entered - Long-Term Extension Study||17
8339016|NCT01318135|20556987|P8|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
8339017|NCT01318135|20556988|P7|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
8339018|NCT01318135|20556989|P6|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
8339019|NCT01318135|20556990|P5|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
8339020|NCT01318135|20556991|P4|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
8339021|NCT01318135|20556992|P3|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
8339022|NCT01318135|20556993|P2|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
8339023|NCT01318135|20556994|P1|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
8339024|NCT01318135|20556987|P8|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
8339025|NCT01318135|20556988|P7|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
8339026|NCT01318135|20556989|P6|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
8339027|NCT01318135|20556990|P5|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
8339028|NCT01318135|20556991|P4|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
8339029|NCT01318135|20556992|P3|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
8339030|NCT01318135|20556993|P2|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
8339031|NCT01318135|20556994|P1|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
8339032|NCT01318135|20556987|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339033|NCT01318135|20556988|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339034|NCT01318135|20556989|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339035|NCT01318135|20556990|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339036|NCT01318135|20556991|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339037|NCT01318135|20556992|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339038|NCT01318135|20556993|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339039|NCT01318135|20556994|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
8339040|NCT01318135|20556987|P8|COMPLETED|Enrolled - Long-Term Extension Study||49
8339041|NCT01318135|20556988|P7|COMPLETED|Enrolled - Long-Term Extension Study||50
8339042|NCT01318135|20556989|P6|COMPLETED|Enrolled - Long-Term Extension Study||90
8339043|NCT01318135|20556990|P5|COMPLETED|Enrolled - Long-Term Extension Study||91
8339044|NCT01318135|20556991|P4|COMPLETED|Enrolled - Long-Term Extension Study||49
8339045|NCT01318135|20556992|P3|COMPLETED|Enrolled - Long-Term Extension Study||46
8339046|NCT01318135|20556993|P2|COMPLETED|Enrolled - Long-Term Extension Study||102
8339047|NCT01318135|20556994|P1|COMPLETED|Enrolled - Long-Term Extension Study||97
8339048|NCT01318135|20556987|P8|STARTED|Enrolled - Long-Term Extension Study||49
8339049|NCT01318135|20556988|P7|STARTED|Enrolled - Long-Term Extension Study||50
8339050|NCT01318135|20556989|P6|STARTED|Enrolled - Long-Term Extension Study||90
8339051|NCT01318135|20556990|P5|STARTED|Enrolled - Long-Term Extension Study||91
8339052|NCT01318135|20556991|P4|STARTED|Enrolled - Long-Term Extension Study||49
8339053|NCT01318135|20556992|P3|STARTED|Enrolled - Long-Term Extension Study||46
8339054|NCT01318135|20556993|P2|STARTED|Enrolled - Long-Term Extension Study||102
8339055|NCT01318135|20556994|P1|STARTED|Enrolled - Long-Term Extension Study||99
8339056|NCT01318122|20557126|P4|NOT COMPLETED|Entered - Long-Term Extension Study||4
8339057|NCT01318122|20557127|P3|NOT COMPLETED|Entered - Long-Term Extension Study||6
8339058|NCT01318122|20557128|P2|NOT COMPLETED|Entered - Long-Term Extension Study||11
8339059|NCT01318122|20557129|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
8339060|NCT01318122|20557126|P4|COMPLETED|Entered - Long-Term Extension Study||48
8339061|NCT01318122|20557127|P3|COMPLETED|Entered - Long-Term Extension Study||49
8339062|NCT01318122|20557128|P2|COMPLETED|Entered - Long-Term Extension Study||99
8339063|NCT01318122|20557129|P1|COMPLETED|Entered - Long-Term Extension Study||96
8339064|NCT01318122|20557126|P4|STARTED|Entered - Long-Term Extension Study||52
8339065|NCT01318122|20557127|P3|STARTED|Entered - Long-Term Extension Study||55
8339066|NCT01318122|20557128|P2|STARTED|Entered - Long-Term Extension Study||110
8339067|NCT01318122|20557129|P1|STARTED|Entered - Long-Term Extension Study||105
8339068|NCT01318122|20557126|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
8339069|NCT01318122|20557127|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
8339070|NCT01318122|20557128|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8339071|NCT01318122|20557129|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
8339072|NCT01318122|20557126|P4|COMPLETED|Enrolled - Long-Term Extension Study||52
8339073|NCT01318122|20557127|P3|COMPLETED|Enrolled - Long-Term Extension Study||55
8339074|NCT01318122|20557128|P2|COMPLETED|Enrolled - Long-Term Extension Study||110
8339075|NCT01318122|20557129|P1|COMPLETED|Enrolled - Long-Term Extension Study||105
8339076|NCT01318122|20557126|P4|STARTED|Enrolled - Long-Term Extension Study||53
8339077|NCT01318122|20557127|P3|STARTED|Enrolled - Long-Term Extension Study||57
8339078|NCT01318122|20557128|P2|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
8339079|NCT01318122|20557129|P1|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
8339080|NCT01318109|20557198|P3|NOT COMPLETED|Overall Study||0
8339081|NCT01318109|20557199|P2|NOT COMPLETED|Overall Study||3
8339082|NCT01318109|20557200|P1|NOT COMPLETED|Overall Study||1
8339083|NCT01318109|20557198|P3|COMPLETED|Overall Study||100
8339084|NCT01318109|20557199|P2|COMPLETED|Overall Study||93
8339085|NCT01318109|20557200|P1|COMPLETED|Overall Study||91
8339086|NCT01318109|20557198|P3|STARTED|Overall Study||100
8339087|NCT01318109|20557199|P2|STARTED|Overall Study||96
8339088|NCT01318109|20557200|P1|STARTED|Overall Study||92
8339089|NCT01318083|20557235|P3|NOT COMPLETED|Overall Study||5
8339090|NCT01318083|20557236|P2|NOT COMPLETED|Overall Study||2
8339091|NCT01318083|20557237|P1|NOT COMPLETED|Overall Study||6
8339092|NCT01318083|20557235|P3|COMPLETED|Overall Study||98
8339093|NCT01318083|20557236|P2|COMPLETED|Overall Study||102
8339094|NCT01318083|20557237|P1|COMPLETED|Overall Study||99
8339095|NCT01318083|20557235|P3|STARTED|Overall Study||103
8339096|NCT01318083|20557236|P2|STARTED|Overall Study||104
8339097|NCT01318083|20557237|P1|STARTED|Overall Study||105
8339098|NCT01318070|20557272|P3|NOT COMPLETED|Overall Study||7
8339099|NCT01318070|20557273|P2|NOT COMPLETED|Overall Study||2
8339100|NCT01318070|20557274|P1|NOT COMPLETED|Overall Study||2
8339101|NCT01318070|20557272|P3|COMPLETED|Overall Study||108
8339102|NCT01318070|20557273|P2|COMPLETED|Overall Study||111
8339103|NCT01318070|20557274|P1|COMPLETED|Overall Study||109
8339104|NCT01318070|20557272|P3|STARTED|Overall Study||115
8339105|NCT01318070|20557273|P2|STARTED|Overall Study||113
8339106|NCT01318070|20557274|P1|STARTED|Overall Study||111
8339107|NCT01318018|20557308|P2|NOT COMPLETED|Overall Study||0
8339108|NCT01318018|20557309|P1|NOT COMPLETED|Overall Study||0
8339109|NCT01318018|20557308|P2|COMPLETED|Overall Study||10
8339110|NCT01318018|20557309|P1|COMPLETED|Overall Study||10
8339111|NCT01318018|20557308|P2|STARTED|Overall Study||10
8339112|NCT01318018|20557309|P1|STARTED|Overall Study||10
8339113|NCT01317940|20557321|P6|NOT COMPLETED|Overall Study||0
8339114|NCT01317940|20557322|P5|NOT COMPLETED|Overall Study||1
8339115|NCT01317940|20557323|P4|NOT COMPLETED|Overall Study||1
8339116|NCT01317940|20557324|P3|NOT COMPLETED|Overall Study||5
8339117|NCT01317940|20557325|P2|NOT COMPLETED|Overall Study||0
8339118|NCT01317940|20557326|P1|NOT COMPLETED|Overall Study||1
8339119|NCT01317940|20557321|P6|COMPLETED|Overall Study||4
8339120|NCT01317940|20557322|P5|COMPLETED|Overall Study||12
8339121|NCT01317940|20557323|P4|COMPLETED|Overall Study||5
8339122|NCT01317940|20557324|P3|COMPLETED|Overall Study||15
8339123|NCT01317940|20557325|P2|COMPLETED|Overall Study||10
8339124|NCT01317940|20557326|P1|COMPLETED|Overall Study||18
8339125|NCT01317940|20557321|P6|STARTED|Overall Study||4
8339126|NCT01317940|20557322|P5|STARTED|Overall Study||13
8339127|NCT01317940|20557323|P4|STARTED|Overall Study||6
8339128|NCT01317940|20557324|P3|STARTED|Overall Study||20
8339129|NCT01317940|20557325|P2|STARTED|Overall Study||10
8339130|NCT01317940|20557326|P1|STARTED|Overall Study||19
8339131|NCT01317901|20557347|P2|NOT COMPLETED|Overall Study||0
8339132|NCT01317901|20557348|P1|NOT COMPLETED|Overall Study||0
8339133|NCT01317901|20557347|P2|COMPLETED|Overall Study||6
8339134|NCT01317901|20557348|P1|COMPLETED|Overall Study||6
8339135|NCT01317901|20557347|P2|STARTED|Overall Study||6
8339136|NCT01317901|20557348|P1|STARTED|Overall Study||6
8339137|NCT01317797|20557357|P3|NOT COMPLETED|Overall Study||1
8339138|NCT01317797|20557358|P2|NOT COMPLETED|Overall Study||1
8339139|NCT01317797|20557359|P1|NOT COMPLETED|Overall Study||0
8339140|NCT01317797|20557357|P3|COMPLETED|Overall Study||8
8339141|NCT01317797|20557358|P2|COMPLETED|Overall Study||6
8339142|NCT01317797|20557359|P1|COMPLETED|Overall Study||8
8339143|NCT01317797|20557357|P3|STARTED|Overall Study||9
8339144|NCT01317797|20557358|P2|STARTED|Overall Study||7
8339145|NCT01317797|20557359|P1|STARTED|Overall Study||8
8339146|NCT01317667|20557414|P3|NOT COMPLETED|Overall Study||0
8339147|NCT01317667|20557415|P2|NOT COMPLETED|Overall Study||0
8339148|NCT01317667|20557416|P1|NOT COMPLETED|Overall Study||0
8339149|NCT01317667|20557414|P3|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
8339150|NCT01317667|20557415|P2|COMPLETED|Overall Study||10
8339151|NCT01317667|20557416|P1|COMPLETED|Overall Study||10
8339152|NCT01317667|20557414|P3|STARTED|Overall Study||10
8339153|NCT01317667|20557415|P2|STARTED|Overall Study||10
8339154|NCT01317667|20557416|P1|STARTED|Overall Study||10
8339155|NCT01317641|20557436|P9|NOT COMPLETED|Overall Study||5
8339156|NCT01317641|20557437|P8|NOT COMPLETED|Overall Study||5
8339157|NCT01317641|20557438|P7|NOT COMPLETED|Overall Study||3
8339158|NCT01317641|20557439|P6|NOT COMPLETED|Overall Study||0
8339159|NCT01317641|20557440|P5|NOT COMPLETED|Overall Study||0
8339160|NCT01317641|20557441|P4|NOT COMPLETED|Overall Study||1
8339161|NCT01317641|20557442|P3|NOT COMPLETED|Overall Study||0
8339162|NCT01317641|20557443|P2|NOT COMPLETED|Overall Study||1
8339163|NCT01317641|20557444|P1|NOT COMPLETED|Overall Study||1
8339164|NCT01317641|20557436|P9|COMPLETED|Overall Study||31
8339165|NCT01317641|20557437|P8|COMPLETED|Overall Study||33
8339166|NCT01317641|20557438|P7|COMPLETED|Overall Study||35
8339167|NCT01317641|20557439|P6|COMPLETED|Overall Study||3
8339168|NCT01317641|20557440|P5|COMPLETED|Overall Study||3
8339169|NCT01317641|20557441|P4|COMPLETED|Overall Study||3
8339170|NCT01317641|20557442|P3|COMPLETED|Overall Study||3
8339171|NCT01317641|20557443|P2|COMPLETED|Overall Study||6
8339172|NCT01317641|20557444|P1|COMPLETED|Overall Study||3
8339173|NCT01317641|20557436|P9|STARTED|Overall Study||36
8339174|NCT01317641|20557437|P8|STARTED|Overall Study||38
8339175|NCT01317641|20557438|P7|STARTED|Overall Study||38
8339176|NCT01317641|20557439|P6|STARTED|Overall Study||3
8339177|NCT01317641|20557440|P5|STARTED|Overall Study||3
8339178|NCT01317641|20557441|P4|STARTED|Overall Study||4
8339179|NCT01317641|20557442|P3|STARTED|Overall Study||3
8339180|NCT01317641|20557443|P2|STARTED|Overall Study||7
8339181|NCT01317641|20557444|P1|STARTED|Overall Study||4
8339182|NCT01317615|20557546|P1|NOT COMPLETED|Overall Study||49
8339183|NCT01317615|20557546|P1|COMPLETED|Overall Study||0
8339184|NCT01317615|20557546|P1|STARTED|Overall Study||49
8339185|NCT01317550|20557559|P4|NOT COMPLETED|Overall Study||0
8339186|NCT01317550|20557560|P3|NOT COMPLETED|Overall Study||0
8339187|NCT01317550|20557561|P2|NOT COMPLETED|Overall Study||0
8339188|NCT01317550|20557562|P1|NOT COMPLETED|Overall Study||2
8339189|NCT01317550|20557559|P4|COMPLETED|Overall Study||3
8339190|NCT01317550|20557560|P3|COMPLETED|Overall Study||3
8339191|NCT01317550|20557561|P2|COMPLETED|Overall Study||3
8339192|NCT01317550|20557562|P1|COMPLETED|Overall Study||3
8339193|NCT01317550|20557559|P4|STARTED|Overall Study||3
8339194|NCT01317550|20557560|P3|STARTED|Overall Study||3
8339195|NCT01317550|20557561|P2|STARTED|Overall Study||3
8339196|NCT01317550|20557562|P1|STARTED|Overall Study||5
8339197|NCT01317472|20557574|P2|NOT COMPLETED|Overall Study||0
8339198|NCT01317472|20557575|P1|NOT COMPLETED|Overall Study||2
8339199|NCT01317472|20557574|P2|COMPLETED|Overall Study||2
8339200|NCT01317472|20557575|P1|COMPLETED|Overall Study||7
8339201|NCT01317472|20557574|P2|STARTED|Overall Study||2
8339202|NCT01317472|20557575|P1|STARTED|Overall Study||9
8339255|NCT01317095|20557628|P2|NOT COMPLETED|Overall Study||0
8339256|NCT01317095|20557629|P1|NOT COMPLETED|Overall Study||0
8339257|NCT01317095|20557628|P2|COMPLETED|Overall Study||41
8339258|NCT01317095|20557629|P1|COMPLETED|Overall Study||39
8339259|NCT01317095|20557628|P2|STARTED|Overall Study||41
8339260|NCT01317095|20557629|P1|STARTED|Overall Study||39
8339261|NCT01317030|20557643|P2|NOT COMPLETED|Overall Study||0
8339262|NCT01317030|20557644|P1|NOT COMPLETED|Overall Study||0
8339263|NCT01317030|20557643|P2|COMPLETED|Overall Study||13
8339264|NCT01317030|20557644|P1|COMPLETED|Overall Study||12
8339265|NCT01317030|20557643|P2|STARTED|Overall Study||13
8339266|NCT01317030|20557644|P1|STARTED|Overall Study||12
8339267|NCT01317004|20557652|P2|NOT COMPLETED|Overall Study||9
8339268|NCT01317004|20557653|P1|NOT COMPLETED|Overall Study||4
8339269|NCT01317004|20557652|P2|COMPLETED|Overall Study||5
8339270|NCT01317004|20557653|P1|COMPLETED|Overall Study||47
8339271|NCT01317004|20557652|P2|Safety Set|Overall Study||11
8339272|NCT01317004|20557653|P1|Safety Set|Overall Study||50
8339273|NCT01317004|20557652|P2|STARTED|Overall Study||14
8339274|NCT01317004|20557653|P1|STARTED|Overall Study||51
8339275|NCT01316939|20557674|P3|NOT COMPLETED|Overall Study||69
8339276|NCT01316939|20557675|P2|NOT COMPLETED|Overall Study||68
8339277|NCT01316939|20557676|P1|NOT COMPLETED|Overall Study||63
8339278|NCT01316939|20557674|P3|COMPLETED|Overall Study||7
8339279|NCT01316939|20557675|P2|COMPLETED|Overall Study||9
8339280|NCT01316939|20557676|P1|COMPLETED|Overall Study||13
8339281|NCT01316939|20557674|P3|STARTED|Overall Study||76
8339282|NCT01316939|20557675|P2|STARTED|Overall Study||77
8339283|NCT01316939|20557676|P1|STARTED|Overall Study||76
8339284|NCT01316926|20557756|P2|NOT COMPLETED|Period 2||0
8339285|NCT01316926|20557757|P1|NOT COMPLETED|Period 2||0
8339286|NCT01316926|20557756|P2|COMPLETED|Period 2||30
8339287|NCT01316926|20557757|P1|COMPLETED|Period 2||29
8339288|NCT01316926|20557756|P2|STARTED|Period 2||30
8339289|NCT01316926|20557757|P1|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
8339290|NCT01316926|20557756|P2|NOT COMPLETED|Period 1||0
8339291|NCT01316926|20557757|P1|NOT COMPLETED|Period 1||0
8339292|NCT01316926|20557756|P2|COMPLETED|Period 1||30
8339293|NCT01316926|20557757|P1|COMPLETED|Period 1||30
8339294|NCT01316926|20557756|P2|STARTED|Period 1||30
8339295|NCT01316926|20557757|P1|STARTED|Period 1||30
8339296|NCT01316913|20557771|P4|NOT COMPLETED|Overall Study||39
8339297|NCT01316913|20557772|P3|NOT COMPLETED|Overall Study||49
8339298|NCT01316913|20557773|P2|NOT COMPLETED|Overall Study||54
8339299|NCT01316913|20557774|P1|NOT COMPLETED|Overall Study||57
8339300|NCT01316913|20557771|P4|COMPLETED|Overall Study||176
8339301|NCT01316913|20557772|P3|COMPLETED|Overall Study||166
8339302|NCT01316913|20557773|P2|COMPLETED|Overall Study||163
8339303|NCT01316913|20557774|P1|COMPLETED|Overall Study||165
8339304|NCT01316913|20557771|P4|STARTED|Overall Study||215
8339305|NCT01316913|20557772|P3|STARTED|Overall Study||215
8339306|NCT01316913|20557773|P2|STARTED|Overall Study||217
8339307|NCT01316913|20557774|P1|STARTED|Overall Study||222
8339308|NCT01316900|20557796|P4|NOT COMPLETED|Overall Study||31
8339309|NCT01316900|20557797|P3|NOT COMPLETED|Overall Study||41
8339310|NCT01316900|20557798|P2|NOT COMPLETED|Overall Study||31
8339311|NCT01316900|20557799|P1|NOT COMPLETED|Overall Study||44
8339312|NCT01316900|20557796|P4|COMPLETED|Overall Study||177
8339313|NCT01316900|20557797|P3|COMPLETED|Overall Study||173
8339314|NCT01316900|20557798|P2|COMPLETED|Overall Study||181
8339315|NCT01316900|20557799|P1|COMPLETED|Overall Study||165
8339316|NCT01316900|20557796|P4|STARTED|Overall Study||208
8339317|NCT01316900|20557797|P3|STARTED|Overall Study||214
8339318|NCT01316900|20557798|P2|STARTED|Overall Study||212
8339319|NCT01316900|20557799|P1|STARTED|Overall Study||209
8339320|NCT01316887|20557820|P3|NOT COMPLETED|Overall Study||83
8339321|NCT01316887|20557821|P2|NOT COMPLETED|Overall Study||94
8339322|NCT01316887|20557822|P1|NOT COMPLETED|Overall Study||43
8339323|NCT01316887|20557820|P3|COMPLETED|Overall Study||143
8339324|NCT01316887|20557821|P2|COMPLETED|Overall Study||133
8339325|NCT01316887|20557822|P1|COMPLETED|Overall Study||66
8339326|NCT01316887|20557820|P3|STARTED|Overall Study||226
8339327|NCT01316887|20557821|P2|STARTED|Overall Study||227
8339328|NCT01316887|20557822|P1|STARTED|Overall Study||109
8339329|NCT01316770|20557884|P2|NOT COMPLETED|Overall Study||0
8339330|NCT01316770|20557885|P1|NOT COMPLETED|Overall Study||0
8339331|NCT01316770|20557884|P2|COMPLETED|Overall Study||9
8339332|NCT01316770|20557885|P1|COMPLETED|Overall Study||9
8339333|NCT01316770|20557884|P2|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
8339334|NCT01316770|20557885|P1|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
8339335|NCT01316692|20557947|P1|NOT COMPLETED|Overall Study||12
8339336|NCT01316692|20557947|P1|COMPLETED|Overall Study||0
8339337|NCT01316692|20557947|P1|STARTED|Overall Study||12
8339338|NCT01316614|20557956|P1|NOT COMPLETED|Overall Study||37
8339339|NCT01316614|20557956|P1|COMPLETED|Overall Study||100
8339340|NCT01316614|20557956|P1|STARTED|Overall Study||137
8339341|NCT01316575|20557973|P2|NOT COMPLETED|Overall Study||1
8339342|NCT01316575|20557974|P1|NOT COMPLETED|Overall Study||2
8339343|NCT01316575|20557973|P2|COMPLETED|Overall Study||19
8339344|NCT01316575|20557974|P1|COMPLETED|Overall Study||18
8339345|NCT01316575|20557973|P2|STARTED|Overall Study||20
8339346|NCT01316575|20557974|P1|STARTED|Overall Study||20
8339347|NCT01316510|20557988|P2|NOT COMPLETED|Overall Study||0
8339348|NCT01316510|20557989|P1|NOT COMPLETED|Overall Study||0
8339349|NCT01316510|20557988|P2|COMPLETED|Overall Study||12
8339350|NCT01316510|20557989|P1|COMPLETED|Overall Study||12
8339351|NCT01316510|20557988|P2|STARTED|Overall Study||12
8339352|NCT01316510|20557989|P1|STARTED|Overall Study||12
8339353|NCT01316419|20557997|P1|NOT COMPLETED|Overall Study||265
8339354|NCT01316419|20557997|P1|COMPLETED|Overall Study||1824
8339355|NCT01316419|20557997|P1|STARTED|Overall Study||2089
8339356|NCT01316380|20558023|P3|NOT COMPLETED|Overall Study||3
8339357|NCT01316380|20558024|P2|NOT COMPLETED|Overall Study||5
8339358|NCT01316380|20558025|P1|NOT COMPLETED|Overall Study||2
8339359|NCT01316380|20558023|P3|COMPLETED|Overall Study||152
8339360|NCT01316380|20558024|P2|COMPLETED|Overall Study||149
8339361|NCT01316380|20558025|P1|COMPLETED|Overall Study||154
8339362|NCT01316380|20558023|P3|STARTED|Overall Study||155
8339363|NCT01316380|20558024|P2|STARTED|Overall Study||154
8339364|NCT01316380|20558025|P1|STARTED|Overall Study||156
8339365|NCT01316341|20558066|P3|NOT COMPLETED|Overall Study||0
8339366|NCT01316341|20558067|P2|NOT COMPLETED|Overall Study||0
8339367|NCT01316341|20558068|P1|NOT COMPLETED|Overall Study||0
8339368|NCT01316341|20558066|P3|COMPLETED|Overall Study||9
8339369|NCT01316341|20558067|P2|COMPLETED|Overall Study||9
8339370|NCT01316341|20558068|P1|COMPLETED|Overall Study||6
8339371|NCT01316341|20558066|P3|STARTED|Overall Study||9
8339372|NCT01316341|20558067|P2|STARTED|Overall Study||9
8339373|NCT01316341|20558068|P1|STARTED|Overall Study||6
8339374|NCT01316315|20558136|P2|NOT COMPLETED|Sequence 2||0
8339375|NCT01316315|20558137|P1|NOT COMPLETED|Sequence 2||0
8339376|NCT01316315|20558136|P2|COMPLETED|Sequence 2||7
8339377|NCT01316315|20558137|P1|COMPLETED|Sequence 2||7
8339378|NCT01316315|20558136|P2|STARTED|Sequence 2||7
8339379|NCT01316315|20558137|P1|STARTED|Sequence 2||7
8339380|NCT01316315|20558136|P2|NOT COMPLETED|Sequence 1||0
8339381|NCT01316315|20558137|P1|NOT COMPLETED|Sequence 1||0
8339382|NCT01316315|20558136|P2|COMPLETED|Sequence 1||7
8339383|NCT01316315|20558137|P1|COMPLETED|Sequence 1||7
8339384|NCT01316315|20558136|P2|STARTED|Sequence 1||7
8339385|NCT01316315|20558137|P1|STARTED|Sequence 1||7
8339386|NCT01316302|20558151|P2|NOT COMPLETED|Overall Study||11
8339387|NCT01316302|20558152|P1|NOT COMPLETED|Overall Study||10
8339388|NCT01316302|20558151|P2|COMPLETED|Overall Study||22
8339389|NCT01316302|20558152|P1|COMPLETED|Overall Study||20
8339390|NCT01316302|20558151|P2|STARTED|Overall Study||33
8339391|NCT01316302|20558152|P1|STARTED|Overall Study||30
8339392|NCT01316276|20558162|P1|NOT COMPLETED|Overall Study||67
8339393|NCT01316276|20558162|P1|COMPLETED|Overall Study||139
8339394|NCT01316276|20558162|P1|STARTED|Overall Study||206
8339395|NCT01316263|20558183|P2|NOT COMPLETED|Overall Study||0
8339396|NCT01316263|20558184|P1|NOT COMPLETED|Overall Study||0
8339397|NCT01316263|20558183|P2|COMPLETED|Overall Study||14
8339398|NCT01316263|20558184|P1|COMPLETED|Overall Study||7
8339399|NCT01316263|20558183|P2|Received Any Study Drug|Overall Study||14
8339400|NCT01316263|20558184|P1|Received Any Study Drug|Overall Study||7
8339401|NCT01316263|20558183|P2|STARTED|Overall Study||14
8339402|NCT01316263|20558184|P1|STARTED|Overall Study||7
8339403|NCT01316224|20558210|P1|NOT COMPLETED|Overall Study||10
8339404|NCT01316224|20558210|P1|COMPLETED|Overall Study||42
8339405|NCT01316224|20558210|P1|Completed Visit 4 to Rheumatologist|Overall Study||28
8339406|NCT01316224|20558210|P1|Completed Visit 4 to Dermatologist|Overall Study||42
8339407|NCT01316224|20558210|P1|Completed Visit 3 to Rheumatologist|Overall Study||39
8339408|NCT01316224|20558210|P1|Completed Visit 3 to Dermatologist|Overall Study||48
8339409|NCT01316224|20558210|P1|Completed Visit 2 to Dermatologist|Overall Study||51
8339410|NCT01316224|20558210|P1|Completed Visit 1 to Rheumatologist|Overall Study||49
8339411|NCT01316224|20558210|P1|Completed Visit 1 to Dermatologist|Overall Study||52
8339412|NCT01316224|20558210|P1|STARTED|Overall Study||52
8339413|NCT01316211|20558226|P2|NOT COMPLETED|Overall Study||12
8339414|NCT01316211|20558227|P1|NOT COMPLETED|Overall Study||11
8339415|NCT01316211|20558226|P2|COMPLETED|Overall Study||111
8339416|NCT01316211|20558227|P1|COMPLETED|Overall Study||105
8339417|NCT01316211|20558226|P2|STARTED|Overall Study||123
8339418|NCT01316211|20558227|P1|STARTED|Overall Study||116
8339419|NCT01316055|20558263|P3|NOT COMPLETED|Overall Study||0
8339420|NCT01316055|20558264|P2|NOT COMPLETED|Overall Study||0
8339421|NCT01316055|20558265|P1|NOT COMPLETED|Overall Study||1
8339422|NCT01316055|20558263|P3|COMPLETED|Overall Study||12
8339423|NCT01316055|20558264|P2|COMPLETED|Overall Study||17
8339424|NCT01316055|20558265|P1|COMPLETED|Overall Study||12
8339425|NCT01316055|20558263|P3|STARTED|Overall Study||12
8339426|NCT01316055|20558264|P2|STARTED|Overall Study||17
8339427|NCT01316055|20558265|P1|STARTED|Overall Study||13
8339428|NCT01316042|20558281|P2|NOT COMPLETED|Overall Study||1
8339429|NCT01316042|20558282|P1|NOT COMPLETED|Overall Study||0
8339430|NCT01316042|20558281|P2|COMPLETED|Overall Study||1
8339431|NCT01316042|20558282|P1|COMPLETED|Overall Study||2
8339432|NCT01316042|20558281|P2|STARTED|Overall Study||2
8339433|NCT01316042|20558282|P1|STARTED|Overall Study||2
8339434|NCT01315873|20558288|P1|NOT COMPLETED|Overall Study||0
8339435|NCT01315873|20558288|P1|COMPLETED|Overall Study||24
8339436|NCT01315873|20558288|P1|STARTED|Overall Study||24
8339437|NCT01315847|20558296|P2|NOT COMPLETED|Part III, Period 2||0
8339438|NCT01315847|20558297|P1|NOT COMPLETED|Part III, Period 2||0
8339439|NCT01315847|20558296|P2|COMPLETED|Part III, Period 2||3
8339440|NCT01315847|20558297|P1|COMPLETED|Part III, Period 2||0
8339441|NCT01315847|20558296|P2|Received [11C]MK-4232|Part III, Period 2||3
8339442|NCT01315847|20558297|P1|Received [11C]MK-4232|Part III, Period 2||0
8339443|NCT01315847|20558296|P2|Received Telcagepant|Part III, Period 2||3
8339444|NCT01315847|20558297|P1|Received Telcagepant|Part III, Period 2||0
8339445|NCT01315847|20558296|P2|STARTED|Part III, Period 2||3
8339446|NCT01315847|20558297|P1|STARTED|Part III, Period 2||0
8339447|NCT01315847|20558296|P2|NOT COMPLETED|Part III, Period 1||1
8339448|NCT01315847|20558297|P1|NOT COMPLETED|Part III, Period 1||0
8339449|NCT01315847|20558296|P2|COMPLETED|Part III, Period 1||3
8339450|NCT01315847|20558297|P1|COMPLETED|Part III, Period 1||0
8339451|NCT01315847|20558296|P2|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
8339452|NCT01315847|20558297|P1|Received [11C]MK-4232|Part III, Period 1||0
8339453|NCT01315847|20558296|P2|Received Telcagepant|Part III, Period 1||4
8339454|NCT01315847|20558297|P1|Received Telcagepant|Part III, Period 1||0
8339455|NCT01315847|20558296|P2|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
8339456|NCT01315847|20558297|P1|STARTED|Part III, Period 1||0
8339457|NCT01315847|20558296|P2|NOT COMPLETED|Part I, Period 2||0
8339458|NCT01315847|20558297|P1|NOT COMPLETED|Part I, Period 2||0
8339459|NCT01315847|20558296|P2|COMPLETED|Part I, Period 2||0
8339460|NCT01315847|20558297|P1|COMPLETED|Part I, Period 2||3
8339461|NCT01315847|20558296|P2|Received [11C]MK-4232|Part I, Period 2||0
8339462|NCT01315847|20558297|P1|Received [11C]MK-4232|Part I, Period 2||3
8339463|NCT01315847|20558296|P2|Received Telcagepant|Part I, Period 2||0
8339464|NCT01315847|20558297|P1|Received Telcagepant|Part I, Period 2||3
8339465|NCT01315847|20558296|P2|STARTED|Part I, Period 2||0
8339466|NCT01315847|20558297|P1|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
8339467|NCT01315847|20558296|P2|NOT COMPLETED|Part I, Period 1||0
8339468|NCT01315847|20558297|P1|NOT COMPLETED|Part I, Period 1||3
8339469|NCT01315847|20558296|P2|COMPLETED|Part I, Period 1||0
8339470|NCT01315847|20558297|P1|COMPLETED|Part I, Period 1||2
8339471|NCT01315847|20558296|P2|Received [11C]MK-4232|Part I, Period 1||0
8339472|NCT01315847|20558297|P1|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
8339473|NCT01315847|20558296|P2|Received Telcagepant|Part I, Period 1||0
8339474|NCT01315847|20558297|P1|Received Telcagepant|Part I, Period 1||5
8339475|NCT01315847|20558296|P2|STARTED|Part I, Period 1||0
8339476|NCT01315847|20558297|P1|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
8339477|NCT01315678|20558311|P2|NOT COMPLETED|Overall Study||6
8339478|NCT01315678|20558312|P1|NOT COMPLETED|Overall Study||14
8339479|NCT01315678|20558311|P2|COMPLETED|Overall Study||140
8339480|NCT01315678|20558312|P1|COMPLETED|Overall Study||134
8339481|NCT01315678|20558311|P2|STARTED|Overall Study||146
8339482|NCT01315678|20558312|P1|STARTED|Overall Study||148
8339483|NCT01315665|20558332|P2|NOT COMPLETED|Overall Study||0
8339484|NCT01315665|20558333|P1|NOT COMPLETED|Overall Study||0
8339485|NCT01315665|20558332|P2|COMPLETED|Overall Study||5
8339486|NCT01315665|20558333|P1|COMPLETED|Overall Study||10
8339487|NCT01315665|20558332|P2|STARTED|Overall Study||5
8339488|NCT01315665|20558333|P1|STARTED|Overall Study||10
8339489|NCT01315574|20558349|P2|NOT COMPLETED|Overall Study||0
8339490|NCT01315574|20558350|P1|NOT COMPLETED|Overall Study||0
8339491|NCT01315574|20558349|P2|COMPLETED|Overall Study||7
8339492|NCT01315574|20558350|P1|COMPLETED|Overall Study||7
8339493|NCT01315574|20558349|P2|STARTED|Overall Study||7
8339494|NCT01315574|20558350|P1|STARTED|Overall Study||7
8339495|NCT01315353|20558363|P3|NOT COMPLETED|Overall Study||13
8339496|NCT01315353|20558364|P2|NOT COMPLETED|Overall Study||23
8339497|NCT01315353|20558365|P1|NOT COMPLETED|Overall Study||29
8339498|NCT01315353|20558363|P3|COMPLETED|Overall Study||166
8339499|NCT01315353|20558364|P2|COMPLETED|Overall Study||120
8339500|NCT01315353|20558365|P1|COMPLETED|Overall Study||116
8339501|NCT01315353|20558363|P3|STARTED|Overall Study||179
8339502|NCT01315353|20558364|P2|STARTED|Overall Study||143
8339503|NCT01315353|20558365|P1|STARTED|Overall Study||145
8339504|NCT01315249|20558392|P2|NOT COMPLETED|Overall Study||47
8339505|NCT01315249|20558393|P1|NOT COMPLETED|Overall Study||44
8339506|NCT01315249|20558392|P2|COMPLETED|Overall Study||217
8339507|NCT01315249|20558393|P1|COMPLETED|Overall Study||215
8339508|NCT01315249|20558392|P2|STARTED|Overall Study||264
8339509|NCT01315249|20558393|P1|STARTED|Overall Study||259
8339510|NCT01315236|20558421|P2|NOT COMPLETED|12-Month Follow-up Period||1
8339511|NCT01315236|20558422|P1|NOT COMPLETED|12-Month Follow-up Period||1
8339512|NCT01315236|20558421|P2|COMPLETED|12-Month Follow-up Period||31
8339513|NCT01315236|20558422|P1|COMPLETED|12-Month Follow-up Period||26
8339514|NCT01315236|20558421|P2|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32
8339515|NCT01315236|20558422|P1|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27
8339516|NCT01315236|20558421|P2|NOT COMPLETED|Open-label Phase||2
8339517|NCT01315236|20558422|P1|NOT COMPLETED|Open-label Phase||1
8339518|NCT01315236|20558421|P2|COMPLETED|Open-label Phase||41
8339519|NCT01315236|20558422|P1|COMPLETED|Open-label Phase||34
8339520|NCT01315236|20558421|P2|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43
8339521|NCT01315236|20558422|P1|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35
8339522|NCT01315236|20558421|P2|NOT COMPLETED|Double-blind Phase||0
8339523|NCT01315236|20558422|P1|NOT COMPLETED|Double-blind Phase||4
8339524|NCT01315236|20558421|P2|COMPLETED|Double-blind Phase||45
8339525|NCT01315236|20558422|P1|COMPLETED|Double-blind Phase||40
8339526|NCT01315236|20558421|P2|STARTED|Double-blind Phase||45
8339527|NCT01315236|20558422|P1|STARTED|Double-blind Phase||44
8339528|NCT01315158|20558446|P2|NOT COMPLETED|Overall Study||0
8339529|NCT01315158|20558447|P1|NOT COMPLETED|Overall Study||0
8339530|NCT01315158|20558446|P2|COMPLETED|Overall Study||19
8339531|NCT01315158|20558447|P1|COMPLETED|Overall Study||17
8339532|NCT01315158|20558446|P2|STARTED|Overall Study||19
8339533|NCT01315158|20558447|P1|STARTED|Overall Study||17
8339534|NCT01315145|20558471|P2|NOT COMPLETED|Overall Study||5
8339535|NCT01315145|20558472|P1|NOT COMPLETED|Overall Study||17
8339536|NCT01315145|20558471|P2|COMPLETED|Overall Study||11
8339537|NCT01315145|20558472|P1|COMPLETED|Overall Study||105
8339538|NCT01315145|20558471|P2|STARTED|Overall Study||16
8339539|NCT01315145|20558472|P1|STARTED|Overall Study||122
8339540|NCT01315132|20558478|P1|NOT COMPLETED|Overall Study||1
8339541|NCT01315132|20558478|P1|COMPLETED|Overall Study||46
8339542|NCT01315132|20558478|P1|STARTED|Overall Study||47
8339543|NCT01315028|20558485|P2|NOT COMPLETED|Overall Study||1
8339544|NCT01315028|20558486|P1|NOT COMPLETED|Overall Study||1
8339545|NCT01315028|20558485|P2|COMPLETED|Overall Study||9
8339546|NCT01315028|20558486|P1|COMPLETED|Overall Study||9
8339547|NCT01315028|20558485|P2|STARTED|Overall Study||10
8339548|NCT01315028|20558486|P1|STARTED|Overall Study||10
8339549|NCT01315002|20558498|P2|NOT COMPLETED|Overall Study||5
8339550|NCT01315002|20558499|P1|NOT COMPLETED|Overall Study||5
8339551|NCT01315002|20558498|P2|COMPLETED|Overall Study||55
8339552|NCT01315002|20558499|P1|COMPLETED|Overall Study||56
8339553|NCT01315002|20558498|P2|STARTED|Overall Study||60
8339554|NCT01315002|20558499|P1|STARTED|Overall Study||61
8339555|NCT01314963|20558505|P1|NOT COMPLETED|Overall Study||0
8339556|NCT01314963|20558505|P1|COMPLETED|Overall Study||50
8339557|NCT01314963|20558505|P1|STARTED|Overall Study||50
8339558|NCT01314911|20558513|P2|NOT COMPLETED|Overall Study||6
8339559|NCT01314911|20558514|P1|NOT COMPLETED|Overall Study||5
8339560|NCT01314911|20558513|P2|COMPLETED|Overall Study||274
8339561|NCT01314911|20558514|P1|COMPLETED|Overall Study||273
8339562|NCT01314911|20558513|P2|STARTED|Overall Study||280
8339563|NCT01314911|20558514|P1|STARTED|Overall Study||278
8339564|NCT01314872|20558565|P15|NOT COMPLETED|Period 2||24
8339565|NCT01314872|20558566|P14|NOT COMPLETED|Period 2||53
8339566|NCT01314872|20558567|P13|NOT COMPLETED|Period 2||60
8339567|NCT01314872|20558568|P12|NOT COMPLETED|Period 2||48
8339568|NCT01314872|20558569|P11|NOT COMPLETED|Period 2||0
8339569|NCT01314872|20558570|P10|NOT COMPLETED|Period 2||0
8339570|NCT01314872|20558571|P9|NOT COMPLETED|Period 2||0
8339571|NCT01314872|20558572|P8|NOT COMPLETED|Period 2||0
8339572|NCT01314872|20558573|P7|NOT COMPLETED|Period 2||0
8339573|NCT01314872|20558574|P6|NOT COMPLETED|Period 2||0
8339574|NCT01314872|20558575|P5|NOT COMPLETED|Period 2||0
8339575|NCT01314872|20558576|P4|NOT COMPLETED|Period 2||0
8339576|NCT01314872|20558577|P3|NOT COMPLETED|Period 2||0
8339577|NCT01314872|20558578|P2|NOT COMPLETED|Period 2||0
8339578|NCT01314872|20558579|P1|NOT COMPLETED|Period 2||0
8339579|NCT01314872|20558565|P15|COMPLETED|Period 2||110
8339580|NCT01314872|20558566|P14|COMPLETED|Period 2||187
8339581|NCT01314872|20558567|P13|COMPLETED|Period 2||188
8339582|NCT01314872|20558568|P12|COMPLETED|Period 2||175
8339583|NCT01314872|20558569|P11|COMPLETED|Period 2||0
8339584|NCT01314872|20558570|P10|COMPLETED|Period 2||0
8339585|NCT01314872|20558571|P9|COMPLETED|Period 2||0
8339586|NCT01314872|20558572|P8|COMPLETED|Period 2||0
8339587|NCT01314872|20558573|P7|COMPLETED|Period 2||0
8339588|NCT01314872|20558574|P6|COMPLETED|Period 2||0
8339589|NCT01314872|20558575|P5|COMPLETED|Period 2||0
8339590|NCT01314872|20558576|P4|COMPLETED|Period 2||0
8339591|NCT01314872|20558577|P3|COMPLETED|Period 2||0
8339592|NCT01314872|20558578|P2|COMPLETED|Period 2||0
8339593|NCT01314872|20558579|P1|COMPLETED|Period 2||0
8339594|NCT01314872|20558565|P15|STARTED|Period 2||134
8339595|NCT01314872|20558566|P14|STARTED|Period 2||240
8339596|NCT01314872|20558567|P13|STARTED|Period 2||248
8339597|NCT01314872|20558568|P12|STARTED|Period 2||223
8339598|NCT01314872|20558569|P11|STARTED|Period 2||0
8339599|NCT01314872|20558570|P10|STARTED|Period 2||0
8339600|NCT01314872|20558571|P9|STARTED|Period 2||0
8339601|NCT01314872|20558572|P8|STARTED|Period 2||0
8339602|NCT01314872|20558573|P7|STARTED|Period 2||0
8339603|NCT01314872|20558574|P6|STARTED|Period 2||0
8339604|NCT01314872|20558575|P5|STARTED|Period 2||0
8339605|NCT01314872|20558576|P4|STARTED|Period 2||0
8339606|NCT01314872|20558577|P3|STARTED|Period 2||0
8339607|NCT01314872|20558578|P2|STARTED|Period 2||0
8339608|NCT01314872|20558579|P1|STARTED|Period 2||0
8339609|NCT01314872|20558565|P15|NOT COMPLETED|Treatment Period 1||0
8339610|NCT01314872|20558566|P14|NOT COMPLETED|Treatment Period 1||0
8339611|NCT01314872|20558567|P13|NOT COMPLETED|Treatment Period 1||0
8339612|NCT01314872|20558568|P12|NOT COMPLETED|Treatment Period 1||0
8339613|NCT01314872|20558569|P11|NOT COMPLETED|Treatment Period 1||3
8339614|NCT01314872|20558570|P10|NOT COMPLETED|Treatment Period 1||4
8339615|NCT01314872|20558571|P9|NOT COMPLETED|Treatment Period 1||6
8339616|NCT01314872|20558572|P8|NOT COMPLETED|Treatment Period 1||7
8339617|NCT01314872|20558573|P7|NOT COMPLETED|Treatment Period 1||8
8339618|NCT01314872|20558574|P6|NOT COMPLETED|Treatment Period 1||7
8339619|NCT01314872|20558575|P5|NOT COMPLETED|Treatment Period 1||7
8339620|NCT01314872|20558576|P4|NOT COMPLETED|Treatment Period 1||7
8339621|NCT01314872|20558577|P3|NOT COMPLETED|Treatment Period 1||6
8339622|NCT01314872|20558578|P2|NOT COMPLETED|Treatment Period 1||6
8339623|NCT01314872|20558579|P1|NOT COMPLETED|Treatment Period 1||10
8339624|NCT01314872|20558565|P15|COMPLETED|Treatment Period 1||0
8339625|NCT01314872|20558566|P14|COMPLETED|Treatment Period 1||0
8339626|NCT01314872|20558567|P13|COMPLETED|Treatment Period 1||0
8339627|NCT01314872|20558568|P12|COMPLETED|Treatment Period 1||0
8339628|NCT01314872|20558569|P11|COMPLETED|Treatment Period 1||107
8339629|NCT01314872|20558570|P10|COMPLETED|Treatment Period 1||118
8339630|NCT01314872|20558571|P9|COMPLETED|Treatment Period 1||106
8339631|NCT01314872|20558572|P8|COMPLETED|Treatment Period 1||57
8339632|NCT01314872|20558573|P7|COMPLETED|Treatment Period 1||126
8339633|NCT01314872|20558574|P6|COMPLETED|Treatment Period 1||128
8339634|NCT01314872|20558575|P5|COMPLETED|Treatment Period 1||142
8339635|NCT01314872|20558576|P4|COMPLETED|Treatment Period 1||143
8339636|NCT01314872|20558577|P3|COMPLETED|Treatment Period 1||128
8339637|NCT01314872|20558578|P2|COMPLETED|Treatment Period 1||138
8339638|NCT01314872|20558579|P1|COMPLETED|Treatment Period 1||131
8339639|NCT01314872|20558565|P15|STARTED|Treatment Period 1||0
8339640|NCT01314872|20558566|P14|STARTED|Treatment Period 1||0
8339641|NCT01314872|20558567|P13|STARTED|Treatment Period 1||0
8339642|NCT01314872|20558568|P12|STARTED|Treatment Period 1||0
8339643|NCT01314872|20558569|P11|STARTED|Treatment Period 1||110
8339644|NCT01314872|20558570|P10|STARTED|Treatment Period 1||122
8339645|NCT01314872|20558571|P9|STARTED|Treatment Period 1||112
8339646|NCT01314872|20558572|P8|STARTED|Treatment Period 1||64
8339647|NCT01314872|20558573|P7|STARTED|Treatment Period 1||134
8339648|NCT01314872|20558574|P6|STARTED|Treatment Period 1||135
8339649|NCT01314872|20558575|P5|STARTED|Treatment Period 1||149
8339650|NCT01314872|20558576|P4|STARTED|Treatment Period 1||150
8339651|NCT01314872|20558577|P3|STARTED|Treatment Period 1||134
8339652|NCT01314872|20558578|P2|STARTED|Treatment Period 1||144
8339653|NCT01314872|20558579|P1|STARTED|Treatment Period 1||141
8339654|NCT01314742|20558672|P2|NOT COMPLETED|Overall Study||0
8339655|NCT01314742|20558673|P1|NOT COMPLETED|Overall Study||0
8339656|NCT01314742|20558672|P2|COMPLETED|Overall Study||21
8339657|NCT01314742|20558673|P1|COMPLETED|Overall Study||20
8339658|NCT01314742|20558672|P2|STARTED|Overall Study||21
8339659|NCT01314742|20558673|P1|STARTED|Overall Study||20
8339660|NCT01314716|20558683|P2|NOT COMPLETED|Open-Label Phase||12
8339661|NCT01314716|20558684|P1|NOT COMPLETED|Open-Label Phase||10
8339662|NCT01314716|20558683|P2|COMPLETED|Open-Label Phase||98
8339663|NCT01314716|20558684|P1|COMPLETED|Open-Label Phase||102
8339664|NCT01314716|20558683|P2|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
8339665|NCT01314716|20558684|P1|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
8339666|NCT01314716|20558683|P2|NOT COMPLETED|Double-Blind Phase||15
8339667|NCT01314716|20558684|P1|NOT COMPLETED|Double-Blind Phase||17
8339668|NCT01314716|20558683|P2|COMPLETED|Double-Blind Phase||123
8339669|NCT01314716|20558684|P1|COMPLETED|Double-Blind Phase||119
8339670|NCT01314716|20558683|P2|Randomized and Treated|Double-Blind Phase||137
8339671|NCT01314716|20558684|P1|Randomized and Treated|Double-Blind Phase||135
8339672|NCT01314716|20558683|P2|STARTED|Double-Blind Phase||138
8339673|NCT01314716|20558684|P1|STARTED|Double-Blind Phase||136
8339674|NCT01314703|20558696|P1|NOT COMPLETED|Overall Study||8
8339675|NCT01314703|20558696|P1|COMPLETED|Overall Study||27
8339676|NCT01314703|20558696|P1|Discontinued When Enrollment Completed|Overall Study||3
8339677|NCT01314703|20558696|P1|Non Qualified Bacterial Screening Counts|Overall Study||3
8339678|NCT01314703|20558696|P1|Excluded Prior to Screening Baseline|Overall Study||2
8339679|NCT01314703|20558696|P1|Completed Study|Overall Study||27
8339680|NCT01314703|20558696|P1|Completed Treatment Visit|Overall Study||27
8339681|NCT01314703|20558696|P1|Completed Screen Visit|Overall Study||33
8339682|NCT01314703|20558696|P1|Signed Informed Consent|Overall Study||35
8339683|NCT01314703|20558696|P1|STARTED|Overall Study||35
8339684|NCT01314443|20558705|P4|NOT COMPLETED|Overall Study||2
8339685|NCT01314443|20558706|P3|NOT COMPLETED|Overall Study||2
8339686|NCT01314443|20558707|P2|NOT COMPLETED|Overall Study||3
8339687|NCT01314443|20558708|P1|NOT COMPLETED|Overall Study||4
8339688|NCT01314443|20558705|P4|COMPLETED|Overall Study||13
8339689|NCT01314443|20558706|P3|COMPLETED|Overall Study||13
8339690|NCT01314443|20558707|P2|COMPLETED|Overall Study||16
8339691|NCT01314443|20558708|P1|COMPLETED|Overall Study||14
8339692|NCT01314443|20558705|P4|STARTED|Overall Study||15
8339693|NCT01314443|20558706|P3|STARTED|Overall Study||15
8339694|NCT01314443|20558707|P2|STARTED|Overall Study||19
8339695|NCT01314443|20558708|P1|STARTED|Overall Study||18
8339696|NCT01314417|20558726|P1|NOT COMPLETED|Overall Study||0
8339697|NCT01314417|20558726|P1|COMPLETED|Overall Study||2
8339698|NCT01314417|20558726|P1|STARTED|Overall Study||2
8339699|NCT01314313|20558757|P2|NOT COMPLETED|Overall Study||311
8339700|NCT01314313|20558758|P1|NOT COMPLETED|Overall Study||227
8339701|NCT01314313|20558757|P2|COMPLETED|Overall Study||710
8339702|NCT01314313|20558758|P1|COMPLETED|Overall Study||784
8339703|NCT01314313|20558757|P2|Valve Implanted|Overall Study||936
8339704|NCT01314313|20558758|P1|Valve Implanted|Overall Study||974
8339705|NCT01314313|20558757|P2|As Treated|Overall Study||944
8339706|NCT01314313|20558758|P1|As Treated|Overall Study||994
8339707|NCT01314313|20558757|P2|STARTED|Overall Study||1021
8339708|NCT01314313|20558758|P1|STARTED|Overall Study||1011
8339709|NCT01314261|20558778|P4|NOT COMPLETED|Overall Study||3
8339710|NCT01314261|20558779|P3|NOT COMPLETED|Overall Study||3
8339711|NCT01314261|20558780|P2|NOT COMPLETED|Overall Study||4
8339712|NCT01314261|20558781|P1|NOT COMPLETED|Overall Study||2
8339713|NCT01314261|20558778|P4|COMPLETED|Overall Study||6
8339714|NCT01314261|20558779|P3|COMPLETED|Overall Study||7
8339715|NCT01314261|20558780|P2|COMPLETED|Overall Study||5
8339716|NCT01314261|20558781|P1|COMPLETED|Overall Study||7
8339717|NCT01314261|20558778|P4|Discontinued pegIFN/RBV|Overall Study||1
8339718|NCT01314261|20558779|P3|Discontinued pegIFN/RBV|Overall Study||5
8339719|NCT01314261|20558780|P2|Discontinued pegIFN/RBV|Overall Study||4
8339720|NCT01314261|20558781|P1|Discontinued pegIFN/RBV|Overall Study||1
8339721|NCT01314261|20558778|P4|Discontinued ABT-267 or Placebo|Overall Study||0
8339722|NCT01314261|20558779|P3|Discontinued ABT-267 or Placebo|Overall Study||1
8339723|NCT01314261|20558780|P2|Discontinued ABT-267 or Placebo|Overall Study||0
8339724|NCT01314261|20558781|P1|Discontinued ABT-267 or Placebo|Overall Study||1
8339725|NCT01314261|20558778|P4|STARTED|Overall Study||9
8339726|NCT01314261|20558779|P3|STARTED|Overall Study||10
8339727|NCT01314261|20558780|P2|STARTED|Overall Study||9
8339728|NCT01314261|20558781|P1|STARTED|Overall Study||9
8339732|NCT01314105|20558841|P2|NOT COMPLETED|Overall Study||12
8339733|NCT01314105|20558842|P1|NOT COMPLETED|Overall Study||7
8339734|NCT01314105|20558841|P2|COMPLETED|Overall Study||0
8339735|NCT01314105|20558842|P1|COMPLETED|Overall Study||0
8339736|NCT01314105|20558841|P2|STARTED|Overall Study||12
8339737|NCT01314105|20558842|P1|STARTED|Overall Study||7
8339738|NCT01314014|20558884|P1|NOT COMPLETED|Overall Study||0
8339739|NCT01314014|20558884|P1|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
8339740|NCT01314014|20558884|P1|STARTED|Overall Study||22
8339741|NCT01314001|20558895|P6|NOT COMPLETED|Overall Study||71
8339742|NCT01314001|20558896|P5|NOT COMPLETED|Overall Study||72
8339743|NCT01314001|20558897|P4|NOT COMPLETED|Overall Study||69
8339744|NCT01314001|20558898|P3|NOT COMPLETED|Overall Study||69
8339745|NCT01314001|20558899|P2|NOT COMPLETED|Overall Study||69
8339746|NCT01314001|20558900|P1|NOT COMPLETED|Overall Study||75
8339747|NCT01314001|20558895|P6|COMPLETED|Overall Study||129
8339748|NCT01314001|20558896|P5|COMPLETED|Overall Study||148
8339749|NCT01314001|20558897|P4|COMPLETED|Overall Study||122
8339750|NCT01314001|20558898|P3|COMPLETED|Overall Study||158
8339751|NCT01314001|20558899|P2|COMPLETED|Overall Study||124
8339752|NCT01314001|20558900|P1|COMPLETED|Overall Study||140
8339753|NCT01314001|20558895|P6|6-Month Follow Up Survey|Overall Study||139
8339754|NCT01314001|20558896|P5|6-Month Follow Up Survey|Overall Study||157
8339755|NCT01314001|20558897|P4|6-Month Follow Up Survey|Overall Study||135
8339756|NCT01314001|20558898|P3|6-Month Follow Up Survey|Overall Study||165
8339757|NCT01314001|20558899|P2|6-Month Follow Up Survey|Overall Study||137
8339758|NCT01314001|20558900|P1|6-Month Follow Up Survey|Overall Study||146
8339759|NCT01314001|20558895|P6|End-of-Treatment Visit|Overall Study||160
8339760|NCT01314001|20558896|P5|End-of-Treatment Visit|Overall Study||174
8339761|NCT01314001|20558897|P4|End-of-Treatment Visit|Overall Study||146
8339762|NCT01314001|20558898|P3|End-of-Treatment Visit|Overall Study||179
8339763|NCT01314001|20558899|P2|End-of-Treatment Visit|Overall Study||141
8339764|NCT01314001|20558900|P1|End-of-Treatment Visit|Overall Study||156
8339765|NCT01314001|20558895|P6|STARTED|Overall Study||200
8339766|NCT01314001|20558896|P5|STARTED|Overall Study||220
8339767|NCT01314001|20558897|P4|STARTED|Overall Study||191
8339768|NCT01314001|20558898|P3|STARTED|Overall Study||227
8339769|NCT01314001|20558899|P2|STARTED|Overall Study||193
8339770|NCT01314001|20558900|P1|STARTED|Overall Study||215
8339771|NCT01313936|20558946|P2|NOT COMPLETED|Overall Study||0
8339772|NCT01313936|20558947|P1|NOT COMPLETED|Overall Study||0
8339773|NCT01313936|20558946|P2|COMPLETED|Overall Study||26
8339774|NCT01313936|20558947|P1|COMPLETED|Overall Study||6
8339775|NCT01313936|20558946|P2|STARTED|Overall Study||26
8339776|NCT01313936|20558947|P1|STARTED|Overall Study||6
8339777|NCT01313923|20558960|P1|NOT COMPLETED|Overall Study||3
8339778|NCT01313923|20558960|P1|COMPLETED|Overall Study||0
8339779|NCT01313923|20558960|P1|STARTED|Overall Study||3
8339780|NCT01313910|20558964|P1|NOT COMPLETED|Overall Study||0
8339781|NCT01313910|20558964|P1|COMPLETED|Overall Study||8
8339782|NCT01313910|20558964|P1|STARTED|Overall Study||8
8339783|NCT01313897|20558972|P1|NOT COMPLETED|Overall Study||2
8339784|NCT01313897|20558972|P1|COMPLETED|Overall Study||8
8339785|NCT01313897|20558972|P1|STARTED|Overall Study||10
8339786|NCT01313884|20558976|P1|NOT COMPLETED|Overall Study||1
8339787|NCT01313884|20558976|P1|COMPLETED|Overall Study||2
8339788|NCT01313884|20558976|P1|STARTED|Overall Study||3
8339789|NCT01313858|20558984|P3|NOT COMPLETED|Overall Study||238
8339790|NCT01313858|20558985|P2|NOT COMPLETED|Overall Study||270
8339791|NCT01313858|20558986|P1|NOT COMPLETED|Overall Study||286
8339792|NCT01313858|20558984|P3|COMPLETED|Overall Study||305
8339793|NCT01313858|20558985|P2|COMPLETED|Overall Study||276
8339794|NCT01313858|20558986|P1|COMPLETED|Overall Study||238
8339795|NCT01313858|20558984|P3|STARTED|Overall Study||543
8339796|NCT01313858|20558985|P2|STARTED|Overall Study||546
8339797|NCT01313858|20558986|P1|STARTED|Overall Study||524
8339798|NCT01313780|20559009|P2|NOT COMPLETED|Overall Study||28
8339799|NCT01313780|20559010|P1|NOT COMPLETED|Overall Study||25
8339800|NCT01313780|20559009|P2|COMPLETED|Overall Study|PPS|31
8339801|NCT01313780|20559010|P1|COMPLETED|Overall Study|PPS|33
8339802|NCT01313780|20559009|P2|STARTED|Overall Study|FAS|59
8339803|NCT01313780|20559010|P1|STARTED|Overall Study|FAS|58
8339804|NCT01313767|20559020|P2|NOT COMPLETED|Overall Study||2
8339805|NCT01313767|20559021|P1|NOT COMPLETED|Overall Study||7
8339806|NCT01313767|20559020|P2|COMPLETED|Overall Study||96
8339807|NCT01313767|20559021|P1|COMPLETED|Overall Study||91
8339808|NCT01313767|20559020|P2|STARTED|Overall Study||98
8339809|NCT01313767|20559021|P1|STARTED|Overall Study||98
8339810|NCT01313728|20559063|P1|NOT COMPLETED|Baseline to Completion||0
8339811|NCT01313728|20559063|P1|COMPLETED|Baseline to Completion||25
8339812|NCT01313728|20559063|P1|STARTED|Baseline to Completion||25
8339813|NCT01313728|20559063|P1|NOT COMPLETED|Informed Consent to Baseline||1
8339814|NCT01313728|20559063|P1|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
8339815|NCT01313728|20559063|P1|STARTED|Informed Consent to Baseline||26
8339816|NCT01313689|20559083|P5|NOT COMPLETED|24-Week Randomization 2||15
8339817|NCT01313689|20559084|P4|NOT COMPLETED|24-Week Randomization 2||1
8339818|NCT01313689|20559085|P3|NOT COMPLETED|24-Week Randomization 2||3
8339819|NCT01313689|20559086|P2|NOT COMPLETED|24-Week Randomization 2||0
8339820|NCT01313689|20559087|P1|NOT COMPLETED|24-Week Randomization 2||0
8339821|NCT01313689|20559083|P5|COMPLETED|24-Week Randomization 2||27
8339822|NCT01313689|20559084|P4|COMPLETED|24-Week Randomization 2||12
8339823|NCT01313689|20559085|P3|COMPLETED|24-Week Randomization 2||21
8339824|NCT01313689|20559086|P2|COMPLETED|24-Week Randomization 2||0
8339825|NCT01313689|20559087|P1|COMPLETED|24-Week Randomization 2||0
8339826|NCT01313689|20559083|P5|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
8339827|NCT01313689|20559084|P4|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
8339828|NCT01313689|20559085|P3|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
8339829|NCT01313689|20559086|P2|STARTED|24-Week Randomization 2||0
8339830|NCT01313689|20559087|P1|STARTED|24-Week Randomization 2||0
8339831|NCT01313689|20559083|P5|NOT COMPLETED|24-Week Randomization 1||0
8339832|NCT01313689|20559084|P4|NOT COMPLETED|24-Week Randomization 1||0
8339833|NCT01313689|20559085|P3|NOT COMPLETED|24-Week Randomization 1||0
8339834|NCT01313689|20559086|P2|NOT COMPLETED|24-Week Randomization 1||10
8339835|NCT01313689|20559087|P1|NOT COMPLETED|24-Week Randomization 1||19
8339836|NCT01313689|20559083|P5|COMPLETED|24-Week Randomization 1||0
8339837|NCT01313689|20559084|P4|COMPLETED|24-Week Randomization 1||0
8339838|NCT01313689|20559085|P3|COMPLETED|24-Week Randomization 1||0
8339839|NCT01313689|20559086|P2|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
8339840|NCT01313689|20559087|P1|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
8339841|NCT01313689|20559083|P5|STARTED|24-Week Randomization 1||0
8339842|NCT01313689|20559084|P4|STARTED|24-Week Randomization 1||0
8339843|NCT01313689|20559085|P3|STARTED|24-Week Randomization 1||0
8339844|NCT01313689|20559086|P2|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
8339845|NCT01313689|20559087|P1|STARTED|24-Week Randomization 1||79
8339846|NCT01313676|20559166|P4|NOT COMPLETED|Overall Study||994
8339847|NCT01313676|20559167|P3|NOT COMPLETED|Overall Study||1088
8339848|NCT01313676|20559168|P2|NOT COMPLETED|Overall Study||1113
8339849|NCT01313676|20559169|P1|NOT COMPLETED|Overall Study||1250
8339850|NCT01313676|20559166|P4|COMPLETED|Overall Study||3146
8339851|NCT01313676|20559167|P3|COMPLETED|Overall Study||3052
8339852|NCT01313676|20559168|P2|COMPLETED|Overall Study||3044
8339853|NCT01313676|20559169|P1|COMPLETED|Overall Study||2881
8339854|NCT01313676|20559166|P4|STARTED|Overall Study||4140
8339855|NCT01313676|20559167|P3|STARTED|Overall Study||4140
8339856|NCT01313676|20559168|P2|STARTED|Overall Study||4157
8339857|NCT01313676|20559169|P1|STARTED|Overall Study||4131
8339858|NCT01313663|20559189|P2|NOT COMPLETED|Overall Study||8
8339859|NCT01313663|20559190|P1|NOT COMPLETED|Overall Study||4
8339860|NCT01313663|20559189|P2|COMPLETED|Overall Study||3
8339861|NCT01313663|20559190|P1|COMPLETED|Overall Study||5
8339862|NCT01313663|20559189|P2|STARTED|Overall Study||11
8339863|NCT01313663|20559190|P1|STARTED|Overall Study||9
8339864|NCT01313650|20559228|P4|NOT COMPLETED|Overall Study||81
8339865|NCT01313650|20559229|P3|NOT COMPLETED|Overall Study||103
8339866|NCT01313650|20559230|P2|NOT COMPLETED|Overall Study||94
8339867|NCT01313650|20559231|P1|NOT COMPLETED|Overall Study||76
8339868|NCT01313650|20559228|P4|COMPLETED|Overall Study||332
8339869|NCT01313650|20559229|P3|COMPLETED|Overall Study||318
8339870|NCT01313650|20559230|P2|COMPLETED|Overall Study||324
8339871|NCT01313650|20559231|P1|COMPLETED|Overall Study||204
8339872|NCT01313650|20559228|P4|STARTED|Overall Study||413
8339873|NCT01313650|20559229|P3|STARTED|Overall Study||421
8339874|NCT01313650|20559230|P2|STARTED|Overall Study||418
8339875|NCT01313650|20559231|P1|STARTED|Overall Study||280
8339876|NCT01313637|20559257|P4|NOT COMPLETED|Overall Study||78
8339877|NCT01313637|20559258|P3|NOT COMPLETED|Overall Study||106
8339878|NCT01313637|20559259|P2|NOT COMPLETED|Overall Study||95
8339879|NCT01313637|20559260|P1|NOT COMPLETED|Overall Study||92
8339880|NCT01313637|20559257|P4|COMPLETED|Overall Study||325
8339881|NCT01313637|20559258|P3|COMPLETED|Overall Study||298
8339882|NCT01313637|20559259|P2|COMPLETED|Overall Study||312
8339883|NCT01313637|20559260|P1|COMPLETED|Overall Study||183
8339884|NCT01313637|20559257|P4|STARTED|Overall Study||403
8339885|NCT01313637|20559258|P3|STARTED|Overall Study||404
8339886|NCT01313637|20559259|P2|STARTED|Overall Study||407
8339887|NCT01313637|20559260|P1|STARTED|Overall Study||275
8339888|NCT01313624|20559284|P2|NOT COMPLETED|Open-Label Phase||13
8339889|NCT01313624|20559285|P1|NOT COMPLETED|Open-Label Phase||4
8339890|NCT01313624|20559284|P2|COMPLETED|Open-Label Phase||109
8339891|NCT01313624|20559285|P1|COMPLETED|Open-Label Phase||92
8339892|NCT01313624|20559284|P2|STARTED|Open-Label Phase||122
8339893|NCT01313624|20559285|P1|STARTED|Open-Label Phase||96
8339894|NCT01313624|20559284|P2|NOT COMPLETED|Double-Blind Phase||10
8339895|NCT01313624|20559285|P1|NOT COMPLETED|Double-Blind Phase||38
8339896|NCT01313624|20559284|P2|COMPLETED|Double-Blind Phase||122
8339897|NCT01313624|20559285|P1|COMPLETED|Double-Blind Phase||96
8339898|NCT01313624|20559284|P2|STARTED|Double-Blind Phase||132
8339899|NCT01313624|20559285|P1|STARTED|Double-Blind Phase||134
8339900|NCT01313559|20559299|P2|NOT COMPLETED|Overall Study||2
8339901|NCT01313559|20559300|P1|NOT COMPLETED|Overall Study||4
8339902|NCT01313559|20559299|P2|COMPLETED|Overall Study||0
8339903|NCT01313559|20559300|P1|COMPLETED|Overall Study||0
8339904|NCT01313559|20559299|P2|STARTED|Overall Study||2
8339905|NCT01313559|20559300|P1|STARTED|Overall Study||4
8339906|NCT01313520|20559314|P2|NOT COMPLETED|Overall Study||0
8339907|NCT01313520|20559315|P1|NOT COMPLETED|Overall Study||0
8339908|NCT01313520|20559314|P2|COMPLETED|Overall Study||31
8339909|NCT01313520|20559315|P1|COMPLETED|Overall Study||30
8339910|NCT01313520|20559314|P2|STARTED|Overall Study||31
8339911|NCT01313520|20559315|P1|STARTED|Overall Study||30
8339912|NCT01313507|20559335|P1|NOT COMPLETED|Overall Study||0
8339913|NCT01313507|20559335|P1|COMPLETED|Overall Study||21
8339914|NCT01313507|20559335|P1|STARTED|Overall Study||21
8339915|NCT01313494|20559343|P2|NOT COMPLETED|Overall Study||50
8339916|NCT01313494|20559344|P1|NOT COMPLETED|Overall Study||67
8339917|NCT01313494|20559343|P2|COMPLETED|Overall Study||263
8339918|NCT01313494|20559344|P1|COMPLETED|Overall Study||246
8339919|NCT01313494|20559343|P2|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
8339920|NCT01313494|20559344|P1|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
8339921|NCT01313494|20559343|P2|STARTED|Overall Study||313
8339922|NCT01313494|20559344|P1|STARTED|Overall Study||313
8339923|NCT01313416|20559396|P1|NOT COMPLETED|Overall Study||0
8339924|NCT01313416|20559396|P1|COMPLETED|Overall Study||2
8339925|NCT01313416|20559396|P1|STARTED|Overall Study||2
8339926|NCT01313312|20559401|P1|NOT COMPLETED|Overall Study||36
8339927|NCT01313312|20559401|P1|COMPLETED|Overall Study||222
8339928|NCT01313312|20559401|P1|Cycle 5|Overall Study||11
8339929|NCT01313312|20559401|P1|Cycle 4|Overall Study||81
8339930|NCT01313312|20559401|P1|Cycle 3|Overall Study||175
8339931|NCT01313312|20559401|P1|Cycle 2|Overall Study||229
8339932|NCT01313312|20559401|P1|Cycle 1|Overall Study||254
8339933|NCT01313312|20559401|P1|STARTED|Overall Study||258
8339934|NCT01313299|20559448|P3|NOT COMPLETED|Overall Study||4
8339935|NCT01313299|20559449|P2|NOT COMPLETED|Overall Study||3
8339936|NCT01313299|20559450|P1|NOT COMPLETED|Overall Study||7
8339937|NCT01313299|20559448|P3|COMPLETED|Overall Study||77
8339938|NCT01313299|20559449|P2|COMPLETED|Overall Study||78
8339939|NCT01313299|20559450|P1|COMPLETED|Overall Study||74
8339940|NCT01313299|20559448|P3|STARTED|Overall Study||81
8339941|NCT01313299|20559449|P2|STARTED|Overall Study||81
8339942|NCT01313299|20559450|P1|STARTED|Overall Study||81
8339943|NCT01313286|20559464|P2|NOT COMPLETED|Period 2||0
8339944|NCT01313286|20559465|P1|NOT COMPLETED|Period 2||0
8339945|NCT01313286|20559464|P2|COMPLETED|Period 2||8
8339946|NCT01313286|20559465|P1|COMPLETED|Period 2||6
8339947|NCT01313286|20559464|P2|STARTED|Period 2||8
8339948|NCT01313286|20559465|P1|STARTED|Period 2||6
8339949|NCT01313286|20559464|P2|NOT COMPLETED|Period 1||0
8339950|NCT01313286|20559465|P1|NOT COMPLETED|Period 1||2
8339951|NCT01313286|20559464|P2|COMPLETED|Period 1||8
8339952|NCT01313286|20559465|P1|COMPLETED|Period 1||6
8339953|NCT01313286|20559464|P2|STARTED|Period 1||8
8339954|NCT01313286|20559465|P1|STARTED|Period 1||8
8339955|NCT01313273|20559475|P2|NOT COMPLETED|Overall Study||1
8339956|NCT01313273|20559476|P1|NOT COMPLETED|Overall Study||2
8339957|NCT01313273|20559475|P2|COMPLETED|Overall Study||0
8339958|NCT01313273|20559476|P1|COMPLETED|Overall Study||0
8339959|NCT01313273|20559475|P2|STARTED|Overall Study||1
8339960|NCT01313273|20559476|P1|STARTED|Overall Study||2
8339961|NCT01313221|20559491|P3|NOT COMPLETED|Overall Study||23
8339962|NCT01313221|20559492|P2|NOT COMPLETED|Overall Study||8
8339963|NCT01313221|20559493|P1|NOT COMPLETED|Overall Study||12
8339964|NCT01313221|20559491|P3|COMPLETED|Overall Study||0
8339965|NCT01313221|20559492|P2|COMPLETED|Overall Study||135
8339966|NCT01313221|20559493|P1|COMPLETED|Overall Study||132
8339967|NCT01313221|20559491|P3|Randomized|Overall Study||0
8339968|NCT01313221|20559492|P2|Randomized|Overall Study||143
8339969|NCT01313221|20559493|P1|Randomized|Overall Study||144
8339970|NCT01313221|20559491|P3|STARTED|Overall Study||23
8339971|NCT01313221|20559492|P2|STARTED|Overall Study||143
8339972|NCT01313221|20559493|P1|STARTED|Overall Study||144
8339973|NCT01313208|20559545|P2|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
8339974|NCT01313208|20559546|P1|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
8339975|NCT01313208|20559545|P2|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
8339976|NCT01313208|20559546|P1|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
8339977|NCT01313208|20559545|P2|STARTED|Open-label Phase (Weeks 13 - 24)||101
8339978|NCT01313208|20559546|P1|STARTED|Open-label Phase (Weeks 13 - 24)||98
8339979|NCT01313208|20559545|P2|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
8339980|NCT01313208|20559546|P1|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
8339981|NCT01313208|20559545|P2|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
8339982|NCT01313208|20559546|P1|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
8339983|NCT01313208|20559545|P2|STARTED|Double-blind Phase (Weeks 1 - 12)||106
8339984|NCT01313208|20559546|P1|STARTED|Double-blind Phase (Weeks 1 - 12)||104
8339985|NCT01313182|20559636|P2|NOT COMPLETED|Overall Study||92
8339986|NCT01313182|20559637|P1|NOT COMPLETED|Overall Study||66
8339987|NCT01313182|20559636|P2|COMPLETED|Overall Study||763
8339988|NCT01313182|20559637|P1|COMPLETED|Overall Study||776
8339989|NCT01313182|20559636|P2|STARTED|Overall Study||855
8339990|NCT01313182|20559637|P1|STARTED|Overall Study||842
8339991|NCT01313117|20559649|P1|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
8339992|NCT01313117|20559649|P1|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
8339993|NCT01313117|20559649|P1|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
8339994|NCT01313117|20559649|P1|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
8339995|NCT01313117|20559649|P1|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
8339996|NCT01313117|20559649|P1|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
8339997|NCT01313117|20559649|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
8339998|NCT01313117|20559649|P1|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
8339999|NCT01313117|20559649|P1|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
8340000|NCT01313117|20559649|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
8340001|NCT01313117|20559649|P1|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
8340002|NCT01313117|20559649|P1|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
8340003|NCT01313117|20559649|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
8340004|NCT01313117|20559649|P1|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
8340005|NCT01313117|20559649|P1|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
8340006|NCT01313078|20559656|P1|NOT COMPLETED|Overall Study||3
8340007|NCT01313078|20559656|P1|COMPLETED|Overall Study||1
8340008|NCT01313078|20559656|P1|STARTED|Overall Study||4
8340009|NCT01313039|20559661|P1|NOT COMPLETED|Overall Study||2
8340010|NCT01313039|20559661|P1|COMPLETED|Overall Study||2
8340011|NCT01313039|20559661|P1|STARTED|Overall Study||4
8340012|NCT01312961|20559667|P2|NOT COMPLETED|Overall Study||7
8340013|NCT01312961|20559668|P1|NOT COMPLETED|Overall Study||17
8340014|NCT01312961|20559667|P2|COMPLETED|Overall Study||45
8340015|NCT01312961|20559668|P1|COMPLETED|Overall Study||35
8340016|NCT01312961|20559667|P2|Treated|Overall Study||52
8340017|NCT01312961|20559668|P1|Treated|Overall Study||52
8340018|NCT01312961|20559667|P2|STARTED|Overall Study||52
8340019|NCT01312961|20559668|P1|STARTED|Overall Study||52
8340020|NCT01312948|20559694|P1|NOT COMPLETED|Overall Study||0
8340021|NCT01312948|20559694|P1|COMPLETED|Overall Study||6
8340022|NCT01312948|20559694|P1|STARTED|Overall Study||6
8340023|NCT01312909|20559704|P3|NOT COMPLETED|Overall Study||47
8340024|NCT01312909|20559705|P2|NOT COMPLETED|Overall Study||36
8340025|NCT01312909|20559706|P1|NOT COMPLETED|Overall Study||42
8340026|NCT01312909|20559704|P3|COMPLETED|Overall Study||53
8340027|NCT01312909|20559705|P2|COMPLETED|Overall Study||67
8340028|NCT01312909|20559706|P1|COMPLETED|Overall Study||67
8340029|NCT01312909|20559704|P3|Treated|Overall Study||99
8340030|NCT01312909|20559705|P2|Treated|Overall Study||100
8340031|NCT01312909|20559706|P1|Treated|Overall Study||108
8340032|NCT01312909|20559704|P3|STARTED|Overall Study||100
8340033|NCT01312909|20559705|P2|STARTED|Overall Study||103
8340034|NCT01312909|20559706|P1|STARTED|Overall Study||109
8340035|NCT01312844|20559755|P2|NOT COMPLETED|Overall Study||0
8340036|NCT01312844|20559756|P1|NOT COMPLETED|Overall Study||0
8340037|NCT01312844|20559755|P2|COMPLETED|Overall Study||3
8340038|NCT01312844|20559756|P1|COMPLETED|Overall Study||4
8340039|NCT01312844|20559755|P2|STARTED|Overall Study||3
8340040|NCT01312844|20559756|P1|STARTED|Overall Study||4
8340041|NCT01312818|20559778|P1|NOT COMPLETED|Overall Study||0
8340042|NCT01312818|20559778|P1|COMPLETED|Overall Study||2
8340043|NCT01312818|20559778|P1|STARTED|Overall Study||2
8340044|NCT01312805|20559786|P2|NOT COMPLETED|Overall Study||0
8340045|NCT01312805|20559787|P1|NOT COMPLETED|Overall Study||0
8340046|NCT01312805|20559786|P2|COMPLETED|Overall Study||1082
8340047|NCT01312805|20559787|P1|COMPLETED|Overall Study||1016
8340048|NCT01312805|20559786|P2|STARTED|Overall Study||1082
8340049|NCT01312805|20559787|P1|STARTED|Overall Study||1016
8340050|NCT01312779|20559793|P1|NOT COMPLETED|Overall Study||32
8340051|NCT01312779|20559793|P1|COMPLETED|Overall Study||7
8340052|NCT01312779|20559793|P1|Implanted With Device|Overall Study||12
8340053|NCT01312779|20559793|P1|STARTED|Overall Study||39
8340054|NCT01312766|20559825|P2|NOT COMPLETED|Overall Study||5
8340055|NCT01312766|20559826|P1|NOT COMPLETED|Overall Study||6
8340056|NCT01312766|20559825|P2|COMPLETED|Overall Study||130
8340057|NCT01312766|20559826|P1|COMPLETED|Overall Study||129
8340058|NCT01312766|20559825|P2|STARTED|Overall Study||135
8340059|NCT01312766|20559826|P1|STARTED|Overall Study||135
8340060|NCT01312675|20559858|P2|NOT COMPLETED|Overall Study||0
8340061|NCT01312675|20559859|P1|NOT COMPLETED|Overall Study||0
8340062|NCT01312675|20559858|P2|COMPLETED|Overall Study||7
8340063|NCT01312675|20559859|P1|COMPLETED|Overall Study||9
8340064|NCT01312675|20559858|P2|STARTED|Overall Study||7
8340065|NCT01312675|20559859|P1|STARTED|Overall Study||9
8340066|NCT01312519|20559867|P2|NOT COMPLETED|Overall Study||0
8340067|NCT01312519|20559868|P1|NOT COMPLETED|Overall Study||0
8340068|NCT01312519|20559867|P2|COMPLETED|Overall Study||24
8340069|NCT01312519|20559868|P1|COMPLETED|Overall Study||26
8340070|NCT01312519|20559867|P2|STARTED|Overall Study||24
8340071|NCT01312519|20559868|P1|STARTED|Overall Study||26
8340072|NCT01312467|20559876|P1|NOT COMPLETED|Overall Study||13
8340073|NCT01312467|20559876|P1|COMPLETED|Overall Study||32
8340074|NCT01312467|20559876|P1|STARTED|Overall Study||45
8340075|NCT01312428|20559885|P2|NOT COMPLETED|Overall Study||4
8340076|NCT01312428|20559886|P1|NOT COMPLETED|Overall Study||3
8340077|NCT01312428|20559885|P2|COMPLETED|Overall Study||0
8340078|NCT01312428|20559886|P1|COMPLETED|Overall Study||0
8340079|NCT01312428|20559885|P2|STARTED|Overall Study||4
8340080|NCT01312428|20559886|P1|STARTED|Overall Study||3
8340081|NCT01312272|20559896|P2|NOT COMPLETED|Overall Study||1
8340082|NCT01312272|20559897|P1|NOT COMPLETED|Overall Study||0
8340083|NCT01312272|20559896|P2|COMPLETED|Overall Study||11
8340084|NCT01312272|20559897|P1|COMPLETED|Overall Study||12
8340085|NCT01312272|20559896|P2|STARTED|Overall Study||12
8340086|NCT01312272|20559897|P1|STARTED|Overall Study||12
8340105|NCT01312129|20559956|P2|NOT COMPLETED|Second Intervention (24 Hours)||1
8340106|NCT01312129|20559957|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
8340107|NCT01312129|20559956|P2|COMPLETED|Second Intervention (24 Hours)||6
8340108|NCT01312129|20559957|P1|COMPLETED|Second Intervention (24 Hours)||6
8340109|NCT01312129|20559956|P2|Alcohol Cue|Second Intervention (24 Hours)||6
8340110|NCT01312129|20559957|P1|Alcohol Cue|Second Intervention (24 Hours)||6
8340111|NCT01312129|20559956|P2|Control Cue|Second Intervention (24 Hours)||6
8340112|NCT01312129|20559957|P1|Control Cue|Second Intervention (24 Hours)||6
8340113|NCT01312129|20559956|P2|STARTED|Second Intervention (24 Hours)||7
8340114|NCT01312129|20559957|P1|STARTED|Second Intervention (24 Hours)||6
8340115|NCT01312129|20559956|P2|NOT COMPLETED|Washout (1 Week)||0
8340116|NCT01312129|20559957|P1|NOT COMPLETED|Washout (1 Week)||0
8340117|NCT01312129|20559956|P2|COMPLETED|Washout (1 Week)||7
8340118|NCT01312129|20559957|P1|COMPLETED|Washout (1 Week)||6
8340119|NCT01312129|20559956|P2|STARTED|Washout (1 Week)||7
8340120|NCT01312129|20559957|P1|STARTED|Washout (1 Week)||6
8340121|NCT01312129|20559956|P2|NOT COMPLETED|First Intervention (24 Hours)||0
8340122|NCT01312129|20559957|P1|NOT COMPLETED|First Intervention (24 Hours)||0
8340123|NCT01312129|20559956|P2|COMPLETED|First Intervention (24 Hours)||7
8340124|NCT01312129|20559957|P1|COMPLETED|First Intervention (24 Hours)||6
8340125|NCT01312129|20559956|P2|Alcohol Cue|First Intervention (24 Hours)||7
8340126|NCT01312129|20559957|P1|Alcohol Cue|First Intervention (24 Hours)||6
8340127|NCT01312129|20559956|P2|Control Cue|First Intervention (24 Hours)||7
8340128|NCT01312129|20559957|P1|Control Cue|First Intervention (24 Hours)||6
8340129|NCT01312129|20559956|P2|STARTED|First Intervention (24 Hours)||7
8340130|NCT01312129|20559957|P1|STARTED|First Intervention (24 Hours)||6
8340131|NCT01312038|20559965|P2|NOT COMPLETED|Overall Study||0
8340132|NCT01312038|20559966|P1|NOT COMPLETED|Overall Study||0
8340133|NCT01312038|20559965|P2|COMPLETED|Overall Study||12
8340134|NCT01312038|20559966|P1|COMPLETED|Overall Study||13
8340135|NCT01312038|20559965|P2|STARTED|Overall Study||12
8340136|NCT01312038|20559966|P1|STARTED|Overall Study||13
8340137|NCT01311895|20559974|P2|NOT COMPLETED|Overall Study||0
8340138|NCT01311895|20559975|P1|NOT COMPLETED|Overall Study||0
8340139|NCT01311895|20559974|P2|COMPLETED|Overall Study||175
8340140|NCT01311895|20559975|P1|COMPLETED|Overall Study||175
8340141|NCT01311895|20559974|P2|STARTED|Overall Study||175
8340142|NCT01311895|20559975|P1|STARTED|Overall Study||175
8340143|NCT01311687|20559987|P2|NOT COMPLETED|PFS Follow-up Phase||0
8340144|NCT01311687|20559988|P1|NOT COMPLETED|PFS Follow-up Phase||0
8340145|NCT01311687|20559987|P2|COMPLETED|PFS Follow-up Phase||8
8340146|NCT01311687|20559988|P1|COMPLETED|PFS Follow-up Phase||11
8340147|NCT01311687|20559987|P2|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
8340148|NCT01311687|20559988|P1|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
8340149|NCT01311687|20559987|P2|STARTED|PFS Follow-up Phase||8
8340150|NCT01311687|20559988|P1|STARTED|PFS Follow-up Phase||11
8340151|NCT01311687|20559987|P2|NOT COMPLETED|Treatment Phase||0
8340152|NCT01311687|20559988|P1|NOT COMPLETED|Treatment Phase||0
8340153|NCT01311687|20559987|P2|COMPLETED|Treatment Phase||153
8340154|NCT01311687|20559988|P1|COMPLETED|Treatment Phase||302
8340155|NCT01311687|20559987|P2|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
8340156|NCT01311687|20559988|P1|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
8340157|NCT01311687|20559987|P2|Received Study Drug|Treatment Phase||150
8340158|NCT01311687|20559988|P1|Received Study Drug|Treatment Phase||300
8340159|NCT01311687|20559987|P2|STARTED|Treatment Phase||153
8340160|NCT01311687|20559988|P1|STARTED|Treatment Phase||302
8340161|NCT01311661|20560042|P1|NOT COMPLETED|Overall Study||7
8340162|NCT01311661|20560042|P1|COMPLETED|Overall Study||199
8340163|NCT01311661|20560042|P1|Received Olo 10 mcg qd|Overall Study||102
8340164|NCT01311661|20560042|P1|Received Olo 5 mcg Bid|Overall Study||101
8340165|NCT01311661|20560042|P1|Received Olo 5 mcg qd|Overall Study||101
8340166|NCT01311661|20560042|P1|Received Olo 2.5 mcg Bid|Overall Study||101
8340167|NCT01311661|20560042|P1|Received Placebo|Overall Study||201
8340168|NCT01311661|20560042|P1|STARTED|Overall Study|Entered and treated|206
8340178|NCT01311557|20560234|P2|NOT COMPLETED|Overall Study||6
8340179|NCT01311557|20560235|P1|NOT COMPLETED|Overall Study||5
8340180|NCT01311557|20560234|P2|COMPLETED|Overall Study||645
8340181|NCT01311557|20560235|P1|COMPLETED|Overall Study||646
8340182|NCT01311557|20560234|P2|STARTED|Overall Study||651
8340183|NCT01311557|20560235|P1|STARTED|Overall Study||651
8340184|NCT01311505|20560251|P2|NOT COMPLETED|Second Intervention Period||0
8340185|NCT01311505|20560252|P1|NOT COMPLETED|Second Intervention Period||0
8340186|NCT01311505|20560251|P2|COMPLETED|Second Intervention Period||10
8340187|NCT01311505|20560252|P1|COMPLETED|Second Intervention Period||10
8340188|NCT01311505|20560251|P2|STARTED|Second Intervention Period||10
8340189|NCT01311505|20560252|P1|STARTED|Second Intervention Period||10
8340190|NCT01311505|20560251|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8340191|NCT01311505|20560252|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8340192|NCT01311505|20560251|P2|COMPLETED|Washout Period (at Least 7 Days)||10
8340193|NCT01311505|20560252|P1|COMPLETED|Washout Period (at Least 7 Days)||10
8340194|NCT01311505|20560251|P2|STARTED|Washout Period (at Least 7 Days)||10
8340195|NCT01311505|20560252|P1|STARTED|Washout Period (at Least 7 Days)||10
8340196|NCT01311505|20560251|P2|NOT COMPLETED|First Intervention Period||1
8340197|NCT01311505|20560252|P1|NOT COMPLETED|First Intervention Period||0
8340198|NCT01311505|20560251|P2|COMPLETED|First Intervention Period||10
8340199|NCT01311505|20560252|P1|COMPLETED|First Intervention Period||10
8340200|NCT01311505|20560251|P2|STARTED|First Intervention Period||11
8340201|NCT01311505|20560252|P1|STARTED|First Intervention Period||10
8340202|NCT01311362|20560280|P1|NOT COMPLETED|Ambrisentan and SJW||0
8340203|NCT01311362|20560280|P1|COMPLETED|Ambrisentan and SJW||20
8340204|NCT01311362|20560280|P1|STARTED|Ambrisentan and SJW||20
8340205|NCT01311362|20560280|P1|NOT COMPLETED|Ambrisentan Steady-state||0
8340206|NCT01311362|20560280|P1|COMPLETED|Ambrisentan Steady-state||20
8340207|NCT01311362|20560280|P1|STARTED|Ambrisentan Steady-state||20
8340208|NCT01311362|20560280|P1|NOT COMPLETED|Ambrisentan Single Dose||0
8340209|NCT01311362|20560280|P1|COMPLETED|Ambrisentan Single Dose||20
8340210|NCT01311362|20560280|P1|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
8340211|NCT01311102|20560293|P2|NOT COMPLETED|Overall Study||0
8340212|NCT01311102|20560294|P1|NOT COMPLETED|Overall Study||0
8340213|NCT01311102|20560293|P2|COMPLETED|Overall Study||20
8340214|NCT01311102|20560294|P1|COMPLETED|Overall Study||20
8340215|NCT01311102|20560293|P2|STARTED|Overall Study||20
8340216|NCT01311102|20560294|P1|STARTED|Overall Study||20
8340223|NCT01310868|20560315|P1|NOT COMPLETED|Overall Study||13
8340224|NCT01310868|20560315|P1|COMPLETED|Overall Study||59
8340225|NCT01310868|20560315|P1|STARTED|Overall Study||72
8340226|NCT01310855|20560323|P2|NOT COMPLETED|Overall Study||0
8340227|NCT01310855|20560324|P1|NOT COMPLETED|Overall Study||0
8340228|NCT01310855|20560323|P2|COMPLETED|Overall Study||19
8340229|NCT01310855|20560324|P1|COMPLETED|Overall Study||19
8340230|NCT01310855|20560323|P2|STARTED|Overall Study||19
8340231|NCT01310855|20560324|P1|STARTED|Overall Study||19
8340232|NCT01310803|20560332|P2|NOT COMPLETED|Overall Study||0
8340233|NCT01310803|20560333|P1|NOT COMPLETED|Overall Study||1
8340234|NCT01310803|20560332|P2|COMPLETED|Overall Study||0
8340235|NCT01310803|20560333|P1|COMPLETED|Overall Study||0
8340236|NCT01310803|20560332|P2|STARTED|Overall Study||0
8340237|NCT01310803|20560333|P1|STARTED|Overall Study||1
8340238|NCT01310777|20560344|P3|NOT COMPLETED|Overall Study||30
8340239|NCT01310777|20560345|P2|NOT COMPLETED|Overall Study||14
8340240|NCT01310777|20560346|P1|NOT COMPLETED|Overall Study||33
8340241|NCT01310777|20560344|P3|COMPLETED|Overall Study||145
8340242|NCT01310777|20560345|P2|COMPLETED|Overall Study||178
8340243|NCT01310777|20560346|P1|COMPLETED|Overall Study||160
8340244|NCT01310777|20560344|P3|STARTED|Overall Study||175
8340245|NCT01310777|20560345|P2|STARTED|Overall Study||192
8340246|NCT01310777|20560346|P1|STARTED|Overall Study||193
8340247|NCT01310699|20560356|P2|NOT COMPLETED|Overall Study||6
8340248|NCT01310699|20560357|P1|NOT COMPLETED|Overall Study||4
8340249|NCT01310699|20560356|P2|COMPLETED|Overall Study||143
8340250|NCT01310699|20560357|P1|COMPLETED|Overall Study||128
8340251|NCT01310699|20560356|P2|STARTED|Overall Study||149
8340252|NCT01310699|20560357|P1|STARTED|Overall Study||132
8340253|NCT01310582|20560369|P2|NOT COMPLETED|Overall Study||0
8340254|NCT01310582|20560370|P1|NOT COMPLETED|Overall Study||0
8340255|NCT01310582|20560369|P2|COMPLETED|Overall Study||26
8340256|NCT01310582|20560370|P1|COMPLETED|Overall Study||31
8340257|NCT01310582|20560369|P2|STARTED|Overall Study||26
8340258|NCT01310582|20560370|P1|STARTED|Overall Study||31
8340259|NCT01310413|20560384|P7|NOT COMPLETED|From Day U0 to Day U385||3
8340260|NCT01310413|20560385|P6|NOT COMPLETED|From Day U0 to Day U385||0
8340261|NCT01310413|20560386|P5|NOT COMPLETED|From Day U0 to Day U385||0
8340262|NCT01310413|20560387|P4|NOT COMPLETED|From Day U0 to Day U385||0
8340263|NCT01310413|20560388|P3|NOT COMPLETED|From Day U0 to Day U385||0
8340264|NCT01310413|20560389|P2|NOT COMPLETED|From Day U0 to Day U385||0
8340265|NCT01310413|20560390|P1|NOT COMPLETED|From Day U0 to Day U385||0
8340266|NCT01310413|20560384|P7|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
8340267|NCT01310413|20560385|P6|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8340268|NCT01310413|20560386|P5|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8340269|NCT01310413|20560387|P4|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8340270|NCT01310413|20560388|P3|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8340271|NCT01310413|20560389|P2|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8340272|NCT01310413|20560390|P1|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8340273|NCT01310413|20560384|P7|STARTED|From Day U0 to Day U385|Upto Day U42|155
8340274|NCT01310413|20560385|P6|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8340275|NCT01310413|20560386|P5|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8340276|NCT01310413|20560387|P4|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
8340277|NCT01310413|20560388|P3|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8340278|NCT01310413|20560389|P2|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8340279|NCT01310413|20560390|P1|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
8340280|NCT01310413|20560384|P7|NOT COMPLETED|Day 0 to Day 385||0
8340281|NCT01310413|20560385|P6|NOT COMPLETED|Day 0 to Day 385||3
8340282|NCT01310413|20560386|P5|NOT COMPLETED|Day 0 to Day 385||3
8340283|NCT01310413|20560387|P4|NOT COMPLETED|Day 0 to Day 385||8
8340284|NCT01310413|20560388|P3|NOT COMPLETED|Day 0 to Day 385||7
8340285|NCT01310413|20560389|P2|NOT COMPLETED|Day 0 to Day 385||8
8340286|NCT01310413|20560390|P1|NOT COMPLETED|Day 0 to Day 385||27
8340287|NCT01310413|20560384|P7|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
8340288|NCT01310413|20560385|P6|COMPLETED|Day 0 to Day 385||77
8340289|NCT01310413|20560386|P5|COMPLETED|Day 0 to Day 385||73
8340290|NCT01310413|20560387|P4|COMPLETED|Day 0 to Day 385||67
8340291|NCT01310413|20560388|P3|COMPLETED|Day 0 to Day 385||203
8340292|NCT01310413|20560389|P2|COMPLETED|Day 0 to Day 385||190
8340293|NCT01310413|20560390|P1|COMPLETED|Day 0 to Day 385||172
8340294|NCT01310413|20560384|P7|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
8340295|NCT01310413|20560385|P6|STARTED|Day 0 to Day 385||80
8340296|NCT01310413|20560386|P5|STARTED|Day 0 to Day 385||76
8340297|NCT01310413|20560387|P4|STARTED|Day 0 to Day 385||75
8340298|NCT01310413|20560388|P3|STARTED|Day 0 to Day 385||210
8340299|NCT01310413|20560389|P2|STARTED|Day 0 to Day 385||198
8340300|NCT01310413|20560390|P1|STARTED|Day 0 to Day 385||199
8340301|NCT01310400|20560546|P3|NOT COMPLETED|Overall Study||30
8340302|NCT01310400|20560547|P2|NOT COMPLETED|Overall Study||32
8340303|NCT01310400|20560548|P1|NOT COMPLETED|Overall Study||28
8340304|NCT01310400|20560546|P3|COMPLETED|Overall Study||422
8340305|NCT01310400|20560547|P2|COMPLETED|Overall Study||420
8340306|NCT01310400|20560548|P1|COMPLETED|Overall Study||424
8340307|NCT01310400|20560546|P3|STARTED|Overall Study||452
8340308|NCT01310400|20560547|P2|STARTED|Overall Study||452
8340309|NCT01310400|20560548|P1|STARTED|Overall Study||452
8340310|NCT01310179|20560565|P1|NOT COMPLETED|Overall Study||0
8340311|NCT01310179|20560565|P1|COMPLETED|Overall Study||12
8340312|NCT01310179|20560565|P1|STARTED|Overall Study||12
8340313|NCT01310127|20560572|P2|NOT COMPLETED|Overall Study||1
8340314|NCT01310127|20560573|P1|NOT COMPLETED|Overall Study||2
8340315|NCT01310127|20560572|P2|COMPLETED|Overall Study||10
8340316|NCT01310127|20560573|P1|COMPLETED|Overall Study||10
8340317|NCT01310127|20560572|P2|STARTED|Overall Study||11
8340318|NCT01310127|20560573|P1|STARTED|Overall Study||12
8340319|NCT01310075|20560587|P2|NOT COMPLETED|Overall Study||10
8340320|NCT01310075|20560588|P1|NOT COMPLETED|Overall Study||14
8340321|NCT01310075|20560587|P2|COMPLETED|Overall Study||35
8340322|NCT01310075|20560588|P1|COMPLETED|Overall Study||31
8340323|NCT01310075|20560587|P2|STARTED|Overall Study||45
8340324|NCT01310075|20560588|P1|STARTED|Overall Study||45
8340325|NCT01310036|20560594|P1|NOT COMPLETED|Overall Study||202
8340326|NCT01310036|20560594|P1|COMPLETED|Overall Study||6
8340327|NCT01310036|20560594|P1|STARTED|Overall Study||208
8340328|NCT01309997|20560607|P2|NOT COMPLETED|Overall Study||6
8340329|NCT01309997|20560608|P1|NOT COMPLETED|Overall Study||5
8340330|NCT01309997|20560607|P2|COMPLETED|Overall Study||31
8340331|NCT01309997|20560608|P1|COMPLETED|Overall Study||30
8340332|NCT01309997|20560607|P2|Crossed Over to Second Arm|Overall Study||23
8340333|NCT01309997|20560608|P1|Crossed Over to Second Arm|Overall Study||19
8340334|NCT01309997|20560607|P2|Remained on First Arm Only|Overall Study||14
8340335|NCT01309997|20560608|P1|Remained on First Arm Only|Overall Study||16
8340336|NCT01309997|20560607|P2|STARTED|Overall Study||37
8340337|NCT01309997|20560608|P1|STARTED|Overall Study||35
8340338|NCT01309919|20560632|P2|NOT COMPLETED|Overall Study||48
8340339|NCT01309919|20560633|P1|NOT COMPLETED|Overall Study||17
8340340|NCT01309919|20560632|P2|COMPLETED|Overall Study||27
8340341|NCT01309919|20560633|P1|COMPLETED|Overall Study||58
8340342|NCT01309919|20560632|P2|STARTED|Overall Study||75
8340343|NCT01309919|20560633|P1|STARTED|Overall Study||75
8340344|NCT01309906|20560645|P2|NOT COMPLETED|Overall Study||1
8340345|NCT01309906|20560646|P1|NOT COMPLETED|Overall Study||1
8340346|NCT01309906|20560645|P2|COMPLETED|Overall Study||32
8340347|NCT01309906|20560646|P1|COMPLETED|Overall Study||32
8340348|NCT01309906|20560645|P2|STARTED|Overall Study||33
8340349|NCT01309906|20560646|P1|STARTED|Overall Study||33
8340350|NCT01309893|20560656|P2|NOT COMPLETED|Week 2 - Crossover Intervention||1
8340351|NCT01309893|20560657|P1|NOT COMPLETED|Week 2 - Crossover Intervention||1
8340352|NCT01309893|20560656|P2|COMPLETED|Week 2 - Crossover Intervention||32
8340353|NCT01309893|20560657|P1|COMPLETED|Week 2 - Crossover Intervention||32
8340354|NCT01309893|20560656|P2|STARTED|Week 2 - Crossover Intervention||33
8340355|NCT01309893|20560657|P1|STARTED|Week 2 - Crossover Intervention||33
8340356|NCT01309893|20560656|P2|NOT COMPLETED|Week 1 - First Intervention||0
8340357|NCT01309893|20560657|P1|NOT COMPLETED|Week 1 - First Intervention||0
8340358|NCT01309893|20560656|P2|COMPLETED|Week 1 - First Intervention||33
8340359|NCT01309893|20560657|P1|COMPLETED|Week 1 - First Intervention||33
8340360|NCT01309893|20560656|P2|STARTED|Week 1 - First Intervention||33
8340361|NCT01309893|20560657|P1|STARTED|Week 1 - First Intervention||33
8340362|NCT01309880|20560667|P2|NOT COMPLETED|Overall Study||0
8340363|NCT01309880|20560668|P1|NOT COMPLETED|Overall Study||0
8340364|NCT01309880|20560667|P2|COMPLETED|Overall Study||33
8340365|NCT01309880|20560668|P1|COMPLETED|Overall Study||33
8340366|NCT01309880|20560667|P2|STARTED|Overall Study||33
8340367|NCT01309880|20560668|P1|STARTED|Overall Study||33
8340368|NCT01309867|20560678|P2|NOT COMPLETED|Overall Study||12
8340369|NCT01309867|20560679|P1|NOT COMPLETED|Overall Study||3
8340370|NCT01309867|20560678|P2|COMPLETED|Overall Study||139
8340371|NCT01309867|20560679|P1|COMPLETED|Overall Study||148
8340372|NCT01309867|20560678|P2|STARTED|Overall Study||151
8340373|NCT01309867|20560679|P1|STARTED|Overall Study||151
8340374|NCT01309841|20560694|P3|NOT COMPLETED|Overall Study||37
8340375|NCT01309841|20560695|P2|NOT COMPLETED|Overall Study||41
8340376|NCT01309841|20560696|P1|NOT COMPLETED|Overall Study||39
8340377|NCT01309841|20560694|P3|COMPLETED|Overall Study||180
8340378|NCT01309841|20560695|P2|COMPLETED|Overall Study||177
8340379|NCT01309841|20560696|P1|COMPLETED|Overall Study||178
8340380|NCT01309841|20560694|P3|STARTED|Overall Study||217
8340381|NCT01309841|20560695|P2|STARTED|Overall Study||218
8340382|NCT01309841|20560696|P1|STARTED|Overall Study||217
8340383|NCT01309828|20560736|P2|NOT COMPLETED|Overall Study||16
8340384|NCT01309828|20560737|P1|NOT COMPLETED|Overall Study||16
8340385|NCT01309828|20560736|P2|COMPLETED|Overall Study||60
8340386|NCT01309828|20560737|P1|COMPLETED|Overall Study||61
8340387|NCT01309828|20560736|P2|STARTED|Overall Study||76
8340388|NCT01309828|20560737|P1|STARTED|Overall Study||77
8340389|NCT01309802|20560751|P2|NOT COMPLETED|Overall Study||9
8340390|NCT01309802|20560752|P1|NOT COMPLETED|Overall Study||12
8340391|NCT01309802|20560751|P2|COMPLETED|Overall Study||14
8340392|NCT01309802|20560752|P1|COMPLETED|Overall Study||13
8340393|NCT01309802|20560751|P2|STARTED|Overall Study||23
8340394|NCT01309802|20560752|P1|STARTED|Overall Study||25
8340395|NCT01309737|20560771|P5|NOT COMPLETED|Week 16 to 52||33
8340396|NCT01309737|20560772|P4|NOT COMPLETED|Week 16 to 52||34
8340397|NCT01309737|20560773|P3|NOT COMPLETED|Week 16 to 52||0
8340398|NCT01309737|20560774|P2|NOT COMPLETED|Week 16 to 52||103
8340399|NCT01309737|20560775|P1|NOT COMPLETED|Week 16 to 52||133
8340400|NCT01309737|20560771|P5|COMPLETED|Week 16 to 52||44
8340401|NCT01309737|20560772|P4|COMPLETED|Week 16 to 52||41
8340402|NCT01309737|20560773|P3|COMPLETED|Week 16 to 52||0
8340403|NCT01309737|20560774|P2|COMPLETED|Week 16 to 52||238
8340404|NCT01309737|20560775|P1|COMPLETED|Week 16 to 52||198
8340405|NCT01309737|20560771|P5|STARTED|Week 16 to 52||77
8340406|NCT01309737|20560772|P4|STARTED|Week 16 to 52||75
8340407|NCT01309737|20560773|P3|STARTED|Week 16 to 52||0
8340408|NCT01309737|20560774|P2|STARTED|Week 16 to 52||341
8340409|NCT01309737|20560775|P1|STARTED|Week 16 to 52||331
8340410|NCT01309737|20560771|P5|NOT COMPLETED|Week 0 to 16||0
8340411|NCT01309737|20560772|P4|NOT COMPLETED|Week 0 to 16||0
8340412|NCT01309737|20560773|P3|NOT COMPLETED|Week 0 to 16||44
8340413|NCT01309737|20560774|P2|NOT COMPLETED|Week 0 to 16||40
8340414|NCT01309737|20560775|P1|NOT COMPLETED|Week 0 to 16||52
8340415|NCT01309737|20560771|P5|COMPLETED|Week 0 to 16||0
8340416|NCT01309737|20560772|P4|COMPLETED|Week 0 to 16||0
8340417|NCT01309737|20560773|P3|COMPLETED|Week 0 to 16||152
8340418|NCT01309737|20560774|P2|COMPLETED|Week 0 to 16||341
8340419|NCT01309737|20560775|P1|COMPLETED|Week 0 to 16||331
8340420|NCT01309737|20560771|P5|Treated|Week 0 to 16||0
8340421|NCT01309737|20560772|P4|Treated|Week 0 to 16||0
8340422|NCT01309737|20560773|P3|Treated|Week 0 to 16||196
8340423|NCT01309737|20560774|P2|Treated|Week 0 to 16||381
8340424|NCT01309737|20560775|P1|Treated|Week 0 to 16||382
8340425|NCT01309737|20560771|P5|STARTED|Week 0 to 16||0
8340426|NCT01309737|20560772|P4|STARTED|Week 0 to 16||0
8340427|NCT01309737|20560773|P3|STARTED|Week 0 to 16||196
8340428|NCT01309737|20560774|P2|STARTED|Week 0 to 16||381
8340429|NCT01309737|20560775|P1|STARTED|Week 0 to 16||383
8340430|NCT01309672|20560970|P1|NOT COMPLETED|Overall Study||37
8340431|NCT01309672|20560970|P1|COMPLETED|Overall Study||4
8340432|NCT01309672|20560970|P1|Received Protocol Treatment|Overall Study||40
8340433|NCT01309672|20560970|P1|STARTED|Overall Study||41
8340434|NCT01309659|20560980|P2|NOT COMPLETED|Overall Study||1
8340435|NCT01309659|20560981|P1|NOT COMPLETED|Overall Study||0
8340436|NCT01309659|20560980|P2|COMPLETED|Overall Study||9
8340437|NCT01309659|20560981|P1|COMPLETED|Overall Study||9
8340438|NCT01309659|20560980|P2|STARTED|Overall Study||10
8340439|NCT01309659|20560981|P1|STARTED|Overall Study||9
8340440|NCT01309646|20561023|P2|NOT COMPLETED|Overall Study||0
8340441|NCT01309646|20561024|P1|NOT COMPLETED|Overall Study||0
8340442|NCT01309646|20561023|P2|COMPLETED|Overall Study||227
8340443|NCT01309646|20561024|P1|COMPLETED|Overall Study||224
8340444|NCT01309646|20561023|P2|STARTED|Overall Study||227
8340445|NCT01309646|20561024|P1|STARTED|Overall Study||224
8340446|NCT01309581|20561064|P2|NOT COMPLETED|Overall Study||0
8340447|NCT01309581|20561065|P1|NOT COMPLETED|Overall Study||0
8340448|NCT01309581|20561064|P2|COMPLETED|Overall Study||1
8340449|NCT01309581|20561065|P1|COMPLETED|Overall Study||2
8340450|NCT01309581|20561064|P2|STARTED|Overall Study||1
8340451|NCT01309581|20561065|P1|STARTED|Overall Study||2
8340452|NCT01309451|20561075|P2|NOT COMPLETED|Overall Study||3
8340453|NCT01309451|20561076|P1|NOT COMPLETED|Overall Study||2
8340454|NCT01309451|20561075|P2|COMPLETED|Overall Study|unit of measure is number of eyes|18
8340455|NCT01309451|20561076|P1|COMPLETED|Overall Study|unit of measure is number of eyes|17
8340456|NCT01309451|20561075|P2|STARTED|Overall Study|unit of measure is number of eyes|21
8340457|NCT01309451|20561076|P1|STARTED|Overall Study|unit of measure is number of eyes|19
8340458|NCT01309386|20561086|P2|NOT COMPLETED|Overall Study||21
8340459|NCT01309386|20561087|P1|NOT COMPLETED|Overall Study||22
8340460|NCT01309386|20561086|P2|COMPLETED|Overall Study||29
8340461|NCT01309386|20561087|P1|COMPLETED|Overall Study||28
8340462|NCT01309386|20561086|P2|STARTED|Overall Study||50
8340463|NCT01309386|20561087|P1|STARTED|Overall Study||50
8340464|NCT01309360|20561108|P3|NOT COMPLETED|Overall Study||0
8340465|NCT01309360|20561109|P2|NOT COMPLETED|Overall Study||0
8340466|NCT01309360|20561110|P1|NOT COMPLETED|Overall Study||0
8340467|NCT01309360|20561108|P3|COMPLETED|Overall Study||40
8340468|NCT01309360|20561109|P2|COMPLETED|Overall Study||40
8340469|NCT01309360|20561110|P1|COMPLETED|Overall Study||40
8340470|NCT01309360|20561108|P3|STARTED|Overall Study||40
8340471|NCT01309360|20561109|P2|STARTED|Overall Study||40
8340472|NCT01309360|20561110|P1|STARTED|Overall Study||40
8340473|NCT01309308|20561135|P2|NOT COMPLETED|Overall Study||4
8340474|NCT01309308|20561136|P1|NOT COMPLETED|Overall Study||6
8340475|NCT01309308|20561135|P2|COMPLETED|Overall Study||71
8340476|NCT01309308|20561136|P1|COMPLETED|Overall Study||69
8340477|NCT01309308|20561135|P2|STARTED|Overall Study||75
8340478|NCT01309308|20561136|P1|STARTED|Overall Study||75
8340479|NCT01309282|20561144|P1|NOT COMPLETED|Overall Study||1
8340480|NCT01309282|20561144|P1|COMPLETED|Overall Study||8
8340481|NCT01309282|20561144|P1|STARTED|Overall Study||9
8340482|NCT01309269|20561161|P1|NOT COMPLETED|Overall Study||840
8340483|NCT01309269|20561161|P1|COMPLETED|Overall Study||245
8340484|NCT01309269|20561161|P1|Treated|Overall Study||978
8340485|NCT01309269|20561161|P1|STARTED|Overall Study||1085
8340486|NCT01309243|20561169|P2|NOT COMPLETED|Extension Phase||0
8340487|NCT01309243|20561170|P1|NOT COMPLETED|Extension Phase||6
8340488|NCT01309243|20561169|P2|COMPLETED|Extension Phase||117
8340489|NCT01309243|20561170|P1|COMPLETED|Extension Phase||34
8340490|NCT01309243|20561169|P2|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
8340491|NCT01309243|20561170|P1|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
8340492|NCT01309243|20561169|P2|NOT COMPLETED|Randomized Phase Through Week 96||109
8340493|NCT01309243|20561170|P1|NOT COMPLETED|Randomized Phase Through Week 96||84
8340494|NCT01309243|20561169|P2|COMPLETED|Randomized Phase Through Week 96||290
8340495|NCT01309243|20561170|P1|COMPLETED|Randomized Phase Through Week 96||316
8340496|NCT01309243|20561169|P2|Randomized and Treated|Randomized Phase Through Week 96||392
8340497|NCT01309243|20561170|P1|Randomized and Treated|Randomized Phase Through Week 96||394
8340498|NCT01309243|20561169|P2|STARTED|Randomized Phase Through Week 96||399
8340499|NCT01309243|20561170|P1|STARTED|Randomized Phase Through Week 96||400
8340500|NCT01309204|20561196|P2|NOT COMPLETED|Overall Study||75
8340501|NCT01309204|20561197|P1|NOT COMPLETED|Overall Study||67
8340502|NCT01309204|20561196|P2|COMPLETED|Overall Study||361
8340503|NCT01309204|20561197|P1|COMPLETED|Overall Study||385
8340504|NCT01309204|20561196|P2|STARTED|Overall Study||436
8340505|NCT01309204|20561197|P1|STARTED|Overall Study||452
8340506|NCT01309165|20561205|P2|NOT COMPLETED|Overall Study||7
8340507|NCT01309165|20561206|P1|NOT COMPLETED|Overall Study||6
8340508|NCT01309165|20561205|P2|COMPLETED|Overall Study||9
8340509|NCT01309165|20561206|P1|COMPLETED|Overall Study||13
8340510|NCT01309165|20561205|P2|Included in Primary Analysis|Overall Study||12
8340511|NCT01309165|20561206|P1|Included in Primary Analysis|Overall Study||14
8340512|NCT01309165|20561205|P2|Received Allocated Intervention|Overall Study||14
8340513|NCT01309165|20561206|P1|Received Allocated Intervention|Overall Study||16
8340514|NCT01309165|20561205|P2|STARTED|Overall Study||16
8340515|NCT01309165|20561206|P1|STARTED|Overall Study||19
8340516|NCT01309100|20561218|P1|NOT COMPLETED|Overall Study||2
8340517|NCT01309100|20561218|P1|COMPLETED|Overall Study||142
8340518|NCT01309100|20561218|P1|STARTED|Overall Study||144
8340519|NCT01308918|20561229|P1|NOT COMPLETED|Overall Study||0
8340520|NCT01308918|20561229|P1|COMPLETED|Overall Study||50
8340521|NCT01308918|20561229|P1|STARTED|Overall Study||50
8340522|NCT01308853|20561236|P1|NOT COMPLETED|Overall Study||4
8340523|NCT01308853|20561236|P1|COMPLETED|Overall Study||20
8340524|NCT01308853|20561236|P1|STARTED|Overall Study||24
8340525|NCT01308840|20561241|P1|NOT COMPLETED|Overall Study||0
8340526|NCT01308840|20561241|P1|COMPLETED|Overall Study||31
8340527|NCT01308840|20561241|P1|STARTED|Overall Study||31
8340528|NCT01308814|20561250|P2|NOT COMPLETED|Overall Study||23
8340529|NCT01308814|20561251|P1|NOT COMPLETED|Overall Study||17
8340530|NCT01308814|20561250|P2|COMPLETED|Overall Study||63
8340531|NCT01308814|20561251|P1|COMPLETED|Overall Study||69
8340532|NCT01308814|20561250|P2|STARTED|Overall Study||86
8340533|NCT01308814|20561251|P1|STARTED|Overall Study||86
8340534|NCT01308788|20561271|P2|NOT COMPLETED|2-year Treatment||11
8340535|NCT01308788|20561272|P1|NOT COMPLETED|2-year Treatment||4
8340536|NCT01308788|20561271|P2|COMPLETED|2-year Treatment||10
8340537|NCT01308788|20561272|P1|COMPLETED|2-year Treatment||10
8340538|NCT01308788|20561271|P2|STARTED|2-year Treatment||21
8340539|NCT01308788|20561272|P1|STARTED|2-year Treatment||14
8340540|NCT01308788|20561271|P2|NOT COMPLETED|6-month Treatment||0
8340541|NCT01308788|20561272|P1|NOT COMPLETED|6-month Treatment||0
8340542|NCT01308788|20561271|P2|COMPLETED|6-month Treatment||21
8340543|NCT01308788|20561272|P1|COMPLETED|6-month Treatment||14
8340544|NCT01308788|20561271|P2|STARTED|6-month Treatment||21
8340545|NCT01308788|20561272|P1|STARTED|6-month Treatment||14
8340546|NCT01308762|20561307|P3|NOT COMPLETED|Overall Study||0
8340547|NCT01308762|20561308|P2|NOT COMPLETED|Overall Study||1
8340548|NCT01308762|20561309|P1|NOT COMPLETED|Overall Study||0
8340549|NCT01308762|20561307|P3|COMPLETED|Overall Study||6
8340550|NCT01308762|20561308|P2|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
8340551|NCT01308762|20561309|P1|COMPLETED|Overall Study||6
8340552|NCT01308762|20561307|P3|STARTED|Overall Study||6
8340553|NCT01308762|20561308|P2|STARTED|Overall Study||7
8340554|NCT01308762|20561309|P1|STARTED|Overall Study||6
8340555|NCT01308749|20561322|P2|NOT COMPLETED|Period 2: Open Label Treatment||2
8340556|NCT01308749|20561323|P1|NOT COMPLETED|Period 2: Open Label Treatment||0
8340557|NCT01308749|20561322|P2|COMPLETED|Period 2: Open Label Treatment||11
8340558|NCT01308749|20561323|P1|COMPLETED|Period 2: Open Label Treatment||11
8340559|NCT01308749|20561322|P2|STARTED|Period 2: Open Label Treatment||13
8340560|NCT01308749|20561323|P1|STARTED|Period 2: Open Label Treatment||11
8340561|NCT01308749|20561322|P2|NOT COMPLETED|Period 1: Double Blind Treatment||0
8340562|NCT01308749|20561323|P1|NOT COMPLETED|Period 1: Double Blind Treatment||1
8340563|NCT01308749|20561322|P2|COMPLETED|Period 1: Double Blind Treatment||13
8340564|NCT01308749|20561323|P1|COMPLETED|Period 1: Double Blind Treatment||11
8340565|NCT01308749|20561322|P2|STARTED|Period 1: Double Blind Treatment||13
8340566|NCT01308749|20561323|P1|STARTED|Period 1: Double Blind Treatment||12
8340567|NCT01308736|20561353|P2|NOT COMPLETED|Overall Study||5
8340568|NCT01308736|20561354|P1|NOT COMPLETED|Overall Study||6
8340569|NCT01308736|20561353|P2|COMPLETED|Overall Study||27
8340570|NCT01308736|20561354|P1|COMPLETED|Overall Study||25
8340571|NCT01308736|20561353|P2|STARTED|Overall Study||32
8340572|NCT01308736|20561354|P1|STARTED|Overall Study||31
8340573|NCT01308619|20561362|P2|NOT COMPLETED|Overall Study||3
8340574|NCT01308619|20561363|P1|NOT COMPLETED|Overall Study||7
8340575|NCT01308619|20561362|P2|COMPLETED|Overall Study||83
8340576|NCT01308619|20561363|P1|COMPLETED|Overall Study||77
8340577|NCT01308619|20561362|P2|STARTED|Overall Study||86
8340578|NCT01308619|20561363|P1|STARTED|Overall Study||84
8340579|NCT01308580|20561377|P2|NOT COMPLETED|Overall Study||7
8340580|NCT01308580|20561378|P1|NOT COMPLETED|Overall Study||12
8340581|NCT01308580|20561377|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
8340582|NCT01308580|20561378|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
8340583|NCT01308580|20561377|P2|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
8340584|NCT01308580|20561378|P1|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
8340585|NCT01308580|20561377|P2|STARTED|Overall Study||602
8340586|NCT01308580|20561378|P1|STARTED|Overall Study||598
8340587|NCT01308567|20561421|P3|NOT COMPLETED|Overall Study||4
8340588|NCT01308567|20561422|P2|NOT COMPLETED|Overall Study||4
8340589|NCT01308567|20561423|P1|NOT COMPLETED|Overall Study||2
8340590|NCT01308567|20561421|P3|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
8340591|NCT01308567|20561422|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
8340592|NCT01308567|20561423|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
8340593|NCT01308567|20561421|P3|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
8340594|NCT01308567|20561422|P2|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
8340595|NCT01308567|20561423|P1|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
8340596|NCT01308567|20561421|P3|STARTED|Overall Study|Randomized|388
8340597|NCT01308567|20561422|P2|STARTED|Overall Study|Randomized|389
8340598|NCT01308567|20561423|P1|STARTED|Overall Study|Randomized|391
8340599|NCT01308476|20561463|P2|NOT COMPLETED|Overall Study||2
8340600|NCT01308476|20561464|P1|NOT COMPLETED|Overall Study||3
8340601|NCT01308476|20561463|P2|COMPLETED|Overall Study||45
8340602|NCT01308476|20561464|P1|COMPLETED|Overall Study||45
8340603|NCT01308476|20561463|P2|STARTED|Overall Study|Entered and treated.|47
8340604|NCT01308476|20561464|P1|STARTED|Overall Study|Entered and treated.|48
8340605|NCT01308463|20561484|P1|NOT COMPLETED|Overall Study||29
8340606|NCT01308463|20561484|P1|COMPLETED|Overall Study||0
8340607|NCT01308463|20561484|P1|12 Years|Overall Study||2
8340608|NCT01308463|20561484|P1|11 Years|Overall Study||8
8340609|NCT01308463|20561484|P1|10 Years|Overall Study||8
8340610|NCT01308463|20561484|P1|9 Years|Overall Study||11
8340611|NCT01308463|20561484|P1|8 Years|Overall Study||14
8340612|NCT01308463|20561484|P1|7 Years|Overall Study||12
8340613|NCT01308463|20561484|P1|6 Years|Overall Study||11
8340614|NCT01308463|20561484|P1|5 Years|Overall Study||20
8340615|NCT01308463|20561484|P1|4 Years|Overall Study||20
8340616|NCT01308463|20561484|P1|3 Years|Overall Study||17
8340617|NCT01308463|20561484|P1|2 Years|Overall Study||18
8340618|NCT01308463|20561484|P1|1 Year|Overall Study||21
8340619|NCT01308463|20561484|P1|6 Months|Overall Study||23
8340620|NCT01308463|20561484|P1|STARTED|Overall Study||29
8340621|NCT01308450|20561491|P1|NOT COMPLETED|Overall Study||2
8340622|NCT01308450|20561491|P1|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
8340623|NCT01308450|20561491|P1|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
8340624|NCT01308424|20561497|P3|NOT COMPLETED|Randomization||2
8340625|NCT01308424|20561498|P2|NOT COMPLETED|Randomization||3
8340626|NCT01308424|20561499|P1|NOT COMPLETED|Randomization||0
8340627|NCT01308424|20561497|P3|COMPLETED|Randomization||82
8340628|NCT01308424|20561498|P2|COMPLETED|Randomization||84
8340629|NCT01308424|20561499|P1|COMPLETED|Randomization||0
8340630|NCT01308424|20561497|P3|STARTED|Randomization||84
8340631|NCT01308424|20561498|P2|STARTED|Randomization||87
8340632|NCT01308424|20561499|P1|STARTED|Randomization||0
8340633|NCT01308424|20561497|P3|NOT COMPLETED|Baseline Eligibility||0
8340634|NCT01308424|20561498|P2|NOT COMPLETED|Baseline Eligibility||0
8340635|NCT01308424|20561499|P1|NOT COMPLETED|Baseline Eligibility||71
8340636|NCT01308424|20561497|P3|COMPLETED|Baseline Eligibility||0
8340637|NCT01308424|20561498|P2|COMPLETED|Baseline Eligibility||0
8340638|NCT01308424|20561499|P1|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
8340639|NCT01308424|20561497|P3|STARTED|Baseline Eligibility||0
8340640|NCT01308424|20561498|P2|STARTED|Baseline Eligibility||0
8340641|NCT01308424|20561499|P1|STARTED|Baseline Eligibility||242
8340642|NCT01308294|20561509|P3|NOT COMPLETED|Cycle 3||0
8340643|NCT01308294|20561510|P2|NOT COMPLETED|Cycle 3||1
8340644|NCT01308294|20561511|P1|NOT COMPLETED|Cycle 3||0
8340645|NCT01308294|20561509|P3|COMPLETED|Cycle 3||0
8340646|NCT01308294|20561510|P2|COMPLETED|Cycle 3||4
8340647|NCT01308294|20561511|P1|COMPLETED|Cycle 3||10
8340648|NCT01308294|20561509|P3|STARTED|Cycle 3||0
8340649|NCT01308294|20561510|P2|STARTED|Cycle 3||5
8340650|NCT01308294|20561511|P1|STARTED|Cycle 3||10
8340651|NCT01308294|20561509|P3|NOT COMPLETED|Cycle 2||0
8340652|NCT01308294|20561510|P2|NOT COMPLETED|Cycle 2||1
8340653|NCT01308294|20561511|P1|NOT COMPLETED|Cycle 2||0
8340654|NCT01308294|20561509|P3|COMPLETED|Cycle 2||0
8340655|NCT01308294|20561510|P2|COMPLETED|Cycle 2||5
8340656|NCT01308294|20561511|P1|COMPLETED|Cycle 2||10
8340657|NCT01308294|20561509|P3|STARTED|Cycle 2||0
8340658|NCT01308294|20561510|P2|STARTED|Cycle 2||6
8340659|NCT01308294|20561511|P1|STARTED|Cycle 2||10
8340660|NCT01308294|20561509|P3|NOT COMPLETED|Cycle 1||0
8340661|NCT01308294|20561510|P2|NOT COMPLETED|Cycle 1||0
8340662|NCT01308294|20561511|P1|NOT COMPLETED|Cycle 1||0
8340663|NCT01308294|20561509|P3|COMPLETED|Cycle 1||0
8340664|NCT01308294|20561510|P2|COMPLETED|Cycle 1||6
8340665|NCT01308294|20561511|P1|COMPLETED|Cycle 1||10
8340666|NCT01308294|20561509|P3|STARTED|Cycle 1||0
8340667|NCT01308294|20561510|P2|STARTED|Cycle 1||6
8340668|NCT01308294|20561511|P1|STARTED|Cycle 1||10
8340669|NCT01308060|20561539|P2|NOT COMPLETED|Part B||8
8340670|NCT01308060|20561540|P1|NOT COMPLETED|Part B||19
8340671|NCT01308060|20561539|P2|COMPLETED|Part B||69
8340672|NCT01308060|20561540|P1|COMPLETED|Part B||219
8340673|NCT01308060|20561539|P2|STARTED|Part B||77
8340674|NCT01308060|20561540|P1|STARTED|Part B||238
8340675|NCT01308060|20561539|P2|NOT COMPLETED|Part A||6
8340676|NCT01308060|20561540|P1|NOT COMPLETED|Part A||14
8340677|NCT01308060|20561539|P2|COMPLETED|Part A||77
8340678|NCT01308060|20561540|P1|COMPLETED|Part A||238
8340679|NCT01308060|20561539|P2|STARTED|Part A||83
8340680|NCT01308060|20561540|P1|STARTED|Part A||252
8340681|NCT01308008|20561551|P2|NOT COMPLETED|12 Months||4
8340682|NCT01308008|20561552|P1|NOT COMPLETED|12 Months||8
8340683|NCT01308008|20561551|P2|COMPLETED|12 Months||58
8340684|NCT01308008|20561552|P1|COMPLETED|12 Months||46
8340685|NCT01308008|20561551|P2|STARTED|12 Months||62
8340686|NCT01308008|20561552|P1|STARTED|12 Months||54
8340687|NCT01308008|20561551|P2|NOT COMPLETED|6 Months||9
8340688|NCT01308008|20561552|P1|NOT COMPLETED|6 Months||8
8340689|NCT01308008|20561551|P2|COMPLETED|6 Months||62
8340690|NCT01308008|20561552|P1|COMPLETED|6 Months||54
8340691|NCT01308008|20561551|P2|STARTED|6 Months||71
8340692|NCT01308008|20561552|P1|STARTED|6 Months||62
8340693|NCT01308008|20561551|P2|NOT COMPLETED|4 Weeks||2
8340694|NCT01308008|20561552|P1|NOT COMPLETED|4 Weeks||9
8340695|NCT01308008|20561551|P2|COMPLETED|4 Weeks||71
8340696|NCT01308008|20561552|P1|COMPLETED|4 Weeks||62
8340697|NCT01308008|20561551|P2|STARTED|4 Weeks||73
8340698|NCT01308008|20561552|P1|STARTED|4 Weeks||71
8340699|NCT01307956|20561562|P1|NOT COMPLETED|Overall Study||0
8340700|NCT01307956|20561562|P1|COMPLETED|Overall Study||11
8340701|NCT01307956|20561562|P1|STARTED|Overall Study||11
8340702|NCT01307930|20561569|P1|NOT COMPLETED|Overall Study||2
8340703|NCT01307930|20561569|P1|COMPLETED|Overall Study||18
8340704|NCT01307930|20561569|P1|STARTED|Overall Study||20
8340705|NCT01307891|20561575|P2|NOT COMPLETED|Overall Study||1
8340706|NCT01307891|20561576|P1|NOT COMPLETED|Overall Study||3
8340707|NCT01307891|20561575|P2|COMPLETED|Overall Study||21
8340708|NCT01307891|20561576|P1|COMPLETED|Overall Study||39
8340709|NCT01307891|20561575|P2|STARTED|Overall Study||22
8340710|NCT01307891|20561576|P1|STARTED|Overall Study||42
8340711|NCT01307787|20561588|P2|NOT COMPLETED|Overall Study||0
8340712|NCT01307787|20561589|P1|NOT COMPLETED|Overall Study||2
8340713|NCT01307787|20561588|P2|COMPLETED|Overall Study||15
8340714|NCT01307787|20561589|P1|COMPLETED|Overall Study||17
8340715|NCT01307787|20561588|P2|T2= After 22 Weeks at Follow-up|Overall Study||15
8340716|NCT01307787|20561589|P1|T2= After 22 Weeks at Follow-up|Overall Study||17
8340717|NCT01307787|20561588|P2|T1= After 9 Weeks Post Intervention|Overall Study||15
8340718|NCT01307787|20561589|P1|T1= After 9 Weeks Post Intervention|Overall Study||18
8340719|NCT01307787|20561588|P2|STARTED|Overall Study||15
8340720|NCT01307787|20561589|P1|STARTED|Overall Study||19
8340721|NCT01307748|20561612|P3|NOT COMPLETED|Overall Study||0
8340722|NCT01307748|20561613|P2|NOT COMPLETED|Overall Study||0
8340723|NCT01307748|20561614|P1|NOT COMPLETED|Overall Study||0
8340724|NCT01307748|20561612|P3|COMPLETED|Overall Study||30
8340725|NCT01307748|20561613|P2|COMPLETED|Overall Study||31
8340726|NCT01307748|20561614|P1|COMPLETED|Overall Study||31
8340727|NCT01307748|20561612|P3|STARTED|Overall Study||30
8340728|NCT01307748|20561613|P2|STARTED|Overall Study||31
8340729|NCT01307748|20561614|P1|STARTED|Overall Study||31
8340730|NCT01307631|20561628|P2|NOT COMPLETED|Overall Study||0
8340731|NCT01307631|20561629|P1|NOT COMPLETED|Overall Study||0
8340732|NCT01307631|20561628|P2|COMPLETED|Overall Study||28
8340733|NCT01307631|20561629|P1|COMPLETED|Overall Study||9
8340734|NCT01307631|20561628|P2|STARTED|Overall Study||28
8340735|NCT01307631|20561629|P1|STARTED|Overall Study||9
8340736|NCT01307618|20561639|P2|NOT COMPLETED|Overall Study||0
8340737|NCT01307618|20561640|P1|NOT COMPLETED|Overall Study||0
8340738|NCT01307618|20561639|P2|COMPLETED|Overall Study||5
8340739|NCT01307618|20561640|P1|COMPLETED|Overall Study||5
8340740|NCT01307618|20561639|P2|STARTED|Overall Study||5
8340741|NCT01307618|20561640|P1|STARTED|Overall Study||5
8340752|NCT01307462|20561684|P1|NOT COMPLETED|Overall Study||1
8340753|NCT01307462|20561684|P1|COMPLETED|Overall Study||35
8340754|NCT01307462|20561684|P1|STARTED|Overall Study||36
8340755|NCT01307449|20561701|P4|NOT COMPLETED|Overall Study||0
8340756|NCT01307449|20561702|P3|NOT COMPLETED|Overall Study||0
8340757|NCT01307449|20561703|P2|NOT COMPLETED|Overall Study||0
8340758|NCT01307449|20561704|P1|NOT COMPLETED|Overall Study||1
8340759|NCT01307449|20561701|P4|COMPLETED|Overall Study||11
8340760|NCT01307449|20561702|P3|COMPLETED|Overall Study||11
8340761|NCT01307449|20561703|P2|COMPLETED|Overall Study||33
8340762|NCT01307449|20561704|P1|COMPLETED|Overall Study||32
8340763|NCT01307449|20561701|P4|STARTED|Overall Study||11
8340764|NCT01307449|20561702|P3|STARTED|Overall Study||11
8340765|NCT01307449|20561703|P2|STARTED|Overall Study||33
8340766|NCT01307449|20561704|P1|STARTED|Overall Study||33
8340767|NCT01307423|20561737|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
8340768|NCT01307423|20561738|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
8340769|NCT01307423|20561739|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8340770|NCT01307423|20561740|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8340771|NCT01307423|20561741|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8340772|NCT01307423|20561742|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8340773|NCT01307423|20561743|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
8340774|NCT01307423|20561744|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
8340775|NCT01307423|20561745|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8340776|NCT01307423|20561737|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
8340777|NCT01307423|20561738|P8|COMPLETED|Long-term Safety Phase (Year 5)||37
8340778|NCT01307423|20561739|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
8340779|NCT01307423|20561740|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
8340780|NCT01307423|20561741|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
8340781|NCT01307423|20561742|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
8340782|NCT01307423|20561743|P3|COMPLETED|Long-term Safety Phase (Year 5)||80
8340783|NCT01307423|20561744|P2|COMPLETED|Long-term Safety Phase (Year 5)||71
8340784|NCT01307423|20561745|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
8340785|NCT01307423|20561737|P9|STARTED|Long-term Safety Phase (Year 5)||44
8340786|NCT01307423|20561738|P8|STARTED|Long-term Safety Phase (Year 5)||38
8340787|NCT01307423|20561739|P7|STARTED|Long-term Safety Phase (Year 5)||0
8340788|NCT01307423|20561740|P6|STARTED|Long-term Safety Phase (Year 5)||0
8340789|NCT01307423|20561741|P5|STARTED|Long-term Safety Phase (Year 5)||0
8340790|NCT01307423|20561742|P4|STARTED|Long-term Safety Phase (Year 5)||0
8340791|NCT01307423|20561743|P3|STARTED|Long-term Safety Phase (Year 5)||86
8340792|NCT01307423|20561744|P2|STARTED|Long-term Safety Phase (Year 5)||81
8340793|NCT01307423|20561745|P1|STARTED|Long-term Safety Phase (Year 5)||0
8340794|NCT01307423|20561737|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
8340795|NCT01307423|20561738|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
8340796|NCT01307423|20561739|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8340797|NCT01307423|20561740|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8340798|NCT01307423|20561741|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8340799|NCT01307423|20561742|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8340800|NCT01307423|20561743|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
8340801|NCT01307423|20561744|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
8340802|NCT01307423|20561745|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8340803|NCT01307423|20561737|P9|COMPLETED|Long-term Safety Phase (Year 4)||44
8340804|NCT01307423|20561738|P8|COMPLETED|Long-term Safety Phase (Year 4)||38
8340805|NCT01307423|20561739|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
8340806|NCT01307423|20561740|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
8340807|NCT01307423|20561741|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
8340808|NCT01307423|20561742|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
8340809|NCT01307423|20561743|P3|COMPLETED|Long-term Safety Phase (Year 4)||86
8340810|NCT01307423|20561744|P2|COMPLETED|Long-term Safety Phase (Year 4)||81
8340811|NCT01307423|20561745|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
8340812|NCT01307423|20561737|P9|STARTED|Long-term Safety Phase (Year 4)||49
8340813|NCT01307423|20561738|P8|STARTED|Long-term Safety Phase (Year 4)||40
8340814|NCT01307423|20561739|P7|STARTED|Long-term Safety Phase (Year 4)||0
8340815|NCT01307423|20561740|P6|STARTED|Long-term Safety Phase (Year 4)||0
8340816|NCT01307423|20561741|P5|STARTED|Long-term Safety Phase (Year 4)||0
8340817|NCT01307423|20561742|P4|STARTED|Long-term Safety Phase (Year 4)||0
8340818|NCT01307423|20561743|P3|STARTED|Long-term Safety Phase (Year 4)||91
8340819|NCT01307423|20561744|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
8340820|NCT01307423|20561745|P1|STARTED|Long-term Safety Phase (Year 4)||0
8340821|NCT01307423|20561737|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
8340822|NCT01307423|20561738|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
8340823|NCT01307423|20561739|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8340824|NCT01307423|20561740|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8340825|NCT01307423|20561741|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8340826|NCT01307423|20561742|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8340827|NCT01307423|20561743|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
8340828|NCT01307423|20561744|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
8340829|NCT01307423|20561745|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8340830|NCT01307423|20561737|P9|COMPLETED|Long-term Safety Phase (Year 3)||49
8340831|NCT01307423|20561738|P8|COMPLETED|Long-term Safety Phase (Year 3)||40
8340832|NCT01307423|20561739|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
8340833|NCT01307423|20561740|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
8340834|NCT01307423|20561741|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
8340835|NCT01307423|20561742|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
8340836|NCT01307423|20561743|P3|COMPLETED|Long-term Safety Phase (Year 3)||91
8340837|NCT01307423|20561744|P2|COMPLETED|Long-term Safety Phase (Year 3)||90
8340838|NCT01307423|20561745|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
8340839|NCT01307423|20561737|P9|STARTED|Long-term Safety Phase (Year 3)||60
8340840|NCT01307423|20561738|P8|STARTED|Long-term Safety Phase (Year 3)||48
8340841|NCT01307423|20561739|P7|STARTED|Long-term Safety Phase (Year 3)||0
8340842|NCT01307423|20561740|P6|STARTED|Long-term Safety Phase (Year 3)||0
8340843|NCT01307423|20561741|P5|STARTED|Long-term Safety Phase (Year 3)||0
8340844|NCT01307423|20561742|P4|STARTED|Long-term Safety Phase (Year 3)||0
8340845|NCT01307423|20561743|P3|STARTED|Long-term Safety Phase (Year 3)||109
8340846|NCT01307423|20561744|P2|STARTED|Long-term Safety Phase (Year 3)||99
8340847|NCT01307423|20561745|P1|STARTED|Long-term Safety Phase (Year 3)||0
8340848|NCT01307423|20561737|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
8340849|NCT01307423|20561738|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
8340850|NCT01307423|20561739|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8340851|NCT01307423|20561740|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8340852|NCT01307423|20561741|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8340853|NCT01307423|20561742|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8340854|NCT01307423|20561743|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
8340855|NCT01307423|20561744|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
8340856|NCT01307423|20561745|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8340857|NCT01307423|20561737|P9|COMPLETED|Long-term Safety Phase (Year 2)||60
8340858|NCT01307423|20561738|P8|COMPLETED|Long-term Safety Phase (Year 2)||48
8340859|NCT01307423|20561739|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
8340860|NCT01307423|20561740|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
8340861|NCT01307423|20561741|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
8340862|NCT01307423|20561742|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
8340863|NCT01307423|20561743|P3|COMPLETED|Long-term Safety Phase (Year 2)||109
8340864|NCT01307423|20561744|P2|COMPLETED|Long-term Safety Phase (Year 2)||99
8340865|NCT01307423|20561745|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
8340866|NCT01307423|20561737|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
8340867|NCT01307423|20561738|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
8340868|NCT01307423|20561739|P7|STARTED|Long-term Safety Phase (Year 2)||0
8340869|NCT01307423|20561740|P6|STARTED|Long-term Safety Phase (Year 2)||0
8340870|NCT01307423|20561741|P5|STARTED|Long-term Safety Phase (Year 2)||0
8340871|NCT01307423|20561742|P4|STARTED|Long-term Safety Phase (Year 2)||0
8340872|NCT01307423|20561743|P3|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
8340873|NCT01307423|20561744|P2|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
8340874|NCT01307423|20561745|P1|STARTED|Long-term Safety Phase (Year 2)||0
8340875|NCT01307423|20561737|P9|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
8340876|NCT01307423|20561738|P8|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
8340877|NCT01307423|20561739|P7|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
8340878|NCT01307423|20561740|P6|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
8340879|NCT01307423|20561741|P5|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
8340880|NCT01307423|20561742|P4|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
8340881|NCT01307423|20561743|P3|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
8340882|NCT01307423|20561744|P2|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
8340883|NCT01307423|20561745|P1|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
8340884|NCT01307423|20561737|P9|COMPLETED|Active Treatment Phase (Week 25-52)||0
8340885|NCT01307423|20561738|P8|COMPLETED|Active Treatment Phase (Week 25-52)||0
8340886|NCT01307423|20561739|P7|COMPLETED|Active Treatment Phase (Week 25-52)||25
8340887|NCT01307423|20561740|P6|COMPLETED|Active Treatment Phase (Week 25-52)||43
8340888|NCT01307423|20561741|P5|COMPLETED|Active Treatment Phase (Week 25-52)||23
8340889|NCT01307423|20561742|P4|COMPLETED|Active Treatment Phase (Week 25-52)||38
8340890|NCT01307423|20561743|P3|COMPLETED|Active Treatment Phase (Week 25-52)||141
8340891|NCT01307423|20561744|P2|COMPLETED|Active Treatment Phase (Week 25-52)||132
8340892|NCT01307423|20561745|P1|COMPLETED|Active Treatment Phase (Week 25-52)||0
8340893|NCT01307423|20561737|P9|STARTED|Active Treatment Phase (Week 25-52)||0
8340894|NCT01307423|20561738|P8|STARTED|Active Treatment Phase (Week 25-52)||0
8340895|NCT01307423|20561739|P7|STARTED|Active Treatment Phase (Week 25-52)||26
8340896|NCT01307423|20561740|P6|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
8340897|NCT01307423|20561741|P5|STARTED|Active Treatment Phase (Week 25-52)||26
8340898|NCT01307423|20561742|P4|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
8340899|NCT01307423|20561743|P3|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
8340900|NCT01307423|20561744|P2|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
8340901|NCT01307423|20561745|P1|STARTED|Active Treatment Phase (Week 25-52)||0
8340902|NCT01307423|20561737|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340903|NCT01307423|20561738|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340904|NCT01307423|20561739|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340905|NCT01307423|20561740|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340906|NCT01307423|20561741|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340907|NCT01307423|20561742|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340908|NCT01307423|20561743|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
8340909|NCT01307423|20561744|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
8340910|NCT01307423|20561745|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
8340911|NCT01307423|20561737|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340912|NCT01307423|20561738|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340913|NCT01307423|20561739|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340914|NCT01307423|20561740|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340915|NCT01307423|20561741|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340916|NCT01307423|20561742|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8340917|NCT01307423|20561743|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
8340918|NCT01307423|20561744|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
8340919|NCT01307423|20561745|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
8340920|NCT01307423|20561737|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340921|NCT01307423|20561738|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340922|NCT01307423|20561739|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340923|NCT01307423|20561740|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340924|NCT01307423|20561741|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340925|NCT01307423|20561742|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340926|NCT01307423|20561743|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
8340927|NCT01307423|20561744|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
8340928|NCT01307423|20561745|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
8340929|NCT01307423|20561737|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340930|NCT01307423|20561738|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340931|NCT01307423|20561739|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340932|NCT01307423|20561740|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340933|NCT01307423|20561741|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340934|NCT01307423|20561742|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8340935|NCT01307423|20561743|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
8340936|NCT01307423|20561744|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
8340937|NCT01307423|20561745|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
8340938|NCT01307423|20561737|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8340939|NCT01307423|20561738|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8340940|NCT01307423|20561739|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8340941|NCT01307423|20561740|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8340942|NCT01307423|20561741|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8340943|NCT01307423|20561742|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8340944|NCT01307423|20561743|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
8340945|NCT01307423|20561744|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
8340946|NCT01307423|20561745|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
8340947|NCT01307423|20561737|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8340948|NCT01307423|20561738|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8340949|NCT01307423|20561739|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8340950|NCT01307423|20561740|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8340951|NCT01307423|20561741|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8340952|NCT01307423|20561742|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8340953|NCT01307423|20561743|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
8340954|NCT01307423|20561744|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
8340955|NCT01307423|20561745|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
8340956|NCT01307397|20561929|P1|NOT COMPLETED|Overall Study||0
8340957|NCT01307397|20561929|P1|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
8340958|NCT01307397|20561929|P1|STARTED|Overall Study||3219
8340959|NCT01307319|20561951|P3|NOT COMPLETED|Overall Study||7
8340960|NCT01307319|20561952|P2|NOT COMPLETED|Overall Study||8
8340961|NCT01307319|20561953|P1|NOT COMPLETED|Overall Study||4
8340962|NCT01307319|20561951|P3|COMPLETED|Overall Study||227
8340963|NCT01307319|20561952|P2|COMPLETED|Overall Study||234
8340964|NCT01307319|20561953|P1|COMPLETED|Overall Study||235
8340965|NCT01307319|20561951|P3|ITT Population|Overall Study||234
8340966|NCT01307319|20561952|P2|ITT Population|Overall Study||241
8340967|NCT01307319|20561953|P1|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
8340968|NCT01307319|20561951|P3|Safety Population|Overall Study||234
8340969|NCT01307319|20561952|P2|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
8340970|NCT01307319|20561953|P1|Safety Population|Overall Study||239
8340971|NCT01307319|20561951|P3|STARTED|Overall Study|Randomized|234
8340972|NCT01307319|20561952|P2|STARTED|Overall Study|Randomized|242
8340973|NCT01307319|20561953|P1|STARTED|Overall Study|Randomized|239
8340974|NCT01307267|20561987|P23|NOT COMPLETED|Overall Study||4
8340975|NCT01307267|20561988|P22|NOT COMPLETED|Overall Study||5
8340976|NCT01307267|20561989|P21|NOT COMPLETED|Overall Study||3
8340977|NCT01307267|20561990|P20|NOT COMPLETED|Overall Study||32
8340978|NCT01307267|20561991|P19|NOT COMPLETED|Overall Study||2
8340979|NCT01307267|20561992|P18|NOT COMPLETED|Overall Study||1
8340980|NCT01307267|20561993|P17|NOT COMPLETED|Overall Study||1
8340981|NCT01307267|20561994|P16|NOT COMPLETED|Overall Study||1
8340982|NCT01307267|20561995|P15|NOT COMPLETED|Overall Study||2
8340983|NCT01307267|20561996|P14|NOT COMPLETED|Overall Study||0
8340984|NCT01307267|20561997|P13|NOT COMPLETED|Overall Study||1
8340985|NCT01307267|20561998|P12|NOT COMPLETED|Overall Study||11
8340986|NCT01307267|20561999|P11|NOT COMPLETED|Overall Study||6
8340987|NCT01307267|20562000|P10|NOT COMPLETED|Overall Study||5
8340988|NCT01307267|20562001|P9|NOT COMPLETED|Overall Study||30
8340989|NCT01307267|20562002|P8|NOT COMPLETED|Overall Study||4
8340990|NCT01307267|20562003|P7|NOT COMPLETED|Overall Study||2
8340991|NCT01307267|20562004|P6|NOT COMPLETED|Overall Study||41
8340992|NCT01307267|20562005|P5|NOT COMPLETED|Overall Study||1
8340993|NCT01307267|20562006|P4|NOT COMPLETED|Overall Study||3
8340994|NCT01307267|20562007|P3|NOT COMPLETED|Overall Study||5
8340995|NCT01307267|20562008|P2|NOT COMPLETED|Overall Study||3
8340996|NCT01307267|20562009|P1|NOT COMPLETED|Overall Study||4
8340997|NCT01307267|20561987|P23|COMPLETED|Overall Study||0
8340998|NCT01307267|20561988|P22|COMPLETED|Overall Study||0
8340999|NCT01307267|20561989|P21|COMPLETED|Overall Study||0
8341000|NCT01307267|20561990|P20|COMPLETED|Overall Study||0
8341001|NCT01307267|20561991|P19|COMPLETED|Overall Study||2
8341002|NCT01307267|20561992|P18|COMPLETED|Overall Study||2
8341003|NCT01307267|20561993|P17|COMPLETED|Overall Study||2
8341004|NCT01307267|20561994|P16|COMPLETED|Overall Study||2
8341005|NCT01307267|20561995|P15|COMPLETED|Overall Study||2
8341006|NCT01307267|20561996|P14|COMPLETED|Overall Study||3
8341007|NCT01307267|20561997|P13|COMPLETED|Overall Study||2
8341008|NCT01307267|20561998|P12|COMPLETED|Overall Study||0
8341009|NCT01307267|20561999|P11|COMPLETED|Overall Study||0
8341010|NCT01307267|20562000|P10|COMPLETED|Overall Study||0
8341011|NCT01307267|20562001|P9|COMPLETED|Overall Study||1
8341012|NCT01307267|20562002|P8|COMPLETED|Overall Study||0
8341013|NCT01307267|20562003|P7|COMPLETED|Overall Study||1
8341014|NCT01307267|20562004|P6|COMPLETED|Overall Study||1
8341015|NCT01307267|20562005|P5|COMPLETED|Overall Study||2
8341016|NCT01307267|20562006|P4|COMPLETED|Overall Study||1
8341017|NCT01307267|20562007|P3|COMPLETED|Overall Study||1
8341018|NCT01307267|20562008|P2|COMPLETED|Overall Study||0
8341019|NCT01307267|20562009|P1|COMPLETED|Overall Study||0
8341020|NCT01307267|20561987|P23|STARTED|Overall Study||4
8341021|NCT01307267|20561988|P22|STARTED|Overall Study||5
8341022|NCT01307267|20561989|P21|STARTED|Overall Study||3
8341023|NCT01307267|20561990|P20|STARTED|Overall Study||32
8341024|NCT01307267|20561991|P19|STARTED|Overall Study||4
8341025|NCT01307267|20561992|P18|STARTED|Overall Study||3
8341026|NCT01307267|20561993|P17|STARTED|Overall Study||3
8341027|NCT01307267|20561994|P16|STARTED|Overall Study||3
8341028|NCT01307267|20561995|P15|STARTED|Overall Study||4
8341029|NCT01307267|20561996|P14|STARTED|Overall Study||3
8341030|NCT01307267|20561997|P13|STARTED|Overall Study||3
8341031|NCT01307267|20561998|P12|STARTED|Overall Study||11
8341032|NCT01307267|20561999|P11|STARTED|Overall Study||6
8341033|NCT01307267|20562000|P10|STARTED|Overall Study||5
8341034|NCT01307267|20562001|P9|STARTED|Overall Study||31
8341035|NCT01307267|20562002|P8|STARTED|Overall Study||4
8341036|NCT01307267|20562003|P7|STARTED|Overall Study||3
8341037|NCT01307267|20562004|P6|STARTED|Overall Study||42
8341038|NCT01307267|20562005|P5|STARTED|Overall Study||3
8341039|NCT01307267|20562006|P4|STARTED|Overall Study||4
8341040|NCT01307267|20562007|P3|STARTED|Overall Study||6
8341041|NCT01307267|20562008|P2|STARTED|Overall Study||3
8341042|NCT01307267|20562009|P1|STARTED|Overall Study||4
8341043|NCT01307111|20562600|P2|NOT COMPLETED|1-2 Week IUD Check up||2
8341044|NCT01307111|20562601|P1|NOT COMPLETED|1-2 Week IUD Check up||2
8341045|NCT01307111|20562600|P2|COMPLETED|1-2 Week IUD Check up||38
8341046|NCT01307111|20562601|P1|COMPLETED|1-2 Week IUD Check up||38
8341047|NCT01307111|20562600|P2|STARTED|1-2 Week IUD Check up||40
8341048|NCT01307111|20562601|P1|STARTED|1-2 Week IUD Check up||40
8341049|NCT01307111|20562600|P2|NOT COMPLETED|IUD Insertion||0
8341050|NCT01307111|20562601|P1|NOT COMPLETED|IUD Insertion||2
8341051|NCT01307111|20562600|P2|COMPLETED|IUD Insertion||40
8341052|NCT01307111|20562601|P1|COMPLETED|IUD Insertion||40
8341053|NCT01307111|20562600|P2|STARTED|IUD Insertion||40
8341054|NCT01307111|20562601|P1|STARTED|IUD Insertion||42
8341055|NCT01307098|20562612|P3|NOT COMPLETED|Overall Study||0
8341056|NCT01307098|20562613|P2|NOT COMPLETED|Overall Study||0
8341057|NCT01307098|20562614|P1|NOT COMPLETED|Overall Study||0
8341058|NCT01307098|20562612|P3|COMPLETED|Overall Study||3
8341059|NCT01307098|20562613|P2|COMPLETED|Overall Study||3
8341060|NCT01307098|20562614|P1|COMPLETED|Overall Study||3
8341061|NCT01307098|20562612|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8341062|NCT01307098|20562613|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8341063|NCT01307098|20562614|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8341064|NCT01307098|20562612|P3|STARTED|Overall Study||3
8341065|NCT01307098|20562613|P2|STARTED|Overall Study||3
8341066|NCT01307098|20562614|P1|STARTED|Overall Study||3
8341067|NCT01307046|20562624|P2|NOT COMPLETED|Overall Study||11
8341068|NCT01307046|20562625|P1|NOT COMPLETED|Overall Study||12
8341069|NCT01307046|20562624|P2|COMPLETED|Overall Study||159
8341070|NCT01307046|20562625|P1|COMPLETED|Overall Study||154
8341071|NCT01307046|20562624|P2|STARTED|Overall Study||170
8341072|NCT01307046|20562625|P1|STARTED|Overall Study||166
8341073|NCT01307033|20562637|P4|NOT COMPLETED|44-week Open-label Extension||12
8341074|NCT01307033|20562638|P3|NOT COMPLETED|44-week Open-label Extension||11
8341075|NCT01307033|20562639|P2|NOT COMPLETED|44-week Open-label Extension||0
8341076|NCT01307033|20562640|P1|NOT COMPLETED|44-week Open-label Extension||0
8341077|NCT01307033|20562637|P4|COMPLETED|44-week Open-label Extension||115
8341078|NCT01307033|20562638|P3|COMPLETED|44-week Open-label Extension||120
8341079|NCT01307033|20562639|P2|COMPLETED|44-week Open-label Extension||0
8341080|NCT01307033|20562640|P1|COMPLETED|44-week Open-label Extension||0
8341081|NCT01307033|20562637|P4|STARTED|44-week Open-label Extension||127
8341082|NCT01307033|20562638|P3|STARTED|44-week Open-label Extension||131
8341083|NCT01307033|20562639|P2|STARTED|44-week Open-label Extension||0
8341084|NCT01307033|20562640|P1|STARTED|44-week Open-label Extension||0
8341085|NCT01307033|20562637|P4|NOT COMPLETED|8-week Double-blind Period||0
8341086|NCT01307033|20562638|P3|NOT COMPLETED|8-week Double-blind Period||0
8341087|NCT01307033|20562639|P2|NOT COMPLETED|8-week Double-blind Period||7
8341088|NCT01307033|20562640|P1|NOT COMPLETED|8-week Double-blind Period||13
8341089|NCT01307033|20562637|P4|COMPLETED|8-week Double-blind Period||0
8341090|NCT01307033|20562638|P3|COMPLETED|8-week Double-blind Period||0
8341091|NCT01307033|20562639|P2|COMPLETED|8-week Double-blind Period||127
8341092|NCT01307033|20562640|P1|COMPLETED|8-week Double-blind Period||131
8341093|NCT01307033|20562637|P4|STARTED|8-week Double-blind Period||0
8341094|NCT01307033|20562638|P3|STARTED|8-week Double-blind Period||0
8341095|NCT01307033|20562639|P2|STARTED|8-week Double-blind Period||134
8341096|NCT01307033|20562640|P1|STARTED|8-week Double-blind Period||144
8341097|NCT01307020|20562662|P10|NOT COMPLETED|Overall Study||0
8341098|NCT01307020|20562663|P9|NOT COMPLETED|Overall Study||0
8341099|NCT01307020|20562664|P8|NOT COMPLETED|Overall Study||0
8341100|NCT01307020|20562665|P7|NOT COMPLETED|Overall Study||1
8341101|NCT01307020|20562666|P6|NOT COMPLETED|Overall Study||0
8341102|NCT01307020|20562667|P5|NOT COMPLETED|Overall Study||0
8341103|NCT01307020|20562668|P4|NOT COMPLETED|Overall Study||1
8341104|NCT01307020|20562669|P3|NOT COMPLETED|Overall Study||1
8341105|NCT01307020|20562670|P2|NOT COMPLETED|Overall Study||1
8341106|NCT01307020|20562671|P1|NOT COMPLETED|Overall Study||0
8341107|NCT01307020|20562662|P10|COMPLETED|Overall Study||62
8341108|NCT01307020|20562663|P9|COMPLETED|Overall Study||61
8341109|NCT01307020|20562664|P8|COMPLETED|Overall Study||60
8341110|NCT01307020|20562665|P7|COMPLETED|Overall Study||58
8341111|NCT01307020|20562666|P6|COMPLETED|Overall Study||61
8341112|NCT01307020|20562667|P5|COMPLETED|Overall Study||60
8341113|NCT01307020|20562668|P4|COMPLETED|Overall Study||60
8341114|NCT01307020|20562669|P3|COMPLETED|Overall Study||62
8341115|NCT01307020|20562670|P2|COMPLETED|Overall Study||62
8341116|NCT01307020|20562671|P1|COMPLETED|Overall Study||61
8341117|NCT01307020|20562662|P10|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
8341118|NCT01307020|20562663|P9|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
8341119|NCT01307020|20562664|P8|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
8341120|NCT01307020|20562665|P7|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
8341121|NCT01307020|20562666|P6|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
8341122|NCT01307020|20562667|P5|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
8341123|NCT01307020|20562668|P4|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
8341124|NCT01307020|20562669|P3|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
8341125|NCT01307020|20562670|P2|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
8341126|NCT01307020|20562671|P1|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
8341127|NCT01307020|20562662|P10|Safety Population|Overall Study||62
8341128|NCT01307020|20562663|P9|Safety Population|Overall Study||61
8341129|NCT01307020|20562664|P8|Safety Population|Overall Study||60
8341130|NCT01307020|20562665|P7|Safety Population|Overall Study||59
8341131|NCT01307020|20562666|P6|Safety Population|Overall Study||61
8341132|NCT01307020|20562667|P5|Safety Population|Overall Study||60
8341133|NCT01307020|20562668|P4|Safety Population|Overall Study||61
8341134|NCT01307020|20562669|P3|Safety Population|Overall Study||63
8341135|NCT01307020|20562670|P2|Safety Population|Overall Study||63
8341136|NCT01307020|20562671|P1|Safety Population|Overall Study||61
8341137|NCT01307020|20562662|P10|STARTED|Overall Study||62
8341138|NCT01307020|20562663|P9|STARTED|Overall Study||61
8341139|NCT01307020|20562664|P8|STARTED|Overall Study||60
8341140|NCT01307020|20562665|P7|STARTED|Overall Study||59
8341141|NCT01307020|20562666|P6|STARTED|Overall Study||61
8341142|NCT01307020|20562667|P5|STARTED|Overall Study||60
8341143|NCT01307020|20562668|P4|STARTED|Overall Study||61
8341144|NCT01307020|20562669|P3|STARTED|Overall Study||63
8341145|NCT01307020|20562670|P2|STARTED|Overall Study||63
8341146|NCT01307020|20562671|P1|STARTED|Overall Study||61
8341147|NCT01307007|20562715|P2|NOT COMPLETED|Overall Study||0
8341148|NCT01307007|20562716|P1|NOT COMPLETED|Overall Study||0
8341149|NCT01307007|20562715|P2|COMPLETED|Overall Study||30
8341150|NCT01307007|20562716|P1|COMPLETED|Overall Study||25
8341151|NCT01307007|20562715|P2|STARTED|Overall Study||30
8341152|NCT01307007|20562716|P1|STARTED|Overall Study||25
8341153|NCT01306968|20562726|P4|NOT COMPLETED|Overall Study||4
8341154|NCT01306968|20562727|P3|NOT COMPLETED|Overall Study||1
8341155|NCT01306968|20562728|P2|NOT COMPLETED|Overall Study||3
8341156|NCT01306968|20562729|P1|NOT COMPLETED|Overall Study||1
8341157|NCT01306968|20562726|P4|COMPLETED|Overall Study||21
8341158|NCT01306968|20562727|P3|COMPLETED|Overall Study||23
8341159|NCT01306968|20562728|P2|COMPLETED|Overall Study||20
8341160|NCT01306968|20562729|P1|COMPLETED|Overall Study||6
8341161|NCT01306968|20562726|P4|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
8341162|NCT01306968|20562727|P3|STARTED|Overall Study||24
8341163|NCT01306968|20562728|P2|STARTED|Overall Study||23
8341164|NCT01306968|20562729|P1|STARTED|Overall Study||7
8341165|NCT01306942|20562754|P4|NOT COMPLETED|Phase II||16
8341166|NCT01306942|20562755|P3|NOT COMPLETED|Phase II||0
8341167|NCT01306942|20562756|P2|NOT COMPLETED|Phase II||0
8341168|NCT01306942|20562757|P1|NOT COMPLETED|Phase II||2
8341169|NCT01306942|20562754|P4|COMPLETED|Phase II||11
8341170|NCT01306942|20562755|P3|COMPLETED|Phase II||0
8341171|NCT01306942|20562756|P2|COMPLETED|Phase II||0
8341172|NCT01306942|20562757|P1|COMPLETED|Phase II||0
8341173|NCT01306942|20562754|P4|STARTED|Phase II||27
8341174|NCT01306942|20562755|P3|STARTED|Phase II||0
8341175|NCT01306942|20562756|P2|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0
8341176|NCT01306942|20562757|P1|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2
8341177|NCT01306942|20562754|P4|NOT COMPLETED|Phase I||0
8341178|NCT01306942|20562755|P3|NOT COMPLETED|Phase I||0
8341179|NCT01306942|20562756|P2|NOT COMPLETED|Phase I||3
8341180|NCT01306942|20562757|P1|NOT COMPLETED|Phase I||5
8341181|NCT01306942|20562754|P4|COMPLETED|Phase I||0
8341182|NCT01306942|20562755|P3|COMPLETED|Phase I||0
8341183|NCT01306942|20562756|P2|COMPLETED|Phase I||1
8341184|NCT01306942|20562757|P1|COMPLETED|Phase I||1
8341185|NCT01306942|20562754|P4|STARTED|Phase I||0
8341186|NCT01306942|20562755|P3|STARTED|Phase I||0
8341187|NCT01306942|20562756|P2|STARTED|Phase I||4
8341188|NCT01306942|20562757|P1|STARTED|Phase I||6
8341189|NCT01306890|20562789|P1|NOT COMPLETED|Overall Study||1519
8341190|NCT01306890|20562789|P1|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457
8341191|NCT01306890|20562789|P1|STARTED|Overall Study||1976
8341192|NCT01306877|20562796|P2|NOT COMPLETED|Overall Study||4
8341193|NCT01306877|20562797|P1|NOT COMPLETED|Overall Study||3
8341194|NCT01306877|20562796|P2|COMPLETED|Overall Study||67
8341195|NCT01306877|20562797|P1|COMPLETED|Overall Study||75
8341196|NCT01306877|20562796|P2|STARTED|Overall Study||71
8341197|NCT01306877|20562797|P1|STARTED|Overall Study||78
8341198|NCT01306656|20562817|P2|NOT COMPLETED|Overall Study||0
8341199|NCT01306656|20562818|P1|NOT COMPLETED|Overall Study||1
8341200|NCT01306656|20562817|P2|COMPLETED|Overall Study||2
8341201|NCT01306656|20562818|P1|COMPLETED|Overall Study||6
8341202|NCT01306656|20562817|P2|STARTED|Overall Study||2
8341203|NCT01306656|20562818|P1|STARTED|Overall Study||7
8341204|NCT01306643|20562830|P1|NOT COMPLETED|Overall Study||13
8341205|NCT01306643|20562830|P1|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
8341206|NCT01306643|20562830|P1|STARTED|Overall Study||18
8341207|NCT01306617|20562842|P3|NOT COMPLETED|Overall Study||5
8341208|NCT01306617|20562843|P2|NOT COMPLETED|Overall Study||1
8341209|NCT01306617|20562844|P1|NOT COMPLETED|Overall Study||1
8341210|NCT01306617|20562842|P3|COMPLETED|Overall Study|The number of participants who completed study drug|12
8341211|NCT01306617|20562843|P2|COMPLETED|Overall Study|The number of participants who completed study drug|13
8341212|NCT01306617|20562844|P1|COMPLETED|Overall Study|The number of participants who completed study drug|18
8341213|NCT01306617|20562842|P3|STARTED|Overall Study||17
8341214|NCT01306617|20562843|P2|STARTED|Overall Study||14
8341215|NCT01306617|20562844|P1|STARTED|Overall Study||19
8341216|NCT01306331|20562887|P2|NOT COMPLETED|Overall Study||877
8341217|NCT01306331|20562888|P1|NOT COMPLETED|Overall Study||901
8341218|NCT01306331|20562887|P2|COMPLETED|Overall Study||788
8341219|NCT01306331|20562888|P1|COMPLETED|Overall Study||758
8341220|NCT01306331|20562887|P2|STARTED|Overall Study||1665
8341221|NCT01306331|20562888|P1|STARTED|Overall Study||1659
8341222|NCT01306305|20562898|P2|NOT COMPLETED|Overall Study||0
8341223|NCT01306305|20562899|P1|NOT COMPLETED|Overall Study||2
8341224|NCT01306305|20562898|P2|COMPLETED|Overall Study||55
8341225|NCT01306305|20562899|P1|COMPLETED|Overall Study||53
8341226|NCT01306305|20562898|P2|STARTED|Overall Study||55
8341227|NCT01306305|20562899|P1|STARTED|Overall Study||55
8341228|NCT01306292|20562915|P4|NOT COMPLETED|Second Injection||0
8341229|NCT01306292|20562916|P3|NOT COMPLETED|Second Injection||1
8341230|NCT01306292|20562917|P2|NOT COMPLETED|Second Injection||0
8341231|NCT01306292|20562918|P1|NOT COMPLETED|Second Injection||0
8341232|NCT01306292|20562915|P4|COMPLETED|Second Injection||10
8341233|NCT01306292|20562916|P3|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
8341234|NCT01306292|20562917|P2|COMPLETED|Second Injection||8
8341235|NCT01306292|20562918|P1|COMPLETED|Second Injection||10
8341236|NCT01306292|20562915|P4|STARTED|Second Injection||10
8341237|NCT01306292|20562916|P3|STARTED|Second Injection||8
8341238|NCT01306292|20562917|P2|STARTED|Second Injection||8
8341239|NCT01306292|20562918|P1|STARTED|Second Injection||10
8341240|NCT01306292|20562915|P4|NOT COMPLETED|Washout (at Least 10 Minutes)||0
8341241|NCT01306292|20562916|P3|NOT COMPLETED|Washout (at Least 10 Minutes)||0
8341242|NCT01306292|20562917|P2|NOT COMPLETED|Washout (at Least 10 Minutes)||0
8341243|NCT01306292|20562918|P1|NOT COMPLETED|Washout (at Least 10 Minutes)||0
8341244|NCT01306292|20562915|P4|COMPLETED|Washout (at Least 10 Minutes)||10
8341245|NCT01306292|20562916|P3|COMPLETED|Washout (at Least 10 Minutes)||8
8341246|NCT01306292|20562917|P2|COMPLETED|Washout (at Least 10 Minutes)||8
8341247|NCT01306292|20562918|P1|COMPLETED|Washout (at Least 10 Minutes)||10
8341248|NCT01306292|20562915|P4|STARTED|Washout (at Least 10 Minutes)||10
8341249|NCT01306292|20562916|P3|STARTED|Washout (at Least 10 Minutes)||8
8341250|NCT01306292|20562917|P2|STARTED|Washout (at Least 10 Minutes)||8
8341251|NCT01306292|20562918|P1|STARTED|Washout (at Least 10 Minutes)||10
8341252|NCT01306292|20562915|P4|NOT COMPLETED|First Injection||0
8341253|NCT01306292|20562916|P3|NOT COMPLETED|First Injection||0
8341254|NCT01306292|20562917|P2|NOT COMPLETED|First Injection||0
8341255|NCT01306292|20562918|P1|NOT COMPLETED|First Injection||0
8341256|NCT01306292|20562915|P4|COMPLETED|First Injection||10
8341257|NCT01306292|20562916|P3|COMPLETED|First Injection||8
8341258|NCT01306292|20562917|P2|COMPLETED|First Injection||8
8341259|NCT01306292|20562918|P1|COMPLETED|First Injection||10
8341260|NCT01306292|20562915|P4|STARTED|First Injection||10
8341261|NCT01306292|20562916|P3|STARTED|First Injection||8
8341262|NCT01306292|20562917|P2|STARTED|First Injection||8
8341263|NCT01306292|20562918|P1|STARTED|First Injection||10
8341264|NCT01306253|20562936|P2|NOT COMPLETED|Overall Study||1
8341265|NCT01306253|20562937|P1|NOT COMPLETED|Overall Study||1
8341266|NCT01306253|20562936|P2|COMPLETED|Overall Study||56
8341267|NCT01306253|20562937|P1|COMPLETED|Overall Study||56
8341268|NCT01306253|20562936|P2|STARTED|Overall Study||57
8341269|NCT01306253|20562937|P1|STARTED|Overall Study||57
8341270|NCT01306214|20562954|P3|NOT COMPLETED|Overall Study||22
8341271|NCT01306214|20562955|P2|NOT COMPLETED|Overall Study||28
8341272|NCT01306214|20562956|P1|NOT COMPLETED|Overall Study||28
8341273|NCT01306214|20562954|P3|COMPLETED|Overall Study||168
8341274|NCT01306214|20562955|P2|COMPLETED|Overall Study||159
8341275|NCT01306214|20562956|P1|COMPLETED|Overall Study||161
8341276|NCT01306214|20562954|P3|STARTED|Overall Study||190
8341277|NCT01306214|20562955|P2|STARTED|Overall Study||187
8341278|NCT01306214|20562956|P1|STARTED|Overall Study||189
8341279|NCT01306201|20562973|P1|NOT COMPLETED|Overall Study||10
8341280|NCT01306201|20562973|P1|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
8341281|NCT01306201|20562973|P1|STARTED|Overall Study||63
8341282|NCT01306175|20562981|P1|NOT COMPLETED|Second Intervention||0
8341283|NCT01306175|20562981|P1|COMPLETED|Second Intervention||20
8341284|NCT01306175|20562981|P1|STARTED|Second Intervention||20
8341285|NCT01306175|20562981|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
8341286|NCT01306175|20562981|P1|COMPLETED|Washout Period of at Least 14 Days||20
8341287|NCT01306175|20562981|P1|STARTED|Washout Period of at Least 14 Days||20
8341288|NCT01306175|20562981|P1|NOT COMPLETED|First Intervention||0
8341289|NCT01306175|20562981|P1|COMPLETED|First Intervention||20
8341290|NCT01306175|20562981|P1|STARTED|First Intervention||20
8341291|NCT01306162|20562995|P4|NOT COMPLETED|Period 4||0
8341292|NCT01306162|20562996|P3|NOT COMPLETED|Period 4||0
8341293|NCT01306162|20562997|P2|NOT COMPLETED|Period 4||0
8341294|NCT01306162|20562998|P1|NOT COMPLETED|Period 4||0
8341295|NCT01306162|20562995|P4|COMPLETED|Period 4||8
8341296|NCT01306162|20562996|P3|COMPLETED|Period 4||9
8341297|NCT01306162|20562997|P2|COMPLETED|Period 4||8
8341298|NCT01306162|20562998|P1|COMPLETED|Period 4||9
8341299|NCT01306162|20562995|P4|STARTED|Period 4||8
8341300|NCT01306162|20562996|P3|STARTED|Period 4||9
8341301|NCT01306162|20562997|P2|STARTED|Period 4||8
8341302|NCT01306162|20562998|P1|STARTED|Period 4||9
8341303|NCT01306162|20562995|P4|NOT COMPLETED|Washout 2||0
8341304|NCT01306162|20562996|P3|NOT COMPLETED|Washout 2||0
8341305|NCT01306162|20562997|P2|NOT COMPLETED|Washout 2||0
8341306|NCT01306162|20562998|P1|NOT COMPLETED|Washout 2||0
8341307|NCT01306162|20562995|P4|COMPLETED|Washout 2||8
8341308|NCT01306162|20562996|P3|COMPLETED|Washout 2||9
8341309|NCT01306162|20562997|P2|COMPLETED|Washout 2||8
8341310|NCT01306162|20562998|P1|COMPLETED|Washout 2||9
8341311|NCT01306162|20562995|P4|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
8341312|NCT01306162|20562996|P3|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
8341313|NCT01306162|20562997|P2|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
8341314|NCT01306162|20562998|P1|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
8341315|NCT01306162|20562995|P4|NOT COMPLETED|Period 3||0
8341316|NCT01306162|20562996|P3|NOT COMPLETED|Period 3||0
8341317|NCT01306162|20562997|P2|NOT COMPLETED|Period 3||0
8341318|NCT01306162|20562998|P1|NOT COMPLETED|Period 3||0
8341319|NCT01306162|20562995|P4|COMPLETED|Period 3||8
8341320|NCT01306162|20562996|P3|COMPLETED|Period 3||9
8341321|NCT01306162|20562997|P2|COMPLETED|Period 3||8
8341322|NCT01306162|20562998|P1|COMPLETED|Period 3||9
8341323|NCT01306162|20562995|P4|STARTED|Period 3||8
8341324|NCT01306162|20562996|P3|STARTED|Period 3||9
8341325|NCT01306162|20562997|P2|STARTED|Period 3||8
8341326|NCT01306162|20562998|P1|STARTED|Period 3||9
8341327|NCT01306162|20562995|P4|NOT COMPLETED|Period 2||0
8341328|NCT01306162|20562996|P3|NOT COMPLETED|Period 2||0
8341329|NCT01306162|20562997|P2|NOT COMPLETED|Period 2||0
8341330|NCT01306162|20562998|P1|NOT COMPLETED|Period 2||0
8341331|NCT01306162|20562995|P4|COMPLETED|Period 2||8
8341332|NCT01306162|20562996|P3|COMPLETED|Period 2||9
8341333|NCT01306162|20562997|P2|COMPLETED|Period 2||8
8341334|NCT01306162|20562998|P1|COMPLETED|Period 2||9
8341335|NCT01306162|20562995|P4|STARTED|Period 2|No washout phase after Period 2.|8
8341336|NCT01306162|20562996|P3|STARTED|Period 2|No washout phase after Period 2.|9
8341337|NCT01306162|20562997|P2|STARTED|Period 2|No washout phase after Period 2.|8
8341338|NCT01306162|20562998|P1|STARTED|Period 2|No washout phase after Period 2.|9
8341339|NCT01306162|20562995|P4|NOT COMPLETED|Washout 1||0
8341340|NCT01306162|20562996|P3|NOT COMPLETED|Washout 1||0
8341341|NCT01306162|20562997|P2|NOT COMPLETED|Washout 1||1
8341342|NCT01306162|20562998|P1|NOT COMPLETED|Washout 1||0
8341343|NCT01306162|20562995|P4|COMPLETED|Washout 1||8
8341344|NCT01306162|20562996|P3|COMPLETED|Washout 1||9
8341345|NCT01306162|20562997|P2|COMPLETED|Washout 1||8
8341346|NCT01306162|20562998|P1|COMPLETED|Washout 1||9
8341347|NCT01306162|20562995|P4|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
8341348|NCT01306162|20562996|P3|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
8341349|NCT01306162|20562997|P2|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
8341350|NCT01306162|20562998|P1|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
8341351|NCT01306162|20562995|P4|NOT COMPLETED|Period 1||1
8341352|NCT01306162|20562996|P3|NOT COMPLETED|Period 1||0
8341353|NCT01306162|20562997|P2|NOT COMPLETED|Period 1||0
8341354|NCT01306162|20562998|P1|NOT COMPLETED|Period 1||0
8341355|NCT01306162|20562995|P4|COMPLETED|Period 1||8
8341356|NCT01306162|20562996|P3|COMPLETED|Period 1||9
8341357|NCT01306162|20562997|P2|COMPLETED|Period 1||9
8341358|NCT01306162|20562998|P1|COMPLETED|Period 1||9
8341359|NCT01306162|20562995|P4|STARTED|Period 1||9
8341360|NCT01306162|20562996|P3|STARTED|Period 1||9
8341361|NCT01306162|20562997|P2|STARTED|Period 1||9
8341362|NCT01306162|20562998|P1|STARTED|Period 1||9
8341363|NCT01306058|20563026|P1|NOT COMPLETED|Overall Study||2
8341364|NCT01306058|20563026|P1|COMPLETED|Overall Study||25
8341365|NCT01306058|20563026|P1|STARTED|Overall Study||27
8341366|NCT01306032|20563053|P6|NOT COMPLETED|Disease Progression/Crossover||0
8341367|NCT01306032|20563054|P5|NOT COMPLETED|Disease Progression/Crossover||0
8341368|NCT01306032|20563055|P4|NOT COMPLETED|Disease Progression/Crossover||3
8341369|NCT01306032|20563056|P3|NOT COMPLETED|Disease Progression/Crossover||0
8341370|NCT01306032|20563057|P2|NOT COMPLETED|Disease Progression/Crossover||2
8341371|NCT01306032|20563058|P1|NOT COMPLETED|Disease Progression/Crossover||0
8341372|NCT01306032|20563053|P6|COMPLETED|Disease Progression/Crossover||0
8341373|NCT01306032|20563054|P5|COMPLETED|Disease Progression/Crossover||0
8341374|NCT01306032|20563055|P4|COMPLETED|Disease Progression/Crossover||26
8341375|NCT01306032|20563056|P3|COMPLETED|Disease Progression/Crossover||0
8341376|NCT01306032|20563057|P2|COMPLETED|Disease Progression/Crossover||14
8341377|NCT01306032|20563058|P1|COMPLETED|Disease Progression/Crossover||0
8341378|NCT01306032|20563053|P6|STARTED|Disease Progression/Crossover||0
8341379|NCT01306032|20563054|P5|STARTED|Disease Progression/Crossover||0
8341380|NCT01306032|20563055|P4|STARTED|Disease Progression/Crossover||29
8341381|NCT01306032|20563056|P3|STARTED|Disease Progression/Crossover||0
8341382|NCT01306032|20563057|P2|STARTED|Disease Progression/Crossover||16
8341383|NCT01306032|20563058|P1|STARTED|Disease Progression/Crossover||0
8341384|NCT01306032|20563053|P6|NOT COMPLETED|First Intervention||2
8341385|NCT01306032|20563054|P5|NOT COMPLETED|First Intervention||2
8341386|NCT01306032|20563055|P4|NOT COMPLETED|First Intervention||1
8341387|NCT01306032|20563056|P3|NOT COMPLETED|First Intervention||2
8341388|NCT01306032|20563057|P2|NOT COMPLETED|First Intervention||2
8341389|NCT01306032|20563058|P1|NOT COMPLETED|First Intervention||1
8341390|NCT01306032|20563053|P6|COMPLETED|First Intervention||0
8341391|NCT01306032|20563054|P5|COMPLETED|First Intervention||0
8341392|NCT01306032|20563055|P4|COMPLETED|First Intervention||37
8341393|NCT01306032|20563056|P3|COMPLETED|First Intervention||35
8341394|NCT01306032|20563057|P2|COMPLETED|First Intervention||18
8341395|NCT01306032|20563058|P1|COMPLETED|First Intervention||21
8341396|NCT01306032|20563053|P6|STARTED|First Intervention||2
8341397|NCT01306032|20563054|P5|STARTED|First Intervention||2
8341398|NCT01306032|20563055|P4|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
8341399|NCT01306032|20563056|P3|STARTED|First Intervention||37
8341400|NCT01306032|20563057|P2|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
8341401|NCT01306032|20563058|P1|STARTED|First Intervention||22
8341402|NCT01305941|20563110|P1|NOT COMPLETED|Overall Study||10
8341403|NCT01305941|20563110|P1|COMPLETED|Overall Study||22
8341404|NCT01305941|20563110|P1|STARTED|Overall Study||32
8341405|NCT01305811|20563124|P2|NOT COMPLETED|Overall Study||11
8341406|NCT01305811|20563125|P1|NOT COMPLETED|Overall Study||8
8341407|NCT01305811|20563124|P2|COMPLETED|Overall Study||41
8341408|NCT01305811|20563125|P1|COMPLETED|Overall Study||44
8341409|NCT01305811|20563124|P2|STARTED|Overall Study||52
8341410|NCT01305811|20563125|P1|STARTED|Overall Study||52
8341411|NCT01305772|20563135|P2|NOT COMPLETED|Overall Study||0
8341412|NCT01305772|20563136|P1|NOT COMPLETED|Overall Study||0
8341413|NCT01305772|20563135|P2|COMPLETED|Overall Study||1
8341414|NCT01305772|20563136|P1|COMPLETED|Overall Study||5
8341415|NCT01305772|20563135|P2|RT + Panitumumab Dose #2 / #3|Overall Study||1
8341416|NCT01305772|20563136|P1|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
8341417|NCT01305772|20563135|P2|Surgery/Biopsy #2|Overall Study||1
8341418|NCT01305772|20563136|P1|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
8341419|NCT01305772|20563135|P2|Research PET/CT #2|Overall Study||1
8341420|NCT01305772|20563136|P1|Research PET/CT #2|Overall Study||5
8341421|NCT01305772|20563135|P2|Panitumumab Dose #1|Overall Study||1
8341422|NCT01305772|20563136|P1|Panitumumab Dose #1|Overall Study||5
8341423|NCT01305772|20563135|P2|Research PET/CT #1|Overall Study||1
8341424|NCT01305772|20563136|P1|Research PET/CT #1|Overall Study||5
8341425|NCT01305772|20563135|P2|Genomic Screening + Biopsy #1|Overall Study||1
8341426|NCT01305772|20563136|P1|Genomic Screening + Biopsy #1|Overall Study||5
8341427|NCT01305772|20563135|P2|STARTED|Overall Study||1
8341428|NCT01305772|20563136|P1|STARTED|Overall Study||5
8341429|NCT01305655|20563143|P1|NOT COMPLETED|Overall Study||0
8341430|NCT01305655|20563143|P1|COMPLETED|Overall Study|December 31, 2014|47
8341431|NCT01305655|20563143|P1|STARTED|Overall Study|July 2008|47
8341432|NCT01305577|20563150|P3|NOT COMPLETED|Overall Study||10
8341433|NCT01305577|20563151|P2|NOT COMPLETED|Overall Study||11
8341434|NCT01305577|20563152|P1|NOT COMPLETED|Overall Study||13
8341435|NCT01305577|20563150|P3|COMPLETED|Overall Study||112
8341436|NCT01305577|20563151|P2|COMPLETED|Overall Study||110
8341437|NCT01305577|20563152|P1|COMPLETED|Overall Study||107
8341438|NCT01305577|20563150|P3|Received Treatment|Overall Study||122
8341439|NCT01305577|20563151|P2|Received Treatment|Overall Study||121
8341440|NCT01305577|20563152|P1|Received Treatment|Overall Study||119
8341441|NCT01305577|20563150|P3|STARTED|Overall Study||122
8341442|NCT01305577|20563151|P2|STARTED|Overall Study||121
8341443|NCT01305577|20563152|P1|STARTED|Overall Study||120
8341444|NCT01305564|20563181|P1|NOT COMPLETED|Overall Study||37
8341445|NCT01305564|20563181|P1|COMPLETED|Overall Study||163
8341446|NCT01305564|20563181|P1|STARTED|Overall Study||200
8341447|NCT01305473|20563196|P1|NOT COMPLETED|Overall Study||0
8341448|NCT01305473|20563196|P1|COMPLETED|Overall Study||90
8341449|NCT01305473|20563196|P1|STARTED|Overall Study||90
8341450|NCT01305408|20563208|P2|NOT COMPLETED|Overall Study||31
8341451|NCT01305408|20563209|P1|NOT COMPLETED|Overall Study||32
8341452|NCT01305408|20563208|P2|COMPLETED|Overall Study||169
8341453|NCT01305408|20563209|P1|COMPLETED|Overall Study||167
8341454|NCT01305408|20563208|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
8341455|NCT01305408|20563209|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
8341456|NCT01305408|20563208|P2|Safety Population|Overall Study|Treated participants.|200
8341457|NCT01305408|20563209|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
8341458|NCT01305408|20563208|P2|STARTED|Overall Study||200
8341459|NCT01305408|20563209|P1|STARTED|Overall Study||199
8341460|NCT01305356|20563261|P2|NOT COMPLETED|Overall Study||0
8341461|NCT01305356|20563262|P1|NOT COMPLETED|Overall Study||0
8341462|NCT01305356|20563261|P2|COMPLETED|Overall Study||167
8341463|NCT01305356|20563262|P1|COMPLETED|Overall Study||132
8341464|NCT01305356|20563261|P2|STARTED|Overall Study||167
8341465|NCT01305356|20563262|P1|STARTED|Overall Study||132
8341466|NCT01305265|20563278|P2|NOT COMPLETED|Overall Study||6
8341467|NCT01305265|20563279|P1|NOT COMPLETED|Overall Study||2
8341468|NCT01305265|20563278|P2|COMPLETED|Overall Study||64
8341469|NCT01305265|20563279|P1|COMPLETED|Overall Study||69
8341470|NCT01305265|20563278|P2|STARTED|Overall Study||70
8341471|NCT01305265|20563279|P1|STARTED|Overall Study||71
8341472|NCT01305252|20563287|P2|NOT COMPLETED|Overall Study||0
8341473|NCT01305252|20563288|P1|NOT COMPLETED|Overall Study||1
8341474|NCT01305252|20563287|P2|COMPLETED|Overall Study||11
8341475|NCT01305252|20563288|P1|COMPLETED|Overall Study||9
8341476|NCT01305252|20563287|P2|STARTED|Overall Study||11
8341477|NCT01305252|20563288|P1|STARTED|Overall Study||10
8341478|NCT01305239|20563302|P1|NOT COMPLETED|Overall Study||23
8341479|NCT01305239|20563302|P1|COMPLETED|Overall Study||375
8341480|NCT01305239|20563302|P1|Intent to Treat Population|Overall Study||287
8341481|NCT01305239|20563302|P1|Safety Set|Overall Study||397
8341482|NCT01305239|20563302|P1|STARTED|Overall Study||398
8341483|NCT01305213|20563312|P2|NOT COMPLETED|Overall Study||0
8341484|NCT01305213|20563313|P1|NOT COMPLETED|Overall Study||0
8341485|NCT01305213|20563312|P2|COMPLETED|Overall Study||54
8341486|NCT01305213|20563313|P1|COMPLETED|Overall Study||53
8341487|NCT01305213|20563312|P2|STARTED|Overall Study||54
8341488|NCT01305213|20563313|P1|STARTED|Overall Study||53
8341489|NCT01305200|20563332|P3|NOT COMPLETED|Overall Study||3
8341490|NCT01305200|20563333|P2|NOT COMPLETED|Overall Study||31
8341491|NCT01305200|20563334|P1|NOT COMPLETED|Overall Study||29
8341492|NCT01305200|20563332|P3|COMPLETED|Overall Study||0
8341493|NCT01305200|20563333|P2|COMPLETED|Overall Study||81
8341494|NCT01305200|20563334|P1|COMPLETED|Overall Study||82
8341495|NCT01305200|20563332|P3|STARTED|Overall Study||3
8341496|NCT01305200|20563333|P2|STARTED|Overall Study||112
8341497|NCT01305200|20563334|P1|STARTED|Overall Study||111
8341498|NCT01305044|20563364|P2|NOT COMPLETED|Overall Study||6
8341499|NCT01305044|20563365|P1|NOT COMPLETED|Overall Study||3
8341500|NCT01305044|20563364|P2|COMPLETED|Overall Study||25
8341501|NCT01305044|20563365|P1|COMPLETED|Overall Study||29
8341502|NCT01305044|20563364|P2|STARTED|Overall Study||31
8341503|NCT01305044|20563365|P1|STARTED|Overall Study||32
8341504|NCT01304966|20563389|P1|NOT COMPLETED|Overall Study||0
8341505|NCT01304966|20563389|P1|COMPLETED|Overall Study||15
8341506|NCT01304966|20563389|P1|STARTED|Overall Study||15
8341507|NCT01304940|20563397|P2|NOT COMPLETED|Overall Study||0
8341508|NCT01304940|20563398|P1|NOT COMPLETED|Overall Study||3
8341509|NCT01304940|20563397|P2|COMPLETED|Overall Study||25
8341510|NCT01304940|20563398|P1|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22
8341511|NCT01304940|20563397|P2|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
8341512|NCT01304940|20563398|P1|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
8341513|NCT01304940|20563397|P2|STARTED|Overall Study||25
8341514|NCT01304940|20563398|P1|STARTED|Overall Study||25
8341515|NCT01304706|20563404|P1|NOT COMPLETED|Overall Study||17
8341516|NCT01304706|20563404|P1|COMPLETED|Overall Study||104
8341517|NCT01304706|20563404|P1|STARTED|Overall Study||121
8341518|NCT01304693|20563413|P5|NOT COMPLETED|Overall Study||1
8341519|NCT01304693|20563414|P4|NOT COMPLETED|Overall Study||1
8341520|NCT01304693|20563415|P3|NOT COMPLETED|Overall Study||1
8341521|NCT01304693|20563416|P2|NOT COMPLETED|Overall Study||0
8341522|NCT01304693|20563417|P1|NOT COMPLETED|Overall Study||0
8341523|NCT01304693|20563413|P5|COMPLETED|Overall Study||60
8341524|NCT01304693|20563414|P4|COMPLETED|Overall Study||39
8341525|NCT01304693|20563415|P3|COMPLETED|Overall Study||47
8341526|NCT01304693|20563416|P2|COMPLETED|Overall Study||35
8341527|NCT01304693|20563417|P1|COMPLETED|Overall Study||10
8341528|NCT01304693|20563413|P5|STARTED|Overall Study||61
8341529|NCT01304693|20563414|P4|STARTED|Overall Study||40
8341530|NCT01304693|20563415|P3|STARTED|Overall Study||48
8341531|NCT01304693|20563416|P2|STARTED|Overall Study||35
8341532|NCT01304693|20563417|P1|STARTED|Overall Study||10
8341539|NCT01304589|20563455|P1|NOT COMPLETED|Overall Study||13
8341540|NCT01304589|20563455|P1|COMPLETED|Overall Study||18
8341541|NCT01304589|20563455|P1|STARTED|Overall Study||31
8341542|NCT01304498|20563464|P2|NOT COMPLETED|Overall Study||5
8341543|NCT01304498|20563465|P1|NOT COMPLETED|Overall Study||6
8341544|NCT01304498|20563464|P2|COMPLETED|Overall Study||295
8341545|NCT01304498|20563465|P1|COMPLETED|Overall Study||294
8341546|NCT01304498|20563464|P2|Received ≥1 Dose|Overall Study||300
8341547|NCT01304498|20563465|P1|Received ≥1 Dose|Overall Study||300
8341548|NCT01304498|20563464|P2|STARTED|Overall Study||300
8341549|NCT01304498|20563465|P1|STARTED|Overall Study||300
8341550|NCT01304407|20563485|P1|NOT COMPLETED|Overall Study||0
8341551|NCT01304407|20563485|P1|COMPLETED|Overall Study||29
8341552|NCT01304407|20563485|P1|STARTED|Overall Study||29
8341553|NCT01304329|20563489|P6|NOT COMPLETED|Third Intervention (3 Days)||0
8341554|NCT01304329|20563490|P5|NOT COMPLETED|Third Intervention (3 Days)||0
8341555|NCT01304329|20563491|P4|NOT COMPLETED|Third Intervention (3 Days)||0
8341556|NCT01304329|20563492|P3|NOT COMPLETED|Third Intervention (3 Days)||0
8341557|NCT01304329|20563493|P2|NOT COMPLETED|Third Intervention (3 Days)||1
8341558|NCT01304329|20563494|P1|NOT COMPLETED|Third Intervention (3 Days)||0
8341559|NCT01304329|20563489|P6|COMPLETED|Third Intervention (3 Days)||3
8341560|NCT01304329|20563490|P5|COMPLETED|Third Intervention (3 Days)||3
8341561|NCT01304329|20563491|P4|COMPLETED|Third Intervention (3 Days)||3
8341562|NCT01304329|20563492|P3|COMPLETED|Third Intervention (3 Days)||3
8341563|NCT01304329|20563493|P2|COMPLETED|Third Intervention (3 Days)||2
8341564|NCT01304329|20563494|P1|COMPLETED|Third Intervention (3 Days)||3
8341565|NCT01304329|20563489|P6|STARTED|Third Intervention (3 Days)||3
8341566|NCT01304329|20563490|P5|STARTED|Third Intervention (3 Days)||3
8341567|NCT01304329|20563491|P4|STARTED|Third Intervention (3 Days)||3
8341568|NCT01304329|20563492|P3|STARTED|Third Intervention (3 Days)||3
8341569|NCT01304329|20563493|P2|STARTED|Third Intervention (3 Days)||3
8341570|NCT01304329|20563494|P1|STARTED|Third Intervention (3 Days)||3
8341571|NCT01304329|20563489|P6|NOT COMPLETED|Second Intervention (3 Days)||0
8341572|NCT01304329|20563490|P5|NOT COMPLETED|Second Intervention (3 Days)||0
8341573|NCT01304329|20563491|P4|NOT COMPLETED|Second Intervention (3 Days)||0
8341574|NCT01304329|20563492|P3|NOT COMPLETED|Second Intervention (3 Days)||0
8341575|NCT01304329|20563493|P2|NOT COMPLETED|Second Intervention (3 Days)||0
8341576|NCT01304329|20563494|P1|NOT COMPLETED|Second Intervention (3 Days)||0
8341577|NCT01304329|20563489|P6|COMPLETED|Second Intervention (3 Days)||3
8341578|NCT01304329|20563490|P5|COMPLETED|Second Intervention (3 Days)||3
8341579|NCT01304329|20563491|P4|COMPLETED|Second Intervention (3 Days)||3
8341580|NCT01304329|20563492|P3|COMPLETED|Second Intervention (3 Days)||3
8341581|NCT01304329|20563493|P2|COMPLETED|Second Intervention (3 Days)||3
8341582|NCT01304329|20563494|P1|COMPLETED|Second Intervention (3 Days)||3
8341583|NCT01304329|20563489|P6|STARTED|Second Intervention (3 Days)||3
8341584|NCT01304329|20563490|P5|STARTED|Second Intervention (3 Days)||3
8341585|NCT01304329|20563491|P4|STARTED|Second Intervention (3 Days)||3
8341586|NCT01304329|20563492|P3|STARTED|Second Intervention (3 Days)||3
8341587|NCT01304329|20563493|P2|STARTED|Second Intervention (3 Days)||3
8341588|NCT01304329|20563494|P1|STARTED|Second Intervention (3 Days)||3
8341589|NCT01304329|20563489|P6|NOT COMPLETED|First Intervention (3 Days)||0
8341590|NCT01304329|20563490|P5|NOT COMPLETED|First Intervention (3 Days)||0
8341591|NCT01304329|20563491|P4|NOT COMPLETED|First Intervention (3 Days)||0
8341592|NCT01304329|20563492|P3|NOT COMPLETED|First Intervention (3 Days)||0
8341593|NCT01304329|20563493|P2|NOT COMPLETED|First Intervention (3 Days)||0
8341594|NCT01304329|20563494|P1|NOT COMPLETED|First Intervention (3 Days)||0
8341595|NCT01304329|20563489|P6|COMPLETED|First Intervention (3 Days)||3
8341596|NCT01304329|20563490|P5|COMPLETED|First Intervention (3 Days)||3
8341597|NCT01304329|20563491|P4|COMPLETED|First Intervention (3 Days)||3
8341598|NCT01304329|20563492|P3|COMPLETED|First Intervention (3 Days)||3
8341599|NCT01304329|20563493|P2|COMPLETED|First Intervention (3 Days)||3
8341600|NCT01304329|20563494|P1|COMPLETED|First Intervention (3 Days)||3
8341601|NCT01304329|20563489|P6|STARTED|First Intervention (3 Days)||3
8341602|NCT01304329|20563490|P5|STARTED|First Intervention (3 Days)||3
8341603|NCT01304329|20563491|P4|STARTED|First Intervention (3 Days)||3
8341604|NCT01304329|20563492|P3|STARTED|First Intervention (3 Days)||3
8341605|NCT01304329|20563493|P2|STARTED|First Intervention (3 Days)||3
8341606|NCT01304329|20563494|P1|STARTED|First Intervention (3 Days)||3
8341607|NCT01304316|20563511|P1|NOT COMPLETED|Overall Study||0
8341608|NCT01304316|20563511|P1|COMPLETED|Overall Study||12
8341609|NCT01304316|20563511|P1|STARTED|Overall Study||12
8341616|NCT01304238|20563547|P10|NOT COMPLETED|Overall Study||0
8341617|NCT01304238|20563548|P9|NOT COMPLETED|Overall Study||0
8341618|NCT01304238|20563549|P8|NOT COMPLETED|Overall Study||0
8341619|NCT01304238|20563550|P7|NOT COMPLETED|Overall Study||0
8341620|NCT01304238|20563551|P6|NOT COMPLETED|Overall Study||0
8341621|NCT01304238|20563552|P5|NOT COMPLETED|Overall Study||0
8341622|NCT01304238|20563553|P4|NOT COMPLETED|Overall Study||0
8341623|NCT01304238|20563554|P3|NOT COMPLETED|Overall Study||0
8341624|NCT01304238|20563555|P2|NOT COMPLETED|Overall Study||0
8341625|NCT01304238|20563556|P1|NOT COMPLETED|Overall Study||0
8341626|NCT01304238|20563547|P10|COMPLETED|Overall Study||3
8341627|NCT01304238|20563548|P9|COMPLETED|Overall Study||1
8341628|NCT01304238|20563549|P8|COMPLETED|Overall Study||4
8341629|NCT01304238|20563550|P7|COMPLETED|Overall Study||5
8341630|NCT01304238|20563551|P6|COMPLETED|Overall Study||11
8341631|NCT01304238|20563552|P5|COMPLETED|Overall Study||11
8341632|NCT01304238|20563553|P4|COMPLETED|Overall Study||78
8341633|NCT01304238|20563554|P3|COMPLETED|Overall Study||46
8341634|NCT01304238|20563555|P2|COMPLETED|Overall Study||4
8341635|NCT01304238|20563556|P1|COMPLETED|Overall Study||32
8341636|NCT01304238|20563547|P10|STARTED|Overall Study||3
8341637|NCT01304238|20563548|P9|STARTED|Overall Study||1
8341638|NCT01304238|20563549|P8|STARTED|Overall Study||4
8341639|NCT01304238|20563550|P7|STARTED|Overall Study||5
8341640|NCT01304238|20563551|P6|STARTED|Overall Study||11
8341641|NCT01304238|20563552|P5|STARTED|Overall Study||11
8341642|NCT01304238|20563553|P4|STARTED|Overall Study||78
8341643|NCT01304238|20563554|P3|STARTED|Overall Study||46
8341644|NCT01304238|20563555|P2|STARTED|Overall Study||4
8341645|NCT01304238|20563556|P1|STARTED|Overall Study||32
8341646|NCT01304147|20563628|P2|NOT COMPLETED|Second Intervention (7days)||1
8341647|NCT01304147|20563629|P1|NOT COMPLETED|Second Intervention (7days)||1
8341648|NCT01304147|20563628|P2|COMPLETED|Second Intervention (7days)||9
8341649|NCT01304147|20563629|P1|COMPLETED|Second Intervention (7days)||9
8341650|NCT01304147|20563628|P2|STARTED|Second Intervention (7days)||10
8341651|NCT01304147|20563629|P1|STARTED|Second Intervention (7days)||10
8341652|NCT01304147|20563628|P2|NOT COMPLETED|Washout (1 Day)||0
8341653|NCT01304147|20563629|P1|NOT COMPLETED|Washout (1 Day)||0
8341654|NCT01304147|20563628|P2|COMPLETED|Washout (1 Day)||10
8341655|NCT01304147|20563629|P1|COMPLETED|Washout (1 Day)||10
8341656|NCT01304147|20563628|P2|STARTED|Washout (1 Day)||10
8341657|NCT01304147|20563629|P1|STARTED|Washout (1 Day)||10
8341658|NCT01304147|20563628|P2|NOT COMPLETED|First Intervention (7days)||0
8341659|NCT01304147|20563629|P1|NOT COMPLETED|First Intervention (7days)||0
8341660|NCT01304147|20563628|P2|COMPLETED|First Intervention (7days)||10
8341661|NCT01304147|20563629|P1|COMPLETED|First Intervention (7days)||10
8341662|NCT01304147|20563628|P2|STARTED|First Intervention (7days)||10
8341663|NCT01304147|20563629|P1|STARTED|First Intervention (7days)||10
8341664|NCT01304082|20563637|P5|NOT COMPLETED|Overall Study||0
8341665|NCT01304082|20563638|P4|NOT COMPLETED|Overall Study||0
8341666|NCT01304082|20563639|P3|NOT COMPLETED|Overall Study||0
8341667|NCT01304082|20563640|P2|NOT COMPLETED|Overall Study||0
8341668|NCT01304082|20563641|P1|NOT COMPLETED|Overall Study||0
8341669|NCT01304082|20563637|P5|COMPLETED|Overall Study||5
8341670|NCT01304082|20563638|P4|COMPLETED|Overall Study||8
8341671|NCT01304082|20563639|P3|COMPLETED|Overall Study||11
8341672|NCT01304082|20563640|P2|COMPLETED|Overall Study||2
8341673|NCT01304082|20563641|P1|COMPLETED|Overall Study||3
8341674|NCT01304082|20563637|P5|Third Intervention|Overall Study||5
8341675|NCT01304082|20563638|P4|Third Intervention|Overall Study||8
8341676|NCT01304082|20563639|P3|Third Intervention|Overall Study||11
8341677|NCT01304082|20563640|P2|Third Intervention|Overall Study||2
8341678|NCT01304082|20563641|P1|Third Intervention|Overall Study||3
8341679|NCT01304082|20563637|P5|Second Intervention|Overall Study||5
8341680|NCT01304082|20563638|P4|Second Intervention|Overall Study||8
8341681|NCT01304082|20563639|P3|Second Intervention|Overall Study||11
8341682|NCT01304082|20563640|P2|Second Intervention|Overall Study||2
8341683|NCT01304082|20563641|P1|Second Intervention|Overall Study||3
8341684|NCT01304082|20563637|P5|First Intervention|Overall Study||5
8341685|NCT01304082|20563638|P4|First Intervention|Overall Study||8
8341686|NCT01304082|20563639|P3|First Intervention|Overall Study||11
8341687|NCT01304082|20563640|P2|First Intervention|Overall Study||2
8341688|NCT01304082|20563641|P1|First Intervention|Overall Study||3
8341689|NCT01304082|20563637|P5|STARTED|Overall Study||5
8341690|NCT01304082|20563638|P4|STARTED|Overall Study||8
8341691|NCT01304082|20563639|P3|STARTED|Overall Study||11
8341692|NCT01304082|20563640|P2|STARTED|Overall Study||2
8341693|NCT01304082|20563641|P1|STARTED|Overall Study||3
8341694|NCT01303965|20563660|P2|NOT COMPLETED|Overall Study||10
8341695|NCT01303965|20563661|P1|NOT COMPLETED|Overall Study||3
8341696|NCT01303965|20563660|P2|COMPLETED|Overall Study||1
8341697|NCT01303965|20563661|P1|COMPLETED|Overall Study||0
8341698|NCT01303965|20563660|P2|STARTED|Overall Study||11
8341699|NCT01303965|20563661|P1|STARTED|Overall Study||3
8341700|NCT01303939|20563675|P2|NOT COMPLETED|Overall Study||0
8341701|NCT01303939|20563676|P1|NOT COMPLETED|Overall Study||7
8341702|NCT01303939|20563675|P2|COMPLETED|Overall Study||15
8341703|NCT01303939|20563676|P1|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
8341704|NCT01303939|20563675|P2|STARTED|Overall Study||15
8341705|NCT01303939|20563676|P1|STARTED|Overall Study||22
8341706|NCT01303861|20563689|P4|NOT COMPLETED|Overall Study||59
8341707|NCT01303861|20563690|P3|NOT COMPLETED|Overall Study||36
8341708|NCT01303861|20563691|P2|NOT COMPLETED|Overall Study||25
8341709|NCT01303861|20563692|P1|NOT COMPLETED|Overall Study||58
8341710|NCT01303861|20563689|P4|COMPLETED|Overall Study||54
8341711|NCT01303861|20563690|P3|COMPLETED|Overall Study||19
8341712|NCT01303861|20563691|P2|COMPLETED|Overall Study||25
8341713|NCT01303861|20563692|P1|COMPLETED|Overall Study||51
8341714|NCT01303861|20563689|P4|Finished Treatment Phase|Overall Study||72
8341715|NCT01303861|20563690|P3|Finished Treatment Phase|Overall Study||39
8341716|NCT01303861|20563691|P2|Finished Treatment Phase|Overall Study||34
8341717|NCT01303861|20563692|P1|Finished Treatment Phase|Overall Study||71
8341718|NCT01303861|20563689|P4|STARTED|Overall Study||113
8341719|NCT01303861|20563690|P3|STARTED|Overall Study||55
8341720|NCT01303861|20563691|P2|STARTED|Overall Study||50
8341721|NCT01303861|20563692|P1|STARTED|Overall Study||109
8341722|NCT01303835|20563713|P2|NOT COMPLETED|Overall Study||25
8341723|NCT01303835|20563714|P1|NOT COMPLETED|Overall Study||19
8341724|NCT01303835|20563713|P2|COMPLETED|Overall Study||31
8341725|NCT01303835|20563714|P1|COMPLETED|Overall Study||35
8341726|NCT01303835|20563713|P2|STARTED|Overall Study||56
8341727|NCT01303835|20563714|P1|STARTED|Overall Study||54
8341728|NCT01303744|20563728|P4|NOT COMPLETED|Overall Study||0
8341729|NCT01303744|20563729|P3|NOT COMPLETED|Overall Study||0
8341730|NCT01303744|20563730|P2|NOT COMPLETED|Overall Study||0
8341731|NCT01303744|20563731|P1|NOT COMPLETED|Overall Study||0
8341732|NCT01303744|20563728|P4|COMPLETED|Overall Study||24
8341733|NCT01303744|20563729|P3|COMPLETED|Overall Study||24
8341734|NCT01303744|20563730|P2|COMPLETED|Overall Study||24
8341735|NCT01303744|20563731|P1|COMPLETED|Overall Study||24
8341736|NCT01303744|20563728|P4|STARTED|Overall Study||24
8341737|NCT01303744|20563729|P3|STARTED|Overall Study||24
8341738|NCT01303744|20563730|P2|STARTED|Overall Study||24
8341739|NCT01303744|20563731|P1|STARTED|Overall Study||24
8341740|NCT01303627|20563751|P2|NOT COMPLETED|Overall Study||1
8341741|NCT01303627|20563752|P1|NOT COMPLETED|Overall Study||0
8341742|NCT01303627|20563751|P2|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
8341743|NCT01303627|20563752|P1|COMPLETED|Overall Study||21
8341744|NCT01303627|20563751|P2|STARTED|Overall Study||21
8341745|NCT01303627|20563752|P1|STARTED|Overall Study||21
8341746|NCT01303510|20563760|P2|NOT COMPLETED|Overall Study||0
8341747|NCT01303510|20563761|P1|NOT COMPLETED|Overall Study||1
8341748|NCT01303510|20563760|P2|COMPLETED|Overall Study||56
8341749|NCT01303510|20563761|P1|COMPLETED|Overall Study||54
8341750|NCT01303510|20563760|P2|STARTED|Overall Study||56
8341751|NCT01303510|20563761|P1|STARTED|Overall Study||55
8341752|NCT01303445|20563775|P2|NOT COMPLETED|Follow-up Period (14 Days)||1
8341753|NCT01303445|20563776|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
8341754|NCT01303445|20563775|P2|COMPLETED|Follow-up Period (14 Days)||25
8341755|NCT01303445|20563776|P1|COMPLETED|Follow-up Period (14 Days)||26
8341756|NCT01303445|20563775|P2|STARTED|Follow-up Period (14 Days)||26
8341757|NCT01303445|20563776|P1|STARTED|Follow-up Period (14 Days)||26
8341758|NCT01303445|20563775|P2|NOT COMPLETED|Fourth Intervention (7 Days)||0
8341759|NCT01303445|20563776|P1|NOT COMPLETED|Fourth Intervention (7 Days)||1
8341760|NCT01303445|20563775|P2|COMPLETED|Fourth Intervention (7 Days)||26
8341761|NCT01303445|20563776|P1|COMPLETED|Fourth Intervention (7 Days)||26
8341762|NCT01303445|20563775|P2|STARTED|Fourth Intervention (7 Days)||26
8341763|NCT01303445|20563776|P1|STARTED|Fourth Intervention (7 Days)||27
8341764|NCT01303445|20563775|P2|NOT COMPLETED|Third Intervention (7 Days)||0
8341765|NCT01303445|20563776|P1|NOT COMPLETED|Third Intervention (7 Days)||0
8341766|NCT01303445|20563775|P2|COMPLETED|Third Intervention (7 Days)||26
8341767|NCT01303445|20563776|P1|COMPLETED|Third Intervention (7 Days)||27
8341768|NCT01303445|20563775|P2|STARTED|Third Intervention (7 Days)||26
8341769|NCT01303445|20563776|P1|STARTED|Third Intervention (7 Days)||27
8341770|NCT01303445|20563775|P2|NOT COMPLETED|Washout (14 Days)||2
8341771|NCT01303445|20563776|P1|NOT COMPLETED|Washout (14 Days)||1
8341772|NCT01303445|20563775|P2|COMPLETED|Washout (14 Days)||26
8341773|NCT01303445|20563776|P1|COMPLETED|Washout (14 Days)||27
8341774|NCT01303445|20563775|P2|STARTED|Washout (14 Days)||28
8341775|NCT01303445|20563776|P1|STARTED|Washout (14 Days)||28
8341776|NCT01303445|20563775|P2|NOT COMPLETED|Second Intervention (7 Days)||2
8341777|NCT01303445|20563776|P1|NOT COMPLETED|Second Intervention (7 Days)||1
8341778|NCT01303445|20563775|P2|COMPLETED|Second Intervention (7 Days)||28
8341779|NCT01303445|20563776|P1|COMPLETED|Second Intervention (7 Days)||28
8341780|NCT01303445|20563775|P2|STARTED|Second Intervention (7 Days)||30
8341781|NCT01303445|20563776|P1|STARTED|Second Intervention (7 Days)||29
8341782|NCT01303445|20563775|P2|NOT COMPLETED|First Intervention (7 Days)||0
8341783|NCT01303445|20563776|P1|NOT COMPLETED|First Intervention (7 Days)||1
8341784|NCT01303445|20563775|P2|COMPLETED|First Intervention (7 Days)||30
8341785|NCT01303445|20563776|P1|COMPLETED|First Intervention (7 Days)||29
8341786|NCT01303445|20563775|P2|STARTED|First Intervention (7 Days)||30
8341787|NCT01303445|20563776|P1|STARTED|First Intervention (7 Days)||30
8341788|NCT01303419|20563806|P1|NOT COMPLETED|Overall Study||96
8341789|NCT01303419|20563806|P1|COMPLETED|Overall Study||128
8341790|NCT01303419|20563806|P1|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224
8341791|NCT01303406|20563816|P2|NOT COMPLETED|Overall Study||1
8341792|NCT01303406|20563817|P1|NOT COMPLETED|Overall Study||0
8341793|NCT01303406|20563816|P2|COMPLETED|Overall Study||15
8341794|NCT01303406|20563817|P1|COMPLETED|Overall Study||13
8341795|NCT01303406|20563816|P2|STARTED|Overall Study||16
8341796|NCT01303406|20563817|P1|STARTED|Overall Study||13
8341797|NCT01303380|20563825|P1|NOT COMPLETED|Overall Study||1
8341798|NCT01303380|20563825|P1|COMPLETED|Overall Study||8
8341799|NCT01303380|20563825|P1|STARTED|Overall Study||9
8341800|NCT01303224|20563855|P4|NOT COMPLETED|Overall Study||10
8341801|NCT01303224|20563856|P3|NOT COMPLETED|Overall Study||6
8341802|NCT01303224|20563857|P2|NOT COMPLETED|Overall Study||11
8341803|NCT01303224|20563858|P1|NOT COMPLETED|Overall Study||11
8341804|NCT01303224|20563855|P4|COMPLETED|Overall Study||133
8341805|NCT01303224|20563856|P3|COMPLETED|Overall Study||133
8341806|NCT01303224|20563857|P2|COMPLETED|Overall Study||131
8341807|NCT01303224|20563858|P1|COMPLETED|Overall Study||130
8341808|NCT01303224|20563855|P4|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
8341809|NCT01303224|20563856|P3|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
8341810|NCT01303224|20563857|P2|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
8341811|NCT01303224|20563858|P1|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
8341812|NCT01303224|20563855|P4|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
8341813|NCT01303224|20563856|P3|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
8341814|NCT01303224|20563857|P2|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
8341815|NCT01303224|20563858|P1|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
8341816|NCT01303159|20563884|P1|NOT COMPLETED|Overall Study||23
8341817|NCT01303159|20563884|P1|COMPLETED|Overall Study||6
8341818|NCT01303159|20563884|P1|STARTED|Overall Study||29
8341819|NCT01303003|20563891|P2|NOT COMPLETED|Overall Study||0
8341820|NCT01303003|20563892|P1|NOT COMPLETED|Overall Study||0
8341821|NCT01303003|20563891|P2|COMPLETED|Overall Study||0
8341822|NCT01303003|20563892|P1|COMPLETED|Overall Study||0
8341823|NCT01303003|20563891|P2|STARTED|Overall Study||0
8341824|NCT01303003|20563892|P1|STARTED|Overall Study||0
8341825|NCT01302964|20563902|P2|NOT COMPLETED|Overall Study||0
8341826|NCT01302964|20563903|P1|NOT COMPLETED|Overall Study||1
8341827|NCT01302964|20563902|P2|COMPLETED|Overall Study||10
8341828|NCT01302964|20563903|P1|COMPLETED|Overall Study||19
8341829|NCT01302964|20563902|P2|STARTED|Overall Study||10
8341830|NCT01302964|20563903|P1|STARTED|Overall Study||20
8341831|NCT01302899|20563913|P2|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
8341832|NCT01302899|20563914|P1|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
8341833|NCT01302899|20563913|P2|COMPLETED|Period 4 (Weeks 19 to 26)||3
8341834|NCT01302899|20563914|P1|COMPLETED|Period 4 (Weeks 19 to 26)||3
8341835|NCT01302899|20563913|P2|STARTED|Period 4 (Weeks 19 to 26)||3
8341836|NCT01302899|20563914|P1|STARTED|Period 4 (Weeks 19 to 26)||3
8341837|NCT01302899|20563913|P2|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
8341838|NCT01302899|20563914|P1|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
8341839|NCT01302899|20563913|P2|COMPLETED|Period 3 (Weeks 13 to 18)||3
8341840|NCT01302899|20563914|P1|COMPLETED|Period 3 (Weeks 13 to 18)||3
8341841|NCT01302899|20563913|P2|STARTED|Period 3 (Weeks 13 to 18)||3
8341842|NCT01302899|20563914|P1|STARTED|Period 3 (Weeks 13 to 18)||3
8341843|NCT01302899|20563913|P2|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
8341844|NCT01302899|20563914|P1|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
8341845|NCT01302899|20563913|P2|COMPLETED|Period 2 (Weeks 7 to 12)||3
8341846|NCT01302899|20563914|P1|COMPLETED|Period 2 (Weeks 7 to 12)||3
8341847|NCT01302899|20563913|P2|STARTED|Period 2 (Weeks 7 to 12)||4
8341848|NCT01302899|20563914|P1|STARTED|Period 2 (Weeks 7 to 12)||4
8341849|NCT01302899|20563913|P2|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
8341850|NCT01302899|20563914|P1|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
8341851|NCT01302899|20563913|P2|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
8341852|NCT01302899|20563914|P1|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
8341853|NCT01302899|20563913|P2|STARTED|Period 1 (Day 1 to End of Week 6)||4
8341854|NCT01302899|20563914|P1|STARTED|Period 1 (Day 1 to End of Week 6)||4
8341855|NCT01302860|20563964|P1|NOT COMPLETED|Overall Study||0
8341856|NCT01302860|20563964|P1|COMPLETED|Overall Study||17
8341857|NCT01302860|20563964|P1|STARTED|Overall Study||17
8341890|NCT01302808|20564025|P4|NOT COMPLETED|Overall Study||0
8341891|NCT01302808|20564026|P3|NOT COMPLETED|Overall Study||0
8341892|NCT01302808|20564027|P2|NOT COMPLETED|Overall Study||0
8341893|NCT01302808|20564028|P1|NOT COMPLETED|Overall Study||0
8341894|NCT01302808|20564025|P4|COMPLETED|Overall Study||3
8341895|NCT01302808|20564026|P3|COMPLETED|Overall Study||4
8341896|NCT01302808|20564027|P2|COMPLETED|Overall Study||7
8341897|NCT01302808|20564028|P1|COMPLETED|Overall Study||3
8341898|NCT01302808|20564025|P4|STARTED|Overall Study||3
8341899|NCT01302808|20564026|P3|STARTED|Overall Study||4
8341900|NCT01302808|20564027|P2|STARTED|Overall Study||7
8341901|NCT01302808|20564028|P1|STARTED|Overall Study||3
8341902|NCT01302743|20564043|P3|NOT COMPLETED|Overall Study||2
8341903|NCT01302743|20564044|P2|NOT COMPLETED|Overall Study||1
8341904|NCT01302743|20564045|P1|NOT COMPLETED|Overall Study||1
8341905|NCT01302743|20564043|P3|COMPLETED|Overall Study||8
8341906|NCT01302743|20564044|P2|COMPLETED|Overall Study||7
8341907|NCT01302743|20564045|P1|COMPLETED|Overall Study||6
8341908|NCT01302743|20564043|P3|STARTED|Overall Study||10
8341909|NCT01302743|20564044|P2|STARTED|Overall Study||8
8341910|NCT01302743|20564045|P1|STARTED|Overall Study||7
8341911|NCT01302691|20564058|P2|NOT COMPLETED|Overall Study||6
8341912|NCT01302691|20564059|P1|NOT COMPLETED|Overall Study||10
8341913|NCT01302691|20564058|P2|COMPLETED|Overall Study||157
8341914|NCT01302691|20564059|P1|COMPLETED|Overall Study||154
8341915|NCT01302691|20564058|P2|STARTED|Overall Study||163
8341916|NCT01302691|20564059|P1|STARTED|Overall Study||164
8341917|NCT01302548|20564079|P2|NOT COMPLETED|Overall Study||1
8341918|NCT01302548|20564080|P1|NOT COMPLETED|Overall Study||2
8341919|NCT01302548|20564079|P2|COMPLETED|Overall Study||18
8341920|NCT01302548|20564080|P1|COMPLETED|Overall Study||12
8341921|NCT01302548|20564079|P2|STARTED|Overall Study||19
8341922|NCT01302548|20564080|P1|STARTED|Overall Study||14
8341923|NCT01302483|20564092|P2|NOT COMPLETED|Overall Study||0
8341924|NCT01302483|20564093|P1|NOT COMPLETED|Overall Study||0
8341925|NCT01302483|20564092|P2|COMPLETED|Overall Study||15
8341926|NCT01302483|20564093|P1|COMPLETED|Overall Study||30
8341927|NCT01302483|20564092|P2|STARTED|Overall Study||15
8341928|NCT01302483|20564093|P1|STARTED|Overall Study||30
8341929|NCT01302444|20564109|P2|NOT COMPLETED|Overall Study||0
8341930|NCT01302444|20564110|P1|NOT COMPLETED|Overall Study||0
8341931|NCT01302444|20564109|P2|COMPLETED|Overall Study||0
8341932|NCT01302444|20564110|P1|COMPLETED|Overall Study||1
8341933|NCT01302444|20564109|P2|STARTED|Overall Study||0
8341934|NCT01302444|20564110|P1|STARTED|Overall Study||1
8341935|NCT01302418|20564130|P1|NOT COMPLETED|Overall Study||18
8341936|NCT01302418|20564130|P1|COMPLETED|Overall Study||254
8341937|NCT01302418|20564130|P1|STARTED|Overall Study||272
8341938|NCT01302392|20564136|P2|NOT COMPLETED|Overall Study||1
8341939|NCT01302392|20564137|P1|NOT COMPLETED|Overall Study||7
8341940|NCT01302392|20564136|P2|COMPLETED|Overall Study||156
8341941|NCT01302392|20564137|P1|COMPLETED|Overall Study||151
8341942|NCT01302392|20564136|P2|Treated|Overall Study||157
8341943|NCT01302392|20564137|P1|Treated|Overall Study||153
8341944|NCT01302392|20564136|P2|STARTED|Overall Study||157
8341945|NCT01302392|20564137|P1|STARTED|Overall Study||158
8341946|NCT01302379|20564161|P4|NOT COMPLETED|Overall Study||4
8341947|NCT01302379|20564162|P3|NOT COMPLETED|Overall Study||4
8341948|NCT01302379|20564163|P2|NOT COMPLETED|Overall Study||5
8341949|NCT01302379|20564164|P1|NOT COMPLETED|Overall Study||7
8341950|NCT01302379|20564161|P4|COMPLETED|Overall Study||79
8341951|NCT01302379|20564162|P3|COMPLETED|Overall Study||80
8341952|NCT01302379|20564163|P2|COMPLETED|Overall Study||78
8341953|NCT01302379|20564164|P1|COMPLETED|Overall Study||76
8341954|NCT01302379|20564161|P4|STARTED|Overall Study||83
8341955|NCT01302379|20564162|P3|STARTED|Overall Study||84
8341956|NCT01302379|20564163|P2|STARTED|Overall Study||83
8341957|NCT01302379|20564164|P1|STARTED|Overall Study||83
8341958|NCT01302366|20564188|P1|NOT COMPLETED|Overall Study||5
8341959|NCT01302366|20564188|P1|COMPLETED|Overall Study||15
8341960|NCT01302366|20564188|P1|STARTED|Overall Study||20
8341961|NCT01302119|20564196|P2|NOT COMPLETED|Overall Study||28
8341962|NCT01302119|20564197|P1|NOT COMPLETED|Overall Study||50
8341963|NCT01302119|20564196|P2|COMPLETED|Overall Study||177
8341964|NCT01302119|20564197|P1|COMPLETED|Overall Study||349
8341965|NCT01302119|20564196|P2|STARTED|Overall Study||205
8341966|NCT01302119|20564197|P1|STARTED|Overall Study||399
8341967|NCT01302067|20564212|P3|NOT COMPLETED|Overall Study||98
8341968|NCT01302067|20564213|P2|NOT COMPLETED|Overall Study||34
8341969|NCT01302067|20564214|P1|NOT COMPLETED|Overall Study||78
8341970|NCT01302067|20564212|P3|COMPLETED|Overall Study||681
8341971|NCT01302067|20564213|P2|COMPLETED|Overall Study||352
8341972|NCT01302067|20564214|P1|COMPLETED|Overall Study||712
8341973|NCT01302067|20564212|P3|STARTED|Overall Study||779
8341974|NCT01302067|20564213|P2|STARTED|Overall Study||386
8341975|NCT01302067|20564214|P1|STARTED|Overall Study||790
8341976|NCT01302054|20564285|P3|NOT COMPLETED|Double-Blind Treatment Phase||46
8341977|NCT01302054|20564286|P2|NOT COMPLETED|Double-Blind Treatment Phase||27
8341978|NCT01302054|20564287|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
8341979|NCT01302054|20564285|P3|COMPLETED|Double-Blind Treatment Phase||255
8341980|NCT01302054|20564286|P2|COMPLETED|Double-Blind Treatment Phase||281
8341981|NCT01302054|20564287|P1|COMPLETED|Double-Blind Treatment Phase||0
8341982|NCT01302054|20564285|P3|STARTED|Double-Blind Treatment Phase||301
8341983|NCT01302054|20564286|P2|STARTED|Double-Blind Treatment Phase||308
8341984|NCT01302054|20564287|P1|STARTED|Double-Blind Treatment Phase||0
8341985|NCT01302054|20564285|P3|NOT COMPLETED|Between Open-Label and Double Blind||0
8341986|NCT01302054|20564286|P2|NOT COMPLETED|Between Open-Label and Double Blind||0
8341987|NCT01302054|20564287|P1|NOT COMPLETED|Between Open-Label and Double Blind||2
8341988|NCT01302054|20564285|P3|COMPLETED|Between Open-Label and Double Blind||0
8341989|NCT01302054|20564286|P2|COMPLETED|Between Open-Label and Double Blind||0
8341990|NCT01302054|20564287|P1|COMPLETED|Between Open-Label and Double Blind||609
8341991|NCT01302054|20564285|P3|STARTED|Between Open-Label and Double Blind||0
8341992|NCT01302054|20564286|P2|STARTED|Between Open-Label and Double Blind||0
8341993|NCT01302054|20564287|P1|STARTED|Between Open-Label and Double Blind||611
8341994|NCT01302054|20564285|P3|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
8341995|NCT01302054|20564286|P2|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
8341996|NCT01302054|20564287|P1|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
8341997|NCT01302054|20564285|P3|COMPLETED|Tolterodine Open-Label Run-In Phase||0
8341998|NCT01302054|20564286|P2|COMPLETED|Tolterodine Open-Label Run-In Phase||0
8341999|NCT01302054|20564287|P1|COMPLETED|Tolterodine Open-Label Run-In Phase||611
8342000|NCT01302054|20564285|P3|STARTED|Tolterodine Open-Label Run-In Phase||0
8342001|NCT01302054|20564286|P2|STARTED|Tolterodine Open-Label Run-In Phase||0
8342002|NCT01302054|20564287|P1|STARTED|Tolterodine Open-Label Run-In Phase||990
8342003|NCT01302041|20564314|P1|NOT COMPLETED|Overall Study||40
8342004|NCT01302041|20564314|P1|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
8342005|NCT01302041|20564314|P1|Treatment Received|Overall Study||67
8342006|NCT01302041|20564314|P1|STARTED|Overall Study||67
8342007|NCT01301963|20564345|P2|NOT COMPLETED|Overall Study||0
8342008|NCT01301963|20564346|P1|NOT COMPLETED|Overall Study||0
8342009|NCT01301963|20564345|P2|COMPLETED|Overall Study||4
8342010|NCT01301963|20564346|P1|COMPLETED|Overall Study||5
8342011|NCT01301963|20564345|P2|STARTED|Overall Study||4
8342012|NCT01301963|20564346|P1|STARTED|Overall Study||5
8342013|NCT01301950|20564356|P2|NOT COMPLETED|Overall Study||1
8342014|NCT01301950|20564357|P1|NOT COMPLETED|Overall Study||0
8342015|NCT01301950|20564356|P2|COMPLETED|Overall Study||14
8342016|NCT01301950|20564357|P1|COMPLETED|Overall Study||15
8342017|NCT01301950|20564356|P2|STARTED|Overall Study||15
8342018|NCT01301950|20564357|P1|STARTED|Overall Study||15
8342019|NCT01301833|20564375|P4|NOT COMPLETED|Overall Study||7
8342020|NCT01301833|20564376|P3|NOT COMPLETED|Overall Study||7
8342021|NCT01301833|20564377|P2|NOT COMPLETED|Overall Study||8
8342022|NCT01301833|20564378|P1|NOT COMPLETED|Overall Study||15
8342023|NCT01301833|20564375|P4|COMPLETED|Overall Study||68
8342024|NCT01301833|20564376|P3|COMPLETED|Overall Study||88
8342025|NCT01301833|20564377|P2|COMPLETED|Overall Study||72
8342026|NCT01301833|20564378|P1|COMPLETED|Overall Study||197
8342027|NCT01301833|20564375|P4|STARTED|Overall Study||75
8342028|NCT01301833|20564376|P3|STARTED|Overall Study||95
8342029|NCT01301833|20564377|P2|STARTED|Overall Study||80
8342030|NCT01301833|20564378|P1|STARTED|Overall Study||212
8342031|NCT01301742|20564404|P2|NOT COMPLETED|Second Intervention||0
8342032|NCT01301742|20564405|P1|NOT COMPLETED|Second Intervention||0
8342033|NCT01301742|20564404|P2|COMPLETED|Second Intervention||9
8342034|NCT01301742|20564405|P1|COMPLETED|Second Intervention||9
8342035|NCT01301742|20564404|P2|STARTED|Second Intervention||9
8342036|NCT01301742|20564405|P1|STARTED|Second Intervention||9
8342037|NCT01301742|20564404|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
8342038|NCT01301742|20564405|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
8342039|NCT01301742|20564404|P2|COMPLETED|Washout Period of at Least 7 Days||9
8342040|NCT01301742|20564405|P1|COMPLETED|Washout Period of at Least 7 Days||9
8342041|NCT01301742|20564404|P2|STARTED|Washout Period of at Least 7 Days||9
8342042|NCT01301742|20564405|P1|STARTED|Washout Period of at Least 7 Days||9
8342043|NCT01301742|20564404|P2|NOT COMPLETED|First Intervention||0
8342044|NCT01301742|20564405|P1|NOT COMPLETED|First Intervention||0
8342045|NCT01301742|20564404|P2|COMPLETED|First Intervention||9
8342046|NCT01301742|20564405|P1|COMPLETED|First Intervention||9
8342047|NCT01301742|20564404|P2|STARTED|First Intervention||9
8342048|NCT01301742|20564405|P1|STARTED|First Intervention||9
8342049|NCT01301729|20564416|P1|NOT COMPLETED|Overall Study||4
8342050|NCT01301729|20564416|P1|COMPLETED|Overall Study||28
8342051|NCT01301729|20564416|P1|STARTED|Overall Study||32
8342052|NCT01301625|20564427|P1|NOT COMPLETED|Overall Study||35
8342053|NCT01301625|20564427|P1|COMPLETED|Overall Study||43
8342054|NCT01301625|20564427|P1|STARTED|Overall Study||78
8342055|NCT01301508|20564499|P2|NOT COMPLETED|Overall Study||3
8342056|NCT01301508|20564500|P1|NOT COMPLETED|Overall Study||1
8342057|NCT01301508|20564499|P2|COMPLETED|Overall Study||22
8342058|NCT01301508|20564500|P1|COMPLETED|Overall Study||20
8342059|NCT01301508|20564499|P2|STARTED|Overall Study||25
8342060|NCT01301508|20564500|P1|STARTED|Overall Study||21
8342061|NCT01301456|20564530|P12|NOT COMPLETED|Stage 2||0
8342062|NCT01301456|20564531|P11|NOT COMPLETED|Stage 2||1
8342063|NCT01301456|20564532|P10|NOT COMPLETED|Stage 2||0
8342064|NCT01301456|20564533|P9|NOT COMPLETED|Stage 2||0
8342065|NCT01301456|20564534|P8|NOT COMPLETED|Stage 2||0
8342066|NCT01301456|20564535|P7|NOT COMPLETED|Stage 2||0
8342067|NCT01301456|20564536|P6|NOT COMPLETED|Stage 2||0
8342068|NCT01301456|20564537|P5|NOT COMPLETED|Stage 2||0
8342069|NCT01301456|20564538|P4|NOT COMPLETED|Stage 2||0
8342070|NCT01301456|20564539|P3|NOT COMPLETED|Stage 2||0
8342071|NCT01301456|20564540|P2|NOT COMPLETED|Stage 2||0
8342072|NCT01301456|20564541|P1|NOT COMPLETED|Stage 2||0
8342073|NCT01301456|20564530|P12|COMPLETED|Stage 2||6
8342074|NCT01301456|20564531|P11|COMPLETED|Stage 2||6
8342075|NCT01301456|20564532|P10|COMPLETED|Stage 2||7
8342076|NCT01301456|20564533|P9|COMPLETED|Stage 2||5
8342077|NCT01301456|20564534|P8|COMPLETED|Stage 2||7
8342078|NCT01301456|20564535|P7|COMPLETED|Stage 2||0
8342079|NCT01301456|20564536|P6|COMPLETED|Stage 2||0
8342080|NCT01301456|20564537|P5|COMPLETED|Stage 2||0
8342081|NCT01301456|20564538|P4|COMPLETED|Stage 2||0
8342082|NCT01301456|20564539|P3|COMPLETED|Stage 2||0
8342083|NCT01301456|20564540|P2|COMPLETED|Stage 2||0
8342084|NCT01301456|20564541|P1|COMPLETED|Stage 2||0
8342085|NCT01301456|20564530|P12|Received Treatment|Stage 2||6
8342086|NCT01301456|20564531|P11|Received Treatment|Stage 2||7
8342087|NCT01301456|20564532|P10|Received Treatment|Stage 2||7
8342088|NCT01301456|20564533|P9|Received Treatment|Stage 2||5
8342089|NCT01301456|20564534|P8|Received Treatment|Stage 2||7
8342090|NCT01301456|20564535|P7|Received Treatment|Stage 2||0
8342091|NCT01301456|20564536|P6|Received Treatment|Stage 2||0
8342092|NCT01301456|20564537|P5|Received Treatment|Stage 2||0
8342093|NCT01301456|20564538|P4|Received Treatment|Stage 2||0
8342094|NCT01301456|20564539|P3|Received Treatment|Stage 2||0
8342095|NCT01301456|20564540|P2|Received Treatment|Stage 2||0
8342096|NCT01301456|20564541|P1|Received Treatment|Stage 2||0
8342097|NCT01301456|20564530|P12|STARTED|Stage 2||6
8342098|NCT01301456|20564531|P11|STARTED|Stage 2||7
8342099|NCT01301456|20564532|P10|STARTED|Stage 2||7
8342100|NCT01301456|20564533|P9|STARTED|Stage 2||5
8342101|NCT01301456|20564534|P8|STARTED|Stage 2||7
8342102|NCT01301456|20564535|P7|STARTED|Stage 2||0
8342103|NCT01301456|20564536|P6|STARTED|Stage 2||0
8342104|NCT01301456|20564537|P5|STARTED|Stage 2||0
8342105|NCT01301456|20564538|P4|STARTED|Stage 2||0
8342106|NCT01301456|20564539|P3|STARTED|Stage 2||0
8342107|NCT01301456|20564540|P2|STARTED|Stage 2||0
8342108|NCT01301456|20564541|P1|STARTED|Stage 2||0
8342109|NCT01301456|20564530|P12|NOT COMPLETED|Stage 1||0
8342110|NCT01301456|20564531|P11|NOT COMPLETED|Stage 1||0
8342111|NCT01301456|20564532|P10|NOT COMPLETED|Stage 1||0
8342112|NCT01301456|20564533|P9|NOT COMPLETED|Stage 1||0
8342113|NCT01301456|20564534|P8|NOT COMPLETED|Stage 1||0
8342114|NCT01301456|20564535|P7|NOT COMPLETED|Stage 1||1
8342115|NCT01301456|20564536|P6|NOT COMPLETED|Stage 1||0
8342116|NCT01301456|20564537|P5|NOT COMPLETED|Stage 1||1
8342117|NCT01301456|20564538|P4|NOT COMPLETED|Stage 1||0
8342118|NCT01301456|20564539|P3|NOT COMPLETED|Stage 1||1
8342119|NCT01301456|20564540|P2|NOT COMPLETED|Stage 1||0
8342120|NCT01301456|20564541|P1|NOT COMPLETED|Stage 1||0
8342121|NCT01301456|20564530|P12|COMPLETED|Stage 1||0
8342122|NCT01301456|20564531|P11|COMPLETED|Stage 1||0
8342123|NCT01301456|20564532|P10|COMPLETED|Stage 1||0
8342124|NCT01301456|20564533|P9|COMPLETED|Stage 1||0
8342125|NCT01301456|20564534|P8|COMPLETED|Stage 1||0
8342126|NCT01301456|20564535|P7|COMPLETED|Stage 1||7
8342127|NCT01301456|20564536|P6|COMPLETED|Stage 1||5
8342128|NCT01301456|20564537|P5|COMPLETED|Stage 1||6
8342129|NCT01301456|20564538|P4|COMPLETED|Stage 1||6
8342130|NCT01301456|20564539|P3|COMPLETED|Stage 1||5
8342131|NCT01301456|20564540|P2|COMPLETED|Stage 1||5
8342132|NCT01301456|20564541|P1|COMPLETED|Stage 1||15
8342133|NCT01301456|20564530|P12|Received Treatment|Stage 1||0
8342134|NCT01301456|20564531|P11|Received Treatment|Stage 1||0
8342135|NCT01301456|20564532|P10|Received Treatment|Stage 1||0
8342136|NCT01301456|20564533|P9|Received Treatment|Stage 1||0
8342137|NCT01301456|20564534|P8|Received Treatment|Stage 1||0
8342138|NCT01301456|20564535|P7|Received Treatment|Stage 1||7
8342139|NCT01301456|20564536|P6|Received Treatment|Stage 1||5
8342140|NCT01301456|20564537|P5|Received Treatment|Stage 1||7
8342141|NCT01301456|20564538|P4|Received Treatment|Stage 1||6
8342142|NCT01301456|20564539|P3|Received Treatment|Stage 1||6
8342143|NCT01301456|20564540|P2|Received Treatment|Stage 1||5
8342144|NCT01301456|20564541|P1|Received Treatment|Stage 1||15
8342145|NCT01301456|20564530|P12|STARTED|Stage 1||0
8342146|NCT01301456|20564531|P11|STARTED|Stage 1||0
8342147|NCT01301456|20564532|P10|STARTED|Stage 1||0
8342148|NCT01301456|20564533|P9|STARTED|Stage 1||0
8342149|NCT01301456|20564534|P8|STARTED|Stage 1||0
8342150|NCT01301456|20564535|P7|STARTED|Stage 1||8
8342151|NCT01301456|20564536|P6|STARTED|Stage 1||5
8342152|NCT01301456|20564537|P5|STARTED|Stage 1||7
8342153|NCT01301456|20564538|P4|STARTED|Stage 1||6
8342154|NCT01301456|20564539|P3|STARTED|Stage 1||6
8342155|NCT01301456|20564540|P2|STARTED|Stage 1||5
8342156|NCT01301456|20564541|P1|STARTED|Stage 1||15
8342157|NCT01301391|20564767|P1|NOT COMPLETED|Overall Study||26
8342158|NCT01301391|20564767|P1|COMPLETED|Overall Study||4
8342159|NCT01301391|20564767|P1|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
8342160|NCT01301274|20564779|P2|NOT COMPLETED|Overall Study||1
8342161|NCT01301274|20564780|P1|NOT COMPLETED|Overall Study||2
8342162|NCT01301274|20564779|P2|COMPLETED|Overall Study||31
8342163|NCT01301274|20564780|P1|COMPLETED|Overall Study||32
8342164|NCT01301274|20564779|P2|STARTED|Overall Study||32
8342165|NCT01301274|20564780|P1|STARTED|Overall Study||34
8342166|NCT01301092|20564795|P3|NOT COMPLETED|Overall Study||1
8342167|NCT01301092|20564796|P2|NOT COMPLETED|Overall Study||0
8342168|NCT01301092|20564797|P1|NOT COMPLETED|Overall Study||0
8342169|NCT01301092|20564795|P3|COMPLETED|Overall Study||7
8342170|NCT01301092|20564796|P2|COMPLETED|Overall Study||16
8342171|NCT01301092|20564797|P1|COMPLETED|Overall Study||6
8342172|NCT01301092|20564795|P3|STARTED|Overall Study||8
8342173|NCT01301092|20564796|P2|STARTED|Overall Study||16
8342174|NCT01301092|20564797|P1|STARTED|Overall Study||6
8342175|NCT01301079|20564814|P2|NOT COMPLETED|Overall Study||2
8342176|NCT01301079|20564815|P1|NOT COMPLETED|Overall Study||2
8342177|NCT01301079|20564814|P2|COMPLETED|Overall Study||28
8342178|NCT01301079|20564815|P1|COMPLETED|Overall Study||28
8342179|NCT01301079|20564814|P2|STARTED|Overall Study||30
8342180|NCT01301079|20564815|P1|STARTED|Overall Study||30
8342181|NCT01301066|20564893|P2|NOT COMPLETED|Overall Study||35
8342182|NCT01301066|20564894|P1|NOT COMPLETED|Overall Study||27
8342183|NCT01301066|20564893|P2|COMPLETED|Overall Study||91
8342184|NCT01301066|20564894|P1|COMPLETED|Overall Study||99
8342185|NCT01301066|20564893|P2|STARTED|Overall Study||126
8342186|NCT01301066|20564894|P1|STARTED|Overall Study||126
8342187|NCT01301027|20564902|P2|NOT COMPLETED|Overall Study||10
8342188|NCT01301027|20564903|P1|NOT COMPLETED|Overall Study||8
8342189|NCT01301027|20564902|P2|COMPLETED|Overall Study||37
8342190|NCT01301027|20564903|P1|COMPLETED|Overall Study||40
8342191|NCT01301027|20564902|P2|STARTED|Overall Study||47
8342192|NCT01301027|20564903|P1|STARTED|Overall Study||48
8342193|NCT01301001|20564915|P2|NOT COMPLETED|Second Intervention||0
8342194|NCT01301001|20564916|P1|NOT COMPLETED|Second Intervention||4
8342195|NCT01301001|20564915|P2|COMPLETED|Second Intervention||36
8342196|NCT01301001|20564916|P1|COMPLETED|Second Intervention||30
8342197|NCT01301001|20564915|P2|STARTED|Second Intervention||36
8342198|NCT01301001|20564916|P1|STARTED|Second Intervention||34
8342199|NCT01301001|20564915|P2|NOT COMPLETED|Washout (2 Weeks)||0
8342200|NCT01301001|20564916|P1|NOT COMPLETED|Washout (2 Weeks)||0
8342201|NCT01301001|20564915|P2|COMPLETED|Washout (2 Weeks)||36
8342202|NCT01301001|20564916|P1|COMPLETED|Washout (2 Weeks)||34
8342203|NCT01301001|20564915|P2|STARTED|Washout (2 Weeks)||36
8342204|NCT01301001|20564916|P1|STARTED|Washout (2 Weeks)||34
8342205|NCT01301001|20564915|P2|NOT COMPLETED|First Intervention||9
8342206|NCT01301001|20564916|P1|NOT COMPLETED|First Intervention||10
8342207|NCT01301001|20564915|P2|COMPLETED|First Intervention||36
8342208|NCT01301001|20564916|P1|COMPLETED|First Intervention||34
8342209|NCT01301001|20564915|P2|STARTED|First Intervention||45
8342210|NCT01301001|20564916|P1|STARTED|First Intervention||44
8342211|NCT01300949|20564929|P3|NOT COMPLETED|Overall Study||0
8342212|NCT01300949|20564930|P2|NOT COMPLETED|Overall Study||0
8342213|NCT01300949|20564931|P1|NOT COMPLETED|Overall Study||0
8342214|NCT01300949|20564929|P3|COMPLETED|Overall Study||35
8342215|NCT01300949|20564930|P2|COMPLETED|Overall Study||125
8342216|NCT01300949|20564931|P1|COMPLETED|Overall Study||154
8342217|NCT01300949|20564929|P3|STARTED|Overall Study||35
8342218|NCT01300949|20564930|P2|STARTED|Overall Study||125
8342219|NCT01300949|20564931|P1|STARTED|Overall Study||154
8342220|NCT01300923|20564939|P2|NOT COMPLETED|Overall Study||2
8342221|NCT01300923|20564940|P1|NOT COMPLETED|Overall Study||0
8342222|NCT01300923|20564939|P2|COMPLETED|Overall Study||0
8342223|NCT01300923|20564940|P1|COMPLETED|Overall Study||12
8342224|NCT01300923|20564939|P2|STARTED|Overall Study||2
8342225|NCT01300923|20564940|P1|STARTED|Overall Study||12
8342226|NCT01300819|20564953|P2|NOT COMPLETED|Overall Study||44
8342227|NCT01300819|20564954|P1|NOT COMPLETED|Overall Study||22
8342228|NCT01300819|20564953|P2|COMPLETED|Overall Study||180
8342229|NCT01300819|20564954|P1|COMPLETED|Overall Study||103
8342230|NCT01300819|20564953|P2|STARTED|Overall Study||224
8342231|NCT01300819|20564954|P1|STARTED|Overall Study||125
8342232|NCT01300767|20564982|P1|NOT COMPLETED|Overall Study||4
8342233|NCT01300767|20564982|P1|COMPLETED|Overall Study||70
8342234|NCT01300767|20564982|P1|STARTED|Overall Study||74
8342235|NCT01300741|20565010|P1|NOT COMPLETED|Overall Study||3
8342236|NCT01300741|20565010|P1|COMPLETED|Overall Study||72
8342237|NCT01300741|20565010|P1|STARTED|Overall Study||75
8342238|NCT01300728|20565040|P2|NOT COMPLETED|Overall Study||1
8342239|NCT01300728|20565041|P1|NOT COMPLETED|Overall Study||2
8342240|NCT01300728|20565040|P2|COMPLETED|Overall Study||25
8342241|NCT01300728|20565041|P1|COMPLETED|Overall Study||24
8342242|NCT01300728|20565040|P2|STARTED|Overall Study||26
8342243|NCT01300728|20565041|P1|STARTED|Overall Study||26
8342244|NCT01300650|20565055|P1|NOT COMPLETED|Overall Study||1
8342245|NCT01300650|20565055|P1|COMPLETED|Overall Study||7
8342246|NCT01300650|20565055|P1|STARTED|Overall Study||8
8342247|NCT01300624|20565061|P1|NOT COMPLETED|Overall Study||0
8342248|NCT01300624|20565061|P1|COMPLETED|Overall Study||11
8342249|NCT01300624|20565061|P1|STARTED|Overall Study||11
8342250|NCT01300572|20565071|P1|NOT COMPLETED|Overall Study||1
8342251|NCT01300572|20565071|P1|COMPLETED|Overall Study||15
8342252|NCT01300572|20565071|P1|STARTED|Overall Study||16
8342253|NCT01300559|20565086|P2|NOT COMPLETED|Overall Study||0
8342254|NCT01300559|20565087|P1|NOT COMPLETED|Overall Study||0
8342255|NCT01300559|20565086|P2|COMPLETED|Overall Study||30
8342256|NCT01300559|20565087|P1|COMPLETED|Overall Study||30
8342257|NCT01300559|20565086|P2|STARTED|Overall Study||30
8342258|NCT01300559|20565087|P1|STARTED|Overall Study||30
8342259|NCT01300546|20565095|P2|NOT COMPLETED|Overall Study||6
8342260|NCT01300546|20565096|P1|NOT COMPLETED|Overall Study||1
8342261|NCT01300546|20565095|P2|COMPLETED|Overall Study||14
8342262|NCT01300546|20565096|P1|COMPLETED|Overall Study||18
8342263|NCT01300546|20565095|P2|STARTED|Overall Study||20
8342264|NCT01300546|20565096|P1|STARTED|Overall Study||19
8342265|NCT01300455|20565126|P2|NOT COMPLETED|Period 2||0
8342266|NCT01300455|20565127|P1|NOT COMPLETED|Period 2||0
8342267|NCT01300455|20565126|P2|COMPLETED|Period 2||13
8342268|NCT01300455|20565127|P1|COMPLETED|Period 2||12
8342269|NCT01300455|20565126|P2|STARTED|Period 2||13
8342270|NCT01300455|20565127|P1|STARTED|Period 2||12
8342271|NCT01300455|20565126|P2|NOT COMPLETED|Washout||0
8342272|NCT01300455|20565127|P1|NOT COMPLETED|Washout||1
8342273|NCT01300455|20565126|P2|COMPLETED|Washout||13
8342274|NCT01300455|20565127|P1|COMPLETED|Washout||12
8342275|NCT01300455|20565126|P2|STARTED|Washout||13
8342276|NCT01300455|20565127|P1|STARTED|Washout||13
8342277|NCT01300455|20565126|P2|NOT COMPLETED|Period 1||0
8342278|NCT01300455|20565127|P1|NOT COMPLETED|Period 1||0
8342279|NCT01300455|20565126|P2|COMPLETED|Period 1||13
8342280|NCT01300455|20565127|P1|COMPLETED|Period 1||13
8342281|NCT01300455|20565126|P2|STARTED|Period 1||13
8342282|NCT01300455|20565127|P1|STARTED|Period 1||13
8342283|NCT01300351|20565147|P2|NOT COMPLETED|Overall Study||38
8342284|NCT01300351|20565148|P1|NOT COMPLETED|Overall Study||36
8342285|NCT01300351|20565147|P2|COMPLETED|Overall Study||72
8342286|NCT01300351|20565148|P1|COMPLETED|Overall Study||75
8342287|NCT01300351|20565147|P2|Received Study Treatment|Overall Study||110
8342288|NCT01300351|20565148|P1|Received Study Treatment|Overall Study||109
8342289|NCT01300351|20565147|P2|STARTED|Overall Study||110
8342290|NCT01300351|20565148|P1|STARTED|Overall Study||111
8342291|NCT01300338|20565164|P2|NOT COMPLETED|Overall Study||0
8342292|NCT01300338|20565165|P1|NOT COMPLETED|Overall Study||5
8342293|NCT01300338|20565164|P2|COMPLETED|Overall Study||25
8342294|NCT01300338|20565165|P1|COMPLETED|Overall Study||20
8342295|NCT01300338|20565164|P2|STARTED|Overall Study||25
8342296|NCT01300338|20565165|P1|STARTED|Overall Study||25
8342297|NCT01300286|20565173|P1|NOT COMPLETED|Overall Study||1
8342298|NCT01300286|20565173|P1|COMPLETED|Overall Study||22
8342299|NCT01300286|20565173|P1|STARTED|Overall Study||23
8342300|NCT01300260|20565183|P2|NOT COMPLETED|Period 2 of Study: Second Intervention||1
8342301|NCT01300260|20565184|P1|NOT COMPLETED|Period 2 of Study: Second Intervention||0
8342302|NCT01300260|20565183|P2|COMPLETED|Period 2 of Study: Second Intervention||15
8342303|NCT01300260|20565184|P1|COMPLETED|Period 2 of Study: Second Intervention||14
8342304|NCT01300260|20565183|P2|STARTED|Period 2 of Study: Second Intervention||16
8342305|NCT01300260|20565184|P1|STARTED|Period 2 of Study: Second Intervention||14
8342306|NCT01300260|20565183|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
8342307|NCT01300260|20565184|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
8342308|NCT01300260|20565183|P2|COMPLETED|Washout Period of at Least 28 Days||16
8342309|NCT01300260|20565184|P1|COMPLETED|Washout Period of at Least 28 Days||14
8342310|NCT01300260|20565183|P2|STARTED|Washout Period of at Least 28 Days||16
8342311|NCT01300260|20565184|P1|STARTED|Washout Period of at Least 28 Days||14
8342312|NCT01300260|20565183|P2|NOT COMPLETED|Period 1 of Study: First Intervention||1
8342313|NCT01300260|20565184|P1|NOT COMPLETED|Period 1 of Study: First Intervention||1
8342314|NCT01300260|20565183|P2|COMPLETED|Period 1 of Study: First Intervention||16
8342315|NCT01300260|20565184|P1|COMPLETED|Period 1 of Study: First Intervention||14
8342316|NCT01300260|20565183|P2|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
8342317|NCT01300260|20565184|P1|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
8342318|NCT01300260|20565183|P2|STARTED|Period 1 of Study: First Intervention||17
8342319|NCT01300260|20565184|P1|STARTED|Period 1 of Study: First Intervention||15
8342320|NCT01300247|20565216|P2|NOT COMPLETED|Overall Study||2
8342321|NCT01300247|20565217|P1|NOT COMPLETED|Overall Study||4
8342322|NCT01300247|20565216|P2|COMPLETED|Overall Study||18
8342323|NCT01300247|20565217|P1|COMPLETED|Overall Study||17
8342324|NCT01300247|20565216|P2|STARTED|Overall Study||20
8342325|NCT01300247|20565217|P1|STARTED|Overall Study||21
8342326|NCT01300234|20565249|P2|NOT COMPLETED|Overall Study||27
8342327|NCT01300234|20565250|P1|NOT COMPLETED|Overall Study||28
8342328|NCT01300234|20565249|P2|COMPLETED|Overall Study||228
8342329|NCT01300234|20565250|P1|COMPLETED|Overall Study||229
8342330|NCT01300234|20565249|P2|STARTED|Overall Study||255
8342331|NCT01300234|20565250|P1|STARTED|Overall Study||257
8342332|NCT01300065|20565286|P2|NOT COMPLETED|Overall Study||3
8342333|NCT01300065|20565287|P1|NOT COMPLETED|Overall Study||6
8342334|NCT01300065|20565286|P2|COMPLETED|Overall Study||217
8342335|NCT01300065|20565287|P1|COMPLETED|Overall Study||215
8342336|NCT01300065|20565286|P2|STARTED|Overall Study||220
8342337|NCT01300065|20565287|P1|STARTED|Overall Study||221
8342338|NCT01300052|20565297|P2|NOT COMPLETED|Overall Study||3
8342339|NCT01300052|20565298|P1|NOT COMPLETED|Overall Study||6
8342340|NCT01300052|20565297|P2|COMPLETED|Overall Study||19
8342341|NCT01300052|20565298|P1|COMPLETED|Overall Study||40
8342342|NCT01300052|20565297|P2|STARTED|Overall Study||22
8342343|NCT01300052|20565298|P1|STARTED|Overall Study||46
8342344|NCT01299961|20565316|P1|NOT COMPLETED|Overall Study||6
8342345|NCT01299961|20565316|P1|COMPLETED|Overall Study||19
8342346|NCT01299961|20565316|P1|STARTED|Overall Study||25
8342347|NCT01299909|20565325|P3|NOT COMPLETED|Overall Study||17
8342348|NCT01299909|20565326|P2|NOT COMPLETED|Overall Study||18
8342349|NCT01299909|20565327|P1|NOT COMPLETED|Overall Study||22
8342350|NCT01299909|20565325|P3|COMPLETED|Overall Study||23
8342351|NCT01299909|20565326|P2|COMPLETED|Overall Study||49
8342352|NCT01299909|20565327|P1|COMPLETED|Overall Study||46
8342353|NCT01299909|20565325|P3|STARTED|Overall Study||40
8342354|NCT01299909|20565326|P2|STARTED|Overall Study||67
8342355|NCT01299909|20565327|P1|STARTED|Overall Study||68
8342356|NCT01299896|20565342|P2|NOT COMPLETED|Overall Study||18
8342357|NCT01299896|20565343|P1|NOT COMPLETED|Overall Study||1
8342358|NCT01299896|20565342|P2|COMPLETED|Overall Study||296
8342359|NCT01299896|20565343|P1|COMPLETED|Overall Study||318
8342360|NCT01299896|20565342|P2|STARTED|Overall Study||314
8342361|NCT01299896|20565343|P1|STARTED|Overall Study||319
8342362|NCT01299805|20565351|P2|NOT COMPLETED|Overall Study||0
8342363|NCT01299805|20565352|P1|NOT COMPLETED|Overall Study||2
8342364|NCT01299805|20565351|P2|COMPLETED|Overall Study||5
8342365|NCT01299805|20565352|P1|COMPLETED|Overall Study||10
8342366|NCT01299805|20565351|P2|STARTED|Overall Study||5
8342367|NCT01299805|20565352|P1|STARTED|Overall Study||12
8342368|NCT01299766|20565382|P2|NOT COMPLETED|Overall Study||23
8342369|NCT01299766|20565383|P1|NOT COMPLETED|Overall Study||34
8342370|NCT01299766|20565382|P2|COMPLETED|Overall Study||87
8342371|NCT01299766|20565383|P1|COMPLETED|Overall Study||77
8342372|NCT01299766|20565382|P2|STARTED|Overall Study||110
8342373|NCT01299766|20565383|P1|STARTED|Overall Study||111
8342383|NCT01299610|20565443|P3|NOT COMPLETED|Overall Study||0
8342384|NCT01299610|20565444|P2|NOT COMPLETED|Overall Study||0
8342385|NCT01299610|20565445|P1|NOT COMPLETED|Overall Study||0
8342386|NCT01299610|20565443|P3|COMPLETED|Overall Study||10
8342387|NCT01299610|20565444|P2|COMPLETED|Overall Study||5
8342388|NCT01299610|20565445|P1|COMPLETED|Overall Study||10
8342389|NCT01299610|20565443|P3|STARTED|Overall Study||10
8342390|NCT01299610|20565444|P2|STARTED|Overall Study||5
8342391|NCT01299610|20565445|P1|STARTED|Overall Study||10
8342392|NCT01299584|20565490|P1|NOT COMPLETED|Overall Study||9
8342393|NCT01299584|20565490|P1|COMPLETED|Overall Study||766
8342394|NCT01299584|20565490|P1|STARTED|Overall Study||775
8342395|NCT01299571|20565497|P1|NOT COMPLETED|Overall Study||107
8342396|NCT01299571|20565497|P1|COMPLETED|Overall Study||3870
8342397|NCT01299571|20565497|P1|STARTED|Overall Study||3977
8342398|NCT01299480|20565508|P5|NOT COMPLETED|Overall Study||20
8342399|NCT01299480|20565509|P4|NOT COMPLETED|Overall Study||25
8342400|NCT01299480|20565510|P3|NOT COMPLETED|Overall Study||41
8342401|NCT01299480|20565511|P2|NOT COMPLETED|Overall Study||35
8342402|NCT01299480|20565512|P1|NOT COMPLETED|Overall Study||42
8342403|NCT01299480|20565508|P5|COMPLETED|Overall Study||123
8342404|NCT01299480|20565509|P4|COMPLETED|Overall Study||261
8342405|NCT01299480|20565510|P3|COMPLETED|Overall Study||386
8342406|NCT01299480|20565511|P2|COMPLETED|Overall Study||395
8342407|NCT01299480|20565512|P1|COMPLETED|Overall Study||385
8342408|NCT01299480|20565508|P5|STARTED|Overall Study||143
8342409|NCT01299480|20565509|P4|STARTED|Overall Study||286
8342410|NCT01299480|20565510|P3|STARTED|Overall Study||427
8342411|NCT01299480|20565511|P2|STARTED|Overall Study||430
8342412|NCT01299480|20565512|P1|STARTED|Overall Study||427
8342413|NCT01299454|20565551|P4|NOT COMPLETED|Overall Study||0
8342414|NCT01299454|20565552|P3|NOT COMPLETED|Overall Study||0
8342415|NCT01299454|20565553|P2|NOT COMPLETED|Overall Study||0
8342416|NCT01299454|20565554|P1|NOT COMPLETED|Overall Study||0
8342417|NCT01299454|20565551|P4|COMPLETED|Overall Study||23
8342418|NCT01299454|20565552|P3|COMPLETED|Overall Study||6
8342419|NCT01299454|20565553|P2|COMPLETED|Overall Study||8
8342420|NCT01299454|20565554|P1|COMPLETED|Overall Study||8
8342421|NCT01299454|20565551|P4|STARTED|Overall Study||23
8342422|NCT01299454|20565552|P3|STARTED|Overall Study||6
8342423|NCT01299454|20565553|P2|STARTED|Overall Study||8
8342424|NCT01299454|20565554|P1|STARTED|Overall Study||8
8342425|NCT01299389|20565714|P4|NOT COMPLETED|Post-observational||6
8342426|NCT01299389|20565715|P3|NOT COMPLETED|Post-observational||12
8342427|NCT01299389|20565716|P2|NOT COMPLETED|Post-observational||0
8342428|NCT01299389|20565717|P1|NOT COMPLETED|Post-observational||0
8342429|NCT01299389|20565714|P4|COMPLETED|Post-observational||149
8342430|NCT01299389|20565715|P3|COMPLETED|Post-observational||144
8342431|NCT01299389|20565716|P2|COMPLETED|Post-observational||0
8342432|NCT01299389|20565717|P1|COMPLETED|Post-observational||0
8342433|NCT01299389|20565714|P4|STARTED|Post-observational||155
8342434|NCT01299389|20565715|P3|STARTED|Post-observational||156
8342435|NCT01299389|20565716|P2|STARTED|Post-observational||0
8342436|NCT01299389|20565717|P1|STARTED|Post-observational||0
8342437|NCT01299389|20565714|P4|NOT COMPLETED|Double-blind||0
8342438|NCT01299389|20565715|P3|NOT COMPLETED|Double-blind||0
8342439|NCT01299389|20565716|P2|NOT COMPLETED|Double-blind||64
8342440|NCT01299389|20565717|P1|NOT COMPLETED|Double-blind||109
8342441|NCT01299389|20565714|P4|COMPLETED|Double-blind||0
8342442|NCT01299389|20565715|P3|COMPLETED|Double-blind||0
8342443|NCT01299389|20565716|P2|COMPLETED|Double-blind||95
8342444|NCT01299389|20565717|P1|COMPLETED|Double-blind||55
8342445|NCT01299389|20565714|P4|STARTED|Double-blind||0
8342446|NCT01299389|20565715|P3|STARTED|Double-blind||0
8342447|NCT01299389|20565716|P2|STARTED|Double-blind||159
8342448|NCT01299389|20565717|P1|STARTED|Double-blind||164
8342449|NCT01299376|20565739|P2|NOT COMPLETED|Extension (Weeks 9 to 52)||15
8342450|NCT01299376|20565740|P1|NOT COMPLETED|Extension (Weeks 9 to 52)||10
8342451|NCT01299376|20565739|P2|COMPLETED|Extension (Weeks 9 to 52)||118
8342452|NCT01299376|20565740|P1|COMPLETED|Extension (Weeks 9 to 52)||124
8342453|NCT01299376|20565739|P2|STARTED|Extension (Weeks 9 to 52)||133
8342454|NCT01299376|20565740|P1|STARTED|Extension (Weeks 9 to 52)||134
8342455|NCT01299376|20565739|P2|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
8342456|NCT01299376|20565740|P1|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
8342457|NCT01299376|20565739|P2|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
8342458|NCT01299376|20565740|P1|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
8342459|NCT01299376|20565739|P2|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
8342460|NCT01299376|20565740|P1|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
8342461|NCT01299285|20565770|P1|NOT COMPLETED|Overall Study||0
8342462|NCT01299285|20565770|P1|COMPLETED|Overall Study||6
8342463|NCT01299285|20565770|P1|STARTED|Overall Study||6
8342464|NCT01299272|20565783|P4|NOT COMPLETED|Double-blind (DB) Randomized Period||58
8342465|NCT01299272|20565784|P3|NOT COMPLETED|Double-blind (DB) Randomized Period||70
8342466|NCT01299272|20565785|P2|NOT COMPLETED|Double-blind (DB) Randomized Period||0
8342467|NCT01299272|20565786|P1|NOT COMPLETED|Double-blind (DB) Randomized Period||0
8342468|NCT01299272|20565783|P4|COMPLETED|Double-blind (DB) Randomized Period||234
8342469|NCT01299272|20565784|P3|COMPLETED|Double-blind (DB) Randomized Period||224
8342470|NCT01299272|20565785|P2|COMPLETED|Double-blind (DB) Randomized Period||0
8342471|NCT01299272|20565786|P1|COMPLETED|Double-blind (DB) Randomized Period||0
8342472|NCT01299272|20565783|P4|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
8342473|NCT01299272|20565784|P3|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
8342474|NCT01299272|20565785|P2|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
8342475|NCT01299272|20565786|P1|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
8342476|NCT01299272|20565783|P4|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
8342477|NCT01299272|20565784|P3|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
8342478|NCT01299272|20565785|P2|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
8342479|NCT01299272|20565786|P1|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
8342480|NCT01299272|20565783|P4|STARTED|Double-blind (DB) Randomized Period||292
8342481|NCT01299272|20565784|P3|STARTED|Double-blind (DB) Randomized Period||294
8342482|NCT01299272|20565785|P2|STARTED|Double-blind (DB) Randomized Period||0
8342483|NCT01299272|20565786|P1|STARTED|Double-blind (DB) Randomized Period||0
8342484|NCT01299272|20565783|P4|NOT COMPLETED|Stabilization Open-label (OL) Period||0
8342485|NCT01299272|20565784|P3|NOT COMPLETED|Stabilization Open-label (OL) Period||0
8342486|NCT01299272|20565785|P2|NOT COMPLETED|Stabilization Open-label (OL) Period||249
8342487|NCT01299272|20565786|P1|NOT COMPLETED|Stabilization Open-label (OL) Period||0
8342488|NCT01299272|20565783|P4|COMPLETED|Stabilization Open-label (OL) Period||0
8342489|NCT01299272|20565784|P3|COMPLETED|Stabilization Open-label (OL) Period||0
8342490|NCT01299272|20565785|P2|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
8342491|NCT01299272|20565786|P1|COMPLETED|Stabilization Open-label (OL) Period||0
8342492|NCT01299272|20565783|P4|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
8342493|NCT01299272|20565784|P3|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
8342494|NCT01299272|20565785|P2|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
8342495|NCT01299272|20565786|P1|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
8342496|NCT01299272|20565783|P4|STARTED|Stabilization Open-label (OL) Period||0
8342497|NCT01299272|20565784|P3|STARTED|Stabilization Open-label (OL) Period||0
8342498|NCT01299272|20565785|P2|STARTED|Stabilization Open-label (OL) Period||835
8342499|NCT01299272|20565786|P1|STARTED|Stabilization Open-label (OL) Period||0
8342500|NCT01299272|20565783|P4|NOT COMPLETED|Acute Open-label (OL) Period||0
8342501|NCT01299272|20565784|P3|NOT COMPLETED|Acute Open-label (OL) Period||0
8342502|NCT01299272|20565785|P2|NOT COMPLETED|Acute Open-label (OL) Period||0
8342503|NCT01299272|20565786|P1|NOT COMPLETED|Acute Open-label (OL) Period||414
8342504|NCT01299272|20565783|P4|COMPLETED|Acute Open-label (OL) Period||0
8342505|NCT01299272|20565784|P3|COMPLETED|Acute Open-label (OL) Period||0
8342506|NCT01299272|20565785|P2|COMPLETED|Acute Open-label (OL) Period||0
8342507|NCT01299272|20565786|P1|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
8342508|NCT01299272|20565783|P4|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
8342509|NCT01299272|20565784|P3|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
8342510|NCT01299272|20565785|P2|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
8342511|NCT01299272|20565786|P1|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
8342512|NCT01299272|20565783|P4|STARTED|Acute Open-label (OL) Period||0
8342513|NCT01299272|20565784|P3|STARTED|Acute Open-label (OL) Period||0
8342514|NCT01299272|20565785|P2|STARTED|Acute Open-label (OL) Period||0
8342515|NCT01299272|20565786|P1|STARTED|Acute Open-label (OL) Period||1249
8342516|NCT01299116|20565841|P3|NOT COMPLETED|Overall Study||11
8342517|NCT01299116|20565842|P2|NOT COMPLETED|Overall Study||9
8342518|NCT01299116|20565843|P1|NOT COMPLETED|Overall Study||65
8342519|NCT01299116|20565841|P3|COMPLETED|Overall Study||184
8342520|NCT01299116|20565842|P2|COMPLETED|Overall Study||168
8342521|NCT01299116|20565843|P1|COMPLETED|Overall Study||457
8342522|NCT01299116|20565841|P3|STARTED|Overall Study||195
8342523|NCT01299116|20565842|P2|STARTED|Overall Study||177
8342524|NCT01299116|20565843|P1|STARTED|Overall Study||522
8342525|NCT01299103|20565860|P3|NOT COMPLETED|Overall Study||2
8342526|NCT01299103|20565861|P2|NOT COMPLETED|Overall Study||2
8342527|NCT01299103|20565862|P1|NOT COMPLETED|Overall Study||0
8342528|NCT01299103|20565860|P3|COMPLETED|Overall Study||8
8342529|NCT01299103|20565861|P2|COMPLETED|Overall Study||13
8342530|NCT01299103|20565862|P1|COMPLETED|Overall Study||15
8342531|NCT01299103|20565860|P3|STARTED|Overall Study||10
8342532|NCT01299103|20565861|P2|STARTED|Overall Study||15
8342533|NCT01299103|20565862|P1|STARTED|Overall Study||15
8342534|NCT01299090|20565873|P1|NOT COMPLETED|Overall Study||0
8342535|NCT01299090|20565873|P1|COMPLETED|Overall Study||49
8342536|NCT01299090|20565873|P1|STARTED|Overall Study||49
8342537|NCT01299077|20565878|P1|NOT COMPLETED|Overall Study||0
8342538|NCT01299077|20565878|P1|COMPLETED|Overall Study||478
8342539|NCT01299077|20565878|P1|STARTED|Overall Study||478
8342540|NCT01299038|20565888|P2|NOT COMPLETED|Overall Study||0
8342541|NCT01299038|20565889|P1|NOT COMPLETED|Overall Study||1
8342542|NCT01299038|20565888|P2|COMPLETED|Overall Study|Evaluable|10
8342543|NCT01299038|20565889|P1|COMPLETED|Overall Study|Evaluable|9
8342544|NCT01299038|20565888|P2|STARTED|Overall Study|Consented|10
8342545|NCT01299038|20565889|P1|STARTED|Overall Study|Consented|10
8342546|NCT01299025|20565897|P2|NOT COMPLETED|Overall Study||1
8342547|NCT01299025|20565898|P1|NOT COMPLETED|Overall Study||3
8342548|NCT01299025|20565897|P2|COMPLETED|Overall Study||41
8342549|NCT01299025|20565898|P1|COMPLETED|Overall Study||39
8342550|NCT01299025|20565897|P2|STARTED|Overall Study||42
8342551|NCT01299025|20565898|P1|STARTED|Overall Study||42
8342552|NCT01298921|20565912|P2|NOT COMPLETED|Overall Study||0
8342553|NCT01298921|20565913|P1|NOT COMPLETED|Overall Study||0
8342554|NCT01298921|20565912|P2|COMPLETED|Overall Study||0
8342555|NCT01298921|20565913|P1|COMPLETED|Overall Study||0
8342556|NCT01298921|20565912|P2|STARTED|Overall Study||0
8342557|NCT01298921|20565913|P1|STARTED|Overall Study||0
8342558|NCT01298778|20565923|P2|NOT COMPLETED|Overall Study||6
8342559|NCT01298778|20565924|P1|NOT COMPLETED|Overall Study||3
8342560|NCT01298778|20565923|P2|COMPLETED|Overall Study||30
8342561|NCT01298778|20565924|P1|COMPLETED|Overall Study||30
8342562|NCT01298778|20565923|P2|STARTED|Overall Study||36
8342563|NCT01298778|20565924|P1|STARTED|Overall Study||33
8342564|NCT01298765|20565944|P1|NOT COMPLETED|Long-Term Treatment Period||99
8342565|NCT01298765|20565944|P1|COMPLETED|Long-Term Treatment Period||127
8342566|NCT01298765|20565944|P1|STARTED|Long-Term Treatment Period||226
8342567|NCT01298765|20565944|P1|NOT COMPLETED|Titration Period||76
8342568|NCT01298765|20565944|P1|COMPLETED|Titration Period||226
8342569|NCT01298765|20565944|P1|STARTED|Titration Period||302
8342570|NCT01298752|20565954|P2|NOT COMPLETED|Overall Study||26
8342571|NCT01298752|20565955|P1|NOT COMPLETED|Overall Study||43
8342572|NCT01298752|20565954|P2|COMPLETED|Overall Study||31
8342573|NCT01298752|20565955|P1|COMPLETED|Overall Study||77
8342574|NCT01298752|20565954|P2|STARTED|Overall Study||57
8342575|NCT01298752|20565955|P1|STARTED|Overall Study||120
8342576|NCT01298700|20565965|P2|NOT COMPLETED|Overall Study||100
8342577|NCT01298700|20565966|P1|NOT COMPLETED|Overall Study||101
8342578|NCT01298700|20565965|P2|COMPLETED|Overall Study||303
8342579|NCT01298700|20565966|P1|COMPLETED|Overall Study||302
8342580|NCT01298700|20565965|P2|Safety Population: Received Study Drug|Overall Study||398
8342581|NCT01298700|20565966|P1|Safety Population: Received Study Drug|Overall Study||400
8342582|NCT01298700|20565965|P2|STARTED|Overall Study||403
8342583|NCT01298700|20565966|P1|STARTED|Overall Study||403
8342584|NCT01298661|20565977|P3|NOT COMPLETED|Overall Study||2
8342585|NCT01298661|20565978|P2|NOT COMPLETED|Overall Study||0
8342586|NCT01298661|20565979|P1|NOT COMPLETED|Overall Study||2
8342587|NCT01298661|20565977|P3|COMPLETED|Overall Study||32
8342588|NCT01298661|20565978|P2|COMPLETED|Overall Study||24
8342589|NCT01298661|20565979|P1|COMPLETED|Overall Study||31
8342590|NCT01298661|20565977|P3|STARTED|Overall Study||34
8342591|NCT01298661|20565978|P2|STARTED|Overall Study||24
8342592|NCT01298661|20565979|P1|STARTED|Overall Study||33
8342593|NCT01298648|20566057|P1|NOT COMPLETED|Overall Study||23
8342594|NCT01298648|20566057|P1|COMPLETED|Overall Study||1693
8342595|NCT01298648|20566057|P1|STARTED|Overall Study||1716
8342596|NCT01298596|20566068|P2|NOT COMPLETED|Overall Study||33
8342597|NCT01298596|20566069|P1|NOT COMPLETED|Overall Study||28
8342598|NCT01298596|20566068|P2|COMPLETED|Overall Study||167
8342599|NCT01298596|20566069|P1|COMPLETED|Overall Study||172
8342600|NCT01298596|20566068|P2|STARTED|Overall Study||200
8342601|NCT01298596|20566069|P1|STARTED|Overall Study||200
8342602|NCT01298570|20566079|P2|NOT COMPLETED|Overall Study||61
8342603|NCT01298570|20566080|P1|NOT COMPLETED|Overall Study||120
8342604|NCT01298570|20566079|P2|COMPLETED|Overall Study||0
8342605|NCT01298570|20566080|P1|COMPLETED|Overall Study||0
8342606|NCT01298570|20566079|P2|STARTED|Overall Study||61
8342607|NCT01298570|20566080|P1|STARTED|Overall Study||120
8342608|NCT01298544|20566096|P1|NOT COMPLETED|Overall Study||0
8342609|NCT01298544|20566096|P1|COMPLETED|Overall Study||335
8342610|NCT01298544|20566096|P1|STARTED|Overall Study||335
8342611|NCT01298531|20566107|P2|NOT COMPLETED|Overall Study||7
8342612|NCT01298531|20566108|P1|NOT COMPLETED|Overall Study||9
8342613|NCT01298531|20566107|P2|COMPLETED|Overall Study||41
8342614|NCT01298531|20566108|P1|COMPLETED|Overall Study||33
8342615|NCT01298531|20566107|P2|STARTED|Overall Study||48
8342616|NCT01298531|20566108|P1|STARTED|Overall Study||42
8342617|NCT01298518|20566237|P3|NOT COMPLETED|Overall Study||1
8342618|NCT01298518|20566238|P2|NOT COMPLETED|Overall Study||0
8342619|NCT01298518|20566239|P1|NOT COMPLETED|Overall Study||0
8342620|NCT01298518|20566237|P3|COMPLETED|Overall Study||15
8342621|NCT01298518|20566238|P2|COMPLETED|Overall Study||16
8342622|NCT01298518|20566239|P1|COMPLETED|Overall Study||16
8342623|NCT01298518|20566237|P3|STARTED|Overall Study||16
8342624|NCT01298518|20566238|P2|STARTED|Overall Study||16
8342625|NCT01298518|20566239|P1|STARTED|Overall Study||16
8342629|NCT01298362|20566299|P2|NOT COMPLETED|Overall Study||43
8342630|NCT01298362|20566300|P1|NOT COMPLETED|Overall Study||38
8342631|NCT01298362|20566299|P2|COMPLETED|Overall Study||123
8342632|NCT01298362|20566300|P1|COMPLETED|Overall Study||86
8342633|NCT01298362|20566299|P2|STARTED|Overall Study||166
8342634|NCT01298362|20566300|P1|STARTED|Overall Study||124
8342635|NCT01298323|20566320|P2|NOT COMPLETED|Overall Study||88
8342636|NCT01298323|20566321|P1|NOT COMPLETED|Overall Study||86
8342637|NCT01298323|20566320|P2|COMPLETED|Overall Study||15
8342638|NCT01298323|20566321|P1|COMPLETED|Overall Study||16
8342639|NCT01298323|20566320|P2|Ongoing|Overall Study||55
8342640|NCT01298323|20566321|P1|Ongoing|Overall Study||55
8342641|NCT01298323|20566320|P2|STARTED|Overall Study||103
8342642|NCT01298323|20566321|P1|STARTED|Overall Study||102
8342643|NCT01298219|20566329|P2|NOT COMPLETED|Overall Study||36
8342644|NCT01298219|20566330|P1|NOT COMPLETED|Overall Study||50
8342645|NCT01298219|20566329|P2|COMPLETED|Overall Study||184
8342646|NCT01298219|20566330|P1|COMPLETED|Overall Study||169
8342647|NCT01298219|20566329|P2|Safety Analysis Set|Overall Study||220
8342648|NCT01298219|20566330|P1|Safety Analysis Set|Overall Study||219
8342649|NCT01298219|20566329|P2|Intention to Treat (ITT)|Overall Study||220
8342650|NCT01298219|20566330|P1|Intention to Treat (ITT)|Overall Study||219
8342651|NCT01298219|20566329|P2|STARTED|Overall Study||220
8342652|NCT01298219|20566330|P1|STARTED|Overall Study||219
8342653|NCT01298193|20566344|P1|NOT COMPLETED|Efficacy Phase (Second Cycle)||1
8342654|NCT01298193|20566344|P1|COMPLETED|Efficacy Phase (Second Cycle)||23
8342655|NCT01298193|20566344|P1|STARTED|Efficacy Phase (Second Cycle)||24
8342656|NCT01298193|20566344|P1|NOT COMPLETED|Observational Phase (First Cycle)||27
8342657|NCT01298193|20566344|P1|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185
8342658|NCT01298193|20566344|P1|STARTED|Observational Phase (First Cycle)||212
8342659|NCT01298167|20566359|P2|NOT COMPLETED|Overall Study||0
8342660|NCT01298167|20566360|P1|NOT COMPLETED|Overall Study||1
8342661|NCT01298167|20566359|P2|COMPLETED|Overall Study||8
8342662|NCT01298167|20566360|P1|COMPLETED|Overall Study||5
8342663|NCT01298167|20566359|P2|STARTED|Overall Study||8
8342664|NCT01298167|20566360|P1|STARTED|Overall Study||6
8342669|NCT01298128|20566378|P2|NOT COMPLETED|Overall Study||8
8342670|NCT01298128|20566379|P1|NOT COMPLETED|Overall Study||9
8342671|NCT01298128|20566378|P2|COMPLETED|Overall Study||27
8342672|NCT01298128|20566379|P1|COMPLETED|Overall Study||26
8342673|NCT01298128|20566378|P2|STARTED|Overall Study||35
8342674|NCT01298128|20566379|P1|STARTED|Overall Study||35
8342675|NCT01298063|20566390|P5|NOT COMPLETED|Overall Study||0
8342676|NCT01298063|20566391|P4|NOT COMPLETED|Overall Study||0
8342677|NCT01298063|20566392|P3|NOT COMPLETED|Overall Study||0
8342678|NCT01298063|20566393|P2|NOT COMPLETED|Overall Study||0
8342679|NCT01298063|20566394|P1|NOT COMPLETED|Overall Study||0
8342680|NCT01298063|20566390|P5|COMPLETED|Overall Study||8
8342681|NCT01298063|20566391|P4|COMPLETED|Overall Study||8
8342682|NCT01298063|20566392|P3|COMPLETED|Overall Study||8
8342683|NCT01298063|20566393|P2|COMPLETED|Overall Study||3
8342684|NCT01298063|20566394|P1|COMPLETED|Overall Study||8
8342685|NCT01298063|20566390|P5|STARTED|Overall Study||8
8342686|NCT01298063|20566391|P4|STARTED|Overall Study||8
8342687|NCT01298063|20566392|P3|STARTED|Overall Study||8
8342688|NCT01298063|20566393|P2|STARTED|Overall Study||3
8342689|NCT01298063|20566394|P1|STARTED|Overall Study||8
8342690|NCT01297985|20566423|P2|NOT COMPLETED|Overall Study||53
8342691|NCT01297985|20566424|P1|NOT COMPLETED|Overall Study||55
8342692|NCT01297985|20566423|P2|COMPLETED|Overall Study||163
8342693|NCT01297985|20566424|P1|COMPLETED|Overall Study||157
8342694|NCT01297985|20566423|P2|STARTED|Overall Study||216
8342695|NCT01297985|20566424|P1|STARTED|Overall Study||212
8342702|NCT01297920|20566490|P3|NOT COMPLETED|Overall Study||57
8342703|NCT01297920|20566491|P2|NOT COMPLETED|Overall Study||27
8342704|NCT01297920|20566492|P1|NOT COMPLETED|Overall Study||58
8342705|NCT01297920|20566490|P3|COMPLETED|Overall Study||178
8342706|NCT01297920|20566491|P2|COMPLETED|Overall Study||207
8342707|NCT01297920|20566492|P1|COMPLETED|Overall Study||163
8342708|NCT01297920|20566490|P3|STARTED|Overall Study||235
8342709|NCT01297920|20566491|P2|STARTED|Overall Study||234
8342710|NCT01297920|20566492|P1|STARTED|Overall Study||221
8342711|NCT01297595|20566500|P2|NOT COMPLETED|Second Intervention Period||0
8342712|NCT01297595|20566501|P1|NOT COMPLETED|Second Intervention Period||0
8342713|NCT01297595|20566500|P2|COMPLETED|Second Intervention Period||11
8342714|NCT01297595|20566501|P1|COMPLETED|Second Intervention Period||11
8342715|NCT01297595|20566500|P2|STARTED|Second Intervention Period||11
8342716|NCT01297595|20566501|P1|STARTED|Second Intervention Period||11
8342717|NCT01297595|20566500|P2|NOT COMPLETED|Washout Period (At Least 14 Days)||0
8342718|NCT01297595|20566501|P1|NOT COMPLETED|Washout Period (At Least 14 Days)||0
8342719|NCT01297595|20566500|P2|COMPLETED|Washout Period (At Least 14 Days)||11
8342720|NCT01297595|20566501|P1|COMPLETED|Washout Period (At Least 14 Days)||11
8342721|NCT01297595|20566500|P2|STARTED|Washout Period (At Least 14 Days)||11
8342722|NCT01297595|20566501|P1|STARTED|Washout Period (At Least 14 Days)||11
8342723|NCT01297595|20566500|P2|NOT COMPLETED|First Intervention Period||0
8342724|NCT01297595|20566501|P1|NOT COMPLETED|First Intervention Period||0
8342725|NCT01297595|20566500|P2|COMPLETED|First Intervention Period||11
8342726|NCT01297595|20566501|P1|COMPLETED|First Intervention Period||11
8342727|NCT01297595|20566500|P2|STARTED|First Intervention Period||11
8342728|NCT01297595|20566501|P1|STARTED|First Intervention Period||11
8342729|NCT01297517|20566536|P3|NOT COMPLETED|Overall Study||27
8342730|NCT01297517|20566537|P2|NOT COMPLETED|Overall Study||12
8342731|NCT01297517|20566538|P1|NOT COMPLETED|Overall Study||27
8342732|NCT01297517|20566536|P3|COMPLETED|Overall Study||193
8342733|NCT01297517|20566537|P2|COMPLETED|Overall Study||214
8342734|NCT01297517|20566538|P1|COMPLETED|Overall Study||187
8342735|NCT01297517|20566536|P3|STARTED|Overall Study||220
8342736|NCT01297517|20566537|P2|STARTED|Overall Study||226
8342737|NCT01297517|20566538|P1|STARTED|Overall Study||214
8342738|NCT01297504|20566546|P1|NOT COMPLETED|Overall Study||67
8342739|NCT01297504|20566546|P1|COMPLETED|Overall Study||397
8342740|NCT01297504|20566546|P1|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
8342741|NCT01297504|20566546|P1|STARTED|Overall Study||464
8342742|NCT01297491|20566560|P2|NOT COMPLETED|Overall Study||33
8342743|NCT01297491|20566561|P1|NOT COMPLETED|Overall Study||30
8342744|NCT01297491|20566560|P2|COMPLETED|Overall Study||0
8342745|NCT01297491|20566561|P1|COMPLETED|Overall Study||0
8342746|NCT01297491|20566560|P2|STARTED|Overall Study||33
8342747|NCT01297491|20566561|P1|STARTED|Overall Study||30
8342754|NCT01297348|20566614|P2|NOT COMPLETED|Overall Study||0
8342755|NCT01297348|20566615|P1|NOT COMPLETED|Overall Study||0
8342756|NCT01297348|20566614|P2|COMPLETED|Overall Study||586401
8342757|NCT01297348|20566615|P1|COMPLETED|Overall Study||12281
8342758|NCT01297348|20566614|P2|STARTED|Overall Study||586401
8342759|NCT01297348|20566615|P1|STARTED|Overall Study||12281
8342760|NCT01297335|20566625|P1|NOT COMPLETED|Overall Study||0
8342761|NCT01297335|20566625|P1|COMPLETED|Overall Study||10
8342762|NCT01297335|20566625|P1|STARTED|Overall Study||10
8342763|NCT01297322|20566633|P2|NOT COMPLETED|Overall Study||4
8342764|NCT01297322|20566634|P1|NOT COMPLETED|Overall Study||1
8342765|NCT01297322|20566633|P2|COMPLETED|Overall Study||274
8342766|NCT01297322|20566634|P1|COMPLETED|Overall Study||141
8342767|NCT01297322|20566633|P2|STARTED|Overall Study||278
8342768|NCT01297322|20566634|P1|STARTED|Overall Study||142
8342774|NCT01297283|20566670|P1|NOT COMPLETED|Overall Study||19
8342775|NCT01297283|20566670|P1|COMPLETED|Overall Study||176
8342776|NCT01297283|20566670|P1|STARTED|Overall Study||195
8342777|NCT01297270|20566678|P3|NOT COMPLETED|Overall Study||29
8342778|NCT01297270|20566679|P2|NOT COMPLETED|Overall Study||72
8342779|NCT01297270|20566680|P1|NOT COMPLETED|Overall Study||45
8342780|NCT01297270|20566678|P3|COMPLETED|Overall Study||103
8342781|NCT01297270|20566679|P2|COMPLETED|Overall Study||192
8342782|NCT01297270|20566680|P1|COMPLETED|Overall Study||217
8342783|NCT01297270|20566678|P3|STARTED|Overall Study||132
8342784|NCT01297270|20566679|P2|STARTED|Overall Study||264
8342785|NCT01297270|20566680|P1|STARTED|Overall Study||262
8342786|NCT01297257|20566718|P1|NOT COMPLETED|Overall Study||0
8342787|NCT01297257|20566718|P1|COMPLETED|Overall Study||7740
8342788|NCT01297257|20566718|P1|STARTED|Overall Study||7740
8342789|NCT01297244|20566725|P2|NOT COMPLETED|Overall Study||6
8342790|NCT01297244|20566726|P1|NOT COMPLETED|Overall Study||35
8342791|NCT01297244|20566725|P2|COMPLETED|Overall Study||9
8342792|NCT01297244|20566726|P1|COMPLETED|Overall Study||55
8342793|NCT01297244|20566725|P2|STARTED|Overall Study||15
8342794|NCT01297244|20566726|P1|STARTED|Overall Study||90
8342795|NCT01297062|20566746|P7|NOT COMPLETED|Overall Study||8
8342796|NCT01297062|20566747|P6|NOT COMPLETED|Overall Study||1
8342797|NCT01297062|20566748|P5|NOT COMPLETED|Overall Study||2
8342798|NCT01297062|20566749|P4|NOT COMPLETED|Overall Study||1
8342799|NCT01297062|20566750|P3|NOT COMPLETED|Overall Study||2
8342800|NCT01297062|20566751|P2|NOT COMPLETED|Overall Study||1
8342801|NCT01297062|20566752|P1|NOT COMPLETED|Overall Study||4
8342802|NCT01297062|20566746|P7|COMPLETED|Overall Study||0
8342803|NCT01297062|20566747|P6|COMPLETED|Overall Study||13
8342804|NCT01297062|20566748|P5|COMPLETED|Overall Study||13
8342805|NCT01297062|20566749|P4|COMPLETED|Overall Study||13
8342806|NCT01297062|20566750|P3|COMPLETED|Overall Study||12
8342807|NCT01297062|20566751|P2|COMPLETED|Overall Study||13
8342808|NCT01297062|20566752|P1|COMPLETED|Overall Study||11
8342809|NCT01297062|20566746|P7|Evaluable Population|Overall Study||0
8342810|NCT01297062|20566747|P6|Evaluable Population|Overall Study||13
8342811|NCT01297062|20566748|P5|Evaluable Population|Overall Study||13
8342812|NCT01297062|20566749|P4|Evaluable Population|Overall Study||13
8342813|NCT01297062|20566750|P3|Evaluable Population|Overall Study||12
8342814|NCT01297062|20566751|P2|Evaluable Population|Overall Study||12
8342815|NCT01297062|20566752|P1|Evaluable Population|Overall Study||11
8342816|NCT01297062|20566746|P7|Intent to Treat (ITT)|Overall Study||0
8342817|NCT01297062|20566747|P6|Intent to Treat (ITT)|Overall Study||14
8342818|NCT01297062|20566748|P5|Intent to Treat (ITT)|Overall Study||15
8342819|NCT01297062|20566749|P4|Intent to Treat (ITT)|Overall Study||14
8342820|NCT01297062|20566750|P3|Intent to Treat (ITT)|Overall Study||14
8342821|NCT01297062|20566751|P2|Intent to Treat (ITT)|Overall Study||14
8342822|NCT01297062|20566752|P1|Intent to Treat (ITT)|Overall Study||15
8342823|NCT01297062|20566746|P7|STARTED|Overall Study||8
8342824|NCT01297062|20566747|P6|STARTED|Overall Study||14
8342825|NCT01297062|20566748|P5|STARTED|Overall Study||15
8342826|NCT01297062|20566749|P4|STARTED|Overall Study||14
8342827|NCT01297062|20566750|P3|STARTED|Overall Study||14
8342828|NCT01297062|20566751|P2|STARTED|Overall Study||14
8342829|NCT01297062|20566752|P1|STARTED|Overall Study||15
8342830|NCT01296932|20566783|P9|NOT COMPLETED|Overall Study||4
8342831|NCT01296932|20566784|P8|NOT COMPLETED|Overall Study||2
8342832|NCT01296932|20566785|P7|NOT COMPLETED|Overall Study||6
8342833|NCT01296932|20566786|P6|NOT COMPLETED|Overall Study||3
8342834|NCT01296932|20566787|P5|NOT COMPLETED|Overall Study||3
8342835|NCT01296932|20566788|P4|NOT COMPLETED|Overall Study||6
8342836|NCT01296932|20566789|P3|NOT COMPLETED|Overall Study||6
8342837|NCT01296932|20566790|P2|NOT COMPLETED|Overall Study||3
8342838|NCT01296932|20566791|P1|NOT COMPLETED|Overall Study||3
8342839|NCT01296932|20566783|P9|COMPLETED|Overall Study||0
8342840|NCT01296932|20566784|P8|COMPLETED|Overall Study||1
8342841|NCT01296932|20566785|P7|COMPLETED|Overall Study||0
8342842|NCT01296932|20566786|P6|COMPLETED|Overall Study||0
8342843|NCT01296932|20566787|P5|COMPLETED|Overall Study||0
8342844|NCT01296932|20566788|P4|COMPLETED|Overall Study||0
8342845|NCT01296932|20566789|P3|COMPLETED|Overall Study||0
8342846|NCT01296932|20566790|P2|COMPLETED|Overall Study||0
8342847|NCT01296932|20566791|P1|COMPLETED|Overall Study||0
8342848|NCT01296932|20566783|P9|STARTED|Overall Study||4
8342849|NCT01296932|20566784|P8|STARTED|Overall Study||3
8342850|NCT01296932|20566785|P7|STARTED|Overall Study||6
8342851|NCT01296932|20566786|P6|STARTED|Overall Study||3
8342852|NCT01296932|20566787|P5|STARTED|Overall Study||3
8342853|NCT01296932|20566788|P4|STARTED|Overall Study||6
8342854|NCT01296932|20566789|P3|STARTED|Overall Study||6
8342855|NCT01296932|20566790|P2|STARTED|Overall Study||3
8342856|NCT01296932|20566791|P1|STARTED|Overall Study||3
8342857|NCT01296841|20566877|P2|NOT COMPLETED|Overall Study||0
8342858|NCT01296841|20566878|P1|NOT COMPLETED|Overall Study||0
8342859|NCT01296841|20566877|P2|COMPLETED|Overall Study||15
8342860|NCT01296841|20566878|P1|COMPLETED|Overall Study||19
8342861|NCT01296841|20566877|P2|STARTED|Overall Study||15
8342862|NCT01296841|20566878|P1|STARTED|Overall Study||19
8342863|NCT01296815|20566890|P2|NOT COMPLETED|Overall Study||0
8342864|NCT01296815|20566891|P1|NOT COMPLETED|Overall Study||0
8342865|NCT01296815|20566890|P2|COMPLETED|Overall Study||7
8342866|NCT01296815|20566891|P1|COMPLETED|Overall Study||7
8342867|NCT01296815|20566890|P2|STARTED|Overall Study||7
8342868|NCT01296815|20566891|P1|STARTED|Overall Study||7
8342869|NCT01296763|20566900|P3|NOT COMPLETED|Overall Study||0
8342870|NCT01296763|20566901|P2|NOT COMPLETED|Overall Study||0
8342871|NCT01296763|20566902|P1|NOT COMPLETED|Overall Study||0
8342872|NCT01296763|20566900|P3|COMPLETED|Overall Study||6
8342873|NCT01296763|20566901|P2|COMPLETED|Overall Study||5
8342874|NCT01296763|20566902|P1|COMPLETED|Overall Study||7
8342875|NCT01296763|20566900|P3|STARTED|Overall Study||6
8342876|NCT01296763|20566901|P2|STARTED|Overall Study||5
8342877|NCT01296763|20566902|P1|STARTED|Overall Study||7
8342878|NCT01296698|20566915|P2|NOT COMPLETED|Overall Study||13
8342879|NCT01296698|20566916|P1|NOT COMPLETED|Overall Study||244
8342880|NCT01296698|20566915|P2|COMPLETED|Overall Study||0
8342881|NCT01296698|20566916|P1|COMPLETED|Overall Study||0
8342882|NCT01296698|20566915|P2|STARTED|Overall Study||13
8342883|NCT01296698|20566916|P1|STARTED|Overall Study||244
8342884|NCT01296672|20566970|P2|NOT COMPLETED|Overall Study||18
8342885|NCT01296672|20566971|P1|NOT COMPLETED|Overall Study||73
8342886|NCT01296672|20566970|P2|COMPLETED|Overall Study||59
8342887|NCT01296672|20566971|P1|COMPLETED|Overall Study||233
8342888|NCT01296672|20566970|P2|STARTED|Overall Study||77
8342889|NCT01296672|20566971|P1|STARTED|Overall Study||306
8342890|NCT01296646|20566983|P2|NOT COMPLETED|Overall Study||11
8342891|NCT01296646|20566984|P1|NOT COMPLETED|Overall Study||11
8342892|NCT01296646|20566983|P2|COMPLETED|Overall Study||29
8342893|NCT01296646|20566984|P1|COMPLETED|Overall Study||29
8342894|NCT01296646|20566983|P2|STARTED|Overall Study||40
8342895|NCT01296646|20566984|P1|STARTED|Overall Study||40
8342896|NCT01296568|20566992|P1|NOT COMPLETED|Continued Access Phase||3
8342897|NCT01296568|20566992|P1|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
8342898|NCT01296568|20566992|P1|STARTED|Continued Access Phase||3
8342899|NCT01296568|20566992|P1|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
8342900|NCT01296568|20566992|P1|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
8342901|NCT01296568|20566992|P1|STARTED|[^14C]LY2603618 Single Dose and Washout||3
8342902|NCT01296542|20567008|P2|NOT COMPLETED|Overall Study||2
8342903|NCT01296542|20567009|P1|NOT COMPLETED|Overall Study||0
8342904|NCT01296542|20567008|P2|COMPLETED|Overall Study||28
8342905|NCT01296542|20567009|P1|COMPLETED|Overall Study||30
8342906|NCT01296542|20567008|P2|STARTED|Overall Study||30
8342907|NCT01296542|20567009|P1|STARTED|Overall Study||30
8342908|NCT01296412|20567017|P2|NOT COMPLETED|Overall Study||70
8342909|NCT01296412|20567018|P1|NOT COMPLETED|Overall Study||51
8342910|NCT01296412|20567017|P2|COMPLETED|Overall Study||257
8342911|NCT01296412|20567018|P1|COMPLETED|Overall Study||275
8342912|NCT01296412|20567017|P2|STARTED|Overall Study||327
8342913|NCT01296412|20567018|P1|STARTED|Overall Study||326
8342914|NCT01296360|20567032|P2|NOT COMPLETED|Overall Study||8
8342915|NCT01296360|20567033|P1|NOT COMPLETED|Overall Study||6
8342916|NCT01296360|20567032|P2|COMPLETED|Overall Study||142
8342917|NCT01296360|20567033|P1|COMPLETED|Overall Study||144
8342918|NCT01296360|20567032|P2|Visit 2a (Month 13)|Overall Study||0
8342919|NCT01296360|20567033|P1|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
8342920|NCT01296360|20567032|P2|Visit 2 (Month 12)|Overall Study||149
8342921|NCT01296360|20567033|P1|Visit 2 (Month 12)|Overall Study|booster was administered|148
8342922|NCT01296360|20567032|P2|STARTED|Overall Study||150
8342923|NCT01296360|20567033|P1|STARTED|Overall Study||150
8342924|NCT01296347|20567041|P2|NOT COMPLETED|12 Month Follow up||3
8342925|NCT01296347|20567042|P1|NOT COMPLETED|12 Month Follow up||4
8342926|NCT01296347|20567041|P2|COMPLETED|12 Month Follow up||28
8342927|NCT01296347|20567042|P1|COMPLETED|12 Month Follow up||28
8342928|NCT01296347|20567041|P2|STARTED|12 Month Follow up||31
8342929|NCT01296347|20567042|P1|STARTED|12 Month Follow up||32
8342930|NCT01296347|20567041|P2|NOT COMPLETED|6 Month Follow up||2
8342931|NCT01296347|20567042|P1|NOT COMPLETED|6 Month Follow up||2
8342932|NCT01296347|20567041|P2|COMPLETED|6 Month Follow up||31
8342933|NCT01296347|20567042|P1|COMPLETED|6 Month Follow up||32
8342934|NCT01296347|20567041|P2|STARTED|6 Month Follow up||33
8342935|NCT01296347|20567042|P1|STARTED|6 Month Follow up||34
8342936|NCT01296347|20567041|P2|NOT COMPLETED|3 Month Follow up||1
8342937|NCT01296347|20567042|P1|NOT COMPLETED|3 Month Follow up||1
8342938|NCT01296347|20567041|P2|COMPLETED|3 Month Follow up||33
8342939|NCT01296347|20567042|P1|COMPLETED|3 Month Follow up||34
8342940|NCT01296347|20567041|P2|STARTED|3 Month Follow up||34
8342941|NCT01296347|20567042|P1|STARTED|3 Month Follow up||35
8342942|NCT01296347|20567041|P2|NOT COMPLETED|6 Week Follow up||1
8342943|NCT01296347|20567042|P1|NOT COMPLETED|6 Week Follow up||0
8342944|NCT01296347|20567041|P2|COMPLETED|6 Week Follow up||34
8342945|NCT01296347|20567042|P1|COMPLETED|6 Week Follow up||35
8342946|NCT01296347|20567041|P2|STARTED|6 Week Follow up||35
8342947|NCT01296347|20567042|P1|STARTED|6 Week Follow up||35
8342948|NCT01296347|20567041|P2|NOT COMPLETED|Allocation||4
8342949|NCT01296347|20567042|P1|NOT COMPLETED|Allocation||3
8342950|NCT01296347|20567041|P2|COMPLETED|Allocation||35
8342951|NCT01296347|20567042|P1|COMPLETED|Allocation||35
8342952|NCT01296347|20567041|P2|STARTED|Allocation||39
8342953|NCT01296347|20567042|P1|STARTED|Allocation||38
8342954|NCT01296191|20567060|P2|NOT COMPLETED|Overall Study||1
8342955|NCT01296191|20567061|P1|NOT COMPLETED|Overall Study||3
8342956|NCT01296191|20567060|P2|COMPLETED|Overall Study||59
8342957|NCT01296191|20567061|P1|COMPLETED|Overall Study||57
8342958|NCT01296191|20567060|P2|STARTED|Overall Study||60
8342959|NCT01296191|20567061|P1|STARTED|Overall Study||60
8342960|NCT01296152|20567067|P1|NOT COMPLETED|Overall Study||1
8342961|NCT01296152|20567067|P1|COMPLETED|Overall Study||24
8342962|NCT01296152|20567067|P1|STARTED|Overall Study||25
8342963|NCT01296035|20567094|P1|NOT COMPLETED|Overall Study||1
8342964|NCT01296035|20567094|P1|COMPLETED|Overall Study||7
8342965|NCT01296035|20567094|P1|STARTED|Overall Study||8
8342966|NCT01295905|20567101|P2|NOT COMPLETED|Overall Study||0
8342967|NCT01295905|20567102|P1|NOT COMPLETED|Overall Study||2
8342968|NCT01295905|20567101|P2|COMPLETED|Overall Study||30
8342969|NCT01295905|20567102|P1|COMPLETED|Overall Study||58
8342970|NCT01295905|20567101|P2|STARTED|Overall Study||30
8342971|NCT01295905|20567102|P1|STARTED|Overall Study||60
8342972|NCT01295879|20567114|P1|NOT COMPLETED|Overall Study||0
8342973|NCT01295879|20567114|P1|COMPLETED|Overall Study||29
8342974|NCT01295879|20567114|P1|STARTED|Overall Study||29
8342975|NCT01295840|20567120|P1|NOT COMPLETED|Overall Study||1
8342976|NCT01295840|20567120|P1|COMPLETED|Overall Study||50
8342977|NCT01295840|20567120|P1|STARTED|Overall Study||51
8342978|NCT01295827|20567146|P15|NOT COMPLETED|Overall Study||0
8342979|NCT01295827|20567147|P14|NOT COMPLETED|Overall Study||0
8342980|NCT01295827|20567148|P13|NOT COMPLETED|Overall Study||0
8342981|NCT01295827|20567149|P12|NOT COMPLETED|Overall Study||186
8342982|NCT01295827|20567150|P11|NOT COMPLETED|Overall Study||276
8342983|NCT01295827|20567151|P10|NOT COMPLETED|Overall Study||55
8342984|NCT01295827|20567152|P9|NOT COMPLETED|Overall Study||169
8342985|NCT01295827|20567153|P8|NOT COMPLETED|Overall Study||297
8342986|NCT01295827|20567154|P7|NOT COMPLETED|Overall Study||146
8342987|NCT01295827|20567155|P6|NOT COMPLETED|Overall Study||6
8342988|NCT01295827|20567156|P5|NOT COMPLETED|Overall Study||2
8342989|NCT01295827|20567157|P4|NOT COMPLETED|Overall Study||4
8342990|NCT01295827|20567158|P3|NOT COMPLETED|Overall Study||12
8342991|NCT01295827|20567159|P2|NOT COMPLETED|Overall Study||3
8342992|NCT01295827|20567160|P1|NOT COMPLETED|Overall Study||4
8342993|NCT01295827|20567146|P15|COMPLETED|Overall Study||0
8342994|NCT01295827|20567147|P14|COMPLETED|Overall Study||0
8342995|NCT01295827|20567148|P13|COMPLETED|Overall Study||0
8342996|NCT01295827|20567149|P12|COMPLETED|Overall Study||17
8342997|NCT01295827|20567150|P11|COMPLETED|Overall Study||20
8342998|NCT01295827|20567151|P10|COMPLETED|Overall Study||6
8342999|NCT01295827|20567152|P9|COMPLETED|Overall Study||14
8343000|NCT01295827|20567153|P8|COMPLETED|Overall Study||24
8343001|NCT01295827|20567154|P7|COMPLETED|Overall Study||18
8343002|NCT01295827|20567155|P6|COMPLETED|Overall Study||0
8343003|NCT01295827|20567156|P5|COMPLETED|Overall Study||1
8343004|NCT01295827|20567157|P4|COMPLETED|Overall Study||0
8343005|NCT01295827|20567158|P3|COMPLETED|Overall Study||0
8343006|NCT01295827|20567159|P2|COMPLETED|Overall Study||0
8343007|NCT01295827|20567160|P1|COMPLETED|Overall Study||0
8343008|NCT01295827|20567146|P15|Treated (All Treated Population)|Overall Study||0
8343009|NCT01295827|20567147|P14|Treated (All Treated Population)|Overall Study||0
8343010|NCT01295827|20567148|P13|Treated (All Treated Population)|Overall Study||0
8343011|NCT01295827|20567149|P12|Treated (All Treated Population)|Overall Study||202
8343012|NCT01295827|20567150|P11|Treated (All Treated Population)|Overall Study||287
8343013|NCT01295827|20567151|P10|Treated (All Treated Population)|Overall Study||61
8343014|NCT01295827|20567152|P9|Treated (All Treated Population)|Overall Study||180
8343015|NCT01295827|20567153|P8|Treated (All Treated Population)|Overall Study||313
8343016|NCT01295827|20567154|P7|Treated (All Treated Population)|Overall Study||162
8343017|NCT01295827|20567155|P6|Treated (All Treated Population)|Overall Study||6
8343018|NCT01295827|20567156|P5|Treated (All Treated Population)|Overall Study||3
8343019|NCT01295827|20567157|P4|Treated (All Treated Population)|Overall Study||4
8343020|NCT01295827|20567158|P3|Treated (All Treated Population)|Overall Study||10
8343021|NCT01295827|20567159|P2|Treated (All Treated Population)|Overall Study||3
8343022|NCT01295827|20567160|P1|Treated (All Treated Population)|Overall Study||4
8343023|NCT01295827|20567146|P15|STARTED|Overall Study||0
8343024|NCT01295827|20567147|P14|STARTED|Overall Study||0
8343025|NCT01295827|20567148|P13|STARTED|Overall Study||0
8343026|NCT01295827|20567149|P12|STARTED|Overall Study||203
8343027|NCT01295827|20567150|P11|STARTED|Overall Study||296
8343028|NCT01295827|20567151|P10|STARTED|Overall Study||61
8343029|NCT01295827|20567152|P9|STARTED|Overall Study||183
8343030|NCT01295827|20567153|P8|STARTED|Overall Study||321
8343031|NCT01295827|20567154|P7|STARTED|Overall Study||164
8343032|NCT01295827|20567155|P6|STARTED|Overall Study||6
8343033|NCT01295827|20567156|P5|STARTED|Overall Study||3
8343034|NCT01295827|20567157|P4|STARTED|Overall Study||4
8343035|NCT01295827|20567158|P3|STARTED|Overall Study||12
8343036|NCT01295827|20567159|P2|STARTED|Overall Study||3
8343037|NCT01295827|20567160|P1|STARTED|Overall Study||4
8343038|NCT01295814|20567533|P2|NOT COMPLETED|Overall Study||2
8343039|NCT01295814|20567534|P1|NOT COMPLETED|Overall Study||2
8343040|NCT01295814|20567533|P2|COMPLETED|Overall Study||19
8343041|NCT01295814|20567534|P1|COMPLETED|Overall Study||20
8343042|NCT01295814|20567533|P2|STARTED|Overall Study||21
8343043|NCT01295814|20567534|P1|STARTED|Overall Study||22
8343044|NCT01295710|20567550|P2|NOT COMPLETED|Overall Study||50
8343045|NCT01295710|20567551|P1|NOT COMPLETED|Overall Study||78
8343046|NCT01295710|20567550|P2|COMPLETED|Overall Study||78
8343047|NCT01295710|20567551|P1|COMPLETED|Overall Study||48
8343048|NCT01295710|20567550|P2|STARTED|Overall Study|Randomized and treated|128
8343049|NCT01295710|20567551|P1|STARTED|Overall Study|Randomized and treated|126
8343050|NCT01295671|20567614|P3|NOT COMPLETED|Overall Study||3
8343051|NCT01295671|20567615|P2|NOT COMPLETED|Overall Study||7
8343052|NCT01295671|20567616|P1|NOT COMPLETED|Overall Study||7
8343053|NCT01295671|20567614|P3|COMPLETED|Overall Study||66
8343054|NCT01295671|20567615|P2|COMPLETED|Overall Study||60
8343055|NCT01295671|20567616|P1|COMPLETED|Overall Study||60
8343056|NCT01295671|20567614|P3|STARTED|Overall Study||69
8343057|NCT01295671|20567615|P2|STARTED|Overall Study||67
8343058|NCT01295671|20567616|P1|STARTED|Overall Study||67
8343059|NCT01295515|20567654|P1|NOT COMPLETED|Overall Study||0
8343060|NCT01295515|20567654|P1|COMPLETED|Overall Study||7
8343061|NCT01295515|20567654|P1|STARTED|Overall Study||7
8343062|NCT01295320|20567662|P1|NOT COMPLETED|Overall Study||10
8343063|NCT01295320|20567662|P1|COMPLETED|Overall Study||119
8343064|NCT01295320|20567662|P1|STARTED|Overall Study||129
8343065|NCT01295281|20567679|P2|NOT COMPLETED|Second Intervention (7days)||0
8343066|NCT01295281|20567680|P1|NOT COMPLETED|Second Intervention (7days)||0
8343067|NCT01295281|20567679|P2|COMPLETED|Second Intervention (7days)||51
8343068|NCT01295281|20567680|P1|COMPLETED|Second Intervention (7days)||53
8343069|NCT01295281|20567679|P2|STARTED|Second Intervention (7days)||51
8343070|NCT01295281|20567680|P1|STARTED|Second Intervention (7days)||53
8343071|NCT01295281|20567679|P2|NOT COMPLETED|First Intervention (7 Days)||1
8343072|NCT01295281|20567680|P1|NOT COMPLETED|First Intervention (7 Days)||0
8343073|NCT01295281|20567679|P2|COMPLETED|First Intervention (7 Days)||51
8343074|NCT01295281|20567680|P1|COMPLETED|First Intervention (7 Days)||53
8343075|NCT01295281|20567679|P2|STARTED|First Intervention (7 Days)||52
8343076|NCT01295281|20567680|P1|STARTED|First Intervention (7 Days)||53
8343077|NCT01295216|20567688|P2|NOT COMPLETED|Overall Study||34
8343078|NCT01295216|20567689|P1|NOT COMPLETED|Overall Study||50
8343079|NCT01295216|20567688|P2|COMPLETED|Overall Study||287
8343080|NCT01295216|20567689|P1|COMPLETED|Overall Study||266
8343081|NCT01295216|20567688|P2|STARTED|Overall Study||321
8343082|NCT01295216|20567689|P1|STARTED|Overall Study||316
8343083|NCT01295112|20567707|P2|NOT COMPLETED|Overall Study||0
8343084|NCT01295112|20567708|P1|NOT COMPLETED|Overall Study||0
8343085|NCT01295112|20567707|P2|COMPLETED|Overall Study||33
8343086|NCT01295112|20567708|P1|COMPLETED|Overall Study||35
8343087|NCT01295112|20567707|P2|STARTED|Overall Study||33
8343088|NCT01295112|20567708|P1|STARTED|Overall Study||35
8343089|NCT01295034|20567718|P2|NOT COMPLETED|Overall Study||5
8343090|NCT01295034|20567719|P1|NOT COMPLETED|Overall Study||5
8343091|NCT01295034|20567718|P2|COMPLETED|Overall Study||25
8343092|NCT01295034|20567719|P1|COMPLETED|Overall Study||27
8343093|NCT01295034|20567718|P2|STARTED|Overall Study||30
8343094|NCT01295034|20567719|P1|STARTED|Overall Study||32
8343095|NCT01294917|20567727|P1|NOT COMPLETED|Overall Study||6
8343096|NCT01294917|20567727|P1|COMPLETED|Overall Study||36
8343097|NCT01294917|20567727|P1|Received OptiFree RepleniSH MPS|Overall Study||36
8343098|NCT01294917|20567727|P1|Received Clear Care|Overall Study||36
8343099|NCT01294917|20567727|P1|Received Investigational MPS|Overall Study||36
8343100|NCT01294917|20567727|P1|STARTED|Overall Study||42
8343101|NCT01294800|20567737|P4|NOT COMPLETED|Overall Study||16
8343102|NCT01294800|20567738|P3|NOT COMPLETED|Overall Study||17
8343103|NCT01294800|20567739|P2|NOT COMPLETED|Overall Study||10
8343104|NCT01294800|20567740|P1|NOT COMPLETED|Overall Study||11
8343105|NCT01294800|20567737|P4|COMPLETED|Overall Study||97
8343106|NCT01294800|20567738|P3|COMPLETED|Overall Study||96
8343107|NCT01294800|20567739|P2|COMPLETED|Overall Study||103
8343108|NCT01294800|20567740|P1|COMPLETED|Overall Study||100
8343109|NCT01294800|20567737|P4|STARTED|Overall Study||113
8343110|NCT01294800|20567738|P3|STARTED|Overall Study||113
8343111|NCT01294800|20567739|P2|STARTED|Overall Study||113
8343112|NCT01294800|20567740|P1|STARTED|Overall Study||111
8343113|NCT01294787|20567766|P6|NOT COMPLETED|Period 3||0
8343114|NCT01294787|20567767|P5|NOT COMPLETED|Period 3||1
8343115|NCT01294787|20567768|P4|NOT COMPLETED|Period 3||0
8343116|NCT01294787|20567769|P3|NOT COMPLETED|Period 3||0
8343117|NCT01294787|20567770|P2|NOT COMPLETED|Period 3||0
8343118|NCT01294787|20567771|P1|NOT COMPLETED|Period 3||0
8343119|NCT01294787|20567766|P6|COMPLETED|Period 3||13
8343120|NCT01294787|20567767|P5|COMPLETED|Period 3||13
8343121|NCT01294787|20567768|P4|COMPLETED|Period 3||9
8343122|NCT01294787|20567769|P3|COMPLETED|Period 3||13
8343123|NCT01294787|20567770|P2|COMPLETED|Period 3||13
8343124|NCT01294787|20567771|P1|COMPLETED|Period 3||12
8343125|NCT01294787|20567766|P6|STARTED|Period 3||13
8343126|NCT01294787|20567767|P5|STARTED|Period 3||14
8343127|NCT01294787|20567768|P4|STARTED|Period 3||9
8343128|NCT01294787|20567769|P3|STARTED|Period 3||13
8343129|NCT01294787|20567770|P2|STARTED|Period 3||13
8343130|NCT01294787|20567771|P1|STARTED|Period 3||12
8343131|NCT01294787|20567766|P6|NOT COMPLETED|Period 2||0
8343132|NCT01294787|20567767|P5|NOT COMPLETED|Period 2||0
8343133|NCT01294787|20567768|P4|NOT COMPLETED|Period 2||2
8343134|NCT01294787|20567769|P3|NOT COMPLETED|Period 2||0
8343135|NCT01294787|20567770|P2|NOT COMPLETED|Period 2||3
8343136|NCT01294787|20567771|P1|NOT COMPLETED|Period 2||0
8343137|NCT01294787|20567766|P6|COMPLETED|Period 2||13
8343138|NCT01294787|20567767|P5|COMPLETED|Period 2||14
8343139|NCT01294787|20567768|P4|COMPLETED|Period 2||9
8343140|NCT01294787|20567769|P3|COMPLETED|Period 2||13
8343141|NCT01294787|20567770|P2|COMPLETED|Period 2||13
8343142|NCT01294787|20567771|P1|COMPLETED|Period 2||12
8343143|NCT01294787|20567766|P6|STARTED|Period 2||13
8343144|NCT01294787|20567767|P5|STARTED|Period 2||14
8343145|NCT01294787|20567768|P4|STARTED|Period 2||11
8343146|NCT01294787|20567769|P3|STARTED|Period 2||13
8343147|NCT01294787|20567770|P2|STARTED|Period 2||16
8343148|NCT01294787|20567771|P1|STARTED|Period 2||12
8343149|NCT01294787|20567766|P6|NOT COMPLETED|Period 1||2
8343150|NCT01294787|20567767|P5|NOT COMPLETED|Period 1||2
8343151|NCT01294787|20567768|P4|NOT COMPLETED|Period 1||1
8343152|NCT01294787|20567769|P3|NOT COMPLETED|Period 1||1
8343153|NCT01294787|20567770|P2|NOT COMPLETED|Period 1||0
8343154|NCT01294787|20567771|P1|NOT COMPLETED|Period 1||0
8343155|NCT01294787|20567766|P6|COMPLETED|Period 1||13
8343156|NCT01294787|20567767|P5|COMPLETED|Period 1||14
8343157|NCT01294787|20567768|P4|COMPLETED|Period 1||11
8343158|NCT01294787|20567769|P3|COMPLETED|Period 1||13
8343159|NCT01294787|20567770|P2|COMPLETED|Period 1||16
8343160|NCT01294787|20567771|P1|COMPLETED|Period 1||12
8343161|NCT01294787|20567766|P6|STARTED|Period 1|One randomized participant did not receive study drug|15
8343162|NCT01294787|20567767|P5|STARTED|Period 1||16
8343163|NCT01294787|20567768|P4|STARTED|Period 1||12
8343164|NCT01294787|20567769|P3|STARTED|Period 1||14
8343165|NCT01294787|20567770|P2|STARTED|Period 1||16
8343166|NCT01294787|20567771|P1|STARTED|Period 1||12
8343167|NCT01294748|20567815|P2|NOT COMPLETED|Overall Study||2
8343168|NCT01294748|20567816|P1|NOT COMPLETED|Overall Study||5
8343169|NCT01294748|20567815|P2|COMPLETED|Overall Study|At 270 days|59
8343170|NCT01294748|20567816|P1|COMPLETED|Overall Study|At 270 days|118
8343171|NCT01294748|20567815|P2|STARTED|Overall Study||61
8343172|NCT01294748|20567816|P1|STARTED|Overall Study||123
8343173|NCT01294709|20567842|P2|NOT COMPLETED|Period 2||0
8343174|NCT01294709|20567843|P1|NOT COMPLETED|Period 2||1
8343175|NCT01294709|20567842|P2|COMPLETED|Period 2||31
8343176|NCT01294709|20567843|P1|COMPLETED|Period 2||28
8343177|NCT01294709|20567842|P2|STARTED|Period 2||31
8343178|NCT01294709|20567843|P1|STARTED|Period 2||29
8343179|NCT01294709|20567842|P2|NOT COMPLETED|Washout Period||1
8343180|NCT01294709|20567843|P1|NOT COMPLETED|Washout Period||1
8343181|NCT01294709|20567842|P2|COMPLETED|Washout Period||31
8343182|NCT01294709|20567843|P1|COMPLETED|Washout Period||29
8343183|NCT01294709|20567842|P2|STARTED|Washout Period||32
8343184|NCT01294709|20567843|P1|STARTED|Washout Period||30
8343185|NCT01294709|20567842|P2|NOT COMPLETED|Period 1||1
8343186|NCT01294709|20567843|P1|NOT COMPLETED|Period 1||1
8343187|NCT01294709|20567842|P2|COMPLETED|Period 1||32
8343188|NCT01294709|20567843|P1|COMPLETED|Period 1||30
8343189|NCT01294709|20567842|P2|STARTED|Period 1||33
8343190|NCT01294709|20567843|P1|STARTED|Period 1||31
8343191|NCT01294696|20567862|P1|NOT COMPLETED|Overall Study||74
8343192|NCT01294696|20567862|P1|COMPLETED|Overall Study||1187
8343193|NCT01294696|20567862|P1|STARTED|Overall Study||1261
8343194|NCT01294683|20567876|P2|NOT COMPLETED|Post Crossover (Period III)||32
8343195|NCT01294683|20567877|P1|NOT COMPLETED|Post Crossover (Period III)||33
8343196|NCT01294683|20567876|P2|COMPLETED|Post Crossover (Period III)||190
8343197|NCT01294683|20567877|P1|COMPLETED|Post Crossover (Period III)||199
8343198|NCT01294683|20567876|P2|STARTED|Post Crossover (Period III)||222
8343199|NCT01294683|20567877|P1|STARTED|Post Crossover (Period III)||232
8343200|NCT01294683|20567876|P2|NOT COMPLETED|Precrossover (Periods I/II)||266
8343201|NCT01294683|20567877|P1|NOT COMPLETED|Precrossover (Periods I/II)||257
8343202|NCT01294683|20567876|P2|COMPLETED|Precrossover (Periods I/II)||222
8343203|NCT01294683|20567877|P1|COMPLETED|Precrossover (Periods I/II)||232
8343204|NCT01294683|20567876|P2|Treated|Precrossover (Periods I/II)||486
8343205|NCT01294683|20567877|P1|Treated|Precrossover (Periods I/II)||486
8343206|NCT01294683|20567876|P2|STARTED|Precrossover (Periods I/II)||488
8343207|NCT01294683|20567877|P1|STARTED|Precrossover (Periods I/II)||489
8343208|NCT01294644|20567930|P3|NOT COMPLETED|Overall Study||14
8343209|NCT01294644|20567931|P2|NOT COMPLETED|Overall Study||10
8343210|NCT01294644|20567932|P1|NOT COMPLETED|Overall Study||10
8343211|NCT01294644|20567930|P3|COMPLETED|Overall Study||103
8343212|NCT01294644|20567931|P2|COMPLETED|Overall Study||112
8343213|NCT01294644|20567932|P1|COMPLETED|Overall Study||111
8343214|NCT01294644|20567930|P3|Received Treatment|Overall Study||114
8343215|NCT01294644|20567931|P2|Received Treatment|Overall Study||122
8343216|NCT01294644|20567932|P1|Received Treatment|Overall Study||118
8343217|NCT01294644|20567930|P3|STARTED|Overall Study||117
8343218|NCT01294644|20567931|P2|STARTED|Overall Study||122
8343219|NCT01294644|20567932|P1|STARTED|Overall Study||121
8343220|NCT01294592|20567963|P2|NOT COMPLETED|Overall Study||73
8343221|NCT01294592|20567964|P1|NOT COMPLETED|Overall Study||77
8343222|NCT01294592|20567963|P2|COMPLETED|Overall Study||300
8343223|NCT01294592|20567964|P1|COMPLETED|Overall Study||292
8343224|NCT01294592|20567963|P2|STARTED|Overall Study||373
8343225|NCT01294592|20567964|P1|STARTED|Overall Study||369
8343226|NCT01294579|20567992|P1|NOT COMPLETED|Overall Study||35
8343227|NCT01294579|20567992|P1|COMPLETED|Overall Study||14
8343228|NCT01294579|20567992|P1|STARTED|Overall Study||49
8343229|NCT01294553|20568002|P1|NOT COMPLETED|Overall Study||269
8343230|NCT01294553|20568002|P1|COMPLETED|Overall Study||713
8343231|NCT01294553|20568002|P1|STARTED|Overall Study||982
8343232|NCT01294514|20568008|P1|NOT COMPLETED|Overall Study||1
8343233|NCT01294514|20568008|P1|COMPLETED|Overall Study||26
8343234|NCT01294514|20568008|P1|STARTED|Overall Study||27
8343235|NCT01294462|20568018|P2|NOT COMPLETED|Overall Study||63
8343236|NCT01294462|20568019|P1|NOT COMPLETED|Overall Study||66
8343237|NCT01294462|20568018|P2|COMPLETED|Overall Study||337
8343238|NCT01294462|20568019|P1|COMPLETED|Overall Study||335
8343239|NCT01294462|20568018|P2|Received Randomized Treatment|Overall Study||380
8343240|NCT01294462|20568019|P1|Received Randomized Treatment|Overall Study||387
8343241|NCT01294462|20568018|P2|STARTED|Overall Study||400
8343242|NCT01294462|20568019|P1|STARTED|Overall Study||401
8343243|NCT01294449|20568033|P2|NOT COMPLETED|Overall Study||15
8343244|NCT01294449|20568034|P1|NOT COMPLETED|Overall Study||12
8343245|NCT01294449|20568033|P2|COMPLETED|Overall Study||237
8343246|NCT01294449|20568034|P1|COMPLETED|Overall Study||144
8343247|NCT01294449|20568033|P2|Consent to Registry|Overall Study||245
8343248|NCT01294449|20568034|P1|Consent to Registry|Overall Study||149
8343249|NCT01294449|20568033|P2|STARTED|Overall Study||252
8343250|NCT01294449|20568034|P1|STARTED|Overall Study||156
8343251|NCT01294436|20568042|P2|NOT COMPLETED|Overall Study||70
8343252|NCT01294436|20568043|P1|NOT COMPLETED|Overall Study||28
8343253|NCT01294436|20568042|P2|COMPLETED|Overall Study||409
8343254|NCT01294436|20568043|P1|COMPLETED|Overall Study||221
8343255|NCT01294436|20568042|P2|STARTED|Overall Study||479
8343256|NCT01294436|20568043|P1|STARTED|Overall Study||249
8343257|NCT01294423|20568078|P3|NOT COMPLETED|Overall Study||8
8343258|NCT01294423|20568079|P2|NOT COMPLETED|Overall Study||9
8343259|NCT01294423|20568080|P1|NOT COMPLETED|Overall Study||5
8343260|NCT01294423|20568078|P3|COMPLETED|Overall Study||79
8343261|NCT01294423|20568079|P2|COMPLETED|Overall Study||79
8343262|NCT01294423|20568080|P1|COMPLETED|Overall Study||81
8343263|NCT01294423|20568078|P3|STARTED|Overall Study||87
8343264|NCT01294423|20568079|P2|STARTED|Overall Study||88
8343265|NCT01294423|20568080|P1|STARTED|Overall Study||86
8343266|NCT01294397|20568094|P1|NOT COMPLETED|Overall Study||2
8343267|NCT01294397|20568094|P1|COMPLETED|Overall Study||17
8343268|NCT01294397|20568094|P1|STARTED|Overall Study||19
8343269|NCT01294384|20568107|P3|NOT COMPLETED|Overall Study||9
8343270|NCT01294384|20568108|P2|NOT COMPLETED|Overall Study||6
8343271|NCT01294384|20568109|P1|NOT COMPLETED|Overall Study||4
8343272|NCT01294384|20568107|P3|COMPLETED|Overall Study||95
8343273|NCT01294384|20568108|P2|COMPLETED|Overall Study||94
8343274|NCT01294384|20568109|P1|COMPLETED|Overall Study||97
8343275|NCT01294384|20568107|P3|STARTED|Overall Study||104
8343276|NCT01294384|20568108|P2|STARTED|Overall Study||100
8343277|NCT01294384|20568109|P1|STARTED|Overall Study||101
8343278|NCT01294371|20568138|P1|NOT COMPLETED|Overall Study||34
8343279|NCT01294371|20568138|P1|COMPLETED|Overall Study||357
8343280|NCT01294371|20568138|P1|Treated|Overall Study||390
8343281|NCT01294371|20568138|P1|STARTED|Overall Study||391
8343282|NCT01294358|20568146|P5|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
8343283|NCT01294358|20568147|P4|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343284|NCT01294358|20568148|P3|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343285|NCT01294358|20568149|P2|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343286|NCT01294358|20568150|P1|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343287|NCT01294358|20568146|P5|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343288|NCT01294358|20568147|P4|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343289|NCT01294358|20568148|P3|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343290|NCT01294358|20568149|P2|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343291|NCT01294358|20568150|P1|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
8343292|NCT01294358|20568146|P5|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
8343293|NCT01294358|20568147|P4|STARTED|Cohort 5: 3/8/12-3/9/12||0
8343294|NCT01294358|20568148|P3|STARTED|Cohort 5: 3/8/12-3/9/12||0
8343295|NCT01294358|20568149|P2|STARTED|Cohort 5: 3/8/12-3/9/12||0
8343296|NCT01294358|20568150|P1|STARTED|Cohort 5: 3/8/12-3/9/12||0
8343297|NCT01294358|20568146|P5|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343298|NCT01294358|20568147|P4|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
8343299|NCT01294358|20568148|P3|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343300|NCT01294358|20568149|P2|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343301|NCT01294358|20568150|P1|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343302|NCT01294358|20568146|P5|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343303|NCT01294358|20568147|P4|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
8343304|NCT01294358|20568148|P3|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343305|NCT01294358|20568149|P2|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343306|NCT01294358|20568150|P1|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
8343307|NCT01294358|20568146|P5|STARTED|Cohort 4: 12/30/11-2/17/17||0
8343308|NCT01294358|20568147|P4|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
8343309|NCT01294358|20568148|P3|STARTED|Cohort 4: 12/30/11-2/17/17||0
8343310|NCT01294358|20568149|P2|STARTED|Cohort 4: 12/30/11-2/17/17||0
8343311|NCT01294358|20568150|P1|STARTED|Cohort 4: 12/30/11-2/17/17||0
8343312|NCT01294358|20568146|P5|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343313|NCT01294358|20568147|P4|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343314|NCT01294358|20568148|P3|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
8343315|NCT01294358|20568149|P2|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343316|NCT01294358|20568150|P1|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343317|NCT01294358|20568146|P5|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343318|NCT01294358|20568147|P4|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343319|NCT01294358|20568148|P3|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
8343320|NCT01294358|20568149|P2|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343321|NCT01294358|20568150|P1|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
8343322|NCT01294358|20568146|P5|STARTED|Cohort 3: 12/1/11-10/6/12||0
8343323|NCT01294358|20568147|P4|STARTED|Cohort 3: 12/1/11-10/6/12||0
8343324|NCT01294358|20568148|P3|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
8343325|NCT01294358|20568149|P2|STARTED|Cohort 3: 12/1/11-10/6/12||0
8343326|NCT01294358|20568150|P1|STARTED|Cohort 3: 12/1/11-10/6/12||0
8343327|NCT01294358|20568146|P5|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343328|NCT01294358|20568147|P4|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343329|NCT01294358|20568148|P3|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343330|NCT01294358|20568149|P2|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
8343331|NCT01294358|20568150|P1|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343332|NCT01294358|20568146|P5|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343333|NCT01294358|20568147|P4|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343334|NCT01294358|20568148|P3|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343335|NCT01294358|20568149|P2|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
8343336|NCT01294358|20568150|P1|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
8343337|NCT01294358|20568146|P5|STARTED|Cohort 2: 6/9/11-9/17/12||0
8343338|NCT01294358|20568147|P4|STARTED|Cohort 2: 6/9/11-9/17/12||0
8343339|NCT01294358|20568148|P3|STARTED|Cohort 2: 6/9/11-9/17/12||0
8343340|NCT01294358|20568149|P2|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
8343341|NCT01294358|20568150|P1|STARTED|Cohort 2: 6/9/11-9/17/12||0
8343342|NCT01294358|20568146|P5|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343343|NCT01294358|20568147|P4|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343344|NCT01294358|20568148|P3|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343345|NCT01294358|20568149|P2|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343346|NCT01294358|20568150|P1|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343347|NCT01294358|20568146|P5|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343348|NCT01294358|20568147|P4|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343349|NCT01294358|20568148|P3|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343350|NCT01294358|20568149|P2|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
8343351|NCT01294358|20568150|P1|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
8343352|NCT01294358|20568146|P5|STARTED|Cohort 1: 5/11/11-11/9/11||0
8343353|NCT01294358|20568147|P4|STARTED|Cohort 1: 5/11/11-11/9/11||0
8343354|NCT01294358|20568148|P3|STARTED|Cohort 1: 5/11/11-11/9/11||0
8343355|NCT01294358|20568149|P2|STARTED|Cohort 1: 5/11/11-11/9/11||0
8343356|NCT01294358|20568150|P1|STARTED|Cohort 1: 5/11/11-11/9/11||4
8343357|NCT01294319|20568212|P8|NOT COMPLETED|Overall Study||0
8343358|NCT01294319|20568213|P7|NOT COMPLETED|Overall Study||0
8343359|NCT01294319|20568214|P6|NOT COMPLETED|Overall Study||0
8343360|NCT01294319|20568215|P5|NOT COMPLETED|Overall Study||0
8343361|NCT01294319|20568216|P4|NOT COMPLETED|Overall Study||0
8343362|NCT01294319|20568217|P3|NOT COMPLETED|Overall Study||0
8343363|NCT01294319|20568218|P2|NOT COMPLETED|Overall Study||0
8343364|NCT01294319|20568219|P1|NOT COMPLETED|Overall Study||0
8343365|NCT01294319|20568212|P8|COMPLETED|Overall Study||5
8343366|NCT01294319|20568213|P7|COMPLETED|Overall Study||5
8343367|NCT01294319|20568214|P6|COMPLETED|Overall Study||4
8343368|NCT01294319|20568215|P5|COMPLETED|Overall Study||5
8343369|NCT01294319|20568216|P4|COMPLETED|Overall Study||5
8343370|NCT01294319|20568217|P3|COMPLETED|Overall Study||5
8343371|NCT01294319|20568218|P2|COMPLETED|Overall Study||6
8343372|NCT01294319|20568219|P1|COMPLETED|Overall Study||4
8343373|NCT01294319|20568212|P8|STARTED|Overall Study||5
8343374|NCT01294319|20568213|P7|STARTED|Overall Study||5
8343375|NCT01294319|20568214|P6|STARTED|Overall Study||4
8343376|NCT01294319|20568215|P5|STARTED|Overall Study||5
8343377|NCT01294319|20568216|P4|STARTED|Overall Study||5
8343378|NCT01294319|20568217|P3|STARTED|Overall Study||5
8343379|NCT01294319|20568218|P2|STARTED|Overall Study||6
8343380|NCT01294319|20568219|P1|STARTED|Overall Study||4
8343381|NCT01294306|20568229|P2|NOT COMPLETED|Overall Study||0
8343382|NCT01294306|20568230|P1|NOT COMPLETED|Overall Study||0
8343383|NCT01294306|20568229|P2|COMPLETED|Overall Study||35
8343384|NCT01294306|20568230|P1|COMPLETED|Overall Study||45
8343385|NCT01294306|20568229|P2|STARTED|Overall Study||35
8343386|NCT01294306|20568230|P1|STARTED|Overall Study||45
8343387|NCT01294267|20568244|P1|NOT COMPLETED|Overall Study||0
8343388|NCT01294267|20568244|P1|COMPLETED|Overall Study||20
8343389|NCT01294267|20568244|P1|STARTED|Overall Study||20
8343390|NCT01294241|20568250|P1|NOT COMPLETED|Overall Study||0
8343391|NCT01294241|20568250|P1|COMPLETED|Overall Study||10
8343392|NCT01294241|20568250|P1|STARTED|Overall Study||10
8343393|NCT01294228|20568258|P1|NOT COMPLETED|Overall Study||0
8343394|NCT01294228|20568258|P1|COMPLETED|Overall Study||1001
8343395|NCT01294228|20568258|P1|STARTED|Overall Study||1001
8343396|NCT01294163|20568265|P3|NOT COMPLETED|Overall Study||3
8343397|NCT01294163|20568266|P2|NOT COMPLETED|Overall Study||0
8343398|NCT01294163|20568267|P1|NOT COMPLETED|Overall Study||1
8343399|NCT01294163|20568265|P3|COMPLETED|Overall Study||163
8343400|NCT01294163|20568266|P2|COMPLETED|Overall Study||165
8343401|NCT01294163|20568267|P1|COMPLETED|Overall Study||177
8343402|NCT01294163|20568265|P3|STARTED|Overall Study||166
8343403|NCT01294163|20568266|P2|STARTED|Overall Study||165
8343404|NCT01294163|20568267|P1|STARTED|Overall Study||178
8343405|NCT01294150|20568278|P2|NOT COMPLETED|Overall Study||2
8343406|NCT01294150|20568279|P1|NOT COMPLETED|Overall Study||2
8343407|NCT01294150|20568278|P2|COMPLETED|Overall Study||64
8343408|NCT01294150|20568279|P1|COMPLETED|Overall Study||138
8343409|NCT01294150|20568278|P2|STARTED|Overall Study||66
8343410|NCT01294150|20568279|P1|STARTED|Overall Study||140
8343411|NCT01294098|20568292|P3|NOT COMPLETED|Overall Study||1
8343412|NCT01294098|20568293|P2|NOT COMPLETED|Overall Study||1
8343413|NCT01294098|20568294|P1|NOT COMPLETED|Overall Study||0
8343414|NCT01294098|20568292|P3|COMPLETED|Overall Study||0
8343415|NCT01294098|20568293|P2|COMPLETED|Overall Study||0
8343416|NCT01294098|20568294|P1|COMPLETED|Overall Study||0
8343417|NCT01294098|20568292|P3|STARTED|Overall Study||1
8343418|NCT01294098|20568293|P2|STARTED|Overall Study||1
8343419|NCT01294098|20568294|P1|STARTED|Overall Study||0
8343420|NCT01294046|20568308|P1|NOT COMPLETED|Overall Study||3
8343421|NCT01294046|20568308|P1|COMPLETED|Overall Study||0
8343422|NCT01294046|20568308|P1|STARTED|Overall Study||3
8343423|NCT01293968|20568323|P2|NOT COMPLETED|Overall Study||3
8343424|NCT01293968|20568324|P1|NOT COMPLETED|Overall Study||3
8343425|NCT01293968|20568323|P2|COMPLETED|Overall Study||14
8343426|NCT01293968|20568324|P1|COMPLETED|Overall Study||17
8343427|NCT01293968|20568323|P2|STARTED|Overall Study||17
8343428|NCT01293968|20568324|P1|STARTED|Overall Study||20
8343429|NCT01293825|20568330|P1|NOT COMPLETED|Overall Study||10
8343430|NCT01293825|20568330|P1|COMPLETED|Overall Study||20
8343431|NCT01293825|20568330|P1|STARTED|Overall Study||30
8343432|NCT01293695|20568344|P2|NOT COMPLETED|Overall Study||7
8343433|NCT01293695|20568345|P1|NOT COMPLETED|Overall Study||15
8343434|NCT01293695|20568344|P2|COMPLETED|Overall Study||87
8343435|NCT01293695|20568345|P1|COMPLETED|Overall Study||78
8343436|NCT01293695|20568344|P2|STARTED|Overall Study||94
8343437|NCT01293695|20568345|P1|STARTED|Overall Study||93
8343441|NCT01293539|20568364|P1|NOT COMPLETED|Overall Study||1
8343442|NCT01293539|20568364|P1|COMPLETED|Overall Study||9
8343443|NCT01293539|20568364|P1|STARTED|Overall Study||10
8343444|NCT01293240|20568368|P1|NOT COMPLETED|Overall Study||2
8343445|NCT01293240|20568368|P1|COMPLETED|Overall Study||115
8343446|NCT01293240|20568368|P1|STARTED|Overall Study||117
8343447|NCT01293123|20568385|P2|NOT COMPLETED|Overall Study||1
8343448|NCT01293123|20568386|P1|NOT COMPLETED|Overall Study||0
8343449|NCT01293123|20568385|P2|COMPLETED|Overall Study||0
8343450|NCT01293123|20568386|P1|COMPLETED|Overall Study||1
8343451|NCT01293123|20568385|P2|STARTED|Overall Study||1
8343452|NCT01293123|20568386|P1|STARTED|Overall Study||1
8343453|NCT01293084|20568400|P1|NOT COMPLETED|Overall Study||5
8343454|NCT01293084|20568400|P1|COMPLETED|Overall Study||12
8343455|NCT01293084|20568400|P1|STARTED|Overall Study||17
8343456|NCT01293032|20568412|P4|NOT COMPLETED|Treatment||1
8343457|NCT01293032|20568413|P3|NOT COMPLETED|Treatment||1
8343458|NCT01293032|20568414|P2|NOT COMPLETED|Treatment||5
8343459|NCT01293032|20568415|P1|NOT COMPLETED|Treatment||2
8343460|NCT01293032|20568412|P4|COMPLETED|Treatment||13
8343461|NCT01293032|20568413|P3|COMPLETED|Treatment||10
8343462|NCT01293032|20568414|P2|COMPLETED|Treatment||14
8343463|NCT01293032|20568415|P1|COMPLETED|Treatment||10
8343464|NCT01293032|20568412|P4|STARTED|Treatment||14
8343465|NCT01293032|20568413|P3|STARTED|Treatment||11
8343466|NCT01293032|20568414|P2|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
8343467|NCT01293032|20568415|P1|STARTED|Treatment||12
8343468|NCT01293032|20568412|P4|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
8343469|NCT01293032|20568413|P3|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
8343470|NCT01293032|20568414|P2|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
8343471|NCT01293032|20568415|P1|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
8343472|NCT01293032|20568412|P4|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
8343473|NCT01293032|20568413|P3|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
8343474|NCT01293032|20568414|P2|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
8343475|NCT01293032|20568415|P1|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
8343476|NCT01293032|20568412|P4|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
8343477|NCT01293032|20568413|P3|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
8343478|NCT01293032|20568414|P2|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
8343479|NCT01293032|20568415|P1|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
8343480|NCT01293032|20568412|P4|STARTED|Recurrence Score(RS)Assigned/Randomized||14
8343481|NCT01293032|20568413|P3|STARTED|Recurrence Score(RS)Assigned/Randomized||16
8343482|NCT01293032|20568414|P2|STARTED|Recurrence Score(RS)Assigned/Randomized||17
8343483|NCT01293032|20568415|P1|STARTED|Recurrence Score(RS)Assigned/Randomized||12
8343484|NCT01293006|20568426|P4|NOT COMPLETED|Period 2||0
8343485|NCT01293006|20568427|P3|NOT COMPLETED|Period 2||0
8343486|NCT01293006|20568428|P2|NOT COMPLETED|Period 2||0
8343487|NCT01293006|20568429|P1|NOT COMPLETED|Period 2||1
8343488|NCT01293006|20568426|P4|COMPLETED|Period 2||3
8343489|NCT01293006|20568427|P3|COMPLETED|Period 2||9
8343490|NCT01293006|20568428|P2|COMPLETED|Period 2||2
8343491|NCT01293006|20568429|P1|COMPLETED|Period 2||10
8343492|NCT01293006|20568426|P4|STARTED|Period 2||3
8343493|NCT01293006|20568427|P3|STARTED|Period 2||9
8343494|NCT01293006|20568428|P2|STARTED|Period 2||2
8343495|NCT01293006|20568429|P1|STARTED|Period 2||11
8343496|NCT01293006|20568426|P4|NOT COMPLETED|Washout||0
8343497|NCT01293006|20568427|P3|NOT COMPLETED|Washout||0
8343498|NCT01293006|20568428|P2|NOT COMPLETED|Washout||0
8343499|NCT01293006|20568429|P1|NOT COMPLETED|Washout||0
8343500|NCT01293006|20568426|P4|COMPLETED|Washout||3
8343501|NCT01293006|20568427|P3|COMPLETED|Washout||9
8343502|NCT01293006|20568428|P2|COMPLETED|Washout||2
8343503|NCT01293006|20568429|P1|COMPLETED|Washout||11
8343504|NCT01293006|20568426|P4|STARTED|Washout||3
8343505|NCT01293006|20568427|P3|STARTED|Washout||9
8343506|NCT01293006|20568428|P2|STARTED|Washout||2
8343507|NCT01293006|20568429|P1|STARTED|Washout||11
8343508|NCT01293006|20568426|P4|NOT COMPLETED|Period 1||0
8343509|NCT01293006|20568427|P3|NOT COMPLETED|Period 1||0
8343510|NCT01293006|20568428|P2|NOT COMPLETED|Period 1||0
8343511|NCT01293006|20568429|P1|NOT COMPLETED|Period 1||0
8343512|NCT01293006|20568426|P4|COMPLETED|Period 1||3
8343513|NCT01293006|20568427|P3|COMPLETED|Period 1||9
8343514|NCT01293006|20568428|P2|COMPLETED|Period 1||2
8343515|NCT01293006|20568429|P1|COMPLETED|Period 1||11
8343516|NCT01293006|20568426|P4|STARTED|Period 1||3
8343517|NCT01293006|20568427|P3|STARTED|Period 1||9
8343518|NCT01293006|20568428|P2|STARTED|Period 1||2
8343519|NCT01293006|20568429|P1|STARTED|Period 1||11
8343520|NCT01292928|20568450|P1|NOT COMPLETED|Overall Study||24
8343521|NCT01292928|20568450|P1|COMPLETED|Overall Study||275
8343522|NCT01292928|20568450|P1|Completed 12-Month Clinical Follow-up|Overall Study||266
8343523|NCT01292928|20568450|P1|STARTED|Overall Study||299
8343524|NCT01292876|20568467|P1|NOT COMPLETED|Overall Study||4
8343525|NCT01292876|20568467|P1|COMPLETED|Overall Study||13
8343526|NCT01292876|20568467|P1|STARTED|Overall Study||17
8343527|NCT01292837|20568473|P1|NOT COMPLETED|Overall Study||2
8343528|NCT01292837|20568473|P1|COMPLETED|Overall Study||11
8343529|NCT01292837|20568473|P1|STARTED|Overall Study||13
8343530|NCT01292798|20568482|P1|NOT COMPLETED|Overall Study||0
8343531|NCT01292798|20568482|P1|COMPLETED|Overall Study||43
8343532|NCT01292798|20568482|P1|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
8343533|NCT01292798|20568482|P1|STARTED|Overall Study||43
8343534|NCT01292746|20568488|P1|NOT COMPLETED|Overall Study||0
8343535|NCT01292746|20568488|P1|COMPLETED|Overall Study||14
8343536|NCT01292746|20568488|P1|STARTED|Overall Study||14
8343537|NCT01292642|20568492|P1|NOT COMPLETED|Overall Study||5
8343538|NCT01292642|20568492|P1|COMPLETED|Overall Study||7
8343539|NCT01292642|20568492|P1|STARTED|Overall Study||12
8343540|NCT01292629|20568500|P1|NOT COMPLETED|Overall Study||0
8343541|NCT01292629|20568500|P1|COMPLETED|Overall Study||125
8343542|NCT01292629|20568500|P1|STARTED|Overall Study||125
8343543|NCT01292603|20568510|P6|NOT COMPLETED|Overall Survival Status||10
8343544|NCT01292603|20568511|P5|NOT COMPLETED|Overall Survival Status||16
8343545|NCT01292603|20568512|P4|NOT COMPLETED|Overall Survival Status||1
8343546|NCT01292603|20568513|P3|NOT COMPLETED|Overall Survival Status||3
8343547|NCT01292603|20568514|P2|NOT COMPLETED|Overall Survival Status||1
8343548|NCT01292603|20568515|P1|NOT COMPLETED|Overall Survival Status||3
8343549|NCT01292603|20568510|P6|COMPLETED|Overall Survival Status||78
8343550|NCT01292603|20568511|P5|COMPLETED|Overall Survival Status||72
8343551|NCT01292603|20568512|P4|COMPLETED|Overall Survival Status||7
8343552|NCT01292603|20568513|P3|COMPLETED|Overall Survival Status||20
8343553|NCT01292603|20568514|P2|COMPLETED|Overall Survival Status||16
8343554|NCT01292603|20568515|P1|COMPLETED|Overall Survival Status||13
8343555|NCT01292603|20568510|P6|STARTED|Overall Survival Status||88
8343556|NCT01292603|20568511|P5|STARTED|Overall Survival Status||88
8343557|NCT01292603|20568512|P4|STARTED|Overall Survival Status||8
8343558|NCT01292603|20568513|P3|STARTED|Overall Survival Status||23
8343559|NCT01292603|20568514|P2|STARTED|Overall Survival Status||17
8343560|NCT01292603|20568515|P1|STARTED|Overall Survival Status||16
8343561|NCT01292603|20568510|P6|NOT COMPLETED|Part 2: Regular Follow-Up||12
8343562|NCT01292603|20568511|P5|NOT COMPLETED|Part 2: Regular Follow-Up||19
8343563|NCT01292603|20568512|P4|NOT COMPLETED|Part 2: Regular Follow-Up||0
8343564|NCT01292603|20568513|P3|NOT COMPLETED|Part 2: Regular Follow-Up||0
8343565|NCT01292603|20568514|P2|NOT COMPLETED|Part 2: Regular Follow-Up||0
8343566|NCT01292603|20568515|P1|NOT COMPLETED|Part 2: Regular Follow-Up||0
8343567|NCT01292603|20568510|P6|COMPLETED|Part 2: Regular Follow-Up||75
8343568|NCT01292603|20568511|P5|COMPLETED|Part 2: Regular Follow-Up||68
8343569|NCT01292603|20568512|P4|COMPLETED|Part 2: Regular Follow-Up||0
8343570|NCT01292603|20568513|P3|COMPLETED|Part 2: Regular Follow-Up||0
8343571|NCT01292603|20568514|P2|COMPLETED|Part 2: Regular Follow-Up||0
8343572|NCT01292603|20568515|P1|COMPLETED|Part 2: Regular Follow-Up||0
8343573|NCT01292603|20568510|P6|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
8343574|NCT01292603|20568511|P5|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
8343575|NCT01292603|20568512|P4|STARTED|Part 2: Regular Follow-Up||0
8343576|NCT01292603|20568513|P3|STARTED|Part 2: Regular Follow-Up||0
8343577|NCT01292603|20568514|P2|STARTED|Part 2: Regular Follow-Up||0
8343578|NCT01292603|20568515|P1|STARTED|Part 2: Regular Follow-Up||0
8343579|NCT01292603|20568510|P6|NOT COMPLETED|Part 2: Dose Confirmation Period||15
8343580|NCT01292603|20568511|P5|NOT COMPLETED|Part 2: Dose Confirmation Period||16
8343581|NCT01292603|20568512|P4|NOT COMPLETED|Part 2: Dose Confirmation Period||0
8343582|NCT01292603|20568513|P3|NOT COMPLETED|Part 2: Dose Confirmation Period||0
8343583|NCT01292603|20568514|P2|NOT COMPLETED|Part 2: Dose Confirmation Period||0
8343584|NCT01292603|20568515|P1|NOT COMPLETED|Part 2: Dose Confirmation Period||0
8343585|NCT01292603|20568510|P6|COMPLETED|Part 2: Dose Confirmation Period||73
8343586|NCT01292603|20568511|P5|COMPLETED|Part 2: Dose Confirmation Period||72
8343587|NCT01292603|20568512|P4|COMPLETED|Part 2: Dose Confirmation Period||0
8343588|NCT01292603|20568513|P3|COMPLETED|Part 2: Dose Confirmation Period||0
8343589|NCT01292603|20568514|P2|COMPLETED|Part 2: Dose Confirmation Period||0
8343590|NCT01292603|20568515|P1|COMPLETED|Part 2: Dose Confirmation Period||0
8343591|NCT01292603|20568510|P6|STARTED|Part 2: Dose Confirmation Period||88
8343592|NCT01292603|20568511|P5|STARTED|Part 2: Dose Confirmation Period||88
8343593|NCT01292603|20568512|P4|STARTED|Part 2: Dose Confirmation Period||0
8343594|NCT01292603|20568513|P3|STARTED|Part 2: Dose Confirmation Period||0
8343595|NCT01292603|20568514|P2|STARTED|Part 2: Dose Confirmation Period||0
8343596|NCT01292603|20568515|P1|STARTED|Part 2: Dose Confirmation Period||0
8343597|NCT01292603|20568510|P6|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
8343598|NCT01292603|20568511|P5|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
8343599|NCT01292603|20568512|P4|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
8343600|NCT01292603|20568513|P3|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
8343601|NCT01292603|20568514|P2|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
8343602|NCT01292603|20568515|P1|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
8343603|NCT01292603|20568510|P6|COMPLETED|Part 1: Regular Follow-Up Period||0
8343604|NCT01292603|20568511|P5|COMPLETED|Part 1: Regular Follow-Up Period||0
8343605|NCT01292603|20568512|P4|COMPLETED|Part 1: Regular Follow-Up Period||7
8343606|NCT01292603|20568513|P3|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
8343694|NCT01292057|20568744|P2|STARTED|Overall Study||50
8343607|NCT01292603|20568514|P2|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
8343608|NCT01292603|20568515|P1|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
8343609|NCT01292603|20568510|P6|STARTED|Part 1: Regular Follow-Up Period||0
8343610|NCT01292603|20568511|P5|STARTED|Part 1: Regular Follow-Up Period||0
8343611|NCT01292603|20568512|P4|STARTED|Part 1: Regular Follow-Up Period||8
8343612|NCT01292603|20568513|P3|STARTED|Part 1: Regular Follow-Up Period||23
8343613|NCT01292603|20568514|P2|STARTED|Part 1: Regular Follow-Up Period||17
8343614|NCT01292603|20568515|P1|STARTED|Part 1: Regular Follow-Up Period||16
8343615|NCT01292603|20568510|P6|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8343616|NCT01292603|20568511|P5|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8343617|NCT01292603|20568512|P4|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
8343618|NCT01292603|20568513|P3|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8343619|NCT01292603|20568514|P2|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8343620|NCT01292603|20568515|P1|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
8343621|NCT01292603|20568510|P6|COMPLETED|Part 1: Pilot Dose Selection Period||0
8343622|NCT01292603|20568511|P5|COMPLETED|Part 1: Pilot Dose Selection Period||0
8343623|NCT01292603|20568512|P4|COMPLETED|Part 1: Pilot Dose Selection Period||0
8343624|NCT01292603|20568513|P3|COMPLETED|Part 1: Pilot Dose Selection Period||23
8343625|NCT01292603|20568514|P2|COMPLETED|Part 1: Pilot Dose Selection Period||17
8343626|NCT01292603|20568515|P1|COMPLETED|Part 1: Pilot Dose Selection Period||16
8343627|NCT01292603|20568510|P6|STARTED|Part 1: Pilot Dose Selection Period||0
8343628|NCT01292603|20568511|P5|STARTED|Part 1: Pilot Dose Selection Period||0
8343629|NCT01292603|20568512|P4|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
8343630|NCT01292603|20568513|P3|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
8343631|NCT01292603|20568514|P2|STARTED|Part 1: Pilot Dose Selection Period||17
8343632|NCT01292603|20568515|P1|STARTED|Part 1: Pilot Dose Selection Period||16
8343633|NCT01292538|20568561|P2|NOT COMPLETED|Overall Study||0
8343634|NCT01292538|20568562|P1|NOT COMPLETED|Overall Study||0
8343635|NCT01292538|20568561|P2|COMPLETED|Overall Study||32
8343636|NCT01292538|20568562|P1|COMPLETED|Overall Study||35
8343637|NCT01292538|20568561|P2|STARTED|Overall Study||32
8343638|NCT01292538|20568562|P1|STARTED|Overall Study||35
8343639|NCT01292486|20568568|P1|NOT COMPLETED|Overall Study||6
8343640|NCT01292486|20568568|P1|COMPLETED|Overall Study||26
8343641|NCT01292486|20568568|P1|STARTED|Overall Study||32
8343642|NCT01292473|20568582|P4|NOT COMPLETED|Overall Study||12
8343643|NCT01292473|20568583|P3|NOT COMPLETED|Overall Study||9
8343644|NCT01292473|20568584|P2|NOT COMPLETED|Overall Study||7
8343645|NCT01292473|20568585|P1|NOT COMPLETED|Overall Study||5
8343646|NCT01292473|20568582|P4|COMPLETED|Overall Study||67
8343647|NCT01292473|20568583|P3|COMPLETED|Overall Study||74
8343648|NCT01292473|20568584|P2|COMPLETED|Overall Study||75
8343649|NCT01292473|20568585|P1|COMPLETED|Overall Study||74
8343650|NCT01292473|20568582|P4|STARTED|Overall Study||79
8343651|NCT01292473|20568583|P3|STARTED|Overall Study||83
8343652|NCT01292473|20568584|P2|STARTED|Overall Study||82
8343653|NCT01292473|20568585|P1|STARTED|Overall Study||79
8343654|NCT01292447|20568629|P2|NOT COMPLETED|Overall Study||3
8343655|NCT01292447|20568630|P1|NOT COMPLETED|Overall Study||2
8343656|NCT01292447|20568629|P2|COMPLETED|Overall Study||72
8343657|NCT01292447|20568630|P1|COMPLETED|Overall Study||73
8343658|NCT01292447|20568629|P2|STARTED|Overall Study||75
8343659|NCT01292447|20568630|P1|STARTED|Overall Study||75
8343660|NCT01292304|20568636|P1|NOT COMPLETED|Overall Study||0
8343661|NCT01292304|20568636|P1|COMPLETED|Overall Study||10
8343662|NCT01292304|20568636|P1|STARTED|Overall Study||10
8343663|NCT01292265|20568644|P1|NOT COMPLETED|Overall Study||0
8343664|NCT01292265|20568644|P1|COMPLETED|Overall Study||3
8343665|NCT01292265|20568644|P1|STARTED|Overall Study||3
8343666|NCT01292239|20568653|P2|NOT COMPLETED|Overall Study||7
8343667|NCT01292239|20568654|P1|NOT COMPLETED|Overall Study||4
8343668|NCT01292239|20568653|P2|COMPLETED|Overall Study||53
8343669|NCT01292239|20568654|P1|COMPLETED|Overall Study||119
8343670|NCT01292239|20568653|P2|STARTED|Overall Study||60
8343671|NCT01292239|20568654|P1|STARTED|Overall Study||123
8343672|NCT01292226|20568675|P1|NOT COMPLETED|Overall Study||13
8343673|NCT01292226|20568675|P1|COMPLETED|Overall Study||32
8343674|NCT01292226|20568675|P1|STARTED|Overall Study||45
8343675|NCT01292187|20568708|P2|NOT COMPLETED|Overall Study||13
8343676|NCT01292187|20568709|P1|NOT COMPLETED|Overall Study||17
8343677|NCT01292187|20568708|P2|COMPLETED|Overall Study||30
8343678|NCT01292187|20568709|P1|COMPLETED|Overall Study||69
8343679|NCT01292187|20568708|P2|STARTED|Overall Study||43
8343680|NCT01292187|20568709|P1|STARTED|Overall Study||86
8343681|NCT01292135|20568719|P2|NOT COMPLETED|Overall Study||9
8343682|NCT01292135|20568720|P1|NOT COMPLETED|Overall Study||0
8343683|NCT01292135|20568719|P2|COMPLETED|Overall Study||21
8343684|NCT01292135|20568720|P1|COMPLETED|Overall Study||3
8343685|NCT01292135|20568719|P2|STARTED|Overall Study||30
8343686|NCT01292135|20568720|P1|STARTED|Overall Study||3
8343687|NCT01292070|20568738|P1|NOT COMPLETED|Overall Study||0
8343688|NCT01292070|20568738|P1|COMPLETED|Overall Study||4
8343689|NCT01292070|20568738|P1|STARTED|Overall Study||4
8343690|NCT01292057|20568744|P2|NOT COMPLETED|Overall Study||2
8343691|NCT01292057|20568745|P1|NOT COMPLETED|Overall Study||2
8343692|NCT01292057|20568744|P2|COMPLETED|Overall Study||48
8343693|NCT01292057|20568745|P1|COMPLETED|Overall Study||47
8343695|NCT01292057|20568745|P1|STARTED|Overall Study||49
8343696|NCT01292005|20568755|P2|NOT COMPLETED|Overall Study||0
8343697|NCT01292005|20568756|P1|NOT COMPLETED|Overall Study||0
8343698|NCT01292005|20568755|P2|COMPLETED|Overall Study||14
8343699|NCT01292005|20568756|P1|COMPLETED|Overall Study||14
8343700|NCT01292005|20568755|P2|STARTED|Overall Study||14
8343701|NCT01292005|20568756|P1|STARTED|Overall Study||14
8343702|NCT01291836|20568780|P2|NOT COMPLETED|Overall Study||0
8343703|NCT01291836|20568781|P1|NOT COMPLETED|Overall Study||0
8343704|NCT01291836|20568780|P2|COMPLETED|Overall Study||71
8343705|NCT01291836|20568781|P1|COMPLETED|Overall Study||930
8343706|NCT01291836|20568780|P2|STARTED|Overall Study||71
8343707|NCT01291836|20568781|P1|STARTED|Overall Study||930
8343708|NCT01291784|20568787|P3|NOT COMPLETED|Overall Study||0
8343709|NCT01291784|20568788|P2|NOT COMPLETED|Overall Study||1
8343710|NCT01291784|20568789|P1|NOT COMPLETED|Overall Study||0
8343711|NCT01291784|20568787|P3|COMPLETED|Overall Study||1
8343712|NCT01291784|20568788|P2|COMPLETED|Overall Study||0
8343713|NCT01291784|20568789|P1|COMPLETED|Overall Study||1
8343714|NCT01291784|20568787|P3|STARTED|Overall Study||1
8343715|NCT01291784|20568788|P2|STARTED|Overall Study||1
8343716|NCT01291784|20568789|P1|STARTED|Overall Study||1
8343717|NCT01291498|20568809|P1|NOT COMPLETED|Overall Study||1
8343718|NCT01291498|20568809|P1|COMPLETED|Overall Study||0
8343719|NCT01291498|20568809|P1|STARTED|Overall Study||1
8343720|NCT01291277|20568817|P2|NOT COMPLETED|Overall Study||3
8343721|NCT01291277|20568818|P1|NOT COMPLETED|Overall Study||5
8343722|NCT01291277|20568817|P2|COMPLETED|Overall Study||42
8343723|NCT01291277|20568818|P1|COMPLETED|Overall Study||40
8343724|NCT01291277|20568817|P2|STARTED|Overall Study||45
8343725|NCT01291277|20568818|P1|STARTED|Overall Study||45
8343726|NCT01291264|20568824|P1|NOT COMPLETED|Overall Study||0
8343727|NCT01291264|20568824|P1|COMPLETED|Overall Study||260
8343728|NCT01291264|20568824|P1|STARTED|Overall Study||260
8343729|NCT01291225|20568830|P2|NOT COMPLETED|Overall Study||39
8343730|NCT01291225|20568831|P1|NOT COMPLETED|Overall Study||85
8343731|NCT01291225|20568830|P2|COMPLETED|Overall Study||121
8343732|NCT01291225|20568831|P1|COMPLETED|Overall Study||66
8343733|NCT01291225|20568830|P2|STARTED|Overall Study||160
8343734|NCT01291225|20568831|P1|STARTED|Overall Study||151
8343747|NCT01291160|20568912|P2|NOT COMPLETED|Overall Study||16
8343748|NCT01291160|20568913|P1|NOT COMPLETED|Overall Study||18
8343749|NCT01291160|20568912|P2|COMPLETED|Overall Study||48
8343750|NCT01291160|20568913|P1|COMPLETED|Overall Study||48
8343751|NCT01291160|20568912|P2|STARTED|Overall Study||64
8343752|NCT01291160|20568913|P1|STARTED|Overall Study||66
8343753|NCT01291108|20568923|P6|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
8343754|NCT01291108|20568924|P5|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
8343755|NCT01291108|20568925|P4|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
8343756|NCT01291108|20568926|P3|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
8343757|NCT01291108|20568927|P2|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
8343758|NCT01291108|20568928|P1|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
8343759|NCT01291108|20568923|P6|COMPLETED|Month 2 (Adjunctive Therapy)||25
8343760|NCT01291108|20568924|P5|COMPLETED|Month 2 (Adjunctive Therapy)||34
8343761|NCT01291108|20568925|P4|COMPLETED|Month 2 (Adjunctive Therapy)||0
8343762|NCT01291108|20568926|P3|COMPLETED|Month 2 (Adjunctive Therapy)||24
8343763|NCT01291108|20568927|P2|COMPLETED|Month 2 (Adjunctive Therapy)||38
8343764|NCT01291108|20568928|P1|COMPLETED|Month 2 (Adjunctive Therapy)||0
8343765|NCT01291108|20568923|P6|STARTED|Month 2 (Adjunctive Therapy)||26
8343766|NCT01291108|20568924|P5|STARTED|Month 2 (Adjunctive Therapy)||34
8343767|NCT01291108|20568925|P4|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
8343768|NCT01291108|20568926|P3|STARTED|Month 2 (Adjunctive Therapy)||24
8343769|NCT01291108|20568927|P2|STARTED|Month 2 (Adjunctive Therapy)||40
8343770|NCT01291108|20568928|P1|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
8343771|NCT01291108|20568923|P6|NOT COMPLETED|Month 1 (Monotherapy)||0
8343772|NCT01291108|20568924|P5|NOT COMPLETED|Month 1 (Monotherapy)||0
8343773|NCT01291108|20568925|P4|NOT COMPLETED|Month 1 (Monotherapy)||0
8343774|NCT01291108|20568926|P3|NOT COMPLETED|Month 1 (Monotherapy)||0
8343775|NCT01291108|20568927|P2|NOT COMPLETED|Month 1 (Monotherapy)||0
8343776|NCT01291108|20568928|P1|NOT COMPLETED|Month 1 (Monotherapy)||1
8343777|NCT01291108|20568923|P6|COMPLETED|Month 1 (Monotherapy)||0
8343778|NCT01291108|20568924|P5|COMPLETED|Month 1 (Monotherapy)||0
8343779|NCT01291108|20568925|P4|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
8343780|NCT01291108|20568926|P3|COMPLETED|Month 1 (Monotherapy)||0
8343781|NCT01291108|20568927|P2|COMPLETED|Month 1 (Monotherapy)||0
8343782|NCT01291108|20568928|P1|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
8343783|NCT01291108|20568923|P6|STARTED|Month 1 (Monotherapy)||0
8343784|NCT01291108|20568924|P5|STARTED|Month 1 (Monotherapy)||0
8343785|NCT01291108|20568925|P4|STARTED|Month 1 (Monotherapy)||60
8343786|NCT01291108|20568926|P3|STARTED|Month 1 (Monotherapy)||0
8343787|NCT01291108|20568927|P2|STARTED|Month 1 (Monotherapy)||0
8343788|NCT01291108|20568928|P1|STARTED|Month 1 (Monotherapy)||65
8343789|NCT01291056|20568944|P2|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
8343790|NCT01291056|20568945|P1|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
8343791|NCT01291056|20568944|P2|COMPLETED|Intervention Two (Menstration Days 3-7)||10
8343792|NCT01291056|20568945|P1|COMPLETED|Intervention Two (Menstration Days 3-7)||10
8343793|NCT01291056|20568944|P2|STARTED|Intervention Two (Menstration Days 3-7)||10
8343794|NCT01291056|20568945|P1|STARTED|Intervention Two (Menstration Days 3-7)||10
8343795|NCT01291056|20568944|P2|NOT COMPLETED|Washout||0
8343796|NCT01291056|20568945|P1|NOT COMPLETED|Washout||0
8343797|NCT01291056|20568944|P2|COMPLETED|Washout||10
8343798|NCT01291056|20568945|P1|COMPLETED|Washout||10
8343799|NCT01291056|20568944|P2|STARTED|Washout||10
8343800|NCT01291056|20568945|P1|STARTED|Washout||10
8343801|NCT01291056|20568944|P2|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
8343802|NCT01291056|20568945|P1|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
8343803|NCT01291056|20568944|P2|COMPLETED|Intervention One (Menstraution Day 3-7)||10
8343804|NCT01291056|20568945|P1|COMPLETED|Intervention One (Menstraution Day 3-7)||10
8343805|NCT01291056|20568944|P2|STARTED|Intervention One (Menstraution Day 3-7)||10
8343806|NCT01291056|20568945|P1|STARTED|Intervention One (Menstraution Day 3-7)||10
8343807|NCT01291017|20568957|P1|NOT COMPLETED|Overall Study||5
8343808|NCT01291017|20568957|P1|COMPLETED|Overall Study||14
8343809|NCT01291017|20568957|P1|STARTED|Overall Study||19
8343810|NCT01290978|20568965|P1|NOT COMPLETED|Overall Study||0
8343811|NCT01290978|20568965|P1|COMPLETED|Overall Study||22
8343812|NCT01290978|20568965|P1|STARTED|Overall Study||22
8343813|NCT01290952|20568974|P2|NOT COMPLETED|Overall Study||14
8343814|NCT01290952|20568975|P1|NOT COMPLETED|Overall Study||12
8343815|NCT01290952|20568974|P2|COMPLETED|Overall Study||193
8343816|NCT01290952|20568975|P1|COMPLETED|Overall Study||192
8343817|NCT01290952|20568974|P2|STARTED|Overall Study||207
8343818|NCT01290952|20568975|P1|STARTED|Overall Study||204
8343819|NCT01290913|20568983|P1|NOT COMPLETED|Overall Study||1
8343820|NCT01290913|20568983|P1|COMPLETED|Overall Study||12
8343821|NCT01290913|20568983|P1|STARTED|Overall Study||13
8343822|NCT01290887|20568990|P2|NOT COMPLETED|Overall Study||536
8343823|NCT01290887|20568991|P1|NOT COMPLETED|Overall Study||466
8343824|NCT01290887|20568990|P2|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
8343825|NCT01290887|20568991|P1|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
8343826|NCT01290887|20568990|P2|Safety Analysis Set|Overall Study||571
8343827|NCT01290887|20568991|P1|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
8343828|NCT01290887|20568990|P2|STARTED|Overall Study||571
8343829|NCT01290887|20568991|P1|STARTED|Overall Study||481
8343830|NCT01290874|20569031|P2|NOT COMPLETED|Overall Study||404
8343831|NCT01290874|20569032|P1|NOT COMPLETED|Overall Study||410
8343832|NCT01290874|20569031|P2|COMPLETED|Overall Study||134
8343833|NCT01290874|20569032|P1|COMPLETED|Overall Study||122
8343834|NCT01290874|20569031|P2|STARTED|Overall Study||538
8343835|NCT01290874|20569032|P1|STARTED|Overall Study||532
8343836|NCT01290822|20569052|P1|NOT COMPLETED|Overall Study||11
8343837|NCT01290822|20569052|P1|COMPLETED|Overall Study||1
8343838|NCT01290822|20569052|P1|STARTED|Overall Study||12
8343839|NCT01290796|20569061|P1|NOT COMPLETED|Overall Study||30
8343840|NCT01290796|20569061|P1|COMPLETED|Overall Study||123
8343841|NCT01290796|20569061|P1|STARTED|Overall Study||153
8343842|NCT01290757|20569077|P2|NOT COMPLETED|Overall Study||2
8343843|NCT01290757|20569078|P1|NOT COMPLETED|Overall Study||2
8343844|NCT01290757|20569077|P2|COMPLETED|Overall Study||88
8343845|NCT01290757|20569078|P1|COMPLETED|Overall Study||88
8343846|NCT01290757|20569077|P2|STARTED|Overall Study||90
8343847|NCT01290757|20569078|P1|STARTED|Overall Study||90
8343848|NCT01290731|20569094|P1|NOT COMPLETED|Overall Study||1
8343849|NCT01290731|20569094|P1|COMPLETED|Overall Study||48
8343850|NCT01290731|20569094|P1|STARTED|Overall Study||49
8343851|NCT01290718|20569106|P1|NOT COMPLETED|Overall Study||4
8343852|NCT01290718|20569106|P1|COMPLETED|Overall Study||0
8343853|NCT01290718|20569106|P1|STARTED|Overall Study||4
8343854|NCT01290679|20569115|P2|NOT COMPLETED|Overall Study||21
8343855|NCT01290679|20569116|P1|NOT COMPLETED|Overall Study||16
8343856|NCT01290679|20569115|P2|COMPLETED|Overall Study||113
8343857|NCT01290679|20569116|P1|COMPLETED|Overall Study||241
8343858|NCT01290679|20569115|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
8343859|NCT01290679|20569116|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
8343860|NCT01290666|20569185|P1|NOT COMPLETED|Overall Study||38
8343861|NCT01290666|20569185|P1|COMPLETED|Overall Study||55
8343862|NCT01290666|20569185|P1|STARTED|Overall Study||93
8343863|NCT01290640|20569191|P2|NOT COMPLETED|Overall Study||0
8343864|NCT01290640|20569192|P1|NOT COMPLETED|Overall Study||0
8343865|NCT01290640|20569191|P2|COMPLETED|Overall Study||10
8343866|NCT01290640|20569192|P1|COMPLETED|Overall Study||12
8343867|NCT01290640|20569191|P2|STARTED|Overall Study||10
8343868|NCT01290640|20569192|P1|STARTED|Overall Study||12
8343869|NCT01290627|20569203|P3|NOT COMPLETED|Overall Study||0
8343870|NCT01290627|20569204|P2|NOT COMPLETED|Overall Study||0
8343871|NCT01290627|20569205|P1|NOT COMPLETED|Overall Study||0
8343872|NCT01290627|20569203|P3|COMPLETED|Overall Study||10
8343873|NCT01290627|20569204|P2|COMPLETED|Overall Study||10
8343874|NCT01290627|20569205|P1|COMPLETED|Overall Study||10
8343875|NCT01290627|20569203|P3|STARTED|Overall Study||10
8343876|NCT01290627|20569204|P2|STARTED|Overall Study||10
8343877|NCT01290627|20569205|P1|STARTED|Overall Study||10
8343878|NCT01290614|20569227|P2|NOT COMPLETED|Overall Study||0
8343879|NCT01290614|20569228|P1|NOT COMPLETED|Overall Study||552
8343880|NCT01290614|20569227|P2|COMPLETED|Overall Study||1129
8343881|NCT01290614|20569228|P1|COMPLETED|Overall Study||518
8343882|NCT01290614|20569227|P2|STARTED|Overall Study||1129
8343883|NCT01290614|20569228|P1|STARTED|Overall Study||1070
8343884|NCT01290601|20569238|P4|NOT COMPLETED|Overall Study||0
8343885|NCT01290601|20569239|P3|NOT COMPLETED|Overall Study||0
8343886|NCT01290601|20569240|P2|NOT COMPLETED|Overall Study||5
8343887|NCT01290601|20569241|P1|NOT COMPLETED|Overall Study||11
8343888|NCT01290601|20569238|P4|COMPLETED|Overall Study||0
8343889|NCT01290601|20569239|P3|COMPLETED|Overall Study||0
8343890|NCT01290601|20569240|P2|COMPLETED|Overall Study||19
8343891|NCT01290601|20569241|P1|COMPLETED|Overall Study||35
8343892|NCT01290601|20569238|P4|STARTED|Overall Study||0
8343893|NCT01290601|20569239|P3|STARTED|Overall Study||0
8343894|NCT01290601|20569240|P2|STARTED|Overall Study||24
8343895|NCT01290601|20569241|P1|STARTED|Overall Study||46
8343896|NCT01290536|20569255|P1|NOT COMPLETED|Overall Study||0
8343897|NCT01290536|20569255|P1|COMPLETED|Overall Study||42
8343898|NCT01290536|20569255|P1|STARTED|Overall Study||42
8343899|NCT01290523|20569262|P1|NOT COMPLETED|Overall Study||3
8343900|NCT01290523|20569262|P1|COMPLETED|Overall Study||11
8343901|NCT01290523|20569262|P1|STARTED|Overall Study||14
8343902|NCT01290484|20569267|P1|NOT COMPLETED|Overall Study||0
8343903|NCT01290484|20569267|P1|COMPLETED|Overall Study||7
8343904|NCT01290484|20569267|P1|STARTED|Overall Study||7
8343905|NCT01290445|20569274|P3|NOT COMPLETED|Overall Study||0
8343906|NCT01290445|20569275|P2|NOT COMPLETED|Overall Study||0
8343907|NCT01290445|20569276|P1|NOT COMPLETED|Overall Study||0
8343908|NCT01290445|20569274|P3|COMPLETED|Overall Study||806438
8343909|NCT01290445|20569275|P2|COMPLETED|Overall Study||78412
8343910|NCT01290445|20569276|P1|COMPLETED|Overall Study||335
8343911|NCT01290445|20569274|P3|STARTED|Overall Study||806438
8343912|NCT01290445|20569275|P2|STARTED|Overall Study||78412
8343913|NCT01290445|20569276|P1|STARTED|Overall Study||335
8343914|NCT01290341|20569301|P2|NOT COMPLETED|Overall Study||29
8343915|NCT01290341|20569302|P1|NOT COMPLETED|Overall Study||92
8343916|NCT01290341|20569301|P2|COMPLETED|Overall Study||258
8343917|NCT01290341|20569302|P1|COMPLETED|Overall Study||481
8343918|NCT01290341|20569301|P2|STARTED|Overall Study||287
8343919|NCT01290341|20569302|P1|STARTED|Overall Study||573
8343920|NCT01290315|20569314|P4|NOT COMPLETED|Overall Study||5
8343921|NCT01290315|20569315|P3|NOT COMPLETED|Overall Study||0
8343922|NCT01290315|20569316|P2|NOT COMPLETED|Overall Study||3
8343923|NCT01290315|20569317|P1|NOT COMPLETED|Overall Study||3
8343924|NCT01290315|20569314|P4|COMPLETED|Overall Study||8
8343925|NCT01290315|20569315|P3|COMPLETED|Overall Study||10
8343926|NCT01290315|20569316|P2|COMPLETED|Overall Study||9
8343927|NCT01290315|20569317|P1|COMPLETED|Overall Study||11
8343928|NCT01290315|20569314|P4|STARTED|Overall Study||13
8343929|NCT01290315|20569315|P3|STARTED|Overall Study||10
8343930|NCT01290315|20569316|P2|STARTED|Overall Study||12
8343931|NCT01290315|20569317|P1|STARTED|Overall Study||14
8343932|NCT01290263|20569339|P5|NOT COMPLETED|Overall Study||37
8343933|NCT01290263|20569340|P4|NOT COMPLETED|Overall Study||27
8343934|NCT01290263|20569341|P3|NOT COMPLETED|Overall Study||7
8343935|NCT01290263|20569342|P2|NOT COMPLETED|Overall Study||3
8343936|NCT01290263|20569343|P1|NOT COMPLETED|Overall Study||11
8343937|NCT01290263|20569339|P5|COMPLETED|Overall Study||0
8343938|NCT01290263|20569340|P4|COMPLETED|Overall Study||0
8343939|NCT01290263|20569341|P3|COMPLETED|Overall Study||0
8343940|NCT01290263|20569342|P2|COMPLETED|Overall Study||0
8343941|NCT01290263|20569343|P1|COMPLETED|Overall Study||0
8343942|NCT01290263|20569339|P5|STARTED|Overall Study||37
8343943|NCT01290263|20569340|P4|STARTED|Overall Study||27
8343944|NCT01290263|20569341|P3|STARTED|Overall Study||7
8343945|NCT01290263|20569342|P2|STARTED|Overall Study||3
8343946|NCT01290263|20569343|P1|STARTED|Overall Study||11
8343947|NCT01290237|20569361|P2|NOT COMPLETED|Overall Study||2
8343948|NCT01290237|20569362|P1|NOT COMPLETED|Overall Study||11
8343949|NCT01290237|20569361|P2|COMPLETED|Overall Study||27
8343950|NCT01290237|20569362|P1|COMPLETED|Overall Study||19
8343951|NCT01290237|20569361|P2|STARTED|Overall Study||29
8343952|NCT01290237|20569362|P1|STARTED|Overall Study||30
8343953|NCT01290224|20569370|P1|NOT COMPLETED|Overall Study||5
8343954|NCT01290224|20569370|P1|COMPLETED|Overall Study||5
8343955|NCT01290224|20569370|P1|STARTED|Overall Study||10
8343956|NCT01290094|20569381|P1|NOT COMPLETED|Overall Study||6
8343957|NCT01290094|20569381|P1|COMPLETED|Overall Study||35
8343958|NCT01290094|20569381|P1|STARTED|Overall Study||41
8343959|NCT01290068|20569394|P2|NOT COMPLETED|Overall Study||6
8343960|NCT01290068|20569395|P1|NOT COMPLETED|Overall Study||7
8343961|NCT01290068|20569394|P2|COMPLETED|Overall Study||94
8343962|NCT01290068|20569395|P1|COMPLETED|Overall Study||101
8343963|NCT01290068|20569394|P2|Implanted|Overall Study||98
8343964|NCT01290068|20569395|P1|Implanted|Overall Study||108
8343965|NCT01290068|20569394|P2|STARTED|Overall Study||100
8343966|NCT01290068|20569395|P1|STARTED|Overall Study||108
8343967|NCT01290029|20569407|P1|NOT COMPLETED|Overall Study||2
8343968|NCT01290029|20569407|P1|COMPLETED|Overall Study||12
8343969|NCT01290029|20569407|P1|Received Study Treatment|Overall Study||12
8343970|NCT01290029|20569407|P1|STARTED|Overall Study||14
8343971|NCT01289990|20569433|P13|NOT COMPLETED|Overall Study||98
8343972|NCT01289990|20569434|P12|NOT COMPLETED|Overall Study||68
8343973|NCT01289990|20569435|P11|NOT COMPLETED|Overall Study||76
8343974|NCT01289990|20569436|P10|NOT COMPLETED|Overall Study||86
8343975|NCT01289990|20569437|P9|NOT COMPLETED|Overall Study||75
8343976|NCT01289990|20569438|P8|NOT COMPLETED|Overall Study||55
8343977|NCT01289990|20569439|P7|NOT COMPLETED|Overall Study||88
8343978|NCT01289990|20569440|P6|NOT COMPLETED|Overall Study||74
8343979|NCT01289990|20569441|P5|NOT COMPLETED|Overall Study||72
8343980|NCT01289990|20569442|P4|NOT COMPLETED|Overall Study||87
8343981|NCT01289990|20569443|P3|NOT COMPLETED|Overall Study||109
8343982|NCT01289990|20569444|P2|NOT COMPLETED|Overall Study||81
8343983|NCT01289990|20569445|P1|NOT COMPLETED|Overall Study||77
8343984|NCT01289990|20569433|P13|COMPLETED|Overall Study||127
8343985|NCT01289990|20569434|P12|COMPLETED|Overall Study||150
8343986|NCT01289990|20569435|P11|COMPLETED|Overall Study||150
8343987|NCT01289990|20569436|P10|COMPLETED|Overall Study||121
8343988|NCT01289990|20569437|P9|COMPLETED|Overall Study||139
8343989|NCT01289990|20569438|P8|COMPLETED|Overall Study||162
8343990|NCT01289990|20569439|P7|COMPLETED|Overall Study||78
8343991|NCT01289990|20569440|P6|COMPLETED|Overall Study||94
8343992|NCT01289990|20569441|P5|COMPLETED|Overall Study||93
8343993|NCT01289990|20569442|P4|COMPLETED|Overall Study||136
8343994|NCT01289990|20569443|P3|COMPLETED|Overall Study||119
8343995|NCT01289990|20569444|P2|COMPLETED|Overall Study||143
8343996|NCT01289990|20569445|P1|COMPLETED|Overall Study||147
8343997|NCT01289990|20569433|P13|STARTED|Overall Study||225
8343998|NCT01289990|20569434|P12|STARTED|Overall Study||218
8343999|NCT01289990|20569435|P11|STARTED|Overall Study||226
8344000|NCT01289990|20569436|P10|STARTED|Overall Study||207
8344001|NCT01289990|20569437|P9|STARTED|Overall Study||214
8344002|NCT01289990|20569438|P8|STARTED|Overall Study||217
8344003|NCT01289990|20569439|P7|STARTED|Overall Study||166
8344004|NCT01289990|20569440|P6|STARTED|Overall Study||168
8344005|NCT01289990|20569441|P5|STARTED|Overall Study||165
8344006|NCT01289990|20569442|P4|STARTED|Overall Study||223
8344007|NCT01289990|20569443|P3|STARTED|Overall Study||228
8344008|NCT01289990|20569444|P2|STARTED|Overall Study||224
8344009|NCT01289990|20569445|P1|STARTED|Overall Study||224
8344010|NCT01289912|20569631|P2|NOT COMPLETED|Overall Study||2
8344011|NCT01289912|20569632|P1|NOT COMPLETED|Overall Study||3
8344012|NCT01289912|20569631|P2|COMPLETED|Overall Study||13
8344013|NCT01289912|20569632|P1|COMPLETED|Overall Study||29
8344014|NCT01289912|20569631|P2|STARTED|Overall Study||15
8344015|NCT01289912|20569632|P1|STARTED|Overall Study||32
8344016|NCT01289847|20569662|P1|NOT COMPLETED|Overall Study||1
8344017|NCT01289847|20569662|P1|COMPLETED|Overall Study||24
8344018|NCT01289847|20569662|P1|STARTED|Overall Study||25
8344019|NCT01289821|20569671|P1|NOT COMPLETED|Survival Follow-up Period||18
8344020|NCT01289821|20569671|P1|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
8344021|NCT01289821|20569671|P1|STARTED|Survival Follow-up Period||52
8344022|NCT01289821|20569671|P1|NOT COMPLETED|Safety Follow-up Period||5
8344023|NCT01289821|20569671|P1|COMPLETED|Safety Follow-up Period||49
8344024|NCT01289821|20569671|P1|STARTED|Safety Follow-up Period||54
8344025|NCT01289821|20569671|P1|NOT COMPLETED|Treatment Period||54
8344026|NCT01289821|20569671|P1|COMPLETED|Treatment Period||0
8344027|NCT01289821|20569671|P1|Participants Received Regorafenib|Treatment Period||54
8344028|NCT01289821|20569671|P1|STARTED|Treatment Period||54
8344029|NCT01289782|20569682|P2|NOT COMPLETED|Overall Study||12
8344030|NCT01289782|20569683|P1|NOT COMPLETED|Overall Study||25
8344031|NCT01289782|20569682|P2|COMPLETED|Overall Study||118
8344032|NCT01289782|20569683|P1|COMPLETED|Overall Study||239
8344033|NCT01289782|20569682|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
8344034|NCT01289782|20569683|P1|STARTED|Overall Study||264
8344035|NCT01289678|20569752|P1|NOT COMPLETED|Overall Study||6
8344036|NCT01289678|20569752|P1|COMPLETED|Overall Study||12
8344037|NCT01289678|20569752|P1|STARTED|Overall Study||18
8344038|NCT01289665|20569758|P2|NOT COMPLETED|Overall Study||0
8344039|NCT01289665|20569759|P1|NOT COMPLETED|Overall Study||1
8344040|NCT01289665|20569758|P2|COMPLETED|Overall Study||60
8344041|NCT01289665|20569759|P1|COMPLETED|Overall Study||59
8344042|NCT01289665|20569758|P2|STARTED|Overall Study||60
8344043|NCT01289665|20569759|P1|STARTED|Overall Study||60
8344044|NCT01289639|20569768|P3|NOT COMPLETED|Overall Study||0
8344045|NCT01289639|20569769|P2|NOT COMPLETED|Overall Study||0
8344046|NCT01289639|20569770|P1|NOT COMPLETED|Overall Study||1
8344047|NCT01289639|20569768|P3|COMPLETED|Overall Study||0
8344048|NCT01289639|20569769|P2|COMPLETED|Overall Study||6
8344049|NCT01289639|20569770|P1|COMPLETED|Overall Study||4
8344050|NCT01289639|20569768|P3|STARTED|Overall Study||0
8344051|NCT01289639|20569769|P2|STARTED|Overall Study||6
8344052|NCT01289639|20569770|P1|STARTED|Overall Study||5
8344053|NCT01289574|20569796|P3|NOT COMPLETED|Overall Study||3
8344054|NCT01289574|20569797|P2|NOT COMPLETED|Overall Study||3
8344055|NCT01289574|20569798|P1|NOT COMPLETED|Overall Study||7
8344056|NCT01289574|20569796|P3|COMPLETED|Overall Study||60
8344057|NCT01289574|20569797|P2|COMPLETED|Overall Study||57
8344058|NCT01289574|20569798|P1|COMPLETED|Overall Study||51
8344059|NCT01289574|20569796|P3|STARTED|Overall Study||63
8344060|NCT01289574|20569797|P2|STARTED|Overall Study||60
8344061|NCT01289574|20569798|P1|STARTED|Overall Study||58
8344062|NCT01289548|20569815|P3|NOT COMPLETED|Overall Study||0
8344063|NCT01289548|20569816|P2|NOT COMPLETED|Overall Study||0
8344064|NCT01289548|20569817|P1|NOT COMPLETED|Overall Study||0
8344065|NCT01289548|20569815|P3|COMPLETED|Overall Study||40
8344066|NCT01289548|20569816|P2|COMPLETED|Overall Study||40
8344067|NCT01289548|20569817|P1|COMPLETED|Overall Study||40
8344068|NCT01289548|20569815|P3|Recipients|Overall Study||20
8344069|NCT01289548|20569816|P2|Recipients|Overall Study||20
8344070|NCT01289548|20569817|P1|Recipients|Overall Study||20
8344071|NCT01289548|20569815|P3|Donors|Overall Study||20
8344072|NCT01289548|20569816|P2|Donors|Overall Study||20
8344073|NCT01289548|20569817|P1|Donors|Overall Study||20
8344074|NCT01289548|20569815|P3|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
8344075|NCT01289548|20569816|P2|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
8344076|NCT01289548|20569817|P1|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
8344077|NCT01289522|20569861|P1|NOT COMPLETED|Overall Study||11
8344078|NCT01289522|20569861|P1|COMPLETED|Overall Study||43
8344079|NCT01289522|20569861|P1|STARTED|Overall Study||54
8344080|NCT01289457|20569870|P3|NOT COMPLETED|Overall Study||0
8344081|NCT01289457|20569871|P2|NOT COMPLETED|Overall Study||0
8344082|NCT01289457|20569872|P1|NOT COMPLETED|Overall Study||0
8344083|NCT01289457|20569870|P3|COMPLETED|Overall Study||113
8344084|NCT01289457|20569871|P2|COMPLETED|Overall Study||157
8344085|NCT01289457|20569872|P1|COMPLETED|Overall Study||12
8344086|NCT01289457|20569870|P3|STARTED|Overall Study||113
8344087|NCT01289457|20569871|P2|STARTED|Overall Study||157
8344088|NCT01289457|20569872|P1|STARTED|Overall Study||12
8344089|NCT01289431|20569896|P7|NOT COMPLETED|Overall Study||1
8344090|NCT01289431|20569897|P6|NOT COMPLETED|Overall Study||2
8344091|NCT01289431|20569898|P5|NOT COMPLETED|Overall Study||2
8344092|NCT01289431|20569899|P4|NOT COMPLETED|Overall Study||5
8344093|NCT01289431|20569900|P3|NOT COMPLETED|Overall Study||4
8344094|NCT01289431|20569901|P2|NOT COMPLETED|Overall Study||2
8344095|NCT01289431|20569902|P1|NOT COMPLETED|Overall Study||5
8344096|NCT01289431|20569896|P7|COMPLETED|Overall Study||33
8344097|NCT01289431|20569897|P6|COMPLETED|Overall Study||31
8344098|NCT01289431|20569898|P5|COMPLETED|Overall Study||32
8344099|NCT01289431|20569899|P4|COMPLETED|Overall Study||28
8344100|NCT01289431|20569900|P3|COMPLETED|Overall Study||30
8344101|NCT01289431|20569901|P2|COMPLETED|Overall Study||32
8344102|NCT01289431|20569902|P1|COMPLETED|Overall Study||29
8344103|NCT01289431|20569896|P7|STARTED|Overall Study||34
8344104|NCT01289431|20569897|P6|STARTED|Overall Study||33
8344105|NCT01289431|20569898|P5|STARTED|Overall Study||34
8344106|NCT01289431|20569899|P4|STARTED|Overall Study||33
8344107|NCT01289431|20569900|P3|STARTED|Overall Study||34
8344108|NCT01289431|20569901|P2|STARTED|Overall Study||34
8344109|NCT01289431|20569902|P1|STARTED|Overall Study||34
8344110|NCT01289418|20569942|P1|NOT COMPLETED|Day 29 Survey||2468
8344111|NCT01289418|20569942|P1|COMPLETED|Day 29 Survey||4057
8344112|NCT01289418|20569942|P1|STARTED|Day 29 Survey||6525
8344113|NCT01289418|20569942|P1|NOT COMPLETED|Day 8 Survey||2218
8344114|NCT01289418|20569942|P1|COMPLETED|Day 8 Survey||4307
8344115|NCT01289418|20569942|P1|STARTED|Day 8 Survey||6525
8344116|NCT01289392|20569951|P3|NOT COMPLETED|Overall Study||0
8344117|NCT01289392|20569952|P2|NOT COMPLETED|Overall Study||0
8344118|NCT01289392|20569953|P1|NOT COMPLETED|Overall Study||0
8344119|NCT01289392|20569951|P3|COMPLETED|Overall Study||7
8344120|NCT01289392|20569952|P2|COMPLETED|Overall Study||9
8344121|NCT01289392|20569953|P1|COMPLETED|Overall Study||9
8344122|NCT01289392|20569951|P3|STARTED|Overall Study||7
8344123|NCT01289392|20569952|P2|STARTED|Overall Study||9
8344124|NCT01289392|20569953|P1|STARTED|Overall Study||9
8344125|NCT01289353|20569961|P1|NOT COMPLETED|Overall Study||2
8344126|NCT01289353|20569961|P1|COMPLETED|Overall Study||90
8344127|NCT01289353|20569961|P1|STARTED|Overall Study||92
8344128|NCT01289275|20569971|P4|NOT COMPLETED|Overall Study||0
8344129|NCT01289275|20569972|P3|NOT COMPLETED|Overall Study||0
8344130|NCT01289275|20569973|P2|NOT COMPLETED|Overall Study||0
8344131|NCT01289275|20569974|P1|NOT COMPLETED|Overall Study||0
8344132|NCT01289275|20569971|P4|COMPLETED|Overall Study||316
8344133|NCT01289275|20569972|P3|COMPLETED|Overall Study||317
8344134|NCT01289275|20569973|P2|COMPLETED|Overall Study||320
8344135|NCT01289275|20569974|P1|COMPLETED|Overall Study||317
8344136|NCT01289275|20569971|P4|STARTED|Overall Study||316
8344137|NCT01289275|20569972|P3|STARTED|Overall Study||317
8344138|NCT01289275|20569973|P2|STARTED|Overall Study||320
8344139|NCT01289275|20569974|P1|STARTED|Overall Study||317
8344140|NCT01289210|20569996|P1|NOT COMPLETED|Overall Study||1
8344141|NCT01289210|20569996|P1|COMPLETED|Overall Study||1
8344142|NCT01289210|20569996|P1|STARTED|Overall Study||2
8344143|NCT01289119|20570006|P6|NOT COMPLETED|Overall Study||4
8344144|NCT01289119|20570007|P5|NOT COMPLETED|Overall Study||5
8344145|NCT01289119|20570008|P4|NOT COMPLETED|Overall Study||6
8344146|NCT01289119|20570009|P3|NOT COMPLETED|Overall Study||9
8344147|NCT01289119|20570010|P2|NOT COMPLETED|Overall Study||9
8344148|NCT01289119|20570011|P1|NOT COMPLETED|Overall Study||9
8344149|NCT01289119|20570006|P6|COMPLETED|Overall Study||57
8344150|NCT01289119|20570007|P5|COMPLETED|Overall Study||58
8344151|NCT01289119|20570008|P4|COMPLETED|Overall Study||93
8344152|NCT01289119|20570009|P3|COMPLETED|Overall Study||89
8344153|NCT01289119|20570010|P2|COMPLETED|Overall Study||83
8344154|NCT01289119|20570011|P1|COMPLETED|Overall Study||84
8344155|NCT01289119|20570006|P6|Treated|Overall Study||61
8344156|NCT01289119|20570007|P5|Treated|Overall Study||63
8344157|NCT01289119|20570008|P4|Treated|Overall Study||99
8344158|NCT01289119|20570009|P3|Treated|Overall Study||98
8344159|NCT01289119|20570010|P2|Treated|Overall Study||92
8344160|NCT01289119|20570011|P1|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
8344161|NCT01289119|20570006|P6|STARTED|Overall Study||61
8344162|NCT01289119|20570007|P5|STARTED|Overall Study||63
8344163|NCT01289119|20570008|P4|STARTED|Overall Study||99
8344164|NCT01289119|20570009|P3|STARTED|Overall Study||98
8344165|NCT01289119|20570010|P2|STARTED|Overall Study||92
8344166|NCT01289119|20570011|P1|STARTED|Overall Study||93
8344167|NCT01289080|20570093|P2|NOT COMPLETED|Overall Study||0
8344168|NCT01289080|20570094|P1|NOT COMPLETED|Overall Study||0
8344169|NCT01289080|20570093|P2|COMPLETED|Overall Study||10
8344170|NCT01289080|20570094|P1|COMPLETED|Overall Study||9
8344171|NCT01289080|20570093|P2|STARTED|Overall Study||10
8344172|NCT01289080|20570094|P1|STARTED|Overall Study||9
8344173|NCT01289067|20570125|P1|NOT COMPLETED|Overall Study||0
8344174|NCT01289067|20570125|P1|COMPLETED|Overall Study||13
8344175|NCT01289067|20570125|P1|STARTED|Overall Study||13
8344176|NCT01289041|20570132|P1|NOT COMPLETED|Overall Study||70
8344177|NCT01289041|20570132|P1|COMPLETED|Overall Study||0
8344178|NCT01289041|20570132|P1|STARTED|Overall Study||70
8344179|NCT01289028|20570144|P1|NOT COMPLETED|Overall Study||83
8344180|NCT01289028|20570144|P1|COMPLETED|Overall Study||42
8344181|NCT01289028|20570144|P1|STARTED|Overall Study||125
8344182|NCT01289015|20570158|P2|NOT COMPLETED|Overall Study||54
8344183|NCT01289015|20570159|P1|NOT COMPLETED|Overall Study||99
8344184|NCT01289015|20570158|P2|COMPLETED|Overall Study||230
8344185|NCT01289015|20570159|P1|COMPLETED|Overall Study||472
8344186|NCT01289015|20570158|P2|STARTED|Overall Study||284
8344187|NCT01289015|20570159|P1|STARTED|Overall Study||571
8344188|NCT01288989|20570172|P5|NOT COMPLETED|Overall Study||6
8344189|NCT01288989|20570173|P4|NOT COMPLETED|Overall Study||1
8344190|NCT01288989|20570174|P3|NOT COMPLETED|Overall Study||0
8344191|NCT01288989|20570175|P2|NOT COMPLETED|Overall Study||0
8344192|NCT01288989|20570176|P1|NOT COMPLETED|Overall Study||1
8344193|NCT01288989|20570172|P5|COMPLETED|Overall Study||15
8344194|NCT01288989|20570173|P4|COMPLETED|Overall Study||10
8344195|NCT01288989|20570174|P3|COMPLETED|Overall Study||3
8344196|NCT01288989|20570175|P2|COMPLETED|Overall Study||3
8344197|NCT01288989|20570176|P1|COMPLETED|Overall Study||5
8344198|NCT01288989|20570172|P5|Received at Least 1 Dose of Study Drug|Overall Study||21
8344199|NCT01288989|20570173|P4|Received at Least 1 Dose of Study Drug|Overall Study||11
8344200|NCT01288989|20570174|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8344201|NCT01288989|20570175|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8344202|NCT01288989|20570176|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8344203|NCT01288989|20570172|P5|STARTED|Overall Study||21
8344204|NCT01288989|20570173|P4|STARTED|Overall Study||11
8344205|NCT01288989|20570174|P3|STARTED|Overall Study||3
8344206|NCT01288989|20570175|P2|STARTED|Overall Study||3
8344207|NCT01288989|20570176|P1|STARTED|Overall Study||6
8344208|NCT01288976|20570237|P3|NOT COMPLETED|Overall Study||20
8344209|NCT01288976|20570238|P2|NOT COMPLETED|Overall Study||27
8344210|NCT01288976|20570239|P1|NOT COMPLETED|Overall Study||178
8344211|NCT01288976|20570237|P3|COMPLETED|Overall Study||85
8344212|NCT01288976|20570238|P2|COMPLETED|Overall Study||22
8344213|NCT01288976|20570239|P1|COMPLETED|Overall Study||389
8344214|NCT01288976|20570237|P3|STARTED|Overall Study||105
8344215|NCT01288976|20570238|P2|STARTED|Overall Study||49
8344216|NCT01288976|20570239|P1|STARTED|Overall Study||567
8344217|NCT01288937|20570268|P2|NOT COMPLETED|Overall Study||0
8344218|NCT01288937|20570269|P1|NOT COMPLETED|Overall Study||1
8344219|NCT01288937|20570268|P2|COMPLETED|Overall Study||2
8344220|NCT01288937|20570269|P1|COMPLETED|Overall Study||3
8344221|NCT01288937|20570268|P2|STARTED|Overall Study||2
8344222|NCT01288937|20570269|P1|STARTED|Overall Study||4
8344223|NCT01288911|20570277|P2|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
8344224|NCT01288911|20570278|P1|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
8344225|NCT01288911|20570277|P2|COMPLETED|Open-label Period (All Enzalutamide)||0
8344226|NCT01288911|20570278|P1|COMPLETED|Open-label Period (All Enzalutamide)||0
8344227|NCT01288911|20570277|P2|Received Treatment|Open-label Period (All Enzalutamide)||9
8344228|NCT01288911|20570278|P1|Received Treatment|Open-label Period (All Enzalutamide)||42
8344229|NCT01288911|20570277|P2|STARTED|Open-label Period (All Enzalutamide)||9
8344230|NCT01288911|20570278|P1|STARTED|Open-label Period (All Enzalutamide)||42
8344231|NCT01288911|20570277|P2|NOT COMPLETED|Double-blind Period||182
8344232|NCT01288911|20570278|P1|NOT COMPLETED|Double-blind Period||142
8344233|NCT01288911|20570277|P2|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
8344234|NCT01288911|20570278|P1|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
8344235|NCT01288911|20570277|P2|Received Treatment|Double-blind Period||189
8344236|NCT01288911|20570278|P1|Received Treatment|Double-blind Period||183
8344237|NCT01288911|20570277|P2|STARTED|Double-blind Period||191
8344238|NCT01288911|20570278|P1|STARTED|Double-blind Period||184
8344239|NCT01288859|20570309|P6|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344240|NCT01288859|20570310|P5|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344241|NCT01288859|20570311|P4|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344242|NCT01288859|20570312|P3|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344243|NCT01288859|20570313|P2|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344244|NCT01288859|20570314|P1|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344245|NCT01288859|20570309|P6|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344246|NCT01288859|20570310|P5|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
8344247|NCT01288859|20570311|P4|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
8344248|NCT01288859|20570312|P3|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344249|NCT01288859|20570313|P2|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344250|NCT01288859|20570314|P1|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
8344251|NCT01288859|20570309|P6|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
8344252|NCT01288859|20570310|P5|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
8344253|NCT01288859|20570311|P4|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
8344254|NCT01288859|20570312|P3|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
8344255|NCT01288859|20570313|P2|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
8344256|NCT01288859|20570314|P1|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
8344257|NCT01288859|20570309|P6|NOT COMPLETED|Washout Period of 1 Week||0
8344258|NCT01288859|20570310|P5|NOT COMPLETED|Washout Period of 1 Week||0
8344259|NCT01288859|20570311|P4|NOT COMPLETED|Washout Period of 1 Week||0
8344260|NCT01288859|20570312|P3|NOT COMPLETED|Washout Period of 1 Week||0
8344261|NCT01288859|20570313|P2|NOT COMPLETED|Washout Period of 1 Week||0
8344262|NCT01288859|20570314|P1|NOT COMPLETED|Washout Period of 1 Week||0
8344263|NCT01288859|20570309|P6|COMPLETED|Washout Period of 1 Week||0
8344264|NCT01288859|20570310|P5|COMPLETED|Washout Period of 1 Week||5
8344265|NCT01288859|20570311|P4|COMPLETED|Washout Period of 1 Week||5
8344266|NCT01288859|20570312|P3|COMPLETED|Washout Period of 1 Week||0
8344267|NCT01288859|20570313|P2|COMPLETED|Washout Period of 1 Week||0
8344268|NCT01288859|20570314|P1|COMPLETED|Washout Period of 1 Week||0
8344269|NCT01288859|20570309|P6|STARTED|Washout Period of 1 Week||0
8344270|NCT01288859|20570310|P5|STARTED|Washout Period of 1 Week||5
8344271|NCT01288859|20570311|P4|STARTED|Washout Period of 1 Week||5
8344272|NCT01288859|20570312|P3|STARTED|Washout Period of 1 Week||0
8344273|NCT01288859|20570313|P2|STARTED|Washout Period of 1 Week||0
8344274|NCT01288859|20570314|P1|STARTED|Washout Period of 1 Week||0
8344275|NCT01288859|20570309|P6|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344276|NCT01288859|20570310|P5|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344277|NCT01288859|20570311|P4|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344278|NCT01288859|20570312|P3|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344279|NCT01288859|20570313|P2|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344280|NCT01288859|20570314|P1|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344281|NCT01288859|20570309|P6|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344282|NCT01288859|20570310|P5|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
8344283|NCT01288859|20570311|P4|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
8344284|NCT01288859|20570312|P3|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344285|NCT01288859|20570313|P2|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344286|NCT01288859|20570314|P1|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
8344287|NCT01288859|20570309|P6|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
8344288|NCT01288859|20570310|P5|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
8344289|NCT01288859|20570311|P4|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
8344290|NCT01288859|20570312|P3|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
8344291|NCT01288859|20570313|P2|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
8344292|NCT01288859|20570314|P1|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
8344293|NCT01288859|20570309|P6|NOT COMPLETED|Washout Period of 1 Week||0
8344294|NCT01288859|20570310|P5|NOT COMPLETED|Washout Period of 1 Week||0
8344295|NCT01288859|20570311|P4|NOT COMPLETED|Washout Period of 1 Week||0
8344296|NCT01288859|20570312|P3|NOT COMPLETED|Washout Period of 1 Week||0
8344297|NCT01288859|20570313|P2|NOT COMPLETED|Washout Period of 1 Week||0
8344298|NCT01288859|20570314|P1|NOT COMPLETED|Washout Period of 1 Week||0
8344299|NCT01288859|20570309|P6|COMPLETED|Washout Period of 1 Week||0
8344300|NCT01288859|20570310|P5|COMPLETED|Washout Period of 1 Week||5
8344301|NCT01288859|20570311|P4|COMPLETED|Washout Period of 1 Week||5
8344302|NCT01288859|20570312|P3|COMPLETED|Washout Period of 1 Week||0
8344303|NCT01288859|20570313|P2|COMPLETED|Washout Period of 1 Week||0
8344304|NCT01288859|20570314|P1|COMPLETED|Washout Period of 1 Week||0
8344305|NCT01288859|20570309|P6|STARTED|Washout Period of 1 Week||0
8344306|NCT01288859|20570310|P5|STARTED|Washout Period of 1 Week||5
8344307|NCT01288859|20570311|P4|STARTED|Washout Period of 1 Week||5
8344308|NCT01288859|20570312|P3|STARTED|Washout Period of 1 Week||0
8344309|NCT01288859|20570313|P2|STARTED|Washout Period of 1 Week||0
8344310|NCT01288859|20570314|P1|STARTED|Washout Period of 1 Week||0
8344311|NCT01288859|20570309|P6|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344312|NCT01288859|20570310|P5|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344313|NCT01288859|20570311|P4|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344314|NCT01288859|20570312|P3|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344315|NCT01288859|20570313|P2|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344316|NCT01288859|20570314|P1|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344317|NCT01288859|20570309|P6|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344318|NCT01288859|20570310|P5|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344319|NCT01288859|20570311|P4|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344320|NCT01288859|20570312|P3|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
8344321|NCT01288859|20570313|P2|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
8344322|NCT01288859|20570314|P1|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344323|NCT01288859|20570309|P6|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344324|NCT01288859|20570310|P5|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344325|NCT01288859|20570311|P4|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344326|NCT01288859|20570312|P3|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
8344327|NCT01288859|20570313|P2|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
8344328|NCT01288859|20570314|P1|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
8344329|NCT01288859|20570309|P6|NOT COMPLETED|Washout Period of 1 Week||0
8344330|NCT01288859|20570310|P5|NOT COMPLETED|Washout Period of 1 Week||0
8344331|NCT01288859|20570311|P4|NOT COMPLETED|Washout Period of 1 Week||0
8344332|NCT01288859|20570312|P3|NOT COMPLETED|Washout Period of 1 Week||0
8344333|NCT01288859|20570313|P2|NOT COMPLETED|Washout Period of 1 Week||0
8344334|NCT01288859|20570314|P1|NOT COMPLETED|Washout Period of 1 Week||0
8344335|NCT01288859|20570309|P6|COMPLETED|Washout Period of 1 Week||0
8344336|NCT01288859|20570310|P5|COMPLETED|Washout Period of 1 Week||0
8344337|NCT01288859|20570311|P4|COMPLETED|Washout Period of 1 Week||0
8344338|NCT01288859|20570312|P3|COMPLETED|Washout Period of 1 Week||5
8344339|NCT01288859|20570313|P2|COMPLETED|Washout Period of 1 Week||5
8344340|NCT01288859|20570314|P1|COMPLETED|Washout Period of 1 Week||0
8344341|NCT01288859|20570309|P6|STARTED|Washout Period of 1 Week||0
8344342|NCT01288859|20570310|P5|STARTED|Washout Period of 1 Week||0
8344343|NCT01288859|20570311|P4|STARTED|Washout Period of 1 Week||0
8344344|NCT01288859|20570312|P3|STARTED|Washout Period of 1 Week||5
8344345|NCT01288859|20570313|P2|STARTED|Washout Period of 1 Week||5
8344346|NCT01288859|20570314|P1|STARTED|Washout Period of 1 Week||0
8344347|NCT01288859|20570309|P6|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344348|NCT01288859|20570310|P5|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344349|NCT01288859|20570311|P4|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344350|NCT01288859|20570312|P3|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344351|NCT01288859|20570313|P2|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344352|NCT01288859|20570314|P1|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344353|NCT01288859|20570309|P6|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344354|NCT01288859|20570310|P5|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344355|NCT01288859|20570311|P4|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344356|NCT01288859|20570312|P3|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
8344357|NCT01288859|20570313|P2|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
8344358|NCT01288859|20570314|P1|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344359|NCT01288859|20570309|P6|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344360|NCT01288859|20570310|P5|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344361|NCT01288859|20570311|P4|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344362|NCT01288859|20570312|P3|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
8344363|NCT01288859|20570313|P2|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
8344364|NCT01288859|20570314|P1|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
8344365|NCT01288859|20570309|P6|NOT COMPLETED|Washout Period of 1 Week||0
8344366|NCT01288859|20570310|P5|NOT COMPLETED|Washout Period of 1 Week||0
8344367|NCT01288859|20570311|P4|NOT COMPLETED|Washout Period of 1 Week||0
8344368|NCT01288859|20570312|P3|NOT COMPLETED|Washout Period of 1 Week||0
8344369|NCT01288859|20570313|P2|NOT COMPLETED|Washout Period of 1 Week||0
8344370|NCT01288859|20570314|P1|NOT COMPLETED|Washout Period of 1 Week||0
8344371|NCT01288859|20570309|P6|COMPLETED|Washout Period of 1 Week||5
8344372|NCT01288859|20570310|P5|COMPLETED|Washout Period of 1 Week||0
8344373|NCT01288859|20570311|P4|COMPLETED|Washout Period of 1 Week||0
8344374|NCT01288859|20570312|P3|COMPLETED|Washout Period of 1 Week||0
8344375|NCT01288859|20570313|P2|COMPLETED|Washout Period of 1 Week||0
8344376|NCT01288859|20570314|P1|COMPLETED|Washout Period of 1 Week||5
8344377|NCT01288859|20570309|P6|STARTED|Washout Period of 1 Week||5
8344378|NCT01288859|20570310|P5|STARTED|Washout Period of 1 Week||0
8344379|NCT01288859|20570311|P4|STARTED|Washout Period of 1 Week||0
8344380|NCT01288859|20570312|P3|STARTED|Washout Period of 1 Week||0
8344381|NCT01288859|20570313|P2|STARTED|Washout Period of 1 Week||0
8344382|NCT01288859|20570314|P1|STARTED|Washout Period of 1 Week||5
8344383|NCT01288859|20570309|P6|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344384|NCT01288859|20570310|P5|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344385|NCT01288859|20570311|P4|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344386|NCT01288859|20570312|P3|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344387|NCT01288859|20570313|P2|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344388|NCT01288859|20570314|P1|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344389|NCT01288859|20570309|P6|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
8344390|NCT01288859|20570310|P5|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344391|NCT01288859|20570311|P4|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344392|NCT01288859|20570312|P3|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344393|NCT01288859|20570313|P2|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
8344394|NCT01288859|20570314|P1|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
8344395|NCT01288859|20570309|P6|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
8344396|NCT01288859|20570310|P5|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
8344397|NCT01288859|20570311|P4|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
8344398|NCT01288859|20570312|P3|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
8344399|NCT01288859|20570313|P2|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
8344400|NCT01288859|20570314|P1|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
8344401|NCT01288859|20570309|P6|NOT COMPLETED|Washout Period of 1 Week||0
8344402|NCT01288859|20570310|P5|NOT COMPLETED|Washout Period of 1 Week||0
8344403|NCT01288859|20570311|P4|NOT COMPLETED|Washout Period of 1 Week||0
8344404|NCT01288859|20570312|P3|NOT COMPLETED|Washout Period of 1 Week||0
8344405|NCT01288859|20570313|P2|NOT COMPLETED|Washout Period of 1 Week||0
8344406|NCT01288859|20570314|P1|NOT COMPLETED|Washout Period of 1 Week||0
8344407|NCT01288859|20570309|P6|COMPLETED|Washout Period of 1 Week||5
8344408|NCT01288859|20570310|P5|COMPLETED|Washout Period of 1 Week||0
8344409|NCT01288859|20570311|P4|COMPLETED|Washout Period of 1 Week||0
8344410|NCT01288859|20570312|P3|COMPLETED|Washout Period of 1 Week||0
8344411|NCT01288859|20570313|P2|COMPLETED|Washout Period of 1 Week||0
8344412|NCT01288859|20570314|P1|COMPLETED|Washout Period of 1 Week||5
8344413|NCT01288859|20570309|P6|STARTED|Washout Period of 1 Week||5
8344414|NCT01288859|20570310|P5|STARTED|Washout Period of 1 Week||0
8344415|NCT01288859|20570311|P4|STARTED|Washout Period of 1 Week||0
8344416|NCT01288859|20570312|P3|STARTED|Washout Period of 1 Week||0
8344417|NCT01288859|20570313|P2|STARTED|Washout Period of 1 Week||0
8344418|NCT01288859|20570314|P1|STARTED|Washout Period of 1 Week||5
8344419|NCT01288859|20570309|P6|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344420|NCT01288859|20570310|P5|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344421|NCT01288859|20570311|P4|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344422|NCT01288859|20570312|P3|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344423|NCT01288859|20570313|P2|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344424|NCT01288859|20570314|P1|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344425|NCT01288859|20570309|P6|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
8344426|NCT01288859|20570310|P5|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344427|NCT01288859|20570311|P4|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344428|NCT01288859|20570312|P3|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344429|NCT01288859|20570313|P2|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
8344430|NCT01288859|20570314|P1|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
8344431|NCT01288859|20570309|P6|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
8344432|NCT01288859|20570310|P5|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
8344433|NCT01288859|20570311|P4|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
8344434|NCT01288859|20570312|P3|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
8344435|NCT01288859|20570313|P2|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
8344436|NCT01288859|20570314|P1|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
8344437|NCT01288833|20570342|P2|NOT COMPLETED|Overall Study||0
8344438|NCT01288833|20570343|P1|NOT COMPLETED|Overall Study||0
8344439|NCT01288833|20570342|P2|COMPLETED|Overall Study||281
8344440|NCT01288833|20570343|P1|COMPLETED|Overall Study||277
8344441|NCT01288833|20570342|P2|STARTED|Overall Study||281
8344442|NCT01288833|20570343|P1|STARTED|Overall Study||277
8344443|NCT01288807|20570357|P1|NOT COMPLETED|Overall Study||0
8344444|NCT01288807|20570357|P1|COMPLETED|Overall Study||8
8344445|NCT01288807|20570357|P1|STARTED|Overall Study||8
8344446|NCT01288781|20570367|P2|NOT COMPLETED|Overall Study||0
8344447|NCT01288781|20570368|P1|NOT COMPLETED|Overall Study||0
8344448|NCT01288781|20570367|P2|COMPLETED|Overall Study||12
8344449|NCT01288781|20570368|P1|COMPLETED|Overall Study||11
8344450|NCT01288781|20570367|P2|STARTED|Overall Study||12
8344451|NCT01288781|20570368|P1|STARTED|Overall Study||11
8344452|NCT01288729|20570388|P2|NOT COMPLETED|Overall Study||0
8344453|NCT01288729|20570389|P1|NOT COMPLETED|Overall Study||1
8344454|NCT01288729|20570388|P2|COMPLETED|Overall Study||10
8344455|NCT01288729|20570389|P1|COMPLETED|Overall Study||9
8344456|NCT01288729|20570388|P2|STARTED|Overall Study||10
8344457|NCT01288729|20570389|P1|STARTED|Overall Study||10
8344458|NCT01288612|20570398|P3|NOT COMPLETED|Overall Study||82
8344459|NCT01288612|20570399|P2|NOT COMPLETED|Overall Study||82
8344460|NCT01288612|20570400|P1|NOT COMPLETED|Overall Study||89
8344461|NCT01288612|20570398|P3|COMPLETED|Overall Study||76
8344462|NCT01288612|20570399|P2|COMPLETED|Overall Study||69
8344463|NCT01288612|20570400|P1|COMPLETED|Overall Study||61
8344464|NCT01288612|20570398|P3|Agreed to Take Part|Overall Study||76
8344465|NCT01288612|20570399|P2|Agreed to Take Part|Overall Study||72
8344466|NCT01288612|20570400|P1|Agreed to Take Part|Overall Study||61
8344467|NCT01288612|20570398|P3|Contacted|Overall Study||138
8344468|NCT01288612|20570399|P2|Contacted|Overall Study||135
8344469|NCT01288612|20570400|P1|Contacted|Overall Study||139
8344470|NCT01288612|20570398|P3|STARTED|Overall Study||158
8344471|NCT01288612|20570399|P2|STARTED|Overall Study||151
8344472|NCT01288612|20570400|P1|STARTED|Overall Study||150
8344473|NCT01288534|20570429|P1|NOT COMPLETED|Overall Study||0
8344474|NCT01288534|20570429|P1|COMPLETED|Overall Study||68
8344475|NCT01288534|20570429|P1|STARTED|Overall Study||68
8344476|NCT01288521|20570439|P2|NOT COMPLETED|Overall Study||0
8344477|NCT01288521|20570440|P1|NOT COMPLETED|Overall Study||0
8344478|NCT01288521|20570439|P2|COMPLETED|Overall Study||5
8344479|NCT01288521|20570440|P1|COMPLETED|Overall Study||3
8344480|NCT01288521|20570439|P2|STARTED|Overall Study||5
8344481|NCT01288521|20570440|P1|STARTED|Overall Study||3
8344482|NCT01288469|20570449|P3|NOT COMPLETED|Overall Study||2
8344483|NCT01288469|20570450|P2|NOT COMPLETED|Overall Study||3
8344484|NCT01288469|20570451|P1|NOT COMPLETED|Overall Study||7
8344485|NCT01288469|20570449|P3|COMPLETED|Overall Study||28
8344486|NCT01288469|20570450|P2|COMPLETED|Overall Study||28
8344487|NCT01288469|20570451|P1|COMPLETED|Overall Study||24
8344488|NCT01288469|20570449|P3|Treated|Overall Study||30
8344489|NCT01288469|20570450|P2|Treated|Overall Study||31
8344490|NCT01288469|20570451|P1|Treated|Overall Study||31
8344491|NCT01288469|20570449|P3|STARTED|Overall Study|Randomized|30
8344492|NCT01288469|20570450|P2|STARTED|Overall Study|Randomized|31
8344493|NCT01288469|20570451|P1|STARTED|Overall Study|Randomized|31
8344494|NCT01288443|20570483|P6|NOT COMPLETED|Overall Study||5
8344495|NCT01288443|20570484|P5|NOT COMPLETED|Overall Study||7
8344496|NCT01288443|20570485|P4|NOT COMPLETED|Overall Study||4
8344497|NCT01288443|20570486|P3|NOT COMPLETED|Overall Study||1
8344498|NCT01288443|20570487|P2|NOT COMPLETED|Overall Study||1
8344499|NCT01288443|20570488|P1|NOT COMPLETED|Overall Study||0
8344500|NCT01288443|20570483|P6|COMPLETED|Overall Study||25
8344501|NCT01288443|20570484|P5|COMPLETED|Overall Study||23
8344502|NCT01288443|20570485|P4|COMPLETED|Overall Study||27
8344503|NCT01288443|20570486|P3|COMPLETED|Overall Study||30
8344504|NCT01288443|20570487|P2|COMPLETED|Overall Study||29
8344505|NCT01288443|20570488|P1|COMPLETED|Overall Study||31
8344506|NCT01288443|20570483|P6|Treated|Overall Study||30
8344507|NCT01288443|20570484|P5|Treated|Overall Study||29
8344508|NCT01288443|20570485|P4|Treated|Overall Study||31
8344509|NCT01288443|20570486|P3|Treated|Overall Study||31
8344510|NCT01288443|20570487|P2|Treated|Overall Study||30
8344511|NCT01288443|20570488|P1|Treated|Overall Study||31
8344512|NCT01288443|20570483|P6|STARTED|Overall Study|Randomized|30
8344513|NCT01288443|20570484|P5|STARTED|Overall Study|Randomized|30
8344514|NCT01288443|20570485|P4|STARTED|Overall Study|Randomized|31
8344515|NCT01288443|20570486|P3|STARTED|Overall Study|Randomized|31
8344516|NCT01288443|20570487|P2|STARTED|Overall Study|Randomized|30
8344517|NCT01288443|20570488|P1|STARTED|Overall Study|Randomized|31
8344518|NCT01288430|20570548|P10|NOT COMPLETED|Part 2||3
8344519|NCT01288430|20570549|P9|NOT COMPLETED|Part 2||12
8344520|NCT01288430|20570550|P8|NOT COMPLETED|Part 2||12
8344521|NCT01288430|20570551|P7|NOT COMPLETED|Part 2||0
8344522|NCT01288430|20570552|P6|NOT COMPLETED|Part 2||0
8344523|NCT01288430|20570553|P5|NOT COMPLETED|Part 2||0
8344524|NCT01288430|20570554|P4|NOT COMPLETED|Part 2||0
8344525|NCT01288430|20570555|P3|NOT COMPLETED|Part 2||0
8344526|NCT01288430|20570556|P2|NOT COMPLETED|Part 2||0
8344527|NCT01288430|20570557|P1|NOT COMPLETED|Part 2||0
8344528|NCT01288430|20570548|P10|COMPLETED|Part 2||0
8344529|NCT01288430|20570549|P9|COMPLETED|Part 2||0
8344530|NCT01288430|20570550|P8|COMPLETED|Part 2||0
8344531|NCT01288430|20570551|P7|COMPLETED|Part 2||0
8344532|NCT01288430|20570552|P6|COMPLETED|Part 2||0
8344533|NCT01288430|20570553|P5|COMPLETED|Part 2||0
8344534|NCT01288430|20570554|P4|COMPLETED|Part 2||0
8344535|NCT01288430|20570555|P3|COMPLETED|Part 2||0
8344536|NCT01288430|20570556|P2|COMPLETED|Part 2||0
8344537|NCT01288430|20570557|P1|COMPLETED|Part 2||0
8344538|NCT01288430|20570548|P10|STARTED|Part 2||3
8344539|NCT01288430|20570549|P9|STARTED|Part 2||12
8344540|NCT01288430|20570550|P8|STARTED|Part 2||12
8344541|NCT01288430|20570551|P7|STARTED|Part 2||0
8344542|NCT01288430|20570552|P6|STARTED|Part 2||0
8344543|NCT01288430|20570553|P5|STARTED|Part 2||0
8344544|NCT01288430|20570554|P4|STARTED|Part 2||0
8344545|NCT01288430|20570555|P3|STARTED|Part 2||0
8344546|NCT01288430|20570556|P2|STARTED|Part 2||0
8344547|NCT01288430|20570557|P1|STARTED|Part 2||0
8344548|NCT01288430|20570548|P10|NOT COMPLETED|Part 1||0
8344549|NCT01288430|20570549|P9|NOT COMPLETED|Part 1||0
8344550|NCT01288430|20570550|P8|NOT COMPLETED|Part 1||0
8344551|NCT01288430|20570551|P7|NOT COMPLETED|Part 1||7
8344552|NCT01288430|20570552|P6|NOT COMPLETED|Part 1||6
8344553|NCT01288430|20570553|P5|NOT COMPLETED|Part 1||3
8344554|NCT01288430|20570554|P4|NOT COMPLETED|Part 1||7
8344555|NCT01288430|20570555|P3|NOT COMPLETED|Part 1||5
8344556|NCT01288430|20570556|P2|NOT COMPLETED|Part 1||3
8344557|NCT01288430|20570557|P1|NOT COMPLETED|Part 1||2
8344558|NCT01288430|20570548|P10|COMPLETED|Part 1||0
8344559|NCT01288430|20570549|P9|COMPLETED|Part 1||0
8344560|NCT01288430|20570550|P8|COMPLETED|Part 1||0
8344561|NCT01288430|20570551|P7|COMPLETED|Part 1||0
8344562|NCT01288430|20570552|P6|COMPLETED|Part 1||0
8344563|NCT01288430|20570553|P5|COMPLETED|Part 1||0
8344564|NCT01288430|20570554|P4|COMPLETED|Part 1||0
8344565|NCT01288430|20570555|P3|COMPLETED|Part 1||0
8344566|NCT01288430|20570556|P2|COMPLETED|Part 1||0
8344567|NCT01288430|20570557|P1|COMPLETED|Part 1||0
8344568|NCT01288430|20570548|P10|STARTED|Part 1||0
8344569|NCT01288430|20570549|P9|STARTED|Part 1||0
8344570|NCT01288430|20570550|P8|STARTED|Part 1||0
8344571|NCT01288430|20570551|P7|STARTED|Part 1||7
8344572|NCT01288430|20570552|P6|STARTED|Part 1||6
8344573|NCT01288430|20570553|P5|STARTED|Part 1||3
8344574|NCT01288430|20570554|P4|STARTED|Part 1||7
8344575|NCT01288430|20570555|P3|STARTED|Part 1||5
8344576|NCT01288430|20570556|P2|STARTED|Part 1||3
8344577|NCT01288430|20570557|P1|STARTED|Part 1||2
8344578|NCT01288287|20570681|P1|NOT COMPLETED|Overall Study||46
8344579|NCT01288287|20570681|P1|COMPLETED|Overall Study||103
8344580|NCT01288287|20570681|P1|Full Analysis Set|Overall Study||111
8344581|NCT01288287|20570681|P1|Safety Set|Overall Study||147
8344582|NCT01288287|20570681|P1|STARTED|Overall Study||149
8344583|NCT01288209|20570696|P2|NOT COMPLETED|Overall Study||3
8344584|NCT01288209|20570697|P1|NOT COMPLETED|Overall Study||2
8344585|NCT01288209|20570696|P2|COMPLETED|Overall Study||50
8344586|NCT01288209|20570697|P1|COMPLETED|Overall Study||51
8344587|NCT01288209|20570696|P2|STARTED|Overall Study||53
8344588|NCT01288209|20570697|P1|STARTED|Overall Study||53
8344589|NCT01288079|20570727|P4|NOT COMPLETED|Overall Study||17
8344590|NCT01288079|20570728|P3|NOT COMPLETED|Overall Study||19
8344591|NCT01288079|20570729|P2|NOT COMPLETED|Overall Study||27
8344592|NCT01288079|20570730|P1|NOT COMPLETED|Overall Study||20
8344593|NCT01288079|20570727|P4|COMPLETED|Overall Study||18
8344594|NCT01288079|20570728|P3|COMPLETED|Overall Study||18
8344595|NCT01288079|20570729|P2|COMPLETED|Overall Study||9
8344596|NCT01288079|20570730|P1|COMPLETED|Overall Study||17
8344597|NCT01288079|20570727|P4|STARTED|Overall Study||35
8344598|NCT01288079|20570728|P3|STARTED|Overall Study||37
8344599|NCT01288079|20570729|P2|STARTED|Overall Study||36
8344600|NCT01288079|20570730|P1|STARTED|Overall Study||37
8344601|NCT01288053|20570740|P1|NOT COMPLETED|Overall Study||1
8344602|NCT01288053|20570740|P1|COMPLETED|Overall Study||8
8344603|NCT01288053|20570740|P1|STARTED|Overall Study||9
8344604|NCT01288027|20570744|P1|NOT COMPLETED|Overall Study||0
8344605|NCT01288027|20570744|P1|COMPLETED|Overall Study||16
8344606|NCT01288027|20570744|P1|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
8344607|NCT01288027|20570744|P1|STARTED|Overall Study||16
8344608|NCT01287897|20570758|P4|NOT COMPLETED|Overall Study||7
8344609|NCT01287897|20570759|P3|NOT COMPLETED|Overall Study||12
8344610|NCT01287897|20570760|P2|NOT COMPLETED|Overall Study||11
8344611|NCT01287897|20570761|P1|NOT COMPLETED|Overall Study||11
8344612|NCT01287897|20570758|P4|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
8344613|NCT01287897|20570759|P3|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
8344614|NCT01287897|20570760|P2|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
8344615|NCT01287897|20570761|P1|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
8344616|NCT01287897|20570758|P4|Enrolled in NCT01345318|Overall Study||29
8344617|NCT01287897|20570759|P3|Enrolled in NCT01345318|Overall Study||56
8344618|NCT01287897|20570760|P2|Enrolled in NCT01345318|Overall Study||50
8344619|NCT01287897|20570761|P1|Enrolled in NCT01345318|Overall Study||56
8344620|NCT01287897|20570758|P4|Completed Follow-up Period|Overall Study||4
8344621|NCT01287897|20570759|P3|Completed Follow-up Period|Overall Study||3
8344622|NCT01287897|20570760|P2|Completed Follow-up Period|Overall Study||8
8344623|NCT01287897|20570761|P1|Completed Follow-up Period|Overall Study||3
8344624|NCT01287897|20570758|P4|Completed Treatment Period|Overall Study||29
8344625|NCT01287897|20570759|P3|Completed Treatment Period|Overall Study||58
8344626|NCT01287897|20570760|P2|Completed Treatment Period|Overall Study||52
8344627|NCT01287897|20570761|P1|Completed Treatment Period|Overall Study||58
8344628|NCT01287897|20570758|P4|Treated|Overall Study||40
8344629|NCT01287897|20570759|P3|Treated|Overall Study||71
8344630|NCT01287897|20570760|P2|Treated|Overall Study||67
8344631|NCT01287897|20570761|P1|Treated|Overall Study||69
8344632|NCT01287897|20570758|P4|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
8344633|NCT01287897|20570759|P3|STARTED|Overall Study||71
8344634|NCT01287897|20570760|P2|STARTED|Overall Study||69
8344635|NCT01287897|20570761|P1|STARTED|Overall Study||70
8344636|NCT01287832|20570812|P2|NOT COMPLETED|Overall Study||1
8344637|NCT01287832|20570813|P1|NOT COMPLETED|Overall Study||1
8344638|NCT01287832|20570812|P2|COMPLETED|Overall Study||4
8344639|NCT01287832|20570813|P1|COMPLETED|Overall Study||5
8344640|NCT01287832|20570812|P2|STARTED|Overall Study||5
8344641|NCT01287832|20570813|P1|STARTED|Overall Study||6
8344642|NCT01287754|20570821|P2|NOT COMPLETED|Overall Study||21
8344643|NCT01287754|20570822|P1|NOT COMPLETED|Overall Study||3
8344644|NCT01287754|20570821|P2|COMPLETED|Overall Study||0
8344645|NCT01287754|20570822|P1|COMPLETED|Overall Study||0
8344646|NCT01287754|20570821|P2|STARTED|Overall Study||21
8344647|NCT01287754|20570822|P1|STARTED|Overall Study||3
8344648|NCT01287741|20570834|P2|NOT COMPLETED|Overall Study||615
8344649|NCT01287741|20570835|P1|NOT COMPLETED|Overall Study||626
8344650|NCT01287741|20570834|P2|COMPLETED|Overall Study||91
8344651|NCT01287741|20570835|P1|COMPLETED|Overall Study||86
8344652|NCT01287741|20570834|P2|STARTED|Overall Study||706
8344653|NCT01287741|20570835|P1|STARTED|Overall Study||712
8344654|NCT01287611|20570871|P2|NOT COMPLETED|Overall Study||19
8344655|NCT01287611|20570872|P1|NOT COMPLETED|Overall Study||33
8344656|NCT01287611|20570871|P2|COMPLETED|Overall Study||65
8344657|NCT01287611|20570872|P1|COMPLETED|Overall Study||51
8344658|NCT01287611|20570871|P2|The Number of Patients Who Underwent C/S|Overall Study||84
8344659|NCT01287611|20570872|P1|The Number of Patients Who Underwent C/S|Overall Study||84
8344660|NCT01287611|20570871|P2|STARTED|Overall Study||84
8344661|NCT01287611|20570872|P1|STARTED|Overall Study||84
8344662|NCT01287520|20570889|P9|NOT COMPLETED|Overall Study||5
8344663|NCT01287520|20570890|P8|NOT COMPLETED|Overall Study||5
8344664|NCT01287520|20570891|P7|NOT COMPLETED|Overall Study||2
8344665|NCT01287520|20570892|P6|NOT COMPLETED|Overall Study||4
8344666|NCT01287520|20570893|P5|NOT COMPLETED|Overall Study||3
8344667|NCT01287520|20570894|P4|NOT COMPLETED|Overall Study||7
8344668|NCT01287520|20570895|P3|NOT COMPLETED|Overall Study||5
8344669|NCT01287520|20570896|P2|NOT COMPLETED|Overall Study||7
8344670|NCT01287520|20570897|P1|NOT COMPLETED|Overall Study||3
8344671|NCT01287520|20570889|P9|COMPLETED|Overall Study||0
8344672|NCT01287520|20570890|P8|COMPLETED|Overall Study||0
8344673|NCT01287520|20570891|P7|COMPLETED|Overall Study||0
8344674|NCT01287520|20570892|P6|COMPLETED|Overall Study||0
8344675|NCT01287520|20570893|P5|COMPLETED|Overall Study||0
8344676|NCT01287520|20570894|P4|COMPLETED|Overall Study||0
8344677|NCT01287520|20570895|P3|COMPLETED|Overall Study||0
8344678|NCT01287520|20570896|P2|COMPLETED|Overall Study||0
8344679|NCT01287520|20570897|P1|COMPLETED|Overall Study||0
8344680|NCT01287520|20570889|P9|STARTED|Overall Study||5
8344681|NCT01287520|20570890|P8|STARTED|Overall Study||5
8344682|NCT01287520|20570891|P7|STARTED|Overall Study||2
8344683|NCT01287520|20570892|P6|STARTED|Overall Study||4
8344684|NCT01287520|20570893|P5|STARTED|Overall Study||3
8344685|NCT01287520|20570894|P4|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
8344686|NCT01287520|20570895|P3|STARTED|Overall Study||5
8344687|NCT01287520|20570896|P2|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
8344688|NCT01287520|20570897|P1|STARTED|Overall Study||3
8344689|NCT01287416|20570961|P2|NOT COMPLETED|6 Month Follow-up||2
8344690|NCT01287416|20570962|P1|NOT COMPLETED|6 Month Follow-up||3
8344691|NCT01287416|20570961|P2|COMPLETED|6 Month Follow-up||22
8344692|NCT01287416|20570962|P1|COMPLETED|6 Month Follow-up||28
8344693|NCT01287416|20570961|P2|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
8344694|NCT01287416|20570962|P1|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
8344695|NCT01287416|20570961|P2|NOT COMPLETED|Pre-post Training||25
8344696|NCT01287416|20570962|P1|NOT COMPLETED|Pre-post Training||22
8344697|NCT01287416|20570961|P2|COMPLETED|Pre-post Training||23
8344698|NCT01287416|20570962|P1|COMPLETED|Pre-post Training||26
8344699|NCT01287416|20570961|P2|Post Training Questionnaire|Pre-post Training||23
8344700|NCT01287416|20570962|P1|Post Training Questionnaire|Pre-post Training||26
8344701|NCT01287416|20570961|P2|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
8344702|NCT01287416|20570962|P1|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
8344703|NCT01287416|20570961|P2|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
8344704|NCT01287416|20570962|P1|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
8344705|NCT01287403|20570998|P1|NOT COMPLETED|6th and Last Intervention (1 Day)||0
8344706|NCT01287403|20570998|P1|COMPLETED|6th and Last Intervention (1 Day)||13
8344707|NCT01287403|20570998|P1|STARTED|6th and Last Intervention (1 Day)||13
8344708|NCT01287403|20570998|P1|NOT COMPLETED|Washout (7 Days)||0
8344709|NCT01287403|20570998|P1|COMPLETED|Washout (7 Days)||13
8344710|NCT01287403|20570998|P1|STARTED|Washout (7 Days)||13
8344711|NCT01287403|20570998|P1|NOT COMPLETED|5th Intervention (1 Day)||0
8344712|NCT01287403|20570998|P1|COMPLETED|5th Intervention (1 Day)||13
8344713|NCT01287403|20570998|P1|STARTED|5th Intervention (1 Day)||13
8344714|NCT01287403|20570998|P1|NOT COMPLETED|Washout (7 Days)||0
8344715|NCT01287403|20570998|P1|COMPLETED|Washout (7 Days)||13
8344716|NCT01287403|20570998|P1|STARTED|Washout (7 Days)||13
8344717|NCT01287403|20570998|P1|NOT COMPLETED|4th Intervention (1 Day)||0
8344718|NCT01287403|20570998|P1|COMPLETED|4th Intervention (1 Day)||13
8344719|NCT01287403|20570998|P1|STARTED|4th Intervention (1 Day)||13
8344720|NCT01287403|20570998|P1|NOT COMPLETED|Washout (7 Days)||0
8344721|NCT01287403|20570998|P1|COMPLETED|Washout (7 Days)||13
8344722|NCT01287403|20570998|P1|STARTED|Washout (7 Days)||13
8344723|NCT01287403|20570998|P1|NOT COMPLETED|3rd Intervention (1 Day)||0
8344724|NCT01287403|20570998|P1|COMPLETED|3rd Intervention (1 Day)||13
8344725|NCT01287403|20570998|P1|STARTED|3rd Intervention (1 Day)||13
8344726|NCT01287403|20570998|P1|NOT COMPLETED|Washout (7 Days)||0
8344727|NCT01287403|20570998|P1|COMPLETED|Washout (7 Days)||13
8344728|NCT01287403|20570998|P1|STARTED|Washout (7 Days)||13
8344729|NCT01287403|20570998|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
8344730|NCT01287403|20570998|P1|COMPLETED|2nd Intervention (1 Day)||13
8344731|NCT01287403|20570998|P1|STARTED|2nd Intervention (1 Day)||13
8344732|NCT01287403|20570998|P1|NOT COMPLETED|Washout 7 Days||0
8344733|NCT01287403|20570998|P1|COMPLETED|Washout 7 Days||13
8344734|NCT01287403|20570998|P1|STARTED|Washout 7 Days||13
8344735|NCT01287403|20570998|P1|NOT COMPLETED|1st Intervention (1 Day)||1
8344736|NCT01287403|20570998|P1|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
8344737|NCT01287403|20570998|P1|STARTED|1st Intervention (1 Day)||14
8344738|NCT01287403|20570998|P1|NOT COMPLETED|Diet Restriction (7 Days)||0
8344739|NCT01287403|20570998|P1|COMPLETED|Diet Restriction (7 Days)||14
8344740|NCT01287403|20570998|P1|STARTED|Diet Restriction (7 Days)||14
8344741|NCT01287377|20571015|P3|NOT COMPLETED|Overall Study||0
8344742|NCT01287377|20571016|P2|NOT COMPLETED|Overall Study||0
8344743|NCT01287377|20571017|P1|NOT COMPLETED|Overall Study||0
8344744|NCT01287377|20571015|P3|COMPLETED|Overall Study|Study Complete|82
8344745|NCT01287377|20571016|P2|COMPLETED|Overall Study|Study Complete|81
8344746|NCT01287377|20571017|P1|COMPLETED|Overall Study|Study Complete|80
8344747|NCT01287377|20571015|P3|STARTED|Overall Study||82
8344748|NCT01287377|20571016|P2|STARTED|Overall Study||81
8344749|NCT01287377|20571017|P1|STARTED|Overall Study||80
8344750|NCT01287364|20571030|P2|NOT COMPLETED|Overall Study||10
8344751|NCT01287364|20571031|P1|NOT COMPLETED|Overall Study||9
8344752|NCT01287364|20571030|P2|COMPLETED|Overall Study||81
8344753|NCT01287364|20571031|P1|COMPLETED|Overall Study||85
8344754|NCT01287364|20571030|P2|STARTED|Overall Study||91
8344755|NCT01287364|20571031|P1|STARTED|Overall Study||94
8344756|NCT01287221|20571053|P2|NOT COMPLETED|Overall Study||5
8344757|NCT01287221|20571054|P1|NOT COMPLETED|Overall Study||4
8344758|NCT01287221|20571053|P2|COMPLETED|Overall Study||45
8344759|NCT01287221|20571054|P1|COMPLETED|Overall Study||46
8344760|NCT01287221|20571053|P2|Completed 12 Months Follow-up|Overall Study||39
8344761|NCT01287221|20571054|P1|Completed 12 Months Follow-up|Overall Study||40
8344762|NCT01287221|20571053|P2|Completed 9 Months Follow-up|Overall Study||40
8344763|NCT01287221|20571054|P1|Completed 9 Months Follow-up|Overall Study||42
8344764|NCT01287221|20571053|P2|Completed 6 Months Follow-up|Overall Study||43
8344765|NCT01287221|20571054|P1|Completed 6 Months Follow-up|Overall Study||47
8344766|NCT01287221|20571053|P2|Completed 3 Months Follow-up|Overall Study||50
8344767|NCT01287221|20571054|P1|Completed 3 Months Follow-up|Overall Study||49
8344768|NCT01287221|20571053|P2|STARTED|Overall Study||50
8344769|NCT01287221|20571054|P1|STARTED|Overall Study||50
8344770|NCT01287208|20571074|P2|NOT COMPLETED|Phase 2: Team Competition||0
8344771|NCT01287208|20571075|P1|NOT COMPLETED|Phase 2: Team Competition||0
8344772|NCT01287208|20571074|P2|COMPLETED|Phase 2: Team Competition||49
8344773|NCT01287208|20571075|P1|COMPLETED|Phase 2: Team Competition||50
8344774|NCT01287208|20571074|P2|STARTED|Phase 2: Team Competition||49
8344775|NCT01287208|20571075|P1|STARTED|Phase 2: Team Competition||50
8344776|NCT01287208|20571074|P2|NOT COMPLETED|Phase 1: Randomized Phase||3
8344777|NCT01287208|20571075|P1|NOT COMPLETED|Phase 1: Randomized Phase||2
8344778|NCT01287208|20571074|P2|COMPLETED|Phase 1: Randomized Phase||49
8344779|NCT01287208|20571075|P1|COMPLETED|Phase 1: Randomized Phase||50
8344780|NCT01287208|20571074|P2|STARTED|Phase 1: Randomized Phase||52
8344781|NCT01287208|20571075|P1|STARTED|Phase 1: Randomized Phase||52
8344782|NCT01287195|20571089|P1|NOT COMPLETED|Overall Study||2
8344783|NCT01287195|20571089|P1|COMPLETED|Overall Study||4
8344784|NCT01287195|20571089|P1|STARTED|Overall Study||6
8344785|NCT01287117|20571104|P4|NOT COMPLETED|Overall Study||12
8344786|NCT01287117|20571105|P3|NOT COMPLETED|Overall Study||16
8344787|NCT01287117|20571106|P2|NOT COMPLETED|Overall Study||14
8344788|NCT01287117|20571107|P1|NOT COMPLETED|Overall Study||15
8344789|NCT01287117|20571104|P4|COMPLETED|Overall Study||69
8344790|NCT01287117|20571105|P3|COMPLETED|Overall Study||64
8344791|NCT01287117|20571106|P2|COMPLETED|Overall Study||64
8344792|NCT01287117|20571107|P1|COMPLETED|Overall Study||65
8344793|NCT01287117|20571104|P4|Received Treatment|Overall Study||81
8344794|NCT01287117|20571105|P3|Received Treatment|Overall Study||80
8344795|NCT01287117|20571106|P2|Received Treatment|Overall Study||77
8344796|NCT01287117|20571107|P1|Received Treatment|Overall Study||80
8344797|NCT01287117|20571104|P4|STARTED|Overall Study||81
8344798|NCT01287117|20571105|P3|STARTED|Overall Study||80
8344799|NCT01287117|20571106|P2|STARTED|Overall Study||78
8344800|NCT01287117|20571107|P1|STARTED|Overall Study||80
8344801|NCT01287104|20571157|P4|NOT COMPLETED|Overall Study||3
8344802|NCT01287104|20571158|P3|NOT COMPLETED|Overall Study||7
8344803|NCT01287104|20571159|P2|NOT COMPLETED|Overall Study||5
8344804|NCT01287104|20571160|P1|NOT COMPLETED|Overall Study||1
8344805|NCT01287104|20571157|P4|COMPLETED|Overall Study||8
8344806|NCT01287104|20571158|P3|COMPLETED|Overall Study||5
8344807|NCT01287104|20571159|P2|COMPLETED|Overall Study||2
8344808|NCT01287104|20571160|P1|COMPLETED|Overall Study||3
8344809|NCT01287104|20571157|P4|STARTED|Overall Study||11
8344810|NCT01287104|20571158|P3|STARTED|Overall Study||12
8344811|NCT01287104|20571159|P2|STARTED|Overall Study||7
8344812|NCT01287104|20571160|P1|STARTED|Overall Study||4
8344813|NCT01287078|20571195|P2|NOT COMPLETED|Overall Study||2
8344814|NCT01287078|20571196|P1|NOT COMPLETED|Overall Study||10
8344815|NCT01287078|20571195|P2|COMPLETED|Overall Study||1
8344816|NCT01287078|20571196|P1|COMPLETED|Overall Study||10
8344817|NCT01287078|20571195|P2|STARTED|Overall Study||3
8344818|NCT01287078|20571196|P1|STARTED|Overall Study||20
8344819|NCT01287065|20571216|P6|NOT COMPLETED|Treatment Period 3||0
8344820|NCT01287065|20571217|P5|NOT COMPLETED|Treatment Period 3||0
8344821|NCT01287065|20571218|P4|NOT COMPLETED|Treatment Period 3||0
8344822|NCT01287065|20571219|P3|NOT COMPLETED|Treatment Period 3||0
8344823|NCT01287065|20571220|P2|NOT COMPLETED|Treatment Period 3||0
8344824|NCT01287065|20571221|P1|NOT COMPLETED|Treatment Period 3||0
8344825|NCT01287065|20571216|P6|COMPLETED|Treatment Period 3||4
8344826|NCT01287065|20571217|P5|COMPLETED|Treatment Period 3||4
8344827|NCT01287065|20571218|P4|COMPLETED|Treatment Period 3||4
8344828|NCT01287065|20571219|P3|COMPLETED|Treatment Period 3||4
8344829|NCT01287065|20571220|P2|COMPLETED|Treatment Period 3||4
8344830|NCT01287065|20571221|P1|COMPLETED|Treatment Period 3||4
8344831|NCT01287065|20571216|P6|STARTED|Treatment Period 3||4
8344832|NCT01287065|20571217|P5|STARTED|Treatment Period 3||4
8344833|NCT01287065|20571218|P4|STARTED|Treatment Period 3||4
8344834|NCT01287065|20571219|P3|STARTED|Treatment Period 3||4
8344835|NCT01287065|20571220|P2|STARTED|Treatment Period 3||4
8344836|NCT01287065|20571221|P1|STARTED|Treatment Period 3||4
8344837|NCT01287065|20571216|P6|NOT COMPLETED|Washout Period 2||0
8344838|NCT01287065|20571217|P5|NOT COMPLETED|Washout Period 2||0
8344839|NCT01287065|20571218|P4|NOT COMPLETED|Washout Period 2||0
8344840|NCT01287065|20571219|P3|NOT COMPLETED|Washout Period 2||0
8344841|NCT01287065|20571220|P2|NOT COMPLETED|Washout Period 2||0
8344842|NCT01287065|20571221|P1|NOT COMPLETED|Washout Period 2||0
8344843|NCT01287065|20571216|P6|COMPLETED|Washout Period 2||4
8344844|NCT01287065|20571217|P5|COMPLETED|Washout Period 2||4
8344845|NCT01287065|20571218|P4|COMPLETED|Washout Period 2||4
8344846|NCT01287065|20571219|P3|COMPLETED|Washout Period 2||4
8344847|NCT01287065|20571220|P2|COMPLETED|Washout Period 2||4
8344848|NCT01287065|20571221|P1|COMPLETED|Washout Period 2||4
8344849|NCT01287065|20571216|P6|STARTED|Washout Period 2||4
8344850|NCT01287065|20571217|P5|STARTED|Washout Period 2||4
8344851|NCT01287065|20571218|P4|STARTED|Washout Period 2||4
8344852|NCT01287065|20571219|P3|STARTED|Washout Period 2||4
8344853|NCT01287065|20571220|P2|STARTED|Washout Period 2||4
8344854|NCT01287065|20571221|P1|STARTED|Washout Period 2||4
8344855|NCT01287065|20571216|P6|NOT COMPLETED|Treatment Period 2||0
8344856|NCT01287065|20571217|P5|NOT COMPLETED|Treatment Period 2||0
8344857|NCT01287065|20571218|P4|NOT COMPLETED|Treatment Period 2||0
8344858|NCT01287065|20571219|P3|NOT COMPLETED|Treatment Period 2||0
8344859|NCT01287065|20571220|P2|NOT COMPLETED|Treatment Period 2||0
8344860|NCT01287065|20571221|P1|NOT COMPLETED|Treatment Period 2||0
8344861|NCT01287065|20571216|P6|COMPLETED|Treatment Period 2||4
8344862|NCT01287065|20571217|P5|COMPLETED|Treatment Period 2||4
8344863|NCT01287065|20571218|P4|COMPLETED|Treatment Period 2||4
8344864|NCT01287065|20571219|P3|COMPLETED|Treatment Period 2||4
8344865|NCT01287065|20571220|P2|COMPLETED|Treatment Period 2||4
8344866|NCT01287065|20571221|P1|COMPLETED|Treatment Period 2||4
8344867|NCT01287065|20571216|P6|STARTED|Treatment Period 2||4
8344868|NCT01287065|20571217|P5|STARTED|Treatment Period 2||4
8344869|NCT01287065|20571218|P4|STARTED|Treatment Period 2||4
8344870|NCT01287065|20571219|P3|STARTED|Treatment Period 2||4
8344871|NCT01287065|20571220|P2|STARTED|Treatment Period 2||4
8344872|NCT01287065|20571221|P1|STARTED|Treatment Period 2||4
8344873|NCT01287065|20571216|P6|NOT COMPLETED|Washout Period 1||0
8344874|NCT01287065|20571217|P5|NOT COMPLETED|Washout Period 1||0
8344875|NCT01287065|20571218|P4|NOT COMPLETED|Washout Period 1||0
8344876|NCT01287065|20571219|P3|NOT COMPLETED|Washout Period 1||0
8344877|NCT01287065|20571220|P2|NOT COMPLETED|Washout Period 1||0
8344878|NCT01287065|20571221|P1|NOT COMPLETED|Washout Period 1||0
8344879|NCT01287065|20571216|P6|COMPLETED|Washout Period 1||4
8344880|NCT01287065|20571217|P5|COMPLETED|Washout Period 1||4
8344881|NCT01287065|20571218|P4|COMPLETED|Washout Period 1||4
8344882|NCT01287065|20571219|P3|COMPLETED|Washout Period 1||4
8344883|NCT01287065|20571220|P2|COMPLETED|Washout Period 1||4
8344884|NCT01287065|20571221|P1|COMPLETED|Washout Period 1||4
8344885|NCT01287065|20571216|P6|STARTED|Washout Period 1||4
8344886|NCT01287065|20571217|P5|STARTED|Washout Period 1||4
8344887|NCT01287065|20571218|P4|STARTED|Washout Period 1||4
8344888|NCT01287065|20571219|P3|STARTED|Washout Period 1||4
8344889|NCT01287065|20571220|P2|STARTED|Washout Period 1||4
8344890|NCT01287065|20571221|P1|STARTED|Washout Period 1||4
8344891|NCT01287065|20571216|P6|NOT COMPLETED|Treatment Period 1||1
8344892|NCT01287065|20571217|P5|NOT COMPLETED|Treatment Period 1||1
8344893|NCT01287065|20571218|P4|NOT COMPLETED|Treatment Period 1||0
8344894|NCT01287065|20571219|P3|NOT COMPLETED|Treatment Period 1||0
8344895|NCT01287065|20571220|P2|NOT COMPLETED|Treatment Period 1||0
8344896|NCT01287065|20571221|P1|NOT COMPLETED|Treatment Period 1||0
8344897|NCT01287065|20571216|P6|COMPLETED|Treatment Period 1||4
8344898|NCT01287065|20571217|P5|COMPLETED|Treatment Period 1||4
8344899|NCT01287065|20571218|P4|COMPLETED|Treatment Period 1||4
8344900|NCT01287065|20571219|P3|COMPLETED|Treatment Period 1||4
8344901|NCT01287065|20571220|P2|COMPLETED|Treatment Period 1||4
8344902|NCT01287065|20571221|P1|COMPLETED|Treatment Period 1||4
8344903|NCT01287065|20571216|P6|STARTED|Treatment Period 1||5
8344904|NCT01287065|20571217|P5|STARTED|Treatment Period 1||5
8344905|NCT01287065|20571218|P4|STARTED|Treatment Period 1||4
8344906|NCT01287065|20571219|P3|STARTED|Treatment Period 1||4
8344907|NCT01287065|20571220|P2|STARTED|Treatment Period 1||4
8344908|NCT01287065|20571221|P1|STARTED|Treatment Period 1||4
8344909|NCT01287039|20571240|P2|NOT COMPLETED|Overall Study||27
8344910|NCT01287039|20571241|P1|NOT COMPLETED|Overall Study||29
8344911|NCT01287039|20571240|P2|COMPLETED|Overall Study||218
8344912|NCT01287039|20571241|P1|COMPLETED|Overall Study||215
8344913|NCT01287039|20571240|P2|STARTED|Overall Study||245
8344914|NCT01287039|20571241|P1|STARTED|Overall Study||244
8344915|NCT01287013|20571274|P3|NOT COMPLETED|Overall Study||21
8344916|NCT01287013|20571275|P2|NOT COMPLETED|Overall Study||5
8344917|NCT01287013|20571276|P1|NOT COMPLETED|Overall Study||3
8344918|NCT01287013|20571274|P3|COMPLETED|Overall Study||0
8344919|NCT01287013|20571275|P2|COMPLETED|Overall Study||29
8344920|NCT01287013|20571276|P1|COMPLETED|Overall Study||29
8344921|NCT01287013|20571274|P3|STARTED|Overall Study||21
8344922|NCT01287013|20571275|P2|STARTED|Overall Study||34
8344923|NCT01287013|20571276|P1|STARTED|Overall Study||32
8344924|NCT01286987|20571306|P15|NOT COMPLETED|Part 2: Dose Expansion||2
8344925|NCT01286987|20571307|P14|NOT COMPLETED|Part 2: Dose Expansion||24
8344926|NCT01286987|20571308|P13|NOT COMPLETED|Part 2: Dose Expansion||12
8344927|NCT01286987|20571309|P12|NOT COMPLETED|Part 2: Dose Expansion||10
8344928|NCT01286987|20571310|P11|NOT COMPLETED|Part 2: Dose Expansion||10
8344929|NCT01286987|20571311|P10|NOT COMPLETED|Part 2: Dose Expansion||11
8344930|NCT01286987|20571312|P9|NOT COMPLETED|Part 2: Dose Expansion||0
8344931|NCT01286987|20571313|P8|NOT COMPLETED|Part 2: Dose Expansion||0
8344932|NCT01286987|20571314|P7|NOT COMPLETED|Part 2: Dose Expansion||0
8344933|NCT01286987|20571315|P6|NOT COMPLETED|Part 2: Dose Expansion||0
8344934|NCT01286987|20571316|P5|NOT COMPLETED|Part 2: Dose Expansion||0
8344935|NCT01286987|20571317|P4|NOT COMPLETED|Part 2: Dose Expansion||0
8344936|NCT01286987|20571318|P3|NOT COMPLETED|Part 2: Dose Expansion||0
8344937|NCT01286987|20571319|P2|NOT COMPLETED|Part 2: Dose Expansion||0
8344938|NCT01286987|20571320|P1|NOT COMPLETED|Part 2: Dose Expansion||0
8344939|NCT01286987|20571306|P15|COMPLETED|Part 2: Dose Expansion||1
8344940|NCT01286987|20571307|P14|COMPLETED|Part 2: Dose Expansion||0
8344941|NCT01286987|20571308|P13|COMPLETED|Part 2: Dose Expansion||0
8344942|NCT01286987|20571309|P12|COMPLETED|Part 2: Dose Expansion||1
8344943|NCT01286987|20571310|P11|COMPLETED|Part 2: Dose Expansion||2
8344944|NCT01286987|20571311|P10|COMPLETED|Part 2: Dose Expansion||1
8344945|NCT01286987|20571312|P9|COMPLETED|Part 2: Dose Expansion||0
8344946|NCT01286987|20571313|P8|COMPLETED|Part 2: Dose Expansion||0
8344947|NCT01286987|20571314|P7|COMPLETED|Part 2: Dose Expansion||0
8344948|NCT01286987|20571315|P6|COMPLETED|Part 2: Dose Expansion||0
8344949|NCT01286987|20571316|P5|COMPLETED|Part 2: Dose Expansion||0
8344950|NCT01286987|20571317|P4|COMPLETED|Part 2: Dose Expansion||0
8344951|NCT01286987|20571318|P3|COMPLETED|Part 2: Dose Expansion||0
8344952|NCT01286987|20571319|P2|COMPLETED|Part 2: Dose Expansion||0
8344953|NCT01286987|20571320|P1|COMPLETED|Part 2: Dose Expansion||0
8344954|NCT01286987|20571306|P15|Treated|Part 2: Dose Expansion||3
8344955|NCT01286987|20571307|P14|Treated|Part 2: Dose Expansion||23
8344956|NCT01286987|20571308|P13|Treated|Part 2: Dose Expansion||12
8344957|NCT01286987|20571309|P12|Treated|Part 2: Dose Expansion||10
8344958|NCT01286987|20571310|P11|Treated|Part 2: Dose Expansion||11
8344959|NCT01286987|20571311|P10|Treated|Part 2: Dose Expansion||12
8344960|NCT01286987|20571312|P9|Treated|Part 2: Dose Expansion||0
8344961|NCT01286987|20571313|P8|Treated|Part 2: Dose Expansion||0
8344962|NCT01286987|20571314|P7|Treated|Part 2: Dose Expansion||0
8344963|NCT01286987|20571315|P6|Treated|Part 2: Dose Expansion||0
8344964|NCT01286987|20571316|P5|Treated|Part 2: Dose Expansion||0
8344965|NCT01286987|20571317|P4|Treated|Part 2: Dose Expansion||0
8344966|NCT01286987|20571318|P3|Treated|Part 2: Dose Expansion||0
8344967|NCT01286987|20571319|P2|Treated|Part 2: Dose Expansion||0
8344968|NCT01286987|20571320|P1|Treated|Part 2: Dose Expansion||0
8344969|NCT01286987|20571306|P15|STARTED|Part 2: Dose Expansion||3
8344970|NCT01286987|20571307|P14|STARTED|Part 2: Dose Expansion||24
8344971|NCT01286987|20571308|P13|STARTED|Part 2: Dose Expansion||12
8344972|NCT01286987|20571309|P12|STARTED|Part 2: Dose Expansion||11
8344973|NCT01286987|20571310|P11|STARTED|Part 2: Dose Expansion||12
8344974|NCT01286987|20571311|P10|STARTED|Part 2: Dose Expansion||12
8344975|NCT01286987|20571312|P9|STARTED|Part 2: Dose Expansion||0
8344976|NCT01286987|20571313|P8|STARTED|Part 2: Dose Expansion||0
8344977|NCT01286987|20571314|P7|STARTED|Part 2: Dose Expansion||0
8344978|NCT01286987|20571315|P6|STARTED|Part 2: Dose Expansion||0
8344979|NCT01286987|20571316|P5|STARTED|Part 2: Dose Expansion||0
8344980|NCT01286987|20571317|P4|STARTED|Part 2: Dose Expansion||0
8344981|NCT01286987|20571318|P3|STARTED|Part 2: Dose Expansion||0
8344982|NCT01286987|20571319|P2|STARTED|Part 2: Dose Expansion||0
8344983|NCT01286987|20571320|P1|STARTED|Part 2: Dose Expansion||0
8344984|NCT01286987|20571306|P15|NOT COMPLETED|Part 1: Dose Escalation||0
8344985|NCT01286987|20571307|P14|NOT COMPLETED|Part 1: Dose Escalation||0
8344986|NCT01286987|20571308|P13|NOT COMPLETED|Part 1: Dose Escalation||0
8344987|NCT01286987|20571309|P12|NOT COMPLETED|Part 1: Dose Escalation||0
8344988|NCT01286987|20571310|P11|NOT COMPLETED|Part 1: Dose Escalation||0
8344989|NCT01286987|20571311|P10|NOT COMPLETED|Part 1: Dose Escalation||0
8344990|NCT01286987|20571312|P9|NOT COMPLETED|Part 1: Dose Escalation||6
8344991|NCT01286987|20571313|P8|NOT COMPLETED|Part 1: Dose Escalation||5
8344992|NCT01286987|20571314|P7|NOT COMPLETED|Part 1: Dose Escalation||5
8344993|NCT01286987|20571315|P6|NOT COMPLETED|Part 1: Dose Escalation||6
8344994|NCT01286987|20571316|P5|NOT COMPLETED|Part 1: Dose Escalation||3
8344995|NCT01286987|20571317|P4|NOT COMPLETED|Part 1: Dose Escalation||3
8344996|NCT01286987|20571318|P3|NOT COMPLETED|Part 1: Dose Escalation||3
8344997|NCT01286987|20571319|P2|NOT COMPLETED|Part 1: Dose Escalation||3
8344998|NCT01286987|20571320|P1|NOT COMPLETED|Part 1: Dose Escalation||3
8344999|NCT01286987|20571306|P15|COMPLETED|Part 1: Dose Escalation||0
8345000|NCT01286987|20571307|P14|COMPLETED|Part 1: Dose Escalation||0
8345001|NCT01286987|20571308|P13|COMPLETED|Part 1: Dose Escalation||0
8345002|NCT01286987|20571309|P12|COMPLETED|Part 1: Dose Escalation||0
8345003|NCT01286987|20571310|P11|COMPLETED|Part 1: Dose Escalation||0
8345004|NCT01286987|20571311|P10|COMPLETED|Part 1: Dose Escalation||0
8345005|NCT01286987|20571312|P9|COMPLETED|Part 1: Dose Escalation||0
8345006|NCT01286987|20571313|P8|COMPLETED|Part 1: Dose Escalation||1
8345007|NCT01286987|20571314|P7|COMPLETED|Part 1: Dose Escalation||1
8345008|NCT01286987|20571315|P6|COMPLETED|Part 1: Dose Escalation||0
8345009|NCT01286987|20571316|P5|COMPLETED|Part 1: Dose Escalation||0
8345010|NCT01286987|20571317|P4|COMPLETED|Part 1: Dose Escalation||0
8345011|NCT01286987|20571318|P3|COMPLETED|Part 1: Dose Escalation||0
8345012|NCT01286987|20571319|P2|COMPLETED|Part 1: Dose Escalation||0
8345013|NCT01286987|20571320|P1|COMPLETED|Part 1: Dose Escalation||0
8345014|NCT01286987|20571306|P15|Breast Cancer|Part 1: Dose Escalation||0
8345015|NCT01286987|20571307|P14|Breast Cancer|Part 1: Dose Escalation||0
8345016|NCT01286987|20571308|P13|Breast Cancer|Part 1: Dose Escalation||0
8345017|NCT01286987|20571309|P12|Breast Cancer|Part 1: Dose Escalation||0
8345018|NCT01286987|20571310|P11|Breast Cancer|Part 1: Dose Escalation||0
8345019|NCT01286987|20571311|P10|Breast Cancer|Part 1: Dose Escalation||0
8345020|NCT01286987|20571312|P9|Breast Cancer|Part 1: Dose Escalation||3
8345021|NCT01286987|20571313|P8|Breast Cancer|Part 1: Dose Escalation||2
8345022|NCT01286987|20571314|P7|Breast Cancer|Part 1: Dose Escalation||2
8345023|NCT01286987|20571315|P6|Breast Cancer|Part 1: Dose Escalation||1
8345024|NCT01286987|20571316|P5|Breast Cancer|Part 1: Dose Escalation||0
8345025|NCT01286987|20571317|P4|Breast Cancer|Part 1: Dose Escalation||0
8345026|NCT01286987|20571318|P3|Breast Cancer|Part 1: Dose Escalation||0
8345027|NCT01286987|20571319|P2|Breast Cancer|Part 1: Dose Escalation||0
8345028|NCT01286987|20571320|P1|Breast Cancer|Part 1: Dose Escalation||0
8345029|NCT01286987|20571306|P15|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8345030|NCT01286987|20571307|P14|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8345031|NCT01286987|20571308|P13|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8345032|NCT01286987|20571309|P12|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8345033|NCT01286987|20571310|P11|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8345034|NCT01286987|20571311|P10|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
8345035|NCT01286987|20571312|P9|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
8345036|NCT01286987|20571313|P8|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
8345037|NCT01286987|20571314|P7|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
8345038|NCT01286987|20571315|P6|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
8345039|NCT01286987|20571316|P5|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
8345040|NCT01286987|20571317|P4|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
8345041|NCT01286987|20571318|P3|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
8345042|NCT01286987|20571319|P2|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
8345043|NCT01286987|20571320|P1|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
8345044|NCT01286987|20571306|P15|Pancreatic Cancer|Part 1: Dose Escalation||0
8345045|NCT01286987|20571307|P14|Pancreatic Cancer|Part 1: Dose Escalation||0
8345046|NCT01286987|20571308|P13|Pancreatic Cancer|Part 1: Dose Escalation||0
8345047|NCT01286987|20571309|P12|Pancreatic Cancer|Part 1: Dose Escalation||0
8345048|NCT01286987|20571310|P11|Pancreatic Cancer|Part 1: Dose Escalation||0
8345049|NCT01286987|20571311|P10|Pancreatic Cancer|Part 1: Dose Escalation||0
8345050|NCT01286987|20571312|P9|Pancreatic Cancer|Part 1: Dose Escalation||0
8345051|NCT01286987|20571313|P8|Pancreatic Cancer|Part 1: Dose Escalation||0
8345052|NCT01286987|20571314|P7|Pancreatic Cancer|Part 1: Dose Escalation||0
8345053|NCT01286987|20571315|P6|Pancreatic Cancer|Part 1: Dose Escalation||0
8345054|NCT01286987|20571316|P5|Pancreatic Cancer|Part 1: Dose Escalation||0
8345055|NCT01286987|20571317|P4|Pancreatic Cancer|Part 1: Dose Escalation||0
8345056|NCT01286987|20571318|P3|Pancreatic Cancer|Part 1: Dose Escalation||0
8345057|NCT01286987|20571319|P2|Pancreatic Cancer|Part 1: Dose Escalation||2
8345058|NCT01286987|20571320|P1|Pancreatic Cancer|Part 1: Dose Escalation||1
8345059|NCT01286987|20571306|P15|Ewing Cancer|Part 1: Dose Escalation||0
8345060|NCT01286987|20571307|P14|Ewing Cancer|Part 1: Dose Escalation||0
8345061|NCT01286987|20571308|P13|Ewing Cancer|Part 1: Dose Escalation||0
8345062|NCT01286987|20571309|P12|Ewing Cancer|Part 1: Dose Escalation||0
8345063|NCT01286987|20571310|P11|Ewing Cancer|Part 1: Dose Escalation||0
8345064|NCT01286987|20571311|P10|Ewing Cancer|Part 1: Dose Escalation||0
8345065|NCT01286987|20571312|P9|Ewing Cancer|Part 1: Dose Escalation||1
8345066|NCT01286987|20571313|P8|Ewing Cancer|Part 1: Dose Escalation||1
8345067|NCT01286987|20571314|P7|Ewing Cancer|Part 1: Dose Escalation||0
8345068|NCT01286987|20571315|P6|Ewing Cancer|Part 1: Dose Escalation||0
8345069|NCT01286987|20571316|P5|Ewing Cancer|Part 1: Dose Escalation||0
8345070|NCT01286987|20571317|P4|Ewing Cancer|Part 1: Dose Escalation||0
8345071|NCT01286987|20571318|P3|Ewing Cancer|Part 1: Dose Escalation||0
8345072|NCT01286987|20571319|P2|Ewing Cancer|Part 1: Dose Escalation||0
8345073|NCT01286987|20571320|P1|Ewing Cancer|Part 1: Dose Escalation||0
8345074|NCT01286987|20571306|P15|Prostate Cancer|Part 1: Dose Escalation||0
8345075|NCT01286987|20571307|P14|Prostate Cancer|Part 1: Dose Escalation||0
8345076|NCT01286987|20571308|P13|Prostate Cancer|Part 1: Dose Escalation||0
8345077|NCT01286987|20571309|P12|Prostate Cancer|Part 1: Dose Escalation||0
8345078|NCT01286987|20571310|P11|Prostate Cancer|Part 1: Dose Escalation||0
8345079|NCT01286987|20571311|P10|Prostate Cancer|Part 1: Dose Escalation||0
8345080|NCT01286987|20571312|P9|Prostate Cancer|Part 1: Dose Escalation||0
8345081|NCT01286987|20571313|P8|Prostate Cancer|Part 1: Dose Escalation||0
8345082|NCT01286987|20571314|P7|Prostate Cancer|Part 1: Dose Escalation||0
8345083|NCT01286987|20571315|P6|Prostate Cancer|Part 1: Dose Escalation||1
8345084|NCT01286987|20571316|P5|Prostate Cancer|Part 1: Dose Escalation||0
8345085|NCT01286987|20571317|P4|Prostate Cancer|Part 1: Dose Escalation||0
8345086|NCT01286987|20571318|P3|Prostate Cancer|Part 1: Dose Escalation||0
8345087|NCT01286987|20571319|P2|Prostate Cancer|Part 1: Dose Escalation||0
8345088|NCT01286987|20571320|P1|Prostate Cancer|Part 1: Dose Escalation||0
8345089|NCT01286987|20571306|P15|Colorectal Cancer|Part 1: Dose Escalation||0
8345090|NCT01286987|20571307|P14|Colorectal Cancer|Part 1: Dose Escalation||0
8345091|NCT01286987|20571308|P13|Colorectal Cancer|Part 1: Dose Escalation||0
8345092|NCT01286987|20571309|P12|Colorectal Cancer|Part 1: Dose Escalation||0
8345093|NCT01286987|20571310|P11|Colorectal Cancer|Part 1: Dose Escalation||0
8345094|NCT01286987|20571311|P10|Colorectal Cancer|Part 1: Dose Escalation||0
8345095|NCT01286987|20571312|P9|Colorectal Cancer|Part 1: Dose Escalation||0
8345096|NCT01286987|20571313|P8|Colorectal Cancer|Part 1: Dose Escalation||0
8345097|NCT01286987|20571314|P7|Colorectal Cancer|Part 1: Dose Escalation||0
8345098|NCT01286987|20571315|P6|Colorectal Cancer|Part 1: Dose Escalation||0
8345099|NCT01286987|20571316|P5|Colorectal Cancer|Part 1: Dose Escalation||0
8345100|NCT01286987|20571317|P4|Colorectal Cancer|Part 1: Dose Escalation||0
8345101|NCT01286987|20571318|P3|Colorectal Cancer|Part 1: Dose Escalation||1
8345102|NCT01286987|20571319|P2|Colorectal Cancer|Part 1: Dose Escalation||0
8345103|NCT01286987|20571320|P1|Colorectal Cancer|Part 1: Dose Escalation||1
8345104|NCT01286987|20571306|P15|STARTED|Part 1: Dose Escalation||0
8345105|NCT01286987|20571307|P14|STARTED|Part 1: Dose Escalation||0
8345106|NCT01286987|20571308|P13|STARTED|Part 1: Dose Escalation||0
8345107|NCT01286987|20571309|P12|STARTED|Part 1: Dose Escalation||0
8345108|NCT01286987|20571310|P11|STARTED|Part 1: Dose Escalation||0
8345109|NCT01286987|20571311|P10|STARTED|Part 1: Dose Escalation||0
8345110|NCT01286987|20571312|P9|STARTED|Part 1: Dose Escalation||6
8345111|NCT01286987|20571313|P8|STARTED|Part 1: Dose Escalation||6
8345112|NCT01286987|20571314|P7|STARTED|Part 1: Dose Escalation||6
8345113|NCT01286987|20571315|P6|STARTED|Part 1: Dose Escalation||6
8345114|NCT01286987|20571316|P5|STARTED|Part 1: Dose Escalation||3
8345115|NCT01286987|20571317|P4|STARTED|Part 1: Dose Escalation||3
8345116|NCT01286987|20571318|P3|STARTED|Part 1: Dose Escalation||3
8345117|NCT01286987|20571319|P2|STARTED|Part 1: Dose Escalation||3
8345118|NCT01286987|20571320|P1|STARTED|Part 1: Dose Escalation||3
8345119|NCT01286870|20571461|P1|NOT COMPLETED|Overall Study||0
8345120|NCT01286870|20571461|P1|COMPLETED|Overall Study||11
8345121|NCT01286870|20571461|P1|STARTED|Overall Study||11
8345122|NCT01286818|20571466|P1|NOT COMPLETED|Overall Study||0
8345123|NCT01286818|20571466|P1|COMPLETED|Overall Study||6
8345124|NCT01286818|20571466|P1|Completed DLT Assessment Period|Overall Study||5
8345125|NCT01286818|20571466|P1|STARTED|Overall Study||6
8345126|NCT01286805|20571480|P2|NOT COMPLETED|Overall Study||1
8345127|NCT01286805|20571481|P1|NOT COMPLETED|Overall Study||0
8345128|NCT01286805|20571480|P2|COMPLETED|Overall Study||41
8345129|NCT01286805|20571481|P1|COMPLETED|Overall Study||41
8345130|NCT01286805|20571480|P2|STARTED|Overall Study||42
8345131|NCT01286805|20571481|P1|STARTED|Overall Study||41
8345135|NCT01286753|20571553|P2|NOT COMPLETED|Overall Study||25
8345136|NCT01286753|20571554|P1|NOT COMPLETED|Overall Study||26
8345137|NCT01286753|20571553|P2|COMPLETED|Overall Study||0
8345138|NCT01286753|20571554|P1|COMPLETED|Overall Study||0
8345139|NCT01286753|20571553|P2|STARTED|Overall Study||25
8345140|NCT01286753|20571554|P1|STARTED|Overall Study||26
8345141|NCT01286740|20571572|P1|NOT COMPLETED|Overall Study||2
8345142|NCT01286740|20571572|P1|COMPLETED|Overall Study||48
8345143|NCT01286740|20571572|P1|Week 12 (Primary Endpoint)|Overall Study||49
8345144|NCT01286740|20571572|P1|Enrolled and Treated|Overall Study||49
8345145|NCT01286740|20571572|P1|STARTED|Overall Study||50
8345146|NCT01286558|20571590|P2|NOT COMPLETED|Overall Study||2
8345147|NCT01286558|20571591|P1|NOT COMPLETED|Overall Study||1
8345148|NCT01286558|20571590|P2|COMPLETED|Overall Study||111
8345149|NCT01286558|20571591|P1|COMPLETED|Overall Study||111
8345150|NCT01286558|20571590|P2|STARTED|Overall Study||113
8345151|NCT01286558|20571591|P1|STARTED|Overall Study||112
8345152|NCT01286493|20571621|P1|NOT COMPLETED|Overall Study||3
8345153|NCT01286493|20571621|P1|COMPLETED|Overall Study||30
8345154|NCT01286493|20571621|P1|STARTED|Overall Study||33
8345155|NCT01286480|20571627|P2|NOT COMPLETED|Overall Study||3
8345156|NCT01286480|20571628|P1|NOT COMPLETED|Overall Study||5
8345157|NCT01286480|20571627|P2|COMPLETED|Overall Study||31
8345158|NCT01286480|20571628|P1|COMPLETED|Overall Study||27
8345159|NCT01286480|20571627|P2|STARTED|Overall Study||34
8345160|NCT01286480|20571628|P1|STARTED|Overall Study||32
8345161|NCT01286454|20571636|P11|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345162|NCT01286454|20571637|P10|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345163|NCT01286454|20571638|P9|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345164|NCT01286454|20571639|P8|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345165|NCT01286454|20571640|P7|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345166|NCT01286454|20571641|P6|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345167|NCT01286454|20571642|P5|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345168|NCT01286454|20571643|P4|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345169|NCT01286454|20571644|P3|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345170|NCT01286454|20571645|P2|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345171|NCT01286454|20571646|P1|NOT COMPLETED|Part II- Sixth Intervention Period||0
8345172|NCT01286454|20571636|P11|COMPLETED|Part II- Sixth Intervention Period||20
8345173|NCT01286454|20571637|P10|COMPLETED|Part II- Sixth Intervention Period||0
8345174|NCT01286454|20571638|P9|COMPLETED|Part II- Sixth Intervention Period||0
8345175|NCT01286454|20571639|P8|COMPLETED|Part II- Sixth Intervention Period||0
8345176|NCT01286454|20571640|P7|COMPLETED|Part II- Sixth Intervention Period||0
8345177|NCT01286454|20571641|P6|COMPLETED|Part II- Sixth Intervention Period||0
8345178|NCT01286454|20571642|P5|COMPLETED|Part II- Sixth Intervention Period||0
8345179|NCT01286454|20571643|P4|COMPLETED|Part II- Sixth Intervention Period||0
8345180|NCT01286454|20571644|P3|COMPLETED|Part II- Sixth Intervention Period||0
8345181|NCT01286454|20571645|P2|COMPLETED|Part II- Sixth Intervention Period||0
8345182|NCT01286454|20571646|P1|COMPLETED|Part II- Sixth Intervention Period||0
8345183|NCT01286454|20571636|P11|STARTED|Part II- Sixth Intervention Period||20
8345184|NCT01286454|20571637|P10|STARTED|Part II- Sixth Intervention Period||0
8345185|NCT01286454|20571638|P9|STARTED|Part II- Sixth Intervention Period||0
8345186|NCT01286454|20571639|P8|STARTED|Part II- Sixth Intervention Period||0
8345187|NCT01286454|20571640|P7|STARTED|Part II- Sixth Intervention Period||0
8345188|NCT01286454|20571641|P6|STARTED|Part II- Sixth Intervention Period||0
8345189|NCT01286454|20571642|P5|STARTED|Part II- Sixth Intervention Period||0
8345190|NCT01286454|20571643|P4|STARTED|Part II- Sixth Intervention Period||0
8345191|NCT01286454|20571644|P3|STARTED|Part II- Sixth Intervention Period||0
8345192|NCT01286454|20571645|P2|STARTED|Part II- Sixth Intervention Period||0
8345193|NCT01286454|20571646|P1|STARTED|Part II- Sixth Intervention Period||0
8345194|NCT01286454|20571636|P11|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345195|NCT01286454|20571637|P10|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345196|NCT01286454|20571638|P9|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345197|NCT01286454|20571639|P8|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345198|NCT01286454|20571640|P7|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345199|NCT01286454|20571641|P6|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345200|NCT01286454|20571642|P5|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345201|NCT01286454|20571643|P4|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345202|NCT01286454|20571644|P3|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345203|NCT01286454|20571645|P2|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345204|NCT01286454|20571646|P1|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345205|NCT01286454|20571636|P11|COMPLETED|Washout Period (Approximately 2 Weeks)||0
8345206|NCT01286454|20571637|P10|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345207|NCT01286454|20571638|P9|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345208|NCT01286454|20571639|P8|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345209|NCT01286454|20571640|P7|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345210|NCT01286454|20571641|P6|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345211|NCT01286454|20571642|P5|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345212|NCT01286454|20571643|P4|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345213|NCT01286454|20571644|P3|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345214|NCT01286454|20571645|P2|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345215|NCT01286454|20571646|P1|COMPLETED|Washout Period (Approximately 2 Weeks)||2
8345216|NCT01286454|20571636|P11|STARTED|Washout Period (Approximately 2 Weeks)||0
8345217|NCT01286454|20571637|P10|STARTED|Washout Period (Approximately 2 Weeks)||2
8345218|NCT01286454|20571638|P9|STARTED|Washout Period (Approximately 2 Weeks)||2
8345219|NCT01286454|20571639|P8|STARTED|Washout Period (Approximately 2 Weeks)||2
8345220|NCT01286454|20571640|P7|STARTED|Washout Period (Approximately 2 Weeks)||2
8345221|NCT01286454|20571641|P6|STARTED|Washout Period (Approximately 2 Weeks)||2
8345222|NCT01286454|20571642|P5|STARTED|Washout Period (Approximately 2 Weeks)||2
8345223|NCT01286454|20571643|P4|STARTED|Washout Period (Approximately 2 Weeks)||2
8345224|NCT01286454|20571644|P3|STARTED|Washout Period (Approximately 2 Weeks)||2
8345225|NCT01286454|20571645|P2|STARTED|Washout Period (Approximately 2 Weeks)||2
8345226|NCT01286454|20571646|P1|STARTED|Washout Period (Approximately 2 Weeks)||2
8345227|NCT01286454|20571636|P11|NOT COMPLETED|Fifth Intervention Period||0
8345228|NCT01286454|20571637|P10|NOT COMPLETED|Fifth Intervention Period||0
8345229|NCT01286454|20571638|P9|NOT COMPLETED|Fifth Intervention Period||0
8345230|NCT01286454|20571639|P8|NOT COMPLETED|Fifth Intervention Period||0
8345231|NCT01286454|20571640|P7|NOT COMPLETED|Fifth Intervention Period||0
8345232|NCT01286454|20571641|P6|NOT COMPLETED|Fifth Intervention Period||0
8345233|NCT01286454|20571642|P5|NOT COMPLETED|Fifth Intervention Period||0
8345234|NCT01286454|20571643|P4|NOT COMPLETED|Fifth Intervention Period||0
8345235|NCT01286454|20571644|P3|NOT COMPLETED|Fifth Intervention Period||0
8345236|NCT01286454|20571645|P2|NOT COMPLETED|Fifth Intervention Period||0
8345237|NCT01286454|20571646|P1|NOT COMPLETED|Fifth Intervention Period||0
8345238|NCT01286454|20571636|P11|COMPLETED|Fifth Intervention Period||0
8345239|NCT01286454|20571637|P10|COMPLETED|Fifth Intervention Period||2
8345240|NCT01286454|20571638|P9|COMPLETED|Fifth Intervention Period||2
8345241|NCT01286454|20571639|P8|COMPLETED|Fifth Intervention Period||2
8345242|NCT01286454|20571640|P7|COMPLETED|Fifth Intervention Period||2
8345243|NCT01286454|20571641|P6|COMPLETED|Fifth Intervention Period||2
8345244|NCT01286454|20571642|P5|COMPLETED|Fifth Intervention Period||2
8345245|NCT01286454|20571643|P4|COMPLETED|Fifth Intervention Period||2
8345246|NCT01286454|20571644|P3|COMPLETED|Fifth Intervention Period||2
8345247|NCT01286454|20571645|P2|COMPLETED|Fifth Intervention Period||2
8345248|NCT01286454|20571646|P1|COMPLETED|Fifth Intervention Period||2
8345249|NCT01286454|20571636|P11|STARTED|Fifth Intervention Period||0
8345250|NCT01286454|20571637|P10|STARTED|Fifth Intervention Period||2
8345251|NCT01286454|20571638|P9|STARTED|Fifth Intervention Period||2
8345252|NCT01286454|20571639|P8|STARTED|Fifth Intervention Period||2
8345253|NCT01286454|20571640|P7|STARTED|Fifth Intervention Period||2
8345254|NCT01286454|20571641|P6|STARTED|Fifth Intervention Period||2
8345255|NCT01286454|20571642|P5|STARTED|Fifth Intervention Period||2
8345256|NCT01286454|20571643|P4|STARTED|Fifth Intervention Period||2
8345257|NCT01286454|20571644|P3|STARTED|Fifth Intervention Period||2
8345258|NCT01286454|20571645|P2|STARTED|Fifth Intervention Period||2
8345259|NCT01286454|20571646|P1|STARTED|Fifth Intervention Period||2
8345260|NCT01286454|20571636|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345261|NCT01286454|20571637|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345262|NCT01286454|20571638|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345263|NCT01286454|20571639|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345264|NCT01286454|20571640|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345265|NCT01286454|20571641|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345266|NCT01286454|20571642|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345267|NCT01286454|20571643|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345268|NCT01286454|20571644|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345269|NCT01286454|20571645|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345270|NCT01286454|20571646|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345271|NCT01286454|20571636|P11|COMPLETED|Washout Period (At Least 3 Days)||0
8345272|NCT01286454|20571637|P10|COMPLETED|Washout Period (At Least 3 Days)||2
8345273|NCT01286454|20571638|P9|COMPLETED|Washout Period (At Least 3 Days)||2
8345274|NCT01286454|20571639|P8|COMPLETED|Washout Period (At Least 3 Days)||2
8345275|NCT01286454|20571640|P7|COMPLETED|Washout Period (At Least 3 Days)||2
8345276|NCT01286454|20571641|P6|COMPLETED|Washout Period (At Least 3 Days)||2
8345277|NCT01286454|20571642|P5|COMPLETED|Washout Period (At Least 3 Days)||2
8345278|NCT01286454|20571643|P4|COMPLETED|Washout Period (At Least 3 Days)||2
8345279|NCT01286454|20571644|P3|COMPLETED|Washout Period (At Least 3 Days)||2
8345280|NCT01286454|20571645|P2|COMPLETED|Washout Period (At Least 3 Days)||2
8345281|NCT01286454|20571646|P1|COMPLETED|Washout Period (At Least 3 Days)||2
8345282|NCT01286454|20571636|P11|STARTED|Washout Period (At Least 3 Days)||0
8345283|NCT01286454|20571637|P10|STARTED|Washout Period (At Least 3 Days)||2
8345284|NCT01286454|20571638|P9|STARTED|Washout Period (At Least 3 Days)||2
8345285|NCT01286454|20571639|P8|STARTED|Washout Period (At Least 3 Days)||2
8345286|NCT01286454|20571640|P7|STARTED|Washout Period (At Least 3 Days)||2
8345287|NCT01286454|20571641|P6|STARTED|Washout Period (At Least 3 Days)||2
8345288|NCT01286454|20571642|P5|STARTED|Washout Period (At Least 3 Days)||2
8345289|NCT01286454|20571643|P4|STARTED|Washout Period (At Least 3 Days)||2
8345290|NCT01286454|20571644|P3|STARTED|Washout Period (At Least 3 Days)||2
8345291|NCT01286454|20571645|P2|STARTED|Washout Period (At Least 3 Days)||2
8345292|NCT01286454|20571646|P1|STARTED|Washout Period (At Least 3 Days)||2
8345293|NCT01286454|20571636|P11|NOT COMPLETED|Fourth Intervention Period||0
8345294|NCT01286454|20571637|P10|NOT COMPLETED|Fourth Intervention Period||0
8345295|NCT01286454|20571638|P9|NOT COMPLETED|Fourth Intervention Period||0
8345296|NCT01286454|20571639|P8|NOT COMPLETED|Fourth Intervention Period||0
8345297|NCT01286454|20571640|P7|NOT COMPLETED|Fourth Intervention Period||0
8345298|NCT01286454|20571641|P6|NOT COMPLETED|Fourth Intervention Period||0
8345299|NCT01286454|20571642|P5|NOT COMPLETED|Fourth Intervention Period||0
8345300|NCT01286454|20571643|P4|NOT COMPLETED|Fourth Intervention Period||0
8345301|NCT01286454|20571644|P3|NOT COMPLETED|Fourth Intervention Period||0
8345302|NCT01286454|20571645|P2|NOT COMPLETED|Fourth Intervention Period||0
8345303|NCT01286454|20571646|P1|NOT COMPLETED|Fourth Intervention Period||0
8345304|NCT01286454|20571636|P11|COMPLETED|Fourth Intervention Period||0
8345305|NCT01286454|20571637|P10|COMPLETED|Fourth Intervention Period||2
8345306|NCT01286454|20571638|P9|COMPLETED|Fourth Intervention Period||2
8345307|NCT01286454|20571639|P8|COMPLETED|Fourth Intervention Period||2
8345308|NCT01286454|20571640|P7|COMPLETED|Fourth Intervention Period||2
8345309|NCT01286454|20571641|P6|COMPLETED|Fourth Intervention Period||2
8345310|NCT01286454|20571642|P5|COMPLETED|Fourth Intervention Period||2
8345311|NCT01286454|20571643|P4|COMPLETED|Fourth Intervention Period||2
8345312|NCT01286454|20571644|P3|COMPLETED|Fourth Intervention Period||2
8345313|NCT01286454|20571645|P2|COMPLETED|Fourth Intervention Period||2
8345314|NCT01286454|20571646|P1|COMPLETED|Fourth Intervention Period||2
8345315|NCT01286454|20571636|P11|STARTED|Fourth Intervention Period||0
8345316|NCT01286454|20571637|P10|STARTED|Fourth Intervention Period||2
8345317|NCT01286454|20571638|P9|STARTED|Fourth Intervention Period||2
8345318|NCT01286454|20571639|P8|STARTED|Fourth Intervention Period||2
8345319|NCT01286454|20571640|P7|STARTED|Fourth Intervention Period||2
8345320|NCT01286454|20571641|P6|STARTED|Fourth Intervention Period||2
8345321|NCT01286454|20571642|P5|STARTED|Fourth Intervention Period||2
8345322|NCT01286454|20571643|P4|STARTED|Fourth Intervention Period||2
8345323|NCT01286454|20571644|P3|STARTED|Fourth Intervention Period||2
8345324|NCT01286454|20571645|P2|STARTED|Fourth Intervention Period||2
8345325|NCT01286454|20571646|P1|STARTED|Fourth Intervention Period||2
8345326|NCT01286454|20571636|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345327|NCT01286454|20571637|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345328|NCT01286454|20571638|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345329|NCT01286454|20571639|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345330|NCT01286454|20571640|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345331|NCT01286454|20571641|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345332|NCT01286454|20571642|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345333|NCT01286454|20571643|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345334|NCT01286454|20571644|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345335|NCT01286454|20571645|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345336|NCT01286454|20571646|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345337|NCT01286454|20571636|P11|COMPLETED|Washout Period (At Least 3 Days)||0
8345338|NCT01286454|20571637|P10|COMPLETED|Washout Period (At Least 3 Days)||2
8345339|NCT01286454|20571638|P9|COMPLETED|Washout Period (At Least 3 Days)||2
8345340|NCT01286454|20571639|P8|COMPLETED|Washout Period (At Least 3 Days)||2
8345341|NCT01286454|20571640|P7|COMPLETED|Washout Period (At Least 3 Days)||2
8345342|NCT01286454|20571641|P6|COMPLETED|Washout Period (At Least 3 Days)||2
8345343|NCT01286454|20571642|P5|COMPLETED|Washout Period (At Least 3 Days)||2
8345344|NCT01286454|20571643|P4|COMPLETED|Washout Period (At Least 3 Days)||2
8345345|NCT01286454|20571644|P3|COMPLETED|Washout Period (At Least 3 Days)||2
8345346|NCT01286454|20571645|P2|COMPLETED|Washout Period (At Least 3 Days)||2
8345347|NCT01286454|20571646|P1|COMPLETED|Washout Period (At Least 3 Days)||2
8345348|NCT01286454|20571636|P11|STARTED|Washout Period (At Least 3 Days)||0
8345349|NCT01286454|20571637|P10|STARTED|Washout Period (At Least 3 Days)||2
8345350|NCT01286454|20571638|P9|STARTED|Washout Period (At Least 3 Days)||2
8345351|NCT01286454|20571639|P8|STARTED|Washout Period (At Least 3 Days)||2
8345352|NCT01286454|20571640|P7|STARTED|Washout Period (At Least 3 Days)||2
8345353|NCT01286454|20571641|P6|STARTED|Washout Period (At Least 3 Days)||2
8345354|NCT01286454|20571642|P5|STARTED|Washout Period (At Least 3 Days)||2
8345355|NCT01286454|20571643|P4|STARTED|Washout Period (At Least 3 Days)||2
8345356|NCT01286454|20571644|P3|STARTED|Washout Period (At Least 3 Days)||2
8345357|NCT01286454|20571645|P2|STARTED|Washout Period (At Least 3 Days)||2
8345358|NCT01286454|20571646|P1|STARTED|Washout Period (At Least 3 Days)||2
8345359|NCT01286454|20571636|P11|NOT COMPLETED|Third Intervention Period||0
8345360|NCT01286454|20571637|P10|NOT COMPLETED|Third Intervention Period||0
8345361|NCT01286454|20571638|P9|NOT COMPLETED|Third Intervention Period||0
8345362|NCT01286454|20571639|P8|NOT COMPLETED|Third Intervention Period||0
8345363|NCT01286454|20571640|P7|NOT COMPLETED|Third Intervention Period||0
8345364|NCT01286454|20571641|P6|NOT COMPLETED|Third Intervention Period||0
8345365|NCT01286454|20571642|P5|NOT COMPLETED|Third Intervention Period||0
8345366|NCT01286454|20571643|P4|NOT COMPLETED|Third Intervention Period||0
8345367|NCT01286454|20571644|P3|NOT COMPLETED|Third Intervention Period||0
8345368|NCT01286454|20571645|P2|NOT COMPLETED|Third Intervention Period||0
8345369|NCT01286454|20571646|P1|NOT COMPLETED|Third Intervention Period||0
8345370|NCT01286454|20571636|P11|COMPLETED|Third Intervention Period||0
8345371|NCT01286454|20571637|P10|COMPLETED|Third Intervention Period||2
8345372|NCT01286454|20571638|P9|COMPLETED|Third Intervention Period||2
8345373|NCT01286454|20571639|P8|COMPLETED|Third Intervention Period||2
8345374|NCT01286454|20571640|P7|COMPLETED|Third Intervention Period||2
8345375|NCT01286454|20571641|P6|COMPLETED|Third Intervention Period||2
8345376|NCT01286454|20571642|P5|COMPLETED|Third Intervention Period||2
8345377|NCT01286454|20571643|P4|COMPLETED|Third Intervention Period||2
8345378|NCT01286454|20571644|P3|COMPLETED|Third Intervention Period||2
8345379|NCT01286454|20571645|P2|COMPLETED|Third Intervention Period||2
8345380|NCT01286454|20571646|P1|COMPLETED|Third Intervention Period||2
8345381|NCT01286454|20571636|P11|STARTED|Third Intervention Period||0
8345382|NCT01286454|20571637|P10|STARTED|Third Intervention Period||2
8345383|NCT01286454|20571638|P9|STARTED|Third Intervention Period||2
8345384|NCT01286454|20571639|P8|STARTED|Third Intervention Period||2
8345385|NCT01286454|20571640|P7|STARTED|Third Intervention Period||2
8345386|NCT01286454|20571641|P6|STARTED|Third Intervention Period||2
8345387|NCT01286454|20571642|P5|STARTED|Third Intervention Period||2
8345388|NCT01286454|20571643|P4|STARTED|Third Intervention Period||2
8345389|NCT01286454|20571644|P3|STARTED|Third Intervention Period||2
8345390|NCT01286454|20571645|P2|STARTED|Third Intervention Period||2
8345391|NCT01286454|20571646|P1|STARTED|Third Intervention Period||2
8345392|NCT01286454|20571636|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345393|NCT01286454|20571637|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345394|NCT01286454|20571638|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345395|NCT01286454|20571639|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345396|NCT01286454|20571640|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345397|NCT01286454|20571641|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345398|NCT01286454|20571642|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345399|NCT01286454|20571643|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345400|NCT01286454|20571644|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345401|NCT01286454|20571645|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345402|NCT01286454|20571646|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345403|NCT01286454|20571636|P11|COMPLETED|Washout Period (At Least 3 Days)||0
8345404|NCT01286454|20571637|P10|COMPLETED|Washout Period (At Least 3 Days)||2
8345405|NCT01286454|20571638|P9|COMPLETED|Washout Period (At Least 3 Days)||2
8345406|NCT01286454|20571639|P8|COMPLETED|Washout Period (At Least 3 Days)||2
8345407|NCT01286454|20571640|P7|COMPLETED|Washout Period (At Least 3 Days)||2
8345408|NCT01286454|20571641|P6|COMPLETED|Washout Period (At Least 3 Days)||2
8345409|NCT01286454|20571642|P5|COMPLETED|Washout Period (At Least 3 Days)||2
8345410|NCT01286454|20571643|P4|COMPLETED|Washout Period (At Least 3 Days)||2
8345411|NCT01286454|20571644|P3|COMPLETED|Washout Period (At Least 3 Days)||2
8345412|NCT01286454|20571645|P2|COMPLETED|Washout Period (At Least 3 Days)||2
8345413|NCT01286454|20571646|P1|COMPLETED|Washout Period (At Least 3 Days)||2
8345414|NCT01286454|20571636|P11|STARTED|Washout Period (At Least 3 Days)||0
8345415|NCT01286454|20571637|P10|STARTED|Washout Period (At Least 3 Days)||2
8345416|NCT01286454|20571638|P9|STARTED|Washout Period (At Least 3 Days)||2
8345417|NCT01286454|20571639|P8|STARTED|Washout Period (At Least 3 Days)||2
8345418|NCT01286454|20571640|P7|STARTED|Washout Period (At Least 3 Days)||2
8345419|NCT01286454|20571641|P6|STARTED|Washout Period (At Least 3 Days)||2
8345420|NCT01286454|20571642|P5|STARTED|Washout Period (At Least 3 Days)||2
8345421|NCT01286454|20571643|P4|STARTED|Washout Period (At Least 3 Days)||2
8345422|NCT01286454|20571644|P3|STARTED|Washout Period (At Least 3 Days)||2
8345423|NCT01286454|20571645|P2|STARTED|Washout Period (At Least 3 Days)||2
8345424|NCT01286454|20571646|P1|STARTED|Washout Period (At Least 3 Days)||2
8345425|NCT01286454|20571636|P11|NOT COMPLETED|Second Intervention Period||0
8345426|NCT01286454|20571637|P10|NOT COMPLETED|Second Intervention Period||0
8345427|NCT01286454|20571638|P9|NOT COMPLETED|Second Intervention Period||0
8345428|NCT01286454|20571639|P8|NOT COMPLETED|Second Intervention Period||0
8345429|NCT01286454|20571640|P7|NOT COMPLETED|Second Intervention Period||0
8345430|NCT01286454|20571641|P6|NOT COMPLETED|Second Intervention Period||0
8345431|NCT01286454|20571642|P5|NOT COMPLETED|Second Intervention Period||0
8345432|NCT01286454|20571643|P4|NOT COMPLETED|Second Intervention Period||0
8345433|NCT01286454|20571644|P3|NOT COMPLETED|Second Intervention Period||0
8345434|NCT01286454|20571645|P2|NOT COMPLETED|Second Intervention Period||0
8345435|NCT01286454|20571646|P1|NOT COMPLETED|Second Intervention Period||0
8345436|NCT01286454|20571636|P11|COMPLETED|Second Intervention Period||0
8345437|NCT01286454|20571637|P10|COMPLETED|Second Intervention Period||2
8345438|NCT01286454|20571638|P9|COMPLETED|Second Intervention Period||2
8345439|NCT01286454|20571639|P8|COMPLETED|Second Intervention Period||2
8345440|NCT01286454|20571640|P7|COMPLETED|Second Intervention Period||2
8345441|NCT01286454|20571641|P6|COMPLETED|Second Intervention Period||2
8345442|NCT01286454|20571642|P5|COMPLETED|Second Intervention Period||2
8345443|NCT01286454|20571643|P4|COMPLETED|Second Intervention Period||2
8345444|NCT01286454|20571644|P3|COMPLETED|Second Intervention Period||2
8345445|NCT01286454|20571645|P2|COMPLETED|Second Intervention Period||2
8345446|NCT01286454|20571646|P1|COMPLETED|Second Intervention Period||2
8345447|NCT01286454|20571636|P11|STARTED|Second Intervention Period||0
8345448|NCT01286454|20571637|P10|STARTED|Second Intervention Period||2
8345449|NCT01286454|20571638|P9|STARTED|Second Intervention Period||2
8345450|NCT01286454|20571639|P8|STARTED|Second Intervention Period||2
8345451|NCT01286454|20571640|P7|STARTED|Second Intervention Period||2
8345452|NCT01286454|20571641|P6|STARTED|Second Intervention Period||2
8345453|NCT01286454|20571642|P5|STARTED|Second Intervention Period||2
8345454|NCT01286454|20571643|P4|STARTED|Second Intervention Period||2
8345455|NCT01286454|20571644|P3|STARTED|Second Intervention Period||2
8345456|NCT01286454|20571645|P2|STARTED|Second Intervention Period||2
8345457|NCT01286454|20571646|P1|STARTED|Second Intervention Period||2
8345458|NCT01286454|20571636|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345459|NCT01286454|20571637|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345460|NCT01286454|20571638|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345461|NCT01286454|20571639|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345462|NCT01286454|20571640|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345463|NCT01286454|20571641|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345464|NCT01286454|20571642|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345465|NCT01286454|20571643|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345466|NCT01286454|20571644|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345467|NCT01286454|20571645|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345468|NCT01286454|20571646|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
8345469|NCT01286454|20571636|P11|COMPLETED|Washout Period (At Least 3 Days)||0
8345470|NCT01286454|20571637|P10|COMPLETED|Washout Period (At Least 3 Days)||2
8345471|NCT01286454|20571638|P9|COMPLETED|Washout Period (At Least 3 Days)||2
8345472|NCT01286454|20571639|P8|COMPLETED|Washout Period (At Least 3 Days)||2
8345473|NCT01286454|20571640|P7|COMPLETED|Washout Period (At Least 3 Days)||2
8345474|NCT01286454|20571641|P6|COMPLETED|Washout Period (At Least 3 Days)||2
8345475|NCT01286454|20571642|P5|COMPLETED|Washout Period (At Least 3 Days)||2
8345476|NCT01286454|20571643|P4|COMPLETED|Washout Period (At Least 3 Days)||2
8345477|NCT01286454|20571644|P3|COMPLETED|Washout Period (At Least 3 Days)||2
8345478|NCT01286454|20571645|P2|COMPLETED|Washout Period (At Least 3 Days)||2
8345479|NCT01286454|20571646|P1|COMPLETED|Washout Period (At Least 3 Days)||2
8345480|NCT01286454|20571636|P11|STARTED|Washout Period (At Least 3 Days)||0
8345481|NCT01286454|20571637|P10|STARTED|Washout Period (At Least 3 Days)||2
8345482|NCT01286454|20571638|P9|STARTED|Washout Period (At Least 3 Days)||2
8345483|NCT01286454|20571639|P8|STARTED|Washout Period (At Least 3 Days)||2
8345484|NCT01286454|20571640|P7|STARTED|Washout Period (At Least 3 Days)||2
8345485|NCT01286454|20571641|P6|STARTED|Washout Period (At Least 3 Days)||2
8345486|NCT01286454|20571642|P5|STARTED|Washout Period (At Least 3 Days)||2
8345487|NCT01286454|20571643|P4|STARTED|Washout Period (At Least 3 Days)||2
8345488|NCT01286454|20571644|P3|STARTED|Washout Period (At Least 3 Days)||2
8345489|NCT01286454|20571645|P2|STARTED|Washout Period (At Least 3 Days)||2
8345490|NCT01286454|20571646|P1|STARTED|Washout Period (At Least 3 Days)||2
8345491|NCT01286454|20571636|P11|NOT COMPLETED|Part I- First Intervention Period||0
8345492|NCT01286454|20571637|P10|NOT COMPLETED|Part I- First Intervention Period||0
8345493|NCT01286454|20571638|P9|NOT COMPLETED|Part I- First Intervention Period||0
8345494|NCT01286454|20571639|P8|NOT COMPLETED|Part I- First Intervention Period||0
8345495|NCT01286454|20571640|P7|NOT COMPLETED|Part I- First Intervention Period||0
8345496|NCT01286454|20571641|P6|NOT COMPLETED|Part I- First Intervention Period||0
8345497|NCT01286454|20571642|P5|NOT COMPLETED|Part I- First Intervention Period||0
8345498|NCT01286454|20571643|P4|NOT COMPLETED|Part I- First Intervention Period||0
8345499|NCT01286454|20571644|P3|NOT COMPLETED|Part I- First Intervention Period||0
8345500|NCT01286454|20571645|P2|NOT COMPLETED|Part I- First Intervention Period||0
8345501|NCT01286454|20571646|P1|NOT COMPLETED|Part I- First Intervention Period||0
8345502|NCT01286454|20571636|P11|COMPLETED|Part I- First Intervention Period||0
8345503|NCT01286454|20571637|P10|COMPLETED|Part I- First Intervention Period||2
8345504|NCT01286454|20571638|P9|COMPLETED|Part I- First Intervention Period||2
8345505|NCT01286454|20571639|P8|COMPLETED|Part I- First Intervention Period||2
8345506|NCT01286454|20571640|P7|COMPLETED|Part I- First Intervention Period||2
8345507|NCT01286454|20571641|P6|COMPLETED|Part I- First Intervention Period||2
8345508|NCT01286454|20571642|P5|COMPLETED|Part I- First Intervention Period||2
8345509|NCT01286454|20571643|P4|COMPLETED|Part I- First Intervention Period||2
8345510|NCT01286454|20571644|P3|COMPLETED|Part I- First Intervention Period||2
8345511|NCT01286454|20571645|P2|COMPLETED|Part I- First Intervention Period||2
8345512|NCT01286454|20571646|P1|COMPLETED|Part I- First Intervention Period||2
8345513|NCT01286454|20571636|P11|STARTED|Part I- First Intervention Period||0
8345514|NCT01286454|20571637|P10|STARTED|Part I- First Intervention Period||2
8345515|NCT01286454|20571638|P9|STARTED|Part I- First Intervention Period||2
8345516|NCT01286454|20571639|P8|STARTED|Part I- First Intervention Period||2
8345517|NCT01286454|20571640|P7|STARTED|Part I- First Intervention Period||2
8345518|NCT01286454|20571641|P6|STARTED|Part I- First Intervention Period||2
8345519|NCT01286454|20571642|P5|STARTED|Part I- First Intervention Period||2
8345520|NCT01286454|20571643|P4|STARTED|Part I- First Intervention Period||2
8345521|NCT01286454|20571644|P3|STARTED|Part I- First Intervention Period||2
8345522|NCT01286454|20571645|P2|STARTED|Part I- First Intervention Period||2
8345523|NCT01286454|20571646|P1|STARTED|Part I- First Intervention Period||2
8345524|NCT01286441|20571688|P4|NOT COMPLETED|Overall Study||11
8345525|NCT01286441|20571689|P3|NOT COMPLETED|Overall Study||7
8345526|NCT01286441|20571690|P2|NOT COMPLETED|Overall Study||7
8345527|NCT01286441|20571691|P1|NOT COMPLETED|Overall Study||7
8345528|NCT01286441|20571688|P4|COMPLETED|Overall Study||37
8345529|NCT01286441|20571689|P3|COMPLETED|Overall Study||39
8345530|NCT01286441|20571690|P2|COMPLETED|Overall Study||37
8345531|NCT01286441|20571691|P1|COMPLETED|Overall Study||38
8345532|NCT01286441|20571688|P4|STARTED|Overall Study||48
8345533|NCT01286441|20571689|P3|STARTED|Overall Study||46
8345534|NCT01286441|20571690|P2|STARTED|Overall Study||44
8345535|NCT01286441|20571691|P1|STARTED|Overall Study||45
8345536|NCT01286402|20571707|P2|NOT COMPLETED|Overall Study||0
8345537|NCT01286402|20571708|P1|NOT COMPLETED|Overall Study||0
8345538|NCT01286402|20571707|P2|COMPLETED|Overall Study||6
8345539|NCT01286402|20571708|P1|COMPLETED|Overall Study||5
8345540|NCT01286402|20571707|P2|STARTED|Overall Study||6
8345541|NCT01286402|20571708|P1|STARTED|Overall Study||5
8345542|NCT01286324|20571716|P2|NOT COMPLETED|Overall Study||0
8345543|NCT01286324|20571717|P1|NOT COMPLETED|Overall Study||0
8345544|NCT01286324|20571716|P2|COMPLETED|Overall Study||17
8345545|NCT01286324|20571717|P1|COMPLETED|Overall Study||17
8345546|NCT01286324|20571716|P2|STARTED|Overall Study||17
8345547|NCT01286324|20571717|P1|STARTED|Overall Study||17
8345548|NCT01286311|20571735|P2|NOT COMPLETED|Overall Study||0
8345549|NCT01286311|20571736|P1|NOT COMPLETED|Overall Study||14
8345550|NCT01286311|20571735|P2|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
8345551|NCT01286311|20571736|P1|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
8345552|NCT01286311|20571735|P2|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
8345553|NCT01286311|20571736|P1|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
8345560|NCT01286259|20571763|P1|NOT COMPLETED|Overall Study||0
8345561|NCT01286259|20571763|P1|COMPLETED|Overall Study||16
8345562|NCT01286259|20571763|P1|STARTED|Overall Study||16
8345563|NCT01286207|20571773|P3|NOT COMPLETED|Overall Study||90
8345564|NCT01286207|20571774|P2|NOT COMPLETED|Overall Study||248
8345565|NCT01286207|20571775|P1|NOT COMPLETED|Overall Study||298
8345566|NCT01286207|20571773|P3|COMPLETED|Overall Study||261
8345567|NCT01286207|20571774|P2|COMPLETED|Overall Study||609
8345568|NCT01286207|20571775|P1|COMPLETED|Overall Study||453
8345569|NCT01286207|20571773|P3|STARTED|Overall Study||351
8345570|NCT01286207|20571774|P2|STARTED|Overall Study||857
8345571|NCT01286207|20571775|P1|STARTED|Overall Study||751
8345572|NCT01286168|20571795|P1|NOT COMPLETED|Overall Study||3
8345573|NCT01286168|20571795|P1|COMPLETED|Overall Study||101
8345574|NCT01286168|20571795|P1|STARTED|Overall Study||104
8345575|NCT01286129|20571809|P2|NOT COMPLETED|Overall Study||5
8345576|NCT01286129|20571810|P1|NOT COMPLETED|Overall Study||8
8345577|NCT01286129|20571809|P2|COMPLETED|Overall Study||13
8345578|NCT01286129|20571810|P1|COMPLETED|Overall Study||19
8345579|NCT01286129|20571809|P2|STARTED|Overall Study||18
8345580|NCT01286129|20571810|P1|STARTED|Overall Study||27
8345581|NCT01286077|20571820|P2|NOT COMPLETED|Overall Study||7
8345582|NCT01286077|20571821|P1|NOT COMPLETED|Overall Study||10
8345583|NCT01286077|20571820|P2|COMPLETED|Overall Study||46
8345584|NCT01286077|20571821|P1|COMPLETED|Overall Study||41
8345585|NCT01286077|20571820|P2|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
8345586|NCT01286077|20571821|P1|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
8345587|NCT01286012|20571857|P2|NOT COMPLETED|Overall Study||14
8345588|NCT01286012|20571858|P1|NOT COMPLETED|Overall Study||13
8345589|NCT01286012|20571857|P2|COMPLETED|Overall Study||40
8345590|NCT01286012|20571858|P1|COMPLETED|Overall Study||41
8345591|NCT01286012|20571857|P2|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
8345592|NCT01286012|20571858|P1|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
8345593|NCT01285960|20571872|P1|NOT COMPLETED|Overall Study||6
8345594|NCT01285960|20571872|P1|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102
8345595|NCT01285960|20571872|P1|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108
8345596|NCT01285947|20571878|P2|NOT COMPLETED|Overall Study||0
8345597|NCT01285947|20571879|P1|NOT COMPLETED|Overall Study||0
8345598|NCT01285947|20571878|P2|COMPLETED|Overall Study||10
8345599|NCT01285947|20571879|P1|COMPLETED|Overall Study||10
8345600|NCT01285947|20571878|P2|STARTED|Overall Study||10
8345601|NCT01285947|20571879|P1|STARTED|Overall Study||10
8345602|NCT01285908|20571885|P3|NOT COMPLETED|Treatment Crossover||0
8345603|NCT01285908|20571886|P2|NOT COMPLETED|Treatment Crossover||0
8345604|NCT01285908|20571887|P1|NOT COMPLETED|Treatment Crossover||0
8345605|NCT01285908|20571885|P3|COMPLETED|Treatment Crossover||2
8345606|NCT01285908|20571886|P2|COMPLETED|Treatment Crossover||2
8345607|NCT01285908|20571887|P1|COMPLETED|Treatment Crossover||0
8345608|NCT01285908|20571885|P3|STARTED|Treatment Crossover||2
8345609|NCT01285908|20571886|P2|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
8345610|NCT01285908|20571887|P1|STARTED|Treatment Crossover||0
8345611|NCT01285908|20571885|P3|NOT COMPLETED|Baseline Measurement||0
8345612|NCT01285908|20571886|P2|NOT COMPLETED|Baseline Measurement||0
8345613|NCT01285908|20571887|P1|NOT COMPLETED|Baseline Measurement||3
8345614|NCT01285908|20571885|P3|COMPLETED|Baseline Measurement||0
8345615|NCT01285908|20571886|P2|COMPLETED|Baseline Measurement||0
8345616|NCT01285908|20571887|P1|COMPLETED|Baseline Measurement||3
8345617|NCT01285908|20571885|P3|STARTED|Baseline Measurement||0
8345618|NCT01285908|20571886|P2|STARTED|Baseline Measurement||0
8345619|NCT01285908|20571887|P1|STARTED|Baseline Measurement||6
8345620|NCT01285843|20571921|P2|NOT COMPLETED|Overall Study||2
8345621|NCT01285843|20571922|P1|NOT COMPLETED|Overall Study||2
8345622|NCT01285843|20571921|P2|COMPLETED|Overall Study||18
8345623|NCT01285843|20571922|P1|COMPLETED|Overall Study||18
8345624|NCT01285843|20571921|P2|STARTED|Overall Study||20
8345625|NCT01285843|20571922|P1|STARTED|Overall Study||20
8345626|NCT01285791|20571937|P3|NOT COMPLETED|Overall Study||0
8345627|NCT01285791|20571938|P2|NOT COMPLETED|Overall Study||0
8345628|NCT01285791|20571939|P1|NOT COMPLETED|Overall Study||0
8345629|NCT01285791|20571937|P3|COMPLETED|Overall Study||13
8345630|NCT01285791|20571938|P2|COMPLETED|Overall Study||15
8345631|NCT01285791|20571939|P1|COMPLETED|Overall Study||11
8345632|NCT01285791|20571937|P3|STARTED|Overall Study||13
8345633|NCT01285791|20571938|P2|STARTED|Overall Study||15
8345634|NCT01285791|20571939|P1|STARTED|Overall Study||11
8345635|NCT01285713|20571949|P2|NOT COMPLETED|Overall Study||0
8345636|NCT01285713|20571950|P1|NOT COMPLETED|Overall Study||0
8345637|NCT01285713|20571949|P2|COMPLETED|Overall Study||41
8345638|NCT01285713|20571950|P1|COMPLETED|Overall Study||42
8345639|NCT01285713|20571949|P2|STARTED|Overall Study||41
8345640|NCT01285713|20571950|P1|STARTED|Overall Study||42
8345641|NCT01285635|20571959|P3|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
8345642|NCT01285635|20571960|P2|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
8345643|NCT01285635|20571961|P1|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
8345644|NCT01285635|20571959|P3|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
8345645|NCT01285635|20571960|P2|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
8345646|NCT01285635|20571961|P1|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
8345647|NCT01285635|20571959|P3|STARTED|Second Intervention (10, 3 Week Cycles)||11
8345648|NCT01285635|20571960|P2|STARTED|Second Intervention (10, 3 Week Cycles)||11
8345649|NCT01285635|20571961|P1|STARTED|Second Intervention (10, 3 Week Cycles)||13
8345650|NCT01285635|20571959|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
8345651|NCT01285635|20571960|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
8345652|NCT01285635|20571961|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8345653|NCT01285635|20571959|P3|COMPLETED|First Intervention (2 Weeks)||11
8345654|NCT01285635|20571960|P2|COMPLETED|First Intervention (2 Weeks)||11
8345655|NCT01285635|20571961|P1|COMPLETED|First Intervention (2 Weeks)||13
8345656|NCT01285635|20571959|P3|STARTED|First Intervention (2 Weeks)||11
8345657|NCT01285635|20571960|P2|STARTED|First Intervention (2 Weeks)||11
8345658|NCT01285635|20571961|P1|STARTED|First Intervention (2 Weeks)||13
8345659|NCT01285609|20571981|P2|NOT COMPLETED|Treated With Blinded Therapy||359
8345660|NCT01285609|20571982|P1|NOT COMPLETED|Treated With Blinded Therapy||387
8345661|NCT01285609|20571981|P2|COMPLETED|Treated With Blinded Therapy||2
8345662|NCT01285609|20571982|P1|COMPLETED|Treated With Blinded Therapy||1
8345663|NCT01285609|20571981|P2|STARTED|Treated With Blinded Therapy||361
8345664|NCT01285609|20571982|P1|STARTED|Treated With Blinded Therapy||388
8345665|NCT01285609|20571981|P2|NOT COMPLETED|Randomized||116
8345666|NCT01285609|20571982|P1|NOT COMPLETED|Randomized||91
8345667|NCT01285609|20571981|P2|COMPLETED|Randomized||361
8345668|NCT01285609|20571982|P1|COMPLETED|Randomized||388
8345669|NCT01285609|20571981|P2|Treated With Chemotherapy (1st Dose)|Randomized||473
8345670|NCT01285609|20571982|P1|Treated With Chemotherapy (1st Dose)|Randomized||475
8345671|NCT01285609|20571981|P2|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
8345672|NCT01285609|20571982|P1|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
8345673|NCT01285518|20572000|P8|NOT COMPLETED|Overall Study||0
8345674|NCT01285518|20572001|P7|NOT COMPLETED|Overall Study||0
8345675|NCT01285518|20572002|P6|NOT COMPLETED|Overall Study||1
8345676|NCT01285518|20572003|P5|NOT COMPLETED|Overall Study||0
8345677|NCT01285518|20572004|P4|NOT COMPLETED|Overall Study||0
8345678|NCT01285518|20572005|P3|NOT COMPLETED|Overall Study||0
8345679|NCT01285518|20572006|P2|NOT COMPLETED|Overall Study||0
8345680|NCT01285518|20572007|P1|NOT COMPLETED|Overall Study||0
8345681|NCT01285518|20572000|P8|COMPLETED|Overall Study||14
8345682|NCT01285518|20572001|P7|COMPLETED|Overall Study||10
8345683|NCT01285518|20572002|P6|COMPLETED|Overall Study||9
8345684|NCT01285518|20572003|P5|COMPLETED|Overall Study||10
8345685|NCT01285518|20572004|P4|COMPLETED|Overall Study||10
8345686|NCT01285518|20572005|P3|COMPLETED|Overall Study||10
8345687|NCT01285518|20572006|P2|COMPLETED|Overall Study||10
8345688|NCT01285518|20572007|P1|COMPLETED|Overall Study||10
8345689|NCT01285518|20572000|P8|STARTED|Overall Study||14
8345690|NCT01285518|20572001|P7|STARTED|Overall Study||10
8345691|NCT01285518|20572002|P6|STARTED|Overall Study||10
8345692|NCT01285518|20572003|P5|STARTED|Overall Study||10
8345693|NCT01285518|20572004|P4|STARTED|Overall Study||10
8345694|NCT01285518|20572005|P3|STARTED|Overall Study||10
8345695|NCT01285518|20572006|P2|STARTED|Overall Study||10
8345696|NCT01285518|20572007|P1|STARTED|Overall Study||10
8345697|NCT01285492|20572267|P2|NOT COMPLETED|Overall Study||1
8345698|NCT01285492|20572268|P1|NOT COMPLETED|Overall Study||17
8345699|NCT01285492|20572267|P2|COMPLETED|Overall Study||38
8345700|NCT01285492|20572268|P1|COMPLETED|Overall Study||104
8345701|NCT01285492|20572267|P2|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
8345702|NCT01285492|20572268|P1|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
8345703|NCT01285492|20572267|P2|STARTED|Overall Study|All patients randomized to this group|39
8345704|NCT01285492|20572268|P1|STARTED|Overall Study|All patients randomized to this group|121
8345705|NCT01285427|20572286|P1|NOT COMPLETED|Overall Study||1
8345706|NCT01285427|20572286|P1|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
8345707|NCT01285427|20572286|P1|STARTED|Overall Study||300
8345708|NCT01285401|20572300|P2|NOT COMPLETED|Overall Study||29
8345709|NCT01285401|20572301|P1|NOT COMPLETED|Overall Study||17
8345710|NCT01285401|20572300|P2|COMPLETED|Overall Study||88
8345711|NCT01285401|20572301|P1|COMPLETED|Overall Study||98
8345712|NCT01285401|20572300|P2|Treated|Overall Study||116
8345713|NCT01285401|20572301|P1|Treated|Overall Study||113
8345714|NCT01285401|20572300|P2|STARTED|Overall Study||117
8345715|NCT01285401|20572301|P1|STARTED|Overall Study||115
8345716|NCT01285349|20572342|P3|NOT COMPLETED|Overall Study||27
8345717|NCT01285349|20572343|P2|NOT COMPLETED|Overall Study||20
8345718|NCT01285349|20572344|P1|NOT COMPLETED|Overall Study||27
8345719|NCT01285349|20572342|P3|COMPLETED|Overall Study||157
8345720|NCT01285349|20572343|P2|COMPLETED|Overall Study||170
8345721|NCT01285349|20572344|P1|COMPLETED|Overall Study||163
8345722|NCT01285349|20572342|P3|STARTED|Overall Study||184
8345723|NCT01285349|20572343|P2|STARTED|Overall Study||190
8345724|NCT01285349|20572344|P1|STARTED|Overall Study||190
8345725|NCT01285323|20572357|P2|NOT COMPLETED|Overall Study||30
8345726|NCT01285323|20572358|P1|NOT COMPLETED|Overall Study||33
8345727|NCT01285323|20572357|P2|COMPLETED|Overall Study||202
8345728|NCT01285323|20572358|P1|COMPLETED|Overall Study||199
8345729|NCT01285323|20572357|P2|Safety Analysis Set|Overall Study||232
8345730|NCT01285323|20572358|P1|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
8345731|NCT01285323|20572357|P2|Full Analysis Set|Overall Study||232
8345732|NCT01285323|20572358|P1|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
8345733|NCT01285323|20572357|P2|STARTED|Overall Study||232
8345734|NCT01285323|20572358|P1|STARTED|Overall Study||232
8345735|NCT01285310|20572393|P5|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
8345736|NCT01285310|20572394|P4|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
8345737|NCT01285310|20572395|P3|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
8345738|NCT01285310|20572396|P2|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
8345739|NCT01285310|20572397|P1|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
8345740|NCT01285310|20572393|P5|COMPLETED|Active Treatment Phase: Weeks 25-52||23
8345741|NCT01285310|20572394|P4|COMPLETED|Active Treatment Phase: Weeks 25-52||17
8345742|NCT01285310|20572395|P3|COMPLETED|Active Treatment Phase: Weeks 25-52||34
8345743|NCT01285310|20572396|P2|COMPLETED|Active Treatment Phase: Weeks 25-52||31
8345744|NCT01285310|20572397|P1|COMPLETED|Active Treatment Phase: Weeks 25-52||0
8345745|NCT01285310|20572393|P5|STARTED|Active Treatment Phase: Weeks 25-52||42
8345746|NCT01285310|20572394|P4|STARTED|Active Treatment Phase: Weeks 25-52||27
8345747|NCT01285310|20572395|P3|STARTED|Active Treatment Phase: Weeks 25-52||60
8345748|NCT01285310|20572396|P2|STARTED|Active Treatment Phase: Weeks 25-52||63
8345749|NCT01285310|20572397|P1|STARTED|Active Treatment Phase: Weeks 25-52||0
8345750|NCT01285310|20572393|P5|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
8345751|NCT01285310|20572394|P4|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
8345752|NCT01285310|20572395|P3|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
8345753|NCT01285310|20572396|P2|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
8345754|NCT01285310|20572397|P1|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
8345755|NCT01285310|20572393|P5|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
8345756|NCT01285310|20572394|P4|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
8345757|NCT01285310|20572395|P3|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
8345758|NCT01285310|20572396|P2|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
8345759|NCT01285310|20572397|P1|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
8345760|NCT01285310|20572393|P5|STARTED|Placebo Controlled Phase: Weeks 0-24||0
8345761|NCT01285310|20572394|P4|STARTED|Placebo Controlled Phase: Weeks 0-24||0
8345762|NCT01285310|20572395|P3|STARTED|Placebo Controlled Phase: Weeks 0-24||76
8345763|NCT01285310|20572396|P2|STARTED|Placebo Controlled Phase: Weeks 0-24||82
8345764|NCT01285310|20572397|P1|STARTED|Placebo Controlled Phase: Weeks 0-24||79
8345765|NCT01285076|20572630|P1|NOT COMPLETED|Overall Study||0
8345766|NCT01285076|20572630|P1|COMPLETED|Overall Study||834
8345767|NCT01285076|20572630|P1|STARTED|Overall Study||834
8345768|NCT01285050|20572643|P1|NOT COMPLETED|Overall Study||1
8345769|NCT01285050|20572643|P1|COMPLETED|Overall Study||19
8345770|NCT01285050|20572643|P1|STARTED|Overall Study||20
8345771|NCT01285024|20572650|P2|NOT COMPLETED|Overall Study||0
8345772|NCT01285024|20572651|P1|NOT COMPLETED|Overall Study||0
8345773|NCT01285024|20572650|P2|COMPLETED|Overall Study||60
8345774|NCT01285024|20572651|P1|COMPLETED|Overall Study||49
8345775|NCT01285024|20572650|P2|STARTED|Overall Study||60
8345776|NCT01285024|20572651|P1|STARTED|Overall Study||49
8345777|NCT01284959|20572662|P3|NOT COMPLETED|Overall Study||1
8345778|NCT01284959|20572663|P2|NOT COMPLETED|Overall Study||0
8345779|NCT01284959|20572664|P1|NOT COMPLETED|Overall Study||1
8345780|NCT01284959|20572662|P3|COMPLETED|Overall Study||10
8345781|NCT01284959|20572663|P2|COMPLETED|Overall Study||12
8345782|NCT01284959|20572664|P1|COMPLETED|Overall Study||10
8345783|NCT01284959|20572662|P3|STARTED|Overall Study||11
8345784|NCT01284959|20572663|P2|STARTED|Overall Study||12
8345785|NCT01284959|20572664|P1|STARTED|Overall Study||11
8345786|NCT01284634|20572694|P4|NOT COMPLETED|Overall Study||1
8345787|NCT01284634|20572695|P3|NOT COMPLETED|Overall Study||2
8345788|NCT01284634|20572696|P2|NOT COMPLETED|Overall Study||0
8345789|NCT01284634|20572697|P1|NOT COMPLETED|Overall Study||1
8345790|NCT01284634|20572694|P4|COMPLETED|Overall Study||4
8345791|NCT01284634|20572695|P3|COMPLETED|Overall Study||5
8345792|NCT01284634|20572696|P2|COMPLETED|Overall Study||6
8345793|NCT01284634|20572697|P1|COMPLETED|Overall Study||6
8345794|NCT01284634|20572694|P4|Intent to Treat (ITT) Analysis Set|Overall Study||5
8345795|NCT01284634|20572695|P3|Intent to Treat (ITT) Analysis Set|Overall Study||7
8345796|NCT01284634|20572696|P2|Intent to Treat (ITT) Analysis Set|Overall Study||6
8345797|NCT01284634|20572697|P1|Intent to Treat (ITT) Analysis Set|Overall Study||7
8345798|NCT01284634|20572694|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
8345799|NCT01284634|20572695|P3|Received at Least 1 Dose of Study Drug|Overall Study||7
8345800|NCT01284634|20572696|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8345801|NCT01284634|20572697|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
8345802|NCT01284634|20572694|P4|STARTED|Overall Study||5
8345803|NCT01284634|20572695|P3|STARTED|Overall Study||7
8345804|NCT01284634|20572696|P2|STARTED|Overall Study||6
8345805|NCT01284634|20572697|P1|STARTED|Overall Study||7
8345806|NCT01284621|20572727|P6|NOT COMPLETED|Third Intervention (8 Days)||0
8345807|NCT01284621|20572728|P5|NOT COMPLETED|Third Intervention (8 Days)||0
8345808|NCT01284621|20572729|P4|NOT COMPLETED|Third Intervention (8 Days)||0
8345809|NCT01284621|20572730|P3|NOT COMPLETED|Third Intervention (8 Days)||0
8345810|NCT01284621|20572731|P2|NOT COMPLETED|Third Intervention (8 Days)||0
8345811|NCT01284621|20572732|P1|NOT COMPLETED|Third Intervention (8 Days)||0
8345812|NCT01284621|20572727|P6|COMPLETED|Third Intervention (8 Days)||4
8345813|NCT01284621|20572728|P5|COMPLETED|Third Intervention (8 Days)||3
8345814|NCT01284621|20572729|P4|COMPLETED|Third Intervention (8 Days)||4
8345815|NCT01284621|20572730|P3|COMPLETED|Third Intervention (8 Days)||4
8345816|NCT01284621|20572731|P2|COMPLETED|Third Intervention (8 Days)||4
8345817|NCT01284621|20572732|P1|COMPLETED|Third Intervention (8 Days)||3
8345818|NCT01284621|20572727|P6|STARTED|Third Intervention (8 Days)||4
8345819|NCT01284621|20572728|P5|STARTED|Third Intervention (8 Days)||3
8345820|NCT01284621|20572729|P4|STARTED|Third Intervention (8 Days)||4
8345821|NCT01284621|20572730|P3|STARTED|Third Intervention (8 Days)||4
8345822|NCT01284621|20572731|P2|STARTED|Third Intervention (8 Days)||4
8345823|NCT01284621|20572732|P1|STARTED|Third Intervention (8 Days)||3
8345824|NCT01284621|20572727|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8345825|NCT01284621|20572728|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8345826|NCT01284621|20572729|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8345827|NCT01284621|20572730|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8345828|NCT01284621|20572731|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8345829|NCT01284621|20572732|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8345830|NCT01284621|20572727|P6|COMPLETED|Washout Period 2 (7 Days)||4
8345831|NCT01284621|20572728|P5|COMPLETED|Washout Period 2 (7 Days)||3
8345832|NCT01284621|20572729|P4|COMPLETED|Washout Period 2 (7 Days)||4
8345833|NCT01284621|20572730|P3|COMPLETED|Washout Period 2 (7 Days)||4
8345834|NCT01284621|20572731|P2|COMPLETED|Washout Period 2 (7 Days)||4
8345835|NCT01284621|20572732|P1|COMPLETED|Washout Period 2 (7 Days)||3
8345836|NCT01284621|20572727|P6|STARTED|Washout Period 2 (7 Days)||4
8345837|NCT01284621|20572728|P5|STARTED|Washout Period 2 (7 Days)||3
8345838|NCT01284621|20572729|P4|STARTED|Washout Period 2 (7 Days)||4
8345839|NCT01284621|20572730|P3|STARTED|Washout Period 2 (7 Days)||4
8345840|NCT01284621|20572731|P2|STARTED|Washout Period 2 (7 Days)||4
8345841|NCT01284621|20572732|P1|STARTED|Washout Period 2 (7 Days)||3
8345842|NCT01284621|20572727|P6|NOT COMPLETED|Second Intervention (8 Days)||0
8345843|NCT01284621|20572728|P5|NOT COMPLETED|Second Intervention (8 Days)||0
8345844|NCT01284621|20572729|P4|NOT COMPLETED|Second Intervention (8 Days)||0
8345845|NCT01284621|20572730|P3|NOT COMPLETED|Second Intervention (8 Days)||0
8345846|NCT01284621|20572731|P2|NOT COMPLETED|Second Intervention (8 Days)||0
8345847|NCT01284621|20572732|P1|NOT COMPLETED|Second Intervention (8 Days)||0
8345848|NCT01284621|20572727|P6|COMPLETED|Second Intervention (8 Days)||4
8345849|NCT01284621|20572728|P5|COMPLETED|Second Intervention (8 Days)||3
8345850|NCT01284621|20572729|P4|COMPLETED|Second Intervention (8 Days)||4
8345851|NCT01284621|20572730|P3|COMPLETED|Second Intervention (8 Days)||4
8345852|NCT01284621|20572731|P2|COMPLETED|Second Intervention (8 Days)||4
8345853|NCT01284621|20572732|P1|COMPLETED|Second Intervention (8 Days)||3
8345854|NCT01284621|20572727|P6|STARTED|Second Intervention (8 Days)||4
8345855|NCT01284621|20572728|P5|STARTED|Second Intervention (8 Days)||3
8345856|NCT01284621|20572729|P4|STARTED|Second Intervention (8 Days)||4
8345857|NCT01284621|20572730|P3|STARTED|Second Intervention (8 Days)||4
8345858|NCT01284621|20572731|P2|STARTED|Second Intervention (8 Days)||4
8345859|NCT01284621|20572732|P1|STARTED|Second Intervention (8 Days)||3
8345860|NCT01284621|20572727|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
8345861|NCT01284621|20572728|P5|NOT COMPLETED|Washout Period 1 (7 Days)||1
8345862|NCT01284621|20572729|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8345863|NCT01284621|20572730|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8345864|NCT01284621|20572731|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8345865|NCT01284621|20572732|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8345866|NCT01284621|20572727|P6|COMPLETED|Washout Period 1 (7 Days)||4
8345867|NCT01284621|20572728|P5|COMPLETED|Washout Period 1 (7 Days)||3
8345868|NCT01284621|20572729|P4|COMPLETED|Washout Period 1 (7 Days)||4
8345869|NCT01284621|20572730|P3|COMPLETED|Washout Period 1 (7 Days)||4
8345870|NCT01284621|20572731|P2|COMPLETED|Washout Period 1 (7 Days)||4
8345871|NCT01284621|20572732|P1|COMPLETED|Washout Period 1 (7 Days)||3
8345872|NCT01284621|20572727|P6|STARTED|Washout Period 1 (7 Days)||4
8345873|NCT01284621|20572728|P5|STARTED|Washout Period 1 (7 Days)||4
8345874|NCT01284621|20572729|P4|STARTED|Washout Period 1 (7 Days)||4
8345875|NCT01284621|20572730|P3|STARTED|Washout Period 1 (7 Days)||4
8345876|NCT01284621|20572731|P2|STARTED|Washout Period 1 (7 Days)||4
8345877|NCT01284621|20572732|P1|STARTED|Washout Period 1 (7 Days)||3
8345878|NCT01284621|20572727|P6|NOT COMPLETED|First Intervention (8 Days)||0
8345879|NCT01284621|20572728|P5|NOT COMPLETED|First Intervention (8 Days)||0
8345880|NCT01284621|20572729|P4|NOT COMPLETED|First Intervention (8 Days)||0
8345881|NCT01284621|20572730|P3|NOT COMPLETED|First Intervention (8 Days)||0
8345882|NCT01284621|20572731|P2|NOT COMPLETED|First Intervention (8 Days)||0
8345883|NCT01284621|20572732|P1|NOT COMPLETED|First Intervention (8 Days)||0
8345884|NCT01284621|20572727|P6|COMPLETED|First Intervention (8 Days)||4
8345885|NCT01284621|20572728|P5|COMPLETED|First Intervention (8 Days)||4
8345886|NCT01284621|20572729|P4|COMPLETED|First Intervention (8 Days)||4
8345887|NCT01284621|20572730|P3|COMPLETED|First Intervention (8 Days)||4
8345888|NCT01284621|20572731|P2|COMPLETED|First Intervention (8 Days)||4
8345889|NCT01284621|20572732|P1|COMPLETED|First Intervention (8 Days)||3
8345890|NCT01284621|20572727|P6|STARTED|First Intervention (8 Days)||4
8345891|NCT01284621|20572728|P5|STARTED|First Intervention (8 Days)||4
8345892|NCT01284621|20572729|P4|STARTED|First Intervention (8 Days)||4
8345893|NCT01284621|20572730|P3|STARTED|First Intervention (8 Days)||4
8345894|NCT01284621|20572731|P2|STARTED|First Intervention (8 Days)||4
8345895|NCT01284621|20572732|P1|STARTED|First Intervention (8 Days)||3
8345896|NCT01284517|20572776|P2|NOT COMPLETED|Overall Study||36
8345897|NCT01284517|20572777|P1|NOT COMPLETED|Overall Study||32
8345898|NCT01284517|20572776|P2|COMPLETED|Overall Study||140
8345899|NCT01284517|20572777|P1|COMPLETED|Overall Study||148
8345900|NCT01284517|20572776|P2|STARTED|Overall Study||176
8345901|NCT01284517|20572777|P1|STARTED|Overall Study||180
8345902|NCT01284504|20572789|P2|NOT COMPLETED|Overall Study||0
8345903|NCT01284504|20572790|P1|NOT COMPLETED|Overall Study||0
8345904|NCT01284504|20572789|P2|COMPLETED|Overall Study||0
8345905|NCT01284504|20572790|P1|COMPLETED|Overall Study||0
8345906|NCT01284504|20572789|P2|STARTED|Overall Study||0
8345907|NCT01284504|20572790|P1|STARTED|Overall Study||0
8345908|NCT01284491|20572800|P1|NOT COMPLETED|Overall Study||13
8345909|NCT01284491|20572800|P1|COMPLETED|Overall Study||0
8345910|NCT01284491|20572800|P1|STARTED|Overall Study||13
8345911|NCT01284426|20572806|P1|NOT COMPLETED|Overall Study||2
8345912|NCT01284426|20572806|P1|COMPLETED|Overall Study||92
8345913|NCT01284426|20572806|P1|STARTED|Overall Study||94
8345914|NCT01284361|20572810|P1|NOT COMPLETED|Overall Study||9
8345915|NCT01284361|20572810|P1|COMPLETED|Overall Study||82
8345916|NCT01284361|20572810|P1|STARTED|Overall Study||91
8345917|NCT01284335|20572830|P13|NOT COMPLETED|Overall Study||0
8345918|NCT01284335|20572831|P12|NOT COMPLETED|Overall Study||0
8345919|NCT01284335|20572832|P11|NOT COMPLETED|Overall Study||0
8345920|NCT01284335|20572833|P10|NOT COMPLETED|Overall Study||0
8345921|NCT01284335|20572834|P9|NOT COMPLETED|Overall Study||0
8345922|NCT01284335|20572835|P8|NOT COMPLETED|Overall Study||0
8345923|NCT01284335|20572836|P7|NOT COMPLETED|Overall Study||0
8345924|NCT01284335|20572837|P6|NOT COMPLETED|Overall Study||0
8345925|NCT01284335|20572838|P5|NOT COMPLETED|Overall Study||0
8345926|NCT01284335|20572839|P4|NOT COMPLETED|Overall Study||0
8345927|NCT01284335|20572840|P3|NOT COMPLETED|Overall Study||0
8345928|NCT01284335|20572841|P2|NOT COMPLETED|Overall Study||0
8345929|NCT01284335|20572842|P1|NOT COMPLETED|Overall Study||0
8345930|NCT01284335|20572830|P13|COMPLETED|Overall Study||12
8345931|NCT01284335|20572831|P12|COMPLETED|Overall Study||16
8345932|NCT01284335|20572832|P11|COMPLETED|Overall Study||45
8345933|NCT01284335|20572833|P10|COMPLETED|Overall Study||14
8345934|NCT01284335|20572834|P9|COMPLETED|Overall Study||4
8345935|NCT01284335|20572835|P8|COMPLETED|Overall Study||6
8345936|NCT01284335|20572836|P7|COMPLETED|Overall Study||19
8345937|NCT01284335|20572837|P6|COMPLETED|Overall Study||26
8345938|NCT01284335|20572838|P5|COMPLETED|Overall Study||24
8345939|NCT01284335|20572839|P4|COMPLETED|Overall Study||5
8345940|NCT01284335|20572840|P3|COMPLETED|Overall Study||5
8345941|NCT01284335|20572841|P2|COMPLETED|Overall Study||33
8345942|NCT01284335|20572842|P1|COMPLETED|Overall Study||25
8345943|NCT01284335|20572830|P13|Received at Least One Dose of Study Drug|Overall Study||12
8345944|NCT01284335|20572831|P12|Received at Least One Dose of Study Drug|Overall Study||16
8346121|NCT01283334|20573368|P1|STARTED|Overall Study||20
8345945|NCT01284335|20572832|P11|Received at Least One Dose of Study Drug|Overall Study||45
8345946|NCT01284335|20572833|P10|Received at Least One Dose of Study Drug|Overall Study||14
8345947|NCT01284335|20572834|P9|Received at Least One Dose of Study Drug|Overall Study||4
8345948|NCT01284335|20572835|P8|Received at Least One Dose of Study Drug|Overall Study||6
8345949|NCT01284335|20572836|P7|Received at Least One Dose of Study Drug|Overall Study||19
8345950|NCT01284335|20572837|P6|Received at Least One Dose of Study Drug|Overall Study||26
8345951|NCT01284335|20572838|P5|Received at Least One Dose of Study Drug|Overall Study||24
8345952|NCT01284335|20572839|P4|Received at Least One Dose of Study Drug|Overall Study||5
8345953|NCT01284335|20572840|P3|Received at Least One Dose of Study Drug|Overall Study||5
8345954|NCT01284335|20572841|P2|Received at Least One Dose of Study Drug|Overall Study||33
8345955|NCT01284335|20572842|P1|Received at Least One Dose of Study Drug|Overall Study||25
8345956|NCT01284335|20572830|P13|STARTED|Overall Study||12
8345957|NCT01284335|20572831|P12|STARTED|Overall Study||16
8345958|NCT01284335|20572832|P11|STARTED|Overall Study||45
8345959|NCT01284335|20572833|P10|STARTED|Overall Study||14
8345960|NCT01284335|20572834|P9|STARTED|Overall Study||4
8345961|NCT01284335|20572835|P8|STARTED|Overall Study||6
8345962|NCT01284335|20572836|P7|STARTED|Overall Study||19
8345963|NCT01284335|20572837|P6|STARTED|Overall Study||26
8345964|NCT01284335|20572838|P5|STARTED|Overall Study||24
8345965|NCT01284335|20572839|P4|STARTED|Overall Study||5
8345966|NCT01284335|20572840|P3|STARTED|Overall Study||5
8345967|NCT01284335|20572841|P2|STARTED|Overall Study||33
8345968|NCT01284335|20572842|P1|STARTED|Overall Study||25
8345969|NCT01284296|20572890|P1|NOT COMPLETED|Overall Study||0
8345970|NCT01284296|20572890|P1|COMPLETED|Overall Study||20
8345971|NCT01284296|20572890|P1|STARTED|Overall Study||20
8345972|NCT01284244|20572897|P2|NOT COMPLETED|Overall Study||0
8345973|NCT01284244|20572898|P1|NOT COMPLETED|Overall Study||0
8345974|NCT01284244|20572897|P2|COMPLETED|Overall Study||18
8345975|NCT01284244|20572898|P1|COMPLETED|Overall Study||18
8345976|NCT01284244|20572897|P2|STARTED|Overall Study||18
8345977|NCT01284244|20572898|P1|STARTED|Overall Study||18
8345978|NCT01284140|20572906|P2|NOT COMPLETED|Subjects With Paired 24hr Collections||6
8345979|NCT01284140|20572907|P1|NOT COMPLETED|Subjects With Paired 24hr Collections||5
8345980|NCT01284140|20572906|P2|COMPLETED|Subjects With Paired 24hr Collections||5
8345981|NCT01284140|20572907|P1|COMPLETED|Subjects With Paired 24hr Collections||6
8345982|NCT01284140|20572906|P2|STARTED|Subjects With Paired 24hr Collections||11
8345983|NCT01284140|20572907|P1|STARTED|Subjects With Paired 24hr Collections||11
8345984|NCT01284140|20572906|P2|NOT COMPLETED|Randomization and Intervention||0
8345985|NCT01284140|20572907|P1|NOT COMPLETED|Randomization and Intervention||0
8345986|NCT01284140|20572906|P2|COMPLETED|Randomization and Intervention||11
8345987|NCT01284140|20572907|P1|COMPLETED|Randomization and Intervention||11
8345988|NCT01284140|20572906|P2|STARTED|Randomization and Intervention||11
8345989|NCT01284140|20572907|P1|STARTED|Randomization and Intervention||11
8345990|NCT01284127|20572921|P1|NOT COMPLETED|Overall Study||7
8345991|NCT01284127|20572921|P1|COMPLETED|Overall Study||31
8345992|NCT01284127|20572921|P1|STARTED|Overall Study||38
8345993|NCT01284114|20572930|P1|NOT COMPLETED|Overall Study||4
8345994|NCT01284114|20572930|P1|COMPLETED|Overall Study||19
8345995|NCT01284114|20572930|P1|STARTED|Overall Study||23
8345996|NCT01284062|20572942|P4|NOT COMPLETED|Overall Study||14
8345997|NCT01284062|20572943|P3|NOT COMPLETED|Overall Study||6
8345998|NCT01284062|20572944|P2|NOT COMPLETED|Overall Study||8
8345999|NCT01284062|20572945|P1|NOT COMPLETED|Overall Study||11
8346000|NCT01284062|20572942|P4|COMPLETED|Overall Study||7
8346001|NCT01284062|20572943|P3|COMPLETED|Overall Study||15
8346002|NCT01284062|20572944|P2|COMPLETED|Overall Study||13
8346003|NCT01284062|20572945|P1|COMPLETED|Overall Study||10
8346004|NCT01284062|20572942|P4|STARTED|Overall Study||21
8346005|NCT01284062|20572943|P3|STARTED|Overall Study||21
8346006|NCT01284062|20572944|P2|STARTED|Overall Study||21
8346007|NCT01284062|20572945|P1|STARTED|Overall Study||21
8346008|NCT01283971|20573019|P2|NOT COMPLETED|Overall Study||12
8346009|NCT01283971|20573020|P1|NOT COMPLETED|Overall Study||15
8346010|NCT01283971|20573019|P2|COMPLETED|Overall Study||36
8346011|NCT01283971|20573020|P1|COMPLETED|Overall Study||33
8346012|NCT01283971|20573019|P2|Intent to Treat Population|Overall Study||48
8346013|NCT01283971|20573020|P1|Intent to Treat Population|Overall Study||46
8346014|NCT01283971|20573019|P2|STARTED|Overall Study||48
8346015|NCT01283971|20573020|P1|STARTED|Overall Study||48
8346016|NCT01283581|20573067|P3|NOT COMPLETED|Overall Study||20
8346017|NCT01283581|20573068|P2|NOT COMPLETED|Overall Study||14
8346018|NCT01283581|20573069|P1|NOT COMPLETED|Overall Study||12
8346019|NCT01283581|20573067|P3|COMPLETED|Overall Study||78
8346020|NCT01283581|20573068|P2|COMPLETED|Overall Study||63
8346021|NCT01283581|20573069|P1|COMPLETED|Overall Study||69
8346022|NCT01283581|20573067|P3|STARTED|Overall Study||98
8346023|NCT01283581|20573068|P2|STARTED|Overall Study||77
8346024|NCT01283581|20573069|P1|STARTED|Overall Study||81
8346025|NCT01283555|20573095|P2|NOT COMPLETED|Second Intervention||0
8346026|NCT01283555|20573096|P1|NOT COMPLETED|Second Intervention||0
8346027|NCT01283555|20573095|P2|COMPLETED|Second Intervention||12
8346028|NCT01283555|20573096|P1|COMPLETED|Second Intervention||13
8346029|NCT01283555|20573095|P2|STARTED|Second Intervention||12
8346030|NCT01283555|20573096|P1|STARTED|Second Intervention||13
8346031|NCT01283555|20573095|P2|NOT COMPLETED|Washout Period of at Least 21 Days||0
8346032|NCT01283555|20573096|P1|NOT COMPLETED|Washout Period of at Least 21 Days||0
8346033|NCT01283555|20573095|P2|COMPLETED|Washout Period of at Least 21 Days||12
8346034|NCT01283555|20573096|P1|COMPLETED|Washout Period of at Least 21 Days||13
8346035|NCT01283555|20573095|P2|STARTED|Washout Period of at Least 21 Days||12
8346036|NCT01283555|20573096|P1|STARTED|Washout Period of at Least 21 Days||13
8346037|NCT01283555|20573095|P2|NOT COMPLETED|First Intervention||0
8346038|NCT01283555|20573096|P1|NOT COMPLETED|First Intervention||0
8346039|NCT01283555|20573095|P2|COMPLETED|First Intervention||12
8346040|NCT01283555|20573096|P1|COMPLETED|First Intervention||13
8346041|NCT01283555|20573095|P2|STARTED|First Intervention||12
8346042|NCT01283555|20573096|P1|STARTED|First Intervention||13
8346043|NCT01283542|20573139|P1|NOT COMPLETED|Extension Phase||3
8346044|NCT01283542|20573139|P1|COMPLETED|Extension Phase||10
8346045|NCT01283542|20573139|P1|Safety Analysis Set|Extension Phase||13
8346046|NCT01283542|20573139|P1|Full Analysis Set (FAS)|Extension Phase||13
8346047|NCT01283542|20573139|P1|STARTED|Extension Phase||13
8346048|NCT01283542|20573139|P1|NOT COMPLETED|Main Phase||7
8346049|NCT01283542|20573139|P1|COMPLETED|Main Phase||13
8346050|NCT01283542|20573139|P1|Safety Analysis Set|Main Phase||20
8346051|NCT01283542|20573139|P1|Full Analysis Set (FAS)|Main Phase||20
8346052|NCT01283542|20573139|P1|STARTED|Main Phase||20
8346053|NCT01283516|20573204|P9|NOT COMPLETED|Overall Study||255
8346054|NCT01283516|20573205|P8|NOT COMPLETED|Overall Study||5
8346055|NCT01283516|20573206|P7|NOT COMPLETED|Overall Study||10
8346056|NCT01283516|20573207|P6|NOT COMPLETED|Overall Study||10
8346057|NCT01283516|20573208|P5|NOT COMPLETED|Overall Study||14
8346058|NCT01283516|20573209|P4|NOT COMPLETED|Overall Study||3
8346059|NCT01283516|20573210|P3|NOT COMPLETED|Overall Study||3
8346060|NCT01283516|20573211|P2|NOT COMPLETED|Overall Study||2
8346061|NCT01283516|20573212|P1|NOT COMPLETED|Overall Study||2
8346062|NCT01283516|20573204|P9|COMPLETED|Overall Study||0
8346063|NCT01283516|20573205|P8|COMPLETED|Overall Study||0
8346064|NCT01283516|20573206|P7|COMPLETED|Overall Study||0
8346065|NCT01283516|20573207|P6|COMPLETED|Overall Study||0
8346066|NCT01283516|20573208|P5|COMPLETED|Overall Study||0
8346067|NCT01283516|20573209|P4|COMPLETED|Overall Study||0
8346068|NCT01283516|20573210|P3|COMPLETED|Overall Study||0
8346069|NCT01283516|20573211|P2|COMPLETED|Overall Study||0
8346070|NCT01283516|20573212|P1|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0
8346071|NCT01283516|20573204|P9|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9
8346072|NCT01283516|20573205|P8|Non-NSCLC|Overall Study||0
8346073|NCT01283516|20573206|P7|Non-NSCLC|Overall Study||1
8346074|NCT01283516|20573207|P6|Non-NSCLC|Overall Study||0
8346075|NCT01283516|20573208|P5|Non-NSCLC|Overall Study||2
8346076|NCT01283516|20573209|P4|Non-NSCLC|Overall Study||0
8346077|NCT01283516|20573210|P3|Non-NSCLC|Overall Study||1
8346078|NCT01283516|20573211|P2|Non-NSCLC|Overall Study||1
8346079|NCT01283516|20573212|P1|Non-NSCLC|Overall Study||0
8346080|NCT01283516|20573204|P9|Dose-Determining Set (DDS)|Overall Study||8
8346081|NCT01283516|20573205|P8|Dose-Determining Set (DDS)|Overall Study||5
8346082|NCT01283516|20573206|P7|Dose-Determining Set (DDS)|Overall Study||10
8346083|NCT01283516|20573207|P6|Dose-Determining Set (DDS)|Overall Study||8
8346084|NCT01283516|20573208|P5|Dose-Determining Set (DDS)|Overall Study||14
8346085|NCT01283516|20573209|P4|Dose-Determining Set (DDS)|Overall Study||3
8346086|NCT01283516|20573210|P3|Dose-Determining Set (DDS)|Overall Study||3
8346087|NCT01283516|20573211|P2|Dose-Determining Set (DDS)|Overall Study||1
8346088|NCT01283516|20573212|P1|Dose-Determining Set (DDS)|Overall Study||2
8346089|NCT01283516|20573204|P9|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
8346090|NCT01283516|20573205|P8|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
8346091|NCT01283516|20573206|P7|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
8346092|NCT01283516|20573207|P6|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
8346093|NCT01283516|20573208|P5|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
8346094|NCT01283516|20573209|P4|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
8346095|NCT01283516|20573210|P3|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
8346096|NCT01283516|20573211|P2|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
8346097|NCT01283516|20573212|P1|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
8346098|NCT01283516|20573204|P9|STARTED|Overall Study||255
8346099|NCT01283516|20573205|P8|STARTED|Overall Study||5
8346100|NCT01283516|20573206|P7|STARTED|Overall Study||10
8346101|NCT01283516|20573207|P6|STARTED|Overall Study||10
8346102|NCT01283516|20573208|P5|STARTED|Overall Study||14
8346103|NCT01283516|20573209|P4|STARTED|Overall Study||3
8346104|NCT01283516|20573210|P3|STARTED|Overall Study||3
8346105|NCT01283516|20573211|P2|STARTED|Overall Study||2
8346106|NCT01283516|20573212|P1|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
8346107|NCT01283464|20573334|P2|NOT COMPLETED|Overall Study||1
8346108|NCT01283464|20573335|P1|NOT COMPLETED|Overall Study||2
8346109|NCT01283464|20573334|P2|COMPLETED|Overall Study||11
8346110|NCT01283464|20573335|P1|COMPLETED|Overall Study||10
8346111|NCT01283464|20573334|P2|STARTED|Overall Study||12
8346112|NCT01283464|20573335|P1|STARTED|Overall Study||12
8346113|NCT01283386|20573343|P2|NOT COMPLETED|Overall Study||12
8346114|NCT01283386|20573344|P1|NOT COMPLETED|Overall Study||8
8346115|NCT01283386|20573343|P2|COMPLETED|Overall Study||4
8346116|NCT01283386|20573344|P1|COMPLETED|Overall Study||2
8346117|NCT01283386|20573343|P2|STARTED|Overall Study||16
8346118|NCT01283386|20573344|P1|STARTED|Overall Study||10
8346119|NCT01283334|20573368|P1|NOT COMPLETED|Overall Study||7
8346120|NCT01283334|20573368|P1|COMPLETED|Overall Study||13
8346122|NCT01283321|20573376|P2|NOT COMPLETED|Overall Study||0
8346123|NCT01283321|20573377|P1|NOT COMPLETED|Overall Study||0
8346124|NCT01283321|20573376|P2|COMPLETED|Overall Study||10
8346125|NCT01283321|20573377|P1|COMPLETED|Overall Study||10
8346126|NCT01283321|20573376|P2|STARTED|Overall Study||10
8346127|NCT01283321|20573377|P1|STARTED|Overall Study||10
8346128|NCT01283282|20573391|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8346129|NCT01283282|20573392|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8346130|NCT01283282|20573391|P2|COMPLETED|Second Intervention (6 Weeks)||19
8346131|NCT01283282|20573392|P1|COMPLETED|Second Intervention (6 Weeks)||22
8346132|NCT01283282|20573391|P2|STARTED|Second Intervention (6 Weeks)||19
8346133|NCT01283282|20573392|P1|STARTED|Second Intervention (6 Weeks)||22
8346134|NCT01283282|20573391|P2|NOT COMPLETED|First Intervention (6 Weeks)||4
8346135|NCT01283282|20573392|P1|NOT COMPLETED|First Intervention (6 Weeks)||3
8346136|NCT01283282|20573391|P2|COMPLETED|First Intervention (6 Weeks)||19
8346137|NCT01283282|20573392|P1|COMPLETED|First Intervention (6 Weeks)||22
8346138|NCT01283282|20573391|P2|STARTED|First Intervention (6 Weeks)||23
8346139|NCT01283282|20573392|P1|STARTED|First Intervention (6 Weeks)||25
8346140|NCT01283152|20573412|P2|NOT COMPLETED|Overall Study||0
8346141|NCT01283152|20573413|P1|NOT COMPLETED|Overall Study||2
8346142|NCT01283152|20573412|P2|COMPLETED|Overall Study||25
8346143|NCT01283152|20573413|P1|COMPLETED|Overall Study||23
8346144|NCT01283152|20573412|P2|24-hr HESA Attempted|Overall Study||25
8346145|NCT01283152|20573413|P1|24-hr HESA Attempted|Overall Study||25
8346146|NCT01283152|20573412|P2|Study Treatment Received|Overall Study||25
8346147|NCT01283152|20573413|P1|Study Treatment Received|Overall Study||25
8346148|NCT01283152|20573412|P2|ITT Population|Overall Study||25
8346149|NCT01283152|20573413|P1|ITT Population|Overall Study||25
8346150|NCT01283152|20573412|P2|STARTED|Overall Study||25
8346151|NCT01283152|20573413|P1|STARTED|Overall Study||25
8346152|NCT01283139|20573427|P4|NOT COMPLETED|Overall Study||15
8346153|NCT01283139|20573428|P3|NOT COMPLETED|Overall Study||18
8346154|NCT01283139|20573429|P2|NOT COMPLETED|Overall Study||18
8346155|NCT01283139|20573430|P1|NOT COMPLETED|Overall Study||17
8346156|NCT01283139|20573427|P4|COMPLETED|Overall Study||92
8346157|NCT01283139|20573428|P3|COMPLETED|Overall Study||91
8346158|NCT01283139|20573429|P2|COMPLETED|Overall Study||90
8346159|NCT01283139|20573430|P1|COMPLETED|Overall Study||91
8346160|NCT01283139|20573427|P4|STARTED|Overall Study||107
8346161|NCT01283139|20573428|P3|STARTED|Overall Study||109
8346162|NCT01283139|20573429|P2|STARTED|Overall Study||108
8346163|NCT01283139|20573430|P1|STARTED|Overall Study||108
8346164|NCT01283035|20573472|P1|NOT COMPLETED|Overall Study||1
8346165|NCT01283035|20573472|P1|COMPLETED|Overall Study||5
8346166|NCT01283035|20573472|P1|STARTED|Overall Study||6
8346167|NCT01283022|20573481|P1|NOT COMPLETED|Overall Study||0
8346168|NCT01283022|20573481|P1|COMPLETED|Overall Study||24
8346169|NCT01283022|20573481|P1|STARTED|Overall Study||24
8346170|NCT01283009|20573489|P2|NOT COMPLETED|Overall Study||117
8346171|NCT01283009|20573490|P1|NOT COMPLETED|Overall Study||118
8346172|NCT01283009|20573489|P2|COMPLETED|Overall Study||180
8346173|NCT01283009|20573490|P1|COMPLETED|Overall Study||169
8346174|NCT01283009|20573489|P2|STARTED|Overall Study||297
8346175|NCT01283009|20573490|P1|STARTED|Overall Study||287
8346176|NCT01282866|20573496|P1|NOT COMPLETED|Overall Study||1
8346177|NCT01282866|20573496|P1|COMPLETED|Overall Study||34
8346178|NCT01282866|20573496|P1|STARTED|Overall Study||35
8346179|NCT01282814|20573504|P2|NOT COMPLETED|Second Intervention||0
8346180|NCT01282814|20573505|P1|NOT COMPLETED|Second Intervention||0
8346181|NCT01282814|20573504|P2|COMPLETED|Second Intervention||9
8346182|NCT01282814|20573505|P1|COMPLETED|Second Intervention||10
8346183|NCT01282814|20573504|P2|STARTED|Second Intervention||9
8346184|NCT01282814|20573505|P1|STARTED|Second Intervention||10
8346185|NCT01282814|20573504|P2|NOT COMPLETED|Washout of 7 Days||0
8346186|NCT01282814|20573505|P1|NOT COMPLETED|Washout of 7 Days||2
8346187|NCT01282814|20573504|P2|COMPLETED|Washout of 7 Days||9
8346188|NCT01282814|20573505|P1|COMPLETED|Washout of 7 Days||10
8346189|NCT01282814|20573504|P2|STARTED|Washout of 7 Days||9
8346190|NCT01282814|20573505|P1|STARTED|Washout of 7 Days||12
8346191|NCT01282814|20573504|P2|NOT COMPLETED|First Intervention||3
8346192|NCT01282814|20573505|P1|NOT COMPLETED|First Intervention||0
8346193|NCT01282814|20573504|P2|COMPLETED|First Intervention||9
8346194|NCT01282814|20573505|P1|COMPLETED|First Intervention||12
8346195|NCT01282814|20573504|P2|STARTED|First Intervention||12
8346196|NCT01282814|20573505|P1|STARTED|First Intervention||12
8346197|NCT01282801|20573517|P2|NOT COMPLETED|Second Intervention||1
8346198|NCT01282801|20573518|P1|NOT COMPLETED|Second Intervention||0
8346199|NCT01282801|20573517|P2|COMPLETED|Second Intervention||8
8346200|NCT01282801|20573518|P1|COMPLETED|Second Intervention||9
8346201|NCT01282801|20573517|P2|STARTED|Second Intervention||9
8346202|NCT01282801|20573518|P1|STARTED|Second Intervention||9
8346203|NCT01282801|20573517|P2|NOT COMPLETED|Washout of 7 Days||0
8346204|NCT01282801|20573518|P1|NOT COMPLETED|Washout of 7 Days||0
8346205|NCT01282801|20573517|P2|COMPLETED|Washout of 7 Days||9
8346206|NCT01282801|20573518|P1|COMPLETED|Washout of 7 Days||9
8346207|NCT01282801|20573517|P2|STARTED|Washout of 7 Days||9
8346208|NCT01282801|20573518|P1|STARTED|Washout of 7 Days||9
8346209|NCT01282801|20573517|P2|NOT COMPLETED|First Intervention||0
8346210|NCT01282801|20573518|P1|NOT COMPLETED|First Intervention||0
8346211|NCT01282801|20573517|P2|COMPLETED|First Intervention||9
8346212|NCT01282801|20573518|P1|COMPLETED|First Intervention||9
8346213|NCT01282801|20573517|P2|STARTED|First Intervention||9
8346214|NCT01282801|20573518|P1|STARTED|First Intervention||9
8346215|NCT01282723|20573534|P1|NOT COMPLETED|Overall Study||0
8346216|NCT01282723|20573534|P1|COMPLETED|Overall Study||20
8346217|NCT01282723|20573534|P1|STARTED|Overall Study||20
8346218|NCT01282710|20573538|P1|NOT COMPLETED|Overall Study||0
8346219|NCT01282710|20573538|P1|COMPLETED|Overall Study||20
8346220|NCT01282710|20573538|P1|STARTED|Overall Study||20
8346221|NCT01282476|20573542|P1|NOT COMPLETED|Overall Study||11
8346222|NCT01282476|20573542|P1|COMPLETED|Overall Study||7
8346223|NCT01282476|20573542|P1|STARTED|Overall Study||18
8346224|NCT01282463|20573551|P3|NOT COMPLETED|Overall Study||4
8346225|NCT01282463|20573552|P2|NOT COMPLETED|Overall Study||4
8346226|NCT01282463|20573553|P1|NOT COMPLETED|Overall Study||8
8346227|NCT01282463|20573551|P3|COMPLETED|Overall Study||46
8346228|NCT01282463|20573552|P2|COMPLETED|Overall Study||45
8346229|NCT01282463|20573553|P1|COMPLETED|Overall Study||41
8346230|NCT01282463|20573551|P3|Received at Least 1 Dose of Study Drug|Overall Study||49
8346231|NCT01282463|20573552|P2|Received at Least 1 Dose of Study Drug|Overall Study||46
8346232|NCT01282463|20573553|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
8346233|NCT01282463|20573551|P3|STARTED|Overall Study||50
8346234|NCT01282463|20573552|P2|STARTED|Overall Study||49
8346235|NCT01282463|20573553|P1|STARTED|Overall Study||49
8346236|NCT01282424|20573591|P1|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64
8346237|NCT01282424|20573591|P1|COMPLETED|Long-term Follow-up Period (5 Years)||20
8346238|NCT01282424|20573591|P1|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84
8346239|NCT01282424|20573591|P1|NOT COMPLETED|Treatment Period (TP) (81 Months)||46
8346240|NCT01282424|20573591|P1|COMPLETED|Treatment Period (TP) (81 Months)||79
8346241|NCT01282424|20573591|P1|Completed: Death|Treatment Period (TP) (81 Months)||9
8346242|NCT01282424|20573591|P1|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70
8346243|NCT01282424|20573591|P1|STARTED|Treatment Period (TP) (81 Months)||125
8346244|NCT01282372|20573608|P1|NOT COMPLETED|Overall Study||79
8346245|NCT01282372|20573608|P1|COMPLETED|Overall Study||421
8346246|NCT01282372|20573608|P1|STARTED|Overall Study||500
8346247|NCT01282294|20573636|P1|NOT COMPLETED|Overall Study||19
8346248|NCT01282294|20573636|P1|COMPLETED|Overall Study||81
8346249|NCT01282294|20573636|P1|12 Months|Overall Study||86
8346250|NCT01282294|20573636|P1|6 Months|Overall Study||94
8346251|NCT01282294|20573636|P1|3 Months|Overall Study||95
8346252|NCT01282294|20573636|P1|6 Weeks|Overall Study||95
8346253|NCT01282294|20573636|P1|Post-operative|Overall Study||99
8346254|NCT01282294|20573636|P1|Intra-operative|Overall Study||99
8346255|NCT01282294|20573636|P1|STARTED|Overall Study||100
8346256|NCT01282242|20573656|P2|NOT COMPLETED|Overall Study||0
8346257|NCT01282242|20573657|P1|NOT COMPLETED|Overall Study||0
8346258|NCT01282242|20573656|P2|COMPLETED|Overall Study||8
8346259|NCT01282242|20573657|P1|COMPLETED|Overall Study||80
8346260|NCT01282242|20573656|P2|STARTED|Overall Study||8
8346261|NCT01282242|20573657|P1|STARTED|Overall Study||80
8346262|NCT01282229|20573665|P1|NOT COMPLETED|Overall Study||2
8346263|NCT01282229|20573665|P1|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
8346264|NCT01282229|20573665|P1|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
8346265|NCT01282216|20573697|P4|NOT COMPLETED|Overall Study||8
8346266|NCT01282216|20573698|P3|NOT COMPLETED|Overall Study||33
8346267|NCT01282216|20573699|P2|NOT COMPLETED|Overall Study||0
8346268|NCT01282216|20573700|P1|NOT COMPLETED|Overall Study||0
8346269|NCT01282216|20573697|P4|COMPLETED|Overall Study||0
8346270|NCT01282216|20573698|P3|COMPLETED|Overall Study||19
8346271|NCT01282216|20573699|P2|COMPLETED|Overall Study||26
8346272|NCT01282216|20573700|P1|COMPLETED|Overall Study||18
8346273|NCT01282216|20573697|P4|STARTED|Overall Study||8
8346274|NCT01282216|20573698|P3|STARTED|Overall Study||52
8346275|NCT01282216|20573699|P2|STARTED|Overall Study||26
8346276|NCT01282216|20573700|P1|STARTED|Overall Study||18
8346277|NCT01282203|20573710|P1|NOT COMPLETED|Overall Study||1
8346278|NCT01282203|20573710|P1|COMPLETED|Overall Study||1121
8346279|NCT01282203|20573710|P1|STARTED|Overall Study||1122
8346280|NCT01282164|20573732|P2|NOT COMPLETED|Overall Study||0
8346281|NCT01282164|20573733|P1|NOT COMPLETED|Overall Study||1
8346282|NCT01282164|20573732|P2|COMPLETED|Overall Study||14
8346283|NCT01282164|20573733|P1|COMPLETED|Overall Study||28
8346284|NCT01282164|20573732|P2|STARTED|Overall Study||14
8346285|NCT01282164|20573733|P1|STARTED|Overall Study||29
8346286|NCT01282138|20573758|P2|NOT COMPLETED|CAPT||0
8346287|NCT01282138|20573759|P1|NOT COMPLETED|CAPT||0
8346288|NCT01282138|20573758|P2|COMPLETED|CAPT||7
8346289|NCT01282138|20573759|P1|COMPLETED|CAPT||6
8346290|NCT01282138|20573758|P2|STARTED|CAPT||7
8346291|NCT01282138|20573759|P1|STARTED|CAPT||6
8346292|NCT01282138|20573758|P2|NOT COMPLETED|EEC||0
8346293|NCT01282138|20573759|P1|NOT COMPLETED|EEC||0
8346294|NCT01282138|20573758|P2|COMPLETED|EEC||7
8346295|NCT01282138|20573759|P1|COMPLETED|EEC||6
8346296|NCT01282138|20573758|P2|STARTED|EEC||7
8346297|NCT01282138|20573759|P1|STARTED|EEC||6
8346298|NCT01282086|20573767|P1|NOT COMPLETED|Overall Study||0
8346299|NCT01282086|20573767|P1|COMPLETED|Overall Study||1365
8346300|NCT01282086|20573767|P1|STARTED|Overall Study||1365
8346301|NCT01281969|20573786|P3|NOT COMPLETED|Overall Study||12
8346302|NCT01281969|20573787|P2|NOT COMPLETED|Overall Study||0
8346303|NCT01281969|20573788|P1|NOT COMPLETED|Overall Study||1
8346304|NCT01281969|20573786|P3|COMPLETED|Overall Study||0
8346305|NCT01281969|20573787|P2|COMPLETED|Overall Study||18
8346306|NCT01281969|20573788|P1|COMPLETED|Overall Study||17
8346307|NCT01281969|20573786|P3|STARTED|Overall Study||12
8346308|NCT01281969|20573787|P2|STARTED|Overall Study||18
8346309|NCT01281969|20573788|P1|STARTED|Overall Study||18
8346310|NCT01281956|20573800|P2|NOT COMPLETED|2nd Intervention (3 Months)||0
8346311|NCT01281956|20573801|P1|NOT COMPLETED|2nd Intervention (3 Months)||1
8346312|NCT01281956|20573800|P2|COMPLETED|2nd Intervention (3 Months)||5
8346313|NCT01281956|20573801|P1|COMPLETED|2nd Intervention (3 Months)||4
8346314|NCT01281956|20573800|P2|STARTED|2nd Intervention (3 Months)||5
8346315|NCT01281956|20573801|P1|STARTED|2nd Intervention (3 Months)||5
8346316|NCT01281956|20573800|P2|NOT COMPLETED|1st Intervention (3 Months)||0
8346317|NCT01281956|20573801|P1|NOT COMPLETED|1st Intervention (3 Months)||0
8346318|NCT01281956|20573800|P2|COMPLETED|1st Intervention (3 Months)||5
8346319|NCT01281956|20573801|P1|COMPLETED|1st Intervention (3 Months)||5
8346320|NCT01281956|20573800|P2|STARTED|1st Intervention (3 Months)||5
8346321|NCT01281956|20573801|P1|STARTED|1st Intervention (3 Months)||5
8346322|NCT01281917|20573832|P1|NOT COMPLETED|Overall Study||1
8346323|NCT01281917|20573832|P1|COMPLETED|Overall Study||39
8346324|NCT01281917|20573832|P1|STARTED|Overall Study||40
8346325|NCT01281865|20573844|P2|NOT COMPLETED|Overall Study||1
8346326|NCT01281865|20573845|P1|NOT COMPLETED|Overall Study||3
8346327|NCT01281865|20573844|P2|COMPLETED|Overall Study||1
8346328|NCT01281865|20573845|P1|COMPLETED|Overall Study||9
8346329|NCT01281865|20573844|P2|STARTED|Overall Study||2
8346330|NCT01281865|20573845|P1|STARTED|Overall Study||12
8346331|NCT01281839|20573853|P2|NOT COMPLETED|Overall Study||14
8346332|NCT01281839|20573854|P1|NOT COMPLETED|Overall Study||10
8346333|NCT01281839|20573853|P2|COMPLETED|Overall Study||119
8346334|NCT01281839|20573854|P1|COMPLETED|Overall Study||250
8346335|NCT01281839|20573853|P2|STARTED|Overall Study||133
8346336|NCT01281839|20573854|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
8346337|NCT01281644|20573915|P1|NOT COMPLETED|Overall Study||5
8346338|NCT01281644|20573915|P1|COMPLETED|Overall Study||18
8346339|NCT01281644|20573915|P1|STARTED|Overall Study||23
8346340|NCT01281501|20573925|P2|NOT COMPLETED|Overall Study||0
8346341|NCT01281501|20573926|P1|NOT COMPLETED|Overall Study||0
8346342|NCT01281501|20573925|P2|COMPLETED|Overall Study||43
8346343|NCT01281501|20573926|P1|COMPLETED|Overall Study||44
8346344|NCT01281501|20573925|P2|STARTED|Overall Study||43
8346345|NCT01281501|20573926|P1|STARTED|Overall Study||44
8346346|NCT01281475|20573940|P2|NOT COMPLETED|Overall Study||8
8346347|NCT01281475|20573941|P1|NOT COMPLETED|Overall Study||4
8346348|NCT01281475|20573940|P2|COMPLETED|Overall Study||26
8346349|NCT01281475|20573941|P1|COMPLETED|Overall Study||29
8346350|NCT01281475|20573940|P2|STARTED|Overall Study||34
8346351|NCT01281475|20573941|P1|STARTED|Overall Study||33
8346352|NCT01281306|20573956|P7|NOT COMPLETED|Overall Study||7
8346353|NCT01281306|20573957|P6|NOT COMPLETED|Overall Study||7
8346354|NCT01281306|20573958|P5|NOT COMPLETED|Overall Study||9
8346355|NCT01281306|20573959|P4|NOT COMPLETED|Overall Study||11
8346356|NCT01281306|20573960|P3|NOT COMPLETED|Overall Study||8
8346357|NCT01281306|20573961|P2|NOT COMPLETED|Overall Study||4
8346358|NCT01281306|20573962|P1|NOT COMPLETED|Overall Study||8
8346359|NCT01281306|20573956|P7|COMPLETED|Overall Study||51
8346360|NCT01281306|20573957|P6|COMPLETED|Overall Study||135
8346361|NCT01281306|20573958|P5|COMPLETED|Overall Study||134
8346362|NCT01281306|20573959|P4|COMPLETED|Overall Study||123
8346363|NCT01281306|20573960|P3|COMPLETED|Overall Study||133
8346364|NCT01281306|20573961|P2|COMPLETED|Overall Study||141
8346365|NCT01281306|20573962|P1|COMPLETED|Overall Study||136
8346366|NCT01281306|20573956|P7|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
8346367|NCT01281306|20573957|P6|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
8346368|NCT01281306|20573958|P5|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
8346369|NCT01281306|20573959|P4|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
8346370|NCT01281306|20573960|P3|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
8346371|NCT01281306|20573961|P2|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
8346372|NCT01281306|20573962|P1|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
8346373|NCT01281306|20573956|P7|Safety Set|Overall Study||58
8346374|NCT01281306|20573957|P6|Safety Set|Overall Study||142
8346375|NCT01281306|20573958|P5|Safety Set|Overall Study||143
8346376|NCT01281306|20573959|P4|Safety Set|Overall Study||133
8346377|NCT01281306|20573960|P3|Safety Set|Overall Study||141
8346378|NCT01281306|20573961|P2|Safety Set|Overall Study||145
8346379|NCT01281306|20573962|P1|Safety Set|Overall Study||143
8346380|NCT01281306|20573956|P7|Full Analysis Set|Overall Study||58
8346381|NCT01281306|20573957|P6|Full Analysis Set|Overall Study||142
8346382|NCT01281306|20573958|P5|Full Analysis Set|Overall Study||143
8346383|NCT01281306|20573959|P4|Full Analysis Set|Overall Study||133
8346384|NCT01281306|20573960|P3|Full Analysis Set|Overall Study||141
8346385|NCT01281306|20573961|P2|Full Analysis Set|Overall Study||145
8346386|NCT01281306|20573962|P1|Full Analysis Set|Overall Study||143
8346387|NCT01281306|20573956|P7|STARTED|Overall Study||58
8346388|NCT01281306|20573957|P6|STARTED|Overall Study||142
8346389|NCT01281306|20573958|P5|STARTED|Overall Study||143
8346390|NCT01281306|20573959|P4|STARTED|Overall Study||134
8346391|NCT01281306|20573960|P3|STARTED|Overall Study||141
8346392|NCT01281306|20573961|P2|STARTED|Overall Study||145
8346393|NCT01281306|20573962|P1|STARTED|Overall Study||144
8346394|NCT01281202|20574078|P2|NOT COMPLETED|Overall Study||36
8346395|NCT01281202|20574079|P1|NOT COMPLETED|Overall Study||28
8346396|NCT01281202|20574078|P2|COMPLETED|Overall Study||68
8346397|NCT01281202|20574079|P1|COMPLETED|Overall Study||75
8346398|NCT01281202|20574078|P2|STARTED|Overall Study||104
8346399|NCT01281202|20574079|P1|STARTED|Overall Study||103
8346400|NCT01281124|20574087|P1|NOT COMPLETED|Overall Study||1
8346401|NCT01281124|20574087|P1|COMPLETED|Overall Study||0
8346402|NCT01281124|20574087|P1|STARTED|Overall Study||1
8346409|NCT01280981|20574102|P1|NOT COMPLETED|Overall Study||92
8346410|NCT01280981|20574102|P1|COMPLETED|Overall Study||196
8346411|NCT01280981|20574102|P1|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
8346412|NCT01280981|20574102|P1|STARTED|Overall Study||288
8346413|NCT01280968|20574113|P2|NOT COMPLETED|Overall Study||3
8346414|NCT01280968|20574114|P1|NOT COMPLETED|Overall Study||18
8346415|NCT01280968|20574113|P2|COMPLETED|Overall Study||4
8346416|NCT01280968|20574114|P1|COMPLETED|Overall Study||27
8346417|NCT01280968|20574113|P2|STARTED|Overall Study||7
8346418|NCT01280968|20574114|P1|STARTED|Overall Study||45
8346419|NCT01280955|20574130|P1|NOT COMPLETED|Overall Study||3
8346420|NCT01280955|20574130|P1|COMPLETED|Overall Study||27
8346421|NCT01280955|20574130|P1|STARTED|Overall Study||30
8346422|NCT01280942|20574163|P2|NOT COMPLETED|Overall Study||0
8346423|NCT01280942|20574164|P1|NOT COMPLETED|Overall Study||0
8346424|NCT01280942|20574163|P2|COMPLETED|Overall Study||9911
8346425|NCT01280942|20574164|P1|COMPLETED|Overall Study||10120
8346426|NCT01280942|20574163|P2|STARTED|Overall Study||9911
8346427|NCT01280942|20574164|P1|STARTED|Overall Study||10120
8346428|NCT01280903|20574174|P2|NOT COMPLETED|Overall Study||16
8346429|NCT01280903|20574175|P1|NOT COMPLETED|Overall Study||23
8346430|NCT01280903|20574174|P2|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
8346431|NCT01280903|20574175|P1|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
8346432|NCT01280903|20574174|P2|STARTED|Overall Study||91
8346433|NCT01280903|20574175|P1|STARTED|Overall Study||91
8346434|NCT01280812|20574242|P3|NOT COMPLETED|Overall Study||1
8346435|NCT01280812|20574243|P2|NOT COMPLETED|Overall Study||2
8346436|NCT01280812|20574244|P1|NOT COMPLETED|Overall Study||3
8346437|NCT01280812|20574242|P3|COMPLETED|Overall Study||68
8346438|NCT01280812|20574243|P2|COMPLETED|Overall Study||69
8346439|NCT01280812|20574244|P1|COMPLETED|Overall Study||67
8346440|NCT01280812|20574242|P3|STARTED|Overall Study||69
8346441|NCT01280812|20574243|P2|STARTED|Overall Study||71
8346442|NCT01280812|20574244|P1|STARTED|Overall Study||70
8346443|NCT01280721|20574267|P1|NOT COMPLETED|Overall Study||22
8346444|NCT01280721|20574267|P1|COMPLETED|Overall Study||113
8346445|NCT01280721|20574267|P1|STARTED|Overall Study||135
8346446|NCT01280695|20574287|P5|NOT COMPLETED|Overall Study||2
8346447|NCT01280695|20574288|P4|NOT COMPLETED|Overall Study||4
8346448|NCT01280695|20574289|P3|NOT COMPLETED|Overall Study||5
8346449|NCT01280695|20574290|P2|NOT COMPLETED|Overall Study||1
8346450|NCT01280695|20574291|P1|NOT COMPLETED|Overall Study||0
8346451|NCT01280695|20574287|P5|COMPLETED|Overall Study||24
8346452|NCT01280695|20574288|P4|COMPLETED|Overall Study||22
8346453|NCT01280695|20574289|P3|COMPLETED|Overall Study||21
8346454|NCT01280695|20574290|P2|COMPLETED|Overall Study||24
8346455|NCT01280695|20574291|P1|COMPLETED|Overall Study||26
8346456|NCT01280695|20574287|P5|STARTED|Overall Study||26
8346457|NCT01280695|20574288|P4|STARTED|Overall Study||26
8346458|NCT01280695|20574289|P3|STARTED|Overall Study||26
8346459|NCT01280695|20574290|P2|STARTED|Overall Study||25
8346460|NCT01280695|20574291|P1|STARTED|Overall Study||26
8346461|NCT01280656|20574331|P3|NOT COMPLETED|Overall Study||63
8346462|NCT01280656|20574332|P2|NOT COMPLETED|Overall Study||47
8346463|NCT01280656|20574333|P1|NOT COMPLETED|Overall Study||3
8346464|NCT01280656|20574331|P3|COMPLETED|Overall Study||223
8346465|NCT01280656|20574332|P2|COMPLETED|Overall Study||265
8346466|NCT01280656|20574333|P1|COMPLETED|Overall Study||59
8346467|NCT01280656|20574331|P3|STARTED|Overall Study||286
8346468|NCT01280656|20574332|P2|STARTED|Overall Study||312
8346469|NCT01280656|20574333|P1|STARTED|Overall Study||62
8346470|NCT01280604|20574379|P2|NOT COMPLETED|Overall Study||5
8346471|NCT01280604|20574380|P1|NOT COMPLETED|Overall Study||9
8346472|NCT01280604|20574379|P2|COMPLETED|Overall Study||28
8346473|NCT01280604|20574380|P1|COMPLETED|Overall Study||24
8346474|NCT01280604|20574379|P2|Subjects Meeting All Inclusion Criteria|Overall Study||29
8346475|NCT01280604|20574380|P1|Subjects Meeting All Inclusion Criteria|Overall Study||25
8346476|NCT01280604|20574379|P2|STARTED|Overall Study||33
8346477|NCT01280604|20574380|P1|STARTED|Overall Study||33
8346478|NCT01280591|20574400|P4|NOT COMPLETED|Overall Study||3
8346479|NCT01280591|20574401|P3|NOT COMPLETED|Overall Study||0
8346480|NCT01280591|20574402|P2|NOT COMPLETED|Overall Study||0
8346481|NCT01280591|20574403|P1|NOT COMPLETED|Overall Study||0
8346482|NCT01280591|20574400|P4|COMPLETED|Overall Study||99
8346483|NCT01280591|20574401|P3|COMPLETED|Overall Study||203
8346484|NCT01280591|20574402|P2|COMPLETED|Overall Study||204
8346485|NCT01280591|20574403|P1|COMPLETED|Overall Study||203
8346486|NCT01280591|20574400|P4|STARTED|Overall Study||102
8346487|NCT01280591|20574401|P3|STARTED|Overall Study||203
8346488|NCT01280591|20574402|P2|STARTED|Overall Study||204
8346489|NCT01280591|20574403|P1|STARTED|Overall Study||203
8346490|NCT01280552|20574495|P2|NOT COMPLETED|Overall Study||1
8346491|NCT01280552|20574496|P1|NOT COMPLETED|Overall Study||6
8346492|NCT01280552|20574495|P2|COMPLETED|Overall Study||42
8346493|NCT01280552|20574496|P1|COMPLETED|Overall Study|Survival is still being assessed|75
8346494|NCT01280552|20574495|P2|STARTED|Overall Study||43
8346495|NCT01280552|20574496|P1|STARTED|Overall Study||81
8346496|NCT01280409|20574510|P2|NOT COMPLETED|Overall Study||19
8346497|NCT01280409|20574511|P1|NOT COMPLETED|Overall Study||16
8346498|NCT01280409|20574510|P2|COMPLETED|Overall Study||36
8346499|NCT01280409|20574511|P1|COMPLETED|Overall Study||43
8346500|NCT01280409|20574510|P2|STARTED|Overall Study||55
8346501|NCT01280409|20574511|P1|STARTED|Overall Study||59
8346502|NCT01280357|20574541|P1|NOT COMPLETED|Overall Study||26
8346503|NCT01280357|20574541|P1|COMPLETED|Overall Study||34
8346504|NCT01280357|20574541|P1|STARTED|Overall Study||60
8346505|NCT01280266|20574550|P2|NOT COMPLETED|Second Intervention (Week 5-9)||0
8346506|NCT01280266|20574551|P1|NOT COMPLETED|Second Intervention (Week 5-9)||0
8346507|NCT01280266|20574550|P2|COMPLETED|Second Intervention (Week 5-9)||12
8346508|NCT01280266|20574551|P1|COMPLETED|Second Intervention (Week 5-9)||14
8346509|NCT01280266|20574550|P2|STARTED|Second Intervention (Week 5-9)||12
8346510|NCT01280266|20574551|P1|STARTED|Second Intervention (Week 5-9)||14
8346511|NCT01280266|20574550|P2|NOT COMPLETED|Washout Period (Week 4-5)||0
8346512|NCT01280266|20574551|P1|NOT COMPLETED|Washout Period (Week 4-5)||0
8346513|NCT01280266|20574550|P2|COMPLETED|Washout Period (Week 4-5)||12
8346514|NCT01280266|20574551|P1|COMPLETED|Washout Period (Week 4-5)||14
8346515|NCT01280266|20574550|P2|STARTED|Washout Period (Week 4-5)||12
8346516|NCT01280266|20574551|P1|STARTED|Washout Period (Week 4-5)||14
8346517|NCT01280266|20574550|P2|NOT COMPLETED|First Intervention (Week 1-4)||2
8346518|NCT01280266|20574551|P1|NOT COMPLETED|First Intervention (Week 1-4)||1
8346519|NCT01280266|20574550|P2|COMPLETED|First Intervention (Week 1-4)||12
8346520|NCT01280266|20574551|P1|COMPLETED|First Intervention (Week 1-4)||14
8346521|NCT01280266|20574550|P2|STARTED|First Intervention (Week 1-4)||14
8346522|NCT01280266|20574551|P1|STARTED|First Intervention (Week 1-4)||15
8346523|NCT01280201|20574573|P1|NOT COMPLETED|Overall Study||0
8346524|NCT01280201|20574573|P1|COMPLETED|Overall Study||44
8346525|NCT01280201|20574573|P1|STARTED|Overall Study||44
8346526|NCT01280123|20574585|P3|NOT COMPLETED|Overall Study||1
8346527|NCT01280123|20574586|P2|NOT COMPLETED|Overall Study||4
8346528|NCT01280123|20574587|P1|NOT COMPLETED|Overall Study||1
8346529|NCT01280123|20574585|P3|COMPLETED|Overall Study||70
8346530|NCT01280123|20574586|P2|COMPLETED|Overall Study||63
8346531|NCT01280123|20574587|P1|COMPLETED|Overall Study||71
8346532|NCT01280123|20574585|P3|STARTED|Overall Study||71
8346533|NCT01280123|20574586|P2|STARTED|Overall Study||67
8346534|NCT01280123|20574587|P1|STARTED|Overall Study||72
8346535|NCT01280110|20574612|P2|NOT COMPLETED|Overall Study||0
8346536|NCT01280110|20574613|P1|NOT COMPLETED|Overall Study||0
8346537|NCT01280110|20574612|P2|COMPLETED|Overall Study||22
8346538|NCT01280110|20574613|P1|COMPLETED|Overall Study||22
8346539|NCT01280110|20574612|P2|STARTED|Overall Study||22
8346540|NCT01280110|20574613|P1|STARTED|Overall Study||22
8346541|NCT01280058|20574623|P2|NOT COMPLETED|Overall Study||0
8346542|NCT01280058|20574624|P1|NOT COMPLETED|Overall Study||0
8346543|NCT01280058|20574623|P2|COMPLETED|Overall Study||37
8346544|NCT01280058|20574624|P1|COMPLETED|Overall Study||36
8346545|NCT01280058|20574623|P2|STARTED|Overall Study||37
8346546|NCT01280058|20574624|P1|STARTED|Overall Study||36
8346547|NCT01279954|20574642|P2|NOT COMPLETED|Overall Study||4
8346548|NCT01279954|20574643|P1|NOT COMPLETED|Overall Study||3
8346549|NCT01279954|20574642|P2|COMPLETED|Overall Study||1
8346550|NCT01279954|20574643|P1|COMPLETED|Overall Study||2
8346551|NCT01279954|20574642|P2|STARTED|Overall Study||5
8346552|NCT01279954|20574643|P1|STARTED|Overall Study||5
8346553|NCT01279850|20574654|P1|NOT COMPLETED|Overall Study||91
8346554|NCT01279850|20574654|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800
8346555|NCT01279850|20574654|P1|STARTED|Overall Study||891
8346556|NCT01279681|20574670|P2|NOT COMPLETED|Overall Study||17
8346557|NCT01279681|20574671|P1|NOT COMPLETED|Overall Study||15
8346558|NCT01279681|20574670|P2|COMPLETED|Overall Study||0
8346559|NCT01279681|20574671|P1|COMPLETED|Overall Study||0
8346560|NCT01279681|20574670|P2|STARTED|Overall Study||17
8346561|NCT01279681|20574671|P1|STARTED|Overall Study||15
8346562|NCT01279616|20574683|P1|NOT COMPLETED|Overall Study||7
8346563|NCT01279616|20574683|P1|COMPLETED|Overall Study||1
8346564|NCT01279616|20574683|P1|STARTED|Overall Study||8
8346565|NCT01279564|20574689|P2|NOT COMPLETED|Overall Study||0
8346566|NCT01279564|20574690|P1|NOT COMPLETED|Overall Study||0
8346567|NCT01279564|20574689|P2|COMPLETED|Overall Study||32
8346568|NCT01279564|20574690|P1|COMPLETED|Overall Study||40
8346569|NCT01279564|20574689|P2|STARTED|Overall Study||32
8346570|NCT01279564|20574690|P1|STARTED|Overall Study||40
8346571|NCT01279486|20574696|P1|NOT COMPLETED|Overall Study||1
8346572|NCT01279486|20574696|P1|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
8346573|NCT01279486|20574696|P1|STARTED|Overall Study||120
8346574|NCT01279447|20574702|P2|NOT COMPLETED|Overall Study||1
8346575|NCT01279447|20574703|P1|NOT COMPLETED|Overall Study||3
8346576|NCT01279447|20574702|P2|COMPLETED|Overall Study||33
8346577|NCT01279447|20574703|P1|COMPLETED|Overall Study||31
8346578|NCT01279447|20574702|P2|STARTED|Overall Study||34
8346579|NCT01279447|20574703|P1|STARTED|Overall Study||34
8346580|NCT01279343|20574711|P2|NOT COMPLETED|Overall Study||6
8346581|NCT01279343|20574712|P1|NOT COMPLETED|Overall Study||2
8346582|NCT01279343|20574711|P2|COMPLETED|Overall Study||58
8346583|NCT01279343|20574712|P1|COMPLETED|Overall Study||57
8346584|NCT01279343|20574711|P2|STARTED|Overall Study||64
8346585|NCT01279343|20574712|P1|STARTED|Overall Study||59
8346586|NCT01279317|20574736|P2|NOT COMPLETED|Period 2||0
8346587|NCT01279317|20574737|P1|NOT COMPLETED|Period 2||0
8346588|NCT01279317|20574736|P2|COMPLETED|Period 2||6
8346589|NCT01279317|20574737|P1|COMPLETED|Period 2||6
8346590|NCT01279317|20574736|P2|STARTED|Period 2||6
8346591|NCT01279317|20574737|P1|STARTED|Period 2||6
8346592|NCT01279317|20574736|P2|NOT COMPLETED|Washout||0
8346593|NCT01279317|20574737|P1|NOT COMPLETED|Washout||0
8346594|NCT01279317|20574736|P2|COMPLETED|Washout||6
8346595|NCT01279317|20574737|P1|COMPLETED|Washout||6
8346596|NCT01279317|20574736|P2|STARTED|Washout||6
8346597|NCT01279317|20574737|P1|STARTED|Washout||6
8346598|NCT01279317|20574736|P2|NOT COMPLETED|Period 1||0
8346599|NCT01279317|20574737|P1|NOT COMPLETED|Period 1||0
8346600|NCT01279317|20574736|P2|COMPLETED|Period 1||6
8346601|NCT01279317|20574737|P1|COMPLETED|Period 1||6
8346602|NCT01279317|20574736|P2|STARTED|Period 1||6
8346603|NCT01279317|20574737|P1|STARTED|Period 1||6
8346604|NCT01279265|20574744|P2|NOT COMPLETED|Overall Study||6
8346605|NCT01279265|20574745|P1|NOT COMPLETED|Overall Study||4
8346606|NCT01279265|20574744|P2|COMPLETED|Overall Study||11
8346607|NCT01279265|20574745|P1|COMPLETED|Overall Study||9
8346608|NCT01279265|20574744|P2|STARTED|Overall Study||17
8346609|NCT01279265|20574745|P1|STARTED|Overall Study||13
8346610|NCT01279200|20574757|P2|NOT COMPLETED|Overall Study||7
8346611|NCT01279200|20574758|P1|NOT COMPLETED|Overall Study||2
8346612|NCT01279200|20574757|P2|COMPLETED|Overall Study||4
8346613|NCT01279200|20574758|P1|COMPLETED|Overall Study||8
8346614|NCT01279200|20574757|P2|STARTED|Overall Study||11
8346615|NCT01279200|20574758|P1|STARTED|Overall Study||10
8346616|NCT01279187|20574768|P2|NOT COMPLETED|Overall Study||0
8346617|NCT01279187|20574769|P1|NOT COMPLETED|Overall Study||0
8346618|NCT01279187|20574768|P2|COMPLETED|Overall Study||13
8346619|NCT01279187|20574769|P1|COMPLETED|Overall Study||14
8346620|NCT01279187|20574768|P2|STARTED|Overall Study||13
8346621|NCT01279187|20574769|P1|STARTED|Overall Study||14
8346622|NCT01279109|20574785|P2|NOT COMPLETED|Overall Study||12
8346623|NCT01279109|20574786|P1|NOT COMPLETED|Overall Study||13
8346624|NCT01279109|20574785|P2|COMPLETED|Overall Study||55
8346625|NCT01279109|20574786|P1|COMPLETED|Overall Study||55
8346626|NCT01279109|20574785|P2|STARTED|Overall Study||67
8346627|NCT01279109|20574786|P1|STARTED|Overall Study||68
8346628|NCT01279070|20574796|P2|NOT COMPLETED|Overall Study||4
8346629|NCT01279070|20574797|P1|NOT COMPLETED|Overall Study||5
8346630|NCT01279070|20574796|P2|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
8346631|NCT01279070|20574797|P1|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
8346632|NCT01279070|20574796|P2|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
8346633|NCT01279070|20574797|P1|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
8346634|NCT01279044|20574816|P3|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
8346635|NCT01279044|20574817|P2|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
8346636|NCT01279044|20574818|P1|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
8346637|NCT01279044|20574816|P3|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
8346638|NCT01279044|20574817|P2|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
8346639|NCT01279044|20574818|P1|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
8346640|NCT01279044|20574816|P3|STARTED|PHASE 2 - Randmonized Controlled Trial||164
8346641|NCT01279044|20574817|P2|STARTED|PHASE 2 - Randmonized Controlled Trial||162
8346642|NCT01279044|20574818|P1|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
8346643|NCT01279044|20574816|P3|NOT COMPLETED|PHASE 1 - Formative||0
8346644|NCT01279044|20574817|P2|NOT COMPLETED|PHASE 1 - Formative||0
8346645|NCT01279044|20574818|P1|NOT COMPLETED|PHASE 1 - Formative||0
8346646|NCT01279044|20574816|P3|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
8346647|NCT01279044|20574817|P2|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
8346648|NCT01279044|20574818|P1|COMPLETED|PHASE 1 - Formative||59
8346649|NCT01279044|20574816|P3|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
8346650|NCT01279044|20574817|P2|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
8346651|NCT01279044|20574818|P1|STARTED|PHASE 1 - Formative||59
8346652|NCT01278953|20574838|P2|NOT COMPLETED|Overall Study||11
8346653|NCT01278953|20574839|P1|NOT COMPLETED|Overall Study||9
8346654|NCT01278953|20574838|P2|COMPLETED|Overall Study||134
8346655|NCT01278953|20574839|P1|COMPLETED|Overall Study||146
8346656|NCT01278953|20574838|P2|STARTED|Overall Study||145
8346657|NCT01278953|20574839|P1|STARTED|Overall Study||155
8346658|NCT01278927|20574851|P4|NOT COMPLETED|Overall Study||0
8346659|NCT01278927|20574852|P3|NOT COMPLETED|Overall Study||0
8346660|NCT01278927|20574853|P2|NOT COMPLETED|Overall Study||0
8346661|NCT01278927|20574854|P1|NOT COMPLETED|Overall Study||0
8346662|NCT01278927|20574851|P4|COMPLETED|Overall Study||175
8346663|NCT01278927|20574852|P3|COMPLETED|Overall Study||178
8346664|NCT01278927|20574853|P2|COMPLETED|Overall Study||178
8346665|NCT01278927|20574854|P1|COMPLETED|Overall Study||180
8346666|NCT01278927|20574851|P4|STARTED|Overall Study||175
8346667|NCT01278927|20574852|P3|STARTED|Overall Study||178
8346668|NCT01278927|20574853|P2|STARTED|Overall Study||178
8346669|NCT01278927|20574854|P1|STARTED|Overall Study||180
8346670|NCT01278862|20574894|P2|NOT COMPLETED|Overall Study||1
8346671|NCT01278862|20574895|P1|NOT COMPLETED|Overall Study||1
8346672|NCT01278862|20574894|P2|COMPLETED|Overall Study||42
8346673|NCT01278862|20574895|P1|COMPLETED|Overall Study||44
8346674|NCT01278862|20574894|P2|STARTED|Overall Study||43
8346675|NCT01278862|20574895|P1|STARTED|Overall Study||45
8346676|NCT01278797|20574903|P2|NOT COMPLETED|Period 2||0
8346677|NCT01278797|20574904|P1|NOT COMPLETED|Period 2||0
8346678|NCT01278797|20574903|P2|COMPLETED|Period 2||13
8346679|NCT01278797|20574904|P1|COMPLETED|Period 2||13
8346680|NCT01278797|20574903|P2|STARTED|Period 2||13
8346681|NCT01278797|20574904|P1|STARTED|Period 2||13
8346682|NCT01278797|20574903|P2|NOT COMPLETED|Washout Period of 21 Days||0
8346683|NCT01278797|20574904|P1|NOT COMPLETED|Washout Period of 21 Days||0
8346684|NCT01278797|20574903|P2|COMPLETED|Washout Period of 21 Days||13
8346685|NCT01278797|20574904|P1|COMPLETED|Washout Period of 21 Days||13
8346686|NCT01278797|20574903|P2|STARTED|Washout Period of 21 Days||13
8346687|NCT01278797|20574904|P1|STARTED|Washout Period of 21 Days||13
8346688|NCT01278797|20574903|P2|NOT COMPLETED|Period 1||1
8346689|NCT01278797|20574904|P1|NOT COMPLETED|Period 1||1
8346690|NCT01278797|20574903|P2|COMPLETED|Period 1||13
8346691|NCT01278797|20574904|P1|COMPLETED|Period 1||13
8346692|NCT01278797|20574903|P2|STARTED|Period 1||14
8346693|NCT01278797|20574904|P1|STARTED|Period 1||14
8346694|NCT01278745|20574916|P4|NOT COMPLETED|Overall Study||78
8346695|NCT01278745|20574917|P3|NOT COMPLETED|Overall Study||121
8346696|NCT01278745|20574918|P2|NOT COMPLETED|Overall Study||6
8346697|NCT01278745|20574919|P1|NOT COMPLETED|Overall Study||5
8346698|NCT01278745|20574916|P4|COMPLETED|Overall Study||0
8346699|NCT01278745|20574917|P3|COMPLETED|Overall Study||0
8346700|NCT01278745|20574918|P2|COMPLETED|Overall Study||68
8346701|NCT01278745|20574919|P1|COMPLETED|Overall Study||84
8346702|NCT01278745|20574916|P4|STARTED|Overall Study||78
8346703|NCT01278745|20574917|P3|STARTED|Overall Study||121
8346704|NCT01278745|20574918|P2|STARTED|Overall Study||74
8346705|NCT01278745|20574919|P1|STARTED|Overall Study||89
8346706|NCT01278615|20574951|P1|NOT COMPLETED|Overall Study||2
8346707|NCT01278615|20574951|P1|COMPLETED|Overall Study||14
8346708|NCT01278615|20574951|P1|STARTED|Overall Study||16
8346709|NCT01278485|20574961|P1|NOT COMPLETED|Overall Study||0
8346710|NCT01278485|20574961|P1|COMPLETED|Overall Study||719
8346711|NCT01278485|20574961|P1|STARTED|Overall Study||719
8346712|NCT01278407|20574977|P5|NOT COMPLETED|Extension Phase||30
8346713|NCT01278407|20574978|P4|NOT COMPLETED|Extension Phase||12
8346714|NCT01278407|20574979|P3|NOT COMPLETED|Extension Phase||0
8346715|NCT01278407|20574980|P2|NOT COMPLETED|Extension Phase||0
8346716|NCT01278407|20574981|P1|NOT COMPLETED|Extension Phase||0
8346717|NCT01278407|20574977|P5|COMPLETED|Extension Phase||66
8346718|NCT01278407|20574978|P4|COMPLETED|Extension Phase||34
8346719|NCT01278407|20574979|P3|COMPLETED|Extension Phase||0
8346720|NCT01278407|20574980|P2|COMPLETED|Extension Phase||0
8346721|NCT01278407|20574981|P1|COMPLETED|Extension Phase||0
8346722|NCT01278407|20574977|P5|STARTED|Extension Phase||96
8346723|NCT01278407|20574978|P4|STARTED|Extension Phase||46
8346724|NCT01278407|20574979|P3|STARTED|Extension Phase||0
8346725|NCT01278407|20574980|P2|STARTED|Extension Phase||0
8346726|NCT01278407|20574981|P1|STARTED|Extension Phase||0
8346727|NCT01278407|20574977|P5|NOT COMPLETED|Confirmatory Phase||0
8346728|NCT01278407|20574978|P4|NOT COMPLETED|Confirmatory Phase||0
8346729|NCT01278407|20574979|P3|NOT COMPLETED|Confirmatory Phase||6
8346730|NCT01278407|20574980|P2|NOT COMPLETED|Confirmatory Phase||16
8346731|NCT01278407|20574981|P1|NOT COMPLETED|Confirmatory Phase||9
8346732|NCT01278407|20574977|P5|COMPLETED|Confirmatory Phase||0
8346733|NCT01278407|20574978|P4|COMPLETED|Confirmatory Phase||0
8346734|NCT01278407|20574979|P3|COMPLETED|Confirmatory Phase||43
8346735|NCT01278407|20574980|P2|COMPLETED|Confirmatory Phase||31
8346736|NCT01278407|20574981|P1|COMPLETED|Confirmatory Phase||37
8346737|NCT01278407|20574977|P5|STARTED|Confirmatory Phase||0
8346738|NCT01278407|20574978|P4|STARTED|Confirmatory Phase||0
8346739|NCT01278407|20574979|P3|STARTED|Confirmatory Phase||49
8346740|NCT01278407|20574980|P2|STARTED|Confirmatory Phase||47
8346741|NCT01278407|20574981|P1|STARTED|Confirmatory Phase||46
8346742|NCT01278394|20574994|P1|NOT COMPLETED|Overall Study||1
8346743|NCT01278394|20574994|P1|COMPLETED|Overall Study||28
8346744|NCT01278394|20574994|P1|STARTED|Overall Study||29
8346745|NCT01278342|20575007|P3|NOT COMPLETED|Overall Study||0
8346746|NCT01278342|20575008|P2|NOT COMPLETED|Overall Study||1
8346747|NCT01278342|20575009|P1|NOT COMPLETED|Overall Study||4
8346748|NCT01278342|20575007|P3|COMPLETED|Overall Study||32
8346749|NCT01278342|20575008|P2|COMPLETED|Overall Study||30
8346750|NCT01278342|20575009|P1|COMPLETED|Overall Study||3
8346751|NCT01278342|20575007|P3|STARTED|Overall Study||32
8346752|NCT01278342|20575008|P2|STARTED|Overall Study||31
8346753|NCT01278342|20575009|P1|STARTED|Overall Study||7
8346754|NCT01278303|20575023|P1|NOT COMPLETED|Overall Study||0
8346755|NCT01278303|20575023|P1|COMPLETED|Overall Study||82
8346756|NCT01278303|20575023|P1|STARTED|Overall Study||82
8346757|NCT01278173|20575029|P1|NOT COMPLETED|Overall Study||27
8346758|NCT01278173|20575029|P1|COMPLETED|Overall Study||38
8346759|NCT01278173|20575029|P1|STARTED|Overall Study||65
8346760|NCT01278160|20575036|P2|NOT COMPLETED|Overall Study||6
8346761|NCT01278160|20575037|P1|NOT COMPLETED|Overall Study||5
8346762|NCT01278160|20575036|P2|COMPLETED|Overall Study||84
8346763|NCT01278160|20575037|P1|COMPLETED|Overall Study||84
8346764|NCT01278160|20575036|P2|STARTED|Overall Study||90
8346765|NCT01278160|20575037|P1|STARTED|Overall Study||89
8346766|NCT01278030|20575053|P2|NOT COMPLETED|Overall Study||4
8346767|NCT01278030|20575054|P1|NOT COMPLETED|Overall Study||8
8346768|NCT01278030|20575053|P2|COMPLETED|Overall Study||31
8346769|NCT01278030|20575054|P1|COMPLETED|Overall Study||35
8346770|NCT01278030|20575053|P2|STARTED|Overall Study||35
8346771|NCT01278030|20575054|P1|STARTED|Overall Study||43
8346772|NCT01277887|20575062|P2|NOT COMPLETED|Post-Quit Treatment Phase||5
8346773|NCT01277887|20575063|P1|NOT COMPLETED|Post-Quit Treatment Phase||3
8346774|NCT01277887|20575062|P2|COMPLETED|Post-Quit Treatment Phase||5
8346775|NCT01277887|20575063|P1|COMPLETED|Post-Quit Treatment Phase||3
8346776|NCT01277887|20575062|P2|STARTED|Post-Quit Treatment Phase||10
8346777|NCT01277887|20575063|P1|STARTED|Post-Quit Treatment Phase||6
8346778|NCT01277887|20575062|P2|NOT COMPLETED|Pre-Quit Treatment Phase||0
8346779|NCT01277887|20575063|P1|NOT COMPLETED|Pre-Quit Treatment Phase||3
8346780|NCT01277887|20575062|P2|COMPLETED|Pre-Quit Treatment Phase||10
8346781|NCT01277887|20575063|P1|COMPLETED|Pre-Quit Treatment Phase||6
8346782|NCT01277887|20575062|P2|Entered Study|Pre-Quit Treatment Phase||10
8346783|NCT01277887|20575063|P1|Entered Study|Pre-Quit Treatment Phase||7
8346784|NCT01277887|20575062|P2|STARTED|Pre-Quit Treatment Phase||10
8346785|NCT01277887|20575063|P1|STARTED|Pre-Quit Treatment Phase||9
8346786|NCT01277861|20575075|P2|NOT COMPLETED|Overall Study||2
8346787|NCT01277861|20575076|P1|NOT COMPLETED|Overall Study||2
8346788|NCT01277861|20575075|P2|COMPLETED|Overall Study||47
8346789|NCT01277861|20575076|P1|COMPLETED|Overall Study||49
8346790|NCT01277861|20575075|P2|STARTED|Overall Study||49
8346791|NCT01277861|20575076|P1|STARTED|Overall Study||51
8346792|NCT01277822|20575088|P2|NOT COMPLETED|Overall Study||11
8346793|NCT01277822|20575089|P1|NOT COMPLETED|Overall Study||15
8346794|NCT01277822|20575088|P2|COMPLETED|Overall Study||155
8346795|NCT01277822|20575089|P1|COMPLETED|Overall Study||153
8346796|NCT01277822|20575088|P2|STARTED|Overall Study||166
8346797|NCT01277822|20575089|P1|STARTED|Overall Study||168
8346798|NCT01277783|20575109|P1|NOT COMPLETED|Overall Study||0
8346799|NCT01277783|20575109|P1|COMPLETED|Overall Study||138
8346800|NCT01277783|20575109|P1|STARTED|Overall Study||138
8346801|NCT01277757|20575125|P1|NOT COMPLETED|Overall Study||2
8346802|NCT01277757|20575125|P1|COMPLETED|Overall Study||28
8346803|NCT01277757|20575125|P1|STARTED|Overall Study||30
8346804|NCT01277744|20575132|P1|NOT COMPLETED|Overall Study||2
8346805|NCT01277744|20575132|P1|COMPLETED|Overall Study||20
8346806|NCT01277744|20575132|P1|STARTED|Overall Study||22
8346807|NCT01277718|20575137|P2|NOT COMPLETED|Period 3 - Third Intervention||0
8346808|NCT01277718|20575138|P1|NOT COMPLETED|Period 3 - Third Intervention||0
8346809|NCT01277718|20575137|P2|COMPLETED|Period 3 - Third Intervention||7
8346810|NCT01277718|20575138|P1|COMPLETED|Period 3 - Third Intervention||10
8346811|NCT01277718|20575137|P2|STARTED|Period 3 - Third Intervention||7
8346812|NCT01277718|20575138|P1|STARTED|Period 3 - Third Intervention||10
8346813|NCT01277718|20575137|P2|NOT COMPLETED|Washout Period of 13 Days||0
8346814|NCT01277718|20575138|P1|NOT COMPLETED|Washout Period of 13 Days||0
8346815|NCT01277718|20575137|P2|COMPLETED|Washout Period of 13 Days||7
8346816|NCT01277718|20575138|P1|COMPLETED|Washout Period of 13 Days||10
8346817|NCT01277718|20575137|P2|STARTED|Washout Period of 13 Days||7
8346818|NCT01277718|20575138|P1|STARTED|Washout Period of 13 Days||10
8346819|NCT01277718|20575137|P2|NOT COMPLETED|Period 2 - Second Intervention||3
8346820|NCT01277718|20575138|P1|NOT COMPLETED|Period 2 - Second Intervention||0
8346821|NCT01277718|20575137|P2|COMPLETED|Period 2 - Second Intervention||7
8346822|NCT01277718|20575138|P1|COMPLETED|Period 2 - Second Intervention||10
8346823|NCT01277718|20575137|P2|STARTED|Period 2 - Second Intervention||10
8346824|NCT01277718|20575138|P1|STARTED|Period 2 - Second Intervention||10
8346825|NCT01277718|20575137|P2|NOT COMPLETED|Washout Period of 13 Days||0
8346826|NCT01277718|20575138|P1|NOT COMPLETED|Washout Period of 13 Days||0
8346827|NCT01277718|20575137|P2|COMPLETED|Washout Period of 13 Days||10
8346828|NCT01277718|20575138|P1|COMPLETED|Washout Period of 13 Days||10
8346829|NCT01277718|20575137|P2|STARTED|Washout Period of 13 Days||10
8346830|NCT01277718|20575138|P1|STARTED|Washout Period of 13 Days||10
8346831|NCT01277718|20575137|P2|NOT COMPLETED|Period 1 - First Intervention||0
8346832|NCT01277718|20575138|P1|NOT COMPLETED|Period 1 - First Intervention||0
8346833|NCT01277718|20575137|P2|COMPLETED|Period 1 - First Intervention||10
8346834|NCT01277718|20575138|P1|COMPLETED|Period 1 - First Intervention||10
8346835|NCT01277718|20575137|P2|STARTED|Period 1 - First Intervention||10
8346836|NCT01277718|20575138|P1|STARTED|Period 1 - First Intervention||10
8346837|NCT01277666|20575152|P3|NOT COMPLETED|Overall Study||49
8346838|NCT01277666|20575153|P2|NOT COMPLETED|Overall Study||59
8346839|NCT01277666|20575154|P1|NOT COMPLETED|Overall Study||45
8346840|NCT01277666|20575152|P3|COMPLETED|Overall Study||153
8346841|NCT01277666|20575153|P2|COMPLETED|Overall Study||144
8346842|NCT01277666|20575154|P1|COMPLETED|Overall Study||158
8346843|NCT01277666|20575152|P3|STARTED|Overall Study||202
8346844|NCT01277666|20575153|P2|STARTED|Overall Study||203
8346845|NCT01277666|20575154|P1|STARTED|Overall Study||203
8346846|NCT01277601|20575187|P4|NOT COMPLETED|Overall Study||36
8346847|NCT01277601|20575188|P3|NOT COMPLETED|Overall Study||27
8346848|NCT01277601|20575189|P2|NOT COMPLETED|Overall Study||48
8346849|NCT01277601|20575190|P1|NOT COMPLETED|Overall Study||37
8346850|NCT01277601|20575187|P4|COMPLETED|Overall Study||150
8346851|NCT01277601|20575188|P3|COMPLETED|Overall Study||163
8346852|NCT01277601|20575189|P2|COMPLETED|Overall Study||139
8346853|NCT01277601|20575190|P1|COMPLETED|Overall Study||151
8346854|NCT01277601|20575187|P4|STARTED|Overall Study||186
8346855|NCT01277601|20575188|P3|STARTED|Overall Study||190
8346856|NCT01277601|20575189|P2|STARTED|Overall Study||187
8346857|NCT01277601|20575190|P1|STARTED|Overall Study||188
8346858|NCT01277549|20575281|P2|NOT COMPLETED|Overall Study||14
8346859|NCT01277549|20575282|P1|NOT COMPLETED|Overall Study||26
8346860|NCT01277549|20575281|P2|COMPLETED|Overall Study||15
8346861|NCT01277549|20575282|P1|COMPLETED|Overall Study||15
8346862|NCT01277549|20575281|P2|STARTED|Overall Study||29
8346863|NCT01277549|20575282|P1|STARTED|Overall Study||41
8346864|NCT01277523|20575299|P3|NOT COMPLETED|Overall Study||0
8346865|NCT01277523|20575300|P2|NOT COMPLETED|Overall Study||1
8346866|NCT01277523|20575301|P1|NOT COMPLETED|Overall Study||3
8346867|NCT01277523|20575299|P3|COMPLETED|Overall Study||130
8346868|NCT01277523|20575300|P2|COMPLETED|Overall Study||126
8346869|NCT01277523|20575301|P1|COMPLETED|Overall Study||132
8346870|NCT01277523|20575299|P3|STARTED|Overall Study||130
8346871|NCT01277523|20575300|P2|STARTED|Overall Study||127
8346872|NCT01277523|20575301|P1|STARTED|Overall Study||135
8346873|NCT01277510|20575353|P2|NOT COMPLETED|Open-label Phase||3
8346874|NCT01277510|20575354|P1|NOT COMPLETED|Open-label Phase||7
8346875|NCT01277510|20575353|P2|COMPLETED|Open-label Phase|Completed investigational product|1
8346876|NCT01277510|20575354|P1|COMPLETED|Open-label Phase|Completed investigational product|1
8346877|NCT01277510|20575353|P2|Received Investigational Product|Open-label Phase||4
8346878|NCT01277510|20575354|P1|Received Investigational Product|Open-label Phase||6
8346879|NCT01277510|20575353|P2|STARTED|Open-label Phase||4
8346880|NCT01277510|20575354|P1|STARTED|Open-label Phase||8
8346881|NCT01277510|20575353|P2|NOT COMPLETED|Double-blind Phase||18
8346882|NCT01277510|20575354|P1|NOT COMPLETED|Double-blind Phase||13
8346883|NCT01277510|20575353|P2|COMPLETED|Double-blind Phase|Completed investigational product|4
8346884|NCT01277510|20575354|P1|COMPLETED|Double-blind Phase|Completed investigational product|8
8346885|NCT01277510|20575353|P2|Received Investigational Product|Double-blind Phase||22
8346886|NCT01277510|20575354|P1|Received Investigational Product|Double-blind Phase||21
8346887|NCT01277510|20575353|P2|STARTED|Double-blind Phase||22
8346888|NCT01277510|20575354|P1|STARTED|Double-blind Phase||21
8346889|NCT01277354|20575378|P2|NOT COMPLETED|Overall Study||0
8346890|NCT01277354|20575379|P1|NOT COMPLETED|Overall Study||0
8346891|NCT01277354|20575378|P2|COMPLETED|Overall Study||1
8346892|NCT01277354|20575379|P1|COMPLETED|Overall Study||1
8346893|NCT01277354|20575378|P2|STARTED|Overall Study||1
8346894|NCT01277354|20575379|P1|STARTED|Overall Study||1
8346895|NCT01277341|20575389|P4|NOT COMPLETED|Overall Study||6
8346896|NCT01277341|20575390|P3|NOT COMPLETED|Overall Study||4
8346897|NCT01277341|20575391|P2|NOT COMPLETED|Overall Study||5
8346898|NCT01277341|20575392|P1|NOT COMPLETED|Overall Study||4
8346899|NCT01277341|20575389|P4|COMPLETED|Overall Study||146
8346900|NCT01277341|20575390|P3|COMPLETED|Overall Study||145
8346901|NCT01277341|20575391|P2|COMPLETED|Overall Study||145
8346902|NCT01277341|20575392|P1|COMPLETED|Overall Study||146
8346903|NCT01277341|20575389|P4|STARTED|Overall Study||152
8346904|NCT01277341|20575390|P3|STARTED|Overall Study||149
8346905|NCT01277341|20575391|P2|STARTED|Overall Study||150
8346906|NCT01277341|20575392|P1|STARTED|Overall Study||150
8346907|NCT01277302|20575405|P3|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
8346908|NCT01277302|20575406|P2|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
8346909|NCT01277302|20575407|P1|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
8346910|NCT01277302|20575405|P3|COMPLETED|8-Month Alternate Dose Regimen Period||13
8346911|NCT01277302|20575406|P2|COMPLETED|8-Month Alternate Dose Regimen Period||82
8346912|NCT01277302|20575407|P1|COMPLETED|8-Month Alternate Dose Regimen Period||80
8346913|NCT01277302|20575405|P3|STARTED|8-Month Alternate Dose Regimen Period||19
8346914|NCT01277302|20575406|P2|STARTED|8-Month Alternate Dose Regimen Period||86
8346915|NCT01277302|20575407|P1|STARTED|8-Month Alternate Dose Regimen Period||85
8346916|NCT01277302|20575405|P3|NOT COMPLETED|7-Month Fixed Treatment Period||12
8346917|NCT01277302|20575406|P2|NOT COMPLETED|7-Month Fixed Treatment Period||0
8346918|NCT01277302|20575407|P1|NOT COMPLETED|7-Month Fixed Treatment Period||0
8346919|NCT01277302|20575405|P3|COMPLETED|7-Month Fixed Treatment Period||19
8346920|NCT01277302|20575406|P2|COMPLETED|7-Month Fixed Treatment Period||86
8346921|NCT01277302|20575407|P1|COMPLETED|7-Month Fixed Treatment Period||85
8346922|NCT01277302|20575405|P3|STARTED|7-Month Fixed Treatment Period||31
8346923|NCT01277302|20575406|P2|STARTED|7-Month Fixed Treatment Period||86
8346924|NCT01277302|20575407|P1|STARTED|7-Month Fixed Treatment Period||85
8346925|NCT01277211|20575439|P2|NOT COMPLETED|Overall Study||63
8346926|NCT01277211|20575440|P1|NOT COMPLETED|Overall Study||150
8346927|NCT01277211|20575439|P2|COMPLETED|Overall Study||182
8346928|NCT01277211|20575440|P1|COMPLETED|Overall Study||588
8346929|NCT01277211|20575439|P2|Treated|Overall Study||232
8346930|NCT01277211|20575440|P1|Treated|Overall Study||714
8346931|NCT01277211|20575439|P2|STARTED|Overall Study||245
8346932|NCT01277211|20575440|P1|STARTED|Overall Study||738
8346933|NCT01277159|20575455|P5|NOT COMPLETED|Overall Study||5
8346934|NCT01277159|20575456|P4|NOT COMPLETED|Overall Study||3
8346935|NCT01277159|20575457|P3|NOT COMPLETED|Overall Study||3
8346936|NCT01277159|20575458|P2|NOT COMPLETED|Overall Study||1
8346937|NCT01277159|20575459|P1|NOT COMPLETED|Overall Study||4
8346938|NCT01277159|20575455|P5|COMPLETED|Overall Study||16
8346939|NCT01277159|20575456|P4|COMPLETED|Overall Study||19
8346940|NCT01277159|20575457|P3|COMPLETED|Overall Study||19
8346941|NCT01277159|20575458|P2|COMPLETED|Overall Study||21
8346942|NCT01277159|20575459|P1|COMPLETED|Overall Study||17
8346943|NCT01277159|20575455|P5|STARTED|Overall Study||21
8346944|NCT01277159|20575456|P4|STARTED|Overall Study||22
8346945|NCT01277159|20575457|P3|STARTED|Overall Study||22
8346946|NCT01277159|20575458|P2|STARTED|Overall Study||22
8346947|NCT01277159|20575459|P1|STARTED|Overall Study||21
8346948|NCT01277081|20575473|P2|NOT COMPLETED|Overall Study||0
8346949|NCT01277081|20575474|P1|NOT COMPLETED|Overall Study||0
8346950|NCT01277081|20575473|P2|COMPLETED|Overall Study||100
8346951|NCT01277081|20575474|P1|COMPLETED|Overall Study||100
8346952|NCT01277081|20575473|P2|STARTED|Overall Study||100
8346953|NCT01277081|20575474|P1|STARTED|Overall Study||100
8346954|NCT01277042|20575492|P2|NOT COMPLETED|Overall Study||5
8346955|NCT01277042|20575493|P1|NOT COMPLETED|Overall Study||8
8346956|NCT01277042|20575492|P2|COMPLETED|Overall Study||601
8346957|NCT01277042|20575493|P1|COMPLETED|Overall Study||598
8346958|NCT01277042|20575492|P2|STARTED|Overall Study||606
8346959|NCT01277042|20575493|P1|STARTED|Overall Study||606
8346966|NCT01276847|20575529|P3|NOT COMPLETED|Overall Study||0
8346967|NCT01276847|20575530|P2|NOT COMPLETED|Overall Study||0
8346968|NCT01276847|20575531|P1|NOT COMPLETED|Overall Study||1
8346969|NCT01276847|20575529|P3|COMPLETED|Overall Study||20
8346970|NCT01276847|20575530|P2|COMPLETED|Overall Study||10
8346971|NCT01276847|20575531|P1|COMPLETED|Overall Study||9
8346972|NCT01276847|20575529|P3|STARTED|Overall Study||20
8346973|NCT01276847|20575530|P2|STARTED|Overall Study||10
8346974|NCT01276847|20575531|P1|STARTED|Overall Study||10
8346975|NCT01276821|20575541|P2|NOT COMPLETED|Overall Study||1
8346976|NCT01276821|20575542|P1|NOT COMPLETED|Overall Study||0
8346977|NCT01276821|20575541|P2|COMPLETED|Overall Study||49
8346978|NCT01276821|20575542|P1|COMPLETED|Overall Study||50
8346979|NCT01276821|20575541|P2|STARTED|Overall Study||50
8346980|NCT01276821|20575542|P1|STARTED|Overall Study||50
8346981|NCT01276756|20575562|P2|NOT COMPLETED|Overall Study||2
8346982|NCT01276756|20575563|P1|NOT COMPLETED|Overall Study||5
8346983|NCT01276756|20575562|P2|COMPLETED|Overall Study||48
8346984|NCT01276756|20575563|P1|COMPLETED|Overall Study||45
8346985|NCT01276756|20575562|P2|STARTED|Overall Study||50
8346986|NCT01276756|20575563|P1|STARTED|Overall Study||50
8346987|NCT01276652|20575580|P3|NOT COMPLETED|Period 2: Observational||0
8346988|NCT01276652|20575581|P2|NOT COMPLETED|Period 2: Observational||0
8346989|NCT01276652|20575582|P1|NOT COMPLETED|Period 2: Observational||0
8346990|NCT01276652|20575580|P3|COMPLETED|Period 2: Observational||5
8346991|NCT01276652|20575581|P2|COMPLETED|Period 2: Observational||8
8346992|NCT01276652|20575582|P1|COMPLETED|Period 2: Observational||9
8346993|NCT01276652|20575580|P3|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
8346994|NCT01276652|20575581|P2|STARTED|Period 2: Observational||8
8346995|NCT01276652|20575582|P1|STARTED|Period 2: Observational||9
8346996|NCT01276652|20575580|P3|NOT COMPLETED|Period 1: Randomization||0
8346997|NCT01276652|20575581|P2|NOT COMPLETED|Period 1: Randomization||0
8346998|NCT01276652|20575582|P1|NOT COMPLETED|Period 1: Randomization||0
8346999|NCT01276652|20575580|P3|COMPLETED|Period 1: Randomization||0
8347000|NCT01276652|20575581|P2|COMPLETED|Period 1: Randomization||8
8347001|NCT01276652|20575582|P1|COMPLETED|Period 1: Randomization||9
8347002|NCT01276652|20575580|P3|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
8347003|NCT01276652|20575581|P2|STARTED|Period 1: Randomization||8
8347004|NCT01276652|20575582|P1|STARTED|Period 1: Randomization||9
8347005|NCT01276639|20575608|P5|NOT COMPLETED|Week 16 to 52||21
8347006|NCT01276639|20575609|P4|NOT COMPLETED|Week 16 to 52||16
8347007|NCT01276639|20575610|P3|NOT COMPLETED|Week 16 to 52||0
8347008|NCT01276639|20575611|P2|NOT COMPLETED|Week 16 to 52||101
8347009|NCT01276639|20575612|P1|NOT COMPLETED|Week 16 to 52||127
8347010|NCT01276639|20575608|P5|COMPLETED|Week 16 to 52||45
8347011|NCT01276639|20575609|P4|COMPLETED|Week 16 to 52||50
8347012|NCT01276639|20575610|P3|COMPLETED|Week 16 to 52||0
8347013|NCT01276639|20575611|P2|COMPLETED|Week 16 to 52||219
8347014|NCT01276639|20575612|P1|COMPLETED|Week 16 to 52||186
8347015|NCT01276639|20575608|P5|STARTED|Week 16 to 52||66
8347016|NCT01276639|20575609|P4|STARTED|Week 16 to 52||66
8347017|NCT01276639|20575610|P3|STARTED|Week 16 to 52||0
8347018|NCT01276639|20575611|P2|STARTED|Week 16 to 52||320
8347019|NCT01276639|20575612|P1|STARTED|Week 16 to 52||313
8347020|NCT01276639|20575608|P5|NOT COMPLETED|Week 0 to 16||0
8347021|NCT01276639|20575609|P4|NOT COMPLETED|Week 0 to 16||0
8347022|NCT01276639|20575610|P3|NOT COMPLETED|Week 0 to 16||45
8347023|NCT01276639|20575611|P2|NOT COMPLETED|Week 0 to 16||41
8347024|NCT01276639|20575612|P1|NOT COMPLETED|Week 0 to 16||50
8347025|NCT01276639|20575608|P5|COMPLETED|Week 0 to 16||0
8347026|NCT01276639|20575609|P4|COMPLETED|Week 0 to 16||0
8347027|NCT01276639|20575610|P3|COMPLETED|Week 0 to 16||132
8347028|NCT01276639|20575611|P2|COMPLETED|Week 0 to 16||320
8347029|NCT01276639|20575612|P1|COMPLETED|Week 0 to 16||313
8347030|NCT01276639|20575608|P5|Treated|Week 0 to 16||0
8347031|NCT01276639|20575609|P4|Treated|Week 0 to 16||0
8347032|NCT01276639|20575610|P3|Treated|Week 0 to 16||177
8347033|NCT01276639|20575611|P2|Treated|Week 0 to 16||360
8347034|NCT01276639|20575612|P1|Treated|Week 0 to 16||363
8347035|NCT01276639|20575608|P5|STARTED|Week 0 to 16||0
8347036|NCT01276639|20575609|P4|STARTED|Week 0 to 16||0
8347037|NCT01276639|20575610|P3|STARTED|Week 0 to 16||177
8347038|NCT01276639|20575611|P2|STARTED|Week 0 to 16||361
8347039|NCT01276639|20575612|P1|STARTED|Week 0 to 16||363
8347040|NCT01276535|20575807|P1|NOT COMPLETED|Overall Study||0
8347041|NCT01276535|20575807|P1|COMPLETED|Overall Study||12
8347042|NCT01276535|20575807|P1|STARTED|Overall Study||12
8347055|NCT01276457|20575873|P2|NOT COMPLETED|Extension Study||2
8347056|NCT01276457|20575874|P1|NOT COMPLETED|Extension Study||6
8347057|NCT01276457|20575873|P2|COMPLETED|Extension Study||110
8347058|NCT01276457|20575874|P1|COMPLETED|Extension Study||105
8347059|NCT01276457|20575873|P2|STARTED|Extension Study||112
8347060|NCT01276457|20575874|P1|STARTED|Extension Study||111
8347061|NCT01276457|20575873|P2|NOT COMPLETED|Core Study||20
8347062|NCT01276457|20575874|P1|NOT COMPLETED|Core Study||13
8347063|NCT01276457|20575873|P2|COMPLETED|Core Study||123
8347064|NCT01276457|20575874|P1|COMPLETED|Core Study||129
8347065|NCT01276457|20575873|P2|STARTED|Core Study||143
8347066|NCT01276457|20575874|P1|STARTED|Core Study||142
8347067|NCT01276353|20575888|P2|NOT COMPLETED|Extension||9
8347068|NCT01276353|20575889|P1|NOT COMPLETED|Extension||7
8347069|NCT01276353|20575888|P2|COMPLETED|Extension||14
8347070|NCT01276353|20575889|P1|COMPLETED|Extension||12
8347071|NCT01276353|20575888|P2|STARTED|Extension||23
8347072|NCT01276353|20575889|P1|STARTED|Extension||19
8347073|NCT01276353|20575888|P2|NOT COMPLETED|Double-blind||0
8347074|NCT01276353|20575889|P1|NOT COMPLETED|Double-blind||3
8347075|NCT01276353|20575888|P2|COMPLETED|Double-blind||23
8347076|NCT01276353|20575889|P1|COMPLETED|Double-blind||19
8347077|NCT01276353|20575888|P2|STARTED|Double-blind||23
8347078|NCT01276353|20575889|P1|STARTED|Double-blind||22
8347079|NCT01276327|20575901|P2|NOT COMPLETED|Overall Study||3
8347080|NCT01276327|20575902|P1|NOT COMPLETED|Overall Study||2
8347081|NCT01276327|20575901|P2|COMPLETED|Overall Study||29
8347082|NCT01276327|20575902|P1|COMPLETED|Overall Study||30
8347083|NCT01276327|20575901|P2|STARTED|Overall Study||32
8347084|NCT01276327|20575902|P1|STARTED|Overall Study||32
8347085|NCT01276314|20575928|P4|NOT COMPLETED|Overall Study||5
8347086|NCT01276314|20575929|P3|NOT COMPLETED|Overall Study||4
8347087|NCT01276314|20575930|P2|NOT COMPLETED|Overall Study||10
8347088|NCT01276314|20575931|P1|NOT COMPLETED|Overall Study||10
8347089|NCT01276314|20575928|P4|COMPLETED|Overall Study||17
8347090|NCT01276314|20575929|P3|COMPLETED|Overall Study||18
8347091|NCT01276314|20575930|P2|COMPLETED|Overall Study||33
8347092|NCT01276314|20575931|P1|COMPLETED|Overall Study||38
8347093|NCT01276314|20575928|P4|STARTED|Overall Study||22
8347094|NCT01276314|20575929|P3|STARTED|Overall Study||22
8347095|NCT01276314|20575930|P2|STARTED|Overall Study||43
8347096|NCT01276314|20575931|P1|STARTED|Overall Study||48
8347097|NCT01276301|20575941|P2|NOT COMPLETED|Second Intervention||0
8347098|NCT01276301|20575942|P1|NOT COMPLETED|Second Intervention||0
8347099|NCT01276301|20575941|P2|COMPLETED|Second Intervention||8
8347100|NCT01276301|20575942|P1|COMPLETED|Second Intervention||8
8347101|NCT01276301|20575941|P2|STARTED|Second Intervention||8
8347102|NCT01276301|20575942|P1|STARTED|Second Intervention||8
8347103|NCT01276301|20575941|P2|NOT COMPLETED|Washout Period of 7 Days||0
8347104|NCT01276301|20575942|P1|NOT COMPLETED|Washout Period of 7 Days||0
8347105|NCT01276301|20575941|P2|COMPLETED|Washout Period of 7 Days||8
8347106|NCT01276301|20575942|P1|COMPLETED|Washout Period of 7 Days||8
8347107|NCT01276301|20575941|P2|STARTED|Washout Period of 7 Days||8
8347108|NCT01276301|20575942|P1|STARTED|Washout Period of 7 Days||8
8347109|NCT01276301|20575941|P2|NOT COMPLETED|First Intervention||0
8347110|NCT01276301|20575942|P1|NOT COMPLETED|First Intervention||0
8347111|NCT01276301|20575941|P2|COMPLETED|First Intervention||8
8347112|NCT01276301|20575942|P1|COMPLETED|First Intervention||8
8347113|NCT01276301|20575941|P2|STARTED|First Intervention||8
8347114|NCT01276301|20575942|P1|STARTED|First Intervention||8
8347115|NCT01276288|20575969|P4|NOT COMPLETED|Overall Study||0
8347116|NCT01276288|20575970|P3|NOT COMPLETED|Overall Study||0
8347117|NCT01276288|20575971|P2|NOT COMPLETED|Overall Study||1
8347118|NCT01276288|20575972|P1|NOT COMPLETED|Overall Study||2
8347119|NCT01276288|20575969|P4|COMPLETED|Overall Study||5
8347120|NCT01276288|20575970|P3|COMPLETED|Overall Study||5
8347121|NCT01276288|20575971|P2|COMPLETED|Overall Study||5
8347122|NCT01276288|20575972|P1|COMPLETED|Overall Study||5
8347123|NCT01276288|20575969|P4|Received EMPA+TOR|Overall Study||5
8347124|NCT01276288|20575970|P3|Received EMPA+TOR|Overall Study||5
8347125|NCT01276288|20575971|P2|Received EMPA+TOR|Overall Study||0
8347126|NCT01276288|20575972|P1|Received EMPA+TOR|Overall Study||0
8347127|NCT01276288|20575969|P4|Received EMPA+HCT|Overall Study||0
8347128|NCT01276288|20575970|P3|Received EMPA+HCT|Overall Study||0
8347129|NCT01276288|20575971|P2|Received EMPA+HCT|Overall Study||5
8347130|NCT01276288|20575972|P1|Received EMPA+HCT|Overall Study||5
8347131|NCT01276288|20575969|P4|Received EMPA|Overall Study||5
8347132|NCT01276288|20575970|P3|Received EMPA|Overall Study||5
8347133|NCT01276288|20575971|P2|Received EMPA|Overall Study||5
8347134|NCT01276288|20575972|P1|Received EMPA|Overall Study||6
8347135|NCT01276288|20575969|P4|STARTED|Overall Study||5
8347136|NCT01276288|20575970|P3|STARTED|Overall Study||5
8347137|NCT01276288|20575971|P2|STARTED|Overall Study||6
8347138|NCT01276288|20575972|P1|STARTED|Overall Study||7
8347139|NCT01276223|20576099|P3|NOT COMPLETED|Overall Study||3
8347140|NCT01276223|20576100|P2|NOT COMPLETED|Overall Study||4
8347141|NCT01276223|20576101|P1|NOT COMPLETED|Overall Study||11
8347142|NCT01276223|20576099|P3|COMPLETED|Overall Study||101
8347143|NCT01276223|20576100|P2|COMPLETED|Overall Study||103
8347144|NCT01276223|20576101|P1|COMPLETED|Overall Study||67
8347145|NCT01276223|20576099|P3|STARTED|Overall Study||104
8347146|NCT01276223|20576100|P2|STARTED|Overall Study||107
8347147|NCT01276223|20576101|P1|STARTED|Overall Study||78
8347148|NCT01276197|20576110|P2|NOT COMPLETED|Overall Study||110
8347149|NCT01276197|20576111|P1|NOT COMPLETED|Overall Study||108
8347150|NCT01276197|20576110|P2|COMPLETED|Overall Study||200
8347151|NCT01276197|20576111|P1|COMPLETED|Overall Study||200
8347152|NCT01276197|20576110|P2|STARTED|Overall Study||310
8347153|NCT01276197|20576111|P1|STARTED|Overall Study||308
8347154|NCT01276171|20576122|P3|NOT COMPLETED|Overall Study||0
8347155|NCT01276171|20576123|P2|NOT COMPLETED|Overall Study||0
8347156|NCT01276171|20576124|P1|NOT COMPLETED|Overall Study||0
8347157|NCT01276171|20576122|P3|COMPLETED|Overall Study||256
8347158|NCT01276171|20576123|P2|COMPLETED|Overall Study||244
8347159|NCT01276171|20576124|P1|COMPLETED|Overall Study||249
8347160|NCT01276171|20576122|P3|STARTED|Overall Study||256
8347161|NCT01276171|20576123|P2|STARTED|Overall Study||244
8347162|NCT01276171|20576124|P1|STARTED|Overall Study||249
8347163|NCT01276106|20576142|P4|NOT COMPLETED|Overall Study||13
8347164|NCT01276106|20576143|P3|NOT COMPLETED|Overall Study||16
8347165|NCT01276106|20576144|P2|NOT COMPLETED|Overall Study||9
8347166|NCT01276106|20576145|P1|NOT COMPLETED|Overall Study||12
8347167|NCT01276106|20576142|P4|COMPLETED|Overall Study||52
8347168|NCT01276106|20576143|P3|COMPLETED|Overall Study||49
8347169|NCT01276106|20576144|P2|COMPLETED|Overall Study||55
8347170|NCT01276106|20576145|P1|COMPLETED|Overall Study||53
8347171|NCT01276106|20576142|P4|STARTED|Overall Study||65
8347172|NCT01276106|20576143|P3|STARTED|Overall Study||65
8347173|NCT01276106|20576144|P2|STARTED|Overall Study||64
8347174|NCT01276106|20576145|P1|STARTED|Overall Study||65
8347175|NCT01276054|20576157|P2|NOT COMPLETED|Overall Study||2
8347176|NCT01276054|20576158|P1|NOT COMPLETED|Overall Study||2
8347177|NCT01276054|20576157|P2|COMPLETED|Overall Study||0
8347178|NCT01276054|20576158|P1|COMPLETED|Overall Study||0
8347179|NCT01276054|20576157|P2|STARTED|Overall Study||2
8347180|NCT01276054|20576158|P1|STARTED|Overall Study||2
8347181|NCT01276041|20576164|P1|NOT COMPLETED|Overall Study||3
8347182|NCT01276041|20576164|P1|COMPLETED|Overall Study||67
8347183|NCT01276041|20576164|P1|STARTED|Overall Study||70
8347184|NCT01275833|20576173|P2|NOT COMPLETED|Overall Study||1
8347185|NCT01275833|20576174|P1|NOT COMPLETED|Overall Study||1
8347186|NCT01275833|20576173|P2|COMPLETED|Overall Study||0
8347187|NCT01275833|20576174|P1|COMPLETED|Overall Study||0
8347188|NCT01275833|20576173|P2|STARTED|Overall Study||1
8347189|NCT01275833|20576174|P1|STARTED|Overall Study||1
8347190|NCT01275755|20576182|P2|NOT COMPLETED|Run-out Placebo Period||0
8347191|NCT01275755|20576183|P1|NOT COMPLETED|Run-out Placebo Period||1
8347192|NCT01275755|20576182|P2|COMPLETED|Run-out Placebo Period||37
8347193|NCT01275755|20576183|P1|COMPLETED|Run-out Placebo Period||38
8347194|NCT01275755|20576182|P2|STARTED|Run-out Placebo Period||37
8347195|NCT01275755|20576183|P1|STARTED|Run-out Placebo Period||39
8347196|NCT01275755|20576182|P2|NOT COMPLETED|Double-blind Treatment Period||3
8347197|NCT01275755|20576183|P1|NOT COMPLETED|Double-blind Treatment Period||2
8347198|NCT01275755|20576182|P2|COMPLETED|Double-blind Treatment Period||37
8347199|NCT01275755|20576183|P1|COMPLETED|Double-blind Treatment Period||39
8347200|NCT01275755|20576182|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
8347201|NCT01275755|20576183|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
8347202|NCT01275755|20576182|P2|STARTED|Double-blind Treatment Period||40
8347203|NCT01275755|20576183|P1|STARTED|Double-blind Treatment Period||41
8347204|NCT01275755|20576182|P2|NOT COMPLETED|Run-in Placebo Period||0
8347205|NCT01275755|20576183|P1|NOT COMPLETED|Run-in Placebo Period||0
8347206|NCT01275755|20576182|P2|COMPLETED|Run-in Placebo Period||40
8347207|NCT01275755|20576183|P1|COMPLETED|Run-in Placebo Period||41
8347208|NCT01275755|20576182|P2|STARTED|Run-in Placebo Period||40
8347209|NCT01275755|20576183|P1|STARTED|Run-in Placebo Period||41
8347216|NCT01275664|20576210|P1|NOT COMPLETED|Overall Study||0
8347217|NCT01275664|20576210|P1|COMPLETED|Overall Study||4
8347218|NCT01275664|20576210|P1|STARTED|Overall Study||4
8347219|NCT01275625|20576218|P1|NOT COMPLETED|Overall Study||13
8347220|NCT01275625|20576218|P1|COMPLETED|Overall Study||64
8347221|NCT01275625|20576218|P1|Treated|Overall Study||77
8347222|NCT01275625|20576218|P1|STARTED|Overall Study||77
8347223|NCT01275586|20576232|P1|NOT COMPLETED|Overall Study||3
8347224|NCT01275586|20576232|P1|COMPLETED|Overall Study||3
8347225|NCT01275586|20576232|P1|STARTED|Overall Study||6
8347226|NCT01275430|20576236|P1|NOT COMPLETED|Overall Study||9
8347227|NCT01275430|20576236|P1|COMPLETED|Overall Study||18
8347228|NCT01275430|20576236|P1|STARTED|Overall Study||27
8347241|NCT01275339|20576301|P4|NOT COMPLETED|Overall Study||0
8347242|NCT01275339|20576302|P3|NOT COMPLETED|Overall Study||1
8347243|NCT01275339|20576303|P2|NOT COMPLETED|Overall Study||0
8347244|NCT01275339|20576304|P1|NOT COMPLETED|Overall Study||1
8347245|NCT01275339|20576301|P4|COMPLETED|Overall Study||4
8347246|NCT01275339|20576302|P3|COMPLETED|Overall Study||3
8347247|NCT01275339|20576303|P2|COMPLETED|Overall Study||0
8347248|NCT01275339|20576304|P1|COMPLETED|Overall Study||1
8347249|NCT01275339|20576301|P4|STARTED|Overall Study||4
8347250|NCT01275339|20576302|P3|STARTED|Overall Study||4
8347251|NCT01275339|20576303|P2|STARTED|Overall Study||0
8347252|NCT01275339|20576304|P1|STARTED|Overall Study||2
8347253|NCT01275313|20576316|P2|NOT COMPLETED|Overall Study||52
8347254|NCT01275313|20576317|P1|NOT COMPLETED|Overall Study||25
8347255|NCT01275313|20576316|P2|COMPLETED|Overall Study||79
8347256|NCT01275313|20576317|P1|COMPLETED|Overall Study||102
8347257|NCT01275313|20576316|P2|STARTED|Overall Study||131
8347258|NCT01275313|20576317|P1|STARTED|Overall Study||127
8347289|NCT01275196|20576332|P2|NOT COMPLETED|Overall Study||21
8347290|NCT01275196|20576333|P1|NOT COMPLETED|Overall Study||20
8347291|NCT01275196|20576332|P2|COMPLETED|Overall Study||113
8347292|NCT01275196|20576333|P1|COMPLETED|Overall Study||113
8347293|NCT01275196|20576332|P2|Intended to Continue Into Extension|Overall Study||113
8347294|NCT01275196|20576333|P1|Intended to Continue Into Extension|Overall Study||112
8347295|NCT01275196|20576332|P2|STARTED|Overall Study||134
8347296|NCT01275196|20576333|P1|STARTED|Overall Study||133
8347297|NCT01275170|20576380|P8|NOT COMPLETED|Part 2: Period 2||0
8347298|NCT01275170|20576381|P7|NOT COMPLETED|Part 2: Period 2||0
8347299|NCT01275170|20576382|P6|NOT COMPLETED|Part 2: Period 2||0
8347300|NCT01275170|20576383|P5|NOT COMPLETED|Part 2: Period 2||0
8347301|NCT01275170|20576384|P4|NOT COMPLETED|Part 2: Period 2||0
8347302|NCT01275170|20576385|P3|NOT COMPLETED|Part 2: Period 2||0
8347303|NCT01275170|20576386|P2|NOT COMPLETED|Part 2: Period 2||0
8347304|NCT01275170|20576387|P1|NOT COMPLETED|Part 2: Period 2||0
8347305|NCT01275170|20576380|P8|COMPLETED|Part 2: Period 2||6
8347306|NCT01275170|20576381|P7|COMPLETED|Part 2: Period 2||6
8347307|NCT01275170|20576382|P6|COMPLETED|Part 2: Period 2||0
8347308|NCT01275170|20576383|P5|COMPLETED|Part 2: Period 2||0
8347309|NCT01275170|20576384|P4|COMPLETED|Part 2: Period 2||0
8347310|NCT01275170|20576385|P3|COMPLETED|Part 2: Period 2||0
8347311|NCT01275170|20576386|P2|COMPLETED|Part 2: Period 2||0
8347312|NCT01275170|20576387|P1|COMPLETED|Part 2: Period 2||0
8347313|NCT01275170|20576380|P8|STARTED|Part 2: Period 2||6
8347314|NCT01275170|20576381|P7|STARTED|Part 2: Period 2||6
8347315|NCT01275170|20576382|P6|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0
8347316|NCT01275170|20576383|P5|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
8347317|NCT01275170|20576384|P4|STARTED|Part 2: Period 2||0
8347318|NCT01275170|20576385|P3|STARTED|Part 2: Period 2||0
8347319|NCT01275170|20576386|P2|STARTED|Part 2: Period 2||0
8347320|NCT01275170|20576387|P1|STARTED|Part 2: Period 2||0
8347321|NCT01275170|20576380|P8|NOT COMPLETED|Part 2: Period 1||0
8347322|NCT01275170|20576381|P7|NOT COMPLETED|Part 2: Period 1||0
8347323|NCT01275170|20576382|P6|NOT COMPLETED|Part 2: Period 1||0
8347324|NCT01275170|20576383|P5|NOT COMPLETED|Part 2: Period 1||0
8347325|NCT01275170|20576384|P4|NOT COMPLETED|Part 2: Period 1||0
8347326|NCT01275170|20576385|P3|NOT COMPLETED|Part 2: Period 1||0
8347327|NCT01275170|20576386|P2|NOT COMPLETED|Part 2: Period 1||0
8347328|NCT01275170|20576387|P1|NOT COMPLETED|Part 2: Period 1||0
8347329|NCT01275170|20576380|P8|COMPLETED|Part 2: Period 1||6
8347330|NCT01275170|20576381|P7|COMPLETED|Part 2: Period 1||6
8347331|NCT01275170|20576382|P6|COMPLETED|Part 2: Period 1||6
8347332|NCT01275170|20576383|P5|COMPLETED|Part 2: Period 1||6
8347333|NCT01275170|20576384|P4|COMPLETED|Part 2: Period 1||0
8347334|NCT01275170|20576385|P3|COMPLETED|Part 2: Period 1||0
8347335|NCT01275170|20576386|P2|COMPLETED|Part 2: Period 1||0
8347336|NCT01275170|20576387|P1|COMPLETED|Part 2: Period 1||0
8347337|NCT01275170|20576380|P8|STARTED|Part 2: Period 1||6
8347338|NCT01275170|20576381|P7|STARTED|Part 2: Period 1||6
8347339|NCT01275170|20576382|P6|STARTED|Part 2: Period 1||6
8347340|NCT01275170|20576383|P5|STARTED|Part 2: Period 1||6
8347341|NCT01275170|20576384|P4|STARTED|Part 2: Period 1||0
8347342|NCT01275170|20576385|P3|STARTED|Part 2: Period 1||0
8347343|NCT01275170|20576386|P2|STARTED|Part 2: Period 1||0
8347344|NCT01275170|20576387|P1|STARTED|Part 2: Period 1||0
8347345|NCT01275170|20576380|P8|NOT COMPLETED|Part 1: Period 2||0
8347346|NCT01275170|20576381|P7|NOT COMPLETED|Part 1: Period 2||0
8347347|NCT01275170|20576382|P6|NOT COMPLETED|Part 1: Period 2||0
8347348|NCT01275170|20576383|P5|NOT COMPLETED|Part 1: Period 2||0
8347349|NCT01275170|20576384|P4|NOT COMPLETED|Part 1: Period 2||0
8347350|NCT01275170|20576385|P3|NOT COMPLETED|Part 1: Period 2||0
8347351|NCT01275170|20576386|P2|NOT COMPLETED|Part 1: Period 2||0
8347352|NCT01275170|20576387|P1|NOT COMPLETED|Part 1: Period 2||0
8347353|NCT01275170|20576380|P8|COMPLETED|Part 1: Period 2||6
8347354|NCT01275170|20576381|P7|COMPLETED|Part 1: Period 2||6
8347355|NCT01275170|20576382|P6|COMPLETED|Part 1: Period 2||0
8347356|NCT01275170|20576383|P5|COMPLETED|Part 1: Period 2||0
8347357|NCT01275170|20576384|P4|COMPLETED|Part 1: Period 2||0
8347358|NCT01275170|20576385|P3|COMPLETED|Part 1: Period 2||0
8347359|NCT01275170|20576386|P2|COMPLETED|Part 1: Period 2||0
8347360|NCT01275170|20576387|P1|COMPLETED|Part 1: Period 2||0
8347361|NCT01275170|20576380|P8|STARTED|Part 1: Period 2||6
8347362|NCT01275170|20576381|P7|STARTED|Part 1: Period 2||6
8347363|NCT01275170|20576382|P6|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
8347364|NCT01275170|20576383|P5|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
8347365|NCT01275170|20576384|P4|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0
8347366|NCT01275170|20576385|P3|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0
8347367|NCT01275170|20576386|P2|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0
8347368|NCT01275170|20576387|P1|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0
8347369|NCT01275170|20576380|P8|NOT COMPLETED|Part 1: Period 1||0
8347370|NCT01275170|20576381|P7|NOT COMPLETED|Part 1: Period 1||0
8347371|NCT01275170|20576382|P6|NOT COMPLETED|Part 1: Period 1||0
8347372|NCT01275170|20576383|P5|NOT COMPLETED|Part 1: Period 1||0
8347373|NCT01275170|20576384|P4|NOT COMPLETED|Part 1: Period 1||0
8347374|NCT01275170|20576385|P3|NOT COMPLETED|Part 1: Period 1||0
8347375|NCT01275170|20576386|P2|NOT COMPLETED|Part 1: Period 1||0
8347376|NCT01275170|20576387|P1|NOT COMPLETED|Part 1: Period 1||1
8347377|NCT01275170|20576380|P8|COMPLETED|Part 1: Period 1||6
8347378|NCT01275170|20576381|P7|COMPLETED|Part 1: Period 1||6
8347379|NCT01275170|20576382|P6|COMPLETED|Part 1: Period 1||6
8347380|NCT01275170|20576383|P5|COMPLETED|Part 1: Period 1||6
8347381|NCT01275170|20576384|P4|COMPLETED|Part 1: Period 1||6
8347382|NCT01275170|20576385|P3|COMPLETED|Part 1: Period 1||6
8347383|NCT01275170|20576386|P2|COMPLETED|Part 1: Period 1||6
8347384|NCT01275170|20576387|P1|COMPLETED|Part 1: Period 1||6
8347385|NCT01275170|20576380|P8|Treated|Part 1: Period 1||6
8347386|NCT01275170|20576381|P7|Treated|Part 1: Period 1||6
8347387|NCT01275170|20576382|P6|Treated|Part 1: Period 1||6
8347388|NCT01275170|20576383|P5|Treated|Part 1: Period 1||6
8347389|NCT01275170|20576384|P4|Treated|Part 1: Period 1||6
8347390|NCT01275170|20576385|P3|Treated|Part 1: Period 1||6
8347391|NCT01275170|20576386|P2|Treated|Part 1: Period 1||6
8347392|NCT01275170|20576387|P1|Treated|Part 1: Period 1||6
8347393|NCT01275170|20576380|P8|STARTED|Part 1: Period 1||6
8347394|NCT01275170|20576381|P7|STARTED|Part 1: Period 1||6
8347395|NCT01275170|20576382|P6|STARTED|Part 1: Period 1||6
8347396|NCT01275170|20576383|P5|STARTED|Part 1: Period 1||6
8347397|NCT01275170|20576384|P4|STARTED|Part 1: Period 1||6
8347398|NCT01275170|20576385|P3|STARTED|Part 1: Period 1||6
8347399|NCT01275170|20576386|P2|STARTED|Part 1: Period 1||6
8347400|NCT01275170|20576387|P1|STARTED|Part 1: Period 1||7
8347401|NCT01275144|20576605|P2|NOT COMPLETED|Second Intervention (6 Days)||0
8347402|NCT01275144|20576606|P1|NOT COMPLETED|Second Intervention (6 Days)||1
8347403|NCT01275144|20576605|P2|COMPLETED|Second Intervention (6 Days)||14
8347404|NCT01275144|20576606|P1|COMPLETED|Second Intervention (6 Days)||13
8347405|NCT01275144|20576605|P2|STARTED|Second Intervention (6 Days)||14
8347406|NCT01275144|20576606|P1|STARTED|Second Intervention (6 Days)||14
8347407|NCT01275144|20576605|P2|NOT COMPLETED|Washout (7 Days)||0
8347408|NCT01275144|20576606|P1|NOT COMPLETED|Washout (7 Days)||0
8347409|NCT01275144|20576605|P2|COMPLETED|Washout (7 Days)||14
8347410|NCT01275144|20576606|P1|COMPLETED|Washout (7 Days)||14
8347411|NCT01275144|20576605|P2|STARTED|Washout (7 Days)||14
8347412|NCT01275144|20576606|P1|STARTED|Washout (7 Days)||14
8347413|NCT01275144|20576605|P2|NOT COMPLETED|First Intervention (6 Days)||0
8347414|NCT01275144|20576606|P1|NOT COMPLETED|First Intervention (6 Days)||0
8347415|NCT01275144|20576605|P2|COMPLETED|First Intervention (6 Days)||14
8347416|NCT01275144|20576606|P1|COMPLETED|First Intervention (6 Days)||14
8347417|NCT01275144|20576605|P2|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
8347418|NCT01275144|20576606|P1|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
8347419|NCT01275144|20576605|P2|STARTED|First Intervention (6 Days)||14
8347420|NCT01275144|20576606|P1|STARTED|First Intervention (6 Days)||14
8347421|NCT01275131|20576664|P4|NOT COMPLETED|Period 2 (Crossover)||2
8347422|NCT01275131|20576665|P3|NOT COMPLETED|Period 2 (Crossover)||1
8347423|NCT01275131|20576666|P2|NOT COMPLETED|Period 2 (Crossover)||1
8347424|NCT01275131|20576667|P1|NOT COMPLETED|Period 2 (Crossover)||1
8347425|NCT01275131|20576664|P4|COMPLETED|Period 2 (Crossover)||8
8347426|NCT01275131|20576665|P3|COMPLETED|Period 2 (Crossover)||9
8347427|NCT01275131|20576666|P2|COMPLETED|Period 2 (Crossover)||8
8347428|NCT01275131|20576667|P1|COMPLETED|Period 2 (Crossover)||8
8347429|NCT01275131|20576664|P4|STARTED|Period 2 (Crossover)||10
8347430|NCT01275131|20576665|P3|STARTED|Period 2 (Crossover)||10
8347431|NCT01275131|20576666|P2|STARTED|Period 2 (Crossover)||9
8347432|NCT01275131|20576667|P1|STARTED|Period 2 (Crossover)||9
8347433|NCT01275131|20576664|P4|NOT COMPLETED|5- to 14-Day Washout Period||0
8347434|NCT01275131|20576665|P3|NOT COMPLETED|5- to 14-Day Washout Period||0
8347435|NCT01275131|20576666|P2|NOT COMPLETED|5- to 14-Day Washout Period||0
8347436|NCT01275131|20576667|P1|NOT COMPLETED|5- to 14-Day Washout Period||0
8347437|NCT01275131|20576664|P4|COMPLETED|5- to 14-Day Washout Period||10
8347438|NCT01275131|20576665|P3|COMPLETED|5- to 14-Day Washout Period||10
8347439|NCT01275131|20576666|P2|COMPLETED|5- to 14-Day Washout Period||9
8347440|NCT01275131|20576667|P1|COMPLETED|5- to 14-Day Washout Period||9
8347441|NCT01275131|20576664|P4|STARTED|5- to 14-Day Washout Period||10
8347442|NCT01275131|20576665|P3|STARTED|5- to 14-Day Washout Period||10
8347443|NCT01275131|20576666|P2|STARTED|5- to 14-Day Washout Period||9
8347444|NCT01275131|20576667|P1|STARTED|5- to 14-Day Washout Period||9
8347445|NCT01275131|20576664|P4|NOT COMPLETED|Period 1||2
8347446|NCT01275131|20576665|P3|NOT COMPLETED|Period 1||3
8347447|NCT01275131|20576666|P2|NOT COMPLETED|Period 1||0
8347448|NCT01275131|20576667|P1|NOT COMPLETED|Period 1||2
8347449|NCT01275131|20576664|P4|COMPLETED|Period 1||10
8347450|NCT01275131|20576665|P3|COMPLETED|Period 1||10
8347451|NCT01275131|20576666|P2|COMPLETED|Period 1||9
8347452|NCT01275131|20576667|P1|COMPLETED|Period 1||9
8347453|NCT01275131|20576664|P4|Received at Least One Dose of Study Drug|Period 1||12
8347454|NCT01275131|20576665|P3|Received at Least One Dose of Study Drug|Period 1||13
8347455|NCT01275131|20576666|P2|Received at Least One Dose of Study Drug|Period 1||9
8347456|NCT01275131|20576667|P1|Received at Least One Dose of Study Drug|Period 1||11
8347457|NCT01275131|20576664|P4|STARTED|Period 1||12
8347458|NCT01275131|20576665|P3|STARTED|Period 1||13
8347459|NCT01275131|20576666|P2|STARTED|Period 1||9
8347460|NCT01275131|20576667|P1|STARTED|Period 1||11
8347461|NCT01275092|20576701|P1|NOT COMPLETED|Overall Study||0
8347462|NCT01275092|20576701|P1|COMPLETED|Overall Study||164
8347463|NCT01275092|20576701|P1|STARTED|Overall Study||164
8347464|NCT01275066|20576710|P3|NOT COMPLETED|Overall Study||1
8347465|NCT01275066|20576711|P2|NOT COMPLETED|Overall Study||0
8347466|NCT01275066|20576712|P1|NOT COMPLETED|Overall Study||1
8347467|NCT01275066|20576710|P3|COMPLETED|Overall Study||57
8347468|NCT01275066|20576711|P2|COMPLETED|Overall Study||59
8347469|NCT01275066|20576712|P1|COMPLETED|Overall Study||59
8347470|NCT01275066|20576710|P3|Treated|Overall Study||58
8347471|NCT01275066|20576711|P2|Treated|Overall Study||59
8347472|NCT01275066|20576712|P1|Treated|Overall Study||59
8347473|NCT01275066|20576710|P3|STARTED|Overall Study||58
8347474|NCT01275066|20576711|P2|STARTED|Overall Study||59
8347475|NCT01275066|20576712|P1|STARTED|Overall Study||60
8347476|NCT01275053|20576726|P1|NOT COMPLETED|Overall Study||0
8347477|NCT01275053|20576726|P1|COMPLETED|Overall Study||12
8347478|NCT01275053|20576726|P1|STARTED|Overall Study||12
8347479|NCT01274897|20576732|P2|NOT COMPLETED|Overall Study||0
8347480|NCT01274897|20576733|P1|NOT COMPLETED|Overall Study||0
8347481|NCT01274897|20576732|P2|COMPLETED|Overall Study||153
8347482|NCT01274897|20576733|P1|COMPLETED|Overall Study||297
8347483|NCT01274897|20576732|P2|STARTED|Overall Study||153
8347484|NCT01274897|20576733|P1|STARTED|Overall Study||297
8347485|NCT01274715|20576745|P1|NOT COMPLETED|Overall Study||4
8347486|NCT01274715|20576745|P1|COMPLETED|Overall Study||8
8347487|NCT01274715|20576745|P1|Screened Out at Baseline|Overall Study||3
8347488|NCT01274715|20576745|P1|STARTED|Overall Study||12
8347489|NCT01274637|20576752|P2|NOT COMPLETED|Overall Study||2
8347490|NCT01274637|20576753|P1|NOT COMPLETED|Overall Study||0
8347491|NCT01274637|20576752|P2|COMPLETED|Overall Study||30
8347492|NCT01274637|20576753|P1|COMPLETED|Overall Study||30
8347493|NCT01274637|20576752|P2|STARTED|Overall Study||32
8347494|NCT01274637|20576753|P1|STARTED|Overall Study||30
8347495|NCT01274611|20576769|P1|NOT COMPLETED|Overall Study||0
8347496|NCT01274611|20576769|P1|COMPLETED|Overall Study||20
8347497|NCT01274611|20576769|P1|STARTED|Overall Study||20
8347498|NCT01274585|20576779|P2|NOT COMPLETED|Overall Study||0
8347499|NCT01274585|20576780|P1|NOT COMPLETED|Overall Study||0
8347500|NCT01274585|20576779|P2|COMPLETED|Overall Study||3
8347501|NCT01274585|20576780|P1|COMPLETED|Overall Study||2
8347502|NCT01274585|20576779|P2|STARTED|Overall Study||3
8347503|NCT01274585|20576780|P1|STARTED|Overall Study||2
8347504|NCT01274559|20576792|P2|NOT COMPLETED|Overall Study||145
8347505|NCT01274559|20576793|P1|NOT COMPLETED|Overall Study||197
8347506|NCT01274559|20576792|P2|COMPLETED|Overall Study||441
8347507|NCT01274559|20576793|P1|COMPLETED|Overall Study||390
8347508|NCT01274559|20576792|P2|Treated|Overall Study||572
8347509|NCT01274559|20576793|P1|Treated|Overall Study||572
8347510|NCT01274559|20576792|P2|STARTED|Overall Study||586
8347511|NCT01274559|20576793|P1|STARTED|Overall Study||587
8347512|NCT01274533|20576843|P1|NOT COMPLETED|Overall Study||4
8347513|NCT01274533|20576843|P1|COMPLETED|Overall Study||0
8347514|NCT01274533|20576843|P1|STARTED|Overall Study||4
8347515|NCT01274520|20576850|P2|NOT COMPLETED|Overall Study||0
8347516|NCT01274520|20576851|P1|NOT COMPLETED|Overall Study||0
8347517|NCT01274520|20576850|P2|COMPLETED|Overall Study||24
8347518|NCT01274520|20576851|P1|COMPLETED|Overall Study||25
8347519|NCT01274520|20576850|P2|STARTED|Overall Study||24
8347520|NCT01274520|20576851|P1|STARTED|Overall Study||25
8347521|NCT01274429|20576879|P1|NOT COMPLETED|Overall Study||5
8347522|NCT01274429|20576879|P1|COMPLETED|Overall Study||0
8347523|NCT01274429|20576879|P1|STARTED|Overall Study||5
8347524|NCT01274351|20576884|P1|NOT COMPLETED|Overall Study||20
8347525|NCT01274351|20576884|P1|COMPLETED|Overall Study||92
8347526|NCT01274351|20576884|P1|STARTED|Overall Study||112
8347527|NCT01274182|20576896|P3|NOT COMPLETED|Overall Study||12
8347528|NCT01274182|20576897|P2|NOT COMPLETED|Overall Study||18
8347529|NCT01274182|20576898|P1|NOT COMPLETED|Overall Study||21
8347530|NCT01274182|20576896|P3|COMPLETED|Overall Study||80
8347531|NCT01274182|20576897|P2|COMPLETED|Overall Study||69
8347532|NCT01274182|20576898|P1|COMPLETED|Overall Study||112
8347533|NCT01274182|20576896|P3|24 Weeks|Overall Study||84
8347534|NCT01274182|20576897|P2|24 Weeks|Overall Study||83
8347535|NCT01274182|20576898|P1|24 Weeks|Overall Study||123
8347536|NCT01274182|20576896|P3|STARTED|Overall Study||92
8347537|NCT01274182|20576897|P2|STARTED|Overall Study||87
8347538|NCT01274182|20576898|P1|STARTED|Overall Study||133
8347539|NCT01273896|20576935|P1|NOT COMPLETED|Overall Study||0
8347540|NCT01273896|20576935|P1|COMPLETED|Overall Study||22
8347541|NCT01273896|20576935|P1|STARTED|Overall Study||22
8347542|NCT01273883|20576939|P2|NOT COMPLETED|Second Intervention||1
8347543|NCT01273883|20576940|P1|NOT COMPLETED|Second Intervention||2
8347544|NCT01273883|20576939|P2|COMPLETED|Second Intervention||17
8347545|NCT01273883|20576940|P1|COMPLETED|Second Intervention||15
8347546|NCT01273883|20576939|P2|STARTED|Second Intervention||18
8347547|NCT01273883|20576940|P1|STARTED|Second Intervention||17
8347548|NCT01273883|20576939|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8347549|NCT01273883|20576940|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8347550|NCT01273883|20576939|P2|COMPLETED|Washout Period of 2 Weeks||18
8347551|NCT01273883|20576940|P1|COMPLETED|Washout Period of 2 Weeks||17
8347552|NCT01273883|20576939|P2|STARTED|Washout Period of 2 Weeks||18
8347553|NCT01273883|20576940|P1|STARTED|Washout Period of 2 Weeks||17
8347554|NCT01273883|20576939|P2|NOT COMPLETED|First Intervention||1
8347555|NCT01273883|20576940|P1|NOT COMPLETED|First Intervention||2
8347556|NCT01273883|20576939|P2|COMPLETED|First Intervention||18
8347557|NCT01273883|20576940|P1|COMPLETED|First Intervention||17
8347558|NCT01273883|20576939|P2|STARTED|First Intervention|Received at least 1 dose of study drug.|19
8347559|NCT01273883|20576940|P1|STARTED|First Intervention|Received at least 1 dose of study drug.|19
8347560|NCT01273857|20576954|P2|NOT COMPLETED|Overall Study||0
8347561|NCT01273857|20576955|P1|NOT COMPLETED|Overall Study||0
8347562|NCT01273857|20576954|P2|COMPLETED|Overall Study||7
8347563|NCT01273857|20576955|P1|COMPLETED|Overall Study||7
8347564|NCT01273857|20576954|P2|STARTED|Overall Study||7
8347565|NCT01273857|20576955|P1|STARTED|Overall Study||7
8347566|NCT01273818|20576966|P3|NOT COMPLETED|Overall Study||9
8347567|NCT01273818|20576967|P2|NOT COMPLETED|Overall Study||2
8347568|NCT01273818|20576968|P1|NOT COMPLETED|Overall Study||13
8347569|NCT01273818|20576966|P3|COMPLETED|Overall Study||91
8347570|NCT01273818|20576967|P2|COMPLETED|Overall Study||98
8347571|NCT01273818|20576968|P1|COMPLETED|Overall Study||87
8347572|NCT01273818|20576966|P3|STARTED|Overall Study||100
8347573|NCT01273818|20576967|P2|STARTED|Overall Study||100
8347574|NCT01273818|20576968|P1|STARTED|Overall Study||100
8347575|NCT01273805|20576978|P2|NOT COMPLETED|Overall Study||10
8347576|NCT01273805|20576979|P1|NOT COMPLETED|Overall Study||10
8347577|NCT01273805|20576978|P2|COMPLETED|Overall Study||0
8347578|NCT01273805|20576979|P1|COMPLETED|Overall Study||0
8347579|NCT01273805|20576978|P2|STARTED|Overall Study||10
8347580|NCT01273805|20576979|P1|STARTED|Overall Study||10
8347581|NCT01273766|20576998|P3|NOT COMPLETED|Overall Study||0
8347582|NCT01273766|20576999|P2|NOT COMPLETED|Overall Study||0
8347583|NCT01273766|20577000|P1|NOT COMPLETED|Overall Study||0
8347584|NCT01273766|20576998|P3|COMPLETED|Overall Study||5
8347585|NCT01273766|20576999|P2|COMPLETED|Overall Study||7
8347586|NCT01273766|20577000|P1|COMPLETED|Overall Study||4
8347587|NCT01273766|20576998|P3|STARTED|Overall Study||5
8347588|NCT01273766|20576999|P2|STARTED|Overall Study||7
8347589|NCT01273766|20577000|P1|STARTED|Overall Study||4
8347590|NCT01273623|20577010|P1|NOT COMPLETED|Overall Study||29
8347591|NCT01273623|20577010|P1|COMPLETED|Overall Study|met IVUS criteria|26
8347592|NCT01273623|20577010|P1|STARTED|Overall Study|met angiographic criteria|55
8347593|NCT01273597|20577017|P1|NOT COMPLETED|Overall Study||8
8347594|NCT01273597|20577017|P1|COMPLETED|Overall Study||52
8347595|NCT01273597|20577017|P1|STARTED|Overall Study||60
8347596|NCT01273519|20577032|P3|NOT COMPLETED|Overall Study||8
8347597|NCT01273519|20577033|P2|NOT COMPLETED|Overall Study||5
8347598|NCT01273519|20577034|P1|NOT COMPLETED|Overall Study||19
8347599|NCT01273519|20577032|P3|COMPLETED|Overall Study||39
8347600|NCT01273519|20577033|P2|COMPLETED|Overall Study||25
8347601|NCT01273519|20577034|P1|COMPLETED|Overall Study||59
8347602|NCT01273519|20577032|P3|STARTED|Overall Study||47
8347603|NCT01273519|20577033|P2|STARTED|Overall Study||30
8347604|NCT01273519|20577034|P1|STARTED|Overall Study||78
8347605|NCT01273207|20577067|P1|NOT COMPLETED|Overall Study||5
8347606|NCT01273207|20577067|P1|COMPLETED|Overall Study||2
8347607|NCT01273207|20577067|P1|STARTED|Overall Study||7
8347608|NCT01273181|20577077|P4|NOT COMPLETED|Phase 2, Dose 2||1
8347609|NCT01273181|20577078|P3|NOT COMPLETED|Phase 2, Dose 2||0
8347610|NCT01273181|20577079|P2|NOT COMPLETED|Phase 2, Dose 2||0
8347611|NCT01273181|20577080|P1|NOT COMPLETED|Phase 2, Dose 2||0
8347612|NCT01273181|20577077|P4|COMPLETED|Phase 2, Dose 2||0
8347613|NCT01273181|20577078|P3|COMPLETED|Phase 2, Dose 2||0
8347614|NCT01273181|20577079|P2|COMPLETED|Phase 2, Dose 2||0
8347615|NCT01273181|20577080|P1|COMPLETED|Phase 2, Dose 2||0
8347616|NCT01273181|20577077|P4|STARTED|Phase 2, Dose 2||1
8347617|NCT01273181|20577078|P3|STARTED|Phase 2, Dose 2||0
8347618|NCT01273181|20577079|P2|STARTED|Phase 2, Dose 2||0
8347619|NCT01273181|20577080|P1|STARTED|Phase 2, Dose 2||0
8347620|NCT01273181|20577077|P4|NOT COMPLETED|Phase 2, Dose 1||0
8347621|NCT01273181|20577078|P3|NOT COMPLETED|Phase 2, Dose 1||1
8347622|NCT01273181|20577079|P2|NOT COMPLETED|Phase 2, Dose 1||0
8347623|NCT01273181|20577080|P1|NOT COMPLETED|Phase 2, Dose 1||0
8347624|NCT01273181|20577077|P4|COMPLETED|Phase 2, Dose 1||0
8347625|NCT01273181|20577078|P3|COMPLETED|Phase 2, Dose 1||1
8347626|NCT01273181|20577079|P2|COMPLETED|Phase 2, Dose 1||0
8347627|NCT01273181|20577080|P1|COMPLETED|Phase 2, Dose 1||0
8347628|NCT01273181|20577077|P4|STARTED|Phase 2, Dose 1||0
8347629|NCT01273181|20577078|P3|STARTED|Phase 2, Dose 1||2
8347630|NCT01273181|20577079|P2|STARTED|Phase 2, Dose 1||0
8347631|NCT01273181|20577080|P1|STARTED|Phase 2, Dose 1||0
8347632|NCT01273181|20577077|P4|NOT COMPLETED|Phase I, Dose 2||0
8347633|NCT01273181|20577078|P3|NOT COMPLETED|Phase I, Dose 2||0
8347634|NCT01273181|20577079|P2|NOT COMPLETED|Phase I, Dose 2||1
8347635|NCT01273181|20577080|P1|NOT COMPLETED|Phase I, Dose 2||0
8347636|NCT01273181|20577077|P4|COMPLETED|Phase I, Dose 2||0
8347637|NCT01273181|20577078|P3|COMPLETED|Phase I, Dose 2||0
8347638|NCT01273181|20577079|P2|COMPLETED|Phase I, Dose 2||2
8347639|NCT01273181|20577080|P1|COMPLETED|Phase I, Dose 2||0
8347640|NCT01273181|20577077|P4|STARTED|Phase I, Dose 2||0
8347641|NCT01273181|20577078|P3|STARTED|Phase I, Dose 2||0
8347642|NCT01273181|20577079|P2|STARTED|Phase I, Dose 2||3
8347643|NCT01273181|20577080|P1|STARTED|Phase I, Dose 2||0
8347644|NCT01273181|20577077|P4|NOT COMPLETED|Phase I, Dose 1||0
8347645|NCT01273181|20577078|P3|NOT COMPLETED|Phase I, Dose 1||0
8347646|NCT01273181|20577079|P2|NOT COMPLETED|Phase I, Dose 1||0
8347647|NCT01273181|20577080|P1|NOT COMPLETED|Phase I, Dose 1||1
8347648|NCT01273181|20577077|P4|COMPLETED|Phase I, Dose 1||0
8347649|NCT01273181|20577078|P3|COMPLETED|Phase I, Dose 1||0
8347650|NCT01273181|20577079|P2|COMPLETED|Phase I, Dose 1||0
8347651|NCT01273181|20577080|P1|COMPLETED|Phase I, Dose 1||2
8347652|NCT01273181|20577077|P4|STARTED|Phase I, Dose 1||0
8347653|NCT01273181|20577078|P3|STARTED|Phase I, Dose 1||0
8347654|NCT01273181|20577079|P2|STARTED|Phase I, Dose 1||0
8347655|NCT01273181|20577080|P1|STARTED|Phase I, Dose 1||3
8347656|NCT01273155|20577098|P7|NOT COMPLETED|Overall Study||6
8347657|NCT01273155|20577099|P6|NOT COMPLETED|Overall Study||5
8347658|NCT01273155|20577100|P5|NOT COMPLETED|Overall Study||2
8347659|NCT01273155|20577101|P4|NOT COMPLETED|Overall Study||1
8347660|NCT01273155|20577102|P3|NOT COMPLETED|Overall Study||12
8347661|NCT01273155|20577103|P2|NOT COMPLETED|Overall Study||4
8347662|NCT01273155|20577104|P1|NOT COMPLETED|Overall Study||2
8347663|NCT01273155|20577098|P7|COMPLETED|Overall Study||2
8347664|NCT01273155|20577099|P6|COMPLETED|Overall Study||5
8347665|NCT01273155|20577100|P5|COMPLETED|Overall Study||3
8347666|NCT01273155|20577101|P4|COMPLETED|Overall Study||4
8347667|NCT01273155|20577102|P3|COMPLETED|Overall Study||6
8347668|NCT01273155|20577103|P2|COMPLETED|Overall Study||8
8347669|NCT01273155|20577104|P1|COMPLETED|Overall Study||12
8347670|NCT01273155|20577098|P7|STARTED|Overall Study||8
8347671|NCT01273155|20577099|P6|STARTED|Overall Study||10
8347672|NCT01273155|20577100|P5|STARTED|Overall Study||5
8347673|NCT01273155|20577101|P4|STARTED|Overall Study||5
8347674|NCT01273155|20577102|P3|STARTED|Overall Study||18
8347675|NCT01273155|20577103|P2|STARTED|Overall Study||12
8347676|NCT01273155|20577104|P1|STARTED|Overall Study||14
8347677|NCT01273064|20577181|P5|NOT COMPLETED|Overall Study||10
8347678|NCT01273064|20577182|P4|NOT COMPLETED|Overall Study||20
8347679|NCT01273064|20577183|P3|NOT COMPLETED|Overall Study||31
8347680|NCT01273064|20577184|P2|NOT COMPLETED|Overall Study||30
8347681|NCT01273064|20577185|P1|NOT COMPLETED|Overall Study||23
8347682|NCT01273064|20577181|P5|COMPLETED|Overall Study||0
8347683|NCT01273064|20577182|P4|COMPLETED|Overall Study||0
8347684|NCT01273064|20577183|P3|COMPLETED|Overall Study||0
8347685|NCT01273064|20577184|P2|COMPLETED|Overall Study||0
8347686|NCT01273064|20577185|P1|COMPLETED|Overall Study||0
8347687|NCT01273064|20577181|P5|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
8347688|NCT01273064|20577182|P4|STARTED|Overall Study||20
8347689|NCT01273064|20577183|P3|STARTED|Overall Study||31
8347690|NCT01273064|20577184|P2|STARTED|Overall Study||30
8347691|NCT01273064|20577185|P1|STARTED|Overall Study||23
8347692|NCT01273038|20577204|P2|NOT COMPLETED|Second Intervention (14 Days)||2
8347693|NCT01273038|20577205|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8347694|NCT01273038|20577204|P2|COMPLETED|Second Intervention (14 Days)||8
8347695|NCT01273038|20577205|P1|COMPLETED|Second Intervention (14 Days)||10
8347696|NCT01273038|20577204|P2|STARTED|Second Intervention (14 Days)||10
8347697|NCT01273038|20577205|P1|STARTED|Second Intervention (14 Days)||10
8347698|NCT01273038|20577204|P2|NOT COMPLETED|First Intervention (14 Days)||0
8347699|NCT01273038|20577205|P1|NOT COMPLETED|First Intervention (14 Days)||0
8347700|NCT01273038|20577204|P2|COMPLETED|First Intervention (14 Days)||10
8347701|NCT01273038|20577205|P1|COMPLETED|First Intervention (14 Days)||10
8347702|NCT01273038|20577204|P2|STARTED|First Intervention (14 Days)||10
8347703|NCT01273038|20577205|P1|STARTED|First Intervention (14 Days)||10
8347704|NCT01272999|20577213|P2|NOT COMPLETED|Overall Study||0
8347705|NCT01272999|20577214|P1|NOT COMPLETED|Overall Study||0
8347706|NCT01272999|20577213|P2|COMPLETED|Overall Study||34
8347707|NCT01272999|20577214|P1|COMPLETED|Overall Study||357
8347708|NCT01272999|20577213|P2|STARTED|Overall Study||34
8347709|NCT01272999|20577214|P1|STARTED|Overall Study||357
8347710|NCT01272960|20577240|P2|NOT COMPLETED|Overall Study||0
8347711|NCT01272960|20577241|P1|NOT COMPLETED|Overall Study||0
8347712|NCT01272960|20577240|P2|COMPLETED|Overall Study||15
8347713|NCT01272960|20577241|P1|COMPLETED|Overall Study||14
8347714|NCT01272960|20577240|P2|STARTED|Overall Study||15
8347715|NCT01272960|20577241|P1|STARTED|Overall Study||14
8347716|NCT01272947|20577255|P2|NOT COMPLETED|Overall Study||2
8347717|NCT01272947|20577256|P1|NOT COMPLETED|Overall Study||2
8347718|NCT01272947|20577255|P2|COMPLETED|Overall Study||98
8347719|NCT01272947|20577256|P1|COMPLETED|Overall Study||102
8347720|NCT01272947|20577255|P2|STARTED|Overall Study||100
8347721|NCT01272947|20577256|P1|STARTED|Overall Study||104
8347722|NCT01272934|20577266|P2|NOT COMPLETED|Overall Study||2
8347723|NCT01272934|20577267|P1|NOT COMPLETED|Overall Study||0
8347724|NCT01272934|20577266|P2|COMPLETED|Overall Study||101
8347725|NCT01272934|20577267|P1|COMPLETED|Overall Study||102
8347726|NCT01272934|20577266|P2|STARTED|Overall Study||103
8347727|NCT01272934|20577267|P1|STARTED|Overall Study||102
8347728|NCT01272921|20577277|P2|NOT COMPLETED|Overall Study||1
8347729|NCT01272921|20577278|P1|NOT COMPLETED|Overall Study||2
8347730|NCT01272921|20577277|P2|COMPLETED|Overall Study||70
8347731|NCT01272921|20577278|P1|COMPLETED|Overall Study||69
8347732|NCT01272921|20577277|P2|STARTED|Overall Study||71
8347733|NCT01272921|20577278|P1|STARTED|Overall Study||71
8347734|NCT01272908|20577286|P1|NOT COMPLETED|Re-Treatment Period||6
8347735|NCT01272908|20577286|P1|COMPLETED|Re-Treatment Period||71
8347736|NCT01272908|20577286|P1|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
8347737|NCT01272908|20577286|P1|NOT COMPLETED|Initial Treatment Period||8
8347738|NCT01272908|20577286|P1|COMPLETED|Initial Treatment Period||112
8347739|NCT01272908|20577286|P1|STARTED|Initial Treatment Period||120
8347740|NCT01272882|20577320|P1|NOT COMPLETED|Overall Study||0
8347741|NCT01272882|20577320|P1|COMPLETED|Overall Study||13
8347742|NCT01272882|20577320|P1|STARTED|Overall Study||13
8347743|NCT01272869|20577326|P2|NOT COMPLETED|Period 2 (14 Days)||0
8347744|NCT01272869|20577327|P1|NOT COMPLETED|Period 2 (14 Days)||1
8347745|NCT01272869|20577326|P2|COMPLETED|Period 2 (14 Days)||10
8347746|NCT01272869|20577327|P1|COMPLETED|Period 2 (14 Days)||9
8347747|NCT01272869|20577326|P2|STARTED|Period 2 (14 Days)||10
8347748|NCT01272869|20577327|P1|STARTED|Period 2 (14 Days)||10
8347749|NCT01272869|20577326|P2|NOT COMPLETED|Period 1 (14 Days)||0
8347750|NCT01272869|20577327|P1|NOT COMPLETED|Period 1 (14 Days)||0
8347751|NCT01272869|20577326|P2|COMPLETED|Period 1 (14 Days)||10
8347752|NCT01272869|20577327|P1|COMPLETED|Period 1 (14 Days)||10
8347753|NCT01272869|20577326|P2|STARTED|Period 1 (14 Days)||10
8347754|NCT01272869|20577327|P1|STARTED|Period 1 (14 Days)||10
8347755|NCT01272830|20577335|P2|NOT COMPLETED|Overall Study||5
8347756|NCT01272830|20577336|P1|NOT COMPLETED|Overall Study||8
8347757|NCT01272830|20577335|P2|COMPLETED|Overall Study||21
8347758|NCT01272830|20577336|P1|COMPLETED|Overall Study||17
8347759|NCT01272830|20577335|P2|STARTED|Overall Study||26
8347760|NCT01272830|20577336|P1|STARTED|Overall Study||25
8347761|NCT01272804|20577354|P6|NOT COMPLETED|Overall Study||1
8347762|NCT01272804|20577355|P5|NOT COMPLETED|Overall Study||2
8347763|NCT01272804|20577356|P4|NOT COMPLETED|Overall Study||0
8347764|NCT01272804|20577357|P3|NOT COMPLETED|Overall Study||0
8347765|NCT01272804|20577358|P2|NOT COMPLETED|Overall Study||0
8347766|NCT01272804|20577359|P1|NOT COMPLETED|Overall Study||1
8347767|NCT01272804|20577354|P6|COMPLETED|Overall Study||15
8347768|NCT01272804|20577355|P5|COMPLETED|Overall Study||7
8347769|NCT01272804|20577356|P4|COMPLETED|Overall Study||9
8347770|NCT01272804|20577357|P3|COMPLETED|Overall Study||9
8347771|NCT01272804|20577358|P2|COMPLETED|Overall Study||9
8347772|NCT01272804|20577359|P1|COMPLETED|Overall Study||8
8347773|NCT01272804|20577354|P6|STARTED|Overall Study||16
8347774|NCT01272804|20577355|P5|STARTED|Overall Study||9
8347775|NCT01272804|20577356|P4|STARTED|Overall Study||9
8347776|NCT01272804|20577357|P3|STARTED|Overall Study||9
8347777|NCT01272804|20577358|P2|STARTED|Overall Study||9
8347778|NCT01272804|20577359|P1|STARTED|Overall Study||9
8347779|NCT01272661|20577517|P3|NOT COMPLETED|Overall Study||72
8347780|NCT01272661|20577518|P2|NOT COMPLETED|Overall Study||209
8347781|NCT01272661|20577519|P1|NOT COMPLETED|Overall Study||126
8347782|NCT01272661|20577517|P3|COMPLETED|Overall Study||314
8347783|NCT01272661|20577518|P2|COMPLETED|Overall Study||288
8347784|NCT01272661|20577519|P1|COMPLETED|Overall Study||287
8347785|NCT01272661|20577517|P3|STARTED|Overall Study||386
8347786|NCT01272661|20577518|P2|STARTED|Overall Study||497
8347787|NCT01272661|20577519|P1|STARTED|Overall Study||413
8347788|NCT01272635|20577544|P4|NOT COMPLETED|Overall Study||23
8347789|NCT01272635|20577545|P3|NOT COMPLETED|Overall Study||31
8347790|NCT01272635|20577546|P2|NOT COMPLETED|Overall Study||20
8347791|NCT01272635|20577547|P1|NOT COMPLETED|Overall Study||31
8347792|NCT01272635|20577544|P4|COMPLETED|Overall Study||129
8347793|NCT01272635|20577545|P3|COMPLETED|Overall Study||117
8347794|NCT01272635|20577546|P2|COMPLETED|Overall Study||134
8347795|NCT01272635|20577547|P1|COMPLETED|Overall Study||122
8347796|NCT01272635|20577544|P4|STARTED|Overall Study||152
8347797|NCT01272635|20577545|P3|STARTED|Overall Study||148
8347798|NCT01272635|20577546|P2|STARTED|Overall Study||154
8347799|NCT01272635|20577547|P1|STARTED|Overall Study||153
8347800|NCT01272583|20577565|P2|NOT COMPLETED|Overall Study||0
8347801|NCT01272583|20577566|P1|NOT COMPLETED|Overall Study||0
8347802|NCT01272583|20577565|P2|COMPLETED|Overall Study||8
8347803|NCT01272583|20577566|P1|COMPLETED|Overall Study||8
8347804|NCT01272583|20577565|P2|STARTED|Overall Study||8
8347805|NCT01272583|20577566|P1|STARTED|Overall Study||8
8347806|NCT01272388|20577597|P2|NOT COMPLETED|Overall Study||0
8347807|NCT01272388|20577598|P1|NOT COMPLETED|Overall Study||0
8347808|NCT01272388|20577597|P2|COMPLETED|Overall Study||0
8347809|NCT01272388|20577598|P1|COMPLETED|Overall Study||1
8347810|NCT01272388|20577597|P2|STARTED|Overall Study||0
8347811|NCT01272388|20577598|P1|STARTED|Overall Study||1
8347821|NCT01272245|20577620|P1|NOT COMPLETED|Overall Study||0
8347822|NCT01272245|20577620|P1|COMPLETED|Overall Study||36
8347823|NCT01272245|20577620|P1|STARTED|Overall Study||36
8347824|NCT01272232|20577631|P3|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
8347825|NCT01272232|20577632|P2|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
8347826|NCT01272232|20577633|P1|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
8347827|NCT01272232|20577631|P3|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
8347828|NCT01272232|20577632|P2|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
8347829|NCT01272232|20577633|P1|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
8347830|NCT01272232|20577631|P3|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
8347831|NCT01272232|20577632|P2|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
8347832|NCT01272232|20577633|P1|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
8347833|NCT01272232|20577631|P3|NOT COMPLETED|Weeks 0-56||72
8347834|NCT01272232|20577632|P2|NOT COMPLETED|Weeks 0-56||47
8347835|NCT01272232|20577633|P1|NOT COMPLETED|Weeks 0-56||99
8347836|NCT01272232|20577631|P3|COMPLETED|Weeks 0-56||140
8347837|NCT01272232|20577632|P2|COMPLETED|Weeks 0-56||164
8347838|NCT01272232|20577633|P1|COMPLETED|Weeks 0-56||324
8347839|NCT01272232|20577631|P3|Exposed|Weeks 0-56||212
8347840|NCT01272232|20577632|P2|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
8347841|NCT01272232|20577633|P1|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
8347842|NCT01272232|20577631|P3|STARTED|Weeks 0-56||212
8347843|NCT01272232|20577632|P2|STARTED|Weeks 0-56||211
8347844|NCT01272232|20577633|P1|STARTED|Weeks 0-56||423
8347845|NCT01272219|20577678|P6|NOT COMPLETED|Main + Extension Period: Week 0-172||422
8347846|NCT01272219|20577679|P5|NOT COMPLETED|Main + Extension Period: Week 0-172||722
8347847|NCT01272219|20577680|P4|NOT COMPLETED|Main + Extension Period: Week 0-172||0
8347848|NCT01272219|20577681|P3|NOT COMPLETED|Main + Extension Period: Week 0-172||0
8347849|NCT01272219|20577682|P2|NOT COMPLETED|Main + Extension Period: Week 0-172||0
8347850|NCT01272219|20577683|P1|NOT COMPLETED|Main + Extension Period: Week 0-172||0
8347851|NCT01272219|20577678|P6|COMPLETED|Main + Extension Period: Week 0-172||327
8347852|NCT01272219|20577679|P5|COMPLETED|Main + Extension Period: Week 0-172||783
8347853|NCT01272219|20577680|P4|COMPLETED|Main + Extension Period: Week 0-172||0
8347854|NCT01272219|20577681|P3|COMPLETED|Main + Extension Period: Week 0-172||0
8347855|NCT01272219|20577682|P2|COMPLETED|Main + Extension Period: Week 0-172||0
8347856|NCT01272219|20577683|P1|COMPLETED|Main + Extension Period: Week 0-172||0
8347857|NCT01272219|20577678|P6|Exposed|Main + Extension Period: Week 0-172||747
8347858|NCT01272219|20577679|P5|Exposed|Main + Extension Period: Week 0-172||1501
8347859|NCT01272219|20577680|P4|Exposed|Main + Extension Period: Week 0-172||0
8347860|NCT01272219|20577681|P3|Exposed|Main + Extension Period: Week 0-172||0
8347861|NCT01272219|20577682|P2|Exposed|Main + Extension Period: Week 0-172||0
8347862|NCT01272219|20577683|P1|Exposed|Main + Extension Period: Week 0-172||0
8347863|NCT01272219|20577678|P6|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
8347864|NCT01272219|20577679|P5|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
8347865|NCT01272219|20577680|P4|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
8347866|NCT01272219|20577681|P3|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
8347867|NCT01272219|20577682|P2|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
8347868|NCT01272219|20577683|P1|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
8347869|NCT01272219|20577678|P6|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8347870|NCT01272219|20577679|P5|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8347871|NCT01272219|20577680|P4|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
8347872|NCT01272219|20577681|P3|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
8347873|NCT01272219|20577682|P2|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
8347874|NCT01272219|20577683|P1|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8347875|NCT01272219|20577678|P6|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8347876|NCT01272219|20577679|P5|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8347877|NCT01272219|20577680|P4|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
8347878|NCT01272219|20577681|P3|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
8347879|NCT01272219|20577682|P2|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
8347880|NCT01272219|20577683|P1|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
8347881|NCT01272219|20577678|P6|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
8347882|NCT01272219|20577679|P5|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
8347883|NCT01272219|20577680|P4|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
8347884|NCT01272219|20577681|P3|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
8347885|NCT01272219|20577682|P2|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
8347886|NCT01272219|20577683|P1|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
8347887|NCT01272219|20577678|P6|NOT COMPLETED|Main Period: Week 0 to Week 56||252
8347888|NCT01272219|20577679|P5|NOT COMPLETED|Main Period: Week 0 to Week 56||418
8347889|NCT01272219|20577680|P4|NOT COMPLETED|Main Period: Week 0 to Week 56||191
8347890|NCT01272219|20577681|P3|NOT COMPLETED|Main Period: Week 0 to Week 56||0
8347891|NCT01272219|20577682|P2|NOT COMPLETED|Main Period: Week 0 to Week 56||0
8347892|NCT01272219|20577683|P1|NOT COMPLETED|Main Period: Week 0 to Week 56||280
8347893|NCT01272219|20577678|P6|COMPLETED|Main Period: Week 0 to Week 56||505
8347894|NCT01272219|20577679|P5|COMPLETED|Main Period: Week 0 to Week 56||1110
8347895|NCT01272219|20577680|P4|COMPLETED|Main Period: Week 0 to Week 56||296
8347896|NCT01272219|20577681|P3|COMPLETED|Main Period: Week 0 to Week 56||0
8347897|NCT01272219|20577682|P2|COMPLETED|Main Period: Week 0 to Week 56||0
8347898|NCT01272219|20577683|P1|COMPLETED|Main Period: Week 0 to Week 56||679
8347899|NCT01272219|20577678|P6|Exposed|Main Period: Week 0 to Week 56||755
8347900|NCT01272219|20577679|P5|Exposed|Main Period: Week 0 to Week 56||1524
8347901|NCT01272219|20577680|P4|Exposed|Main Period: Week 0 to Week 56||487
8347902|NCT01272219|20577681|P3|Exposed|Main Period: Week 0 to Week 56||0
8347903|NCT01272219|20577682|P2|Exposed|Main Period: Week 0 to Week 56||0
8347904|NCT01272219|20577683|P1|Exposed|Main Period: Week 0 to Week 56||957
8347905|NCT01272219|20577678|P6|STARTED|Main Period: Week 0 to Week 56||757
8347906|NCT01272219|20577679|P5|STARTED|Main Period: Week 0 to Week 56||1528
8347907|NCT01272219|20577680|P4|STARTED|Main Period: Week 0 to Week 56||487
8347908|NCT01272219|20577681|P3|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
8347909|NCT01272219|20577682|P2|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
8347910|NCT01272219|20577683|P1|STARTED|Main Period: Week 0 to Week 56||959
8347911|NCT01272193|20577717|P2|NOT COMPLETED|Overall Study||12
8347912|NCT01272193|20577718|P1|NOT COMPLETED|Overall Study||10
8347913|NCT01272193|20577717|P2|COMPLETED|Overall Study||137
8347914|NCT01272193|20577718|P1|COMPLETED|Overall Study||137
8347915|NCT01272193|20577717|P2|STARTED|Overall Study||149
8347916|NCT01272193|20577718|P1|STARTED|Overall Study||147
8347917|NCT01272180|20577738|P4|NOT COMPLETED|Overall Study||14
8347918|NCT01272180|20577739|P3|NOT COMPLETED|Overall Study||13
8347919|NCT01272180|20577740|P2|NOT COMPLETED|Overall Study||21
8347920|NCT01272180|20577741|P1|NOT COMPLETED|Overall Study||17
8347921|NCT01272180|20577738|P4|COMPLETED|Overall Study||107
8347922|NCT01272180|20577739|P3|COMPLETED|Overall Study||109
8347923|NCT01272180|20577740|P2|COMPLETED|Overall Study||100
8347924|NCT01272180|20577741|P1|COMPLETED|Overall Study||103
8347925|NCT01272180|20577738|P4|STARTED|Overall Study||121
8347926|NCT01272180|20577739|P3|STARTED|Overall Study||122
8347927|NCT01272180|20577740|P2|STARTED|Overall Study||121
8347928|NCT01272180|20577741|P1|STARTED|Overall Study||120
8347929|NCT01272141|20577781|P1|NOT COMPLETED|Overall Study||0
8347930|NCT01272141|20577781|P1|COMPLETED|Overall Study||5
8347931|NCT01272141|20577781|P1|STARTED|Overall Study||5
8347932|NCT01272076|20577786|P1|NOT COMPLETED|Overall Study||0
8347933|NCT01272076|20577786|P1|COMPLETED|Overall Study||52
8347934|NCT01272076|20577786|P1|STARTED|Overall Study||52
8347935|NCT01272011|20577793|P3|NOT COMPLETED|Overall Study||0
8347936|NCT01272011|20577794|P2|NOT COMPLETED|Overall Study||2
8347937|NCT01272011|20577795|P1|NOT COMPLETED|Overall Study||0
8347938|NCT01272011|20577793|P3|COMPLETED|Overall Study||3
8347939|NCT01272011|20577794|P2|COMPLETED|Overall Study||8
8347940|NCT01272011|20577795|P1|COMPLETED|Overall Study||3
8347941|NCT01272011|20577793|P3|STARTED|Overall Study||3
8347942|NCT01272011|20577794|P2|STARTED|Overall Study||10
8347943|NCT01272011|20577795|P1|STARTED|Overall Study||3
8347944|NCT01271946|20577808|P2|NOT COMPLETED|Overall Study||0
8347945|NCT01271946|20577809|P1|NOT COMPLETED|Overall Study||0
8347946|NCT01271946|20577808|P2|COMPLETED|Overall Study||5
8347947|NCT01271946|20577809|P1|COMPLETED|Overall Study||346
8347948|NCT01271946|20577808|P2|STARTED|Overall Study||5
8347949|NCT01271946|20577809|P1|STARTED|Overall Study||346
8347950|NCT01271933|20577831|P3|NOT COMPLETED|Double-Blind Phase||12
8347951|NCT01271933|20577832|P2|NOT COMPLETED|Double-Blind Phase||17
8347952|NCT01271933|20577833|P1|NOT COMPLETED|Double-Blind Phase||0
8347953|NCT01271933|20577831|P3|COMPLETED|Double-Blind Phase||47
8347954|NCT01271933|20577832|P2|COMPLETED|Double-Blind Phase||46
8347955|NCT01271933|20577833|P1|COMPLETED|Double-Blind Phase||0
8347956|NCT01271933|20577831|P3|Treated|Double-Blind Phase||58
8347957|NCT01271933|20577832|P2|Treated|Double-Blind Phase||63
8347958|NCT01271933|20577833|P1|Treated|Double-Blind Phase||0
8347959|NCT01271933|20577831|P3|STARTED|Double-Blind Phase||59
8347960|NCT01271933|20577832|P2|STARTED|Double-Blind Phase||63
8347961|NCT01271933|20577833|P1|STARTED|Double-Blind Phase||0
8347962|NCT01271933|20577831|P3|NOT COMPLETED|Single-Blind Phase||0
8347963|NCT01271933|20577832|P2|NOT COMPLETED|Single-Blind Phase||0
8347964|NCT01271933|20577833|P1|NOT COMPLETED|Single-Blind Phase||121
8347965|NCT01271933|20577831|P3|COMPLETED|Single-Blind Phase||0
8347966|NCT01271933|20577832|P2|COMPLETED|Single-Blind Phase||0
8347967|NCT01271933|20577833|P1|COMPLETED|Single-Blind Phase||320
8347968|NCT01271933|20577831|P3|STARTED|Single-Blind Phase||0
8347969|NCT01271933|20577832|P2|STARTED|Single-Blind Phase||0
8347970|NCT01271933|20577833|P1|STARTED|Single-Blind Phase||441
8347971|NCT01271907|20577933|P3|NOT COMPLETED|Overall Study||0
8347972|NCT01271907|20577934|P2|NOT COMPLETED|Overall Study||0
8347973|NCT01271907|20577935|P1|NOT COMPLETED|Overall Study||0
8347974|NCT01271907|20577933|P3|COMPLETED|Overall Study||0
8347975|NCT01271907|20577934|P2|COMPLETED|Overall Study||0
8347976|NCT01271907|20577935|P1|COMPLETED|Overall Study||3
8347977|NCT01271907|20577933|P3|STARTED|Overall Study||0
8347978|NCT01271907|20577934|P2|STARTED|Overall Study||0
8347979|NCT01271907|20577935|P1|STARTED|Overall Study||3
8347986|NCT01271855|20577962|P2|NOT COMPLETED|Overall Study||0
8347987|NCT01271855|20577963|P1|NOT COMPLETED|Overall Study||0
8347988|NCT01271855|20577962|P2|COMPLETED|Overall Study||52
8347989|NCT01271855|20577963|P1|COMPLETED|Overall Study||48
8347990|NCT01271855|20577962|P2|STARTED|Overall Study||52
8347991|NCT01271855|20577963|P1|STARTED|Overall Study||48
8347992|NCT01271803|20577976|P3|NOT COMPLETED|Overall Study||2
8347993|NCT01271803|20577977|P2|NOT COMPLETED|Overall Study||39
8347994|NCT01271803|20577978|P1|NOT COMPLETED|Overall Study||55
8347995|NCT01271803|20577976|P3|COMPLETED|Overall Study||0
8347996|NCT01271803|20577977|P2|COMPLETED|Overall Study||24
8347997|NCT01271803|20577978|P1|COMPLETED|Overall Study||11
8347998|NCT01271803|20577976|P3|STARTED|Overall Study||2
8347999|NCT01271803|20577977|P2|STARTED|Overall Study||63
8348000|NCT01271803|20577978|P1|STARTED|Overall Study||66
8348001|NCT01271725|20578140|P2|NOT COMPLETED|Part B||12
8348002|NCT01271725|20578141|P1|NOT COMPLETED|Part B||0
8348003|NCT01271725|20578140|P2|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27
8348004|NCT01271725|20578141|P1|COMPLETED|Part B||0
8348005|NCT01271725|20578140|P2|STARTED|Part B||39
8348006|NCT01271725|20578141|P1|STARTED|Part B||0
8348007|NCT01271725|20578140|P2|NOT COMPLETED|Part A||0
8348008|NCT01271725|20578141|P1|NOT COMPLETED|Part A||35
8348009|NCT01271725|20578140|P2|COMPLETED|Part A||0
8348010|NCT01271725|20578141|P1|COMPLETED|Part A||39
8348011|NCT01271725|20578140|P2|STARTED|Part A||0
8348012|NCT01271725|20578141|P1|STARTED|Part A|Started are the treated patients|74
8348013|NCT01271686|20578168|P1|NOT COMPLETED|Overall Study||0
8348014|NCT01271686|20578168|P1|COMPLETED|Overall Study||16
8348015|NCT01271686|20578168|P1|STARTED|Overall Study||16
8348016|NCT01271543|20578174|P2|NOT COMPLETED|Overall Study||1
8348017|NCT01271543|20578175|P1|NOT COMPLETED|Overall Study||1
8348018|NCT01271543|20578174|P2|COMPLETED|Overall Study||29
8348019|NCT01271543|20578175|P1|COMPLETED|Overall Study||29
8348020|NCT01271543|20578174|P2|STARTED|Overall Study||30
8348021|NCT01271543|20578175|P1|STARTED|Overall Study||30
8348022|NCT01271452|20578185|P2|NOT COMPLETED|Overall Study||8
8348023|NCT01271452|20578186|P1|NOT COMPLETED|Overall Study||7
8348024|NCT01271452|20578185|P2|COMPLETED|Overall Study||104
8348025|NCT01271452|20578186|P1|COMPLETED|Overall Study||105
8348026|NCT01271452|20578185|P2|STARTED|Overall Study||112
8348027|NCT01271452|20578186|P1|STARTED|Overall Study||112
8348028|NCT01271413|20578208|P2|NOT COMPLETED|Overall Study||8
8348029|NCT01271413|20578209|P1|NOT COMPLETED|Overall Study||9
8348030|NCT01271413|20578208|P2|COMPLETED|Overall Study||28
8348031|NCT01271413|20578209|P1|COMPLETED|Overall Study||28
8348032|NCT01271413|20578208|P2|STARTED|Overall Study||36
8348033|NCT01271413|20578209|P1|STARTED|Overall Study||37
8348034|NCT01271244|20578217|P2|NOT COMPLETED|Overall Study||3
8348035|NCT01271244|20578218|P1|NOT COMPLETED|Overall Study||7
8348036|NCT01271244|20578217|P2|COMPLETED|Overall Study||5
8348037|NCT01271244|20578218|P1|COMPLETED|Overall Study||11
8348038|NCT01271244|20578217|P2|STARTED|Overall Study||8
8348039|NCT01271244|20578218|P1|STARTED|Overall Study||18
8348040|NCT01271036|20578228|P2|NOT COMPLETED|Overall Study||0
8348041|NCT01271036|20578229|P1|NOT COMPLETED|Overall Study||0
8348042|NCT01271036|20578228|P2|COMPLETED|Overall Study||62
8348043|NCT01271036|20578229|P1|COMPLETED|Overall Study||62
8348044|NCT01271036|20578228|P2|STARTED|Overall Study||62
8348045|NCT01271036|20578229|P1|STARTED|Overall Study||62
8348046|NCT01271010|20578243|P1|NOT COMPLETED|Overall Study||61
8348047|NCT01271010|20578243|P1|COMPLETED|Overall Study||28
8348048|NCT01271010|20578243|P1|STARTED|Overall Study||89
8348049|NCT01270971|20578258|P2|NOT COMPLETED|Overall Study||23
8348050|NCT01270971|20578259|P1|NOT COMPLETED|Overall Study||52
8348051|NCT01270971|20578258|P2|COMPLETED|Overall Study||171
8348052|NCT01270971|20578259|P1|COMPLETED|Overall Study||348
8348053|NCT01270971|20578258|P2|STARTED|Overall Study||194
8348054|NCT01270971|20578259|P1|STARTED|Overall Study||400
8348055|NCT01270958|20578271|P1|NOT COMPLETED|Overall Study||4
8348056|NCT01270958|20578271|P1|COMPLETED|Overall Study||56
8348057|NCT01270958|20578271|P1|STARTED|Overall Study||60
8348058|NCT01270919|20578295|P1|NOT COMPLETED|Overall Study||0
8348059|NCT01270919|20578295|P1|COMPLETED|Overall Study||0
8348060|NCT01270919|20578295|P1|STARTED|Overall Study|One participant was enrolled but was censored.|0
8348061|NCT01270880|20578300|P1|NOT COMPLETED|Overall Study||1
8348062|NCT01270880|20578300|P1|COMPLETED|Overall Study||17
8348063|NCT01270880|20578300|P1|STARTED|Overall Study||18
8348064|NCT01270867|20578311|P2|NOT COMPLETED|Overall Study||0
8348065|NCT01270867|20578312|P1|NOT COMPLETED|Overall Study||1
8348066|NCT01270867|20578311|P2|COMPLETED|Overall Study||88
8348067|NCT01270867|20578312|P1|COMPLETED|Overall Study||89
8348068|NCT01270867|20578311|P2|STARTED|Overall Study||88
8348069|NCT01270867|20578312|P1|STARTED|Overall Study||90
8348070|NCT01270841|20578330|P4|NOT COMPLETED|Overall Study||13
8348071|NCT01270841|20578331|P3|NOT COMPLETED|Overall Study||11
8348072|NCT01270841|20578332|P2|NOT COMPLETED|Overall Study||14
8348073|NCT01270841|20578333|P1|NOT COMPLETED|Overall Study||13
8348074|NCT01270841|20578330|P4|COMPLETED|Overall Study||20
8348075|NCT01270841|20578331|P3|COMPLETED|Overall Study||18
8348076|NCT01270841|20578332|P2|COMPLETED|Overall Study||19
8348077|NCT01270841|20578333|P1|COMPLETED|Overall Study||16
8348078|NCT01270841|20578330|P4|STARTED|Overall Study||33
8348079|NCT01270841|20578331|P3|STARTED|Overall Study||29
8348080|NCT01270841|20578332|P2|STARTED|Overall Study||33
8348081|NCT01270841|20578333|P1|STARTED|Overall Study||29
8348082|NCT01270802|20578357|P2|NOT COMPLETED|Overall Study||1
8348083|NCT01270802|20578358|P1|NOT COMPLETED|Overall Study||2
8348084|NCT01270802|20578357|P2|COMPLETED|Overall Study||14
8348085|NCT01270802|20578358|P1|COMPLETED|Overall Study||13
8348086|NCT01270802|20578357|P2|STARTED|Overall Study||15
8348087|NCT01270802|20578358|P1|STARTED|Overall Study||15
8348088|NCT01270711|20578374|P8|NOT COMPLETED|Part 2: Effectiveness||0
8348089|NCT01270711|20578375|P7|NOT COMPLETED|Part 2: Effectiveness||0
8348090|NCT01270711|20578376|P6|NOT COMPLETED|Part 2: Effectiveness||0
8348091|NCT01270711|20578377|P5|NOT COMPLETED|Part 2: Effectiveness||0
8348092|NCT01270711|20578378|P4|NOT COMPLETED|Part 2: Effectiveness||0
8348093|NCT01270711|20578379|P3|NOT COMPLETED|Part 2: Effectiveness||0
8348094|NCT01270711|20578380|P2|NOT COMPLETED|Part 2: Effectiveness||0
8348095|NCT01270711|20578381|P1|NOT COMPLETED|Part 2: Effectiveness||0
8348096|NCT01270711|20578374|P8|COMPLETED|Part 2: Effectiveness||48
8348097|NCT01270711|20578375|P7|COMPLETED|Part 2: Effectiveness||2
8348098|NCT01270711|20578376|P6|COMPLETED|Part 2: Effectiveness||11
8348099|NCT01270711|20578377|P5|COMPLETED|Part 2: Effectiveness||0
8348100|NCT01270711|20578378|P4|COMPLETED|Part 2: Effectiveness||0
8348101|NCT01270711|20578379|P3|COMPLETED|Part 2: Effectiveness||0
8348102|NCT01270711|20578380|P2|COMPLETED|Part 2: Effectiveness||0
8348103|NCT01270711|20578381|P1|COMPLETED|Part 2: Effectiveness||0
8348104|NCT01270711|20578374|P8|STARTED|Part 2: Effectiveness||48
8348105|NCT01270711|20578375|P7|STARTED|Part 2: Effectiveness||2
8348106|NCT01270711|20578376|P6|STARTED|Part 2: Effectiveness||11
8348107|NCT01270711|20578377|P5|STARTED|Part 2: Effectiveness||0
8348108|NCT01270711|20578378|P4|STARTED|Part 2: Effectiveness||0
8348109|NCT01270711|20578379|P3|STARTED|Part 2: Effectiveness||0
8348110|NCT01270711|20578380|P2|STARTED|Part 2: Effectiveness||0
8348111|NCT01270711|20578381|P1|STARTED|Part 2: Effectiveness||0
8348112|NCT01270711|20578374|P8|NOT COMPLETED|Part 1: Compliance||0
8348113|NCT01270711|20578375|P7|NOT COMPLETED|Part 1: Compliance||0
8348114|NCT01270711|20578376|P6|NOT COMPLETED|Part 1: Compliance||0
8348115|NCT01270711|20578377|P5|NOT COMPLETED|Part 1: Compliance||0
8348116|NCT01270711|20578378|P4|NOT COMPLETED|Part 1: Compliance||0
8348117|NCT01270711|20578379|P3|NOT COMPLETED|Part 1: Compliance||0
8348118|NCT01270711|20578380|P2|NOT COMPLETED|Part 1: Compliance||0
8348119|NCT01270711|20578381|P1|NOT COMPLETED|Part 1: Compliance||0
8348120|NCT01270711|20578374|P8|COMPLETED|Part 1: Compliance||0
8348121|NCT01270711|20578375|P7|COMPLETED|Part 1: Compliance||0
8348122|NCT01270711|20578376|P6|COMPLETED|Part 1: Compliance||0
8348123|NCT01270711|20578377|P5|COMPLETED|Part 1: Compliance||2024
8348124|NCT01270711|20578378|P4|COMPLETED|Part 1: Compliance||5486
8348125|NCT01270711|20578379|P3|COMPLETED|Part 1: Compliance||326
8348126|NCT01270711|20578380|P2|COMPLETED|Part 1: Compliance||6580
8348127|NCT01270711|20578381|P1|COMPLETED|Part 1: Compliance||7537
8348128|NCT01270711|20578374|P8|STARTED|Part 1: Compliance||0
8348129|NCT01270711|20578375|P7|STARTED|Part 1: Compliance||0
8348130|NCT01270711|20578376|P6|STARTED|Part 1: Compliance||0
8348131|NCT01270711|20578377|P5|STARTED|Part 1: Compliance||2024
8348132|NCT01270711|20578378|P4|STARTED|Part 1: Compliance||5486
8348133|NCT01270711|20578379|P3|STARTED|Part 1: Compliance||326
8348134|NCT01270711|20578380|P2|STARTED|Part 1: Compliance||6580
8348135|NCT01270711|20578381|P1|STARTED|Part 1: Compliance||7537
8348136|NCT01270659|20578482|P4|NOT COMPLETED|Overall Study||0
8348137|NCT01270659|20578483|P3|NOT COMPLETED|Overall Study||0
8348138|NCT01270659|20578484|P2|NOT COMPLETED|Overall Study||0
8348139|NCT01270659|20578485|P1|NOT COMPLETED|Overall Study||0
8348140|NCT01270659|20578482|P4|COMPLETED|Overall Study||25
8348141|NCT01270659|20578483|P3|COMPLETED|Overall Study||4
8348142|NCT01270659|20578484|P2|COMPLETED|Overall Study||25
8348143|NCT01270659|20578485|P1|COMPLETED|Overall Study||6
8348144|NCT01270659|20578482|P4|STARTED|Overall Study||25
8348145|NCT01270659|20578483|P3|STARTED|Overall Study||4
8348146|NCT01270659|20578484|P2|STARTED|Overall Study||25
8348147|NCT01270659|20578485|P1|STARTED|Overall Study||6
8348148|NCT01270620|20578505|P2|NOT COMPLETED|Overall Study||3
8348149|NCT01270620|20578506|P1|NOT COMPLETED|Overall Study||1
8348150|NCT01270620|20578505|P2|COMPLETED|Overall Study||47
8348151|NCT01270620|20578506|P1|COMPLETED|Overall Study||49
8348152|NCT01270620|20578505|P2|STARTED|Overall Study||50
8348153|NCT01270620|20578506|P1|STARTED|Overall Study||50
8348154|NCT01270581|20578558|P2|NOT COMPLETED|Overall Study||0
8348155|NCT01270581|20578559|P1|NOT COMPLETED|Overall Study||1
8348156|NCT01270581|20578558|P2|COMPLETED|Overall Study||3
8348157|NCT01270581|20578559|P1|COMPLETED|Overall Study||3
8348158|NCT01270581|20578558|P2|STARTED|Overall Study||3
8348159|NCT01270581|20578559|P1|STARTED|Overall Study||4
8348160|NCT01270555|20578565|P1|NOT COMPLETED|Overall Study||13
8348161|NCT01270555|20578565|P1|COMPLETED|Overall Study||19
8348162|NCT01270555|20578565|P1|STARTED|Overall Study||32
8348163|NCT01270542|20578577|P2|NOT COMPLETED|Overall Study||1
8348164|NCT01270542|20578578|P1|NOT COMPLETED|Overall Study||1
8348165|NCT01270542|20578577|P2|COMPLETED|Overall Study||8
8348166|NCT01270542|20578578|P1|COMPLETED|Overall Study||9
8348167|NCT01270542|20578577|P2|STARTED|Overall Study||9
8348168|NCT01270542|20578578|P1|STARTED|Overall Study||10
8348169|NCT01270529|20578591|P3|NOT COMPLETED|Overall Study||0
8348170|NCT01270529|20578592|P2|NOT COMPLETED|Overall Study||0
8348171|NCT01270529|20578593|P1|NOT COMPLETED|Overall Study||0
8348172|NCT01270529|20578591|P3|COMPLETED|Overall Study||25
8348173|NCT01270529|20578592|P2|COMPLETED|Overall Study||7
8348174|NCT01270529|20578593|P1|COMPLETED|Overall Study||12
8348175|NCT01270529|20578591|P3|STARTED|Overall Study||25
8348176|NCT01270529|20578592|P2|STARTED|Overall Study||7
8348177|NCT01270529|20578593|P1|STARTED|Overall Study||12
8348178|NCT01270503|20578601|P1|NOT COMPLETED|Overall Study||1
8348179|NCT01270503|20578601|P1|COMPLETED|Overall Study||537
8348180|NCT01270503|20578601|P1|STARTED|Overall Study||538
8348181|NCT01270464|20578609|P3|NOT COMPLETED|Overall Study||18
8348182|NCT01270464|20578610|P2|NOT COMPLETED|Overall Study||12
8348183|NCT01270464|20578611|P1|NOT COMPLETED|Overall Study||20
8348184|NCT01270464|20578609|P3|COMPLETED|Overall Study||88
8348185|NCT01270464|20578610|P2|COMPLETED|Overall Study||92
8348186|NCT01270464|20578611|P1|COMPLETED|Overall Study||85
8348187|NCT01270464|20578609|P3|Pharmacokinetic Analysis Set|Overall Study||103
8348188|NCT01270464|20578610|P2|Pharmacokinetic Analysis Set|Overall Study||103
8348189|NCT01270464|20578611|P1|Pharmacokinetic Analysis Set|Overall Study||105
8348190|NCT01270464|20578609|P3|Full Analysis Set|Overall Study||103
8348191|NCT01270464|20578610|P2|Full Analysis Set|Overall Study||103
8348192|NCT01270464|20578611|P1|Full Analysis Set|Overall Study||105
8348193|NCT01270464|20578609|P3|Safety Analysis Set|Overall Study||103
8348194|NCT01270464|20578610|P2|Safety Analysis Set|Overall Study||103
8348195|NCT01270464|20578611|P1|Safety Analysis Set|Overall Study||105
8348196|NCT01270464|20578609|P3|STARTED|Overall Study||106
8348197|NCT01270464|20578610|P2|STARTED|Overall Study||104
8348198|NCT01270464|20578611|P1|STARTED|Overall Study||105
8348208|NCT01270256|20578676|P2|NOT COMPLETED|Overall Study||0
8348209|NCT01270256|20578677|P1|NOT COMPLETED|Overall Study||1
8348210|NCT01270256|20578676|P2|COMPLETED|Overall Study||20
8348211|NCT01270256|20578677|P1|COMPLETED|Overall Study||20
8348212|NCT01270256|20578676|P2|STARTED|Overall Study||20
8348213|NCT01270256|20578677|P1|STARTED|Overall Study||21
8348223|NCT01270126|20578748|P2|NOT COMPLETED|Overall Study||0
8348224|NCT01270126|20578749|P1|NOT COMPLETED|Overall Study||0
8348225|NCT01270126|20578748|P2|COMPLETED|Overall Study||10
8348226|NCT01270126|20578749|P1|COMPLETED|Overall Study||12
8348227|NCT01270126|20578748|P2|STARTED|Overall Study||10
8348228|NCT01270126|20578749|P1|STARTED|Overall Study||12
8348229|NCT01269918|20578757|P2|NOT COMPLETED|Overall Study||3
8348230|NCT01269918|20578758|P1|NOT COMPLETED|Overall Study||0
8348231|NCT01269918|20578757|P2|COMPLETED|Overall Study||68
8348232|NCT01269918|20578758|P1|COMPLETED|Overall Study||71
8348233|NCT01269918|20578757|P2|STARTED|Overall Study||71
8348234|NCT01269918|20578758|P1|STARTED|Overall Study||71
8348235|NCT01269801|20578792|P2|NOT COMPLETED|Overall Study||3
8348236|NCT01269801|20578793|P1|NOT COMPLETED|Overall Study||0
8348237|NCT01269801|20578792|P2|COMPLETED|Overall Study||77
8348238|NCT01269801|20578793|P1|COMPLETED|Overall Study||74
8348239|NCT01269801|20578792|P2|STARTED|Overall Study||80
8348240|NCT01269801|20578793|P1|STARTED|Overall Study||74
8348241|NCT01269749|20578801|P2|NOT COMPLETED|Overall Study||0
8348242|NCT01269749|20578802|P1|NOT COMPLETED|Overall Study||0
8348243|NCT01269749|20578801|P2|COMPLETED|Overall Study||3
8348244|NCT01269749|20578802|P1|COMPLETED|Overall Study||16
8348245|NCT01269749|20578801|P2|STARTED|Overall Study||3
8348246|NCT01269749|20578802|P1|STARTED|Overall Study||16
8348247|NCT01269736|20578812|P2|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
8348248|NCT01269736|20578813|P1|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
8348249|NCT01269736|20578812|P2|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
8348250|NCT01269736|20578813|P1|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
8348251|NCT01269736|20578812|P2|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
8348252|NCT01269736|20578813|P1|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
8348253|NCT01269736|20578812|P2|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
8348254|NCT01269736|20578813|P1|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
8348255|NCT01269736|20578812|P2|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
8348256|NCT01269736|20578813|P1|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
8348257|NCT01269736|20578812|P2|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
8348258|NCT01269736|20578813|P1|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
8348259|NCT01269736|20578812|P2|NOT COMPLETED|Patient Quality of Care Assessments||0
8348260|NCT01269736|20578813|P1|NOT COMPLETED|Patient Quality of Care Assessments||0
8348261|NCT01269736|20578812|P2|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
8348262|NCT01269736|20578813|P1|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
8348263|NCT01269736|20578812|P2|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
8348264|NCT01269736|20578813|P1|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
8348265|NCT01269736|20578812|P2|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
8348266|NCT01269736|20578813|P1|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
8348267|NCT01269736|20578812|P2|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
8348268|NCT01269736|20578813|P1|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
8348269|NCT01269736|20578812|P2|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
8348270|NCT01269736|20578813|P1|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
8348271|NCT01269736|20578812|P2|NOT COMPLETED|Nurses' Knowledge Assessments||0
8348272|NCT01269736|20578813|P1|NOT COMPLETED|Nurses' Knowledge Assessments||0
8348273|NCT01269736|20578812|P2|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
8348274|NCT01269736|20578813|P1|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
8348275|NCT01269736|20578812|P2|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
8348276|NCT01269736|20578813|P1|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
8348277|NCT01269736|20578812|P2|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
8348278|NCT01269736|20578813|P1|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
8348279|NCT01269736|20578812|P2|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
8348280|NCT01269736|20578813|P1|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
8348281|NCT01269736|20578812|P2|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
8348282|NCT01269736|20578813|P1|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
8348283|NCT01269710|20578825|P1|NOT COMPLETED|Overall Study||3
8348284|NCT01269710|20578825|P1|COMPLETED|Overall Study|This refers to Week 52.|1
8348285|NCT01269710|20578825|P1|Week 36|Overall Study||2
8348286|NCT01269710|20578825|P1|Week 12|Overall Study||3
8348287|NCT01269710|20578825|P1|STARTED|Overall Study||4
8348288|NCT01269385|20578833|P4|NOT COMPLETED|Overall Study||0
8348289|NCT01269385|20578834|P3|NOT COMPLETED|Overall Study||0
8348290|NCT01269385|20578835|P2|NOT COMPLETED|Overall Study||1
8348291|NCT01269385|20578836|P1|NOT COMPLETED|Overall Study||1
8348292|NCT01269385|20578833|P4|COMPLETED|Overall Study||8
8348293|NCT01269385|20578834|P3|COMPLETED|Overall Study||6
8348294|NCT01269385|20578835|P2|COMPLETED|Overall Study||3
8348295|NCT01269385|20578836|P1|COMPLETED|Overall Study||3
8348296|NCT01269385|20578833|P4|STARTED|Overall Study||8
8348297|NCT01269385|20578834|P3|STARTED|Overall Study||6
8348298|NCT01269385|20578835|P2|STARTED|Overall Study||4
8348299|NCT01269385|20578836|P1|STARTED|Overall Study||4
8348300|NCT01269372|20578850|P1|NOT COMPLETED|Overall Study||0
8348301|NCT01269372|20578850|P1|COMPLETED|Overall Study||30
8348302|NCT01269372|20578850|P1|STARTED|Overall Study||30
8348303|NCT01269346|20578861|P1|NOT COMPLETED|Extension Phase||43
8348304|NCT01269346|20578861|P1|COMPLETED|Extension Phase||0
8348305|NCT01269346|20578861|P1|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
8348306|NCT01269346|20578861|P1|NOT COMPLETED|Treatment Phase||9
8348307|NCT01269346|20578861|P1|COMPLETED|Treatment Phase||43
8348308|NCT01269346|20578861|P1|Completed 6 Cycles|Treatment Phase||45
8348309|NCT01269346|20578861|P1|STARTED|Treatment Phase||52
8348310|NCT01269125|20578872|P3|NOT COMPLETED|Overall Study||0
8348311|NCT01269125|20578873|P2|NOT COMPLETED|Overall Study||5
8348312|NCT01269125|20578874|P1|NOT COMPLETED|Overall Study||7
8348313|NCT01269125|20578872|P3|COMPLETED|Overall Study||60
8348314|NCT01269125|20578873|P2|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
8348315|NCT01269125|20578874|P1|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
8348316|NCT01269125|20578872|P3|STARTED|Overall Study||60
8348317|NCT01269125|20578873|P2|STARTED|Overall Study||60
8348318|NCT01269125|20578874|P1|STARTED|Overall Study||60
8348319|NCT01269047|20578897|P3|NOT COMPLETED|Overall Study||1
8348320|NCT01269047|20578898|P2|NOT COMPLETED|Overall Study||2
8348321|NCT01269047|20578899|P1|NOT COMPLETED|Overall Study||1
8348322|NCT01269047|20578897|P3|COMPLETED|Overall Study||10
8348323|NCT01269047|20578898|P2|COMPLETED|Overall Study||11
8348324|NCT01269047|20578899|P1|COMPLETED|Overall Study||12
8348325|NCT01269047|20578897|P3|STARTED|Overall Study||11
8348326|NCT01269047|20578898|P2|STARTED|Overall Study||13
8348327|NCT01269047|20578899|P1|STARTED|Overall Study||13
8348328|NCT01268943|20578918|P4|NOT COMPLETED|Overall Study||0
8348329|NCT01268943|20578919|P3|NOT COMPLETED|Overall Study||0
8348330|NCT01268943|20578920|P2|NOT COMPLETED|Overall Study||0
8348331|NCT01268943|20578921|P1|NOT COMPLETED|Overall Study||0
8348332|NCT01268943|20578918|P4|COMPLETED|Overall Study||6
8348333|NCT01268943|20578919|P3|COMPLETED|Overall Study||3
8348334|NCT01268943|20578920|P2|COMPLETED|Overall Study||3
8348335|NCT01268943|20578921|P1|COMPLETED|Overall Study||6
8348336|NCT01268943|20578918|P4|STARTED|Overall Study||6
8348337|NCT01268943|20578919|P3|STARTED|Overall Study||3
8348338|NCT01268943|20578920|P2|STARTED|Overall Study||3
8348339|NCT01268943|20578921|P1|STARTED|Overall Study||6
8348340|NCT01268891|20578933|P2|NOT COMPLETED|Overall Study||8
8348341|NCT01268891|20578934|P1|NOT COMPLETED|Overall Study||8
8348342|NCT01268891|20578933|P2|COMPLETED|Overall Study||58
8348343|NCT01268891|20578934|P1|COMPLETED|Overall Study||58
8348344|NCT01268891|20578933|P2|STARTED|Overall Study||66
8348345|NCT01268891|20578934|P1|STARTED|Overall Study||66
8348349|NCT01268644|20578953|P1|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0
8348350|NCT01268644|20578953|P1|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7
8348351|NCT01268644|20578953|P1|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7
8348352|NCT01268644|20578953|P1|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0
8348353|NCT01268644|20578953|P1|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7
8348354|NCT01268644|20578953|P1|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7
8348355|NCT01268644|20578953|P1|NOT COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||0
8348356|NCT01268644|20578953|P1|COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||8
8348357|NCT01268644|20578953|P1|STARTED|Phase A (Weeks 0-12) Leptin Therapy||8
8348358|NCT01268644|20578953|P1|NOT COMPLETED|Baseline Period (Week 0)||0
8348359|NCT01268644|20578953|P1|COMPLETED|Baseline Period (Week 0)||8
8348360|NCT01268644|20578953|P1|STARTED|Baseline Period (Week 0)||8
8348361|NCT01268566|20578960|P1|NOT COMPLETED|Overall Study||43
8348362|NCT01268566|20578960|P1|COMPLETED|Overall Study||13
8348363|NCT01268566|20578960|P1|STARTED|Overall Study||56
8348364|NCT01268553|20578978|P1|NOT COMPLETED|Overall Study||0
8348365|NCT01268553|20578978|P1|COMPLETED|Overall Study||6
8348366|NCT01268553|20578978|P1|STARTED|Overall Study||6
8348367|NCT01268514|20578987|P1|NOT COMPLETED|Overall Study||41
8348368|NCT01268514|20578987|P1|COMPLETED|Overall Study||74
8348369|NCT01268514|20578987|P1|Participants Who Received the Device|Overall Study||114
8348370|NCT01268514|20578987|P1|STARTED|Overall Study||115
8348371|NCT01268501|20578996|P1|NOT COMPLETED|Overall Study||9
8348372|NCT01268501|20578996|P1|COMPLETED|Overall Study||87
8348373|NCT01268501|20578996|P1|STARTED|Overall Study||96
8348374|NCT01268488|20579000|P1|NOT COMPLETED|Overall Study||5
8348375|NCT01268488|20579000|P1|COMPLETED|Overall Study||93
8348376|NCT01268488|20579000|P1|STARTED|Overall Study||98
8348377|NCT01268306|20579007|P1|NOT COMPLETED|Overall Study||1
8348378|NCT01268306|20579007|P1|COMPLETED|Overall Study||7
8348379|NCT01268306|20579007|P1|STARTED|Overall Study||8
8348380|NCT01268293|20579011|P1|NOT COMPLETED|Overall Study||9
8348381|NCT01268293|20579011|P1|COMPLETED|Overall Study||0
8348382|NCT01268293|20579011|P1|Completed Cycle 1|Overall Study||9
8348383|NCT01268293|20579011|P1|STARTED|Overall Study||9
8348384|NCT01268267|20579016|P1|NOT COMPLETED|Overall Study||1
8348385|NCT01268267|20579016|P1|COMPLETED|Overall Study||93
8348386|NCT01268267|20579016|P1|STARTED|Overall Study||94
8348387|NCT01268189|20579023|P1|NOT COMPLETED|Overall Study||3
8348388|NCT01268189|20579023|P1|COMPLETED|Overall Study||17
8348389|NCT01268189|20579023|P1|STARTED|Overall Study||20
8348390|NCT01268150|20579037|P1|NOT COMPLETED|Extension Phase||27
8348391|NCT01268150|20579037|P1|COMPLETED|Extension Phase||1
8348392|NCT01268150|20579037|P1|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
8348393|NCT01268150|20579037|P1|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
8348394|NCT01268150|20579037|P1|NOT COMPLETED|Treatment Phase||28
8348395|NCT01268150|20579037|P1|COMPLETED|Treatment Phase||28
8348396|NCT01268150|20579037|P1|STARTED|Treatment Phase||56
8348397|NCT01268111|20579047|P2|NOT COMPLETED|Overall Study||0
8348398|NCT01268111|20579048|P1|NOT COMPLETED|Overall Study||0
8348399|NCT01268111|20579047|P2|COMPLETED|Overall Study||6
8348400|NCT01268111|20579048|P1|COMPLETED|Overall Study||6
8348401|NCT01268111|20579047|P2|STARTED|Overall Study||6
8348402|NCT01268111|20579048|P1|STARTED|Overall Study||6
8348409|NCT01268059|20579069|P4|NOT COMPLETED|Overall Study||5
8348410|NCT01268059|20579070|P3|NOT COMPLETED|Overall Study||3
8348411|NCT01268059|20579071|P2|NOT COMPLETED|Overall Study||35
8348412|NCT01268059|20579072|P1|NOT COMPLETED|Overall Study||28
8348413|NCT01268059|20579069|P4|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
8348414|NCT01268059|20579070|P3|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
8348415|NCT01268059|20579071|P2|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|10
8348416|NCT01268059|20579072|P1|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|12
8348417|NCT01268059|20579069|P4|STARTED|Overall Study||8
8348418|NCT01268059|20579070|P3|STARTED|Overall Study||6
8348419|NCT01268059|20579071|P2|STARTED|Overall Study|Arm applicable for both dose-determination (Phase 1b) and randomization phase (Phase 2) of study.|45
8348420|NCT01268059|20579072|P1|STARTED|Overall Study||40
8348421|NCT01268046|20579133|P4|NOT COMPLETED|Overall Study||1
8348422|NCT01268046|20579134|P3|NOT COMPLETED|Overall Study||1
8348423|NCT01268046|20579135|P2|NOT COMPLETED|Overall Study||0
8348424|NCT01268046|20579136|P1|NOT COMPLETED|Overall Study||1
8348425|NCT01268046|20579133|P4|COMPLETED|Overall Study||7
8348426|NCT01268046|20579134|P3|COMPLETED|Overall Study||7
8348427|NCT01268046|20579135|P2|COMPLETED|Overall Study||9
8348428|NCT01268046|20579136|P1|COMPLETED|Overall Study||12
8348429|NCT01268046|20579133|P4|STARTED|Overall Study||8
8348430|NCT01268046|20579134|P3|STARTED|Overall Study||8
8348431|NCT01268046|20579135|P2|STARTED|Overall Study||9
8348432|NCT01268046|20579136|P1|STARTED|Overall Study||13
8348433|NCT01267994|20579146|P1|NOT COMPLETED|Overall Study||2
8348434|NCT01267994|20579146|P1|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
8348435|NCT01267994|20579146|P1|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
8348442|NCT01267929|20579157|P2|NOT COMPLETED|Overall Study||0
8348443|NCT01267929|20579158|P1|NOT COMPLETED|Overall Study||0
8348444|NCT01267929|20579157|P2|COMPLETED|Overall Study||15
8348445|NCT01267929|20579158|P1|COMPLETED|Overall Study||15
8348446|NCT01267929|20579157|P2|STARTED|Overall Study||15
8348447|NCT01267929|20579158|P1|STARTED|Overall Study||15
8348448|NCT01267864|20579167|P3|NOT COMPLETED|Overall Study||0
8348449|NCT01267864|20579168|P2|NOT COMPLETED|Overall Study||0
8348450|NCT01267864|20579169|P1|NOT COMPLETED|Overall Study||0
8348451|NCT01267864|20579167|P3|COMPLETED|Overall Study||110
8348452|NCT01267864|20579168|P2|COMPLETED|Overall Study||110
8348453|NCT01267864|20579169|P1|COMPLETED|Overall Study||110
8348454|NCT01267864|20579167|P3|STARTED|Overall Study||110
8348455|NCT01267864|20579168|P2|STARTED|Overall Study||110
8348456|NCT01267864|20579169|P1|STARTED|Overall Study||110
8348457|NCT01267825|20579188|P2|NOT COMPLETED|Overall Study||0
8348458|NCT01267825|20579189|P1|NOT COMPLETED|Overall Study||1
8348459|NCT01267825|20579188|P2|COMPLETED|Overall Study||0
8348460|NCT01267825|20579189|P1|COMPLETED|Overall Study||0
8348461|NCT01267825|20579188|P2|STARTED|Overall Study||0
8348462|NCT01267825|20579189|P1|STARTED|Overall Study||1
8348463|NCT01267656|20579199|P2|NOT COMPLETED|Overall Study||1
8348464|NCT01267656|20579200|P1|NOT COMPLETED|Overall Study||1
8348465|NCT01267656|20579199|P2|COMPLETED|Overall Study||82
8348466|NCT01267656|20579200|P1|COMPLETED|Overall Study||82
8348467|NCT01267656|20579199|P2|STARTED|Overall Study||83
8348468|NCT01267656|20579200|P1|STARTED|Overall Study||83
8348469|NCT01267422|20579206|P2|NOT COMPLETED|Safety and Efficacy Study||0
8348470|NCT01267422|20579207|P1|NOT COMPLETED|Safety and Efficacy Study||0
8348471|NCT01267422|20579206|P2|COMPLETED|Safety and Efficacy Study||4
8348472|NCT01267422|20579207|P1|COMPLETED|Safety and Efficacy Study||5
8348473|NCT01267422|20579206|P2|STARTED|Safety and Efficacy Study||4
8348474|NCT01267422|20579207|P1|STARTED|Safety and Efficacy Study||5
8348475|NCT01267422|20579206|P2|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
8348476|NCT01267422|20579207|P1|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
8348477|NCT01267422|20579206|P2|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
8348478|NCT01267422|20579207|P1|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
8348479|NCT01267422|20579206|P2|STARTED|Intravitreal rAAV2-ND4 Injection||4
8348480|NCT01267422|20579207|P1|STARTED|Intravitreal rAAV2-ND4 Injection||5
8348481|NCT01267292|20579227|P2|NOT COMPLETED|Overall Study||6
8348482|NCT01267292|20579228|P1|NOT COMPLETED|Overall Study||4
8348483|NCT01267292|20579227|P2|COMPLETED|Overall Study||20
8348484|NCT01267292|20579228|P1|COMPLETED|Overall Study||20
8348485|NCT01267292|20579227|P2|STARTED|Overall Study||26
8348486|NCT01267292|20579228|P1|STARTED|Overall Study||24
8348487|NCT01267279|20579264|P2|NOT COMPLETED|Overall Study||6
8348488|NCT01267279|20579265|P1|NOT COMPLETED|Overall Study||2
8348489|NCT01267279|20579264|P2|COMPLETED|Overall Study||21
8348490|NCT01267279|20579265|P1|COMPLETED|Overall Study||22
8348491|NCT01267279|20579264|P2|STARTED|Overall Study||27
8348492|NCT01267279|20579265|P1|STARTED|Overall Study||24
8348493|NCT01267266|20579271|P2|NOT COMPLETED|Randomized Phase||0
8348494|NCT01267266|20579272|P1|NOT COMPLETED|Randomized Phase||0
8348495|NCT01267266|20579271|P2|COMPLETED|Randomized Phase||5
8348496|NCT01267266|20579272|P1|COMPLETED|Randomized Phase||3
8348497|NCT01267266|20579271|P2|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
8348498|NCT01267266|20579272|P1|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
8348499|NCT01267266|20579271|P2|NOT COMPLETED|Lead-in Phase||0
8348500|NCT01267266|20579272|P1|NOT COMPLETED|Lead-in Phase||23
8348501|NCT01267266|20579271|P2|COMPLETED|Lead-in Phase||0
8348502|NCT01267266|20579272|P1|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
8348503|NCT01267266|20579271|P2|STARTED|Lead-in Phase||0
8348504|NCT01267266|20579272|P1|STARTED|Lead-in Phase||31
8348505|NCT01267266|20579271|P2|NOT COMPLETED|Enrollment Phase||0
8348506|NCT01267266|20579272|P1|NOT COMPLETED|Enrollment Phase||2
8348507|NCT01267266|20579271|P2|COMPLETED|Enrollment Phase||0
8348508|NCT01267266|20579272|P1|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
8348509|NCT01267266|20579271|P2|STARTED|Enrollment Phase||0
8348510|NCT01267266|20579272|P1|STARTED|Enrollment Phase||33
8348511|NCT01267253|20579285|P1|NOT COMPLETED|Overall Study||3
8348512|NCT01267253|20579285|P1|COMPLETED|Overall Study|Eligible and treated patients|28
8348513|NCT01267253|20579285|P1|STARTED|Overall Study||31
8348514|NCT01267240|20579293|P1|NOT COMPLETED|Overall Study||0
8348515|NCT01267240|20579293|P1|COMPLETED|Overall Study||25
8348516|NCT01267240|20579293|P1|STARTED|Overall Study||25
8348517|NCT01267227|20579303|P4|NOT COMPLETED|Overall Study||3
8348518|NCT01267227|20579304|P3|NOT COMPLETED|Overall Study||2
8348519|NCT01267227|20579305|P2|NOT COMPLETED|Overall Study||1
8348520|NCT01267227|20579306|P1|NOT COMPLETED|Overall Study||1
8348521|NCT01267227|20579303|P4|COMPLETED|Overall Study||17
8348522|NCT01267227|20579304|P3|COMPLETED|Overall Study||18
8348523|NCT01267227|20579305|P2|COMPLETED|Overall Study||19
8348524|NCT01267227|20579306|P1|COMPLETED|Overall Study||19
8348525|NCT01267227|20579303|P4|STARTED|Overall Study||20
8348526|NCT01267227|20579304|P3|STARTED|Overall Study||20
8348527|NCT01267227|20579305|P2|STARTED|Overall Study||20
8348528|NCT01267227|20579306|P1|STARTED|Overall Study||20
8348529|NCT01267201|20579324|P6|NOT COMPLETED|Third Intervention Period||0
8348530|NCT01267201|20579325|P5|NOT COMPLETED|Third Intervention Period||0
8348531|NCT01267201|20579326|P4|NOT COMPLETED|Third Intervention Period||0
8348532|NCT01267201|20579327|P3|NOT COMPLETED|Third Intervention Period||0
8348533|NCT01267201|20579328|P2|NOT COMPLETED|Third Intervention Period||0
8348534|NCT01267201|20579329|P1|NOT COMPLETED|Third Intervention Period||0
8348535|NCT01267201|20579324|P6|COMPLETED|Third Intervention Period||4
8348536|NCT01267201|20579325|P5|COMPLETED|Third Intervention Period||4
8348537|NCT01267201|20579326|P4|COMPLETED|Third Intervention Period||4
8348538|NCT01267201|20579327|P3|COMPLETED|Third Intervention Period||4
8348539|NCT01267201|20579328|P2|COMPLETED|Third Intervention Period||3
8348540|NCT01267201|20579329|P1|COMPLETED|Third Intervention Period||3
8348541|NCT01267201|20579324|P6|STARTED|Third Intervention Period||4
8348542|NCT01267201|20579325|P5|STARTED|Third Intervention Period||4
8348543|NCT01267201|20579326|P4|STARTED|Third Intervention Period||4
8348544|NCT01267201|20579327|P3|STARTED|Third Intervention Period||4
8348545|NCT01267201|20579328|P2|STARTED|Third Intervention Period||3
8348546|NCT01267201|20579329|P1|STARTED|Third Intervention Period||3
8348547|NCT01267201|20579324|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348548|NCT01267201|20579325|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348549|NCT01267201|20579326|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348550|NCT01267201|20579327|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348551|NCT01267201|20579328|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348552|NCT01267201|20579329|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348553|NCT01267201|20579324|P6|COMPLETED|Washout Period (At Least 2 Days)||4
8348554|NCT01267201|20579325|P5|COMPLETED|Washout Period (At Least 2 Days)||4
8348555|NCT01267201|20579326|P4|COMPLETED|Washout Period (At Least 2 Days)||4
8348556|NCT01267201|20579327|P3|COMPLETED|Washout Period (At Least 2 Days)||4
8348557|NCT01267201|20579328|P2|COMPLETED|Washout Period (At Least 2 Days)||3
8348558|NCT01267201|20579329|P1|COMPLETED|Washout Period (At Least 2 Days)||3
8348559|NCT01267201|20579324|P6|STARTED|Washout Period (At Least 2 Days)||4
8348560|NCT01267201|20579325|P5|STARTED|Washout Period (At Least 2 Days)||4
8348561|NCT01267201|20579326|P4|STARTED|Washout Period (At Least 2 Days)||4
8348562|NCT01267201|20579327|P3|STARTED|Washout Period (At Least 2 Days)||4
8348563|NCT01267201|20579328|P2|STARTED|Washout Period (At Least 2 Days)||3
8348564|NCT01267201|20579329|P1|STARTED|Washout Period (At Least 2 Days)||3
8348565|NCT01267201|20579324|P6|NOT COMPLETED|Second Intervention Period||0
8348566|NCT01267201|20579325|P5|NOT COMPLETED|Second Intervention Period||0
8348567|NCT01267201|20579326|P4|NOT COMPLETED|Second Intervention Period||0
8348568|NCT01267201|20579327|P3|NOT COMPLETED|Second Intervention Period||0
8348569|NCT01267201|20579328|P2|NOT COMPLETED|Second Intervention Period||1
8348570|NCT01267201|20579329|P1|NOT COMPLETED|Second Intervention Period||0
8348571|NCT01267201|20579324|P6|COMPLETED|Second Intervention Period||4
8348572|NCT01267201|20579325|P5|COMPLETED|Second Intervention Period||4
8348573|NCT01267201|20579326|P4|COMPLETED|Second Intervention Period||4
8348574|NCT01267201|20579327|P3|COMPLETED|Second Intervention Period||4
8348575|NCT01267201|20579328|P2|COMPLETED|Second Intervention Period||3
8348576|NCT01267201|20579329|P1|COMPLETED|Second Intervention Period||3
8348577|NCT01267201|20579324|P6|STARTED|Second Intervention Period||4
8348578|NCT01267201|20579325|P5|STARTED|Second Intervention Period||4
8348579|NCT01267201|20579326|P4|STARTED|Second Intervention Period||4
8348580|NCT01267201|20579327|P3|STARTED|Second Intervention Period||4
8348581|NCT01267201|20579328|P2|STARTED|Second Intervention Period||4
8348582|NCT01267201|20579329|P1|STARTED|Second Intervention Period||3
8348583|NCT01267201|20579324|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348584|NCT01267201|20579325|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348585|NCT01267201|20579326|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348586|NCT01267201|20579327|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348587|NCT01267201|20579328|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348588|NCT01267201|20579329|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
8348589|NCT01267201|20579324|P6|COMPLETED|Washout Period (At Least 2 Days)||4
8348590|NCT01267201|20579325|P5|COMPLETED|Washout Period (At Least 2 Days)||4
8348591|NCT01267201|20579326|P4|COMPLETED|Washout Period (At Least 2 Days)||4
8348592|NCT01267201|20579327|P3|COMPLETED|Washout Period (At Least 2 Days)||4
8348593|NCT01267201|20579328|P2|COMPLETED|Washout Period (At Least 2 Days)||4
8348594|NCT01267201|20579329|P1|COMPLETED|Washout Period (At Least 2 Days)||3
8348595|NCT01267201|20579324|P6|STARTED|Washout Period (At Least 2 Days)||4
8348596|NCT01267201|20579325|P5|STARTED|Washout Period (At Least 2 Days)||4
8348597|NCT01267201|20579326|P4|STARTED|Washout Period (At Least 2 Days)||4
8348598|NCT01267201|20579327|P3|STARTED|Washout Period (At Least 2 Days)||4
8348599|NCT01267201|20579328|P2|STARTED|Washout Period (At Least 2 Days)||4
8348600|NCT01267201|20579329|P1|STARTED|Washout Period (At Least 2 Days)||3
8348601|NCT01267201|20579324|P6|NOT COMPLETED|First Intervention Period||0
8348602|NCT01267201|20579325|P5|NOT COMPLETED|First Intervention Period||0
8348603|NCT01267201|20579326|P4|NOT COMPLETED|First Intervention Period||0
8348604|NCT01267201|20579327|P3|NOT COMPLETED|First Intervention Period||0
8348605|NCT01267201|20579328|P2|NOT COMPLETED|First Intervention Period||0
8348606|NCT01267201|20579329|P1|NOT COMPLETED|First Intervention Period||1
8348607|NCT01267201|20579324|P6|COMPLETED|First Intervention Period||4
8348608|NCT01267201|20579325|P5|COMPLETED|First Intervention Period||4
8348609|NCT01267201|20579326|P4|COMPLETED|First Intervention Period||4
8348610|NCT01267201|20579327|P3|COMPLETED|First Intervention Period||4
8348611|NCT01267201|20579328|P2|COMPLETED|First Intervention Period||4
8348612|NCT01267201|20579329|P1|COMPLETED|First Intervention Period||3
8348613|NCT01267201|20579324|P6|STARTED|First Intervention Period||4
8348614|NCT01267201|20579325|P5|STARTED|First Intervention Period||4
8348615|NCT01267201|20579326|P4|STARTED|First Intervention Period||4
8348616|NCT01267201|20579327|P3|STARTED|First Intervention Period||4
8348617|NCT01267201|20579328|P2|STARTED|First Intervention Period||4
8348618|NCT01267201|20579329|P1|STARTED|First Intervention Period||4
8348619|NCT01267175|20579346|P1|NOT COMPLETED|Overall Study||2
8348620|NCT01267175|20579346|P1|COMPLETED|Overall Study||29
8348621|NCT01267175|20579346|P1|STARTED|Overall Study||31
8348622|NCT01267136|20579353|P2|NOT COMPLETED|Overall Study||6
8348623|NCT01267136|20579354|P1|NOT COMPLETED|Overall Study||4
8348624|NCT01267136|20579353|P2|COMPLETED|Overall Study||36
8348625|NCT01267136|20579354|P1|COMPLETED|Overall Study||38
8348626|NCT01267136|20579353|P2|STARTED|Overall Study||42
8348627|NCT01267136|20579354|P1|STARTED|Overall Study||42
8348628|NCT01267045|20579364|P2|NOT COMPLETED|6-month Outcome||3
8348629|NCT01267045|20579365|P1|NOT COMPLETED|6-month Outcome||0
8348630|NCT01267045|20579364|P2|COMPLETED|6-month Outcome||23
8348631|NCT01267045|20579365|P1|COMPLETED|6-month Outcome||22
8348632|NCT01267045|20579364|P2|STARTED|6-month Outcome||26
8348633|NCT01267045|20579365|P1|STARTED|6-month Outcome||22
8348634|NCT01267045|20579364|P2|NOT COMPLETED|2-month Outcomes||3
8348635|NCT01267045|20579365|P1|NOT COMPLETED|2-month Outcomes||4
8348636|NCT01267045|20579364|P2|COMPLETED|2-month Outcomes||26
8348637|NCT01267045|20579365|P1|COMPLETED|2-month Outcomes||22
8348638|NCT01267045|20579364|P2|STARTED|2-month Outcomes||29
8348639|NCT01267045|20579365|P1|STARTED|2-month Outcomes||26
8348640|NCT01267019|20579400|P3|NOT COMPLETED|Overall Study||6
8348641|NCT01267019|20579401|P2|NOT COMPLETED|Overall Study||6
8348642|NCT01267019|20579402|P1|NOT COMPLETED|Overall Study||6
8348643|NCT01267019|20579400|P3|COMPLETED|Overall Study||47
8348644|NCT01267019|20579401|P2|COMPLETED|Overall Study||47
8348645|NCT01267019|20579402|P1|COMPLETED|Overall Study||41
8348646|NCT01267019|20579400|P3|STARTED|Overall Study||53
8348647|NCT01267019|20579401|P2|STARTED|Overall Study||53
8348648|NCT01267019|20579402|P1|STARTED|Overall Study||47
8348649|NCT01266993|20579418|P2|NOT COMPLETED|Booster Phase (Month 68-69)||2
8348650|NCT01266993|20579419|P1|NOT COMPLETED|Booster Phase (Month 68-69)||5
8348651|NCT01266993|20579418|P2|COMPLETED|Booster Phase (Month 68-69)||60
8348652|NCT01266993|20579419|P1|COMPLETED|Booster Phase (Month 68-69)||174
8348653|NCT01266993|20579418|P2|STARTED|Booster Phase (Month 68-69)||62
8348654|NCT01266993|20579419|P1|STARTED|Booster Phase (Month 68-69)||179
8348655|NCT01266993|20579418|P2|NOT COMPLETED|Persistence Phase (Month 56-68)||0
8348656|NCT01266993|20579419|P1|NOT COMPLETED|Persistence Phase (Month 56-68)||0
8348657|NCT01266993|20579418|P2|COMPLETED|Persistence Phase (Month 56-68)||67
8348658|NCT01266993|20579419|P1|COMPLETED|Persistence Phase (Month 56-68)||193
8348659|NCT01266993|20579418|P2|STARTED|Persistence Phase (Month 56-68)||67
8348660|NCT01266993|20579419|P1|STARTED|Persistence Phase (Month 56-68)||193
8348661|NCT01266993|20579418|P2|NOT COMPLETED|Persistence Phase (Month 44-56)||0
8348662|NCT01266993|20579419|P1|NOT COMPLETED|Persistence Phase (Month 44-56)||0
8348663|NCT01266993|20579418|P2|COMPLETED|Persistence Phase (Month 44-56)||68
8348664|NCT01266993|20579419|P1|COMPLETED|Persistence Phase (Month 44-56)||193
8348665|NCT01266993|20579418|P2|STARTED|Persistence Phase (Month 44-56)||68
8348666|NCT01266993|20579419|P1|STARTED|Persistence Phase (Month 44-56)||193
8348667|NCT01266993|20579418|P2|NOT COMPLETED|Persistence Phase (Month 32-44)||0
8348668|NCT01266993|20579419|P1|NOT COMPLETED|Persistence Phase (Month 32-44)||0
8348669|NCT01266993|20579418|P2|COMPLETED|Persistence Phase (Month 32-44)||72
8348670|NCT01266993|20579419|P1|COMPLETED|Persistence Phase (Month 32-44)||199
8348671|NCT01266993|20579418|P2|STARTED|Persistence Phase (Month 32-44)||72
8348672|NCT01266993|20579419|P1|STARTED|Persistence Phase (Month 32-44)||199
8348673|NCT01266967|20579489|P2|NOT COMPLETED|Overall Study||83
8348674|NCT01266967|20579490|P1|NOT COMPLETED|Overall Study||89
8348675|NCT01266967|20579489|P2|COMPLETED|Overall Study||0
8348676|NCT01266967|20579490|P1|COMPLETED|Overall Study||0
8348677|NCT01266967|20579489|P2|STARTED|Overall Study||83
8348678|NCT01266967|20579490|P1|STARTED|Overall Study||89
8348679|NCT01266876|20579542|P5|NOT COMPLETED|Overall Study||0
8348680|NCT01266876|20579543|P4|NOT COMPLETED|Overall Study||1
8348681|NCT01266876|20579544|P3|NOT COMPLETED|Overall Study||0
8348682|NCT01266876|20579545|P2|NOT COMPLETED|Overall Study||0
8348683|NCT01266876|20579546|P1|NOT COMPLETED|Overall Study||0
8348684|NCT01266876|20579542|P5|COMPLETED|Overall Study||16
8348685|NCT01266876|20579543|P4|COMPLETED|Overall Study||14
8348686|NCT01266876|20579544|P3|COMPLETED|Overall Study||16
8348687|NCT01266876|20579545|P2|COMPLETED|Overall Study||15
8348688|NCT01266876|20579546|P1|COMPLETED|Overall Study||15
8348689|NCT01266876|20579542|P5|STARTED|Overall Study||16
8348690|NCT01266876|20579543|P4|STARTED|Overall Study||15
8348691|NCT01266876|20579544|P3|STARTED|Overall Study||16
8348692|NCT01266876|20579545|P2|STARTED|Overall Study||15
8348693|NCT01266876|20579546|P1|STARTED|Overall Study||15
8348694|NCT01266850|20579653|P5|NOT COMPLETED|Overall Study||30
8348695|NCT01266850|20579654|P4|NOT COMPLETED|Overall Study||28
8348696|NCT01266850|20579655|P3|NOT COMPLETED|Overall Study||24
8348697|NCT01266850|20579656|P2|NOT COMPLETED|Overall Study||36
8348698|NCT01266850|20579657|P1|NOT COMPLETED|Overall Study||30
8348699|NCT01266850|20579653|P5|COMPLETED|Overall Study||297
8348700|NCT01266850|20579654|P4|COMPLETED|Overall Study||301
8348701|NCT01266850|20579655|P3|COMPLETED|Overall Study||214
8348702|NCT01266850|20579656|P2|COMPLETED|Overall Study||212
8348703|NCT01266850|20579657|P1|COMPLETED|Overall Study||212
8348704|NCT01266850|20579653|P5|Received Third Vaccine|Overall Study||299
8348705|NCT01266850|20579654|P4|Received Third Vaccine|Overall Study||0
8348706|NCT01266850|20579655|P3|Received Third Vaccine|Overall Study||217
8348707|NCT01266850|20579656|P2|Received Third Vaccine|Overall Study||221
8348708|NCT01266850|20579657|P1|Received Third Vaccine|Overall Study||221
8348709|NCT01266850|20579653|P5|Received Second Vaccine|Overall Study||307
8348710|NCT01266850|20579654|P4|Received Second Vaccine|Overall Study||311
8348711|NCT01266850|20579655|P3|Received Second Vaccine|Overall Study||227
8348712|NCT01266850|20579656|P2|Received Second Vaccine|Overall Study||233
8348713|NCT01266850|20579657|P1|Received Second Vaccine|Overall Study||231
8348714|NCT01266850|20579653|P5|STARTED|Overall Study||327
8348715|NCT01266850|20579654|P4|STARTED|Overall Study||329
8348716|NCT01266850|20579655|P3|STARTED|Overall Study||238
8348717|NCT01266850|20579656|P2|STARTED|Overall Study||248
8348718|NCT01266850|20579657|P1|STARTED|Overall Study||242
8348719|NCT01266824|20579711|P2|NOT COMPLETED|Overall Study||3
8348720|NCT01266824|20579712|P1|NOT COMPLETED|Overall Study||2
8348721|NCT01266824|20579711|P2|COMPLETED|Overall Study||0
8348722|NCT01266824|20579712|P1|COMPLETED|Overall Study||0
8348723|NCT01266824|20579711|P2|STARTED|Overall Study||3
8348724|NCT01266824|20579712|P1|STARTED|Overall Study||2
8348725|NCT01266603|20579724|P1|NOT COMPLETED|Overall Study||42
8348726|NCT01266603|20579724|P1|COMPLETED|Overall Study||2
8348727|NCT01266603|20579724|P1|Maintenance Completion|Overall Study||2
8348728|NCT01266603|20579724|P1|Continued to Maintenance- MAGE-A3|Overall Study||4
8348729|NCT01266603|20579724|P1|Patients Evaluable for Response|Overall Study||16
8348730|NCT01266603|20579724|P1|Patients Evaluable for Safety|Overall Study||17
8348731|NCT01266603|20579724|P1|MAGE-A3 Positive Tumor|Overall Study||18
8348732|NCT01266603|20579724|P1|STARTED|Overall Study||44
8348733|NCT01266590|20579730|P1|NOT COMPLETED|Overall Study||6
8348734|NCT01266590|20579730|P1|COMPLETED|Overall Study||24
8348735|NCT01266590|20579730|P1|STARTED|Overall Study||30
8348736|NCT01266460|20579741|P1|NOT COMPLETED|Overall Study||34
8348737|NCT01266460|20579741|P1|COMPLETED|Overall Study||16
8348738|NCT01266460|20579741|P1|STARTED|Overall Study||50
8348739|NCT01266447|20579750|P1|NOT COMPLETED|Overall Study||0
8348740|NCT01266447|20579750|P1|COMPLETED|Overall Study|Eligible and treated patients|27
8348741|NCT01266447|20579750|P1|STARTED|Overall Study||27
8348742|NCT01266317|20579759|P1|NOT COMPLETED|Overall Study||2
8348743|NCT01266317|20579759|P1|COMPLETED|Overall Study||7
8348744|NCT01266317|20579759|P1|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
8348745|NCT01266291|20579764|P1|NOT COMPLETED|Overall Study||1
8348746|NCT01266291|20579764|P1|COMPLETED|Overall Study||0
8348747|NCT01266291|20579764|P1|STARTED|Overall Study||1
8348748|NCT01266265|20579771|P2|NOT COMPLETED|Overall Study||190
8348749|NCT01266265|20579772|P1|NOT COMPLETED|Overall Study||205
8348750|NCT01266265|20579771|P2|COMPLETED|Overall Study||477
8348751|NCT01266265|20579772|P1|COMPLETED|Overall Study||461
8348752|NCT01266265|20579771|P2|STARTED|Overall Study||667
8348753|NCT01266265|20579772|P1|STARTED|Overall Study||666
8348754|NCT01266161|20579780|P2|NOT COMPLETED|Overall Study||1
8348755|NCT01266161|20579781|P1|NOT COMPLETED|Overall Study||4
8348756|NCT01266161|20579780|P2|COMPLETED|Overall Study||53
8348757|NCT01266161|20579781|P1|COMPLETED|Overall Study||48
8348758|NCT01266161|20579780|P2|STARTED|Overall Study||54
8348759|NCT01266161|20579781|P1|STARTED|Overall Study||52
8348760|NCT01266148|20579813|P2|NOT COMPLETED|Overall Study||3
8348761|NCT01266148|20579814|P1|NOT COMPLETED|Overall Study||7
8348762|NCT01266148|20579813|P2|COMPLETED|Overall Study||56
8348763|NCT01266148|20579814|P1|COMPLETED|Overall Study||49
8348764|NCT01266148|20579813|P2|STARTED|Overall Study||59
8348765|NCT01266148|20579814|P1|STARTED|Overall Study||56
8348766|NCT01266122|20579842|P2|NOT COMPLETED|Overall Study||6
8348767|NCT01266122|20579843|P1|NOT COMPLETED|Overall Study||6
8348768|NCT01266122|20579842|P2|COMPLETED|Overall Study||42
8348769|NCT01266122|20579843|P1|COMPLETED|Overall Study||42
8348770|NCT01266122|20579842|P2|STARTED|Overall Study||48
8348771|NCT01266122|20579843|P1|STARTED|Overall Study||48
8348772|NCT01266070|20579851|P1|NOT COMPLETED|Overall Study||4
8348773|NCT01266070|20579851|P1|COMPLETED|Overall Study||2
8348774|NCT01266070|20579851|P1|STARTED|Overall Study||6
8348775|NCT01266031|20579859|P3|NOT COMPLETED|Overall Study||2
8348776|NCT01266031|20579860|P2|NOT COMPLETED|Overall Study||3
8348777|NCT01266031|20579861|P1|NOT COMPLETED|Overall Study||0
8348778|NCT01266031|20579859|P3|COMPLETED|Overall Study||47
8348779|NCT01266031|20579860|P2|COMPLETED|Overall Study||38
8348780|NCT01266031|20579861|P1|COMPLETED|Overall Study||6
8348781|NCT01266031|20579859|P3|STARTED|Overall Study||49
8348782|NCT01266031|20579860|P2|STARTED|Overall Study||41
8348783|NCT01266031|20579861|P1|STARTED|Overall Study||6
8348784|NCT01266018|20579888|P2|NOT COMPLETED|Overall Study||1
8348785|NCT01266018|20579889|P1|NOT COMPLETED|Overall Study||1
8348786|NCT01266018|20579888|P2|COMPLETED|Overall Study||12
8348787|NCT01266018|20579889|P1|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
8348788|NCT01266018|20579888|P2|STARTED|Overall Study||13
8348789|NCT01266018|20579889|P1|STARTED|Overall Study||9
8348790|NCT01265992|20579900|P1|NOT COMPLETED|Overall Study||9
8348791|NCT01265992|20579900|P1|COMPLETED|Overall Study||41
8348792|NCT01265992|20579900|P1|Received Treatment|Overall Study||49
8348793|NCT01265992|20579900|P1|STARTED|Overall Study||50
8348794|NCT01265966|20579916|P3|NOT COMPLETED|Overall Study||2
8348795|NCT01265966|20579917|P2|NOT COMPLETED|Overall Study||2
8348796|NCT01265966|20579918|P1|NOT COMPLETED|Overall Study||3
8348797|NCT01265966|20579916|P3|COMPLETED|Overall Study||27
8348798|NCT01265966|20579917|P2|COMPLETED|Overall Study||39
8348799|NCT01265966|20579918|P1|COMPLETED|Overall Study||44
8348800|NCT01265966|20579916|P3|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
8348801|NCT01265966|20579917|P2|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
8348802|NCT01265966|20579918|P1|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
8348803|NCT01265966|20579916|P3|STARTED|Overall Study||29
8348804|NCT01265966|20579917|P2|STARTED|Overall Study||41
8348805|NCT01265966|20579918|P1|STARTED|Overall Study||47
8348806|NCT01265953|20579928|P2|NOT COMPLETED|Overall Study||3
8348807|NCT01265953|20579929|P1|NOT COMPLETED|Overall Study||5
8348808|NCT01265953|20579928|P2|COMPLETED|Overall Study||45
8348809|NCT01265953|20579929|P1|COMPLETED|Overall Study||45
8348810|NCT01265953|20579928|P2|STARTED|Overall Study||48
8348811|NCT01265953|20579929|P1|STARTED|Overall Study||50
8348812|NCT01265875|20579941|P1|NOT COMPLETED|Overall Study||1
8348813|NCT01265875|20579941|P1|COMPLETED|Overall Study||11
8348814|NCT01265875|20579941|P1|STARTED|Overall Study||12
8348815|NCT01265823|20579949|P1|NOT COMPLETED|Overall Study||7
8348816|NCT01265823|20579949|P1|COMPLETED|Overall Study||143
8348817|NCT01265823|20579949|P1|STARTED|Overall Study||150
8348818|NCT01265797|20579978|P2|NOT COMPLETED|Open Label Month||1
8348819|NCT01265797|20579979|P1|NOT COMPLETED|Open Label Month||0
8348820|NCT01265797|20579978|P2|COMPLETED|Open Label Month||26
8348821|NCT01265797|20579979|P1|COMPLETED|Open Label Month||24
8348822|NCT01265797|20579978|P2|STARTED|Open Label Month||27
8348823|NCT01265797|20579979|P1|STARTED|Open Label Month||24
8348824|NCT01265797|20579978|P2|NOT COMPLETED|Blinded Month||2
8348825|NCT01265797|20579979|P1|NOT COMPLETED|Blinded Month||10
8348826|NCT01265797|20579978|P2|COMPLETED|Blinded Month||27
8348827|NCT01265797|20579979|P1|COMPLETED|Blinded Month||24
8348828|NCT01265797|20579978|P2|STARTED|Blinded Month||29
8348829|NCT01265797|20579979|P1|STARTED|Blinded Month||34
8348830|NCT01265797|20579978|P2|NOT COMPLETED|Run-in Month||5
8348831|NCT01265797|20579979|P1|NOT COMPLETED|Run-in Month||0
8348832|NCT01265797|20579978|P2|COMPLETED|Run-in Month||29
8348833|NCT01265797|20579979|P1|COMPLETED|Run-in Month||34
8348834|NCT01265797|20579978|P2|STARTED|Run-in Month||34
8348835|NCT01265797|20579979|P1|STARTED|Run-in Month||34
8348836|NCT01265784|20580010|P3|NOT COMPLETED|Overall Study||4
8348837|NCT01265784|20580011|P2|NOT COMPLETED|Overall Study||8
8348838|NCT01265784|20580012|P1|NOT COMPLETED|Overall Study||12
8348839|NCT01265784|20580010|P3|COMPLETED|Overall Study||26
8348840|NCT01265784|20580011|P2|COMPLETED|Overall Study||49
8348841|NCT01265784|20580012|P1|COMPLETED|Overall Study||44
8348842|NCT01265784|20580010|P3|Received at Least 1 Dose of Study Drug|Overall Study||29
8348843|NCT01265784|20580011|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
8348844|NCT01265784|20580012|P1|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
8348845|NCT01265784|20580010|P3|STARTED|Overall Study||30
8348846|NCT01265784|20580011|P2|STARTED|Overall Study||57
8348847|NCT01265784|20580012|P1|STARTED|Overall Study||56
8348854|NCT01265667|20580115|P2|NOT COMPLETED|Overall Study||13
8348855|NCT01265667|20580116|P1|NOT COMPLETED|Overall Study||20
8348856|NCT01265667|20580115|P2|COMPLETED|Overall Study||135
8348857|NCT01265667|20580116|P1|COMPLETED|Overall Study||125
8348858|NCT01265667|20580115|P2|STARTED|Overall Study||148
8348859|NCT01265667|20580116|P1|STARTED|Overall Study||145
8348860|NCT01265615|20580132|P4|NOT COMPLETED|Overall Study||3
8348861|NCT01265615|20580133|P3|NOT COMPLETED|Overall Study||4
8348862|NCT01265615|20580134|P2|NOT COMPLETED|Overall Study||2
8348863|NCT01265615|20580135|P1|NOT COMPLETED|Overall Study||2
8348864|NCT01265615|20580132|P4|COMPLETED|Overall Study||27
8348865|NCT01265615|20580133|P3|COMPLETED|Overall Study||26
8348866|NCT01265615|20580134|P2|COMPLETED|Overall Study||28
8348867|NCT01265615|20580135|P1|COMPLETED|Overall Study||28
8348868|NCT01265615|20580132|P4|STARTED|Overall Study||30
8348869|NCT01265615|20580133|P3|STARTED|Overall Study||30
8348870|NCT01265615|20580134|P2|STARTED|Overall Study||30
8348871|NCT01265615|20580135|P1|STARTED|Overall Study||30
8348872|NCT01265563|20580186|P5|NOT COMPLETED|Overall Study||2
8348873|NCT01265563|20580187|P4|NOT COMPLETED|Overall Study||0
8348874|NCT01265563|20580188|P3|NOT COMPLETED|Overall Study||1
8348875|NCT01265563|20580189|P2|NOT COMPLETED|Overall Study||1
8348876|NCT01265563|20580190|P1|NOT COMPLETED|Overall Study||0
8348877|NCT01265563|20580186|P5|COMPLETED|Overall Study||14
8348878|NCT01265563|20580187|P4|COMPLETED|Overall Study||16
8348879|NCT01265563|20580188|P3|COMPLETED|Overall Study||16
8348880|NCT01265563|20580189|P2|COMPLETED|Overall Study||12
8348881|NCT01265563|20580190|P1|COMPLETED|Overall Study||16
8348882|NCT01265563|20580186|P5|STARTED|Overall Study||16
8348883|NCT01265563|20580187|P4|STARTED|Overall Study||16
8348884|NCT01265563|20580188|P3|STARTED|Overall Study||17
8348885|NCT01265563|20580189|P2|STARTED|Overall Study||13
8348886|NCT01265563|20580190|P1|STARTED|Overall Study||16
8348887|NCT01265550|20580216|P4|NOT COMPLETED|Post Randomization||0
8348888|NCT01265550|20580217|P3|NOT COMPLETED|Post Randomization||20
8348889|NCT01265550|20580218|P2|NOT COMPLETED|Post Randomization||8
8348890|NCT01265550|20580219|P1|NOT COMPLETED|Post Randomization||15
8348891|NCT01265550|20580216|P4|COMPLETED|Post Randomization||0
8348892|NCT01265550|20580217|P3|COMPLETED|Post Randomization||6
8348893|NCT01265550|20580218|P2|COMPLETED|Post Randomization||19
8348894|NCT01265550|20580219|P1|COMPLETED|Post Randomization||10
8348895|NCT01265550|20580216|P4|STARTED|Post Randomization||0
8348896|NCT01265550|20580217|P3|STARTED|Post Randomization||26
8348897|NCT01265550|20580218|P2|STARTED|Post Randomization||27
8348898|NCT01265550|20580219|P1|STARTED|Post Randomization||25
8348899|NCT01265550|20580216|P4|NOT COMPLETED|Pre Randomization||288
8348900|NCT01265550|20580217|P3|NOT COMPLETED|Pre Randomization||0
8348901|NCT01265550|20580218|P2|NOT COMPLETED|Pre Randomization||0
8348902|NCT01265550|20580219|P1|NOT COMPLETED|Pre Randomization||0
8348903|NCT01265550|20580216|P4|COMPLETED|Pre Randomization||78
8348904|NCT01265550|20580217|P3|COMPLETED|Pre Randomization||0
8348905|NCT01265550|20580218|P2|COMPLETED|Pre Randomization||0
8348906|NCT01265550|20580219|P1|COMPLETED|Pre Randomization||0
8348907|NCT01265550|20580216|P4|STARTED|Pre Randomization||366
8348908|NCT01265550|20580217|P3|STARTED|Pre Randomization||0
8348909|NCT01265550|20580218|P2|STARTED|Pre Randomization||0
8348910|NCT01265550|20580219|P1|STARTED|Pre Randomization||0
8348911|NCT01265537|20580311|P2|NOT COMPLETED|Overall Study||2
8348912|NCT01265537|20580312|P1|NOT COMPLETED|Overall Study||2
8348913|NCT01265537|20580311|P2|COMPLETED|Overall Study||13
8348914|NCT01265537|20580312|P1|COMPLETED|Overall Study||13
8348915|NCT01265537|20580311|P2|STARTED|Overall Study||15
8348916|NCT01265537|20580312|P1|STARTED|Overall Study||15
8348917|NCT01265524|20580342|P2|NOT COMPLETED|Overall Study||6
8348918|NCT01265524|20580343|P1|NOT COMPLETED|Overall Study||18
8348919|NCT01265524|20580342|P2|COMPLETED|Overall Study||46
8348920|NCT01265524|20580343|P1|COMPLETED|Overall Study||41
8348921|NCT01265524|20580342|P2|STARTED|Overall Study||52
8348922|NCT01265524|20580343|P1|STARTED|Overall Study||59
8348923|NCT01265511|20580363|P2|NOT COMPLETED|Overall Study||3
8348924|NCT01265511|20580364|P1|NOT COMPLETED|Overall Study||2
8348925|NCT01265511|20580363|P2|COMPLETED|Overall Study||5
8348926|NCT01265511|20580364|P1|COMPLETED|Overall Study||0
8348927|NCT01265511|20580363|P2|STARTED|Overall Study||8
8348928|NCT01265511|20580364|P1|STARTED|Overall Study||2
8348929|NCT01265498|20580378|P2|NOT COMPLETED|Overall Study||33
8348930|NCT01265498|20580379|P1|NOT COMPLETED|Overall Study||31
8348931|NCT01265498|20580378|P2|COMPLETED|Overall Study||109
8348932|NCT01265498|20580379|P1|COMPLETED|Overall Study||110
8348933|NCT01265498|20580378|P2|Both Baseline and Week 72 Biopsy|Overall Study||98
8348934|NCT01265498|20580379|P1|Both Baseline and Week 72 Biopsy|Overall Study||102
8348935|NCT01265498|20580378|P2|STARTED|Overall Study||142
8348936|NCT01265498|20580379|P1|STARTED|Overall Study||141
8348937|NCT01265459|20580482|P3|NOT COMPLETED|Overall Study||2
8348938|NCT01265459|20580483|P2|NOT COMPLETED|Overall Study||0
8348939|NCT01265459|20580484|P1|NOT COMPLETED|Overall Study||0
8348940|NCT01265459|20580482|P3|COMPLETED|Overall Study||20
8348941|NCT01265459|20580483|P2|COMPLETED|Overall Study||23
8348942|NCT01265459|20580484|P1|COMPLETED|Overall Study||23
8348943|NCT01265459|20580482|P3|STARTED|Overall Study||22
8348944|NCT01265459|20580483|P2|STARTED|Overall Study||23
8348945|NCT01265459|20580484|P1|STARTED|Overall Study||23
8348946|NCT01265446|20580506|P2|NOT COMPLETED|Overall Study||0
8348947|NCT01265446|20580507|P1|NOT COMPLETED|Overall Study||1
8348948|NCT01265446|20580506|P2|COMPLETED|Overall Study||125
8348949|NCT01265446|20580507|P1|COMPLETED|Overall Study||124
8348950|NCT01265446|20580506|P2|STARTED|Overall Study||125
8348951|NCT01265446|20580507|P1|STARTED|Overall Study||125
8348952|NCT01265420|20580515|P1|NOT COMPLETED|Overall Study||1
8348953|NCT01265420|20580515|P1|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
8348954|NCT01265420|20580515|P1|STARTED|Overall Study||7
8348955|NCT01265394|20580519|P1|NOT COMPLETED|Overall Study||37
8348956|NCT01265394|20580519|P1|COMPLETED|Overall Study||181
8348957|NCT01265394|20580519|P1|STARTED|Overall Study||218
8348958|NCT01265056|20580526|P2|NOT COMPLETED|Follow up||3
8348959|NCT01265056|20580527|P1|NOT COMPLETED|Follow up||7
8348960|NCT01265056|20580526|P2|COMPLETED|Follow up||24
8348961|NCT01265056|20580527|P1|COMPLETED|Follow up||19
8348962|NCT01265056|20580526|P2|STARTED|Follow up||27
8348963|NCT01265056|20580527|P1|STARTED|Follow up||26
8348964|NCT01265056|20580526|P2|NOT COMPLETED|Initial Study Period||2
8348965|NCT01265056|20580527|P1|NOT COMPLETED|Initial Study Period||2
8348966|NCT01265056|20580526|P2|COMPLETED|Initial Study Period||25
8348967|NCT01265056|20580527|P1|COMPLETED|Initial Study Period||24
8348968|NCT01265056|20580526|P2|STARTED|Initial Study Period||27
8348969|NCT01265056|20580527|P1|STARTED|Initial Study Period||26
8348970|NCT01264965|20580537|P1|NOT COMPLETED|Overall Study||10
8348971|NCT01264965|20580537|P1|COMPLETED|Overall Study||15
8348972|NCT01264965|20580537|P1|STARTED|Overall Study||25
8348973|NCT01264952|20580545|P3|NOT COMPLETED|Overall Study||0
8348974|NCT01264952|20580546|P2|NOT COMPLETED|Overall Study||0
8348975|NCT01264952|20580547|P1|NOT COMPLETED|Overall Study||0
8348976|NCT01264952|20580545|P3|COMPLETED|Overall Study||8
8348977|NCT01264952|20580546|P2|COMPLETED|Overall Study||2
8348978|NCT01264952|20580547|P1|COMPLETED|Overall Study||6
8348979|NCT01264952|20580545|P3|STARTED|Overall Study||8
8348980|NCT01264952|20580546|P2|STARTED|Overall Study||2
8348981|NCT01264952|20580547|P1|STARTED|Overall Study||6
8348982|NCT01264939|20580563|P2|NOT COMPLETED|Overall Study||28
8348983|NCT01264939|20580564|P1|NOT COMPLETED|Overall Study||18
8348984|NCT01264939|20580563|P2|COMPLETED|Overall Study||224
8348985|NCT01264939|20580564|P1|COMPLETED|Overall Study||66
8348986|NCT01264939|20580563|P2|STARTED|Overall Study||252
8348987|NCT01264939|20580564|P1|STARTED|Overall Study||84
8348988|NCT01264887|20580590|P1|NOT COMPLETED|Overall Study||31
8348989|NCT01264887|20580590|P1|COMPLETED|Overall Study||0
8348990|NCT01264887|20580590|P1|STARTED|Overall Study||31
8348991|NCT01264835|20580601|P1|NOT COMPLETED|Overall Study||1
8348992|NCT01264835|20580601|P1|COMPLETED|Overall Study||1
8348993|NCT01264835|20580601|P1|STARTED|Overall Study||2
8348994|NCT01264770|20580611|P6|NOT COMPLETED|Overall Study||6
8348995|NCT01264770|20580612|P5|NOT COMPLETED|Overall Study||8
8348996|NCT01264770|20580613|P4|NOT COMPLETED|Overall Study||6
8348997|NCT01264770|20580614|P3|NOT COMPLETED|Overall Study||16
8348998|NCT01264770|20580615|P2|NOT COMPLETED|Overall Study||10
8348999|NCT01264770|20580616|P1|NOT COMPLETED|Overall Study||18
8349000|NCT01264770|20580611|P6|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
8349001|NCT01264770|20580612|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
8349002|NCT01264770|20580613|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
8349003|NCT01264770|20580614|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
8349004|NCT01264770|20580615|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
8349005|NCT01264770|20580616|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
8349006|NCT01264770|20580611|P6|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
8349007|NCT01264770|20580612|P5|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
8349008|NCT01264770|20580613|P4|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
8349009|NCT01264770|20580614|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
8349010|NCT01264770|20580615|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
8349011|NCT01264770|20580616|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
8349012|NCT01264770|20580611|P6|STARTED|Overall Study|Patients who received treatment|25
8349013|NCT01264770|20580612|P5|STARTED|Overall Study|Patients who received treatment|27
8349014|NCT01264770|20580613|P4|STARTED|Overall Study|Patients who received treatment|54
8349015|NCT01264770|20580614|P3|STARTED|Overall Study|Patients who received treatment|57
8349016|NCT01264770|20580615|P2|STARTED|Overall Study|Patients who received treatment|48
8349017|NCT01264770|20580616|P1|STARTED|Overall Study|Patients who received treatment|54
8349018|NCT01264718|20580702|P2|NOT COMPLETED|Overall Study||43
8349019|NCT01264718|20580703|P1|NOT COMPLETED|Overall Study||49
8349020|NCT01264718|20580702|P2|COMPLETED|Overall Study||114
8349021|NCT01264718|20580703|P1|COMPLETED|Overall Study||123
8349022|NCT01264718|20580702|P2|STARTED|Overall Study||157
8349023|NCT01264718|20580703|P1|STARTED|Overall Study||172
8349024|NCT01264705|20580718|P3|NOT COMPLETED|Overall Study||0
8349025|NCT01264705|20580719|P2|NOT COMPLETED|Overall Study||0
8349026|NCT01264705|20580720|P1|NOT COMPLETED|Overall Study||0
8349027|NCT01264705|20580718|P3|COMPLETED|Overall Study||41
8349028|NCT01264705|20580719|P2|COMPLETED|Overall Study||3
8349029|NCT01264705|20580720|P1|COMPLETED|Overall Study||3
8349030|NCT01264705|20580718|P3|STARTED|Overall Study||41
8349031|NCT01264705|20580719|P2|STARTED|Overall Study||3
8349032|NCT01264705|20580720|P1|STARTED|Overall Study||3
8349033|NCT01264679|20580740|P1|NOT COMPLETED|Overall Study||5
8349034|NCT01264679|20580740|P1|COMPLETED|Overall Study||3
8349035|NCT01264679|20580740|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
8349036|NCT01264679|20580740|P1|STARTED|Overall Study||8
8349037|NCT01264614|20580748|P2|NOT COMPLETED|Overall Study||2
8349038|NCT01264614|20580749|P1|NOT COMPLETED|Overall Study||1
8349039|NCT01264614|20580748|P2|COMPLETED|Overall Study||7
8349040|NCT01264614|20580749|P1|COMPLETED|Overall Study||12
8349041|NCT01264614|20580748|P2|STARTED|Overall Study||9
8349042|NCT01264614|20580749|P1|STARTED|Overall Study||13
8349043|NCT01264601|20580765|P2|NOT COMPLETED|Overall Study||0
8349044|NCT01264601|20580766|P1|NOT COMPLETED|Overall Study||0
8349045|NCT01264601|20580765|P2|COMPLETED|Overall Study||14
8349046|NCT01264601|20580766|P1|COMPLETED|Overall Study||17
8349047|NCT01264601|20580765|P2|STARTED|Overall Study||14
8349048|NCT01264601|20580766|P1|STARTED|Overall Study||17
8349049|NCT01264419|20580774|P1|NOT COMPLETED|Overall Study||3
8349050|NCT01264419|20580774|P1|COMPLETED|Overall Study||72
8349051|NCT01264419|20580774|P1|STARTED|Overall Study||75
8349052|NCT01264380|20580779|P3|NOT COMPLETED|Period C||14
8349053|NCT01264380|20580780|P2|NOT COMPLETED|Period C||0
8349054|NCT01264380|20580781|P1|NOT COMPLETED|Period C||0
8349055|NCT01264380|20580779|P3|COMPLETED|Period C||2
8349056|NCT01264380|20580780|P2|COMPLETED|Period C||0
8349057|NCT01264380|20580781|P1|COMPLETED|Period C||0
8349058|NCT01264380|20580779|P3|STARTED|Period C||16
8349059|NCT01264380|20580780|P2|STARTED|Period C||0
8349060|NCT01264380|20580781|P1|STARTED|Period C||0
8349061|NCT01264380|20580779|P3|NOT COMPLETED|Period B||0
8349062|NCT01264380|20580780|P2|NOT COMPLETED|Period B||0
8349063|NCT01264380|20580781|P1|NOT COMPLETED|Period B||0
8349064|NCT01264380|20580779|P3|COMPLETED|Period B||0
8349065|NCT01264380|20580780|P2|COMPLETED|Period B||8
8349066|NCT01264380|20580781|P1|COMPLETED|Period B||8
8349067|NCT01264380|20580779|P3|STARTED|Period B||0
8349068|NCT01264380|20580780|P2|STARTED|Period B||8
8349069|NCT01264380|20580781|P1|STARTED|Period B||8
8349070|NCT01264380|20580779|P3|NOT COMPLETED|Period A||0
8349071|NCT01264380|20580780|P2|NOT COMPLETED|Period A||0
8349072|NCT01264380|20580781|P1|NOT COMPLETED|Period A||0
8349073|NCT01264380|20580779|P3|COMPLETED|Period A||0
8349074|NCT01264380|20580780|P2|COMPLETED|Period A||8
8349075|NCT01264380|20580781|P1|COMPLETED|Period A||8
8349076|NCT01264380|20580779|P3|STARTED|Period A||0
8349077|NCT01264380|20580780|P2|STARTED|Period A||8
8349078|NCT01264380|20580781|P1|STARTED|Period A||8
8349079|NCT01264081|20580802|P1|NOT COMPLETED|Analysis||0
8349080|NCT01264081|20580802|P1|COMPLETED|Analysis||2
8349081|NCT01264081|20580802|P1|STARTED|Analysis||2
8349082|NCT01264081|20580802|P1|NOT COMPLETED|Started Treatment||2
8349083|NCT01264081|20580802|P1|COMPLETED|Started Treatment||2
8349084|NCT01264081|20580802|P1|STARTED|Started Treatment||4
8349085|NCT01264081|20580802|P1|NOT COMPLETED|Participants Screened||30
8349086|NCT01264081|20580802|P1|COMPLETED|Participants Screened||4
8349087|NCT01264081|20580802|P1|STARTED|Participants Screened||34
8349088|NCT01264016|20580807|P1|NOT COMPLETED|Overall Study||2
8349089|NCT01264016|20580807|P1|COMPLETED|Overall Study||94
8349090|NCT01264016|20580807|P1|STARTED|Overall Study||96
8349091|NCT01263938|20580813|P1|NOT COMPLETED|Overall Study||0
8349092|NCT01263938|20580813|P1|COMPLETED|Overall Study||5
8349093|NCT01263938|20580813|P1|STARTED|Overall Study||5
8349094|NCT01263925|20580822|P2|NOT COMPLETED|Overall Study||52
8349095|NCT01263925|20580823|P1|NOT COMPLETED|Overall Study||51
8349096|NCT01263925|20580822|P2|COMPLETED|Overall Study||233
8349097|NCT01263925|20580823|P1|COMPLETED|Overall Study||225
8349098|NCT01263925|20580822|P2|Full Analysis Set|Overall Study||272
8349099|NCT01263925|20580823|P1|Full Analysis Set|Overall Study||269
8349100|NCT01263925|20580822|P2|STARTED|Overall Study||285
8349101|NCT01263925|20580823|P1|STARTED|Overall Study||276
8349102|NCT01263873|20580857|P2|NOT COMPLETED|Overall Study||1
8349103|NCT01263873|20580858|P1|NOT COMPLETED|Overall Study||1
8349104|NCT01263873|20580857|P2|COMPLETED|Overall Study||29
8349105|NCT01263873|20580858|P1|COMPLETED|Overall Study||29
8349106|NCT01263873|20580857|P2|STARTED|Overall Study||30
8349107|NCT01263873|20580858|P1|STARTED|Overall Study||30
8349108|NCT01263782|20580872|P4|NOT COMPLETED|Overall Study||1
8349109|NCT01263782|20580873|P3|NOT COMPLETED|Overall Study||3
8349110|NCT01263782|20580874|P2|NOT COMPLETED|Overall Study||0
8349111|NCT01263782|20580875|P1|NOT COMPLETED|Overall Study||0
8349112|NCT01263782|20580872|P4|COMPLETED|Overall Study||5
8349113|NCT01263782|20580873|P3|COMPLETED|Overall Study||3
8349114|NCT01263782|20580874|P2|COMPLETED|Overall Study||6
8349115|NCT01263782|20580875|P1|COMPLETED|Overall Study||6
8349116|NCT01263782|20580872|P4|STARTED|Overall Study||6
8349117|NCT01263782|20580873|P3|STARTED|Overall Study||6
8349118|NCT01263782|20580874|P2|STARTED|Overall Study||6
8349119|NCT01263782|20580875|P1|STARTED|Overall Study||6
8349120|NCT01263717|20580891|P2|NOT COMPLETED|Overall Study||6
8349121|NCT01263717|20580892|P1|NOT COMPLETED|Overall Study||5
8349122|NCT01263717|20580891|P2|COMPLETED|Overall Study||20
8349123|NCT01263717|20580892|P1|COMPLETED|Overall Study||23
8349124|NCT01263717|20580891|P2|Baseline Visit|Overall Study||22
8349125|NCT01263717|20580892|P1|Baseline Visit|Overall Study||28
8349126|NCT01263717|20580891|P2|STARTED|Overall Study||26
8349127|NCT01263717|20580892|P1|STARTED|Overall Study||28
8349128|NCT01263704|20580920|P1|NOT COMPLETED|Overall Study||29
8349129|NCT01263704|20580920|P1|COMPLETED|Overall Study||13
8349130|NCT01263704|20580920|P1|STARTED|Overall Study||42
8349131|NCT01263691|20580935|P6|NOT COMPLETED|Overall Study||0
8349132|NCT01263691|20580936|P5|NOT COMPLETED|Overall Study||0
8349133|NCT01263691|20580937|P4|NOT COMPLETED|Overall Study||1
8349134|NCT01263691|20580938|P3|NOT COMPLETED|Overall Study||1
8349135|NCT01263691|20580939|P2|NOT COMPLETED|Overall Study||0
8349136|NCT01263691|20580940|P1|NOT COMPLETED|Overall Study||3
8349137|NCT01263691|20580935|P6|COMPLETED|Overall Study||15
8349138|NCT01263691|20580936|P5|COMPLETED|Overall Study||18
8349139|NCT01263691|20580937|P4|COMPLETED|Overall Study||18
8349140|NCT01263691|20580938|P3|COMPLETED|Overall Study||16
8349141|NCT01263691|20580939|P2|COMPLETED|Overall Study||18
8349142|NCT01263691|20580940|P1|COMPLETED|Overall Study||15
8349143|NCT01263691|20580935|P6|STARTED|Overall Study||15
8349144|NCT01263691|20580936|P5|STARTED|Overall Study||18
8349145|NCT01263691|20580937|P4|STARTED|Overall Study||19
8349146|NCT01263691|20580938|P3|STARTED|Overall Study||17
8349147|NCT01263691|20580939|P2|STARTED|Overall Study||18
8349148|NCT01263691|20580940|P1|STARTED|Overall Study||18
8349149|NCT01263665|20581050|P1|NOT COMPLETED|Overall Study||9
8349150|NCT01263665|20581050|P1|COMPLETED|Overall Study||62
8349151|NCT01263665|20581050|P1|STARTED|Overall Study||71
8349152|NCT01263639|20581057|P2|NOT COMPLETED|Overall Study||79
8349153|NCT01263639|20581058|P1|NOT COMPLETED|Overall Study||73
8349154|NCT01263639|20581057|P2|COMPLETED|Overall Study||42
8349155|NCT01263639|20581058|P1|COMPLETED|Overall Study||34
8349156|NCT01263639|20581057|P2|STARTED|Overall Study||121
8349157|NCT01263639|20581058|P1|STARTED|Overall Study||107
8349158|NCT01263561|20581066|P2|NOT COMPLETED|Overall Study||2
8349159|NCT01263561|20581067|P1|NOT COMPLETED|Overall Study||1
8349160|NCT01263561|20581066|P2|COMPLETED|Overall Study||31
8349161|NCT01263561|20581067|P1|COMPLETED|Overall Study||30
8349162|NCT01263561|20581066|P2|STARTED|Overall Study||33
8349163|NCT01263561|20581067|P1|STARTED|Overall Study||31
8349164|NCT01263509|20581079|P4|NOT COMPLETED|Entered - Long-Term Extension Study||2
8349165|NCT01263509|20581080|P3|NOT COMPLETED|Entered - Long-Term Extension Study||5
8349166|NCT01263509|20581081|P2|NOT COMPLETED|Entered - Long-Term Extension Study||12
8349167|NCT01263509|20581082|P1|NOT COMPLETED|Entered - Long-Term Extension Study||8
8349168|NCT01263509|20581079|P4|COMPLETED|Entered - Long-Term Extension Study||24
8349169|NCT01263509|20581080|P3|COMPLETED|Entered - Long-Term Extension Study||27
8349170|NCT01263509|20581081|P2|COMPLETED|Entered - Long-Term Extension Study||48
8349171|NCT01263509|20581082|P1|COMPLETED|Entered - Long-Term Extension Study||53
8349172|NCT01263509|20581079|P4|STARTED|Entered - Long-Term Extension Study||26
8349173|NCT01263509|20581080|P3|STARTED|Entered - Long-Term Extension Study||32
8349174|NCT01263509|20581081|P2|STARTED|Entered - Long-Term Extension Study||60
8349175|NCT01263509|20581082|P1|STARTED|Entered - Long-Term Extension Study||61
8349176|NCT01263509|20581079|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349177|NCT01263509|20581080|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349178|NCT01263509|20581081|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349179|NCT01263509|20581082|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349180|NCT01263509|20581079|P4|COMPLETED|Enrolled - Long-Term Extension Study||26
8349181|NCT01263509|20581080|P3|COMPLETED|Enrolled - Long-Term Extension Study||32
8349182|NCT01263509|20581081|P2|COMPLETED|Enrolled - Long-Term Extension Study||60
8349183|NCT01263509|20581082|P1|COMPLETED|Enrolled - Long-Term Extension Study||61
8349184|NCT01263509|20581079|P4|STARTED|Enrolled - Long-Term Extension Study||26
8349185|NCT01263509|20581080|P3|STARTED|Enrolled - Long-Term Extension Study||32
8349186|NCT01263509|20581081|P2|STARTED|Enrolled - Long-Term Extension Study||60
8349187|NCT01263509|20581082|P1|STARTED|Enrolled - Long-Term Extension Study||61
8349188|NCT01263496|20581211|P9|NOT COMPLETED|Entered - Long-Term Extension Study||3
8349189|NCT01263496|20581212|P8|NOT COMPLETED|Entered - Long-Term Extension Study||1
8349190|NCT01263496|20581213|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
8349191|NCT01263496|20581214|P6|NOT COMPLETED|Entered - Long-Term Extension Study||1
8349192|NCT01263496|20581215|P5|NOT COMPLETED|Entered - Long-Term Extension Study||10
8349193|NCT01263496|20581216|P4|NOT COMPLETED|Entered - Long-Term Extension Study||6
8349194|NCT01263496|20581217|P3|NOT COMPLETED|Entered - Long-Term Extension Study||10
8349195|NCT01263496|20581218|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
8349196|NCT01263496|20581219|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
8349197|NCT01263496|20581211|P9|COMPLETED|Entered - Long-Term Extension Study||15
8349198|NCT01263496|20581212|P8|COMPLETED|Entered - Long-Term Extension Study||16
8349199|NCT01263496|20581213|P7|COMPLETED|Entered - Long-Term Extension Study||16
8349200|NCT01263496|20581214|P6|COMPLETED|Entered - Long-Term Extension Study||16
8349201|NCT01263496|20581215|P5|COMPLETED|Entered - Long-Term Extension Study||61
8349202|NCT01263496|20581216|P4|COMPLETED|Entered - Long-Term Extension Study||68
8349203|NCT01263496|20581217|P3|COMPLETED|Entered - Long-Term Extension Study||62
8349204|NCT01263496|20581218|P2|COMPLETED|Entered - Long-Term Extension Study||59
8349205|NCT01263496|20581219|P1|COMPLETED|Entered - Long-Term Extension Study||62
8349206|NCT01263496|20581211|P9|STARTED|Entered - Long-Term Extension Study||18
8349207|NCT01263496|20581212|P8|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
8349208|NCT01263496|20581213|P7|STARTED|Entered - Long-Term Extension Study||17
8349209|NCT01263496|20581214|P6|STARTED|Entered - Long-Term Extension Study||17
8349210|NCT01263496|20581215|P5|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
8349211|NCT01263496|20581216|P4|STARTED|Entered - Long-Term Extension Study||74
8349212|NCT01263496|20581217|P3|STARTED|Entered - Long-Term Extension Study||72
8349213|NCT01263496|20581218|P2|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
8349214|NCT01263496|20581219|P1|STARTED|Entered - Long-Term Extension Study||71
8349215|NCT01263496|20581211|P9|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349216|NCT01263496|20581212|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349217|NCT01263496|20581213|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349218|NCT01263496|20581214|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349219|NCT01263496|20581215|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
8349220|NCT01263496|20581216|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
8349221|NCT01263496|20581217|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349222|NCT01263496|20581218|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
8349223|NCT01263496|20581219|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
8349224|NCT01263496|20581211|P9|COMPLETED|Enrolled - Long-Term Extension Study||18
8349225|NCT01263496|20581212|P8|COMPLETED|Enrolled - Long-Term Extension Study||18
8349226|NCT01263496|20581213|P7|COMPLETED|Enrolled - Long-Term Extension Study||17
8349227|NCT01263496|20581214|P6|COMPLETED|Enrolled - Long-Term Extension Study||17
8349228|NCT01263496|20581215|P5|COMPLETED|Enrolled - Long-Term Extension Study||72
8349229|NCT01263496|20581216|P4|COMPLETED|Enrolled - Long-Term Extension Study||74
8349230|NCT01263496|20581217|P3|COMPLETED|Enrolled - Long-Term Extension Study||72
8349231|NCT01263496|20581218|P2|COMPLETED|Enrolled - Long-Term Extension Study||75
8349232|NCT01263496|20581219|P1|COMPLETED|Enrolled - Long-Term Extension Study||71
8349233|NCT01263496|20581211|P9|STARTED|Enrolled - Long-Term Extension Study||18
8349234|NCT01263496|20581212|P8|STARTED|Enrolled - Long-Term Extension Study||18
8349235|NCT01263496|20581213|P7|STARTED|Enrolled - Long-Term Extension Study||17
8349236|NCT01263496|20581214|P6|STARTED|Enrolled - Long-Term Extension Study||17
8349237|NCT01263496|20581215|P5|STARTED|Enrolled - Long-Term Extension Study||74
8349238|NCT01263496|20581216|P4|STARTED|Enrolled - Long-Term Extension Study||75
8349239|NCT01263496|20581217|P3|STARTED|Enrolled - Long-Term Extension Study||72
8349240|NCT01263496|20581218|P2|STARTED|Enrolled - Long-Term Extension Study||75
8349241|NCT01263496|20581219|P1|STARTED|Enrolled - Long-Term Extension Study||72
8349242|NCT01263483|20581514|P3|NOT COMPLETED|Overall Study||5
8349243|NCT01263483|20581515|P2|NOT COMPLETED|Overall Study||2
8349244|NCT01263483|20581516|P1|NOT COMPLETED|Overall Study||7
8349245|NCT01263483|20581514|P3|COMPLETED|Overall Study||74
8349246|NCT01263483|20581515|P2|COMPLETED|Overall Study||74
8349247|NCT01263483|20581516|P1|COMPLETED|Overall Study||68
8349248|NCT01263483|20581514|P3|STARTED|Overall Study||79
8349249|NCT01263483|20581515|P2|STARTED|Overall Study||76
8349250|NCT01263483|20581516|P1|STARTED|Overall Study||75
8349251|NCT01263470|20581578|P6|NOT COMPLETED|Overall Study||5
8349252|NCT01263470|20581579|P5|NOT COMPLETED|Overall Study||3
8349253|NCT01263470|20581580|P4|NOT COMPLETED|Overall Study||3
8349254|NCT01263470|20581581|P3|NOT COMPLETED|Overall Study||4
8349255|NCT01263470|20581582|P2|NOT COMPLETED|Overall Study||5
8349256|NCT01263470|20581583|P1|NOT COMPLETED|Overall Study||2
8349257|NCT01263470|20581578|P6|COMPLETED|Overall Study||78
8349258|NCT01263470|20581579|P5|COMPLETED|Overall Study||76
8349259|NCT01263470|20581580|P4|COMPLETED|Overall Study||77
8349260|NCT01263470|20581581|P3|COMPLETED|Overall Study||80
8349261|NCT01263470|20581582|P2|COMPLETED|Overall Study||74
8349262|NCT01263470|20581583|P1|COMPLETED|Overall Study||73
8349263|NCT01263470|20581578|P6|STARTED|Overall Study||83
8349264|NCT01263470|20581579|P5|STARTED|Overall Study||79
8349265|NCT01263470|20581580|P4|STARTED|Overall Study||80
8349266|NCT01263470|20581581|P3|STARTED|Overall Study||84
8349267|NCT01263470|20581582|P2|STARTED|Overall Study||79
8349268|NCT01263470|20581583|P1|STARTED|Overall Study||75
8349269|NCT01263444|20581693|P1|NOT COMPLETED|Overall Study||10
8349270|NCT01263444|20581693|P1|COMPLETED|Overall Study||37
8349271|NCT01263444|20581693|P1|STARTED|Overall Study||47
8349272|NCT01263314|20581702|P8|NOT COMPLETED|Period 3||0
8349273|NCT01263314|20581703|P7|NOT COMPLETED|Period 3||0
8349274|NCT01263314|20581704|P6|NOT COMPLETED|Period 3||0
8349275|NCT01263314|20581705|P5|NOT COMPLETED|Period 3||0
8349276|NCT01263314|20581706|P4|NOT COMPLETED|Period 3||0
8349277|NCT01263314|20581707|P3|NOT COMPLETED|Period 3||0
8349278|NCT01263314|20581708|P2|NOT COMPLETED|Period 3||0
8349279|NCT01263314|20581709|P1|NOT COMPLETED|Period 3||0
8349280|NCT01263314|20581702|P8|COMPLETED|Period 3||2
8349281|NCT01263314|20581703|P7|COMPLETED|Period 3||2
8349282|NCT01263314|20581704|P6|COMPLETED|Period 3||2
8349283|NCT01263314|20581705|P5|COMPLETED|Period 3||2
8349284|NCT01263314|20581706|P4|COMPLETED|Period 3||2
8349285|NCT01263314|20581707|P3|COMPLETED|Period 3||2
8349286|NCT01263314|20581708|P2|COMPLETED|Period 3||2
8349287|NCT01263314|20581709|P1|COMPLETED|Period 3||2
8349288|NCT01263314|20581702|P8|STARTED|Period 3||2
8349289|NCT01263314|20581703|P7|STARTED|Period 3||2
8349290|NCT01263314|20581704|P6|STARTED|Period 3||2
8349291|NCT01263314|20581705|P5|STARTED|Period 3||2
8349292|NCT01263314|20581706|P4|STARTED|Period 3||2
8349293|NCT01263314|20581707|P3|STARTED|Period 3||2
8349294|NCT01263314|20581708|P2|STARTED|Period 3||2
8349295|NCT01263314|20581709|P1|STARTED|Period 3||2
8349296|NCT01263314|20581702|P8|NOT COMPLETED|Period 2||0
8349297|NCT01263314|20581703|P7|NOT COMPLETED|Period 2||0
8349298|NCT01263314|20581704|P6|NOT COMPLETED|Period 2||0
8349299|NCT01263314|20581705|P5|NOT COMPLETED|Period 2||0
8349300|NCT01263314|20581706|P4|NOT COMPLETED|Period 2||0
8349301|NCT01263314|20581707|P3|NOT COMPLETED|Period 2||0
8349302|NCT01263314|20581708|P2|NOT COMPLETED|Period 2||0
8349303|NCT01263314|20581709|P1|NOT COMPLETED|Period 2||0
8349304|NCT01263314|20581702|P8|COMPLETED|Period 2||2
8349305|NCT01263314|20581703|P7|COMPLETED|Period 2||2
8349306|NCT01263314|20581704|P6|COMPLETED|Period 2||2
8349307|NCT01263314|20581705|P5|COMPLETED|Period 2||2
8349308|NCT01263314|20581706|P4|COMPLETED|Period 2||2
8349309|NCT01263314|20581707|P3|COMPLETED|Period 2||2
8349310|NCT01263314|20581708|P2|COMPLETED|Period 2||2
8349311|NCT01263314|20581709|P1|COMPLETED|Period 2||2
8349312|NCT01263314|20581702|P8|STARTED|Period 2||2
8349313|NCT01263314|20581703|P7|STARTED|Period 2||2
8349314|NCT01263314|20581704|P6|STARTED|Period 2||2
8349315|NCT01263314|20581705|P5|STARTED|Period 2||2
8349316|NCT01263314|20581706|P4|STARTED|Period 2||2
8349317|NCT01263314|20581707|P3|STARTED|Period 2||2
8349318|NCT01263314|20581708|P2|STARTED|Period 2||2
8349319|NCT01263314|20581709|P1|STARTED|Period 2||2
8349320|NCT01263314|20581702|P8|NOT COMPLETED|Period 1||0
8349321|NCT01263314|20581703|P7|NOT COMPLETED|Period 1||0
8349322|NCT01263314|20581704|P6|NOT COMPLETED|Period 1||0
8349323|NCT01263314|20581705|P5|NOT COMPLETED|Period 1||0
8349324|NCT01263314|20581706|P4|NOT COMPLETED|Period 1||0
8349325|NCT01263314|20581707|P3|NOT COMPLETED|Period 1||0
8349326|NCT01263314|20581708|P2|NOT COMPLETED|Period 1||0
8349327|NCT01263314|20581709|P1|NOT COMPLETED|Period 1||0
8349328|NCT01263314|20581702|P8|COMPLETED|Period 1||2
8349329|NCT01263314|20581703|P7|COMPLETED|Period 1||2
8349330|NCT01263314|20581704|P6|COMPLETED|Period 1||2
8349331|NCT01263314|20581705|P5|COMPLETED|Period 1||2
8349332|NCT01263314|20581706|P4|COMPLETED|Period 1||2
8349333|NCT01263314|20581707|P3|COMPLETED|Period 1||2
8349334|NCT01263314|20581708|P2|COMPLETED|Period 1||2
8349335|NCT01263314|20581709|P1|COMPLETED|Period 1||2
8349336|NCT01263314|20581702|P8|STARTED|Period 1||2
8349337|NCT01263314|20581703|P7|STARTED|Period 1||2
8349338|NCT01263314|20581704|P6|STARTED|Period 1||2
8349339|NCT01263314|20581705|P5|STARTED|Period 1||2
8349340|NCT01263314|20581706|P4|STARTED|Period 1||2
8349341|NCT01263314|20581707|P3|STARTED|Period 1||2
8349342|NCT01263314|20581708|P2|STARTED|Period 1||2
8349343|NCT01263314|20581709|P1|STARTED|Period 1||2
8349344|NCT01263301|20581817|P2|NOT COMPLETED|Overall Study||0
8349345|NCT01263301|20581818|P1|NOT COMPLETED|Overall Study||0
8349346|NCT01263301|20581817|P2|COMPLETED|Overall Study||11
8349347|NCT01263301|20581818|P1|COMPLETED|Overall Study||5
8349348|NCT01263301|20581817|P2|STARTED|Overall Study||11
8349349|NCT01263301|20581818|P1|STARTED|Overall Study||5
8349350|NCT01263223|20581830|P2|NOT COMPLETED|7-day Follow-up||1
8349351|NCT01263223|20581831|P1|NOT COMPLETED|7-day Follow-up||1
8349352|NCT01263223|20581830|P2|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
8349353|NCT01263223|20581831|P1|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
8349354|NCT01263223|20581830|P2|STARTED|7-day Follow-up||11
8349355|NCT01263223|20581831|P1|STARTED|7-day Follow-up||12
8349356|NCT01263223|20581830|P2|NOT COMPLETED|Period 3||0
8349357|NCT01263223|20581831|P1|NOT COMPLETED|Period 3||0
8349358|NCT01263223|20581830|P2|COMPLETED|Period 3||11
8349359|NCT01263223|20581831|P1|COMPLETED|Period 3||12
8349360|NCT01263223|20581830|P2|STARTED|Period 3||11
8349361|NCT01263223|20581831|P1|STARTED|Period 3||12
8349362|NCT01263223|20581830|P2|NOT COMPLETED|Period 2||1
8349363|NCT01263223|20581831|P1|NOT COMPLETED|Period 2||0
8349364|NCT01263223|20581830|P2|COMPLETED|Period 2||11
8349365|NCT01263223|20581831|P1|COMPLETED|Period 2||12
8349366|NCT01263223|20581830|P2|STARTED|Period 2||12
8349367|NCT01263223|20581831|P1|STARTED|Period 2||12
8349368|NCT01263223|20581830|P2|NOT COMPLETED|3-Day Washout||0
8349369|NCT01263223|20581831|P1|NOT COMPLETED|3-Day Washout||0
8349370|NCT01263223|20581830|P2|COMPLETED|3-Day Washout||12
8349371|NCT01263223|20581831|P1|COMPLETED|3-Day Washout||12
8349372|NCT01263223|20581830|P2|STARTED|3-Day Washout||12
8349373|NCT01263223|20581831|P1|STARTED|3-Day Washout||12
8349374|NCT01263223|20581830|P2|NOT COMPLETED|Period 1||0
8349375|NCT01263223|20581831|P1|NOT COMPLETED|Period 1||0
8349376|NCT01263223|20581830|P2|COMPLETED|Period 1||12
8349377|NCT01263223|20581831|P1|COMPLETED|Period 1||12
8349378|NCT01263223|20581830|P2|STARTED|Period 1||12
8349379|NCT01263223|20581831|P1|STARTED|Period 1||12
8349380|NCT01263197|20581854|P6|NOT COMPLETED|Third Intervention (Period 3)||0
8349381|NCT01263197|20581855|P5|NOT COMPLETED|Third Intervention (Period 3)||0
8349382|NCT01263197|20581856|P4|NOT COMPLETED|Third Intervention (Period 3)||0
8349383|NCT01263197|20581857|P3|NOT COMPLETED|Third Intervention (Period 3)||0
8349384|NCT01263197|20581858|P2|NOT COMPLETED|Third Intervention (Period 3)||1
8349385|NCT01263197|20581859|P1|NOT COMPLETED|Third Intervention (Period 3)||0
8349386|NCT01263197|20581854|P6|COMPLETED|Third Intervention (Period 3)||6
8349387|NCT01263197|20581855|P5|COMPLETED|Third Intervention (Period 3)||7
8349388|NCT01263197|20581856|P4|COMPLETED|Third Intervention (Period 3)||7
8349389|NCT01263197|20581857|P3|COMPLETED|Third Intervention (Period 3)||8
8349390|NCT01263197|20581858|P2|COMPLETED|Third Intervention (Period 3)||7
8349391|NCT01263197|20581859|P1|COMPLETED|Third Intervention (Period 3)||8
8349392|NCT01263197|20581854|P6|STARTED|Third Intervention (Period 3)||6
8349393|NCT01263197|20581855|P5|STARTED|Third Intervention (Period 3)||7
8349394|NCT01263197|20581856|P4|STARTED|Third Intervention (Period 3)||7
8349395|NCT01263197|20581857|P3|STARTED|Third Intervention (Period 3)||8
8349396|NCT01263197|20581858|P2|STARTED|Third Intervention (Period 3)||8
8349397|NCT01263197|20581859|P1|STARTED|Third Intervention (Period 3)||8
8349398|NCT01263197|20581854|P6|NOT COMPLETED|Washout Period 2||1
8349399|NCT01263197|20581855|P5|NOT COMPLETED|Washout Period 2||0
8349400|NCT01263197|20581856|P4|NOT COMPLETED|Washout Period 2||1
8349401|NCT01263197|20581857|P3|NOT COMPLETED|Washout Period 2||0
8349402|NCT01263197|20581858|P2|NOT COMPLETED|Washout Period 2||0
8349403|NCT01263197|20581859|P1|NOT COMPLETED|Washout Period 2||0
8349404|NCT01263197|20581854|P6|COMPLETED|Washout Period 2||6
8349405|NCT01263197|20581855|P5|COMPLETED|Washout Period 2||7
8349406|NCT01263197|20581856|P4|COMPLETED|Washout Period 2||7
8349407|NCT01263197|20581857|P3|COMPLETED|Washout Period 2||8
8349408|NCT01263197|20581858|P2|COMPLETED|Washout Period 2||8
8349409|NCT01263197|20581859|P1|COMPLETED|Washout Period 2||8
8349410|NCT01263197|20581854|P6|STARTED|Washout Period 2||7
8349411|NCT01263197|20581855|P5|STARTED|Washout Period 2||7
8349412|NCT01263197|20581856|P4|STARTED|Washout Period 2||8
8349413|NCT01263197|20581857|P3|STARTED|Washout Period 2||8
8349414|NCT01263197|20581858|P2|STARTED|Washout Period 2||8
8349415|NCT01263197|20581859|P1|STARTED|Washout Period 2||8
8349416|NCT01263197|20581854|P6|NOT COMPLETED|Second Intervention (Period 2)||0
8349417|NCT01263197|20581855|P5|NOT COMPLETED|Second Intervention (Period 2)||0
8349418|NCT01263197|20581856|P4|NOT COMPLETED|Second Intervention (Period 2)||0
8349419|NCT01263197|20581857|P3|NOT COMPLETED|Second Intervention (Period 2)||0
8349420|NCT01263197|20581858|P2|NOT COMPLETED|Second Intervention (Period 2)||0
8349421|NCT01263197|20581859|P1|NOT COMPLETED|Second Intervention (Period 2)||0
8349422|NCT01263197|20581854|P6|COMPLETED|Second Intervention (Period 2)||7
8349423|NCT01263197|20581855|P5|COMPLETED|Second Intervention (Period 2)||7
8349424|NCT01263197|20581856|P4|COMPLETED|Second Intervention (Period 2)||8
8349425|NCT01263197|20581857|P3|COMPLETED|Second Intervention (Period 2)||8
8349426|NCT01263197|20581858|P2|COMPLETED|Second Intervention (Period 2)||8
8349427|NCT01263197|20581859|P1|COMPLETED|Second Intervention (Period 2)||8
8349428|NCT01263197|20581854|P6|STARTED|Second Intervention (Period 2)||7
8349429|NCT01263197|20581855|P5|STARTED|Second Intervention (Period 2)||7
8349430|NCT01263197|20581856|P4|STARTED|Second Intervention (Period 2)||8
8349431|NCT01263197|20581857|P3|STARTED|Second Intervention (Period 2)||8
8349432|NCT01263197|20581858|P2|STARTED|Second Intervention (Period 2)||8
8349433|NCT01263197|20581859|P1|STARTED|Second Intervention (Period 2)||8
8349434|NCT01263197|20581854|P6|NOT COMPLETED|Washout Period 1||0
8349435|NCT01263197|20581855|P5|NOT COMPLETED|Washout Period 1||1
8349436|NCT01263197|20581856|P4|NOT COMPLETED|Washout Period 1||0
8349437|NCT01263197|20581857|P3|NOT COMPLETED|Washout Period 1||0
8349438|NCT01263197|20581858|P2|NOT COMPLETED|Washout Period 1||0
8349439|NCT01263197|20581859|P1|NOT COMPLETED|Washout Period 1||0
8349440|NCT01263197|20581854|P6|COMPLETED|Washout Period 1||7
8349441|NCT01263197|20581855|P5|COMPLETED|Washout Period 1||7
8349442|NCT01263197|20581856|P4|COMPLETED|Washout Period 1||8
8349443|NCT01263197|20581857|P3|COMPLETED|Washout Period 1||8
8349444|NCT01263197|20581858|P2|COMPLETED|Washout Period 1||8
8349445|NCT01263197|20581859|P1|COMPLETED|Washout Period 1||8
8349446|NCT01263197|20581854|P6|STARTED|Washout Period 1||7
8349447|NCT01263197|20581855|P5|STARTED|Washout Period 1||8
8349448|NCT01263197|20581856|P4|STARTED|Washout Period 1||8
8349449|NCT01263197|20581857|P3|STARTED|Washout Period 1||8
8349450|NCT01263197|20581858|P2|STARTED|Washout Period 1||8
8349451|NCT01263197|20581859|P1|STARTED|Washout Period 1||8
8349452|NCT01263197|20581854|P6|NOT COMPLETED|First Intervention (Period 1)||1
8349453|NCT01263197|20581855|P5|NOT COMPLETED|First Intervention (Period 1)||0
8349454|NCT01263197|20581856|P4|NOT COMPLETED|First Intervention (Period 1)||0
8349455|NCT01263197|20581857|P3|NOT COMPLETED|First Intervention (Period 1)||0
8349456|NCT01263197|20581858|P2|NOT COMPLETED|First Intervention (Period 1)||0
8349457|NCT01263197|20581859|P1|NOT COMPLETED|First Intervention (Period 1)||0
8349458|NCT01263197|20581854|P6|COMPLETED|First Intervention (Period 1)||7
8349459|NCT01263197|20581855|P5|COMPLETED|First Intervention (Period 1)||8
8349460|NCT01263197|20581856|P4|COMPLETED|First Intervention (Period 1)||8
8349461|NCT01263197|20581857|P3|COMPLETED|First Intervention (Period 1)||8
8349462|NCT01263197|20581858|P2|COMPLETED|First Intervention (Period 1)||8
8349463|NCT01263197|20581859|P1|COMPLETED|First Intervention (Period 1)||8
8349464|NCT01263197|20581854|P6|STARTED|First Intervention (Period 1)||8
8349465|NCT01263197|20581855|P5|STARTED|First Intervention (Period 1)||8
8349466|NCT01263197|20581856|P4|STARTED|First Intervention (Period 1)||8
8349467|NCT01263197|20581857|P3|STARTED|First Intervention (Period 1)||8
8349468|NCT01263197|20581858|P2|STARTED|First Intervention (Period 1)||8
8349469|NCT01263197|20581859|P1|STARTED|First Intervention (Period 1)||8
8349470|NCT01263132|20581887|P2|NOT COMPLETED|Overall Study||0
8349471|NCT01263132|20581888|P1|NOT COMPLETED|Overall Study||0
8349472|NCT01263132|20581887|P2|COMPLETED|Overall Study||37
8349473|NCT01263132|20581888|P1|COMPLETED|Overall Study||38
8349474|NCT01263132|20581887|P2|STARTED|Overall Study||37
8349475|NCT01263132|20581888|P1|STARTED|Overall Study||38
8349476|NCT01263119|20581902|P1|NOT COMPLETED|Period 2||2
8349477|NCT01263119|20581902|P1|COMPLETED|Period 2||14
8349478|NCT01263119|20581902|P1|STARTED|Period 2||16
8349479|NCT01263119|20581902|P1|NOT COMPLETED|Period 1||2
8349480|NCT01263119|20581902|P1|COMPLETED|Period 1||16
8349481|NCT01263119|20581902|P1|STARTED|Period 1||18
8349482|NCT01263106|20581923|P2|NOT COMPLETED|Period 2 (7 Days)||0
8349483|NCT01263106|20581924|P1|NOT COMPLETED|Period 2 (7 Days)||0
8349484|NCT01263106|20581923|P2|COMPLETED|Period 2 (7 Days)||9
8349485|NCT01263106|20581924|P1|COMPLETED|Period 2 (7 Days)||10
8349486|NCT01263106|20581923|P2|STARTED|Period 2 (7 Days)||9
8349487|NCT01263106|20581924|P1|STARTED|Period 2 (7 Days)||10
8349488|NCT01263106|20581923|P2|NOT COMPLETED|Washout (at Least 7 Days)||1
8349489|NCT01263106|20581924|P1|NOT COMPLETED|Washout (at Least 7 Days)||1
8349490|NCT01263106|20581923|P2|COMPLETED|Washout (at Least 7 Days)||9
8349491|NCT01263106|20581924|P1|COMPLETED|Washout (at Least 7 Days)||10
8349492|NCT01263106|20581923|P2|STARTED|Washout (at Least 7 Days)||10
8349493|NCT01263106|20581924|P1|STARTED|Washout (at Least 7 Days)||11
8349494|NCT01263106|20581923|P2|NOT COMPLETED|Period 1 (7 Days)||0
8349495|NCT01263106|20581924|P1|NOT COMPLETED|Period 1 (7 Days)||0
8349496|NCT01263106|20581923|P2|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10
8349497|NCT01263106|20581924|P1|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11
8349498|NCT01263106|20581923|P2|STARTED|Period 1 (7 Days)||10
8349499|NCT01263106|20581924|P1|STARTED|Period 1 (7 Days)||11
8349500|NCT01263093|20581939|P2|NOT COMPLETED|Period 2||0
8349501|NCT01263093|20581940|P1|NOT COMPLETED|Period 2||1
8349502|NCT01263093|20581939|P2|COMPLETED|Period 2||23
8349503|NCT01263093|20581940|P1|COMPLETED|Period 2||22
8349504|NCT01263093|20581939|P2|STARTED|Period 2||23
8349505|NCT01263093|20581940|P1|STARTED|Period 2||23
8349506|NCT01263093|20581939|P2|NOT COMPLETED|Washout||0
8349507|NCT01263093|20581940|P1|NOT COMPLETED|Washout||1
8349508|NCT01263093|20581939|P2|COMPLETED|Washout||23
8349509|NCT01263093|20581940|P1|COMPLETED|Washout||23
8349510|NCT01263093|20581939|P2|STARTED|Washout||23
8349511|NCT01263093|20581940|P1|STARTED|Washout||24
8349512|NCT01263093|20581939|P2|NOT COMPLETED|Period 1||0
8349513|NCT01263093|20581940|P1|NOT COMPLETED|Period 1||0
8349514|NCT01263093|20581939|P2|COMPLETED|Period 1||23
8349515|NCT01263093|20581940|P1|COMPLETED|Period 1||24
8349516|NCT01263093|20581939|P2|STARTED|Period 1||23
8349517|NCT01263093|20581940|P1|STARTED|Period 1||24
8349518|NCT01263054|20581957|P2|NOT COMPLETED|Overall Study||6
8349519|NCT01263054|20581958|P1|NOT COMPLETED|Overall Study||5
8349520|NCT01263054|20581957|P2|COMPLETED|Overall Study||28
8349521|NCT01263054|20581958|P1|COMPLETED|Overall Study||24
8349522|NCT01263054|20581957|P2|STARTED|Overall Study||34
8349523|NCT01263054|20581958|P1|STARTED|Overall Study||29
8349524|NCT01263028|20581976|P1|NOT COMPLETED|Overall Study||6
8349525|NCT01263028|20581976|P1|COMPLETED|Overall Study||0
8349526|NCT01263028|20581976|P1|STARTED|Overall Study||6
8349527|NCT01263015|20581986|P2|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
8349528|NCT01263015|20581987|P1|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
8349529|NCT01263015|20581986|P2|COMPLETED|Open-label Phase: 48 Weeks Duration||278
8349530|NCT01263015|20581987|P1|COMPLETED|Open-label Phase: 48 Weeks Duration||317
8349531|NCT01263015|20581986|P2|STARTED|Open-label Phase: 48 Weeks Duration||309
8349532|NCT01263015|20581987|P1|STARTED|Open-label Phase: 48 Weeks Duration||341
8349533|NCT01263015|20581986|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
8349534|NCT01263015|20581987|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
8349535|NCT01263015|20581986|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
8349536|NCT01263015|20581987|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
8349537|NCT01263015|20581986|P2|STARTED|Double-blind Phase: 96 Weeks Duration||419
8349538|NCT01263015|20581987|P1|STARTED|Double-blind Phase: 96 Weeks Duration||414
8349539|NCT01262989|20582013|P2|NOT COMPLETED|Period 2||1
8349540|NCT01262989|20582014|P1|NOT COMPLETED|Period 2||0
8349541|NCT01262989|20582013|P2|COMPLETED|Period 2||16
8349542|NCT01262989|20582014|P1|COMPLETED|Period 2||19
8349543|NCT01262989|20582013|P2|STARTED|Period 2||17
8349544|NCT01262989|20582014|P1|STARTED|Period 2||19
8349545|NCT01262989|20582013|P2|NOT COMPLETED|7-Day Washout Period||0
8349546|NCT01262989|20582014|P1|NOT COMPLETED|7-Day Washout Period||0
8349547|NCT01262989|20582013|P2|COMPLETED|7-Day Washout Period||17
8349548|NCT01262989|20582014|P1|COMPLETED|7-Day Washout Period||19
8349549|NCT01262989|20582013|P2|STARTED|7-Day Washout Period||17
8349550|NCT01262989|20582014|P1|STARTED|7-Day Washout Period||19
8349551|NCT01262989|20582013|P2|NOT COMPLETED|Period 1||3
8349552|NCT01262989|20582014|P1|NOT COMPLETED|Period 1||1
8349553|NCT01262989|20582013|P2|COMPLETED|Period 1||17
8349554|NCT01262989|20582014|P1|COMPLETED|Period 1||19
8349555|NCT01262989|20582013|P2|STARTED|Period 1||20
8349556|NCT01262989|20582014|P1|STARTED|Period 1||20
8349557|NCT01262976|20582030|P6|NOT COMPLETED|Up to Year 3||4
8349558|NCT01262976|20582031|P5|NOT COMPLETED|Up to Year 3||2
8349559|NCT01262976|20582032|P4|NOT COMPLETED|Up to Year 3||5
8349560|NCT01262976|20582033|P3|NOT COMPLETED|Up to Year 3||7
8349561|NCT01262976|20582034|P2|NOT COMPLETED|Up to Year 3||2
8349562|NCT01262976|20582035|P1|NOT COMPLETED|Up to Year 3||6
8349563|NCT01262976|20582030|P6|COMPLETED|Up to Year 3||36
8349564|NCT01262976|20582031|P5|COMPLETED|Up to Year 3||38
8349565|NCT01262976|20582032|P4|COMPLETED|Up to Year 3||35
8349566|NCT01262976|20582033|P3|COMPLETED|Up to Year 3||33
8349567|NCT01262976|20582034|P2|COMPLETED|Up to Year 3||38
8349568|NCT01262976|20582035|P1|COMPLETED|Up to Year 3||34
8349569|NCT01262976|20582030|P6|STARTED|Up to Year 3||40
8349570|NCT01262976|20582031|P5|STARTED|Up to Year 3||40
8349571|NCT01262976|20582032|P4|STARTED|Up to Year 3||40
8349572|NCT01262976|20582033|P3|STARTED|Up to Year 3||40
8349573|NCT01262976|20582034|P2|STARTED|Up to Year 3||40
8349574|NCT01262976|20582035|P1|STARTED|Up to Year 3||40
8349575|NCT01262976|20582030|P6|NOT COMPLETED|Up to Year 2||5
8349576|NCT01262976|20582031|P5|NOT COMPLETED|Up to Year 2||4
8349577|NCT01262976|20582032|P4|NOT COMPLETED|Up to Year 2||4
8349578|NCT01262976|20582033|P3|NOT COMPLETED|Up to Year 2||5
8349579|NCT01262976|20582034|P2|NOT COMPLETED|Up to Year 2||1
8349580|NCT01262976|20582035|P1|NOT COMPLETED|Up to Year 2||5
8349581|NCT01262976|20582030|P6|COMPLETED|Up to Year 2||35
8349582|NCT01262976|20582031|P5|COMPLETED|Up to Year 2||36
8349583|NCT01262976|20582032|P4|COMPLETED|Up to Year 2||36
8349584|NCT01262976|20582033|P3|COMPLETED|Up to Year 2||35
8349585|NCT01262976|20582034|P2|COMPLETED|Up to Year 2||39
8349586|NCT01262976|20582035|P1|COMPLETED|Up to Year 2||35
8349587|NCT01262976|20582030|P6|STARTED|Up to Year 2||40
8349588|NCT01262976|20582031|P5|STARTED|Up to Year 2||40
8349589|NCT01262976|20582032|P4|STARTED|Up to Year 2||40
8349590|NCT01262976|20582033|P3|STARTED|Up to Year 2||40
8349591|NCT01262976|20582034|P2|STARTED|Up to Year 2||40
8349592|NCT01262976|20582035|P1|STARTED|Up to Year 2||40
8349593|NCT01262976|20582030|P6|NOT COMPLETED|Up to Year 1||9
8349594|NCT01262976|20582031|P5|NOT COMPLETED|Up to Year 1||11
8349595|NCT01262976|20582032|P4|NOT COMPLETED|Up to Year 1||4
8349596|NCT01262976|20582033|P3|NOT COMPLETED|Up to Year 1||3
8349597|NCT01262976|20582034|P2|NOT COMPLETED|Up to Year 1||1
8349598|NCT01262976|20582035|P1|NOT COMPLETED|Up to Year 1||9
8349599|NCT01262976|20582030|P6|COMPLETED|Up to Year 1||31
8349600|NCT01262976|20582031|P5|COMPLETED|Up to Year 1||29
8349601|NCT01262976|20582032|P4|COMPLETED|Up to Year 1||36
8349602|NCT01262976|20582033|P3|COMPLETED|Up to Year 1||37
8349603|NCT01262976|20582034|P2|COMPLETED|Up to Year 1||39
8349604|NCT01262976|20582035|P1|COMPLETED|Up to Year 1||31
8349605|NCT01262976|20582030|P6|STARTED|Up to Year 1||40
8349606|NCT01262976|20582031|P5|STARTED|Up to Year 1||40
8349607|NCT01262976|20582032|P4|STARTED|Up to Year 1||40
8349608|NCT01262976|20582033|P3|STARTED|Up to Year 1||40
8349609|NCT01262976|20582034|P2|STARTED|Up to Year 1||40
8349610|NCT01262976|20582035|P1|STARTED|Up to Year 1||40
8349611|NCT01262976|20582030|P6|NOT COMPLETED|Up to Month 7||4
8349612|NCT01262976|20582031|P5|NOT COMPLETED|Up to Month 7||2
8349613|NCT01262976|20582032|P4|NOT COMPLETED|Up to Month 7||6
8349614|NCT01262976|20582033|P3|NOT COMPLETED|Up to Month 7||6
8349615|NCT01262976|20582034|P2|NOT COMPLETED|Up to Month 7||0
8349616|NCT01262976|20582035|P1|NOT COMPLETED|Up to Month 7||5
8349617|NCT01262976|20582030|P6|COMPLETED|Up to Month 7||36
8349618|NCT01262976|20582031|P5|COMPLETED|Up to Month 7||38
8349619|NCT01262976|20582032|P4|COMPLETED|Up to Month 7||34
8349620|NCT01262976|20582033|P3|COMPLETED|Up to Month 7||34
8349621|NCT01262976|20582034|P2|COMPLETED|Up to Month 7||40
8349622|NCT01262976|20582035|P1|COMPLETED|Up to Month 7||35
8349623|NCT01262976|20582030|P6|STARTED|Up to Month 7||40
8349624|NCT01262976|20582031|P5|STARTED|Up to Month 7||40
8349625|NCT01262976|20582032|P4|STARTED|Up to Month 7||40
8349626|NCT01262976|20582033|P3|STARTED|Up to Month 7||40
8349627|NCT01262976|20582034|P2|STARTED|Up to Month 7||40
8349628|NCT01262976|20582035|P1|STARTED|Up to Month 7||40
8349629|NCT01262976|20582030|P6|NOT COMPLETED|Up to Month 2||4
8349630|NCT01262976|20582031|P5|NOT COMPLETED|Up to Month 2||2
8349631|NCT01262976|20582032|P4|NOT COMPLETED|Up to Month 2||2
8349632|NCT01262976|20582033|P3|NOT COMPLETED|Up to Month 2||1
8349633|NCT01262976|20582034|P2|NOT COMPLETED|Up to Month 2||1
8349634|NCT01262976|20582035|P1|NOT COMPLETED|Up to Month 2||3
8349635|NCT01262976|20582030|P6|COMPLETED|Up to Month 2||36
8349636|NCT01262976|20582031|P5|COMPLETED|Up to Month 2||38
8349637|NCT01262976|20582032|P4|COMPLETED|Up to Month 2||38
8349638|NCT01262976|20582033|P3|COMPLETED|Up to Month 2||39
8349639|NCT01262976|20582034|P2|COMPLETED|Up to Month 2||39
8349640|NCT01262976|20582035|P1|COMPLETED|Up to Month 2||37
8349641|NCT01262976|20582030|P6|STARTED|Up to Month 2||40
8349642|NCT01262976|20582031|P5|STARTED|Up to Month 2||40
8349643|NCT01262976|20582032|P4|STARTED|Up to Month 2||40
8349644|NCT01262976|20582033|P3|STARTED|Up to Month 2||40
8349645|NCT01262976|20582034|P2|STARTED|Up to Month 2||40
8349646|NCT01262976|20582035|P1|STARTED|Up to Month 2||40
8349659|NCT01262872|20582322|P8|NOT COMPLETED|Step 2||6
8349660|NCT01262872|20582323|P7|NOT COMPLETED|Step 2||9
8349661|NCT01262872|20582324|P6|NOT COMPLETED|Step 2||9
8349662|NCT01262872|20582325|P5|NOT COMPLETED|Step 2||5
8349663|NCT01262872|20582326|P4|NOT COMPLETED|Step 2||10
8349664|NCT01262872|20582327|P3|NOT COMPLETED|Step 2||9
8349665|NCT01262872|20582328|P2|NOT COMPLETED|Step 2||0
8349666|NCT01262872|20582329|P1|NOT COMPLETED|Step 2||0
8349667|NCT01262872|20582322|P8|COMPLETED|Step 2||194
8349668|NCT01262872|20582323|P7|COMPLETED|Step 2||191
8349669|NCT01262872|20582324|P6|COMPLETED|Step 2||191
8349670|NCT01262872|20582325|P5|COMPLETED|Step 2||195
8349671|NCT01262872|20582326|P4|COMPLETED|Step 2||190
8349672|NCT01262872|20582327|P3|COMPLETED|Step 2||191
8349673|NCT01262872|20582328|P2|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349674|NCT01262872|20582329|P1|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349675|NCT01262872|20582322|P8|STARTED|Step 2||200
8349676|NCT01262872|20582323|P7|STARTED|Step 2||200
8349677|NCT01262872|20582324|P6|STARTED|Step 2||200
8349678|NCT01262872|20582325|P5|STARTED|Step 2||200
8349679|NCT01262872|20582326|P4|STARTED|Step 2||200
8349680|NCT01262872|20582327|P3|STARTED|Step 2||200
8349681|NCT01262872|20582328|P2|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349682|NCT01262872|20582329|P1|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349683|NCT01262872|20582322|P8|NOT COMPLETED|Step 1||0
8349684|NCT01262872|20582323|P7|NOT COMPLETED|Step 1||0
8349685|NCT01262872|20582324|P6|NOT COMPLETED|Step 1||0
8349686|NCT01262872|20582325|P5|NOT COMPLETED|Step 1||0
8349687|NCT01262872|20582326|P4|NOT COMPLETED|Step 1||0
8349688|NCT01262872|20582327|P3|NOT COMPLETED|Step 1||0
8349689|NCT01262872|20582328|P2|NOT COMPLETED|Step 1||0
8349690|NCT01262872|20582329|P1|NOT COMPLETED|Step 1||0
8349691|NCT01262872|20582322|P8|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349692|NCT01262872|20582323|P7|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349693|NCT01262872|20582324|P6|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349694|NCT01262872|20582325|P5|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349695|NCT01262872|20582326|P4|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
8349696|NCT01262872|20582327|P3|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349697|NCT01262872|20582328|P2|COMPLETED|Step 1||60
8349698|NCT01262872|20582329|P1|COMPLETED|Step 1||60
8349699|NCT01262872|20582322|P8|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349700|NCT01262872|20582323|P7|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349701|NCT01262872|20582324|P6|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349702|NCT01262872|20582325|P5|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349703|NCT01262872|20582326|P4|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349704|NCT01262872|20582327|P3|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
8349705|NCT01262872|20582328|P2|STARTED|Step 1||60
8349706|NCT01262872|20582329|P1|STARTED|Step 1||60
8349707|NCT01262846|20582596|P2|NOT COMPLETED|Overall Study||3
8349708|NCT01262846|20582597|P1|NOT COMPLETED|Overall Study||2
8349709|NCT01262846|20582596|P2|COMPLETED|Overall Study||97
8349710|NCT01262846|20582597|P1|COMPLETED|Overall Study||93
8349711|NCT01262846|20582596|P2|STARTED|Overall Study||100
8349712|NCT01262846|20582597|P1|STARTED|Overall Study||95
8349713|NCT01262820|20582603|P1|NOT COMPLETED|Overall Study||15
8349714|NCT01262820|20582603|P1|COMPLETED|Overall Study||0
8349715|NCT01262820|20582603|P1|STARTED|Overall Study||15
8349716|NCT01262755|20582610|P1|NOT COMPLETED|Overall Study||0
8349717|NCT01262755|20582610|P1|COMPLETED|Overall Study||450
8349718|NCT01262755|20582610|P1|STARTED|Overall Study||450
8349719|NCT01262677|20582617|P3|NOT COMPLETED|Overall Study||12
8349720|NCT01262677|20582618|P2|NOT COMPLETED|Overall Study||15
8349721|NCT01262677|20582619|P1|NOT COMPLETED|Overall Study||9
8349722|NCT01262677|20582617|P3|COMPLETED|Overall Study||98
8349723|NCT01262677|20582618|P2|COMPLETED|Overall Study||98
8349724|NCT01262677|20582619|P1|COMPLETED|Overall Study||91
8349725|NCT01262677|20582617|P3|STARTED|Overall Study||110
8349726|NCT01262677|20582618|P2|STARTED|Overall Study||113
8349727|NCT01262677|20582619|P1|STARTED|Overall Study||100
8349728|NCT01262651|20582710|P2|NOT COMPLETED|Overall Study||48
8349729|NCT01262651|20582711|P1|NOT COMPLETED|Overall Study||58
8349730|NCT01262651|20582710|P2|COMPLETED|Overall Study||150
8349731|NCT01262651|20582711|P1|COMPLETED|Overall Study||141
8349732|NCT01262651|20582710|P2|ITT Population|Overall Study||198
8349733|NCT01262651|20582711|P1|ITT Population|Overall Study||199
8349734|NCT01262651|20582710|P2|Safety Population|Overall Study||198
8349735|NCT01262651|20582711|P1|Safety Population|Overall Study||199
8349736|NCT01262651|20582710|P2|Received at Least 1 Dose of Study Drug|Overall Study||198
8349737|NCT01262651|20582711|P1|Received at Least 1 Dose of Study Drug|Overall Study||199
8349738|NCT01262651|20582710|P2|STARTED|Overall Study||198
8349739|NCT01262651|20582711|P1|STARTED|Overall Study||199
8349740|NCT01262599|20582739|P2|NOT COMPLETED|Overall Study||0
8349741|NCT01262599|20582740|P1|NOT COMPLETED|Overall Study||0
8349742|NCT01262599|20582739|P2|COMPLETED|Overall Study||16
8349743|NCT01262599|20582740|P1|COMPLETED|Overall Study||16
8349744|NCT01262599|20582739|P2|STARTED|Overall Study||16
8349745|NCT01262599|20582740|P1|STARTED|Overall Study||16
8349746|NCT01262573|20582752|P2|NOT COMPLETED|Overall Study||1
8349747|NCT01262573|20582753|P1|NOT COMPLETED|Overall Study||0
8349748|NCT01262573|20582752|P2|COMPLETED|Overall Study||31
8349749|NCT01262573|20582753|P1|COMPLETED|Overall Study||32
8349750|NCT01262573|20582752|P2|STARTED|Overall Study||32
8349751|NCT01262573|20582753|P1|STARTED|Overall Study||32
8349752|NCT01262560|20582764|P3|NOT COMPLETED|Overall Study||2
8349753|NCT01262560|20582765|P2|NOT COMPLETED|Overall Study||1
8349754|NCT01262560|20582766|P1|NOT COMPLETED|Overall Study||0
8349755|NCT01262560|20582764|P3|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
8349756|NCT01262560|20582765|P2|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
8349757|NCT01262560|20582766|P1|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
8349758|NCT01262560|20582764|P3|STARTED|Overall Study||56
8349759|NCT01262560|20582765|P2|STARTED|Overall Study||54
8349760|NCT01262560|20582766|P1|STARTED|Overall Study||53
8349761|NCT01262547|20582801|P1|NOT COMPLETED|Overall Study||0
8349762|NCT01262547|20582801|P1|COMPLETED|Overall Study||3
8349763|NCT01262547|20582801|P1|STARTED|Overall Study||3
8349764|NCT01262456|20582815|P3|NOT COMPLETED|1-Month Open-Label Extension Period||5
8349765|NCT01262456|20582816|P2|NOT COMPLETED|1-Month Open-Label Extension Period||3
8349766|NCT01262456|20582817|P1|NOT COMPLETED|1-Month Open-Label Extension Period||4
8349767|NCT01262456|20582815|P3|COMPLETED|1-Month Open-Label Extension Period||98
8349768|NCT01262456|20582816|P2|COMPLETED|1-Month Open-Label Extension Period||97
8349769|NCT01262456|20582817|P1|COMPLETED|1-Month Open-Label Extension Period||120
8349770|NCT01262456|20582815|P3|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
8349771|NCT01262456|20582816|P2|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
8349772|NCT01262456|20582817|P1|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
8349773|NCT01262456|20582815|P3|STARTED|1-Month Open-Label Extension Period||103
8349774|NCT01262456|20582816|P2|STARTED|1-Month Open-Label Extension Period||100
8349775|NCT01262456|20582817|P1|STARTED|1-Month Open-Label Extension Period||124
8349776|NCT01262456|20582815|P3|NOT COMPLETED|3-Month Double-Blind Period||26
8349777|NCT01262456|20582816|P2|NOT COMPLETED|3-Month Double-Blind Period||23
8349778|NCT01262456|20582817|P1|NOT COMPLETED|3-Month Double-Blind Period||19
8349779|NCT01262456|20582815|P3|COMPLETED|3-Month Double-Blind Period||103
8349780|NCT01262456|20582816|P2|COMPLETED|3-Month Double-Blind Period||100
8349781|NCT01262456|20582817|P1|COMPLETED|3-Month Double-Blind Period||124
8349782|NCT01262456|20582815|P3|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
8349866|NCT01262092|20582969|P2|COMPLETED|Buprenorphine Taper||12
8349867|NCT01262092|20582970|P1|COMPLETED|Buprenorphine Taper||11
8349783|NCT01262456|20582816|P2|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
8349784|NCT01262456|20582817|P1|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
8349785|NCT01262456|20582815|P3|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
8349786|NCT01262456|20582816|P2|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
8349787|NCT01262456|20582817|P1|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
8349788|NCT01262456|20582815|P3|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
8349789|NCT01262456|20582816|P2|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
8349790|NCT01262456|20582817|P1|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
8349791|NCT01262365|20582861|P3|NOT COMPLETED|Overall Study||94
8349792|NCT01262365|20582862|P2|NOT COMPLETED|Overall Study||81
8349793|NCT01262365|20582863|P1|NOT COMPLETED|Overall Study||90
8349794|NCT01262365|20582861|P3|COMPLETED|Overall Study||171
8349795|NCT01262365|20582862|P2|COMPLETED|Overall Study||181
8349796|NCT01262365|20582863|P1|COMPLETED|Overall Study||176
8349797|NCT01262365|20582861|P3|STARTED|Overall Study||265
8349798|NCT01262365|20582862|P2|STARTED|Overall Study||262
8349799|NCT01262365|20582863|P1|STARTED|Overall Study||266
8349800|NCT01262352|20582888|P2|NOT COMPLETED|Period 2||0
8349801|NCT01262352|20582889|P1|NOT COMPLETED|Period 2||0
8349802|NCT01262352|20582888|P2|COMPLETED|Period 2||8
8349803|NCT01262352|20582889|P1|COMPLETED|Period 2||9
8349804|NCT01262352|20582888|P2|Dosed|Period 2||8
8349805|NCT01262352|20582889|P1|Dosed|Period 2||9
8349806|NCT01262352|20582888|P2|STARTED|Period 2||8
8349807|NCT01262352|20582889|P1|STARTED|Period 2||9
8349808|NCT01262352|20582888|P2|NOT COMPLETED|Washout||2
8349809|NCT01262352|20582889|P1|NOT COMPLETED|Washout||1
8349810|NCT01262352|20582888|P2|COMPLETED|Washout||8
8349811|NCT01262352|20582889|P1|COMPLETED|Washout||9
8349812|NCT01262352|20582888|P2|STARTED|Washout||10
8349813|NCT01262352|20582889|P1|STARTED|Washout||10
8349814|NCT01262352|20582888|P2|NOT COMPLETED|Period 1||0
8349815|NCT01262352|20582889|P1|NOT COMPLETED|Period 1||1
8349816|NCT01262352|20582888|P2|COMPLETED|Period 1||10
8349817|NCT01262352|20582889|P1|COMPLETED|Period 1||10
8349818|NCT01262352|20582888|P2|Dosed|Period 1||10
8349819|NCT01262352|20582889|P1|Dosed|Period 1||10
8349820|NCT01262352|20582888|P2|STARTED|Period 1||10
8349821|NCT01262352|20582889|P1|STARTED|Period 1||11
8349822|NCT01262339|20582901|P1|NOT COMPLETED|Overall Study||0
8349823|NCT01262339|20582901|P1|COMPLETED|Overall Study||2
8349824|NCT01262339|20582901|P1|STARTED|Overall Study||2
8349825|NCT01262287|20582907|P2|NOT COMPLETED|Overall Study||1
8349826|NCT01262287|20582908|P1|NOT COMPLETED|Overall Study||2
8349827|NCT01262287|20582907|P2|COMPLETED|Overall Study||18
8349828|NCT01262287|20582908|P1|COMPLETED|Overall Study||18
8349829|NCT01262287|20582907|P2|STARTED|Overall Study||19
8349830|NCT01262287|20582908|P1|STARTED|Overall Study||20
8349831|NCT01262131|20582921|P3|NOT COMPLETED|Overall Study||0
8349832|NCT01262131|20582922|P2|NOT COMPLETED|Overall Study||0
8349833|NCT01262131|20582923|P1|NOT COMPLETED|Overall Study||0
8349834|NCT01262131|20582921|P3|COMPLETED|Overall Study||4
8349835|NCT01262131|20582922|P2|COMPLETED|Overall Study||4
8349836|NCT01262131|20582923|P1|COMPLETED|Overall Study||5
8349837|NCT01262131|20582921|P3|STARTED|Overall Study||4
8349838|NCT01262131|20582922|P2|STARTED|Overall Study||4
8349839|NCT01262131|20582923|P1|STARTED|Overall Study||5
8349840|NCT01262118|20582933|P2|NOT COMPLETED|Treatment Period (6 Weeks)||0
8349841|NCT01262118|20582934|P1|NOT COMPLETED|Treatment Period (6 Weeks)||0
8349842|NCT01262118|20582933|P2|COMPLETED|Treatment Period (6 Weeks)||0
8349843|NCT01262118|20582934|P1|COMPLETED|Treatment Period (6 Weeks)||36
8349844|NCT01262118|20582933|P2|STARTED|Treatment Period (6 Weeks)||0
8349845|NCT01262118|20582934|P1|STARTED|Treatment Period (6 Weeks)||36
8349846|NCT01262118|20582933|P2|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
8349847|NCT01262118|20582934|P1|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
8349848|NCT01262118|20582933|P2|COMPLETED|Baseline Assessment Period (3 Days)||33
8349849|NCT01262118|20582934|P1|COMPLETED|Baseline Assessment Period (3 Days)||36
8349850|NCT01262118|20582933|P2|STARTED|Baseline Assessment Period (3 Days)||33
8349851|NCT01262118|20582934|P1|STARTED|Baseline Assessment Period (3 Days)||36
8349852|NCT01262105|20582960|P2|NOT COMPLETED|Overall Study||0
8349853|NCT01262105|20582961|P1|NOT COMPLETED|Overall Study||0
8349854|NCT01262105|20582960|P2|COMPLETED|Overall Study||10
8349855|NCT01262105|20582961|P1|COMPLETED|Overall Study||13
8349856|NCT01262105|20582960|P2|STARTED|Overall Study||10
8349857|NCT01262105|20582961|P1|STARTED|Overall Study||13
8349858|NCT01262092|20582969|P2|NOT COMPLETED|Gabapentin Taper||0
8349859|NCT01262092|20582970|P1|NOT COMPLETED|Gabapentin Taper||1
8349860|NCT01262092|20582969|P2|COMPLETED|Gabapentin Taper||11
8349861|NCT01262092|20582970|P1|COMPLETED|Gabapentin Taper||9
8349862|NCT01262092|20582969|P2|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
8349863|NCT01262092|20582970|P1|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
8349864|NCT01262092|20582969|P2|NOT COMPLETED|Buprenorphine Taper||1
8349865|NCT01262092|20582970|P1|NOT COMPLETED|Buprenorphine Taper||1
8349868|NCT01262092|20582969|P2|STARTED|Buprenorphine Taper||13
8349869|NCT01262092|20582970|P1|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
8349870|NCT01262092|20582969|P2|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
8349871|NCT01262092|20582970|P1|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
8349872|NCT01262092|20582969|P2|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
8349873|NCT01262092|20582970|P1|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
8349874|NCT01262092|20582969|P2|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
8349875|NCT01262092|20582970|P1|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
8349876|NCT01262027|20582976|P1|NOT COMPLETED|Overall Study||5
8349877|NCT01262027|20582976|P1|COMPLETED|Overall Study||17
8349878|NCT01262027|20582976|P1|STARTED|Overall Study||22
8349879|NCT01261975|20582981|P1|NOT COMPLETED|Overall Study||1
8349880|NCT01261975|20582981|P1|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
8349881|NCT01261975|20582981|P1|STARTED|Overall Study|36 Participants 72 eyes started|36
8349882|NCT01261819|20583002|P2|NOT COMPLETED|Overall Study||0
8349883|NCT01261819|20583003|P1|NOT COMPLETED|Overall Study||0
8349884|NCT01261819|20583002|P2|COMPLETED|Overall Study||33
8349885|NCT01261819|20583003|P1|COMPLETED|Overall Study||33
8349886|NCT01261819|20583002|P2|STARTED|Overall Study||33
8349887|NCT01261819|20583003|P1|STARTED|Overall Study||33
8349888|NCT01261793|20583012|P3|NOT COMPLETED|Overall Study||82
8349889|NCT01261793|20583013|P2|NOT COMPLETED|Overall Study||91
8349890|NCT01261793|20583014|P1|NOT COMPLETED|Overall Study||85
8349891|NCT01261793|20583012|P3|COMPLETED|Overall Study||184
8349892|NCT01261793|20583013|P2|COMPLETED|Overall Study||171
8349893|NCT01261793|20583014|P1|COMPLETED|Overall Study||178
8349894|NCT01261793|20583012|P3|STARTED|Overall Study||266
8349895|NCT01261793|20583013|P2|STARTED|Overall Study||262
8349896|NCT01261793|20583014|P1|STARTED|Overall Study||263
8349897|NCT01261780|20583039|P2|NOT COMPLETED|Overall Study||2
8349898|NCT01261780|20583040|P1|NOT COMPLETED|Overall Study||2
8349899|NCT01261780|20583039|P2|COMPLETED|Overall Study||5
8349900|NCT01261780|20583040|P1|COMPLETED|Overall Study||5
8349901|NCT01261780|20583039|P2|STARTED|Overall Study||7
8349902|NCT01261780|20583040|P1|STARTED|Overall Study||7
8349903|NCT01261624|20583050|P2|NOT COMPLETED|Week 13 to Week 24||1
8349904|NCT01261624|20583051|P1|NOT COMPLETED|Week 13 to Week 24||0
8349905|NCT01261624|20583050|P2|COMPLETED|Week 13 to Week 24||10
8349906|NCT01261624|20583051|P1|COMPLETED|Week 13 to Week 24||1
8349907|NCT01261624|20583050|P2|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
8349908|NCT01261624|20583051|P1|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
8349909|NCT01261624|20583050|P2|NOT COMPLETED|Week 0 to Week 12||3
8349910|NCT01261624|20583051|P1|NOT COMPLETED|Week 0 to Week 12||1
8349911|NCT01261624|20583050|P2|COMPLETED|Week 0 to Week 12||3
8349912|NCT01261624|20583051|P1|COMPLETED|Week 0 to Week 12||9
8349913|NCT01261624|20583050|P2|STARTED|Week 0 to Week 12||6
8349914|NCT01261624|20583051|P1|STARTED|Week 0 to Week 12||10
8349915|NCT01261611|20583071|P3|NOT COMPLETED|Treatment Cycle 5||0
8349916|NCT01261611|20583072|P2|NOT COMPLETED|Treatment Cycle 5||0
8349917|NCT01261611|20583073|P1|NOT COMPLETED|Treatment Cycle 5||3
8349918|NCT01261611|20583071|P3|COMPLETED|Treatment Cycle 5||0
8349919|NCT01261611|20583072|P2|COMPLETED|Treatment Cycle 5||0
8349920|NCT01261611|20583073|P1|COMPLETED|Treatment Cycle 5||217
8349921|NCT01261611|20583071|P3|STARTED|Treatment Cycle 5||0
8349922|NCT01261611|20583072|P2|STARTED|Treatment Cycle 5||0
8349923|NCT01261611|20583073|P1|STARTED|Treatment Cycle 5||220
8349924|NCT01261611|20583071|P3|NOT COMPLETED|Treatment Cycle 4||0
8349925|NCT01261611|20583072|P2|NOT COMPLETED|Treatment Cycle 4||0
8349926|NCT01261611|20583073|P1|NOT COMPLETED|Treatment Cycle 4||96
8349927|NCT01261611|20583071|P3|COMPLETED|Treatment Cycle 4||0
8349928|NCT01261611|20583072|P2|COMPLETED|Treatment Cycle 4||0
8349929|NCT01261611|20583073|P1|COMPLETED|Treatment Cycle 4||220
8349930|NCT01261611|20583071|P3|STARTED|Treatment Cycle 4||0
8349931|NCT01261611|20583072|P2|STARTED|Treatment Cycle 4||0
8349932|NCT01261611|20583073|P1|STARTED|Treatment Cycle 4||316
8349933|NCT01261611|20583071|P3|NOT COMPLETED|Treatment Cycle 3||0
8349934|NCT01261611|20583072|P2|NOT COMPLETED|Treatment Cycle 3||0
8349935|NCT01261611|20583073|P1|NOT COMPLETED|Treatment Cycle 3||30
8349936|NCT01261611|20583071|P3|COMPLETED|Treatment Cycle 3||0
8349937|NCT01261611|20583072|P2|COMPLETED|Treatment Cycle 3||0
8349938|NCT01261611|20583073|P1|COMPLETED|Treatment Cycle 3||316
8349939|NCT01261611|20583071|P3|STARTED|Treatment Cycle 3||0
8349940|NCT01261611|20583072|P2|STARTED|Treatment Cycle 3||0
8349941|NCT01261611|20583073|P1|STARTED|Treatment Cycle 3||346
8349942|NCT01261611|20583071|P3|NOT COMPLETED|Treatment Cycle 2||0
8349943|NCT01261611|20583072|P2|NOT COMPLETED|Treatment Cycle 2||0
8349944|NCT01261611|20583073|P1|NOT COMPLETED|Treatment Cycle 2||13
8349945|NCT01261611|20583071|P3|COMPLETED|Treatment Cycle 2||0
8349946|NCT01261611|20583072|P2|COMPLETED|Treatment Cycle 2||0
8349947|NCT01261611|20583073|P1|COMPLETED|Treatment Cycle 2||346
8349948|NCT01261611|20583071|P3|STARTED|Treatment Cycle 2||0
8349949|NCT01261611|20583072|P2|STARTED|Treatment Cycle 2||0
8349950|NCT01261611|20583073|P1|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359
8349951|NCT01261611|20583071|P3|NOT COMPLETED|Treatment Cycle 1||2
8349952|NCT01261611|20583072|P2|NOT COMPLETED|Treatment Cycle 1||3
8349953|NCT01261611|20583073|P1|NOT COMPLETED|Treatment Cycle 1||4
8349954|NCT01261611|20583071|P3|COMPLETED|Treatment Cycle 1||52
8349955|NCT01261611|20583072|P2|COMPLETED|Treatment Cycle 1||156
8349956|NCT01261611|20583073|P1|COMPLETED|Treatment Cycle 1||152
8349957|NCT01261611|20583071|P3|STARTED|Treatment Cycle 1||54
8349958|NCT01261611|20583072|P2|STARTED|Treatment Cycle 1||159
8349959|NCT01261611|20583073|P1|STARTED|Treatment Cycle 1||156
8349960|NCT01261559|20583111|P2|NOT COMPLETED|Overall Study||0
8349961|NCT01261559|20583112|P1|NOT COMPLETED|Overall Study||0
8349962|NCT01261559|20583111|P2|COMPLETED|Overall Study||36
8349963|NCT01261559|20583112|P1|COMPLETED|Overall Study||36
8349964|NCT01261559|20583111|P2|STARTED|Overall Study||36
8349965|NCT01261559|20583112|P1|STARTED|Overall Study||36
8349966|NCT01261507|20583124|P1|NOT COMPLETED|Overall Study||0
8349967|NCT01261507|20583124|P1|COMPLETED|Overall Study||15
8349968|NCT01261507|20583124|P1|STARTED|Overall Study||15
8349969|NCT01261390|20583137|P4|NOT COMPLETED|Overall Study||8
8349970|NCT01261390|20583138|P3|NOT COMPLETED|Overall Study||7
8349971|NCT01261390|20583139|P2|NOT COMPLETED|Overall Study||9
8349972|NCT01261390|20583140|P1|NOT COMPLETED|Overall Study||7
8349973|NCT01261390|20583137|P4|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
8349974|NCT01261390|20583138|P3|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
8349975|NCT01261390|20583139|P2|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
8349976|NCT01261390|20583140|P1|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
8349977|NCT01261390|20583137|P4|12-Month Visit|Overall Study||19
8349978|NCT01261390|20583138|P3|12-Month Visit|Overall Study||19
8349979|NCT01261390|20583139|P2|12-Month Visit|Overall Study||21
8349980|NCT01261390|20583140|P1|12-Month Visit|Overall Study||23
8349981|NCT01261390|20583137|P4|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
8349982|NCT01261390|20583138|P3|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
8349983|NCT01261390|20583139|P2|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
8349984|NCT01261390|20583140|P1|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
8349985|NCT01261390|20583137|P4|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
8349986|NCT01261390|20583138|P3|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
8349987|NCT01261390|20583139|P2|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
8349988|NCT01261390|20583140|P1|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
8349989|NCT01261338|20583304|P2|NOT COMPLETED|Overall Study||2
8349990|NCT01261338|20583305|P1|NOT COMPLETED|Overall Study||3
8349991|NCT01261338|20583304|P2|COMPLETED|Overall Study||12
8349992|NCT01261338|20583305|P1|COMPLETED|Overall Study||11
8349993|NCT01261338|20583304|P2|STARTED|Overall Study||14
8349994|NCT01261338|20583305|P1|STARTED|Overall Study|One person in the olestra group started 4 months after the trial began.|14
8350004|NCT01261247|20583350|P1|NOT COMPLETED|Overall Study||2
8350005|NCT01261247|20583350|P1|COMPLETED|Overall Study||39
8350006|NCT01261247|20583350|P1|STARTED|Overall Study||41
8350007|NCT01261052|20583357|P1|NOT COMPLETED|APD Only Intervention (33 Hours)||0
8350008|NCT01261052|20583357|P1|COMPLETED|APD Only Intervention (33 Hours)||14
8350009|NCT01261052|20583357|P1|STARTED|APD Only Intervention (33 Hours)||14
8350010|NCT01261052|20583357|P1|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
8350011|NCT01261052|20583357|P1|COMPLETED|FMPD/APD Intervention (33 Hours)||14
8350012|NCT01261052|20583357|P1|STARTED|FMPD/APD Intervention (33 Hours)||14
8350013|NCT01261000|20583363|P1|NOT COMPLETED|Overall Study||1
8350014|NCT01261000|20583363|P1|COMPLETED|Overall Study||7
8350015|NCT01261000|20583363|P1|STARTED|Overall Study||8
8350016|NCT01260948|20583369|P2|NOT COMPLETED|Second Intervention||1
8350017|NCT01260948|20583370|P1|NOT COMPLETED|Second Intervention||0
8350018|NCT01260948|20583369|P2|COMPLETED|Second Intervention||9
8350019|NCT01260948|20583370|P1|COMPLETED|Second Intervention||12
8350020|NCT01260948|20583369|P2|STARTED|Second Intervention||10
8350021|NCT01260948|20583370|P1|STARTED|Second Intervention||12
8350022|NCT01260948|20583369|P2|NOT COMPLETED|Washout of 28 Days||3
8350023|NCT01260948|20583370|P1|NOT COMPLETED|Washout of 28 Days||1
8350024|NCT01260948|20583369|P2|COMPLETED|Washout of 28 Days||10
8350025|NCT01260948|20583370|P1|COMPLETED|Washout of 28 Days||12
8350026|NCT01260948|20583369|P2|STARTED|Washout of 28 Days||13
8350027|NCT01260948|20583370|P1|STARTED|Washout of 28 Days||13
8350028|NCT01260948|20583369|P2|NOT COMPLETED|First Intervention||0
8350029|NCT01260948|20583370|P1|NOT COMPLETED|First Intervention||0
8350030|NCT01260948|20583369|P2|COMPLETED|First Intervention||13
8350031|NCT01260948|20583370|P1|COMPLETED|First Intervention||13
8350032|NCT01260948|20583369|P2|STARTED|First Intervention||13
8350033|NCT01260948|20583370|P1|STARTED|First Intervention||13
8350034|NCT01260922|20583380|P2|NOT COMPLETED|Second Intervention||2
8350035|NCT01260922|20583381|P1|NOT COMPLETED|Second Intervention||0
8350036|NCT01260922|20583380|P2|COMPLETED|Second Intervention||8
8350037|NCT01260922|20583381|P1|COMPLETED|Second Intervention||9
8350038|NCT01260922|20583380|P2|STARTED|Second Intervention||10
8350039|NCT01260922|20583381|P1|STARTED|Second Intervention||9
8350040|NCT01260922|20583380|P2|NOT COMPLETED|Washout of 28 Days||2
8350041|NCT01260922|20583381|P1|NOT COMPLETED|Washout of 28 Days||4
8350042|NCT01260922|20583380|P2|COMPLETED|Washout of 28 Days||10
8350043|NCT01260922|20583381|P1|COMPLETED|Washout of 28 Days||9
8350044|NCT01260922|20583380|P2|STARTED|Washout of 28 Days||12
8350045|NCT01260922|20583381|P1|STARTED|Washout of 28 Days||13
8350046|NCT01260922|20583380|P2|NOT COMPLETED|First Intervention||1
8350047|NCT01260922|20583381|P1|NOT COMPLETED|First Intervention||0
8350048|NCT01260922|20583380|P2|COMPLETED|First Intervention||12
8350049|NCT01260922|20583381|P1|COMPLETED|First Intervention||13
8350050|NCT01260922|20583380|P2|STARTED|First Intervention||13
8350051|NCT01260922|20583381|P1|STARTED|First Intervention||13
8350052|NCT01260896|20583391|P2|NOT COMPLETED|Second Intervention||0
8350053|NCT01260896|20583392|P1|NOT COMPLETED|Second Intervention||0
8350054|NCT01260896|20583391|P2|COMPLETED|Second Intervention||12
8350055|NCT01260896|20583392|P1|COMPLETED|Second Intervention||10
8350056|NCT01260896|20583391|P2|STARTED|Second Intervention||12
8350057|NCT01260896|20583392|P1|STARTED|Second Intervention||10
8350058|NCT01260896|20583391|P2|NOT COMPLETED|Washout of 7 Days||0
8350059|NCT01260896|20583392|P1|NOT COMPLETED|Washout of 7 Days||0
8350060|NCT01260896|20583391|P2|COMPLETED|Washout of 7 Days||12
8350061|NCT01260896|20583392|P1|COMPLETED|Washout of 7 Days||10
8350062|NCT01260896|20583391|P2|STARTED|Washout of 7 Days||12
8350063|NCT01260896|20583392|P1|STARTED|Washout of 7 Days||10
8350064|NCT01260896|20583391|P2|NOT COMPLETED|First Intervention||0
8350065|NCT01260896|20583392|P1|NOT COMPLETED|First Intervention||2
8350066|NCT01260896|20583391|P2|COMPLETED|First Intervention||12
8350067|NCT01260896|20583392|P1|COMPLETED|First Intervention||10
8350068|NCT01260896|20583391|P2|STARTED|First Intervention||12
8350069|NCT01260896|20583392|P1|STARTED|First Intervention||12
8350070|NCT01260883|20583411|P3|NOT COMPLETED|Overall Study||0
8350071|NCT01260883|20583412|P2|NOT COMPLETED|Overall Study||0
8350072|NCT01260883|20583413|P1|NOT COMPLETED|Overall Study||0
8350073|NCT01260883|20583411|P3|COMPLETED|Overall Study||18
8350074|NCT01260883|20583412|P2|COMPLETED|Overall Study||11
8350075|NCT01260883|20583413|P1|COMPLETED|Overall Study||22
8350076|NCT01260883|20583411|P3|STARTED|Overall Study||18
8350077|NCT01260883|20583412|P2|STARTED|Overall Study||11
8350078|NCT01260883|20583413|P1|STARTED|Overall Study||22
8350079|NCT01260701|20583450|P1|NOT COMPLETED|Overall Study||75
8350080|NCT01260701|20583450|P1|COMPLETED|Overall Study||0
8350081|NCT01260701|20583450|P1|Eligible and Began Protocol Therapy|Overall Study||70
8350082|NCT01260701|20583450|P1|Eligible|Overall Study||71
8350083|NCT01260701|20583450|P1|STARTED|Overall Study||75
8350084|NCT01260688|20583459|P2|NOT COMPLETED|Overall Study||0
8350085|NCT01260688|20583460|P1|NOT COMPLETED|Overall Study||0
8350086|NCT01260688|20583459|P2|COMPLETED|Overall Study||11
8350087|NCT01260688|20583460|P1|COMPLETED|Overall Study||11
8350088|NCT01260688|20583459|P2|STARTED|Overall Study||11
8350089|NCT01260688|20583460|P1|STARTED|Overall Study||11
8350090|NCT01260662|20583497|P3|NOT COMPLETED|Overall Study||0
8350091|NCT01260662|20583498|P2|NOT COMPLETED|Overall Study||0
8350092|NCT01260662|20583499|P1|NOT COMPLETED|Overall Study||0
8350093|NCT01260662|20583497|P3|COMPLETED|Overall Study||96
8350094|NCT01260662|20583498|P2|COMPLETED|Overall Study||85
8350095|NCT01260662|20583499|P1|COMPLETED|Overall Study||90
8350096|NCT01260662|20583497|P3|STARTED|Overall Study||96
8350097|NCT01260662|20583498|P2|STARTED|Overall Study||85
8350098|NCT01260662|20583499|P1|STARTED|Overall Study||90
8350099|NCT01260649|20583518|P2|NOT COMPLETED|Overall Study||1
8350100|NCT01260649|20583519|P1|NOT COMPLETED|Overall Study||2
8350101|NCT01260649|20583518|P2|COMPLETED|Overall Study||8
8350102|NCT01260649|20583519|P1|COMPLETED|Overall Study||6
8350103|NCT01260649|20583518|P2|STARTED|Overall Study||9
8350104|NCT01260649|20583519|P1|STARTED|Overall Study||8
8350105|NCT01260584|20583531|P4|NOT COMPLETED|Period 2||1
8350106|NCT01260584|20583532|P3|NOT COMPLETED|Period 2||5
8350107|NCT01260584|20583533|P2|NOT COMPLETED|Period 2||3
8350108|NCT01260584|20583534|P1|NOT COMPLETED|Period 2||1
8350109|NCT01260584|20583531|P4|COMPLETED|Period 2||26
8350110|NCT01260584|20583532|P3|COMPLETED|Period 2||20
8350111|NCT01260584|20583533|P2|COMPLETED|Period 2||25
8350112|NCT01260584|20583534|P1|COMPLETED|Period 2||26
8350113|NCT01260584|20583531|P4|STARTED|Period 2||27
8350114|NCT01260584|20583532|P3|STARTED|Period 2||25
8350115|NCT01260584|20583533|P2|STARTED|Period 2||28
8350116|NCT01260584|20583534|P1|STARTED|Period 2||27
8350117|NCT01260584|20583531|P4|NOT COMPLETED|Period 1||1
8350118|NCT01260584|20583532|P3|NOT COMPLETED|Period 1||2
8350119|NCT01260584|20583533|P2|NOT COMPLETED|Period 1||0
8350120|NCT01260584|20583534|P1|NOT COMPLETED|Period 1||0
8350121|NCT01260584|20583531|P4|COMPLETED|Period 1||27
8350122|NCT01260584|20583532|P3|COMPLETED|Period 1||25
8350123|NCT01260584|20583533|P2|COMPLETED|Period 1||28
8350124|NCT01260584|20583534|P1|COMPLETED|Period 1||27
8350125|NCT01260584|20583531|P4|STARTED|Period 1||28
8350126|NCT01260584|20583532|P3|STARTED|Period 1||27
8350127|NCT01260584|20583533|P2|STARTED|Period 1||28
8350128|NCT01260584|20583534|P1|STARTED|Period 1||27
8350129|NCT01260493|20583570|P2|NOT COMPLETED|Overall Study||4
8350130|NCT01260493|20583571|P1|NOT COMPLETED|Overall Study||16
8350131|NCT01260493|20583570|P2|COMPLETED|Overall Study||85
8350132|NCT01260493|20583571|P1|COMPLETED|Overall Study||76
8350133|NCT01260493|20583570|P2|STARTED|Overall Study||89
8350134|NCT01260493|20583571|P1|STARTED|Overall Study||92
8350135|NCT01260467|20583577|P1|NOT COMPLETED|Overall Study||2
8350136|NCT01260467|20583577|P1|COMPLETED|Overall Study||2
8350137|NCT01260467|20583577|P1|STARTED|Overall Study||4
8350138|NCT01260454|20583583|P1|NOT COMPLETED|Overall Study||0
8350139|NCT01260454|20583583|P1|COMPLETED|Overall Study||6
8350140|NCT01260454|20583583|P1|STARTED|Overall Study||6
8350141|NCT01260350|20583609|P22|NOT COMPLETED|Overall Study||0
8350142|NCT01260350|20583610|P21|NOT COMPLETED|Overall Study||3
8350143|NCT01260350|20583611|P20|NOT COMPLETED|Overall Study||0
8350144|NCT01260350|20583612|P19|NOT COMPLETED|Overall Study||0
8350145|NCT01260350|20583613|P18|NOT COMPLETED|Overall Study||1
8350146|NCT01260350|20583614|P17|NOT COMPLETED|Overall Study||0
8350147|NCT01260350|20583615|P16|NOT COMPLETED|Overall Study||0
8350148|NCT01260350|20583616|P15|NOT COMPLETED|Overall Study||0
8350149|NCT01260350|20583617|P14|NOT COMPLETED|Overall Study||0
8350150|NCT01260350|20583618|P13|NOT COMPLETED|Overall Study||0
8350151|NCT01260350|20583619|P12|NOT COMPLETED|Overall Study||0
8350152|NCT01260350|20583620|P11|NOT COMPLETED|Overall Study||0
8350153|NCT01260350|20583621|P10|NOT COMPLETED|Overall Study||0
8350154|NCT01260350|20583622|P9|NOT COMPLETED|Overall Study||1
8350155|NCT01260350|20583623|P8|NOT COMPLETED|Overall Study||0
8350156|NCT01260350|20583624|P7|NOT COMPLETED|Overall Study||0
8350157|NCT01260350|20583625|P6|NOT COMPLETED|Overall Study||0
8350158|NCT01260350|20583626|P5|NOT COMPLETED|Overall Study||0
8350159|NCT01260350|20583627|P4|NOT COMPLETED|Overall Study||0
8350160|NCT01260350|20583628|P3|NOT COMPLETED|Overall Study||0
8350161|NCT01260350|20583629|P2|NOT COMPLETED|Overall Study||0
8350162|NCT01260350|20583630|P1|NOT COMPLETED|Overall Study||0
8350163|NCT01260350|20583609|P22|COMPLETED|Overall Study||0
8350164|NCT01260350|20583610|P21|COMPLETED|Overall Study||22
8350165|NCT01260350|20583611|P20|COMPLETED|Overall Study||14
8350166|NCT01260350|20583612|P19|COMPLETED|Overall Study||0
8350167|NCT01260350|20583613|P18|COMPLETED|Overall Study||9
8350168|NCT01260350|20583614|P17|COMPLETED|Overall Study||9
8350169|NCT01260350|20583615|P16|COMPLETED|Overall Study||10
8350170|NCT01260350|20583616|P15|COMPLETED|Overall Study||25
8350171|NCT01260350|20583617|P14|COMPLETED|Overall Study||10
8350172|NCT01260350|20583618|P13|COMPLETED|Overall Study||25
8350173|NCT01260350|20583619|P12|COMPLETED|Overall Study||9
8350174|NCT01260350|20583620|P11|COMPLETED|Overall Study||10
8350175|NCT01260350|20583621|P10|COMPLETED|Overall Study||25
8350176|NCT01260350|20583622|P9|COMPLETED|Overall Study||24
8350177|NCT01260350|20583623|P8|COMPLETED|Overall Study||25
8350178|NCT01260350|20583624|P7|COMPLETED|Overall Study||10
8350179|NCT01260350|20583625|P6|COMPLETED|Overall Study||10
8350180|NCT01260350|20583626|P5|COMPLETED|Overall Study||10
8350181|NCT01260350|20583627|P4|COMPLETED|Overall Study||11
8350182|NCT01260350|20583628|P3|COMPLETED|Overall Study||10
8350183|NCT01260350|20583629|P2|COMPLETED|Overall Study||9
8350184|NCT01260350|20583630|P1|COMPLETED|Overall Study||10
8350185|NCT01260350|20583609|P22|STARTED|Overall Study||0
8350186|NCT01260350|20583610|P21|STARTED|Overall Study||25
8350187|NCT01260350|20583611|P20|STARTED|Overall Study||14
8350188|NCT01260350|20583612|P19|STARTED|Overall Study||0
8350189|NCT01260350|20583613|P18|STARTED|Overall Study||10
8350190|NCT01260350|20583614|P17|STARTED|Overall Study||9
8350191|NCT01260350|20583615|P16|STARTED|Overall Study||10
8350192|NCT01260350|20583616|P15|STARTED|Overall Study||25
8350193|NCT01260350|20583617|P14|STARTED|Overall Study||10
8350194|NCT01260350|20583618|P13|STARTED|Overall Study||25
8350195|NCT01260350|20583619|P12|STARTED|Overall Study||9
8350196|NCT01260350|20583620|P11|STARTED|Overall Study||10
8350197|NCT01260350|20583621|P10|STARTED|Overall Study||25
8350198|NCT01260350|20583622|P9|STARTED|Overall Study||25
8350199|NCT01260350|20583623|P8|STARTED|Overall Study||25
8350200|NCT01260350|20583624|P7|STARTED|Overall Study||10
8350201|NCT01260350|20583625|P6|STARTED|Overall Study||10
8350202|NCT01260350|20583626|P5|STARTED|Overall Study||10
8350203|NCT01260350|20583627|P4|STARTED|Overall Study||11
8350204|NCT01260350|20583628|P3|STARTED|Overall Study||10
8350205|NCT01260350|20583629|P2|STARTED|Overall Study||9
8350206|NCT01260350|20583630|P1|STARTED|Overall Study||10
8350213|NCT01260311|20583837|P1|NOT COMPLETED|Overall Study||127
8350214|NCT01260311|20583837|P1|COMPLETED|Overall Study||381
8350215|NCT01260311|20583837|P1|STARTED|Overall Study||508
8350216|NCT01260272|20583847|P2|NOT COMPLETED|Overall Study||2
8350217|NCT01260272|20583848|P1|NOT COMPLETED|Overall Study||2
8350218|NCT01260272|20583847|P2|COMPLETED|Overall Study||30
8350219|NCT01260272|20583848|P1|COMPLETED|Overall Study||15
8350220|NCT01260272|20583847|P2|STARTED|Overall Study||32
8350221|NCT01260272|20583848|P1|STARTED|Overall Study||17
8350222|NCT01260194|20583868|P1|NOT COMPLETED|Overall Study||1
8350223|NCT01260194|20583868|P1|COMPLETED|Overall Study||3
8350224|NCT01260194|20583868|P1|STARTED|Overall Study||4
8350225|NCT01260181|20583880|P1|NOT COMPLETED|Overall Study||1
8350226|NCT01260181|20583880|P1|COMPLETED|Overall Study||29
8350227|NCT01260181|20583880|P1|STARTED|Overall Study||30
8350228|NCT01260142|20583895|P6|NOT COMPLETED|Treatment Period 2||0
8350229|NCT01260142|20583896|P5|NOT COMPLETED|Treatment Period 2||0
8350230|NCT01260142|20583897|P4|NOT COMPLETED|Treatment Period 2||0
8350231|NCT01260142|20583898|P3|NOT COMPLETED|Treatment Period 2||0
8350232|NCT01260142|20583899|P2|NOT COMPLETED|Treatment Period 2||0
8350233|NCT01260142|20583900|P1|NOT COMPLETED|Treatment Period 2||0
8350234|NCT01260142|20583895|P6|COMPLETED|Treatment Period 2||3
8350235|NCT01260142|20583896|P5|COMPLETED|Treatment Period 2||4
8350236|NCT01260142|20583897|P4|COMPLETED|Treatment Period 2||6
8350237|NCT01260142|20583898|P3|COMPLETED|Treatment Period 2||6
8350238|NCT01260142|20583899|P2|COMPLETED|Treatment Period 2||5
8350239|NCT01260142|20583900|P1|COMPLETED|Treatment Period 2||5
8350240|NCT01260142|20583895|P6|STARTED|Treatment Period 2||3
8350241|NCT01260142|20583896|P5|STARTED|Treatment Period 2||4
8350242|NCT01260142|20583897|P4|STARTED|Treatment Period 2||6
8350243|NCT01260142|20583898|P3|STARTED|Treatment Period 2||6
8350244|NCT01260142|20583899|P2|STARTED|Treatment Period 2||5
8350245|NCT01260142|20583900|P1|STARTED|Treatment Period 2||5
8350246|NCT01260142|20583895|P6|NOT COMPLETED|Treatment Period 1||3
8350247|NCT01260142|20583896|P5|NOT COMPLETED|Treatment Period 1||2
8350248|NCT01260142|20583897|P4|NOT COMPLETED|Treatment Period 1||0
8350249|NCT01260142|20583898|P3|NOT COMPLETED|Treatment Period 1||0
8350250|NCT01260142|20583899|P2|NOT COMPLETED|Treatment Period 1||1
8350251|NCT01260142|20583900|P1|NOT COMPLETED|Treatment Period 1||1
8350252|NCT01260142|20583895|P6|COMPLETED|Treatment Period 1||3
8350253|NCT01260142|20583896|P5|COMPLETED|Treatment Period 1||4
8350254|NCT01260142|20583897|P4|COMPLETED|Treatment Period 1||6
8350255|NCT01260142|20583898|P3|COMPLETED|Treatment Period 1||6
8350256|NCT01260142|20583899|P2|COMPLETED|Treatment Period 1||5
8350257|NCT01260142|20583900|P1|COMPLETED|Treatment Period 1||5
8350258|NCT01260142|20583895|P6|STARTED|Treatment Period 1||6
8350259|NCT01260142|20583896|P5|STARTED|Treatment Period 1||6
8350260|NCT01260142|20583897|P4|STARTED|Treatment Period 1||6
8350261|NCT01260142|20583898|P3|STARTED|Treatment Period 1||6
8350262|NCT01260142|20583899|P2|STARTED|Treatment Period 1||6
8350263|NCT01260142|20583900|P1|STARTED|Treatment Period 1||6
8350264|NCT01259869|20583950|P1|NOT COMPLETED|Overall Study||1
8350265|NCT01259869|20583950|P1|COMPLETED|Overall Study||33
8350266|NCT01259869|20583950|P1|STARTED|Overall Study||34
8350267|NCT01259856|20583956|P2|NOT COMPLETED|Overall Study||74
8350268|NCT01259856|20583957|P1|NOT COMPLETED|Overall Study||69
8350269|NCT01259856|20583956|P2|COMPLETED|Overall Study||12
8350270|NCT01259856|20583957|P1|COMPLETED|Overall Study||13
8350271|NCT01259856|20583956|P2|STARTED|Overall Study||86
8350272|NCT01259856|20583957|P1|STARTED|Overall Study||82
8350289|NCT01259713|20584016|P2|NOT COMPLETED|Overall Study||41
8350290|NCT01259713|20584017|P1|NOT COMPLETED|Overall Study||95
8350291|NCT01259713|20584016|P2|COMPLETED|Overall Study||77
8350292|NCT01259713|20584017|P1|COMPLETED|Overall Study||142
8350293|NCT01259713|20584016|P2|STARTED|Overall Study||118
8350294|NCT01259713|20584017|P1|STARTED|Overall Study||237
8350295|NCT01259596|20584041|P2|NOT COMPLETED|Overall Study||6
8350296|NCT01259596|20584042|P1|NOT COMPLETED|Overall Study||4
8350297|NCT01259596|20584041|P2|COMPLETED|Overall Study||65
8350298|NCT01259596|20584042|P1|COMPLETED|Overall Study||66
8350299|NCT01259596|20584041|P2|STARTED|Overall Study||71
8350300|NCT01259596|20584042|P1|STARTED|Overall Study||70
8350301|NCT01259492|20584064|P4|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
8350302|NCT01259492|20584065|P3|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
8350303|NCT01259492|20584066|P2|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
8350304|NCT01259492|20584067|P1|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
8350305|NCT01259492|20584064|P4|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
8350306|NCT01259492|20584065|P3|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
8350307|NCT01259492|20584066|P2|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
8350308|NCT01259492|20584067|P1|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
8350309|NCT01259492|20584064|P4|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
8350310|NCT01259492|20584065|P3|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
8350311|NCT01259492|20584066|P2|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
8350312|NCT01259492|20584067|P1|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
8350313|NCT01259492|20584064|P4|STARTED|Period 3 (Week 15 to End of Week 40)||123
8350314|NCT01259492|20584065|P3|STARTED|Period 3 (Week 15 to End of Week 40)||120
8350315|NCT01259492|20584066|P2|STARTED|Period 3 (Week 15 to End of Week 40)||132
8350399|NCT01259297|20584201|P1|COMPLETED|Double Blind Randomized Period||242
8350316|NCT01259492|20584067|P1|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
8350317|NCT01259492|20584064|P4|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
8350318|NCT01259492|20584065|P3|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
8350319|NCT01259492|20584066|P2|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
8350320|NCT01259492|20584067|P1|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
8350321|NCT01259492|20584064|P4|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
8350322|NCT01259492|20584065|P3|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
8350323|NCT01259492|20584066|P2|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
8350324|NCT01259492|20584067|P1|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
8350325|NCT01259492|20584064|P4|STARTED|Period 2 (Week 10 to Week 14)||153
8350326|NCT01259492|20584065|P3|STARTED|Period 2 (Week 10 to Week 14)||138
8350327|NCT01259492|20584066|P2|STARTED|Period 2 (Week 10 to Week 14)||141
8350328|NCT01259492|20584067|P1|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
8350329|NCT01259492|20584064|P4|NOT COMPLETED|Period 1 (9 Weeks)||28
8350330|NCT01259492|20584065|P3|NOT COMPLETED|Period 1 (9 Weeks)||43
8350331|NCT01259492|20584066|P2|NOT COMPLETED|Period 1 (9 Weeks)||41
8350332|NCT01259492|20584067|P1|NOT COMPLETED|Period 1 (9 Weeks)||29
8350333|NCT01259492|20584064|P4|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
8350334|NCT01259492|20584065|P3|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
8350335|NCT01259492|20584066|P2|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
8350336|NCT01259492|20584067|P1|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
8350337|NCT01259492|20584064|P4|Full Analysis Set|Period 1 (9 Weeks)||172
8350338|NCT01259492|20584065|P3|Full Analysis Set|Period 1 (9 Weeks)||179
8350339|NCT01259492|20584066|P2|Full Analysis Set|Period 1 (9 Weeks)||175
8350340|NCT01259492|20584067|P1|Full Analysis Set|Period 1 (9 Weeks)||174
8350341|NCT01259492|20584064|P4|STARTED|Period 1 (9 Weeks)||181
8350342|NCT01259492|20584065|P3|STARTED|Period 1 (9 Weeks)||181
8350343|NCT01259492|20584066|P2|STARTED|Period 1 (9 Weeks)||182
8350344|NCT01259492|20584067|P1|STARTED|Period 1 (9 Weeks)||181
8350345|NCT01259466|20584116|P2|NOT COMPLETED|Overall Study||9
8350346|NCT01259466|20584117|P1|NOT COMPLETED|Overall Study||1
8350347|NCT01259466|20584116|P2|COMPLETED|Overall Study||18
8350348|NCT01259466|20584117|P1|COMPLETED|Overall Study||26
8350349|NCT01259466|20584116|P2|STARTED|Overall Study||27
8350350|NCT01259466|20584117|P1|STARTED|Overall Study||27
8350351|NCT01259440|20584127|P2|NOT COMPLETED|Overall Study||0
8350352|NCT01259440|20584128|P1|NOT COMPLETED|Overall Study||0
8350353|NCT01259440|20584127|P2|COMPLETED|Overall Study||10
8350354|NCT01259440|20584128|P1|COMPLETED|Overall Study||13
8350355|NCT01259440|20584127|P2|STARTED|Overall Study||10
8350356|NCT01259440|20584128|P1|STARTED|Overall Study||13
8350357|NCT01259427|20584136|P2|NOT COMPLETED|Overall Study||14
8350358|NCT01259427|20584137|P1|NOT COMPLETED|Overall Study||18
8350359|NCT01259427|20584136|P2|COMPLETED|Overall Study||110
8350360|NCT01259427|20584137|P1|COMPLETED|Overall Study||106
8350361|NCT01259427|20584136|P2|STARTED|Overall Study||124
8350362|NCT01259427|20584137|P1|STARTED|Overall Study||124
8350363|NCT01259401|20584155|P2|NOT COMPLETED|4-month Follow-up||2
8350364|NCT01259401|20584156|P1|NOT COMPLETED|4-month Follow-up||0
8350365|NCT01259401|20584155|P2|COMPLETED|4-month Follow-up||19
8350366|NCT01259401|20584156|P1|COMPLETED|4-month Follow-up||21
8350367|NCT01259401|20584155|P2|STARTED|4-month Follow-up||21
8350368|NCT01259401|20584156|P1|STARTED|4-month Follow-up||21
8350369|NCT01259401|20584155|P2|NOT COMPLETED|End of 4-week Intervention||0
8350370|NCT01259401|20584156|P1|NOT COMPLETED|End of 4-week Intervention||0
8350371|NCT01259401|20584155|P2|COMPLETED|End of 4-week Intervention||21
8350372|NCT01259401|20584156|P1|COMPLETED|End of 4-week Intervention||21
8350373|NCT01259401|20584155|P2|STARTED|End of 4-week Intervention||21
8350374|NCT01259401|20584156|P1|STARTED|End of 4-week Intervention||21
8350375|NCT01259388|20584166|P2|NOT COMPLETED|Overall Study||1
8350376|NCT01259388|20584167|P1|NOT COMPLETED|Overall Study||5
8350377|NCT01259388|20584166|P2|COMPLETED|Overall Study||11
8350378|NCT01259388|20584167|P1|COMPLETED|Overall Study||6
8350379|NCT01259388|20584166|P2|STARTED|Overall Study||12
8350380|NCT01259388|20584167|P1|STARTED|Overall Study||11
8350381|NCT01259375|20584177|P1|NOT COMPLETED|Overall Study||1
8350382|NCT01259375|20584177|P1|COMPLETED|Overall Study||23
8350383|NCT01259375|20584177|P1|STARTED|Overall Study||24
8350384|NCT01259297|20584194|P8|NOT COMPLETED|Double Blind Randomized Period||3
8350385|NCT01259297|20584195|P7|NOT COMPLETED|Double Blind Randomized Period||6
8350386|NCT01259297|20584196|P6|NOT COMPLETED|Double Blind Randomized Period||8
8350387|NCT01259297|20584197|P5|NOT COMPLETED|Double Blind Randomized Period||4
8350388|NCT01259297|20584198|P4|NOT COMPLETED|Double Blind Randomized Period||4
8350389|NCT01259297|20584199|P3|NOT COMPLETED|Double Blind Randomized Period||1
8350390|NCT01259297|20584200|P2|NOT COMPLETED|Double Blind Randomized Period||3
8350391|NCT01259297|20584201|P1|NOT COMPLETED|Double Blind Randomized Period||2
8350392|NCT01259297|20584194|P8|COMPLETED|Double Blind Randomized Period||196
8350393|NCT01259297|20584195|P7|COMPLETED|Double Blind Randomized Period||190
8350394|NCT01259297|20584196|P6|COMPLETED|Double Blind Randomized Period||245
8350395|NCT01259297|20584197|P5|COMPLETED|Double Blind Randomized Period||247
8350396|NCT01259297|20584198|P4|COMPLETED|Double Blind Randomized Period||191
8350397|NCT01259297|20584199|P3|COMPLETED|Double Blind Randomized Period||188
8350398|NCT01259297|20584200|P2|COMPLETED|Double Blind Randomized Period||229
8350400|NCT01259297|20584194|P8|STARTED|Double Blind Randomized Period||199
8350401|NCT01259297|20584195|P7|STARTED|Double Blind Randomized Period||196
8350402|NCT01259297|20584196|P6|STARTED|Double Blind Randomized Period||253
8350403|NCT01259297|20584197|P5|STARTED|Double Blind Randomized Period||251
8350404|NCT01259297|20584198|P4|STARTED|Double Blind Randomized Period||195
8350405|NCT01259297|20584199|P3|STARTED|Double Blind Randomized Period||189
8350406|NCT01259297|20584200|P2|STARTED|Double Blind Randomized Period||232
8350407|NCT01259297|20584201|P1|STARTED|Double Blind Randomized Period||244
8350408|NCT01259297|20584194|P8|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350409|NCT01259297|20584195|P7|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350410|NCT01259297|20584196|P6|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350411|NCT01259297|20584197|P5|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350412|NCT01259297|20584198|P4|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350413|NCT01259297|20584199|P3|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
8350414|NCT01259297|20584200|P2|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350415|NCT01259297|20584201|P1|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
8350416|NCT01259297|20584194|P8|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350417|NCT01259297|20584195|P7|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350418|NCT01259297|20584196|P6|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350419|NCT01259297|20584197|P5|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350420|NCT01259297|20584198|P4|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350421|NCT01259297|20584199|P3|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
8350422|NCT01259297|20584200|P2|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
8350423|NCT01259297|20584201|P1|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
8350424|NCT01259297|20584194|P8|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8350425|NCT01259297|20584195|P7|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8350426|NCT01259297|20584196|P6|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8350427|NCT01259297|20584197|P5|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8350428|NCT01259297|20584198|P4|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8350429|NCT01259297|20584199|P3|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
8350430|NCT01259297|20584200|P2|STARTED|Run-in Open Label Period (4-5 Weeks)||0
8350431|NCT01259297|20584201|P1|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
8350432|NCT01259284|20584232|P3|NOT COMPLETED|Overall Study||0
8350433|NCT01259284|20584233|P2|NOT COMPLETED|Overall Study||0
8350434|NCT01259284|20584234|P1|NOT COMPLETED|Overall Study||2
8350435|NCT01259284|20584232|P3|COMPLETED|Overall Study||0
8350436|NCT01259284|20584233|P2|COMPLETED|Overall Study||0
8350437|NCT01259284|20584234|P1|COMPLETED|Overall Study||0
8350438|NCT01259284|20584232|P3|STARTED|Overall Study||0
8350439|NCT01259284|20584233|P2|STARTED|Overall Study||0
8350440|NCT01259284|20584234|P1|STARTED|Overall Study||2
8350441|NCT01259245|20584244|P2|NOT COMPLETED|Overall Study||26
8350442|NCT01259245|20584245|P1|NOT COMPLETED|Overall Study||28
8350443|NCT01259245|20584244|P2|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
8350444|NCT01259245|20584245|P1|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
8350445|NCT01259245|20584244|P2|STARTED|Overall Study||94
8350446|NCT01259245|20584245|P1|STARTED|Overall Study||98
8350447|NCT01259128|20584271|P2|NOT COMPLETED|Overall Study||2
8350448|NCT01259128|20584272|P1|NOT COMPLETED|Overall Study||0
8350449|NCT01259128|20584271|P2|COMPLETED|Overall Study||15
8350450|NCT01259128|20584272|P1|COMPLETED|Overall Study||15
8350451|NCT01259128|20584271|P2|STARTED|Overall Study||17
8350452|NCT01259128|20584272|P1|STARTED|Overall Study||15
8350453|NCT01259115|20584282|P2|NOT COMPLETED|Period 2||0
8350454|NCT01259115|20584283|P1|NOT COMPLETED|Period 2||1
8350455|NCT01259115|20584282|P2|COMPLETED|Period 2||9
8350456|NCT01259115|20584283|P1|COMPLETED|Period 2||6
8350457|NCT01259115|20584282|P2|STARTED|Period 2||9
8350458|NCT01259115|20584283|P1|STARTED|Period 2||7
8350459|NCT01259115|20584282|P2|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
8350460|NCT01259115|20584283|P1|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
8350461|NCT01259115|20584282|P2|COMPLETED|Period: Washout Period of 4 to 18 Days||9
8350462|NCT01259115|20584283|P1|COMPLETED|Period: Washout Period of 4 to 18 Days||7
8350463|NCT01259115|20584282|P2|STARTED|Period: Washout Period of 4 to 18 Days||9
8350464|NCT01259115|20584283|P1|STARTED|Period: Washout Period of 4 to 18 Days||7
8350465|NCT01259115|20584282|P2|NOT COMPLETED|Period 1||1
8350466|NCT01259115|20584283|P1|NOT COMPLETED|Period 1||3
8350467|NCT01259115|20584282|P2|COMPLETED|Period 1||9
8350468|NCT01259115|20584283|P1|COMPLETED|Period 1||7
8350469|NCT01259115|20584282|P2|STARTED|Period 1||10
8350470|NCT01259115|20584283|P1|STARTED|Period 1||10
8350471|NCT01259102|20584319|P5|NOT COMPLETED|Overall Study||1
8350472|NCT01259102|20584320|P4|NOT COMPLETED|Overall Study||2
8350473|NCT01259102|20584321|P3|NOT COMPLETED|Overall Study||2
8350474|NCT01259102|20584322|P2|NOT COMPLETED|Overall Study||0
8350475|NCT01259102|20584323|P1|NOT COMPLETED|Overall Study||1
8350476|NCT01259102|20584319|P5|COMPLETED|Overall Study||13
8350477|NCT01259102|20584320|P4|COMPLETED|Overall Study||12
8350478|NCT01259102|20584321|P3|COMPLETED|Overall Study||13
8350479|NCT01259102|20584322|P2|COMPLETED|Overall Study||14
8350480|NCT01259102|20584323|P1|COMPLETED|Overall Study||12
8350481|NCT01259102|20584319|P5|STARTED|Overall Study||14
8350482|NCT01259102|20584320|P4|STARTED|Overall Study||14
8350483|NCT01259102|20584321|P3|STARTED|Overall Study||15
8350484|NCT01259102|20584322|P2|STARTED|Overall Study||14
8350485|NCT01259102|20584323|P1|STARTED|Overall Study||13
8350486|NCT01259089|20584380|P6|NOT COMPLETED|Survival Follow up for Two Years||19
8350487|NCT01259089|20584381|P5|NOT COMPLETED|Survival Follow up for Two Years||6
8350488|NCT01259089|20584382|P4|NOT COMPLETED|Survival Follow up for Two Years||3
8350489|NCT01259089|20584383|P3|NOT COMPLETED|Survival Follow up for Two Years||2
8350490|NCT01259089|20584384|P2|NOT COMPLETED|Survival Follow up for Two Years||2
8350491|NCT01259089|20584385|P1|NOT COMPLETED|Survival Follow up for Two Years||3
8350492|NCT01259089|20584380|P6|COMPLETED|Survival Follow up for Two Years||0
8350493|NCT01259089|20584381|P5|COMPLETED|Survival Follow up for Two Years||0
8350494|NCT01259089|20584382|P4|COMPLETED|Survival Follow up for Two Years||0
8350495|NCT01259089|20584383|P3|COMPLETED|Survival Follow up for Two Years||1
8350496|NCT01259089|20584384|P2|COMPLETED|Survival Follow up for Two Years||1
8350497|NCT01259089|20584385|P1|COMPLETED|Survival Follow up for Two Years||0
8350498|NCT01259089|20584380|P6|STARTED|Survival Follow up for Two Years||19
8350499|NCT01259089|20584381|P5|STARTED|Survival Follow up for Two Years||6
8350500|NCT01259089|20584382|P4|STARTED|Survival Follow up for Two Years||3
8350501|NCT01259089|20584383|P3|STARTED|Survival Follow up for Two Years||3
8350502|NCT01259089|20584384|P2|STARTED|Survival Follow up for Two Years||3
8350503|NCT01259089|20584385|P1|STARTED|Survival Follow up for Two Years||3
8350504|NCT01259089|20584380|P6|NOT COMPLETED|Continued Treatment After 8 Weeks||1
8350505|NCT01259089|20584381|P5|NOT COMPLETED|Continued Treatment After 8 Weeks||2
8350506|NCT01259089|20584382|P4|NOT COMPLETED|Continued Treatment After 8 Weeks||1
8350507|NCT01259089|20584383|P3|NOT COMPLETED|Continued Treatment After 8 Weeks||1
8350508|NCT01259089|20584384|P2|NOT COMPLETED|Continued Treatment After 8 Weeks||1
8350509|NCT01259089|20584385|P1|NOT COMPLETED|Continued Treatment After 8 Weeks||2
8350510|NCT01259089|20584380|P6|COMPLETED|Continued Treatment After 8 Weeks||7
8350511|NCT01259089|20584381|P5|COMPLETED|Continued Treatment After 8 Weeks||0
8350512|NCT01259089|20584382|P4|COMPLETED|Continued Treatment After 8 Weeks||1
8350513|NCT01259089|20584383|P3|COMPLETED|Continued Treatment After 8 Weeks||1
8350514|NCT01259089|20584384|P2|COMPLETED|Continued Treatment After 8 Weeks||2
8350515|NCT01259089|20584385|P1|COMPLETED|Continued Treatment After 8 Weeks||1
8350516|NCT01259089|20584380|P6|STARTED|Continued Treatment After 8 Weeks||8
8350517|NCT01259089|20584381|P5|STARTED|Continued Treatment After 8 Weeks||2
8350518|NCT01259089|20584382|P4|STARTED|Continued Treatment After 8 Weeks||2
8350519|NCT01259089|20584383|P3|STARTED|Continued Treatment After 8 Weeks||2
8350520|NCT01259089|20584384|P2|STARTED|Continued Treatment After 8 Weeks||3
8350521|NCT01259089|20584385|P1|STARTED|Continued Treatment After 8 Weeks||3
8350522|NCT01259089|20584380|P6|NOT COMPLETED|Confirmed Response at 8 Weeks||10
8350523|NCT01259089|20584381|P5|NOT COMPLETED|Confirmed Response at 8 Weeks||4
8350524|NCT01259089|20584382|P4|NOT COMPLETED|Confirmed Response at 8 Weeks||1
8350525|NCT01259089|20584383|P3|NOT COMPLETED|Confirmed Response at 8 Weeks||1
8350526|NCT01259089|20584384|P2|NOT COMPLETED|Confirmed Response at 8 Weeks||0
8350527|NCT01259089|20584385|P1|NOT COMPLETED|Confirmed Response at 8 Weeks||0
8350528|NCT01259089|20584380|P6|COMPLETED|Confirmed Response at 8 Weeks||8
8350529|NCT01259089|20584381|P5|COMPLETED|Confirmed Response at 8 Weeks||2
8350530|NCT01259089|20584382|P4|COMPLETED|Confirmed Response at 8 Weeks||2
8350531|NCT01259089|20584383|P3|COMPLETED|Confirmed Response at 8 Weeks||2
8350532|NCT01259089|20584384|P2|COMPLETED|Confirmed Response at 8 Weeks||3
8350533|NCT01259089|20584385|P1|COMPLETED|Confirmed Response at 8 Weeks||3
8350534|NCT01259089|20584380|P6|STARTED|Confirmed Response at 8 Weeks||18
8350535|NCT01259089|20584381|P5|STARTED|Confirmed Response at 8 Weeks||6
8350536|NCT01259089|20584382|P4|STARTED|Confirmed Response at 8 Weeks||3
8350537|NCT01259089|20584383|P3|STARTED|Confirmed Response at 8 Weeks||3
8350538|NCT01259089|20584384|P2|STARTED|Confirmed Response at 8 Weeks||3
8350539|NCT01259089|20584385|P1|STARTED|Confirmed Response at 8 Weeks||3
8350540|NCT01259089|20584380|P6|NOT COMPLETED|Reached First Response at 4 Weeks||2
8350541|NCT01259089|20584381|P5|NOT COMPLETED|Reached First Response at 4 Weeks||0
8350542|NCT01259089|20584382|P4|NOT COMPLETED|Reached First Response at 4 Weeks||0
8350543|NCT01259089|20584383|P3|NOT COMPLETED|Reached First Response at 4 Weeks||0
8350544|NCT01259089|20584384|P2|NOT COMPLETED|Reached First Response at 4 Weeks||0
8350545|NCT01259089|20584385|P1|NOT COMPLETED|Reached First Response at 4 Weeks||0
8350546|NCT01259089|20584380|P6|COMPLETED|Reached First Response at 4 Weeks||18
8350547|NCT01259089|20584381|P5|COMPLETED|Reached First Response at 4 Weeks||6
8350548|NCT01259089|20584382|P4|COMPLETED|Reached First Response at 4 Weeks||3
8350549|NCT01259089|20584383|P3|COMPLETED|Reached First Response at 4 Weeks||3
8350550|NCT01259089|20584384|P2|COMPLETED|Reached First Response at 4 Weeks||3
8350551|NCT01259089|20584385|P1|COMPLETED|Reached First Response at 4 Weeks||3
8350552|NCT01259089|20584380|P6|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
8350553|NCT01259089|20584381|P5|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
8350554|NCT01259089|20584382|P4|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
8350555|NCT01259089|20584383|P3|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
8350556|NCT01259089|20584384|P2|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
8350557|NCT01259089|20584385|P1|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
8350558|NCT01259089|20584380|P6|Started Treatment on Study|Reached First Response at 4 Weeks||19
8350559|NCT01259089|20584381|P5|Started Treatment on Study|Reached First Response at 4 Weeks||6
8350560|NCT01259089|20584382|P4|Started Treatment on Study|Reached First Response at 4 Weeks||3
8350561|NCT01259089|20584383|P3|Started Treatment on Study|Reached First Response at 4 Weeks||3
8350562|NCT01259089|20584384|P2|Started Treatment on Study|Reached First Response at 4 Weeks||3
8350563|NCT01259089|20584385|P1|Started Treatment on Study|Reached First Response at 4 Weeks||3
8350564|NCT01259089|20584380|P6|STARTED|Reached First Response at 4 Weeks||20
8350565|NCT01259089|20584381|P5|STARTED|Reached First Response at 4 Weeks||6
8350566|NCT01259089|20584382|P4|STARTED|Reached First Response at 4 Weeks||3
8350567|NCT01259089|20584383|P3|STARTED|Reached First Response at 4 Weeks||3
8350568|NCT01259089|20584384|P2|STARTED|Reached First Response at 4 Weeks||3
8350569|NCT01259089|20584385|P1|STARTED|Reached First Response at 4 Weeks||3
8350570|NCT01259063|20584404|P1|NOT COMPLETED|Overall Study||0
8350571|NCT01259063|20584404|P1|COMPLETED|Overall Study||33
8350572|NCT01259063|20584404|P1|STARTED|Overall Study||33
8350573|NCT01259024|20584413|P1|NOT COMPLETED|Overall Study||1
8350574|NCT01259024|20584413|P1|COMPLETED|Overall Study||0
8350575|NCT01259024|20584413|P1|STARTED|Overall Study||1
8350576|NCT01259011|20584422|P2|NOT COMPLETED|After Patient Death||0
8350577|NCT01259011|20584423|P1|NOT COMPLETED|After Patient Death||0
8350578|NCT01259011|20584422|P2|COMPLETED|After Patient Death||28
8350579|NCT01259011|20584423|P1|COMPLETED|After Patient Death||17
8350580|NCT01259011|20584422|P2|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
8350581|NCT01259011|20584423|P1|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
8350582|NCT01259011|20584422|P2|NOT COMPLETED|Main Study Period||0
8350583|NCT01259011|20584423|P1|NOT COMPLETED|Main Study Period||0
8350584|NCT01259011|20584422|P2|COMPLETED|Main Study Period||109
8350585|NCT01259011|20584423|P1|COMPLETED|Main Study Period||101
8350586|NCT01259011|20584422|P2|STARTED|Main Study Period|109 dyads (=218 individuals)|109
8350587|NCT01259011|20584423|P1|STARTED|Main Study Period|101 dyads (=202 individuals)|101
8350588|NCT01258998|20584433|P1|NOT COMPLETED|Overall Study||1
8350589|NCT01258998|20584433|P1|COMPLETED|Overall Study||59
8350590|NCT01258998|20584433|P1|STARTED|Overall Study||60
8350591|NCT01258985|20584446|P2|NOT COMPLETED|Overall Study||0
8350592|NCT01258985|20584447|P1|NOT COMPLETED|Overall Study||0
8350593|NCT01258985|20584446|P2|COMPLETED|Overall Study||98
8350594|NCT01258985|20584447|P1|COMPLETED|Overall Study||106
8350595|NCT01258985|20584446|P2|STARTED|Overall Study||98
8350596|NCT01258985|20584447|P1|STARTED|Overall Study||106
8350597|NCT01258855|20584475|P2|NOT COMPLETED|Overall Study||0
8350598|NCT01258855|20584476|P1|NOT COMPLETED|Overall Study||0
8350599|NCT01258855|20584475|P2|COMPLETED|Overall Study||29
8350600|NCT01258855|20584476|P1|COMPLETED|Overall Study||55
8350601|NCT01258855|20584475|P2|STARTED|Overall Study||29
8350602|NCT01258855|20584476|P1|STARTED|Overall Study||55
8350603|NCT01258803|20584494|P6|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8350604|NCT01258803|20584495|P5|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8350605|NCT01258803|20584496|P4|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8350606|NCT01258803|20584497|P3|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8350607|NCT01258803|20584498|P2|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8350608|NCT01258803|20584499|P1|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
8350609|NCT01258803|20584494|P6|COMPLETED|Treatment Period 4 (1 Dose)||15
8350610|NCT01258803|20584495|P5|COMPLETED|Treatment Period 4 (1 Dose)||15
8350611|NCT01258803|20584496|P4|COMPLETED|Treatment Period 4 (1 Dose)||15
8350612|NCT01258803|20584497|P3|COMPLETED|Treatment Period 4 (1 Dose)||14
8350613|NCT01258803|20584498|P2|COMPLETED|Treatment Period 4 (1 Dose)||14
8350614|NCT01258803|20584499|P1|COMPLETED|Treatment Period 4 (1 Dose)||14
8350615|NCT01258803|20584494|P6|STARTED|Treatment Period 4 (1 Dose)||15
8350616|NCT01258803|20584495|P5|STARTED|Treatment Period 4 (1 Dose)||15
8350617|NCT01258803|20584496|P4|STARTED|Treatment Period 4 (1 Dose)||15
8350618|NCT01258803|20584497|P3|STARTED|Treatment Period 4 (1 Dose)||14
8350619|NCT01258803|20584498|P2|STARTED|Treatment Period 4 (1 Dose)||14
8350620|NCT01258803|20584499|P1|STARTED|Treatment Period 4 (1 Dose)||14
8350621|NCT01258803|20584494|P6|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8350622|NCT01258803|20584495|P5|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8350623|NCT01258803|20584496|P4|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8350624|NCT01258803|20584497|P3|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
8350625|NCT01258803|20584498|P2|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8350626|NCT01258803|20584499|P1|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
8350627|NCT01258803|20584494|P6|COMPLETED|Treatment Period 3 (1 Dose)||15
8350628|NCT01258803|20584495|P5|COMPLETED|Treatment Period 3 (1 Dose)||15
8350629|NCT01258803|20584496|P4|COMPLETED|Treatment Period 3 (1 Dose)||15
8350630|NCT01258803|20584497|P3|COMPLETED|Treatment Period 3 (1 Dose)||14
8350631|NCT01258803|20584498|P2|COMPLETED|Treatment Period 3 (1 Dose)||14
8350632|NCT01258803|20584499|P1|COMPLETED|Treatment Period 3 (1 Dose)||14
8350633|NCT01258803|20584494|P6|STARTED|Treatment Period 3 (1 Dose)||15
8350634|NCT01258803|20584495|P5|STARTED|Treatment Period 3 (1 Dose)||15
8350635|NCT01258803|20584496|P4|STARTED|Treatment Period 3 (1 Dose)||15
8350636|NCT01258803|20584497|P3|STARTED|Treatment Period 3 (1 Dose)||15
8350637|NCT01258803|20584498|P2|STARTED|Treatment Period 3 (1 Dose)||14
8350638|NCT01258803|20584499|P1|STARTED|Treatment Period 3 (1 Dose)||14
8350639|NCT01258803|20584494|P6|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
8350640|NCT01258803|20584495|P5|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
8350641|NCT01258803|20584496|P4|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
8350642|NCT01258803|20584497|P3|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
8350643|NCT01258803|20584498|P2|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
8350644|NCT01258803|20584499|P1|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
8350645|NCT01258803|20584494|P6|COMPLETED|Treatment Period 2 (1 Dose)||15
8350646|NCT01258803|20584495|P5|COMPLETED|Treatment Period 2 (1 Dose)||15
8350647|NCT01258803|20584496|P4|COMPLETED|Treatment Period 2 (1 Dose)||15
8350648|NCT01258803|20584497|P3|COMPLETED|Treatment Period 2 (1 Dose)||15
8350649|NCT01258803|20584498|P2|COMPLETED|Treatment Period 2 (1 Dose)||14
8350650|NCT01258803|20584499|P1|COMPLETED|Treatment Period 2 (1 Dose)||14
8350651|NCT01258803|20584494|P6|STARTED|Treatment Period 2 (1 Dose)||16
8350652|NCT01258803|20584495|P5|STARTED|Treatment Period 2 (1 Dose)||15
8350653|NCT01258803|20584496|P4|STARTED|Treatment Period 2 (1 Dose)||15
8350654|NCT01258803|20584497|P3|STARTED|Treatment Period 2 (1 Dose)||15
8350655|NCT01258803|20584498|P2|STARTED|Treatment Period 2 (1 Dose)||16
8350656|NCT01258803|20584499|P1|STARTED|Treatment Period 2 (1 Dose)||15
8350657|NCT01258803|20584494|P6|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8350658|NCT01258803|20584495|P5|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8350659|NCT01258803|20584496|P4|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8350660|NCT01258803|20584497|P3|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8350661|NCT01258803|20584498|P2|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8350662|NCT01258803|20584499|P1|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
8350663|NCT01258803|20584494|P6|COMPLETED|Treatment Period 1 (1 Dose)||16
8350664|NCT01258803|20584495|P5|COMPLETED|Treatment Period 1 (1 Dose)||15
8350665|NCT01258803|20584496|P4|COMPLETED|Treatment Period 1 (1 Dose)||15
8350666|NCT01258803|20584497|P3|COMPLETED|Treatment Period 1 (1 Dose)||15
8350667|NCT01258803|20584498|P2|COMPLETED|Treatment Period 1 (1 Dose)||16
8350668|NCT01258803|20584499|P1|COMPLETED|Treatment Period 1 (1 Dose)||15
8350669|NCT01258803|20584494|P6|STARTED|Treatment Period 1 (1 Dose)||16
8350670|NCT01258803|20584495|P5|STARTED|Treatment Period 1 (1 Dose)||15
8350671|NCT01258803|20584496|P4|STARTED|Treatment Period 1 (1 Dose)||15
8350672|NCT01258803|20584497|P3|STARTED|Treatment Period 1 (1 Dose)||15
8350673|NCT01258803|20584498|P2|STARTED|Treatment Period 1 (1 Dose)||16
8350674|NCT01258803|20584499|P1|STARTED|Treatment Period 1 (1 Dose)||15
8350675|NCT01258790|20584527|P2|NOT COMPLETED|Overall Study||0
8350676|NCT01258790|20584528|P1|NOT COMPLETED|Overall Study||0
8350677|NCT01258790|20584527|P2|COMPLETED|Overall Study||6
8350678|NCT01258790|20584528|P1|COMPLETED|Overall Study||6
8350679|NCT01258790|20584527|P2|STARTED|Overall Study||6
8350680|NCT01258790|20584528|P1|STARTED|Overall Study||6
8350681|NCT01258738|20584536|P2|NOT COMPLETED|Open-label Period||21
8350682|NCT01258738|20584537|P1|NOT COMPLETED|Open-label Period||17
8350683|NCT01258738|20584536|P2|COMPLETED|Open-label Period||85
8350684|NCT01258738|20584537|P1|COMPLETED|Open-label Period||85
8350685|NCT01258738|20584536|P2|STARTED|Open-label Period||106
8350686|NCT01258738|20584537|P1|STARTED|Open-label Period||102
8350687|NCT01258738|20584536|P2|NOT COMPLETED|Double-blind Period||7
8350688|NCT01258738|20584537|P1|NOT COMPLETED|Double-blind Period||9
8350689|NCT01258738|20584536|P2|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
8350690|NCT01258738|20584537|P1|COMPLETED|Double-blind Period||102
8350691|NCT01258738|20584536|P2|Treated|Double-blind Period||113
8350692|NCT01258738|20584537|P1|Treated|Double-blind Period||111
8350693|NCT01258738|20584536|P2|STARTED|Double-blind Period||114
8350694|NCT01258738|20584537|P1|STARTED|Double-blind Period||111
8350695|NCT01258660|20584675|P2|NOT COMPLETED|Overall Study||11
8350696|NCT01258660|20584676|P1|NOT COMPLETED|Overall Study||11
8350697|NCT01258660|20584675|P2|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
8350698|NCT01258660|20584676|P1|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
8350699|NCT01258660|20584675|P2|Completed Treatment|Overall Study||81
8350700|NCT01258660|20584676|P1|Completed Treatment|Overall Study||79
8350701|NCT01258660|20584675|P2|Received Treatment|Overall Study||82
8350702|NCT01258660|20584676|P1|Received Treatment|Overall Study||79
8350703|NCT01258660|20584675|P2|STARTED|Overall Study|randomized and received at least one dose of treatment|86
8350704|NCT01258660|20584676|P1|STARTED|Overall Study|randomized and received at least one dose of treatment|86
8350705|NCT01258608|20584695|P2|NOT COMPLETED|Overall Study||19
8350706|NCT01258608|20584696|P1|NOT COMPLETED|Overall Study||21
8350707|NCT01258608|20584695|P2|COMPLETED|Overall Study||31
8350708|NCT01258608|20584696|P1|COMPLETED|Overall Study||30
8350709|NCT01258608|20584695|P2|STARTED|Overall Study||50
8350710|NCT01258608|20584696|P1|STARTED|Overall Study||51
8350711|NCT01258595|20584744|P2|NOT COMPLETED|Overall Study||1
8350712|NCT01258595|20584745|P1|NOT COMPLETED|Overall Study||1
8350713|NCT01258595|20584744|P2|COMPLETED|Overall Study||151
8350714|NCT01258595|20584745|P1|COMPLETED|Overall Study||147
8350715|NCT01258595|20584744|P2|STARTED|Overall Study||152
8350716|NCT01258595|20584745|P1|STARTED|Overall Study||148
8350717|NCT01258582|20584761|P2|NOT COMPLETED|Overall Study||258
8350718|NCT01258582|20584762|P1|NOT COMPLETED|Overall Study||282
8350719|NCT01258582|20584761|P2|COMPLETED|Overall Study||563
8350720|NCT01258582|20584762|P1|COMPLETED|Overall Study||548
8350721|NCT01258582|20584761|P2|STARTED|Overall Study||821
8350722|NCT01258582|20584762|P1|STARTED|Overall Study||830
8350723|NCT01258504|20584768|P1|NOT COMPLETED|Bosentan and SJW||0
8350724|NCT01258504|20584768|P1|COMPLETED|Bosentan and SJW||13
8350725|NCT01258504|20584768|P1|STARTED|Bosentan and SJW||13
8350726|NCT01258504|20584768|P1|NOT COMPLETED|Bosentan Steady-state||0
8350727|NCT01258504|20584768|P1|COMPLETED|Bosentan Steady-state||13
8350728|NCT01258504|20584768|P1|STARTED|Bosentan Steady-state||13
8350729|NCT01258504|20584768|P1|NOT COMPLETED|Bosentan Single Dose||0
8350730|NCT01258504|20584768|P1|COMPLETED|Bosentan Single Dose||13
8350731|NCT01258504|20584768|P1|STARTED|Bosentan Single Dose||13
8350732|NCT01258387|20584787|P7|NOT COMPLETED|Overall Study||0
8350733|NCT01258387|20584788|P6|NOT COMPLETED|Overall Study||0
8350734|NCT01258387|20584789|P5|NOT COMPLETED|Overall Study||0
8350735|NCT01258387|20584790|P4|NOT COMPLETED|Overall Study||0
8350736|NCT01258387|20584791|P3|NOT COMPLETED|Overall Study||0
8350737|NCT01258387|20584792|P2|NOT COMPLETED|Overall Study||0
8350738|NCT01258387|20584793|P1|NOT COMPLETED|Overall Study||0
8350739|NCT01258387|20584787|P7|COMPLETED|Overall Study||4
8350740|NCT01258387|20584788|P6|COMPLETED|Overall Study||6
8350741|NCT01258387|20584789|P5|COMPLETED|Overall Study||6
8350742|NCT01258387|20584790|P4|COMPLETED|Overall Study||6
8350743|NCT01258387|20584791|P3|COMPLETED|Overall Study||6
8350744|NCT01258387|20584792|P2|COMPLETED|Overall Study||6
8350745|NCT01258387|20584793|P1|COMPLETED|Overall Study||6
8350746|NCT01258387|20584787|P7|Patients Randomized to Placebo|Overall Study||1
8350747|NCT01258387|20584788|P6|Patients Randomized to Placebo|Overall Study||2
8350748|NCT01258387|20584789|P5|Patients Randomized to Placebo|Overall Study||2
8350749|NCT01258387|20584790|P4|Patients Randomized to Placebo|Overall Study||2
8350750|NCT01258387|20584791|P3|Patients Randomized to Placebo|Overall Study||2
8350751|NCT01258387|20584792|P2|Patients Randomized to Placebo|Overall Study||2
8350752|NCT01258387|20584793|P1|Patients Randomized to Placebo|Overall Study||2
8350753|NCT01258387|20584787|P7|Patients Randomized to GGF2|Overall Study||3
8350754|NCT01258387|20584788|P6|Patients Randomized to GGF2|Overall Study||4
8350755|NCT01258387|20584789|P5|Patients Randomized to GGF2|Overall Study||4
8350756|NCT01258387|20584790|P4|Patients Randomized to GGF2|Overall Study||4
8350757|NCT01258387|20584791|P3|Patients Randomized to GGF2|Overall Study||4
8350758|NCT01258387|20584792|P2|Patients Randomized to GGF2|Overall Study||4
8350759|NCT01258387|20584793|P1|Patients Randomized to GGF2|Overall Study||4
8350760|NCT01258387|20584787|P7|STARTED|Overall Study||4
8350761|NCT01258387|20584788|P6|STARTED|Overall Study||6
8350762|NCT01258387|20584789|P5|STARTED|Overall Study||6
8350763|NCT01258387|20584790|P4|STARTED|Overall Study||6
8350764|NCT01258387|20584791|P3|STARTED|Overall Study||6
8350765|NCT01258387|20584792|P2|STARTED|Overall Study||6
8350766|NCT01258387|20584793|P1|STARTED|Overall Study||6
8350767|NCT01258374|20584835|P1|NOT COMPLETED|Overall Study||0
8350768|NCT01258374|20584835|P1|COMPLETED|Overall Study||15
8350769|NCT01258374|20584835|P1|STARTED|Overall Study||15
8350770|NCT01258348|20584842|P5|NOT COMPLETED|Overall Study||6
8350771|NCT01258348|20584843|P4|NOT COMPLETED|Overall Study||6
8350772|NCT01258348|20584844|P3|NOT COMPLETED|Overall Study||3
8350773|NCT01258348|20584845|P2|NOT COMPLETED|Overall Study||5
8350774|NCT01258348|20584846|P1|NOT COMPLETED|Overall Study||1
8350775|NCT01258348|20584842|P5|COMPLETED|Overall Study||0
8350776|NCT01258348|20584843|P4|COMPLETED|Overall Study||0
8350777|NCT01258348|20584844|P3|COMPLETED|Overall Study||0
8350778|NCT01258348|20584845|P2|COMPLETED|Overall Study||0
8350779|NCT01258348|20584846|P1|COMPLETED|Overall Study||0
8350780|NCT01258348|20584842|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8350781|NCT01258348|20584843|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8350782|NCT01258348|20584844|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8350783|NCT01258348|20584845|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
8350784|NCT01258348|20584846|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
8350785|NCT01258348|20584842|P5|STARTED|Overall Study||6
8350786|NCT01258348|20584843|P4|STARTED|Overall Study||6
8350787|NCT01258348|20584844|P3|STARTED|Overall Study||3
8350788|NCT01258348|20584845|P2|STARTED|Overall Study||5
8350789|NCT01258348|20584846|P1|STARTED|Overall Study||1
8350790|NCT01258153|20584874|P3|NOT COMPLETED|Overall Study||1
8350791|NCT01258153|20584875|P2|NOT COMPLETED|Overall Study||1
8350792|NCT01258153|20584876|P1|NOT COMPLETED|Overall Study||1
8350793|NCT01258153|20584874|P3|COMPLETED|Overall Study||36
8350794|NCT01258153|20584875|P2|COMPLETED|Overall Study||37
8350795|NCT01258153|20584876|P1|COMPLETED|Overall Study||39
8350796|NCT01258153|20584874|P3|STARTED|Overall Study||37
8350797|NCT01258153|20584875|P2|STARTED|Overall Study||38
8350798|NCT01258153|20584876|P1|STARTED|Overall Study||40
8350799|NCT01258101|20584903|P4|NOT COMPLETED|Overall Study||25
8350800|NCT01258101|20584904|P3|NOT COMPLETED|Overall Study||11
8350801|NCT01258101|20584905|P2|NOT COMPLETED|Overall Study||34
8350802|NCT01258101|20584906|P1|NOT COMPLETED|Overall Study||33
8350803|NCT01258101|20584903|P4|COMPLETED|Overall Study||27
8350804|NCT01258101|20584904|P3|COMPLETED|Overall Study||22
8350805|NCT01258101|20584905|P2|COMPLETED|Overall Study||110
8350806|NCT01258101|20584906|P1|COMPLETED|Overall Study||118
8350807|NCT01258101|20584903|P4|Standard Analysis Population|Overall Study||26
8350808|NCT01258101|20584904|P3|Standard Analysis Population|Overall Study||21
8350809|NCT01258101|20584905|P2|Standard Analysis Population|Overall Study||110
8350810|NCT01258101|20584906|P1|Standard Analysis Population|Overall Study||115
8350811|NCT01258101|20584903|P4|Safety Analysis Population|Overall Study||48
8350812|NCT01258101|20584904|P3|Safety Analysis Population|Overall Study||30
8350813|NCT01258101|20584905|P2|Safety Analysis Population|Overall Study||141
8350814|NCT01258101|20584906|P1|Safety Analysis Population|Overall Study||144
8350815|NCT01258101|20584903|P4|STARTED|Overall Study||52
8350816|NCT01258101|20584904|P3|STARTED|Overall Study||33
8350817|NCT01258101|20584905|P2|STARTED|Overall Study||144
8350818|NCT01258101|20584906|P1|STARTED|Overall Study||151
8350825|NCT01258049|20584967|P2|NOT COMPLETED|Overall Study||2
8350826|NCT01258049|20584968|P1|NOT COMPLETED|Overall Study||2
8350827|NCT01258049|20584967|P2|COMPLETED|Overall Study||72
8350828|NCT01258049|20584968|P1|COMPLETED|Overall Study||75
8350829|NCT01258049|20584967|P2|STARTED|Overall Study||74
8350830|NCT01258049|20584968|P1|STARTED|Overall Study||77
8350831|NCT01257880|20585006|P2|NOT COMPLETED|Overall Study||0
8350832|NCT01257880|20585007|P1|NOT COMPLETED|Overall Study||0
8350833|NCT01257880|20585006|P2|COMPLETED|Overall Study||19
8350834|NCT01257880|20585007|P1|COMPLETED|Overall Study||12
8350835|NCT01257880|20585006|P2|STARTED|Overall Study||19
8350836|NCT01257880|20585007|P1|STARTED|Overall Study||12
8350837|NCT01257802|20585017|P2|NOT COMPLETED|Overall Study||6
8350838|NCT01257802|20585018|P1|NOT COMPLETED|Overall Study||1
8350839|NCT01257802|20585017|P2|COMPLETED|Overall Study||2
8350840|NCT01257802|20585018|P1|COMPLETED|Overall Study||5
8350841|NCT01257802|20585017|P2|6 Month / 24 Week Visit|Overall Study||2
8350842|NCT01257802|20585018|P1|6 Month / 24 Week Visit|Overall Study||5
8350843|NCT01257802|20585017|P2|STARTED|Overall Study||8
8350844|NCT01257802|20585018|P1|STARTED|Overall Study||6
8350845|NCT01257750|20585032|P1|NOT COMPLETED|Overall Study||0
8350846|NCT01257750|20585032|P1|COMPLETED|Overall Study||20
8350847|NCT01257750|20585032|P1|STARTED|Overall Study||20
8350848|NCT01257737|20585045|P2|NOT COMPLETED|Overall Study||4
8350849|NCT01257737|20585046|P1|NOT COMPLETED|Overall Study||2
8350850|NCT01257737|20585045|P2|COMPLETED|Overall Study||39
8350851|NCT01257737|20585046|P1|COMPLETED|Overall Study||43
8350852|NCT01257737|20585045|P2|STARTED|Overall Study||43
8350853|NCT01257737|20585046|P1|STARTED|Overall Study||45
8350854|NCT01257698|20585066|P2|NOT COMPLETED|Overall Study||0
8350855|NCT01257698|20585067|P1|NOT COMPLETED|Overall Study||4
8350856|NCT01257698|20585066|P2|COMPLETED|Overall Study||9
8350857|NCT01257698|20585067|P1|COMPLETED|Overall Study||8
8350858|NCT01257698|20585066|P2|STARTED|Overall Study||9
8350859|NCT01257698|20585067|P1|STARTED|Overall Study||12
8350860|NCT01257581|20585076|P3|NOT COMPLETED|Overall Study||6
8350861|NCT01257581|20585077|P2|NOT COMPLETED|Overall Study||3
8350862|NCT01257581|20585078|P1|NOT COMPLETED|Overall Study||5
8350863|NCT01257581|20585076|P3|COMPLETED|Overall Study||11
8350864|NCT01257581|20585077|P2|COMPLETED|Overall Study||18
8350865|NCT01257581|20585078|P1|COMPLETED|Overall Study||17
8350866|NCT01257581|20585076|P3|STARTED|Overall Study||17
8350867|NCT01257581|20585077|P2|STARTED|Overall Study||21
8350868|NCT01257581|20585078|P1|STARTED|Overall Study||22
8350872|NCT01257542|20585130|P2|NOT COMPLETED|Overall Study||7
8350873|NCT01257542|20585131|P1|NOT COMPLETED|Overall Study||3
8350874|NCT01257542|20585130|P2|COMPLETED|Overall Study||45
8350875|NCT01257542|20585131|P1|COMPLETED|Overall Study||52
8350876|NCT01257542|20585130|P2|STARTED|Overall Study||52
8350877|NCT01257542|20585131|P1|STARTED|Overall Study||55
8350878|NCT01257503|20585151|P2|NOT COMPLETED|Overall Study||11
8350879|NCT01257503|20585152|P1|NOT COMPLETED|Overall Study||8
8350880|NCT01257503|20585151|P2|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
8350881|NCT01257503|20585152|P1|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
8350882|NCT01257503|20585151|P2|Returned Dosage Logbooks|Overall Study||80
8350883|NCT01257503|20585152|P1|Returned Dosage Logbooks|Overall Study||75
8350884|NCT01257503|20585151|P2|Returned Symptom Diaries|Overall Study||83
8350885|NCT01257503|20585152|P1|Returned Symptom Diaries|Overall Study||80
8350886|NCT01257503|20585151|P2|STARTED|Overall Study||130
8350887|NCT01257503|20585152|P1|STARTED|Overall Study||133
8350888|NCT01257438|20585168|P2|NOT COMPLETED|Overall Study||46
8350889|NCT01257438|20585169|P1|NOT COMPLETED|Overall Study||30
8350890|NCT01257438|20585168|P2|COMPLETED|Overall Study||97
8350891|NCT01257438|20585169|P1|COMPLETED|Overall Study||102
8350892|NCT01257438|20585168|P2|STARTED|Overall Study||143
8350893|NCT01257438|20585169|P1|STARTED|Overall Study||132
8350894|NCT01257425|20585181|P2|NOT COMPLETED|Overall Study||6
8350895|NCT01257425|20585182|P1|NOT COMPLETED|Overall Study||6
8350896|NCT01257425|20585181|P2|COMPLETED|Overall Study||45
8350897|NCT01257425|20585182|P1|COMPLETED|Overall Study||46
8350898|NCT01257425|20585181|P2|STARTED|Overall Study||51
8350899|NCT01257425|20585182|P1|STARTED|Overall Study||52
8350900|NCT01257347|20585204|P4|NOT COMPLETED|Overall Study||0
8350901|NCT01257347|20585205|P3|NOT COMPLETED|Overall Study||0
8350902|NCT01257347|20585206|P2|NOT COMPLETED|Overall Study||0
8350903|NCT01257347|20585207|P1|NOT COMPLETED|Overall Study||0
8350904|NCT01257347|20585204|P4|COMPLETED|Overall Study||65
8350905|NCT01257347|20585205|P3|COMPLETED|Overall Study||35
8350906|NCT01257347|20585206|P2|COMPLETED|Overall Study||12
8350907|NCT01257347|20585207|P1|COMPLETED|Overall Study||12
8350908|NCT01257347|20585204|P4|STARTED|Overall Study||65
8350909|NCT01257347|20585205|P3|STARTED|Overall Study||35
8350910|NCT01257347|20585206|P2|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
8350911|NCT01257347|20585207|P1|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
8350912|NCT01257230|20585224|P3|NOT COMPLETED|Overall Study||6
8350913|NCT01257230|20585225|P2|NOT COMPLETED|Overall Study||10
8350914|NCT01257230|20585226|P1|NOT COMPLETED|Overall Study||6
8350915|NCT01257230|20585224|P3|COMPLETED|Overall Study||129
8350916|NCT01257230|20585225|P2|COMPLETED|Overall Study||115
8350917|NCT01257230|20585226|P1|COMPLETED|Overall Study||132
8350918|NCT01257230|20585224|P3|STARTED|Overall Study||135
8350919|NCT01257230|20585225|P2|STARTED|Overall Study||125
8350920|NCT01257230|20585226|P1|STARTED|Overall Study||138
8350921|NCT01257217|20585281|P2|NOT COMPLETED|Overall Study||0
8350922|NCT01257217|20585282|P1|NOT COMPLETED|Overall Study||2
8350923|NCT01257217|20585281|P2|COMPLETED|Overall Study||10
8350924|NCT01257217|20585282|P1|COMPLETED|Overall Study||13
8350925|NCT01257217|20585281|P2|STARTED|Overall Study||10
8350926|NCT01257217|20585282|P1|STARTED|Overall Study||15
8350927|NCT01257204|20585303|P3|NOT COMPLETED|Follow-up Period (up to Week 48)||10
8350928|NCT01257204|20585304|P2|NOT COMPLETED|Follow-up Period (up to Week 48)||6
8350929|NCT01257204|20585305|P1|NOT COMPLETED|Follow-up Period (up to Week 48)||1
8350930|NCT01257204|20585303|P3|COMPLETED|Follow-up Period (up to Week 48)||39
8350931|NCT01257204|20585304|P2|COMPLETED|Follow-up Period (up to Week 48)||41
8350932|NCT01257204|20585305|P1|COMPLETED|Follow-up Period (up to Week 48)||48
8350933|NCT01257204|20585303|P3|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
8350934|NCT01257204|20585304|P2|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
8350935|NCT01257204|20585305|P1|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
8350936|NCT01257204|20585303|P3|NOT COMPLETED|Treatment Period (up to Week 24)||9
8350937|NCT01257204|20585304|P2|NOT COMPLETED|Treatment Period (up to Week 24)||6
8350938|NCT01257204|20585305|P1|NOT COMPLETED|Treatment Period (up to Week 24)||5
8350939|NCT01257204|20585303|P3|COMPLETED|Treatment Period (up to Week 24)||42
8350940|NCT01257204|20585304|P2|COMPLETED|Treatment Period (up to Week 24)||44
8350941|NCT01257204|20585305|P1|COMPLETED|Treatment Period (up to Week 24)||45
8350942|NCT01257204|20585303|P3|STARTED|Treatment Period (up to Week 24)||51
8350943|NCT01257204|20585304|P2|STARTED|Treatment Period (up to Week 24)||50
8350944|NCT01257204|20585305|P1|STARTED|Treatment Period (up to Week 24)||50
8350945|NCT01257087|20585351|P2|NOT COMPLETED|Overall Study||0
8350946|NCT01257087|20585352|P1|NOT COMPLETED|Overall Study||0
8350947|NCT01257087|20585351|P2|COMPLETED|Overall Study||17
8350948|NCT01257087|20585352|P1|COMPLETED|Overall Study||18
8350949|NCT01257087|20585351|P2|STARTED|Overall Study||17
8350950|NCT01257087|20585352|P1|STARTED|Overall Study||18
8350951|NCT01256983|20585364|P2|NOT COMPLETED|Overall Study||3
8350952|NCT01256983|20585365|P1|NOT COMPLETED|Overall Study||1
8350953|NCT01256983|20585364|P2|COMPLETED|Overall Study||12
8350954|NCT01256983|20585365|P1|COMPLETED|Overall Study||14
8350955|NCT01256983|20585364|P2|STARTED|Overall Study||15
8350956|NCT01256983|20585365|P1|STARTED|Overall Study||15
8350957|NCT01256944|20585373|P2|NOT COMPLETED|Overall Study||0
8350958|NCT01256944|20585374|P1|NOT COMPLETED|Overall Study||0
8350959|NCT01256944|20585373|P2|COMPLETED|Overall Study||220
8350960|NCT01256944|20585374|P1|COMPLETED|Overall Study||70
8350961|NCT01256944|20585373|P2|STARTED|Overall Study||220
8350962|NCT01256944|20585374|P1|STARTED|Overall Study||70
8350963|NCT01256918|20585402|P1|NOT COMPLETED|Overall Study||0
8350964|NCT01256918|20585402|P1|COMPLETED|Overall Study||200
8350965|NCT01256918|20585402|P1|Full Thickness Nuclear Crack Achieved|Overall Study||200
8350966|NCT01256918|20585402|P1|STARTED|Overall Study||200
8350967|NCT01256879|20585413|P1|NOT COMPLETED|Overall Study||1
8350968|NCT01256879|20585413|P1|COMPLETED|Overall Study||24
8350969|NCT01256879|20585413|P1|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
8350970|NCT01256879|20585413|P1|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
8350971|NCT01256879|20585413|P1|CimTest-B|Overall Study|24 started this intervention and 24 completed|24
8350972|NCT01256879|20585413|P1|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25
8350973|NCT01256879|20585413|P1|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25
8350974|NCT01256840|20585426|P3|NOT COMPLETED|Overall Study||0
8350975|NCT01256840|20585427|P2|NOT COMPLETED|Overall Study||0
8350976|NCT01256840|20585428|P1|NOT COMPLETED|Overall Study||0
8350977|NCT01256840|20585426|P3|COMPLETED|Overall Study||25
8350978|NCT01256840|20585427|P2|COMPLETED|Overall Study||16
8350979|NCT01256840|20585428|P1|COMPLETED|Overall Study||30
8350980|NCT01256840|20585426|P3|STARTED|Overall Study||25
8350981|NCT01256840|20585427|P2|STARTED|Overall Study||16
8350982|NCT01256840|20585428|P1|STARTED|Overall Study||30
8350983|NCT01256788|20585439|P3|NOT COMPLETED|Overall Study||3
8350984|NCT01256788|20585440|P2|NOT COMPLETED|Overall Study||8
8350985|NCT01256788|20585441|P1|NOT COMPLETED|Overall Study||5
8350986|NCT01256788|20585439|P3|COMPLETED|Overall Study||5
8350987|NCT01256788|20585440|P2|COMPLETED|Overall Study||6
8350988|NCT01256788|20585441|P1|COMPLETED|Overall Study||7
8350989|NCT01256788|20585439|P3|STARTED|Overall Study||8
8350990|NCT01256788|20585440|P2|STARTED|Overall Study||14
8350991|NCT01256788|20585441|P1|STARTED|Overall Study||12
8350992|NCT01256684|20585452|P3|NOT COMPLETED|Overall Study||11
8350993|NCT01256684|20585453|P2|NOT COMPLETED|Overall Study||13
8350994|NCT01256684|20585454|P1|NOT COMPLETED|Overall Study||9
8350995|NCT01256684|20585452|P3|COMPLETED|Overall Study||76
8350996|NCT01256684|20585453|P2|COMPLETED|Overall Study||74
8350997|NCT01256684|20585454|P1|COMPLETED|Overall Study||72
8350998|NCT01256684|20585452|P3|ITT Population|Overall Study||81
8350999|NCT01256684|20585453|P2|ITT Population|Overall Study||79
8351000|NCT01256684|20585454|P1|ITT Population|Overall Study||77
8351001|NCT01256684|20585452|P3|Safety Population|Overall Study||87
8351002|NCT01256684|20585453|P2|Safety Population|Overall Study||86
8351003|NCT01256684|20585454|P1|Safety Population|Overall Study||80
8351004|NCT01256684|20585452|P3|STARTED|Overall Study||87
8351005|NCT01256684|20585453|P2|STARTED|Overall Study||87
8351006|NCT01256684|20585454|P1|STARTED|Overall Study||81
8351007|NCT01256671|20585486|P1|NOT COMPLETED|Overall Study||95
8351008|NCT01256671|20585486|P1|COMPLETED|Overall Study||435
8351009|NCT01256671|20585486|P1|Safety Population|Overall Study||521
8351010|NCT01256671|20585486|P1|STARTED|Overall Study||530
8351011|NCT01256658|20585499|P2|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
8351012|NCT01256658|20585500|P1|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
8351013|NCT01256658|20585499|P2|COMPLETED|Period 2 - Follow up Only - No Treatment||0
8351014|NCT01256658|20585500|P1|COMPLETED|Period 2 - Follow up Only - No Treatment||0
8351015|NCT01256658|20585499|P2|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
8351016|NCT01256658|20585500|P1|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
8351017|NCT01256658|20585499|P2|Death|Period 2 - Follow up Only - No Treatment||8
8351018|NCT01256658|20585500|P1|Death|Period 2 - Follow up Only - No Treatment||6
8351019|NCT01256658|20585499|P2|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
8351020|NCT01256658|20585500|P1|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
8351021|NCT01256658|20585499|P2|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
8351022|NCT01256658|20585500|P1|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
8351023|NCT01256658|20585499|P2|NOT COMPLETED|Period 1||748
8351024|NCT01256658|20585500|P1|NOT COMPLETED|Period 1||920
8351025|NCT01256658|20585499|P2|COMPLETED|Period 1||6510
8351026|NCT01256658|20585500|P1|COMPLETED|Period 1||5897
8351027|NCT01256658|20585499|P2|STARTED|Period 1||7258
8351028|NCT01256658|20585500|P1|STARTED|Period 1||6817
8351029|NCT01256593|20585550|P1|NOT COMPLETED|Overall Study||214
8351030|NCT01256593|20585550|P1|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613
8351031|NCT01256593|20585550|P1|STARTED|Overall Study||3827
8351032|NCT01256567|20585564|P1|NOT COMPLETED|Overall Study||1
8351033|NCT01256567|20585564|P1|COMPLETED|Overall Study||6
8351034|NCT01256567|20585564|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
8351035|NCT01256567|20585564|P1|STARTED|Overall Study||7
8351036|NCT01256502|20585574|P1|NOT COMPLETED|Overall Study||10
8351037|NCT01256502|20585574|P1|COMPLETED|Overall Study||129
8351038|NCT01256502|20585574|P1|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
8351039|NCT01256476|20585586|P2|NOT COMPLETED|Overall Study||7
8351040|NCT01256476|20585587|P1|NOT COMPLETED|Overall Study||6
8351041|NCT01256476|20585586|P2|COMPLETED|Overall Study||157
8351042|NCT01256476|20585587|P1|COMPLETED|Overall Study||158
8351043|NCT01256476|20585586|P2|STARTED|Overall Study||164
8351044|NCT01256476|20585587|P1|STARTED|Overall Study||164
8351045|NCT01256450|20585595|P3|NOT COMPLETED|Double-blind Treatment||37
8351046|NCT01256450|20585596|P2|NOT COMPLETED|Double-blind Treatment||28
8351047|NCT01256450|20585597|P1|NOT COMPLETED|Double-blind Treatment||0
8351048|NCT01256450|20585595|P3|COMPLETED|Double-blind Treatment||81
8351049|NCT01256450|20585596|P2|COMPLETED|Double-blind Treatment||89
8351050|NCT01256450|20585597|P1|COMPLETED|Double-blind Treatment||0
8351051|NCT01256450|20585595|P3|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
8351052|NCT01256450|20585596|P2|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
8351053|NCT01256450|20585597|P1|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
8351054|NCT01256450|20585595|P3|NOT COMPLETED|Open-label Titration||0
8351055|NCT01256450|20585596|P2|NOT COMPLETED|Open-label Titration||0
8351056|NCT01256450|20585597|P1|NOT COMPLETED|Open-label Titration||99
8351057|NCT01256450|20585595|P3|COMPLETED|Open-label Titration||0
8351058|NCT01256450|20585596|P2|COMPLETED|Open-label Titration||0
8351059|NCT01256450|20585597|P1|COMPLETED|Open-label Titration||235
8351060|NCT01256450|20585595|P3|STARTED|Open-label Titration||0
8351061|NCT01256450|20585596|P2|STARTED|Open-label Titration||0
8351062|NCT01256450|20585597|P1|STARTED|Open-label Titration||334
8351063|NCT01256424|20585626|P4|NOT COMPLETED|Overall Study||7
8351064|NCT01256424|20585627|P3|NOT COMPLETED|Overall Study||7
8351065|NCT01256424|20585628|P2|NOT COMPLETED|Overall Study||8
8351066|NCT01256424|20585629|P1|NOT COMPLETED|Overall Study||9
8351067|NCT01256424|20585626|P4|COMPLETED|Overall Study||61
8351068|NCT01256424|20585627|P3|COMPLETED|Overall Study||55
8351069|NCT01256424|20585628|P2|COMPLETED|Overall Study||59
8351070|NCT01256424|20585629|P1|COMPLETED|Overall Study||56
8351071|NCT01256424|20585626|P4|STARTED|Overall Study||68
8351072|NCT01256424|20585627|P3|STARTED|Overall Study||62
8351073|NCT01256424|20585628|P2|STARTED|Overall Study||67
8351074|NCT01256424|20585629|P1|STARTED|Overall Study||65
8351075|NCT01256411|20585655|P6|NOT COMPLETED|Extension by Mono or Combination Therapy||4
8351076|NCT01256411|20585656|P5|NOT COMPLETED|Extension by Mono or Combination Therapy||17
8351077|NCT01256411|20585657|P4|NOT COMPLETED|Extension by Mono or Combination Therapy||0
8351078|NCT01256411|20585658|P3|NOT COMPLETED|Extension by Mono or Combination Therapy||0
8351079|NCT01256411|20585659|P2|NOT COMPLETED|Extension by Mono or Combination Therapy||0
8351080|NCT01256411|20585660|P1|NOT COMPLETED|Extension by Mono or Combination Therapy||0
8351081|NCT01256411|20585655|P6|COMPLETED|Extension by Mono or Combination Therapy||109
8351082|NCT01256411|20585656|P5|COMPLETED|Extension by Mono or Combination Therapy||211
8351083|NCT01256411|20585657|P4|COMPLETED|Extension by Mono or Combination Therapy||0
8351084|NCT01256411|20585658|P3|COMPLETED|Extension by Mono or Combination Therapy||0
8351085|NCT01256411|20585659|P2|COMPLETED|Extension by Mono or Combination Therapy||0
8351086|NCT01256411|20585660|P1|COMPLETED|Extension by Mono or Combination Therapy||0
8351087|NCT01256411|20585655|P6|STARTED|Extension by Mono or Combination Therapy||113
8351088|NCT01256411|20585656|P5|STARTED|Extension by Mono or Combination Therapy||228
8351089|NCT01256411|20585657|P4|STARTED|Extension by Mono or Combination Therapy||0
8351090|NCT01256411|20585658|P3|STARTED|Extension by Mono or Combination Therapy||0
8351091|NCT01256411|20585659|P2|STARTED|Extension by Mono or Combination Therapy||0
8351092|NCT01256411|20585660|P1|STARTED|Extension by Mono or Combination Therapy||0
8351093|NCT01256411|20585655|P6|NOT COMPLETED|Extension by Maximum Treatment||0
8351094|NCT01256411|20585656|P5|NOT COMPLETED|Extension by Maximum Treatment||0
8351095|NCT01256411|20585657|P4|NOT COMPLETED|Extension by Maximum Treatment||0
8351096|NCT01256411|20585658|P3|NOT COMPLETED|Extension by Maximum Treatment||4
8351097|NCT01256411|20585659|P2|NOT COMPLETED|Extension by Maximum Treatment||10
8351098|NCT01256411|20585660|P1|NOT COMPLETED|Extension by Maximum Treatment||7
8351099|NCT01256411|20585655|P6|COMPLETED|Extension by Maximum Treatment||0
8351100|NCT01256411|20585656|P5|COMPLETED|Extension by Maximum Treatment||0
8351101|NCT01256411|20585657|P4|COMPLETED|Extension by Maximum Treatment||4
8351102|NCT01256411|20585658|P3|COMPLETED|Extension by Maximum Treatment||105
8351103|NCT01256411|20585659|P2|COMPLETED|Extension by Maximum Treatment||79
8351104|NCT01256411|20585660|P1|COMPLETED|Extension by Maximum Treatment||132
8351105|NCT01256411|20585655|P6|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8351106|NCT01256411|20585656|P5|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8351107|NCT01256411|20585657|P4|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8351108|NCT01256411|20585658|P3|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8351109|NCT01256411|20585659|P2|Down Titrated to 100 mg|Extension by Maximum Treatment||0
8351110|NCT01256411|20585660|P1|Down Titrated to 100 mg|Extension by Maximum Treatment||12
8351111|NCT01256411|20585655|P6|STARTED|Extension by Maximum Treatment||0
8351112|NCT01256411|20585656|P5|STARTED|Extension by Maximum Treatment||0
8351113|NCT01256411|20585657|P4|STARTED|Extension by Maximum Treatment||4
8351114|NCT01256411|20585658|P3|STARTED|Extension by Maximum Treatment||109
8351115|NCT01256411|20585659|P2|STARTED|Extension by Maximum Treatment||89
8351116|NCT01256411|20585660|P1|STARTED|Extension by Maximum Treatment||139
8351120|NCT01256385|20585690|P2|NOT COMPLETED|Overall Study||3
8351121|NCT01256385|20585691|P1|NOT COMPLETED|Overall Study||3
8351122|NCT01256385|20585690|P2|COMPLETED|Overall Study||40
8351123|NCT01256385|20585691|P1|COMPLETED|Overall Study||40
8351124|NCT01256385|20585690|P2|Crossover From Arm B to Arm A|Overall Study||15
8351125|NCT01256385|20585691|P1|Crossover From Arm B to Arm A|Overall Study||0
8351126|NCT01256385|20585690|P2|STARTED|Overall Study||43
8351127|NCT01256385|20585691|P1|STARTED|Overall Study||43
8351128|NCT01256294|20585711|P2|NOT COMPLETED|Overall Study||2
8351129|NCT01256294|20585712|P1|NOT COMPLETED|Overall Study||4
8351130|NCT01256294|20585711|P2|COMPLETED|Overall Study||33
8351131|NCT01256294|20585712|P1|COMPLETED|Overall Study||32
8351132|NCT01256294|20585711|P2|STARTED|Overall Study||35
8351133|NCT01256294|20585712|P1|STARTED|Overall Study||36
8351134|NCT01256281|20585728|P1|NOT COMPLETED|Overall Study||0
8351135|NCT01256281|20585728|P1|COMPLETED|Overall Study||2
8351136|NCT01256281|20585728|P1|STARTED|Overall Study||2
8351137|NCT01256190|20585734|P2|NOT COMPLETED|Overall Study||0
8351138|NCT01256190|20585735|P1|NOT COMPLETED|Overall Study||2
8351139|NCT01256190|20585734|P2|COMPLETED|Overall Study||17
8351140|NCT01256190|20585735|P1|COMPLETED|Overall Study||37
8351141|NCT01256190|20585734|P2|STARTED|Overall Study||17
8351142|NCT01256190|20585735|P1|STARTED|Overall Study||39
8351143|NCT01256177|20585751|P2|NOT COMPLETED|Overall Study||37
8351144|NCT01256177|20585752|P1|NOT COMPLETED|Overall Study||50
8351145|NCT01256177|20585751|P2|COMPLETED|Overall Study||111
8351146|NCT01256177|20585752|P1|COMPLETED|Overall Study||98
8351147|NCT01256177|20585751|P2|STARTED|Overall Study||148
8351148|NCT01256177|20585752|P1|STARTED|Overall Study||148
8351149|NCT01256164|20585776|P2|NOT COMPLETED|Overall Study||0
8351150|NCT01256164|20585777|P1|NOT COMPLETED|Overall Study||0
8351151|NCT01256164|20585776|P2|COMPLETED|Overall Study||23
8351152|NCT01256164|20585777|P1|COMPLETED|Overall Study||47
8351153|NCT01256164|20585776|P2|STARTED|Overall Study||23
8351154|NCT01256164|20585777|P1|STARTED|Overall Study||47
8351155|NCT01256086|20585795|P4|NOT COMPLETED|Treatment Day 4||0
8351156|NCT01256086|20585796|P3|NOT COMPLETED|Treatment Day 4||0
8351157|NCT01256086|20585797|P2|NOT COMPLETED|Treatment Day 4||0
8351158|NCT01256086|20585798|P1|NOT COMPLETED|Treatment Day 4||0
8351159|NCT01256086|20585795|P4|COMPLETED|Treatment Day 4||11
8351160|NCT01256086|20585796|P3|COMPLETED|Treatment Day 4||9
8351161|NCT01256086|20585797|P2|COMPLETED|Treatment Day 4||10
8351162|NCT01256086|20585798|P1|COMPLETED|Treatment Day 4||11
8351163|NCT01256086|20585795|P4|STARTED|Treatment Day 4||11
8351164|NCT01256086|20585796|P3|STARTED|Treatment Day 4||9
8351165|NCT01256086|20585797|P2|STARTED|Treatment Day 4||10
8351166|NCT01256086|20585798|P1|STARTED|Treatment Day 4||11
8351167|NCT01256086|20585795|P4|NOT COMPLETED|Treatment Day 3||0
8351168|NCT01256086|20585796|P3|NOT COMPLETED|Treatment Day 3||0
8351169|NCT01256086|20585797|P2|NOT COMPLETED|Treatment Day 3||0
8351170|NCT01256086|20585798|P1|NOT COMPLETED|Treatment Day 3||0
8351171|NCT01256086|20585795|P4|COMPLETED|Treatment Day 3||11
8351172|NCT01256086|20585796|P3|COMPLETED|Treatment Day 3||9
8351173|NCT01256086|20585797|P2|COMPLETED|Treatment Day 3||10
8351174|NCT01256086|20585798|P1|COMPLETED|Treatment Day 3||11
8351175|NCT01256086|20585795|P4|STARTED|Treatment Day 3||11
8351176|NCT01256086|20585796|P3|STARTED|Treatment Day 3||9
8351177|NCT01256086|20585797|P2|STARTED|Treatment Day 3||10
8351178|NCT01256086|20585798|P1|STARTED|Treatment Day 3||11
8351179|NCT01256086|20585795|P4|NOT COMPLETED|Treatment Day 2||0
8351180|NCT01256086|20585796|P3|NOT COMPLETED|Treatment Day 2||0
8351181|NCT01256086|20585797|P2|NOT COMPLETED|Treatment Day 2||0
8351182|NCT01256086|20585798|P1|NOT COMPLETED|Treatment Day 2||0
8351183|NCT01256086|20585795|P4|COMPLETED|Treatment Day 2||11
8351184|NCT01256086|20585796|P3|COMPLETED|Treatment Day 2||9
8351185|NCT01256086|20585797|P2|COMPLETED|Treatment Day 2||10
8351186|NCT01256086|20585798|P1|COMPLETED|Treatment Day 2||11
8351187|NCT01256086|20585795|P4|STARTED|Treatment Day 2||11
8351188|NCT01256086|20585796|P3|STARTED|Treatment Day 2||9
8351189|NCT01256086|20585797|P2|STARTED|Treatment Day 2||10
8351190|NCT01256086|20585798|P1|STARTED|Treatment Day 2||11
8351191|NCT01256086|20585795|P4|NOT COMPLETED|Treatment Day 1||0
8351192|NCT01256086|20585796|P3|NOT COMPLETED|Treatment Day 1||0
8351193|NCT01256086|20585797|P2|NOT COMPLETED|Treatment Day 1||0
8351194|NCT01256086|20585798|P1|NOT COMPLETED|Treatment Day 1||0
8351195|NCT01256086|20585795|P4|COMPLETED|Treatment Day 1||11
8351196|NCT01256086|20585796|P3|COMPLETED|Treatment Day 1||11
8351197|NCT01256086|20585797|P2|COMPLETED|Treatment Day 1||11
8351198|NCT01256086|20585798|P1|COMPLETED|Treatment Day 1||11
8351199|NCT01256086|20585795|P4|STARTED|Treatment Day 1||11
8351200|NCT01256086|20585796|P3|STARTED|Treatment Day 1||11
8351201|NCT01256086|20585797|P2|STARTED|Treatment Day 1||11
8351202|NCT01256086|20585798|P1|STARTED|Treatment Day 1||11
8351203|NCT01256060|20585808|P4|NOT COMPLETED|Overall Study||0
8351204|NCT01256060|20585809|P3|NOT COMPLETED|Overall Study||0
8351205|NCT01256060|20585810|P2|NOT COMPLETED|Overall Study||1
8351206|NCT01256060|20585811|P1|NOT COMPLETED|Overall Study||0
8351207|NCT01256060|20585808|P4|COMPLETED|Overall Study||6
8351208|NCT01256060|20585809|P3|COMPLETED|Overall Study||3
8351209|NCT01256060|20585810|P2|COMPLETED|Overall Study||2
8351210|NCT01256060|20585811|P1|COMPLETED|Overall Study||3
8351211|NCT01256060|20585808|P4|STARTED|Overall Study||6
8351212|NCT01256060|20585809|P3|STARTED|Overall Study||3
8351213|NCT01256060|20585810|P2|STARTED|Overall Study||3
8351214|NCT01256060|20585811|P1|STARTED|Overall Study||3
8351215|NCT01256034|20585820|P2|NOT COMPLETED|Overall Study||25
8351216|NCT01256034|20585821|P1|NOT COMPLETED|Overall Study||25
8351217|NCT01256034|20585820|P2|COMPLETED|Overall Study||0
8351218|NCT01256034|20585821|P1|COMPLETED|Overall Study||0
8351219|NCT01256034|20585820|P2|STARTED|Overall Study||25
8351220|NCT01256034|20585821|P1|STARTED|Overall Study||25
8351221|NCT01256008|20585830|P3|NOT COMPLETED|Overall Study||21
8351222|NCT01256008|20585831|P2|NOT COMPLETED|Overall Study||7
8351223|NCT01256008|20585832|P1|NOT COMPLETED|Overall Study||8
8351224|NCT01256008|20585830|P3|COMPLETED|Overall Study||175
8351225|NCT01256008|20585831|P2|COMPLETED|Overall Study||91
8351226|NCT01256008|20585832|P1|COMPLETED|Overall Study||90
8351227|NCT01256008|20585830|P3|STARTED|Overall Study||196
8351228|NCT01256008|20585831|P2|STARTED|Overall Study||98
8351229|NCT01256008|20585832|P1|STARTED|Overall Study||98
8351230|NCT01255904|20585854|P2|NOT COMPLETED|Overall Study||4
8351231|NCT01255904|20585855|P1|NOT COMPLETED|Overall Study||1
8351232|NCT01255904|20585854|P2|COMPLETED|Overall Study||41
8351233|NCT01255904|20585855|P1|COMPLETED|Overall Study||44
8351234|NCT01255904|20585854|P2|STARTED|Overall Study||45
8351235|NCT01255904|20585855|P1|STARTED|Overall Study||45
8351236|NCT01255865|20585868|P7|NOT COMPLETED|Overall Study||0
8351237|NCT01255865|20585869|P6|NOT COMPLETED|Overall Study||0
8351238|NCT01255865|20585870|P5|NOT COMPLETED|Overall Study||0
8351239|NCT01255865|20585871|P4|NOT COMPLETED|Overall Study||0
8351240|NCT01255865|20585872|P3|NOT COMPLETED|Overall Study||0
8351241|NCT01255865|20585873|P2|NOT COMPLETED|Overall Study||0
8351242|NCT01255865|20585874|P1|NOT COMPLETED|Overall Study||0
8351243|NCT01255865|20585868|P7|COMPLETED|Overall Study||20
8351244|NCT01255865|20585869|P6|COMPLETED|Overall Study||20
8351245|NCT01255865|20585870|P5|COMPLETED|Overall Study||20
8351246|NCT01255865|20585871|P4|COMPLETED|Overall Study||30
8351247|NCT01255865|20585872|P3|COMPLETED|Overall Study||10
8351248|NCT01255865|20585873|P2|COMPLETED|Overall Study||10
8351249|NCT01255865|20585874|P1|COMPLETED|Overall Study||1
8351250|NCT01255865|20585868|P7|STARTED|Overall Study||20
8351251|NCT01255865|20585869|P6|STARTED|Overall Study||20
8351252|NCT01255865|20585870|P5|STARTED|Overall Study||20
8351253|NCT01255865|20585871|P4|STARTED|Overall Study||30
8351254|NCT01255865|20585872|P3|STARTED|Overall Study||10
8351255|NCT01255865|20585873|P2|STARTED|Overall Study||10
8351256|NCT01255865|20585874|P1|STARTED|Overall Study||1
8351257|NCT01255787|20585894|P4|NOT COMPLETED|Overall Study||22
8351258|NCT01255787|20585895|P3|NOT COMPLETED|Overall Study||18
8351259|NCT01255787|20585896|P2|NOT COMPLETED|Overall Study||17
8351260|NCT01255787|20585897|P1|NOT COMPLETED|Overall Study||16
8351261|NCT01255787|20585894|P4|COMPLETED|Overall Study||132
8351262|NCT01255787|20585895|P3|COMPLETED|Overall Study||132
8351263|NCT01255787|20585896|P2|COMPLETED|Overall Study||127
8351264|NCT01255787|20585897|P1|COMPLETED|Overall Study||136
8351265|NCT01255787|20585894|P4|Treated|Overall Study||150
8351266|NCT01255787|20585895|P3|Treated|Overall Study||148
8351267|NCT01255787|20585896|P2|Treated|Overall Study||144
8351268|NCT01255787|20585897|P1|Treated|Overall Study||152
8351269|NCT01255787|20585894|P4|STARTED|Overall Study||154
8351270|NCT01255787|20585895|P3|STARTED|Overall Study||150
8351271|NCT01255787|20585896|P2|STARTED|Overall Study||144
8351272|NCT01255787|20585897|P1|STARTED|Overall Study||152
8351273|NCT01255761|20585925|P2|NOT COMPLETED|Overall Study||175
8351274|NCT01255761|20585926|P1|NOT COMPLETED|Overall Study||182
8351275|NCT01255761|20585925|P2|COMPLETED|Overall Study||192
8351276|NCT01255761|20585926|P1|COMPLETED|Overall Study||187
8351277|NCT01255761|20585925|P2|STARTED|Overall Study||367
8351278|NCT01255761|20585926|P1|STARTED|Overall Study||369
8351279|NCT01255722|20586011|P3|NOT COMPLETED|Overall Study||1
8351280|NCT01255722|20586012|P2|NOT COMPLETED|Overall Study||1
8351281|NCT01255722|20586013|P1|NOT COMPLETED|Overall Study||3
8351282|NCT01255722|20586011|P3|COMPLETED|Overall Study||152
8351283|NCT01255722|20586012|P2|COMPLETED|Overall Study||159
8351284|NCT01255722|20586013|P1|COMPLETED|Overall Study||152
8351285|NCT01255722|20586011|P3|STARTED|Overall Study||153
8351286|NCT01255722|20586012|P2|STARTED|Overall Study||160
8351287|NCT01255722|20586013|P1|STARTED|Overall Study||155
8351288|NCT01255631|20586038|P2|NOT COMPLETED|Overall Study||6
8351289|NCT01255631|20586039|P1|NOT COMPLETED|Overall Study||9
8351290|NCT01255631|20586038|P2|COMPLETED|Overall Study|study terminated due to poor enrollment|3
8351291|NCT01255631|20586039|P1|COMPLETED|Overall Study|study terminated due to poor enrollment|4
8351292|NCT01255631|20586038|P2|STARTED|Overall Study||9
8351293|NCT01255631|20586039|P1|STARTED|Overall Study||13
8351294|NCT01255592|20586057|P2|NOT COMPLETED|Overall Study||1
8351295|NCT01255592|20586058|P1|NOT COMPLETED|Overall Study||6
8351296|NCT01255592|20586057|P2|COMPLETED|Overall Study||25
8351297|NCT01255592|20586058|P1|COMPLETED|Overall Study||20
8351298|NCT01255592|20586057|P2|STARTED|Overall Study||26
8351299|NCT01255592|20586058|P1|STARTED|Overall Study||26
8351300|NCT01255449|20586114|P1|NOT COMPLETED|Overall Study||0
8351301|NCT01255449|20586114|P1|COMPLETED|Overall Study||26
8351302|NCT01255449|20586114|P1|STARTED|Overall Study||26
8351303|NCT01255436|20586121|P2|NOT COMPLETED|Overall Study||194
8351304|NCT01255436|20586122|P1|NOT COMPLETED|Overall Study||182
8351305|NCT01255436|20586121|P2|COMPLETED|Overall Study||135
8351306|NCT01255436|20586122|P1|COMPLETED|Overall Study||151
8351307|NCT01255436|20586121|P2|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
8351308|NCT01255436|20586122|P1|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
8351309|NCT01255423|20586136|P2|NOT COMPLETED|Overall Study||3
8351310|NCT01255423|20586137|P1|NOT COMPLETED|Overall Study||3
8351311|NCT01255423|20586136|P2|COMPLETED|Overall Study||99
8351312|NCT01255423|20586137|P1|COMPLETED|Overall Study||101
8351313|NCT01255423|20586136|P2|STARTED|Overall Study||102
8351314|NCT01255423|20586137|P1|STARTED|Overall Study||104
8351315|NCT01255306|20586153|P2|NOT COMPLETED|Overall Study||1
8351316|NCT01255306|20586154|P1|NOT COMPLETED|Overall Study||1
8351317|NCT01255306|20586153|P2|COMPLETED|Overall Study||32
8351318|NCT01255306|20586154|P1|COMPLETED|Overall Study||25
8351319|NCT01255306|20586153|P2|STARTED|Overall Study||33
8351320|NCT01255306|20586154|P1|STARTED|Overall Study||26
8351321|NCT01255163|20586165|P2|NOT COMPLETED|Overall Study||5
8351322|NCT01255163|20586166|P1|NOT COMPLETED|Overall Study||4
8351323|NCT01255163|20586165|P2|COMPLETED|Overall Study||9
8351324|NCT01255163|20586166|P1|COMPLETED|Overall Study||9
8351325|NCT01255163|20586165|P2|STARTED|Overall Study||14
8351326|NCT01255163|20586166|P1|STARTED|Overall Study||13
8351327|NCT01255137|20586188|P1|NOT COMPLETED|Overall Study||0
8351328|NCT01255137|20586188|P1|COMPLETED|Overall Study||13
8351329|NCT01255137|20586188|P1|STARTED|Overall Study||13
8351330|NCT01254890|20586195|P2|NOT COMPLETED|Overall Study||10
8351331|NCT01254890|20586196|P1|NOT COMPLETED|Overall Study||1
8351332|NCT01254890|20586195|P2|COMPLETED|Overall Study||47
8351333|NCT01254890|20586196|P1|COMPLETED|Overall Study||2
8351334|NCT01254890|20586195|P2|STARTED|Overall Study||57
8351335|NCT01254890|20586196|P1|STARTED|Overall Study||3
8351336|NCT01254877|20586205|P3|NOT COMPLETED|Overall Study||5
8351337|NCT01254877|20586206|P2|NOT COMPLETED|Overall Study||11
8351338|NCT01254877|20586207|P1|NOT COMPLETED|Overall Study||10
8351339|NCT01254877|20586205|P3|COMPLETED|Overall Study||64
8351340|NCT01254877|20586206|P2|COMPLETED|Overall Study||58
8351341|NCT01254877|20586207|P1|COMPLETED|Overall Study||57
8351342|NCT01254877|20586205|P3|STARTED|Overall Study||69
8351343|NCT01254877|20586206|P2|STARTED|Overall Study||69
8351344|NCT01254877|20586207|P1|STARTED|Overall Study||67
8351345|NCT01254851|20586232|P2|NOT COMPLETED|Overall Study||9
8351346|NCT01254851|20586233|P1|NOT COMPLETED|Overall Study||8
8351347|NCT01254851|20586232|P2|COMPLETED|Overall Study||68
8351348|NCT01254851|20586233|P1|COMPLETED|Overall Study||61
8351349|NCT01254851|20586232|P2|STARTED|Overall Study||77
8351350|NCT01254851|20586233|P1|STARTED|Overall Study||69
8351351|NCT01254760|20586239|P2|NOT COMPLETED|Second Period, 5 Days of Wear||0
8351352|NCT01254760|20586240|P1|NOT COMPLETED|Second Period, 5 Days of Wear||0
8351353|NCT01254760|20586239|P2|COMPLETED|Second Period, 5 Days of Wear||38
8351354|NCT01254760|20586240|P1|COMPLETED|Second Period, 5 Days of Wear||34
8351355|NCT01254760|20586239|P2|STARTED|Second Period, 5 Days of Wear||38
8351356|NCT01254760|20586240|P1|STARTED|Second Period, 5 Days of Wear||34
8351357|NCT01254760|20586239|P2|NOT COMPLETED|First Period, 5 Days of Wear||0
8351358|NCT01254760|20586240|P1|NOT COMPLETED|First Period, 5 Days of Wear||0
8351359|NCT01254760|20586239|P2|COMPLETED|First Period, 5 Days of Wear||38
8351360|NCT01254760|20586240|P1|COMPLETED|First Period, 5 Days of Wear||34
8351361|NCT01254760|20586239|P2|STARTED|First Period, 5 Days of Wear||38
8351362|NCT01254760|20586240|P1|STARTED|First Period, 5 Days of Wear||34
8351363|NCT01254747|20586258|P4|NOT COMPLETED|Overall Study||2
8351364|NCT01254747|20586259|P3|NOT COMPLETED|Overall Study||4
8351365|NCT01254747|20586260|P2|NOT COMPLETED|Overall Study||6
8351366|NCT01254747|20586261|P1|NOT COMPLETED|Overall Study||0
8351367|NCT01254747|20586258|P4|COMPLETED|Overall Study||28
8351368|NCT01254747|20586259|P3|COMPLETED|Overall Study||26
8351369|NCT01254747|20586260|P2|COMPLETED|Overall Study||23
8351370|NCT01254747|20586261|P1|COMPLETED|Overall Study||40
8351371|NCT01254747|20586258|P4|STARTED|Overall Study||30
8351372|NCT01254747|20586259|P3|STARTED|Overall Study||30
8351373|NCT01254747|20586260|P2|STARTED|Overall Study||29
8351374|NCT01254747|20586261|P1|STARTED|Overall Study||40
8351375|NCT01254721|20586301|P2|NOT COMPLETED|Overall Study||22
8351376|NCT01254721|20586302|P1|NOT COMPLETED|Overall Study||15
8351377|NCT01254721|20586301|P2|COMPLETED|Overall Study||42
8351378|NCT01254721|20586302|P1|COMPLETED|Overall Study||52
8351379|NCT01254721|20586301|P2|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
8351380|NCT01254721|20586302|P1|STARTED|Overall Study|Seroquel XR: 300mg|67
8351381|NCT01254669|20586312|P2|NOT COMPLETED|Overall Study||4
8351382|NCT01254669|20586313|P1|NOT COMPLETED|Overall Study||3
8351383|NCT01254669|20586312|P2|COMPLETED|Overall Study||96
8351384|NCT01254669|20586313|P1|COMPLETED|Overall Study||97
8351385|NCT01254669|20586312|P2|STARTED|Overall Study||100
8351386|NCT01254669|20586313|P1|STARTED|Overall Study||100
8351387|NCT01254656|20586324|P3|NOT COMPLETED|Overall Study||18
8351388|NCT01254656|20586325|P2|NOT COMPLETED|Overall Study||43
8351389|NCT01254656|20586326|P1|NOT COMPLETED|Overall Study||47
8351390|NCT01254656|20586324|P3|COMPLETED|Overall Study||0
8351391|NCT01254656|20586325|P2|COMPLETED|Overall Study||0
8351392|NCT01254656|20586326|P1|COMPLETED|Overall Study||0
8351393|NCT01254656|20586324|P3|Treated|Overall Study||18
8351394|NCT01254656|20586325|P2|Treated|Overall Study||43
8351395|NCT01254656|20586326|P1|Treated|Overall Study||47
8351396|NCT01254656|20586324|P3|STARTED|Overall Study||18
8351397|NCT01254656|20586325|P2|STARTED|Overall Study||43
8351398|NCT01254656|20586326|P1|STARTED|Overall Study||47
8351399|NCT01254643|20586352|P1|NOT COMPLETED|Overall Study||1
8351400|NCT01254643|20586352|P1|COMPLETED|Overall Study||99
8351401|NCT01254643|20586352|P1|Vaccination 3|Overall Study||99
8351402|NCT01254643|20586352|P1|Vaccination 2|Overall Study||99
8351403|NCT01254643|20586352|P1|Vaccination 1|Overall Study||100
8351404|NCT01254643|20586352|P1|STARTED|Overall Study||100
8351405|NCT01254630|20586364|P4|NOT COMPLETED|Overall Study||1285
8351406|NCT01254630|20586365|P3|NOT COMPLETED|Overall Study||812
8351407|NCT01254630|20586366|P2|NOT COMPLETED|Overall Study||1288
8351408|NCT01254630|20586367|P1|NOT COMPLETED|Overall Study||802
8351409|NCT01254630|20586364|P4|COMPLETED|Overall Study||0
8351410|NCT01254630|20586365|P3|COMPLETED|Overall Study||552
8351411|NCT01254630|20586366|P2|COMPLETED|Overall Study||0
8351412|NCT01254630|20586367|P1|COMPLETED|Overall Study||546
8351413|NCT01254630|20586364|P4|Received Vaccination 4|Overall Study||1160
8351414|NCT01254630|20586365|P3|Received Vaccination 4|Overall Study||1212
8351415|NCT01254630|20586366|P2|Received Vaccination 4|Overall Study||1145
8351416|NCT01254630|20586367|P1|Received Vaccination 4|Overall Study||1155
8351417|NCT01254630|20586364|P4|Received Vaccination 3|Overall Study||1194
8351418|NCT01254630|20586365|P3|Received Vaccination 3|Overall Study||1247
8351419|NCT01254630|20586366|P2|Received Vaccination 3|Overall Study||1178
8351420|NCT01254630|20586367|P1|Received Vaccination 3|Overall Study||1198
8351421|NCT01254630|20586364|P4|Received Vaccination 2|Overall Study||1226
8351422|NCT01254630|20586365|P3|Received Vaccination 2|Overall Study||1286
8351423|NCT01254630|20586366|P2|Received Vaccination 2|Overall Study||1217
8351424|NCT01254630|20586367|P1|Received Vaccination 2|Overall Study||1255
8351425|NCT01254630|20586364|P4|Received Vaccination 1|Overall Study||1275
8351426|NCT01254630|20586365|P3|Received Vaccination 1|Overall Study||1350
8351427|NCT01254630|20586366|P2|Received Vaccination 1|Overall Study||1277
8351428|NCT01254630|20586367|P1|Received Vaccination 1|Overall Study||1328
8351429|NCT01254630|20586364|P4|STARTED|Overall Study||1285
8351430|NCT01254630|20586365|P3|STARTED|Overall Study||1364
8351431|NCT01254630|20586366|P2|STARTED|Overall Study||1288
8351432|NCT01254630|20586367|P1|STARTED|Overall Study||1348
8351433|NCT01254604|20586387|P2|NOT COMPLETED|Overall Study||9
8351434|NCT01254604|20586388|P1|NOT COMPLETED|Overall Study||8
8351435|NCT01254604|20586387|P2|COMPLETED|Overall Study||86
8351436|NCT01254604|20586388|P1|COMPLETED|Overall Study||87
8351437|NCT01254604|20586387|P2|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
8351438|NCT01254604|20586388|P1|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
8351439|NCT01254604|20586387|P2|STARTED|Overall Study||95
8351440|NCT01254604|20586388|P1|STARTED|Overall Study||95
8351441|NCT01254565|20586406|P6|NOT COMPLETED|Overall Study||4
8351442|NCT01254565|20586407|P5|NOT COMPLETED|Overall Study||4
8351443|NCT01254565|20586408|P4|NOT COMPLETED|Overall Study||1
8351444|NCT01254565|20586409|P3|NOT COMPLETED|Overall Study||0
8351445|NCT01254565|20586410|P2|NOT COMPLETED|Overall Study||1
8351446|NCT01254565|20586411|P1|NOT COMPLETED|Overall Study||1
8351447|NCT01254565|20586406|P6|COMPLETED|Overall Study||13
8351448|NCT01254565|20586407|P5|COMPLETED|Overall Study||12
8351449|NCT01254565|20586408|P4|COMPLETED|Overall Study||20
8351450|NCT01254565|20586409|P3|COMPLETED|Overall Study||21
8351451|NCT01254565|20586410|P2|COMPLETED|Overall Study||6
8351452|NCT01254565|20586411|P1|COMPLETED|Overall Study||4
8351453|NCT01254565|20586406|P6|Received Treatment|Overall Study||13
8351454|NCT01254565|20586407|P5|Received Treatment|Overall Study||13
8351455|NCT01254565|20586408|P4|Received Treatment|Overall Study||21
8351456|NCT01254565|20586409|P3|Received Treatment|Overall Study||21
8351457|NCT01254565|20586410|P2|Received Treatment|Overall Study||6
8351458|NCT01254565|20586411|P1|Received Treatment|Overall Study||4
8351459|NCT01254565|20586406|P6|STARTED|Overall Study||17
8351460|NCT01254565|20586407|P5|STARTED|Overall Study||16
8351461|NCT01254565|20586408|P4|STARTED|Overall Study||21
8351462|NCT01254565|20586409|P3|STARTED|Overall Study||21
8351463|NCT01254565|20586410|P2|STARTED|Overall Study||7
8351464|NCT01254565|20586411|P1|STARTED|Overall Study||5
8351465|NCT01254552|20586461|P1|NOT COMPLETED|CCTA With Xenetix 350||6
8351466|NCT01254552|20586461|P1|COMPLETED|CCTA With Xenetix 350||322
8351467|NCT01254552|20586461|P1|STARTED|CCTA With Xenetix 350||328
8351468|NCT01254552|20586461|P1|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20
8351469|NCT01254552|20586461|P1|COMPLETED|Delayed-enhanced MRI With Dotarem||328
8351470|NCT01254552|20586461|P1|STARTED|Delayed-enhanced MRI With Dotarem||348
8351471|NCT01254552|20586461|P1|NOT COMPLETED|Screening Visit||3
8351472|NCT01254552|20586461|P1|COMPLETED|Screening Visit||348
8351473|NCT01254552|20586461|P1|STARTED|Screening Visit||351
8351474|NCT01254422|20586471|P2|NOT COMPLETED|Overall Study||1
8351475|NCT01254422|20586472|P1|NOT COMPLETED|Overall Study||3
8351476|NCT01254422|20586471|P2|COMPLETED|Overall Study||50
8351477|NCT01254422|20586472|P1|COMPLETED|Overall Study||196
8351478|NCT01254422|20586471|P2|STARTED|Overall Study||51
8351479|NCT01254422|20586472|P1|STARTED|Overall Study||199
8351510|NCT01254344|20586572|P2|NOT COMPLETED|Overall Study||19
8351511|NCT01254344|20586573|P1|NOT COMPLETED|Overall Study||13
8351512|NCT01254344|20586572|P2|COMPLETED|Overall Study||281
8351513|NCT01254344|20586573|P1|COMPLETED|Overall Study||286
8351514|NCT01254344|20586572|P2|Treated|Overall Study||297
8351515|NCT01254344|20586573|P1|Treated|Overall Study||290
8351516|NCT01254344|20586572|P2|STARTED|Overall Study||300
8351517|NCT01254344|20586573|P1|STARTED|Overall Study||299
8351518|NCT01254331|20586581|P1|NOT COMPLETED|Extension Phase||4
8351519|NCT01254331|20586581|P1|COMPLETED|Extension Phase||41
8351520|NCT01254331|20586581|P1|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
8351521|NCT01254331|20586581|P1|NOT COMPLETED|Initial Phase||5
8351522|NCT01254331|20586581|P1|COMPLETED|Initial Phase||46
8351523|NCT01254331|20586581|P1|STARTED|Initial Phase||51
8351524|NCT01254318|20586599|P1|NOT COMPLETED|Overall Study||52
8351525|NCT01254318|20586599|P1|COMPLETED|Overall Study|Alive at end of study|78
8351526|NCT01254318|20586599|P1|STARTED|Overall Study|Alive at start of study|130
8351527|NCT01254305|20586608|P3|NOT COMPLETED|Overall Study||17
8351528|NCT01254305|20586609|P2|NOT COMPLETED|Overall Study||18
8351529|NCT01254305|20586610|P1|NOT COMPLETED|Overall Study||22
8351530|NCT01254305|20586608|P3|COMPLETED|Overall Study||62
8351531|NCT01254305|20586609|P2|COMPLETED|Overall Study||72
8351532|NCT01254305|20586610|P1|COMPLETED|Overall Study||71
8351533|NCT01254305|20586608|P3|Safety Population|Overall Study||77
8351534|NCT01254305|20586609|P2|Safety Population|Overall Study||85
8351535|NCT01254305|20586610|P1|Safety Population|Overall Study||89
8351536|NCT01254305|20586608|P3|STARTED|Overall Study||79
8351537|NCT01254305|20586609|P2|STARTED|Overall Study||90
8351538|NCT01254305|20586610|P1|STARTED|Overall Study||93
8351539|NCT01254292|20586626|P2|NOT COMPLETED|LCS12 Extension Phase||0
8351540|NCT01254292|20586627|P1|NOT COMPLETED|LCS12 Extension Phase||37
8351541|NCT01254292|20586626|P2|COMPLETED|LCS12 Extension Phase||0
8351542|NCT01254292|20586627|P1|COMPLETED|LCS12 Extension Phase||163
8351543|NCT01254292|20586626|P2|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
8351544|NCT01254292|20586627|P1|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
8351545|NCT01254292|20586626|P2|NOT COMPLETED|Comparative Phase||81
8351546|NCT01254292|20586627|P1|NOT COMPLETED|Comparative Phase||55
8351547|NCT01254292|20586626|P2|COMPLETED|Comparative Phase||204
8351548|NCT01254292|20586627|P1|COMPLETED|Comparative Phase||227
8351549|NCT01254292|20586626|P2|Participants Received Treatment|Comparative Phase|safety population|281
8351550|NCT01254292|20586627|P1|Participants Received Treatment|Comparative Phase|safety population|279
8351551|NCT01254292|20586626|P2|STARTED|Comparative Phase||285
8351552|NCT01254292|20586627|P1|STARTED|Comparative Phase||282
8351553|NCT01254214|20586689|P2|NOT COMPLETED|Overall Study||1
8351554|NCT01254214|20586690|P1|NOT COMPLETED|Overall Study||3
8351555|NCT01254214|20586689|P2|COMPLETED|Overall Study||27
8351556|NCT01254214|20586690|P1|COMPLETED|Overall Study||24
8351557|NCT01254214|20586689|P2|STARTED|Overall Study||28
8351558|NCT01254214|20586690|P1|STARTED|Overall Study||27
8351559|NCT01254188|20586704|P1|NOT COMPLETED|Overall Study||93
8351560|NCT01254188|20586704|P1|COMPLETED|Overall Study||328
8351561|NCT01254188|20586704|P1|STARTED|Overall Study||421
8351562|NCT01254045|20586715|P6|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8351563|NCT01254045|20586716|P5|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8351564|NCT01254045|20586717|P4|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8351565|NCT01254045|20586718|P3|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8351566|NCT01254045|20586719|P2|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8351567|NCT01254045|20586720|P1|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
8351568|NCT01254045|20586715|P6|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
8351569|NCT01254045|20586716|P5|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
8351570|NCT01254045|20586717|P4|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
8351571|NCT01254045|20586718|P3|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
8351572|NCT01254045|20586719|P2|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
8351573|NCT01254045|20586720|P1|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
8351574|NCT01254045|20586715|P6|STARTED|Third/Time 3 (1 Day at Week 3)||1
8351575|NCT01254045|20586716|P5|STARTED|Third/Time 3 (1 Day at Week 3)||1
8351576|NCT01254045|20586717|P4|STARTED|Third/Time 3 (1 Day at Week 3)||1
8351577|NCT01254045|20586718|P3|STARTED|Third/Time 3 (1 Day at Week 3)||2
8351578|NCT01254045|20586719|P2|STARTED|Third/Time 3 (1 Day at Week 3)||2
8351579|NCT01254045|20586720|P1|STARTED|Third/Time 3 (1 Day at Week 3)||1
8351580|NCT01254045|20586715|P6|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8351581|NCT01254045|20586716|P5|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8351582|NCT01254045|20586717|P4|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8351583|NCT01254045|20586718|P3|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8351584|NCT01254045|20586719|P2|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8351585|NCT01254045|20586720|P1|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
8351586|NCT01254045|20586715|P6|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
8351587|NCT01254045|20586716|P5|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
8351588|NCT01254045|20586717|P4|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
8351589|NCT01254045|20586718|P3|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
8351590|NCT01254045|20586719|P2|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
8351591|NCT01254045|20586720|P1|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
8351592|NCT01254045|20586715|P6|STARTED|Second/Time 2 (1 Day at Week 2)||1
8351593|NCT01254045|20586716|P5|STARTED|Second/Time 2 (1 Day at Week 2)||1
8351594|NCT01254045|20586717|P4|STARTED|Second/Time 2 (1 Day at Week 2)||1
8351595|NCT01254045|20586718|P3|STARTED|Second/Time 2 (1 Day at Week 2)||2
8351596|NCT01254045|20586719|P2|STARTED|Second/Time 2 (1 Day at Week 2)||2
8351597|NCT01254045|20586720|P1|STARTED|Second/Time 2 (1 Day at Week 2)||1
8351598|NCT01254045|20586715|P6|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8351599|NCT01254045|20586716|P5|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8351600|NCT01254045|20586717|P4|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8351601|NCT01254045|20586718|P3|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8351602|NCT01254045|20586719|P2|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
8351603|NCT01254045|20586720|P1|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
8351604|NCT01254045|20586715|P6|COMPLETED|First/Baseline (1 Day at Week 1 )||1
8351605|NCT01254045|20586716|P5|COMPLETED|First/Baseline (1 Day at Week 1 )||1
8351606|NCT01254045|20586717|P4|COMPLETED|First/Baseline (1 Day at Week 1 )||1
8351607|NCT01254045|20586718|P3|COMPLETED|First/Baseline (1 Day at Week 1 )||2
8351608|NCT01254045|20586719|P2|COMPLETED|First/Baseline (1 Day at Week 1 )||2
8351609|NCT01254045|20586720|P1|COMPLETED|First/Baseline (1 Day at Week 1 )||1
8351610|NCT01254045|20586715|P6|STARTED|First/Baseline (1 Day at Week 1 )||1
8351611|NCT01254045|20586716|P5|STARTED|First/Baseline (1 Day at Week 1 )||1
8351612|NCT01254045|20586717|P4|STARTED|First/Baseline (1 Day at Week 1 )||1
8351613|NCT01254045|20586718|P3|STARTED|First/Baseline (1 Day at Week 1 )||2
8351614|NCT01254045|20586719|P2|STARTED|First/Baseline (1 Day at Week 1 )||2
8351615|NCT01254045|20586720|P1|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
8351616|NCT01254019|20586733|P2|NOT COMPLETED|Overall Study||4
8351617|NCT01254019|20586734|P1|NOT COMPLETED|Overall Study||1
8351618|NCT01254019|20586733|P2|COMPLETED|Overall Study||121
8351619|NCT01254019|20586734|P1|COMPLETED|Overall Study||60
8351620|NCT01254019|20586733|P2|STARTED|Overall Study||125
8351621|NCT01254019|20586734|P1|STARTED|Overall Study||61
8351622|NCT01253980|20586787|P2|NOT COMPLETED|Overall Study||0
8351623|NCT01253980|20586788|P1|NOT COMPLETED|Overall Study||0
8351624|NCT01253980|20586787|P2|COMPLETED|Overall Study||39
8351625|NCT01253980|20586788|P1|COMPLETED|Overall Study||35
8351626|NCT01253980|20586787|P2|STARTED|Overall Study||39
8351627|NCT01253980|20586788|P1|STARTED|Overall Study||35
8351628|NCT01253902|20586797|P3|NOT COMPLETED|Overall Study||4
8351629|NCT01253902|20586798|P2|NOT COMPLETED|Overall Study||2
8351630|NCT01253902|20586799|P1|NOT COMPLETED|Overall Study||5
8351631|NCT01253902|20586797|P3|COMPLETED|Overall Study||51
8351632|NCT01253902|20586798|P2|COMPLETED|Overall Study||51
8351633|NCT01253902|20586799|P1|COMPLETED|Overall Study||51
8351634|NCT01253902|20586797|P3|STARTED|Overall Study||55
8351635|NCT01253902|20586798|P2|STARTED|Overall Study||53
8351636|NCT01253902|20586799|P1|STARTED|Overall Study||56
8351637|NCT01253824|20586815|P2|NOT COMPLETED|Overall Study||0
8351638|NCT01253824|20586816|P1|NOT COMPLETED|Overall Study||0
8351639|NCT01253824|20586815|P2|COMPLETED|Overall Study||7
8351640|NCT01253824|20586816|P1|COMPLETED|Overall Study||7
8351641|NCT01253824|20586815|P2|STARTED|Overall Study||7
8351642|NCT01253824|20586816|P1|STARTED|Overall Study||7
8351643|NCT01253811|20586828|P1|NOT COMPLETED|Overall Study||1
8351644|NCT01253811|20586828|P1|COMPLETED|Overall Study||5
8351645|NCT01253811|20586828|P1|Exposed|Overall Study||6
8351646|NCT01253811|20586828|P1|STARTED|Overall Study||6
8351647|NCT01253642|20586847|P1|NOT COMPLETED|Overall Study||5
8351648|NCT01253642|20586847|P1|COMPLETED|Overall Study||6
8351649|NCT01253642|20586847|P1|STARTED|Overall Study||11
8351650|NCT01253577|20586859|P1|NOT COMPLETED|Overall Study||3
8351651|NCT01253577|20586859|P1|COMPLETED|Overall Study||102
8351652|NCT01253577|20586859|P1|STARTED|Overall Study||105
8351653|NCT01253564|20586867|P1|NOT COMPLETED|Overall Study||24
8351654|NCT01253564|20586867|P1|COMPLETED|Overall Study||0
8351655|NCT01253564|20586867|P1|STARTED|Overall Study||24
8351656|NCT01253525|20586884|P1|NOT COMPLETED|Overall Study||0
8351657|NCT01253525|20586884|P1|COMPLETED|Overall Study||6
8351658|NCT01253525|20586884|P1|Received Any Quantity of Study Drug|Overall Study||6
8351659|NCT01253525|20586884|P1|STARTED|Overall Study||6
8351660|NCT01253460|20586911|P1|NOT COMPLETED|Overall Study||0
8351661|NCT01253460|20586911|P1|COMPLETED|Overall Study||18
8351662|NCT01253460|20586911|P1|STARTED|Overall Study||18
8351663|NCT01253447|20586916|P1|NOT COMPLETED|Overall Study||2
8351664|NCT01253447|20586916|P1|COMPLETED|Overall Study||17
8351665|NCT01253447|20586916|P1|STARTED|Overall Study||19
8351666|NCT01253421|20586926|P5|NOT COMPLETED|Drug+Scanning Visit||1
8351667|NCT01253421|20586927|P4|NOT COMPLETED|Drug+Scanning Visit||0
8351668|NCT01253421|20586928|P3|NOT COMPLETED|Drug+Scanning Visit||0
8351669|NCT01253421|20586929|P2|NOT COMPLETED|Drug+Scanning Visit||0
8351670|NCT01253421|20586930|P1|NOT COMPLETED|Drug+Scanning Visit||0
8351671|NCT01253421|20586926|P5|COMPLETED|Drug+Scanning Visit||14
8351672|NCT01253421|20586927|P4|COMPLETED|Drug+Scanning Visit||16
8351673|NCT01253421|20586928|P3|COMPLETED|Drug+Scanning Visit||14
8351674|NCT01253421|20586929|P2|COMPLETED|Drug+Scanning Visit||15
8351675|NCT01253421|20586930|P1|COMPLETED|Drug+Scanning Visit||0
8351676|NCT01253421|20586926|P5|Received Drug Challenge|Drug+Scanning Visit||15
8351677|NCT01253421|20586927|P4|Received Drug Challenge|Drug+Scanning Visit||16
8351678|NCT01253421|20586928|P3|Received Drug Challenge|Drug+Scanning Visit||14
8351679|NCT01253421|20586929|P2|Received Drug Challenge|Drug+Scanning Visit||15
8351680|NCT01253421|20586930|P1|Received Drug Challenge|Drug+Scanning Visit||0
8351681|NCT01253421|20586926|P5|STARTED|Drug+Scanning Visit||15
8351682|NCT01253421|20586927|P4|STARTED|Drug+Scanning Visit||16
8351683|NCT01253421|20586928|P3|STARTED|Drug+Scanning Visit||14
8351684|NCT01253421|20586929|P2|STARTED|Drug+Scanning Visit||15
8351685|NCT01253421|20586930|P1|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
8351686|NCT01253421|20586926|P5|NOT COMPLETED|Assessment and Scheduling||0
8351687|NCT01253421|20586927|P4|NOT COMPLETED|Assessment and Scheduling||0
8351688|NCT01253421|20586928|P3|NOT COMPLETED|Assessment and Scheduling||0
8351689|NCT01253421|20586929|P2|NOT COMPLETED|Assessment and Scheduling||0
8351690|NCT01253421|20586930|P1|NOT COMPLETED|Assessment and Scheduling||99
8351691|NCT01253421|20586926|P5|COMPLETED|Assessment and Scheduling||0
8351692|NCT01253421|20586927|P4|COMPLETED|Assessment and Scheduling||0
8351693|NCT01253421|20586928|P3|COMPLETED|Assessment and Scheduling||0
8351694|NCT01253421|20586929|P2|COMPLETED|Assessment and Scheduling||0
8351695|NCT01253421|20586930|P1|COMPLETED|Assessment and Scheduling||60
8351696|NCT01253421|20586926|P5|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
8351697|NCT01253421|20586927|P4|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
8351698|NCT01253421|20586928|P3|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
8351699|NCT01253421|20586929|P2|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
8351700|NCT01253421|20586930|P1|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
8351701|NCT01253421|20586926|P5|Eligible After Screening Visit|Assessment and Scheduling||0
8351702|NCT01253421|20586927|P4|Eligible After Screening Visit|Assessment and Scheduling||0
8351703|NCT01253421|20586928|P3|Eligible After Screening Visit|Assessment and Scheduling||0
8351704|NCT01253421|20586929|P2|Eligible After Screening Visit|Assessment and Scheduling||0
8351705|NCT01253421|20586930|P1|Eligible After Screening Visit|Assessment and Scheduling||85
8351706|NCT01253421|20586926|P5|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
8351707|NCT01253421|20586927|P4|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
8351708|NCT01253421|20586928|P3|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
8351709|NCT01253421|20586929|P2|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
8351710|NCT01253421|20586930|P1|STARTED|Assessment and Scheduling||159
8351711|NCT01253408|20586979|P3|NOT COMPLETED|Overall Study||0
8351712|NCT01253408|20586980|P2|NOT COMPLETED|Overall Study||1
8351713|NCT01253408|20586981|P1|NOT COMPLETED|Overall Study||0
8351714|NCT01253408|20586979|P3|COMPLETED|Overall Study||13
8351715|NCT01253408|20586980|P2|COMPLETED|Overall Study||12
8351716|NCT01253408|20586981|P1|COMPLETED|Overall Study||10
8351717|NCT01253408|20586979|P3|STARTED|Overall Study||13
8351718|NCT01253408|20586980|P2|STARTED|Overall Study||13
8351719|NCT01253408|20586981|P1|STARTED|Overall Study||10
8351720|NCT01253369|20587004|P1|NOT COMPLETED|Overall Study||33
8351721|NCT01253369|20587004|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
8351722|NCT01253369|20587004|P1|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
8351723|NCT01253369|20587004|P1|STARTED|Overall Study||33
8351724|NCT01253343|20587011|P2|NOT COMPLETED|Overall Study||0
8351725|NCT01253343|20587012|P1|NOT COMPLETED|Overall Study||0
8351726|NCT01253343|20587011|P2|COMPLETED|Overall Study||8
8351727|NCT01253343|20587012|P1|COMPLETED|Overall Study||9
8351728|NCT01253343|20587011|P2|STARTED|Overall Study||8
8351729|NCT01253343|20587012|P1|STARTED|Overall Study||9
8351730|NCT01253317|20587034|P1|NOT COMPLETED|Overall Study||2
8351731|NCT01253317|20587034|P1|COMPLETED|Overall Study||10
8351732|NCT01253317|20587034|P1|STARTED|Overall Study||12
8351733|NCT01253304|20587046|P4|NOT COMPLETED|Overall Study||1
8351734|NCT01253304|20587047|P3|NOT COMPLETED|Overall Study||0
8351735|NCT01253304|20587048|P2|NOT COMPLETED|Overall Study||0
8351736|NCT01253304|20587049|P1|NOT COMPLETED|Overall Study||0
8351737|NCT01253304|20587046|P4|COMPLETED|Overall Study||2
8351738|NCT01253304|20587047|P3|COMPLETED|Overall Study||6
8351739|NCT01253304|20587048|P2|COMPLETED|Overall Study||6
8351740|NCT01253304|20587049|P1|COMPLETED|Overall Study||11
8351741|NCT01253304|20587046|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8351742|NCT01253304|20587047|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8351743|NCT01253304|20587048|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8351744|NCT01253304|20587049|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
8351745|NCT01253304|20587046|P4|STARTED|Overall Study||3
8351746|NCT01253304|20587047|P3|STARTED|Overall Study||6
8351747|NCT01253304|20587048|P2|STARTED|Overall Study||6
8351748|NCT01253304|20587049|P1|STARTED|Overall Study||11
8351749|NCT01253291|20587088|P5|NOT COMPLETED|Overall Study||2
8351750|NCT01253291|20587089|P4|NOT COMPLETED|Overall Study||0
8351751|NCT01253291|20587090|P3|NOT COMPLETED|Overall Study||0
8351752|NCT01253291|20587091|P2|NOT COMPLETED|Overall Study||2
8351753|NCT01253291|20587092|P1|NOT COMPLETED|Overall Study||4
8351754|NCT01253291|20587088|P5|COMPLETED|Overall Study||3
8351755|NCT01253291|20587089|P4|COMPLETED|Overall Study||5
8351756|NCT01253291|20587090|P3|COMPLETED|Overall Study||4
8351757|NCT01253291|20587091|P2|COMPLETED|Overall Study||4
8351758|NCT01253291|20587092|P1|COMPLETED|Overall Study||2
8351759|NCT01253291|20587088|P5|Received Study Drug During BCDL|Overall Study||5
8351760|NCT01253291|20587089|P4|Received Study Drug During BCDL|Overall Study||5
8351761|NCT01253291|20587090|P3|Received Study Drug During BCDL|Overall Study||4
8351762|NCT01253291|20587091|P2|Received Study Drug During BCDL|Overall Study||6
8351763|NCT01253291|20587092|P1|Received Study Drug During BCDL|Overall Study||6
8351764|NCT01253291|20587088|P5|STARTED|Overall Study||5
8351765|NCT01253291|20587089|P4|STARTED|Overall Study||5
8351766|NCT01253291|20587090|P3|STARTED|Overall Study||4
8351767|NCT01253291|20587091|P2|STARTED|Overall Study||6
8351768|NCT01253291|20587092|P1|STARTED|Overall Study||6
8351769|NCT01253265|20587116|P5|NOT COMPLETED|Overall Study||1
8351770|NCT01253265|20587117|P4|NOT COMPLETED|Overall Study||0
8351771|NCT01253265|20587118|P3|NOT COMPLETED|Overall Study||0
8351772|NCT01253265|20587119|P2|NOT COMPLETED|Overall Study||0
8351773|NCT01253265|20587120|P1|NOT COMPLETED|Overall Study||1
8351774|NCT01253265|20587116|P5|COMPLETED|Overall Study||7
8351775|NCT01253265|20587117|P4|COMPLETED|Overall Study||6
8351776|NCT01253265|20587118|P3|COMPLETED|Overall Study||6
8351777|NCT01253265|20587119|P2|COMPLETED|Overall Study||6
8351778|NCT01253265|20587120|P1|COMPLETED|Overall Study||5
8351779|NCT01253265|20587116|P5|STARTED|Overall Study||8
8351780|NCT01253265|20587117|P4|STARTED|Overall Study||6
8351781|NCT01253265|20587118|P3|STARTED|Overall Study||6
8351782|NCT01253265|20587119|P2|STARTED|Overall Study||6
8351783|NCT01253265|20587120|P1|STARTED|Overall Study||6
8351784|NCT01253226|20587169|P5|NOT COMPLETED|Overall Study||2
8351785|NCT01253226|20587170|P4|NOT COMPLETED|Overall Study||1
8351786|NCT01253226|20587171|P3|NOT COMPLETED|Overall Study||1
8351787|NCT01253226|20587172|P2|NOT COMPLETED|Overall Study||1
8351788|NCT01253226|20587173|P1|NOT COMPLETED|Overall Study||0
8351789|NCT01253226|20587169|P5|COMPLETED|Overall Study||6
8351790|NCT01253226|20587170|P4|COMPLETED|Overall Study||5
8351791|NCT01253226|20587171|P3|COMPLETED|Overall Study||5
8351792|NCT01253226|20587172|P2|COMPLETED|Overall Study||5
8351793|NCT01253226|20587173|P1|COMPLETED|Overall Study||6
8351794|NCT01253226|20587169|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
8351795|NCT01253226|20587170|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8351796|NCT01253226|20587171|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8351797|NCT01253226|20587172|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8351798|NCT01253226|20587173|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8351799|NCT01253226|20587169|P5|STARTED|Overall Study||8
8351800|NCT01253226|20587170|P4|STARTED|Overall Study||6
8351801|NCT01253226|20587171|P3|STARTED|Overall Study||6
8351802|NCT01253226|20587172|P2|STARTED|Overall Study||6
8351803|NCT01253226|20587173|P1|STARTED|Overall Study||6
8351804|NCT01253200|20587233|P5|NOT COMPLETED|Overall Study||5
8351805|NCT01253200|20587234|P4|NOT COMPLETED|Overall Study||5
8351806|NCT01253200|20587235|P3|NOT COMPLETED|Overall Study||2
8351807|NCT01253200|20587236|P2|NOT COMPLETED|Overall Study||19
8351808|NCT01253200|20587237|P1|NOT COMPLETED|Overall Study||21
8351809|NCT01253200|20587233|P5|COMPLETED|Overall Study||0
8351810|NCT01253200|20587234|P4|COMPLETED|Overall Study||12
8351811|NCT01253200|20587235|P3|COMPLETED|Overall Study||28
8351812|NCT01253200|20587236|P2|COMPLETED|Overall Study||106
8351813|NCT01253200|20587237|P1|COMPLETED|Overall Study||104
8351814|NCT01253200|20587233|P5|3 Month Follow-up|Overall Study||0
8351815|NCT01253200|20587234|P4|3 Month Follow-up|Overall Study||12
8351816|NCT01253200|20587235|P3|3 Month Follow-up|Overall Study||28
8351817|NCT01253200|20587236|P2|3 Month Follow-up|Overall Study||106
8351818|NCT01253200|20587237|P1|3 Month Follow-up|Overall Study||104
8351819|NCT01253200|20587233|P5|10 Day Follow-up|Overall Study||0
8351820|NCT01253200|20587234|P4|10 Day Follow-up|Overall Study||12
8351821|NCT01253200|20587235|P3|10 Day Follow-up|Overall Study||28
8351822|NCT01253200|20587236|P2|10 Day Follow-up|Overall Study||111
8351823|NCT01253200|20587237|P1|10 Day Follow-up|Overall Study||106
8351824|NCT01253200|20587233|P5|Procedure|Overall Study||0
8351825|NCT01253200|20587234|P4|Procedure|Overall Study||12
8351826|NCT01253200|20587235|P3|Procedure|Overall Study||28
8351827|NCT01253200|20587236|P2|Procedure|Overall Study||111
8351828|NCT01253200|20587237|P1|Procedure|Overall Study||109
8351829|NCT01253200|20587233|P5|STARTED|Overall Study||5
8351830|NCT01253200|20587234|P4|STARTED|Overall Study||17
8351831|NCT01253200|20587235|P3|STARTED|Overall Study||30
8351832|NCT01253200|20587236|P2|STARTED|Overall Study||125
8351833|NCT01253200|20587237|P1|STARTED|Overall Study||125
8351834|NCT01253187|20587252|P6|NOT COMPLETED|Period 3||0
8351835|NCT01253187|20587253|P5|NOT COMPLETED|Period 3||1
8351836|NCT01253187|20587254|P4|NOT COMPLETED|Period 3||0
8351837|NCT01253187|20587255|P3|NOT COMPLETED|Period 3||0
8351838|NCT01253187|20587256|P2|NOT COMPLETED|Period 3||1
8351839|NCT01253187|20587257|P1|NOT COMPLETED|Period 3||1
8351840|NCT01253187|20587252|P6|COMPLETED|Period 3||6
8351841|NCT01253187|20587253|P5|COMPLETED|Period 3||7
8351842|NCT01253187|20587254|P4|COMPLETED|Period 3||7
8351843|NCT01253187|20587255|P3|COMPLETED|Period 3||7
8351844|NCT01253187|20587256|P2|COMPLETED|Period 3||7
8351845|NCT01253187|20587257|P1|COMPLETED|Period 3||6
8351846|NCT01253187|20587252|P6|STARTED|Period 3||6
8351847|NCT01253187|20587253|P5|STARTED|Period 3||8
8351848|NCT01253187|20587254|P4|STARTED|Period 3||7
8351849|NCT01253187|20587255|P3|STARTED|Period 3||7
8351850|NCT01253187|20587256|P2|STARTED|Period 3||8
8351851|NCT01253187|20587257|P1|STARTED|Period 3||7
8351852|NCT01253187|20587252|P6|NOT COMPLETED|Period 2||0
8351853|NCT01253187|20587253|P5|NOT COMPLETED|Period 2||1
8351854|NCT01253187|20587254|P4|NOT COMPLETED|Period 2||0
8351855|NCT01253187|20587255|P3|NOT COMPLETED|Period 2||0
8351856|NCT01253187|20587256|P2|NOT COMPLETED|Period 2||0
8351857|NCT01253187|20587257|P1|NOT COMPLETED|Period 2||0
8351858|NCT01253187|20587252|P6|COMPLETED|Period 2||6
8351859|NCT01253187|20587253|P5|COMPLETED|Period 2||8
8351860|NCT01253187|20587254|P4|COMPLETED|Period 2||7
8351861|NCT01253187|20587255|P3|COMPLETED|Period 2||7
8351862|NCT01253187|20587256|P2|COMPLETED|Period 2||8
8351863|NCT01253187|20587257|P1|COMPLETED|Period 2||7
8351864|NCT01253187|20587252|P6|STARTED|Period 2||6
8351865|NCT01253187|20587253|P5|STARTED|Period 2||9
8351866|NCT01253187|20587254|P4|STARTED|Period 2||7
8351867|NCT01253187|20587255|P3|STARTED|Period 2||7
8351868|NCT01253187|20587256|P2|STARTED|Period 2||8
8351869|NCT01253187|20587257|P1|STARTED|Period 2||7
8351870|NCT01253187|20587252|P6|NOT COMPLETED|Period 1||0
8351871|NCT01253187|20587253|P5|NOT COMPLETED|Period 1||0
8351872|NCT01253187|20587254|P4|NOT COMPLETED|Period 1||0
8351873|NCT01253187|20587255|P3|NOT COMPLETED|Period 1||0
8351874|NCT01253187|20587256|P2|NOT COMPLETED|Period 1||0
8351875|NCT01253187|20587257|P1|NOT COMPLETED|Period 1||0
8351876|NCT01253187|20587252|P6|COMPLETED|Period 1||6
8351877|NCT01253187|20587253|P5|COMPLETED|Period 1||9
8351878|NCT01253187|20587254|P4|COMPLETED|Period 1||7
8351879|NCT01253187|20587255|P3|COMPLETED|Period 1||7
8351880|NCT01253187|20587256|P2|COMPLETED|Period 1||8
8351881|NCT01253187|20587257|P1|COMPLETED|Period 1||7
8351882|NCT01253187|20587252|P6|STARTED|Period 1||6
8351883|NCT01253187|20587253|P5|STARTED|Period 1||9
8351884|NCT01253187|20587254|P4|STARTED|Period 1||7
8351885|NCT01253187|20587255|P3|STARTED|Period 1||7
8351886|NCT01253187|20587256|P2|STARTED|Period 1||8
8351887|NCT01253187|20587257|P1|STARTED|Period 1||7
8351888|NCT01253174|20587286|P6|NOT COMPLETED|Period 3||0
8351889|NCT01253174|20587287|P5|NOT COMPLETED|Period 3||1
8351890|NCT01253174|20587288|P4|NOT COMPLETED|Period 3||0
8351891|NCT01253174|20587289|P3|NOT COMPLETED|Period 3||1
8351892|NCT01253174|20587290|P2|NOT COMPLETED|Period 3||1
8351893|NCT01253174|20587291|P1|NOT COMPLETED|Period 3||0
8351894|NCT01253174|20587286|P6|COMPLETED|Period 3||7
8351895|NCT01253174|20587287|P5|COMPLETED|Period 3||7
8351896|NCT01253174|20587288|P4|COMPLETED|Period 3||7
8351897|NCT01253174|20587289|P3|COMPLETED|Period 3||6
8351898|NCT01253174|20587290|P2|COMPLETED|Period 3||8
8351899|NCT01253174|20587291|P1|COMPLETED|Period 3||6
8351900|NCT01253174|20587286|P6|STARTED|Period 3||7
8351901|NCT01253174|20587287|P5|STARTED|Period 3||8
8351902|NCT01253174|20587288|P4|STARTED|Period 3||7
8351903|NCT01253174|20587289|P3|STARTED|Period 3||7
8351904|NCT01253174|20587290|P2|STARTED|Period 3||9
8351905|NCT01253174|20587291|P1|STARTED|Period 3||6
8351906|NCT01253174|20587286|P6|NOT COMPLETED|Period 2||0
8351907|NCT01253174|20587287|P5|NOT COMPLETED|Period 2||0
8351908|NCT01253174|20587288|P4|NOT COMPLETED|Period 2||0
8351909|NCT01253174|20587289|P3|NOT COMPLETED|Period 2||1
8351910|NCT01253174|20587290|P2|NOT COMPLETED|Period 2||0
8351911|NCT01253174|20587291|P1|NOT COMPLETED|Period 2||0
8351912|NCT01253174|20587286|P6|COMPLETED|Period 2||7
8351913|NCT01253174|20587287|P5|COMPLETED|Period 2||8
8351914|NCT01253174|20587288|P4|COMPLETED|Period 2||7
8351915|NCT01253174|20587289|P3|COMPLETED|Period 2||7
8351916|NCT01253174|20587290|P2|COMPLETED|Period 2||9
8351917|NCT01253174|20587291|P1|COMPLETED|Period 2||6
8351918|NCT01253174|20587286|P6|STARTED|Period 2||7
8351919|NCT01253174|20587287|P5|STARTED|Period 2||8
8351920|NCT01253174|20587288|P4|STARTED|Period 2||7
8351921|NCT01253174|20587289|P3|STARTED|Period 2||8
8351922|NCT01253174|20587290|P2|STARTED|Period 2||9
8351923|NCT01253174|20587291|P1|STARTED|Period 2||6
8351924|NCT01253174|20587286|P6|NOT COMPLETED|Period 1||0
8351925|NCT01253174|20587287|P5|NOT COMPLETED|Period 1||1
8351926|NCT01253174|20587288|P4|NOT COMPLETED|Period 1||0
8351927|NCT01253174|20587289|P3|NOT COMPLETED|Period 1||1
8351928|NCT01253174|20587290|P2|NOT COMPLETED|Period 1||1
8351929|NCT01253174|20587291|P1|NOT COMPLETED|Period 1||0
8351930|NCT01253174|20587286|P6|COMPLETED|Period 1||7
8351931|NCT01253174|20587287|P5|COMPLETED|Period 1||8
8351932|NCT01253174|20587288|P4|COMPLETED|Period 1||7
8351933|NCT01253174|20587289|P3|COMPLETED|Period 1||8
8351934|NCT01253174|20587290|P2|COMPLETED|Period 1||9
8351935|NCT01253174|20587291|P1|COMPLETED|Period 1||6
8351936|NCT01253174|20587286|P6|STARTED|Period 1||7
8351937|NCT01253174|20587287|P5|STARTED|Period 1||9
8351938|NCT01253174|20587288|P4|STARTED|Period 1||7
8351939|NCT01253174|20587289|P3|STARTED|Period 1||9
8351940|NCT01253174|20587290|P2|STARTED|Period 1||10
8351941|NCT01253174|20587291|P1|STARTED|Period 1||6
8351942|NCT01253148|20587320|P1|NOT COMPLETED|Overall Study||0
8351943|NCT01253148|20587320|P1|COMPLETED|Overall Study||25
8351944|NCT01253148|20587320|P1|STARTED|Overall Study||25
8351945|NCT01253135|20587326|P1|NOT COMPLETED|Amended Protocol||1
8351946|NCT01253135|20587326|P1|COMPLETED|Amended Protocol||24
8351947|NCT01253135|20587326|P1|STARTED|Amended Protocol||25
8351948|NCT01253135|20587326|P1|NOT COMPLETED|Original Protocol||15
8351949|NCT01253135|20587326|P1|COMPLETED|Original Protocol||0
8351950|NCT01253135|20587326|P1|STARTED|Original Protocol||15
8351954|NCT01253044|20587345|P2|NOT COMPLETED|Overall Study||29
8351955|NCT01253044|20587346|P1|NOT COMPLETED|Overall Study||38
8351956|NCT01253044|20587345|P2|COMPLETED|Overall Study||51
8351957|NCT01253044|20587346|P1|COMPLETED|Overall Study||42
8351958|NCT01253044|20587345|P2|STARTED|Overall Study||80
8351959|NCT01253044|20587346|P1|STARTED|Overall Study||80
8351960|NCT01253018|20587356|P2|NOT COMPLETED|Overall Study||2
8351961|NCT01253018|20587357|P1|NOT COMPLETED|Overall Study||4
8351962|NCT01253018|20587356|P2|COMPLETED|Overall Study||21
8351963|NCT01253018|20587357|P1|COMPLETED|Overall Study||18
8351964|NCT01253018|20587356|P2|STARTED|Overall Study||23
8351965|NCT01253018|20587357|P1|STARTED|Overall Study||22
8351966|NCT01252966|20587371|P2|NOT COMPLETED|Overall Study||13
8351967|NCT01252966|20587372|P1|NOT COMPLETED|Overall Study||23
8351968|NCT01252966|20587371|P2|COMPLETED|Overall Study||92
8351969|NCT01252966|20587372|P1|COMPLETED|Overall Study||85
8351970|NCT01252966|20587371|P2|STARTED|Overall Study||105
8351971|NCT01252966|20587372|P1|STARTED|Overall Study||108
8351972|NCT01252953|20587388|P2|NOT COMPLETED|Overall Study||38
8351973|NCT01252953|20587389|P1|NOT COMPLETED|Overall Study||38
8351974|NCT01252953|20587388|P2|COMPLETED|Overall Study||15186
8351975|NCT01252953|20587389|P1|COMPLETED|Overall Study||15187
8351976|NCT01252953|20587388|P2|STARTED|Overall Study||15224
8351977|NCT01252953|20587389|P1|STARTED|Overall Study||15225
8351978|NCT01252940|20587403|P2|NOT COMPLETED|Extension Phase||3
8351979|NCT01252940|20587404|P1|NOT COMPLETED|Extension Phase||10
8351980|NCT01252940|20587403|P2|COMPLETED|Extension Phase||46
8351981|NCT01252940|20587404|P1|COMPLETED|Extension Phase||100
8351982|NCT01252940|20587403|P2|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
8351983|NCT01252940|20587404|P1|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
8351984|NCT01252940|20587403|P2|NOT COMPLETED|Main Study Phase||12
8351985|NCT01252940|20587404|P1|NOT COMPLETED|Main Study Phase||26
8352078|NCT01252134|20587705|P4|COMPLETED|Period 3, 8 Hours||5
8351986|NCT01252940|20587403|P2|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
8351987|NCT01252940|20587404|P1|COMPLETED|Main Study Phase||295
8351988|NCT01252940|20587403|P2|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
8351989|NCT01252940|20587404|P1|Completed 24 Weeks|Main Study Phase||0
8351990|NCT01252940|20587403|P2|STARTED|Main Study Phase||161
8351991|NCT01252940|20587404|P1|STARTED|Main Study Phase||321
8351992|NCT01252810|20587435|P2|NOT COMPLETED|Overall Study||3
8351993|NCT01252810|20587436|P1|NOT COMPLETED|Overall Study||14
8351994|NCT01252810|20587435|P2|COMPLETED|Overall Study||139
8351995|NCT01252810|20587436|P1|COMPLETED|Overall Study||128
8351996|NCT01252810|20587435|P2|STARTED|Overall Study||142
8351997|NCT01252810|20587436|P1|STARTED|Overall Study||142
8351998|NCT01252745|20587449|P3|NOT COMPLETED|Overall Study||0
8351999|NCT01252745|20587450|P2|NOT COMPLETED|Overall Study||0
8352000|NCT01252745|20587451|P1|NOT COMPLETED|Overall Study||0
8352001|NCT01252745|20587449|P3|COMPLETED|Overall Study||7
8352002|NCT01252745|20587450|P2|COMPLETED|Overall Study||7
8352003|NCT01252745|20587451|P1|COMPLETED|Overall Study||8
8352004|NCT01252745|20587449|P3|STARTED|Overall Study||7
8352005|NCT01252745|20587450|P2|STARTED|Overall Study||7
8352006|NCT01252745|20587451|P1|STARTED|Overall Study||8
8352007|NCT01252667|20587471|P6|NOT COMPLETED|Overall Study||1
8352008|NCT01252667|20587472|P5|NOT COMPLETED|Overall Study||0
8352009|NCT01252667|20587473|P4|NOT COMPLETED|Overall Study||0
8352010|NCT01252667|20587474|P3|NOT COMPLETED|Overall Study||0
8352011|NCT01252667|20587475|P2|NOT COMPLETED|Overall Study||0
8352012|NCT01252667|20587476|P1|NOT COMPLETED|Overall Study||0
8352013|NCT01252667|20587471|P6|COMPLETED|Overall Study||34
8352014|NCT01252667|20587472|P5|COMPLETED|Overall Study||0
8352015|NCT01252667|20587473|P4|COMPLETED|Overall Study||0
8352016|NCT01252667|20587474|P3|COMPLETED|Overall Study||3
8352017|NCT01252667|20587475|P2|COMPLETED|Overall Study||3
8352018|NCT01252667|20587476|P1|COMPLETED|Overall Study||3
8352019|NCT01252667|20587471|P6|STARTED|Overall Study||35
8352020|NCT01252667|20587472|P5|STARTED|Overall Study||0
8352021|NCT01252667|20587473|P4|STARTED|Overall Study||0
8352022|NCT01252667|20587474|P3|STARTED|Overall Study||3
8352023|NCT01252667|20587475|P2|STARTED|Overall Study||3
8352024|NCT01252667|20587476|P1|STARTED|Overall Study||3
8352025|NCT01252355|20587541|P3|NOT COMPLETED|Overall Study||179
8352026|NCT01252355|20587542|P2|NOT COMPLETED|Overall Study||178
8352027|NCT01252355|20587543|P1|NOT COMPLETED|Overall Study||177
8352028|NCT01252355|20587541|P3|COMPLETED|Overall Study||0
8352029|NCT01252355|20587542|P2|COMPLETED|Overall Study||0
8352030|NCT01252355|20587543|P1|COMPLETED|Overall Study||0
8352031|NCT01252355|20587541|P3|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
8352032|NCT01252355|20587542|P2|Treated|Overall Study||178
8352033|NCT01252355|20587543|P1|Treated|Overall Study||175
8352034|NCT01252355|20587541|P3|STARTED|Overall Study|Randomized.|179
8352035|NCT01252355|20587542|P2|STARTED|Overall Study|Randomized.|178
8352036|NCT01252355|20587543|P1|STARTED|Overall Study|Randomized.|177
8352037|NCT01252290|20587581|P1|NOT COMPLETED|Overall Study||1
8352038|NCT01252290|20587581|P1|COMPLETED|Overall Study||34
8352039|NCT01252290|20587581|P1|STARTED|Overall Study||35
8352040|NCT01252277|20587589|P1|NOT COMPLETED|Overall Study||2
8352041|NCT01252277|20587589|P1|COMPLETED|Overall Study||34
8352042|NCT01252277|20587589|P1|STARTED|Overall Study||36
8352043|NCT01252251|20587597|P1|NOT COMPLETED|Overall Study||1
8352044|NCT01252251|20587597|P1|COMPLETED|Overall Study||13
8352045|NCT01252251|20587597|P1|STARTED|Overall Study||14
8352046|NCT01252238|20587609|P3|NOT COMPLETED|Overall Study||4
8352047|NCT01252238|20587610|P2|NOT COMPLETED|Overall Study||4
8352048|NCT01252238|20587611|P1|NOT COMPLETED|Overall Study||4
8352049|NCT01252238|20587609|P3|COMPLETED|Overall Study|sponsor terminated study|4
8352050|NCT01252238|20587610|P2|COMPLETED|Overall Study|sponsor terminated study|4
8352051|NCT01252238|20587611|P1|COMPLETED|Overall Study|sponsor terminated study|4
8352052|NCT01252238|20587609|P3|STARTED|Overall Study||8
8352053|NCT01252238|20587610|P2|STARTED|Overall Study||8
8352054|NCT01252238|20587611|P1|STARTED|Overall Study||8
8352055|NCT01252186|20587628|P3|NOT COMPLETED|Overall Study||34
8352056|NCT01252186|20587629|P2|NOT COMPLETED|Overall Study||32
8352057|NCT01252186|20587630|P1|NOT COMPLETED|Overall Study||30
8352058|NCT01252186|20587628|P3|COMPLETED|Overall Study||53
8352059|NCT01252186|20587629|P2|COMPLETED|Overall Study||59
8352060|NCT01252186|20587630|P1|COMPLETED|Overall Study||57
8352061|NCT01252186|20587628|P3|Received Study Drug|Overall Study||80
8352062|NCT01252186|20587629|P2|Received Study Drug|Overall Study||89
8352063|NCT01252186|20587630|P1|Received Study Drug|Overall Study||83
8352064|NCT01252186|20587628|P3|STARTED|Overall Study||87
8352065|NCT01252186|20587629|P2|STARTED|Overall Study||91
8352066|NCT01252186|20587630|P1|STARTED|Overall Study||87
8352067|NCT01252147|20587698|P1|NOT COMPLETED|Overall Study||0
8352068|NCT01252147|20587698|P1|COMPLETED|Overall Study||68
8352069|NCT01252147|20587698|P1|STARTED|Overall Study||68
8352070|NCT01252134|20587703|P6|NOT COMPLETED|Period 3, 8 Hours||0
8352071|NCT01252134|20587704|P5|NOT COMPLETED|Period 3, 8 Hours||0
8352072|NCT01252134|20587705|P4|NOT COMPLETED|Period 3, 8 Hours||0
8352073|NCT01252134|20587706|P3|NOT COMPLETED|Period 3, 8 Hours||0
8352074|NCT01252134|20587707|P2|NOT COMPLETED|Period 3, 8 Hours||0
8352075|NCT01252134|20587708|P1|NOT COMPLETED|Period 3, 8 Hours||0
8352076|NCT01252134|20587703|P6|COMPLETED|Period 3, 8 Hours||4
8352077|NCT01252134|20587704|P5|COMPLETED|Period 3, 8 Hours||3
8352079|NCT01252134|20587706|P3|COMPLETED|Period 3, 8 Hours||2
8352080|NCT01252134|20587707|P2|COMPLETED|Period 3, 8 Hours||3
8352081|NCT01252134|20587708|P1|COMPLETED|Period 3, 8 Hours||3
8352082|NCT01252134|20587703|P6|STARTED|Period 3, 8 Hours||4
8352083|NCT01252134|20587704|P5|STARTED|Period 3, 8 Hours||3
8352084|NCT01252134|20587705|P4|STARTED|Period 3, 8 Hours||5
8352085|NCT01252134|20587706|P3|STARTED|Period 3, 8 Hours||2
8352086|NCT01252134|20587707|P2|STARTED|Period 3, 8 Hours||3
8352087|NCT01252134|20587708|P1|STARTED|Period 3, 8 Hours||3
8352088|NCT01252134|20587703|P6|NOT COMPLETED|Period 2, 8 Hours||0
8352089|NCT01252134|20587704|P5|NOT COMPLETED|Period 2, 8 Hours||0
8352090|NCT01252134|20587705|P4|NOT COMPLETED|Period 2, 8 Hours||0
8352091|NCT01252134|20587706|P3|NOT COMPLETED|Period 2, 8 Hours||0
8352092|NCT01252134|20587707|P2|NOT COMPLETED|Period 2, 8 Hours||0
8352093|NCT01252134|20587708|P1|NOT COMPLETED|Period 2, 8 Hours||0
8352094|NCT01252134|20587703|P6|COMPLETED|Period 2, 8 Hours||4
8352095|NCT01252134|20587704|P5|COMPLETED|Period 2, 8 Hours||3
8352096|NCT01252134|20587705|P4|COMPLETED|Period 2, 8 Hours||5
8352097|NCT01252134|20587706|P3|COMPLETED|Period 2, 8 Hours||2
8352098|NCT01252134|20587707|P2|COMPLETED|Period 2, 8 Hours||3
8352099|NCT01252134|20587708|P1|COMPLETED|Period 2, 8 Hours||3
8352100|NCT01252134|20587703|P6|STARTED|Period 2, 8 Hours||4
8352101|NCT01252134|20587704|P5|STARTED|Period 2, 8 Hours||3
8352102|NCT01252134|20587705|P4|STARTED|Period 2, 8 Hours||5
8352103|NCT01252134|20587706|P3|STARTED|Period 2, 8 Hours||2
8352104|NCT01252134|20587707|P2|STARTED|Period 2, 8 Hours||3
8352105|NCT01252134|20587708|P1|STARTED|Period 2, 8 Hours||3
8352106|NCT01252134|20587703|P6|NOT COMPLETED|Period 1, 8 Hours||0
8352107|NCT01252134|20587704|P5|NOT COMPLETED|Period 1, 8 Hours||0
8352108|NCT01252134|20587705|P4|NOT COMPLETED|Period 1, 8 Hours||0
8352109|NCT01252134|20587706|P3|NOT COMPLETED|Period 1, 8 Hours||1
8352110|NCT01252134|20587707|P2|NOT COMPLETED|Period 1, 8 Hours||1
8352111|NCT01252134|20587708|P1|NOT COMPLETED|Period 1, 8 Hours||0
8352112|NCT01252134|20587703|P6|COMPLETED|Period 1, 8 Hours||4
8352113|NCT01252134|20587704|P5|COMPLETED|Period 1, 8 Hours||3
8352114|NCT01252134|20587705|P4|COMPLETED|Period 1, 8 Hours||5
8352115|NCT01252134|20587706|P3|COMPLETED|Period 1, 8 Hours||2
8352116|NCT01252134|20587707|P2|COMPLETED|Period 1, 8 Hours||3
8352117|NCT01252134|20587708|P1|COMPLETED|Period 1, 8 Hours||3
8352118|NCT01252134|20587703|P6|STARTED|Period 1, 8 Hours||4
8352119|NCT01252134|20587704|P5|STARTED|Period 1, 8 Hours||3
8352120|NCT01252134|20587705|P4|STARTED|Period 1, 8 Hours||5
8352121|NCT01252134|20587706|P3|STARTED|Period 1, 8 Hours||3
8352122|NCT01252134|20587707|P2|STARTED|Period 1, 8 Hours||4
8352123|NCT01252134|20587708|P1|STARTED|Period 1, 8 Hours||3
8352124|NCT01252095|20587727|P2|NOT COMPLETED|Overall Study||0
8352125|NCT01252095|20587728|P1|NOT COMPLETED|Overall Study||1
8352126|NCT01252095|20587727|P2|COMPLETED|Overall Study||1
8352127|NCT01252095|20587728|P1|COMPLETED|Overall Study||2
8352128|NCT01252095|20587727|P2|STARTED|Overall Study||1
8352129|NCT01252095|20587728|P1|STARTED|Overall Study||3
8352130|NCT01251978|20587736|P2|NOT COMPLETED|Overall Study||0
8352131|NCT01251978|20587737|P1|NOT COMPLETED|Overall Study||0
8352132|NCT01251978|20587736|P2|COMPLETED|Overall Study||3
8352133|NCT01251978|20587737|P1|COMPLETED|Overall Study||5
8352134|NCT01251978|20587736|P2|STARTED|Overall Study||3
8352135|NCT01251978|20587737|P1|STARTED|Overall Study||5
8352136|NCT01251965|20587749|P3|NOT COMPLETED|Overall Study||11
8352137|NCT01251965|20587750|P2|NOT COMPLETED|Overall Study||2
8352138|NCT01251965|20587751|P1|NOT COMPLETED|Overall Study||1
8352139|NCT01251965|20587749|P3|COMPLETED|Overall Study||7
8352140|NCT01251965|20587750|P2|COMPLETED|Overall Study||3
8352141|NCT01251965|20587751|P1|COMPLETED|Overall Study||3
8352142|NCT01251965|20587749|P3|STARTED|Overall Study||18
8352143|NCT01251965|20587750|P2|STARTED|Overall Study||5
8352144|NCT01251965|20587751|P1|STARTED|Overall Study||4
8352145|NCT01251952|20587763|P1|NOT COMPLETED|Overall Study||1
8352146|NCT01251952|20587763|P1|COMPLETED|Overall Study||1
8352147|NCT01251952|20587763|P1|STARTED|Overall Study||2
8352160|NCT01251770|20587798|P2|NOT COMPLETED|Overall Study||7
8352161|NCT01251770|20587799|P1|NOT COMPLETED|Overall Study||13
8352162|NCT01251770|20587798|P2|COMPLETED|Overall Study||29
8352163|NCT01251770|20587799|P1|COMPLETED|Overall Study||29
8352164|NCT01251770|20587798|P2|STARTED|Overall Study||36
8352165|NCT01251770|20587799|P1|STARTED|Overall Study||42
8352166|NCT01251757|20587810|P3|NOT COMPLETED|Overall Study||0
8352167|NCT01251757|20587811|P2|NOT COMPLETED|Overall Study||0
8352168|NCT01251757|20587812|P1|NOT COMPLETED|Overall Study||0
8352169|NCT01251757|20587810|P3|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
8352170|NCT01251757|20587811|P2|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
8352171|NCT01251757|20587812|P1|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
8352172|NCT01251757|20587810|P3|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
8352173|NCT01251757|20587811|P2|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
8352174|NCT01251757|20587812|P1|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
8352175|NCT01251744|20587843|P2|NOT COMPLETED|Overall Study||0
8352176|NCT01251744|20587844|P1|NOT COMPLETED|Overall Study||1
8352177|NCT01251744|20587843|P2|COMPLETED|Overall Study||78
8352178|NCT01251744|20587844|P1|COMPLETED|Overall Study||76
8352179|NCT01251744|20587843|P2|STARTED|Overall Study||78
8352180|NCT01251744|20587844|P1|STARTED|Overall Study||77
8352181|NCT01251653|20587902|P9|NOT COMPLETED|Overall Study||6
8352182|NCT01251653|20587903|P8|NOT COMPLETED|Overall Study||12
8352183|NCT01251653|20587904|P7|NOT COMPLETED|Overall Study||18
8352184|NCT01251653|20587905|P6|NOT COMPLETED|Overall Study||18
8352185|NCT01251653|20587906|P5|NOT COMPLETED|Overall Study||2
8352186|NCT01251653|20587907|P4|NOT COMPLETED|Overall Study||6
8352187|NCT01251653|20587908|P3|NOT COMPLETED|Overall Study||20
8352188|NCT01251653|20587909|P2|NOT COMPLETED|Overall Study||8
8352189|NCT01251653|20587910|P1|NOT COMPLETED|Overall Study||3
8352190|NCT01251653|20587902|P9|COMPLETED|Overall Study||0
8352191|NCT01251653|20587903|P8|COMPLETED|Overall Study||0
8352192|NCT01251653|20587904|P7|COMPLETED|Overall Study||0
8352193|NCT01251653|20587905|P6|COMPLETED|Overall Study||0
8352194|NCT01251653|20587906|P5|COMPLETED|Overall Study||0
8352195|NCT01251653|20587907|P4|COMPLETED|Overall Study||0
8352196|NCT01251653|20587908|P3|COMPLETED|Overall Study||0
8352197|NCT01251653|20587909|P2|COMPLETED|Overall Study||0
8352198|NCT01251653|20587910|P1|COMPLETED|Overall Study||0
8352199|NCT01251653|20587902|P9|STARTED|Overall Study||6
8352200|NCT01251653|20587903|P8|STARTED|Overall Study||12
8352201|NCT01251653|20587904|P7|STARTED|Overall Study||18
8352202|NCT01251653|20587905|P6|STARTED|Overall Study||18
8352203|NCT01251653|20587906|P5|STARTED|Overall Study||2
8352204|NCT01251653|20587907|P4|STARTED|Overall Study||6
8352205|NCT01251653|20587908|P3|STARTED|Overall Study||20
8352206|NCT01251653|20587909|P2|STARTED|Overall Study||8
8352207|NCT01251653|20587910|P1|STARTED|Overall Study||3
8352208|NCT01251614|20588038|P3|NOT COMPLETED|Overall Study||8
8352209|NCT01251614|20588039|P2|NOT COMPLETED|Overall Study||13
8352210|NCT01251614|20588040|P1|NOT COMPLETED|Overall Study||3
8352211|NCT01251614|20588038|P3|COMPLETED|Overall Study||30
8352212|NCT01251614|20588039|P2|COMPLETED|Overall Study||26
8352213|NCT01251614|20588040|P1|COMPLETED|Overall Study||34
8352214|NCT01251614|20588038|P3|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
8352215|NCT01251614|20588039|P2|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
8352216|NCT01251614|20588040|P1|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
8352217|NCT01251614|20588038|P3|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
8352218|NCT01251614|20588039|P2|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
8352219|NCT01251614|20588040|P1|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
8352220|NCT01251614|20588038|P3|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
8352221|NCT01251614|20588039|P2|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
8352222|NCT01251614|20588040|P1|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
8352223|NCT01251614|20588038|P3|STARTED|Overall Study||38
8352224|NCT01251614|20588039|P2|STARTED|Overall Study||39
8352225|NCT01251614|20588040|P1|STARTED|Overall Study||37
8352232|NCT01251575|20588147|P1|NOT COMPLETED|Overall Study||1
8352233|NCT01251575|20588147|P1|COMPLETED|Overall Study||76
8352234|NCT01251575|20588147|P1|STARTED|Overall Study||77
8352235|NCT01251536|20588157|P3|NOT COMPLETED|Overall Study||0
8352236|NCT01251536|20588158|P2|NOT COMPLETED|Overall Study||0
8352237|NCT01251536|20588159|P1|NOT COMPLETED|Overall Study||0
8352238|NCT01251536|20588157|P3|COMPLETED|Overall Study||7
8352239|NCT01251536|20588158|P2|COMPLETED|Overall Study||93
8352240|NCT01251536|20588159|P1|COMPLETED|Overall Study||8
8352241|NCT01251536|20588157|P3|STARTED|Overall Study||7
8352242|NCT01251536|20588158|P2|STARTED|Overall Study||93
8352243|NCT01251536|20588159|P1|STARTED|Overall Study||8
8352244|NCT01251393|20588231|P2|NOT COMPLETED|Overall Study||44
8352245|NCT01251393|20588232|P1|NOT COMPLETED|Overall Study||32
8352246|NCT01251393|20588231|P2|COMPLETED|Overall Study||11
8352247|NCT01251393|20588232|P1|COMPLETED|Overall Study||24
8352248|NCT01251393|20588231|P2|STARTED|Overall Study||55
8352249|NCT01251393|20588232|P1|STARTED|Overall Study||56
8352250|NCT01251380|20588238|P1|NOT COMPLETED|Overall Study||22
8352251|NCT01251380|20588238|P1|COMPLETED|Overall Study||194
8352252|NCT01251380|20588238|P1|Cycle 4|Overall Study||11
8352253|NCT01251380|20588238|P1|Cycle 3|Overall Study||86
8352254|NCT01251380|20588238|P1|Cycle 2|Overall Study||175
8352255|NCT01251380|20588238|P1|Cycle 1|Overall Study||207
8352256|NCT01251380|20588238|P1|STARTED|Overall Study|Safety population.|216
8352257|NCT01251367|20588262|P1|NOT COMPLETED|Overall Study||76
8352258|NCT01251367|20588262|P1|COMPLETED|Overall Study||269
8352259|NCT01251367|20588262|P1|Cycle 4|Overall Study||139
8352260|NCT01251367|20588262|P1|Cycle 3|Overall Study||224
8352261|NCT01251367|20588262|P1|Cycle 2|Overall Study||297
8352262|NCT01251367|20588262|P1|Cycle 1|Overall Study||345
8352263|NCT01251367|20588262|P1|STARTED|Overall Study||345
8352264|NCT01251354|20588297|P1|NOT COMPLETED|Overall Study||6
8352265|NCT01251354|20588297|P1|COMPLETED|Overall Study||0
8352266|NCT01251354|20588297|P1|STARTED|Overall Study||6
8352267|NCT01251315|20588313|P6|NOT COMPLETED|Overall Study||0
8352268|NCT01251315|20588314|P5|NOT COMPLETED|Overall Study||0
8352269|NCT01251315|20588315|P4|NOT COMPLETED|Overall Study||0
8352270|NCT01251315|20588316|P3|NOT COMPLETED|Overall Study||0
8352271|NCT01251315|20588317|P2|NOT COMPLETED|Overall Study||0
8352272|NCT01251315|20588318|P1|NOT COMPLETED|Overall Study||0
8352273|NCT01251315|20588313|P6|COMPLETED|Overall Study||4
8352274|NCT01251315|20588314|P5|COMPLETED|Overall Study||4
8352275|NCT01251315|20588315|P4|COMPLETED|Overall Study||4
8352276|NCT01251315|20588316|P3|COMPLETED|Overall Study||4
8352277|NCT01251315|20588317|P2|COMPLETED|Overall Study||4
8352278|NCT01251315|20588318|P1|COMPLETED|Overall Study||4
8352279|NCT01251315|20588313|P6|STARTED|Overall Study||4
8352280|NCT01251315|20588314|P5|STARTED|Overall Study||4
8352281|NCT01251315|20588315|P4|STARTED|Overall Study||4
8352282|NCT01251315|20588316|P3|STARTED|Overall Study||4
8352283|NCT01251315|20588317|P2|STARTED|Overall Study||4
8352284|NCT01251315|20588318|P1|STARTED|Overall Study||4
8352285|NCT01251276|20588340|P2|NOT COMPLETED|Overall Study||1
8352286|NCT01251276|20588341|P1|NOT COMPLETED|Overall Study||1
8352287|NCT01251276|20588340|P2|COMPLETED|Overall Study||107
8352288|NCT01251276|20588341|P1|COMPLETED|Overall Study||95
8352289|NCT01251276|20588340|P2|Vaccinated|Overall Study||108
8352290|NCT01251276|20588341|P1|Vaccinated|Overall Study||96
8352291|NCT01251276|20588340|P2|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
8352292|NCT01251276|20588341|P1|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
8352293|NCT01251146|20588359|P2|NOT COMPLETED|Overall Study||10
8352294|NCT01251146|20588360|P1|NOT COMPLETED|Overall Study||3
8352295|NCT01251146|20588359|P2|COMPLETED|Overall Study||81
8352296|NCT01251146|20588360|P1|COMPLETED|Overall Study||83
8352297|NCT01251146|20588359|P2|STARTED|Overall Study||91
8352298|NCT01251146|20588360|P1|STARTED|Overall Study||86
8352299|NCT01251120|20588382|P2|NOT COMPLETED|Overall Study||1
8352300|NCT01251120|20588383|P1|NOT COMPLETED|Overall Study||0
8352301|NCT01251120|20588382|P2|COMPLETED|Overall Study||0
8352302|NCT01251120|20588383|P1|COMPLETED|Overall Study||1
8352303|NCT01251120|20588382|P2|STARTED|Overall Study||1
8352304|NCT01251120|20588383|P1|STARTED|Overall Study||1
8352305|NCT01251042|20588405|P2|NOT COMPLETED|Overall Study||0
8352306|NCT01251042|20588406|P1|NOT COMPLETED|Overall Study||0
8352307|NCT01251042|20588405|P2|COMPLETED|Overall Study||23
8352308|NCT01251042|20588406|P1|COMPLETED|Overall Study||26
8352309|NCT01251042|20588405|P2|STARTED|Overall Study||23
8352310|NCT01251042|20588406|P1|STARTED|Overall Study||26
8352311|NCT01250990|20588438|P2|NOT COMPLETED|Overall Study||2
8352312|NCT01250990|20588439|P1|NOT COMPLETED|Overall Study||4
8352313|NCT01250990|20588438|P2|COMPLETED|Overall Study||9
8352314|NCT01250990|20588439|P1|COMPLETED|Overall Study||7
8352315|NCT01250990|20588438|P2|STARTED|Overall Study||11
8352316|NCT01250990|20588439|P1|STARTED|Overall Study||11
8352317|NCT01250977|20588447|P2|NOT COMPLETED|Overall Study||2
8352318|NCT01250977|20588448|P1|NOT COMPLETED|Overall Study||0
8352319|NCT01250977|20588447|P2|COMPLETED|Overall Study||12
8352320|NCT01250977|20588448|P1|COMPLETED|Overall Study||6
8352321|NCT01250977|20588447|P2|STARTED|Overall Study||14
8352322|NCT01250977|20588448|P1|STARTED|Overall Study||6
8352323|NCT01250925|20588463|P3|NOT COMPLETED|Overall Study||2
8352324|NCT01250925|20588464|P2|NOT COMPLETED|Overall Study||3
8352325|NCT01250925|20588465|P1|NOT COMPLETED|Overall Study||5
8352326|NCT01250925|20588463|P3|COMPLETED|Overall Study||30
8352327|NCT01250925|20588464|P2|COMPLETED|Overall Study||28
8352328|NCT01250925|20588465|P1|COMPLETED|Overall Study||26
8352329|NCT01250925|20588463|P3|STARTED|Overall Study||32
8352330|NCT01250925|20588464|P2|STARTED|Overall Study||31
8352331|NCT01250925|20588465|P1|STARTED|Overall Study||31
8352335|NCT01250899|20588512|P2|NOT COMPLETED|Overall Study||0
8352336|NCT01250899|20588513|P1|NOT COMPLETED|Overall Study||0
8352337|NCT01250899|20588512|P2|COMPLETED|Overall Study||82
8352338|NCT01250899|20588513|P1|COMPLETED|Overall Study||40
8352339|NCT01250899|20588512|P2|STARTED|Overall Study||82
8352340|NCT01250899|20588513|P1|STARTED|Overall Study||40
8352341|NCT01250873|20588517|P1|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1
8352342|NCT01250873|20588517|P1|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17
8352343|NCT01250873|20588517|P1|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18
8352344|NCT01250873|20588517|P1|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0
8352345|NCT01250873|20588517|P1|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18
8352346|NCT01250873|20588517|P1|STARTED|Period 2: Sertraline (Day 4, 5-10)||18
8352347|NCT01250873|20588517|P1|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2
8352348|NCT01250873|20588517|P1|COMPLETED|Period 1: LY2216684 (Days 1-3)||18
8352349|NCT01250873|20588517|P1|STARTED|Period 1: LY2216684 (Days 1-3)||20
8352350|NCT01250834|20588528|P1|NOT COMPLETED|Overall Study||0
8352351|NCT01250834|20588528|P1|COMPLETED|Overall Study||27
8352352|NCT01250834|20588528|P1|STARTED|Overall Study||27
8352353|NCT01250769|20588549|P4|NOT COMPLETED|Overall Study||0
8352354|NCT01250769|20588550|P3|NOT COMPLETED|Overall Study||2
8352355|NCT01250769|20588551|P2|NOT COMPLETED|Overall Study||1
8352356|NCT01250769|20588552|P1|NOT COMPLETED|Overall Study||0
8352357|NCT01250769|20588549|P4|COMPLETED|Overall Study||11
8352358|NCT01250769|20588550|P3|COMPLETED|Overall Study||73
8352359|NCT01250769|20588551|P2|COMPLETED|Overall Study||72
8352360|NCT01250769|20588552|P1|COMPLETED|Overall Study||11
8352361|NCT01250769|20588549|P4|Day 14|Overall Study||11
8352362|NCT01250769|20588550|P3|Day 14|Overall Study||74
8352363|NCT01250769|20588551|P2|Day 14|Overall Study||72
8352364|NCT01250769|20588552|P1|Day 14|Overall Study||11
8352365|NCT01250769|20588549|P4|STARTED|Overall Study||11
8352366|NCT01250769|20588550|P3|STARTED|Overall Study||75
8352367|NCT01250769|20588551|P2|STARTED|Overall Study||73
8352368|NCT01250769|20588552|P1|STARTED|Overall Study||11
8352369|NCT01250756|20588584|P2|NOT COMPLETED|After Toddler Dose||1
8352370|NCT01250756|20588585|P1|NOT COMPLETED|After Toddler Dose||0
8352371|NCT01250756|20588584|P2|COMPLETED|After Toddler Dose||147
8352372|NCT01250756|20588585|P1|COMPLETED|After Toddler Dose||0
8352373|NCT01250756|20588584|P2|STARTED|After Toddler Dose||148
8352374|NCT01250756|20588585|P1|STARTED|After Toddler Dose||0
8352375|NCT01250756|20588584|P2|NOT COMPLETED|Toddler Dose||1
8352376|NCT01250756|20588585|P1|NOT COMPLETED|Toddler Dose||0
8352377|NCT01250756|20588584|P2|COMPLETED|Toddler Dose||148
8352378|NCT01250756|20588585|P1|COMPLETED|Toddler Dose||122
8352379|NCT01250756|20588584|P2|STARTED|Toddler Dose||149
8352380|NCT01250756|20588585|P1|STARTED|Toddler Dose||122
8352381|NCT01250756|20588584|P2|NOT COMPLETED|After Infant Series||4
8352382|NCT01250756|20588585|P1|NOT COMPLETED|After Infant Series||11
8352383|NCT01250756|20588584|P2|COMPLETED|After Infant Series||149
8352384|NCT01250756|20588585|P1|COMPLETED|After Infant Series||122
8352385|NCT01250756|20588584|P2|STARTED|After Infant Series||153
8352386|NCT01250756|20588585|P1|STARTED|After Infant Series||133
8352387|NCT01250756|20588584|P2|NOT COMPLETED|Infant Series||7
8352388|NCT01250756|20588585|P1|NOT COMPLETED|Infant Series||28
8352389|NCT01250756|20588584|P2|COMPLETED|Infant Series||153
8352390|NCT01250756|20588585|P1|COMPLETED|Infant Series||133
8352391|NCT01250756|20588584|P2|Vaccinated Dose 3|Infant Series||155
8352392|NCT01250756|20588585|P1|Vaccinated Dose 3|Infant Series||133
8352393|NCT01250756|20588584|P2|Vaccinated Dose 2|Infant Series||157
8352394|NCT01250756|20588585|P1|Vaccinated Dose 2|Infant Series||147
8352395|NCT01250756|20588584|P2|Vaccinated Dose 1|Infant Series||158
8352396|NCT01250756|20588585|P1|Vaccinated Dose 1|Infant Series||159
8352397|NCT01250756|20588584|P2|STARTED|Infant Series||160
8352398|NCT01250756|20588585|P1|STARTED|Infant Series||161
8352399|NCT01250730|20588638|P3|NOT COMPLETED|Overall Study||0
8352400|NCT01250730|20588639|P2|NOT COMPLETED|Overall Study||0
8352401|NCT01250730|20588640|P1|NOT COMPLETED|Overall Study||0
8352402|NCT01250730|20588638|P3|COMPLETED|Overall Study||6
8352403|NCT01250730|20588639|P2|COMPLETED|Overall Study||6
8352404|NCT01250730|20588640|P1|COMPLETED|Overall Study||6
8352405|NCT01250730|20588638|P3|STARTED|Overall Study||6
8352406|NCT01250730|20588639|P2|STARTED|Overall Study||6
8352407|NCT01250730|20588640|P1|STARTED|Overall Study||6
8352408|NCT01250717|20588696|P1|NOT COMPLETED|Overall Study||0
8352409|NCT01250717|20588696|P1|COMPLETED|Overall Study||28
8352410|NCT01250717|20588696|P1|STARTED|Overall Study||28
8352411|NCT01250509|20588702|P2|NOT COMPLETED|Overall Study||2
8352412|NCT01250509|20588703|P1|NOT COMPLETED|Overall Study||5
8352413|NCT01250509|20588702|P2|COMPLETED|Overall Study||21
8352414|NCT01250509|20588703|P1|COMPLETED|Overall Study||19
8352415|NCT01250509|20588702|P2|STARTED|Overall Study||23
8352416|NCT01250509|20588703|P1|STARTED|Overall Study||24
8352417|NCT01250418|20588717|P2|NOT COMPLETED|Overall Study||1
8352418|NCT01250418|20588718|P1|NOT COMPLETED|Overall Study||1
8352419|NCT01250418|20588717|P2|COMPLETED|Overall Study||15
8352420|NCT01250418|20588718|P1|COMPLETED|Overall Study||8
8352421|NCT01250418|20588717|P2|STARTED|Overall Study||16
8352422|NCT01250418|20588718|P1|STARTED|Overall Study||9
8352423|NCT01250379|20588726|P2|NOT COMPLETED|Overall Study||193
8352424|NCT01250379|20588727|P1|NOT COMPLETED|Overall Study||202
8352425|NCT01250379|20588726|P2|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
8352426|NCT01250379|20588727|P1|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
8352427|NCT01250379|20588726|P2|STARTED|Overall Study||247
8352428|NCT01250379|20588727|P1|STARTED|Overall Study||247
8352429|NCT01250210|20588788|P3|NOT COMPLETED|Overall Study||8
8352430|NCT01250210|20588789|P2|NOT COMPLETED|Overall Study||4
8352431|NCT01250210|20588790|P1|NOT COMPLETED|Overall Study||4
8352432|NCT01250210|20588788|P3|COMPLETED|Overall Study||25
8352433|NCT01250210|20588789|P2|COMPLETED|Overall Study||41
8352434|NCT01250210|20588790|P1|COMPLETED|Overall Study||41
8352435|NCT01250210|20588788|P3|STARTED|Overall Study||33
8352436|NCT01250210|20588789|P2|STARTED|Overall Study||45
8352437|NCT01250210|20588790|P1|STARTED|Overall Study||45
8352438|NCT01250184|20588804|P3|NOT COMPLETED|Overall Study||0
8352439|NCT01250184|20588805|P2|NOT COMPLETED|Overall Study||0
8352440|NCT01250184|20588806|P1|NOT COMPLETED|Overall Study||0
8352441|NCT01250184|20588804|P3|COMPLETED|Overall Study||43
8352442|NCT01250184|20588805|P2|COMPLETED|Overall Study||41
8352443|NCT01250184|20588806|P1|COMPLETED|Overall Study||43
8352444|NCT01250184|20588804|P3|STARTED|Overall Study||43
8352445|NCT01250184|20588805|P2|STARTED|Overall Study||41
8352446|NCT01250184|20588806|P1|STARTED|Overall Study||43
8352447|NCT01250171|20588832|P3|NOT COMPLETED|Overall Study||0
8352448|NCT01250171|20588833|P2|NOT COMPLETED|Overall Study||0
8352449|NCT01250171|20588834|P1|NOT COMPLETED|Overall Study||1
8352450|NCT01250171|20588832|P3|COMPLETED|Overall Study||24
8352451|NCT01250171|20588833|P2|COMPLETED|Overall Study||22
8352452|NCT01250171|20588834|P1|COMPLETED|Overall Study||25
8352453|NCT01250171|20588832|P3|STARTED|Overall Study||24
8352454|NCT01250171|20588833|P2|STARTED|Overall Study||22
8352455|NCT01250171|20588834|P1|STARTED|Overall Study||26
8352456|NCT01250145|20588865|P2|NOT COMPLETED|Overall Study||5
8352457|NCT01250145|20588866|P1|NOT COMPLETED|Overall Study||2
8352458|NCT01250145|20588865|P2|COMPLETED|Overall Study||205
8352459|NCT01250145|20588866|P1|COMPLETED|Overall Study||39
8352460|NCT01250145|20588865|P2|STARTED|Overall Study||210
8352461|NCT01250145|20588866|P1|STARTED|Overall Study||41
8352462|NCT01250119|20588886|P2|NOT COMPLETED|Treatment Phase||41
8352463|NCT01250119|20588887|P1|NOT COMPLETED|Treatment Phase||0
8352464|NCT01250119|20588886|P2|COMPLETED|Treatment Phase||0
8352465|NCT01250119|20588887|P1|COMPLETED|Treatment Phase||0
8352466|NCT01250119|20588886|P2|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
8352467|NCT01250119|20588887|P1|STARTED|Treatment Phase||0
8352468|NCT01250119|20588886|P2|NOT COMPLETED|Diagnostic Phase||0
8352469|NCT01250119|20588887|P1|NOT COMPLETED|Diagnostic Phase||113
8352470|NCT01250119|20588886|P2|COMPLETED|Diagnostic Phase||0
8352471|NCT01250119|20588887|P1|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
8352472|NCT01250119|20588886|P2|STARTED|Diagnostic Phase||0
8352473|NCT01250119|20588887|P1|STARTED|Diagnostic Phase||688
8352474|NCT01250054|20588902|P2|NOT COMPLETED|Period 2, One Week of Wear||0
8352475|NCT01250054|20588903|P1|NOT COMPLETED|Period 2, One Week of Wear||1
8352476|NCT01250054|20588902|P2|COMPLETED|Period 2, One Week of Wear||8
8352477|NCT01250054|20588903|P1|COMPLETED|Period 2, One Week of Wear||6
8352478|NCT01250054|20588902|P2|STARTED|Period 2, One Week of Wear||8
8352479|NCT01250054|20588903|P1|STARTED|Period 2, One Week of Wear||7
8352480|NCT01250054|20588902|P2|NOT COMPLETED|Period 1, One Week of Wear||0
8352481|NCT01250054|20588903|P1|NOT COMPLETED|Period 1, One Week of Wear||0
8352482|NCT01250054|20588902|P2|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
8352483|NCT01250054|20588903|P1|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
8352484|NCT01250054|20588902|P2|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
8352485|NCT01250054|20588903|P1|STARTED|Period 1, One Week of Wear||8
8352486|NCT01250002|20588911|P2|NOT COMPLETED|Overall Study||3
8352487|NCT01250002|20588912|P1|NOT COMPLETED|Overall Study||4
8352488|NCT01250002|20588911|P2|COMPLETED|Overall Study||32
8352489|NCT01250002|20588912|P1|COMPLETED|Overall Study||31
8352490|NCT01250002|20588911|P2|STARTED|Overall Study||35
8352491|NCT01250002|20588912|P1|STARTED|Overall Study||35
8352492|NCT01249872|20588926|P6|NOT COMPLETED|Overall Study||0
8352493|NCT01249872|20588927|P5|NOT COMPLETED|Overall Study||0
8352494|NCT01249872|20588928|P4|NOT COMPLETED|Overall Study||0
8352495|NCT01249872|20588929|P3|NOT COMPLETED|Overall Study||0
8352496|NCT01249872|20588930|P2|NOT COMPLETED|Overall Study||0
8352497|NCT01249872|20588931|P1|NOT COMPLETED|Overall Study||0
8352498|NCT01249872|20588926|P6|COMPLETED|Overall Study||16
8352499|NCT01249872|20588927|P5|COMPLETED|Overall Study||16
8352500|NCT01249872|20588928|P4|COMPLETED|Overall Study||16
8352501|NCT01249872|20588929|P3|COMPLETED|Overall Study||16
8352502|NCT01249872|20588930|P2|COMPLETED|Overall Study||16
8352503|NCT01249872|20588931|P1|COMPLETED|Overall Study||16
8352504|NCT01249872|20588926|P6|STARTED|Overall Study||16
8352505|NCT01249872|20588927|P5|STARTED|Overall Study||16
8352506|NCT01249872|20588928|P4|STARTED|Overall Study||16
8352507|NCT01249872|20588929|P3|STARTED|Overall Study||16
8352508|NCT01249872|20588930|P2|STARTED|Overall Study||16
8352509|NCT01249872|20588931|P1|STARTED|Overall Study||16
8352510|NCT01249833|20588977|P2|NOT COMPLETED|Overall Study||1
8352511|NCT01249833|20588978|P1|NOT COMPLETED|Overall Study||0
8352512|NCT01249833|20588977|P2|COMPLETED|Overall Study||62
8352513|NCT01249833|20588978|P1|COMPLETED|Overall Study||59
8352514|NCT01249833|20588977|P2|STARTED|Overall Study||63
8352515|NCT01249833|20588978|P1|STARTED|Overall Study||59
8352516|NCT01249664|20588992|P2|NOT COMPLETED|Overall Study||0
8352517|NCT01249664|20588993|P1|NOT COMPLETED|Overall Study||6
8352518|NCT01249664|20588992|P2|COMPLETED|Overall Study|Completers of study visits up to week 48|31
8352519|NCT01249664|20588993|P1|COMPLETED|Overall Study|Completers of study visits up to week 48|85
8352520|NCT01249664|20588992|P2|Completed 48 Weeks Treatment|Overall Study||24
8352521|NCT01249664|20588993|P1|Completed 48 Weeks Treatment|Overall Study||78
8352522|NCT01249664|20588992|P2|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
8352523|NCT01249664|20588993|P1|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
8352524|NCT01249664|20588992|P2|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
8352611|NCT01249131|20589238|P6|NOT COMPLETED|Washout Period of 10 Days||0
8352525|NCT01249664|20588993|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
8352526|NCT01249664|20588992|P2|Participants Received Treatment|Overall Study|Safety population|31
8352527|NCT01249664|20588993|P1|Participants Received Treatment|Overall Study|Safety population|91
8352528|NCT01249664|20588992|P2|STARTED|Overall Study||31
8352529|NCT01249664|20588993|P1|STARTED|Overall Study||91
8352530|NCT01249651|20589043|P1|NOT COMPLETED|Overall Study||7
8352531|NCT01249651|20589043|P1|COMPLETED|Overall Study|Completed the 8-week treatment period|94
8352532|NCT01249651|20589043|P1|STARTED|Overall Study|Enrolled|101
8352533|NCT01249625|20589052|P2|NOT COMPLETED|Overall Study||0
8352534|NCT01249625|20589053|P1|NOT COMPLETED|Overall Study||0
8352535|NCT01249625|20589052|P2|COMPLETED|Overall Study||1488
8352536|NCT01249625|20589053|P1|COMPLETED|Overall Study||1374
8352537|NCT01249625|20589052|P2|STARTED|Overall Study||1488
8352538|NCT01249625|20589053|P1|STARTED|Overall Study||1374
8352539|NCT01249417|20589072|P3|NOT COMPLETED|Treatment Phase - ITT Population||4
8352540|NCT01249417|20589073|P2|NOT COMPLETED|Treatment Phase - ITT Population||4
8352541|NCT01249417|20589074|P1|NOT COMPLETED|Treatment Phase - ITT Population||1
8352542|NCT01249417|20589072|P3|COMPLETED|Treatment Phase - ITT Population||73
8352543|NCT01249417|20589073|P2|COMPLETED|Treatment Phase - ITT Population||75
8352544|NCT01249417|20589074|P1|COMPLETED|Treatment Phase - ITT Population||78
8352545|NCT01249417|20589072|P3|STARTED|Treatment Phase - ITT Population||77
8352546|NCT01249417|20589073|P2|STARTED|Treatment Phase - ITT Population||79
8352547|NCT01249417|20589074|P1|STARTED|Treatment Phase - ITT Population||79
8352548|NCT01249417|20589072|P3|NOT COMPLETED|Randomised Population||4
8352549|NCT01249417|20589073|P2|NOT COMPLETED|Randomised Population||1
8352550|NCT01249417|20589074|P1|NOT COMPLETED|Randomised Population||1
8352551|NCT01249417|20589072|P3|COMPLETED|Randomised Population||77
8352552|NCT01249417|20589073|P2|COMPLETED|Randomised Population||79
8352553|NCT01249417|20589074|P1|COMPLETED|Randomised Population||79
8352554|NCT01249417|20589072|P3|Treated|Randomised Population||79
8352555|NCT01249417|20589073|P2|Treated|Randomised Population||80
8352556|NCT01249417|20589074|P1|Treated|Randomised Population||80
8352557|NCT01249417|20589072|P3|STARTED|Randomised Population||81
8352558|NCT01249417|20589073|P2|STARTED|Randomised Population||80
8352559|NCT01249417|20589074|P1|STARTED|Randomised Population||80
8352560|NCT01249404|20589091|P3|NOT COMPLETED|Overall Study||7
8352561|NCT01249404|20589092|P2|NOT COMPLETED|Overall Study||8
8352562|NCT01249404|20589093|P1|NOT COMPLETED|Overall Study||7
8352563|NCT01249404|20589091|P3|COMPLETED|Overall Study||125
8352564|NCT01249404|20589092|P2|COMPLETED|Overall Study||121
8352565|NCT01249404|20589093|P1|COMPLETED|Overall Study||120
8352566|NCT01249404|20589091|P3|STARTED|Overall Study||132
8352567|NCT01249404|20589092|P2|STARTED|Overall Study||129
8352568|NCT01249404|20589093|P1|STARTED|Overall Study||127
8352569|NCT01249365|20589170|P1|NOT COMPLETED|Overall Study||1
8352570|NCT01249365|20589170|P1|COMPLETED|Overall Study||198
8352571|NCT01249365|20589170|P1|STARTED|Overall Study||199
8352572|NCT01249274|20589178|P2|NOT COMPLETED|Overall Study||6
8352573|NCT01249274|20589179|P1|NOT COMPLETED|Overall Study||4
8352574|NCT01249274|20589178|P2|COMPLETED|Overall Study||19
8352575|NCT01249274|20589179|P1|COMPLETED|Overall Study||21
8352576|NCT01249274|20589178|P2|Completed Post Trial Visit But Not tx|Overall Study||2
8352577|NCT01249274|20589179|P1|Completed Post Trial Visit But Not tx|Overall Study||1
8352578|NCT01249274|20589178|P2|Completed Treatment & Post Trial Visit|Overall Study||17
8352579|NCT01249274|20589179|P1|Completed Treatment & Post Trial Visit|Overall Study||20
8352580|NCT01249274|20589178|P2|Completed Treatment|Overall Study||19
8352581|NCT01249274|20589179|P1|Completed Treatment|Overall Study||21
8352582|NCT01249274|20589178|P2|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
8352583|NCT01249274|20589179|P1|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
8352584|NCT01249261|20589205|P2|NOT COMPLETED|Overall Study||0
8352585|NCT01249261|20589206|P1|NOT COMPLETED|Overall Study||1
8352586|NCT01249261|20589205|P2|COMPLETED|Overall Study||31
8352587|NCT01249261|20589206|P1|COMPLETED|Overall Study||29
8352588|NCT01249261|20589205|P2|STARTED|Overall Study||31
8352589|NCT01249261|20589206|P1|STARTED|Overall Study||30
8352590|NCT01249157|20589234|P1|NOT COMPLETED|Overall Study||1
8352591|NCT01249157|20589234|P1|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
8352592|NCT01249157|20589234|P1|STARTED|Overall Study||1
8352593|NCT01249131|20589238|P6|NOT COMPLETED|Third Intervention||0
8352594|NCT01249131|20589239|P5|NOT COMPLETED|Third Intervention||0
8352595|NCT01249131|20589240|P4|NOT COMPLETED|Third Intervention||0
8352596|NCT01249131|20589241|P3|NOT COMPLETED|Third Intervention||0
8352597|NCT01249131|20589242|P2|NOT COMPLETED|Third Intervention||0
8352598|NCT01249131|20589243|P1|NOT COMPLETED|Third Intervention||0
8352599|NCT01249131|20589238|P6|COMPLETED|Third Intervention||4
8352600|NCT01249131|20589239|P5|COMPLETED|Third Intervention||2
8352601|NCT01249131|20589240|P4|COMPLETED|Third Intervention||3
8352602|NCT01249131|20589241|P3|COMPLETED|Third Intervention||4
8352603|NCT01249131|20589242|P2|COMPLETED|Third Intervention||3
8352604|NCT01249131|20589243|P1|COMPLETED|Third Intervention||3
8352605|NCT01249131|20589238|P6|STARTED|Third Intervention||4
8352606|NCT01249131|20589239|P5|STARTED|Third Intervention||2
8352607|NCT01249131|20589240|P4|STARTED|Third Intervention||3
8352608|NCT01249131|20589241|P3|STARTED|Third Intervention||4
8352609|NCT01249131|20589242|P2|STARTED|Third Intervention||3
8352610|NCT01249131|20589243|P1|STARTED|Third Intervention||3
8352612|NCT01249131|20589239|P5|NOT COMPLETED|Washout Period of 10 Days||0
8352613|NCT01249131|20589240|P4|NOT COMPLETED|Washout Period of 10 Days||0
8352614|NCT01249131|20589241|P3|NOT COMPLETED|Washout Period of 10 Days||0
8352615|NCT01249131|20589242|P2|NOT COMPLETED|Washout Period of 10 Days||0
8352616|NCT01249131|20589243|P1|NOT COMPLETED|Washout Period of 10 Days||0
8352617|NCT01249131|20589238|P6|COMPLETED|Washout Period of 10 Days||4
8352618|NCT01249131|20589239|P5|COMPLETED|Washout Period of 10 Days||2
8352619|NCT01249131|20589240|P4|COMPLETED|Washout Period of 10 Days||3
8352620|NCT01249131|20589241|P3|COMPLETED|Washout Period of 10 Days||4
8352621|NCT01249131|20589242|P2|COMPLETED|Washout Period of 10 Days||3
8352622|NCT01249131|20589243|P1|COMPLETED|Washout Period of 10 Days||3
8352623|NCT01249131|20589238|P6|STARTED|Washout Period of 10 Days||4
8352624|NCT01249131|20589239|P5|STARTED|Washout Period of 10 Days||2
8352625|NCT01249131|20589240|P4|STARTED|Washout Period of 10 Days||3
8352626|NCT01249131|20589241|P3|STARTED|Washout Period of 10 Days||4
8352627|NCT01249131|20589242|P2|STARTED|Washout Period of 10 Days||3
8352628|NCT01249131|20589243|P1|STARTED|Washout Period of 10 Days||3
8352629|NCT01249131|20589238|P6|NOT COMPLETED|Second Intervention||0
8352630|NCT01249131|20589239|P5|NOT COMPLETED|Second Intervention||0
8352631|NCT01249131|20589240|P4|NOT COMPLETED|Second Intervention||0
8352632|NCT01249131|20589241|P3|NOT COMPLETED|Second Intervention||0
8352633|NCT01249131|20589242|P2|NOT COMPLETED|Second Intervention||0
8352634|NCT01249131|20589243|P1|NOT COMPLETED|Second Intervention||0
8352635|NCT01249131|20589238|P6|COMPLETED|Second Intervention||4
8352636|NCT01249131|20589239|P5|COMPLETED|Second Intervention||2
8352637|NCT01249131|20589240|P4|COMPLETED|Second Intervention||3
8352638|NCT01249131|20589241|P3|COMPLETED|Second Intervention||4
8352639|NCT01249131|20589242|P2|COMPLETED|Second Intervention||3
8352640|NCT01249131|20589243|P1|COMPLETED|Second Intervention||3
8352641|NCT01249131|20589238|P6|STARTED|Second Intervention||4
8352642|NCT01249131|20589239|P5|STARTED|Second Intervention||2
8352643|NCT01249131|20589240|P4|STARTED|Second Intervention||3
8352644|NCT01249131|20589241|P3|STARTED|Second Intervention||4
8352645|NCT01249131|20589242|P2|STARTED|Second Intervention||3
8352646|NCT01249131|20589243|P1|STARTED|Second Intervention||3
8352647|NCT01249131|20589238|P6|NOT COMPLETED|Washout Period of 10 Days||0
8352648|NCT01249131|20589239|P5|NOT COMPLETED|Washout Period of 10 Days||1
8352649|NCT01249131|20589240|P4|NOT COMPLETED|Washout Period of 10 Days||0
8352650|NCT01249131|20589241|P3|NOT COMPLETED|Washout Period of 10 Days||0
8352651|NCT01249131|20589242|P2|NOT COMPLETED|Washout Period of 10 Days||0
8352652|NCT01249131|20589243|P1|NOT COMPLETED|Washout Period of 10 Days||0
8352653|NCT01249131|20589238|P6|COMPLETED|Washout Period of 10 Days||4
8352654|NCT01249131|20589239|P5|COMPLETED|Washout Period of 10 Days||2
8352655|NCT01249131|20589240|P4|COMPLETED|Washout Period of 10 Days||3
8352656|NCT01249131|20589241|P3|COMPLETED|Washout Period of 10 Days||4
8352657|NCT01249131|20589242|P2|COMPLETED|Washout Period of 10 Days||3
8352658|NCT01249131|20589243|P1|COMPLETED|Washout Period of 10 Days||3
8352659|NCT01249131|20589238|P6|STARTED|Washout Period of 10 Days||4
8352660|NCT01249131|20589239|P5|STARTED|Washout Period of 10 Days||3
8352661|NCT01249131|20589240|P4|STARTED|Washout Period of 10 Days||3
8352662|NCT01249131|20589241|P3|STARTED|Washout Period of 10 Days||4
8352663|NCT01249131|20589242|P2|STARTED|Washout Period of 10 Days||3
8352664|NCT01249131|20589243|P1|STARTED|Washout Period of 10 Days||3
8352665|NCT01249131|20589238|P6|NOT COMPLETED|First Intervention||0
8352666|NCT01249131|20589239|P5|NOT COMPLETED|First Intervention||0
8352667|NCT01249131|20589240|P4|NOT COMPLETED|First Intervention||0
8352668|NCT01249131|20589241|P3|NOT COMPLETED|First Intervention||0
8352669|NCT01249131|20589242|P2|NOT COMPLETED|First Intervention||0
8352670|NCT01249131|20589243|P1|NOT COMPLETED|First Intervention||0
8352671|NCT01249131|20589238|P6|COMPLETED|First Intervention||4
8352672|NCT01249131|20589239|P5|COMPLETED|First Intervention||3
8352673|NCT01249131|20589240|P4|COMPLETED|First Intervention||3
8352674|NCT01249131|20589241|P3|COMPLETED|First Intervention||4
8352675|NCT01249131|20589242|P2|COMPLETED|First Intervention||3
8352676|NCT01249131|20589243|P1|COMPLETED|First Intervention||3
8352677|NCT01249131|20589238|P6|STARTED|First Intervention||4
8352678|NCT01249131|20589239|P5|STARTED|First Intervention||3
8352679|NCT01249131|20589240|P4|STARTED|First Intervention||3
8352680|NCT01249131|20589241|P3|STARTED|First Intervention||4
8352681|NCT01249131|20589242|P2|STARTED|First Intervention||3
8352682|NCT01249131|20589243|P1|STARTED|First Intervention||3
8352683|NCT01249118|20589263|P3|NOT COMPLETED|Second Washout Period||0
8352684|NCT01249118|20589264|P2|NOT COMPLETED|Second Washout Period||0
8352685|NCT01249118|20589265|P1|NOT COMPLETED|Second Washout Period||0
8352686|NCT01249118|20589263|P3|COMPLETED|Second Washout Period||5
8352687|NCT01249118|20589264|P2|COMPLETED|Second Washout Period||5
8352688|NCT01249118|20589265|P1|COMPLETED|Second Washout Period||2
8352689|NCT01249118|20589263|P3|STARTED|Second Washout Period||5
8352690|NCT01249118|20589264|P2|STARTED|Second Washout Period||5
8352691|NCT01249118|20589265|P1|STARTED|Second Washout Period||2
8352692|NCT01249118|20589263|P3|NOT COMPLETED|Second Intervention Period||0
8352693|NCT01249118|20589264|P2|NOT COMPLETED|Second Intervention Period||0
8352694|NCT01249118|20589265|P1|NOT COMPLETED|Second Intervention Period||0
8352695|NCT01249118|20589263|P3|COMPLETED|Second Intervention Period||5
8352696|NCT01249118|20589264|P2|COMPLETED|Second Intervention Period||5
8352697|NCT01249118|20589265|P1|COMPLETED|Second Intervention Period||2
8352698|NCT01249118|20589263|P3|STARTED|Second Intervention Period||5
8352699|NCT01249118|20589264|P2|STARTED|Second Intervention Period||5
8352700|NCT01249118|20589265|P1|STARTED|Second Intervention Period||2
8352701|NCT01249118|20589263|P3|NOT COMPLETED|First Washout Period||0
8352702|NCT01249118|20589264|P2|NOT COMPLETED|First Washout Period||1
8352703|NCT01249118|20589265|P1|NOT COMPLETED|First Washout Period||0
8352704|NCT01249118|20589263|P3|COMPLETED|First Washout Period||5
8352705|NCT01249118|20589264|P2|COMPLETED|First Washout Period||5
8352706|NCT01249118|20589265|P1|COMPLETED|First Washout Period||2
8352707|NCT01249118|20589263|P3|STARTED|First Washout Period||5
8352708|NCT01249118|20589264|P2|STARTED|First Washout Period||6
8352709|NCT01249118|20589265|P1|STARTED|First Washout Period||2
8352710|NCT01249118|20589263|P3|NOT COMPLETED|First Intervention Period||0
8352711|NCT01249118|20589264|P2|NOT COMPLETED|First Intervention Period||0
8352712|NCT01249118|20589265|P1|NOT COMPLETED|First Intervention Period||0
8352713|NCT01249118|20589263|P3|COMPLETED|First Intervention Period||5
8352714|NCT01249118|20589264|P2|COMPLETED|First Intervention Period||6
8352715|NCT01249118|20589265|P1|COMPLETED|First Intervention Period||2
8352716|NCT01249118|20589263|P3|STARTED|First Intervention Period||5
8352717|NCT01249118|20589264|P2|STARTED|First Intervention Period||6
8352718|NCT01249118|20589265|P1|STARTED|First Intervention Period||2
8352719|NCT01249092|20589299|P1|NOT COMPLETED|Overall Study||2
8352720|NCT01249092|20589299|P1|COMPLETED|Overall Study||18
8352721|NCT01249092|20589299|P1|STARTED|Overall Study||20
8352722|NCT01249027|20589305|P1|NOT COMPLETED|5 Years Clinical Follow up||68
8352723|NCT01249027|20589305|P1|COMPLETED|5 Years Clinical Follow up||2142
8352724|NCT01249027|20589305|P1|STARTED|5 Years Clinical Follow up||2210
8352725|NCT01249027|20589305|P1|NOT COMPLETED|4 Years Clinical Follow up||13
8352726|NCT01249027|20589305|P1|COMPLETED|4 Years Clinical Follow up||2210
8352727|NCT01249027|20589305|P1|STARTED|4 Years Clinical Follow up||2223
8352728|NCT01249027|20589305|P1|NOT COMPLETED|3 Years Clinical Follow up||31
8352729|NCT01249027|20589305|P1|COMPLETED|3 Years Clinical Follow up||2223
8352730|NCT01249027|20589305|P1|STARTED|3 Years Clinical Follow up||2254
8352731|NCT01249027|20589305|P1|NOT COMPLETED|2 Years Clinical Follow up||137
8352732|NCT01249027|20589305|P1|COMPLETED|2 Years Clinical Follow up||2254
8352733|NCT01249027|20589305|P1|STARTED|2 Years Clinical Follow up||2391
8352734|NCT01249027|20589305|P1|NOT COMPLETED|1 Year Clinical Follow up||91
8352735|NCT01249027|20589305|P1|COMPLETED|1 Year Clinical Follow up||2391
8352736|NCT01249027|20589305|P1|STARTED|1 Year Clinical Follow up||2482
8352737|NCT01248962|20589376|P2|NOT COMPLETED|Overall Study||16
8352738|NCT01248962|20589377|P1|NOT COMPLETED|Overall Study||16
8352739|NCT01248962|20589376|P2|COMPLETED|Overall Study||56
8352740|NCT01248962|20589377|P1|COMPLETED|Overall Study||58
8352741|NCT01248962|20589376|P2|STARTED|Overall Study||72
8352742|NCT01248962|20589377|P1|STARTED|Overall Study||74
8352743|NCT01248949|20589393|P5|NOT COMPLETED|Overall Study||4
8352744|NCT01248949|20589394|P4|NOT COMPLETED|Overall Study||10
8352745|NCT01248949|20589395|P3|NOT COMPLETED|Overall Study||37
8352746|NCT01248949|20589396|P2|NOT COMPLETED|Overall Study||13
8352747|NCT01248949|20589397|P1|NOT COMPLETED|Overall Study||33
8352748|NCT01248949|20589393|P5|COMPLETED|Overall Study||3
8352749|NCT01248949|20589394|P4|COMPLETED|Overall Study||3
8352750|NCT01248949|20589395|P3|COMPLETED|Overall Study||1
8352751|NCT01248949|20589396|P2|COMPLETED|Overall Study||3
8352752|NCT01248949|20589397|P1|COMPLETED|Overall Study||9
8352753|NCT01248949|20589393|P5|STARTED|Overall Study||7
8352754|NCT01248949|20589394|P4|STARTED|Overall Study||13
8352755|NCT01248949|20589395|P3|STARTED|Overall Study||38
8352756|NCT01248949|20589396|P2|STARTED|Overall Study||16
8352757|NCT01248949|20589397|P1|STARTED|Overall Study||42
8352758|NCT01248936|20589509|P1|NOT COMPLETED|Overall Study||374
8352759|NCT01248936|20589509|P1|COMPLETED|Overall Study||0
8352760|NCT01248936|20589509|P1|STARTED|Overall Study||374
8352761|NCT01248884|20589522|P3|NOT COMPLETED|Overall Study||1
8352762|NCT01248884|20589523|P2|NOT COMPLETED|Overall Study||3
8352763|NCT01248884|20589524|P1|NOT COMPLETED|Overall Study||2
8352764|NCT01248884|20589522|P3|COMPLETED|Overall Study||238
8352765|NCT01248884|20589523|P2|COMPLETED|Overall Study||239
8352766|NCT01248884|20589524|P1|COMPLETED|Overall Study||238
8352767|NCT01248884|20589522|P3|STARTED|Overall Study||239
8352768|NCT01248884|20589523|P2|STARTED|Overall Study||242
8352769|NCT01248884|20589524|P1|STARTED|Overall Study||240
8352770|NCT01248793|20589582|P2|NOT COMPLETED|Overall Study||6
8352771|NCT01248793|20589583|P1|NOT COMPLETED|Overall Study||4
8352772|NCT01248793|20589582|P2|COMPLETED|Overall Study||102
8352773|NCT01248793|20589583|P1|COMPLETED|Overall Study||101
8352774|NCT01248793|20589582|P2|STARTED|Overall Study||108
8352775|NCT01248793|20589583|P1|STARTED|Overall Study||105
8352776|NCT01248780|20589597|P2|NOT COMPLETED|Overall Study||15
8352777|NCT01248780|20589598|P1|NOT COMPLETED|Overall Study||9
8352778|NCT01248780|20589597|P2|COMPLETED|Overall Study||117
8352779|NCT01248780|20589598|P1|COMPLETED|Overall Study||123
8352780|NCT01248780|20589597|P2|STARTED|Overall Study||132
8352781|NCT01248780|20589598|P1|STARTED|Overall Study||132
8352782|NCT01248741|20589610|P1|NOT COMPLETED|Overall Study||0
8352783|NCT01248741|20589610|P1|COMPLETED|Overall Study||20
8352784|NCT01248741|20589610|P1|STARTED|Overall Study||20
8352785|NCT01248728|20589616|P2|NOT COMPLETED|Overall Study||2
8352786|NCT01248728|20589617|P1|NOT COMPLETED|Overall Study||4
8352787|NCT01248728|20589616|P2|COMPLETED|Overall Study||17
8352788|NCT01248728|20589617|P1|COMPLETED|Overall Study||15
8352789|NCT01248728|20589616|P2|STARTED|Overall Study||19
8352790|NCT01248728|20589617|P1|STARTED|Overall Study||19
8352791|NCT01248715|20589633|P2|NOT COMPLETED|Overall Study||510
8352792|NCT01248715|20589634|P1|NOT COMPLETED|Overall Study||501
8352793|NCT01248715|20589633|P2|COMPLETED|Overall Study||41
8352794|NCT01248715|20589634|P1|COMPLETED|Overall Study||55
8352795|NCT01248715|20589633|P2|STARTED|Overall Study||551
8352796|NCT01248715|20589634|P1|STARTED|Overall Study||556
8352797|NCT01248585|20589654|P2|NOT COMPLETED|Overall Study||0
8352798|NCT01248585|20589655|P1|NOT COMPLETED|Overall Study||0
8352799|NCT01248585|20589654|P2|COMPLETED|Overall Study||150
8352800|NCT01248585|20589655|P1|COMPLETED|Overall Study||148
8352801|NCT01248585|20589654|P2|STARTED|Overall Study||150
8352802|NCT01248585|20589655|P1|STARTED|Overall Study||148
8352803|NCT01248468|20589672|P3|NOT COMPLETED|Overall Study||4
8352804|NCT01248468|20589673|P2|NOT COMPLETED|Overall Study||14
8352805|NCT01248468|20589674|P1|NOT COMPLETED|Overall Study||15
8352806|NCT01248468|20589672|P3|COMPLETED|Overall Study||145
8352807|NCT01248468|20589673|P2|COMPLETED|Overall Study||290
8352808|NCT01248468|20589674|P1|COMPLETED|Overall Study||284
8352809|NCT01248468|20589672|P3|ITT Population|Overall Study||125
8352810|NCT01248468|20589673|P2|ITT Population|Overall Study||261
8352811|NCT01248468|20589674|P1|ITT Population|Overall Study||256
8352812|NCT01248468|20589672|P3|Safety Population|Overall Study||133
8352813|NCT01248468|20589673|P2|Safety Population|Overall Study||271
8352814|NCT01248468|20589674|P1|Safety Population|Overall Study||266
8352815|NCT01248468|20589672|P3|STARTED|Overall Study||149
8352816|NCT01248468|20589673|P2|STARTED|Overall Study||304
8352817|NCT01248468|20589674|P1|STARTED|Overall Study||299
8352818|NCT01248455|20589691|P1|NOT COMPLETED|Overall Study||1
8352819|NCT01248455|20589691|P1|COMPLETED|Overall Study||8
8352820|NCT01248455|20589691|P1|STARTED|Overall Study||9
8352821|NCT01248416|20589699|P3|NOT COMPLETED|Overall Study||1
8352822|NCT01248416|20589700|P2|NOT COMPLETED|Overall Study||0
8352823|NCT01248416|20589701|P1|NOT COMPLETED|Overall Study||4
8352824|NCT01248416|20589699|P3|COMPLETED|Overall Study||25
8352825|NCT01248416|20589700|P2|COMPLETED|Overall Study||25
8352826|NCT01248416|20589701|P1|COMPLETED|Overall Study||21
8352827|NCT01248416|20589699|P3|STARTED|Overall Study||26
8352828|NCT01248416|20589700|P2|STARTED|Overall Study||25
8352829|NCT01248416|20589701|P1|STARTED|Overall Study||25
8352830|NCT01248364|20589736|P4|NOT COMPLETED|Overall Study||0
8352831|NCT01248364|20589737|P3|NOT COMPLETED|Overall Study||0
8352832|NCT01248364|20589738|P2|NOT COMPLETED|Overall Study||1
8352833|NCT01248364|20589739|P1|NOT COMPLETED|Overall Study||0
8352834|NCT01248364|20589736|P4|COMPLETED|Overall Study||12
8352835|NCT01248364|20589737|P3|COMPLETED|Overall Study||13
8352836|NCT01248364|20589738|P2|COMPLETED|Overall Study||33
8352837|NCT01248364|20589739|P1|COMPLETED|Overall Study||32
8352838|NCT01248364|20589736|P4|Completed Chronic Phase:28-day Treatment|Overall Study||0
8352839|NCT01248364|20589737|P3|Completed Chronic Phase:28-day Treatment|Overall Study||13
8352840|NCT01248364|20589738|P2|Completed Chronic Phase:28-day Treatment|Overall Study||33
8352841|NCT01248364|20589739|P1|Completed Chronic Phase:28-day Treatment|Overall Study||32
8352842|NCT01248364|20589736|P4|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
8352843|NCT01248364|20589737|P3|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
8352844|NCT01248364|20589738|P2|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
8352845|NCT01248364|20589739|P1|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
8352846|NCT01248364|20589736|P4|STARTED|Overall Study||12
8352847|NCT01248364|20589737|P3|STARTED|Overall Study||13
8352848|NCT01248364|20589738|P2|STARTED|Overall Study||34
8352849|NCT01248364|20589739|P1|STARTED|Overall Study||32
8352850|NCT01248221|20589787|P2|NOT COMPLETED|Overall Study||0
8352851|NCT01248221|20589788|P1|NOT COMPLETED|Overall Study||0
8352852|NCT01248221|20589787|P2|COMPLETED|Overall Study||15
8352853|NCT01248221|20589788|P1|COMPLETED|Overall Study||15
8352854|NCT01248221|20589787|P2|STARTED|Overall Study||15
8352855|NCT01248221|20589788|P1|STARTED|Overall Study||15
8352856|NCT01248130|20589802|P2|NOT COMPLETED|Overall Study||0
8352857|NCT01248130|20589803|P1|NOT COMPLETED|Overall Study||2
8352858|NCT01248130|20589802|P2|COMPLETED|Overall Study||4
8352859|NCT01248130|20589803|P1|COMPLETED|Overall Study||1
8352860|NCT01248130|20589802|P2|STARTED|Overall Study||4
8352861|NCT01248130|20589803|P1|STARTED|Overall Study||3
8352862|NCT01248104|20589813|P2|NOT COMPLETED|Overall Study||8
8352863|NCT01248104|20589814|P1|NOT COMPLETED|Overall Study||10
8352864|NCT01248104|20589813|P2|COMPLETED|Overall Study||42
8352865|NCT01248104|20589814|P1|COMPLETED|Overall Study||40
8352866|NCT01248104|20589813|P2|STARTED|Overall Study||50
8352867|NCT01248104|20589814|P1|STARTED|Overall Study||50
8352868|NCT01248065|20589822|P2|NOT COMPLETED|Overall Study||22
8352869|NCT01248065|20589823|P1|NOT COMPLETED|Overall Study||26
8352870|NCT01248065|20589822|P2|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
8352871|NCT01248065|20589823|P1|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
8352872|NCT01248065|20589822|P2|STARTED|Overall Study||201
8352873|NCT01248065|20589823|P1|STARTED|Overall Study||207
8352874|NCT01248013|20589833|P1|NOT COMPLETED|Overall Study||14
8352875|NCT01248013|20589833|P1|COMPLETED|Overall Study||75
8352876|NCT01248013|20589833|P1|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
8352877|NCT01248013|20589833|P1|STARTED|Overall Study||89
8352878|NCT01247974|20589839|P2|NOT COMPLETED|Overall Study||19
8352879|NCT01247974|20589840|P1|NOT COMPLETED|Overall Study||26
8352880|NCT01247974|20589839|P2|COMPLETED|Overall Study||203
8352881|NCT01247974|20589840|P1|COMPLETED|Overall Study||191
8352882|NCT01247974|20589839|P2|STARTED|Overall Study||222
8352883|NCT01247974|20589840|P1|STARTED|Overall Study||217
8352884|NCT01247922|20589848|P1|NOT COMPLETED|Overall Study||4
8352885|NCT01247922|20589848|P1|COMPLETED|Overall Study||0
8352886|NCT01247922|20589848|P1|Treated|Overall Study||4
8352887|NCT01247922|20589848|P1|STARTED|Overall Study||4
8352888|NCT01247675|20589858|P4|NOT COMPLETED|Overall Study||0
8352889|NCT01247675|20589859|P3|NOT COMPLETED|Overall Study||0
8352890|NCT01247675|20589860|P2|NOT COMPLETED|Overall Study||2
8352891|NCT01247675|20589861|P1|NOT COMPLETED|Overall Study||2
8352892|NCT01247675|20589858|P4|COMPLETED|Overall Study||8
8352893|NCT01247675|20589859|P3|COMPLETED|Overall Study||9
8352894|NCT01247675|20589860|P2|COMPLETED|Overall Study||8
8352895|NCT01247675|20589861|P1|COMPLETED|Overall Study||8
8352896|NCT01247675|20589858|P4|STARTED|Overall Study||8
8352897|NCT01247675|20589859|P3|STARTED|Overall Study||9
8352898|NCT01247675|20589860|P2|STARTED|Overall Study||10
8352899|NCT01247675|20589861|P1|STARTED|Overall Study||10
8352900|NCT01247571|20589883|P1|NOT COMPLETED|Overall Study||3
8352901|NCT01247571|20589883|P1|COMPLETED|Overall Study||19
8352902|NCT01247571|20589883|P1|STARTED|Overall Study||22
8352903|NCT01247428|20589891|P1|NOT COMPLETED|Overall Study||0
8352904|NCT01247428|20589891|P1|COMPLETED|Overall Study||30
8352905|NCT01247428|20589891|P1|STARTED|Overall Study||30
8352906|NCT01247363|20589912|P1|NOT COMPLETED|Overall Study||0
8352907|NCT01247363|20589912|P1|COMPLETED|Overall Study||20
8352908|NCT01247363|20589912|P1|STARTED|Overall Study||20
8352909|NCT01247350|20589946|P5|NOT COMPLETED|Overall Study||1
8352910|NCT01247350|20589947|P4|NOT COMPLETED|Overall Study||1
8352911|NCT01247350|20589948|P3|NOT COMPLETED|Overall Study||1
8352912|NCT01247350|20589949|P2|NOT COMPLETED|Overall Study||0
8352913|NCT01247350|20589950|P1|NOT COMPLETED|Overall Study||0
8352914|NCT01247350|20589946|P5|COMPLETED|Overall Study||8
8352915|NCT01247350|20589947|P4|COMPLETED|Overall Study||6
8352916|NCT01247350|20589948|P3|COMPLETED|Overall Study||5
8352917|NCT01247350|20589949|P2|COMPLETED|Overall Study||6
8352918|NCT01247350|20589950|P1|COMPLETED|Overall Study||6
8352919|NCT01247350|20589946|P5|Received Multiple Doses of Study Drug|Overall Study||5
8352920|NCT01247350|20589947|P4|Received Multiple Doses of Study Drug|Overall Study||6
8352921|NCT01247350|20589948|P3|Received Multiple Doses of Study Drug|Overall Study||6
8352922|NCT01247350|20589949|P2|Received Multiple Doses of Study Drug|Overall Study||0
8352923|NCT01247350|20589950|P1|Received Multiple Doses of Study Drug|Overall Study||0
8352924|NCT01247350|20589946|P5|STARTED|Overall Study||9
8352925|NCT01247350|20589947|P4|STARTED|Overall Study||7
8352926|NCT01247350|20589948|P3|STARTED|Overall Study||6
8352927|NCT01247350|20589949|P2|STARTED|Overall Study||6
8352928|NCT01247350|20589950|P1|STARTED|Overall Study||6
8352929|NCT01247324|20590008|P2|NOT COMPLETED|Overall Study||44
8352930|NCT01247324|20590009|P1|NOT COMPLETED|Overall Study||71
8352931|NCT01247324|20590008|P2|COMPLETED|Overall Study||366
8352932|NCT01247324|20590009|P1|COMPLETED|Overall Study||340
8352933|NCT01247324|20590008|P2|STARTED|Overall Study||410
8352934|NCT01247324|20590009|P1|STARTED|Overall Study||411
8352935|NCT01247298|20590040|P1|NOT COMPLETED|Overall Study||0
8352936|NCT01247298|20590040|P1|COMPLETED|Overall Study||17
8352937|NCT01247298|20590040|P1|STARTED|Overall Study||17
8352938|NCT01247285|20590050|P2|NOT COMPLETED|Second Intervention||0
8352939|NCT01247285|20590051|P1|NOT COMPLETED|Second Intervention||0
8352940|NCT01247285|20590050|P2|COMPLETED|Second Intervention||13
8352941|NCT01247285|20590051|P1|COMPLETED|Second Intervention||13
8352942|NCT01247285|20590050|P2|STARTED|Second Intervention||13
8352943|NCT01247285|20590051|P1|STARTED|Second Intervention||13
8352944|NCT01247285|20590050|P2|NOT COMPLETED|Washout of 28 Days||0
8352945|NCT01247285|20590051|P1|NOT COMPLETED|Washout of 28 Days||0
8352946|NCT01247285|20590050|P2|COMPLETED|Washout of 28 Days||13
8352947|NCT01247285|20590051|P1|COMPLETED|Washout of 28 Days||13
8352948|NCT01247285|20590050|P2|STARTED|Washout of 28 Days||13
8352949|NCT01247285|20590051|P1|STARTED|Washout of 28 Days||13
8352950|NCT01247285|20590050|P2|NOT COMPLETED|First Intervention||0
8352951|NCT01247285|20590051|P1|NOT COMPLETED|First Intervention||0
8352952|NCT01247285|20590050|P2|COMPLETED|First Intervention||13
8352953|NCT01247285|20590051|P1|COMPLETED|First Intervention||13
8352954|NCT01247285|20590050|P2|STARTED|First Intervention||13
8352955|NCT01247285|20590051|P1|STARTED|First Intervention||13
8352956|NCT01247272|20590069|P2|NOT COMPLETED|Second Intervention||0
8352957|NCT01247272|20590070|P1|NOT COMPLETED|Second Intervention||0
8352958|NCT01247272|20590069|P2|COMPLETED|Second Intervention||13
8352959|NCT01247272|20590070|P1|COMPLETED|Second Intervention||13
8352960|NCT01247272|20590069|P2|STARTED|Second Intervention||13
8352961|NCT01247272|20590070|P1|STARTED|Second Intervention||13
8352962|NCT01247272|20590069|P2|NOT COMPLETED|Washout of 28 Days||0
8352963|NCT01247272|20590070|P1|NOT COMPLETED|Washout of 28 Days||0
8352964|NCT01247272|20590069|P2|COMPLETED|Washout of 28 Days||13
8352965|NCT01247272|20590070|P1|COMPLETED|Washout of 28 Days||13
8352966|NCT01247272|20590069|P2|STARTED|Washout of 28 Days||13
8352967|NCT01247272|20590070|P1|STARTED|Washout of 28 Days||13
8352968|NCT01247272|20590069|P2|NOT COMPLETED|First Intervention||0
8352969|NCT01247272|20590070|P1|NOT COMPLETED|First Intervention||0
8352970|NCT01247272|20590069|P2|COMPLETED|First Intervention||13
8352971|NCT01247272|20590070|P1|COMPLETED|First Intervention||13
8352972|NCT01247272|20590069|P2|STARTED|First Intervention||13
8352973|NCT01247272|20590070|P1|STARTED|First Intervention||13
8352974|NCT01247220|20590088|P2|NOT COMPLETED|Overall Study||0
8352975|NCT01247220|20590089|P1|NOT COMPLETED|Overall Study||0
8352976|NCT01247220|20590088|P2|COMPLETED|Overall Study||6
8352977|NCT01247220|20590089|P1|COMPLETED|Overall Study||6
8352978|NCT01247220|20590088|P2|STARTED|Overall Study||6
8352979|NCT01247220|20590089|P1|STARTED|Overall Study||6
8352980|NCT01247090|20590102|P3|NOT COMPLETED|Overall Study||0
8352981|NCT01247090|20590103|P2|NOT COMPLETED|Overall Study||1
8352982|NCT01247090|20590104|P1|NOT COMPLETED|Overall Study||1
8352983|NCT01247090|20590102|P3|COMPLETED|Overall Study||4
8352984|NCT01247090|20590103|P2|COMPLETED|Overall Study||3
8352985|NCT01247090|20590104|P1|COMPLETED|Overall Study||3
8352986|NCT01247090|20590102|P3|STARTED|Overall Study||4
8352987|NCT01247090|20590103|P2|STARTED|Overall Study||4
8352988|NCT01247090|20590104|P1|STARTED|Overall Study||4
8352989|NCT01247064|20590114|P2|NOT COMPLETED|Overall Study||0
8352990|NCT01247064|20590115|P1|NOT COMPLETED|Overall Study||0
8352991|NCT01247064|20590114|P2|COMPLETED|Overall Study||31
8352992|NCT01247064|20590115|P1|COMPLETED|Overall Study||31
8352993|NCT01247064|20590114|P2|STARTED|Overall Study||31
8352994|NCT01247064|20590115|P1|STARTED|Overall Study||31
8352995|NCT01246999|20590133|P4|NOT COMPLETED|Overall Study||2
8352996|NCT01246999|20590134|P3|NOT COMPLETED|Overall Study||0
8352997|NCT01246999|20590135|P2|NOT COMPLETED|Overall Study||1
8352998|NCT01246999|20590136|P1|NOT COMPLETED|Overall Study||0
8352999|NCT01246999|20590133|P4|COMPLETED|Overall Study||15
8353000|NCT01246999|20590134|P3|COMPLETED|Overall Study||2
8353001|NCT01246999|20590135|P2|COMPLETED|Overall Study||3
8353002|NCT01246999|20590136|P1|COMPLETED|Overall Study||11
8353003|NCT01246999|20590133|P4|STARTED|Overall Study||17
8353004|NCT01246999|20590134|P3|STARTED|Overall Study||2
8353005|NCT01246999|20590135|P2|STARTED|Overall Study||4
8353006|NCT01246999|20590136|P1|STARTED|Overall Study||11
8353007|NCT01246986|20590176|P7|NOT COMPLETED|Overall Study||0
8353008|NCT01246986|20590177|P6|NOT COMPLETED|Overall Study||1
8353009|NCT01246986|20590178|P5|NOT COMPLETED|Overall Study||4
8353010|NCT01246986|20590179|P4|NOT COMPLETED|Overall Study||0
8353011|NCT01246986|20590180|P3|NOT COMPLETED|Overall Study||6
8353012|NCT01246986|20590181|P2|NOT COMPLETED|Overall Study||5
8353013|NCT01246986|20590182|P1|NOT COMPLETED|Overall Study||3
8353014|NCT01246986|20590176|P7|COMPLETED|Overall Study||5
8353015|NCT01246986|20590177|P6|COMPLETED|Overall Study||2
8353016|NCT01246986|20590178|P5|COMPLETED|Overall Study||40
8353017|NCT01246986|20590179|P4|COMPLETED|Overall Study||3
8353018|NCT01246986|20590180|P3|COMPLETED|Overall Study||34
8353019|NCT01246986|20590181|P2|COMPLETED|Overall Study||67
8353020|NCT01246986|20590182|P1|COMPLETED|Overall Study||34
8353021|NCT01246986|20590176|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
8353022|NCT01246986|20590177|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
8353023|NCT01246986|20590178|P5|Received at Least 1 Dose of Study Drug|Overall Study||44
8353024|NCT01246986|20590179|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8353025|NCT01246986|20590180|P3|Received at Least 1 Dose of Study Drug|Overall Study||40
8353026|NCT01246986|20590181|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
8353027|NCT01246986|20590182|P1|Received at Least 1 Dose of Study Drug|Overall Study||37
8353028|NCT01246986|20590176|P7|STARTED|Overall Study||5
8353029|NCT01246986|20590177|P6|STARTED|Overall Study||3
8353030|NCT01246986|20590178|P5|STARTED|Overall Study||44
8353031|NCT01246986|20590179|P4|STARTED|Overall Study||3
8353032|NCT01246986|20590180|P3|STARTED|Overall Study||40
8353033|NCT01246986|20590181|P2|STARTED|Overall Study||72
8353034|NCT01246986|20590182|P1|STARTED|Overall Study||37
8353035|NCT01246973|20590242|P2|NOT COMPLETED|Overall Study||47
8353036|NCT01246973|20590243|P1|NOT COMPLETED|Overall Study||61
8353037|NCT01246973|20590242|P2|COMPLETED|Overall Study||295
8353038|NCT01246973|20590243|P1|COMPLETED|Overall Study||283
8353039|NCT01246973|20590242|P2|STARTED|Overall Study||342
8353040|NCT01246973|20590243|P1|STARTED|Overall Study||344
8353041|NCT01246960|20590253|P2|NOT COMPLETED|Overall Study||4
8353042|NCT01246960|20590254|P1|NOT COMPLETED|Overall Study||6
8353043|NCT01246960|20590253|P2|COMPLETED|Overall Study||80
8353044|NCT01246960|20590254|P1|COMPLETED|Overall Study||78
8353045|NCT01246960|20590253|P2|Received Any Quantity of Study Drug|Overall Study||80
8353046|NCT01246960|20590254|P1|Received Any Quantity of Study Drug|Overall Study||82
8353047|NCT01246960|20590253|P2|STARTED|Overall Study||84
8353048|NCT01246960|20590254|P1|STARTED|Overall Study||84
8353049|NCT01246895|20590274|P2|NOT COMPLETED|Overall Study||4
8353050|NCT01246895|20590275|P1|NOT COMPLETED|Overall Study||3
8353051|NCT01246895|20590274|P2|COMPLETED|Overall Study||26
8353052|NCT01246895|20590275|P1|COMPLETED|Overall Study||34
8353053|NCT01246895|20590274|P2|STARTED|Overall Study||30
8353054|NCT01246895|20590275|P1|STARTED|Overall Study||37
8353055|NCT01246791|20590289|P1|NOT COMPLETED|Overall Study||0
8353056|NCT01246791|20590289|P1|COMPLETED|Overall Study||12
8353057|NCT01246791|20590289|P1|STARTED|Overall Study||12
8353058|NCT01246713|20590304|P2|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
8353059|NCT01246713|20590305|P1|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
8353060|NCT01246713|20590304|P2|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
8353061|NCT01246713|20590305|P1|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
8353062|NCT01246713|20590304|P2|STARTED|Second Acetaminophen Dosing (1 Day)||9
8353063|NCT01246713|20590305|P1|STARTED|Second Acetaminophen Dosing (1 Day)||6
8353064|NCT01246713|20590304|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
8353065|NCT01246713|20590305|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
8353066|NCT01246713|20590304|P2|COMPLETED|Washout (at Least 14 Days)||9
8353067|NCT01246713|20590305|P1|COMPLETED|Washout (at Least 14 Days)||6
8353068|NCT01246713|20590304|P2|STARTED|Washout (at Least 14 Days)||9
8353069|NCT01246713|20590305|P1|STARTED|Washout (at Least 14 Days)||6
8353070|NCT01246713|20590304|P2|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
8353071|NCT01246713|20590305|P1|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
8353072|NCT01246713|20590304|P2|COMPLETED|First Acetaminophen Dosing (1 Day)||9
8353073|NCT01246713|20590305|P1|COMPLETED|First Acetaminophen Dosing (1 Day)||6
8353074|NCT01246713|20590304|P2|STARTED|First Acetaminophen Dosing (1 Day)||9
8353075|NCT01246713|20590305|P1|STARTED|First Acetaminophen Dosing (1 Day)||6
8353076|NCT01246583|20590315|P4|NOT COMPLETED|Overall Study||1
8353077|NCT01246583|20590316|P3|NOT COMPLETED|Overall Study||1
8353078|NCT01246583|20590317|P2|NOT COMPLETED|Overall Study||0
8353079|NCT01246583|20590318|P1|NOT COMPLETED|Overall Study||1
8353080|NCT01246583|20590315|P4|COMPLETED|Overall Study||9
8353081|NCT01246583|20590316|P3|COMPLETED|Overall Study||24
8353082|NCT01246583|20590317|P2|COMPLETED|Overall Study||13
8353083|NCT01246583|20590318|P1|COMPLETED|Overall Study||22
8353084|NCT01246583|20590315|P4|STARTED|Overall Study||10
8353085|NCT01246583|20590316|P3|STARTED|Overall Study||25
8353086|NCT01246583|20590317|P2|STARTED|Overall Study||13
8353087|NCT01246583|20590318|P1|STARTED|Overall Study||23
8353088|NCT01246479|20590402|P1|NOT COMPLETED|Overall Study||5
8353089|NCT01246479|20590402|P1|COMPLETED|Overall Study|primary endpoint at Month 12|18
8353090|NCT01246479|20590402|P1|STARTED|Overall Study||23
8353091|NCT01246401|20590412|P2|NOT COMPLETED|Overall Study||0
8353092|NCT01246401|20590413|P1|NOT COMPLETED|Overall Study||0
8353093|NCT01246401|20590412|P2|COMPLETED|Overall Study||27
8353094|NCT01246401|20590413|P1|COMPLETED|Overall Study||66
8353095|NCT01246401|20590412|P2|STARTED|Overall Study||27
8353096|NCT01246401|20590413|P1|STARTED|Overall Study||66
8353097|NCT01246349|20590439|P2|NOT COMPLETED|Overall Study||0
8353098|NCT01246349|20590440|P1|NOT COMPLETED|Overall Study||0
8353099|NCT01246349|20590439|P2|COMPLETED|Overall Study||20
8353100|NCT01246349|20590440|P1|COMPLETED|Overall Study||20
8353101|NCT01246349|20590439|P2|STARTED|Overall Study||20
8353102|NCT01246349|20590440|P1|STARTED|Overall Study||20
8353103|NCT01246258|20590452|P1|NOT COMPLETED|Overall Study||0
8353104|NCT01246258|20590452|P1|COMPLETED|Overall Study||5
8353105|NCT01246258|20590452|P1|STARTED|Overall Study||5
8353106|NCT01246206|20590457|P1|NOT COMPLETED|Overall Study||1
8353107|NCT01246206|20590457|P1|COMPLETED|Overall Study||20
8353108|NCT01246206|20590457|P1|STARTED|Overall Study||21
8353109|NCT01246076|20590468|P1|NOT COMPLETED|Overall Study||0
8353110|NCT01246076|20590468|P1|COMPLETED|Overall Study||24
8353111|NCT01246076|20590468|P1|STARTED|Overall Study||24
8353112|NCT01246063|20590483|P6|NOT COMPLETED|Overall Study||0
8353113|NCT01246063|20590484|P5|NOT COMPLETED|Overall Study||0
8353114|NCT01246063|20590485|P4|NOT COMPLETED|Overall Study||0
8353115|NCT01246063|20590486|P3|NOT COMPLETED|Overall Study||0
8353116|NCT01246063|20590487|P2|NOT COMPLETED|Overall Study||0
8353117|NCT01246063|20590488|P1|NOT COMPLETED|Overall Study||0
8353118|NCT01246063|20590483|P6|COMPLETED|Overall Study||17
8353119|NCT01246063|20590484|P5|COMPLETED|Overall Study||7
8353120|NCT01246063|20590485|P4|COMPLETED|Overall Study||5
8353121|NCT01246063|20590486|P3|COMPLETED|Overall Study||4
8353122|NCT01246063|20590487|P2|COMPLETED|Overall Study||4
8353123|NCT01246063|20590488|P1|COMPLETED|Overall Study||3
8353124|NCT01246063|20590483|P6|STARTED|Overall Study||17
8353125|NCT01246063|20590484|P5|STARTED|Overall Study||7
8353126|NCT01246063|20590485|P4|STARTED|Overall Study||5
8353127|NCT01246063|20590486|P3|STARTED|Overall Study||4
8353128|NCT01246063|20590487|P2|STARTED|Overall Study||4
8353129|NCT01246063|20590488|P1|STARTED|Overall Study||3
8353130|NCT01246050|20590525|P2|NOT COMPLETED|Overall Study||0
8353131|NCT01246050|20590526|P1|NOT COMPLETED|Overall Study||0
8353132|NCT01246050|20590525|P2|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
8353133|NCT01246050|20590526|P1|COMPLETED|Overall Study||6
8353134|NCT01246050|20590525|P2|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
8353135|NCT01246050|20590526|P1|STARTED|Overall Study||6
8353136|NCT01246011|20590535|P3|NOT COMPLETED|Overall Study||4
8353137|NCT01246011|20590536|P2|NOT COMPLETED|Overall Study||0
8353138|NCT01246011|20590537|P1|NOT COMPLETED|Overall Study||0
8353139|NCT01246011|20590535|P3|COMPLETED|Overall Study||5
8353140|NCT01246011|20590536|P2|COMPLETED|Overall Study||0
8353141|NCT01246011|20590537|P1|COMPLETED|Overall Study||0
8353142|NCT01246011|20590535|P3|STARTED|Overall Study||9
8353143|NCT01246011|20590536|P2|STARTED|Overall Study||0
8353144|NCT01246011|20590537|P1|STARTED|Overall Study||0
8353145|NCT01245972|20590551|P3|NOT COMPLETED|Overall Study||0
8353146|NCT01245972|20590552|P2|NOT COMPLETED|Overall Study||0
8353147|NCT01245972|20590553|P1|NOT COMPLETED|Overall Study||0
8353148|NCT01245972|20590551|P3|COMPLETED|Overall Study||8
8353149|NCT01245972|20590552|P2|COMPLETED|Overall Study||8
8353150|NCT01245972|20590553|P1|COMPLETED|Overall Study||7
8353151|NCT01245972|20590551|P3|STARTED|Overall Study||8
8353152|NCT01245972|20590552|P2|STARTED|Overall Study||8
8353153|NCT01245972|20590553|P1|STARTED|Overall Study||7
8353154|NCT01245764|20590565|P4|NOT COMPLETED|Study Phase B||0
8353155|NCT01245764|20590566|P3|NOT COMPLETED|Study Phase B||0
8353156|NCT01245764|20590567|P2|NOT COMPLETED|Study Phase B||0
8353157|NCT01245764|20590568|P1|NOT COMPLETED|Study Phase B||0
8353158|NCT01245764|20590565|P4|COMPLETED|Study Phase B||17
8353159|NCT01245764|20590566|P3|COMPLETED|Study Phase B||0
8353160|NCT01245764|20590567|P2|COMPLETED|Study Phase B||0
8353161|NCT01245764|20590568|P1|COMPLETED|Study Phase B||0
8353162|NCT01245764|20590565|P4|Completed Vaccinations in Study Phase B|Study Phase B||17
8353163|NCT01245764|20590566|P3|Completed Vaccinations in Study Phase B|Study Phase B||0
8353164|NCT01245764|20590567|P2|Completed Vaccinations in Study Phase B|Study Phase B||0
8353165|NCT01245764|20590568|P1|Completed Vaccinations in Study Phase B|Study Phase B||0
8353166|NCT01245764|20590565|P4|STARTED|Study Phase B||17
8353167|NCT01245764|20590566|P3|STARTED|Study Phase B||0
8353168|NCT01245764|20590567|P2|STARTED|Study Phase B||0
8353169|NCT01245764|20590568|P1|STARTED|Study Phase B||0
8353170|NCT01245764|20590565|P4|NOT COMPLETED|Study Phase A||3
8353171|NCT01245764|20590566|P3|NOT COMPLETED|Study Phase A||10
8353172|NCT01245764|20590567|P2|NOT COMPLETED|Study Phase A||5
8353173|NCT01245764|20590568|P1|NOT COMPLETED|Study Phase A||9
8353174|NCT01245764|20590565|P4|COMPLETED|Study Phase A||17
8353175|NCT01245764|20590566|P3|COMPLETED|Study Phase A||110
8353176|NCT01245764|20590567|P2|COMPLETED|Study Phase A||25
8353177|NCT01245764|20590568|P1|COMPLETED|Study Phase A||71
8353178|NCT01245764|20590565|P4|Completed Vaccinations in Study Phase A|Study Phase A||19
8353179|NCT01245764|20590566|P3|Completed Vaccinations in Study Phase A|Study Phase A||117
8353180|NCT01245764|20590567|P2|Completed Vaccinations in Study Phase A|Study Phase A||28
8353181|NCT01245764|20590568|P1|Completed Vaccinations in Study Phase A|Study Phase A||77
8353182|NCT01245764|20590565|P4|STARTED|Study Phase A||20
8353183|NCT01245764|20590566|P3|STARTED|Study Phase A||120
8353184|NCT01245764|20590567|P2|STARTED|Study Phase A||30
8353185|NCT01245764|20590568|P1|STARTED|Study Phase A||80
8353186|NCT01245751|20590606|P4|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8353187|NCT01245751|20590607|P3|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8353188|NCT01245751|20590608|P2|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8353189|NCT01245751|20590609|P1|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8353190|NCT01245751|20590606|P4|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8353191|NCT01245751|20590607|P3|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
8353192|NCT01245751|20590608|P2|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
8353193|NCT01245751|20590609|P1|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
8353194|NCT01245751|20590606|P4|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
8353195|NCT01245751|20590607|P3|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
8353196|NCT01245751|20590608|P2|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
8353197|NCT01245751|20590609|P1|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
8353198|NCT01245751|20590606|P4|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
8353199|NCT01245751|20590607|P3|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
8353200|NCT01245751|20590608|P2|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
8353201|NCT01245751|20590609|P1|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
8353202|NCT01245751|20590606|P4|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
8353203|NCT01245751|20590607|P3|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
8353204|NCT01245751|20590608|P2|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
8353205|NCT01245751|20590609|P1|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
8353206|NCT01245751|20590606|P4|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
8353207|NCT01245751|20590607|P3|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
8353208|NCT01245751|20590608|P2|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
8353209|NCT01245751|20590609|P1|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
8353210|NCT01245751|20590606|P4|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
8353211|NCT01245751|20590607|P3|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
8353212|NCT01245751|20590608|P2|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
8353213|NCT01245751|20590609|P1|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
8353214|NCT01245738|20590622|P1|NOT COMPLETED|Overall Study||40
8353215|NCT01245738|20590622|P1|COMPLETED|Overall Study||474
8353216|NCT01245738|20590622|P1|STARTED|Overall Study||514
8353217|NCT01245699|20590641|P2|NOT COMPLETED|Overall Study||5
8353218|NCT01245699|20590642|P1|NOT COMPLETED|Overall Study||9
8353219|NCT01245699|20590641|P2|COMPLETED|Overall Study||49
8353220|NCT01245699|20590642|P1|COMPLETED|Overall Study||52
8353221|NCT01245699|20590641|P2|STARTED|Overall Study||54
8353222|NCT01245699|20590642|P1|STARTED|Overall Study||61
8353223|NCT01245673|20590658|P1|NOT COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||0
8353224|NCT01245673|20590658|P1|COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||26
8353225|NCT01245673|20590658|P1|STARTED|Maintenance: MAGE-A3, PVC After T Cells||26
8353226|NCT01245673|20590658|P1|NOT COMPLETED|Start Lenalidomide||0
8353227|NCT01245673|20590658|P1|COMPLETED|Start Lenalidomide||26
8353228|NCT01245673|20590658|P1|STARTED|Start Lenalidomide||26
8353229|NCT01245673|20590658|P1|NOT COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||1
8353230|NCT01245673|20590658|P1|COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||26
8353231|NCT01245673|20590658|P1|STARTED|MAGE-A3, Hiltonol®, PVC After T Cells||27
8353232|NCT01245673|20590658|P1|NOT COMPLETED|Activated/Costimulated Autologous T Cell||0
8353233|NCT01245673|20590658|P1|COMPLETED|Activated/Costimulated Autologous T Cell||27
8353234|NCT01245673|20590658|P1|STARTED|Activated/Costimulated Autologous T Cell||27
8353235|NCT01245673|20590658|P1|NOT COMPLETED|Pre Transplant Vaccinations||0
8353236|NCT01245673|20590658|P1|COMPLETED|Pre Transplant Vaccinations||27
8353237|NCT01245673|20590658|P1|Pre Transplant Vaccinations 1-3|Pre Transplant Vaccinations||27
8353238|NCT01245673|20590658|P1|STARTED|Pre Transplant Vaccinations||27
8353239|NCT01245673|20590658|P1|NOT COMPLETED|Enrollment||1
8353240|NCT01245673|20590658|P1|COMPLETED|Enrollment|One subject failed to meet screening criteria for the trial.|27
8353241|NCT01245673|20590658|P1|STARTED|Enrollment||28
8353242|NCT01245647|20590664|P2|NOT COMPLETED|Overall Study||4
8353243|NCT01245647|20590665|P1|NOT COMPLETED|Overall Study||0
8353244|NCT01245647|20590664|P2|COMPLETED|Overall Study||8
8353245|NCT01245647|20590665|P1|COMPLETED|Overall Study||7
8353246|NCT01245647|20590664|P2|STARTED|Overall Study||12
8353247|NCT01245647|20590665|P1|STARTED|Overall Study||7
8353248|NCT01245595|20590681|P2|NOT COMPLETED|Overall Study||0
8353249|NCT01245595|20590682|P1|NOT COMPLETED|Overall Study||0
8353250|NCT01245595|20590681|P2|COMPLETED|Overall Study||72
8353251|NCT01245595|20590682|P1|COMPLETED|Overall Study||72
8353252|NCT01245595|20590681|P2|Completed Full Course of Study Drug|Overall Study||61
8353253|NCT01245595|20590682|P1|Completed Full Course of Study Drug|Overall Study||57
8353254|NCT01245595|20590681|P2|STARTED|Overall Study||72
8353255|NCT01245595|20590682|P1|STARTED|Overall Study||72
8353256|NCT01245439|20590688|P1|NOT COMPLETED|Overall Study||0
8353257|NCT01245439|20590688|P1|COMPLETED|Overall Study||65
8353258|NCT01245439|20590688|P1|STARTED|Overall Study||65
8353259|NCT01245413|20590719|P2|NOT COMPLETED|Athena First,||0
8353260|NCT01245413|20590720|P1|NOT COMPLETED|Athena First,||0
8353261|NCT01245413|20590719|P2|COMPLETED|Athena First,||16
8353262|NCT01245413|20590720|P1|COMPLETED|Athena First,||16
8353263|NCT01245413|20590719|P2|STARTED|Athena First,||16
8353264|NCT01245413|20590720|P1|STARTED|Athena First,||16
8353265|NCT01245413|20590719|P2|NOT COMPLETED|Sensura First,||0
8353266|NCT01245413|20590720|P1|NOT COMPLETED|Sensura First,||0
8353267|NCT01245413|20590719|P2|COMPLETED|Sensura First,||16
8353268|NCT01245413|20590720|P1|COMPLETED|Sensura First,||16
8353269|NCT01245413|20590719|P2|STARTED|Sensura First,||16
8353270|NCT01245413|20590720|P1|STARTED|Sensura First,||16
8353271|NCT01245387|20590726|P1|NOT COMPLETED|Overall Study||813
8353272|NCT01245387|20590726|P1|COMPLETED|Overall Study||188
8353273|NCT01245387|20590726|P1|STARTED|Overall Study||1001
8353274|NCT01245374|20590775|P1|NOT COMPLETED|Overall Study||4
8353275|NCT01245374|20590775|P1|COMPLETED|Overall Study||99
8353276|NCT01245374|20590775|P1|STARTED|Overall Study||103
8353277|NCT01245283|20590798|P3|NOT COMPLETED|Overall Study||11
8353278|NCT01245283|20590799|P2|NOT COMPLETED|Overall Study||11
8353279|NCT01245283|20590800|P1|NOT COMPLETED|Overall Study||14
8353280|NCT01245283|20590798|P3|COMPLETED|Overall Study||19
8353281|NCT01245283|20590799|P2|COMPLETED|Overall Study||17
8353282|NCT01245283|20590800|P1|COMPLETED|Overall Study||18
8353283|NCT01245283|20590798|P3|STARTED|Overall Study||30
8353284|NCT01245283|20590799|P2|STARTED|Overall Study||28
8353285|NCT01245283|20590800|P1|STARTED|Overall Study||32
8353292|NCT01245140|20590845|P2|NOT COMPLETED|Overall Study||10
8353293|NCT01245140|20590846|P1|NOT COMPLETED|Overall Study||3
8353294|NCT01245140|20590845|P2|COMPLETED|Overall Study||14
8353295|NCT01245140|20590846|P1|COMPLETED|Overall Study||6
8353296|NCT01245140|20590845|P2|STARTED|Overall Study||24
8353297|NCT01245140|20590846|P1|STARTED|Overall Study||9
8353298|NCT01245101|20590902|P2|NOT COMPLETED|Period 3 (Treatment)||0
8353299|NCT01245101|20590903|P1|NOT COMPLETED|Period 3 (Treatment)||1
8353300|NCT01245101|20590902|P2|COMPLETED|Period 3 (Treatment)||0
8353301|NCT01245101|20590903|P1|COMPLETED|Period 3 (Treatment)||11
8353302|NCT01245101|20590902|P2|STARTED|Period 3 (Treatment)||0
8353303|NCT01245101|20590903|P1|STARTED|Period 3 (Treatment)||12
8353304|NCT01245101|20590902|P2|NOT COMPLETED|Period 2 (Washout)||0
8353305|NCT01245101|20590903|P1|NOT COMPLETED|Period 2 (Washout)||1
8353306|NCT01245101|20590902|P2|COMPLETED|Period 2 (Washout)||0
8353307|NCT01245101|20590903|P1|COMPLETED|Period 2 (Washout)||12
8353308|NCT01245101|20590902|P2|STARTED|Period 2 (Washout)||0
8353309|NCT01245101|20590903|P1|STARTED|Period 2 (Washout)||13
8353310|NCT01245101|20590902|P2|NOT COMPLETED|Period 1 (Treatment)||0
8353311|NCT01245101|20590903|P1|NOT COMPLETED|Period 1 (Treatment)||2
8353312|NCT01245101|20590902|P2|COMPLETED|Period 1 (Treatment)||0
8353313|NCT01245101|20590903|P1|COMPLETED|Period 1 (Treatment)||13
8353314|NCT01245101|20590902|P2|STARTED|Period 1 (Treatment)||0
8353315|NCT01245101|20590903|P1|STARTED|Period 1 (Treatment)||15
8353316|NCT01245062|20590913|P3|NOT COMPLETED|Cross-over Phase||17
8353317|NCT01245062|20590914|P2|NOT COMPLETED|Cross-over Phase||0
8353318|NCT01245062|20590915|P1|NOT COMPLETED|Cross-over Phase||0
8353319|NCT01245062|20590913|P3|COMPLETED|Cross-over Phase||53
8353320|NCT01245062|20590914|P2|COMPLETED|Cross-over Phase||0
8353321|NCT01245062|20590915|P1|COMPLETED|Cross-over Phase||0
8353322|NCT01245062|20590913|P3|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
8353323|NCT01245062|20590914|P2|STARTED|Cross-over Phase||0
8353324|NCT01245062|20590915|P1|STARTED|Cross-over Phase||0
8353325|NCT01245062|20590913|P3|NOT COMPLETED|Randomization and Crossover Phase||0
8353326|NCT01245062|20590914|P2|NOT COMPLETED|Randomization and Crossover Phase||31
8353327|NCT01245062|20590915|P1|NOT COMPLETED|Randomization and Crossover Phase||41
8353328|NCT01245062|20590913|P3|COMPLETED|Randomization and Crossover Phase||0
8353329|NCT01245062|20590914|P2|COMPLETED|Randomization and Crossover Phase||77
8353330|NCT01245062|20590915|P1|COMPLETED|Randomization and Crossover Phase||173
8353331|NCT01245062|20590913|P3|STARTED|Randomization and Crossover Phase||0
8353332|NCT01245062|20590914|P2|STARTED|Randomization and Crossover Phase||108
8353333|NCT01245062|20590915|P1|STARTED|Randomization and Crossover Phase||214
8353334|NCT01245049|20590953|P2|NOT COMPLETED|Overall Study||4
8353335|NCT01245049|20590954|P1|NOT COMPLETED|Overall Study||1
8353336|NCT01245049|20590953|P2|COMPLETED|Overall Study||126
8353337|NCT01245049|20590954|P1|COMPLETED|Overall Study||254
8353338|NCT01245049|20590953|P2|STARTED|Overall Study||130
8353339|NCT01245049|20590954|P1|STARTED|Overall Study||255
8353340|NCT01244984|20591007|P3|NOT COMPLETED|Overall Study||4
8353341|NCT01244984|20591008|P2|NOT COMPLETED|Overall Study||14
8353342|NCT01244984|20591009|P1|NOT COMPLETED|Overall Study||5
8353343|NCT01244984|20591007|P3|COMPLETED|Overall Study||86
8353344|NCT01244984|20591008|P2|COMPLETED|Overall Study||79
8353345|NCT01244984|20591009|P1|COMPLETED|Overall Study||55
8353346|NCT01244984|20591007|P3|STARTED|Overall Study||90
8353347|NCT01244984|20591008|P2|STARTED|Overall Study||93
8353348|NCT01244984|20591009|P1|STARTED|Overall Study||60
8353349|NCT01244906|20591083|P1|NOT COMPLETED|Overall Study||8
8353350|NCT01244906|20591083|P1|COMPLETED|Overall Study||18
8353351|NCT01244906|20591083|P1|STARTED|Overall Study||26
8353352|NCT01244893|20591092|P2|NOT COMPLETED|Final Visit||0
8353353|NCT01244893|20591093|P1|NOT COMPLETED|Final Visit||0
8353354|NCT01244893|20591092|P2|COMPLETED|Final Visit||21
8353355|NCT01244893|20591093|P1|COMPLETED|Final Visit||21
8353356|NCT01244893|20591092|P2|STARTED|Final Visit||21
8353357|NCT01244893|20591093|P1|STARTED|Final Visit||21
8353358|NCT01244893|20591092|P2|NOT COMPLETED|1-Week Follow Up||0
8353359|NCT01244893|20591093|P1|NOT COMPLETED|1-Week Follow Up||1
8353360|NCT01244893|20591092|P2|COMPLETED|1-Week Follow Up||21
8353361|NCT01244893|20591093|P1|COMPLETED|1-Week Follow Up||21
8353362|NCT01244893|20591092|P2|STARTED|1-Week Follow Up||21
8353363|NCT01244893|20591093|P1|STARTED|1-Week Follow Up||22
8353364|NCT01244893|20591092|P2|NOT COMPLETED|Baseline||1
8353365|NCT01244893|20591093|P1|NOT COMPLETED|Baseline||0
8353366|NCT01244893|20591092|P2|COMPLETED|Baseline||21
8353367|NCT01244893|20591093|P1|COMPLETED|Baseline||22
8353368|NCT01244893|20591092|P2|STARTED|Baseline||22
8353369|NCT01244893|20591093|P1|STARTED|Baseline||22
8353370|NCT01244828|20591105|P1|NOT COMPLETED|Overall Study||78
8353371|NCT01244828|20591105|P1|COMPLETED|Overall Study||79
8353372|NCT01244828|20591105|P1|STARTED|Overall Study|Received study drug|157
8353373|NCT01244815|20591121|P4|NOT COMPLETED|Overall Study||12
8353374|NCT01244815|20591122|P3|NOT COMPLETED|Overall Study||11
8353375|NCT01244815|20591123|P2|NOT COMPLETED|Overall Study||17
8353376|NCT01244815|20591124|P1|NOT COMPLETED|Overall Study||14
8353377|NCT01244815|20591121|P4|COMPLETED|Overall Study||87
8353378|NCT01244815|20591122|P3|COMPLETED|Overall Study||88
8353379|NCT01244815|20591123|P2|COMPLETED|Overall Study||88
8353380|NCT01244815|20591124|P1|COMPLETED|Overall Study||87
8353381|NCT01244815|20591121|P4|Treated|Overall Study||99
8353382|NCT01244815|20591122|P3|Treated|Overall Study||99
8353383|NCT01244815|20591123|P2|Treated|Overall Study||104
8353384|NCT01244815|20591124|P1|Treated|Overall Study||101
8353385|NCT01244815|20591121|P4|STARTED|Overall Study|Randomized|99
8353386|NCT01244815|20591122|P3|STARTED|Overall Study|Randomized|99
8353387|NCT01244815|20591123|P2|STARTED|Overall Study|Randomized|105
8353388|NCT01244815|20591124|P1|STARTED|Overall Study|Randomized|101
8353389|NCT01244724|20591198|P1|NOT COMPLETED|Overall Study||8
8353390|NCT01244724|20591198|P1|COMPLETED|Overall Study||9
8353391|NCT01244724|20591198|P1|Week 2 Visit|Overall Study||15
8353392|NCT01244724|20591198|P1|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
8353393|NCT01244711|20591203|P1|NOT COMPLETED|Overall Study||0
8353394|NCT01244711|20591203|P1|COMPLETED|Overall Study||1
8353395|NCT01244711|20591203|P1|STARTED|Overall Study||1
8353396|NCT01244633|20591207|P1|NOT COMPLETED|Overall Study||3
8353397|NCT01244633|20591207|P1|COMPLETED|Overall Study||15
8353398|NCT01244633|20591207|P1|STARTED|Overall Study||18
8353399|NCT01244620|20591211|P4|NOT COMPLETED|Overall Study||4
8353400|NCT01244620|20591212|P3|NOT COMPLETED|Overall Study||4
8353401|NCT01244620|20591213|P2|NOT COMPLETED|Overall Study||4
8353402|NCT01244620|20591214|P1|NOT COMPLETED|Overall Study||4
8353403|NCT01244620|20591211|P4|COMPLETED|Overall Study||0
8353404|NCT01244620|20591212|P3|COMPLETED|Overall Study||0
8353405|NCT01244620|20591213|P2|COMPLETED|Overall Study||0
8353406|NCT01244620|20591214|P1|COMPLETED|Overall Study||0
8353407|NCT01244620|20591211|P4|STARTED|Overall Study||4
8353408|NCT01244620|20591212|P3|STARTED|Overall Study||4
8353409|NCT01244620|20591213|P2|STARTED|Overall Study||4
8353410|NCT01244620|20591214|P1|STARTED|Overall Study||4
8353411|NCT01244529|20591248|P1|NOT COMPLETED|Overall Study||0
8353412|NCT01244529|20591248|P1|COMPLETED|Overall Study||41
8353413|NCT01244529|20591248|P1|STARTED|Overall Study||41
8353414|NCT01244516|20591273|P3|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
8353415|NCT01244516|20591274|P2|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
8353416|NCT01244516|20591275|P1|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
8353417|NCT01244516|20591273|P3|COMPLETED|Period 2 (1-week to 2-week Visit)||168
8353418|NCT01244516|20591274|P2|COMPLETED|Period 2 (1-week to 2-week Visit)||170
8353419|NCT01244516|20591275|P1|COMPLETED|Period 2 (1-week to 2-week Visit)||163
8353420|NCT01244516|20591273|P3|STARTED|Period 2 (1-week to 2-week Visit)||170
8353421|NCT01244516|20591274|P2|STARTED|Period 2 (1-week to 2-week Visit)||171
8353422|NCT01244516|20591275|P1|STARTED|Period 2 (1-week to 2-week Visit)||166
8353423|NCT01244516|20591273|P3|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
8353424|NCT01244516|20591274|P2|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
8353425|NCT01244516|20591275|P1|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
8353426|NCT01244516|20591273|P3|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
8353427|NCT01244516|20591274|P2|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
8353428|NCT01244516|20591275|P1|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
8353429|NCT01244516|20591273|P3|STARTED|Period 1 (Baseline to 1-week Visit)||173
8353430|NCT01244516|20591274|P2|STARTED|Period 1 (Baseline to 1-week Visit)||177
8353431|NCT01244516|20591275|P1|STARTED|Period 1 (Baseline to 1-week Visit)||170
8353432|NCT01244503|20591288|P1|NOT COMPLETED|Overall Study||0
8353433|NCT01244503|20591288|P1|COMPLETED|Overall Study||61
8353434|NCT01244503|20591288|P1|STARTED|Overall Study||61
8353444|NCT01244477|20591353|P2|NOT COMPLETED|Overall Study||3
8353445|NCT01244477|20591354|P1|NOT COMPLETED|Overall Study||20
8353446|NCT01244477|20591353|P2|COMPLETED|Overall Study||20
8353447|NCT01244477|20591354|P1|COMPLETED|Overall Study||18
8353448|NCT01244477|20591353|P2|STARTED|Overall Study||23
8353449|NCT01244477|20591354|P1|STARTED|Overall Study||38
8353450|NCT01244451|20591366|P1|NOT COMPLETED|Overall Study||13
8353451|NCT01244451|20591366|P1|COMPLETED|Overall Study||36
8353452|NCT01244451|20591366|P1|STARTED|Overall Study||49
8353453|NCT01244425|20591375|P2|NOT COMPLETED|Overall Study||3
8353454|NCT01244425|20591376|P1|NOT COMPLETED|Overall Study||3
8353455|NCT01244425|20591375|P2|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
8353456|NCT01244425|20591376|P1|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
8353457|NCT01244425|20591375|P2|STARTED|Overall Study||35
8353458|NCT01244425|20591376|P1|STARTED|Overall Study||35
8353459|NCT01244412|20591396|P1|NOT COMPLETED|Overall Study||0
8353460|NCT01244412|20591396|P1|COMPLETED|Overall Study||1
8353461|NCT01244412|20591396|P1|STARTED|Overall Study||1
8353462|NCT01244243|20591400|P1|NOT COMPLETED|Overall Study||0
8353463|NCT01244243|20591400|P1|COMPLETED|Overall Study||41
8353464|NCT01244243|20591400|P1|STARTED|Overall Study||41
8353473|NCT01244126|20591431|P3|NOT COMPLETED|Overall Study||9
8353474|NCT01244126|20591432|P2|NOT COMPLETED|Overall Study||3
8353475|NCT01244126|20591433|P1|NOT COMPLETED|Overall Study||3
8353476|NCT01244126|20591431|P3|COMPLETED|Overall Study||48
8353477|NCT01244126|20591432|P2|COMPLETED|Overall Study||52
8353478|NCT01244126|20591433|P1|COMPLETED|Overall Study||56
8353479|NCT01244126|20591431|P3|STARTED|Overall Study||57
8353480|NCT01244126|20591432|P2|STARTED|Overall Study||55
8353481|NCT01244126|20591433|P1|STARTED|Overall Study||59
8353482|NCT01244061|20591446|P2|NOT COMPLETED|Overall Study||103
8353483|NCT01244061|20591447|P1|NOT COMPLETED|Overall Study||82
8353484|NCT01244061|20591446|P2|COMPLETED|Overall Study||144
8353485|NCT01244061|20591447|P1|COMPLETED|Overall Study||169
8353486|NCT01244061|20591446|P2|STARTED|Overall Study||247
8353487|NCT01244061|20591447|P1|STARTED|Overall Study||251
8353488|NCT01244035|20591459|P6|NOT COMPLETED|Part 1: Period 3||1
8353489|NCT01244035|20591460|P5|NOT COMPLETED|Part 1: Period 3||1
8353490|NCT01244035|20591461|P4|NOT COMPLETED|Part 1: Period 3||0
8353491|NCT01244035|20591462|P3|NOT COMPLETED|Part 1: Period 3||0
8353492|NCT01244035|20591463|P2|NOT COMPLETED|Part 1: Period 3||1
8353493|NCT01244035|20591464|P1|NOT COMPLETED|Part 1: Period 3||0
8353494|NCT01244035|20591459|P6|COMPLETED|Part 1: Period 3||2
8353495|NCT01244035|20591460|P5|COMPLETED|Part 1: Period 3||3
8353496|NCT01244035|20591461|P4|COMPLETED|Part 1: Period 3||5
8353497|NCT01244035|20591462|P3|COMPLETED|Part 1: Period 3||3
8353498|NCT01244035|20591463|P2|COMPLETED|Part 1: Period 3||2
8353499|NCT01244035|20591464|P1|COMPLETED|Part 1: Period 3||4
8353500|NCT01244035|20591459|P6|STARTED|Part 1: Period 3||3
8353501|NCT01244035|20591460|P5|STARTED|Part 1: Period 3||4
8353502|NCT01244035|20591461|P4|STARTED|Part 1: Period 3||5
8353503|NCT01244035|20591462|P3|STARTED|Part 1: Period 3||3
8353504|NCT01244035|20591463|P2|STARTED|Part 1: Period 3||3
8353505|NCT01244035|20591464|P1|STARTED|Part 1: Period 3||4
8353506|NCT01244035|20591459|P6|NOT COMPLETED|Part 1: Period 2||0
8353507|NCT01244035|20591460|P5|NOT COMPLETED|Part 1: Period 2||0
8353508|NCT01244035|20591461|P4|NOT COMPLETED|Part 1: Period 2||0
8353509|NCT01244035|20591462|P3|NOT COMPLETED|Part 1: Period 2||1
8353510|NCT01244035|20591463|P2|NOT COMPLETED|Part 1: Period 2||0
8353511|NCT01244035|20591464|P1|NOT COMPLETED|Part 1: Period 2||0
8353512|NCT01244035|20591459|P6|COMPLETED|Part 1: Period 2||3
8353513|NCT01244035|20591460|P5|COMPLETED|Part 1: Period 2||4
8353514|NCT01244035|20591461|P4|COMPLETED|Part 1: Period 2||5
8353515|NCT01244035|20591462|P3|COMPLETED|Part 1: Period 2||3
8353516|NCT01244035|20591463|P2|COMPLETED|Part 1: Period 2||3
8353517|NCT01244035|20591464|P1|COMPLETED|Part 1: Period 2||4
8353518|NCT01244035|20591459|P6|STARTED|Part 1: Period 2||3
8353519|NCT01244035|20591460|P5|STARTED|Part 1: Period 2||4
8353520|NCT01244035|20591461|P4|STARTED|Part 1: Period 2||5
8353521|NCT01244035|20591462|P3|STARTED|Part 1: Period 2||4
8353522|NCT01244035|20591463|P2|STARTED|Part 1: Period 2||3
8353523|NCT01244035|20591464|P1|STARTED|Part 1: Period 2||4
8353524|NCT01244035|20591459|P6|NOT COMPLETED|Part 1: Period 1||2
8353525|NCT01244035|20591460|P5|NOT COMPLETED|Part 1: Period 1||1
8353526|NCT01244035|20591461|P4|NOT COMPLETED|Part 1: Period 1||0
8353527|NCT01244035|20591462|P3|NOT COMPLETED|Part 1: Period 1||2
8353528|NCT01244035|20591463|P2|NOT COMPLETED|Part 1: Period 1||2
8353529|NCT01244035|20591464|P1|NOT COMPLETED|Part 1: Period 1||1
8353530|NCT01244035|20591459|P6|COMPLETED|Part 1: Period 1||3
8353531|NCT01244035|20591460|P5|COMPLETED|Part 1: Period 1||4
8353532|NCT01244035|20591461|P4|COMPLETED|Part 1: Period 1||5
8353533|NCT01244035|20591462|P3|COMPLETED|Part 1: Period 1||4
8353534|NCT01244035|20591463|P2|COMPLETED|Part 1: Period 1||3
8353535|NCT01244035|20591464|P1|COMPLETED|Part 1: Period 1||4
8353536|NCT01244035|20591459|P6|STARTED|Part 1: Period 1||5
8353537|NCT01244035|20591460|P5|STARTED|Part 1: Period 1||5
8353538|NCT01244035|20591461|P4|STARTED|Part 1: Period 1||5
8353539|NCT01244035|20591462|P3|STARTED|Part 1: Period 1||6
8353540|NCT01244035|20591463|P2|STARTED|Part 1: Period 1||5
8353541|NCT01244035|20591464|P1|STARTED|Part 1: Period 1||5
8353542|NCT01243957|20591492|P1|NOT COMPLETED|Overall Study||0
8353543|NCT01243957|20591492|P1|COMPLETED|Overall Study||20
8353544|NCT01243957|20591492|P1|STARTED|Overall Study||20
8353545|NCT01243944|20591505|P2|NOT COMPLETED|Overall Study||51
8353546|NCT01243944|20591506|P1|NOT COMPLETED|Overall Study||45
8353547|NCT01243944|20591505|P2|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61
8353548|NCT01243944|20591506|P1|COMPLETED|Overall Study||65
8353549|NCT01243944|20591505|P2|Followed for Survival|Overall Study||21
8353550|NCT01243944|20591506|P1|Followed for Survival|Overall Study||22
8353551|NCT01243944|20591505|P2|Treated|Overall Study||111
8353552|NCT01243944|20591506|P1|Treated|Overall Study||110
8353553|NCT01243944|20591505|P2|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112
8353554|NCT01243944|20591506|P1|STARTED|Overall Study||110
8353555|NCT01243892|20591534|P2|NOT COMPLETED|Overall Study||0
8353556|NCT01243892|20591535|P1|NOT COMPLETED|Overall Study||2
8353557|NCT01243892|20591534|P2|COMPLETED|Overall Study||3
8353558|NCT01243892|20591535|P1|COMPLETED|Overall Study||13
8353559|NCT01243892|20591534|P2|STARTED|Overall Study||3
8353560|NCT01243892|20591535|P1|STARTED|Overall Study||15
8353561|NCT01243775|20591545|P1|NOT COMPLETED|Overall Study||2
8353562|NCT01243775|20591545|P1|COMPLETED|Overall Study||31
8353563|NCT01243775|20591545|P1|STARTED|Overall Study||33
8353564|NCT01243762|20591559|P7|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
8353565|NCT01243762|20591560|P6|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353566|NCT01243762|20591561|P5|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
8353567|NCT01243762|20591562|P4|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
8353568|NCT01243762|20591563|P3|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353569|NCT01243762|20591564|P2|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
8353570|NCT01243762|20591565|P1|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
8353571|NCT01243762|20591559|P7|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353572|NCT01243762|20591560|P6|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353573|NCT01243762|20591561|P5|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353574|NCT01243762|20591562|P4|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353575|NCT01243762|20591563|P3|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353576|NCT01243762|20591564|P2|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353577|NCT01243762|20591565|P1|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
8353578|NCT01243762|20591559|P7|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
8353579|NCT01243762|20591560|P6|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
8353580|NCT01243762|20591561|P5|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
8353581|NCT01243762|20591562|P4|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
8353582|NCT01243762|20591563|P3|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
8353583|NCT01243762|20591564|P2|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
8353584|NCT01243762|20591565|P1|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
8353585|NCT01243762|20591559|P7|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
8353586|NCT01243762|20591560|P6|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
8353587|NCT01243762|20591561|P5|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
8353588|NCT01243762|20591562|P4|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
8353589|NCT01243762|20591563|P3|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
8353590|NCT01243762|20591564|P2|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
8353591|NCT01243762|20591565|P1|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
8353592|NCT01243762|20591559|P7|COMPLETED|Part 1 (Dose Escalation/MTD)||0
8353593|NCT01243762|20591560|P6|COMPLETED|Part 1 (Dose Escalation/MTD)||0
8353594|NCT01243762|20591561|P5|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
8353595|NCT01243762|20591562|P4|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
8353596|NCT01243762|20591563|P3|COMPLETED|Part 1 (Dose Escalation/MTD)||0
8353597|NCT01243762|20591564|P2|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
8353598|NCT01243762|20591565|P1|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
8353599|NCT01243762|20591559|P7|STARTED|Part 1 (Dose Escalation/MTD)||0
8353600|NCT01243762|20591560|P6|STARTED|Part 1 (Dose Escalation/MTD)||3
8353601|NCT01243762|20591561|P5|STARTED|Part 1 (Dose Escalation/MTD)||10
8353602|NCT01243762|20591562|P4|STARTED|Part 1 (Dose Escalation/MTD)||8
8353603|NCT01243762|20591563|P3|STARTED|Part 1 (Dose Escalation/MTD)||3
8353604|NCT01243762|20591564|P2|STARTED|Part 1 (Dose Escalation/MTD)||13
8353605|NCT01243762|20591565|P1|STARTED|Part 1 (Dose Escalation/MTD)||4
8353606|NCT01243671|20591584|P1|NOT COMPLETED|Overall Study||5
8353607|NCT01243671|20591584|P1|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
8353608|NCT01243671|20591584|P1|Completed 52 Weeks of Treatment|Overall Study||17
8353609|NCT01243671|20591584|P1|Completed 24 Weeks of Treatment|Overall Study||18
8353610|NCT01243671|20591584|P1|STARTED|Overall Study||20
8353611|NCT01243619|20591597|P1|NOT COMPLETED|Overall Study||0
8353612|NCT01243619|20591597|P1|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
8353613|NCT01243619|20591597|P1|STARTED|Overall Study||5
8353614|NCT01243580|20591603|P2|NOT COMPLETED|Overall Study||2
8353615|NCT01243580|20591604|P1|NOT COMPLETED|Overall Study||0
8353616|NCT01243580|20591603|P2|COMPLETED|Overall Study||16
8353617|NCT01243580|20591604|P1|COMPLETED|Overall Study||18
8353618|NCT01243580|20591603|P2|STARTED|Overall Study||18
8353619|NCT01243580|20591604|P1|STARTED|Overall Study||18
8353620|NCT01243567|20591633|P2|NOT COMPLETED|Overall Study||0
8353621|NCT01243567|20591634|P1|NOT COMPLETED|Overall Study||1
8353622|NCT01243567|20591633|P2|COMPLETED|Overall Study||38
8353623|NCT01243567|20591634|P1|COMPLETED|Overall Study||42
8353624|NCT01243567|20591633|P2|STARTED|Overall Study||38
8353625|NCT01243567|20591634|P1|STARTED|Overall Study||43
8353626|NCT01243450|20591651|P3|NOT COMPLETED|Overall Study||67
8353627|NCT01243450|20591652|P2|NOT COMPLETED|Overall Study||25
8353628|NCT01243450|20591653|P1|NOT COMPLETED|Overall Study||83
8353629|NCT01243450|20591651|P3|COMPLETED|Overall Study||337
8353630|NCT01243450|20591652|P2|COMPLETED|Overall Study||110
8353631|NCT01243450|20591653|P1|COMPLETED|Overall Study||318
8353632|NCT01243450|20591651|P3|STARTED|Overall Study||404
8353633|NCT01243450|20591652|P2|STARTED|Overall Study||135
8353634|NCT01243450|20591653|P1|STARTED|Overall Study||401
8353635|NCT01243424|20591663|P2|NOT COMPLETED|Discontinuation From Treatment||1182
8353636|NCT01243424|20591664|P1|NOT COMPLETED|Discontinuation From Treatment||1132
8353637|NCT01243424|20591663|P2|COMPLETED|Discontinuation From Treatment||1832
8353638|NCT01243424|20591664|P1|COMPLETED|Discontinuation From Treatment||1896
8353639|NCT01243424|20591663|P2|Treated|Discontinuation From Treatment||3010
8353640|NCT01243424|20591664|P1|Treated|Discontinuation From Treatment||3023
8353641|NCT01243424|20591663|P2|STARTED|Discontinuation From Treatment||3014
8353642|NCT01243424|20591664|P1|STARTED|Discontinuation From Treatment||3028
8353643|NCT01243424|20591663|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||119
8353644|NCT01243424|20591664|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||129
8353645|NCT01243424|20591663|P2|COMPLETED|Discontinuation From Study (Treated Set)||2895
8353646|NCT01243424|20591664|P1|COMPLETED|Discontinuation From Study (Treated Set)||2899
8353647|NCT01243424|20591663|P2|Treated|Discontinuation From Study (Treated Set)||3010
8353648|NCT01243424|20591664|P1|Treated|Discontinuation From Study (Treated Set)||3023
8353649|NCT01243424|20591663|P2|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146
8353650|NCT01243424|20591664|P1|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123
8353651|NCT01243424|20591663|P2|STARTED|Discontinuation From Study (Treated Set)||3014
8353652|NCT01243424|20591664|P1|STARTED|Discontinuation From Study (Treated Set)||3028
8353653|NCT01243411|20591706|P1|NOT COMPLETED|Overall Study||41
8353654|NCT01243411|20591706|P1|COMPLETED|Overall Study||306
8353655|NCT01243411|20591706|P1|STARTED|Overall Study||347
8353656|NCT01243333|20591718|P1|NOT COMPLETED|Overall Study||8
8353657|NCT01243333|20591718|P1|COMPLETED|Overall Study||18
8353658|NCT01243333|20591718|P1|STARTED|Overall Study||26
8353659|NCT01243320|20591724|P1|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
8353660|NCT01243320|20591724|P1|COMPLETED|32ppm Oral Silver (14 Days)||24
8353661|NCT01243320|20591724|P1|STARTED|32ppm Oral Silver (14 Days)||24
8353662|NCT01243320|20591724|P1|NOT COMPLETED|Washout (3 Days)||0
8353663|NCT01243320|20591724|P1|COMPLETED|Washout (3 Days)||36
8353664|NCT01243320|20591724|P1|STARTED|Washout (3 Days)||36
8353665|NCT01243320|20591724|P1|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
8353666|NCT01243320|20591724|P1|COMPLETED|10ppm Oral Silver (14 Days)||36
8353667|NCT01243320|20591724|P1|STARTED|10ppm Oral Silver (14 Days)||36
8353668|NCT01243320|20591724|P1|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
8353669|NCT01243320|20591724|P1|COMPLETED|10ppm Oral Silver (7 Days)||36
8353670|NCT01243320|20591724|P1|STARTED|10ppm Oral Silver (7 Days)||36
8353671|NCT01243320|20591724|P1|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
8353672|NCT01243320|20591724|P1|COMPLETED|10ppm Oral Silver (3 Days)||36
8353673|NCT01243320|20591724|P1|STARTED|10ppm Oral Silver (3 Days)||36
8353674|NCT01243294|20591800|P2|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
8353675|NCT01243294|20591801|P1|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
8353676|NCT01243294|20591800|P2|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
8353677|NCT01243294|20591801|P1|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
8353678|NCT01243294|20591800|P2|STARTED|Second Intervention (10 Days +/- 2 Days)||26
8353679|NCT01243294|20591801|P1|STARTED|Second Intervention (10 Days +/- 2 Days)||28
8353680|NCT01243294|20591800|P2|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
8353681|NCT01243294|20591801|P1|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
8353682|NCT01243294|20591800|P2|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
8353683|NCT01243294|20591801|P1|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
8353684|NCT01243294|20591800|P2|STARTED|First Intervention (10 Days +/- 2 Days)||26
8353685|NCT01243294|20591801|P1|STARTED|First Intervention (10 Days +/- 2 Days)||28
8353686|NCT01243268|20591817|P1|NOT COMPLETED|Overall Study||64
8353687|NCT01243268|20591817|P1|COMPLETED|Overall Study||610
8353688|NCT01243268|20591817|P1|STARTED|Overall Study||674
8353689|NCT01243242|20591827|P2|NOT COMPLETED|Overall Study||4
8353690|NCT01243242|20591828|P1|NOT COMPLETED|Overall Study||3
8353691|NCT01243242|20591827|P2|COMPLETED|Overall Study||56
8353692|NCT01243242|20591828|P1|COMPLETED|Overall Study||57
8353693|NCT01243242|20591827|P2|STARTED|Overall Study||60
8353694|NCT01243242|20591828|P1|STARTED|Overall Study||60
8353701|NCT01243151|20591864|P5|NOT COMPLETED|Overall Study||0
8353702|NCT01243151|20591865|P4|NOT COMPLETED|Overall Study||2
8353703|NCT01243151|20591866|P3|NOT COMPLETED|Overall Study||1
8353704|NCT01243151|20591867|P2|NOT COMPLETED|Overall Study||1
8353705|NCT01243151|20591868|P1|NOT COMPLETED|Overall Study||0
8353706|NCT01243151|20591864|P5|COMPLETED|Overall Study||14
8353707|NCT01243151|20591865|P4|COMPLETED|Overall Study||12
8353708|NCT01243151|20591866|P3|COMPLETED|Overall Study||13
8353709|NCT01243151|20591867|P2|COMPLETED|Overall Study||13
8353710|NCT01243151|20591868|P1|COMPLETED|Overall Study||12
8353711|NCT01243151|20591864|P5|Treated|Overall Study||14
8353712|NCT01243151|20591865|P4|Treated|Overall Study||13
8353713|NCT01243151|20591866|P3|Treated|Overall Study||14
8353714|NCT01243151|20591867|P2|Treated|Overall Study||14
8353715|NCT01243151|20591868|P1|Treated|Overall Study||12
8353716|NCT01243151|20591864|P5|STARTED|Overall Study||14
8353717|NCT01243151|20591865|P4|STARTED|Overall Study||14
8353718|NCT01243151|20591866|P3|STARTED|Overall Study||14
8353719|NCT01243151|20591867|P2|STARTED|Overall Study||14
8353720|NCT01243151|20591868|P1|STARTED|Overall Study||12
8353721|NCT01243112|20592107|P1|NOT COMPLETED|Overall Study||0
8353722|NCT01243112|20592107|P1|COMPLETED|Overall Study||25
8353723|NCT01243112|20592107|P1|STARTED|Overall Study||25
8353724|NCT01242813|20592112|P1|NOT COMPLETED|Overall Study||2
8353725|NCT01242813|20592112|P1|COMPLETED|Overall Study||18
8353726|NCT01242813|20592112|P1|STARTED|Overall Study||20
8353727|NCT01242748|20592134|P2|NOT COMPLETED|Overall Study||14
8353728|NCT01242748|20592135|P1|NOT COMPLETED|Overall Study||38
8353729|NCT01242748|20592134|P2|COMPLETED|Overall Study||80
8353730|NCT01242748|20592135|P1|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
8353731|NCT01242748|20592134|P2|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
8353732|NCT01242748|20592135|P1|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
8353733|NCT01242748|20592134|P2|CS35/CS35A Safety Analysis Set|Overall Study||283
8353734|NCT01242748|20592135|P1|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
8353735|NCT01242748|20592134|P2|STARTED|Overall Study||94
8353736|NCT01242748|20592135|P1|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
8353737|NCT01242644|20592158|P3|NOT COMPLETED|Overall Study||0
8353738|NCT01242644|20592159|P2|NOT COMPLETED|Overall Study||0
8353739|NCT01242644|20592160|P1|NOT COMPLETED|Overall Study||0
8353740|NCT01242644|20592158|P3|COMPLETED|Overall Study||15
8353741|NCT01242644|20592159|P2|COMPLETED|Overall Study||17
8353742|NCT01242644|20592160|P1|COMPLETED|Overall Study||16
8353743|NCT01242644|20592158|P3|STARTED|Overall Study||15
8353744|NCT01242644|20592159|P2|STARTED|Overall Study||17
8353745|NCT01242644|20592160|P1|STARTED|Overall Study||16
8353746|NCT01242527|20592193|P4|NOT COMPLETED|Overall Study||9
8353747|NCT01242527|20592194|P3|NOT COMPLETED|Overall Study||14
8353748|NCT01242527|20592195|P2|NOT COMPLETED|Overall Study||7
8353749|NCT01242527|20592196|P1|NOT COMPLETED|Overall Study||5
8353750|NCT01242527|20592193|P4|COMPLETED|Overall Study||90
8353751|NCT01242527|20592194|P3|COMPLETED|Overall Study||87
8353752|NCT01242527|20592195|P2|COMPLETED|Overall Study||93
8353753|NCT01242527|20592196|P1|COMPLETED|Overall Study||94
8353754|NCT01242527|20592193|P4|STARTED|Overall Study||99
8353755|NCT01242527|20592194|P3|STARTED|Overall Study||101
8353756|NCT01242527|20592195|P2|STARTED|Overall Study||100
8353757|NCT01242527|20592196|P1|STARTED|Overall Study||99
8353758|NCT01242514|20592209|P3|NOT COMPLETED|Overall Study||212
8353759|NCT01242514|20592210|P2|NOT COMPLETED|Overall Study||357
8353760|NCT01242514|20592211|P1|NOT COMPLETED|Overall Study||1343
8353761|NCT01242514|20592209|P3|COMPLETED|Overall Study|Due to project closure.|0
8353762|NCT01242514|20592210|P2|COMPLETED|Overall Study|Due to project closure.|0
8353763|NCT01242514|20592211|P1|COMPLETED|Overall Study|Due to project closure.|0
8353764|NCT01242514|20592209|P3|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
8353765|NCT01242514|20592210|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
8353766|NCT01242514|20592211|P1|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
8353767|NCT01242514|20592209|P3|STARTED|Overall Study|Patients who received treatment|212
8353768|NCT01242514|20592210|P2|STARTED|Overall Study|Patients who received treatment|357
8353769|NCT01242514|20592211|P1|STARTED|Overall Study|Patients who received treatment|1343
8353770|NCT01242371|20592230|P2|NOT COMPLETED|Overall Study||5
8353771|NCT01242371|20592231|P1|NOT COMPLETED|Overall Study||2
8353772|NCT01242371|20592230|P2|COMPLETED|Overall Study||27
8353773|NCT01242371|20592231|P1|COMPLETED|Overall Study||31
8353774|NCT01242371|20592230|P2|STARTED|Overall Study||32
8353775|NCT01242371|20592231|P1|STARTED|Overall Study||33
8353776|NCT01242241|20592239|P2|NOT COMPLETED|Overall Study||0
8353777|NCT01242241|20592240|P1|NOT COMPLETED|Overall Study||0
8353778|NCT01242241|20592239|P2|COMPLETED|Overall Study||40
8353779|NCT01242241|20592240|P1|COMPLETED|Overall Study||40
8353780|NCT01242241|20592239|P2|STARTED|Overall Study||40
8353781|NCT01242241|20592240|P1|STARTED|Overall Study||40
8353782|NCT01242176|20592248|P2|NOT COMPLETED|Second Intervention||0
8353783|NCT01242176|20592249|P1|NOT COMPLETED|Second Intervention||0
8353784|NCT01242176|20592248|P2|COMPLETED|Second Intervention||10
8353785|NCT01242176|20592249|P1|COMPLETED|Second Intervention||11
8353786|NCT01242176|20592248|P2|STARTED|Second Intervention||10
8353787|NCT01242176|20592249|P1|STARTED|Second Intervention||11
8353788|NCT01242176|20592248|P2|NOT COMPLETED|Washout Period of 7 Days||2
8353789|NCT01242176|20592249|P1|NOT COMPLETED|Washout Period of 7 Days||1
8353790|NCT01242176|20592248|P2|COMPLETED|Washout Period of 7 Days||10
8353791|NCT01242176|20592249|P1|COMPLETED|Washout Period of 7 Days||11
8353792|NCT01242176|20592248|P2|STARTED|Washout Period of 7 Days||12
8353793|NCT01242176|20592249|P1|STARTED|Washout Period of 7 Days||12
8353794|NCT01242176|20592248|P2|NOT COMPLETED|First Intervention||0
8353795|NCT01242176|20592249|P1|NOT COMPLETED|First Intervention||0
8353796|NCT01242176|20592248|P2|COMPLETED|First Intervention||12
8353797|NCT01242176|20592249|P1|COMPLETED|First Intervention||12
8353798|NCT01242176|20592248|P2|STARTED|First Intervention||12
8353799|NCT01242176|20592249|P1|STARTED|First Intervention||12
8353800|NCT01242111|20592259|P1|NOT COMPLETED|Overall Study||3
8353801|NCT01242111|20592259|P1|COMPLETED|Overall Study||17
8353802|NCT01242111|20592259|P1|STARTED|Overall Study||20
8353803|NCT01242085|20592271|P3|NOT COMPLETED|Overall Study||0
8353804|NCT01242085|20592272|P2|NOT COMPLETED|Overall Study||7
8353805|NCT01242085|20592273|P1|NOT COMPLETED|Overall Study||8
8353806|NCT01242085|20592271|P3|COMPLETED|Overall Study||1
8353807|NCT01242085|20592272|P2|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
8353808|NCT01242085|20592273|P1|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
8353809|NCT01242085|20592271|P3|STARTED|Overall Study||1
8353810|NCT01242085|20592272|P2|STARTED|Overall Study||33
8353811|NCT01242085|20592273|P1|STARTED|Overall Study||30
8353812|NCT01242020|20592283|P2|NOT COMPLETED|Overall Study||0
8353813|NCT01242020|20592284|P1|NOT COMPLETED|Overall Study||3
8353814|NCT01242020|20592283|P2|COMPLETED|Overall Study||0
8353815|NCT01242020|20592284|P1|COMPLETED|Overall Study||3
8353816|NCT01242020|20592283|P2|STARTED|Overall Study||0
8353817|NCT01242020|20592284|P1|STARTED|Overall Study||6
8353818|NCT01241916|20592294|P2|NOT COMPLETED|Overall Study||10
8353819|NCT01241916|20592295|P1|NOT COMPLETED|Overall Study||7
8353820|NCT01241916|20592294|P2|COMPLETED|Overall Study||21
8353821|NCT01241916|20592295|P1|COMPLETED|Overall Study||28
8353822|NCT01241916|20592294|P2|STARTED|Overall Study||31
8353823|NCT01241916|20592295|P1|STARTED|Overall Study||35
8353824|NCT01241903|20592305|P2|NOT COMPLETED|Overall Study||0
8353825|NCT01241903|20592306|P1|NOT COMPLETED|Overall Study||1
8353826|NCT01241903|20592305|P2|COMPLETED|Overall Study||27
8353827|NCT01241903|20592306|P1|COMPLETED|Overall Study||26
8353828|NCT01241903|20592305|P2|STARTED|Overall Study||27
8353829|NCT01241903|20592306|P1|STARTED|Overall Study||27
8353830|NCT01241760|20592314|P2|NOT COMPLETED|Overall Study||40
8353831|NCT01241760|20592315|P1|NOT COMPLETED|Overall Study||34
8353832|NCT01241760|20592314|P2|COMPLETED|Overall Study||329
8353833|NCT01241760|20592315|P1|COMPLETED|Overall Study||337
8353834|NCT01241760|20592314|P2|STARTED|Overall Study||369
8353835|NCT01241760|20592315|P1|STARTED|Overall Study||371
8353836|NCT01241604|20592334|P3|NOT COMPLETED|Study Period||0
8353837|NCT01241604|20592335|P2|NOT COMPLETED|Study Period||0
8353838|NCT01241604|20592336|P1|NOT COMPLETED|Study Period||0
8353839|NCT01241604|20592334|P3|COMPLETED|Study Period||3
8353840|NCT01241604|20592335|P2|COMPLETED|Study Period||5
8353841|NCT01241604|20592336|P1|COMPLETED|Study Period||0
8353842|NCT01241604|20592334|P3|STARTED|Study Period||3
8353843|NCT01241604|20592335|P2|STARTED|Study Period||5
8353844|NCT01241604|20592336|P1|STARTED|Study Period||0
8353845|NCT01241604|20592334|P3|NOT COMPLETED|Screening Period||0
8353846|NCT01241604|20592335|P2|NOT COMPLETED|Screening Period||0
8353847|NCT01241604|20592336|P1|NOT COMPLETED|Screening Period||3
8353848|NCT01241604|20592334|P3|COMPLETED|Screening Period||0
8353849|NCT01241604|20592335|P2|COMPLETED|Screening Period||0
8353850|NCT01241604|20592336|P1|COMPLETED|Screening Period||8
8353851|NCT01241604|20592334|P3|STARTED|Screening Period||0
8353852|NCT01241604|20592335|P2|STARTED|Screening Period||0
8353853|NCT01241604|20592336|P1|STARTED|Screening Period||11
8353854|NCT01241591|20592381|P4|NOT COMPLETED|Overall Study||12
8353855|NCT01241591|20592382|P3|NOT COMPLETED|Overall Study||22
8353856|NCT01241591|20592383|P2|NOT COMPLETED|Overall Study||24
8353857|NCT01241591|20592384|P1|NOT COMPLETED|Overall Study||23
8353858|NCT01241591|20592381|P4|COMPLETED|Overall Study||95
8353859|NCT01241591|20592382|P3|COMPLETED|Overall Study||313
8353860|NCT01241591|20592383|P2|COMPLETED|Overall Study||306
8353861|NCT01241591|20592384|P1|COMPLETED|Overall Study||306
8353862|NCT01241591|20592381|P4|STARTED|Overall Study||107
8353863|NCT01241591|20592382|P3|STARTED|Overall Study||335
8353864|NCT01241591|20592383|P2|STARTED|Overall Study||330
8353865|NCT01241591|20592384|P1|STARTED|Overall Study||329
8353866|NCT01241565|20592574|P1|NOT COMPLETED|Overall Study||0
8353867|NCT01241565|20592574|P1|COMPLETED|Overall Study||50
8353868|NCT01241565|20592574|P1|STARTED|Overall Study||50
8353869|NCT01241552|20592587|P4|NOT COMPLETED|Overall Study||64
8353870|NCT01241552|20592588|P3|NOT COMPLETED|Overall Study||60
8353871|NCT01241552|20592589|P2|NOT COMPLETED|Overall Study||63
8353872|NCT01241552|20592590|P1|NOT COMPLETED|Overall Study||41
8353873|NCT01241552|20592587|P4|COMPLETED|Overall Study||340
8353874|NCT01241552|20592588|P3|COMPLETED|Overall Study||343
8353875|NCT01241552|20592589|P2|COMPLETED|Overall Study||340
8353876|NCT01241552|20592590|P1|COMPLETED|Overall Study||201
8353877|NCT01241552|20592587|P4|Treated|Overall Study||397
8353878|NCT01241552|20592588|P3|Treated|Overall Study||388
8353879|NCT01241552|20592589|P2|Treated|Overall Study||392
8353880|NCT01241552|20592590|P1|Treated|Overall Study||235
8353881|NCT01241552|20592587|P4|STARTED|Overall Study||404
8353882|NCT01241552|20592588|P3|STARTED|Overall Study||403
8353883|NCT01241552|20592589|P2|STARTED|Overall Study||403
8353884|NCT01241552|20592590|P1|STARTED|Overall Study||242
8353885|NCT01241539|20592656|P1|NOT COMPLETED|Period 2||0
8353886|NCT01241539|20592656|P1|COMPLETED|Period 2||7
8353887|NCT01241539|20592656|P1|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
8353888|NCT01241539|20592656|P1|NOT COMPLETED|Period 1||0
8353889|NCT01241539|20592656|P1|COMPLETED|Period 1||7
8353890|NCT01241539|20592656|P1|STARTED|Period 1||7
8353891|NCT01241513|20592677|P2|NOT COMPLETED|Overall Study||0
8353892|NCT01241513|20592678|P1|NOT COMPLETED|Overall Study||0
8353893|NCT01241513|20592677|P2|COMPLETED|Overall Study||9
8353894|NCT01241513|20592678|P1|COMPLETED|Overall Study|Study has been completed|10
8353895|NCT01241513|20592677|P2|STARTED|Overall Study||9
8353896|NCT01241513|20592678|P1|STARTED|Overall Study||10
8353897|NCT01241461|20592685|P2|NOT COMPLETED|Overall Study||6
8353898|NCT01241461|20592686|P1|NOT COMPLETED|Overall Study||3
8353899|NCT01241461|20592685|P2|COMPLETED|Overall Study||0
8353900|NCT01241461|20592686|P1|COMPLETED|Overall Study||0
8353901|NCT01241461|20592685|P2|STARTED|Overall Study||6
8353902|NCT01241461|20592686|P1|STARTED|Overall Study||3
8353903|NCT01241448|20592706|P4|NOT COMPLETED|Overall Study||23
8353904|NCT01241448|20592707|P3|NOT COMPLETED|Overall Study||23
8353905|NCT01241448|20592708|P2|NOT COMPLETED|Overall Study||29
8353906|NCT01241448|20592709|P1|NOT COMPLETED|Overall Study||37
8353907|NCT01241448|20592706|P4|COMPLETED|Overall Study||43
8353908|NCT01241448|20592707|P3|COMPLETED|Overall Study||43
8353909|NCT01241448|20592708|P2|COMPLETED|Overall Study||36
8353910|NCT01241448|20592709|P1|COMPLETED|Overall Study||29
8353911|NCT01241448|20592706|P4|ITT With ≥1 Post-Baseline Measure|Overall Study||62
8353912|NCT01241448|20592707|P3|ITT With ≥1 Post-Baseline Measure|Overall Study||64
8353913|NCT01241448|20592708|P2|ITT With ≥1 Post-Baseline Measure|Overall Study||61
8353914|NCT01241448|20592709|P1|ITT With ≥1 Post-Baseline Measure|Overall Study||61
8353915|NCT01241448|20592706|P4|Intent-to-Treat Population (ITT)|Overall Study||64
8353916|NCT01241448|20592707|P3|Intent-to-Treat Population (ITT)|Overall Study||64
8353917|NCT01241448|20592708|P2|Intent-to-Treat Population (ITT)|Overall Study||63
8353918|NCT01241448|20592709|P1|Intent-to-Treat Population (ITT)|Overall Study||63
8353919|NCT01241448|20592706|P4|STARTED|Overall Study||66
8353920|NCT01241448|20592707|P3|STARTED|Overall Study||66
8353921|NCT01241448|20592708|P2|STARTED|Overall Study||65
8353922|NCT01241448|20592709|P1|STARTED|Overall Study||66
8353923|NCT01241435|20592777|P4|NOT COMPLETED|Overall Study||0
8353924|NCT01241435|20592778|P3|NOT COMPLETED|Overall Study||0
8353925|NCT01241435|20592779|P2|NOT COMPLETED|Overall Study||0
8353926|NCT01241435|20592780|P1|NOT COMPLETED|Overall Study||0
8353927|NCT01241435|20592777|P4|COMPLETED|Overall Study||8
8353928|NCT01241435|20592778|P3|COMPLETED|Overall Study||8
8353929|NCT01241435|20592779|P2|COMPLETED|Overall Study||8
8353930|NCT01241435|20592780|P1|COMPLETED|Overall Study||12
8353931|NCT01241435|20592777|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
8353932|NCT01241435|20592778|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
8353933|NCT01241435|20592779|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
8353934|NCT01241435|20592780|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
8353935|NCT01241435|20592777|P4|STARTED|Overall Study||8
8353936|NCT01241435|20592778|P3|STARTED|Overall Study||8
8353937|NCT01241435|20592779|P2|STARTED|Overall Study||8
8353938|NCT01241435|20592780|P1|STARTED|Overall Study||12
8353939|NCT01241318|20592800|P2|NOT COMPLETED|Overall Study||742
8353940|NCT01241318|20592801|P1|NOT COMPLETED|Overall Study||1179
8353941|NCT01241318|20592800|P2|COMPLETED|Overall Study|Infants|19308
8353942|NCT01241318|20592801|P1|COMPLETED|Overall Study|Infants|18450
8353943|NCT01241318|20592800|P2|Liveborn Infant|Overall Study|Infants|19346
8353944|NCT01241318|20592801|P1|Liveborn Infant|Overall Study|Infants|18510
8353945|NCT01241318|20592800|P2|STARTED|Overall Study|Women enrolled|20050
8353946|NCT01241318|20592801|P1|STARTED|Overall Study|Women enrolled|19629
8353947|NCT01241292|20592818|P2|NOT COMPLETED|Overall Study||3
8353948|NCT01241292|20592819|P1|NOT COMPLETED|Overall Study||3
8353949|NCT01241292|20592818|P2|COMPLETED|Overall Study|completed=treatment on-going|0
8353950|NCT01241292|20592819|P1|COMPLETED|Overall Study|completed=treatment on-going|0
8353951|NCT01241292|20592818|P2|Entered Treatment Period|Overall Study||3
8353952|NCT01241292|20592819|P1|Entered Treatment Period|Overall Study||3
8353953|NCT01241292|20592818|P2|STARTED|Overall Study||3
8353954|NCT01241292|20592819|P1|STARTED|Overall Study||3
8353955|NCT01241279|20592843|P2|NOT COMPLETED|Overall Study||1
8353956|NCT01241279|20592844|P1|NOT COMPLETED|Overall Study||0
8353957|NCT01241279|20592843|P2|COMPLETED|Overall Study||1
8353958|NCT01241279|20592844|P1|COMPLETED|Overall Study||4
8353959|NCT01241279|20592843|P2|STARTED|Overall Study||2
8353960|NCT01241279|20592844|P1|STARTED|Overall Study||4
8353961|NCT01241240|20592854|P2|NOT COMPLETED|Overall Study||9
8353962|NCT01241240|20592855|P1|NOT COMPLETED|Overall Study||8
8353963|NCT01241240|20592854|P2|COMPLETED|Overall Study||89
8353964|NCT01241240|20592855|P1|COMPLETED|Overall Study||86
8353965|NCT01241240|20592854|P2|STARTED|Overall Study||98
8353966|NCT01241240|20592855|P1|STARTED|Overall Study||94
8353967|NCT01240915|20592873|P9|NOT COMPLETED|Overall Study||8
8353968|NCT01240915|20592874|P8|NOT COMPLETED|Overall Study||4
8353969|NCT01240915|20592875|P7|NOT COMPLETED|Overall Study||8
8353970|NCT01240915|20592876|P6|NOT COMPLETED|Overall Study||10
8353971|NCT01240915|20592877|P5|NOT COMPLETED|Overall Study||4
8353972|NCT01240915|20592878|P4|NOT COMPLETED|Overall Study||3
8353973|NCT01240915|20592879|P3|NOT COMPLETED|Overall Study||0
8353974|NCT01240915|20592880|P2|NOT COMPLETED|Overall Study||1
8353975|NCT01240915|20592881|P1|NOT COMPLETED|Overall Study||2
8353976|NCT01240915|20592873|P9|COMPLETED|Overall Study||13
8353977|NCT01240915|20592874|P8|COMPLETED|Overall Study||15
8353978|NCT01240915|20592875|P7|COMPLETED|Overall Study||17
8353979|NCT01240915|20592876|P6|COMPLETED|Overall Study||13
8353980|NCT01240915|20592877|P5|COMPLETED|Overall Study||2
8353981|NCT01240915|20592878|P4|COMPLETED|Overall Study||1
8353982|NCT01240915|20592879|P3|COMPLETED|Overall Study||2
8353983|NCT01240915|20592880|P2|COMPLETED|Overall Study||2
8353984|NCT01240915|20592881|P1|COMPLETED|Overall Study||0
8353985|NCT01240915|20592873|P9|STARTED|Overall Study||21
8353986|NCT01240915|20592874|P8|STARTED|Overall Study||19
8353987|NCT01240915|20592875|P7|STARTED|Overall Study||25
8353988|NCT01240915|20592876|P6|STARTED|Overall Study||23
8353989|NCT01240915|20592877|P5|STARTED|Overall Study||6
8353990|NCT01240915|20592878|P4|STARTED|Overall Study||4
8353991|NCT01240915|20592879|P3|STARTED|Overall Study||2
8353992|NCT01240915|20592880|P2|STARTED|Overall Study||3
8353993|NCT01240915|20592881|P1|STARTED|Overall Study||2
8354006|NCT01240863|20593155|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
8354007|NCT01240863|20593156|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
8354008|NCT01240863|20593157|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
8354009|NCT01240863|20593155|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
8354010|NCT01240863|20593156|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
8354011|NCT01240863|20593157|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
8354012|NCT01240863|20593155|P3|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
8354013|NCT01240863|20593156|P2|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
8354014|NCT01240863|20593157|P1|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
8354015|NCT01240863|20593155|P3|STARTED|Double-blind Treatment Period (12 Weeks)||146
8354016|NCT01240863|20593156|P2|STARTED|Double-blind Treatment Period (12 Weeks)||148
8354017|NCT01240863|20593157|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
8354018|NCT01240863|20593155|P3|NOT COMPLETED|Open-label Titration Period||0
8354019|NCT01240863|20593156|P2|NOT COMPLETED|Open-label Titration Period||0
8354020|NCT01240863|20593157|P1|NOT COMPLETED|Open-label Titration Period||97
8354021|NCT01240863|20593155|P3|COMPLETED|Open-label Titration Period||0
8354022|NCT01240863|20593156|P2|COMPLETED|Open-label Titration Period||0
8354023|NCT01240863|20593157|P1|COMPLETED|Open-label Titration Period||294
8354024|NCT01240863|20593155|P3|Safety Analysis Set|Open-label Titration Period||0
8354025|NCT01240863|20593156|P2|Safety Analysis Set|Open-label Titration Period||0
8354026|NCT01240863|20593157|P1|Safety Analysis Set|Open-label Titration Period||389
8354027|NCT01240863|20593155|P3|STARTED|Open-label Titration Period||0
8354028|NCT01240863|20593156|P2|STARTED|Open-label Titration Period||0
8354029|NCT01240863|20593157|P1|STARTED|Open-label Titration Period||391
8354030|NCT01240811|20593219|P3|NOT COMPLETED|Overall Study||1
8354031|NCT01240811|20593220|P2|NOT COMPLETED|Overall Study||1
8354032|NCT01240811|20593221|P1|NOT COMPLETED|Overall Study||0
8354033|NCT01240811|20593219|P3|COMPLETED|Overall Study||16
8354034|NCT01240811|20593220|P2|COMPLETED|Overall Study||16
8354035|NCT01240811|20593221|P1|COMPLETED|Overall Study||8
8354036|NCT01240811|20593219|P3|STARTED|Overall Study||17
8354037|NCT01240811|20593220|P2|STARTED|Overall Study||17
8354038|NCT01240811|20593221|P1|STARTED|Overall Study||8
8354039|NCT01240785|20593237|P2|NOT COMPLETED|Overall Study||3
8354040|NCT01240785|20593238|P1|NOT COMPLETED|Overall Study||1
8354041|NCT01240785|20593237|P2|COMPLETED|Overall Study||107
8354042|NCT01240785|20593238|P1|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
8354043|NCT01240785|20593237|P2|STARTED|Overall Study||110
8354044|NCT01240785|20593238|P1|STARTED|Overall Study||111
8354045|NCT01240746|20593269|P3|NOT COMPLETED|Overall Study||243
8354046|NCT01240746|20593270|P2|NOT COMPLETED|Overall Study||48
8354047|NCT01240746|20593271|P1|NOT COMPLETED|Overall Study||59
8354048|NCT01240746|20593269|P3|COMPLETED|Overall Study||2659
8354049|NCT01240746|20593270|P2|COMPLETED|Overall Study||677
8354050|NCT01240746|20593271|P1|COMPLETED|Overall Study||677
8354051|NCT01240746|20593269|P3|STARTED|Overall Study||2902
8354052|NCT01240746|20593270|P2|STARTED|Overall Study||725
8354053|NCT01240746|20593271|P1|STARTED|Overall Study||736
8354054|NCT01240590|20593326|P5|NOT COMPLETED|Phase II||1
8354055|NCT01240590|20593327|P4|NOT COMPLETED|Phase II||2
8354056|NCT01240590|20593328|P3|NOT COMPLETED|Phase II||0
8354057|NCT01240590|20593329|P2|NOT COMPLETED|Phase II||0
8354058|NCT01240590|20593330|P1|NOT COMPLETED|Phase II||0
8354059|NCT01240590|20593326|P5|COMPLETED|Phase II||0
8354060|NCT01240590|20593327|P4|COMPLETED|Phase II||15
8354061|NCT01240590|20593328|P3|COMPLETED|Phase II||0
8354062|NCT01240590|20593329|P2|COMPLETED|Phase II||0
8354063|NCT01240590|20593330|P1|COMPLETED|Phase II||0
8354064|NCT01240590|20593326|P5|STARTED|Phase II||1
8354065|NCT01240590|20593327|P4|STARTED|Phase II||17
8354066|NCT01240590|20593328|P3|STARTED|Phase II||0
8354067|NCT01240590|20593329|P2|STARTED|Phase II||0
8354068|NCT01240590|20593330|P1|STARTED|Phase II||0
8354069|NCT01240590|20593326|P5|NOT COMPLETED|Phase I||0
8354070|NCT01240590|20593327|P4|NOT COMPLETED|Phase I||0
8354071|NCT01240590|20593328|P3|NOT COMPLETED|Phase I||3
8354072|NCT01240590|20593329|P2|NOT COMPLETED|Phase I||0
8354073|NCT01240590|20593330|P1|NOT COMPLETED|Phase I||0
8354074|NCT01240590|20593326|P5|COMPLETED|Phase I||0
8354075|NCT01240590|20593327|P4|COMPLETED|Phase I||0
8354076|NCT01240590|20593328|P3|COMPLETED|Phase I||0
8354077|NCT01240590|20593329|P2|COMPLETED|Phase I||6
8354078|NCT01240590|20593330|P1|COMPLETED|Phase I||0
8354079|NCT01240590|20593326|P5|STARTED|Phase I||0
8354080|NCT01240590|20593327|P4|STARTED|Phase I||0
8354081|NCT01240590|20593328|P3|STARTED|Phase I||3
8354082|NCT01240590|20593329|P2|STARTED|Phase I||6
8354083|NCT01240590|20593330|P1|STARTED|Phase I||0
8354084|NCT01240551|20593358|P2|NOT COMPLETED|Overall Study||3
8354085|NCT01240551|20593359|P1|NOT COMPLETED|Overall Study||4
8354086|NCT01240551|20593358|P2|COMPLETED|Overall Study||27
8354087|NCT01240551|20593359|P1|COMPLETED|Overall Study||26
8354088|NCT01240551|20593358|P2|STARTED|Overall Study||30
8354089|NCT01240551|20593359|P1|STARTED|Overall Study||30
8354090|NCT01240382|20593369|P2|NOT COMPLETED|Overall Study||4
8354091|NCT01240382|20593370|P1|NOT COMPLETED|Overall Study||2
8354092|NCT01240382|20593369|P2|COMPLETED|Overall Study||139
8354093|NCT01240382|20593370|P1|COMPLETED|Overall Study||142
8354094|NCT01240382|20593369|P2|STARTED|Overall Study||143
8354095|NCT01240382|20593370|P1|STARTED|Overall Study||144
8354096|NCT01240356|20593380|P2|NOT COMPLETED|Overall Study||0
8354097|NCT01240356|20593381|P1|NOT COMPLETED|Overall Study||3
8354098|NCT01240356|20593380|P2|COMPLETED|Overall Study||20
8354099|NCT01240356|20593381|P1|COMPLETED|Overall Study||15
8354100|NCT01240356|20593380|P2|STARTED|Overall Study||20
8354101|NCT01240356|20593381|P1|STARTED|Overall Study||18
8354102|NCT01240330|20593392|P1|NOT COMPLETED|Overall Study||0
8354103|NCT01240330|20593392|P1|COMPLETED|Overall Study||33
8354104|NCT01240330|20593392|P1|STARTED|Overall Study||33
8354105|NCT01240304|20593398|P1|NOT COMPLETED|Overall Study||10
8354106|NCT01240304|20593398|P1|COMPLETED|Overall Study||0
8354107|NCT01240304|20593398|P1|STARTED|Overall Study||10
8354108|NCT01240200|20593404|P2|NOT COMPLETED|12-week Crossover Phase - Period 2||0
8354109|NCT01240200|20593405|P1|NOT COMPLETED|12-week Crossover Phase - Period 2||0
8354110|NCT01240200|20593404|P2|COMPLETED|12-week Crossover Phase - Period 2||23
8354111|NCT01240200|20593405|P1|COMPLETED|12-week Crossover Phase - Period 2||23
8354112|NCT01240200|20593404|P2|STARTED|12-week Crossover Phase - Period 2||23
8354113|NCT01240200|20593405|P1|STARTED|12-week Crossover Phase - Period 2||23
8354114|NCT01240200|20593404|P2|NOT COMPLETED|12-week Crossover Phase - Period 1||1
8354115|NCT01240200|20593405|P1|NOT COMPLETED|12-week Crossover Phase - Period 1||2
8354116|NCT01240200|20593404|P2|COMPLETED|12-week Crossover Phase - Period 1||23
8354117|NCT01240200|20593405|P1|COMPLETED|12-week Crossover Phase - Period 1||23
8354118|NCT01240200|20593404|P2|STARTED|12-week Crossover Phase - Period 1||24
8354119|NCT01240200|20593405|P1|STARTED|12-week Crossover Phase - Period 1||25
8354120|NCT01240135|20593423|P2|NOT COMPLETED|Period Two, 14 Days of Wear||2
8354121|NCT01240135|20593424|P1|NOT COMPLETED|Period Two, 14 Days of Wear||1
8354122|NCT01240135|20593423|P2|COMPLETED|Period Two, 14 Days of Wear||43
8354123|NCT01240135|20593424|P1|COMPLETED|Period Two, 14 Days of Wear||43
8354124|NCT01240135|20593423|P2|STARTED|Period Two, 14 Days of Wear||45
8354125|NCT01240135|20593424|P1|STARTED|Period Two, 14 Days of Wear||44
8354126|NCT01240135|20593423|P2|NOT COMPLETED|Period One, 14 Days of Wear||0
8354127|NCT01240135|20593424|P1|NOT COMPLETED|Period One, 14 Days of Wear||0
8354128|NCT01240135|20593423|P2|COMPLETED|Period One, 14 Days of Wear||45
8354129|NCT01240135|20593424|P1|COMPLETED|Period One, 14 Days of Wear||44
8354130|NCT01240135|20593423|P2|STARTED|Period One, 14 Days of Wear||45
8354131|NCT01240135|20593424|P1|STARTED|Period One, 14 Days of Wear||44
8354132|NCT01240122|20593432|P1|NOT COMPLETED|Overall Study||0
8354133|NCT01240122|20593432|P1|COMPLETED|Overall Study||29
8354134|NCT01240122|20593432|P1|STARTED|Overall Study||29
8354135|NCT01239992|20593441|P1|NOT COMPLETED|Overall Study||2
8354136|NCT01239992|20593441|P1|COMPLETED|Overall Study||10
8354137|NCT01239992|20593441|P1|STARTED|Overall Study||12
8354138|NCT01239797|20593450|P2|NOT COMPLETED|Treated Participants||274
8354139|NCT01239797|20593451|P1|NOT COMPLETED|Treated Participants||235
8354140|NCT01239797|20593450|P2|COMPLETED|Treated Participants|Completed = Still on Treatment|43
8354141|NCT01239797|20593451|P1|COMPLETED|Treated Participants|Completed = Still on Treatment|83
8354142|NCT01239797|20593450|P2|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
8354143|NCT01239797|20593451|P1|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
8354144|NCT01239797|20593450|P2|NOT COMPLETED|Randomized Participants||9
8354145|NCT01239797|20593451|P1|NOT COMPLETED|Randomized Participants||2
8354146|NCT01239797|20593450|P2|COMPLETED|Randomized Participants||316
8354147|NCT01239797|20593451|P1|COMPLETED|Randomized Participants||319
8354148|NCT01239797|20593450|P2|STARTED|Randomized Participants||325
8354149|NCT01239797|20593451|P1|STARTED|Randomized Participants||321
8354150|NCT01239745|20593459|P1|NOT COMPLETED|Overall Study||46
8354151|NCT01239745|20593459|P1|COMPLETED|Overall Study||0
8354152|NCT01239745|20593459|P1|STARTED|Overall Study||46
8354153|NCT01239732|20593470|P1|NOT COMPLETED|Overall Study||1021
8354154|NCT01239732|20593470|P1|COMPLETED|Overall Study||0
8354155|NCT01239732|20593470|P1|STARTED|Overall Study||1021
8354156|NCT01239680|20593483|P2|NOT COMPLETED|Overall Study||0
8354157|NCT01239680|20593484|P1|NOT COMPLETED|Overall Study||2
8354158|NCT01239680|20593483|P2|COMPLETED|Overall Study||2
8354159|NCT01239680|20593484|P1|COMPLETED|Overall Study||1
8354160|NCT01239680|20593483|P2|STARTED|Overall Study||2
8354161|NCT01239680|20593484|P1|STARTED|Overall Study||3
8354162|NCT01239511|20593494|P4|NOT COMPLETED|Overall Study||9
8354163|NCT01239511|20593495|P3|NOT COMPLETED|Overall Study||4
8354164|NCT01239511|20593496|P2|NOT COMPLETED|Overall Study||5
8354165|NCT01239511|20593497|P1|NOT COMPLETED|Overall Study||1
8354166|NCT01239511|20593494|P4|COMPLETED|Overall Study||38
8354167|NCT01239511|20593495|P3|COMPLETED|Overall Study||43
8354168|NCT01239511|20593496|P2|COMPLETED|Overall Study||40
8354169|NCT01239511|20593497|P1|COMPLETED|Overall Study||46
8354170|NCT01239511|20593494|P4|STARTED|Overall Study||47
8354171|NCT01239511|20593495|P3|STARTED|Overall Study||47
8354172|NCT01239511|20593496|P2|STARTED|Overall Study||45
8354173|NCT01239511|20593497|P1|STARTED|Overall Study||47
8354174|NCT01239472|20593509|P2|NOT COMPLETED|Overall Study||3
8354175|NCT01239472|20593510|P1|NOT COMPLETED|Overall Study||5
8354176|NCT01239472|20593509|P2|COMPLETED|Overall Study||12
8354177|NCT01239472|20593510|P1|COMPLETED|Overall Study||10
8354178|NCT01239472|20593509|P2|STARTED|Overall Study||15
8354179|NCT01239472|20593510|P1|STARTED|Overall Study||15
8354180|NCT01239394|20593518|P1|NOT COMPLETED|Overall Study||1
8354181|NCT01239394|20593518|P1|COMPLETED|Overall Study||41
8354182|NCT01239394|20593518|P1|STARTED|Overall Study||42
8354183|NCT01239381|20593525|P1|NOT COMPLETED|Overall Study||2
8354184|NCT01239381|20593525|P1|COMPLETED|Overall Study||90
8354185|NCT01239381|20593525|P1|STARTED|Overall Study||92
8354186|NCT01239368|20593545|P10|NOT COMPLETED|Overall Study||4
8354187|NCT01239368|20593546|P9|NOT COMPLETED|Overall Study||0
8354188|NCT01239368|20593547|P8|NOT COMPLETED|Overall Study||0
8354189|NCT01239368|20593548|P7|NOT COMPLETED|Overall Study||6
8354190|NCT01239368|20593549|P6|NOT COMPLETED|Overall Study||4
8354191|NCT01239368|20593550|P5|NOT COMPLETED|Overall Study||5
8354192|NCT01239368|20593551|P4|NOT COMPLETED|Overall Study||1
8354193|NCT01239368|20593552|P3|NOT COMPLETED|Overall Study||1
8354194|NCT01239368|20593553|P2|NOT COMPLETED|Overall Study||1
8354195|NCT01239368|20593554|P1|NOT COMPLETED|Overall Study||2
8354196|NCT01239368|20593545|P10|COMPLETED|Overall Study||1
8354197|NCT01239368|20593546|P9|COMPLETED|Overall Study||1
8354198|NCT01239368|20593547|P8|COMPLETED|Overall Study||0
8354199|NCT01239368|20593548|P7|COMPLETED|Overall Study||1
8354200|NCT01239368|20593549|P6|COMPLETED|Overall Study||1
8354201|NCT01239368|20593550|P5|COMPLETED|Overall Study||2
8354202|NCT01239368|20593551|P4|COMPLETED|Overall Study||1
8354203|NCT01239368|20593552|P3|COMPLETED|Overall Study||0
8354204|NCT01239368|20593553|P2|COMPLETED|Overall Study||0
8354205|NCT01239368|20593554|P1|COMPLETED|Overall Study||0
8354206|NCT01239368|20593545|P10|STARTED|Overall Study||5
8354207|NCT01239368|20593546|P9|STARTED|Overall Study||1
8354208|NCT01239368|20593547|P8|STARTED|Overall Study||0
8354209|NCT01239368|20593548|P7|STARTED|Overall Study||7
8354210|NCT01239368|20593549|P6|STARTED|Overall Study||5
8354211|NCT01239368|20593550|P5|STARTED|Overall Study||7
8354212|NCT01239368|20593551|P4|STARTED|Overall Study||2
8354213|NCT01239368|20593552|P3|STARTED|Overall Study||1
8354214|NCT01239368|20593553|P2|STARTED|Overall Study||1
8354215|NCT01239368|20593554|P1|STARTED|Overall Study||2
8354216|NCT01239355|20593598|P1|NOT COMPLETED|Overall Study||0
8354217|NCT01239355|20593598|P1|COMPLETED|Overall Study||15
8354218|NCT01239355|20593598|P1|STARTED|Overall Study||15
8354219|NCT01239342|20593606|P2|NOT COMPLETED|Overall Study||6
8354220|NCT01239342|20593607|P1|NOT COMPLETED|Overall Study||3
8354221|NCT01239342|20593606|P2|COMPLETED|Overall Study||8
8354222|NCT01239342|20593607|P1|COMPLETED|Overall Study||26
8354223|NCT01239342|20593606|P2|STARTED|Overall Study||14
8354224|NCT01239342|20593607|P1|STARTED|Overall Study||29
8354225|NCT01239316|20593623|P1|NOT COMPLETED|Overall Study||12
8354226|NCT01239316|20593623|P1|COMPLETED|Overall Study||0
8354227|NCT01239316|20593623|P1|STARTED|Overall Study||12
8354228|NCT01239212|20593631|P1|NOT COMPLETED|Overall Study||0
8354229|NCT01239212|20593631|P1|COMPLETED|Overall Study||7
8354230|NCT01239212|20593631|P1|STARTED|Overall Study||7
8354231|NCT01239160|20593637|P3|NOT COMPLETED|Overall Study||10
8354232|NCT01239160|20593638|P2|NOT COMPLETED|Overall Study||19
8354233|NCT01239160|20593639|P1|NOT COMPLETED|Overall Study||25
8354234|NCT01239160|20593637|P3|COMPLETED|Overall Study||0
8354235|NCT01239160|20593638|P2|COMPLETED|Overall Study||95
8354236|NCT01239160|20593639|P1|COMPLETED|Overall Study||89
8354237|NCT01239160|20593637|P3|STARTED|Overall Study||10
8354238|NCT01239160|20593638|P2|STARTED|Overall Study||114
8354239|NCT01239160|20593639|P1|STARTED|Overall Study||114
8354240|NCT01239121|20593652|P3|NOT COMPLETED|Overall Study||0
8354241|NCT01239121|20593653|P2|NOT COMPLETED|Overall Study||4
8354242|NCT01239121|20593654|P1|NOT COMPLETED|Overall Study||2
8354243|NCT01239121|20593652|P3|COMPLETED|Overall Study||15
8354244|NCT01239121|20593653|P2|COMPLETED|Overall Study||195
8354245|NCT01239121|20593654|P1|COMPLETED|Overall Study||186
8354246|NCT01239121|20593652|P3|STARTED|Overall Study||15
8354247|NCT01239121|20593653|P2|STARTED|Overall Study||199
8354248|NCT01239121|20593654|P1|STARTED|Overall Study||188
8354249|NCT01239056|20593668|P1|NOT COMPLETED|Overall Study||0
8354250|NCT01239056|20593668|P1|COMPLETED|Overall Study||20
8354251|NCT01239056|20593668|P1|STARTED|Overall Study||20
8354252|NCT01239043|20593676|P2|NOT COMPLETED|Overall Study||1
8354253|NCT01239043|20593677|P1|NOT COMPLETED|Overall Study||2
8354254|NCT01239043|20593676|P2|COMPLETED|Overall Study||102
8354255|NCT01239043|20593677|P1|COMPLETED|Overall Study||34
8354256|NCT01239043|20593676|P2|STARTED|Overall Study||103
8354257|NCT01239043|20593677|P1|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
8354258|NCT01238991|20593705|P10|NOT COMPLETED|Overall Study||2
8354259|NCT01238991|20593706|P9|NOT COMPLETED|Overall Study||4
8354260|NCT01238991|20593707|P8|NOT COMPLETED|Overall Study||5
8354261|NCT01238991|20593708|P7|NOT COMPLETED|Overall Study||8
8354262|NCT01238991|20593709|P6|NOT COMPLETED|Overall Study||0
8354263|NCT01238991|20593710|P5|NOT COMPLETED|Overall Study||2
8354264|NCT01238991|20593711|P4|NOT COMPLETED|Overall Study||2
8354265|NCT01238991|20593712|P3|NOT COMPLETED|Overall Study||6
8354266|NCT01238991|20593713|P2|NOT COMPLETED|Overall Study||0
8354267|NCT01238991|20593714|P1|NOT COMPLETED|Overall Study||2
8354268|NCT01238991|20593705|P10|COMPLETED|Overall Study||0
8354269|NCT01238991|20593706|P9|COMPLETED|Overall Study||0
8354270|NCT01238991|20593707|P8|COMPLETED|Overall Study||0
8354271|NCT01238991|20593708|P7|COMPLETED|Overall Study||0
8354272|NCT01238991|20593709|P6|COMPLETED|Overall Study||2
8354273|NCT01238991|20593710|P5|COMPLETED|Overall Study||3
8354274|NCT01238991|20593711|P4|COMPLETED|Overall Study||4
8354275|NCT01238991|20593712|P3|COMPLETED|Overall Study||5
8354276|NCT01238991|20593713|P2|COMPLETED|Overall Study||3
8354277|NCT01238991|20593714|P1|COMPLETED|Overall Study||5
8354278|NCT01238991|20593705|P10|Received Treatment|Overall Study||2
8354279|NCT01238991|20593706|P9|Received Treatment|Overall Study||4
8354280|NCT01238991|20593707|P8|Received Treatment|Overall Study||5
8354281|NCT01238991|20593708|P7|Received Treatment|Overall Study||8
8354282|NCT01238991|20593709|P6|Received Treatment|Overall Study||2
8354283|NCT01238991|20593710|P5|Received Treatment|Overall Study||5
8354284|NCT01238991|20593711|P4|Received Treatment|Overall Study||6
8354285|NCT01238991|20593712|P3|Received Treatment|Overall Study||11
8354286|NCT01238991|20593713|P2|Received Treatment|Overall Study||3
8354287|NCT01238991|20593714|P1|Received Treatment|Overall Study||7
8354288|NCT01238991|20593705|P10|STARTED|Overall Study||2
8354289|NCT01238991|20593706|P9|STARTED|Overall Study||4
8354290|NCT01238991|20593707|P8|STARTED|Overall Study||5
8354291|NCT01238991|20593708|P7|STARTED|Overall Study||8
8354292|NCT01238991|20593709|P6|STARTED|Overall Study||2
8354293|NCT01238991|20593710|P5|STARTED|Overall Study||5
8354294|NCT01238991|20593711|P4|STARTED|Overall Study||6
8354295|NCT01238991|20593712|P3|STARTED|Overall Study||11
8354296|NCT01238991|20593713|P2|STARTED|Overall Study||3
8354297|NCT01238991|20593714|P1|STARTED|Overall Study||7
8354298|NCT01238900|20593801|P1|NOT COMPLETED|<12 Months Post Stent Removal||5
8354299|NCT01238900|20593801|P1|COMPLETED|<12 Months Post Stent Removal||18
8354300|NCT01238900|20593801|P1|STARTED|<12 Months Post Stent Removal||23
8354301|NCT01238900|20593801|P1|NOT COMPLETED|6 Months Post Stent Placement||0
8354302|NCT01238900|20593801|P1|COMPLETED|6 Months Post Stent Placement||23
8354303|NCT01238900|20593801|P1|STARTED|6 Months Post Stent Placement||23
8354304|NCT01238861|20593815|P6|NOT COMPLETED|Overall Study||15
8354305|NCT01238861|20593816|P5|NOT COMPLETED|Overall Study||13
8354306|NCT01238861|20593817|P4|NOT COMPLETED|Overall Study||13
8354307|NCT01238861|20593818|P3|NOT COMPLETED|Overall Study||11
8354308|NCT01238861|20593819|P2|NOT COMPLETED|Overall Study||8
8354309|NCT01238861|20593820|P1|NOT COMPLETED|Overall Study||11
8354310|NCT01238861|20593815|P6|COMPLETED|Overall Study||125
8354311|NCT01238861|20593816|P5|COMPLETED|Overall Study||129
8354312|NCT01238861|20593817|P4|COMPLETED|Overall Study||69
8354313|NCT01238861|20593818|P3|COMPLETED|Overall Study||70
8354314|NCT01238861|20593819|P2|COMPLETED|Overall Study||73
8354315|NCT01238861|20593820|P1|COMPLETED|Overall Study||69
8354316|NCT01238861|20593815|P6|STARTED|Overall Study||140
8354317|NCT01238861|20593816|P5|STARTED|Overall Study||142
8354318|NCT01238861|20593817|P4|STARTED|Overall Study||82
8354319|NCT01238861|20593818|P3|STARTED|Overall Study||81
8354320|NCT01238861|20593819|P2|STARTED|Overall Study||81
8354321|NCT01238861|20593820|P1|STARTED|Overall Study||80
8354322|NCT01238848|20593900|P2|NOT COMPLETED|Overall Study||5
8354323|NCT01238848|20593901|P1|NOT COMPLETED|Overall Study||13
8354324|NCT01238848|20593900|P2|COMPLETED|Overall Study||45
8354325|NCT01238848|20593901|P1|COMPLETED|Overall Study||37
8354326|NCT01238848|20593900|P2|STARTED|Overall Study||50
8354327|NCT01238848|20593901|P1|STARTED|Overall Study||50
8354328|NCT01238835|20593909|P1|NOT COMPLETED|Overall Study||136
8354329|NCT01238835|20593909|P1|COMPLETED|Overall Study||82
8354330|NCT01238835|20593909|P1|STARTED|Overall Study||218
8354331|NCT01238822|20593914|P1|NOT COMPLETED|Overall Study||3
8354332|NCT01238822|20593914|P1|COMPLETED|Overall Study||93
8354333|NCT01238822|20593914|P1|Received High Dosage|Overall Study||93
8354334|NCT01238822|20593914|P1|Received Medium Dosage|Overall Study||93
8354335|NCT01238822|20593914|P1|Received Low Dosage|Overall Study||93
8354336|NCT01238822|20593914|P1|Received Placebo|Overall Study||93
8354337|NCT01238822|20593914|P1|STARTED|Overall Study||96
8354338|NCT01238640|20593924|P1|NOT COMPLETED|Overall Study||0
8354339|NCT01238640|20593924|P1|COMPLETED|Overall Study||84
8354340|NCT01238640|20593924|P1|STARTED|Overall Study||84
8354341|NCT01238588|20593941|P1|NOT COMPLETED|Overall Study||3
8354342|NCT01238588|20593941|P1|COMPLETED|Overall Study||9
8354343|NCT01238588|20593941|P1|STARTED|Overall Study||12
8354344|NCT01238575|20593954|P2|NOT COMPLETED|Overall Study||4
8354345|NCT01238575|20593955|P1|NOT COMPLETED|Overall Study||4
8354346|NCT01238575|20593954|P2|COMPLETED|Overall Study||28
8354347|NCT01238575|20593955|P1|COMPLETED|Overall Study||26
8354348|NCT01238575|20593954|P2|STARTED|Overall Study||32
8354349|NCT01238575|20593955|P1|STARTED|Overall Study||30
8354350|NCT01238549|20593991|P1|NOT COMPLETED|Overall Study||36
8354351|NCT01238549|20593991|P1|COMPLETED|Overall Study||248
8354352|NCT01238549|20593991|P1|STARTED|Overall Study||284
8354353|NCT01238536|20594010|P2|NOT COMPLETED|Overall Study||50
8354354|NCT01238536|20594011|P1|NOT COMPLETED|Overall Study||47
8354355|NCT01238536|20594010|P2|COMPLETED|Overall Study||150
8354356|NCT01238536|20594011|P1|COMPLETED|Overall Study||153
8354357|NCT01238536|20594010|P2|STARTED|Overall Study||200
8354358|NCT01238536|20594011|P1|STARTED|Overall Study||200
8354359|NCT01238471|20594025|P2|NOT COMPLETED|Overall Study||0
8354360|NCT01238471|20594026|P1|NOT COMPLETED|Overall Study||0
8354361|NCT01238471|20594025|P2|COMPLETED|Overall Study||10
8354362|NCT01238471|20594026|P1|COMPLETED|Overall Study||10
8354363|NCT01238471|20594025|P2|STARTED|Overall Study||10
8354364|NCT01238471|20594026|P1|STARTED|Overall Study||10
8354365|NCT01238341|20594032|P1|NOT COMPLETED|Overall Study||0
8354366|NCT01238341|20594032|P1|COMPLETED|Overall Study||7
8354367|NCT01238341|20594032|P1|STARTED|Overall Study||7
8354371|NCT01238172|20594045|P2|NOT COMPLETED|Overall Study||24
8354372|NCT01238172|20594046|P1|NOT COMPLETED|Overall Study||11
8354373|NCT01238172|20594045|P2|COMPLETED|Overall Study||217
8354374|NCT01238172|20594046|P1|COMPLETED|Overall Study||226
8354375|NCT01238172|20594045|P2|STARTED|Overall Study||241
8354376|NCT01238172|20594046|P1|STARTED|Overall Study||237
8354377|NCT01237951|20594058|P1|NOT COMPLETED|Overall Study||1
8354378|NCT01237951|20594058|P1|COMPLETED|Overall Study||74
8354379|NCT01237951|20594058|P1|STARTED|Overall Study||75
8354380|NCT01237899|20594076|P11|NOT COMPLETED|Second Dosing Period||0
8354381|NCT01237899|20594077|P10|NOT COMPLETED|Second Dosing Period||0
8354382|NCT01237899|20594078|P9|NOT COMPLETED|Second Dosing Period||0
8354383|NCT01237899|20594079|P8|NOT COMPLETED|Second Dosing Period||0
8354384|NCT01237899|20594080|P7|NOT COMPLETED|Second Dosing Period||0
8354385|NCT01237899|20594081|P6|NOT COMPLETED|Second Dosing Period||0
8354386|NCT01237899|20594082|P5|NOT COMPLETED|Second Dosing Period||0
8354387|NCT01237899|20594083|P4|NOT COMPLETED|Second Dosing Period||0
8354388|NCT01237899|20594084|P3|NOT COMPLETED|Second Dosing Period||0
8354389|NCT01237899|20594085|P2|NOT COMPLETED|Second Dosing Period||0
8354390|NCT01237899|20594086|P1|NOT COMPLETED|Second Dosing Period||0
8354391|NCT01237899|20594076|P11|COMPLETED|Second Dosing Period||4
8354392|NCT01237899|20594077|P10|COMPLETED|Second Dosing Period||3
8354393|NCT01237899|20594078|P9|COMPLETED|Second Dosing Period||4
8354394|NCT01237899|20594079|P8|COMPLETED|Second Dosing Period||3
8354395|NCT01237899|20594080|P7|COMPLETED|Second Dosing Period||1
8354396|NCT01237899|20594081|P6|COMPLETED|Second Dosing Period||4
8354397|NCT01237899|20594082|P5|COMPLETED|Second Dosing Period||2
8354398|NCT01237899|20594083|P4|COMPLETED|Second Dosing Period||3
8354399|NCT01237899|20594084|P3|COMPLETED|Second Dosing Period||3
8354400|NCT01237899|20594085|P2|COMPLETED|Second Dosing Period||3
8354401|NCT01237899|20594086|P1|COMPLETED|Second Dosing Period||1
8354402|NCT01237899|20594076|P11|STARTED|Second Dosing Period||4
8354403|NCT01237899|20594077|P10|STARTED|Second Dosing Period||3
8354404|NCT01237899|20594078|P9|STARTED|Second Dosing Period||4
8354405|NCT01237899|20594079|P8|STARTED|Second Dosing Period||3
8354406|NCT01237899|20594080|P7|STARTED|Second Dosing Period||1
8354407|NCT01237899|20594081|P6|STARTED|Second Dosing Period||4
8354408|NCT01237899|20594082|P5|STARTED|Second Dosing Period||2
8354409|NCT01237899|20594083|P4|STARTED|Second Dosing Period||3
8354410|NCT01237899|20594084|P3|STARTED|Second Dosing Period||3
8354411|NCT01237899|20594085|P2|STARTED|Second Dosing Period||3
8354412|NCT01237899|20594086|P1|STARTED|Second Dosing Period||1
8354413|NCT01237899|20594076|P11|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354414|NCT01237899|20594077|P10|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354415|NCT01237899|20594078|P9|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354416|NCT01237899|20594079|P8|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354417|NCT01237899|20594080|P7|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354418|NCT01237899|20594081|P6|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354419|NCT01237899|20594082|P5|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354420|NCT01237899|20594083|P4|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354421|NCT01237899|20594084|P3|NOT COMPLETED|Washout Period of at Least 7 Days||1
8354422|NCT01237899|20594085|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354423|NCT01237899|20594086|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
8354424|NCT01237899|20594076|P11|COMPLETED|Washout Period of at Least 7 Days||4
8354425|NCT01237899|20594077|P10|COMPLETED|Washout Period of at Least 7 Days||3
8354426|NCT01237899|20594078|P9|COMPLETED|Washout Period of at Least 7 Days||4
8354427|NCT01237899|20594079|P8|COMPLETED|Washout Period of at Least 7 Days||3
8354428|NCT01237899|20594080|P7|COMPLETED|Washout Period of at Least 7 Days||1
8354429|NCT01237899|20594081|P6|COMPLETED|Washout Period of at Least 7 Days||4
8354430|NCT01237899|20594082|P5|COMPLETED|Washout Period of at Least 7 Days||2
8354431|NCT01237899|20594083|P4|COMPLETED|Washout Period of at Least 7 Days||3
8354432|NCT01237899|20594084|P3|COMPLETED|Washout Period of at Least 7 Days||3
8354433|NCT01237899|20594085|P2|COMPLETED|Washout Period of at Least 7 Days||3
8354434|NCT01237899|20594086|P1|COMPLETED|Washout Period of at Least 7 Days||1
8354435|NCT01237899|20594076|P11|STARTED|Washout Period of at Least 7 Days||4
8354436|NCT01237899|20594077|P10|STARTED|Washout Period of at Least 7 Days||3
8354437|NCT01237899|20594078|P9|STARTED|Washout Period of at Least 7 Days||4
8354438|NCT01237899|20594079|P8|STARTED|Washout Period of at Least 7 Days||3
8354439|NCT01237899|20594080|P7|STARTED|Washout Period of at Least 7 Days||1
8354440|NCT01237899|20594081|P6|STARTED|Washout Period of at Least 7 Days||4
8354441|NCT01237899|20594082|P5|STARTED|Washout Period of at Least 7 Days||2
8354442|NCT01237899|20594083|P4|STARTED|Washout Period of at Least 7 Days||3
8354443|NCT01237899|20594084|P3|STARTED|Washout Period of at Least 7 Days||4
8354444|NCT01237899|20594085|P2|STARTED|Washout Period of at Least 7 Days||3
8354445|NCT01237899|20594086|P1|STARTED|Washout Period of at Least 7 Days||1
8354446|NCT01237899|20594076|P11|NOT COMPLETED|First Dosing Period||0
8354447|NCT01237899|20594077|P10|NOT COMPLETED|First Dosing Period||0
8354448|NCT01237899|20594078|P9|NOT COMPLETED|First Dosing Period||0
8354449|NCT01237899|20594079|P8|NOT COMPLETED|First Dosing Period||0
8354450|NCT01237899|20594080|P7|NOT COMPLETED|First Dosing Period||0
8354451|NCT01237899|20594081|P6|NOT COMPLETED|First Dosing Period||0
8354452|NCT01237899|20594082|P5|NOT COMPLETED|First Dosing Period||0
8354453|NCT01237899|20594083|P4|NOT COMPLETED|First Dosing Period||0
8354454|NCT01237899|20594084|P3|NOT COMPLETED|First Dosing Period||0
8354455|NCT01237899|20594085|P2|NOT COMPLETED|First Dosing Period||0
8354456|NCT01237899|20594086|P1|NOT COMPLETED|First Dosing Period||0
8354457|NCT01237899|20594076|P11|COMPLETED|First Dosing Period||4
8354458|NCT01237899|20594077|P10|COMPLETED|First Dosing Period||3
8354459|NCT01237899|20594078|P9|COMPLETED|First Dosing Period||4
8354460|NCT01237899|20594079|P8|COMPLETED|First Dosing Period||3
8354461|NCT01237899|20594080|P7|COMPLETED|First Dosing Period||1
8354462|NCT01237899|20594081|P6|COMPLETED|First Dosing Period||4
8354463|NCT01237899|20594082|P5|COMPLETED|First Dosing Period||2
8354464|NCT01237899|20594083|P4|COMPLETED|First Dosing Period||3
8354465|NCT01237899|20594084|P3|COMPLETED|First Dosing Period||4
8354466|NCT01237899|20594085|P2|COMPLETED|First Dosing Period||3
8354467|NCT01237899|20594086|P1|COMPLETED|First Dosing Period||1
8354468|NCT01237899|20594076|P11|STARTED|First Dosing Period||4
8354469|NCT01237899|20594077|P10|STARTED|First Dosing Period||3
8354470|NCT01237899|20594078|P9|STARTED|First Dosing Period||4
8354471|NCT01237899|20594079|P8|STARTED|First Dosing Period||3
8354472|NCT01237899|20594080|P7|STARTED|First Dosing Period||1
8354473|NCT01237899|20594081|P6|STARTED|First Dosing Period||4
8354474|NCT01237899|20594082|P5|STARTED|First Dosing Period||2
8354475|NCT01237899|20594083|P4|STARTED|First Dosing Period||3
8354476|NCT01237899|20594084|P3|STARTED|First Dosing Period||4
8354477|NCT01237899|20594085|P2|STARTED|First Dosing Period||3
8354478|NCT01237899|20594086|P1|STARTED|First Dosing Period||1
8354479|NCT01237821|20594116|P2|NOT COMPLETED|Overall Study||0
8354480|NCT01237821|20594117|P1|NOT COMPLETED|Overall Study||6
8354481|NCT01237821|20594116|P2|COMPLETED|Overall Study||34
8354482|NCT01237821|20594117|P1|COMPLETED|Overall Study||26
8354483|NCT01237821|20594116|P2|STARTED|Overall Study||34
8354484|NCT01237821|20594117|P1|STARTED|Overall Study||32
8354485|NCT01237678|20594166|P3|NOT COMPLETED|Phase II||50
8354486|NCT01237678|20594167|P2|NOT COMPLETED|Phase II||98
8354487|NCT01237678|20594168|P1|NOT COMPLETED|Phase II||0
8354488|NCT01237678|20594166|P3|COMPLETED|Phase II||0
8354489|NCT01237678|20594167|P2|COMPLETED|Phase II||0
8354490|NCT01237678|20594168|P1|COMPLETED|Phase II||0
8354491|NCT01237678|20594166|P3|Received Intervention|Phase II||47
8354492|NCT01237678|20594167|P2|Received Intervention|Phase II||94
8354493|NCT01237678|20594168|P1|Received Intervention|Phase II||0
8354494|NCT01237678|20594166|P3|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
8354495|NCT01237678|20594167|P2|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
8354496|NCT01237678|20594168|P1|STARTED|Phase II||0
8354497|NCT01237678|20594166|P3|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8354498|NCT01237678|20594167|P2|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8354499|NCT01237678|20594168|P1|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
8354500|NCT01237678|20594166|P3|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8354501|NCT01237678|20594167|P2|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8354502|NCT01237678|20594168|P1|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
8354503|NCT01237678|20594166|P3|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
8354504|NCT01237678|20594167|P2|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
8354505|NCT01237678|20594168|P1|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
8354506|NCT01237678|20594166|P3|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
8354507|NCT01237678|20594167|P2|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
8354508|NCT01237678|20594168|P1|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
8354509|NCT01237613|20594187|P1|NOT COMPLETED|Overall Study||0
8354510|NCT01237613|20594187|P1|COMPLETED|Overall Study||4
8354511|NCT01237613|20594187|P1|STARTED|Overall Study||4
8354512|NCT01237587|20594213|P2|NOT COMPLETED|Taper Phase||10
8354513|NCT01237587|20594214|P1|NOT COMPLETED|Taper Phase||5
8354514|NCT01237587|20594213|P2|COMPLETED|Taper Phase||34
8354515|NCT01237587|20594214|P1|COMPLETED|Taper Phase||31
8354516|NCT01237587|20594213|P2|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
8354517|NCT01237587|20594214|P1|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
8354518|NCT01237587|20594213|P2|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
8354519|NCT01237587|20594214|P1|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
8354520|NCT01237587|20594213|P2|COMPLETED|Open Label Treatment (Extension Phase)||50
8354521|NCT01237587|20594214|P1|COMPLETED|Open Label Treatment (Extension Phase)||56
8354522|NCT01237587|20594213|P2|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
8354523|NCT01237587|20594214|P1|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
8354524|NCT01237587|20594213|P2|STARTED|Open Label Treatment (Extension Phase)||75
8354525|NCT01237587|20594214|P1|STARTED|Open Label Treatment (Extension Phase)||74
8354526|NCT01237587|20594213|P2|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
8354527|NCT01237587|20594214|P1|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
8354528|NCT01237587|20594213|P2|COMPLETED|Double Blind Treatment (Acute Phase)||75
8354529|NCT01237587|20594214|P1|COMPLETED|Double Blind Treatment (Acute Phase)||74
8354530|NCT01237587|20594213|P2|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
8354531|NCT01237587|20594214|P1|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
8354532|NCT01237587|20594213|P2|STARTED|Double Blind Treatment (Acute Phase)||93
8354533|NCT01237587|20594214|P1|STARTED|Double Blind Treatment (Acute Phase)||91
8354534|NCT01237353|20594261|P1|NOT COMPLETED|Overall Study||0
8354535|NCT01237353|20594261|P1|COMPLETED|Overall Study||6
8354536|NCT01237353|20594261|P1|STARTED|Overall Study||6
8354537|NCT01237340|20594266|P1|NOT COMPLETED|Overall Study||40
8354538|NCT01237340|20594266|P1|COMPLETED|Overall Study||19
8354539|NCT01237340|20594266|P1|STARTED|Overall Study||59
8354540|NCT01237327|20594280|P2|NOT COMPLETED|Overall Study||40
8354541|NCT01237327|20594281|P1|NOT COMPLETED|Overall Study||42
8354542|NCT01237327|20594280|P2|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
8354543|NCT01237327|20594281|P1|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
8354544|NCT01237327|20594280|P2|Continued Treatment in Extension Study|Overall Study||17
8354545|NCT01237327|20594281|P1|Continued Treatment in Extension Study|Overall Study||21
8354546|NCT01237327|20594280|P2|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
8354547|NCT01237327|20594281|P1|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
8354548|NCT01237327|20594280|P2|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
8354549|NCT01237327|20594281|P1|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
8354550|NCT01237327|20594280|P2|STARTED|Overall Study||41
8354551|NCT01237327|20594281|P1|STARTED|Overall Study||43
8354552|NCT01237301|20594297|P2|NOT COMPLETED|Overall Study||4
8354553|NCT01237301|20594298|P1|NOT COMPLETED|Overall Study||5
8354554|NCT01237301|20594297|P2|COMPLETED|Overall Study||55
8354555|NCT01237301|20594298|P1|COMPLETED|Overall Study||60
8354556|NCT01237301|20594297|P2|STARTED|Overall Study||59
8354557|NCT01237301|20594298|P1|STARTED|Overall Study||65
8354558|NCT01237223|20594316|P6|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
8354559|NCT01237223|20594317|P5|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
8354560|NCT01237223|20594318|P4|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
8354561|NCT01237223|20594319|P3|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
8354562|NCT01237223|20594320|P2|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
8354563|NCT01237223|20594321|P1|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
8354564|NCT01237223|20594316|P6|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
8354565|NCT01237223|20594317|P5|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
8354566|NCT01237223|20594318|P4|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
8354567|NCT01237223|20594319|P3|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
8354568|NCT01237223|20594320|P2|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
8354569|NCT01237223|20594321|P1|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
8354570|NCT01237223|20594316|P6|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
8354571|NCT01237223|20594317|P5|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
8354572|NCT01237223|20594318|P4|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
8354573|NCT01237223|20594319|P3|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
8354574|NCT01237223|20594320|P2|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
8354575|NCT01237223|20594321|P1|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
8354576|NCT01237223|20594316|P6|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354577|NCT01237223|20594317|P5|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354578|NCT01237223|20594318|P4|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354579|NCT01237223|20594319|P3|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354580|NCT01237223|20594320|P2|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354581|NCT01237223|20594321|P1|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
8354582|NCT01237223|20594316|P6|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354583|NCT01237223|20594317|P5|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354584|NCT01237223|20594318|P4|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354585|NCT01237223|20594319|P3|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354586|NCT01237223|20594320|P2|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
8354587|NCT01237223|20594321|P1|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
8354588|NCT01237223|20594316|P6|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8354589|NCT01237223|20594317|P5|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8354590|NCT01237223|20594318|P4|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8354591|NCT01237223|20594319|P3|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8354592|NCT01237223|20594320|P2|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
8354593|NCT01237223|20594321|P1|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
8354594|NCT01237197|20594362|P2|NOT COMPLETED|Open Label Period||0
8354595|NCT01237197|20594363|P1|NOT COMPLETED|Open Label Period||0
8354596|NCT01237197|20594362|P2|COMPLETED|Open Label Period||10
8354597|NCT01237197|20594363|P1|COMPLETED|Open Label Period||12
8354598|NCT01237197|20594362|P2|STARTED|Open Label Period||10
8354599|NCT01237197|20594363|P1|STARTED|Open Label Period||12
8354600|NCT01237197|20594362|P2|NOT COMPLETED|Randomization Period||3
8354601|NCT01237197|20594363|P1|NOT COMPLETED|Randomization Period||1
8354602|NCT01237197|20594362|P2|COMPLETED|Randomization Period||10
8354603|NCT01237197|20594363|P1|COMPLETED|Randomization Period||12
8354604|NCT01237197|20594362|P2|STARTED|Randomization Period||13
8354605|NCT01237197|20594363|P1|STARTED|Randomization Period||13
8354606|NCT01237080|20594371|P2|NOT COMPLETED|Overall Study||0
8354607|NCT01237080|20594372|P1|NOT COMPLETED|Overall Study||0
8354608|NCT01237080|20594371|P2|COMPLETED|Overall Study||50
8354609|NCT01237080|20594372|P1|COMPLETED|Overall Study||50
8354610|NCT01237080|20594371|P2|STARTED|Overall Study||50
8354611|NCT01237080|20594372|P1|STARTED|Overall Study||50
8354612|NCT01237054|20594380|P1|NOT COMPLETED|Overall Study||1
8354613|NCT01237054|20594380|P1|COMPLETED|Overall Study||30
8354614|NCT01237054|20594380|P1|STARTED|Overall Study||31
8354615|NCT01237041|20594406|P5|NOT COMPLETED|Overall Study||0
8354616|NCT01237041|20594407|P4|NOT COMPLETED|Overall Study||0
8354617|NCT01237041|20594408|P3|NOT COMPLETED|Overall Study||0
8354618|NCT01237041|20594409|P2|NOT COMPLETED|Overall Study||0
8354619|NCT01237041|20594410|P1|NOT COMPLETED|Overall Study||0
8354620|NCT01237041|20594406|P5|COMPLETED|Overall Study||5
8354621|NCT01237041|20594407|P4|COMPLETED|Overall Study||5
8354622|NCT01237041|20594408|P3|COMPLETED|Overall Study||2
8354623|NCT01237041|20594409|P2|COMPLETED|Overall Study||3
8354624|NCT01237041|20594410|P1|COMPLETED|Overall Study||2
8354625|NCT01237041|20594406|P5|STARTED|Overall Study||5
8354626|NCT01237041|20594407|P4|STARTED|Overall Study||5
8354627|NCT01237041|20594408|P3|STARTED|Overall Study||2
8354628|NCT01237041|20594409|P2|STARTED|Overall Study||3
8354629|NCT01237041|20594410|P1|STARTED|Overall Study||2
8354630|NCT01236768|20594434|P2|NOT COMPLETED|Overall Study||61
8354631|NCT01236768|20594435|P1|NOT COMPLETED|Overall Study||89
8354632|NCT01236768|20594434|P2|COMPLETED|Overall Study||145
8354633|NCT01236768|20594435|P1|COMPLETED|Overall Study||112
8354634|NCT01236768|20594434|P2|STARTED|Overall Study||206
8354635|NCT01236768|20594435|P1|STARTED|Overall Study||201
8354636|NCT01236755|20594449|P1|NOT COMPLETED|Orthokeratology Wearing Phase||8
8354637|NCT01236755|20594449|P1|COMPLETED|Orthokeratology Wearing Phase||66
8354638|NCT01236755|20594449|P1|STARTED|Orthokeratology Wearing Phase||74
8354639|NCT01236755|20594449|P1|NOT COMPLETED|Spectacles Wearing Phase||17
8354640|NCT01236755|20594449|P1|COMPLETED|Spectacles Wearing Phase||74
8354641|NCT01236755|20594449|P1|STARTED|Spectacles Wearing Phase||91
8354642|NCT01236742|20594457|P3|NOT COMPLETED|Overall Study||3
8354643|NCT01236742|20594458|P2|NOT COMPLETED|Overall Study||3
8354644|NCT01236742|20594459|P1|NOT COMPLETED|Overall Study||3
8354645|NCT01236742|20594457|P3|COMPLETED|Overall Study||13
8354646|NCT01236742|20594458|P2|COMPLETED|Overall Study||16
8354647|NCT01236742|20594459|P1|COMPLETED|Overall Study||15
8354648|NCT01236742|20594457|P3|STARTED|Overall Study||16
8354649|NCT01236742|20594458|P2|STARTED|Overall Study||19
8354650|NCT01236742|20594459|P1|STARTED|Overall Study||18
8354651|NCT01236534|20594472|P2|NOT COMPLETED|Overall Study||0
8354652|NCT01236534|20594473|P1|NOT COMPLETED|Overall Study||3
8354653|NCT01236534|20594472|P2|COMPLETED|Overall Study||10
8354654|NCT01236534|20594473|P1|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
8354655|NCT01236534|20594472|P2|STARTED|Overall Study||10
8354656|NCT01236534|20594473|P1|STARTED|Overall Study||11
8354657|NCT01236391|20594481|P1|NOT COMPLETED|Overall Study||16
8354658|NCT01236391|20594481|P1|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
8354659|NCT01236391|20594481|P1|STARTED|Overall Study|Participants who received study treatment|111
8354660|NCT01236365|20594491|P2|NOT COMPLETED|Overall Study||2
8354661|NCT01236365|20594492|P1|NOT COMPLETED|Overall Study||2
8354662|NCT01236365|20594491|P2|COMPLETED|Overall Study||19
8354663|NCT01236365|20594492|P1|COMPLETED|Overall Study||19
8354664|NCT01236365|20594491|P2|STARTED|Overall Study||21
8354665|NCT01236365|20594492|P1|STARTED|Overall Study||21
8354666|NCT01236339|20594516|P2|NOT COMPLETED|Overall Study||13
8354667|NCT01236339|20594517|P1|NOT COMPLETED|Overall Study||11
8354668|NCT01236339|20594516|P2|COMPLETED|Overall Study||0
8354669|NCT01236339|20594517|P1|COMPLETED|Overall Study||2
8354670|NCT01236339|20594516|P2|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
8354671|NCT01236339|20594517|P1|LVP Crossover to TIPS|Overall Study||0
8354672|NCT01236339|20594516|P2|STARTED|Overall Study||13
8354673|NCT01236339|20594517|P1|STARTED|Overall Study||13
8354674|NCT01235923|20594537|P2|NOT COMPLETED|Overall Study||0
8354675|NCT01235923|20594538|P1|NOT COMPLETED|Overall Study||0
8354676|NCT01235923|20594537|P2|COMPLETED|Overall Study||10
8354677|NCT01235923|20594538|P1|COMPLETED|Overall Study||10
8354678|NCT01235923|20594537|P2|STARTED|Overall Study||10
8354679|NCT01235923|20594538|P1|STARTED|Overall Study||10
8354680|NCT01235793|20594546|P1|NOT COMPLETED|Overall Study||6
8354681|NCT01235793|20594546|P1|COMPLETED|Overall Study||5
8354682|NCT01235793|20594546|P1|STARTED|Overall Study||11
8354683|NCT01236573|20594562|P11|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
8354684|NCT01236573|20594563|P10|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354685|NCT01236573|20594564|P9|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354686|NCT01236573|20594565|P8|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354687|NCT01236573|20594566|P7|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354688|NCT01236573|20594567|P6|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354689|NCT01236573|20594568|P5|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354690|NCT01236573|20594569|P4|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354691|NCT01236573|20594570|P3|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354692|NCT01236573|20594571|P2|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354693|NCT01236573|20594572|P1|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354694|NCT01236573|20594562|P11|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
8354695|NCT01236573|20594563|P10|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354696|NCT01236573|20594564|P9|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354697|NCT01236573|20594565|P8|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354698|NCT01236573|20594566|P7|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354699|NCT01236573|20594567|P6|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354700|NCT01236573|20594568|P5|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354701|NCT01236573|20594569|P4|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354702|NCT01236573|20594570|P3|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354703|NCT01236573|20594571|P2|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354704|NCT01236573|20594572|P1|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354705|NCT01236573|20594562|P11|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
8354706|NCT01236573|20594563|P10|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354707|NCT01236573|20594564|P9|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354708|NCT01236573|20594565|P8|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354709|NCT01236573|20594566|P7|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354710|NCT01236573|20594567|P6|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354711|NCT01236573|20594568|P5|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354712|NCT01236573|20594569|P4|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354713|NCT01236573|20594570|P3|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354714|NCT01236573|20594571|P2|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354715|NCT01236573|20594572|P1|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
8354716|NCT01236573|20594562|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354717|NCT01236573|20594563|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
8354718|NCT01236573|20594564|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
8354719|NCT01236573|20594565|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354720|NCT01236573|20594566|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
8354721|NCT01236573|20594567|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354722|NCT01236573|20594568|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354723|NCT01236573|20594569|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354724|NCT01236573|20594570|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354725|NCT01236573|20594571|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354726|NCT01236573|20594572|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354727|NCT01236573|20594562|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354728|NCT01236573|20594563|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
8354729|NCT01236573|20594564|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
8354730|NCT01236573|20594565|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
8354731|NCT01236573|20594566|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
8354732|NCT01236573|20594567|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
8354733|NCT01236573|20594568|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
8354734|NCT01236573|20594569|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354735|NCT01236573|20594570|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354736|NCT01236573|20594571|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354737|NCT01236573|20594572|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354738|NCT01236573|20594562|P11|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354739|NCT01236573|20594563|P10|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
8354740|NCT01236573|20594564|P9|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
8354741|NCT01236573|20594565|P8|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
8354742|NCT01236573|20594566|P7|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
8354743|NCT01236573|20594567|P6|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
8354744|NCT01236573|20594568|P5|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
8354745|NCT01236573|20594569|P4|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354746|NCT01236573|20594570|P3|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354747|NCT01236573|20594571|P2|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354748|NCT01236573|20594572|P1|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
8354749|NCT01236573|20594562|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354750|NCT01236573|20594563|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354751|NCT01236573|20594564|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354752|NCT01236573|20594565|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354753|NCT01236573|20594566|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354754|NCT01236573|20594567|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354755|NCT01236573|20594568|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354756|NCT01236573|20594569|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354757|NCT01236573|20594570|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354758|NCT01236573|20594571|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354759|NCT01236573|20594572|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354760|NCT01236573|20594562|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354761|NCT01236573|20594563|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354762|NCT01236573|20594564|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354763|NCT01236573|20594565|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354764|NCT01236573|20594566|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354765|NCT01236573|20594567|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354766|NCT01236573|20594568|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354767|NCT01236573|20594569|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
8354768|NCT01236573|20594570|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
8354769|NCT01236573|20594571|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
8354770|NCT01236573|20594572|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
8354771|NCT01236573|20594562|P11|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354772|NCT01236573|20594563|P10|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354773|NCT01236573|20594564|P9|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354774|NCT01236573|20594565|P8|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354775|NCT01236573|20594566|P7|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354776|NCT01236573|20594567|P6|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354777|NCT01236573|20594568|P5|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
8354778|NCT01236573|20594569|P4|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
8354779|NCT01236573|20594570|P3|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
8354780|NCT01236573|20594571|P2|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
8354781|NCT01236573|20594572|P1|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
8354800|NCT01236521|20594640|P2|NOT COMPLETED|Overall Study||25
8354801|NCT01236521|20594641|P1|NOT COMPLETED|Overall Study||21
8354802|NCT01236521|20594640|P2|COMPLETED|Overall Study||105
8354803|NCT01236521|20594641|P1|COMPLETED|Overall Study||110
8354804|NCT01236521|20594640|P2|12-moth Completed|Overall Study||105
8354805|NCT01236521|20594641|P1|12-moth Completed|Overall Study||110
8354806|NCT01236521|20594640|P2|9-month Completed|Overall Study||101
8354807|NCT01236521|20594641|P1|9-month Completed|Overall Study||115
8354808|NCT01236521|20594640|P2|6-month Completed|Overall Study||116
8354809|NCT01236521|20594641|P1|6-month Completed|Overall Study||122
8354810|NCT01236521|20594640|P2|3-month Completed|Overall Study||119
8354811|NCT01236521|20594641|P1|3-month Completed|Overall Study||122
8354812|NCT01236521|20594640|P2|STARTED|Overall Study||130
8354813|NCT01236521|20594641|P1|STARTED|Overall Study||131
8354814|NCT01236378|20594669|P1|NOT COMPLETED|Overall Study||0
8354815|NCT01236378|20594669|P1|COMPLETED|Overall Study||24
8354816|NCT01236378|20594669|P1|STARTED|Overall Study||24
8354817|NCT01236352|20594692|P11|NOT COMPLETED|Overall Study||20
8354818|NCT01236352|20594693|P10|NOT COMPLETED|Overall Study||22
8354819|NCT01236352|20594694|P9|NOT COMPLETED|Overall Study||3
8354820|NCT01236352|20594695|P8|NOT COMPLETED|Overall Study||7
8354821|NCT01236352|20594696|P7|NOT COMPLETED|Overall Study||8
8354822|NCT01236352|20594697|P6|NOT COMPLETED|Overall Study||4
8354823|NCT01236352|20594698|P5|NOT COMPLETED|Overall Study||4
8354824|NCT01236352|20594699|P4|NOT COMPLETED|Overall Study||3
8354825|NCT01236352|20594700|P3|NOT COMPLETED|Overall Study||4
8354826|NCT01236352|20594701|P2|NOT COMPLETED|Overall Study||4
8354827|NCT01236352|20594702|P1|NOT COMPLETED|Overall Study||4
8354828|NCT01236352|20594692|P11|COMPLETED|Overall Study||0
8354829|NCT01236352|20594693|P10|COMPLETED|Overall Study||0
8354830|NCT01236352|20594694|P9|COMPLETED|Overall Study||0
8354831|NCT01236352|20594695|P8|COMPLETED|Overall Study||0
8354832|NCT01236352|20594696|P7|COMPLETED|Overall Study||0
8354833|NCT01236352|20594697|P6|COMPLETED|Overall Study||0
8354834|NCT01236352|20594698|P5|COMPLETED|Overall Study||0
8354835|NCT01236352|20594699|P4|COMPLETED|Overall Study||1
8354836|NCT01236352|20594700|P3|COMPLETED|Overall Study||0
8354837|NCT01236352|20594701|P2|COMPLETED|Overall Study||0
8354838|NCT01236352|20594702|P1|COMPLETED|Overall Study||0
8354839|NCT01236352|20594692|P11|STARTED|Overall Study||20
8354840|NCT01236352|20594693|P10|STARTED|Overall Study||22
8354841|NCT01236352|20594694|P9|STARTED|Overall Study||3
8354842|NCT01236352|20594695|P8|STARTED|Overall Study||7
8354843|NCT01236352|20594696|P7|STARTED|Overall Study||8
8354844|NCT01236352|20594697|P6|STARTED|Overall Study||4
8354845|NCT01236352|20594698|P5|STARTED|Overall Study||4
8354846|NCT01236352|20594699|P4|STARTED|Overall Study||4
8354847|NCT01236352|20594700|P3|STARTED|Overall Study||4
8354848|NCT01236352|20594701|P2|STARTED|Overall Study||4
8354849|NCT01236352|20594702|P1|STARTED|Overall Study||4
8354850|NCT01236326|20594871|P2|NOT COMPLETED|Overall Study||4
8354851|NCT01236326|20594872|P1|NOT COMPLETED|Overall Study||1
8354852|NCT01236326|20594871|P2|COMPLETED|Overall Study||51
8354853|NCT01236326|20594872|P1|COMPLETED|Overall Study||49
8354854|NCT01236326|20594871|P2|STARTED|Overall Study||55
8354855|NCT01236326|20594872|P1|STARTED|Overall Study||50
8354856|NCT01236300|20594886|P1|NOT COMPLETED|Overall Study||0
8354857|NCT01236300|20594886|P1|COMPLETED|Overall Study||66
8354858|NCT01236300|20594886|P1|STARTED|Overall Study||66
8354859|NCT01236196|20594896|P2|NOT COMPLETED|Overall Study||8
8354860|NCT01236196|20594897|P1|NOT COMPLETED|Overall Study||1
8354861|NCT01236196|20594896|P2|COMPLETED|Overall Study||13
8354862|NCT01236196|20594897|P1|COMPLETED|Overall Study||17
8354863|NCT01236196|20594896|P2|STARTED|Overall Study||21
8354864|NCT01236196|20594897|P1|STARTED|Overall Study||18
8354865|NCT01236170|20594909|P1|NOT COMPLETED|Overall Study||15
8354866|NCT01236170|20594909|P1|COMPLETED|Overall Study||482
8354867|NCT01236170|20594909|P1|STARTED|Overall Study||497
8354868|NCT01236118|20594920|P3|NOT COMPLETED|Overall Study||3
8354869|NCT01236118|20594921|P2|NOT COMPLETED|Overall Study||1
8354870|NCT01236118|20594922|P1|NOT COMPLETED|Overall Study||2
8354871|NCT01236118|20594920|P3|COMPLETED|Overall Study||14
8354872|NCT01236118|20594921|P2|COMPLETED|Overall Study||4
8354873|NCT01236118|20594922|P1|COMPLETED|Overall Study||4
8354874|NCT01236118|20594920|P3|STARTED|Overall Study||17
8354875|NCT01236118|20594921|P2|STARTED|Overall Study||5
8354876|NCT01236118|20594922|P1|STARTED|Overall Study||6
8354877|NCT01236105|20594930|P1|NOT COMPLETED|Overall Study||0
8354878|NCT01236105|20594930|P1|COMPLETED|Overall Study||21
8354879|NCT01236105|20594930|P1|STARTED|Overall Study||21
8354880|NCT01236053|20594966|P22|NOT COMPLETED|Overall Study||0
8354881|NCT01236053|20594967|P21|NOT COMPLETED|Overall Study||0
8354882|NCT01236053|20594968|P20|NOT COMPLETED|Overall Study||0
8354883|NCT01236053|20594969|P19|NOT COMPLETED|Overall Study||0
8354884|NCT01236053|20594970|P18|NOT COMPLETED|Overall Study||0
8354885|NCT01236053|20594971|P17|NOT COMPLETED|Overall Study||0
8354886|NCT01236053|20594972|P16|NOT COMPLETED|Overall Study||0
8354887|NCT01236053|20594973|P15|NOT COMPLETED|Overall Study||0
8354888|NCT01236053|20594974|P14|NOT COMPLETED|Overall Study||0
8354889|NCT01236053|20594975|P13|NOT COMPLETED|Overall Study||0
8354890|NCT01236053|20594976|P12|NOT COMPLETED|Overall Study||0
8354891|NCT01236053|20594977|P11|NOT COMPLETED|Overall Study||0
8354892|NCT01236053|20594978|P10|NOT COMPLETED|Overall Study||0
8354893|NCT01236053|20594979|P9|NOT COMPLETED|Overall Study||0
8354894|NCT01236053|20594980|P8|NOT COMPLETED|Overall Study||0
8354895|NCT01236053|20594981|P7|NOT COMPLETED|Overall Study||0
8354896|NCT01236053|20594982|P6|NOT COMPLETED|Overall Study||0
8354897|NCT01236053|20594983|P5|NOT COMPLETED|Overall Study||0
8354898|NCT01236053|20594984|P4|NOT COMPLETED|Overall Study||0
8354899|NCT01236053|20594985|P3|NOT COMPLETED|Overall Study||0
8354900|NCT01236053|20594986|P2|NOT COMPLETED|Overall Study||0
8354901|NCT01236053|20594987|P1|NOT COMPLETED|Overall Study||0
8354902|NCT01236053|20594966|P22|COMPLETED|Overall Study||12167
8354903|NCT01236053|20594967|P21|COMPLETED|Overall Study||1272
8354904|NCT01236053|20594968|P20|COMPLETED|Overall Study||20382
8354905|NCT01236053|20594969|P19|COMPLETED|Overall Study||2155
8354906|NCT01236053|20594970|P18|COMPLETED|Overall Study||380
8354907|NCT01236053|20594971|P17|COMPLETED|Overall Study||38
8354908|NCT01236053|20594972|P16|COMPLETED|Overall Study||43559
8354909|NCT01236053|20594973|P15|COMPLETED|Overall Study||4600
8354910|NCT01236053|20594974|P14|COMPLETED|Overall Study||1396
8354911|NCT01236053|20594975|P13|COMPLETED|Overall Study||148
8354912|NCT01236053|20594976|P12|COMPLETED|Overall Study||188924
8354913|NCT01236053|20594977|P11|COMPLETED|Overall Study||19564
8354914|NCT01236053|20594978|P10|COMPLETED|Overall Study||2935
8354915|NCT01236053|20594979|P9|COMPLETED|Overall Study||300
8354916|NCT01236053|20594980|P8|COMPLETED|Overall Study||102836
8354917|NCT01236053|20594981|P7|COMPLETED|Overall Study||10855
8354918|NCT01236053|20594982|P6|COMPLETED|Overall Study||2067
8354919|NCT01236053|20594983|P5|COMPLETED|Overall Study||212
8354920|NCT01236053|20594984|P4|COMPLETED|Overall Study||17853
8354921|NCT01236053|20594985|P3|COMPLETED|Overall Study||1877
8354922|NCT01236053|20594986|P2|COMPLETED|Overall Study||1710950
8354923|NCT01236053|20594987|P1|COMPLETED|Overall Study||179138
8354924|NCT01236053|20594966|P22|STARTED|Overall Study||12167
8354925|NCT01236053|20594967|P21|STARTED|Overall Study||1272
8354926|NCT01236053|20594968|P20|STARTED|Overall Study||20382
8354927|NCT01236053|20594969|P19|STARTED|Overall Study||2155
8354928|NCT01236053|20594970|P18|STARTED|Overall Study||380
8354929|NCT01236053|20594971|P17|STARTED|Overall Study||38
8354930|NCT01236053|20594972|P16|STARTED|Overall Study||43559
8354931|NCT01236053|20594973|P15|STARTED|Overall Study||4600
8354932|NCT01236053|20594974|P14|STARTED|Overall Study||1396
8354933|NCT01236053|20594975|P13|STARTED|Overall Study||148
8354934|NCT01236053|20594976|P12|STARTED|Overall Study||188924
8354935|NCT01236053|20594977|P11|STARTED|Overall Study||19564
8354936|NCT01236053|20594978|P10|STARTED|Overall Study||2935
8354937|NCT01236053|20594979|P9|STARTED|Overall Study||300
8354938|NCT01236053|20594980|P8|STARTED|Overall Study||102836
8354939|NCT01236053|20594981|P7|STARTED|Overall Study||10855
8354940|NCT01236053|20594982|P6|STARTED|Overall Study||2067
8354941|NCT01236053|20594983|P5|STARTED|Overall Study||212
8354942|NCT01236053|20594984|P4|STARTED|Overall Study||17853
8354943|NCT01236053|20594985|P3|STARTED|Overall Study||1877
8354944|NCT01236053|20594986|P2|STARTED|Overall Study||1710950
8354945|NCT01236053|20594987|P1|STARTED|Overall Study||179138
8354946|NCT01236001|20595123|P2|NOT COMPLETED|Overall Study||22
8354947|NCT01236001|20595124|P1|NOT COMPLETED|Overall Study||18
8354948|NCT01236001|20595123|P2|COMPLETED|Overall Study||65
8354949|NCT01236001|20595124|P1|COMPLETED|Overall Study||87
8354950|NCT01236001|20595123|P2|STARTED|Overall Study||87
8354951|NCT01236001|20595124|P1|STARTED|Overall Study||105
8354952|NCT01235975|20595156|P2|NOT COMPLETED|Overall Study||7
8354953|NCT01235975|20595157|P1|NOT COMPLETED|Overall Study||17
8354954|NCT01235975|20595156|P2|COMPLETED|Overall Study||88
8354955|NCT01235975|20595157|P1|COMPLETED|Overall Study||257
8354956|NCT01235975|20595156|P2|STARTED|Overall Study||95
8354957|NCT01235975|20595157|P1|STARTED|Overall Study||274
8354958|NCT01235962|20595193|P4|NOT COMPLETED|Overall Study||86
8354959|NCT01235962|20595194|P3|NOT COMPLETED|Overall Study||118
8354960|NCT01235962|20595195|P2|NOT COMPLETED|Overall Study||35
8354961|NCT01235962|20595196|P1|NOT COMPLETED|Overall Study||46
8354962|NCT01235962|20595193|P4|COMPLETED|Overall Study||478
8354963|NCT01235962|20595194|P3|COMPLETED|Overall Study||453
8354964|NCT01235962|20595195|P2|COMPLETED|Overall Study||170
8354965|NCT01235962|20595196|P1|COMPLETED|Overall Study||152
8354966|NCT01235962|20595193|P4|All Deaths|Overall Study||104
8354967|NCT01235962|20595194|P3|All Deaths|Overall Study||102
8354968|NCT01235962|20595195|P2|All Deaths|Overall Study||46
8354969|NCT01235962|20595196|P1|All Deaths|Overall Study||43
8354970|NCT01235962|20595193|P4|Prem. Withdrawn = Did Not Complete Study|Overall Study||86
8354971|NCT01235962|20595194|P3|Prem. Withdrawn = Did Not Complete Study|Overall Study||118
8354972|NCT01235962|20595195|P2|Prem. Withdrawn = Did Not Complete Study|Overall Study||35
8354973|NCT01235962|20595196|P1|Prem. Withdrawn = Did Not Complete Study|Overall Study||46
8354974|NCT01235962|20595193|P4|STARTED|Overall Study||564
8354975|NCT01235962|20595194|P3|STARTED|Overall Study||571
8354976|NCT01235962|20595195|P2|STARTED|Overall Study||205
8354977|NCT01235962|20595196|P1|STARTED|Overall Study||198
8354978|NCT01235949|20595266|P18|NOT COMPLETED|Booster Phase||2
8354979|NCT01235949|20595267|P17|NOT COMPLETED|Booster Phase||0
8354980|NCT01235949|20595268|P16|NOT COMPLETED|Booster Phase||1
8354981|NCT01235949|20595269|P15|NOT COMPLETED|Booster Phase||2
8354982|NCT01235949|20595270|P14|NOT COMPLETED|Booster Phase||0
8354983|NCT01235949|20595271|P13|NOT COMPLETED|Booster Phase||3
8354984|NCT01235949|20595272|P12|NOT COMPLETED|Booster Phase||3
8354985|NCT01235949|20595273|P11|NOT COMPLETED|Booster Phase||2
8354986|NCT01235949|20595274|P10|NOT COMPLETED|Booster Phase||1
8354987|NCT01235949|20595275|P9|NOT COMPLETED|Booster Phase||2
8354988|NCT01235949|20595276|P8|NOT COMPLETED|Booster Phase||1
8354989|NCT01235949|20595277|P7|NOT COMPLETED|Booster Phase||0
8354990|NCT01235949|20595278|P6|NOT COMPLETED|Booster Phase||0
8354991|NCT01235949|20595279|P5|NOT COMPLETED|Booster Phase||0
8354992|NCT01235949|20595280|P4|NOT COMPLETED|Booster Phase||0
8354993|NCT01235949|20595281|P3|NOT COMPLETED|Booster Phase||0
8354994|NCT01235949|20595282|P2|NOT COMPLETED|Booster Phase||0
8354995|NCT01235949|20595283|P1|NOT COMPLETED|Booster Phase||0
8354996|NCT01235949|20595266|P18|COMPLETED|Booster Phase||65
8354997|NCT01235949|20595267|P17|COMPLETED|Booster Phase||68
8354998|NCT01235949|20595268|P16|COMPLETED|Booster Phase||66
8354999|NCT01235949|20595269|P15|COMPLETED|Booster Phase||60
8355000|NCT01235949|20595270|P14|COMPLETED|Booster Phase||65
8355001|NCT01235949|20595271|P13|COMPLETED|Booster Phase||60
8355002|NCT01235949|20595272|P12|COMPLETED|Booster Phase||60
8355003|NCT01235949|20595273|P11|COMPLETED|Booster Phase||61
8355004|NCT01235949|20595274|P10|COMPLETED|Booster Phase||62
8355005|NCT01235949|20595275|P9|COMPLETED|Booster Phase||61
8355006|NCT01235949|20595276|P8|COMPLETED|Booster Phase||59
8355007|NCT01235949|20595277|P7|COMPLETED|Booster Phase||64
8355008|NCT01235949|20595278|P6|COMPLETED|Booster Phase||0
8355009|NCT01235949|20595279|P5|COMPLETED|Booster Phase||0
8355010|NCT01235949|20595280|P4|COMPLETED|Booster Phase||0
8355011|NCT01235949|20595281|P3|COMPLETED|Booster Phase||0
8355012|NCT01235949|20595282|P2|COMPLETED|Booster Phase||0
8355013|NCT01235949|20595283|P1|COMPLETED|Booster Phase||0
8355014|NCT01235949|20595266|P18|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67
8355015|NCT01235949|20595267|P17|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68
8355016|NCT01235949|20595268|P16|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67
8355017|NCT01235949|20595269|P15|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62
8355018|NCT01235949|20595270|P14|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65
8355019|NCT01235949|20595271|P13|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63
8355020|NCT01235949|20595272|P12|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
8355021|NCT01235949|20595273|P11|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
8355022|NCT01235949|20595274|P10|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
8355023|NCT01235949|20595275|P9|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63
8355024|NCT01235949|20595276|P8|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60
8355025|NCT01235949|20595277|P7|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64
8355026|NCT01235949|20595278|P6|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0
8355027|NCT01235949|20595279|P5|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0
8355028|NCT01235949|20595280|P4|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0
8355029|NCT01235949|20595281|P3|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0
8355030|NCT01235949|20595282|P2|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0
8355031|NCT01235949|20595283|P1|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0
8355032|NCT01235949|20595266|P18|NOT COMPLETED|Primary Phase||0
8355033|NCT01235949|20595267|P17|NOT COMPLETED|Primary Phase||0
8355034|NCT01235949|20595268|P16|NOT COMPLETED|Primary Phase||0
8355035|NCT01235949|20595269|P15|NOT COMPLETED|Primary Phase||0
8355036|NCT01235949|20595270|P14|NOT COMPLETED|Primary Phase||0
8355037|NCT01235949|20595271|P13|NOT COMPLETED|Primary Phase||0
8355038|NCT01235949|20595272|P12|NOT COMPLETED|Primary Phase||0
8355039|NCT01235949|20595273|P11|NOT COMPLETED|Primary Phase||0
8355040|NCT01235949|20595274|P10|NOT COMPLETED|Primary Phase||0
8355041|NCT01235949|20595275|P9|NOT COMPLETED|Primary Phase||0
8355042|NCT01235949|20595276|P8|NOT COMPLETED|Primary Phase||0
8355043|NCT01235949|20595277|P7|NOT COMPLETED|Primary Phase||0
8355044|NCT01235949|20595278|P6|NOT COMPLETED|Primary Phase||7
8355045|NCT01235949|20595279|P5|NOT COMPLETED|Primary Phase||1
8355046|NCT01235949|20595280|P4|NOT COMPLETED|Primary Phase||2
8355047|NCT01235949|20595281|P3|NOT COMPLETED|Primary Phase||3
8355048|NCT01235949|20595282|P2|NOT COMPLETED|Primary Phase||3
8355049|NCT01235949|20595283|P1|NOT COMPLETED|Primary Phase||4
8355050|NCT01235949|20595266|P18|COMPLETED|Primary Phase||0
8355051|NCT01235949|20595267|P17|COMPLETED|Primary Phase||0
8355052|NCT01235949|20595268|P16|COMPLETED|Primary Phase||0
8355053|NCT01235949|20595269|P15|COMPLETED|Primary Phase||0
8355054|NCT01235949|20595270|P14|COMPLETED|Primary Phase||0
8355055|NCT01235949|20595271|P13|COMPLETED|Primary Phase||0
8355056|NCT01235949|20595272|P12|COMPLETED|Primary Phase||0
8355057|NCT01235949|20595273|P11|COMPLETED|Primary Phase||0
8355058|NCT01235949|20595274|P10|COMPLETED|Primary Phase||0
8355059|NCT01235949|20595275|P9|COMPLETED|Primary Phase||0
8355060|NCT01235949|20595276|P8|COMPLETED|Primary Phase||0
8355061|NCT01235949|20595277|P7|COMPLETED|Primary Phase||0
8355062|NCT01235949|20595278|P6|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67
8355063|NCT01235949|20595279|P5|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71
8355064|NCT01235949|20595280|P4|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69
8355065|NCT01235949|20595281|P3|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196
8355066|NCT01235949|20595282|P2|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195
8355067|NCT01235949|20595283|P1|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194
8355068|NCT01235949|20595266|P18|STARTED|Primary Phase||0
8355069|NCT01235949|20595267|P17|STARTED|Primary Phase||0
8355070|NCT01235949|20595268|P16|STARTED|Primary Phase||0
8355071|NCT01235949|20595269|P15|STARTED|Primary Phase||0
8355072|NCT01235949|20595270|P14|STARTED|Primary Phase||0
8355073|NCT01235949|20595271|P13|STARTED|Primary Phase||0
8355074|NCT01235949|20595272|P12|STARTED|Primary Phase||0
8355075|NCT01235949|20595273|P11|STARTED|Primary Phase||0
8355076|NCT01235949|20595274|P10|STARTED|Primary Phase||0
8355077|NCT01235949|20595275|P9|STARTED|Primary Phase||0
8355078|NCT01235949|20595276|P8|STARTED|Primary Phase||0
8355079|NCT01235949|20595277|P7|STARTED|Primary Phase||0
8355080|NCT01235949|20595278|P6|STARTED|Primary Phase||74
8355081|NCT01235949|20595279|P5|STARTED|Primary Phase||72
8355082|NCT01235949|20595280|P4|STARTED|Primary Phase||71
8355083|NCT01235949|20595281|P3|STARTED|Primary Phase||199
8355084|NCT01235949|20595282|P2|STARTED|Primary Phase||198
8355085|NCT01235949|20595283|P1|STARTED|Primary Phase||198
8355086|NCT01235910|20595519|P1|NOT COMPLETED|Overall Study||0
8355087|NCT01235910|20595519|P1|COMPLETED|Overall Study||1
8355088|NCT01235910|20595519|P1|STARTED|Overall Study||1
8355089|NCT01235897|20595525|P1|NOT COMPLETED|Overall Study||0
8355090|NCT01235897|20595525|P1|COMPLETED|Overall Study||16
8355091|NCT01235897|20595525|P1|STARTED|Overall Study||16
8355092|NCT01235741|20595533|P3|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
8355093|NCT01235741|20595534|P2|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
8355094|NCT01235741|20595535|P1|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
8355095|NCT01235741|20595533|P3|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
8355096|NCT01235741|20595534|P2|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
8355097|NCT01235741|20595535|P1|COMPLETED|Follow-Up Post Treatment up to Month 6||0
8355098|NCT01235741|20595533|P3|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
8355099|NCT01235741|20595534|P2|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
8355100|NCT01235741|20595535|P1|STARTED|Follow-Up Post Treatment up to Month 6||0
8355101|NCT01235741|20595533|P3|NOT COMPLETED|Randomized to Treatment||36
8355102|NCT01235741|20595534|P2|NOT COMPLETED|Randomized to Treatment||36
8355103|NCT01235741|20595535|P1|NOT COMPLETED|Randomized to Treatment||0
8355104|NCT01235741|20595533|P3|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
8355105|NCT01235741|20595534|P2|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
8355106|NCT01235741|20595535|P1|COMPLETED|Randomized to Treatment||0
8355107|NCT01235741|20595533|P3|STARTED|Randomized to Treatment||36
8355108|NCT01235741|20595534|P2|STARTED|Randomized to Treatment||36
8355109|NCT01235741|20595535|P1|STARTED|Randomized to Treatment||0
8355110|NCT01235741|20595533|P3|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
8355111|NCT01235741|20595534|P2|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
8355112|NCT01235741|20595535|P1|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
8355113|NCT01235741|20595533|P3|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
8355114|NCT01235741|20595534|P2|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
8355115|NCT01235741|20595535|P1|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
8355116|NCT01235741|20595533|P3|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
8355117|NCT01235741|20595534|P2|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
8355118|NCT01235741|20595535|P1|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
8355119|NCT01235728|20595562|P8|NOT COMPLETED|Overall Study||0
8355120|NCT01235728|20595563|P7|NOT COMPLETED|Overall Study||0
8355121|NCT01235728|20595564|P6|NOT COMPLETED|Overall Study||0
8355122|NCT01235728|20595565|P5|NOT COMPLETED|Overall Study||0
8355123|NCT01235728|20595566|P4|NOT COMPLETED|Overall Study||1
8355124|NCT01235728|20595567|P3|NOT COMPLETED|Overall Study||0
8355125|NCT01235728|20595568|P2|NOT COMPLETED|Overall Study||0
8355126|NCT01235728|20595569|P1|NOT COMPLETED|Overall Study||0
8355127|NCT01235728|20595562|P8|COMPLETED|Overall Study||3
8355128|NCT01235728|20595563|P7|COMPLETED|Overall Study||3
8355129|NCT01235728|20595564|P6|COMPLETED|Overall Study||3
8355130|NCT01235728|20595565|P5|COMPLETED|Overall Study||3
8355131|NCT01235728|20595566|P4|COMPLETED|Overall Study||2
8355132|NCT01235728|20595567|P3|COMPLETED|Overall Study||3
8355133|NCT01235728|20595568|P2|COMPLETED|Overall Study||3
8355134|NCT01235728|20595569|P1|COMPLETED|Overall Study||3
8355135|NCT01235728|20595562|P8|STARTED|Overall Study||3
8355136|NCT01235728|20595563|P7|STARTED|Overall Study||3
8355137|NCT01235728|20595564|P6|STARTED|Overall Study||3
8355138|NCT01235728|20595565|P5|STARTED|Overall Study||3
8355139|NCT01235728|20595566|P4|STARTED|Overall Study||3
8355140|NCT01235728|20595567|P3|STARTED|Overall Study||3
8355141|NCT01235728|20595568|P2|STARTED|Overall Study||3
8355142|NCT01235728|20595569|P1|STARTED|Overall Study||3
8355143|NCT01235715|20595579|P2|NOT COMPLETED|Overall Study||2
8355144|NCT01235715|20595580|P1|NOT COMPLETED|Overall Study||0
8355145|NCT01235715|20595579|P2|COMPLETED|Overall Study||100
8355146|NCT01235715|20595580|P1|COMPLETED|Overall Study||98
8355147|NCT01235715|20595579|P2|STARTED|Overall Study||102
8355148|NCT01235715|20595580|P1|STARTED|Overall Study||98
8355149|NCT01235689|20595620|P2|NOT COMPLETED|Overall Study||32
8355150|NCT01235689|20595621|P1|NOT COMPLETED|Overall Study||29
8355151|NCT01235689|20595620|P2|COMPLETED|Overall Study||90
8355152|NCT01235689|20595621|P1|COMPLETED|Overall Study||93
8355153|NCT01235689|20595620|P2|Randomized at Week 9|Overall Study||53
8355154|NCT01235689|20595621|P1|Randomized at Week 9|Overall Study||59
8355155|NCT01235689|20595620|P2|Early Randomized (Baseline to Week 9)|Overall Study||69
8355156|NCT01235689|20595621|P1|Early Randomized (Baseline to Week 9)|Overall Study||63
8355157|NCT01235689|20595620|P2|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
8355158|NCT01235689|20595621|P1|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
8355159|NCT01235598|20595693|P2|NOT COMPLETED|Overall Study||4
8355160|NCT01235598|20595694|P1|NOT COMPLETED|Overall Study||1
8355161|NCT01235598|20595693|P2|COMPLETED|Overall Study||24
8355162|NCT01235598|20595694|P1|COMPLETED|Overall Study||12
8355163|NCT01235598|20595693|P2|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
8355164|NCT01235598|20595694|P1|STARTED|Overall Study||13
8355165|NCT01235546|20595739|P2|NOT COMPLETED|Overall Study||1
8355166|NCT01235546|20595740|P1|NOT COMPLETED|Overall Study||2
8355167|NCT01235546|20595739|P2|COMPLETED|Overall Study||1018
8355168|NCT01235546|20595740|P1|COMPLETED|Overall Study||992
8355169|NCT01235546|20595739|P2|STARTED|Overall Study||1019
8355170|NCT01235546|20595740|P1|STARTED|Overall Study||994
8355171|NCT01235507|20595764|P1|NOT COMPLETED|Overall Study||2
8355172|NCT01235507|20595764|P1|COMPLETED|Overall Study||69
8355173|NCT01235507|20595764|P1|STARTED|Overall Study||71
8355174|NCT01235442|20595778|P2|NOT COMPLETED|Overall Study||44
8355175|NCT01235442|20595779|P1|NOT COMPLETED|Overall Study||44
8355176|NCT01235442|20595778|P2|COMPLETED|Overall Study||251
8355177|NCT01235442|20595779|P1|COMPLETED|Overall Study||253
8355178|NCT01235442|20595778|P2|STARTED|Overall Study||295
8355179|NCT01235442|20595779|P1|STARTED|Overall Study||297
8355180|NCT01235403|20595797|P1|NOT COMPLETED|Overall Study||26
8355181|NCT01235403|20595797|P1|COMPLETED|Overall Study||74
8355182|NCT01235403|20595797|P1|STARTED|Overall Study||100
8355183|NCT01235377|20595805|P2|NOT COMPLETED|Overall Study||1
8355184|NCT01235377|20595806|P1|NOT COMPLETED|Overall Study||1
8355185|NCT01235377|20595805|P2|COMPLETED|Overall Study||8
8355186|NCT01235377|20595806|P1|COMPLETED|Overall Study||10
8355187|NCT01235377|20595805|P2|STARTED|Overall Study||9
8355188|NCT01235377|20595806|P1|STARTED|Overall Study||11
8355189|NCT01235351|20595814|P2|NOT COMPLETED|Treatment With Different Dose Sequences||0
8355190|NCT01235351|20595815|P1|NOT COMPLETED|Treatment With Different Dose Sequences||0
8355191|NCT01235351|20595814|P2|COMPLETED|Treatment With Different Dose Sequences||82
8355192|NCT01235351|20595815|P1|COMPLETED|Treatment With Different Dose Sequences||233
8355193|NCT01235351|20595814|P2|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41
8355194|NCT01235351|20595815|P1|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0
8355195|NCT01235351|20595814|P2|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41
8355196|NCT01235351|20595815|P1|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0
8355197|NCT01235351|20595814|P2|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0
8355198|NCT01235351|20595815|P1|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117
8355199|NCT01235351|20595814|P2|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0
8355200|NCT01235351|20595815|P1|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116
8355201|NCT01235351|20595814|P2|STARTED|Treatment With Different Dose Sequences||82
8355202|NCT01235351|20595815|P1|STARTED|Treatment With Different Dose Sequences||233
8355203|NCT01235351|20595814|P2|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4
8355204|NCT01235351|20595815|P1|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10
8355205|NCT01235351|20595814|P2|COMPLETED|Initial Treatment With 75 mg and 150 mg||82
8355206|NCT01235351|20595815|P1|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237
8355207|NCT01235351|20595814|P2|STARTED|Initial Treatment With 75 mg and 150 mg||86
8355208|NCT01235351|20595815|P1|STARTED|Initial Treatment With 75 mg and 150 mg||247
8355215|NCT01235234|20595873|P3|NOT COMPLETED|Overall Study||1
8355216|NCT01235234|20595874|P2|NOT COMPLETED|Overall Study||2
8355217|NCT01235234|20595875|P1|NOT COMPLETED|Overall Study||2
8355218|NCT01235234|20595873|P3|COMPLETED|Overall Study||80
8355219|NCT01235234|20595874|P2|COMPLETED|Overall Study||76
8355220|NCT01235234|20595875|P1|COMPLETED|Overall Study||75
8355221|NCT01235234|20595873|P3|STARTED|Overall Study||81
8355222|NCT01235234|20595874|P2|STARTED|Overall Study||78
8355223|NCT01235234|20595875|P1|STARTED|Overall Study||77
8355224|NCT01235195|20595883|P2|NOT COMPLETED|Second Intervention||0
8355225|NCT01235195|20595884|P1|NOT COMPLETED|Second Intervention||0
8355226|NCT01235195|20595883|P2|COMPLETED|Second Intervention||15
8355227|NCT01235195|20595884|P1|COMPLETED|Second Intervention||15
8355228|NCT01235195|20595883|P2|STARTED|Second Intervention||15
8355229|NCT01235195|20595884|P1|STARTED|Second Intervention||15
8355230|NCT01235195|20595883|P2|NOT COMPLETED|Washout Period of At Least 8 Days||0
8355231|NCT01235195|20595884|P1|NOT COMPLETED|Washout Period of At Least 8 Days||0
8355232|NCT01235195|20595883|P2|COMPLETED|Washout Period of At Least 8 Days||15
8355233|NCT01235195|20595884|P1|COMPLETED|Washout Period of At Least 8 Days||15
8355234|NCT01235195|20595883|P2|STARTED|Washout Period of At Least 8 Days||15
8355235|NCT01235195|20595884|P1|STARTED|Washout Period of At Least 8 Days||15
8355236|NCT01235195|20595883|P2|NOT COMPLETED|First Intervention||0
8355237|NCT01235195|20595884|P1|NOT COMPLETED|First Intervention||0
8355238|NCT01235195|20595883|P2|COMPLETED|First Intervention||15
8355239|NCT01235195|20595884|P1|COMPLETED|First Intervention||15
8355240|NCT01235195|20595883|P2|STARTED|First Intervention||15
8355241|NCT01235195|20595884|P1|STARTED|First Intervention||15
8355242|NCT01234922|20595904|P4|NOT COMPLETED|Overall Study||0
8355243|NCT01234922|20595905|P3|NOT COMPLETED|Overall Study||0
8355244|NCT01234922|20595906|P2|NOT COMPLETED|Overall Study||0
8355245|NCT01234922|20595907|P1|NOT COMPLETED|Overall Study||0
8355246|NCT01234922|20595904|P4|COMPLETED|Overall Study||2
8355247|NCT01234922|20595905|P3|COMPLETED|Overall Study||2
8355248|NCT01234922|20595906|P2|COMPLETED|Overall Study||1
8355249|NCT01234922|20595907|P1|COMPLETED|Overall Study||1
8355250|NCT01234922|20595904|P4|STARTED|Overall Study||2
8355251|NCT01234922|20595905|P3|STARTED|Overall Study||2
8355252|NCT01234922|20595906|P2|STARTED|Overall Study||1
8355253|NCT01234922|20595907|P1|STARTED|Overall Study||1
8355254|NCT01234883|20595923|P2|NOT COMPLETED|Overall Study||13
8355255|NCT01234883|20595924|P1|NOT COMPLETED|Overall Study||10
8355256|NCT01234883|20595923|P2|COMPLETED|Overall Study||36
8355257|NCT01234883|20595924|P1|COMPLETED|Overall Study||41
8355258|NCT01234883|20595923|P2|STARTED|Overall Study||49
8355259|NCT01234883|20595924|P1|STARTED|Overall Study||51
8355260|NCT01234870|20595930|P1|NOT COMPLETED|Overall Study||0
8355261|NCT01234870|20595930|P1|COMPLETED|Overall Study||40
8355262|NCT01234870|20595930|P1|STARTED|Overall Study||40
8355263|NCT01234831|20595937|P2|NOT COMPLETED|Overall Study||4
8355264|NCT01234831|20595938|P1|NOT COMPLETED|Overall Study||2
8355265|NCT01234831|20595937|P2|COMPLETED|Overall Study||198
8355266|NCT01234831|20595938|P1|COMPLETED|Overall Study||259
8355267|NCT01234831|20595937|P2|STARTED|Overall Study||202
8355268|NCT01234831|20595938|P1|STARTED|Overall Study||261
8355272|NCT01234714|20595954|P1|NOT COMPLETED|Overall Study||0
8355273|NCT01234714|20595954|P1|COMPLETED|Overall Study||84
8355274|NCT01234714|20595954|P1|STARTED|Overall Study||84
8355275|NCT01234675|20595971|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8355276|NCT01234675|20595972|P1|NOT COMPLETED|Second Intervention (6 Weeks)||2
8355277|NCT01234675|20595971|P2|COMPLETED|Second Intervention (6 Weeks)||8
8355278|NCT01234675|20595972|P1|COMPLETED|Second Intervention (6 Weeks)||7
8355279|NCT01234675|20595971|P2|STARTED|Second Intervention (6 Weeks)||8
8355280|NCT01234675|20595972|P1|STARTED|Second Intervention (6 Weeks)||9
8355281|NCT01234675|20595971|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
8355282|NCT01234675|20595972|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
8355283|NCT01234675|20595971|P2|COMPLETED|First Intervention (6 Weeks)||8
8355284|NCT01234675|20595972|P1|COMPLETED|First Intervention (6 Weeks)||9
8355285|NCT01234675|20595971|P2|STARTED|First Intervention (6 Weeks)||9
8355286|NCT01234675|20595972|P1|STARTED|First Intervention (6 Weeks)||10
8355287|NCT01234649|20596004|P2|NOT COMPLETED|Overall Study||38
8355288|NCT01234649|20596005|P1|NOT COMPLETED|Overall Study||43
8355289|NCT01234649|20596004|P2|COMPLETED|Overall Study||37
8355290|NCT01234649|20596005|P1|COMPLETED|Overall Study||35
8355291|NCT01234649|20596004|P2|STARTED|Overall Study||75
8355292|NCT01234649|20596005|P1|STARTED|Overall Study||78
8355293|NCT01234467|20596053|P1|NOT COMPLETED|Overall Study||12
8355294|NCT01234467|20596053|P1|COMPLETED|Overall Study||11
8355295|NCT01234467|20596053|P1|STARTED|Overall Study||23
8355296|NCT01234402|20596065|P3|NOT COMPLETED|Overall Study||8
8355297|NCT01234402|20596066|P2|NOT COMPLETED|Overall Study||6
8355298|NCT01234402|20596067|P1|NOT COMPLETED|Overall Study||1
8355299|NCT01234402|20596065|P3|COMPLETED|Overall Study||42
8355300|NCT01234402|20596066|P2|COMPLETED|Overall Study||45
8355301|NCT01234402|20596067|P1|COMPLETED|Overall Study||51
8355302|NCT01234402|20596065|P3|Capecitabine Crossover to Icrucumab|Overall Study||1
8355303|NCT01234402|20596066|P2|Capecitabine Crossover to Icrucumab|Overall Study||0
8355304|NCT01234402|20596067|P1|Capecitabine Crossover to Icrucumab|Overall Study||0
8355305|NCT01234402|20596065|P3|Capecitabine Crossover to Ramucirumab|Overall Study||29
8355306|NCT01234402|20596066|P2|Capecitabine Crossover to Ramucirumab|Overall Study||0
8355307|NCT01234402|20596067|P1|Capecitabine Crossover to Ramucirumab|Overall Study||0
8355308|NCT01234402|20596065|P3|Received at Least One Dose of Study Drug|Overall Study||49
8355309|NCT01234402|20596066|P2|Received at Least One Dose of Study Drug|Overall Study||49
8355310|NCT01234402|20596067|P1|Received at Least One Dose of Study Drug|Overall Study||52
8355311|NCT01234402|20596065|P3|STARTED|Overall Study||50
8355312|NCT01234402|20596066|P2|STARTED|Overall Study||51
8355313|NCT01234402|20596067|P1|STARTED|Overall Study||52
8355314|NCT01234350|20596108|P2|NOT COMPLETED|Overall Study||267
8355315|NCT01234350|20596109|P1|NOT COMPLETED|Overall Study||687
8355316|NCT01234350|20596108|P2|COMPLETED|Overall Study||226
8355317|NCT01234350|20596109|P1|COMPLETED|Overall Study||313
8355318|NCT01234350|20596108|P2|STARTED|Overall Study||493
8355319|NCT01234350|20596109|P1|STARTED|Overall Study||1000
8355320|NCT01234337|20596135|P2|NOT COMPLETED|Overall Study||271
8355321|NCT01234337|20596136|P1|NOT COMPLETED|Overall Study||266
8355322|NCT01234337|20596135|P2|COMPLETED|Overall Study||0
8355323|NCT01234337|20596136|P1|COMPLETED|Overall Study||0
8355324|NCT01234337|20596135|P2|Participants Received Treatment|Overall Study||267
8355325|NCT01234337|20596136|P1|Participants Received Treatment|Overall Study||260
8355326|NCT01234337|20596135|P2|STARTED|Overall Study||271
8355327|NCT01234337|20596136|P1|STARTED|Overall Study||266
8355328|NCT01234207|20596164|P2|NOT COMPLETED|Second Intervention||0
8355329|NCT01234207|20596165|P1|NOT COMPLETED|Second Intervention||0
8355330|NCT01234207|20596164|P2|COMPLETED|Second Intervention||48
8355331|NCT01234207|20596165|P1|COMPLETED|Second Intervention||47
8355332|NCT01234207|20596164|P2|STARTED|Second Intervention||48
8355333|NCT01234207|20596165|P1|STARTED|Second Intervention||47
8355334|NCT01234207|20596164|P2|NOT COMPLETED|1-Week Washout Period||0
8355335|NCT01234207|20596165|P1|NOT COMPLETED|1-Week Washout Period||0
8355336|NCT01234207|20596164|P2|COMPLETED|1-Week Washout Period||48
8355337|NCT01234207|20596165|P1|COMPLETED|1-Week Washout Period||47
8355338|NCT01234207|20596164|P2|STARTED|1-Week Washout Period||48
8355339|NCT01234207|20596165|P1|STARTED|1-Week Washout Period||47
8355340|NCT01234207|20596164|P2|NOT COMPLETED|First Intervention||0
8355341|NCT01234207|20596165|P1|NOT COMPLETED|First Intervention||0
8355342|NCT01234207|20596164|P2|COMPLETED|First Intervention||48
8355343|NCT01234207|20596165|P1|COMPLETED|First Intervention||47
8355344|NCT01234207|20596164|P2|STARTED|First Intervention||48
8355345|NCT01234207|20596165|P1|STARTED|First Intervention||47
8355346|NCT01234103|20596187|P2|NOT COMPLETED|Overall Study||0
8355347|NCT01234103|20596188|P1|NOT COMPLETED|Overall Study||0
8355348|NCT01234103|20596187|P2|COMPLETED|Overall Study||391
8355349|NCT01234103|20596188|P1|COMPLETED|Overall Study||542
8355350|NCT01234103|20596187|P2|STARTED|Overall Study||391
8355351|NCT01234103|20596188|P1|STARTED|Overall Study||542
8355352|NCT01233999|20596196|P1|NOT COMPLETED|Overall Study||2
8355353|NCT01233999|20596196|P1|COMPLETED|Overall Study||8
8355354|NCT01233999|20596196|P1|STARTED|Overall Study||10
8355355|NCT01233921|20596202|P2|NOT COMPLETED|Overall Study||0
8355356|NCT01233921|20596203|P1|NOT COMPLETED|Overall Study||0
8355357|NCT01233921|20596202|P2|COMPLETED|Overall Study||3
8355358|NCT01233921|20596203|P1|COMPLETED|Overall Study||3
8355359|NCT01233921|20596202|P2|STARTED|Overall Study||3
8355360|NCT01233921|20596203|P1|STARTED|Overall Study||3
8355361|NCT01233869|20596215|P4|NOT COMPLETED|Extended Treatment Period (46 Months)||16
8355362|NCT01233869|20596216|P3|NOT COMPLETED|Extended Treatment Period (46 Months)||5
8355363|NCT01233869|20596217|P2|NOT COMPLETED|Extended Treatment Period (46 Months)||3
8355364|NCT01233869|20596218|P1|NOT COMPLETED|Extended Treatment Period (46 Months)||14
8355365|NCT01233869|20596215|P4|COMPLETED|Extended Treatment Period (46 Months)||18
8355366|NCT01233869|20596216|P3|COMPLETED|Extended Treatment Period (46 Months)||17
8355367|NCT01233869|20596217|P2|COMPLETED|Extended Treatment Period (46 Months)||0
8355368|NCT01233869|20596218|P1|COMPLETED|Extended Treatment Period (46 Months)||20
8355369|NCT01233869|20596215|P4|STARTED|Extended Treatment Period (46 Months)||34
8355370|NCT01233869|20596216|P3|STARTED|Extended Treatment Period (46 Months)||22
8355371|NCT01233869|20596217|P2|STARTED|Extended Treatment Period (46 Months)||3
8355372|NCT01233869|20596218|P1|STARTED|Extended Treatment Period (46 Months)||34
8355373|NCT01233869|20596215|P4|NOT COMPLETED|Washout Period 30 Days||0
8355374|NCT01233869|20596216|P3|NOT COMPLETED|Washout Period 30 Days||0
8355375|NCT01233869|20596217|P2|NOT COMPLETED|Washout Period 30 Days||0
8355376|NCT01233869|20596218|P1|NOT COMPLETED|Washout Period 30 Days||0
8355377|NCT01233869|20596215|P4|COMPLETED|Washout Period 30 Days||34
8355378|NCT01233869|20596216|P3|COMPLETED|Washout Period 30 Days||22
8355379|NCT01233869|20596217|P2|COMPLETED|Washout Period 30 Days||3
8355380|NCT01233869|20596218|P1|COMPLETED|Washout Period 30 Days||34
8355381|NCT01233869|20596215|P4|STARTED|Washout Period 30 Days||34
8355382|NCT01233869|20596216|P3|STARTED|Washout Period 30 Days||22
8355383|NCT01233869|20596217|P2|STARTED|Washout Period 30 Days||3
8355384|NCT01233869|20596218|P1|STARTED|Washout Period 30 Days||34
8355385|NCT01233869|20596215|P4|NOT COMPLETED|Initial Treatment Period (24 Months)||22
8355386|NCT01233869|20596216|P3|NOT COMPLETED|Initial Treatment Period (24 Months)||2
8355387|NCT01233869|20596217|P2|NOT COMPLETED|Initial Treatment Period (24 Months)||28
8355388|NCT01233869|20596218|P1|NOT COMPLETED|Initial Treatment Period (24 Months)||24
8355389|NCT01233869|20596215|P4|COMPLETED|Initial Treatment Period (24 Months)||34
8355390|NCT01233869|20596216|P3|COMPLETED|Initial Treatment Period (24 Months)||22
8355391|NCT01233869|20596217|P2|COMPLETED|Initial Treatment Period (24 Months)||3
8355392|NCT01233869|20596218|P1|COMPLETED|Initial Treatment Period (24 Months)||34
8355393|NCT01233869|20596215|P4|STARTED|Initial Treatment Period (24 Months)||56
8355394|NCT01233869|20596216|P3|STARTED|Initial Treatment Period (24 Months)||24
8355395|NCT01233869|20596217|P2|STARTED|Initial Treatment Period (24 Months)||31
8355396|NCT01233869|20596218|P1|STARTED|Initial Treatment Period (24 Months)||58
8355397|NCT01233817|20596304|P1|NOT COMPLETED|Overall Study||3
8355398|NCT01233817|20596304|P1|COMPLETED|Overall Study||9
8355399|NCT01233817|20596304|P1|STARTED|Overall Study||12
8355400|NCT01233726|20596311|P3|NOT COMPLETED|Overall Study||1
8355401|NCT01233726|20596312|P2|NOT COMPLETED|Overall Study||0
8355402|NCT01233726|20596313|P1|NOT COMPLETED|Overall Study||1
8355403|NCT01233726|20596311|P3|COMPLETED|Overall Study||52
8355404|NCT01233726|20596312|P2|COMPLETED|Overall Study||53
8355405|NCT01233726|20596313|P1|COMPLETED|Overall Study||52
8355406|NCT01233726|20596311|P3|STARTED|Overall Study||53
8355407|NCT01233726|20596312|P2|STARTED|Overall Study||53
8355408|NCT01233726|20596313|P1|STARTED|Overall Study||53
8355409|NCT01233687|20596351|P1|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
8355410|NCT01233687|20596351|P1|COMPLETED|Phase II AMG 102 + Erlotinib||45
8355411|NCT01233687|20596351|P1|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
8355412|NCT01233687|20596351|P1|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
8355413|NCT01233687|20596351|P1|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
8355414|NCT01233687|20596351|P1|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
8355415|NCT01233687|20596351|P1|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
8355416|NCT01233609|20596361|P2|NOT COMPLETED|Overall Study||2
8355417|NCT01233609|20596362|P1|NOT COMPLETED|Overall Study||9
8355418|NCT01233609|20596361|P2|COMPLETED|Overall Study||42
8355419|NCT01233609|20596362|P1|COMPLETED|Overall Study||37
8355420|NCT01233609|20596361|P2|STARTED|Overall Study||44
8355421|NCT01233609|20596362|P1|STARTED|Overall Study||46
8355425|NCT01233284|20596391|P5|NOT COMPLETED|Period 4 (4 Weeks)||0
8355426|NCT01233284|20596392|P4|NOT COMPLETED|Period 4 (4 Weeks)||1
8355427|NCT01233284|20596393|P3|NOT COMPLETED|Period 4 (4 Weeks)||0
8355428|NCT01233284|20596394|P2|NOT COMPLETED|Period 4 (4 Weeks)||1
8355429|NCT01233284|20596395|P1|NOT COMPLETED|Period 4 (4 Weeks)||0
8355430|NCT01233284|20596391|P5|COMPLETED|Period 4 (4 Weeks)||1
8355431|NCT01233284|20596392|P4|COMPLETED|Period 4 (4 Weeks)||33
8355432|NCT01233284|20596393|P3|COMPLETED|Period 4 (4 Weeks)||35
8355433|NCT01233284|20596394|P2|COMPLETED|Period 4 (4 Weeks)||36
8355434|NCT01233284|20596395|P1|COMPLETED|Period 4 (4 Weeks)||36
8355435|NCT01233284|20596391|P5|STARTED|Period 4 (4 Weeks)||1
8355436|NCT01233284|20596392|P4|STARTED|Period 4 (4 Weeks)||34
8355437|NCT01233284|20596393|P3|STARTED|Period 4 (4 Weeks)||35
8355438|NCT01233284|20596394|P2|STARTED|Period 4 (4 Weeks)||37
8355439|NCT01233284|20596395|P1|STARTED|Period 4 (4 Weeks)||36
8355440|NCT01233284|20596391|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
8355441|NCT01233284|20596392|P4|NOT COMPLETED|Period 3 (4 Weeks)||1
8355442|NCT01233284|20596393|P3|NOT COMPLETED|Period 3 (4 Weeks)||1
8355443|NCT01233284|20596394|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
8355444|NCT01233284|20596395|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
8355445|NCT01233284|20596391|P5|COMPLETED|Period 3 (4 Weeks)||1
8355446|NCT01233284|20596392|P4|COMPLETED|Period 3 (4 Weeks)||34
8355447|NCT01233284|20596393|P3|COMPLETED|Period 3 (4 Weeks)||35
8355448|NCT01233284|20596394|P2|COMPLETED|Period 3 (4 Weeks)||37
8355449|NCT01233284|20596395|P1|COMPLETED|Period 3 (4 Weeks)||36
8355450|NCT01233284|20596391|P5|STARTED|Period 3 (4 Weeks)||1
8355451|NCT01233284|20596392|P4|STARTED|Period 3 (4 Weeks)||35
8355452|NCT01233284|20596393|P3|STARTED|Period 3 (4 Weeks)||36
8355453|NCT01233284|20596394|P2|STARTED|Period 3 (4 Weeks)||37
8355454|NCT01233284|20596395|P1|STARTED|Period 3 (4 Weeks)||36
8355455|NCT01233284|20596391|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
8355456|NCT01233284|20596392|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
8355457|NCT01233284|20596393|P3|NOT COMPLETED|Period 2 (4 Weeks)||1
8355458|NCT01233284|20596394|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
8355459|NCT01233284|20596395|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
8355460|NCT01233284|20596391|P5|COMPLETED|Period 2 (4 Weeks)||1
8355461|NCT01233284|20596392|P4|COMPLETED|Period 2 (4 Weeks)||35
8355462|NCT01233284|20596393|P3|COMPLETED|Period 2 (4 Weeks)||36
8355463|NCT01233284|20596394|P2|COMPLETED|Period 2 (4 Weeks)||37
8355464|NCT01233284|20596395|P1|COMPLETED|Period 2 (4 Weeks)||36
8355465|NCT01233284|20596391|P5|STARTED|Period 2 (4 Weeks)||1
8355466|NCT01233284|20596392|P4|STARTED|Period 2 (4 Weeks)||35
8355467|NCT01233284|20596393|P3|STARTED|Period 2 (4 Weeks)||37
8355468|NCT01233284|20596394|P2|STARTED|Period 2 (4 Weeks)||37
8355469|NCT01233284|20596395|P1|STARTED|Period 2 (4 Weeks)||36
8355470|NCT01233284|20596391|P5|NOT COMPLETED|Period 1 (4 Weeks)||0
8355471|NCT01233284|20596392|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
8355472|NCT01233284|20596393|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
8355473|NCT01233284|20596394|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
8355474|NCT01233284|20596395|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
8355475|NCT01233284|20596391|P5|COMPLETED|Period 1 (4 Weeks)||1
8355476|NCT01233284|20596392|P4|COMPLETED|Period 1 (4 Weeks)||35
8355477|NCT01233284|20596393|P3|COMPLETED|Period 1 (4 Weeks)||37
8355478|NCT01233284|20596394|P2|COMPLETED|Period 1 (4 Weeks)||37
8355479|NCT01233284|20596395|P1|COMPLETED|Period 1 (4 Weeks)||36
8355480|NCT01233284|20596391|P5|STARTED|Period 1 (4 Weeks)||1
8355481|NCT01233284|20596392|P4|STARTED|Period 1 (4 Weeks)||35
8355482|NCT01233284|20596393|P3|STARTED|Period 1 (4 Weeks)||38
8355483|NCT01233284|20596394|P2|STARTED|Period 1 (4 Weeks)||38
8355484|NCT01233284|20596395|P1|STARTED|Period 1 (4 Weeks)||37
8355485|NCT01233258|20596476|P6|NOT COMPLETED|Second Intervention (6 Months)||0
8355486|NCT01233258|20596477|P5|NOT COMPLETED|Second Intervention (6 Months)||0
8355487|NCT01233258|20596478|P4|NOT COMPLETED|Second Intervention (6 Months)||0
8355488|NCT01233258|20596479|P3|NOT COMPLETED|Second Intervention (6 Months)||0
8355489|NCT01233258|20596480|P2|NOT COMPLETED|Second Intervention (6 Months)||0
8355490|NCT01233258|20596481|P1|NOT COMPLETED|Second Intervention (6 Months)||0
8355491|NCT01233258|20596476|P6|COMPLETED|Second Intervention (6 Months)||15
8355492|NCT01233258|20596477|P5|COMPLETED|Second Intervention (6 Months)||16
8355493|NCT01233258|20596478|P4|COMPLETED|Second Intervention (6 Months)||15
8355494|NCT01233258|20596479|P3|COMPLETED|Second Intervention (6 Months)||13
8355495|NCT01233258|20596480|P2|COMPLETED|Second Intervention (6 Months)||10
8355496|NCT01233258|20596481|P1|COMPLETED|Second Intervention (6 Months)||10
8355497|NCT01233258|20596476|P6|STARTED|Second Intervention (6 Months)||15
8355498|NCT01233258|20596477|P5|STARTED|Second Intervention (6 Months)||16
8355499|NCT01233258|20596478|P4|STARTED|Second Intervention (6 Months)||15
8355500|NCT01233258|20596479|P3|STARTED|Second Intervention (6 Months)||13
8355501|NCT01233258|20596480|P2|STARTED|Second Intervention (6 Months)||10
8355502|NCT01233258|20596481|P1|STARTED|Second Intervention (6 Months)||10
8355503|NCT01233258|20596476|P6|NOT COMPLETED|Washout (2-3 Days)||0
8355504|NCT01233258|20596477|P5|NOT COMPLETED|Washout (2-3 Days)||0
8355505|NCT01233258|20596478|P4|NOT COMPLETED|Washout (2-3 Days)||0
8355506|NCT01233258|20596479|P3|NOT COMPLETED|Washout (2-3 Days)||0
8355507|NCT01233258|20596480|P2|NOT COMPLETED|Washout (2-3 Days)||0
8355508|NCT01233258|20596481|P1|NOT COMPLETED|Washout (2-3 Days)||0
8355509|NCT01233258|20596476|P6|COMPLETED|Washout (2-3 Days)||15
8355510|NCT01233258|20596477|P5|COMPLETED|Washout (2-3 Days)||16
8355511|NCT01233258|20596478|P4|COMPLETED|Washout (2-3 Days)||15
8355512|NCT01233258|20596479|P3|COMPLETED|Washout (2-3 Days)||13
8355513|NCT01233258|20596480|P2|COMPLETED|Washout (2-3 Days)||10
8355514|NCT01233258|20596481|P1|COMPLETED|Washout (2-3 Days)||10
8355515|NCT01233258|20596476|P6|STARTED|Washout (2-3 Days)||15
8355516|NCT01233258|20596477|P5|STARTED|Washout (2-3 Days)||16
8355517|NCT01233258|20596478|P4|STARTED|Washout (2-3 Days)||15
8355518|NCT01233258|20596479|P3|STARTED|Washout (2-3 Days)||13
8355519|NCT01233258|20596480|P2|STARTED|Washout (2-3 Days)||10
8355520|NCT01233258|20596481|P1|STARTED|Washout (2-3 Days)||10
8355521|NCT01233258|20596476|P6|NOT COMPLETED|First Intervention (6 Months)||1
8355522|NCT01233258|20596477|P5|NOT COMPLETED|First Intervention (6 Months)||0
8355523|NCT01233258|20596478|P4|NOT COMPLETED|First Intervention (6 Months)||1
8355524|NCT01233258|20596479|P3|NOT COMPLETED|First Intervention (6 Months)||1
8355525|NCT01233258|20596480|P2|NOT COMPLETED|First Intervention (6 Months)||0
8355526|NCT01233258|20596481|P1|NOT COMPLETED|First Intervention (6 Months)||1
8355527|NCT01233258|20596476|P6|COMPLETED|First Intervention (6 Months)||15
8355528|NCT01233258|20596477|P5|COMPLETED|First Intervention (6 Months)||16
8355529|NCT01233258|20596478|P4|COMPLETED|First Intervention (6 Months)||15
8355530|NCT01233258|20596479|P3|COMPLETED|First Intervention (6 Months)||13
8355531|NCT01233258|20596480|P2|COMPLETED|First Intervention (6 Months)||10
8355532|NCT01233258|20596481|P1|COMPLETED|First Intervention (6 Months)||10
8355533|NCT01233258|20596476|P6|Participants Received Treatment|First Intervention (6 Months)||15
8355534|NCT01233258|20596477|P5|Participants Received Treatment|First Intervention (6 Months)||16
8355535|NCT01233258|20596478|P4|Participants Received Treatment|First Intervention (6 Months)||15
8355536|NCT01233258|20596479|P3|Participants Received Treatment|First Intervention (6 Months)||13
8355537|NCT01233258|20596480|P2|Participants Received Treatment|First Intervention (6 Months)||10
8355538|NCT01233258|20596481|P1|Participants Received Treatment|First Intervention (6 Months)||11
8355539|NCT01233258|20596476|P6|STARTED|First Intervention (6 Months)||16
8355540|NCT01233258|20596477|P5|STARTED|First Intervention (6 Months)||16
8355541|NCT01233258|20596478|P4|STARTED|First Intervention (6 Months)||16
8355542|NCT01233258|20596479|P3|STARTED|First Intervention (6 Months)||14
8355543|NCT01233258|20596480|P2|STARTED|First Intervention (6 Months)||10
8355544|NCT01233258|20596481|P1|STARTED|First Intervention (6 Months)||11
8355545|NCT01233232|20596501|P3|NOT COMPLETED|Overall Study||0
8355546|NCT01233232|20596502|P2|NOT COMPLETED|Overall Study||0
8355547|NCT01233232|20596503|P1|NOT COMPLETED|Overall Study||1
8355548|NCT01233232|20596501|P3|COMPLETED|Overall Study||28
8355549|NCT01233232|20596502|P2|COMPLETED|Overall Study||30
8355550|NCT01233232|20596503|P1|COMPLETED|Overall Study||28
8355551|NCT01233232|20596501|P3|STARTED|Overall Study||28
8355552|NCT01233232|20596502|P2|STARTED|Overall Study||30
8355553|NCT01233232|20596503|P1|STARTED|Overall Study||29
8355554|NCT01233076|20596556|P2|NOT COMPLETED|Period 2, One Week||0
8355555|NCT01233076|20596557|P1|NOT COMPLETED|Period 2, One Week||1
8355556|NCT01233076|20596556|P2|COMPLETED|Period 2, One Week||30
8355557|NCT01233076|20596557|P1|COMPLETED|Period 2, One Week||29
8355558|NCT01233076|20596556|P2|STARTED|Period 2, One Week||30
8355559|NCT01233076|20596557|P1|STARTED|Period 2, One Week||30
8355560|NCT01233076|20596556|P2|NOT COMPLETED|Period 1, One Week||0
8355561|NCT01233076|20596557|P1|NOT COMPLETED|Period 1, One Week||0
8355562|NCT01233076|20596556|P2|COMPLETED|Period 1, One Week||30
8355563|NCT01233076|20596557|P1|COMPLETED|Period 1, One Week||30
8355564|NCT01233076|20596556|P2|STARTED|Period 1, One Week||30
8355565|NCT01233076|20596557|P1|STARTED|Period 1, One Week||30
8355566|NCT01233050|20596565|P2|NOT COMPLETED|Overall Study||6
8355567|NCT01233050|20596566|P1|NOT COMPLETED|Overall Study||8
8355568|NCT01233050|20596565|P2|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
8355569|NCT01233050|20596566|P1|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
8355570|NCT01233050|20596565|P2|STARTED|Overall Study||402
8355571|NCT01233050|20596566|P1|STARTED|Overall Study||400
8355572|NCT01232946|20596585|P3|NOT COMPLETED|Overall Study||2
8355573|NCT01232946|20596586|P2|NOT COMPLETED|Overall Study||1
8355574|NCT01232946|20596587|P1|NOT COMPLETED|Overall Study||0
8355575|NCT01232946|20596585|P3|COMPLETED|Overall Study|2 withdrew after baseline measurements|9
8355576|NCT01232946|20596586|P2|COMPLETED|Overall Study|1 participant died unrelated to study|9
8355577|NCT01232946|20596587|P1|COMPLETED|Overall Study||9
8355578|NCT01232946|20596585|P3|STARTED|Overall Study||11
8355579|NCT01232946|20596586|P2|STARTED|Overall Study||10
8355580|NCT01232946|20596587|P1|STARTED|Overall Study||9
8355581|NCT01232920|20596603|P2|NOT COMPLETED|Overall Study||7
8355582|NCT01232920|20596604|P1|NOT COMPLETED|Overall Study||6
8355583|NCT01232920|20596603|P2|COMPLETED|Overall Study||32
8355584|NCT01232920|20596604|P1|COMPLETED|Overall Study||35
8355585|NCT01232920|20596603|P2|STARTED|Overall Study||39
8355586|NCT01232920|20596604|P1|STARTED|Overall Study||41
8355587|NCT01232894|20596618|P2|NOT COMPLETED|Overall Study||8
8355588|NCT01232894|20596619|P1|NOT COMPLETED|Overall Study||12
8355589|NCT01232894|20596618|P2|COMPLETED|Overall Study||22
8355590|NCT01232894|20596619|P1|COMPLETED|Overall Study||48
8355591|NCT01232894|20596618|P2|Received Study Drug|Overall Study||28
8355592|NCT01232894|20596619|P1|Received Study Drug|Overall Study||59
8355593|NCT01232894|20596618|P2|STARTED|Overall Study||30
8355594|NCT01232894|20596619|P1|STARTED|Overall Study||60
8355595|NCT01232868|20596627|P2|NOT COMPLETED|Overall Study||4
8355596|NCT01232868|20596628|P1|NOT COMPLETED|Overall Study||2
8355597|NCT01232868|20596627|P2|COMPLETED|Overall Study||40
8355598|NCT01232868|20596628|P1|COMPLETED|Overall Study||20
8355599|NCT01232868|20596627|P2|STARTED|Overall Study||44
8355600|NCT01232868|20596628|P1|STARTED|Overall Study||22
8355601|NCT01232829|20596636|P1|NOT COMPLETED|Overall Study||0
8355602|NCT01232829|20596636|P1|COMPLETED|Overall Study||18
8355603|NCT01232829|20596636|P1|STARTED|Overall Study||18
8355604|NCT01232790|20596642|P2|NOT COMPLETED|Second Crossover||2
8355605|NCT01232790|20596643|P1|NOT COMPLETED|Second Crossover||1
8355606|NCT01232790|20596642|P2|COMPLETED|Second Crossover||9
8355607|NCT01232790|20596643|P1|COMPLETED|Second Crossover||10
8355608|NCT01232790|20596642|P2|STARTED|Second Crossover||11
8355609|NCT01232790|20596643|P1|STARTED|Second Crossover||11
8355610|NCT01232790|20596642|P2|NOT COMPLETED|First Crossover||0
8355611|NCT01232790|20596643|P1|NOT COMPLETED|First Crossover||1
8355612|NCT01232790|20596642|P2|COMPLETED|First Crossover||11
8355613|NCT01232790|20596643|P1|COMPLETED|First Crossover||11
8355614|NCT01232790|20596642|P2|STARTED|First Crossover||11
8355615|NCT01232790|20596643|P1|STARTED|First Crossover||12
8355616|NCT01232790|20596642|P2|NOT COMPLETED|Initial Assessment||1
8355617|NCT01232790|20596643|P1|NOT COMPLETED|Initial Assessment||0
8355618|NCT01232790|20596642|P2|COMPLETED|Initial Assessment||11
8355619|NCT01232790|20596643|P1|COMPLETED|Initial Assessment||12
8355620|NCT01232790|20596642|P2|STARTED|Initial Assessment||12
8355621|NCT01232790|20596643|P1|STARTED|Initial Assessment||12
8355622|NCT01232790|20596642|P2|NOT COMPLETED|Randomization||2
8355623|NCT01232790|20596643|P1|NOT COMPLETED|Randomization||2
8355624|NCT01232790|20596642|P2|COMPLETED|Randomization||12
8355625|NCT01232790|20596643|P1|COMPLETED|Randomization||12
8355626|NCT01232790|20596642|P2|STARTED|Randomization||14
8355627|NCT01232790|20596643|P1|STARTED|Randomization||14
8355628|NCT01232738|20596697|P1|NOT COMPLETED|Overall Study||13
8355629|NCT01232738|20596697|P1|COMPLETED|Overall Study||23
8355630|NCT01232738|20596697|P1|STARTED|Overall Study||36
8355631|NCT01232569|20596713|P4|NOT COMPLETED|Open-label Extension Period||27
8355632|NCT01232569|20596714|P3|NOT COMPLETED|Open-label Extension Period||27
8355633|NCT01232569|20596715|P2|NOT COMPLETED|Open-label Extension Period||0
8355634|NCT01232569|20596716|P1|NOT COMPLETED|Open-label Extension Period||0
8355635|NCT01232569|20596713|P4|COMPLETED|Open-label Extension Period||200
8355636|NCT01232569|20596714|P3|COMPLETED|Open-label Extension Period||203
8355637|NCT01232569|20596715|P2|COMPLETED|Open-label Extension Period||0
8355638|NCT01232569|20596716|P1|COMPLETED|Open-label Extension Period||0
8355639|NCT01232569|20596713|P4|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
8355640|NCT01232569|20596714|P3|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
8355641|NCT01232569|20596715|P2|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
8355642|NCT01232569|20596716|P1|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
8355643|NCT01232569|20596713|P4|NOT COMPLETED|Double-blind Treatment Period||0
8355644|NCT01232569|20596714|P3|NOT COMPLETED|Double-blind Treatment Period||0
8355645|NCT01232569|20596715|P2|NOT COMPLETED|Double-blind Treatment Period||9
8355646|NCT01232569|20596716|P1|NOT COMPLETED|Double-blind Treatment Period||28
8355647|NCT01232569|20596713|P4|COMPLETED|Double-blind Treatment Period||0
8355648|NCT01232569|20596714|P3|COMPLETED|Double-blind Treatment Period||0
8355649|NCT01232569|20596715|P2|COMPLETED|Double-blind Treatment Period||209
8355650|NCT01232569|20596716|P1|COMPLETED|Double-blind Treatment Period||410
8355651|NCT01232569|20596713|P4|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
8355652|NCT01232569|20596714|P3|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
8355653|NCT01232569|20596715|P2|STARTED|Double-blind Treatment Period||218
8355654|NCT01232569|20596716|P1|STARTED|Double-blind Treatment Period||438
8355655|NCT01232556|20596759|P2|NOT COMPLETED|Overall Study||171
8355656|NCT01232556|20596760|P1|NOT COMPLETED|Overall Study||159
8355657|NCT01232556|20596759|P2|COMPLETED|Overall Study||1
8355658|NCT01232556|20596760|P1|COMPLETED|Overall Study||7
8355659|NCT01232556|20596759|P2|Treated|Overall Study||167
8355660|NCT01232556|20596760|P1|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
8355661|NCT01232556|20596759|P2|STARTED|Overall Study||172
8355662|NCT01232556|20596760|P1|STARTED|Overall Study||166
8355663|NCT01232504|20596783|P3|NOT COMPLETED|Overall Study||8
8355664|NCT01232504|20596784|P2|NOT COMPLETED|Overall Study||2
8355665|NCT01232504|20596785|P1|NOT COMPLETED|Overall Study||9
8355666|NCT01232504|20596783|P3|COMPLETED|Overall Study||61
8355667|NCT01232504|20596784|P2|COMPLETED|Overall Study||67
8355668|NCT01232504|20596785|P1|COMPLETED|Overall Study||59
8355669|NCT01232504|20596783|P3|STARTED|Overall Study||69
8355670|NCT01232504|20596784|P2|STARTED|Overall Study||69
8355671|NCT01232504|20596785|P1|STARTED|Overall Study||68
8355672|NCT01232491|20596819|P2|NOT COMPLETED|Overall Study||63
8355673|NCT01232491|20596820|P1|NOT COMPLETED|Overall Study||60
8355674|NCT01232491|20596819|P2|COMPLETED|Overall Study||242
8355675|NCT01232491|20596820|P1|COMPLETED|Overall Study||246
8355676|NCT01232491|20596819|P2|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
8355677|NCT01232491|20596820|P1|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
8355678|NCT01232491|20596819|P2|STARTED|Overall Study||305
8355679|NCT01232491|20596820|P1|STARTED|Overall Study||306
8355680|NCT01232465|20596840|P2|NOT COMPLETED|Overall Study||0
8355681|NCT01232465|20596841|P1|NOT COMPLETED|Overall Study||0
8355682|NCT01232465|20596840|P2|COMPLETED|Overall Study||402
8355683|NCT01232465|20596841|P1|COMPLETED|Overall Study||337
8355684|NCT01232465|20596840|P2|STARTED|Overall Study||402
8355685|NCT01232465|20596841|P1|STARTED|Overall Study||337
8355686|NCT01232452|20596849|P2|NOT COMPLETED|Overall Study||39
8355687|NCT01232452|20596850|P1|NOT COMPLETED|Overall Study||39
8355688|NCT01232452|20596849|P2|COMPLETED|Overall Study||46
8355689|NCT01232452|20596850|P1|COMPLETED|Overall Study||48
8355690|NCT01232452|20596849|P2|Received at Least One Dose of Study Drug|Overall Study||81
8355691|NCT01232452|20596850|P1|Received at Least One Dose of Study Drug|Overall Study||85
8355692|NCT01232452|20596849|P2|STARTED|Overall Study||85
8355693|NCT01232452|20596850|P1|STARTED|Overall Study||87
8355694|NCT01232296|20596876|P2|NOT COMPLETED|Overall Study||83
8355695|NCT01232296|20596877|P1|NOT COMPLETED|Overall Study||82
8355696|NCT01232296|20596876|P2|COMPLETED|Overall Study||0
8355697|NCT01232296|20596877|P1|COMPLETED|Overall Study||0
8355698|NCT01232296|20596876|P2|Safety Set|Overall Study||83
8355699|NCT01232296|20596877|P1|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
8355700|NCT01232296|20596876|P2|Full Analysis Set|Overall Study||83
8355701|NCT01232296|20596877|P1|Full Analysis Set|Overall Study||82
8355702|NCT01232296|20596876|P2|STARTED|Overall Study||83
8355703|NCT01232296|20596877|P1|STARTED|Overall Study||82
8355704|NCT01232283|20596894|P10|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
8355705|NCT01232283|20596895|P9|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
8355706|NCT01232283|20596896|P8|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355707|NCT01232283|20596897|P7|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355708|NCT01232283|20596898|P6|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355709|NCT01232283|20596899|P5|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355710|NCT01232283|20596900|P4|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355711|NCT01232283|20596901|P3|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355712|NCT01232283|20596902|P2|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355713|NCT01232283|20596903|P1|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355714|NCT01232283|20596894|P10|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
8355715|NCT01232283|20596895|P9|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
8355716|NCT01232283|20596896|P8|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355717|NCT01232283|20596897|P7|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355718|NCT01232283|20596898|P6|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355719|NCT01232283|20596899|P5|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355720|NCT01232283|20596900|P4|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355721|NCT01232283|20596901|P3|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355722|NCT01232283|20596902|P2|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355723|NCT01232283|20596903|P1|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
8355724|NCT01232283|20596894|P10|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
8355725|NCT01232283|20596895|P9|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
8355726|NCT01232283|20596896|P8|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355727|NCT01232283|20596897|P7|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355728|NCT01232283|20596898|P6|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355729|NCT01232283|20596899|P5|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355730|NCT01232283|20596900|P4|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355731|NCT01232283|20596901|P3|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355732|NCT01232283|20596902|P2|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355733|NCT01232283|20596903|P1|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
8355734|NCT01232283|20596894|P10|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355735|NCT01232283|20596895|P9|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355736|NCT01232283|20596896|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
8355737|NCT01232283|20596897|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
8355738|NCT01232283|20596898|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
8355739|NCT01232283|20596899|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
8355740|NCT01232283|20596900|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355741|NCT01232283|20596901|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355742|NCT01232283|20596902|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355743|NCT01232283|20596903|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355744|NCT01232283|20596894|P10|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355745|NCT01232283|20596895|P9|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355746|NCT01232283|20596896|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
8355747|NCT01232283|20596897|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
8355748|NCT01232283|20596898|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
8355749|NCT01232283|20596899|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
8355750|NCT01232283|20596900|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355751|NCT01232283|20596901|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355752|NCT01232283|20596902|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355753|NCT01232283|20596903|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355754|NCT01232283|20596894|P10|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355755|NCT01232283|20596895|P9|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355756|NCT01232283|20596896|P8|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
8355757|NCT01232283|20596897|P7|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
8355758|NCT01232283|20596898|P6|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355759|NCT01232283|20596899|P5|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355760|NCT01232283|20596900|P4|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355761|NCT01232283|20596901|P3|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355762|NCT01232283|20596902|P2|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355763|NCT01232283|20596903|P1|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
8355764|NCT01232283|20596894|P10|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355765|NCT01232283|20596895|P9|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355766|NCT01232283|20596896|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
8355767|NCT01232283|20596897|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
8355768|NCT01232283|20596898|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
8355769|NCT01232283|20596899|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
8355770|NCT01232283|20596900|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355771|NCT01232283|20596901|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355772|NCT01232283|20596902|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355773|NCT01232283|20596903|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
8355774|NCT01232283|20596894|P10|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355775|NCT01232283|20596895|P9|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355776|NCT01232283|20596896|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355777|NCT01232283|20596897|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355778|NCT01232283|20596898|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355779|NCT01232283|20596899|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355780|NCT01232283|20596900|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
8355781|NCT01232283|20596901|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
8355782|NCT01232283|20596902|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355783|NCT01232283|20596903|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
8355784|NCT01232283|20596894|P10|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355785|NCT01232283|20596895|P9|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355786|NCT01232283|20596896|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355787|NCT01232283|20596897|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355788|NCT01232283|20596898|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355789|NCT01232283|20596899|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355790|NCT01232283|20596900|P4|COMPLETED|Maintenance Phase (Weeks16-32)||100
8355791|NCT01232283|20596901|P3|COMPLETED|Maintenance Phase (Weeks16-32)||194
8355792|NCT01232283|20596902|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355793|NCT01232283|20596903|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
8355794|NCT01232283|20596894|P10|STARTED|Maintenance Phase (Weeks16-32)||0
8355795|NCT01232283|20596895|P9|STARTED|Maintenance Phase (Weeks16-32)||0
8355796|NCT01232283|20596896|P8|STARTED|Maintenance Phase (Weeks16-32)||0
8355797|NCT01232283|20596897|P7|STARTED|Maintenance Phase (Weeks16-32)||0
8355798|NCT01232283|20596898|P6|STARTED|Maintenance Phase (Weeks16-32)||0
8355799|NCT01232283|20596899|P5|STARTED|Maintenance Phase (Weeks16-32)||0
8355800|NCT01232283|20596900|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
8355801|NCT01232283|20596901|P3|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
8355802|NCT01232283|20596902|P2|STARTED|Maintenance Phase (Weeks16-32)||0
8355803|NCT01232283|20596903|P1|STARTED|Maintenance Phase (Weeks16-32)||0
8355804|NCT01232283|20596894|P10|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355805|NCT01232283|20596895|P9|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355806|NCT01232283|20596896|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355807|NCT01232283|20596897|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355808|NCT01232283|20596898|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355809|NCT01232283|20596899|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355810|NCT01232283|20596900|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355811|NCT01232283|20596901|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355812|NCT01232283|20596902|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
8355813|NCT01232283|20596903|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
8355814|NCT01232283|20596894|P10|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355815|NCT01232283|20596895|P9|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355816|NCT01232283|20596896|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355817|NCT01232283|20596897|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355818|NCT01232283|20596898|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355819|NCT01232283|20596899|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355820|NCT01232283|20596900|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355821|NCT01232283|20596901|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
8355822|NCT01232283|20596902|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
8355823|NCT01232283|20596903|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
8355824|NCT01232283|20596894|P10|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355825|NCT01232283|20596895|P9|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355826|NCT01232283|20596896|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355827|NCT01232283|20596897|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355828|NCT01232283|20596898|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355829|NCT01232283|20596899|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355830|NCT01232283|20596900|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355831|NCT01232283|20596901|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
8355832|NCT01232283|20596902|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
8355833|NCT01232283|20596903|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
8355834|NCT01232283|20596894|P10|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355835|NCT01232283|20596895|P9|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355836|NCT01232283|20596896|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355837|NCT01232283|20596897|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355838|NCT01232283|20596898|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355839|NCT01232283|20596899|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355840|NCT01232283|20596900|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355841|NCT01232283|20596901|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
8355842|NCT01232283|20596902|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
8355843|NCT01232283|20596903|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
8355844|NCT01232205|20596937|P2|NOT COMPLETED|Overall Study||3
8355845|NCT01232205|20596938|P1|NOT COMPLETED|Overall Study||3
8355846|NCT01232205|20596937|P2|COMPLETED|Overall Study||55
8355847|NCT01232205|20596938|P1|COMPLETED|Overall Study||49
8355848|NCT01232205|20596937|P2|STARTED|Overall Study||58
8355849|NCT01232205|20596938|P1|STARTED|Overall Study||52
8355850|NCT01232127|20596944|P3|NOT COMPLETED|Period 3: Days 18-24||0
8355851|NCT01232127|20596945|P2|NOT COMPLETED|Period 3: Days 18-24||0
8355852|NCT01232127|20596946|P1|NOT COMPLETED|Period 3: Days 18-24||0
8355853|NCT01232127|20596944|P3|COMPLETED|Period 3: Days 18-24||24
8355854|NCT01232127|20596945|P2|COMPLETED|Period 3: Days 18-24||0
8355855|NCT01232127|20596946|P1|COMPLETED|Period 3: Days 18-24||0
8355856|NCT01232127|20596944|P3|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
8355857|NCT01232127|20596945|P2|STARTED|Period 3: Days 18-24||0
8355858|NCT01232127|20596946|P1|STARTED|Period 3: Days 18-24||0
8355859|NCT01232127|20596944|P3|NOT COMPLETED|Period 2: Days 11-17||0
8355860|NCT01232127|20596945|P2|NOT COMPLETED|Period 2: Days 11-17||0
8355861|NCT01232127|20596946|P1|NOT COMPLETED|Period 2: Days 11-17||0
8355862|NCT01232127|20596944|P3|COMPLETED|Period 2: Days 11-17||0
8355863|NCT01232127|20596945|P2|COMPLETED|Period 2: Days 11-17||24
8355864|NCT01232127|20596946|P1|COMPLETED|Period 2: Days 11-17||0
8355865|NCT01232127|20596944|P3|STARTED|Period 2: Days 11-17||0
8355866|NCT01232127|20596945|P2|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
8355867|NCT01232127|20596946|P1|STARTED|Period 2: Days 11-17||0
8355868|NCT01232127|20596944|P3|NOT COMPLETED|Period 1: Days 1-10||0
8355869|NCT01232127|20596945|P2|NOT COMPLETED|Period 1: Days 1-10||0
8355870|NCT01232127|20596946|P1|NOT COMPLETED|Period 1: Days 1-10||1
8355871|NCT01232127|20596944|P3|COMPLETED|Period 1: Days 1-10||0
8355872|NCT01232127|20596945|P2|COMPLETED|Period 1: Days 1-10||0
8355873|NCT01232127|20596946|P1|COMPLETED|Period 1: Days 1-10||24
8355874|NCT01232127|20596944|P3|STARTED|Period 1: Days 1-10||0
8355875|NCT01232127|20596945|P2|STARTED|Period 1: Days 1-10||0
8355876|NCT01232127|20596946|P1|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
8355877|NCT01231984|20596970|P4|NOT COMPLETED|Study Period 2||4
8355878|NCT01231984|20596971|P3|NOT COMPLETED|Study Period 2||0
8355879|NCT01231984|20596972|P2|NOT COMPLETED|Study Period 2||2
8355880|NCT01231984|20596973|P1|NOT COMPLETED|Study Period 2||3
8355881|NCT01231984|20596970|P4|COMPLETED|Study Period 2||56
8355882|NCT01231984|20596971|P3|COMPLETED|Study Period 2||59
8355883|NCT01231984|20596972|P2|COMPLETED|Study Period 2||61
8355884|NCT01231984|20596973|P1|COMPLETED|Study Period 2||54
8355885|NCT01231984|20596970|P4|STARTED|Study Period 2||60
8355886|NCT01231984|20596971|P3|STARTED|Study Period 2||59
8355887|NCT01231984|20596972|P2|STARTED|Study Period 2||63
8355888|NCT01231984|20596973|P1|STARTED|Study Period 2||57
8355889|NCT01231984|20596970|P4|NOT COMPLETED|Study Period 1||9
8355890|NCT01231984|20596971|P3|NOT COMPLETED|Study Period 1||7
8355891|NCT01231984|20596972|P2|NOT COMPLETED|Study Period 1||7
8355892|NCT01231984|20596973|P1|NOT COMPLETED|Study Period 1||12
8355893|NCT01231984|20596970|P4|COMPLETED|Study Period 1||60
8355894|NCT01231984|20596971|P3|COMPLETED|Study Period 1||59
8355895|NCT01231984|20596972|P2|COMPLETED|Study Period 1||63
8355896|NCT01231984|20596973|P1|COMPLETED|Study Period 1||57
8355897|NCT01231984|20596970|P4|STARTED|Study Period 1||69
8355898|NCT01231984|20596971|P3|STARTED|Study Period 1||66
8355899|NCT01231984|20596972|P2|STARTED|Study Period 1||70
8355900|NCT01231984|20596973|P1|STARTED|Study Period 1||69
8355901|NCT01231841|20596994|P1|NOT COMPLETED|Overall Study||0
8355902|NCT01231841|20596994|P1|COMPLETED|Overall Study||20
8355903|NCT01231841|20596994|P1|STARTED|Overall Study||20
8355904|NCT01231750|20597000|P2|NOT COMPLETED|Overall Study||0
8355905|NCT01231750|20597001|P1|NOT COMPLETED|Overall Study||0
8355906|NCT01231750|20597000|P2|COMPLETED|Overall Study||4
8355907|NCT01231750|20597001|P1|COMPLETED|Overall Study||3
8355908|NCT01231750|20597000|P2|STARTED|Overall Study||4
8355909|NCT01231750|20597001|P1|STARTED|Overall Study||3
8355910|NCT01231646|20597019|P2|NOT COMPLETED|Overall Study||0
8355911|NCT01231646|20597020|P1|NOT COMPLETED|Overall Study||0
8355912|NCT01231646|20597019|P2|COMPLETED|Overall Study||10
8355913|NCT01231646|20597020|P1|COMPLETED|Overall Study||28
8355914|NCT01231646|20597019|P2|STARTED|Overall Study||10
8355915|NCT01231646|20597020|P1|STARTED|Overall Study||28
8355916|NCT01231633|20597028|P2|NOT COMPLETED|Overall Study||0
8355917|NCT01231633|20597029|P1|NOT COMPLETED|Overall Study||0
8355918|NCT01231633|20597028|P2|COMPLETED|Overall Study||13
8355919|NCT01231633|20597029|P1|COMPLETED|Overall Study||14
8355920|NCT01231633|20597028|P2|STARTED|Overall Study||13
8355921|NCT01231633|20597029|P1|STARTED|Overall Study||14
8355922|NCT01231620|20597042|P3|NOT COMPLETED|Overall Study||39
8355923|NCT01231620|20597043|P2|NOT COMPLETED|Overall Study||31
8355924|NCT01231620|20597044|P1|NOT COMPLETED|Overall Study||26
8355925|NCT01231620|20597042|P3|COMPLETED|Overall Study||166
8355926|NCT01231620|20597043|P2|COMPLETED|Overall Study||178
8355927|NCT01231620|20597044|P1|COMPLETED|Overall Study||175
8355928|NCT01231620|20597042|P3|STARTED|Overall Study||205
8355929|NCT01231620|20597043|P2|STARTED|Overall Study||209
8355930|NCT01231620|20597044|P1|STARTED|Overall Study||201
8355931|NCT01231607|20597150|P5|NOT COMPLETED|Overall Study||24
8355932|NCT01231607|20597151|P4|NOT COMPLETED|Overall Study||38
8355933|NCT01231607|20597152|P3|NOT COMPLETED|Overall Study||31
8355934|NCT01231607|20597153|P2|NOT COMPLETED|Overall Study||34
8355935|NCT01231607|20597154|P1|NOT COMPLETED|Overall Study||29
8355936|NCT01231607|20597150|P5|COMPLETED|Overall Study||157
8355937|NCT01231607|20597151|P4|COMPLETED|Overall Study||141
8355938|NCT01231607|20597152|P3|COMPLETED|Overall Study||153
8355939|NCT01231607|20597153|P2|COMPLETED|Overall Study||154
8355940|NCT01231607|20597154|P1|COMPLETED|Overall Study||156
8355941|NCT01231607|20597150|P5|STARTED|Overall Study||181
8355942|NCT01231607|20597151|P4|STARTED|Overall Study||179
8355943|NCT01231607|20597152|P3|STARTED|Overall Study||184
8355944|NCT01231607|20597153|P2|STARTED|Overall Study||188
8355945|NCT01231607|20597154|P1|STARTED|Overall Study||185
8355946|NCT01231581|20597246|P2|NOT COMPLETED|Overall Study||80
8355947|NCT01231581|20597247|P1|NOT COMPLETED|Overall Study||80
8355948|NCT01231581|20597246|P2|COMPLETED|Overall Study||0
8355949|NCT01231581|20597247|P1|COMPLETED|Overall Study||0
8355950|NCT01231581|20597246|P2|Ongoing|Overall Study||0
8355951|NCT01231581|20597247|P1|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
8355952|NCT01231581|20597246|P2|STARTED|Overall Study||80
8355953|NCT01231581|20597247|P1|STARTED|Overall Study||80
8355954|NCT01231555|20597268|P3|NOT COMPLETED|Overall Study||8
8355955|NCT01231555|20597269|P2|NOT COMPLETED|Overall Study||7
8355956|NCT01231555|20597270|P1|NOT COMPLETED|Overall Study||8
8355957|NCT01231555|20597268|P3|COMPLETED|Overall Study||0
8355958|NCT01231555|20597269|P2|COMPLETED|Overall Study||0
8355959|NCT01231555|20597270|P1|COMPLETED|Overall Study||0
8355960|NCT01231555|20597268|P3|STARTED|Overall Study||8
8355961|NCT01231555|20597269|P2|STARTED|Overall Study||7
8355962|NCT01231555|20597270|P1|STARTED|Overall Study||8
8355977|NCT01231503|20597332|P8|NOT COMPLETED|Overall Study||8
8355978|NCT01231503|20597333|P7|NOT COMPLETED|Overall Study||7
8355979|NCT01231503|20597334|P6|NOT COMPLETED|Overall Study||16
8355980|NCT01231503|20597335|P5|NOT COMPLETED|Overall Study||10
8355981|NCT01231503|20597336|P4|NOT COMPLETED|Overall Study||8
8355982|NCT01231503|20597337|P3|NOT COMPLETED|Overall Study||12
8355983|NCT01231503|20597338|P2|NOT COMPLETED|Overall Study||13
8355984|NCT01231503|20597339|P1|NOT COMPLETED|Overall Study||14
8355985|NCT01231503|20597332|P8|COMPLETED|Overall Study||52
8355986|NCT01231503|20597333|P7|COMPLETED|Overall Study||53
8355987|NCT01231503|20597334|P6|COMPLETED|Overall Study||44
8355988|NCT01231503|20597335|P5|COMPLETED|Overall Study||50
8355989|NCT01231503|20597336|P4|COMPLETED|Overall Study||52
8355990|NCT01231503|20597337|P3|COMPLETED|Overall Study||48
8355991|NCT01231503|20597338|P2|COMPLETED|Overall Study||46
8355992|NCT01231503|20597339|P1|COMPLETED|Overall Study||46
8355993|NCT01231503|20597332|P8|STARTED|Overall Study||60
8355994|NCT01231503|20597333|P7|STARTED|Overall Study||60
8355995|NCT01231503|20597334|P6|STARTED|Overall Study||60
8355996|NCT01231503|20597335|P5|STARTED|Overall Study||60
8355997|NCT01231503|20597336|P4|STARTED|Overall Study||60
8355998|NCT01231503|20597337|P3|STARTED|Overall Study||60
8355999|NCT01231503|20597338|P2|STARTED|Overall Study||59
8356000|NCT01231503|20597339|P1|STARTED|Overall Study||60
8356001|NCT01231464|20597579|P2|NOT COMPLETED|Overall Study||7
8356002|NCT01231464|20597580|P1|NOT COMPLETED|Overall Study||5
8356003|NCT01231464|20597579|P2|COMPLETED|Overall Study||176
8356004|NCT01231464|20597580|P1|COMPLETED|Overall Study||177
8356005|NCT01231464|20597579|P2|STARTED|Overall Study||183
8356006|NCT01231464|20597580|P1|STARTED|Overall Study||182
8356007|NCT01231412|20597593|P3|NOT COMPLETED|Overall Study||0
8356008|NCT01231412|20597594|P2|NOT COMPLETED|Overall Study||1
8356009|NCT01231412|20597595|P1|NOT COMPLETED|Overall Study||0
8356010|NCT01231412|20597593|P3|COMPLETED|Overall Study||6
8356011|NCT01231412|20597594|P2|COMPLETED|Overall Study||90
8356012|NCT01231412|20597595|P1|COMPLETED|Overall Study||77
8356013|NCT01231412|20597593|P3|STARTED|Overall Study||6
8356014|NCT01231412|20597594|P2|STARTED|Overall Study||91
8356015|NCT01231412|20597595|P1|STARTED|Overall Study||77
8356016|NCT01231399|20597618|P1|NOT COMPLETED|Overall Study||0
8356017|NCT01231399|20597618|P1|COMPLETED|Overall Study||6
8356018|NCT01231399|20597618|P1|STARTED|Overall Study||6
8356035|NCT01231334|20597652|P2|NOT COMPLETED|Overall Study||21
8356036|NCT01231334|20597653|P1|NOT COMPLETED|Overall Study||19
8356037|NCT01231334|20597652|P2|COMPLETED|Overall Study||120
8356038|NCT01231334|20597653|P1|COMPLETED|Overall Study||126
8356039|NCT01231334|20597652|P2|STARTED|Overall Study||141
8356040|NCT01231334|20597653|P1|STARTED|Overall Study||145
8356041|NCT01231321|20597671|P1|NOT COMPLETED|Overall Study||5
8356042|NCT01231321|20597671|P1|COMPLETED|Overall Study||95
8356043|NCT01231321|20597671|P1|STARTED|Overall Study||100
8356044|NCT01231230|20597682|P1|NOT COMPLETED|Overall Study||0
8356045|NCT01231230|20597682|P1|COMPLETED|Overall Study||14
8356046|NCT01231230|20597682|P1|Placebo|Overall Study||14
8356047|NCT01231230|20597682|P1|Fluticasone/Salmeterol|Overall Study||14
8356048|NCT01231230|20597682|P1|Salmeterol|Overall Study||14
8356049|NCT01231230|20597682|P1|Fluticasone|Overall Study||14
8356050|NCT01231230|20597682|P1|STARTED|Overall Study||14
8356051|NCT01230931|20597694|P2|NOT COMPLETED|Overall Study||0
8356052|NCT01230931|20597695|P1|NOT COMPLETED|Overall Study||0
8356053|NCT01230931|20597694|P2|COMPLETED|Overall Study||10
8356054|NCT01230931|20597695|P1|COMPLETED|Overall Study||10
8356055|NCT01230931|20597694|P2|STARTED|Overall Study||10
8356056|NCT01230931|20597695|P1|STARTED|Overall Study||10
8356057|NCT01230892|20597719|P2|NOT COMPLETED|Overall Study||1
8356058|NCT01230892|20597720|P1|NOT COMPLETED|Overall Study||3
8356059|NCT01230892|20597719|P2|COMPLETED|Overall Study||13
8356060|NCT01230892|20597720|P1|COMPLETED|Overall Study||12
8356061|NCT01230892|20597719|P2|STARTED|Overall Study||14
8356062|NCT01230892|20597720|P1|STARTED|Overall Study||15
8356063|NCT01230827|20597730|P4|NOT COMPLETED|Overall Study||78
8356064|NCT01230827|20597731|P3|NOT COMPLETED|Overall Study||65
8356065|NCT01230827|20597732|P2|NOT COMPLETED|Overall Study||11
8356066|NCT01230827|20597733|P1|NOT COMPLETED|Overall Study||19
8356067|NCT01230827|20597730|P4|COMPLETED|Overall Study||0
8356068|NCT01230827|20597731|P3|COMPLETED|Overall Study||0
8356069|NCT01230827|20597732|P2|COMPLETED|Overall Study||0
8356070|NCT01230827|20597733|P1|COMPLETED|Overall Study||0
8356071|NCT01230827|20597730|P4|STARTED|Overall Study||78
8356072|NCT01230827|20597731|P3|STARTED|Overall Study||65
8356073|NCT01230827|20597732|P2|STARTED|Overall Study||11
8356074|NCT01230827|20597733|P1|STARTED|Overall Study||19
8356075|NCT01230814|20597749|P2|NOT COMPLETED|Overall Study||4
8356076|NCT01230814|20597750|P1|NOT COMPLETED|Overall Study||13
8356077|NCT01230814|20597749|P2|COMPLETED|Overall Study||112
8356078|NCT01230814|20597750|P1|COMPLETED|Overall Study||105
8356079|NCT01230814|20597749|P2|STARTED|Overall Study||116
8356080|NCT01230814|20597750|P1|STARTED|Overall Study||118
8356081|NCT01230801|20597765|P3|NOT COMPLETED|Overall Study||1
8356082|NCT01230801|20597766|P2|NOT COMPLETED|Overall Study||0
8356083|NCT01230801|20597767|P1|NOT COMPLETED|Overall Study||0
8356084|NCT01230801|20597765|P3|COMPLETED|Overall Study||15
8356085|NCT01230801|20597766|P2|COMPLETED|Overall Study||3
8356086|NCT01230801|20597767|P1|COMPLETED|Overall Study||3
8356087|NCT01230801|20597765|P3|STARTED|Overall Study||16
8356088|NCT01230801|20597766|P2|STARTED|Overall Study||3
8356089|NCT01230801|20597767|P1|STARTED|Overall Study||3
8356090|NCT01230788|20597800|P1|NOT COMPLETED|Overall Study||1
8356091|NCT01230788|20597800|P1|COMPLETED|Overall Study||0
8356092|NCT01230788|20597800|P1|STARTED|Overall Study||1
8356093|NCT01230749|20597812|P4|NOT COMPLETED|Overall Study||2
8356094|NCT01230749|20597813|P3|NOT COMPLETED|Overall Study||2
8356095|NCT01230749|20597814|P2|NOT COMPLETED|Overall Study||2
8356096|NCT01230749|20597815|P1|NOT COMPLETED|Overall Study||0
8356097|NCT01230749|20597812|P4|COMPLETED|Overall Study||20
8356098|NCT01230749|20597813|P3|COMPLETED|Overall Study||21
8356099|NCT01230749|20597814|P2|COMPLETED|Overall Study||20
8356100|NCT01230749|20597815|P1|COMPLETED|Overall Study||22
8356101|NCT01230749|20597812|P4|STARTED|Overall Study||22
8356102|NCT01230749|20597813|P3|STARTED|Overall Study||23
8356103|NCT01230749|20597814|P2|STARTED|Overall Study||22
8356104|NCT01230749|20597815|P1|STARTED|Overall Study||22
8356105|NCT01230710|20597850|P1|NOT COMPLETED|Overall Study||49
8356106|NCT01230710|20597850|P1|COMPLETED|Overall Study||2
8356107|NCT01230710|20597850|P1|STARTED|Overall Study||51
8356108|NCT01230593|20597861|P3|NOT COMPLETED|Overall Study||12
8356109|NCT01230593|20597862|P2|NOT COMPLETED|Overall Study||18
8356110|NCT01230593|20597863|P1|NOT COMPLETED|Overall Study||15
8356111|NCT01230593|20597861|P3|COMPLETED|Overall Study||38
8356112|NCT01230593|20597862|P2|COMPLETED|Overall Study||32
8356113|NCT01230593|20597863|P1|COMPLETED|Overall Study||35
8356114|NCT01230593|20597861|P3|STARTED|Overall Study||50
8356115|NCT01230593|20597862|P2|STARTED|Overall Study||50
8356116|NCT01230593|20597863|P1|STARTED|Overall Study||50
8356117|NCT01230554|20597874|P1|NOT COMPLETED|Overall Study||3
8356118|NCT01230554|20597874|P1|COMPLETED|Overall Study||209
8356119|NCT01230554|20597874|P1|STARTED|Overall Study||212
8356120|NCT01230502|20597884|P3|NOT COMPLETED|Overall Study||0
8356121|NCT01230502|20597885|P2|NOT COMPLETED|Overall Study||0
8356122|NCT01230502|20597886|P1|NOT COMPLETED|Overall Study||0
8356123|NCT01230502|20597884|P3|COMPLETED|Overall Study||0
8356124|NCT01230502|20597885|P2|COMPLETED|Overall Study||0
8356125|NCT01230502|20597886|P1|COMPLETED|Overall Study||9
8356126|NCT01230502|20597884|P3|STARTED|Overall Study||0
8356127|NCT01230502|20597885|P2|STARTED|Overall Study||0
8356128|NCT01230502|20597886|P1|STARTED|Overall Study||9
8356129|NCT01230489|20597897|P1|NOT COMPLETED|Overall Study||5
8356130|NCT01230489|20597897|P1|COMPLETED|Overall Study||8
8356131|NCT01230489|20597897|P1|STARTED|Overall Study||13
8356132|NCT01230424|20597903|P2|NOT COMPLETED|Overall Study||0
8356133|NCT01230424|20597904|P1|NOT COMPLETED|Overall Study||0
8356134|NCT01230424|20597903|P2|COMPLETED|Overall Study||70
8356135|NCT01230424|20597904|P1|COMPLETED|Overall Study||70
8356136|NCT01230424|20597903|P2|STARTED|Overall Study||70
8356137|NCT01230424|20597904|P1|STARTED|Overall Study||70
8356138|NCT01230307|20597932|P2|NOT COMPLETED|Overall Study||2
8356139|NCT01230307|20597933|P1|NOT COMPLETED|Overall Study||0
8356140|NCT01230307|20597932|P2|COMPLETED|Overall Study||4
8356141|NCT01230307|20597933|P1|COMPLETED|Overall Study||6
8356142|NCT01230307|20597932|P2|STARTED|Overall Study||6
8356143|NCT01230307|20597933|P1|STARTED|Overall Study||6
8356144|NCT01230177|20597945|P1|NOT COMPLETED|Overall Study||0
8356145|NCT01230177|20597945|P1|COMPLETED|Overall Study||3
8356146|NCT01230177|20597945|P1|STARTED|Overall Study||3
8356147|NCT01230125|20597955|P2|NOT COMPLETED|Overall Study||50
8356148|NCT01230125|20597956|P1|NOT COMPLETED|Overall Study||73
8356149|NCT01230125|20597955|P2|COMPLETED|Overall Study||54
8356150|NCT01230125|20597956|P1|COMPLETED|Overall Study||134
8356151|NCT01230125|20597955|P2|STARTED|Overall Study||104
8356152|NCT01230125|20597956|P1|STARTED|Overall Study||207
8356153|NCT01230060|20597966|P1|NOT COMPLETED|Overall Study||1
8356154|NCT01230060|20597966|P1|COMPLETED|Overall Study||121
8356155|NCT01230060|20597966|P1|STARTED|Overall Study||122
8356156|NCT01230021|20597970|P1|NOT COMPLETED|Overall Study||0
8356157|NCT01230021|20597970|P1|COMPLETED|Overall Study||6
8356158|NCT01230021|20597970|P1|STARTED|Overall Study||6
8356165|NCT01229891|20598006|P3|NOT COMPLETED|Overall Study||0
8356166|NCT01229891|20598007|P2|NOT COMPLETED|Overall Study||0
8356167|NCT01229891|20598008|P1|NOT COMPLETED|Overall Study||0
8356168|NCT01229891|20598006|P3|COMPLETED|Overall Study||30
8356169|NCT01229891|20598007|P2|COMPLETED|Overall Study||30
8356170|NCT01229891|20598008|P1|COMPLETED|Overall Study||30
8356171|NCT01229891|20598006|P3|STARTED|Overall Study||30
8356172|NCT01229891|20598007|P2|STARTED|Overall Study||30
8356173|NCT01229891|20598008|P1|STARTED|Overall Study||30
8356174|NCT01229735|20598039|P2|NOT COMPLETED|Overall Study||66
8356175|NCT01229735|20598040|P1|NOT COMPLETED|Overall Study||66
8356176|NCT01229735|20598039|P2|COMPLETED|Overall Study||100
8356177|NCT01229735|20598040|P1|COMPLETED|Overall Study||111
8356178|NCT01229735|20598039|P2|STARTED|Overall Study||166
8356179|NCT01229735|20598040|P1|STARTED|Overall Study||177
8356180|NCT01229722|20598056|P2|NOT COMPLETED|Overall Study||4
8356181|NCT01229722|20598057|P1|NOT COMPLETED|Overall Study||0
8356182|NCT01229722|20598056|P2|COMPLETED|Overall Study||30
8356183|NCT01229722|20598057|P1|COMPLETED|Overall Study||36
8356184|NCT01229722|20598056|P2|STARTED|Overall Study||34
8356185|NCT01229722|20598057|P1|STARTED|Overall Study||36
8356186|NCT01229527|20598070|P3|NOT COMPLETED|Overall Study||0
8356187|NCT01229527|20598071|P2|NOT COMPLETED|Overall Study||0
8356188|NCT01229527|20598072|P1|NOT COMPLETED|Overall Study||0
8356189|NCT01229527|20598070|P3|COMPLETED|Overall Study||30
8356190|NCT01229527|20598071|P2|COMPLETED|Overall Study||30
8356191|NCT01229527|20598072|P1|COMPLETED|Overall Study||30
8356192|NCT01229527|20598070|P3|STARTED|Overall Study||30
8356193|NCT01229527|20598071|P2|STARTED|Overall Study||30
8356194|NCT01229527|20598072|P1|STARTED|Overall Study||30
8356195|NCT01229462|20598085|P2|NOT COMPLETED|Overall Study||9
8356196|NCT01229462|20598086|P1|NOT COMPLETED|Overall Study||5
8356197|NCT01229462|20598085|P2|COMPLETED|Overall Study||109
8356198|NCT01229462|20598086|P1|COMPLETED|Overall Study||115
8356199|NCT01229462|20598085|P2|STARTED|Overall Study||118
8356200|NCT01229462|20598086|P1|STARTED|Overall Study||120
8356201|NCT01229449|20598097|P5|NOT COMPLETED|Overall Study||1
8356202|NCT01229449|20598098|P4|NOT COMPLETED|Overall Study||1
8356203|NCT01229449|20598099|P3|NOT COMPLETED|Overall Study||2
8356204|NCT01229449|20598100|P2|NOT COMPLETED|Overall Study||4
8356205|NCT01229449|20598101|P1|NOT COMPLETED|Overall Study||1
8356206|NCT01229449|20598097|P5|COMPLETED|Overall Study||54
8356207|NCT01229449|20598098|P4|COMPLETED|Overall Study||112
8356208|NCT01229449|20598099|P3|COMPLETED|Overall Study||167
8356209|NCT01229449|20598100|P2|COMPLETED|Overall Study||164
8356210|NCT01229449|20598101|P1|COMPLETED|Overall Study||172
8356211|NCT01229449|20598097|P5|STARTED|Overall Study||55
8356212|NCT01229449|20598098|P4|STARTED|Overall Study||113
8356213|NCT01229449|20598099|P3|STARTED|Overall Study||169
8356214|NCT01229449|20598100|P2|STARTED|Overall Study||168
8356215|NCT01229449|20598101|P1|STARTED|Overall Study||173
8356216|NCT01229436|20598158|P1|NOT COMPLETED|Overall Study||5
8356217|NCT01229436|20598158|P1|COMPLETED|Overall Study||249
8356218|NCT01229436|20598158|P1|STARTED|Overall Study||254
8356219|NCT01229423|20598196|P1|NOT COMPLETED|Overall Study||15
8356220|NCT01229423|20598196|P1|COMPLETED|Overall Study||47
8356221|NCT01229423|20598196|P1|STARTED|Overall Study||62
8356222|NCT01229410|20598207|P2|NOT COMPLETED|Overall Study||3
8356223|NCT01229410|20598208|P1|NOT COMPLETED|Overall Study||5
8356224|NCT01229410|20598207|P2|COMPLETED|Overall Study||9
8356225|NCT01229410|20598208|P1|COMPLETED|Overall Study||7
8356226|NCT01229410|20598207|P2|STARTED|Overall Study||12
8356227|NCT01229410|20598208|P1|STARTED|Overall Study||12
8356228|NCT01229397|20598220|P2|NOT COMPLETED|Overall Study||9
8356229|NCT01229397|20598221|P1|NOT COMPLETED|Overall Study||11
8356230|NCT01229397|20598220|P2|COMPLETED|Overall Study||93
8356231|NCT01229397|20598221|P1|COMPLETED|Overall Study||92
8356232|NCT01229397|20598220|P2|STARTED|Overall Study||102
8356233|NCT01229397|20598221|P1|STARTED|Overall Study||103
8356234|NCT01229371|20598239|P4|NOT COMPLETED|Overall Study||0
8356235|NCT01229371|20598240|P3|NOT COMPLETED|Overall Study||0
8356236|NCT01229371|20598241|P2|NOT COMPLETED|Overall Study||1
8356237|NCT01229371|20598242|P1|NOT COMPLETED|Overall Study||0
8356238|NCT01229371|20598239|P4|COMPLETED|Overall Study||110
8356239|NCT01229371|20598240|P3|COMPLETED|Overall Study||110
8356240|NCT01229371|20598241|P2|COMPLETED|Overall Study||110
8356241|NCT01229371|20598242|P1|COMPLETED|Overall Study||109
8356242|NCT01229371|20598239|P4|STARTED|Overall Study||110
8356243|NCT01229371|20598240|P3|STARTED|Overall Study||110
8356244|NCT01229371|20598241|P2|STARTED|Overall Study||111
8356245|NCT01229371|20598242|P1|STARTED|Overall Study||109
8356246|NCT01229267|20598269|P5|NOT COMPLETED|Overall Study||220
8356247|NCT01229267|20598270|P4|NOT COMPLETED|Overall Study||35
8356248|NCT01229267|20598271|P3|NOT COMPLETED|Overall Study||86
8356249|NCT01229267|20598272|P2|NOT COMPLETED|Overall Study||82
8356250|NCT01229267|20598273|P1|NOT COMPLETED|Overall Study||81
8356251|NCT01229267|20598269|P5|COMPLETED|Overall Study||344
8356252|NCT01229267|20598270|P4|COMPLETED|Overall Study||71
8356253|NCT01229267|20598271|P3|COMPLETED|Overall Study||101
8356254|NCT01229267|20598272|P2|COMPLETED|Overall Study||102
8356255|NCT01229267|20598273|P1|COMPLETED|Overall Study||108
8356256|NCT01229267|20598269|P5|Received Vaccination 4|Overall Study||477
8356257|NCT01229267|20598270|P4|Received Vaccination 4|Overall Study||87
8356258|NCT01229267|20598271|P3|Received Vaccination 4|Overall Study||149
8356259|NCT01229267|20598272|P2|Received Vaccination 4|Overall Study||149
8356260|NCT01229267|20598273|P1|Received Vaccination 4|Overall Study||155
8356261|NCT01229267|20598269|P5|Received Vaccination 3|Overall Study||491
8356262|NCT01229267|20598270|P4|Received Vaccination 3|Overall Study||89
8356263|NCT01229267|20598271|P3|Received Vaccination 3|Overall Study||160
8356264|NCT01229267|20598272|P2|Received Vaccination 3|Overall Study||155
8356265|NCT01229267|20598273|P1|Received Vaccination 3|Overall Study||163
8356266|NCT01229267|20598269|P5|Received Vaccination 2|Overall Study||511
8356267|NCT01229267|20598270|P4|Received Vaccination 2|Overall Study||94
8356268|NCT01229267|20598271|P3|Received Vaccination 2|Overall Study||168
8356269|NCT01229267|20598272|P2|Received Vaccination 2|Overall Study||163
8356270|NCT01229267|20598273|P1|Received Vaccination 2|Overall Study||171
8356271|NCT01229267|20598269|P5|Received Vaccination 1|Overall Study||556
8356272|NCT01229267|20598270|P4|Received Vaccination 1|Overall Study||104
8356273|NCT01229267|20598271|P3|Received Vaccination 1|Overall Study||186
8356274|NCT01229267|20598272|P2|Received Vaccination 1|Overall Study||180
8356275|NCT01229267|20598273|P1|Received Vaccination 1|Overall Study||188
8356276|NCT01229267|20598269|P5|STARTED|Overall Study||564
8356277|NCT01229267|20598270|P4|STARTED|Overall Study||106
8356278|NCT01229267|20598271|P3|STARTED|Overall Study||187
8356279|NCT01229267|20598272|P2|STARTED|Overall Study||184
8356280|NCT01229267|20598273|P1|STARTED|Overall Study||189
8356281|NCT01229254|20598292|P3|NOT COMPLETED|Overall Study||12
8356282|NCT01229254|20598293|P2|NOT COMPLETED|Overall Study||16
8356283|NCT01229254|20598294|P1|NOT COMPLETED|Overall Study||15
8356284|NCT01229254|20598292|P3|COMPLETED|Overall Study||61
8356285|NCT01229254|20598293|P2|COMPLETED|Overall Study||58
8356286|NCT01229254|20598294|P1|COMPLETED|Overall Study||27
8356287|NCT01229254|20598292|P3|STARTED|Overall Study||73
8356288|NCT01229254|20598293|P2|STARTED|Overall Study||74
8356289|NCT01229254|20598294|P1|STARTED|Overall Study||42
8356290|NCT01229228|20598308|P5|NOT COMPLETED|Overall Study||1
8356291|NCT01229228|20598309|P4|NOT COMPLETED|Overall Study||0
8356292|NCT01229228|20598310|P3|NOT COMPLETED|Overall Study||1
8356293|NCT01229228|20598311|P2|NOT COMPLETED|Overall Study||0
8356294|NCT01229228|20598312|P1|NOT COMPLETED|Overall Study||1
8356295|NCT01229228|20598308|P5|COMPLETED|Overall Study||50
8356296|NCT01229228|20598309|P4|COMPLETED|Overall Study||51
8356297|NCT01229228|20598310|P3|COMPLETED|Overall Study||49
8356298|NCT01229228|20598311|P2|COMPLETED|Overall Study||51
8356299|NCT01229228|20598312|P1|COMPLETED|Overall Study||50
8356300|NCT01229228|20598308|P5|STARTED|Overall Study||51
8356301|NCT01229228|20598309|P4|STARTED|Overall Study||51
8356302|NCT01229228|20598310|P3|STARTED|Overall Study||50
8356303|NCT01229228|20598311|P2|STARTED|Overall Study||51
8356304|NCT01229228|20598312|P1|STARTED|Overall Study||51
8356305|NCT01229176|20598332|P8|NOT COMPLETED|Overall Study||3
8356306|NCT01229176|20598333|P7|NOT COMPLETED|Overall Study||0
8356307|NCT01229176|20598334|P6|NOT COMPLETED|Overall Study||2
8356308|NCT01229176|20598335|P5|NOT COMPLETED|Overall Study||2
8356309|NCT01229176|20598336|P4|NOT COMPLETED|Overall Study||1
8356310|NCT01229176|20598337|P3|NOT COMPLETED|Overall Study||0
8356311|NCT01229176|20598338|P2|NOT COMPLETED|Overall Study||3
8356312|NCT01229176|20598339|P1|NOT COMPLETED|Overall Study||0
8356313|NCT01229176|20598332|P8|COMPLETED|Overall Study||17
8356314|NCT01229176|20598333|P7|COMPLETED|Overall Study||20
8356315|NCT01229176|20598334|P6|COMPLETED|Overall Study||18
8356316|NCT01229176|20598335|P5|COMPLETED|Overall Study||18
8356317|NCT01229176|20598336|P4|COMPLETED|Overall Study||19
8356318|NCT01229176|20598337|P3|COMPLETED|Overall Study||20
8356319|NCT01229176|20598338|P2|COMPLETED|Overall Study||37
8356320|NCT01229176|20598339|P1|COMPLETED|Overall Study||40
8356321|NCT01229176|20598332|P8|STARTED|Overall Study||20
8356322|NCT01229176|20598333|P7|STARTED|Overall Study||20
8356323|NCT01229176|20598334|P6|STARTED|Overall Study||20
8356324|NCT01229176|20598335|P5|STARTED|Overall Study||20
8356325|NCT01229176|20598336|P4|STARTED|Overall Study||20
8356326|NCT01229176|20598337|P3|STARTED|Overall Study||20
8356327|NCT01229176|20598338|P2|STARTED|Overall Study||40
8356328|NCT01229176|20598339|P1|STARTED|Overall Study||40
8356329|NCT01229150|20598393|P4|NOT COMPLETED|Overall Study||0
8356330|NCT01229150|20598394|P3|NOT COMPLETED|Overall Study||0
8356331|NCT01229150|20598395|P2|NOT COMPLETED|Overall Study||2
8356332|NCT01229150|20598396|P1|NOT COMPLETED|Overall Study||2
8356333|NCT01229150|20598393|P4|COMPLETED|Overall Study||19
8356334|NCT01229150|20598394|P3|COMPLETED|Overall Study||19
8356335|NCT01229150|20598395|P2|COMPLETED|Overall Study||9
8356336|NCT01229150|20598396|P1|COMPLETED|Overall Study||28
8356337|NCT01229150|20598393|P4|STARTED|Overall Study||19
8356338|NCT01229150|20598394|P3|STARTED|Overall Study||19
8356339|NCT01229150|20598395|P2|STARTED|Overall Study||11
8356340|NCT01229150|20598396|P1|STARTED|Overall Study||30
8356341|NCT01229111|20598453|P1|NOT COMPLETED|Overall Study||1
8356342|NCT01229111|20598453|P1|COMPLETED|Overall Study||13
8356343|NCT01229111|20598453|P1|STARTED|Overall Study||14
8356344|NCT01228968|20598461|P1|NOT COMPLETED|Overall Study||0
8356345|NCT01228968|20598461|P1|COMPLETED|Overall Study||9
8356346|NCT01228968|20598461|P1|STARTED|Overall Study||9
8356347|NCT01228929|20598471|P3|NOT COMPLETED|High Temperature Condition||0
8356348|NCT01228929|20598472|P2|NOT COMPLETED|High Temperature Condition||0
8356349|NCT01228929|20598473|P1|NOT COMPLETED|High Temperature Condition||0
8356350|NCT01228929|20598471|P3|COMPLETED|High Temperature Condition||6
8356351|NCT01228929|20598472|P2|COMPLETED|High Temperature Condition||6
8356352|NCT01228929|20598473|P1|COMPLETED|High Temperature Condition||6
8356353|NCT01228929|20598471|P3|STARTED|High Temperature Condition||6
8356354|NCT01228929|20598472|P2|STARTED|High Temperature Condition||6
8356355|NCT01228929|20598473|P1|STARTED|High Temperature Condition||6
8356356|NCT01228929|20598471|P3|NOT COMPLETED|Low Humidity Condition||0
8356357|NCT01228929|20598472|P2|NOT COMPLETED|Low Humidity Condition||0
8356358|NCT01228929|20598473|P1|NOT COMPLETED|Low Humidity Condition||0
8356359|NCT01228929|20598471|P3|COMPLETED|Low Humidity Condition||6
8356360|NCT01228929|20598472|P2|COMPLETED|Low Humidity Condition||6
8356361|NCT01228929|20598473|P1|COMPLETED|Low Humidity Condition||6
8356362|NCT01228929|20598471|P3|STARTED|Low Humidity Condition||6
8356363|NCT01228929|20598472|P2|STARTED|Low Humidity Condition||6
8356364|NCT01228929|20598473|P1|STARTED|Low Humidity Condition||6
8356365|NCT01228929|20598471|P3|NOT COMPLETED|Nominal Condition||0
8356366|NCT01228929|20598472|P2|NOT COMPLETED|Nominal Condition||0
8356367|NCT01228929|20598473|P1|NOT COMPLETED|Nominal Condition||0
8356368|NCT01228929|20598471|P3|COMPLETED|Nominal Condition||6
8356369|NCT01228929|20598472|P2|COMPLETED|Nominal Condition||6
8356370|NCT01228929|20598473|P1|COMPLETED|Nominal Condition||6
8356371|NCT01228929|20598471|P3|STARTED|Nominal Condition||6
8356372|NCT01228929|20598472|P2|STARTED|Nominal Condition||6
8356373|NCT01228929|20598473|P1|STARTED|Nominal Condition||6
8356374|NCT01228903|20598483|P2|NOT COMPLETED|Overall Study||5
8356375|NCT01228903|20598484|P1|NOT COMPLETED|Overall Study||5
8356376|NCT01228903|20598483|P2|COMPLETED|Overall Study||34
8356377|NCT01228903|20598484|P1|COMPLETED|Overall Study||36
8356378|NCT01228903|20598483|P2|STARTED|Overall Study||39
8356379|NCT01228903|20598484|P1|STARTED|Overall Study||41
8356380|NCT01228747|20598502|P2|NOT COMPLETED|Overall Study||45
8356381|NCT01228747|20598503|P1|NOT COMPLETED|Overall Study||65
8356382|NCT01228747|20598502|P2|COMPLETED|Overall Study||81
8356383|NCT01228747|20598503|P1|COMPLETED|Overall Study||60
8356384|NCT01228747|20598502|P2|STARTED|Overall Study||126
8356385|NCT01228747|20598503|P1|STARTED|Overall Study||125
8356386|NCT01228734|20598519|P2|NOT COMPLETED|Overall Study||4
8356387|NCT01228734|20598520|P1|NOT COMPLETED|Overall Study||0
8356388|NCT01228734|20598519|P2|COMPLETED|Overall Study||200
8356389|NCT01228734|20598520|P1|COMPLETED|Overall Study||193
8356390|NCT01228734|20598519|P2|Modified Safety Population|Overall Study||199
8356391|NCT01228734|20598520|P1|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
8356392|NCT01228734|20598519|P2|Modified Intent-to-treat Population|Overall Study||200
8356393|NCT01228734|20598520|P1|Modified Intent-to-treat Population|Overall Study||193
8356394|NCT01228734|20598519|P2|STARTED|Overall Study||204
8356395|NCT01228734|20598520|P1|STARTED|Overall Study||193
8356396|NCT01228591|20598534|P2|NOT COMPLETED|Final Visit||0
8356397|NCT01228591|20598535|P1|NOT COMPLETED|Final Visit||0
8356398|NCT01228591|20598534|P2|COMPLETED|Final Visit||16
8356399|NCT01228591|20598535|P1|COMPLETED|Final Visit||17
8356400|NCT01228591|20598534|P2|STARTED|Final Visit||16
8356401|NCT01228591|20598535|P1|STARTED|Final Visit||17
8356402|NCT01228591|20598534|P2|NOT COMPLETED|1-Week Follow-Up||0
8356403|NCT01228591|20598535|P1|NOT COMPLETED|1-Week Follow-Up||0
8356404|NCT01228591|20598534|P2|COMPLETED|1-Week Follow-Up||16
8356405|NCT01228591|20598535|P1|COMPLETED|1-Week Follow-Up||17
8356406|NCT01228591|20598534|P2|STARTED|1-Week Follow-Up||16
8356407|NCT01228591|20598535|P1|STARTED|1-Week Follow-Up||17
8356408|NCT01228591|20598534|P2|NOT COMPLETED|Baseline||2
8356409|NCT01228591|20598535|P1|NOT COMPLETED|Baseline||1
8356410|NCT01228591|20598534|P2|COMPLETED|Baseline||16
8356411|NCT01228591|20598535|P1|COMPLETED|Baseline||17
8356412|NCT01228591|20598534|P2|STARTED|Baseline||18
8356413|NCT01228591|20598535|P1|STARTED|Baseline||18
8356414|NCT01228435|20598553|P2|NOT COMPLETED|Overall Study||0
8356415|NCT01228435|20598554|P1|NOT COMPLETED|Overall Study||0
8356416|NCT01228435|20598553|P2|COMPLETED|Overall Study||2
8356417|NCT01228435|20598554|P1|COMPLETED|Overall Study||1
8356418|NCT01228435|20598553|P2|STARTED|Overall Study||2
8356419|NCT01228435|20598554|P1|STARTED|Overall Study||1
8356420|NCT01228318|20598564|P2|NOT COMPLETED|Overall Study||7
8356421|NCT01228318|20598565|P1|NOT COMPLETED|Overall Study||4
8356422|NCT01228318|20598564|P2|COMPLETED|Overall Study||22
8356423|NCT01228318|20598565|P1|COMPLETED|Overall Study||30
8356424|NCT01228318|20598564|P2|STARTED|Overall Study||29
8356425|NCT01228318|20598565|P1|STARTED|Overall Study||34
8356426|NCT01228175|20598581|P2|NOT COMPLETED|Overall Study||53
8356427|NCT01228175|20598582|P1|NOT COMPLETED|Overall Study||66
8356428|NCT01228175|20598581|P2|COMPLETED|Overall Study||46
8356429|NCT01228175|20598582|P1|COMPLETED|Overall Study||53
8356430|NCT01228175|20598581|P2|STARTED|Overall Study||99
8356431|NCT01228175|20598582|P1|STARTED|Overall Study||119
8356432|NCT01228149|20598590|P2|NOT COMPLETED|Overall Study||4
8356433|NCT01228149|20598591|P1|NOT COMPLETED|Overall Study||5
8356434|NCT01228149|20598590|P2|COMPLETED|Overall Study||26
8356435|NCT01228149|20598591|P1|COMPLETED|Overall Study||27
8356436|NCT01228149|20598590|P2|STARTED|Overall Study||30
8356437|NCT01228149|20598591|P1|STARTED|Overall Study||32
8356438|NCT01228084|20598613|P1|NOT COMPLETED|Overall Study||4
8356439|NCT01228084|20598613|P1|COMPLETED|Overall Study||16
8356440|NCT01228084|20598613|P1|STARTED|Overall Study||20
8356441|NCT01228071|20598624|P1|NOT COMPLETED|Overall Study||2
8356442|NCT01228071|20598624|P1|COMPLETED|Overall Study||32
8356443|NCT01228071|20598624|P1|STARTED|Overall Study||34
8356444|NCT01228019|20598630|P1|NOT COMPLETED|Overall Study||304
8356445|NCT01228019|20598630|P1|COMPLETED|Overall Study||862
8356446|NCT01228019|20598630|P1|STARTED|Overall Study||1166
8356447|NCT01227993|20598645|P1|NOT COMPLETED|Overall Study||0
8356448|NCT01227993|20598645|P1|COMPLETED|Overall Study||3
8356449|NCT01227993|20598645|P1|STARTED|Overall Study||3
8356450|NCT01227980|20598657|P2|NOT COMPLETED|Overall Study||5
8356451|NCT01227980|20598658|P1|NOT COMPLETED|Overall Study||2
8356452|NCT01227980|20598657|P2|COMPLETED|Overall Study||25
8356453|NCT01227980|20598658|P1|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
8356454|NCT01227980|20598657|P2|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
8356455|NCT01227980|20598658|P1|Measure Drug Level Concentration|Overall Study||10
8356456|NCT01227980|20598657|P2|Scripts Challenge Sessions|Overall Study||25
8356457|NCT01227980|20598658|P1|Scripts Challenge Sessions|Overall Study||26
8356458|NCT01227980|20598657|P2|STARTED|Overall Study||30
8356459|NCT01227980|20598658|P1|STARTED|Overall Study||40
8356460|NCT01227967|20598696|P2|NOT COMPLETED|Overall Study||13
8356461|NCT01227967|20598697|P1|NOT COMPLETED|Overall Study||16
8356462|NCT01227967|20598696|P2|COMPLETED|Overall Study||303
8356463|NCT01227967|20598697|P1|COMPLETED|Overall Study||298
8356464|NCT01227967|20598696|P2|STARTED|Overall Study||316
8356465|NCT01227967|20598697|P1|STARTED|Overall Study||314
8356466|NCT01227954|20598731|P1|NOT COMPLETED|Overall Study||13
8356467|NCT01227954|20598731|P1|COMPLETED|Overall Study|Eligible subjects available for analysis|100
8356468|NCT01227954|20598731|P1|STARTED|Overall Study||113
8356469|NCT01227928|20598745|P2|NOT COMPLETED|Overall Study||17
8356470|NCT01227928|20598746|P1|NOT COMPLETED|Overall Study||22
8356471|NCT01227928|20598745|P2|COMPLETED|Overall Study||56
8356472|NCT01227928|20598746|P1|COMPLETED|Overall Study||50
8356473|NCT01227928|20598745|P2|STARTED|Overall Study||73
8356474|NCT01227928|20598746|P1|STARTED|Overall Study||72
8356475|NCT01227902|20598784|P4|NOT COMPLETED|Overall Study||10
8356476|NCT01227902|20598785|P3|NOT COMPLETED|Overall Study||19
8356477|NCT01227902|20598786|P2|NOT COMPLETED|Overall Study||13
8356478|NCT01227902|20598787|P1|NOT COMPLETED|Overall Study||18
8356479|NCT01227902|20598784|P4|COMPLETED|Overall Study||42
8356480|NCT01227902|20598785|P3|COMPLETED|Overall Study||25
8356481|NCT01227902|20598786|P2|COMPLETED|Overall Study||38
8356482|NCT01227902|20598787|P1|COMPLETED|Overall Study||38
8356483|NCT01227902|20598784|P4|STARTED|Overall Study||52
8356484|NCT01227902|20598785|P3|STARTED|Overall Study||44
8356485|NCT01227902|20598786|P2|STARTED|Overall Study||51
8356486|NCT01227902|20598787|P1|STARTED|Overall Study||56
8356487|NCT01227889|20598880|P2|NOT COMPLETED|Crossover Phase||37
8356488|NCT01227889|20598881|P1|NOT COMPLETED|Crossover Phase||0
8356489|NCT01227889|20598880|P2|COMPLETED|Crossover Phase||0
8356490|NCT01227889|20598881|P1|COMPLETED|Crossover Phase||0
8356491|NCT01227889|20598880|P2|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
8356492|NCT01227889|20598881|P1|STARTED|Crossover Phase||0
8356493|NCT01227889|20598880|P2|NOT COMPLETED|Randomized Phase (RP)||63
8356494|NCT01227889|20598881|P1|NOT COMPLETED|Randomized Phase (RP)||187
8356495|NCT01227889|20598880|P2|COMPLETED|Randomized Phase (RP)||0
8356496|NCT01227889|20598881|P1|COMPLETED|Randomized Phase (RP)||0
8356497|NCT01227889|20598880|P2|STARTED|Randomized Phase (RP)||63
8356498|NCT01227889|20598881|P1|STARTED|Randomized Phase (RP)||187
8356499|NCT01227824|20598908|P3|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
8356500|NCT01227824|20598909|P2|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
8356501|NCT01227824|20598910|P1|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
8356502|NCT01227824|20598908|P3|COMPLETED|Open-label Phase: Median of 1267 Days||294
8356503|NCT01227824|20598909|P2|COMPLETED|Open-label Phase: Median of 1267 Days||0
8356504|NCT01227824|20598910|P1|COMPLETED|Open-label Phase: Median of 1267 Days||0
8356505|NCT01227824|20598908|P3|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
8356506|NCT01227824|20598909|P2|STARTED|Open-label Phase: Median of 1267 Days||0
8356507|NCT01227824|20598910|P1|STARTED|Open-label Phase: Median of 1267 Days||0
8356508|NCT01227824|20598908|P3|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
8356509|NCT01227824|20598909|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
8356510|NCT01227824|20598910|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
8356511|NCT01227824|20598908|P3|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
8356512|NCT01227824|20598909|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
8356513|NCT01227824|20598910|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
8356514|NCT01227824|20598908|P3|STARTED|Double-blind Phase: 96 Weeks Duration||0
8356515|NCT01227824|20598909|P2|STARTED|Double-blind Phase: 96 Weeks Duration||411
8356516|NCT01227824|20598910|P1|STARTED|Double-blind Phase: 96 Weeks Duration||411
8356517|NCT01227785|20598939|P1|NOT COMPLETED|Overall Study||12
8356518|NCT01227785|20598939|P1|COMPLETED|Overall Study||108
8356519|NCT01227785|20598939|P1|STARTED|Overall Study||120
8356520|NCT01227707|20599005|P1|NOT COMPLETED|Overall Study||24
8356521|NCT01227707|20599005|P1|COMPLETED|Overall Study||19
8356522|NCT01227707|20599005|P1|STARTED|Overall Study||43
8356523|NCT01227681|20599024|P3|NOT COMPLETED|Overall Study||0
8356524|NCT01227681|20599025|P2|NOT COMPLETED|Overall Study||0
8356525|NCT01227681|20599026|P1|NOT COMPLETED|Overall Study||0
8356526|NCT01227681|20599024|P3|COMPLETED|Overall Study||0
8356527|NCT01227681|20599025|P2|COMPLETED|Overall Study||0
8356528|NCT01227681|20599026|P1|COMPLETED|Overall Study||4
8356529|NCT01227681|20599024|P3|STARTED|Overall Study||0
8356530|NCT01227681|20599025|P2|STARTED|Overall Study||0
8356531|NCT01227681|20599026|P1|STARTED|Overall Study||4
8356532|NCT01227668|20599032|P2|NOT COMPLETED|Phase 2 (Randomization Phase)||25
8356533|NCT01227668|20599033|P1|NOT COMPLETED|Phase 2 (Randomization Phase)||19
8356534|NCT01227668|20599032|P2|COMPLETED|Phase 2 (Randomization Phase)||19
8356535|NCT01227668|20599033|P1|COMPLETED|Phase 2 (Randomization Phase)||22
8356536|NCT01227668|20599032|P2|Received Treatment|Phase 2 (Randomization Phase)||43
8356537|NCT01227668|20599033|P1|Received Treatment|Phase 2 (Randomization Phase)||39
8356538|NCT01227668|20599032|P2|STARTED|Phase 2 (Randomization Phase)|Randomized|44
8356539|NCT01227668|20599033|P1|STARTED|Phase 2 (Randomization Phase)|Randomized|41
8356540|NCT01227668|20599032|P2|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
8356541|NCT01227668|20599033|P1|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
8356542|NCT01227668|20599032|P2|COMPLETED|Phase 1 (Stabilization Phase)||0
8356543|NCT01227668|20599033|P1|COMPLETED|Phase 1 (Stabilization Phase)||85
8356544|NCT01227668|20599032|P2|Received Treatment|Phase 1 (Stabilization Phase)||0
8356545|NCT01227668|20599033|P1|Received Treatment|Phase 1 (Stabilization Phase)||155
8356546|NCT01227668|20599032|P2|STARTED|Phase 1 (Stabilization Phase)||0
8356547|NCT01227668|20599033|P1|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
8356548|NCT01227655|20599050|P3|NOT COMPLETED|Overall Study||14
8356549|NCT01227655|20599051|P2|NOT COMPLETED|Overall Study||26
8356550|NCT01227655|20599052|P1|NOT COMPLETED|Overall Study||11
8356551|NCT01227655|20599050|P3|COMPLETED|Overall Study||130
8356552|NCT01227655|20599051|P2|COMPLETED|Overall Study||128
8356553|NCT01227655|20599052|P1|COMPLETED|Overall Study||118
8356554|NCT01227655|20599050|P3|Full Analysis Set|Overall Study||135
8356555|NCT01227655|20599051|P2|Full Analysis Set|Overall Study||147
8356556|NCT01227655|20599052|P1|Full Analysis Set|Overall Study||125
8356557|NCT01227655|20599050|P3|Safety Set|Overall Study||136
8356558|NCT01227655|20599051|P2|Safety Set|Overall Study||150
8356559|NCT01227655|20599052|P1|Safety Set|Overall Study||125
8356560|NCT01227655|20599050|P3|STARTED|Overall Study||144
8356561|NCT01227655|20599051|P2|STARTED|Overall Study||154
8356562|NCT01227655|20599052|P1|STARTED|Overall Study||129
8356563|NCT01227629|20599079|P10|NOT COMPLETED|Overall Study||2
8356564|NCT01227629|20599080|P9|NOT COMPLETED|Overall Study||6
8356565|NCT01227629|20599081|P8|NOT COMPLETED|Overall Study||6
8356566|NCT01227629|20599082|P7|NOT COMPLETED|Overall Study||8
8356567|NCT01227629|20599083|P6|NOT COMPLETED|Overall Study||1
8356568|NCT01227629|20599084|P5|NOT COMPLETED|Overall Study||2
8356569|NCT01227629|20599085|P4|NOT COMPLETED|Overall Study||8
8356570|NCT01227629|20599086|P3|NOT COMPLETED|Overall Study||1
8356571|NCT01227629|20599087|P2|NOT COMPLETED|Overall Study||2
8356572|NCT01227629|20599088|P1|NOT COMPLETED|Overall Study||2
8356573|NCT01227629|20599079|P10|COMPLETED|Overall Study||68
8356574|NCT01227629|20599080|P9|COMPLETED|Overall Study||24
8356575|NCT01227629|20599081|P8|COMPLETED|Overall Study||27
8356576|NCT01227629|20599082|P7|COMPLETED|Overall Study||90
8356577|NCT01227629|20599083|P6|COMPLETED|Overall Study||32
8356578|NCT01227629|20599084|P5|COMPLETED|Overall Study||32
8356579|NCT01227629|20599085|P4|COMPLETED|Overall Study||91
8356580|NCT01227629|20599086|P3|COMPLETED|Overall Study||26
8356581|NCT01227629|20599087|P2|COMPLETED|Overall Study||18
8356582|NCT01227629|20599088|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
8356583|NCT01227629|20599079|P10|STARTED|Overall Study||70
8356584|NCT01227629|20599080|P9|STARTED|Overall Study||30
8356585|NCT01227629|20599081|P8|STARTED|Overall Study||33
8356586|NCT01227629|20599082|P7|STARTED|Overall Study||98
8356587|NCT01227629|20599083|P6|STARTED|Overall Study||33
8356588|NCT01227629|20599084|P5|STARTED|Overall Study||34
8356589|NCT01227629|20599085|P4|STARTED|Overall Study||99
8356590|NCT01227629|20599086|P3|STARTED|Overall Study||27
8356591|NCT01227629|20599087|P2|STARTED|Overall Study||20
8356592|NCT01227629|20599088|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
8356593|NCT01227616|20599326|P2|NOT COMPLETED|Overall Study||23
8356594|NCT01227616|20599327|P1|NOT COMPLETED|Overall Study||54
8356595|NCT01227616|20599326|P2|COMPLETED|Overall Study||74
8356596|NCT01227616|20599327|P1|COMPLETED|Overall Study||142
8356597|NCT01227616|20599326|P2|STARTED|Overall Study||97
8356598|NCT01227616|20599327|P1|STARTED|Overall Study||196
8356599|NCT01227577|20599337|P1|NOT COMPLETED|Overall Study||35
8356600|NCT01227577|20599337|P1|COMPLETED|Overall Study||93
8356601|NCT01227577|20599337|P1|STARTED|Overall Study||128
8356602|NCT01227564|20599352|P3|NOT COMPLETED|Overall Study||6
8356603|NCT01227564|20599353|P2|NOT COMPLETED|Overall Study||2
8356604|NCT01227564|20599354|P1|NOT COMPLETED|Overall Study||4
8356605|NCT01227564|20599352|P3|COMPLETED|Overall Study|Completed study|15
8356606|NCT01227564|20599353|P2|COMPLETED|Overall Study|Completed study|18
8356607|NCT01227564|20599354|P1|COMPLETED|Overall Study|Completed study|18
8356608|NCT01227564|20599352|P3|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
8356609|NCT01227564|20599353|P2|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
8356610|NCT01227564|20599354|P1|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
8356611|NCT01227564|20599352|P3|Treated|Overall Study||21
8356612|NCT01227564|20599353|P2|Treated|Overall Study||20
8356613|NCT01227564|20599354|P1|Treated|Overall Study||22
8356614|NCT01227564|20599352|P3|STARTED|Overall Study||21
8356615|NCT01227564|20599353|P2|STARTED|Overall Study||20
8356616|NCT01227564|20599354|P1|STARTED|Overall Study||22
8356617|NCT01227551|20599485|P1|NOT COMPLETED|Overall Study||34
8356618|NCT01227551|20599485|P1|COMPLETED|Overall Study||23
8356619|NCT01227551|20599485|P1|STARTED|Overall Study||57
8356620|NCT01227512|20599492|P2|NOT COMPLETED|Overall Study||10
8356621|NCT01227512|20599493|P1|NOT COMPLETED|Overall Study||13
8356622|NCT01227512|20599492|P2|COMPLETED|Overall Study||48
8356623|NCT01227512|20599493|P1|COMPLETED|Overall Study||53
8356624|NCT01227512|20599492|P2|STARTED|Overall Study||58
8356625|NCT01227512|20599493|P1|STARTED|Overall Study||66
8356626|NCT01227434|20599515|P2|NOT COMPLETED|Overall Study||0
8356627|NCT01227434|20599516|P1|NOT COMPLETED|Overall Study||0
8356628|NCT01227434|20599515|P2|COMPLETED|Overall Study||16
8356629|NCT01227434|20599516|P1|COMPLETED|Overall Study||6
8356630|NCT01227434|20599515|P2|STARTED|Overall Study||16
8356631|NCT01227434|20599516|P1|STARTED|Overall Study||6
8356632|NCT01227421|20599527|P3|NOT COMPLETED|Overall Study||10
8356633|NCT01227421|20599528|P2|NOT COMPLETED|Overall Study||18
8356634|NCT01227421|20599529|P1|NOT COMPLETED|Overall Study||11
8356635|NCT01227421|20599527|P3|COMPLETED|Overall Study||201
8356636|NCT01227421|20599528|P2|COMPLETED|Overall Study||194
8356637|NCT01227421|20599529|P1|COMPLETED|Overall Study||190
8356638|NCT01227421|20599527|P3|STARTED|Overall Study||211
8356639|NCT01227421|20599528|P2|STARTED|Overall Study||212
8356640|NCT01227421|20599529|P1|STARTED|Overall Study||201
8356641|NCT01227395|20599581|P2|NOT COMPLETED|Overall Study||1
8356642|NCT01227395|20599582|P1|NOT COMPLETED|Overall Study||0
8356643|NCT01227395|20599581|P2|COMPLETED|Overall Study||84
8356644|NCT01227395|20599582|P1|COMPLETED|Overall Study||391
8356645|NCT01227395|20599581|P2|STARTED|Overall Study||85
8356646|NCT01227395|20599582|P1|STARTED|Overall Study||391
8356647|NCT01227382|20599610|P1|NOT COMPLETED|Overall Study||0
8356648|NCT01227382|20599610|P1|COMPLETED|Overall Study||26
8356649|NCT01227382|20599610|P1|STARTED|Overall Study||26
8356650|NCT01227278|20599622|P2|NOT COMPLETED|Overall Study||8
8356651|NCT01227278|20599623|P1|NOT COMPLETED|Overall Study||5
8356652|NCT01227278|20599622|P2|COMPLETED|Overall Study||43
8356653|NCT01227278|20599623|P1|COMPLETED|Overall Study||45
8356654|NCT01227278|20599622|P2|STARTED|Overall Study||51
8356655|NCT01227278|20599623|P1|STARTED|Overall Study||50
8356656|NCT01227265|20599650|P3|NOT COMPLETED|Overall Study||14
8356657|NCT01227265|20599651|P2|NOT COMPLETED|Overall Study||20
8356658|NCT01227265|20599652|P1|NOT COMPLETED|Overall Study||19
8356659|NCT01227265|20599650|P3|COMPLETED|Overall Study||145
8356660|NCT01227265|20599651|P2|COMPLETED|Overall Study||139
8356661|NCT01227265|20599652|P1|COMPLETED|Overall Study||139
8356662|NCT01227265|20599650|P3|Treated|Overall Study||159
8356663|NCT01227265|20599651|P2|Treated|Overall Study||157
8356664|NCT01227265|20599652|P1|Treated|Overall Study||157
8356665|NCT01227265|20599650|P3|STARTED|Overall Study||159
8356666|NCT01227265|20599651|P2|STARTED|Overall Study||159
8356667|NCT01227265|20599652|P1|STARTED|Overall Study||158
8356668|NCT01227252|20599682|P4|NOT COMPLETED|Overall Study||0
8356669|NCT01227252|20599683|P3|NOT COMPLETED|Overall Study||0
8356670|NCT01227252|20599684|P2|NOT COMPLETED|Overall Study||3
8356671|NCT01227252|20599685|P1|NOT COMPLETED|Overall Study||0
8356672|NCT01227252|20599682|P4|COMPLETED|Overall Study||10
8356673|NCT01227252|20599683|P3|COMPLETED|Overall Study||10
8356674|NCT01227252|20599684|P2|COMPLETED|Overall Study||7
8356675|NCT01227252|20599685|P1|COMPLETED|Overall Study||12
8356676|NCT01227252|20599682|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
8356677|NCT01227252|20599683|P3|Received at Least 1 Dose of Study Drug|Overall Study||10
8356678|NCT01227252|20599684|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
8356679|NCT01227252|20599685|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
8356680|NCT01227252|20599682|P4|STARTED|Overall Study||10
8356681|NCT01227252|20599683|P3|STARTED|Overall Study||10
8356682|NCT01227252|20599684|P2|STARTED|Overall Study||10
8356683|NCT01227252|20599685|P1|STARTED|Overall Study||12
8356684|NCT01227057|20599714|P2|NOT COMPLETED|Overall Study||8
8356685|NCT01227057|20599715|P1|NOT COMPLETED|Overall Study||6
8356686|NCT01227057|20599714|P2|COMPLETED|Overall Study||19
8356687|NCT01227057|20599715|P1|COMPLETED|Overall Study||25
8356688|NCT01227057|20599714|P2|STARTED|Overall Study||27
8356689|NCT01227057|20599715|P1|STARTED|Overall Study||31
8356690|NCT01227044|20599727|P2|NOT COMPLETED|Overall Study||9
8356691|NCT01227044|20599728|P1|NOT COMPLETED|Overall Study||6
8356692|NCT01227044|20599727|P2|COMPLETED|Overall Study||17
8356693|NCT01227044|20599728|P1|COMPLETED|Overall Study||19
8356694|NCT01227044|20599727|P2|STARTED|Overall Study||26
8356695|NCT01227044|20599728|P1|STARTED|Overall Study||25
8356696|NCT01227018|20599736|P1|NOT COMPLETED|Overall Study||15
8356697|NCT01227018|20599736|P1|COMPLETED|Overall Study||0
8356698|NCT01227018|20599736|P1|STARTED|Overall Study||15
8356699|NCT01227005|20599746|P2|NOT COMPLETED|Overall Study||1
8356700|NCT01227005|20599747|P1|NOT COMPLETED|Overall Study||5
8356701|NCT01227005|20599746|P2|COMPLETED|Overall Study||51
8356702|NCT01227005|20599747|P1|COMPLETED|Overall Study||50
8356703|NCT01227005|20599746|P2|STARTED|Overall Study||52
8356704|NCT01227005|20599747|P1|STARTED|Overall Study||55
8356705|NCT01226979|20599757|P1|NOT COMPLETED|Overall Study||0
8356706|NCT01226979|20599757|P1|COMPLETED|Overall Study||16
8356707|NCT01226979|20599757|P1|STARTED|Overall Study||16
8356708|NCT01226914|20599768|P2|NOT COMPLETED|Overall Study||0
8356709|NCT01226914|20599769|P1|NOT COMPLETED|Overall Study||0
8356710|NCT01226914|20599768|P2|COMPLETED|Overall Study||27
8356711|NCT01226914|20599769|P1|COMPLETED|Overall Study||28
8356712|NCT01226914|20599768|P2|STARTED|Overall Study||27
8356713|NCT01226914|20599769|P1|STARTED|Overall Study||28
8356714|NCT01226745|20599781|P6|NOT COMPLETED|Overall Study||5
8356715|NCT01226745|20599782|P5|NOT COMPLETED|Overall Study||4
8356716|NCT01226745|20599783|P4|NOT COMPLETED|Overall Study||5
8356717|NCT01226745|20599784|P3|NOT COMPLETED|Overall Study||20
8356718|NCT01226745|20599785|P2|NOT COMPLETED|Overall Study||16
8356719|NCT01226745|20599786|P1|NOT COMPLETED|Overall Study||17
8356720|NCT01226745|20599781|P6|COMPLETED|Overall Study||24
8356721|NCT01226745|20599782|P5|COMPLETED|Overall Study||22
8356722|NCT01226745|20599783|P4|COMPLETED|Overall Study||24
8356723|NCT01226745|20599784|P3|COMPLETED|Overall Study||69
8356724|NCT01226745|20599785|P2|COMPLETED|Overall Study||71
8356725|NCT01226745|20599786|P1|COMPLETED|Overall Study||63
8356726|NCT01226745|20599781|P6|STARTED|Overall Study||29
8356727|NCT01226745|20599782|P5|STARTED|Overall Study||26
8356728|NCT01226745|20599783|P4|STARTED|Overall Study||29
8356729|NCT01226745|20599784|P3|STARTED|Overall Study||89
8356730|NCT01226745|20599785|P2|STARTED|Overall Study||87
8356731|NCT01226745|20599786|P1|STARTED|Overall Study||80
8356732|NCT01226732|20599866|P6|NOT COMPLETED|Overall Study||6
8356733|NCT01226732|20599867|P5|NOT COMPLETED|Overall Study||3
8356734|NCT01226732|20599868|P4|NOT COMPLETED|Overall Study||5
8356735|NCT01226732|20599869|P3|NOT COMPLETED|Overall Study||3
8356736|NCT01226732|20599870|P2|NOT COMPLETED|Overall Study||3
8356737|NCT01226732|20599871|P1|NOT COMPLETED|Overall Study||3
8356738|NCT01226732|20599866|P6|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
8356739|NCT01226732|20599867|P5|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
8356740|NCT01226732|20599868|P4|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
8356741|NCT01226732|20599869|P3|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
8356742|NCT01226732|20599870|P2|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
8356743|NCT01226732|20599871|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
8356744|NCT01226732|20599866|P6|STARTED|Overall Study||6
8356745|NCT01226732|20599867|P5|STARTED|Overall Study||3
8356746|NCT01226732|20599868|P4|STARTED|Overall Study||5
8356747|NCT01226732|20599869|P3|STARTED|Overall Study||3
8356748|NCT01226732|20599870|P2|STARTED|Overall Study||3
8356749|NCT01226732|20599871|P1|STARTED|Overall Study||3
8356750|NCT01226719|20599887|P1|NOT COMPLETED|Overall Study||13
8356751|NCT01226719|20599887|P1|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
8356752|NCT01226719|20599887|P1|STARTED|Overall Study||15
8356753|NCT01226706|20599897|P2|NOT COMPLETED|Overall Study||0
8356754|NCT01226706|20599898|P1|NOT COMPLETED|Overall Study||0
8356755|NCT01226706|20599897|P2|COMPLETED|Overall Study||11
8356756|NCT01226706|20599898|P1|COMPLETED|Overall Study||10
8356757|NCT01226706|20599897|P2|STARTED|Overall Study||11
8356758|NCT01226706|20599898|P1|STARTED|Overall Study||10
8356759|NCT01226511|20599982|P2|NOT COMPLETED|Taper Period||3
8356760|NCT01226511|20599983|P1|NOT COMPLETED|Taper Period||5
8356761|NCT01226511|20599982|P2|COMPLETED|Taper Period||54
8356762|NCT01226511|20599983|P1|COMPLETED|Taper Period||46
8356763|NCT01226511|20599982|P2|STARTED|Taper Period||57
8356764|NCT01226511|20599983|P1|STARTED|Taper Period||51
8356765|NCT01226511|20599982|P2|NOT COMPLETED|Extension Treatment Period||27
8356766|NCT01226511|20599983|P1|NOT COMPLETED|Extension Treatment Period||27
8356767|NCT01226511|20599982|P2|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
8356768|NCT01226511|20599983|P1|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
8356769|NCT01226511|20599982|P2|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
8356770|NCT01226511|20599983|P1|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
8356771|NCT01226511|20599982|P2|NOT COMPLETED|Acute Treatment Period||31
8356772|NCT01226511|20599983|P1|NOT COMPLETED|Acute Treatment Period||32
8356773|NCT01226511|20599982|P2|COMPLETED|Acute Treatment Period||110
8356774|NCT01226511|20599983|P1|COMPLETED|Acute Treatment Period||108
8356775|NCT01226511|20599982|P2|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
8356776|NCT01226511|20599983|P1|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
8356777|NCT01226485|20600026|P7|NOT COMPLETED|Overall Study||0
8356778|NCT01226485|20600027|P6|NOT COMPLETED|Overall Study||0
8356779|NCT01226485|20600028|P5|NOT COMPLETED|Overall Study||0
8356780|NCT01226485|20600029|P4|NOT COMPLETED|Overall Study||0
8356781|NCT01226485|20600030|P3|NOT COMPLETED|Overall Study||0
8356782|NCT01226485|20600031|P2|NOT COMPLETED|Overall Study||0
8356783|NCT01226485|20600032|P1|NOT COMPLETED|Overall Study||0
8356784|NCT01226485|20600026|P7|COMPLETED|Overall Study||40
8356785|NCT01226485|20600027|P6|COMPLETED|Overall Study||19
8356786|NCT01226485|20600028|P5|COMPLETED|Overall Study||7
8356787|NCT01226485|20600029|P4|COMPLETED|Overall Study||6
8356788|NCT01226485|20600030|P3|COMPLETED|Overall Study||3
8356789|NCT01226485|20600031|P2|COMPLETED|Overall Study||6
8356790|NCT01226485|20600032|P1|COMPLETED|Overall Study||3
8356791|NCT01226485|20600026|P7|Received at Least One Dose of Drug|Overall Study||40
8356792|NCT01226485|20600027|P6|Received at Least One Dose of Drug|Overall Study||19
8356793|NCT01226485|20600028|P5|Received at Least One Dose of Drug|Overall Study||7
8356794|NCT01226485|20600029|P4|Received at Least One Dose of Drug|Overall Study||6
8356795|NCT01226485|20600030|P3|Received at Least One Dose of Drug|Overall Study||3
8356796|NCT01226485|20600031|P2|Received at Least One Dose of Drug|Overall Study||6
8356797|NCT01226485|20600032|P1|Received at Least One Dose of Drug|Overall Study||3
8356798|NCT01226485|20600026|P7|STARTED|Overall Study||40
8356799|NCT01226485|20600027|P6|STARTED|Overall Study||19
8356800|NCT01226485|20600028|P5|STARTED|Overall Study||7
8356801|NCT01226485|20600029|P4|STARTED|Overall Study||6
8356802|NCT01226485|20600030|P3|STARTED|Overall Study||3
8356803|NCT01226485|20600031|P2|STARTED|Overall Study||6
8356804|NCT01226485|20600032|P1|STARTED|Overall Study||3
8356805|NCT01226472|20600081|P1|NOT COMPLETED|Overall Study||1
8356806|NCT01226472|20600081|P1|COMPLETED|Overall Study||0
8356807|NCT01226472|20600081|P1|STARTED|Overall Study||1
8356808|NCT01226459|20600088|P2|NOT COMPLETED|Overall Study||32
8356809|NCT01226459|20600089|P1|NOT COMPLETED|Overall Study||21
8356810|NCT01226459|20600088|P2|COMPLETED|Overall Study||171
8356811|NCT01226459|20600089|P1|COMPLETED|Overall Study||180
8356812|NCT01226459|20600088|P2|STARTED|Overall Study||203
8356813|NCT01226459|20600089|P1|STARTED|Overall Study||201
8356814|NCT01226420|20600099|P1|NOT COMPLETED|Overall Study||0
8356815|NCT01226420|20600099|P1|COMPLETED|Overall Study||6
8356816|NCT01226420|20600099|P1|STARTED|Overall Study||6
8356817|NCT01226121|20600107|P3|NOT COMPLETED|Overall Study||1
8356818|NCT01226121|20600108|P2|NOT COMPLETED|Overall Study||0
8356819|NCT01226121|20600109|P1|NOT COMPLETED|Overall Study||2
8356820|NCT01226121|20600107|P3|COMPLETED|Overall Study||12
8356821|NCT01226121|20600108|P2|COMPLETED|Overall Study||11
8356822|NCT01226121|20600109|P1|COMPLETED|Overall Study||11
8356823|NCT01226121|20600107|P3|30 Day Evaluation|Overall Study||13
8356824|NCT01226121|20600108|P2|30 Day Evaluation|Overall Study||11
8356825|NCT01226121|20600109|P1|30 Day Evaluation|Overall Study||12
8356826|NCT01226121|20600107|P3|STARTED|Overall Study||13
8356827|NCT01226121|20600108|P2|STARTED|Overall Study||11
8356828|NCT01226121|20600109|P1|STARTED|Overall Study||13
8356829|NCT01226095|20600120|P1|NOT COMPLETED|Overall Study||1
8356830|NCT01226095|20600120|P1|COMPLETED|Overall Study||518
8356831|NCT01226095|20600120|P1|STARTED|Overall Study||519
8356832|NCT01226043|20600145|P4|NOT COMPLETED|30-week Observational Phase||13
8356833|NCT01226043|20600146|P3|NOT COMPLETED|30-week Observational Phase||6
8356834|NCT01226043|20600147|P2|NOT COMPLETED|30-week Observational Phase||0
8356835|NCT01226043|20600148|P1|NOT COMPLETED|30-week Observational Phase||0
8356836|NCT01226043|20600145|P4|COMPLETED|30-week Observational Phase||140
8356837|NCT01226043|20600146|P3|COMPLETED|30-week Observational Phase||153
8356838|NCT01226043|20600147|P2|COMPLETED|30-week Observational Phase||0
8356839|NCT01226043|20600148|P1|COMPLETED|30-week Observational Phase||0
8356840|NCT01226043|20600145|P4|TREATED|30-week Observational Phase||153
8356841|NCT01226043|20600146|P3|TREATED|30-week Observational Phase||159
8356842|NCT01226043|20600147|P2|TREATED|30-week Observational Phase||0
8356843|NCT01226043|20600148|P1|TREATED|30-week Observational Phase||0
8356844|NCT01226043|20600145|P4|STARTED|30-week Observational Phase||153
8356845|NCT01226043|20600146|P3|STARTED|30-week Observational Phase||159
8356846|NCT01226043|20600147|P2|STARTED|30-week Observational Phase||0
8356847|NCT01226043|20600148|P1|STARTED|30-week Observational Phase||0
8356848|NCT01226043|20600145|P4|NOT COMPLETED|6-week Re-randomization Phase||11
8356849|NCT01226043|20600146|P3|NOT COMPLETED|6-week Re-randomization Phase||7
8356850|NCT01226043|20600147|P2|NOT COMPLETED|6-week Re-randomization Phase||0
8356851|NCT01226043|20600148|P1|NOT COMPLETED|6-week Re-randomization Phase||0
8356852|NCT01226043|20600145|P4|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
8356853|NCT01226043|20600146|P3|COMPLETED|6-week Re-randomization Phase||159
8356854|NCT01226043|20600147|P2|COMPLETED|6-week Re-randomization Phase||0
8356855|NCT01226043|20600148|P1|COMPLETED|6-week Re-randomization Phase||0
8356856|NCT01226043|20600145|P4|TREATED|6-week Re-randomization Phase||165
8356857|NCT01226043|20600146|P3|TREATED|6-week Re-randomization Phase||165
8356858|NCT01226043|20600147|P2|TREATED|6-week Re-randomization Phase||0
8356859|NCT01226043|20600148|P1|TREATED|6-week Re-randomization Phase||0
8356860|NCT01226043|20600145|P4|STARTED|6-week Re-randomization Phase||167
8356861|NCT01226043|20600146|P3|STARTED|6-week Re-randomization Phase||166
8356862|NCT01226043|20600147|P2|STARTED|6-week Re-randomization Phase||0
8356863|NCT01226043|20600148|P1|STARTED|6-week Re-randomization Phase||0
8356864|NCT01226043|20600145|P4|NOT COMPLETED|4-week Crossover Phase - Period 2||0
8356865|NCT01226043|20600146|P3|NOT COMPLETED|4-week Crossover Phase - Period 2||0
8356866|NCT01226043|20600147|P2|NOT COMPLETED|4-week Crossover Phase - Period 2||6
8356867|NCT01226043|20600148|P1|NOT COMPLETED|4-week Crossover Phase - Period 2||4
8356868|NCT01226043|20600145|P4|COMPLETED|4-week Crossover Phase - Period 2||0
8356869|NCT01226043|20600146|P3|COMPLETED|4-week Crossover Phase - Period 2||0
8356870|NCT01226043|20600147|P2|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
8356871|NCT01226043|20600148|P1|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
8356872|NCT01226043|20600145|P4|TREATED|4-week Crossover Phase - Period 2||0
8356873|NCT01226043|20600146|P3|TREATED|4-week Crossover Phase - Period 2||0
8356874|NCT01226043|20600147|P2|TREATED|4-week Crossover Phase - Period 2||194
8356875|NCT01226043|20600148|P1|TREATED|4-week Crossover Phase - Period 2||199
8356876|NCT01226043|20600145|P4|STARTED|4-week Crossover Phase - Period 2||0
8356877|NCT01226043|20600146|P3|STARTED|4-week Crossover Phase - Period 2||0
8356878|NCT01226043|20600147|P2|STARTED|4-week Crossover Phase - Period 2||194
8356879|NCT01226043|20600148|P1|STARTED|4-week Crossover Phase - Period 2||199
8356880|NCT01226043|20600145|P4|NOT COMPLETED|4-week Crossover Phase - Period 1||0
8356881|NCT01226043|20600146|P3|NOT COMPLETED|4-week Crossover Phase - Period 1||0
8356882|NCT01226043|20600147|P2|NOT COMPLETED|4-week Crossover Phase - Period 1||9
8356883|NCT01226043|20600148|P1|NOT COMPLETED|4-week Crossover Phase - Period 1||3
8356884|NCT01226043|20600145|P4|COMPLETED|4-week Crossover Phase - Period 1||0
8356885|NCT01226043|20600146|P3|COMPLETED|4-week Crossover Phase - Period 1||0
8356886|NCT01226043|20600147|P2|COMPLETED|4-week Crossover Phase - Period 1||194
8356887|NCT01226043|20600148|P1|COMPLETED|4-week Crossover Phase - Period 1||199
8356888|NCT01226043|20600145|P4|TREATED|4-week Crossover Phase - Period 1||0
8356889|NCT01226043|20600146|P3|TREATED|4-week Crossover Phase - Period 1||0
8356890|NCT01226043|20600147|P2|TREATED|4-week Crossover Phase - Period 1||200
8356891|NCT01226043|20600148|P1|TREATED|4-week Crossover Phase - Period 1||202
8356892|NCT01226043|20600145|P4|STARTED|4-week Crossover Phase - Period 1||0
8356893|NCT01226043|20600146|P3|STARTED|4-week Crossover Phase - Period 1||0
8356894|NCT01226043|20600147|P2|STARTED|4-week Crossover Phase - Period 1||203
8356895|NCT01226043|20600148|P1|STARTED|4-week Crossover Phase - Period 1||202
8356896|NCT01225991|20600186|P1|NOT COMPLETED|Overall Study||6
8356897|NCT01225991|20600186|P1|COMPLETED|Overall Study||12
8356898|NCT01225991|20600186|P1|STARTED|Overall Study||18
8356899|NCT01225952|20600197|P3|NOT COMPLETED|Overall Study||6
8356900|NCT01225952|20600198|P2|NOT COMPLETED|Overall Study||4
8356901|NCT01225952|20600199|P1|NOT COMPLETED|Overall Study||6
8356902|NCT01225952|20600197|P3|COMPLETED|Overall Study||25
8356903|NCT01225952|20600198|P2|COMPLETED|Overall Study||27
8356904|NCT01225952|20600199|P1|COMPLETED|Overall Study||25
8356905|NCT01225952|20600197|P3|STARTED|Overall Study||31
8356906|NCT01225952|20600198|P2|STARTED|Overall Study||31
8356907|NCT01225952|20600199|P1|STARTED|Overall Study||31
8356908|NCT01225926|20600284|P2|NOT COMPLETED|Overall Study||0
8356909|NCT01225926|20600285|P1|NOT COMPLETED|Overall Study||0
8356910|NCT01225926|20600284|P2|COMPLETED|Overall Study||12
8356911|NCT01225926|20600285|P1|COMPLETED|Overall Study||12
8356912|NCT01225926|20600284|P2|STARTED|Overall Study||12
8356913|NCT01225926|20600285|P1|STARTED|Overall Study||12
8356914|NCT01225887|20600291|P1|NOT COMPLETED|Overall Study||5
8356915|NCT01225887|20600291|P1|COMPLETED|Overall Study||32
8356916|NCT01225887|20600291|P1|STARTED|Overall Study||37
8356917|NCT01225835|20600301|P2|NOT COMPLETED|Overall Study||3
8356918|NCT01225835|20600302|P1|NOT COMPLETED|Overall Study||7
8356919|NCT01225835|20600301|P2|COMPLETED|Overall Study|hCG criterion met|59
8356920|NCT01225835|20600302|P1|COMPLETED|Overall Study|hCG criterion met|55
8356921|NCT01225835|20600301|P2|Per Protocol Population|Overall Study||58
8356922|NCT01225835|20600302|P1|Per Protocol Population|Overall Study||48
8356923|NCT01225835|20600301|P2|STARTED|Overall Study||62
8356924|NCT01225835|20600302|P1|STARTED|Overall Study||62
8356925|NCT01225822|20600350|P5|NOT COMPLETED|Overall Study||31
8356926|NCT01225822|20600351|P4|NOT COMPLETED|Overall Study||52
8356927|NCT01225822|20600352|P3|NOT COMPLETED|Overall Study||38
8356928|NCT01225822|20600353|P2|NOT COMPLETED|Overall Study||56
8356929|NCT01225822|20600354|P1|NOT COMPLETED|Overall Study||38
8356930|NCT01225822|20600350|P5|COMPLETED|Overall Study||361
8356931|NCT01225822|20600351|P4|COMPLETED|Overall Study||333
8356932|NCT01225822|20600352|P3|COMPLETED|Overall Study||355
8356933|NCT01225822|20600353|P2|COMPLETED|Overall Study||334
8356934|NCT01225822|20600354|P1|COMPLETED|Overall Study||351
8356935|NCT01225822|20600350|P5|STARTED|Overall Study||392
8356936|NCT01225822|20600351|P4|STARTED|Overall Study||385
8356937|NCT01225822|20600352|P3|STARTED|Overall Study||393
8356938|NCT01225822|20600353|P2|STARTED|Overall Study||390
8356939|NCT01225822|20600354|P1|STARTED|Overall Study||389
8356940|NCT01225731|20600421|P13|NOT COMPLETED|Part 3||7
8356941|NCT01225731|20600422|P12|NOT COMPLETED|Part 3||10
8356942|NCT01225731|20600423|P11|NOT COMPLETED|Part 3||6
8356943|NCT01225731|20600424|P10|NOT COMPLETED|Part 3||0
8356944|NCT01225731|20600425|P9|NOT COMPLETED|Part 3||0
8356945|NCT01225731|20600426|P8|NOT COMPLETED|Part 3||0
8356946|NCT01225731|20600427|P7|NOT COMPLETED|Part 3||0
8356947|NCT01225731|20600428|P6|NOT COMPLETED|Part 3||0
8356948|NCT01225731|20600429|P5|NOT COMPLETED|Part 3||0
8356949|NCT01225731|20600430|P4|NOT COMPLETED|Part 3||0
8356950|NCT01225731|20600431|P3|NOT COMPLETED|Part 3||0
8356951|NCT01225731|20600432|P2|NOT COMPLETED|Part 3||0
8356952|NCT01225731|20600433|P1|NOT COMPLETED|Part 3||0
8356953|NCT01225731|20600421|P13|COMPLETED|Part 3||60
8356954|NCT01225731|20600422|P12|COMPLETED|Part 3||116
8356955|NCT01225731|20600423|P11|COMPLETED|Part 3||80
8356956|NCT01225731|20600424|P10|COMPLETED|Part 3||10
8356957|NCT01225731|20600425|P9|COMPLETED|Part 3||0
8356958|NCT01225731|20600426|P8|COMPLETED|Part 3||0
8356959|NCT01225731|20600427|P7|COMPLETED|Part 3||0
8356960|NCT01225731|20600428|P6|COMPLETED|Part 3||0
8356961|NCT01225731|20600429|P5|COMPLETED|Part 3||0
8356962|NCT01225731|20600430|P4|COMPLETED|Part 3||0
8356963|NCT01225731|20600431|P3|COMPLETED|Part 3||0
8356964|NCT01225731|20600432|P2|COMPLETED|Part 3||0
8356965|NCT01225731|20600433|P1|COMPLETED|Part 3||0
8356966|NCT01225731|20600421|P13|STARTED|Part 3|Not all participants entered follow-up|67
8356967|NCT01225731|20600422|P12|STARTED|Part 3|Not all participants entered follow-up|126
8356968|NCT01225731|20600423|P11|STARTED|Part 3|Not all participants entered follow-up|86
8356969|NCT01225731|20600424|P10|STARTED|Part 3|Not all participants entered follow-up|10
8356970|NCT01225731|20600425|P9|STARTED|Part 3|Participants could enter the follow-up period|0
8356971|NCT01225731|20600426|P8|STARTED|Part 3|Participants could enter the follow-up period|0
8356972|NCT01225731|20600427|P7|STARTED|Part 3|Participants could enter the follow-up period|0
8356973|NCT01225731|20600428|P6|STARTED|Part 3|Participants could enter the follow-up period|0
8356974|NCT01225731|20600429|P5|STARTED|Part 3||0
8356975|NCT01225731|20600430|P4|STARTED|Part 3||0
8356976|NCT01225731|20600431|P3|STARTED|Part 3||0
8356977|NCT01225731|20600432|P2|STARTED|Part 3||0
8356978|NCT01225731|20600433|P1|STARTED|Part 3||0
8356979|NCT01225731|20600421|P13|NOT COMPLETED|Part 2||0
8356980|NCT01225731|20600422|P12|NOT COMPLETED|Part 2||0
8356981|NCT01225731|20600423|P11|NOT COMPLETED|Part 2||0
8356982|NCT01225731|20600424|P10|NOT COMPLETED|Part 2||0
8356983|NCT01225731|20600425|P9|NOT COMPLETED|Part 2||11
8356984|NCT01225731|20600426|P8|NOT COMPLETED|Part 2||25
8356985|NCT01225731|20600427|P7|NOT COMPLETED|Part 2||8
8356986|NCT01225731|20600428|P6|NOT COMPLETED|Part 2||3
8356987|NCT01225731|20600429|P5|NOT COMPLETED|Part 2||0
8356988|NCT01225731|20600430|P4|NOT COMPLETED|Part 2||0
8356989|NCT01225731|20600431|P3|NOT COMPLETED|Part 2||0
8356990|NCT01225731|20600432|P2|NOT COMPLETED|Part 2||0
8356991|NCT01225731|20600433|P1|NOT COMPLETED|Part 2||0
8356992|NCT01225731|20600421|P13|COMPLETED|Part 2||0
8356993|NCT01225731|20600422|P12|COMPLETED|Part 2||0
8356994|NCT01225731|20600423|P11|COMPLETED|Part 2||0
8356995|NCT01225731|20600424|P10|COMPLETED|Part 2||0
8356996|NCT01225731|20600425|P9|COMPLETED|Part 2||68
8356997|NCT01225731|20600426|P8|COMPLETED|Part 2||128
8356998|NCT01225731|20600427|P7|COMPLETED|Part 2||86
8356999|NCT01225731|20600428|P6|COMPLETED|Part 2||10
8357000|NCT01225731|20600429|P5|COMPLETED|Part 2||0
8357001|NCT01225731|20600430|P4|COMPLETED|Part 2||0
8357002|NCT01225731|20600431|P3|COMPLETED|Part 2||0
8357003|NCT01225731|20600432|P2|COMPLETED|Part 2||0
8357004|NCT01225731|20600433|P1|COMPLETED|Part 2||0
8357005|NCT01225731|20600421|P13|STARTED|Part 2||0
8357006|NCT01225731|20600422|P12|STARTED|Part 2||0
8357007|NCT01225731|20600423|P11|STARTED|Part 2||0
8357008|NCT01225731|20600424|P10|STARTED|Part 2||0
8357009|NCT01225731|20600425|P9|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
8357010|NCT01225731|20600426|P8|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
8357011|NCT01225731|20600427|P7|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
8357012|NCT01225731|20600428|P6|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
8357013|NCT01225731|20600429|P5|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
8357014|NCT01225731|20600430|P4|STARTED|Part 2|Participants could progress into Part 2|0
8357015|NCT01225731|20600431|P3|STARTED|Part 2|Participants could progress into Part 2|0
8357016|NCT01225731|20600432|P2|STARTED|Part 2|Participants could progress into Part 2|0
8357017|NCT01225731|20600433|P1|STARTED|Part 2|Participants could progress into Part 2|0
8357018|NCT01225731|20600421|P13|NOT COMPLETED|Part 1||0
8357019|NCT01225731|20600422|P12|NOT COMPLETED|Part 1||0
8357020|NCT01225731|20600423|P11|NOT COMPLETED|Part 1||0
8357021|NCT01225731|20600424|P10|NOT COMPLETED|Part 1||0
8357022|NCT01225731|20600425|P9|NOT COMPLETED|Part 1||0
8357023|NCT01225731|20600426|P8|NOT COMPLETED|Part 1||0
8357024|NCT01225731|20600427|P7|NOT COMPLETED|Part 1||0
8357025|NCT01225731|20600428|P6|NOT COMPLETED|Part 1||0
8357026|NCT01225731|20600429|P5|NOT COMPLETED|Part 1||6
8357027|NCT01225731|20600430|P4|NOT COMPLETED|Part 1||2
8357028|NCT01225731|20600431|P3|NOT COMPLETED|Part 1||1
8357029|NCT01225731|20600432|P2|NOT COMPLETED|Part 1||5
8357030|NCT01225731|20600433|P1|NOT COMPLETED|Part 1||2
8357031|NCT01225731|20600421|P13|COMPLETED|Part 1||0
8357032|NCT01225731|20600422|P12|COMPLETED|Part 1||0
8357033|NCT01225731|20600423|P11|COMPLETED|Part 1||0
8357034|NCT01225731|20600424|P10|COMPLETED|Part 1||0
8357035|NCT01225731|20600425|P9|COMPLETED|Part 1||0
8357036|NCT01225731|20600426|P8|COMPLETED|Part 1||0
8357037|NCT01225731|20600427|P7|COMPLETED|Part 1||0
8357038|NCT01225731|20600428|P6|COMPLETED|Part 1||0
8357039|NCT01225731|20600429|P5|COMPLETED|Part 1||40
8357040|NCT01225731|20600430|P4|COMPLETED|Part 1||84
8357041|NCT01225731|20600431|P3|COMPLETED|Part 1||88
8357042|NCT01225731|20600432|P2|COMPLETED|Part 1||87
8357043|NCT01225731|20600433|P1|COMPLETED|Part 1||40
8357044|NCT01225731|20600421|P13|STARTED|Part 1||0
8357045|NCT01225731|20600422|P12|STARTED|Part 1||0
8357046|NCT01225731|20600423|P11|STARTED|Part 1||0
8357047|NCT01225731|20600424|P10|STARTED|Part 1||0
8357048|NCT01225731|20600425|P9|STARTED|Part 1||0
8357049|NCT01225731|20600426|P8|STARTED|Part 1||0
8357050|NCT01225731|20600427|P7|STARTED|Part 1||0
8357051|NCT01225731|20600428|P6|STARTED|Part 1||0
8357052|NCT01225731|20600429|P5|STARTED|Part 1||46
8357053|NCT01225731|20600430|P4|STARTED|Part 1||86
8357054|NCT01225731|20600431|P3|STARTED|Part 1||89
8357055|NCT01225731|20600432|P2|STARTED|Part 1||92
8357056|NCT01225731|20600433|P1|STARTED|Part 1||42
8357057|NCT01225562|20600528|P3|NOT COMPLETED|Overall Study||53
8357058|NCT01225562|20600529|P2|NOT COMPLETED|Overall Study||56
8357059|NCT01225562|20600530|P1|NOT COMPLETED|Overall Study||55
8357060|NCT01225562|20600528|P3|COMPLETED|Overall Study||7014
8357061|NCT01225562|20600529|P2|COMPLETED|Overall Study||6989
8357062|NCT01225562|20600530|P1|COMPLETED|Overall Study||6995
8357063|NCT01225562|20600528|P3|STARTED|Overall Study||7067
8357064|NCT01225562|20600529|P2|STARTED|Overall Study||7045
8357065|NCT01225562|20600530|P1|STARTED|Overall Study||7050
8357066|NCT01225549|20600547|P10|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357067|NCT01225549|20600548|P9|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357068|NCT01225549|20600549|P8|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357069|NCT01225549|20600550|P7|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357070|NCT01225549|20600551|P6|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357071|NCT01225549|20600552|P5|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357072|NCT01225549|20600553|P4|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357073|NCT01225549|20600554|P3|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357074|NCT01225549|20600555|P2|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357075|NCT01225549|20600556|P1|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
8357076|NCT01225549|20600547|P10|COMPLETED|Period 7 - Fourth Treatment Period||1
8357077|NCT01225549|20600548|P9|COMPLETED|Period 7 - Fourth Treatment Period||4
8357078|NCT01225549|20600549|P8|COMPLETED|Period 7 - Fourth Treatment Period||1
8357079|NCT01225549|20600550|P7|COMPLETED|Period 7 - Fourth Treatment Period||3
8357080|NCT01225549|20600551|P6|COMPLETED|Period 7 - Fourth Treatment Period||1
8357081|NCT01225549|20600552|P5|COMPLETED|Period 7 - Fourth Treatment Period||1
8357082|NCT01225549|20600553|P4|COMPLETED|Period 7 - Fourth Treatment Period||0
8357083|NCT01225549|20600554|P3|COMPLETED|Period 7 - Fourth Treatment Period||3
8357084|NCT01225549|20600555|P2|COMPLETED|Period 7 - Fourth Treatment Period||3
8357085|NCT01225549|20600556|P1|COMPLETED|Period 7 - Fourth Treatment Period||1
8357086|NCT01225549|20600547|P10|STARTED|Period 7 - Fourth Treatment Period||1
8357087|NCT01225549|20600548|P9|STARTED|Period 7 - Fourth Treatment Period||4
8357088|NCT01225549|20600549|P8|STARTED|Period 7 - Fourth Treatment Period||1
8357089|NCT01225549|20600550|P7|STARTED|Period 7 - Fourth Treatment Period||3
8357090|NCT01225549|20600551|P6|STARTED|Period 7 - Fourth Treatment Period||1
8357091|NCT01225549|20600552|P5|STARTED|Period 7 - Fourth Treatment Period||1
8357092|NCT01225549|20600553|P4|STARTED|Period 7 - Fourth Treatment Period||0
8357093|NCT01225549|20600554|P3|STARTED|Period 7 - Fourth Treatment Period||3
8357094|NCT01225549|20600555|P2|STARTED|Period 7 - Fourth Treatment Period||3
8357095|NCT01225549|20600556|P1|STARTED|Period 7 - Fourth Treatment Period||1
8357096|NCT01225549|20600547|P10|NOT COMPLETED|Period 6 - Washout||0
8357097|NCT01225549|20600548|P9|NOT COMPLETED|Period 6 - Washout||0
8357098|NCT01225549|20600549|P8|NOT COMPLETED|Period 6 - Washout||0
8357099|NCT01225549|20600550|P7|NOT COMPLETED|Period 6 - Washout||0
8357100|NCT01225549|20600551|P6|NOT COMPLETED|Period 6 - Washout||0
8357101|NCT01225549|20600552|P5|NOT COMPLETED|Period 6 - Washout||0
8357102|NCT01225549|20600553|P4|NOT COMPLETED|Period 6 - Washout||1
8357103|NCT01225549|20600554|P3|NOT COMPLETED|Period 6 - Washout||0
8357104|NCT01225549|20600555|P2|NOT COMPLETED|Period 6 - Washout||0
8357105|NCT01225549|20600556|P1|NOT COMPLETED|Period 6 - Washout||0
8357106|NCT01225549|20600547|P10|COMPLETED|Period 6 - Washout||1
8357107|NCT01225549|20600548|P9|COMPLETED|Period 6 - Washout||4
8357108|NCT01225549|20600549|P8|COMPLETED|Period 6 - Washout||1
8357109|NCT01225549|20600550|P7|COMPLETED|Period 6 - Washout||3
8357110|NCT01225549|20600551|P6|COMPLETED|Period 6 - Washout||1
8357111|NCT01225549|20600552|P5|COMPLETED|Period 6 - Washout||1
8357112|NCT01225549|20600553|P4|COMPLETED|Period 6 - Washout||0
8357113|NCT01225549|20600554|P3|COMPLETED|Period 6 - Washout||3
8357114|NCT01225549|20600555|P2|COMPLETED|Period 6 - Washout||3
8357115|NCT01225549|20600556|P1|COMPLETED|Period 6 - Washout||1
8357116|NCT01225549|20600547|P10|STARTED|Period 6 - Washout||1
8357117|NCT01225549|20600548|P9|STARTED|Period 6 - Washout||4
8357118|NCT01225549|20600549|P8|STARTED|Period 6 - Washout||1
8357119|NCT01225549|20600550|P7|STARTED|Period 6 - Washout||3
8357120|NCT01225549|20600551|P6|STARTED|Period 6 - Washout||1
8357121|NCT01225549|20600552|P5|STARTED|Period 6 - Washout||1
8357122|NCT01225549|20600553|P4|STARTED|Period 6 - Washout||1
8357123|NCT01225549|20600554|P3|STARTED|Period 6 - Washout||3
8357124|NCT01225549|20600555|P2|STARTED|Period 6 - Washout||3
8357125|NCT01225549|20600556|P1|STARTED|Period 6 - Washout||1
8357126|NCT01225549|20600547|P10|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357127|NCT01225549|20600548|P9|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357128|NCT01225549|20600549|P8|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357129|NCT01225549|20600550|P7|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357130|NCT01225549|20600551|P6|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357131|NCT01225549|20600552|P5|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357132|NCT01225549|20600553|P4|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357133|NCT01225549|20600554|P3|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357134|NCT01225549|20600555|P2|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357135|NCT01225549|20600556|P1|NOT COMPLETED|Period 5 - Third Treatment Period||0
8357136|NCT01225549|20600547|P10|COMPLETED|Period 5 - Third Treatment Period||1
8357137|NCT01225549|20600548|P9|COMPLETED|Period 5 - Third Treatment Period||4
8357138|NCT01225549|20600549|P8|COMPLETED|Period 5 - Third Treatment Period||1
8357139|NCT01225549|20600550|P7|COMPLETED|Period 5 - Third Treatment Period||3
8357140|NCT01225549|20600551|P6|COMPLETED|Period 5 - Third Treatment Period||1
8357141|NCT01225549|20600552|P5|COMPLETED|Period 5 - Third Treatment Period||1
8357142|NCT01225549|20600553|P4|COMPLETED|Period 5 - Third Treatment Period||1
8357143|NCT01225549|20600554|P3|COMPLETED|Period 5 - Third Treatment Period||3
8357144|NCT01225549|20600555|P2|COMPLETED|Period 5 - Third Treatment Period||3
8357145|NCT01225549|20600556|P1|COMPLETED|Period 5 - Third Treatment Period||1
8357146|NCT01225549|20600547|P10|STARTED|Period 5 - Third Treatment Period||1
8357147|NCT01225549|20600548|P9|STARTED|Period 5 - Third Treatment Period||4
8357148|NCT01225549|20600549|P8|STARTED|Period 5 - Third Treatment Period||1
8357149|NCT01225549|20600550|P7|STARTED|Period 5 - Third Treatment Period||3
8357150|NCT01225549|20600551|P6|STARTED|Period 5 - Third Treatment Period||1
8357151|NCT01225549|20600552|P5|STARTED|Period 5 - Third Treatment Period||1
8357152|NCT01225549|20600553|P4|STARTED|Period 5 - Third Treatment Period||1
8357153|NCT01225549|20600554|P3|STARTED|Period 5 - Third Treatment Period||3
8357154|NCT01225549|20600555|P2|STARTED|Period 5 - Third Treatment Period||3
8357155|NCT01225549|20600556|P1|STARTED|Period 5 - Third Treatment Period||1
8357156|NCT01225549|20600547|P10|NOT COMPLETED|Period 4 - Washout||0
8357157|NCT01225549|20600548|P9|NOT COMPLETED|Period 4 - Washout||0
8357158|NCT01225549|20600549|P8|NOT COMPLETED|Period 4 - Washout||0
8357159|NCT01225549|20600550|P7|NOT COMPLETED|Period 4 - Washout||0
8357160|NCT01225549|20600551|P6|NOT COMPLETED|Period 4 - Washout||0
8357161|NCT01225549|20600552|P5|NOT COMPLETED|Period 4 - Washout||0
8357162|NCT01225549|20600553|P4|NOT COMPLETED|Period 4 - Washout||0
8357163|NCT01225549|20600554|P3|NOT COMPLETED|Period 4 - Washout||0
8357164|NCT01225549|20600555|P2|NOT COMPLETED|Period 4 - Washout||1
8357165|NCT01225549|20600556|P1|NOT COMPLETED|Period 4 - Washout||0
8357166|NCT01225549|20600547|P10|COMPLETED|Period 4 - Washout||1
8357167|NCT01225549|20600548|P9|COMPLETED|Period 4 - Washout||4
8357168|NCT01225549|20600549|P8|COMPLETED|Period 4 - Washout||1
8357169|NCT01225549|20600550|P7|COMPLETED|Period 4 - Washout||3
8357170|NCT01225549|20600551|P6|COMPLETED|Period 4 - Washout||1
8357171|NCT01225549|20600552|P5|COMPLETED|Period 4 - Washout||1
8357172|NCT01225549|20600553|P4|COMPLETED|Period 4 - Washout||1
8357173|NCT01225549|20600554|P3|COMPLETED|Period 4 - Washout||3
8357174|NCT01225549|20600555|P2|COMPLETED|Period 4 - Washout||3
8357175|NCT01225549|20600556|P1|COMPLETED|Period 4 - Washout||1
8357176|NCT01225549|20600547|P10|STARTED|Period 4 - Washout||1
8357177|NCT01225549|20600548|P9|STARTED|Period 4 - Washout||4
8357178|NCT01225549|20600549|P8|STARTED|Period 4 - Washout||1
8357179|NCT01225549|20600550|P7|STARTED|Period 4 - Washout||3
8357180|NCT01225549|20600551|P6|STARTED|Period 4 - Washout||1
8357181|NCT01225549|20600552|P5|STARTED|Period 4 - Washout||1
8357182|NCT01225549|20600553|P4|STARTED|Period 4 - Washout||1
8357183|NCT01225549|20600554|P3|STARTED|Period 4 - Washout||3
8357184|NCT01225549|20600555|P2|STARTED|Period 4 - Washout||4
8357185|NCT01225549|20600556|P1|STARTED|Period 4 - Washout||1
8357186|NCT01225549|20600547|P10|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357187|NCT01225549|20600548|P9|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357188|NCT01225549|20600549|P8|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357189|NCT01225549|20600550|P7|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357190|NCT01225549|20600551|P6|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357191|NCT01225549|20600552|P5|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357192|NCT01225549|20600553|P4|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357193|NCT01225549|20600554|P3|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357194|NCT01225549|20600555|P2|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357195|NCT01225549|20600556|P1|NOT COMPLETED|Period 3 - Second Treatment Period||0
8357196|NCT01225549|20600547|P10|COMPLETED|Period 3 - Second Treatment Period||1
8357197|NCT01225549|20600548|P9|COMPLETED|Period 3 - Second Treatment Period||4
8357198|NCT01225549|20600549|P8|COMPLETED|Period 3 - Second Treatment Period||1
8357199|NCT01225549|20600550|P7|COMPLETED|Period 3 - Second Treatment Period||3
8357200|NCT01225549|20600551|P6|COMPLETED|Period 3 - Second Treatment Period||1
8357201|NCT01225549|20600552|P5|COMPLETED|Period 3 - Second Treatment Period||1
8357202|NCT01225549|20600553|P4|COMPLETED|Period 3 - Second Treatment Period||1
8357203|NCT01225549|20600554|P3|COMPLETED|Period 3 - Second Treatment Period||3
8357204|NCT01225549|20600555|P2|COMPLETED|Period 3 - Second Treatment Period||4
8357205|NCT01225549|20600556|P1|COMPLETED|Period 3 - Second Treatment Period||1
8357206|NCT01225549|20600547|P10|STARTED|Period 3 - Second Treatment Period||1
8357207|NCT01225549|20600548|P9|STARTED|Period 3 - Second Treatment Period||4
8357208|NCT01225549|20600549|P8|STARTED|Period 3 - Second Treatment Period||1
8357209|NCT01225549|20600550|P7|STARTED|Period 3 - Second Treatment Period||3
8357210|NCT01225549|20600551|P6|STARTED|Period 3 - Second Treatment Period||1
8357211|NCT01225549|20600552|P5|STARTED|Period 3 - Second Treatment Period||1
8357212|NCT01225549|20600553|P4|STARTED|Period 3 - Second Treatment Period||1
8357213|NCT01225549|20600554|P3|STARTED|Period 3 - Second Treatment Period||3
8357214|NCT01225549|20600555|P2|STARTED|Period 3 - Second Treatment Period||4
8357215|NCT01225549|20600556|P1|STARTED|Period 3 - Second Treatment Period||1
8357216|NCT01225549|20600547|P10|NOT COMPLETED|Period 2 - Washout||0
8357217|NCT01225549|20600548|P9|NOT COMPLETED|Period 2 - Washout||0
8357218|NCT01225549|20600549|P8|NOT COMPLETED|Period 2 - Washout||0
8357219|NCT01225549|20600550|P7|NOT COMPLETED|Period 2 - Washout||0
8357220|NCT01225549|20600551|P6|NOT COMPLETED|Period 2 - Washout||0
8357221|NCT01225549|20600552|P5|NOT COMPLETED|Period 2 - Washout||0
8357222|NCT01225549|20600553|P4|NOT COMPLETED|Period 2 - Washout||0
8357223|NCT01225549|20600554|P3|NOT COMPLETED|Period 2 - Washout||0
8357224|NCT01225549|20600555|P2|NOT COMPLETED|Period 2 - Washout||0
8357225|NCT01225549|20600556|P1|NOT COMPLETED|Period 2 - Washout||0
8357226|NCT01225549|20600547|P10|COMPLETED|Period 2 - Washout||1
8357227|NCT01225549|20600548|P9|COMPLETED|Period 2 - Washout||4
8357228|NCT01225549|20600549|P8|COMPLETED|Period 2 - Washout||1
8357229|NCT01225549|20600550|P7|COMPLETED|Period 2 - Washout||3
8357230|NCT01225549|20600551|P6|COMPLETED|Period 2 - Washout||1
8357231|NCT01225549|20600552|P5|COMPLETED|Period 2 - Washout||1
8357232|NCT01225549|20600553|P4|COMPLETED|Period 2 - Washout||1
8357233|NCT01225549|20600554|P3|COMPLETED|Period 2 - Washout||3
8357234|NCT01225549|20600555|P2|COMPLETED|Period 2 - Washout||4
8357235|NCT01225549|20600556|P1|COMPLETED|Period 2 - Washout||1
8357236|NCT01225549|20600547|P10|STARTED|Period 2 - Washout||1
8357237|NCT01225549|20600548|P9|STARTED|Period 2 - Washout||4
8357238|NCT01225549|20600549|P8|STARTED|Period 2 - Washout||1
8357239|NCT01225549|20600550|P7|STARTED|Period 2 - Washout||3
8357240|NCT01225549|20600551|P6|STARTED|Period 2 - Washout||1
8357241|NCT01225549|20600552|P5|STARTED|Period 2 - Washout||1
8357242|NCT01225549|20600553|P4|STARTED|Period 2 - Washout||1
8357243|NCT01225549|20600554|P3|STARTED|Period 2 - Washout||3
8357244|NCT01225549|20600555|P2|STARTED|Period 2 - Washout||4
8357245|NCT01225549|20600556|P1|STARTED|Period 2 - Washout||1
8357246|NCT01225549|20600547|P10|NOT COMPLETED|Period 1 - First Treatment Period||0
8357247|NCT01225549|20600548|P9|NOT COMPLETED|Period 1 - First Treatment Period||0
8357248|NCT01225549|20600549|P8|NOT COMPLETED|Period 1 - First Treatment Period||0
8357249|NCT01225549|20600550|P7|NOT COMPLETED|Period 1 - First Treatment Period||0
8357250|NCT01225549|20600551|P6|NOT COMPLETED|Period 1 - First Treatment Period||0
8357251|NCT01225549|20600552|P5|NOT COMPLETED|Period 1 - First Treatment Period||0
8357252|NCT01225549|20600553|P4|NOT COMPLETED|Period 1 - First Treatment Period||0
8357253|NCT01225549|20600554|P3|NOT COMPLETED|Period 1 - First Treatment Period||0
8357254|NCT01225549|20600555|P2|NOT COMPLETED|Period 1 - First Treatment Period||0
8357255|NCT01225549|20600556|P1|NOT COMPLETED|Period 1 - First Treatment Period||0
8357256|NCT01225549|20600547|P10|COMPLETED|Period 1 - First Treatment Period||1
8357257|NCT01225549|20600548|P9|COMPLETED|Period 1 - First Treatment Period||4
8357258|NCT01225549|20600549|P8|COMPLETED|Period 1 - First Treatment Period||1
8357259|NCT01225549|20600550|P7|COMPLETED|Period 1 - First Treatment Period||3
8357260|NCT01225549|20600551|P6|COMPLETED|Period 1 - First Treatment Period||1
8357261|NCT01225549|20600552|P5|COMPLETED|Period 1 - First Treatment Period||1
8357262|NCT01225549|20600553|P4|COMPLETED|Period 1 - First Treatment Period||1
8357263|NCT01225549|20600554|P3|COMPLETED|Period 1 - First Treatment Period||3
8357264|NCT01225549|20600555|P2|COMPLETED|Period 1 - First Treatment Period||4
8357265|NCT01225549|20600556|P1|COMPLETED|Period 1 - First Treatment Period||1
8357266|NCT01225549|20600547|P10|STARTED|Period 1 - First Treatment Period||1
8357267|NCT01225549|20600548|P9|STARTED|Period 1 - First Treatment Period||4
8357268|NCT01225549|20600549|P8|STARTED|Period 1 - First Treatment Period||1
8357269|NCT01225549|20600550|P7|STARTED|Period 1 - First Treatment Period||3
8357270|NCT01225549|20600551|P6|STARTED|Period 1 - First Treatment Period||1
8357271|NCT01225549|20600552|P5|STARTED|Period 1 - First Treatment Period||1
8357272|NCT01225549|20600553|P4|STARTED|Period 1 - First Treatment Period||1
8357273|NCT01225549|20600554|P3|STARTED|Period 1 - First Treatment Period||3
8357274|NCT01225549|20600555|P2|STARTED|Period 1 - First Treatment Period||4
8357275|NCT01225549|20600556|P1|STARTED|Period 1 - First Treatment Period||1
8357276|NCT01225354|20600598|P1|NOT COMPLETED|Overall Study||1
8357277|NCT01225354|20600598|P1|COMPLETED|Overall Study||19
8357278|NCT01225354|20600598|P1|STARTED|Overall Study||20
8357279|NCT01225341|20600609|P2|NOT COMPLETED|Overall Study||0
8357280|NCT01225341|20600610|P1|NOT COMPLETED|Overall Study||0
8357281|NCT01225341|20600609|P2|COMPLETED|Overall Study||0
8357282|NCT01225341|20600610|P1|COMPLETED|Overall Study||0
8357283|NCT01225341|20600609|P2|STARTED|Overall Study||0
8357284|NCT01225341|20600610|P1|STARTED|Overall Study||0
8357285|NCT01225289|20600624|P2|NOT COMPLETED|Overall Study||1
8357286|NCT01225289|20600625|P1|NOT COMPLETED|Overall Study||0
8357287|NCT01225289|20600624|P2|COMPLETED|Overall Study||17
8357288|NCT01225289|20600625|P1|COMPLETED|Overall Study||18
8357289|NCT01225289|20600624|P2|STARTED|Overall Study||18
8357290|NCT01225289|20600625|P1|STARTED|Overall Study||18
8357291|NCT01225263|20600639|P2|NOT COMPLETED|Weeks 13 to 24||1
8357292|NCT01225263|20600640|P1|NOT COMPLETED|Weeks 13 to 24||4
8357293|NCT01225263|20600639|P2|COMPLETED|Weeks 13 to 24||28
8357294|NCT01225263|20600640|P1|COMPLETED|Weeks 13 to 24||24
8357295|NCT01225263|20600639|P2|STARTED|Weeks 13 to 24||29
8357296|NCT01225263|20600640|P1|STARTED|Weeks 13 to 24||28
8357297|NCT01225263|20600639|P2|NOT COMPLETED|Weeks 1 to 12||0
8357298|NCT01225263|20600640|P1|NOT COMPLETED|Weeks 1 to 12||0
8357299|NCT01225263|20600639|P2|COMPLETED|Weeks 1 to 12||29
8357300|NCT01225263|20600640|P1|COMPLETED|Weeks 1 to 12||28
8357301|NCT01225263|20600639|P2|STARTED|Weeks 1 to 12||29
8357302|NCT01225263|20600640|P1|STARTED|Weeks 1 to 12||28
8357303|NCT01225250|20600650|P2|NOT COMPLETED|Overall Study||5
8357304|NCT01225250|20600651|P1|NOT COMPLETED|Overall Study||5
8357305|NCT01225250|20600650|P2|COMPLETED|Overall Study||10
8357306|NCT01225250|20600651|P1|COMPLETED|Overall Study||10
8357307|NCT01225250|20600650|P2|STARTED|Overall Study||15
8357308|NCT01225250|20600651|P1|STARTED|Overall Study||15
8357309|NCT01225211|20600677|P10|NOT COMPLETED|Overall Study||5
8357310|NCT01225211|20600678|P9|NOT COMPLETED|Overall Study||1
8357311|NCT01225211|20600679|P8|NOT COMPLETED|Overall Study||0
8357312|NCT01225211|20600680|P7|NOT COMPLETED|Overall Study||1
8357313|NCT01225211|20600681|P6|NOT COMPLETED|Overall Study||0
8357314|NCT01225211|20600682|P5|NOT COMPLETED|Overall Study||0
8357315|NCT01225211|20600683|P4|NOT COMPLETED|Overall Study||0
8357316|NCT01225211|20600684|P3|NOT COMPLETED|Overall Study||1
8357317|NCT01225211|20600685|P2|NOT COMPLETED|Overall Study||0
8357318|NCT01225211|20600686|P1|NOT COMPLETED|Overall Study||0
8357319|NCT01225211|20600677|P10|COMPLETED|Overall Study||57
8357320|NCT01225211|20600678|P9|COMPLETED|Overall Study||62
8357321|NCT01225211|20600679|P8|COMPLETED|Overall Study||11
8357322|NCT01225211|20600680|P7|COMPLETED|Overall Study||41
8357323|NCT01225211|20600681|P6|COMPLETED|Overall Study||21
8357324|NCT01225211|20600682|P5|COMPLETED|Overall Study||23
8357325|NCT01225211|20600683|P4|COMPLETED|Overall Study||27
8357326|NCT01225211|20600684|P3|COMPLETED|Overall Study||20
8357327|NCT01225211|20600685|P2|COMPLETED|Overall Study||20
8357328|NCT01225211|20600686|P1|COMPLETED|Overall Study||21
8357329|NCT01225211|20600677|P10|STARTED|Overall Study||62
8357330|NCT01225211|20600678|P9|STARTED|Overall Study||63
8357331|NCT01225211|20600679|P8|STARTED|Overall Study||11
8357332|NCT01225211|20600680|P7|STARTED|Overall Study||42
8357333|NCT01225211|20600681|P6|STARTED|Overall Study||21
8357334|NCT01225211|20600682|P5|STARTED|Overall Study||23
8357335|NCT01225211|20600683|P4|STARTED|Overall Study||27
8357336|NCT01225211|20600684|P3|STARTED|Overall Study||21
8357337|NCT01225211|20600685|P2|STARTED|Overall Study||20
8357338|NCT01225211|20600686|P1|STARTED|Overall Study||21
8357339|NCT01225172|20600789|P2|NOT COMPLETED|Overall Study||1
8357340|NCT01225172|20600790|P1|NOT COMPLETED|Overall Study||6
8357341|NCT01225172|20600789|P2|COMPLETED|Overall Study||6
8357342|NCT01225172|20600790|P1|COMPLETED|Overall Study||46
8357343|NCT01225172|20600789|P2|STARTED|Overall Study||7
8357344|NCT01225172|20600790|P1|STARTED|Overall Study||52
8357345|NCT01225159|20600812|P2|NOT COMPLETED|Overall Study||0
8357346|NCT01225159|20600813|P1|NOT COMPLETED|Overall Study||1
8357347|NCT01225159|20600812|P2|COMPLETED|Overall Study||100
8357348|NCT01225159|20600813|P1|COMPLETED|Overall Study||99
8357349|NCT01225159|20600812|P2|STARTED|Overall Study||100
8357350|NCT01225159|20600813|P1|STARTED|Overall Study||100
8357351|NCT01225146|20600823|P2|NOT COMPLETED|Overall Study||2
8357352|NCT01225146|20600824|P1|NOT COMPLETED|Overall Study||0
8357353|NCT01225146|20600823|P2|COMPLETED|Overall Study||0
8357354|NCT01225146|20600824|P1|COMPLETED|Overall Study||6
8357355|NCT01225146|20600823|P2|STARTED|Overall Study||2
8357356|NCT01225146|20600824|P1|STARTED|Overall Study||6
8357357|NCT01225068|20600842|P2|NOT COMPLETED|Overall Study||1
8357358|NCT01225068|20600843|P1|NOT COMPLETED|Overall Study||4
8357359|NCT01225068|20600842|P2|COMPLETED|Overall Study||19
8357360|NCT01225068|20600843|P1|COMPLETED|Overall Study||16
8357361|NCT01225068|20600842|P2|STARTED|Overall Study||20
8357362|NCT01225068|20600843|P1|STARTED|Overall Study||20
8357363|NCT01225055|20600852|P3|NOT COMPLETED|Overall Study||3
8357364|NCT01225055|20600853|P2|NOT COMPLETED|Overall Study||2
8357365|NCT01225055|20600854|P1|NOT COMPLETED|Overall Study||0
8357366|NCT01225055|20600852|P3|COMPLETED|Overall Study||18
8357367|NCT01225055|20600853|P2|COMPLETED|Overall Study||18
8357368|NCT01225055|20600854|P1|COMPLETED|Overall Study||20
8357369|NCT01225055|20600852|P3|STARTED|Overall Study||21
8357370|NCT01225055|20600853|P2|STARTED|Overall Study||20
8357371|NCT01225055|20600854|P1|STARTED|Overall Study||20
8357372|NCT01225029|20600879|P2|NOT COMPLETED|Overall Study||0
8357373|NCT01225029|20600880|P1|NOT COMPLETED|Overall Study||0
8357374|NCT01225029|20600879|P2|COMPLETED|Overall Study||32
8357375|NCT01225029|20600880|P1|COMPLETED|Overall Study||32
8357376|NCT01225029|20600879|P2|STARTED|Overall Study||32
8357377|NCT01225029|20600880|P1|STARTED|Overall Study||32
8357378|NCT01224925|20600892|P2|NOT COMPLETED|Overall Study||2
8357379|NCT01224925|20600893|P1|NOT COMPLETED|Overall Study||3
8357380|NCT01224925|20600892|P2|COMPLETED|Overall Study||31
8357381|NCT01224925|20600893|P1|COMPLETED|Overall Study||34
8357382|NCT01224925|20600892|P2|STARTED|Overall Study||33
8357383|NCT01224925|20600893|P1|STARTED|Overall Study||37
8357384|NCT01224821|20600901|P1|NOT COMPLETED|Long-Term Follow-Up||11
8357385|NCT01224821|20600901|P1|COMPLETED|Long-Term Follow-Up||0
8357386|NCT01224821|20600901|P1|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
8357387|NCT01224821|20600901|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
8357388|NCT01224821|20600901|P1|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
8357389|NCT01224821|20600901|P1|STARTED|Dosimetric and Therapeutic Treatment||47
8357390|NCT01224782|20600920|P1|NOT COMPLETED|Overall Study||264
8357391|NCT01224782|20600920|P1|COMPLETED|Overall Study||730
8357392|NCT01224782|20600920|P1|STARTED|Overall Study||994
8357393|NCT01224678|20600931|P2|NOT COMPLETED|Overall Study||0
8357394|NCT01224678|20600932|P1|NOT COMPLETED|Overall Study||0
8357395|NCT01224678|20600931|P2|COMPLETED|Overall Study||150
8357396|NCT01224678|20600932|P1|COMPLETED|Overall Study||150
8357397|NCT01224678|20600931|P2|STARTED|Overall Study||150
8357398|NCT01224678|20600932|P1|STARTED|Overall Study||150
8357399|NCT01224639|20600946|P8|NOT COMPLETED|Overall Study||2
8357400|NCT01224639|20600947|P7|NOT COMPLETED|Overall Study||1
8357401|NCT01224639|20600948|P6|NOT COMPLETED|Overall Study||0
8357402|NCT01224639|20600949|P5|NOT COMPLETED|Overall Study||2
8357403|NCT01224639|20600950|P4|NOT COMPLETED|Overall Study||0
8357404|NCT01224639|20600951|P3|NOT COMPLETED|Overall Study||0
8357405|NCT01224639|20600952|P2|NOT COMPLETED|Overall Study||0
8357406|NCT01224639|20600953|P1|NOT COMPLETED|Overall Study||0
8357407|NCT01224639|20600946|P8|COMPLETED|Overall Study||3
8357408|NCT01224639|20600947|P7|COMPLETED|Overall Study||17
8357409|NCT01224639|20600948|P6|COMPLETED|Overall Study||4
8357410|NCT01224639|20600949|P5|COMPLETED|Overall Study||19
8357411|NCT01224639|20600950|P4|COMPLETED|Overall Study||3
8357412|NCT01224639|20600951|P3|COMPLETED|Overall Study||21
8357413|NCT01224639|20600952|P2|COMPLETED|Overall Study||5
8357414|NCT01224639|20600953|P1|COMPLETED|Overall Study||19
8357415|NCT01224639|20600946|P8|STARTED|Overall Study||5
8357416|NCT01224639|20600947|P7|STARTED|Overall Study||18
8357417|NCT01224639|20600948|P6|STARTED|Overall Study||4
8357418|NCT01224639|20600949|P5|STARTED|Overall Study||21
8357419|NCT01224639|20600950|P4|STARTED|Overall Study||3
8357420|NCT01224639|20600951|P3|STARTED|Overall Study||21
8357421|NCT01224639|20600952|P2|STARTED|Overall Study||5
8357422|NCT01224639|20600953|P1|STARTED|Overall Study||19
8357423|NCT01224626|20601059|P1|NOT COMPLETED|Overall Study||1
8357424|NCT01224626|20601059|P1|COMPLETED|Overall Study||41
8357425|NCT01224626|20601059|P1|STARTED|Overall Study||42
8357426|NCT01224444|20601065|P1|NOT COMPLETED|Overall Study||0
8357427|NCT01224444|20601065|P1|COMPLETED|Overall Study||269
8357428|NCT01224444|20601065|P1|STARTED|Overall Study||269
8357429|NCT01224431|20601071|P2|NOT COMPLETED|Overall Study||5
8357430|NCT01224431|20601072|P1|NOT COMPLETED|Overall Study||0
8357431|NCT01224431|20601071|P2|COMPLETED|Overall Study||25
8357432|NCT01224431|20601072|P1|COMPLETED|Overall Study||30
8357433|NCT01224431|20601071|P2|STARTED|Overall Study||30
8357434|NCT01224431|20601072|P1|STARTED|Overall Study||30
8357435|NCT01224236|20601082|P2|NOT COMPLETED|Overall Study||1
8357436|NCT01224236|20601083|P1|NOT COMPLETED|Overall Study||1
8357437|NCT01224236|20601082|P2|COMPLETED|Overall Study||73
8357438|NCT01224236|20601083|P1|COMPLETED|Overall Study||75
8357439|NCT01224236|20601082|P2|STARTED|Overall Study||74
8357440|NCT01224236|20601083|P1|STARTED|Overall Study||76
8357441|NCT01224210|20601091|P1|NOT COMPLETED|Overall Study||7
8357442|NCT01224210|20601091|P1|COMPLETED|Overall Study||23
8357443|NCT01224210|20601091|P1|STARTED|Overall Study||30
8357444|NCT01224171|20601098|P2|NOT COMPLETED|Overall Study||13
8357445|NCT01224171|20601099|P1|NOT COMPLETED|Overall Study||15
8357446|NCT01224171|20601098|P2|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
8357447|NCT01224171|20601099|P1|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
8357448|NCT01224171|20601098|P2|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
8357449|NCT01224171|20601099|P1|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
8357450|NCT01224171|20601098|P2|STARTED|Overall Study||209
8357451|NCT01224171|20601099|P1|STARTED|Overall Study||207
8357452|NCT01224158|20601121|P2|NOT COMPLETED|Overall Study||0
8357453|NCT01224158|20601122|P1|NOT COMPLETED|Overall Study||1
8357454|NCT01224158|20601121|P2|COMPLETED|Overall Study||77
8357455|NCT01224158|20601122|P1|COMPLETED|Overall Study||75
8357456|NCT01224158|20601121|P2|STARTED|Overall Study||77
8357457|NCT01224158|20601122|P1|STARTED|Overall Study||76
8357458|NCT01224145|20601138|P1|NOT COMPLETED|Overall Study||0
8357459|NCT01224145|20601138|P1|COMPLETED|Overall Study||10
8357460|NCT01224145|20601138|P1|STARTED|Overall Study||10
8357461|NCT01224015|20601149|P3|NOT COMPLETED|Overall Study||13
8357462|NCT01224015|20601150|P2|NOT COMPLETED|Overall Study||16
8357463|NCT01224015|20601151|P1|NOT COMPLETED|Overall Study||14
8357464|NCT01224015|20601149|P3|COMPLETED|Overall Study||83
8357465|NCT01224015|20601150|P2|COMPLETED|Overall Study||211
8357466|NCT01224015|20601151|P1|COMPLETED|Overall Study||347
8357467|NCT01224015|20601149|P3|STARTED|Overall Study||96
8357468|NCT01224015|20601150|P2|STARTED|Overall Study||227
8357469|NCT01224015|20601151|P1|STARTED|Overall Study||361
8357470|NCT01223963|20601159|P1|NOT COMPLETED|Overall Study||0
8357471|NCT01223963|20601159|P1|COMPLETED|Overall Study||93
8357472|NCT01223963|20601159|P1|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
8357473|NCT01223937|20601166|P2|NOT COMPLETED|Overall Study||18
8357474|NCT01223937|20601167|P1|NOT COMPLETED|Overall Study||17
8357475|NCT01223937|20601166|P2|COMPLETED|Overall Study||119
8357476|NCT01223937|20601167|P1|COMPLETED|Overall Study||114
8357477|NCT01223937|20601166|P2|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
8357478|NCT01223937|20601167|P1|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
8357479|NCT01223937|20601166|P2|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
8357480|NCT01223937|20601167|P1|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
8357481|NCT01223937|20601166|P2|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
8357482|NCT01223937|20601167|P1|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
8357483|NCT01223703|20601191|P2|NOT COMPLETED|Overall Study||0
8357484|NCT01223703|20601192|P1|NOT COMPLETED|Overall Study||0
8357485|NCT01223703|20601191|P2|COMPLETED|Overall Study||66
8357486|NCT01223703|20601192|P1|COMPLETED|Overall Study||67
8357487|NCT01223703|20601191|P2|STARTED|Overall Study||66
8357488|NCT01223703|20601192|P1|STARTED|Overall Study||67
8357489|NCT01223469|20601206|P2|NOT COMPLETED|Overall Study||0
8357490|NCT01223469|20601207|P1|NOT COMPLETED|Overall Study||0
8357491|NCT01223469|20601206|P2|COMPLETED|Overall Study||43
8357492|NCT01223469|20601207|P1|COMPLETED|Overall Study||34
8357493|NCT01223469|20601206|P2|STARTED|Overall Study||43
8357494|NCT01223469|20601207|P1|STARTED|Overall Study||34
8357495|NCT01223404|20601213|P6|NOT COMPLETED|Third Intervention (1 Day)||0
8357496|NCT01223404|20601214|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8357497|NCT01223404|20601215|P4|NOT COMPLETED|Third Intervention (1 Day)||1
8357498|NCT01223404|20601216|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8357499|NCT01223404|20601217|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8357500|NCT01223404|20601218|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8357501|NCT01223404|20601213|P6|COMPLETED|Third Intervention (1 Day)||3
8357502|NCT01223404|20601214|P5|COMPLETED|Third Intervention (1 Day)||2
8357503|NCT01223404|20601215|P4|COMPLETED|Third Intervention (1 Day)||3
8357504|NCT01223404|20601216|P3|COMPLETED|Third Intervention (1 Day)||4
8357505|NCT01223404|20601217|P2|COMPLETED|Third Intervention (1 Day)||3
8357506|NCT01223404|20601218|P1|COMPLETED|Third Intervention (1 Day)||3
8357507|NCT01223404|20601213|P6|STARTED|Third Intervention (1 Day)||3
8357508|NCT01223404|20601214|P5|STARTED|Third Intervention (1 Day)||2
8357509|NCT01223404|20601215|P4|STARTED|Third Intervention (1 Day)||4
8357510|NCT01223404|20601216|P3|STARTED|Third Intervention (1 Day)||4
8357511|NCT01223404|20601217|P2|STARTED|Third Intervention (1 Day)||3
8357512|NCT01223404|20601218|P1|STARTED|Third Intervention (1 Day)||3
8357513|NCT01223404|20601213|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8357514|NCT01223404|20601214|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8357515|NCT01223404|20601215|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8357516|NCT01223404|20601216|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8357517|NCT01223404|20601217|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8357518|NCT01223404|20601218|P1|NOT COMPLETED|Second Intervention (1 Day)||1
8357519|NCT01223404|20601213|P6|COMPLETED|Second Intervention (1 Day)||3
8357520|NCT01223404|20601214|P5|COMPLETED|Second Intervention (1 Day)||2
8357521|NCT01223404|20601215|P4|COMPLETED|Second Intervention (1 Day)||4
8357522|NCT01223404|20601216|P3|COMPLETED|Second Intervention (1 Day)||4
8357523|NCT01223404|20601217|P2|COMPLETED|Second Intervention (1 Day)||3
8357524|NCT01223404|20601218|P1|COMPLETED|Second Intervention (1 Day)||3
8357525|NCT01223404|20601213|P6|STARTED|Second Intervention (1 Day)||3
8357526|NCT01223404|20601214|P5|STARTED|Second Intervention (1 Day)||2
8357527|NCT01223404|20601215|P4|STARTED|Second Intervention (1 Day)||4
8357528|NCT01223404|20601216|P3|STARTED|Second Intervention (1 Day)||4
8357529|NCT01223404|20601217|P2|STARTED|Second Intervention (1 Day)||3
8357530|NCT01223404|20601218|P1|STARTED|Second Intervention (1 Day)||4
8357531|NCT01223404|20601213|P6|NOT COMPLETED|First Intervention (1 Day)||0
8357532|NCT01223404|20601214|P5|NOT COMPLETED|First Intervention (1 Day)||0
8357533|NCT01223404|20601215|P4|NOT COMPLETED|First Intervention (1 Day)||1
8357534|NCT01223404|20601216|P3|NOT COMPLETED|First Intervention (1 Day)||0
8357535|NCT01223404|20601217|P2|NOT COMPLETED|First Intervention (1 Day)||0
8357536|NCT01223404|20601218|P1|NOT COMPLETED|First Intervention (1 Day)||0
8357537|NCT01223404|20601213|P6|COMPLETED|First Intervention (1 Day)||3
8357538|NCT01223404|20601214|P5|COMPLETED|First Intervention (1 Day)||2
8357539|NCT01223404|20601215|P4|COMPLETED|First Intervention (1 Day)||4
8357540|NCT01223404|20601216|P3|COMPLETED|First Intervention (1 Day)||4
8357541|NCT01223404|20601217|P2|COMPLETED|First Intervention (1 Day)||3
8357542|NCT01223404|20601218|P1|COMPLETED|First Intervention (1 Day)||4
8357543|NCT01223404|20601213|P6|STARTED|First Intervention (1 Day)||3
8357544|NCT01223404|20601214|P5|STARTED|First Intervention (1 Day)||2
8357545|NCT01223404|20601215|P4|STARTED|First Intervention (1 Day)||5
8357546|NCT01223404|20601216|P3|STARTED|First Intervention (1 Day)||4
8357547|NCT01223404|20601217|P2|STARTED|First Intervention (1 Day)||3
8357548|NCT01223404|20601218|P1|STARTED|First Intervention (1 Day)||4
8357549|NCT01223378|20601246|P5|NOT COMPLETED|Overall Study||3
8357550|NCT01223378|20601247|P4|NOT COMPLETED|Overall Study||1
8357551|NCT01223378|20601248|P3|NOT COMPLETED|Overall Study||3
8357552|NCT01223378|20601249|P2|NOT COMPLETED|Overall Study||4
8357553|NCT01223378|20601250|P1|NOT COMPLETED|Overall Study||6
8357554|NCT01223378|20601246|P5|COMPLETED|Overall Study||79
8357555|NCT01223378|20601247|P4|COMPLETED|Overall Study||80
8357556|NCT01223378|20601248|P3|COMPLETED|Overall Study||80
8357557|NCT01223378|20601249|P2|COMPLETED|Overall Study||81
8357558|NCT01223378|20601250|P1|COMPLETED|Overall Study||76
8357559|NCT01223378|20601246|P5|STARTED|Overall Study||82
8357560|NCT01223378|20601247|P4|STARTED|Overall Study||81
8357561|NCT01223378|20601248|P3|STARTED|Overall Study||83
8357562|NCT01223378|20601249|P2|STARTED|Overall Study||85
8357563|NCT01223378|20601250|P1|STARTED|Overall Study||82
8357564|NCT01223365|20601282|P1|NOT COMPLETED|Open-label Treatment Period||102
8357565|NCT01223365|20601282|P1|COMPLETED|Open-label Treatment Period||189
8357566|NCT01223365|20601282|P1|STARTED|Open-label Treatment Period||291
8357567|NCT01223365|20601282|P1|NOT COMPLETED|Open-label Titration Period||39
8357568|NCT01223365|20601282|P1|COMPLETED|Open-label Titration Period||291
8357569|NCT01223365|20601282|P1|Achieved Stable Pain Relief|Open-label Titration Period||294
8357570|NCT01223365|20601282|P1|Safety Analysis Set|Open-label Titration Period||329
8357571|NCT01223365|20601282|P1|STARTED|Open-label Titration Period||330
8357572|NCT01223352|20601325|P2|NOT COMPLETED|Overall Study||0
8357573|NCT01223352|20601326|P1|NOT COMPLETED|Overall Study||0
8357574|NCT01223352|20601325|P2|COMPLETED|Overall Study||33
8357575|NCT01223352|20601326|P1|COMPLETED|Overall Study||31
8357576|NCT01223352|20601325|P2|STARTED|Overall Study||33
8357577|NCT01223352|20601326|P1|STARTED|Overall Study||31
8357578|NCT01223235|20601346|P1|NOT COMPLETED|Overall Study||1
8357579|NCT01223235|20601346|P1|COMPLETED|Overall Study||21
8357580|NCT01223235|20601346|P1|STARTED|Overall Study||22
8357581|NCT01223196|20601354|P2|NOT COMPLETED|Overall Study||0
8357582|NCT01223196|20601355|P1|NOT COMPLETED|Overall Study||4
8357583|NCT01223196|20601354|P2|COMPLETED|Overall Study||11
8357584|NCT01223196|20601355|P1|COMPLETED|Overall Study||9
8357585|NCT01223196|20601354|P2|STARTED|Overall Study||11
8357586|NCT01223196|20601355|P1|STARTED|Overall Study||13
8357587|NCT01223183|20601367|P2|NOT COMPLETED|Imaging Day 2||0
8357588|NCT01223183|20601368|P1|NOT COMPLETED|Imaging Day 2||0
8357589|NCT01223183|20601367|P2|COMPLETED|Imaging Day 2||9
8357590|NCT01223183|20601368|P1|COMPLETED|Imaging Day 2||8
8357591|NCT01223183|20601367|P2|STARTED|Imaging Day 2||9
8357592|NCT01223183|20601368|P1|STARTED|Imaging Day 2||8
8357593|NCT01223183|20601367|P2|NOT COMPLETED|Washout Period (5-24 Days)||0
8357594|NCT01223183|20601368|P1|NOT COMPLETED|Washout Period (5-24 Days)||2
8357595|NCT01223183|20601367|P2|COMPLETED|Washout Period (5-24 Days)||9
8357596|NCT01223183|20601368|P1|COMPLETED|Washout Period (5-24 Days)||8
8357597|NCT01223183|20601367|P2|STARTED|Washout Period (5-24 Days)||9
8357598|NCT01223183|20601368|P1|STARTED|Washout Period (5-24 Days)||10
8357599|NCT01223183|20601367|P2|NOT COMPLETED|Imaging Day 1||1
8357600|NCT01223183|20601368|P1|NOT COMPLETED|Imaging Day 1||0
8357601|NCT01223183|20601367|P2|COMPLETED|Imaging Day 1||9
8357602|NCT01223183|20601368|P1|COMPLETED|Imaging Day 1||10
8357603|NCT01223183|20601367|P2|STARTED|Imaging Day 1||10
8357604|NCT01223183|20601368|P1|STARTED|Imaging Day 1||10
8357605|NCT01223027|20601378|P2|NOT COMPLETED|Overall Study||277
8357606|NCT01223027|20601379|P1|NOT COMPLETED|Overall Study||274
8357607|NCT01223027|20601378|P2|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
8357608|NCT01223027|20601379|P1|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
8357609|NCT01223027|20601378|P2|STARTED|Overall Study||286
8357610|NCT01223027|20601379|P1|STARTED|Overall Study||284
8357611|NCT01223001|20601402|P2|NOT COMPLETED|Overall Study||4
8357612|NCT01223001|20601403|P1|NOT COMPLETED|Overall Study||4
8357613|NCT01223001|20601402|P2|COMPLETED|Overall Study||0
8357614|NCT01223001|20601403|P1|COMPLETED|Overall Study||0
8357615|NCT01223001|20601402|P2|STARTED|Overall Study||4
8357616|NCT01223001|20601403|P1|STARTED|Overall Study||4
8357617|NCT01222884|20601411|P2|NOT COMPLETED|Overall Study||4
8357618|NCT01222884|20601412|P1|NOT COMPLETED|Overall Study||24
8357619|NCT01222884|20601411|P2|COMPLETED|Overall Study||113
8357620|NCT01222884|20601412|P1|COMPLETED|Overall Study||210
8357621|NCT01222884|20601411|P2|STARTED|Overall Study||117
8357622|NCT01222884|20601412|P1|STARTED|Overall Study||234
8357623|NCT01222871|20601422|P2|NOT COMPLETED|Overall Study||0
8357624|NCT01222871|20601423|P1|NOT COMPLETED|Overall Study||0
8357625|NCT01222871|20601422|P2|COMPLETED|Overall Study||0
8357626|NCT01222871|20601423|P1|COMPLETED|Overall Study||0
8357627|NCT01222871|20601422|P2|STARTED|Overall Study||0
8357628|NCT01222871|20601423|P1|STARTED|Overall Study||0
8357629|NCT01222832|20601432|P2|NOT COMPLETED|Overall Study||1
8357630|NCT01222832|20601433|P1|NOT COMPLETED|Overall Study||0
8357631|NCT01222832|20601432|P2|COMPLETED|Overall Study||112
8357632|NCT01222832|20601433|P1|COMPLETED|Overall Study||113
8357633|NCT01222832|20601432|P2|STARTED|Overall Study||113
8357634|NCT01222832|20601433|P1|STARTED|Overall Study||113
8357635|NCT01222715|20601441|P2|NOT COMPLETED|Overall Study||27
8357636|NCT01222715|20601442|P1|NOT COMPLETED|Overall Study||36
8357637|NCT01222715|20601441|P2|COMPLETED|Overall Study||16
8357638|NCT01222715|20601442|P1|COMPLETED|Overall Study||8
8357639|NCT01222715|20601441|P2|STARTED|Overall Study||43
8357640|NCT01222715|20601442|P1|STARTED|Overall Study||44
8357641|NCT01222689|20601452|P1|NOT COMPLETED|Overall Study||0
8357642|NCT01222689|20601452|P1|COMPLETED|Overall Study||46
8357643|NCT01222689|20601452|P1|STARTED|Overall Study||46
8357644|NCT01222585|20601465|P1|NOT COMPLETED|Overall Study||0
8357645|NCT01222585|20601465|P1|COMPLETED|Overall Study||24
8357646|NCT01222585|20601465|P1|STARTED|Overall Study||24
8357647|NCT01222572|20601475|P3|NOT COMPLETED|Overall Study||0
8357648|NCT01222572|20601476|P2|NOT COMPLETED|Overall Study||0
8357649|NCT01222572|20601477|P1|NOT COMPLETED|Overall Study||0
8357650|NCT01222572|20601475|P3|COMPLETED|Overall Study||0
8357651|NCT01222572|20601476|P2|COMPLETED|Overall Study||0
8357652|NCT01222572|20601477|P1|COMPLETED|Overall Study||1
8357653|NCT01222572|20601475|P3|STARTED|Overall Study||0
8357654|NCT01222572|20601476|P2|STARTED|Overall Study||0
8357655|NCT01222572|20601477|P1|STARTED|Overall Study||1
8357656|NCT01222533|20601481|P1|NOT COMPLETED|Overall Study||14
8357657|NCT01222533|20601481|P1|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
8357658|NCT01222533|20601481|P1|Received Tio HH18|Overall Study||146
8357659|NCT01222533|20601481|P1|Received Tio R5|Overall Study||150
8357660|NCT01222533|20601481|P1|Received Tio R2.5|Overall Study||145
8357661|NCT01222533|20601481|P1|Received Tio R1.25|Overall Study||147
8357662|NCT01222533|20601481|P1|Received Placebo|Overall Study||147
8357663|NCT01222533|20601481|P1|STARTED|Overall Study|Entered and treated.|154
8357664|NCT01222520|20601620|P2|NOT COMPLETED|Double-blind Period||2
8357665|NCT01222520|20601621|P1|NOT COMPLETED|Double-blind Period||1
8357666|NCT01222520|20601620|P2|COMPLETED|Double-blind Period||85
8357667|NCT01222520|20601621|P1|COMPLETED|Double-blind Period||86
8357668|NCT01222520|20601620|P2|STARTED|Double-blind Period||87
8357669|NCT01222520|20601621|P1|STARTED|Double-blind Period||87
8357670|NCT01222520|20601620|P2|NOT COMPLETED|Open-label run-in Period||23
8357671|NCT01222520|20601621|P1|NOT COMPLETED|Open-label run-in Period||0
8357672|NCT01222520|20601620|P2|COMPLETED|Open-label run-in Period||174
8357673|NCT01222520|20601621|P1|COMPLETED|Open-label run-in Period||0
8357674|NCT01222520|20601620|P2|STARTED|Open-label run-in Period||197
8357675|NCT01222520|20601621|P1|STARTED|Open-label run-in Period||0
8357676|NCT01222507|20601639|P1|NOT COMPLETED|Overall Study||2
8357677|NCT01222507|20601639|P1|COMPLETED|Overall Study||60
8357678|NCT01222507|20601639|P1|STARTED|Overall Study||62
8357679|NCT01222494|20601646|P3|NOT COMPLETED|Overall Study||4
8357680|NCT01222494|20601647|P2|NOT COMPLETED|Overall Study||4
8357681|NCT01222494|20601648|P1|NOT COMPLETED|Overall Study||1
8357682|NCT01222494|20601646|P3|COMPLETED|Overall Study||17
8357683|NCT01222494|20601647|P2|COMPLETED|Overall Study||15
8357684|NCT01222494|20601648|P1|COMPLETED|Overall Study||6
8357685|NCT01222494|20601646|P3|STARTED|Overall Study||21
8357686|NCT01222494|20601647|P2|STARTED|Overall Study||19
8357687|NCT01222494|20601648|P1|STARTED|Overall Study||7
8357688|NCT01222416|20601667|P2|NOT COMPLETED|Overall Study||0
8357689|NCT01222416|20601668|P1|NOT COMPLETED|Overall Study||20
8357690|NCT01222416|20601667|P2|COMPLETED|Overall Study||0
8357691|NCT01222416|20601668|P1|COMPLETED|Overall Study||30
8357692|NCT01222416|20601667|P2|STARTED|Overall Study||0
8357693|NCT01222416|20601668|P1|STARTED|Overall Study||50
8357694|NCT01222403|20601678|P2|NOT COMPLETED|Overall Study||2
8357695|NCT01222403|20601679|P1|NOT COMPLETED|Overall Study||0
8357696|NCT01222403|20601678|P2|COMPLETED|Overall Study||379
8357697|NCT01222403|20601679|P1|COMPLETED|Overall Study||386
8357698|NCT01222403|20601678|P2|STARTED|Overall Study||381
8357699|NCT01222403|20601679|P1|STARTED|Overall Study||386
8357700|NCT01222390|20601689|P1|NOT COMPLETED|Overall Study||0
8357701|NCT01222390|20601689|P1|COMPLETED|Overall Study||12
8357702|NCT01222390|20601689|P1|STARTED|Overall Study||12
8357703|NCT01222299|20601697|P4|NOT COMPLETED|Overall Study||5
8357704|NCT01222299|20601698|P3|NOT COMPLETED|Overall Study||2
8357705|NCT01222299|20601699|P2|NOT COMPLETED|Overall Study||2
8357706|NCT01222299|20601700|P1|NOT COMPLETED|Overall Study||0
8357707|NCT01222299|20601697|P4|COMPLETED|Overall Study||18
8357708|NCT01222299|20601698|P3|COMPLETED|Overall Study||20
8357709|NCT01222299|20601699|P2|COMPLETED|Overall Study||21
8357710|NCT01222299|20601700|P1|COMPLETED|Overall Study||21
8357711|NCT01222299|20601697|P4|STARTED|Overall Study||23
8357712|NCT01222299|20601698|P3|STARTED|Overall Study||22
8357713|NCT01222299|20601699|P2|STARTED|Overall Study||23
8357714|NCT01222299|20601700|P1|STARTED|Overall Study||21
8357715|NCT01222286|20601712|P2|NOT COMPLETED|Overall Study||0
8357716|NCT01222286|20601713|P1|NOT COMPLETED|Overall Study||0
8357717|NCT01222286|20601712|P2|COMPLETED|Overall Study||14
8357718|NCT01222286|20601713|P1|COMPLETED|Overall Study||16
8357719|NCT01222286|20601712|P2|STARTED|Overall Study||14
8357720|NCT01222286|20601713|P1|STARTED|Overall Study||16
8357721|NCT01222273|20601725|P1|NOT COMPLETED|Overall Study||0
8357722|NCT01222273|20601725|P1|COMPLETED|Overall Study||7
8357723|NCT01222273|20601725|P1|STARTED|Overall Study||7
8357724|NCT01222260|20601731|P1|NOT COMPLETED|Overall Study||2
8357725|NCT01222260|20601731|P1|COMPLETED|Overall Study||29
8357726|NCT01222260|20601731|P1|STARTED|Overall Study||31
8357739|NCT01222234|20601806|P3|NOT COMPLETED|Overall Study||2
8357740|NCT01222234|20601807|P2|NOT COMPLETED|Overall Study||2
8357741|NCT01222234|20601808|P1|NOT COMPLETED|Overall Study||0
8357742|NCT01222234|20601806|P3|COMPLETED|Overall Study||22
8357743|NCT01222234|20601807|P2|COMPLETED|Overall Study||15
8357744|NCT01222234|20601808|P1|COMPLETED|Overall Study||15
8357745|NCT01222234|20601806|P3|STARTED|Overall Study||24
8357746|NCT01222234|20601807|P2|STARTED|Overall Study||17
8357747|NCT01222234|20601808|P1|STARTED|Overall Study||15
8357748|NCT01222195|20601817|P1|NOT COMPLETED|Overall Study||0
8357749|NCT01222195|20601817|P1|COMPLETED|Overall Study||1
8357750|NCT01222195|20601817|P1|STARTED|Overall Study||1
8357751|NCT01222117|20601832|P11|NOT COMPLETED|Overall Study||0
8357752|NCT01222117|20601833|P10|NOT COMPLETED|Overall Study||2
8357753|NCT01222117|20601834|P9|NOT COMPLETED|Overall Study||3
8357754|NCT01222117|20601835|P8|NOT COMPLETED|Overall Study||0
8357755|NCT01222117|20601836|P7|NOT COMPLETED|Overall Study||0
8357756|NCT01222117|20601837|P6|NOT COMPLETED|Overall Study||1
8357757|NCT01222117|20601838|P5|NOT COMPLETED|Overall Study||1
8357758|NCT01222117|20601839|P4|NOT COMPLETED|Overall Study||1
8357759|NCT01222117|20601840|P3|NOT COMPLETED|Overall Study||0
8357760|NCT01222117|20601841|P2|NOT COMPLETED|Overall Study||1
8357761|NCT01222117|20601842|P1|NOT COMPLETED|Overall Study||3
8357762|NCT01222117|20601832|P11|COMPLETED|Overall Study||6
8357763|NCT01222117|20601833|P10|COMPLETED|Overall Study||17
8357764|NCT01222117|20601834|P9|COMPLETED|Overall Study||20
8357765|NCT01222117|20601835|P8|COMPLETED|Overall Study||12
8357766|NCT01222117|20601836|P7|COMPLETED|Overall Study||13
8357767|NCT01222117|20601837|P6|COMPLETED|Overall Study||9
8357768|NCT01222117|20601838|P5|COMPLETED|Overall Study||8
8357769|NCT01222117|20601839|P4|COMPLETED|Overall Study||19
8357770|NCT01222117|20601840|P3|COMPLETED|Overall Study||22
8357771|NCT01222117|20601841|P2|COMPLETED|Overall Study||19
8357772|NCT01222117|20601842|P1|COMPLETED|Overall Study||17
8357773|NCT01222117|20601832|P11|STARTED|Overall Study||6
8357774|NCT01222117|20601833|P10|STARTED|Overall Study||19
8357775|NCT01222117|20601834|P9|STARTED|Overall Study||23
8357776|NCT01222117|20601835|P8|STARTED|Overall Study||12
8357777|NCT01222117|20601836|P7|STARTED|Overall Study||13
8357778|NCT01222117|20601837|P6|STARTED|Overall Study||10
8357779|NCT01222117|20601838|P5|STARTED|Overall Study||9
8357780|NCT01222117|20601839|P4|STARTED|Overall Study||20
8357781|NCT01222117|20601840|P3|STARTED|Overall Study||22
8357782|NCT01222117|20601841|P2|STARTED|Overall Study||20
8357783|NCT01222117|20601842|P1|STARTED|Overall Study||20
8357784|NCT01222104|20601877|P1|NOT COMPLETED|Overall Study||47
8357785|NCT01222104|20601877|P1|COMPLETED|Overall Study||587
8357786|NCT01222104|20601877|P1|Completed 30-day Visit-No Angio-Seal|Overall Study||90
8357787|NCT01222104|20601877|P1|Completed 30-day Visit-Angio-Seal|Overall Study||497
8357788|NCT01222104|20601877|P1|Successful Deployment and Hemostasis|Overall Study||524
8357789|NCT01222104|20601877|P1|Successful Deployment|Overall Study||529
8357790|NCT01222104|20601877|P1|Angio-Seal Deployment Attempted|Overall Study||534
8357791|NCT01222104|20601877|P1|STARTED|Overall Study||634
8357792|NCT01222091|20601891|P2|NOT COMPLETED|Overall Study||0
8357793|NCT01222091|20601892|P1|NOT COMPLETED|Overall Study||0
8357794|NCT01222091|20601891|P2|COMPLETED|Overall Study||5
8357795|NCT01222091|20601892|P1|COMPLETED|Overall Study||5
8357796|NCT01222091|20601891|P2|STARTED|Overall Study||5
8357797|NCT01222091|20601892|P1|STARTED|Overall Study||5
8357798|NCT01222078|20601900|P1|NOT COMPLETED|Overall Study||1
8357799|NCT01222078|20601900|P1|COMPLETED|Overall Study||0
8357800|NCT01222078|20601900|P1|STARTED|Overall Study||1
8357801|NCT01221948|20601934|P1|NOT COMPLETED|Overall Study||14
8357802|NCT01221948|20601934|P1|COMPLETED|Overall Study||39
8357803|NCT01221948|20601934|P1|STARTED|Overall Study||53
8357807|NCT01221753|20601953|P1|NOT COMPLETED|Overall Study||1
8357808|NCT01221753|20601953|P1|COMPLETED|Overall Study||6
8357809|NCT01221753|20601953|P1|STARTED|Overall Study||7
8357810|NCT01221727|20601960|P2|NOT COMPLETED|Overall Study||1
8357811|NCT01221727|20601961|P1|NOT COMPLETED|Overall Study||3
8357812|NCT01221727|20601960|P2|COMPLETED|Overall Study||8
8357813|NCT01221727|20601961|P1|COMPLETED|Overall Study||18
8357814|NCT01221727|20601960|P2|Treated|Overall Study|Number of subjects received investigational product|8
8357815|NCT01221727|20601961|P1|Treated|Overall Study|Number of subjects received investigational product|19
8357816|NCT01221727|20601960|P2|STARTED|Overall Study|Number of subjects randomized into the study|9
8357817|NCT01221727|20601961|P1|STARTED|Overall Study|Number of subjects randomized into the study|21
8357818|NCT01221623|20601982|P2|NOT COMPLETED|Overall Study||14
8357819|NCT01221623|20601983|P1|NOT COMPLETED|Overall Study||38
8357820|NCT01221623|20601982|P2|COMPLETED|Overall Study||127
8357821|NCT01221623|20601983|P1|COMPLETED|Overall Study||236
8357822|NCT01221623|20601982|P2|STARTED|Overall Study||141
8357823|NCT01221623|20601983|P1|STARTED|Overall Study||274
8357824|NCT01221597|20602007|P2|NOT COMPLETED|Overall Study||16
8357825|NCT01221597|20602008|P1|NOT COMPLETED|Overall Study||36
8357826|NCT01221597|20602007|P2|COMPLETED|Overall Study||124
8357827|NCT01221597|20602008|P1|COMPLETED|Overall Study||241
8357828|NCT01221597|20602007|P2|STARTED|Overall Study||140
8357829|NCT01221597|20602008|P1|STARTED|Overall Study||277
8357830|NCT01221441|20602032|P2|NOT COMPLETED|Overall Study||12
8357831|NCT01221441|20602033|P1|NOT COMPLETED|Overall Study||22
8357832|NCT01221441|20602032|P2|COMPLETED|Overall Study||23
8357833|NCT01221441|20602033|P1|COMPLETED|Overall Study||45
8357834|NCT01221441|20602032|P2|STARTED|Overall Study||35
8357835|NCT01221441|20602033|P1|STARTED|Overall Study||67
8357836|NCT01221363|20602065|P2|NOT COMPLETED|Overall Study||5
8357837|NCT01221363|20602066|P1|NOT COMPLETED|Overall Study||12
8357838|NCT01221363|20602065|P2|COMPLETED|Overall Study||68
8357839|NCT01221363|20602066|P1|COMPLETED|Overall Study||81
8357840|NCT01221363|20602065|P2|STARTED|Overall Study||73
8357841|NCT01221363|20602066|P1|STARTED|Overall Study||93
8357842|NCT01221350|20602076|P2|NOT COMPLETED|Overall Study||3
8357843|NCT01221350|20602077|P1|NOT COMPLETED|Overall Study||5
8357844|NCT01221350|20602076|P2|COMPLETED|Overall Study||24
8357845|NCT01221350|20602077|P1|COMPLETED|Overall Study||23
8357846|NCT01221350|20602076|P2|Analysis Population|Overall Study||24
8357847|NCT01221350|20602077|P1|Analysis Population|Overall Study||23
8357848|NCT01221350|20602076|P2|Received Intervention|Overall Study||27
8357849|NCT01221350|20602077|P1|Received Intervention|Overall Study||28
8357850|NCT01221350|20602076|P2|STARTED|Overall Study||27
8357851|NCT01221350|20602077|P1|STARTED|Overall Study||28
8357852|NCT01221311|20602119|P2|NOT COMPLETED|Overall Study||0
8357853|NCT01221311|20602120|P1|NOT COMPLETED|Overall Study||0
8357854|NCT01221311|20602119|P2|COMPLETED|Overall Study||55
8357855|NCT01221311|20602120|P1|COMPLETED|Overall Study||57
8357856|NCT01221311|20602119|P2|STARTED|Overall Study||55
8357857|NCT01221311|20602120|P1|STARTED|Overall Study||57
8357858|NCT01221298|20602126|P1|NOT COMPLETED|Overall Study||0
8357859|NCT01221298|20602126|P1|COMPLETED|Overall Study|The number of participants who completed study drug|11
8357860|NCT01221298|20602126|P1|STARTED|Overall Study||11
8357861|NCT01221285|20602136|P1|NOT COMPLETED|Overall Study||1
8357862|NCT01221285|20602136|P1|COMPLETED|Overall Study||10
8357863|NCT01221285|20602136|P1|STARTED|Overall Study||11
8357864|NCT01221272|20602145|P2|NOT COMPLETED|Period 2||2
8357865|NCT01221272|20602146|P1|NOT COMPLETED|Period 2||0
8357866|NCT01221272|20602145|P2|COMPLETED|Period 2||37
8357867|NCT01221272|20602146|P1|COMPLETED|Period 2||39
8357868|NCT01221272|20602145|P2|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
8357869|NCT01221272|20602146|P1|STARTED|Period 2||39
8357870|NCT01221272|20602145|P2|NOT COMPLETED|Period 1||2
8357871|NCT01221272|20602146|P1|NOT COMPLETED|Period 1||2
8357872|NCT01221272|20602145|P2|COMPLETED|Period 1||38
8357873|NCT01221272|20602146|P1|COMPLETED|Period 1||39
8357874|NCT01221272|20602145|P2|STARTED|Period 1||40
8357875|NCT01221272|20602146|P1|STARTED|Period 1||41
8357876|NCT01221233|20602163|P2|NOT COMPLETED|Overall Study||1
8357877|NCT01221233|20602164|P1|NOT COMPLETED|Overall Study||3
8357878|NCT01221233|20602163|P2|COMPLETED|Overall Study||19
8357879|NCT01221233|20602164|P1|COMPLETED|Overall Study||15
8357880|NCT01221233|20602163|P2|STARTED|Overall Study||20
8357881|NCT01221233|20602164|P1|STARTED|Overall Study||18
8357882|NCT01221207|20602173|P3|NOT COMPLETED|Overall Study||21
8357883|NCT01221207|20602174|P2|NOT COMPLETED|Overall Study||9
8357884|NCT01221207|20602175|P1|NOT COMPLETED|Overall Study||32
8357885|NCT01221207|20602173|P3|COMPLETED|Overall Study||54
8357886|NCT01221207|20602174|P2|COMPLETED|Overall Study||66
8357887|NCT01221207|20602175|P1|COMPLETED|Overall Study||43
8357888|NCT01221207|20602173|P3|STARTED|Overall Study||75
8357889|NCT01221207|20602174|P2|STARTED|Overall Study||75
8357890|NCT01221207|20602175|P1|STARTED|Overall Study||75
8357891|NCT01221194|20602185|P2|NOT COMPLETED|Overall Study||0
8357892|NCT01221194|20602186|P1|NOT COMPLETED|Overall Study||0
8357893|NCT01221194|20602185|P2|COMPLETED|Overall Study||186
8357894|NCT01221194|20602186|P1|COMPLETED|Overall Study||195
8357895|NCT01221194|20602185|P2|STARTED|Overall Study||186
8357896|NCT01221194|20602186|P1|STARTED|Overall Study||195
8357897|NCT01221181|20602192|P1|NOT COMPLETED|Overall Study||1
8357898|NCT01221181|20602192|P1|COMPLETED|Overall Study||5
8357899|NCT01221181|20602192|P1|STARTED|Overall Study||6
8357900|NCT01221090|20602200|P4|NOT COMPLETED|Overall Study||22
8357901|NCT01221090|20602201|P3|NOT COMPLETED|Overall Study||42
8357902|NCT01221090|20602202|P2|NOT COMPLETED|Overall Study||34
8357903|NCT01221090|20602203|P1|NOT COMPLETED|Overall Study||15
8357904|NCT01221090|20602200|P4|COMPLETED|Overall Study||73
8357905|NCT01221090|20602201|P3|COMPLETED|Overall Study||57
8357906|NCT01221090|20602202|P2|COMPLETED|Overall Study||47
8357907|NCT01221090|20602203|P1|COMPLETED|Overall Study||86
8357908|NCT01221090|20602200|P4|STARTED|Overall Study||95
8357909|NCT01221090|20602201|P3|STARTED|Overall Study||99
8357910|NCT01221090|20602202|P2|STARTED|Overall Study||81
8357911|NCT01221090|20602203|P1|STARTED|Overall Study||101
8357912|NCT01220999|20602234|P5|NOT COMPLETED|Overall Study||0
8357913|NCT01220999|20602235|P4|NOT COMPLETED|Overall Study||0
8357914|NCT01220999|20602236|P3|NOT COMPLETED|Overall Study||1
8357915|NCT01220999|20602237|P2|NOT COMPLETED|Overall Study||0
8357916|NCT01220999|20602238|P1|NOT COMPLETED|Overall Study||0
8357917|NCT01220999|20602234|P5|COMPLETED|Overall Study||5
8357918|NCT01220999|20602235|P4|COMPLETED|Overall Study||3
8357919|NCT01220999|20602236|P3|COMPLETED|Overall Study||4
8357920|NCT01220999|20602237|P2|COMPLETED|Overall Study||4
8357921|NCT01220999|20602238|P1|COMPLETED|Overall Study||2
8357922|NCT01220999|20602234|P5|STARTED|Overall Study||5
8357923|NCT01220999|20602235|P4|STARTED|Overall Study||3
8357924|NCT01220999|20602236|P3|STARTED|Overall Study||5
8357925|NCT01220999|20602237|P2|STARTED|Overall Study||4
8357926|NCT01220999|20602238|P1|STARTED|Overall Study||2
8357927|NCT01220973|20602315|P1|NOT COMPLETED|Overall Study||4
8357928|NCT01220973|20602315|P1|COMPLETED|Overall Study||23
8357929|NCT01220973|20602315|P1|STARTED|Overall Study||27
8357930|NCT01220869|20602319|P1|NOT COMPLETED|Overall Study||6
8357931|NCT01220869|20602319|P1|COMPLETED|Overall Study||104
8357932|NCT01220869|20602319|P1|STARTED|Overall Study||110
8357933|NCT01220739|20602329|P2|NOT COMPLETED|Overall Study||0
8357934|NCT01220739|20602330|P1|NOT COMPLETED|Overall Study||0
8357935|NCT01220739|20602329|P2|COMPLETED|Overall Study||5
8357936|NCT01220739|20602330|P1|COMPLETED|Overall Study||7
8357937|NCT01220739|20602329|P2|STARTED|Overall Study||5
8357938|NCT01220739|20602330|P1|STARTED|Overall Study||7
8357939|NCT01220726|20602340|P2|NOT COMPLETED|Overall Study||2
8357940|NCT01220726|20602341|P1|NOT COMPLETED|Overall Study||0
8357941|NCT01220726|20602340|P2|COMPLETED|Overall Study||13
8357942|NCT01220726|20602341|P1|COMPLETED|Overall Study||15
8357943|NCT01220726|20602340|P2|STARTED|Overall Study||15
8357944|NCT01220726|20602341|P1|STARTED|Overall Study||15
8357945|NCT01220687|20602361|P2|NOT COMPLETED|Overall Study||1
8357946|NCT01220687|20602362|P1|NOT COMPLETED|Overall Study||2
8357947|NCT01220687|20602361|P2|COMPLETED|Overall Study||14
8357948|NCT01220687|20602362|P1|COMPLETED|Overall Study||14
8357949|NCT01220687|20602361|P2|STARTED|Overall Study||15
8357950|NCT01220687|20602362|P1|STARTED|Overall Study||16
8357951|NCT01220609|20602388|P1|NOT COMPLETED|Overall Study||3
8357952|NCT01220609|20602388|P1|COMPLETED|Overall Study|Eligible and treated patients|23
8357953|NCT01220609|20602388|P1|STARTED|Overall Study||26
8357960|NCT01220466|20602412|P3|NOT COMPLETED|Overall Study||0
8357961|NCT01220466|20602413|P2|NOT COMPLETED|Overall Study||0
8357962|NCT01220466|20602414|P1|NOT COMPLETED|Overall Study||0
8357963|NCT01220466|20602412|P3|COMPLETED|Overall Study|16 eyes|10
8357964|NCT01220466|20602413|P2|COMPLETED|Overall Study|108 eyes|56
8357965|NCT01220466|20602414|P1|COMPLETED|Overall Study|19 eyes|11
8357966|NCT01220466|20602412|P3|STARTED|Overall Study|16 eyes|10
8357967|NCT01220466|20602413|P2|STARTED|Overall Study|108 eyes|56
8357968|NCT01220466|20602414|P1|STARTED|Overall Study|19 eyes|11
8357969|NCT01220414|20602436|P4|NOT COMPLETED|Overall Study||1
8357970|NCT01220414|20602437|P3|NOT COMPLETED|Overall Study||0
8357971|NCT01220414|20602438|P2|NOT COMPLETED|Overall Study||0
8357972|NCT01220414|20602439|P1|NOT COMPLETED|Overall Study||1
8357973|NCT01220414|20602436|P4|COMPLETED|Overall Study||14
8357974|NCT01220414|20602437|P3|COMPLETED|Overall Study||14
8357975|NCT01220414|20602438|P2|COMPLETED|Overall Study||14
8357976|NCT01220414|20602439|P1|COMPLETED|Overall Study||14
8357977|NCT01220414|20602436|P4|STARTED|Overall Study||15
8357978|NCT01220414|20602437|P3|STARTED|Overall Study||14
8357979|NCT01220414|20602438|P2|STARTED|Overall Study||14
8357980|NCT01220414|20602439|P1|STARTED|Overall Study||15
8357981|NCT01220401|20602446|P1|NOT COMPLETED|Overall Study||3
8357982|NCT01220401|20602446|P1|COMPLETED|Overall Study||18
8357983|NCT01220401|20602446|P1|STARTED|Overall Study||21
8357984|NCT01220297|20602455|P1|NOT COMPLETED|Overall Study||3
8357985|NCT01220297|20602455|P1|COMPLETED|Overall Study||0
8357986|NCT01220297|20602455|P1|STARTED|Overall Study||3
8357987|NCT01220180|20602472|P1|NOT COMPLETED|Overall Study||207
8357988|NCT01220180|20602472|P1|COMPLETED|Overall Study||3968
8357989|NCT01220180|20602472|P1|Treated|Overall Study||4174
8357990|NCT01220180|20602472|P1|STARTED|Overall Study||4175
8357991|NCT01220167|20602498|P3|NOT COMPLETED|Period 3||0
8357992|NCT01220167|20602499|P2|NOT COMPLETED|Period 3||1
8357993|NCT01220167|20602500|P1|NOT COMPLETED|Period 3||0
8357994|NCT01220167|20602498|P3|COMPLETED|Period 3||6
8357995|NCT01220167|20602499|P2|COMPLETED|Period 3||5
8357996|NCT01220167|20602500|P1|COMPLETED|Period 3||6
8357997|NCT01220167|20602498|P3|STARTED|Period 3||6
8357998|NCT01220167|20602499|P2|STARTED|Period 3||6
8357999|NCT01220167|20602500|P1|STARTED|Period 3||6
8358000|NCT01220167|20602498|P3|NOT COMPLETED|Period 2||0
8358001|NCT01220167|20602499|P2|NOT COMPLETED|Period 2||0
8358002|NCT01220167|20602500|P1|NOT COMPLETED|Period 2||0
8358003|NCT01220167|20602498|P3|COMPLETED|Period 2||6
8358004|NCT01220167|20602499|P2|COMPLETED|Period 2||6
8358005|NCT01220167|20602500|P1|COMPLETED|Period 2||6
8358006|NCT01220167|20602498|P3|STARTED|Period 2||6
8358007|NCT01220167|20602499|P2|STARTED|Period 2||6
8358008|NCT01220167|20602500|P1|STARTED|Period 2||6
8358009|NCT01220167|20602498|P3|NOT COMPLETED|Period 1||0
8358010|NCT01220167|20602499|P2|NOT COMPLETED|Period 1||0
8358011|NCT01220167|20602500|P1|NOT COMPLETED|Period 1||0
8358012|NCT01220167|20602498|P3|COMPLETED|Period 1||6
8358013|NCT01220167|20602499|P2|COMPLETED|Period 1||6
8358014|NCT01220167|20602500|P1|COMPLETED|Period 1||6
8358015|NCT01220167|20602498|P3|STARTED|Period 1||6
8358016|NCT01220167|20602499|P2|STARTED|Period 1||6
8358017|NCT01220167|20602500|P1|STARTED|Period 1||6
8358039|NCT01219985|20602724|P1|NOT COMPLETED|Overall Study||20
8358040|NCT01219985|20602724|P1|COMPLETED|Overall Study||30
8358041|NCT01219985|20602724|P1|STARTED|Overall Study||50
8358042|NCT01219959|20602732|P2|NOT COMPLETED|Overall Study||23
8358043|NCT01219959|20602733|P1|NOT COMPLETED|Overall Study||7
8358044|NCT01219959|20602732|P2|COMPLETED|Overall Study||101
8358045|NCT01219959|20602733|P1|COMPLETED|Overall Study||120
8358046|NCT01219959|20602732|P2|STARTED|Overall Study||124
8358047|NCT01219959|20602733|P1|STARTED|Overall Study||127
8358048|NCT01219933|20602781|P1|NOT COMPLETED|Overall Study||38
8358049|NCT01219933|20602781|P1|COMPLETED|Overall Study||30
8358050|NCT01219933|20602781|P1|STARTED|Overall Study||68
8358051|NCT01219881|20602820|P2|NOT COMPLETED|Overall Study||5
8358052|NCT01219881|20602821|P1|NOT COMPLETED|Overall Study||4
8358053|NCT01219881|20602820|P2|COMPLETED|Overall Study||32
8358054|NCT01219881|20602821|P1|COMPLETED|Overall Study||34
8358055|NCT01219881|20602820|P2|STARTED|Overall Study||37
8358056|NCT01219881|20602821|P1|STARTED|Overall Study||38
8358057|NCT01219855|20602838|P5|NOT COMPLETED|Overall Study||1
8358058|NCT01219855|20602839|P4|NOT COMPLETED|Overall Study||1
8358059|NCT01219855|20602840|P3|NOT COMPLETED|Overall Study||1
8358060|NCT01219855|20602841|P2|NOT COMPLETED|Overall Study||5
8358061|NCT01219855|20602842|P1|NOT COMPLETED|Overall Study||1
8358062|NCT01219855|20602838|P5|COMPLETED|Overall Study||13
8358063|NCT01219855|20602839|P4|COMPLETED|Overall Study||12
8358064|NCT01219855|20602840|P3|COMPLETED|Overall Study||16
8358065|NCT01219855|20602841|P2|COMPLETED|Overall Study||12
8358066|NCT01219855|20602842|P1|COMPLETED|Overall Study||16
8358067|NCT01219855|20602838|P5|STARTED|Overall Study||14
8358068|NCT01219855|20602839|P4|STARTED|Overall Study||13
8358069|NCT01219855|20602840|P3|STARTED|Overall Study||17
8358070|NCT01219855|20602841|P2|STARTED|Overall Study||17
8358071|NCT01219855|20602842|P1|STARTED|Overall Study||17
8358072|NCT01219777|20602878|P1|NOT COMPLETED|Overall Study||0
8358073|NCT01219777|20602878|P1|COMPLETED|Overall Study||9
8358074|NCT01219777|20602878|P1|STARTED|Overall Study||9
8358075|NCT01219738|20602883|P1|NOT COMPLETED|Overall Study||0
8358076|NCT01219738|20602883|P1|COMPLETED|Overall Study||20
8358077|NCT01219738|20602883|P1|Budesonide 720- 4 Times|Overall Study||20
8358078|NCT01219738|20602883|P1|Budesonide 1440|Overall Study||20
8358079|NCT01219738|20602883|P1|Budesonide 720|Overall Study||20
8358080|NCT01219738|20602883|P1|Budesonide 360|Overall Study||20
8358081|NCT01219738|20602883|P1|STARTED|Overall Study||20
8358082|NCT01219673|20602904|P8|NOT COMPLETED|Overall Study||0
8358083|NCT01219673|20602905|P7|NOT COMPLETED|Overall Study||0
8358084|NCT01219673|20602906|P6|NOT COMPLETED|Overall Study||0
8358085|NCT01219673|20602907|P5|NOT COMPLETED|Overall Study||0
8358086|NCT01219673|20602908|P4|NOT COMPLETED|Overall Study||0
8358087|NCT01219673|20602909|P3|NOT COMPLETED|Overall Study||0
8358088|NCT01219673|20602910|P2|NOT COMPLETED|Overall Study||0
8358089|NCT01219673|20602911|P1|NOT COMPLETED|Overall Study||0
8358090|NCT01219673|20602904|P8|COMPLETED|Overall Study||0
8358091|NCT01219673|20602905|P7|COMPLETED|Overall Study||0
8358092|NCT01219673|20602906|P6|COMPLETED|Overall Study||0
8358093|NCT01219673|20602907|P5|COMPLETED|Overall Study||0
8358094|NCT01219673|20602908|P4|COMPLETED|Overall Study||0
8358095|NCT01219673|20602909|P3|COMPLETED|Overall Study||1
8358096|NCT01219673|20602910|P2|COMPLETED|Overall Study||0
8358097|NCT01219673|20602911|P1|COMPLETED|Overall Study||0
8358098|NCT01219673|20602904|P8|STARTED|Overall Study||0
8358099|NCT01219673|20602905|P7|STARTED|Overall Study||0
8358100|NCT01219673|20602906|P6|STARTED|Overall Study||0
8358101|NCT01219673|20602907|P5|STARTED|Overall Study||0
8358102|NCT01219673|20602908|P4|STARTED|Overall Study||0
8358103|NCT01219673|20602909|P3|STARTED|Overall Study||1
8358104|NCT01219673|20602910|P2|STARTED|Overall Study||0
8358105|NCT01219673|20602911|P1|STARTED|Overall Study||0
8358106|NCT01218997|20602931|P2|NOT COMPLETED|Overall Study||41
8358107|NCT01218997|20602932|P1|NOT COMPLETED|Overall Study||245
8358108|NCT01218997|20602931|P2|COMPLETED|Overall Study||24
8358109|NCT01218997|20602932|P1|COMPLETED|Overall Study||126
8358110|NCT01218997|20602931|P2|STARTED|Overall Study||65
8358111|NCT01218997|20602932|P1|STARTED|Overall Study||371
8358112|NCT01218984|20602941|P3|NOT COMPLETED|Overall Study||3
8358113|NCT01218984|20602942|P2|NOT COMPLETED|Overall Study||2
8358114|NCT01218984|20602943|P1|NOT COMPLETED|Overall Study||1
8358115|NCT01218984|20602941|P3|COMPLETED|Overall Study||7
8358116|NCT01218984|20602942|P2|COMPLETED|Overall Study||6
8358117|NCT01218984|20602943|P1|COMPLETED|Overall Study||8
8358118|NCT01218984|20602941|P3|STARTED|Overall Study||10
8358119|NCT01218984|20602942|P2|STARTED|Overall Study||8
8358120|NCT01218984|20602943|P1|STARTED|Overall Study||9
8358121|NCT01218971|20602953|P2|NOT COMPLETED|Overall Study||80
8358122|NCT01218971|20602954|P1|NOT COMPLETED|Overall Study||104
8358123|NCT01218971|20602953|P2|COMPLETED|Overall Study||77
8358124|NCT01218971|20602954|P1|COMPLETED|Overall Study||71
8358125|NCT01218971|20602953|P2|STARTED|Overall Study||157
8358126|NCT01218971|20602954|P1|STARTED|Overall Study||175
8358127|NCT01218958|20602967|P3|NOT COMPLETED|Overall Study||81
8358128|NCT01218958|20602968|P2|NOT COMPLETED|Overall Study||81
8358129|NCT01218958|20602969|P1|NOT COMPLETED|Overall Study||84
8358130|NCT01218958|20602967|P3|COMPLETED|Overall Study||128
8358131|NCT01218958|20602968|P2|COMPLETED|Overall Study||124
8358132|NCT01218958|20602969|P1|COMPLETED|Overall Study||126
8358133|NCT01218958|20602967|P3|STARTED|Overall Study||209
8358134|NCT01218958|20602968|P2|STARTED|Overall Study||205
8358135|NCT01218958|20602969|P1|STARTED|Overall Study||210
8358136|NCT01218867|20602991|P11|NOT COMPLETED|Overall Study||0
8358137|NCT01218867|20602992|P10|NOT COMPLETED|Overall Study||0
8358138|NCT01218867|20602993|P9|NOT COMPLETED|Overall Study||0
8358139|NCT01218867|20602994|P8|NOT COMPLETED|Overall Study||0
8358140|NCT01218867|20602995|P7|NOT COMPLETED|Overall Study||1
8358141|NCT01218867|20602996|P6|NOT COMPLETED|Overall Study||0
8358142|NCT01218867|20602997|P5|NOT COMPLETED|Overall Study||0
8358143|NCT01218867|20602998|P4|NOT COMPLETED|Overall Study||0
8358144|NCT01218867|20602999|P3|NOT COMPLETED|Overall Study||0
8358145|NCT01218867|20603000|P2|NOT COMPLETED|Overall Study||0
8358146|NCT01218867|20603001|P1|NOT COMPLETED|Overall Study||0
8358147|NCT01218867|20602991|P11|COMPLETED|Overall Study||2
8358148|NCT01218867|20602992|P10|COMPLETED|Overall Study||4
8358149|NCT01218867|20602993|P9|COMPLETED|Overall Study||3
8358150|NCT01218867|20602994|P8|COMPLETED|Overall Study||3
8358151|NCT01218867|20602995|P7|COMPLETED|Overall Study||3
8358152|NCT01218867|20602996|P6|COMPLETED|Overall Study||1
8358153|NCT01218867|20602997|P5|COMPLETED|Overall Study||1
8358154|NCT01218867|20602998|P4|COMPLETED|Overall Study||1
8358155|NCT01218867|20602999|P3|COMPLETED|Overall Study||3
8358156|NCT01218867|20603000|P2|COMPLETED|Overall Study||1
8358157|NCT01218867|20603001|P1|COMPLETED|Overall Study||1
8358158|NCT01218867|20602991|P11|STARTED|Overall Study||2
8358159|NCT01218867|20602992|P10|STARTED|Overall Study||4
8358160|NCT01218867|20602993|P9|STARTED|Overall Study||3
8358161|NCT01218867|20602994|P8|STARTED|Overall Study||3
8358162|NCT01218867|20602995|P7|STARTED|Overall Study||4
8358163|NCT01218867|20602996|P6|STARTED|Overall Study||1
8358164|NCT01218867|20602997|P5|STARTED|Overall Study||1
8358165|NCT01218867|20602998|P4|STARTED|Overall Study||1
8358166|NCT01218867|20602999|P3|STARTED|Overall Study||3
8358167|NCT01218867|20603000|P2|STARTED|Overall Study||1
8358168|NCT01218867|20603001|P1|STARTED|Overall Study||1
8358169|NCT01218802|20603049|P2|NOT COMPLETED|Overall Study||18
8358170|NCT01218802|20603050|P1|NOT COMPLETED|Overall Study||10
8358171|NCT01218802|20603049|P2|COMPLETED|Overall Study||57
8358172|NCT01218802|20603050|P1|COMPLETED|Overall Study||62
8358173|NCT01218802|20603049|P2|STARTED|Overall Study||75
8358174|NCT01218802|20603050|P1|STARTED|Overall Study||72
8358175|NCT01218672|20603060|P2|NOT COMPLETED|Overall Study||21
8358176|NCT01218672|20603061|P1|NOT COMPLETED|Overall Study||11
8358177|NCT01218672|20603060|P2|COMPLETED|Overall Study||121
8358178|NCT01218672|20603061|P1|COMPLETED|Overall Study||128
8358179|NCT01218672|20603060|P2|Treated|Overall Study||133
8358180|NCT01218672|20603061|P1|Treated|Overall Study||136
8358181|NCT01218672|20603060|P2|STARTED|Overall Study||142
8358182|NCT01218672|20603061|P1|STARTED|Overall Study||139
8358183|NCT01218659|20603087|P3|NOT COMPLETED|12-Month OLE||10
8358184|NCT01218659|20603088|P2|NOT COMPLETED|12-Month OLE||0
8358185|NCT01218659|20603089|P1|NOT COMPLETED|12-Month OLE||0
8358186|NCT01218659|20603087|P3|COMPLETED|12-Month OLE||42
8358187|NCT01218659|20603088|P2|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8358188|NCT01218659|20603089|P1|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8358189|NCT01218659|20603087|P3|Modified Intent-to-Treat (mITT)|12-Month OLE||46
8358190|NCT01218659|20603088|P2|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8358191|NCT01218659|20603089|P1|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8358192|NCT01218659|20603087|P3|Safety Population|12-Month OLE||51
8358193|NCT01218659|20603088|P2|Safety Population|12-Month OLE||0
8358194|NCT01218659|20603089|P1|Safety Population|12-Month OLE||0
8358195|NCT01218659|20603087|P3|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
8358196|NCT01218659|20603088|P2|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8358197|NCT01218659|20603089|P1|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
8358198|NCT01218659|20603087|P3|NOT COMPLETED|18-Month Randomized Period||0
8358199|NCT01218659|20603088|P2|NOT COMPLETED|18-Month Randomized Period||6
8358200|NCT01218659|20603089|P1|NOT COMPLETED|18-Month Randomized Period||2
8358201|NCT01218659|20603087|P3|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
8358202|NCT01218659|20603088|P2|COMPLETED|18-Month Randomized Period||18
8358203|NCT01218659|20603089|P1|COMPLETED|18-Month Randomized Period||34
8358204|NCT01218659|20603087|P3|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
8358205|NCT01218659|20603088|P2|Safety Population|18-Month Randomized Period||21
8358206|NCT01218659|20603089|P1|Safety Population|18-Month Randomized Period||36
8358207|NCT01218659|20603087|P3|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
8358208|NCT01218659|20603088|P2|STARTED|18-Month Randomized Period||24
8358209|NCT01218659|20603089|P1|STARTED|18-Month Randomized Period||36
8358210|NCT01218646|20603104|P4|NOT COMPLETED|Overall Study||1
8358211|NCT01218646|20603105|P3|NOT COMPLETED|Overall Study||2
8358212|NCT01218646|20603106|P2|NOT COMPLETED|Overall Study||0
8358213|NCT01218646|20603107|P1|NOT COMPLETED|Overall Study||1
8358214|NCT01218646|20603104|P4|COMPLETED|Overall Study||63
8358215|NCT01218646|20603105|P3|COMPLETED|Overall Study||223
8358216|NCT01218646|20603106|P2|COMPLETED|Overall Study||225
8358217|NCT01218646|20603107|P1|COMPLETED|Overall Study||224
8358218|NCT01218646|20603104|P4|STARTED|Overall Study||64
8358219|NCT01218646|20603105|P3|STARTED|Overall Study||225
8358220|NCT01218646|20603106|P2|STARTED|Overall Study||225
8358221|NCT01218646|20603107|P1|STARTED|Overall Study||225
8358222|NCT01218594|20603145|P1|NOT COMPLETED|Overall Study||12
8358223|NCT01218594|20603145|P1|COMPLETED|Overall Study||36
8358224|NCT01218594|20603145|P1|STARTED|Overall Study||48
8358225|NCT01218516|20603151|P4|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
8358226|NCT01218516|20603152|P3|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
8358227|NCT01218516|20603153|P2|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
8358228|NCT01218516|20603154|P1|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
8358229|NCT01218516|20603151|P4|COMPLETED|Monotherapy (up to 23.5 Months)||28
8358230|NCT01218516|20603152|P3|COMPLETED|Monotherapy (up to 23.5 Months)||38
8358231|NCT01218516|20603153|P2|COMPLETED|Monotherapy (up to 23.5 Months)||0
8358232|NCT01218516|20603154|P1|COMPLETED|Monotherapy (up to 23.5 Months)||0
8358233|NCT01218516|20603151|P4|Safety Analysis Set|Monotherapy (up to 23.5 Months)|Three participants were randomized to placebo but actually received Farletuzumab.|31
8358234|NCT01218516|20603152|P3|Safety Analysis Set|Monotherapy (up to 23.5 Months)||35
8358235|NCT01218516|20603153|P2|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
8358236|NCT01218516|20603154|P1|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
8358237|NCT01218516|20603151|P4|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|28
8358238|NCT01218516|20603152|P3|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|38
8358239|NCT01218516|20603153|P2|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
8358240|NCT01218516|20603154|P1|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
8358241|NCT01218516|20603151|P4|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
8358242|NCT01218516|20603152|P3|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
8358243|NCT01218516|20603153|P2|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||35
8358244|NCT01218516|20603154|P1|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||29
8358245|NCT01218516|20603151|P4|COMPLETED|Combination Therapy (up to 4.5 Months)||0
8358246|NCT01218516|20603152|P3|COMPLETED|Combination Therapy (up to 4.5 Months)||0
8358247|NCT01218516|20603153|P2|COMPLETED|Combination Therapy (up to 4.5 Months)||28
8358248|NCT01218516|20603154|P1|COMPLETED|Combination Therapy (up to 4.5 Months)||38
8358249|NCT01218516|20603151|P4|STARTED|Combination Therapy (up to 4.5 Months)||0
8358250|NCT01218516|20603152|P3|STARTED|Combination Therapy (up to 4.5 Months)||0
8358251|NCT01218516|20603153|P2|STARTED|Combination Therapy (up to 4.5 Months)||63
8358252|NCT01218516|20603154|P1|STARTED|Combination Therapy (up to 4.5 Months)||67
8358253|NCT01218477|20603176|P4|NOT COMPLETED|Overall Study||2
8358254|NCT01218477|20603177|P3|NOT COMPLETED|Overall Study||14
8358255|NCT01218477|20603178|P2|NOT COMPLETED|Overall Study||8
8358256|NCT01218477|20603179|P1|NOT COMPLETED|Overall Study||3
8358257|NCT01218477|20603176|P4|COMPLETED|Overall Study|Still receiving study drug|0
8358258|NCT01218477|20603177|P3|COMPLETED|Overall Study|Still receiving study drug|0
8358259|NCT01218477|20603178|P2|COMPLETED|Overall Study|Still receiving study drug|0
8358260|NCT01218477|20603179|P1|COMPLETED|Overall Study|Still receiving study drug|0
8358261|NCT01218477|20603176|P4|STARTED|Overall Study|Participants who received treatment|2
8358262|NCT01218477|20603177|P3|STARTED|Overall Study|Participants who received treatment|14
8358263|NCT01218477|20603178|P2|STARTED|Overall Study|Participants who received treatment|8
8358264|NCT01218477|20603179|P1|STARTED|Overall Study|Participants who received treatment|3
8358277|NCT01218399|20603351|P2|NOT COMPLETED|Overall Study||0
8358278|NCT01218399|20603352|P1|NOT COMPLETED|Overall Study||0
8358279|NCT01218399|20603351|P2|COMPLETED|Overall Study||5
8358280|NCT01218399|20603352|P1|COMPLETED|Overall Study||5
8358281|NCT01218399|20603351|P2|STARTED|Overall Study||5
8358282|NCT01218399|20603352|P1|STARTED|Overall Study||5
8358283|NCT01218308|20603362|P2|NOT COMPLETED|Overall Study||120
8358284|NCT01218308|20603363|P1|NOT COMPLETED|Overall Study||103
8358285|NCT01218308|20603362|P2|COMPLETED|Overall Study||2464
8358286|NCT01218308|20603363|P1|COMPLETED|Overall Study||2481
8358287|NCT01218308|20603362|P2|STARTED|Overall Study||2584
8358288|NCT01218308|20603363|P1|STARTED|Overall Study||2584
8358289|NCT01218243|20603407|P2|NOT COMPLETED|Overall Study||14
8358290|NCT01218243|20603408|P1|NOT COMPLETED|Overall Study||9
8358291|NCT01218243|20603407|P2|COMPLETED|Overall Study||36
8358292|NCT01218243|20603408|P1|COMPLETED|Overall Study||41
8358293|NCT01218243|20603407|P2|Treatment Completed|Overall Study||42
8358294|NCT01218243|20603408|P1|Treatment Completed|Overall Study||45
8358295|NCT01218243|20603407|P2|STARTED|Overall Study||50
8358296|NCT01218243|20603408|P1|STARTED|Overall Study||50
8358297|NCT01218204|20603424|P4|NOT COMPLETED|Part B Pooled Treatment Arm||3
8358298|NCT01218204|20603425|P3|NOT COMPLETED|Part B Pooled Treatment Arm||0
8358299|NCT01218204|20603426|P2|NOT COMPLETED|Part B Pooled Treatment Arm||0
8358300|NCT01218204|20603427|P1|NOT COMPLETED|Part B Pooled Treatment Arm||0
8358301|NCT01218204|20603424|P4|COMPLETED|Part B Pooled Treatment Arm||127
8358302|NCT01218204|20603425|P3|COMPLETED|Part B Pooled Treatment Arm||0
8358303|NCT01218204|20603426|P2|COMPLETED|Part B Pooled Treatment Arm||0
8358304|NCT01218204|20603427|P1|COMPLETED|Part B Pooled Treatment Arm||0
8358305|NCT01218204|20603424|P4|STARTED|Part B Pooled Treatment Arm||130
8358306|NCT01218204|20603425|P3|STARTED|Part B Pooled Treatment Arm||0
8358307|NCT01218204|20603426|P2|STARTED|Part B Pooled Treatment Arm||0
8358308|NCT01218204|20603427|P1|STARTED|Part B Pooled Treatment Arm||0
8358309|NCT01218204|20603424|P4|NOT COMPLETED|Part B Run-in||0
8358310|NCT01218204|20603425|P3|NOT COMPLETED|Part B Run-in||6
8358311|NCT01218204|20603426|P2|NOT COMPLETED|Part B Run-in||0
8358312|NCT01218204|20603427|P1|NOT COMPLETED|Part B Run-in||0
8358313|NCT01218204|20603424|P4|COMPLETED|Part B Run-in||0
8358314|NCT01218204|20603425|P3|COMPLETED|Part B Run-in||83
8358315|NCT01218204|20603426|P2|COMPLETED|Part B Run-in||0
8358316|NCT01218204|20603427|P1|COMPLETED|Part B Run-in||0
8358317|NCT01218204|20603424|P4|STARTED|Part B Run-in||0
8358318|NCT01218204|20603425|P3|STARTED|Part B Run-in||89
8358319|NCT01218204|20603426|P2|STARTED|Part B Run-in||0
8358320|NCT01218204|20603427|P1|STARTED|Part B Run-in||0
8358321|NCT01218204|20603424|P4|NOT COMPLETED|Part B Washout||0
8358322|NCT01218204|20603425|P3|NOT COMPLETED|Part B Washout||0
8358323|NCT01218204|20603426|P2|NOT COMPLETED|Part B Washout||145
8358324|NCT01218204|20603427|P1|NOT COMPLETED|Part B Washout||0
8358325|NCT01218204|20603424|P4|COMPLETED|Part B Washout||0
8358326|NCT01218204|20603425|P3|COMPLETED|Part B Washout||0
8358327|NCT01218204|20603426|P2|COMPLETED|Part B Washout||136
8358328|NCT01218204|20603427|P1|COMPLETED|Part B Washout||0
8358329|NCT01218204|20603424|P4|STARTED|Part B Washout||0
8358330|NCT01218204|20603425|P3|STARTED|Part B Washout||0
8358331|NCT01218204|20603426|P2|STARTED|Part B Washout||281
8358332|NCT01218204|20603427|P1|STARTED|Part B Washout||0
8358333|NCT01218204|20603424|P4|NOT COMPLETED|Part A||0
8358334|NCT01218204|20603425|P3|NOT COMPLETED|Part A||0
8358335|NCT01218204|20603426|P2|NOT COMPLETED|Part A||0
8358336|NCT01218204|20603427|P1|NOT COMPLETED|Part A||0
8358337|NCT01218204|20603424|P4|COMPLETED|Part A||0
8358338|NCT01218204|20603425|P3|COMPLETED|Part A||0
8358339|NCT01218204|20603426|P2|COMPLETED|Part A||0
8358340|NCT01218204|20603427|P1|COMPLETED|Part A||6
8358341|NCT01218204|20603424|P4|STARTED|Part A||0
8358342|NCT01218204|20603425|P3|STARTED|Part A||0
8358343|NCT01218204|20603426|P2|STARTED|Part A||0
8358344|NCT01218204|20603427|P1|STARTED|Part A||6
8358345|NCT01218126|20603691|P4|NOT COMPLETED|Overall Study||35
8358346|NCT01218126|20603692|P3|NOT COMPLETED|Overall Study||24
8358347|NCT01218126|20603693|P2|NOT COMPLETED|Overall Study||22
8358348|NCT01218126|20603694|P1|NOT COMPLETED|Overall Study||24
8358349|NCT01218126|20603691|P4|COMPLETED|Overall Study||114
8358350|NCT01218126|20603692|P3|COMPLETED|Overall Study||127
8358351|NCT01218126|20603693|P2|COMPLETED|Overall Study||127
8358352|NCT01218126|20603694|P1|COMPLETED|Overall Study||129
8358353|NCT01218126|20603691|P4|STARTED|Overall Study||149
8358354|NCT01218126|20603692|P3|STARTED|Overall Study||151
8358355|NCT01218126|20603693|P2|STARTED|Overall Study||149
8358356|NCT01218126|20603694|P1|STARTED|Overall Study||153
8358357|NCT01218113|20603735|P3|NOT COMPLETED|Overall Study||6
8358358|NCT01218113|20603736|P2|NOT COMPLETED|Overall Study||1
8358359|NCT01218113|20603737|P1|NOT COMPLETED|Overall Study||5
8358360|NCT01218113|20603735|P3|COMPLETED|Overall Study||58
8358361|NCT01218113|20603736|P2|COMPLETED|Overall Study||63
8358362|NCT01218113|20603737|P1|COMPLETED|Overall Study||57
8358363|NCT01218113|20603735|P3|STARTED|Overall Study||64
8358364|NCT01218113|20603736|P2|STARTED|Overall Study||64
8358365|NCT01218113|20603737|P1|STARTED|Overall Study||62
8358366|NCT01218100|20603918|P4|NOT COMPLETED|Overall Study||34
8358367|NCT01218100|20603919|P3|NOT COMPLETED|Overall Study||27
8358368|NCT01218100|20603920|P2|NOT COMPLETED|Overall Study||25
8358369|NCT01218100|20603921|P1|NOT COMPLETED|Overall Study||24
8358370|NCT01218100|20603918|P4|COMPLETED|Overall Study||156
8358371|NCT01218100|20603919|P3|COMPLETED|Overall Study||162
8358372|NCT01218100|20603920|P2|COMPLETED|Overall Study||165
8358373|NCT01218100|20603921|P1|COMPLETED|Overall Study||71
8358374|NCT01218100|20603918|P4|STARTED|Overall Study||190
8358375|NCT01218100|20603919|P3|STARTED|Overall Study||189
8358376|NCT01218100|20603920|P2|STARTED|Overall Study||190
8358377|NCT01218100|20603921|P1|STARTED|Overall Study||95
8358378|NCT01218087|20603937|P2|NOT COMPLETED|Overall Study||6
8358379|NCT01218087|20603938|P1|NOT COMPLETED|Overall Study||15
8358380|NCT01218087|20603937|P2|COMPLETED|Overall Study||35
8358381|NCT01218087|20603938|P1|COMPLETED|Overall Study||27
8358382|NCT01218087|20603937|P2|STARTED|Overall Study||41
8358383|NCT01218087|20603938|P1|STARTED|Overall Study||42
8358384|NCT01218048|20603946|P1|NOT COMPLETED|Overall Study||0
8358385|NCT01218048|20603946|P1|COMPLETED|Overall Study||40
8358386|NCT01218048|20603946|P1|STARTED|Overall Study||40
8358387|NCT01218009|20603960|P2|NOT COMPLETED|Overall Study||165
8358388|NCT01218009|20603961|P1|NOT COMPLETED|Overall Study||166
8358389|NCT01218009|20603960|P2|COMPLETED|Overall Study||0
8358390|NCT01218009|20603961|P1|COMPLETED|Overall Study||0
8358391|NCT01218009|20603960|P2|STARTED|Overall Study||165
8358392|NCT01218009|20603961|P1|STARTED|Overall Study||166
8358393|NCT01217957|20603984|P5|NOT COMPLETED|Phase 2||1
8358394|NCT01217957|20603985|P4|NOT COMPLETED|Phase 2||0
8358395|NCT01217957|20603986|P3|NOT COMPLETED|Phase 2||0
8358396|NCT01217957|20603987|P2|NOT COMPLETED|Phase 2||0
8358397|NCT01217957|20603988|P1|NOT COMPLETED|Phase 2||0
8358398|NCT01217957|20603984|P5|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
8358399|NCT01217957|20603985|P4|COMPLETED|Phase 2||0
8358400|NCT01217957|20603986|P3|COMPLETED|Phase 2||0
8358401|NCT01217957|20603987|P2|COMPLETED|Phase 2||0
8358402|NCT01217957|20603988|P1|COMPLETED|Phase 2||0
8358403|NCT01217957|20603984|P5|STARTED|Phase 2||50
8358404|NCT01217957|20603985|P4|STARTED|Phase 2||0
8358405|NCT01217957|20603986|P3|STARTED|Phase 2||0
8358406|NCT01217957|20603987|P2|STARTED|Phase 2||0
8358407|NCT01217957|20603988|P1|STARTED|Phase 2||0
8358408|NCT01217957|20603984|P5|NOT COMPLETED|Phase 1||0
8358409|NCT01217957|20603985|P4|NOT COMPLETED|Phase 1||1
8358410|NCT01217957|20603986|P3|NOT COMPLETED|Phase 1||1
8358411|NCT01217957|20603987|P2|NOT COMPLETED|Phase 1||0
8358412|NCT01217957|20603988|P1|NOT COMPLETED|Phase 1||1
8358413|NCT01217957|20603984|P5|COMPLETED|Phase 1||0
8358414|NCT01217957|20603985|P4|COMPLETED|Phase 1||2
8358415|NCT01217957|20603986|P3|COMPLETED|Phase 1||5
8358416|NCT01217957|20603987|P2|COMPLETED|Phase 1||3
8358417|NCT01217957|20603988|P1|COMPLETED|Phase 1||2
8358418|NCT01217957|20603984|P5|STARTED|Phase 1||0
8358419|NCT01217957|20603985|P4|STARTED|Phase 1||3
8358420|NCT01217957|20603986|P3|STARTED|Phase 1||6
8358421|NCT01217957|20603987|P2|STARTED|Phase 1||3
8358422|NCT01217957|20603988|P1|STARTED|Phase 1||3
8358423|NCT01217944|20604047|P3|NOT COMPLETED|Overall Study||0
8358424|NCT01217944|20604048|P2|NOT COMPLETED|Overall Study||4
8358425|NCT01217944|20604049|P1|NOT COMPLETED|Overall Study||6
8358426|NCT01217944|20604047|P3|COMPLETED|Overall Study||55
8358427|NCT01217944|20604048|P2|COMPLETED|Overall Study||112
8358428|NCT01217944|20604049|P1|COMPLETED|Overall Study||100
8358429|NCT01217944|20604047|P3|Completed 6 Months|Overall Study||55
8358430|NCT01217944|20604048|P2|Completed 6 Months|Overall Study||116
8358431|NCT01217944|20604049|P1|Completed 6 Months|Overall Study||103
8358432|NCT01217944|20604047|P3|Completed 3 Months|Overall Study||55
8358433|NCT01217944|20604048|P2|Completed 3 Months|Overall Study||116
8358434|NCT01217944|20604049|P1|Completed 3 Months|Overall Study||105
8358435|NCT01217944|20604047|P3|STARTED|Overall Study||55
8358436|NCT01217944|20604048|P2|STARTED|Overall Study||116
8358437|NCT01217944|20604049|P1|STARTED|Overall Study||106
8358438|NCT01217892|20604092|P4|NOT COMPLETED|Overall Study||8
8358439|NCT01217892|20604093|P3|NOT COMPLETED|Overall Study||9
8358440|NCT01217892|20604094|P2|NOT COMPLETED|Overall Study||6
8358441|NCT01217892|20604095|P1|NOT COMPLETED|Overall Study||7
8358442|NCT01217892|20604092|P4|COMPLETED|Overall Study||93
8358443|NCT01217892|20604093|P3|COMPLETED|Overall Study||90
8358444|NCT01217892|20604094|P2|COMPLETED|Overall Study||94
8358445|NCT01217892|20604095|P1|COMPLETED|Overall Study||93
8358446|NCT01217892|20604092|P4|STARTED|Overall Study||101
8358447|NCT01217892|20604093|P3|STARTED|Overall Study||99
8358448|NCT01217892|20604094|P2|STARTED|Overall Study||100
8358449|NCT01217892|20604095|P1|STARTED|Overall Study||100
8358450|NCT01217840|20604123|P2|NOT COMPLETED|Overall Study||3
8358451|NCT01217840|20604124|P1|NOT COMPLETED|Overall Study||6
8358452|NCT01217840|20604123|P2|COMPLETED|Overall Study||17
8358453|NCT01217840|20604124|P1|COMPLETED|Overall Study||14
8358454|NCT01217840|20604123|P2|STARTED|Overall Study||20
8358455|NCT01217840|20604124|P1|STARTED|Overall Study||20
8358462|NCT01217814|20604158|P3|NOT COMPLETED|Overall Study||1
8358463|NCT01217814|20604159|P2|NOT COMPLETED|Overall Study||1
8358464|NCT01217814|20604160|P1|NOT COMPLETED|Overall Study||1
8358465|NCT01217814|20604158|P3|COMPLETED|Overall Study||6
8358466|NCT01217814|20604159|P2|COMPLETED|Overall Study||4
8358467|NCT01217814|20604160|P1|COMPLETED|Overall Study||3
8358468|NCT01217814|20604158|P3|STARTED|Overall Study||7
8358469|NCT01217814|20604159|P2|STARTED|Overall Study||5
8358470|NCT01217814|20604160|P1|STARTED|Overall Study||4
8358471|NCT01217801|20604186|P2|NOT COMPLETED|Period 2||0
8358472|NCT01217801|20604187|P1|NOT COMPLETED|Period 2||0
8358473|NCT01217801|20604186|P2|COMPLETED|Period 2||22
8358474|NCT01217801|20604187|P1|COMPLETED|Period 2||23
8358475|NCT01217801|20604186|P2|STARTED|Period 2||22
8358476|NCT01217801|20604187|P1|STARTED|Period 2||23
8358477|NCT01217801|20604186|P2|NOT COMPLETED|Period 1||2
8358478|NCT01217801|20604187|P1|NOT COMPLETED|Period 1||1
8358479|NCT01217801|20604186|P2|COMPLETED|Period 1||22
8358480|NCT01217801|20604187|P1|COMPLETED|Period 1||23
8358481|NCT01217801|20604186|P2|STARTED|Period 1||24
8358482|NCT01217801|20604187|P1|STARTED|Period 1||24
8358483|NCT01217749|20604196|P3|NOT COMPLETED|Overall Study||2
8358484|NCT01217749|20604197|P2|NOT COMPLETED|Overall Study||3
8358485|NCT01217749|20604198|P1|NOT COMPLETED|Overall Study||3
8358486|NCT01217749|20604196|P3|COMPLETED|Overall Study||22
8358487|NCT01217749|20604197|P2|COMPLETED|Overall Study||17
8358488|NCT01217749|20604198|P1|COMPLETED|Overall Study||24
8358489|NCT01217749|20604196|P3|STARTED|Overall Study||24
8358490|NCT01217749|20604197|P2|STARTED|Overall Study||20
8358491|NCT01217749|20604198|P1|STARTED|Overall Study||27
8358492|NCT01217606|20604216|P2|NOT COMPLETED|9-Month Masked Extension||11
8358493|NCT01217606|20604217|P1|NOT COMPLETED|9-Month Masked Extension||13
8358494|NCT01217606|20604216|P2|COMPLETED|9-Month Masked Extension||62
8358495|NCT01217606|20604217|P1|COMPLETED|9-Month Masked Extension||54
8358496|NCT01217606|20604216|P2|Not Enrolled in Masked Extension|9-Month Masked Extension||10
8358497|NCT01217606|20604217|P1|Not Enrolled in Masked Extension|9-Month Masked Extension||9
8358498|NCT01217606|20604216|P2|STARTED|9-Month Masked Extension||73
8358499|NCT01217606|20604217|P1|STARTED|9-Month Masked Extension||67
8358500|NCT01217606|20604216|P2|NOT COMPLETED|Initial Treatment Phase||12
8358501|NCT01217606|20604217|P1|NOT COMPLETED|Initial Treatment Phase||14
8358502|NCT01217606|20604216|P2|COMPLETED|Initial Treatment Phase||83
8358503|NCT01217606|20604217|P1|COMPLETED|Initial Treatment Phase||76
8358504|NCT01217606|20604216|P2|STARTED|Initial Treatment Phase||95
8358505|NCT01217606|20604217|P1|STARTED|Initial Treatment Phase||90
8358506|NCT01217515|20604230|P3|NOT COMPLETED|Overall Study||10
8358507|NCT01217515|20604231|P2|NOT COMPLETED|Overall Study||8
8358508|NCT01217515|20604232|P1|NOT COMPLETED|Overall Study||7
8358509|NCT01217515|20604230|P3|COMPLETED|Overall Study||145
8358510|NCT01217515|20604231|P2|COMPLETED|Overall Study||148
8358511|NCT01217515|20604232|P1|COMPLETED|Overall Study||147
8358512|NCT01217515|20604230|P3|STARTED|Overall Study||155
8358513|NCT01217515|20604231|P2|STARTED|Overall Study||156
8358514|NCT01217515|20604232|P1|STARTED|Overall Study||154
8358515|NCT01217476|20604248|P2|NOT COMPLETED|Overall Study||7
8358516|NCT01217476|20604249|P1|NOT COMPLETED|Overall Study||12
8358517|NCT01217476|20604248|P2|COMPLETED|Overall Study||95
8358518|NCT01217476|20604249|P1|COMPLETED|Overall Study||93
8358519|NCT01217476|20604248|P2|STARTED|Overall Study||102
8358520|NCT01217476|20604249|P1|STARTED|Overall Study||105
8358521|NCT01217463|20604259|P2|NOT COMPLETED|Overall Study||8
8358522|NCT01217463|20604260|P1|NOT COMPLETED|Overall Study||13
8358523|NCT01217463|20604259|P2|COMPLETED|Overall Study||94
8358524|NCT01217463|20604260|P1|COMPLETED|Overall Study||86
8358525|NCT01217463|20604259|P2|STARTED|Overall Study||102
8358526|NCT01217463|20604260|P1|STARTED|Overall Study||99
8358533|NCT01217411|20604283|P2|NOT COMPLETED|Overall Study||2
8358534|NCT01217411|20604284|P1|NOT COMPLETED|Overall Study||3
8358535|NCT01217411|20604283|P2|COMPLETED|Overall Study||0
8358536|NCT01217411|20604284|P1|COMPLETED|Overall Study||0
8358537|NCT01217411|20604283|P2|20mg|Overall Study||0
8358538|NCT01217411|20604284|P1|20mg|Overall Study||0
8358539|NCT01217411|20604283|P2|10mg|Overall Study||0
8358540|NCT01217411|20604284|P1|10mg|Overall Study||0
8358541|NCT01217411|20604283|P2|5mg|Overall Study||2
8358542|NCT01217411|20604284|P1|5mg|Overall Study||3
8358543|NCT01217411|20604283|P2|STARTED|Overall Study||2
8358544|NCT01217411|20604284|P1|STARTED|Overall Study||3
8358545|NCT01217385|20604292|P1|NOT COMPLETED|Overall Study||26
8358546|NCT01217385|20604292|P1|COMPLETED|Overall Study||34
8358547|NCT01217385|20604292|P1|STARTED|Overall Study||60
8358548|NCT01217307|20604304|P2|NOT COMPLETED|Overall Study||1
8358549|NCT01217307|20604305|P1|NOT COMPLETED|Overall Study||0
8358550|NCT01217307|20604304|P2|COMPLETED|Overall Study||188
8358551|NCT01217307|20604305|P1|COMPLETED|Overall Study||191
8358552|NCT01217307|20604304|P2|STARTED|Overall Study||189
8358553|NCT01217307|20604305|P1|STARTED|Overall Study||191
8358554|NCT01217229|20604311|P1|NOT COMPLETED|Overall Study||20
8358555|NCT01217229|20604311|P1|COMPLETED|Overall Study||0
8358556|NCT01217229|20604311|P1|STARTED|Overall Study||20
8358557|NCT01217190|20604320|P2|NOT COMPLETED|Second Dosing||2
8358558|NCT01217190|20604321|P1|NOT COMPLETED|Second Dosing||0
8358559|NCT01217190|20604320|P2|COMPLETED|Second Dosing|Two subjects withdrew for personal reasons (other than adverse event).|22
8358560|NCT01217190|20604321|P1|COMPLETED|Second Dosing||24
8358561|NCT01217190|20604320|P2|STARTED|Second Dosing||24
8358562|NCT01217190|20604321|P1|STARTED|Second Dosing||24
8358563|NCT01217190|20604320|P2|NOT COMPLETED|First Dosing||0
8358564|NCT01217190|20604321|P1|NOT COMPLETED|First Dosing||0
8358565|NCT01217190|20604320|P2|COMPLETED|First Dosing||24
8358566|NCT01217190|20604321|P1|COMPLETED|First Dosing||24
8358567|NCT01217190|20604320|P2|STARTED|First Dosing||24
8358568|NCT01217190|20604321|P1|STARTED|First Dosing||24
8358569|NCT01217112|20604336|P5|NOT COMPLETED|Overall Study||1
8358570|NCT01217112|20604337|P4|NOT COMPLETED|Overall Study||2
8358571|NCT01217112|20604338|P3|NOT COMPLETED|Overall Study||1
8358572|NCT01217112|20604339|P2|NOT COMPLETED|Overall Study||2
8358573|NCT01217112|20604340|P1|NOT COMPLETED|Overall Study||0
8358574|NCT01217112|20604336|P5|COMPLETED|Overall Study||13
8358575|NCT01217112|20604337|P4|COMPLETED|Overall Study||10
8358576|NCT01217112|20604338|P3|COMPLETED|Overall Study||12
8358577|NCT01217112|20604339|P2|COMPLETED|Overall Study||10
8358578|NCT01217112|20604340|P1|COMPLETED|Overall Study||11
8358579|NCT01217112|20604336|P5|STARTED|Overall Study||14
8358580|NCT01217112|20604337|P4|STARTED|Overall Study||12
8358581|NCT01217112|20604338|P3|STARTED|Overall Study||13
8358582|NCT01217112|20604339|P2|STARTED|Overall Study||12
8358583|NCT01217112|20604340|P1|STARTED|Overall Study||11
8358584|NCT01217073|20604573|P8|NOT COMPLETED|Extension Period||20
8358585|NCT01217073|20604574|P7|NOT COMPLETED|Extension Period||91
8358586|NCT01217073|20604575|P6|NOT COMPLETED|Extension Period||0
8358587|NCT01217073|20604576|P5|NOT COMPLETED|Extension Period||0
8358588|NCT01217073|20604577|P4|NOT COMPLETED|Extension Period||0
8358589|NCT01217073|20604578|P3|NOT COMPLETED|Extension Period||0
8358590|NCT01217073|20604579|P2|NOT COMPLETED|Extension Period||0
8358591|NCT01217073|20604580|P1|NOT COMPLETED|Extension Period||0
8358592|NCT01217073|20604573|P8|COMPLETED|Extension Period||60
8358593|NCT01217073|20604574|P7|COMPLETED|Extension Period||314
8358594|NCT01217073|20604575|P6|COMPLETED|Extension Period||0
8358595|NCT01217073|20604576|P5|COMPLETED|Extension Period||0
8358596|NCT01217073|20604577|P4|COMPLETED|Extension Period||0
8358597|NCT01217073|20604578|P3|COMPLETED|Extension Period||0
8358598|NCT01217073|20604579|P2|COMPLETED|Extension Period||0
8358599|NCT01217073|20604580|P1|COMPLETED|Extension Period||0
8358600|NCT01217073|20604573|P8|STARTED|Extension Period||80
8358601|NCT01217073|20604574|P7|STARTED|Extension Period||405
8358602|NCT01217073|20604575|P6|STARTED|Extension Period||0
8358603|NCT01217073|20604576|P5|STARTED|Extension Period||0
8358604|NCT01217073|20604577|P4|STARTED|Extension Period||0
8358605|NCT01217073|20604578|P3|STARTED|Extension Period||0
8358606|NCT01217073|20604579|P2|STARTED|Extension Period||0
8358607|NCT01217073|20604580|P1|STARTED|Extension Period||0
8358608|NCT01217073|20604573|P8|NOT COMPLETED|Base Period||0
8358609|NCT01217073|20604574|P7|NOT COMPLETED|Base Period||0
8358610|NCT01217073|20604575|P6|NOT COMPLETED|Base Period||9
8358611|NCT01217073|20604576|P5|NOT COMPLETED|Base Period||15
8358612|NCT01217073|20604577|P4|NOT COMPLETED|Base Period||2
8358613|NCT01217073|20604578|P3|NOT COMPLETED|Base Period||7
8358614|NCT01217073|20604579|P2|NOT COMPLETED|Base Period||5
8358615|NCT01217073|20604580|P1|NOT COMPLETED|Base Period||7
8358616|NCT01217073|20604573|P8|COMPLETED|Base Period||0
8358617|NCT01217073|20604574|P7|COMPLETED|Base Period||0
8358618|NCT01217073|20604575|P6|COMPLETED|Base Period||105
8358619|NCT01217073|20604576|P5|COMPLETED|Base Period||99
8358620|NCT01217073|20604577|P4|COMPLETED|Base Period||113
8358621|NCT01217073|20604578|P3|COMPLETED|Base Period||107
8358622|NCT01217073|20604579|P2|COMPLETED|Base Period||110
8358623|NCT01217073|20604580|P1|COMPLETED|Base Period||106
8358624|NCT01217073|20604573|P8|STARTED|Base Period||0
8358625|NCT01217073|20604574|P7|STARTED|Base Period||0
8358626|NCT01217073|20604575|P6|STARTED|Base Period||114
8358627|NCT01217073|20604576|P5|STARTED|Base Period||114
8358628|NCT01217073|20604577|P4|STARTED|Base Period||115
8358629|NCT01217073|20604578|P3|STARTED|Base Period||114
8358630|NCT01217073|20604579|P2|STARTED|Base Period||115
8358631|NCT01217073|20604580|P1|STARTED|Base Period||113
8358632|NCT01217047|20604652|P3|NOT COMPLETED|Overall Study||0
8358633|NCT01217047|20604653|P2|NOT COMPLETED|Overall Study||1
8358634|NCT01217047|20604654|P1|NOT COMPLETED|Overall Study||0
8358635|NCT01217047|20604652|P3|COMPLETED|Overall Study||3
8358636|NCT01217047|20604653|P2|COMPLETED|Overall Study||3
8358637|NCT01217047|20604654|P1|COMPLETED|Overall Study||3
8358638|NCT01217047|20604652|P3|STARTED|Overall Study||3
8358639|NCT01217047|20604653|P2|STARTED|Overall Study||4
8358640|NCT01217047|20604654|P1|STARTED|Overall Study||3
8358641|NCT01216943|20604695|P1|NOT COMPLETED|Overall Study||13
8358642|NCT01216943|20604695|P1|COMPLETED|Overall Study||113
8358643|NCT01216943|20604695|P1|STARTED|Overall Study||126
8358644|NCT01216761|20604699|P3|NOT COMPLETED|Overall Study||0
8358645|NCT01216761|20604700|P2|NOT COMPLETED|Overall Study||0
8358646|NCT01216761|20604701|P1|NOT COMPLETED|Overall Study||0
8358647|NCT01216761|20604699|P3|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
8358648|NCT01216761|20604700|P2|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
8358649|NCT01216761|20604701|P1|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
8358650|NCT01216761|20604699|P3|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
8358651|NCT01216761|20604700|P2|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
8358652|NCT01216761|20604701|P1|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
8358653|NCT01216748|20604709|P1|NOT COMPLETED|Overall Study||0
8358654|NCT01216748|20604709|P1|COMPLETED|Overall Study||10
8358655|NCT01216748|20604709|P1|Eucapnic Hyperventilation|Overall Study||10
8358656|NCT01216748|20604709|P1|Hypercapnic Hyperventilation|Overall Study||10
8358657|NCT01216748|20604709|P1|Hypocapnic Hyperventilation|Overall Study||10
8358658|NCT01216748|20604709|P1|Quiet Breathing|Overall Study||10
8358659|NCT01216748|20604709|P1|STARTED|Overall Study||10
8358660|NCT01216735|20604716|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8358661|NCT01216735|20604717|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8358662|NCT01216735|20604716|P2|COMPLETED|Second Intervention (3 Weeks)||7
8358663|NCT01216735|20604717|P1|COMPLETED|Second Intervention (3 Weeks)||8
8358664|NCT01216735|20604716|P2|STARTED|Second Intervention (3 Weeks)||7
8358665|NCT01216735|20604717|P1|STARTED|Second Intervention (3 Weeks)||8
8358666|NCT01216735|20604716|P2|NOT COMPLETED|Washout (3 Weeks)||0
8358667|NCT01216735|20604717|P1|NOT COMPLETED|Washout (3 Weeks)||0
8358668|NCT01216735|20604716|P2|COMPLETED|Washout (3 Weeks)||7
8358669|NCT01216735|20604717|P1|COMPLETED|Washout (3 Weeks)||8
8358670|NCT01216735|20604716|P2|STARTED|Washout (3 Weeks)||7
8358671|NCT01216735|20604717|P1|STARTED|Washout (3 Weeks)||8
8358672|NCT01216735|20604716|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
8358673|NCT01216735|20604717|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
8358674|NCT01216735|20604716|P2|COMPLETED|First Intervention (3 Weeks)||7
8358675|NCT01216735|20604717|P1|COMPLETED|First Intervention (3 Weeks)||8
8358676|NCT01216735|20604716|P2|STARTED|First Intervention (3 Weeks)||7
8358677|NCT01216735|20604717|P1|STARTED|First Intervention (3 Weeks)||8
8358678|NCT01216631|20604728|P3|NOT COMPLETED|Overall Study||0
8358679|NCT01216631|20604729|P2|NOT COMPLETED|Overall Study||0
8358680|NCT01216631|20604730|P1|NOT COMPLETED|Overall Study||0
8358681|NCT01216631|20604728|P3|COMPLETED|Overall Study||1
8358682|NCT01216631|20604729|P2|COMPLETED|Overall Study||0
8358683|NCT01216631|20604730|P1|COMPLETED|Overall Study||0
8358684|NCT01216631|20604728|P3|STARTED|Overall Study||1
8358685|NCT01216631|20604729|P2|STARTED|Overall Study||0
8358686|NCT01216631|20604730|P1|STARTED|Overall Study||0
8358687|NCT01216410|20604741|P3|NOT COMPLETED|Overall Study||3
8358688|NCT01216410|20604742|P2|NOT COMPLETED|Overall Study||1
8358689|NCT01216410|20604743|P1|NOT COMPLETED|Overall Study||2
8358690|NCT01216410|20604741|P3|COMPLETED|Overall Study||100
8358691|NCT01216410|20604742|P2|COMPLETED|Overall Study||99
8358692|NCT01216410|20604743|P1|COMPLETED|Overall Study||101
8358693|NCT01216410|20604741|P3|STARTED|Overall Study||103
8358694|NCT01216410|20604742|P2|STARTED|Overall Study||100
8358695|NCT01216410|20604743|P1|STARTED|Overall Study||103
8358696|NCT01216397|20604763|P2|NOT COMPLETED|Period 2||0
8358697|NCT01216397|20604764|P1|NOT COMPLETED|Period 2||0
8358698|NCT01216397|20604763|P2|COMPLETED|Period 2||20
8358699|NCT01216397|20604764|P1|COMPLETED|Period 2||20
8358700|NCT01216397|20604763|P2|STARTED|Period 2||20
8358701|NCT01216397|20604764|P1|STARTED|Period 2||20
8358702|NCT01216397|20604763|P2|NOT COMPLETED|Washout (35 Days)||0
8358703|NCT01216397|20604764|P1|NOT COMPLETED|Washout (35 Days)||0
8358704|NCT01216397|20604763|P2|COMPLETED|Washout (35 Days)||20
8358705|NCT01216397|20604764|P1|COMPLETED|Washout (35 Days)||20
8358706|NCT01216397|20604763|P2|STARTED|Washout (35 Days)||20
8358707|NCT01216397|20604764|P1|STARTED|Washout (35 Days)||20
8358708|NCT01216397|20604763|P2|NOT COMPLETED|Period 1||0
8358709|NCT01216397|20604764|P1|NOT COMPLETED|Period 1||0
8358710|NCT01216397|20604763|P2|COMPLETED|Period 1||20
8358711|NCT01216397|20604764|P1|COMPLETED|Period 1||20
8358712|NCT01216397|20604763|P2|STARTED|Period 1||20
8358713|NCT01216397|20604764|P1|STARTED|Period 1||20
8358714|NCT01216332|20604818|P2|NOT COMPLETED|Overall Study||0
8358715|NCT01216332|20604819|P1|NOT COMPLETED|Overall Study||4
8358716|NCT01216332|20604818|P2|COMPLETED|Overall Study||16
8358717|NCT01216332|20604819|P1|COMPLETED|Overall Study||30
8358718|NCT01216332|20604818|P2|STARTED|Overall Study||16
8358719|NCT01216332|20604819|P1|STARTED|Overall Study||34
8358720|NCT01216319|20604837|P1|NOT COMPLETED|Overall Study||4
8358721|NCT01216319|20604837|P1|COMPLETED|Overall Study||46
8358722|NCT01216319|20604837|P1|STARTED|Overall Study||50
8358723|NCT01216241|20604844|P2|NOT COMPLETED|Overall Study||0
8358724|NCT01216241|20604845|P1|NOT COMPLETED|Overall Study||0
8358725|NCT01216241|20604844|P2|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
8358726|NCT01216241|20604845|P1|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
8358727|NCT01216241|20604844|P2|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
8358728|NCT01216241|20604845|P1|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
8358729|NCT01216176|20604854|P3|NOT COMPLETED|Overall Study||1
8358730|NCT01216176|20604855|P2|NOT COMPLETED|Overall Study||8
8358731|NCT01216176|20604856|P1|NOT COMPLETED|Overall Study||0
8358732|NCT01216176|20604854|P3|COMPLETED|Overall Study||19
8358733|NCT01216176|20604855|P2|COMPLETED|Overall Study||31
8358734|NCT01216176|20604856|P1|COMPLETED|Overall Study||12
8358735|NCT01216176|20604854|P3|STARTED|Overall Study||20
8358736|NCT01216176|20604855|P2|STARTED|Overall Study||39
8358737|NCT01216176|20604856|P1|STARTED|Overall Study||12
8358738|NCT01216163|20604879|P3|NOT COMPLETED|Overall Study||0
8358739|NCT01216163|20604880|P2|NOT COMPLETED|Overall Study||1
8358740|NCT01216163|20604881|P1|NOT COMPLETED|Overall Study||1
8358741|NCT01216163|20604879|P3|COMPLETED|Overall Study||85
8358742|NCT01216163|20604880|P2|COMPLETED|Overall Study||87
8358743|NCT01216163|20604881|P1|COMPLETED|Overall Study||44
8358744|NCT01216163|20604879|P3|STARTED|Overall Study||85
8358745|NCT01216163|20604880|P2|STARTED|Overall Study||88
8358746|NCT01216163|20604881|P1|STARTED|Overall Study||45
8358747|NCT01216072|20604933|P2|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
8358748|NCT01216072|20604934|P1|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
8358749|NCT01216072|20604933|P2|COMPLETED|Open-Label Extension Period (3 Months)||181
8358750|NCT01216072|20604934|P1|COMPLETED|Open-Label Extension Period (3 Months)||0
8358751|NCT01216072|20604933|P2|Safety Set|Open-Label Extension Period (3 Months)||193
8358752|NCT01216072|20604934|P1|Safety Set|Open-Label Extension Period (3 Months)||0
8358753|NCT01216072|20604933|P2|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
8358754|NCT01216072|20604934|P1|STARTED|Open-Label Extension Period (3 Months)||0
8358755|NCT01216072|20604933|P2|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
8358756|NCT01216072|20604934|P1|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
8358757|NCT01216072|20604933|P2|COMPLETED|Open-Label Core Period ( 6 Months)||229
8358758|NCT01216072|20604934|P1|COMPLETED|Open-Label Core Period ( 6 Months)||714
8358759|NCT01216072|20604933|P2|Safety Set|Open-Label Core Period ( 6 Months)||245
8358760|NCT01216072|20604934|P1|Safety Set|Open-Label Core Period ( 6 Months)||783
8358761|NCT01216072|20604933|P2|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
8358762|NCT01216072|20604934|P1|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
8358763|NCT01216072|20604933|P2|STARTED|Open-Label Core Period ( 6 Months)||263
8358764|NCT01216072|20604934|P1|STARTED|Open-Label Core Period ( 6 Months)||790
8358765|NCT01215981|20604962|P2|NOT COMPLETED|Overall Study||1
8358766|NCT01215981|20604963|P1|NOT COMPLETED|Overall Study||2
8358767|NCT01215981|20604962|P2|COMPLETED|Overall Study||32
8358768|NCT01215981|20604963|P1|COMPLETED|Overall Study||33
8358769|NCT01215981|20604962|P2|STARTED|Overall Study||33
8358770|NCT01215981|20604963|P1|STARTED|Overall Study||35
8358771|NCT01215968|20604973|P2|NOT COMPLETED|Overall Study||7
8358772|NCT01215968|20604974|P1|NOT COMPLETED|Overall Study||2
8358773|NCT01215968|20604973|P2|COMPLETED|Overall Study||18
8358774|NCT01215968|20604974|P1|COMPLETED|Overall Study||11
8358775|NCT01215968|20604973|P2|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
8358776|NCT01215968|20604974|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
8358777|NCT01215968|20604973|P2|STARTED|Overall Study||25
8358778|NCT01215968|20604974|P1|STARTED|Overall Study||13
8358779|NCT01215955|20604994|P4|NOT COMPLETED|Overall Study||53
8358780|NCT01215955|20604995|P3|NOT COMPLETED|Overall Study||48
8358781|NCT01215955|20604996|P2|NOT COMPLETED|Overall Study||53
8358782|NCT01215955|20604997|P1|NOT COMPLETED|Overall Study||45
8358783|NCT01215955|20604994|P4|COMPLETED|Overall Study||241
8358784|NCT01215955|20604995|P3|COMPLETED|Overall Study||244
8358785|NCT01215955|20604996|P2|COMPLETED|Overall Study||210
8358786|NCT01215955|20604997|P1|COMPLETED|Overall Study||223
8358787|NCT01215955|20604994|P4|Received at Least 1 Dose of Study Drug|Overall Study||290
8358788|NCT01215955|20604995|P3|Received at Least 1 Dose of Study Drug|Overall Study||288
8358789|NCT01215955|20604996|P2|Received at Least 1 Dose of Study Drug|Overall Study||261
8358790|NCT01215955|20604997|P1|Received at Least 1 Dose of Study Drug|Overall Study||267
8358791|NCT01215955|20604994|P4|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
8358792|NCT01215955|20604995|P3|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
8358793|NCT01215955|20604996|P2|STARTED|Overall Study||263
8358794|NCT01215955|20604997|P1|STARTED|Overall Study||268
8358795|NCT01215942|20605065|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||146
8358796|NCT01215942|20605066|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||85
8358797|NCT01215942|20605065|P2|COMPLETED|Post-Treatment Follow-Up Period||445
8358798|NCT01215942|20605066|P1|COMPLETED|Post-Treatment Follow-Up Period||283
8358799|NCT01215942|20605065|P2|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
8358800|NCT01215942|20605066|P1|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
8358801|NCT01215942|20605065|P2|NOT COMPLETED|Treatment Period||672
8358802|NCT01215942|20605066|P1|NOT COMPLETED|Treatment Period||414
8358803|NCT01215942|20605065|P2|COMPLETED|Treatment Period||0
8358804|NCT01215942|20605066|P1|COMPLETED|Treatment Period||0
8358805|NCT01215942|20605065|P2|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
8358806|NCT01215942|20605066|P1|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
8358807|NCT01215929|20605183|P2|NOT COMPLETED|Overall Study||5
8358808|NCT01215929|20605184|P1|NOT COMPLETED|Overall Study||6
8358809|NCT01215929|20605183|P2|COMPLETED|Overall Study||12
8358810|NCT01215929|20605184|P1|COMPLETED|Overall Study||12
8358811|NCT01215929|20605183|P2|STARTED|Overall Study||17
8358812|NCT01215929|20605184|P1|STARTED|Overall Study||18
8358813|NCT01215916|20605199|P9|NOT COMPLETED|Overall Study||2
8358814|NCT01215916|20605200|P8|NOT COMPLETED|Overall Study||3
8358815|NCT01215916|20605201|P7|NOT COMPLETED|Overall Study||9
8358816|NCT01215916|20605202|P6|NOT COMPLETED|Overall Study||4
8358817|NCT01215916|20605203|P5|NOT COMPLETED|Overall Study||6
8358818|NCT01215916|20605204|P4|NOT COMPLETED|Overall Study||6
8358819|NCT01215916|20605205|P3|NOT COMPLETED|Overall Study||3
8358820|NCT01215916|20605206|P2|NOT COMPLETED|Overall Study||5
8358821|NCT01215916|20605207|P1|NOT COMPLETED|Overall Study||1
8358822|NCT01215916|20605199|P9|COMPLETED|Overall Study||0
8358823|NCT01215916|20605200|P8|COMPLETED|Overall Study||0
8358824|NCT01215916|20605201|P7|COMPLETED|Overall Study||0
8358825|NCT01215916|20605202|P6|COMPLETED|Overall Study||0
8358826|NCT01215916|20605203|P5|COMPLETED|Overall Study||0
8358827|NCT01215916|20605204|P4|COMPLETED|Overall Study||0
8358828|NCT01215916|20605205|P3|COMPLETED|Overall Study||0
8358829|NCT01215916|20605206|P2|COMPLETED|Overall Study||0
8358830|NCT01215916|20605207|P1|COMPLETED|Overall Study||0
8358831|NCT01215916|20605199|P9|Received at Least 1 Dose of Either Drug|Overall Study||2
8358832|NCT01215916|20605200|P8|Received at Least 1 Dose of Either Drug|Overall Study||3
8358833|NCT01215916|20605201|P7|Received at Least 1 Dose of Either Drug|Overall Study||9
8358834|NCT01215916|20605202|P6|Received at Least 1 Dose of Either Drug|Overall Study||4
8358835|NCT01215916|20605203|P5|Received at Least 1 Dose of Either Drug|Overall Study||6
8358836|NCT01215916|20605204|P4|Received at Least 1 Dose of Either Drug|Overall Study||6
8358837|NCT01215916|20605205|P3|Received at Least 1 Dose of Either Drug|Overall Study||3
8358838|NCT01215916|20605206|P2|Received at Least 1 Dose of Either Drug|Overall Study||5
8358839|NCT01215916|20605207|P1|Received at Least 1 Dose of Either Drug|Overall Study||1
8358840|NCT01215916|20605199|P9|STARTED|Overall Study||2
8358841|NCT01215916|20605200|P8|STARTED|Overall Study||3
8358842|NCT01215916|20605201|P7|STARTED|Overall Study||9
8358843|NCT01215916|20605202|P6|STARTED|Overall Study||4
8358844|NCT01215916|20605203|P5|STARTED|Overall Study||6
8358845|NCT01215916|20605204|P4|STARTED|Overall Study||6
8358846|NCT01215916|20605205|P3|STARTED|Overall Study||3
8358847|NCT01215916|20605206|P2|STARTED|Overall Study||5
8358848|NCT01215916|20605207|P1|STARTED|Overall Study||1
8358849|NCT01215851|20605241|P6|NOT COMPLETED|Follow up Period||1
8358850|NCT01215851|20605242|P5|NOT COMPLETED|Follow up Period||0
8358851|NCT01215851|20605243|P4|NOT COMPLETED|Follow up Period||0
8358852|NCT01215851|20605244|P3|NOT COMPLETED|Follow up Period||0
8358853|NCT01215851|20605245|P2|NOT COMPLETED|Follow up Period||0
8358854|NCT01215851|20605246|P1|NOT COMPLETED|Follow up Period||0
8358855|NCT01215851|20605241|P6|COMPLETED|Follow up Period||13
8358856|NCT01215851|20605242|P5|COMPLETED|Follow up Period||10
8358857|NCT01215851|20605243|P4|COMPLETED|Follow up Period||12
8358858|NCT01215851|20605244|P3|COMPLETED|Follow up Period||14
8358859|NCT01215851|20605245|P2|COMPLETED|Follow up Period||14
8358860|NCT01215851|20605246|P1|COMPLETED|Follow up Period||14
8358861|NCT01215851|20605241|P6|STARTED|Follow up Period||14
8358862|NCT01215851|20605242|P5|STARTED|Follow up Period||10
8358863|NCT01215851|20605243|P4|STARTED|Follow up Period||12
8358864|NCT01215851|20605244|P3|STARTED|Follow up Period||14
8358865|NCT01215851|20605245|P2|STARTED|Follow up Period||14
8358866|NCT01215851|20605246|P1|STARTED|Follow up Period||14
8358867|NCT01215851|20605241|P6|NOT COMPLETED|Treatment Period||1
8358868|NCT01215851|20605242|P5|NOT COMPLETED|Treatment Period||0
8358869|NCT01215851|20605243|P4|NOT COMPLETED|Treatment Period||3
8358870|NCT01215851|20605244|P3|NOT COMPLETED|Treatment Period||1
8358871|NCT01215851|20605245|P2|NOT COMPLETED|Treatment Period||1
8358872|NCT01215851|20605246|P1|NOT COMPLETED|Treatment Period||1
8358873|NCT01215851|20605241|P6|COMPLETED|Treatment Period||14
8358874|NCT01215851|20605242|P5|COMPLETED|Treatment Period||10
8358875|NCT01215851|20605243|P4|COMPLETED|Treatment Period||12
8358876|NCT01215851|20605244|P3|COMPLETED|Treatment Period||14
8358877|NCT01215851|20605245|P2|COMPLETED|Treatment Period||14
8358878|NCT01215851|20605246|P1|COMPLETED|Treatment Period||14
8358879|NCT01215851|20605241|P6|STARTED|Treatment Period||15
8358880|NCT01215851|20605242|P5|STARTED|Treatment Period||10
8358881|NCT01215851|20605243|P4|STARTED|Treatment Period||15
8358882|NCT01215851|20605244|P3|STARTED|Treatment Period||15
8358883|NCT01215851|20605245|P2|STARTED|Treatment Period||15
8358884|NCT01215851|20605246|P1|STARTED|Treatment Period||15
8358885|NCT01215786|20605287|P3|NOT COMPLETED|Overall Study||0
8358886|NCT01215786|20605288|P2|NOT COMPLETED|Overall Study||0
8358887|NCT01215786|20605289|P1|NOT COMPLETED|Overall Study||0
8358888|NCT01215786|20605287|P3|COMPLETED|Overall Study||10
8358889|NCT01215786|20605288|P2|COMPLETED|Overall Study||19
8358890|NCT01215786|20605289|P1|COMPLETED|Overall Study||21
8358891|NCT01215786|20605287|P3|STARTED|Overall Study||10
8358892|NCT01215786|20605288|P2|STARTED|Overall Study||19
8358893|NCT01215786|20605289|P1|STARTED|Overall Study||21
8358894|NCT01215734|20605305|P2|NOT COMPLETED|Overall Study||1
8358895|NCT01215734|20605306|P1|NOT COMPLETED|Overall Study||0
8358896|NCT01215734|20605305|P2|COMPLETED|Overall Study||14
8358897|NCT01215734|20605306|P1|COMPLETED|Overall Study||29
8358898|NCT01215734|20605305|P2|STARTED|Overall Study||15
8358899|NCT01215734|20605306|P1|STARTED|Overall Study||29
8358900|NCT01215721|20605314|P1|NOT COMPLETED|Overall Study||2
8358901|NCT01215721|20605314|P1|COMPLETED|Overall Study||38
8358902|NCT01215721|20605314|P1|STARTED|Overall Study||40
8358903|NCT01215695|20605320|P2|NOT COMPLETED|Overall Study||0
8358904|NCT01215695|20605321|P1|NOT COMPLETED|Overall Study||0
8358905|NCT01215695|20605320|P2|COMPLETED|Overall Study||70
8358906|NCT01215695|20605321|P1|COMPLETED|Overall Study||70
8358907|NCT01215695|20605320|P2|STARTED|Overall Study||70
8358908|NCT01215695|20605321|P1|STARTED|Overall Study||70
8358909|NCT01215643|20605340|P5|NOT COMPLETED|Overall Study||11
8358910|NCT01215643|20605341|P4|NOT COMPLETED|Overall Study||4
8358911|NCT01215643|20605342|P3|NOT COMPLETED|Overall Study||12
8358912|NCT01215643|20605343|P2|NOT COMPLETED|Overall Study||4
8358913|NCT01215643|20605344|P1|NOT COMPLETED|Overall Study||9
8358914|NCT01215643|20605340|P5|COMPLETED|Overall Study||29
8358915|NCT01215643|20605341|P4|COMPLETED|Overall Study||35
8358916|NCT01215643|20605342|P3|COMPLETED|Overall Study||82
8358917|NCT01215643|20605343|P2|COMPLETED|Overall Study||80
8358918|NCT01215643|20605344|P1|COMPLETED|Overall Study||74
8358919|NCT01215643|20605340|P5|STARTED|Overall Study||40
8358920|NCT01215643|20605341|P4|STARTED|Overall Study||39
8358921|NCT01215643|20605342|P3|STARTED|Overall Study||94
8358922|NCT01215643|20605343|P2|STARTED|Overall Study||84
8358923|NCT01215643|20605344|P1|STARTED|Overall Study||83
8358924|NCT01215513|20605446|P1|NOT COMPLETED|Overall Study||45
8358925|NCT01215513|20605446|P1|COMPLETED|Overall Study||112
8358926|NCT01215513|20605446|P1|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
8358927|NCT01215513|20605446|P1|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
8358928|NCT01215513|20605446|P1|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
8358929|NCT01215513|20605446|P1|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
8358930|NCT01215435|20605455|P2|NOT COMPLETED|Overall Study||16
8358931|NCT01215435|20605456|P1|NOT COMPLETED|Overall Study||19
8358932|NCT01215435|20605455|P2|COMPLETED|Overall Study||107
8358933|NCT01215435|20605456|P1|COMPLETED|Overall Study||103
8358934|NCT01215435|20605455|P2|STARTED|Overall Study||123
8358935|NCT01215435|20605456|P1|STARTED|Overall Study||122
8358936|NCT01215422|20605470|P4|NOT COMPLETED|Overall Study||8
8358937|NCT01215422|20605471|P3|NOT COMPLETED|Overall Study||3
8358938|NCT01215422|20605472|P2|NOT COMPLETED|Overall Study||0
8358939|NCT01215422|20605473|P1|NOT COMPLETED|Overall Study||8
8358940|NCT01215422|20605470|P4|COMPLETED|Overall Study||193
8358941|NCT01215422|20605471|P3|COMPLETED|Overall Study||193
8358942|NCT01215422|20605472|P2|COMPLETED|Overall Study||249
8358943|NCT01215422|20605473|P1|COMPLETED|Overall Study||6
8358944|NCT01215422|20605470|P4|STARTED|Overall Study||201
8358945|NCT01215422|20605471|P3|STARTED|Overall Study||196
8358946|NCT01215422|20605472|P2|STARTED|Overall Study||249
8358947|NCT01215422|20605473|P1|STARTED|Overall Study||14
8358948|NCT01215357|20605495|P1|NOT COMPLETED|Overall Study||12
8358949|NCT01215357|20605495|P1|COMPLETED|Overall Study||22
8358950|NCT01215357|20605495|P1|STARTED|Overall Study||34
8358951|NCT01215344|20605501|P2|NOT COMPLETED|Overall Study||0
8358952|NCT01215344|20605502|P1|NOT COMPLETED|Overall Study||10
8358953|NCT01215344|20605501|P2|COMPLETED|Overall Study||3
8358954|NCT01215344|20605502|P1|COMPLETED|Overall Study||23
8358955|NCT01215344|20605501|P2|STARTED|Overall Study||3
8358956|NCT01215344|20605502|P1|STARTED|Overall Study||33
8358957|NCT01215318|20605512|P2|NOT COMPLETED|Overall Study||0
8358958|NCT01215318|20605513|P1|NOT COMPLETED|Overall Study||0
8358959|NCT01215318|20605512|P2|COMPLETED|Overall Study||24
8358960|NCT01215318|20605513|P1|COMPLETED|Overall Study||20
8358961|NCT01215318|20605512|P2|STARTED|Overall Study||24
8358962|NCT01215318|20605513|P1|STARTED|Overall Study||20
8358963|NCT01215292|20605526|P5|NOT COMPLETED|Overall Study||0
8358964|NCT01215292|20605527|P4|NOT COMPLETED|Overall Study||0
8358965|NCT01215292|20605528|P3|NOT COMPLETED|Overall Study||0
8358966|NCT01215292|20605529|P2|NOT COMPLETED|Overall Study||0
8358967|NCT01215292|20605530|P1|NOT COMPLETED|Overall Study||0
8358968|NCT01215292|20605526|P5|COMPLETED|Overall Study||8
8358969|NCT01215292|20605527|P4|COMPLETED|Overall Study||8
8358970|NCT01215292|20605528|P3|COMPLETED|Overall Study||8
8358971|NCT01215292|20605529|P2|COMPLETED|Overall Study||8
8358972|NCT01215292|20605530|P1|COMPLETED|Overall Study||8
8358973|NCT01215292|20605526|P5|STARTED|Overall Study||8
8358974|NCT01215292|20605527|P4|STARTED|Overall Study||8
8358975|NCT01215292|20605528|P3|STARTED|Overall Study||8
8358976|NCT01215292|20605529|P2|STARTED|Overall Study||8
8358977|NCT01215292|20605530|P1|STARTED|Overall Study||8
8358978|NCT01215279|20605554|P2|NOT COMPLETED|Overall Study||0
8358979|NCT01215279|20605555|P1|NOT COMPLETED|Overall Study||0
8358980|NCT01215279|20605554|P2|COMPLETED|Overall Study||32
8358981|NCT01215279|20605555|P1|COMPLETED|Overall Study||31
8358982|NCT01215279|20605554|P2|STARTED|Overall Study||32
8358983|NCT01215279|20605555|P1|STARTED|Overall Study||31
8358984|NCT01215253|20605621|P2|NOT COMPLETED|Overall Study||63
8358985|NCT01215253|20605622|P1|NOT COMPLETED|Overall Study||86
8358986|NCT01215253|20605621|P2|COMPLETED|Overall Study||439
8358987|NCT01215253|20605622|P1|COMPLETED|Overall Study||424
8358988|NCT01215253|20605621|P2|STARTED|Overall Study||502
8358989|NCT01215253|20605622|P1|STARTED|Overall Study||510
8358990|NCT01215240|20605652|P2|NOT COMPLETED|Overall Study||0
8358991|NCT01215240|20605653|P1|NOT COMPLETED|Overall Study||0
8358992|NCT01215240|20605652|P2|COMPLETED|Overall Study||12
8358993|NCT01215240|20605653|P1|COMPLETED|Overall Study||10
8358994|NCT01215240|20605652|P2|STARTED|Overall Study||12
8358995|NCT01215240|20605653|P1|STARTED|Overall Study||10
8358996|NCT01215227|20605675|P6|NOT COMPLETED|Overall Study||58
8358997|NCT01215227|20605676|P5|NOT COMPLETED|Overall Study||48
8358998|NCT01215227|20605677|P4|NOT COMPLETED|Overall Study||49
8358999|NCT01215227|20605678|P3|NOT COMPLETED|Overall Study||57
8359000|NCT01215227|20605679|P2|NOT COMPLETED|Overall Study||119
8359001|NCT01215227|20605680|P1|NOT COMPLETED|Overall Study||121
8359002|NCT01215227|20605675|P6|COMPLETED|Overall Study||51
8359003|NCT01215227|20605676|P5|COMPLETED|Overall Study||45
8359004|NCT01215227|20605677|P4|COMPLETED|Overall Study||48
8359005|NCT01215227|20605678|P3|COMPLETED|Overall Study||50
8359006|NCT01215227|20605679|P2|COMPLETED|Overall Study||96
8359007|NCT01215227|20605680|P1|COMPLETED|Overall Study||97
8359008|NCT01215227|20605675|P6|Treated|Overall Study||108
8359009|NCT01215227|20605676|P5|Treated|Overall Study||93
8359010|NCT01215227|20605677|P4|Treated|Overall Study||96
8359011|NCT01215227|20605678|P3|Treated|Overall Study||106
8359012|NCT01215227|20605679|P2|Treated|Overall Study||215
8359013|NCT01215227|20605680|P1|Treated|Overall Study||218
8359014|NCT01215227|20605675|P6|STARTED|Overall Study||109
8359015|NCT01215227|20605676|P5|STARTED|Overall Study||93
8359016|NCT01215227|20605677|P4|STARTED|Overall Study||97
8359017|NCT01215227|20605678|P3|STARTED|Overall Study||107
8359018|NCT01215227|20605679|P2|STARTED|Overall Study||215
8359019|NCT01215227|20605680|P1|STARTED|Overall Study||218
8359020|NCT01215188|20605727|P3|NOT COMPLETED|Overall Study||52
8359021|NCT01215188|20605728|P2|NOT COMPLETED|Overall Study||59
8359022|NCT01215188|20605729|P1|NOT COMPLETED|Overall Study||58
8359023|NCT01215188|20605727|P3|COMPLETED|Overall Study||326
8359024|NCT01215188|20605728|P2|COMPLETED|Overall Study||327
8359025|NCT01215188|20605729|P1|COMPLETED|Overall Study||320
8359026|NCT01215188|20605727|P3|STARTED|Overall Study||378
8359027|NCT01215188|20605728|P2|STARTED|Overall Study||386
8359028|NCT01215188|20605729|P1|STARTED|Overall Study||378
8359029|NCT01215175|20605781|P5|NOT COMPLETED|Overall Study||0
8359030|NCT01215175|20605782|P4|NOT COMPLETED|Overall Study||1
8359031|NCT01215175|20605783|P3|NOT COMPLETED|Overall Study||0
8359032|NCT01215175|20605784|P2|NOT COMPLETED|Overall Study||1
8359033|NCT01215175|20605785|P1|NOT COMPLETED|Overall Study||0
8359034|NCT01215175|20605781|P5|COMPLETED|Overall Study||28
8359035|NCT01215175|20605782|P4|COMPLETED|Overall Study||28
8359036|NCT01215175|20605783|P3|COMPLETED|Overall Study||33
8359037|NCT01215175|20605784|P2|COMPLETED|Overall Study||29
8359038|NCT01215175|20605785|P1|COMPLETED|Overall Study||30
8359039|NCT01215175|20605781|P5|Treated|Overall Study||28
8359040|NCT01215175|20605782|P4|Treated|Overall Study||29
8359041|NCT01215175|20605783|P3|Treated|Overall Study||33
8359042|NCT01215175|20605784|P2|Treated|Overall Study||30
8359043|NCT01215175|20605785|P1|Treated|Overall Study||30
8359044|NCT01215175|20605781|P5|STARTED|Overall Study||28
8359045|NCT01215175|20605782|P4|STARTED|Overall Study||29
8359046|NCT01215175|20605783|P3|STARTED|Overall Study||33
8359047|NCT01215175|20605784|P2|STARTED|Overall Study||30
8359048|NCT01215175|20605785|P1|STARTED|Overall Study||30
8359049|NCT01215123|20605827|P1|NOT COMPLETED|Overall Study||0
8359050|NCT01215123|20605827|P1|COMPLETED|Overall Study||28
8359051|NCT01215123|20605827|P1|STARTED|Overall Study||28
8359052|NCT01215110|20605837|P5|NOT COMPLETED|Overall Study||0
8359053|NCT01215110|20605838|P4|NOT COMPLETED|Overall Study||1
8359054|NCT01215110|20605839|P3|NOT COMPLETED|Overall Study||2
8359055|NCT01215110|20605840|P2|NOT COMPLETED|Overall Study||0
8359056|NCT01215110|20605841|P1|NOT COMPLETED|Overall Study||0
8359057|NCT01215110|20605837|P5|COMPLETED|Overall Study||8
8359058|NCT01215110|20605838|P4|COMPLETED|Overall Study||14
8359059|NCT01215110|20605839|P3|COMPLETED|Overall Study||13
8359060|NCT01215110|20605840|P2|COMPLETED|Overall Study||15
8359061|NCT01215110|20605841|P1|COMPLETED|Overall Study||15
8359062|NCT01215110|20605837|P5|STARTED|Overall Study||8
8359063|NCT01215110|20605838|P4|STARTED|Overall Study||15
8359064|NCT01215110|20605839|P3|STARTED|Overall Study||15
8359065|NCT01215110|20605840|P2|STARTED|Overall Study||15
8359066|NCT01215110|20605841|P1|STARTED|Overall Study||15
8359067|NCT01215097|20605902|P2|NOT COMPLETED|Overall Study||14
8359068|NCT01215097|20605903|P1|NOT COMPLETED|Overall Study||12
8359069|NCT01215097|20605902|P2|COMPLETED|Overall Study||191
8359070|NCT01215097|20605903|P1|COMPLETED|Overall Study||88
8359071|NCT01215097|20605902|P2|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
8359072|NCT01215097|20605903|P1|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
8359073|NCT01215032|20605935|P1|NOT COMPLETED|Overall Study||20
8359074|NCT01215032|20605935|P1|COMPLETED|Overall Study||1
8359075|NCT01215032|20605935|P1|STARTED|Overall Study||21
8359076|NCT01214980|20605945|P2|NOT COMPLETED|Overall Study||2
8359077|NCT01214980|20605946|P1|NOT COMPLETED|Overall Study||3
8359078|NCT01214980|20605945|P2|COMPLETED|Overall Study||14
8359079|NCT01214980|20605946|P1|COMPLETED|Overall Study||13
8359080|NCT01214980|20605945|P2|STARTED|Overall Study||16
8359081|NCT01214980|20605946|P1|STARTED|Overall Study||16
8359085|NCT01214850|20605971|P3|NOT COMPLETED|Overall Study||161
8359086|NCT01214850|20605972|P2|NOT COMPLETED|Overall Study||144
8359087|NCT01214850|20605973|P1|NOT COMPLETED|Overall Study||183
8359088|NCT01214850|20605971|P3|COMPLETED|Overall Study||826
8359089|NCT01214850|20605972|P2|COMPLETED|Overall Study||844
8359090|NCT01214850|20605973|P1|COMPLETED|Overall Study||796
8359091|NCT01214850|20605971|P3|STARTED|Overall Study||987
8359092|NCT01214850|20605972|P2|STARTED|Overall Study||988
8359093|NCT01214850|20605973|P1|STARTED|Overall Study||979
8359094|NCT01214837|20606057|P3|NOT COMPLETED|Overall Study||62
8359095|NCT01214837|20606058|P2|NOT COMPLETED|Overall Study||64
8359096|NCT01214837|20606059|P1|NOT COMPLETED|Overall Study||54
8359097|NCT01214837|20606057|P3|COMPLETED|Overall Study||184
8359098|NCT01214837|20606058|P2|COMPLETED|Overall Study||192
8359099|NCT01214837|20606059|P1|COMPLETED|Overall Study||195
8359100|NCT01214837|20606057|P3|STARTED|Overall Study||246
8359101|NCT01214837|20606058|P2|STARTED|Overall Study||256
8359102|NCT01214837|20606059|P1|STARTED|Overall Study||249
8359103|NCT01214824|20606096|P1|NOT COMPLETED|Overall Study||3
8359104|NCT01214824|20606096|P1|COMPLETED|Overall Study||29
8359105|NCT01214824|20606096|P1|STARTED|Overall Study||32
8359106|NCT01214811|20606103|P1|NOT COMPLETED|Overall Study||3
8359107|NCT01214811|20606103|P1|COMPLETED|Overall Study||24
8359108|NCT01214811|20606103|P1|STARTED|Overall Study||27
8359109|NCT01214759|20606107|P1|NOT COMPLETED|Overall Study||48
8359110|NCT01214759|20606107|P1|COMPLETED|Overall Study||55
8359111|NCT01214759|20606107|P1|28 Days nPEP Completion|Overall Study||85
8359112|NCT01214759|20606107|P1|STARTED|Overall Study||103
8359113|NCT01214720|20606115|P2|NOT COMPLETED|Overall Study||68
8359114|NCT01214720|20606116|P1|NOT COMPLETED|Overall Study||85
8359115|NCT01214720|20606115|P2|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
8359116|NCT01214720|20606116|P1|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
8359117|NCT01214720|20606115|P2|STARTED|Overall Study||301
8359118|NCT01214720|20606116|P1|STARTED|Overall Study||306
8359119|NCT01214668|20606139|P6|NOT COMPLETED|Overall Study||6
8359120|NCT01214668|20606140|P5|NOT COMPLETED|Overall Study||6
8359121|NCT01214668|20606141|P4|NOT COMPLETED|Overall Study||6
8359122|NCT01214668|20606142|P3|NOT COMPLETED|Overall Study||6
8359123|NCT01214668|20606143|P2|NOT COMPLETED|Overall Study||3
8359124|NCT01214668|20606144|P1|NOT COMPLETED|Overall Study||4
8359125|NCT01214668|20606139|P6|COMPLETED|Overall Study||0
8359126|NCT01214668|20606140|P5|COMPLETED|Overall Study||0
8359127|NCT01214668|20606141|P4|COMPLETED|Overall Study||0
8359128|NCT01214668|20606142|P3|COMPLETED|Overall Study||0
8359129|NCT01214668|20606143|P2|COMPLETED|Overall Study||0
8359130|NCT01214668|20606144|P1|COMPLETED|Overall Study||0
8359131|NCT01214668|20606139|P6|Received at Least One Dose of Study Drug|Overall Study||6
8359132|NCT01214668|20606140|P5|Received at Least One Dose of Study Drug|Overall Study||6
8359133|NCT01214668|20606141|P4|Received at Least One Dose of Study Drug|Overall Study||6
8359134|NCT01214668|20606142|P3|Received at Least One Dose of Study Drug|Overall Study||6
8359135|NCT01214668|20606143|P2|Received at Least One Dose of Study Drug|Overall Study||3
8359136|NCT01214668|20606144|P1|Received at Least One Dose of Study Drug|Overall Study||4
8359137|NCT01214668|20606139|P6|STARTED|Overall Study||6
8359138|NCT01214668|20606140|P5|STARTED|Overall Study||6
8359139|NCT01214668|20606141|P4|STARTED|Overall Study||6
8359140|NCT01214668|20606142|P3|STARTED|Overall Study||6
8359141|NCT01214668|20606143|P2|STARTED|Overall Study||3
8359142|NCT01214668|20606144|P1|STARTED|Overall Study||4
8359143|NCT01214655|20606181|P3|NOT COMPLETED|Part C||7
8359144|NCT01214655|20606182|P2|NOT COMPLETED|Part C||0
8359145|NCT01214655|20606183|P1|NOT COMPLETED|Part C||0
8359146|NCT01214655|20606181|P3|COMPLETED|Part C||1
8359147|NCT01214655|20606182|P2|COMPLETED|Part C||0
8359148|NCT01214655|20606183|P1|COMPLETED|Part C||0
8359149|NCT01214655|20606181|P3|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8
8359150|NCT01214655|20606182|P2|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
8359151|NCT01214655|20606183|P1|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
8359152|NCT01214655|20606181|P3|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8
8359153|NCT01214655|20606182|P2|STARTED|Part C||0
8359154|NCT01214655|20606183|P1|STARTED|Part C||0
8359155|NCT01214655|20606181|P3|NOT COMPLETED|Part B||0
8359156|NCT01214655|20606182|P2|NOT COMPLETED|Part B||13
8359157|NCT01214655|20606183|P1|NOT COMPLETED|Part B||0
8359158|NCT01214655|20606181|P3|COMPLETED|Part B||0
8359159|NCT01214655|20606182|P2|COMPLETED|Part B||2
8359160|NCT01214655|20606183|P1|COMPLETED|Part B||0
8359161|NCT01214655|20606181|P3|Joined 14 mg/m²/Day|Part B||0
8359162|NCT01214655|20606182|P2|Joined 14 mg/m²/Day|Part B||3
8359163|NCT01214655|20606183|P1|Joined 14 mg/m²/Day|Part B||0
8359164|NCT01214655|20606181|P3|Escalated From 12 to 14 mg/m²/Day|Part B||0
8359165|NCT01214655|20606182|P2|Escalated From 12 to 14 mg/m²/Day|Part B||1
8359166|NCT01214655|20606183|P1|Escalated From 12 to 14 mg/m²/Day|Part B||0
8359167|NCT01214655|20606181|P3|Joined 12 mg/m²/Day|Part B||0
8359168|NCT01214655|20606182|P2|Joined 12 mg/m²/Day|Part B||5
8359169|NCT01214655|20606183|P1|Joined 12 mg/m²/Day|Part B||0
8359170|NCT01214655|20606181|P3|Escalated to 12 mg/m²/Day|Part B||0
8359171|NCT01214655|20606182|P2|Escalated to 12 mg/m²/Day|Part B||2
8359172|NCT01214655|20606183|P1|Escalated to 12 mg/m²/Day|Part B||0
8359173|NCT01214655|20606181|P3|Joined 10 mg/m²/Day Study D|Part B||0
8359174|NCT01214655|20606182|P2|Joined 10 mg/m²/Day Study D|Part B||3
8359175|NCT01214655|20606183|P1|Joined 10 mg/m²/Day Study D|Part B||0
8359176|NCT01214655|20606181|P3|Escalated From 8 to 10 mg/m²/Day|Part B||0
8359177|NCT01214655|20606182|P2|Escalated From 8 to 10 mg/m²/Day|Part B||2
8359178|NCT01214655|20606183|P1|Escalated From 8 to 10 mg/m²/Day|Part B||0
8359179|NCT01214655|20606181|P3|Recieved 8 mg/m²/Day Study Drug|Part B||0
8359180|NCT01214655|20606182|P2|Recieved 8 mg/m²/Day Study Drug|Part B||4
8359181|NCT01214655|20606183|P1|Recieved 8 mg/m²/Day Study Drug|Part B||0
8359182|NCT01214655|20606181|P3|Received at Least 1 Dose of Study Drug|Part B||0
8359183|NCT01214655|20606182|P2|Received at Least 1 Dose of Study Drug|Part B||15
8359184|NCT01214655|20606183|P1|Received at Least 1 Dose of Study Drug|Part B||0
8359185|NCT01214655|20606181|P3|STARTED|Part B||0
8359186|NCT01214655|20606182|P2|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15
8359187|NCT01214655|20606183|P1|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0
8359188|NCT01214655|20606181|P3|NOT COMPLETED|Part A||0
8359189|NCT01214655|20606182|P2|NOT COMPLETED|Part A||0
8359190|NCT01214655|20606183|P1|NOT COMPLETED|Part A||8
8359191|NCT01214655|20606181|P3|COMPLETED|Part A||0
8359192|NCT01214655|20606182|P2|COMPLETED|Part A||0
8359193|NCT01214655|20606183|P1|COMPLETED|Part A||2
8359194|NCT01214655|20606181|P3|Received 6 mg Study Drug|Part A||0
8359195|NCT01214655|20606182|P2|Received 6 mg Study Drug|Part A||0
8359196|NCT01214655|20606183|P1|Received 6 mg Study Drug|Part A||5
8359197|NCT01214655|20606181|P3|Joined 6 mg Group|Part A||0
8359198|NCT01214655|20606182|P2|Joined 6 mg Group|Part A||0
8359199|NCT01214655|20606183|P1|Joined 6 mg Group|Part A||4
8359200|NCT01214655|20606181|P3|Escalated From 5 mg Study Drug|Part A||0
8359201|NCT01214655|20606182|P2|Escalated From 5 mg Study Drug|Part A||0
8359202|NCT01214655|20606183|P1|Escalated From 5 mg Study Drug|Part A||1
8359203|NCT01214655|20606181|P3|Joined 5 mg Study Drug|Part A||0
8359204|NCT01214655|20606182|P2|Joined 5 mg Study Drug|Part A||0
8359205|NCT01214655|20606183|P1|Joined 5 mg Study Drug|Part A||2
8359206|NCT01214655|20606181|P3|Escalated From 4 mg Study Drug|Part A||0
8359207|NCT01214655|20606182|P2|Escalated From 4 mg Study Drug|Part A||0
8359208|NCT01214655|20606183|P1|Escalated From 4 mg Study Drug|Part A||0
8359209|NCT01214655|20606181|P3|Joined 4 mg Group|Part A||0
8359210|NCT01214655|20606182|P2|Joined 4 mg Group|Part A||0
8359211|NCT01214655|20606183|P1|Joined 4 mg Group|Part A||1
8359212|NCT01214655|20606181|P3|Escalated From 2 to 4 mg/m²/Day|Part A||0
8359213|NCT01214655|20606182|P2|Escalated From 2 to 4 mg/m²/Day|Part A||0
8359214|NCT01214655|20606183|P1|Escalated From 2 to 4 mg/m²/Day|Part A||3
8359215|NCT01214655|20606181|P3|Received 2 mg Study Drug|Part A||0
8359216|NCT01214655|20606182|P2|Received 2 mg Study Drug|Part A||0
8359217|NCT01214655|20606183|P1|Received 2 mg Study Drug|Part A||3
8359218|NCT01214655|20606181|P3|STARTED|Part A||0
8359219|NCT01214655|20606182|P2|STARTED|Part A||0
8359220|NCT01214655|20606183|P1|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10
8359221|NCT01214642|20606256|P12|NOT COMPLETED|Overall Study||6
8359222|NCT01214642|20606257|P11|NOT COMPLETED|Overall Study||4
8359223|NCT01214642|20606258|P10|NOT COMPLETED|Overall Study||4
8359224|NCT01214642|20606259|P9|NOT COMPLETED|Overall Study||13
8359225|NCT01214642|20606260|P8|NOT COMPLETED|Overall Study||3
8359226|NCT01214642|20606261|P7|NOT COMPLETED|Overall Study||6
8359227|NCT01214642|20606262|P6|NOT COMPLETED|Overall Study||3
8359228|NCT01214642|20606263|P5|NOT COMPLETED|Overall Study||6
8359229|NCT01214642|20606264|P4|NOT COMPLETED|Overall Study||6
8359230|NCT01214642|20606265|P3|NOT COMPLETED|Overall Study||6
8359231|NCT01214642|20606266|P2|NOT COMPLETED|Overall Study||3
8359232|NCT01214642|20606267|P1|NOT COMPLETED|Overall Study||3
8359233|NCT01214642|20606256|P12|COMPLETED|Overall Study||0
8359234|NCT01214642|20606257|P11|COMPLETED|Overall Study||0
8359235|NCT01214642|20606258|P10|COMPLETED|Overall Study||0
8359236|NCT01214642|20606259|P9|COMPLETED|Overall Study||0
8359237|NCT01214642|20606260|P8|COMPLETED|Overall Study||0
8359238|NCT01214642|20606261|P7|COMPLETED|Overall Study||0
8359239|NCT01214642|20606262|P6|COMPLETED|Overall Study||0
8359240|NCT01214642|20606263|P5|COMPLETED|Overall Study||0
8359241|NCT01214642|20606264|P4|COMPLETED|Overall Study||0
8359242|NCT01214642|20606265|P3|COMPLETED|Overall Study||0
8359243|NCT01214642|20606266|P2|COMPLETED|Overall Study||0
8359244|NCT01214642|20606267|P1|COMPLETED|Overall Study||0
8359245|NCT01214642|20606256|P12|Complete at Least 2 Cycles of Study Drug|Overall Study||5
8359246|NCT01214642|20606257|P11|Complete at Least 2 Cycles of Study Drug|Overall Study||2
8359247|NCT01214642|20606258|P10|Complete at Least 2 Cycles of Study Drug|Overall Study||2
8359248|NCT01214642|20606259|P9|Complete at Least 2 Cycles of Study Drug|Overall Study||12
8359249|NCT01214642|20606260|P8|Complete at Least 2 Cycles of Study Drug|Overall Study||3
8359250|NCT01214642|20606261|P7|Complete at Least 2 Cycles of Study Drug|Overall Study||6
8359251|NCT01214642|20606262|P6|Complete at Least 2 Cycles of Study Drug|Overall Study||1
8359252|NCT01214642|20606263|P5|Complete at Least 2 Cycles of Study Drug|Overall Study||6
8359253|NCT01214642|20606264|P4|Complete at Least 2 Cycles of Study Drug|Overall Study||4
8359254|NCT01214642|20606265|P3|Complete at Least 2 Cycles of Study Drug|Overall Study||5
8359255|NCT01214642|20606266|P2|Complete at Least 2 Cycles of Study Drug|Overall Study||1
8359256|NCT01214642|20606267|P1|Complete at Least 2 Cycles of Study Drug|Overall Study||3
8359257|NCT01214642|20606256|P12|Received at Least 1 Dose of Study Drug|Overall Study||6
8359258|NCT01214642|20606257|P11|Received at Least 1 Dose of Study Drug|Overall Study||4
8359259|NCT01214642|20606258|P10|Received at Least 1 Dose of Study Drug|Overall Study||4
8359260|NCT01214642|20606259|P9|Received at Least 1 Dose of Study Drug|Overall Study||13
8359261|NCT01214642|20606260|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
8359262|NCT01214642|20606261|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
8359263|NCT01214642|20606262|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
8359264|NCT01214642|20606263|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8359265|NCT01214642|20606264|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8359266|NCT01214642|20606265|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8359267|NCT01214642|20606266|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8359268|NCT01214642|20606267|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8359269|NCT01214642|20606256|P12|STARTED|Overall Study||6
8359270|NCT01214642|20606257|P11|STARTED|Overall Study||4
8359271|NCT01214642|20606258|P10|STARTED|Overall Study||4
8359272|NCT01214642|20606259|P9|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
8359273|NCT01214642|20606260|P8|STARTED|Overall Study||3
8359274|NCT01214642|20606261|P7|STARTED|Overall Study||6
8359275|NCT01214642|20606262|P6|STARTED|Overall Study||3
8359276|NCT01214642|20606263|P5|STARTED|Overall Study||6
8359277|NCT01214642|20606264|P4|STARTED|Overall Study||6
8359278|NCT01214642|20606265|P3|STARTED|Overall Study||6
8359279|NCT01214642|20606266|P2|STARTED|Overall Study||3
8359280|NCT01214642|20606267|P1|STARTED|Overall Study||3
8359281|NCT01214629|20606347|P11|NOT COMPLETED|Overall Study||2
8359282|NCT01214629|20606348|P10|NOT COMPLETED|Overall Study||7
8359283|NCT01214629|20606349|P9|NOT COMPLETED|Overall Study||1
8359284|NCT01214629|20606350|P8|NOT COMPLETED|Overall Study||1
8359285|NCT01214629|20606351|P7|NOT COMPLETED|Overall Study||1
8359286|NCT01214629|20606352|P6|NOT COMPLETED|Overall Study||4
8359287|NCT01214629|20606353|P5|NOT COMPLETED|Overall Study||2
8359288|NCT01214629|20606354|P4|NOT COMPLETED|Overall Study||2
8359289|NCT01214629|20606355|P3|NOT COMPLETED|Overall Study||0
8359290|NCT01214629|20606356|P2|NOT COMPLETED|Overall Study||1
8359291|NCT01214629|20606357|P1|NOT COMPLETED|Overall Study||1
8359292|NCT01214629|20606347|P11|COMPLETED|Overall Study||1
8359293|NCT01214629|20606348|P10|COMPLETED|Overall Study||11
8359294|NCT01214629|20606349|P9|COMPLETED|Overall Study||2
8359295|NCT01214629|20606350|P8|COMPLETED|Overall Study||2
8359296|NCT01214629|20606351|P7|COMPLETED|Overall Study||4
8359297|NCT01214629|20606352|P6|COMPLETED|Overall Study||9
8359298|NCT01214629|20606353|P5|COMPLETED|Overall Study||1
8359299|NCT01214629|20606354|P4|COMPLETED|Overall Study||1
8359300|NCT01214629|20606355|P3|COMPLETED|Overall Study||1
8359301|NCT01214629|20606356|P2|COMPLETED|Overall Study||0
8359302|NCT01214629|20606357|P1|COMPLETED|Overall Study||0
8359303|NCT01214629|20606347|P11|Received at Least 1 Dose of Study Drug|Overall Study||3
8359304|NCT01214629|20606348|P10|Received at Least 1 Dose of Study Drug|Overall Study||18
8359305|NCT01214629|20606349|P9|Received at Least 1 Dose of Study Drug|Overall Study||3
8359306|NCT01214629|20606350|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
8359307|NCT01214629|20606351|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
8359308|NCT01214629|20606352|P6|Received at Least 1 Dose of Study Drug|Overall Study||13
8359309|NCT01214629|20606353|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
8359310|NCT01214629|20606354|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8359311|NCT01214629|20606355|P3|Received at Least 1 Dose of Study Drug|Overall Study||1
8359312|NCT01214629|20606356|P2|Received at Least 1 Dose of Study Drug|Overall Study||1
8359313|NCT01214629|20606357|P1|Received at Least 1 Dose of Study Drug|Overall Study||1
8359314|NCT01214629|20606347|P11|STARTED|Overall Study||3
8359315|NCT01214629|20606348|P10|STARTED|Overall Study||18
8359316|NCT01214629|20606349|P9|STARTED|Overall Study||3
8359317|NCT01214629|20606350|P8|STARTED|Overall Study||3
8359318|NCT01214629|20606351|P7|STARTED|Overall Study||5
8359319|NCT01214629|20606352|P6|STARTED|Overall Study||13
8359320|NCT01214629|20606353|P5|STARTED|Overall Study||3
8359321|NCT01214629|20606354|P4|STARTED|Overall Study||3
8359322|NCT01214629|20606355|P3|STARTED|Overall Study||1
8359323|NCT01214629|20606356|P2|STARTED|Overall Study||1
8359324|NCT01214629|20606357|P1|STARTED|Overall Study||1
8359325|NCT01214616|20606422|P4|NOT COMPLETED|Overall Study||6
8359326|NCT01214616|20606423|P3|NOT COMPLETED|Overall Study||3
8359327|NCT01214616|20606424|P2|NOT COMPLETED|Overall Study||5
8359328|NCT01214616|20606425|P1|NOT COMPLETED|Overall Study||3
8359329|NCT01214616|20606422|P4|COMPLETED|Overall Study||0
8359330|NCT01214616|20606423|P3|COMPLETED|Overall Study||0
8359331|NCT01214616|20606424|P2|COMPLETED|Overall Study||0
8359332|NCT01214616|20606425|P1|COMPLETED|Overall Study||0
8359333|NCT01214616|20606422|P4|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
8359334|NCT01214616|20606423|P3|STARTED|Overall Study||3
8359335|NCT01214616|20606424|P2|STARTED|Overall Study||5
8359336|NCT01214616|20606425|P1|STARTED|Overall Study||3
8359337|NCT01214603|20606462|P3|NOT COMPLETED|Overall Study||4
8359338|NCT01214603|20606463|P2|NOT COMPLETED|Overall Study||1
8359339|NCT01214603|20606464|P1|NOT COMPLETED|Overall Study||5
8359340|NCT01214603|20606462|P3|COMPLETED|Overall Study||3
8359341|NCT01214603|20606463|P2|COMPLETED|Overall Study||5
8359342|NCT01214603|20606464|P1|COMPLETED|Overall Study||2
8359343|NCT01214603|20606462|P3|Received at Least 1 Dose of LY2090314|Overall Study||7
8359344|NCT01214603|20606463|P2|Received at Least 1 Dose of LY2090314|Overall Study||6
8359345|NCT01214603|20606464|P1|Received at Least 1 Dose of LY2090314|Overall Study||7
8359346|NCT01214603|20606462|P3|STARTED|Overall Study||7
8359347|NCT01214603|20606463|P2|STARTED|Overall Study||6
8359348|NCT01214603|20606464|P1|STARTED|Overall Study||7
8359349|NCT01214434|20606487|P2|NOT COMPLETED|Overall Study||2
8359350|NCT01214434|20606488|P1|NOT COMPLETED|Overall Study||4
8359351|NCT01214434|20606487|P2|COMPLETED|Overall Study||25
8359352|NCT01214434|20606488|P1|COMPLETED|Overall Study||11
8359353|NCT01214434|20606487|P2|STARTED|Overall Study||27
8359354|NCT01214434|20606488|P1|STARTED|Overall Study||15
8359355|NCT01214395|20606504|P1|NOT COMPLETED|Overall Study||5
8359356|NCT01214395|20606504|P1|COMPLETED|Overall Study||0
8359357|NCT01214395|20606504|P1|STARTED|Overall Study||5
8359358|NCT01214356|20606511|P2|NOT COMPLETED|Overall Study||14
8359359|NCT01214356|20606512|P1|NOT COMPLETED|Overall Study||17
8359360|NCT01214356|20606511|P2|COMPLETED|Overall Study||13
8359361|NCT01214356|20606512|P1|COMPLETED|Overall Study||10
8359362|NCT01214356|20606511|P2|STARTED|Overall Study||27
8359363|NCT01214356|20606512|P1|STARTED|Overall Study||27
8359364|NCT01214330|20606518|P1|NOT COMPLETED|Overall Study||48
8359365|NCT01214330|20606518|P1|COMPLETED|Overall Study||102
8359366|NCT01214330|20606518|P1|STARTED|Overall Study||150
8359367|NCT01214317|20606524|P2|NOT COMPLETED|Overall Study||0
8359368|NCT01214317|20606525|P1|NOT COMPLETED|Overall Study||0
8359369|NCT01214317|20606524|P2|COMPLETED|Overall Study||22
8359370|NCT01214317|20606525|P1|COMPLETED|Overall Study||18
8359371|NCT01214317|20606524|P2|STARTED|Overall Study||22
8359372|NCT01214317|20606525|P1|STARTED|Overall Study||18
8359373|NCT01214252|20606533|P1|NOT COMPLETED|Overall Study||82
8359374|NCT01214252|20606533|P1|COMPLETED|Overall Study||343
8359375|NCT01214252|20606533|P1|STARTED|Overall Study||425
8359376|NCT01214239|20606541|P2|NOT COMPLETED|Overall Study||18
8359377|NCT01214239|20606542|P1|NOT COMPLETED|Overall Study||12
8359378|NCT01214239|20606541|P2|COMPLETED|Overall Study||182
8359379|NCT01214239|20606542|P1|COMPLETED|Overall Study||87
8359380|NCT01214239|20606541|P2|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
8359381|NCT01214239|20606542|P1|STARTED|Overall Study|patients who were randomised and treated with placebo|99
8359382|NCT01214200|20606574|P1|NOT COMPLETED|Overall Study||11
8359383|NCT01214200|20606574|P1|COMPLETED|Overall Study||9
8359384|NCT01214200|20606574|P1|STARTED|Overall Study||20
8359385|NCT01214187|20606588|P2|NOT COMPLETED|Overall Study||6
8359386|NCT01214187|20606589|P1|NOT COMPLETED|Overall Study||7
8359387|NCT01214187|20606588|P2|COMPLETED|Overall Study||23
8359388|NCT01214187|20606589|P1|COMPLETED|Overall Study||22
8359389|NCT01214187|20606588|P2|STARTED|Overall Study||29
8359390|NCT01214187|20606589|P1|STARTED|Overall Study||29
8359391|NCT01214174|20606606|P3|NOT COMPLETED|Overall Study||1
8359392|NCT01214174|20606607|P2|NOT COMPLETED|Overall Study||0
8359393|NCT01214174|20606608|P1|NOT COMPLETED|Overall Study||0
8359394|NCT01214174|20606606|P3|COMPLETED|Overall Study||13
8359395|NCT01214174|20606607|P2|COMPLETED|Overall Study||16
8359396|NCT01214174|20606608|P1|COMPLETED|Overall Study||13
8359397|NCT01214174|20606606|P3|STARTED|Overall Study||14
8359398|NCT01214174|20606607|P2|STARTED|Overall Study||16
8359399|NCT01214174|20606608|P1|STARTED|Overall Study||13
8359400|NCT01214161|20606618|P2|NOT COMPLETED|Overall Study||0
8359401|NCT01214161|20606619|P1|NOT COMPLETED|Overall Study||0
8359402|NCT01214161|20606618|P2|COMPLETED|Overall Study||100
8359403|NCT01214161|20606619|P1|COMPLETED|Overall Study||100
8359404|NCT01214161|20606618|P2|STARTED|Overall Study||100
8359405|NCT01214161|20606619|P1|STARTED|Overall Study||100
8359406|NCT01214109|20606629|P4|NOT COMPLETED|Overall Study||0
8359407|NCT01214109|20606630|P3|NOT COMPLETED|Overall Study||0
8359408|NCT01214109|20606631|P2|NOT COMPLETED|Overall Study||0
8359409|NCT01214109|20606632|P1|NOT COMPLETED|Overall Study||0
8359410|NCT01214109|20606629|P4|COMPLETED|Overall Study||24
8359411|NCT01214109|20606630|P3|COMPLETED|Overall Study||24
8359412|NCT01214109|20606631|P2|COMPLETED|Overall Study||24
8359413|NCT01214109|20606632|P1|COMPLETED|Overall Study||24
8359414|NCT01214109|20606629|P4|STARTED|Overall Study||24
8359415|NCT01214109|20606630|P3|STARTED|Overall Study||24
8359416|NCT01214109|20606631|P2|STARTED|Overall Study||24
8359417|NCT01214109|20606632|P1|STARTED|Overall Study||24
8359418|NCT01214083|20606724|P3|NOT COMPLETED|Overall Study||10
8359419|NCT01214083|20606725|P2|NOT COMPLETED|Overall Study||10
8359420|NCT01214083|20606726|P1|NOT COMPLETED|Overall Study||12
8359421|NCT01214083|20606724|P3|COMPLETED|Overall Study||21
8359422|NCT01214083|20606725|P2|COMPLETED|Overall Study||23
8359423|NCT01214083|20606726|P1|COMPLETED|Overall Study||19
8359424|NCT01214083|20606724|P3|STARTED|Overall Study||31
8359425|NCT01214083|20606725|P2|STARTED|Overall Study||33
8359426|NCT01214083|20606726|P1|STARTED|Overall Study||31
8359427|NCT01214044|20606758|P1|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4
8359428|NCT01214044|20606758|P1|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10
8359429|NCT01214044|20606758|P1|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14
8359430|NCT01214044|20606758|P1|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3
8359431|NCT01214044|20606758|P1|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14
8359432|NCT01214044|20606758|P1|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17
8359433|NCT01214044|20606758|P1|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2
8359434|NCT01214044|20606758|P1|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17
8359435|NCT01214044|20606758|P1|STARTED|Visit 2: End Washout & Start Placebo||19
8359436|NCT01214044|20606758|P1|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12
8359437|NCT01214044|20606758|P1|COMPLETED|Visit 1: Screening and Consent, Washout||19
8359438|NCT01214044|20606758|P1|STARTED|Visit 1: Screening and Consent, Washout||31
8359439|NCT01213966|20606772|P4|NOT COMPLETED|Overall Study||1
8359440|NCT01213966|20606773|P3|NOT COMPLETED|Overall Study||3
8359441|NCT01213966|20606774|P2|NOT COMPLETED|Overall Study||0
8359442|NCT01213966|20606775|P1|NOT COMPLETED|Overall Study||1
8359443|NCT01213966|20606772|P4|COMPLETED|Overall Study||20
8359444|NCT01213966|20606773|P3|COMPLETED|Overall Study||17
8359445|NCT01213966|20606774|P2|COMPLETED|Overall Study||20
8359446|NCT01213966|20606775|P1|COMPLETED|Overall Study||19
8359447|NCT01213966|20606772|P4|STARTED|Overall Study||21
8359448|NCT01213966|20606773|P3|STARTED|Overall Study||20
8359449|NCT01213966|20606774|P2|STARTED|Overall Study||20
8359450|NCT01213966|20606775|P1|STARTED|Overall Study||20
8359451|NCT01213940|20606787|P2|NOT COMPLETED|Overall Study||0
8359452|NCT01213940|20606788|P1|NOT COMPLETED|Overall Study||0
8359453|NCT01213940|20606787|P2|COMPLETED|Overall Study||6
8359454|NCT01213940|20606788|P1|COMPLETED|Overall Study||14
8359455|NCT01213940|20606787|P2|STARTED|Overall Study||6
8359456|NCT01213940|20606788|P1|STARTED|Overall Study||14
8359457|NCT01213836|20606796|P2|NOT COMPLETED|Period 2, Second Intervention||0
8359458|NCT01213836|20606797|P1|NOT COMPLETED|Period 2, Second Intervention||0
8359459|NCT01213836|20606796|P2|COMPLETED|Period 2, Second Intervention||29
8359460|NCT01213836|20606797|P1|COMPLETED|Period 2, Second Intervention||31
8359461|NCT01213836|20606796|P2|STARTED|Period 2, Second Intervention||29
8359462|NCT01213836|20606797|P1|STARTED|Period 2, Second Intervention||31
8359463|NCT01213836|20606796|P2|NOT COMPLETED|Period 1, First Intervention||3
8359464|NCT01213836|20606797|P1|NOT COMPLETED|Period 1, First Intervention||3
8359465|NCT01213836|20606796|P2|COMPLETED|Period 1, First Intervention||29
8359466|NCT01213836|20606797|P1|COMPLETED|Period 1, First Intervention||31
8359467|NCT01213836|20606796|P2|STARTED|Period 1, First Intervention||32
8359468|NCT01213836|20606797|P1|STARTED|Period 1, First Intervention||34
8359469|NCT01213823|20606817|P2|NOT COMPLETED|Overall Study||0
8359470|NCT01213823|20606818|P1|NOT COMPLETED|Overall Study||0
8359471|NCT01213823|20606817|P2|COMPLETED|Overall Study||467
8359472|NCT01213823|20606818|P1|COMPLETED|Overall Study||69
8359473|NCT01213823|20606817|P2|STARTED|Overall Study||467
8359474|NCT01213823|20606818|P1|STARTED|Overall Study||69
8359475|NCT01213706|20606824|P1|NOT COMPLETED|WBPA||0
8359476|NCT01213706|20606824|P1|COMPLETED|WBPA||45
8359477|NCT01213706|20606824|P1|STARTED|WBPA||45
8359478|NCT01213706|20606824|P1|NOT COMPLETED|Washout (1 Hour)||0
8359479|NCT01213706|20606824|P1|COMPLETED|Washout (1 Hour)||45
8359480|NCT01213706|20606824|P1|STARTED|Washout (1 Hour)||45
8359481|NCT01213706|20606824|P1|NOT COMPLETED|Sham WBPA||0
8359482|NCT01213706|20606824|P1|COMPLETED|Sham WBPA||45
8359483|NCT01213706|20606824|P1|STARTED|Sham WBPA||45
8359484|NCT01213589|20606833|P3|NOT COMPLETED|Overall Study||8
8359485|NCT01213589|20606834|P2|NOT COMPLETED|Overall Study||5
8359486|NCT01213589|20606835|P1|NOT COMPLETED|Overall Study||13
8359487|NCT01213589|20606833|P3|COMPLETED|Overall Study||18
8359488|NCT01213589|20606834|P2|COMPLETED|Overall Study||19
8359489|NCT01213589|20606835|P1|COMPLETED|Overall Study||37
8359490|NCT01213589|20606833|P3|STARTED|Overall Study||26
8359491|NCT01213589|20606834|P2|STARTED|Overall Study||24
8359492|NCT01213589|20606835|P1|STARTED|Overall Study||50
8359493|NCT01213576|20606865|P4|NOT COMPLETED|Overall Study||4
8359494|NCT01213576|20606866|P3|NOT COMPLETED|Overall Study||5
8359495|NCT01213576|20606867|P2|NOT COMPLETED|Overall Study||4
8359496|NCT01213576|20606868|P1|NOT COMPLETED|Overall Study||3
8359497|NCT01213576|20606865|P4|COMPLETED|Overall Study||13
8359498|NCT01213576|20606866|P3|COMPLETED|Overall Study||13
8359499|NCT01213576|20606867|P2|COMPLETED|Overall Study||13
8359500|NCT01213576|20606868|P1|COMPLETED|Overall Study||15
8359501|NCT01213576|20606865|P4|STARTED|Overall Study||17
8359502|NCT01213576|20606866|P3|STARTED|Overall Study||18
8359503|NCT01213576|20606867|P2|STARTED|Overall Study||17
8359504|NCT01213576|20606868|P1|STARTED|Overall Study||18
8359505|NCT01213524|20606884|P1|NOT COMPLETED|Session 7||0
8359506|NCT01213524|20606884|P1|COMPLETED|Session 7||56
8359507|NCT01213524|20606884|P1|STARTED|Session 7||56
8359508|NCT01213524|20606884|P1|NOT COMPLETED|Session 6||0
8359509|NCT01213524|20606884|P1|COMPLETED|Session 6|Number who continued in the study to the next session|56
8359510|NCT01213524|20606884|P1|STARTED|Session 6||56
8359511|NCT01213524|20606884|P1|NOT COMPLETED|Session 5||0
8359512|NCT01213524|20606884|P1|COMPLETED|Session 5|Number who continued in the study to the next session|56
8359513|NCT01213524|20606884|P1|STARTED|Session 5||56
8359514|NCT01213524|20606884|P1|NOT COMPLETED|Session 4||3
8359515|NCT01213524|20606884|P1|COMPLETED|Session 4|Number who continued in the study to the next session|56
8359516|NCT01213524|20606884|P1|STARTED|Session 4||59
8359517|NCT01213524|20606884|P1|NOT COMPLETED|Session 3||4
8359518|NCT01213524|20606884|P1|COMPLETED|Session 3|Number who continued in study to next session|59
8359519|NCT01213524|20606884|P1|STARTED|Session 3||63
8359520|NCT01213524|20606884|P1|NOT COMPLETED|Session 2||5
8359521|NCT01213524|20606884|P1|COMPLETED|Session 2|Number who continued in the study to the next session|63
8359522|NCT01213524|20606884|P1|STARTED|Session 2||68
8359523|NCT01213524|20606884|P1|NOT COMPLETED|Baseline||7
8359524|NCT01213524|20606884|P1|COMPLETED|Baseline|Number of participants who continued in the study past baseline|68
8359610|NCT01213043|20607047|P2|COMPLETED|Treatment Period 1||15
8359525|NCT01213524|20606884|P1|STARTED|Baseline|Total number who signed informed consent.|75
8359526|NCT01213472|20606898|P1|NOT COMPLETED|Overall Study||27
8359527|NCT01213472|20606898|P1|COMPLETED|Overall Study||6
8359528|NCT01213472|20606898|P1|STARTED|Overall Study||33
8359529|NCT01213329|20606921|P2|NOT COMPLETED|Phase 2||0
8359530|NCT01213329|20606922|P1|NOT COMPLETED|Phase 2||0
8359531|NCT01213329|20606921|P2|COMPLETED|Phase 2||0
8359532|NCT01213329|20606922|P1|COMPLETED|Phase 2||0
8359533|NCT01213329|20606921|P2|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
8359534|NCT01213329|20606922|P1|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
8359535|NCT01213329|20606921|P2|NOT COMPLETED|Screening||0
8359536|NCT01213329|20606922|P1|NOT COMPLETED|Screening||0
8359537|NCT01213329|20606921|P2|COMPLETED|Screening||25
8359538|NCT01213329|20606922|P1|COMPLETED|Screening||25
8359539|NCT01213329|20606921|P2|STARTED|Screening||25
8359540|NCT01213329|20606922|P1|STARTED|Screening||25
8359541|NCT01213316|20606928|P1|NOT COMPLETED|Overall Study||0
8359542|NCT01213316|20606928|P1|COMPLETED|Overall Study||451
8359543|NCT01213316|20606928|P1|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
8359544|NCT01213316|20606928|P1|Discontinued Treatment Before 48 Weeks|Overall Study||67
8359545|NCT01213316|20606928|P1|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
8359546|NCT01213316|20606928|P1|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
8359547|NCT01213316|20606928|P1|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
8359548|NCT01213264|20606947|P3|NOT COMPLETED|Overall Study||6
8359549|NCT01213264|20606948|P2|NOT COMPLETED|Overall Study||2
8359550|NCT01213264|20606949|P1|NOT COMPLETED|Overall Study||2
8359551|NCT01213264|20606947|P3|COMPLETED|Overall Study||321
8359552|NCT01213264|20606948|P2|COMPLETED|Overall Study||175
8359553|NCT01213264|20606949|P1|COMPLETED|Overall Study||153
8359554|NCT01213264|20606947|P3|STARTED|Overall Study||327
8359555|NCT01213264|20606948|P2|STARTED|Overall Study||177
8359556|NCT01213264|20606949|P1|STARTED|Overall Study||155
8359557|NCT01213251|20606969|P3|NOT COMPLETED|Overall Study||11
8359558|NCT01213251|20606970|P2|NOT COMPLETED|Overall Study||4
8359559|NCT01213251|20606971|P1|NOT COMPLETED|Overall Study||6
8359560|NCT01213251|20606969|P3|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
8359561|NCT01213251|20606970|P2|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
8359562|NCT01213251|20606971|P1|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
8359563|NCT01213251|20606969|P3|STARTED|Overall Study||45
8359564|NCT01213251|20606970|P2|STARTED|Overall Study||41
8359565|NCT01213251|20606971|P1|STARTED|Overall Study||40
8359569|NCT01213173|20606998|P2|NOT COMPLETED|Overall Study||16
8359570|NCT01213173|20606999|P1|NOT COMPLETED|Overall Study||12
8359571|NCT01213173|20606998|P2|COMPLETED|Overall Study|Patients who completed the study|110
8359572|NCT01213173|20606999|P1|COMPLETED|Overall Study|Patients who completed the study|113
8359573|NCT01213173|20606998|P2|Patients Included in PP Population|Overall Study||89
8359574|NCT01213173|20606999|P1|Patients Included in PP Population|Overall Study||102
8359575|NCT01213173|20606998|P2|Patients Included in ITT Population|Overall Study||115
8359576|NCT01213173|20606999|P1|Patients Included in ITT Population|Overall Study||116
8359577|NCT01213173|20606998|P2|Patients Included in Safety Population|Overall Study||112
8359578|NCT01213173|20606999|P1|Patients Included in Safety Population|Overall Study||139
8359579|NCT01213173|20606998|P2|STARTED|Overall Study|Patients who were randomized and received treatment|126
8359580|NCT01213173|20606999|P1|STARTED|Overall Study|Patients who were randomized and received treatment|125
8359581|NCT01213082|20607032|P3|NOT COMPLETED|Overall Study||5
8359582|NCT01213082|20607033|P2|NOT COMPLETED|Overall Study||7
8359583|NCT01213082|20607034|P1|NOT COMPLETED|Overall Study||6
8359584|NCT01213082|20607032|P3|COMPLETED|Overall Study||6
8359585|NCT01213082|20607033|P2|COMPLETED|Overall Study||4
8359586|NCT01213082|20607034|P1|COMPLETED|Overall Study||6
8359587|NCT01213082|20607032|P3|STARTED|Overall Study||11
8359588|NCT01213082|20607033|P2|STARTED|Overall Study||11
8359589|NCT01213082|20607034|P1|STARTED|Overall Study||12
8359590|NCT01213043|20607047|P2|NOT COMPLETED|Follow-up||0
8359591|NCT01213043|20607048|P1|NOT COMPLETED|Follow-up||0
8359592|NCT01213043|20607047|P2|COMPLETED|Follow-up||15
8359593|NCT01213043|20607048|P1|COMPLETED|Follow-up||15
8359594|NCT01213043|20607047|P2|STARTED|Follow-up||15
8359595|NCT01213043|20607048|P1|STARTED|Follow-up||15
8359596|NCT01213043|20607047|P2|NOT COMPLETED|Treatment Period 2||0
8359597|NCT01213043|20607048|P1|NOT COMPLETED|Treatment Period 2||0
8359598|NCT01213043|20607047|P2|COMPLETED|Treatment Period 2||15
8359599|NCT01213043|20607048|P1|COMPLETED|Treatment Period 2||15
8359600|NCT01213043|20607047|P2|STARTED|Treatment Period 2||15
8359601|NCT01213043|20607048|P1|STARTED|Treatment Period 2||15
8359602|NCT01213043|20607047|P2|NOT COMPLETED|Washout Period||0
8359603|NCT01213043|20607048|P1|NOT COMPLETED|Washout Period||0
8359604|NCT01213043|20607047|P2|COMPLETED|Washout Period||15
8359605|NCT01213043|20607048|P1|COMPLETED|Washout Period||15
8359606|NCT01213043|20607047|P2|STARTED|Washout Period||15
8359607|NCT01213043|20607048|P1|STARTED|Washout Period||15
8359608|NCT01213043|20607047|P2|NOT COMPLETED|Treatment Period 1||0
8359609|NCT01213043|20607048|P1|NOT COMPLETED|Treatment Period 1||0
8359611|NCT01213043|20607048|P1|COMPLETED|Treatment Period 1||15
8359612|NCT01213043|20607047|P2|STARTED|Treatment Period 1||15
8359613|NCT01213043|20607048|P1|STARTED|Treatment Period 1||15
8359614|NCT01212991|20607076|P3|NOT COMPLETED|Open-label||234
8359615|NCT01212991|20607077|P2|NOT COMPLETED|Open-label||0
8359616|NCT01212991|20607078|P1|NOT COMPLETED|Open-label||0
8359617|NCT01212991|20607076|P3|COMPLETED|Open-label||0
8359618|NCT01212991|20607077|P2|COMPLETED|Open-label||0
8359619|NCT01212991|20607078|P1|COMPLETED|Open-label||0
8359620|NCT01212991|20607076|P3|STARTED|Open-label|previous placebo treated participants were given the opportunity to receive enzalutamide|234
8359621|NCT01212991|20607077|P2|STARTED|Open-label|participants were given the opportunity to receive open-label access to enzalutamide|0
8359622|NCT01212991|20607078|P1|STARTED|Open-label||0
8359623|NCT01212991|20607076|P3|NOT COMPLETED|Double-blind||0
8359624|NCT01212991|20607077|P2|NOT COMPLETED|Double-blind||611
8359625|NCT01212991|20607078|P1|NOT COMPLETED|Double-blind||872
8359626|NCT01212991|20607076|P3|COMPLETED|Double-blind||0
8359627|NCT01212991|20607077|P2|COMPLETED|Double-blind||234
8359628|NCT01212991|20607078|P1|COMPLETED|Double-blind||0
8359629|NCT01212991|20607076|P3|Safety Population|Double-blind||0
8359630|NCT01212991|20607077|P2|Safety Population|Double-blind||844
8359631|NCT01212991|20607078|P1|Safety Population|Double-blind||871
8359632|NCT01212991|20607076|P3|STARTED|Double-blind||0
8359633|NCT01212991|20607077|P2|STARTED|Double-blind||845
8359634|NCT01212991|20607078|P1|STARTED|Double-blind||872
8359635|NCT01212952|20607109|P3|NOT COMPLETED|Overall Study||0
8359636|NCT01212952|20607110|P2|NOT COMPLETED|Overall Study||0
8359637|NCT01212952|20607111|P1|NOT COMPLETED|Overall Study||0
8359638|NCT01212952|20607109|P3|COMPLETED|Overall Study||41
8359639|NCT01212952|20607110|P2|COMPLETED|Overall Study||6
8359640|NCT01212952|20607111|P1|COMPLETED|Overall Study||3
8359641|NCT01212952|20607109|P3|STARTED|Overall Study||41
8359642|NCT01212952|20607110|P2|STARTED|Overall Study||6
8359643|NCT01212952|20607111|P1|STARTED|Overall Study||3
8359644|NCT01212900|20607129|P2|NOT COMPLETED|Overall Study||7
8359645|NCT01212900|20607130|P1|NOT COMPLETED|Overall Study||12
8359646|NCT01212900|20607129|P2|COMPLETED|Overall Study||107
8359647|NCT01212900|20607130|P1|COMPLETED|Overall Study||104
8359648|NCT01212900|20607129|P2|STARTED|Overall Study||114
8359649|NCT01212900|20607130|P1|STARTED|Overall Study||116
8359650|NCT01212874|20607138|P2|NOT COMPLETED|Overall Study||23
8359651|NCT01212874|20607139|P1|NOT COMPLETED|Overall Study||22
8359652|NCT01212874|20607138|P2|COMPLETED|Overall Study||12
8359653|NCT01212874|20607139|P1|COMPLETED|Overall Study||13
8359654|NCT01212874|20607138|P2|Received Allocated Intervention|Overall Study||12
8359655|NCT01212874|20607139|P1|Received Allocated Intervention|Overall Study||13
8359656|NCT01212874|20607138|P2|STARTED|Overall Study||35
8359657|NCT01212874|20607139|P1|STARTED|Overall Study||35
8359658|NCT01212770|20607150|P9|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
8359659|NCT01212770|20607151|P8|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
8359660|NCT01212770|20607152|P7|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8359661|NCT01212770|20607153|P6|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8359662|NCT01212770|20607154|P5|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8359663|NCT01212770|20607155|P4|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8359664|NCT01212770|20607156|P3|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
8359665|NCT01212770|20607157|P2|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
8359666|NCT01212770|20607158|P1|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
8359667|NCT01212770|20607150|P9|COMPLETED|Long-term Safety Phase (Year 5)||41
8359668|NCT01212770|20607151|P8|COMPLETED|Long-term Safety Phase (Year 5)||30
8359669|NCT01212770|20607152|P7|COMPLETED|Long-term Safety Phase (Year 5)||0
8359670|NCT01212770|20607153|P6|COMPLETED|Long-term Safety Phase (Year 5)||0
8359671|NCT01212770|20607154|P5|COMPLETED|Long-term Safety Phase (Year 5)||0
8359672|NCT01212770|20607155|P4|COMPLETED|Long-term Safety Phase (Year 5)||0
8359673|NCT01212770|20607156|P3|COMPLETED|Long-term Safety Phase (Year 5)||72
8359674|NCT01212770|20607157|P2|COMPLETED|Long-term Safety Phase (Year 5)||68
8359675|NCT01212770|20607158|P1|COMPLETED|Long-term Safety Phase (Year 5)||0
8359676|NCT01212770|20607150|P9|STARTED|Long-term Safety Phase (Year 5)||42
8359677|NCT01212770|20607151|P8|STARTED|Long-term Safety Phase (Year 5)||32
8359678|NCT01212770|20607152|P7|STARTED|Long-term Safety Phase (Year 5)||0
8359679|NCT01212770|20607153|P6|STARTED|Long-term Safety Phase (Year 5)||0
8359680|NCT01212770|20607154|P5|STARTED|Long-term Safety Phase (Year 5)||0
8359681|NCT01212770|20607155|P4|STARTED|Long-term Safety Phase (Year 5)||0
8359682|NCT01212770|20607156|P3|STARTED|Long-term Safety Phase (Year 5)||83
8359683|NCT01212770|20607157|P2|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
8359684|NCT01212770|20607158|P1|STARTED|Long-term Safety Phase (Year 5)||0
8359685|NCT01212770|20607150|P9|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
8359686|NCT01212770|20607151|P8|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
8359687|NCT01212770|20607152|P7|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8359688|NCT01212770|20607153|P6|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8359689|NCT01212770|20607154|P5|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8359690|NCT01212770|20607155|P4|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8359691|NCT01212770|20607156|P3|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
8359692|NCT01212770|20607157|P2|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
8359693|NCT01212770|20607158|P1|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
8359694|NCT01212770|20607150|P9|COMPLETED|Long-term Safety Phase (Year 4)||42
8359695|NCT01212770|20607151|P8|COMPLETED|Long-term Safety Phase (Year 4)||32
8359696|NCT01212770|20607152|P7|COMPLETED|Long-term Safety Phase (Year 4)||0
8359697|NCT01212770|20607153|P6|COMPLETED|Long-term Safety Phase (Year 4)||0
8359698|NCT01212770|20607154|P5|COMPLETED|Long-term Safety Phase (Year 4)||0
8359699|NCT01212770|20607155|P4|COMPLETED|Long-term Safety Phase (Year 4)||0
8359700|NCT01212770|20607156|P3|COMPLETED|Long-term Safety Phase (Year 4)||83
8359701|NCT01212770|20607157|P2|COMPLETED|Long-term Safety Phase (Year 4)||71
8359702|NCT01212770|20607158|P1|COMPLETED|Long-term Safety Phase (Year 4)||0
8359703|NCT01212770|20607150|P9|STARTED|Long-term Safety Phase (Year 4)||44
8359704|NCT01212770|20607151|P8|STARTED|Long-term Safety Phase (Year 4)||35
8359705|NCT01212770|20607152|P7|STARTED|Long-term Safety Phase (Year 4)||0
8359706|NCT01212770|20607153|P6|STARTED|Long-term Safety Phase (Year 4)||0
8359707|NCT01212770|20607154|P5|STARTED|Long-term Safety Phase (Year 4)||0
8359708|NCT01212770|20607155|P4|STARTED|Long-term Safety Phase (Year 4)||0
8359709|NCT01212770|20607156|P3|STARTED|Long-term Safety Phase (Year 4)||94
8359710|NCT01212770|20607157|P2|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
8359711|NCT01212770|20607158|P1|STARTED|Long-term Safety Phase (Year 4)||0
8359712|NCT01212770|20607150|P9|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
8359713|NCT01212770|20607151|P8|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
8359714|NCT01212770|20607152|P7|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8359715|NCT01212770|20607153|P6|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8359716|NCT01212770|20607154|P5|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8359717|NCT01212770|20607155|P4|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8359718|NCT01212770|20607156|P3|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
8359719|NCT01212770|20607157|P2|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
8359720|NCT01212770|20607158|P1|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
8359721|NCT01212770|20607150|P9|COMPLETED|Long-term Safety Phase (Year 3)||44
8359722|NCT01212770|20607151|P8|COMPLETED|Long-term Safety Phase (Year 3)||35
8359723|NCT01212770|20607152|P7|COMPLETED|Long-term Safety Phase (Year 3)||0
8359724|NCT01212770|20607153|P6|COMPLETED|Long-term Safety Phase (Year 3)||0
8359725|NCT01212770|20607154|P5|COMPLETED|Long-term Safety Phase (Year 3)||0
8359726|NCT01212770|20607155|P4|COMPLETED|Long-term Safety Phase (Year 3)||0
8359727|NCT01212770|20607156|P3|COMPLETED|Long-term Safety Phase (Year 3)||94
8359728|NCT01212770|20607157|P2|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
8359729|NCT01212770|20607158|P1|COMPLETED|Long-term Safety Phase (Year 3)||0
8359730|NCT01212770|20607150|P9|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
8359731|NCT01212770|20607151|P8|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
8359732|NCT01212770|20607152|P7|STARTED|Long-term Safety Phase (Year 3)||0
8359733|NCT01212770|20607153|P6|STARTED|Long-term Safety Phase (Year 3)||0
8359734|NCT01212770|20607154|P5|STARTED|Long-term Safety Phase (Year 3)||0
8359735|NCT01212770|20607155|P4|STARTED|Long-term Safety Phase (Year 3)||0
8359736|NCT01212770|20607156|P3|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
8359737|NCT01212770|20607157|P2|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
8359738|NCT01212770|20607158|P1|STARTED|Long-term Safety Phase (Year 3)||0
8359739|NCT01212770|20607150|P9|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
8359740|NCT01212770|20607151|P8|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
8359741|NCT01212770|20607152|P7|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8359742|NCT01212770|20607153|P6|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8359743|NCT01212770|20607154|P5|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8359744|NCT01212770|20607155|P4|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8359745|NCT01212770|20607156|P3|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
8359746|NCT01212770|20607157|P2|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
8359747|NCT01212770|20607158|P1|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
8359748|NCT01212770|20607150|P9|COMPLETED|Long-term Safety Phase (Year 2)||50
8359749|NCT01212770|20607151|P8|COMPLETED|Long-term Safety Phase (Year 2)||42
8359750|NCT01212770|20607152|P7|COMPLETED|Long-term Safety Phase (Year 2)||0
8359751|NCT01212770|20607153|P6|COMPLETED|Long-term Safety Phase (Year 2)||0
8359752|NCT01212770|20607154|P5|COMPLETED|Long-term Safety Phase (Year 2)||0
8359753|NCT01212770|20607155|P4|COMPLETED|Long-term Safety Phase (Year 2)||0
8359754|NCT01212770|20607156|P3|COMPLETED|Long-term Safety Phase (Year 2)||106
8359755|NCT01212770|20607157|P2|COMPLETED|Long-term Safety Phase (Year 2)||88
8359756|NCT01212770|20607158|P1|COMPLETED|Long-term Safety Phase (Year 2)||0
8359757|NCT01212770|20607150|P9|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
8359758|NCT01212770|20607151|P8|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
8359759|NCT01212770|20607152|P7|STARTED|Long-term Safety Phase (Year 2)||0
8359760|NCT01212770|20607153|P6|STARTED|Long-term Safety Phase (Year 2)||0
8359761|NCT01212770|20607154|P5|STARTED|Long-term Safety Phase (Year 2)||0
8359762|NCT01212770|20607155|P4|STARTED|Long-term Safety Phase (Year 2)||0
8359763|NCT01212770|20607156|P3|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
8359764|NCT01212770|20607157|P2|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
8359765|NCT01212770|20607158|P1|STARTED|Long-term Safety Phase (Year 2)||0
8359766|NCT01212770|20607150|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8359767|NCT01212770|20607151|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8359768|NCT01212770|20607152|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
8359769|NCT01212770|20607153|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
8359770|NCT01212770|20607154|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
8359771|NCT01212770|20607155|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
8359772|NCT01212770|20607156|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
8359773|NCT01212770|20607157|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
8359774|NCT01212770|20607158|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8359775|NCT01212770|20607150|P9|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8359776|NCT01212770|20607151|P8|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8359777|NCT01212770|20607152|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
8359778|NCT01212770|20607153|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
8359779|NCT01212770|20607154|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
8359780|NCT01212770|20607155|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
8359781|NCT01212770|20607156|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
8359782|NCT01212770|20607157|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
8359783|NCT01212770|20607158|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
8359784|NCT01212770|20607150|P9|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
8359785|NCT01212770|20607151|P8|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
8359786|NCT01212770|20607152|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
8359787|NCT01212770|20607153|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
8359788|NCT01212770|20607154|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
8359789|NCT01212770|20607155|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
8359790|NCT01212770|20607156|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
8359791|NCT01212770|20607157|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
8359792|NCT01212770|20607158|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
8359793|NCT01212770|20607150|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359794|NCT01212770|20607151|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359795|NCT01212770|20607152|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359796|NCT01212770|20607153|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359797|NCT01212770|20607154|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359798|NCT01212770|20607155|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359799|NCT01212770|20607156|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
8359800|NCT01212770|20607157|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
8359801|NCT01212770|20607158|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
8359802|NCT01212770|20607150|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359803|NCT01212770|20607151|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359804|NCT01212770|20607152|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359805|NCT01212770|20607153|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359806|NCT01212770|20607154|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359807|NCT01212770|20607155|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359808|NCT01212770|20607156|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
8359809|NCT01212770|20607157|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
8359810|NCT01212770|20607158|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
8359811|NCT01212770|20607150|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359812|NCT01212770|20607151|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359813|NCT01212770|20607152|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359814|NCT01212770|20607153|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359815|NCT01212770|20607154|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359816|NCT01212770|20607155|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359817|NCT01212770|20607156|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
8359818|NCT01212770|20607157|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
8359819|NCT01212770|20607158|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
8359820|NCT01212770|20607150|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359821|NCT01212770|20607151|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359822|NCT01212770|20607152|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359823|NCT01212770|20607153|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359824|NCT01212770|20607154|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359825|NCT01212770|20607155|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8359826|NCT01212770|20607156|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
8359827|NCT01212770|20607157|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
8359828|NCT01212770|20607158|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
8359829|NCT01212770|20607150|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8359830|NCT01212770|20607151|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8359831|NCT01212770|20607152|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8359832|NCT01212770|20607153|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8359833|NCT01212770|20607154|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8359834|NCT01212770|20607155|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8359835|NCT01212770|20607156|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
8359836|NCT01212770|20607157|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
8359837|NCT01212770|20607158|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
8359838|NCT01212770|20607150|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8359839|NCT01212770|20607151|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8359840|NCT01212770|20607152|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8359841|NCT01212770|20607153|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8359842|NCT01212770|20607154|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8359843|NCT01212770|20607155|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8359844|NCT01212770|20607156|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
8359845|NCT01212770|20607157|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
8359846|NCT01212770|20607158|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
8359847|NCT01212757|20607355|P9|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
8359848|NCT01212757|20607356|P8|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
8359849|NCT01212757|20607357|P7|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8359850|NCT01212757|20607358|P6|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8359851|NCT01212757|20607359|P5|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8359852|NCT01212757|20607360|P4|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8359853|NCT01212757|20607361|P3|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
8359854|NCT01212757|20607362|P2|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
8359855|NCT01212757|20607363|P1|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
8359856|NCT01212757|20607355|P9|COMPLETED|Long-Term Safety Phase (Year 5)||37
8359857|NCT01212757|20607356|P8|COMPLETED|Long-Term Safety Phase (Year 5)||33
8359858|NCT01212757|20607357|P7|COMPLETED|Long-Term Safety Phase (Year 5)||0
8359859|NCT01212757|20607358|P6|COMPLETED|Long-Term Safety Phase (Year 5)||0
8359860|NCT01212757|20607359|P5|COMPLETED|Long-Term Safety Phase (Year 5)||0
8359861|NCT01212757|20607360|P4|COMPLETED|Long-Term Safety Phase (Year 5)||0
8359862|NCT01212757|20607361|P3|COMPLETED|Long-Term Safety Phase (Year 5)||69
8359863|NCT01212757|20607362|P2|COMPLETED|Long-Term Safety Phase (Year 5)||72
8359864|NCT01212757|20607363|P1|COMPLETED|Long-Term Safety Phase (Year 5)||0
8359865|NCT01212757|20607355|P9|STARTED|Long-Term Safety Phase (Year 5)||39
8359866|NCT01212757|20607356|P8|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
8359867|NCT01212757|20607357|P7|STARTED|Long-Term Safety Phase (Year 5)||0
8359868|NCT01212757|20607358|P6|STARTED|Long-Term Safety Phase (Year 5)||0
8359869|NCT01212757|20607359|P5|STARTED|Long-Term Safety Phase (Year 5)||0
8359870|NCT01212757|20607360|P4|STARTED|Long-Term Safety Phase (Year 5)||0
8359871|NCT01212757|20607361|P3|STARTED|Long-Term Safety Phase (Year 5)||77
8359872|NCT01212757|20607362|P2|STARTED|Long-Term Safety Phase (Year 5)||80
8359873|NCT01212757|20607363|P1|STARTED|Long-Term Safety Phase (Year 5)||0
8359874|NCT01212757|20607355|P9|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
8359875|NCT01212757|20607356|P8|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
8359876|NCT01212757|20607357|P7|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8359877|NCT01212757|20607358|P6|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8359878|NCT01212757|20607359|P5|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8359879|NCT01212757|20607360|P4|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8359880|NCT01212757|20607361|P3|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
8359881|NCT01212757|20607362|P2|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
8359882|NCT01212757|20607363|P1|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
8359883|NCT01212757|20607355|P9|COMPLETED|Long-Term Safety Phase (Year 4)||39
8359884|NCT01212757|20607356|P8|COMPLETED|Long-Term Safety Phase (Year 4)||37
8359885|NCT01212757|20607357|P7|COMPLETED|Long-Term Safety Phase (Year 4)||0
8359886|NCT01212757|20607358|P6|COMPLETED|Long-Term Safety Phase (Year 4)||0
8359887|NCT01212757|20607359|P5|COMPLETED|Long-Term Safety Phase (Year 4)||0
8359888|NCT01212757|20607360|P4|COMPLETED|Long-Term Safety Phase (Year 4)||0
8359889|NCT01212757|20607361|P3|COMPLETED|Long-Term Safety Phase (Year 4)||77
8359890|NCT01212757|20607362|P2|COMPLETED|Long-Term Safety Phase (Year 4)||80
8359891|NCT01212757|20607363|P1|COMPLETED|Long-Term Safety Phase (Year 4)||0
8359892|NCT01212757|20607355|P9|STARTED|Long-Term Safety Phase (Year 4)||46
8359893|NCT01212757|20607356|P8|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
8359894|NCT01212757|20607357|P7|STARTED|Long-Term Safety Phase (Year 4)||0
8359895|NCT01212757|20607358|P6|STARTED|Long-Term Safety Phase (Year 4)||0
8359896|NCT01212757|20607359|P5|STARTED|Long-Term Safety Phase (Year 4)||0
8359897|NCT01212757|20607360|P4|STARTED|Long-Term Safety Phase (Year 4)||0
8359898|NCT01212757|20607361|P3|STARTED|Long-Term Safety Phase (Year 4)||84
8359899|NCT01212757|20607362|P2|STARTED|Long-Term Safety Phase (Year 4)||89
8359900|NCT01212757|20607363|P1|STARTED|Long-Term Safety Phase (Year 4)||0
8359901|NCT01212757|20607355|P9|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
8359902|NCT01212757|20607356|P8|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
8359903|NCT01212757|20607357|P7|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8359904|NCT01212757|20607358|P6|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8359905|NCT01212757|20607359|P5|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8359906|NCT01212757|20607360|P4|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8359907|NCT01212757|20607361|P3|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
8359908|NCT01212757|20607362|P2|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
8359909|NCT01212757|20607363|P1|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
8359910|NCT01212757|20607355|P9|COMPLETED|Long-Term Safety Phase (Year 3)||46
8359911|NCT01212757|20607356|P8|COMPLETED|Long-Term Safety Phase (Year 3)||42
8359912|NCT01212757|20607357|P7|COMPLETED|Long-Term Safety Phase (Year 3)||0
8359913|NCT01212757|20607358|P6|COMPLETED|Long-Term Safety Phase (Year 3)||0
8359914|NCT01212757|20607359|P5|COMPLETED|Long-Term Safety Phase (Year 3)||0
8359915|NCT01212757|20607360|P4|COMPLETED|Long-Term Safety Phase (Year 3)||0
8359916|NCT01212757|20607361|P3|COMPLETED|Long-Term Safety Phase (Year 3)||84
8359917|NCT01212757|20607362|P2|COMPLETED|Long-Term Safety Phase (Year 3)||89
8359918|NCT01212757|20607363|P1|COMPLETED|Long-Term Safety Phase (Year 3)||0
8359919|NCT01212757|20607355|P9|STARTED|Long-Term Safety Phase (Year 3)||51
8359920|NCT01212757|20607356|P8|STARTED|Long-Term Safety Phase (Year 3)||48
8359921|NCT01212757|20607357|P7|STARTED|Long-Term Safety Phase (Year 3)||0
8359922|NCT01212757|20607358|P6|STARTED|Long-Term Safety Phase (Year 3)||0
8359923|NCT01212757|20607359|P5|STARTED|Long-Term Safety Phase (Year 3)||0
8359924|NCT01212757|20607360|P4|STARTED|Long-Term Safety Phase (Year 3)||0
8359925|NCT01212757|20607361|P3|STARTED|Long-Term Safety Phase (Year 3)||95
8359926|NCT01212757|20607362|P2|STARTED|Long-Term Safety Phase (Year 3)||107
8359927|NCT01212757|20607363|P1|STARTED|Long-Term Safety Phase (Year 3)||0
8359928|NCT01212757|20607355|P9|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
8359929|NCT01212757|20607356|P8|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
8359930|NCT01212757|20607357|P7|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8359931|NCT01212757|20607358|P6|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8359932|NCT01212757|20607359|P5|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8359933|NCT01212757|20607360|P4|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8359934|NCT01212757|20607361|P3|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
8359935|NCT01212757|20607362|P2|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
8359936|NCT01212757|20607363|P1|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
8359937|NCT01212757|20607355|P9|COMPLETED|Long-Term Safety Phase (Year 2)||51
8359938|NCT01212757|20607356|P8|COMPLETED|Long-Term Safety Phase (Year 2)||48
8359939|NCT01212757|20607357|P7|COMPLETED|Long-Term Safety Phase (Year 2)||0
8359940|NCT01212757|20607358|P6|COMPLETED|Long-Term Safety Phase (Year 2)||0
8359941|NCT01212757|20607359|P5|COMPLETED|Long-Term Safety Phase (Year 2)||0
8359942|NCT01212757|20607360|P4|COMPLETED|Long-Term Safety Phase (Year 2)||0
8359943|NCT01212757|20607361|P3|COMPLETED|Long-Term Safety Phase (Year 2)||95
8359944|NCT01212757|20607362|P2|COMPLETED|Long-Term Safety Phase (Year 2)||107
8359945|NCT01212757|20607363|P1|COMPLETED|Long-Term Safety Phase (Year 2)||0
8359946|NCT01212757|20607355|P9|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
8359947|NCT01212757|20607356|P8|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
8359948|NCT01212757|20607357|P7|STARTED|Long-Term Safety Phase (Year 2)||0
8359949|NCT01212757|20607358|P6|STARTED|Long-Term Safety Phase (Year 2)||0
8359950|NCT01212757|20607359|P5|STARTED|Long-Term Safety Phase (Year 2)||0
8359951|NCT01212757|20607360|P4|STARTED|Long-Term Safety Phase (Year 2)||0
8359952|NCT01212757|20607361|P3|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
8359953|NCT01212757|20607362|P2|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
8359954|NCT01212757|20607363|P1|STARTED|Long-Term Safety Phase (Year 2)||0
8359955|NCT01212757|20607355|P9|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8359956|NCT01212757|20607356|P8|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8359957|NCT01212757|20607357|P7|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8359958|NCT01212757|20607358|P6|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
8359959|NCT01212757|20607359|P5|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
8359960|NCT01212757|20607360|P4|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
8359961|NCT01212757|20607361|P3|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
8359962|NCT01212757|20607362|P2|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
8359963|NCT01212757|20607363|P1|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8359964|NCT01212757|20607355|P9|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8359965|NCT01212757|20607356|P8|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8359966|NCT01212757|20607357|P7|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
8359967|NCT01212757|20607358|P6|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
8359968|NCT01212757|20607359|P5|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
8359969|NCT01212757|20607360|P4|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
8359970|NCT01212757|20607361|P3|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
8359971|NCT01212757|20607362|P2|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
8359972|NCT01212757|20607363|P1|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
8359973|NCT01212757|20607355|P9|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8359974|NCT01212757|20607356|P8|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8359975|NCT01212757|20607357|P7|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
8359976|NCT01212757|20607358|P6|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
8359977|NCT01212757|20607359|P5|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
8359978|NCT01212757|20607360|P4|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
8359979|NCT01212757|20607361|P3|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
8359980|NCT01212757|20607362|P2|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
8359981|NCT01212757|20607363|P1|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
8359982|NCT01212757|20607355|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359983|NCT01212757|20607356|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359984|NCT01212757|20607357|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359985|NCT01212757|20607358|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359986|NCT01212757|20607359|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359987|NCT01212757|20607360|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359988|NCT01212757|20607361|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
8359989|NCT01212757|20607362|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
8359990|NCT01212757|20607363|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
8359991|NCT01212757|20607355|P9|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359992|NCT01212757|20607356|P8|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359993|NCT01212757|20607357|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359994|NCT01212757|20607358|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359995|NCT01212757|20607359|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359996|NCT01212757|20607360|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
8359997|NCT01212757|20607361|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
8359998|NCT01212757|20607362|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
8359999|NCT01212757|20607363|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
8360000|NCT01212757|20607355|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360001|NCT01212757|20607356|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360002|NCT01212757|20607357|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360003|NCT01212757|20607358|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360004|NCT01212757|20607359|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360005|NCT01212757|20607360|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360006|NCT01212757|20607361|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
8360007|NCT01212757|20607362|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
8360008|NCT01212757|20607363|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
8360009|NCT01212757|20607355|P9|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360010|NCT01212757|20607356|P8|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360011|NCT01212757|20607357|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360012|NCT01212757|20607358|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360013|NCT01212757|20607359|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360014|NCT01212757|20607360|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
8360015|NCT01212757|20607361|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
8360016|NCT01212757|20607362|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
8360017|NCT01212757|20607363|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
8360018|NCT01212757|20607355|P9|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8360019|NCT01212757|20607356|P8|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8360020|NCT01212757|20607357|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8360021|NCT01212757|20607358|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8360022|NCT01212757|20607359|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8360023|NCT01212757|20607360|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
8360024|NCT01212757|20607361|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
8360025|NCT01212757|20607362|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
8360026|NCT01212757|20607363|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
8360027|NCT01212757|20607355|P9|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8360028|NCT01212757|20607356|P8|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8360029|NCT01212757|20607357|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8360030|NCT01212757|20607358|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8360031|NCT01212757|20607359|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8360032|NCT01212757|20607360|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
8360033|NCT01212757|20607361|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
8360034|NCT01212757|20607362|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
8360035|NCT01212757|20607363|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
8360036|NCT01212744|20607547|P1|NOT COMPLETED|Overall Study||1
8360037|NCT01212744|20607547|P1|COMPLETED|Overall Study||15
8360038|NCT01212744|20607547|P1|STARTED|Overall Study||16
8360042|NCT01212588|20607566|P2|NOT COMPLETED|Overall Study||2
8360043|NCT01212588|20607567|P1|NOT COMPLETED|Overall Study||1
8360044|NCT01212588|20607566|P2|COMPLETED|Overall Study||10
8360045|NCT01212588|20607567|P1|COMPLETED|Overall Study||9
8360046|NCT01212588|20607566|P2|STARTED|Overall Study||12
8360047|NCT01212588|20607567|P1|STARTED|Overall Study||10
8360048|NCT01212484|20607601|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
8360049|NCT01212484|20607602|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8360050|NCT01212484|20607601|P2|COMPLETED|Second Intervention (4 Weeks)||3
8360051|NCT01212484|20607602|P1|COMPLETED|Second Intervention (4 Weeks)||5
8360052|NCT01212484|20607601|P2|STARTED|Second Intervention (4 Weeks)||4
8360053|NCT01212484|20607602|P1|STARTED|Second Intervention (4 Weeks)||5
8360054|NCT01212484|20607601|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
8360055|NCT01212484|20607602|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8360056|NCT01212484|20607601|P2|COMPLETED|First Intervention (4 Weeks)||4
8360057|NCT01212484|20607602|P1|COMPLETED|First Intervention (4 Weeks)||5
8360058|NCT01212484|20607601|P2|STARTED|First Intervention (4 Weeks)||6
8360059|NCT01212484|20607602|P1|STARTED|First Intervention (4 Weeks)||5
8360060|NCT01212484|20607601|P2|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
8360061|NCT01212484|20607602|P1|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
8360062|NCT01212484|20607601|P2|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
8360063|NCT01212484|20607602|P1|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
8360064|NCT01212484|20607601|P2|STARTED|Carbidopa Titration Period (4 Weeks)||6
8360065|NCT01212484|20607602|P1|STARTED|Carbidopa Titration Period (4 Weeks)||6
8360066|NCT01212471|20607615|P3|NOT COMPLETED|Overall Study||7
8360067|NCT01212471|20607616|P2|NOT COMPLETED|Overall Study||3
8360068|NCT01212471|20607617|P1|NOT COMPLETED|Overall Study||2
8360069|NCT01212471|20607615|P3|COMPLETED|Overall Study||132
8360070|NCT01212471|20607616|P2|COMPLETED|Overall Study||137
8360071|NCT01212471|20607617|P1|COMPLETED|Overall Study||139
8360072|NCT01212471|20607615|P3|STARTED|Overall Study||139
8360073|NCT01212471|20607616|P2|STARTED|Overall Study||140
8360074|NCT01212471|20607617|P1|STARTED|Overall Study||141
8360075|NCT01212445|20607628|P3|NOT COMPLETED|Overall Study||0
8360076|NCT01212445|20607629|P2|NOT COMPLETED|Overall Study||0
8360077|NCT01212445|20607630|P1|NOT COMPLETED|Overall Study||0
8360078|NCT01212445|20607628|P3|COMPLETED|Overall Study||51
8360079|NCT01212445|20607629|P2|COMPLETED|Overall Study||51
8360080|NCT01212445|20607630|P1|COMPLETED|Overall Study||52
8360081|NCT01212445|20607628|P3|STARTED|Overall Study||51
8360082|NCT01212445|20607629|P2|STARTED|Overall Study||51
8360083|NCT01212445|20607630|P1|STARTED|Overall Study||52
8360084|NCT01212302|20607659|P1|NOT COMPLETED|Overall Study||0
8360085|NCT01212302|20607659|P1|COMPLETED|Overall Study||504
8360086|NCT01212302|20607659|P1|STARTED|Overall Study||504
8360087|NCT01212185|20607665|P2|NOT COMPLETED|Overall Study||1
8360088|NCT01212185|20607666|P1|NOT COMPLETED|Overall Study||2
8360089|NCT01212185|20607665|P2|COMPLETED|Overall Study||7
8360090|NCT01212185|20607666|P1|COMPLETED|Overall Study||4
8360091|NCT01212185|20607665|P2|STARTED|Overall Study||8
8360092|NCT01212185|20607666|P1|STARTED|Overall Study||6
8360093|NCT01212172|20607674|P2|NOT COMPLETED|Overall Study||1
8360094|NCT01212172|20607675|P1|NOT COMPLETED|Overall Study||1
8360095|NCT01212172|20607674|P2|COMPLETED|Overall Study||9
8360096|NCT01212172|20607675|P1|COMPLETED|Overall Study||9
8360097|NCT01212172|20607674|P2|STARTED|Overall Study||10
8360098|NCT01212172|20607675|P1|STARTED|Overall Study||10
8360099|NCT01212159|20607685|P2|NOT COMPLETED|Overall Study||12
8360100|NCT01212159|20607686|P1|NOT COMPLETED|Overall Study||12
8360101|NCT01212159|20607685|P2|COMPLETED|Overall Study||32
8360102|NCT01212159|20607686|P1|COMPLETED|Overall Study||14
8360103|NCT01212159|20607685|P2|STARTED|Overall Study||44
8360104|NCT01212159|20607686|P1|STARTED|Overall Study||26
8360105|NCT01212107|20607708|P12|NOT COMPLETED|Overall Study||32
8360106|NCT01212107|20607709|P11|NOT COMPLETED|Overall Study||1
8360107|NCT01212107|20607710|P10|NOT COMPLETED|Overall Study||2
8360108|NCT01212107|20607711|P9|NOT COMPLETED|Overall Study||2
8360109|NCT01212107|20607712|P8|NOT COMPLETED|Overall Study||1
8360110|NCT01212107|20607713|P7|NOT COMPLETED|Overall Study||0
8360111|NCT01212107|20607714|P6|NOT COMPLETED|Overall Study||1
8360112|NCT01212107|20607715|P5|NOT COMPLETED|Overall Study||1
8360113|NCT01212107|20607716|P4|NOT COMPLETED|Overall Study||0
8360114|NCT01212107|20607717|P3|NOT COMPLETED|Overall Study||3
8360115|NCT01212107|20607718|P2|NOT COMPLETED|Overall Study||1
8360116|NCT01212107|20607719|P1|NOT COMPLETED|Overall Study||1
8360117|NCT01212107|20607708|P12|COMPLETED|Overall Study||26
8360118|NCT01212107|20607709|P11|COMPLETED|Overall Study||2
8360119|NCT01212107|20607710|P10|COMPLETED|Overall Study||1
8360120|NCT01212107|20607711|P9|COMPLETED|Overall Study||1
8360121|NCT01212107|20607712|P8|COMPLETED|Overall Study||2
8360122|NCT01212107|20607713|P7|COMPLETED|Overall Study||3
8360123|NCT01212107|20607714|P6|COMPLETED|Overall Study||2
8360124|NCT01212107|20607715|P5|COMPLETED|Overall Study||2
8360125|NCT01212107|20607716|P4|COMPLETED|Overall Study||3
8360126|NCT01212107|20607717|P3|COMPLETED|Overall Study||3
8360127|NCT01212107|20607718|P2|COMPLETED|Overall Study||2
8360128|NCT01212107|20607719|P1|COMPLETED|Overall Study||2
8360129|NCT01212107|20607708|P12|STARTED|Overall Study||58
8360130|NCT01212107|20607709|P11|STARTED|Overall Study||3
8360131|NCT01212107|20607710|P10|STARTED|Overall Study||3
8360132|NCT01212107|20607711|P9|STARTED|Overall Study||3
8360133|NCT01212107|20607712|P8|STARTED|Overall Study||3
8360134|NCT01212107|20607713|P7|STARTED|Overall Study||3
8360135|NCT01212107|20607714|P6|STARTED|Overall Study||3
8360136|NCT01212107|20607715|P5|STARTED|Overall Study||3
8360137|NCT01212107|20607716|P4|STARTED|Overall Study||3
8360138|NCT01212107|20607717|P3|STARTED|Overall Study||6
8360139|NCT01212107|20607718|P2|STARTED|Overall Study||3
8360140|NCT01212107|20607719|P1|STARTED|Overall Study||3
8360141|NCT01212094|20607785|P3|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
8360142|NCT01212094|20607786|P2|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
8360143|NCT01212094|20607787|P1|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
8360144|NCT01212094|20607785|P3|COMPLETED|Years 2 & 3: Treatment Randomization||7
8360145|NCT01212094|20607786|P2|COMPLETED|Years 2 & 3: Treatment Randomization||5
8360146|NCT01212094|20607787|P1|COMPLETED|Years 2 & 3: Treatment Randomization||0
8360147|NCT01212094|20607785|P3|STARTED|Years 2 & 3: Treatment Randomization||18
8360148|NCT01212094|20607786|P2|STARTED|Years 2 & 3: Treatment Randomization||9
8360149|NCT01212094|20607787|P1|STARTED|Years 2 & 3: Treatment Randomization||0
8360150|NCT01212094|20607785|P3|NOT COMPLETED|Year 1: Baseline Monitoring||0
8360151|NCT01212094|20607786|P2|NOT COMPLETED|Year 1: Baseline Monitoring||0
8360152|NCT01212094|20607787|P1|NOT COMPLETED|Year 1: Baseline Monitoring||16
8360153|NCT01212094|20607785|P3|COMPLETED|Year 1: Baseline Monitoring||0
8360154|NCT01212094|20607786|P2|COMPLETED|Year 1: Baseline Monitoring||0
8360155|NCT01212094|20607787|P1|COMPLETED|Year 1: Baseline Monitoring||27
8360156|NCT01212094|20607785|P3|STARTED|Year 1: Baseline Monitoring||0
8360157|NCT01212094|20607786|P2|STARTED|Year 1: Baseline Monitoring||0
8360158|NCT01212094|20607787|P1|STARTED|Year 1: Baseline Monitoring||43
8360159|NCT01211873|20607821|P3|NOT COMPLETED|Overall Study||2
8360160|NCT01211873|20607822|P2|NOT COMPLETED|Overall Study||2
8360161|NCT01211873|20607823|P1|NOT COMPLETED|Overall Study||5
8360162|NCT01211873|20607821|P3|COMPLETED|Overall Study||36
8360163|NCT01211873|20607822|P2|COMPLETED|Overall Study||117
8360164|NCT01211873|20607823|P1|COMPLETED|Overall Study||240
8360165|NCT01211873|20607821|P3|STARTED|Overall Study||38
8360166|NCT01211873|20607822|P2|STARTED|Overall Study||119
8360167|NCT01211873|20607823|P1|STARTED|Overall Study||245
8360168|NCT01211769|20607846|P4|NOT COMPLETED|Overall Study||11
8360169|NCT01211769|20607847|P3|NOT COMPLETED|Overall Study||8
8360170|NCT01211769|20607848|P2|NOT COMPLETED|Overall Study||10
8360171|NCT01211769|20607849|P1|NOT COMPLETED|Overall Study||9
8360172|NCT01211769|20607846|P4|COMPLETED|Overall Study||9
8360173|NCT01211769|20607847|P3|COMPLETED|Overall Study||12
8360174|NCT01211769|20607848|P2|COMPLETED|Overall Study||10
8360175|NCT01211769|20607849|P1|COMPLETED|Overall Study||11
8360176|NCT01211769|20607846|P4|Participants/Group|Overall Study||20
8360177|NCT01211769|20607847|P3|Participants/Group|Overall Study||20
8360178|NCT01211769|20607848|P2|Participants/Group|Overall Study||20
8360179|NCT01211769|20607849|P1|Participants/Group|Overall Study||20
8360180|NCT01211769|20607846|P4|STARTED|Overall Study||20
8360181|NCT01211769|20607847|P3|STARTED|Overall Study||20
8360182|NCT01211769|20607848|P2|STARTED|Overall Study||20
8360183|NCT01211769|20607849|P1|STARTED|Overall Study||20
8360184|NCT01211756|20607867|P1|NOT COMPLETED|Overall Study||0
8360185|NCT01211756|20607867|P1|COMPLETED|Overall Study||1
8360186|NCT01211756|20607867|P1|STARTED|Overall Study||1
8360187|NCT01211730|20607885|P2|NOT COMPLETED|Overall Study||0
8360188|NCT01211730|20607886|P1|NOT COMPLETED|Overall Study||0
8360189|NCT01211730|20607885|P2|COMPLETED|Overall Study||82
8360190|NCT01211730|20607886|P1|COMPLETED|Overall Study||82
8360191|NCT01211730|20607885|P2|STARTED|Overall Study||82
8360192|NCT01211730|20607886|P1|STARTED|Overall Study||82
8360193|NCT01211665|20607904|P2|NOT COMPLETED|Overall Study||0
8360194|NCT01211665|20607905|P1|NOT COMPLETED|Overall Study||2
8360195|NCT01211665|20607904|P2|COMPLETED|Overall Study|completed treatment with study drug|1
8360196|NCT01211665|20607905|P1|COMPLETED|Overall Study||0
8360197|NCT01211665|20607904|P2|STARTED|Overall Study||1
8360198|NCT01211665|20607905|P1|STARTED|Overall Study||2
8360199|NCT01211613|20607932|P3|NOT COMPLETED|Overall Study||2
8360200|NCT01211613|20607933|P2|NOT COMPLETED|Overall Study||2
8360201|NCT01211613|20607934|P1|NOT COMPLETED|Overall Study||3
8360202|NCT01211613|20607932|P3|COMPLETED|Overall Study||33
8360203|NCT01211613|20607933|P2|COMPLETED|Overall Study||33
8360204|NCT01211613|20607934|P1|COMPLETED|Overall Study||34
8360205|NCT01211613|20607932|P3|STARTED|Overall Study||35
8360206|NCT01211613|20607933|P2|STARTED|Overall Study||35
8360207|NCT01211613|20607934|P1|STARTED|Overall Study||37
8360208|NCT01211600|20607947|P2|NOT COMPLETED|Overall Study||0
8360209|NCT01211600|20607948|P1|NOT COMPLETED|Overall Study||0
8360210|NCT01211600|20607947|P2|COMPLETED|Overall Study||376
8360211|NCT01211600|20607948|P1|COMPLETED|Overall Study||370
8360212|NCT01211600|20607947|P2|STARTED|Overall Study||376
8360213|NCT01211600|20607948|P1|STARTED|Overall Study||370
8360214|NCT01211535|20607980|P2|NOT COMPLETED|Overall Study||1
8360215|NCT01211535|20607981|P1|NOT COMPLETED|Overall Study||0
8360216|NCT01211535|20607980|P2|COMPLETED|Overall Study||51
8360217|NCT01211535|20607981|P1|COMPLETED|Overall Study||52
8360218|NCT01211535|20607980|P2|STARTED|Overall Study||52
8360219|NCT01211535|20607981|P1|STARTED|Overall Study||52
8360220|NCT01211522|20607990|P3|NOT COMPLETED|Overall Study||5
8360221|NCT01211522|20607991|P2|NOT COMPLETED|Overall Study||7
8360222|NCT01211522|20607992|P1|NOT COMPLETED|Overall Study||3
8360223|NCT01211522|20607990|P3|COMPLETED|Overall Study||179
8360224|NCT01211522|20607991|P2|COMPLETED|Overall Study||183
8360225|NCT01211522|20607992|P1|COMPLETED|Overall Study||189
8360226|NCT01211522|20607990|P3|STARTED|Overall Study||184
8360227|NCT01211522|20607991|P2|STARTED|Overall Study||190
8360228|NCT01211522|20607992|P1|STARTED|Overall Study||192
8360235|NCT01211288|20608042|P2|NOT COMPLETED|Overall Study||1
8360236|NCT01211288|20608043|P1|NOT COMPLETED|Overall Study||1
8360237|NCT01211288|20608042|P2|COMPLETED|Overall Study||19
8360238|NCT01211288|20608043|P1|COMPLETED|Overall Study||20
8360239|NCT01211288|20608042|P2|STARTED|Overall Study||20
8360240|NCT01211288|20608043|P1|STARTED|Overall Study||21
8360241|NCT01211262|20608061|P2|NOT COMPLETED|Overall Study||10
8360242|NCT01211262|20608062|P1|NOT COMPLETED|Overall Study||23
8360243|NCT01211262|20608061|P2|COMPLETED|Overall Study||8
8360244|NCT01211262|20608062|P1|COMPLETED|Overall Study||43
8360245|NCT01211262|20608061|P2|STARTED|Overall Study||18
8360246|NCT01211262|20608062|P1|STARTED|Overall Study||66
8360247|NCT01211197|20608102|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8360248|NCT01211197|20608103|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8360249|NCT01211197|20608104|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8360250|NCT01211197|20608105|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8360251|NCT01211197|20608106|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8360252|NCT01211197|20608107|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8360253|NCT01211197|20608102|P6|COMPLETED|Treatment Period 3 (1 Day)||2
8360254|NCT01211197|20608103|P5|COMPLETED|Treatment Period 3 (1 Day)||2
8360255|NCT01211197|20608104|P4|COMPLETED|Treatment Period 3 (1 Day)||3
8360256|NCT01211197|20608105|P3|COMPLETED|Treatment Period 3 (1 Day)||2
8360257|NCT01211197|20608106|P2|COMPLETED|Treatment Period 3 (1 Day)||3
8360258|NCT01211197|20608107|P1|COMPLETED|Treatment Period 3 (1 Day)||2
8360259|NCT01211197|20608102|P6|STARTED|Treatment Period 3 (1 Day)||2
8360260|NCT01211197|20608103|P5|STARTED|Treatment Period 3 (1 Day)||2
8360261|NCT01211197|20608104|P4|STARTED|Treatment Period 3 (1 Day)||3
8360262|NCT01211197|20608105|P3|STARTED|Treatment Period 3 (1 Day)||2
8360263|NCT01211197|20608106|P2|STARTED|Treatment Period 3 (1 Day)||3
8360264|NCT01211197|20608107|P1|STARTED|Treatment Period 3 (1 Day)||2
8360265|NCT01211197|20608102|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8360266|NCT01211197|20608103|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8360267|NCT01211197|20608104|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8360268|NCT01211197|20608105|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8360269|NCT01211197|20608106|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8360270|NCT01211197|20608107|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
8360271|NCT01211197|20608102|P6|COMPLETED|Washout Period 2 (7 Days)||2
8360272|NCT01211197|20608103|P5|COMPLETED|Washout Period 2 (7 Days)||2
8360273|NCT01211197|20608104|P4|COMPLETED|Washout Period 2 (7 Days)||3
8360274|NCT01211197|20608105|P3|COMPLETED|Washout Period 2 (7 Days)||2
8360275|NCT01211197|20608106|P2|COMPLETED|Washout Period 2 (7 Days)||3
8360276|NCT01211197|20608107|P1|COMPLETED|Washout Period 2 (7 Days)||2
8360277|NCT01211197|20608102|P6|STARTED|Washout Period 2 (7 Days)||2
8360278|NCT01211197|20608103|P5|STARTED|Washout Period 2 (7 Days)||2
8360279|NCT01211197|20608104|P4|STARTED|Washout Period 2 (7 Days)||3
8360280|NCT01211197|20608105|P3|STARTED|Washout Period 2 (7 Days)||2
8360281|NCT01211197|20608106|P2|STARTED|Washout Period 2 (7 Days)||3
8360282|NCT01211197|20608107|P1|STARTED|Washout Period 2 (7 Days)||3
8360283|NCT01211197|20608102|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8360284|NCT01211197|20608103|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8360285|NCT01211197|20608104|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8360286|NCT01211197|20608105|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8360287|NCT01211197|20608106|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8360288|NCT01211197|20608107|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8360289|NCT01211197|20608102|P6|COMPLETED|Treatment Period 2 (1 Day)||2
8360290|NCT01211197|20608103|P5|COMPLETED|Treatment Period 2 (1 Day)||2
8360291|NCT01211197|20608104|P4|COMPLETED|Treatment Period 2 (1 Day)||3
8360292|NCT01211197|20608105|P3|COMPLETED|Treatment Period 2 (1 Day)||2
8360293|NCT01211197|20608106|P2|COMPLETED|Treatment Period 2 (1 Day)||3
8360294|NCT01211197|20608107|P1|COMPLETED|Treatment Period 2 (1 Day)||3
8360295|NCT01211197|20608102|P6|STARTED|Treatment Period 2 (1 Day)||2
8360296|NCT01211197|20608103|P5|STARTED|Treatment Period 2 (1 Day)||2
8360297|NCT01211197|20608104|P4|STARTED|Treatment Period 2 (1 Day)||3
8360298|NCT01211197|20608105|P3|STARTED|Treatment Period 2 (1 Day)||2
8360299|NCT01211197|20608106|P2|STARTED|Treatment Period 2 (1 Day)||3
8360300|NCT01211197|20608107|P1|STARTED|Treatment Period 2 (1 Day)||3
8360301|NCT01211197|20608102|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
8360302|NCT01211197|20608103|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8360303|NCT01211197|20608104|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8360304|NCT01211197|20608105|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
8360305|NCT01211197|20608106|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8360306|NCT01211197|20608107|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8360307|NCT01211197|20608102|P6|COMPLETED|Washout Period 1 (7 Days)||2
8360308|NCT01211197|20608103|P5|COMPLETED|Washout Period 1 (7 Days)||2
8360309|NCT01211197|20608104|P4|COMPLETED|Washout Period 1 (7 Days)||3
8360310|NCT01211197|20608105|P3|COMPLETED|Washout Period 1 (7 Days)||2
8360311|NCT01211197|20608106|P2|COMPLETED|Washout Period 1 (7 Days)||3
8360312|NCT01211197|20608107|P1|COMPLETED|Washout Period 1 (7 Days)||3
8360313|NCT01211197|20608102|P6|STARTED|Washout Period 1 (7 Days)||2
8360314|NCT01211197|20608103|P5|STARTED|Washout Period 1 (7 Days)||2
8360315|NCT01211197|20608104|P4|STARTED|Washout Period 1 (7 Days)||3
8360316|NCT01211197|20608105|P3|STARTED|Washout Period 1 (7 Days)||3
8360317|NCT01211197|20608106|P2|STARTED|Washout Period 1 (7 Days)||3
8360318|NCT01211197|20608107|P1|STARTED|Washout Period 1 (7 Days)||3
8360319|NCT01211197|20608102|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8360320|NCT01211197|20608103|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8360321|NCT01211197|20608104|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8360322|NCT01211197|20608105|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8360323|NCT01211197|20608106|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8360324|NCT01211197|20608107|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8360325|NCT01211197|20608102|P6|COMPLETED|Treatment Period 1 (1 Day)||2
8360326|NCT01211197|20608103|P5|COMPLETED|Treatment Period 1 (1 Day)||2
8360327|NCT01211197|20608104|P4|COMPLETED|Treatment Period 1 (1 Day)||3
8360328|NCT01211197|20608105|P3|COMPLETED|Treatment Period 1 (1 Day)||3
8360329|NCT01211197|20608106|P2|COMPLETED|Treatment Period 1 (1 Day)||3
8360330|NCT01211197|20608107|P1|COMPLETED|Treatment Period 1 (1 Day)||3
8360331|NCT01211197|20608102|P6|STARTED|Treatment Period 1 (1 Day)||2
8360332|NCT01211197|20608103|P5|STARTED|Treatment Period 1 (1 Day)||2
8360333|NCT01211197|20608104|P4|STARTED|Treatment Period 1 (1 Day)||3
8360334|NCT01211197|20608105|P3|STARTED|Treatment Period 1 (1 Day)||3
8360335|NCT01211197|20608106|P2|STARTED|Treatment Period 1 (1 Day)||3
8360336|NCT01211197|20608107|P1|STARTED|Treatment Period 1 (1 Day)||3
8360337|NCT01211184|20608154|P3|NOT COMPLETED|Overall Study||1
8360338|NCT01211184|20608155|P2|NOT COMPLETED|Overall Study||2
8360339|NCT01211184|20608156|P1|NOT COMPLETED|Overall Study||0
8360340|NCT01211184|20608154|P3|COMPLETED|Overall Study||19
8360341|NCT01211184|20608155|P2|COMPLETED|Overall Study||18
8360342|NCT01211184|20608156|P1|COMPLETED|Overall Study||20
8360343|NCT01211184|20608154|P3|STARTED|Overall Study||20
8360344|NCT01211184|20608155|P2|STARTED|Overall Study||20
8360345|NCT01211184|20608156|P1|STARTED|Overall Study||20
8360346|NCT01211145|20608171|P4|NOT COMPLETED|Overall Study||20
8360347|NCT01211145|20608172|P3|NOT COMPLETED|Overall Study||13
8360348|NCT01211145|20608173|P2|NOT COMPLETED|Overall Study||17
8360349|NCT01211145|20608174|P1|NOT COMPLETED|Overall Study||26
8360350|NCT01211145|20608171|P4|COMPLETED|Overall Study||268
8360351|NCT01211145|20608172|P3|COMPLETED|Overall Study||86
8360352|NCT01211145|20608173|P2|COMPLETED|Overall Study||98
8360353|NCT01211145|20608174|P1|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
8360354|NCT01211145|20608171|P4|STARTED|Overall Study||288
8360355|NCT01211145|20608172|P3|STARTED|Overall Study||99
8360356|NCT01211145|20608173|P2|STARTED|Overall Study||115
8360357|NCT01211145|20608174|P1|STARTED|Overall Study||296
8360358|NCT01211106|20608206|P2|NOT COMPLETED|Overall Study||11
8360359|NCT01211106|20608207|P1|NOT COMPLETED|Overall Study||13
8360360|NCT01211106|20608206|P2|COMPLETED|Overall Study||77
8360361|NCT01211106|20608207|P1|COMPLETED|Overall Study||82
8360362|NCT01211106|20608206|P2|STARTED|Overall Study||88
8360363|NCT01211106|20608207|P1|STARTED|Overall Study||95
8360364|NCT01210820|20608217|P2|NOT COMPLETED|Overall Study||0
8360365|NCT01210820|20608218|P1|NOT COMPLETED|Overall Study||0
8360366|NCT01210820|20608217|P2|COMPLETED|Overall Study||4
8360367|NCT01210820|20608218|P1|COMPLETED|Overall Study||17
8360368|NCT01210820|20608217|P2|STARTED|Overall Study||4
8360369|NCT01210820|20608218|P1|STARTED|Overall Study||17
8360370|NCT01210807|20608228|P2|NOT COMPLETED|Overall Study||3
8360371|NCT01210807|20608229|P1|NOT COMPLETED|Overall Study||3
8360372|NCT01210807|20608228|P2|COMPLETED|Overall Study||31
8360373|NCT01210807|20608229|P1|COMPLETED|Overall Study||33
8360374|NCT01210807|20608228|P2|STARTED|Overall Study||34
8360375|NCT01210807|20608229|P1|STARTED|Overall Study||36
8360376|NCT01210716|20608237|P2|NOT COMPLETED|Second TPE Procedure||0
8360377|NCT01210716|20608238|P1|NOT COMPLETED|Second TPE Procedure||3
8360378|NCT01210716|20608237|P2|COMPLETED|Second TPE Procedure||15
8360379|NCT01210716|20608238|P1|COMPLETED|Second TPE Procedure||15
8360380|NCT01210716|20608237|P2|STARTED|Second TPE Procedure||15
8360381|NCT01210716|20608238|P1|STARTED|Second TPE Procedure||18
8360382|NCT01210716|20608237|P2|NOT COMPLETED|First TPE Procedure||2
8360383|NCT01210716|20608238|P1|NOT COMPLETED|First TPE Procedure||2
8360384|NCT01210716|20608237|P2|COMPLETED|First TPE Procedure||15
8360385|NCT01210716|20608238|P1|COMPLETED|First TPE Procedure||18
8360386|NCT01210716|20608237|P2|STARTED|First TPE Procedure||17
8360387|NCT01210716|20608238|P1|STARTED|First TPE Procedure||20
8360388|NCT01210690|20608244|P1|NOT COMPLETED|Overall Study||26
8360389|NCT01210690|20608244|P1|COMPLETED|Overall Study||75
8360390|NCT01210690|20608244|P1|STARTED|Overall Study||101
8360391|NCT01210664|20608257|P4|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
8360392|NCT01210664|20608258|P3|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360393|NCT01210664|20608259|P2|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360394|NCT01210664|20608260|P1|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360395|NCT01210664|20608257|P4|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
8360396|NCT01210664|20608258|P3|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360397|NCT01210664|20608259|P2|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360398|NCT01210664|20608260|P1|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360399|NCT01210664|20608257|P4|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
8360400|NCT01210664|20608258|P3|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360401|NCT01210664|20608259|P2|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360402|NCT01210664|20608260|P1|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360403|NCT01210664|20608257|P4|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
8360404|NCT01210664|20608258|P3|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360405|NCT01210664|20608259|P2|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360406|NCT01210664|20608260|P1|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
8360407|NCT01210664|20608257|P4|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360408|NCT01210664|20608258|P3|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
8360409|NCT01210664|20608259|P2|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360410|NCT01210664|20608260|P1|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360411|NCT01210664|20608257|P4|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360412|NCT01210664|20608258|P3|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
8360413|NCT01210664|20608259|P2|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360414|NCT01210664|20608260|P1|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360415|NCT01210664|20608257|P4|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360416|NCT01210664|20608258|P3|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
8360417|NCT01210664|20608259|P2|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360418|NCT01210664|20608260|P1|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360419|NCT01210664|20608257|P4|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360420|NCT01210664|20608258|P3|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
8360421|NCT01210664|20608259|P2|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360422|NCT01210664|20608260|P1|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
8360423|NCT01210664|20608257|P4|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360424|NCT01210664|20608258|P3|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360425|NCT01210664|20608259|P2|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360426|NCT01210664|20608260|P1|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360427|NCT01210664|20608257|P4|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360428|NCT01210664|20608258|P3|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360429|NCT01210664|20608259|P2|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
8360430|NCT01210664|20608260|P1|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360431|NCT01210664|20608257|P4|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360432|NCT01210664|20608258|P3|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360433|NCT01210664|20608259|P2|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
8360434|NCT01210664|20608260|P1|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360435|NCT01210664|20608257|P4|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360436|NCT01210664|20608258|P3|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360437|NCT01210664|20608259|P2|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
8360438|NCT01210664|20608260|P1|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
8360439|NCT01210664|20608257|P4|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360440|NCT01210664|20608258|P3|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360441|NCT01210664|20608259|P2|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360442|NCT01210664|20608260|P1|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360443|NCT01210664|20608257|P4|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360444|NCT01210664|20608258|P3|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360445|NCT01210664|20608259|P2|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360446|NCT01210664|20608260|P1|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
8360447|NCT01210664|20608257|P4|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360448|NCT01210664|20608258|P3|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360449|NCT01210664|20608259|P2|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360450|NCT01210664|20608260|P1|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
8360451|NCT01210664|20608257|P4|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360452|NCT01210664|20608258|P3|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360453|NCT01210664|20608259|P2|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
8360454|NCT01210664|20608260|P1|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
8360455|NCT01210651|20608288|P2|NOT COMPLETED|Overall Study||8
8360456|NCT01210651|20608289|P1|NOT COMPLETED|Overall Study||5
8360457|NCT01210651|20608288|P2|COMPLETED|Overall Study||10
8360458|NCT01210651|20608289|P1|COMPLETED|Overall Study||15
8360459|NCT01210651|20608288|P2|Number Attending 1st Assigned Session|Overall Study||12
8360460|NCT01210651|20608289|P1|Number Attending 1st Assigned Session|Overall Study||18
8360461|NCT01210651|20608288|P2|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
8360462|NCT01210651|20608289|P1|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
8360463|NCT01210560|20608305|P9|NOT COMPLETED|Intervention 3 (7 Days)||0
8360464|NCT01210560|20608306|P8|NOT COMPLETED|Intervention 3 (7 Days)||0
8360465|NCT01210560|20608307|P7|NOT COMPLETED|Intervention 3 (7 Days)||0
8360466|NCT01210560|20608308|P6|NOT COMPLETED|Intervention 3 (7 Days)||0
8360467|NCT01210560|20608309|P5|NOT COMPLETED|Intervention 3 (7 Days)||0
8360468|NCT01210560|20608310|P4|NOT COMPLETED|Intervention 3 (7 Days)||0
8360469|NCT01210560|20608311|P3|NOT COMPLETED|Intervention 3 (7 Days)||0
8360470|NCT01210560|20608312|P2|NOT COMPLETED|Intervention 3 (7 Days)||0
8360471|NCT01210560|20608313|P1|NOT COMPLETED|Intervention 3 (7 Days)||0
8360472|NCT01210560|20608305|P9|COMPLETED|Intervention 3 (7 Days)||5
8360473|NCT01210560|20608306|P8|COMPLETED|Intervention 3 (7 Days)||4
8360474|NCT01210560|20608307|P7|COMPLETED|Intervention 3 (7 Days)||4
8360475|NCT01210560|20608308|P6|COMPLETED|Intervention 3 (7 Days)||2
8360476|NCT01210560|20608309|P5|COMPLETED|Intervention 3 (7 Days)||2
8360477|NCT01210560|20608310|P4|COMPLETED|Intervention 3 (7 Days)||2
8360478|NCT01210560|20608311|P3|COMPLETED|Intervention 3 (7 Days)||2
8360479|NCT01210560|20608312|P2|COMPLETED|Intervention 3 (7 Days)||2
8360480|NCT01210560|20608313|P1|COMPLETED|Intervention 3 (7 Days)||2
8360481|NCT01210560|20608305|P9|STARTED|Intervention 3 (7 Days)||5
8360482|NCT01210560|20608306|P8|STARTED|Intervention 3 (7 Days)||4
8360483|NCT01210560|20608307|P7|STARTED|Intervention 3 (7 Days)||4
8360484|NCT01210560|20608308|P6|STARTED|Intervention 3 (7 Days)||2
8360485|NCT01210560|20608309|P5|STARTED|Intervention 3 (7 Days)||2
8360486|NCT01210560|20608310|P4|STARTED|Intervention 3 (7 Days)||2
8360487|NCT01210560|20608311|P3|STARTED|Intervention 3 (7 Days)||2
8360488|NCT01210560|20608312|P2|STARTED|Intervention 3 (7 Days)||2
8360489|NCT01210560|20608313|P1|STARTED|Intervention 3 (7 Days)||2
8360490|NCT01210560|20608305|P9|NOT COMPLETED|Intervention 2 (7 Days)||0
8360491|NCT01210560|20608306|P8|NOT COMPLETED|Intervention 2 (7 Days)||0
8360492|NCT01210560|20608307|P7|NOT COMPLETED|Intervention 2 (7 Days)||0
8360493|NCT01210560|20608308|P6|NOT COMPLETED|Intervention 2 (7 Days)||0
8360494|NCT01210560|20608309|P5|NOT COMPLETED|Intervention 2 (7 Days)||0
8360495|NCT01210560|20608310|P4|NOT COMPLETED|Intervention 2 (7 Days)||0
8360496|NCT01210560|20608311|P3|NOT COMPLETED|Intervention 2 (7 Days)||0
8360497|NCT01210560|20608312|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
8360498|NCT01210560|20608313|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
8360499|NCT01210560|20608305|P9|COMPLETED|Intervention 2 (7 Days)||5
8360500|NCT01210560|20608306|P8|COMPLETED|Intervention 2 (7 Days)||4
8360501|NCT01210560|20608307|P7|COMPLETED|Intervention 2 (7 Days)||4
8360502|NCT01210560|20608308|P6|COMPLETED|Intervention 2 (7 Days)||2
8360503|NCT01210560|20608309|P5|COMPLETED|Intervention 2 (7 Days)||2
8360504|NCT01210560|20608310|P4|COMPLETED|Intervention 2 (7 Days)||2
8360505|NCT01210560|20608311|P3|COMPLETED|Intervention 2 (7 Days)||2
8360506|NCT01210560|20608312|P2|COMPLETED|Intervention 2 (7 Days)||2
8360507|NCT01210560|20608313|P1|COMPLETED|Intervention 2 (7 Days)||2
8360508|NCT01210560|20608305|P9|STARTED|Intervention 2 (7 Days)||5
8360509|NCT01210560|20608306|P8|STARTED|Intervention 2 (7 Days)||4
8360510|NCT01210560|20608307|P7|STARTED|Intervention 2 (7 Days)||4
8360511|NCT01210560|20608308|P6|STARTED|Intervention 2 (7 Days)||2
8360512|NCT01210560|20608309|P5|STARTED|Intervention 2 (7 Days)||2
8360513|NCT01210560|20608310|P4|STARTED|Intervention 2 (7 Days)||2
8360514|NCT01210560|20608311|P3|STARTED|Intervention 2 (7 Days)||2
8360515|NCT01210560|20608312|P2|STARTED|Intervention 2 (7 Days)||2
8360516|NCT01210560|20608313|P1|STARTED|Intervention 2 (7 Days)||2
8360517|NCT01210560|20608305|P9|NOT COMPLETED|Intervention 1 (7 Days)||0
8360518|NCT01210560|20608306|P8|NOT COMPLETED|Intervention 1 (7 Days)||0
8360519|NCT01210560|20608307|P7|NOT COMPLETED|Intervention 1 (7 Days)||0
8360520|NCT01210560|20608308|P6|NOT COMPLETED|Intervention 1 (7 Days)||0
8360521|NCT01210560|20608309|P5|NOT COMPLETED|Intervention 1 (7 Days)||0
8360522|NCT01210560|20608310|P4|NOT COMPLETED|Intervention 1 (7 Days)||0
8360523|NCT01210560|20608311|P3|NOT COMPLETED|Intervention 1 (7 Days)||0
8360524|NCT01210560|20608312|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
8360525|NCT01210560|20608313|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
8360526|NCT01210560|20608305|P9|COMPLETED|Intervention 1 (7 Days)||5
8360527|NCT01210560|20608306|P8|COMPLETED|Intervention 1 (7 Days)||4
8360528|NCT01210560|20608307|P7|COMPLETED|Intervention 1 (7 Days)||4
8360529|NCT01210560|20608308|P6|COMPLETED|Intervention 1 (7 Days)||2
8360530|NCT01210560|20608309|P5|COMPLETED|Intervention 1 (7 Days)||2
8360531|NCT01210560|20608310|P4|COMPLETED|Intervention 1 (7 Days)||2
8360532|NCT01210560|20608311|P3|COMPLETED|Intervention 1 (7 Days)||2
8360533|NCT01210560|20608312|P2|COMPLETED|Intervention 1 (7 Days)||2
8360534|NCT01210560|20608313|P1|COMPLETED|Intervention 1 (7 Days)||2
8360535|NCT01210560|20608305|P9|STARTED|Intervention 1 (7 Days)||5
8360536|NCT01210560|20608306|P8|STARTED|Intervention 1 (7 Days)||4
8360537|NCT01210560|20608307|P7|STARTED|Intervention 1 (7 Days)||4
8360538|NCT01210560|20608308|P6|STARTED|Intervention 1 (7 Days)||2
8360539|NCT01210560|20608309|P5|STARTED|Intervention 1 (7 Days)||2
8360540|NCT01210560|20608310|P4|STARTED|Intervention 1 (7 Days)||2
8360541|NCT01210560|20608311|P3|STARTED|Intervention 1 (7 Days)||2
8360542|NCT01210560|20608312|P2|STARTED|Intervention 1 (7 Days)||2
8360543|NCT01210560|20608313|P1|STARTED|Intervention 1 (7 Days)||2
8360544|NCT01210495|20608409|P4|NOT COMPLETED|Overall Study||68
8360545|NCT01210495|20608410|P3|NOT COMPLETED|Overall Study||134
8360546|NCT01210495|20608411|P2|NOT COMPLETED|Overall Study||7
8360547|NCT01210495|20608412|P1|NOT COMPLETED|Overall Study||15
8360548|NCT01210495|20608409|P4|COMPLETED|Overall Study||0
8360549|NCT01210495|20608410|P3|COMPLETED|Overall Study||0
8360550|NCT01210495|20608411|P2|COMPLETED|Overall Study||0
8360551|NCT01210495|20608412|P1|COMPLETED|Overall Study||0
8360552|NCT01210495|20608409|P4|STARTED|Overall Study||68
8360553|NCT01210495|20608410|P3|STARTED|Overall Study||134
8360554|NCT01210495|20608411|P2|STARTED|Overall Study||7
8360555|NCT01210495|20608412|P1|STARTED|Overall Study||15
8360556|NCT01210443|20608474|P1|NOT COMPLETED|Overall Study||2
8360557|NCT01210443|20608474|P1|COMPLETED|Overall Study||0
8360558|NCT01210443|20608474|P1|STARTED|Overall Study||2
8360586|NCT01210222|20608690|P1|NOT COMPLETED|Overall Study||3
8360587|NCT01210222|20608690|P1|COMPLETED|Overall Study||32
8360588|NCT01210222|20608690|P1|STARTED|Overall Study||35
8360589|NCT01210170|20608703|P1|NOT COMPLETED|Overall Study||7
8360590|NCT01210170|20608703|P1|COMPLETED|Overall Study||15
8360591|NCT01210170|20608703|P1|STARTED|Overall Study||22
8360592|NCT01210144|20608726|P2|NOT COMPLETED|Overall Study||0
8360593|NCT01210144|20608727|P1|NOT COMPLETED|Overall Study||3
8360594|NCT01210144|20608726|P2|COMPLETED|Overall Study||11
8360595|NCT01210144|20608727|P1|COMPLETED|Overall Study||10
8360596|NCT01210144|20608726|P2|STARTED|Overall Study||11
8360597|NCT01210144|20608727|P1|STARTED|Overall Study||13
8360598|NCT01210118|20608749|P2|NOT COMPLETED|Overall Study||5
8360599|NCT01210118|20608750|P1|NOT COMPLETED|Overall Study||3
8360600|NCT01210118|20608749|P2|COMPLETED|Overall Study||42
8360601|NCT01210118|20608750|P1|COMPLETED|Overall Study||42
8360602|NCT01210118|20608749|P2|STARTED|Overall Study||47
8360603|NCT01210118|20608750|P1|STARTED|Overall Study||45
8360604|NCT01210079|20608764|P2|NOT COMPLETED|Overall Study||0
8360605|NCT01210079|20608765|P1|NOT COMPLETED|Overall Study||0
8360606|NCT01210079|20608764|P2|COMPLETED|Overall Study||16
8360607|NCT01210079|20608765|P1|COMPLETED|Overall Study||10
8360608|NCT01210079|20608764|P2|STARTED|Overall Study||16
8360609|NCT01210079|20608765|P1|STARTED|Overall Study||10
8360610|NCT01210001|20608774|P3|NOT COMPLETED|Overall Study||12
8360611|NCT01210001|20608775|P2|NOT COMPLETED|Overall Study||11
8360612|NCT01210001|20608776|P1|NOT COMPLETED|Overall Study||19
8360613|NCT01210001|20608774|P3|COMPLETED|Overall Study||156
8360614|NCT01210001|20608775|P2|COMPLETED|Overall Study||154
8360615|NCT01210001|20608776|P1|COMPLETED|Overall Study||147
8360616|NCT01210001|20608774|P3|STARTED|Overall Study||168
8360617|NCT01210001|20608775|P2|STARTED|Overall Study||165
8360618|NCT01210001|20608776|P1|STARTED|Overall Study||166
8360619|NCT01209949|20608796|P1|NOT COMPLETED|Overall Study||3
8360620|NCT01209949|20608796|P1|COMPLETED|Overall Study||27
8360621|NCT01209949|20608796|P1|STARTED|Overall Study||30
8360622|NCT01209832|20608802|P1|NOT COMPLETED|Maintenance Period 2 (M1)||0
8360623|NCT01209832|20608802|P1|COMPLETED|Maintenance Period 2 (M1)||3
8360624|NCT01209832|20608802|P1|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3
8360625|NCT01209832|20608802|P1|NOT COMPLETED|Maintenance Period 1 (M1)||0
8360626|NCT01209832|20608802|P1|COMPLETED|Maintenance Period 1 (M1)||4
8360627|NCT01209832|20608802|P1|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4
8360628|NCT01209832|20608802|P1|NOT COMPLETED|Period 2||1
8360629|NCT01209832|20608802|P1|COMPLETED|Period 2||9
8360630|NCT01209832|20608802|P1|STARTED|Period 2||10
8360631|NCT01209832|20608802|P1|NOT COMPLETED|Period 1||1
8360632|NCT01209832|20608802|P1|COMPLETED|Period 1||10
8360633|NCT01209832|20608802|P1|Received At Least 1 Dose of Study Drug|Period 1||10
8360634|NCT01209832|20608802|P1|STARTED|Period 1||11
8360635|NCT01209780|20608821|P5|NOT COMPLETED|Overall Study||5
8360636|NCT01209780|20608822|P4|NOT COMPLETED|Overall Study||10
8360637|NCT01209780|20608823|P3|NOT COMPLETED|Overall Study||4
8360638|NCT01209780|20608824|P2|NOT COMPLETED|Overall Study||18
8360639|NCT01209780|20608825|P1|NOT COMPLETED|Overall Study||26
8360640|NCT01209780|20608821|P5|COMPLETED|Overall Study||407
8360641|NCT01209780|20608822|P4|COMPLETED|Overall Study||807
8360642|NCT01209780|20608823|P3|COMPLETED|Overall Study||44
8360643|NCT01209780|20608824|P2|COMPLETED|Overall Study||467
8360644|NCT01209780|20608825|P1|COMPLETED|Overall Study||1016
8360645|NCT01209780|20608821|P5|STARTED|Overall Study||412
8360646|NCT01209780|20608822|P4|STARTED|Overall Study||817
8360647|NCT01209780|20608823|P3|STARTED|Overall Study||48
8360648|NCT01209780|20608824|P2|STARTED|Overall Study||485
8360649|NCT01209780|20608825|P1|STARTED|Overall Study||1042
8360650|NCT01209767|20608851|P1|NOT COMPLETED|Overall Study||4
8360651|NCT01209767|20608851|P1|COMPLETED|Overall Study||18
8360652|NCT01209767|20608851|P1|STARTED|Overall Study||22
8360653|NCT01209702|20608861|P4|NOT COMPLETED|Overall Study||153
8360654|NCT01209702|20608862|P3|NOT COMPLETED|Overall Study||51
8360655|NCT01209702|20608863|P2|NOT COMPLETED|Overall Study||51
8360656|NCT01209702|20608864|P1|NOT COMPLETED|Overall Study||51
8360657|NCT01209702|20608861|P4|COMPLETED|Overall Study||0
8360658|NCT01209702|20608862|P3|COMPLETED|Overall Study||0
8360659|NCT01209702|20608863|P2|COMPLETED|Overall Study||0
8360660|NCT01209702|20608864|P1|COMPLETED|Overall Study||0
8360661|NCT01209702|20608861|P4|Completed 24 Weeks Treatment|Overall Study||10
8360662|NCT01209702|20608862|P3|Completed 24 Weeks Treatment|Overall Study||3
8360663|NCT01209702|20608863|P2|Completed 24 Weeks Treatment|Overall Study||28
8360664|NCT01209702|20608864|P1|Completed 24 Weeks Treatment|Overall Study||19
8360665|NCT01209702|20608861|P4|Completed 12 Weeks Treatment|Overall Study||59
8360666|NCT01209702|20608862|P3|Completed 12 Weeks Treatment|Overall Study||12
8360667|NCT01209702|20608863|P2|Completed 12 Weeks Treatment|Overall Study||48
8360668|NCT01209702|20608864|P1|Completed 12 Weeks Treatment|Overall Study||50
8360669|NCT01209702|20608861|P4|Escape or Switched to Tocilizumab|Overall Study||0
8360670|NCT01209702|20608862|P3|Escape or Switched to Tocilizumab|Overall Study||6
8360671|NCT01209702|20608863|P2|Escape or Switched to Tocilizumab|Overall Study||0
8360672|NCT01209702|20608864|P1|Escape or Switched to Tocilizumab|Overall Study||51
8360673|NCT01209702|20608861|P4|Treated|Overall Study||152
8360674|NCT01209702|20608862|P3|Treated|Overall Study||51
8360675|NCT01209702|20608863|P2|Treated|Overall Study||51
8360676|NCT01209702|20608864|P1|Treated|Overall Study||51
8360677|NCT01209702|20608861|P4|STARTED|Overall Study||153
8360678|NCT01209702|20608862|P3|STARTED|Overall Study||51
8360679|NCT01209702|20608863|P2|STARTED|Overall Study||51
8360680|NCT01209702|20608864|P1|STARTED|Overall Study||51
8360681|NCT01209689|20608920|P2|NOT COMPLETED|Overall Study||22
8360682|NCT01209689|20608921|P1|NOT COMPLETED|Overall Study||91
8360683|NCT01209689|20608920|P2|COMPLETED|Overall Study||0
8360684|NCT01209689|20608921|P1|COMPLETED|Overall Study||0
8360685|NCT01209689|20608920|P2|STARTED|Overall Study||22
8360686|NCT01209689|20608921|P1|STARTED|Overall Study||91
8360691|NCT01209598|20608960|P2|NOT COMPLETED|Overall Study||0
8360692|NCT01209598|20608961|P1|NOT COMPLETED|Overall Study||1
8360693|NCT01209598|20608960|P2|COMPLETED|Overall Study||60
8360694|NCT01209598|20608961|P1|COMPLETED|Overall Study||29
8360695|NCT01209598|20608960|P2|STARTED|Overall Study||60
8360696|NCT01209598|20608961|P1|STARTED|Overall Study||30
8360697|NCT01209520|20608969|P1|NOT COMPLETED|Overall Study||3
8360698|NCT01209520|20608969|P1|COMPLETED|Overall Study||3
8360699|NCT01209520|20608969|P1|STARTED|Overall Study||6
8360700|NCT01209442|20608974|P1|NOT COMPLETED|Overall Study||0
8360701|NCT01209442|20608974|P1|COMPLETED|Overall Study||30
8360702|NCT01209442|20608974|P1|STARTED|Overall Study||30
8360703|NCT01209325|20608979|P1|NOT COMPLETED|Overall Study||43
8360704|NCT01209325|20608979|P1|COMPLETED|Overall Study||106
8360705|NCT01209325|20608979|P1|Returned After Week 28|Overall Study||124
8360706|NCT01209325|20608979|P1|Received Third Vaccine Infjection|Overall Study||138
8360707|NCT01209325|20608979|P1|Received Second Vaccine Injection|Overall Study||141
8360708|NCT01209325|20608979|P1|Received First Vaccine Injection|Overall Study||144
8360709|NCT01209325|20608979|P1|Eligible|Overall Study||145
8360710|NCT01209325|20608979|P1|STARTED|Overall Study||149
8360711|NCT01209286|20609034|P3|NOT COMPLETED|Overall Study||3
8360712|NCT01209286|20609035|P2|NOT COMPLETED|Overall Study||10
8360713|NCT01209286|20609036|P1|NOT COMPLETED|Overall Study||5
8360714|NCT01209286|20609034|P3|COMPLETED|Overall Study||3
8360715|NCT01209286|20609035|P2|COMPLETED|Overall Study||13
8360716|NCT01209286|20609036|P1|COMPLETED|Overall Study||2
8360717|NCT01209286|20609034|P3|STARTED|Overall Study||6
8360718|NCT01209286|20609035|P2|STARTED|Overall Study||23
8360719|NCT01209286|20609036|P1|STARTED|Overall Study||7
8360720|NCT01209260|20609089|P2|NOT COMPLETED|Overall Study||0
8360721|NCT01209260|20609090|P1|NOT COMPLETED|Overall Study||0
8360722|NCT01209260|20609089|P2|COMPLETED|Overall Study||36
8360723|NCT01209260|20609090|P1|COMPLETED|Overall Study||36
8360724|NCT01209260|20609089|P2|STARTED|Overall Study||36
8360725|NCT01209260|20609090|P1|STARTED|Overall Study||36
8360726|NCT01209234|20609104|P2|NOT COMPLETED|Overall Study||7
8360727|NCT01209234|20609105|P1|NOT COMPLETED|Overall Study||12
8360728|NCT01209234|20609104|P2|COMPLETED|Overall Study||1063
8360729|NCT01209234|20609105|P1|COMPLETED|Overall Study||1058
8360730|NCT01209234|20609104|P2|STARTED|Overall Study||1070
8360731|NCT01209234|20609105|P1|STARTED|Overall Study||1070
8360732|NCT01209195|20609115|P6|NOT COMPLETED|Overall Study||0
8360733|NCT01209195|20609116|P5|NOT COMPLETED|Overall Study||0
8360734|NCT01209195|20609117|P4|NOT COMPLETED|Overall Study||0
8360735|NCT01209195|20609118|P3|NOT COMPLETED|Overall Study||0
8360736|NCT01209195|20609119|P2|NOT COMPLETED|Overall Study||0
8360737|NCT01209195|20609120|P1|NOT COMPLETED|Overall Study||0
8360738|NCT01209195|20609115|P6|COMPLETED|Overall Study||13
8360739|NCT01209195|20609116|P5|COMPLETED|Overall Study||6
8360740|NCT01209195|20609117|P4|COMPLETED|Overall Study||6
8360741|NCT01209195|20609118|P3|COMPLETED|Overall Study||6
8360742|NCT01209195|20609119|P2|COMPLETED|Overall Study||3
8360743|NCT01209195|20609120|P1|COMPLETED|Overall Study||7
8360744|NCT01209195|20609115|P6|STARTED|Overall Study||13
8360745|NCT01209195|20609116|P5|STARTED|Overall Study||6
8360746|NCT01209195|20609117|P4|STARTED|Overall Study||6
8360747|NCT01209195|20609118|P3|STARTED|Overall Study||6
8360748|NCT01209195|20609119|P2|STARTED|Overall Study||3
8360749|NCT01209195|20609120|P1|STARTED|Overall Study||7
8360750|NCT01209143|20609156|P2|NOT COMPLETED|Overall Study||20
8360751|NCT01209143|20609157|P1|NOT COMPLETED|Overall Study||19
8360752|NCT01209143|20609156|P2|COMPLETED|Overall Study||8
8360753|NCT01209143|20609157|P1|COMPLETED|Overall Study||5
8360754|NCT01209143|20609156|P2|STARTED|Overall Study||28
8360755|NCT01209143|20609157|P1|STARTED|Overall Study||24
8360756|NCT01209078|20609167|P2|NOT COMPLETED|Overall Study||3
8360757|NCT01209078|20609168|P1|NOT COMPLETED|Overall Study||16
8360758|NCT01209078|20609167|P2|COMPLETED|Overall Study||24
8360759|NCT01209078|20609168|P1|COMPLETED|Overall Study||41
8360760|NCT01209078|20609167|P2|STARTED|Overall Study||27
8360761|NCT01209078|20609168|P1|STARTED|Overall Study||57
8360762|NCT01208961|20609243|P2|NOT COMPLETED|High-Fat Period IV||0
8360763|NCT01208961|20609244|P1|NOT COMPLETED|High-Fat Period IV||0
8360764|NCT01208961|20609243|P2|COMPLETED|High-Fat Period IV||26
8360765|NCT01208961|20609244|P1|COMPLETED|High-Fat Period IV||25
8360766|NCT01208961|20609243|P2|STARTED|High-Fat Period IV||26
8360767|NCT01208961|20609244|P1|STARTED|High-Fat Period IV||25
8360768|NCT01208961|20609243|P2|NOT COMPLETED|High-Fat Period III||0
8360769|NCT01208961|20609244|P1|NOT COMPLETED|High-Fat Period III||1
8360770|NCT01208961|20609243|P2|COMPLETED|High-Fat Period III||26
8360771|NCT01208961|20609244|P1|COMPLETED|High-Fat Period III||25
8360772|NCT01208961|20609243|P2|STARTED|High-Fat Period III||26
8360773|NCT01208961|20609244|P1|STARTED|High-Fat Period III||26
8360774|NCT01208961|20609243|P2|NOT COMPLETED|Low-Fat Period II||0
8360775|NCT01208961|20609244|P1|NOT COMPLETED|Low-Fat Period II||0
8360776|NCT01208961|20609243|P2|COMPLETED|Low-Fat Period II||27
8360777|NCT01208961|20609244|P1|COMPLETED|Low-Fat Period II||26
8360778|NCT01208961|20609243|P2|STARTED|Low-Fat Period II||27
8360779|NCT01208961|20609244|P1|STARTED|Low-Fat Period II||26
8360780|NCT01208961|20609243|P2|NOT COMPLETED|Low-Fat Period I||0
8360781|NCT01208961|20609244|P1|NOT COMPLETED|Low-Fat Period I||0
8360782|NCT01208961|20609243|P2|COMPLETED|Low-Fat Period I||27
8360783|NCT01208961|20609244|P1|COMPLETED|Low-Fat Period I||27
8360784|NCT01208961|20609243|P2|STARTED|Low-Fat Period I||27
8360785|NCT01208961|20609244|P1|STARTED|Low-Fat Period I||27
8360786|NCT01208922|20609255|P2|NOT COMPLETED|Overall Study||10
8360787|NCT01208922|20609256|P1|NOT COMPLETED|Overall Study||11
8360788|NCT01208922|20609255|P2|COMPLETED|Overall Study||405
8360789|NCT01208922|20609256|P1|COMPLETED|Overall Study||409
8360790|NCT01208922|20609255|P2|STARTED|Overall Study||415
8360791|NCT01208922|20609256|P1|STARTED|Overall Study||420
8360792|NCT01208870|20609266|P2|NOT COMPLETED|Overall Study||8
8360793|NCT01208870|20609267|P1|NOT COMPLETED|Overall Study||2
8360794|NCT01208870|20609266|P2|COMPLETED|Overall Study||36
8360795|NCT01208870|20609267|P1|COMPLETED|Overall Study||44
8360796|NCT01208870|20609266|P2|Pilot 2|Overall Study||22
8360797|NCT01208870|20609267|P1|Pilot 2|Overall Study||26
8360798|NCT01208870|20609266|P2|Pilot 1|Overall Study||22
8360799|NCT01208870|20609267|P1|Pilot 1|Overall Study||20
8360800|NCT01208870|20609266|P2|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
8360801|NCT01208870|20609267|P1|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
8360802|NCT01208415|20609283|P1|NOT COMPLETED|Overall Study||40
8360803|NCT01208415|20609283|P1|COMPLETED|Overall Study||0
8360804|NCT01208415|20609283|P1|6 Months|Overall Study||37
8360805|NCT01208415|20609283|P1|STARTED|Overall Study||40
8360806|NCT01208402|20609289|P2|NOT COMPLETED|Overall Study||0
8360807|NCT01208402|20609290|P1|NOT COMPLETED|Overall Study||1
8360808|NCT01208402|20609289|P2|COMPLETED|Overall Study||28
8360809|NCT01208402|20609290|P1|COMPLETED|Overall Study||30
8360810|NCT01208402|20609289|P2|STARTED|Overall Study||28
8360811|NCT01208402|20609290|P1|STARTED|Overall Study||31
8360812|NCT01208337|20609306|P1|NOT COMPLETED|Overall Study||3
8360813|NCT01208337|20609306|P1|COMPLETED|Overall Study||20
8360814|NCT01208337|20609306|P1|Five-year Follow-up|Overall Study||20
8360815|NCT01208337|20609306|P1|One-year Follow-up|Overall Study||23
8360816|NCT01208337|20609306|P1|STARTED|Overall Study||23
8360817|NCT01208233|20609320|P6|NOT COMPLETED|Overall Study||21
8360818|NCT01208233|20609321|P5|NOT COMPLETED|Overall Study||24
8360819|NCT01208233|20609322|P4|NOT COMPLETED|Overall Study||1
8360820|NCT01208233|20609323|P3|NOT COMPLETED|Overall Study||4
8360821|NCT01208233|20609324|P2|NOT COMPLETED|Overall Study||3
8360822|NCT01208233|20609325|P1|NOT COMPLETED|Overall Study||5
8360823|NCT01208233|20609320|P6|COMPLETED|Overall Study||46
8360824|NCT01208233|20609321|P5|COMPLETED|Overall Study||46
8360825|NCT01208233|20609322|P4|COMPLETED|Overall Study||9
8360826|NCT01208233|20609323|P3|COMPLETED|Overall Study||7
8360827|NCT01208233|20609324|P2|COMPLETED|Overall Study||6
8360828|NCT01208233|20609325|P1|COMPLETED|Overall Study||6
8360829|NCT01208233|20609320|P6|STARTED|Overall Study||67
8360830|NCT01208233|20609321|P5|STARTED|Overall Study||70
8360831|NCT01208233|20609322|P4|STARTED|Overall Study||10
8360832|NCT01208233|20609323|P3|STARTED|Overall Study||11
8360833|NCT01208233|20609324|P2|STARTED|Overall Study||9
8360834|NCT01208233|20609325|P1|STARTED|Overall Study||11
8360835|NCT01208220|20609438|P2|NOT COMPLETED|Overall Study||0
8360836|NCT01208220|20609439|P1|NOT COMPLETED|Overall Study||0
8360837|NCT01208220|20609438|P2|COMPLETED|Overall Study||1
8360838|NCT01208220|20609439|P1|COMPLETED|Overall Study||1
8360839|NCT01208220|20609438|P2|STARTED|Overall Study||1
8360840|NCT01208220|20609439|P1|STARTED|Overall Study||1
8360841|NCT01208207|20609450|P7|NOT COMPLETED|Part II||11
8360842|NCT01208207|20609451|P6|NOT COMPLETED|Part II||16
8360843|NCT01208207|20609452|P5|NOT COMPLETED|Part II||23
8360844|NCT01208207|20609453|P4|NOT COMPLETED|Part II||32
8360845|NCT01208207|20609454|P3|NOT COMPLETED|Part II||0
8360846|NCT01208207|20609455|P2|NOT COMPLETED|Part II||0
8360847|NCT01208207|20609456|P1|NOT COMPLETED|Part II||0
8360848|NCT01208207|20609450|P7|COMPLETED|Part II||131
8360849|NCT01208207|20609451|P6|COMPLETED|Part II||129
8360850|NCT01208207|20609452|P5|COMPLETED|Part II||295
8360851|NCT01208207|20609453|P4|COMPLETED|Part II||282
8360852|NCT01208207|20609454|P3|COMPLETED|Part II||0
8360853|NCT01208207|20609455|P2|COMPLETED|Part II||0
8360854|NCT01208207|20609456|P1|COMPLETED|Part II||0
8360855|NCT01208207|20609450|P7|STARTED|Part II||142
8360856|NCT01208207|20609451|P6|STARTED|Part II||145
8360857|NCT01208207|20609452|P5|STARTED|Part II||318
8360858|NCT01208207|20609453|P4|STARTED|Part II||314
8360859|NCT01208207|20609454|P3|STARTED|Part II||0
8360860|NCT01208207|20609455|P2|STARTED|Part II||0
8360861|NCT01208207|20609456|P1|STARTED|Part II||0
8360862|NCT01208207|20609450|P7|NOT COMPLETED|Part I||0
8360863|NCT01208207|20609451|P6|NOT COMPLETED|Part I||0
8360864|NCT01208207|20609452|P5|NOT COMPLETED|Part I||0
8360865|NCT01208207|20609453|P4|NOT COMPLETED|Part I||0
8360866|NCT01208207|20609454|P3|NOT COMPLETED|Part I||15
8360867|NCT01208207|20609455|P2|NOT COMPLETED|Part I||11
8360868|NCT01208207|20609456|P1|NOT COMPLETED|Part I||70
8360869|NCT01208207|20609450|P7|COMPLETED|Part I||0
8360870|NCT01208207|20609451|P6|COMPLETED|Part I||0
8360871|NCT01208207|20609452|P5|COMPLETED|Part I||0
8360872|NCT01208207|20609453|P4|COMPLETED|Part I||0
8360873|NCT01208207|20609454|P3|COMPLETED|Part I||142
8360874|NCT01208207|20609455|P2|COMPLETED|Part I||145
8360875|NCT01208207|20609456|P1|COMPLETED|Part I||632
8360876|NCT01208207|20609450|P7|STARTED|Part I||0
8360877|NCT01208207|20609451|P6|STARTED|Part I||0
8360878|NCT01208207|20609452|P5|STARTED|Part I||0
8360879|NCT01208207|20609453|P4|STARTED|Part I||0
8360880|NCT01208207|20609454|P3|STARTED|Part I||157
8360881|NCT01208207|20609455|P2|STARTED|Part I||156
8360882|NCT01208207|20609456|P1|STARTED|Part I||702
8360883|NCT01208181|20609483|P5|NOT COMPLETED|Part 2||0
8360884|NCT01208181|20609484|P4|NOT COMPLETED|Part 2||20
8360885|NCT01208181|20609485|P3|NOT COMPLETED|Part 2||16
8360886|NCT01208181|20609486|P2|NOT COMPLETED|Part 2||0
8360887|NCT01208181|20609487|P1|NOT COMPLETED|Part 2||0
8360888|NCT01208181|20609483|P5|COMPLETED|Part 2||0
8360889|NCT01208181|20609484|P4|COMPLETED|Part 2||343
8360890|NCT01208181|20609485|P3|COMPLETED|Part 2||334
8360891|NCT01208181|20609486|P2|COMPLETED|Part 2||0
8360892|NCT01208181|20609487|P1|COMPLETED|Part 2||0
8360893|NCT01208181|20609483|P5|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
8360894|NCT01208181|20609484|P4|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
8360895|NCT01208181|20609485|P3|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
8360896|NCT01208181|20609486|P2|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
8360897|NCT01208181|20609487|P1|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
8360898|NCT01208181|20609483|P5|NOT COMPLETED|Part 1||22
8360899|NCT01208181|20609484|P4|NOT COMPLETED|Part 1||0
8360900|NCT01208181|20609485|P3|NOT COMPLETED|Part 1||0
8360901|NCT01208181|20609486|P2|NOT COMPLETED|Part 1||55
8360902|NCT01208181|20609487|P1|NOT COMPLETED|Part 1||99
8360903|NCT01208181|20609483|P5|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
8360904|NCT01208181|20609484|P4|COMPLETED|Part 1||0
8360905|NCT01208181|20609485|P3|COMPLETED|Part 1||0
8360906|NCT01208181|20609486|P2|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
8360907|NCT01208181|20609487|P1|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
8360908|NCT01208181|20609483|P5|STARTED|Part 1||118
8360909|NCT01208181|20609484|P4|STARTED|Part 1||0
8360910|NCT01208181|20609485|P3|STARTED|Part 1||0
8360911|NCT01208181|20609486|P2|STARTED|Part 1||468
8360912|NCT01208181|20609487|P1|STARTED|Part 1||818
8360913|NCT01208103|20609516|P1|NOT COMPLETED|Overall Study||2
8360914|NCT01208103|20609516|P1|COMPLETED|Overall Study||28
8360915|NCT01208103|20609516|P1|STARTED|Overall Study||30
8360916|NCT01208038|20609524|P1|NOT COMPLETED|Overall Study||1
8360917|NCT01208038|20609524|P1|COMPLETED|Overall Study|Patient withdrew before commencing study drug|21
8360918|NCT01208038|20609524|P1|STARTED|Overall Study||22
8360919|NCT01207934|20609534|P3|NOT COMPLETED|Overall Study||0
8360920|NCT01207934|20609535|P2|NOT COMPLETED|Overall Study||0
8360921|NCT01207934|20609536|P1|NOT COMPLETED|Overall Study||0
8360922|NCT01207934|20609534|P3|COMPLETED|Overall Study||6
8360923|NCT01207934|20609535|P2|COMPLETED|Overall Study||6
8360924|NCT01207934|20609536|P1|COMPLETED|Overall Study||6
8360925|NCT01207934|20609534|P3|STARTED|Overall Study||6
8360926|NCT01207934|20609535|P2|STARTED|Overall Study||6
8360927|NCT01207934|20609536|P1|STARTED|Overall Study||6
8360928|NCT01207908|20609555|P2|NOT COMPLETED|Overall Study||1
8360929|NCT01207908|20609556|P1|NOT COMPLETED|Overall Study||5
8360930|NCT01207908|20609555|P2|COMPLETED|Overall Study||21
8360931|NCT01207908|20609556|P1|COMPLETED|Overall Study||17
8360932|NCT01207908|20609555|P2|STARTED|Overall Study||22
8360933|NCT01207908|20609556|P1|STARTED|Overall Study||22
8360934|NCT01207765|20609566|P1|NOT COMPLETED|Overall Study||0
8360935|NCT01207765|20609566|P1|COMPLETED|Overall Study||8
8360936|NCT01207765|20609566|P1|STARTED|Overall Study||8
8360937|NCT01207726|20609574|P2|NOT COMPLETED|Overall Study||0
8360938|NCT01207726|20609575|P1|NOT COMPLETED|Overall Study||0
8360939|NCT01207726|20609574|P2|COMPLETED|Overall Study||6
8360940|NCT01207726|20609575|P1|COMPLETED|Overall Study||7
8360941|NCT01207726|20609574|P2|STARTED|Overall Study||6
8360942|NCT01207726|20609575|P1|STARTED|Overall Study||7
8360943|NCT01207687|20609593|P1|NOT COMPLETED|Overall Study||2
8360944|NCT01207687|20609593|P1|COMPLETED|Overall Study||12
8360945|NCT01207687|20609593|P1|STARTED|Overall Study||14
8360946|NCT01207648|20609623|P1|NOT COMPLETED|Overall Study||0
8360947|NCT01207648|20609623|P1|COMPLETED|Overall Study||307
8360948|NCT01207648|20609623|P1|STARTED|Overall Study||307
8360949|NCT01207596|20609631|P1|NOT COMPLETED|Overall Study||9
8360950|NCT01207596|20609631|P1|COMPLETED|Overall Study||21
8360951|NCT01207596|20609631|P1|STARTED|Overall Study||30
8360952|NCT01207583|20609644|P3|NOT COMPLETED|Overall Study||1
8360953|NCT01207583|20609645|P2|NOT COMPLETED|Overall Study||5
8360954|NCT01207583|20609646|P1|NOT COMPLETED|Overall Study||1
8360955|NCT01207583|20609644|P3|COMPLETED|Overall Study||54
8360956|NCT01207583|20609645|P2|COMPLETED|Overall Study||26
8360957|NCT01207583|20609646|P1|COMPLETED|Overall Study||13
8360958|NCT01207583|20609644|P3|Dose 4|Overall Study||0
8360959|NCT01207583|20609645|P2|Dose 4|Overall Study||0
8360960|NCT01207583|20609646|P1|Dose 4|Overall Study||7
8360961|NCT01207583|20609644|P3|Dose 3|Overall Study||0
8360962|NCT01207583|20609645|P2|Dose 3|Overall Study||27
8360963|NCT01207583|20609646|P1|Dose 3|Overall Study||13
8360964|NCT01207583|20609644|P3|Dose 2|Overall Study||54
8360965|NCT01207583|20609645|P2|Dose 2|Overall Study||29
8360966|NCT01207583|20609646|P1|Dose 2|Overall Study||13
8360967|NCT01207583|20609644|P3|Dose 1|Overall Study||55
8360968|NCT01207583|20609645|P2|Dose 1|Overall Study||31
8360969|NCT01207583|20609646|P1|Dose 1|Overall Study||14
8360970|NCT01207583|20609644|P3|STARTED|Overall Study||55
8360971|NCT01207583|20609645|P2|STARTED|Overall Study||31
8360972|NCT01207583|20609646|P1|STARTED|Overall Study||14
8360973|NCT01207570|20609686|P2|NOT COMPLETED|The Second Stage (After Crossover)||0
8360974|NCT01207570|20609687|P1|NOT COMPLETED|The Second Stage (After Crossover)||0
8360975|NCT01207570|20609686|P2|COMPLETED|The Second Stage (After Crossover)||23
8360976|NCT01207570|20609687|P1|COMPLETED|The Second Stage (After Crossover)||31
8360977|NCT01207570|20609686|P2|STARTED|The Second Stage (After Crossover)||23
8360978|NCT01207570|20609687|P1|STARTED|The Second Stage (After Crossover)||31
8360979|NCT01207570|20609686|P2|NOT COMPLETED|The First Stage (Before Crossover)||0
8360980|NCT01207570|20609687|P1|NOT COMPLETED|The First Stage (Before Crossover)||0
8360981|NCT01207570|20609686|P2|COMPLETED|The First Stage (Before Crossover)||31
8360982|NCT01207570|20609687|P1|COMPLETED|The First Stage (Before Crossover)||23
8360983|NCT01207570|20609686|P2|STARTED|The First Stage (Before Crossover)||31
8360984|NCT01207570|20609687|P1|STARTED|The First Stage (Before Crossover)||23
8360988|NCT01207466|20609705|P2|NOT COMPLETED|Period 2, One Week of Wear||0
8360989|NCT01207466|20609706|P1|NOT COMPLETED|Period 2, One Week of Wear||0
8360990|NCT01207466|20609705|P2|COMPLETED|Period 2, One Week of Wear||48
8360991|NCT01207466|20609706|P1|COMPLETED|Period 2, One Week of Wear||45
8360992|NCT01207466|20609705|P2|STARTED|Period 2, One Week of Wear||48
8360993|NCT01207466|20609706|P1|STARTED|Period 2, One Week of Wear||45
8360994|NCT01207466|20609705|P2|NOT COMPLETED|Period 1, One Week of Wear||0
8360995|NCT01207466|20609706|P1|NOT COMPLETED|Period 1, One Week of Wear||0
8360996|NCT01207466|20609705|P2|COMPLETED|Period 1, One Week of Wear||48
8360997|NCT01207466|20609706|P1|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
8360998|NCT01207466|20609705|P2|STARTED|Period 1, One Week of Wear||48
8360999|NCT01207466|20609706|P1|STARTED|Period 1, One Week of Wear||46
8361000|NCT01207453|20609714|P2|NOT COMPLETED|2nd Intervention||2
8361001|NCT01207453|20609715|P1|NOT COMPLETED|2nd Intervention||2
8361002|NCT01207453|20609714|P2|COMPLETED|2nd Intervention||15
8361003|NCT01207453|20609715|P1|COMPLETED|2nd Intervention||17
8361004|NCT01207453|20609714|P2|STARTED|2nd Intervention||17
8361005|NCT01207453|20609715|P1|STARTED|2nd Intervention||19
8361006|NCT01207453|20609714|P2|NOT COMPLETED|Washout||0
8361007|NCT01207453|20609715|P1|NOT COMPLETED|Washout||2
8361008|NCT01207453|20609714|P2|COMPLETED|Washout||17
8361009|NCT01207453|20609715|P1|COMPLETED|Washout||19
8361010|NCT01207453|20609714|P2|STARTED|Washout||17
8361011|NCT01207453|20609715|P1|STARTED|Washout||21
8361012|NCT01207453|20609714|P2|NOT COMPLETED|First Intervention||1
8361013|NCT01207453|20609715|P1|NOT COMPLETED|First Intervention||2
8361014|NCT01207453|20609714|P2|COMPLETED|First Intervention||17
8361015|NCT01207453|20609715|P1|COMPLETED|First Intervention||21
8361016|NCT01207453|20609714|P2|STARTED|First Intervention||18
8361017|NCT01207453|20609715|P1|STARTED|First Intervention||23
8361039|NCT01207427|20609814|P3|NOT COMPLETED|Run-out Placebo Period||0
8361040|NCT01207427|20609815|P2|NOT COMPLETED|Run-out Placebo Period||0
8361041|NCT01207427|20609816|P1|NOT COMPLETED|Run-out Placebo Period||0
8361042|NCT01207427|20609814|P3|COMPLETED|Run-out Placebo Period||41
8361043|NCT01207427|20609815|P2|COMPLETED|Run-out Placebo Period||43
8361044|NCT01207427|20609816|P1|COMPLETED|Run-out Placebo Period||40
8361045|NCT01207427|20609814|P3|STARTED|Run-out Placebo Period||41
8361046|NCT01207427|20609815|P2|STARTED|Run-out Placebo Period||43
8361047|NCT01207427|20609816|P1|STARTED|Run-out Placebo Period||40
8361048|NCT01207427|20609814|P3|NOT COMPLETED|Double-blind Treatment Period||2
8361049|NCT01207427|20609815|P2|NOT COMPLETED|Double-blind Treatment Period||2
8361050|NCT01207427|20609816|P1|NOT COMPLETED|Double-blind Treatment Period||3
8361051|NCT01207427|20609814|P3|COMPLETED|Double-blind Treatment Period||41
8361052|NCT01207427|20609815|P2|COMPLETED|Double-blind Treatment Period||43
8361053|NCT01207427|20609816|P1|COMPLETED|Double-blind Treatment Period||40
8361054|NCT01207427|20609814|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
8361055|NCT01207427|20609815|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
8361056|NCT01207427|20609816|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
8361057|NCT01207427|20609814|P3|STARTED|Double-blind Treatment Period||43
8361058|NCT01207427|20609815|P2|STARTED|Double-blind Treatment Period||45
8361059|NCT01207427|20609816|P1|STARTED|Double-blind Treatment Period||43
8361060|NCT01207427|20609814|P3|NOT COMPLETED|Run-in Placebo Period||0
8361061|NCT01207427|20609815|P2|NOT COMPLETED|Run-in Placebo Period||0
8361062|NCT01207427|20609816|P1|NOT COMPLETED|Run-in Placebo Period||0
8361063|NCT01207427|20609814|P3|COMPLETED|Run-in Placebo Period||43
8361064|NCT01207427|20609815|P2|COMPLETED|Run-in Placebo Period||45
8361065|NCT01207427|20609816|P1|COMPLETED|Run-in Placebo Period||43
8361066|NCT01207427|20609814|P3|STARTED|Run-in Placebo Period||43
8361067|NCT01207427|20609815|P2|STARTED|Run-in Placebo Period||45
8361068|NCT01207427|20609816|P1|STARTED|Run-in Placebo Period||43
8361069|NCT01207414|20609826|P2|NOT COMPLETED|Overall Study||82
8361070|NCT01207414|20609827|P1|NOT COMPLETED|Overall Study||73
8361071|NCT01207414|20609826|P2|COMPLETED|Overall Study||178
8361072|NCT01207414|20609827|P1|COMPLETED|Overall Study||168
8361073|NCT01207414|20609826|P2|Safety Population: Received Study Drug|Overall Study||260
8361074|NCT01207414|20609827|P1|Safety Population: Received Study Drug|Overall Study||240
8361075|NCT01207414|20609826|P2|STARTED|Overall Study||260
8361076|NCT01207414|20609827|P1|STARTED|Overall Study|Includes 1 patient randomized in error.|241
8361077|NCT01207401|20609845|P2|NOT COMPLETED|Overall Study||0
8361078|NCT01207401|20609846|P1|NOT COMPLETED|Overall Study||0
8361079|NCT01207401|20609845|P2|COMPLETED|Overall Study||24
8361080|NCT01207401|20609846|P1|COMPLETED|Overall Study||26
8361081|NCT01207401|20609845|P2|STARTED|Overall Study||24
8361082|NCT01207401|20609846|P1|STARTED|Overall Study||26
8361083|NCT01207388|20609852|P1|NOT COMPLETED|Overall Study||68
8361084|NCT01207388|20609852|P1|COMPLETED|Overall Study||48
8361085|NCT01207388|20609852|P1|STARTED|Overall Study||116
8361086|NCT01207219|20609877|P3|NOT COMPLETED|Overall Study||7
8361087|NCT01207219|20609878|P2|NOT COMPLETED|Overall Study||11
8361088|NCT01207219|20609879|P1|NOT COMPLETED|Overall Study||11
8361089|NCT01207219|20609877|P3|COMPLETED|Overall Study||32
8361090|NCT01207219|20609878|P2|COMPLETED|Overall Study||29
8361091|NCT01207219|20609879|P1|COMPLETED|Overall Study||34
8361092|NCT01207219|20609877|P3|Included in ITT Analysis|Overall Study||38
8361093|NCT01207219|20609878|P2|Included in ITT Analysis|Overall Study||37
8361094|NCT01207219|20609879|P1|Included in ITT Analysis|Overall Study||40
8361095|NCT01207219|20609877|P3|STARTED|Overall Study||39
8361096|NCT01207219|20609878|P2|STARTED|Overall Study||40
8361097|NCT01207219|20609879|P1|STARTED|Overall Study||45
8361098|NCT01207102|20609899|P1|NOT COMPLETED|Overall Study||10
8361099|NCT01207102|20609899|P1|COMPLETED|Overall Study||0
8361100|NCT01207102|20609899|P1|STARTED|Overall Study||10
8361101|NCT01206816|20609911|P7|NOT COMPLETED|Overall Study||6
8361102|NCT01206816|20609912|P6|NOT COMPLETED|Overall Study||19
8361103|NCT01206816|20609913|P5|NOT COMPLETED|Overall Study||3
8361104|NCT01206816|20609914|P4|NOT COMPLETED|Overall Study||3
8361105|NCT01206816|20609915|P3|NOT COMPLETED|Overall Study||20
8361106|NCT01206816|20609916|P2|NOT COMPLETED|Overall Study||3
8361107|NCT01206816|20609917|P1|NOT COMPLETED|Overall Study||3
8361108|NCT01206816|20609911|P7|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,'PD' from aftb.|0
8361109|NCT01206816|20609912|P6|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, 'Other AE' from aftb|0
8361110|NCT01206816|20609913|P5|COMPLETED|Overall Study||0
8361111|NCT01206816|20609914|P4|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, 'Other AE' from aftb|0
8361112|NCT01206816|20609915|P3|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,'DLT' from aftb|0
8361113|NCT01206816|20609916|P2|COMPLETED|Overall Study||0
8361114|NCT01206816|20609917|P1|COMPLETED|Overall Study||0
8361115|NCT01206816|20609911|P7|STARTED|Overall Study|Started=Treated|6
8361116|NCT01206816|20609912|P6|STARTED|Overall Study|Started=Treated|19
8361117|NCT01206816|20609913|P5|STARTED|Overall Study|Started=Treated|3
8361118|NCT01206816|20609914|P4|STARTED|Overall Study|Started=Treated|3
8361119|NCT01206816|20609915|P3|STARTED|Overall Study|Started=Treated|20
8361120|NCT01206816|20609916|P2|STARTED|Overall Study|Started=Treated|3
8361121|NCT01206816|20609917|P1|STARTED|Overall Study|Started=Treated|3
8361122|NCT01206777|20609963|P1|NOT COMPLETED|Overall Study||2
8361123|NCT01206777|20609963|P1|COMPLETED|Overall Study||50
8361220|NCT01206322|20610168|P4|COMPLETED|Overall Study||5
8361124|NCT01206777|20609963|P1|Discontinued Trial and Deemed Ineligible|Overall Study||2
8361125|NCT01206777|20609963|P1|STARTED|Overall Study||52
8361126|NCT01206764|20609969|P1|NOT COMPLETED|Overall Study||138
8361127|NCT01206764|20609969|P1|COMPLETED|Overall Study||4
8361128|NCT01206764|20609969|P1|STARTED|Overall Study||142
8361129|NCT01206738|20609980|P3|NOT COMPLETED|Overall Study||19
8361130|NCT01206738|20609981|P2|NOT COMPLETED|Overall Study||25
8361131|NCT01206738|20609982|P1|NOT COMPLETED|Overall Study||23
8361132|NCT01206738|20609980|P3|COMPLETED|Overall Study||42
8361133|NCT01206738|20609981|P2|COMPLETED|Overall Study||49
8361134|NCT01206738|20609982|P1|COMPLETED|Overall Study||40
8361135|NCT01206738|20609980|P3|STARTED|Overall Study||61
8361136|NCT01206738|20609981|P2|STARTED|Overall Study||74
8361137|NCT01206738|20609982|P1|STARTED|Overall Study||63
8361138|NCT01206660|20609994|P2|NOT COMPLETED|Overall Study||0
8361139|NCT01206660|20609995|P1|NOT COMPLETED|Overall Study||0
8361140|NCT01206660|20609994|P2|COMPLETED|Overall Study||60
8361141|NCT01206660|20609995|P1|COMPLETED|Overall Study||60
8361142|NCT01206660|20609994|P2|STARTED|Overall Study||60
8361143|NCT01206660|20609995|P1|STARTED|Overall Study||60
8361150|NCT01206595|20610016|P2|NOT COMPLETED|Overall Study||0
8361151|NCT01206595|20610017|P1|NOT COMPLETED|Overall Study||0
8361152|NCT01206595|20610016|P2|COMPLETED|Overall Study||20
8361153|NCT01206595|20610017|P1|COMPLETED|Overall Study||38
8361154|NCT01206595|20610016|P2|STARTED|Overall Study||20
8361155|NCT01206595|20610017|P1|STARTED|Overall Study||38
8361156|NCT01206582|20610027|P2|NOT COMPLETED|Overall Study||2
8361157|NCT01206582|20610028|P1|NOT COMPLETED|Overall Study||2
8361158|NCT01206582|20610027|P2|COMPLETED|Overall Study||7
8361159|NCT01206582|20610028|P1|COMPLETED|Overall Study||9
8361160|NCT01206582|20610027|P2|STARTED|Overall Study||9
8361161|NCT01206582|20610028|P1|STARTED|Overall Study||11
8361162|NCT01206517|20610060|P6|NOT COMPLETED|Overall Study||0
8361163|NCT01206517|20610061|P5|NOT COMPLETED|Overall Study||1
8361164|NCT01206517|20610062|P4|NOT COMPLETED|Overall Study||0
8361165|NCT01206517|20610063|P3|NOT COMPLETED|Overall Study||2
8361166|NCT01206517|20610064|P2|NOT COMPLETED|Overall Study||0
8361167|NCT01206517|20610065|P1|NOT COMPLETED|Overall Study||0
8361168|NCT01206517|20610060|P6|COMPLETED|Overall Study||4
8361169|NCT01206517|20610061|P5|COMPLETED|Overall Study||3
8361170|NCT01206517|20610062|P4|COMPLETED|Overall Study||4
8361171|NCT01206517|20610063|P3|COMPLETED|Overall Study||4
8361172|NCT01206517|20610064|P2|COMPLETED|Overall Study||6
8361173|NCT01206517|20610065|P1|COMPLETED|Overall Study||6
8361174|NCT01206517|20610060|P6|STARTED|Overall Study||4
8361175|NCT01206517|20610061|P5|STARTED|Overall Study||4
8361176|NCT01206517|20610062|P4|STARTED|Overall Study||4
8361177|NCT01206517|20610063|P3|STARTED|Overall Study||6
8361178|NCT01206517|20610064|P2|STARTED|Overall Study||6
8361179|NCT01206517|20610065|P1|STARTED|Overall Study||6
8361180|NCT01206478|20610096|P2|NOT COMPLETED|Overall Study||5
8361181|NCT01206478|20610097|P1|NOT COMPLETED|Overall Study||2
8361182|NCT01206478|20610096|P2|COMPLETED|Overall Study||7
8361183|NCT01206478|20610097|P1|COMPLETED|Overall Study||7
8361184|NCT01206478|20610096|P2|STARTED|Overall Study||12
8361185|NCT01206478|20610097|P1|STARTED|Overall Study||9
8361186|NCT01206465|20610105|P5|NOT COMPLETED|Overall Study||0
8361187|NCT01206465|20610106|P4|NOT COMPLETED|Overall Study||0
8361188|NCT01206465|20610107|P3|NOT COMPLETED|Overall Study||0
8361189|NCT01206465|20610108|P2|NOT COMPLETED|Overall Study||0
8361190|NCT01206465|20610109|P1|NOT COMPLETED|Overall Study||0
8361191|NCT01206465|20610105|P5|COMPLETED|Overall Study||6
8361192|NCT01206465|20610106|P4|COMPLETED|Overall Study||6
8361193|NCT01206465|20610107|P3|COMPLETED|Overall Study||6
8361194|NCT01206465|20610108|P2|COMPLETED|Overall Study||6
8361195|NCT01206465|20610109|P1|COMPLETED|Overall Study||3
8361196|NCT01206465|20610105|P5|STARTED|Overall Study||6
8361197|NCT01206465|20610106|P4|STARTED|Overall Study||6
8361198|NCT01206465|20610107|P3|STARTED|Overall Study||6
8361199|NCT01206465|20610108|P2|STARTED|Overall Study||6
8361200|NCT01206465|20610109|P1|STARTED|Overall Study||3
8361201|NCT01206452|20610130|P2|NOT COMPLETED|Overall Study||0
8361202|NCT01206452|20610131|P1|NOT COMPLETED|Overall Study||0
8361203|NCT01206452|20610130|P2|COMPLETED|Overall Study||30
8361204|NCT01206452|20610131|P1|COMPLETED|Overall Study||30
8361205|NCT01206452|20610130|P2|STARTED|Overall Study||30
8361206|NCT01206452|20610131|P1|STARTED|Overall Study||30
8361207|NCT01206439|20610145|P1|NOT COMPLETED|Overall Study||1
8361208|NCT01206439|20610145|P1|COMPLETED|Overall Study||1
8361209|NCT01206439|20610145|P1|STARTED|Overall Study||2
8361210|NCT01206387|20610151|P2|NOT COMPLETED|Overall Study||0
8361211|NCT01206387|20610152|P1|NOT COMPLETED|Overall Study||1
8361212|NCT01206387|20610151|P2|COMPLETED|Overall Study||60
8361213|NCT01206387|20610152|P1|COMPLETED|Overall Study||59
8361214|NCT01206387|20610151|P2|STARTED|Overall Study||60
8361215|NCT01206387|20610152|P1|STARTED|Overall Study||60
8361216|NCT01206322|20610168|P4|NOT COMPLETED|Overall Study||1
8361217|NCT01206322|20610169|P3|NOT COMPLETED|Overall Study||0
8361218|NCT01206322|20610170|P2|NOT COMPLETED|Overall Study||0
8361219|NCT01206322|20610171|P1|NOT COMPLETED|Overall Study||0
8361221|NCT01206322|20610169|P3|COMPLETED|Overall Study||9
8361222|NCT01206322|20610170|P2|COMPLETED|Overall Study||11
8361223|NCT01206322|20610171|P1|COMPLETED|Overall Study||4
8361224|NCT01206322|20610168|P4|STARTED|Overall Study||6
8361225|NCT01206322|20610169|P3|STARTED|Overall Study||9
8361226|NCT01206322|20610170|P2|STARTED|Overall Study||11
8361227|NCT01206322|20610171|P1|STARTED|Overall Study||4
8361228|NCT01206140|20610187|P2|NOT COMPLETED|Overall Study||0
8361229|NCT01206140|20610188|P1|NOT COMPLETED|Overall Study||1
8361230|NCT01206140|20610187|P2|COMPLETED|Overall Study||35
8361231|NCT01206140|20610188|P1|COMPLETED|Overall Study||34
8361232|NCT01206140|20610187|P2|STARTED|Overall Study||35
8361233|NCT01206140|20610188|P1|STARTED|Overall Study||35
8361234|NCT01206101|20610200|P2|NOT COMPLETED|Overall Study||1
8361235|NCT01206101|20610201|P1|NOT COMPLETED|Overall Study||2
8361236|NCT01206101|20610200|P2|COMPLETED|Overall Study||0
8361237|NCT01206101|20610201|P1|COMPLETED|Overall Study||0
8361238|NCT01206101|20610200|P2|STARTED|Overall Study||1
8361239|NCT01206101|20610201|P1|STARTED|Overall Study||2
8361240|NCT01206062|20610219|P2|NOT COMPLETED|Overall Study||0
8361241|NCT01206062|20610220|P1|NOT COMPLETED|Overall Study||0
8361242|NCT01206062|20610219|P2|COMPLETED|Overall Study||4683
8361243|NCT01206062|20610220|P1|COMPLETED|Overall Study||4678
8361244|NCT01206062|20610219|P2|STARTED|Overall Study||4683
8361245|NCT01206062|20610220|P1|STARTED|Overall Study||4678
8361246|NCT01205828|20610236|P1|NOT COMPLETED|Overall Study||0
8361247|NCT01205828|20610236|P1|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
8361248|NCT01205828|20610236|P1|STARTED|Overall Study||16
8361249|NCT01205776|20610246|P2|NOT COMPLETED|Overall Study||95
8361250|NCT01205776|20610247|P1|NOT COMPLETED|Overall Study||64
8361251|NCT01205776|20610246|P2|COMPLETED|Overall Study||862
8361252|NCT01205776|20610247|P1|COMPLETED|Overall Study||884
8361253|NCT01205776|20610246|P2|STARTED|Overall Study||957
8361254|NCT01205776|20610247|P1|STARTED|Overall Study||948
8361255|NCT01205685|20610435|P1|NOT COMPLETED|Overall Study||11
8361256|NCT01205685|20610435|P1|COMPLETED|Overall Study||0
8361257|NCT01205685|20610435|P1|STARTED|Overall Study||11
8361258|NCT01205646|20610442|P1|NOT COMPLETED|Overall Study||0
8361259|NCT01205646|20610442|P1|COMPLETED|Overall Study||11
8361260|NCT01205646|20610442|P1|STARTED|Overall Study||11
8361261|NCT01205581|20610455|P6|NOT COMPLETED|Overall Study||0
8361262|NCT01205581|20610456|P5|NOT COMPLETED|Overall Study||0
8361263|NCT01205581|20610457|P4|NOT COMPLETED|Overall Study||0
8361264|NCT01205581|20610458|P3|NOT COMPLETED|Overall Study||0
8361265|NCT01205581|20610459|P2|NOT COMPLETED|Overall Study||0
8361266|NCT01205581|20610460|P1|NOT COMPLETED|Overall Study||1
8361267|NCT01205581|20610455|P6|COMPLETED|Overall Study||20
8361268|NCT01205581|20610456|P5|COMPLETED|Overall Study||20
8361269|NCT01205581|20610457|P4|COMPLETED|Overall Study||9
8361270|NCT01205581|20610458|P3|COMPLETED|Overall Study||8
8361271|NCT01205581|20610459|P2|COMPLETED|Overall Study||13
8361272|NCT01205581|20610460|P1|COMPLETED|Overall Study||13
8361273|NCT01205581|20610455|P6|STARTED|Overall Study||20
8361274|NCT01205581|20610456|P5|STARTED|Overall Study||20
8361275|NCT01205581|20610457|P4|STARTED|Overall Study||9
8361276|NCT01205581|20610458|P3|STARTED|Overall Study||8
8361277|NCT01205581|20610459|P2|STARTED|Overall Study||13
8361278|NCT01205581|20610460|P1|STARTED|Overall Study||14
8361279|NCT01205568|20610524|P2|NOT COMPLETED|Overall Study||0
8361280|NCT01205568|20610525|P1|NOT COMPLETED|Overall Study||0
8361281|NCT01205568|20610524|P2|COMPLETED|Overall Study||47
8361282|NCT01205568|20610525|P1|COMPLETED|Overall Study||65
8361283|NCT01205568|20610524|P2|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
8361284|NCT01205568|20610525|P1|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
8361285|NCT01205529|20610530|P1|NOT COMPLETED|Overall Study||55
8361286|NCT01205529|20610530|P1|COMPLETED|Overall Study||106
8361287|NCT01205529|20610530|P1|STARTED|Overall Study||161
8361288|NCT01205503|20610536|P2|NOT COMPLETED|Second Intervention (2nd Cycle)||0
8361289|NCT01205503|20610537|P1|NOT COMPLETED|Second Intervention (2nd Cycle)||0
8361290|NCT01205503|20610536|P2|COMPLETED|Second Intervention (2nd Cycle)||16
8361291|NCT01205503|20610537|P1|COMPLETED|Second Intervention (2nd Cycle)||16
8361292|NCT01205503|20610536|P2|STARTED|Second Intervention (2nd Cycle)||16
8361293|NCT01205503|20610537|P1|STARTED|Second Intervention (2nd Cycle)||16
8361294|NCT01205503|20610536|P2|NOT COMPLETED|First Intervention (1st Cycle)||0
8361295|NCT01205503|20610537|P1|NOT COMPLETED|First Intervention (1st Cycle)||0
8361296|NCT01205503|20610536|P2|COMPLETED|First Intervention (1st Cycle)||16
8361297|NCT01205503|20610537|P1|COMPLETED|First Intervention (1st Cycle)||16
8361298|NCT01205503|20610536|P2|STARTED|First Intervention (1st Cycle)||16
8361299|NCT01205503|20610537|P1|STARTED|First Intervention (1st Cycle)||16
8361300|NCT01205451|20610553|P2|NOT COMPLETED|Overall Study||10
8361301|NCT01205451|20610554|P1|NOT COMPLETED|Overall Study||6
8361302|NCT01205451|20610553|P2|COMPLETED|Overall Study||46
8361303|NCT01205451|20610554|P1|COMPLETED|Overall Study||47
8361304|NCT01205451|20610553|P2|STARTED|Overall Study||56
8361305|NCT01205451|20610554|P1|STARTED|Overall Study||53
8361306|NCT01205438|20610599|P3|NOT COMPLETED|Overall Study||88
8361307|NCT01205438|20610600|P2|NOT COMPLETED|Overall Study||87
8361308|NCT01205438|20610601|P1|NOT COMPLETED|Overall Study||77
8361309|NCT01205438|20610599|P3|COMPLETED|Overall Study||288
8361310|NCT01205438|20610600|P2|COMPLETED|Overall Study||289
8361311|NCT01205438|20610601|P1|COMPLETED|Overall Study||295
8361312|NCT01205438|20610599|P3|Participated in Follow Up|Overall Study||66
8361313|NCT01205438|20610600|P2|Participated in Follow Up|Overall Study||78
8361314|NCT01205438|20610601|P1|Participated in Follow Up|Overall Study||72
8361315|NCT01205438|20610599|P3|Received At Least One Dose of Study Drug|Overall Study||376
8361316|NCT01205438|20610600|P2|Received At Least One Dose of Study Drug|Overall Study||374
8361317|NCT01205438|20610601|P1|Received At Least One Dose of Study Drug|Overall Study||371
8361318|NCT01205438|20610599|P3|STARTED|Overall Study||376
8361319|NCT01205438|20610600|P2|STARTED|Overall Study||376
8361320|NCT01205438|20610601|P1|STARTED|Overall Study||372
8361321|NCT01205399|20610651|P1|NOT COMPLETED|Overall Study||0
8361322|NCT01205399|20610651|P1|COMPLETED|Overall Study||78
8361323|NCT01205399|20610651|P1|STARTED|Overall Study||78
8361324|NCT01205269|20610657|P6|NOT COMPLETED|Period 5 - Third Intervention||0
8361325|NCT01205269|20610658|P5|NOT COMPLETED|Period 5 - Third Intervention||0
8361326|NCT01205269|20610659|P4|NOT COMPLETED|Period 5 - Third Intervention||0
8361327|NCT01205269|20610660|P3|NOT COMPLETED|Period 5 - Third Intervention||0
8361328|NCT01205269|20610661|P2|NOT COMPLETED|Period 5 - Third Intervention||0
8361329|NCT01205269|20610662|P1|NOT COMPLETED|Period 5 - Third Intervention||0
8361330|NCT01205269|20610657|P6|COMPLETED|Period 5 - Third Intervention||5
8361331|NCT01205269|20610658|P5|COMPLETED|Period 5 - Third Intervention||5
8361332|NCT01205269|20610659|P4|COMPLETED|Period 5 - Third Intervention||5
8361333|NCT01205269|20610660|P3|COMPLETED|Period 5 - Third Intervention||4
8361334|NCT01205269|20610661|P2|COMPLETED|Period 5 - Third Intervention||4
8361335|NCT01205269|20610662|P1|COMPLETED|Period 5 - Third Intervention||4
8361336|NCT01205269|20610657|P6|STARTED|Period 5 - Third Intervention||5
8361337|NCT01205269|20610658|P5|STARTED|Period 5 - Third Intervention||5
8361338|NCT01205269|20610659|P4|STARTED|Period 5 - Third Intervention||5
8361339|NCT01205269|20610660|P3|STARTED|Period 5 - Third Intervention||4
8361340|NCT01205269|20610661|P2|STARTED|Period 5 - Third Intervention||4
8361341|NCT01205269|20610662|P1|STARTED|Period 5 - Third Intervention||4
8361342|NCT01205269|20610657|P6|NOT COMPLETED|Period 4 - Washout||0
8361343|NCT01205269|20610658|P5|NOT COMPLETED|Period 4 - Washout||0
8361344|NCT01205269|20610659|P4|NOT COMPLETED|Period 4 - Washout||1
8361345|NCT01205269|20610660|P3|NOT COMPLETED|Period 4 - Washout||0
8361346|NCT01205269|20610661|P2|NOT COMPLETED|Period 4 - Washout||0
8361347|NCT01205269|20610662|P1|NOT COMPLETED|Period 4 - Washout||0
8361348|NCT01205269|20610657|P6|COMPLETED|Period 4 - Washout||5
8361349|NCT01205269|20610658|P5|COMPLETED|Period 4 - Washout||5
8361350|NCT01205269|20610659|P4|COMPLETED|Period 4 - Washout||5
8361351|NCT01205269|20610660|P3|COMPLETED|Period 4 - Washout||4
8361352|NCT01205269|20610661|P2|COMPLETED|Period 4 - Washout||4
8361353|NCT01205269|20610662|P1|COMPLETED|Period 4 - Washout||4
8361354|NCT01205269|20610657|P6|STARTED|Period 4 - Washout||5
8361355|NCT01205269|20610658|P5|STARTED|Period 4 - Washout||5
8361356|NCT01205269|20610659|P4|STARTED|Period 4 - Washout||6
8361357|NCT01205269|20610660|P3|STARTED|Period 4 - Washout||4
8361358|NCT01205269|20610661|P2|STARTED|Period 4 - Washout||4
8361359|NCT01205269|20610662|P1|STARTED|Period 4 - Washout||4
8361360|NCT01205269|20610657|P6|NOT COMPLETED|Period 3 - Second Intervention||0
8361361|NCT01205269|20610658|P5|NOT COMPLETED|Period 3 - Second Intervention||0
8361362|NCT01205269|20610659|P4|NOT COMPLETED|Period 3 - Second Intervention||0
8361363|NCT01205269|20610660|P3|NOT COMPLETED|Period 3 - Second Intervention||0
8361364|NCT01205269|20610661|P2|NOT COMPLETED|Period 3 - Second Intervention||0
8361365|NCT01205269|20610662|P1|NOT COMPLETED|Period 3 - Second Intervention||0
8361366|NCT01205269|20610657|P6|COMPLETED|Period 3 - Second Intervention||5
8361367|NCT01205269|20610658|P5|COMPLETED|Period 3 - Second Intervention||5
8361368|NCT01205269|20610659|P4|COMPLETED|Period 3 - Second Intervention||6
8361369|NCT01205269|20610660|P3|COMPLETED|Period 3 - Second Intervention||4
8361370|NCT01205269|20610661|P2|COMPLETED|Period 3 - Second Intervention||4
8361371|NCT01205269|20610662|P1|COMPLETED|Period 3 - Second Intervention||4
8361372|NCT01205269|20610657|P6|STARTED|Period 3 - Second Intervention||5
8361373|NCT01205269|20610658|P5|STARTED|Period 3 - Second Intervention||5
8361374|NCT01205269|20610659|P4|STARTED|Period 3 - Second Intervention||6
8361375|NCT01205269|20610660|P3|STARTED|Period 3 - Second Intervention||4
8361376|NCT01205269|20610661|P2|STARTED|Period 3 - Second Intervention||4
8361377|NCT01205269|20610662|P1|STARTED|Period 3 - Second Intervention||4
8361378|NCT01205269|20610657|P6|NOT COMPLETED|Period 2 - Washout||0
8361379|NCT01205269|20610658|P5|NOT COMPLETED|Period 2 - Washout||0
8361380|NCT01205269|20610659|P4|NOT COMPLETED|Period 2 - Washout||0
8361381|NCT01205269|20610660|P3|NOT COMPLETED|Period 2 - Washout||0
8361382|NCT01205269|20610661|P2|NOT COMPLETED|Period 2 - Washout||0
8361383|NCT01205269|20610662|P1|NOT COMPLETED|Period 2 - Washout||0
8361384|NCT01205269|20610657|P6|COMPLETED|Period 2 - Washout||5
8361385|NCT01205269|20610658|P5|COMPLETED|Period 2 - Washout||5
8361386|NCT01205269|20610659|P4|COMPLETED|Period 2 - Washout||6
8361387|NCT01205269|20610660|P3|COMPLETED|Period 2 - Washout||4
8361388|NCT01205269|20610661|P2|COMPLETED|Period 2 - Washout||4
8361389|NCT01205269|20610662|P1|COMPLETED|Period 2 - Washout||4
8361390|NCT01205269|20610657|P6|STARTED|Period 2 - Washout||5
8361391|NCT01205269|20610658|P5|STARTED|Period 2 - Washout||5
8361392|NCT01205269|20610659|P4|STARTED|Period 2 - Washout||6
8361393|NCT01205269|20610660|P3|STARTED|Period 2 - Washout||4
8361394|NCT01205269|20610661|P2|STARTED|Period 2 - Washout||4
8361395|NCT01205269|20610662|P1|STARTED|Period 2 - Washout||4
8361396|NCT01205269|20610657|P6|NOT COMPLETED|Period 1 - First Intervention||0
8361397|NCT01205269|20610658|P5|NOT COMPLETED|Period 1 - First Intervention||0
8361398|NCT01205269|20610659|P4|NOT COMPLETED|Period 1 - First Intervention||0
8361399|NCT01205269|20610660|P3|NOT COMPLETED|Period 1 - First Intervention||0
8361400|NCT01205269|20610661|P2|NOT COMPLETED|Period 1 - First Intervention||0
8361401|NCT01205269|20610662|P1|NOT COMPLETED|Period 1 - First Intervention||0
8361402|NCT01205269|20610657|P6|COMPLETED|Period 1 - First Intervention||5
8361403|NCT01205269|20610658|P5|COMPLETED|Period 1 - First Intervention||5
8361404|NCT01205269|20610659|P4|COMPLETED|Period 1 - First Intervention||6
8361405|NCT01205269|20610660|P3|COMPLETED|Period 1 - First Intervention||4
8361406|NCT01205269|20610661|P2|COMPLETED|Period 1 - First Intervention||4
8361407|NCT01205269|20610662|P1|COMPLETED|Period 1 - First Intervention||4
8361408|NCT01205269|20610657|P6|STARTED|Period 1 - First Intervention||5
8361409|NCT01205269|20610658|P5|STARTED|Period 1 - First Intervention||5
8361410|NCT01205269|20610659|P4|STARTED|Period 1 - First Intervention||6
8361411|NCT01205269|20610660|P3|STARTED|Period 1 - First Intervention||4
8361412|NCT01205269|20610661|P2|STARTED|Period 1 - First Intervention||4
8361413|NCT01205269|20610662|P1|STARTED|Period 1 - First Intervention||4
8361414|NCT01205230|20610702|P2|NOT COMPLETED|Overall Study||0
8361415|NCT01205230|20610703|P1|NOT COMPLETED|Overall Study||5
8361416|NCT01205230|20610702|P2|COMPLETED|Overall Study||13
8361417|NCT01205230|20610703|P1|COMPLETED|Overall Study||16
8361418|NCT01205230|20610702|P2|Combination Therapy|Overall Study||13
8361419|NCT01205230|20610703|P1|Combination Therapy|Overall Study||21
8361420|NCT01205230|20610702|P2|STARTED|Overall Study||13
8361421|NCT01205230|20610703|P1|STARTED|Overall Study||21
8361422|NCT01205165|20610746|P1|NOT COMPLETED|Overall Study||2
8361423|NCT01205165|20610746|P1|COMPLETED|Overall Study||102
8361424|NCT01205165|20610746|P1|STARTED|Overall Study||104
8361425|NCT01205152|20610759|P1|NOT COMPLETED|Overall Study||1
8361426|NCT01205152|20610759|P1|COMPLETED|Overall Study||9
8361427|NCT01205152|20610759|P1|STARTED|Overall Study||10
8361428|NCT01205126|20610772|P2|NOT COMPLETED|Maintenance Phase||40
8361429|NCT01205126|20610773|P1|NOT COMPLETED|Maintenance Phase||37
8361430|NCT01205126|20610772|P2|COMPLETED|Maintenance Phase||67
8361431|NCT01205126|20610773|P1|COMPLETED|Maintenance Phase||70
8361432|NCT01205126|20610772|P2|STARTED|Maintenance Phase||107
8361433|NCT01205126|20610773|P1|STARTED|Maintenance Phase||107
8361434|NCT01205126|20610772|P2|NOT COMPLETED|Between Titration & Maintenance Phase||4
8361435|NCT01205126|20610773|P1|NOT COMPLETED|Between Titration & Maintenance Phase||0
8361436|NCT01205126|20610772|P2|COMPLETED|Between Titration & Maintenance Phase||107
8361437|NCT01205126|20610773|P1|COMPLETED|Between Titration & Maintenance Phase||107
8361438|NCT01205126|20610772|P2|STARTED|Between Titration & Maintenance Phase||111
8361439|NCT01205126|20610773|P1|STARTED|Between Titration & Maintenance Phase||107
8361440|NCT01205126|20610772|P2|NOT COMPLETED|Titration Phase||19
8361441|NCT01205126|20610773|P1|NOT COMPLETED|Titration Phase||23
8361442|NCT01205126|20610772|P2|COMPLETED|Titration Phase||111
8361443|NCT01205126|20610773|P1|COMPLETED|Titration Phase||107
8361444|NCT01205126|20610772|P2|STARTED|Titration Phase||130
8361445|NCT01205126|20610773|P1|STARTED|Titration Phase||130
8361446|NCT01205035|20610791|P2|NOT COMPLETED|Overall Study||0
8361447|NCT01205035|20610792|P1|NOT COMPLETED|Overall Study||2
8361448|NCT01205035|20610791|P2|COMPLETED|Overall Study||3
8361449|NCT01205035|20610792|P1|COMPLETED|Overall Study||1
8361450|NCT01205035|20610791|P2|STARTED|Overall Study||3
8361451|NCT01205035|20610792|P1|STARTED|Overall Study||3
8361452|NCT01204918|20610809|P3|NOT COMPLETED|Overall Study||5
8361453|NCT01204918|20610810|P2|NOT COMPLETED|Overall Study||10
8361454|NCT01204918|20610811|P1|NOT COMPLETED|Overall Study||4
8361455|NCT01204918|20610809|P3|COMPLETED|Overall Study||35
8361456|NCT01204918|20610810|P2|COMPLETED|Overall Study||29
8361457|NCT01204918|20610811|P1|COMPLETED|Overall Study||21
8361458|NCT01204918|20610809|P3|Stage 2 End|Overall Study||35
8361459|NCT01204918|20610810|P2|Stage 2 End|Overall Study||29
8361460|NCT01204918|20610811|P1|Stage 2 End|Overall Study||21
8361461|NCT01204918|20610809|P3|Stage 2 Begin|Overall Study||36
8361462|NCT01204918|20610810|P2|Stage 2 Begin|Overall Study||35
8361463|NCT01204918|20610811|P1|Stage 2 Begin|Overall Study||22
8361464|NCT01204918|20610809|P3|Stage 1 End|Overall Study||36
8361465|NCT01204918|20610810|P2|Stage 1 End|Overall Study||35
8361466|NCT01204918|20610811|P1|Stage 1 End|Overall Study||22
8361467|NCT01204918|20610809|P3|Stage 1 Begin|Overall Study||40
8361468|NCT01204918|20610810|P2|Stage 1 Begin|Overall Study||39
8361469|NCT01204918|20610811|P1|Stage 1 Begin|Overall Study||25
8361470|NCT01204918|20610809|P3|STARTED|Overall Study||40
8361471|NCT01204918|20610810|P2|STARTED|Overall Study||39
8361472|NCT01204918|20610811|P1|STARTED|Overall Study||25
8361476|NCT01204853|20610833|P1|NOT COMPLETED|Overall Study||0
8361477|NCT01204853|20610833|P1|COMPLETED|Overall Study||2
8361478|NCT01204853|20610833|P1|STARTED|Overall Study||2
8361479|NCT01204788|20610845|P2|NOT COMPLETED|Overall Study||3
8361480|NCT01204788|20610846|P1|NOT COMPLETED|Overall Study||1
8361481|NCT01204788|20610845|P2|COMPLETED|Overall Study||0
8361482|NCT01204788|20610846|P1|COMPLETED|Overall Study||0
8361483|NCT01204788|20610845|P2|STARTED|Overall Study||3
8361484|NCT01204788|20610846|P1|STARTED|Overall Study||1
8361485|NCT01204775|20610854|P2|NOT COMPLETED|Overall Study||1
8361486|NCT01204775|20610855|P1|NOT COMPLETED|Overall Study||1
8361487|NCT01204775|20610854|P2|COMPLETED|Overall Study||3
8361488|NCT01204775|20610855|P1|COMPLETED|Overall Study||3
8361489|NCT01204775|20610854|P2|Double-blind Treatment Period|Overall Study||4
8361490|NCT01204775|20610855|P1|Double-blind Treatment Period|Overall Study||4
8361491|NCT01204775|20610854|P2|STARTED|Overall Study||4
8361492|NCT01204775|20610855|P1|STARTED|Overall Study||4
8361493|NCT01204736|20610865|P4|NOT COMPLETED|Overall Study||0
8361494|NCT01204736|20610866|P3|NOT COMPLETED|Overall Study||0
8361495|NCT01204736|20610867|P2|NOT COMPLETED|Overall Study||0
8361496|NCT01204736|20610868|P1|NOT COMPLETED|Overall Study||0
8361497|NCT01204736|20610865|P4|COMPLETED|Overall Study||2
8361498|NCT01204736|20610866|P3|COMPLETED|Overall Study||3
8361499|NCT01204736|20610867|P2|COMPLETED|Overall Study||5
8361500|NCT01204736|20610868|P1|COMPLETED|Overall Study||4
8361501|NCT01204736|20610865|P4|STARTED|Overall Study||2
8361502|NCT01204736|20610866|P3|STARTED|Overall Study||3
8361503|NCT01204736|20610867|P2|STARTED|Overall Study||5
8361504|NCT01204736|20610868|P1|STARTED|Overall Study||4
8361505|NCT01204710|20610880|P2|NOT COMPLETED|Optional Olaratumab Monotherapy||3
8361506|NCT01204710|20610881|P1|NOT COMPLETED|Optional Olaratumab Monotherapy||0
8361507|NCT01204710|20610880|P2|COMPLETED|Optional Olaratumab Monotherapy||16
8361508|NCT01204710|20610881|P1|COMPLETED|Optional Olaratumab Monotherapy||0
8361509|NCT01204710|20610880|P2|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
8361510|NCT01204710|20610881|P1|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
8361511|NCT01204710|20610880|P2|NOT COMPLETED|Randomization Treatment||13
8361512|NCT01204710|20610881|P1|NOT COMPLETED|Randomization Treatment||14
8361513|NCT01204710|20610880|P2|COMPLETED|Randomization Treatment||47
8361514|NCT01204710|20610881|P1|COMPLETED|Randomization Treatment||49
8361515|NCT01204710|20610880|P2|Received ≥1 Dose of Study Drug|Randomization Treatment||59
8361516|NCT01204710|20610881|P1|Received ≥1 Dose of Study Drug|Randomization Treatment||62
8361517|NCT01204710|20610880|P2|STARTED|Randomization Treatment||60
8361518|NCT01204710|20610881|P1|STARTED|Randomization Treatment||63
8361519|NCT01204697|20610917|P2|NOT COMPLETED|Overall Study||36
8361520|NCT01204697|20610918|P1|NOT COMPLETED|Overall Study||31
8361521|NCT01204697|20610917|P2|COMPLETED|Overall Study||2
8361522|NCT01204697|20610918|P1|COMPLETED|Overall Study||5
8361523|NCT01204697|20610917|P2|Treated|Overall Study||37
8361524|NCT01204697|20610918|P1|Treated|Overall Study||36
8361525|NCT01204697|20610917|P2|STARTED|Overall Study||38
8361526|NCT01204697|20610918|P1|STARTED|Overall Study||36
8361527|NCT01204671|20610939|P5|NOT COMPLETED|Overall Study||4
8361528|NCT01204671|20610940|P4|NOT COMPLETED|Overall Study||13
8361529|NCT01204671|20610941|P3|NOT COMPLETED|Overall Study||13
8361530|NCT01204671|20610942|P2|NOT COMPLETED|Overall Study||15
8361531|NCT01204671|20610943|P1|NOT COMPLETED|Overall Study||14
8361532|NCT01204671|20610939|P5|COMPLETED|Overall Study||606
8361533|NCT01204671|20610940|P4|COMPLETED|Overall Study||997
8361534|NCT01204671|20610941|P3|COMPLETED|Overall Study||998
8361535|NCT01204671|20610942|P2|COMPLETED|Overall Study||998
8361536|NCT01204671|20610943|P1|COMPLETED|Overall Study||998
8361537|NCT01204671|20610939|P5|STARTED|Overall Study||610
8361538|NCT01204671|20610940|P4|STARTED|Overall Study||1010
8361539|NCT01204671|20610941|P3|STARTED|Overall Study||1011
8361540|NCT01204671|20610942|P2|STARTED|Overall Study||1013
8361541|NCT01204671|20610943|P1|STARTED|Overall Study||1012
8361542|NCT01204658|20611005|P4|NOT COMPLETED|Booster Phase||0
8361543|NCT01204658|20611006|P3|NOT COMPLETED|Booster Phase||0
8361544|NCT01204658|20611007|P2|NOT COMPLETED|Booster Phase||0
8361545|NCT01204658|20611008|P1|NOT COMPLETED|Booster Phase||0
8361546|NCT01204658|20611005|P4|COMPLETED|Booster Phase||140
8361547|NCT01204658|20611006|P3|COMPLETED|Booster Phase||140
8361548|NCT01204658|20611007|P2|COMPLETED|Booster Phase||140
8361549|NCT01204658|20611008|P1|COMPLETED|Booster Phase||144
8361550|NCT01204658|20611005|P4|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
8361551|NCT01204658|20611006|P3|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
8361552|NCT01204658|20611007|P2|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
8361553|NCT01204658|20611008|P1|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
8361554|NCT01204658|20611005|P4|NOT COMPLETED|Primary Phase||0
8361555|NCT01204658|20611006|P3|NOT COMPLETED|Primary Phase||1
8361556|NCT01204658|20611007|P2|NOT COMPLETED|Primary Phase||0
8361557|NCT01204658|20611008|P1|NOT COMPLETED|Primary Phase||0
8361558|NCT01204658|20611005|P4|COMPLETED|Primary Phase||142
8361559|NCT01204658|20611006|P3|COMPLETED|Primary Phase||144
8361560|NCT01204658|20611007|P2|COMPLETED|Primary Phase||142
8361561|NCT01204658|20611008|P1|COMPLETED|Primary Phase||146
8361562|NCT01204658|20611005|P4|STARTED|Primary Phase||142
8361563|NCT01204658|20611006|P3|STARTED|Primary Phase||145
8361564|NCT01204658|20611007|P2|STARTED|Primary Phase||142
8361565|NCT01204658|20611008|P1|STARTED|Primary Phase||146
8361566|NCT01204398|20611126|P1|NOT COMPLETED|Overall Study||1
8361567|NCT01204398|20611126|P1|COMPLETED|Overall Study|Completed trial medication.|26
8361568|NCT01204398|20611126|P1|STARTED|Overall Study|Entered and treated.|27
8361569|NCT01204294|20611143|P7|NOT COMPLETED|Overall Study||2
8361570|NCT01204294|20611144|P6|NOT COMPLETED|Overall Study||5
8361571|NCT01204294|20611145|P5|NOT COMPLETED|Overall Study||2
8361572|NCT01204294|20611146|P4|NOT COMPLETED|Overall Study||11
8361573|NCT01204294|20611147|P3|NOT COMPLETED|Overall Study||5
8361574|NCT01204294|20611148|P2|NOT COMPLETED|Overall Study||8
8361575|NCT01204294|20611149|P1|NOT COMPLETED|Overall Study||3
8361576|NCT01204294|20611143|P7|COMPLETED|Overall Study||59
8361577|NCT01204294|20611144|P6|COMPLETED|Overall Study||58
8361578|NCT01204294|20611145|P5|COMPLETED|Overall Study||83
8361579|NCT01204294|20611146|P4|COMPLETED|Overall Study||132
8361580|NCT01204294|20611147|P3|COMPLETED|Overall Study||69
8361581|NCT01204294|20611148|P2|COMPLETED|Overall Study||58
8361582|NCT01204294|20611149|P1|COMPLETED|Overall Study||79
8361583|NCT01204294|20611143|P7|STARTED|Overall Study||61
8361584|NCT01204294|20611144|P6|STARTED|Overall Study||63
8361585|NCT01204294|20611145|P5|STARTED|Overall Study||85
8361586|NCT01204294|20611146|P4|STARTED|Overall Study||143
8361587|NCT01204294|20611147|P3|STARTED|Overall Study||74
8361588|NCT01204294|20611148|P2|STARTED|Overall Study||66
8361589|NCT01204294|20611149|P1|STARTED|Overall Study||82
8361590|NCT01204255|20611172|P1|NOT COMPLETED|Overall Study||1
8361591|NCT01204255|20611172|P1|COMPLETED|Overall Study||10
8361592|NCT01204255|20611172|P1|STARTED|Overall Study||11
8361593|NCT01204203|20611177|P1|NOT COMPLETED|Overall Study||0
8361594|NCT01204203|20611177|P1|COMPLETED|Overall Study||8
8361595|NCT01204203|20611177|P1|STARTED|Overall Study||8
8361596|NCT01203956|20611183|P2|NOT COMPLETED|Second Two-week Period||6
8361597|NCT01203956|20611184|P1|NOT COMPLETED|Second Two-week Period||5
8361598|NCT01203956|20611183|P2|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
8361599|NCT01203956|20611184|P1|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
8361600|NCT01203956|20611183|P2|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
8361601|NCT01203956|20611184|P1|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
8361602|NCT01203956|20611183|P2|STARTED|Second Two-week Period||13
8361603|NCT01203956|20611184|P1|STARTED|Second Two-week Period||15
8361604|NCT01203956|20611183|P2|NOT COMPLETED|First Two-week Period||0
8361605|NCT01203956|20611184|P1|NOT COMPLETED|First Two-week Period||0
8361606|NCT01203956|20611183|P2|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
8361607|NCT01203956|20611184|P1|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
8361608|NCT01203956|20611183|P2|STARTED|First Two-week Period||13
8361609|NCT01203956|20611184|P1|STARTED|First Two-week Period||15
8361610|NCT01203930|20611193|P2|NOT COMPLETED|Overall Study||41
8361611|NCT01203930|20611194|P1|NOT COMPLETED|Overall Study||21
8361612|NCT01203930|20611193|P2|COMPLETED|Overall Study||0
8361613|NCT01203930|20611194|P1|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
8361614|NCT01203930|20611193|P2|STARTED|Overall Study||41
8361615|NCT01203930|20611194|P1|STARTED|Overall Study||64
8361616|NCT01203917|20611216|P1|NOT COMPLETED|Overall Study||36
8361617|NCT01203917|20611216|P1|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
8361618|NCT01203917|20611216|P1|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
8361619|NCT01203878|20611229|P3|NOT COMPLETED|Overall Study||3
8361620|NCT01203878|20611230|P2|NOT COMPLETED|Overall Study||0
8361621|NCT01203878|20611231|P1|NOT COMPLETED|Overall Study||0
8361622|NCT01203878|20611229|P3|COMPLETED|Overall Study||0
8361623|NCT01203878|20611230|P2|COMPLETED|Overall Study||9
8361624|NCT01203878|20611231|P1|COMPLETED|Overall Study||9
8361625|NCT01203878|20611229|P3|STARTED|Overall Study||3
8361626|NCT01203878|20611230|P2|STARTED|Overall Study||9
8361627|NCT01203878|20611231|P1|STARTED|Overall Study||9
8361628|NCT01203852|20611242|P1|NOT COMPLETED|Chlorthalidone 8 Weeks||0
8361629|NCT01203852|20611242|P1|COMPLETED|Chlorthalidone 8 Weeks||328
8361630|NCT01203852|20611242|P1|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
8361631|NCT01203852|20611242|P1|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
8361632|NCT01203852|20611242|P1|NOT COMPLETED|Washout 2 Weeks||46
8361633|NCT01203852|20611242|P1|COMPLETED|Washout 2 Weeks||282
8361634|NCT01203852|20611242|P1|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
8361635|NCT01203852|20611242|P1|NOT COMPLETED|Metoprolol 8 Weeks||470
8361636|NCT01203852|20611242|P1|COMPLETED|Metoprolol 8 Weeks||369
8361637|NCT01203852|20611242|P1|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
8361638|NCT01203826|20611251|P2|NOT COMPLETED|Overall Study||0
8361639|NCT01203826|20611252|P1|NOT COMPLETED|Overall Study||0
8361640|NCT01203826|20611251|P2|COMPLETED|Overall Study||6
8361641|NCT01203826|20611252|P1|COMPLETED|Overall Study||6
8361642|NCT01203826|20611251|P2|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
8361643|NCT01203826|20611252|P1|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
8361644|NCT01203787|20611260|P2|NOT COMPLETED|Overall Study||27
8361645|NCT01203787|20611261|P1|NOT COMPLETED|Overall Study||31
8361646|NCT01203787|20611260|P2|COMPLETED|Overall Study||30
8361647|NCT01203787|20611261|P1|COMPLETED|Overall Study||32
8361648|NCT01203787|20611260|P2|STARTED|Overall Study||57
8361649|NCT01203787|20611261|P1|STARTED|Overall Study||63
8361650|NCT01203644|20611281|P2|NOT COMPLETED|Overall Study||0
8361651|NCT01203644|20611282|P1|NOT COMPLETED|Overall Study||0
8361652|NCT01203644|20611281|P2|COMPLETED|Overall Study||50
8361653|NCT01203644|20611282|P1|COMPLETED|Overall Study||26
8361654|NCT01203644|20611281|P2|STARTED|Overall Study||50
8361655|NCT01203644|20611282|P1|STARTED|Overall Study||26
8361656|NCT01203319|20611294|P3|NOT COMPLETED|Overall Study||5
8361657|NCT01203319|20611295|P2|NOT COMPLETED|Overall Study||9
8361658|NCT01203319|20611296|P1|NOT COMPLETED|Overall Study||6
8361659|NCT01203319|20611294|P3|COMPLETED|Overall Study||217
8361660|NCT01203319|20611295|P2|COMPLETED|Overall Study||426
8361661|NCT01203319|20611296|P1|COMPLETED|Overall Study||428
8361662|NCT01203319|20611294|P3|STARTED|Overall Study||222
8361663|NCT01203319|20611295|P2|STARTED|Overall Study||435
8361664|NCT01203319|20611296|P1|STARTED|Overall Study||434
8361665|NCT01203189|20611313|P3|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
8361666|NCT01203189|20611314|P2|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
8361667|NCT01203189|20611315|P1|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
8361668|NCT01203189|20611313|P3|COMPLETED|Cross Over Period 4 Weeks Treatment||3
8361669|NCT01203189|20611314|P2|COMPLETED|Cross Over Period 4 Weeks Treatment||0
8361670|NCT01203189|20611315|P1|COMPLETED|Cross Over Period 4 Weeks Treatment||0
8361671|NCT01203189|20611313|P3|STARTED|Cross Over Period 4 Weeks Treatment||3
8361672|NCT01203189|20611314|P2|STARTED|Cross Over Period 4 Weeks Treatment||0
8361673|NCT01203189|20611315|P1|STARTED|Cross Over Period 4 Weeks Treatment||0
8361674|NCT01203189|20611313|P3|NOT COMPLETED|First 4 Weeks Treatment||0
8361675|NCT01203189|20611314|P2|NOT COMPLETED|First 4 Weeks Treatment||2
8361676|NCT01203189|20611315|P1|NOT COMPLETED|First 4 Weeks Treatment||2
8361677|NCT01203189|20611313|P3|COMPLETED|First 4 Weeks Treatment||3
8361678|NCT01203189|20611314|P2|COMPLETED|First 4 Weeks Treatment||8
8361679|NCT01203189|20611315|P1|COMPLETED|First 4 Weeks Treatment||8
8361680|NCT01203189|20611313|P3|STARTED|First 4 Weeks Treatment||3
8361681|NCT01203189|20611314|P2|STARTED|First 4 Weeks Treatment||10
8361682|NCT01203189|20611315|P1|STARTED|First 4 Weeks Treatment||10
8361683|NCT01203098|20611332|P3|NOT COMPLETED|Overall Study||11
8361684|NCT01203098|20611333|P2|NOT COMPLETED|Overall Study||4
8361685|NCT01203098|20611334|P1|NOT COMPLETED|Overall Study||6
8361686|NCT01203098|20611332|P3|COMPLETED|Overall Study||78
8361687|NCT01203098|20611333|P2|COMPLETED|Overall Study||82
8361688|NCT01203098|20611334|P1|COMPLETED|Overall Study||83
8361689|NCT01203098|20611332|P3|Safety Analysis Dataset|Overall Study||87
8361690|NCT01203098|20611333|P2|Safety Analysis Dataset|Overall Study||85
8361691|NCT01203098|20611334|P1|Safety Analysis Dataset|Overall Study||89
8361692|NCT01203098|20611332|P3|STARTED|Overall Study||89
8361693|NCT01203098|20611333|P2|STARTED|Overall Study||86
8361694|NCT01203098|20611334|P1|STARTED|Overall Study||89
8361695|NCT01203072|20611350|P5|NOT COMPLETED|Overall Study||6
8361696|NCT01203072|20611351|P4|NOT COMPLETED|Overall Study||6
8361697|NCT01203072|20611352|P3|NOT COMPLETED|Overall Study||3
8361698|NCT01203072|20611353|P2|NOT COMPLETED|Overall Study||6
8361699|NCT01203072|20611354|P1|NOT COMPLETED|Overall Study||10
8361700|NCT01203072|20611350|P5|COMPLETED|Overall Study||96
8361701|NCT01203072|20611351|P4|COMPLETED|Overall Study||100
8361702|NCT01203072|20611352|P3|COMPLETED|Overall Study||101
8361703|NCT01203072|20611353|P2|COMPLETED|Overall Study||100
8361704|NCT01203072|20611354|P1|COMPLETED|Overall Study||95
8361705|NCT01203072|20611350|P5|STARTED|Overall Study||102
8361706|NCT01203072|20611351|P4|STARTED|Overall Study||106
8361707|NCT01203072|20611352|P3|STARTED|Overall Study||104
8361708|NCT01203072|20611353|P2|STARTED|Overall Study||106
8361709|NCT01203072|20611354|P1|STARTED|Overall Study||105
8361710|NCT01203046|20611373|P2|NOT COMPLETED|Overall Study||0
8361711|NCT01203046|20611374|P1|NOT COMPLETED|Overall Study||0
8361712|NCT01203046|20611373|P2|COMPLETED|Overall Study||28
8361713|NCT01203046|20611374|P1|COMPLETED|Overall Study||28
8361714|NCT01203046|20611373|P2|STARTED|Overall Study||28
8361715|NCT01203046|20611374|P1|STARTED|Overall Study||28
8361716|NCT01202994|20611382|P1|NOT COMPLETED|Overall Study||0
8361717|NCT01202994|20611382|P1|COMPLETED|Overall Study||27
8361718|NCT01202994|20611382|P1|STARTED|Overall Study||27
8361719|NCT01202955|20611389|P2|NOT COMPLETED|Period 3: 10 Days||0
8361720|NCT01202955|20611390|P1|NOT COMPLETED|Period 3: 10 Days||0
8361721|NCT01202955|20611389|P2|COMPLETED|Period 3: 10 Days||8
8361722|NCT01202955|20611390|P1|COMPLETED|Period 3: 10 Days||9
8361723|NCT01202955|20611389|P2|STARTED|Period 3: 10 Days||8
8361724|NCT01202955|20611390|P1|STARTED|Period 3: 10 Days||9
8361725|NCT01202955|20611389|P2|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
8361726|NCT01202955|20611390|P1|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
8361727|NCT01202955|20611389|P2|COMPLETED|Period 2: 7 Days (Wash-Out)||8
8361728|NCT01202955|20611390|P1|COMPLETED|Period 2: 7 Days (Wash-Out)||9
8361729|NCT01202955|20611389|P2|STARTED|Period 2: 7 Days (Wash-Out)||8
8361730|NCT01202955|20611390|P1|STARTED|Period 2: 7 Days (Wash-Out)||9
8361731|NCT01202955|20611389|P2|NOT COMPLETED|Period 1: 10 Days||2
8361732|NCT01202955|20611390|P1|NOT COMPLETED|Period 1: 10 Days||0
8361733|NCT01202955|20611389|P2|COMPLETED|Period 1: 10 Days||8
8361734|NCT01202955|20611390|P1|COMPLETED|Period 1: 10 Days||9
8361735|NCT01202955|20611389|P2|STARTED|Period 1: 10 Days||10
8361736|NCT01202955|20611390|P1|STARTED|Period 1: 10 Days||9
8361737|NCT01202903|20611402|P2|NOT COMPLETED|Overall Study||16
8361738|NCT01202903|20611403|P1|NOT COMPLETED|Overall Study||11
8361739|NCT01202903|20611402|P2|COMPLETED|Overall Study||292
8361740|NCT01202903|20611403|P1|COMPLETED|Overall Study||297
8361741|NCT01202903|20611402|P2|Safety Set*|Overall Study||299
8361742|NCT01202903|20611403|P1|Safety Set*|Overall Study||310
8361743|NCT01202903|20611402|P2|Full Analysis Set|Overall Study||302
8361744|NCT01202903|20611403|P1|Full Analysis Set|Overall Study||306
8361745|NCT01202903|20611402|P2|STARTED|Overall Study||308
8361746|NCT01202903|20611403|P1|STARTED|Overall Study||308
8361747|NCT01202877|20611430|P3|NOT COMPLETED|Overall Study||6
8361748|NCT01202877|20611431|P2|NOT COMPLETED|Overall Study||1
8361749|NCT01202877|20611432|P1|NOT COMPLETED|Overall Study||0
8361750|NCT01202877|20611430|P3|COMPLETED|Overall Study||34
8361751|NCT01202877|20611431|P2|COMPLETED|Overall Study||7
8361752|NCT01202877|20611432|P1|COMPLETED|Overall Study||6
8361753|NCT01202877|20611430|P3|STARTED|Overall Study||40
8361754|NCT01202877|20611431|P2|STARTED|Overall Study||8
8361755|NCT01202877|20611432|P1|STARTED|Overall Study||6
8361756|NCT01202773|20611446|P3|NOT COMPLETED|Overall Study||55
8361757|NCT01202773|20611447|P2|NOT COMPLETED|Overall Study||43
8361758|NCT01202773|20611448|P1|NOT COMPLETED|Overall Study||57
8361759|NCT01202773|20611446|P3|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
8361760|NCT01202773|20611447|P2|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
8361761|NCT01202773|20611448|P1|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
8361762|NCT01202773|20611446|P3|Post-Treatment Follow-Up Population|Overall Study||51
8361763|NCT01202773|20611447|P2|Post-Treatment Follow-Up Population|Overall Study||36
8361764|NCT01202773|20611448|P1|Post-Treatment Follow-Up Population|Overall Study||46
8361765|NCT01202773|20611446|P3|Week 16 NR|Overall Study||37
8361766|NCT01202773|20611447|P2|Week 16 NR|Overall Study||33
8361767|NCT01202773|20611448|P1|Week 16 NR|Overall Study||23
8361768|NCT01202773|20611446|P3|Received at Least 1 Dose of Study Drug|Overall Study||154
8361769|NCT01202773|20611447|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
8361770|NCT01202773|20611448|P1|Received at Least 1 Dose of Study Drug|Overall Study||153
8361771|NCT01202773|20611446|P3|STARTED|Overall Study||155
8361772|NCT01202773|20611447|P2|STARTED|Overall Study||148
8361773|NCT01202773|20611448|P1|STARTED|Overall Study||153
8361774|NCT01202760|20611525|P3|NOT COMPLETED|Overall Study||35
8361775|NCT01202760|20611526|P2|NOT COMPLETED|Overall Study||52
8361776|NCT01202760|20611527|P1|NOT COMPLETED|Overall Study||47
8361777|NCT01202760|20611525|P3|COMPLETED|Overall Study||216
8361778|NCT01202760|20611526|P2|COMPLETED|Overall Study||322
8361779|NCT01202760|20611527|P1|COMPLETED|Overall Study||332
8361780|NCT01202760|20611525|P3|Received at Least One Dose of Study Drug|Overall Study||250
8361781|NCT01202760|20611526|P2|Received at Least One Dose of Study Drug|Overall Study||371
8361782|NCT01202760|20611527|P1|Received at Least One Dose of Study Drug|Overall Study||379
8361783|NCT01202760|20611525|P3|STARTED|Overall Study||251
8361784|NCT01202760|20611526|P2|STARTED|Overall Study||374
8361785|NCT01202760|20611527|P1|STARTED|Overall Study||379
8361786|NCT01202747|20611595|P1|NOT COMPLETED|Overall Study||1
8361787|NCT01202747|20611595|P1|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
8361788|NCT01202747|20611595|P1|STARTED|Overall Study||50
8361789|NCT01202721|20611603|P4|NOT COMPLETED|Overall Study||0
8361790|NCT01202721|20611604|P3|NOT COMPLETED|Overall Study||0
8361791|NCT01202721|20611605|P2|NOT COMPLETED|Overall Study||0
8361792|NCT01202721|20611606|P1|NOT COMPLETED|Overall Study||0
8361793|NCT01202721|20611603|P4|COMPLETED|Overall Study||27
8361794|NCT01202721|20611604|P3|COMPLETED|Overall Study||14
8361795|NCT01202721|20611605|P2|COMPLETED|Overall Study||26
8361796|NCT01202721|20611606|P1|COMPLETED|Overall Study||18
8361797|NCT01202721|20611603|P4|STARTED|Overall Study||27
8361798|NCT01202721|20611604|P3|STARTED|Overall Study||14
8361799|NCT01202721|20611605|P2|STARTED|Overall Study||26
8361800|NCT01202721|20611606|P1|STARTED|Overall Study||18
8361801|NCT01202656|20611622|P2|NOT COMPLETED|CrossoverCycle||0
8361802|NCT01202656|20611623|P1|NOT COMPLETED|CrossoverCycle||0
8361803|NCT01202656|20611622|P2|COMPLETED|CrossoverCycle||14
8361804|NCT01202656|20611623|P1|COMPLETED|CrossoverCycle||18
8361805|NCT01202656|20611622|P2|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
8361806|NCT01202656|20611623|P1|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
8361807|NCT01202656|20611622|P2|NOT COMPLETED|Cycle 1||0
8361808|NCT01202656|20611623|P1|NOT COMPLETED|Cycle 1||0
8361809|NCT01202656|20611622|P2|COMPLETED|Cycle 1||62
8361810|NCT01202656|20611623|P1|COMPLETED|Cycle 1||67
8361811|NCT01202656|20611622|P2|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
8361812|NCT01202656|20611623|P1|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
8361813|NCT01202643|20611633|P2|NOT COMPLETED|Crossover Cycle||0
8361814|NCT01202643|20611634|P1|NOT COMPLETED|Crossover Cycle||0
8361815|NCT01202643|20611633|P2|COMPLETED|Crossover Cycle||2
8361816|NCT01202643|20611634|P1|COMPLETED|Crossover Cycle||1
8361817|NCT01202643|20611633|P2|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
8361818|NCT01202643|20611634|P1|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
8361819|NCT01202643|20611633|P2|NOT COMPLETED|Period 1||0
8361820|NCT01202643|20611634|P1|NOT COMPLETED|Period 1||0
8361821|NCT01202643|20611633|P2|COMPLETED|Period 1||6
8361822|NCT01202643|20611634|P1|COMPLETED|Period 1||6
8361823|NCT01202643|20611633|P2|STARTED|Period 1||6
8361824|NCT01202643|20611634|P1|STARTED|Period 1||6
8361825|NCT01202591|20611648|P6|NOT COMPLETED|Overall Study||4
8361826|NCT01202591|20611649|P5|NOT COMPLETED|Overall Study||5
8361827|NCT01202591|20611650|P4|NOT COMPLETED|Overall Study||7
8361828|NCT01202591|20611651|P3|NOT COMPLETED|Overall Study||11
8361829|NCT01202591|20611652|P2|NOT COMPLETED|Overall Study||5
8361830|NCT01202591|20611653|P1|NOT COMPLETED|Overall Study||5
8361831|NCT01202591|20611648|P6|COMPLETED|Overall Study||0
8361832|NCT01202591|20611649|P5|COMPLETED|Overall Study||0
8361833|NCT01202591|20611650|P4|COMPLETED|Overall Study||2
8361834|NCT01202591|20611651|P3|COMPLETED|Overall Study||1
8361835|NCT01202591|20611652|P2|COMPLETED|Overall Study||0
8361836|NCT01202591|20611653|P1|COMPLETED|Overall Study||0
8361837|NCT01202591|20611648|P6|STARTED|Overall Study||4
8361838|NCT01202591|20611649|P5|STARTED|Overall Study||5
8361839|NCT01202591|20611650|P4|STARTED|Overall Study||9
8361840|NCT01202591|20611651|P3|STARTED|Overall Study||12
8361841|NCT01202591|20611652|P2|STARTED|Overall Study||5
8361842|NCT01202591|20611653|P1|STARTED|Overall Study||5
8361843|NCT01202578|20611667|P1|NOT COMPLETED|Overall Study||0
8361844|NCT01202578|20611667|P1|COMPLETED|Overall Study||53
8361845|NCT01202578|20611667|P1|STARTED|Overall Study||53
8361846|NCT01202565|20611674|P1|NOT COMPLETED|Overall Study||67
8361847|NCT01202565|20611674|P1|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
8361848|NCT01202565|20611674|P1|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
8361849|NCT01202565|20611674|P1|STARTED|Overall Study||506
8361850|NCT01202409|20611697|P1|NOT COMPLETED|Overall Study||8
8361851|NCT01202409|20611697|P1|COMPLETED|Overall Study||11
8361852|NCT01202409|20611697|P1|STARTED|Overall Study||19
8361853|NCT01202279|20611704|P2|NOT COMPLETED|Overall Study||27
8361854|NCT01202279|20611705|P1|NOT COMPLETED|Overall Study||37
8361855|NCT01202279|20611704|P2|COMPLETED|Overall Study||561
8361856|NCT01202279|20611705|P1|COMPLETED|Overall Study||554
8361857|NCT01202279|20611704|P2|STARTED|Overall Study||588
8361858|NCT01202279|20611705|P1|STARTED|Overall Study||591
8361859|NCT01202253|20611713|P1|NOT COMPLETED|Overall Study||0
8361860|NCT01202253|20611713|P1|COMPLETED|Overall Study||50
8361861|NCT01202253|20611713|P1|STARTED|Overall Study||50
8361862|NCT01202188|20611762|P5|NOT COMPLETED|Overall Study||45
8361863|NCT01202188|20611763|P4|NOT COMPLETED|Overall Study||42
8361864|NCT01202188|20611764|P3|NOT COMPLETED|Overall Study||53
8361865|NCT01202188|20611765|P2|NOT COMPLETED|Overall Study||56
8361866|NCT01202188|20611766|P1|NOT COMPLETED|Overall Study||38
8361867|NCT01202188|20611762|P5|COMPLETED|Overall Study||189
8361868|NCT01202188|20611763|P4|COMPLETED|Overall Study||441
8361869|NCT01202188|20611764|P3|COMPLETED|Overall Study||422
8361870|NCT01202188|20611765|P2|COMPLETED|Overall Study||421
8361871|NCT01202188|20611766|P1|COMPLETED|Overall Study||437
8361872|NCT01202188|20611762|P5|Safety Set; Received Study Drug|Overall Study||232
8361873|NCT01202188|20611763|P4|Safety Set; Received Study Drug|Overall Study||480
8361874|NCT01202188|20611764|P3|Safety Set; Received Study Drug|Overall Study||473
8361875|NCT01202188|20611765|P2|Safety Set; Received Study Drug|Overall Study||476
8361876|NCT01202188|20611766|P1|Safety Set; Received Study Drug|Overall Study||474
8361877|NCT01202188|20611762|P5|STARTED|Overall Study||234
8361878|NCT01202188|20611763|P4|STARTED|Overall Study||483
8361879|NCT01202188|20611764|P3|STARTED|Overall Study||475
8361880|NCT01202188|20611765|P2|STARTED|Overall Study||477
8361881|NCT01202188|20611766|P1|STARTED|Overall Study||475
8361882|NCT01202175|20611874|P1|NOT COMPLETED|Overall Study||5
8361883|NCT01202175|20611874|P1|COMPLETED|Overall Study||45
8361884|NCT01202175|20611874|P1|Pacebo|Overall Study||25
8361885|NCT01202175|20611874|P1|Nebivolol|Overall Study||25
8361886|NCT01202175|20611874|P1|STARTED|Overall Study||50
8361887|NCT01202162|20611903|P2|NOT COMPLETED|Overall Study||2
8361888|NCT01202162|20611904|P1|NOT COMPLETED|Overall Study||3
8361889|NCT01202162|20611903|P2|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
8361890|NCT01202162|20611904|P1|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
8361891|NCT01202162|20611903|P2|STARTED|Overall Study||42
8361892|NCT01202162|20611904|P1|STARTED|Overall Study||43
8361893|NCT01202110|20611914|P2|NOT COMPLETED|Overall Study||0
8361894|NCT01202110|20611915|P1|NOT COMPLETED|Overall Study||0
8361895|NCT01202110|20611914|P2|COMPLETED|Overall Study||0
8361896|NCT01202110|20611915|P1|COMPLETED|Overall Study||10
8361897|NCT01202110|20611914|P2|STARTED|Overall Study||0
8361898|NCT01202110|20611915|P1|STARTED|Overall Study||10
8361899|NCT01202071|20611919|P4|NOT COMPLETED|Overall Study||0
8361900|NCT01202071|20611920|P3|NOT COMPLETED|Overall Study||0
8361901|NCT01202071|20611921|P2|NOT COMPLETED|Overall Study||0
8361902|NCT01202071|20611922|P1|NOT COMPLETED|Overall Study||0
8361903|NCT01202071|20611919|P4|COMPLETED|Overall Study||6
8361904|NCT01202071|20611920|P3|COMPLETED|Overall Study||6
8361905|NCT01202071|20611921|P2|COMPLETED|Overall Study||6
8361906|NCT01202071|20611922|P1|COMPLETED|Overall Study||6
8361907|NCT01202071|20611919|P4|STARTED|Overall Study||6
8361908|NCT01202071|20611920|P3|STARTED|Overall Study||6
8361909|NCT01202071|20611921|P2|STARTED|Overall Study||6
8361910|NCT01202071|20611922|P1|STARTED|Overall Study||6
8361911|NCT01201967|20611942|P2|NOT COMPLETED|Overall Study||5
8361912|NCT01201967|20611943|P1|NOT COMPLETED|Overall Study||6
8361913|NCT01201967|20611942|P2|COMPLETED|Overall Study||86
8361914|NCT01201967|20611943|P1|COMPLETED|Overall Study||86
8361915|NCT01201967|20611942|P2|STARTED|Overall Study||91
8361916|NCT01201967|20611943|P1|STARTED|Overall Study||92
8361917|NCT01201915|20611968|P3|NOT COMPLETED|Overall Study||6
8361918|NCT01201915|20611969|P2|NOT COMPLETED|Overall Study||11
8361919|NCT01201915|20611970|P1|NOT COMPLETED|Overall Study||8
8361920|NCT01201915|20611968|P3|COMPLETED|Overall Study||19
8361921|NCT01201915|20611969|P2|COMPLETED|Overall Study||14
8361922|NCT01201915|20611970|P1|COMPLETED|Overall Study||16
8361923|NCT01201915|20611968|P3|STARTED|Overall Study||25
8361924|NCT01201915|20611969|P2|STARTED|Overall Study||25
8361925|NCT01201915|20611970|P1|STARTED|Overall Study||24
8361926|NCT01201811|20611981|P1|NOT COMPLETED|Overall Study||19
8361927|NCT01201811|20611981|P1|COMPLETED|Overall Study||25
8361928|NCT01201811|20611981|P1|STARTED|Overall Study||44
8361929|NCT01201798|20612003|P2|NOT COMPLETED|Overall Study||15
8361930|NCT01201798|20612004|P1|NOT COMPLETED|Overall Study||9
8361931|NCT01201798|20612003|P2|COMPLETED|Overall Study||39
8361932|NCT01201798|20612004|P1|COMPLETED|Overall Study||47
8361933|NCT01201798|20612003|P2|STARTED|Overall Study||54
8361934|NCT01201798|20612004|P1|STARTED|Overall Study||56
8361935|NCT01201785|20612028|P1|NOT COMPLETED|Overall Study||16
8361936|NCT01201785|20612028|P1|COMPLETED|Overall Study||20
8361937|NCT01201785|20612028|P1|STARTED|Overall Study||36
8361938|NCT01201772|20612035|P3|NOT COMPLETED|Overall Study||0
8361939|NCT01201772|20612036|P2|NOT COMPLETED|Overall Study||0
8361940|NCT01201772|20612037|P1|NOT COMPLETED|Overall Study||1
8361941|NCT01201772|20612035|P3|COMPLETED|Overall Study||21
8361942|NCT01201772|20612036|P2|COMPLETED|Overall Study||21
8361943|NCT01201772|20612037|P1|COMPLETED|Overall Study||22
8361944|NCT01201772|20612035|P3|STARTED|Overall Study||21
8361945|NCT01201772|20612036|P2|STARTED|Overall Study||21
8361946|NCT01201772|20612037|P1|STARTED|Overall Study||23
8361947|NCT01201759|20612045|P2|NOT COMPLETED|Visit 5||0
8361948|NCT01201759|20612046|P1|NOT COMPLETED|Visit 5||0
8361949|NCT01201759|20612045|P2|COMPLETED|Visit 5||3
8361950|NCT01201759|20612046|P1|COMPLETED|Visit 5||7
8361951|NCT01201759|20612045|P2|STARTED|Visit 5||3
8361952|NCT01201759|20612046|P1|STARTED|Visit 5||7
8361953|NCT01201759|20612045|P2|NOT COMPLETED|Visit 4 Crossover||1
8361954|NCT01201759|20612046|P1|NOT COMPLETED|Visit 4 Crossover||0
8361955|NCT01201759|20612045|P2|COMPLETED|Visit 4 Crossover||3
8361956|NCT01201759|20612046|P1|COMPLETED|Visit 4 Crossover||7
8361957|NCT01201759|20612045|P2|STARTED|Visit 4 Crossover||4
8361958|NCT01201759|20612046|P1|STARTED|Visit 4 Crossover||7
8361959|NCT01201759|20612045|P2|NOT COMPLETED|Visit 3 - Washout||3
8361960|NCT01201759|20612046|P1|NOT COMPLETED|Visit 3 - Washout||1
8361961|NCT01201759|20612045|P2|COMPLETED|Visit 3 - Washout||4
8361962|NCT01201759|20612046|P1|COMPLETED|Visit 3 - Washout||7
8361963|NCT01201759|20612045|P2|STARTED|Visit 3 - Washout||7
8361964|NCT01201759|20612046|P1|STARTED|Visit 3 - Washout||8
8361965|NCT01201759|20612045|P2|NOT COMPLETED|Visit 2||0
8361966|NCT01201759|20612046|P1|NOT COMPLETED|Visit 2||0
8361967|NCT01201759|20612045|P2|COMPLETED|Visit 2||7
8361968|NCT01201759|20612046|P1|COMPLETED|Visit 2||8
8361969|NCT01201759|20612045|P2|STARTED|Visit 2||7
8361970|NCT01201759|20612046|P1|STARTED|Visit 2||8
8361971|NCT01201759|20612045|P2|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
8361972|NCT01201759|20612046|P1|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
8361973|NCT01201759|20612045|P2|COMPLETED|Visit 1 Wash-in ( Untreated)||7
8361974|NCT01201759|20612046|P1|COMPLETED|Visit 1 Wash-in ( Untreated)||8
8361975|NCT01201759|20612045|P2|STARTED|Visit 1 Wash-in ( Untreated)||8
8361976|NCT01201759|20612046|P1|STARTED|Visit 1 Wash-in ( Untreated)||10
8361977|NCT01201629|20612060|P2|NOT COMPLETED|Overall Study||0
8361978|NCT01201629|20612061|P1|NOT COMPLETED|Overall Study||0
8361979|NCT01201629|20612060|P2|COMPLETED|Overall Study||8
8361980|NCT01201629|20612061|P1|COMPLETED|Overall Study||8
8361981|NCT01201629|20612060|P2|STARTED|Overall Study||8
8361982|NCT01201629|20612061|P1|STARTED|Overall Study||8
8361983|NCT01201486|20612071|P1|NOT COMPLETED|Overall Study||0
8361984|NCT01201486|20612071|P1|COMPLETED|Overall Study||6781
8361985|NCT01201486|20612071|P1|STARTED|Overall Study||6781
8361991|NCT01201343|20612089|P1|NOT COMPLETED|Overall Study||19
8361992|NCT01201343|20612089|P1|COMPLETED|Overall Study||60
8361993|NCT01201343|20612089|P1|Treated|Overall Study||76
8361994|NCT01201343|20612089|P1|STARTED|Overall Study||79
8361995|NCT01201317|20612103|P3|NOT COMPLETED|Overall Study||8
8361996|NCT01201317|20612104|P2|NOT COMPLETED|Overall Study||7
8361997|NCT01201317|20612105|P1|NOT COMPLETED|Overall Study||9
8361998|NCT01201317|20612103|P3|COMPLETED|Overall Study||33
8361999|NCT01201317|20612104|P2|COMPLETED|Overall Study||38
8362000|NCT01201317|20612105|P1|COMPLETED|Overall Study||39
8362001|NCT01201317|20612103|P3|STARTED|Overall Study||41
8362002|NCT01201317|20612104|P2|STARTED|Overall Study||45
8362003|NCT01201317|20612105|P1|STARTED|Overall Study||48
8362004|NCT01201265|20612125|P1|NOT COMPLETED|Overall Study||38
8362005|NCT01201265|20612125|P1|COMPLETED|Overall Study||2
8362006|NCT01201265|20612125|P1|STARTED|Overall Study||40
8362007|NCT01201057|20612141|P4|NOT COMPLETED|Overall Study||4
8362008|NCT01201057|20612142|P3|NOT COMPLETED|Overall Study||5
8362009|NCT01201057|20612143|P2|NOT COMPLETED|Overall Study||4
8362010|NCT01201057|20612144|P1|NOT COMPLETED|Overall Study||2
8362011|NCT01201057|20612141|P4|COMPLETED|Overall Study||29
8362012|NCT01201057|20612142|P3|COMPLETED|Overall Study||27
8362013|NCT01201057|20612143|P2|COMPLETED|Overall Study||29
8362014|NCT01201057|20612144|P1|COMPLETED|Overall Study||32
8362015|NCT01201057|20612141|P4|STARTED|Overall Study||33
8362016|NCT01201057|20612142|P3|STARTED|Overall Study||32
8362017|NCT01201057|20612143|P2|STARTED|Overall Study||33
8362018|NCT01201057|20612144|P1|STARTED|Overall Study||34
8362019|NCT01200992|20612172|P2|NOT COMPLETED|Overall Study||41
8362020|NCT01200992|20612173|P1|NOT COMPLETED|Overall Study||37
8362021|NCT01200992|20612172|P2|COMPLETED|Overall Study||4
8362022|NCT01200992|20612173|P1|COMPLETED|Overall Study||2
8362023|NCT01200992|20612172|P2|STARTED|Overall Study||45
8362024|NCT01200992|20612173|P1|STARTED|Overall Study||39
8362025|NCT01200875|20612181|P1|NOT COMPLETED|Overall Study||0
8362026|NCT01200875|20612181|P1|COMPLETED|Overall Study||25
8362027|NCT01200875|20612181|P1|STARTED|Overall Study||25
8362028|NCT01200862|20612188|P3|NOT COMPLETED|Part 2||0
8362029|NCT01200862|20612189|P2|NOT COMPLETED|Part 2||1
8362030|NCT01200862|20612190|P1|NOT COMPLETED|Part 2||0
8362031|NCT01200862|20612188|P3|COMPLETED|Part 2||8
8362032|NCT01200862|20612189|P2|COMPLETED|Part 2||6
8362033|NCT01200862|20612190|P1|COMPLETED|Part 2||0
8362034|NCT01200862|20612188|P3|STARTED|Part 2||8
8362035|NCT01200862|20612189|P2|STARTED|Part 2||7
8362036|NCT01200862|20612190|P1|STARTED|Part 2||0
8362037|NCT01200862|20612188|P3|NOT COMPLETED|Part 1||0
8362038|NCT01200862|20612189|P2|NOT COMPLETED|Part 1||0
8362039|NCT01200862|20612190|P1|NOT COMPLETED|Part 1||1
8362040|NCT01200862|20612188|P3|COMPLETED|Part 1||0
8362041|NCT01200862|20612189|P2|COMPLETED|Part 1||0
8362042|NCT01200862|20612190|P1|COMPLETED|Part 1||13
8362043|NCT01200862|20612188|P3|STARTED|Part 1||0
8362044|NCT01200862|20612189|P2|STARTED|Part 1||0
8362045|NCT01200862|20612190|P1|STARTED|Part 1||14
8362046|NCT01200810|20612204|P2|NOT COMPLETED|Overall Study||5
8362047|NCT01200810|20612205|P1|NOT COMPLETED|Overall Study||5
8362048|NCT01200810|20612204|P2|COMPLETED|Overall Study||0
8362049|NCT01200810|20612205|P1|COMPLETED|Overall Study||0
8362050|NCT01200810|20612204|P2|STARTED|Overall Study||5
8362051|NCT01200810|20612205|P1|STARTED|Overall Study||5
8362052|NCT01200797|20612225|P1|NOT COMPLETED|Overall Study||19
8362053|NCT01200797|20612225|P1|COMPLETED|Overall Study||0
8362054|NCT01200797|20612225|P1|STARTED|Overall Study||19
8362055|NCT01200758|20612235|P4|NOT COMPLETED|Stage 2||50
8362056|NCT01200758|20612236|P3|NOT COMPLETED|Stage 2||41
8362057|NCT01200758|20612237|P2|NOT COMPLETED|Stage 2||0
8362058|NCT01200758|20612238|P1|NOT COMPLETED|Stage 2||0
8362059|NCT01200758|20612235|P4|COMPLETED|Stage 2|Participants completed treatment period.|92
8362060|NCT01200758|20612236|P3|COMPLETED|Stage 2|Participants completed treatment period.|100
8362061|NCT01200758|20612237|P2|COMPLETED|Stage 2||0
8362062|NCT01200758|20612238|P1|COMPLETED|Stage 2||0
8362063|NCT01200758|20612235|P4|STARTED|Stage 2||142
8362064|NCT01200758|20612236|P3|STARTED|Stage 2||141
8362065|NCT01200758|20612237|P2|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
8362066|NCT01200758|20612238|P1|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
8362067|NCT01200758|20612235|P4|NOT COMPLETED|Stage I||0
8362068|NCT01200758|20612236|P3|NOT COMPLETED|Stage I||0
8362069|NCT01200758|20612237|P2|NOT COMPLETED|Stage I||17
8362070|NCT01200758|20612238|P1|NOT COMPLETED|Stage I||18
8362071|NCT01200758|20612235|P4|COMPLETED|Stage I||0
8362072|NCT01200758|20612236|P3|COMPLETED|Stage I||0
8362073|NCT01200758|20612237|P2|COMPLETED|Stage I|Participants completed treatment period.|46
8362074|NCT01200758|20612238|P1|COMPLETED|Stage I|Participants completed treatment period.|46
8362075|NCT01200758|20612235|P4|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
8362076|NCT01200758|20612236|P3|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
8362077|NCT01200758|20612237|P2|STARTED|Stage I||63
8362078|NCT01200758|20612238|P1|STARTED|Stage I||64
8362079|NCT01200602|20612294|P2|NOT COMPLETED|Overall Study||0
8362080|NCT01200602|20612295|P1|NOT COMPLETED|Overall Study||0
8362081|NCT01200602|20612294|P2|COMPLETED|Overall Study||0
8362082|NCT01200602|20612295|P1|COMPLETED|Overall Study||0
8362083|NCT01200602|20612294|P2|STARTED|Overall Study||0
8362084|NCT01200602|20612295|P1|STARTED|Overall Study||0
8362085|NCT01200589|20612311|P2|NOT COMPLETED|Overall Study||189
8362086|NCT01200589|20612312|P1|NOT COMPLETED|Overall Study||190
8362087|NCT01200589|20612311|P2|COMPLETED|Overall Study||30
8362088|NCT01200589|20612312|P1|COMPLETED|Overall Study||29
8362089|NCT01200589|20612311|P2|Safety Set|Overall Study||218
8362090|NCT01200589|20612312|P1|Safety Set|Overall Study||217
8362091|NCT01200589|20612311|P2|Intent-to-treat (ITT) Analysis Set|Overall Study||219
8362092|NCT01200589|20612312|P1|Intent-to-treat (ITT) Analysis Set|Overall Study||219
8362093|NCT01200589|20612311|P2|STARTED|Overall Study||219
8362094|NCT01200589|20612312|P1|STARTED|Overall Study||219
8362095|NCT01200524|20612339|P3|NOT COMPLETED|Overall Study||4
8362096|NCT01200524|20612340|P2|NOT COMPLETED|Overall Study||1
8362097|NCT01200524|20612341|P1|NOT COMPLETED|Overall Study||2
8362098|NCT01200524|20612339|P3|COMPLETED|Overall Study||40
8362099|NCT01200524|20612340|P2|COMPLETED|Overall Study||47
8362100|NCT01200524|20612341|P1|COMPLETED|Overall Study||39
8362101|NCT01200524|20612339|P3|STARTED|Overall Study||44
8362102|NCT01200524|20612340|P2|STARTED|Overall Study||48
8362103|NCT01200524|20612341|P1|STARTED|Overall Study||41
8362104|NCT01200511|20612361|P1|NOT COMPLETED|Overall Study||5
8362105|NCT01200511|20612361|P1|COMPLETED|Overall Study||44
8362106|NCT01200511|20612361|P1|STARTED|Overall Study||49
8362107|NCT01200498|20612369|P1|NOT COMPLETED|Overall Study||0
8362108|NCT01200498|20612369|P1|COMPLETED|Overall Study||22
8362109|NCT01200498|20612369|P1|STARTED|Overall Study||22
8362110|NCT01200485|20612373|P3|NOT COMPLETED|Cycle 2: Randomization||0
8362111|NCT01200485|20612374|P2|NOT COMPLETED|Cycle 2: Randomization||0
8362112|NCT01200485|20612375|P1|NOT COMPLETED|Cycle 2: Randomization||0
8362113|NCT01200485|20612373|P3|COMPLETED|Cycle 2: Randomization||25
8362114|NCT01200485|20612374|P2|COMPLETED|Cycle 2: Randomization||21
8362115|NCT01200485|20612375|P1|COMPLETED|Cycle 2: Randomization||0
8362116|NCT01200485|20612373|P3|STARTED|Cycle 2: Randomization||25
8362117|NCT01200485|20612374|P2|STARTED|Cycle 2: Randomization|Six not randomized: Methemoglobinemia-1, Kidney failure-2, Chemotherapy changed-2, Not evaluable-1|21
8362118|NCT01200485|20612375|P1|STARTED|Cycle 2: Randomization|Of 55 enrolled on study, 52 participants were treated in Cycle 1, only 46 randomized to Cycle 2|0
8362119|NCT01200485|20612373|P3|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
8362120|NCT01200485|20612374|P2|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
8362121|NCT01200485|20612375|P1|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3
8362122|NCT01200485|20612373|P3|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
8362123|NCT01200485|20612374|P2|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
8362124|NCT01200485|20612375|P1|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52
8362125|NCT01200485|20612373|P3|STARTED|Cycle 1: Rasburicase Alone Delivery||0
8362126|NCT01200485|20612374|P2|STARTED|Cycle 1: Rasburicase Alone Delivery||0
8362127|NCT01200485|20612375|P1|STARTED|Cycle 1: Rasburicase Alone Delivery|Of 55 participants screened, only 52 treated.|55
8362128|NCT01200433|20612386|P2|NOT COMPLETED|Overall Study||0
8362129|NCT01200433|20612387|P1|NOT COMPLETED|Overall Study||0
8362130|NCT01200433|20612386|P2|COMPLETED|Overall Study||23
8362131|NCT01200433|20612387|P1|COMPLETED|Overall Study||21
8362132|NCT01200433|20612386|P2|STARTED|Overall Study||23
8362133|NCT01200433|20612387|P1|STARTED|Overall Study||21
8362134|NCT01200394|20612409|P2|NOT COMPLETED|Overall Study||28
8362135|NCT01200394|20612410|P1|NOT COMPLETED|Overall Study||2
8362136|NCT01200394|20612409|P2|COMPLETED|Overall Study||164
8362137|NCT01200394|20612410|P1|COMPLETED|Overall Study||62
8362138|NCT01200394|20612409|P2|STARTED|Overall Study||192
8362139|NCT01200394|20612410|P1|STARTED|Overall Study||64
8362140|NCT01200368|20612448|P3|NOT COMPLETED|Toddler Dose||1
8362141|NCT01200368|20612449|P2|NOT COMPLETED|Toddler Dose||3
8362142|NCT01200368|20612450|P1|NOT COMPLETED|Toddler Dose||0
8362143|NCT01200368|20612448|P3|COMPLETED|Toddler Dose||168
8362144|NCT01200368|20612449|P2|COMPLETED|Toddler Dose||159
8362145|NCT01200368|20612450|P1|COMPLETED|Toddler Dose||162
8362146|NCT01200368|20612448|P3|STARTED|Toddler Dose||169
8362147|NCT01200368|20612449|P2|STARTED|Toddler Dose||162
8362148|NCT01200368|20612450|P1|STARTED|Toddler Dose||162
8362149|NCT01200368|20612448|P3|NOT COMPLETED|After Infant Series||9
8362150|NCT01200368|20612449|P2|NOT COMPLETED|After Infant Series||16
8362151|NCT01200368|20612450|P1|NOT COMPLETED|After Infant Series||18
8362152|NCT01200368|20612448|P3|COMPLETED|After Infant Series||169
8362153|NCT01200368|20612449|P2|COMPLETED|After Infant Series||162
8362154|NCT01200368|20612450|P1|COMPLETED|After Infant Series||162
8362155|NCT01200368|20612448|P3|STARTED|After Infant Series||178
8362156|NCT01200368|20612449|P2|STARTED|After Infant Series||178
8362157|NCT01200368|20612450|P1|STARTED|After Infant Series||180
8362158|NCT01200368|20612448|P3|NOT COMPLETED|Infant Series||6
8362159|NCT01200368|20612449|P2|NOT COMPLETED|Infant Series||6
8362160|NCT01200368|20612450|P1|NOT COMPLETED|Infant Series||3
8362161|NCT01200368|20612448|P3|COMPLETED|Infant Series||178
8362162|NCT01200368|20612449|P2|COMPLETED|Infant Series||178
8362163|NCT01200368|20612450|P1|COMPLETED|Infant Series||180
8362164|NCT01200368|20612448|P3|Vaccinated Dose 3|Infant Series||182
8362165|NCT01200368|20612449|P2|Vaccinated Dose 3|Infant Series||178
8362166|NCT01200368|20612450|P1|Vaccinated Dose 3|Infant Series||181
8362167|NCT01200368|20612448|P3|Vaccinated Dose 2|Infant Series||183
8362168|NCT01200368|20612449|P2|Vaccinated Dose 2|Infant Series||182
8362169|NCT01200368|20612450|P1|Vaccinated Dose 2|Infant Series||183
8362170|NCT01200368|20612448|P3|Vaccinated Dose 1|Infant Series||183
8362171|NCT01200368|20612449|P2|Vaccinated Dose 1|Infant Series||183
8362172|NCT01200368|20612450|P1|Vaccinated Dose 1|Infant Series||183
8362173|NCT01200368|20612448|P3|STARTED|Infant Series||184
8362174|NCT01200368|20612449|P2|STARTED|Infant Series||184
8362175|NCT01200368|20612450|P1|STARTED|Infant Series||183
8362176|NCT01200355|20612516|P2|NOT COMPLETED|Overall Study||2
8362177|NCT01200355|20612517|P1|NOT COMPLETED|Overall Study||7
8362178|NCT01200355|20612516|P2|COMPLETED|Overall Study||53
8362179|NCT01200355|20612517|P1|COMPLETED|Overall Study||51
8362180|NCT01200355|20612516|P2|STARTED|Overall Study||55
8362181|NCT01200355|20612517|P1|STARTED|Overall Study||58
8362182|NCT01200342|20612531|P1|NOT COMPLETED|Overall Study||1
8362183|NCT01200342|20612531|P1|COMPLETED|Overall Study||6
8362184|NCT01200342|20612531|P1|STARTED|Overall Study||7
8362185|NCT01200329|20612536|P1|NOT COMPLETED|Overall Study||3
8362186|NCT01200329|20612536|P1|COMPLETED|Overall Study||78
8362187|NCT01200329|20612536|P1|STARTED|Overall Study||81
8362188|NCT01200290|20612541|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||2
8362189|NCT01200290|20612541|P1|COMPLETED|Post-Treatment Follow-Up Period||16
8362190|NCT01200290|20612541|P1|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
8362191|NCT01200290|20612541|P1|NOT COMPLETED|Treatment Period||1
8362192|NCT01200290|20612541|P1|COMPLETED|Treatment Period||17
8362193|NCT01200290|20612541|P1|Received at Least 1 Dose of Study Drug|Treatment Period||18
8362194|NCT01200290|20612541|P1|STARTED|Treatment Period||18
8362195|NCT01200238|20612554|P2|NOT COMPLETED|Overall Study||10
8362196|NCT01200238|20612555|P1|NOT COMPLETED|Overall Study||7
8362197|NCT01200238|20612554|P2|COMPLETED|Overall Study||0
8362198|NCT01200238|20612555|P1|COMPLETED|Overall Study||0
8362199|NCT01200238|20612554|P2|STARTED|Overall Study||10
8362200|NCT01200238|20612555|P1|STARTED|Overall Study||7
8362201|NCT01200160|20612573|P1|NOT COMPLETED|Overall Study||62
8362202|NCT01200160|20612573|P1|COMPLETED|Overall Study||66
8362203|NCT01200160|20612573|P1|STARTED|Overall Study||128
8362204|NCT01200069|20612579|P2|NOT COMPLETED|Overall Study||1
8362205|NCT01200069|20612580|P1|NOT COMPLETED|Overall Study||0
8362206|NCT01200069|20612579|P2|COMPLETED|Overall Study||5
8362207|NCT01200069|20612580|P1|COMPLETED|Overall Study||8
8362208|NCT01200069|20612579|P2|STARTED|Overall Study||6
8362209|NCT01200069|20612580|P1|STARTED|Overall Study||8
8362210|NCT01200030|20612635|P3|NOT COMPLETED|Overall Study||0
8362211|NCT01200030|20612636|P2|NOT COMPLETED|Overall Study||0
8362212|NCT01200030|20612637|P1|NOT COMPLETED|Overall Study||0
8362213|NCT01200030|20612635|P3|COMPLETED|Overall Study||12
8362214|NCT01200030|20612636|P2|COMPLETED|Overall Study||13
8362215|NCT01200030|20612637|P1|COMPLETED|Overall Study||12
8362216|NCT01200030|20612635|P3|STARTED|Overall Study||12
8362217|NCT01200030|20612636|P2|STARTED|Overall Study||13
8362218|NCT01200030|20612637|P1|STARTED|Overall Study||12
8362219|NCT01199965|20612650|P2|NOT COMPLETED|Overall Study||0
8362220|NCT01199965|20612651|P1|NOT COMPLETED|Overall Study||1
8362221|NCT01199965|20612650|P2|COMPLETED|Overall Study||24
8362222|NCT01199965|20612651|P1|COMPLETED|Overall Study||22
8362223|NCT01199965|20612650|P2|STARTED|Overall Study||24
8362224|NCT01199965|20612651|P1|STARTED|Overall Study||23
8362225|NCT01199952|20612667|P2|NOT COMPLETED|Overall Study||45
8362226|NCT01199952|20612668|P1|NOT COMPLETED|Overall Study||52
8362227|NCT01199952|20612667|P2|COMPLETED|Overall Study||59
8362228|NCT01199952|20612668|P1|COMPLETED|Overall Study||51
8362229|NCT01199952|20612667|P2|STARTED|Overall Study||104
8362230|NCT01199952|20612668|P1|STARTED|Overall Study||103
8362231|NCT01199939|20612676|P1|NOT COMPLETED|Overall Study||13
8362232|NCT01199939|20612676|P1|COMPLETED|Overall Study||41
8362233|NCT01199939|20612676|P1|STARTED|Overall Study|Number of enrolled participants|54
8362234|NCT01199926|20612695|P2|NOT COMPLETED|Overall Study||4
8362235|NCT01199926|20612696|P1|NOT COMPLETED|Overall Study||7
8362236|NCT01199926|20612695|P2|COMPLETED|Overall Study||13
8362237|NCT01199926|20612696|P1|COMPLETED|Overall Study||10
8362238|NCT01199926|20612695|P2|STARTED|Overall Study||17
8362239|NCT01199926|20612696|P1|STARTED|Overall Study||17
8362240|NCT01199861|20612708|P2|NOT COMPLETED|Overall Study||0
8362241|NCT01199861|20612709|P1|NOT COMPLETED|Overall Study||2
8362242|NCT01199861|20612708|P2|COMPLETED|Overall Study||43
8362243|NCT01199861|20612709|P1|COMPLETED|Overall Study||93
8362244|NCT01199861|20612708|P2|STARTED|Overall Study||43
8362245|NCT01199861|20612709|P1|STARTED|Overall Study||95
8362246|NCT01199822|20612730|P3|NOT COMPLETED|Overall Study||0
8362247|NCT01199822|20612731|P2|NOT COMPLETED|Overall Study||1
8362248|NCT01199822|20612732|P1|NOT COMPLETED|Overall Study||0
8362249|NCT01199822|20612730|P3|COMPLETED|Overall Study||6
8362250|NCT01199822|20612731|P2|COMPLETED|Overall Study||6
8362251|NCT01199822|20612732|P1|COMPLETED|Overall Study||3
8362252|NCT01199822|20612730|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8362253|NCT01199822|20612731|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
8362254|NCT01199822|20612732|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8362255|NCT01199822|20612730|P3|STARTED|Overall Study||6
8362256|NCT01199822|20612731|P2|STARTED|Overall Study||7
8362257|NCT01199822|20612732|P1|STARTED|Overall Study||3
8362258|NCT01199744|20612765|P1|NOT COMPLETED|Overall Study||0
8362259|NCT01199744|20612765|P1|COMPLETED|Overall Study||1575
8362260|NCT01199744|20612765|P1|STARTED|Overall Study||1575
8362261|NCT01199731|20612781|P3|NOT COMPLETED|Overall Study||10
8362262|NCT01199731|20612782|P2|NOT COMPLETED|Overall Study||11
8362263|NCT01199731|20612783|P1|NOT COMPLETED|Overall Study||9
8362264|NCT01199731|20612781|P3|COMPLETED|Overall Study||0
8362265|NCT01199731|20612782|P2|COMPLETED|Overall Study||0
8362266|NCT01199731|20612783|P1|COMPLETED|Overall Study||0
8362267|NCT01199731|20612781|P3|STARTED|Overall Study||10
8362268|NCT01199731|20612782|P2|STARTED|Overall Study||11
8362269|NCT01199731|20612783|P1|STARTED|Overall Study||9
8362270|NCT01199705|20612821|P1|NOT COMPLETED|SCIG Treatment (Efficacy)||0
8362271|NCT01199705|20612821|P1|COMPLETED|SCIG Treatment (Efficacy)||24
8362272|NCT01199705|20612821|P1|STARTED|SCIG Treatment (Efficacy)||24
8362273|NCT01199705|20612821|P1|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
8362274|NCT01199705|20612821|P1|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
8362275|NCT01199705|20612821|P1|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
8362276|NCT01199705|20612821|P1|NOT COMPLETED|IVIG Treatment||0
8362277|NCT01199705|20612821|P1|COMPLETED|IVIG Treatment||25
8362278|NCT01199705|20612821|P1|STARTED|IVIG Treatment||25
8362279|NCT01199601|20612853|P2|NOT COMPLETED|Overall Study||78
8362280|NCT01199601|20612854|P1|NOT COMPLETED|Overall Study||69
8362281|NCT01199601|20612853|P2|COMPLETED|Overall Study||344
8362282|NCT01199601|20612854|P1|COMPLETED|Overall Study||353
8362283|NCT01199601|20612853|P2|STARTED|Overall Study|Intervention Group|422
8362284|NCT01199601|20612854|P1|STARTED|Overall Study|Control Group|422
8362285|NCT01199575|20612864|P1|NOT COMPLETED|Overall Study||5
8362286|NCT01199575|20612864|P1|COMPLETED|Overall Study||25
8362287|NCT01199575|20612864|P1|STARTED|Overall Study||30
8362288|NCT01199471|20612869|P1|NOT COMPLETED|Overall Study||6
8362289|NCT01199471|20612869|P1|COMPLETED|Overall Study||3994
8362290|NCT01199471|20612869|P1|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
8362291|NCT01199380|20612880|P2|NOT COMPLETED|Overall Study||15
8362292|NCT01199380|20612881|P1|NOT COMPLETED|Overall Study||10
8362293|NCT01199380|20612880|P2|COMPLETED|Overall Study||81
8362294|NCT01199380|20612881|P1|COMPLETED|Overall Study||78
8362295|NCT01199380|20612880|P2|STARTED|Overall Study||96
8362296|NCT01199380|20612881|P1|STARTED|Overall Study||88
8362297|NCT01199263|20612889|P2|NOT COMPLETED|Overall Study||2
8362298|NCT01199263|20612890|P1|NOT COMPLETED|Overall Study||6
8362299|NCT01199263|20612889|P2|COMPLETED|Overall Study||52
8362300|NCT01199263|20612890|P1|COMPLETED|Overall Study||48
8362301|NCT01199263|20612889|P2|STARTED|Overall Study||54
8362302|NCT01199263|20612890|P1|STARTED|Overall Study||54
8362303|NCT01199237|20612906|P2|NOT COMPLETED|Overall Study||0
8362304|NCT01199237|20612907|P1|NOT COMPLETED|Overall Study||0
8362305|NCT01199237|20612906|P2|COMPLETED|Overall Study||40
8362306|NCT01199237|20612907|P1|COMPLETED|Overall Study||41
8362307|NCT01199237|20612906|P2|STARTED|Overall Study||40
8362308|NCT01199237|20612907|P1|STARTED|Overall Study||41
8362309|NCT01199198|20612923|P2|NOT COMPLETED|Overall Study||11
8362310|NCT01199198|20612924|P1|NOT COMPLETED|Overall Study||7
8362311|NCT01199198|20612923|P2|COMPLETED|Overall Study||13
8362312|NCT01199198|20612924|P1|COMPLETED|Overall Study||17
8362313|NCT01199198|20612923|P2|STARTED|Overall Study||24
8362314|NCT01199198|20612924|P1|STARTED|Overall Study||24
8362315|NCT01199146|20612932|P1|NOT COMPLETED|Overall Study||3
8362316|NCT01199146|20612932|P1|COMPLETED|Overall Study||39
8362317|NCT01199146|20612932|P1|STARTED|Overall Study||42
8362330|NCT01199055|20612977|P3|NOT COMPLETED|Overall Study||4
8362331|NCT01199055|20612978|P2|NOT COMPLETED|Overall Study||3
8362332|NCT01199055|20612979|P1|NOT COMPLETED|Overall Study||2
8362333|NCT01199055|20612977|P3|COMPLETED|Overall Study||5
8362334|NCT01199055|20612978|P2|COMPLETED|Overall Study||1
8362335|NCT01199055|20612979|P1|COMPLETED|Overall Study||1
8362336|NCT01199055|20612977|P3|STARTED|Overall Study||9
8362337|NCT01199055|20612978|P2|STARTED|Overall Study||4
8362338|NCT01199055|20612979|P1|STARTED|Overall Study||3
8362339|NCT01199042|20613004|P1|NOT COMPLETED|At Home (3 Months)||1
8362340|NCT01199042|20613004|P1|COMPLETED|At Home (3 Months)||26
8362341|NCT01199042|20613004|P1|STARTED|At Home (3 Months)||27
8362342|NCT01199042|20613004|P1|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
8362343|NCT01199042|20613004|P1|COMPLETED|Sleep Laboratory (3 Nights)||27
8362344|NCT01199042|20613004|P1|STARTED|Sleep Laboratory (3 Nights)||29
8362345|NCT01199016|20613013|P1|NOT COMPLETED|Overall Study||77
8362346|NCT01199016|20613013|P1|COMPLETED|Overall Study||162
8362347|NCT01199016|20613013|P1|Treated|Overall Study||236
8362348|NCT01199016|20613013|P1|STARTED|Overall Study||239
8362349|NCT01198977|20613022|P2|NOT COMPLETED|Overall Study||0
8362350|NCT01198977|20613023|P1|NOT COMPLETED|Overall Study||1
8362351|NCT01198977|20613022|P2|COMPLETED|Overall Study||33
8362352|NCT01198977|20613023|P1|COMPLETED|Overall Study||30
8362353|NCT01198977|20613022|P2|STARTED|Overall Study||33
8362354|NCT01198977|20613023|P1|STARTED|Overall Study||31
8362355|NCT01198873|20613035|P2|NOT COMPLETED|Overall Study||32
8362356|NCT01198873|20613036|P1|NOT COMPLETED|Overall Study||37
8362357|NCT01198873|20613035|P2|COMPLETED|Overall Study||3
8362358|NCT01198873|20613036|P1|COMPLETED|Overall Study||4
8362359|NCT01198873|20613035|P2|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
8362360|NCT01198873|20613036|P1|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
8362361|NCT01198873|20613035|P2|Treated|Overall Study||35
8362362|NCT01198873|20613036|P1|Treated|Overall Study||41
8362363|NCT01198873|20613035|P2|STARTED|Overall Study||35
8362364|NCT01198873|20613036|P1|STARTED|Overall Study||41
8362365|NCT01198795|20613050|P1|NOT COMPLETED|Overall Study||82
8362366|NCT01198795|20613050|P1|COMPLETED|Overall Study||80
8362367|NCT01198795|20613050|P1|STARTED|Overall Study||162
8362368|NCT01198769|20613054|P1|NOT COMPLETED|Overall Study||0
8362369|NCT01198769|20613054|P1|COMPLETED|Overall Study||15
8362370|NCT01198769|20613054|P1|STARTED|Overall Study||15
8362371|NCT01198756|20613067|P4|NOT COMPLETED|Overall Study||26
8362372|NCT01198756|20613068|P3|NOT COMPLETED|Overall Study||30
8362373|NCT01198756|20613069|P2|NOT COMPLETED|Overall Study||40
8362374|NCT01198756|20613070|P1|NOT COMPLETED|Overall Study||38
8362375|NCT01198756|20613067|P4|COMPLETED|Overall Study||275
8362376|NCT01198756|20613068|P3|COMPLETED|Overall Study||902
8362377|NCT01198756|20613069|P2|COMPLETED|Overall Study||889
8362378|NCT01198756|20613070|P1|COMPLETED|Overall Study||894
8362379|NCT01198756|20613067|P4|STARTED|Overall Study||301
8362380|NCT01198756|20613068|P3|STARTED|Overall Study||932
8362381|NCT01198756|20613069|P2|STARTED|Overall Study||929
8362382|NCT01198756|20613070|P1|STARTED|Overall Study||932
8362383|NCT01198691|20613168|P2|NOT COMPLETED|6 Week Post-partum Survey||24
8362384|NCT01198691|20613169|P1|NOT COMPLETED|6 Week Post-partum Survey||29
8362385|NCT01198691|20613168|P2|COMPLETED|6 Week Post-partum Survey||26
8362386|NCT01198691|20613169|P1|COMPLETED|6 Week Post-partum Survey||21
8362387|NCT01198691|20613168|P2|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
8362388|NCT01198691|20613169|P1|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
8362389|NCT01198691|20613168|P2|NOT COMPLETED|Survey Prior to Discharge||33
8362390|NCT01198691|20613169|P1|NOT COMPLETED|Survey Prior to Discharge||32
8362391|NCT01198691|20613168|P2|COMPLETED|Survey Prior to Discharge||17
8362392|NCT01198691|20613169|P1|COMPLETED|Survey Prior to Discharge||18
8362393|NCT01198691|20613168|P2|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
8362394|NCT01198691|20613169|P1|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
8362395|NCT01198691|20613168|P2|NOT COMPLETED|Completed VAS Score at Discharge||6
8362396|NCT01198691|20613169|P1|NOT COMPLETED|Completed VAS Score at Discharge||5
8362397|NCT01198691|20613168|P2|COMPLETED|Completed VAS Score at Discharge||44
8362398|NCT01198691|20613169|P1|COMPLETED|Completed VAS Score at Discharge||45
8362399|NCT01198691|20613168|P2|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
8362400|NCT01198691|20613169|P1|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
8362401|NCT01198691|20613168|P2|NOT COMPLETED|Completed VAS Score Postop Day 1||4
8362402|NCT01198691|20613169|P1|NOT COMPLETED|Completed VAS Score Postop Day 1||3
8362403|NCT01198691|20613168|P2|COMPLETED|Completed VAS Score Postop Day 1||46
8362404|NCT01198691|20613169|P1|COMPLETED|Completed VAS Score Postop Day 1||47
8362405|NCT01198691|20613168|P2|STARTED|Completed VAS Score Postop Day 1||50
8362406|NCT01198691|20613169|P1|STARTED|Completed VAS Score Postop Day 1||50
8362407|NCT01198691|20613168|P2|NOT COMPLETED|Completed Surgery -Received Intervention||0
8362408|NCT01198691|20613169|P1|NOT COMPLETED|Completed Surgery -Received Intervention||0
8362409|NCT01198691|20613168|P2|COMPLETED|Completed Surgery -Received Intervention||50
8362410|NCT01198691|20613169|P1|COMPLETED|Completed Surgery -Received Intervention||50
8362411|NCT01198691|20613168|P2|STARTED|Completed Surgery -Received Intervention||50
8362412|NCT01198691|20613169|P1|STARTED|Completed Surgery -Received Intervention||50
8362413|NCT01198600|20613181|P4|NOT COMPLETED|Phase 3: 43 Days of Wear||0
8362414|NCT01198600|20613182|P3|NOT COMPLETED|Phase 3: 43 Days of Wear||0
8362415|NCT01198600|20613183|P2|NOT COMPLETED|Phase 3: 43 Days of Wear||0
8362416|NCT01198600|20613184|P1|NOT COMPLETED|Phase 3: 43 Days of Wear||0
8362417|NCT01198600|20613181|P4|COMPLETED|Phase 3: 43 Days of Wear||38
8362418|NCT01198600|20613182|P3|COMPLETED|Phase 3: 43 Days of Wear||0
8362419|NCT01198600|20613183|P2|COMPLETED|Phase 3: 43 Days of Wear||0
8362420|NCT01198600|20613184|P1|COMPLETED|Phase 3: 43 Days of Wear||0
8362421|NCT01198600|20613181|P4|STARTED|Phase 3: 43 Days of Wear||38
8362422|NCT01198600|20613182|P3|STARTED|Phase 3: 43 Days of Wear||0
8362423|NCT01198600|20613183|P2|STARTED|Phase 3: 43 Days of Wear||0
8362424|NCT01198600|20613184|P1|STARTED|Phase 3: 43 Days of Wear||0
8362425|NCT01198600|20613181|P4|NOT COMPLETED|Phase 2: 56 Days of Wear||0
8362426|NCT01198600|20613182|P3|NOT COMPLETED|Phase 2: 56 Days of Wear||5
8362427|NCT01198600|20613183|P2|NOT COMPLETED|Phase 2: 56 Days of Wear||0
8362428|NCT01198600|20613184|P1|NOT COMPLETED|Phase 2: 56 Days of Wear||0
8362429|NCT01198600|20613181|P4|COMPLETED|Phase 2: 56 Days of Wear||0
8362430|NCT01198600|20613182|P3|COMPLETED|Phase 2: 56 Days of Wear||62
8362431|NCT01198600|20613183|P2|COMPLETED|Phase 2: 56 Days of Wear||0
8362432|NCT01198600|20613184|P1|COMPLETED|Phase 2: 56 Days of Wear||0
8362433|NCT01198600|20613181|P4|STARTED|Phase 2: 56 Days of Wear||0
8362434|NCT01198600|20613182|P3|STARTED|Phase 2: 56 Days of Wear||67
8362435|NCT01198600|20613183|P2|STARTED|Phase 2: 56 Days of Wear||0
8362436|NCT01198600|20613184|P1|STARTED|Phase 2: 56 Days of Wear||0
8362437|NCT01198600|20613181|P4|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8362438|NCT01198600|20613182|P3|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8362439|NCT01198600|20613183|P2|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
8362440|NCT01198600|20613184|P1|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8362441|NCT01198600|20613181|P4|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8362442|NCT01198600|20613182|P3|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
8362443|NCT01198600|20613183|P2|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
8362444|NCT01198600|20613184|P1|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
8362445|NCT01198600|20613181|P4|STARTED|Phase 1: Period Two, 30 Days of Wear||0
8362446|NCT01198600|20613182|P3|STARTED|Phase 1: Period Two, 30 Days of Wear||0
8362447|NCT01198600|20613183|P2|STARTED|Phase 1: Period Two, 30 Days of Wear||36
8362448|NCT01198600|20613184|P1|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
8362449|NCT01198600|20613181|P4|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
8362450|NCT01198600|20613182|P3|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
8362451|NCT01198600|20613183|P2|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
8362452|NCT01198600|20613184|P1|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
8362453|NCT01198600|20613181|P4|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
8362454|NCT01198600|20613182|P3|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
8362455|NCT01198600|20613183|P2|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
8362456|NCT01198600|20613184|P1|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
8362457|NCT01198600|20613181|P4|STARTED|Phase 1: Period One, 30 Days of Wear||0
8362458|NCT01198600|20613182|P3|STARTED|Phase 1: Period One, 30 Days of Wear||0
8362459|NCT01198600|20613183|P2|STARTED|Phase 1: Period One, 30 Days of Wear||37
8362460|NCT01198600|20613184|P1|STARTED|Phase 1: Period One, 30 Days of Wear||35
8362461|NCT01198587|20613210|P4|NOT COMPLETED|Overall Study||0
8362462|NCT01198587|20613211|P3|NOT COMPLETED|Overall Study||9
8362463|NCT01198587|20613212|P2|NOT COMPLETED|Overall Study||0
8362464|NCT01198587|20613213|P1|NOT COMPLETED|Overall Study||8
8362465|NCT01198587|20613210|P4|COMPLETED|Overall Study||5
8362466|NCT01198587|20613211|P3|COMPLETED|Overall Study||21
8362467|NCT01198587|20613212|P2|COMPLETED|Overall Study||5
8362468|NCT01198587|20613213|P1|COMPLETED|Overall Study||23
8362469|NCT01198587|20613210|P4|STARTED|Overall Study||5
8362470|NCT01198587|20613211|P3|STARTED|Overall Study||30
8362471|NCT01198587|20613212|P2|STARTED|Overall Study||5
8362472|NCT01198587|20613213|P1|STARTED|Overall Study||31
8362473|NCT01198574|20613235|P4|NOT COMPLETED|Overall Study||4
8362474|NCT01198574|20613236|P3|NOT COMPLETED|Overall Study||1
8362475|NCT01198574|20613237|P2|NOT COMPLETED|Overall Study||1
8362476|NCT01198574|20613238|P1|NOT COMPLETED|Overall Study||4
8362477|NCT01198574|20613235|P4|COMPLETED|Overall Study||98
8362478|NCT01198574|20613236|P3|COMPLETED|Overall Study||99
8362479|NCT01198574|20613237|P2|COMPLETED|Overall Study||101
8362480|NCT01198574|20613238|P1|COMPLETED|Overall Study||94
8362481|NCT01198574|20613235|P4|STARTED|Overall Study||102
8362482|NCT01198574|20613236|P3|STARTED|Overall Study||100
8362483|NCT01198574|20613237|P2|STARTED|Overall Study||102
8362484|NCT01198574|20613238|P1|STARTED|Overall Study||98
8362485|NCT01198548|20613256|P1|NOT COMPLETED|Overall Study||10
8362486|NCT01198548|20613256|P1|COMPLETED|Overall Study||0
8362487|NCT01198548|20613256|P1|STARTED|Overall Study||10
8362488|NCT01198509|20613271|P6|NOT COMPLETED|Overall Study||0
8362489|NCT01198509|20613272|P5|NOT COMPLETED|Overall Study||0
8362490|NCT01198509|20613273|P4|NOT COMPLETED|Overall Study||0
8362491|NCT01198509|20613274|P3|NOT COMPLETED|Overall Study||0
8362492|NCT01198509|20613275|P2|NOT COMPLETED|Overall Study||0
8362493|NCT01198509|20613276|P1|NOT COMPLETED|Overall Study||1
8362494|NCT01198509|20613271|P6|COMPLETED|Overall Study||58
8362495|NCT01198509|20613272|P5|COMPLETED|Overall Study||20
8362496|NCT01198509|20613273|P4|COMPLETED|Overall Study||66
8362497|NCT01198509|20613274|P3|COMPLETED|Overall Study||19
8362498|NCT01198509|20613275|P2|COMPLETED|Overall Study||10
8362499|NCT01198509|20613276|P1|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
8362500|NCT01198509|20613271|P6|STARTED|Overall Study||58
8362501|NCT01198509|20613272|P5|STARTED|Overall Study||20
8362502|NCT01198509|20613273|P4|STARTED|Overall Study||66
8362503|NCT01198509|20613274|P3|STARTED|Overall Study||19
8362504|NCT01198509|20613275|P2|STARTED|Overall Study||10
8362505|NCT01198509|20613276|P1|STARTED|Overall Study||5
8362506|NCT01198470|20613293|P1|NOT COMPLETED|Overall Study||2
8362507|NCT01198470|20613293|P1|COMPLETED|Overall Study||18
8362508|NCT01198470|20613293|P1|STARTED|Overall Study||20
8362509|NCT01198366|20613306|P6|NOT COMPLETED|Overall Study||13
8362510|NCT01198366|20613307|P5|NOT COMPLETED|Overall Study||15
8362511|NCT01198366|20613308|P4|NOT COMPLETED|Overall Study||5
8362512|NCT01198366|20613309|P3|NOT COMPLETED|Overall Study||8
8362513|NCT01198366|20613310|P2|NOT COMPLETED|Overall Study||7
8362514|NCT01198366|20613311|P1|NOT COMPLETED|Overall Study||12
8362515|NCT01198366|20613306|P6|COMPLETED|Overall Study||128
8362516|NCT01198366|20613307|P5|COMPLETED|Overall Study||125
8362517|NCT01198366|20613308|P4|COMPLETED|Overall Study||47
8362518|NCT01198366|20613309|P3|COMPLETED|Overall Study||43
8362519|NCT01198366|20613310|P2|COMPLETED|Overall Study||44
8362520|NCT01198366|20613311|P1|COMPLETED|Overall Study||40
8362521|NCT01198366|20613306|P6|STARTED|Overall Study||141
8362522|NCT01198366|20613307|P5|STARTED|Overall Study||140
8362523|NCT01198366|20613308|P4|STARTED|Overall Study||52
8362524|NCT01198366|20613309|P3|STARTED|Overall Study||51
8362525|NCT01198366|20613310|P2|STARTED|Overall Study||51
8362526|NCT01198366|20613311|P1|STARTED|Overall Study||52
8362527|NCT01198327|20613349|P1|NOT COMPLETED|Overall Study||10
8362528|NCT01198327|20613349|P1|COMPLETED|Overall Study||56
8362529|NCT01198327|20613349|P1|STARTED|Overall Study||66
8362530|NCT01198275|20613359|P2|NOT COMPLETED|Overall Study||5
8362531|NCT01198275|20613360|P1|NOT COMPLETED|Overall Study||6
8362532|NCT01198275|20613359|P2|COMPLETED|Overall Study||94
8362533|NCT01198275|20613360|P1|COMPLETED|Overall Study||94
8362534|NCT01198275|20613359|P2|STARTED|Overall Study||99
8362535|NCT01198275|20613360|P1|STARTED|Overall Study||100
8362536|NCT01198158|20613368|P2|NOT COMPLETED|Overall Study||0
8362537|NCT01198158|20613369|P1|NOT COMPLETED|Overall Study||0
8362538|NCT01198158|20613368|P2|COMPLETED|Overall Study||36
8362539|NCT01198158|20613369|P1|COMPLETED|Overall Study||41
8362540|NCT01198158|20613368|P2|STARTED|Overall Study||36
8362541|NCT01198158|20613369|P1|STARTED|Overall Study||41
8362542|NCT01198145|20613383|P2|NOT COMPLETED|Overall Study||1
8362543|NCT01198145|20613384|P1|NOT COMPLETED|Overall Study||1
8362544|NCT01198145|20613383|P2|COMPLETED|Overall Study||42
8362545|NCT01198145|20613384|P1|COMPLETED|Overall Study||43
8362546|NCT01198145|20613383|P2|STARTED|Overall Study||43
8362547|NCT01198145|20613384|P1|STARTED|Overall Study||44
8362548|NCT01198132|20613406|P2|NOT COMPLETED|Overall Study||21
8362549|NCT01198132|20613407|P1|NOT COMPLETED|Overall Study||18
8362550|NCT01198132|20613406|P2|COMPLETED|Overall Study||45
8362551|NCT01198132|20613407|P1|COMPLETED|Overall Study||45
8362552|NCT01198132|20613406|P2|STARTED|Overall Study||66
8362553|NCT01198132|20613407|P1|STARTED|Overall Study||63
8362554|NCT01198028|20613431|P1|NOT COMPLETED|Overall Study||10
8362555|NCT01198028|20613431|P1|COMPLETED|Overall Study||29
8362556|NCT01198028|20613431|P1|STARTED|Overall Study||39
8362557|NCT01198002|20613443|P3|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
8362558|NCT01198002|20613444|P2|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
8362559|NCT01198002|20613445|P1|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
8362560|NCT01198002|20613443|P3|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
8362561|NCT01198002|20613444|P2|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
8362562|NCT01198002|20613445|P1|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
8362563|NCT01198002|20613443|P3|STARTED|Treatment Period 2 (Weeks 52-100)||80
8362564|NCT01198002|20613444|P2|STARTED|Treatment Period 2 (Weeks 52-100)||73
8362565|NCT01198002|20613445|P1|STARTED|Treatment Period 2 (Weeks 52-100)||70
8362566|NCT01198002|20613443|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
8362567|NCT01198002|20613444|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
8362568|NCT01198002|20613445|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
8362569|NCT01198002|20613443|P3|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
8362570|NCT01198002|20613444|P2|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
8362571|NCT01198002|20613445|P1|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
8362572|NCT01198002|20613443|P3|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
8362573|NCT01198002|20613444|P2|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
8362574|NCT01198002|20613445|P1|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
8362575|NCT01198002|20613443|P3|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
8362576|NCT01198002|20613444|P2|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
8362577|NCT01198002|20613445|P1|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
8362578|NCT01198002|20613443|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
8362579|NCT01198002|20613444|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
8362580|NCT01198002|20613445|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
8362581|NCT01198002|20613443|P3|STARTED|Treatment Period 1 (Weeks 0-52)||349
8362582|NCT01198002|20613444|P2|STARTED|Treatment Period 1 (Weeks 0-52)||347
8362583|NCT01198002|20613445|P1|STARTED|Treatment Period 1 (Weeks 0-52)||345
8362584|NCT01197911|20613560|P3|NOT COMPLETED|Overall Study||1
8362585|NCT01197911|20613561|P2|NOT COMPLETED|Overall Study||0
8362586|NCT01197911|20613562|P1|NOT COMPLETED|Overall Study||0
8362587|NCT01197911|20613560|P3|COMPLETED|Overall Study||9
8362588|NCT01197911|20613561|P2|COMPLETED|Overall Study||10
8362589|NCT01197911|20613562|P1|COMPLETED|Overall Study||18
8362590|NCT01197911|20613560|P3|STARTED|Overall Study||10
8362591|NCT01197911|20613561|P2|STARTED|Overall Study||10
8362592|NCT01197911|20613562|P1|STARTED|Overall Study||18
8362593|NCT01197898|20613647|P2|NOT COMPLETED|Overall Study||0
8362594|NCT01197898|20613648|P1|NOT COMPLETED|Overall Study||0
8362595|NCT01197898|20613647|P2|COMPLETED|Overall Study||5
8362596|NCT01197898|20613648|P1|COMPLETED|Overall Study||5
8362597|NCT01197898|20613647|P2|STARTED|Overall Study||5
8362598|NCT01197898|20613648|P1|STARTED|Overall Study||5
8362608|NCT01197794|20613677|P7|NOT COMPLETED|Overall Study||21
8362609|NCT01197794|20613678|P6|NOT COMPLETED|Overall Study||19
8362610|NCT01197794|20613679|P5|NOT COMPLETED|Overall Study||14
8362611|NCT01197794|20613680|P4|NOT COMPLETED|Overall Study||12
8362612|NCT01197794|20613681|P3|NOT COMPLETED|Overall Study||13
8362613|NCT01197794|20613682|P2|NOT COMPLETED|Overall Study||15
8362614|NCT01197794|20613683|P1|NOT COMPLETED|Overall Study||16
8362615|NCT01197794|20613677|P7|COMPLETED|Overall Study||142
8362616|NCT01197794|20613678|P6|COMPLETED|Overall Study||144
8362617|NCT01197794|20613679|P5|COMPLETED|Overall Study||149
8362618|NCT01197794|20613680|P4|COMPLETED|Overall Study||152
8362619|NCT01197794|20613681|P3|COMPLETED|Overall Study||153
8362620|NCT01197794|20613682|P2|COMPLETED|Overall Study||146
8362621|NCT01197794|20613683|P1|COMPLETED|Overall Study||148
8362622|NCT01197794|20613677|P7|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
8362623|NCT01197794|20613678|P6|STARTED|Overall Study||163
8362624|NCT01197794|20613679|P5|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
8362625|NCT01197794|20613680|P4|STARTED|Overall Study||164
8362626|NCT01197794|20613681|P3|STARTED|Overall Study|Two participants did not receive study treatment|166
8362627|NCT01197794|20613682|P2|STARTED|Overall Study|Two participants did not receive study treatment|161
8362628|NCT01197794|20613683|P1|STARTED|Overall Study||164
8362629|NCT01197755|20613765|P3|NOT COMPLETED|Overall Study||54
8362630|NCT01197755|20613766|P2|NOT COMPLETED|Overall Study||43
8362631|NCT01197755|20613767|P1|NOT COMPLETED|Overall Study||38
8362632|NCT01197755|20613765|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
8362633|NCT01197755|20613766|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
8362634|NCT01197755|20613767|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
8362635|NCT01197755|20613765|P3|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
8362636|NCT01197755|20613766|P2|Randomised But Did Not Receive Treatment|Overall Study||0
8362637|NCT01197755|20613767|P1|Randomised But Did Not Receive Treatment|Overall Study||0
8362638|NCT01197755|20613765|P3|STARTED|Overall Study|Patients who received treatment|109
8362639|NCT01197755|20613766|P2|STARTED|Overall Study|Patients who received treatment|108
8362640|NCT01197755|20613767|P1|STARTED|Overall Study|Patients who received treatment|105
8362641|NCT01197612|20613807|P1|NOT COMPLETED|Overall Study||12
8362642|NCT01197612|20613807|P1|COMPLETED|Overall Study||6
8362643|NCT01197612|20613807|P1|Returned for Week 24|Overall Study||6
8362644|NCT01197612|20613807|P1|Week 3|Overall Study||16
8362645|NCT01197612|20613807|P1|STARTED|Overall Study||18
8362646|NCT01197573|20613822|P4|NOT COMPLETED|Overall Study||0
8362647|NCT01197573|20613823|P3|NOT COMPLETED|Overall Study||0
8362648|NCT01197573|20613824|P2|NOT COMPLETED|Overall Study||0
8362649|NCT01197573|20613825|P1|NOT COMPLETED|Overall Study||0
8362650|NCT01197573|20613822|P4|COMPLETED|Overall Study||12
8362651|NCT01197573|20613823|P3|COMPLETED|Overall Study||12
8362652|NCT01197573|20613824|P2|COMPLETED|Overall Study||46
8362653|NCT01197573|20613825|P1|COMPLETED|Overall Study||33
8362654|NCT01197573|20613822|P4|STARTED|Overall Study||12
8362655|NCT01197573|20613823|P3|STARTED|Overall Study||12
8362656|NCT01197573|20613824|P2|STARTED|Overall Study||46
8362657|NCT01197573|20613825|P1|STARTED|Overall Study||33
8362658|NCT01197560|20613839|P2|NOT COMPLETED|Overall Study||53
8362659|NCT01197560|20613840|P1|NOT COMPLETED|Overall Study||54
8362660|NCT01197560|20613839|P2|COMPLETED|Overall Study||4
8362661|NCT01197560|20613840|P1|COMPLETED|Overall Study||0
8362662|NCT01197560|20613839|P2|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0
8362663|NCT01197560|20613840|P1|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14
8362664|NCT01197560|20613839|P2|Lenalidomide Crossover|Overall Study||29
8362665|NCT01197560|20613840|P1|Lenalidomide Crossover|Overall Study||0
8362666|NCT01197560|20613839|P2|Received ≥ One Dose Study Drug|Overall Study||55
8362667|NCT01197560|20613840|P1|Received ≥ One Dose Study Drug|Overall Study||54
8362668|NCT01197560|20613839|P2|STARTED|Overall Study|This is the intent to treat population|57
8362669|NCT01197560|20613840|P1|STARTED|Overall Study|This is the intent to treat population|54
8362673|NCT01197534|20613887|P3|NOT COMPLETED|Overall Study||173
8362674|NCT01197534|20613888|P2|NOT COMPLETED|Overall Study||130
8362675|NCT01197534|20613889|P1|NOT COMPLETED|Overall Study||134
8362676|NCT01197534|20613887|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
8362677|NCT01197534|20613888|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
8362678|NCT01197534|20613889|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
8362679|NCT01197534|20613887|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
8362680|NCT01197534|20613888|P2|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
8362681|NCT01197534|20613889|P1|Randomised But Did Not Receive Treatment|Overall Study||0
8362682|NCT01197534|20613887|P3|STARTED|Overall Study|Patients who received treatment|302
8362683|NCT01197534|20613888|P2|STARTED|Overall Study|Patients who received treatment|298
8362684|NCT01197534|20613889|P1|STARTED|Overall Study|Patients who received treatment|308
8362685|NCT01197521|20613933|P3|NOT COMPLETED|Overall Study||143
8362686|NCT01197521|20613934|P2|NOT COMPLETED|Overall Study||113
8362687|NCT01197521|20613935|P1|NOT COMPLETED|Overall Study||103
8362688|NCT01197521|20613933|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
8362689|NCT01197521|20613934|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
8362690|NCT01197521|20613935|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
8362691|NCT01197521|20613933|P3|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
8362692|NCT01197521|20613934|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
8362693|NCT01197521|20613935|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
8362694|NCT01197521|20613933|P3|STARTED|Overall Study|Patients who received treatment|304
8362695|NCT01197521|20613934|P2|STARTED|Overall Study|Patients who received treatment|304
8362696|NCT01197521|20613935|P1|STARTED|Overall Study|Patients who received treatment|310
8362697|NCT01197508|20613980|P4|NOT COMPLETED|Overall Study||16
8362698|NCT01197508|20613981|P3|NOT COMPLETED|Overall Study||49
8362699|NCT01197508|20613982|P2|NOT COMPLETED|Overall Study||30
8362700|NCT01197508|20613983|P1|NOT COMPLETED|Overall Study||23
8362701|NCT01197508|20613980|P4|COMPLETED|Overall Study||158
8362702|NCT01197508|20613981|P3|COMPLETED|Overall Study||125
8362703|NCT01197508|20613982|P2|COMPLETED|Overall Study||144
8362704|NCT01197508|20613983|P1|COMPLETED|Overall Study||151
8362705|NCT01197508|20613980|P4|Received Treatment|Overall Study||174
8362706|NCT01197508|20613981|P3|Received Treatment|Overall Study||171
8362707|NCT01197508|20613982|P2|Received Treatment|Overall Study||174
8362708|NCT01197508|20613983|P1|Received Treatment|Overall Study||174
8362709|NCT01197508|20613980|P4|STARTED|Overall Study||174
8362710|NCT01197508|20613981|P3|STARTED|Overall Study||174
8362711|NCT01197508|20613982|P2|STARTED|Overall Study||174
8362712|NCT01197508|20613983|P1|STARTED|Overall Study||174
8362713|NCT01197495|20614079|P2|NOT COMPLETED|Overall Study||7
8362714|NCT01197495|20614080|P1|NOT COMPLETED|Overall Study||13
8362715|NCT01197495|20614079|P2|COMPLETED|Overall Study||49
8362716|NCT01197495|20614080|P1|COMPLETED|Overall Study||144
8362717|NCT01197495|20614079|P2|STARTED|Overall Study||56
8362718|NCT01197495|20614080|P1|STARTED|Overall Study||157
8362719|NCT01197456|20614093|P2|NOT COMPLETED|Overall Study||0
8362720|NCT01197456|20614094|P1|NOT COMPLETED|Overall Study||0
8362721|NCT01197456|20614093|P2|COMPLETED|Overall Study||61
8362722|NCT01197456|20614094|P1|COMPLETED|Overall Study||171
8362723|NCT01197456|20614093|P2|STARTED|Overall Study||61
8362724|NCT01197456|20614094|P1|STARTED|Overall Study||171
8362725|NCT01197417|20614104|P2|NOT COMPLETED|Overall Study||18
8362726|NCT01197417|20614105|P1|NOT COMPLETED|Overall Study||8
8362727|NCT01197417|20614104|P2|COMPLETED|Overall Study||86
8362728|NCT01197417|20614105|P1|COMPLETED|Overall Study||96
8362729|NCT01197417|20614104|P2|Received Study Drug|Overall Study||103
8362730|NCT01197417|20614105|P1|Received Study Drug|Overall Study||101
8362731|NCT01197417|20614104|P2|STARTED|Overall Study||104
8362732|NCT01197417|20614105|P1|STARTED|Overall Study||104
8362733|NCT01197378|20614123|P1|NOT COMPLETED|Overall Study||7
8362734|NCT01197378|20614123|P1|COMPLETED|Overall Study||53
8362735|NCT01197378|20614123|P1|Received Treatment|Overall Study||59
8362736|NCT01197378|20614123|P1|STARTED|Overall Study||60
8362737|NCT01197326|20614131|P2|NOT COMPLETED|Overall Study||0
8362738|NCT01197326|20614132|P1|NOT COMPLETED|Overall Study||0
8362739|NCT01197326|20614131|P2|COMPLETED|Overall Study||209
8362740|NCT01197326|20614132|P1|COMPLETED|Overall Study||205
8362741|NCT01197326|20614131|P2|STARTED|Overall Study||209
8362742|NCT01197326|20614132|P1|STARTED|Overall Study||205
8362743|NCT01197300|20614142|P2|NOT COMPLETED|Overall Study||2
8362744|NCT01197300|20614143|P1|NOT COMPLETED|Overall Study||0
8362745|NCT01197300|20614142|P2|COMPLETED|Overall Study||13
8362746|NCT01197300|20614143|P1|COMPLETED|Overall Study||10
8362747|NCT01197300|20614142|P2|STARTED|Overall Study||15
8362748|NCT01197300|20614143|P1|STARTED|Overall Study||10
8362749|NCT01196988|20614175|P4|NOT COMPLETED|Overall Study||1
8362750|NCT01196988|20614176|P3|NOT COMPLETED|Overall Study||25
8362751|NCT01196988|20614177|P2|NOT COMPLETED|Overall Study||32
8362752|NCT01196988|20614178|P1|NOT COMPLETED|Overall Study||24
8362753|NCT01196988|20614175|P4|COMPLETED|Overall Study||276
8362754|NCT01196988|20614176|P3|COMPLETED|Overall Study||886
8362755|NCT01196988|20614177|P2|COMPLETED|Overall Study||880
8362756|NCT01196988|20614178|P1|COMPLETED|Overall Study||891
8362757|NCT01196988|20614175|P4|STARTED|Overall Study||277
8362758|NCT01196988|20614176|P3|STARTED|Overall Study||911
8362759|NCT01196988|20614177|P2|STARTED|Overall Study||912
8362760|NCT01196988|20614178|P1|STARTED|Overall Study||915
8362761|NCT01196975|20614272|P5|NOT COMPLETED|Overall Study||13
8362762|NCT01196975|20614273|P4|NOT COMPLETED|Overall Study||6
8362763|NCT01196975|20614274|P3|NOT COMPLETED|Overall Study||5
8362764|NCT01196975|20614275|P2|NOT COMPLETED|Overall Study||9
8362765|NCT01196975|20614276|P1|NOT COMPLETED|Overall Study||15
8362766|NCT01196975|20614272|P5|COMPLETED|Overall Study||205
8362767|NCT01196975|20614273|P4|COMPLETED|Overall Study||207
8362768|NCT01196975|20614274|P3|COMPLETED|Overall Study||420
8362769|NCT01196975|20614275|P2|COMPLETED|Overall Study||415
8362770|NCT01196975|20614276|P1|COMPLETED|Overall Study||408
8362771|NCT01196975|20614272|P5|STARTED|Overall Study||218
8362772|NCT01196975|20614273|P4|STARTED|Overall Study||213
8362773|NCT01196975|20614274|P3|STARTED|Overall Study||425
8362774|NCT01196975|20614275|P2|STARTED|Overall Study||424
8362775|NCT01196975|20614276|P1|STARTED|Overall Study||423
8362784|NCT01196923|20614433|P1|NOT COMPLETED|Overall Study||0
8362785|NCT01196923|20614433|P1|COMPLETED|Overall Study||20
8362786|NCT01196923|20614433|P1|STARTED|Overall Study||20
8362787|NCT01196871|20614443|P6|NOT COMPLETED|Stage 2: Period 2||0
8362788|NCT01196871|20614444|P5|NOT COMPLETED|Stage 2: Period 2||0
8362789|NCT01196871|20614445|P4|NOT COMPLETED|Stage 2: Period 2||0
8362790|NCT01196871|20614446|P3|NOT COMPLETED|Stage 2: Period 2||0
8362791|NCT01196871|20614447|P2|NOT COMPLETED|Stage 2: Period 2||0
8362792|NCT01196871|20614448|P1|NOT COMPLETED|Stage 2: Period 2||0
8362793|NCT01196871|20614443|P6|COMPLETED|Stage 2: Period 2||4
8362794|NCT01196871|20614444|P5|COMPLETED|Stage 2: Period 2||6
8362795|NCT01196871|20614445|P4|COMPLETED|Stage 2: Period 2||1
8362796|NCT01196871|20614446|P3|COMPLETED|Stage 2: Period 2||0
8362797|NCT01196871|20614447|P2|COMPLETED|Stage 2: Period 2||0
8362798|NCT01196871|20614448|P1|COMPLETED|Stage 2: Period 2||0
8362799|NCT01196871|20614443|P6|PK Population|Stage 2: Period 2||4
8362800|NCT01196871|20614444|P5|PK Population|Stage 2: Period 2||6
8362801|NCT01196871|20614445|P4|PK Population|Stage 2: Period 2||1
8362802|NCT01196871|20614446|P3|PK Population|Stage 2: Period 2||0
8362803|NCT01196871|20614447|P2|PK Population|Stage 2: Period 2||0
8362804|NCT01196871|20614448|P1|PK Population|Stage 2: Period 2||0
8362805|NCT01196871|20614443|P6|STARTED|Stage 2: Period 2||4
8362884|NCT01196871|20614444|P5|NOT COMPLETED|Stage 1: Period 1||0
8362806|NCT01196871|20614444|P5|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
8362807|NCT01196871|20614445|P4|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
8362808|NCT01196871|20614446|P3|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
8362809|NCT01196871|20614447|P2|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
8362810|NCT01196871|20614448|P1|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
8362811|NCT01196871|20614443|P6|NOT COMPLETED|Stage 2: Period 1||0
8362812|NCT01196871|20614444|P5|NOT COMPLETED|Stage 2: Period 1||0
8362813|NCT01196871|20614445|P4|NOT COMPLETED|Stage 2: Period 1||0
8362814|NCT01196871|20614446|P3|NOT COMPLETED|Stage 2: Period 1||0
8362815|NCT01196871|20614447|P2|NOT COMPLETED|Stage 2: Period 1||0
8362816|NCT01196871|20614448|P1|NOT COMPLETED|Stage 2: Period 1||0
8362817|NCT01196871|20614443|P6|COMPLETED|Stage 2: Period 1||4
8362818|NCT01196871|20614444|P5|COMPLETED|Stage 2: Period 1||5
8362819|NCT01196871|20614445|P4|COMPLETED|Stage 2: Period 1||2
8362820|NCT01196871|20614446|P3|COMPLETED|Stage 2: Period 1||0
8362821|NCT01196871|20614447|P2|COMPLETED|Stage 2: Period 1||0
8362822|NCT01196871|20614448|P1|COMPLETED|Stage 2: Period 1||0
8362823|NCT01196871|20614443|P6|PK Population|Stage 2: Period 1||4
8362824|NCT01196871|20614444|P5|PK Population|Stage 2: Period 1||5
8362825|NCT01196871|20614445|P4|PK Population|Stage 2: Period 1||1
8362826|NCT01196871|20614446|P3|PK Population|Stage 2: Period 1||0
8362827|NCT01196871|20614447|P2|PK Population|Stage 2: Period 1||0
8362828|NCT01196871|20614448|P1|PK Population|Stage 2: Period 1||0
8362829|NCT01196871|20614443|P6|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
8362830|NCT01196871|20614444|P5|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
8362831|NCT01196871|20614445|P4|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
8362832|NCT01196871|20614446|P3|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
8362833|NCT01196871|20614447|P2|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
8362834|NCT01196871|20614448|P1|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
8362835|NCT01196871|20614443|P6|STARTED|Stage 2: Period 1||4
8362836|NCT01196871|20614444|P5|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
8362837|NCT01196871|20614445|P4|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
8362838|NCT01196871|20614446|P3|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
8362839|NCT01196871|20614447|P2|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
8362840|NCT01196871|20614448|P1|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
8362841|NCT01196871|20614443|P6|NOT COMPLETED|Stage 1: Period 3||0
8362842|NCT01196871|20614444|P5|NOT COMPLETED|Stage 1: Period 3||0
8362843|NCT01196871|20614445|P4|NOT COMPLETED|Stage 1: Period 3||0
8362844|NCT01196871|20614446|P3|NOT COMPLETED|Stage 1: Period 3||0
8362845|NCT01196871|20614447|P2|NOT COMPLETED|Stage 1: Period 3||0
8362846|NCT01196871|20614448|P1|NOT COMPLETED|Stage 1: Period 3||0
8362847|NCT01196871|20614443|P6|COMPLETED|Stage 1: Period 3||0
8362848|NCT01196871|20614444|P5|COMPLETED|Stage 1: Period 3||0
8362849|NCT01196871|20614445|P4|COMPLETED|Stage 1: Period 3||0
8362850|NCT01196871|20614446|P3|COMPLETED|Stage 1: Period 3||4
8362851|NCT01196871|20614447|P2|COMPLETED|Stage 1: Period 3||3
8362852|NCT01196871|20614448|P1|COMPLETED|Stage 1: Period 3||5
8362853|NCT01196871|20614443|P6|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
8362854|NCT01196871|20614444|P5|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
8362855|NCT01196871|20614445|P4|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
8362856|NCT01196871|20614446|P3|STARTED|Stage 1: Period 3||4
8362857|NCT01196871|20614447|P2|STARTED|Stage 1: Period 3||3
8362858|NCT01196871|20614448|P1|STARTED|Stage 1: Period 3||5
8362859|NCT01196871|20614443|P6|NOT COMPLETED|Stage 1: Period 2||0
8362860|NCT01196871|20614444|P5|NOT COMPLETED|Stage 1: Period 2||0
8362861|NCT01196871|20614445|P4|NOT COMPLETED|Stage 1: Period 2||0
8362862|NCT01196871|20614446|P3|NOT COMPLETED|Stage 1: Period 2||0
8362863|NCT01196871|20614447|P2|NOT COMPLETED|Stage 1: Period 2||0
8362864|NCT01196871|20614448|P1|NOT COMPLETED|Stage 1: Period 2||0
8362865|NCT01196871|20614443|P6|COMPLETED|Stage 1: Period 2||0
8362866|NCT01196871|20614444|P5|COMPLETED|Stage 1: Period 2||0
8362867|NCT01196871|20614445|P4|COMPLETED|Stage 1: Period 2||0
8362868|NCT01196871|20614446|P3|COMPLETED|Stage 1: Period 2||4
8362869|NCT01196871|20614447|P2|COMPLETED|Stage 1: Period 2||3
8362870|NCT01196871|20614448|P1|COMPLETED|Stage 1: Period 2||5
8362871|NCT01196871|20614443|P6|PK Population|Stage 1: Period 2||0
8362872|NCT01196871|20614444|P5|PK Population|Stage 1: Period 2||0
8362873|NCT01196871|20614445|P4|PK Population|Stage 1: Period 2||0
8362874|NCT01196871|20614446|P3|PK Population|Stage 1: Period 2||4
8362875|NCT01196871|20614447|P2|PK Population|Stage 1: Period 2||3
8362876|NCT01196871|20614448|P1|PK Population|Stage 1: Period 2||5
8362877|NCT01196871|20614443|P6|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
8362878|NCT01196871|20614444|P5|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
8362879|NCT01196871|20614445|P4|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
8362880|NCT01196871|20614446|P3|STARTED|Stage 1: Period 2||4
8362881|NCT01196871|20614447|P2|STARTED|Stage 1: Period 2||3
8362882|NCT01196871|20614448|P1|STARTED|Stage 1: Period 2||5
8362883|NCT01196871|20614443|P6|NOT COMPLETED|Stage 1: Period 1||0
8362885|NCT01196871|20614445|P4|NOT COMPLETED|Stage 1: Period 1||0
8362886|NCT01196871|20614446|P3|NOT COMPLETED|Stage 1: Period 1||0
8362887|NCT01196871|20614447|P2|NOT COMPLETED|Stage 1: Period 1||0
8362888|NCT01196871|20614448|P1|NOT COMPLETED|Stage 1: Period 1||0
8362889|NCT01196871|20614443|P6|COMPLETED|Stage 1: Period 1||0
8362890|NCT01196871|20614444|P5|COMPLETED|Stage 1: Period 1||0
8362891|NCT01196871|20614445|P4|COMPLETED|Stage 1: Period 1||0
8362892|NCT01196871|20614446|P3|COMPLETED|Stage 1: Period 1||4
8362893|NCT01196871|20614447|P2|COMPLETED|Stage 1: Period 1||3
8362894|NCT01196871|20614448|P1|COMPLETED|Stage 1: Period 1||5
8362895|NCT01196871|20614443|P6|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
8362896|NCT01196871|20614444|P5|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
8362897|NCT01196871|20614445|P4|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
8362898|NCT01196871|20614446|P3|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
8362899|NCT01196871|20614447|P2|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
8362900|NCT01196871|20614448|P1|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
8362901|NCT01196871|20614443|P6|PK Population|Stage 1: Period 1||0
8362902|NCT01196871|20614444|P5|PK Population|Stage 1: Period 1||0
8362903|NCT01196871|20614445|P4|PK Population|Stage 1: Period 1||0
8362904|NCT01196871|20614446|P3|PK Population|Stage 1: Period 1||4
8362905|NCT01196871|20614447|P2|PK Population|Stage 1: Period 1||3
8362906|NCT01196871|20614448|P1|PK Population|Stage 1: Period 1||5
8362907|NCT01196871|20614443|P6|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
8362908|NCT01196871|20614444|P5|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
8362909|NCT01196871|20614445|P4|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
8362910|NCT01196871|20614446|P3|STARTED|Stage 1: Period 1||4
8362911|NCT01196871|20614447|P2|STARTED|Stage 1: Period 1||3
8362912|NCT01196871|20614448|P1|STARTED|Stage 1: Period 1||5
8362913|NCT01196819|20614533|P2|NOT COMPLETED|Overall Study||0
8362914|NCT01196819|20614534|P1|NOT COMPLETED|Overall Study||6
8362915|NCT01196819|20614533|P2|COMPLETED|Overall Study||227
8362916|NCT01196819|20614534|P1|COMPLETED|Overall Study||225
8362917|NCT01196819|20614533|P2|STARTED|Overall Study||227
8362918|NCT01196819|20614534|P1|STARTED|Overall Study||231
8362919|NCT01196793|20614554|P1|NOT COMPLETED|Overall Study||0
8362920|NCT01196793|20614554|P1|COMPLETED|Overall Study||108
8362921|NCT01196793|20614554|P1|STARTED|Overall Study||108
8362922|NCT01196741|20614560|P2|NOT COMPLETED|Overall Study||28
8362923|NCT01196741|20614561|P1|NOT COMPLETED|Overall Study||60
8362924|NCT01196741|20614560|P2|COMPLETED|Overall Study||8
8362925|NCT01196741|20614561|P1|COMPLETED|Overall Study||11
8362926|NCT01196741|20614560|P2|STARTED|Overall Study||36
8362927|NCT01196741|20614561|P1|STARTED|Overall Study||71
8362928|NCT01196533|20614575|P1|NOT COMPLETED|Overall Study||0
8362929|NCT01196533|20614575|P1|COMPLETED|Overall Study||94
8362930|NCT01196533|20614575|P1|STARTED|Overall Study||94
8362931|NCT01196442|20614579|P1|NOT COMPLETED|Overall Study||0
8362932|NCT01196442|20614579|P1|COMPLETED|Overall Study||39
8362933|NCT01196442|20614579|P1|STARTED|Overall Study||39
8362934|NCT01196429|20614591|P2|NOT COMPLETED|Overall Study||0
8362935|NCT01196429|20614592|P1|NOT COMPLETED|Overall Study||3
8362936|NCT01196429|20614591|P2|COMPLETED|Overall Study||45
8362937|NCT01196429|20614592|P1|COMPLETED|Overall Study||42
8362938|NCT01196429|20614591|P2|STARTED|Overall Study||45
8362939|NCT01196429|20614592|P1|STARTED|Overall Study||45
8362940|NCT01196416|20614608|P1|NOT COMPLETED|Overall Study||2
8362941|NCT01196416|20614608|P1|COMPLETED|Overall Study||12
8362942|NCT01196416|20614608|P1|STARTED|Overall Study||14
8362943|NCT01196377|20614626|P4|NOT COMPLETED|Overall Study||0
8362944|NCT01196377|20614627|P3|NOT COMPLETED|Overall Study||0
8362945|NCT01196377|20614628|P2|NOT COMPLETED|Overall Study||0
8362946|NCT01196377|20614629|P1|NOT COMPLETED|Overall Study||0
8362947|NCT01196377|20614626|P4|COMPLETED|Overall Study||4
8362948|NCT01196377|20614627|P3|COMPLETED|Overall Study||4
8362949|NCT01196377|20614628|P2|COMPLETED|Overall Study||4
8362950|NCT01196377|20614629|P1|COMPLETED|Overall Study||4
8362951|NCT01196377|20614626|P4|STARTED|Overall Study||4
8362952|NCT01196377|20614627|P3|STARTED|Overall Study||4
8362953|NCT01196377|20614628|P2|STARTED|Overall Study||4
8362954|NCT01196377|20614629|P1|STARTED|Overall Study||4
8362955|NCT01196117|20614639|P2|NOT COMPLETED|CPAP||0
8362956|NCT01196117|20614640|P1|NOT COMPLETED|CPAP||0
8362957|NCT01196117|20614639|P2|COMPLETED|CPAP||18
8362958|NCT01196117|20614640|P1|COMPLETED|CPAP||0
8362959|NCT01196117|20614639|P2|STARTED|CPAP||18
8362960|NCT01196117|20614640|P1|STARTED|CPAP||0
8362961|NCT01196117|20614639|P2|NOT COMPLETED|Placebo, Then CPAP||0
8362962|NCT01196117|20614640|P1|NOT COMPLETED|Placebo, Then CPAP||0
8362963|NCT01196117|20614639|P2|COMPLETED|Placebo, Then CPAP||0
8362964|NCT01196117|20614640|P1|COMPLETED|Placebo, Then CPAP||18
8362965|NCT01196117|20614639|P2|STARTED|Placebo, Then CPAP||0
8362966|NCT01196117|20614640|P1|STARTED|Placebo, Then CPAP||18
8362967|NCT01196104|20614666|P2|NOT COMPLETED|Overall Study||5
8362968|NCT01196104|20614667|P1|NOT COMPLETED|Overall Study||4
8362969|NCT01196104|20614666|P2|COMPLETED|Overall Study||15
8362970|NCT01196104|20614667|P1|COMPLETED|Overall Study||15
8362971|NCT01196104|20614666|P2|STARTED|Overall Study||20
8362972|NCT01196104|20614667|P1|STARTED|Overall Study||19
8362973|NCT01196091|20614710|P3|NOT COMPLETED|Overall Study||104
8362974|NCT01196091|20614711|P2|NOT COMPLETED|Overall Study||98
8362975|NCT01196091|20614712|P1|NOT COMPLETED|Overall Study||88
8362976|NCT01196091|20614710|P3|COMPLETED|Overall Study||284
8362977|NCT01196091|20614711|P2|COMPLETED|Overall Study||291
8362978|NCT01196091|20614712|P1|COMPLETED|Overall Study||299
8362979|NCT01196091|20614710|P3|Follow-Up|Overall Study||128
8362980|NCT01196091|20614711|P2|Follow-Up|Overall Study||105
8362981|NCT01196091|20614712|P1|Follow-Up|Overall Study||103
8362982|NCT01196091|20614710|P3|ITT-Received Drug and Excluded Sites|Overall Study||379
8362983|NCT01196091|20614711|P2|ITT-Received Drug and Excluded Sites|Overall Study||378
8362984|NCT01196091|20614712|P1|ITT-Received Drug and Excluded Sites|Overall Study||381
8362985|NCT01196091|20614710|P3|Received at Least 1 Dose of Study Drug|Overall Study||387
8362986|NCT01196091|20614711|P2|Received at Least 1 Dose of Study Drug|Overall Study||389
8362987|NCT01196091|20614712|P1|Received at Least 1 Dose of Study Drug|Overall Study||386
8362988|NCT01196091|20614710|P3|STARTED|Overall Study||388
8362989|NCT01196091|20614711|P2|STARTED|Overall Study||389
8362990|NCT01196091|20614712|P1|STARTED|Overall Study||387
8362991|NCT01196078|20614764|P2|NOT COMPLETED|Overall Study||37
8362992|NCT01196078|20614765|P1|NOT COMPLETED|Overall Study||33
8362993|NCT01196078|20614764|P2|COMPLETED|Overall Study||20
8362994|NCT01196078|20614765|P1|COMPLETED|Overall Study||24
8362995|NCT01196078|20614764|P2|STARTED|Overall Study||57
8362996|NCT01196078|20614765|P1|STARTED|Overall Study||57
8362997|NCT01196052|20614793|P1|NOT COMPLETED|Overall Study||23
8362998|NCT01196052|20614793|P1|COMPLETED|Overall Study||130
8362999|NCT01196052|20614793|P1|Received Trastuzumab Emtansine|Overall Study||148
8363000|NCT01196052|20614793|P1|STARTED|Overall Study||153
8363001|NCT01196026|20614810|P6|NOT COMPLETED|Overall Study||0
8363002|NCT01196026|20614811|P5|NOT COMPLETED|Overall Study||1
8363003|NCT01196026|20614812|P4|NOT COMPLETED|Overall Study||0
8363004|NCT01196026|20614813|P3|NOT COMPLETED|Overall Study||0
8363005|NCT01196026|20614814|P2|NOT COMPLETED|Overall Study||8
8363006|NCT01196026|20614815|P1|NOT COMPLETED|Overall Study||1
8363007|NCT01196026|20614810|P6|COMPLETED|Overall Study||24
8363008|NCT01196026|20614811|P5|COMPLETED|Overall Study||42
8363009|NCT01196026|20614812|P4|COMPLETED|Overall Study||10
8363010|NCT01196026|20614813|P3|COMPLETED|Overall Study||23
8363011|NCT01196026|20614814|P2|COMPLETED|Overall Study||36
8363012|NCT01196026|20614815|P1|COMPLETED|Overall Study||9
8363013|NCT01196026|20614810|P6|Completed at Day 28|Overall Study||24
8363014|NCT01196026|20614811|P5|Completed at Day 28|Overall Study||42
8363015|NCT01196026|20614812|P4|Completed at Day 28|Overall Study||10
8363016|NCT01196026|20614813|P3|Completed at Day 28|Overall Study||23
8363017|NCT01196026|20614814|P2|Completed at Day 28|Overall Study||41
8363018|NCT01196026|20614815|P1|Completed at Day 28|Overall Study||9
8363019|NCT01196026|20614810|P6|STARTED|Overall Study||24
8363020|NCT01196026|20614811|P5|STARTED|Overall Study||43
8363021|NCT01196026|20614812|P4|STARTED|Overall Study||10
8363022|NCT01196026|20614813|P3|STARTED|Overall Study||23
8363023|NCT01196026|20614814|P2|STARTED|Overall Study||44
8363024|NCT01196026|20614815|P1|STARTED|Overall Study||10
8363025|NCT01195948|20615049|P3|NOT COMPLETED|Overall Study||2
8363026|NCT01195948|20615050|P2|NOT COMPLETED|Overall Study||1
8363027|NCT01195948|20615051|P1|NOT COMPLETED|Overall Study||0
8363028|NCT01195948|20615049|P3|COMPLETED|Overall Study||9
8363029|NCT01195948|20615050|P2|COMPLETED|Overall Study||9
8363030|NCT01195948|20615051|P1|COMPLETED|Overall Study||10
8363031|NCT01195948|20615049|P3|Week 24|Overall Study||10
8363032|NCT01195948|20615050|P2|Week 24|Overall Study||10
8363033|NCT01195948|20615051|P1|Week 24|Overall Study||10
8363034|NCT01195948|20615049|P3|STARTED|Overall Study||11
8363035|NCT01195948|20615050|P2|STARTED|Overall Study||10
8363036|NCT01195948|20615051|P1|STARTED|Overall Study||10
8363037|NCT01195922|20615083|P1|NOT COMPLETED|Overall Study||0
8363038|NCT01195922|20615083|P1|COMPLETED|Overall Study||16
8363039|NCT01195922|20615083|P1|STARTED|Overall Study||16
8363040|NCT01195883|20615091|P2|NOT COMPLETED|Overall Study||26
8363041|NCT01195883|20615092|P1|NOT COMPLETED|Overall Study||19
8363042|NCT01195883|20615091|P2|COMPLETED|Overall Study||523
8363043|NCT01195883|20615092|P1|COMPLETED|Overall Study||534
8363044|NCT01195883|20615091|P2|STARTED|Overall Study||549
8363045|NCT01195883|20615092|P1|STARTED|Overall Study||553
8363046|NCT01195844|20615104|P1|NOT COMPLETED|Overall Study||40
8363047|NCT01195844|20615104|P1|COMPLETED|Overall Study||190
8363048|NCT01195844|20615104|P1|STARTED|Overall Study||230
8363049|NCT01195831|20615121|P2|NOT COMPLETED|Overall Study||10
8363050|NCT01195831|20615122|P1|NOT COMPLETED|Overall Study||8
8363051|NCT01195831|20615121|P2|COMPLETED|Overall Study||114
8363052|NCT01195831|20615122|P1|COMPLETED|Overall Study||112
8363053|NCT01195831|20615121|P2|STARTED|Overall Study||124
8363054|NCT01195831|20615122|P1|STARTED|Overall Study||120
8363055|NCT01195779|20615150|P14|NOT COMPLETED|Overall Study||0
8363056|NCT01195779|20615151|P13|NOT COMPLETED|Overall Study||0
8363057|NCT01195779|20615152|P12|NOT COMPLETED|Overall Study||0
8363058|NCT01195779|20615153|P11|NOT COMPLETED|Overall Study||0
8363059|NCT01195779|20615154|P10|NOT COMPLETED|Overall Study||0
8363060|NCT01195779|20615155|P9|NOT COMPLETED|Overall Study||0
8363061|NCT01195779|20615156|P8|NOT COMPLETED|Overall Study||0
8363062|NCT01195779|20615157|P7|NOT COMPLETED|Overall Study||0
8363063|NCT01195779|20615158|P6|NOT COMPLETED|Overall Study||0
8363064|NCT01195779|20615159|P5|NOT COMPLETED|Overall Study||0
8363065|NCT01195779|20615160|P4|NOT COMPLETED|Overall Study||0
8363066|NCT01195779|20615161|P3|NOT COMPLETED|Overall Study||0
8363067|NCT01195779|20615162|P2|NOT COMPLETED|Overall Study||0
8363068|NCT01195779|20615163|P1|NOT COMPLETED|Overall Study||0
8363069|NCT01195779|20615150|P14|COMPLETED|Overall Study||1
8363070|NCT01195779|20615151|P13|COMPLETED|Overall Study||0
8363071|NCT01195779|20615152|P12|COMPLETED|Overall Study||1
8363072|NCT01195779|20615153|P11|COMPLETED|Overall Study||0
8363073|NCT01195779|20615154|P10|COMPLETED|Overall Study||0
8363074|NCT01195779|20615155|P9|COMPLETED|Overall Study||0
8363075|NCT01195779|20615156|P8|COMPLETED|Overall Study||1
8363076|NCT01195779|20615157|P7|COMPLETED|Overall Study||0
8363077|NCT01195779|20615158|P6|COMPLETED|Overall Study||0
8363078|NCT01195779|20615159|P5|COMPLETED|Overall Study||1
8363079|NCT01195779|20615160|P4|COMPLETED|Overall Study||0
8363080|NCT01195779|20615161|P3|COMPLETED|Overall Study||0
8363081|NCT01195779|20615162|P2|COMPLETED|Overall Study||0
8363082|NCT01195779|20615163|P1|COMPLETED|Overall Study||0
8363083|NCT01195779|20615150|P14|STARTED|Overall Study||1
8363084|NCT01195779|20615151|P13|STARTED|Overall Study||0
8363085|NCT01195779|20615152|P12|STARTED|Overall Study||1
8363086|NCT01195779|20615153|P11|STARTED|Overall Study||0
8363087|NCT01195779|20615154|P10|STARTED|Overall Study||0
8363088|NCT01195779|20615155|P9|STARTED|Overall Study||0
8363089|NCT01195779|20615156|P8|STARTED|Overall Study||1
8363090|NCT01195779|20615157|P7|STARTED|Overall Study||0
8363091|NCT01195779|20615158|P6|STARTED|Overall Study||0
8363092|NCT01195779|20615159|P5|STARTED|Overall Study||1
8363093|NCT01195779|20615160|P4|STARTED|Overall Study||0
8363094|NCT01195779|20615161|P3|STARTED|Overall Study||0
8363095|NCT01195779|20615162|P2|STARTED|Overall Study||0
8363096|NCT01195779|20615163|P1|STARTED|Overall Study||0
8363097|NCT01195701|20615335|P2|NOT COMPLETED|Overall Study||5
8363098|NCT01195701|20615336|P1|NOT COMPLETED|Overall Study||0
8363099|NCT01195701|20615335|P2|COMPLETED|Overall Study||20
8363100|NCT01195701|20615336|P1|COMPLETED|Overall Study||10
8363101|NCT01195701|20615335|P2|STARTED|Overall Study||25
8363102|NCT01195701|20615336|P1|STARTED|Overall Study||10
8363103|NCT01195675|20615362|P1|NOT COMPLETED|Overall Study||3
8363104|NCT01195675|20615362|P1|COMPLETED|Overall Study||27
8363105|NCT01195675|20615362|P1|Received Placebo 2|Overall Study||28
8363106|NCT01195675|20615362|P1|Received Placebo 1|Overall Study||29
8363107|NCT01195675|20615362|P1|Received Moxifloxacin|Overall Study||29
8363108|NCT01195675|20615362|P1|Received Empa 200mg|Overall Study||30
8363109|NCT01195675|20615362|P1|Received Empa 25mg|Overall Study||28
8363110|NCT01195675|20615362|P1|STARTED|Overall Study||30
8363111|NCT01195662|20615395|P3|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
8363112|NCT01195662|20615396|P2|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
8363113|NCT01195662|20615397|P1|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
8363114|NCT01195662|20615395|P3|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
8363115|NCT01195662|20615396|P2|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
8363116|NCT01195662|20615397|P1|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
8363117|NCT01195662|20615395|P3|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
8363118|NCT01195662|20615396|P2|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
8363119|NCT01195662|20615397|P1|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
8363120|NCT01195662|20615395|P3|NOT COMPLETED|Double Blind Treatment Period||14
8363121|NCT01195662|20615396|P2|NOT COMPLETED|Double Blind Treatment Period||14
8363122|NCT01195662|20615397|P1|NOT COMPLETED|Double Blind Treatment Period||22
8363123|NCT01195662|20615395|P3|COMPLETED|Double Blind Treatment Period||119
8363124|NCT01195662|20615396|P2|COMPLETED|Double Blind Treatment Period||211
8363125|NCT01195662|20615397|P1|COMPLETED|Double Blind Treatment Period||202
8363126|NCT01195662|20615395|P3|STARTED|Double Blind Treatment Period||133
8363127|NCT01195662|20615396|P2|STARTED|Double Blind Treatment Period||225
8363128|NCT01195662|20615397|P1|STARTED|Double Blind Treatment Period||224
8363129|NCT01195636|20615427|P2|NOT COMPLETED|Second Intervention (3 Weeks)||2
8363130|NCT01195636|20615428|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
8363131|NCT01195636|20615427|P2|COMPLETED|Second Intervention (3 Weeks)||27
8363132|NCT01195636|20615428|P1|COMPLETED|Second Intervention (3 Weeks)||27
8363133|NCT01195636|20615427|P2|STARTED|Second Intervention (3 Weeks)||29
8363134|NCT01195636|20615428|P1|STARTED|Second Intervention (3 Weeks)||28
8363135|NCT01195636|20615427|P2|NOT COMPLETED|Washout Period (2 Weeks)||3
8363136|NCT01195636|20615428|P1|NOT COMPLETED|Washout Period (2 Weeks)||2
8363137|NCT01195636|20615427|P2|COMPLETED|Washout Period (2 Weeks)||29
8363138|NCT01195636|20615428|P1|COMPLETED|Washout Period (2 Weeks)||28
8363139|NCT01195636|20615427|P2|STARTED|Washout Period (2 Weeks)||32
8363140|NCT01195636|20615428|P1|STARTED|Washout Period (2 Weeks)||30
8363141|NCT01195636|20615427|P2|NOT COMPLETED|First Intervention (3 Weeks)||3
8363142|NCT01195636|20615428|P1|NOT COMPLETED|First Intervention (3 Weeks)||5
8363143|NCT01195636|20615427|P2|COMPLETED|First Intervention (3 Weeks)||32
8363144|NCT01195636|20615428|P1|COMPLETED|First Intervention (3 Weeks)||30
8363145|NCT01195636|20615427|P2|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
8363146|NCT01195636|20615428|P1|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
8363147|NCT01195636|20615427|P2|STARTED|First Intervention (3 Weeks)||35
8363148|NCT01195636|20615428|P1|STARTED|First Intervention (3 Weeks)||35
8363149|NCT01195623|20615454|P2|NOT COMPLETED|Overall Study||37
8363150|NCT01195623|20615455|P1|NOT COMPLETED|Overall Study||35
8363151|NCT01195623|20615454|P2|COMPLETED|Overall Study|129 legs|108
8363152|NCT01195623|20615455|P1|COMPLETED|Overall Study|127 legs|113
8363153|NCT01195623|20615454|P2|STARTED|Overall Study|177 legs total operated|145
8363154|NCT01195623|20615455|P1|STARTED|Overall Study|166 legs total operated|148
8363155|NCT01195597|20615463|P1|NOT COMPLETED|Overall Study||13
8363156|NCT01195597|20615463|P1|COMPLETED|Overall Study||27
8363157|NCT01195597|20615463|P1|STARTED|Overall Study||40
8363158|NCT01195584|20615471|P3|NOT COMPLETED|Overall Study||0
8363159|NCT01195584|20615472|P2|NOT COMPLETED|Overall Study||0
8363160|NCT01195584|20615473|P1|NOT COMPLETED|Overall Study||0
8363161|NCT01195584|20615471|P3|COMPLETED|Overall Study||27
8363162|NCT01195584|20615472|P2|COMPLETED|Overall Study||25
8363163|NCT01195584|20615473|P1|COMPLETED|Overall Study||20
8363164|NCT01195584|20615471|P3|STARTED|Overall Study||27
8363165|NCT01195584|20615472|P2|STARTED|Overall Study||25
8363166|NCT01195584|20615473|P1|STARTED|Overall Study||20
8363167|NCT01195545|20615484|P1|NOT COMPLETED|Overall Study||4
8363168|NCT01195545|20615484|P1|COMPLETED|Overall Study||16
8363169|NCT01195545|20615484|P1|STARTED|Overall Study||20
8363170|NCT01195467|20615491|P1|NOT COMPLETED|Overall Study||10
8363171|NCT01195467|20615491|P1|COMPLETED|Overall Study||30
8363172|NCT01195467|20615491|P1|STARTED|Overall Study||40
8363173|NCT01195415|20615496|P1|NOT COMPLETED|Overall Study||2
8363174|NCT01195415|20615496|P1|COMPLETED|Overall Study||23
8363175|NCT01195415|20615496|P1|STARTED|Overall Study||25
8363176|NCT01195363|20615505|P2|NOT COMPLETED|Overall Study||9
8363177|NCT01195363|20615506|P1|NOT COMPLETED|Overall Study||11
8363178|NCT01195363|20615505|P2|COMPLETED|Overall Study||4
8363179|NCT01195363|20615506|P1|COMPLETED|Overall Study||4
8363180|NCT01195363|20615505|P2|STARTED|Overall Study||13
8363181|NCT01195363|20615506|P1|STARTED|Overall Study||15
8363182|NCT01195272|20615512|P1|NOT COMPLETED|Overall Study||4
8363183|NCT01195272|20615512|P1|COMPLETED|Overall Study||17
8363184|NCT01195272|20615512|P1|STARTED|Overall Study||21
8363185|NCT01195116|20615531|P2|NOT COMPLETED|Overall Study||0
8363186|NCT01195116|20615532|P1|NOT COMPLETED|Overall Study||0
8363187|NCT01195116|20615531|P2|COMPLETED|Overall Study||20
8363188|NCT01195116|20615532|P1|COMPLETED|Overall Study||21
8363189|NCT01195116|20615531|P2|STARTED|Overall Study||20
8363190|NCT01195116|20615532|P1|STARTED|Overall Study||21
8363191|NCT01195103|20615541|P3|NOT COMPLETED|Overall Study||0
8363192|NCT01195103|20615542|P2|NOT COMPLETED|Overall Study||0
8363193|NCT01195103|20615543|P1|NOT COMPLETED|Overall Study||1
8363194|NCT01195103|20615541|P3|COMPLETED|Overall Study||5
8363195|NCT01195103|20615542|P2|COMPLETED|Overall Study||2
8363196|NCT01195103|20615543|P1|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
8363197|NCT01195103|20615541|P3|STARTED|Overall Study||5
8363198|NCT01195103|20615542|P2|STARTED|Overall Study||2
8363199|NCT01195103|20615543|P1|STARTED|Overall Study||6
8363200|NCT01195090|20615553|P2|NOT COMPLETED|Overall Study||8
8363201|NCT01195090|20615554|P1|NOT COMPLETED|Overall Study||6
8363202|NCT01195090|20615553|P2|COMPLETED|Overall Study||52
8363203|NCT01195090|20615554|P1|COMPLETED|Overall Study||54
8363204|NCT01195090|20615553|P2|STARTED|Overall Study||60
8363205|NCT01195090|20615554|P1|STARTED|Overall Study||60
8363206|NCT01195025|20615612|P5|NOT COMPLETED|Third Intervention C||0
8363207|NCT01195025|20615613|P4|NOT COMPLETED|Third Intervention C||0
8363208|NCT01195025|20615614|P3|NOT COMPLETED|Third Intervention C||0
8363209|NCT01195025|20615615|P2|NOT COMPLETED|Third Intervention C||0
8363210|NCT01195025|20615616|P1|NOT COMPLETED|Third Intervention C||0
8363211|NCT01195025|20615612|P5|COMPLETED|Third Intervention C||1
8363212|NCT01195025|20615613|P4|COMPLETED|Third Intervention C||2
8363213|NCT01195025|20615614|P3|COMPLETED|Third Intervention C||2
8363214|NCT01195025|20615615|P2|COMPLETED|Third Intervention C||3
8363215|NCT01195025|20615616|P1|COMPLETED|Third Intervention C||2
8363216|NCT01195025|20615612|P5|STARTED|Third Intervention C||1
8363217|NCT01195025|20615613|P4|STARTED|Third Intervention C||2
8363218|NCT01195025|20615614|P3|STARTED|Third Intervention C||2
8363219|NCT01195025|20615615|P2|STARTED|Third Intervention C||3
8363220|NCT01195025|20615616|P1|STARTED|Third Intervention C||2
8363221|NCT01195025|20615612|P5|NOT COMPLETED|Second Intervention B||0
8363222|NCT01195025|20615613|P4|NOT COMPLETED|Second Intervention B||0
8363223|NCT01195025|20615614|P3|NOT COMPLETED|Second Intervention B||0
8363224|NCT01195025|20615615|P2|NOT COMPLETED|Second Intervention B||0
8363225|NCT01195025|20615616|P1|NOT COMPLETED|Second Intervention B||0
8363226|NCT01195025|20615612|P5|COMPLETED|Second Intervention B||1
8363227|NCT01195025|20615613|P4|COMPLETED|Second Intervention B||2
8363228|NCT01195025|20615614|P3|COMPLETED|Second Intervention B||2
8363229|NCT01195025|20615615|P2|COMPLETED|Second Intervention B||3
8363230|NCT01195025|20615616|P1|COMPLETED|Second Intervention B||2
8363231|NCT01195025|20615612|P5|STARTED|Second Intervention B||1
8363232|NCT01195025|20615613|P4|STARTED|Second Intervention B||2
8363233|NCT01195025|20615614|P3|STARTED|Second Intervention B||2
8363234|NCT01195025|20615615|P2|STARTED|Second Intervention B||3
8363235|NCT01195025|20615616|P1|STARTED|Second Intervention B||2
8363236|NCT01195025|20615612|P5|NOT COMPLETED|First Intervention A||0
8363237|NCT01195025|20615613|P4|NOT COMPLETED|First Intervention A||0
8363238|NCT01195025|20615614|P3|NOT COMPLETED|First Intervention A||0
8363239|NCT01195025|20615615|P2|NOT COMPLETED|First Intervention A||0
8363240|NCT01195025|20615616|P1|NOT COMPLETED|First Intervention A||0
8363241|NCT01195025|20615612|P5|COMPLETED|First Intervention A||1
8363242|NCT01195025|20615613|P4|COMPLETED|First Intervention A||2
8363243|NCT01195025|20615614|P3|COMPLETED|First Intervention A||2
8363244|NCT01195025|20615615|P2|COMPLETED|First Intervention A||3
8363245|NCT01195025|20615616|P1|COMPLETED|First Intervention A||2
8363246|NCT01195025|20615612|P5|STARTED|First Intervention A||1
8363247|NCT01195025|20615613|P4|STARTED|First Intervention A||2
8363248|NCT01195025|20615614|P3|STARTED|First Intervention A||2
8363249|NCT01195025|20615615|P2|STARTED|First Intervention A||3
8363250|NCT01195025|20615616|P1|STARTED|First Intervention A||2
8363251|NCT01194999|20615623|P1|NOT COMPLETED|Overall Study||17
8363252|NCT01194999|20615623|P1|COMPLETED|Overall Study||115
8363253|NCT01194999|20615623|P1|STARTED|Overall Study||132
8363254|NCT01194973|20615627|P1|NOT COMPLETED|26 Week Treatment Period||3
8363255|NCT01194973|20615627|P1|COMPLETED|26 Week Treatment Period||38
8363256|NCT01194973|20615627|P1|STARTED|26 Week Treatment Period||41
8363257|NCT01194973|20615627|P1|NOT COMPLETED|Screening Period||3
8363258|NCT01194973|20615627|P1|COMPLETED|Screening Period||41
8363259|NCT01194973|20615627|P1|STARTED|Screening Period||44
8363260|NCT01194908|20615642|P1|NOT COMPLETED|Overall Study||0
8363261|NCT01194908|20615642|P1|COMPLETED|Overall Study||5
8363262|NCT01194908|20615642|P1|STARTED|Overall Study||5
8363263|NCT01194869|20615647|P1|NOT COMPLETED|Overall Study||4
8363264|NCT01194869|20615647|P1|COMPLETED|Overall Study||21
8363265|NCT01194869|20615647|P1|STARTED|Overall Study||25
8363266|NCT01194856|20615655|P2|NOT COMPLETED|Overall Study||0
8363267|NCT01194856|20615656|P1|NOT COMPLETED|Overall Study||1
8363268|NCT01194856|20615655|P2|COMPLETED|Overall Study||0
8363269|NCT01194856|20615656|P1|COMPLETED|Overall Study||0
8363270|NCT01194856|20615655|P2|STARTED|Overall Study||0
8363271|NCT01194856|20615656|P1|STARTED|Overall Study||1
8363272|NCT01194830|20615678|P2|NOT COMPLETED|Overall Study||27
8363273|NCT01194830|20615679|P1|NOT COMPLETED|Overall Study||36
8363274|NCT01194830|20615678|P2|COMPLETED|Overall Study||83
8363275|NCT01194830|20615679|P1|COMPLETED|Overall Study||88
8363276|NCT01194830|20615678|P2|STARTED|Overall Study||110
8363277|NCT01194830|20615679|P1|STARTED|Overall Study||124
8363278|NCT01194804|20615701|P1|NOT COMPLETED|Overall Study||1
8363279|NCT01194804|20615701|P1|COMPLETED|Overall Study||26
8363280|NCT01194804|20615701|P1|STARTED|Overall Study||27
8363281|NCT01194674|20615709|P1|NOT COMPLETED|Overall Study||0
8363282|NCT01194674|20615709|P1|COMPLETED|Overall Study||2
8363283|NCT01194674|20615709|P1|STARTED|Overall Study||2
8363284|NCT01194570|20615723|P2|NOT COMPLETED|Overall Study||488
8363285|NCT01194570|20615724|P1|NOT COMPLETED|Overall Study||244
8363286|NCT01194570|20615723|P2|COMPLETED|Overall Study||0
8363287|NCT01194570|20615724|P1|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
8363288|NCT01194570|20615723|P2|STARTED|Overall Study||488
8363289|NCT01194570|20615724|P1|STARTED|Overall Study||244
8363290|NCT01194531|20615744|P2|NOT COMPLETED|Overall Study||3
8363291|NCT01194531|20615745|P1|NOT COMPLETED|Overall Study||5
8363292|NCT01194531|20615744|P2|COMPLETED|Overall Study||27
8363293|NCT01194531|20615745|P1|COMPLETED|Overall Study||24
8363294|NCT01194531|20615744|P2|STARTED|Overall Study||30
8363295|NCT01194531|20615745|P1|STARTED|Overall Study||29
8363296|NCT01194479|20615753|P4|NOT COMPLETED|Overall Study||0
8363297|NCT01194479|20615754|P3|NOT COMPLETED|Overall Study||0
8363298|NCT01194479|20615755|P2|NOT COMPLETED|Overall Study||0
8363299|NCT01194479|20615756|P1|NOT COMPLETED|Overall Study||0
8363300|NCT01194479|20615753|P4|COMPLETED|Overall Study||5
8363301|NCT01194479|20615754|P3|COMPLETED|Overall Study||2
8363302|NCT01194479|20615755|P2|COMPLETED|Overall Study||4
8363303|NCT01194479|20615756|P1|COMPLETED|Overall Study||3
8363304|NCT01194479|20615753|P4|Cross-over at Second Visit|Overall Study||5
8363305|NCT01194479|20615754|P3|Cross-over at Second Visit|Overall Study||2
8363306|NCT01194479|20615755|P2|Cross-over at Second Visit|Overall Study||4
8363307|NCT01194479|20615756|P1|Cross-over at Second Visit|Overall Study||3
8363308|NCT01194479|20615753|P4|STARTED|Overall Study||5
8363309|NCT01194479|20615754|P3|STARTED|Overall Study||2
8363310|NCT01194479|20615755|P2|STARTED|Overall Study||4
8363311|NCT01194479|20615756|P1|STARTED|Overall Study||3
8363312|NCT01194466|20615778|P3|NOT COMPLETED|Overall Study||0
8363313|NCT01194466|20615779|P2|NOT COMPLETED|Overall Study||0
8363314|NCT01194466|20615780|P1|NOT COMPLETED|Overall Study||0
8363315|NCT01194466|20615778|P3|COMPLETED|Overall Study||13
8363316|NCT01194466|20615779|P2|COMPLETED|Overall Study||14
8363317|NCT01194466|20615780|P1|COMPLETED|Overall Study||14
8363318|NCT01194466|20615778|P3|STARTED|Overall Study||13
8363319|NCT01194466|20615779|P2|STARTED|Overall Study||14
8363320|NCT01194466|20615780|P1|STARTED|Overall Study||14
8363321|NCT01194453|20615790|P2|NOT COMPLETED|Overall Study||17
8363322|NCT01194453|20615791|P1|NOT COMPLETED|Overall Study||17
8363323|NCT01194453|20615790|P2|COMPLETED|Overall Study||127
8363324|NCT01194453|20615791|P1|COMPLETED|Overall Study||127
8363325|NCT01194453|20615790|P2|STARTED|Overall Study||144
8363326|NCT01194453|20615791|P1|STARTED|Overall Study||144
8363327|NCT01194440|20615799|P1|NOT COMPLETED|6-months (2nd Dose)||4
8363328|NCT01194440|20615799|P1|COMPLETED|6-months (2nd Dose)||48
8363329|NCT01194440|20615799|P1|STARTED|6-months (2nd Dose)||52
8363330|NCT01194440|20615799|P1|NOT COMPLETED|Baseline (First Dose)||7
8363331|NCT01194440|20615799|P1|COMPLETED|Baseline (First Dose)||52
8363332|NCT01194440|20615799|P1|STARTED|Baseline (First Dose)||59
8363333|NCT01194427|20615806|P1|NOT COMPLETED|Overall Study||0
8363334|NCT01194427|20615806|P1|COMPLETED|Overall Study||2
8363335|NCT01194427|20615806|P1|STARTED|Overall Study||2
8363336|NCT01194414|20615812|P4|NOT COMPLETED|72 Weeks Open Label Extension||26
8363337|NCT01194414|20615813|P3|NOT COMPLETED|72 Weeks Open Label Extension||8
8363338|NCT01194414|20615814|P2|NOT COMPLETED|72 Weeks Open Label Extension||66
8363339|NCT01194414|20615815|P1|NOT COMPLETED|72 Weeks Open Label Extension||79
8363340|NCT01194414|20615812|P4|COMPLETED|72 Weeks Open Label Extension||160
8363341|NCT01194414|20615813|P3|COMPLETED|72 Weeks Open Label Extension||40
8363342|NCT01194414|20615814|P2|COMPLETED|72 Weeks Open Label Extension||311
8363343|NCT01194414|20615815|P1|COMPLETED|72 Weeks Open Label Extension||445
8363344|NCT01194414|20615812|P4|STARTED|72 Weeks Open Label Extension||186
8363345|NCT01194414|20615813|P3|STARTED|72 Weeks Open Label Extension||48
8363346|NCT01194414|20615814|P2|STARTED|72 Weeks Open Label Extension||377
8363347|NCT01194414|20615815|P1|STARTED|72 Weeks Open Label Extension||524
8363348|NCT01194414|20615812|P4|NOT COMPLETED|24 Weeks Double Blind Period||0
8363349|NCT01194414|20615813|P3|NOT COMPLETED|24 Weeks Double Blind Period||0
8363350|NCT01194414|20615814|P2|NOT COMPLETED|24 Weeks Double Blind Period||67
8363351|NCT01194414|20615815|P1|NOT COMPLETED|24 Weeks Double Blind Period||59
8363352|NCT01194414|20615812|P4|COMPLETED|24 Weeks Double Blind Period||0
8363353|NCT01194414|20615813|P3|COMPLETED|24 Weeks Double Blind Period||0
8363354|NCT01194414|20615814|P2|COMPLETED|24 Weeks Double Blind Period||564
8363355|NCT01194414|20615815|P1|COMPLETED|24 Weeks Double Blind Period||572
8363356|NCT01194414|20615812|P4|Per Protocol Population|24 Weeks Double Blind Period||0
8363357|NCT01194414|20615813|P3|Per Protocol Population|24 Weeks Double Blind Period||0
8363358|NCT01194414|20615814|P2|Per Protocol Population|24 Weeks Double Blind Period||537
8363359|NCT01194414|20615815|P1|Per Protocol Population|24 Weeks Double Blind Period||558
8363360|NCT01194414|20615812|P4|STARTED|24 Weeks Double Blind Period||0
8363361|NCT01194414|20615813|P3|STARTED|24 Weeks Double Blind Period||0
8363362|NCT01194414|20615814|P2|STARTED|24 Weeks Double Blind Period||631
8363363|NCT01194414|20615815|P1|STARTED|24 Weeks Double Blind Period||631
8363364|NCT01194297|20615877|P2|NOT COMPLETED|Overall Study||0
8363365|NCT01194297|20615878|P1|NOT COMPLETED|Overall Study||0
8363366|NCT01194297|20615877|P2|COMPLETED|Overall Study||1
8363367|NCT01194297|20615878|P1|COMPLETED|Overall Study||2
8363368|NCT01194297|20615877|P2|STARTED|Overall Study||1
8363369|NCT01194297|20615878|P1|STARTED|Overall Study||2
8363370|NCT01194271|20615886|P1|NOT COMPLETED|Overall Study||3
8363371|NCT01194271|20615886|P1|COMPLETED|Overall Study||16
8363372|NCT01194271|20615886|P1|STARTED|Overall Study||19
8363373|NCT01194258|20615890|P5|NOT COMPLETED|Period 2 (12 Weeks)||2
8363374|NCT01194258|20615891|P4|NOT COMPLETED|Period 2 (12 Weeks)||0
8363375|NCT01194258|20615892|P3|NOT COMPLETED|Period 2 (12 Weeks)||1
8363376|NCT01194258|20615893|P2|NOT COMPLETED|Period 2 (12 Weeks)||2
8363377|NCT01194258|20615894|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
8363378|NCT01194258|20615890|P5|COMPLETED|Period 2 (12 Weeks)||30
8363379|NCT01194258|20615891|P4|COMPLETED|Period 2 (12 Weeks)||29
8363380|NCT01194258|20615892|P3|COMPLETED|Period 2 (12 Weeks)||29
8363381|NCT01194258|20615893|P2|COMPLETED|Period 2 (12 Weeks)||27
8363382|NCT01194258|20615894|P1|COMPLETED|Period 2 (12 Weeks)||0
8363383|NCT01194258|20615890|P5|STARTED|Period 2 (12 Weeks)||32
8363384|NCT01194258|20615891|P4|STARTED|Period 2 (12 Weeks)||29
8363385|NCT01194258|20615892|P3|STARTED|Period 2 (12 Weeks)||30
8363386|NCT01194258|20615893|P2|STARTED|Period 2 (12 Weeks)||29
8363387|NCT01194258|20615894|P1|STARTED|Period 2 (12 Weeks)||0
8363388|NCT01194258|20615890|P5|NOT COMPLETED|Period 1 (12 Weeks)||1
8363389|NCT01194258|20615891|P4|NOT COMPLETED|Period 1 (12 Weeks)||0
8363390|NCT01194258|20615892|P3|NOT COMPLETED|Period 1 (12 Weeks)||0
8363391|NCT01194258|20615893|P2|NOT COMPLETED|Period 1 (12 Weeks)||0
8363392|NCT01194258|20615894|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
8363393|NCT01194258|20615890|P5|COMPLETED|Period 1 (12 Weeks)||32
8363394|NCT01194258|20615891|P4|COMPLETED|Period 1 (12 Weeks)||29
8363395|NCT01194258|20615892|P3|COMPLETED|Period 1 (12 Weeks)||30
8363396|NCT01194258|20615893|P2|COMPLETED|Period 1 (12 Weeks)||29
8363397|NCT01194258|20615894|P1|COMPLETED|Period 1 (12 Weeks)||0
8363398|NCT01194258|20615890|P5|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
8363399|NCT01194258|20615891|P4|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
8363400|NCT01194258|20615892|P3|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
8363401|NCT01194258|20615893|P2|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
8363402|NCT01194258|20615894|P1|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
8363403|NCT01194258|20615890|P5|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
8363404|NCT01194258|20615891|P4|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
8363405|NCT01194258|20615892|P3|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
8363406|NCT01194258|20615893|P2|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
8363407|NCT01194258|20615894|P1|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
8363408|NCT01194258|20615890|P5|NOT COMPLETED|Titration Period||0
8363409|NCT01194258|20615891|P4|NOT COMPLETED|Titration Period||0
8363410|NCT01194258|20615892|P3|NOT COMPLETED|Titration Period||0
8363411|NCT01194258|20615893|P2|NOT COMPLETED|Titration Period||0
8363412|NCT01194258|20615894|P1|NOT COMPLETED|Titration Period||11
8363413|NCT01194258|20615890|P5|COMPLETED|Titration Period||0
8363414|NCT01194258|20615891|P4|COMPLETED|Titration Period||0
8363415|NCT01194258|20615892|P3|COMPLETED|Titration Period||0
8363416|NCT01194258|20615893|P2|COMPLETED|Titration Period||0
8363417|NCT01194258|20615894|P1|COMPLETED|Titration Period||121
8363418|NCT01194258|20615890|P5|STARTED|Titration Period||0
8363419|NCT01194258|20615891|P4|STARTED|Titration Period||0
8363420|NCT01194258|20615892|P3|STARTED|Titration Period||0
8363421|NCT01194258|20615893|P2|STARTED|Titration Period||0
8363422|NCT01194258|20615894|P1|STARTED|Titration Period||132
8363423|NCT01194245|20615918|P5|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8363424|NCT01194245|20615919|P4|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8363425|NCT01194245|20615920|P3|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8363426|NCT01194245|20615921|P2|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8363427|NCT01194245|20615922|P1|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8363428|NCT01194245|20615918|P5|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
8363429|NCT01194245|20615919|P4|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
8363430|NCT01194245|20615920|P3|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
8363431|NCT01194245|20615921|P2|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
8363432|NCT01194245|20615922|P1|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
8363433|NCT01194245|20615918|P5|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
8363434|NCT01194245|20615919|P4|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
8363435|NCT01194245|20615920|P3|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
8363436|NCT01194245|20615921|P2|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
8363437|NCT01194245|20615922|P1|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
8363438|NCT01194245|20615918|P5|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
8363439|NCT01194245|20615919|P4|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
8363440|NCT01194245|20615920|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
8363441|NCT01194245|20615921|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
8363442|NCT01194245|20615922|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
8363443|NCT01194245|20615918|P5|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
8363444|NCT01194245|20615919|P4|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
8363445|NCT01194245|20615920|P3|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
8363446|NCT01194245|20615921|P2|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
8363447|NCT01194245|20615922|P1|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
8363448|NCT01194245|20615918|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
8363449|NCT01194245|20615919|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
8363450|NCT01194245|20615920|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
8363451|NCT01194245|20615921|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
8363452|NCT01194245|20615922|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
8363453|NCT01194245|20615918|P5|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
8363454|NCT01194245|20615919|P4|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
8363455|NCT01194245|20615920|P3|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
8363456|NCT01194245|20615921|P2|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
8363457|NCT01194245|20615922|P1|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
8363458|NCT01194245|20615918|P5|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
8363459|NCT01194245|20615919|P4|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
8363460|NCT01194245|20615920|P3|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
8363461|NCT01194245|20615921|P2|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
8363462|NCT01194245|20615922|P1|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
8363463|NCT01194245|20615918|P5|COMPLETED|Titration Period (4 to 6 Weeks)||0
8363464|NCT01194245|20615919|P4|COMPLETED|Titration Period (4 to 6 Weeks)||0
8363465|NCT01194245|20615920|P3|COMPLETED|Titration Period (4 to 6 Weeks)||0
8363466|NCT01194245|20615921|P2|COMPLETED|Titration Period (4 to 6 Weeks)||0
8363467|NCT01194245|20615922|P1|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
8363468|NCT01194245|20615918|P5|STARTED|Titration Period (4 to 6 Weeks)||0
8363469|NCT01194245|20615919|P4|STARTED|Titration Period (4 to 6 Weeks)||0
8363470|NCT01194245|20615920|P3|STARTED|Titration Period (4 to 6 Weeks)||0
8363471|NCT01194245|20615921|P2|STARTED|Titration Period (4 to 6 Weeks)||0
8363472|NCT01194245|20615922|P1|STARTED|Titration Period (4 to 6 Weeks)||135
8363473|NCT01194219|20615943|P10|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
8363474|NCT01194219|20615944|P9|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
8363475|NCT01194219|20615945|P8|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363476|NCT01194219|20615946|P7|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363477|NCT01194219|20615947|P6|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363478|NCT01194219|20615948|P5|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363479|NCT01194219|20615949|P4|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363480|NCT01194219|20615950|P3|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363481|NCT01194219|20615951|P2|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363482|NCT01194219|20615952|P1|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363483|NCT01194219|20615943|P10|COMPLETED|Long-Term Extension Weeks 52 to 260||41
8363484|NCT01194219|20615944|P9|COMPLETED|Long-Term Extension Weeks 52 to 260||86
8363485|NCT01194219|20615945|P8|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363486|NCT01194219|20615946|P7|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363487|NCT01194219|20615947|P6|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363488|NCT01194219|20615948|P5|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363489|NCT01194219|20615949|P4|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363490|NCT01194219|20615950|P3|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363491|NCT01194219|20615951|P2|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363492|NCT01194219|20615952|P1|COMPLETED|Long-Term Extension Weeks 52 to 260||0
8363493|NCT01194219|20615943|P10|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
8363561|NCT01194219|20615951|P2|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363494|NCT01194219|20615944|P9|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
8363495|NCT01194219|20615945|P8|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363496|NCT01194219|20615946|P7|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363497|NCT01194219|20615947|P6|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363498|NCT01194219|20615948|P5|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363499|NCT01194219|20615949|P4|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363500|NCT01194219|20615950|P3|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363501|NCT01194219|20615951|P2|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363502|NCT01194219|20615952|P1|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
8363503|NCT01194219|20615943|P10|STARTED|Long-Term Extension Weeks 52 to 260||153
8363504|NCT01194219|20615944|P9|STARTED|Long-Term Extension Weeks 52 to 260||306
8363505|NCT01194219|20615945|P8|STARTED|Long-Term Extension Weeks 52 to 260||0
8363506|NCT01194219|20615946|P7|STARTED|Long-Term Extension Weeks 52 to 260||0
8363507|NCT01194219|20615947|P6|STARTED|Long-Term Extension Weeks 52 to 260||0
8363508|NCT01194219|20615948|P5|STARTED|Long-Term Extension Weeks 52 to 260||0
8363509|NCT01194219|20615949|P4|STARTED|Long-Term Extension Weeks 52 to 260||0
8363510|NCT01194219|20615950|P3|STARTED|Long-Term Extension Weeks 52 to 260||0
8363511|NCT01194219|20615951|P2|STARTED|Long-Term Extension Weeks 52 to 260||0
8363512|NCT01194219|20615952|P1|STARTED|Long-Term Extension Weeks 52 to 260||0
8363513|NCT01194219|20615943|P10|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363514|NCT01194219|20615944|P9|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363515|NCT01194219|20615945|P8|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
8363516|NCT01194219|20615946|P7|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
8363517|NCT01194219|20615947|P6|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
8363518|NCT01194219|20615948|P5|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
8363519|NCT01194219|20615949|P4|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363520|NCT01194219|20615950|P3|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363521|NCT01194219|20615951|P2|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363522|NCT01194219|20615952|P1|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363523|NCT01194219|20615943|P10|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363524|NCT01194219|20615944|P9|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363525|NCT01194219|20615945|P8|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
8363526|NCT01194219|20615946|P7|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
8363527|NCT01194219|20615947|P6|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
8363528|NCT01194219|20615948|P5|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
8363529|NCT01194219|20615949|P4|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363530|NCT01194219|20615950|P3|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363531|NCT01194219|20615951|P2|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363532|NCT01194219|20615952|P1|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
8363533|NCT01194219|20615943|P10|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363534|NCT01194219|20615944|P9|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363535|NCT01194219|20615945|P8|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
8363536|NCT01194219|20615946|P7|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
8363537|NCT01194219|20615947|P6|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363538|NCT01194219|20615948|P5|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363539|NCT01194219|20615949|P4|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363540|NCT01194219|20615950|P3|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363541|NCT01194219|20615951|P2|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363542|NCT01194219|20615952|P1|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
8363543|NCT01194219|20615943|P10|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8363544|NCT01194219|20615944|P9|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8363545|NCT01194219|20615945|P8|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
8363546|NCT01194219|20615946|P7|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
8363547|NCT01194219|20615947|P6|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
8363548|NCT01194219|20615948|P5|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
8363549|NCT01194219|20615949|P4|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8363550|NCT01194219|20615950|P3|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8363551|NCT01194219|20615951|P2|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8363552|NCT01194219|20615952|P1|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
8363553|NCT01194219|20615943|P10|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363554|NCT01194219|20615944|P9|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363555|NCT01194219|20615945|P8|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363556|NCT01194219|20615946|P7|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363557|NCT01194219|20615947|P6|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363558|NCT01194219|20615948|P5|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363559|NCT01194219|20615949|P4|NOT COMPLETED|Maintenance Phase Weeks16-32||30
8363560|NCT01194219|20615950|P3|NOT COMPLETED|Maintenance Phase Weeks16-32||70
8363562|NCT01194219|20615952|P1|NOT COMPLETED|Maintenance Phase Weeks16-32||0
8363563|NCT01194219|20615943|P10|COMPLETED|Maintenance Phase Weeks16-32||0
8363564|NCT01194219|20615944|P9|COMPLETED|Maintenance Phase Weeks16-32||0
8363565|NCT01194219|20615945|P8|COMPLETED|Maintenance Phase Weeks16-32||0
8363566|NCT01194219|20615946|P7|COMPLETED|Maintenance Phase Weeks16-32||0
8363567|NCT01194219|20615947|P6|COMPLETED|Maintenance Phase Weeks16-32||0
8363568|NCT01194219|20615948|P5|COMPLETED|Maintenance Phase Weeks16-32||0
8363569|NCT01194219|20615949|P4|COMPLETED|Maintenance Phase Weeks16-32||215
8363570|NCT01194219|20615950|P3|COMPLETED|Maintenance Phase Weeks16-32||424
8363571|NCT01194219|20615951|P2|COMPLETED|Maintenance Phase Weeks16-32||0
8363572|NCT01194219|20615952|P1|COMPLETED|Maintenance Phase Weeks16-32||0
8363573|NCT01194219|20615943|P10|Received Apremilast|Maintenance Phase Weeks16-32||0
8363574|NCT01194219|20615944|P9|Received Apremilast|Maintenance Phase Weeks16-32||0
8363575|NCT01194219|20615945|P8|Received Apremilast|Maintenance Phase Weeks16-32||0
8363576|NCT01194219|20615946|P7|Received Apremilast|Maintenance Phase Weeks16-32||0
8363577|NCT01194219|20615947|P6|Received Apremilast|Maintenance Phase Weeks16-32||0
8363578|NCT01194219|20615948|P5|Received Apremilast|Maintenance Phase Weeks16-32||0
8363579|NCT01194219|20615949|P4|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
8363580|NCT01194219|20615950|P3|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
8363581|NCT01194219|20615951|P2|Received Apremilast|Maintenance Phase Weeks16-32||0
8363582|NCT01194219|20615952|P1|Received Apremilast|Maintenance Phase Weeks16-32||0
8363583|NCT01194219|20615943|P10|STARTED|Maintenance Phase Weeks16-32||0
8363584|NCT01194219|20615944|P9|STARTED|Maintenance Phase Weeks16-32||0
8363585|NCT01194219|20615945|P8|STARTED|Maintenance Phase Weeks16-32||0
8363586|NCT01194219|20615946|P7|STARTED|Maintenance Phase Weeks16-32||0
8363587|NCT01194219|20615947|P6|STARTED|Maintenance Phase Weeks16-32||0
8363588|NCT01194219|20615948|P5|STARTED|Maintenance Phase Weeks16-32||0
8363589|NCT01194219|20615949|P4|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
8363590|NCT01194219|20615950|P3|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
8363591|NCT01194219|20615951|P2|STARTED|Maintenance Phase Weeks16-32||0
8363592|NCT01194219|20615952|P1|STARTED|Maintenance Phase Weeks16-32||0
8363593|NCT01194219|20615943|P10|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363594|NCT01194219|20615944|P9|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363595|NCT01194219|20615945|P8|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363596|NCT01194219|20615946|P7|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363597|NCT01194219|20615947|P6|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363598|NCT01194219|20615948|P5|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363599|NCT01194219|20615949|P4|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363600|NCT01194219|20615950|P3|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363601|NCT01194219|20615951|P2|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
8363602|NCT01194219|20615952|P1|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
8363603|NCT01194219|20615943|P10|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363604|NCT01194219|20615944|P9|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363605|NCT01194219|20615945|P8|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363606|NCT01194219|20615946|P7|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363607|NCT01194219|20615947|P6|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363608|NCT01194219|20615948|P5|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363609|NCT01194219|20615949|P4|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363610|NCT01194219|20615950|P3|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
8363611|NCT01194219|20615951|P2|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
8363612|NCT01194219|20615952|P1|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
8363613|NCT01194219|20615943|P10|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363614|NCT01194219|20615944|P9|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363615|NCT01194219|20615945|P8|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363616|NCT01194219|20615946|P7|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363617|NCT01194219|20615947|P6|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363618|NCT01194219|20615948|P5|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363619|NCT01194219|20615949|P4|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363620|NCT01194219|20615950|P3|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
8363621|NCT01194219|20615951|P2|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
8363622|NCT01194219|20615952|P1|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
8363623|NCT01194219|20615943|P10|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363624|NCT01194219|20615944|P9|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363625|NCT01194219|20615945|P8|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363626|NCT01194219|20615946|P7|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363627|NCT01194219|20615947|P6|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363628|NCT01194219|20615948|P5|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363629|NCT01194219|20615949|P4|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363630|NCT01194219|20615950|P3|STARTED|Placebo-Controlled Phase Weeks 0-16||0
8363631|NCT01194219|20615951|P2|STARTED|Placebo-Controlled Phase Weeks 0-16||282
8363632|NCT01194219|20615952|P1|STARTED|Placebo-Controlled Phase Weeks 0-16||562
8363633|NCT01194154|20615986|P2|NOT COMPLETED|Overall Study||33
8363634|NCT01194154|20615987|P1|NOT COMPLETED|Overall Study||49
8363635|NCT01194154|20615986|P2|COMPLETED|Overall Study||91
8363636|NCT01194154|20615987|P1|COMPLETED|Overall Study||68
8363637|NCT01194154|20615986|P2|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
8363638|NCT01194154|20615987|P1|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
8363639|NCT01194154|20615986|P2|Full Analysis Set|Overall Study||120
8363640|NCT01194154|20615987|P1|Full Analysis Set|Overall Study||115
8363641|NCT01194154|20615986|P2|STARTED|Overall Study||124
8363642|NCT01194154|20615987|P1|STARTED|Overall Study||117
8363643|NCT01194089|20616007|P2|NOT COMPLETED|Overall Study||0
8363644|NCT01194089|20616008|P1|NOT COMPLETED|Overall Study||0
8363645|NCT01194089|20616007|P2|COMPLETED|Overall Study||47
8363646|NCT01194089|20616008|P1|COMPLETED|Overall Study||42
8363647|NCT01194089|20616007|P2|STARTED|Overall Study||47
8363648|NCT01194089|20616008|P1|STARTED|Overall Study||42
8363649|NCT01193920|20616028|P10|NOT COMPLETED|Overall Study||7
8363650|NCT01193920|20616029|P9|NOT COMPLETED|Overall Study||5
8363651|NCT01193920|20616030|P8|NOT COMPLETED|Overall Study||4
8363652|NCT01193920|20616031|P7|NOT COMPLETED|Overall Study||6
8363653|NCT01193920|20616032|P6|NOT COMPLETED|Overall Study||4
8363654|NCT01193920|20616033|P5|NOT COMPLETED|Overall Study||6
8363655|NCT01193920|20616034|P4|NOT COMPLETED|Overall Study||4
8363656|NCT01193920|20616035|P3|NOT COMPLETED|Overall Study||6
8363657|NCT01193920|20616036|P2|NOT COMPLETED|Overall Study||0
8363658|NCT01193920|20616037|P1|NOT COMPLETED|Overall Study||3
8363659|NCT01193920|20616028|P10|COMPLETED|Overall Study||74
8363660|NCT01193920|20616029|P9|COMPLETED|Overall Study||71
8363661|NCT01193920|20616030|P8|COMPLETED|Overall Study||76
8363662|NCT01193920|20616031|P7|COMPLETED|Overall Study||74
8363663|NCT01193920|20616032|P6|COMPLETED|Overall Study||76
8363664|NCT01193920|20616033|P5|COMPLETED|Overall Study||74
8363665|NCT01193920|20616034|P4|COMPLETED|Overall Study||76
8363666|NCT01193920|20616035|P3|COMPLETED|Overall Study||74
8363667|NCT01193920|20616036|P2|COMPLETED|Overall Study||20
8363668|NCT01193920|20616037|P1|COMPLETED|Overall Study||37
8363669|NCT01193920|20616028|P10|STARTED|Overall Study||81
8363670|NCT01193920|20616029|P9|STARTED|Overall Study||76
8363671|NCT01193920|20616030|P8|STARTED|Overall Study||80
8363672|NCT01193920|20616031|P7|STARTED|Overall Study||80
8363673|NCT01193920|20616032|P6|STARTED|Overall Study||80
8363674|NCT01193920|20616033|P5|STARTED|Overall Study||80
8363675|NCT01193920|20616034|P4|STARTED|Overall Study||80
8363676|NCT01193920|20616035|P3|STARTED|Overall Study||80
8363677|NCT01193920|20616036|P2|STARTED|Overall Study||20
8363678|NCT01193920|20616037|P1|STARTED|Overall Study||40
8363679|NCT01193907|20616091|P4|NOT COMPLETED|Overall Study||1
8363680|NCT01193907|20616092|P3|NOT COMPLETED|Overall Study||0
8363681|NCT01193907|20616093|P2|NOT COMPLETED|Overall Study||0
8363682|NCT01193907|20616094|P1|NOT COMPLETED|Overall Study||1
8363683|NCT01193907|20616091|P4|COMPLETED|Overall Study||21
8363684|NCT01193907|20616092|P3|COMPLETED|Overall Study||22
8363685|NCT01193907|20616093|P2|COMPLETED|Overall Study||22
8363686|NCT01193907|20616094|P1|COMPLETED|Overall Study||21
8363687|NCT01193907|20616091|P4|STARTED|Overall Study||22
8363688|NCT01193907|20616092|P3|STARTED|Overall Study||22
8363689|NCT01193907|20616093|P2|STARTED|Overall Study||22
8363690|NCT01193907|20616094|P1|STARTED|Overall Study||22
8363691|NCT01193868|20616116|P1|NOT COMPLETED|Overall Study||0
8363692|NCT01193868|20616116|P1|COMPLETED|Overall Study||6
8363693|NCT01193868|20616116|P1|STARTED|Overall Study||6
8363769|NCT01193686|20616172|P2|NOT COMPLETED|Overall Study||1
8363770|NCT01193686|20616173|P1|NOT COMPLETED|Overall Study||7
8363771|NCT01193686|20616172|P2|COMPLETED|Overall Study||8
8363772|NCT01193686|20616173|P1|COMPLETED|Overall Study||8
8363773|NCT01193686|20616172|P2|Completed Visits and Final Assessment|Overall Study||8
8363774|NCT01193686|20616173|P1|Completed Visits and Final Assessment|Overall Study||8
8363775|NCT01193686|20616172|P2|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
8363776|NCT01193686|20616173|P1|Completed Mentor Training|Overall Study||9
8363777|NCT01193686|20616172|P2|Completed Baseline Assessment|Overall Study||9
8363778|NCT01193686|20616173|P1|Completed Baseline Assessment|Overall Study||15
8363779|NCT01193686|20616172|P2|STARTED|Overall Study||9
8363780|NCT01193686|20616173|P1|STARTED|Overall Study||15
8363781|NCT01193660|20616190|P3|NOT COMPLETED|Overall Study||2
8363782|NCT01193660|20616191|P2|NOT COMPLETED|Overall Study||3
8363783|NCT01193660|20616192|P1|NOT COMPLETED|Overall Study||4
8363784|NCT01193660|20616190|P3|COMPLETED|Overall Study||32
8363785|NCT01193660|20616191|P2|COMPLETED|Overall Study||33
8363786|NCT01193660|20616192|P1|COMPLETED|Overall Study||31
8363787|NCT01193660|20616190|P3|STARTED|Overall Study||34
8363788|NCT01193660|20616191|P2|STARTED|Overall Study||36
8363789|NCT01193660|20616192|P1|STARTED|Overall Study||35
8363790|NCT01193608|20616236|P6|NOT COMPLETED|Overall Study||2
8363791|NCT01193608|20616237|P5|NOT COMPLETED|Overall Study||5
8363792|NCT01193608|20616238|P4|NOT COMPLETED|Overall Study||3
8363793|NCT01193608|20616239|P3|NOT COMPLETED|Overall Study||2
8363794|NCT01193608|20616240|P2|NOT COMPLETED|Overall Study||2
8363795|NCT01193608|20616241|P1|NOT COMPLETED|Overall Study||0
8363796|NCT01193608|20616236|P6|COMPLETED|Overall Study||17
8363797|NCT01193608|20616237|P5|COMPLETED|Overall Study||19
8363798|NCT01193608|20616238|P4|COMPLETED|Overall Study||14
8363799|NCT01193608|20616239|P3|COMPLETED|Overall Study||14
8363800|NCT01193608|20616240|P2|COMPLETED|Overall Study||4
8363801|NCT01193608|20616241|P1|COMPLETED|Overall Study||6
8363802|NCT01193608|20616236|P6|STARTED|Overall Study||19
8363803|NCT01193608|20616237|P5|STARTED|Overall Study||24
8363804|NCT01193608|20616238|P4|STARTED|Overall Study||17
8363805|NCT01193608|20616239|P3|STARTED|Overall Study||16
8363806|NCT01193608|20616240|P2|STARTED|Overall Study||6
8363807|NCT01193608|20616241|P1|STARTED|Overall Study||6
8363808|NCT01193582|20616478|P4|NOT COMPLETED|12 Month Follow-up||11
8363809|NCT01193582|20616479|P3|NOT COMPLETED|12 Month Follow-up||4
8363810|NCT01193582|20616480|P2|NOT COMPLETED|12 Month Follow-up||0
8363811|NCT01193582|20616481|P1|NOT COMPLETED|12 Month Follow-up||6
8363812|NCT01193582|20616478|P4|COMPLETED|12 Month Follow-up||166
8363813|NCT01193582|20616479|P3|COMPLETED|12 Month Follow-up||113
8363814|NCT01193582|20616480|P2|COMPLETED|12 Month Follow-up||88
8363815|NCT01193582|20616481|P1|COMPLETED|12 Month Follow-up||83
8363816|NCT01193582|20616478|P4|STARTED|12 Month Follow-up||177
8363817|NCT01193582|20616479|P3|STARTED|12 Month Follow-up||117
8363818|NCT01193582|20616480|P2|STARTED|12 Month Follow-up||88
8363819|NCT01193582|20616481|P1|STARTED|12 Month Follow-up||89
8363820|NCT01193582|20616478|P4|NOT COMPLETED|Vaccination Series||3
8363821|NCT01193582|20616479|P3|NOT COMPLETED|Vaccination Series||8
8363822|NCT01193582|20616480|P2|NOT COMPLETED|Vaccination Series||13
8363823|NCT01193582|20616481|P1|NOT COMPLETED|Vaccination Series||11
8363824|NCT01193582|20616478|P4|COMPLETED|Vaccination Series||177
8363825|NCT01193582|20616479|P3|COMPLETED|Vaccination Series||117
8363826|NCT01193582|20616480|P2|COMPLETED|Vaccination Series||88
8363827|NCT01193582|20616481|P1|COMPLETED|Vaccination Series||89
8363828|NCT01193582|20616478|P4|Vaccinated Dose 4|Vaccination Series||0
8363829|NCT01193582|20616479|P3|Vaccinated Dose 4|Vaccination Series||0
8363830|NCT01193582|20616480|P2|Vaccinated Dose 4|Vaccination Series||0
8363831|NCT01193582|20616481|P1|Vaccinated Dose 4|Vaccination Series||90
8363832|NCT01193582|20616478|P4|Vaccinated Dose 3|Vaccination Series||0
8363833|NCT01193582|20616479|P3|Vaccinated Dose 3|Vaccination Series||0
8363834|NCT01193582|20616480|P2|Vaccinated Dose 3|Vaccination Series||89
8363835|NCT01193582|20616481|P1|Vaccinated Dose 3|Vaccination Series||90
8363836|NCT01193582|20616478|P4|Vaccinated Dose 2|Vaccination Series||0
8363837|NCT01193582|20616479|P3|Vaccinated Dose 2|Vaccination Series||118
8363838|NCT01193582|20616480|P2|Vaccinated Dose 2|Vaccination Series||91
8363839|NCT01193582|20616481|P1|Vaccinated Dose 2|Vaccination Series||92
8363840|NCT01193582|20616478|P4|Vaccinated Dose 1|Vaccination Series||180
8363841|NCT01193582|20616479|P3|Vaccinated Dose 1|Vaccination Series||125
8363842|NCT01193582|20616480|P2|Vaccinated Dose 1|Vaccination Series||100
8363843|NCT01193582|20616481|P1|Vaccinated Dose 1|Vaccination Series||100
8363844|NCT01193582|20616478|P4|STARTED|Vaccination Series||180
8363845|NCT01193582|20616479|P3|STARTED|Vaccination Series||125
8363846|NCT01193582|20616480|P2|STARTED|Vaccination Series||101
8363847|NCT01193582|20616481|P1|STARTED|Vaccination Series||100
8363848|NCT01193556|20616511|P2|NOT COMPLETED|Overall Study||25
8363849|NCT01193556|20616512|P1|NOT COMPLETED|Overall Study||26
8363850|NCT01193556|20616511|P2|COMPLETED|Overall Study||0
8363851|NCT01193556|20616512|P1|COMPLETED|Overall Study||0
8363852|NCT01193556|20616511|P2|STARTED|Overall Study||25
8363853|NCT01193556|20616512|P1|STARTED|Overall Study||26
8363854|NCT01193530|20616522|P2|NOT COMPLETED|Overall Study||5
8363855|NCT01193530|20616523|P1|NOT COMPLETED|Overall Study||3
8363856|NCT01193530|20616522|P2|COMPLETED|Overall Study||3
8363857|NCT01193530|20616523|P1|COMPLETED|Overall Study||1
8363858|NCT01193530|20616522|P2|STARTED|Overall Study||8
8363859|NCT01193530|20616523|P1|STARTED|Overall Study||4
8363860|NCT01193517|20616532|P3|NOT COMPLETED|Overall Study||0
8363861|NCT01193517|20616533|P2|NOT COMPLETED|Overall Study||0
8363862|NCT01193517|20616534|P1|NOT COMPLETED|Overall Study||1
8363863|NCT01193517|20616532|P3|COMPLETED|Overall Study||11
8363864|NCT01193517|20616533|P2|COMPLETED|Overall Study||12
8363865|NCT01193517|20616534|P1|COMPLETED|Overall Study||2
8363866|NCT01193517|20616532|P3|STARTED|Overall Study||11
8363867|NCT01193517|20616533|P2|STARTED|Overall Study||12
8363868|NCT01193517|20616534|P1|STARTED|Overall Study||3
8363869|NCT01193348|20616543|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
8363870|NCT01193348|20616543|P1|COMPLETED|Post Treatment Period (Patients Who Disc||8
8363871|NCT01193348|20616543|P1|STARTED|Post Treatment Period (Patients Who Disc||10
8363872|NCT01193348|20616543|P1|NOT COMPLETED|Extension Treatment Period||1
8363873|NCT01193348|20616543|P1|COMPLETED|Extension Treatment Period||16
8363874|NCT01193348|20616543|P1|STARTED|Extension Treatment Period||17
8363875|NCT01193348|20616543|P1|NOT COMPLETED|Treatment Period (26 Weeks)||3
8363876|NCT01193348|20616543|P1|COMPLETED|Treatment Period (26 Weeks)||19
8363877|NCT01193348|20616543|P1|STARTED|Treatment Period (26 Weeks)||22
8363878|NCT01193348|20616543|P1|NOT COMPLETED|Screening Period||5
8363879|NCT01193348|20616543|P1|COMPLETED|Screening Period||22
8363880|NCT01193348|20616543|P1|STARTED|Screening Period||27
8363881|NCT01193335|20616563|P2|NOT COMPLETED|2-Year Follow-up||8
8363882|NCT01193335|20616564|P1|NOT COMPLETED|2-Year Follow-up||7
8363883|NCT01193335|20616563|P2|COMPLETED|2-Year Follow-up||80
8363884|NCT01193335|20616564|P1|COMPLETED|2-Year Follow-up||81
8363885|NCT01193335|20616563|P2|STARTED|2-Year Follow-up||88
8363886|NCT01193335|20616564|P1|STARTED|2-Year Follow-up||88
8363887|NCT01193335|20616563|P2|NOT COMPLETED|1-Year Follow-up||9
8363888|NCT01193335|20616564|P1|NOT COMPLETED|1-Year Follow-up||11
8363889|NCT01193335|20616563|P2|COMPLETED|1-Year Follow-up||88
8363890|NCT01193335|20616564|P1|COMPLETED|1-Year Follow-up||88
8363891|NCT01193335|20616563|P2|STARTED|1-Year Follow-up||97
8363892|NCT01193335|20616564|P1|STARTED|1-Year Follow-up||99
8363893|NCT01193335|20616563|P2|NOT COMPLETED|Toddler Dose||0
8363894|NCT01193335|20616564|P1|NOT COMPLETED|Toddler Dose||0
8363895|NCT01193335|20616563|P2|COMPLETED|Toddler Dose||97
8363896|NCT01193335|20616564|P1|COMPLETED|Toddler Dose||99
8363897|NCT01193335|20616563|P2|STARTED|Toddler Dose||97
8363898|NCT01193335|20616564|P1|STARTED|Toddler Dose||99
8363899|NCT01193335|20616563|P2|NOT COMPLETED|After Infant Series||3
8363900|NCT01193335|20616564|P1|NOT COMPLETED|After Infant Series||1
8363901|NCT01193335|20616563|P2|COMPLETED|After Infant Series||97
8363902|NCT01193335|20616564|P1|COMPLETED|After Infant Series||99
8363903|NCT01193335|20616563|P2|STARTED|After Infant Series||100
8363904|NCT01193335|20616564|P1|STARTED|After Infant Series||100
8363905|NCT01193335|20616563|P2|NOT COMPLETED|Infant Series||0
8363906|NCT01193335|20616564|P1|NOT COMPLETED|Infant Series||0
8363907|NCT01193335|20616563|P2|COMPLETED|Infant Series||100
8363908|NCT01193335|20616564|P1|COMPLETED|Infant Series||100
8363909|NCT01193335|20616563|P2|STARTED|Infant Series||100
8363910|NCT01193335|20616564|P1|STARTED|Infant Series||100
8363911|NCT01193283|20616659|P1|NOT COMPLETED|Overall Study||1
8363912|NCT01193283|20616659|P1|COMPLETED|Overall Study||21
8363913|NCT01193283|20616659|P1|STARTED|Overall Study||22
8363914|NCT01193257|20616665|P2|NOT COMPLETED|Overall Study||734
8363915|NCT01193257|20616666|P1|NOT COMPLETED|Overall Study||365
8363916|NCT01193257|20616665|P2|COMPLETED|Overall Study||0
8363917|NCT01193257|20616666|P1|COMPLETED|Overall Study||0
8363918|NCT01193257|20616665|P2|Treated|Overall Study||732
8363919|NCT01193257|20616666|P1|Treated|Overall Study||363
8363920|NCT01193257|20616665|P2|STARTED|Overall Study||734
8363921|NCT01193257|20616666|P1|STARTED|Overall Study||365
8363922|NCT01193244|20616716|P2|NOT COMPLETED|Overall Study||390
8363923|NCT01193244|20616717|P1|NOT COMPLETED|Overall Study||388
8363924|NCT01193244|20616716|P2|COMPLETED|Overall Study||391
8363925|NCT01193244|20616717|P1|COMPLETED|Overall Study||391
8363926|NCT01193244|20616716|P2|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
8363927|NCT01193244|20616717|P1|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
8363928|NCT01193244|20616716|P2|STARTED|Overall Study||781
8363929|NCT01193244|20616717|P1|STARTED|Overall Study||779
8363930|NCT01193218|20616772|P8|NOT COMPLETED|12-52 Weeks||4
8363931|NCT01193218|20616773|P7|NOT COMPLETED|12-52 Weeks||3
8363932|NCT01193218|20616774|P6|NOT COMPLETED|12-52 Weeks||5
8363933|NCT01193218|20616775|P5|NOT COMPLETED|12-52 Weeks||4
8363934|NCT01193218|20616776|P4|NOT COMPLETED|12-52 Weeks||3
8363935|NCT01193218|20616777|P3|NOT COMPLETED|12-52 Weeks||4
8363936|NCT01193218|20616778|P2|NOT COMPLETED|12-52 Weeks||0
8363937|NCT01193218|20616779|P1|NOT COMPLETED|12-52 Weeks||5
8363938|NCT01193218|20616772|P8|COMPLETED|12-52 Weeks||49
8363939|NCT01193218|20616773|P7|COMPLETED|12-52 Weeks||51
8363940|NCT01193218|20616774|P6|COMPLETED|12-52 Weeks||101
8363941|NCT01193218|20616775|P5|COMPLETED|12-52 Weeks||104
8363942|NCT01193218|20616776|P4|COMPLETED|12-52 Weeks||50
8363943|NCT01193218|20616777|P3|COMPLETED|12-52 Weeks||50
8363944|NCT01193218|20616778|P2|COMPLETED|12-52 Weeks||50
8363945|NCT01193218|20616779|P1|COMPLETED|12-52 Weeks||45
8363946|NCT01193218|20616772|P8|STARTED|12-52 Weeks||53
8363947|NCT01193218|20616773|P7|STARTED|12-52 Weeks||54
8363948|NCT01193218|20616774|P6|STARTED|12-52 Weeks||106
8363949|NCT01193218|20616775|P5|STARTED|12-52 Weeks||108
8363950|NCT01193218|20616776|P4|STARTED|12-52 Weeks||53
8363951|NCT01193218|20616777|P3|STARTED|12-52 Weeks||54
8363952|NCT01193218|20616778|P2|STARTED|12-52 Weeks||50
8363953|NCT01193218|20616779|P1|STARTED|12-52 Weeks||50
8363954|NCT01193218|20616772|P8|NOT COMPLETED|0-12 Weeks||0
8363955|NCT01193218|20616773|P7|NOT COMPLETED|0-12 Weeks||3
8363956|NCT01193218|20616774|P6|NOT COMPLETED|0-12 Weeks||3
8363957|NCT01193218|20616775|P5|NOT COMPLETED|0-12 Weeks||1
8363958|NCT01193218|20616776|P4|NOT COMPLETED|0-12 Weeks||0
8363959|NCT01193218|20616777|P3|NOT COMPLETED|0-12 Weeks||3
8363960|NCT01193218|20616778|P2|NOT COMPLETED|0-12 Weeks||0
8363961|NCT01193218|20616779|P1|NOT COMPLETED|0-12 Weeks||9
8363962|NCT01193218|20616772|P8|COMPLETED|0-12 Weeks||0
8363963|NCT01193218|20616773|P7|COMPLETED|0-12 Weeks||107
8363964|NCT01193218|20616774|P6|COMPLETED|0-12 Weeks||106
8363965|NCT01193218|20616775|P5|COMPLETED|0-12 Weeks||108
8363966|NCT01193218|20616776|P4|COMPLETED|0-12 Weeks||0
8363967|NCT01193218|20616777|P3|COMPLETED|0-12 Weeks||107
8363968|NCT01193218|20616778|P2|COMPLETED|0-12 Weeks||0
8363969|NCT01193218|20616779|P1|COMPLETED|0-12 Weeks||100
8363970|NCT01193218|20616772|P8|STARTED|0-12 Weeks|It is actually N/A|0
8363971|NCT01193218|20616773|P7|STARTED|0-12 Weeks|It is actually empa 50mg group|110
8363972|NCT01193218|20616774|P6|STARTED|0-12 Weeks||109
8363973|NCT01193218|20616775|P5|STARTED|0-12 Weeks||109
8363974|NCT01193218|20616776|P4|STARTED|0-12 Weeks|It is actually N/A|0
8363975|NCT01193218|20616777|P3|STARTED|0-12 Weeks|It is actually empa 5mg group|110
8363976|NCT01193218|20616778|P2|STARTED|0-12 Weeks|It is actually N/A|0
8363977|NCT01193218|20616779|P1|STARTED|0-12 Weeks|It is actually placebo group|109
8363978|NCT01193153|20616810|P2|NOT COMPLETED|Double Blind Relapse Prevention Period||105
8363979|NCT01193153|20616811|P1|NOT COMPLETED|Double Blind Relapse Prevention Period||64
8363980|NCT01193153|20616810|P2|COMPLETED|Double Blind Relapse Prevention Period||65
8363981|NCT01193153|20616811|P1|COMPLETED|Double Blind Relapse Prevention Period||100
8363982|NCT01193153|20616810|P2|STARTED|Double Blind Relapse Prevention Period||170
8363983|NCT01193153|20616811|P1|STARTED|Double Blind Relapse Prevention Period||164
8363984|NCT01193153|20616810|P2|NOT COMPLETED|Open-label Stabilization Period||0
8363985|NCT01193153|20616811|P1|NOT COMPLETED|Open-label Stabilization Period||98
8363986|NCT01193153|20616810|P2|COMPLETED|Open-label Stabilization Period||0
8363987|NCT01193153|20616811|P1|COMPLETED|Open-label Stabilization Period||334
8363988|NCT01193153|20616810|P2|STARTED|Open-label Stabilization Period||0
8363989|NCT01193153|20616811|P1|STARTED|Open-label Stabilization Period||432
8363990|NCT01193153|20616810|P2|NOT COMPLETED|Open-label Lead in Period||0
8363991|NCT01193153|20616811|P1|NOT COMPLETED|Open-label Lead in Period||235
8363992|NCT01193153|20616810|P2|COMPLETED|Open-label Lead in Period||0
8363993|NCT01193153|20616811|P1|COMPLETED|Open-label Lead in Period||432
8363994|NCT01193153|20616810|P2|STARTED|Open-label Lead in Period||0
8363995|NCT01193153|20616811|P1|STARTED|Open-label Lead in Period||667
8363996|NCT01193127|20616846|P4|NOT COMPLETED|Treated||1
8363997|NCT01193127|20616847|P3|NOT COMPLETED|Treated||0
8363998|NCT01193127|20616848|P2|NOT COMPLETED|Treated||0
8363999|NCT01193127|20616849|P1|NOT COMPLETED|Treated||0
8364000|NCT01193127|20616846|P4|COMPLETED|Treated||55
8364001|NCT01193127|20616847|P3|COMPLETED|Treated||55
8364002|NCT01193127|20616848|P2|COMPLETED|Treated||54
8364003|NCT01193127|20616849|P1|COMPLETED|Treated||57
8364004|NCT01193127|20616846|P4|STARTED|Treated||56
8364005|NCT01193127|20616847|P3|STARTED|Treated||55
8364006|NCT01193127|20616848|P2|STARTED|Treated||54
8364007|NCT01193127|20616849|P1|STARTED|Treated||57
8364008|NCT01193127|20616846|P4|NOT COMPLETED|Randomized||1
8364009|NCT01193127|20616847|P3|NOT COMPLETED|Randomized||0
8364010|NCT01193127|20616848|P2|NOT COMPLETED|Randomized||0
8364011|NCT01193127|20616849|P1|NOT COMPLETED|Randomized||0
8364012|NCT01193127|20616846|P4|COMPLETED|Randomized||56
8364013|NCT01193127|20616847|P3|COMPLETED|Randomized||55
8364014|NCT01193127|20616848|P2|COMPLETED|Randomized||54
8364015|NCT01193127|20616849|P1|COMPLETED|Randomized||57
8364016|NCT01193127|20616846|P4|STARTED|Randomized||57
8364017|NCT01193127|20616847|P3|STARTED|Randomized||55
8364018|NCT01193127|20616848|P2|STARTED|Randomized||54
8364019|NCT01193127|20616849|P1|STARTED|Randomized||57
8364020|NCT01193114|20617153|P2|NOT COMPLETED|Overall Study||0
8364021|NCT01193114|20617154|P1|NOT COMPLETED|Overall Study||0
8364022|NCT01193114|20617153|P2|COMPLETED|Overall Study||30
8364023|NCT01193114|20617154|P1|COMPLETED|Overall Study||30
8364024|NCT01193114|20617153|P2|STARTED|Overall Study||30
8364025|NCT01193114|20617154|P1|STARTED|Overall Study||30
8364026|NCT01193101|20617174|P4|NOT COMPLETED|Overall Study||12
8364027|NCT01193101|20617175|P3|NOT COMPLETED|Overall Study||3
8364028|NCT01193101|20617176|P2|NOT COMPLETED|Overall Study||7
8364029|NCT01193101|20617177|P1|NOT COMPLETED|Overall Study||5
8364030|NCT01193101|20617174|P4|COMPLETED|Overall Study||80
8364031|NCT01193101|20617175|P3|COMPLETED|Overall Study||93
8364032|NCT01193101|20617176|P2|COMPLETED|Overall Study||94
8364033|NCT01193101|20617177|P1|COMPLETED|Overall Study||95
8364034|NCT01193101|20617174|P4|Placebo Withdrawal Set|Overall Study||80
8364035|NCT01193101|20617175|P3|Placebo Withdrawal Set|Overall Study||93
8364036|NCT01193101|20617176|P2|Placebo Withdrawal Set|Overall Study||94
8364037|NCT01193101|20617177|P1|Placebo Withdrawal Set|Overall Study||95
8364038|NCT01193101|20617174|P4|Full Analysis Set|Overall Study||92
8364039|NCT01193101|20617175|P3|Full Analysis Set|Overall Study||96
8364040|NCT01193101|20617176|P2|Full Analysis Set|Overall Study||101
8364041|NCT01193101|20617177|P1|Full Analysis Set|Overall Study||100
8364042|NCT01193101|20617174|P4|STARTED|Overall Study||92
8364043|NCT01193101|20617175|P3|STARTED|Overall Study||96
8364044|NCT01193101|20617176|P2|STARTED|Overall Study||101
8364045|NCT01193101|20617177|P1|STARTED|Overall Study||100
8364046|NCT01193049|20617233|P2|NOT COMPLETED|Period 3 : Double Blind Crossover||0
8364047|NCT01193049|20617234|P1|NOT COMPLETED|Period 3 : Double Blind Crossover||0
8364048|NCT01193049|20617233|P2|COMPLETED|Period 3 : Double Blind Crossover||6
8364049|NCT01193049|20617234|P1|COMPLETED|Period 3 : Double Blind Crossover||5
8364050|NCT01193049|20617233|P2|STARTED|Period 3 : Double Blind Crossover||6
8364051|NCT01193049|20617234|P1|STARTED|Period 3 : Double Blind Crossover||5
8364052|NCT01193049|20617233|P2|NOT COMPLETED|Washout 2 : 21 Day Washout||0
8364053|NCT01193049|20617234|P1|NOT COMPLETED|Washout 2 : 21 Day Washout||0
8364054|NCT01193049|20617233|P2|COMPLETED|Washout 2 : 21 Day Washout||6
8364055|NCT01193049|20617234|P1|COMPLETED|Washout 2 : 21 Day Washout||5
8364056|NCT01193049|20617233|P2|STARTED|Washout 2 : 21 Day Washout||6
8364057|NCT01193049|20617234|P1|STARTED|Washout 2 : 21 Day Washout||5
8364058|NCT01193049|20617233|P2|NOT COMPLETED|Period 2 : Double Blind Crossover||0
8364059|NCT01193049|20617234|P1|NOT COMPLETED|Period 2 : Double Blind Crossover||0
8364060|NCT01193049|20617233|P2|COMPLETED|Period 2 : Double Blind Crossover||6
8364061|NCT01193049|20617234|P1|COMPLETED|Period 2 : Double Blind Crossover||5
8364062|NCT01193049|20617233|P2|STARTED|Period 2 : Double Blind Crossover||6
8364063|NCT01193049|20617234|P1|STARTED|Period 2 : Double Blind Crossover||5
8364064|NCT01193049|20617233|P2|NOT COMPLETED|Washout 1 : 21 Day Washout||0
8364065|NCT01193049|20617234|P1|NOT COMPLETED|Washout 1 : 21 Day Washout||0
8364066|NCT01193049|20617233|P2|COMPLETED|Washout 1 : 21 Day Washout||6
8364067|NCT01193049|20617234|P1|COMPLETED|Washout 1 : 21 Day Washout||5
8364068|NCT01193049|20617233|P2|STARTED|Washout 1 : 21 Day Washout||6
8364069|NCT01193049|20617234|P1|STARTED|Washout 1 : 21 Day Washout||5
8364070|NCT01193049|20617233|P2|NOT COMPLETED|Period 1: Placebo Run-In||0
8364071|NCT01193049|20617234|P1|NOT COMPLETED|Period 1: Placebo Run-In||0
8364072|NCT01193049|20617233|P2|COMPLETED|Period 1: Placebo Run-In||6
8364073|NCT01193049|20617234|P1|COMPLETED|Period 1: Placebo Run-In||5
8364074|NCT01193049|20617233|P2|STARTED|Period 1: Placebo Run-In||6
8364075|NCT01193049|20617234|P1|STARTED|Period 1: Placebo Run-In||5
8364076|NCT01193010|20617266|P2|NOT COMPLETED|Overall Study||0
8364077|NCT01193010|20617267|P1|NOT COMPLETED|Overall Study||3
8364078|NCT01193010|20617266|P2|COMPLETED|Overall Study||20
8364079|NCT01193010|20617267|P1|COMPLETED|Overall Study||17
8364080|NCT01193010|20617266|P2|STARTED|Overall Study||20
8364081|NCT01193010|20617267|P1|STARTED|Overall Study||20
8364082|NCT01192828|20617279|P1|NOT COMPLETED|Overall Study||0
8364083|NCT01192828|20617279|P1|COMPLETED|Overall Study||14
8364084|NCT01192828|20617279|P1|STARTED|Overall Study||14
8364085|NCT01192815|20617294|P1|NOT COMPLETED|Overall Study||2
8364086|NCT01192815|20617294|P1|COMPLETED|Overall Study||0
8364087|NCT01192815|20617294|P1|STARTED|Overall Study||2
8364108|NCT01192698|20617368|P2|NOT COMPLETED|Overall Study||0
8364109|NCT01192698|20617369|P1|NOT COMPLETED|Overall Study||0
8364110|NCT01192698|20617368|P2|COMPLETED|Overall Study||5
8364111|NCT01192698|20617369|P1|COMPLETED|Overall Study||10
8364112|NCT01192698|20617368|P2|STARTED|Overall Study||5
8364113|NCT01192698|20617369|P1|STARTED|Overall Study||10
8364114|NCT01192542|20617375|P2|NOT COMPLETED|Period 2||0
8364115|NCT01192542|20617376|P1|NOT COMPLETED|Period 2||0
8364116|NCT01192542|20617375|P2|COMPLETED|Period 2||20
8364117|NCT01192542|20617376|P1|COMPLETED|Period 2||18
8364118|NCT01192542|20617375|P2|STARTED|Period 2||20
8364119|NCT01192542|20617376|P1|STARTED|Period 2||18
8364120|NCT01192542|20617375|P2|NOT COMPLETED|Period 1||0
8364121|NCT01192542|20617376|P1|NOT COMPLETED|Period 1||0
8364122|NCT01192542|20617375|P2|COMPLETED|Period 1||20
8364123|NCT01192542|20617376|P1|COMPLETED|Period 1||18
8364124|NCT01192542|20617375|P2|STARTED|Period 1||20
8364125|NCT01192542|20617376|P1|STARTED|Period 1||18
8364126|NCT01192516|20617390|P3|NOT COMPLETED|Overall Study||8
8364127|NCT01192516|20617391|P2|NOT COMPLETED|Overall Study||17
8364128|NCT01192516|20617392|P1|NOT COMPLETED|Overall Study||20
8364129|NCT01192516|20617390|P3|COMPLETED|Overall Study||55
8364130|NCT01192516|20617391|P2|COMPLETED|Overall Study||49
8364131|NCT01192516|20617392|P1|COMPLETED|Overall Study||46
8364132|NCT01192516|20617390|P3|STARTED|Overall Study|Indicates number of people initially randomized to group|63
8364133|NCT01192516|20617391|P2|STARTED|Overall Study|Indicates number of people initially randomized to group|66
8364134|NCT01192516|20617392|P1|STARTED|Overall Study|Indicates number of people initially randomized to group|66
8364135|NCT01192412|20617426|P2|NOT COMPLETED|Overall Study||2
8364136|NCT01192412|20617427|P1|NOT COMPLETED|Overall Study||4
8364137|NCT01192412|20617426|P2|COMPLETED|Overall Study||488
8364138|NCT01192412|20617427|P1|COMPLETED|Overall Study||493
8364139|NCT01192412|20617426|P2|STARTED|Overall Study||490
8364140|NCT01192412|20617427|P1|STARTED|Overall Study||497
8364141|NCT01192399|20617435|P1|NOT COMPLETED|Overall Study||2
8364142|NCT01192399|20617435|P1|COMPLETED|Overall Study||27
8364143|NCT01192399|20617435|P1|STARTED|Overall Study||29
8364147|NCT01192295|20617468|P2|NOT COMPLETED|Overall Study||23
8364148|NCT01192295|20617469|P1|NOT COMPLETED|Overall Study||10
8364149|NCT01192295|20617468|P2|COMPLETED|Overall Study||105
8364150|NCT01192295|20617469|P1|COMPLETED|Overall Study||17
8364151|NCT01192295|20617468|P2|STARTED|Overall Study||128
8364152|NCT01192295|20617469|P1|STARTED|Overall Study||27
8364153|NCT01192282|20617490|P1|NOT COMPLETED|Overall Study||0
8364154|NCT01192282|20617490|P1|COMPLETED|Overall Study||156
8364155|NCT01192282|20617490|P1|STARTED|Overall Study||156
8364156|NCT01192204|20617507|P2|NOT COMPLETED|Overall Study||0
8364157|NCT01192204|20617508|P1|NOT COMPLETED|Overall Study||1
8364158|NCT01192204|20617507|P2|COMPLETED|Overall Study||18
8364159|NCT01192204|20617508|P1|COMPLETED|Overall Study||22
8364160|NCT01192204|20617507|P2|STARTED|Overall Study||18
8364161|NCT01192204|20617508|P1|STARTED|Overall Study||23
8364162|NCT01192191|20617520|P2|NOT COMPLETED|Overall Study||21
8364163|NCT01192191|20617521|P1|NOT COMPLETED|Overall Study||11
8364164|NCT01192191|20617520|P2|COMPLETED|Overall Study||106
8364165|NCT01192191|20617521|P1|COMPLETED|Overall Study||49
8364166|NCT01192191|20617520|P2|STARTED|Overall Study||127
8364167|NCT01192191|20617521|P1|STARTED|Overall Study||60
8364168|NCT01192178|20617547|P2|NOT COMPLETED|Overall Study||23
8364169|NCT01192178|20617548|P1|NOT COMPLETED|Overall Study||24
8364170|NCT01192178|20617547|P2|COMPLETED|Overall Study||145
8364171|NCT01192178|20617548|P1|COMPLETED|Overall Study||147
8364172|NCT01192178|20617547|P2|STARTED|Overall Study||168
8364173|NCT01192178|20617548|P1|STARTED|Overall Study||171
8364174|NCT01192152|20617568|P2|NOT COMPLETED|Period 3||0
8364175|NCT01192152|20617569|P1|NOT COMPLETED|Period 3||1
8364176|NCT01192152|20617568|P2|COMPLETED|Period 3||0
8364177|NCT01192152|20617569|P1|COMPLETED|Period 3||14
8364178|NCT01192152|20617568|P2|STARTED|Period 3||0
8364179|NCT01192152|20617569|P1|STARTED|Period 3||15
8364180|NCT01192152|20617568|P2|NOT COMPLETED|Period 2||0
8364181|NCT01192152|20617569|P1|NOT COMPLETED|Period 2||0
8364182|NCT01192152|20617568|P2|COMPLETED|Period 2||14
8364183|NCT01192152|20617569|P1|COMPLETED|Period 2||15
8364184|NCT01192152|20617568|P2|STARTED|Period 2||14
8364185|NCT01192152|20617569|P1|STARTED|Period 2||15
8364186|NCT01192152|20617568|P2|NOT COMPLETED|Period 1||1
8364187|NCT01192152|20617569|P1|NOT COMPLETED|Period 1||0
8364188|NCT01192152|20617568|P2|COMPLETED|Period 1||14
8364189|NCT01192152|20617569|P1|COMPLETED|Period 1||15
8364190|NCT01192152|20617568|P2|STARTED|Period 1||15
8364191|NCT01192152|20617569|P1|STARTED|Period 1||15
8364192|NCT01192139|20617670|P6|NOT COMPLETED|Period 3||0
8364193|NCT01192139|20617671|P5|NOT COMPLETED|Period 3||0
8364194|NCT01192139|20617672|P4|NOT COMPLETED|Period 3||0
8364195|NCT01192139|20617673|P3|NOT COMPLETED|Period 3||0
8364196|NCT01192139|20617674|P2|NOT COMPLETED|Period 3||0
8364197|NCT01192139|20617675|P1|NOT COMPLETED|Period 3||0
8364198|NCT01192139|20617670|P6|COMPLETED|Period 3||5
8364199|NCT01192139|20617671|P5|COMPLETED|Period 3||5
8364200|NCT01192139|20617672|P4|COMPLETED|Period 3||5
8364201|NCT01192139|20617673|P3|COMPLETED|Period 3||5
8364202|NCT01192139|20617674|P2|COMPLETED|Period 3||5
8364203|NCT01192139|20617675|P1|COMPLETED|Period 3||5
8364204|NCT01192139|20617670|P6|STARTED|Period 3||5
8364205|NCT01192139|20617671|P5|STARTED|Period 3||5
8364206|NCT01192139|20617672|P4|STARTED|Period 3||5
8364207|NCT01192139|20617673|P3|STARTED|Period 3||5
8364208|NCT01192139|20617674|P2|STARTED|Period 3||5
8364209|NCT01192139|20617675|P1|STARTED|Period 3||5
8364210|NCT01192139|20617670|P6|NOT COMPLETED|Period 2||0
8364211|NCT01192139|20617671|P5|NOT COMPLETED|Period 2||0
8364212|NCT01192139|20617672|P4|NOT COMPLETED|Period 2||0
8364213|NCT01192139|20617673|P3|NOT COMPLETED|Period 2||0
8364214|NCT01192139|20617674|P2|NOT COMPLETED|Period 2||0
8364215|NCT01192139|20617675|P1|NOT COMPLETED|Period 2||0
8364216|NCT01192139|20617670|P6|COMPLETED|Period 2||5
8364217|NCT01192139|20617671|P5|COMPLETED|Period 2||5
8364218|NCT01192139|20617672|P4|COMPLETED|Period 2||5
8364219|NCT01192139|20617673|P3|COMPLETED|Period 2||5
8364220|NCT01192139|20617674|P2|COMPLETED|Period 2||5
8364221|NCT01192139|20617675|P1|COMPLETED|Period 2||5
8364222|NCT01192139|20617670|P6|STARTED|Period 2||5
8364223|NCT01192139|20617671|P5|STARTED|Period 2||5
8364224|NCT01192139|20617672|P4|STARTED|Period 2||5
8364225|NCT01192139|20617673|P3|STARTED|Period 2||5
8364226|NCT01192139|20617674|P2|STARTED|Period 2||5
8364227|NCT01192139|20617675|P1|STARTED|Period 2||5
8364228|NCT01192139|20617670|P6|NOT COMPLETED|Period 1||0
8364229|NCT01192139|20617671|P5|NOT COMPLETED|Period 1||0
8364230|NCT01192139|20617672|P4|NOT COMPLETED|Period 1||0
8364231|NCT01192139|20617673|P3|NOT COMPLETED|Period 1||0
8364232|NCT01192139|20617674|P2|NOT COMPLETED|Period 1||0
8364233|NCT01192139|20617675|P1|NOT COMPLETED|Period 1||0
8364234|NCT01192139|20617670|P6|COMPLETED|Period 1||5
8364235|NCT01192139|20617671|P5|COMPLETED|Period 1||5
8364236|NCT01192139|20617672|P4|COMPLETED|Period 1||5
8364237|NCT01192139|20617673|P3|COMPLETED|Period 1||5
8364238|NCT01192139|20617674|P2|COMPLETED|Period 1||5
8364239|NCT01192139|20617675|P1|COMPLETED|Period 1||5
8364240|NCT01192139|20617670|P6|STARTED|Period 1||5
8364241|NCT01192139|20617671|P5|STARTED|Period 1||5
8364242|NCT01192139|20617672|P4|STARTED|Period 1||5
8364243|NCT01192139|20617673|P3|STARTED|Period 1||5
8364244|NCT01192139|20617674|P2|STARTED|Period 1||5
8364245|NCT01192139|20617675|P1|STARTED|Period 1||5
8364246|NCT01192126|20617740|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8364247|NCT01192126|20617741|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8364248|NCT01192126|20617740|P2|COMPLETED|Second Intervention (1 Week)||50
8364249|NCT01192126|20617741|P1|COMPLETED|Second Intervention (1 Week)||49
8364250|NCT01192126|20617740|P2|STARTED|Second Intervention (1 Week)||50
8364251|NCT01192126|20617741|P1|STARTED|Second Intervention (1 Week)||49
8364252|NCT01192126|20617740|P2|NOT COMPLETED|First Intervention (1 Week)||1
8364253|NCT01192126|20617741|P1|NOT COMPLETED|First Intervention (1 Week)||2
8364254|NCT01192126|20617740|P2|COMPLETED|First Intervention (1 Week)||50
8364255|NCT01192126|20617741|P1|COMPLETED|First Intervention (1 Week)||49
8364256|NCT01192126|20617740|P2|STARTED|First Intervention (1 Week)||51
8364257|NCT01192126|20617741|P1|STARTED|First Intervention (1 Week)||51
8364258|NCT01192100|20617749|P6|NOT COMPLETED|Overall Study||0
8364259|NCT01192100|20617750|P5|NOT COMPLETED|Overall Study||1
8364260|NCT01192100|20617751|P4|NOT COMPLETED|Overall Study||1
8364261|NCT01192100|20617752|P3|NOT COMPLETED|Overall Study||0
8364262|NCT01192100|20617753|P2|NOT COMPLETED|Overall Study||0
8364263|NCT01192100|20617754|P1|NOT COMPLETED|Overall Study||0
8364264|NCT01192100|20617749|P6|COMPLETED|Overall Study||2
8364265|NCT01192100|20617750|P5|COMPLETED|Overall Study||2
8364266|NCT01192100|20617751|P4|COMPLETED|Overall Study||3
8364267|NCT01192100|20617752|P3|COMPLETED|Overall Study||3
8364268|NCT01192100|20617753|P2|COMPLETED|Overall Study||4
8364269|NCT01192100|20617754|P1|COMPLETED|Overall Study||6
8364270|NCT01192100|20617749|P6|Began 3rd Intervention Week|Overall Study||2
8364271|NCT01192100|20617750|P5|Began 3rd Intervention Week|Overall Study||2
8364272|NCT01192100|20617751|P4|Began 3rd Intervention Week|Overall Study||3
8364273|NCT01192100|20617752|P3|Began 3rd Intervention Week|Overall Study||3
8364274|NCT01192100|20617753|P2|Began 3rd Intervention Week|Overall Study||4
8364275|NCT01192100|20617754|P1|Began 3rd Intervention Week|Overall Study||6
8364276|NCT01192100|20617749|P6|Began 2nd Intervention Week|Overall Study||2
8364277|NCT01192100|20617750|P5|Began 2nd Intervention Week|Overall Study||2
8364278|NCT01192100|20617751|P4|Began 2nd Intervention Week|Overall Study||3
8364279|NCT01192100|20617752|P3|Began 2nd Intervention Week|Overall Study||3
8364280|NCT01192100|20617753|P2|Began 2nd Intervention Week|Overall Study||4
8364281|NCT01192100|20617754|P1|Began 2nd Intervention Week|Overall Study||6
8364282|NCT01192100|20617749|P6|Began 1st Intervention Week|Overall Study||2
8364283|NCT01192100|20617750|P5|Began 1st Intervention Week|Overall Study||3
8364284|NCT01192100|20617751|P4|Began 1st Intervention Week|Overall Study||4
8364285|NCT01192100|20617752|P3|Began 1st Intervention Week|Overall Study||3
8364286|NCT01192100|20617753|P2|Began 1st Intervention Week|Overall Study||4
8364287|NCT01192100|20617754|P1|Began 1st Intervention Week|Overall Study||6
8364288|NCT01192100|20617749|P6|STARTED|Overall Study||2
8364289|NCT01192100|20617750|P5|STARTED|Overall Study||3
8364290|NCT01192100|20617751|P4|STARTED|Overall Study||4
8364291|NCT01192100|20617752|P3|STARTED|Overall Study||3
8364292|NCT01192100|20617753|P2|STARTED|Overall Study||4
8364293|NCT01192100|20617754|P1|STARTED|Overall Study||6
8364294|NCT01192022|20617774|P5|NOT COMPLETED|Overall Study||1
8364295|NCT01192022|20617775|P4|NOT COMPLETED|Overall Study||2
8364296|NCT01192022|20617776|P3|NOT COMPLETED|Overall Study||1
8364297|NCT01192022|20617777|P2|NOT COMPLETED|Overall Study||11
8364298|NCT01192022|20617778|P1|NOT COMPLETED|Overall Study||13
8364299|NCT01192022|20617774|P5|COMPLETED|Overall Study||11
8364300|NCT01192022|20617775|P4|COMPLETED|Overall Study||7
8364301|NCT01192022|20617776|P3|COMPLETED|Overall Study||7
8364302|NCT01192022|20617777|P2|COMPLETED|Overall Study||99
8364303|NCT01192022|20617778|P1|COMPLETED|Overall Study||101
8364304|NCT01192022|20617774|P5|Safety Population-Received Treatment|Overall Study||12
8364305|NCT01192022|20617775|P4|Safety Population-Received Treatment|Overall Study||9
8364306|NCT01192022|20617776|P3|Safety Population-Received Treatment|Overall Study||8
8364307|NCT01192022|20617777|P2|Safety Population-Received Treatment|Overall Study||109
8364308|NCT01192022|20617778|P1|Safety Population-Received Treatment|Overall Study||114
8364309|NCT01192022|20617774|P5|STARTED|Overall Study||12
8364310|NCT01192022|20617775|P4|STARTED|Overall Study||9
8364311|NCT01192022|20617776|P3|STARTED|Overall Study||8
8364312|NCT01192022|20617777|P2|STARTED|Overall Study||110
8364313|NCT01192022|20617778|P1|STARTED|Overall Study||114
8364314|NCT01191944|20617801|P2|NOT COMPLETED|Overall Study||19
8364315|NCT01191944|20617802|P1|NOT COMPLETED|Overall Study||17
8364316|NCT01191944|20617801|P2|COMPLETED|Overall Study|Completed titration/maintenance|220
8364317|NCT01191944|20617802|P1|COMPLETED|Overall Study|Completed titration/maintenance|217
8364318|NCT01191944|20617801|P2|STARTED|Overall Study|Treated titration/maintenance|239
8364319|NCT01191944|20617802|P1|STARTED|Overall Study|Treated titration/maintenance|234
8364320|NCT01191840|20617848|P2|NOT COMPLETED|Overall Study||15
8364321|NCT01191840|20617849|P1|NOT COMPLETED|Overall Study||14
8364322|NCT01191840|20617848|P2|COMPLETED|Overall Study||240
8364323|NCT01191840|20617849|P1|COMPLETED|Overall Study||240
8364324|NCT01191840|20617848|P2|STARTED|Overall Study||255
8364325|NCT01191840|20617849|P1|STARTED|Overall Study||254
8364326|NCT01191827|20617865|P2|NOT COMPLETED|Overall Study||0
8364327|NCT01191827|20617866|P1|NOT COMPLETED|Overall Study||0
8364328|NCT01191827|20617865|P2|COMPLETED|Overall Study||20
8364329|NCT01191827|20617866|P1|COMPLETED|Overall Study||20
8364330|NCT01191827|20617865|P2|STARTED|Overall Study||20
8364331|NCT01191827|20617866|P1|STARTED|Overall Study||20
8364332|NCT01191801|20617874|P2|NOT COMPLETED|Overall Study||337
8364333|NCT01191801|20617875|P1|NOT COMPLETED|Overall Study||316
8364334|NCT01191801|20617874|P2|COMPLETED|Overall Study||18
8364335|NCT01191801|20617875|P1|COMPLETED|Overall Study||40
8364336|NCT01191801|20617874|P2|STARTED|Overall Study||355
8364337|NCT01191801|20617875|P1|STARTED|Overall Study||356
8364338|NCT01191788|20617895|P2|NOT COMPLETED|Overall Study||22
8364339|NCT01191788|20617896|P1|NOT COMPLETED|Overall Study||21
8364340|NCT01191788|20617895|P2|COMPLETED|Overall Study|Completed 3-month followup|137
8364341|NCT01191788|20617896|P1|COMPLETED|Overall Study|Completed 3-month followup|119
8364342|NCT01191788|20617895|P2|STARTED|Overall Study||159
8364343|NCT01191788|20617896|P1|STARTED|Overall Study||140
8364344|NCT01191762|20617906|P2|NOT COMPLETED|Overall Study||0
8364345|NCT01191762|20617907|P1|NOT COMPLETED|Overall Study||1
8364346|NCT01191762|20617906|P2|COMPLETED|Overall Study||15
8364347|NCT01191762|20617907|P1|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
8364348|NCT01191762|20617906|P2|STARTED|Overall Study||15
8364349|NCT01191762|20617907|P1|STARTED|Overall Study||15
8364350|NCT01191749|20617913|P1|NOT COMPLETED|Overall Study||0
8364351|NCT01191749|20617913|P1|COMPLETED|Overall Study||7
8364352|NCT01191749|20617913|P1|STARTED|Overall Study||7
8364353|NCT01191736|20617924|P7|NOT COMPLETED|Overall Study||0
8364354|NCT01191736|20617925|P6|NOT COMPLETED|Overall Study||0
8364355|NCT01191736|20617926|P5|NOT COMPLETED|Overall Study||0
8364356|NCT01191736|20617927|P4|NOT COMPLETED|Overall Study||0
8364357|NCT01191736|20617928|P3|NOT COMPLETED|Overall Study||0
8364358|NCT01191736|20617929|P2|NOT COMPLETED|Overall Study||0
8364359|NCT01191736|20617930|P1|NOT COMPLETED|Overall Study||0
8364360|NCT01191736|20617924|P7|COMPLETED|Overall Study||45
8364361|NCT01191736|20617925|P6|COMPLETED|Overall Study||50
8364362|NCT01191736|20617926|P5|COMPLETED|Overall Study||48
8364363|NCT01191736|20617927|P4|COMPLETED|Overall Study||46
8364364|NCT01191736|20617928|P3|COMPLETED|Overall Study||49
8364365|NCT01191736|20617929|P2|COMPLETED|Overall Study||47
8364366|NCT01191736|20617930|P1|COMPLETED|Overall Study||51
8364367|NCT01191736|20617924|P7|STARTED|Overall Study||45
8364368|NCT01191736|20617925|P6|STARTED|Overall Study||50
8364369|NCT01191736|20617926|P5|STARTED|Overall Study||48
8364370|NCT01191736|20617927|P4|STARTED|Overall Study||46
8364371|NCT01191736|20617928|P3|STARTED|Overall Study||49
8364372|NCT01191736|20617929|P2|STARTED|Overall Study||47
8364373|NCT01191736|20617930|P1|STARTED|Overall Study||51
8364374|NCT01191723|20617953|P6|NOT COMPLETED|Overall Study||0
8364375|NCT01191723|20617954|P5|NOT COMPLETED|Overall Study||0
8364376|NCT01191723|20617955|P4|NOT COMPLETED|Overall Study||0
8364377|NCT01191723|20617956|P3|NOT COMPLETED|Overall Study||0
8364378|NCT01191723|20617957|P2|NOT COMPLETED|Overall Study||0
8364379|NCT01191723|20617958|P1|NOT COMPLETED|Overall Study||0
8364380|NCT01191723|20617953|P6|COMPLETED|Overall Study||9
8364381|NCT01191723|20617954|P5|COMPLETED|Overall Study||9
8364382|NCT01191723|20617955|P4|COMPLETED|Overall Study||9
8364383|NCT01191723|20617956|P3|COMPLETED|Overall Study||9
8364384|NCT01191723|20617957|P2|COMPLETED|Overall Study||9
8364385|NCT01191723|20617958|P1|COMPLETED|Overall Study||9
8364386|NCT01191723|20617953|P6|STARTED|Overall Study||9
8364387|NCT01191723|20617954|P5|STARTED|Overall Study||9
8364388|NCT01191723|20617955|P4|STARTED|Overall Study||9
8364389|NCT01191723|20617956|P3|STARTED|Overall Study||9
8364390|NCT01191723|20617957|P2|STARTED|Overall Study||9
8364391|NCT01191723|20617958|P1|STARTED|Overall Study||9
8364392|NCT01191476|20617979|P3|NOT COMPLETED|Overall Study||0
8364393|NCT01191476|20617980|P2|NOT COMPLETED|Overall Study||4
8364394|NCT01191476|20617981|P1|NOT COMPLETED|Overall Study||3
8364395|NCT01191476|20617979|P3|COMPLETED|Overall Study||111
8364396|NCT01191476|20617980|P2|COMPLETED|Overall Study||107
8364397|NCT01191476|20617981|P1|COMPLETED|Overall Study||109
8364398|NCT01191476|20617979|P3|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
8364399|NCT01191476|20617980|P2|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
8364400|NCT01191476|20617981|P1|STARTED|Overall Study||112
8364401|NCT01191411|20618004|P3|NOT COMPLETED|Overall Study||3427
8364402|NCT01191411|20618005|P2|NOT COMPLETED|Overall Study||361
8364403|NCT01191411|20618006|P1|NOT COMPLETED|Overall Study||945
8364404|NCT01191411|20618004|P3|COMPLETED|Overall Study||471
8364405|NCT01191411|20618005|P2|COMPLETED|Overall Study||118
8364406|NCT01191411|20618006|P1|COMPLETED|Overall Study||648
8364407|NCT01191411|20618004|P3|STARTED|Overall Study||3898
8364408|NCT01191411|20618005|P2|STARTED|Overall Study||479
8364409|NCT01191411|20618006|P1|STARTED|Overall Study||1593
8364410|NCT01191398|20618017|P3|NOT COMPLETED|Overall Study||0
8364411|NCT01191398|20618018|P2|NOT COMPLETED|Overall Study||0
8364412|NCT01191398|20618019|P1|NOT COMPLETED|Overall Study||0
8364413|NCT01191398|20618017|P3|COMPLETED|Overall Study||18
8364414|NCT01191398|20618018|P2|COMPLETED|Overall Study||17
8364415|NCT01191398|20618019|P1|COMPLETED|Overall Study||17
8364416|NCT01191398|20618017|P3|STARTED|Overall Study||18
8364417|NCT01191398|20618018|P2|STARTED|Overall Study||17
8364418|NCT01191398|20618019|P1|STARTED|Overall Study||17
8364419|NCT01191333|20618032|P2|NOT COMPLETED|Overall Study||18
8364420|NCT01191333|20618033|P1|NOT COMPLETED|Overall Study||21
8364421|NCT01191333|20618032|P2|COMPLETED|Overall Study||65
8364422|NCT01191333|20618033|P1|COMPLETED|Overall Study||60
8364423|NCT01191333|20618032|P2|STARTED|Overall Study||83
8364424|NCT01191333|20618033|P1|STARTED|Overall Study||81
8364425|NCT01191320|20618052|P3|NOT COMPLETED|Overall Study||7
8364426|NCT01191320|20618053|P2|NOT COMPLETED|Overall Study||6
8364427|NCT01191320|20618054|P1|NOT COMPLETED|Overall Study||7
8364428|NCT01191320|20618052|P3|COMPLETED|Overall Study||31
8364429|NCT01191320|20618053|P2|COMPLETED|Overall Study||32
8364430|NCT01191320|20618054|P1|COMPLETED|Overall Study||36
8364431|NCT01191320|20618052|P3|STARTED|Overall Study||38
8364432|NCT01191320|20618053|P2|STARTED|Overall Study||38
8364433|NCT01191320|20618054|P1|STARTED|Overall Study||43
8364434|NCT01191268|20618065|P3|NOT COMPLETED|Overall Study||52
8364435|NCT01191268|20618066|P2|NOT COMPLETED|Overall Study||55
8364436|NCT01191268|20618067|P1|NOT COMPLETED|Overall Study||58
8364437|NCT01191268|20618065|P3|COMPLETED|Overall Study||244
8364438|NCT01191268|20618066|P2|COMPLETED|Overall Study||238
8364439|NCT01191268|20618067|P1|COMPLETED|Overall Study||237
8364440|NCT01191268|20618065|P3|Received at Least One Dose of Study Drug|Overall Study||296
8364441|NCT01191268|20618066|P2|Received at Least One Dose of Study Drug|Overall Study||293
8364442|NCT01191268|20618067|P1|Received at Least One Dose of Study Drug|Overall Study||295
8364443|NCT01191268|20618065|P3|STARTED|Overall Study||296
8364444|NCT01191268|20618066|P2|STARTED|Overall Study||293
8364445|NCT01191268|20618067|P1|STARTED|Overall Study||295
8364446|NCT01191255|20618164|P4|NOT COMPLETED|Efficacy Assessment Period||6
8364447|NCT01191255|20618165|P3|NOT COMPLETED|Efficacy Assessment Period||26
8364448|NCT01191255|20618166|P2|NOT COMPLETED|Efficacy Assessment Period||0
8364449|NCT01191255|20618167|P1|NOT COMPLETED|Efficacy Assessment Period||0
8364450|NCT01191255|20618164|P4|COMPLETED|Efficacy Assessment Period||90
8364451|NCT01191255|20618165|P3|COMPLETED|Efficacy Assessment Period||70
8364452|NCT01191255|20618166|P2|COMPLETED|Efficacy Assessment Period||0
8364453|NCT01191255|20618167|P1|COMPLETED|Efficacy Assessment Period||0
8364454|NCT01191255|20618164|P4|STARTED|Efficacy Assessment Period||96
8364455|NCT01191255|20618165|P3|STARTED|Efficacy Assessment Period||96
8364456|NCT01191255|20618166|P2|STARTED|Efficacy Assessment Period||0
8364457|NCT01191255|20618167|P1|STARTED|Efficacy Assessment Period||0
8364458|NCT01191255|20618164|P4|NOT COMPLETED|Safety Assessment Period||0
8364459|NCT01191255|20618165|P3|NOT COMPLETED|Safety Assessment Period||0
8364460|NCT01191255|20618166|P2|NOT COMPLETED|Safety Assessment Period||99
8364461|NCT01191255|20618167|P1|NOT COMPLETED|Safety Assessment Period||38
8364462|NCT01191255|20618164|P4|COMPLETED|Safety Assessment Period||0
8364463|NCT01191255|20618165|P3|COMPLETED|Safety Assessment Period||0
8364464|NCT01191255|20618166|P2|COMPLETED|Safety Assessment Period||193
8364465|NCT01191255|20618167|P1|COMPLETED|Safety Assessment Period||111
8364466|NCT01191255|20618164|P4|Safety Population|Safety Assessment Period||0
8364467|NCT01191255|20618165|P3|Safety Population|Safety Assessment Period||0
8364468|NCT01191255|20618166|P2|Safety Population|Safety Assessment Period||289
8364469|NCT01191255|20618167|P1|Safety Population|Safety Assessment Period||149
8364470|NCT01191255|20618164|P4|STARTED|Safety Assessment Period||0
8364471|NCT01191255|20618165|P3|STARTED|Safety Assessment Period||0
8364472|NCT01191255|20618166|P2|STARTED|Safety Assessment Period||292
8364473|NCT01191255|20618167|P1|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
8364474|NCT01191242|20618193|P1|NOT COMPLETED|Overall Study||0
8364475|NCT01191242|20618193|P1|COMPLETED|Overall Study||31
8364476|NCT01191242|20618193|P1|STARTED|Overall Study||31
8364477|NCT01191190|20618208|P1|NOT COMPLETED|Overall Study||1
8364478|NCT01191190|20618208|P1|COMPLETED|Overall Study||20
8364479|NCT01191190|20618208|P1|STARTED|Overall Study||21
8364480|NCT01191086|20618221|P1|NOT COMPLETED|Overall Study||62
8364481|NCT01191086|20618221|P1|COMPLETED|Overall Study||148
8364482|NCT01191086|20618221|P1|STARTED|Overall Study||210
8364576|NCT01190891|20618266|P2|NOT COMPLETED|Overall Study||0
8364577|NCT01190891|20618267|P1|NOT COMPLETED|Overall Study||6
8364578|NCT01190891|20618266|P2|COMPLETED|Overall Study||52
8364579|NCT01190891|20618267|P1|COMPLETED|Overall Study||46
8364580|NCT01190891|20618266|P2|STARTED|Overall Study||52
8364581|NCT01190891|20618267|P1|STARTED|Overall Study||52
8364594|NCT01190865|20618292|P1|NOT COMPLETED|Overall Study||3
8364595|NCT01190865|20618292|P1|COMPLETED|Overall Study||25
8364596|NCT01190865|20618292|P1|STARTED|Overall Study||28
8364597|NCT01190839|20618299|P2|NOT COMPLETED|Overall Study||147
8364598|NCT01190839|20618300|P1|NOT COMPLETED|Overall Study||150
8364599|NCT01190839|20618299|P2|COMPLETED|Overall Study||0
8364600|NCT01190839|20618300|P1|COMPLETED|Overall Study||0
8364601|NCT01190839|20618299|P2|Treated|Overall Study||143
8364602|NCT01190839|20618300|P1|Treated|Overall Study||148
8364603|NCT01190839|20618299|P2|STARTED|Overall Study||147
8364604|NCT01190839|20618300|P1|STARTED|Overall Study||150
8364605|NCT01190813|20618314|P2|NOT COMPLETED|Overall Study||4
8364606|NCT01190813|20618315|P1|NOT COMPLETED|Overall Study||4
8364607|NCT01190813|20618314|P2|COMPLETED|Overall Study||45
8364608|NCT01190813|20618315|P1|COMPLETED|Overall Study||86
8364609|NCT01190813|20618314|P2|26-week Visit|Overall Study|0 missed, 0 dropped|45
8364610|NCT01190813|20618315|P1|26-week Visit|Overall Study|0 missed, 0 dropped|86
8364611|NCT01190813|20618314|P2|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
8364612|NCT01190813|20618315|P1|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
8364613|NCT01190813|20618314|P2|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
8364614|NCT01190813|20618315|P1|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
8364615|NCT01190813|20618314|P2|16-week Visit|Overall Study|2 dropped|46
8364616|NCT01190813|20618315|P1|16-week Visit|Overall Study|1 dropped|87
8364617|NCT01190813|20618314|P2|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
8364618|NCT01190813|20618315|P1|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
8364619|NCT01190813|20618314|P2|10-week Visit|Overall Study|0 dropped, 0 missed|48
8364620|NCT01190813|20618315|P1|10-week Visit|Overall Study|0 missed, 0 dropped|88
8364621|NCT01190813|20618314|P2|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
8364622|NCT01190813|20618315|P1|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
8364623|NCT01190813|20618314|P2|4-week Visit|Overall Study|1 missed, 1 dropped|47
8364624|NCT01190813|20618315|P1|4-week Visit|Overall Study|0 missed, 1 dropped|88
8364625|NCT01190813|20618314|P2|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
8364626|NCT01190813|20618315|P1|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
8364627|NCT01190813|20618314|P2|STARTED|Overall Study||49
8364628|NCT01190813|20618315|P1|STARTED|Overall Study||90
8364629|NCT01190566|20618407|P2|NOT COMPLETED|Overall Study||0
8364630|NCT01190566|20618408|P1|NOT COMPLETED|Overall Study||0
8364631|NCT01190566|20618407|P2|COMPLETED|Overall Study||42
8364632|NCT01190566|20618408|P1|COMPLETED|Overall Study||6
8364633|NCT01190566|20618407|P2|STARTED|Overall Study||42
8364634|NCT01190566|20618408|P1|STARTED|Overall Study||6
8364635|NCT01190527|20618429|P1|NOT COMPLETED|Overall Study||0
8364636|NCT01190527|20618429|P1|COMPLETED|Overall Study||42
8364637|NCT01190527|20618429|P1|STARTED|Overall Study||42
8364638|NCT01190514|20618436|P4|NOT COMPLETED|Fourth Intervention (Period 4)||0
8364639|NCT01190514|20618437|P3|NOT COMPLETED|Fourth Intervention (Period 4)||0
8364640|NCT01190514|20618438|P2|NOT COMPLETED|Fourth Intervention (Period 4)||0
8364641|NCT01190514|20618439|P1|NOT COMPLETED|Fourth Intervention (Period 4)||0
8364642|NCT01190514|20618436|P4|COMPLETED|Fourth Intervention (Period 4)||10
8364643|NCT01190514|20618437|P3|COMPLETED|Fourth Intervention (Period 4)||10
8364644|NCT01190514|20618438|P2|COMPLETED|Fourth Intervention (Period 4)||10
8364645|NCT01190514|20618439|P1|COMPLETED|Fourth Intervention (Period 4)||9
8364646|NCT01190514|20618436|P4|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
8364647|NCT01190514|20618437|P3|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
8364648|NCT01190514|20618438|P2|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
8364649|NCT01190514|20618439|P1|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
8364650|NCT01190514|20618436|P4|NOT COMPLETED|Third Intervention (Period 3)||0
8364651|NCT01190514|20618437|P3|NOT COMPLETED|Third Intervention (Period 3)||0
8364652|NCT01190514|20618438|P2|NOT COMPLETED|Third Intervention (Period 3)||0
8364653|NCT01190514|20618439|P1|NOT COMPLETED|Third Intervention (Period 3)||1
8364654|NCT01190514|20618436|P4|COMPLETED|Third Intervention (Period 3)||10
8364655|NCT01190514|20618437|P3|COMPLETED|Third Intervention (Period 3)||10
8364656|NCT01190514|20618438|P2|COMPLETED|Third Intervention (Period 3)||10
8364657|NCT01190514|20618439|P1|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
8364658|NCT01190514|20618436|P4|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
8364659|NCT01190514|20618437|P3|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
8364660|NCT01190514|20618438|P2|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
8364661|NCT01190514|20618439|P1|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
8364662|NCT01190514|20618436|P4|NOT COMPLETED|Second Intervention (Period 2)||0
8364663|NCT01190514|20618437|P3|NOT COMPLETED|Second Intervention (Period 2)||0
8364664|NCT01190514|20618438|P2|NOT COMPLETED|Second Intervention (Period 2)||0
8364665|NCT01190514|20618439|P1|NOT COMPLETED|Second Intervention (Period 2)||0
8364666|NCT01190514|20618436|P4|COMPLETED|Second Intervention (Period 2)||10
8364667|NCT01190514|20618437|P3|COMPLETED|Second Intervention (Period 2)||10
8364668|NCT01190514|20618438|P2|COMPLETED|Second Intervention (Period 2)||10
8364669|NCT01190514|20618439|P1|COMPLETED|Second Intervention (Period 2)||10
8364670|NCT01190514|20618436|P4|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
8364671|NCT01190514|20618437|P3|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
8364672|NCT01190514|20618438|P2|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
8364673|NCT01190514|20618439|P1|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
8364674|NCT01190514|20618436|P4|NOT COMPLETED|First Intervention (Period 1)||0
8364675|NCT01190514|20618437|P3|NOT COMPLETED|First Intervention (Period 1)||0
8364676|NCT01190514|20618438|P2|NOT COMPLETED|First Intervention (Period 1)||0
8364677|NCT01190514|20618439|P1|NOT COMPLETED|First Intervention (Period 1)||1
8364678|NCT01190514|20618436|P4|COMPLETED|First Intervention (Period 1)||10
8364679|NCT01190514|20618437|P3|COMPLETED|First Intervention (Period 1)||10
8364680|NCT01190514|20618438|P2|COMPLETED|First Intervention (Period 1)||10
8364681|NCT01190514|20618439|P1|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
8364682|NCT01190514|20618436|P4|STARTED|First Intervention (Period 1)||10
8364683|NCT01190514|20618437|P3|STARTED|First Intervention (Period 1)||10
8364684|NCT01190514|20618438|P2|STARTED|First Intervention (Period 1)||10
8364685|NCT01190514|20618439|P1|STARTED|First Intervention (Period 1)||11
8364686|NCT01190475|20618472|P3|NOT COMPLETED|Overall Study||1
8364687|NCT01190475|20618473|P2|NOT COMPLETED|Overall Study||0
8364688|NCT01190475|20618474|P1|NOT COMPLETED|Overall Study||0
8364689|NCT01190475|20618472|P3|COMPLETED|Overall Study||1
8364690|NCT01190475|20618473|P2|COMPLETED|Overall Study||2
8364691|NCT01190475|20618474|P1|COMPLETED|Overall Study||2
8364692|NCT01190475|20618472|P3|STARTED|Overall Study||2
8364693|NCT01190475|20618473|P2|STARTED|Overall Study||2
8364694|NCT01190475|20618474|P1|STARTED|Overall Study||2
8364701|NCT01190436|20618499|P1|NOT COMPLETED|Overall Study||39
8364702|NCT01190436|20618499|P1|COMPLETED|Overall Study||86
8364703|NCT01190436|20618499|P1|STARTED|Overall Study||125
8364704|NCT01190410|20618515|P2|NOT COMPLETED|Overall Study||9
8364705|NCT01190410|20618516|P1|NOT COMPLETED|Overall Study||1
8364706|NCT01190410|20618515|P2|COMPLETED|Overall Study||3
8364707|NCT01190410|20618516|P1|COMPLETED|Overall Study||3
8364708|NCT01190410|20618515|P2|Re-Induction|Overall Study||2
8364709|NCT01190410|20618516|P1|Re-Induction|Overall Study||0
8364710|NCT01190410|20618515|P2|STARTED|Overall Study||12
8364711|NCT01190410|20618516|P1|STARTED|Overall Study||4
8364712|NCT01190306|20618535|P2|NOT COMPLETED|Overall Study||0
8364713|NCT01190306|20618536|P1|NOT COMPLETED|Overall Study||0
8364714|NCT01190306|20618535|P2|COMPLETED|Overall Study||66
8364715|NCT01190306|20618536|P1|COMPLETED|Overall Study||61
8364716|NCT01190306|20618535|P2|STARTED|Overall Study||66
8364717|NCT01190306|20618536|P1|STARTED|Overall Study||61
8364724|NCT01190254|20618556|P3|NOT COMPLETED|Overall Study||22
8364725|NCT01190254|20618557|P2|NOT COMPLETED|Overall Study||17
8364726|NCT01190254|20618558|P1|NOT COMPLETED|Overall Study||21
8364727|NCT01190254|20618556|P3|COMPLETED|Overall Study||84
8364728|NCT01190254|20618557|P2|COMPLETED|Overall Study||81
8364729|NCT01190254|20618558|P1|COMPLETED|Overall Study||81
8364730|NCT01190254|20618556|P3|Treated|Overall Study||106
8364731|NCT01190254|20618557|P2|Treated|Overall Study||98
8364732|NCT01190254|20618558|P1|Treated|Overall Study||102
8364733|NCT01190254|20618556|P3|STARTED|Overall Study||106
8364734|NCT01190254|20618557|P2|STARTED|Overall Study||98
8364735|NCT01190254|20618558|P1|STARTED|Overall Study||102
8364736|NCT01190228|20618623|P3|NOT COMPLETED|Overall Study||0
8364737|NCT01190228|20618624|P2|NOT COMPLETED|Overall Study||0
8364738|NCT01190228|20618625|P1|NOT COMPLETED|Overall Study||5
8364739|NCT01190228|20618623|P3|COMPLETED|Overall Study||59
8364740|NCT01190228|20618624|P2|COMPLETED|Overall Study||46
8364741|NCT01190228|20618625|P1|COMPLETED|Overall Study||344
8364742|NCT01190228|20618623|P3|STARTED|Overall Study||59
8364743|NCT01190228|20618624|P2|STARTED|Overall Study||46
8364744|NCT01190228|20618625|P1|STARTED|Overall Study||349
8364745|NCT01190215|20618648|P2|NOT COMPLETED|Up to Month 6||0
8364746|NCT01190215|20618649|P1|NOT COMPLETED|Up to Month 6||2
8364747|NCT01190215|20618648|P2|COMPLETED|Up to Month 6||39
8364748|NCT01190215|20618649|P1|COMPLETED|Up to Month 6||36
8364749|NCT01190215|20618648|P2|STARTED|Up to Month 6||39
8364750|NCT01190215|20618649|P1|STARTED|Up to Month 6||38
8364751|NCT01190215|20618648|P2|NOT COMPLETED|Up to Day 28||0
8364752|NCT01190215|20618649|P1|NOT COMPLETED|Up to Day 28||0
8364753|NCT01190215|20618648|P2|COMPLETED|Up to Day 28||39
8364754|NCT01190215|20618649|P1|COMPLETED|Up to Day 28||38
8364755|NCT01190215|20618648|P2|STARTED|Up to Day 28||39
8364756|NCT01190215|20618649|P1|STARTED|Up to Day 28||38
8364757|NCT01190202|20618721|P4|NOT COMPLETED|Overall Study||0
8364758|NCT01190202|20618722|P3|NOT COMPLETED|Overall Study||0
8364759|NCT01190202|20618723|P2|NOT COMPLETED|Overall Study||0
8364760|NCT01190202|20618724|P1|NOT COMPLETED|Overall Study||0
8364761|NCT01190202|20618721|P4|COMPLETED|Overall Study||2400
8364762|NCT01190202|20618722|P3|COMPLETED|Overall Study||6400
8364763|NCT01190202|20618723|P2|COMPLETED|Overall Study||6414
8364764|NCT01190202|20618724|P1|COMPLETED|Overall Study||6404
8364765|NCT01190202|20618721|P4|STARTED|Overall Study||2400
8364766|NCT01190202|20618722|P3|STARTED|Overall Study||6400
8364767|NCT01190202|20618723|P2|STARTED|Overall Study||6414
8364768|NCT01190202|20618724|P1|STARTED|Overall Study||6404
8364769|NCT01190189|20618982|P1|NOT COMPLETED|Overall Study||6
8364770|NCT01190189|20618982|P1|COMPLETED|Overall Study||131
8364771|NCT01190189|20618982|P1|STARTED|Overall Study||137
8364772|NCT01190176|20618989|P1|NOT COMPLETED|Overall Study||2
8364773|NCT01190176|20618989|P1|COMPLETED|Overall Study||30
8364774|NCT01190176|20618989|P1|STARTED|Overall Study||32
8364775|NCT01190150|20619010|P2|NOT COMPLETED|Second Treatment||0
8364776|NCT01190150|20619011|P1|NOT COMPLETED|Second Treatment||0
8364777|NCT01190150|20619010|P2|COMPLETED|Second Treatment||7
8364778|NCT01190150|20619011|P1|COMPLETED|Second Treatment||10
8364779|NCT01190150|20619010|P2|STARTED|Second Treatment||7
8364780|NCT01190150|20619011|P1|STARTED|Second Treatment||10
8364781|NCT01190150|20619010|P2|NOT COMPLETED|Washout||2
8364782|NCT01190150|20619011|P1|NOT COMPLETED|Washout||0
8364783|NCT01190150|20619010|P2|COMPLETED|Washout||7
8364784|NCT01190150|20619011|P1|COMPLETED|Washout||10
8364785|NCT01190150|20619010|P2|STARTED|Washout||9
8364786|NCT01190150|20619011|P1|STARTED|Washout||10
8364787|NCT01190150|20619010|P2|NOT COMPLETED|First Treatment||0
8364788|NCT01190150|20619011|P1|NOT COMPLETED|First Treatment||1
8364789|NCT01190150|20619010|P2|COMPLETED|First Treatment||9
8364790|NCT01190150|20619011|P1|COMPLETED|First Treatment||10
8364791|NCT01190150|20619010|P2|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
8364792|NCT01190150|20619011|P1|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
8364793|NCT01190124|20619038|P3|NOT COMPLETED|Overall Study||1
8364794|NCT01190124|20619039|P2|NOT COMPLETED|Overall Study||0
8364795|NCT01190124|20619040|P1|NOT COMPLETED|Overall Study||17
8364796|NCT01190124|20619038|P3|COMPLETED|Overall Study||19
8364797|NCT01190124|20619039|P2|COMPLETED|Overall Study||24
8364798|NCT01190124|20619040|P1|COMPLETED|Overall Study||90
8364799|NCT01190124|20619038|P3|STARTED|Overall Study||20
8364800|NCT01190124|20619039|P2|STARTED|Overall Study||24
8364801|NCT01190124|20619040|P1|STARTED|Overall Study||107
8364802|NCT01190098|20619078|P2|NOT COMPLETED|Overall Study||2
8364803|NCT01190098|20619079|P1|NOT COMPLETED|Overall Study||3
8364804|NCT01190098|20619078|P2|COMPLETED|Overall Study||8
8364805|NCT01190098|20619079|P1|COMPLETED|Overall Study||39
8364806|NCT01190098|20619078|P2|STARTED|Overall Study||10
8364807|NCT01190098|20619079|P1|STARTED|Overall Study||42
8364808|NCT01190085|20619102|P3|NOT COMPLETED|Overall Study||0
8364809|NCT01190085|20619103|P2|NOT COMPLETED|Overall Study||0
8364810|NCT01190085|20619104|P1|NOT COMPLETED|Overall Study||0
8364811|NCT01190085|20619102|P3|COMPLETED|Overall Study||18
8364812|NCT01190085|20619103|P2|COMPLETED|Overall Study||14
8364813|NCT01190085|20619104|P1|COMPLETED|Overall Study||13
8364814|NCT01190085|20619102|P3|STARTED|Overall Study||18
8364815|NCT01190085|20619103|P2|STARTED|Overall Study||14
8364816|NCT01190085|20619104|P1|STARTED|Overall Study||13
8364817|NCT01190020|20619120|P2|NOT COMPLETED|Overall Study||0
8364818|NCT01190020|20619121|P1|NOT COMPLETED|Overall Study||7
8364819|NCT01190020|20619120|P2|COMPLETED|Overall Study||12
8364820|NCT01190020|20619121|P1|COMPLETED|Overall Study||22
8364821|NCT01190020|20619120|P2|STARTED|Overall Study||12
8364822|NCT01190020|20619121|P1|STARTED|Overall Study||29
8364823|NCT01189890|20619135|P2|NOT COMPLETED|Overall Study||39
8364824|NCT01189890|20619136|P1|NOT COMPLETED|Overall Study||37
8364825|NCT01189890|20619135|P2|COMPLETED|Overall Study||200
8364826|NCT01189890|20619136|P1|COMPLETED|Overall Study||204
8364827|NCT01189890|20619135|P2|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
8364828|NCT01189890|20619136|P1|STARTED|Overall Study||241
8364829|NCT01189812|20619158|P2|NOT COMPLETED|Overall Study||8
8364830|NCT01189812|20619159|P1|NOT COMPLETED|Overall Study||8
8364831|NCT01189812|20619158|P2|COMPLETED|Overall Study||32
8364832|NCT01189812|20619159|P1|COMPLETED|Overall Study||32
8364833|NCT01189812|20619158|P2|STARTED|Overall Study||40
8364834|NCT01189812|20619159|P1|STARTED|Overall Study||40
8364835|NCT01189760|20619168|P3|NOT COMPLETED|Overall Study||51
8364836|NCT01189760|20619169|P2|NOT COMPLETED|Overall Study||23
8364837|NCT01189760|20619170|P1|NOT COMPLETED|Overall Study||14
8364838|NCT01189760|20619168|P3|COMPLETED|Overall Study||255
8364839|NCT01189760|20619169|P2|COMPLETED|Overall Study||283
8364840|NCT01189760|20619170|P1|COMPLETED|Overall Study||291
8364841|NCT01189760|20619168|P3|STARTED|Overall Study||306
8364842|NCT01189760|20619169|P2|STARTED|Overall Study||306
8364843|NCT01189760|20619170|P1|STARTED|Overall Study||305
8364844|NCT01189747|20619204|P2|NOT COMPLETED|Overall Study||18
8364845|NCT01189747|20619205|P1|NOT COMPLETED|Overall Study||12
8364846|NCT01189747|20619204|P2|COMPLETED|Overall Study||206
8364847|NCT01189747|20619205|P1|COMPLETED|Overall Study||210
8364848|NCT01189747|20619204|P2|STARTED|Overall Study||224
8364849|NCT01189747|20619205|P1|STARTED|Overall Study||222
8364850|NCT01189617|20619229|P2|NOT COMPLETED|Overall Study||0
8364851|NCT01189617|20619230|P1|NOT COMPLETED|Overall Study||0
8364852|NCT01189617|20619229|P2|COMPLETED|Overall Study||35
8364853|NCT01189617|20619230|P1|COMPLETED|Overall Study||35
8364854|NCT01189617|20619229|P2|STARTED|Overall Study||35
8364855|NCT01189617|20619230|P1|STARTED|Overall Study||35
8364856|NCT01189604|20619243|P7|NOT COMPLETED|Overall Study||1
8364857|NCT01189604|20619244|P6|NOT COMPLETED|Overall Study||1
8364858|NCT01189604|20619245|P5|NOT COMPLETED|Overall Study||2
8364859|NCT01189604|20619246|P4|NOT COMPLETED|Overall Study||0
8364860|NCT01189604|20619247|P3|NOT COMPLETED|Overall Study||0
8364861|NCT01189604|20619248|P2|NOT COMPLETED|Overall Study||1
8364862|NCT01189604|20619249|P1|NOT COMPLETED|Overall Study||1
8364863|NCT01189604|20619243|P7|COMPLETED|Overall Study||9
8364864|NCT01189604|20619244|P6|COMPLETED|Overall Study||10
8364865|NCT01189604|20619245|P5|COMPLETED|Overall Study||18
8364866|NCT01189604|20619246|P4|COMPLETED|Overall Study||20
8364867|NCT01189604|20619247|P3|COMPLETED|Overall Study||20
8364868|NCT01189604|20619248|P2|COMPLETED|Overall Study||20
8364869|NCT01189604|20619249|P1|COMPLETED|Overall Study||20
8364870|NCT01189604|20619243|P7|Administered Study Drug|Overall Study||10
8364871|NCT01189604|20619244|P6|Administered Study Drug|Overall Study||10
8364872|NCT01189604|20619245|P5|Administered Study Drug|Overall Study||20
8364873|NCT01189604|20619246|P4|Administered Study Drug|Overall Study||20
8364874|NCT01189604|20619247|P3|Administered Study Drug|Overall Study||20
8364875|NCT01189604|20619248|P2|Administered Study Drug|Overall Study||20
8364876|NCT01189604|20619249|P1|Administered Study Drug|Overall Study||20
8364877|NCT01189604|20619243|P7|STARTED|Overall Study||10
8364878|NCT01189604|20619244|P6|STARTED|Overall Study||11
8364879|NCT01189604|20619245|P5|STARTED|Overall Study||20
8364880|NCT01189604|20619246|P4|STARTED|Overall Study||20
8364881|NCT01189604|20619247|P3|STARTED|Overall Study||20
8364882|NCT01189604|20619248|P2|STARTED|Overall Study||21
8364883|NCT01189604|20619249|P1|STARTED|Overall Study||21
8364884|NCT01189500|20619293|P1|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
8364885|NCT01189500|20619293|P1|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
8364886|NCT01189500|20619293|P1|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
8364887|NCT01189500|20619293|P1|NOT COMPLETED|Period 1: TAMOX Alone||1
8364888|NCT01189500|20619293|P1|COMPLETED|Period 1: TAMOX Alone||29
8364889|NCT01189500|20619293|P1|STARTED|Period 1: TAMOX Alone||30
8364890|NCT01189487|20619354|P1|NOT COMPLETED|Overall Study||3
8364891|NCT01189487|20619354|P1|COMPLETED|Overall Study||44
8364892|NCT01189487|20619354|P1|STARTED|Overall Study|Treated participants|47
8364893|NCT01189461|20619362|P1|NOT COMPLETED|Overall Study||34
8364894|NCT01189461|20619362|P1|COMPLETED|Overall Study||12
8364895|NCT01189461|20619362|P1|STARTED|Overall Study||46
8364896|NCT01189435|20619369|P1|NOT COMPLETED|Overall Study||2
8364897|NCT01189435|20619369|P1|COMPLETED|Overall Study||0
8364898|NCT01189435|20619369|P1|STARTED|Overall Study||2
8364899|NCT01189409|20619375|P2|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
8364900|NCT01189409|20619376|P1|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
8364901|NCT01189409|20619375|P2|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
8364902|NCT01189409|20619376|P1|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
8364903|NCT01189409|20619375|P2|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
8364904|NCT01189409|20619376|P1|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
8364905|NCT01189409|20619375|P2|NOT COMPLETED|First 3 Weeks||10
8364906|NCT01189409|20619376|P1|NOT COMPLETED|First 3 Weeks||18
8364907|NCT01189409|20619375|P2|COMPLETED|First 3 Weeks||23
8364908|NCT01189409|20619376|P1|COMPLETED|First 3 Weeks||19
8364909|NCT01189409|20619375|P2|STARTED|First 3 Weeks||33
8364910|NCT01189409|20619376|P1|STARTED|First 3 Weeks||37
8364911|NCT01189370|20619391|P3|NOT COMPLETED|Dose Level 3||6
8364912|NCT01189370|20619392|P2|NOT COMPLETED|Dose Level 3||0
8364913|NCT01189370|20619393|P1|NOT COMPLETED|Dose Level 3||0
8364914|NCT01189370|20619391|P3|COMPLETED|Dose Level 3||6
8364915|NCT01189370|20619392|P2|COMPLETED|Dose Level 3||0
8364916|NCT01189370|20619393|P1|COMPLETED|Dose Level 3||0
8364917|NCT01189370|20619391|P3|STARTED|Dose Level 3||12
8364918|NCT01189370|20619392|P2|STARTED|Dose Level 3||0
8364919|NCT01189370|20619393|P1|STARTED|Dose Level 3||0
8364920|NCT01189370|20619391|P3|NOT COMPLETED|Dose Level 2||0
8364921|NCT01189370|20619392|P2|NOT COMPLETED|Dose Level 2||4
8364922|NCT01189370|20619393|P1|NOT COMPLETED|Dose Level 2||0
8364923|NCT01189370|20619391|P3|COMPLETED|Dose Level 2||0
8364924|NCT01189370|20619392|P2|COMPLETED|Dose Level 2||12
8364925|NCT01189370|20619393|P1|COMPLETED|Dose Level 2||0
8364926|NCT01189370|20619391|P3|STARTED|Dose Level 2||0
8364927|NCT01189370|20619392|P2|STARTED|Dose Level 2||16
8364928|NCT01189370|20619393|P1|STARTED|Dose Level 2||0
8364929|NCT01189370|20619391|P3|NOT COMPLETED|Dose Level 1||0
8364930|NCT01189370|20619392|P2|NOT COMPLETED|Dose Level 1||0
8364931|NCT01189370|20619393|P1|NOT COMPLETED|Dose Level 1||9
8364932|NCT01189370|20619391|P3|COMPLETED|Dose Level 1||0
8364933|NCT01189370|20619392|P2|COMPLETED|Dose Level 1||0
8364934|NCT01189370|20619393|P1|COMPLETED|Dose Level 1||16
8364935|NCT01189370|20619391|P3|STARTED|Dose Level 1||0
8364936|NCT01189370|20619392|P2|STARTED|Dose Level 1||0
8364937|NCT01189370|20619393|P1|STARTED|Dose Level 1||25
8364938|NCT01189292|20619402|P2|NOT COMPLETED|Per Protocol Analysis||16
8364939|NCT01189292|20619403|P1|NOT COMPLETED|Per Protocol Analysis||11
8364940|NCT01189292|20619402|P2|COMPLETED|Per Protocol Analysis||60
8364941|NCT01189292|20619403|P1|COMPLETED|Per Protocol Analysis||65
8364942|NCT01189292|20619402|P2|STARTED|Per Protocol Analysis||76
8364943|NCT01189292|20619403|P1|STARTED|Per Protocol Analysis||76
8364944|NCT01189292|20619402|P2|NOT COMPLETED|Intention to Treat Analysis||0
8364945|NCT01189292|20619403|P1|NOT COMPLETED|Intention to Treat Analysis||0
8364946|NCT01189292|20619402|P2|COMPLETED|Intention to Treat Analysis||76
8364947|NCT01189292|20619403|P1|COMPLETED|Intention to Treat Analysis||76
8364948|NCT01189292|20619402|P2|STARTED|Intention to Treat Analysis||76
8364949|NCT01189292|20619403|P1|STARTED|Intention to Treat Analysis||76
8364950|NCT01189279|20619424|P3|NOT COMPLETED|Overall Study||1
8364951|NCT01189279|20619425|P2|NOT COMPLETED|Overall Study||0
8364952|NCT01189279|20619426|P1|NOT COMPLETED|Overall Study||1
8364953|NCT01189279|20619424|P3|COMPLETED|Overall Study||13
8364954|NCT01189279|20619425|P2|COMPLETED|Overall Study||14
8364955|NCT01189279|20619426|P1|COMPLETED|Overall Study||13
8364956|NCT01189279|20619424|P3|STARTED|Overall Study||14
8364957|NCT01189279|20619425|P2|STARTED|Overall Study||14
8364958|NCT01189279|20619426|P1|STARTED|Overall Study||14
8364968|NCT01189240|20619478|P3|NOT COMPLETED|Overall Study||0
8364969|NCT01189240|20619479|P2|NOT COMPLETED|Overall Study||0
8364970|NCT01189240|20619480|P1|NOT COMPLETED|Overall Study||0
8364971|NCT01189240|20619478|P3|COMPLETED|Overall Study||3
8364972|NCT01189240|20619479|P2|COMPLETED|Overall Study||6
8364973|NCT01189240|20619480|P1|COMPLETED|Overall Study||4
8364974|NCT01189240|20619478|P3|STARTED|Overall Study||3
8364975|NCT01189240|20619479|P2|STARTED|Overall Study||6
8364976|NCT01189240|20619480|P1|STARTED|Overall Study||4
8364977|NCT01189227|20619501|P2|NOT COMPLETED|Overall Study||3
8364978|NCT01189227|20619502|P1|NOT COMPLETED|Overall Study||6
8364979|NCT01189227|20619501|P2|COMPLETED|Overall Study||0
8364980|NCT01189227|20619502|P1|COMPLETED|Overall Study||0
8364981|NCT01189227|20619501|P2|STARTED|Overall Study||3
8364982|NCT01189227|20619502|P1|STARTED|Overall Study||6
8364983|NCT01189201|20619508|P1|NOT COMPLETED|Overall Study||1
8364984|NCT01189201|20619508|P1|COMPLETED|Overall Study||41
8364985|NCT01189201|20619508|P1|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
8364986|NCT01189201|20619508|P1|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
8364987|NCT01189201|20619508|P1|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
8364988|NCT01189201|20619508|P1|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
8364989|NCT01189201|20619508|P1|STARTED|Overall Study||42
8364990|NCT01189136|20619564|P2|NOT COMPLETED|Overall Study||0
8364991|NCT01189136|20619565|P1|NOT COMPLETED|Overall Study||0
8364992|NCT01189136|20619564|P2|COMPLETED|Overall Study||42
8364993|NCT01189136|20619565|P1|COMPLETED|Overall Study||42
8364994|NCT01189136|20619564|P2|STARTED|Overall Study||42
8364995|NCT01189136|20619565|P1|STARTED|Overall Study||42
8364996|NCT01189123|20619579|P2|NOT COMPLETED|Overall Study||6
8364997|NCT01189123|20619580|P1|NOT COMPLETED|Overall Study||2
8364998|NCT01189123|20619579|P2|COMPLETED|Overall Study||47
8364999|NCT01189123|20619580|P1|COMPLETED|Overall Study||50
8365000|NCT01189123|20619579|P2|STARTED|Overall Study||53
8365001|NCT01189123|20619580|P1|STARTED|Overall Study||52
8365002|NCT01189110|20619590|P2|NOT COMPLETED|Overall Study||0
8365003|NCT01189110|20619591|P1|NOT COMPLETED|Overall Study||0
8365004|NCT01189110|20619590|P2|COMPLETED|Overall Study||61
8365005|NCT01189110|20619591|P1|COMPLETED|Overall Study|February, 2011|64
8365006|NCT01189110|20619590|P2|STARTED|Overall Study||61
8365007|NCT01189110|20619591|P1|STARTED|Overall Study|September, 2010|64
8365008|NCT01189071|20619599|P2|NOT COMPLETED|Overall Study||0
8365009|NCT01189071|20619600|P1|NOT COMPLETED|Overall Study||0
8365010|NCT01189071|20619599|P2|COMPLETED|Overall Study||0
8365011|NCT01189071|20619600|P1|COMPLETED|Overall Study||0
8365012|NCT01189071|20619599|P2|STARTED|Overall Study||0
8365013|NCT01189071|20619600|P1|STARTED|Overall Study||0
8365014|NCT01189032|20619611|P3|NOT COMPLETED|Overall Study||6
8365015|NCT01189032|20619612|P2|NOT COMPLETED|Overall Study||7
8365016|NCT01189032|20619613|P1|NOT COMPLETED|Overall Study||5
8365017|NCT01189032|20619611|P3|COMPLETED|Overall Study||90
8365018|NCT01189032|20619612|P2|COMPLETED|Overall Study||89
8365019|NCT01189032|20619613|P1|COMPLETED|Overall Study||89
8365020|NCT01189032|20619611|P3|STARTED|Overall Study||96
8365021|NCT01189032|20619612|P2|STARTED|Overall Study||96
8365022|NCT01189032|20619613|P1|STARTED|Overall Study||94
8365023|NCT01188967|20619623|P2|NOT COMPLETED|Overall Study||4
8365024|NCT01188967|20619624|P1|NOT COMPLETED|Overall Study||5
8365025|NCT01188967|20619623|P2|COMPLETED|Overall Study||4
8365026|NCT01188967|20619624|P1|COMPLETED|Overall Study||5
8365027|NCT01188967|20619623|P2|STARTED|Overall Study||8
8365028|NCT01188967|20619624|P1|STARTED|Overall Study||10
8365029|NCT01188928|20619640|P4|NOT COMPLETED|Overall Study||18
8365030|NCT01188928|20619641|P3|NOT COMPLETED|Overall Study||14
8365031|NCT01188928|20619642|P2|NOT COMPLETED|Overall Study||62
8365032|NCT01188928|20619643|P1|NOT COMPLETED|Overall Study||38
8365033|NCT01188928|20619640|P4|COMPLETED|Overall Study||77
8365034|NCT01188928|20619641|P3|COMPLETED|Overall Study||82
8365035|NCT01188928|20619642|P2|COMPLETED|Overall Study||417
8365036|NCT01188928|20619643|P1|COMPLETED|Overall Study||444
8365037|NCT01188928|20619640|P4|STARTED|Overall Study||95
8365038|NCT01188928|20619641|P3|STARTED|Overall Study||96
8365039|NCT01188928|20619642|P2|STARTED|Overall Study||479
8365040|NCT01188928|20619643|P1|STARTED|Overall Study||482
8365041|NCT01188876|20619665|P1|NOT COMPLETED|Overall Study||0
8365042|NCT01188876|20619665|P1|COMPLETED|Overall Study||50
8365043|NCT01188876|20619665|P1|STARTED|Overall Study||50
8365044|NCT01188811|20619677|P2|NOT COMPLETED|Overall Study||2
8365045|NCT01188811|20619678|P1|NOT COMPLETED|Overall Study||6
8365046|NCT01188811|20619677|P2|COMPLETED|Overall Study||24
8365047|NCT01188811|20619678|P1|COMPLETED|Overall Study||22
8365048|NCT01188811|20619677|P2|STARTED|Overall Study||26
8365049|NCT01188811|20619678|P1|STARTED|Overall Study||28
8365050|NCT01188798|20619690|P2|NOT COMPLETED|Overall Study||3
8365051|NCT01188798|20619691|P1|NOT COMPLETED|Overall Study||2
8365052|NCT01188798|20619690|P2|COMPLETED|Overall Study||1
8365053|NCT01188798|20619691|P1|COMPLETED|Overall Study||0
8365054|NCT01188798|20619690|P2|STARTED|Overall Study||4
8365055|NCT01188798|20619691|P1|STARTED|Overall Study||2
8365056|NCT01188772|20619703|P4|NOT COMPLETED|Overall Study||1
8365057|NCT01188772|20619704|P3|NOT COMPLETED|Overall Study||11
8365058|NCT01188772|20619705|P2|NOT COMPLETED|Overall Study||3
8365059|NCT01188772|20619706|P1|NOT COMPLETED|Overall Study||5
8365060|NCT01188772|20619703|P4|COMPLETED|Overall Study||24
8365061|NCT01188772|20619704|P3|COMPLETED|Overall Study||15
8365062|NCT01188772|20619705|P2|COMPLETED|Overall Study||45
8365063|NCT01188772|20619706|P1|COMPLETED|Overall Study||43
8365064|NCT01188772|20619703|P4|Randomized and Treated|Overall Study||25
8365065|NCT01188772|20619704|P3|Randomized and Treated|Overall Study||26
8365066|NCT01188772|20619705|P2|Randomized and Treated|Overall Study||47
8365067|NCT01188772|20619706|P1|Randomized and Treated|Overall Study||48
8365068|NCT01188772|20619703|P4|STARTED|Overall Study||25
8365069|NCT01188772|20619704|P3|STARTED|Overall Study||26
8365070|NCT01188772|20619705|P2|STARTED|Overall Study||48
8365071|NCT01188772|20619706|P1|STARTED|Overall Study||48
8365072|NCT01188694|20619764|P3|NOT COMPLETED|Overall Study||1
8365073|NCT01188694|20619765|P2|NOT COMPLETED|Overall Study||1
8365074|NCT01188694|20619766|P1|NOT COMPLETED|Overall Study||5
8365075|NCT01188694|20619764|P3|COMPLETED|Overall Study||10
8365076|NCT01188694|20619765|P2|COMPLETED|Overall Study||15
8365077|NCT01188694|20619766|P1|COMPLETED|Overall Study||10
8365078|NCT01188694|20619764|P3|STARTED|Overall Study||11
8365079|NCT01188694|20619765|P2|STARTED|Overall Study||16
8365080|NCT01188694|20619766|P1|STARTED|Overall Study||15
8365093|NCT01188668|20619795|P1|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
8365094|NCT01188668|20619795|P1|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
8365095|NCT01188668|20619795|P1|STARTED|Period 2: Coadministration ARIP + DVS SR||36
8365096|NCT01188668|20619795|P1|NOT COMPLETED|Period 1: ARIP Alone||2
8365097|NCT01188668|20619795|P1|COMPLETED|Period 1: ARIP Alone||36
8365098|NCT01188668|20619795|P1|STARTED|Period 1: ARIP Alone||38
8365099|NCT01188655|20619828|P1|NOT COMPLETED|Overall Study||13
8365100|NCT01188655|20619828|P1|COMPLETED|Overall Study||76
8365101|NCT01188655|20619828|P1|STARTED|Overall Study||89
8365102|NCT01188603|20619843|P1|NOT COMPLETED|Overall Study||0
8365103|NCT01188603|20619843|P1|COMPLETED|Overall Study||24
8365104|NCT01188603|20619843|P1|STARTED|Overall Study||24
8365105|NCT01188577|20619853|P2|NOT COMPLETED|Visit 2||0
8365106|NCT01188577|20619854|P1|NOT COMPLETED|Visit 2||0
8365107|NCT01188577|20619853|P2|COMPLETED|Visit 2||12
8365108|NCT01188577|20619854|P1|COMPLETED|Visit 2||11
8365109|NCT01188577|20619853|P2|STARTED|Visit 2||12
8365110|NCT01188577|20619854|P1|STARTED|Visit 2||11
8365111|NCT01188577|20619853|P2|NOT COMPLETED|3-14 Day Washout||0
8365112|NCT01188577|20619854|P1|NOT COMPLETED|3-14 Day Washout||0
8365113|NCT01188577|20619853|P2|COMPLETED|3-14 Day Washout||12
8365114|NCT01188577|20619854|P1|COMPLETED|3-14 Day Washout||11
8365115|NCT01188577|20619853|P2|STARTED|3-14 Day Washout||12
8365116|NCT01188577|20619854|P1|STARTED|3-14 Day Washout||11
8365117|NCT01188577|20619853|P2|NOT COMPLETED|Visit 1||0
8365118|NCT01188577|20619854|P1|NOT COMPLETED|Visit 1||0
8365119|NCT01188577|20619853|P2|COMPLETED|Visit 1||12
8365120|NCT01188577|20619854|P1|COMPLETED|Visit 1||11
8365121|NCT01188577|20619853|P2|STARTED|Visit 1||12
8365122|NCT01188577|20619854|P1|STARTED|Visit 1||11
8365123|NCT01188564|20619872|P2|NOT COMPLETED|Open Label Phase||0
8365124|NCT01188564|20619873|P1|NOT COMPLETED|Open Label Phase||0
8365125|NCT01188564|20619872|P2|COMPLETED|Open Label Phase||20
8365126|NCT01188564|20619873|P1|COMPLETED|Open Label Phase||24
8365127|NCT01188564|20619872|P2|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
8365128|NCT01188564|20619873|P1|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
8365129|NCT01188564|20619872|P2|NOT COMPLETED|Double-blind Phase||0
8365130|NCT01188564|20619873|P1|NOT COMPLETED|Double-blind Phase||1
8365131|NCT01188564|20619872|P2|COMPLETED|Double-blind Phase||31
8365132|NCT01188564|20619873|P1|COMPLETED|Double-blind Phase||43
8365133|NCT01188564|20619872|P2|STARTED|Double-blind Phase||31
8365134|NCT01188564|20619873|P1|STARTED|Double-blind Phase||44
8365135|NCT01188551|20619885|P4|NOT COMPLETED|Overall Study||0
8365136|NCT01188551|20619886|P3|NOT COMPLETED|Overall Study||0
8365137|NCT01188551|20619887|P2|NOT COMPLETED|Overall Study||0
8365138|NCT01188551|20619888|P1|NOT COMPLETED|Overall Study||1
8365139|NCT01188551|20619885|P4|COMPLETED|Overall Study||25
8365140|NCT01188551|20619886|P3|COMPLETED|Overall Study||25
8365141|NCT01188551|20619887|P2|COMPLETED|Overall Study||25
8365142|NCT01188551|20619888|P1|COMPLETED|Overall Study||24
8365143|NCT01188551|20619885|P4|STARTED|Overall Study||25
8365144|NCT01188551|20619886|P3|STARTED|Overall Study||25
8365145|NCT01188551|20619887|P2|STARTED|Overall Study||25
8365146|NCT01188551|20619888|P1|STARTED|Overall Study||25
8365153|NCT01188499|20619918|P5|NOT COMPLETED|Overall Study||0
8365154|NCT01188499|20619919|P4|NOT COMPLETED|Overall Study||0
8365155|NCT01188499|20619920|P3|NOT COMPLETED|Overall Study||0
8365156|NCT01188499|20619921|P2|NOT COMPLETED|Overall Study||0
8365157|NCT01188499|20619922|P1|NOT COMPLETED|Overall Study||0
8365158|NCT01188499|20619918|P5|COMPLETED|Overall Study||18
8365159|NCT01188499|20619919|P4|COMPLETED|Overall Study||18
8365160|NCT01188499|20619920|P3|COMPLETED|Overall Study||33
8365161|NCT01188499|20619921|P2|COMPLETED|Overall Study||83
8365162|NCT01188499|20619922|P1|COMPLETED|Overall Study||24
8365163|NCT01188499|20619918|P5|STARTED|Overall Study||18
8365164|NCT01188499|20619919|P4|STARTED|Overall Study||18
8365165|NCT01188499|20619920|P3|STARTED|Overall Study||33
8365166|NCT01188499|20619921|P2|STARTED|Overall Study||83
8365167|NCT01188499|20619922|P1|STARTED|Overall Study||24
8365168|NCT01188460|20619941|P2|NOT COMPLETED|Overall Study||0
8365169|NCT01188460|20619942|P1|NOT COMPLETED|Overall Study||0
8365170|NCT01188460|20619941|P2|COMPLETED|Overall Study||23
8365171|NCT01188460|20619942|P1|COMPLETED|Overall Study||25
8365172|NCT01188460|20619941|P2|STARTED|Overall Study||23
8365173|NCT01188460|20619942|P1|STARTED|Overall Study||25
8365174|NCT01188447|20619968|P1|NOT COMPLETED|Overall Study||0
8365175|NCT01188447|20619968|P1|COMPLETED|Overall Study||4034
8365176|NCT01188447|20619968|P1|STARTED|Overall Study||4034
8365177|NCT01188421|20619979|P3|NOT COMPLETED|Overall Study||14
8365178|NCT01188421|20619980|P2|NOT COMPLETED|Overall Study||10
8365179|NCT01188421|20619981|P1|NOT COMPLETED|Overall Study||3
8365180|NCT01188421|20619979|P3|COMPLETED|Overall Study||22
8365181|NCT01188421|20619980|P2|COMPLETED|Overall Study||26
8365182|NCT01188421|20619981|P1|COMPLETED|Overall Study||28
8365183|NCT01188421|20619979|P3|STARTED|Overall Study||36
8365184|NCT01188421|20619980|P2|STARTED|Overall Study||36
8365185|NCT01188421|20619981|P1|STARTED|Overall Study||31
8365186|NCT01188369|20619991|P2|NOT COMPLETED|Overall Study||0
8365187|NCT01188369|20619992|P1|NOT COMPLETED|Overall Study||0
8365188|NCT01188369|20619991|P2|COMPLETED|Overall Study||10
8365189|NCT01188369|20619992|P1|COMPLETED|Overall Study||10
8365190|NCT01188369|20619991|P2|STARTED|Overall Study||10
8365191|NCT01188369|20619992|P1|STARTED|Overall Study||10
8365192|NCT01188343|20620001|P3|NOT COMPLETED|Overall Study||1
8365193|NCT01188343|20620002|P2|NOT COMPLETED|Overall Study||26
8365194|NCT01188343|20620003|P1|NOT COMPLETED|Overall Study||1
8365195|NCT01188343|20620001|P3|COMPLETED|Overall Study||220
8365196|NCT01188343|20620002|P2|COMPLETED|Overall Study||193
8365197|NCT01188343|20620003|P1|COMPLETED|Overall Study||101
8365198|NCT01188343|20620001|P3|STARTED|Overall Study||221
8365199|NCT01188343|20620002|P2|STARTED|Overall Study||219
8365200|NCT01188343|20620003|P1|STARTED|Overall Study||102
8365201|NCT01188226|20620029|P1|NOT COMPLETED|Overall Study||4
8365202|NCT01188226|20620029|P1|COMPLETED|Overall Study||6
8365203|NCT01188226|20620029|P1|STARTED|Overall Study||10
8365204|NCT01188109|20620068|P1|NOT COMPLETED|Overall Study||0
8365205|NCT01188109|20620068|P1|COMPLETED|Overall Study||22
8365206|NCT01188109|20620068|P1|STARTED|Overall Study||22
8365207|NCT01187953|20620075|P2|NOT COMPLETED|Overall Study||21
8365208|NCT01187953|20620076|P1|NOT COMPLETED|Overall Study||15
8365209|NCT01187953|20620075|P2|COMPLETED|Overall Study||254
8365210|NCT01187953|20620076|P1|COMPLETED|Overall Study||253
8365211|NCT01187953|20620075|P2|Dosed|Overall Study||271
8365212|NCT01187953|20620076|P1|Dosed|Overall Study||266
8365213|NCT01187953|20620075|P2|STARTED|Overall Study||275
8365214|NCT01187953|20620076|P1|STARTED|Overall Study||268
8365215|NCT01187914|20620084|P1|NOT COMPLETED|Overall Study||0
8365216|NCT01187914|20620084|P1|COMPLETED|Overall Study||40
8365217|NCT01187914|20620084|P1|STARTED|Overall Study||40
8365218|NCT01187901|20620090|P2|NOT COMPLETED|Overall Study||10
8365219|NCT01187901|20620091|P1|NOT COMPLETED|Overall Study||9
8365220|NCT01187901|20620090|P2|COMPLETED|Overall Study||36
8365221|NCT01187901|20620091|P1|COMPLETED|Overall Study||37
8365222|NCT01187901|20620090|P2|STARTED|Overall Study||46
8365223|NCT01187901|20620091|P1|STARTED|Overall Study||46
8365224|NCT01187771|20620109|P2|NOT COMPLETED|Overall Study||3
8365225|NCT01187771|20620110|P1|NOT COMPLETED|Overall Study||3
8365226|NCT01187771|20620109|P2|COMPLETED|Overall Study||18
8365227|NCT01187771|20620110|P1|COMPLETED|Overall Study||25
8365228|NCT01187771|20620109|P2|STARTED|Overall Study||21
8365229|NCT01187771|20620110|P1|STARTED|Overall Study||28
8365230|NCT01187550|20620132|P2|NOT COMPLETED|Overall Study||1
8365231|NCT01187550|20620133|P1|NOT COMPLETED|Overall Study||14
8365232|NCT01187550|20620132|P2|COMPLETED|Overall Study||29
8365233|NCT01187550|20620133|P1|COMPLETED|Overall Study||169
8365234|NCT01187550|20620132|P2|Treated|Overall Study||30
8365235|NCT01187550|20620133|P1|Treated|Overall Study||175
8365236|NCT01187550|20620132|P2|STARTED|Overall Study||30
8365237|NCT01187550|20620133|P1|STARTED|Overall Study||183
8365238|NCT01187511|20620151|P2|NOT COMPLETED|Overall Study||1
8365239|NCT01187511|20620152|P1|NOT COMPLETED|Overall Study||8
8365240|NCT01187511|20620151|P2|COMPLETED|Overall Study||21
8365241|NCT01187511|20620152|P1|COMPLETED|Overall Study||14
8365242|NCT01187511|20620151|P2|STARTED|Overall Study||22
8365243|NCT01187511|20620152|P1|STARTED|Overall Study||22
8365244|NCT01187498|20620260|P2|NOT COMPLETED|Overall Study||10
8365245|NCT01187498|20620261|P1|NOT COMPLETED|Overall Study||9
8365246|NCT01187498|20620260|P2|COMPLETED|Overall Study||60
8365247|NCT01187498|20620261|P1|COMPLETED|Overall Study||64
8365248|NCT01187498|20620260|P2|STARTED|Overall Study||70
8365249|NCT01187498|20620261|P1|STARTED|Overall Study||73
8365250|NCT01187446|20620289|P2|NOT COMPLETED|Overall Study||1
8365251|NCT01187446|20620290|P1|NOT COMPLETED|Overall Study||0
8365252|NCT01187446|20620289|P2|COMPLETED|Overall Study||13
8365253|NCT01187446|20620290|P1|COMPLETED|Overall Study||14
8365254|NCT01187446|20620289|P2|STARTED|Overall Study||14
8365255|NCT01187446|20620290|P1|STARTED|Overall Study||14
8365256|NCT01187433|20620306|P2|NOT COMPLETED|Overall Study||4
8365257|NCT01187433|20620307|P1|NOT COMPLETED|Overall Study||11
8365258|NCT01187433|20620306|P2|COMPLETED|Overall Study||46
8365259|NCT01187433|20620307|P1|COMPLETED|Overall Study||89
8365260|NCT01187433|20620306|P2|STARTED|Overall Study||50
8365261|NCT01187433|20620307|P1|STARTED|Overall Study||100
8365262|NCT01187407|20620337|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
8365263|NCT01187407|20620338|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
8365264|NCT01187407|20620339|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
8365265|NCT01187407|20620340|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
8365266|NCT01187407|20620341|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365267|NCT01187407|20620337|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
8365268|NCT01187407|20620338|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
8365269|NCT01187407|20620339|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
8365270|NCT01187407|20620340|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
8365271|NCT01187407|20620341|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365272|NCT01187407|20620337|P5|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
8365273|NCT01187407|20620338|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
8365274|NCT01187407|20620339|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
8365275|NCT01187407|20620340|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
8365276|NCT01187407|20620341|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365277|NCT01187407|20620337|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
8365278|NCT01187407|20620338|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
8365279|NCT01187407|20620339|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
8365280|NCT01187407|20620340|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
8365281|NCT01187407|20620341|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365282|NCT01187407|20620337|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365283|NCT01187407|20620338|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365284|NCT01187407|20620339|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365285|NCT01187407|20620340|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365286|NCT01187407|20620341|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
8365287|NCT01187407|20620337|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365288|NCT01187407|20620338|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365289|NCT01187407|20620339|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365290|NCT01187407|20620340|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365291|NCT01187407|20620341|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
8365292|NCT01187407|20620337|P5|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8365293|NCT01187407|20620338|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8365294|NCT01187407|20620339|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8365295|NCT01187407|20620340|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8365296|NCT01187407|20620341|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
8365297|NCT01187407|20620337|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8365298|NCT01187407|20620338|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8365299|NCT01187407|20620339|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8365300|NCT01187407|20620340|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8365301|NCT01187407|20620341|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
8365302|NCT01187381|20620411|P1|NOT COMPLETED|Overall Study||0
8365303|NCT01187381|20620411|P1|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
8365304|NCT01187381|20620411|P1|STARTED|Overall Study||250
8365305|NCT01187355|20620423|P2|NOT COMPLETED|Overall Study||20
8365306|NCT01187355|20620424|P1|NOT COMPLETED|Overall Study||18
8365307|NCT01187355|20620423|P2|COMPLETED|Overall Study||277
8365308|NCT01187355|20620424|P1|COMPLETED|Overall Study||276
8365309|NCT01187355|20620423|P2|STARTED|Overall Study||297
8365310|NCT01187355|20620424|P1|STARTED|Overall Study||294
8365311|NCT01187329|20620436|P2|NOT COMPLETED|Overall Study||2
8365312|NCT01187329|20620437|P1|NOT COMPLETED|Overall Study||1
8365313|NCT01187329|20620436|P2|COMPLETED|Overall Study||48
8365314|NCT01187329|20620437|P1|COMPLETED|Overall Study||49
8365315|NCT01187329|20620436|P2|STARTED|Overall Study||50
8365316|NCT01187329|20620437|P1|STARTED|Overall Study||50
8365317|NCT01187043|20620454|P5|NOT COMPLETED|Overall Study||2
8365318|NCT01187043|20620455|P4|NOT COMPLETED|Overall Study||0
8365319|NCT01187043|20620456|P3|NOT COMPLETED|Overall Study||4
8365320|NCT01187043|20620457|P2|NOT COMPLETED|Overall Study||0
8365321|NCT01187043|20620458|P1|NOT COMPLETED|Overall Study||1
8365322|NCT01187043|20620454|P5|COMPLETED|Overall Study||10
8365323|NCT01187043|20620455|P4|COMPLETED|Overall Study||12
8365324|NCT01187043|20620456|P3|COMPLETED|Overall Study||8
8365325|NCT01187043|20620457|P2|COMPLETED|Overall Study||10
8365326|NCT01187043|20620458|P1|COMPLETED|Overall Study||11
8365327|NCT01187043|20620454|P5|STARTED|Overall Study||12
8365328|NCT01187043|20620455|P4|STARTED|Overall Study||12
8365329|NCT01187043|20620456|P3|STARTED|Overall Study||12
8365330|NCT01187043|20620457|P2|STARTED|Overall Study||10
8365331|NCT01187043|20620458|P1|STARTED|Overall Study||12
8365335|NCT01187004|20620476|P2|NOT COMPLETED|Overall Study||0
8365336|NCT01187004|20620477|P1|NOT COMPLETED|Overall Study||0
8365337|NCT01187004|20620476|P2|COMPLETED|Overall Study||144
8365338|NCT01187004|20620477|P1|COMPLETED|Overall Study||20
8365339|NCT01187004|20620476|P2|STARTED|Overall Study||144
8365340|NCT01187004|20620477|P1|STARTED|Overall Study||20
8365341|NCT01186978|20620484|P1|NOT COMPLETED|Overall Study||1
8365342|NCT01186978|20620484|P1|COMPLETED|Overall Study||62
8365343|NCT01186978|20620484|P1|STARTED|Overall Study||63
8365344|NCT01186939|20620491|P1|NOT COMPLETED|Overall Study||40
8365345|NCT01186939|20620491|P1|COMPLETED|Overall Study||0
8365346|NCT01186939|20620491|P1|STARTED|Overall Study||40
8365347|NCT01186848|20620495|P1|NOT COMPLETED|Overall Study||8
8365348|NCT01186848|20620495|P1|COMPLETED|Overall Study||22
8365349|NCT01186848|20620495|P1|STARTED|Overall Study||30
8365350|NCT01186809|20620501|P1|NOT COMPLETED|Overall Study||30
8365351|NCT01186809|20620501|P1|COMPLETED|Overall Study||43
8365352|NCT01186809|20620501|P1|STARTED|Overall Study||73
8365353|NCT01186796|20620507|P2|NOT COMPLETED|Overall Study||2
8365354|NCT01186796|20620508|P1|NOT COMPLETED|Overall Study||4
8365355|NCT01186796|20620507|P2|COMPLETED|Overall Study||14
8365356|NCT01186796|20620508|P1|COMPLETED|Overall Study||10
8365357|NCT01186796|20620507|P2|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
8365358|NCT01186796|20620508|P1|STARTED|Overall Study||14
8365359|NCT01186770|20620526|P4|NOT COMPLETED|Overall Study||58
8365360|NCT01186770|20620527|P3|NOT COMPLETED|Overall Study||52
8365361|NCT01186770|20620528|P2|NOT COMPLETED|Overall Study||46
8365362|NCT01186770|20620529|P1|NOT COMPLETED|Overall Study||41
8365363|NCT01186770|20620526|P4|COMPLETED|Overall Study||143
8365364|NCT01186770|20620527|P3|COMPLETED|Overall Study||148
8365365|NCT01186770|20620528|P2|COMPLETED|Overall Study||156
8365366|NCT01186770|20620529|P1|COMPLETED|Overall Study||160
8365367|NCT01186770|20620526|P4|Intent-to-treat (ITT Population)|Overall Study||201
8365368|NCT01186770|20620527|P3|Intent-to-treat (ITT Population)|Overall Study||200
8365369|NCT01186770|20620528|P2|Intent-to-treat (ITT Population)|Overall Study||201
8365370|NCT01186770|20620529|P1|Intent-to-treat (ITT Population)|Overall Study||201
8365371|NCT01186770|20620526|P4|STARTED|Overall Study||201
8365372|NCT01186770|20620527|P3|STARTED|Overall Study||200
8365373|NCT01186770|20620528|P2|STARTED|Overall Study||202
8365374|NCT01186770|20620529|P1|STARTED|Overall Study||201
8365375|NCT01186744|20620553|P6|NOT COMPLETED|Overall Study||26
8365376|NCT01186744|20620554|P5|NOT COMPLETED|Overall Study||6
8365377|NCT01186744|20620555|P4|NOT COMPLETED|Overall Study||12
8365378|NCT01186744|20620556|P3|NOT COMPLETED|Overall Study||6
8365379|NCT01186744|20620557|P2|NOT COMPLETED|Overall Study||152
8365380|NCT01186744|20620558|P1|NOT COMPLETED|Overall Study||208
8365381|NCT01186744|20620553|P6|COMPLETED|Overall Study||107
8365382|NCT01186744|20620554|P5|COMPLETED|Overall Study||39
8365383|NCT01186744|20620555|P4|COMPLETED|Overall Study||70
8365384|NCT01186744|20620556|P3|COMPLETED|Overall Study||25
8365385|NCT01186744|20620557|P2|COMPLETED|Overall Study||5
8365386|NCT01186744|20620558|P1|COMPLETED|Overall Study||10
8365387|NCT01186744|20620553|P6|STARTED|Overall Study||133
8365388|NCT01186744|20620554|P5|STARTED|Overall Study||45
8365389|NCT01186744|20620555|P4|STARTED|Overall Study||82
8365390|NCT01186744|20620556|P3|STARTED|Overall Study||31
8365391|NCT01186744|20620557|P2|STARTED|Overall Study||157
8365392|NCT01186744|20620558|P1|STARTED|Overall Study||218
8365393|NCT01186705|20620974|P1|NOT COMPLETED|Overall Study||0
8365394|NCT01186705|20620974|P1|COMPLETED|Overall Study||1
8365395|NCT01186705|20620974|P1|STARTED|Overall Study||1
8365396|NCT01186692|20620978|P1|NOT COMPLETED|Overall Study||32
8365397|NCT01186692|20620978|P1|COMPLETED|Overall Study||99
8365398|NCT01186692|20620978|P1|STARTED|Overall Study||131
8365399|NCT01186562|20620988|P2|NOT COMPLETED|Overall Study||2
8365400|NCT01186562|20620989|P1|NOT COMPLETED|Overall Study||4
8365401|NCT01186562|20620988|P2|COMPLETED|Overall Study||27
8365402|NCT01186562|20620989|P1|COMPLETED|Overall Study||50
8365403|NCT01186562|20620988|P2|STARTED|Overall Study||29
8365404|NCT01186562|20620989|P1|STARTED|Overall Study||54
8365405|NCT01186458|20621005|P1|NOT COMPLETED|Overall Study||1
8365406|NCT01186458|20621005|P1|COMPLETED|Overall Study||3
8365407|NCT01186458|20621005|P1|STARTED|Overall Study||4
8365414|NCT01186406|20621022|P1|NOT COMPLETED|Overall Study||0
8365415|NCT01186406|20621022|P1|COMPLETED|Overall Study||41
8365416|NCT01186406|20621022|P1|STARTED|Overall Study||41
8365417|NCT01186328|20621029|P3|NOT COMPLETED|Overall Study||0
8365418|NCT01186328|20621030|P2|NOT COMPLETED|Overall Study||0
8365419|NCT01186328|20621031|P1|NOT COMPLETED|Overall Study||1
8365420|NCT01186328|20621029|P3|COMPLETED|Overall Study||0
8365421|NCT01186328|20621030|P2|COMPLETED|Overall Study||0
8365422|NCT01186328|20621031|P1|COMPLETED|Overall Study||5
8365423|NCT01186328|20621029|P3|STARTED|Overall Study||0
8365424|NCT01186328|20621030|P2|STARTED|Overall Study||0
8365425|NCT01186328|20621031|P1|STARTED|Overall Study||6
8365426|NCT01186250|20621039|P2|NOT COMPLETED|Overall Study||0
8365427|NCT01186250|20621040|P1|NOT COMPLETED|Overall Study||1
8365428|NCT01186250|20621039|P2|COMPLETED|Overall Study||9
8365429|NCT01186250|20621040|P1|COMPLETED|Overall Study||8
8365430|NCT01186250|20621039|P2|STARTED|Overall Study||9
8365431|NCT01186250|20621040|P1|STARTED|Overall Study||9
8365432|NCT01185964|20621061|P4|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
8365433|NCT01185964|20621062|P3|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8365434|NCT01185964|20621063|P2|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8365435|NCT01185964|20621064|P1|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8365436|NCT01185964|20621061|P4|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
8365437|NCT01185964|20621062|P3|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8365438|NCT01185964|20621063|P2|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8365439|NCT01185964|20621064|P1|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
8365440|NCT01185964|20621061|P4|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
8365441|NCT01185964|20621062|P3|STARTED|Optional Olaratumab Monotherapy on Dox||0
8365442|NCT01185964|20621063|P2|STARTED|Optional Olaratumab Monotherapy on Dox||0
8365443|NCT01185964|20621064|P1|STARTED|Optional Olaratumab Monotherapy on Dox||0
8365444|NCT01185964|20621061|P4|NOT COMPLETED|Phase 1b and Phase 2||0
8365445|NCT01185964|20621062|P3|NOT COMPLETED|Phase 1b and Phase 2||9
8365446|NCT01185964|20621063|P2|NOT COMPLETED|Phase 1b and Phase 2||10
8365447|NCT01185964|20621064|P1|NOT COMPLETED|Phase 1b and Phase 2||2
8365448|NCT01185964|20621061|P4|COMPLETED|Phase 1b and Phase 2||0
8365449|NCT01185964|20621062|P3|COMPLETED|Phase 1b and Phase 2||58
8365450|NCT01185964|20621063|P2|COMPLETED|Phase 1b and Phase 2||56
8365451|NCT01185964|20621064|P1|COMPLETED|Phase 1b and Phase 2||13
8365452|NCT01185964|20621061|P4|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
8365453|NCT01185964|20621062|P3|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
8365454|NCT01185964|20621063|P2|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
8365455|NCT01185964|20621064|P1|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
8365456|NCT01185964|20621061|P4|STARTED|Phase 1b and Phase 2||0
8365457|NCT01185964|20621062|P3|STARTED|Phase 1b and Phase 2||67
8365458|NCT01185964|20621063|P2|STARTED|Phase 1b and Phase 2||66
8365459|NCT01185964|20621064|P1|STARTED|Phase 1b and Phase 2||15
8365460|NCT01185834|20621090|P1|NOT COMPLETED|Overall Study||14
8365461|NCT01185834|20621090|P1|COMPLETED|Overall Study||104
8365462|NCT01185834|20621090|P1|STARTED|Overall Study||118
8365463|NCT01185821|20621100|P5|NOT COMPLETED|Overall Study||24
8365464|NCT01185821|20621101|P4|NOT COMPLETED|Overall Study||6
8365465|NCT01185821|20621102|P3|NOT COMPLETED|Overall Study||10
8365466|NCT01185821|20621103|P2|NOT COMPLETED|Overall Study||9
8365467|NCT01185821|20621104|P1|NOT COMPLETED|Overall Study||7
8365468|NCT01185821|20621100|P5|COMPLETED|Overall Study||26
8365469|NCT01185821|20621101|P4|COMPLETED|Overall Study||23
8365470|NCT01185821|20621102|P3|COMPLETED|Overall Study||33
8365471|NCT01185821|20621103|P2|COMPLETED|Overall Study||20
8365472|NCT01185821|20621104|P1|COMPLETED|Overall Study||26
8365473|NCT01185821|20621100|P5|Patients on Placebo in Core|Overall Study||2
8365474|NCT01185821|20621101|P4|Patients on Placebo in Core|Overall Study||8
8365475|NCT01185821|20621102|P3|Patients on Placebo in Core|Overall Study||9
8365476|NCT01185821|20621103|P2|Patients on Placebo in Core|Overall Study||7
8365477|NCT01185821|20621104|P1|Patients on Placebo in Core|Overall Study||8
8365478|NCT01185821|20621100|P5|Patients Without Washout|Overall Study||17
8365479|NCT01185821|20621101|P4|Patients Without Washout|Overall Study||0
8365480|NCT01185821|20621102|P3|Patients Without Washout|Overall Study||4
8365481|NCT01185821|20621103|P2|Patients Without Washout|Overall Study||0
8365482|NCT01185821|20621104|P1|Patients Without Washout|Overall Study||0
8365483|NCT01185821|20621100|P5|Patients With Washout|Overall Study||33
8365484|NCT01185821|20621101|P4|Patients With Washout|Overall Study||29
8365485|NCT01185821|20621102|P3|Patients With Washout|Overall Study||39
8365486|NCT01185821|20621103|P2|Patients With Washout|Overall Study||29
8365487|NCT01185821|20621104|P1|Patients With Washout|Overall Study||33
8365488|NCT01185821|20621100|P5|STARTED|Overall Study||50
8365489|NCT01185821|20621101|P4|STARTED|Overall Study||29
8365490|NCT01185821|20621102|P3|STARTED|Overall Study||43
8365491|NCT01185821|20621103|P2|STARTED|Overall Study||29
8365492|NCT01185821|20621104|P1|STARTED|Overall Study||33
8365493|NCT01185782|20621155|P2|NOT COMPLETED|Overall Study||11
8365494|NCT01185782|20621156|P1|NOT COMPLETED|Overall Study||6
8365495|NCT01185782|20621155|P2|COMPLETED|Overall Study||125
8365496|NCT01185782|20621156|P1|COMPLETED|Overall Study||123
8365497|NCT01185782|20621155|P2|Treated|Overall Study||132
8365498|NCT01185782|20621156|P1|Treated|Overall Study||129
8365499|NCT01185782|20621155|P2|STARTED|Overall Study||136
8365500|NCT01185782|20621156|P1|STARTED|Overall Study||129
8365501|NCT01185704|20621184|P2|NOT COMPLETED|Overall Study||8
8365502|NCT01185704|20621185|P1|NOT COMPLETED|Overall Study||13
8365503|NCT01185704|20621184|P2|COMPLETED|Overall Study||60
8365504|NCT01185704|20621185|P1|COMPLETED|Overall Study||55
8365505|NCT01185704|20621184|P2|Treated|Overall Study||65
8365506|NCT01185704|20621185|P1|Treated|Overall Study||65
8365507|NCT01185704|20621184|P2|STARTED|Overall Study||68
8365508|NCT01185704|20621185|P1|STARTED|Overall Study||68
8365509|NCT01185639|20621219|P1|NOT COMPLETED|Overall Study||2
8365510|NCT01185639|20621219|P1|COMPLETED|Overall Study||27
8365511|NCT01185639|20621219|P1|STARTED|Overall Study||29
8365512|NCT01185600|20621229|P2|NOT COMPLETED|Overall Study||45
8365513|NCT01185600|20621230|P1|NOT COMPLETED|Overall Study||32
8365514|NCT01185600|20621229|P2|COMPLETED|Overall Study||59
8365515|NCT01185600|20621230|P1|COMPLETED|Overall Study||41
8365516|NCT01185600|20621229|P2|STARTED|Overall Study||104
8365517|NCT01185600|20621230|P1|STARTED|Overall Study||73
8365518|NCT01185561|20621252|P2|NOT COMPLETED|Overall Study||12
8365519|NCT01185561|20621253|P1|NOT COMPLETED|Overall Study||2
8365520|NCT01185561|20621252|P2|COMPLETED|Overall Study||26
8365521|NCT01185561|20621253|P1|COMPLETED|Overall Study||34
8365522|NCT01185561|20621252|P2|STARTED|Overall Study||38
8365523|NCT01185561|20621253|P1|STARTED|Overall Study||36
8365524|NCT01185548|20621265|P1|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
8365525|NCT01185548|20621265|P1|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
8365526|NCT01185548|20621265|P1|STARTED|Period 3: Tasisulam and Tolbutamide||2
8365527|NCT01185548|20621265|P1|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
8365528|NCT01185548|20621265|P1|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
8365529|NCT01185548|20621265|P1|STARTED|Period 2: Tasisulam and Tolbutamide||4
8365530|NCT01185548|20621265|P1|NOT COMPLETED|Period 1 : Tolbutamide||0
8365531|NCT01185548|20621265|P1|COMPLETED|Period 1 : Tolbutamide||4
8365532|NCT01185548|20621265|P1|STARTED|Period 1 : Tolbutamide||4
8365533|NCT01185522|20621278|P1|NOT COMPLETED|Overall Study||108
8365534|NCT01185522|20621278|P1|COMPLETED|Overall Study||585
8365535|NCT01185522|20621278|P1|STARTED|Overall Study||693
8365536|NCT01185509|20621304|P2|NOT COMPLETED|Overall Study||20
8365537|NCT01185509|20621305|P1|NOT COMPLETED|Overall Study||11
8365538|NCT01185509|20621304|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8365539|NCT01185509|20621305|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8365540|NCT01185509|20621304|P2|STARTED|Overall Study||20
8365541|NCT01185509|20621305|P1|STARTED|Overall Study||11
8365542|NCT01185353|20621321|P10|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
8365543|NCT01185353|20621322|P9|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
8365544|NCT01185353|20621323|P8|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
8365545|NCT01185353|20621324|P7|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8365546|NCT01185353|20621325|P6|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8365547|NCT01185353|20621326|P5|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8365548|NCT01185353|20621327|P4|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8365549|NCT01185353|20621328|P3|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8365550|NCT01185353|20621329|P2|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8365551|NCT01185353|20621330|P1|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
8365552|NCT01185353|20621321|P10|COMPLETED|Part D (Weeks 76 Through 128)||17
8365553|NCT01185353|20621322|P9|COMPLETED|Part D (Weeks 76 Through 128)||40
8365554|NCT01185353|20621323|P8|COMPLETED|Part D (Weeks 76 Through 128)||76
8365555|NCT01185353|20621324|P7|COMPLETED|Part D (Weeks 76 Through 128)||0
8365556|NCT01185353|20621325|P6|COMPLETED|Part D (Weeks 76 Through 128)||0
8365557|NCT01185353|20621326|P5|COMPLETED|Part D (Weeks 76 Through 128)||0
8365558|NCT01185353|20621327|P4|COMPLETED|Part D (Weeks 76 Through 128)||0
8365559|NCT01185353|20621328|P3|COMPLETED|Part D (Weeks 76 Through 128)||0
8365560|NCT01185353|20621329|P2|COMPLETED|Part D (Weeks 76 Through 128)||0
8365561|NCT01185353|20621330|P1|COMPLETED|Part D (Weeks 76 Through 128)||0
8365562|NCT01185353|20621321|P10|STARTED|Part D (Weeks 76 Through 128)||18
8365563|NCT01185353|20621322|P9|STARTED|Part D (Weeks 76 Through 128)||47
8365564|NCT01185353|20621323|P8|STARTED|Part D (Weeks 76 Through 128)||79
8365565|NCT01185353|20621324|P7|STARTED|Part D (Weeks 76 Through 128)||0
8365566|NCT01185353|20621325|P6|STARTED|Part D (Weeks 76 Through 128)||0
8365567|NCT01185353|20621326|P5|STARTED|Part D (Weeks 76 Through 128)||0
8365568|NCT01185353|20621327|P4|STARTED|Part D (Weeks 76 Through 128)||0
8365569|NCT01185353|20621328|P3|STARTED|Part D (Weeks 76 Through 128)||0
8365570|NCT01185353|20621329|P2|STARTED|Part D (Weeks 76 Through 128)||0
8365571|NCT01185353|20621330|P1|STARTED|Part D (Weeks 76 Through 128)||0
8365572|NCT01185353|20621321|P10|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
8365573|NCT01185353|20621322|P9|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
8365574|NCT01185353|20621323|P8|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
8365575|NCT01185353|20621324|P7|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8365576|NCT01185353|20621325|P6|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8365577|NCT01185353|20621326|P5|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8365578|NCT01185353|20621327|P4|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8365579|NCT01185353|20621328|P3|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8365580|NCT01185353|20621329|P2|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8365581|NCT01185353|20621330|P1|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
8365582|NCT01185353|20621321|P10|COMPLETED|Part C (Weeks 24 Through 76)||24
8365583|NCT01185353|20621322|P9|COMPLETED|Part C (Weeks 24 Through 76)||53
8365584|NCT01185353|20621323|P8|COMPLETED|Part C (Weeks 24 Through 76)||92
8365585|NCT01185353|20621324|P7|COMPLETED|Part C (Weeks 24 Through 76)||0
8365586|NCT01185353|20621325|P6|COMPLETED|Part C (Weeks 24 Through 76)||0
8365587|NCT01185353|20621326|P5|COMPLETED|Part C (Weeks 24 Through 76)||0
8365588|NCT01185353|20621327|P4|COMPLETED|Part C (Weeks 24 Through 76)||0
8365589|NCT01185353|20621328|P3|COMPLETED|Part C (Weeks 24 Through 76)||0
8365590|NCT01185353|20621329|P2|COMPLETED|Part C (Weeks 24 Through 76)||0
8365591|NCT01185353|20621330|P1|COMPLETED|Part C (Weeks 24 Through 76)||0
8365592|NCT01185353|20621321|P10|STARTED|Part C (Weeks 24 Through 76)||32
8365593|NCT01185353|20621322|P9|STARTED|Part C (Weeks 24 Through 76)||61
8365594|NCT01185353|20621323|P8|STARTED|Part C (Weeks 24 Through 76)||108
8365595|NCT01185353|20621324|P7|STARTED|Part C (Weeks 24 Through 76)||0
8365596|NCT01185353|20621325|P6|STARTED|Part C (Weeks 24 Through 76)||0
8365597|NCT01185353|20621326|P5|STARTED|Part C (Weeks 24 Through 76)||0
8365598|NCT01185353|20621327|P4|STARTED|Part C (Weeks 24 Through 76)||0
8365599|NCT01185353|20621328|P3|STARTED|Part C (Weeks 24 Through 76)||0
8365600|NCT01185353|20621329|P2|STARTED|Part C (Weeks 24 Through 76)||0
8365601|NCT01185353|20621330|P1|STARTED|Part C (Weeks 24 Through 76)||0
8365602|NCT01185353|20621321|P10|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8365603|NCT01185353|20621322|P9|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8365604|NCT01185353|20621323|P8|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8365605|NCT01185353|20621324|P7|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
8365606|NCT01185353|20621325|P6|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
8365607|NCT01185353|20621326|P5|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8365608|NCT01185353|20621327|P4|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
8365609|NCT01185353|20621328|P3|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
8365610|NCT01185353|20621329|P2|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
8365611|NCT01185353|20621330|P1|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
8365612|NCT01185353|20621321|P10|COMPLETED|Part B (Weeks 12 Through 24)||0
8365613|NCT01185353|20621322|P9|COMPLETED|Part B (Weeks 12 Through 24)||0
8365614|NCT01185353|20621323|P8|COMPLETED|Part B (Weeks 12 Through 24)||0
8365615|NCT01185353|20621324|P7|COMPLETED|Part B (Weeks 12 Through 24)||57
8365616|NCT01185353|20621325|P6|COMPLETED|Part B (Weeks 12 Through 24)||59
8365617|NCT01185353|20621326|P5|COMPLETED|Part B (Weeks 12 Through 24)||0
8365618|NCT01185353|20621327|P4|COMPLETED|Part B (Weeks 12 Through 24)||45
8365619|NCT01185353|20621328|P3|COMPLETED|Part B (Weeks 12 Through 24)||48
8365620|NCT01185353|20621329|P2|COMPLETED|Part B (Weeks 12 Through 24)||50
8365621|NCT01185353|20621330|P1|COMPLETED|Part B (Weeks 12 Through 24)||0
8365622|NCT01185353|20621321|P10|STARTED|Part B (Weeks 12 Through 24)||0
8365623|NCT01185353|20621322|P9|STARTED|Part B (Weeks 12 Through 24)||0
8365624|NCT01185353|20621323|P8|STARTED|Part B (Weeks 12 Through 24)||0
8365625|NCT01185353|20621324|P7|STARTED|Part B (Weeks 12 Through 24)||63
8365626|NCT01185353|20621325|P6|STARTED|Part B (Weeks 12 Through 24)||63
8365627|NCT01185353|20621326|P5|STARTED|Part B (Weeks 12 Through 24)||0
8365628|NCT01185353|20621327|P4|STARTED|Part B (Weeks 12 Through 24)||49
8365629|NCT01185353|20621328|P3|STARTED|Part B (Weeks 12 Through 24)||50
8365630|NCT01185353|20621329|P2|STARTED|Part B (Weeks 12 Through 24)||51
8365631|NCT01185353|20621330|P1|STARTED|Part B (Weeks 12 Through 24)||0
8365632|NCT01185353|20621321|P10|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8365633|NCT01185353|20621322|P9|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8365634|NCT01185353|20621323|P8|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8365635|NCT01185353|20621324|P7|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8365636|NCT01185353|20621325|P6|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
8365637|NCT01185353|20621326|P5|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
8365638|NCT01185353|20621327|P4|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
8365639|NCT01185353|20621328|P3|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
8365640|NCT01185353|20621329|P2|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
8365641|NCT01185353|20621330|P1|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
8365642|NCT01185353|20621321|P10|COMPLETED|Part A (Weeks 0 Through 12)||0
8365643|NCT01185353|20621322|P9|COMPLETED|Part A (Weeks 0 Through 12)||0
8365644|NCT01185353|20621323|P8|COMPLETED|Part A (Weeks 0 Through 12)||0
8365645|NCT01185353|20621324|P7|COMPLETED|Part A (Weeks 0 Through 12)||0
8365646|NCT01185353|20621325|P6|COMPLETED|Part A (Weeks 0 Through 12)||0
8365647|NCT01185353|20621326|P5|COMPLETED|Part A (Weeks 0 Through 12)||82
8365648|NCT01185353|20621327|P4|COMPLETED|Part A (Weeks 0 Through 12)||49
8365649|NCT01185353|20621328|P3|COMPLETED|Part A (Weeks 0 Through 12)||50
8365650|NCT01185353|20621329|P2|COMPLETED|Part A (Weeks 0 Through 12)||51
8365651|NCT01185353|20621330|P1|COMPLETED|Part A (Weeks 0 Through 12)||44
8365652|NCT01185353|20621321|P10|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8365653|NCT01185353|20621322|P9|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8365654|NCT01185353|20621323|P8|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8365655|NCT01185353|20621324|P7|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8365656|NCT01185353|20621325|P6|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
8365657|NCT01185353|20621326|P5|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
8365658|NCT01185353|20621327|P4|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
8365659|NCT01185353|20621328|P3|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
8365660|NCT01185353|20621329|P2|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
8365661|NCT01185353|20621330|P1|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
8365662|NCT01185353|20621321|P10|STARTED|Part A (Weeks 0 Through 12)||0
8365663|NCT01185353|20621322|P9|STARTED|Part A (Weeks 0 Through 12)||0
8365664|NCT01185353|20621323|P8|STARTED|Part A (Weeks 0 Through 12)||0
8365665|NCT01185353|20621324|P7|STARTED|Part A (Weeks 0 Through 12)||0
8365666|NCT01185353|20621325|P6|STARTED|Part A (Weeks 0 Through 12)||0
8365667|NCT01185353|20621326|P5|STARTED|Part A (Weeks 0 Through 12)||98
8365668|NCT01185353|20621327|P4|STARTED|Part A (Weeks 0 Through 12)||50
8365669|NCT01185353|20621328|P3|STARTED|Part A (Weeks 0 Through 12)||52
8365670|NCT01185353|20621329|P2|STARTED|Part A (Weeks 0 Through 12)||52
8365671|NCT01185353|20621330|P1|STARTED|Part A (Weeks 0 Through 12)||49
8365672|NCT01185340|20621491|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
8365673|NCT01185340|20621492|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
8365674|NCT01185340|20621493|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
8365675|NCT01185340|20621494|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365676|NCT01185340|20621491|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
8365677|NCT01185340|20621492|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
8365678|NCT01185340|20621493|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
8365679|NCT01185340|20621494|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365680|NCT01185340|20621491|P4|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
8365681|NCT01185340|20621492|P3|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
8365682|NCT01185340|20621493|P2|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
8365683|NCT01185340|20621494|P1|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365684|NCT01185340|20621491|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
8365685|NCT01185340|20621492|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
8365686|NCT01185340|20621493|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
8365687|NCT01185340|20621494|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8365688|NCT01185340|20621491|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365689|NCT01185340|20621492|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365690|NCT01185340|20621493|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365691|NCT01185340|20621494|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
8365692|NCT01185340|20621491|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365693|NCT01185340|20621492|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365694|NCT01185340|20621493|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8365695|NCT01185340|20621494|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
8365696|NCT01185340|20621491|P4|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8365697|NCT01185340|20621492|P3|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8365698|NCT01185340|20621493|P2|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
8365699|NCT01185340|20621494|P1|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
8365700|NCT01185340|20621491|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8365701|NCT01185340|20621492|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8365702|NCT01185340|20621493|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8365703|NCT01185340|20621494|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
8365704|NCT01185301|20621546|P4|NOT COMPLETED|Overall Study||9
8365705|NCT01185301|20621547|P3|NOT COMPLETED|Overall Study||6
8365706|NCT01185301|20621548|P2|NOT COMPLETED|Overall Study||7
8365707|NCT01185301|20621549|P1|NOT COMPLETED|Overall Study||15
8365708|NCT01185301|20621546|P4|COMPLETED|Overall Study||89
8365709|NCT01185301|20621547|P3|COMPLETED|Overall Study||93
8365710|NCT01185301|20621548|P2|COMPLETED|Overall Study||93
8365711|NCT01185301|20621549|P1|COMPLETED|Overall Study||83
8365712|NCT01185301|20621546|P4|STARTED|Overall Study||98
8365713|NCT01185301|20621547|P3|STARTED|Overall Study||99
8365714|NCT01185301|20621548|P2|STARTED|Overall Study||100
8365715|NCT01185301|20621549|P1|STARTED|Overall Study||98
8365716|NCT01185288|20621609|P2|NOT COMPLETED|Overall Study||16
8365717|NCT01185288|20621610|P1|NOT COMPLETED|Overall Study||19
8365718|NCT01185288|20621609|P2|COMPLETED|Overall Study||139
8365719|NCT01185288|20621610|P1|COMPLETED|Overall Study||135
8365720|NCT01185288|20621609|P2|STARTED|Overall Study||155
8365721|NCT01185288|20621610|P1|STARTED|Overall Study||154
8365722|NCT01185249|20621628|P1|NOT COMPLETED|Overall Study||42
8365723|NCT01185249|20621628|P1|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
8365724|NCT01185249|20621628|P1|STARTED|Overall Study|Total number of patients consented to participate.|66
8365725|NCT01185171|20621633|P1|NOT COMPLETED|Maintenance||12
8365726|NCT01185171|20621633|P1|COMPLETED|Maintenance||48
8365727|NCT01185171|20621633|P1|STARTED|Maintenance||60
8365728|NCT01185171|20621633|P1|NOT COMPLETED|Concurrent Chemo and Radiation Treatment||3
8365729|NCT01185171|20621633|P1|COMPLETED|Concurrent Chemo and Radiation Treatment||66
8365730|NCT01185171|20621633|P1|STARTED|Concurrent Chemo and Radiation Treatment||69
8365731|NCT01185171|20621633|P1|NOT COMPLETED|Induction Chemotherapy||2
8365732|NCT01185171|20621633|P1|COMPLETED|Induction Chemotherapy||57
8365733|NCT01185171|20621633|P1|STARTED|Induction Chemotherapy||59
8365734|NCT01185080|20621643|P3|NOT COMPLETED|Overall Study||1
8365735|NCT01185080|20621644|P2|NOT COMPLETED|Overall Study||1
8365736|NCT01185080|20621645|P1|NOT COMPLETED|Overall Study||1
8365737|NCT01185080|20621643|P3|COMPLETED|Overall Study||16
8365738|NCT01185080|20621644|P2|COMPLETED|Overall Study||15
8365739|NCT01185080|20621645|P1|COMPLETED|Overall Study||49
8365740|NCT01185080|20621643|P3|STARTED|Overall Study||17
8365741|NCT01185080|20621644|P2|STARTED|Overall Study||16
8365742|NCT01185080|20621645|P1|STARTED|Overall Study||50
8365746|NCT01184989|20621697|P1|NOT COMPLETED|Overall Study||12
8365747|NCT01184989|20621697|P1|COMPLETED|Overall Study||100
8365748|NCT01184989|20621697|P1|STARTED|Overall Study|Treated Patients|112
8365749|NCT01184898|20621703|P1|NOT COMPLETED|Overall Study||0
8365750|NCT01184898|20621703|P1|COMPLETED|Overall Study||36
8365751|NCT01184898|20621703|P1|STARTED|Overall Study||36
8365752|NCT01184885|20621710|P1|NOT COMPLETED|Overall Study||0
8365753|NCT01184885|20621710|P1|COMPLETED|Overall Study||7
8365754|NCT01184885|20621710|P1|STARTED|Overall Study||7
8365755|NCT01184872|20621717|P2|NOT COMPLETED|Overall Study||8
8365756|NCT01184872|20621718|P1|NOT COMPLETED|Overall Study||10
8365757|NCT01184872|20621717|P2|COMPLETED|Overall Study||31
8365758|NCT01184872|20621718|P1|COMPLETED|Overall Study||71
8365759|NCT01184872|20621717|P2|Microbiologically Evaluable Set (MES)|Overall Study||27
8365760|NCT01184872|20621718|P1|Microbiologically Evaluable Set (MES)|Overall Study||65
8365761|NCT01184872|20621717|P2|Clinical Evaluable Set (CES)|Overall Study||30
8365762|NCT01184872|20621718|P1|Clinical Evaluable Set (CES)|Overall Study||73
8365763|NCT01184872|20621717|P2|Safety Set|Overall Study||40
8365764|NCT01184872|20621718|P1|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
8365765|NCT01184872|20621717|P2|STARTED|Overall Study||39
8365766|NCT01184872|20621718|P1|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
8365767|NCT01184859|20621737|P5|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
8365768|NCT01184859|20621738|P4|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
8365769|NCT01184859|20621739|P3|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
8365770|NCT01184859|20621740|P2|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
8365771|NCT01184859|20621741|P1|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
8365772|NCT01184859|20621737|P5|COMPLETED|Period 2: Daily Dose for 28 Days||22
8365773|NCT01184859|20621738|P4|COMPLETED|Period 2: Daily Dose for 28 Days||22
8365774|NCT01184859|20621739|P3|COMPLETED|Period 2: Daily Dose for 28 Days||22
8365775|NCT01184859|20621740|P2|COMPLETED|Period 2: Daily Dose for 28 Days||23
8365776|NCT01184859|20621741|P1|COMPLETED|Period 2: Daily Dose for 28 Days||22
8365777|NCT01184859|20621737|P5|STARTED|Period 2: Daily Dose for 28 Days||23
8365778|NCT01184859|20621738|P4|STARTED|Period 2: Daily Dose for 28 Days||22
8365779|NCT01184859|20621739|P3|STARTED|Period 2: Daily Dose for 28 Days||22
8365780|NCT01184859|20621740|P2|STARTED|Period 2: Daily Dose for 28 Days||23
8365781|NCT01184859|20621741|P1|STARTED|Period 2: Daily Dose for 28 Days||23
8365782|NCT01184859|20621737|P5|NOT COMPLETED|Washout Period||0
8365783|NCT01184859|20621738|P4|NOT COMPLETED|Washout Period||0
8365784|NCT01184859|20621739|P3|NOT COMPLETED|Washout Period||0
8365785|NCT01184859|20621740|P2|NOT COMPLETED|Washout Period||0
8365786|NCT01184859|20621741|P1|NOT COMPLETED|Washout Period||0
8365787|NCT01184859|20621737|P5|COMPLETED|Washout Period||23
8365788|NCT01184859|20621738|P4|COMPLETED|Washout Period||22
8365789|NCT01184859|20621739|P3|COMPLETED|Washout Period||22
8365790|NCT01184859|20621740|P2|COMPLETED|Washout Period||23
8365791|NCT01184859|20621741|P1|COMPLETED|Washout Period||23
8365792|NCT01184859|20621737|P5|STARTED|Washout Period||23
8365793|NCT01184859|20621738|P4|STARTED|Washout Period||22
8365794|NCT01184859|20621739|P3|STARTED|Washout Period||22
8365795|NCT01184859|20621740|P2|STARTED|Washout Period||23
8365796|NCT01184859|20621741|P1|STARTED|Washout Period||23
8365797|NCT01184859|20621737|P5|NOT COMPLETED|Period 1: Single Dose||1
8365798|NCT01184859|20621738|P4|NOT COMPLETED|Period 1: Single Dose||0
8365799|NCT01184859|20621739|P3|NOT COMPLETED|Period 1: Single Dose||0
8365800|NCT01184859|20621740|P2|NOT COMPLETED|Period 1: Single Dose||2
8365801|NCT01184859|20621741|P1|NOT COMPLETED|Period 1: Single Dose||0
8365802|NCT01184859|20621737|P5|COMPLETED|Period 1: Single Dose||23
8365803|NCT01184859|20621738|P4|COMPLETED|Period 1: Single Dose||22
8365804|NCT01184859|20621739|P3|COMPLETED|Period 1: Single Dose||22
8365805|NCT01184859|20621740|P2|COMPLETED|Period 1: Single Dose||23
8365806|NCT01184859|20621741|P1|COMPLETED|Period 1: Single Dose||23
8365807|NCT01184859|20621737|P5|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
8365808|NCT01184859|20621738|P4|Per Protocol (PP)|Period 1: Single Dose||21
8365809|NCT01184859|20621739|P3|Per Protocol (PP)|Period 1: Single Dose||22
8365810|NCT01184859|20621740|P2|Per Protocol (PP)|Period 1: Single Dose||23
8365811|NCT01184859|20621741|P1|Per Protocol (PP)|Period 1: Single Dose||23
8365812|NCT01184859|20621737|P5|Full Analysis Set (FAS)|Period 1: Single Dose||24
8365813|NCT01184859|20621738|P4|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
8365814|NCT01184859|20621739|P3|Full Analysis Set (FAS)|Period 1: Single Dose||22
8365815|NCT01184859|20621740|P2|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
8365816|NCT01184859|20621741|P1|Full Analysis Set (FAS)|Period 1: Single Dose||23
8365817|NCT01184859|20621737|P5|STARTED|Period 1: Single Dose||24
8365818|NCT01184859|20621738|P4|STARTED|Period 1: Single Dose||22
8365819|NCT01184859|20621739|P3|STARTED|Period 1: Single Dose||22
8365820|NCT01184859|20621740|P2|STARTED|Period 1: Single Dose||25
8365821|NCT01184859|20621741|P1|STARTED|Period 1: Single Dose||23
8365822|NCT01184846|20621833|P1|NOT COMPLETED|Overall Study||3
8365823|NCT01184846|20621833|P1|COMPLETED|Overall Study||25
8365824|NCT01184846|20621833|P1|STARTED|Overall Study||28
8365825|NCT01184755|20621854|P3|NOT COMPLETED|Overall Study||6
8365826|NCT01184755|20621855|P2|NOT COMPLETED|Overall Study||11
8365827|NCT01184755|20621856|P1|NOT COMPLETED|Overall Study||25
8365828|NCT01184755|20621854|P3|COMPLETED|Overall Study||56
8365829|NCT01184755|20621855|P2|COMPLETED|Overall Study||54
8365830|NCT01184755|20621856|P1|COMPLETED|Overall Study||101
8365831|NCT01184755|20621854|P3|STARTED|Overall Study||62
8365832|NCT01184755|20621855|P2|STARTED|Overall Study||65
8365833|NCT01184755|20621856|P1|STARTED|Overall Study||126
8365834|NCT01184508|20621866|P2|NOT COMPLETED|Overall Study||15
8365835|NCT01184508|20621867|P1|NOT COMPLETED|Overall Study||16
8365836|NCT01184508|20621866|P2|COMPLETED|Overall Study||27
8365837|NCT01184508|20621867|P1|COMPLETED|Overall Study||29
8365838|NCT01184508|20621866|P2|Received at Least 1 Dose of Study Drug|Overall Study||41
8365839|NCT01184508|20621867|P1|Received at Least 1 Dose of Study Drug|Overall Study||45
8365840|NCT01184508|20621866|P2|STARTED|Overall Study||42
8365841|NCT01184508|20621867|P1|STARTED|Overall Study||45
8365842|NCT01184456|20621894|P2|NOT COMPLETED|Overall Study||0
8365843|NCT01184456|20621895|P1|NOT COMPLETED|Overall Study||0
8365844|NCT01184456|20621894|P2|COMPLETED|Overall Study||0
8365845|NCT01184456|20621895|P1|COMPLETED|Overall Study||0
8365846|NCT01184456|20621894|P2|STARTED|Overall Study||0
8365847|NCT01184456|20621895|P1|STARTED|Overall Study||0
8365848|NCT01184417|20621903|P2|NOT COMPLETED|Overall Study||0
8365849|NCT01184417|20621904|P1|NOT COMPLETED|Overall Study||0
8365850|NCT01184417|20621903|P2|COMPLETED|Overall Study||51
8365851|NCT01184417|20621904|P1|COMPLETED|Overall Study||51
8365852|NCT01184417|20621903|P2|STARTED|Overall Study||51
8365853|NCT01184417|20621904|P1|STARTED|Overall Study||51
8365854|NCT01184326|20621927|P3|NOT COMPLETED|Overall Study||14
8365855|NCT01184326|20621928|P2|NOT COMPLETED|Overall Study||6
8365856|NCT01184326|20621929|P1|NOT COMPLETED|Overall Study||3
8365857|NCT01184326|20621927|P3|COMPLETED|Overall Study||0
8365858|NCT01184326|20621928|P2|COMPLETED|Overall Study||0
8365859|NCT01184326|20621929|P1|COMPLETED|Overall Study||0
8365860|NCT01184326|20621927|P3|STARTED|Overall Study||14
8365861|NCT01184326|20621928|P2|STARTED|Overall Study||6
8365862|NCT01184326|20621929|P1|STARTED|Overall Study||3
8365863|NCT01184118|20621943|P1|NOT COMPLETED|Overall Study||18
8365864|NCT01184118|20621943|P1|COMPLETED|Overall Study||18
8365865|NCT01184118|20621943|P1|FP MDI as Indicated (2 Weeks)|Overall Study||18
8365866|NCT01184118|20621943|P1|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
8365867|NCT01184118|20621943|P1|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
8365868|NCT01184118|20621943|P1|STARTED|Overall Study||36
8365869|NCT01184079|20621951|P2|NOT COMPLETED|Overall Study||2
8365870|NCT01184079|20621952|P1|NOT COMPLETED|Overall Study||14
8365871|NCT01184079|20621951|P2|COMPLETED|Overall Study||107
8365872|NCT01184079|20621952|P1|COMPLETED|Overall Study||97
8365873|NCT01184079|20621951|P2|Final Blood Draw|Overall Study||107
8365874|NCT01184079|20621952|P1|Final Blood Draw|Overall Study||97
8365875|NCT01184079|20621951|P2|Dose 3|Overall Study||107
8365876|NCT01184079|20621952|P1|Dose 3|Overall Study||101
8365877|NCT01184079|20621951|P2|Dose 2|Overall Study||108
8365878|NCT01184079|20621952|P1|Dose 2|Overall Study||110
8365879|NCT01184079|20621951|P2|STARTED|Overall Study||109
8365880|NCT01184079|20621952|P1|STARTED|Overall Study||111
8365881|NCT01184053|20621962|P1|NOT COMPLETED|Overall Study||3
8365882|NCT01184053|20621962|P1|COMPLETED|Overall Study||0
8365883|NCT01184053|20621962|P1|STARTED|Overall Study||3
8365884|NCT01184014|20621971|P2|NOT COMPLETED|Overall Study||6
8365885|NCT01184014|20621972|P1|NOT COMPLETED|Overall Study||5
8365886|NCT01184014|20621971|P2|COMPLETED|Overall Study||31
8365887|NCT01184014|20621972|P1|COMPLETED|Overall Study||30
8365888|NCT01184014|20621971|P2|STARTED|Overall Study||37
8365889|NCT01184014|20621972|P1|STARTED|Overall Study||35
8365890|NCT01183975|20621978|P1|NOT COMPLETED|Overall Study||73
8365891|NCT01183975|20621978|P1|COMPLETED|Overall Study||444
8365892|NCT01183975|20621978|P1|STARTED|Overall Study||517
8365893|NCT01183923|20621983|P2|NOT COMPLETED|Intervention 2 (7 Days)||0
8365894|NCT01183923|20621984|P1|NOT COMPLETED|Intervention 2 (7 Days)||0
8365895|NCT01183923|20621983|P2|COMPLETED|Intervention 2 (7 Days)||0
8365896|NCT01183923|20621984|P1|COMPLETED|Intervention 2 (7 Days)||1
8365897|NCT01183923|20621983|P2|STARTED|Intervention 2 (7 Days)||0
8365898|NCT01183923|20621984|P1|STARTED|Intervention 2 (7 Days)||1
8365899|NCT01183923|20621983|P2|NOT COMPLETED|Washout (14 Days)||0
8365900|NCT01183923|20621984|P1|NOT COMPLETED|Washout (14 Days)||0
8365901|NCT01183923|20621983|P2|COMPLETED|Washout (14 Days)||0
8365902|NCT01183923|20621984|P1|COMPLETED|Washout (14 Days)||1
8365903|NCT01183923|20621983|P2|STARTED|Washout (14 Days)||0
8365904|NCT01183923|20621984|P1|STARTED|Washout (14 Days)||1
8365905|NCT01183923|20621983|P2|NOT COMPLETED|Intervention 1 (7 Days)||0
8365906|NCT01183923|20621984|P1|NOT COMPLETED|Intervention 1 (7 Days)||0
8365907|NCT01183923|20621983|P2|COMPLETED|Intervention 1 (7 Days)||0
8365908|NCT01183923|20621984|P1|COMPLETED|Intervention 1 (7 Days)||1
8365909|NCT01183923|20621983|P2|STARTED|Intervention 1 (7 Days)||0
8365910|NCT01183923|20621984|P1|STARTED|Intervention 1 (7 Days)||1
8365911|NCT01183897|20621989|P1|NOT COMPLETED|Overall Study||0
8365912|NCT01183897|20621989|P1|COMPLETED|Overall Study||31
8365913|NCT01183897|20621989|P1|STARTED|Overall Study||31
8365914|NCT01183884|20621995|P1|NOT COMPLETED|Overall Study||38
8365915|NCT01183884|20621995|P1|COMPLETED|Overall Study||8
8365916|NCT01183884|20621995|P1|STARTED|Overall Study||46
8365917|NCT01183858|20622003|P2|NOT COMPLETED|Overall Study||156
8365918|NCT01183858|20622004|P1|NOT COMPLETED|Overall Study||153
8365919|NCT01183858|20622003|P2|COMPLETED|Overall Study||3
8365920|NCT01183858|20622004|P1|COMPLETED|Overall Study||1
8365921|NCT01183858|20622003|P2|Safety Population|Overall Study||158
8365922|NCT01183858|20622004|P1|Safety Population|Overall Study||154
8365923|NCT01183858|20622003|P2|STARTED|Overall Study||159
8365924|NCT01183858|20622004|P1|STARTED|Overall Study||154
8365925|NCT01183780|20622026|P2|NOT COMPLETED|Overall Study||25
8365926|NCT01183780|20622027|P1|NOT COMPLETED|Overall Study||31
8365927|NCT01183780|20622026|P2|COMPLETED|Overall Study||511
8365928|NCT01183780|20622027|P1|COMPLETED|Overall Study||505
8365929|NCT01183780|20622026|P2|Received at Least 1 Dose of Study Drug|Overall Study||529
8365930|NCT01183780|20622027|P1|Received at Least 1 Dose of Study Drug|Overall Study||528
8365931|NCT01183780|20622026|P2|STARTED|Overall Study||536
8365932|NCT01183780|20622027|P1|STARTED|Overall Study||536
8365933|NCT01183728|20622044|P1|NOT COMPLETED|Overall Study||0
8365934|NCT01183728|20622044|P1|COMPLETED|Overall Study||12
8365935|NCT01183728|20622044|P1|STARTED|Overall Study||12
8365936|NCT01183689|20622052|P3|NOT COMPLETED|Overall Study||0
8365937|NCT01183689|20622053|P2|NOT COMPLETED|Overall Study||0
8365938|NCT01183689|20622054|P1|NOT COMPLETED|Overall Study||0
8365939|NCT01183689|20622052|P3|COMPLETED|Overall Study||197
8365940|NCT01183689|20622053|P2|COMPLETED|Overall Study||200
8365941|NCT01183689|20622054|P1|COMPLETED|Overall Study||202
8365942|NCT01183689|20622052|P3|Year 4 Visit|Overall Study||30
8365943|NCT01183689|20622053|P2|Year 4 Visit|Overall Study||33
8365944|NCT01183689|20622054|P1|Year 4 Visit|Overall Study||38
8365945|NCT01183689|20622052|P3|Year 3 Visit|Overall Study||126
8365946|NCT01183689|20622053|P2|Year 3 Visit|Overall Study||125
8365947|NCT01183689|20622054|P1|Year 3 Visit|Overall Study||139
8365948|NCT01183689|20622052|P3|Year 2 Visit|Overall Study||174
8365949|NCT01183689|20622053|P2|Year 2 Visit|Overall Study||172
8365950|NCT01183689|20622054|P1|Year 2 Visit|Overall Study||178
8365951|NCT01183689|20622052|P3|Year 1 Visit|Overall Study||183
8365952|NCT01183689|20622053|P2|Year 1 Visit|Overall Study||172
8365953|NCT01183689|20622054|P1|Year 1 Visit|Overall Study||187
8365954|NCT01183689|20622052|P3|Month 4 Visit|Overall Study||187
8365955|NCT01183689|20622053|P2|Month 4 Visit|Overall Study||192
8365956|NCT01183689|20622054|P1|Month 4 Visit|Overall Study||197
8365957|NCT01183689|20622052|P3|STARTED|Overall Study||197
8365958|NCT01183689|20622053|P2|STARTED|Overall Study||200
8365959|NCT01183689|20622054|P1|STARTED|Overall Study||202
8365960|NCT01183650|20622124|P2|NOT COMPLETED|Overall Study||0
8365961|NCT01183650|20622125|P1|NOT COMPLETED|Overall Study||0
8365962|NCT01183650|20622124|P2|COMPLETED|Overall Study||12
8365963|NCT01183650|20622125|P1|COMPLETED|Overall Study||12
8365964|NCT01183650|20622124|P2|STARTED|Overall Study||12
8365965|NCT01183650|20622125|P1|STARTED|Overall Study||12
8365966|NCT01183559|20622135|P1|NOT COMPLETED|Overall Study||0
8365967|NCT01183559|20622135|P1|COMPLETED|Overall Study||9
8365968|NCT01183559|20622135|P1|STARTED|Overall Study||9
8365969|NCT01183546|20622140|P1|NOT COMPLETED|Overall Study||0
8365970|NCT01183546|20622140|P1|COMPLETED|Overall Study||53
8365971|NCT01183546|20622140|P1|STARTED|Overall Study||53
8365972|NCT01183533|20622147|P1|NOT COMPLETED|Overall Study||0
8365973|NCT01183533|20622147|P1|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
8365974|NCT01183533|20622147|P1|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
8365975|NCT01183481|20622153|P1|NOT COMPLETED|Overall Study||0
8365976|NCT01183481|20622153|P1|COMPLETED|Overall Study||19
8365977|NCT01183481|20622153|P1|STARTED|Overall Study||19
8365978|NCT01183468|20622165|P4|NOT COMPLETED|Overall Study||0
8365979|NCT01183468|20622166|P3|NOT COMPLETED|Overall Study||0
8365980|NCT01183468|20622167|P2|NOT COMPLETED|Overall Study||2
8365981|NCT01183468|20622168|P1|NOT COMPLETED|Overall Study||3
8365982|NCT01183468|20622165|P4|COMPLETED|Overall Study||0
8365983|NCT01183468|20622166|P3|COMPLETED|Overall Study||0
8365984|NCT01183468|20622167|P2|COMPLETED|Overall Study||7
8365985|NCT01183468|20622168|P1|COMPLETED|Overall Study||5
8365986|NCT01183468|20622165|P4|STARTED|Overall Study||0
8365987|NCT01183468|20622166|P3|STARTED|Overall Study||0
8365988|NCT01183468|20622167|P2|STARTED|Overall Study||9
8365989|NCT01183468|20622168|P1|STARTED|Overall Study||8
8365990|NCT01183429|20622176|P1|NOT COMPLETED|Overall Study||0
8365991|NCT01183429|20622176|P1|COMPLETED|Overall Study||39
8365992|NCT01183429|20622176|P1|STARTED|Overall Study||39
8365993|NCT01183416|20622182|P1|NOT COMPLETED|Overall Study||0
8365994|NCT01183416|20622182|P1|COMPLETED|Overall Study||4
8365995|NCT01183416|20622182|P1|STARTED|Overall Study||4
8365996|NCT01183390|20622190|P2|NOT COMPLETED|Second Intervention||0
8365997|NCT01183390|20622191|P1|NOT COMPLETED|Second Intervention||0
8365998|NCT01183390|20622190|P2|COMPLETED|Second Intervention||10
8365999|NCT01183390|20622191|P1|COMPLETED|Second Intervention||11
8366000|NCT01183390|20622190|P2|STARTED|Second Intervention||10
8366001|NCT01183390|20622191|P1|STARTED|Second Intervention||11
8366002|NCT01183390|20622190|P2|NOT COMPLETED|Washout of 21 Days||0
8366003|NCT01183390|20622191|P1|NOT COMPLETED|Washout of 21 Days||0
8366004|NCT01183390|20622190|P2|COMPLETED|Washout of 21 Days||10
8366005|NCT01183390|20622191|P1|COMPLETED|Washout of 21 Days||11
8366006|NCT01183390|20622190|P2|STARTED|Washout of 21 Days||10
8366007|NCT01183390|20622191|P1|STARTED|Washout of 21 Days||11
8366008|NCT01183390|20622190|P2|NOT COMPLETED|First Intervention||1
8366009|NCT01183390|20622191|P1|NOT COMPLETED|First Intervention||0
8366010|NCT01183390|20622190|P2|COMPLETED|First Intervention||10
8366011|NCT01183390|20622191|P1|COMPLETED|First Intervention||11
8366012|NCT01183390|20622190|P2|STARTED|First Intervention||11
8366013|NCT01183390|20622191|P1|STARTED|First Intervention||11
8366014|NCT01183312|20622201|P2|NOT COMPLETED|Second Intervention Day||0
8366015|NCT01183312|20622202|P1|NOT COMPLETED|Second Intervention Day||0
8366016|NCT01183312|20622201|P2|COMPLETED|Second Intervention Day||5
8366017|NCT01183312|20622202|P1|COMPLETED|Second Intervention Day||5
8366018|NCT01183312|20622201|P2|STARTED|Second Intervention Day||5
8366019|NCT01183312|20622202|P1|STARTED|Second Intervention Day||5
8366020|NCT01183312|20622201|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
8366021|NCT01183312|20622202|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
8366022|NCT01183312|20622201|P2|COMPLETED|Washout Period of at Least 1 Week||5
8366023|NCT01183312|20622202|P1|COMPLETED|Washout Period of at Least 1 Week||5
8366024|NCT01183312|20622201|P2|STARTED|Washout Period of at Least 1 Week||5
8366025|NCT01183312|20622202|P1|STARTED|Washout Period of at Least 1 Week||5
8366026|NCT01183312|20622201|P2|NOT COMPLETED|First Intervention Day||0
8366027|NCT01183312|20622202|P1|NOT COMPLETED|First Intervention Day||0
8366028|NCT01183312|20622201|P2|COMPLETED|First Intervention Day||5
8366029|NCT01183312|20622202|P1|COMPLETED|First Intervention Day||5
8366030|NCT01183312|20622201|P2|STARTED|First Intervention Day||5
8366031|NCT01183312|20622202|P1|STARTED|First Intervention Day||5
8366032|NCT01183260|20622224|P2|NOT COMPLETED|Overall Study||2
8366033|NCT01183260|20622225|P1|NOT COMPLETED|Overall Study||4
8366034|NCT01183260|20622224|P2|COMPLETED|Overall Study||9
8366035|NCT01183260|20622225|P1|COMPLETED|Overall Study||10
8366036|NCT01183260|20622224|P2|STARTED|Overall Study||11
8366037|NCT01183260|20622225|P1|STARTED|Overall Study||14
8366056|NCT01183169|20622250|P7|NOT COMPLETED|Post-switch Phase||9
8366057|NCT01183169|20622251|P6|NOT COMPLETED|Post-switch Phase||14
8366058|NCT01183169|20622252|P5|NOT COMPLETED|Post-switch Phase||0
8366059|NCT01183169|20622253|P4|NOT COMPLETED|Post-switch Phase||0
8366060|NCT01183169|20622254|P3|NOT COMPLETED|Post-switch Phase||0
8366061|NCT01183169|20622255|P2|NOT COMPLETED|Post-switch Phase||0
8366062|NCT01183169|20622256|P1|NOT COMPLETED|Post-switch Phase||0
8366063|NCT01183169|20622250|P7|COMPLETED|Post-switch Phase||21
8366064|NCT01183169|20622251|P6|COMPLETED|Post-switch Phase||21
8366065|NCT01183169|20622252|P5|COMPLETED|Post-switch Phase||0
8366066|NCT01183169|20622253|P4|COMPLETED|Post-switch Phase||0
8366067|NCT01183169|20622254|P3|COMPLETED|Post-switch Phase||0
8366068|NCT01183169|20622255|P2|COMPLETED|Post-switch Phase||0
8366069|NCT01183169|20622256|P1|COMPLETED|Post-switch Phase||0
8366070|NCT01183169|20622250|P7|Completed Treatment|Post-switch Phase||13
8366071|NCT01183169|20622251|P6|Completed Treatment|Post-switch Phase||12
8366072|NCT01183169|20622252|P5|Completed Treatment|Post-switch Phase||0
8366073|NCT01183169|20622253|P4|Completed Treatment|Post-switch Phase||0
8366074|NCT01183169|20622254|P3|Completed Treatment|Post-switch Phase||0
8366075|NCT01183169|20622255|P2|Completed Treatment|Post-switch Phase||0
8366076|NCT01183169|20622256|P1|Completed Treatment|Post-switch Phase||0
8366077|NCT01183169|20622250|P7|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
8366078|NCT01183169|20622251|P6|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
8366079|NCT01183169|20622252|P5|STARTED|Post-switch Phase|Not a post-switch group|0
8366080|NCT01183169|20622253|P4|STARTED|Post-switch Phase|Not a post-switch group|0
8366081|NCT01183169|20622254|P3|STARTED|Post-switch Phase|Not a post-switch group|0
8366082|NCT01183169|20622255|P2|STARTED|Post-switch Phase|Not a post-switch group|0
8366083|NCT01183169|20622256|P1|STARTED|Post-switch Phase|Not a post-switch group|0
8366084|NCT01183169|20622250|P7|NOT COMPLETED|Main Phase||0
8366085|NCT01183169|20622251|P6|NOT COMPLETED|Main Phase||0
8366086|NCT01183169|20622252|P5|NOT COMPLETED|Main Phase||26
8366087|NCT01183169|20622253|P4|NOT COMPLETED|Main Phase||37
8366088|NCT01183169|20622254|P3|NOT COMPLETED|Main Phase||41
8366089|NCT01183169|20622255|P2|NOT COMPLETED|Main Phase||22
8366090|NCT01183169|20622256|P1|NOT COMPLETED|Main Phase||27
8366091|NCT01183169|20622250|P7|COMPLETED|Main Phase||0
8366092|NCT01183169|20622251|P6|COMPLETED|Main Phase||0
8366093|NCT01183169|20622252|P5|COMPLETED|Main Phase||83
8366094|NCT01183169|20622253|P4|COMPLETED|Main Phase||18
8366095|NCT01183169|20622254|P3|COMPLETED|Main Phase||18
8366096|NCT01183169|20622255|P2|COMPLETED|Main Phase||93
8366097|NCT01183169|20622256|P1|COMPLETED|Main Phase||94
8366098|NCT01183169|20622250|P7|Switched to ALV|Main Phase||0
8366099|NCT01183169|20622251|P6|Switched to ALV|Main Phase||0
8366100|NCT01183169|20622252|P5|Switched to ALV|Main Phase||0
8366101|NCT01183169|20622253|P4|Switched to ALV|Main Phase||30
8366102|NCT01183169|20622254|P3|Switched to ALV|Main Phase||35
8366103|NCT01183169|20622255|P2|Switched to ALV|Main Phase||0
8366104|NCT01183169|20622256|P1|Switched to ALV|Main Phase||0
8366105|NCT01183169|20622250|P7|Completed Treatment|Main Phase||0
8366106|NCT01183169|20622251|P6|Completed Treatment|Main Phase||0
8366107|NCT01183169|20622252|P5|Completed Treatment|Main Phase||77
8366108|NCT01183169|20622253|P4|Completed Treatment|Main Phase||17
8366109|NCT01183169|20622254|P3|Completed Treatment|Main Phase||17
8366110|NCT01183169|20622255|P2|Completed Treatment|Main Phase||78
8366111|NCT01183169|20622256|P1|Completed Treatment|Main Phase||72
8366112|NCT01183169|20622250|P7|STARTED|Main Phase||0
8366113|NCT01183169|20622251|P6|STARTED|Main Phase||0
8366114|NCT01183169|20622252|P5|STARTED|Main Phase||109
8366115|NCT01183169|20622253|P4|STARTED|Main Phase||55
8366116|NCT01183169|20622254|P3|STARTED|Main Phase||59
8366117|NCT01183169|20622255|P2|STARTED|Main Phase||115
8366118|NCT01183169|20622256|P1|STARTED|Main Phase||121
8366119|NCT01183143|20622328|P1|NOT COMPLETED|Overall Study||150
8366120|NCT01183143|20622328|P1|COMPLETED|Overall Study||65
8366121|NCT01183143|20622328|P1|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
8366122|NCT01183143|20622328|P1|STARTED|Overall Study||215
8366123|NCT01183104|20622344|P2|NOT COMPLETED|Overall Study||92
8366124|NCT01183104|20622345|P1|NOT COMPLETED|Overall Study||77
8366125|NCT01183104|20622344|P2|COMPLETED|Overall Study||60
8366126|NCT01183104|20622345|P1|COMPLETED|Overall Study||76
8366127|NCT01183104|20622344|P2|Enrolled in Extension Study|Overall Study||61
8366128|NCT01183104|20622345|P1|Enrolled in Extension Study|Overall Study||80
8366129|NCT01183104|20622344|P2|Completed 52-week Treatment|Overall Study||111
8366130|NCT01183104|20622345|P1|Completed 52-week Treatment|Overall Study||119
8366131|NCT01183104|20622344|P2|Continued Treatment for 12 Weeks|Overall Study||129
8366132|NCT01183104|20622345|P1|Continued Treatment for 12 Weeks|Overall Study||143
8366133|NCT01183104|20622344|P2|Received Study Drug|Overall Study||143
8366134|NCT01183104|20622345|P1|Received Study Drug|Overall Study||148
8366135|NCT01183104|20622344|P2|STARTED|Overall Study||152
8366136|NCT01183104|20622345|P1|STARTED|Overall Study||153
8366137|NCT01183065|20622361|P1|NOT COMPLETED|Overall Study||1
8366138|NCT01183065|20622361|P1|COMPLETED|Overall Study||12
8366139|NCT01183065|20622361|P1|STARTED|Overall Study||13
8366140|NCT01183013|20622372|P7|NOT COMPLETED|Overall Study||37
8366141|NCT01183013|20622373|P6|NOT COMPLETED|Overall Study||45
8366142|NCT01183013|20622374|P5|NOT COMPLETED|Overall Study||36
8366143|NCT01183013|20622375|P4|NOT COMPLETED|Overall Study||30
8366144|NCT01183013|20622376|P3|NOT COMPLETED|Overall Study||41
8366145|NCT01183013|20622377|P2|NOT COMPLETED|Overall Study||39
8366146|NCT01183013|20622378|P1|NOT COMPLETED|Overall Study||45
8366147|NCT01183013|20622372|P7|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
8366148|NCT01183013|20622373|P6|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
8366149|NCT01183013|20622374|P5|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
8366150|NCT01183013|20622375|P4|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
8366151|NCT01183013|20622376|P3|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
8366152|NCT01183013|20622377|P2|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
8366153|NCT01183013|20622378|P1|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
8366154|NCT01183013|20622372|P7|STARTED|Overall Study||133
8366155|NCT01183013|20622373|P6|STARTED|Overall Study||133
8366156|NCT01183013|20622374|P5|STARTED|Overall Study||126
8366157|NCT01183013|20622375|P4|STARTED|Overall Study||135
8366158|NCT01183013|20622376|P3|STARTED|Overall Study||138
8366159|NCT01183013|20622377|P2|STARTED|Overall Study||140
8366160|NCT01183013|20622378|P1|STARTED|Overall Study||131
8366161|NCT01182844|20622459|P2|NOT COMPLETED|Overall Study||2
8366162|NCT01182844|20622460|P1|NOT COMPLETED|Overall Study||0
8366163|NCT01182844|20622459|P2|COMPLETED|Overall Study||13
8366164|NCT01182844|20622460|P1|COMPLETED|Overall Study||15
8366165|NCT01182844|20622459|P2|STARTED|Overall Study||15
8366166|NCT01182844|20622460|P1|STARTED|Overall Study||15
8366167|NCT01182805|20622478|P1|NOT COMPLETED|Overall Study||0
8366168|NCT01182805|20622478|P1|COMPLETED|Overall Study||50
8366169|NCT01182805|20622478|P1|STARTED|Overall Study||50
8366170|NCT01182727|20622487|P1|NOT COMPLETED|Overall Study||0
8366171|NCT01182727|20622487|P1|COMPLETED|Overall Study||10
8366172|NCT01182727|20622487|P1|STARTED|Overall Study||10
8366173|NCT01182675|20622493|P2|NOT COMPLETED|Overall Study||0
8366174|NCT01182675|20622494|P1|NOT COMPLETED|Overall Study||0
8366175|NCT01182675|20622493|P2|COMPLETED|Overall Study||0
8366176|NCT01182675|20622494|P1|COMPLETED|Overall Study||7
8366177|NCT01182675|20622493|P2|STARTED|Overall Study||0
8366178|NCT01182675|20622494|P1|STARTED|Overall Study||7
8366179|NCT01182610|20622510|P1|NOT COMPLETED|Overall Study||0
8366180|NCT01182610|20622510|P1|COMPLETED|Overall Study||1
8366181|NCT01182610|20622510|P1|STARTED|Overall Study||1
8366182|NCT01182493|20622520|P2|NOT COMPLETED|Overall Study||7
8366183|NCT01182493|20622521|P1|NOT COMPLETED|Overall Study||16
8366184|NCT01182493|20622520|P2|COMPLETED|Overall Study||156
8366185|NCT01182493|20622521|P1|COMPLETED|Overall Study||152
8366186|NCT01182493|20622520|P2|STARTED|Overall Study||163
8366187|NCT01182493|20622521|P1|STARTED|Overall Study||168
8366188|NCT01182480|20622539|P1|NOT COMPLETED|Overall Study||0
8366189|NCT01182480|20622539|P1|COMPLETED|Overall Study||47
8366190|NCT01182480|20622539|P1|STARTED|Overall Study||47
8366191|NCT01182441|20622545|P2|NOT COMPLETED|Overall Study||119
8366192|NCT01182441|20622546|P1|NOT COMPLETED|Overall Study||220
8366193|NCT01182441|20622545|P2|COMPLETED|Overall Study||19
8366194|NCT01182441|20622546|P1|COMPLETED|Overall Study||49
8366195|NCT01182441|20622545|P2|STARTED|Overall Study||138
8366196|NCT01182441|20622546|P1|STARTED|Overall Study||269
8366197|NCT01182428|20622557|P2|NOT COMPLETED|Overall Study||1
8366198|NCT01182428|20622558|P1|NOT COMPLETED|Overall Study||11
8366199|NCT01182428|20622557|P2|COMPLETED|Overall Study||150
8366200|NCT01182428|20622558|P1|COMPLETED|Overall Study||293
8366201|NCT01182428|20622557|P2|STARTED|Overall Study||151
8366202|NCT01182428|20622558|P1|STARTED|Overall Study||304
8366203|NCT01182415|20622622|P1|NOT COMPLETED|Overall Study||1
8366204|NCT01182415|20622622|P1|COMPLETED|Overall Study||29
8366205|NCT01182415|20622622|P1|STARTED|Overall Study||30
8366206|NCT01182376|20622631|P2|NOT COMPLETED|Overall Study||5
8366207|NCT01182376|20622632|P1|NOT COMPLETED|Overall Study||11
8366208|NCT01182376|20622631|P2|COMPLETED|Overall Study||13
8366209|NCT01182376|20622632|P1|COMPLETED|Overall Study||4
8366210|NCT01182376|20622631|P2|STARTED|Overall Study||18
8366211|NCT01182376|20622632|P1|STARTED|Overall Study||15
8366212|NCT01182350|20622638|P5|NOT COMPLETED|Overall Study||3
8366213|NCT01182350|20622639|P4|NOT COMPLETED|Overall Study||3
8366214|NCT01182350|20622640|P3|NOT COMPLETED|Overall Study||3
8366215|NCT01182350|20622641|P2|NOT COMPLETED|Overall Study||14
8366216|NCT01182350|20622642|P1|NOT COMPLETED|Overall Study||27
8366217|NCT01182350|20622638|P5|COMPLETED|Overall Study||0
8366218|NCT01182350|20622639|P4|COMPLETED|Overall Study||0
8366219|NCT01182350|20622640|P3|COMPLETED|Overall Study||0
8366220|NCT01182350|20622641|P2|COMPLETED|Overall Study||0
8366221|NCT01182350|20622642|P1|COMPLETED|Overall Study||3
8366222|NCT01182350|20622638|P5|Started Assigned Chemoradiation|Overall Study||0
8366223|NCT01182350|20622639|P4|Started Assigned Chemoradiation|Overall Study||2
8366224|NCT01182350|20622640|P3|Started Assigned Chemoradiation|Overall Study||2
8366225|NCT01182350|20622641|P2|Started Assigned Chemoradiation|Overall Study||14
8366226|NCT01182350|20622642|P1|Started Assigned Chemoradiation|Overall Study||27
8366227|NCT01182350|20622638|P5|Underwent Stereotactic Biopsy|Overall Study||0
8366228|NCT01182350|20622639|P4|Underwent Stereotactic Biopsy|Overall Study||3
8366229|NCT01182350|20622640|P3|Underwent Stereotactic Biopsy|Overall Study||3
8366230|NCT01182350|20622641|P2|Underwent Stereotactic Biopsy|Overall Study||14
8366231|NCT01182350|20622642|P1|Underwent Stereotactic Biopsy|Overall Study||30
8366232|NCT01182350|20622638|P5|STARTED|Overall Study||3
8366233|NCT01182350|20622639|P4|STARTED|Overall Study||3
8366234|NCT01182350|20622640|P3|STARTED|Overall Study||3
8366235|NCT01182350|20622641|P2|STARTED|Overall Study||14
8366236|NCT01182350|20622642|P1|STARTED|Overall Study||30
8366237|NCT01182337|20622664|P2|NOT COMPLETED|Overall Study||2
8366238|NCT01182337|20622665|P1|NOT COMPLETED|Overall Study||3
8366239|NCT01182337|20622664|P2|COMPLETED|Overall Study||7
8366240|NCT01182337|20622665|P1|COMPLETED|Overall Study||19
8366241|NCT01182337|20622664|P2|STARTED|Overall Study||9
8366242|NCT01182337|20622665|P1|STARTED|Overall Study||22
8366243|NCT01182298|20622683|P1|NOT COMPLETED|Overall Study||6
8366244|NCT01182298|20622683|P1|COMPLETED|Overall Study||4
8366245|NCT01182298|20622683|P1|STARTED|Overall Study||10
8366246|NCT01182285|20622687|P3|NOT COMPLETED|Third Intervention Week 11-52||8
8366247|NCT01182285|20622688|P2|NOT COMPLETED|Third Intervention Week 11-52||0
8366248|NCT01182285|20622689|P1|NOT COMPLETED|Third Intervention Week 11-52||0
8366249|NCT01182285|20622687|P3|COMPLETED|Third Intervention Week 11-52||0
8366250|NCT01182285|20622688|P2|COMPLETED|Third Intervention Week 11-52||0
8366251|NCT01182285|20622689|P1|COMPLETED|Third Intervention Week 11-52||0
8366252|NCT01182285|20622687|P3|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
8366253|NCT01182285|20622688|P2|STARTED|Third Intervention Week 11-52||0
8366254|NCT01182285|20622689|P1|STARTED|Third Intervention Week 11-52||0
8366255|NCT01182285|20622687|P3|NOT COMPLETED|Second Intervention Week 11-17||0
8366256|NCT01182285|20622688|P2|NOT COMPLETED|Second Intervention Week 11-17||0
8366257|NCT01182285|20622689|P1|NOT COMPLETED|Second Intervention Week 11-17||0
8366258|NCT01182285|20622687|P3|COMPLETED|Second Intervention Week 11-17||0
8366259|NCT01182285|20622688|P2|COMPLETED|Second Intervention Week 11-17||0
8366260|NCT01182285|20622689|P1|COMPLETED|Second Intervention Week 11-17||0
8366261|NCT01182285|20622687|P3|STARTED|Second Intervention Week 11-17||0
8366262|NCT01182285|20622688|P2|STARTED|Second Intervention Week 11-17||0
8366263|NCT01182285|20622689|P1|STARTED|Second Intervention Week 11-17||0
8366264|NCT01182285|20622687|P3|NOT COMPLETED|First Intervention Week 1-10||0
8366265|NCT01182285|20622688|P2|NOT COMPLETED|First Intervention Week 1-10||0
8366266|NCT01182285|20622689|P1|NOT COMPLETED|First Intervention Week 1-10||3
8366267|NCT01182285|20622687|P3|COMPLETED|First Intervention Week 1-10||0
8366268|NCT01182285|20622688|P2|COMPLETED|First Intervention Week 1-10||0
8366269|NCT01182285|20622689|P1|COMPLETED|First Intervention Week 1-10||10
8366270|NCT01182285|20622687|P3|STARTED|First Intervention Week 1-10||0
8366271|NCT01182285|20622688|P2|STARTED|First Intervention Week 1-10||0
8366272|NCT01182285|20622689|P1|STARTED|First Intervention Week 1-10||13
8366273|NCT01182207|20622699|P2|NOT COMPLETED|Second Intervention||0
8366274|NCT01182207|20622700|P1|NOT COMPLETED|Second Intervention||1
8366275|NCT01182207|20622699|P2|COMPLETED|Second Intervention||14
8366276|NCT01182207|20622700|P1|COMPLETED|Second Intervention||17
8366277|NCT01182207|20622699|P2|STARTED|Second Intervention||14
8366278|NCT01182207|20622700|P1|STARTED|Second Intervention||18
8366279|NCT01182207|20622699|P2|NOT COMPLETED|Washout of 28 Days||0
8366280|NCT01182207|20622700|P1|NOT COMPLETED|Washout of 28 Days||0
8366281|NCT01182207|20622699|P2|COMPLETED|Washout of 28 Days||14
8366282|NCT01182207|20622700|P1|COMPLETED|Washout of 28 Days||18
8366283|NCT01182207|20622699|P2|STARTED|Washout of 28 Days||14
8366284|NCT01182207|20622700|P1|STARTED|Washout of 28 Days||18
8366285|NCT01182207|20622699|P2|NOT COMPLETED|First Intervention||1
8366286|NCT01182207|20622700|P1|NOT COMPLETED|First Intervention||0
8366287|NCT01182207|20622699|P2|COMPLETED|First Intervention||14
8366288|NCT01182207|20622700|P1|COMPLETED|First Intervention||18
8366289|NCT01182207|20622699|P2|STARTED|First Intervention||15
8366290|NCT01182207|20622700|P1|STARTED|First Intervention||18
8366291|NCT01182194|20622718|P2|NOT COMPLETED|Second Intervention||0
8366292|NCT01182194|20622719|P1|NOT COMPLETED|Second Intervention||0
8366293|NCT01182194|20622718|P2|COMPLETED|Second Intervention||16
8366294|NCT01182194|20622719|P1|COMPLETED|Second Intervention||15
8366295|NCT01182194|20622718|P2|STARTED|Second Intervention||16
8366296|NCT01182194|20622719|P1|STARTED|Second Intervention||15
8366297|NCT01182194|20622718|P2|NOT COMPLETED|Washout of 28 Days||0
8366298|NCT01182194|20622719|P1|NOT COMPLETED|Washout of 28 Days||1
8366299|NCT01182194|20622718|P2|COMPLETED|Washout of 28 Days||16
8366300|NCT01182194|20622719|P1|COMPLETED|Washout of 28 Days||15
8366301|NCT01182194|20622718|P2|STARTED|Washout of 28 Days||16
8366302|NCT01182194|20622719|P1|STARTED|Washout of 28 Days||16
8366303|NCT01182194|20622718|P2|NOT COMPLETED|First Intervention||0
8366304|NCT01182194|20622719|P1|NOT COMPLETED|First Intervention||0
8366305|NCT01182194|20622718|P2|COMPLETED|First Intervention||16
8366306|NCT01182194|20622719|P1|COMPLETED|First Intervention||16
8366307|NCT01182194|20622718|P2|STARTED|First Intervention||16
8366308|NCT01182194|20622719|P1|STARTED|First Intervention||16
8366309|NCT01182181|20622737|P2|NOT COMPLETED|Second Intervention||0
8366310|NCT01182181|20622738|P1|NOT COMPLETED|Second Intervention||0
8366311|NCT01182181|20622737|P2|COMPLETED|Second Intervention||10
8366312|NCT01182181|20622738|P1|COMPLETED|Second Intervention||10
8366313|NCT01182181|20622737|P2|STARTED|Second Intervention||10
8366314|NCT01182181|20622738|P1|STARTED|Second Intervention||10
8366315|NCT01182181|20622737|P2|NOT COMPLETED|Washout of 21 Days||1
8366316|NCT01182181|20622738|P1|NOT COMPLETED|Washout of 21 Days||0
8366317|NCT01182181|20622737|P2|COMPLETED|Washout of 21 Days||10
8366318|NCT01182181|20622738|P1|COMPLETED|Washout of 21 Days||10
8366319|NCT01182181|20622737|P2|STARTED|Washout of 21 Days||11
8366320|NCT01182181|20622738|P1|STARTED|Washout of 21 Days||10
8366321|NCT01182181|20622737|P2|NOT COMPLETED|First Intervention||0
8366322|NCT01182181|20622738|P1|NOT COMPLETED|First Intervention||1
8366323|NCT01182181|20622737|P2|COMPLETED|First Intervention||11
8366324|NCT01182181|20622738|P1|COMPLETED|First Intervention||10
8366325|NCT01182181|20622737|P2|STARTED|First Intervention||11
8366326|NCT01182181|20622738|P1|STARTED|First Intervention||11
8366327|NCT01182103|20622748|P2|NOT COMPLETED|Overall Study||0
8366328|NCT01182103|20622749|P1|NOT COMPLETED|Overall Study||0
8366329|NCT01182103|20622748|P2|COMPLETED|Overall Study||62
8366330|NCT01182103|20622749|P1|COMPLETED|Overall Study||48
8366331|NCT01182103|20622748|P2|STARTED|Overall Study||62
8366332|NCT01182103|20622749|P1|STARTED|Overall Study||48
8366333|NCT01181986|20622763|P3|NOT COMPLETED|Phase 2||0
8366334|NCT01181986|20622764|P2|NOT COMPLETED|Phase 2||4
8366335|NCT01181986|20622765|P1|NOT COMPLETED|Phase 2||0
8366336|NCT01181986|20622763|P3|COMPLETED|Phase 2||0
8366337|NCT01181986|20622764|P2|COMPLETED|Phase 2||18
8366338|NCT01181986|20622765|P1|COMPLETED|Phase 2||18
8366339|NCT01181986|20622763|P3|STARTED|Phase 2|N/A for Sub-study 2|0
8366340|NCT01181986|20622764|P2|STARTED|Phase 2||22
8366341|NCT01181986|20622765|P1|STARTED|Phase 2||18
8366342|NCT01181986|20622763|P3|NOT COMPLETED|Phase 1||2
8366343|NCT01181986|20622764|P2|NOT COMPLETED|Phase 1||1
8366344|NCT01181986|20622765|P1|NOT COMPLETED|Phase 1||1
8366345|NCT01181986|20622763|P3|COMPLETED|Phase 1||32
8366346|NCT01181986|20622764|P2|COMPLETED|Phase 1||22
8366347|NCT01181986|20622765|P1|COMPLETED|Phase 1||18
8366348|NCT01181986|20622763|P3|Exendin-9+Exenatide|Phase 1||33
8366349|NCT01181986|20622764|P2|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
8366350|NCT01181986|20622765|P1|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
8366351|NCT01181986|20622763|P3|Saline+Placebo|Phase 1||33
8366352|NCT01181986|20622764|P2|Saline+Placebo|Phase 1|N/A for this arm|0
8366353|NCT01181986|20622765|P1|Saline+Placebo|Phase 1|N/A for this arm|0
8366354|NCT01181986|20622763|P3|Saline+Exenatide|Phase 1||32
8366355|NCT01181986|20622764|P2|Saline+Exenatide|Phase 1|N/A for this arm|0
8366356|NCT01181986|20622765|P1|Saline+Exenatide|Phase 1|N/A for this arm|0
8366357|NCT01181986|20622763|P3|STARTED|Phase 1||34
8366358|NCT01181986|20622764|P2|STARTED|Phase 1||23
8366359|NCT01181986|20622765|P1|STARTED|Phase 1||19
8366360|NCT01181947|20622781|P1|NOT COMPLETED|Overall Study||0
8366361|NCT01181947|20622781|P1|COMPLETED|Overall Study||100
8366362|NCT01181947|20622781|P1|STARTED|Overall Study||100
8366363|NCT01181921|20622786|P1|NOT COMPLETED|Overall Study||1
8366364|NCT01181921|20622786|P1|COMPLETED|Overall Study||0
8366365|NCT01181921|20622786|P1|STARTED|Overall Study||1
8366366|NCT01181895|20622793|P3|NOT COMPLETED|Overall Study||18
8366367|NCT01181895|20622794|P2|NOT COMPLETED|Overall Study||14
8366368|NCT01181895|20622795|P1|NOT COMPLETED|Overall Study||17
8366369|NCT01181895|20622793|P3|COMPLETED|Overall Study||98
8366370|NCT01181895|20622794|P2|COMPLETED|Overall Study||101
8366371|NCT01181895|20622795|P1|COMPLETED|Overall Study||99
8366372|NCT01181895|20622793|P3|STARTED|Overall Study||116
8366373|NCT01181895|20622794|P2|STARTED|Overall Study||115
8366374|NCT01181895|20622795|P1|STARTED|Overall Study||116
8366375|NCT01181804|20622828|P4|NOT COMPLETED|Period 4, Fasted (Part 2)||0
8366376|NCT01181804|20622829|P3|NOT COMPLETED|Period 4, Fasted (Part 2)||1
8366377|NCT01181804|20622830|P2|NOT COMPLETED|Period 4, Fasted (Part 2)||0
8366378|NCT01181804|20622831|P1|NOT COMPLETED|Period 4, Fasted (Part 2)||0
8366379|NCT01181804|20622828|P4|COMPLETED|Period 4, Fasted (Part 2)||58
8366380|NCT01181804|20622829|P3|COMPLETED|Period 4, Fasted (Part 2)||58
8366381|NCT01181804|20622830|P2|COMPLETED|Period 4, Fasted (Part 2)||0
8366382|NCT01181804|20622831|P1|COMPLETED|Period 4, Fasted (Part 2)||0
8366383|NCT01181804|20622828|P4|STARTED|Period 4, Fasted (Part 2)||58
8366384|NCT01181804|20622829|P3|STARTED|Period 4, Fasted (Part 2)||59
8366385|NCT01181804|20622830|P2|STARTED|Period 4, Fasted (Part 2)||0
8366386|NCT01181804|20622831|P1|STARTED|Period 4, Fasted (Part 2)||0
8366387|NCT01181804|20622828|P4|NOT COMPLETED|Period 3, Fasted (Part 2)||0
8366388|NCT01181804|20622829|P3|NOT COMPLETED|Period 3, Fasted (Part 2)||0
8366389|NCT01181804|20622830|P2|NOT COMPLETED|Period 3, Fasted (Part 2)||0
8366390|NCT01181804|20622831|P1|NOT COMPLETED|Period 3, Fasted (Part 2)||0
8366391|NCT01181804|20622828|P4|COMPLETED|Period 3, Fasted (Part 2)||58
8366392|NCT01181804|20622829|P3|COMPLETED|Period 3, Fasted (Part 2)||59
8366393|NCT01181804|20622830|P2|COMPLETED|Period 3, Fasted (Part 2)||0
8366394|NCT01181804|20622831|P1|COMPLETED|Period 3, Fasted (Part 2)||0
8366395|NCT01181804|20622828|P4|STARTED|Period 3, Fasted (Part 2)||58
8366396|NCT01181804|20622829|P3|STARTED|Period 3, Fasted (Part 2)||59
8366397|NCT01181804|20622830|P2|STARTED|Period 3, Fasted (Part 2)||0
8366398|NCT01181804|20622831|P1|STARTED|Period 3, Fasted (Part 2)||0
8366399|NCT01181804|20622828|P4|NOT COMPLETED|Period 2, Fed (Part 1)||0
8366400|NCT01181804|20622829|P3|NOT COMPLETED|Period 2, Fed (Part 1)||0
8366401|NCT01181804|20622830|P2|NOT COMPLETED|Period 2, Fed (Part 1)||0
8366402|NCT01181804|20622831|P1|NOT COMPLETED|Period 2, Fed (Part 1)||0
8366403|NCT01181804|20622828|P4|COMPLETED|Period 2, Fed (Part 1)||0
8366404|NCT01181804|20622829|P3|COMPLETED|Period 2, Fed (Part 1)||0
8366405|NCT01181804|20622830|P2|COMPLETED|Period 2, Fed (Part 1)||30
8366406|NCT01181804|20622831|P1|COMPLETED|Period 2, Fed (Part 1)||30
8366407|NCT01181804|20622828|P4|STARTED|Period 2, Fed (Part 1)||0
8366408|NCT01181804|20622829|P3|STARTED|Period 2, Fed (Part 1)||0
8366409|NCT01181804|20622830|P2|STARTED|Period 2, Fed (Part 1)||30
8366410|NCT01181804|20622831|P1|STARTED|Period 2, Fed (Part 1)||30
8366411|NCT01181804|20622828|P4|NOT COMPLETED|Period 1, Fed (Part 1)||0
8366412|NCT01181804|20622829|P3|NOT COMPLETED|Period 1, Fed (Part 1)||0
8366413|NCT01181804|20622830|P2|NOT COMPLETED|Period 1, Fed (Part 1)||0
8366414|NCT01181804|20622831|P1|NOT COMPLETED|Period 1, Fed (Part 1)||0
8366415|NCT01181804|20622828|P4|COMPLETED|Period 1, Fed (Part 1)||0
8366416|NCT01181804|20622829|P3|COMPLETED|Period 1, Fed (Part 1)||0
8366417|NCT01181804|20622830|P2|COMPLETED|Period 1, Fed (Part 1)||30
8366418|NCT01181804|20622831|P1|COMPLETED|Period 1, Fed (Part 1)||30
8366419|NCT01181804|20622828|P4|STARTED|Period 1, Fed (Part 1)||0
8366420|NCT01181804|20622829|P3|STARTED|Period 1, Fed (Part 1)||0
8366421|NCT01181804|20622830|P2|STARTED|Period 1, Fed (Part 1)||30
8366422|NCT01181804|20622831|P1|STARTED|Period 1, Fed (Part 1)||30
8366423|NCT01181778|20622853|P1|NOT COMPLETED|Overall Study||48
8366424|NCT01181778|20622853|P1|COMPLETED|Overall Study||1871
8366425|NCT01181778|20622853|P1|STARTED|Overall Study||1919
8366426|NCT01181726|20622861|P2|NOT COMPLETED|Second Intervention||0
8366427|NCT01181726|20622862|P1|NOT COMPLETED|Second Intervention||0
8366428|NCT01181726|20622861|P2|COMPLETED|Second Intervention||20
8366429|NCT01181726|20622862|P1|COMPLETED|Second Intervention||19
8366430|NCT01181726|20622861|P2|STARTED|Second Intervention||20
8366431|NCT01181726|20622862|P1|STARTED|Second Intervention||19
8366432|NCT01181726|20622861|P2|NOT COMPLETED|Washout of 28 Days||0
8366433|NCT01181726|20622862|P1|NOT COMPLETED|Washout of 28 Days||0
8366434|NCT01181726|20622861|P2|COMPLETED|Washout of 28 Days||20
8366435|NCT01181726|20622862|P1|COMPLETED|Washout of 28 Days||19
8366436|NCT01181726|20622861|P2|STARTED|Washout of 28 Days||20
8366437|NCT01181726|20622862|P1|STARTED|Washout of 28 Days||19
8366438|NCT01181726|20622861|P2|NOT COMPLETED|First Intervention||0
8366439|NCT01181726|20622862|P1|NOT COMPLETED|First Intervention||1
8366440|NCT01181726|20622861|P2|COMPLETED|First Intervention||20
8366441|NCT01181726|20622862|P1|COMPLETED|First Intervention||19
8366442|NCT01181726|20622861|P2|STARTED|First Intervention||20
8366443|NCT01181726|20622862|P1|STARTED|First Intervention||20
8366444|NCT01181674|20622911|P3|NOT COMPLETED|Overall Study||2
8366445|NCT01181674|20622912|P2|NOT COMPLETED|Overall Study||0
8366446|NCT01181674|20622913|P1|NOT COMPLETED|Overall Study||0
8366447|NCT01181674|20622911|P3|COMPLETED|Overall Study|28 included in analyses|26
8366448|NCT01181674|20622912|P2|COMPLETED|Overall Study||27
8366449|NCT01181674|20622913|P1|COMPLETED|Overall Study||28
8366450|NCT01181674|20622911|P3|STARTED|Overall Study||28
8366451|NCT01181674|20622912|P2|STARTED|Overall Study||27
8366452|NCT01181674|20622913|P1|STARTED|Overall Study||28
8366453|NCT01181609|20622942|P1|NOT COMPLETED|Overall Study||53
8366454|NCT01181609|20622942|P1|COMPLETED|Overall Study||1
8366455|NCT01181609|20622942|P1|STARTED|Overall Study||54
8366456|NCT01181596|20622953|P1|NOT COMPLETED|Overall Study||0
8366457|NCT01181596|20622953|P1|COMPLETED|Overall Study||31
8366458|NCT01181596|20622953|P1|STARTED|Overall Study||31
8366459|NCT01181531|20622960|P2|NOT COMPLETED|Overall Study||53
8366460|NCT01181531|20622961|P1|NOT COMPLETED|Overall Study||61
8366461|NCT01181531|20622960|P2|COMPLETED|Overall Study||102
8366462|NCT01181531|20622961|P1|COMPLETED|Overall Study||96
8366463|NCT01181531|20622960|P2|Received Investigational Product|Overall Study||153
8366464|NCT01181531|20622961|P1|Received Investigational Product|Overall Study||155
8366465|NCT01181531|20622960|P2|STARTED|Overall Study|Subjects are randomized after washout.|155
8366466|NCT01181531|20622961|P1|STARTED|Overall Study|Subjects are randomized after washout.|157
8366467|NCT01181492|20622974|P3|NOT COMPLETED|Overall Study||0
8366468|NCT01181492|20622975|P2|NOT COMPLETED|Overall Study||0
8366469|NCT01181492|20622976|P1|NOT COMPLETED|Overall Study||0
8366470|NCT01181492|20622974|P3|COMPLETED|Overall Study||7
8366471|NCT01181492|20622975|P2|COMPLETED|Overall Study||66
8366472|NCT01181492|20622976|P1|COMPLETED|Overall Study||103
8366473|NCT01181492|20622974|P3|STARTED|Overall Study||7
8366474|NCT01181492|20622975|P2|STARTED|Overall Study||66
8366475|NCT01181492|20622976|P1|STARTED|Overall Study||103
8366476|NCT01181479|20622992|P3|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
8366477|NCT01181479|20622993|P2|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
8366478|NCT01181479|20622994|P1|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
8366479|NCT01181479|20622992|P3|COMPLETED|Crossover Subjects Recieve AG200-15||150
8366480|NCT01181479|20622993|P2|COMPLETED|Crossover Subjects Recieve AG200-15||0
8366481|NCT01181479|20622994|P1|COMPLETED|Crossover Subjects Recieve AG200-15||0
8366482|NCT01181479|20622992|P3|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
8366483|NCT01181479|20622993|P2|STARTED|Crossover Subjects Recieve AG200-15||0
8366484|NCT01181479|20622994|P1|STARTED|Crossover Subjects Recieve AG200-15||0
8366485|NCT01181479|20622992|P3|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
8366486|NCT01181479|20622993|P2|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
8366487|NCT01181479|20622994|P1|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
8366488|NCT01181479|20622992|P3|COMPLETED|Subjects Receive AG200-15 or Lessina||0
8366489|NCT01181479|20622993|P2|COMPLETED|Subjects Receive AG200-15 or Lessina||249
8366490|NCT01181479|20622994|P1|COMPLETED|Subjects Receive AG200-15 or Lessina||485
8366491|NCT01181479|20622992|P3|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
8366492|NCT01181479|20622993|P2|STARTED|Subjects Receive AG200-15 or Lessina||375
8366493|NCT01181479|20622994|P1|STARTED|Subjects Receive AG200-15 or Lessina||1129
8366494|NCT01181349|20623009|P1|NOT COMPLETED|Overall Study||0
8366495|NCT01181349|20623009|P1|COMPLETED|Overall Study||350
8366496|NCT01181349|20623009|P1|STARTED|Overall Study||350
8366497|NCT01181323|20623025|P4|NOT COMPLETED|Overall Study||3
8366498|NCT01181323|20623026|P3|NOT COMPLETED|Overall Study||1
8366499|NCT01181323|20623027|P2|NOT COMPLETED|Overall Study||3
8366500|NCT01181323|20623028|P1|NOT COMPLETED|Overall Study||1
8366501|NCT01181323|20623025|P4|COMPLETED|Overall Study||122
8366502|NCT01181323|20623026|P3|COMPLETED|Overall Study||123
8366503|NCT01181323|20623027|P2|COMPLETED|Overall Study||121
8366504|NCT01181323|20623028|P1|COMPLETED|Overall Study||123
8366505|NCT01181323|20623025|P4|STARTED|Overall Study||125
8366506|NCT01181323|20623026|P3|STARTED|Overall Study||124
8366507|NCT01181323|20623027|P2|STARTED|Overall Study||124
8366508|NCT01181323|20623028|P1|STARTED|Overall Study||124
8366509|NCT01181271|20623103|P1|NOT COMPLETED|Allogeneic Transplant||0
8366510|NCT01181271|20623103|P1|COMPLETED|Allogeneic Transplant||29
8366511|NCT01181271|20623103|P1|STARTED|Allogeneic Transplant||29
8366512|NCT01181271|20623103|P1|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
8366513|NCT01181271|20623103|P1|COMPLETED|Evaluation for Allogeneic Transplant||29
8366514|NCT01181271|20623103|P1|STARTED|Evaluation for Allogeneic Transplant||42
8366515|NCT01181271|20623103|P1|NOT COMPLETED|Autologous Transplant||0
8366516|NCT01181271|20623103|P1|COMPLETED|Autologous Transplant||42
8366517|NCT01181271|20623103|P1|STARTED|Autologous Transplant||42
8366518|NCT01181258|20623118|P1|NOT COMPLETED|Overall Study||0
8366519|NCT01181258|20623118|P1|COMPLETED|Overall Study||16
8366520|NCT01181258|20623118|P1|STARTED|Overall Study||16
8366521|NCT01181167|20623127|P2|NOT COMPLETED|Overall Study||32
8366522|NCT01181167|20623128|P1|NOT COMPLETED|Overall Study||23
8366523|NCT01181167|20623127|P2|COMPLETED|Overall Study||271
8366524|NCT01181167|20623128|P1|COMPLETED|Overall Study||284
8366525|NCT01181167|20623127|P2|Efficacy Analysis Population|Overall Study||248
8366526|NCT01181167|20623128|P1|Efficacy Analysis Population|Overall Study||255
8366527|NCT01181167|20623127|P2|STARTED|Overall Study||303
8366528|NCT01181167|20623128|P1|STARTED|Overall Study||307
8366529|NCT01181141|20623138|P2|NOT COMPLETED|Overall Study||4
8366530|NCT01181141|20623139|P1|NOT COMPLETED|Overall Study||12
8366531|NCT01181141|20623138|P2|COMPLETED|Overall Study||26
8366532|NCT01181141|20623139|P1|COMPLETED|Overall Study||50
8366533|NCT01181141|20623138|P2|Safety Analysis Population|Overall Study||29
8366534|NCT01181141|20623139|P1|Safety Analysis Population|Overall Study||59
8366535|NCT01181141|20623138|P2|STARTED|Overall Study||30
8366536|NCT01181141|20623139|P1|STARTED|Overall Study||62
8366537|NCT01181128|20623148|P3|NOT COMPLETED|Overall Study||1
8366538|NCT01181128|20623149|P2|NOT COMPLETED|Overall Study||5
8366539|NCT01181128|20623150|P1|NOT COMPLETED|Overall Study||6
8366540|NCT01181128|20623148|P3|COMPLETED|Overall Study||22
8366541|NCT01181128|20623149|P2|COMPLETED|Overall Study||19
8366542|NCT01181128|20623150|P1|COMPLETED|Overall Study||112
8366543|NCT01181128|20623148|P3|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
8366544|NCT01181128|20623149|P2|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
8366545|NCT01181128|20623150|P1|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
8366546|NCT01181128|20623148|P3|Pharmacokinetic (PK) Subgroup|Overall Study||0
8366547|NCT01181128|20623149|P2|Pharmacokinetic (PK) Subgroup|Overall Study||0
8366548|NCT01181128|20623150|P1|Pharmacokinetic (PK) Subgroup|Overall Study||30
8366549|NCT01181128|20623148|P3|STARTED|Overall Study||23
8366550|NCT01181128|20623149|P2|STARTED|Overall Study||24
8366551|NCT01181128|20623150|P1|STARTED|Overall Study||118
8366552|NCT01181102|20623238|P2|NOT COMPLETED|Overall Study||46
8366553|NCT01181102|20623239|P1|NOT COMPLETED|Overall Study||51
8366554|NCT01181102|20623238|P2|COMPLETED|Overall Study||310
8366555|NCT01181102|20623239|P1|COMPLETED|Overall Study||309
8366556|NCT01181102|20623238|P2|Efficacy Analysis Population|Overall Study||295
8366557|NCT01181102|20623239|P1|Efficacy Analysis Population|Overall Study||299
8366558|NCT01181102|20623238|P2|Safety Analysis Set|Overall Study||349
8366559|NCT01181102|20623239|P1|Safety Analysis Set|Overall Study||354
8366560|NCT01181102|20623238|P2|STARTED|Overall Study||356
8366561|NCT01181102|20623239|P1|STARTED|Overall Study||360
8366562|NCT01181076|20623249|P2|NOT COMPLETED|Overall Study||12
8366563|NCT01181076|20623250|P1|NOT COMPLETED|Overall Study||19
8366564|NCT01181076|20623249|P2|COMPLETED|Overall Study|As determined|48
8366565|NCT01181076|20623250|P1|COMPLETED|Overall Study||40
8366566|NCT01181076|20623249|P2|STARTED|Overall Study||60
8366567|NCT01181076|20623250|P1|STARTED|Overall Study||59
8366568|NCT01181050|20623272|P2|NOT COMPLETED|Overall Study||0
8366569|NCT01181050|20623273|P1|NOT COMPLETED|Overall Study||0
8366570|NCT01181050|20623272|P2|COMPLETED|Overall Study||22
8366571|NCT01181050|20623273|P1|COMPLETED|Overall Study||41
8366572|NCT01181050|20623272|P2|STARTED|Overall Study||22
8366573|NCT01181050|20623273|P1|STARTED|Overall Study||41
8366574|NCT01181011|20623283|P1|NOT COMPLETED|Overall Study||3
8366575|NCT01181011|20623283|P1|COMPLETED|Overall Study||25
8366576|NCT01181011|20623283|P1|Received Amlodipine 5mg|Overall Study||26
8366577|NCT01181011|20623283|P1|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
8366578|NCT01181011|20623283|P1|Received Telmisartan 80mg|Overall Study||27
8366579|NCT01181011|20623283|P1|STARTED|Overall Study||28
8366580|NCT01180998|20623333|P3|NOT COMPLETED|Overall Study||10
8366581|NCT01180998|20623334|P2|NOT COMPLETED|Overall Study||4
8366582|NCT01180998|20623335|P1|NOT COMPLETED|Overall Study||4
8366583|NCT01180998|20623333|P3|COMPLETED|Overall Study||51
8366584|NCT01180998|20623334|P2|COMPLETED|Overall Study||68
8366585|NCT01180998|20623335|P1|COMPLETED|Overall Study||63
8366586|NCT01180998|20623333|P3|STARTED|Overall Study||61
8366587|NCT01180998|20623334|P2|STARTED|Overall Study||72
8366588|NCT01180998|20623335|P1|STARTED|Overall Study||67
8366589|NCT01180985|20623349|P2|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
8366590|NCT01180985|20623350|P1|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
8366591|NCT01180985|20623349|P2|COMPLETED|Period 2 (7 +/- 1 Days)||26
8366592|NCT01180985|20623350|P1|COMPLETED|Period 2 (7 +/- 1 Days)||26
8366593|NCT01180985|20623349|P2|STARTED|Period 2 (7 +/- 1 Days)||26
8366594|NCT01180985|20623350|P1|STARTED|Period 2 (7 +/- 1 Days)||27
8366595|NCT01180985|20623349|P2|NOT COMPLETED|Period 1 (7 +/- Days)||0
8366596|NCT01180985|20623350|P1|NOT COMPLETED|Period 1 (7 +/- Days)||0
8366597|NCT01180985|20623349|P2|COMPLETED|Period 1 (7 +/- Days)||26
8366598|NCT01180985|20623350|P1|COMPLETED|Period 1 (7 +/- Days)||27
8366599|NCT01180985|20623349|P2|STARTED|Period 1 (7 +/- Days)||26
8366600|NCT01180985|20623350|P1|STARTED|Period 1 (7 +/- Days)||27
8366601|NCT01180894|20623369|P2|NOT COMPLETED|Overall Study||0
8366602|NCT01180894|20623370|P1|NOT COMPLETED|Overall Study||0
8366603|NCT01180894|20623369|P2|COMPLETED|Overall Study||75
8366604|NCT01180894|20623370|P1|COMPLETED|Overall Study||75
8366605|NCT01180894|20623369|P2|STARTED|Overall Study||75
8366606|NCT01180894|20623370|P1|STARTED|Overall Study||75
8366607|NCT01180790|20623389|P7|NOT COMPLETED|Overall Study||1
8366608|NCT01180790|20623390|P6|NOT COMPLETED|Overall Study||7
8366609|NCT01180790|20623391|P5|NOT COMPLETED|Overall Study||5
8366610|NCT01180790|20623392|P4|NOT COMPLETED|Overall Study||9
8366611|NCT01180790|20623393|P3|NOT COMPLETED|Overall Study||13
8366612|NCT01180790|20623394|P2|NOT COMPLETED|Overall Study||5
8366613|NCT01180790|20623395|P1|NOT COMPLETED|Overall Study||9
8366614|NCT01180790|20623389|P7|COMPLETED|Overall Study||18
8366615|NCT01180790|20623390|P6|COMPLETED|Overall Study||13
8366616|NCT01180790|20623391|P5|COMPLETED|Overall Study||14
8366617|NCT01180790|20623392|P4|COMPLETED|Overall Study||6
8366618|NCT01180790|20623393|P3|COMPLETED|Overall Study||4
8366619|NCT01180790|20623394|P2|COMPLETED|Overall Study||11
8366620|NCT01180790|20623395|P1|COMPLETED|Overall Study||7
8366621|NCT01180790|20623389|P7|STARTED|Overall Study||19
8366622|NCT01180790|20623390|P6|STARTED|Overall Study||20
8366623|NCT01180790|20623391|P5|STARTED|Overall Study||19
8366624|NCT01180790|20623392|P4|STARTED|Overall Study||15
8366625|NCT01180790|20623393|P3|STARTED|Overall Study||17
8366626|NCT01180790|20623394|P2|STARTED|Overall Study||16
8366627|NCT01180790|20623395|P1|STARTED|Overall Study||16
8366628|NCT01180777|20623460|P1|NOT COMPLETED|Overall Study||12
8366629|NCT01180777|20623460|P1|COMPLETED|Overall Study||80
8366630|NCT01180777|20623460|P1|STARTED|Overall Study||92
8366631|NCT01180660|20623474|P2|NOT COMPLETED|Overall Study||0
8366632|NCT01180660|20623475|P1|NOT COMPLETED|Overall Study||1
8366633|NCT01180660|20623474|P2|COMPLETED|Overall Study||26
8366634|NCT01180660|20623475|P1|COMPLETED|Overall Study||24
8366635|NCT01180660|20623474|P2|STARTED|Overall Study||26
8366636|NCT01180660|20623475|P1|STARTED|Overall Study||25
8366637|NCT01180647|20623485|P2|NOT COMPLETED|Overall Study||6
8366638|NCT01180647|20623486|P1|NOT COMPLETED|Overall Study||5
8366639|NCT01180647|20623485|P2|COMPLETED|Overall Study||11
8366640|NCT01180647|20623486|P1|COMPLETED|Overall Study||12
8366641|NCT01180647|20623485|P2|STARTED|Overall Study||17
8366642|NCT01180647|20623486|P1|STARTED|Overall Study||17
8366643|NCT01180478|20623504|P2|NOT COMPLETED|Overall Study||188
8366644|NCT01180478|20623505|P1|NOT COMPLETED|Overall Study||181
8366645|NCT01180478|20623504|P2|COMPLETED|Overall Study||293
8366646|NCT01180478|20623505|P1|COMPLETED|Overall Study||303
8366647|NCT01180478|20623504|P2|STARTED|Overall Study||481
8366648|NCT01180478|20623505|P1|STARTED|Overall Study||484
8366649|NCT01180400|20623521|P2|NOT COMPLETED|Overall Study||27
8366650|NCT01180400|20623522|P1|NOT COMPLETED|Overall Study||25
8366651|NCT01180400|20623521|P2|COMPLETED|Overall Study||121
8366652|NCT01180400|20623522|P1|COMPLETED|Overall Study||122
8366653|NCT01180400|20623521|P2|Received Treatment|Overall Study||146
8366654|NCT01180400|20623522|P1|Received Treatment|Overall Study||147
8366655|NCT01180400|20623521|P2|STARTED|Overall Study||148
8366656|NCT01180400|20623522|P1|STARTED|Overall Study||147
8366657|NCT01180296|20623570|P2|NOT COMPLETED|Overall Study||2
8366658|NCT01180296|20623571|P1|NOT COMPLETED|Overall Study||1
8366659|NCT01180296|20623570|P2|COMPLETED|Overall Study||14
8366660|NCT01180296|20623571|P1|COMPLETED|Overall Study||19
8366661|NCT01180296|20623570|P2|STARTED|Overall Study||16
8366662|NCT01180296|20623571|P1|STARTED|Overall Study||20
8366663|NCT01180244|20623581|P2|NOT COMPLETED|Overall Study||8
8366664|NCT01180244|20623582|P1|NOT COMPLETED|Overall Study||6
8366665|NCT01180244|20623581|P2|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
8366666|NCT01180244|20623582|P1|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
8366667|NCT01180244|20623581|P2|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
8366668|NCT01180244|20623582|P1|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
8366758|NCT01179568|20623722|P1|Completed Week 12 Assessment|Overall Study||69
8366669|NCT01180244|20623581|P2|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
8366670|NCT01180244|20623582|P1|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
8366671|NCT01180127|20623600|P4|NOT COMPLETED|Overall Study||1
8366672|NCT01180127|20623601|P3|NOT COMPLETED|Overall Study||1
8366673|NCT01180127|20623602|P2|NOT COMPLETED|Overall Study||0
8366674|NCT01180127|20623603|P1|NOT COMPLETED|Overall Study||2
8366675|NCT01180127|20623600|P4|COMPLETED|Overall Study||9
8366676|NCT01180127|20623601|P3|COMPLETED|Overall Study||9
8366677|NCT01180127|20623602|P2|COMPLETED|Overall Study||11
8366678|NCT01180127|20623603|P1|COMPLETED|Overall Study||8
8366679|NCT01180127|20623600|P4|STARTED|Overall Study||10
8366680|NCT01180127|20623601|P3|STARTED|Overall Study||10
8366681|NCT01180127|20623602|P2|STARTED|Overall Study||11
8366682|NCT01180127|20623603|P1|STARTED|Overall Study||10
8366683|NCT01180049|20623627|P2|NOT COMPLETED|Overall Study||48
8366684|NCT01180049|20623628|P1|NOT COMPLETED|Overall Study||53
8366685|NCT01180049|20623627|P2|COMPLETED|Overall Study||0
8366686|NCT01180049|20623628|P1|COMPLETED|Overall Study||0
8366687|NCT01180049|20623627|P2|STARTED|Overall Study||48
8366688|NCT01180049|20623628|P1|STARTED|Overall Study||53
8366689|NCT01180036|20623650|P2|NOT COMPLETED|Overall Study||0
8366690|NCT01180036|20623651|P1|NOT COMPLETED|Overall Study||0
8366691|NCT01180036|20623650|P2|COMPLETED|Overall Study||65
8366692|NCT01180036|20623651|P1|COMPLETED|Overall Study||65
8366693|NCT01180036|20623650|P2|STARTED|Overall Study||65
8366694|NCT01180036|20623651|P1|STARTED|Overall Study||65
8366695|NCT01179984|20623659|P1|NOT COMPLETED|Overall Study||18
8366696|NCT01179984|20623659|P1|COMPLETED|Overall Study||58
8366697|NCT01179984|20623659|P1|STARTED|Overall Study||76
8366698|NCT01179919|20623665|P1|NOT COMPLETED|Overall Study||2
8366699|NCT01179919|20623665|P1|COMPLETED|Overall Study||19
8366700|NCT01179919|20623665|P1|STARTED|Overall Study||21
8366701|NCT01179737|20623674|P4|NOT COMPLETED|Extension||0
8366702|NCT01179737|20623675|P3|NOT COMPLETED|Extension||0
8366703|NCT01179737|20623676|P2|NOT COMPLETED|Extension||0
8366704|NCT01179737|20623677|P1|NOT COMPLETED|Extension||3
8366705|NCT01179737|20623674|P4|COMPLETED|Extension||0
8366706|NCT01179737|20623675|P3|COMPLETED|Extension||0
8366707|NCT01179737|20623676|P2|COMPLETED|Extension||0
8366708|NCT01179737|20623677|P1|COMPLETED|Extension||0
8366709|NCT01179737|20623674|P4|STARTED|Extension||0
8366710|NCT01179737|20623675|P3|STARTED|Extension||0
8366711|NCT01179737|20623676|P2|STARTED|Extension|One patient did not enrol in the extension|0
8366712|NCT01179737|20623677|P1|STARTED|Extension|Two patients did not enrol in the extension|3
8366713|NCT01179737|20623674|P4|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
8366714|NCT01179737|20623675|P3|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
8366715|NCT01179737|20623676|P2|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
8366716|NCT01179737|20623677|P1|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
8366717|NCT01179737|20623674|P4|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
8366718|NCT01179737|20623675|P3|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
8366719|NCT01179737|20623676|P2|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
8366720|NCT01179737|20623677|P1|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
8366721|NCT01179737|20623674|P4|STARTED|Cohort 1 & Cohort 2 Expansion||0
8366722|NCT01179737|20623675|P3|STARTED|Cohort 1 & Cohort 2 Expansion||0
8366723|NCT01179737|20623676|P2|STARTED|Cohort 1 & Cohort 2 Expansion||1
8366724|NCT01179737|20623677|P1|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
8366725|NCT01179737|20623674|P4|NOT COMPLETED|Cohort 1 & Cohort 2||4
8366726|NCT01179737|20623675|P3|NOT COMPLETED|Cohort 1 & Cohort 2||4
8366727|NCT01179737|20623676|P2|NOT COMPLETED|Cohort 1 & Cohort 2||2
8366728|NCT01179737|20623677|P1|NOT COMPLETED|Cohort 1 & Cohort 2||5
8366729|NCT01179737|20623674|P4|COMPLETED|Cohort 1 & Cohort 2||0
8366730|NCT01179737|20623675|P3|COMPLETED|Cohort 1 & Cohort 2||0
8366731|NCT01179737|20623676|P2|COMPLETED|Cohort 1 & Cohort 2||1
8366732|NCT01179737|20623677|P1|COMPLETED|Cohort 1 & Cohort 2||7
8366733|NCT01179737|20623674|P4|STARTED|Cohort 1 & Cohort 2||4
8366734|NCT01179737|20623675|P3|STARTED|Cohort 1 & Cohort 2||4
8366735|NCT01179737|20623676|P2|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
8366736|NCT01179737|20623677|P1|STARTED|Cohort 1 & Cohort 2||12
8366737|NCT01179672|20623688|P2|NOT COMPLETED|Overall Study||26
8366738|NCT01179672|20623689|P1|NOT COMPLETED|Overall Study||30
8366739|NCT01179672|20623688|P2|COMPLETED|Overall Study||176
8366740|NCT01179672|20623689|P1|COMPLETED|Overall Study||173
8366741|NCT01179672|20623688|P2|Entered Taper|Overall Study||177
8366742|NCT01179672|20623689|P1|Entered Taper|Overall Study||181
8366743|NCT01179672|20623688|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
8366744|NCT01179672|20623689|P1|Received at Least 1 Dose of Study Drug|Overall Study||202
8366745|NCT01179672|20623688|P2|STARTED|Overall Study||202
8366746|NCT01179672|20623689|P1|STARTED|Overall Study||203
8366747|NCT01179568|20623719|P4|NOT COMPLETED|Overall Study||20
8366748|NCT01179568|20623720|P3|NOT COMPLETED|Overall Study||23
8366749|NCT01179568|20623721|P2|NOT COMPLETED|Overall Study||38
8366750|NCT01179568|20623722|P1|NOT COMPLETED|Overall Study||28
8366751|NCT01179568|20623719|P4|COMPLETED|Overall Study||76
8366752|NCT01179568|20623720|P3|COMPLETED|Overall Study||76
8366753|NCT01179568|20623721|P2|COMPLETED|Overall Study||61
8366754|NCT01179568|20623722|P1|COMPLETED|Overall Study||73
8366755|NCT01179568|20623719|P4|Completed Week 12 Assessment|Overall Study||75
8366756|NCT01179568|20623720|P3|Completed Week 12 Assessment|Overall Study||76
8366757|NCT01179568|20623721|P2|Completed Week 12 Assessment|Overall Study||69
8366759|NCT01179568|20623719|P4|STARTED|Overall Study||96
8366760|NCT01179568|20623720|P3|STARTED|Overall Study||99
8366761|NCT01179568|20623721|P2|STARTED|Overall Study||99
8366762|NCT01179568|20623722|P1|STARTED|Overall Study||101
8366763|NCT01179516|20623745|P3|NOT COMPLETED|Overall Study||31
8366764|NCT01179516|20623746|P2|NOT COMPLETED|Overall Study||26
8366765|NCT01179516|20623747|P1|NOT COMPLETED|Overall Study||27
8366766|NCT01179516|20623745|P3|COMPLETED|Overall Study||121
8366767|NCT01179516|20623746|P2|COMPLETED|Overall Study||131
8366768|NCT01179516|20623747|P1|COMPLETED|Overall Study||133
8366769|NCT01179516|20623745|P3|Treated|Overall Study||151
8366770|NCT01179516|20623746|P2|Treated|Overall Study||154
8366771|NCT01179516|20623747|P1|Treated|Overall Study||160
8366772|NCT01179516|20623745|P3|STARTED|Overall Study||152
8366773|NCT01179516|20623746|P2|STARTED|Overall Study||157
8366774|NCT01179516|20623747|P1|STARTED|Overall Study||160
8366775|NCT01179490|20623770|P1|NOT COMPLETED|Overall Study||0
8366776|NCT01179490|20623770|P1|COMPLETED|Overall Study||5
8366777|NCT01179490|20623770|P1|STARTED|Overall Study||5
8366778|NCT01179477|20623791|P1|NOT COMPLETED|Overall Study||1087
8366779|NCT01179477|20623791|P1|COMPLETED|Overall Study||843
8366780|NCT01179477|20623791|P1|STARTED|Overall Study||1930
8366781|NCT01179399|20623796|P1|NOT COMPLETED|Overall Study||32
8366782|NCT01179399|20623796|P1|COMPLETED|Overall Study||0
8366783|NCT01179399|20623796|P1|STARTED|Overall Study||32
8366784|NCT01179347|20623802|P2|NOT COMPLETED|Open-label Period (12 Weeks)||16
8366785|NCT01179347|20623803|P1|NOT COMPLETED|Open-label Period (12 Weeks)||15
8366786|NCT01179347|20623802|P2|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
8366787|NCT01179347|20623803|P1|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
8366788|NCT01179347|20623802|P2|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
8366789|NCT01179347|20623803|P1|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
8366790|NCT01179347|20623802|P2|NOT COMPLETED|Double-blind Period (12 Weeks)||14
8366791|NCT01179347|20623803|P1|NOT COMPLETED|Double-blind Period (12 Weeks)||8
8366792|NCT01179347|20623802|P2|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
8366793|NCT01179347|20623803|P1|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
8366794|NCT01179347|20623802|P2|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
8366795|NCT01179347|20623803|P1|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
8366796|NCT01179334|20623825|P2|NOT COMPLETED|Long-term Extension (LTE) Period||6
8366797|NCT01179334|20623826|P1|NOT COMPLETED|Long-term Extension (LTE) Period||11
8366798|NCT01179334|20623825|P2|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
8366799|NCT01179334|20623826|P1|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
8366800|NCT01179334|20623825|P2|STARTED|Long-term Extension (LTE) Period||6
8366801|NCT01179334|20623826|P1|STARTED|Long-term Extension (LTE) Period||11
8366802|NCT01179334|20623825|P2|NOT COMPLETED|Treatment Period||0
8366803|NCT01179334|20623826|P1|NOT COMPLETED|Treatment Period||1
8366804|NCT01179334|20623825|P2|COMPLETED|Treatment Period||6
8366805|NCT01179334|20623826|P1|COMPLETED|Treatment Period||11
8366806|NCT01179334|20623825|P2|Participants Received Treatment|Treatment Period||6
8366807|NCT01179334|20623826|P1|Participants Received Treatment|Treatment Period||12
8366808|NCT01179334|20623825|P2|STARTED|Treatment Period||6
8366809|NCT01179334|20623826|P1|STARTED|Treatment Period||12
8366810|NCT01179217|20623856|P2|NOT COMPLETED|Overall Study||19
8366811|NCT01179217|20623857|P1|NOT COMPLETED|Overall Study||55
8366812|NCT01179217|20623856|P2|COMPLETED|Overall Study||59
8366813|NCT01179217|20623857|P1|COMPLETED|Overall Study||97
8366814|NCT01179217|20623856|P2|STARTED|Overall Study||78
8366815|NCT01179217|20623857|P1|STARTED|Overall Study||152
8366816|NCT01179191|20623881|P1|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
8366817|NCT01179191|20623881|P1|COMPLETED|Maintenance Phase (8 Weeks)||234
8366818|NCT01179191|20623881|P1|STARTED|Maintenance Phase (8 Weeks)||351
8366819|NCT01179191|20623881|P1|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
8366820|NCT01179191|20623881|P1|COMPLETED|Titration Phase (up to 6 Weeks)||351
8366821|NCT01179191|20623881|P1|STARTED|Titration Phase (up to 6 Weeks)||684
8366822|NCT01179113|20623900|P2|NOT COMPLETED|Overall Study||0
8366823|NCT01179113|20623901|P1|NOT COMPLETED|Overall Study||0
8366824|NCT01179113|20623900|P2|COMPLETED|Overall Study||16
8366825|NCT01179113|20623901|P1|COMPLETED|Overall Study||17
8366826|NCT01179113|20623900|P2|STARTED|Overall Study||16
8366827|NCT01179113|20623901|P1|STARTED|Overall Study||17
8366828|NCT01179048|20623913|P2|NOT COMPLETED|Overall Study||159
8366829|NCT01179048|20623914|P1|NOT COMPLETED|Overall Study||139
8366830|NCT01179048|20623913|P2|COMPLETED|Overall Study||4513
8366831|NCT01179048|20623914|P1|COMPLETED|Overall Study||4529
8366832|NCT01179048|20623913|P2|STARTED|Overall Study||4672
8366833|NCT01179048|20623914|P1|STARTED|Overall Study||4668
8366834|NCT01178944|20623930|P1|NOT COMPLETED|Overall Study||0
8366835|NCT01178944|20623930|P1|COMPLETED|Overall Study||35
8366836|NCT01178944|20623930|P1|STARTED|Overall Study||35
8366837|NCT01178853|20623941|P2|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
8366838|NCT01178853|20623942|P1|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
8366839|NCT01178853|20623941|P2|COMPLETED|Period 4 (Warfarin + Study Drug)||19
8366840|NCT01178853|20623942|P1|COMPLETED|Period 4 (Warfarin + Study Drug)||21
8366841|NCT01178853|20623941|P2|STARTED|Period 4 (Warfarin + Study Drug)||22
8366842|NCT01178853|20623942|P1|STARTED|Period 4 (Warfarin + Study Drug)||21
8366843|NCT01178853|20623941|P2|NOT COMPLETED|Period 3 (Warfarin Titration)||0
8366844|NCT01178853|20623942|P1|NOT COMPLETED|Period 3 (Warfarin Titration)||1
8366845|NCT01178853|20623941|P2|COMPLETED|Period 3 (Warfarin Titration)||22
8366846|NCT01178853|20623942|P1|COMPLETED|Period 3 (Warfarin Titration)||21
8366847|NCT01178853|20623941|P2|STARTED|Period 3 (Warfarin Titration)||22
8366848|NCT01178853|20623942|P1|STARTED|Period 3 (Warfarin Titration)||22
8366849|NCT01178853|20623941|P2|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
8366850|NCT01178853|20623942|P1|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
8366851|NCT01178853|20623941|P2|COMPLETED|Period 2 (Warfarin + Study Drug)||22
8366852|NCT01178853|20623942|P1|COMPLETED|Period 2 (Warfarin + Study Drug)||22
8366853|NCT01178853|20623941|P2|STARTED|Period 2 (Warfarin + Study Drug)||22
8366854|NCT01178853|20623942|P1|STARTED|Period 2 (Warfarin + Study Drug)||23
8366855|NCT01178853|20623941|P2|NOT COMPLETED|Period 1 (Warfarin Titration)||2
8366856|NCT01178853|20623942|P1|NOT COMPLETED|Period 1 (Warfarin Titration)||1
8366857|NCT01178853|20623941|P2|COMPLETED|Period 1 (Warfarin Titration)||22
8366858|NCT01178853|20623942|P1|COMPLETED|Period 1 (Warfarin Titration)||23
8366859|NCT01178853|20623941|P2|STARTED|Period 1 (Warfarin Titration)||24
8366860|NCT01178853|20623942|P1|STARTED|Period 1 (Warfarin Titration)||24
8366861|NCT01178827|20623951|P3|NOT COMPLETED|Overall Study||0
8366862|NCT01178827|20623952|P2|NOT COMPLETED|Overall Study||0
8366863|NCT01178827|20623953|P1|NOT COMPLETED|Overall Study||0
8366864|NCT01178827|20623951|P3|COMPLETED|Overall Study||4
8366865|NCT01178827|20623952|P2|COMPLETED|Overall Study||10
8366866|NCT01178827|20623953|P1|COMPLETED|Overall Study||6
8366867|NCT01178827|20623951|P3|STARTED|Overall Study||4
8366868|NCT01178827|20623952|P2|STARTED|Overall Study||10
8366869|NCT01178827|20623953|P1|STARTED|Overall Study||6
8366870|NCT01178762|20623982|P1|NOT COMPLETED|Overall Study||15
8366871|NCT01178762|20623982|P1|COMPLETED|Overall Study||27
8366872|NCT01178762|20623982|P1|STARTED|Overall Study||42
8366873|NCT01178671|20623988|P2|NOT COMPLETED|Overall Study||15
8366874|NCT01178671|20623989|P1|NOT COMPLETED|Overall Study||12
8366875|NCT01178671|20623988|P2|COMPLETED|Overall Study||3
8366876|NCT01178671|20623989|P1|COMPLETED|Overall Study||6
8366877|NCT01178671|20623988|P2|STARTED|Overall Study||18
8366878|NCT01178671|20623989|P1|STARTED|Overall Study||18
8366879|NCT01178528|20624016|P3|NOT COMPLETED|Overall Study||0
8366880|NCT01178528|20624017|P2|NOT COMPLETED|Overall Study||0
8366881|NCT01178528|20624018|P1|NOT COMPLETED|Overall Study||0
8366882|NCT01178528|20624016|P3|COMPLETED|Overall Study||42
8366883|NCT01178528|20624017|P2|COMPLETED|Overall Study||38
8366884|NCT01178528|20624018|P1|COMPLETED|Overall Study||41
8366885|NCT01178528|20624016|P3|STARTED|Overall Study||42
8366886|NCT01178528|20624017|P2|STARTED|Overall Study||38
8366887|NCT01178528|20624018|P1|STARTED|Overall Study||41
8366888|NCT01178385|20624037|P2|NOT COMPLETED|Overall Study||0
8366889|NCT01178385|20624038|P1|NOT COMPLETED|Overall Study||2
8366890|NCT01178385|20624037|P2|COMPLETED|Overall Study||21
8366891|NCT01178385|20624038|P1|COMPLETED|Overall Study||22
8366892|NCT01178385|20624037|P2|STARTED|Overall Study||21
8366893|NCT01178385|20624038|P1|STARTED|Overall Study||24
8366894|NCT01178333|20624051|P3|NOT COMPLETED|Overall Study||0
8366895|NCT01178333|20624052|P2|NOT COMPLETED|Overall Study||0
8366896|NCT01178333|20624053|P1|NOT COMPLETED|Overall Study||0
8366897|NCT01178333|20624051|P3|COMPLETED|Overall Study||87
8366898|NCT01178333|20624052|P2|COMPLETED|Overall Study||284
8366899|NCT01178333|20624053|P1|COMPLETED|Overall Study||71
8366900|NCT01178333|20624051|P3|STARTED|Overall Study||87
8366901|NCT01178333|20624052|P2|STARTED|Overall Study||284
8366902|NCT01178333|20624053|P1|STARTED|Overall Study||71
8366906|NCT01178281|20624131|P3|NOT COMPLETED|Overall Study||0
8366907|NCT01178281|20624132|P2|NOT COMPLETED|Overall Study||0
8366908|NCT01178281|20624133|P1|NOT COMPLETED|Overall Study||0
8366909|NCT01178281|20624131|P3|COMPLETED|Overall Study||15
8366910|NCT01178281|20624132|P2|COMPLETED|Overall Study||84
8366911|NCT01178281|20624133|P1|COMPLETED|Overall Study||168
8366912|NCT01178281|20624131|P3|Received Study Drug|Overall Study||15
8366913|NCT01178281|20624132|P2|Received Study Drug|Overall Study||83
8366914|NCT01178281|20624133|P1|Received Study Drug|Overall Study||167
8366915|NCT01178281|20624131|P3|STARTED|Overall Study||15
8366916|NCT01178281|20624132|P2|STARTED|Overall Study||84
8366917|NCT01178281|20624133|P1|STARTED|Overall Study||168
8366918|NCT01178268|20624160|P2|NOT COMPLETED|Overall Study||1
8366919|NCT01178268|20624161|P1|NOT COMPLETED|Overall Study||7
8366920|NCT01178268|20624160|P2|COMPLETED|Overall Study||120
8366921|NCT01178268|20624161|P1|COMPLETED|Overall Study||360
8366922|NCT01178268|20624160|P2|STARTED|Overall Study||121
8366923|NCT01178268|20624161|P1|STARTED|Overall Study||367
8366924|NCT01178216|20624378|P1|NOT COMPLETED|Overall Study||2
8366925|NCT01178216|20624378|P1|COMPLETED|Overall Study||39
8366926|NCT01178216|20624378|P1|STARTED|Overall Study||41
8366927|NCT01178138|20624387|P1|NOT COMPLETED|Overall Study||23
8366928|NCT01178138|20624387|P1|COMPLETED|Overall Study||1
8366929|NCT01178138|20624387|P1|Completed 3 Sessions|Overall Study||1
8366930|NCT01178138|20624387|P1|Completed 5 Sessions|Overall Study||1
8366931|NCT01178138|20624387|P1|Completed 6 Sessions|Overall Study||1
8366932|NCT01178138|20624387|P1|STARTED|Overall Study||24
8366933|NCT01178125|20624408|P1|NOT COMPLETED|Overall Study||1178
8366934|NCT01178125|20624408|P1|COMPLETED|Overall Study||1680
8366935|NCT01178125|20624408|P1|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
8366936|NCT01178125|20624408|P1|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
8366937|NCT01178125|20624408|P1|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
8366938|NCT01178125|20624408|P1|STARTED|Overall Study|Number enrolled.|2858
8366939|NCT01178099|20624439|P2|NOT COMPLETED|Overall Study||1
8366940|NCT01178099|20624440|P1|NOT COMPLETED|Overall Study||0
8366941|NCT01178099|20624439|P2|COMPLETED|Overall Study||12
8366942|NCT01178099|20624440|P1|COMPLETED|Overall Study||13
8366943|NCT01178099|20624439|P2|STARTED|Overall Study||13
8366944|NCT01178099|20624440|P1|STARTED|Overall Study||13
8366945|NCT01178086|20624480|P1|NOT COMPLETED|Overall Study||332
8366946|NCT01178086|20624480|P1|COMPLETED|Overall Study||349
8366947|NCT01178086|20624480|P1|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
8366948|NCT01178086|20624480|P1|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
8366949|NCT01178073|20624507|P3|NOT COMPLETED|Overall Study||46
8366950|NCT01178073|20624508|P2|NOT COMPLETED|Overall Study||44
8366951|NCT01178073|20624509|P1|NOT COMPLETED|Overall Study||62
8366952|NCT01178073|20624507|P3|COMPLETED|Overall Study||105
8366953|NCT01178073|20624508|P2|COMPLETED|Overall Study||108
8366954|NCT01178073|20624509|P1|COMPLETED|Overall Study||240
8366955|NCT01178073|20624507|P3|STARTED|Overall Study||151
8366956|NCT01178073|20624508|P2|STARTED|Overall Study||152
8366957|NCT01178073|20624509|P1|STARTED|Overall Study||302
8366958|NCT01177969|20624540|P2|NOT COMPLETED|Overall Study||3
8366959|NCT01177969|20624541|P1|NOT COMPLETED|Overall Study||3
8366960|NCT01177969|20624540|P2|COMPLETED|Overall Study||11
8366961|NCT01177969|20624541|P1|COMPLETED|Overall Study||16
8366962|NCT01177969|20624540|P2|STARTED|Overall Study||14
8366963|NCT01177969|20624541|P1|STARTED|Overall Study||19
8366964|NCT01177956|20624549|P1|NOT COMPLETED|Overall Study||0
8366965|NCT01177956|20624549|P1|COMPLETED|Overall Study||68
8366966|NCT01177956|20624549|P1|STARTED|Overall Study||68
8366967|NCT01177943|20624564|P2|NOT COMPLETED|Second Intervention||0
8366968|NCT01177943|20624565|P1|NOT COMPLETED|Second Intervention||0
8366969|NCT01177943|20624564|P2|COMPLETED|Second Intervention||21
8366970|NCT01177943|20624565|P1|COMPLETED|Second Intervention||19
8366971|NCT01177943|20624564|P2|STARTED|Second Intervention||21
8366972|NCT01177943|20624565|P1|STARTED|Second Intervention||19
8366973|NCT01177943|20624564|P2|NOT COMPLETED|First Intervention||0
8366974|NCT01177943|20624565|P1|NOT COMPLETED|First Intervention||2
8366975|NCT01177943|20624564|P2|COMPLETED|First Intervention||21
8366976|NCT01177943|20624565|P1|COMPLETED|First Intervention||19
8366977|NCT01177943|20624564|P2|STARTED|First Intervention||21
8366978|NCT01177943|20624565|P1|STARTED|First Intervention||21
8366979|NCT01177813|20624578|P5|NOT COMPLETED|Overall Study||9
8366980|NCT01177813|20624579|P4|NOT COMPLETED|Overall Study||17
8366981|NCT01177813|20624580|P3|NOT COMPLETED|Overall Study||20
8366982|NCT01177813|20624581|P2|NOT COMPLETED|Overall Study||18
8366983|NCT01177813|20624582|P1|NOT COMPLETED|Overall Study||41
8366984|NCT01177813|20624578|P5|COMPLETED|Overall Study||78
8366985|NCT01177813|20624579|P4|COMPLETED|Overall Study||206
8366986|NCT01177813|20624580|P3|COMPLETED|Overall Study||204
8366987|NCT01177813|20624581|P2|COMPLETED|Overall Study||206
8366988|NCT01177813|20624582|P1|COMPLETED|Overall Study||187
8366989|NCT01177813|20624578|P5|STARTED|Overall Study||87
8366990|NCT01177813|20624579|P4|STARTED|Overall Study||223
8366991|NCT01177813|20624580|P3|STARTED|Overall Study||224
8366992|NCT01177813|20624581|P2|STARTED|Overall Study||224
8366993|NCT01177813|20624582|P1|STARTED|Overall Study||228
8366994|NCT01177800|20624611|P2|NOT COMPLETED|Overall Study||5
8366995|NCT01177800|20624612|P1|NOT COMPLETED|Overall Study||10
8366996|NCT01177800|20624611|P2|COMPLETED|Overall Study||40
8366997|NCT01177800|20624612|P1|COMPLETED|Overall Study||74
8366998|NCT01177800|20624611|P2|STARTED|Overall Study||45
8366999|NCT01177800|20624612|P1|STARTED|Overall Study||84
8367003|NCT01177722|20624634|P4|NOT COMPLETED|Overall Study||7
8367004|NCT01177722|20624635|P3|NOT COMPLETED|Overall Study||9
8367005|NCT01177722|20624636|P2|NOT COMPLETED|Overall Study||10
8367006|NCT01177722|20624637|P1|NOT COMPLETED|Overall Study||13
8367007|NCT01177722|20624634|P4|COMPLETED|Overall Study||338
8367008|NCT01177722|20624635|P3|COMPLETED|Overall Study||333
8367009|NCT01177722|20624636|P2|COMPLETED|Overall Study||334
8367010|NCT01177722|20624637|P1|COMPLETED|Overall Study||331
8367011|NCT01177722|20624634|P4|STARTED|Overall Study||345
8367012|NCT01177722|20624635|P3|STARTED|Overall Study||342
8367013|NCT01177722|20624636|P2|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
8367014|NCT01177722|20624637|P1|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
8367015|NCT01177709|20624663|P1|NOT COMPLETED|Overall Study||0
8367016|NCT01177709|20624663|P1|COMPLETED|Overall Study||12
8367017|NCT01177709|20624663|P1|STARTED|Overall Study||12
8367018|NCT01177670|20624669|P1|NOT COMPLETED|Overall Study||169
8367019|NCT01177670|20624669|P1|COMPLETED|Overall Study||0
8367020|NCT01177670|20624669|P1|STARTED|Overall Study||169
8367021|NCT01177553|20624676|P2|NOT COMPLETED|Overall Study||0
8367022|NCT01177553|20624677|P1|NOT COMPLETED|Overall Study||1
8367023|NCT01177553|20624676|P2|COMPLETED|Overall Study|data as of March 2009|2
8367024|NCT01177553|20624677|P1|COMPLETED|Overall Study|data as of March 2009|2
8367025|NCT01177553|20624676|P2|STARTED|Overall Study||2
8367026|NCT01177553|20624677|P1|STARTED|Overall Study||3
8367027|NCT01177410|20624686|P3|NOT COMPLETED|Overall Study||5
8367028|NCT01177410|20624687|P2|NOT COMPLETED|Overall Study||7
8367029|NCT01177410|20624688|P1|NOT COMPLETED|Overall Study||1
8367030|NCT01177410|20624686|P3|COMPLETED|Overall Study||45
8367031|NCT01177410|20624687|P2|COMPLETED|Overall Study||40
8367032|NCT01177410|20624688|P1|COMPLETED|Overall Study||50
8367033|NCT01177410|20624686|P3|STARTED|Overall Study||50
8367034|NCT01177410|20624687|P2|STARTED|Overall Study||47
8367035|NCT01177410|20624688|P1|STARTED|Overall Study||51
8367036|NCT01177384|20624701|P2|NOT COMPLETED|Overall Study||26
8367037|NCT01177384|20624702|P1|NOT COMPLETED|Overall Study||14
8367038|NCT01177384|20624701|P2|COMPLETED|Overall Study||164
8367039|NCT01177384|20624702|P1|COMPLETED|Overall Study||177
8367040|NCT01177384|20624701|P2|STARTED|Overall Study|Includes the second randomization of a participant|190
8367041|NCT01177384|20624702|P1|STARTED|Overall Study||191
8367042|NCT01177228|20624718|P4|NOT COMPLETED|Overall Study||0
8367043|NCT01177228|20624719|P3|NOT COMPLETED|Overall Study||0
8367044|NCT01177228|20624720|P2|NOT COMPLETED|Overall Study||2
8367045|NCT01177228|20624721|P1|NOT COMPLETED|Overall Study||1
8367046|NCT01177228|20624718|P4|COMPLETED|Overall Study||11
8367047|NCT01177228|20624719|P3|COMPLETED|Overall Study||14
8367048|NCT01177228|20624720|P2|COMPLETED|Overall Study||11
8367049|NCT01177228|20624721|P1|COMPLETED|Overall Study||8
8367050|NCT01177228|20624718|P4|Received Treatment|Overall Study||11
8367051|NCT01177228|20624719|P3|Received Treatment|Overall Study||14
8367052|NCT01177228|20624720|P2|Received Treatment|Overall Study||12
8367053|NCT01177228|20624721|P1|Received Treatment|Overall Study||9
8367054|NCT01177228|20624718|P4|STARTED|Overall Study||11
8367055|NCT01177228|20624719|P3|STARTED|Overall Study||14
8367056|NCT01177228|20624720|P2|STARTED|Overall Study||13
8367057|NCT01177228|20624721|P1|STARTED|Overall Study||9
8367058|NCT01177189|20624761|P2|NOT COMPLETED|Overall Study||0
8367059|NCT01177189|20624762|P1|NOT COMPLETED|Overall Study||0
8367060|NCT01177189|20624761|P2|COMPLETED|Overall Study||45
8367061|NCT01177189|20624762|P1|COMPLETED|Overall Study||42
8367062|NCT01177189|20624761|P2|STARTED|Overall Study||45
8367063|NCT01177189|20624762|P1|STARTED|Overall Study||42
8367064|NCT01177137|20624775|P3|NOT COMPLETED|Overall Study||2
8367065|NCT01177137|20624776|P2|NOT COMPLETED|Overall Study||10
8367066|NCT01177137|20624777|P1|NOT COMPLETED|Overall Study||10
8367067|NCT01177137|20624775|P3|COMPLETED|Overall Study||47
8367068|NCT01177137|20624776|P2|COMPLETED|Overall Study||41
8367069|NCT01177137|20624777|P1|COMPLETED|Overall Study||41
8367070|NCT01177137|20624775|P3|STARTED|Overall Study||49
8367071|NCT01177137|20624776|P2|STARTED|Overall Study||51
8367072|NCT01177137|20624777|P1|STARTED|Overall Study||51
8367073|NCT01177098|20624844|P2|NOT COMPLETED|Overall Study||12
8367074|NCT01177098|20624845|P1|NOT COMPLETED|Overall Study||9
8367075|NCT01177098|20624844|P2|COMPLETED|Overall Study||271
8367076|NCT01177098|20624845|P1|COMPLETED|Overall Study||269
8367077|NCT01177098|20624844|P2|STARTED|Overall Study||283
8367078|NCT01177098|20624845|P1|STARTED|Overall Study||278
8367079|NCT01177059|20624861|P1|NOT COMPLETED|Overall Study||50
8367080|NCT01177059|20624861|P1|COMPLETED|Overall Study||18
8367081|NCT01177059|20624861|P1|STARTED|Overall Study||68
8367082|NCT01177007|20624867|P1|NOT COMPLETED|Overall Study||38
8367083|NCT01177007|20624867|P1|COMPLETED|Overall Study||12
8367084|NCT01177007|20624867|P1|Completed First Clinical and Imaging|Overall Study||43
8367085|NCT01177007|20624867|P1|Completed First Y90 Treatment|Overall Study||50
8367086|NCT01177007|20624867|P1|STARTED|Overall Study||50
8367087|NCT01176968|20624881|P2|NOT COMPLETED|Overall Study||82
8367088|NCT01176968|20624882|P1|NOT COMPLETED|Overall Study||84
8367089|NCT01176968|20624881|P2|COMPLETED|Overall Study||424
8367090|NCT01176968|20624882|P1|COMPLETED|Overall Study||422
8367091|NCT01176968|20624881|P2|Treated|Overall Study||505
8367092|NCT01176968|20624882|P1|Treated|Overall Study||505
8367093|NCT01176968|20624881|P2|STARTED|Overall Study||506
8367094|NCT01176968|20624882|P1|STARTED|Overall Study||506
8367095|NCT01176955|20624916|P2|NOT COMPLETED|Overall Study||2
8367096|NCT01176955|20624917|P1|NOT COMPLETED|Overall Study||3
8367097|NCT01176955|20624916|P2|COMPLETED|Overall Study||8
8367098|NCT01176955|20624917|P1|COMPLETED|Overall Study||7
8367099|NCT01176955|20624916|P2|STARTED|Overall Study||10
8367100|NCT01176955|20624917|P1|STARTED|Overall Study||10
8367101|NCT01176916|20624928|P1|NOT COMPLETED|Overall Study||167
8367102|NCT01176916|20624928|P1|COMPLETED|Overall Study||397
8367103|NCT01176916|20624928|P1|Assigne But Not Treated|Overall Study||6
8367104|NCT01176916|20624928|P1|Treated|Overall Study||558
8367105|NCT01176916|20624928|P1|STARTED|Overall Study||564
8367106|NCT01176877|20624938|P1|NOT COMPLETED|Overall Study||9
8367107|NCT01176877|20624938|P1|COMPLETED|Overall Study||31
8367108|NCT01176877|20624938|P1|STARTED|Overall Study||40
8367109|NCT01176773|20624943|P1|NOT COMPLETED|Overall Study||3
8367110|NCT01176773|20624943|P1|COMPLETED|Overall Study||59
8367111|NCT01176773|20624943|P1|STARTED|Overall Study||62
8367112|NCT01176617|20624954|P3|NOT COMPLETED|6 - 12 Months (Randomized)||0
8367113|NCT01176617|20624955|P2|NOT COMPLETED|6 - 12 Months (Randomized)||0
8367114|NCT01176617|20624956|P1|NOT COMPLETED|6 - 12 Months (Randomized)||5
8367115|NCT01176617|20624954|P3|COMPLETED|6 - 12 Months (Randomized)||0
8367116|NCT01176617|20624955|P2|COMPLETED|6 - 12 Months (Randomized)||20
8367117|NCT01176617|20624956|P1|COMPLETED|6 - 12 Months (Randomized)||13
8367118|NCT01176617|20624954|P3|STARTED|6 - 12 Months (Randomized)||0
8367119|NCT01176617|20624955|P2|STARTED|6 - 12 Months (Randomized)||20
8367120|NCT01176617|20624956|P1|STARTED|6 - 12 Months (Randomized)||18
8367121|NCT01176617|20624954|P3|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
8367122|NCT01176617|20624955|P2|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
8367123|NCT01176617|20624956|P1|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
8367124|NCT01176617|20624954|P3|COMPLETED|1 - 6 Months (Ron-randomized)||38
8367125|NCT01176617|20624955|P2|COMPLETED|1 - 6 Months (Ron-randomized)||0
8367126|NCT01176617|20624956|P1|COMPLETED|1 - 6 Months (Ron-randomized)||0
8367127|NCT01176617|20624954|P3|STARTED|1 - 6 Months (Ron-randomized)||38
8367128|NCT01176617|20624955|P2|STARTED|1 - 6 Months (Ron-randomized)||0
8367129|NCT01176617|20624956|P1|STARTED|1 - 6 Months (Ron-randomized)||0
8367130|NCT01176591|20624967|P2|NOT COMPLETED|Session 2||0
8367131|NCT01176591|20624968|P1|NOT COMPLETED|Session 2||0
8367132|NCT01176591|20624967|P2|COMPLETED|Session 2||3
8367133|NCT01176591|20624968|P1|COMPLETED|Session 2||10
8367134|NCT01176591|20624967|P2|STARTED|Session 2||3
8367135|NCT01176591|20624968|P1|STARTED|Session 2||10
8367136|NCT01176591|20624967|P2|NOT COMPLETED|Session 1||0
8367137|NCT01176591|20624968|P1|NOT COMPLETED|Session 1||0
8367138|NCT01176591|20624967|P2|COMPLETED|Session 1||3
8367139|NCT01176591|20624968|P1|COMPLETED|Session 1||10
8367140|NCT01176591|20624967|P2|STARTED|Session 1||3
8367141|NCT01176591|20624968|P1|STARTED|Session 1||10
8367142|NCT01176565|20624986|P2|NOT COMPLETED|Overall Study||19
8367143|NCT01176565|20624987|P1|NOT COMPLETED|Overall Study||20
8367144|NCT01176565|20624986|P2|COMPLETED|Overall Study||481
8367145|NCT01176565|20624987|P1|COMPLETED|Overall Study||480
8367146|NCT01176565|20624986|P2|STARTED|Overall Study||500
8367147|NCT01176565|20624987|P1|STARTED|Overall Study||500
8367148|NCT01176513|20625005|P1|NOT COMPLETED|Overall Study||3
8367149|NCT01176513|20625005|P1|COMPLETED|Overall Study||22
8367150|NCT01176513|20625005|P1|STARTED|Overall Study||25
8367151|NCT01176448|20625010|P1|NOT COMPLETED|Overall Study||0
8367152|NCT01176448|20625010|P1|COMPLETED|Overall Study||6
8367153|NCT01176448|20625010|P1|STARTED|Overall Study||6
8367154|NCT01176435|20625021|P3|NOT COMPLETED|Overall Study||0
8367155|NCT01176435|20625022|P2|NOT COMPLETED|Overall Study||0
8367156|NCT01176435|20625023|P1|NOT COMPLETED|Overall Study||0
8367157|NCT01176435|20625021|P3|COMPLETED|Overall Study||15
8367158|NCT01176435|20625022|P2|COMPLETED|Overall Study||15
8367159|NCT01176435|20625023|P1|COMPLETED|Overall Study||15
8367160|NCT01176435|20625021|P3|STARTED|Overall Study||15
8367161|NCT01176435|20625022|P2|STARTED|Overall Study||15
8367162|NCT01176435|20625023|P1|STARTED|Overall Study||15
8367163|NCT01176292|20625033|P2|NOT COMPLETED|Overall Study||9
8367164|NCT01176292|20625034|P1|NOT COMPLETED|Overall Study||5
8367165|NCT01176292|20625033|P2|COMPLETED|Overall Study||62
8367166|NCT01176292|20625034|P1|COMPLETED|Overall Study||66
8367167|NCT01176292|20625033|P2|STARTED|Overall Study||71
8367168|NCT01176292|20625034|P1|STARTED|Overall Study||71
8367169|NCT01176266|20625052|P1|NOT COMPLETED|Overall Study||9
8367170|NCT01176266|20625052|P1|COMPLETED|Overall Study||60
8367171|NCT01176266|20625052|P1|STARTED|Overall Study||69
8367172|NCT01176240|20625076|P2|NOT COMPLETED|Study 306B||17
8367173|NCT01176240|20625077|P1|NOT COMPLETED|Study 306B||26
8367174|NCT01176240|20625076|P2|COMPLETED|Study 306B||68
8367175|NCT01176240|20625077|P1|COMPLETED|Study 306B||63
8367176|NCT01176240|20625076|P2|4 wk of Stable Dosing and Visit 6|Study 306B||73
8367177|NCT01176240|20625077|P1|4 wk of Stable Dosing and Visit 6|Study 306B||67
8367178|NCT01176240|20625076|P2|2 wk of Stable Dosing and Visit 5|Study 306B||75
8367179|NCT01176240|20625077|P1|2 wk of Stable Dosing and Visit 5|Study 306B||68
8367180|NCT01176240|20625076|P2|1 wk of Stable Dosing and Visit 4|Study 306B||78
8367181|NCT01176240|20625077|P1|1 wk of Stable Dosing and Visit 4|Study 306B||69
8367182|NCT01176240|20625076|P2|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
8367183|NCT01176240|20625077|P1|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
8367184|NCT01176240|20625076|P2|STARTED|Study 306B||85
8367185|NCT01176240|20625077|P1|STARTED|Study 306B||89
8367186|NCT01176240|20625076|P2|NOT COMPLETED|Study 306A||3
8367187|NCT01176240|20625077|P1|NOT COMPLETED|Study 306A||3
8367188|NCT01176240|20625076|P2|COMPLETED|Study 306A||24
8367189|NCT01176240|20625077|P1|COMPLETED|Study 306A||21
8367190|NCT01176240|20625076|P2|STARTED|Study 306A||27
8367191|NCT01176240|20625077|P1|STARTED|Study 306A||24
8367192|NCT01176058|20625103|P2|NOT COMPLETED|Overall Study||3
8367193|NCT01176058|20625104|P1|NOT COMPLETED|Overall Study||4
8367194|NCT01176058|20625103|P2|COMPLETED|Overall Study||5
8367195|NCT01176058|20625104|P1|COMPLETED|Overall Study||5
8367196|NCT01176058|20625103|P2|STARTED|Overall Study||8
8367197|NCT01176058|20625104|P1|STARTED|Overall Study||9
8367198|NCT01176032|20625128|P2|NOT COMPLETED|Overall Study||1
8367199|NCT01176032|20625129|P1|NOT COMPLETED|Overall Study||6
8367200|NCT01176032|20625128|P2|COMPLETED|Overall Study||36
8367201|NCT01176032|20625129|P1|COMPLETED|Overall Study||31
8367202|NCT01176032|20625128|P2|Intention-to-treat (ITT) Population|Overall Study||37
8367203|NCT01176032|20625129|P1|Intention-to-treat (ITT) Population|Overall Study||32
8367204|NCT01176032|20625128|P2|STARTED|Overall Study||37
8367205|NCT01176032|20625129|P1|STARTED|Overall Study|"Started indicates randomized and safety population"|37
8367206|NCT01175980|20625187|P1|NOT COMPLETED|Overall Study||0
8367207|NCT01175980|20625187|P1|COMPLETED|Overall Study||30
8367208|NCT01175980|20625187|P1|STARTED|Overall Study||30
8367209|NCT01175902|20625206|P2|NOT COMPLETED|Overall Study||0
8367210|NCT01175902|20625207|P1|NOT COMPLETED|Overall Study||0
8367211|NCT01175902|20625206|P2|COMPLETED|Overall Study||22
8367212|NCT01175902|20625207|P1|COMPLETED|Overall Study||22
8367213|NCT01175902|20625206|P2|STARTED|Overall Study||22
8367214|NCT01175902|20625207|P1|STARTED|Overall Study||22
8367215|NCT01175850|20625225|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
8367216|NCT01175850|20625226|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
8367217|NCT01175850|20625225|P2|COMPLETED|IN.PACT SFA II Phase||55
8367218|NCT01175850|20625226|P1|COMPLETED|IN.PACT SFA II Phase||109
8367219|NCT01175850|20625225|P2|STARTED|IN.PACT SFA II Phase||60
8367220|NCT01175850|20625226|P1|STARTED|IN.PACT SFA II Phase||121
8367221|NCT01175850|20625225|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
8367222|NCT01175850|20625226|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
8367223|NCT01175850|20625225|P2|COMPLETED|IN.PACT SFA I Phase||49
8367224|NCT01175850|20625226|P1|COMPLETED|IN.PACT SFA I Phase||88
8367225|NCT01175850|20625225|P2|STARTED|IN.PACT SFA I Phase||51
8367226|NCT01175850|20625226|P1|STARTED|IN.PACT SFA I Phase||99
8367227|NCT01175824|20625270|P2|NOT COMPLETED|Overall Study||22
8367228|NCT01175824|20625271|P1|NOT COMPLETED|Overall Study||16
8367229|NCT01175824|20625270|P2|COMPLETED|Overall Study||220
8367230|NCT01175824|20625271|P1|COMPLETED|Overall Study||220
8367231|NCT01175824|20625270|P2|Received at Least 1 Dose of Study Drug|Overall Study||240
8367232|NCT01175824|20625271|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
8367233|NCT01175824|20625270|P2|STARTED|Overall Study||242
8367234|NCT01175824|20625271|P1|STARTED|Overall Study||236
8367235|NCT01175811|20625305|P2|NOT COMPLETED|Overall Study||14
8367236|NCT01175811|20625306|P1|NOT COMPLETED|Overall Study||16
8367237|NCT01175811|20625305|P2|COMPLETED|Overall Study||189
8367238|NCT01175811|20625306|P1|COMPLETED|Overall Study||183
8367239|NCT01175811|20625305|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
8367240|NCT01175811|20625306|P1|Received at Least 1 Dose of Study Drug|Overall Study||197
8367241|NCT01175811|20625305|P2|STARTED|Overall Study||203
8367242|NCT01175811|20625306|P1|STARTED|Overall Study||199
8367243|NCT01175798|20625332|P2|NOT COMPLETED|Overall Study||21
8367244|NCT01175798|20625333|P1|NOT COMPLETED|Overall Study||7
8367245|NCT01175798|20625332|P2|COMPLETED|Overall Study||41
8367246|NCT01175798|20625333|P1|COMPLETED|Overall Study||27
8367247|NCT01175798|20625332|P2|STARTED|Overall Study||62
8367248|NCT01175798|20625333|P1|STARTED|Overall Study||34
8367249|NCT01175707|20625341|P2|NOT COMPLETED|Overall Study||6
8367250|NCT01175707|20625342|P1|NOT COMPLETED|Overall Study||4
8367251|NCT01175707|20625341|P2|COMPLETED|Overall Study||34
8367252|NCT01175707|20625342|P1|COMPLETED|Overall Study||36
8367253|NCT01175707|20625341|P2|STARTED|Overall Study||40
8367254|NCT01175707|20625342|P1|STARTED|Overall Study||40
8367255|NCT01175668|20625378|P2|NOT COMPLETED|Overall Study||0
8367256|NCT01175668|20625379|P1|NOT COMPLETED|Overall Study||2
8367257|NCT01175668|20625378|P2|COMPLETED|Overall Study||34
8367258|NCT01175668|20625379|P1|COMPLETED|Overall Study||32
8367259|NCT01175668|20625378|P2|STARTED|Overall Study||34
8367260|NCT01175668|20625379|P1|STARTED|Overall Study||34
8367261|NCT01175590|20625389|P2|NOT COMPLETED|Overall Study||10
8367262|NCT01175590|20625390|P1|NOT COMPLETED|Overall Study||12
8367263|NCT01175590|20625389|P2|COMPLETED|Overall Study||161
8367264|NCT01175590|20625390|P1|COMPLETED|Overall Study||335
8367265|NCT01175590|20625389|P2|Safety Population|Overall Study||170
8367266|NCT01175590|20625390|P1|Safety Population|Overall Study||344
8367267|NCT01175590|20625389|P2|Modified Intent to Treat Population|Overall Study||87
8367268|NCT01175590|20625390|P1|Modified Intent to Treat Population|Overall Study||212
8367269|NCT01175590|20625389|P2|STARTED|Overall Study||171
8367270|NCT01175590|20625390|P1|STARTED|Overall Study||347
8367271|NCT01175473|20625424|P2|NOT COMPLETED|Overall Study||2
8367272|NCT01175473|20625425|P1|NOT COMPLETED|Overall Study||2
8367273|NCT01175473|20625424|P2|COMPLETED|Overall Study||69
8367274|NCT01175473|20625425|P1|COMPLETED|Overall Study||75
8367275|NCT01175473|20625424|P2|Pharmacodynamic (PD) Population|Overall Study||68
8367276|NCT01175473|20625425|P1|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
8367277|NCT01175473|20625424|P2|Safety Population|Overall Study||71
8367278|NCT01175473|20625425|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
8367279|NCT01175473|20625424|P2|STARTED|Overall Study||71
8367280|NCT01175473|20625425|P1|STARTED|Overall Study|Randomized and treated.|77
8367281|NCT01175434|20625451|P2|NOT COMPLETED|Overall Study||0
8367282|NCT01175434|20625452|P1|NOT COMPLETED|Overall Study||0
8367283|NCT01175434|20625451|P2|COMPLETED|Overall Study||51
8367284|NCT01175434|20625452|P1|COMPLETED|Overall Study||48
8367285|NCT01175434|20625451|P2|STARTED|Overall Study||51
8367286|NCT01175434|20625452|P1|STARTED|Overall Study||48
8367287|NCT01175395|20625458|P1|NOT COMPLETED|Overall Study||0
8367288|NCT01175395|20625458|P1|COMPLETED|Overall Study||10
8367289|NCT01175395|20625458|P1|STARTED|Overall Study||10
8367290|NCT01175382|20625466|P3|NOT COMPLETED|Overall Study||6
8367291|NCT01175382|20625467|P2|NOT COMPLETED|Overall Study||7
8367292|NCT01175382|20625468|P1|NOT COMPLETED|Overall Study||8
8367293|NCT01175382|20625466|P3|COMPLETED|Overall Study||59
8367294|NCT01175382|20625467|P2|COMPLETED|Overall Study||61
8367295|NCT01175382|20625468|P1|COMPLETED|Overall Study||63
8367296|NCT01175382|20625466|P3|STARTED|Overall Study||65
8367297|NCT01175382|20625467|P2|STARTED|Overall Study||68
8367298|NCT01175382|20625468|P1|STARTED|Overall Study||71
8367299|NCT01175369|20625547|P2|NOT COMPLETED|Overall Study||5
8367300|NCT01175369|20625548|P1|NOT COMPLETED|Overall Study||2
8367301|NCT01175369|20625547|P2|COMPLETED|Overall Study||260
8367302|NCT01175369|20625548|P1|COMPLETED|Overall Study||263
8367303|NCT01175369|20625547|P2|STARTED|Overall Study||265
8367304|NCT01175369|20625548|P1|STARTED|Overall Study||265
8367308|NCT01175343|20625560|P1|NOT COMPLETED|Overall Study||0
8367309|NCT01175343|20625560|P1|COMPLETED|Overall Study||44
8367310|NCT01175343|20625560|P1|STARTED|Overall Study||44
8367311|NCT01175317|20625572|P2|NOT COMPLETED|Overall Study||0
8367312|NCT01175317|20625573|P1|NOT COMPLETED|Overall Study||0
8367313|NCT01175317|20625572|P2|COMPLETED|Overall Study||31
8367314|NCT01175317|20625573|P1|COMPLETED|Overall Study||27
8367315|NCT01175317|20625572|P2|STARTED|Overall Study||31
8367316|NCT01175317|20625573|P1|STARTED|Overall Study||27
8367317|NCT01175226|20625583|P2|NOT COMPLETED|Overall Study||5
8367318|NCT01175226|20625584|P1|NOT COMPLETED|Overall Study||11
8367319|NCT01175226|20625583|P2|COMPLETED|Overall Study||140
8367320|NCT01175226|20625584|P1|COMPLETED|Overall Study||144
8367321|NCT01175226|20625583|P2|STARTED|Overall Study||145
8367322|NCT01175226|20625584|P1|STARTED|Overall Study||155
8367335|NCT01175148|20625642|P2|NOT COMPLETED|Overall Study||0
8367336|NCT01175148|20625643|P1|NOT COMPLETED|Overall Study||0
8367337|NCT01175148|20625642|P2|COMPLETED|Overall Study||30
8367338|NCT01175148|20625643|P1|COMPLETED|Overall Study||30
8367339|NCT01175148|20625642|P2|STARTED|Overall Study||30
8367340|NCT01175148|20625643|P1|STARTED|Overall Study||30
8367341|NCT01175135|20625652|P4|NOT COMPLETED|Overall Study||14
8367342|NCT01175135|20625653|P3|NOT COMPLETED|Overall Study||12
8367343|NCT01175135|20625654|P2|NOT COMPLETED|Overall Study||22
8367344|NCT01175135|20625655|P1|NOT COMPLETED|Overall Study||16
8367345|NCT01175135|20625652|P4|COMPLETED|Overall Study||60
8367346|NCT01175135|20625653|P3|COMPLETED|Overall Study||25
8367347|NCT01175135|20625654|P2|COMPLETED|Overall Study||52
8367348|NCT01175135|20625655|P1|COMPLETED|Overall Study||58
8367349|NCT01175135|20625652|P4|Analyzed for Efficacy|Overall Study||73
8367350|NCT01175135|20625653|P3|Analyzed for Efficacy|Overall Study||34
8367351|NCT01175135|20625654|P2|Analyzed for Efficacy|Overall Study||73
8367352|NCT01175135|20625655|P1|Analyzed for Efficacy|Overall Study||74
8367353|NCT01175135|20625652|P4|Treated|Overall Study||74
8367354|NCT01175135|20625653|P3|Treated|Overall Study||36
8367355|NCT01175135|20625654|P2|Treated|Overall Study||74
8367356|NCT01175135|20625655|P1|Treated|Overall Study||74
8367357|NCT01175135|20625652|P4|STARTED|Overall Study||74
8367358|NCT01175135|20625653|P3|STARTED|Overall Study||37
8367359|NCT01175135|20625654|P2|STARTED|Overall Study||74
8367360|NCT01175135|20625655|P1|STARTED|Overall Study||74
8367361|NCT01175083|20625743|P6|NOT COMPLETED|Booster Epoch||0
8367362|NCT01175083|20625744|P5|NOT COMPLETED|Booster Epoch||0
8367363|NCT01175083|20625745|P4|NOT COMPLETED|Booster Epoch||1
8367364|NCT01175083|20625746|P3|NOT COMPLETED|Booster Epoch||1
8367365|NCT01175083|20625747|P2|NOT COMPLETED|Booster Epoch||0
8367366|NCT01175083|20625748|P1|NOT COMPLETED|Booster Epoch||0
8367367|NCT01175083|20625743|P6|COMPLETED|Booster Epoch||0
8367368|NCT01175083|20625744|P5|COMPLETED|Booster Epoch||0
8367369|NCT01175083|20625745|P4|COMPLETED|Booster Epoch||49
8367370|NCT01175083|20625746|P3|COMPLETED|Booster Epoch||49
8367371|NCT01175083|20625747|P2|COMPLETED|Booster Epoch||49
8367372|NCT01175083|20625748|P1|COMPLETED|Booster Epoch||49
8367373|NCT01175083|20625743|P6|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
8367374|NCT01175083|20625744|P5|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
8367375|NCT01175083|20625745|P4|STARTED|Booster Epoch||50
8367376|NCT01175083|20625746|P3|STARTED|Booster Epoch||50
8367377|NCT01175083|20625747|P2|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
8367378|NCT01175083|20625748|P1|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
8367379|NCT01175083|20625743|P6|NOT COMPLETED|Primary Epoch||3
8367380|NCT01175083|20625744|P5|NOT COMPLETED|Primary Epoch||0
8367381|NCT01175083|20625745|P4|NOT COMPLETED|Primary Epoch||0
8367382|NCT01175083|20625746|P3|NOT COMPLETED|Primary Epoch||0
8367383|NCT01175083|20625747|P2|NOT COMPLETED|Primary Epoch||0
8367384|NCT01175083|20625748|P1|NOT COMPLETED|Primary Epoch||0
8367385|NCT01175083|20625743|P6|COMPLETED|Primary Epoch||47
8367386|NCT01175083|20625744|P5|COMPLETED|Primary Epoch||50
8367387|NCT01175083|20625745|P4|COMPLETED|Primary Epoch||50
8367388|NCT01175083|20625746|P3|COMPLETED|Primary Epoch||50
8367389|NCT01175083|20625747|P2|COMPLETED|Primary Epoch||50
8367390|NCT01175083|20625748|P1|COMPLETED|Primary Epoch||50
8367391|NCT01175083|20625743|P6|STARTED|Primary Epoch||50
8367392|NCT01175083|20625744|P5|STARTED|Primary Epoch||50
8367393|NCT01175083|20625745|P4|STARTED|Primary Epoch||50
8367394|NCT01175083|20625746|P3|STARTED|Primary Epoch||50
8367395|NCT01175083|20625747|P2|STARTED|Primary Epoch||50
8367396|NCT01175083|20625748|P1|STARTED|Primary Epoch||50
8367397|NCT01175031|20625830|P1|NOT COMPLETED|Overall Study||0
8367398|NCT01175031|20625830|P1|COMPLETED|Overall Study||45
8367399|NCT01175031|20625830|P1|STARTED|Overall Study||45
8367400|NCT01175018|20625840|P2|NOT COMPLETED|Overall Study||1
8367401|NCT01175018|20625841|P1|NOT COMPLETED|Overall Study||3
8367402|NCT01175018|20625840|P2|COMPLETED|Overall Study||14
8367403|NCT01175018|20625841|P1|COMPLETED|Overall Study||12
8367404|NCT01175018|20625840|P2|STARTED|Overall Study||15
8367405|NCT01175018|20625841|P1|STARTED|Overall Study||15
8367406|NCT01175005|20625877|P1|NOT COMPLETED|Overall Study||0
8367407|NCT01175005|20625877|P1|COMPLETED|Overall Study||62
8367408|NCT01175005|20625877|P1|STARTED|Overall Study||62
8367409|NCT01174823|20625884|P2|NOT COMPLETED|Overall Study||4
8367410|NCT01174823|20625885|P1|NOT COMPLETED|Overall Study||7
8367411|NCT01174823|20625884|P2|COMPLETED|Overall Study||119
8367412|NCT01174823|20625885|P1|COMPLETED|Overall Study||115
8367413|NCT01174823|20625884|P2|STARTED|Overall Study||123
8367414|NCT01174823|20625885|P1|STARTED|Overall Study||122
8367415|NCT01174784|20625903|P1|NOT COMPLETED|Overall Study||4
8367416|NCT01174784|20625903|P1|COMPLETED|Overall Study|While 88 subjects did complete the procedure, 4 were considered screen failures post-procedure.|84
8367417|NCT01174784|20625903|P1|STARTED|Overall Study||88
8367418|NCT01174576|20625908|P1|NOT COMPLETED|Overall Study||0
8367419|NCT01174576|20625908|P1|COMPLETED|Overall Study||16
8367420|NCT01174576|20625908|P1|STARTED|Overall Study|All participants received all interventions without exception.|16
8367421|NCT01174563|20625949|P1|NOT COMPLETED|Overall Study||60
8367422|NCT01174563|20625949|P1|COMPLETED|Overall Study||0
8367423|NCT01174563|20625949|P1|Safety Set|Overall Study||59
8367424|NCT01174563|20625949|P1|Efficacy Set|Overall Study||59
8367425|NCT01174563|20625949|P1|STARTED|Overall Study||60
8367426|NCT01174550|20625957|P2|NOT COMPLETED|Overall Study||873
8367427|NCT01174550|20625958|P1|NOT COMPLETED|Overall Study||1270
8367428|NCT01174550|20625957|P2|COMPLETED|Overall Study||4123
8367429|NCT01174550|20625958|P1|COMPLETED|Overall Study||3737
8367430|NCT01174550|20625957|P2|STARTED|Overall Study||4996
8367431|NCT01174550|20625958|P1|STARTED|Overall Study||5007
8367432|NCT01174459|20625986|P1|NOT COMPLETED|Overall Study||5
8367433|NCT01174459|20625986|P1|COMPLETED|Overall Study|Case report form (CRF) collected|566
8367434|NCT01174459|20625986|P1|STARTED|Overall Study|Registered patients|571
8367471|NCT01174368|20626181|P1|NOT COMPLETED|Overall Study||1
8367472|NCT01174368|20626181|P1|COMPLETED|Overall Study||0
8367473|NCT01174368|20626181|P1|STARTED|Overall Study||1
8367474|NCT01174342|20626187|P1|NOT COMPLETED|Overall Study||4
8367475|NCT01174342|20626187|P1|COMPLETED|Overall Study||26
8367476|NCT01174342|20626187|P1|STARTED|Overall Study||30
8367477|NCT01174264|20626194|P3|NOT COMPLETED|Steady-state Pharmacokinetics||2
8367478|NCT01174264|20626195|P2|NOT COMPLETED|Steady-state Pharmacokinetics||0
8367479|NCT01174264|20626196|P1|NOT COMPLETED|Steady-state Pharmacokinetics||6
8367480|NCT01174264|20626194|P3|COMPLETED|Steady-state Pharmacokinetics||27
8367481|NCT01174264|20626195|P2|COMPLETED|Steady-state Pharmacokinetics||0
8367482|NCT01174264|20626196|P1|COMPLETED|Steady-state Pharmacokinetics||25
8367483|NCT01174264|20626194|P3|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
8367484|NCT01174264|20626195|P2|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
8367485|NCT01174264|20626196|P1|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
8367486|NCT01174264|20626194|P3|NOT COMPLETED|Single Dose Pharmacokinetics||2
8367487|NCT01174264|20626195|P2|NOT COMPLETED|Single Dose Pharmacokinetics||0
8367488|NCT01174264|20626196|P1|NOT COMPLETED|Single Dose Pharmacokinetics||1
8367489|NCT01174264|20626194|P3|COMPLETED|Single Dose Pharmacokinetics||18
8367490|NCT01174264|20626195|P2|COMPLETED|Single Dose Pharmacokinetics||20
8367491|NCT01174264|20626196|P1|COMPLETED|Single Dose Pharmacokinetics||22
8367492|NCT01174264|20626194|P3|STARTED|Single Dose Pharmacokinetics||20
8367493|NCT01174264|20626195|P2|STARTED|Single Dose Pharmacokinetics||20
8367494|NCT01174264|20626196|P1|STARTED|Single Dose Pharmacokinetics||23
8367495|NCT01174238|20626228|P1|NOT COMPLETED|Overall Study||2
8367496|NCT01174238|20626228|P1|COMPLETED|Overall Study||36
8367497|NCT01174238|20626228|P1|Participants That Underwent FLT-PET Scan|Overall Study||6
8367498|NCT01174238|20626228|P1|STARTED|Overall Study||38
8367499|NCT01174186|20626239|P2|NOT COMPLETED|Overall Study||3
8367500|NCT01174186|20626240|P1|NOT COMPLETED|Overall Study||0
8367501|NCT01174186|20626239|P2|COMPLETED|Overall Study||12
8367502|NCT01174186|20626240|P1|COMPLETED|Overall Study||15
8367503|NCT01174186|20626239|P2|STARTED|Overall Study||15
8367504|NCT01174186|20626240|P1|STARTED|Overall Study|Patients were included over three years|15
8367505|NCT01174173|20626247|P1|NOT COMPLETED|Overall Study||1
8367506|NCT01174173|20626247|P1|COMPLETED|Overall Study||10
8367507|NCT01174173|20626247|P1|STARTED|Overall Study||11
8367508|NCT01174160|20626258|P2|NOT COMPLETED|Overall Study||6
8367509|NCT01174160|20626259|P1|NOT COMPLETED|Overall Study||8
8367510|NCT01174160|20626258|P2|COMPLETED|Overall Study||56
8367511|NCT01174160|20626259|P1|COMPLETED|Overall Study||53
8367512|NCT01174160|20626258|P2|Discontinued Post Dose|Overall Study||0
8367513|NCT01174160|20626259|P1|Discontinued Post Dose|Overall Study||2
8367514|NCT01174160|20626258|P2|Dosed|Overall Study||56
8367515|NCT01174160|20626259|P1|Dosed|Overall Study||55
8367516|NCT01174160|20626258|P2|Discontinued Pre Dose|Overall Study||6
8367517|NCT01174160|20626259|P1|Discontinued Pre Dose|Overall Study||6
8367518|NCT01174160|20626258|P2|STARTED|Overall Study||62
8367519|NCT01174160|20626259|P1|STARTED|Overall Study||61
8367520|NCT01174082|20626267|P2|NOT COMPLETED|Overall Study||0
8367521|NCT01174082|20626268|P1|NOT COMPLETED|Overall Study||0
8367522|NCT01174082|20626267|P2|COMPLETED|Overall Study||1
8367523|NCT01174082|20626268|P1|COMPLETED|Overall Study||1
8367524|NCT01174082|20626267|P2|STARTED|Overall Study||1
8367525|NCT01174082|20626268|P1|STARTED|Overall Study||1
8367526|NCT01174043|20626274|P1|NOT COMPLETED|Overall Study||11
8367527|NCT01174043|20626274|P1|COMPLETED|Overall Study||0
8367528|NCT01174043|20626274|P1|STARTED|Overall Study||11
8367544|NCT01174004|20626313|P2|NOT COMPLETED|Overall Study||16
8367545|NCT01174004|20626314|P1|NOT COMPLETED|Overall Study||7
8367546|NCT01174004|20626313|P2|COMPLETED|Overall Study||89
8367547|NCT01174004|20626314|P1|COMPLETED|Overall Study||87
8367548|NCT01174004|20626313|P2|STARTED|Overall Study||105
8367549|NCT01174004|20626314|P1|STARTED|Overall Study||94
8367550|NCT01173874|20626324|P2|NOT COMPLETED|Overall Study||23
8367551|NCT01173874|20626325|P1|NOT COMPLETED|Overall Study||23
8367552|NCT01173874|20626324|P2|COMPLETED|Overall Study||41
8367553|NCT01173874|20626325|P1|COMPLETED|Overall Study||33
8367554|NCT01173874|20626324|P2|STARTED|Overall Study||64
8367555|NCT01173874|20626325|P1|STARTED|Overall Study||56
8367556|NCT01173848|20626339|P2|NOT COMPLETED|Overall Study||8
8367557|NCT01173848|20626340|P1|NOT COMPLETED|Overall Study||4
8367558|NCT01173848|20626339|P2|COMPLETED|Overall Study||3
8367559|NCT01173848|20626340|P1|COMPLETED|Overall Study||4
8367560|NCT01173848|20626339|P2|STARTED|Overall Study||11
8367561|NCT01173848|20626340|P1|STARTED|Overall Study||8
8367562|NCT01173718|20626345|P1|NOT COMPLETED|Overall Study||44
8367563|NCT01173718|20626345|P1|COMPLETED|Overall Study||94
8367564|NCT01173718|20626345|P1|STARTED|Overall Study||138
8367565|NCT01173679|20626354|P1|NOT COMPLETED|Overall Study||1
8367566|NCT01173679|20626354|P1|COMPLETED|Overall Study||9
8367567|NCT01173679|20626354|P1|STARTED|Overall Study||10
8367568|NCT01173653|20626362|P2|NOT COMPLETED|Overall Study||41
8367569|NCT01173653|20626363|P1|NOT COMPLETED|Overall Study||53
8367570|NCT01173653|20626362|P2|COMPLETED|Overall Study||49
8367571|NCT01173653|20626363|P1|COMPLETED|Overall Study||56
8367572|NCT01173653|20626362|P2|STARTED|Overall Study||90
8367573|NCT01173653|20626363|P1|STARTED|Overall Study||109
8367574|NCT01173601|20626373|P5|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
8367575|NCT01173601|20626374|P4|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
8367576|NCT01173601|20626375|P3|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
8367577|NCT01173601|20626376|P2|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
8367578|NCT01173601|20626377|P1|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8367579|NCT01173601|20626373|P5|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
8367580|NCT01173601|20626374|P4|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
8367581|NCT01173601|20626375|P3|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
8367582|NCT01173601|20626376|P2|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
8367583|NCT01173601|20626377|P1|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8367584|NCT01173601|20626373|P5|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
8367585|NCT01173601|20626374|P4|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
8367586|NCT01173601|20626375|P3|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
8367587|NCT01173601|20626376|P2|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
8367588|NCT01173601|20626377|P1|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8367589|NCT01173601|20626373|P5|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8367590|NCT01173601|20626374|P4|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8367591|NCT01173601|20626375|P3|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
8367592|NCT01173601|20626376|P2|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
8367593|NCT01173601|20626377|P1|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8367594|NCT01173601|20626373|P5|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
8367595|NCT01173601|20626374|P4|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
8367596|NCT01173601|20626375|P3|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
8367597|NCT01173601|20626376|P2|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
8367598|NCT01173601|20626377|P1|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
8367599|NCT01173601|20626373|P5|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367600|NCT01173601|20626374|P4|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367601|NCT01173601|20626375|P3|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367602|NCT01173601|20626376|P2|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367603|NCT01173601|20626377|P1|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
8367604|NCT01173601|20626373|P5|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367605|NCT01173601|20626374|P4|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367606|NCT01173601|20626375|P3|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367607|NCT01173601|20626376|P2|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
8367608|NCT01173601|20626377|P1|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
8367609|NCT01173601|20626373|P5|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
8367610|NCT01173601|20626374|P4|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
8367611|NCT01173601|20626375|P3|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
8367612|NCT01173601|20626376|P2|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
8367613|NCT01173601|20626377|P1|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
8367614|NCT01173601|20626373|P5|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8367615|NCT01173601|20626374|P4|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8367616|NCT01173601|20626375|P3|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8367617|NCT01173601|20626376|P2|STARTED|Confirmation (CF) Phase, 3 Weeks||0
8367618|NCT01173601|20626377|P1|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
8367619|NCT01173523|20626454|P2|NOT COMPLETED|Overall Study||12
8367620|NCT01173523|20626455|P1|NOT COMPLETED|Overall Study||13
8367621|NCT01173523|20626454|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8367622|NCT01173523|20626455|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
8367623|NCT01173523|20626454|P2|STARTED|Overall Study||12
8367624|NCT01173523|20626455|P1|STARTED|Overall Study||13
8367625|NCT01173471|20626471|P4|NOT COMPLETED|Overall Study||1
8367626|NCT01173471|20626472|P3|NOT COMPLETED|Overall Study||3
8367627|NCT01173471|20626473|P2|NOT COMPLETED|Overall Study||0
8367628|NCT01173471|20626474|P1|NOT COMPLETED|Overall Study||2
8367629|NCT01173471|20626471|P4|COMPLETED|Overall Study|Completed study|18
8367630|NCT01173471|20626472|P3|COMPLETED|Overall Study|Completed study|15
8367631|NCT01173471|20626473|P2|COMPLETED|Overall Study|Completed study|7
8367632|NCT01173471|20626474|P1|COMPLETED|Overall Study|Completed study|4
8367633|NCT01173471|20626471|P4|Completed Treatment|Overall Study||18
8367634|NCT01173471|20626472|P3|Completed Treatment|Overall Study||15
8367635|NCT01173471|20626473|P2|Completed Treatment|Overall Study||7
8367636|NCT01173471|20626474|P1|Completed Treatment|Overall Study||4
8367637|NCT01173471|20626471|P4|Received Treatment|Overall Study||19
8367638|NCT01173471|20626472|P3|Received Treatment|Overall Study||18
8367639|NCT01173471|20626473|P2|Received Treatment|Overall Study||7
8367640|NCT01173471|20626474|P1|Received Treatment|Overall Study||6
8367641|NCT01173471|20626471|P4|STARTED|Overall Study|Randomized|19
8367642|NCT01173471|20626472|P3|STARTED|Overall Study|Randomized|18
8367643|NCT01173471|20626473|P2|STARTED|Overall Study|Randomized|7
8367644|NCT01173471|20626474|P1|STARTED|Overall Study|Randomized|6
8367645|NCT01173211|20626498|P6|NOT COMPLETED|Overall Study||0
8367646|NCT01173211|20626499|P5|NOT COMPLETED|Overall Study||0
8367647|NCT01173211|20626500|P4|NOT COMPLETED|Overall Study||0
8367648|NCT01173211|20626501|P3|NOT COMPLETED|Overall Study||2
8367649|NCT01173211|20626502|P2|NOT COMPLETED|Overall Study||1
8367650|NCT01173211|20626503|P1|NOT COMPLETED|Overall Study||2
8367651|NCT01173211|20626498|P6|COMPLETED|Overall Study||13
8367652|NCT01173211|20626499|P5|COMPLETED|Overall Study||16
8367653|NCT01173211|20626500|P4|COMPLETED|Overall Study||15
8367654|NCT01173211|20626501|P3|COMPLETED|Overall Study||44
8367655|NCT01173211|20626502|P2|COMPLETED|Overall Study||44
8367656|NCT01173211|20626503|P1|COMPLETED|Overall Study||46
8367657|NCT01173211|20626498|P6|STARTED|Overall Study||13
8367658|NCT01173211|20626499|P5|STARTED|Overall Study||16
8367659|NCT01173211|20626500|P4|STARTED|Overall Study||15
8367660|NCT01173211|20626501|P3|STARTED|Overall Study||46
8367661|NCT01173211|20626502|P2|STARTED|Overall Study||45
8367662|NCT01173211|20626503|P1|STARTED|Overall Study||48
8367663|NCT01173159|20626604|P1|NOT COMPLETED|Overall Study||0
8367664|NCT01173159|20626604|P1|COMPLETED|Overall Study||10
8367665|NCT01173159|20626604|P1|STARTED|Overall Study||10
8367666|NCT01173120|20626614|P1|NOT COMPLETED|Overall Study||62
8367667|NCT01173120|20626614|P1|COMPLETED|Overall Study||0
8367668|NCT01173120|20626614|P1|Discontinued ACP Substudy and Main Study|Overall Study||5
8367669|NCT01173120|20626614|P1|Switched Back to Main Study|Overall Study||57
8367670|NCT01173120|20626614|P1|STARTED|Overall Study||62
8367671|NCT01173055|20626632|P2|NOT COMPLETED|Period 2 - Day 64 to 112||1
8367672|NCT01173055|20626633|P1|NOT COMPLETED|Period 2 - Day 64 to 112||0
8367673|NCT01173055|20626632|P2|COMPLETED|Period 2 - Day 64 to 112||9
8367674|NCT01173055|20626633|P1|COMPLETED|Period 2 - Day 64 to 112||8
8367675|NCT01173055|20626632|P2|STARTED|Period 2 - Day 64 to 112||10
8367676|NCT01173055|20626633|P1|STARTED|Period 2 - Day 64 to 112||8
8367677|NCT01173055|20626632|P2|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
8367678|NCT01173055|20626633|P1|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
8367679|NCT01173055|20626632|P2|COMPLETED|Placebo Washout Period - Day 50 to 63||10
8367680|NCT01173055|20626633|P1|COMPLETED|Placebo Washout Period - Day 50 to 63||8
8367681|NCT01173055|20626632|P2|STARTED|Placebo Washout Period - Day 50 to 63||10
8367682|NCT01173055|20626633|P1|STARTED|Placebo Washout Period - Day 50 to 63||8
8367683|NCT01173055|20626632|P2|NOT COMPLETED|Period 1 - Day 1 to 49||2
8367684|NCT01173055|20626633|P1|NOT COMPLETED|Period 1 - Day 1 to 49||2
8367685|NCT01173055|20626632|P2|COMPLETED|Period 1 - Day 1 to 49||10
8367686|NCT01173055|20626633|P1|COMPLETED|Period 1 - Day 1 to 49||8
8367687|NCT01173055|20626632|P2|STARTED|Period 1 - Day 1 to 49||12
8367688|NCT01173055|20626633|P1|STARTED|Period 1 - Day 1 to 49||10
8367689|NCT01173029|20626651|P2|NOT COMPLETED|Overall Study||0
8367690|NCT01173029|20626652|P1|NOT COMPLETED|Overall Study||0
8367691|NCT01173029|20626651|P2|COMPLETED|Overall Study||31
8367692|NCT01173029|20626652|P1|COMPLETED|Overall Study||61
8367693|NCT01173029|20626651|P2|STARTED|Overall Study||31
8367694|NCT01173029|20626652|P1|STARTED|Overall Study||61
8367695|NCT01173016|20626669|P1|NOT COMPLETED|Overall Study||1
8367696|NCT01173016|20626669|P1|COMPLETED|Overall Study||10
8367697|NCT01173016|20626669|P1|STARTED|Overall Study||11
8367698|NCT01172938|20626684|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
8367699|NCT01172938|20626685|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
8367700|NCT01172938|20626686|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367701|NCT01172938|20626687|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367702|NCT01172938|20626688|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367703|NCT01172938|20626689|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367704|NCT01172938|20626690|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
8367705|NCT01172938|20626691|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
8367706|NCT01172938|20626692|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367707|NCT01172938|20626684|P9|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
8367708|NCT01172938|20626685|P8|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
8367709|NCT01172938|20626686|P7|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367710|NCT01172938|20626687|P6|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367711|NCT01172938|20626688|P5|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367712|NCT01172938|20626689|P4|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367713|NCT01172938|20626690|P3|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
8367714|NCT01172938|20626691|P2|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
8367715|NCT01172938|20626692|P1|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
8367716|NCT01172938|20626684|P9|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367717|NCT01172938|20626685|P8|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
8367718|NCT01172938|20626686|P7|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367719|NCT01172938|20626687|P6|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367720|NCT01172938|20626688|P5|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367721|NCT01172938|20626689|P4|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367722|NCT01172938|20626690|P3|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367723|NCT01172938|20626691|P2|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367724|NCT01172938|20626692|P1|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
8367725|NCT01172938|20626684|P9|STARTED|Active-Treatment Phase (Weeks 208-260)||34
8367726|NCT01172938|20626685|P8|STARTED|Active-Treatment Phase (Weeks 208-260)||32
8367727|NCT01172938|20626686|P7|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8367728|NCT01172938|20626687|P6|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8367729|NCT01172938|20626688|P5|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8367730|NCT01172938|20626689|P4|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8367731|NCT01172938|20626690|P3|STARTED|Active-Treatment Phase (Weeks 208-260)||88
8367732|NCT01172938|20626691|P2|STARTED|Active-Treatment Phase (Weeks 208-260)||75
8367733|NCT01172938|20626692|P1|STARTED|Active-Treatment Phase (Weeks 208-260)||0
8367734|NCT01172938|20626684|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
8367735|NCT01172938|20626685|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
8367736|NCT01172938|20626686|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367737|NCT01172938|20626687|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367738|NCT01172938|20626688|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367739|NCT01172938|20626689|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367740|NCT01172938|20626690|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
8367741|NCT01172938|20626691|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
8367742|NCT01172938|20626692|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367743|NCT01172938|20626684|P9|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
8367744|NCT01172938|20626685|P8|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
8367745|NCT01172938|20626686|P7|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367746|NCT01172938|20626687|P6|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367747|NCT01172938|20626688|P5|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367748|NCT01172938|20626689|P4|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367749|NCT01172938|20626690|P3|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
8367750|NCT01172938|20626691|P2|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
8367751|NCT01172938|20626692|P1|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
8367752|NCT01172938|20626684|P9|STARTED|Active-Treatment Phase (Weeks 156-208)||41
8367753|NCT01172938|20626685|P8|STARTED|Active-Treatment Phase (Weeks 156-208)||41
8367754|NCT01172938|20626686|P7|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8367755|NCT01172938|20626687|P6|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8367756|NCT01172938|20626688|P5|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8367757|NCT01172938|20626689|P4|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8367758|NCT01172938|20626690|P3|STARTED|Active-Treatment Phase (Weeks 156-208)||93
8367759|NCT01172938|20626691|P2|STARTED|Active-Treatment Phase (Weeks 156-208)||84
8367760|NCT01172938|20626692|P1|STARTED|Active-Treatment Phase (Weeks 156-208)||0
8367761|NCT01172938|20626684|P9|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
8367762|NCT01172938|20626685|P8|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
8367763|NCT01172938|20626686|P7|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367764|NCT01172938|20626687|P6|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367765|NCT01172938|20626688|P5|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367766|NCT01172938|20626689|P4|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367767|NCT01172938|20626690|P3|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
8367768|NCT01172938|20626691|P2|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
8367769|NCT01172938|20626692|P1|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367770|NCT01172938|20626684|P9|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
8367771|NCT01172938|20626685|P8|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
8367772|NCT01172938|20626686|P7|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367773|NCT01172938|20626687|P6|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367774|NCT01172938|20626688|P5|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367775|NCT01172938|20626689|P4|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367776|NCT01172938|20626690|P3|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
8367777|NCT01172938|20626691|P2|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
8367778|NCT01172938|20626692|P1|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
8367779|NCT01172938|20626684|P9|STARTED|Active-Treatment Phase Weeks (104-156)||45
8367780|NCT01172938|20626685|P8|STARTED|Active-Treatment Phase Weeks (104-156)||46
8367781|NCT01172938|20626686|P7|STARTED|Active-Treatment Phase Weeks (104-156)||0
8367782|NCT01172938|20626687|P6|STARTED|Active-Treatment Phase Weeks (104-156)||0
8367783|NCT01172938|20626688|P5|STARTED|Active-Treatment Phase Weeks (104-156)||0
8367784|NCT01172938|20626689|P4|STARTED|Active-Treatment Phase Weeks (104-156)||0
8367785|NCT01172938|20626690|P3|STARTED|Active-Treatment Phase Weeks (104-156)||100
8367786|NCT01172938|20626691|P2|STARTED|Active-Treatment Phase Weeks (104-156)||95
8367787|NCT01172938|20626692|P1|STARTED|Active-Treatment Phase Weeks (104-156)||0
8367788|NCT01172938|20626684|P9|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
8367789|NCT01172938|20626685|P8|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
8367790|NCT01172938|20626686|P7|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367791|NCT01172938|20626687|P6|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367792|NCT01172938|20626688|P5|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367793|NCT01172938|20626689|P4|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367794|NCT01172938|20626690|P3|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
8367795|NCT01172938|20626691|P2|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
8367796|NCT01172938|20626692|P1|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367797|NCT01172938|20626684|P9|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
8367798|NCT01172938|20626685|P8|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
8367799|NCT01172938|20626686|P7|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367800|NCT01172938|20626687|P6|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367801|NCT01172938|20626688|P5|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367802|NCT01172938|20626689|P4|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367803|NCT01172938|20626690|P3|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
8367804|NCT01172938|20626691|P2|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
8367805|NCT01172938|20626692|P1|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
8367806|NCT01172938|20626684|P9|STARTED|Active-Treatment Phase (Weeks 52-104)||49
8367807|NCT01172938|20626685|P8|STARTED|Active-Treatment Phase (Weeks 52-104)||61
8367808|NCT01172938|20626686|P7|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8367809|NCT01172938|20626687|P6|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8367810|NCT01172938|20626688|P5|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8367811|NCT01172938|20626689|P4|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8367812|NCT01172938|20626690|P3|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
8367813|NCT01172938|20626691|P2|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
8367814|NCT01172938|20626692|P1|STARTED|Active-Treatment Phase (Weeks 52-104)||0
8367815|NCT01172938|20626684|P9|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8367816|NCT01172938|20626685|P8|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8367817|NCT01172938|20626686|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
8367818|NCT01172938|20626687|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
8367819|NCT01172938|20626688|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
8367820|NCT01172938|20626689|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
8367821|NCT01172938|20626690|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
8367822|NCT01172938|20626691|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
8367823|NCT01172938|20626692|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8367824|NCT01172938|20626684|P9|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8367825|NCT01172938|20626685|P8|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8367826|NCT01172938|20626686|P7|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
8367827|NCT01172938|20626687|P6|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
8367828|NCT01172938|20626688|P5|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
8367829|NCT01172938|20626689|P4|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
8367830|NCT01172938|20626690|P3|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
8367831|NCT01172938|20626691|P2|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
8367832|NCT01172938|20626692|P1|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
8367833|NCT01172938|20626684|P9|STARTED|Active Treatment Phase (Weeks 25-52)||0
8367834|NCT01172938|20626685|P8|STARTED|Active Treatment Phase (Weeks 25-52)||0
8367835|NCT01172938|20626686|P7|STARTED|Active Treatment Phase (Weeks 25-52)||24
8367836|NCT01172938|20626687|P6|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
8367837|NCT01172938|20626688|P5|STARTED|Active Treatment Phase (Weeks 25-52)||23
8367838|NCT01172938|20626689|P4|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
8367839|NCT01172938|20626690|P3|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
8367840|NCT01172938|20626691|P2|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
8367841|NCT01172938|20626692|P1|STARTED|Active Treatment Phase (Weeks 25-52)||0
8367842|NCT01172938|20626684|P9|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367843|NCT01172938|20626685|P8|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367844|NCT01172938|20626686|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367845|NCT01172938|20626687|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367846|NCT01172938|20626688|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367847|NCT01172938|20626689|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367848|NCT01172938|20626690|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
8367849|NCT01172938|20626691|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
8367850|NCT01172938|20626692|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
8367851|NCT01172938|20626684|P9|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367852|NCT01172938|20626685|P8|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367853|NCT01172938|20626686|P7|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367854|NCT01172938|20626687|P6|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367855|NCT01172938|20626688|P5|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367856|NCT01172938|20626689|P4|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
8367857|NCT01172938|20626690|P3|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
8367858|NCT01172938|20626691|P2|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
8367859|NCT01172938|20626692|P1|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
8367860|NCT01172938|20626684|P9|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8367861|NCT01172938|20626685|P8|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8367862|NCT01172938|20626686|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8367863|NCT01172938|20626687|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8367864|NCT01172938|20626688|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8367865|NCT01172938|20626689|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
8367866|NCT01172938|20626690|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
8367867|NCT01172938|20626691|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
8367868|NCT01172938|20626692|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
8367869|NCT01172938|20626684|P9|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8367870|NCT01172938|20626685|P8|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8367871|NCT01172938|20626686|P7|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8367872|NCT01172938|20626687|P6|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8367873|NCT01172938|20626688|P5|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8367874|NCT01172938|20626689|P4|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
8367875|NCT01172938|20626690|P3|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
8367876|NCT01172938|20626691|P2|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
8367877|NCT01172938|20626692|P1|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
8367878|NCT01172938|20626684|P9|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8367879|NCT01172938|20626685|P8|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8367880|NCT01172938|20626686|P7|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8367881|NCT01172938|20626687|P6|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8367882|NCT01172938|20626688|P5|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8367883|NCT01172938|20626689|P4|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
8367884|NCT01172938|20626690|P3|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
8367885|NCT01172938|20626691|P2|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
8367886|NCT01172938|20626692|P1|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
8367887|NCT01172938|20626684|P9|STARTED|Placebo-controlled Phase (Week 0-24)||0
8367888|NCT01172938|20626685|P8|STARTED|Placebo-controlled Phase (Week 0-24)||0
8367889|NCT01172938|20626686|P7|STARTED|Placebo-controlled Phase (Week 0-24)||0
8367890|NCT01172938|20626687|P6|STARTED|Placebo-controlled Phase (Week 0-24)||0
8367891|NCT01172938|20626688|P5|STARTED|Placebo-controlled Phase (Week 0-24)||0
8367892|NCT01172938|20626689|P4|STARTED|Placebo-controlled Phase (Week 0-24)||0
8367893|NCT01172938|20626690|P3|STARTED|Placebo-controlled Phase (Week 0-24)||168
8367894|NCT01172938|20626691|P2|STARTED|Placebo-controlled Phase (Week 0-24)||168
8367895|NCT01172938|20626692|P1|STARTED|Placebo-controlled Phase (Week 0-24)||168
8367896|NCT01172873|20626878|P2|NOT COMPLETED|Overall Study||2
8367897|NCT01172873|20626879|P1|NOT COMPLETED|Overall Study||3
8367898|NCT01172873|20626878|P2|COMPLETED|Overall Study||3
8367899|NCT01172873|20626879|P1|COMPLETED|Overall Study||8
8367900|NCT01172873|20626878|P2|STARTED|Overall Study||5
8367901|NCT01172873|20626879|P1|STARTED|Overall Study||11
8367902|NCT01172847|20626889|P1|NOT COMPLETED|Overall Study||3
8367903|NCT01172847|20626889|P1|COMPLETED|Overall Study||21
8367904|NCT01172847|20626889|P1|Oseltamivir + Rimantadine|Overall Study||21
8367905|NCT01172847|20626889|P1|Rimantadine|Overall Study||22
8367906|NCT01172847|20626889|P1|Oseltamivir|Overall Study||24
8367907|NCT01172847|20626889|P1|STARTED|Overall Study||24
8367908|NCT01172821|20626918|P4|NOT COMPLETED|Overall Study||17
8367909|NCT01172821|20626919|P3|NOT COMPLETED|Overall Study||13
8367910|NCT01172821|20626920|P2|NOT COMPLETED|Overall Study||12
8367911|NCT01172821|20626921|P1|NOT COMPLETED|Overall Study||14
8367912|NCT01172821|20626918|P4|COMPLETED|Overall Study||249
8367913|NCT01172821|20626919|P3|COMPLETED|Overall Study||240
8367914|NCT01172821|20626920|P2|COMPLETED|Overall Study||245
8367915|NCT01172821|20626921|P1|COMPLETED|Overall Study||240
8367916|NCT01172821|20626918|P4|STARTED|Overall Study|Entered and Treated|266
8367917|NCT01172821|20626919|P3|STARTED|Overall Study|Entered and Treated|253
8367918|NCT01172821|20626920|P2|STARTED|Overall Study|Entered and Treated|257
8367919|NCT01172821|20626921|P1|STARTED|Overall Study|Entered and Treated|254
8367920|NCT01172808|20627011|P4|NOT COMPLETED|Overall Study||15
8367921|NCT01172808|20627012|P3|NOT COMPLETED|Overall Study||23
8367922|NCT01172808|20627013|P2|NOT COMPLETED|Overall Study||13
8367923|NCT01172808|20627014|P1|NOT COMPLETED|Overall Study||21
8367924|NCT01172808|20627011|P4|COMPLETED|Overall Study||260
8367925|NCT01172808|20627012|P3|COMPLETED|Overall Study||241
8367926|NCT01172808|20627013|P2|COMPLETED|Overall Study||249
8367927|NCT01172808|20627014|P1|COMPLETED|Overall Study||248
8367928|NCT01172808|20627011|P4|STARTED|Overall Study|Entered and Treated|275
8367929|NCT01172808|20627012|P3|STARTED|Overall Study|Entered and Treated|264
8367930|NCT01172808|20627013|P2|STARTED|Overall Study|Entered and Treated|262
8367931|NCT01172808|20627014|P1|STARTED|Overall Study|Entered and Treated|269
8367932|NCT01172639|20627105|P5|NOT COMPLETED|Overall Study||6
8367933|NCT01172639|20627106|P4|NOT COMPLETED|Overall Study||11
8367934|NCT01172639|20627107|P3|NOT COMPLETED|Overall Study||16
8367935|NCT01172639|20627108|P2|NOT COMPLETED|Overall Study||11
8367936|NCT01172639|20627109|P1|NOT COMPLETED|Overall Study||13
8367937|NCT01172639|20627105|P5|COMPLETED|Overall Study||41
8367938|NCT01172639|20627106|P4|COMPLETED|Overall Study||32
8367939|NCT01172639|20627107|P3|COMPLETED|Overall Study||77
8367940|NCT01172639|20627108|P2|COMPLETED|Overall Study||87
8367941|NCT01172639|20627109|P1|COMPLETED|Overall Study||85
8367942|NCT01172639|20627105|P5|Week 52|Overall Study||45
8367943|NCT01172639|20627106|P4|Week 52|Overall Study||38
8367944|NCT01172639|20627107|P3|Week 52|Overall Study||88
8367945|NCT01172639|20627108|P2|Week 52|Overall Study||89
8367946|NCT01172639|20627109|P1|Week 52|Overall Study||89
8367947|NCT01172639|20627105|P5|Week 16|Overall Study||47
8367948|NCT01172639|20627106|P4|Week 16|Overall Study||39
8367949|NCT01172639|20627107|P3|Week 16|Overall Study||91
8367950|NCT01172639|20627108|P2|Week 16|Overall Study||96
8367951|NCT01172639|20627109|P1|Week 16|Overall Study||94
8367952|NCT01172639|20627105|P5|STARTED|Overall Study||47
8367953|NCT01172639|20627106|P4|STARTED|Overall Study||43
8367954|NCT01172639|20627107|P3|STARTED|Overall Study||93
8367955|NCT01172639|20627108|P2|STARTED|Overall Study||98
8367956|NCT01172639|20627109|P1|STARTED|Overall Study||98
8367957|NCT01172600|20627153|P2|NOT COMPLETED|Overall Study||0
8367958|NCT01172600|20627154|P1|NOT COMPLETED|Overall Study||0
8367959|NCT01172600|20627153|P2|COMPLETED|Overall Study||39
8367960|NCT01172600|20627154|P1|COMPLETED|Overall Study||39
8367961|NCT01172600|20627153|P2|STARTED|Overall Study||39
8367962|NCT01172600|20627154|P1|STARTED|Overall Study||39
8367963|NCT01172535|20627184|P1|NOT COMPLETED|Overall Study||8
8367964|NCT01172535|20627184|P1|COMPLETED|Overall Study||89
8367965|NCT01172535|20627184|P1|STARTED|Overall Study||97
8367966|NCT01172522|20627201|P2|NOT COMPLETED|Overall Study||0
8367967|NCT01172522|20627202|P1|NOT COMPLETED|Overall Study||0
8367968|NCT01172522|20627201|P2|COMPLETED|Overall Study||15
8367969|NCT01172522|20627202|P1|COMPLETED|Overall Study||15
8367970|NCT01172522|20627201|P2|STARTED|Overall Study||15
8367971|NCT01172522|20627202|P1|STARTED|Overall Study||15
8367972|NCT01172418|20627209|P2|NOT COMPLETED|Overall Study||0
8367973|NCT01172418|20627210|P1|NOT COMPLETED|Overall Study||0
8367974|NCT01172418|20627209|P2|COMPLETED|Overall Study||100
8367975|NCT01172418|20627210|P1|COMPLETED|Overall Study||100
8367976|NCT01172418|20627209|P2|STARTED|Overall Study||100
8367977|NCT01172418|20627210|P1|STARTED|Overall Study||100
8367978|NCT01172353|20627226|P2|NOT COMPLETED|Overall Study||0
8367979|NCT01172353|20627227|P1|NOT COMPLETED|Overall Study||0
8367980|NCT01172353|20627226|P2|COMPLETED|Overall Study||151
8367981|NCT01172353|20627227|P1|COMPLETED|Overall Study||150
8367982|NCT01172353|20627226|P2|STARTED|Overall Study||151
8367983|NCT01172353|20627227|P1|STARTED|Overall Study||150
8367984|NCT01172288|20627237|P2|NOT COMPLETED|Overall Study||1
8367985|NCT01172288|20627238|P1|NOT COMPLETED|Overall Study||1
8367986|NCT01172288|20627237|P2|COMPLETED|Overall Study||13
8367987|NCT01172288|20627238|P1|COMPLETED|Overall Study||16
8367988|NCT01172288|20627237|P2|STARTED|Overall Study||14
8367989|NCT01172288|20627238|P1|STARTED|Overall Study||17
8367990|NCT01172275|20627254|P2|NOT COMPLETED|Overall Study||0
8367991|NCT01172275|20627255|P1|NOT COMPLETED|Overall Study||2
8367992|NCT01172275|20627254|P2|COMPLETED|Overall Study||6
8367993|NCT01172275|20627255|P1|COMPLETED|Overall Study||3
8367994|NCT01172275|20627254|P2|STARTED|Overall Study||6
8367995|NCT01172275|20627255|P1|STARTED|Overall Study||5
8367996|NCT01172197|20627265|P2|NOT COMPLETED|Overall Study||0
8367997|NCT01172197|20627266|P1|NOT COMPLETED|Overall Study||0
8367998|NCT01172197|20627265|P2|COMPLETED|Overall Study||7
8367999|NCT01172197|20627266|P1|COMPLETED|Overall Study||7
8368000|NCT01172197|20627265|P2|STARTED|Overall Study||7
8368001|NCT01172197|20627266|P1|STARTED|Overall Study||7
8368002|NCT01172184|20627272|P1|NOT COMPLETED|Overall Study||0
8368003|NCT01172184|20627272|P1|COMPLETED|Overall Study||111
8368004|NCT01172184|20627272|P1|STARTED|Overall Study||111
8368005|NCT01172145|20627280|P2|NOT COMPLETED|Overall Study||0
8368006|NCT01172145|20627281|P1|NOT COMPLETED|Overall Study||0
8368007|NCT01172145|20627280|P2|COMPLETED|Overall Study||11
8368008|NCT01172145|20627281|P1|COMPLETED|Overall Study||11
8368009|NCT01172145|20627280|P2|STARTED|Overall Study||11
8368010|NCT01172145|20627281|P1|STARTED|Overall Study||11
8368011|NCT01172067|20627303|P2|NOT COMPLETED|Overall Study||37
8368012|NCT01172067|20627304|P1|NOT COMPLETED|Overall Study||47
8368013|NCT01172067|20627303|P2|COMPLETED|Overall Study||163
8368014|NCT01172067|20627304|P1|COMPLETED|Overall Study||153
8368015|NCT01172067|20627303|P2|STARTED|Overall Study||200
8368016|NCT01172067|20627304|P1|STARTED|Overall Study||200
8368017|NCT01171989|20627313|P3|NOT COMPLETED|Overall Study||1
8368018|NCT01171989|20627314|P2|NOT COMPLETED|Overall Study||0
8368019|NCT01171989|20627315|P1|NOT COMPLETED|Overall Study||0
8368020|NCT01171989|20627313|P3|COMPLETED|Overall Study||120
8368021|NCT01171989|20627314|P2|COMPLETED|Overall Study||133
8368022|NCT01171989|20627315|P1|COMPLETED|Overall Study||137
8368023|NCT01171989|20627313|P3|STARTED|Overall Study||121
8368024|NCT01171989|20627314|P2|STARTED|Overall Study||133
8368025|NCT01171989|20627315|P1|STARTED|Overall Study||137
8368026|NCT01171976|20627389|P3|NOT COMPLETED|Overall Study||15
8368027|NCT01171976|20627390|P2|NOT COMPLETED|Overall Study||11
8368028|NCT01171976|20627391|P1|NOT COMPLETED|Overall Study||14
8368029|NCT01171976|20627389|P3|COMPLETED|Overall Study||108
8368030|NCT01171976|20627390|P2|COMPLETED|Overall Study||117
8368031|NCT01171976|20627391|P1|COMPLETED|Overall Study||107
8368032|NCT01171976|20627389|P3|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
8368033|NCT01171976|20627390|P2|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
8368034|NCT01171976|20627391|P1|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
8368035|NCT01171976|20627389|P3|STARTED|Overall Study||123
8368036|NCT01171976|20627390|P2|STARTED|Overall Study||128
8368037|NCT01171976|20627391|P1|STARTED|Overall Study||121
8368038|NCT01171963|20627428|P2|NOT COMPLETED|Overall Study||168
8368039|NCT01171963|20627429|P1|NOT COMPLETED|Overall Study||148
8368040|NCT01171963|20627428|P2|COMPLETED|Overall Study||1499
8368041|NCT01171963|20627429|P1|COMPLETED|Overall Study||1518
8368042|NCT01171963|20627428|P2|STARTED|Overall Study||1667
8368043|NCT01171963|20627429|P1|STARTED|Overall Study||1666
8368044|NCT01171924|20627487|P2|NOT COMPLETED|Overall Study||23
8368045|NCT01171924|20627488|P1|NOT COMPLETED|Overall Study||23
8368046|NCT01171924|20627487|P2|COMPLETED|Overall Study||0
8368047|NCT01171924|20627488|P1|COMPLETED|Overall Study||0
8368048|NCT01171924|20627487|P2|STARTED|Overall Study||23
8368049|NCT01171924|20627488|P1|STARTED|Overall Study||23
8368062|NCT01171820|20627525|P2|NOT COMPLETED|Overall Study||6
8368063|NCT01171820|20627526|P1|NOT COMPLETED|Overall Study||6
8368064|NCT01171820|20627525|P2|COMPLETED|Overall Study||212
8368065|NCT01171820|20627526|P1|COMPLETED|Overall Study||100
8368066|NCT01171820|20627525|P2|STARTED|Overall Study||218
8368067|NCT01171820|20627526|P1|STARTED|Overall Study||106
8368068|NCT01171794|20627582|P2|NOT COMPLETED|Overall Study||0
8368069|NCT01171794|20627583|P1|NOT COMPLETED|Overall Study||3
8368070|NCT01171794|20627582|P2|COMPLETED|Overall Study||42
8368071|NCT01171794|20627583|P1|COMPLETED|Overall Study||44
8368072|NCT01171794|20627582|P2|STARTED|Overall Study||42
8368073|NCT01171794|20627583|P1|STARTED|Overall Study||47
8368074|NCT01171690|20627593|P2|NOT COMPLETED|Overall Study||0
8368075|NCT01171690|20627594|P1|NOT COMPLETED|Overall Study||0
8368076|NCT01171690|20627593|P2|COMPLETED|Overall Study||5
8368077|NCT01171690|20627594|P1|COMPLETED|Overall Study||5
8368078|NCT01171690|20627593|P2|STARTED|Overall Study||5
8368079|NCT01171690|20627594|P1|STARTED|Overall Study||5
8368080|NCT01171677|20627604|P2|NOT COMPLETED|Overall Study||3
8368081|NCT01171677|20627605|P1|NOT COMPLETED|Overall Study||6
8368082|NCT01171677|20627604|P2|COMPLETED|Overall Study||12
8368083|NCT01171677|20627605|P1|COMPLETED|Overall Study||11
8368084|NCT01171677|20627604|P2|STARTED|Overall Study||15
8368085|NCT01171677|20627605|P1|STARTED|Overall Study||17
8368086|NCT01171625|20627637|P1|NOT COMPLETED|Overall Study||180
8368087|NCT01171625|20627637|P1|COMPLETED|Overall Study||103
8368088|NCT01171625|20627637|P1|Subjects Implanted With Device|Overall Study||258
8368089|NCT01171625|20627637|P1|STARTED|Overall Study||283
8368090|NCT01171612|20627670|P1|NOT COMPLETED|Overall Study||51
8368091|NCT01171612|20627670|P1|COMPLETED|Overall Study||432
8368092|NCT01171612|20627670|P1|STARTED|Overall Study||483
8368093|NCT01171534|20627680|P2|NOT COMPLETED|Overall Study||3
8368094|NCT01171534|20627681|P1|NOT COMPLETED|Overall Study||0
8368095|NCT01171534|20627680|P2|COMPLETED|Overall Study||4
8368096|NCT01171534|20627681|P1|COMPLETED|Overall Study||0
8368097|NCT01171534|20627680|P2|STARTED|Overall Study||7
8368098|NCT01171534|20627681|P1|STARTED|Overall Study|retrospective arm never performed on study|0
8368099|NCT01171521|20627693|P1|NOT COMPLETED|Overall Study||6
8368100|NCT01171521|20627693|P1|COMPLETED|Overall Study||0
8368101|NCT01171521|20627693|P1|STARTED|Overall Study||6
8368102|NCT01171183|20627700|P2|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
8368103|NCT01171183|20627701|P1|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
8368104|NCT01171183|20627700|P2|COMPLETED|Outpatient Participation (Weeks 3-10)||4
8368105|NCT01171183|20627701|P1|COMPLETED|Outpatient Participation (Weeks 3-10)||2
8368106|NCT01171183|20627700|P2|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
8368107|NCT01171183|20627701|P1|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
8368108|NCT01171183|20627700|P2|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
8368109|NCT01171183|20627701|P1|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
8368110|NCT01171183|20627700|P2|COMPLETED|Residential Facility (Weeks 1-2)||10
8368111|NCT01171183|20627701|P1|COMPLETED|Residential Facility (Weeks 1-2)||13
8368112|NCT01171183|20627700|P2|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
8368113|NCT01171183|20627701|P1|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
8368114|NCT01171118|20627709|P1|NOT COMPLETED|Overall Study||0
8368115|NCT01171118|20627709|P1|COMPLETED|Overall Study||10
8368116|NCT01171118|20627709|P1|STARTED|Overall Study||10
8368117|NCT01170962|20627722|P3|NOT COMPLETED|Follow up Period||6
8368118|NCT01170962|20627723|P2|NOT COMPLETED|Follow up Period||27
8368119|NCT01170962|20627724|P1|NOT COMPLETED|Follow up Period||39
8368120|NCT01170962|20627722|P3|COMPLETED|Follow up Period||9
8368121|NCT01170962|20627723|P2|COMPLETED|Follow up Period||165
8368122|NCT01170962|20627724|P1|COMPLETED|Follow up Period||159
8368123|NCT01170962|20627722|P3|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
8368124|NCT01170962|20627723|P2|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
8368125|NCT01170962|20627724|P1|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
8368126|NCT01170962|20627722|P3|NOT COMPLETED|Treatment Period||12
8368127|NCT01170962|20627723|P2|NOT COMPLETED|Treatment Period||111
8368128|NCT01170962|20627724|P1|NOT COMPLETED|Treatment Period||127
8368129|NCT01170962|20627722|P3|COMPLETED|Treatment Period||5
8368130|NCT01170962|20627723|P2|COMPLETED|Treatment Period||88
8368131|NCT01170962|20627724|P1|COMPLETED|Treatment Period||76
8368132|NCT01170962|20627722|P3|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||0
8368133|NCT01170962|20627723|P2|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||36
8368134|NCT01170962|20627724|P1|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||28
8368135|NCT01170962|20627722|P3|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||0
8368136|NCT01170962|20627723|P2|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||36
8368137|NCT01170962|20627724|P1|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||30
8368138|NCT01170962|20627722|P3|No PDR|Treatment Period||17
8368139|NCT01170962|20627723|P2|No PDR|Treatment Period||127
8368140|NCT01170962|20627724|P1|No PDR|Treatment Period||145
8368141|NCT01170962|20627722|P3|STARTED|Treatment Period||17
8368142|NCT01170962|20627723|P2|STARTED|Treatment Period||199
8368143|NCT01170962|20627724|P1|STARTED|Treatment Period||203
8368144|NCT01170949|20627770|P2|NOT COMPLETED|Overall Study||4
8368145|NCT01170949|20627771|P1|NOT COMPLETED|Overall Study||7
8368146|NCT01170949|20627770|P2|COMPLETED|Overall Study||22
8368147|NCT01170949|20627771|P1|COMPLETED|Overall Study||43
8368148|NCT01170949|20627770|P2|STARTED|Overall Study||26
8368149|NCT01170949|20627771|P1|STARTED|Overall Study||50
8368150|NCT01170884|20627779|P2|NOT COMPLETED|Overall Study||2
8368151|NCT01170884|20627780|P1|NOT COMPLETED|Overall Study||5
8368152|NCT01170884|20627779|P2|COMPLETED|Overall Study||60
8368153|NCT01170884|20627780|P1|COMPLETED|Overall Study||54
8368154|NCT01170884|20627779|P2|STARTED|Overall Study||62
8368155|NCT01170884|20627780|P1|STARTED|Overall Study||59
8368156|NCT01170754|20627788|P2|NOT COMPLETED|Overall Study||0
8368157|NCT01170754|20627789|P1|NOT COMPLETED|Overall Study||0
8368158|NCT01170754|20627788|P2|COMPLETED|Overall Study||70
8368159|NCT01170754|20627789|P1|COMPLETED|Overall Study||66
8368160|NCT01170754|20627788|P2|STARTED|Overall Study||70
8368161|NCT01170754|20627789|P1|STARTED|Overall Study||66
8368162|NCT01170663|20627819|P2|NOT COMPLETED|Overall Study||20
8368163|NCT01170663|20627820|P1|NOT COMPLETED|Overall Study||14
8368164|NCT01170663|20627819|P2|COMPLETED|Overall Study||315
8368165|NCT01170663|20627820|P1|COMPLETED|Overall Study||316
8368166|NCT01170663|20627819|P2|Received Any Treatment (Safety Pop)|Overall Study||329
8368167|NCT01170663|20627820|P1|Received Any Treatment (Safety Pop)|Overall Study||327
8368168|NCT01170663|20627819|P2|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
8368169|NCT01170663|20627820|P1|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
8368170|NCT01170598|20627848|P1|NOT COMPLETED|Overall Study||6
8368171|NCT01170598|20627848|P1|COMPLETED|Overall Study||29
8368172|NCT01170598|20627848|P1|STARTED|Overall Study||35
8368173|NCT01170546|20627867|P4|NOT COMPLETED|Overall Study||0
8368174|NCT01170546|20627868|P3|NOT COMPLETED|Overall Study||0
8368175|NCT01170546|20627869|P2|NOT COMPLETED|Overall Study||0
8368176|NCT01170546|20627870|P1|NOT COMPLETED|Overall Study||0
8368177|NCT01170546|20627867|P4|COMPLETED|Overall Study||8
8368178|NCT01170546|20627868|P3|COMPLETED|Overall Study||6
8368179|NCT01170546|20627869|P2|COMPLETED|Overall Study||7
8368180|NCT01170546|20627870|P1|COMPLETED|Overall Study||7
8368181|NCT01170546|20627867|P4|STARTED|Overall Study||8
8368182|NCT01170546|20627868|P3|STARTED|Overall Study||6
8368183|NCT01170546|20627869|P2|STARTED|Overall Study||7
8368184|NCT01170546|20627870|P1|STARTED|Overall Study||7
8368185|NCT01170533|20627880|P2|NOT COMPLETED|Pantoprazole Cross-over||0
8368186|NCT01170533|20627881|P1|NOT COMPLETED|Pantoprazole Cross-over||0
8368187|NCT01170533|20627880|P2|COMPLETED|Pantoprazole Cross-over||20
8368188|NCT01170533|20627881|P1|COMPLETED|Pantoprazole Cross-over||0
8368189|NCT01170533|20627880|P2|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
8368190|NCT01170533|20627881|P1|STARTED|Pantoprazole Cross-over||0
8368191|NCT01170533|20627880|P2|NOT COMPLETED|Omeprazole Cross-over||0
8368192|NCT01170533|20627881|P1|NOT COMPLETED|Omeprazole Cross-over||0
8368193|NCT01170533|20627880|P2|COMPLETED|Omeprazole Cross-over||0
8368194|NCT01170533|20627881|P1|COMPLETED|Omeprazole Cross-over||20
8368195|NCT01170533|20627880|P2|STARTED|Omeprazole Cross-over||0
8368196|NCT01170533|20627881|P1|STARTED|Omeprazole Cross-over||20
8368197|NCT01170390|20627893|P3|NOT COMPLETED|Randomized Treatment||0
8368198|NCT01170390|20627894|P2|NOT COMPLETED|Randomized Treatment||1
8368199|NCT01170390|20627895|P1|NOT COMPLETED|Randomized Treatment||0
8368200|NCT01170390|20627893|P3|COMPLETED|Randomized Treatment||15
8368201|NCT01170390|20627894|P2|COMPLETED|Randomized Treatment||16
8368202|NCT01170390|20627895|P1|COMPLETED|Randomized Treatment||0
8368203|NCT01170390|20627893|P3|STARTED|Randomized Treatment||15
8368204|NCT01170390|20627894|P2|STARTED|Randomized Treatment||17
8368205|NCT01170390|20627895|P1|STARTED|Randomized Treatment||0
8368206|NCT01170390|20627893|P3|NOT COMPLETED|Oral Contraceptives||0
8368207|NCT01170390|20627894|P2|NOT COMPLETED|Oral Contraceptives||0
8368208|NCT01170390|20627895|P1|NOT COMPLETED|Oral Contraceptives||1
8368209|NCT01170390|20627893|P3|COMPLETED|Oral Contraceptives||0
8368210|NCT01170390|20627894|P2|COMPLETED|Oral Contraceptives||0
8368211|NCT01170390|20627895|P1|COMPLETED|Oral Contraceptives||31
8368212|NCT01170390|20627893|P3|STARTED|Oral Contraceptives||0
8368213|NCT01170390|20627894|P2|STARTED|Oral Contraceptives||0
8368214|NCT01170390|20627895|P1|STARTED|Oral Contraceptives||32
8368215|NCT01170364|20627911|P2|NOT COMPLETED|Overall Study||1
8368216|NCT01170364|20627912|P1|NOT COMPLETED|Overall Study||4
8368217|NCT01170364|20627911|P2|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
8368218|NCT01170364|20627912|P1|COMPLETED|Overall Study||4
8368219|NCT01170364|20627911|P2|STARTED|Overall Study||6
8368220|NCT01170364|20627912|P1|STARTED|Overall Study||8
8368221|NCT01170273|20627920|P2|NOT COMPLETED|Overall Study||9
8368222|NCT01170273|20627921|P1|NOT COMPLETED|Overall Study||8
8368223|NCT01170273|20627920|P2|COMPLETED|Overall Study||57
8368224|NCT01170273|20627921|P1|COMPLETED|Overall Study||56
8368225|NCT01170273|20627920|P2|STARTED|Overall Study||66
8368226|NCT01170273|20627921|P1|STARTED|Overall Study||64
8368227|NCT01170247|20627929|P2|NOT COMPLETED|Overall Study||0
8368228|NCT01170247|20627930|P1|NOT COMPLETED|Overall Study||0
8368229|NCT01170247|20627929|P2|COMPLETED|Overall Study||1
8368230|NCT01170247|20627930|P1|COMPLETED|Overall Study||2
8368231|NCT01170247|20627929|P2|STARTED|Overall Study||1
8368232|NCT01170247|20627930|P1|STARTED|Overall Study||2
8368233|NCT01170221|20627938|P2|NOT COMPLETED|Overall Study||28
8368234|NCT01170221|20627939|P1|NOT COMPLETED|Overall Study||33
8368235|NCT01170221|20627938|P2|COMPLETED|Overall Study||307
8368236|NCT01170221|20627939|P1|COMPLETED|Overall Study||299
8368237|NCT01170221|20627938|P2|STARTED|Overall Study||335
8368238|NCT01170221|20627939|P1|STARTED|Overall Study||332
8368239|NCT01170208|20627962|P3|NOT COMPLETED|Overall Study||2
8368240|NCT01170208|20627963|P2|NOT COMPLETED|Overall Study||0
8368241|NCT01170208|20627964|P1|NOT COMPLETED|Overall Study||6
8368242|NCT01170208|20627962|P3|COMPLETED|Overall Study||4
8368243|NCT01170208|20627963|P2|COMPLETED|Overall Study||20
8368244|NCT01170208|20627964|P1|COMPLETED|Overall Study||14
8368245|NCT01170208|20627962|P3|STARTED|Overall Study||6
8368246|NCT01170208|20627963|P2|STARTED|Overall Study||20
8368247|NCT01170208|20627964|P1|STARTED|Overall Study||20
8368248|NCT01170117|20627983|P2|NOT COMPLETED|Overall Study||20
8368249|NCT01170117|20627984|P1|NOT COMPLETED|Overall Study||30
8368250|NCT01170117|20627983|P2|COMPLETED|Overall Study||55
8368251|NCT01170117|20627984|P1|COMPLETED|Overall Study||47
8368252|NCT01170117|20627983|P2|STARTED|Overall Study||75
8368253|NCT01170117|20627984|P1|STARTED|Overall Study||77
8368254|NCT01170091|20627992|P1|NOT COMPLETED|Overall Study||24
8368255|NCT01170091|20627992|P1|COMPLETED|Overall Study||627
8368256|NCT01170091|20627992|P1|STARTED|Overall Study||651
8368257|NCT01170065|20628002|P3|NOT COMPLETED|Overall Study||26
8368258|NCT01170065|20628003|P2|NOT COMPLETED|Overall Study||92
8368259|NCT01170065|20628004|P1|NOT COMPLETED|Overall Study||28
8368260|NCT01170065|20628002|P3|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
8368261|NCT01170065|20628003|P2|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|34
8368262|NCT01170065|20628004|P1|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
8368263|NCT01170065|20628002|P3|STARTED|Overall Study||35
8368264|NCT01170065|20628003|P2|STARTED|Overall Study||126
8368265|NCT01170065|20628004|P1|STARTED|Overall Study||37
8368266|NCT01170039|20628035|P2|NOT COMPLETED|Overall Study||6
8368267|NCT01170039|20628036|P1|NOT COMPLETED|Overall Study||8
8368268|NCT01170039|20628035|P2|COMPLETED|Overall Study||33
8368269|NCT01170039|20628036|P1|COMPLETED|Overall Study||29
8368270|NCT01170039|20628035|P2|STARTED|Overall Study||39
8368271|NCT01170039|20628036|P1|STARTED|Overall Study||37
8368272|NCT01169987|20628048|P1|NOT COMPLETED|Overall Study||31
8368273|NCT01169987|20628048|P1|COMPLETED|Overall Study||160
8368274|NCT01169987|20628048|P1|STARTED|Overall Study||191
8368275|NCT01169779|20628114|P2|NOT COMPLETED|Overall Study||17
8368276|NCT01169779|20628115|P1|NOT COMPLETED|Overall Study||11
8368277|NCT01169779|20628114|P2|COMPLETED|Overall Study||179
8368278|NCT01169779|20628115|P1|COMPLETED|Overall Study||184
8368279|NCT01169779|20628114|P2|Subgroup for Standardized Meal Test|Overall Study||121
8368280|NCT01169779|20628115|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
8368281|NCT01169779|20628114|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||195
8368282|NCT01169779|20628115|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
8368283|NCT01169779|20628114|P2|Treated/Safety Population|Overall Study||196
8368284|NCT01169779|20628115|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
8368285|NCT01169779|20628114|P2|STARTED|Overall Study||196
8368286|NCT01169779|20628115|P1|STARTED|Overall Study|Randomized.|195
8368287|NCT01169753|20628141|P2|NOT COMPLETED|Overall Study||1
8368288|NCT01169753|20628142|P1|NOT COMPLETED|Overall Study||0
8368289|NCT01169753|20628141|P2|COMPLETED|Overall Study||0
8368290|NCT01169753|20628142|P1|COMPLETED|Overall Study||0
8368291|NCT01169753|20628141|P2|STARTED|Overall Study||1
8368292|NCT01169753|20628142|P1|STARTED|Overall Study||0
8368293|NCT01169701|20628150|P2|NOT COMPLETED|Overall Study||10
8368294|NCT01169701|20628151|P1|NOT COMPLETED|Overall Study||5
8368295|NCT01169701|20628150|P2|COMPLETED|Overall Study||25
8368296|NCT01169701|20628151|P1|COMPLETED|Overall Study||31
8368297|NCT01169701|20628150|P2|Intent to Treat (ITT) Set|Overall Study||28
8368298|NCT01169701|20628151|P1|Intent to Treat (ITT) Set|Overall Study||32
8368299|NCT01169701|20628150|P2|Safety Set|Overall Study||35
8368300|NCT01169701|20628151|P1|Safety Set|Overall Study||36
8368301|NCT01169701|20628150|P2|STARTED|Overall Study||35
8368302|NCT01169701|20628151|P1|STARTED|Overall Study||36
8368303|NCT01169675|20628188|P5|NOT COMPLETED|Overall Study||6
8368304|NCT01169675|20628189|P4|NOT COMPLETED|Overall Study||17
8368305|NCT01169675|20628190|P3|NOT COMPLETED|Overall Study||7
8368306|NCT01169675|20628191|P2|NOT COMPLETED|Overall Study||3
8368307|NCT01169675|20628192|P1|NOT COMPLETED|Overall Study||20
8368308|NCT01169675|20628188|P5|COMPLETED|Overall Study||0
8368309|NCT01169675|20628189|P4|COMPLETED|Overall Study||0
8368310|NCT01169675|20628190|P3|COMPLETED|Overall Study||0
8368311|NCT01169675|20628191|P2|COMPLETED|Overall Study||0
8368312|NCT01169675|20628192|P1|COMPLETED|Overall Study||0
8368313|NCT01169675|20628188|P5|STARTED|Overall Study||6
8368314|NCT01169675|20628189|P4|STARTED|Overall Study||17
8368315|NCT01169675|20628190|P3|STARTED|Overall Study||7
8368316|NCT01169675|20628191|P2|STARTED|Overall Study||3
8368317|NCT01169675|20628192|P1|STARTED|Overall Study||20
8368318|NCT01169649|20628229|P1|NOT COMPLETED|Overall Study||3
8368319|NCT01169649|20628229|P1|COMPLETED|Overall Study||8
8368320|NCT01169649|20628229|P1|STARTED|Overall Study||11
8368321|NCT01169636|20628238|P5|NOT COMPLETED|Overall Study||3
8368322|NCT01169636|20628239|P4|NOT COMPLETED|Overall Study||1
8368323|NCT01169636|20628240|P3|NOT COMPLETED|Overall Study||3
8368324|NCT01169636|20628241|P2|NOT COMPLETED|Overall Study||0
8368325|NCT01169636|20628242|P1|NOT COMPLETED|Overall Study||0
8368326|NCT01169636|20628238|P5|COMPLETED|Overall Study||11
8368327|NCT01169636|20628239|P4|COMPLETED|Overall Study||12
8368328|NCT01169636|20628240|P3|COMPLETED|Overall Study||17
8368329|NCT01169636|20628241|P2|COMPLETED|Overall Study||6
8368330|NCT01169636|20628242|P1|COMPLETED|Overall Study||3
8368331|NCT01169636|20628238|P5|STARTED|Overall Study||14
8368332|NCT01169636|20628239|P4|STARTED|Overall Study||13
8368333|NCT01169636|20628240|P3|STARTED|Overall Study||20
8368334|NCT01169636|20628241|P2|STARTED|Overall Study||6
8368335|NCT01169636|20628242|P1|STARTED|Overall Study||3
8368336|NCT01169610|20628256|P1|NOT COMPLETED|Overall Study||0
8368337|NCT01169610|20628256|P1|COMPLETED|Overall Study||1
8368338|NCT01169610|20628256|P1|STARTED|Overall Study||1
8368339|NCT01169558|20628264|P1|NOT COMPLETED|Overall Study||156
8368340|NCT01169558|20628264|P1|COMPLETED|Overall Study||6
8368341|NCT01169558|20628264|P1|STARTED|Overall Study||162
8368342|NCT01169519|20628271|P1|NOT COMPLETED|Overall Study||0
8368343|NCT01169519|20628271|P1|COMPLETED|Overall Study||21
8368344|NCT01169519|20628271|P1|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
8368345|NCT01169493|20628289|P6|NOT COMPLETED|Period 3 (6 Months)||0
8368346|NCT01169493|20628290|P5|NOT COMPLETED|Period 3 (6 Months)||0
8368347|NCT01169493|20628291|P4|NOT COMPLETED|Period 3 (6 Months)||0
8368348|NCT01169493|20628292|P3|NOT COMPLETED|Period 3 (6 Months)||1
8368349|NCT01169493|20628293|P2|NOT COMPLETED|Period 3 (6 Months)||2
8368350|NCT01169493|20628294|P1|NOT COMPLETED|Period 3 (6 Months)||0
8368351|NCT01169493|20628289|P6|COMPLETED|Period 3 (6 Months)||2
8368352|NCT01169493|20628290|P5|COMPLETED|Period 3 (6 Months)||0
8368353|NCT01169493|20628291|P4|COMPLETED|Period 3 (6 Months)||0
8368354|NCT01169493|20628292|P3|COMPLETED|Period 3 (6 Months)||2
8368355|NCT01169493|20628293|P2|COMPLETED|Period 3 (6 Months)||1
8368356|NCT01169493|20628294|P1|COMPLETED|Period 3 (6 Months)||2
8368357|NCT01169493|20628289|P6|STARTED|Period 3 (6 Months)||2
8368358|NCT01169493|20628290|P5|STARTED|Period 3 (6 Months)||0
8368359|NCT01169493|20628291|P4|STARTED|Period 3 (6 Months)||0
8368360|NCT01169493|20628292|P3|STARTED|Period 3 (6 Months)||3
8368361|NCT01169493|20628293|P2|STARTED|Period 3 (6 Months)||3
8368362|NCT01169493|20628294|P1|STARTED|Period 3 (6 Months)||2
8368363|NCT01169493|20628289|P6|NOT COMPLETED|Period 2 (6 Months)||0
8368364|NCT01169493|20628290|P5|NOT COMPLETED|Period 2 (6 Months)||0
8368365|NCT01169493|20628291|P4|NOT COMPLETED|Period 2 (6 Months)||0
8368366|NCT01169493|20628292|P3|NOT COMPLETED|Period 2 (6 Months)||0
8368367|NCT01169493|20628293|P2|NOT COMPLETED|Period 2 (6 Months)||0
8368368|NCT01169493|20628294|P1|NOT COMPLETED|Period 2 (6 Months)||0
8368369|NCT01169493|20628289|P6|COMPLETED|Period 2 (6 Months)||2
8368370|NCT01169493|20628290|P5|COMPLETED|Period 2 (6 Months)||0
8368371|NCT01169493|20628291|P4|COMPLETED|Period 2 (6 Months)||0
8368372|NCT01169493|20628292|P3|COMPLETED|Period 2 (6 Months)||3
8368373|NCT01169493|20628293|P2|COMPLETED|Period 2 (6 Months)||3
8368374|NCT01169493|20628294|P1|COMPLETED|Period 2 (6 Months)||2
8368375|NCT01169493|20628289|P6|STARTED|Period 2 (6 Months)||2
8368376|NCT01169493|20628290|P5|STARTED|Period 2 (6 Months)||0
8368377|NCT01169493|20628291|P4|STARTED|Period 2 (6 Months)||0
8368378|NCT01169493|20628292|P3|STARTED|Period 2 (6 Months)||3
8368379|NCT01169493|20628293|P2|STARTED|Period 2 (6 Months)||3
8368380|NCT01169493|20628294|P1|STARTED|Period 2 (6 Months)||2
8368381|NCT01169493|20628289|P6|NOT COMPLETED|Period 1 (6 Months)||3
8368382|NCT01169493|20628290|P5|NOT COMPLETED|Period 1 (6 Months)||0
8368383|NCT01169493|20628291|P4|NOT COMPLETED|Period 1 (6 Months)||0
8368384|NCT01169493|20628292|P3|NOT COMPLETED|Period 1 (6 Months)||2
8368385|NCT01169493|20628293|P2|NOT COMPLETED|Period 1 (6 Months)||1
8368386|NCT01169493|20628294|P1|NOT COMPLETED|Period 1 (6 Months)||0
8368387|NCT01169493|20628289|P6|COMPLETED|Period 1 (6 Months)||2
8368388|NCT01169493|20628290|P5|COMPLETED|Period 1 (6 Months)||0
8368389|NCT01169493|20628291|P4|COMPLETED|Period 1 (6 Months)||0
8368390|NCT01169493|20628292|P3|COMPLETED|Period 1 (6 Months)||3
8368391|NCT01169493|20628293|P2|COMPLETED|Period 1 (6 Months)||3
8368392|NCT01169493|20628294|P1|COMPLETED|Period 1 (6 Months)||2
8368393|NCT01169493|20628289|P6|STARTED|Period 1 (6 Months)||5
8368394|NCT01169493|20628290|P5|STARTED|Period 1 (6 Months)||0
8368395|NCT01169493|20628291|P4|STARTED|Period 1 (6 Months)||0
8368396|NCT01169493|20628292|P3|STARTED|Period 1 (6 Months)||5
8368397|NCT01169493|20628293|P2|STARTED|Period 1 (6 Months)||4
8368398|NCT01169493|20628294|P1|STARTED|Period 1 (6 Months)||2
8368399|NCT01169467|20628325|P2|NOT COMPLETED|Overall Study||4
8368400|NCT01169467|20628326|P1|NOT COMPLETED|Overall Study||7
8368401|NCT01169467|20628325|P2|COMPLETED|Overall Study||36
8368402|NCT01169467|20628326|P1|COMPLETED|Overall Study||37
8368403|NCT01169467|20628325|P2|STARTED|Overall Study||40
8368404|NCT01169467|20628326|P1|STARTED|Overall Study||44
8368405|NCT01169350|20628340|P1|NOT COMPLETED|Overall Study||5
8368406|NCT01169350|20628340|P1|COMPLETED|Overall Study||3
8368407|NCT01169350|20628340|P1|STARTED|Overall Study||8
8368408|NCT01169311|20628347|P1|NOT COMPLETED|Overall Study||0
8368409|NCT01169311|20628347|P1|COMPLETED|Overall Study||27
8368410|NCT01169311|20628347|P1|STARTED|Overall Study||27
8368423|NCT01169103|20628478|P2|NOT COMPLETED|Overall Study||4
8368424|NCT01169103|20628479|P1|NOT COMPLETED|Overall Study||6
8368425|NCT01169103|20628478|P2|COMPLETED|Overall Study||7
8368426|NCT01169103|20628479|P1|COMPLETED|Overall Study||5
8368427|NCT01169103|20628478|P2|STARTED|Overall Study||11
8368428|NCT01169103|20628479|P1|STARTED|Overall Study||11
8368429|NCT01169064|20628495|P2|NOT COMPLETED|Overall Study||0
8368430|NCT01169064|20628496|P1|NOT COMPLETED|Overall Study||0
8368431|NCT01169064|20628495|P2|COMPLETED|Overall Study||236
8368432|NCT01169064|20628496|P1|COMPLETED|Overall Study||239
8368433|NCT01169064|20628495|P2|STARTED|Overall Study||236
8368434|NCT01169064|20628496|P1|STARTED|Overall Study||239
8368435|NCT01169038|20628506|P1|NOT COMPLETED|Overall Study||7
8368436|NCT01169038|20628506|P1|COMPLETED|Overall Study||8
8368437|NCT01169038|20628506|P1|STARTED|Overall Study||15
8368438|NCT01168999|20628514|P4|NOT COMPLETED|Overall Study||0
8368439|NCT01168999|20628515|P3|NOT COMPLETED|Overall Study||0
8368440|NCT01168999|20628516|P2|NOT COMPLETED|Overall Study||1
8368441|NCT01168999|20628517|P1|NOT COMPLETED|Overall Study||2
8368442|NCT01168999|20628514|P4|COMPLETED|Overall Study||28
8368443|NCT01168999|20628515|P3|COMPLETED|Overall Study||27
8368444|NCT01168999|20628516|P2|COMPLETED|Overall Study||26
8368445|NCT01168999|20628517|P1|COMPLETED|Overall Study||26
8368446|NCT01168999|20628514|P4|STARTED|Overall Study||28
8368447|NCT01168999|20628515|P3|STARTED|Overall Study||27
8368448|NCT01168999|20628516|P2|STARTED|Overall Study||27
8368449|NCT01168999|20628517|P1|STARTED|Overall Study||28
8368450|NCT01168986|20628562|P3|NOT COMPLETED|Overall Study||0
8368451|NCT01168986|20628563|P2|NOT COMPLETED|Overall Study||1
8368452|NCT01168986|20628564|P1|NOT COMPLETED|Overall Study||2
8368453|NCT01168986|20628562|P3|COMPLETED|Overall Study||21
8368454|NCT01168986|20628563|P2|COMPLETED|Overall Study||20
8368455|NCT01168986|20628564|P1|COMPLETED|Overall Study||18
8368456|NCT01168986|20628562|P3|STARTED|Overall Study||21
8368457|NCT01168986|20628563|P2|STARTED|Overall Study||21
8368458|NCT01168986|20628564|P1|STARTED|Overall Study||20
8368459|NCT01168973|20628583|P2|NOT COMPLETED|Overall Study||611
8368460|NCT01168973|20628584|P1|NOT COMPLETED|Overall Study||613
8368461|NCT01168973|20628583|P2|COMPLETED|Overall Study||14
8368462|NCT01168973|20628584|P1|COMPLETED|Overall Study||15
8368463|NCT01168973|20628583|P2|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
8368464|NCT01168973|20628584|P1|Received Any Quantity of Any Study Drug|Overall Study||624
8368465|NCT01168973|20628583|P2|STARTED|Overall Study||625
8368466|NCT01168973|20628584|P1|STARTED|Overall Study||628
8368467|NCT01168934|20628605|P2|NOT COMPLETED|Second Intervention Period||0
8368468|NCT01168934|20628606|P1|NOT COMPLETED|Second Intervention Period||0
8368469|NCT01168934|20628605|P2|COMPLETED|Second Intervention Period||7
8368470|NCT01168934|20628606|P1|COMPLETED|Second Intervention Period||7
8368471|NCT01168934|20628605|P2|STARTED|Second Intervention Period||7
8368472|NCT01168934|20628606|P1|STARTED|Second Intervention Period||7
8368473|NCT01168934|20628605|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8368474|NCT01168934|20628606|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8368475|NCT01168934|20628605|P2|COMPLETED|Washout Period (at Least 14 Days)||7
8368476|NCT01168934|20628606|P1|COMPLETED|Washout Period (at Least 14 Days)||7
8368477|NCT01168934|20628605|P2|STARTED|Washout Period (at Least 14 Days)||7
8368478|NCT01168934|20628606|P1|STARTED|Washout Period (at Least 14 Days)||7
8368479|NCT01168934|20628605|P2|NOT COMPLETED|First Intervention Period||0
8368480|NCT01168934|20628606|P1|NOT COMPLETED|First Intervention Period||0
8368481|NCT01168934|20628605|P2|COMPLETED|First Intervention Period||7
8368482|NCT01168934|20628606|P1|COMPLETED|First Intervention Period||7
8368483|NCT01168934|20628605|P2|STARTED|First Intervention Period||7
8368484|NCT01168934|20628606|P1|STARTED|First Intervention Period||7
8368485|NCT01168908|20628640|P2|NOT COMPLETED|Open Label||1
8368486|NCT01168908|20628641|P1|NOT COMPLETED|Open Label||1
8368487|NCT01168908|20628640|P2|COMPLETED|Open Label||7
8368488|NCT01168908|20628641|P1|COMPLETED|Open Label||6
8368489|NCT01168908|20628640|P2|STARTED|Open Label||8
8368490|NCT01168908|20628641|P1|STARTED|Open Label||7
8368491|NCT01168908|20628640|P2|NOT COMPLETED|Double Blind, Placebo Controlled||2
8368492|NCT01168908|20628641|P1|NOT COMPLETED|Double Blind, Placebo Controlled||3
8368493|NCT01168908|20628640|P2|COMPLETED|Double Blind, Placebo Controlled||8
8368494|NCT01168908|20628641|P1|COMPLETED|Double Blind, Placebo Controlled||7
8368495|NCT01168908|20628640|P2|STARTED|Double Blind, Placebo Controlled||10
8368496|NCT01168908|20628641|P1|STARTED|Double Blind, Placebo Controlled||10
8368497|NCT01168856|20628659|P2|NOT COMPLETED|Overall Study||343
8368498|NCT01168856|20628660|P1|NOT COMPLETED|Overall Study||18
8368499|NCT01168856|20628659|P2|COMPLETED|Overall Study||215
8368500|NCT01168856|20628660|P1|COMPLETED|Overall Study||158
8368501|NCT01168856|20628659|P2|STARTED|Overall Study||558
8368502|NCT01168856|20628660|P1|STARTED|Overall Study||176
8368503|NCT01168726|20628720|P3|NOT COMPLETED|Overall Study||5
8368504|NCT01168726|20628721|P2|NOT COMPLETED|Overall Study||9
8368505|NCT01168726|20628722|P1|NOT COMPLETED|Overall Study||8
8368506|NCT01168726|20628720|P3|COMPLETED|Overall Study||128
8368507|NCT01168726|20628721|P2|COMPLETED|Overall Study||112
8368508|NCT01168726|20628722|P1|COMPLETED|Overall Study||103
8368509|NCT01168726|20628720|P3|STARTED|Overall Study||133
8368510|NCT01168726|20628721|P2|STARTED|Overall Study||121
8368511|NCT01168726|20628722|P1|STARTED|Overall Study||111
8368512|NCT01168687|20628741|P2|NOT COMPLETED|Overall Study||0
8368513|NCT01168687|20628742|P1|NOT COMPLETED|Overall Study||0
8368514|NCT01168687|20628741|P2|COMPLETED|Overall Study||23
8368515|NCT01168687|20628742|P1|COMPLETED|Overall Study||23
8368516|NCT01168687|20628741|P2|STARTED|Overall Study||23
8368517|NCT01168687|20628742|P1|STARTED|Overall Study||23
8368518|NCT01168674|20628748|P2|NOT COMPLETED|Overall Study||0
8368519|NCT01168674|20628749|P1|NOT COMPLETED|Overall Study||0
8368520|NCT01168674|20628748|P2|COMPLETED|Overall Study||24
8368521|NCT01168674|20628749|P1|COMPLETED|Overall Study||25
8368522|NCT01168674|20628748|P2|STARTED|Overall Study||24
8368523|NCT01168674|20628749|P1|STARTED|Overall Study||25
8368524|NCT01168596|20628758|P2|NOT COMPLETED|Overall Study||1
8368525|NCT01168596|20628759|P1|NOT COMPLETED|Overall Study||3
8368526|NCT01168596|20628758|P2|COMPLETED|Overall Study||13
8368527|NCT01168596|20628759|P1|COMPLETED|Overall Study||13
8368528|NCT01168596|20628758|P2|STARTED|Overall Study||14
8368529|NCT01168596|20628759|P1|STARTED|Overall Study||16
8368530|NCT01168427|20628803|P1|NOT COMPLETED|Overall Study||1
8368531|NCT01168427|20628803|P1|COMPLETED|Overall Study||65
8368532|NCT01168427|20628803|P1|STARTED|Overall Study||66
8368533|NCT01168401|20628819|P11|NOT COMPLETED|Overall Study||0
8368534|NCT01168401|20628820|P10|NOT COMPLETED|Overall Study||0
8368535|NCT01168401|20628821|P9|NOT COMPLETED|Overall Study||0
8368536|NCT01168401|20628822|P8|NOT COMPLETED|Overall Study||0
8368537|NCT01168401|20628823|P7|NOT COMPLETED|Overall Study||0
8368538|NCT01168401|20628824|P6|NOT COMPLETED|Overall Study||0
8368539|NCT01168401|20628825|P5|NOT COMPLETED|Overall Study||0
8368540|NCT01168401|20628826|P4|NOT COMPLETED|Overall Study||2
8368541|NCT01168401|20628827|P3|NOT COMPLETED|Overall Study||2
8368542|NCT01168401|20628828|P2|NOT COMPLETED|Overall Study||1
8368543|NCT01168401|20628829|P1|NOT COMPLETED|Overall Study||1
8368544|NCT01168401|20628819|P11|COMPLETED|Overall Study||8
8368545|NCT01168401|20628820|P10|COMPLETED|Overall Study||8
8368546|NCT01168401|20628821|P9|COMPLETED|Overall Study||9
8368547|NCT01168401|20628822|P8|COMPLETED|Overall Study||10
8368548|NCT01168401|20628823|P7|COMPLETED|Overall Study||10
8368549|NCT01168401|20628824|P6|COMPLETED|Overall Study||9
8368550|NCT01168401|20628825|P5|COMPLETED|Overall Study||9
8368551|NCT01168401|20628826|P4|COMPLETED|Overall Study||7
8368552|NCT01168401|20628827|P3|COMPLETED|Overall Study||8
8368553|NCT01168401|20628828|P2|COMPLETED|Overall Study||9
8368554|NCT01168401|20628829|P1|COMPLETED|Overall Study||9
8368555|NCT01168401|20628819|P11|STARTED|Overall Study||8
8368556|NCT01168401|20628820|P10|STARTED|Overall Study||8
8368557|NCT01168401|20628821|P9|STARTED|Overall Study||9
8368558|NCT01168401|20628822|P8|STARTED|Overall Study||10
8368559|NCT01168401|20628823|P7|STARTED|Overall Study||10
8368560|NCT01168401|20628824|P6|STARTED|Overall Study||9
8368561|NCT01168401|20628825|P5|STARTED|Overall Study||9
8368562|NCT01168401|20628826|P4|STARTED|Overall Study||9
8368563|NCT01168401|20628827|P3|STARTED|Overall Study||10
8368564|NCT01168401|20628828|P2|STARTED|Overall Study||10
8368565|NCT01168401|20628829|P1|STARTED|Overall Study||10
8368566|NCT01168349|20629062|P1|NOT COMPLETED|Overall Study||301
8368567|NCT01168349|20629062|P1|COMPLETED|Overall Study||754
8368568|NCT01168349|20629062|P1|STARTED|Overall Study||1055
8368569|NCT01168232|20629168|P1|NOT COMPLETED|Overall Study||8
8368570|NCT01168232|20629168|P1|COMPLETED|Overall Study|Eligible and treated patients|34
8368571|NCT01168232|20629168|P1|STARTED|Overall Study||42
8368575|NCT01168024|20629183|P2|NOT COMPLETED|Overall Study||0
8368576|NCT01168024|20629184|P1|NOT COMPLETED|Overall Study||0
8368577|NCT01168024|20629183|P2|COMPLETED|Overall Study||3
8368578|NCT01168024|20629184|P1|COMPLETED|Overall Study||13
8368579|NCT01168024|20629183|P2|STARTED|Overall Study||3
8368580|NCT01168024|20629184|P1|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
8368581|NCT01167907|20629198|P2|NOT COMPLETED|Overall Study||1
8368582|NCT01167907|20629199|P1|NOT COMPLETED|Overall Study||2
8368583|NCT01167907|20629198|P2|COMPLETED|Overall Study||14
8368584|NCT01167907|20629199|P1|COMPLETED|Overall Study||15
8368585|NCT01167907|20629198|P2|STARTED|Overall Study||15
8368586|NCT01167907|20629199|P1|STARTED|Overall Study||17
8368587|NCT01167881|20629217|P2|NOT COMPLETED|Overall Study||191
8368588|NCT01167881|20629218|P1|NOT COMPLETED|Overall Study||159
8368589|NCT01167881|20629217|P2|COMPLETED|Overall Study||589
8368590|NCT01167881|20629218|P1|COMPLETED|Overall Study||610
8368591|NCT01167881|20629217|P2|Completed After 4 Years Treatment|Overall Study||462
8368592|NCT01167881|20629218|P1|Completed After 4 Years Treatment|Overall Study||515
8368593|NCT01167881|20629217|P2|Completed After 2 Years Treatment|Overall Study||127
8368594|NCT01167881|20629218|P1|Completed After 2 Years Treatment|Overall Study||95
8368595|NCT01167881|20629217|P2|STARTED|Overall Study||780
8368596|NCT01167881|20629218|P1|STARTED|Overall Study||769
8368597|NCT01167829|20629242|P1|NOT COMPLETED|Overall Study||0
8368598|NCT01167829|20629242|P1|COMPLETED|Overall Study||12
8368599|NCT01167829|20629242|P1|STARTED|Overall Study||12
8368606|NCT01167634|20629272|P4|NOT COMPLETED|Overall Study||4
8368607|NCT01167634|20629273|P3|NOT COMPLETED|Overall Study||3
8368608|NCT01167634|20629274|P2|NOT COMPLETED|Overall Study||4
8368609|NCT01167634|20629275|P1|NOT COMPLETED|Overall Study||2
8368610|NCT01167634|20629272|P4|COMPLETED|Overall Study||29
8368611|NCT01167634|20629273|P3|COMPLETED|Overall Study||30
8368612|NCT01167634|20629274|P2|COMPLETED|Overall Study||29
8368613|NCT01167634|20629275|P1|COMPLETED|Overall Study||31
8368614|NCT01167634|20629272|P4|STARTED|Overall Study||33
8368615|NCT01167634|20629273|P3|STARTED|Overall Study||33
8368616|NCT01167634|20629274|P2|STARTED|Overall Study||33
8368617|NCT01167634|20629275|P1|STARTED|Overall Study||33
8368618|NCT01167608|20629285|P1|NOT COMPLETED|Overall Study||114
8368619|NCT01167608|20629285|P1|COMPLETED|Overall Study||769
8368620|NCT01167608|20629285|P1|STARTED|Overall Study||883
8368621|NCT01167582|20629296|P2|NOT COMPLETED|Overall Study||1
8368622|NCT01167582|20629297|P1|NOT COMPLETED|Overall Study||0
8368623|NCT01167582|20629296|P2|COMPLETED|Overall Study||54
8368624|NCT01167582|20629297|P1|COMPLETED|Overall Study||55
8368625|NCT01167582|20629296|P2|STARTED|Overall Study||55
8368626|NCT01167582|20629297|P1|STARTED|Overall Study||55
8368627|NCT01167569|20629329|P2|NOT COMPLETED|Overall Study||2
8368628|NCT01167569|20629330|P1|NOT COMPLETED|Overall Study||1
8368629|NCT01167569|20629329|P2|COMPLETED|Overall Study||27
8368630|NCT01167569|20629330|P1|COMPLETED|Overall Study||27
8368631|NCT01167569|20629329|P2|STARTED|Overall Study||29
8368632|NCT01167569|20629330|P1|STARTED|Overall Study||28
8368633|NCT01167504|20629338|P1|NOT COMPLETED|Overall Study||3
8368634|NCT01167504|20629338|P1|COMPLETED|Overall Study||12
8368635|NCT01167504|20629338|P1|STARTED|Overall Study||15
8368636|NCT01167452|20629343|P1|NOT COMPLETED|Overall Study||0
8368637|NCT01167452|20629343|P1|COMPLETED|Overall Study||36
8368638|NCT01167452|20629343|P1|STARTED|Overall Study||36
8368639|NCT01167426|20629348|P1|NOT COMPLETED|Overall Study||10
8368640|NCT01167426|20629348|P1|COMPLETED|Overall Study||138
8368641|NCT01167426|20629348|P1|STARTED|Overall Study||148
8368642|NCT01167257|20629356|P2|NOT COMPLETED|Overall Study||3
8368643|NCT01167257|20629357|P1|NOT COMPLETED|Overall Study||3
8368644|NCT01167257|20629356|P2|COMPLETED|Overall Study||28
8368645|NCT01167257|20629357|P1|COMPLETED|Overall Study||28
8368646|NCT01167257|20629356|P2|STARTED|Overall Study||31
8368647|NCT01167257|20629357|P1|STARTED|Overall Study||31
8368648|NCT01167192|20629379|P1|NOT COMPLETED|Overall Study||4
8368649|NCT01167192|20629379|P1|COMPLETED|Overall Study||6
8368650|NCT01167192|20629379|P1|STARTED|Overall Study||10
8368651|NCT01167179|20629396|P2|NOT COMPLETED|Overall Study||21
8368652|NCT01167179|20629397|P1|NOT COMPLETED|Overall Study||15
8368653|NCT01167179|20629396|P2|COMPLETED|Overall Study||59
8368654|NCT01167179|20629397|P1|COMPLETED|Overall Study||65
8368655|NCT01167179|20629396|P2|STARTED|Overall Study||80
8368656|NCT01167179|20629397|P1|STARTED|Overall Study||80
8368657|NCT01167153|20629407|P2|NOT COMPLETED|Overall Study||33
8368658|NCT01167153|20629408|P1|NOT COMPLETED|Overall Study||18
8368659|NCT01167153|20629407|P2|COMPLETED|Overall Study||249
8368660|NCT01167153|20629408|P1|COMPLETED|Overall Study||264
8368661|NCT01167153|20629407|P2|Intention to Treat (ITT)|Overall Study||268
8368662|NCT01167153|20629408|P1|Intention to Treat (ITT)|Overall Study||272
8368663|NCT01167153|20629407|P2|STARTED|Overall Study||282
8368664|NCT01167153|20629408|P1|STARTED|Overall Study||282
8368665|NCT01167140|20629426|P1|NOT COMPLETED|Overall Study||1
8368666|NCT01167140|20629426|P1|COMPLETED|Overall Study||41
8368667|NCT01167140|20629426|P1|STARTED|Overall Study||42
8368668|NCT01167023|20629434|P3|NOT COMPLETED|Overall Study||2
8368669|NCT01167023|20629435|P2|NOT COMPLETED|Overall Study||3
8368670|NCT01167023|20629436|P1|NOT COMPLETED|Overall Study||0
8368671|NCT01167023|20629434|P3|COMPLETED|Overall Study||39
8368672|NCT01167023|20629435|P2|COMPLETED|Overall Study||18
8368673|NCT01167023|20629436|P1|COMPLETED|Overall Study||0
8368674|NCT01167023|20629434|P3|Received at Least 1 Dose of Study Drug|Overall Study||41
8368675|NCT01167023|20629435|P2|Received at Least 1 Dose of Study Drug|Overall Study||19
8368676|NCT01167023|20629436|P1|Received at Least 1 Dose of Study Drug|Overall Study||0
8368677|NCT01167023|20629434|P3|STARTED|Overall Study||41
8368678|NCT01167023|20629435|P2|STARTED|Overall Study||21
8368679|NCT01167023|20629436|P1|STARTED|Overall Study||0
8368686|NCT01166971|20629467|P2|NOT COMPLETED|Overall Study||1
8368687|NCT01166971|20629468|P1|NOT COMPLETED|Overall Study||1
8368688|NCT01166971|20629467|P2|COMPLETED|Overall Study||30
8368689|NCT01166971|20629468|P1|COMPLETED|Overall Study||32
8368690|NCT01166971|20629467|P2|STARTED|Overall Study||31
8368691|NCT01166971|20629468|P1|STARTED|Overall Study||33
8368692|NCT01166958|20629476|P2|NOT COMPLETED|Overall Study||0
8368693|NCT01166958|20629477|P1|NOT COMPLETED|Overall Study||1
8368694|NCT01166958|20629476|P2|COMPLETED|Overall Study||13
8368695|NCT01166958|20629477|P1|COMPLETED|Overall Study||12
8368696|NCT01166958|20629476|P2|STARTED|Overall Study||13
8368697|NCT01166958|20629477|P1|STARTED|Overall Study||13
8368698|NCT01166945|20629493|P2|NOT COMPLETED|Day 30||3
8368699|NCT01166945|20629494|P1|NOT COMPLETED|Day 30||4
8368700|NCT01166945|20629493|P2|COMPLETED|Day 30||37
8368701|NCT01166945|20629494|P1|COMPLETED|Day 30||38
8368702|NCT01166945|20629493|P2|STARTED|Day 30||40
8368703|NCT01166945|20629494|P1|STARTED|Day 30||42
8368704|NCT01166945|20629493|P2|NOT COMPLETED|Day 20||0
8368705|NCT01166945|20629494|P1|NOT COMPLETED|Day 20||0
8368706|NCT01166945|20629493|P2|COMPLETED|Day 20||40
8368707|NCT01166945|20629494|P1|COMPLETED|Day 20||42
8368708|NCT01166945|20629493|P2|STARTED|Day 20||40
8368709|NCT01166945|20629494|P1|STARTED|Day 20||42
8368710|NCT01166945|20629493|P2|NOT COMPLETED|Day 15||1
8368711|NCT01166945|20629494|P1|NOT COMPLETED|Day 15||2
8368712|NCT01166945|20629493|P2|COMPLETED|Day 15||40
8368713|NCT01166945|20629494|P1|COMPLETED|Day 15||42
8368714|NCT01166945|20629493|P2|STARTED|Day 15||41
8368715|NCT01166945|20629494|P1|STARTED|Day 15||44
8368716|NCT01166945|20629493|P2|NOT COMPLETED|Day 10||2
8368717|NCT01166945|20629494|P1|NOT COMPLETED|Day 10||3
8368718|NCT01166945|20629493|P2|COMPLETED|Day 10||41
8368719|NCT01166945|20629494|P1|COMPLETED|Day 10||44
8368720|NCT01166945|20629493|P2|STARTED|Day 10||43
8368721|NCT01166945|20629494|P1|STARTED|Day 10||47
8368722|NCT01166945|20629493|P2|NOT COMPLETED|Day 5||0
8368723|NCT01166945|20629494|P1|NOT COMPLETED|Day 5||0
8368724|NCT01166945|20629493|P2|COMPLETED|Day 5||43
8368725|NCT01166945|20629494|P1|COMPLETED|Day 5||47
8368726|NCT01166945|20629493|P2|STARTED|Day 5||43
8368727|NCT01166945|20629494|P1|STARTED|Day 5||47
8368728|NCT01166945|20629493|P2|NOT COMPLETED|Randomized||4
8368729|NCT01166945|20629494|P1|NOT COMPLETED|Randomized||4
8368730|NCT01166945|20629493|P2|COMPLETED|Randomized||43
8368731|NCT01166945|20629494|P1|COMPLETED|Randomized||47
8368732|NCT01166945|20629493|P2|STARTED|Randomized||47
8368733|NCT01166945|20629494|P1|STARTED|Randomized||51
8368734|NCT01166763|20629502|P1|NOT COMPLETED|Overall Study||3
8368735|NCT01166763|20629502|P1|COMPLETED|Overall Study||27
8368736|NCT01166763|20629502|P1|STARTED|Overall Study||30
8368737|NCT01166750|20629510|P2|NOT COMPLETED|Overall Study||0
8368738|NCT01166750|20629511|P1|NOT COMPLETED|Overall Study||1
8368739|NCT01166750|20629510|P2|COMPLETED|Overall Study||13
8368740|NCT01166750|20629511|P1|COMPLETED|Overall Study||9
8368741|NCT01166750|20629510|P2|STARTED|Overall Study||13
8368742|NCT01166750|20629511|P1|STARTED|Overall Study||10
8368743|NCT01166724|20629519|P2|NOT COMPLETED|Overall Study||5
8368744|NCT01166724|20629520|P1|NOT COMPLETED|Overall Study||7
8368745|NCT01166724|20629519|P2|COMPLETED|Overall Study||0
8368746|NCT01166724|20629520|P1|COMPLETED|Overall Study||0
8368747|NCT01166724|20629519|P2|STARTED|Overall Study||5
8368748|NCT01166724|20629520|P1|STARTED|Overall Study||7
8368749|NCT01166659|20629528|P1|NOT COMPLETED|Overall Study||13
8368750|NCT01166659|20629528|P1|COMPLETED|Overall Study||35
8368751|NCT01166659|20629528|P1|STARTED|Overall Study||48
8368752|NCT01166646|20629537|P2|NOT COMPLETED|Overall Study||1
8368753|NCT01166646|20629538|P1|NOT COMPLETED|Overall Study||1
8368754|NCT01166646|20629537|P2|COMPLETED|Overall Study||21
8368755|NCT01166646|20629538|P1|COMPLETED|Overall Study||20
8368756|NCT01166646|20629537|P2|STARTED|Overall Study||22
8368757|NCT01166646|20629538|P1|STARTED|Overall Study||21
8368758|NCT01166568|20629557|P3|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
8368759|NCT01166568|20629558|P2|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
8368760|NCT01166568|20629559|P1|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
8368761|NCT01166568|20629557|P3|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
8368762|NCT01166568|20629558|P2|COMPLETED|Implantation- Nonrandomized & Randomized||32
8368763|NCT01166568|20629559|P1|COMPLETED|Implantation- Nonrandomized & Randomized||274
8368764|NCT01166568|20629557|P3|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
8368765|NCT01166568|20629558|P2|STARTED|Implantation- Nonrandomized & Randomized||33
8368766|NCT01166568|20629559|P1|STARTED|Implantation- Nonrandomized & Randomized||288
8368767|NCT01166568|20629557|P3|NOT COMPLETED|Deferred Implantation- Randomized||1
8368768|NCT01166568|20629558|P2|NOT COMPLETED|Deferred Implantation- Randomized||0
8368769|NCT01166568|20629559|P1|NOT COMPLETED|Deferred Implantation- Randomized||0
8368770|NCT01166568|20629557|P3|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
8368771|NCT01166568|20629558|P2|COMPLETED|Deferred Implantation- Randomized||0
8368772|NCT01166568|20629559|P1|COMPLETED|Deferred Implantation- Randomized||0
8368773|NCT01166568|20629557|P3|STARTED|Deferred Implantation- Randomized||16
8368774|NCT01166568|20629558|P2|STARTED|Deferred Implantation- Randomized||0
8368775|NCT01166568|20629559|P1|STARTED|Deferred Implantation- Randomized||0
8368776|NCT01166438|20629572|P2|NOT COMPLETED|Off Treatment Follow-up Phase||56
8368777|NCT01166438|20629573|P1|NOT COMPLETED|Off Treatment Follow-up Phase||34
8368778|NCT01166438|20629572|P2|COMPLETED|Off Treatment Follow-up Phase||33
8368779|NCT01166438|20629573|P1|COMPLETED|Off Treatment Follow-up Phase||51
8368780|NCT01166438|20629572|P2|STARTED|Off Treatment Follow-up Phase||89
8368781|NCT01166438|20629573|P1|STARTED|Off Treatment Follow-up Phase||85
8368782|NCT01166438|20629572|P2|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
8368783|NCT01166438|20629573|P1|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
8368784|NCT01166438|20629572|P2|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
8368785|NCT01166438|20629573|P1|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
8368786|NCT01166438|20629572|P2|Treated|Double-blind Phase: 1st 6 Months||126
8368787|NCT01166438|20629573|P1|Treated|Double-blind Phase: 1st 6 Months||121
8368788|NCT01166438|20629572|P2|STARTED|Double-blind Phase: 1st 6 Months||127
8368789|NCT01166438|20629573|P1|STARTED|Double-blind Phase: 1st 6 Months||122
8368790|NCT01166373|20629591|P4|NOT COMPLETED|Overall Study||5
8368791|NCT01166373|20629592|P3|NOT COMPLETED|Overall Study||4
8368792|NCT01166373|20629593|P2|NOT COMPLETED|Overall Study||4
8368793|NCT01166373|20629594|P1|NOT COMPLETED|Overall Study||5
8368794|NCT01166373|20629591|P4|COMPLETED|Overall Study||92
8368795|NCT01166373|20629592|P3|COMPLETED|Overall Study||87
8368796|NCT01166373|20629593|P2|COMPLETED|Overall Study||87
8368797|NCT01166373|20629594|P1|COMPLETED|Overall Study||90
8368798|NCT01166373|20629591|P4|Completed E-OPTIMAL Year 5 Visit|Overall Study||64
8368799|NCT01166373|20629592|P3|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
8368800|NCT01166373|20629593|P2|Completed E-OPTIMAL Year 5 Visit|Overall Study||56
8368801|NCT01166373|20629594|P1|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
8368802|NCT01166373|20629591|P4|Completed E-OPTIMAL Year 4 Visit|Overall Study||68
8368803|NCT01166373|20629592|P3|Completed E-OPTIMAL Year 4 Visit|Overall Study||63
8368804|NCT01166373|20629593|P2|Completed E-OPTIMAL Year 4 Visit|Overall Study||61
8368805|NCT01166373|20629594|P1|Completed E-OPTIMAL Year 4 Visit|Overall Study||67
8368806|NCT01166373|20629591|P4|Completed E-OPTIMAL Year 3 Visit|Overall Study||77
8368807|NCT01166373|20629592|P3|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
8368808|NCT01166373|20629593|P2|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
8368809|NCT01166373|20629594|P1|Completed E-OPTIMAL Year 3 Visit|Overall Study||70
8368810|NCT01166373|20629591|P4|Consented to Participate E-OPTIMAL|Overall Study||78
8368811|NCT01166373|20629592|P3|Consented to Participate E-OPTIMAL|Overall Study||69
8368812|NCT01166373|20629593|P2|Consented to Participate E-OPTIMAL|Overall Study||66
8368813|NCT01166373|20629594|P1|Consented to Participate E-OPTIMAL|Overall Study||72
8368814|NCT01166373|20629591|P4|Randomized to No Video|Overall Study||42
8368815|NCT01166373|20629592|P3|Randomized to No Video|Overall Study||34
8368816|NCT01166373|20629593|P2|Randomized to No Video|Overall Study||30
8368817|NCT01166373|20629594|P1|Randomized to No Video|Overall Study||45
8368818|NCT01166373|20629591|P4|Randomized to Video|Overall Study||40
8368819|NCT01166373|20629592|P3|Randomized to Video|Overall Study||38
8368820|NCT01166373|20629593|P2|Randomized to Video|Overall Study||43
8368821|NCT01166373|20629594|P1|Randomized to Video|Overall Study||32
8368822|NCT01166373|20629591|P4|Completed OPTIMAL Year 2 Visit|Overall Study||87
8368823|NCT01166373|20629592|P3|Completed OPTIMAL Year 2 Visit|Overall Study||79
8368824|NCT01166373|20629593|P2|Completed OPTIMAL Year 2 Visit|Overall Study||80
8368825|NCT01166373|20629594|P1|Completed OPTIMAL Year 2 Visit|Overall Study||81
8368826|NCT01166373|20629591|P4|STARTED|Overall Study||97
8368827|NCT01166373|20629592|P3|STARTED|Overall Study||91
8368828|NCT01166373|20629593|P2|STARTED|Overall Study||91
8368829|NCT01166373|20629594|P1|STARTED|Overall Study||95
8368830|NCT01166347|20629694|P2|NOT COMPLETED|Overall Study||1
8368831|NCT01166347|20629695|P1|NOT COMPLETED|Overall Study||2
8368832|NCT01166347|20629694|P2|COMPLETED|Overall Study||148
8368833|NCT01166347|20629695|P1|COMPLETED|Overall Study||295
8368834|NCT01166347|20629694|P2|STARTED|Overall Study||149
8368835|NCT01166347|20629695|P1|STARTED|Overall Study||297
8368854|NCT01166230|20629753|P2|NOT COMPLETED|Overall Study||16
8368855|NCT01166230|20629754|P1|NOT COMPLETED|Overall Study||19
8368856|NCT01166230|20629753|P2|COMPLETED|Overall Study||255
8368857|NCT01166230|20629754|P1|COMPLETED|Overall Study||261
8368858|NCT01166230|20629753|P2|STARTED|Overall Study||271
8368859|NCT01166230|20629754|P1|STARTED|Overall Study||280
8368860|NCT01166178|20629768|P2|NOT COMPLETED|Overall Study||8
8368861|NCT01166178|20629769|P1|NOT COMPLETED|Overall Study||21
8368862|NCT01166178|20629768|P2|COMPLETED|Overall Study||0
8368863|NCT01166178|20629769|P1|COMPLETED|Overall Study||0
8368864|NCT01166178|20629768|P2|STARTED|Overall Study||8
8368865|NCT01166178|20629769|P1|STARTED|Overall Study||21
8368866|NCT01166139|20629795|P1|NOT COMPLETED|Overall Study||3
8368867|NCT01166139|20629795|P1|COMPLETED|Overall Study||7
8368868|NCT01166139|20629795|P1|STARTED|Overall Study||10
8368869|NCT01166126|20629801|P1|NOT COMPLETED|Overall Study||0
8368870|NCT01166126|20629801|P1|COMPLETED|Overall Study||4
8368871|NCT01166126|20629801|P1|STARTED|Overall Study||4
8368872|NCT01165996|20629808|P1|NOT COMPLETED|Overall Study||2
8368873|NCT01165996|20629808|P1|COMPLETED|Overall Study||23
8368874|NCT01165996|20629808|P1|Maintenance Phase|Overall Study||23
8368875|NCT01165996|20629808|P1|Induction Phase|Overall Study||25
8368876|NCT01165996|20629808|P1|STARTED|Overall Study||25
8368877|NCT01165983|20629820|P2|NOT COMPLETED|Overall Study||7
8368878|NCT01165983|20629821|P1|NOT COMPLETED|Overall Study||5
8368879|NCT01165983|20629820|P2|COMPLETED|Overall Study||42
8368880|NCT01165983|20629821|P1|COMPLETED|Overall Study||46
8368881|NCT01165983|20629820|P2|STARTED|Overall Study||49
8368882|NCT01165983|20629821|P1|STARTED|Overall Study||51
8368883|NCT01165840|20629865|P1|NOT COMPLETED|Overall Study||0
8368884|NCT01165840|20629865|P1|COMPLETED|Overall Study||36
8368885|NCT01165840|20629865|P1|STARTED|Overall Study||36
8368886|NCT01165775|20629869|P1|NOT COMPLETED|Overall Study||2
8368887|NCT01165775|20629869|P1|COMPLETED|Overall Study||15
8368888|NCT01165775|20629869|P1|STARTED|Overall Study||17
8368889|NCT01165684|20629879|P2|NOT COMPLETED|Overall Study||52
8368890|NCT01165684|20629880|P1|NOT COMPLETED|Overall Study||28
8368891|NCT01165684|20629879|P2|COMPLETED|Overall Study||148
8368892|NCT01165684|20629880|P1|COMPLETED|Overall Study||173
8368893|NCT01165684|20629879|P2|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
8368894|NCT01165684|20629880|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
8368895|NCT01165684|20629879|P2|STARTED|Overall Study||200
8368896|NCT01165684|20629880|P1|STARTED|Overall Study||201
8368897|NCT01165554|20629914|P1|NOT COMPLETED|Overall Study||23
8368898|NCT01165554|20629914|P1|COMPLETED|Overall Study||180
8368899|NCT01165554|20629914|P1|STARTED|Overall Study|This was the number of subjects that started the study.|203
8368900|NCT01165541|20629921|P1|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
8368901|NCT01165541|20629921|P1|COMPLETED|Quetiapine XR and Mirtazepine||11
8368902|NCT01165541|20629921|P1|STARTED|Quetiapine XR and Mirtazepine||16
8368903|NCT01165541|20629921|P1|NOT COMPLETED|Quetiapine XR Monotherapy||4
8368904|NCT01165541|20629921|P1|COMPLETED|Quetiapine XR Monotherapy||16
8368905|NCT01165541|20629921|P1|STARTED|Quetiapine XR Monotherapy||20
8368906|NCT01165450|20629927|P1|NOT COMPLETED|Overall Study||0
8368907|NCT01165450|20629927|P1|COMPLETED|Overall Study||2
8368908|NCT01165450|20629927|P1|STARTED|Overall Study||2
8368909|NCT01165424|20629937|P1|NOT COMPLETED|Overall Study||4
8368910|NCT01165424|20629937|P1|COMPLETED|Overall Study||76
8368911|NCT01165424|20629937|P1|STARTED|Overall Study||80
8368912|NCT01165320|20629944|P3|NOT COMPLETED|Overall Study||0
8368913|NCT01165320|20629945|P2|NOT COMPLETED|Overall Study||4
8368914|NCT01165320|20629946|P1|NOT COMPLETED|Overall Study||3
8368915|NCT01165320|20629944|P3|COMPLETED|Overall Study||0
8368916|NCT01165320|20629945|P2|COMPLETED|Overall Study||4
8368917|NCT01165320|20629946|P1|COMPLETED|Overall Study||9
8368918|NCT01165320|20629944|P3|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
8368919|NCT01165320|20629945|P2|STARTED|Overall Study||8
8368920|NCT01165320|20629946|P1|STARTED|Overall Study||12
8368921|NCT01165307|20629956|P2|NOT COMPLETED|Overall Study||3
8368922|NCT01165307|20629957|P1|NOT COMPLETED|Overall Study||14
8368923|NCT01165307|20629956|P2|COMPLETED|Overall Study||31
8368924|NCT01165307|20629957|P1|COMPLETED|Overall Study||19
8368925|NCT01165307|20629956|P2|STARTED|Overall Study||34
8368926|NCT01165307|20629957|P1|STARTED|Overall Study||33
8368927|NCT01165281|20629987|P2|NOT COMPLETED|Overall Study||51
8368928|NCT01165281|20629988|P1|NOT COMPLETED|Overall Study||58
8368929|NCT01165281|20629987|P2|COMPLETED|Overall Study||121
8368930|NCT01165281|20629988|P1|COMPLETED|Overall Study||110
8368931|NCT01165281|20629987|P2|STARTED|Overall Study||172
8368932|NCT01165281|20629988|P1|STARTED|Overall Study||168
8368933|NCT01165242|20630009|P3|NOT COMPLETED|Overall Study||14
8368934|NCT01165242|20630010|P2|NOT COMPLETED|Overall Study||10
8368935|NCT01165242|20630011|P1|NOT COMPLETED|Overall Study||10
8368936|NCT01165242|20630009|P3|COMPLETED|Overall Study||324
8368937|NCT01165242|20630010|P2|COMPLETED|Overall Study||326
8368938|NCT01165242|20630011|P1|COMPLETED|Overall Study||327
8368939|NCT01165242|20630009|P3|STARTED|Overall Study||338
8368940|NCT01165242|20630010|P2|STARTED|Overall Study||336
8368941|NCT01165242|20630011|P1|STARTED|Overall Study||337
8368942|NCT01165229|20630045|P2|NOT COMPLETED|Overall Study||1190
8368943|NCT01165229|20630046|P1|NOT COMPLETED|Overall Study||1180
8368944|NCT01165229|20630045|P2|COMPLETED|Overall Study||5760
8368945|NCT01165229|20630046|P1|COMPLETED|Overall Study||5770
8368946|NCT01165229|20630045|P2|STARTED|Overall Study||6950
8368947|NCT01165229|20630046|P1|STARTED|Overall Study||6950
8368948|NCT01165216|20630180|P2|NOT COMPLETED|Overall Study||7
8368949|NCT01165216|20630181|P1|NOT COMPLETED|Overall Study||8
8368950|NCT01165216|20630180|P2|COMPLETED|Overall Study|Completed=still on study drug|0
8368951|NCT01165216|20630181|P1|COMPLETED|Overall Study|Completed=still on study drug|0
8368952|NCT01165216|20630180|P2|Received at Least 1 Dose of Ipilimumab|Overall Study||6
8368953|NCT01165216|20630181|P1|Received at Least 1 Dose of Ipilimumab|Overall Study||6
8368954|NCT01165216|20630180|P2|STARTED|Overall Study|Participants who received any study drug|7
8368955|NCT01165216|20630181|P1|STARTED|Overall Study|Participants who received any study drug|8
8368956|NCT01165203|20630203|P2|NOT COMPLETED|Extended Safety Follow-up Phase||4
8368957|NCT01165203|20630204|P1|NOT COMPLETED|Extended Safety Follow-up Phase||7
8368958|NCT01165203|20630203|P2|COMPLETED|Extended Safety Follow-up Phase||45
8368959|NCT01165203|20630204|P1|COMPLETED|Extended Safety Follow-up Phase||67
8368960|NCT01165203|20630203|P2|STARTED|Extended Safety Follow-up Phase||49
8368961|NCT01165203|20630204|P1|STARTED|Extended Safety Follow-up Phase||74
8368962|NCT01165203|20630203|P2|NOT COMPLETED|Active Phase||2
8368963|NCT01165203|20630204|P1|NOT COMPLETED|Active Phase||5
8368964|NCT01165203|20630203|P2|COMPLETED|Active Phase||47
8368965|NCT01165203|20630204|P1|COMPLETED|Active Phase||69
8368966|NCT01165203|20630203|P2|STARTED|Active Phase||49
8368967|NCT01165203|20630204|P1|STARTED|Active Phase||74
8368974|NCT01165138|20630424|P4|NOT COMPLETED|Overall Study||22
8368975|NCT01165138|20630425|P3|NOT COMPLETED|Overall Study||20
8368976|NCT01165138|20630426|P2|NOT COMPLETED|Overall Study||52
8368977|NCT01165138|20630427|P1|NOT COMPLETED|Overall Study||0
8368978|NCT01165138|20630424|P4|COMPLETED|Overall Study||179
8368979|NCT01165138|20630425|P3|COMPLETED|Overall Study||185
8368980|NCT01165138|20630426|P2|COMPLETED|Overall Study||151
8368981|NCT01165138|20630427|P1|COMPLETED|Overall Study||0
8368982|NCT01165138|20630424|P4|STARTED|Overall Study||201
8368983|NCT01165138|20630425|P3|STARTED|Overall Study||205
8368984|NCT01165138|20630426|P2|STARTED|Overall Study||203
8368985|NCT01165138|20630427|P1|STARTED|Overall Study||0
8368986|NCT01165112|20630486|P1|NOT COMPLETED|Overall Study||0
8368987|NCT01165112|20630486|P1|COMPLETED|Overall Study||48
8368988|NCT01165112|20630486|P1|STARTED|Overall Study||48
8368989|NCT01165047|20630493|P1|NOT COMPLETED|Overall Study||0
8368990|NCT01165047|20630493|P1|COMPLETED|Overall Study||10
8368991|NCT01165047|20630493|P1|STARTED|Overall Study||10
8368992|NCT01165021|20630497|P1|NOT COMPLETED|Overall Study||1
8368993|NCT01165021|20630497|P1|COMPLETED|Overall Study||18
8368994|NCT01165021|20630497|P1|3 Cycles of Chemo, Then Surgery|Overall Study||15
8368995|NCT01165021|20630497|P1|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
8368996|NCT01165021|20630497|P1|≥1 Dose Chemo|Overall Study||19
8368997|NCT01165021|20630497|P1|STARTED|Overall Study||19
8368998|NCT01164956|20630505|P3|NOT COMPLETED|Overall Study||1
8368999|NCT01164956|20630506|P2|NOT COMPLETED|Overall Study||0
8369000|NCT01164956|20630507|P1|NOT COMPLETED|Overall Study||1
8369001|NCT01164956|20630505|P3|COMPLETED|Overall Study||0
8369002|NCT01164956|20630506|P2|COMPLETED|Overall Study||1
8369003|NCT01164956|20630507|P1|COMPLETED|Overall Study||0
8369004|NCT01164956|20630505|P3|Evaluable for pedsFACIT-F Score Change|Overall Study||0
8369005|NCT01164956|20630506|P2|Evaluable for pedsFACIT-F Score Change|Overall Study||1
8369006|NCT01164956|20630507|P1|Evaluable for pedsFACIT-F Score Change|Overall Study||0
8369007|NCT01164956|20630505|P3|STARTED|Overall Study||1
8369008|NCT01164956|20630506|P2|STARTED|Overall Study||1
8369009|NCT01164956|20630507|P1|STARTED|Overall Study||1
8369010|NCT01164891|20630515|P1|NOT COMPLETED|Overall Study||6
8369011|NCT01164891|20630515|P1|COMPLETED|Overall Study||1
8369012|NCT01164891|20630515|P1|STARTED|Overall Study||7
8369013|NCT01164865|20630535|P2|NOT COMPLETED|Overall Study||1
8369014|NCT01164865|20630536|P1|NOT COMPLETED|Overall Study||2
8369015|NCT01164865|20630535|P2|COMPLETED|Overall Study||38
8369016|NCT01164865|20630536|P1|COMPLETED|Overall Study||37
8369017|NCT01164865|20630535|P2|STARTED|Overall Study||39
8369018|NCT01164865|20630536|P1|STARTED|Overall Study||39
8369019|NCT01164722|20630546|P2|NOT COMPLETED|Overall Study||15
8369020|NCT01164722|20630547|P1|NOT COMPLETED|Overall Study||18
8369021|NCT01164722|20630546|P2|COMPLETED|Overall Study||45
8369022|NCT01164722|20630547|P1|COMPLETED|Overall Study||42
8369023|NCT01164722|20630546|P2|STARTED|Overall Study||60
8369024|NCT01164722|20630547|P1|STARTED|Overall Study||60
8369025|NCT01164644|20630563|P2|NOT COMPLETED|Overall Study||1
8369026|NCT01164644|20630564|P1|NOT COMPLETED|Overall Study||3
8369027|NCT01164644|20630563|P2|COMPLETED|Overall Study||13
8369028|NCT01164644|20630564|P1|COMPLETED|Overall Study||9
8369029|NCT01164644|20630563|P2|STARTED|Overall Study||14
8369030|NCT01164644|20630564|P1|STARTED|Overall Study||12
8369031|NCT01164579|20630577|P3|NOT COMPLETED|Overall Study||16
8369032|NCT01164579|20630578|P2|NOT COMPLETED|Overall Study||9
8369033|NCT01164579|20630579|P1|NOT COMPLETED|Overall Study||8
8369034|NCT01164579|20630577|P3|COMPLETED|Overall Study||21
8369035|NCT01164579|20630578|P2|COMPLETED|Overall Study||27
8369036|NCT01164579|20630579|P1|COMPLETED|Overall Study||28
8369037|NCT01164579|20630577|P3|STARTED|Overall Study||37
8369038|NCT01164579|20630578|P2|STARTED|Overall Study||36
8369039|NCT01164579|20630579|P1|STARTED|Overall Study||36
8369040|NCT01164501|20630659|P3|NOT COMPLETED|Overall Study||42
8369041|NCT01164501|20630660|P2|NOT COMPLETED|Overall Study||10
8369042|NCT01164501|20630661|P1|NOT COMPLETED|Overall Study||43
8369043|NCT01164501|20630659|P3|COMPLETED|Overall Study||280
8369044|NCT01164501|20630660|P2|COMPLETED|Overall Study||88
8369045|NCT01164501|20630661|P1|COMPLETED|Overall Study||278
8369046|NCT01164501|20630659|P3|STARTED|Overall Study||322
8369047|NCT01164501|20630660|P2|STARTED|Overall Study||98
8369048|NCT01164501|20630661|P1|STARTED|Overall Study||321
8369049|NCT01164475|20630678|P2|NOT COMPLETED|Overall Study||2
8369050|NCT01164475|20630679|P1|NOT COMPLETED|Overall Study||2
8369051|NCT01164475|20630678|P2|COMPLETED|Overall Study||29
8369052|NCT01164475|20630679|P1|COMPLETED|Overall Study||28
8369053|NCT01164475|20630678|P2|STARTED|Overall Study||31
8369054|NCT01164475|20630679|P1|STARTED|Overall Study||30
8369055|NCT01164137|20630705|P2|NOT COMPLETED|Overall Study||0
8369056|NCT01164137|20630706|P1|NOT COMPLETED|Overall Study||3
8369057|NCT01164137|20630705|P2|COMPLETED|Overall Study||76
8369058|NCT01164137|20630706|P1|COMPLETED|Overall Study||77
8369059|NCT01164137|20630705|P2|STARTED|Overall Study||76
8369060|NCT01164137|20630706|P1|STARTED|Overall Study||80
8369061|NCT01164098|20630722|P2|NOT COMPLETED|Overall Study||0
8369062|NCT01164098|20630723|P1|NOT COMPLETED|Overall Study||0
8369063|NCT01164098|20630722|P2|COMPLETED|Overall Study||15
8369064|NCT01164098|20630723|P1|COMPLETED|Overall Study||15
8369065|NCT01164098|20630722|P2|STARTED|Overall Study||15
8369066|NCT01164098|20630723|P1|STARTED|Overall Study||15
8369067|NCT01164007|20630733|P1|NOT COMPLETED|Overall Study||40
8369068|NCT01164007|20630733|P1|COMPLETED|Overall Study||0
8369069|NCT01164007|20630733|P1|Treated|Overall Study||37
8369070|NCT01164007|20630733|P1|STARTED|Overall Study||40
8369071|NCT01163955|20630749|P2|NOT COMPLETED|Overall Study||4
8369072|NCT01163955|20630750|P1|NOT COMPLETED|Overall Study||0
8369073|NCT01163955|20630749|P2|COMPLETED|Overall Study||26
8369074|NCT01163955|20630750|P1|COMPLETED|Overall Study||26
8369075|NCT01163955|20630749|P2|STARTED|Overall Study||30
8369076|NCT01163955|20630750|P1|STARTED|Overall Study||26
8369077|NCT01163916|20630759|P3|NOT COMPLETED|Overall Study||20
8369078|NCT01163916|20630760|P2|NOT COMPLETED|Overall Study||4
8369079|NCT01163916|20630761|P1|NOT COMPLETED|Overall Study||30
8369080|NCT01163916|20630759|P3|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
8369081|NCT01163916|20630760|P2|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
8369082|NCT01163916|20630761|P1|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
8369083|NCT01163916|20630759|P3|Safety Population|Overall Study||91
8369084|NCT01163916|20630760|P2|Safety Population|Overall Study||35
8369085|NCT01163916|20630761|P1|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
8369086|NCT01163916|20630759|P3|STARTED|Overall Study||91
8369087|NCT01163916|20630760|P2|STARTED|Overall Study||35
8369088|NCT01163916|20630761|P1|STARTED|Overall Study||126
8369089|NCT01163851|20630799|P2|NOT COMPLETED|Overall Study||1
8369090|NCT01163851|20630800|P1|NOT COMPLETED|Overall Study||1
8369091|NCT01163851|20630799|P2|COMPLETED|Overall Study||11
8369092|NCT01163851|20630800|P1|COMPLETED|Overall Study||12
8369093|NCT01163851|20630799|P2|Treated|Overall Study||12
8369094|NCT01163851|20630800|P1|Treated|Overall Study||12
8369095|NCT01163851|20630799|P2|STARTED|Overall Study||12
8369096|NCT01163851|20630800|P1|STARTED|Overall Study||13
8369097|NCT01163786|20630878|P1|NOT COMPLETED|Completed Follow up (Visit 9 and 10)||1
8369098|NCT01163786|20630878|P1|COMPLETED|Completed Follow up (Visit 9 and 10)||13
8369099|NCT01163786|20630878|P1|Completed Week 18 Follow up (Visit 10)|Completed Follow up (Visit 9 and 10)||13
8369100|NCT01163786|20630878|P1|Completed Week 12 Follow up (Visit 9)|Completed Follow up (Visit 9 and 10)||14
8369101|NCT01163786|20630878|P1|STARTED|Completed Follow up (Visit 9 and 10)||14
8369102|NCT01163786|20630878|P1|NOT COMPLETED|Treatment With Bortezomib||3
8369103|NCT01163786|20630878|P1|COMPLETED|Treatment With Bortezomib||14
8369104|NCT01163786|20630878|P1|Completed 2nd Cycle|Treatment With Bortezomib|One patient completed cycle 2 but missed one dose of Bortezomib.|14
8369105|NCT01163786|20630878|P1|Completed 1st Cycle|Treatment With Bortezomib||17
8369106|NCT01163786|20630878|P1|STARTED|Treatment With Bortezomib||17
8369107|NCT01163760|20630884|P4|NOT COMPLETED|Period 4 (Follow-up)||0
8369108|NCT01163760|20630885|P3|NOT COMPLETED|Period 4 (Follow-up)||0
8369109|NCT01163760|20630886|P2|NOT COMPLETED|Period 4 (Follow-up)||0
8369110|NCT01163760|20630887|P1|NOT COMPLETED|Period 4 (Follow-up)||0
8369111|NCT01163760|20630884|P4|COMPLETED|Period 4 (Follow-up)||12
8369112|NCT01163760|20630885|P3|COMPLETED|Period 4 (Follow-up)||13
8369113|NCT01163760|20630886|P2|COMPLETED|Period 4 (Follow-up)||13
8369114|NCT01163760|20630887|P1|COMPLETED|Period 4 (Follow-up)||12
8369115|NCT01163760|20630884|P4|STARTED|Period 4 (Follow-up)||12
8369116|NCT01163760|20630885|P3|STARTED|Period 4 (Follow-up)||13
8369117|NCT01163760|20630886|P2|STARTED|Period 4 (Follow-up)||13
8369118|NCT01163760|20630887|P1|STARTED|Period 4 (Follow-up)||12
8369119|NCT01163760|20630884|P4|NOT COMPLETED|Period 3 (Fit)||0
8369120|NCT01163760|20630885|P3|NOT COMPLETED|Period 3 (Fit)||0
8369121|NCT01163760|20630886|P2|NOT COMPLETED|Period 3 (Fit)||0
8369122|NCT01163760|20630887|P1|NOT COMPLETED|Period 3 (Fit)||0
8369123|NCT01163760|20630884|P4|COMPLETED|Period 3 (Fit)||12
8369124|NCT01163760|20630885|P3|COMPLETED|Period 3 (Fit)||13
8369125|NCT01163760|20630886|P2|COMPLETED|Period 3 (Fit)||13
8369126|NCT01163760|20630887|P1|COMPLETED|Period 3 (Fit)||12
8369127|NCT01163760|20630884|P4|STARTED|Period 3 (Fit)||12
8369128|NCT01163760|20630885|P3|STARTED|Period 3 (Fit)||13
8369129|NCT01163760|20630886|P2|STARTED|Period 3 (Fit)||13
8369130|NCT01163760|20630887|P1|STARTED|Period 3 (Fit)||12
8369131|NCT01163760|20630884|P4|NOT COMPLETED|Period 2 (Follow-up)||0
8369132|NCT01163760|20630885|P3|NOT COMPLETED|Period 2 (Follow-up)||0
8369133|NCT01163760|20630886|P2|NOT COMPLETED|Period 2 (Follow-up)||0
8369134|NCT01163760|20630887|P1|NOT COMPLETED|Period 2 (Follow-up)||0
8369135|NCT01163760|20630884|P4|COMPLETED|Period 2 (Follow-up)||12
8369136|NCT01163760|20630885|P3|COMPLETED|Period 2 (Follow-up)||13
8369137|NCT01163760|20630886|P2|COMPLETED|Period 2 (Follow-up)||13
8369138|NCT01163760|20630887|P1|COMPLETED|Period 2 (Follow-up)||12
8369139|NCT01163760|20630884|P4|STARTED|Period 2 (Follow-up)||12
8369140|NCT01163760|20630885|P3|STARTED|Period 2 (Follow-up)||13
8369141|NCT01163760|20630886|P2|STARTED|Period 2 (Follow-up)||13
8369142|NCT01163760|20630887|P1|STARTED|Period 2 (Follow-up)||12
8369143|NCT01163760|20630884|P4|NOT COMPLETED|Period 1 (Fit)||0
8369144|NCT01163760|20630885|P3|NOT COMPLETED|Period 1 (Fit)||0
8369145|NCT01163760|20630886|P2|NOT COMPLETED|Period 1 (Fit)||0
8369146|NCT01163760|20630887|P1|NOT COMPLETED|Period 1 (Fit)||0
8369147|NCT01163760|20630884|P4|COMPLETED|Period 1 (Fit)||12
8369148|NCT01163760|20630885|P3|COMPLETED|Period 1 (Fit)||13
8369149|NCT01163760|20630886|P2|COMPLETED|Period 1 (Fit)||13
8369150|NCT01163760|20630887|P1|COMPLETED|Period 1 (Fit)||12
8369151|NCT01163760|20630884|P4|STARTED|Period 1 (Fit)||12
8369152|NCT01163760|20630885|P3|STARTED|Period 1 (Fit)||13
8369153|NCT01163760|20630886|P2|STARTED|Period 1 (Fit)||13
8369154|NCT01163760|20630887|P1|STARTED|Period 1 (Fit)||12
8369155|NCT01163747|20630901|P2|NOT COMPLETED|Overall Study||11
8369156|NCT01163747|20630902|P1|NOT COMPLETED|Overall Study||6
8369157|NCT01163747|20630901|P2|COMPLETED|Overall Study||49
8369158|NCT01163747|20630902|P1|COMPLETED|Overall Study||25
8369159|NCT01163747|20630901|P2|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
8369160|NCT01163747|20630902|P1|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
8369161|NCT01163747|20630901|P2|STARTED|Overall Study||60
8369162|NCT01163747|20630902|P1|STARTED|Overall Study||31
8369163|NCT01163721|20630922|P2|NOT COMPLETED|Overall Study||12
8369164|NCT01163721|20630923|P1|NOT COMPLETED|Overall Study||8
8369165|NCT01163721|20630922|P2|COMPLETED|Overall Study||29
8369166|NCT01163721|20630923|P1|COMPLETED|Overall Study||31
8369167|NCT01163721|20630922|P2|STARTED|Overall Study||41
8369168|NCT01163721|20630923|P1|STARTED|Overall Study||39
8369169|NCT01163656|20630935|P2|NOT COMPLETED|Overall Study||3
8369170|NCT01163656|20630936|P1|NOT COMPLETED|Overall Study||3
8369171|NCT01163656|20630935|P2|COMPLETED|Overall Study||30
8369172|NCT01163656|20630936|P1|COMPLETED|Overall Study||30
8369173|NCT01163656|20630935|P2|STARTED|Overall Study||33
8369174|NCT01163656|20630936|P1|STARTED|Overall Study||33
8369175|NCT01163643|20630948|P6|NOT COMPLETED|Overall Study||7
8369176|NCT01163643|20630949|P5|NOT COMPLETED|Overall Study||8
8369177|NCT01163643|20630950|P4|NOT COMPLETED|Overall Study||5
8369178|NCT01163643|20630951|P3|NOT COMPLETED|Overall Study||2
8369179|NCT01163643|20630952|P2|NOT COMPLETED|Overall Study||2
8369180|NCT01163643|20630953|P1|NOT COMPLETED|Overall Study||6
8369181|NCT01163643|20630948|P6|COMPLETED|Overall Study||66
8369182|NCT01163643|20630949|P5|COMPLETED|Overall Study||61
8369183|NCT01163643|20630950|P4|COMPLETED|Overall Study||69
8369184|NCT01163643|20630951|P3|COMPLETED|Overall Study||33
8369185|NCT01163643|20630952|P2|COMPLETED|Overall Study||35
8369186|NCT01163643|20630953|P1|COMPLETED|Overall Study||62
8369187|NCT01163643|20630948|P6|STARTED|Overall Study||73
8369188|NCT01163643|20630949|P5|STARTED|Overall Study||69
8369189|NCT01163643|20630950|P4|STARTED|Overall Study||74
8369190|NCT01163643|20630951|P3|STARTED|Overall Study||35
8369191|NCT01163643|20630952|P2|STARTED|Overall Study||37
8369192|NCT01163643|20630953|P1|STARTED|Overall Study||68
8369193|NCT01163617|20630973|P8|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369194|NCT01163617|20630974|P7|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369195|NCT01163617|20630975|P6|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369196|NCT01163617|20630976|P5|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369197|NCT01163617|20630977|P4|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369198|NCT01163617|20630978|P3|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369199|NCT01163617|20630979|P2|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369200|NCT01163617|20630980|P1|NOT COMPLETED|Phase B (Injection Time), Week 4||0
8369201|NCT01163617|20630973|P8|COMPLETED|Phase B (Injection Time), Week 4||20
8369202|NCT01163617|20630974|P7|COMPLETED|Phase B (Injection Time), Week 4||16
8369203|NCT01163617|20630975|P6|COMPLETED|Phase B (Injection Time), Week 4||27
8369204|NCT01163617|20630976|P5|COMPLETED|Phase B (Injection Time), Week 4||18
8369205|NCT01163617|20630977|P4|COMPLETED|Phase B (Injection Time), Week 4||0
8369206|NCT01163617|20630978|P3|COMPLETED|Phase B (Injection Time), Week 4||0
8369207|NCT01163617|20630979|P2|COMPLETED|Phase B (Injection Time), Week 4||0
8369208|NCT01163617|20630980|P1|COMPLETED|Phase B (Injection Time), Week 4||0
8369209|NCT01163617|20630973|P8|STARTED|Phase B (Injection Time), Week 4||20
8369210|NCT01163617|20630974|P7|STARTED|Phase B (Injection Time), Week 4||16
8369211|NCT01163617|20630975|P6|STARTED|Phase B (Injection Time), Week 4||27
8369212|NCT01163617|20630976|P5|STARTED|Phase B (Injection Time), Week 4||18
8369213|NCT01163617|20630977|P4|STARTED|Phase B (Injection Time), Week 4||0
8369214|NCT01163617|20630978|P3|STARTED|Phase B (Injection Time), Week 4||0
8369215|NCT01163617|20630979|P2|STARTED|Phase B (Injection Time), Week 4||0
8369216|NCT01163617|20630980|P1|STARTED|Phase B (Injection Time), Week 4||0
8369217|NCT01163617|20630973|P8|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369218|NCT01163617|20630974|P7|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369219|NCT01163617|20630975|P6|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369220|NCT01163617|20630976|P5|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369221|NCT01163617|20630977|P4|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369222|NCT01163617|20630978|P3|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
8369223|NCT01163617|20630979|P2|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
8369224|NCT01163617|20630980|P1|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369225|NCT01163617|20630973|P8|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369226|NCT01163617|20630974|P7|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369227|NCT01163617|20630975|P6|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369228|NCT01163617|20630976|P5|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
8369229|NCT01163617|20630977|P4|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
8369230|NCT01163617|20630978|P3|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
8369231|NCT01163617|20630979|P2|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
8369232|NCT01163617|20630980|P1|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
8369233|NCT01163617|20630973|P8|STARTED|Phase A (User Experience), Weeks 0 and 2||0
8369234|NCT01163617|20630974|P7|STARTED|Phase A (User Experience), Weeks 0 and 2||0
8369235|NCT01163617|20630975|P6|STARTED|Phase A (User Experience), Weeks 0 and 2||0
8369236|NCT01163617|20630976|P5|STARTED|Phase A (User Experience), Weeks 0 and 2||0
8369237|NCT01163617|20630977|P4|STARTED|Phase A (User Experience), Weeks 0 and 2||21
8369238|NCT01163617|20630978|P3|STARTED|Phase A (User Experience), Weeks 0 and 2||21
8369239|NCT01163617|20630979|P2|STARTED|Phase A (User Experience), Weeks 0 and 2||23
8369240|NCT01163617|20630980|P1|STARTED|Phase A (User Experience), Weeks 0 and 2||19
8369241|NCT01163604|20631002|P2|NOT COMPLETED|Overall Study||0
8369242|NCT01163604|20631003|P1|NOT COMPLETED|Overall Study||0
8369243|NCT01163604|20631002|P2|COMPLETED|Overall Study|August 2011|56
8369244|NCT01163604|20631003|P1|COMPLETED|Overall Study|August 2011|58
8369245|NCT01163604|20631002|P2|STARTED|Overall Study|August 2010|56
8369246|NCT01163604|20631003|P1|STARTED|Overall Study|August 2010|58
8369247|NCT01163474|20631009|P1|NOT COMPLETED|Overall Study||16
8369248|NCT01163474|20631009|P1|COMPLETED|Overall Study||24
8369249|NCT01163474|20631009|P1|STARTED|Overall Study||40
8369250|NCT01163461|20631016|P2|NOT COMPLETED|Overall Study||0
8369251|NCT01163461|20631017|P1|NOT COMPLETED|Overall Study||0
8369252|NCT01163461|20631016|P2|COMPLETED|Overall Study||14
8369253|NCT01163461|20631017|P1|COMPLETED|Overall Study||14
8369254|NCT01163461|20631016|P2|STARTED|Overall Study||14
8369255|NCT01163461|20631017|P1|STARTED|Overall Study||14
8369256|NCT01163318|20631021|P1|NOT COMPLETED|Overall Study||268
8369257|NCT01163318|20631021|P1|COMPLETED|Overall Study||284
8369258|NCT01163318|20631021|P1|STARTED|Overall Study||552
8369259|NCT01163292|20631030|P2|NOT COMPLETED|Overall Study||22
8369260|NCT01163292|20631031|P1|NOT COMPLETED|Overall Study||41
8369261|NCT01163292|20631030|P2|COMPLETED|Overall Study||92
8369262|NCT01163292|20631031|P1|COMPLETED|Overall Study||65
8369263|NCT01163292|20631030|P2|STARTED|Overall Study||114
8369264|NCT01163292|20631031|P1|STARTED|Overall Study||106
8369265|NCT01163279|20631047|P2|NOT COMPLETED|Overall Study||0
8369266|NCT01163279|20631048|P1|NOT COMPLETED|Overall Study||2
8369267|NCT01163279|20631047|P2|COMPLETED|Overall Study||9
8369268|NCT01163279|20631048|P1|COMPLETED|Overall Study||8
8369269|NCT01163279|20631047|P2|STARTED|Overall Study||9
8369270|NCT01163279|20631048|P1|STARTED|Overall Study||10
8369271|NCT01163266|20631077|P3|NOT COMPLETED|Overall Study||28
8369272|NCT01163266|20631078|P2|NOT COMPLETED|Overall Study||31
8369273|NCT01163266|20631079|P1|NOT COMPLETED|Overall Study||18
8369274|NCT01163266|20631077|P3|COMPLETED|Overall Study||122
8369275|NCT01163266|20631078|P2|COMPLETED|Overall Study||124
8369276|NCT01163266|20631079|P1|COMPLETED|Overall Study||139
8369277|NCT01163266|20631077|P3|Treated|Overall Study||150
8369278|NCT01163266|20631078|P2|Treated|Overall Study||155
8369279|NCT01163266|20631079|P1|Treated|Overall Study||157
8369280|NCT01163266|20631077|P3|STARTED|Overall Study||150
8369281|NCT01163266|20631078|P2|STARTED|Overall Study||155
8369282|NCT01163266|20631079|P1|STARTED|Overall Study||157
8369283|NCT01163253|20631104|P2|NOT COMPLETED|Overall Study||586
8369284|NCT01163253|20631105|P1|NOT COMPLETED|Overall Study||2281
8369285|NCT01163253|20631104|P2|COMPLETED|Overall Study||0
8369286|NCT01163253|20631105|P1|COMPLETED|Overall Study||0
8369287|NCT01163253|20631104|P2|STARTED|Overall Study||586
8369288|NCT01163253|20631105|P1|STARTED|Overall Study||2281
8369289|NCT01163214|20631267|P2|NOT COMPLETED|Overall Study||0
8369290|NCT01163214|20631268|P1|NOT COMPLETED|Overall Study||0
8369291|NCT01163214|20631267|P2|COMPLETED|Overall Study||81
8369292|NCT01163214|20631268|P1|COMPLETED|Overall Study||79
8369293|NCT01163214|20631267|P2|STARTED|Overall Study||81
8369294|NCT01163214|20631268|P1|STARTED|Overall Study||79
8369295|NCT01163162|20631284|P1|NOT COMPLETED|Overall Study||0
8369296|NCT01163162|20631284|P1|COMPLETED|Overall Study||16
8369297|NCT01163162|20631284|P1|STARTED|Overall Study||16
8369298|NCT01163149|20631293|P3|NOT COMPLETED|Extension Treatment Period||2
8369299|NCT01163149|20631294|P2|NOT COMPLETED|Extension Treatment Period||1
8369300|NCT01163149|20631295|P1|NOT COMPLETED|Extension Treatment Period||2
8369301|NCT01163149|20631293|P3|COMPLETED|Extension Treatment Period||4
8369302|NCT01163149|20631294|P2|COMPLETED|Extension Treatment Period||5
8369303|NCT01163149|20631295|P1|COMPLETED|Extension Treatment Period||5
8369304|NCT01163149|20631293|P3|STARTED|Extension Treatment Period||6
8369305|NCT01163149|20631294|P2|STARTED|Extension Treatment Period||6
8369306|NCT01163149|20631295|P1|STARTED|Extension Treatment Period||7
8369307|NCT01163149|20631293|P3|NOT COMPLETED|Primary Treatment Period||0
8369308|NCT01163149|20631294|P2|NOT COMPLETED|Primary Treatment Period||0
8369309|NCT01163149|20631295|P1|NOT COMPLETED|Primary Treatment Period||0
8369310|NCT01163149|20631293|P3|COMPLETED|Primary Treatment Period||6
8369311|NCT01163149|20631294|P2|COMPLETED|Primary Treatment Period||6
8369312|NCT01163149|20631295|P1|COMPLETED|Primary Treatment Period||7
8369313|NCT01163149|20631293|P3|STARTED|Primary Treatment Period||6
8369314|NCT01163149|20631294|P2|STARTED|Primary Treatment Period||6
8369315|NCT01163149|20631295|P1|STARTED|Primary Treatment Period||7
8369316|NCT01163097|20631340|P3|NOT COMPLETED|Overall Study||0
8369317|NCT01163097|20631341|P2|NOT COMPLETED|Overall Study||0
8369318|NCT01163097|20631342|P1|NOT COMPLETED|Overall Study||6
8369319|NCT01163097|20631340|P3|COMPLETED|Overall Study||8
8369320|NCT01163097|20631341|P2|COMPLETED|Overall Study||16
8369321|NCT01163097|20631342|P1|COMPLETED|Overall Study||14
8369322|NCT01163097|20631340|P3|STARTED|Overall Study||8
8369323|NCT01163097|20631341|P2|STARTED|Overall Study||16
8369324|NCT01163097|20631342|P1|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
8369325|NCT01163084|20631394|P2|NOT COMPLETED|Overall Study||0
8369326|NCT01163084|20631395|P1|NOT COMPLETED|Overall Study||0
8369327|NCT01163084|20631394|P2|COMPLETED|Overall Study||5
8369328|NCT01163084|20631395|P1|COMPLETED|Overall Study||4
8369329|NCT01163084|20631394|P2|STARTED|Overall Study||5
8369330|NCT01163084|20631395|P1|STARTED|Overall Study||4
8369331|NCT01163032|20631404|P3|NOT COMPLETED|Open Label Extension Phase||16
8369332|NCT01163032|20631405|P2|NOT COMPLETED|Open Label Extension Phase||0
8369333|NCT01163032|20631406|P1|NOT COMPLETED|Open Label Extension Phase||0
8369334|NCT01163032|20631404|P3|COMPLETED|Open Label Extension Phase||39
8369335|NCT01163032|20631405|P2|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
8369336|NCT01163032|20631406|P1|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
8369337|NCT01163032|20631404|P3|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
8369338|NCT01163032|20631405|P2|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
8369339|NCT01163032|20631406|P1|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
8369340|NCT01163032|20631404|P3|NOT COMPLETED|Randomization Phase||0
8369341|NCT01163032|20631405|P2|NOT COMPLETED|Randomization Phase||12
8369342|NCT01163032|20631406|P1|NOT COMPLETED|Randomization Phase||10
8369343|NCT01163032|20631404|P3|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
8369344|NCT01163032|20631405|P2|COMPLETED|Randomization Phase||30
8369345|NCT01163032|20631406|P1|COMPLETED|Randomization Phase||32
8369346|NCT01163032|20631404|P3|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
8369347|NCT01163032|20631405|P2|STARTED|Randomization Phase||42
8369348|NCT01163032|20631406|P1|STARTED|Randomization Phase||42
8369349|NCT01162863|20631439|P3|NOT COMPLETED|Overall Study||0
8369350|NCT01162863|20631440|P2|NOT COMPLETED|Overall Study||1
8369351|NCT01162863|20631441|P1|NOT COMPLETED|Overall Study||1
8369352|NCT01162863|20631439|P3|COMPLETED|Overall Study||17
8369353|NCT01162863|20631440|P2|COMPLETED|Overall Study||16
8369354|NCT01162863|20631441|P1|COMPLETED|Overall Study||17
8369355|NCT01162863|20631439|P3|STARTED|Overall Study||17
8369356|NCT01162863|20631440|P2|STARTED|Overall Study||17
8369357|NCT01162863|20631441|P1|STARTED|Overall Study||18
8369358|NCT01162733|20631457|P2|NOT COMPLETED|Overall Study||25
8369359|NCT01162733|20631458|P1|NOT COMPLETED|Overall Study||27
8369360|NCT01162733|20631457|P2|COMPLETED|Overall Study||25
8369361|NCT01162733|20631458|P1|COMPLETED|Overall Study||22
8369362|NCT01162733|20631457|P2|STARTED|Overall Study||50
8369363|NCT01162733|20631458|P1|STARTED|Overall Study||49
8369364|NCT01162551|20631466|P1|NOT COMPLETED|Overall Study||0
8369365|NCT01162551|20631466|P1|COMPLETED|Overall Study||3
8369366|NCT01162551|20631466|P1|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3
8369367|NCT01162499|20631471|P2|NOT COMPLETED|Intervention 2 (4 Hours)||0
8369368|NCT01162499|20631472|P1|NOT COMPLETED|Intervention 2 (4 Hours)||0
8369369|NCT01162499|20631471|P2|COMPLETED|Intervention 2 (4 Hours)||3
8369370|NCT01162499|20631472|P1|COMPLETED|Intervention 2 (4 Hours)||3
8369371|NCT01162499|20631471|P2|STARTED|Intervention 2 (4 Hours)||3
8369372|NCT01162499|20631472|P1|STARTED|Intervention 2 (4 Hours)||3
8369373|NCT01162499|20631471|P2|NOT COMPLETED|Intervention 1 (4 Hours)||1
8369374|NCT01162499|20631472|P1|NOT COMPLETED|Intervention 1 (4 Hours)||0
8369375|NCT01162499|20631471|P2|COMPLETED|Intervention 1 (4 Hours)||3
8369376|NCT01162499|20631472|P1|COMPLETED|Intervention 1 (4 Hours)||3
8369377|NCT01162499|20631471|P2|Received Intervention|Intervention 1 (4 Hours)||3
8369378|NCT01162499|20631472|P1|Received Intervention|Intervention 1 (4 Hours)||3
8369379|NCT01162499|20631471|P2|STARTED|Intervention 1 (4 Hours)||4
8369380|NCT01162499|20631472|P1|STARTED|Intervention 1 (4 Hours)||3
8369381|NCT01162486|20631497|P5|NOT COMPLETED|Overall Study||0
8369382|NCT01162486|20631498|P4|NOT COMPLETED|Overall Study||1
8369383|NCT01162486|20631499|P3|NOT COMPLETED|Overall Study||1
8369384|NCT01162486|20631500|P2|NOT COMPLETED|Overall Study||0
8369385|NCT01162486|20631501|P1|NOT COMPLETED|Overall Study||2
8369386|NCT01162486|20631497|P5|COMPLETED|Overall Study||6
8369387|NCT01162486|20631498|P4|COMPLETED|Overall Study||6
8369388|NCT01162486|20631499|P3|COMPLETED|Overall Study||5
8369389|NCT01162486|20631500|P2|COMPLETED|Overall Study||6
8369390|NCT01162486|20631501|P1|COMPLETED|Overall Study||6
8369391|NCT01162486|20631497|P5|Took at Least One Dose Study Drug|Overall Study||6
8369392|NCT01162486|20631498|P4|Took at Least One Dose Study Drug|Overall Study||7
8369393|NCT01162486|20631499|P3|Took at Least One Dose Study Drug|Overall Study||6
8369394|NCT01162486|20631500|P2|Took at Least One Dose Study Drug|Overall Study||6
8369395|NCT01162486|20631501|P1|Took at Least One Dose Study Drug|Overall Study||8
8369396|NCT01162486|20631497|P5|STARTED|Overall Study||6
8369397|NCT01162486|20631498|P4|STARTED|Overall Study||7
8369398|NCT01162486|20631499|P3|STARTED|Overall Study||6
8369399|NCT01162486|20631500|P2|STARTED|Overall Study||6
8369400|NCT01162486|20631501|P1|STARTED|Overall Study||8
8369401|NCT01162473|20631534|P2|NOT COMPLETED|Overall Study||5
8369402|NCT01162473|20631535|P1|NOT COMPLETED|Overall Study||2
8369403|NCT01162473|20631534|P2|COMPLETED|Overall Study||12
8369404|NCT01162473|20631535|P1|COMPLETED|Overall Study||6
8369405|NCT01162473|20631534|P2|STARTED|Overall Study||17
8369406|NCT01162473|20631535|P1|STARTED|Overall Study||8
8369407|NCT01162421|20631543|P2|NOT COMPLETED|Overall Study||13
8369408|NCT01162421|20631544|P1|NOT COMPLETED|Overall Study||8
8369409|NCT01162421|20631543|P2|COMPLETED|Overall Study||27
8369410|NCT01162421|20631544|P1|COMPLETED|Overall Study||29
8369411|NCT01162421|20631543|P2|STARTED|Overall Study||40
8369412|NCT01162421|20631544|P1|STARTED|Overall Study||37
8369413|NCT01162382|20631622|P1|NOT COMPLETED|Overall Study||0
8369414|NCT01162382|20631622|P1|COMPLETED|Overall Study||0
8369415|NCT01162382|20631622|P1|STARTED|Overall Study||0
8369416|NCT01162343|20631627|P1|NOT COMPLETED|Overall Study||92
8369417|NCT01162343|20631627|P1|COMPLETED|Overall Study||406
8369418|NCT01162343|20631627|P1|STARTED|Overall Study||498
8369419|NCT01162317|20631633|P2|NOT COMPLETED|Overall Study||2
8369420|NCT01162317|20631634|P1|NOT COMPLETED|Overall Study||3
8369421|NCT01162317|20631633|P2|COMPLETED|Overall Study||28
8369422|NCT01162317|20631634|P1|COMPLETED|Overall Study||27
8369423|NCT01162317|20631633|P2|STARTED|Overall Study||30
8369424|NCT01162317|20631634|P1|STARTED|Overall Study||30
8369425|NCT01162304|20631642|P1|NOT COMPLETED|Overall Study||11
8369426|NCT01162304|20631642|P1|COMPLETED|Overall Study||7
8369427|NCT01162304|20631642|P1|STARTED|Overall Study||18
8369428|NCT01162239|20631660|P4|NOT COMPLETED|Extended Follow-up||6
8369429|NCT01162239|20631661|P3|NOT COMPLETED|Extended Follow-up||8
8369430|NCT01162239|20631662|P2|NOT COMPLETED|Extended Follow-up||13
8369431|NCT01162239|20631663|P1|NOT COMPLETED|Extended Follow-up||8
8369432|NCT01162239|20631660|P4|COMPLETED|Extended Follow-up||41
8369433|NCT01162239|20631661|P3|COMPLETED|Extended Follow-up||37
8369434|NCT01162239|20631662|P2|COMPLETED|Extended Follow-up||32
8369435|NCT01162239|20631663|P1|COMPLETED|Extended Follow-up||39
8369436|NCT01162239|20631660|P4|STARTED|Extended Follow-up||47
8369437|NCT01162239|20631661|P3|STARTED|Extended Follow-up||45
8369438|NCT01162239|20631662|P2|STARTED|Extended Follow-up||45
8369439|NCT01162239|20631663|P1|STARTED|Extended Follow-up||47
8369440|NCT01162239|20631660|P4|NOT COMPLETED|Treatment Phase||5
8369441|NCT01162239|20631661|P3|NOT COMPLETED|Treatment Phase||4
8369442|NCT01162239|20631662|P2|NOT COMPLETED|Treatment Phase||7
8369443|NCT01162239|20631663|P1|NOT COMPLETED|Treatment Phase||6
8369444|NCT01162239|20631660|P4|COMPLETED|Treatment Phase||50
8369445|NCT01162239|20631661|P3|COMPLETED|Treatment Phase||48
8369446|NCT01162239|20631662|P2|COMPLETED|Treatment Phase||47
8369447|NCT01162239|20631663|P1|COMPLETED|Treatment Phase||49
8369448|NCT01162239|20631660|P4|Week 52|Treatment Phase||50
8369449|NCT01162239|20631661|P3|Week 52|Treatment Phase||48
8369450|NCT01162239|20631662|P2|Week 52|Treatment Phase||47
8369451|NCT01162239|20631663|P1|Week 52|Treatment Phase||49
8369452|NCT01162239|20631660|P4|Week 24|Treatment Phase||50
8369453|NCT01162239|20631661|P3|Week 24|Treatment Phase||48
8369454|NCT01162239|20631662|P2|Week 24|Treatment Phase||48
8369455|NCT01162239|20631663|P1|Week 24|Treatment Phase||51
8369456|NCT01162239|20631660|P4|Week 12|Treatment Phase||53
8369457|NCT01162239|20631661|P3|Week 12|Treatment Phase||49
8369458|NCT01162239|20631662|P2|Week 12|Treatment Phase||51
8369459|NCT01162239|20631663|P1|Week 12|Treatment Phase||50
8369460|NCT01162239|20631660|P4|STARTED|Treatment Phase||55
8369461|NCT01162239|20631661|P3|STARTED|Treatment Phase||52
8369462|NCT01162239|20631662|P2|STARTED|Treatment Phase||54
8369463|NCT01162239|20631663|P1|STARTED|Treatment Phase||55
8369464|NCT01162135|20631693|P1|NOT COMPLETED|Overall Study||3
8369465|NCT01162135|20631693|P1|COMPLETED|Overall Study||13
8369466|NCT01162135|20631693|P1|STARTED|Overall Study||16
8369467|NCT01162122|20631699|P2|NOT COMPLETED|Overall Study||196
8369468|NCT01162122|20631700|P1|NOT COMPLETED|Overall Study||191
8369469|NCT01162122|20631699|P2|COMPLETED|Overall Study||3356
8369470|NCT01162122|20631700|P1|COMPLETED|Overall Study||3361
8369471|NCT01162122|20631699|P2|Vaccinated|Overall Study||3541
8369472|NCT01162122|20631700|P1|Vaccinated|Overall Study||3541
8369473|NCT01162122|20631699|P2|STARTED|Overall Study||3552
8369474|NCT01162122|20631700|P1|STARTED|Overall Study||3552
8369475|NCT01162096|20631757|P1|NOT COMPLETED|Overall Study||0
8369476|NCT01162096|20631757|P1|COMPLETED|Overall Study||34
8369477|NCT01162096|20631757|P1|STARTED|Overall Study||34
8369478|NCT01162005|20631765|P2|NOT COMPLETED|Overall Study||0
8369479|NCT01162005|20631766|P1|NOT COMPLETED|Overall Study||0
8369480|NCT01162005|20631765|P2|COMPLETED|Overall Study||33
8369481|NCT01162005|20631766|P1|COMPLETED|Overall Study||44
8369482|NCT01162005|20631765|P2|STARTED|Overall Study||33
8369483|NCT01162005|20631766|P1|STARTED|Overall Study||44
8369484|NCT01161862|20631776|P2|NOT COMPLETED|Overall Study||0
8369485|NCT01161862|20631777|P1|NOT COMPLETED|Overall Study||0
8369486|NCT01161862|20631776|P2|COMPLETED|Overall Study||12
8369487|NCT01161862|20631777|P1|COMPLETED|Overall Study||12
8369488|NCT01161862|20631776|P2|STARTED|Overall Study||12
8369489|NCT01161862|20631777|P1|STARTED|Overall Study||12
8369490|NCT01161771|20631797|P1|NOT COMPLETED|Overall Study||0
8369491|NCT01161771|20631797|P1|COMPLETED|Overall Study||32
8369492|NCT01161771|20631797|P1|STARTED|Overall Study||32
8369493|NCT01161628|20631806|P1|NOT COMPLETED|Overall Study||8
8369494|NCT01161628|20631806|P1|COMPLETED|Overall Study||17
8369495|NCT01161628|20631806|P1|STARTED|Overall Study||25
8369496|NCT01161563|20631820|P2|NOT COMPLETED|Overall Study||6
8369497|NCT01161563|20631821|P1|NOT COMPLETED|Overall Study||5
8369498|NCT01161563|20631820|P2|COMPLETED|Overall Study||49
8369499|NCT01161563|20631821|P1|COMPLETED|Overall Study||58
8369500|NCT01161563|20631820|P2|STARTED|Overall Study||55
8369501|NCT01161563|20631821|P1|STARTED|Overall Study||63
8369502|NCT01161537|20631829|P1|NOT COMPLETED|Part B||2
8369503|NCT01161537|20631829|P1|COMPLETED|Part B||7
8369504|NCT01161537|20631829|P1|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
8369505|NCT01161537|20631829|P1|NOT COMPLETED|Part A||0
8369506|NCT01161537|20631829|P1|COMPLETED|Part A||8
8369507|NCT01161537|20631829|P1|STARTED|Part A||8
8369508|NCT01161524|20631847|P3|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24
8369509|NCT01161524|20631848|P2|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
8369510|NCT01161524|20631849|P1|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
8369511|NCT01161524|20631847|P3|COMPLETED|Extension Phase (Approximately 83 Weeks)||90
8369512|NCT01161524|20631848|P2|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
8369513|NCT01161524|20631849|P1|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
8369514|NCT01161524|20631847|P3|STARTED|Extension Phase (Approximately 83 Weeks)||114
8369515|NCT01161524|20631848|P2|STARTED|Extension Phase (Approximately 83 Weeks)||0
8369516|NCT01161524|20631849|P1|STARTED|Extension Phase (Approximately 83 Weeks)||0
8369517|NCT01161524|20631847|P3|NOT COMPLETED|Core Study (23 Weeks)||0
8369518|NCT01161524|20631848|P2|NOT COMPLETED|Core Study (23 Weeks)||5
8369519|NCT01161524|20631849|P1|NOT COMPLETED|Core Study (23 Weeks)||9
8369520|NCT01161524|20631847|P3|COMPLETED|Core Study (23 Weeks)||0
8369521|NCT01161524|20631848|P2|COMPLETED|Core Study (23 Weeks)||43
8369522|NCT01161524|20631849|P1|COMPLETED|Core Study (23 Weeks)||76
8369523|NCT01161524|20631847|P3|STARTED|Core Study (23 Weeks)||0
8369524|NCT01161524|20631848|P2|STARTED|Core Study (23 Weeks)||48
8369525|NCT01161524|20631849|P1|STARTED|Core Study (23 Weeks)||85
8369526|NCT01161498|20631888|P2|NOT COMPLETED|Overall Study||1
8369527|NCT01161498|20631889|P1|NOT COMPLETED|Overall Study||0
8369528|NCT01161498|20631888|P2|COMPLETED|Overall Study||1
8369529|NCT01161498|20631889|P1|COMPLETED|Overall Study||3
8369530|NCT01161498|20631888|P2|STARTED|Overall Study||2
8369531|NCT01161498|20631889|P1|STARTED|Overall Study||3
8369532|NCT01161472|20631913|P4|NOT COMPLETED|Fourth Intervention Period||0
8369533|NCT01161472|20631914|P3|NOT COMPLETED|Fourth Intervention Period||0
8369534|NCT01161472|20631915|P2|NOT COMPLETED|Fourth Intervention Period||0
8369535|NCT01161472|20631916|P1|NOT COMPLETED|Fourth Intervention Period||0
8369536|NCT01161472|20631913|P4|COMPLETED|Fourth Intervention Period||5
8369537|NCT01161472|20631914|P3|COMPLETED|Fourth Intervention Period||5
8369538|NCT01161472|20631915|P2|COMPLETED|Fourth Intervention Period||5
8369539|NCT01161472|20631916|P1|COMPLETED|Fourth Intervention Period||4
8369540|NCT01161472|20631913|P4|STARTED|Fourth Intervention Period||5
8369541|NCT01161472|20631914|P3|STARTED|Fourth Intervention Period||5
8369542|NCT01161472|20631915|P2|STARTED|Fourth Intervention Period||5
8369543|NCT01161472|20631916|P1|STARTED|Fourth Intervention Period||4
8369544|NCT01161472|20631913|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369545|NCT01161472|20631914|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369546|NCT01161472|20631915|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369547|NCT01161472|20631916|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369548|NCT01161472|20631913|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369549|NCT01161472|20631914|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369550|NCT01161472|20631915|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369551|NCT01161472|20631916|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
8369552|NCT01161472|20631913|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369553|NCT01161472|20631914|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369554|NCT01161472|20631915|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369555|NCT01161472|20631916|P1|STARTED|Washout Period (At Least 3 to 6 Days)||4
8369556|NCT01161472|20631913|P4|NOT COMPLETED|Third Intervention Period||0
8369557|NCT01161472|20631914|P3|NOT COMPLETED|Third Intervention Period||0
8369558|NCT01161472|20631915|P2|NOT COMPLETED|Third Intervention Period||0
8369559|NCT01161472|20631916|P1|NOT COMPLETED|Third Intervention Period||0
8369560|NCT01161472|20631913|P4|COMPLETED|Third Intervention Period||5
8369561|NCT01161472|20631914|P3|COMPLETED|Third Intervention Period||5
8369562|NCT01161472|20631915|P2|COMPLETED|Third Intervention Period||5
8369563|NCT01161472|20631916|P1|COMPLETED|Third Intervention Period||4
8369564|NCT01161472|20631913|P4|STARTED|Third Intervention Period||5
8369565|NCT01161472|20631914|P3|STARTED|Third Intervention Period||5
8369566|NCT01161472|20631915|P2|STARTED|Third Intervention Period||5
8369567|NCT01161472|20631916|P1|STARTED|Third Intervention Period||4
8369568|NCT01161472|20631913|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369569|NCT01161472|20631914|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369570|NCT01161472|20631915|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369571|NCT01161472|20631916|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
8369572|NCT01161472|20631913|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369573|NCT01161472|20631914|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369574|NCT01161472|20631915|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369575|NCT01161472|20631916|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
8369576|NCT01161472|20631913|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369577|NCT01161472|20631914|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369578|NCT01161472|20631915|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369579|NCT01161472|20631916|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369580|NCT01161472|20631913|P4|NOT COMPLETED|Second Intervention Period||0
8369581|NCT01161472|20631914|P3|NOT COMPLETED|Second Intervention Period||0
8369582|NCT01161472|20631915|P2|NOT COMPLETED|Second Intervention Period||0
8369583|NCT01161472|20631916|P1|NOT COMPLETED|Second Intervention Period||0
8369584|NCT01161472|20631913|P4|COMPLETED|Second Intervention Period||5
8369585|NCT01161472|20631914|P3|COMPLETED|Second Intervention Period||5
8369586|NCT01161472|20631915|P2|COMPLETED|Second Intervention Period||5
8369587|NCT01161472|20631916|P1|COMPLETED|Second Intervention Period||5
8369588|NCT01161472|20631913|P4|STARTED|Second Intervention Period||5
8369589|NCT01161472|20631914|P3|STARTED|Second Intervention Period||5
8369590|NCT01161472|20631915|P2|STARTED|Second Intervention Period||5
8369591|NCT01161472|20631916|P1|STARTED|Second Intervention Period||5
8369592|NCT01161472|20631913|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369593|NCT01161472|20631914|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369594|NCT01161472|20631915|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369595|NCT01161472|20631916|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
8369596|NCT01161472|20631913|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369597|NCT01161472|20631914|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369598|NCT01161472|20631915|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369599|NCT01161472|20631916|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
8369600|NCT01161472|20631913|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369601|NCT01161472|20631914|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369602|NCT01161472|20631915|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369603|NCT01161472|20631916|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
8369604|NCT01161472|20631913|P4|NOT COMPLETED|First Intervention Period||0
8369605|NCT01161472|20631914|P3|NOT COMPLETED|First Intervention Period||0
8369606|NCT01161472|20631915|P2|NOT COMPLETED|First Intervention Period||0
8369607|NCT01161472|20631916|P1|NOT COMPLETED|First Intervention Period||0
8369608|NCT01161472|20631913|P4|COMPLETED|First Intervention Period||5
8369609|NCT01161472|20631914|P3|COMPLETED|First Intervention Period||5
8369610|NCT01161472|20631915|P2|COMPLETED|First Intervention Period||5
8369611|NCT01161472|20631916|P1|COMPLETED|First Intervention Period||5
8369612|NCT01161472|20631913|P4|Treated|First Intervention Period||5
8369613|NCT01161472|20631914|P3|Treated|First Intervention Period||5
8369614|NCT01161472|20631915|P2|Treated|First Intervention Period||5
8369615|NCT01161472|20631916|P1|Treated|First Intervention Period||5
8369616|NCT01161472|20631913|P4|STARTED|First Intervention Period||5
8369617|NCT01161472|20631914|P3|STARTED|First Intervention Period||5
8369618|NCT01161472|20631915|P2|STARTED|First Intervention Period||5
8369619|NCT01161472|20631916|P1|STARTED|First Intervention Period||5
8369620|NCT01161446|20631972|P2|NOT COMPLETED|Overall Study||15
8369621|NCT01161446|20631973|P1|NOT COMPLETED|Overall Study||18
8369622|NCT01161446|20631972|P2|COMPLETED|Overall Study||99
8369623|NCT01161446|20631973|P1|COMPLETED|Overall Study||98
8369624|NCT01161446|20631972|P2|STARTED|Overall Study||114
8369625|NCT01161446|20631973|P1|STARTED|Overall Study||116
8369626|NCT01161420|20631985|P1|NOT COMPLETED|Withdrawal Study - Withdrawal||0
8369627|NCT01161420|20631985|P1|COMPLETED|Withdrawal Study - Withdrawal||23
8369628|NCT01161420|20631985|P1|STARTED|Withdrawal Study - Withdrawal||23
8369629|NCT01161420|20631985|P1|NOT COMPLETED|Withdrawal Study - Maintenance||0
8369630|NCT01161420|20631985|P1|COMPLETED|Withdrawal Study - Maintenance||23
8369631|NCT01161420|20631985|P1|STARTED|Withdrawal Study - Maintenance||23
8369632|NCT01161420|20631985|P1|NOT COMPLETED|Inspire Therapy||2
8369633|NCT01161420|20631985|P1|COMPLETED|Inspire Therapy||124
8369634|NCT01161420|20631985|P1|STARTED|Inspire Therapy||126
8369635|NCT01161407|20631999|P2|NOT COMPLETED|Overall Study||1
8369636|NCT01161407|20632000|P1|NOT COMPLETED|Overall Study||3
8369637|NCT01161407|20631999|P2|COMPLETED|Overall Study||5
8369638|NCT01161407|20632000|P1|COMPLETED|Overall Study||3
8369639|NCT01161407|20631999|P2|STARTED|Overall Study||6
8369640|NCT01161407|20632000|P1|STARTED|Overall Study||6
8369641|NCT01161329|20632012|P2|NOT COMPLETED|Overall Study||10
8369642|NCT01161329|20632013|P1|NOT COMPLETED|Overall Study||4
8369643|NCT01161329|20632012|P2|COMPLETED|Overall Study||24
8369644|NCT01161329|20632013|P1|COMPLETED|Overall Study||29
8369645|NCT01161329|20632012|P2|STARTED|Overall Study||34
8369646|NCT01161329|20632013|P1|STARTED|Overall Study||33
8369647|NCT01161225|20632024|P3|NOT COMPLETED|Overall Study||2
8369648|NCT01161225|20632025|P2|NOT COMPLETED|Overall Study||9
8369649|NCT01161225|20632026|P1|NOT COMPLETED|Overall Study||14
8369650|NCT01161225|20632024|P3|COMPLETED|Overall Study||12
8369651|NCT01161225|20632025|P2|COMPLETED|Overall Study||44
8369652|NCT01161225|20632026|P1|COMPLETED|Overall Study||45
8369653|NCT01161225|20632024|P3|STARTED|Overall Study||14
8369654|NCT01161225|20632025|P2|STARTED|Overall Study||53
8369655|NCT01161225|20632026|P1|STARTED|Overall Study||59
8369656|NCT01161173|20632055|P1|NOT COMPLETED|Overall Study||347
8369657|NCT01161173|20632055|P1|COMPLETED|Overall Study||0
8369658|NCT01161173|20632055|P1|STARTED|Overall Study||347
8369659|NCT01161160|20632067|P3|NOT COMPLETED|Overall Study||0
8369660|NCT01161160|20632068|P2|NOT COMPLETED|Overall Study||0
8369661|NCT01161160|20632069|P1|NOT COMPLETED|Overall Study||0
8369662|NCT01161160|20632067|P3|COMPLETED|Overall Study||58
8369663|NCT01161160|20632068|P2|COMPLETED|Overall Study||75
8369664|NCT01161160|20632069|P1|COMPLETED|Overall Study||76
8369665|NCT01161160|20632067|P3|STARTED|Overall Study||58
8369666|NCT01161160|20632068|P2|STARTED|Overall Study||75
8369667|NCT01161160|20632069|P1|STARTED|Overall Study||76
8369668|NCT01161121|20632140|P1|NOT COMPLETED|Overall Study||0
8369669|NCT01161121|20632140|P1|COMPLETED|Overall Study||46
8369670|NCT01161121|20632140|P1|STARTED|Overall Study||46
8369671|NCT01161043|20632150|P1|NOT COMPLETED|Overall Study||3
8369672|NCT01161043|20632150|P1|COMPLETED|Overall Study||80
8369673|NCT01161043|20632150|P1|STARTED|Overall Study||83
8369674|NCT01160848|20632157|P2|NOT COMPLETED|Overall Study||0
8369675|NCT01160848|20632158|P1|NOT COMPLETED|Overall Study||0
8369676|NCT01160848|20632157|P2|COMPLETED|Overall Study||8
8369677|NCT01160848|20632158|P1|COMPLETED|Overall Study||12
8369678|NCT01160848|20632157|P2|STARTED|Overall Study||8
8369679|NCT01160848|20632158|P1|STARTED|Overall Study||12
8369680|NCT01160822|20632187|P7|NOT COMPLETED|Overall Study||9
8369681|NCT01160822|20632188|P6|NOT COMPLETED|Overall Study||7
8369682|NCT01160822|20632189|P5|NOT COMPLETED|Overall Study||9
8369683|NCT01160822|20632190|P4|NOT COMPLETED|Overall Study||0
8369684|NCT01160822|20632191|P3|NOT COMPLETED|Overall Study||0
8369685|NCT01160822|20632192|P2|NOT COMPLETED|Overall Study||0
8369686|NCT01160822|20632193|P1|NOT COMPLETED|Overall Study||0
8369687|NCT01160822|20632187|P7|COMPLETED|Overall Study||44
8369688|NCT01160822|20632188|P6|COMPLETED|Overall Study||40
8369689|NCT01160822|20632189|P5|COMPLETED|Overall Study||36
8369690|NCT01160822|20632190|P4|COMPLETED|Overall Study||5
8369691|NCT01160822|20632191|P3|COMPLETED|Overall Study||6
8369692|NCT01160822|20632192|P2|COMPLETED|Overall Study||7
8369693|NCT01160822|20632193|P1|COMPLETED|Overall Study||6
8369694|NCT01160822|20632187|P7|STARTED|Overall Study||53
8369695|NCT01160822|20632188|P6|STARTED|Overall Study||47
8369696|NCT01160822|20632189|P5|STARTED|Overall Study||45
8369697|NCT01160822|20632190|P4|STARTED|Overall Study||5
8369698|NCT01160822|20632191|P3|STARTED|Overall Study||6
8369699|NCT01160822|20632192|P2|STARTED|Overall Study||7
8369700|NCT01160822|20632193|P1|STARTED|Overall Study||6
8369701|NCT01160770|20632282|P1|NOT COMPLETED|Overall Study||79
8369702|NCT01160770|20632282|P1|COMPLETED|Overall Study||188
8369703|NCT01160770|20632282|P1|STARTED|Overall Study||267
8369704|NCT01160744|20632295|P4|NOT COMPLETED|Overall Study||4
8369705|NCT01160744|20632296|P3|NOT COMPLETED|Overall Study||7
8369706|NCT01160744|20632297|P2|NOT COMPLETED|Overall Study||5
8369707|NCT01160744|20632298|P1|NOT COMPLETED|Overall Study||11
8369708|NCT01160744|20632295|P4|COMPLETED|Overall Study||67
8369709|NCT01160744|20632296|P3|COMPLETED|Overall Study||62
8369710|NCT01160744|20632297|P2|COMPLETED|Overall Study||64
8369711|NCT01160744|20632298|P1|COMPLETED|Overall Study||60
8369712|NCT01160744|20632295|P4|Received Study Drug|Overall Study||71
8369713|NCT01160744|20632296|P3|Received Study Drug|Overall Study||63
8369714|NCT01160744|20632297|P2|Received Study Drug|Overall Study||67
8369715|NCT01160744|20632298|P1|Received Study Drug|Overall Study||69
8369716|NCT01160744|20632295|P4|STARTED|Overall Study||71
8369717|NCT01160744|20632296|P3|STARTED|Overall Study||69
8369718|NCT01160744|20632297|P2|STARTED|Overall Study||69
8369719|NCT01160744|20632298|P1|STARTED|Overall Study||71
8369720|NCT01160640|20632334|P2|NOT COMPLETED|Overall Study||6
8369721|NCT01160640|20632335|P1|NOT COMPLETED|Overall Study||4
8369722|NCT01160640|20632334|P2|COMPLETED|Overall Study||110
8369723|NCT01160640|20632335|P1|COMPLETED|Overall Study||113
8369724|NCT01160640|20632334|P2|STARTED|Overall Study||116
8369725|NCT01160640|20632335|P1|STARTED|Overall Study||117
8369726|NCT01160614|20632351|P2|NOT COMPLETED|Overall Study||2
8369727|NCT01160614|20632352|P1|NOT COMPLETED|Overall Study||0
8369728|NCT01160614|20632351|P2|COMPLETED|Overall Study||23
8369729|NCT01160614|20632352|P1|COMPLETED|Overall Study||5
8369730|NCT01160614|20632351|P2|STARTED|Overall Study||25
8369731|NCT01160614|20632352|P1|STARTED|Overall Study||5
8369732|NCT01160484|20632400|P1|NOT COMPLETED|Overall Study||18
8369733|NCT01160484|20632400|P1|COMPLETED|Overall Study||22
8369734|NCT01160484|20632400|P1|STARTED|Overall Study||40
8369735|NCT01160458|20632410|P1|NOT COMPLETED|Overall Study||0
8369736|NCT01160458|20632410|P1|COMPLETED|Overall Study||20
8369737|NCT01160458|20632410|P1|STARTED|Overall Study||20
8369738|NCT01160445|20632420|P2|NOT COMPLETED|Overall Study||0
8369739|NCT01160445|20632421|P1|NOT COMPLETED|Overall Study||0
8369740|NCT01160445|20632420|P2|COMPLETED|Overall Study||2
8369741|NCT01160445|20632421|P1|COMPLETED|Overall Study||7
8369742|NCT01160445|20632420|P2|STARTED|Overall Study||2
8369743|NCT01160445|20632421|P1|STARTED|Overall Study||7
8369744|NCT01160380|20632431|P2|NOT COMPLETED|Overall Study||5
8369745|NCT01160380|20632432|P1|NOT COMPLETED|Overall Study||8
8369746|NCT01160380|20632431|P2|COMPLETED|Overall Study||20
8369747|NCT01160380|20632432|P1|COMPLETED|Overall Study||17
8369748|NCT01160380|20632431|P2|STARTED|Overall Study||25
8369749|NCT01160380|20632432|P1|STARTED|Overall Study||25
8369750|NCT01160354|20632453|P3|NOT COMPLETED|Overall Study||1
8369751|NCT01160354|20632454|P2|NOT COMPLETED|Overall Study||1
8369752|NCT01160354|20632455|P1|NOT COMPLETED|Overall Study||0
8369753|NCT01160354|20632453|P3|COMPLETED|Overall Study||14
8369754|NCT01160354|20632454|P2|COMPLETED|Overall Study||3
8369755|NCT01160354|20632455|P1|COMPLETED|Overall Study||3
8369756|NCT01160354|20632453|P3|STARTED|Overall Study||15
8369757|NCT01160354|20632454|P2|STARTED|Overall Study||4
8369758|NCT01160354|20632455|P1|STARTED|Overall Study||3
8369759|NCT01160289|20632474|P6|NOT COMPLETED|Post-Randomization Period||14
8369760|NCT01160289|20632475|P5|NOT COMPLETED|Post-Randomization Period||9
8369761|NCT01160289|20632476|P4|NOT COMPLETED|Post-Randomization Period||21
8369762|NCT01160289|20632477|P3|NOT COMPLETED|Post-Randomization Period||24
8369763|NCT01160289|20632478|P2|NOT COMPLETED|Post-Randomization Period||20
8369764|NCT01160289|20632479|P1|NOT COMPLETED|Post-Randomization Period||0
8369765|NCT01160289|20632474|P6|COMPLETED|Post-Randomization Period||73
8369766|NCT01160289|20632475|P5|COMPLETED|Post-Randomization Period||80
8369767|NCT01160289|20632476|P4|COMPLETED|Post-Randomization Period||31
8369768|NCT01160289|20632477|P3|COMPLETED|Post-Randomization Period||73
8369769|NCT01160289|20632478|P2|COMPLETED|Post-Randomization Period||65
8369770|NCT01160289|20632479|P1|COMPLETED|Post-Randomization Period||0
8369771|NCT01160289|20632474|P6|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87
8369772|NCT01160289|20632475|P5|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89
8369773|NCT01160289|20632476|P4|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52
8369774|NCT01160289|20632477|P3|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97
8369775|NCT01160289|20632478|P2|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85
8369776|NCT01160289|20632479|P1|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0
8369777|NCT01160289|20632474|P6|STARTED|Post-Randomization Period||87
8369778|NCT01160289|20632475|P5|STARTED|Post-Randomization Period||89
8369779|NCT01160289|20632476|P4|STARTED|Post-Randomization Period||52
8369780|NCT01160289|20632477|P3|STARTED|Post-Randomization Period||97
8369781|NCT01160289|20632478|P2|STARTED|Post-Randomization Period||85
8369782|NCT01160289|20632479|P1|STARTED|Post-Randomization Period||0
8369783|NCT01160289|20632474|P6|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8369784|NCT01160289|20632475|P5|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8369785|NCT01160289|20632476|P4|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8369786|NCT01160289|20632477|P3|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8369787|NCT01160289|20632478|P2|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
8369788|NCT01160289|20632479|P1|NOT COMPLETED|Screening, Washout, and Lead-In Period||484
8369789|NCT01160289|20632474|P6|COMPLETED|Screening, Washout, and Lead-In Period||0
8369790|NCT01160289|20632475|P5|COMPLETED|Screening, Washout, and Lead-In Period||0
8369791|NCT01160289|20632476|P4|COMPLETED|Screening, Washout, and Lead-In Period||0
8369792|NCT01160289|20632477|P3|COMPLETED|Screening, Washout, and Lead-In Period||0
8369793|NCT01160289|20632478|P2|COMPLETED|Screening, Washout, and Lead-In Period||0
8369794|NCT01160289|20632479|P1|COMPLETED|Screening, Washout, and Lead-In Period||410
8369795|NCT01160289|20632474|P6|STARTED|Screening, Washout, and Lead-In Period||0
8369796|NCT01160289|20632475|P5|STARTED|Screening, Washout, and Lead-In Period||0
8369797|NCT01160289|20632476|P4|STARTED|Screening, Washout, and Lead-In Period||0
8369798|NCT01160289|20632477|P3|STARTED|Screening, Washout, and Lead-In Period||0
8369799|NCT01160289|20632478|P2|STARTED|Screening, Washout, and Lead-In Period||0
8369800|NCT01160289|20632479|P1|STARTED|Screening, Washout, and Lead-In Period||894
8369801|NCT01160237|20632540|P3|NOT COMPLETED|Overall Study||0
8369802|NCT01160237|20632541|P2|NOT COMPLETED|Overall Study||0
8369803|NCT01160237|20632542|P1|NOT COMPLETED|Overall Study||0
8369804|NCT01160237|20632540|P3|COMPLETED|Overall Study||0
8369805|NCT01160237|20632541|P2|COMPLETED|Overall Study||3
8369806|NCT01160237|20632542|P1|COMPLETED|Overall Study||4
8369807|NCT01160237|20632540|P3|STARTED|Overall Study||0
8369808|NCT01160237|20632541|P2|STARTED|Overall Study||3
8369809|NCT01160237|20632542|P1|STARTED|Overall Study||4
8369822|NCT01160198|20632603|P3|NOT COMPLETED|Overall Study||1
8369823|NCT01160198|20632604|P2|NOT COMPLETED|Overall Study||3
8369824|NCT01160198|20632605|P1|NOT COMPLETED|Overall Study||2
8369825|NCT01160198|20632603|P3|COMPLETED|Overall Study||89
8369826|NCT01160198|20632604|P2|COMPLETED|Overall Study||88
8369827|NCT01160198|20632605|P1|COMPLETED|Overall Study||87
8369828|NCT01160198|20632603|P3|STARTED|Overall Study||90
8369829|NCT01160198|20632604|P2|STARTED|Overall Study||91
8369830|NCT01160198|20632605|P1|STARTED|Overall Study||89
8369831|NCT01159938|20632627|P5|NOT COMPLETED|Second Study Period||0
8369832|NCT01159938|20632628|P4|NOT COMPLETED|Second Study Period||0
8369833|NCT01159938|20632629|P3|NOT COMPLETED|Second Study Period||0
8369834|NCT01159938|20632630|P2|NOT COMPLETED|Second Study Period||0
8369835|NCT01159938|20632631|P1|NOT COMPLETED|Second Study Period||0
8369836|NCT01159938|20632627|P5|COMPLETED|Second Study Period||12
8369837|NCT01159938|20632628|P4|COMPLETED|Second Study Period||12
8369838|NCT01159938|20632629|P3|COMPLETED|Second Study Period||10
8369839|NCT01159938|20632630|P2|COMPLETED|Second Study Period||11
8369840|NCT01159938|20632631|P1|COMPLETED|Second Study Period||0
8369841|NCT01159938|20632627|P5|STARTED|Second Study Period||12
8369842|NCT01159938|20632628|P4|STARTED|Second Study Period||12
8369843|NCT01159938|20632629|P3|STARTED|Second Study Period||10
8369844|NCT01159938|20632630|P2|STARTED|Second Study Period||11
8369845|NCT01159938|20632631|P1|STARTED|Second Study Period||0
8369846|NCT01159938|20632627|P5|NOT COMPLETED|First Study Period||0
8369847|NCT01159938|20632628|P4|NOT COMPLETED|First Study Period||0
8369848|NCT01159938|20632629|P3|NOT COMPLETED|First Study Period||1
8369849|NCT01159938|20632630|P2|NOT COMPLETED|First Study Period||0
8369850|NCT01159938|20632631|P1|NOT COMPLETED|First Study Period||0
8369851|NCT01159938|20632627|P5|COMPLETED|First Study Period||12
8369852|NCT01159938|20632628|P4|COMPLETED|First Study Period||12
8369853|NCT01159938|20632629|P3|COMPLETED|First Study Period||10
8369854|NCT01159938|20632630|P2|COMPLETED|First Study Period||11
8369855|NCT01159938|20632631|P1|COMPLETED|First Study Period||26
8369856|NCT01159938|20632627|P5|Safety and Efficacy Analysis Population|First Study Period||12
8369857|NCT01159938|20632628|P4|Safety and Efficacy Analysis Population|First Study Period||12
8369858|NCT01159938|20632629|P3|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
8369859|NCT01159938|20632630|P2|Safety and Efficacy Analysis Population|First Study Period||11
8369860|NCT01159938|20632631|P1|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
8369861|NCT01159938|20632627|P5|Received at Least 1 Dose of Study Drug|First Study Period||12
8369862|NCT01159938|20632628|P4|Received at Least 1 Dose of Study Drug|First Study Period||12
8369863|NCT01159938|20632629|P3|Received at Least 1 Dose of Study Drug|First Study Period||11
8369864|NCT01159938|20632630|P2|Received at Least 1 Dose of Study Drug|First Study Period||11
8369865|NCT01159938|20632631|P1|Received at Least 1 Dose of Study Drug|First Study Period||0
8369866|NCT01159938|20632627|P5|STARTED|First Study Period||12
8369867|NCT01159938|20632628|P4|STARTED|First Study Period||12
8369868|NCT01159938|20632629|P3|STARTED|First Study Period||11
8369869|NCT01159938|20632630|P2|STARTED|First Study Period||11
8369870|NCT01159938|20632631|P1|STARTED|First Study Period||26
8369871|NCT01159912|20632694|P3|NOT COMPLETED|Overall Study||26
8369872|NCT01159912|20632695|P2|NOT COMPLETED|Overall Study||22
8369873|NCT01159912|20632696|P1|NOT COMPLETED|Overall Study||40
8369874|NCT01159912|20632694|P3|COMPLETED|Overall Study||88
8369875|NCT01159912|20632695|P2|COMPLETED|Overall Study||92
8369876|NCT01159912|20632696|P1|COMPLETED|Overall Study||75
8369877|NCT01159912|20632694|P3|STARTED|Overall Study||114
8369878|NCT01159912|20632695|P2|STARTED|Overall Study||114
8369879|NCT01159912|20632696|P1|STARTED|Overall Study||115
8369880|NCT01159769|20632719|P1|NOT COMPLETED|Overall Study||1
8369881|NCT01159769|20632719|P1|COMPLETED|Overall Study||214
8369882|NCT01159769|20632719|P1|STARTED|Overall Study||215
8369883|NCT01159743|20632726|P2|NOT COMPLETED|Overall Study||0
8369884|NCT01159743|20632727|P1|NOT COMPLETED|Overall Study||0
8369885|NCT01159743|20632726|P2|COMPLETED|Overall Study||109
8369886|NCT01159743|20632727|P1|COMPLETED|Overall Study||237
8369887|NCT01159743|20632726|P2|STARTED|Overall Study||109
8369888|NCT01159743|20632727|P1|STARTED|Overall Study||237
8369889|NCT01159691|20632739|P1|NOT COMPLETED|Overall Study||22
8369890|NCT01159691|20632739|P1|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
8369891|NCT01159691|20632739|P1|STARTED|Overall Study||76
8369892|NCT01159665|20632752|P6|NOT COMPLETED|Overall Study||0
8369893|NCT01159665|20632753|P5|NOT COMPLETED|Overall Study||0
8369894|NCT01159665|20632754|P4|NOT COMPLETED|Overall Study||0
8369895|NCT01159665|20632755|P3|NOT COMPLETED|Overall Study||0
8369896|NCT01159665|20632756|P2|NOT COMPLETED|Overall Study||1
8369897|NCT01159665|20632757|P1|NOT COMPLETED|Overall Study||0
8369898|NCT01159665|20632752|P6|COMPLETED|Overall Study||4
8369899|NCT01159665|20632753|P5|COMPLETED|Overall Study||4
8369900|NCT01159665|20632754|P4|COMPLETED|Overall Study||4
8369901|NCT01159665|20632755|P3|COMPLETED|Overall Study||8
8369902|NCT01159665|20632756|P2|COMPLETED|Overall Study||8
8369903|NCT01159665|20632757|P1|COMPLETED|Overall Study||9
8369904|NCT01159665|20632752|P6|STARTED|Overall Study||4
8369905|NCT01159665|20632753|P5|STARTED|Overall Study||4
8369906|NCT01159665|20632754|P4|STARTED|Overall Study||4
8369907|NCT01159665|20632755|P3|STARTED|Overall Study||8
8369908|NCT01159665|20632756|P2|STARTED|Overall Study||9
8369909|NCT01159665|20632757|P1|STARTED|Overall Study||9
8369910|NCT01159600|20632785|P8|NOT COMPLETED|Overall Study||18
8369911|NCT01159600|20632786|P7|NOT COMPLETED|Overall Study||19
8369912|NCT01159600|20632787|P6|NOT COMPLETED|Overall Study||18
8369913|NCT01159600|20632788|P5|NOT COMPLETED|Overall Study||24
8369914|NCT01159600|20632789|P4|NOT COMPLETED|Overall Study||11
8369915|NCT01159600|20632790|P3|NOT COMPLETED|Overall Study||18
8369916|NCT01159600|20632791|P2|NOT COMPLETED|Overall Study||8
8369917|NCT01159600|20632792|P1|NOT COMPLETED|Overall Study||21
8369918|NCT01159600|20632785|P8|COMPLETED|Overall Study||85
8369919|NCT01159600|20632786|P7|COMPLETED|Overall Study||199
8369920|NCT01159600|20632787|P6|COMPLETED|Overall Study||208
8369921|NCT01159600|20632788|P5|COMPLETED|Overall Study||201
8369922|NCT01159600|20632789|P4|COMPLETED|Overall Study||58
8369923|NCT01159600|20632790|P3|COMPLETED|Overall Study||196
8369924|NCT01159600|20632791|P2|COMPLETED|Overall Study||209
8369925|NCT01159600|20632792|P1|COMPLETED|Overall Study||186
8369926|NCT01159600|20632785|P8|STARTED|Overall Study||103
8369927|NCT01159600|20632786|P7|STARTED|Overall Study||218
8369928|NCT01159600|20632787|P6|STARTED|Overall Study||226
8369929|NCT01159600|20632788|P5|STARTED|Overall Study||225
8369930|NCT01159600|20632789|P4|STARTED|Overall Study||69
8369931|NCT01159600|20632790|P3|STARTED|Overall Study||214
8369932|NCT01159600|20632791|P2|STARTED|Overall Study||217
8369933|NCT01159600|20632792|P1|STARTED|Overall Study||207
8369934|NCT01159574|20632834|P1|NOT COMPLETED|Follow Up Phase||20
8369935|NCT01159574|20632834|P1|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
8369936|NCT01159574|20632834|P1|STARTED|Follow Up Phase||112
8369937|NCT01159574|20632834|P1|NOT COMPLETED|Treatment Phase||21
8369938|NCT01159574|20632834|P1|COMPLETED|Treatment Phase||100
8369939|NCT01159574|20632834|P1|STARTED|Treatment Phase||121
8369940|NCT01159535|20632843|P3|NOT COMPLETED|Overall Study||31
8369941|NCT01159535|20632844|P2|NOT COMPLETED|Overall Study||24
8369942|NCT01159535|20632845|P1|NOT COMPLETED|Overall Study||24
8369943|NCT01159535|20632843|P3|COMPLETED|Overall Study||64
8369944|NCT01159535|20632844|P2|COMPLETED|Overall Study||64
8369945|NCT01159535|20632845|P1|COMPLETED|Overall Study||79
8369946|NCT01159535|20632843|P3|STARTED|Overall Study||95
8369947|NCT01159535|20632844|P2|STARTED|Overall Study||88
8369948|NCT01159535|20632845|P1|STARTED|Overall Study||103
8369949|NCT01159431|20632855|P2|NOT COMPLETED|Overall Study||6
8369950|NCT01159431|20632856|P1|NOT COMPLETED|Overall Study||2
8369951|NCT01159431|20632855|P2|COMPLETED|Overall Study||19
8369952|NCT01159431|20632856|P1|COMPLETED|Overall Study||23
8369953|NCT01159431|20632855|P2|STARTED|Overall Study||25
8369954|NCT01159431|20632856|P1|STARTED|Overall Study||25
8369955|NCT01159262|20632875|P3|NOT COMPLETED|Overall Study||0
8369956|NCT01159262|20632876|P2|NOT COMPLETED|Overall Study||0
8369957|NCT01159262|20632877|P1|NOT COMPLETED|Overall Study||0
8369958|NCT01159262|20632875|P3|COMPLETED|Overall Study||8
8369959|NCT01159262|20632876|P2|COMPLETED|Overall Study||14
8369960|NCT01159262|20632877|P1|COMPLETED|Overall Study||14
8369961|NCT01159262|20632875|P3|STARTED|Overall Study||8
8369962|NCT01159262|20632876|P2|STARTED|Overall Study||14
8369963|NCT01159262|20632877|P1|STARTED|Overall Study||14
8369964|NCT01159171|20632909|P1|NOT COMPLETED|Overall Study||50
8369965|NCT01159171|20632909|P1|COMPLETED|Overall Study||0
8369966|NCT01159171|20632909|P1|STARTED|Overall Study||50
8369967|NCT01159067|20632924|P1|NOT COMPLETED|Overall Study||0
8369968|NCT01159067|20632924|P1|COMPLETED|Overall Study||1
8369969|NCT01159067|20632924|P1|STARTED|Overall Study||1
8369970|NCT01159054|20632931|P1|NOT COMPLETED|Overall Study||20
8369971|NCT01159054|20632931|P1|COMPLETED|Overall Study||2
8369972|NCT01159054|20632931|P1|STARTED|Overall Study||22
8369973|NCT01159015|20632945|P2|NOT COMPLETED|Overall Study||7
8369974|NCT01159015|20632946|P1|NOT COMPLETED|Overall Study||18
8369975|NCT01159015|20632945|P2|COMPLETED|Overall Study||170
8369976|NCT01159015|20632946|P1|COMPLETED|Overall Study||339
8369977|NCT01159015|20632945|P2|STARTED|Overall Study||177
8369978|NCT01159015|20632946|P1|STARTED|Overall Study||357
8369979|NCT01158976|20632954|P2|NOT COMPLETED|Overall Study||4
8369980|NCT01158976|20632955|P1|NOT COMPLETED|Overall Study||9
8369981|NCT01158976|20632954|P2|COMPLETED|Overall Study||17
8369982|NCT01158976|20632955|P1|COMPLETED|Overall Study||34
8369983|NCT01158976|20632954|P2|STARTED|Overall Study||21
8369984|NCT01158976|20632955|P1|STARTED|Overall Study||43
8369985|NCT01158950|20632997|P2|NOT COMPLETED|2nd Intervention (1 Day)||0
8369986|NCT01158950|20632998|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
8369987|NCT01158950|20632997|P2|COMPLETED|2nd Intervention (1 Day)||11
8369988|NCT01158950|20632998|P1|COMPLETED|2nd Intervention (1 Day)||12
8369989|NCT01158950|20632997|P2|STARTED|2nd Intervention (1 Day)||11
8369990|NCT01158950|20632998|P1|STARTED|2nd Intervention (1 Day)||12
8369991|NCT01158950|20632997|P2|NOT COMPLETED|Washout (1 Week)||0
8369992|NCT01158950|20632998|P1|NOT COMPLETED|Washout (1 Week)||0
8369993|NCT01158950|20632997|P2|COMPLETED|Washout (1 Week)||11
8369994|NCT01158950|20632998|P1|COMPLETED|Washout (1 Week)||12
8369995|NCT01158950|20632997|P2|STARTED|Washout (1 Week)||11
8369996|NCT01158950|20632998|P1|STARTED|Washout (1 Week)||12
8369997|NCT01158950|20632997|P2|NOT COMPLETED|1st Intervention (1 Day)||2
8369998|NCT01158950|20632998|P1|NOT COMPLETED|1st Intervention (1 Day)||1
8369999|NCT01158950|20632997|P2|COMPLETED|1st Intervention (1 Day)||11
8370000|NCT01158950|20632998|P1|COMPLETED|1st Intervention (1 Day)||12
8370001|NCT01158950|20632997|P2|Data Collected|1st Intervention (1 Day)||11
8370002|NCT01158950|20632998|P1|Data Collected|1st Intervention (1 Day)||12
8370003|NCT01158950|20632997|P2|STARTED|1st Intervention (1 Day)||13
8370004|NCT01158950|20632998|P1|STARTED|1st Intervention (1 Day)||13
8370005|NCT01158924|20633006|P2|NOT COMPLETED|Overall Study||3
8370006|NCT01158924|20633007|P1|NOT COMPLETED|Overall Study||1
8370007|NCT01158924|20633006|P2|COMPLETED|Overall Study||23
8370008|NCT01158924|20633007|P1|COMPLETED|Overall Study||13
8370009|NCT01158924|20633006|P2|STARTED|Overall Study||26
8370010|NCT01158924|20633007|P1|STARTED|Overall Study||14
8370011|NCT01158885|20633021|P1|NOT COMPLETED|Treatment Course 2||0
8370012|NCT01158885|20633021|P1|COMPLETED|Treatment Course 2||0
8370013|NCT01158885|20633021|P1|STARTED|Treatment Course 2||0
8370014|NCT01158885|20633021|P1|NOT COMPLETED|Treatment Course 1||0
8370015|NCT01158885|20633021|P1|COMPLETED|Treatment Course 1||2
8370016|NCT01158885|20633021|P1|STARTED|Treatment Course 1||2
8370017|NCT01158820|20633029|P2|NOT COMPLETED|Overall Study||0
8370018|NCT01158820|20633030|P1|NOT COMPLETED|Overall Study||0
8370019|NCT01158820|20633029|P2|COMPLETED|Overall Study||25
8370020|NCT01158820|20633030|P1|COMPLETED|Overall Study||25
8370021|NCT01158820|20633029|P2|STARTED|Overall Study||25
8370022|NCT01158820|20633030|P1|STARTED|Overall Study||25
8370023|NCT01158716|20633052|P2|NOT COMPLETED|Overall Study||1
8370024|NCT01158716|20633053|P1|NOT COMPLETED|Overall Study||1
8370025|NCT01158716|20633052|P2|COMPLETED|Overall Study||47
8370026|NCT01158716|20633053|P1|COMPLETED|Overall Study||47
8370027|NCT01158716|20633052|P2|STARTED|Overall Study||48
8370028|NCT01158716|20633053|P1|STARTED|Overall Study||48
8370029|NCT01158703|20633061|P2|NOT COMPLETED|Overall Study||0
8370030|NCT01158703|20633062|P1|NOT COMPLETED|Overall Study||0
8370031|NCT01158703|20633061|P2|COMPLETED|Overall Study||8
8370032|NCT01158703|20633062|P1|COMPLETED|Overall Study||12
8370033|NCT01158703|20633061|P2|STARTED|Overall Study||8
8370034|NCT01158703|20633062|P1|STARTED|Overall Study||12
8370035|NCT01158651|20633078|P1|NOT COMPLETED|Overall Study||1
8370036|NCT01158651|20633078|P1|COMPLETED|Overall Study||22
8370037|NCT01158651|20633078|P1|STARTED|Overall Study||23
8370038|NCT01158573|20633087|P4|NOT COMPLETED|Overall Study||0
8370039|NCT01158573|20633088|P3|NOT COMPLETED|Overall Study||0
8370040|NCT01158573|20633089|P2|NOT COMPLETED|Overall Study||0
8370041|NCT01158573|20633090|P1|NOT COMPLETED|Overall Study||0
8370042|NCT01158573|20633087|P4|COMPLETED|Overall Study||28
8370043|NCT01158573|20633088|P3|COMPLETED|Overall Study||29
8370044|NCT01158573|20633089|P2|COMPLETED|Overall Study||30
8370045|NCT01158573|20633090|P1|COMPLETED|Overall Study|Study completed at 117 subjects.|30
8370046|NCT01158573|20633087|P4|STARTED|Overall Study||28
8370047|NCT01158573|20633088|P3|STARTED|Overall Study||29
8370048|NCT01158573|20633089|P2|STARTED|Overall Study||30
8370049|NCT01158573|20633090|P1|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
8370050|NCT01158534|20633112|P1|NOT COMPLETED|Overall Study||3
8370051|NCT01158534|20633112|P1|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
8370052|NCT01158534|20633112|P1|STARTED|Overall Study||17
8370053|NCT01158521|20633120|P1|NOT COMPLETED|Overall Study||0
8370054|NCT01158521|20633120|P1|COMPLETED|Overall Study||25
8370055|NCT01158521|20633120|P1|STARTED|Overall Study||25
8370056|NCT01158404|20633137|P8|NOT COMPLETED|Overall Study||2
8370057|NCT01158404|20633138|P7|NOT COMPLETED|Overall Study||1
8370058|NCT01158404|20633139|P6|NOT COMPLETED|Overall Study||1
8370059|NCT01158404|20633140|P5|NOT COMPLETED|Overall Study||3
8370060|NCT01158404|20633141|P4|NOT COMPLETED|Overall Study||0
8370061|NCT01158404|20633142|P3|NOT COMPLETED|Overall Study||0
8370062|NCT01158404|20633143|P2|NOT COMPLETED|Overall Study||1
8370063|NCT01158404|20633144|P1|NOT COMPLETED|Overall Study||0
8370064|NCT01158404|20633137|P8|COMPLETED|Overall Study||6
8370065|NCT01158404|20633138|P7|COMPLETED|Overall Study||2
8370066|NCT01158404|20633139|P6|COMPLETED|Overall Study||4
8370067|NCT01158404|20633140|P5|COMPLETED|Overall Study||3
8370068|NCT01158404|20633141|P4|COMPLETED|Overall Study||3
8370069|NCT01158404|20633142|P3|COMPLETED|Overall Study||3
8370070|NCT01158404|20633143|P2|COMPLETED|Overall Study||3
8370071|NCT01158404|20633144|P1|COMPLETED|Overall Study||3
8370072|NCT01158404|20633137|P8|Received at Least 1 Dose of Study Drug|Overall Study||8
8370073|NCT01158404|20633138|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
8370074|NCT01158404|20633139|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
8370075|NCT01158404|20633140|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
8370076|NCT01158404|20633141|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8370077|NCT01158404|20633142|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8370078|NCT01158404|20633143|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
8370079|NCT01158404|20633144|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8370080|NCT01158404|20633137|P8|STARTED|Overall Study||8
8370081|NCT01158404|20633138|P7|STARTED|Overall Study||3
8370082|NCT01158404|20633139|P6|STARTED|Overall Study||5
8370083|NCT01158404|20633140|P5|STARTED|Overall Study||6
8370084|NCT01158404|20633141|P4|STARTED|Overall Study||3
8370085|NCT01158404|20633142|P3|STARTED|Overall Study||3
8370086|NCT01158404|20633143|P2|STARTED|Overall Study||4
8370087|NCT01158404|20633144|P1|STARTED|Overall Study||3
8370088|NCT01158378|20633186|P2|NOT COMPLETED|Overall Study||9
8370089|NCT01158378|20633187|P1|NOT COMPLETED|Overall Study||10
8370090|NCT01158378|20633186|P2|COMPLETED|Overall Study||117
8370091|NCT01158378|20633187|P1|COMPLETED|Overall Study||114
8370092|NCT01158378|20633186|P2|STARTED|Overall Study||126
8370093|NCT01158378|20633187|P1|STARTED|Overall Study||124
8370094|NCT01158261|20633199|P1|NOT COMPLETED|Overall Study||17
8370095|NCT01158261|20633199|P1|COMPLETED|Overall Study||283
8370096|NCT01158261|20633199|P1|STARTED|Overall Study||300
8370097|NCT01158222|20633203|P1|NOT COMPLETED|Overall Study||17
8370098|NCT01158222|20633203|P1|COMPLETED|Overall Study||20
8370099|NCT01158222|20633203|P1|STARTED|Overall Study||37
8370100|NCT01158157|20633209|P1|NOT COMPLETED|Overall Study||0
8370101|NCT01158157|20633209|P1|COMPLETED|Overall Study||25
8370102|NCT01158157|20633209|P1|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25
8370103|NCT01158118|20633215|P2|NOT COMPLETED|Overall Study||3
8370104|NCT01158118|20633216|P1|NOT COMPLETED|Overall Study||1
8370105|NCT01158118|20633215|P2|COMPLETED|Overall Study||21
8370106|NCT01158118|20633216|P1|COMPLETED|Overall Study||23
8370107|NCT01158118|20633215|P2|STARTED|Overall Study||24
8370108|NCT01158118|20633216|P1|STARTED|Overall Study||24
8370109|NCT01157897|20633236|P4|NOT COMPLETED|Overall Study||1
8370110|NCT01157897|20633237|P3|NOT COMPLETED|Overall Study||0
8370111|NCT01157897|20633238|P2|NOT COMPLETED|Overall Study||2
8370112|NCT01157897|20633239|P1|NOT COMPLETED|Overall Study||2
8370113|NCT01157897|20633236|P4|COMPLETED|Overall Study||5
8370114|NCT01157897|20633237|P3|COMPLETED|Overall Study||10
8370115|NCT01157897|20633238|P2|COMPLETED|Overall Study||8
8370116|NCT01157897|20633239|P1|COMPLETED|Overall Study||8
8370117|NCT01157897|20633236|P4|STARTED|Overall Study||6
8370118|NCT01157897|20633237|P3|STARTED|Overall Study||10
8370119|NCT01157897|20633238|P2|STARTED|Overall Study||10
8370120|NCT01157897|20633239|P1|STARTED|Overall Study||10
8370121|NCT01157845|20633264|P1|NOT COMPLETED|Overall Study||35
8370122|NCT01157845|20633264|P1|COMPLETED|Overall Study||130
8370123|NCT01157845|20633264|P1|STARTED|Overall Study||165
8370124|NCT01157676|20633271|P2|NOT COMPLETED|Surgery||9
8370125|NCT01157676|20633272|P1|NOT COMPLETED|Surgery||1
8370126|NCT01157676|20633271|P2|COMPLETED|Surgery|advanced disease=2, inadequate visualization=1, inability to tolerate position=1, colonic mass=1.|150
8370127|NCT01157676|20633272|P1|COMPLETED|Surgery||152
8370128|NCT01157676|20633271|P2|STARTED|Surgery||159
8370129|NCT01157676|20633272|P1|STARTED|Surgery||153
8370130|NCT01157676|20633271|P2|NOT COMPLETED|Randomization||17
8370131|NCT01157676|20633272|P1|NOT COMPLETED|Randomization||21
8370132|NCT01157676|20633271|P2|COMPLETED|Randomization||159
8370133|NCT01157676|20633272|P1|COMPLETED|Randomization||153
8370134|NCT01157676|20633271|P2|STARTED|Randomization||176
8370135|NCT01157676|20633272|P1|STARTED|Randomization||174
8370136|NCT01157676|20633271|P2|NOT COMPLETED|Enrollment||0
8370137|NCT01157676|20633272|P1|NOT COMPLETED|Enrollment||0
8370138|NCT01157676|20633271|P2|COMPLETED|Enrollment||176
8370139|NCT01157676|20633272|P1|COMPLETED|Enrollment||174
8370140|NCT01157676|20633271|P2|STARTED|Enrollment||176
8370141|NCT01157676|20633272|P1|STARTED|Enrollment||174
8370142|NCT01157533|20633318|P1|NOT COMPLETED|Overall Study||0
8370143|NCT01157533|20633318|P1|COMPLETED|Overall Study||1
8370144|NCT01157533|20633318|P1|STARTED|Overall Study||1
8370145|NCT01157429|20633324|P2|NOT COMPLETED|Overall Study||4
8370146|NCT01157429|20633325|P1|NOT COMPLETED|Overall Study||4
8370147|NCT01157429|20633324|P2|COMPLETED|Overall Study||8
8370148|NCT01157429|20633325|P1|COMPLETED|Overall Study||8
8370149|NCT01157429|20633324|P2|STARTED|Overall Study||12
8370150|NCT01157429|20633325|P1|STARTED|Overall Study||12
8370151|NCT01157416|20633333|P2|NOT COMPLETED|Overall Study||0
8370152|NCT01157416|20633334|P1|NOT COMPLETED|Overall Study||2
8370153|NCT01157416|20633333|P2|COMPLETED|Overall Study||16
8370154|NCT01157416|20633334|P1|COMPLETED|Overall Study||15
8370155|NCT01157416|20633333|P2|STARTED|Overall Study||16
8370156|NCT01157416|20633334|P1|STARTED|Overall Study||17
8370157|NCT01157377|20633347|P7|NOT COMPLETED|Overall Study||2
8370158|NCT01157377|20633348|P6|NOT COMPLETED|Overall Study||3
8370159|NCT01157377|20633349|P5|NOT COMPLETED|Overall Study||2
8370160|NCT01157377|20633350|P4|NOT COMPLETED|Overall Study||1
8370161|NCT01157377|20633351|P3|NOT COMPLETED|Overall Study||1
8370162|NCT01157377|20633352|P2|NOT COMPLETED|Overall Study||3
8370163|NCT01157377|20633353|P1|NOT COMPLETED|Overall Study||2
8370164|NCT01157377|20633347|P7|COMPLETED|Overall Study||27
8370165|NCT01157377|20633348|P6|COMPLETED|Overall Study||16
8370166|NCT01157377|20633349|P5|COMPLETED|Overall Study||18
8370167|NCT01157377|20633350|P4|COMPLETED|Overall Study||14
8370168|NCT01157377|20633351|P3|COMPLETED|Overall Study||26
8370169|NCT01157377|20633352|P2|COMPLETED|Overall Study||20
8370170|NCT01157377|20633353|P1|COMPLETED|Overall Study||21
8370171|NCT01157377|20633347|P7|STARTED|Overall Study||29
8370172|NCT01157377|20633348|P6|STARTED|Overall Study||19
8370173|NCT01157377|20633349|P5|STARTED|Overall Study||20
8370174|NCT01157377|20633350|P4|STARTED|Overall Study||15
8370175|NCT01157377|20633351|P3|STARTED|Overall Study||27
8370176|NCT01157377|20633352|P2|STARTED|Overall Study||23
8370177|NCT01157377|20633353|P1|STARTED|Overall Study||23
8370178|NCT01157364|20633375|P6|NOT COMPLETED|Overall Study||1
8370179|NCT01157364|20633376|P5|NOT COMPLETED|Overall Study||2
8370180|NCT01157364|20633377|P4|NOT COMPLETED|Overall Study||2
8370181|NCT01157364|20633378|P3|NOT COMPLETED|Overall Study||4
8370182|NCT01157364|20633379|P2|NOT COMPLETED|Overall Study||4
8370183|NCT01157364|20633380|P1|NOT COMPLETED|Overall Study||2
8370184|NCT01157364|20633375|P6|COMPLETED|Overall Study||22
8370185|NCT01157364|20633376|P5|COMPLETED|Overall Study||9
8370186|NCT01157364|20633377|P4|COMPLETED|Overall Study||16
8370187|NCT01157364|20633378|P3|COMPLETED|Overall Study||17
8370188|NCT01157364|20633379|P2|COMPLETED|Overall Study||17
8370189|NCT01157364|20633380|P1|COMPLETED|Overall Study||13
8370190|NCT01157364|20633375|P6|STARTED|Overall Study||23
8370191|NCT01157364|20633376|P5|STARTED|Overall Study||11
8370192|NCT01157364|20633377|P4|STARTED|Overall Study||18
8370193|NCT01157364|20633378|P3|STARTED|Overall Study||21
8370194|NCT01157364|20633379|P2|STARTED|Overall Study||21
8370195|NCT01157364|20633380|P1|STARTED|Overall Study||15
8370196|NCT01157351|20633414|P2|NOT COMPLETED|Overall Study||132
8370197|NCT01157351|20633415|P1|NOT COMPLETED|Overall Study||137
8370198|NCT01157351|20633414|P2|COMPLETED|Overall Study||88
8370199|NCT01157351|20633415|P1|COMPLETED|Overall Study||93
8370200|NCT01157351|20633414|P2|Treated|Overall Study||218
8370201|NCT01157351|20633415|P1|Treated|Overall Study||226
8370202|NCT01157351|20633414|P2|STARTED|Overall Study||220
8370203|NCT01157351|20633415|P1|STARTED|Overall Study||230
8370204|NCT01157234|20633433|P2|NOT COMPLETED|Overall Study||0
8370205|NCT01157234|20633434|P1|NOT COMPLETED|Overall Study||1
8370206|NCT01157234|20633433|P2|COMPLETED|Overall Study||15
8370207|NCT01157234|20633434|P1|COMPLETED|Overall Study||14
8370208|NCT01157234|20633433|P2|STARTED|Overall Study||15
8370209|NCT01157234|20633434|P1|STARTED|Overall Study||15
8370210|NCT01157182|20633466|P2|NOT COMPLETED|Second Intervention||0
8370211|NCT01157182|20633467|P1|NOT COMPLETED|Second Intervention||0
8370212|NCT01157182|20633466|P2|COMPLETED|Second Intervention||18
8370213|NCT01157182|20633467|P1|COMPLETED|Second Intervention||16
8370214|NCT01157182|20633466|P2|STARTED|Second Intervention||18
8370215|NCT01157182|20633467|P1|STARTED|Second Intervention||16
8370216|NCT01157182|20633466|P2|NOT COMPLETED|Washout of 28 Days||0
8370217|NCT01157182|20633467|P1|NOT COMPLETED|Washout of 28 Days||2
8370218|NCT01157182|20633466|P2|COMPLETED|Washout of 28 Days||18
8370219|NCT01157182|20633467|P1|COMPLETED|Washout of 28 Days||16
8370220|NCT01157182|20633466|P2|STARTED|Washout of 28 Days||18
8370221|NCT01157182|20633467|P1|STARTED|Washout of 28 Days||18
8370222|NCT01157182|20633466|P2|NOT COMPLETED|First Intervention||0
8370223|NCT01157182|20633467|P1|NOT COMPLETED|First Intervention||0
8370224|NCT01157182|20633466|P2|COMPLETED|First Intervention||18
8370225|NCT01157182|20633467|P1|COMPLETED|First Intervention||18
8370226|NCT01157182|20633466|P2|STARTED|First Intervention||18
8370227|NCT01157182|20633467|P1|STARTED|First Intervention||18
8370228|NCT01157169|20633515|P2|NOT COMPLETED|Second Intervention||1
8370229|NCT01157169|20633516|P1|NOT COMPLETED|Second Intervention||0
8370230|NCT01157169|20633515|P2|COMPLETED|Second Intervention||17
8370231|NCT01157169|20633516|P1|COMPLETED|Second Intervention||16
8370232|NCT01157169|20633515|P2|STARTED|Second Intervention||18
8370233|NCT01157169|20633516|P1|STARTED|Second Intervention||16
8370234|NCT01157169|20633515|P2|NOT COMPLETED|Washout of 10 Days||0
8370235|NCT01157169|20633516|P1|NOT COMPLETED|Washout of 10 Days||0
8370236|NCT01157169|20633515|P2|COMPLETED|Washout of 10 Days||18
8370237|NCT01157169|20633516|P1|COMPLETED|Washout of 10 Days||16
8370238|NCT01157169|20633515|P2|STARTED|Washout of 10 Days||18
8370239|NCT01157169|20633516|P1|STARTED|Washout of 10 Days||16
8370240|NCT01157169|20633515|P2|NOT COMPLETED|First Intervention||2
8370241|NCT01157169|20633516|P1|NOT COMPLETED|First Intervention||4
8370242|NCT01157169|20633515|P2|COMPLETED|First Intervention||18
8370243|NCT01157169|20633516|P1|COMPLETED|First Intervention||16
8370244|NCT01157169|20633515|P2|STARTED|First Intervention||20
8370245|NCT01157169|20633516|P1|STARTED|First Intervention||20
8370246|NCT01157117|20633535|P3|NOT COMPLETED|Overall Study||15
8370247|NCT01157117|20633536|P2|NOT COMPLETED|Overall Study||11
8370248|NCT01157117|20633537|P1|NOT COMPLETED|Overall Study||9
8370249|NCT01157117|20633535|P3|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
8370250|NCT01157117|20633536|P2|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
8370251|NCT01157117|20633537|P1|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
8370252|NCT01157117|20633535|P3|Completed Final Month 38 Study Visit|Overall Study||3
8370253|NCT01157117|20633536|P2|Completed Final Month 38 Study Visit|Overall Study||18
8370254|NCT01157117|20633537|P1|Completed Final Month 38 Study Visit|Overall Study||19
8370255|NCT01157117|20633535|P3|Completed Month 32 Tolerance OFC|Overall Study||0
8370256|NCT01157117|20633536|P2|Completed Month 32 Tolerance OFC|Overall Study||20
8370257|NCT01157117|20633537|P1|Completed Month 32 Tolerance OFC|Overall Study||24
8370258|NCT01157117|20633535|P3|Discontinued Milk OIT at Month 30|Overall Study||0
8370259|NCT01157117|20633536|P2|Discontinued Milk OIT at Month 30|Overall Study||20
8370260|NCT01157117|20633537|P1|Discontinued Milk OIT at Month 30|Overall Study||24
8370261|NCT01157117|20633535|P3|Completed Month 28 Desensitization OFC|Overall Study||0
8370262|NCT01157117|20633536|P2|Completed Month 28 Desensitization OFC|Overall Study||24
8370263|NCT01157117|20633537|P1|Completed Month 28 Desensitization OFC|Overall Study||26
8370264|NCT01157117|20633535|P3|Unblinded at Month 16|Overall Study||0
8370265|NCT01157117|20633536|P2|Unblinded at Month 16|Overall Study||26
8370266|NCT01157117|20633537|P1|Unblinded at Month 16|Overall Study||26
8370267|NCT01157117|20633535|P3|Reached Milk OIT Maintenance Dosing|Overall Study||0
8370268|NCT01157117|20633536|P2|Reached Milk OIT Maintenance Dosing|Overall Study||26
8370269|NCT01157117|20633537|P1|Reached Milk OIT Maintenance Dosing|Overall Study||26
8370270|NCT01157117|20633535|P3|Began Milk OIT Dosing at Month 4|Overall Study||0
8370271|NCT01157117|20633536|P2|Began Milk OIT Dosing at Month 4|Overall Study||28
8370272|NCT01157117|20633537|P1|Began Milk OIT Dosing at Month 4|Overall Study||27
8370273|NCT01157117|20633535|P3|Began Omalizumab or Placebo Dosing|Overall Study||0
8370274|NCT01157117|20633536|P2|Began Omalizumab or Placebo Dosing|Overall Study||28
8370275|NCT01157117|20633537|P1|Began Omalizumab or Placebo Dosing|Overall Study||27
8370276|NCT01157117|20633535|P3|STARTED|Overall Study||20
8370277|NCT01157117|20633536|P2|STARTED|Overall Study||29
8370278|NCT01157117|20633537|P1|STARTED|Overall Study||28
8370279|NCT01157078|20633578|P2|NOT COMPLETED|Overall Study||36
8370280|NCT01157078|20633579|P1|NOT COMPLETED|Overall Study||35
8370281|NCT01157078|20633578|P2|COMPLETED|Overall Study||124
8370282|NCT01157078|20633579|P1|COMPLETED|Overall Study||124
8370283|NCT01157078|20633578|P2|Received Treatment|Overall Study||159
8370284|NCT01157078|20633579|P1|Received Treatment|Overall Study||157
8370285|NCT01157078|20633578|P2|STARTED|Overall Study||160
8370286|NCT01157078|20633579|P1|STARTED|Overall Study||159
8370287|NCT01157065|20633629|P2|NOT COMPLETED|Overall Study||1
8370288|NCT01157065|20633630|P1|NOT COMPLETED|Overall Study||0
8370289|NCT01157065|20633629|P2|COMPLETED|Overall Study||10
8370290|NCT01157065|20633630|P1|COMPLETED|Overall Study||38
8370291|NCT01157065|20633629|P2|STARTED|Overall Study||11
8370292|NCT01157065|20633630|P1|STARTED|Overall Study||38
8370293|NCT01156987|20633640|P2|NOT COMPLETED|Overall Study||11
8370294|NCT01156987|20633641|P1|NOT COMPLETED|Overall Study||0
8370295|NCT01156987|20633640|P2|COMPLETED|Overall Study||12
8370296|NCT01156987|20633641|P1|COMPLETED|Overall Study||8
8370297|NCT01156987|20633640|P2|STARTED|Overall Study||23
8370298|NCT01156987|20633641|P1|STARTED|Overall Study||8
8370299|NCT01156844|20633651|P4|NOT COMPLETED|Overall Study||6
8370300|NCT01156844|20633652|P3|NOT COMPLETED|Overall Study||6
8370301|NCT01156844|20633653|P2|NOT COMPLETED|Overall Study||2
8370302|NCT01156844|20633654|P1|NOT COMPLETED|Overall Study||2
8370303|NCT01156844|20633651|P4|COMPLETED|Overall Study||41
8370304|NCT01156844|20633652|P3|COMPLETED|Overall Study||42
8370305|NCT01156844|20633653|P2|COMPLETED|Overall Study||46
8370306|NCT01156844|20633654|P1|COMPLETED|Overall Study||46
8370307|NCT01156844|20633651|P4|PD & Safety Sets: Received Study Drug|Overall Study||46
8370308|NCT01156844|20633652|P3|PD & Safety Sets: Received Study Drug|Overall Study||48
8370309|NCT01156844|20633653|P2|PD & Safety Sets: Received Study Drug|Overall Study||47
8370310|NCT01156844|20633654|P1|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
8370311|NCT01156844|20633651|P4|STARTED|Overall Study||47
8370312|NCT01156844|20633652|P3|STARTED|Overall Study||48
8370313|NCT01156844|20633653|P2|STARTED|Overall Study||48
8370314|NCT01156844|20633654|P1|STARTED|Overall Study|Randomized participants.|48
8370315|NCT01156805|20633675|P2|NOT COMPLETED|Overall Study||56
8370316|NCT01156805|20633676|P1|NOT COMPLETED|Overall Study||56
8370317|NCT01156805|20633675|P2|COMPLETED|Overall Study||216
8370318|NCT01156805|20633676|P1|COMPLETED|Overall Study||181
8370319|NCT01156805|20633675|P2|STARTED|Overall Study||272
8370320|NCT01156805|20633676|P1|STARTED|Overall Study||237
8370321|NCT01156792|20633688|P1|NOT COMPLETED|Overall Study||69
8370322|NCT01156792|20633688|P1|COMPLETED|Overall Study||93
8370323|NCT01156792|20633688|P1|STARTED|Overall Study||162
8370324|NCT01156714|20633756|P3|NOT COMPLETED|Overall Study||3
8370325|NCT01156714|20633757|P2|NOT COMPLETED|Overall Study||4
8370326|NCT01156714|20633758|P1|NOT COMPLETED|Overall Study||9
8370327|NCT01156714|20633756|P3|COMPLETED|Overall Study||17
8370328|NCT01156714|20633757|P2|COMPLETED|Overall Study||15
8370329|NCT01156714|20633758|P1|COMPLETED|Overall Study||11
8370330|NCT01156714|20633756|P3|STARTED|Overall Study||20
8370331|NCT01156714|20633757|P2|STARTED|Overall Study||19
8370332|NCT01156714|20633758|P1|STARTED|Overall Study||20
8370333|NCT01156701|20633781|P4|NOT COMPLETED|Overall Study||0
8370334|NCT01156701|20633782|P3|NOT COMPLETED|Overall Study||0
8370335|NCT01156701|20633783|P2|NOT COMPLETED|Overall Study||0
8370336|NCT01156701|20633784|P1|NOT COMPLETED|Overall Study||0
8370337|NCT01156701|20633781|P4|COMPLETED|Overall Study||6725
8370338|NCT01156701|20633782|P3|COMPLETED|Overall Study||163716
8370339|NCT01156701|20633783|P2|COMPLETED|Overall Study||1007
8370340|NCT01156701|20633784|P1|COMPLETED|Overall Study||257
8370341|NCT01156701|20633781|P4|STARTED|Overall Study||6725
8370342|NCT01156701|20633782|P3|STARTED|Overall Study||163716
8370343|NCT01156701|20633783|P2|STARTED|Overall Study||1007
8370344|NCT01156701|20633784|P1|STARTED|Overall Study||257
8370345|NCT01156675|20633821|P3|NOT COMPLETED|Overall Study||2
8370346|NCT01156675|20633822|P2|NOT COMPLETED|Overall Study||25
8370347|NCT01156675|20633823|P1|NOT COMPLETED|Overall Study||34
8370348|NCT01156675|20633821|P3|COMPLETED|Overall Study||0
8370349|NCT01156675|20633822|P2|COMPLETED|Overall Study||81
8370350|NCT01156675|20633823|P1|COMPLETED|Overall Study||73
8370351|NCT01156675|20633821|P3|STARTED|Overall Study||2
8370352|NCT01156675|20633822|P2|STARTED|Overall Study||106
8370353|NCT01156675|20633823|P1|STARTED|Overall Study||107
8370354|NCT01156597|20633857|P2|NOT COMPLETED|Overall Study||1
8370355|NCT01156597|20633858|P1|NOT COMPLETED|Overall Study||3
8370356|NCT01156597|20633857|P2|COMPLETED|Overall Study||13
8370357|NCT01156597|20633858|P1|COMPLETED|Overall Study||13
8370358|NCT01156597|20633857|P2|STARTED|Overall Study||14
8370359|NCT01156597|20633858|P1|STARTED|Overall Study||16
8370360|NCT01156571|20633870|P2|NOT COMPLETED|Overall Study||19
8370361|NCT01156571|20633871|P1|NOT COMPLETED|Overall Study||17
8370449|NCT01155869|20634262|P2|STARTED|Overall Study||4
8370362|NCT01156571|20633870|P2|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
8370363|NCT01156571|20633871|P1|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
8370364|NCT01156571|20633870|P2|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
8370365|NCT01156571|20633871|P1|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
8370366|NCT01156532|20633881|P1|NOT COMPLETED|Overall Study||2
8370367|NCT01156532|20633881|P1|COMPLETED|Overall Study||28
8370368|NCT01156532|20633881|P1|STARTED|Overall Study||30
8370369|NCT01156480|20633893|P2|NOT COMPLETED|Overall Study||1
8370370|NCT01156480|20633894|P1|NOT COMPLETED|Overall Study||0
8370371|NCT01156480|20633893|P2|COMPLETED|Overall Study||1
8370372|NCT01156480|20633894|P1|COMPLETED|Overall Study||0
8370373|NCT01156480|20633893|P2|STARTED|Overall Study||2
8370374|NCT01156480|20633894|P1|STARTED|Overall Study||0
8370375|NCT01156376|20633923|P3|NOT COMPLETED|Overall Study||4
8370376|NCT01156376|20633924|P2|NOT COMPLETED|Overall Study||0
8370377|NCT01156376|20633925|P1|NOT COMPLETED|Overall Study||1
8370378|NCT01156376|20633923|P3|COMPLETED|Overall Study||23
8370379|NCT01156376|20633924|P2|COMPLETED|Overall Study||26
8370380|NCT01156376|20633925|P1|COMPLETED|Overall Study||26
8370381|NCT01156376|20633923|P3|STARTED|Overall Study||27
8370382|NCT01156376|20633924|P2|STARTED|Overall Study||26
8370383|NCT01156376|20633925|P1|STARTED|Overall Study||27
8370384|NCT01156363|20634146|P1|NOT COMPLETED|Overall Study||22
8370385|NCT01156363|20634146|P1|COMPLETED|Overall Study||64
8370386|NCT01156363|20634146|P1|STARTED|Overall Study||86
8370387|NCT01156311|20634168|P4|NOT COMPLETED|6-month Add-on Therapy Period||10
8370388|NCT01156311|20634169|P3|NOT COMPLETED|6-month Add-on Therapy Period||12
8370389|NCT01156311|20634170|P2|NOT COMPLETED|6-month Add-on Therapy Period||0
8370390|NCT01156311|20634171|P1|NOT COMPLETED|6-month Add-on Therapy Period||0
8370391|NCT01156311|20634168|P4|COMPLETED|6-month Add-on Therapy Period||37
8370392|NCT01156311|20634169|P3|COMPLETED|6-month Add-on Therapy Period||45
8370393|NCT01156311|20634170|P2|COMPLETED|6-month Add-on Therapy Period||0
8370394|NCT01156311|20634171|P1|COMPLETED|6-month Add-on Therapy Period||0
8370395|NCT01156311|20634168|P4|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
8370396|NCT01156311|20634169|P3|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
8370397|NCT01156311|20634170|P2|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
8370398|NCT01156311|20634171|P1|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
8370399|NCT01156311|20634168|P4|STARTED|6-month Add-on Therapy Period||47
8370400|NCT01156311|20634169|P3|STARTED|6-month Add-on Therapy Period||57
8370401|NCT01156311|20634170|P2|STARTED|6-month Add-on Therapy Period||0
8370402|NCT01156311|20634171|P1|STARTED|6-month Add-on Therapy Period||0
8370403|NCT01156311|20634168|P4|NOT COMPLETED|2-Month Monotherapy Period||0
8370404|NCT01156311|20634169|P3|NOT COMPLETED|2-Month Monotherapy Period||0
8370405|NCT01156311|20634170|P2|NOT COMPLETED|2-Month Monotherapy Period||2
8370406|NCT01156311|20634171|P1|NOT COMPLETED|2-Month Monotherapy Period||2
8370407|NCT01156311|20634168|P4|COMPLETED|2-Month Monotherapy Period||0
8370408|NCT01156311|20634169|P3|COMPLETED|2-Month Monotherapy Period||0
8370409|NCT01156311|20634170|P2|COMPLETED|2-Month Monotherapy Period||47
8370410|NCT01156311|20634171|P1|COMPLETED|2-Month Monotherapy Period||57
8370411|NCT01156311|20634168|P4|STARTED|2-Month Monotherapy Period||0
8370412|NCT01156311|20634169|P3|STARTED|2-Month Monotherapy Period||0
8370413|NCT01156311|20634170|P2|STARTED|2-Month Monotherapy Period||49
8370414|NCT01156311|20634171|P1|STARTED|2-Month Monotherapy Period||59
8370415|NCT01156142|20634195|P2|NOT COMPLETED|Overall Study||7
8370416|NCT01156142|20634196|P1|NOT COMPLETED|Overall Study||8
8370417|NCT01156142|20634195|P2|COMPLETED|Overall Study||71
8370418|NCT01156142|20634196|P1|COMPLETED|Overall Study||69
8370419|NCT01156142|20634195|P2|STARTED|Overall Study||78
8370420|NCT01156142|20634196|P1|STARTED|Overall Study||77
8370421|NCT01156116|20634214|P2|NOT COMPLETED|Overall Study||1
8370422|NCT01156116|20634215|P1|NOT COMPLETED|Overall Study||5
8370423|NCT01156116|20634214|P2|COMPLETED|Overall Study||12
8370424|NCT01156116|20634215|P1|COMPLETED|Overall Study||21
8370425|NCT01156116|20634214|P2|STARTED|Overall Study||13
8370426|NCT01156116|20634215|P1|STARTED|Overall Study||26
8370427|NCT01156051|20634229|P2|NOT COMPLETED|Overall Study||1
8370428|NCT01156051|20634230|P1|NOT COMPLETED|Overall Study||1
8370429|NCT01156051|20634229|P2|COMPLETED|Overall Study||16
8370430|NCT01156051|20634230|P1|COMPLETED|Overall Study||11
8370431|NCT01156051|20634229|P2|STARTED|Overall Study||17
8370432|NCT01156051|20634230|P1|STARTED|Overall Study||12
8370433|NCT01156012|20634244|P2|NOT COMPLETED|Overall Study||3
8370434|NCT01156012|20634245|P1|NOT COMPLETED|Overall Study||7
8370435|NCT01156012|20634244|P2|COMPLETED|Overall Study||186
8370436|NCT01156012|20634245|P1|COMPLETED|Overall Study||206
8370437|NCT01156012|20634244|P2|STARTED|Overall Study||189
8370438|NCT01156012|20634245|P1|STARTED|Overall Study||213
8370439|NCT01155999|20634253|P2|NOT COMPLETED|Overall Study||4
8370440|NCT01155999|20634254|P1|NOT COMPLETED|Overall Study||7
8370441|NCT01155999|20634253|P2|COMPLETED|Overall Study||136
8370442|NCT01155999|20634254|P1|COMPLETED|Overall Study||139
8370443|NCT01155999|20634253|P2|STARTED|Overall Study||140
8370444|NCT01155999|20634254|P1|STARTED|Overall Study||146
8370445|NCT01155869|20634262|P2|NOT COMPLETED|Overall Study||1
8370446|NCT01155869|20634263|P1|NOT COMPLETED|Overall Study||3
8370447|NCT01155869|20634262|P2|COMPLETED|Overall Study||3
8370448|NCT01155869|20634263|P1|COMPLETED|Overall Study||0
8370450|NCT01155869|20634263|P1|STARTED|Overall Study||3
8370451|NCT01155830|20634274|P3|NOT COMPLETED|Overall Study||0
8370452|NCT01155830|20634275|P2|NOT COMPLETED|Overall Study||0
8370453|NCT01155830|20634276|P1|NOT COMPLETED|Overall Study||0
8370454|NCT01155830|20634274|P3|COMPLETED|Overall Study||21
8370455|NCT01155830|20634275|P2|COMPLETED|Overall Study||0
8370456|NCT01155830|20634276|P1|COMPLETED|Overall Study||0
8370457|NCT01155830|20634274|P3|STARTED|Overall Study||21
8370458|NCT01155830|20634275|P2|STARTED|Overall Study||0
8370459|NCT01155830|20634276|P1|STARTED|Overall Study||0
8370469|NCT01155726|20634372|P4|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
8370470|NCT01155726|20634373|P3|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
8370471|NCT01155726|20634374|P2|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
8370472|NCT01155726|20634375|P1|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
8370473|NCT01155726|20634372|P4|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
8370474|NCT01155726|20634373|P3|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
8370475|NCT01155726|20634374|P2|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
8370476|NCT01155726|20634375|P1|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
8370477|NCT01155726|20634372|P4|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
8370478|NCT01155726|20634373|P3|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
8370479|NCT01155726|20634374|P2|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
8370480|NCT01155726|20634375|P1|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
8370481|NCT01155726|20634372|P4|NOT COMPLETED|Period 1, 3 Days (Masked)||0
8370482|NCT01155726|20634373|P3|NOT COMPLETED|Period 1, 3 Days (Masked)||2
8370483|NCT01155726|20634374|P2|NOT COMPLETED|Period 1, 3 Days (Masked)||0
8370484|NCT01155726|20634375|P1|NOT COMPLETED|Period 1, 3 Days (Masked)||1
8370485|NCT01155726|20634372|P4|COMPLETED|Period 1, 3 Days (Masked)||25
8370486|NCT01155726|20634373|P3|COMPLETED|Period 1, 3 Days (Masked)||28
8370487|NCT01155726|20634374|P2|COMPLETED|Period 1, 3 Days (Masked)||20
8370488|NCT01155726|20634375|P1|COMPLETED|Period 1, 3 Days (Masked)||23
8370489|NCT01155726|20634372|P4|STARTED|Period 1, 3 Days (Masked)||25
8370490|NCT01155726|20634373|P3|STARTED|Period 1, 3 Days (Masked)||30
8370491|NCT01155726|20634374|P2|STARTED|Period 1, 3 Days (Masked)||20
8370492|NCT01155726|20634375|P1|STARTED|Period 1, 3 Days (Masked)||24
8370493|NCT01155661|20634397|P1|NOT COMPLETED|Overall Study||280
8370494|NCT01155661|20634397|P1|COMPLETED|Overall Study||328
8370495|NCT01155661|20634397|P1|STARTED|Overall Study||608
8370496|NCT01155583|20634432|P9|NOT COMPLETED|Phase II - Expansion Phase||0
8370497|NCT01155583|20634433|P8|NOT COMPLETED|Phase II - Expansion Phase||0
8370498|NCT01155583|20634434|P7|NOT COMPLETED|Phase II - Expansion Phase||0
8370499|NCT01155583|20634435|P6|NOT COMPLETED|Phase II - Expansion Phase||0
8370500|NCT01155583|20634436|P5|NOT COMPLETED|Phase II - Expansion Phase||0
8370501|NCT01155583|20634437|P4|NOT COMPLETED|Phase II - Expansion Phase||0
8370502|NCT01155583|20634438|P3|NOT COMPLETED|Phase II - Expansion Phase||0
8370503|NCT01155583|20634439|P2|NOT COMPLETED|Phase II - Expansion Phase||0
8370504|NCT01155583|20634440|P1|NOT COMPLETED|Phase II - Expansion Phase||0
8370505|NCT01155583|20634432|P9|COMPLETED|Phase II - Expansion Phase||11
8370506|NCT01155583|20634433|P8|COMPLETED|Phase II - Expansion Phase||0
8370507|NCT01155583|20634434|P7|COMPLETED|Phase II - Expansion Phase||0
8370508|NCT01155583|20634435|P6|COMPLETED|Phase II - Expansion Phase||0
8370509|NCT01155583|20634436|P5|COMPLETED|Phase II - Expansion Phase||0
8370510|NCT01155583|20634437|P4|COMPLETED|Phase II - Expansion Phase||0
8370511|NCT01155583|20634438|P3|COMPLETED|Phase II - Expansion Phase||0
8370512|NCT01155583|20634439|P2|COMPLETED|Phase II - Expansion Phase||0
8370513|NCT01155583|20634440|P1|COMPLETED|Phase II - Expansion Phase||0
8370514|NCT01155583|20634432|P9|STARTED|Phase II - Expansion Phase||11
8370515|NCT01155583|20634433|P8|STARTED|Phase II - Expansion Phase||0
8370516|NCT01155583|20634434|P7|STARTED|Phase II - Expansion Phase||0
8370517|NCT01155583|20634435|P6|STARTED|Phase II - Expansion Phase||0
8370518|NCT01155583|20634436|P5|STARTED|Phase II - Expansion Phase||0
8370519|NCT01155583|20634437|P4|STARTED|Phase II - Expansion Phase||0
8370520|NCT01155583|20634438|P3|STARTED|Phase II - Expansion Phase||0
8370521|NCT01155583|20634439|P2|STARTED|Phase II - Expansion Phase||0
8370522|NCT01155583|20634440|P1|STARTED|Phase II - Expansion Phase||0
8370523|NCT01155583|20634432|P9|NOT COMPLETED|Phase I||0
8370524|NCT01155583|20634433|P8|NOT COMPLETED|Phase I||3
8370525|NCT01155583|20634434|P7|NOT COMPLETED|Phase I||0
8370526|NCT01155583|20634435|P6|NOT COMPLETED|Phase I||0
8370527|NCT01155583|20634436|P5|NOT COMPLETED|Phase I||1
8370528|NCT01155583|20634437|P4|NOT COMPLETED|Phase I||0
8370529|NCT01155583|20634438|P3|NOT COMPLETED|Phase I||0
8370530|NCT01155583|20634439|P2|NOT COMPLETED|Phase I||0
8370531|NCT01155583|20634440|P1|NOT COMPLETED|Phase I||0
8370532|NCT01155583|20634432|P9|COMPLETED|Phase I||0
8370533|NCT01155583|20634433|P8|COMPLETED|Phase I||5
8370534|NCT01155583|20634434|P7|COMPLETED|Phase I||3
8370535|NCT01155583|20634435|P6|COMPLETED|Phase I||0
8370536|NCT01155583|20634436|P5|COMPLETED|Phase I||6
8370537|NCT01155583|20634437|P4|COMPLETED|Phase I||6
8370538|NCT01155583|20634438|P3|COMPLETED|Phase I||4
8370539|NCT01155583|20634439|P2|COMPLETED|Phase I||3
8370540|NCT01155583|20634440|P1|COMPLETED|Phase I||3
8370541|NCT01155583|20634432|P9|STARTED|Phase I||0
8370542|NCT01155583|20634433|P8|STARTED|Phase I||8
8370543|NCT01155583|20634434|P7|STARTED|Phase I||3
8370544|NCT01155583|20634435|P6|STARTED|Phase I||0
8370545|NCT01155583|20634436|P5|STARTED|Phase I||7
8370546|NCT01155583|20634437|P4|STARTED|Phase I||6
8370547|NCT01155583|20634438|P3|STARTED|Phase I||4
8370548|NCT01155583|20634439|P2|STARTED|Phase I||3
8370549|NCT01155583|20634440|P1|STARTED|Phase I||3
8370550|NCT01155570|20634459|P1|NOT COMPLETED|Overall Study||142
8370551|NCT01155570|20634459|P1|COMPLETED|Overall Study||592
8370552|NCT01155570|20634459|P1|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
8370553|NCT01155570|20634459|P1|STARTED|Overall Study|Safety Analysis Population|734
8370554|NCT01155531|20634493|P4|NOT COMPLETED|Overall Study||1
8370555|NCT01155531|20634494|P3|NOT COMPLETED|Overall Study||2
8370556|NCT01155531|20634495|P2|NOT COMPLETED|Overall Study||0
8370557|NCT01155531|20634496|P1|NOT COMPLETED|Overall Study||1
8370558|NCT01155531|20634493|P4|COMPLETED|Overall Study||9
8370559|NCT01155531|20634494|P3|COMPLETED|Overall Study||8
8370560|NCT01155531|20634495|P2|COMPLETED|Overall Study||10
8370561|NCT01155531|20634496|P1|COMPLETED|Overall Study||9
8370562|NCT01155531|20634493|P4|STARTED|Overall Study||10
8370563|NCT01155531|20634494|P3|STARTED|Overall Study||10
8370564|NCT01155531|20634495|P2|STARTED|Overall Study||10
8370565|NCT01155531|20634496|P1|STARTED|Overall Study||10
8370566|NCT01155518|20634520|P6|NOT COMPLETED|Overall Study||0
8370567|NCT01155518|20634521|P5|NOT COMPLETED|Overall Study||0
8370568|NCT01155518|20634522|P4|NOT COMPLETED|Overall Study||0
8370569|NCT01155518|20634523|P3|NOT COMPLETED|Overall Study||0
8370570|NCT01155518|20634524|P2|NOT COMPLETED|Overall Study||1
8370571|NCT01155518|20634525|P1|NOT COMPLETED|Overall Study||0
8370572|NCT01155518|20634520|P6|COMPLETED|Overall Study||2
8370573|NCT01155518|20634521|P5|COMPLETED|Overall Study||1
8370574|NCT01155518|20634522|P4|COMPLETED|Overall Study||0
8370575|NCT01155518|20634523|P3|COMPLETED|Overall Study||0
8370576|NCT01155518|20634524|P2|COMPLETED|Overall Study|never started the study|0
8370577|NCT01155518|20634525|P1|COMPLETED|Overall Study||1
8370578|NCT01155518|20634520|P6|STARTED|Overall Study||2
8370579|NCT01155518|20634521|P5|STARTED|Overall Study||1
8370580|NCT01155518|20634522|P4|STARTED|Overall Study||0
8370581|NCT01155518|20634523|P3|STARTED|Overall Study||0
8370582|NCT01155518|20634524|P2|STARTED|Overall Study||1
8370583|NCT01155518|20634525|P1|STARTED|Overall Study||1
8370584|NCT01155479|20634544|P5|NOT COMPLETED|Part II||55
8370585|NCT01155479|20634545|P4|NOT COMPLETED|Part II||50
8370586|NCT01155479|20634546|P3|NOT COMPLETED|Part II||58
8370587|NCT01155479|20634547|P2|NOT COMPLETED|Part II||61
8370588|NCT01155479|20634548|P1|NOT COMPLETED|Part II||59
8370589|NCT01155479|20634544|P5|COMPLETED|Part II||126
8370590|NCT01155479|20634545|P4|COMPLETED|Part II||127
8370591|NCT01155479|20634546|P3|COMPLETED|Part II||109
8370592|NCT01155479|20634547|P2|COMPLETED|Part II||116
8370593|NCT01155479|20634548|P1|COMPLETED|Part II||107
8370594|NCT01155479|20634544|P5|STARTED|Part II||181
8370595|NCT01155479|20634545|P4|STARTED|Part II||177
8370596|NCT01155479|20634546|P3|STARTED|Part II||167
8370597|NCT01155479|20634547|P2|STARTED|Part II||177
8370598|NCT01155479|20634548|P1|STARTED|Part II||166
8370599|NCT01155479|20634544|P5|NOT COMPLETED|Part I||23
8370600|NCT01155479|20634545|P4|NOT COMPLETED|Part I||27
8370601|NCT01155479|20634546|P3|NOT COMPLETED|Part I||39
8370602|NCT01155479|20634547|P2|NOT COMPLETED|Part I||27
8370603|NCT01155479|20634548|P1|NOT COMPLETED|Part I||38
8370604|NCT01155479|20634544|P5|COMPLETED|Part I||181
8370605|NCT01155479|20634545|P4|COMPLETED|Part I||177
8370606|NCT01155479|20634546|P3|COMPLETED|Part I||167
8370607|NCT01155479|20634547|P2|COMPLETED|Part I||177
8370608|NCT01155479|20634548|P1|COMPLETED|Part I||166
8370609|NCT01155479|20634544|P5|Treated|Part I||203
8370610|NCT01155479|20634545|P4|Treated|Part I||198
8370611|NCT01155479|20634546|P3|Treated|Part I||204
8370612|NCT01155479|20634547|P2|Treated|Part I||202
8370613|NCT01155479|20634548|P1|Treated|Part I||200
8370614|NCT01155479|20634544|P5|STARTED|Part I||204
8370615|NCT01155479|20634545|P4|STARTED|Part I||204
8370616|NCT01155479|20634546|P3|STARTED|Part I||206
8370617|NCT01155479|20634547|P2|STARTED|Part I||204
8370618|NCT01155479|20634548|P1|STARTED|Part I||204
8370619|NCT01155466|20634600|P5|NOT COMPLETED|Overall Study||27
8370620|NCT01155466|20634601|P4|NOT COMPLETED|Overall Study||21
8370621|NCT01155466|20634602|P3|NOT COMPLETED|Overall Study||20
8370622|NCT01155466|20634603|P2|NOT COMPLETED|Overall Study||25
8370623|NCT01155466|20634604|P1|NOT COMPLETED|Overall Study||22
8370624|NCT01155466|20634600|P5|COMPLETED|Overall Study|Completed treatment phase|129
8370625|NCT01155466|20634601|P4|COMPLETED|Overall Study|Completed treatment phase|134
8370626|NCT01155466|20634602|P3|COMPLETED|Overall Study|Completed treatment phase|136
8370627|NCT01155466|20634603|P2|COMPLETED|Overall Study|Completed treatment phase|130
8370628|NCT01155466|20634604|P1|COMPLETED|Overall Study|Completed treatment phase|134
8370629|NCT01155466|20634600|P5|Treated|Overall Study||154
8370630|NCT01155466|20634601|P4|Treated|Overall Study||155
8370631|NCT01155466|20634602|P3|Treated|Overall Study||153
8370632|NCT01155466|20634603|P2|Treated|Overall Study||153
8370633|NCT01155466|20634604|P1|Treated|Overall Study||154
8370634|NCT01155466|20634600|P5|STARTED|Overall Study||156
8370635|NCT01155466|20634601|P4|STARTED|Overall Study||155
8370636|NCT01155466|20634602|P3|STARTED|Overall Study||156
8370637|NCT01155466|20634603|P2|STARTED|Overall Study||155
8370638|NCT01155466|20634604|P1|STARTED|Overall Study||156
8370639|NCT01155388|20634658|P2|NOT COMPLETED|Overall Study||0
8370640|NCT01155388|20634659|P1|NOT COMPLETED|Overall Study||1
8370641|NCT01155388|20634658|P2|COMPLETED|Overall Study||6
8370642|NCT01155388|20634659|P1|COMPLETED|Overall Study||7
8370643|NCT01155388|20634658|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8370644|NCT01155388|20634659|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8370645|NCT01155388|20634658|P2|STARTED|Overall Study||6
8370646|NCT01155388|20634659|P1|STARTED|Overall Study||8
8370647|NCT01155375|20634669|P2|NOT COMPLETED|Overall Study||0
8370648|NCT01155375|20634670|P1|NOT COMPLETED|Overall Study||1
8370649|NCT01155375|20634669|P2|COMPLETED|Overall Study||6
8370650|NCT01155375|20634670|P1|COMPLETED|Overall Study||7
8370651|NCT01155375|20634669|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8370652|NCT01155375|20634670|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8370653|NCT01155375|20634669|P2|STARTED|Overall Study||6
8370654|NCT01155375|20634670|P1|STARTED|Overall Study||8
8370655|NCT01155336|20634680|P2|NOT COMPLETED|Overall Study||0
8370656|NCT01155336|20634681|P1|NOT COMPLETED|Overall Study||0
8370657|NCT01155336|20634680|P2|COMPLETED|Overall Study|We did not complete the study.|4
8370658|NCT01155336|20634681|P1|COMPLETED|Overall Study|We did not complete the study.|0
8370659|NCT01155336|20634680|P2|STARTED|Overall Study|We did not complete the study.|4
8370660|NCT01155336|20634681|P1|STARTED|Overall Study|We did not complete the study.|0
8370661|NCT01155323|20634689|P2|NOT COMPLETED|Second Intervention||1
8370662|NCT01155323|20634690|P1|NOT COMPLETED|Second Intervention||1
8370663|NCT01155323|20634689|P2|COMPLETED|Second Intervention||56
8370664|NCT01155323|20634690|P1|COMPLETED|Second Intervention||58
8370665|NCT01155323|20634689|P2|STARTED|Second Intervention||57
8370666|NCT01155323|20634690|P1|STARTED|Second Intervention||59
8370667|NCT01155323|20634689|P2|NOT COMPLETED|First Intervention||1
8370668|NCT01155323|20634690|P1|NOT COMPLETED|First Intervention||1
8370669|NCT01155323|20634689|P2|COMPLETED|First Intervention||57
8370670|NCT01155323|20634690|P1|COMPLETED|First Intervention||59
8370671|NCT01155323|20634689|P2|STARTED|First Intervention||58
8370672|NCT01155323|20634690|P1|STARTED|First Intervention||60
8370673|NCT01155284|20634708|P2|NOT COMPLETED|Overall Study||5
8370674|NCT01155284|20634709|P1|NOT COMPLETED|Overall Study||7
8370675|NCT01155284|20634708|P2|COMPLETED|Overall Study||18
8370676|NCT01155284|20634709|P1|COMPLETED|Overall Study||40
8370677|NCT01155284|20634708|P2|STARTED|Overall Study||23
8370678|NCT01155284|20634709|P1|STARTED|Overall Study||47
8370679|NCT01155219|20634719|P2|NOT COMPLETED|Overall Study||3
8370680|NCT01155219|20634720|P1|NOT COMPLETED|Overall Study||4
8370681|NCT01155219|20634719|P2|COMPLETED|Overall Study||70
8370682|NCT01155219|20634720|P1|COMPLETED|Overall Study||73
8370683|NCT01155219|20634719|P2|STARTED|Overall Study||73
8370684|NCT01155219|20634720|P1|STARTED|Overall Study||77
8370685|NCT01155193|20634730|P4|NOT COMPLETED|Overall Study||91
8370686|NCT01155193|20634731|P3|NOT COMPLETED|Overall Study||12
8370687|NCT01155193|20634732|P2|NOT COMPLETED|Overall Study||13
8370688|NCT01155193|20634733|P1|NOT COMPLETED|Overall Study||238
8370689|NCT01155193|20634730|P4|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
8370690|NCT01155193|20634731|P3|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
8370691|NCT01155193|20634732|P2|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
8370692|NCT01155193|20634733|P1|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
8370693|NCT01155193|20634730|P4|STARTED|Overall Study||13802
8370694|NCT01155193|20634731|P3|STARTED|Overall Study||2260
8370695|NCT01155193|20634732|P2|STARTED|Overall Study||3818
8370696|NCT01155193|20634733|P1|STARTED|Overall Study||10924
8370697|NCT01155180|20634760|P2|NOT COMPLETED|Overall Study||0
8370698|NCT01155180|20634761|P1|NOT COMPLETED|Overall Study||0
8370699|NCT01155180|20634760|P2|COMPLETED|Overall Study||6
8370700|NCT01155180|20634761|P1|COMPLETED|Overall Study||18
8370701|NCT01155180|20634760|P2|STARTED|Overall Study||6
8370702|NCT01155180|20634761|P1|STARTED|Overall Study||18
8370703|NCT01155167|20634769|P2|NOT COMPLETED|Overall Study||0
8370704|NCT01155167|20634770|P1|NOT COMPLETED|Overall Study||3
8370705|NCT01155167|20634769|P2|COMPLETED|Overall Study||43
8370706|NCT01155167|20634770|P1|COMPLETED|Overall Study||40
8370707|NCT01155167|20634769|P2|STARTED|Overall Study||43
8370708|NCT01155167|20634770|P1|STARTED|Overall Study||43
8370709|NCT01155154|20634783|P3|NOT COMPLETED|Overall Study||0
8370710|NCT01155154|20634784|P2|NOT COMPLETED|Overall Study||0
8370711|NCT01155154|20634785|P1|NOT COMPLETED|Overall Study||0
8370712|NCT01155154|20634783|P3|COMPLETED|Overall Study||24
8370713|NCT01155154|20634784|P2|COMPLETED|Overall Study||24
8370714|NCT01155154|20634785|P1|COMPLETED|Overall Study||25
8370715|NCT01155154|20634783|P3|STARTED|Overall Study||24
8370716|NCT01155154|20634784|P2|STARTED|Overall Study||24
8370717|NCT01155154|20634785|P1|STARTED|Overall Study||25
8370718|NCT01155141|20634793|P1|NOT COMPLETED|Overall Study||2
8370719|NCT01155141|20634793|P1|COMPLETED|Overall Study||14
8370720|NCT01155141|20634793|P1|STARTED|Overall Study||16
8370721|NCT01155063|20634805|P1|NOT COMPLETED|Overall Study||89
8370722|NCT01155063|20634805|P1|COMPLETED|Overall Study||0
8370723|NCT01155063|20634805|P1|STARTED|Overall Study||89
8370724|NCT01155050|20634819|P4|NOT COMPLETED|Overall Study||22
8370725|NCT01155050|20634820|P3|NOT COMPLETED|Overall Study||19
8370726|NCT01155050|20634821|P2|NOT COMPLETED|Overall Study||20
8370727|NCT01155050|20634822|P1|NOT COMPLETED|Overall Study||15
8370728|NCT01155050|20634819|P4|COMPLETED|Overall Study||27
8370729|NCT01155050|20634820|P3|COMPLETED|Overall Study||33
8370730|NCT01155050|20634821|P2|COMPLETED|Overall Study||31
8370731|NCT01155050|20634822|P1|COMPLETED|Overall Study||35
8370732|NCT01155050|20634819|P4|STARTED|Overall Study||49
8370733|NCT01155050|20634820|P3|STARTED|Overall Study||52
8370734|NCT01155050|20634821|P2|STARTED|Overall Study||51
8370735|NCT01155050|20634822|P1|STARTED|Overall Study||50
8370736|NCT01155024|20634860|P2|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
8370737|NCT01155024|20634861|P1|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
8370738|NCT01155024|20634860|P2|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
8370739|NCT01155024|20634861|P1|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
8370740|NCT01155024|20634860|P2|STARTED|Direct Manufactured Socket 3 Month Trial||10
8370741|NCT01155024|20634861|P1|STARTED|Direct Manufactured Socket 3 Month Trial||0
8370742|NCT01155024|20634860|P2|NOT COMPLETED|Second Socket Intervention Fitting||0
8370743|NCT01155024|20634861|P1|NOT COMPLETED|Second Socket Intervention Fitting||0
8370744|NCT01155024|20634860|P2|COMPLETED|Second Socket Intervention Fitting||5
8370745|NCT01155024|20634861|P1|COMPLETED|Second Socket Intervention Fitting||5
8370746|NCT01155024|20634860|P2|STARTED|Second Socket Intervention Fitting||5
8370747|NCT01155024|20634861|P1|STARTED|Second Socket Intervention Fitting||5
8370748|NCT01155024|20634860|P2|NOT COMPLETED|First Socket Intervention Fitting||0
8370749|NCT01155024|20634861|P1|NOT COMPLETED|First Socket Intervention Fitting||0
8370750|NCT01155024|20634860|P2|COMPLETED|First Socket Intervention Fitting||5
8370751|NCT01155024|20634861|P1|COMPLETED|First Socket Intervention Fitting||5
8370752|NCT01155024|20634860|P2|STARTED|First Socket Intervention Fitting||5
8370753|NCT01155024|20634861|P1|STARTED|First Socket Intervention Fitting||5
8370754|NCT01155011|20634871|P2|NOT COMPLETED|6 to 12 Months||10
8370755|NCT01155011|20634872|P1|NOT COMPLETED|6 to 12 Months||9
8370756|NCT01155011|20634871|P2|COMPLETED|6 to 12 Months||121
8370757|NCT01155011|20634872|P1|COMPLETED|6 to 12 Months||120
8370758|NCT01155011|20634871|P2|STARTED|6 to 12 Months||131
8370759|NCT01155011|20634872|P1|STARTED|6 to 12 Months||129
8370760|NCT01155011|20634871|P2|NOT COMPLETED|Baseline to 6 Months||25
8370761|NCT01155011|20634872|P1|NOT COMPLETED|Baseline to 6 Months||22
8370762|NCT01155011|20634871|P2|COMPLETED|Baseline to 6 Months||131
8370763|NCT01155011|20634872|P1|COMPLETED|Baseline to 6 Months||129
8370764|NCT01155011|20634871|P2|STARTED|Baseline to 6 Months||156
8370765|NCT01155011|20634872|P1|STARTED|Baseline to 6 Months||151
8370766|NCT01154985|20634885|P3|NOT COMPLETED|Overall Study||18
8370767|NCT01154985|20634886|P2|NOT COMPLETED|Overall Study||27
8370768|NCT01154985|20634887|P1|NOT COMPLETED|Overall Study||17
8370769|NCT01154985|20634885|P3|COMPLETED|Overall Study||68
8370770|NCT01154985|20634886|P2|COMPLETED|Overall Study||55
8370771|NCT01154985|20634887|P1|COMPLETED|Overall Study||58
8370772|NCT01154985|20634885|P3|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
8370773|NCT01154985|20634886|P2|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
8370774|NCT01154985|20634887|P1|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
8370775|NCT01154985|20634885|P3|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
8370776|NCT01154985|20634886|P2|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
8370777|NCT01154985|20634887|P1|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
8370778|NCT01154985|20634885|P3|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
8370779|NCT01154985|20634886|P2|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
8370780|NCT01154985|20634887|P1|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
8370781|NCT01154985|20634885|P3|STARTED|Overall Study|Randomized|86
8370782|NCT01154985|20634886|P2|STARTED|Overall Study|Randomized|82
8370783|NCT01154985|20634887|P1|STARTED|Overall Study|Randomized|75
8370784|NCT01154816|20634913|P12|NOT COMPLETED|Overall Study||4
8370785|NCT01154816|20634914|P11|NOT COMPLETED|Overall Study||11
8370786|NCT01154816|20634915|P10|NOT COMPLETED|Overall Study||10
8370787|NCT01154816|20634916|P9|NOT COMPLETED|Overall Study||9
8370788|NCT01154816|20634917|P8|NOT COMPLETED|Overall Study||7
8370789|NCT01154816|20634918|P7|NOT COMPLETED|Overall Study||6
8370790|NCT01154816|20634919|P6|NOT COMPLETED|Overall Study||8
8370791|NCT01154816|20634920|P5|NOT COMPLETED|Overall Study||10
8370792|NCT01154816|20634921|P4|NOT COMPLETED|Overall Study||10
8370793|NCT01154816|20634922|P3|NOT COMPLETED|Overall Study||10
8370794|NCT01154816|20634923|P2|NOT COMPLETED|Overall Study||10
8370795|NCT01154816|20634924|P1|NOT COMPLETED|Overall Study||20
8370796|NCT01154816|20634913|P12|COMPLETED|Overall Study||0
8370797|NCT01154816|20634914|P11|COMPLETED|Overall Study||0
8370798|NCT01154816|20634915|P10|COMPLETED|Overall Study||0
8370799|NCT01154816|20634916|P9|COMPLETED|Overall Study||1
8370800|NCT01154816|20634917|P8|COMPLETED|Overall Study||0
8370801|NCT01154816|20634918|P7|COMPLETED|Overall Study||0
8370802|NCT01154816|20634919|P6|COMPLETED|Overall Study||0
8370803|NCT01154816|20634920|P5|COMPLETED|Overall Study||0
8370804|NCT01154816|20634921|P4|COMPLETED|Overall Study||0
8370805|NCT01154816|20634922|P3|COMPLETED|Overall Study||0
8370806|NCT01154816|20634923|P2|COMPLETED|Overall Study||2
8370807|NCT01154816|20634924|P1|COMPLETED|Overall Study||0
8370808|NCT01154816|20634913|P12|STARTED|Overall Study||4
8370809|NCT01154816|20634914|P11|STARTED|Overall Study||11
8370810|NCT01154816|20634915|P10|STARTED|Overall Study||10
8370811|NCT01154816|20634916|P9|STARTED|Overall Study||10
8370812|NCT01154816|20634917|P8|STARTED|Overall Study||7
8370813|NCT01154816|20634918|P7|STARTED|Overall Study||6
8370814|NCT01154816|20634919|P6|STARTED|Overall Study||8
8370815|NCT01154816|20634920|P5|STARTED|Overall Study||10
8370816|NCT01154816|20634921|P4|STARTED|Overall Study||10
8370817|NCT01154816|20634922|P3|STARTED|Overall Study||10
8370818|NCT01154816|20634923|P2|STARTED|Overall Study||12
8370819|NCT01154816|20634924|P1|STARTED|Overall Study||20
8370820|NCT01154751|20634957|P1|NOT COMPLETED|3-year Follow-up||49
8370821|NCT01154751|20634957|P1|COMPLETED|3-year Follow-up||34
8370822|NCT01154751|20634957|P1|STARTED|3-year Follow-up||83
8370823|NCT01154751|20634957|P1|NOT COMPLETED|2-year Follow-up||10
8370824|NCT01154751|20634957|P1|COMPLETED|2-year Follow-up||83
8370825|NCT01154751|20634957|P1|STARTED|2-year Follow-up||93
8370826|NCT01154751|20634957|P1|NOT COMPLETED|1-year Follow-up||5
8370827|NCT01154751|20634957|P1|COMPLETED|1-year Follow-up||93
8370828|NCT01154751|20634957|P1|STARTED|1-year Follow-up||98
8370829|NCT01154751|20634957|P1|NOT COMPLETED|6-month Follow-up||11
8370830|NCT01154751|20634957|P1|COMPLETED|6-month Follow-up||98
8370831|NCT01154751|20634957|P1|STARTED|6-month Follow-up||109
8370832|NCT01154699|20634982|P2|NOT COMPLETED|Second Intervention||0
8370833|NCT01154699|20634983|P1|NOT COMPLETED|Second Intervention||0
8370834|NCT01154699|20634982|P2|COMPLETED|Second Intervention||8
8370835|NCT01154699|20634983|P1|COMPLETED|Second Intervention||13
8370836|NCT01154699|20634982|P2|Subjects With Asthma + OSA|Second Intervention||2
8370837|NCT01154699|20634983|P1|Subjects With Asthma + OSA|Second Intervention||6
8370838|NCT01154699|20634982|P2|Subjects With Asthma Only|Second Intervention||6
8370839|NCT01154699|20634983|P1|Subjects With Asthma Only|Second Intervention||7
8370840|NCT01154699|20634982|P2|STARTED|Second Intervention||8
8370841|NCT01154699|20634983|P1|STARTED|Second Intervention||13
8370842|NCT01154699|20634982|P2|NOT COMPLETED|Washout Period (4 Weeks)||0
8370843|NCT01154699|20634983|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
8370844|NCT01154699|20634982|P2|COMPLETED|Washout Period (4 Weeks)||8
8370845|NCT01154699|20634983|P1|COMPLETED|Washout Period (4 Weeks)||13
8370846|NCT01154699|20634982|P2|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
8370847|NCT01154699|20634983|P1|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
8370848|NCT01154699|20634982|P2|Subjects With Asthma Only|Washout Period (4 Weeks)||6
8370849|NCT01154699|20634983|P1|Subjects With Asthma Only|Washout Period (4 Weeks)||7
8370850|NCT01154699|20634982|P2|STARTED|Washout Period (4 Weeks)||8
8370851|NCT01154699|20634983|P1|STARTED|Washout Period (4 Weeks)||13
8370852|NCT01154699|20634982|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8370853|NCT01154699|20634983|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8370854|NCT01154699|20634982|P2|COMPLETED|First Intervention (4 Weeks)||8
8370855|NCT01154699|20634983|P1|COMPLETED|First Intervention (4 Weeks)||13
8370856|NCT01154699|20634982|P2|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
8370857|NCT01154699|20634983|P1|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
8370858|NCT01154699|20634982|P2|Subjects With Asthma Only|First Intervention (4 Weeks)||6
8370859|NCT01154699|20634983|P1|Subjects With Asthma Only|First Intervention (4 Weeks)||7
8370860|NCT01154699|20634982|P2|STARTED|First Intervention (4 Weeks)||8
8370861|NCT01154699|20634983|P1|STARTED|First Intervention (4 Weeks)||13
8370862|NCT01154673|20635001|P2|NOT COMPLETED|Overall Study||0
8370863|NCT01154673|20635002|P1|NOT COMPLETED|Overall Study||2
8370864|NCT01154673|20635001|P2|COMPLETED|Overall Study||16
8370865|NCT01154673|20635002|P1|COMPLETED|Overall Study||14
8370866|NCT01154673|20635001|P2|STARTED|Overall Study||16
8370867|NCT01154673|20635002|P1|STARTED|Overall Study||16
8370868|NCT01154634|20635012|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
8370869|NCT01154634|20635013|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
8370870|NCT01154634|20635014|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
8370871|NCT01154634|20635015|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
8370872|NCT01154634|20635012|P4|COMPLETED|Period 7 - Fourth Intervention||5
8370873|NCT01154634|20635013|P3|COMPLETED|Period 7 - Fourth Intervention||4
8370874|NCT01154634|20635014|P2|COMPLETED|Period 7 - Fourth Intervention||7
8370875|NCT01154634|20635015|P1|COMPLETED|Period 7 - Fourth Intervention||4
8370876|NCT01154634|20635012|P4|STARTED|Period 7 - Fourth Intervention||5
8370877|NCT01154634|20635013|P3|STARTED|Period 7 - Fourth Intervention||4
8370878|NCT01154634|20635014|P2|STARTED|Period 7 - Fourth Intervention||7
8370879|NCT01154634|20635015|P1|STARTED|Period 7 - Fourth Intervention||4
8370880|NCT01154634|20635012|P4|NOT COMPLETED|Period 6 - Washout||0
8370881|NCT01154634|20635013|P3|NOT COMPLETED|Period 6 - Washout||0
8370882|NCT01154634|20635014|P2|NOT COMPLETED|Period 6 - Washout||0
8370883|NCT01154634|20635015|P1|NOT COMPLETED|Period 6 - Washout||0
8370884|NCT01154634|20635012|P4|COMPLETED|Period 6 - Washout||5
8370885|NCT01154634|20635013|P3|COMPLETED|Period 6 - Washout||4
8370886|NCT01154634|20635014|P2|COMPLETED|Period 6 - Washout||7
8370887|NCT01154634|20635015|P1|COMPLETED|Period 6 - Washout||4
8370888|NCT01154634|20635012|P4|STARTED|Period 6 - Washout||5
8370889|NCT01154634|20635013|P3|STARTED|Period 6 - Washout||4
8370890|NCT01154634|20635014|P2|STARTED|Period 6 - Washout||7
8370891|NCT01154634|20635015|P1|STARTED|Period 6 - Washout||4
8370892|NCT01154634|20635012|P4|NOT COMPLETED|Period 5 - Third Intervention||0
8370893|NCT01154634|20635013|P3|NOT COMPLETED|Period 5 - Third Intervention||0
8370894|NCT01154634|20635014|P2|NOT COMPLETED|Period 5 - Third Intervention||0
8370895|NCT01154634|20635015|P1|NOT COMPLETED|Period 5 - Third Intervention||0
8370896|NCT01154634|20635012|P4|COMPLETED|Period 5 - Third Intervention||5
8370897|NCT01154634|20635013|P3|COMPLETED|Period 5 - Third Intervention||4
8370898|NCT01154634|20635014|P2|COMPLETED|Period 5 - Third Intervention||7
8370899|NCT01154634|20635015|P1|COMPLETED|Period 5 - Third Intervention||4
8370900|NCT01154634|20635012|P4|STARTED|Period 5 - Third Intervention||5
8370901|NCT01154634|20635013|P3|STARTED|Period 5 - Third Intervention||4
8370902|NCT01154634|20635014|P2|STARTED|Period 5 - Third Intervention||7
8370903|NCT01154634|20635015|P1|STARTED|Period 5 - Third Intervention||4
8370904|NCT01154634|20635012|P4|NOT COMPLETED|Period 4 - Washout||0
8370905|NCT01154634|20635013|P3|NOT COMPLETED|Period 4 - Washout||0
8370906|NCT01154634|20635014|P2|NOT COMPLETED|Period 4 - Washout||0
8370907|NCT01154634|20635015|P1|NOT COMPLETED|Period 4 - Washout||0
8370908|NCT01154634|20635012|P4|COMPLETED|Period 4 - Washout||5
8370909|NCT01154634|20635013|P3|COMPLETED|Period 4 - Washout||4
8370910|NCT01154634|20635014|P2|COMPLETED|Period 4 - Washout||7
8370911|NCT01154634|20635015|P1|COMPLETED|Period 4 - Washout||4
8370912|NCT01154634|20635012|P4|STARTED|Period 4 - Washout||5
8370913|NCT01154634|20635013|P3|STARTED|Period 4 - Washout||4
8370914|NCT01154634|20635014|P2|STARTED|Period 4 - Washout||7
8370915|NCT01154634|20635015|P1|STARTED|Period 4 - Washout||4
8370916|NCT01154634|20635012|P4|NOT COMPLETED|Period 3- Second Intervention||0
8370917|NCT01154634|20635013|P3|NOT COMPLETED|Period 3- Second Intervention||0
8370918|NCT01154634|20635014|P2|NOT COMPLETED|Period 3- Second Intervention||0
8370919|NCT01154634|20635015|P1|NOT COMPLETED|Period 3- Second Intervention||0
8370920|NCT01154634|20635012|P4|COMPLETED|Period 3- Second Intervention||5
8370921|NCT01154634|20635013|P3|COMPLETED|Period 3- Second Intervention||4
8370922|NCT01154634|20635014|P2|COMPLETED|Period 3- Second Intervention||7
8370923|NCT01154634|20635015|P1|COMPLETED|Period 3- Second Intervention||4
8370924|NCT01154634|20635012|P4|STARTED|Period 3- Second Intervention||5
8370925|NCT01154634|20635013|P3|STARTED|Period 3- Second Intervention||4
8370926|NCT01154634|20635014|P2|STARTED|Period 3- Second Intervention||7
8370927|NCT01154634|20635015|P1|STARTED|Period 3- Second Intervention||4
8370928|NCT01154634|20635012|P4|NOT COMPLETED|Period 2 - Washout||0
8370929|NCT01154634|20635013|P3|NOT COMPLETED|Period 2 - Washout||0
8370930|NCT01154634|20635014|P2|NOT COMPLETED|Period 2 - Washout||0
8370931|NCT01154634|20635015|P1|NOT COMPLETED|Period 2 - Washout||0
8370932|NCT01154634|20635012|P4|COMPLETED|Period 2 - Washout||5
8370933|NCT01154634|20635013|P3|COMPLETED|Period 2 - Washout||4
8370934|NCT01154634|20635014|P2|COMPLETED|Period 2 - Washout||7
8370935|NCT01154634|20635015|P1|COMPLETED|Period 2 - Washout||4
8370936|NCT01154634|20635012|P4|STARTED|Period 2 - Washout||5
8370937|NCT01154634|20635013|P3|STARTED|Period 2 - Washout||4
8370938|NCT01154634|20635014|P2|STARTED|Period 2 - Washout||7
8370939|NCT01154634|20635015|P1|STARTED|Period 2 - Washout||4
8370940|NCT01154634|20635012|P4|NOT COMPLETED|Period 1 - First Intervention||0
8370941|NCT01154634|20635013|P3|NOT COMPLETED|Period 1 - First Intervention||0
8370942|NCT01154634|20635014|P2|NOT COMPLETED|Period 1 - First Intervention||0
8370943|NCT01154634|20635015|P1|NOT COMPLETED|Period 1 - First Intervention||0
8370944|NCT01154634|20635012|P4|COMPLETED|Period 1 - First Intervention||5
8370945|NCT01154634|20635013|P3|COMPLETED|Period 1 - First Intervention||4
8370946|NCT01154634|20635014|P2|COMPLETED|Period 1 - First Intervention||7
8370947|NCT01154634|20635015|P1|COMPLETED|Period 1 - First Intervention||4
8370948|NCT01154634|20635012|P4|STARTED|Period 1 - First Intervention||5
8370949|NCT01154634|20635013|P3|STARTED|Period 1 - First Intervention||4
8370950|NCT01154634|20635014|P2|STARTED|Period 1 - First Intervention||7
8370951|NCT01154634|20635015|P1|STARTED|Period 1 - First Intervention||4
8370952|NCT01154452|20635057|P4|NOT COMPLETED|Phase II||6
8370953|NCT01154452|20635058|P3|NOT COMPLETED|Phase II||5
8370954|NCT01154452|20635059|P2|NOT COMPLETED|Phase II||0
8370955|NCT01154452|20635060|P1|NOT COMPLETED|Phase II||0
8370956|NCT01154452|20635057|P4|COMPLETED|Phase II||27
8370957|NCT01154452|20635058|P3|COMPLETED|Phase II||30
8370958|NCT01154452|20635059|P2|COMPLETED|Phase II||0
8370959|NCT01154452|20635060|P1|COMPLETED|Phase II||0
8370960|NCT01154452|20635057|P4|STARTED|Phase II||33
8370961|NCT01154452|20635058|P3|STARTED|Phase II||35
8370962|NCT01154452|20635059|P2|STARTED|Phase II||0
8370963|NCT01154452|20635060|P1|STARTED|Phase II||0
8370964|NCT01154452|20635057|P4|NOT COMPLETED|Phase Ib||0
8370965|NCT01154452|20635058|P3|NOT COMPLETED|Phase Ib||0
8370966|NCT01154452|20635059|P2|NOT COMPLETED|Phase Ib||1
8370967|NCT01154452|20635060|P1|NOT COMPLETED|Phase Ib||3
8370968|NCT01154452|20635057|P4|COMPLETED|Phase Ib||0
8370969|NCT01154452|20635058|P3|COMPLETED|Phase Ib||0
8370970|NCT01154452|20635059|P2|COMPLETED|Phase Ib||3
8370971|NCT01154452|20635060|P1|COMPLETED|Phase Ib||3
8370972|NCT01154452|20635057|P4|STARTED|Phase Ib||0
8370973|NCT01154452|20635058|P3|STARTED|Phase Ib||0
8370974|NCT01154452|20635059|P2|STARTED|Phase Ib||4
8370975|NCT01154452|20635060|P1|STARTED|Phase Ib||6
8370976|NCT01154335|20635076|P3|NOT COMPLETED|Overall Study||5
8370977|NCT01154335|20635077|P2|NOT COMPLETED|Overall Study||6
8370978|NCT01154335|20635078|P1|NOT COMPLETED|Overall Study||7
8370979|NCT01154335|20635076|P3|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
8370980|NCT01154335|20635077|P2|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
8371066|NCT01154218|20635133|P1|NOT COMPLETED|Second Intervention Period||0
8370981|NCT01154335|20635078|P1|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
8370982|NCT01154335|20635076|P3|STARTED|Overall Study||5
8370983|NCT01154335|20635077|P2|STARTED|Overall Study||6
8370984|NCT01154335|20635078|P1|STARTED|Overall Study||7
8370985|NCT01154322|20635085|P1|NOT COMPLETED|Overall Study||2
8370986|NCT01154322|20635085|P1|COMPLETED|Overall Study||14
8370987|NCT01154322|20635085|P1|STARTED|Overall Study||16
8370988|NCT01154296|20635092|P2|NOT COMPLETED|6-month Follow-up||328
8370989|NCT01154296|20635093|P1|NOT COMPLETED|6-month Follow-up||328
8370990|NCT01154296|20635092|P2|COMPLETED|6-month Follow-up||2179
8370991|NCT01154296|20635093|P1|COMPLETED|6-month Follow-up||2177
8370992|NCT01154296|20635092|P2|STARTED|6-month Follow-up||2507
8370993|NCT01154296|20635093|P1|STARTED|6-month Follow-up||2505
8370994|NCT01154296|20635092|P2|NOT COMPLETED|Randomization and Intervention||2
8370995|NCT01154296|20635093|P1|NOT COMPLETED|Randomization and Intervention||5
8370996|NCT01154296|20635092|P2|COMPLETED|Randomization and Intervention||2505
8370997|NCT01154296|20635093|P1|COMPLETED|Randomization and Intervention||2500
8370998|NCT01154296|20635092|P2|STARTED|Randomization and Intervention||2507
8370999|NCT01154296|20635093|P1|STARTED|Randomization and Intervention||2505
8371000|NCT01154283|20635111|P2|NOT COMPLETED|7-12 Weeks||1
8371001|NCT01154283|20635112|P1|NOT COMPLETED|7-12 Weeks||1
8371002|NCT01154283|20635111|P2|COMPLETED|7-12 Weeks||10
8371003|NCT01154283|20635112|P1|COMPLETED|7-12 Weeks||6
8371004|NCT01154283|20635111|P2|STARTED|7-12 Weeks||11
8371005|NCT01154283|20635112|P1|STARTED|7-12 Weeks||7
8371006|NCT01154283|20635111|P2|NOT COMPLETED|0-6 Weeks||3
8371007|NCT01154283|20635112|P1|NOT COMPLETED|0-6 Weeks||7
8371008|NCT01154283|20635111|P2|COMPLETED|0-6 Weeks||11
8371009|NCT01154283|20635112|P1|COMPLETED|0-6 Weeks||7
8371010|NCT01154283|20635111|P2|STARTED|0-6 Weeks||14
8371011|NCT01154283|20635112|P1|STARTED|0-6 Weeks||14
8371012|NCT01154231|20635124|P1|NOT COMPLETED|Overall Study||2
8371013|NCT01154231|20635124|P1|COMPLETED|Overall Study||312
8371014|NCT01154231|20635124|P1|STARTED|Overall Study||314
8371015|NCT01154218|20635130|P4|NOT COMPLETED|Fourth Intervention Period||0
8371016|NCT01154218|20635131|P3|NOT COMPLETED|Fourth Intervention Period||0
8371017|NCT01154218|20635132|P2|NOT COMPLETED|Fourth Intervention Period||0
8371018|NCT01154218|20635133|P1|NOT COMPLETED|Fourth Intervention Period||1
8371019|NCT01154218|20635130|P4|COMPLETED|Fourth Intervention Period||8
8371020|NCT01154218|20635131|P3|COMPLETED|Fourth Intervention Period||9
8371021|NCT01154218|20635132|P2|COMPLETED|Fourth Intervention Period||8
8371022|NCT01154218|20635133|P1|COMPLETED|Fourth Intervention Period||8
8371023|NCT01154218|20635130|P4|STARTED|Fourth Intervention Period||8
8371024|NCT01154218|20635131|P3|STARTED|Fourth Intervention Period||9
8371025|NCT01154218|20635132|P2|STARTED|Fourth Intervention Period||8
8371026|NCT01154218|20635133|P1|STARTED|Fourth Intervention Period||9
8371027|NCT01154218|20635130|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||1
8371028|NCT01154218|20635131|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371029|NCT01154218|20635132|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371030|NCT01154218|20635133|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371031|NCT01154218|20635130|P4|COMPLETED|Washout Period (at Least 14 Days)||8
8371032|NCT01154218|20635131|P3|COMPLETED|Washout Period (at Least 14 Days)||9
8371033|NCT01154218|20635132|P2|COMPLETED|Washout Period (at Least 14 Days)||8
8371034|NCT01154218|20635133|P1|COMPLETED|Washout Period (at Least 14 Days)||9
8371035|NCT01154218|20635130|P4|STARTED|Washout Period (at Least 14 Days)||9
8371036|NCT01154218|20635131|P3|STARTED|Washout Period (at Least 14 Days)||9
8371037|NCT01154218|20635132|P2|STARTED|Washout Period (at Least 14 Days)||8
8371038|NCT01154218|20635133|P1|STARTED|Washout Period (at Least 14 Days)||9
8371039|NCT01154218|20635130|P4|NOT COMPLETED|Third Intervention Period||0
8371040|NCT01154218|20635131|P3|NOT COMPLETED|Third Intervention Period||0
8371041|NCT01154218|20635132|P2|NOT COMPLETED|Third Intervention Period||1
8371042|NCT01154218|20635133|P1|NOT COMPLETED|Third Intervention Period||0
8371043|NCT01154218|20635130|P4|COMPLETED|Third Intervention Period||9
8371044|NCT01154218|20635131|P3|COMPLETED|Third Intervention Period||9
8371045|NCT01154218|20635132|P2|COMPLETED|Third Intervention Period||8
8371046|NCT01154218|20635133|P1|COMPLETED|Third Intervention Period||9
8371047|NCT01154218|20635130|P4|STARTED|Third Intervention Period||9
8371048|NCT01154218|20635131|P3|STARTED|Third Intervention Period||9
8371049|NCT01154218|20635132|P2|STARTED|Third Intervention Period||9
8371050|NCT01154218|20635133|P1|STARTED|Third Intervention Period||9
8371051|NCT01154218|20635130|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371052|NCT01154218|20635131|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371053|NCT01154218|20635132|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371054|NCT01154218|20635133|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371055|NCT01154218|20635130|P4|COMPLETED|Washout Period (at Least 14 Days)||9
8371056|NCT01154218|20635131|P3|COMPLETED|Washout Period (at Least 14 Days)||9
8371057|NCT01154218|20635132|P2|COMPLETED|Washout Period (at Least 14 Days)||9
8371058|NCT01154218|20635133|P1|COMPLETED|Washout Period (at Least 14 Days)||9
8371059|NCT01154218|20635130|P4|STARTED|Washout Period (at Least 14 Days)||9
8371060|NCT01154218|20635131|P3|STARTED|Washout Period (at Least 14 Days)||9
8371061|NCT01154218|20635132|P2|STARTED|Washout Period (at Least 14 Days)||9
8371062|NCT01154218|20635133|P1|STARTED|Washout Period (at Least 14 Days)||9
8371063|NCT01154218|20635130|P4|NOT COMPLETED|Second Intervention Period||0
8371064|NCT01154218|20635131|P3|NOT COMPLETED|Second Intervention Period||0
8371065|NCT01154218|20635132|P2|NOT COMPLETED|Second Intervention Period||0
8371067|NCT01154218|20635130|P4|COMPLETED|Second Intervention Period||9
8371068|NCT01154218|20635131|P3|COMPLETED|Second Intervention Period||9
8371069|NCT01154218|20635132|P2|COMPLETED|Second Intervention Period||9
8371070|NCT01154218|20635133|P1|COMPLETED|Second Intervention Period||9
8371071|NCT01154218|20635130|P4|STARTED|Second Intervention Period||9
8371072|NCT01154218|20635131|P3|STARTED|Second Intervention Period||9
8371073|NCT01154218|20635132|P2|STARTED|Second Intervention Period||9
8371074|NCT01154218|20635133|P1|STARTED|Second Intervention Period||9
8371075|NCT01154218|20635130|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371076|NCT01154218|20635131|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371077|NCT01154218|20635132|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371078|NCT01154218|20635133|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8371079|NCT01154218|20635130|P4|COMPLETED|Washout Period (at Least 14 Days)||9
8371080|NCT01154218|20635131|P3|COMPLETED|Washout Period (at Least 14 Days)||9
8371081|NCT01154218|20635132|P2|COMPLETED|Washout Period (at Least 14 Days)||9
8371082|NCT01154218|20635133|P1|COMPLETED|Washout Period (at Least 14 Days)||9
8371083|NCT01154218|20635130|P4|STARTED|Washout Period (at Least 14 Days)||9
8371084|NCT01154218|20635131|P3|STARTED|Washout Period (at Least 14 Days)||9
8371085|NCT01154218|20635132|P2|STARTED|Washout Period (at Least 14 Days)||9
8371086|NCT01154218|20635133|P1|STARTED|Washout Period (at Least 14 Days)||9
8371087|NCT01154218|20635130|P4|NOT COMPLETED|First Intervention Period||0
8371088|NCT01154218|20635131|P3|NOT COMPLETED|First Intervention Period||0
8371089|NCT01154218|20635132|P2|NOT COMPLETED|First Intervention Period||0
8371090|NCT01154218|20635133|P1|NOT COMPLETED|First Intervention Period||0
8371091|NCT01154218|20635130|P4|COMPLETED|First Intervention Period||9
8371092|NCT01154218|20635131|P3|COMPLETED|First Intervention Period||9
8371093|NCT01154218|20635132|P2|COMPLETED|First Intervention Period||9
8371094|NCT01154218|20635133|P1|COMPLETED|First Intervention Period||9
8371095|NCT01154218|20635130|P4|STARTED|First Intervention Period||9
8371096|NCT01154218|20635131|P3|STARTED|First Intervention Period||9
8371097|NCT01154218|20635132|P2|STARTED|First Intervention Period||9
8371098|NCT01154218|20635133|P1|STARTED|First Intervention Period||9
8371099|NCT01154192|20635186|P3|NOT COMPLETED|Overall Study||0
8371100|NCT01154192|20635187|P2|NOT COMPLETED|Overall Study||0
8371101|NCT01154192|20635188|P1|NOT COMPLETED|Overall Study||0
8371102|NCT01154192|20635186|P3|COMPLETED|Overall Study||0
8371103|NCT01154192|20635187|P2|COMPLETED|Overall Study||10
8371104|NCT01154192|20635188|P1|COMPLETED|Overall Study||14
8371105|NCT01154192|20635186|P3|STARTED|Overall Study||0
8371106|NCT01154192|20635187|P2|STARTED|Overall Study||10
8371107|NCT01154192|20635188|P1|STARTED|Overall Study||14
8371108|NCT01154166|20635207|P2|NOT COMPLETED|Overall Study||12
8371109|NCT01154166|20635208|P1|NOT COMPLETED|Overall Study||34
8371110|NCT01154166|20635207|P2|COMPLETED|Overall Study||163
8371111|NCT01154166|20635208|P1|COMPLETED|Overall Study||135
8371112|NCT01154166|20635207|P2|STARTED|Overall Study||175
8371113|NCT01154166|20635208|P1|STARTED|Overall Study||169
8371114|NCT01154153|20635240|P2|NOT COMPLETED|Overall Study||3
8371115|NCT01154153|20635241|P1|NOT COMPLETED|Overall Study||5
8371116|NCT01154153|20635240|P2|COMPLETED|Overall Study||66
8371117|NCT01154153|20635241|P1|COMPLETED|Overall Study||66
8371118|NCT01154153|20635240|P2|STARTED|Overall Study||69
8371119|NCT01154153|20635241|P1|STARTED|Overall Study||71
8371120|NCT01154140|20635259|P2|NOT COMPLETED|Overall Study||102
8371121|NCT01154140|20635260|P1|NOT COMPLETED|Overall Study||91
8371122|NCT01154140|20635259|P2|COMPLETED|Overall Study||69
8371123|NCT01154140|20635260|P1|COMPLETED|Overall Study||81
8371124|NCT01154140|20635259|P2|Treated|Overall Study||169
8371125|NCT01154140|20635260|P1|Treated|Overall Study||171
8371126|NCT01154140|20635259|P2|STARTED|Overall Study||171
8371127|NCT01154140|20635260|P1|STARTED|Overall Study||172
8371128|NCT01154127|20635313|P2|NOT COMPLETED|Period 2 (21 Days)||1
8371129|NCT01154127|20635314|P1|NOT COMPLETED|Period 2 (21 Days)||0
8371130|NCT01154127|20635313|P2|COMPLETED|Period 2 (21 Days)||46
8371131|NCT01154127|20635314|P1|COMPLETED|Period 2 (21 Days)||49
8371132|NCT01154127|20635313|P2|STARTED|Period 2 (21 Days)||47
8371133|NCT01154127|20635314|P1|STARTED|Period 2 (21 Days)||49
8371134|NCT01154127|20635313|P2|NOT COMPLETED|Washout (14 - 28 Days)||0
8371135|NCT01154127|20635314|P1|NOT COMPLETED|Washout (14 - 28 Days)||3
8371136|NCT01154127|20635313|P2|COMPLETED|Washout (14 - 28 Days)||47
8371137|NCT01154127|20635314|P1|COMPLETED|Washout (14 - 28 Days)||49
8371138|NCT01154127|20635313|P2|STARTED|Washout (14 - 28 Days)||47
8371139|NCT01154127|20635314|P1|STARTED|Washout (14 - 28 Days)||52
8371140|NCT01154127|20635313|P2|NOT COMPLETED|Period 1 (21 Days)||6
8371141|NCT01154127|20635314|P1|NOT COMPLETED|Period 1 (21 Days)||3
8371142|NCT01154127|20635313|P2|COMPLETED|Period 1 (21 Days)||47
8371143|NCT01154127|20635314|P1|COMPLETED|Period 1 (21 Days)||52
8371144|NCT01154127|20635313|P2|STARTED|Period 1 (21 Days)||53
8371145|NCT01154127|20635314|P1|STARTED|Period 1 (21 Days)||55
8371146|NCT01154101|20635341|P5|NOT COMPLETED|Overall Study||1
8371147|NCT01154101|20635342|P4|NOT COMPLETED|Overall Study||2
8371148|NCT01154101|20635343|P3|NOT COMPLETED|Overall Study||3
8371149|NCT01154101|20635344|P2|NOT COMPLETED|Overall Study||4
8371150|NCT01154101|20635345|P1|NOT COMPLETED|Overall Study||0
8371151|NCT01154101|20635341|P5|COMPLETED|Overall Study||0
8371152|NCT01154101|20635342|P4|COMPLETED|Overall Study||9
8371153|NCT01154101|20635343|P3|COMPLETED|Overall Study||9
8371154|NCT01154101|20635344|P2|COMPLETED|Overall Study||5
8371155|NCT01154101|20635345|P1|COMPLETED|Overall Study||7
8371156|NCT01154101|20635341|P5|STARTED|Overall Study||1
8371157|NCT01154101|20635342|P4|STARTED|Overall Study||11
8371158|NCT01154101|20635343|P3|STARTED|Overall Study||12
8371159|NCT01154101|20635344|P2|STARTED|Overall Study||9
8371160|NCT01154101|20635345|P1|STARTED|Overall Study||7
8371161|NCT01154088|20635400|P3|NOT COMPLETED|Overall Study||7
8371162|NCT01154088|20635401|P2|NOT COMPLETED|Overall Study||6
8371163|NCT01154088|20635402|P1|NOT COMPLETED|Overall Study||4
8371164|NCT01154088|20635400|P3|COMPLETED|Overall Study||383
8371165|NCT01154088|20635401|P2|COMPLETED|Overall Study||384
8371166|NCT01154088|20635402|P1|COMPLETED|Overall Study||386
8371167|NCT01154088|20635400|P3|STARTED|Overall Study||390
8371168|NCT01154088|20635401|P2|STARTED|Overall Study||390
8371169|NCT01154088|20635402|P1|STARTED|Overall Study||390
8371170|NCT01154036|20635442|P8|NOT COMPLETED|Phase II||6
8371171|NCT01154036|20635443|P7|NOT COMPLETED|Phase II||9
8371172|NCT01154036|20635444|P6|NOT COMPLETED|Phase II||5
8371173|NCT01154036|20635445|P5|NOT COMPLETED|Phase II||8
8371174|NCT01154036|20635446|P4|NOT COMPLETED|Phase II||1
8371175|NCT01154036|20635447|P3|NOT COMPLETED|Phase II||0
8371176|NCT01154036|20635448|P2|NOT COMPLETED|Phase II||0
8371177|NCT01154036|20635449|P1|NOT COMPLETED|Phase II||0
8371178|NCT01154036|20635442|P8|COMPLETED|Phase II||200
8371179|NCT01154036|20635443|P7|COMPLETED|Phase II||225
8371180|NCT01154036|20635444|P6|COMPLETED|Phase II||121
8371181|NCT01154036|20635445|P5|COMPLETED|Phase II||116
8371182|NCT01154036|20635446|P4|COMPLETED|Phase II||27
8371183|NCT01154036|20635447|P3|COMPLETED|Phase II||0
8371184|NCT01154036|20635448|P2|COMPLETED|Phase II||0
8371185|NCT01154036|20635449|P1|COMPLETED|Phase II||0
8371186|NCT01154036|20635442|P8|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
8371187|NCT01154036|20635443|P7|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
8371188|NCT01154036|20635444|P6|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
8371189|NCT01154036|20635445|P5|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
8371190|NCT01154036|20635446|P4|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
8371191|NCT01154036|20635447|P3|STARTED|Phase II||0
8371192|NCT01154036|20635448|P2|STARTED|Phase II||0
8371193|NCT01154036|20635449|P1|STARTED|Phase II||0
8371194|NCT01154036|20635442|P8|NOT COMPLETED|Phase I||0
8371195|NCT01154036|20635443|P7|NOT COMPLETED|Phase I||0
8371196|NCT01154036|20635444|P6|NOT COMPLETED|Phase I||0
8371197|NCT01154036|20635445|P5|NOT COMPLETED|Phase I||0
8371198|NCT01154036|20635446|P4|NOT COMPLETED|Phase I||0
8371199|NCT01154036|20635447|P3|NOT COMPLETED|Phase I||56
8371200|NCT01154036|20635448|P2|NOT COMPLETED|Phase I||28
8371201|NCT01154036|20635449|P1|NOT COMPLETED|Phase I||3
8371202|NCT01154036|20635442|P8|COMPLETED|Phase I||0
8371203|NCT01154036|20635443|P7|COMPLETED|Phase I||0
8371204|NCT01154036|20635444|P6|COMPLETED|Phase I||0
8371205|NCT01154036|20635445|P5|COMPLETED|Phase I||0
8371206|NCT01154036|20635446|P4|COMPLETED|Phase I||0
8371207|NCT01154036|20635447|P3|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
8371208|NCT01154036|20635448|P2|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
8371209|NCT01154036|20635449|P1|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
8371210|NCT01154036|20635442|P8|STARTED|Phase I||0
8371211|NCT01154036|20635443|P7|STARTED|Phase I||0
8371212|NCT01154036|20635444|P6|STARTED|Phase I||0
8371213|NCT01154036|20635445|P5|STARTED|Phase I||0
8371214|NCT01154036|20635446|P4|STARTED|Phase I||0
8371215|NCT01154036|20635447|P3|STARTED|Phase I||944
8371216|NCT01154036|20635448|P2|STARTED|Phase I||483
8371217|NCT01154036|20635449|P1|STARTED|Phase I||120
8371218|NCT01154010|20635573|P2|NOT COMPLETED|Overall Study||1
8371219|NCT01154010|20635574|P1|NOT COMPLETED|Overall Study||0
8371220|NCT01154010|20635573|P2|COMPLETED|Overall Study||8
8371221|NCT01154010|20635574|P1|COMPLETED|Overall Study||9
8371222|NCT01154010|20635573|P2|STARTED|Overall Study||9
8371223|NCT01154010|20635574|P1|STARTED|Overall Study||9
8371224|NCT01153984|20635580|P1|NOT COMPLETED|Overall Study||2
8371225|NCT01153984|20635580|P1|COMPLETED|Overall Study||21
8371226|NCT01153984|20635580|P1|STARTED|Overall Study||23
8371227|NCT01153971|20635591|P1|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
8371228|NCT01153971|20635591|P1|COMPLETED|Follow-up (Months 17-40 of Study)||37
8371229|NCT01153971|20635591|P1|STARTED|Follow-up (Months 17-40 of Study)||41
8371230|NCT01153971|20635591|P1|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
8371231|NCT01153971|20635591|P1|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
8371232|NCT01153971|20635591|P1|STARTED|Maintenance Phase (Months 8-16 of Study)||44
8371233|NCT01153971|20635591|P1|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
8371234|NCT01153971|20635591|P1|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
8371235|NCT01153971|20635591|P1|STARTED|Induction Phase (Months 1 to 7 of Study)||47
8371236|NCT01153958|20635614|P2|NOT COMPLETED|Overall Study||32
8371237|NCT01153958|20635615|P1|NOT COMPLETED|Overall Study||36
8371238|NCT01153958|20635614|P2|COMPLETED|Overall Study||35
8371239|NCT01153958|20635615|P1|COMPLETED|Overall Study||30
8371240|NCT01153958|20635614|P2|STARTED|Overall Study||67
8371241|NCT01153958|20635615|P1|STARTED|Overall Study||66
8371242|NCT01153893|20635633|P2|NOT COMPLETED|Overall Study||0
8371243|NCT01153893|20635634|P1|NOT COMPLETED|Overall Study||1
8371244|NCT01153893|20635633|P2|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
8371338|NCT01153321|20635987|P2|COMPLETED|Overall Study||19
8371245|NCT01153893|20635634|P1|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
8371246|NCT01153893|20635633|P2|STARTED|Overall Study||36
8371247|NCT01153893|20635634|P1|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
8371248|NCT01153841|20635660|P2|NOT COMPLETED|Overall Study||0
8371249|NCT01153841|20635661|P1|NOT COMPLETED|Overall Study||6
8371250|NCT01153841|20635660|P2|COMPLETED|Overall Study||99
8371251|NCT01153841|20635661|P1|COMPLETED|Overall Study||193
8371252|NCT01153841|20635660|P2|STARTED|Overall Study||99
8371253|NCT01153841|20635661|P1|STARTED|Overall Study||199
8371254|NCT01153815|20635677|P2|NOT COMPLETED|Overall Study||5
8371255|NCT01153815|20635678|P1|NOT COMPLETED|Overall Study||9
8371256|NCT01153815|20635677|P2|COMPLETED|Overall Study||82
8371257|NCT01153815|20635678|P1|COMPLETED|Overall Study||74
8371258|NCT01153815|20635677|P2|STARTED|Overall Study||87
8371259|NCT01153815|20635678|P1|STARTED|Overall Study||83
8371260|NCT01153763|20635700|P1|NOT COMPLETED|Overall Study||21
8371261|NCT01153763|20635700|P1|COMPLETED|Overall Study||71
8371262|NCT01153763|20635700|P1|STARTED|Overall Study||92
8371263|NCT01153724|20635716|P1|NOT COMPLETED|Treatment Period 2||2
8371264|NCT01153724|20635716|P1|COMPLETED|Treatment Period 2||32
8371265|NCT01153724|20635716|P1|STARTED|Treatment Period 2||34
8371266|NCT01153724|20635716|P1|NOT COMPLETED|Treatment Period 1||1
8371267|NCT01153724|20635716|P1|COMPLETED|Treatment Period 1||34
8371268|NCT01153724|20635716|P1|STARTED|Treatment Period 1||35
8371269|NCT01153711|20635736|P1|NOT COMPLETED|Overall Study||0
8371270|NCT01153711|20635736|P1|COMPLETED|Overall Study||32
8371271|NCT01153711|20635736|P1|STARTED|Overall Study||32
8371272|NCT01153698|20635756|P1|NOT COMPLETED|Overall Study||29
8371273|NCT01153698|20635756|P1|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
8371274|NCT01153698|20635756|P1|STARTED|Overall Study|Entered and treated.|168
8371275|NCT01153685|20635772|P2|NOT COMPLETED|Overall Study||0
8371276|NCT01153685|20635773|P1|NOT COMPLETED|Overall Study||0
8371277|NCT01153685|20635772|P2|COMPLETED|Overall Study||70
8371278|NCT01153685|20635773|P1|COMPLETED|Overall Study||50
8371279|NCT01153685|20635772|P2|STARTED|Overall Study||70
8371280|NCT01153685|20635773|P1|STARTED|Overall Study||50
8371281|NCT01153672|20635797|P1|NOT COMPLETED|Overall Study||2
8371282|NCT01153672|20635797|P1|COMPLETED|Overall Study||6
8371283|NCT01153672|20635797|P1|STARTED|Overall Study||8
8371284|NCT01153633|20635807|P2|NOT COMPLETED|Overall Study||4
8371285|NCT01153633|20635808|P1|NOT COMPLETED|Overall Study||4
8371286|NCT01153633|20635807|P2|COMPLETED|Overall Study||13
8371287|NCT01153633|20635808|P1|COMPLETED|Overall Study||13
8371288|NCT01153633|20635807|P2|STARTED|Overall Study||17
8371289|NCT01153633|20635808|P1|STARTED|Overall Study||17
8371290|NCT01153620|20635826|P2|NOT COMPLETED|Overall Study||0
8371291|NCT01153620|20635827|P1|NOT COMPLETED|Overall Study||0
8371292|NCT01153620|20635826|P2|COMPLETED|Overall Study|30 patients (31 wounds)|30
8371293|NCT01153620|20635827|P1|COMPLETED|Overall Study||30
8371294|NCT01153620|20635826|P2|STARTED|Overall Study|30 patients (31 wounds)|30
8371295|NCT01153620|20635827|P1|STARTED|Overall Study||30
8371296|NCT01153581|20635833|P1|NOT COMPLETED|Overall Study||0
8371297|NCT01153581|20635833|P1|COMPLETED|Overall Study||109
8371298|NCT01153581|20635833|P1|STARTED|Overall Study||109
8371299|NCT01153516|20635845|P2|NOT COMPLETED|Overall Study||0
8371300|NCT01153516|20635846|P1|NOT COMPLETED|Overall Study||2
8371301|NCT01153516|20635845|P2|COMPLETED|Overall Study||10
8371302|NCT01153516|20635846|P1|COMPLETED|Overall Study||10
8371303|NCT01153516|20635845|P2|STARTED|Overall Study||10
8371304|NCT01153516|20635846|P1|STARTED|Overall Study||12
8371305|NCT01153503|20635859|P3|NOT COMPLETED|Overall Study||0
8371306|NCT01153503|20635860|P2|NOT COMPLETED|Overall Study||1
8371307|NCT01153503|20635861|P1|NOT COMPLETED|Overall Study||0
8371308|NCT01153503|20635859|P3|COMPLETED|Overall Study||25
8371309|NCT01153503|20635860|P2|COMPLETED|Overall Study||24
8371310|NCT01153503|20635861|P1|COMPLETED|Overall Study||25
8371311|NCT01153503|20635859|P3|STARTED|Overall Study||25
8371312|NCT01153503|20635860|P2|STARTED|Overall Study||25
8371313|NCT01153503|20635861|P1|STARTED|Overall Study||25
8371314|NCT01153425|20635871|P2|NOT COMPLETED|Overall Study||3
8371315|NCT01153425|20635872|P1|NOT COMPLETED|Overall Study||3
8371316|NCT01153425|20635871|P2|COMPLETED|Overall Study||14
8371317|NCT01153425|20635872|P1|COMPLETED|Overall Study||13
8371318|NCT01153425|20635871|P2|STARTED|Overall Study||17
8371319|NCT01153425|20635872|P1|STARTED|Overall Study||16
8371320|NCT01153347|20635884|P4|NOT COMPLETED|Overall Study||32
8371321|NCT01153347|20635885|P3|NOT COMPLETED|Overall Study||50
8371322|NCT01153347|20635886|P2|NOT COMPLETED|Overall Study||44
8371323|NCT01153347|20635887|P1|NOT COMPLETED|Overall Study||33
8371324|NCT01153347|20635884|P4|COMPLETED|Overall Study||129
8371325|NCT01153347|20635885|P3|COMPLETED|Overall Study||110
8371326|NCT01153347|20635886|P2|COMPLETED|Overall Study||116
8371327|NCT01153347|20635887|P1|COMPLETED|Overall Study||127
8371328|NCT01153347|20635884|P4|Received Treatment|Overall Study||160
8371329|NCT01153347|20635885|P3|Received Treatment|Overall Study||158
8371330|NCT01153347|20635886|P2|Received Treatment|Overall Study||158
8371331|NCT01153347|20635887|P1|Received Treatment|Overall Study||160
8371332|NCT01153347|20635884|P4|STARTED|Overall Study||161
8371333|NCT01153347|20635885|P3|STARTED|Overall Study||160
8371334|NCT01153347|20635886|P2|STARTED|Overall Study||160
8371335|NCT01153347|20635887|P1|STARTED|Overall Study||160
8371336|NCT01153321|20635987|P2|NOT COMPLETED|Overall Study||3
8371337|NCT01153321|20635988|P1|NOT COMPLETED|Overall Study||1
8371339|NCT01153321|20635988|P1|COMPLETED|Overall Study||21
8371340|NCT01153321|20635987|P2|STARTED|Overall Study||22
8371341|NCT01153321|20635988|P1|STARTED|Overall Study||22
8371342|NCT01153269|20636100|P1|NOT COMPLETED|Overall Study||2
8371343|NCT01153269|20636100|P1|COMPLETED|Overall Study||31
8371344|NCT01153269|20636100|P1|Participants Analyzed|Overall Study||33
8371345|NCT01153269|20636100|P1|STARTED|Overall Study||33
8371346|NCT01153009|20636163|P4|NOT COMPLETED|Overall Study||37
8371347|NCT01153009|20636164|P3|NOT COMPLETED|Overall Study||41
8371348|NCT01153009|20636165|P2|NOT COMPLETED|Overall Study||34
8371349|NCT01153009|20636166|P1|NOT COMPLETED|Overall Study||32
8371350|NCT01153009|20636163|P4|COMPLETED|Overall Study||115
8371351|NCT01153009|20636164|P3|COMPLETED|Overall Study||113
8371352|NCT01153009|20636165|P2|COMPLETED|Overall Study||113
8371353|NCT01153009|20636166|P1|COMPLETED|Overall Study||129
8371354|NCT01153009|20636163|P4|Treated|Overall Study||150
8371355|NCT01153009|20636164|P3|Treated|Overall Study||154
8371356|NCT01153009|20636165|P2|Treated|Overall Study||147
8371357|NCT01153009|20636166|P1|Treated|Overall Study||159
8371358|NCT01153009|20636163|P4|STARTED|Overall Study||152
8371359|NCT01153009|20636164|P3|STARTED|Overall Study||154
8371360|NCT01153009|20636165|P2|STARTED|Overall Study||147
8371361|NCT01153009|20636166|P1|STARTED|Overall Study||161
8371362|NCT01152996|20636196|P1|NOT COMPLETED|Overall Study||537
8371363|NCT01152996|20636196|P1|COMPLETED|Overall Study||538
8371364|NCT01152996|20636196|P1|Treated|Overall Study||1073
8371365|NCT01152996|20636196|P1|STARTED|Overall Study||1075
8371366|NCT01152814|20636209|P1|NOT COMPLETED|Overall Study||2
8371367|NCT01152814|20636209|P1|COMPLETED|Overall Study||62
8371368|NCT01152814|20636209|P1|STARTED|Overall Study||64
8371369|NCT01152788|20636218|P2|NOT COMPLETED|Overall Study||4
8371370|NCT01152788|20636219|P1|NOT COMPLETED|Overall Study||0
8371371|NCT01152788|20636218|P2|COMPLETED|Overall Study||28
8371372|NCT01152788|20636219|P1|COMPLETED|Overall Study||32
8371373|NCT01152788|20636218|P2|STARTED|Overall Study||32
8371374|NCT01152788|20636219|P1|STARTED|Overall Study||32
8371375|NCT01152697|20636231|P1|NOT COMPLETED|Overall Study||19
8371376|NCT01152697|20636231|P1|COMPLETED|Overall Study||11
8371377|NCT01152697|20636231|P1|STARTED|Overall Study||30
8371378|NCT01152580|20636256|P2|NOT COMPLETED|Overall Study||1
8371379|NCT01152580|20636257|P1|NOT COMPLETED|Overall Study||0
8371380|NCT01152580|20636256|P2|COMPLETED|Overall Study||13
8371381|NCT01152580|20636257|P1|COMPLETED|Overall Study||5
8371382|NCT01152580|20636256|P2|STARTED|Overall Study||14
8371383|NCT01152580|20636257|P1|STARTED|Overall Study||5
8371384|NCT01152554|20636279|P2|NOT COMPLETED|Overall Study||111
8371385|NCT01152554|20636280|P1|NOT COMPLETED|Overall Study||334
8371386|NCT01152554|20636279|P2|COMPLETED|Overall Study||92
8371387|NCT01152554|20636280|P1|COMPLETED|Overall Study||276
8371388|NCT01152554|20636279|P2|Received Treatment|Overall Study||201
8371389|NCT01152554|20636280|P1|Received Treatment|Overall Study||607
8371390|NCT01152554|20636279|P2|STARTED|Overall Study||203
8371391|NCT01152554|20636280|P1|STARTED|Overall Study||610
8371392|NCT01152515|20636304|P2|NOT COMPLETED|Overall Study||0
8371393|NCT01152515|20636305|P1|NOT COMPLETED|Overall Study||0
8371394|NCT01152515|20636304|P2|COMPLETED|Overall Study||25
8371395|NCT01152515|20636305|P1|COMPLETED|Overall Study||25
8371396|NCT01152515|20636304|P2|STARTED|Overall Study||25
8371397|NCT01152515|20636305|P1|STARTED|Overall Study||25
8371398|NCT01152450|20636319|P6|NOT COMPLETED|Period 3 (4 Weeks)||0
8371399|NCT01152450|20636320|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
8371400|NCT01152450|20636321|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
8371401|NCT01152450|20636322|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
8371402|NCT01152450|20636323|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
8371403|NCT01152450|20636324|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
8371404|NCT01152450|20636319|P6|COMPLETED|Period 3 (4 Weeks)||12
8371405|NCT01152450|20636320|P5|COMPLETED|Period 3 (4 Weeks)||16
8371406|NCT01152450|20636321|P4|COMPLETED|Period 3 (4 Weeks)||15
8371407|NCT01152450|20636322|P3|COMPLETED|Period 3 (4 Weeks)||16
8371408|NCT01152450|20636323|P2|COMPLETED|Period 3 (4 Weeks)||15
8371409|NCT01152450|20636324|P1|COMPLETED|Period 3 (4 Weeks)||15
8371410|NCT01152450|20636319|P6|STARTED|Period 3 (4 Weeks)||12
8371411|NCT01152450|20636320|P5|STARTED|Period 3 (4 Weeks)||16
8371412|NCT01152450|20636321|P4|STARTED|Period 3 (4 Weeks)||15
8371413|NCT01152450|20636322|P3|STARTED|Period 3 (4 Weeks)||16
8371414|NCT01152450|20636323|P2|STARTED|Period 3 (4 Weeks)||15
8371415|NCT01152450|20636324|P1|STARTED|Period 3 (4 Weeks)||15
8371416|NCT01152450|20636319|P6|NOT COMPLETED|Period 2 (4 Weeks)||0
8371417|NCT01152450|20636320|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
8371418|NCT01152450|20636321|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
8371419|NCT01152450|20636322|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
8371420|NCT01152450|20636323|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
8371421|NCT01152450|20636324|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
8371422|NCT01152450|20636319|P6|COMPLETED|Period 2 (4 Weeks)||12
8371423|NCT01152450|20636320|P5|COMPLETED|Period 2 (4 Weeks)||16
8371424|NCT01152450|20636321|P4|COMPLETED|Period 2 (4 Weeks)||15
8371425|NCT01152450|20636322|P3|COMPLETED|Period 2 (4 Weeks)||16
8371426|NCT01152450|20636323|P2|COMPLETED|Period 2 (4 Weeks)||15
8371427|NCT01152450|20636324|P1|COMPLETED|Period 2 (4 Weeks)||15
8371428|NCT01152450|20636319|P6|STARTED|Period 2 (4 Weeks)||12
8371429|NCT01152450|20636320|P5|STARTED|Period 2 (4 Weeks)||16
8371430|NCT01152450|20636321|P4|STARTED|Period 2 (4 Weeks)||15
8371431|NCT01152450|20636322|P3|STARTED|Period 2 (4 Weeks)||16
8371432|NCT01152450|20636323|P2|STARTED|Period 2 (4 Weeks)||15
8371433|NCT01152450|20636324|P1|STARTED|Period 2 (4 Weeks)||15
8371434|NCT01152450|20636319|P6|NOT COMPLETED|Period 1 (4 Weeks)||1
8371435|NCT01152450|20636320|P5|NOT COMPLETED|Period 1 (4 Weeks)||2
8371436|NCT01152450|20636321|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
8371437|NCT01152450|20636322|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
8371438|NCT01152450|20636323|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
8371439|NCT01152450|20636324|P1|NOT COMPLETED|Period 1 (4 Weeks)||0
8371440|NCT01152450|20636319|P6|COMPLETED|Period 1 (4 Weeks)||12
8371441|NCT01152450|20636320|P5|COMPLETED|Period 1 (4 Weeks)||16
8371442|NCT01152450|20636321|P4|COMPLETED|Period 1 (4 Weeks)||15
8371443|NCT01152450|20636322|P3|COMPLETED|Period 1 (4 Weeks)||16
8371444|NCT01152450|20636323|P2|COMPLETED|Period 1 (4 Weeks)||15
8371445|NCT01152450|20636324|P1|COMPLETED|Period 1 (4 Weeks)||15
8371446|NCT01152450|20636319|P6|STARTED|Period 1 (4 Weeks)||13
8371447|NCT01152450|20636320|P5|STARTED|Period 1 (4 Weeks)||18
8371448|NCT01152450|20636321|P4|STARTED|Period 1 (4 Weeks)||15
8371449|NCT01152450|20636322|P3|STARTED|Period 1 (4 Weeks)||17
8371450|NCT01152450|20636323|P2|STARTED|Period 1 (4 Weeks)||16
8371451|NCT01152450|20636324|P1|STARTED|Period 1 (4 Weeks)||15
8371452|NCT01152437|20636395|P3|NOT COMPLETED|Overall Study||43
8371453|NCT01152437|20636396|P2|NOT COMPLETED|Overall Study||15
8371454|NCT01152437|20636397|P1|NOT COMPLETED|Overall Study||36
8371455|NCT01152437|20636395|P3|COMPLETED|Overall Study||0
8371456|NCT01152437|20636396|P2|COMPLETED|Overall Study||0
8371457|NCT01152437|20636397|P1|COMPLETED|Overall Study||0
8371458|NCT01152437|20636395|P3|STARTED|Overall Study|entered|43
8371459|NCT01152437|20636396|P2|STARTED|Overall Study|randomised|15
8371460|NCT01152437|20636397|P1|STARTED|Overall Study|randomised|36
8371461|NCT01152385|20636417|P4|NOT COMPLETED|Overall Study||5
8371462|NCT01152385|20636418|P3|NOT COMPLETED|Overall Study||5
8371463|NCT01152385|20636419|P2|NOT COMPLETED|Overall Study||6
8371464|NCT01152385|20636420|P1|NOT COMPLETED|Overall Study||9
8371465|NCT01152385|20636417|P4|COMPLETED|Overall Study||50
8371466|NCT01152385|20636418|P3|COMPLETED|Overall Study||51
8371467|NCT01152385|20636419|P2|COMPLETED|Overall Study||52
8371468|NCT01152385|20636420|P1|COMPLETED|Overall Study||46
8371469|NCT01152385|20636417|P4|STARTED|Overall Study||55
8371470|NCT01152385|20636418|P3|STARTED|Overall Study||56
8371471|NCT01152385|20636419|P2|STARTED|Overall Study||58
8371472|NCT01152385|20636420|P1|STARTED|Overall Study||55
8371473|NCT01152359|20636460|P2|NOT COMPLETED|Overall Study||22
8371474|NCT01152359|20636461|P1|NOT COMPLETED|Overall Study||24
8371475|NCT01152359|20636460|P2|COMPLETED|Overall Study||80
8371476|NCT01152359|20636461|P1|COMPLETED|Overall Study||81
8371477|NCT01152359|20636460|P2|STARTED|Overall Study||102
8371478|NCT01152359|20636461|P1|STARTED|Overall Study||105
8371479|NCT01152307|20636473|P2|NOT COMPLETED|Overall Study||0
8371480|NCT01152307|20636474|P1|NOT COMPLETED|Overall Study||0
8371481|NCT01152307|20636473|P2|COMPLETED|Overall Study||214
8371482|NCT01152307|20636474|P1|COMPLETED|Overall Study||191
8371483|NCT01152307|20636473|P2|STARTED|Overall Study||214
8371484|NCT01152307|20636474|P1|STARTED|Overall Study||191
8371485|NCT01152294|20636482|P2|NOT COMPLETED|Overall Study||0
8371486|NCT01152294|20636483|P1|NOT COMPLETED|Overall Study||0
8371487|NCT01152294|20636482|P2|COMPLETED|Overall Study||188
8371488|NCT01152294|20636483|P1|COMPLETED|Overall Study||213
8371489|NCT01152294|20636482|P2|STARTED|Overall Study||188
8371490|NCT01152294|20636483|P1|STARTED|Overall Study||213
8371491|NCT01152190|20636491|P2|NOT COMPLETED|Overall Study||8
8371492|NCT01152190|20636492|P1|NOT COMPLETED|Overall Study||5
8371493|NCT01152190|20636491|P2|COMPLETED|Overall Study||39
8371494|NCT01152190|20636492|P1|COMPLETED|Overall Study||45
8371495|NCT01152190|20636491|P2|Received at Least 1 Dose of Study Drug|Overall Study||47
8371496|NCT01152190|20636492|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
8371497|NCT01152190|20636491|P2|STARTED|Overall Study||47
8371498|NCT01152190|20636492|P1|STARTED|Overall Study||50
8371499|NCT01152112|20636506|P2|NOT COMPLETED|Overall Study||0
8371500|NCT01152112|20636507|P1|NOT COMPLETED|Overall Study||0
8371501|NCT01152112|20636506|P2|COMPLETED|Overall Study||32
8371502|NCT01152112|20636507|P1|COMPLETED|Overall Study||42
8371503|NCT01152112|20636506|P2|STARTED|Overall Study||32
8371504|NCT01152112|20636507|P1|STARTED|Overall Study||42
8371505|NCT01152021|20636515|P2|NOT COMPLETED|Overall Study||6
8371506|NCT01152021|20636516|P1|NOT COMPLETED|Overall Study||6
8371507|NCT01152021|20636515|P2|COMPLETED|Overall Study||1
8371508|NCT01152021|20636516|P1|COMPLETED|Overall Study||2
8371509|NCT01152021|20636515|P2|STARTED|Overall Study||7
8371510|NCT01152021|20636516|P1|STARTED|Overall Study||8
8371511|NCT01151904|20636524|P1|NOT COMPLETED|Overall Study||0
8371512|NCT01151904|20636524|P1|COMPLETED|Overall Study||17
8371513|NCT01151904|20636524|P1|STARTED|Overall Study||17
8371514|NCT01151852|20636532|P2|NOT COMPLETED|Overall Study||0
8371515|NCT01151852|20636533|P1|NOT COMPLETED|Overall Study||0
8371516|NCT01151852|20636532|P2|COMPLETED|Overall Study||40
8371517|NCT01151852|20636533|P1|COMPLETED|Overall Study||41
8371518|NCT01151852|20636532|P2|STARTED|Overall Study||40
8371519|NCT01151852|20636533|P1|STARTED|Overall Study||41
8371520|NCT01151813|20636549|P2|NOT COMPLETED|Period 2||0
8371521|NCT01151813|20636550|P1|NOT COMPLETED|Period 2||0
8371522|NCT01151813|20636549|P2|COMPLETED|Period 2||7
8371523|NCT01151813|20636550|P1|COMPLETED|Period 2||8
8371524|NCT01151813|20636549|P2|STARTED|Period 2||7
8371525|NCT01151813|20636550|P1|STARTED|Period 2||8
8371526|NCT01151813|20636549|P2|NOT COMPLETED|Period 1||0
8371527|NCT01151813|20636550|P1|NOT COMPLETED|Period 1||0
8371528|NCT01151813|20636549|P2|COMPLETED|Period 1||7
8371529|NCT01151813|20636550|P1|COMPLETED|Period 1||8
8371530|NCT01151813|20636549|P2|STARTED|Period 1||7
8371531|NCT01151813|20636550|P1|STARTED|Period 1||8
8371532|NCT01151761|20636562|P1|NOT COMPLETED|Overall Study||0
8371533|NCT01151761|20636562|P1|COMPLETED|Overall Study||2
8371534|NCT01151761|20636562|P1|STARTED|Overall Study||2
8371535|NCT01151618|20636573|P1|NOT COMPLETED|Overall Study||9
8371536|NCT01151618|20636573|P1|COMPLETED|Overall Study||13
8371537|NCT01151618|20636573|P1|STARTED|Overall Study||22
8371538|NCT01151579|20636581|P2|NOT COMPLETED|Overall Study||7
8371539|NCT01151579|20636582|P1|NOT COMPLETED|Overall Study||12
8371540|NCT01151579|20636581|P2|COMPLETED|Overall Study||24
8371541|NCT01151579|20636582|P1|COMPLETED|Overall Study||46
8371542|NCT01151579|20636581|P2|STARTED|Overall Study||31
8371543|NCT01151579|20636582|P1|STARTED|Overall Study||58
8371544|NCT01151553|20636592|P1|NOT COMPLETED|Overall Study||0
8371545|NCT01151553|20636592|P1|COMPLETED|Overall Study||5
8371546|NCT01151553|20636592|P1|STARTED|Overall Study||5
8371547|NCT01151540|20636596|P1|NOT COMPLETED|Overall Study||13
8371548|NCT01151540|20636596|P1|COMPLETED|Overall Study||41
8371549|NCT01151540|20636596|P1|STARTED|Overall Study||54
8371550|NCT01151449|20636605|P1|NOT COMPLETED|Overall Study||0
8371551|NCT01151449|20636605|P1|COMPLETED|Overall Study||6
8371552|NCT01151449|20636605|P1|STARTED|Overall Study||6
8371556|NCT01151423|20636645|P2|NOT COMPLETED|Overall Study||18
8371557|NCT01151423|20636646|P1|NOT COMPLETED|Overall Study||16
8371558|NCT01151423|20636645|P2|COMPLETED|Overall Study||21
8371559|NCT01151423|20636646|P1|COMPLETED|Overall Study||20
8371560|NCT01151423|20636645|P2|Received Study Drug|Overall Study||37
8371561|NCT01151423|20636646|P1|Received Study Drug|Overall Study||35
8371562|NCT01151423|20636645|P2|STARTED|Overall Study||39
8371563|NCT01151423|20636646|P1|STARTED|Overall Study||36
8371564|NCT01151410|20636694|P2|NOT COMPLETED|Overall Study||15
8371565|NCT01151410|20636695|P1|NOT COMPLETED|Overall Study||11
8371566|NCT01151410|20636694|P2|COMPLETED|Overall Study||89
8371567|NCT01151410|20636695|P1|COMPLETED|Overall Study||93
8371568|NCT01151410|20636694|P2|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
8371569|NCT01151410|20636695|P1|Safety Set (SAF)|Overall Study||105
8371570|NCT01151410|20636694|P2|STARTED|Overall Study||104
8371571|NCT01151410|20636695|P1|STARTED|Overall Study||104
8371572|NCT01151371|20636708|P3|NOT COMPLETED|Overall Study||7
8371573|NCT01151371|20636709|P2|NOT COMPLETED|Overall Study||1
8371574|NCT01151371|20636710|P1|NOT COMPLETED|Overall Study||5
8371575|NCT01151371|20636708|P3|COMPLETED|Overall Study||146
8371576|NCT01151371|20636709|P2|COMPLETED|Overall Study||149
8371577|NCT01151371|20636710|P1|COMPLETED|Overall Study||144
8371578|NCT01151371|20636708|P3|STARTED|Overall Study||153
8371579|NCT01151371|20636709|P2|STARTED|Overall Study||150
8371580|NCT01151371|20636710|P1|STARTED|Overall Study||149
8371581|NCT01151345|20636739|P2|NOT COMPLETED|Second Intervention Period||0
8371582|NCT01151345|20636740|P1|NOT COMPLETED|Second Intervention Period||0
8371583|NCT01151345|20636739|P2|COMPLETED|Second Intervention Period||12
8371584|NCT01151345|20636740|P1|COMPLETED|Second Intervention Period||13
8371585|NCT01151345|20636739|P2|STARTED|Second Intervention Period||12
8371586|NCT01151345|20636740|P1|STARTED|Second Intervention Period||13
8371587|NCT01151345|20636739|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
8371588|NCT01151345|20636740|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
8371589|NCT01151345|20636739|P2|COMPLETED|Wash-out Period (7 Days)||12
8371590|NCT01151345|20636740|P1|COMPLETED|Wash-out Period (7 Days)||13
8371591|NCT01151345|20636739|P2|STARTED|Wash-out Period (7 Days)||12
8371592|NCT01151345|20636740|P1|STARTED|Wash-out Period (7 Days)||13
8371593|NCT01151345|20636739|P2|NOT COMPLETED|First Intervention Period||1
8371594|NCT01151345|20636740|P1|NOT COMPLETED|First Intervention Period||0
8371595|NCT01151345|20636739|P2|COMPLETED|First Intervention Period||12
8371596|NCT01151345|20636740|P1|COMPLETED|First Intervention Period||13
8371597|NCT01151345|20636739|P2|Treated|First Intervention Period||12
8371598|NCT01151345|20636740|P1|Treated|First Intervention Period||13
8371599|NCT01151345|20636739|P2|STARTED|First Intervention Period||13
8371600|NCT01151345|20636740|P1|STARTED|First Intervention Period||13
8371601|NCT01151280|20636754|P1|NOT COMPLETED|Overall Study||4
8371602|NCT01151280|20636754|P1|COMPLETED|Overall Study||6
8371603|NCT01151280|20636754|P1|STARTED|Overall Study||10
8371604|NCT01151215|20636767|P3|NOT COMPLETED|Overall Study||19
8371605|NCT01151215|20636768|P2|NOT COMPLETED|Overall Study||23
8371606|NCT01151215|20636769|P1|NOT COMPLETED|Overall Study||20
8371607|NCT01151215|20636767|P3|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
8371608|NCT01151215|20636768|P2|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
8371609|NCT01151215|20636769|P1|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
8371610|NCT01151215|20636767|P3|STARTED|Overall Study||121
8371611|NCT01151215|20636768|P2|STARTED|Overall Study||118
8371612|NCT01151215|20636769|P1|STARTED|Overall Study||120
8371613|NCT01151189|20636782|P2|NOT COMPLETED|Overall Study||10
8371614|NCT01151189|20636783|P1|NOT COMPLETED|Overall Study||15
8371615|NCT01151189|20636782|P2|COMPLETED|Overall Study||314
8371616|NCT01151189|20636783|P1|COMPLETED|Overall Study||311
8371617|NCT01151189|20636782|P2|Received Vaccine|Overall Study||324
8371618|NCT01151189|20636783|P1|Received Vaccine|Overall Study||325
8371619|NCT01151189|20636782|P2|STARTED|Overall Study||324
8371620|NCT01151189|20636783|P1|STARTED|Overall Study||326
8371621|NCT01151137|20636807|P2|NOT COMPLETED|Overall Study||28
8371622|NCT01151137|20636808|P1|NOT COMPLETED|Overall Study||16
8371623|NCT01151137|20636807|P2|COMPLETED|Overall Study||1591
8371624|NCT01151137|20636808|P1|COMPLETED|Overall Study||1601
8371625|NCT01151137|20636807|P2|Discontinued Treatment|Overall Study||342
8371626|NCT01151137|20636808|P1|Discontinued Treatment|Overall Study||171
8371627|NCT01151137|20636807|P2|Treated|Overall Study||1613
8371628|NCT01151137|20636808|P1|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
8371629|NCT01151137|20636807|P2|STARTED|Overall Study||1619
8371630|NCT01151137|20636808|P1|STARTED|Overall Study||1617
8371631|NCT01151098|20636826|P1|NOT COMPLETED|Overall Study||117
8371632|NCT01151098|20636826|P1|COMPLETED|Overall Study||72
8371633|NCT01151098|20636826|P1|STARTED|Overall Study|Extension Safety Population|189
8371634|NCT01151085|20636830|P1|NOT COMPLETED|Overall Study||56
8371635|NCT01151085|20636830|P1|COMPLETED|Overall Study||946
8371636|NCT01151085|20636830|P1|STARTED|Overall Study||1002
8371637|NCT01151046|20636848|P2|NOT COMPLETED|Overall Study||0
8371638|NCT01151046|20636849|P1|NOT COMPLETED|Overall Study||3
8371639|NCT01151046|20636848|P2|COMPLETED|Overall Study||59
8371640|NCT01151046|20636849|P1|COMPLETED|Overall Study||56
8371641|NCT01151046|20636848|P2|STARTED|Overall Study||59
8371642|NCT01151046|20636849|P1|STARTED|Overall Study||59
8371643|NCT01151020|20636861|P1|NOT COMPLETED|Overall Study||54
8371644|NCT01151020|20636861|P1|COMPLETED|Overall Study||56
8371645|NCT01151020|20636861|P1|30-day|Overall Study||110
8371646|NCT01151020|20636861|P1|STARTED|Overall Study||110
8371647|NCT01150981|20636868|P2|NOT COMPLETED|Overall Study||2
8371648|NCT01150981|20636869|P1|NOT COMPLETED|Overall Study||4
8371649|NCT01150981|20636868|P2|COMPLETED|Overall Study||13
8371650|NCT01150981|20636869|P1|COMPLETED|Overall Study||16
8371651|NCT01150981|20636868|P2|STARTED|Overall Study||15
8371652|NCT01150981|20636869|P1|STARTED|Overall Study||20
8371659|NCT01150760|20636896|P2|NOT COMPLETED|Overall Study||0
8371660|NCT01150760|20636897|P1|NOT COMPLETED|Overall Study||0
8371661|NCT01150760|20636896|P2|COMPLETED|Overall Study||3525
8371662|NCT01150760|20636897|P1|COMPLETED|Overall Study||3525
8371663|NCT01150760|20636896|P2|STARTED|Overall Study||3525
8371664|NCT01150760|20636897|P1|STARTED|Overall Study||3525
8371665|NCT01150500|20636929|P1|NOT COMPLETED|Overall Study||65
8371666|NCT01150500|20636929|P1|COMPLETED|Overall Study||0
8371667|NCT01150500|20636929|P1|STARTED|Overall Study||65
8371668|NCT01150474|20636940|P2|NOT COMPLETED|Overall Study||3
8371669|NCT01150474|20636941|P1|NOT COMPLETED|Overall Study||10
8371670|NCT01150474|20636940|P2|COMPLETED|Overall Study||49
8371671|NCT01150474|20636941|P1|COMPLETED|Overall Study||41
8371672|NCT01150474|20636940|P2|STARTED|Overall Study||52
8371673|NCT01150474|20636941|P1|STARTED|Overall Study||51
8371674|NCT01150461|20636965|P2|NOT COMPLETED|Overall Study||0
8371675|NCT01150461|20636966|P1|NOT COMPLETED|Overall Study||0
8371676|NCT01150461|20636965|P2|COMPLETED|Overall Study||9
8371677|NCT01150461|20636966|P1|COMPLETED|Overall Study||11
8371678|NCT01150461|20636965|P2|STARTED|Overall Study||9
8371679|NCT01150461|20636966|P1|STARTED|Overall Study||11
8371680|NCT01150409|20636976|P2|NOT COMPLETED|Overall Study||0
8371681|NCT01150409|20636977|P1|NOT COMPLETED|Overall Study||0
8371682|NCT01150409|20636976|P2|COMPLETED|Overall Study||0
8371683|NCT01150409|20636977|P1|COMPLETED|Overall Study||11
8371684|NCT01150409|20636976|P2|STARTED|Overall Study||0
8371685|NCT01150409|20636977|P1|STARTED|Overall Study||11
8371686|NCT01150357|20636986|P3|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
8371687|NCT01150357|20636987|P2|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
8371688|NCT01150357|20636988|P1|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
8371689|NCT01150357|20636986|P3|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
8371690|NCT01150357|20636987|P2|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
8371691|NCT01150357|20636988|P1|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
8371692|NCT01150357|20636986|P3|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
8371693|NCT01150357|20636987|P2|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
8371694|NCT01150357|20636988|P1|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
8371695|NCT01150357|20636986|P3|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
8371696|NCT01150357|20636987|P2|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
8371697|NCT01150357|20636988|P1|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
8371698|NCT01150357|20636986|P3|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
8371699|NCT01150357|20636987|P2|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
8371700|NCT01150357|20636988|P1|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
8371701|NCT01150357|20636986|P3|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
8371702|NCT01150357|20636987|P2|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
8371703|NCT01150357|20636988|P1|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
8371704|NCT01150357|20636986|P3|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
8371705|NCT01150357|20636987|P2|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
8371706|NCT01150357|20636988|P1|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
8371707|NCT01150357|20636986|P3|NOT COMPLETED|Dose Response Phase (Phase 1)||3
8371708|NCT01150357|20636987|P2|NOT COMPLETED|Dose Response Phase (Phase 1)||3
8371709|NCT01150357|20636988|P1|NOT COMPLETED|Dose Response Phase (Phase 1)||1
8371710|NCT01150357|20636986|P3|COMPLETED|Dose Response Phase (Phase 1)||102
8371711|NCT01150357|20636987|P2|COMPLETED|Dose Response Phase (Phase 1)||51
8371712|NCT01150357|20636988|P1|COMPLETED|Dose Response Phase (Phase 1)||107
8371713|NCT01150357|20636986|P3|STARTED|Dose Response Phase (Phase 1)||105
8371714|NCT01150357|20636987|P2|STARTED|Dose Response Phase (Phase 1)||54
8371715|NCT01150357|20636988|P1|STARTED|Dose Response Phase (Phase 1)||108
8371716|NCT01150123|20637068|P18|NOT COMPLETED|Overall Study||1
8371717|NCT01150123|20637069|P17|NOT COMPLETED|Overall Study||0
8371718|NCT01150123|20637070|P16|NOT COMPLETED|Overall Study||1
8371719|NCT01150123|20637071|P15|NOT COMPLETED|Overall Study||0
8371720|NCT01150123|20637072|P14|NOT COMPLETED|Overall Study||0
8371721|NCT01150123|20637073|P13|NOT COMPLETED|Overall Study||3
8371722|NCT01150123|20637074|P12|NOT COMPLETED|Overall Study||1
8371723|NCT01150123|20637075|P11|NOT COMPLETED|Overall Study||2
8371724|NCT01150123|20637076|P10|NOT COMPLETED|Overall Study||1
8371725|NCT01150123|20637077|P9|NOT COMPLETED|Overall Study||5
8371726|NCT01150123|20637078|P8|NOT COMPLETED|Overall Study||3
8371727|NCT01150123|20637079|P7|NOT COMPLETED|Overall Study||0
8371728|NCT01150123|20637080|P6|NOT COMPLETED|Overall Study||6
8371729|NCT01150123|20637081|P5|NOT COMPLETED|Overall Study||3
8371730|NCT01150123|20637082|P4|NOT COMPLETED|Overall Study||3
8371731|NCT01150123|20637083|P3|NOT COMPLETED|Overall Study||4
8371732|NCT01150123|20637084|P2|NOT COMPLETED|Overall Study||2
8371733|NCT01150123|20637085|P1|NOT COMPLETED|Overall Study||3
8371734|NCT01150123|20637068|P18|COMPLETED|Overall Study||19
8371735|NCT01150123|20637069|P17|COMPLETED|Overall Study||40
8371736|NCT01150123|20637070|P16|COMPLETED|Overall Study||39
8371737|NCT01150123|20637071|P15|COMPLETED|Overall Study||40
8371738|NCT01150123|20637072|P14|COMPLETED|Overall Study||40
8371739|NCT01150123|20637073|P13|COMPLETED|Overall Study||37
8371740|NCT01150123|20637074|P12|COMPLETED|Overall Study||39
8371741|NCT01150123|20637075|P11|COMPLETED|Overall Study||38
8371742|NCT01150123|20637076|P10|COMPLETED|Overall Study||39
8371743|NCT01150123|20637077|P9|COMPLETED|Overall Study||15
8371744|NCT01150123|20637078|P8|COMPLETED|Overall Study||37
8371745|NCT01150123|20637079|P7|COMPLETED|Overall Study||39
8371746|NCT01150123|20637080|P6|COMPLETED|Overall Study||34
8371747|NCT01150123|20637081|P5|COMPLETED|Overall Study||37
8371748|NCT01150123|20637082|P4|COMPLETED|Overall Study||37
8371749|NCT01150123|20637083|P3|COMPLETED|Overall Study||35
8371750|NCT01150123|20637084|P2|COMPLETED|Overall Study||38
8371751|NCT01150123|20637085|P1|COMPLETED|Overall Study||37
8371752|NCT01150123|20637068|P18|STARTED|Overall Study||20
8371753|NCT01150123|20637069|P17|STARTED|Overall Study||40
8371754|NCT01150123|20637070|P16|STARTED|Overall Study||40
8371755|NCT01150123|20637071|P15|STARTED|Overall Study||40
8371756|NCT01150123|20637072|P14|STARTED|Overall Study||40
8371757|NCT01150123|20637073|P13|STARTED|Overall Study||40
8371758|NCT01150123|20637074|P12|STARTED|Overall Study||40
8371759|NCT01150123|20637075|P11|STARTED|Overall Study||40
8371760|NCT01150123|20637076|P10|STARTED|Overall Study||40
8371761|NCT01150123|20637077|P9|STARTED|Overall Study||20
8371762|NCT01150123|20637078|P8|STARTED|Overall Study||40
8371763|NCT01150123|20637079|P7|STARTED|Overall Study||39
8371764|NCT01150123|20637080|P6|STARTED|Overall Study||40
8371765|NCT01150123|20637081|P5|STARTED|Overall Study||40
8371766|NCT01150123|20637082|P4|STARTED|Overall Study||40
8371767|NCT01150123|20637083|P3|STARTED|Overall Study||39
8371768|NCT01150123|20637084|P2|STARTED|Overall Study||40
8371769|NCT01150123|20637085|P1|STARTED|Overall Study||40
8371770|NCT01150097|20637261|P3|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
8371771|NCT01150097|20637262|P2|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
8371772|NCT01150097|20637263|P1|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
8371773|NCT01150097|20637261|P3|COMPLETED|Months 24 to 48 Post-transplantation||0
8371774|NCT01150097|20637262|P2|COMPLETED|Months 24 to 48 Post-transplantation||47
8371775|NCT01150097|20637263|P1|COMPLETED|Months 24 to 48 Post-transplantation||95
8371776|NCT01150097|20637261|P3|STARTED|Months 24 to 48 Post-transplantation||0
8371777|NCT01150097|20637262|P2|STARTED|Months 24 to 48 Post-transplantation||51
8371778|NCT01150097|20637263|P1|STARTED|Months 24 to 48 Post-transplantation||106
8371779|NCT01150097|20637261|P3|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
8371780|NCT01150097|20637262|P2|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
8371781|NCT01150097|20637263|P1|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
8371782|NCT01150097|20637261|P3|COMPLETED|Months 24 to 36 Post-transplantation||117
8371783|NCT01150097|20637262|P2|COMPLETED|Months 24 to 36 Post-transplantation||49
8371784|NCT01150097|20637263|P1|COMPLETED|Months 24 to 36 Post-transplantation||96
8371785|NCT01150097|20637261|P3|STARTED|Months 24 to 36 Post-transplantation||125
8371786|NCT01150097|20637262|P2|STARTED|Months 24 to 36 Post-transplantation||51
8371787|NCT01150097|20637263|P1|STARTED|Months 24 to 36 Post-transplantation||106
8371788|NCT01149876|20637290|P4|NOT COMPLETED|Overall Study||0
8371789|NCT01149876|20637291|P3|NOT COMPLETED|Overall Study||1
8371790|NCT01149876|20637292|P2|NOT COMPLETED|Overall Study||0
8371791|NCT01149876|20637293|P1|NOT COMPLETED|Overall Study||1
8371792|NCT01149876|20637290|P4|COMPLETED|Overall Study||18
8371793|NCT01149876|20637291|P3|COMPLETED|Overall Study||20
8371794|NCT01149876|20637292|P2|COMPLETED|Overall Study||20
8371795|NCT01149876|20637293|P1|COMPLETED|Overall Study||20
8371796|NCT01149876|20637290|P4|STARTED|Overall Study||18
8371797|NCT01149876|20637291|P3|STARTED|Overall Study||21
8371798|NCT01149876|20637292|P2|STARTED|Overall Study||20
8371799|NCT01149876|20637293|P1|STARTED|Overall Study||21
8371800|NCT01149863|20637307|P1|NOT COMPLETED|Overall Study||3
8371801|NCT01149863|20637307|P1|COMPLETED|Overall Study||31
8371802|NCT01149863|20637307|P1|STARTED|Overall Study||34
8371803|NCT01149785|20637312|P2|NOT COMPLETED|Second Intervention||0
8371804|NCT01149785|20637313|P1|NOT COMPLETED|Second Intervention||0
8371805|NCT01149785|20637312|P2|COMPLETED|Second Intervention||15
8371806|NCT01149785|20637313|P1|COMPLETED|Second Intervention||0
8371807|NCT01149785|20637312|P2|STARTED|Second Intervention||15
8371808|NCT01149785|20637313|P1|STARTED|Second Intervention||0
8371809|NCT01149785|20637312|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
8371810|NCT01149785|20637313|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
8371811|NCT01149785|20637312|P2|COMPLETED|Washout Period of at Least 14 Days||0
8371812|NCT01149785|20637313|P1|COMPLETED|Washout Period of at Least 14 Days||15
8371813|NCT01149785|20637312|P2|STARTED|Washout Period of at Least 14 Days||0
8371814|NCT01149785|20637313|P1|STARTED|Washout Period of at Least 14 Days||15
8371815|NCT01149785|20637312|P2|NOT COMPLETED|First Intervention||0
8371816|NCT01149785|20637313|P1|NOT COMPLETED|First Intervention||0
8371817|NCT01149785|20637312|P2|COMPLETED|First Intervention||0
8371818|NCT01149785|20637313|P1|COMPLETED|First Intervention||15
8371819|NCT01149785|20637312|P2|STARTED|First Intervention||0
8371820|NCT01149785|20637313|P1|STARTED|First Intervention||15
8371821|NCT01149772|20637347|P2|NOT COMPLETED|Overall Study||21
8371822|NCT01149772|20637348|P1|NOT COMPLETED|Overall Study||48
8371823|NCT01149772|20637347|P2|COMPLETED|Overall Study||101
8371824|NCT01149772|20637348|P1|COMPLETED|Overall Study||132
8371825|NCT01149772|20637347|P2|STARTED|Overall Study||122
8371826|NCT01149772|20637348|P1|STARTED|Overall Study||180
8371827|NCT01149759|20637364|P1|NOT COMPLETED|Overall Study||0
8371828|NCT01149759|20637364|P1|COMPLETED|Overall Study||9
8371829|NCT01149759|20637364|P1|STARTED|Overall Study||9
8371830|NCT01149733|20637371|P2|NOT COMPLETED|Overall Study||0
8371831|NCT01149733|20637372|P1|NOT COMPLETED|Overall Study||0
8371832|NCT01149733|20637371|P2|COMPLETED|Overall Study||16
8371833|NCT01149733|20637372|P1|COMPLETED|Overall Study||16
8371834|NCT01149733|20637371|P2|STARTED|Overall Study||16
8371835|NCT01149733|20637372|P1|STARTED|Overall Study||16
8371836|NCT01149681|20637382|P1|NOT COMPLETED|Overall Study||12
8371837|NCT01149681|20637382|P1|COMPLETED|Overall Study||0
8371838|NCT01149681|20637382|P1|STARTED|Overall Study||12
8371839|NCT01149655|20637390|P4|NOT COMPLETED|Period 3-DB Maintenance Phase||42
8371840|NCT01149655|20637391|P3|NOT COMPLETED|Period 3-DB Maintenance Phase||83
8371841|NCT01149655|20637392|P2|NOT COMPLETED|Period 3-DB Maintenance Phase||0
8371842|NCT01149655|20637393|P1|NOT COMPLETED|Period 3-DB Maintenance Phase||0
8371843|NCT01149655|20637390|P4|COMPLETED|Period 3-DB Maintenance Phase||6
8371844|NCT01149655|20637391|P3|COMPLETED|Period 3-DB Maintenance Phase||15
8371845|NCT01149655|20637392|P2|COMPLETED|Period 3-DB Maintenance Phase||0
8371846|NCT01149655|20637393|P1|COMPLETED|Period 3-DB Maintenance Phase||0
8371847|NCT01149655|20637390|P4|STARTED|Period 3-DB Maintenance Phase||48
8371848|NCT01149655|20637391|P3|STARTED|Period 3-DB Maintenance Phase||98
8371849|NCT01149655|20637392|P2|STARTED|Period 3-DB Maintenance Phase||0
8371850|NCT01149655|20637393|P1|STARTED|Period 3-DB Maintenance Phase||0
8371851|NCT01149655|20637390|P4|NOT COMPLETED|Period 2-Stabilization Phase||0
8371852|NCT01149655|20637391|P3|NOT COMPLETED|Period 2-Stabilization Phase||0
8371853|NCT01149655|20637392|P2|NOT COMPLETED|Period 2-Stabilization Phase||37
8371854|NCT01149655|20637393|P1|NOT COMPLETED|Period 2-Stabilization Phase||0
8371855|NCT01149655|20637390|P4|COMPLETED|Period 2-Stabilization Phase||0
8371856|NCT01149655|20637391|P3|COMPLETED|Period 2-Stabilization Phase||0
8371857|NCT01149655|20637392|P2|COMPLETED|Period 2-Stabilization Phase||146
8371858|NCT01149655|20637393|P1|COMPLETED|Period 2-Stabilization Phase||0
8371859|NCT01149655|20637390|P4|STARTED|Period 2-Stabilization Phase||0
8371860|NCT01149655|20637391|P3|STARTED|Period 2-Stabilization Phase||0
8371861|NCT01149655|20637392|P2|STARTED|Period 2-Stabilization Phase||183
8371862|NCT01149655|20637393|P1|STARTED|Period 2-Stabilization Phase||0
8371863|NCT01149655|20637390|P4|NOT COMPLETED|Period 1 - Conversion Phase||0
8371864|NCT01149655|20637391|P3|NOT COMPLETED|Period 1 - Conversion Phase||0
8371865|NCT01149655|20637392|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
8371866|NCT01149655|20637393|P1|NOT COMPLETED|Period 1 - Conversion Phase||18
8371867|NCT01149655|20637390|P4|COMPLETED|Period 1 - Conversion Phase||0
8371868|NCT01149655|20637391|P3|COMPLETED|Period 1 - Conversion Phase||0
8371869|NCT01149655|20637392|P2|COMPLETED|Period 1 - Conversion Phase||0
8371870|NCT01149655|20637393|P1|COMPLETED|Period 1 - Conversion Phase||168
8371871|NCT01149655|20637390|P4|STARTED|Period 1 - Conversion Phase||0
8371872|NCT01149655|20637391|P3|STARTED|Period 1 - Conversion Phase||0
8371873|NCT01149655|20637392|P2|STARTED|Period 1 - Conversion Phase||0
8371874|NCT01149655|20637393|P1|STARTED|Period 1 - Conversion Phase||186
8371875|NCT01149616|20637423|P2|NOT COMPLETED|Overall Study||0
8371876|NCT01149616|20637424|P1|NOT COMPLETED|Overall Study||0
8371877|NCT01149616|20637423|P2|COMPLETED|Overall Study||41
8371878|NCT01149616|20637424|P1|COMPLETED|Overall Study||41
8371879|NCT01149616|20637423|P2|STARTED|Overall Study||41
8371880|NCT01149616|20637424|P1|STARTED|Overall Study||41
8371881|NCT01149538|20637436|P2|NOT COMPLETED|Overall Study||4
8371882|NCT01149538|20637437|P1|NOT COMPLETED|Overall Study||5
8371883|NCT01149538|20637436|P2|COMPLETED|Overall Study||25
8371884|NCT01149538|20637437|P1|COMPLETED|Overall Study||26
8371885|NCT01149538|20637436|P2|STARTED|Overall Study||29
8371886|NCT01149538|20637437|P1|STARTED|Overall Study||31
8371887|NCT01149512|20637451|P1|NOT COMPLETED|Overall Study||0
8371888|NCT01149512|20637451|P1|COMPLETED|Overall Study||178
8371889|NCT01149512|20637451|P1|STARTED|Overall Study||178
8371890|NCT01149486|20637458|P2|NOT COMPLETED|Second Intervention||0
8371891|NCT01149486|20637459|P1|NOT COMPLETED|Second Intervention||0
8371892|NCT01149486|20637458|P2|COMPLETED|Second Intervention||9
8371893|NCT01149486|20637459|P1|COMPLETED|Second Intervention||10
8371894|NCT01149486|20637458|P2|STARTED|Second Intervention||9
8371895|NCT01149486|20637459|P1|STARTED|Second Intervention||10
8371896|NCT01149486|20637458|P2|NOT COMPLETED|Washout of 7 Days||0
8371897|NCT01149486|20637459|P1|NOT COMPLETED|Washout of 7 Days||0
8371898|NCT01149486|20637458|P2|COMPLETED|Washout of 7 Days||9
8371899|NCT01149486|20637459|P1|COMPLETED|Washout of 7 Days||10
8371900|NCT01149486|20637458|P2|STARTED|Washout of 7 Days||9
8371901|NCT01149486|20637459|P1|STARTED|Washout of 7 Days||10
8371902|NCT01149486|20637458|P2|NOT COMPLETED|First Intervention||1
8371903|NCT01149486|20637459|P1|NOT COMPLETED|First Intervention||0
8371904|NCT01149486|20637458|P2|COMPLETED|First Intervention||9
8371905|NCT01149486|20637459|P1|COMPLETED|First Intervention||10
8371906|NCT01149486|20637458|P2|STARTED|First Intervention||10
8371907|NCT01149486|20637459|P1|STARTED|First Intervention||10
8371908|NCT01149473|20637483|P2|NOT COMPLETED|Second Intervention||0
8371909|NCT01149473|20637484|P1|NOT COMPLETED|Second Intervention||0
8371910|NCT01149473|20637483|P2|COMPLETED|Second Intervention||38
8371911|NCT01149473|20637484|P1|COMPLETED|Second Intervention||38
8371912|NCT01149473|20637483|P2|STARTED|Second Intervention||38
8371913|NCT01149473|20637484|P1|STARTED|Second Intervention||38
8371914|NCT01149473|20637483|P2|NOT COMPLETED|Washout of 7 Days||1
8371915|NCT01149473|20637484|P1|NOT COMPLETED|Washout of 7 Days||1
8371916|NCT01149473|20637483|P2|COMPLETED|Washout of 7 Days||38
8371917|NCT01149473|20637484|P1|COMPLETED|Washout of 7 Days||38
8371918|NCT01149473|20637483|P2|STARTED|Washout of 7 Days||39
8371919|NCT01149473|20637484|P1|STARTED|Washout of 7 Days||39
8371920|NCT01149473|20637483|P2|NOT COMPLETED|First Intervention||1
8371921|NCT01149473|20637484|P1|NOT COMPLETED|First Intervention||1
8371922|NCT01149473|20637483|P2|COMPLETED|First Intervention||39
8371923|NCT01149473|20637484|P1|COMPLETED|First Intervention||39
8371924|NCT01149473|20637483|P2|STARTED|First Intervention||40
8371925|NCT01149473|20637484|P1|STARTED|First Intervention||40
8371926|NCT01149460|20637502|P2|NOT COMPLETED|Overall Study||2
8371927|NCT01149460|20637503|P1|NOT COMPLETED|Overall Study||0
8371928|NCT01149460|20637502|P2|COMPLETED|Overall Study||16
8371929|NCT01149460|20637503|P1|COMPLETED|Overall Study||18
8371930|NCT01149460|20637502|P2|STARTED|Overall Study||18
8371931|NCT01149460|20637503|P1|STARTED|Overall Study||18
8371932|NCT01149434|20637521|P2|NOT COMPLETED|Overall Study||5
8371933|NCT01149434|20637522|P1|NOT COMPLETED|Overall Study||0
8371934|NCT01149434|20637521|P2|COMPLETED|Overall Study||10
8371935|NCT01149434|20637522|P1|COMPLETED|Overall Study||4
8371936|NCT01149434|20637521|P2|STARTED|Overall Study||15
8371937|NCT01149434|20637522|P1|STARTED|Overall Study||4
8371938|NCT01149421|20637536|P3|NOT COMPLETED|Overall Study||44
8371939|NCT01149421|20637537|P2|NOT COMPLETED|Overall Study||29
8371940|NCT01149421|20637538|P1|NOT COMPLETED|Overall Study||52
8371941|NCT01149421|20637536|P3|COMPLETED|Overall Study||206
8371942|NCT01149421|20637537|P2|COMPLETED|Overall Study||225
8371943|NCT01149421|20637538|P1|COMPLETED|Overall Study||199
8371944|NCT01149421|20637536|P3|Received at Least One Dose of Study Drug|Overall Study||250
8371945|NCT01149421|20637537|P2|Received at Least One Dose of Study Drug|Overall Study||254
8371946|NCT01149421|20637538|P1|Received at Least One Dose of Study Drug|Overall Study||251
8371947|NCT01149421|20637536|P3|STARTED|Overall Study||250
8371948|NCT01149421|20637537|P2|STARTED|Overall Study||254
8371949|NCT01149421|20637538|P1|STARTED|Overall Study||251
8371950|NCT01149369|20637619|P2|NOT COMPLETED|Overall Study||3
8371951|NCT01149369|20637620|P1|NOT COMPLETED|Overall Study||6
8371952|NCT01149369|20637619|P2|COMPLETED|Overall Study||60
8371953|NCT01149369|20637620|P1|COMPLETED|Overall Study||57
8371954|NCT01149369|20637619|P2|STARTED|Overall Study||63
8371955|NCT01149369|20637620|P1|STARTED|Overall Study||63
8371956|NCT01149343|20637788|P4|NOT COMPLETED|Overall Study||40
8371957|NCT01149343|20637789|P3|NOT COMPLETED|Overall Study||22
8371958|NCT01149343|20637790|P2|NOT COMPLETED|Overall Study||24
8371959|NCT01149343|20637791|P1|NOT COMPLETED|Overall Study||20
8371960|NCT01149343|20637788|P4|COMPLETED|Overall Study||0
8371961|NCT01149343|20637789|P3|COMPLETED|Overall Study||0
8371962|NCT01149343|20637790|P2|COMPLETED|Overall Study||0
8371963|NCT01149343|20637791|P1|COMPLETED|Overall Study||0
8371964|NCT01149343|20637788|P4|STARTED|Overall Study||40
8371965|NCT01149343|20637789|P3|STARTED|Overall Study||22
8371966|NCT01149343|20637790|P2|STARTED|Overall Study||24
8371967|NCT01149343|20637791|P1|STARTED|Overall Study||20
8371968|NCT01149148|20637876|P2|NOT COMPLETED|Overall Study||2
8371969|NCT01149148|20637877|P1|NOT COMPLETED|Overall Study||2
8371970|NCT01149148|20637876|P2|COMPLETED|Overall Study||11
8371971|NCT01149148|20637877|P1|COMPLETED|Overall Study||10
8371972|NCT01149148|20637876|P2|STARTED|Overall Study||13
8371973|NCT01149148|20637877|P1|STARTED|Overall Study||12
8371974|NCT01149096|20637887|P2|NOT COMPLETED|Overall Study||1
8371975|NCT01149096|20637888|P1|NOT COMPLETED|Overall Study||0
8371976|NCT01149096|20637887|P2|COMPLETED|Overall Study||6
8371977|NCT01149096|20637888|P1|COMPLETED|Overall Study||6
8371978|NCT01149096|20637887|P2|STARTED|Overall Study||7
8371979|NCT01149096|20637888|P1|STARTED|Overall Study||6
8371980|NCT01149057|20637912|P1|NOT COMPLETED|Overall Study||57
8371981|NCT01149057|20637912|P1|COMPLETED|Overall Study||88
8371982|NCT01149057|20637912|P1|STARTED|Overall Study||145
8371983|NCT01148979|20637939|P2|NOT COMPLETED|Overall Study||1
8371984|NCT01148979|20637940|P1|NOT COMPLETED|Overall Study||0
8371985|NCT01148979|20637939|P2|COMPLETED|Overall Study||15
8371986|NCT01148979|20637940|P1|COMPLETED|Overall Study||13
8371987|NCT01148979|20637939|P2|STARTED|Overall Study||16
8371988|NCT01148979|20637940|P1|STARTED|Overall Study||13
8371989|NCT01148940|20637948|P3|NOT COMPLETED|Overall Study||0
8371990|NCT01148940|20637949|P2|NOT COMPLETED|Overall Study||0
8371991|NCT01148940|20637950|P1|NOT COMPLETED|Overall Study||0
8371992|NCT01148940|20637948|P3|COMPLETED|Overall Study||0
8371993|NCT01148940|20637949|P2|COMPLETED|Overall Study||27
8371994|NCT01148940|20637950|P1|COMPLETED|Overall Study||7
8371995|NCT01148940|20637948|P3|STARTED|Overall Study||0
8371996|NCT01148940|20637949|P2|STARTED|Overall Study||27
8371997|NCT01148940|20637950|P1|STARTED|Overall Study||7
8371998|NCT01148862|20637958|P2|NOT COMPLETED|Second Intervention||2
8371999|NCT01148862|20637959|P1|NOT COMPLETED|Second Intervention||0
8372000|NCT01148862|20637958|P2|COMPLETED|Second Intervention||23
8372001|NCT01148862|20637959|P1|COMPLETED|Second Intervention||25
8372002|NCT01148862|20637958|P2|STARTED|Second Intervention||25
8372003|NCT01148862|20637959|P1|STARTED|Second Intervention||25
8372004|NCT01148862|20637958|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8372005|NCT01148862|20637959|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8372006|NCT01148862|20637958|P2|COMPLETED|Washout Period of 2 Weeks||25
8372007|NCT01148862|20637959|P1|COMPLETED|Washout Period of 2 Weeks||25
8372008|NCT01148862|20637958|P2|STARTED|Washout Period of 2 Weeks||25
8372009|NCT01148862|20637959|P1|STARTED|Washout Period of 2 Weeks||25
8372010|NCT01148862|20637958|P2|NOT COMPLETED|First Intervention||0
8372011|NCT01148862|20637959|P1|NOT COMPLETED|First Intervention||0
8372012|NCT01148862|20637958|P2|COMPLETED|First Intervention||25
8372013|NCT01148862|20637959|P1|COMPLETED|First Intervention||25
8372014|NCT01148862|20637958|P2|STARTED|First Intervention||25
8372015|NCT01148862|20637959|P1|STARTED|First Intervention||25
8372016|NCT01148836|20637969|P2|NOT COMPLETED|Overall Study||2
8372017|NCT01148836|20637970|P1|NOT COMPLETED|Overall Study||1
8372018|NCT01148836|20637969|P2|COMPLETED|Overall Study||8
8372019|NCT01148836|20637970|P1|COMPLETED|Overall Study|Enrollment completed|7
8372020|NCT01148836|20637969|P2|STARTED|Overall Study||10
8372021|NCT01148836|20637970|P1|STARTED|Overall Study|Enrollment completed|8
8372022|NCT01148810|20637991|P2|NOT COMPLETED|Overall Study||5
8372023|NCT01148810|20637992|P1|NOT COMPLETED|Overall Study||1
8372024|NCT01148810|20637991|P2|COMPLETED|Overall Study||5
8372025|NCT01148810|20637992|P1|COMPLETED|Overall Study||7
8372026|NCT01148810|20637991|P2|STARTED|Overall Study||10
8372027|NCT01148810|20637992|P1|STARTED|Overall Study||8
8372028|NCT01148771|20638019|P2|NOT COMPLETED|Second Intervention||0
8372029|NCT01148771|20638020|P1|NOT COMPLETED|Second Intervention||0
8372030|NCT01148771|20638019|P2|COMPLETED|Second Intervention||5
8372031|NCT01148771|20638020|P1|COMPLETED|Second Intervention||6
8372032|NCT01148771|20638019|P2|STARTED|Second Intervention||5
8372033|NCT01148771|20638020|P1|STARTED|Second Intervention||6
8372034|NCT01148771|20638019|P2|NOT COMPLETED|Washout Period||1
8372035|NCT01148771|20638020|P1|NOT COMPLETED|Washout Period||0
8372036|NCT01148771|20638019|P2|COMPLETED|Washout Period||5
8372037|NCT01148771|20638020|P1|COMPLETED|Washout Period||6
8372038|NCT01148771|20638019|P2|STARTED|Washout Period||6
8372039|NCT01148771|20638020|P1|STARTED|Washout Period||6
8372040|NCT01148771|20638019|P2|NOT COMPLETED|First Intervention||0
8372041|NCT01148771|20638020|P1|NOT COMPLETED|First Intervention||0
8372042|NCT01148771|20638019|P2|COMPLETED|First Intervention||6
8372043|NCT01148771|20638020|P1|COMPLETED|First Intervention||6
8372044|NCT01148771|20638019|P2|STARTED|First Intervention||6
8372045|NCT01148771|20638020|P1|STARTED|First Intervention||6
8372046|NCT01148745|20638032|P1|NOT COMPLETED|Overall Study||0
8372047|NCT01148745|20638032|P1|COMPLETED|Overall Study||15
8372048|NCT01148745|20638032|P1|STARTED|Overall Study||15
8372049|NCT01148693|20638040|P2|NOT COMPLETED|Overall Study||10
8372050|NCT01148693|20638041|P1|NOT COMPLETED|Overall Study||13
8372051|NCT01148693|20638040|P2|COMPLETED|Overall Study||57
8372052|NCT01148693|20638041|P1|COMPLETED|Overall Study||57
8372053|NCT01148693|20638040|P2|STARTED|Overall Study||67
8372054|NCT01148693|20638041|P1|STARTED|Overall Study||70
8372055|NCT01148563|20638049|P2|NOT COMPLETED|Overall Study||30
8372056|NCT01148563|20638050|P1|NOT COMPLETED|Overall Study||29
8372057|NCT01148563|20638049|P2|COMPLETED|Overall Study||37
8372058|NCT01148563|20638050|P1|COMPLETED|Overall Study||40
8372059|NCT01148563|20638049|P2|STARTED|Overall Study||67
8372060|NCT01148563|20638050|P1|STARTED|Overall Study||69
8372061|NCT01148537|20638061|P3|NOT COMPLETED|Overall Study||3
8372062|NCT01148537|20638062|P2|NOT COMPLETED|Overall Study||0
8372063|NCT01148537|20638063|P1|NOT COMPLETED|Overall Study||3
8372064|NCT01148537|20638061|P3|COMPLETED|Overall Study||41
8372065|NCT01148537|20638062|P2|COMPLETED|Overall Study||44
8372066|NCT01148537|20638063|P1|COMPLETED|Overall Study||41
8372067|NCT01148537|20638061|P3|STARTED|Overall Study||44
8372068|NCT01148537|20638062|P2|STARTED|Overall Study||44
8372069|NCT01148537|20638063|P1|STARTED|Overall Study||44
8372070|NCT01148524|20638093|P9|NOT COMPLETED|Overall Study||0
8372071|NCT01148524|20638094|P8|NOT COMPLETED|Overall Study||0
8372072|NCT01148524|20638095|P7|NOT COMPLETED|Overall Study||0
8372073|NCT01148524|20638096|P6|NOT COMPLETED|Overall Study||0
8372074|NCT01148524|20638097|P5|NOT COMPLETED|Overall Study||0
8372075|NCT01148524|20638098|P4|NOT COMPLETED|Overall Study||0
8372076|NCT01148524|20638099|P3|NOT COMPLETED|Overall Study||0
8372077|NCT01148524|20638100|P2|NOT COMPLETED|Overall Study||0
8372078|NCT01148524|20638101|P1|NOT COMPLETED|Overall Study||0
8372079|NCT01148524|20638093|P9|COMPLETED|Overall Study||151
8372080|NCT01148524|20638094|P8|COMPLETED|Overall Study||51
8372081|NCT01148524|20638095|P7|COMPLETED|Overall Study||153
8372082|NCT01148524|20638096|P6|COMPLETED|Overall Study||106
8372083|NCT01148524|20638097|P5|COMPLETED|Overall Study||57
8372084|NCT01148524|20638098|P4|COMPLETED|Overall Study||102
8372085|NCT01148524|20638099|P3|COMPLETED|Overall Study||53
8372086|NCT01148524|20638100|P2|COMPLETED|Overall Study||95
8372087|NCT01148524|20638101|P1|COMPLETED|Overall Study||49
8372088|NCT01148524|20638093|P9|STARTED|Overall Study||151
8372089|NCT01148524|20638094|P8|STARTED|Overall Study||51
8372090|NCT01148524|20638095|P7|STARTED|Overall Study||153
8372091|NCT01148524|20638096|P6|STARTED|Overall Study||106
8372092|NCT01148524|20638097|P5|STARTED|Overall Study||57
8372093|NCT01148524|20638098|P4|STARTED|Overall Study||102
8372094|NCT01148524|20638099|P3|STARTED|Overall Study||53
8372095|NCT01148524|20638100|P2|STARTED|Overall Study||95
8372096|NCT01148524|20638101|P1|STARTED|Overall Study||49
8372097|NCT01148511|20638149|P3|NOT COMPLETED|Randomized||6
8372098|NCT01148511|20638150|P2|NOT COMPLETED|Randomized||10
8372099|NCT01148511|20638151|P1|NOT COMPLETED|Randomized||0
8372100|NCT01148511|20638149|P3|COMPLETED|Randomized||39
8372101|NCT01148511|20638150|P2|COMPLETED|Randomized||38
8372102|NCT01148511|20638151|P1|COMPLETED|Randomized||0
8372103|NCT01148511|20638149|P3|STARTED|Randomized||45
8372104|NCT01148511|20638150|P2|STARTED|Randomized||48
8372105|NCT01148511|20638151|P1|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
8372106|NCT01148511|20638149|P3|NOT COMPLETED|Exposed to Study Drug||0
8372107|NCT01148511|20638150|P2|NOT COMPLETED|Exposed to Study Drug||0
8372108|NCT01148511|20638151|P1|NOT COMPLETED|Exposed to Study Drug||6
8372109|NCT01148511|20638149|P3|COMPLETED|Exposed to Study Drug||0
8372110|NCT01148511|20638150|P2|COMPLETED|Exposed to Study Drug||0
8372111|NCT01148511|20638151|P1|COMPLETED|Exposed to Study Drug||93
8372112|NCT01148511|20638149|P3|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
8372113|NCT01148511|20638150|P2|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
8372114|NCT01148511|20638151|P1|STARTED|Exposed to Study Drug||99
8372115|NCT01148459|20638172|P2|NOT COMPLETED|Overall Study||11
8372116|NCT01148459|20638173|P1|NOT COMPLETED|Overall Study||12
8372117|NCT01148459|20638172|P2|COMPLETED|Overall Study||90
8372118|NCT01148459|20638173|P1|COMPLETED|Overall Study||87
8372119|NCT01148459|20638172|P2|STARTED|Overall Study||101
8372120|NCT01148459|20638173|P1|STARTED|Overall Study||99
8372121|NCT01148420|20638215|P1|NOT COMPLETED|Overall Study||0
8372122|NCT01148420|20638215|P1|COMPLETED|Overall Study||48
8372123|NCT01148420|20638215|P1|STARTED|Overall Study||48
8372127|NCT01148056|20638259|P1|NOT COMPLETED|Overall Study||0
8372128|NCT01148056|20638259|P1|COMPLETED|Overall Study||2
8372129|NCT01148056|20638259|P1|STARTED|Overall Study||2
8372130|NCT01148017|20638272|P4|NOT COMPLETED|Overall Study||0
8372131|NCT01148017|20638273|P3|NOT COMPLETED|Overall Study||0
8372132|NCT01148017|20638274|P2|NOT COMPLETED|Overall Study||34
8372133|NCT01148017|20638275|P1|NOT COMPLETED|Overall Study||80
8372134|NCT01148017|20638272|P4|COMPLETED|Overall Study||45
8372135|NCT01148017|20638273|P3|COMPLETED|Overall Study||53
8372136|NCT01148017|20638274|P2|COMPLETED|Overall Study||87
8372137|NCT01148017|20638275|P1|COMPLETED|Overall Study||134
8372138|NCT01148017|20638272|P4|STARTED|Overall Study||45
8372139|NCT01148017|20638273|P3|STARTED|Overall Study||53
8372140|NCT01148017|20638274|P2|STARTED|Overall Study||121
8372141|NCT01148017|20638275|P1|STARTED|Overall Study||214
8372148|NCT01147900|20638350|P3|NOT COMPLETED|At Year 10||0
8372149|NCT01147900|20638351|P2|NOT COMPLETED|At Year 10||1
8372150|NCT01147900|20638352|P1|NOT COMPLETED|At Year 10||0
8372151|NCT01147900|20638350|P3|COMPLETED|At Year 10||62
8372152|NCT01147900|20638351|P2|COMPLETED|At Year 10||59
8372153|NCT01147900|20638352|P1|COMPLETED|At Year 10||55
8372154|NCT01147900|20638350|P3|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
8372155|NCT01147900|20638351|P2|STARTED|At Year 10||60
8372156|NCT01147900|20638352|P1|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
8372157|NCT01147900|20638350|P3|NOT COMPLETED|At Year 8.5||0
8372158|NCT01147900|20638351|P2|NOT COMPLETED|At Year 8.5||0
8372159|NCT01147900|20638352|P1|NOT COMPLETED|At Year 8.5||0
8372160|NCT01147900|20638350|P3|COMPLETED|At Year 8.5||66
8372161|NCT01147900|20638351|P2|COMPLETED|At Year 8.5||60
8372162|NCT01147900|20638352|P1|COMPLETED|At Year 8.5||54
8372163|NCT01147900|20638350|P3|STARTED|At Year 8.5||66
8372164|NCT01147900|20638351|P2|STARTED|At Year 8.5||60
8372165|NCT01147900|20638352|P1|STARTED|At Year 8.5||54
8372166|NCT01147874|20638411|P1|NOT COMPLETED|Overall Study||67
8372167|NCT01147874|20638411|P1|COMPLETED|Overall Study||946
8372168|NCT01147874|20638411|P1|STARTED|Overall Study||1013
8372169|NCT01147848|20638419|P3|NOT COMPLETED|Randomized Phase||46
8372170|NCT01147848|20638420|P2|NOT COMPLETED|Randomized Phase||45
8372171|NCT01147848|20638421|P1|NOT COMPLETED|Randomized Phase||0
8372172|NCT01147848|20638419|P3|COMPLETED|Randomized Phase||357
8372173|NCT01147848|20638420|P2|COMPLETED|Randomized Phase||358
8372174|NCT01147848|20638421|P1|COMPLETED|Randomized Phase||0
8372175|NCT01147848|20638419|P3|STARTED|Randomized Phase||403
8372176|NCT01147848|20638420|P2|STARTED|Randomized Phase||403
8372177|NCT01147848|20638421|P1|STARTED|Randomized Phase||0
8372178|NCT01147848|20638419|P3|NOT COMPLETED|Run-in Period||0
8372179|NCT01147848|20638420|P2|NOT COMPLETED|Run-in Period||0
8372180|NCT01147848|20638421|P1|NOT COMPLETED|Run-in Period||758
8372181|NCT01147848|20638419|P3|COMPLETED|Run-in Period||0
8372182|NCT01147848|20638420|P2|COMPLETED|Run-in Period||0
8372183|NCT01147848|20638421|P1|COMPLETED|Run-in Period||806
8372184|NCT01147848|20638419|P3|STARTED|Run-in Period||0
8372185|NCT01147848|20638420|P2|STARTED|Run-in Period||0
8372186|NCT01147848|20638421|P1|STARTED|Run-in Period||1564
8372195|NCT01147809|20638474|P6|NOT COMPLETED|Phase II (168 Days)||33
8372196|NCT01147809|20638475|P5|NOT COMPLETED|Phase II (168 Days)||16
8372197|NCT01147809|20638476|P4|NOT COMPLETED|Phase II (168 Days)||0
8372198|NCT01147809|20638477|P3|NOT COMPLETED|Phase II (168 Days)||0
8372199|NCT01147809|20638478|P2|NOT COMPLETED|Phase II (168 Days)||0
8372200|NCT01147809|20638479|P1|NOT COMPLETED|Phase II (168 Days)||0
8372201|NCT01147809|20638474|P6|COMPLETED|Phase II (168 Days)||19
8372202|NCT01147809|20638475|P5|COMPLETED|Phase II (168 Days)||7
8372203|NCT01147809|20638476|P4|COMPLETED|Phase II (168 Days)||0
8372204|NCT01147809|20638477|P3|COMPLETED|Phase II (168 Days)||0
8372205|NCT01147809|20638478|P2|COMPLETED|Phase II (168 Days)||0
8372206|NCT01147809|20638479|P1|COMPLETED|Phase II (168 Days)||0
8372207|NCT01147809|20638474|P6|Ongoing|Phase II (168 Days)||0
8372208|NCT01147809|20638475|P5|Ongoing|Phase II (168 Days)||1
8372209|NCT01147809|20638476|P4|Ongoing|Phase II (168 Days)||0
8372210|NCT01147809|20638477|P3|Ongoing|Phase II (168 Days)||0
8372211|NCT01147809|20638478|P2|Ongoing|Phase II (168 Days)||0
8372212|NCT01147809|20638479|P1|Ongoing|Phase II (168 Days)||0
8372213|NCT01147809|20638474|P6|STARTED|Phase II (168 Days)||52
8372214|NCT01147809|20638475|P5|STARTED|Phase II (168 Days)||23
8372215|NCT01147809|20638476|P4|STARTED|Phase II (168 Days)||0
8372216|NCT01147809|20638477|P3|STARTED|Phase II (168 Days)||0
8372217|NCT01147809|20638478|P2|STARTED|Phase II (168 Days)||0
8372218|NCT01147809|20638479|P1|STARTED|Phase II (168 Days)||0
8372219|NCT01147809|20638474|P6|NOT COMPLETED|Phase I (168 Days)||0
8372220|NCT01147809|20638475|P5|NOT COMPLETED|Phase I (168 Days)||0
8372221|NCT01147809|20638476|P4|NOT COMPLETED|Phase I (168 Days)||5
8372222|NCT01147809|20638477|P3|NOT COMPLETED|Phase I (168 Days)||2
8372223|NCT01147809|20638478|P2|NOT COMPLETED|Phase I (168 Days)||1
8372224|NCT01147809|20638479|P1|NOT COMPLETED|Phase I (168 Days)||1
8372225|NCT01147809|20638474|P6|COMPLETED|Phase I (168 Days)||0
8372226|NCT01147809|20638475|P5|COMPLETED|Phase I (168 Days)||0
8372227|NCT01147809|20638476|P4|COMPLETED|Phase I (168 Days)||5
8372228|NCT01147809|20638477|P3|COMPLETED|Phase I (168 Days)||2
8372229|NCT01147809|20638478|P2|COMPLETED|Phase I (168 Days)||8
8372230|NCT01147809|20638479|P1|COMPLETED|Phase I (168 Days)||2
8372231|NCT01147809|20638474|P6|STARTED|Phase I (168 Days)||0
8372232|NCT01147809|20638475|P5|STARTED|Phase I (168 Days)||0
8372233|NCT01147809|20638476|P4|STARTED|Phase I (168 Days)||10
8372234|NCT01147809|20638477|P3|STARTED|Phase I (168 Days)||4
8372235|NCT01147809|20638478|P2|STARTED|Phase I (168 Days)||9
8372236|NCT01147809|20638479|P1|STARTED|Phase I (168 Days)||3
8372237|NCT01147744|20638600|P7|NOT COMPLETED|Overall Study||19
8372238|NCT01147744|20638601|P6|NOT COMPLETED|Overall Study||20
8372239|NCT01147744|20638602|P5|NOT COMPLETED|Overall Study||25
8372240|NCT01147744|20638603|P4|NOT COMPLETED|Overall Study||18
8372241|NCT01147744|20638604|P3|NOT COMPLETED|Overall Study||18
8372242|NCT01147744|20638605|P2|NOT COMPLETED|Overall Study||23
8372243|NCT01147744|20638606|P1|NOT COMPLETED|Overall Study||29
8372244|NCT01147744|20638600|P7|COMPLETED|Overall Study||78
8372245|NCT01147744|20638601|P6|COMPLETED|Overall Study||83
8372246|NCT01147744|20638602|P5|COMPLETED|Overall Study||76
8372247|NCT01147744|20638603|P4|COMPLETED|Overall Study||82
8372248|NCT01147744|20638604|P3|COMPLETED|Overall Study||82
8372249|NCT01147744|20638605|P2|COMPLETED|Overall Study||76
8372250|NCT01147744|20638606|P1|COMPLETED|Overall Study||71
8372251|NCT01147744|20638600|P7|STARTED|Overall Study||97
8372252|NCT01147744|20638601|P6|STARTED|Overall Study||103
8372253|NCT01147744|20638602|P5|STARTED|Overall Study||101
8372254|NCT01147744|20638603|P4|STARTED|Overall Study||100
8372255|NCT01147744|20638604|P3|STARTED|Overall Study||100
8372256|NCT01147744|20638605|P2|STARTED|Overall Study||99
8372257|NCT01147744|20638606|P1|STARTED|Overall Study||100
8372258|NCT01147653|20638701|P2|NOT COMPLETED|Year 2||3
8372259|NCT01147653|20638702|P1|NOT COMPLETED|Year 2||2
8372260|NCT01147653|20638701|P2|COMPLETED|Year 2||28
8372261|NCT01147653|20638702|P1|COMPLETED|Year 2||30
8372262|NCT01147653|20638701|P2|STARTED|Year 2||31
8372263|NCT01147653|20638702|P1|STARTED|Year 2||32
8372264|NCT01147653|20638701|P2|NOT COMPLETED|Year 1||0
8372265|NCT01147653|20638702|P1|NOT COMPLETED|Year 1||0
8372266|NCT01147653|20638701|P2|COMPLETED|Year 1||31
8372267|NCT01147653|20638702|P1|COMPLETED|Year 1||32
8372268|NCT01147653|20638701|P2|STARTED|Year 1||31
8372269|NCT01147653|20638702|P1|STARTED|Year 1||32
8372270|NCT01147640|20638763|P2|NOT COMPLETED|Overall Study||1
8372271|NCT01147640|20638764|P1|NOT COMPLETED|Overall Study||5
8372272|NCT01147640|20638763|P2|COMPLETED|Overall Study||38
8372273|NCT01147640|20638764|P1|COMPLETED|Overall Study||78
8372274|NCT01147640|20638763|P2|STARTED|Overall Study||39
8372275|NCT01147640|20638764|P1|STARTED|Overall Study||83
8372276|NCT01147627|20638775|P3|NOT COMPLETED|Overall Study||18
8372277|NCT01147627|20638776|P2|NOT COMPLETED|Overall Study||24
8372278|NCT01147627|20638777|P1|NOT COMPLETED|Overall Study||32
8372279|NCT01147627|20638775|P3|COMPLETED|Overall Study||118
8372280|NCT01147627|20638776|P2|COMPLETED|Overall Study||114
8372281|NCT01147627|20638777|P1|COMPLETED|Overall Study||110
8372282|NCT01147627|20638775|P3|STARTED|Overall Study||136
8372283|NCT01147627|20638776|P2|STARTED|Overall Study||138
8372284|NCT01147627|20638777|P1|STARTED|Overall Study||142
8372285|NCT01147601|20638787|P2|NOT COMPLETED|Overall Study||0
8372286|NCT01147601|20638788|P1|NOT COMPLETED|Overall Study||3
8372287|NCT01147601|20638787|P2|COMPLETED|Overall Study||1
8372288|NCT01147601|20638788|P1|COMPLETED|Overall Study||2
8372289|NCT01147601|20638787|P2|STARTED|Overall Study||1
8372290|NCT01147601|20638788|P1|STARTED|Overall Study||5
8372291|NCT01147497|20638796|P2|NOT COMPLETED|Overall Study||0
8372292|NCT01147497|20638797|P1|NOT COMPLETED|Overall Study||2
8372293|NCT01147497|20638796|P2|COMPLETED|Overall Study||36
8372294|NCT01147497|20638797|P1|COMPLETED|Overall Study||35
8372295|NCT01147497|20638796|P2|STARTED|Overall Study||36
8372296|NCT01147497|20638797|P1|STARTED|Overall Study||37
8372297|NCT01147471|20638817|P2|NOT COMPLETED|6 Month Follow Up||2
8372298|NCT01147471|20638818|P1|NOT COMPLETED|6 Month Follow Up||4
8372299|NCT01147471|20638817|P2|COMPLETED|6 Month Follow Up||4
8372300|NCT01147471|20638818|P1|COMPLETED|6 Month Follow Up||8
8372301|NCT01147471|20638817|P2|STARTED|6 Month Follow Up||6
8372302|NCT01147471|20638818|P1|STARTED|6 Month Follow Up||12
8372303|NCT01147471|20638817|P2|NOT COMPLETED|3 Month Follow Up||2
8372304|NCT01147471|20638818|P1|NOT COMPLETED|3 Month Follow Up||1
8372305|NCT01147471|20638817|P2|COMPLETED|3 Month Follow Up||6
8372306|NCT01147471|20638818|P1|COMPLETED|3 Month Follow Up||12
8372307|NCT01147471|20638817|P2|STARTED|3 Month Follow Up||8
8372308|NCT01147471|20638818|P1|STARTED|3 Month Follow Up||13
8372309|NCT01147471|20638817|P2|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
8372310|NCT01147471|20638818|P1|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
8372311|NCT01147471|20638817|P2|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
8372312|NCT01147471|20638818|P1|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
8372313|NCT01147471|20638817|P2|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
8372314|NCT01147471|20638818|P1|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
8372315|NCT01147471|20638817|P2|NOT COMPLETED|Through Initial Hospital Discharge||0
8372316|NCT01147471|20638818|P1|NOT COMPLETED|Through Initial Hospital Discharge||0
8372317|NCT01147471|20638817|P2|COMPLETED|Through Initial Hospital Discharge||11
8372318|NCT01147471|20638818|P1|COMPLETED|Through Initial Hospital Discharge||13
8372319|NCT01147471|20638817|P2|STARTED|Through Initial Hospital Discharge||11
8372320|NCT01147471|20638818|P1|STARTED|Through Initial Hospital Discharge||13
8372321|NCT01147458|20638832|P4|NOT COMPLETED|Second Intervention||4
8372322|NCT01147458|20638833|P3|NOT COMPLETED|Second Intervention||8
8372323|NCT01147458|20638834|P2|NOT COMPLETED|Second Intervention||7
8372324|NCT01147458|20638835|P1|NOT COMPLETED|Second Intervention||9
8372325|NCT01147458|20638832|P4|COMPLETED|Second Intervention||30
8372326|NCT01147458|20638833|P3|COMPLETED|Second Intervention||27
8372327|NCT01147458|20638834|P2|COMPLETED|Second Intervention||24
8372328|NCT01147458|20638835|P1|COMPLETED|Second Intervention||25
8372329|NCT01147458|20638832|P4|STARTED|Second Intervention||34
8372330|NCT01147458|20638833|P3|STARTED|Second Intervention||35
8372331|NCT01147458|20638834|P2|STARTED|Second Intervention||31
8372332|NCT01147458|20638835|P1|STARTED|Second Intervention||34
8372333|NCT01147458|20638832|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
8372334|NCT01147458|20638833|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
8372335|NCT01147458|20638834|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8372336|NCT01147458|20638835|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8372337|NCT01147458|20638832|P4|COMPLETED|Washout Period of 2 Weeks||34
8372338|NCT01147458|20638833|P3|COMPLETED|Washout Period of 2 Weeks||35
8372339|NCT01147458|20638834|P2|COMPLETED|Washout Period of 2 Weeks||31
8372340|NCT01147458|20638835|P1|COMPLETED|Washout Period of 2 Weeks||34
8372341|NCT01147458|20638832|P4|STARTED|Washout Period of 2 Weeks||34
8372342|NCT01147458|20638833|P3|STARTED|Washout Period of 2 Weeks||35
8372343|NCT01147458|20638834|P2|STARTED|Washout Period of 2 Weeks||31
8372344|NCT01147458|20638835|P1|STARTED|Washout Period of 2 Weeks||34
8372345|NCT01147458|20638832|P4|NOT COMPLETED|First Intervention||14
8372346|NCT01147458|20638833|P3|NOT COMPLETED|First Intervention||12
8372347|NCT01147458|20638834|P2|NOT COMPLETED|First Intervention||16
8372348|NCT01147458|20638835|P1|NOT COMPLETED|First Intervention||14
8372349|NCT01147458|20638832|P4|COMPLETED|First Intervention||34
8372350|NCT01147458|20638833|P3|COMPLETED|First Intervention||35
8372351|NCT01147458|20638834|P2|COMPLETED|First Intervention||31
8372352|NCT01147458|20638835|P1|COMPLETED|First Intervention||34
8372353|NCT01147458|20638832|P4|STARTED|First Intervention||48
8372354|NCT01147458|20638833|P3|STARTED|First Intervention||47
8372355|NCT01147458|20638834|P2|STARTED|First Intervention||47
8372356|NCT01147458|20638835|P1|STARTED|First Intervention||48
8372357|NCT01147406|20638889|P6|NOT COMPLETED|Overall Study||0
8372358|NCT01147406|20638890|P5|NOT COMPLETED|Overall Study||0
8372359|NCT01147406|20638891|P4|NOT COMPLETED|Overall Study||0
8372360|NCT01147406|20638892|P3|NOT COMPLETED|Overall Study||0
8372361|NCT01147406|20638893|P2|NOT COMPLETED|Overall Study||0
8372362|NCT01147406|20638894|P1|NOT COMPLETED|Overall Study||0
8372363|NCT01147406|20638889|P6|COMPLETED|Overall Study||10
8372364|NCT01147406|20638890|P5|COMPLETED|Overall Study||6
8372365|NCT01147406|20638891|P4|COMPLETED|Overall Study||6
8372366|NCT01147406|20638892|P3|COMPLETED|Overall Study||1
8372367|NCT01147406|20638893|P2|COMPLETED|Overall Study||12
8372368|NCT01147406|20638894|P1|COMPLETED|Overall Study||6
8372369|NCT01147406|20638889|P6|STARTED|Overall Study||10
8372370|NCT01147406|20638890|P5|STARTED|Overall Study||6
8372371|NCT01147406|20638891|P4|STARTED|Overall Study||6
8372372|NCT01147406|20638892|P3|STARTED|Overall Study||1
8372373|NCT01147406|20638893|P2|STARTED|Overall Study||12
8372374|NCT01147406|20638894|P1|STARTED|Overall Study||6
8372375|NCT01147393|20638914|P1|NOT COMPLETED|Dose Level -1||1
8372376|NCT01147393|20638914|P1|COMPLETED|Dose Level -1||0
8372377|NCT01147393|20638914|P1|STARTED|Dose Level -1||1
8372378|NCT01147393|20638914|P1|NOT COMPLETED|Dose Level 1||2
8372379|NCT01147393|20638914|P1|COMPLETED|Dose Level 1||1
8372380|NCT01147393|20638914|P1|STARTED|Dose Level 1||3
8372381|NCT01147380|20638924|P2|NOT COMPLETED|Overall Study||0
8372382|NCT01147380|20638925|P1|NOT COMPLETED|Overall Study||0
8372383|NCT01147380|20638924|P2|COMPLETED|Overall Study||12
8372384|NCT01147380|20638925|P1|COMPLETED|Overall Study||6
8372385|NCT01147380|20638924|P2|STARTED|Overall Study||12
8372386|NCT01147380|20638925|P1|STARTED|Overall Study||6
8372387|NCT01147341|20638935|P2|NOT COMPLETED|Open Label Period||0
8372388|NCT01147341|20638936|P1|NOT COMPLETED|Open Label Period||4
8372389|NCT01147341|20638935|P2|COMPLETED|Open Label Period||8
8372390|NCT01147341|20638936|P1|COMPLETED|Open Label Period||22
8372391|NCT01147341|20638935|P2|STARTED|Open Label Period||8
8372392|NCT01147341|20638936|P1|STARTED|Open Label Period||26
8372393|NCT01147341|20638935|P2|NOT COMPLETED|Double Blind Period||2
8372394|NCT01147341|20638936|P1|NOT COMPLETED|Double Blind Period||1
8372395|NCT01147341|20638935|P2|COMPLETED|Double Blind Period||8
8372396|NCT01147341|20638936|P1|COMPLETED|Double Blind Period||26
8372397|NCT01147341|20638935|P2|STARTED|Double Blind Period||10
8372398|NCT01147341|20638936|P1|STARTED|Double Blind Period||27
8372405|NCT01147250|20638999|P2|NOT COMPLETED|Overall Study||105
8372406|NCT01147250|20639000|P1|NOT COMPLETED|Overall Study||110
8372407|NCT01147250|20638999|P2|COMPLETED|Overall Study||2929
8372408|NCT01147250|20639000|P1|COMPLETED|Overall Study||2924
8372409|NCT01147250|20638999|P2|Treated|Overall Study||3031
8372410|NCT01147250|20639000|P1|Treated|Overall Study||3032
8372411|NCT01147250|20638999|P2|STARTED|Overall Study||3034
8372412|NCT01147250|20639000|P1|STARTED|Overall Study||3034
8372413|NCT01147172|20639012|P1|NOT COMPLETED|Overall Study||4
8372414|NCT01147172|20639012|P1|COMPLETED|Overall Study||96
8372415|NCT01147172|20639012|P1|STARTED|Overall Study||100
8372416|NCT01147068|20639030|P7|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
8372417|NCT01147068|20639031|P6|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
8372418|NCT01147068|20639032|P5|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
8372419|NCT01147068|20639033|P4|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
8372420|NCT01147068|20639034|P3|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
8372421|NCT01147068|20639035|P2|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
8372422|NCT01147068|20639036|P1|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
8372423|NCT01147068|20639030|P7|COMPLETED|Subjects That Completed Safety Follow-up||54
8372424|NCT01147068|20639031|P6|COMPLETED|Subjects That Completed Safety Follow-up||52
8372425|NCT01147068|20639032|P5|COMPLETED|Subjects That Completed Safety Follow-up||56
8372426|NCT01147068|20639033|P4|COMPLETED|Subjects That Completed Safety Follow-up||54
8372427|NCT01147068|20639034|P3|COMPLETED|Subjects That Completed Safety Follow-up||55
8372428|NCT01147068|20639035|P2|COMPLETED|Subjects That Completed Safety Follow-up||56
8372429|NCT01147068|20639036|P1|COMPLETED|Subjects That Completed Safety Follow-up||59
8372430|NCT01147068|20639030|P7|STARTED|Subjects That Completed Safety Follow-up||55
8372431|NCT01147068|20639031|P6|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
8372432|NCT01147068|20639032|P5|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
8372433|NCT01147068|20639033|P4|STARTED|Subjects That Completed Safety Follow-up||56
8372434|NCT01147068|20639034|P3|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
8372435|NCT01147068|20639035|P2|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
8372436|NCT01147068|20639036|P1|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
8372437|NCT01147068|20639030|P7|NOT COMPLETED|Subjects That Received 2nd Dose||0
8372438|NCT01147068|20639031|P6|NOT COMPLETED|Subjects That Received 2nd Dose||2
8372439|NCT01147068|20639032|P5|NOT COMPLETED|Subjects That Received 2nd Dose||1
8372440|NCT01147068|20639033|P4|NOT COMPLETED|Subjects That Received 2nd Dose||0
8372441|NCT01147068|20639034|P3|NOT COMPLETED|Subjects That Received 2nd Dose||3
8372442|NCT01147068|20639035|P2|NOT COMPLETED|Subjects That Received 2nd Dose||5
8372443|NCT01147068|20639036|P1|NOT COMPLETED|Subjects That Received 2nd Dose||1
8372444|NCT01147068|20639030|P7|COMPLETED|Subjects That Received 2nd Dose||55
8372445|NCT01147068|20639031|P6|COMPLETED|Subjects That Received 2nd Dose||51
8372446|NCT01147068|20639032|P5|COMPLETED|Subjects That Received 2nd Dose||55
8372447|NCT01147068|20639033|P4|COMPLETED|Subjects That Received 2nd Dose||56
8372448|NCT01147068|20639034|P3|COMPLETED|Subjects That Received 2nd Dose||52
8372449|NCT01147068|20639035|P2|COMPLETED|Subjects That Received 2nd Dose||52
8372450|NCT01147068|20639036|P1|COMPLETED|Subjects That Received 2nd Dose||59
8372451|NCT01147068|20639030|P7|STARTED|Subjects That Received 2nd Dose||55
8372452|NCT01147068|20639031|P6|STARTED|Subjects That Received 2nd Dose||53
8372453|NCT01147068|20639032|P5|STARTED|Subjects That Received 2nd Dose||56
8372454|NCT01147068|20639033|P4|STARTED|Subjects That Received 2nd Dose||56
8372455|NCT01147068|20639034|P3|STARTED|Subjects That Received 2nd Dose||55
8372456|NCT01147068|20639035|P2|STARTED|Subjects That Received 2nd Dose||57
8372457|NCT01147068|20639036|P1|STARTED|Subjects That Received 2nd Dose||60
8372458|NCT01147068|20639030|P7|NOT COMPLETED|Subjects That Received 1st Dose||0
8372459|NCT01147068|20639031|P6|NOT COMPLETED|Subjects That Received 1st Dose||0
8372460|NCT01147068|20639032|P5|NOT COMPLETED|Subjects That Received 1st Dose||0
8372461|NCT01147068|20639033|P4|NOT COMPLETED|Subjects That Received 1st Dose||0
8372462|NCT01147068|20639034|P3|NOT COMPLETED|Subjects That Received 1st Dose||0
8372463|NCT01147068|20639035|P2|NOT COMPLETED|Subjects That Received 1st Dose||0
8372464|NCT01147068|20639036|P1|NOT COMPLETED|Subjects That Received 1st Dose||0
8372465|NCT01147068|20639030|P7|COMPLETED|Subjects That Received 1st Dose||55
8372466|NCT01147068|20639031|P6|COMPLETED|Subjects That Received 1st Dose||53
8372467|NCT01147068|20639032|P5|COMPLETED|Subjects That Received 1st Dose||56
8372468|NCT01147068|20639033|P4|COMPLETED|Subjects That Received 1st Dose||56
8372469|NCT01147068|20639034|P3|COMPLETED|Subjects That Received 1st Dose||55
8372470|NCT01147068|20639035|P2|COMPLETED|Subjects That Received 1st Dose||57
8372471|NCT01147068|20639036|P1|COMPLETED|Subjects That Received 1st Dose||60
8372472|NCT01147068|20639030|P7|STARTED|Subjects That Received 1st Dose||55
8372473|NCT01147068|20639031|P6|STARTED|Subjects That Received 1st Dose||53
8372474|NCT01147068|20639032|P5|STARTED|Subjects That Received 1st Dose||56
8372475|NCT01147068|20639033|P4|STARTED|Subjects That Received 1st Dose||56
8372476|NCT01147068|20639034|P3|STARTED|Subjects That Received 1st Dose||55
8372477|NCT01147068|20639035|P2|STARTED|Subjects That Received 1st Dose||57
8372478|NCT01147068|20639036|P1|STARTED|Subjects That Received 1st Dose||60
8372479|NCT01147055|20639066|P2|NOT COMPLETED|Second Intervention Period||0
8372480|NCT01147055|20639067|P1|NOT COMPLETED|Second Intervention Period||0
8372481|NCT01147055|20639066|P2|COMPLETED|Second Intervention Period||14
8372482|NCT01147055|20639067|P1|COMPLETED|Second Intervention Period||0
8372483|NCT01147055|20639066|P2|STARTED|Second Intervention Period||14
8372484|NCT01147055|20639067|P1|STARTED|Second Intervention Period||0
8372485|NCT01147055|20639066|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8372486|NCT01147055|20639067|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8372487|NCT01147055|20639066|P2|COMPLETED|Washout Period (at Least 14 Days)||0
8372488|NCT01147055|20639067|P1|COMPLETED|Washout Period (at Least 14 Days)||14
8372489|NCT01147055|20639066|P2|STARTED|Washout Period (at Least 14 Days)||0
8372490|NCT01147055|20639067|P1|STARTED|Washout Period (at Least 14 Days)||14
8372491|NCT01147055|20639066|P2|NOT COMPLETED|First Intervention Period||0
8372492|NCT01147055|20639067|P1|NOT COMPLETED|First Intervention Period||1
8372493|NCT01147055|20639066|P2|COMPLETED|First Intervention Period||0
8372494|NCT01147055|20639067|P1|COMPLETED|First Intervention Period||14
8372495|NCT01147055|20639066|P2|STARTED|First Intervention Period||0
8372496|NCT01147055|20639067|P1|STARTED|First Intervention Period||15
8372497|NCT01147042|20639101|P2|NOT COMPLETED|Overall Study||0
8372498|NCT01147042|20639102|P1|NOT COMPLETED|Overall Study||0
8372499|NCT01147042|20639101|P2|COMPLETED|Overall Study||0
8372500|NCT01147042|20639102|P1|COMPLETED|Overall Study||2
8372501|NCT01147042|20639101|P2|STARTED|Overall Study||0
8372502|NCT01147042|20639102|P1|STARTED|Overall Study||2
8372503|NCT01146951|20639109|P2|NOT COMPLETED|Overall Study||1
8372504|NCT01146951|20639110|P1|NOT COMPLETED|Overall Study||4
8372505|NCT01146951|20639109|P2|COMPLETED|Overall Study||29
8372506|NCT01146951|20639110|P1|COMPLETED|Overall Study||25
8372507|NCT01146951|20639109|P2|STARTED|Overall Study||30
8372508|NCT01146951|20639110|P1|STARTED|Overall Study||29
8372509|NCT01146912|20639131|P8|NOT COMPLETED|Overall Study||0
8372510|NCT01146912|20639132|P7|NOT COMPLETED|Overall Study||56
8372511|NCT01146912|20639133|P6|NOT COMPLETED|Overall Study||61
8372512|NCT01146912|20639134|P5|NOT COMPLETED|Overall Study||41
8372513|NCT01146912|20639135|P4|NOT COMPLETED|Overall Study||17
8372514|NCT01146912|20639136|P3|NOT COMPLETED|Overall Study||17
8372515|NCT01146912|20639137|P2|NOT COMPLETED|Overall Study||822
8372516|NCT01146912|20639138|P1|NOT COMPLETED|Overall Study||817
8372517|NCT01146912|20639131|P8|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
8372518|NCT01146912|20639132|P7|COMPLETED|Overall Study||1764
8372519|NCT01146912|20639133|P6|COMPLETED|Overall Study||1760
8372520|NCT01146912|20639134|P5|COMPLETED|Overall Study||1780
8372521|NCT01146912|20639135|P4|COMPLETED|Overall Study||577
8372522|NCT01146912|20639136|P3|COMPLETED|Overall Study||576
8372523|NCT01146912|20639137|P2|COMPLETED|Overall Study||3784
8372524|NCT01146912|20639138|P1|COMPLETED|Overall Study||3790
8372525|NCT01146912|20639131|P8|STARTED|Overall Study||14675
8372526|NCT01146912|20639132|P7|STARTED|Overall Study||1820
8372527|NCT01146912|20639133|P6|STARTED|Overall Study||1821
8372528|NCT01146912|20639134|P5|STARTED|Overall Study||1821
8372529|NCT01146912|20639135|P4|STARTED|Overall Study||594
8372530|NCT01146912|20639136|P3|STARTED|Overall Study||593
8372531|NCT01146912|20639137|P2|STARTED|Overall Study||4606
8372532|NCT01146912|20639138|P1|STARTED|Overall Study||4607
8372533|NCT01146873|20639160|P2|NOT COMPLETED|Overall Study||6
8372534|NCT01146873|20639161|P1|NOT COMPLETED|Overall Study||0
8372535|NCT01146873|20639160|P2|COMPLETED|Overall Study||144
8372536|NCT01146873|20639161|P1|COMPLETED|Overall Study||148
8372537|NCT01146873|20639160|P2|STARTED|Overall Study||150
8372538|NCT01146873|20639161|P1|STARTED|Overall Study||148
8372539|NCT01146860|20639177|P2|NOT COMPLETED|Overall Study||1
8372540|NCT01146860|20639178|P1|NOT COMPLETED|Overall Study||0
8372541|NCT01146860|20639177|P2|COMPLETED|Overall Study||191
8372542|NCT01146860|20639178|P1|COMPLETED|Overall Study||194
8372543|NCT01146860|20639177|P2|STARTED|Overall Study||192
8372544|NCT01146860|20639178|P1|STARTED|Overall Study||194
8372545|NCT01146834|20639197|P5|NOT COMPLETED|Overall Study||0
8372546|NCT01146834|20639198|P4|NOT COMPLETED|Overall Study||0
8372547|NCT01146834|20639199|P3|NOT COMPLETED|Overall Study||2
8372548|NCT01146834|20639200|P2|NOT COMPLETED|Overall Study||0
8372549|NCT01146834|20639201|P1|NOT COMPLETED|Overall Study||3
8372550|NCT01146834|20639197|P5|COMPLETED|Overall Study||0
8372551|NCT01146834|20639198|P4|COMPLETED|Overall Study||0
8372552|NCT01146834|20639199|P3|COMPLETED|Overall Study||21
8372553|NCT01146834|20639200|P2|COMPLETED|Overall Study||4
8372554|NCT01146834|20639201|P1|COMPLETED|Overall Study||17
8372555|NCT01146834|20639197|P5|STARTED|Overall Study||0
8372556|NCT01146834|20639198|P4|STARTED|Overall Study||0
8372557|NCT01146834|20639199|P3|STARTED|Overall Study||23
8372558|NCT01146834|20639200|P2|STARTED|Overall Study||4
8372559|NCT01146834|20639201|P1|STARTED|Overall Study||20
8372563|NCT01146782|20639229|P1|NOT COMPLETED|Primary Endpoint Cohort||6
8372564|NCT01146782|20639229|P1|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
8372565|NCT01146782|20639229|P1|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
8372566|NCT01146782|20639229|P1|NOT COMPLETED|Safety Cohort||83
8372567|NCT01146782|20639229|P1|COMPLETED|Safety Cohort||63
8372568|NCT01146782|20639229|P1|STARTED|Safety Cohort||146
8372569|NCT01146782|20639229|P1|NOT COMPLETED|Screening Cohort||221
8372570|NCT01146782|20639229|P1|COMPLETED|Screening Cohort||146
8372571|NCT01146782|20639229|P1|STARTED|Screening Cohort||367
8372578|NCT01146665|20639247|P2|NOT COMPLETED|Overall Study||16
8372579|NCT01146665|20639248|P1|NOT COMPLETED|Overall Study||10
8372580|NCT01146665|20639247|P2|COMPLETED|Overall Study||10
8372581|NCT01146665|20639248|P1|COMPLETED|Overall Study||8
8372582|NCT01146665|20639247|P2|3-month Post-ED Discharge (Follow-up)|Overall Study||10
8372583|NCT01146665|20639248|P1|3-month Post-ED Discharge (Follow-up)|Overall Study||8
8372584|NCT01146665|20639247|P2|1-month Post-ED Discharge (Follow-up)|Overall Study||12
8372585|NCT01146665|20639248|P1|1-month Post-ED Discharge (Follow-up)|Overall Study||9
8372586|NCT01146665|20639247|P2|STARTED|Overall Study||26
8372587|NCT01146665|20639248|P1|STARTED|Overall Study||18
8372588|NCT01146613|20639280|P2|NOT COMPLETED|Overall Study||12
8372589|NCT01146613|20639281|P1|NOT COMPLETED|Overall Study||7
8372590|NCT01146613|20639280|P2|COMPLETED|Overall Study||89
8372591|NCT01146613|20639281|P1|COMPLETED|Overall Study||92
8372592|NCT01146613|20639280|P2|STARTED|Overall Study||101
8372593|NCT01146613|20639281|P1|STARTED|Overall Study||99
8372594|NCT01146600|20639289|P2|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
8372595|NCT01146600|20639290|P1|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
8372596|NCT01146600|20639289|P2|COMPLETED|Period 2 (Weeks 4 & 5)||10
8372597|NCT01146600|20639290|P1|COMPLETED|Period 2 (Weeks 4 & 5)||10
8372598|NCT01146600|20639289|P2|STARTED|Period 2 (Weeks 4 & 5)||10
8372599|NCT01146600|20639290|P1|STARTED|Period 2 (Weeks 4 & 5)||10
8372600|NCT01146600|20639289|P2|NOT COMPLETED|Washout (Week 3)||0
8372601|NCT01146600|20639290|P1|NOT COMPLETED|Washout (Week 3)||0
8372602|NCT01146600|20639289|P2|COMPLETED|Washout (Week 3)||10
8372603|NCT01146600|20639290|P1|COMPLETED|Washout (Week 3)||10
8372604|NCT01146600|20639289|P2|STARTED|Washout (Week 3)||10
8372605|NCT01146600|20639290|P1|STARTED|Washout (Week 3)||10
8372606|NCT01146600|20639289|P2|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
8372607|NCT01146600|20639290|P1|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
8372608|NCT01146600|20639289|P2|COMPLETED|Period 1 (Weeks 1 & 2)||10
8372609|NCT01146600|20639290|P1|COMPLETED|Period 1 (Weeks 1 & 2)||10
8372610|NCT01146600|20639289|P2|STARTED|Period 1 (Weeks 1 & 2)||10
8372611|NCT01146600|20639290|P1|STARTED|Period 1 (Weeks 1 & 2)||13
8372612|NCT01146496|20639317|P2|NOT COMPLETED|Overall Study||0
8372613|NCT01146496|20639318|P1|NOT COMPLETED|Overall Study||0
8372614|NCT01146496|20639317|P2|COMPLETED|Overall Study||109693
8372615|NCT01146496|20639318|P1|COMPLETED|Overall Study||114168
8372616|NCT01146496|20639317|P2|STARTED|Overall Study||109693
8372617|NCT01146496|20639318|P1|STARTED|Overall Study||114168
8372618|NCT01146457|20639339|P5|NOT COMPLETED|Overall Study||0
8372619|NCT01146457|20639340|P4|NOT COMPLETED|Overall Study||0
8372620|NCT01146457|20639341|P3|NOT COMPLETED|Overall Study||1
8372621|NCT01146457|20639342|P2|NOT COMPLETED|Overall Study||0
8372622|NCT01146457|20639343|P1|NOT COMPLETED|Overall Study||0
8372623|NCT01146457|20639339|P5|COMPLETED|Overall Study||13
8372624|NCT01146457|20639340|P4|COMPLETED|Overall Study||13
8372625|NCT01146457|20639341|P3|COMPLETED|Overall Study||20
8372626|NCT01146457|20639342|P2|COMPLETED|Overall Study||17
8372627|NCT01146457|20639343|P1|COMPLETED|Overall Study||19
8372628|NCT01146457|20639339|P5|STARTED|Overall Study||13
8372629|NCT01146457|20639340|P4|STARTED|Overall Study||13
8372630|NCT01146457|20639341|P3|STARTED|Overall Study||21
8372631|NCT01146457|20639342|P2|STARTED|Overall Study||17
8372632|NCT01146457|20639343|P1|STARTED|Overall Study||19
8372633|NCT01146418|20639357|P4|NOT COMPLETED|Live-Born Infant Follow Up||5
8372634|NCT01146418|20639358|P3|NOT COMPLETED|Live-Born Infant Follow Up||6
8372635|NCT01146418|20639359|P2|NOT COMPLETED|Live-Born Infant Follow Up||0
8372636|NCT01146418|20639360|P1|NOT COMPLETED|Live-Born Infant Follow Up||0
8372637|NCT01146418|20639357|P4|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
8372638|NCT01146418|20639358|P3|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
8372639|NCT01146418|20639359|P2|COMPLETED|Live-Born Infant Follow Up||0
8372640|NCT01146418|20639360|P1|COMPLETED|Live-Born Infant Follow Up||0
8372641|NCT01146418|20639357|P4|STARTED|Live-Born Infant Follow Up||56
8372642|NCT01146418|20639358|P3|STARTED|Live-Born Infant Follow Up||61
8372643|NCT01146418|20639359|P2|STARTED|Live-Born Infant Follow Up||0
8372644|NCT01146418|20639360|P1|STARTED|Live-Born Infant Follow Up||0
8372645|NCT01146418|20639357|P4|NOT COMPLETED|Women/Expectant Mother Follow Up||0
8372646|NCT01146418|20639358|P3|NOT COMPLETED|Women/Expectant Mother Follow Up||0
8372647|NCT01146418|20639359|P2|NOT COMPLETED|Women/Expectant Mother Follow Up||40
8372648|NCT01146418|20639360|P1|NOT COMPLETED|Women/Expectant Mother Follow Up||44
8372649|NCT01146418|20639357|P4|COMPLETED|Women/Expectant Mother Follow Up||0
8372650|NCT01146418|20639358|P3|COMPLETED|Women/Expectant Mother Follow Up||0
8372651|NCT01146418|20639359|P2|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
8372652|NCT01146418|20639360|P1|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
8372653|NCT01146418|20639357|P4|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
8372654|NCT01146418|20639358|P3|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
8372655|NCT01146418|20639359|P2|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
8372656|NCT01146418|20639360|P1|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
8372657|NCT01146418|20639357|P4|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
8372658|NCT01146418|20639358|P3|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
8372659|NCT01146418|20639359|P2|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
8372660|NCT01146418|20639360|P1|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
8372661|NCT01146418|20639357|P4|STARTED|Women/Expectant Mother Follow Up||0
8372662|NCT01146418|20639358|P3|STARTED|Women/Expectant Mother Follow Up||0
8372663|NCT01146418|20639359|P2|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
8372664|NCT01146418|20639360|P1|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
8372665|NCT01146418|20639357|P4|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
8372666|NCT01146418|20639358|P3|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
8372667|NCT01146418|20639359|P2|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
8372668|NCT01146418|20639360|P1|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
8372669|NCT01146418|20639357|P4|COMPLETED|Base Study P06029 (NCT01144416)||0
8372670|NCT01146418|20639358|P3|COMPLETED|Base Study P06029 (NCT01144416)||0
8372671|NCT01146418|20639359|P2|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
8372672|NCT01146418|20639360|P1|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
8372673|NCT01146418|20639357|P4|STARTED|Base Study P06029 (NCT01144416)||0
8372674|NCT01146418|20639358|P3|STARTED|Base Study P06029 (NCT01144416)||0
8372675|NCT01146418|20639359|P2|STARTED|Base Study P06029 (NCT01144416)||696
8372676|NCT01146418|20639360|P1|STARTED|Base Study P06029 (NCT01144416)||694
8372677|NCT01146379|20639376|P4|NOT COMPLETED|Overall Study||1
8372678|NCT01146379|20639377|P3|NOT COMPLETED|Overall Study||0
8372679|NCT01146379|20639378|P2|NOT COMPLETED|Overall Study||1
8372680|NCT01146379|20639379|P1|NOT COMPLETED|Overall Study||1
8372681|NCT01146379|20639376|P4|COMPLETED|Overall Study||20
8372682|NCT01146379|20639377|P3|COMPLETED|Overall Study||21
8372683|NCT01146379|20639378|P2|COMPLETED|Overall Study||21
8372684|NCT01146379|20639379|P1|COMPLETED|Overall Study||20
8372685|NCT01146379|20639376|P4|STARTED|Overall Study||21
8372686|NCT01146379|20639377|P3|STARTED|Overall Study||21
8372687|NCT01146379|20639378|P2|STARTED|Overall Study||22
8372688|NCT01146379|20639379|P1|STARTED|Overall Study||21
8372689|NCT01146288|20639391|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8372690|NCT01146288|20639392|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8372691|NCT01146288|20639391|P2|COMPLETED|Second Intervention (1 Day)||5
8372692|NCT01146288|20639392|P1|COMPLETED|Second Intervention (1 Day)||7
8372693|NCT01146288|20639391|P2|STARTED|Second Intervention (1 Day)||5
8372694|NCT01146288|20639392|P1|STARTED|Second Intervention (1 Day)||7
8372695|NCT01146288|20639391|P2|NOT COMPLETED|First Intervention(1 Day)||1
8372696|NCT01146288|20639392|P1|NOT COMPLETED|First Intervention(1 Day)||0
8372697|NCT01146288|20639391|P2|COMPLETED|First Intervention(1 Day)||5
8372698|NCT01146288|20639392|P1|COMPLETED|First Intervention(1 Day)||7
8372699|NCT01146288|20639391|P2|STARTED|First Intervention(1 Day)||6
8372700|NCT01146288|20639392|P1|STARTED|First Intervention(1 Day)||7
8372701|NCT01146275|20639401|P1|NOT COMPLETED|Overall Study||0
8372702|NCT01146275|20639401|P1|COMPLETED|Overall Study||6
8372703|NCT01146275|20639401|P1|STARTED|Overall Study||6
8372704|NCT01146054|20639406|P1|NOT COMPLETED|Overall Study||10
8372705|NCT01146054|20639406|P1|COMPLETED|Overall Study||49
8372706|NCT01146054|20639406|P1|STARTED|Overall Study||59
8372707|NCT01145898|20639416|P2|NOT COMPLETED|3-year Treatment||16
8372708|NCT01145898|20639417|P1|NOT COMPLETED|3-year Treatment||3
8372709|NCT01145898|20639416|P2|COMPLETED|3-year Treatment||28
8372710|NCT01145898|20639417|P1|COMPLETED|3-year Treatment||9
8372711|NCT01145898|20639416|P2|STARTED|3-year Treatment||44
8372712|NCT01145898|20639417|P1|STARTED|3-year Treatment||12
8372713|NCT01145898|20639416|P2|NOT COMPLETED|6-month Treatment||0
8372714|NCT01145898|20639417|P1|NOT COMPLETED|6-month Treatment||0
8372715|NCT01145898|20639416|P2|COMPLETED|6-month Treatment||44
8372716|NCT01145898|20639417|P1|COMPLETED|6-month Treatment||12
8372717|NCT01145898|20639416|P2|STARTED|6-month Treatment||44
8372718|NCT01145898|20639417|P1|STARTED|6-month Treatment||12
8372719|NCT01145885|20639448|P1|NOT COMPLETED|Overall Study||7
8372720|NCT01145885|20639448|P1|COMPLETED|Overall Study||0
8372721|NCT01145885|20639448|P1|STARTED|Overall Study||7
8372722|NCT01145833|20639482|P2|NOT COMPLETED|Overall Study||0
8372723|NCT01145833|20639483|P1|NOT COMPLETED|Overall Study||3
8372724|NCT01145833|20639482|P2|COMPLETED|Overall Study||25
8372725|NCT01145833|20639483|P1|COMPLETED|Overall Study||22
8372726|NCT01145833|20639482|P2|STARTED|Overall Study||25
8372727|NCT01145833|20639483|P1|STARTED|Overall Study||25
8372728|NCT01145755|20639494|P3|NOT COMPLETED|Overall Study||25
8372729|NCT01145755|20639495|P2|NOT COMPLETED|Overall Study||28
8372730|NCT01145755|20639496|P1|NOT COMPLETED|Overall Study||20
8372731|NCT01145755|20639494|P3|COMPLETED|Overall Study||19
8372732|NCT01145755|20639495|P2|COMPLETED|Overall Study||19
8372733|NCT01145755|20639496|P1|COMPLETED|Overall Study||20
8372734|NCT01145755|20639494|P3|STARTED|Overall Study||44
8372735|NCT01145755|20639495|P2|STARTED|Overall Study||47
8372736|NCT01145755|20639496|P1|STARTED|Overall Study||40
8372737|NCT01145638|20639512|P2|NOT COMPLETED|Overall Study||57
8372738|NCT01145638|20639513|P1|NOT COMPLETED|Overall Study||90
8372739|NCT01145638|20639512|P2|COMPLETED|Overall Study||62
8372740|NCT01145638|20639513|P1|COMPLETED|Overall Study||141
8372741|NCT01145638|20639512|P2|STARTED|Overall Study||119
8372742|NCT01145638|20639513|P1|STARTED|Overall Study||231
8372743|NCT01145625|20639523|P2|NOT COMPLETED|Overall Study||31
8372744|NCT01145625|20639524|P1|NOT COMPLETED|Overall Study||24
8372745|NCT01145625|20639523|P2|COMPLETED|Overall Study||130
8372746|NCT01145625|20639524|P1|COMPLETED|Overall Study||137
8372747|NCT01145625|20639523|P2|STARTED|Overall Study||161
8372748|NCT01145625|20639524|P1|STARTED|Overall Study||161
8372749|NCT01145560|20639537|P3|NOT COMPLETED|Overall Study||2
8372750|NCT01145560|20639538|P2|NOT COMPLETED|Overall Study||4
8372751|NCT01145560|20639539|P1|NOT COMPLETED|Overall Study||4
8372752|NCT01145560|20639537|P3|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
8372753|NCT01145560|20639538|P2|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
8372754|NCT01145560|20639539|P1|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
8372755|NCT01145560|20639537|P3|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
8372756|NCT01145560|20639538|P2|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
8372757|NCT01145560|20639539|P1|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
8372758|NCT01145560|20639537|P3|Received Treatment|Overall Study||99
8372759|NCT01145560|20639538|P2|Received Treatment|Overall Study||98
8372760|NCT01145560|20639539|P1|Received Treatment|Overall Study||99
8372761|NCT01145560|20639537|P3|STARTED|Overall Study||100
8372762|NCT01145560|20639538|P2|STARTED|Overall Study||100
8372763|NCT01145560|20639539|P1|STARTED|Overall Study||100
8372764|NCT01145547|20639556|P2|NOT COMPLETED|Overall Study||0
8372765|NCT01145547|20639557|P1|NOT COMPLETED|Overall Study||0
8372766|NCT01145547|20639556|P2|COMPLETED|Overall Study||3
8372767|NCT01145547|20639557|P1|COMPLETED|Overall Study||4
8372768|NCT01145547|20639556|P2|STARTED|Overall Study||3
8372769|NCT01145547|20639557|P1|STARTED|Overall Study||4
8372770|NCT01145508|20639565|P2|NOT COMPLETED|Overall Study||2
8372771|NCT01145508|20639566|P1|NOT COMPLETED|Overall Study||5
8372772|NCT01145508|20639565|P2|COMPLETED|Overall Study||1
8372773|NCT01145508|20639566|P1|COMPLETED|Overall Study||2
8372774|NCT01145508|20639565|P2|Treated|Overall Study||2
8372775|NCT01145508|20639566|P1|Treated|Overall Study||6
8372776|NCT01145508|20639565|P2|STARTED|Overall Study||3
8372777|NCT01145508|20639566|P1|STARTED|Overall Study||7
8372781|NCT01145482|20639578|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8372782|NCT01145482|20639579|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8372783|NCT01145482|20639578|P2|COMPLETED|Second Intervention (1 Day)||6
8372784|NCT01145482|20639579|P1|COMPLETED|Second Intervention (1 Day)||5
8372785|NCT01145482|20639578|P2|STARTED|Second Intervention (1 Day)||6
8372786|NCT01145482|20639579|P1|STARTED|Second Intervention (1 Day)||5
8372787|NCT01145482|20639578|P2|NOT COMPLETED|First Intervention (1 Day)||1
8372788|NCT01145482|20639579|P1|NOT COMPLETED|First Intervention (1 Day)||0
8372789|NCT01145482|20639578|P2|COMPLETED|First Intervention (1 Day)||5
8372790|NCT01145482|20639579|P1|COMPLETED|First Intervention (1 Day)||6
8372791|NCT01145482|20639578|P2|STARTED|First Intervention (1 Day)||6
8372792|NCT01145482|20639579|P1|STARTED|First Intervention (1 Day)||6
8372793|NCT01145391|20639589|P2|NOT COMPLETED|Overall Study||0
8372794|NCT01145391|20639590|P1|NOT COMPLETED|Overall Study||0
8372795|NCT01145391|20639589|P2|COMPLETED|Overall Study||298
8372796|NCT01145391|20639590|P1|COMPLETED|Overall Study||293
8372797|NCT01145391|20639589|P2|9 Months Post-randomization|Overall Study||298
8372798|NCT01145391|20639590|P1|9 Months Post-randomization|Overall Study||293
8372799|NCT01145391|20639589|P2|STARTED|Overall Study||298
8372800|NCT01145391|20639590|P1|STARTED|Overall Study||293
8372801|NCT01145352|20639598|P1|NOT COMPLETED|Overall Study||11
8372802|NCT01145352|20639598|P1|COMPLETED|Overall Study||102
8372803|NCT01145352|20639598|P1|STARTED|Overall Study||113
8372804|NCT01145222|20639610|P4|NOT COMPLETED|Overall Study||1
8372805|NCT01145222|20639611|P3|NOT COMPLETED|Overall Study||1
8372806|NCT01145222|20639612|P2|NOT COMPLETED|Overall Study||0
8372807|NCT01145222|20639613|P1|NOT COMPLETED|Overall Study||0
8372808|NCT01145222|20639610|P4|COMPLETED|Overall Study||40
8372809|NCT01145222|20639611|P3|COMPLETED|Overall Study||40
8372810|NCT01145222|20639612|P2|COMPLETED|Overall Study||40
8372811|NCT01145222|20639613|P1|COMPLETED|Overall Study||40
8372812|NCT01145222|20639610|P4|Intention to Treat (ITT) Population|Overall Study||40
8372813|NCT01145222|20639611|P3|Intention to Treat (ITT) Population|Overall Study||40
8372814|NCT01145222|20639612|P2|Intention to Treat (ITT) Population|Overall Study||40
8372815|NCT01145222|20639613|P1|Intention to Treat (ITT) Population|Overall Study||40
8372816|NCT01145222|20639610|P4|Safety Population|Overall Study||41
8372817|NCT01145222|20639611|P3|Safety Population|Overall Study||40
8372818|NCT01145222|20639612|P2|Safety Population|Overall Study||40
8372819|NCT01145222|20639613|P1|Safety Population|Overall Study||40
8372820|NCT01145222|20639610|P4|STARTED|Overall Study||41
8372821|NCT01145222|20639611|P3|STARTED|Overall Study||41
8372822|NCT01145222|20639612|P2|STARTED|Overall Study||40
8372823|NCT01145222|20639613|P1|STARTED|Overall Study||40
8372830|NCT01145183|20639644|P4|NOT COMPLETED|Overall Study||0
8372831|NCT01145183|20639645|P3|NOT COMPLETED|Overall Study||0
8372832|NCT01145183|20639646|P2|NOT COMPLETED|Overall Study||0
8372833|NCT01145183|20639647|P1|NOT COMPLETED|Overall Study||0
8372834|NCT01145183|20639644|P4|COMPLETED|Overall Study||10
8372835|NCT01145183|20639645|P3|COMPLETED|Overall Study||19
8372836|NCT01145183|20639646|P2|COMPLETED|Overall Study||26
8372837|NCT01145183|20639647|P1|COMPLETED|Overall Study||21
8372838|NCT01145183|20639644|P4|STARTED|Overall Study||10
8372839|NCT01145183|20639645|P3|STARTED|Overall Study||19
8372840|NCT01145183|20639646|P2|STARTED|Overall Study||26
8372841|NCT01145183|20639647|P1|STARTED|Overall Study||21
8372842|NCT01145066|20639660|P3|NOT COMPLETED|Overall Study||4
8372843|NCT01145066|20639661|P2|NOT COMPLETED|Overall Study||4
8372844|NCT01145066|20639662|P1|NOT COMPLETED|Overall Study||4
8372845|NCT01145066|20639660|P3|COMPLETED|Overall Study||21
8372846|NCT01145066|20639661|P2|COMPLETED|Overall Study||16
8372847|NCT01145066|20639662|P1|COMPLETED|Overall Study||22
8372848|NCT01145066|20639660|P3|STARTED|Overall Study||25
8372849|NCT01145066|20639661|P2|STARTED|Overall Study||20
8372850|NCT01145066|20639662|P1|STARTED|Overall Study||26
8372851|NCT01145053|20639730|P1|NOT COMPLETED|Overall Study||93
8372852|NCT01145053|20639730|P1|COMPLETED|Overall Study||248
8372853|NCT01145053|20639730|P1|STARTED|Overall Study||341
8372854|NCT01145001|20639744|P4|NOT COMPLETED|Overall Study||6
8372855|NCT01145001|20639745|P3|NOT COMPLETED|Overall Study||5
8372856|NCT01145001|20639746|P2|NOT COMPLETED|Overall Study||6
8372857|NCT01145001|20639747|P1|NOT COMPLETED|Overall Study||8
8372858|NCT01145001|20639744|P4|COMPLETED|Overall Study||31
8372859|NCT01145001|20639745|P3|COMPLETED|Overall Study||39
8372860|NCT01145001|20639746|P2|COMPLETED|Overall Study||31
8372861|NCT01145001|20639747|P1|COMPLETED|Overall Study||28
8372862|NCT01145001|20639744|P4|STARTED|Overall Study||37
8372863|NCT01145001|20639745|P3|STARTED|Overall Study||44
8372864|NCT01145001|20639746|P2|STARTED|Overall Study||37
8372865|NCT01145001|20639747|P1|STARTED|Overall Study||36
8372866|NCT01144949|20639763|P2|NOT COMPLETED|Overall Study||14
8372867|NCT01144949|20639764|P1|NOT COMPLETED|Overall Study||11
8372868|NCT01144949|20639763|P2|COMPLETED|Overall Study||106
8372869|NCT01144949|20639764|P1|COMPLETED|Overall Study||108
8372870|NCT01144949|20639763|P2|STARTED|Overall Study||120
8372871|NCT01144949|20639764|P1|STARTED|Overall Study||119
8372872|NCT01144715|20639782|P2|NOT COMPLETED|Overall Study||3
8372873|NCT01144715|20639783|P1|NOT COMPLETED|Overall Study||4
8372874|NCT01144715|20639782|P2|COMPLETED|Overall Study||45
8372875|NCT01144715|20639783|P1|COMPLETED|Overall Study||47
8372876|NCT01144715|20639782|P2|STARTED|Overall Study||48
8372877|NCT01144715|20639783|P1|STARTED|Overall Study||51
8372878|NCT01144663|20639799|P4|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1
8372879|NCT01144663|20639800|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7
8372880|NCT01144663|20639801|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9
8372881|NCT01144663|20639802|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5
8372882|NCT01144663|20639799|P4|COMPLETED|Extended Safety Follow-Up (ESFU)||505
8372883|NCT01144663|20639800|P3|COMPLETED|Extended Safety Follow-Up (ESFU)||496
8372884|NCT01144663|20639801|P2|COMPLETED|Extended Safety Follow-Up (ESFU)||502
8372885|NCT01144663|20639802|P1|COMPLETED|Extended Safety Follow-Up (ESFU)||492
8372886|NCT01144663|20639799|P4|STARTED|Extended Safety Follow-Up (ESFU)||506
8372887|NCT01144663|20639800|P3|STARTED|Extended Safety Follow-Up (ESFU)||503
8372888|NCT01144663|20639801|P2|STARTED|Extended Safety Follow-Up (ESFU)||511
8372889|NCT01144663|20639802|P1|STARTED|Extended Safety Follow-Up (ESFU)||497
8372890|NCT01144663|20639799|P4|NOT COMPLETED|Booster Vaccination Phase||1
8372891|NCT01144663|20639800|P3|NOT COMPLETED|Booster Vaccination Phase||5
8372892|NCT01144663|20639801|P2|NOT COMPLETED|Booster Vaccination Phase||2
8372893|NCT01144663|20639802|P1|NOT COMPLETED|Booster Vaccination Phase||3
8372894|NCT01144663|20639799|P4|COMPLETED|Booster Vaccination Phase||505
8372895|NCT01144663|20639800|P3|COMPLETED|Booster Vaccination Phase||498
8372896|NCT01144663|20639801|P2|COMPLETED|Booster Vaccination Phase||509
8372897|NCT01144663|20639802|P1|COMPLETED|Booster Vaccination Phase||494
8372898|NCT01144663|20639799|P4|STARTED|Booster Vaccination Phase||506
8372899|NCT01144663|20639800|P3|STARTED|Booster Vaccination Phase||503
8372900|NCT01144663|20639801|P2|STARTED|Booster Vaccination Phase||511
8372901|NCT01144663|20639802|P1|STARTED|Booster Vaccination Phase||497
8372902|NCT01144663|20639799|P4|NOT COMPLETED|Primary Vaccination Phase||18
8372903|NCT01144663|20639800|P3|NOT COMPLETED|Primary Vaccination Phase||8
8372904|NCT01144663|20639801|P2|NOT COMPLETED|Primary Vaccination Phase||7
8372905|NCT01144663|20639802|P1|NOT COMPLETED|Primary Vaccination Phase||20
8372906|NCT01144663|20639799|P4|COMPLETED|Primary Vaccination Phase||509
8372907|NCT01144663|20639800|P3|COMPLETED|Primary Vaccination Phase||508
8372908|NCT01144663|20639801|P2|COMPLETED|Primary Vaccination Phase||517
8372909|NCT01144663|20639802|P1|COMPLETED|Primary Vaccination Phase||508
8372910|NCT01144663|20639799|P4|STARTED|Primary Vaccination Phase||527
8372911|NCT01144663|20639800|P3|STARTED|Primary Vaccination Phase||516
8372912|NCT01144663|20639801|P2|STARTED|Primary Vaccination Phase||524
8372913|NCT01144663|20639802|P1|STARTED|Primary Vaccination Phase||528
8372914|NCT01144637|20640006|P4|NOT COMPLETED|Overall Study||56
8372915|NCT01144637|20640007|P3|NOT COMPLETED|Overall Study||60
8372916|NCT01144637|20640008|P2|NOT COMPLETED|Overall Study||76
8372917|NCT01144637|20640009|P1|NOT COMPLETED|Overall Study||74
8372918|NCT01144637|20640006|P4|COMPLETED|Overall Study||946
8372919|NCT01144637|20640007|P3|COMPLETED|Overall Study||939
8372920|NCT01144637|20640008|P2|COMPLETED|Overall Study||929
8372921|NCT01144637|20640009|P1|COMPLETED|Overall Study||925
8372922|NCT01144637|20640006|P4|STARTED|Overall Study||1002
8372923|NCT01144637|20640007|P3|STARTED|Overall Study||999
8372924|NCT01144637|20640008|P2|STARTED|Overall Study||1005
8372925|NCT01144637|20640009|P1|STARTED|Overall Study||999
8372926|NCT01144624|20640066|P3|NOT COMPLETED|Overall Study||0
8372927|NCT01144624|20640067|P2|NOT COMPLETED|Overall Study||0
8372928|NCT01144624|20640068|P1|NOT COMPLETED|Overall Study||0
8372929|NCT01144624|20640066|P3|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
8372930|NCT01144624|20640067|P2|COMPLETED|Overall Study||7
8372931|NCT01144624|20640068|P1|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
8372932|NCT01144624|20640066|P3|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
8372933|NCT01144624|20640067|P2|Completed Treatment|Overall Study||7
8372934|NCT01144624|20640068|P1|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
8372935|NCT01144624|20640066|P3|Received Treatment|Overall Study||6
8372936|NCT01144624|20640067|P2|Received Treatment|Overall Study||7
8372937|NCT01144624|20640068|P1|Received Treatment|Overall Study||7
8372938|NCT01144624|20640066|P3|STARTED|Overall Study||6
8372939|NCT01144624|20640067|P2|STARTED|Overall Study||7
8372940|NCT01144624|20640068|P1|STARTED|Overall Study||7
8372941|NCT01144598|20640082|P1|NOT COMPLETED|Overall Study||0
8372942|NCT01144598|20640082|P1|COMPLETED|Overall Study||356
8372943|NCT01144598|20640082|P1|Analysis Population|Overall Study||356
8372944|NCT01144598|20640082|P1|STARTED|Overall Study||356
8372945|NCT01144494|20640100|P2|NOT COMPLETED|Overall Study||4
8372946|NCT01144494|20640101|P1|NOT COMPLETED|Overall Study||0
8372947|NCT01144494|20640100|P2|COMPLETED|Overall Study||14
8372948|NCT01144494|20640101|P1|COMPLETED|Overall Study||15
8372949|NCT01144494|20640100|P2|STARTED|Overall Study||18
8372950|NCT01144494|20640101|P1|STARTED|Overall Study||15
8372951|NCT01144455|20640120|P3|NOT COMPLETED|Overall Study||36
8372952|NCT01144455|20640121|P2|NOT COMPLETED|Overall Study||42
8372953|NCT01144455|20640122|P1|NOT COMPLETED|Overall Study||50
8372954|NCT01144455|20640120|P3|COMPLETED|Overall Study||38
8372955|NCT01144455|20640121|P2|COMPLETED|Overall Study||29
8372956|NCT01144455|20640122|P1|COMPLETED|Overall Study||19
8372957|NCT01144455|20640120|P3|STARTED|Overall Study||74
8372958|NCT01144455|20640121|P2|STARTED|Overall Study||71
8372959|NCT01144455|20640122|P1|STARTED|Overall Study||69
8372960|NCT01144442|20640130|P1|NOT COMPLETED|Overall Study||0
8372961|NCT01144442|20640130|P1|COMPLETED|Overall Study||10
8372962|NCT01144442|20640130|P1|STARTED|Overall Study||10
8372963|NCT01144416|20640140|P2|NOT COMPLETED|Pregnancy Follow-up Period||10
8372964|NCT01144416|20640141|P1|NOT COMPLETED|Pregnancy Follow-up Period||8
8372965|NCT01144416|20640140|P2|COMPLETED|Pregnancy Follow-up Period||157
8372966|NCT01144416|20640141|P1|COMPLETED|Pregnancy Follow-up Period||146
8372967|NCT01144416|20640140|P2|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
8372968|NCT01144416|20640141|P1|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
8372969|NCT01144416|20640140|P2|NOT COMPLETED|Intervention Period||49
8372970|NCT01144416|20640141|P1|NOT COMPLETED|Intervention Period||62
8372971|NCT01144416|20640140|P2|COMPLETED|Intervention Period||647
8372972|NCT01144416|20640141|P1|COMPLETED|Intervention Period||632
8372973|NCT01144416|20640140|P2|STARTED|Intervention Period||696
8372974|NCT01144416|20640141|P1|STARTED|Intervention Period||694
8372975|NCT01144403|20640157|P1|NOT COMPLETED|Overall Study||5
8372976|NCT01144403|20640157|P1|COMPLETED|Overall Study||3
8372977|NCT01144403|20640157|P1|STARTED|Overall Study||8
8372978|NCT01144377|20640169|P5|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
8372979|NCT01144377|20640170|P4|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
8372980|NCT01144377|20640171|P3|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
8372981|NCT01144377|20640172|P2|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
8372982|NCT01144377|20640173|P1|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
8372983|NCT01144377|20640169|P5|COMPLETED|Optional 40 Week Safety Follow-up Period||21
8372984|NCT01144377|20640170|P4|COMPLETED|Optional 40 Week Safety Follow-up Period||3
8372985|NCT01144377|20640171|P3|COMPLETED|Optional 40 Week Safety Follow-up Period||23
8372986|NCT01144377|20640172|P2|COMPLETED|Optional 40 Week Safety Follow-up Period||24
8372987|NCT01144377|20640173|P1|COMPLETED|Optional 40 Week Safety Follow-up Period||21
8372988|NCT01144377|20640169|P5|STARTED|Optional 40 Week Safety Follow-up Period||23
8372989|NCT01144377|20640170|P4|STARTED|Optional 40 Week Safety Follow-up Period||3
8372990|NCT01144377|20640171|P3|STARTED|Optional 40 Week Safety Follow-up Period||23
8372991|NCT01144377|20640172|P2|STARTED|Optional 40 Week Safety Follow-up Period||25
8372992|NCT01144377|20640173|P1|STARTED|Optional 40 Week Safety Follow-up Period||22
8372993|NCT01144377|20640169|P5|NOT COMPLETED|12 Week Safety Follow-up Period||0
8372994|NCT01144377|20640170|P4|NOT COMPLETED|12 Week Safety Follow-up Period||0
8372995|NCT01144377|20640171|P3|NOT COMPLETED|12 Week Safety Follow-up Period||0
8372996|NCT01144377|20640172|P2|NOT COMPLETED|12 Week Safety Follow-up Period||0
8372997|NCT01144377|20640173|P1|NOT COMPLETED|12 Week Safety Follow-up Period||0
8372998|NCT01144377|20640169|P5|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
8372999|NCT01144377|20640170|P4|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
8373000|NCT01144377|20640171|P3|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
8373001|NCT01144377|20640172|P2|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
8373002|NCT01144377|20640173|P1|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
8373003|NCT01144377|20640169|P5|STARTED|12 Week Safety Follow-up Period||34
8373004|NCT01144377|20640170|P4|STARTED|12 Week Safety Follow-up Period||22
8373005|NCT01144377|20640171|P3|STARTED|12 Week Safety Follow-up Period||25
8373006|NCT01144377|20640172|P2|STARTED|12 Week Safety Follow-up Period||29
8373007|NCT01144377|20640173|P1|STARTED|12 Week Safety Follow-up Period||26
8373008|NCT01144377|20640169|P5|NOT COMPLETED|52 Week Treatment Period||3
8373009|NCT01144377|20640170|P4|NOT COMPLETED|52 Week Treatment Period||4
8373010|NCT01144377|20640171|P3|NOT COMPLETED|52 Week Treatment Period||5
8373011|NCT01144377|20640172|P2|NOT COMPLETED|52 Week Treatment Period||1
8373012|NCT01144377|20640173|P1|NOT COMPLETED|52 Week Treatment Period||5
8373013|NCT01144377|20640169|P5|COMPLETED|52 Week Treatment Period||34
8373014|NCT01144377|20640170|P4|COMPLETED|52 Week Treatment Period||22
8373015|NCT01144377|20640171|P3|COMPLETED|52 Week Treatment Period||25
8373016|NCT01144377|20640172|P2|COMPLETED|52 Week Treatment Period||29
8373017|NCT01144377|20640173|P1|COMPLETED|52 Week Treatment Period||26
8373018|NCT01144377|20640169|P5|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
8373019|NCT01144377|20640170|P4|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
8373020|NCT01144377|20640171|P3|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
8373021|NCT01144377|20640172|P2|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
8373022|NCT01144377|20640173|P1|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
8373023|NCT01144377|20640169|P5|STARTED|52 Week Treatment Period||37
8373024|NCT01144377|20640170|P4|STARTED|52 Week Treatment Period||26
8373025|NCT01144377|20640171|P3|STARTED|52 Week Treatment Period||30
8373026|NCT01144377|20640172|P2|STARTED|52 Week Treatment Period||30
8373027|NCT01144377|20640173|P1|STARTED|52 Week Treatment Period||31
8373028|NCT01144364|20640222|P3|NOT COMPLETED|Follow-Up/Maintenance Phase||41
8373029|NCT01144364|20640223|P2|NOT COMPLETED|Follow-Up/Maintenance Phase||35
8373030|NCT01144364|20640224|P1|NOT COMPLETED|Follow-Up/Maintenance Phase||0
8373031|NCT01144364|20640222|P3|COMPLETED|Follow-Up/Maintenance Phase||60
8373032|NCT01144364|20640223|P2|COMPLETED|Follow-Up/Maintenance Phase||66
8373033|NCT01144364|20640224|P1|COMPLETED|Follow-Up/Maintenance Phase||0
8373034|NCT01144364|20640222|P3|STARTED|Follow-Up/Maintenance Phase||101
8373035|NCT01144364|20640223|P2|STARTED|Follow-Up/Maintenance Phase||101
8373036|NCT01144364|20640224|P1|STARTED|Follow-Up/Maintenance Phase||0
8373037|NCT01144364|20640222|P3|NOT COMPLETED|Induction Phase||0
8373038|NCT01144364|20640223|P2|NOT COMPLETED|Induction Phase||0
8373039|NCT01144364|20640224|P1|NOT COMPLETED|Induction Phase||32
8373040|NCT01144364|20640222|P3|COMPLETED|Induction Phase||0
8373041|NCT01144364|20640223|P2|COMPLETED|Induction Phase||0
8373042|NCT01144364|20640224|P1|COMPLETED|Induction Phase||202
8373043|NCT01144364|20640222|P3|STARTED|Induction Phase||0
8373044|NCT01144364|20640223|P2|STARTED|Induction Phase||0
8373045|NCT01144364|20640224|P1|STARTED|Induction Phase||234
8373046|NCT01144338|20640250|P2|NOT COMPLETED|Overall Study||262
8373047|NCT01144338|20640251|P1|NOT COMPLETED|Overall Study||303
8373048|NCT01144338|20640250|P2|COMPLETED|Overall Study||7094
8373049|NCT01144338|20640251|P1|COMPLETED|Overall Study||7093
8373050|NCT01144338|20640250|P2|STARTED|Overall Study||7356
8373051|NCT01144338|20640251|P1|STARTED|Overall Study||7396
8373052|NCT01144299|20640273|P2|NOT COMPLETED|Overall Study||0
8373053|NCT01144299|20640274|P1|NOT COMPLETED|Overall Study||2
8373054|NCT01144299|20640273|P2|COMPLETED|Overall Study||54
8373055|NCT01144299|20640274|P1|COMPLETED|Overall Study||58
8373056|NCT01144299|20640273|P2|STARTED|Overall Study||54
8373057|NCT01144299|20640274|P1|STARTED|Overall Study||60
8373058|NCT01144286|20640300|P4|NOT COMPLETED|Overall Study||0
8373059|NCT01144286|20640301|P3|NOT COMPLETED|Overall Study||0
8373060|NCT01144286|20640302|P2|NOT COMPLETED|Overall Study||0
8373061|NCT01144286|20640303|P1|NOT COMPLETED|Overall Study||0
8373062|NCT01144286|20640300|P4|COMPLETED|Overall Study||56
8373063|NCT01144286|20640301|P3|COMPLETED|Overall Study||58
8373064|NCT01144286|20640302|P2|COMPLETED|Overall Study||58
8373065|NCT01144286|20640303|P1|COMPLETED|Overall Study||57
8373066|NCT01144286|20640300|P4|STARTED|Overall Study||56
8373067|NCT01144286|20640301|P3|STARTED|Overall Study||58
8373068|NCT01144286|20640302|P2|STARTED|Overall Study||58
8373069|NCT01144286|20640303|P1|STARTED|Overall Study||57
8373070|NCT01144182|20640319|P2|NOT COMPLETED|Overall Study||21
8373071|NCT01144182|20640320|P1|NOT COMPLETED|Overall Study||17
8373072|NCT01144182|20640319|P2|COMPLETED|Overall Study||47
8373073|NCT01144182|20640320|P1|COMPLETED|Overall Study||51
8373074|NCT01144182|20640319|P2|STARTED|Overall Study||68
8373075|NCT01144182|20640320|P1|STARTED|Overall Study||68
8373076|NCT01144143|20640353|P3|NOT COMPLETED|Overall Study||0
8373077|NCT01144143|20640354|P2|NOT COMPLETED|Overall Study||0
8373078|NCT01144143|20640355|P1|NOT COMPLETED|Overall Study||0
8373079|NCT01144143|20640353|P3|COMPLETED|Overall Study||4
8373080|NCT01144143|20640354|P2|COMPLETED|Overall Study||4
8373081|NCT01144143|20640355|P1|COMPLETED|Overall Study||8
8373082|NCT01144143|20640353|P3|STARTED|Overall Study||4
8373083|NCT01144143|20640354|P2|STARTED|Overall Study||4
8373084|NCT01144143|20640355|P1|STARTED|Overall Study||8
8373085|NCT01144052|20640380|P2|NOT COMPLETED|Overall Study||1
8373086|NCT01144052|20640381|P1|NOT COMPLETED|Overall Study||1
8373087|NCT01144052|20640380|P2|COMPLETED|Overall Study||8
8373088|NCT01144052|20640381|P1|COMPLETED|Overall Study||9
8373089|NCT01144052|20640380|P2|STARTED|Overall Study||9
8373090|NCT01144052|20640381|P1|STARTED|Overall Study||10
8373091|NCT01144026|20640403|P2|NOT COMPLETED|Overall Study||0
8373092|NCT01144026|20640404|P1|NOT COMPLETED|Overall Study||0
8373093|NCT01144026|20640403|P2|COMPLETED|Overall Study||5
8373094|NCT01144026|20640404|P1|COMPLETED|Overall Study||10
8373095|NCT01144026|20640403|P2|STARTED|Overall Study||5
8373096|NCT01144026|20640404|P1|STARTED|Overall Study||10
8373097|NCT01143896|20640412|P2|NOT COMPLETED|Overall Study||25
8373098|NCT01143896|20640413|P1|NOT COMPLETED|Overall Study||42
8373099|NCT01143896|20640412|P2|COMPLETED|Overall Study||128
8373100|NCT01143896|20640413|P1|COMPLETED|Overall Study||114
8373101|NCT01143896|20640412|P2|STARTED|Overall Study||153
8373102|NCT01143896|20640413|P1|STARTED|Overall Study||156
8373103|NCT01143883|20640431|P2|NOT COMPLETED|Overall Study||0
8373104|NCT01143883|20640432|P1|NOT COMPLETED|Overall Study||0
8373105|NCT01143883|20640431|P2|COMPLETED|Overall Study||55
8373106|NCT01143883|20640432|P1|COMPLETED|Overall Study||55
8373107|NCT01143883|20640431|P2|STARTED|Overall Study||55
8373108|NCT01143883|20640432|P1|STARTED|Overall Study||55
8373109|NCT01143870|20640441|P3|NOT COMPLETED|Overall Study||0
8373110|NCT01143870|20640442|P2|NOT COMPLETED|Overall Study||0
8373111|NCT01143870|20640443|P1|NOT COMPLETED|Overall Study||0
8373112|NCT01143870|20640441|P3|COMPLETED|Overall Study||61
8373113|NCT01143870|20640442|P2|COMPLETED|Overall Study||58
8373114|NCT01143870|20640443|P1|COMPLETED|Overall Study||58
8373115|NCT01143870|20640441|P3|A1C Imputed|Overall Study||30
8373116|NCT01143870|20640442|P2|A1C Imputed|Overall Study||29
8373117|NCT01143870|20640443|P1|A1C Imputed|Overall Study||31
8373118|NCT01143870|20640441|P3|Had Available 6-month A1C|Overall Study||31
8373119|NCT01143870|20640442|P2|Had Available 6-month A1C|Overall Study||29
8373120|NCT01143870|20640443|P1|Had Available 6-month A1C|Overall Study||27
8373121|NCT01143870|20640441|P3|Post-intervention Survey|Overall Study||61
8373122|NCT01143870|20640442|P2|Post-intervention Survey|Overall Study||50
8373123|NCT01143870|20640443|P1|Post-intervention Survey|Overall Study||53
8373124|NCT01143870|20640441|P3|STARTED|Overall Study||61
8373125|NCT01143870|20640442|P2|STARTED|Overall Study||58
8373126|NCT01143870|20640443|P1|STARTED|Overall Study||58
8373127|NCT01143818|20640451|P1|NOT COMPLETED|Overall Study||250
8373128|NCT01143818|20640451|P1|COMPLETED|Overall Study||799
8373129|NCT01143818|20640451|P1|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
8373130|NCT01143792|20640461|P3|NOT COMPLETED|Overall Study||0
8373131|NCT01143792|20640462|P2|NOT COMPLETED|Overall Study||0
8373132|NCT01143792|20640463|P1|NOT COMPLETED|Overall Study||0
8373133|NCT01143792|20640461|P3|COMPLETED|Overall Study||91
8373134|NCT01143792|20640462|P2|COMPLETED|Overall Study||86
8373135|NCT01143792|20640463|P1|COMPLETED|Overall Study||93
8373136|NCT01143792|20640461|P3|STARTED|Overall Study||91
8373137|NCT01143792|20640462|P2|STARTED|Overall Study||86
8373138|NCT01143792|20640463|P1|STARTED|Overall Study||93
8373139|NCT01143766|20640497|P2|NOT COMPLETED|Overall Study||0
8373140|NCT01143766|20640498|P1|NOT COMPLETED|Overall Study||0
8373141|NCT01143766|20640497|P2|COMPLETED|Overall Study||31
8373142|NCT01143766|20640498|P1|COMPLETED|Overall Study||25
8373143|NCT01143766|20640497|P2|STARTED|Overall Study||31
8373144|NCT01143766|20640498|P1|STARTED|Overall Study||25
8373145|NCT01143727|20640514|P2|NOT COMPLETED|Overall Study||0
8373146|NCT01143727|20640515|P1|NOT COMPLETED|Overall Study||0
8373147|NCT01143727|20640514|P2|COMPLETED|Overall Study||8
8373148|NCT01143727|20640515|P1|COMPLETED|Overall Study||9
8373149|NCT01143727|20640514|P2|STARTED|Overall Study||8
8373150|NCT01143727|20640515|P1|STARTED|Overall Study||9
8373151|NCT01143714|20640525|P2|NOT COMPLETED|Overall Study||3
8373152|NCT01143714|20640526|P1|NOT COMPLETED|Overall Study||7
8373153|NCT01143714|20640525|P2|COMPLETED|Overall Study||25
8373154|NCT01143714|20640526|P1|COMPLETED|Overall Study||22
8373155|NCT01143714|20640525|P2|STARTED|Overall Study||28
8373156|NCT01143714|20640526|P1|STARTED|Overall Study||29
8373157|NCT01143701|20640536|P2|NOT COMPLETED|Overall Study||32
8373158|NCT01143701|20640537|P1|NOT COMPLETED|Overall Study||23
8373159|NCT01143701|20640536|P2|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
8373160|NCT01143701|20640537|P1|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
8373161|NCT01143701|20640536|P2|STARTED|Overall Study||319
8373162|NCT01143701|20640537|P1|STARTED|Overall Study||258
8373163|NCT01143688|20640545|P1|NOT COMPLETED|Overall Study||0
8373164|NCT01143688|20640545|P1|COMPLETED|Overall Study||39
8373165|NCT01143688|20640545|P1|STARTED|Overall Study||39
8373166|NCT01143649|20640564|P6|NOT COMPLETED|Overall Study||2
8373167|NCT01143649|20640565|P5|NOT COMPLETED|Overall Study||1
8373168|NCT01143649|20640566|P4|NOT COMPLETED|Overall Study||0
8373169|NCT01143649|20640567|P3|NOT COMPLETED|Overall Study||0
8373170|NCT01143649|20640568|P2|NOT COMPLETED|Overall Study||0
8373171|NCT01143649|20640569|P1|NOT COMPLETED|Overall Study||0
8373172|NCT01143649|20640564|P6|COMPLETED|Overall Study||3
8373173|NCT01143649|20640565|P5|COMPLETED|Overall Study||4
8373174|NCT01143649|20640566|P4|COMPLETED|Overall Study||10
8373175|NCT01143649|20640567|P3|COMPLETED|Overall Study||10
8373176|NCT01143649|20640568|P2|COMPLETED|Overall Study||7
8373177|NCT01143649|20640569|P1|COMPLETED|Overall Study||7
8373178|NCT01143649|20640564|P6|STARTED|Overall Study||5
8373179|NCT01143649|20640565|P5|STARTED|Overall Study||5
8373180|NCT01143649|20640566|P4|STARTED|Overall Study||10
8373181|NCT01143649|20640567|P3|STARTED|Overall Study||10
8373182|NCT01143649|20640568|P2|STARTED|Overall Study||7
8373183|NCT01143649|20640569|P1|STARTED|Overall Study||7
8373184|NCT01143636|20640586|P4|NOT COMPLETED|Overall Study||0
8373185|NCT01143636|20640587|P3|NOT COMPLETED|Overall Study||0
8373186|NCT01143636|20640588|P2|NOT COMPLETED|Overall Study||1
8373187|NCT01143636|20640589|P1|NOT COMPLETED|Overall Study||1
8373188|NCT01143636|20640586|P4|COMPLETED|Overall Study||7
8373189|NCT01143636|20640587|P3|COMPLETED|Overall Study||8
8373190|NCT01143636|20640588|P2|COMPLETED|Overall Study||4
8373191|NCT01143636|20640589|P1|COMPLETED|Overall Study||5
8373192|NCT01143636|20640586|P4|STARTED|Overall Study||7
8373193|NCT01143636|20640587|P3|STARTED|Overall Study||8
8373194|NCT01143636|20640588|P2|STARTED|Overall Study||5
8373195|NCT01143636|20640589|P1|STARTED|Overall Study||6
8373196|NCT01143610|20640619|P2|NOT COMPLETED|Overall Study||0
8373197|NCT01143610|20640620|P1|NOT COMPLETED|Overall Study||0
8373198|NCT01143610|20640619|P2|COMPLETED|Overall Study||8
8373199|NCT01143610|20640620|P1|COMPLETED|Overall Study||7
8373200|NCT01143610|20640619|P2|STARTED|Overall Study||8
8373201|NCT01143610|20640620|P1|STARTED|Overall Study||7
8373202|NCT01143402|20640631|P3|NOT COMPLETED|Overall Study||1
8373203|NCT01143402|20640632|P2|NOT COMPLETED|Overall Study||1
8373204|NCT01143402|20640633|P1|NOT COMPLETED|Overall Study||1
8373205|NCT01143402|20640631|P3|COMPLETED|Overall Study||18
8373206|NCT01143402|20640632|P2|COMPLETED|Overall Study||49
8373207|NCT01143402|20640633|P1|COMPLETED|Overall Study||50
8373208|NCT01143402|20640631|P3|STARTED|Overall Study||19
8373209|NCT01143402|20640632|P2|STARTED|Overall Study||50
8373210|NCT01143402|20640633|P1|STARTED|Overall Study||51
8373211|NCT01143389|20640644|P2|NOT COMPLETED|Overall Study||25
8373212|NCT01143389|20640645|P1|NOT COMPLETED|Overall Study||26
8373213|NCT01143389|20640644|P2|COMPLETED|Overall Study||232
8373214|NCT01143389|20640645|P1|COMPLETED|Overall Study||227
8373215|NCT01143389|20640644|P2|STARTED|Overall Study||257
8373216|NCT01143389|20640645|P1|STARTED|Overall Study||253
8373217|NCT01143337|20640659|P3|NOT COMPLETED|Overall Study||12
8373218|NCT01143337|20640660|P2|NOT COMPLETED|Overall Study||11
8373219|NCT01143337|20640661|P1|NOT COMPLETED|Overall Study||10
8373220|NCT01143337|20640659|P3|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
8373221|NCT01143337|20640660|P2|COMPLETED|Overall Study||39
8373222|NCT01143337|20640661|P1|COMPLETED|Overall Study||39
8373223|NCT01143337|20640659|P3|STARTED|Overall Study||13
8373224|NCT01143337|20640660|P2|STARTED|Overall Study||50
8373225|NCT01143337|20640661|P1|STARTED|Overall Study||49
8373226|NCT01143324|20640675|P1|NOT COMPLETED|Overall Study||19
8373227|NCT01143324|20640675|P1|COMPLETED|Overall Study||233
8373228|NCT01143324|20640675|P1|STARTED|Overall Study||252
8373229|NCT01143272|20640693|P2|NOT COMPLETED|Overall Study||0
8373230|NCT01143272|20640694|P1|NOT COMPLETED|Overall Study||0
8373231|NCT01143272|20640693|P2|COMPLETED|Overall Study||231
8373232|NCT01143272|20640694|P1|COMPLETED|Overall Study||246
8373233|NCT01143272|20640693|P2|STARTED|Overall Study||231
8373234|NCT01143272|20640694|P1|STARTED|Overall Study||246
8373235|NCT01143259|20640714|P2|NOT COMPLETED|Overall Study||20
8373236|NCT01143259|20640715|P1|NOT COMPLETED|Overall Study||23
8373237|NCT01143259|20640714|P2|COMPLETED|Overall Study||118
8373238|NCT01143259|20640715|P1|COMPLETED|Overall Study||113
8373239|NCT01143259|20640714|P2|STARTED|Overall Study||138
8373240|NCT01143259|20640715|P1|STARTED|Overall Study||136
8373241|NCT01143207|20640723|P1|NOT COMPLETED|Overall Study||2
8373242|NCT01143207|20640723|P1|COMPLETED|Overall Study||24
8373243|NCT01143207|20640723|P1|STARTED|Overall Study||26
8373244|NCT01143142|20640734|P2|NOT COMPLETED|Overall Study||0
8373245|NCT01143142|20640735|P1|NOT COMPLETED|Overall Study||0
8373246|NCT01143142|20640734|P2|COMPLETED|Overall Study||34
8373247|NCT01143142|20640735|P1|COMPLETED|Overall Study||36
8373248|NCT01143142|20640734|P2|STARTED|Overall Study||34
8373249|NCT01143142|20640735|P1|STARTED|Overall Study||36
8373250|NCT01143090|20640743|P1|NOT COMPLETED|Overall Study||51
8373251|NCT01143090|20640743|P1|COMPLETED|Overall Study||98
8373252|NCT01143090|20640743|P1|STARTED|Overall Study||149
8373253|NCT01143077|20640750|P3|NOT COMPLETED|Overall Study||15
8373254|NCT01143077|20640751|P2|NOT COMPLETED|Overall Study||15
8373255|NCT01143077|20640752|P1|NOT COMPLETED|Overall Study||16
8373256|NCT01143077|20640750|P3|COMPLETED|Overall Study||67
8373257|NCT01143077|20640751|P2|COMPLETED|Overall Study||73
8373258|NCT01143077|20640752|P1|COMPLETED|Overall Study||58
8373259|NCT01143077|20640750|P3|STARTED|Overall Study||82
8373260|NCT01143077|20640751|P2|STARTED|Overall Study||88
8373261|NCT01143077|20640752|P1|STARTED|Overall Study||74
8373262|NCT01143051|20640769|P6|NOT COMPLETED|Visit 3||0
8373263|NCT01143051|20640770|P5|NOT COMPLETED|Visit 3||0
8373264|NCT01143051|20640771|P4|NOT COMPLETED|Visit 3||0
8373265|NCT01143051|20640772|P3|NOT COMPLETED|Visit 3||0
8373266|NCT01143051|20640773|P2|NOT COMPLETED|Visit 3||0
8373267|NCT01143051|20640774|P1|NOT COMPLETED|Visit 3||0
8373268|NCT01143051|20640769|P6|COMPLETED|Visit 3||3
8373269|NCT01143051|20640770|P5|COMPLETED|Visit 3||4
8373270|NCT01143051|20640771|P4|COMPLETED|Visit 3||4
8373271|NCT01143051|20640772|P3|COMPLETED|Visit 3||3
8373272|NCT01143051|20640773|P2|COMPLETED|Visit 3||4
8373273|NCT01143051|20640774|P1|COMPLETED|Visit 3||4
8373274|NCT01143051|20640769|P6|STARTED|Visit 3||3
8373275|NCT01143051|20640770|P5|STARTED|Visit 3||4
8373276|NCT01143051|20640771|P4|STARTED|Visit 3||4
8373277|NCT01143051|20640772|P3|STARTED|Visit 3||3
8373278|NCT01143051|20640773|P2|STARTED|Visit 3||4
8373279|NCT01143051|20640774|P1|STARTED|Visit 3||4
8373280|NCT01143051|20640769|P6|NOT COMPLETED|3-14 Day Washout||1
8373281|NCT01143051|20640770|P5|NOT COMPLETED|3-14 Day Washout||0
8373282|NCT01143051|20640771|P4|NOT COMPLETED|3-14 Day Washout||0
8373283|NCT01143051|20640772|P3|NOT COMPLETED|3-14 Day Washout||0
8373284|NCT01143051|20640773|P2|NOT COMPLETED|3-14 Day Washout||0
8373285|NCT01143051|20640774|P1|NOT COMPLETED|3-14 Day Washout||0
8373286|NCT01143051|20640769|P6|COMPLETED|3-14 Day Washout||3
8373287|NCT01143051|20640770|P5|COMPLETED|3-14 Day Washout||4
8373288|NCT01143051|20640771|P4|COMPLETED|3-14 Day Washout||4
8373289|NCT01143051|20640772|P3|COMPLETED|3-14 Day Washout||3
8373290|NCT01143051|20640773|P2|COMPLETED|3-14 Day Washout||4
8373291|NCT01143051|20640774|P1|COMPLETED|3-14 Day Washout||4
8373292|NCT01143051|20640769|P6|STARTED|3-14 Day Washout||4
8373293|NCT01143051|20640770|P5|STARTED|3-14 Day Washout||4
8373294|NCT01143051|20640771|P4|STARTED|3-14 Day Washout||4
8373295|NCT01143051|20640772|P3|STARTED|3-14 Day Washout||3
8373296|NCT01143051|20640773|P2|STARTED|3-14 Day Washout||4
8373297|NCT01143051|20640774|P1|STARTED|3-14 Day Washout||4
8373298|NCT01143051|20640769|P6|NOT COMPLETED|Visit 2||0
8373299|NCT01143051|20640770|P5|NOT COMPLETED|Visit 2||0
8373300|NCT01143051|20640771|P4|NOT COMPLETED|Visit 2||0
8373301|NCT01143051|20640772|P3|NOT COMPLETED|Visit 2||0
8373302|NCT01143051|20640773|P2|NOT COMPLETED|Visit 2||0
8373303|NCT01143051|20640774|P1|NOT COMPLETED|Visit 2||0
8373304|NCT01143051|20640769|P6|COMPLETED|Visit 2||4
8373305|NCT01143051|20640770|P5|COMPLETED|Visit 2||4
8373306|NCT01143051|20640771|P4|COMPLETED|Visit 2||4
8373307|NCT01143051|20640772|P3|COMPLETED|Visit 2||3
8373308|NCT01143051|20640773|P2|COMPLETED|Visit 2||4
8373309|NCT01143051|20640774|P1|COMPLETED|Visit 2||4
8373310|NCT01143051|20640769|P6|STARTED|Visit 2||4
8373311|NCT01143051|20640770|P5|STARTED|Visit 2||4
8373312|NCT01143051|20640771|P4|STARTED|Visit 2||4
8373313|NCT01143051|20640772|P3|STARTED|Visit 2||3
8373314|NCT01143051|20640773|P2|STARTED|Visit 2||4
8373315|NCT01143051|20640774|P1|STARTED|Visit 2||4
8373316|NCT01143051|20640769|P6|NOT COMPLETED|3-14 Day Washout||0
8373317|NCT01143051|20640770|P5|NOT COMPLETED|3-14 Day Washout||0
8373318|NCT01143051|20640771|P4|NOT COMPLETED|3-14 Day Washout||0
8373319|NCT01143051|20640772|P3|NOT COMPLETED|3-14 Day Washout||1
8373320|NCT01143051|20640773|P2|NOT COMPLETED|3-14 Day Washout||0
8373321|NCT01143051|20640774|P1|NOT COMPLETED|3-14 Day Washout||0
8373322|NCT01143051|20640769|P6|COMPLETED|3-14 Day Washout||4
8373323|NCT01143051|20640770|P5|COMPLETED|3-14 Day Washout||4
8373324|NCT01143051|20640771|P4|COMPLETED|3-14 Day Washout||4
8373325|NCT01143051|20640772|P3|COMPLETED|3-14 Day Washout||3
8373326|NCT01143051|20640773|P2|COMPLETED|3-14 Day Washout||4
8373327|NCT01143051|20640774|P1|COMPLETED|3-14 Day Washout||4
8373328|NCT01143051|20640769|P6|STARTED|3-14 Day Washout||4
8373329|NCT01143051|20640770|P5|STARTED|3-14 Day Washout||4
8373330|NCT01143051|20640771|P4|STARTED|3-14 Day Washout||4
8373331|NCT01143051|20640772|P3|STARTED|3-14 Day Washout||4
8373332|NCT01143051|20640773|P2|STARTED|3-14 Day Washout||4
8373333|NCT01143051|20640774|P1|STARTED|3-14 Day Washout||4
8373334|NCT01143051|20640769|P6|NOT COMPLETED|Visit 1||0
8373335|NCT01143051|20640770|P5|NOT COMPLETED|Visit 1||0
8373336|NCT01143051|20640771|P4|NOT COMPLETED|Visit 1||0
8373337|NCT01143051|20640772|P3|NOT COMPLETED|Visit 1||0
8373338|NCT01143051|20640773|P2|NOT COMPLETED|Visit 1||0
8373339|NCT01143051|20640774|P1|NOT COMPLETED|Visit 1||0
8373340|NCT01143051|20640769|P6|COMPLETED|Visit 1||4
8373341|NCT01143051|20640770|P5|COMPLETED|Visit 1||4
8373342|NCT01143051|20640771|P4|COMPLETED|Visit 1||4
8373343|NCT01143051|20640772|P3|COMPLETED|Visit 1||4
8373344|NCT01143051|20640773|P2|COMPLETED|Visit 1||4
8373345|NCT01143051|20640774|P1|COMPLETED|Visit 1||4
8373346|NCT01143051|20640769|P6|STARTED|Visit 1||4
8373347|NCT01143051|20640770|P5|STARTED|Visit 1||4
8373348|NCT01143051|20640771|P4|STARTED|Visit 1||4
8373349|NCT01143051|20640772|P3|STARTED|Visit 1||4
8373350|NCT01143051|20640773|P2|STARTED|Visit 1||4
8373351|NCT01143051|20640774|P1|STARTED|Visit 1||4
8373352|NCT01143038|20640823|P1|NOT COMPLETED|Overall Study||16
8373353|NCT01143038|20640823|P1|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
8373354|NCT01143038|20640823|P1|STARTED|Overall Study||75
8373355|NCT01142947|20640831|P1|NOT COMPLETED|Overall Study||118
8373356|NCT01142947|20640831|P1|COMPLETED|Overall Study||244
8373357|NCT01142947|20640831|P1|STARTED|Overall Study||362
8373358|NCT01142908|20640837|P2|NOT COMPLETED|Overall Study||22
8373359|NCT01142908|20640838|P1|NOT COMPLETED|Overall Study||32
8373360|NCT01142908|20640837|P2|COMPLETED|Overall Study||191
8373361|NCT01142908|20640838|P1|COMPLETED|Overall Study||183
8373362|NCT01142908|20640837|P2|6 Month f/u|Overall Study||196
8373363|NCT01142908|20640838|P1|6 Month f/u|Overall Study||188
8373364|NCT01142908|20640837|P2|STARTED|Overall Study||213
8373365|NCT01142908|20640838|P1|STARTED|Overall Study||215
8373366|NCT01142791|20640884|P2|NOT COMPLETED|Overall Study||6
8373367|NCT01142791|20640885|P1|NOT COMPLETED|Overall Study||7
8373368|NCT01142791|20640884|P2|COMPLETED|Overall Study||0
8373369|NCT01142791|20640885|P1|COMPLETED|Overall Study||108
8373370|NCT01142791|20640884|P2|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6
8373371|NCT01142791|20640885|P1|Safety|Overall Study||115
8373372|NCT01142791|20640884|P2|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6
8373373|NCT01142791|20640885|P1|STARTED|Overall Study||115
8373374|NCT01142726|20640892|P3|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
8373375|NCT01142726|20640893|P2|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
8373376|NCT01142726|20640894|P1|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
8373377|NCT01142726|20640892|P3|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
8373378|NCT01142726|20640893|P2|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
8373379|NCT01142726|20640894|P1|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
8373380|NCT01142726|20640892|P3|STARTED|Re-Exposure Phase: Months 24 up to 30||43
8373381|NCT01142726|20640893|P2|STARTED|Re-Exposure Phase: Months 24 up to 30||48
8373382|NCT01142726|20640894|P1|STARTED|Re-Exposure Phase: Months 24 up to 30||55
8373383|NCT01142726|20640892|P3|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
8373384|NCT01142726|20640893|P2|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
8373385|NCT01142726|20640894|P1|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
8373386|NCT01142726|20640892|P3|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
8373387|NCT01142726|20640893|P2|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
8373388|NCT01142726|20640894|P1|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
8373389|NCT01142726|20640892|P3|STARTED|Withdrawal Phase: Months 12 up to 24||75
8373390|NCT01142726|20640893|P2|STARTED|Withdrawal Phase: Months 12 up to 24||66
8373391|NCT01142726|20640894|P1|STARTED|Withdrawal Phase: Months 12 up to 24||84
8373392|NCT01142726|20640892|P3|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
8373393|NCT01142726|20640893|P2|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
8373394|NCT01142726|20640894|P1|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
8373395|NCT01142726|20640892|P3|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
8373396|NCT01142726|20640893|P2|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
8373397|NCT01142726|20640894|P1|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
8373398|NCT01142726|20640892|P3|STARTED|Treatment Phase: Day 1 Through Month 12||116
8373399|NCT01142726|20640893|P2|STARTED|Treatment Phase: Day 1 Through Month 12||116
8373400|NCT01142726|20640894|P1|STARTED|Treatment Phase: Day 1 Through Month 12||119
8373401|NCT01142661|20640957|P1|NOT COMPLETED|Overall Study||4
8373402|NCT01142661|20640957|P1|COMPLETED|Overall Study||5
8373403|NCT01142661|20640957|P1|STARTED|Overall Study||9
8373404|NCT01142596|20640964|P2|NOT COMPLETED|Overall Study||86
8373405|NCT01142596|20640965|P1|NOT COMPLETED|Overall Study||29
8373406|NCT01142596|20640964|P2|COMPLETED|Overall Study||71
8373407|NCT01142596|20640965|P1|COMPLETED|Overall Study||15
8373408|NCT01142596|20640964|P2|STARTED|Overall Study||157
8373409|NCT01142596|20640965|P1|STARTED|Overall Study||44
8373410|NCT01142466|20641017|P2|NOT COMPLETED|Overall Study||2
8373411|NCT01142466|20641018|P1|NOT COMPLETED|Overall Study||3
8373412|NCT01142466|20641017|P2|COMPLETED|Overall Study||13
8373413|NCT01142466|20641018|P1|COMPLETED|Overall Study||12
8373414|NCT01142466|20641017|P2|STARTED|Overall Study||15
8373415|NCT01142466|20641018|P1|STARTED|Overall Study||15
8373426|NCT01142336|20641051|P2|NOT COMPLETED|Overall Study||2
8373427|NCT01142336|20641052|P1|NOT COMPLETED|Overall Study||1
8373428|NCT01142336|20641051|P2|COMPLETED|Overall Study||21
8373429|NCT01142336|20641052|P1|COMPLETED|Overall Study||25
8373430|NCT01142336|20641051|P2|STARTED|Overall Study||23
8373431|NCT01142336|20641052|P1|STARTED|Overall Study||26
8373432|NCT01142323|20641062|P1|NOT COMPLETED|Overall Study||0
8373433|NCT01142323|20641062|P1|COMPLETED|Overall Study||8
8373434|NCT01142323|20641062|P1|STARTED|Overall Study||8
8373435|NCT01142310|20641070|P2|NOT COMPLETED|Overall Study||12
8373436|NCT01142310|20641071|P1|NOT COMPLETED|Overall Study||9
8373437|NCT01142310|20641070|P2|COMPLETED|Overall Study||16
8373438|NCT01142310|20641071|P1|COMPLETED|Overall Study||17
8373439|NCT01142310|20641070|P2|STARTED|Overall Study||28
8373440|NCT01142310|20641071|P1|STARTED|Overall Study||26
8373441|NCT01142297|20641077|P1|NOT COMPLETED|Overall Study||6
8373442|NCT01142297|20641077|P1|COMPLETED|Overall Study||18
8373443|NCT01142297|20641077|P1|STARTED|Overall Study||24
8373444|NCT01142232|20641089|P5|NOT COMPLETED|Overall Study||34
8373445|NCT01142232|20641090|P4|NOT COMPLETED|Overall Study||5
8373446|NCT01142232|20641091|P3|NOT COMPLETED|Overall Study||3
8373447|NCT01142232|20641092|P2|NOT COMPLETED|Overall Study||4
8373448|NCT01142232|20641093|P1|NOT COMPLETED|Overall Study||3
8373449|NCT01142232|20641089|P5|COMPLETED|Overall Study||10
8373450|NCT01142232|20641090|P4|COMPLETED|Overall Study||1
8373451|NCT01142232|20641091|P3|COMPLETED|Overall Study||0
8373452|NCT01142232|20641092|P2|COMPLETED|Overall Study||0
8373453|NCT01142232|20641093|P1|COMPLETED|Overall Study||0
8373454|NCT01142232|20641089|P5|STARTED|Overall Study||44
8373455|NCT01142232|20641090|P4|STARTED|Overall Study||6
8373456|NCT01142232|20641091|P3|STARTED|Overall Study||3
8373457|NCT01142232|20641092|P2|STARTED|Overall Study||4
8373458|NCT01142232|20641093|P1|STARTED|Overall Study||3
8373459|NCT01142193|20641108|P2|NOT COMPLETED|Overall Study||11
8373460|NCT01142193|20641109|P1|NOT COMPLETED|Overall Study||21
8373461|NCT01142193|20641108|P2|COMPLETED|Overall Study||114
8373462|NCT01142193|20641109|P1|COMPLETED|Overall Study||103
8373463|NCT01142193|20641108|P2|STARTED|Overall Study||125
8373464|NCT01142193|20641109|P1|STARTED|Overall Study||124
8373465|NCT01142128|20641137|P1|NOT COMPLETED|Overall Study||4
8373466|NCT01142128|20641137|P1|COMPLETED|Overall Study||4
8373467|NCT01142128|20641137|P1|Viokase 16 Plus Placebo to Nexium|Overall Study||0
8373468|NCT01142128|20641137|P1|Viokase 16 Plus Nexium|Overall Study||2
8373469|NCT01142128|20641137|P1|Placebo to Nexium, Alone|Overall Study||3
8373470|NCT01142128|20641137|P1|Nexium Alone|Overall Study||3
8373471|NCT01142128|20641137|P1|STARTED|Overall Study||8
8373472|NCT01142115|20641147|P2|NOT COMPLETED|Second Intervention||0
8373473|NCT01142115|20641148|P1|NOT COMPLETED|Second Intervention||0
8373474|NCT01142115|20641147|P2|COMPLETED|Second Intervention||19
8373475|NCT01142115|20641148|P1|COMPLETED|Second Intervention||19
8373476|NCT01142115|20641147|P2|STARTED|Second Intervention||19
8373477|NCT01142115|20641148|P1|STARTED|Second Intervention||19
8373478|NCT01142115|20641147|P2|NOT COMPLETED|First Intervention||1
8373479|NCT01142115|20641148|P1|NOT COMPLETED|First Intervention||2
8373480|NCT01142115|20641147|P2|COMPLETED|First Intervention||19
8373481|NCT01142115|20641148|P1|COMPLETED|First Intervention||19
8373482|NCT01142115|20641147|P2|STARTED|First Intervention||20
8373483|NCT01142115|20641148|P1|STARTED|First Intervention||21
8373484|NCT01142089|20641165|P2|NOT COMPLETED|Overall Study||21
8373485|NCT01142089|20641166|P1|NOT COMPLETED|Overall Study||12
8373486|NCT01142089|20641165|P2|COMPLETED|Overall Study||178
8373487|NCT01142089|20641166|P1|COMPLETED|Overall Study||53
8373488|NCT01142089|20641165|P2|STARTED|Overall Study||199
8373489|NCT01142089|20641166|P1|STARTED|Overall Study||65
8373490|NCT01141907|20641176|P2|NOT COMPLETED|Overall Study||0
8373491|NCT01141907|20641177|P1|NOT COMPLETED|Overall Study||0
8373492|NCT01141907|20641176|P2|COMPLETED|Overall Study||5
8373493|NCT01141907|20641177|P1|COMPLETED|Overall Study||6
8373494|NCT01141907|20641176|P2|STARTED|Overall Study||5
8373495|NCT01141907|20641177|P1|STARTED|Overall Study||6
8373496|NCT01141725|20641183|P3|NOT COMPLETED|Overall Study||0
8373497|NCT01141725|20641184|P2|NOT COMPLETED|Overall Study||0
8373498|NCT01141725|20641185|P1|NOT COMPLETED|Overall Study||0
8373499|NCT01141725|20641183|P3|COMPLETED|Overall Study||3
8373500|NCT01141725|20641184|P2|COMPLETED|Overall Study||33
8373501|NCT01141725|20641185|P1|COMPLETED|Overall Study||3
8373502|NCT01141725|20641183|P3|STARTED|Overall Study||3
8373503|NCT01141725|20641184|P2|STARTED|Overall Study||33
8373504|NCT01141725|20641185|P1|STARTED|Overall Study||3
8373505|NCT01141712|20641197|P1|NOT COMPLETED|Overall Study||3
8373506|NCT01141712|20641197|P1|COMPLETED|Overall Study||40
8373507|NCT01141712|20641197|P1|STARTED|Overall Study||43
8373508|NCT01141660|20641218|P2|NOT COMPLETED|Overall Study||12
8373509|NCT01141660|20641219|P1|NOT COMPLETED|Overall Study||0
8373510|NCT01141660|20641218|P2|COMPLETED|Overall Study||48
8373511|NCT01141660|20641219|P1|COMPLETED|Overall Study||71
8373512|NCT01141660|20641218|P2|STARTED|Overall Study||60
8373513|NCT01141660|20641219|P1|STARTED|Overall Study||71
8373514|NCT01141647|20641227|P1|NOT COMPLETED|Overall Study||46
8373515|NCT01141647|20641227|P1|COMPLETED|Overall Study||167
8373516|NCT01141647|20641227|P1|STARTED|Overall Study||213
8373517|NCT01141608|20641242|P2|NOT COMPLETED|Overall Study||0
8373518|NCT01141608|20641243|P1|NOT COMPLETED|Overall Study||0
8373519|NCT01141608|20641242|P2|COMPLETED|Overall Study||150
8373520|NCT01141608|20641243|P1|COMPLETED|Overall Study||152
8373521|NCT01141608|20641242|P2|STARTED|Overall Study||150
8373522|NCT01141608|20641243|P1|STARTED|Overall Study||152
8373523|NCT01141595|20641249|P1|NOT COMPLETED|Overall Study||2
8373524|NCT01141595|20641249|P1|COMPLETED|Overall Study||8
8373525|NCT01141595|20641249|P1|STARTED|Overall Study||10
8373526|NCT01141569|20641253|P1|NOT COMPLETED|Overall Study||0
8373527|NCT01141569|20641253|P1|COMPLETED|Overall Study||12
8373528|NCT01141569|20641253|P1|STARTED|Overall Study||12
8373529|NCT01141491|20641264|P2|NOT COMPLETED|Overall Study||47
8373530|NCT01141491|20641265|P1|NOT COMPLETED|Overall Study||48
8373531|NCT01141491|20641264|P2|COMPLETED|Overall Study||21
8373532|NCT01141491|20641265|P1|COMPLETED|Overall Study||20
8373533|NCT01141491|20641264|P2|STARTED|Overall Study||68
8373534|NCT01141491|20641265|P1|STARTED|Overall Study||68
8373535|NCT01141374|20641274|P3|NOT COMPLETED|Overall Study||0
8373536|NCT01141374|20641275|P2|NOT COMPLETED|Overall Study||0
8373537|NCT01141374|20641276|P1|NOT COMPLETED|Overall Study||0
8373538|NCT01141374|20641274|P3|COMPLETED|Overall Study||22
8373539|NCT01141374|20641275|P2|COMPLETED|Overall Study||27
8373540|NCT01141374|20641276|P1|COMPLETED|Overall Study||26
8373541|NCT01141374|20641274|P3|STARTED|Overall Study||22
8373542|NCT01141374|20641275|P2|STARTED|Overall Study||27
8373543|NCT01141374|20641276|P1|STARTED|Overall Study||26
8373544|NCT01141283|20641287|P1|NOT COMPLETED|Overall Study||88
8373545|NCT01141283|20641287|P1|COMPLETED|Overall Study||202
8373546|NCT01141283|20641287|P1|STARTED|Overall Study||290
8373547|NCT01141205|20641293|P2|NOT COMPLETED|Overall Study||2
8373548|NCT01141205|20641294|P1|NOT COMPLETED|Overall Study||3
8373549|NCT01141205|20641293|P2|COMPLETED|Overall Study||3
8373550|NCT01141205|20641294|P1|COMPLETED|Overall Study||15
8373551|NCT01141205|20641293|P2|STARTED|Overall Study||5
8373552|NCT01141205|20641294|P1|STARTED|Overall Study||18
8373553|NCT01141075|20641306|P1|NOT COMPLETED|Cycle 2||0
8373554|NCT01141075|20641306|P1|COMPLETED|Cycle 2||11
8373555|NCT01141075|20641306|P1|Received at Least 1 Dose of Study Drug|Cycle 2||11
8373556|NCT01141075|20641306|P1|STARTED|Cycle 2||11
8373557|NCT01141075|20641306|P1|NOT COMPLETED|Cycle 1||0
8373558|NCT01141075|20641306|P1|COMPLETED|Cycle 1||11
8373559|NCT01141075|20641306|P1|Received at Least 1 Dose of Study Drug|Cycle 1||11
8373560|NCT01141075|20641306|P1|STARTED|Cycle 1||11
8373561|NCT01141049|20641320|P2|NOT COMPLETED|Overall Study||8
8373562|NCT01141049|20641321|P1|NOT COMPLETED|Overall Study||5
8373563|NCT01141049|20641320|P2|COMPLETED|Overall Study||13
8373564|NCT01141049|20641321|P1|COMPLETED|Overall Study||14
8373565|NCT01141049|20641320|P2|STARTED|Overall Study||21
8373566|NCT01141049|20641321|P1|STARTED|Overall Study||19
8373567|NCT01140906|20641333|P4|NOT COMPLETED|Overall Study||16
8373568|NCT01140906|20641334|P3|NOT COMPLETED|Overall Study||26
8373569|NCT01140906|20641335|P2|NOT COMPLETED|Overall Study||34
8373570|NCT01140906|20641336|P1|NOT COMPLETED|Overall Study||25
8373571|NCT01140906|20641333|P4|COMPLETED|Overall Study||131
8373572|NCT01140906|20641334|P3|COMPLETED|Overall Study||125
8373573|NCT01140906|20641335|P2|COMPLETED|Overall Study||117
8373574|NCT01140906|20641336|P1|COMPLETED|Overall Study||133
8373575|NCT01140906|20641333|P4|STARTED|Overall Study||147
8373576|NCT01140906|20641334|P3|STARTED|Overall Study||151
8373577|NCT01140906|20641335|P2|STARTED|Overall Study||151
8373578|NCT01140906|20641336|P1|STARTED|Overall Study||158
8373579|NCT01140880|20641376|P2|NOT COMPLETED|Overall Study||44
8373580|NCT01140880|20641377|P1|NOT COMPLETED|Overall Study||14
8373581|NCT01140880|20641376|P2|COMPLETED|Overall Study||56
8373582|NCT01140880|20641377|P1|COMPLETED|Overall Study||56
8373583|NCT01140880|20641376|P2|STARTED|Overall Study||100
8373584|NCT01140880|20641377|P1|STARTED|Overall Study||70
8373585|NCT01140867|20641389|P1|NOT COMPLETED|Overall Study||33
8373586|NCT01140867|20641389|P1|COMPLETED|Overall Study||88
8373587|NCT01140867|20641389|P1|STARTED|Overall Study||121
8373588|NCT01140815|20641398|P2|NOT COMPLETED|Overall Study||0
8373589|NCT01140815|20641399|P1|NOT COMPLETED|Overall Study||0
8373590|NCT01140815|20641398|P2|COMPLETED|Overall Study||25
8373591|NCT01140815|20641399|P1|COMPLETED|Overall Study||25
8373592|NCT01140815|20641398|P2|STARTED|Overall Study||25
8373593|NCT01140815|20641399|P1|STARTED|Overall Study||25
8373594|NCT01140646|20641429|P1|NOT COMPLETED|Overall Study||9
8373595|NCT01140646|20641429|P1|COMPLETED|Overall Study||34
8373596|NCT01140646|20641429|P1|STARTED|Overall Study||43
8373597|NCT01140568|20641437|P1|NOT COMPLETED|Overall Study||36
8373598|NCT01140568|20641437|P1|COMPLETED|Overall Study||2
8373599|NCT01140568|20641437|P1|Treated With Study Drug|Overall Study||34
8373600|NCT01140568|20641437|P1|Screen Fail|Overall Study||4
8373601|NCT01140568|20641437|P1|STARTED|Overall Study||38
8373602|NCT01140503|20641442|P1|NOT COMPLETED|Overall Study||1
8373603|NCT01140503|20641442|P1|COMPLETED|Overall Study||4
8373604|NCT01140503|20641442|P1|STARTED|Overall Study||5
8373605|NCT01140477|20641450|P2|NOT COMPLETED|Overall Study||6
8373606|NCT01140477|20641451|P1|NOT COMPLETED|Overall Study||8
8373607|NCT01140477|20641450|P2|COMPLETED|Overall Study||70
8373608|NCT01140477|20641451|P1|COMPLETED|Overall Study||145
8373609|NCT01140477|20641450|P2|STARTED|Overall Study||76
8373610|NCT01140477|20641451|P1|STARTED|Overall Study||153
8373611|NCT01140451|20641462|P2|NOT COMPLETED|Overall Study||42
8373612|NCT01140451|20641463|P1|NOT COMPLETED|Overall Study||38
8373613|NCT01140451|20641462|P2|COMPLETED|Overall Study||54
8373614|NCT01140451|20641463|P1|COMPLETED|Overall Study||57
8373615|NCT01140451|20641462|P2|144-Week Completer Population|Overall Study||54
8373616|NCT01140451|20641463|P1|144-Week Completer Population|Overall Study||57
8373617|NCT01140451|20641462|P2|96-Week Completer Population|Overall Study||70
8373618|NCT01140451|20641463|P1|96-Week Completer Population|Overall Study||78
8373619|NCT01140451|20641462|P2|As-Treated Population|Overall Study||96
8373620|NCT01140451|20641463|P1|As-Treated Population|Overall Study||95
8373621|NCT01140451|20641462|P2|Completed 96 Weeks|Overall Study||54
8373622|NCT01140451|20641463|P1|Completed 96 Weeks|Overall Study||57
8373623|NCT01140451|20641462|P2|Completed 72 Weeks|Overall Study||62
8373624|NCT01140451|20641463|P1|Completed 72 Weeks|Overall Study||63
8373625|NCT01140451|20641462|P2|Completed 48 Weeks|Overall Study||70
8373626|NCT01140451|20641463|P1|Completed 48 Weeks|Overall Study||78
8373627|NCT01140451|20641462|P2|Completed 24 Weeks|Overall Study||86
8373628|NCT01140451|20641463|P1|Completed 24 Weeks|Overall Study||89
8373629|NCT01140451|20641462|P2|STARTED|Overall Study||96
8373630|NCT01140451|20641463|P1|STARTED|Overall Study||95
8373631|NCT01140360|20641522|P1|NOT COMPLETED|Overall Study||6
8373632|NCT01140360|20641522|P1|COMPLETED|Overall Study||15
8373633|NCT01140360|20641522|P1|STARTED|Overall Study||21
8373634|NCT01140347|20641528|P2|NOT COMPLETED|Overall Study||14
8373635|NCT01140347|20641529|P1|NOT COMPLETED|Overall Study||18
8373636|NCT01140347|20641528|P2|COMPLETED|Overall Study||268
8373637|NCT01140347|20641529|P1|COMPLETED|Overall Study||265
8373638|NCT01140347|20641528|P2|Received at Least 1 Dose of Study Drug|Overall Study||276
8373639|NCT01140347|20641529|P1|Received at Least 1 Dose of Study Drug|Overall Study||277
8373640|NCT01140347|20641528|P2|STARTED|Overall Study||282
8373641|NCT01140347|20641529|P1|STARTED|Overall Study||283
8373642|NCT01140295|20641554|P2|NOT COMPLETED|Overall Study||2
8373643|NCT01140295|20641555|P1|NOT COMPLETED|Overall Study||1
8373644|NCT01140295|20641554|P2|COMPLETED|Overall Study||14
8373645|NCT01140295|20641555|P1|COMPLETED|Overall Study||16
8373646|NCT01140295|20641554|P2|STARTED|Overall Study||16
8373647|NCT01140295|20641555|P1|STARTED|Overall Study||17
8373648|NCT01140191|20641563|P1|NOT COMPLETED|Overall Study||0
8373649|NCT01140191|20641563|P1|COMPLETED|Overall Study||1
8373650|NCT01140191|20641563|P1|STARTED|Overall Study||1
8373651|NCT01140061|20641582|P10|NOT COMPLETED|Extension||1
8373652|NCT01140061|20641583|P9|NOT COMPLETED|Extension||0
8373653|NCT01140061|20641584|P8|NOT COMPLETED|Extension||0
8373654|NCT01140061|20641585|P7|NOT COMPLETED|Extension||0
8373655|NCT01140061|20641586|P6|NOT COMPLETED|Extension||0
8373656|NCT01140061|20641587|P5|NOT COMPLETED|Extension||0
8373657|NCT01140061|20641588|P4|NOT COMPLETED|Extension||0
8373658|NCT01140061|20641589|P3|NOT COMPLETED|Extension||0
8373659|NCT01140061|20641590|P2|NOT COMPLETED|Extension||0
8373660|NCT01140061|20641591|P1|NOT COMPLETED|Extension||0
8373661|NCT01140061|20641582|P10|COMPLETED|Extension||1
8373662|NCT01140061|20641583|P9|COMPLETED|Extension||7
8373663|NCT01140061|20641584|P8|COMPLETED|Extension||0
8373664|NCT01140061|20641585|P7|COMPLETED|Extension||0
8373665|NCT01140061|20641586|P6|COMPLETED|Extension||0
8373666|NCT01140061|20641587|P5|COMPLETED|Extension||0
8373667|NCT01140061|20641588|P4|COMPLETED|Extension||0
8373668|NCT01140061|20641589|P3|COMPLETED|Extension||0
8373669|NCT01140061|20641590|P2|COMPLETED|Extension||0
8373670|NCT01140061|20641591|P1|COMPLETED|Extension||0
8373671|NCT01140061|20641582|P10|STARTED|Extension||2
8373672|NCT01140061|20641583|P9|STARTED|Extension||7
8373673|NCT01140061|20641584|P8|STARTED|Extension||0
8373674|NCT01140061|20641585|P7|STARTED|Extension||0
8373675|NCT01140061|20641586|P6|STARTED|Extension||0
8373676|NCT01140061|20641587|P5|STARTED|Extension||0
8373677|NCT01140061|20641588|P4|STARTED|Extension||0
8373678|NCT01140061|20641589|P3|STARTED|Extension||0
8373679|NCT01140061|20641590|P2|STARTED|Extension||0
8373680|NCT01140061|20641591|P1|STARTED|Extension||0
8373681|NCT01140061|20641582|P10|NOT COMPLETED|Part III||0
8373682|NCT01140061|20641583|P9|NOT COMPLETED|Part III||0
8373683|NCT01140061|20641584|P8|NOT COMPLETED|Part III||0
8373684|NCT01140061|20641585|P7|NOT COMPLETED|Part III||0
8373685|NCT01140061|20641586|P6|NOT COMPLETED|Part III||0
8373686|NCT01140061|20641587|P5|NOT COMPLETED|Part III||0
8373687|NCT01140061|20641588|P4|NOT COMPLETED|Part III||0
8373688|NCT01140061|20641589|P3|NOT COMPLETED|Part III||0
8373689|NCT01140061|20641590|P2|NOT COMPLETED|Part III||0
8373690|NCT01140061|20641591|P1|NOT COMPLETED|Part III||0
8373691|NCT01140061|20641582|P10|COMPLETED|Part III||2
8373692|NCT01140061|20641583|P9|COMPLETED|Part III||7
8373693|NCT01140061|20641584|P8|COMPLETED|Part III||0
8373694|NCT01140061|20641585|P7|COMPLETED|Part III||0
8373695|NCT01140061|20641586|P6|COMPLETED|Part III||0
8373696|NCT01140061|20641587|P5|COMPLETED|Part III||0
8373697|NCT01140061|20641588|P4|COMPLETED|Part III||0
8373698|NCT01140061|20641589|P3|COMPLETED|Part III||0
8373699|NCT01140061|20641590|P2|COMPLETED|Part III||0
8373700|NCT01140061|20641591|P1|COMPLETED|Part III||0
8373701|NCT01140061|20641582|P10|STARTED|Part III|Includes 1 replacement participant|2
8373702|NCT01140061|20641583|P9|STARTED|Part III||7
8373703|NCT01140061|20641584|P8|STARTED|Part III||0
8373704|NCT01140061|20641585|P7|STARTED|Part III||0
8373705|NCT01140061|20641586|P6|STARTED|Part III||0
8373706|NCT01140061|20641587|P5|STARTED|Part III||0
8373707|NCT01140061|20641588|P4|STARTED|Part III||0
8373708|NCT01140061|20641589|P3|STARTED|Part III||0
8373709|NCT01140061|20641590|P2|STARTED|Part III||0
8373710|NCT01140061|20641591|P1|STARTED|Part III||0
8373711|NCT01140061|20641582|P10|NOT COMPLETED|Part II||0
8373712|NCT01140061|20641583|P9|NOT COMPLETED|Part II||0
8373713|NCT01140061|20641584|P8|NOT COMPLETED|Part II||0
8373714|NCT01140061|20641585|P7|NOT COMPLETED|Part II||0
8373715|NCT01140061|20641586|P6|NOT COMPLETED|Part II||0
8373716|NCT01140061|20641587|P5|NOT COMPLETED|Part II||0
8373717|NCT01140061|20641588|P4|NOT COMPLETED|Part II||0
8373718|NCT01140061|20641589|P3|NOT COMPLETED|Part II||0
8373719|NCT01140061|20641590|P2|NOT COMPLETED|Part II||0
8373720|NCT01140061|20641591|P1|NOT COMPLETED|Part II||0
8373721|NCT01140061|20641582|P10|COMPLETED|Part II||0
8373722|NCT01140061|20641583|P9|COMPLETED|Part II||0
8373723|NCT01140061|20641584|P8|COMPLETED|Part II||2
8373724|NCT01140061|20641585|P7|COMPLETED|Part II||6
8373725|NCT01140061|20641586|P6|COMPLETED|Part II||2
8373726|NCT01140061|20641587|P5|COMPLETED|Part II||6
8373727|NCT01140061|20641588|P4|COMPLETED|Part II||2
8373728|NCT01140061|20641589|P3|COMPLETED|Part II||6
8373729|NCT01140061|20641590|P2|COMPLETED|Part II||0
8373730|NCT01140061|20641591|P1|COMPLETED|Part II||0
8373731|NCT01140061|20641582|P10|STARTED|Part II||0
8373732|NCT01140061|20641583|P9|STARTED|Part II||0
8373733|NCT01140061|20641584|P8|STARTED|Part II||2
8373734|NCT01140061|20641585|P7|STARTED|Part II||6
8373735|NCT01140061|20641586|P6|STARTED|Part II||2
8373736|NCT01140061|20641587|P5|STARTED|Part II||6
8373737|NCT01140061|20641588|P4|STARTED|Part II||2
8373738|NCT01140061|20641589|P3|STARTED|Part II||6
8373739|NCT01140061|20641590|P2|STARTED|Part II||0
8373740|NCT01140061|20641591|P1|STARTED|Part II||0
8373741|NCT01140061|20641582|P10|NOT COMPLETED|Part I||0
8373742|NCT01140061|20641583|P9|NOT COMPLETED|Part I||0
8373743|NCT01140061|20641584|P8|NOT COMPLETED|Part I||0
8373744|NCT01140061|20641585|P7|NOT COMPLETED|Part I||0
8373745|NCT01140061|20641586|P6|NOT COMPLETED|Part I||0
8373746|NCT01140061|20641587|P5|NOT COMPLETED|Part I||0
8373747|NCT01140061|20641588|P4|NOT COMPLETED|Part I||0
8373748|NCT01140061|20641589|P3|NOT COMPLETED|Part I||0
8373749|NCT01140061|20641590|P2|NOT COMPLETED|Part I||0
8373750|NCT01140061|20641591|P1|NOT COMPLETED|Part I||1
8373751|NCT01140061|20641582|P10|COMPLETED|Part I||0
8373752|NCT01140061|20641583|P9|COMPLETED|Part I||0
8373753|NCT01140061|20641584|P8|COMPLETED|Part I||0
8373754|NCT01140061|20641585|P7|COMPLETED|Part I||0
8373755|NCT01140061|20641586|P6|COMPLETED|Part I||0
8373756|NCT01140061|20641587|P5|COMPLETED|Part I||0
8373757|NCT01140061|20641588|P4|COMPLETED|Part I||0
8373758|NCT01140061|20641589|P3|COMPLETED|Part I||0
8373759|NCT01140061|20641590|P2|COMPLETED|Part I||2
8373760|NCT01140061|20641591|P1|COMPLETED|Part I||6
8373761|NCT01140061|20641582|P10|STARTED|Part I||0
8373762|NCT01140061|20641583|P9|STARTED|Part I||0
8373763|NCT01140061|20641584|P8|STARTED|Part I||0
8373764|NCT01140061|20641585|P7|STARTED|Part I||0
8373765|NCT01140061|20641586|P6|STARTED|Part I||0
8373766|NCT01140061|20641587|P5|STARTED|Part I||0
8373767|NCT01140061|20641588|P4|STARTED|Part I||0
8373768|NCT01140061|20641589|P3|STARTED|Part I||0
8373769|NCT01140061|20641590|P2|STARTED|Part I||2
8373770|NCT01140061|20641591|P1|STARTED|Part I|Includes 1 replacement participant|7
8373771|NCT01140048|20641618|P1|NOT COMPLETED|Overall Study||45
8373772|NCT01140048|20641618|P1|COMPLETED|Overall Study||298
8373773|NCT01140048|20641618|P1|STARTED|Overall Study||343
8373774|NCT01139996|20641626|P2|NOT COMPLETED|Overall Study||0
8373775|NCT01139996|20641627|P1|NOT COMPLETED|Overall Study||0
8373776|NCT01139996|20641626|P2|COMPLETED|Overall Study||11
8373777|NCT01139996|20641627|P1|COMPLETED|Overall Study||11
8373778|NCT01139996|20641626|P2|STARTED|Overall Study||11
8373779|NCT01139996|20641627|P1|STARTED|Overall Study||11
8373780|NCT01139879|20641633|P1|NOT COMPLETED|Overall Study||0
8373781|NCT01139879|20641633|P1|COMPLETED|Overall Study||10
8373782|NCT01139879|20641633|P1|STARTED|Overall Study||10
8373783|NCT01139814|20641639|P1|NOT COMPLETED|Overall Study||0
8373784|NCT01139814|20641639|P1|COMPLETED|Overall Study||181
8373785|NCT01139814|20641639|P1|STARTED|Overall Study||181
8373786|NCT01139801|20641646|P2|NOT COMPLETED|Overall Study||0
8373787|NCT01139801|20641647|P1|NOT COMPLETED|Overall Study||0
8373788|NCT01139801|20641646|P2|COMPLETED|Overall Study||25
8373789|NCT01139801|20641647|P1|COMPLETED|Overall Study||25
8373790|NCT01139801|20641646|P2|STARTED|Overall Study||25
8373791|NCT01139801|20641647|P1|STARTED|Overall Study||25
8373792|NCT01139775|20641658|P3|NOT COMPLETED|Overall Study||6
8373793|NCT01139775|20641659|P2|NOT COMPLETED|Overall Study||13
8373794|NCT01139775|20641660|P1|NOT COMPLETED|Overall Study||1
8373795|NCT01139775|20641658|P3|COMPLETED|Overall Study||17
8373796|NCT01139775|20641659|P2|COMPLETED|Overall Study||26
8373797|NCT01139775|20641660|P1|COMPLETED|Overall Study||13
8373798|NCT01139775|20641658|P3|Received at Least 1 Dose of Study Drug|Overall Study||22
8373799|NCT01139775|20641659|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
8373800|NCT01139775|20641660|P1|Received at Least 1 Dose of Study Drug|Overall Study||14
8373801|NCT01139775|20641658|P3|STARTED|Overall Study||23
8373802|NCT01139775|20641659|P2|STARTED|Overall Study||39
8373803|NCT01139775|20641660|P1|STARTED|Overall Study||14
8373804|NCT01139762|20641692|P3|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
8373805|NCT01139762|20641693|P2|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
8373806|NCT01139762|20641694|P1|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
8373807|NCT01139762|20641692|P3|COMPLETED|Double-Blind Randomized Active Treatment||286
8373808|NCT01139762|20641693|P2|COMPLETED|Double-Blind Randomized Active Treatment||306
8373809|NCT01139762|20641694|P1|COMPLETED|Double-Blind Randomized Active Treatment||0
8373810|NCT01139762|20641692|P3|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
8373811|NCT01139762|20641693|P2|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
8373812|NCT01139762|20641694|P1|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
8373813|NCT01139762|20641692|P3|STARTED|Double-Blind Randomized Active Treatment||350
8373814|NCT01139762|20641693|P2|STARTED|Double-Blind Randomized Active Treatment||346
8373815|NCT01139762|20641694|P1|STARTED|Double-Blind Randomized Active Treatment||0
8373816|NCT01139762|20641692|P3|NOT COMPLETED|Washout and Placebo Lead-In Period||0
8373817|NCT01139762|20641693|P2|NOT COMPLETED|Washout and Placebo Lead-In Period||0
8373818|NCT01139762|20641694|P1|NOT COMPLETED|Washout and Placebo Lead-In Period||374
8373819|NCT01139762|20641692|P3|COMPLETED|Washout and Placebo Lead-In Period||0
8373820|NCT01139762|20641693|P2|COMPLETED|Washout and Placebo Lead-In Period||0
8373821|NCT01139762|20641694|P1|COMPLETED|Washout and Placebo Lead-In Period||696
8373822|NCT01139762|20641692|P3|STARTED|Washout and Placebo Lead-In Period||0
8373823|NCT01139762|20641693|P2|STARTED|Washout and Placebo Lead-In Period||0
8373824|NCT01139762|20641694|P1|STARTED|Washout and Placebo Lead-In Period||1070
8373825|NCT01139658|20641729|P2|NOT COMPLETED|Overall Study||113
8373826|NCT01139658|20641730|P1|NOT COMPLETED|Overall Study||56
8373827|NCT01139658|20641729|P2|COMPLETED|Overall Study||816
8373828|NCT01139658|20641730|P1|COMPLETED|Overall Study||691
8373829|NCT01139658|20641729|P2|STARTED|Overall Study||929
8373830|NCT01139658|20641730|P1|STARTED|Overall Study||747
8373831|NCT01139580|20641768|P2|NOT COMPLETED|Overall Study||18
8373832|NCT01139580|20641769|P1|NOT COMPLETED|Overall Study||23
8373833|NCT01139580|20641768|P2|COMPLETED|Overall Study||164
8373834|NCT01139580|20641769|P1|COMPLETED|Overall Study||158
8373835|NCT01139580|20641768|P2|STARTED|Overall Study||182
8373836|NCT01139580|20641769|P1|STARTED|Overall Study||181
8373837|NCT01139450|20641788|P3|NOT COMPLETED|Overall Study||38
8373838|NCT01139450|20641789|P2|NOT COMPLETED|Overall Study||25
8373839|NCT01139450|20641790|P1|NOT COMPLETED|Overall Study||27
8373840|NCT01139450|20641788|P3|COMPLETED|Overall Study||262
8373841|NCT01139450|20641789|P2|COMPLETED|Overall Study||272
8373842|NCT01139450|20641790|P1|COMPLETED|Overall Study||275
8373843|NCT01139450|20641788|P3|STARTED|Overall Study||300
8373844|NCT01139450|20641789|P2|STARTED|Overall Study||297
8373845|NCT01139450|20641790|P1|STARTED|Overall Study||302
8373846|NCT01139411|20641800|P2|NOT COMPLETED|Overall Study||4
8373847|NCT01139411|20641801|P1|NOT COMPLETED|Overall Study||2
8373848|NCT01139411|20641800|P2|COMPLETED|Overall Study||19
8373849|NCT01139411|20641801|P1|COMPLETED|Overall Study||24
8373850|NCT01139411|20641800|P2|STARTED|Overall Study||23
8373851|NCT01139411|20641801|P1|STARTED|Overall Study||26
8373852|NCT01139294|20641821|P2|NOT COMPLETED|Overall Study||0
8373853|NCT01139294|20641822|P1|NOT COMPLETED|Overall Study||0
8373854|NCT01139294|20641821|P2|COMPLETED|Overall Study||0
8373855|NCT01139294|20641822|P1|COMPLETED|Overall Study||0
8373856|NCT01139294|20641821|P2|STARTED|Overall Study||0
8373857|NCT01139294|20641822|P1|STARTED|Overall Study||0
8373858|NCT01139190|20641832|P2|NOT COMPLETED|Overall Study||1
8373859|NCT01139190|20641833|P1|NOT COMPLETED|Overall Study||0
8373860|NCT01139190|20641832|P2|COMPLETED|Overall Study||38
8373861|NCT01139190|20641833|P1|COMPLETED|Overall Study||38
8373862|NCT01139190|20641832|P2|STARTED|Overall Study||39
8373863|NCT01139190|20641833|P1|STARTED|Overall Study||38
8373864|NCT01139164|20641842|P3|NOT COMPLETED|Overall Study||0
8373865|NCT01139164|20641843|P2|NOT COMPLETED|Overall Study||2
8373866|NCT01139164|20641844|P1|NOT COMPLETED|Overall Study||0
8373867|NCT01139164|20641842|P3|COMPLETED|Overall Study||7
8373868|NCT01139164|20641843|P2|COMPLETED|Overall Study||65
8373869|NCT01139164|20641844|P1|COMPLETED|Overall Study||4
8373870|NCT01139164|20641842|P3|STARTED|Overall Study||7
8373871|NCT01139164|20641843|P2|STARTED|Overall Study||67
8373872|NCT01139164|20641844|P1|STARTED|Overall Study||4
8373873|NCT01139125|20641858|P1|NOT COMPLETED|Overall Study||1
8373874|NCT01139125|20641858|P1|COMPLETED|Overall Study||2
8373875|NCT01139125|20641858|P1|STARTED|Overall Study||3
8373876|NCT01139047|20641862|P1|NOT COMPLETED|Overall Study||1
8373877|NCT01139047|20641862|P1|COMPLETED|Overall Study||76
8373878|NCT01139047|20641862|P1|STARTED|Overall Study||77
8373879|NCT01139021|20641877|P6|NOT COMPLETED|Overall Study||0
8373880|NCT01139021|20641878|P5|NOT COMPLETED|Overall Study||9
8373881|NCT01139021|20641879|P4|NOT COMPLETED|Overall Study||1
8373882|NCT01139021|20641880|P3|NOT COMPLETED|Overall Study||0
8373883|NCT01139021|20641881|P2|NOT COMPLETED|Overall Study||0
8373884|NCT01139021|20641882|P1|NOT COMPLETED|Overall Study||1
8373885|NCT01139021|20641877|P6|COMPLETED|Overall Study||1
8373886|NCT01139021|20641878|P5|COMPLETED|Overall Study||107
8373887|NCT01139021|20641879|P4|COMPLETED|Overall Study||18
8373888|NCT01139021|20641880|P3|COMPLETED|Overall Study||67
8373889|NCT01139021|20641881|P2|COMPLETED|Overall Study||153
8373890|NCT01139021|20641882|P1|COMPLETED|Overall Study||151
8373891|NCT01139021|20641877|P6|STARTED|Overall Study||1
8373892|NCT01139021|20641878|P5|STARTED|Overall Study||116
8373893|NCT01139021|20641879|P4|STARTED|Overall Study||19
8373894|NCT01139021|20641880|P3|STARTED|Overall Study||67
8373895|NCT01139021|20641881|P2|STARTED|Overall Study||153
8373896|NCT01139021|20641882|P1|STARTED|Overall Study||152
8373897|NCT01139008|20641918|P1|NOT COMPLETED|Overall Study||6
8373898|NCT01139008|20641918|P1|COMPLETED|Overall Study||74
8373899|NCT01139008|20641918|P1|STARTED|Overall Study||80
8373900|NCT01138995|20641929|P2|NOT COMPLETED|Overall Study||25
8373901|NCT01138995|20641930|P1|NOT COMPLETED|Overall Study||10
8373902|NCT01138995|20641929|P2|COMPLETED|Overall Study||74
8373903|NCT01138995|20641930|P1|COMPLETED|Overall Study||88
8373904|NCT01138995|20641929|P2|STARTED|Overall Study||99
8373905|NCT01138995|20641930|P1|STARTED|Overall Study||98
8373906|NCT01138969|20641942|P2|NOT COMPLETED|Overall Study||0
8373907|NCT01138969|20641943|P1|NOT COMPLETED|Overall Study||0
8373908|NCT01138969|20641942|P2|COMPLETED|Overall Study||82
8373909|NCT01138969|20641943|P1|COMPLETED|Overall Study||83
8373910|NCT01138969|20641942|P2|STARTED|Overall Study||82
8373911|NCT01138969|20641943|P1|STARTED|Overall Study||83
8373912|NCT01138917|20641951|P1|NOT COMPLETED|Overall Study||24
8373913|NCT01138917|20641951|P1|COMPLETED|Overall Study||77
8373914|NCT01138917|20641951|P1|STARTED|Overall Study||101
8373931|NCT01138514|20642030|P3|NOT COMPLETED|Overall Study||93
8373932|NCT01138514|20642031|P2|NOT COMPLETED|Overall Study||53
8373933|NCT01138514|20642032|P1|NOT COMPLETED|Overall Study||48
8373934|NCT01138514|20642030|P3|COMPLETED|Overall Study||424
8373935|NCT01138514|20642031|P2|COMPLETED|Overall Study||463
8373936|NCT01138514|20642032|P1|COMPLETED|Overall Study||474
8373937|NCT01138514|20642030|P3|STARTED|Overall Study||517
8373938|NCT01138514|20642031|P2|STARTED|Overall Study||516
8373939|NCT01138514|20642032|P1|STARTED|Overall Study||522
8373940|NCT01138501|20642046|P1|NOT COMPLETED|Overall Study||5
8373941|NCT01138501|20642046|P1|COMPLETED|Overall Study||60
8373942|NCT01138501|20642046|P1|Exposed|Overall Study||63
8373943|NCT01138501|20642046|P1|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
8373944|NCT01138475|20642054|P3|NOT COMPLETED|Overall Study||0
8373945|NCT01138475|20642055|P2|NOT COMPLETED|Overall Study||0
8373946|NCT01138475|20642056|P1|NOT COMPLETED|Overall Study||0
8373947|NCT01138475|20642054|P3|COMPLETED|Overall Study||17
8373948|NCT01138475|20642055|P2|COMPLETED|Overall Study||16
8373949|NCT01138475|20642056|P1|COMPLETED|Overall Study||16
8373950|NCT01138475|20642054|P3|STARTED|Overall Study||17
8373951|NCT01138475|20642055|P2|STARTED|Overall Study||16
8373952|NCT01138475|20642056|P1|STARTED|Overall Study||16
8373953|NCT01138150|20642090|P2|NOT COMPLETED|Overall Study||1
8373954|NCT01138150|20642091|P1|NOT COMPLETED|Overall Study||1
8373955|NCT01138150|20642090|P2|COMPLETED|Overall Study||17
8373956|NCT01138150|20642091|P1|COMPLETED|Overall Study||17
8373957|NCT01138150|20642090|P2|STARTED|Overall Study||18
8373958|NCT01138150|20642091|P1|STARTED|Overall Study||18
8373959|NCT01138124|20642147|P4|NOT COMPLETED|Overall Study||0
8373960|NCT01138124|20642148|P3|NOT COMPLETED|Overall Study||0
8373961|NCT01138124|20642149|P2|NOT COMPLETED|Overall Study||0
8373962|NCT01138124|20642150|P1|NOT COMPLETED|Overall Study||0
8373963|NCT01138124|20642147|P4|COMPLETED|Overall Study||19046
8373964|NCT01138124|20642148|P3|COMPLETED|Overall Study||1981
8373965|NCT01138124|20642149|P2|COMPLETED|Overall Study||30026
8373966|NCT01138124|20642150|P1|COMPLETED|Overall Study||3149
8373967|NCT01138124|20642147|P4|STARTED|Overall Study||19046
8373968|NCT01138124|20642148|P3|STARTED|Overall Study||1981
8373969|NCT01138124|20642149|P2|STARTED|Overall Study||30026
8373970|NCT01138124|20642150|P1|STARTED|Overall Study||3149
8373971|NCT01138111|20642172|P1|NOT COMPLETED|Overall Study||9
8373972|NCT01138111|20642172|P1|COMPLETED|Overall Study||36
8373973|NCT01138111|20642172|P1|STARTED|Overall Study||45
8373974|NCT01138098|20642203|P2|NOT COMPLETED|Overall Study||0
8373975|NCT01138098|20642204|P1|NOT COMPLETED|Overall Study||0
8373976|NCT01138098|20642203|P2|COMPLETED|Overall Study||90
8373977|NCT01138098|20642204|P1|COMPLETED|Overall Study||95
8373978|NCT01138098|20642203|P2|STARTED|Overall Study||90
8373979|NCT01138098|20642204|P1|STARTED|Overall Study||95
8373980|NCT01138046|20642226|P1|NOT COMPLETED|Overall Study||6
8373981|NCT01138046|20642226|P1|COMPLETED|Overall Study||6
8373982|NCT01138046|20642226|P1|STARTED|Overall Study||12
8373983|NCT01138007|20642246|P3|NOT COMPLETED|Overall Study||48
8373984|NCT01138007|20642247|P2|NOT COMPLETED|Overall Study||30
8373985|NCT01138007|20642248|P1|NOT COMPLETED|Overall Study||22
8373986|NCT01138007|20642246|P3|COMPLETED|Overall Study||144
8373987|NCT01138007|20642247|P2|COMPLETED|Overall Study||160
8373988|NCT01138007|20642248|P1|COMPLETED|Overall Study||165
8373989|NCT01138007|20642246|P3|STARTED|Overall Study||192
8373990|NCT01138007|20642247|P2|STARTED|Overall Study||190
8373991|NCT01138007|20642248|P1|STARTED|Overall Study||187
8373992|NCT01137890|20642282|P2|NOT COMPLETED|Overall Study||3
8373993|NCT01137890|20642283|P1|NOT COMPLETED|Overall Study||6
8373994|NCT01137890|20642282|P2|COMPLETED|Overall Study||2
8373995|NCT01137890|20642283|P1|COMPLETED|Overall Study||8
8373996|NCT01137890|20642282|P2|STARTED|Overall Study||5
8373997|NCT01137890|20642283|P1|STARTED|Overall Study||14
8373998|NCT01137812|20642355|P2|NOT COMPLETED|Overall Study||168
8373999|NCT01137812|20642356|P1|NOT COMPLETED|Overall Study||123
8374000|NCT01137812|20642355|P2|COMPLETED|Overall Study||210
8374001|NCT01137812|20642356|P1|COMPLETED|Overall Study||254
8374002|NCT01137812|20642355|P2|STARTED|Overall Study||378
8374003|NCT01137812|20642356|P1|STARTED|Overall Study||377
8374004|NCT01137786|20642376|P2|NOT COMPLETED|Overall Study||3
8374005|NCT01137786|20642377|P1|NOT COMPLETED|Overall Study||1
8374006|NCT01137786|20642376|P2|COMPLETED|Overall Study||21
8374007|NCT01137786|20642377|P1|COMPLETED|Overall Study||24
8374008|NCT01137786|20642376|P2|STARTED|Overall Study||24
8374009|NCT01137786|20642377|P1|STARTED|Overall Study||25
8374010|NCT01137773|20642387|P2|NOT COMPLETED|Overall Study||3
8374011|NCT01137773|20642388|P1|NOT COMPLETED|Overall Study||9
8374012|NCT01137773|20642387|P2|COMPLETED|Overall Study||20
8374013|NCT01137773|20642388|P1|COMPLETED|Overall Study||24
8374014|NCT01137773|20642387|P2|STARTED|Overall Study||23
8374015|NCT01137773|20642388|P1|STARTED|Overall Study||33
8374016|NCT01137682|20642399|P3|NOT COMPLETED|Overall Study||34
8374017|NCT01137682|20642400|P2|NOT COMPLETED|Overall Study||40
8374018|NCT01137682|20642401|P1|NOT COMPLETED|Overall Study||37
8374019|NCT01137682|20642399|P3|COMPLETED|Overall Study||34
8374020|NCT01137682|20642400|P2|COMPLETED|Overall Study||25
8374021|NCT01137682|20642401|P1|COMPLETED|Overall Study||28
8374022|NCT01137682|20642399|P3|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
8374023|NCT01137682|20642400|P2|Safety Set - Extension|Overall Study||54
8374024|NCT01137682|20642401|P1|Safety Set - Extension|Overall Study||57
8374025|NCT01137682|20642399|P3|Safety Set - CORE|Overall Study|2 patients never received drug.|66
8374026|NCT01137682|20642400|P2|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
8374027|NCT01137682|20642401|P1|Safety Set - CORE|Overall Study|2 patients never received drug.|63
8374028|NCT01137682|20642399|P3|Continuing Into Extension|Overall Study||63
8374029|NCT01137682|20642400|P2|Continuing Into Extension|Overall Study||54
8374030|NCT01137682|20642401|P1|Continuing Into Extension|Overall Study||57
8374031|NCT01137682|20642399|P3|Not Continuing Into Extension|Overall Study||2
8374032|NCT01137682|20642400|P2|Not Continuing Into Extension|Overall Study||3
8374033|NCT01137682|20642401|P1|Not Continuing Into Extension|Overall Study||2
8374034|NCT01137682|20642399|P3|Completed 24-Week Core Phase|Overall Study||65
8374035|NCT01137682|20642400|P2|Completed 24-Week Core Phase|Overall Study||57
8374036|NCT01137682|20642401|P1|Completed 24-Week Core Phase|Overall Study||59
8374037|NCT01137682|20642399|P3|Treated|Overall Study||67
8374038|NCT01137682|20642400|P2|Treated|Overall Study||63
8374039|NCT01137682|20642401|P1|Treated|Overall Study||63
8374040|NCT01137682|20642399|P3|Not Treated|Overall Study||1
8374041|NCT01137682|20642400|P2|Not Treated|Overall Study||2
8374042|NCT01137682|20642401|P1|Not Treated|Overall Study||2
8374043|NCT01137682|20642399|P3|STARTED|Overall Study||68
8374044|NCT01137682|20642400|P2|STARTED|Overall Study||65
8374045|NCT01137682|20642401|P1|STARTED|Overall Study||65
8374046|NCT01137604|20642451|P4|NOT COMPLETED|Overall Study||11
8374047|NCT01137604|20642452|P3|NOT COMPLETED|Overall Study||13
8374048|NCT01137604|20642453|P2|NOT COMPLETED|Overall Study||10
8374049|NCT01137604|20642454|P1|NOT COMPLETED|Overall Study||2
8374050|NCT01137604|20642451|P4|COMPLETED|Overall Study||21
8374051|NCT01137604|20642452|P3|COMPLETED|Overall Study||26
8374052|NCT01137604|20642453|P2|COMPLETED|Overall Study||32
8374053|NCT01137604|20642454|P1|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
8374054|NCT01137604|20642451|P4|Treatment Ongoing at Data Cutoff|Overall Study||0
8374055|NCT01137604|20642452|P3|Treatment Ongoing at Data Cutoff|Overall Study||1
8374056|NCT01137604|20642453|P2|Treatment Ongoing at Data Cutoff|Overall Study||3
8374057|NCT01137604|20642454|P1|Treatment Ongoing at Data Cutoff|Overall Study||2
8374058|NCT01137604|20642451|P4|Disease Progression|Overall Study||21
8374059|NCT01137604|20642452|P3|Disease Progression|Overall Study||25
8374060|NCT01137604|20642453|P2|Disease Progression|Overall Study||29
8374061|NCT01137604|20642454|P1|Disease Progression|Overall Study||34
8374062|NCT01137604|20642451|P4|STARTED|Overall Study||32
8374063|NCT01137604|20642452|P3|STARTED|Overall Study||39
8374064|NCT01137604|20642453|P2|STARTED|Overall Study||42
8374065|NCT01137604|20642454|P1|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
8374066|NCT01137578|20642488|P3|NOT COMPLETED|Overall Study||6
8374067|NCT01137578|20642489|P2|NOT COMPLETED|Overall Study||2
8374068|NCT01137578|20642490|P1|NOT COMPLETED|Overall Study||16
8374069|NCT01137578|20642488|P3|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
8374070|NCT01137578|20642489|P2|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
8374071|NCT01137578|20642490|P1|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
8374072|NCT01137578|20642488|P3|STARTED|Overall Study||43
8374073|NCT01137578|20642489|P2|STARTED|Overall Study||14
8374074|NCT01137578|20642490|P1|STARTED|Overall Study||77
8374075|NCT01137539|20642530|P1|NOT COMPLETED|Overall Study||0
8374076|NCT01137539|20642530|P1|COMPLETED|Overall Study||50
8374077|NCT01137539|20642530|P1|STARTED|Overall Study||50
8374078|NCT01137474|20642539|P4|NOT COMPLETED|Overall Study||21
8374079|NCT01137474|20642540|P3|NOT COMPLETED|Overall Study||7
8374080|NCT01137474|20642541|P2|NOT COMPLETED|Overall Study||12
8374081|NCT01137474|20642542|P1|NOT COMPLETED|Overall Study||24
8374082|NCT01137474|20642539|P4|COMPLETED|Overall Study||281
8374083|NCT01137474|20642540|P3|COMPLETED|Overall Study||158
8374084|NCT01137474|20642541|P2|COMPLETED|Overall Study||154
8374085|NCT01137474|20642542|P1|COMPLETED|Overall Study||287
8374086|NCT01137474|20642539|P4|Received Treatment|Overall Study||302
8374087|NCT01137474|20642540|P3|Received Treatment|Overall Study||165
8374088|NCT01137474|20642541|P2|Received Treatment|Overall Study||166
8374089|NCT01137474|20642542|P1|Received Treatment|Overall Study||311
8374090|NCT01137474|20642539|P4|STARTED|Overall Study||302
8374091|NCT01137474|20642540|P3|STARTED|Overall Study||165
8374092|NCT01137474|20642541|P2|STARTED|Overall Study||166
8374093|NCT01137474|20642542|P1|STARTED|Overall Study||311
8374094|NCT01137435|20642560|P1|NOT COMPLETED|Overall Study||28
8374095|NCT01137435|20642560|P1|COMPLETED|Overall Study||659
8374096|NCT01137435|20642560|P1|STARTED|Overall Study||687
8374097|NCT01137396|20642569|P2|NOT COMPLETED|Overall Study||2
8374098|NCT01137396|20642570|P1|NOT COMPLETED|Overall Study||8
8374099|NCT01137396|20642569|P2|COMPLETED|Overall Study||25
8374100|NCT01137396|20642570|P1|COMPLETED|Overall Study||22
8374101|NCT01137396|20642569|P2|STARTED|Overall Study||27
8374102|NCT01137396|20642570|P1|STARTED|Overall Study||30
8374103|NCT01137370|20642580|P2|NOT COMPLETED|Overall Study||0
8374104|NCT01137370|20642581|P1|NOT COMPLETED|Overall Study||0
8374105|NCT01137370|20642580|P2|COMPLETED|Overall Study||87
8374106|NCT01137370|20642581|P1|COMPLETED|Overall Study||116
8374107|NCT01137370|20642580|P2|STARTED|Overall Study||87
8374108|NCT01137370|20642581|P1|STARTED|Overall Study||116
8374109|NCT01137292|20642587|P1|NOT COMPLETED|Overall Study||54
8374110|NCT01137292|20642587|P1|COMPLETED|Overall Study||123
8374111|NCT01137292|20642587|P1|STARTED|Overall Study||177
8374112|NCT01137110|20642596|P2|NOT COMPLETED|Overall Study||0
8374113|NCT01137110|20642597|P1|NOT COMPLETED|Overall Study||1
8374114|NCT01137110|20642596|P2|COMPLETED|Overall Study||49
8374115|NCT01137110|20642597|P1|COMPLETED|Overall Study||34
8374116|NCT01137110|20642596|P2|STARTED|Overall Study||49
8374117|NCT01137110|20642597|P1|STARTED|Overall Study||35
8374118|NCT01137071|20642603|P1|NOT COMPLETED|Overall Study||14
8374119|NCT01137071|20642603|P1|COMPLETED|Overall Study|Of the eligible patients|15
8374120|NCT01137071|20642603|P1|STARTED|Overall Study|all patients considered eligible were included on the study|29
8374121|NCT01137032|20642664|P1|NOT COMPLETED|Overall Study||0
8374122|NCT01137032|20642664|P1|COMPLETED|Overall Study||19
8374123|NCT01137032|20642664|P1|STARTED|Overall Study||19
8374124|NCT01137006|20642677|P7|NOT COMPLETED|Overall Study||0
8374125|NCT01137006|20642678|P6|NOT COMPLETED|Overall Study||0
8374126|NCT01137006|20642679|P5|NOT COMPLETED|Overall Study||0
8374127|NCT01137006|20642680|P4|NOT COMPLETED|Overall Study||0
8374128|NCT01137006|20642681|P3|NOT COMPLETED|Overall Study||0
8374129|NCT01137006|20642682|P2|NOT COMPLETED|Overall Study||0
8374130|NCT01137006|20642683|P1|NOT COMPLETED|Overall Study||0
8374131|NCT01137006|20642677|P7|COMPLETED|Overall Study||3
8374132|NCT01137006|20642678|P6|COMPLETED|Overall Study||4
8374133|NCT01137006|20642679|P5|COMPLETED|Overall Study||3
8374134|NCT01137006|20642680|P4|COMPLETED|Overall Study||3
8374135|NCT01137006|20642681|P3|COMPLETED|Overall Study||8
8374136|NCT01137006|20642682|P2|COMPLETED|Overall Study||3
8374137|NCT01137006|20642683|P1|COMPLETED|Overall Study||3
8374138|NCT01137006|20642677|P7|Completed at Least 1 Treatment Cycle|Overall Study||3
8374139|NCT01137006|20642678|P6|Completed at Least 1 Treatment Cycle|Overall Study||4
8374140|NCT01137006|20642679|P5|Completed at Least 1 Treatment Cycle|Overall Study||3
8374141|NCT01137006|20642680|P4|Completed at Least 1 Treatment Cycle|Overall Study||3
8374142|NCT01137006|20642681|P3|Completed at Least 1 Treatment Cycle|Overall Study||8
8374143|NCT01137006|20642682|P2|Completed at Least 1 Treatment Cycle|Overall Study||3
8374144|NCT01137006|20642683|P1|Completed at Least 1 Treatment Cycle|Overall Study||3
8374145|NCT01137006|20642677|P7|STARTED|Overall Study||3
8374146|NCT01137006|20642678|P6|STARTED|Overall Study||4
8374147|NCT01137006|20642679|P5|STARTED|Overall Study||3
8374148|NCT01137006|20642680|P4|STARTED|Overall Study||3
8374149|NCT01137006|20642681|P3|STARTED|Overall Study||8
8374150|NCT01137006|20642682|P2|STARTED|Overall Study||3
8374151|NCT01137006|20642683|P1|STARTED|Overall Study||3
8374152|NCT01136967|20642759|P2|NOT COMPLETED|Overall Study||27
8374153|NCT01136967|20642760|P1|NOT COMPLETED|Overall Study||24
8374154|NCT01136967|20642759|P2|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
8374155|NCT01136967|20642760|P1|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
8374156|NCT01136967|20642759|P2|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
8374157|NCT01136967|20642760|P1|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
8374158|NCT01136967|20642759|P2|Disease Progression|Overall Study||56
8374159|NCT01136967|20642760|P1|Disease Progression|Overall Study||55
8374160|NCT01136967|20642759|P2|STARTED|Overall Study||89
8374161|NCT01136967|20642760|P1|STARTED|Overall Study||93
8374162|NCT01136954|20642782|P2|NOT COMPLETED|Overall Study||21
8374163|NCT01136954|20642783|P1|NOT COMPLETED|Overall Study||24
8374164|NCT01136954|20642782|P2|COMPLETED|Overall Study||51
8374165|NCT01136954|20642783|P1|COMPLETED|Overall Study||48
8374166|NCT01136954|20642782|P2|STARTED|Overall Study||72
8374167|NCT01136954|20642783|P1|STARTED|Overall Study||72
8374168|NCT01136915|20642797|P2|NOT COMPLETED|Overall Study||1
8374169|NCT01136915|20642798|P1|NOT COMPLETED|Overall Study||2
8374170|NCT01136915|20642797|P2|COMPLETED|Overall Study||6
8374171|NCT01136915|20642798|P1|COMPLETED|Overall Study||6
8374172|NCT01136915|20642797|P2|STARTED|Overall Study||7
8374173|NCT01136915|20642798|P1|STARTED|Overall Study||8
8374174|NCT01136876|20642808|P2|NOT COMPLETED|Overall Study||11
8374175|NCT01136876|20642809|P1|NOT COMPLETED|Overall Study||5
8374176|NCT01136876|20642808|P2|COMPLETED|Overall Study||18
8374177|NCT01136876|20642809|P1|COMPLETED|Overall Study||23
8374178|NCT01136876|20642808|P2|STARTED|Overall Study||29
8374179|NCT01136876|20642809|P1|STARTED|Overall Study||28
8374180|NCT01136798|20642819|P2|NOT COMPLETED|Overall Study||0
8374181|NCT01136798|20642820|P1|NOT COMPLETED|Overall Study||0
8374182|NCT01136798|20642819|P2|COMPLETED|Overall Study||8
8374183|NCT01136798|20642820|P1|COMPLETED|Overall Study||10
8374184|NCT01136798|20642819|P2|STARTED|Overall Study||8
8374185|NCT01136798|20642820|P1|STARTED|Overall Study||10
8374186|NCT01136785|20642838|P2|NOT COMPLETED|Overall Study||1
8374187|NCT01136785|20642839|P1|NOT COMPLETED|Overall Study||2
8374188|NCT01136785|20642838|P2|COMPLETED|Overall Study||6
8374189|NCT01136785|20642839|P1|COMPLETED|Overall Study||13
8374190|NCT01136785|20642838|P2|STARTED|Overall Study||7
8374191|NCT01136785|20642839|P1|STARTED|Overall Study||15
8374192|NCT01136772|20642854|P2|NOT COMPLETED|Overall Study||110
8374193|NCT01136772|20642855|P1|NOT COMPLETED|Overall Study||116
8374194|NCT01136772|20642854|P2|COMPLETED|Overall Study||44
8374195|NCT01136772|20642855|P1|COMPLETED|Overall Study||41
8374196|NCT01136772|20642854|P2|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
8374197|NCT01136772|20642855|P1|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
8374198|NCT01136772|20642854|P2|STARTED|Overall Study||154
8374199|NCT01136772|20642855|P1|STARTED|Overall Study||157
8374200|NCT01136746|20642865|P2|NOT COMPLETED|Overall Study||3
8374201|NCT01136746|20642866|P1|NOT COMPLETED|Overall Study||3
8374202|NCT01136746|20642865|P2|COMPLETED|Overall Study||4
8374203|NCT01136746|20642866|P1|COMPLETED|Overall Study||6
8374204|NCT01136746|20642865|P2|STARTED|Overall Study||7
8374205|NCT01136746|20642866|P1|STARTED|Overall Study||9
8374206|NCT01136733|20642933|P7|NOT COMPLETED|Phase 2||50
8374207|NCT01136733|20642934|P6|NOT COMPLETED|Phase 2||52
8374208|NCT01136733|20642935|P5|NOT COMPLETED|Phase 2||51
8374209|NCT01136733|20642936|P4|NOT COMPLETED|Phase 2||0
8374210|NCT01136733|20642937|P3|NOT COMPLETED|Phase 2||0
8374211|NCT01136733|20642938|P2|NOT COMPLETED|Phase 2||0
8374212|NCT01136733|20642939|P1|NOT COMPLETED|Phase 2||0
8374213|NCT01136733|20642933|P7|COMPLETED|Phase 2||0
8374214|NCT01136733|20642934|P6|COMPLETED|Phase 2||0
8374215|NCT01136733|20642935|P5|COMPLETED|Phase 2||0
8374216|NCT01136733|20642936|P4|COMPLETED|Phase 2||0
8374217|NCT01136733|20642937|P3|COMPLETED|Phase 2||0
8374218|NCT01136733|20642938|P2|COMPLETED|Phase 2||0
8374219|NCT01136733|20642939|P1|COMPLETED|Phase 2||0
8374220|NCT01136733|20642933|P7|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50
8374221|NCT01136733|20642934|P6|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52
8374222|NCT01136733|20642935|P5|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51
8374223|NCT01136733|20642936|P4|STARTED|Phase 2||0
8374224|NCT01136733|20642937|P3|STARTED|Phase 2||0
8374225|NCT01136733|20642938|P2|STARTED|Phase 2||0
8374226|NCT01136733|20642939|P1|STARTED|Phase 2||0
8374227|NCT01136733|20642933|P7|NOT COMPLETED|Phase 1b||0
8374228|NCT01136733|20642934|P6|NOT COMPLETED|Phase 1b||0
8374229|NCT01136733|20642935|P5|NOT COMPLETED|Phase 1b||0
8374230|NCT01136733|20642936|P4|NOT COMPLETED|Phase 1b||0
8374231|NCT01136733|20642937|P3|NOT COMPLETED|Phase 1b||2
8374232|NCT01136733|20642938|P2|NOT COMPLETED|Phase 1b||5
8374233|NCT01136733|20642939|P1|NOT COMPLETED|Phase 1b||1
8374234|NCT01136733|20642933|P7|COMPLETED|Phase 1b||0
8374235|NCT01136733|20642934|P6|COMPLETED|Phase 1b||0
8374236|NCT01136733|20642935|P5|COMPLETED|Phase 1b||0
8374237|NCT01136733|20642936|P4|COMPLETED|Phase 1b||0
8374238|NCT01136733|20642937|P3|COMPLETED|Phase 1b||0
8374239|NCT01136733|20642938|P2|COMPLETED|Phase 1b||6
8374240|NCT01136733|20642939|P1|COMPLETED|Phase 1b||6
8374241|NCT01136733|20642933|P7|STARTED|Phase 1b||0
8374242|NCT01136733|20642934|P6|STARTED|Phase 1b||0
8374243|NCT01136733|20642935|P5|STARTED|Phase 1b||0
8374244|NCT01136733|20642936|P4|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0
8374245|NCT01136733|20642937|P3|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2
8374246|NCT01136733|20642938|P2|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11
8374247|NCT01136733|20642939|P1|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7
8374248|NCT01136655|20643022|P1|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
8374249|NCT01136655|20643022|P1|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
8374250|NCT01136655|20643022|P1|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
8374251|NCT01136655|20643022|P1|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
8374252|NCT01136655|20643022|P1|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
8374253|NCT01136655|20643022|P1|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
8374254|NCT01136655|20643022|P1|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
8374255|NCT01136655|20643022|P1|COMPLETED|Washout After BUD 160 (7 Days)||51
8374256|NCT01136655|20643022|P1|STARTED|Washout After BUD 160 (7 Days)||51
8374257|NCT01136655|20643022|P1|NOT COMPLETED|BUD 160 (1 Dose)||0
8374258|NCT01136655|20643022|P1|COMPLETED|BUD 160 (1 Dose)||51
8374259|NCT01136655|20643022|P1|STARTED|BUD 160 (1 Dose)||51
8374260|NCT01136655|20643022|P1|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
8374261|NCT01136655|20643022|P1|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
8374262|NCT01136655|20643022|P1|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
8374263|NCT01136655|20643022|P1|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
8374264|NCT01136655|20643022|P1|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
8374265|NCT01136655|20643022|P1|STARTED|BUD 160/FM 9.0 (1 Dose)||53
8374266|NCT01136655|20643022|P1|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
8374267|NCT01136655|20643022|P1|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
8374268|NCT01136655|20643022|P1|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
8374269|NCT01136655|20643022|P1|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
8374270|NCT01136655|20643022|P1|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
8374271|NCT01136655|20643022|P1|STARTED|BUD 160/FM 4.5 (1 Dose)||53
8374272|NCT01136655|20643022|P1|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
8374273|NCT01136655|20643022|P1|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
8374274|NCT01136655|20643022|P1|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
8374275|NCT01136655|20643022|P1|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
8374276|NCT01136655|20643022|P1|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
8374277|NCT01136655|20643022|P1|STARTED|BUD 160/FM 2.25 (1 Dose)||54
8374278|NCT01136486|20643048|P1|NOT COMPLETED|Overall Study||0
8374279|NCT01136486|20643048|P1|COMPLETED|Overall Study||56
8374280|NCT01136486|20643048|P1|STARTED|Overall Study||56
8374281|NCT01136408|20643055|P3|NOT COMPLETED|Overall Study||5
8374282|NCT01136408|20643056|P2|NOT COMPLETED|Overall Study||9
8374283|NCT01136408|20643057|P1|NOT COMPLETED|Overall Study||5
8374284|NCT01136408|20643055|P3|COMPLETED|Overall Study||57
8374285|NCT01136408|20643056|P2|COMPLETED|Overall Study||49
8374286|NCT01136408|20643057|P1|COMPLETED|Overall Study||41
8374287|NCT01136408|20643055|P3|STARTED|Overall Study||62
8374288|NCT01136408|20643056|P2|STARTED|Overall Study||58
8374289|NCT01136408|20643057|P1|STARTED|Overall Study||46
8374290|NCT01136382|20643114|P2|NOT COMPLETED|Overall Study||31
8374291|NCT01136382|20643115|P1|NOT COMPLETED|Overall Study||60
8374292|NCT01136382|20643114|P2|COMPLETED|Overall Study||121
8374293|NCT01136382|20643115|P1|COMPLETED|Overall Study||92
8374294|NCT01136382|20643114|P2|STARTED|Overall Study||152
8374295|NCT01136382|20643115|P1|STARTED|Overall Study||152
8374296|NCT01136356|20643141|P2|NOT COMPLETED|Second 18-day Withdrawal||1
8374297|NCT01136356|20643142|P1|NOT COMPLETED|Second 18-day Withdrawal||0
8374298|NCT01136356|20643141|P2|COMPLETED|Second 18-day Withdrawal||5
8374299|NCT01136356|20643142|P1|COMPLETED|Second 18-day Withdrawal||2
8374300|NCT01136356|20643141|P2|STARTED|Second 18-day Withdrawal||6
8374301|NCT01136356|20643142|P1|STARTED|Second 18-day Withdrawal||2
8374302|NCT01136356|20643141|P2|NOT COMPLETED|Second Intervention||0
8374303|NCT01136356|20643142|P1|NOT COMPLETED|Second Intervention||0
8374304|NCT01136356|20643141|P2|COMPLETED|Second Intervention||6
8374305|NCT01136356|20643142|P1|COMPLETED|Second Intervention||2
8374306|NCT01136356|20643141|P2|STARTED|Second Intervention||6
8374307|NCT01136356|20643142|P1|STARTED|Second Intervention||2
8374308|NCT01136356|20643141|P2|NOT COMPLETED|First 18-day Withdrawal||0
8374309|NCT01136356|20643142|P1|NOT COMPLETED|First 18-day Withdrawal||4
8374310|NCT01136356|20643141|P2|COMPLETED|First 18-day Withdrawal||6
8374311|NCT01136356|20643142|P1|COMPLETED|First 18-day Withdrawal||2
8374312|NCT01136356|20643141|P2|STARTED|First 18-day Withdrawal||6
8374313|NCT01136356|20643142|P1|STARTED|First 18-day Withdrawal||6
8374314|NCT01136356|20643141|P2|NOT COMPLETED|First Intervention||0
8374315|NCT01136356|20643142|P1|NOT COMPLETED|First Intervention||0
8374316|NCT01136356|20643141|P2|COMPLETED|First Intervention||6
8374317|NCT01136356|20643142|P1|COMPLETED|First Intervention||6
8374318|NCT01136356|20643141|P2|STARTED|First Intervention||6
8374319|NCT01136356|20643142|P1|STARTED|First Intervention||6
8374320|NCT01136291|20643153|P2|NOT COMPLETED|Overall Study||1
8374321|NCT01136291|20643154|P1|NOT COMPLETED|Overall Study||1
8374322|NCT01136291|20643153|P2|COMPLETED|Overall Study||41
8374323|NCT01136291|20643154|P1|COMPLETED|Overall Study||39
8374324|NCT01136291|20643153|P2|Follow|Overall Study||42
8374325|NCT01136291|20643154|P1|Follow|Overall Study||40
8374326|NCT01136291|20643153|P2|STARTED|Overall Study||42
8374327|NCT01136291|20643154|P1|STARTED|Overall Study||40
8374328|NCT01136226|20643164|P1|NOT COMPLETED|Overall Study||13
8374329|NCT01136226|20643164|P1|COMPLETED|Overall Study||29
8374330|NCT01136226|20643164|P1|STARTED|Overall Study||42
8374331|NCT01136174|20643173|P4|NOT COMPLETED|Overall Study||4
8374332|NCT01136174|20643174|P3|NOT COMPLETED|Overall Study||0
8374333|NCT01136174|20643175|P2|NOT COMPLETED|Overall Study||0
8374334|NCT01136174|20643176|P1|NOT COMPLETED|Overall Study||0
8374335|NCT01136174|20643173|P4|COMPLETED|Overall Study||20
8374336|NCT01136174|20643174|P3|COMPLETED|Overall Study||8
8374337|NCT01136174|20643175|P2|COMPLETED|Overall Study||6
8374338|NCT01136174|20643176|P1|COMPLETED|Overall Study||12
8374339|NCT01136174|20643173|P4|STARTED|Overall Study||24
8374340|NCT01136174|20643174|P3|STARTED|Overall Study||8
8374341|NCT01136174|20643175|P2|STARTED|Overall Study||6
8374342|NCT01136174|20643176|P1|STARTED|Overall Study||12
8374343|NCT01135992|20643256|P1|NOT COMPLETED|Overall Study||21
8374344|NCT01135992|20643256|P1|COMPLETED|Overall Study||122
8374345|NCT01135992|20643256|P1|Full Analysis Set|Overall Study||129
8374346|NCT01135992|20643256|P1|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
8374347|NCT01135992|20643256|P1|STARTED|Overall Study||143
8374348|NCT01135914|20643268|P3|NOT COMPLETED|Overall Study||22
8374349|NCT01135914|20643269|P2|NOT COMPLETED|Overall Study||5
8374350|NCT01135914|20643270|P1|NOT COMPLETED|Overall Study||4
8374351|NCT01135914|20643268|P3|COMPLETED|Overall Study||59
8374352|NCT01135914|20643269|P2|COMPLETED|Overall Study||75
8374353|NCT01135914|20643270|P1|COMPLETED|Overall Study||74
8374354|NCT01135914|20643268|P3|Safety Population|Overall Study||74
8374355|NCT01135914|20643269|P2|Safety Population|Overall Study||75
8374356|NCT01135914|20643270|P1|Safety Population|Overall Study||73
8374357|NCT01135914|20643268|P3|Intent to Treat (ITT) Population|Overall Study||72
8374358|NCT01135914|20643269|P2|Intent to Treat (ITT) Population|Overall Study||75
8374359|NCT01135914|20643270|P1|Intent to Treat (ITT) Population|Overall Study||73
8374360|NCT01135914|20643268|P3|STARTED|Overall Study||81
8374361|NCT01135914|20643269|P2|STARTED|Overall Study||80
8374362|NCT01135914|20643270|P1|STARTED|Overall Study||78
8374363|NCT01135537|20643299|P1|NOT COMPLETED|Overall Study||13
8374364|NCT01135537|20643299|P1|COMPLETED|Overall Study||17
8374365|NCT01135537|20643299|P1|STARTED|Overall Study||30
8374366|NCT01135524|20643303|P1|NOT COMPLETED|Overall Study||196
8374367|NCT01135524|20643303|P1|COMPLETED|Overall Study||0
8374368|NCT01135524|20643303|P1|STARTED|Overall Study||196
8374369|NCT01135511|20643316|P9|NOT COMPLETED|Overall Study||1
8374370|NCT01135511|20643317|P8|NOT COMPLETED|Overall Study||1
8374371|NCT01135511|20643318|P7|NOT COMPLETED|Overall Study||1
8374372|NCT01135511|20643319|P6|NOT COMPLETED|Overall Study||1
8374373|NCT01135511|20643320|P5|NOT COMPLETED|Overall Study||1
8374374|NCT01135511|20643321|P4|NOT COMPLETED|Overall Study||3
8374375|NCT01135511|20643322|P3|NOT COMPLETED|Overall Study||8
8374376|NCT01135511|20643323|P2|NOT COMPLETED|Overall Study||3
8374377|NCT01135511|20643324|P1|NOT COMPLETED|Overall Study||0
8374378|NCT01135511|20643316|P9|COMPLETED|Overall Study||20
8374379|NCT01135511|20643317|P8|COMPLETED|Overall Study||20
8374380|NCT01135511|20643318|P7|COMPLETED|Overall Study||18
8374381|NCT01135511|20643319|P6|COMPLETED|Overall Study||20
8374382|NCT01135511|20643320|P5|COMPLETED|Overall Study||38
8374383|NCT01135511|20643321|P4|COMPLETED|Overall Study||37
8374384|NCT01135511|20643322|P3|COMPLETED|Overall Study||33
8374385|NCT01135511|20643323|P2|COMPLETED|Overall Study||39
8374386|NCT01135511|20643324|P1|COMPLETED|Overall Study||41
8374387|NCT01135511|20643316|P9|STARTED|Overall Study||21
8374388|NCT01135511|20643317|P8|STARTED|Overall Study||21
8374389|NCT01135511|20643318|P7|STARTED|Overall Study||19
8374390|NCT01135511|20643319|P6|STARTED|Overall Study||21
8374391|NCT01135511|20643320|P5|STARTED|Overall Study||39
8374392|NCT01135511|20643321|P4|STARTED|Overall Study||40
8374393|NCT01135511|20643322|P3|STARTED|Overall Study||41
8374394|NCT01135511|20643323|P2|STARTED|Overall Study||42
8374395|NCT01135511|20643324|P1|STARTED|Overall Study||41
8374396|NCT01135498|20643606|P1|NOT COMPLETED|Overall Study||90
8374397|NCT01135498|20643606|P1|COMPLETED|Overall Study||0
8374398|NCT01135498|20643606|P1|STARTED|Overall Study||90
8374399|NCT01135420|20643617|P2|NOT COMPLETED|Overall Study||32
8374400|NCT01135420|20643618|P1|NOT COMPLETED|Overall Study||44
8374401|NCT01135420|20643617|P2|COMPLETED|Overall Study||175
8374402|NCT01135420|20643618|P1|COMPLETED|Overall Study||155
8374403|NCT01135420|20643617|P2|STARTED|Overall Study||207
8374404|NCT01135420|20643618|P1|STARTED|Overall Study||199
8374405|NCT01135381|20643628|P4|NOT COMPLETED|Overall Study||1
8374406|NCT01135381|20643629|P3|NOT COMPLETED|Overall Study||4
8374407|NCT01135381|20643630|P2|NOT COMPLETED|Overall Study||7
8374408|NCT01135381|20643631|P1|NOT COMPLETED|Overall Study||21
8374409|NCT01135381|20643628|P4|COMPLETED|Overall Study||67
8374410|NCT01135381|20643629|P3|COMPLETED|Overall Study||65
8374411|NCT01135381|20643630|P2|COMPLETED|Overall Study||178
8374412|NCT01135381|20643631|P1|COMPLETED|Overall Study||168
8374413|NCT01135381|20643628|P4|STARTED|Overall Study||68
8374414|NCT01135381|20643629|P3|STARTED|Overall Study||69
8374415|NCT01135381|20643630|P2|STARTED|Overall Study||185
8374416|NCT01135381|20643631|P1|STARTED|Overall Study||189
8374417|NCT01135368|20643649|P1|NOT COMPLETED|Overall Study||251
8374418|NCT01135368|20643649|P1|COMPLETED|Overall Study||255
8374419|NCT01135368|20643649|P1|STARTED|Overall Study||506
8374420|NCT01135329|20643765|P1|NOT COMPLETED|Overall Study||0
8374421|NCT01135329|20643765|P1|COMPLETED|Overall Study||15
8374422|NCT01135329|20643765|P1|STARTED|Overall Study||15
8374423|NCT01135186|20643776|P1|NOT COMPLETED|Overall Study||0
8374424|NCT01135186|20643776|P1|COMPLETED|Overall Study||9
8374425|NCT01135186|20643776|P1|STARTED|Overall Study||9
8374426|NCT01135134|20643785|P2|NOT COMPLETED|Overall Study||1
8374427|NCT01135134|20643786|P1|NOT COMPLETED|Overall Study||2
8374428|NCT01135134|20643785|P2|COMPLETED|Overall Study||112
8374429|NCT01135134|20643786|P1|COMPLETED|Overall Study||218
8374430|NCT01135134|20643785|P2|STARTED|Overall Study||113
8374431|NCT01135134|20643786|P1|STARTED|Overall Study||220
8374432|NCT01135095|20643794|P1|NOT COMPLETED|Overall Study||0
8374433|NCT01135095|20643794|P1|COMPLETED|Overall Study||101
8374434|NCT01135095|20643794|P1|STARTED|Overall Study||101
8374435|NCT01135069|20643801|P3|NOT COMPLETED|Overall Study||10
8374436|NCT01135069|20643802|P2|NOT COMPLETED|Overall Study||32
8374437|NCT01135069|20643803|P1|NOT COMPLETED|Overall Study||36
8374438|NCT01135069|20643801|P3|COMPLETED|Overall Study||56
8374439|NCT01135069|20643802|P2|COMPLETED|Overall Study||177
8374440|NCT01135069|20643803|P1|COMPLETED|Overall Study||169
8374441|NCT01135069|20643801|P3|STARTED|Overall Study||66
8374442|NCT01135069|20643802|P2|STARTED|Overall Study||209
8374443|NCT01135069|20643803|P1|STARTED|Overall Study||205
8374444|NCT01135017|20643813|P2|NOT COMPLETED|Overall Study||12
8374445|NCT01135017|20643814|P1|NOT COMPLETED|Overall Study||6
8374446|NCT01135017|20643813|P2|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
8374447|NCT01135017|20643814|P1|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
8374448|NCT01135017|20643813|P2|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
8374449|NCT01135017|20643814|P1|Evaluable for Efficacy|Overall Study||55
8374450|NCT01135017|20643813|P2|Treated|Overall Study||57
8374451|NCT01135017|20643814|P1|Treated|Overall Study||55
8374452|NCT01135017|20643813|P2|STARTED|Overall Study||57
8374453|NCT01135017|20643814|P1|STARTED|Overall Study||55
8374454|NCT01134952|20643830|P1|NOT COMPLETED|Overall Study||0
8374455|NCT01134952|20643830|P1|COMPLETED|Overall Study||11
8374456|NCT01134952|20643830|P1|STARTED|Overall Study||11
8374457|NCT01134939|20643852|P8|NOT COMPLETED|Overall Study||0
8374458|NCT01134939|20643853|P7|NOT COMPLETED|Overall Study||9
8374459|NCT01134939|20643854|P6|NOT COMPLETED|Overall Study||9
8374460|NCT01134939|20643855|P5|NOT COMPLETED|Overall Study||10
8374461|NCT01134939|20643856|P4|NOT COMPLETED|Overall Study||14
8374462|NCT01134939|20643857|P3|NOT COMPLETED|Overall Study||10
8374463|NCT01134939|20643858|P2|NOT COMPLETED|Overall Study||18
8374464|NCT01134939|20643859|P1|NOT COMPLETED|Overall Study||17
8374465|NCT01134939|20643852|P8|COMPLETED|Overall Study||1
8374466|NCT01134939|20643853|P7|COMPLETED|Overall Study||10
8374467|NCT01134939|20643854|P6|COMPLETED|Overall Study||5
8374468|NCT01134939|20643855|P5|COMPLETED|Overall Study||23
8374469|NCT01134939|20643856|P4|COMPLETED|Overall Study||32
8374470|NCT01134939|20643857|P3|COMPLETED|Overall Study||41
8374471|NCT01134939|20643858|P2|COMPLETED|Overall Study||24
8374472|NCT01134939|20643859|P1|COMPLETED|Overall Study||42
8374473|NCT01134939|20643852|P8|STARTED|Overall Study||1
8374474|NCT01134939|20643853|P7|STARTED|Overall Study||19
8374475|NCT01134939|20643854|P6|STARTED|Overall Study||14
8374476|NCT01134939|20643855|P5|STARTED|Overall Study||33
8374477|NCT01134939|20643856|P4|STARTED|Overall Study||46
8374478|NCT01134939|20643857|P3|STARTED|Overall Study||51
8374479|NCT01134939|20643858|P2|STARTED|Overall Study||42
8374480|NCT01134939|20643859|P1|STARTED|Overall Study||59
8374481|NCT01134900|20643971|P2|NOT COMPLETED|Overall Study||0
8374482|NCT01134900|20643972|P1|NOT COMPLETED|Overall Study||0
8374483|NCT01134900|20643971|P2|COMPLETED|Overall Study||196
8374484|NCT01134900|20643972|P1|COMPLETED|Overall Study||200
8374485|NCT01134900|20643971|P2|STARTED|Overall Study||196
8374486|NCT01134900|20643972|P1|STARTED|Overall Study||200
8374487|NCT01134887|20643984|P4|NOT COMPLETED|Overall Study||0
8374488|NCT01134887|20643985|P3|NOT COMPLETED|Overall Study||0
8374489|NCT01134887|20643986|P2|NOT COMPLETED|Overall Study||4
8374490|NCT01134887|20643987|P1|NOT COMPLETED|Overall Study||0
8374491|NCT01134887|20643984|P4|COMPLETED|Overall Study||5
8374492|NCT01134887|20643985|P3|COMPLETED|Overall Study||5
8374493|NCT01134887|20643986|P2|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
8374494|NCT01134887|20643987|P1|COMPLETED|Overall Study||9
8374495|NCT01134887|20643984|P4|STARTED|Overall Study||5
8374496|NCT01134887|20643985|P3|STARTED|Overall Study||5
8374497|NCT01134887|20643986|P2|STARTED|Overall Study||11
8374498|NCT01134887|20643987|P1|STARTED|Overall Study||9
8374499|NCT01134783|20643997|P2|NOT COMPLETED|Overall Study||37
8374500|NCT01134783|20643998|P1|NOT COMPLETED|Overall Study||36
8374501|NCT01134783|20643997|P2|COMPLETED|Overall Study||180
8374502|NCT01134783|20643998|P1|COMPLETED|Overall Study||188
8374503|NCT01134783|20643997|P2|STARTED|Overall Study||217
8374504|NCT01134783|20643998|P1|STARTED|Overall Study||224
8374505|NCT01134731|20644017|P3|NOT COMPLETED|Overall Study||8
8374506|NCT01134731|20644018|P2|NOT COMPLETED|Overall Study||11
8374507|NCT01134731|20644019|P1|NOT COMPLETED|Overall Study||13
8374508|NCT01134731|20644017|P3|COMPLETED|Overall Study||2
8374509|NCT01134731|20644018|P2|COMPLETED|Overall Study||10
8374510|NCT01134731|20644019|P1|COMPLETED|Overall Study||10
8374511|NCT01134731|20644017|P3|STARTED|Overall Study||10
8374512|NCT01134731|20644018|P2|STARTED|Overall Study||21
8374513|NCT01134731|20644019|P1|STARTED|Overall Study||23
8374514|NCT01134705|20644032|P2|NOT COMPLETED|Overall Study||22
8374515|NCT01134705|20644033|P1|NOT COMPLETED|Overall Study||15
8374516|NCT01134705|20644032|P2|COMPLETED|Overall Study||216
8374517|NCT01134705|20644033|P1|COMPLETED|Overall Study||221
8374518|NCT01134705|20644032|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
8374519|NCT01134705|20644033|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
8374520|NCT01134705|20644032|P2|STARTED|Overall Study||238
8374521|NCT01134705|20644033|P1|STARTED|Overall Study||236
8374522|NCT01134627|20644045|P2|NOT COMPLETED|Overall Study||67
8374523|NCT01134627|20644046|P1|NOT COMPLETED|Overall Study||69
8374524|NCT01134627|20644045|P2|COMPLETED|Overall Study||88
8374525|NCT01134627|20644046|P1|COMPLETED|Overall Study||80
8374526|NCT01134627|20644045|P2|STARTED|Overall Study|Number of participants treated.|155
8374527|NCT01134627|20644046|P1|STARTED|Overall Study|Number of participants treated.|149
8374538|NCT01134575|20644090|P3|NOT COMPLETED|Overall Study||0
8374539|NCT01134575|20644091|P2|NOT COMPLETED|Overall Study||0
8374540|NCT01134575|20644092|P1|NOT COMPLETED|Overall Study||0
8374541|NCT01134575|20644090|P3|COMPLETED|Overall Study||42
8374542|NCT01134575|20644091|P2|COMPLETED|Overall Study||45
8374543|NCT01134575|20644092|P1|COMPLETED|Overall Study||3
8374544|NCT01134575|20644090|P3|STARTED|Overall Study||42
8374545|NCT01134575|20644091|P2|STARTED|Overall Study||45
8374546|NCT01134575|20644092|P1|STARTED|Overall Study||3
8374547|NCT01134562|20644105|P5|NOT COMPLETED|Overall Study||0
8374548|NCT01134562|20644106|P4|NOT COMPLETED|Overall Study||0
8374549|NCT01134562|20644107|P3|NOT COMPLETED|Overall Study||0
8374550|NCT01134562|20644108|P2|NOT COMPLETED|Overall Study||1
8374551|NCT01134562|20644109|P1|NOT COMPLETED|Overall Study||0
8374552|NCT01134562|20644105|P5|COMPLETED|Overall Study||8
8374553|NCT01134562|20644106|P4|COMPLETED|Overall Study||8
8374554|NCT01134562|20644107|P3|COMPLETED|Overall Study||4
8374555|NCT01134562|20644108|P2|COMPLETED|Overall Study||3
8374556|NCT01134562|20644109|P1|COMPLETED|Overall Study||4
8374557|NCT01134562|20644105|P5|STARTED|Overall Study||8
8374558|NCT01134562|20644106|P4|STARTED|Overall Study||8
8374559|NCT01134562|20644107|P3|STARTED|Overall Study||4
8374560|NCT01134562|20644108|P2|STARTED|Overall Study||4
8374561|NCT01134562|20644109|P1|STARTED|Overall Study||4
8374562|NCT01134549|20644178|P5|NOT COMPLETED|Overall Study||0
8374563|NCT01134549|20644179|P4|NOT COMPLETED|Overall Study||0
8374564|NCT01134549|20644180|P3|NOT COMPLETED|Overall Study||0
8374565|NCT01134549|20644181|P2|NOT COMPLETED|Overall Study||0
8374566|NCT01134549|20644182|P1|NOT COMPLETED|Overall Study||0
8374567|NCT01134549|20644178|P5|COMPLETED|Overall Study||6
8374568|NCT01134549|20644179|P4|COMPLETED|Overall Study||6
8374569|NCT01134549|20644180|P3|COMPLETED|Overall Study||6
8374570|NCT01134549|20644181|P2|COMPLETED|Overall Study||6
8374571|NCT01134549|20644182|P1|COMPLETED|Overall Study||8
8374572|NCT01134549|20644178|P5|STARTED|Overall Study||6
8374573|NCT01134549|20644179|P4|STARTED|Overall Study||6
8374574|NCT01134549|20644180|P3|STARTED|Overall Study||6
8374575|NCT01134549|20644181|P2|STARTED|Overall Study||6
8374576|NCT01134549|20644182|P1|STARTED|Overall Study||8
8374577|NCT01134510|20644268|P2|NOT COMPLETED|Overall Study||1
8374578|NCT01134510|20644269|P1|NOT COMPLETED|Overall Study||0
8374579|NCT01134510|20644268|P2|COMPLETED|Overall Study||9
8374580|NCT01134510|20644269|P1|COMPLETED|Overall Study||10
8374581|NCT01134510|20644268|P2|Month 3|Overall Study||9
8374582|NCT01134510|20644269|P1|Month 3|Overall Study||10
8374583|NCT01134510|20644268|P2|Month 1|Overall Study||10
8374584|NCT01134510|20644269|P1|Month 1|Overall Study||10
8374585|NCT01134510|20644268|P2|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
8374586|NCT01134510|20644269|P1|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
8374587|NCT01134510|20644268|P2|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
8374588|NCT01134510|20644269|P1|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
8374589|NCT01134510|20644268|P2|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
8374590|NCT01134510|20644269|P1|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
8374591|NCT01134510|20644268|P2|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
8374592|NCT01134510|20644269|P1|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
8374593|NCT01134510|20644268|P2|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
8374594|NCT01134510|20644269|P1|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
8374595|NCT01134510|20644268|P2|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
8374772|NCT01133756|20644831|P1|COMPLETED|Overall Study||0
8374596|NCT01134510|20644269|P1|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
8374597|NCT01134510|20644268|P2|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
8374598|NCT01134510|20644269|P1|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
8374599|NCT01134510|20644268|P2|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
8374600|NCT01134510|20644269|P1|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
8374601|NCT01134393|20644281|P1|NOT COMPLETED|Overall Study||52
8374602|NCT01134393|20644281|P1|COMPLETED|Overall Study|Completed trial medication.|449
8374603|NCT01134393|20644281|P1|STARTED|Overall Study|Entered and treated.|501
8374604|NCT01134328|20644299|P4|NOT COMPLETED|Overall Study||4
8374605|NCT01134328|20644300|P3|NOT COMPLETED|Overall Study||3
8374606|NCT01134328|20644301|P2|NOT COMPLETED|Overall Study||3
8374607|NCT01134328|20644302|P1|NOT COMPLETED|Overall Study||2
8374608|NCT01134328|20644299|P4|COMPLETED|Overall Study||17
8374609|NCT01134328|20644300|P3|COMPLETED|Overall Study||17
8374610|NCT01134328|20644301|P2|COMPLETED|Overall Study||18
8374611|NCT01134328|20644302|P1|COMPLETED|Overall Study||19
8374612|NCT01134328|20644299|P4|STARTED|Overall Study||21
8374613|NCT01134328|20644300|P3|STARTED|Overall Study||20
8374614|NCT01134328|20644301|P2|STARTED|Overall Study||21
8374615|NCT01134328|20644302|P1|STARTED|Overall Study||21
8374616|NCT01134315|20644402|P2|NOT COMPLETED|Overall Study||19
8374617|NCT01134315|20644403|P1|NOT COMPLETED|Overall Study||9
8374618|NCT01134315|20644402|P2|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
8374619|NCT01134315|20644403|P1|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
8374620|NCT01134315|20644402|P2|STARTED|Overall Study||40
8374621|NCT01134315|20644403|P1|STARTED|Overall Study||21
8374622|NCT01134276|20644425|P2|NOT COMPLETED|Overall Study||0
8374623|NCT01134276|20644426|P1|NOT COMPLETED|Overall Study||0
8374624|NCT01134276|20644425|P2|COMPLETED|Overall Study||107
8374625|NCT01134276|20644426|P1|COMPLETED|Overall Study||104
8374626|NCT01134276|20644425|P2|STARTED|Overall Study||107
8374627|NCT01134276|20644426|P1|STARTED|Overall Study||104
8374628|NCT01134263|20644441|P5|NOT COMPLETED|Overall Study||9
8374629|NCT01134263|20644442|P4|NOT COMPLETED|Overall Study||19
8374630|NCT01134263|20644443|P3|NOT COMPLETED|Overall Study||29
8374631|NCT01134263|20644444|P2|NOT COMPLETED|Overall Study||20
8374632|NCT01134263|20644445|P1|NOT COMPLETED|Overall Study||24
8374633|NCT01134263|20644441|P5|COMPLETED|Overall Study||48
8374634|NCT01134263|20644442|P4|COMPLETED|Overall Study||149
8374635|NCT01134263|20644443|P3|COMPLETED|Overall Study||134
8374636|NCT01134263|20644444|P2|COMPLETED|Overall Study||143
8374637|NCT01134263|20644445|P1|COMPLETED|Overall Study||140
8374638|NCT01134263|20644441|P5|Safety Population|Overall Study||57
8374639|NCT01134263|20644442|P4|Safety Population|Overall Study||167
8374640|NCT01134263|20644443|P3|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164
8374641|NCT01134263|20644444|P2|Safety Population|Overall Study||161
8374642|NCT01134263|20644445|P1|Safety Population|Overall Study||163
8374643|NCT01134263|20644441|P5|Received Vaccination 3|Overall Study||49
8374644|NCT01134263|20644442|P4|Received Vaccination 3|Overall Study||151
8374645|NCT01134263|20644443|P3|Received Vaccination 3|Overall Study||134
8374646|NCT01134263|20644444|P2|Received Vaccination 3|Overall Study||145
8374647|NCT01134263|20644445|P1|Received Vaccination 3|Overall Study||140
8374648|NCT01134263|20644441|P5|Received Vaccination 2|Overall Study||53
8374649|NCT01134263|20644442|P4|Received Vaccination 2|Overall Study||154
8374650|NCT01134263|20644443|P3|Received Vaccination 2|Overall Study||139
8374651|NCT01134263|20644444|P2|Received Vaccination 2|Overall Study||152
8374652|NCT01134263|20644445|P1|Received Vaccination 2|Overall Study||151
8374653|NCT01134263|20644441|P5|Received Vaccination 1|Overall Study||57
8374654|NCT01134263|20644442|P4|Received Vaccination 1|Overall Study||167
8374655|NCT01134263|20644443|P3|Received Vaccination 1|Overall Study||163
8374656|NCT01134263|20644444|P2|Received Vaccination 1|Overall Study||162
8374657|NCT01134263|20644445|P1|Received Vaccination 1|Overall Study||163
8374658|NCT01134263|20644441|P5|STARTED|Overall Study||57
8374659|NCT01134263|20644442|P4|STARTED|Overall Study||168
8374660|NCT01134263|20644443|P3|STARTED|Overall Study||163
8374661|NCT01134263|20644444|P2|STARTED|Overall Study||163
8374662|NCT01134263|20644445|P1|STARTED|Overall Study||164
8374663|NCT01134198|20644469|P2|NOT COMPLETED|Phase 2||4
8374664|NCT01134198|20644470|P1|NOT COMPLETED|Phase 2||0
8374665|NCT01134198|20644469|P2|COMPLETED|Phase 2||7
8374666|NCT01134198|20644470|P1|COMPLETED|Phase 2||9
8374667|NCT01134198|20644469|P2|STARTED|Phase 2||11
8374668|NCT01134198|20644470|P1|STARTED|Phase 2||9
8374669|NCT01134198|20644469|P2|NOT COMPLETED|Phase 1||2
8374670|NCT01134198|20644470|P1|NOT COMPLETED|Phase 1||7
8374671|NCT01134198|20644469|P2|COMPLETED|Phase 1||11
8374672|NCT01134198|20644470|P1|COMPLETED|Phase 1||9
8374673|NCT01134198|20644469|P2|STARTED|Phase 1||13
8374674|NCT01134198|20644470|P1|STARTED|Phase 1||16
8374675|NCT01134107|20644478|P2|NOT COMPLETED|Period 2-Second Treatment Intervention||0
8374676|NCT01134107|20644479|P1|NOT COMPLETED|Period 2-Second Treatment Intervention||4
8374677|NCT01134107|20644478|P2|COMPLETED|Period 2-Second Treatment Intervention||61
8374678|NCT01134107|20644479|P1|COMPLETED|Period 2-Second Treatment Intervention||57
8374679|NCT01134107|20644478|P2|STARTED|Period 2-Second Treatment Intervention||61
8374680|NCT01134107|20644479|P1|STARTED|Period 2-Second Treatment Intervention||61
8374773|NCT01133756|20644829|P3|Completed 6 Cycles|Overall Study||0
8374681|NCT01134107|20644478|P2|NOT COMPLETED|Period 1-First Treatment Intervention||5
8374682|NCT01134107|20644479|P1|NOT COMPLETED|Period 1-First Treatment Intervention||6
8374683|NCT01134107|20644478|P2|COMPLETED|Period 1-First Treatment Intervention||61
8374684|NCT01134107|20644479|P1|COMPLETED|Period 1-First Treatment Intervention||61
8374685|NCT01134107|20644478|P2|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
8374686|NCT01134107|20644479|P1|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
8374687|NCT01134107|20644478|P2|STARTED|Period 1-First Treatment Intervention||66
8374688|NCT01134107|20644479|P1|STARTED|Period 1-First Treatment Intervention||67
8374689|NCT01134081|20644511|P1|NOT COMPLETED|Overall Study||0
8374690|NCT01134081|20644511|P1|COMPLETED|Overall Study||44
8374691|NCT01134081|20644511|P1|STARTED|Overall Study||44
8374692|NCT01134055|20644526|P7|NOT COMPLETED|Overall Study||11
8374693|NCT01134055|20644527|P6|NOT COMPLETED|Overall Study||7
8374694|NCT01134055|20644528|P5|NOT COMPLETED|Overall Study||6
8374695|NCT01134055|20644529|P4|NOT COMPLETED|Overall Study||6
8374696|NCT01134055|20644530|P3|NOT COMPLETED|Overall Study||3
8374697|NCT01134055|20644531|P2|NOT COMPLETED|Overall Study||6
8374698|NCT01134055|20644532|P1|NOT COMPLETED|Overall Study||8
8374699|NCT01134055|20644526|P7|COMPLETED|Overall Study||62
8374700|NCT01134055|20644527|P6|COMPLETED|Overall Study||65
8374701|NCT01134055|20644528|P5|COMPLETED|Overall Study||67
8374702|NCT01134055|20644529|P4|COMPLETED|Overall Study||67
8374703|NCT01134055|20644530|P3|COMPLETED|Overall Study||71
8374704|NCT01134055|20644531|P2|COMPLETED|Overall Study||66
8374705|NCT01134055|20644532|P1|COMPLETED|Overall Study||65
8374706|NCT01134055|20644526|P7|STARTED|Overall Study||73
8374707|NCT01134055|20644527|P6|STARTED|Overall Study||72
8374708|NCT01134055|20644528|P5|STARTED|Overall Study||73
8374709|NCT01134055|20644529|P4|STARTED|Overall Study||73
8374710|NCT01134055|20644530|P3|STARTED|Overall Study||74
8374711|NCT01134055|20644531|P2|STARTED|Overall Study||72
8374712|NCT01134055|20644532|P1|STARTED|Overall Study||73
8374713|NCT01134042|20644666|P3|NOT COMPLETED|Overall Study||34
8374714|NCT01134042|20644667|P2|NOT COMPLETED|Overall Study||28
8374715|NCT01134042|20644668|P1|NOT COMPLETED|Overall Study||48
8374716|NCT01134042|20644666|P3|COMPLETED|Overall Study||161
8374717|NCT01134042|20644667|P2|COMPLETED|Overall Study||169
8374718|NCT01134042|20644668|P1|COMPLETED|Overall Study||146
8374719|NCT01134042|20644666|P3|STARTED|Overall Study||195
8374720|NCT01134042|20644667|P2|STARTED|Overall Study||197
8374721|NCT01134042|20644668|P1|STARTED|Overall Study||194
8374722|NCT01134016|20644706|P1|NOT COMPLETED|Overall Study||3
8374723|NCT01134016|20644706|P1|COMPLETED|Overall Study||10
8374724|NCT01134016|20644706|P1|STARTED|Overall Study||13
8374725|NCT01133977|20644744|P5|NOT COMPLETED|Overall Study||38
8374726|NCT01133977|20644745|P4|NOT COMPLETED|Overall Study||39
8374727|NCT01133977|20644746|P3|NOT COMPLETED|Overall Study||6
8374728|NCT01133977|20644747|P2|NOT COMPLETED|Overall Study||7
8374729|NCT01133977|20644748|P1|NOT COMPLETED|Overall Study||3
8374730|NCT01133977|20644744|P5|COMPLETED|Overall Study||1
8374731|NCT01133977|20644745|P4|COMPLETED|Overall Study||3
8374732|NCT01133977|20644746|P3|COMPLETED|Overall Study||0
8374733|NCT01133977|20644747|P2|COMPLETED|Overall Study||0
8374734|NCT01133977|20644748|P1|COMPLETED|Overall Study||0
8374735|NCT01133977|20644744|P5|STARTED|Overall Study|Treated|39
8374736|NCT01133977|20644745|P4|STARTED|Overall Study|Treated|42
8374737|NCT01133977|20644746|P3|STARTED|Overall Study|Treated|6
8374738|NCT01133977|20644747|P2|STARTED|Overall Study|Treated|7
8374739|NCT01133977|20644748|P1|STARTED|Overall Study|Treated|3
8374740|NCT01133860|20644765|P1|NOT COMPLETED|Overall Study||0
8374741|NCT01133860|20644765|P1|COMPLETED|Overall Study||12
8374742|NCT01133860|20644765|P1|STARTED|Overall Study||12
8374743|NCT01133847|20644775|P3|NOT COMPLETED|Follow-Up Phase||7
8374744|NCT01133847|20644776|P2|NOT COMPLETED|Follow-Up Phase||3
8374745|NCT01133847|20644777|P1|NOT COMPLETED|Follow-Up Phase||1
8374746|NCT01133847|20644775|P3|COMPLETED|Follow-Up Phase||60
8374747|NCT01133847|20644776|P2|COMPLETED|Follow-Up Phase||70
8374748|NCT01133847|20644777|P1|COMPLETED|Follow-Up Phase||72
8374749|NCT01133847|20644775|P3|STARTED|Follow-Up Phase||67
8374750|NCT01133847|20644776|P2|STARTED|Follow-Up Phase||73
8374751|NCT01133847|20644777|P1|STARTED|Follow-Up Phase||73
8374752|NCT01133847|20644775|P3|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
8374753|NCT01133847|20644776|P2|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
8374754|NCT01133847|20644777|P1|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
8374755|NCT01133847|20644775|P3|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
8374756|NCT01133847|20644776|P2|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
8374757|NCT01133847|20644777|P1|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
8374758|NCT01133847|20644775|P3|STARTED|Active Treatment Phase (Weeks 1-16)||70
8374759|NCT01133847|20644776|P2|STARTED|Active Treatment Phase (Weeks 1-16)||74
8374760|NCT01133847|20644777|P1|STARTED|Active Treatment Phase (Weeks 1-16)||78
8374761|NCT01133821|20644817|P2|NOT COMPLETED|Overall Study||19
8374762|NCT01133821|20644818|P1|NOT COMPLETED|Overall Study||18
8374763|NCT01133821|20644817|P2|COMPLETED|Overall Study||28
8374764|NCT01133821|20644818|P1|COMPLETED|Overall Study||27
8374765|NCT01133821|20644817|P2|STARTED|Overall Study||47
8374766|NCT01133821|20644818|P1|STARTED|Overall Study||45
8374767|NCT01133756|20644829|P3|NOT COMPLETED|Overall Study||2
8374768|NCT01133756|20644830|P2|NOT COMPLETED|Overall Study||3
8374769|NCT01133756|20644831|P1|NOT COMPLETED|Overall Study||2
8374770|NCT01133756|20644829|P3|COMPLETED|Overall Study||0
8374771|NCT01133756|20644830|P2|COMPLETED|Overall Study||0
8374774|NCT01133756|20644830|P2|Completed 6 Cycles|Overall Study||0
8374775|NCT01133756|20644831|P1|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
8374776|NCT01133756|20644829|P3|STARTED|Overall Study||2
8374777|NCT01133756|20644830|P2|STARTED|Overall Study||3
8374778|NCT01133756|20644831|P1|STARTED|Overall Study||2
8374779|NCT01133704|20644847|P2|NOT COMPLETED|Overall Study||26
8374780|NCT01133704|20644848|P1|NOT COMPLETED|Overall Study||49
8374781|NCT01133704|20644847|P2|COMPLETED|Overall Study|(including 3 year follow-up)|7
8374782|NCT01133704|20644848|P1|COMPLETED|Overall Study|(including 3 year follow-up)|16
8374783|NCT01133704|20644847|P2|STARTED|Overall Study||33
8374784|NCT01133704|20644848|P1|STARTED|Overall Study||65
8374785|NCT01133678|20644858|P2|NOT COMPLETED|Overall Study||1
8374786|NCT01133678|20644859|P1|NOT COMPLETED|Overall Study||1
8374787|NCT01133678|20644858|P2|COMPLETED|Overall Study||24
8374788|NCT01133678|20644859|P1|COMPLETED|Overall Study||24
8374789|NCT01133678|20644858|P2|STARTED|Overall Study||25
8374790|NCT01133678|20644859|P1|STARTED|Overall Study||25
8374791|NCT01133665|20644865|P1|NOT COMPLETED|Overall Study||2
8374792|NCT01133665|20644865|P1|COMPLETED|Overall Study||40
8374793|NCT01133665|20644865|P1|STARTED|Overall Study||42
8374794|NCT01133639|20644908|P2|NOT COMPLETED|Overall Study||0
8374795|NCT01133639|20644909|P1|NOT COMPLETED|Overall Study||0
8374796|NCT01133639|20644908|P2|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0
8374797|NCT01133639|20644909|P1|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
8374798|NCT01133639|20644908|P2|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
8374799|NCT01133639|20644909|P1|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
8374800|NCT01133626|20644925|P3|NOT COMPLETED|Overall Study||2
8374801|NCT01133626|20644926|P2|NOT COMPLETED|Overall Study||5
8374802|NCT01133626|20644927|P1|NOT COMPLETED|Overall Study||1
8374803|NCT01133626|20644925|P3|COMPLETED|Overall Study||9
8374804|NCT01133626|20644926|P2|COMPLETED|Overall Study||41
8374805|NCT01133626|20644927|P1|COMPLETED|Overall Study||49
8374806|NCT01133626|20644925|P3|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
8374807|NCT01133626|20644926|P2|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
8374808|NCT01133626|20644927|P1|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
8374809|NCT01133626|20644925|P3|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
8374810|NCT01133626|20644926|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
8374811|NCT01133626|20644927|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
8374812|NCT01133626|20644925|P3|STARTED|Overall Study||11
8374813|NCT01133626|20644926|P2|STARTED|Overall Study||46
8374814|NCT01133626|20644927|P1|STARTED|Overall Study||50
8374815|NCT01133522|20644945|P10|NOT COMPLETED|Overall Study||0
8374816|NCT01133522|20644946|P9|NOT COMPLETED|Overall Study||0
8374817|NCT01133522|20644947|P8|NOT COMPLETED|Overall Study||0
8374818|NCT01133522|20644948|P7|NOT COMPLETED|Overall Study||0
8374819|NCT01133522|20644949|P6|NOT COMPLETED|Overall Study||0
8374820|NCT01133522|20644950|P5|NOT COMPLETED|Overall Study||1
8374821|NCT01133522|20644951|P4|NOT COMPLETED|Overall Study||1
8374822|NCT01133522|20644952|P3|NOT COMPLETED|Overall Study||0
8374823|NCT01133522|20644953|P2|NOT COMPLETED|Overall Study||1
8374824|NCT01133522|20644954|P1|NOT COMPLETED|Overall Study||0
8374825|NCT01133522|20644945|P10|COMPLETED|Overall Study||4
8374826|NCT01133522|20644946|P9|COMPLETED|Overall Study||2
8374827|NCT01133522|20644947|P8|COMPLETED|Overall Study||9
8374828|NCT01133522|20644948|P7|COMPLETED|Overall Study||2
8374829|NCT01133522|20644949|P6|COMPLETED|Overall Study||6
8374830|NCT01133522|20644950|P5|COMPLETED|Overall Study||6
8374831|NCT01133522|20644951|P4|COMPLETED|Overall Study||6
8374832|NCT01133522|20644952|P3|COMPLETED|Overall Study||6
8374833|NCT01133522|20644953|P2|COMPLETED|Overall Study||6
8374834|NCT01133522|20644954|P1|COMPLETED|Overall Study||10
8374835|NCT01133522|20644945|P10|Received Treatment|Overall Study||4
8374836|NCT01133522|20644946|P9|Received Treatment|Overall Study||2
8374837|NCT01133522|20644947|P8|Received Treatment|Overall Study||9
8374838|NCT01133522|20644948|P7|Received Treatment|Overall Study||2
8374839|NCT01133522|20644949|P6|Received Treatment|Overall Study||6
8374840|NCT01133522|20644950|P5|Received Treatment|Overall Study||6
8374841|NCT01133522|20644951|P4|Received Treatment|Overall Study||6
8374842|NCT01133522|20644952|P3|Received Treatment|Overall Study||6
8374843|NCT01133522|20644953|P2|Received Treatment|Overall Study||6
8374844|NCT01133522|20644954|P1|Received Treatment|Overall Study||10
8374845|NCT01133522|20644945|P10|STARTED|Overall Study||4
8374846|NCT01133522|20644946|P9|STARTED|Overall Study||2
8374847|NCT01133522|20644947|P8|STARTED|Overall Study||9
8374848|NCT01133522|20644948|P7|STARTED|Overall Study||2
8374849|NCT01133522|20644949|P6|STARTED|Overall Study||6
8374850|NCT01133522|20644950|P5|STARTED|Overall Study||7
8374851|NCT01133522|20644951|P4|STARTED|Overall Study||7
8374852|NCT01133522|20644952|P3|STARTED|Overall Study||6
8374853|NCT01133522|20644953|P2|STARTED|Overall Study||7
8374854|NCT01133522|20644954|P1|STARTED|Overall Study||10
8374855|NCT01133418|20645022|P2|NOT COMPLETED|Overall Study||6
8374856|NCT01133418|20645023|P1|NOT COMPLETED|Overall Study||5
8374857|NCT01133418|20645022|P2|COMPLETED|Overall Study||32
8374858|NCT01133418|20645023|P1|COMPLETED|Overall Study||29
8374859|NCT01133418|20645022|P2|STARTED|Overall Study||38
8374860|NCT01133418|20645023|P1|STARTED|Overall Study||34
8374861|NCT01133405|20645045|P10|NOT COMPLETED|Period 3||0
8374862|NCT01133405|20645046|P9|NOT COMPLETED|Period 3||0
8374863|NCT01133405|20645047|P8|NOT COMPLETED|Period 3||0
8374864|NCT01133405|20645048|P7|NOT COMPLETED|Period 3||0
8374865|NCT01133405|20645049|P6|NOT COMPLETED|Period 3||0
8374866|NCT01133405|20645050|P5|NOT COMPLETED|Period 3||0
8374867|NCT01133405|20645051|P4|NOT COMPLETED|Period 3||0
8374868|NCT01133405|20645052|P3|NOT COMPLETED|Period 3||0
8374869|NCT01133405|20645053|P2|NOT COMPLETED|Period 3||0
8374870|NCT01133405|20645054|P1|NOT COMPLETED|Period 3||0
8374871|NCT01133405|20645045|P10|COMPLETED|Period 3||0
8374872|NCT01133405|20645046|P9|COMPLETED|Period 3||0
8374873|NCT01133405|20645047|P8|COMPLETED|Period 3||0
8374874|NCT01133405|20645048|P7|COMPLETED|Period 3||0
8374875|NCT01133405|20645049|P6|COMPLETED|Period 3||2
8374876|NCT01133405|20645050|P5|COMPLETED|Period 3||3
8374877|NCT01133405|20645051|P4|COMPLETED|Period 3||2
8374878|NCT01133405|20645052|P3|COMPLETED|Period 3||4
8374879|NCT01133405|20645053|P2|COMPLETED|Period 3||4
8374880|NCT01133405|20645054|P1|COMPLETED|Period 3||2
8374881|NCT01133405|20645045|P10|Received at Least 1 Dose of Study Drug|Period 3||0
8374882|NCT01133405|20645046|P9|Received at Least 1 Dose of Study Drug|Period 3||0
8374883|NCT01133405|20645047|P8|Received at Least 1 Dose of Study Drug|Period 3||0
8374884|NCT01133405|20645048|P7|Received at Least 1 Dose of Study Drug|Period 3||0
8374885|NCT01133405|20645049|P6|Received at Least 1 Dose of Study Drug|Period 3||2
8374886|NCT01133405|20645050|P5|Received at Least 1 Dose of Study Drug|Period 3||3
8374887|NCT01133405|20645051|P4|Received at Least 1 Dose of Study Drug|Period 3||2
8374888|NCT01133405|20645052|P3|Received at Least 1 Dose of Study Drug|Period 3||4
8374889|NCT01133405|20645053|P2|Received at Least 1 Dose of Study Drug|Period 3||4
8374890|NCT01133405|20645054|P1|Received at Least 1 Dose of Study Drug|Period 3||2
8374891|NCT01133405|20645045|P10|STARTED|Period 3||0
8374892|NCT01133405|20645046|P9|STARTED|Period 3||0
8374893|NCT01133405|20645047|P8|STARTED|Period 3||0
8374894|NCT01133405|20645048|P7|STARTED|Period 3||0
8374895|NCT01133405|20645049|P6|STARTED|Period 3||2
8374896|NCT01133405|20645050|P5|STARTED|Period 3||3
8374897|NCT01133405|20645051|P4|STARTED|Period 3||2
8374898|NCT01133405|20645052|P3|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4
8374899|NCT01133405|20645053|P2|STARTED|Period 3|One participant started and received placebo only in period 3.|4
8374900|NCT01133405|20645054|P1|STARTED|Period 3||2
8374901|NCT01133405|20645045|P10|NOT COMPLETED|Period 2||0
8374902|NCT01133405|20645046|P9|NOT COMPLETED|Period 2||0
8374903|NCT01133405|20645047|P8|NOT COMPLETED|Period 2||0
8374904|NCT01133405|20645048|P7|NOT COMPLETED|Period 2||0
8374905|NCT01133405|20645049|P6|NOT COMPLETED|Period 2||2
8374906|NCT01133405|20645050|P5|NOT COMPLETED|Period 2||0
8374907|NCT01133405|20645051|P4|NOT COMPLETED|Period 2||1
8374908|NCT01133405|20645052|P3|NOT COMPLETED|Period 2||1
8374909|NCT01133405|20645053|P2|NOT COMPLETED|Period 2||1
8374910|NCT01133405|20645054|P1|NOT COMPLETED|Period 2||0
8374911|NCT01133405|20645045|P10|COMPLETED|Period 2||0
8374912|NCT01133405|20645046|P9|COMPLETED|Period 2||0
8374913|NCT01133405|20645047|P8|COMPLETED|Period 2||0
8374914|NCT01133405|20645048|P7|COMPLETED|Period 2||0
8374915|NCT01133405|20645049|P6|COMPLETED|Period 2||2
8374916|NCT01133405|20645050|P5|COMPLETED|Period 2||3
8374917|NCT01133405|20645051|P4|COMPLETED|Period 2||2
8374918|NCT01133405|20645052|P3|COMPLETED|Period 2||3
8374919|NCT01133405|20645053|P2|COMPLETED|Period 2||3
8374920|NCT01133405|20645054|P1|COMPLETED|Period 2||2
8374921|NCT01133405|20645045|P10|Received at Least 1 Dose of Study Drug|Period 2||0
8374922|NCT01133405|20645046|P9|Received at Least 1 Dose of Study Drug|Period 2||0
8374923|NCT01133405|20645047|P8|Received at Least 1 Dose of Study Drug|Period 2||0
8374924|NCT01133405|20645048|P7|Received at Least 1 Dose of Study Drug|Period 2||0
8374925|NCT01133405|20645049|P6|Received at Least 1 Dose of Study Drug|Period 2||4
8374926|NCT01133405|20645050|P5|Received at Least 1 Dose of Study Drug|Period 2||3
8374927|NCT01133405|20645051|P4|Received at Least 1 Dose of Study Drug|Period 2||3
8374928|NCT01133405|20645052|P3|Received at Least 1 Dose of Study Drug|Period 2||4
8374929|NCT01133405|20645053|P2|Received at Least 1 Dose of Study Drug|Period 2||4
8374930|NCT01133405|20645054|P1|Received at Least 1 Dose of Study Drug|Period 2||2
8374931|NCT01133405|20645045|P10|STARTED|Period 2|Cohort D was planned only for single period.|0
8374932|NCT01133405|20645046|P9|STARTED|Period 2|Cohort D was planned only for single period.|0
8374933|NCT01133405|20645047|P8|STARTED|Period 2|Cohort C was planned only for single period.|0
8374934|NCT01133405|20645048|P7|STARTED|Period 2|Cohort C was planned only for single period.|0
8374935|NCT01133405|20645049|P6|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4
8374936|NCT01133405|20645050|P5|STARTED|Period 2||3
8374937|NCT01133405|20645051|P4|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3
8374938|NCT01133405|20645052|P3|STARTED|Period 2||4
8374939|NCT01133405|20645053|P2|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4
8374940|NCT01133405|20645054|P1|STARTED|Period 2||2
8374941|NCT01133405|20645045|P10|NOT COMPLETED|Period 1||0
8374942|NCT01133405|20645046|P9|NOT COMPLETED|Period 1||0
8374943|NCT01133405|20645047|P8|NOT COMPLETED|Period 1||0
8374944|NCT01133405|20645048|P7|NOT COMPLETED|Period 1||1
8374945|NCT01133405|20645049|P6|NOT COMPLETED|Period 1||2
8374946|NCT01133405|20645050|P5|NOT COMPLETED|Period 1||0
8374947|NCT01133405|20645051|P4|NOT COMPLETED|Period 1||4
8374948|NCT01133405|20645052|P3|NOT COMPLETED|Period 1||1
8374949|NCT01133405|20645053|P2|NOT COMPLETED|Period 1||3
8374950|NCT01133405|20645054|P1|NOT COMPLETED|Period 1||1
8374951|NCT01133405|20645045|P10|COMPLETED|Period 1||2
8374952|NCT01133405|20645046|P9|COMPLETED|Period 1||4
8374953|NCT01133405|20645047|P8|COMPLETED|Period 1||2
8374954|NCT01133405|20645048|P7|COMPLETED|Period 1||4
8374955|NCT01133405|20645049|P6|COMPLETED|Period 1||3
8374956|NCT01133405|20645050|P5|COMPLETED|Period 1||3
8374957|NCT01133405|20645051|P4|COMPLETED|Period 1||1
8374958|NCT01133405|20645052|P3|COMPLETED|Period 1||4
8374959|NCT01133405|20645053|P2|COMPLETED|Period 1||3
8374960|NCT01133405|20645054|P1|COMPLETED|Period 1||2
8374961|NCT01133405|20645045|P10|Received at Least 1 Dose of Drug|Period 1||2
8374962|NCT01133405|20645046|P9|Received at Least 1 Dose of Drug|Period 1||4
8374963|NCT01133405|20645047|P8|Received at Least 1 Dose of Drug|Period 1||2
8374964|NCT01133405|20645048|P7|Received at Least 1 Dose of Drug|Period 1||4
8374965|NCT01133405|20645049|P6|Received at Least 1 Dose of Drug|Period 1||4
8374966|NCT01133405|20645050|P5|Received at Least 1 Dose of Drug|Period 1||3
8374967|NCT01133405|20645051|P4|Received at Least 1 Dose of Drug|Period 1||3
8374968|NCT01133405|20645052|P3|Received at Least 1 Dose of Drug|Period 1||4
8374969|NCT01133405|20645053|P2|Received at Least 1 Dose of Drug|Period 1||4
8374970|NCT01133405|20645054|P1|Received at Least 1 Dose of Drug|Period 1||2
8374971|NCT01133405|20645045|P10|Safety Analysis Population|Period 1||2
8374972|NCT01133405|20645046|P9|Safety Analysis Population|Period 1||4
8374973|NCT01133405|20645047|P8|Safety Analysis Population|Period 1||2
8374974|NCT01133405|20645048|P7|Safety Analysis Population|Period 1||5
8374975|NCT01133405|20645049|P6|Safety Analysis Population|Period 1||5
8374976|NCT01133405|20645050|P5|Safety Analysis Population|Period 1||3
8374977|NCT01133405|20645051|P4|Safety Analysis Population|Period 1||5
8374978|NCT01133405|20645052|P3|Safety Analysis Population|Period 1||5
8374979|NCT01133405|20645053|P2|Safety Analysis Population|Period 1||6
8374980|NCT01133405|20645054|P1|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2
8374981|NCT01133405|20645045|P10|STARTED|Period 1||2
8374982|NCT01133405|20645046|P9|STARTED|Period 1||4
8374983|NCT01133405|20645047|P8|STARTED|Period 1||2
8374984|NCT01133405|20645048|P7|STARTED|Period 1||5
8374985|NCT01133405|20645049|P6|STARTED|Period 1||5
8374986|NCT01133405|20645050|P5|STARTED|Period 1||3
8374987|NCT01133405|20645051|P4|STARTED|Period 1||5
8374988|NCT01133405|20645052|P3|STARTED|Period 1||5
8374989|NCT01133405|20645053|P2|STARTED|Period 1||6
8374990|NCT01133405|20645054|P1|STARTED|Period 1||3
8374991|NCT01133392|20645105|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
8374992|NCT01133392|20645106|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
8374993|NCT01133392|20645105|P2|COMPLETED|Fourth Intervention (1 Day)||16
8374994|NCT01133392|20645106|P1|COMPLETED|Fourth Intervention (1 Day)||20
8374995|NCT01133392|20645105|P2|STARTED|Fourth Intervention (1 Day)||16
8374996|NCT01133392|20645106|P1|STARTED|Fourth Intervention (1 Day)||20
8374997|NCT01133392|20645105|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
8374998|NCT01133392|20645106|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
8374999|NCT01133392|20645105|P2|COMPLETED|Interval Between Dosing (4-7 Days)||16
8375000|NCT01133392|20645106|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
8375001|NCT01133392|20645105|P2|STARTED|Interval Between Dosing (4-7 Days)||17
8375002|NCT01133392|20645106|P1|STARTED|Interval Between Dosing (4-7 Days)||20
8375003|NCT01133392|20645105|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8375004|NCT01133392|20645106|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8375005|NCT01133392|20645105|P2|COMPLETED|Third Intervention (1 Day)||17
8375006|NCT01133392|20645106|P1|COMPLETED|Third Intervention (1 Day)||20
8375007|NCT01133392|20645105|P2|STARTED|Third Intervention (1 Day)||17
8375008|NCT01133392|20645106|P1|STARTED|Third Intervention (1 Day)||20
8375009|NCT01133392|20645105|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
8375010|NCT01133392|20645106|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
8375011|NCT01133392|20645105|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
8375012|NCT01133392|20645106|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
8375013|NCT01133392|20645105|P2|STARTED|Interval Between Dosing (4-7 Days)||17
8375014|NCT01133392|20645106|P1|STARTED|Interval Between Dosing (4-7 Days)||20
8375015|NCT01133392|20645105|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8375016|NCT01133392|20645106|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8375017|NCT01133392|20645105|P2|COMPLETED|Second Intervention (1 Day)||17
8375018|NCT01133392|20645106|P1|COMPLETED|Second Intervention (1 Day)||20
8375019|NCT01133392|20645105|P2|STARTED|Second Intervention (1 Day)||17
8375020|NCT01133392|20645106|P1|STARTED|Second Intervention (1 Day)||20
8375021|NCT01133392|20645105|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
8375022|NCT01133392|20645106|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
8375023|NCT01133392|20645105|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
8375024|NCT01133392|20645106|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
8375025|NCT01133392|20645105|P2|STARTED|Interval Between Dosing (4-7 Days)||18
8375026|NCT01133392|20645106|P1|STARTED|Interval Between Dosing (4-7 Days)||20
8375027|NCT01133392|20645105|P2|NOT COMPLETED|First Intervention (1 Day )||0
8375028|NCT01133392|20645106|P1|NOT COMPLETED|First Intervention (1 Day )||0
8375029|NCT01133392|20645105|P2|COMPLETED|First Intervention (1 Day )||18
8375030|NCT01133392|20645106|P1|COMPLETED|First Intervention (1 Day )||20
8375031|NCT01133392|20645105|P2|STARTED|First Intervention (1 Day )||18
8375032|NCT01133392|20645106|P1|STARTED|First Intervention (1 Day )||20
8375033|NCT01133379|20645123|P3|NOT COMPLETED|Overall Study||2
8375034|NCT01133379|20645124|P2|NOT COMPLETED|Overall Study||2
8375035|NCT01133379|20645125|P1|NOT COMPLETED|Overall Study||1
8375036|NCT01133379|20645123|P3|COMPLETED|Overall Study||56
8375037|NCT01133379|20645124|P2|COMPLETED|Overall Study||56
8375038|NCT01133379|20645125|P1|COMPLETED|Overall Study||57
8375039|NCT01133379|20645123|P3|STARTED|Overall Study||58
8375040|NCT01133379|20645124|P2|STARTED|Overall Study||58
8375041|NCT01133379|20645125|P1|STARTED|Overall Study||58
8375042|NCT01133288|20645178|P1|NOT COMPLETED|Intervention Allocation||2
8375043|NCT01133288|20645178|P1|COMPLETED|Intervention Allocation||0
8375044|NCT01133288|20645178|P1|STARTED|Intervention Allocation||2
8375045|NCT01133288|20645178|P1|NOT COMPLETED|Eligibility Assessment||5
8375046|NCT01133288|20645178|P1|COMPLETED|Eligibility Assessment||2
8375047|NCT01133288|20645178|P1|STARTED|Eligibility Assessment||7
8375048|NCT01133275|20645183|P1|NOT COMPLETED|Overall Study||2
8375049|NCT01133275|20645183|P1|COMPLETED|Overall Study||26
8375050|NCT01133275|20645183|P1|STARTED|Overall Study||28
8375051|NCT01133171|20645191|P3|NOT COMPLETED|Overall Study||0
8375052|NCT01133171|20645192|P2|NOT COMPLETED|Overall Study||2
8375053|NCT01133171|20645193|P1|NOT COMPLETED|Overall Study||1
8375054|NCT01133171|20645191|P3|COMPLETED|Overall Study||25
8375055|NCT01133171|20645192|P2|COMPLETED|Overall Study||25
8375056|NCT01133171|20645193|P1|COMPLETED|Overall Study||24
8375057|NCT01133171|20645191|P3|STARTED|Overall Study||25
8375058|NCT01133171|20645192|P2|STARTED|Overall Study||27
8375059|NCT01133171|20645193|P1|STARTED|Overall Study||25
8375060|NCT01133158|20645203|P1|NOT COMPLETED|Overall Study||17
8375061|NCT01133158|20645203|P1|COMPLETED|Overall Study||43
8375062|NCT01133158|20645203|P1|STARTED|Overall Study||60
8375063|NCT01133067|20645209|P1|NOT COMPLETED|Overall Study||139
8375064|NCT01133067|20645209|P1|COMPLETED|Overall Study||61
8375065|NCT01133067|20645209|P1|STARTED|Overall Study||200
8375066|NCT01132846|20645217|P3|NOT COMPLETED|Overall Study||11
8375067|NCT01132846|20645218|P2|NOT COMPLETED|Overall Study||18
8375068|NCT01132846|20645219|P1|NOT COMPLETED|Overall Study||16
8375069|NCT01132846|20645217|P3|COMPLETED|Overall Study||108
8375070|NCT01132846|20645218|P2|COMPLETED|Overall Study||101
8375071|NCT01132846|20645219|P1|COMPLETED|Overall Study||106
8375072|NCT01132846|20645217|P3|STARTED|Overall Study||119
8375073|NCT01132846|20645218|P2|STARTED|Overall Study||119
8375074|NCT01132846|20645219|P1|STARTED|Overall Study||122
8375075|NCT01132820|20645269|P1|NOT COMPLETED|Overall Study||5
8375076|NCT01132820|20645269|P1|COMPLETED|Overall Study||48
8375077|NCT01132820|20645269|P1|STARTED|Overall Study||53
8375078|NCT01132755|20645278|P1|NOT COMPLETED|Overall Study||42
8375079|NCT01132755|20645278|P1|COMPLETED|Overall Study||70
8375080|NCT01132755|20645278|P1|STARTED|Overall Study||112
8375081|NCT01132690|20645285|P2|NOT COMPLETED|Overall Study||0
8375082|NCT01132690|20645286|P1|NOT COMPLETED|Overall Study||0
8375083|NCT01132690|20645285|P2|COMPLETED|Overall Study||5
8375084|NCT01132690|20645286|P1|COMPLETED|Overall Study||6
8375085|NCT01132690|20645285|P2|STARTED|Overall Study||5
8375086|NCT01132690|20645286|P1|STARTED|Overall Study||6
8375087|NCT01132664|20645307|P5|NOT COMPLETED|BM Cohort||6
8375088|NCT01132664|20645308|P4|NOT COMPLETED|BM Cohort||3
8375089|NCT01132664|20645309|P3|NOT COMPLETED|BM Cohort||0
8375090|NCT01132664|20645310|P2|NOT COMPLETED|BM Cohort||0
8375091|NCT01132664|20645311|P1|NOT COMPLETED|BM Cohort||0
8375092|NCT01132664|20645307|P5|COMPLETED|BM Cohort||0
8375093|NCT01132664|20645308|P4|COMPLETED|BM Cohort||0
8375094|NCT01132664|20645309|P3|COMPLETED|BM Cohort||0
8375095|NCT01132664|20645310|P2|COMPLETED|BM Cohort||0
8375096|NCT01132664|20645311|P1|COMPLETED|BM Cohort||0
8375097|NCT01132664|20645307|P5|STARTED|BM Cohort||6
8375098|NCT01132664|20645308|P4|STARTED|BM Cohort||3
8375099|NCT01132664|20645309|P3|STARTED|BM Cohort||0
8375100|NCT01132664|20645310|P2|STARTED|BM Cohort||0
8375101|NCT01132664|20645311|P1|STARTED|BM Cohort||0
8375102|NCT01132664|20645307|P5|NOT COMPLETED|Phase ll||0
8375103|NCT01132664|20645308|P4|NOT COMPLETED|Phase ll||0
8375104|NCT01132664|20645309|P3|NOT COMPLETED|Phase ll||50
8375105|NCT01132664|20645310|P2|NOT COMPLETED|Phase ll||0
8375106|NCT01132664|20645311|P1|NOT COMPLETED|Phase ll||0
8375107|NCT01132664|20645307|P5|COMPLETED|Phase ll||0
8375108|NCT01132664|20645308|P4|COMPLETED|Phase ll||0
8375109|NCT01132664|20645309|P3|COMPLETED|Phase ll||0
8375110|NCT01132664|20645310|P2|COMPLETED|Phase ll||0
8375111|NCT01132664|20645311|P1|COMPLETED|Phase ll||0
8375112|NCT01132664|20645307|P5|STARTED|Phase ll||0
8375113|NCT01132664|20645308|P4|STARTED|Phase ll||0
8375114|NCT01132664|20645309|P3|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
8375115|NCT01132664|20645310|P2|STARTED|Phase ll||0
8375116|NCT01132664|20645311|P1|STARTED|Phase ll||0
8375117|NCT01132664|20645307|P5|NOT COMPLETED|Phase lb||0
8375118|NCT01132664|20645308|P4|NOT COMPLETED|Phase lb||0
8375119|NCT01132664|20645309|P3|NOT COMPLETED|Phase lb||0
8375120|NCT01132664|20645310|P2|NOT COMPLETED|Phase lb||12
8375121|NCT01132664|20645311|P1|NOT COMPLETED|Phase lb||5
8375122|NCT01132664|20645307|P5|COMPLETED|Phase lb||0
8375123|NCT01132664|20645308|P4|COMPLETED|Phase lb||0
8375124|NCT01132664|20645309|P3|COMPLETED|Phase lb||0
8375125|NCT01132664|20645310|P2|COMPLETED|Phase lb||0
8375126|NCT01132664|20645311|P1|COMPLETED|Phase lb||0
8375127|NCT01132664|20645307|P5|STARTED|Phase lb||0
8375128|NCT01132664|20645308|P4|STARTED|Phase lb||0
8375129|NCT01132664|20645309|P3|STARTED|Phase lb||0
8375130|NCT01132664|20645310|P2|STARTED|Phase lb||12
8375131|NCT01132664|20645311|P1|STARTED|Phase lb||5
8375132|NCT01132651|20645345|P2|NOT COMPLETED|Overall Study||1
8375133|NCT01132651|20645346|P1|NOT COMPLETED|Overall Study||1
8375134|NCT01132651|20645345|P2|COMPLETED|Overall Study||4
8375135|NCT01132651|20645346|P1|COMPLETED|Overall Study||3
8375136|NCT01132651|20645345|P2|STARTED|Overall Study||5
8375137|NCT01132651|20645346|P1|STARTED|Overall Study||4
8375138|NCT01132612|20645357|P3|NOT COMPLETED|Overall Study||170
8375139|NCT01132612|20645358|P2|NOT COMPLETED|Overall Study||35
8375140|NCT01132612|20645359|P1|NOT COMPLETED|Overall Study||40
8375141|NCT01132612|20645357|P3|COMPLETED|Overall Study||17
8375142|NCT01132612|20645358|P2|COMPLETED|Overall Study||7
8375143|NCT01132612|20645359|P1|COMPLETED|Overall Study||6
8375144|NCT01132612|20645357|P3|STARTED|Overall Study||187
8375145|NCT01132612|20645358|P2|STARTED|Overall Study||42
8375146|NCT01132612|20645359|P1|STARTED|Overall Study||46
8375147|NCT01132547|20645375|P2|NOT COMPLETED|Overall Study||1
8375148|NCT01132547|20645376|P1|NOT COMPLETED|Overall Study||4
8375149|NCT01132547|20645375|P2|COMPLETED|Overall Study||12
8375150|NCT01132547|20645376|P1|COMPLETED|Overall Study||5
8375151|NCT01132547|20645375|P2|STARTED|Overall Study||13
8375152|NCT01132547|20645376|P1|STARTED|Overall Study||9
8375153|NCT01132508|20645386|P1|NOT COMPLETED|Overall Study||9
8375154|NCT01132508|20645386|P1|COMPLETED|Overall Study||24
8375155|NCT01132508|20645386|P1|104 Weeks|Overall Study||27
8375156|NCT01132508|20645386|P1|78 Weeks|Overall Study||28
8375157|NCT01132508|20645386|P1|52 Weeks|Overall Study||30
8375158|NCT01132508|20645386|P1|26 Weeks|Overall Study||33
8375159|NCT01132508|20645386|P1|12 Weeks|Overall Study||33
8375160|NCT01132508|20645386|P1|6 Weeks|Overall Study||33
8375161|NCT01132508|20645386|P1|Treated at Baseline|Overall Study||33
8375162|NCT01132508|20645386|P1|STARTED|Overall Study||33
8375163|NCT01132495|20645446|P4|NOT COMPLETED|Overall Study||12
8375164|NCT01132495|20645447|P3|NOT COMPLETED|Overall Study||20
8375165|NCT01132495|20645448|P2|NOT COMPLETED|Overall Study||38
8375166|NCT01132495|20645449|P1|NOT COMPLETED|Overall Study||40
8375167|NCT01132495|20645446|P4|COMPLETED|Overall Study||104
8375168|NCT01132495|20645447|P3|COMPLETED|Overall Study||146
8375169|NCT01132495|20645448|P2|COMPLETED|Overall Study||403
8375170|NCT01132495|20645449|P1|COMPLETED|Overall Study||407
8375171|NCT01132495|20645446|P4|STARTED|Overall Study||116
8375172|NCT01132495|20645447|P3|STARTED|Overall Study||166
8375173|NCT01132495|20645448|P2|STARTED|Overall Study||441
8375174|NCT01132495|20645449|P1|STARTED|Overall Study||447
8375175|NCT01132482|20645462|P2|NOT COMPLETED|Overall Study||0
8375176|NCT01132482|20645463|P1|NOT COMPLETED|Overall Study||1
8375177|NCT01132482|20645462|P2|COMPLETED|Overall Study||6
8375178|NCT01132482|20645463|P1|COMPLETED|Overall Study||12
8375179|NCT01132482|20645462|P2|STARTED|Overall Study||6
8375180|NCT01132482|20645463|P1|STARTED|Overall Study||13
8375181|NCT01132378|20645481|P1|NOT COMPLETED|Overall Study||0
8375182|NCT01132378|20645481|P1|COMPLETED|Overall Study||40
8375183|NCT01132378|20645481|P1|STARTED|Overall Study||40
8375184|NCT01132326|20645486|P1|NOT COMPLETED|Overall Study||218
8375185|NCT01132326|20645486|P1|COMPLETED|Overall Study||132
8375186|NCT01132326|20645486|P1|STARTED|Overall Study||350
8375187|NCT01132313|20645502|P12|NOT COMPLETED|Overall Study||0
8375188|NCT01132313|20645503|P11|NOT COMPLETED|Overall Study||1
8375189|NCT01132313|20645504|P10|NOT COMPLETED|Overall Study||20
8375190|NCT01132313|20645505|P9|NOT COMPLETED|Overall Study||21
8375191|NCT01132313|20645506|P8|NOT COMPLETED|Overall Study||8
8375192|NCT01132313|20645507|P7|NOT COMPLETED|Overall Study||30
8375193|NCT01132313|20645508|P6|NOT COMPLETED|Overall Study||25
8375194|NCT01132313|20645509|P5|NOT COMPLETED|Overall Study||45
8375195|NCT01132313|20645510|P4|NOT COMPLETED|Overall Study||32
8375196|NCT01132313|20645511|P3|NOT COMPLETED|Overall Study||20
8375197|NCT01132313|20645512|P2|NOT COMPLETED|Overall Study||0
8375198|NCT01132313|20645513|P1|NOT COMPLETED|Overall Study||3
8375199|NCT01132313|20645502|P12|COMPLETED|Overall Study||2
8375200|NCT01132313|20645503|P11|COMPLETED|Overall Study||0
8375201|NCT01132313|20645504|P10|COMPLETED|Overall Study||5
8375202|NCT01132313|20645505|P9|COMPLETED|Overall Study||5
8375203|NCT01132313|20645506|P8|COMPLETED|Overall Study||24
8375204|NCT01132313|20645507|P7|COMPLETED|Overall Study||19
8375205|NCT01132313|20645508|P6|COMPLETED|Overall Study||54
8375206|NCT01132313|20645509|P5|COMPLETED|Overall Study||34
8375207|NCT01132313|20645510|P4|COMPLETED|Overall Study||48
8375208|NCT01132313|20645511|P3|COMPLETED|Overall Study||61
8375209|NCT01132313|20645512|P2|COMPLETED|Overall Study||17
8375210|NCT01132313|20645513|P1|COMPLETED|Overall Study||14
8375211|NCT01132313|20645502|P12|STARTED|Overall Study||2
8375212|NCT01132313|20645503|P11|STARTED|Overall Study||1
8375213|NCT01132313|20645504|P10|STARTED|Overall Study||25
8375214|NCT01132313|20645505|P9|STARTED|Overall Study||26
8375215|NCT01132313|20645506|P8|STARTED|Overall Study||32
8375216|NCT01132313|20645507|P7|STARTED|Overall Study||49
8375217|NCT01132313|20645508|P6|STARTED|Overall Study||79
8375218|NCT01132313|20645509|P5|STARTED|Overall Study||79
8375219|NCT01132313|20645510|P4|STARTED|Overall Study||80
8375220|NCT01132313|20645511|P3|STARTED|Overall Study||81
8375221|NCT01132313|20645512|P2|STARTED|Overall Study||17
8375222|NCT01132313|20645513|P1|STARTED|Overall Study||17
8375223|NCT01132144|20645570|P2|NOT COMPLETED|Overall Study||0
8375224|NCT01132144|20645571|P1|NOT COMPLETED|Overall Study||0
8375225|NCT01132144|20645570|P2|COMPLETED|Overall Study||79
8375226|NCT01132144|20645571|P1|COMPLETED|Overall Study||79
8375227|NCT01132144|20645570|P2|STARTED|Overall Study||79
8375228|NCT01132144|20645571|P1|STARTED|Overall Study||79
8375229|NCT01132118|20645593|P2|NOT COMPLETED|Second Intervention (8 Weeks)||1
8375230|NCT01132118|20645594|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
8375231|NCT01132118|20645593|P2|COMPLETED|Second Intervention (8 Weeks)||11
8375232|NCT01132118|20645594|P1|COMPLETED|Second Intervention (8 Weeks)||12
8375233|NCT01132118|20645593|P2|STARTED|Second Intervention (8 Weeks)||12
8375234|NCT01132118|20645594|P1|STARTED|Second Intervention (8 Weeks)||12
8375235|NCT01132118|20645593|P2|NOT COMPLETED|First Intervention (8 Weeks)||3
8375236|NCT01132118|20645594|P1|NOT COMPLETED|First Intervention (8 Weeks)||3
8375237|NCT01132118|20645593|P2|COMPLETED|First Intervention (8 Weeks)||12
8375238|NCT01132118|20645594|P1|COMPLETED|First Intervention (8 Weeks)||12
8375239|NCT01132118|20645593|P2|STARTED|First Intervention (8 Weeks)||15
8375240|NCT01132118|20645594|P1|STARTED|First Intervention (8 Weeks)||15
8375241|NCT01131884|20645614|P2|NOT COMPLETED|Overall Study||0
8375242|NCT01131884|20645615|P1|NOT COMPLETED|Overall Study||0
8375243|NCT01131884|20645614|P2|COMPLETED|Overall Study||0
8375244|NCT01131884|20645615|P1|COMPLETED|Overall Study||1
8375245|NCT01131884|20645614|P2|STARTED|Overall Study||0
8375246|NCT01131884|20645615|P1|STARTED|Overall Study||1
8375247|NCT01131676|20645624|P3|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
8375248|NCT01131676|20645625|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
8375249|NCT01131676|20645626|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
8375250|NCT01131676|20645624|P3|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
8375251|NCT01131676|20645625|P2|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
8375252|NCT01131676|20645626|P1|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
8375253|NCT01131676|20645624|P3|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
8375254|NCT01131676|20645625|P2|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
8375255|NCT01131676|20645626|P1|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
8375256|NCT01131676|20645624|P3|STARTED|Discontinuation From Study (Treated Set)||2342
8375257|NCT01131676|20645625|P2|STARTED|Discontinuation From Study (Treated Set)||2345
8375258|NCT01131676|20645626|P1|STARTED|Discontinuation From Study (Treated Set)||2333
8375259|NCT01131676|20645624|P3|NOT COMPLETED|Discontinuation From Treatment||544
8375260|NCT01131676|20645625|P2|NOT COMPLETED|Discontinuation From Treatment||557
8375261|NCT01131676|20645626|P1|NOT COMPLETED|Discontinuation From Treatment||687
8375262|NCT01131676|20645624|P3|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
8375263|NCT01131676|20645625|P2|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
8375264|NCT01131676|20645626|P1|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
8375265|NCT01131676|20645624|P3|STARTED|Discontinuation From Treatment|Randomised|2344
8375266|NCT01131676|20645625|P2|STARTED|Discontinuation From Treatment|Randomised|2347
8375267|NCT01131676|20645626|P1|STARTED|Discontinuation From Treatment|Randomised|2337
8375268|NCT01131585|20645661|P2|NOT COMPLETED|Overall Study||43
8375269|NCT01131585|20645662|P1|NOT COMPLETED|Overall Study||85
8375270|NCT01131585|20645661|P2|COMPLETED|Overall Study||0
8375271|NCT01131585|20645662|P1|COMPLETED|Overall Study||0
8375272|NCT01131585|20645661|P2|STARTED|Overall Study||43
8375273|NCT01131585|20645662|P1|STARTED|Overall Study||85
8375274|NCT01131520|20645670|P2|NOT COMPLETED|Overall Study||4
8375275|NCT01131520|20645671|P1|NOT COMPLETED|Overall Study||1
8375276|NCT01131520|20645670|P2|COMPLETED|Overall Study||176
8375277|NCT01131520|20645671|P1|COMPLETED|Overall Study||179
8375278|NCT01131520|20645670|P2|STARTED|Overall Study||180
8375279|NCT01131520|20645671|P1|STARTED|Overall Study||180
8375280|NCT01131507|20645693|P1|NOT COMPLETED|Overall Study||3
8375281|NCT01131507|20645693|P1|COMPLETED|Overall Study||12
8375282|NCT01131507|20645693|P1|STARTED|Overall Study||15
8375283|NCT01131494|20645698|P1|NOT COMPLETED|Overall Study||2
8375284|NCT01131494|20645698|P1|COMPLETED|Overall Study||15
8375285|NCT01131494|20645698|P1|STARTED|Overall Study||17
8375286|NCT01131455|20645708|P3|NOT COMPLETED|Overall Study||0
8375287|NCT01131455|20645709|P2|NOT COMPLETED|Overall Study||4
8375288|NCT01131455|20645710|P1|NOT COMPLETED|Overall Study||6
8375289|NCT01131455|20645708|P3|COMPLETED|Overall Study||0
8375290|NCT01131455|20645709|P2|COMPLETED|Overall Study||0
8375291|NCT01131455|20645710|P1|COMPLETED|Overall Study||0
8375292|NCT01131455|20645708|P3|STARTED|Overall Study||0
8375293|NCT01131455|20645709|P2|STARTED|Overall Study||4
8375294|NCT01131455|20645710|P1|STARTED|Overall Study||6
8375295|NCT01131312|20645721|P3|NOT COMPLETED|Overall Study||351
8375296|NCT01131312|20645722|P2|NOT COMPLETED|Overall Study||229
8375297|NCT01131312|20645723|P1|NOT COMPLETED|Overall Study||425
8375298|NCT01131312|20645721|P3|COMPLETED|Overall Study||1485
8375299|NCT01131312|20645722|P2|COMPLETED|Overall Study||1156
8375300|NCT01131312|20645723|P1|COMPLETED|Overall Study||1414
8375301|NCT01131312|20645721|P3|STARTED|Overall Study||1836
8375302|NCT01131312|20645722|P2|STARTED|Overall Study||1385
8375303|NCT01131312|20645723|P1|STARTED|Overall Study||1839
8375304|NCT01131299|20645734|P2|NOT COMPLETED|Overall Study||7
8375305|NCT01131299|20645735|P1|NOT COMPLETED|Overall Study||4
8375306|NCT01131299|20645734|P2|COMPLETED|Overall Study||37
8375307|NCT01131299|20645735|P1|COMPLETED|Overall Study||38
8375308|NCT01131299|20645734|P2|STARTED|Overall Study||44
8375309|NCT01131299|20645735|P1|STARTED|Overall Study||42
8375310|NCT01131260|20645748|P2|NOT COMPLETED|Overall Study||47
8375311|NCT01131260|20645749|P1|NOT COMPLETED|Overall Study||44
8375312|NCT01131260|20645748|P2|COMPLETED|Overall Study||5529
8375313|NCT01131260|20645749|P1|COMPLETED|Overall Study||5488
8375314|NCT01131260|20645748|P2|STARTED|Overall Study||5576
8375315|NCT01131260|20645749|P1|STARTED|Overall Study||5532
8375316|NCT01131182|20645797|P2|NOT COMPLETED|Overall Study||16
8375317|NCT01131182|20645798|P1|NOT COMPLETED|Overall Study||16
8375318|NCT01131182|20645797|P2|COMPLETED|Overall Study||521
8375319|NCT01131182|20645798|P1|COMPLETED|Overall Study||513
8375320|NCT01131182|20645797|P2|STARTED|Overall Study||537
8375321|NCT01131182|20645798|P1|STARTED|Overall Study||529
8375322|NCT01131130|20645806|P1|NOT COMPLETED|Period 3- Crossover||1
8375323|NCT01131130|20645806|P1|COMPLETED|Period 3- Crossover||116
8375324|NCT01131130|20645806|P1|STARTED|Period 3- Crossover||117
8375325|NCT01131130|20645806|P1|NOT COMPLETED|Period 2 - Crossover||0
8375326|NCT01131130|20645806|P1|COMPLETED|Period 2 - Crossover||117
8375327|NCT01131130|20645806|P1|STARTED|Period 2 - Crossover||117
8375328|NCT01131130|20645806|P1|NOT COMPLETED|Period 1 - Baseline||1
8375329|NCT01131130|20645806|P1|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
8375330|NCT01131130|20645806|P1|STARTED|Period 1 - Baseline||118
8375331|NCT01131104|20645819|P1|NOT COMPLETED|Overall Study||13
8375332|NCT01131104|20645819|P1|COMPLETED|Overall Study||332
8375333|NCT01131104|20645819|P1|12-Month Analysis Set|Overall Study||26
8375334|NCT01131104|20645819|P1|42-Day Analysis Set|Overall Study||28
8375335|NCT01131104|20645819|P1|30-Day Analysis Set|Overall Study||24
8375336|NCT01131104|20645819|P1|Adjudication-Confirmed NAION Set|Overall Study||279
8375337|NCT01131104|20645819|P1|Study Set|Overall Study||344
8375338|NCT01131104|20645819|P1|STARTED|Overall Study||345
8375339|NCT01131078|20645826|P3|NOT COMPLETED|Overall Study||102
8375340|NCT01131078|20645827|P2|NOT COMPLETED|Overall Study||101
8375341|NCT01131078|20645828|P1|NOT COMPLETED|Overall Study||101
8375342|NCT01131078|20645826|P3|COMPLETED|Overall Study||1
8375343|NCT01131078|20645827|P2|COMPLETED|Overall Study||1
8375344|NCT01131078|20645828|P1|COMPLETED|Overall Study||0
8375345|NCT01131078|20645826|P3|STARTED|Overall Study||103
8375346|NCT01131078|20645827|P2|STARTED|Overall Study||102
8375347|NCT01131078|20645828|P1|STARTED|Overall Study||101
8375348|NCT01131065|20645884|P1|NOT COMPLETED|Overall Study||0
8375349|NCT01131065|20645884|P1|COMPLETED|Overall Study||15
8375350|NCT01131065|20645884|P1|STARTED|Overall Study||15
8375351|NCT01131052|20645892|P2|NOT COMPLETED|Overall Study||0
8375352|NCT01131052|20645893|P1|NOT COMPLETED|Overall Study||0
8375353|NCT01131052|20645892|P2|COMPLETED|Overall Study||75
8375354|NCT01131052|20645893|P1|COMPLETED|Overall Study||75
8375355|NCT01131052|20645892|P2|STARTED|Overall Study||75
8375356|NCT01131052|20645893|P1|STARTED|Overall Study||75
8375357|NCT01130974|20645915|P2|NOT COMPLETED|Overall Study||13
8375358|NCT01130974|20645916|P1|NOT COMPLETED|Overall Study||15
8375359|NCT01130974|20645915|P2|COMPLETED|Overall Study||87
8375360|NCT01130974|20645916|P1|COMPLETED|Overall Study||85
8375361|NCT01130974|20645915|P2|STARTED|Overall Study||100
8375362|NCT01130974|20645916|P1|STARTED|Overall Study||100
8375366|NCT01130883|20645942|P1|NOT COMPLETED|Overall Study||10
8375367|NCT01130883|20645942|P1|COMPLETED|Overall Study||3120
8375368|NCT01130883|20645942|P1|Participants Analyzed|Overall Study||3128
8375369|NCT01130883|20645942|P1|STARTED|Overall Study||3130
8375382|NCT01130740|20646027|P2|NOT COMPLETED|Overall Study||15
8375383|NCT01130740|20646028|P1|NOT COMPLETED|Overall Study||12
8375384|NCT01130740|20646027|P2|COMPLETED|Overall Study||136
8375385|NCT01130740|20646028|P1|COMPLETED|Overall Study||137
8375386|NCT01130740|20646027|P2|STARTED|Overall Study||151
8375387|NCT01130740|20646028|P1|STARTED|Overall Study||149
8375391|NCT01130532|20646063|P4|NOT COMPLETED|Period IV (Weeks 13-16)||10
8375392|NCT01130532|20646064|P3|NOT COMPLETED|Period IV (Weeks 13-16)||0
8375393|NCT01130532|20646065|P2|NOT COMPLETED|Period IV (Weeks 13-16)||0
8375394|NCT01130532|20646066|P1|NOT COMPLETED|Period IV (Weeks 13-16)||0
8375395|NCT01130532|20646063|P4|COMPLETED|Period IV (Weeks 13-16)||552
8375396|NCT01130532|20646064|P3|COMPLETED|Period IV (Weeks 13-16)||0
8375397|NCT01130532|20646065|P2|COMPLETED|Period IV (Weeks 13-16)||0
8375398|NCT01130532|20646066|P1|COMPLETED|Period IV (Weeks 13-16)||0
8375399|NCT01130532|20646063|P4|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
8375400|NCT01130532|20646064|P3|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
8375401|NCT01130532|20646065|P2|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
8375402|NCT01130532|20646066|P1|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
8375403|NCT01130532|20646063|P4|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
8375404|NCT01130532|20646064|P3|STARTED|Period IV (Weeks 13-16)||0
8375405|NCT01130532|20646065|P2|STARTED|Period IV (Weeks 13-16)||0
8375406|NCT01130532|20646066|P1|STARTED|Period IV (Weeks 13-16)||0
8375407|NCT01130532|20646063|P4|NOT COMPLETED|Period III (Weeks 0-12)||0
8375408|NCT01130532|20646064|P3|NOT COMPLETED|Period III (Weeks 0-12)||19
8375409|NCT01130532|20646065|P2|NOT COMPLETED|Period III (Weeks 0-12)||18
8375410|NCT01130532|20646066|P1|NOT COMPLETED|Period III (Weeks 0-12)||21
8375411|NCT01130532|20646063|P4|COMPLETED|Period III (Weeks 0-12)||0
8375412|NCT01130532|20646064|P3|COMPLETED|Period III (Weeks 0-12)||190
8375413|NCT01130532|20646065|P2|COMPLETED|Period III (Weeks 0-12)||189
8375414|NCT01130532|20646066|P1|COMPLETED|Period III (Weeks 0-12)||186
8375415|NCT01130532|20646063|P4|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
8375416|NCT01130532|20646064|P3|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
8375417|NCT01130532|20646065|P2|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
8375418|NCT01130532|20646066|P1|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
8375419|NCT01130532|20646063|P4|STARTED|Period III (Weeks 0-12)||0
8375420|NCT01130532|20646064|P3|STARTED|Period III (Weeks 0-12)||209
8375421|NCT01130532|20646065|P2|STARTED|Period III (Weeks 0-12)||207
8375422|NCT01130532|20646066|P1|STARTED|Period III (Weeks 0-12)||207
8375423|NCT01130493|20646111|P3|NOT COMPLETED|Part 2: OLE||5
8375424|NCT01130493|20646112|P2|NOT COMPLETED|Part 2: OLE||3
8375425|NCT01130493|20646113|P1|NOT COMPLETED|Part 2: OLE||0
8375426|NCT01130493|20646111|P3|COMPLETED|Part 2: OLE||30
8375427|NCT01130493|20646112|P2|COMPLETED|Part 2: OLE||36
8375428|NCT01130493|20646113|P1|COMPLETED|Part 2: OLE||0
8375429|NCT01130493|20646111|P3|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
8375430|NCT01130493|20646112|P2|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
8375431|NCT01130493|20646113|P1|STARTED|Part 2: OLE||0
8375432|NCT01130493|20646111|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
8375433|NCT01130493|20646112|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
8375434|NCT01130493|20646113|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
8375435|NCT01130493|20646111|P3|COMPLETED|Part 1: Double-blind Treatment Period 2||39
8375436|NCT01130493|20646112|P2|COMPLETED|Part 1: Double-blind Treatment Period 2||45
8375437|NCT01130493|20646113|P1|COMPLETED|Part 1: Double-blind Treatment Period 2||0
8375438|NCT01130493|20646111|P3|STARTED|Part 1: Double-blind Treatment Period 2||41
8375439|NCT01130493|20646112|P2|STARTED|Part 1: Double-blind Treatment Period 2||45
8375440|NCT01130493|20646113|P1|STARTED|Part 1: Double-blind Treatment Period 2||0
8375441|NCT01130493|20646111|P3|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
8375442|NCT01130493|20646112|P2|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
8375443|NCT01130493|20646113|P1|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
8375444|NCT01130493|20646111|P3|COMPLETED|Part 1: Open-Label IPX066 Washout||41
8375445|NCT01130493|20646112|P2|COMPLETED|Part 1: Open-Label IPX066 Washout||45
8375446|NCT01130493|20646113|P1|COMPLETED|Part 1: Open-Label IPX066 Washout||0
8375447|NCT01130493|20646111|P3|STARTED|Part 1: Open-Label IPX066 Washout||43
8375448|NCT01130493|20646112|P2|STARTED|Part 1: Open-Label IPX066 Washout||46
8375449|NCT01130493|20646113|P1|STARTED|Part 1: Open-Label IPX066 Washout||0
8375450|NCT01130493|20646111|P3|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
8375451|NCT01130493|20646112|P2|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
8375452|NCT01130493|20646113|P1|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
8375453|NCT01130493|20646111|P3|COMPLETED|Part 1: Double-blind Treatment Period 1||43
8375454|NCT01130493|20646112|P2|COMPLETED|Part 1: Double-blind Treatment Period 1||46
8375455|NCT01130493|20646113|P1|COMPLETED|Part 1: Double-blind Treatment Period 1||0
8375456|NCT01130493|20646111|P3|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
8375457|NCT01130493|20646112|P2|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
8375458|NCT01130493|20646113|P1|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
8375459|NCT01130493|20646111|P3|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
8375460|NCT01130493|20646112|P2|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
8375461|NCT01130493|20646113|P1|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
8375462|NCT01130493|20646111|P3|COMPLETED|Open-label Dose Conversion to IPX066||0
8375463|NCT01130493|20646112|P2|COMPLETED|Open-label Dose Conversion to IPX066||0
8375464|NCT01130493|20646113|P1|COMPLETED|Open-label Dose Conversion to IPX066||91
8375465|NCT01130493|20646111|P3|STARTED|Open-label Dose Conversion to IPX066||0
8375466|NCT01130493|20646112|P2|STARTED|Open-label Dose Conversion to IPX066||0
8375467|NCT01130493|20646113|P1|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
8375468|NCT01130337|20646130|P1|NOT COMPLETED|Overall Study||14
8375469|NCT01130337|20646130|P1|COMPLETED|Overall Study||22
8375470|NCT01130337|20646130|P1|STARTED|Overall Study||36
8375471|NCT01130272|20646142|P5|NOT COMPLETED|Overall Study||52
8375472|NCT01130272|20646143|P4|NOT COMPLETED|Overall Study||68
8375473|NCT01130272|20646144|P3|NOT COMPLETED|Overall Study||48
8375474|NCT01130272|20646145|P2|NOT COMPLETED|Overall Study||42
8375475|NCT01130272|20646146|P1|NOT COMPLETED|Overall Study||59
8375476|NCT01130272|20646142|P5|COMPLETED|Overall Study||117
8375477|NCT01130272|20646143|P4|COMPLETED|Overall Study||103
8375478|NCT01130272|20646144|P3|COMPLETED|Overall Study||121
8375479|NCT01130272|20646145|P2|COMPLETED|Overall Study||131
8375480|NCT01130272|20646146|P1|COMPLETED|Overall Study||48
8375481|NCT01130272|20646142|P5|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159
8375482|NCT01130272|20646143|P4|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172
8375483|NCT01130272|20646144|P3|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165
8375484|NCT01130272|20646145|P2|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170
8375485|NCT01130272|20646146|P1|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105
8375486|NCT01130272|20646142|P5|Safety Analysis Set: as Randomized|Overall Study||162
8375487|NCT01130272|20646143|P4|Safety Analysis Set: as Randomized|Overall Study||167
8375488|NCT01130272|20646144|P3|Safety Analysis Set: as Randomized|Overall Study||166
8375489|NCT01130272|20646145|P2|Safety Analysis Set: as Randomized|Overall Study||171
8375490|NCT01130272|20646146|P1|Safety Analysis Set: as Randomized|Overall Study||105
8375491|NCT01130272|20646142|P5|STARTED|Overall Study||169
8375492|NCT01130272|20646143|P4|STARTED|Overall Study||171
8375493|NCT01130272|20646144|P3|STARTED|Overall Study||169
8375494|NCT01130272|20646145|P2|STARTED|Overall Study||173
8375495|NCT01130272|20646146|P1|STARTED|Overall Study||107
8375496|NCT01130168|20646183|P6|NOT COMPLETED|Period 3||0
8375497|NCT01130168|20646184|P5|NOT COMPLETED|Period 3||0
8375498|NCT01130168|20646185|P4|NOT COMPLETED|Period 3||0
8375499|NCT01130168|20646186|P3|NOT COMPLETED|Period 3||0
8375500|NCT01130168|20646187|P2|NOT COMPLETED|Period 3||0
8375501|NCT01130168|20646188|P1|NOT COMPLETED|Period 3||0
8375502|NCT01130168|20646183|P6|COMPLETED|Period 3||6
8375503|NCT01130168|20646184|P5|COMPLETED|Period 3||5
8375504|NCT01130168|20646185|P4|COMPLETED|Period 3||5
8375505|NCT01130168|20646186|P3|COMPLETED|Period 3||5
8375506|NCT01130168|20646187|P2|COMPLETED|Period 3||6
8375507|NCT01130168|20646188|P1|COMPLETED|Period 3||6
8375508|NCT01130168|20646183|P6|STARTED|Period 3||6
8375509|NCT01130168|20646184|P5|STARTED|Period 3||5
8375510|NCT01130168|20646185|P4|STARTED|Period 3||5
8375511|NCT01130168|20646186|P3|STARTED|Period 3||5
8375512|NCT01130168|20646187|P2|STARTED|Period 3||6
8375513|NCT01130168|20646188|P1|STARTED|Period 3||6
8375514|NCT01130168|20646183|P6|NOT COMPLETED|Period 2||0
8375515|NCT01130168|20646184|P5|NOT COMPLETED|Period 2||0
8375516|NCT01130168|20646185|P4|NOT COMPLETED|Period 2||0
8375517|NCT01130168|20646186|P3|NOT COMPLETED|Period 2||0
8375518|NCT01130168|20646187|P2|NOT COMPLETED|Period 2||0
8375519|NCT01130168|20646188|P1|NOT COMPLETED|Period 2||0
8375520|NCT01130168|20646183|P6|COMPLETED|Period 2||6
8375521|NCT01130168|20646184|P5|COMPLETED|Period 2||5
8375522|NCT01130168|20646185|P4|COMPLETED|Period 2||5
8375523|NCT01130168|20646186|P3|COMPLETED|Period 2||5
8375524|NCT01130168|20646187|P2|COMPLETED|Period 2||6
8375525|NCT01130168|20646188|P1|COMPLETED|Period 2||6
8375526|NCT01130168|20646183|P6|STARTED|Period 2||6
8375527|NCT01130168|20646184|P5|STARTED|Period 2||5
8375528|NCT01130168|20646185|P4|STARTED|Period 2||5
8375529|NCT01130168|20646186|P3|STARTED|Period 2||5
8375530|NCT01130168|20646187|P2|STARTED|Period 2||6
8375531|NCT01130168|20646188|P1|STARTED|Period 2||6
8375532|NCT01130168|20646183|P6|NOT COMPLETED|Period 1||0
8375533|NCT01130168|20646184|P5|NOT COMPLETED|Period 1||0
8375534|NCT01130168|20646185|P4|NOT COMPLETED|Period 1||3
8375535|NCT01130168|20646186|P3|NOT COMPLETED|Period 1||1
8375536|NCT01130168|20646187|P2|NOT COMPLETED|Period 1||1
8375537|NCT01130168|20646188|P1|NOT COMPLETED|Period 1||0
8375538|NCT01130168|20646183|P6|COMPLETED|Period 1||6
8375539|NCT01130168|20646184|P5|COMPLETED|Period 1||5
8375540|NCT01130168|20646185|P4|COMPLETED|Period 1||5
8375541|NCT01130168|20646186|P3|COMPLETED|Period 1||5
8375542|NCT01130168|20646187|P2|COMPLETED|Period 1||6
8375543|NCT01130168|20646188|P1|COMPLETED|Period 1||6
8375544|NCT01130168|20646183|P6|STARTED|Period 1||6
8375545|NCT01130168|20646184|P5|STARTED|Period 1||5
8375546|NCT01130168|20646185|P4|STARTED|Period 1||8
8375547|NCT01130168|20646186|P3|STARTED|Period 1||6
8375548|NCT01130168|20646187|P2|STARTED|Period 1||7
8375549|NCT01130168|20646188|P1|STARTED|Period 1||6
8375550|NCT01130103|20646225|P2|NOT COMPLETED|Maintenance Treatment||2
8375551|NCT01130103|20646226|P1|NOT COMPLETED|Maintenance Treatment||2
8375552|NCT01130103|20646225|P2|COMPLETED|Maintenance Treatment||11
8375553|NCT01130103|20646226|P1|COMPLETED|Maintenance Treatment||11
8375554|NCT01130103|20646225|P2|STARTED|Maintenance Treatment||13
8375555|NCT01130103|20646226|P1|STARTED|Maintenance Treatment||13
8375556|NCT01130103|20646225|P2|NOT COMPLETED|Randomized Treatment||5
8375557|NCT01130103|20646226|P1|NOT COMPLETED|Randomized Treatment||6
8375558|NCT01130103|20646225|P2|COMPLETED|Randomized Treatment||13
8375559|NCT01130103|20646226|P1|COMPLETED|Randomized Treatment||13
8375560|NCT01130103|20646225|P2|STARTED|Randomized Treatment||18
8375561|NCT01130103|20646226|P1|STARTED|Randomized Treatment||19
8375562|NCT01130051|20646240|P2|NOT COMPLETED|Period 2||0
8375563|NCT01130051|20646241|P1|NOT COMPLETED|Period 2||0
8375564|NCT01130051|20646240|P2|COMPLETED|Period 2||6
8375565|NCT01130051|20646241|P1|COMPLETED|Period 2||7
8375566|NCT01130051|20646240|P2|STARTED|Period 2||6
8375567|NCT01130051|20646241|P1|STARTED|Period 2||7
8375568|NCT01130051|20646240|P2|NOT COMPLETED|Washout Period of 14 Days||2
8375569|NCT01130051|20646241|P1|NOT COMPLETED|Washout Period of 14 Days||1
8375570|NCT01130051|20646240|P2|COMPLETED|Washout Period of 14 Days||6
8375571|NCT01130051|20646241|P1|COMPLETED|Washout Period of 14 Days||7
8375572|NCT01130051|20646240|P2|STARTED|Washout Period of 14 Days||8
8375573|NCT01130051|20646241|P1|STARTED|Washout Period of 14 Days||8
8375574|NCT01130051|20646240|P2|NOT COMPLETED|Period 1||0
8375575|NCT01130051|20646241|P1|NOT COMPLETED|Period 1||0
8375576|NCT01130051|20646240|P2|COMPLETED|Period 1||8
8375577|NCT01130051|20646241|P1|COMPLETED|Period 1||8
8375578|NCT01130051|20646240|P2|STARTED|Period 1||8
8375579|NCT01130051|20646241|P1|STARTED|Period 1||8
8375580|NCT01129960|20646255|P4|NOT COMPLETED|Overall Study||13
8375581|NCT01129960|20646256|P3|NOT COMPLETED|Overall Study||26
8375582|NCT01129960|20646257|P2|NOT COMPLETED|Overall Study||22
8375583|NCT01129960|20646258|P1|NOT COMPLETED|Overall Study||30
8375584|NCT01129960|20646255|P4|COMPLETED|Overall Study||70
8375585|NCT01129960|20646256|P3|COMPLETED|Overall Study||56
8375586|NCT01129960|20646257|P2|COMPLETED|Overall Study||61
8375587|NCT01129960|20646258|P1|COMPLETED|Overall Study||54
8375588|NCT01129960|20646255|P4|Full Analysis Set (FAS|Overall Study||71
8375589|NCT01129960|20646256|P3|Full Analysis Set (FAS|Overall Study||68
8375590|NCT01129960|20646257|P2|Full Analysis Set (FAS|Overall Study||67
8375591|NCT01129960|20646258|P1|Full Analysis Set (FAS|Overall Study||71
8375592|NCT01129960|20646255|P4|Per-Protocol|Overall Study||55
8375593|NCT01129960|20646256|P3|Per-Protocol|Overall Study||49
8375594|NCT01129960|20646257|P2|Per-Protocol|Overall Study||52
8375595|NCT01129960|20646258|P1|Per-Protocol|Overall Study||34
8375596|NCT01129960|20646255|P4|Intent-to-Treat|Overall Study||83
8375597|NCT01129960|20646256|P3|Intent-to-Treat|Overall Study||82
8375598|NCT01129960|20646257|P2|Intent-to-Treat|Overall Study||83
8375599|NCT01129960|20646258|P1|Intent-to-Treat|Overall Study||84
8375600|NCT01129960|20646255|P4|Safety|Overall Study||82
8375601|NCT01129960|20646256|P3|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
8375602|NCT01129960|20646257|P2|Safety|Overall Study||83
8375603|NCT01129960|20646258|P1|Safety|Overall Study||84
8375604|NCT01129960|20646255|P4|STARTED|Overall Study||83
8375605|NCT01129960|20646256|P3|STARTED|Overall Study||82
8375606|NCT01129960|20646257|P2|STARTED|Overall Study||83
8375607|NCT01129960|20646258|P1|STARTED|Overall Study||84
8375608|NCT01129921|20646270|P2|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
8375609|NCT01129921|20646271|P1|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
8375610|NCT01129921|20646270|P2|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
8375611|NCT01129921|20646271|P1|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
8375612|NCT01129921|20646270|P2|STARTED|After Sham Cross-over to Mild, One Year||20
8375613|NCT01129921|20646271|P1|STARTED|After Sham Cross-over to Mild, One Year||20
8375614|NCT01129921|20646270|P2|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
8375615|NCT01129921|20646271|P1|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
8375616|NCT01129921|20646270|P2|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
8375617|NCT01129921|20646271|P1|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
8375618|NCT01129921|20646270|P2|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
8375619|NCT01129921|20646271|P1|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
8375620|NCT01129882|20646281|P1|NOT COMPLETED|Overall Study||278
8375621|NCT01129882|20646281|P1|COMPLETED|Overall Study||431
8375622|NCT01129882|20646281|P1|Received at Least 1 Dose of Study Drug|Overall Study||709
8375623|NCT01129882|20646281|P1|STARTED|Overall Study||709
8375624|NCT01129778|20646286|P1|NOT COMPLETED|Overall Study||7
8375625|NCT01129778|20646286|P1|COMPLETED|Overall Study||15
8375626|NCT01129778|20646286|P1|STARTED|Overall Study||22
8375627|NCT01129765|20646291|P1|NOT COMPLETED|Overall Study||0
8375628|NCT01129765|20646291|P1|COMPLETED|Overall Study||30
8375629|NCT01129765|20646291|P1|STARTED|Overall Study||30
8375630|NCT01129622|20646300|P1|NOT COMPLETED|Overall Study||2
8375631|NCT01129622|20646300|P1|COMPLETED|Overall Study||14
8375632|NCT01129622|20646300|P1|STARTED|Overall Study||16
8375633|NCT01129609|20646305|P1|NOT COMPLETED|Overall Study||2
8375634|NCT01129609|20646305|P1|COMPLETED|Overall Study||18
8375635|NCT01129609|20646305|P1|STARTED|Overall Study||20
8375636|NCT01129583|20646311|P2|NOT COMPLETED|Overall Study||2
8375637|NCT01129583|20646312|P1|NOT COMPLETED|Overall Study||3
8375638|NCT01129583|20646311|P2|COMPLETED|Overall Study||7
8375639|NCT01129583|20646312|P1|COMPLETED|Overall Study||6
8375640|NCT01129583|20646311|P2|STARTED|Overall Study||9
8375641|NCT01129583|20646312|P1|STARTED|Overall Study||9
8375642|NCT01129557|20646325|P3|NOT COMPLETED|Overall Study||4
8375643|NCT01129557|20646326|P2|NOT COMPLETED|Overall Study||5
8375644|NCT01129557|20646327|P1|NOT COMPLETED|Overall Study||4
8375645|NCT01129557|20646325|P3|COMPLETED|Overall Study||10
8375646|NCT01129557|20646326|P2|COMPLETED|Overall Study||12
8375647|NCT01129557|20646327|P1|COMPLETED|Overall Study||11
8375648|NCT01129557|20646325|P3|STARTED|Overall Study||14
8375649|NCT01129557|20646326|P2|STARTED|Overall Study||17
8375650|NCT01129557|20646327|P1|STARTED|Overall Study||15
8375651|NCT01129531|20646398|P3|NOT COMPLETED|Treatment Cycle 2||5
8375652|NCT01129531|20646399|P2|NOT COMPLETED|Treatment Cycle 2||3
8375653|NCT01129531|20646400|P1|NOT COMPLETED|Treatment Cycle 2||6
8375654|NCT01129531|20646398|P3|COMPLETED|Treatment Cycle 2||74
8375655|NCT01129531|20646399|P2|COMPLETED|Treatment Cycle 2||92
8375656|NCT01129531|20646400|P1|COMPLETED|Treatment Cycle 2||88
8375657|NCT01129531|20646398|P3|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
8375658|NCT01129531|20646399|P2|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
8375659|NCT01129531|20646400|P1|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
8375660|NCT01129531|20646398|P3|NOT COMPLETED|Treatment Cycle 1||16
8375661|NCT01129531|20646399|P2|NOT COMPLETED|Treatment Cycle 1||6
8375662|NCT01129531|20646400|P1|NOT COMPLETED|Treatment Cycle 1||4
8375663|NCT01129531|20646398|P3|COMPLETED|Treatment Cycle 1||110
8375664|NCT01129531|20646399|P2|COMPLETED|Treatment Cycle 1||78
8375665|NCT01129531|20646400|P1|COMPLETED|Treatment Cycle 1||80
8375666|NCT01129531|20646398|P3|STARTED|Treatment Cycle 1||126
8375667|NCT01129531|20646399|P2|STARTED|Treatment Cycle 1||84
8375668|NCT01129531|20646400|P1|STARTED|Treatment Cycle 1||84
8375669|NCT01129440|20646422|P2|NOT COMPLETED|Overall Study||42
8375670|NCT01129440|20646423|P1|NOT COMPLETED|Overall Study||51
8375671|NCT01129440|20646422|P2|COMPLETED|Overall Study||258
8375672|NCT01129440|20646423|P1|COMPLETED|Overall Study||246
8375673|NCT01129440|20646422|P2|24 Month Follow-up|Overall Study||258
8375674|NCT01129440|20646423|P1|24 Month Follow-up|Overall Study||239
8375675|NCT01129440|20646422|P2|12 Month Follow-up|Overall Study||256
8375676|NCT01129440|20646423|P1|12 Month Follow-up|Overall Study||249
8375677|NCT01129440|20646422|P2|STARTED|Overall Study||300
8375678|NCT01129440|20646423|P1|STARTED|Overall Study||297
8375679|NCT01129336|20646440|P2|NOT COMPLETED|Overall Study||16
8375680|NCT01129336|20646441|P1|NOT COMPLETED|Overall Study||12
8375681|NCT01129336|20646440|P2|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
8375682|NCT01129336|20646441|P1|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
8375683|NCT01129336|20646440|P2|Completed Treatment|Overall Study||3
8375684|NCT01129336|20646441|P1|Completed Treatment|Overall Study||1
8375685|NCT01129336|20646440|P2|STARTED|Overall Study||29
8375686|NCT01129336|20646441|P1|STARTED|Overall Study||15
8375687|NCT01129284|20646456|P3|NOT COMPLETED|Overall Study||1
8375688|NCT01129284|20646457|P2|NOT COMPLETED|Overall Study||0
8375689|NCT01129284|20646458|P1|NOT COMPLETED|Overall Study||2
8375690|NCT01129284|20646456|P3|COMPLETED|Overall Study||4
8375691|NCT01129284|20646457|P2|COMPLETED|Overall Study||5
8375692|NCT01129284|20646458|P1|COMPLETED|Overall Study||3
8375693|NCT01129284|20646456|P3|STARTED|Overall Study||5
8375694|NCT01129284|20646457|P2|STARTED|Overall Study||5
8375695|NCT01129284|20646458|P1|STARTED|Overall Study||5
8375696|NCT01129245|20646471|P2|NOT COMPLETED|Treatment Cycle 2||0
8375697|NCT01129245|20646472|P1|NOT COMPLETED|Treatment Cycle 2||0
8375698|NCT01129245|20646471|P2|COMPLETED|Treatment Cycle 2||10
8375699|NCT01129245|20646472|P1|COMPLETED|Treatment Cycle 2||10
8375700|NCT01129245|20646471|P2|STARTED|Treatment Cycle 2||10
8375701|NCT01129245|20646472|P1|STARTED|Treatment Cycle 2||10
8375702|NCT01129245|20646471|P2|NOT COMPLETED|Washout Cycle||0
8375703|NCT01129245|20646472|P1|NOT COMPLETED|Washout Cycle||0
8375704|NCT01129245|20646471|P2|COMPLETED|Washout Cycle||10
8375705|NCT01129245|20646472|P1|COMPLETED|Washout Cycle||10
8375706|NCT01129245|20646471|P2|STARTED|Washout Cycle||10
8375707|NCT01129245|20646472|P1|STARTED|Washout Cycle||10
8375708|NCT01129245|20646471|P2|NOT COMPLETED|Treatment Cycle 1||0
8375709|NCT01129245|20646472|P1|NOT COMPLETED|Treatment Cycle 1||0
8375710|NCT01129245|20646471|P2|COMPLETED|Treatment Cycle 1||10
8375711|NCT01129245|20646472|P1|COMPLETED|Treatment Cycle 1||10
8375712|NCT01129245|20646471|P2|STARTED|Treatment Cycle 1||10
8375713|NCT01129245|20646472|P1|STARTED|Treatment Cycle 1||10
8375714|NCT01129245|20646471|P2|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
8375715|NCT01129245|20646472|P1|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
8375716|NCT01129245|20646471|P2|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
8375717|NCT01129245|20646472|P1|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
8375718|NCT01129245|20646471|P2|STARTED|Control Cycle (no Celecoxib or Placebo)||10
8375719|NCT01129245|20646472|P1|STARTED|Control Cycle (no Celecoxib or Placebo)||10
8375720|NCT01129206|20646486|P1|NOT COMPLETED|Overall Study||0
8375721|NCT01129206|20646486|P1|COMPLETED|Overall Study||6
8375722|NCT01129206|20646486|P1|STARTED|Overall Study||6
8375723|NCT01129141|20646496|P2|NOT COMPLETED|Overall Study||13
8375724|NCT01129141|20646497|P1|NOT COMPLETED|Overall Study||15
8375725|NCT01129141|20646496|P2|COMPLETED|Overall Study||91
8375726|NCT01129141|20646497|P1|COMPLETED|Overall Study||86
8375727|NCT01129141|20646496|P2|STARTED|Overall Study||104
8375728|NCT01129141|20646497|P1|STARTED|Overall Study||101
8375729|NCT01129128|20646506|P3|NOT COMPLETED|Overall Study||4
8375730|NCT01129128|20646507|P2|NOT COMPLETED|Overall Study||4
8375731|NCT01129128|20646508|P1|NOT COMPLETED|Overall Study||3
8375732|NCT01129128|20646506|P3|COMPLETED|Overall Study||19
8375733|NCT01129128|20646507|P2|COMPLETED|Overall Study||18
8375734|NCT01129128|20646508|P1|COMPLETED|Overall Study||19
8375735|NCT01129128|20646506|P3|STARTED|Overall Study||23
8375736|NCT01129128|20646507|P2|STARTED|Overall Study||22
8375737|NCT01129128|20646508|P1|STARTED|Overall Study||22
8375738|NCT01129115|20646532|P4|NOT COMPLETED|Overall Study||9
8375739|NCT01129115|20646533|P3|NOT COMPLETED|Overall Study||6
8375740|NCT01129115|20646534|P2|NOT COMPLETED|Overall Study||7
8375741|NCT01129115|20646535|P1|NOT COMPLETED|Overall Study||2
8375742|NCT01129115|20646532|P4|COMPLETED|Overall Study||15
8375743|NCT01129115|20646533|P3|COMPLETED|Overall Study||21
8375744|NCT01129115|20646534|P2|COMPLETED|Overall Study||18
8375745|NCT01129115|20646535|P1|COMPLETED|Overall Study||23
8375746|NCT01129115|20646532|P4|STARTED|Overall Study||24
8375747|NCT01129115|20646533|P3|STARTED|Overall Study||27
8375748|NCT01129115|20646534|P2|STARTED|Overall Study||25
8375749|NCT01129115|20646535|P1|STARTED|Overall Study||25
8375750|NCT01129102|20646572|P3|NOT COMPLETED|Overall Study||7
8375751|NCT01129102|20646573|P2|NOT COMPLETED|Overall Study||6
8375752|NCT01129102|20646574|P1|NOT COMPLETED|Overall Study||8
8375753|NCT01129102|20646572|P3|COMPLETED|Overall Study||48
8375754|NCT01129102|20646573|P2|COMPLETED|Overall Study||44
8375755|NCT01129102|20646574|P1|COMPLETED|Overall Study||102
8375756|NCT01129102|20646572|P3|STARTED|Overall Study||55
8375757|NCT01129102|20646573|P2|STARTED|Overall Study||50
8375758|NCT01129102|20646574|P1|STARTED|Overall Study||110
8375759|NCT01129011|20646585|P2|NOT COMPLETED|Overall Study||57
8375760|NCT01129011|20646586|P1|NOT COMPLETED|Overall Study||59
8375761|NCT01129011|20646585|P2|COMPLETED|Overall Study||153
8375762|NCT01129011|20646586|P1|COMPLETED|Overall Study||151
8375763|NCT01129011|20646585|P2|STARTED|Overall Study|Safety, Intent-to-Treat population|210
8375764|NCT01129011|20646586|P1|STARTED|Overall Study|Safety, Intent-to-Treat population|210
8375765|NCT01128972|20646608|P5|NOT COMPLETED|Period V||0
8375766|NCT01128972|20646609|P4|NOT COMPLETED|Period V||0
8375767|NCT01128972|20646610|P3|NOT COMPLETED|Period V||0
8375768|NCT01128972|20646611|P2|NOT COMPLETED|Period V||0
8375769|NCT01128972|20646612|P1|NOT COMPLETED|Period V||0
8375770|NCT01128972|20646608|P5|COMPLETED|Period V||7
8375771|NCT01128972|20646609|P4|COMPLETED|Period V||7
8375772|NCT01128972|20646610|P3|COMPLETED|Period V||7
8375773|NCT01128972|20646611|P2|COMPLETED|Period V||7
8375774|NCT01128972|20646612|P1|COMPLETED|Period V||8
8375775|NCT01128972|20646608|P5|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
8375776|NCT01128972|20646609|P4|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
8375777|NCT01128972|20646610|P3|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
8375778|NCT01128972|20646611|P2|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
8375779|NCT01128972|20646612|P1|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
8375780|NCT01128972|20646608|P5|NOT COMPLETED|Period IV||0
8375781|NCT01128972|20646609|P4|NOT COMPLETED|Period IV||0
8375782|NCT01128972|20646610|P3|NOT COMPLETED|Period IV||0
8375783|NCT01128972|20646611|P2|NOT COMPLETED|Period IV||0
8375784|NCT01128972|20646612|P1|NOT COMPLETED|Period IV||0
8375785|NCT01128972|20646608|P5|COMPLETED|Period IV||7
8375786|NCT01128972|20646609|P4|COMPLETED|Period IV||7
8375787|NCT01128972|20646610|P3|COMPLETED|Period IV||7
8375788|NCT01128972|20646611|P2|COMPLETED|Period IV||8
8375789|NCT01128972|20646612|P1|COMPLETED|Period IV||7
8375790|NCT01128972|20646608|P5|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
8375791|NCT01128972|20646609|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
8375792|NCT01128972|20646610|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
8375793|NCT01128972|20646611|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
8375794|NCT01128972|20646612|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
8375795|NCT01128972|20646608|P5|NOT COMPLETED|Period III||0
8375796|NCT01128972|20646609|P4|NOT COMPLETED|Period III||0
8375797|NCT01128972|20646610|P3|NOT COMPLETED|Period III||0
8375798|NCT01128972|20646611|P2|NOT COMPLETED|Period III||0
8375799|NCT01128972|20646612|P1|NOT COMPLETED|Period III||0
8375800|NCT01128972|20646608|P5|COMPLETED|Period III||7
8375801|NCT01128972|20646609|P4|COMPLETED|Period III||7
8375802|NCT01128972|20646610|P3|COMPLETED|Period III||8
8375803|NCT01128972|20646611|P2|COMPLETED|Period III||7
8375804|NCT01128972|20646612|P1|COMPLETED|Period III||7
8375805|NCT01128972|20646608|P5|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
8375806|NCT01128972|20646609|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
8375807|NCT01128972|20646610|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
8375808|NCT01128972|20646611|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
8375809|NCT01128972|20646612|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
8375810|NCT01128972|20646608|P5|NOT COMPLETED|Period II||0
8375811|NCT01128972|20646609|P4|NOT COMPLETED|Period II||0
8375812|NCT01128972|20646610|P3|NOT COMPLETED|Period II||0
8375813|NCT01128972|20646611|P2|NOT COMPLETED|Period II||0
8375814|NCT01128972|20646612|P1|NOT COMPLETED|Period II||0
8375815|NCT01128972|20646608|P5|COMPLETED|Period II||7
8375816|NCT01128972|20646609|P4|COMPLETED|Period II||8
8375817|NCT01128972|20646610|P3|COMPLETED|Period II||7
8375818|NCT01128972|20646611|P2|COMPLETED|Period II||7
8375819|NCT01128972|20646612|P1|COMPLETED|Period II||7
8375820|NCT01128972|20646608|P5|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
8375821|NCT01128972|20646609|P4|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
8375822|NCT01128972|20646610|P3|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
8375823|NCT01128972|20646611|P2|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
8375824|NCT01128972|20646612|P1|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
8375825|NCT01128972|20646608|P5|NOT COMPLETED|Period I||0
8375826|NCT01128972|20646609|P4|NOT COMPLETED|Period I||0
8375827|NCT01128972|20646610|P3|NOT COMPLETED|Period I||0
8375828|NCT01128972|20646611|P2|NOT COMPLETED|Period I||0
8375829|NCT01128972|20646612|P1|NOT COMPLETED|Period I||0
8375830|NCT01128972|20646608|P5|COMPLETED|Period I||8
8375831|NCT01128972|20646609|P4|COMPLETED|Period I||7
8375832|NCT01128972|20646610|P3|COMPLETED|Period I||7
8375833|NCT01128972|20646611|P2|COMPLETED|Period I||7
8375834|NCT01128972|20646612|P1|COMPLETED|Period I||7
8375835|NCT01128972|20646608|P5|STARTED|Period I||8
8375836|NCT01128972|20646609|P4|STARTED|Period I||7
8375837|NCT01128972|20646610|P3|STARTED|Period I||7
8375838|NCT01128972|20646611|P2|STARTED|Period I||7
8375839|NCT01128972|20646612|P1|STARTED|Period I||7
8375840|NCT01128959|20646641|P1|NOT COMPLETED|Treatment Period||4
8375841|NCT01128959|20646641|P1|COMPLETED|Treatment Period||101
8375842|NCT01128959|20646641|P1|STARTED|Treatment Period||105
8375843|NCT01128959|20646641|P1|NOT COMPLETED|Lead in Period||3
8375844|NCT01128959|20646641|P1|COMPLETED|Lead in Period||105
8375845|NCT01128959|20646641|P1|STARTED|Lead in Period||108
8375846|NCT01128946|20646647|P4|NOT COMPLETED|Period IV||0
8375847|NCT01128946|20646648|P3|NOT COMPLETED|Period IV||0
8375848|NCT01128946|20646649|P2|NOT COMPLETED|Period IV||0
8375849|NCT01128946|20646650|P1|NOT COMPLETED|Period IV||0
8375850|NCT01128946|20646647|P4|COMPLETED|Period IV||19
8375851|NCT01128946|20646648|P3|COMPLETED|Period IV||19
8375852|NCT01128946|20646649|P2|COMPLETED|Period IV||20
8375853|NCT01128946|20646650|P1|COMPLETED|Period IV||19
8375854|NCT01128946|20646647|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
8375855|NCT01128946|20646648|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
8375856|NCT01128946|20646649|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
8375857|NCT01128946|20646650|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
8375858|NCT01128946|20646647|P4|NOT COMPLETED|Period III||0
8375859|NCT01128946|20646648|P3|NOT COMPLETED|Period III||0
8375860|NCT01128946|20646649|P2|NOT COMPLETED|Period III||0
8375861|NCT01128946|20646650|P1|NOT COMPLETED|Period III||1
8375862|NCT01128946|20646647|P4|COMPLETED|Period III||19
8375863|NCT01128946|20646648|P3|COMPLETED|Period III||20
8375864|NCT01128946|20646649|P2|COMPLETED|Period III||19
8375865|NCT01128946|20646650|P1|COMPLETED|Period III||19
8375866|NCT01128946|20646647|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
8375867|NCT01128946|20646648|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
8375868|NCT01128946|20646649|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
8375869|NCT01128946|20646650|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
8375870|NCT01128946|20646647|P4|NOT COMPLETED|Period II||1
8375871|NCT01128946|20646648|P3|NOT COMPLETED|Period II||0
8375872|NCT01128946|20646649|P2|NOT COMPLETED|Period II||1
8375873|NCT01128946|20646650|P1|NOT COMPLETED|Period II||0
8375874|NCT01128946|20646647|P4|COMPLETED|Period II||19
8375875|NCT01128946|20646648|P3|COMPLETED|Period II||20
8375876|NCT01128946|20646649|P2|COMPLETED|Period II||19
8375877|NCT01128946|20646650|P1|COMPLETED|Period II||20
8375878|NCT01128946|20646647|P4|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
8375879|NCT01128946|20646648|P3|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
8375880|NCT01128946|20646649|P2|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
8375881|NCT01128946|20646650|P1|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
8375882|NCT01128946|20646647|P4|NOT COMPLETED|Period I||1
8375883|NCT01128946|20646648|P3|NOT COMPLETED|Period I||1
8375884|NCT01128946|20646649|P2|NOT COMPLETED|Period I||1
8375885|NCT01128946|20646650|P1|NOT COMPLETED|Period I||0
8375886|NCT01128946|20646647|P4|COMPLETED|Period I||20
8375887|NCT01128946|20646648|P3|COMPLETED|Period I||20
8375888|NCT01128946|20646649|P2|COMPLETED|Period I||20
8375889|NCT01128946|20646650|P1|COMPLETED|Period I||20
8375890|NCT01128946|20646647|P4|STARTED|Period I||21
8375891|NCT01128946|20646648|P3|STARTED|Period I||21
8375892|NCT01128946|20646649|P2|STARTED|Period I||21
8375893|NCT01128946|20646650|P1|STARTED|Period I||20
8375894|NCT01128894|20646668|P2|NOT COMPLETED|Overall Study||68
8375895|NCT01128894|20646669|P1|NOT COMPLETED|Overall Study||58
8375896|NCT01128894|20646668|P2|COMPLETED|Overall Study||340
8375897|NCT01128894|20646669|P1|COMPLETED|Overall Study||346
8375898|NCT01128894|20646668|P2|STARTED|Overall Study||408
8375899|NCT01128894|20646669|P1|STARTED|Overall Study||404
8375900|NCT01128842|20646687|P1|NOT COMPLETED|Overall Study||7
8375901|NCT01128842|20646687|P1|COMPLETED|Overall Study||0
8375902|NCT01128842|20646687|P1|STARTED|Overall Study||7
8375903|NCT01128829|20646697|P2|NOT COMPLETED|Overall Study||0
8375904|NCT01128829|20646698|P1|NOT COMPLETED|Overall Study||0
8375905|NCT01128829|20646697|P2|COMPLETED|Overall Study||11
8375906|NCT01128829|20646698|P1|COMPLETED|Overall Study||6
8375907|NCT01128829|20646697|P2|STARTED|Overall Study||11
8375908|NCT01128829|20646698|P1|STARTED|Overall Study||6
8375909|NCT01128738|20646704|P2|NOT COMPLETED|Second TP||3
8375910|NCT01128738|20646705|P1|NOT COMPLETED|Second TP||0
8375911|NCT01128738|20646704|P2|COMPLETED|Second TP||63
8375912|NCT01128738|20646705|P1|COMPLETED|Second TP||34
8375913|NCT01128738|20646704|P2|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
8375914|NCT01128738|20646705|P1|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
8375915|NCT01128738|20646704|P2|NOT COMPLETED|First Treatment Phase (TP)||1
8375916|NCT01128738|20646705|P1|NOT COMPLETED|First Treatment Phase (TP)||4
8375917|NCT01128738|20646704|P2|COMPLETED|First Treatment Phase (TP)||73
8375918|NCT01128738|20646705|P1|COMPLETED|First Treatment Phase (TP)||74
8375919|NCT01128738|20646704|P2|STARTED|First Treatment Phase (TP)||74
8375920|NCT01128738|20646705|P1|STARTED|First Treatment Phase (TP)||78
8375921|NCT01128621|20646830|P2|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
8375922|NCT01128621|20646831|P1|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
8375923|NCT01128621|20646830|P2|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
8375924|NCT01128621|20646831|P1|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
8375925|NCT01128621|20646830|P2|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
8375926|NCT01128621|20646831|P1|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
8375927|NCT01128621|20646830|P2|NOT COMPLETED|Part A: GSK1292263 300 mg||0
8375928|NCT01128621|20646831|P1|NOT COMPLETED|Part A: GSK1292263 300 mg||0
8375929|NCT01128621|20646830|P2|COMPLETED|Part A: GSK1292263 300 mg||0
8375930|NCT01128621|20646831|P1|COMPLETED|Part A: GSK1292263 300 mg||6
8375931|NCT01128621|20646830|P2|STARTED|Part A: GSK1292263 300 mg||0
8375932|NCT01128621|20646831|P1|STARTED|Part A: GSK1292263 300 mg||6
8375933|NCT01128595|20646952|P4|NOT COMPLETED|Treatment Period 4||0
8375934|NCT01128595|20646953|P3|NOT COMPLETED|Treatment Period 4||0
8375935|NCT01128595|20646954|P2|NOT COMPLETED|Treatment Period 4||0
8375936|NCT01128595|20646955|P1|NOT COMPLETED|Treatment Period 4||0
8375937|NCT01128595|20646952|P4|COMPLETED|Treatment Period 4||7
8375938|NCT01128595|20646953|P3|COMPLETED|Treatment Period 4||7
8375939|NCT01128595|20646954|P2|COMPLETED|Treatment Period 4||5
8375940|NCT01128595|20646955|P1|COMPLETED|Treatment Period 4||7
8375941|NCT01128595|20646952|P4|STARTED|Treatment Period 4||7
8375942|NCT01128595|20646953|P3|STARTED|Treatment Period 4||7
8375943|NCT01128595|20646954|P2|STARTED|Treatment Period 4||5
8375944|NCT01128595|20646955|P1|STARTED|Treatment Period 4||7
8375945|NCT01128595|20646952|P4|NOT COMPLETED|Washout Period 3||0
8375946|NCT01128595|20646953|P3|NOT COMPLETED|Washout Period 3||0
8375947|NCT01128595|20646954|P2|NOT COMPLETED|Washout Period 3||0
8375948|NCT01128595|20646955|P1|NOT COMPLETED|Washout Period 3||0
8375949|NCT01128595|20646952|P4|COMPLETED|Washout Period 3||7
8375950|NCT01128595|20646953|P3|COMPLETED|Washout Period 3||7
8375951|NCT01128595|20646954|P2|COMPLETED|Washout Period 3||5
8375952|NCT01128595|20646955|P1|COMPLETED|Washout Period 3||7
8375953|NCT01128595|20646952|P4|STARTED|Washout Period 3||7
8375954|NCT01128595|20646953|P3|STARTED|Washout Period 3||7
8375955|NCT01128595|20646954|P2|STARTED|Washout Period 3||5
8375956|NCT01128595|20646955|P1|STARTED|Washout Period 3||7
8375957|NCT01128595|20646952|P4|NOT COMPLETED|Treatment Period 3||0
8375958|NCT01128595|20646953|P3|NOT COMPLETED|Treatment Period 3||0
8375959|NCT01128595|20646954|P2|NOT COMPLETED|Treatment Period 3||1
8375960|NCT01128595|20646955|P1|NOT COMPLETED|Treatment Period 3||0
8375961|NCT01128595|20646952|P4|COMPLETED|Treatment Period 3||7
8375962|NCT01128595|20646953|P3|COMPLETED|Treatment Period 3||7
8375963|NCT01128595|20646954|P2|COMPLETED|Treatment Period 3||5
8375964|NCT01128595|20646955|P1|COMPLETED|Treatment Period 3||7
8375965|NCT01128595|20646952|P4|STARTED|Treatment Period 3||7
8375966|NCT01128595|20646953|P3|STARTED|Treatment Period 3||7
8375967|NCT01128595|20646954|P2|STARTED|Treatment Period 3||6
8375968|NCT01128595|20646955|P1|STARTED|Treatment Period 3||7
8375969|NCT01128595|20646952|P4|NOT COMPLETED|Washout Period 2||0
8375970|NCT01128595|20646953|P3|NOT COMPLETED|Washout Period 2||0
8375971|NCT01128595|20646954|P2|NOT COMPLETED|Washout Period 2||0
8375972|NCT01128595|20646955|P1|NOT COMPLETED|Washout Period 2||0
8375973|NCT01128595|20646952|P4|COMPLETED|Washout Period 2||7
8375974|NCT01128595|20646953|P3|COMPLETED|Washout Period 2||7
8375975|NCT01128595|20646954|P2|COMPLETED|Washout Period 2||6
8375976|NCT01128595|20646955|P1|COMPLETED|Washout Period 2||7
8375977|NCT01128595|20646952|P4|STARTED|Washout Period 2||7
8375978|NCT01128595|20646953|P3|STARTED|Washout Period 2||7
8375979|NCT01128595|20646954|P2|STARTED|Washout Period 2||6
8375980|NCT01128595|20646955|P1|STARTED|Washout Period 2||7
8375981|NCT01128595|20646952|P4|NOT COMPLETED|Treatment Period 2||0
8375982|NCT01128595|20646953|P3|NOT COMPLETED|Treatment Period 2||0
8375983|NCT01128595|20646954|P2|NOT COMPLETED|Treatment Period 2||0
8375984|NCT01128595|20646955|P1|NOT COMPLETED|Treatment Period 2||0
8375985|NCT01128595|20646952|P4|COMPLETED|Treatment Period 2||7
8375986|NCT01128595|20646953|P3|COMPLETED|Treatment Period 2||7
8375987|NCT01128595|20646954|P2|COMPLETED|Treatment Period 2||6
8375988|NCT01128595|20646955|P1|COMPLETED|Treatment Period 2||7
8375989|NCT01128595|20646952|P4|STARTED|Treatment Period 2||7
8375990|NCT01128595|20646953|P3|STARTED|Treatment Period 2||7
8375991|NCT01128595|20646954|P2|STARTED|Treatment Period 2||6
8375992|NCT01128595|20646955|P1|STARTED|Treatment Period 2||7
8375993|NCT01128595|20646952|P4|NOT COMPLETED|Washout Period 1||0
8375994|NCT01128595|20646953|P3|NOT COMPLETED|Washout Period 1||0
8375995|NCT01128595|20646954|P2|NOT COMPLETED|Washout Period 1||0
8375996|NCT01128595|20646955|P1|NOT COMPLETED|Washout Period 1||0
8375997|NCT01128595|20646952|P4|COMPLETED|Washout Period 1||7
8375998|NCT01128595|20646953|P3|COMPLETED|Washout Period 1||7
8375999|NCT01128595|20646954|P2|COMPLETED|Washout Period 1||6
8376000|NCT01128595|20646955|P1|COMPLETED|Washout Period 1||7
8376001|NCT01128595|20646952|P4|STARTED|Washout Period 1||7
8376002|NCT01128595|20646953|P3|STARTED|Washout Period 1||7
8376003|NCT01128595|20646954|P2|STARTED|Washout Period 1||6
8376004|NCT01128595|20646955|P1|STARTED|Washout Period 1||7
8376005|NCT01128595|20646952|P4|NOT COMPLETED|Treatment Period 1||0
8376006|NCT01128595|20646953|P3|NOT COMPLETED|Treatment Period 1||0
8376007|NCT01128595|20646954|P2|NOT COMPLETED|Treatment Period 1||0
8376008|NCT01128595|20646955|P1|NOT COMPLETED|Treatment Period 1||0
8376009|NCT01128595|20646952|P4|COMPLETED|Treatment Period 1||7
8376010|NCT01128595|20646953|P3|COMPLETED|Treatment Period 1||7
8376011|NCT01128595|20646954|P2|COMPLETED|Treatment Period 1||6
8376012|NCT01128595|20646955|P1|COMPLETED|Treatment Period 1||7
8376013|NCT01128595|20646952|P4|STARTED|Treatment Period 1||7
8376014|NCT01128595|20646953|P3|STARTED|Treatment Period 1||7
8376015|NCT01128595|20646954|P2|STARTED|Treatment Period 1||6
8376016|NCT01128595|20646955|P1|STARTED|Treatment Period 1||7
8376017|NCT01128569|20646985|P6|NOT COMPLETED|Treatment Period 3||0
8376018|NCT01128569|20646986|P5|NOT COMPLETED|Treatment Period 3||0
8376019|NCT01128569|20646987|P4|NOT COMPLETED|Treatment Period 3||0
8376020|NCT01128569|20646988|P3|NOT COMPLETED|Treatment Period 3||0
8376021|NCT01128569|20646989|P2|NOT COMPLETED|Treatment Period 3||0
8376022|NCT01128569|20646990|P1|NOT COMPLETED|Treatment Period 3||0
8376023|NCT01128569|20646985|P6|COMPLETED|Treatment Period 3||9
8376024|NCT01128569|20646986|P5|COMPLETED|Treatment Period 3||9
8376025|NCT01128569|20646987|P4|COMPLETED|Treatment Period 3||8
8376026|NCT01128569|20646988|P3|COMPLETED|Treatment Period 3||8
8376027|NCT01128569|20646989|P2|COMPLETED|Treatment Period 3||7
8376028|NCT01128569|20646990|P1|COMPLETED|Treatment Period 3||9
8376029|NCT01128569|20646985|P6|STARTED|Treatment Period 3||9
8376030|NCT01128569|20646986|P5|STARTED|Treatment Period 3||9
8376031|NCT01128569|20646987|P4|STARTED|Treatment Period 3||8
8376032|NCT01128569|20646988|P3|STARTED|Treatment Period 3||8
8376033|NCT01128569|20646989|P2|STARTED|Treatment Period 3||7
8376034|NCT01128569|20646990|P1|STARTED|Treatment Period 3||9
8376035|NCT01128569|20646985|P6|NOT COMPLETED|Washout Period 2||0
8376036|NCT01128569|20646986|P5|NOT COMPLETED|Washout Period 2||0
8376037|NCT01128569|20646987|P4|NOT COMPLETED|Washout Period 2||0
8376038|NCT01128569|20646988|P3|NOT COMPLETED|Washout Period 2||0
8376039|NCT01128569|20646989|P2|NOT COMPLETED|Washout Period 2||0
8376040|NCT01128569|20646990|P1|NOT COMPLETED|Washout Period 2||0
8376041|NCT01128569|20646985|P6|COMPLETED|Washout Period 2||9
8376042|NCT01128569|20646986|P5|COMPLETED|Washout Period 2||9
8376043|NCT01128569|20646987|P4|COMPLETED|Washout Period 2||8
8376044|NCT01128569|20646988|P3|COMPLETED|Washout Period 2||8
8376045|NCT01128569|20646989|P2|COMPLETED|Washout Period 2||7
8376046|NCT01128569|20646990|P1|COMPLETED|Washout Period 2||9
8376047|NCT01128569|20646985|P6|STARTED|Washout Period 2||9
8376048|NCT01128569|20646986|P5|STARTED|Washout Period 2||9
8376049|NCT01128569|20646987|P4|STARTED|Washout Period 2||8
8376050|NCT01128569|20646988|P3|STARTED|Washout Period 2||8
8376051|NCT01128569|20646989|P2|STARTED|Washout Period 2||7
8376052|NCT01128569|20646990|P1|STARTED|Washout Period 2||9
8376053|NCT01128569|20646985|P6|NOT COMPLETED|Treatment Period 2||0
8376054|NCT01128569|20646986|P5|NOT COMPLETED|Treatment Period 2||0
8376055|NCT01128569|20646987|P4|NOT COMPLETED|Treatment Period 2||0
8376056|NCT01128569|20646988|P3|NOT COMPLETED|Treatment Period 2||0
8376057|NCT01128569|20646989|P2|NOT COMPLETED|Treatment Period 2||1
8376058|NCT01128569|20646990|P1|NOT COMPLETED|Treatment Period 2||0
8376059|NCT01128569|20646985|P6|COMPLETED|Treatment Period 2||9
8376060|NCT01128569|20646986|P5|COMPLETED|Treatment Period 2||9
8376061|NCT01128569|20646987|P4|COMPLETED|Treatment Period 2||8
8376062|NCT01128569|20646988|P3|COMPLETED|Treatment Period 2||8
8376063|NCT01128569|20646989|P2|COMPLETED|Treatment Period 2||7
8376064|NCT01128569|20646990|P1|COMPLETED|Treatment Period 2||9
8376065|NCT01128569|20646985|P6|STARTED|Treatment Period 2||9
8376066|NCT01128569|20646986|P5|STARTED|Treatment Period 2||9
8376067|NCT01128569|20646987|P4|STARTED|Treatment Period 2||8
8376068|NCT01128569|20646988|P3|STARTED|Treatment Period 2||8
8376069|NCT01128569|20646989|P2|STARTED|Treatment Period 2||8
8376070|NCT01128569|20646990|P1|STARTED|Treatment Period 2||9
8376071|NCT01128569|20646985|P6|NOT COMPLETED|Washout Period 1||0
8376072|NCT01128569|20646986|P5|NOT COMPLETED|Washout Period 1||0
8376073|NCT01128569|20646987|P4|NOT COMPLETED|Washout Period 1||0
8376074|NCT01128569|20646988|P3|NOT COMPLETED|Washout Period 1||1
8376075|NCT01128569|20646989|P2|NOT COMPLETED|Washout Period 1||0
8376076|NCT01128569|20646990|P1|NOT COMPLETED|Washout Period 1||0
8376077|NCT01128569|20646985|P6|COMPLETED|Washout Period 1||9
8376078|NCT01128569|20646986|P5|COMPLETED|Washout Period 1||9
8376079|NCT01128569|20646987|P4|COMPLETED|Washout Period 1||8
8376080|NCT01128569|20646988|P3|COMPLETED|Washout Period 1||8
8376081|NCT01128569|20646989|P2|COMPLETED|Washout Period 1||8
8376082|NCT01128569|20646990|P1|COMPLETED|Washout Period 1||9
8376083|NCT01128569|20646985|P6|STARTED|Washout Period 1||9
8376084|NCT01128569|20646986|P5|STARTED|Washout Period 1||9
8376085|NCT01128569|20646987|P4|STARTED|Washout Period 1||8
8376086|NCT01128569|20646988|P3|STARTED|Washout Period 1||9
8376087|NCT01128569|20646989|P2|STARTED|Washout Period 1||8
8376088|NCT01128569|20646990|P1|STARTED|Washout Period 1||9
8376089|NCT01128569|20646985|P6|NOT COMPLETED|Treatment Period 1||0
8376090|NCT01128569|20646986|P5|NOT COMPLETED|Treatment Period 1||0
8376091|NCT01128569|20646987|P4|NOT COMPLETED|Treatment Period 1||0
8376092|NCT01128569|20646988|P3|NOT COMPLETED|Treatment Period 1||0
8376093|NCT01128569|20646989|P2|NOT COMPLETED|Treatment Period 1||0
8376094|NCT01128569|20646990|P1|NOT COMPLETED|Treatment Period 1||0
8376095|NCT01128569|20646985|P6|COMPLETED|Treatment Period 1||9
8376096|NCT01128569|20646986|P5|COMPLETED|Treatment Period 1||9
8376097|NCT01128569|20646987|P4|COMPLETED|Treatment Period 1||8
8376098|NCT01128569|20646988|P3|COMPLETED|Treatment Period 1||9
8376099|NCT01128569|20646989|P2|COMPLETED|Treatment Period 1||8
8376100|NCT01128569|20646990|P1|COMPLETED|Treatment Period 1||9
8376101|NCT01128569|20646985|P6|STARTED|Treatment Period 1||9
8376102|NCT01128569|20646986|P5|STARTED|Treatment Period 1||9
8376103|NCT01128569|20646987|P4|STARTED|Treatment Period 1||8
8376104|NCT01128569|20646988|P3|STARTED|Treatment Period 1||9
8376105|NCT01128569|20646989|P2|STARTED|Treatment Period 1||8
8376106|NCT01128569|20646990|P1|STARTED|Treatment Period 1||9
8376107|NCT01128543|20647007|P1|NOT COMPLETED|Overall Study||4
8376108|NCT01128543|20647007|P1|COMPLETED|Overall Study||25
8376109|NCT01128543|20647007|P1|STARTED|Overall Study||29
8376110|NCT01128426|20647013|P1|NOT COMPLETED|Overall Study||0
8376111|NCT01128426|20647013|P1|COMPLETED|Overall Study||53902
8376112|NCT01128426|20647013|P1|STARTED|Overall Study||53902
8376113|NCT01128413|20647033|P2|NOT COMPLETED|Overall Study||1
8376114|NCT01128413|20647034|P1|NOT COMPLETED|Overall Study||4
8376115|NCT01128413|20647033|P2|COMPLETED|Overall Study||10
8376116|NCT01128413|20647034|P1|COMPLETED|Overall Study||7
8376117|NCT01128413|20647033|P2|STARTED|Overall Study||11
8376118|NCT01128413|20647034|P1|STARTED|Overall Study||11
8376119|NCT01128400|20647043|P3|NOT COMPLETED|Overall Study||16
8376120|NCT01128400|20647044|P2|NOT COMPLETED|Overall Study||1
8376121|NCT01128400|20647045|P1|NOT COMPLETED|Overall Study||2
8376122|NCT01128400|20647043|P3|COMPLETED|Overall Study||7
8376123|NCT01128400|20647044|P2|COMPLETED|Overall Study||8
8376124|NCT01128400|20647045|P1|COMPLETED|Overall Study||6
8376125|NCT01128400|20647043|P3|STARTED|Overall Study||23
8376126|NCT01128400|20647044|P2|STARTED|Overall Study||9
8376127|NCT01128400|20647045|P1|STARTED|Overall Study||8
8376128|NCT01128387|20647058|P2|NOT COMPLETED|Overall Study||1
8376129|NCT01128387|20647059|P1|NOT COMPLETED|Overall Study||0
8376130|NCT01128387|20647058|P2|COMPLETED|Overall Study||5
8376131|NCT01128387|20647059|P1|COMPLETED|Overall Study||5
8376132|NCT01128387|20647058|P2|STARTED|Overall Study||6
8376133|NCT01128387|20647059|P1|STARTED|Overall Study||5
8376134|NCT01128361|20647069|P2|NOT COMPLETED|Overall Study||3
8376135|NCT01128361|20647070|P1|NOT COMPLETED|Overall Study||5
8376136|NCT01128361|20647069|P2|COMPLETED|Overall Study||34
8376137|NCT01128361|20647070|P1|COMPLETED|Overall Study||34
8376138|NCT01128361|20647069|P2|STARTED|Overall Study||37
8376139|NCT01128361|20647070|P1|STARTED|Overall Study||39
8376140|NCT01128296|20647082|P6|NOT COMPLETED|Overall Study||5
8376141|NCT01128296|20647083|P5|NOT COMPLETED|Overall Study||0
8376142|NCT01128296|20647084|P4|NOT COMPLETED|Overall Study||0
8376143|NCT01128296|20647085|P3|NOT COMPLETED|Overall Study||0
8376144|NCT01128296|20647086|P2|NOT COMPLETED|Overall Study||0
8376145|NCT01128296|20647087|P1|NOT COMPLETED|Overall Study||0
8376146|NCT01128296|20647082|P6|COMPLETED|Overall Study||21
8376147|NCT01128296|20647083|P5|COMPLETED|Overall Study||1
8376148|NCT01128296|20647084|P4|COMPLETED|Overall Study||1
8376149|NCT01128296|20647085|P3|COMPLETED|Overall Study||1
8376150|NCT01128296|20647086|P2|COMPLETED|Overall Study||1
8376151|NCT01128296|20647087|P1|COMPLETED|Overall Study||1
8376152|NCT01128296|20647082|P6|STARTED|Overall Study||26
8376153|NCT01128296|20647083|P5|STARTED|Overall Study||1
8376154|NCT01128296|20647084|P4|STARTED|Overall Study||1
8376155|NCT01128296|20647085|P3|STARTED|Overall Study||1
8376156|NCT01128296|20647086|P2|STARTED|Overall Study||1
8376157|NCT01128296|20647087|P1|STARTED|Overall Study||1
8376158|NCT01128270|20647105|P1|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
8376159|NCT01128270|20647105|P1|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
8376160|NCT01128270|20647105|P1|STARTED|Therapeutic Chloral Hydrate (2B)||8
8376161|NCT01128270|20647105|P1|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
8376162|NCT01128270|20647105|P1|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
8376163|NCT01128270|20647105|P1|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
8376164|NCT01128270|20647105|P1|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
8376165|NCT01128270|20647105|P1|COMPLETED|Environmental Chloral Hydrate (1B)||8
8376166|NCT01128270|20647105|P1|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
8376167|NCT01128270|20647105|P1|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
8376168|NCT01128270|20647105|P1|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
8376169|NCT01128270|20647105|P1|STARTED|Environment Chloral Hydrate and DCA (1A)||7
8376170|NCT01128244|20647118|P1|NOT COMPLETED|Overall Study||3
8376171|NCT01128244|20647118|P1|COMPLETED|Overall Study||10
8376172|NCT01128244|20647118|P1|STARTED|Overall Study||13
8376173|NCT01128192|20647128|P3|NOT COMPLETED|Overall Study||0
8376174|NCT01128192|20647129|P2|NOT COMPLETED|Overall Study||0
8376175|NCT01128192|20647130|P1|NOT COMPLETED|Overall Study||0
8376176|NCT01128192|20647128|P3|COMPLETED|Overall Study||7
8376177|NCT01128192|20647129|P2|COMPLETED|Overall Study||19
8376178|NCT01128192|20647130|P1|COMPLETED|Overall Study||19
8376179|NCT01128192|20647128|P3|STARTED|Overall Study||7
8376180|NCT01128192|20647129|P2|STARTED|Overall Study||19
8376181|NCT01128192|20647130|P1|STARTED|Overall Study||19
8376188|NCT01128153|20647180|P2|NOT COMPLETED|Overall Study||15
8376189|NCT01128153|20647181|P1|NOT COMPLETED|Overall Study||16
8376190|NCT01128153|20647180|P2|COMPLETED|Overall Study|Completed 24 weeks|113
8376191|NCT01128153|20647181|P1|COMPLETED|Overall Study|Completed 24 weeks|113
8376192|NCT01128153|20647180|P2|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
8376193|NCT01128153|20647181|P1|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
8376194|NCT01128153|20647180|P2|STARTED|Overall Study|Randomised|128
8376195|NCT01128153|20647181|P1|STARTED|Overall Study|Randomised|129
8376196|NCT01128114|20647197|P1|NOT COMPLETED|Overall Study||8
8376197|NCT01128114|20647197|P1|COMPLETED|Overall Study||24
8376198|NCT01128114|20647197|P1|STARTED|Overall Study||32
8376199|NCT01128049|20647204|P3|NOT COMPLETED|Overall Study||0
8376200|NCT01128049|20647205|P2|NOT COMPLETED|Overall Study||0
8376201|NCT01128049|20647206|P1|NOT COMPLETED|Overall Study||0
8376202|NCT01128049|20647204|P3|COMPLETED|Overall Study||5
8376203|NCT01128049|20647205|P2|COMPLETED|Overall Study||5
8376204|NCT01128049|20647206|P1|COMPLETED|Overall Study||5
8376205|NCT01128049|20647204|P3|STARTED|Overall Study||5
8376206|NCT01128049|20647205|P2|STARTED|Overall Study||5
8376207|NCT01128049|20647206|P1|STARTED|Overall Study||5
8376208|NCT01127763|20647214|P1|NOT COMPLETED|Overall Study||5
8376209|NCT01127763|20647214|P1|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
8376210|NCT01127763|20647214|P1|STARTED|Overall Study||25
8376211|NCT01127737|20647225|P2|NOT COMPLETED|Overall Study||0
8376212|NCT01127737|20647226|P1|NOT COMPLETED|Overall Study||0
8376213|NCT01127737|20647225|P2|COMPLETED|Overall Study||38
8376214|NCT01127737|20647226|P1|COMPLETED|Overall Study||37
8376215|NCT01127737|20647225|P2|STARTED|Overall Study||38
8376216|NCT01127737|20647226|P1|STARTED|Overall Study||37
8376217|NCT01127659|20647238|P6|NOT COMPLETED|Overall Study||0
8376218|NCT01127659|20647239|P5|NOT COMPLETED|Overall Study||0
8376219|NCT01127659|20647240|P4|NOT COMPLETED|Overall Study||4
8376220|NCT01127659|20647241|P3|NOT COMPLETED|Overall Study||2
8376221|NCT01127659|20647242|P2|NOT COMPLETED|Overall Study||8
8376222|NCT01127659|20647243|P1|NOT COMPLETED|Overall Study||2
8376223|NCT01127659|20647238|P6|COMPLETED|Overall Study||21
8376224|NCT01127659|20647239|P5|COMPLETED|Overall Study||50
8376225|NCT01127659|20647240|P4|COMPLETED|Overall Study||6
8376226|NCT01127659|20647241|P3|COMPLETED|Overall Study||10
8376227|NCT01127659|20647242|P2|COMPLETED|Overall Study||14
8376228|NCT01127659|20647243|P1|COMPLETED|Overall Study||20
8376229|NCT01127659|20647238|P6|STARTED|Overall Study||21
8376230|NCT01127659|20647239|P5|STARTED|Overall Study||50
8376231|NCT01127659|20647240|P4|STARTED|Overall Study||10
8376232|NCT01127659|20647241|P3|STARTED|Overall Study||12
8376233|NCT01127659|20647242|P2|STARTED|Overall Study||22
8376234|NCT01127659|20647243|P1|STARTED|Overall Study||22
8376235|NCT01127646|20647259|P2|NOT COMPLETED|Overall Study||1
8376236|NCT01127646|20647260|P1|NOT COMPLETED|Overall Study||1
8376237|NCT01127646|20647259|P2|COMPLETED|Overall Study||7
8376238|NCT01127646|20647260|P1|COMPLETED|Overall Study||14
8376239|NCT01127646|20647259|P2|STARTED|Overall Study||8
8376240|NCT01127646|20647260|P1|STARTED|Overall Study||15
8376241|NCT01127633|20647294|P2|NOT COMPLETED|Overall Study||673
8376242|NCT01127633|20647295|P1|NOT COMPLETED|Overall Study||653
8376243|NCT01127633|20647294|P2|COMPLETED|Overall Study||61
8376244|NCT01127633|20647295|P1|COMPLETED|Overall Study||70
8376245|NCT01127633|20647294|P2|Received at Least 1 Dose of Study Drug|Overall Study||734
8376246|NCT01127633|20647295|P1|Received at Least 1 Dose of Study Drug|Overall Study||723
8376247|NCT01127633|20647294|P2|STARTED|Overall Study||734
8376248|NCT01127633|20647295|P1|STARTED|Overall Study||723
8376249|NCT01127607|20647327|P2|NOT COMPLETED|Phase II (Between Subjects)||2
8376250|NCT01127607|20647328|P1|NOT COMPLETED|Phase II (Between Subjects)||1
8376251|NCT01127607|20647327|P2|COMPLETED|Phase II (Between Subjects)||11
8376252|NCT01127607|20647328|P1|COMPLETED|Phase II (Between Subjects)||13
8376253|NCT01127607|20647327|P2|STARTED|Phase II (Between Subjects)||13
8376254|NCT01127607|20647328|P1|STARTED|Phase II (Between Subjects)||14
8376255|NCT01127607|20647327|P2|NOT COMPLETED|Phase I (Within Subjects)||0
8376256|NCT01127607|20647328|P1|NOT COMPLETED|Phase I (Within Subjects)||0
8376257|NCT01127607|20647327|P2|COMPLETED|Phase I (Within Subjects)||13
8376258|NCT01127607|20647328|P1|COMPLETED|Phase I (Within Subjects)||14
8376259|NCT01127607|20647327|P2|STARTED|Phase I (Within Subjects)||13
8376260|NCT01127607|20647328|P1|STARTED|Phase I (Within Subjects)||14
8376261|NCT01127581|20647401|P2|NOT COMPLETED|Overall Study||0
8376262|NCT01127581|20647402|P1|NOT COMPLETED|Overall Study||0
8376263|NCT01127581|20647401|P2|COMPLETED|Overall Study||680
8376264|NCT01127581|20647402|P1|COMPLETED|Overall Study||678
8376265|NCT01127581|20647401|P2|STARTED|Overall Study||680
8376266|NCT01127581|20647402|P1|STARTED|Overall Study||678
8376267|NCT01127503|20647430|P2|NOT COMPLETED|Overall Study||0
8376268|NCT01127503|20647431|P1|NOT COMPLETED|Overall Study||0
8376269|NCT01127503|20647430|P2|COMPLETED|Overall Study||1
8376270|NCT01127503|20647431|P1|COMPLETED|Overall Study||1
8376271|NCT01127503|20647430|P2|STARTED|Overall Study||1
8376272|NCT01127503|20647431|P1|STARTED|Overall Study||1
8376273|NCT01127438|20647445|P6|NOT COMPLETED|Overall Study||0
8376274|NCT01127438|20647446|P5|NOT COMPLETED|Overall Study||0
8376275|NCT01127438|20647447|P4|NOT COMPLETED|Overall Study||0
8376276|NCT01127438|20647448|P3|NOT COMPLETED|Overall Study||0
8376277|NCT01127438|20647449|P2|NOT COMPLETED|Overall Study||0
8376278|NCT01127438|20647450|P1|NOT COMPLETED|Overall Study||0
8376279|NCT01127438|20647445|P6|COMPLETED|Overall Study||25
8376280|NCT01127438|20647446|P5|COMPLETED|Overall Study||28
8376281|NCT01127438|20647447|P4|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
8376282|NCT01127438|20647448|P3|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
8376283|NCT01127438|20647449|P2|COMPLETED|Overall Study||25
8376284|NCT01127438|20647450|P1|COMPLETED|Overall Study||25
8376285|NCT01127438|20647445|P6|STARTED|Overall Study||25
8376286|NCT01127438|20647446|P5|STARTED|Overall Study||28
8376287|NCT01127438|20647447|P4|STARTED|Overall Study||24
8376288|NCT01127438|20647448|P3|STARTED|Overall Study||26
8376289|NCT01127438|20647449|P2|STARTED|Overall Study||25
8376290|NCT01127438|20647450|P1|STARTED|Overall Study||25
8376291|NCT01127321|20647477|P5|NOT COMPLETED|Overall Study||0
8376292|NCT01127321|20647478|P4|NOT COMPLETED|Overall Study||0
8376293|NCT01127321|20647479|P3|NOT COMPLETED|Overall Study||0
8376294|NCT01127321|20647480|P2|NOT COMPLETED|Overall Study||0
8376295|NCT01127321|20647481|P1|NOT COMPLETED|Overall Study||0
8376296|NCT01127321|20647477|P5|COMPLETED|Overall Study||5
8376297|NCT01127321|20647478|P4|COMPLETED|Overall Study||7
8376298|NCT01127321|20647479|P3|COMPLETED|Overall Study||1
8376299|NCT01127321|20647480|P2|COMPLETED|Overall Study||1
8376300|NCT01127321|20647481|P1|COMPLETED|Overall Study||3
8376301|NCT01127321|20647477|P5|STARTED|Overall Study||5
8376302|NCT01127321|20647478|P4|STARTED|Overall Study||7
8376303|NCT01127321|20647479|P3|STARTED|Overall Study||1
8376304|NCT01127321|20647480|P2|STARTED|Overall Study||1
8376305|NCT01127321|20647481|P1|STARTED|Overall Study||3
8376306|NCT01127256|20647505|P2|NOT COMPLETED|Overall Study||39
8376307|NCT01127256|20647506|P1|NOT COMPLETED|Overall Study||39
8376308|NCT01127256|20647505|P2|COMPLETED|Overall Study||65
8376309|NCT01127256|20647506|P1|COMPLETED|Overall Study||57
8376310|NCT01127256|20647505|P2|STARTED|Overall Study||104
8376311|NCT01127256|20647506|P1|STARTED|Overall Study||96
8376312|NCT01127165|20647518|P2|NOT COMPLETED|Overall Study||19
8376313|NCT01127165|20647519|P1|NOT COMPLETED|Overall Study||16
8376314|NCT01127165|20647518|P2|COMPLETED|Overall Study||41
8376315|NCT01127165|20647519|P1|COMPLETED|Overall Study||49
8376316|NCT01127165|20647518|P2|STARTED|Overall Study||60
8376317|NCT01127165|20647519|P1|STARTED|Overall Study||65
8376318|NCT01127139|20647531|P1|NOT COMPLETED|Overall Study||57
8376319|NCT01127139|20647531|P1|COMPLETED|Overall Study||3771
8376320|NCT01127139|20647531|P1|Number of Participants Analyzed|Overall Study||3828
8376321|NCT01127139|20647531|P1|STARTED|Overall Study||3828
8376322|NCT01127087|20647548|P2|NOT COMPLETED|Overall Study||0
8376323|NCT01127087|20647549|P1|NOT COMPLETED|Overall Study||0
8376324|NCT01127087|20647548|P2|COMPLETED|Overall Study||2
8376325|NCT01127087|20647549|P1|COMPLETED|Overall Study||8
8376326|NCT01127087|20647548|P2|STARTED|Overall Study||2
8376327|NCT01127087|20647549|P1|STARTED|Overall Study||8
8376328|NCT01127061|20647559|P2|NOT COMPLETED|Overall Study||13
8376329|NCT01127061|20647560|P1|NOT COMPLETED|Overall Study||10
8376330|NCT01127061|20647559|P2|COMPLETED|Overall Study||56
8376331|NCT01127061|20647560|P1|COMPLETED|Overall Study||57
8376332|NCT01127061|20647559|P2|STARTED|Overall Study||69
8376333|NCT01127061|20647560|P1|STARTED|Overall Study||67
8376334|NCT01126957|20647590|P1|NOT COMPLETED|Overall Study||0
8376335|NCT01126957|20647590|P1|COMPLETED|Overall Study||103
8376336|NCT01126957|20647590|P1|STARTED|Overall Study||103
8376337|NCT01126879|20647597|P2|NOT COMPLETED|Overall Study||2
8376338|NCT01126879|20647598|P1|NOT COMPLETED|Overall Study||5
8376339|NCT01126879|20647597|P2|COMPLETED|Overall Study||2
8376340|NCT01126879|20647598|P1|COMPLETED|Overall Study||3
8376341|NCT01126879|20647597|P2|Completed 3 Months Genistein/Placebo|Overall Study||2
8376342|NCT01126879|20647598|P1|Completed 3 Months Genistein/Placebo|Overall Study||4
8376343|NCT01126879|20647597|P2|Prostatectomy or Radiation|Overall Study||4
8376344|NCT01126879|20647598|P1|Prostatectomy or Radiation|Overall Study||8
8376345|NCT01126879|20647597|P2|Started 3 Months of Genistein/Placebo|Overall Study||4
8376346|NCT01126879|20647598|P1|Started 3 Months of Genistein/Placebo|Overall Study||8
8376347|NCT01126879|20647597|P2|STARTED|Overall Study||4
8376348|NCT01126879|20647598|P1|STARTED|Overall Study||8
8376349|NCT01126801|20647612|P2|NOT COMPLETED|Overall Study||0
8376350|NCT01126801|20647613|P1|NOT COMPLETED|Overall Study||0
8376351|NCT01126801|20647612|P2|COMPLETED|Overall Study||1
8376352|NCT01126801|20647613|P1|COMPLETED|Overall Study||1
8376353|NCT01126801|20647612|P2|STARTED|Overall Study||1
8376354|NCT01126801|20647613|P1|STARTED|Overall Study||1
8376355|NCT01126723|20647623|P2|NOT COMPLETED|Overall Study||3
8376356|NCT01126723|20647624|P1|NOT COMPLETED|Overall Study||6
8376357|NCT01126723|20647623|P2|COMPLETED|Overall Study||28
8376358|NCT01126723|20647624|P1|COMPLETED|Overall Study||29
8376359|NCT01126723|20647623|P2|STARTED|Overall Study||31
8376360|NCT01126723|20647624|P1|STARTED|Overall Study||35
8376361|NCT01126671|20647632|P2|NOT COMPLETED|Overall Study||1
8376362|NCT01126671|20647633|P1|NOT COMPLETED|Overall Study||2
8376363|NCT01126671|20647632|P2|COMPLETED|Overall Study||29
8376364|NCT01126671|20647633|P1|COMPLETED|Overall Study||24
8376365|NCT01126671|20647632|P2|STARTED|Overall Study||30
8376366|NCT01126671|20647633|P1|STARTED|Overall Study||26
8376367|NCT01126619|20647645|P1|NOT COMPLETED|Overall Study||17
8376368|NCT01126619|20647645|P1|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
8376369|NCT01126619|20647645|P1|STARTED|Overall Study||103
8376370|NCT01126593|20647660|P3|NOT COMPLETED|Overall Study||2
8376371|NCT01126593|20647661|P2|NOT COMPLETED|Overall Study||2
8376372|NCT01126593|20647662|P1|NOT COMPLETED|Overall Study||4
8376373|NCT01126593|20647660|P3|COMPLETED|Overall Study||32
8376374|NCT01126593|20647661|P2|COMPLETED|Overall Study||27
8376375|NCT01126593|20647662|P1|COMPLETED|Overall Study||29
8376376|NCT01126593|20647660|P3|STARTED|Overall Study||34
8376377|NCT01126593|20647661|P2|STARTED|Overall Study||29
8376378|NCT01126593|20647662|P1|STARTED|Overall Study||33
8376379|NCT01126580|20647673|P3|NOT COMPLETED|Overall Study||55
8376380|NCT01126580|20647674|P2|NOT COMPLETED|Overall Study||52
8376381|NCT01126580|20647675|P1|NOT COMPLETED|Overall Study||49
8376382|NCT01126580|20647673|P3|COMPLETED|Overall Study||213
8376383|NCT01126580|20647674|P2|COMPLETED|Overall Study||218
8376384|NCT01126580|20647675|P1|COMPLETED|Overall Study||220
8376385|NCT01126580|20647673|P3|Completed 26 Weeks|Overall Study||226
8376386|NCT01126580|20647674|P2|Completed 26 Weeks|Overall Study||242
8376387|NCT01126580|20647675|P1|Completed 26 Weeks|Overall Study||233
8376388|NCT01126580|20647673|P3|Received at Least 1 Dose of Study Drug|Overall Study||268
8376389|NCT01126580|20647674|P2|Received at Least 1 Dose of Study Drug|Overall Study||270
8376390|NCT01126580|20647675|P1|Received at Least 1 Dose of Study Drug|Overall Study||269
8376391|NCT01126580|20647673|P3|STARTED|Overall Study||268
8376392|NCT01126580|20647674|P2|STARTED|Overall Study||270
8376393|NCT01126580|20647675|P1|STARTED|Overall Study||269
8376394|NCT01126541|20647770|P3|NOT COMPLETED|Overall Study||26
8376395|NCT01126541|20647771|P2|NOT COMPLETED|Overall Study||12
8376396|NCT01126541|20647772|P1|NOT COMPLETED|Overall Study||10
8376397|NCT01126541|20647770|P3|COMPLETED|Overall Study||55
8376398|NCT01126541|20647771|P2|COMPLETED|Overall Study||61
8376399|NCT01126541|20647772|P1|COMPLETED|Overall Study||60
8376400|NCT01126541|20647770|P3|STARTED|Overall Study||81
8376401|NCT01126541|20647771|P2|STARTED|Overall Study||73
8376402|NCT01126541|20647772|P1|STARTED|Overall Study||70
8376403|NCT01126437|20647856|P3|NOT COMPLETED|Overall Study||1313
8376404|NCT01126437|20647857|P2|NOT COMPLETED|Overall Study||1330
8376405|NCT01126437|20647858|P1|NOT COMPLETED|Overall Study||1341
8376406|NCT01126437|20647856|P3|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
8376407|NCT01126437|20647857|P2|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
8376408|NCT01126437|20647858|P1|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
8376409|NCT01126437|20647856|P3|STARTED|Overall Study||5713
8376410|NCT01126437|20647857|P2|STARTED|Overall Study||5729
8376411|NCT01126437|20647858|P1|STARTED|Overall Study||5741
8376412|NCT01126424|20647896|P6|NOT COMPLETED|Overall Study||0
8376413|NCT01126424|20647897|P5|NOT COMPLETED|Overall Study||2
8376414|NCT01126424|20647898|P4|NOT COMPLETED|Overall Study||3
8376415|NCT01126424|20647899|P3|NOT COMPLETED|Overall Study||1
8376416|NCT01126424|20647900|P2|NOT COMPLETED|Overall Study||0
8376417|NCT01126424|20647901|P1|NOT COMPLETED|Overall Study||0
8376418|NCT01126424|20647896|P6|COMPLETED|Overall Study||4
8376419|NCT01126424|20647897|P5|COMPLETED|Overall Study||2
8376420|NCT01126424|20647898|P4|COMPLETED|Overall Study||3
8376421|NCT01126424|20647899|P3|COMPLETED|Overall Study||4
8376422|NCT01126424|20647900|P2|COMPLETED|Overall Study||4
8376423|NCT01126424|20647901|P1|COMPLETED|Overall Study||3
8376424|NCT01126424|20647896|P6|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8376425|NCT01126424|20647897|P5|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8376426|NCT01126424|20647898|P4|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8376427|NCT01126424|20647899|P3|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8376428|NCT01126424|20647900|P2|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
8376429|NCT01126424|20647901|P1|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
8376430|NCT01126424|20647896|P6|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
8376431|NCT01126424|20647897|P5|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
8376432|NCT01126424|20647898|P4|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
8376433|NCT01126424|20647899|P3|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
8376434|NCT01126424|20647900|P2|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
8376435|NCT01126424|20647901|P1|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
8376436|NCT01126359|20647924|P2|NOT COMPLETED|Second Intervention (20-minutes)||0
8376437|NCT01126359|20647925|P1|NOT COMPLETED|Second Intervention (20-minutes)||0
8376438|NCT01126359|20647924|P2|COMPLETED|Second Intervention (20-minutes)||5
8376439|NCT01126359|20647925|P1|COMPLETED|Second Intervention (20-minutes)||5
8376440|NCT01126359|20647924|P2|STARTED|Second Intervention (20-minutes)||5
8376441|NCT01126359|20647925|P1|STARTED|Second Intervention (20-minutes)||5
8376442|NCT01126359|20647924|P2|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
8376443|NCT01126359|20647925|P1|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
8376444|NCT01126359|20647924|P2|COMPLETED|Dressing Replacement/Healing (48-hours)||5
8376445|NCT01126359|20647925|P1|COMPLETED|Dressing Replacement/Healing (48-hours)||5
8376446|NCT01126359|20647924|P2|STARTED|Dressing Replacement/Healing (48-hours)||5
8376447|NCT01126359|20647925|P1|STARTED|Dressing Replacement/Healing (48-hours)||5
8376448|NCT01126359|20647924|P2|NOT COMPLETED|First Intervention (20-minutes)||1
8376449|NCT01126359|20647925|P1|NOT COMPLETED|First Intervention (20-minutes)||0
8376450|NCT01126359|20647924|P2|COMPLETED|First Intervention (20-minutes)||5
8376451|NCT01126359|20647925|P1|COMPLETED|First Intervention (20-minutes)||5
8376452|NCT01126359|20647924|P2|STARTED|First Intervention (20-minutes)||6
8376453|NCT01126359|20647925|P1|STARTED|First Intervention (20-minutes)||5
8376454|NCT01126268|20647937|P1|NOT COMPLETED|Overall Study||1
8376455|NCT01126268|20647937|P1|COMPLETED|Overall Study||37
8376456|NCT01126268|20647937|P1|STARTED|Overall Study||38
8376457|NCT01126099|20647961|P2|NOT COMPLETED|Open-label Extension||1
8376458|NCT01126099|20647962|P1|NOT COMPLETED|Open-label Extension||1
8376459|NCT01126099|20647961|P2|COMPLETED|Open-label Extension||6
8376460|NCT01126099|20647962|P1|COMPLETED|Open-label Extension||4
8376461|NCT01126099|20647961|P2|STARTED|Open-label Extension||7
8376462|NCT01126099|20647962|P1|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
8376463|NCT01126099|20647961|P2|NOT COMPLETED|Double Blind Phase||2
8376464|NCT01126099|20647962|P1|NOT COMPLETED|Double Blind Phase||4
8376465|NCT01126099|20647961|P2|COMPLETED|Double Blind Phase||7
8376466|NCT01126099|20647962|P1|COMPLETED|Double Blind Phase||7
8376467|NCT01126099|20647961|P2|STARTED|Double Blind Phase||9
8376468|NCT01126099|20647962|P1|STARTED|Double Blind Phase||11
8376469|NCT01126060|20647976|P2|NOT COMPLETED|Overall Study||2
8376470|NCT01126060|20647977|P1|NOT COMPLETED|Overall Study||0
8376471|NCT01126060|20647976|P2|COMPLETED|Overall Study||38
8376472|NCT01126060|20647977|P1|COMPLETED|Overall Study||40
8376473|NCT01126060|20647976|P2|STARTED|Overall Study||40
8376474|NCT01126060|20647977|P1|STARTED|Overall Study||40
8376475|NCT01125930|20647985|P2|NOT COMPLETED|Overall Study||10
8376476|NCT01125930|20647986|P1|NOT COMPLETED|Overall Study||1
8376477|NCT01125930|20647985|P2|COMPLETED|Overall Study||36
8376478|NCT01125930|20647986|P1|COMPLETED|Overall Study||21
8376479|NCT01125930|20647985|P2|STARTED|Overall Study||46
8376480|NCT01125930|20647986|P1|STARTED|Overall Study||22
8376481|NCT01125917|20648140|P1|NOT COMPLETED|Overall Study||339
8376482|NCT01125917|20648140|P1|COMPLETED|Overall Study||15
8376483|NCT01125917|20648140|P1|STARTED|Overall Study||354
8376484|NCT01125813|20648144|P1|NOT COMPLETED|Overall Study||6
8376485|NCT01125813|20648144|P1|COMPLETED|Overall Study||30
8376486|NCT01125813|20648144|P1|STARTED|Overall Study||36
8376487|NCT01125800|20648154|P5|NOT COMPLETED|Phase II||11
8376488|NCT01125800|20648155|P4|NOT COMPLETED|Phase II||1
8376489|NCT01125800|20648156|P3|NOT COMPLETED|Phase II||0
8376490|NCT01125800|20648157|P2|NOT COMPLETED|Phase II||0
8376491|NCT01125800|20648158|P1|NOT COMPLETED|Phase II||0
8376492|NCT01125800|20648154|P5|COMPLETED|Phase II||5
8376493|NCT01125800|20648155|P4|COMPLETED|Phase II||0
8376494|NCT01125800|20648156|P3|COMPLETED|Phase II||0
8376495|NCT01125800|20648157|P2|COMPLETED|Phase II||0
8376496|NCT01125800|20648158|P1|COMPLETED|Phase II||0
8376497|NCT01125800|20648154|P5|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
8376498|NCT01125800|20648155|P4|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
8376499|NCT01125800|20648156|P3|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
8376500|NCT01125800|20648157|P2|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
8376501|NCT01125800|20648158|P1|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
8376502|NCT01125800|20648154|P5|NOT COMPLETED|Phase I||0
8376503|NCT01125800|20648155|P4|NOT COMPLETED|Phase I||11
8376504|NCT01125800|20648156|P3|NOT COMPLETED|Phase I||4
8376505|NCT01125800|20648157|P2|NOT COMPLETED|Phase I||9
8376506|NCT01125800|20648158|P1|NOT COMPLETED|Phase I||8
8376507|NCT01125800|20648154|P5|COMPLETED|Phase I||0
8376508|NCT01125800|20648155|P4|COMPLETED|Phase I||10
8376509|NCT01125800|20648156|P3|COMPLETED|Phase I||7
8376510|NCT01125800|20648157|P2|COMPLETED|Phase I||7
8376511|NCT01125800|20648158|P1|COMPLETED|Phase I||3
8376512|NCT01125800|20648154|P5|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
8376513|NCT01125800|20648155|P4|STARTED|Phase I||21
8376514|NCT01125800|20648156|P3|STARTED|Phase I||11
8376515|NCT01125800|20648157|P2|STARTED|Phase I||16
8376516|NCT01125800|20648158|P1|STARTED|Phase I||11
8376517|NCT01125774|20648197|P4|NOT COMPLETED|Overall Study||3
8376518|NCT01125774|20648198|P3|NOT COMPLETED|Overall Study||9
8376519|NCT01125774|20648199|P2|NOT COMPLETED|Overall Study||554
8376520|NCT01125774|20648200|P1|NOT COMPLETED|Overall Study||1125
8376521|NCT01125774|20648197|P4|COMPLETED|Overall Study|Completed study at least once|3
8376522|NCT01125774|20648198|P3|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
8376523|NCT01125774|20648199|P2|COMPLETED|Overall Study||948
8376524|NCT01125774|20648200|P1|COMPLETED|Overall Study||1893
8376525|NCT01125774|20648197|P4|Treated|Overall Study||5
8376526|NCT01125774|20648198|P3|Treated|Overall Study|Received telcagepant|21
8376527|NCT01125774|20648199|P2|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
8376528|NCT01125774|20648200|P1|Treated|Overall Study||2638
8376529|NCT01125774|20648197|P4|STARTED|Overall Study|Unique participants randomized|6
8376530|NCT01125774|20648198|P3|STARTED|Overall Study|Unique participants randomized|22
8376531|NCT01125774|20648199|P2|STARTED|Overall Study|Randomized|1502
8376532|NCT01125774|20648200|P1|STARTED|Overall Study|Randomized|3018
8376533|NCT01125748|20648224|P2|NOT COMPLETED|Overall Study||14
8376534|NCT01125748|20648225|P1|NOT COMPLETED|Overall Study||10
8376535|NCT01125748|20648224|P2|COMPLETED|Overall Study||74
8376536|NCT01125748|20648225|P1|COMPLETED|Overall Study||78
8376537|NCT01125748|20648224|P2|STARTED|Overall Study||88
8376538|NCT01125748|20648225|P1|STARTED|Overall Study||88
8376539|NCT01125722|20648235|P2|NOT COMPLETED|Overall Study||1
8376540|NCT01125722|20648236|P1|NOT COMPLETED|Overall Study||3
8376541|NCT01125722|20648235|P2|COMPLETED|Overall Study||36
8376542|NCT01125722|20648236|P1|COMPLETED|Overall Study||34
8376543|NCT01125722|20648235|P2|STARTED|Overall Study||37
8376544|NCT01125722|20648236|P1|STARTED|Overall Study||37
8376545|NCT01125605|20648250|P1|NOT COMPLETED|Overall Study||0
8376546|NCT01125605|20648250|P1|COMPLETED|Overall Study||325
8376547|NCT01125605|20648250|P1|Safety|Overall Study|1 patient was only analysed for safety|326
8376548|NCT01125605|20648250|P1|STARTED|Overall Study|started = had baseline values|325
8376549|NCT01125566|20648283|P3|NOT COMPLETED|Patients Who Switched From AV to TV||73
8376550|NCT01125566|20648284|P2|NOT COMPLETED|Patients Who Switched From AV to TV||0
8376551|NCT01125566|20648285|P1|NOT COMPLETED|Patients Who Switched From AV to TV||0
8376552|NCT01125566|20648283|P3|COMPLETED|Patients Who Switched From AV to TV||2
8376553|NCT01125566|20648284|P2|COMPLETED|Patients Who Switched From AV to TV||0
8376554|NCT01125566|20648285|P1|COMPLETED|Patients Who Switched From AV to TV||0
8376555|NCT01125566|20648283|P3|STARTED|Patients Who Switched From AV to TV||75
8376556|NCT01125566|20648284|P2|STARTED|Patients Who Switched From AV to TV||0
8376557|NCT01125566|20648285|P1|STARTED|Patients Who Switched From AV to TV||0
8376558|NCT01125566|20648283|P3|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
8376559|NCT01125566|20648284|P2|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169
8376560|NCT01125566|20648285|P1|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265
8376561|NCT01125566|20648283|P3|COMPLETED|Patients Before the Switch (26Apr2013)||0
8376562|NCT01125566|20648284|P2|COMPLETED|Patients Before the Switch (26Apr2013)||0
8376563|NCT01125566|20648285|P1|COMPLETED|Patients Before the Switch (26Apr2013)||74
8376564|NCT01125566|20648283|P3|Treated|Patients Before the Switch (26Apr2013)||0
8376565|NCT01125566|20648284|P2|Treated|Patients Before the Switch (26Apr2013)||169
8376566|NCT01125566|20648285|P1|Treated|Patients Before the Switch (26Apr2013)||337
8376567|NCT01125566|20648283|P3|STARTED|Patients Before the Switch (26Apr2013)||0
8376568|NCT01125566|20648284|P2|STARTED|Patients Before the Switch (26Apr2013)||169
8376569|NCT01125566|20648285|P1|STARTED|Patients Before the Switch (26Apr2013)||339
8376570|NCT01125514|20648298|P1|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
8376571|NCT01125514|20648298|P1|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
8376572|NCT01125514|20648298|P1|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
8376573|NCT01125514|20648298|P1|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
8376574|NCT01125514|20648298|P1|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
8376575|NCT01125514|20648298|P1|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
8376576|NCT01125514|20648298|P1|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
8376577|NCT01125514|20648298|P1|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
8376578|NCT01125514|20648298|P1|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
8376579|NCT01125514|20648298|P1|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
8376580|NCT01125514|20648298|P1|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
8376581|NCT01125202|20648372|P2|NOT COMPLETED|Overall Study||7
8376582|NCT01125202|20648373|P1|NOT COMPLETED|Overall Study||12
8376583|NCT01125202|20648372|P2|COMPLETED|Overall Study||79
8376584|NCT01125202|20648373|P1|COMPLETED|Overall Study||81
8376585|NCT01125202|20648372|P2|STARTED|Overall Study||86
8376586|NCT01125202|20648373|P1|STARTED|Overall Study||93
8376587|NCT01125189|20648398|P3|NOT COMPLETED|Follow up Period||16
8376588|NCT01125189|20648399|P2|NOT COMPLETED|Follow up Period||15
8376589|NCT01125189|20648400|P1|NOT COMPLETED|Follow up Period||20
8376590|NCT01125189|20648398|P3|COMPLETED|Follow up Period||58
8376591|NCT01125189|20648399|P2|COMPLETED|Follow up Period||138
8376592|NCT01125189|20648400|P1|COMPLETED|Follow up Period||132
8376593|NCT01125189|20648398|P3|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
8376594|NCT01125189|20648399|P2|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
8376595|NCT01125189|20648400|P1|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
8376596|NCT01125189|20648398|P3|NOT COMPLETED|Treatment Period||41
8376597|NCT01125189|20648399|P2|NOT COMPLETED|Treatment Period||35
8376598|NCT01125189|20648400|P1|NOT COMPLETED|Treatment Period||31
8376599|NCT01125189|20648398|P3|COMPLETED|Treatment Period||37
8376600|NCT01125189|20648399|P2|COMPLETED|Treatment Period||123
8376601|NCT01125189|20648400|P1|COMPLETED|Treatment Period||128
8376602|NCT01125189|20648398|P3|STARTED|Treatment Period||78
8376603|NCT01125189|20648399|P2|STARTED|Treatment Period||158
8376604|NCT01125189|20648400|P1|STARTED|Treatment Period||159
8376611|NCT01125163|20648432|P2|NOT COMPLETED|Overall Study||0
8376612|NCT01125163|20648433|P1|NOT COMPLETED|Overall Study||0
8376613|NCT01125163|20648432|P2|COMPLETED|Overall Study||74
8376614|NCT01125163|20648433|P1|COMPLETED|Overall Study||76
8376615|NCT01125163|20648432|P2|STARTED|Overall Study||74
8376616|NCT01125163|20648433|P1|STARTED|Overall Study||76
8376617|NCT01125098|20648443|P2|NOT COMPLETED|Overall Study||0
8376618|NCT01125098|20648444|P1|NOT COMPLETED|Overall Study||3
8376619|NCT01125098|20648443|P2|COMPLETED|Overall Study||90
8376620|NCT01125098|20648444|P1|COMPLETED|Overall Study||88
8376621|NCT01125098|20648443|P2|STARTED|Overall Study||90
8376622|NCT01125098|20648444|P1|STARTED|Overall Study||91
8376623|NCT01125046|20648450|P1|NOT COMPLETED|Follow-up/Data Cut Off Point||33
8376624|NCT01125046|20648450|P1|COMPLETED|Follow-up/Data Cut Off Point||16
8376625|NCT01125046|20648450|P1|STARTED|Follow-up/Data Cut Off Point||49
8376626|NCT01125046|20648450|P1|NOT COMPLETED|Continued Treatment After 6 Months||3
8376627|NCT01125046|20648450|P1|COMPLETED|Continued Treatment After 6 Months||33
8376628|NCT01125046|20648450|P1|STARTED|Continued Treatment After 6 Months||36
8376629|NCT01125046|20648450|P1|NOT COMPLETED|First 6 Months of Treatment||14
8376630|NCT01125046|20648450|P1|COMPLETED|First 6 Months of Treatment||36
8376631|NCT01125046|20648450|P1|STARTED|First 6 Months of Treatment||50
8376632|NCT01124955|20648460|P2|NOT COMPLETED|Overall Study||0
8376633|NCT01124955|20648461|P1|NOT COMPLETED|Overall Study||0
8376634|NCT01124955|20648460|P2|COMPLETED|Overall Study||40
8376635|NCT01124955|20648461|P1|COMPLETED|Overall Study||40
8376636|NCT01124955|20648460|P2|STARTED|Overall Study||40
8376637|NCT01124955|20648461|P1|STARTED|Overall Study||40
8376638|NCT01124916|20648477|P2|NOT COMPLETED|Overall Study||2
8376639|NCT01124916|20648478|P1|NOT COMPLETED|Overall Study||3
8376640|NCT01124916|20648477|P2|COMPLETED|Overall Study||38
8376641|NCT01124916|20648478|P1|COMPLETED|Overall Study||35
8376642|NCT01124916|20648477|P2|STARTED|Overall Study||40
8376643|NCT01124916|20648478|P1|STARTED|Overall Study||38
8376644|NCT01124864|20648492|P6|NOT COMPLETED|Overall Study||3
8376645|NCT01124864|20648493|P5|NOT COMPLETED|Overall Study||30
8376646|NCT01124864|20648494|P4|NOT COMPLETED|Overall Study||21
8376647|NCT01124864|20648495|P3|NOT COMPLETED|Overall Study||34
8376648|NCT01124864|20648496|P2|NOT COMPLETED|Overall Study||35
8376649|NCT01124864|20648497|P1|NOT COMPLETED|Overall Study||28
8376650|NCT01124864|20648492|P6|COMPLETED|Overall Study||0
8376651|NCT01124864|20648493|P5|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
8376652|NCT01124864|20648494|P4|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
8376653|NCT01124864|20648495|P3|COMPLETED|Overall Study||0
8376654|NCT01124864|20648496|P2|COMPLETED|Overall Study||0
8376655|NCT01124864|20648497|P1|COMPLETED|Overall Study||0
8376656|NCT01124864|20648492|P6|STARTED|Overall Study||3
8376657|NCT01124864|20648493|P5|STARTED|Overall Study||31
8376658|NCT01124864|20648494|P4|STARTED|Overall Study||22
8376659|NCT01124864|20648495|P3|STARTED|Overall Study||34
8376660|NCT01124864|20648496|P2|STARTED|Overall Study||35
8376661|NCT01124864|20648497|P1|STARTED|Overall Study||28
8376672|NCT01124786|20648578|P2|NOT COMPLETED|Overall Study||5
8376673|NCT01124786|20648579|P1|NOT COMPLETED|Overall Study||4
8376674|NCT01124786|20648578|P2|COMPLETED|Overall Study||180
8376675|NCT01124786|20648579|P1|COMPLETED|Overall Study||178
8376676|NCT01124786|20648578|P2|Tumor Evaluable Population|Overall Study||180
8376677|NCT01124786|20648579|P1|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
8376678|NCT01124786|20648578|P2|Safety Population|Overall Study||181
8376679|NCT01124786|20648579|P1|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
8376680|NCT01124786|20648578|P2|Intent-to-Treat (ITT) Population|Overall Study||185
8376681|NCT01124786|20648579|P1|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
8376682|NCT01124786|20648578|P2|STARTED|Overall Study||185
8376683|NCT01124786|20648579|P1|STARTED|Overall Study||182
8376684|NCT01124734|20648599|P1|NOT COMPLETED|Overall Study||17
8376685|NCT01124734|20648599|P1|COMPLETED|Overall Study|Closed to accrual|0
8376686|NCT01124734|20648599|P1|Initiation of Course 1 Cycle 2|Overall Study||17
8376687|NCT01124734|20648599|P1|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17
8376688|NCT01124734|20648599|P1|STARTED|Overall Study||17
8376692|NCT01124617|20648624|P2|NOT COMPLETED|Overall Study||6
8376693|NCT01124617|20648625|P1|NOT COMPLETED|Overall Study||19
8376694|NCT01124617|20648624|P2|COMPLETED|Overall Study||25
8376695|NCT01124617|20648625|P1|COMPLETED|Overall Study||41
8376696|NCT01124617|20648624|P2|STARTED|Overall Study||31
8376697|NCT01124617|20648625|P1|STARTED|Overall Study||60
8376698|NCT01124604|20648657|P2|NOT COMPLETED|Overall Study||2
8376699|NCT01124604|20648658|P1|NOT COMPLETED|Overall Study||15
8376700|NCT01124604|20648657|P2|COMPLETED|Overall Study||29
8376701|NCT01124604|20648658|P1|COMPLETED|Overall Study||45
8376702|NCT01124604|20648657|P2|STARTED|Overall Study||31
8376703|NCT01124604|20648658|P1|STARTED|Overall Study||60
8376704|NCT01124448|20648697|P2|NOT COMPLETED|Overall Study||3
8376705|NCT01124448|20648698|P1|NOT COMPLETED|Overall Study||2
8376706|NCT01124448|20648697|P2|COMPLETED|Overall Study||12
8376707|NCT01124448|20648698|P1|COMPLETED|Overall Study||23
8376708|NCT01124448|20648697|P2|STARTED|Overall Study||15
8376709|NCT01124448|20648698|P1|STARTED|Overall Study||25
8376710|NCT01124422|20648706|P3|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
8376711|NCT01124422|20648707|P2|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
8376712|NCT01124422|20648708|P1|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
8376713|NCT01124422|20648706|P3|COMPLETED|4-Week Double-blind Treatment Phase||115
8376714|NCT01124422|20648707|P2|COMPLETED|4-Week Double-blind Treatment Phase||120
8376715|NCT01124422|20648708|P1|COMPLETED|4-Week Double-blind Treatment Phase||0
8376716|NCT01124422|20648706|P3|STARTED|4-Week Double-blind Treatment Phase||124
8376717|NCT01124422|20648707|P2|STARTED|4-Week Double-blind Treatment Phase||131
8376718|NCT01124422|20648708|P1|STARTED|4-Week Double-blind Treatment Phase||0
8376719|NCT01124422|20648706|P3|NOT COMPLETED|4-Week Open-label Run-in Phase||0
8376720|NCT01124422|20648707|P2|NOT COMPLETED|4-Week Open-label Run-in Phase||0
8376721|NCT01124422|20648708|P1|NOT COMPLETED|4-Week Open-label Run-in Phase||83
8376722|NCT01124422|20648706|P3|COMPLETED|4-Week Open-label Run-in Phase||0
8376723|NCT01124422|20648707|P2|COMPLETED|4-Week Open-label Run-in Phase||0
8376724|NCT01124422|20648708|P1|COMPLETED|4-Week Open-label Run-in Phase||255
8376725|NCT01124422|20648706|P3|STARTED|4-Week Open-label Run-in Phase||0
8376726|NCT01124422|20648707|P2|STARTED|4-Week Open-label Run-in Phase||0
8376727|NCT01124422|20648708|P1|STARTED|4-Week Open-label Run-in Phase||338
8376728|NCT01124370|20648750|P1|NOT COMPLETED|Overall Study||20
8376729|NCT01124370|20648750|P1|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
8376730|NCT01124370|20648750|P1|3 Month Visit|Overall Study|Defines evaluable population|47
8376731|NCT01124370|20648750|P1|Therapy Initiated|Overall Study||48
8376732|NCT01124370|20648750|P1|Successfully Implanted|Overall Study||50
8376733|NCT01124370|20648750|P1|STARTED|Overall Study|Underwent implant attempt|57
8376734|NCT01124305|20648762|P2|NOT COMPLETED|Overall Study||10
8376735|NCT01124305|20648763|P1|NOT COMPLETED|Overall Study||8
8376736|NCT01124305|20648762|P2|COMPLETED|Overall Study||26
8376737|NCT01124305|20648763|P1|COMPLETED|Overall Study||26
8376738|NCT01124305|20648762|P2|STARTED|Overall Study||36
8376739|NCT01124305|20648763|P1|STARTED|Overall Study||34
8376740|NCT01124292|20648778|P3|NOT COMPLETED|Overall Study||10
8376741|NCT01124292|20648779|P2|NOT COMPLETED|Overall Study||15
8376742|NCT01124292|20648780|P1|NOT COMPLETED|Overall Study||2
8376743|NCT01124292|20648778|P3|COMPLETED|Overall Study||11
8376744|NCT01124292|20648779|P2|COMPLETED|Overall Study||9
8376745|NCT01124292|20648780|P1|COMPLETED|Overall Study||14
8376746|NCT01124292|20648778|P3|STARTED|Overall Study||21
8376747|NCT01124292|20648779|P2|STARTED|Overall Study||24
8376748|NCT01124292|20648780|P1|STARTED|Overall Study||16
8376749|NCT01124188|20648838|P2|NOT COMPLETED|Overall Study||6
8376750|NCT01124188|20648839|P1|NOT COMPLETED|Overall Study||8
8376751|NCT01124188|20648838|P2|COMPLETED|Overall Study||65
8376752|NCT01124188|20648839|P1|COMPLETED|Overall Study||60
8376753|NCT01124188|20648838|P2|STARTED|Overall Study||71
8376754|NCT01124188|20648839|P1|STARTED|Overall Study||68
8376755|NCT01124175|20648851|P2|NOT COMPLETED|Second Intervention||0
8376756|NCT01124175|20648852|P1|NOT COMPLETED|Second Intervention||0
8376757|NCT01124175|20648851|P2|COMPLETED|Second Intervention||38
8376758|NCT01124175|20648852|P1|COMPLETED|Second Intervention||40
8376759|NCT01124175|20648851|P2|STARTED|Second Intervention||38
8376760|NCT01124175|20648852|P1|STARTED|Second Intervention||40
8376761|NCT01124175|20648851|P2|NOT COMPLETED|Washout of 7 Days||2
8376762|NCT01124175|20648852|P1|NOT COMPLETED|Washout of 7 Days||0
8376763|NCT01124175|20648851|P2|COMPLETED|Washout of 7 Days||38
8376764|NCT01124175|20648852|P1|COMPLETED|Washout of 7 Days||40
8376765|NCT01124175|20648851|P2|STARTED|Washout of 7 Days||40
8376766|NCT01124175|20648852|P1|STARTED|Washout of 7 Days||40
8376767|NCT01124175|20648851|P2|NOT COMPLETED|First Intervention||0
8376768|NCT01124175|20648852|P1|NOT COMPLETED|First Intervention||0
8376769|NCT01124175|20648851|P2|COMPLETED|First Intervention||40
8376770|NCT01124175|20648852|P1|COMPLETED|First Intervention||40
8376771|NCT01124175|20648851|P2|STARTED|First Intervention||40
8376772|NCT01124175|20648852|P1|STARTED|First Intervention||40
8376773|NCT01124162|20648870|P2|NOT COMPLETED|Second Intervention||0
8376774|NCT01124162|20648871|P1|NOT COMPLETED|Second Intervention||0
8376775|NCT01124162|20648870|P2|COMPLETED|Second Intervention||40
8376776|NCT01124162|20648871|P1|COMPLETED|Second Intervention||37
8376777|NCT01124162|20648870|P2|STARTED|Second Intervention||40
8376778|NCT01124162|20648871|P1|STARTED|Second Intervention||37
8376779|NCT01124162|20648870|P2|NOT COMPLETED|Washout of 7 Days||0
8376780|NCT01124162|20648871|P1|NOT COMPLETED|Washout of 7 Days||1
8376781|NCT01124162|20648870|P2|COMPLETED|Washout of 7 Days||40
8376782|NCT01124162|20648871|P1|COMPLETED|Washout of 7 Days||37
8376783|NCT01124162|20648870|P2|STARTED|Washout of 7 Days||40
8376784|NCT01124162|20648871|P1|STARTED|Washout of 7 Days||38
8376785|NCT01124162|20648870|P2|NOT COMPLETED|First Intervention||0
8376786|NCT01124162|20648871|P1|NOT COMPLETED|First Intervention||2
8376787|NCT01124162|20648870|P2|COMPLETED|First Intervention||40
8376788|NCT01124162|20648871|P1|COMPLETED|First Intervention||38
8376789|NCT01124162|20648870|P2|STARTED|First Intervention||40
8376790|NCT01124162|20648871|P1|STARTED|First Intervention||40
8376797|NCT01124097|20648907|P4|NOT COMPLETED|Overall Study||14
8376798|NCT01124097|20648908|P3|NOT COMPLETED|Overall Study||20
8376799|NCT01124097|20648909|P2|NOT COMPLETED|Overall Study||22
8376800|NCT01124097|20648910|P1|NOT COMPLETED|Overall Study||34
8376801|NCT01124097|20648907|P4|COMPLETED|Overall Study||46
8376802|NCT01124097|20648908|P3|COMPLETED|Overall Study||40
8376803|NCT01124097|20648909|P2|COMPLETED|Overall Study||38
8376804|NCT01124097|20648910|P1|COMPLETED|Overall Study||26
8376805|NCT01124097|20648907|P4|Efficacy Population|Overall Study||51
8376806|NCT01124097|20648908|P3|Efficacy Population|Overall Study||53
8376807|NCT01124097|20648909|P2|Efficacy Population|Overall Study||53
8376808|NCT01124097|20648910|P1|Efficacy Population|Overall Study||52
8376809|NCT01124097|20648907|P4|Safety Population|Overall Study||60
8376810|NCT01124097|20648908|P3|Safety Population|Overall Study||60
8376811|NCT01124097|20648909|P2|Safety Population|Overall Study||60
8376812|NCT01124097|20648910|P1|Safety Population|Overall Study||60
8376813|NCT01124097|20648907|P4|STARTED|Overall Study||60
8376814|NCT01124097|20648908|P3|STARTED|Overall Study||60
8376815|NCT01124097|20648909|P2|STARTED|Overall Study||60
8376816|NCT01124097|20648910|P1|STARTED|Overall Study||60
8376817|NCT01124045|20648922|P2|NOT COMPLETED|Overall Study||3
8376818|NCT01124045|20648923|P1|NOT COMPLETED|Overall Study||0
8376819|NCT01124045|20648922|P2|COMPLETED|Overall Study||37
8376820|NCT01124045|20648923|P1|COMPLETED|Overall Study||39
8376821|NCT01124045|20648922|P2|STARTED|Overall Study||40
8376822|NCT01124045|20648923|P1|STARTED|Overall Study||39
8376823|NCT01124006|20648956|P3|NOT COMPLETED|Overall Study||2
8376824|NCT01124006|20648957|P2|NOT COMPLETED|Overall Study||2
8376825|NCT01124006|20648958|P1|NOT COMPLETED|Overall Study||3
8376826|NCT01124006|20648956|P3|COMPLETED|Overall Study||2
8376827|NCT01124006|20648957|P2|COMPLETED|Overall Study||8
8376828|NCT01124006|20648958|P1|COMPLETED|Overall Study||7
8376829|NCT01124006|20648956|P3|STARTED|Overall Study||4
8376830|NCT01124006|20648957|P2|STARTED|Overall Study||10
8376831|NCT01124006|20648958|P1|STARTED|Overall Study||10
8376832|NCT01123980|20648986|P2|NOT COMPLETED|Overall Study||24
8376833|NCT01123980|20648987|P1|NOT COMPLETED|Overall Study||19
8376834|NCT01123980|20648986|P2|COMPLETED|Overall Study||236
8376835|NCT01123980|20648987|P1|COMPLETED|Overall Study||242
8376836|NCT01123980|20648986|P2|STARTED|Overall Study||260
8376837|NCT01123980|20648987|P1|STARTED|Overall Study||261
8376838|NCT01123941|20649007|P2|NOT COMPLETED|Overall Study||1
8376839|NCT01123941|20649008|P1|NOT COMPLETED|Overall Study||2
8376840|NCT01123941|20649007|P2|COMPLETED|Overall Study||24
8376841|NCT01123941|20649008|P1|COMPLETED|Overall Study||23
8376842|NCT01123941|20649007|P2|STARTED|Overall Study||25
8376843|NCT01123941|20649008|P1|STARTED|Overall Study||25
8376844|NCT01123928|20649022|P2|NOT COMPLETED|Overall Study||0
8376845|NCT01123928|20649023|P1|NOT COMPLETED|Overall Study||0
8376846|NCT01123928|20649022|P2|COMPLETED|Overall Study||222
8376847|NCT01123928|20649023|P1|COMPLETED|Overall Study||212
8376848|NCT01123928|20649022|P2|STARTED|Overall Study||222
8376849|NCT01123928|20649023|P1|STARTED|Overall Study||212
8376850|NCT01123889|20649043|P2|NOT COMPLETED|Overall Study||1
8376851|NCT01123889|20649044|P1|NOT COMPLETED|Overall Study||3
8376852|NCT01123889|20649043|P2|COMPLETED|Overall Study||6
8376853|NCT01123889|20649044|P1|COMPLETED|Overall Study||2
8376854|NCT01123889|20649043|P2|STARTED|Overall Study||7
8376855|NCT01123889|20649044|P1|STARTED|Overall Study||5
8376856|NCT01123850|20649054|P1|NOT COMPLETED|Overall Study||45
8376857|NCT01123850|20649054|P1|COMPLETED|Overall Study||0
8376858|NCT01123850|20649054|P1|STARTED|Overall Study||45
8376859|NCT01123655|20649061|P3|NOT COMPLETED|Overall Study||1
8376860|NCT01123655|20649062|P2|NOT COMPLETED|Overall Study||1
8376861|NCT01123655|20649063|P1|NOT COMPLETED|Overall Study||1
8376862|NCT01123655|20649061|P3|COMPLETED|Overall Study||7
8376863|NCT01123655|20649062|P2|COMPLETED|Overall Study||3
8376864|NCT01123655|20649063|P1|COMPLETED|Overall Study||9
8376865|NCT01123655|20649061|P3|STARTED|Overall Study||8
8376866|NCT01123655|20649062|P2|STARTED|Overall Study||4
8376867|NCT01123655|20649063|P1|STARTED|Overall Study||10
8376868|NCT01123642|20649135|P1|NOT COMPLETED|Overall Study||68
8376869|NCT01123642|20649135|P1|COMPLETED|Overall Study||277
8376870|NCT01123642|20649135|P1|STARTED|Overall Study||345
8376871|NCT01123512|20649144|P2|NOT COMPLETED|Overall Study||21
8376872|NCT01123512|20649145|P1|NOT COMPLETED|Overall Study||26
8376873|NCT01123512|20649144|P2|COMPLETED|Overall Study||126
8376874|NCT01123512|20649145|P1|COMPLETED|Overall Study||127
8376875|NCT01123512|20649144|P2|STARTED|Overall Study||147
8376876|NCT01123512|20649145|P1|STARTED|Overall Study||153
8376877|NCT01123395|20649151|P2|NOT COMPLETED|Period 2||0
8376878|NCT01123395|20649152|P1|NOT COMPLETED|Period 2||0
8376879|NCT01123395|20649151|P2|COMPLETED|Period 2||7
8376880|NCT01123395|20649152|P1|COMPLETED|Period 2||8
8376881|NCT01123395|20649151|P2|STARTED|Period 2||7
8376882|NCT01123395|20649152|P1|STARTED|Period 2||8
8376883|NCT01123395|20649151|P2|NOT COMPLETED|Washout Period of 14 Days||1
8376884|NCT01123395|20649152|P1|NOT COMPLETED|Washout Period of 14 Days||0
8376885|NCT01123395|20649151|P2|COMPLETED|Washout Period of 14 Days||7
8376886|NCT01123395|20649152|P1|COMPLETED|Washout Period of 14 Days||8
8376887|NCT01123395|20649151|P2|STARTED|Washout Period of 14 Days||8
8376888|NCT01123395|20649152|P1|STARTED|Washout Period of 14 Days||8
8376889|NCT01123395|20649151|P2|NOT COMPLETED|Period 1||0
8376890|NCT01123395|20649152|P1|NOT COMPLETED|Period 1||0
8376891|NCT01123395|20649151|P2|COMPLETED|Period 1||8
8376892|NCT01123395|20649152|P1|COMPLETED|Period 1||8
8376893|NCT01123395|20649151|P2|STARTED|Period 1||8
8376894|NCT01123395|20649152|P1|STARTED|Period 1||8
8376895|NCT01123382|20649164|P2|NOT COMPLETED|Overall Study||6
8376896|NCT01123382|20649165|P1|NOT COMPLETED|Overall Study||2
8376897|NCT01123382|20649164|P2|COMPLETED|Overall Study||6
8376898|NCT01123382|20649165|P1|COMPLETED|Overall Study||11
8376899|NCT01123382|20649164|P2|Received Intervention|Overall Study||10
8376900|NCT01123382|20649165|P1|Received Intervention|Overall Study||12
8376901|NCT01123382|20649164|P2|STARTED|Overall Study||12
8376902|NCT01123382|20649165|P1|STARTED|Overall Study||13
8376903|NCT01123356|20649187|P1|NOT COMPLETED|Overall Study||7
8376904|NCT01123356|20649187|P1|COMPLETED|Overall Study||14
8376905|NCT01123356|20649187|P1|STARTED|Overall Study||21
8376906|NCT01123200|20649195|P1|NOT COMPLETED|Overall Study||1
8376907|NCT01123200|20649195|P1|COMPLETED|Overall Study||0
8376908|NCT01123200|20649195|P1|STARTED|Overall Study||1
8376909|NCT01123161|20649202|P2|NOT COMPLETED|Overall Study||0
8376910|NCT01123161|20649203|P1|NOT COMPLETED|Overall Study||2
8376911|NCT01123161|20649202|P2|COMPLETED|Overall Study||63
8376912|NCT01123161|20649203|P1|COMPLETED|Overall Study||55
8376913|NCT01123161|20649202|P2|STARTED|Overall Study||63
8376914|NCT01123161|20649203|P1|STARTED|Overall Study||57
8376915|NCT01123148|20649221|P1|NOT COMPLETED|Overall Study||2
8376916|NCT01123148|20649221|P1|COMPLETED|Overall Study||12
8376917|NCT01123148|20649221|P1|BCI Calibration >50% Accuracy|Overall Study||13
8376918|NCT01123148|20649221|P1|STARTED|Overall Study||14
8376919|NCT01123083|20649227|P2|NOT COMPLETED|Overall Study||15
8376920|NCT01123083|20649228|P1|NOT COMPLETED|Overall Study||11
8376921|NCT01123083|20649227|P2|COMPLETED|Overall Study||103
8376922|NCT01123083|20649228|P1|COMPLETED|Overall Study||50
8376923|NCT01123083|20649227|P2|STARTED|Overall Study||118
8376924|NCT01123083|20649228|P1|STARTED|Overall Study||61
8376925|NCT01122927|20649252|P2|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
8376926|NCT01122927|20649253|P1|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
8376927|NCT01122927|20649252|P2|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
8376928|NCT01122927|20649253|P1|COMPLETED|Period 2- Open-label Treatment Phase||0
8376929|NCT01122927|20649252|P2|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
8376930|NCT01122927|20649253|P1|STARTED|Period 2- Open-label Treatment Phase||0
8376931|NCT01122927|20649252|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
8376932|NCT01122927|20649253|P1|NOT COMPLETED|Period 1 - Conversion Phase||14
8376933|NCT01122927|20649252|P2|COMPLETED|Period 1 - Conversion Phase||0
8376934|NCT01122927|20649253|P1|COMPLETED|Period 1 - Conversion Phase||283
8376935|NCT01122927|20649252|P2|STARTED|Period 1 - Conversion Phase||0
8376936|NCT01122927|20649253|P1|STARTED|Period 1 - Conversion Phase||297
8376937|NCT01122901|20649286|P2|NOT COMPLETED|Overall Study||0
8376938|NCT01122901|20649287|P1|NOT COMPLETED|Overall Study||0
8376939|NCT01122901|20649286|P2|COMPLETED|Overall Study||7
8376940|NCT01122901|20649287|P1|COMPLETED|Overall Study||40
8376941|NCT01122901|20649286|P2|STARTED|Overall Study||7
8376942|NCT01122901|20649287|P1|STARTED|Overall Study||40
8376943|NCT01122862|20649305|P3|NOT COMPLETED|Period 3||0
8376944|NCT01122862|20649306|P2|NOT COMPLETED|Period 3||0
8376945|NCT01122862|20649307|P1|NOT COMPLETED|Period 3||0
8376946|NCT01122862|20649305|P3|COMPLETED|Period 3||8
8376947|NCT01122862|20649306|P2|COMPLETED|Period 3||7
8376948|NCT01122862|20649307|P1|COMPLETED|Period 3||6
8376949|NCT01122862|20649305|P3|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
8376950|NCT01122862|20649306|P2|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
8376951|NCT01122862|20649307|P1|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
8376952|NCT01122862|20649305|P3|NOT COMPLETED|Period 2||1
8376953|NCT01122862|20649306|P2|NOT COMPLETED|Period 2||0
8376954|NCT01122862|20649307|P1|NOT COMPLETED|Period 2||0
8376955|NCT01122862|20649305|P3|COMPLETED|Period 2||6
8376956|NCT01122862|20649306|P2|COMPLETED|Period 2||7
8376957|NCT01122862|20649307|P1|COMPLETED|Period 2||8
8376958|NCT01122862|20649305|P3|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
8376959|NCT01122862|20649306|P2|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
8376960|NCT01122862|20649307|P1|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
8376961|NCT01122862|20649305|P3|NOT COMPLETED|Period 1||0
8376962|NCT01122862|20649306|P2|NOT COMPLETED|Period 1||1
8376963|NCT01122862|20649307|P1|NOT COMPLETED|Period 1||0
8376964|NCT01122862|20649305|P3|COMPLETED|Period 1||7
8376965|NCT01122862|20649306|P2|COMPLETED|Period 1||7
8376966|NCT01122862|20649307|P1|COMPLETED|Period 1||8
8376967|NCT01122862|20649305|P3|STARTED|Period 1||7
8376968|NCT01122862|20649306|P2|STARTED|Period 1||8
8376969|NCT01122862|20649307|P1|STARTED|Period 1||8
8376970|NCT01122849|20649328|P3|NOT COMPLETED|Overall Study||0
8376971|NCT01122849|20649329|P2|NOT COMPLETED|Overall Study||0
8376972|NCT01122849|20649330|P1|NOT COMPLETED|Overall Study||0
8376973|NCT01122849|20649328|P3|COMPLETED|Overall Study||20
8376974|NCT01122849|20649329|P2|COMPLETED|Overall Study||21
8376975|NCT01122849|20649330|P1|COMPLETED|Overall Study||20
8376976|NCT01122849|20649328|P3|STARTED|Overall Study||20
8376977|NCT01122849|20649329|P2|STARTED|Overall Study||21
8376978|NCT01122849|20649330|P1|STARTED|Overall Study||20
8376979|NCT01122680|20649413|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
8376980|NCT01122680|20649414|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
8376981|NCT01122680|20649415|P2|NOT COMPLETED|Period 3 (4 Weeks)||1
8376982|NCT01122680|20649416|P1|NOT COMPLETED|Period 3 (4 Weeks)||1
8376983|NCT01122680|20649413|P4|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
8376984|NCT01122680|20649414|P3|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
8376985|NCT01122680|20649415|P2|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
8376986|NCT01122680|20649416|P1|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
8376987|NCT01122680|20649413|P4|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
8376988|NCT01122680|20649414|P3|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
8376989|NCT01122680|20649415|P2|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
8376990|NCT01122680|20649416|P1|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
8376991|NCT01122680|20649413|P4|NOT COMPLETED|Period 2 (4 Weeks)||1
8376992|NCT01122680|20649414|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
8376993|NCT01122680|20649415|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
8376994|NCT01122680|20649416|P1|NOT COMPLETED|Period 2 (4 Weeks)||1
8376995|NCT01122680|20649413|P4|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
8376996|NCT01122680|20649414|P3|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
8376997|NCT01122680|20649415|P2|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
8376998|NCT01122680|20649416|P1|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
8376999|NCT01122680|20649413|P4|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
8377000|NCT01122680|20649414|P3|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
8377001|NCT01122680|20649415|P2|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
8377002|NCT01122680|20649416|P1|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
8377003|NCT01122680|20649413|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
8377004|NCT01122680|20649414|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
8377005|NCT01122680|20649415|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
8377006|NCT01122680|20649416|P1|NOT COMPLETED|Period 1 (4 Weeks)||3
8377007|NCT01122680|20649413|P4|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
8377008|NCT01122680|20649414|P3|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
8377009|NCT01122680|20649415|P2|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
8377010|NCT01122680|20649416|P1|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
8377011|NCT01122680|20649413|P4|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
8377012|NCT01122680|20649414|P3|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
8377013|NCT01122680|20649415|P2|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
8377014|NCT01122680|20649416|P1|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
8377015|NCT01122576|20649481|P3|NOT COMPLETED|Post-Cataract Surgery||2
8377016|NCT01122576|20649482|P2|NOT COMPLETED|Post-Cataract Surgery||0
8377017|NCT01122576|20649483|P1|NOT COMPLETED|Post-Cataract Surgery||0
8377018|NCT01122576|20649481|P3|COMPLETED|Post-Cataract Surgery||22
8377019|NCT01122576|20649482|P2|COMPLETED|Post-Cataract Surgery||25
8377020|NCT01122576|20649483|P1|COMPLETED|Post-Cataract Surgery||26
8377021|NCT01122576|20649481|P3|STARTED|Post-Cataract Surgery||24
8377022|NCT01122576|20649482|P2|STARTED|Post-Cataract Surgery||25
8377023|NCT01122576|20649483|P1|STARTED|Post-Cataract Surgery||26
8377024|NCT01122576|20649481|P3|NOT COMPLETED|Pre-Cataract Surgery||2
8377025|NCT01122576|20649482|P2|NOT COMPLETED|Pre-Cataract Surgery||1
8377026|NCT01122576|20649483|P1|NOT COMPLETED|Pre-Cataract Surgery||0
8377027|NCT01122576|20649481|P3|COMPLETED|Pre-Cataract Surgery||24
8377028|NCT01122576|20649482|P2|COMPLETED|Pre-Cataract Surgery||25
8377029|NCT01122576|20649483|P1|COMPLETED|Pre-Cataract Surgery||26
8377030|NCT01122576|20649481|P3|STARTED|Pre-Cataract Surgery||26
8377031|NCT01122576|20649482|P2|STARTED|Pre-Cataract Surgery||26
8377032|NCT01122576|20649483|P1|STARTED|Pre-Cataract Surgery||26
8377033|NCT01122511|20649622|P2|NOT COMPLETED|Overall Study||2
8377034|NCT01122511|20649623|P1|NOT COMPLETED|Overall Study||2
8377035|NCT01122511|20649622|P2|COMPLETED|Overall Study||0
8377036|NCT01122511|20649623|P1|COMPLETED|Overall Study||0
8377037|NCT01122511|20649622|P2|STARTED|Overall Study||2
8377038|NCT01122511|20649623|P1|STARTED|Overall Study||2
8377039|NCT01122446|20649637|P2|NOT COMPLETED|Overall Study||0
8377040|NCT01122446|20649638|P1|NOT COMPLETED|Overall Study||0
8377041|NCT01122446|20649637|P2|COMPLETED|Overall Study||25
8377042|NCT01122446|20649638|P1|COMPLETED|Overall Study||25
8377043|NCT01122446|20649637|P2|STARTED|Overall Study||25
8377044|NCT01122446|20649638|P1|STARTED|Overall Study||25
8377045|NCT01122394|20649664|P2|NOT COMPLETED|Overall Study||4
8377046|NCT01122394|20649665|P1|NOT COMPLETED|Overall Study||3
8377047|NCT01122394|20649664|P2|COMPLETED|Overall Study||70
8377048|NCT01122394|20649665|P1|COMPLETED|Overall Study||63
8377049|NCT01122394|20649664|P2|STARTED|Overall Study||74
8377050|NCT01122394|20649665|P1|STARTED|Overall Study||66
8377051|NCT01122381|20649681|P2|NOT COMPLETED|Overall Study||1
8377052|NCT01122381|20649682|P1|NOT COMPLETED|Overall Study||0
8377053|NCT01122381|20649681|P2|COMPLETED|Overall Study||0
8377054|NCT01122381|20649682|P1|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
8377055|NCT01122381|20649681|P2|STARTED|Overall Study||1
8377056|NCT01122381|20649682|P1|STARTED|Overall Study||1
8377057|NCT01122316|20649688|P1|NOT COMPLETED|Overall Study||2
8377058|NCT01122316|20649688|P1|COMPLETED|Overall Study||8
8377059|NCT01122316|20649688|P1|STARTED|Overall Study||10
8377060|NCT01122264|20649698|P3|NOT COMPLETED|Overall Study||47
8377061|NCT01122264|20649699|P2|NOT COMPLETED|Overall Study||29
8377062|NCT01122264|20649700|P1|NOT COMPLETED|Overall Study||32
8377063|NCT01122264|20649698|P3|COMPLETED|Overall Study||214
8377064|NCT01122264|20649699|P2|COMPLETED|Overall Study||228
8377065|NCT01122264|20649700|P1|COMPLETED|Overall Study||220
8377066|NCT01122264|20649698|P3|Received at Least 1 Dose of Study Drug|Overall Study||260
8377067|NCT01122264|20649699|P2|Received at Least 1 Dose of Study Drug|Overall Study||257
8377068|NCT01122264|20649700|P1|Received at Least 1 Dose of Study Drug|Overall Study||250
8377069|NCT01122264|20649698|P3|STARTED|Overall Study||261
8377070|NCT01122264|20649699|P2|STARTED|Overall Study||257
8377071|NCT01122264|20649700|P1|STARTED|Overall Study||252
8377072|NCT01122238|20649773|P16|NOT COMPLETED|Overall Study||0
8377073|NCT01122238|20649774|P15|NOT COMPLETED|Overall Study||0
8377074|NCT01122238|20649775|P14|NOT COMPLETED|Overall Study||1
8377075|NCT01122238|20649776|P13|NOT COMPLETED|Overall Study||2
8377076|NCT01122238|20649777|P12|NOT COMPLETED|Overall Study||2
8377077|NCT01122238|20649778|P11|NOT COMPLETED|Overall Study||0
8377078|NCT01122238|20649779|P10|NOT COMPLETED|Overall Study||1
8377079|NCT01122238|20649780|P9|NOT COMPLETED|Overall Study||1
8377080|NCT01122238|20649781|P8|NOT COMPLETED|Overall Study||0
8377081|NCT01122238|20649782|P7|NOT COMPLETED|Overall Study||1
8377082|NCT01122238|20649783|P6|NOT COMPLETED|Overall Study||1
8377083|NCT01122238|20649784|P5|NOT COMPLETED|Overall Study||0
8377084|NCT01122238|20649785|P4|NOT COMPLETED|Overall Study||0
8377085|NCT01122238|20649786|P3|NOT COMPLETED|Overall Study||5
8377086|NCT01122238|20649787|P2|NOT COMPLETED|Overall Study||1
8377087|NCT01122238|20649788|P1|NOT COMPLETED|Overall Study||2
8377088|NCT01122238|20649773|P16|COMPLETED|Overall Study||31
8377089|NCT01122238|20649774|P15|COMPLETED|Overall Study||28
8377090|NCT01122238|20649775|P14|COMPLETED|Overall Study||31
8377091|NCT01122238|20649776|P13|COMPLETED|Overall Study||28
8377092|NCT01122238|20649777|P12|COMPLETED|Overall Study||31
8377093|NCT01122238|20649778|P11|COMPLETED|Overall Study||32
8377094|NCT01122238|20649779|P10|COMPLETED|Overall Study||33
8377095|NCT01122238|20649780|P9|COMPLETED|Overall Study||31
8377096|NCT01122238|20649781|P8|COMPLETED|Overall Study||32
8377097|NCT01122238|20649782|P7|COMPLETED|Overall Study||34
8377098|NCT01122238|20649783|P6|COMPLETED|Overall Study||31
8377099|NCT01122238|20649784|P5|COMPLETED|Overall Study||33
8377100|NCT01122238|20649785|P4|COMPLETED|Overall Study||33
8377101|NCT01122238|20649786|P3|COMPLETED|Overall Study||28
8377102|NCT01122238|20649787|P2|COMPLETED|Overall Study||36
8377103|NCT01122238|20649788|P1|COMPLETED|Overall Study||28
8377104|NCT01122238|20649773|P16|STARTED|Overall Study||31
8377105|NCT01122238|20649774|P15|STARTED|Overall Study||28
8377106|NCT01122238|20649775|P14|STARTED|Overall Study||32
8377107|NCT01122238|20649776|P13|STARTED|Overall Study||30
8377108|NCT01122238|20649777|P12|STARTED|Overall Study||33
8377109|NCT01122238|20649778|P11|STARTED|Overall Study||32
8377110|NCT01122238|20649779|P10|STARTED|Overall Study||34
8377111|NCT01122238|20649780|P9|STARTED|Overall Study||32
8377112|NCT01122238|20649781|P8|STARTED|Overall Study||32
8377113|NCT01122238|20649782|P7|STARTED|Overall Study||35
8377114|NCT01122238|20649783|P6|STARTED|Overall Study||32
8377115|NCT01122238|20649784|P5|STARTED|Overall Study||33
8377116|NCT01122238|20649785|P4|STARTED|Overall Study||33
8377117|NCT01122238|20649786|P3|STARTED|Overall Study||33
8377118|NCT01122238|20649787|P2|STARTED|Overall Study||37
8377119|NCT01122238|20649788|P1|STARTED|Overall Study||30
8377120|NCT01122173|20649810|P1|NOT COMPLETED|Overall Study||9
8377121|NCT01122173|20649810|P1|COMPLETED|Overall Study||141
8377122|NCT01122173|20649810|P1|STARTED|Overall Study||150
8377123|NCT01122160|20649817|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8377124|NCT01122160|20649818|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8377125|NCT01122160|20649817|P2|COMPLETED|Second Intervention (7 Days)||5
8377126|NCT01122160|20649818|P1|COMPLETED|Second Intervention (7 Days)||6
8377127|NCT01122160|20649817|P2|STARTED|Second Intervention (7 Days)||5
8377128|NCT01122160|20649818|P1|STARTED|Second Intervention (7 Days)||6
8377129|NCT01122160|20649817|P2|NOT COMPLETED|Washout (7-14 Days)||0
8377130|NCT01122160|20649818|P1|NOT COMPLETED|Washout (7-14 Days)||0
8377131|NCT01122160|20649817|P2|COMPLETED|Washout (7-14 Days)||5
8377132|NCT01122160|20649818|P1|COMPLETED|Washout (7-14 Days)||6
8377133|NCT01122160|20649817|P2|STARTED|Washout (7-14 Days)||5
8377134|NCT01122160|20649818|P1|STARTED|Washout (7-14 Days)||6
8377135|NCT01122160|20649817|P2|NOT COMPLETED|First Intervention (7 Days)||0
8377136|NCT01122160|20649818|P1|NOT COMPLETED|First Intervention (7 Days)||0
8377137|NCT01122160|20649817|P2|COMPLETED|First Intervention (7 Days)||5
8377138|NCT01122160|20649818|P1|COMPLETED|First Intervention (7 Days)||6
8377139|NCT01122160|20649817|P2|STARTED|First Intervention (7 Days)||5
8377140|NCT01122160|20649818|P1|STARTED|First Intervention (7 Days)||6
8377141|NCT01122108|20649824|P2|NOT COMPLETED|Overall Study||0
8377142|NCT01122108|20649825|P1|NOT COMPLETED|Overall Study||0
8377143|NCT01122108|20649824|P2|COMPLETED|Overall Study||21
8377144|NCT01122108|20649825|P1|COMPLETED|Overall Study||21
8377145|NCT01122108|20649824|P2|STARTED|Overall Study||21
8377146|NCT01122108|20649825|P1|STARTED|Overall Study||21
8377147|NCT01122030|20649841|P7|NOT COMPLETED|Overall Study||0
8377148|NCT01122030|20649842|P6|NOT COMPLETED|Overall Study||0
8377149|NCT01122030|20649843|P5|NOT COMPLETED|Overall Study||0
8377150|NCT01122030|20649844|P4|NOT COMPLETED|Overall Study||0
8377151|NCT01122030|20649845|P3|NOT COMPLETED|Overall Study||0
8377152|NCT01122030|20649846|P2|NOT COMPLETED|Overall Study||0
8377153|NCT01122030|20649847|P1|NOT COMPLETED|Overall Study||0
8377154|NCT01122030|20649841|P7|COMPLETED|Overall Study||9
8377155|NCT01122030|20649842|P6|COMPLETED|Overall Study||9
8377156|NCT01122030|20649843|P5|COMPLETED|Overall Study||9
8377157|NCT01122030|20649844|P4|COMPLETED|Overall Study||9
8377158|NCT01122030|20649845|P3|COMPLETED|Overall Study||9
8377159|NCT01122030|20649846|P2|COMPLETED|Overall Study||9
8377160|NCT01122030|20649847|P1|COMPLETED|Overall Study||18
8377161|NCT01122030|20649841|P7|Received Treatment|Overall Study||9
8377162|NCT01122030|20649842|P6|Received Treatment|Overall Study||9
8377163|NCT01122030|20649843|P5|Received Treatment|Overall Study||9
8377164|NCT01122030|20649844|P4|Received Treatment|Overall Study||9
8377165|NCT01122030|20649845|P3|Received Treatment|Overall Study||9
8377166|NCT01122030|20649846|P2|Received Treatment|Overall Study||9
8377167|NCT01122030|20649847|P1|Received Treatment|Overall Study||18
8377168|NCT01122030|20649841|P7|STARTED|Overall Study||9
8377169|NCT01122030|20649842|P6|STARTED|Overall Study||9
8377170|NCT01122030|20649843|P5|STARTED|Overall Study||9
8377171|NCT01122030|20649844|P4|STARTED|Overall Study||9
8377172|NCT01122030|20649845|P3|STARTED|Overall Study||9
8377173|NCT01122030|20649846|P2|STARTED|Overall Study||9
8377174|NCT01122030|20649847|P1|STARTED|Overall Study||18
8377175|NCT01121991|20650033|P1|NOT COMPLETED|Overall Study||6
8377176|NCT01121991|20650033|P1|COMPLETED|Overall Study||46
8377177|NCT01121991|20650033|P1|STARTED|Overall Study|Number of participants treated|52
8377178|NCT01121939|20650044|P1|NOT COMPLETED|Overall Study||43
8377179|NCT01121939|20650044|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
8377180|NCT01121939|20650044|P1|STARTED|Overall Study||43
8377181|NCT01121926|20650058|P2|NOT COMPLETED|Second Intervention Period||0
8377182|NCT01121926|20650059|P1|NOT COMPLETED|Second Intervention Period||0
8377183|NCT01121926|20650058|P2|COMPLETED|Second Intervention Period||13
8377184|NCT01121926|20650059|P1|COMPLETED|Second Intervention Period||14
8377185|NCT01121926|20650058|P2|STARTED|Second Intervention Period||13
8377186|NCT01121926|20650059|P1|STARTED|Second Intervention Period||14
8377187|NCT01121926|20650058|P2|NOT COMPLETED|Washout Period||2
8377188|NCT01121926|20650059|P1|NOT COMPLETED|Washout Period||0
8377189|NCT01121926|20650058|P2|COMPLETED|Washout Period||13
8377190|NCT01121926|20650059|P1|COMPLETED|Washout Period||14
8377191|NCT01121926|20650058|P2|STARTED|Washout Period||15
8377192|NCT01121926|20650059|P1|STARTED|Washout Period||14
8377193|NCT01121926|20650058|P2|NOT COMPLETED|First Intervention Period||0
8377194|NCT01121926|20650059|P1|NOT COMPLETED|First Intervention Period||1
8377195|NCT01121926|20650058|P2|COMPLETED|First Intervention Period||15
8377196|NCT01121926|20650059|P1|COMPLETED|First Intervention Period||14
8377197|NCT01121926|20650058|P2|STARTED|First Intervention Period||15
8377198|NCT01121926|20650059|P1|STARTED|First Intervention Period||15
8377199|NCT01121913|20650077|P4|NOT COMPLETED|Fourth Intervention Period||0
8377200|NCT01121913|20650078|P3|NOT COMPLETED|Fourth Intervention Period||0
8377201|NCT01121913|20650079|P2|NOT COMPLETED|Fourth Intervention Period||0
8377202|NCT01121913|20650080|P1|NOT COMPLETED|Fourth Intervention Period||0
8377203|NCT01121913|20650077|P4|COMPLETED|Fourth Intervention Period||6
8377204|NCT01121913|20650078|P3|COMPLETED|Fourth Intervention Period||3
8377205|NCT01121913|20650079|P2|COMPLETED|Fourth Intervention Period||6
8377206|NCT01121913|20650080|P1|COMPLETED|Fourth Intervention Period||4
8377207|NCT01121913|20650077|P4|STARTED|Fourth Intervention Period||6
8377208|NCT01121913|20650078|P3|STARTED|Fourth Intervention Period||3
8377209|NCT01121913|20650079|P2|STARTED|Fourth Intervention Period||6
8377210|NCT01121913|20650080|P1|STARTED|Fourth Intervention Period||4
8377211|NCT01121913|20650077|P4|NOT COMPLETED|Third Washout Period||0
8377212|NCT01121913|20650078|P3|NOT COMPLETED|Third Washout Period||0
8377213|NCT01121913|20650079|P2|NOT COMPLETED|Third Washout Period||0
8377214|NCT01121913|20650080|P1|NOT COMPLETED|Third Washout Period||1
8377215|NCT01121913|20650077|P4|COMPLETED|Third Washout Period||6
8377216|NCT01121913|20650078|P3|COMPLETED|Third Washout Period||3
8377217|NCT01121913|20650079|P2|COMPLETED|Third Washout Period||6
8377218|NCT01121913|20650080|P1|COMPLETED|Third Washout Period||4
8377219|NCT01121913|20650077|P4|STARTED|Third Washout Period||6
8377220|NCT01121913|20650078|P3|STARTED|Third Washout Period||3
8377221|NCT01121913|20650079|P2|STARTED|Third Washout Period||6
8377222|NCT01121913|20650080|P1|STARTED|Third Washout Period||5
8377223|NCT01121913|20650077|P4|NOT COMPLETED|Third Intervention Period||0
8377224|NCT01121913|20650078|P3|NOT COMPLETED|Third Intervention Period||0
8377225|NCT01121913|20650079|P2|NOT COMPLETED|Third Intervention Period||0
8377226|NCT01121913|20650080|P1|NOT COMPLETED|Third Intervention Period||0
8377227|NCT01121913|20650077|P4|COMPLETED|Third Intervention Period||6
8377228|NCT01121913|20650078|P3|COMPLETED|Third Intervention Period||3
8377229|NCT01121913|20650079|P2|COMPLETED|Third Intervention Period||6
8377230|NCT01121913|20650080|P1|COMPLETED|Third Intervention Period||5
8377231|NCT01121913|20650077|P4|STARTED|Third Intervention Period||6
8377232|NCT01121913|20650078|P3|STARTED|Third Intervention Period||3
8377233|NCT01121913|20650079|P2|STARTED|Third Intervention Period||6
8377234|NCT01121913|20650080|P1|STARTED|Third Intervention Period||5
8377235|NCT01121913|20650077|P4|NOT COMPLETED|Second Washout Period||0
8377236|NCT01121913|20650078|P3|NOT COMPLETED|Second Washout Period||1
8377237|NCT01121913|20650079|P2|NOT COMPLETED|Second Washout Period||0
8377238|NCT01121913|20650080|P1|NOT COMPLETED|Second Washout Period||0
8377239|NCT01121913|20650077|P4|COMPLETED|Second Washout Period||6
8377240|NCT01121913|20650078|P3|COMPLETED|Second Washout Period||3
8377241|NCT01121913|20650079|P2|COMPLETED|Second Washout Period||6
8377242|NCT01121913|20650080|P1|COMPLETED|Second Washout Period||5
8377243|NCT01121913|20650077|P4|STARTED|Second Washout Period||6
8377244|NCT01121913|20650078|P3|STARTED|Second Washout Period||4
8377245|NCT01121913|20650079|P2|STARTED|Second Washout Period||6
8377246|NCT01121913|20650080|P1|STARTED|Second Washout Period||5
8377247|NCT01121913|20650077|P4|NOT COMPLETED|Second Intervention Period||0
8377248|NCT01121913|20650078|P3|NOT COMPLETED|Second Intervention Period||1
8377249|NCT01121913|20650079|P2|NOT COMPLETED|Second Intervention Period||0
8377250|NCT01121913|20650080|P1|NOT COMPLETED|Second Intervention Period||0
8377251|NCT01121913|20650077|P4|COMPLETED|Second Intervention Period||6
8377252|NCT01121913|20650078|P3|COMPLETED|Second Intervention Period||4
8377253|NCT01121913|20650079|P2|COMPLETED|Second Intervention Period||6
8377254|NCT01121913|20650080|P1|COMPLETED|Second Intervention Period||5
8377255|NCT01121913|20650077|P4|STARTED|Second Intervention Period||6
8377256|NCT01121913|20650078|P3|STARTED|Second Intervention Period||5
8377257|NCT01121913|20650079|P2|STARTED|Second Intervention Period||6
8377258|NCT01121913|20650080|P1|STARTED|Second Intervention Period||5
8377259|NCT01121913|20650077|P4|NOT COMPLETED|First Washout Period||0
8377260|NCT01121913|20650078|P3|NOT COMPLETED|First Washout Period||0
8377261|NCT01121913|20650079|P2|NOT COMPLETED|First Washout Period||0
8377262|NCT01121913|20650080|P1|NOT COMPLETED|First Washout Period||1
8377263|NCT01121913|20650077|P4|COMPLETED|First Washout Period||6
8377264|NCT01121913|20650078|P3|COMPLETED|First Washout Period||5
8377265|NCT01121913|20650079|P2|COMPLETED|First Washout Period||6
8377266|NCT01121913|20650080|P1|COMPLETED|First Washout Period||5
8377267|NCT01121913|20650077|P4|STARTED|First Washout Period||6
8377268|NCT01121913|20650078|P3|STARTED|First Washout Period||5
8377269|NCT01121913|20650079|P2|STARTED|First Washout Period||6
8377270|NCT01121913|20650080|P1|STARTED|First Washout Period||6
8377271|NCT01121913|20650077|P4|NOT COMPLETED|First Intervention Period||0
8377272|NCT01121913|20650078|P3|NOT COMPLETED|First Intervention Period||1
8377273|NCT01121913|20650079|P2|NOT COMPLETED|First Intervention Period||0
8377274|NCT01121913|20650080|P1|NOT COMPLETED|First Intervention Period||0
8377275|NCT01121913|20650077|P4|COMPLETED|First Intervention Period||6
8377276|NCT01121913|20650078|P3|COMPLETED|First Intervention Period||5
8377277|NCT01121913|20650079|P2|COMPLETED|First Intervention Period||6
8377278|NCT01121913|20650080|P1|COMPLETED|First Intervention Period||6
8377279|NCT01121913|20650077|P4|STARTED|First Intervention Period||6
8377280|NCT01121913|20650078|P3|STARTED|First Intervention Period||6
8377281|NCT01121913|20650079|P2|STARTED|First Intervention Period||6
8377282|NCT01121913|20650080|P1|STARTED|First Intervention Period||6
8377283|NCT01121900|20650110|P2|NOT COMPLETED|Second Intervention Period||0
8377284|NCT01121900|20650111|P1|NOT COMPLETED|Second Intervention Period||0
8377285|NCT01121900|20650110|P2|COMPLETED|Second Intervention Period||11
8377286|NCT01121900|20650111|P1|COMPLETED|Second Intervention Period||12
8377287|NCT01121900|20650110|P2|STARTED|Second Intervention Period||11
8377288|NCT01121900|20650111|P1|STARTED|Second Intervention Period||12
8377289|NCT01121900|20650110|P2|NOT COMPLETED|Washout Period of 7 Days||1
8377290|NCT01121900|20650111|P1|NOT COMPLETED|Washout Period of 7 Days||0
8377291|NCT01121900|20650110|P2|COMPLETED|Washout Period of 7 Days||11
8377292|NCT01121900|20650111|P1|COMPLETED|Washout Period of 7 Days||12
8377293|NCT01121900|20650110|P2|STARTED|Washout Period of 7 Days||12
8377294|NCT01121900|20650111|P1|STARTED|Washout Period of 7 Days||12
8377295|NCT01121900|20650110|P2|NOT COMPLETED|First Intervention Period||1
8377296|NCT01121900|20650111|P1|NOT COMPLETED|First Intervention Period||1
8377297|NCT01121900|20650110|P2|COMPLETED|First Intervention Period||12
8377298|NCT01121900|20650111|P1|COMPLETED|First Intervention Period||12
8377299|NCT01121900|20650110|P2|STARTED|First Intervention Period||13
8377300|NCT01121900|20650111|P1|STARTED|First Intervention Period||13
8377301|NCT01121757|20650131|P2|NOT COMPLETED|Combination||1
8377302|NCT01121757|20650132|P1|NOT COMPLETED|Combination||2
8377303|NCT01121757|20650131|P2|COMPLETED|Combination||0
8377304|NCT01121757|20650132|P1|COMPLETED|Combination||0
8377305|NCT01121757|20650131|P2|STARTED|Combination||1
8377306|NCT01121757|20650132|P1|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
8377307|NCT01121757|20650131|P2|NOT COMPLETED|Second Drug||0
8377308|NCT01121757|20650132|P1|NOT COMPLETED|Second Drug||0
8377309|NCT01121757|20650131|P2|COMPLETED|Second Drug||1
8377310|NCT01121757|20650132|P1|COMPLETED|Second Drug||4
8377311|NCT01121757|20650131|P2|STARTED|Second Drug||1
8377312|NCT01121757|20650132|P1|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
8377313|NCT01121757|20650131|P2|NOT COMPLETED|First Drug||2
8377314|NCT01121757|20650132|P1|NOT COMPLETED|First Drug||1
8377315|NCT01121757|20650131|P2|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
8377316|NCT01121757|20650132|P1|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
8377317|NCT01121757|20650131|P2|STARTED|First Drug||3
8377318|NCT01121757|20650132|P1|STARTED|First Drug||6
8377319|NCT01121666|20650148|P2|NOT COMPLETED|Overall Study||10
8377320|NCT01121666|20650149|P1|NOT COMPLETED|Overall Study||29
8377321|NCT01121666|20650148|P2|COMPLETED|Overall Study||113
8377322|NCT01121666|20650149|P1|COMPLETED|Overall Study||220
8377323|NCT01121666|20650148|P2|STARTED|Overall Study||123
8377324|NCT01121666|20650149|P1|STARTED|Overall Study||249
8377325|NCT01121575|20650205|P6|NOT COMPLETED|Overall Study||12
8377326|NCT01121575|20650206|P5|NOT COMPLETED|Overall Study||25
8377327|NCT01121575|20650207|P4|NOT COMPLETED|Overall Study||6
8377328|NCT01121575|20650208|P3|NOT COMPLETED|Overall Study||7
8377329|NCT01121575|20650209|P2|NOT COMPLETED|Overall Study||6
8377330|NCT01121575|20650210|P1|NOT COMPLETED|Overall Study||14
8377331|NCT01121575|20650205|P6|COMPLETED|Overall Study||0
8377332|NCT01121575|20650206|P5|COMPLETED|Overall Study||0
8377333|NCT01121575|20650207|P4|COMPLETED|Overall Study||0
8377334|NCT01121575|20650208|P3|COMPLETED|Overall Study||0
8377335|NCT01121575|20650209|P2|COMPLETED|Overall Study||0
8377336|NCT01121575|20650210|P1|COMPLETED|Overall Study||0
8377337|NCT01121575|20650205|P6|Treated|Overall Study||12
8377338|NCT01121575|20650206|P5|Treated|Overall Study||25
8377339|NCT01121575|20650207|P4|Treated|Overall Study||6
8377340|NCT01121575|20650208|P3|Treated|Overall Study||7
8377341|NCT01121575|20650209|P2|Treated|Overall Study||6
8377342|NCT01121575|20650210|P1|Treated|Overall Study||14
8377343|NCT01121575|20650205|P6|STARTED|Overall Study||12
8377344|NCT01121575|20650206|P5|STARTED|Overall Study||25
8377345|NCT01121575|20650207|P4|STARTED|Overall Study||6
8377346|NCT01121575|20650208|P3|STARTED|Overall Study||7
8377347|NCT01121575|20650209|P2|STARTED|Overall Study||6
8377348|NCT01121575|20650210|P1|STARTED|Overall Study||14
8377349|NCT01121562|20650334|P1|NOT COMPLETED|Overall Study||12
8377350|NCT01121562|20650334|P1|COMPLETED|Overall Study||0
8377351|NCT01121562|20650334|P1|STARTED|Overall Study||12
8377352|NCT01121549|20650343|P1|NOT COMPLETED|Overall Study||347
8377353|NCT01121549|20650343|P1|COMPLETED|Overall Study||31
8377354|NCT01121549|20650343|P1|STARTED|Overall Study||378
8377355|NCT01121536|20650354|P1|NOT COMPLETED|Overall Study||361
8377356|NCT01121536|20650354|P1|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
8377357|NCT01121536|20650354|P1|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
8377358|NCT01121536|20650354|P1|Safety Population|Overall Study|Participants treated|863
8377359|NCT01121536|20650354|P1|STARTED|Overall Study||867
8377360|NCT01121484|20650375|P2|NOT COMPLETED|Overall Study||43
8377361|NCT01121484|20650376|P1|NOT COMPLETED|Overall Study||33
8377362|NCT01121484|20650375|P2|COMPLETED|Overall Study||178
8377363|NCT01121484|20650376|P1|COMPLETED|Overall Study||185
8377364|NCT01121484|20650375|P2|Treated|Overall Study||217
8377365|NCT01121484|20650376|P1|Treated|Overall Study||217
8377366|NCT01121484|20650375|P2|STARTED|Overall Study||221
8377367|NCT01121484|20650376|P1|STARTED|Overall Study||218
8377368|NCT01121406|20650394|P2|NOT COMPLETED|Overall Study||55
8377369|NCT01121406|20650395|P1|NOT COMPLETED|Overall Study||55
8377370|NCT01121406|20650394|P2|COMPLETED|Overall Study||0
8377371|NCT01121406|20650395|P1|COMPLETED|Overall Study||0
8377372|NCT01121406|20650394|P2|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
8377373|NCT01121406|20650395|P1|STARTED|Overall Study||55
8377374|NCT01121393|20650445|P2|NOT COMPLETED|Overall Study||84
8377375|NCT01121393|20650446|P1|NOT COMPLETED|Overall Study||242
8377376|NCT01121393|20650445|P2|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
8377377|NCT01121393|20650446|P1|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
8377378|NCT01121393|20650445|P2|Treated|Overall Study|Treated|113
8377379|NCT01121393|20650446|P1|Treated|Overall Study|Treated|239
8377380|NCT01121393|20650445|P2|STARTED|Overall Study|Randomised|122
8377381|NCT01121393|20650446|P1|STARTED|Overall Study|Randomised|242
8377382|NCT01121263|20650491|P2|NOT COMPLETED|Overall Study||15
8377383|NCT01121263|20650492|P1|NOT COMPLETED|Overall Study||25
8377384|NCT01121263|20650491|P2|COMPLETED|Overall Study||83
8377385|NCT01121263|20650492|P1|COMPLETED|Overall Study||175
8377386|NCT01121263|20650491|P2|STARTED|Overall Study||98
8377387|NCT01121263|20650492|P1|STARTED|Overall Study||200
8377388|NCT01121250|20650503|P3|NOT COMPLETED|Overall Study||1
8377389|NCT01121250|20650504|P2|NOT COMPLETED|Overall Study||0
8377390|NCT01121250|20650505|P1|NOT COMPLETED|Overall Study||0
8377391|NCT01121250|20650503|P3|COMPLETED|Overall Study||75
8377392|NCT01121250|20650504|P2|COMPLETED|Overall Study||76
8377393|NCT01121250|20650505|P1|COMPLETED|Overall Study||76
8377394|NCT01121250|20650503|P3|STARTED|Overall Study||76
8377395|NCT01121250|20650504|P2|STARTED|Overall Study||76
8377396|NCT01121250|20650505|P1|STARTED|Overall Study||76
8377397|NCT01121224|20650521|P2|NOT COMPLETED|Overall Study||17
8377398|NCT01121224|20650522|P1|NOT COMPLETED|Overall Study||25
8377399|NCT01121224|20650521|P2|COMPLETED|Overall Study||275
8377400|NCT01121224|20650522|P1|COMPLETED|Overall Study||280
8377401|NCT01121224|20650521|P2|STARTED|Overall Study||292
8377402|NCT01121224|20650522|P1|STARTED|Overall Study||305
8377403|NCT01121211|20650572|P2|NOT COMPLETED|Overall Study||12
8377404|NCT01121211|20650573|P1|NOT COMPLETED|Overall Study||11
8377405|NCT01121211|20650572|P2|COMPLETED|Overall Study||35
8377406|NCT01121211|20650573|P1|COMPLETED|Overall Study||32
8377407|NCT01121211|20650572|P2|STARTED|Overall Study||47
8377408|NCT01121211|20650573|P1|STARTED|Overall Study||43
8377409|NCT01121185|20650583|P2|NOT COMPLETED|Overall Study||1
8377410|NCT01121185|20650584|P1|NOT COMPLETED|Overall Study||1
8377411|NCT01121185|20650583|P2|COMPLETED|Overall Study||5
8377412|NCT01121185|20650584|P1|COMPLETED|Overall Study||6
8377413|NCT01121185|20650583|P2|Transplanted|Overall Study||5
8377414|NCT01121185|20650584|P1|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
8377415|NCT01121185|20650583|P2|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
8377416|NCT01121185|20650584|P1|Infused|Overall Study||7
8377417|NCT01121185|20650583|P2|STARTED|Overall Study||6
8377418|NCT01121185|20650584|P1|STARTED|Overall Study||7
8377419|NCT01121172|20650608|P2|NOT COMPLETED|Overall Study||0
8377420|NCT01121172|20650609|P1|NOT COMPLETED|Overall Study||0
8377421|NCT01121172|20650608|P2|COMPLETED|Overall Study||90
8377422|NCT01121172|20650609|P1|COMPLETED|Overall Study||90
8377423|NCT01121172|20650608|P2|STARTED|Overall Study||90
8377424|NCT01121172|20650609|P1|STARTED|Overall Study||90
8377425|NCT01121146|20650618|P2|NOT COMPLETED|Overall Study||42
8377426|NCT01121146|20650619|P1|NOT COMPLETED|Overall Study||26
8377427|NCT01121146|20650618|P2|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
8377428|NCT01121146|20650619|P1|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
8377429|NCT01121146|20650618|P2|STARTED|Overall Study||114
8377430|NCT01121146|20650619|P1|STARTED|Overall Study||116
8377431|NCT01120990|20650633|P1|NOT COMPLETED|Overall Study||0
8377432|NCT01120990|20650633|P1|COMPLETED|Overall Study||51
8377433|NCT01120990|20650633|P1|STARTED|Overall Study||51
8377434|NCT01120899|20650640|P1|NOT COMPLETED|Overall Study||3
8377435|NCT01120899|20650640|P1|COMPLETED|Overall Study||3
8377436|NCT01120899|20650640|P1|Month 18|Overall Study||3
8377437|NCT01120899|20650640|P1|Month 12|Overall Study||3
8377438|NCT01120899|20650640|P1|Month 6|Overall Study||5
8377439|NCT01120899|20650640|P1|STARTED|Overall Study||6
8377440|NCT01120834|20650660|P1|NOT COMPLETED|Overall Study||0
8377441|NCT01120834|20650660|P1|COMPLETED|Overall Study||18
8377442|NCT01120834|20650660|P1|STARTED|Overall Study||18
8377443|NCT01120808|20650664|P1|NOT COMPLETED|Overall Study||46
8377444|NCT01120808|20650664|P1|COMPLETED|Overall Study||90
8377445|NCT01120808|20650664|P1|STARTED|Overall Study||136
8377446|NCT01120782|20650668|P1|NOT COMPLETED|Overall Study||11
8377447|NCT01120782|20650668|P1|COMPLETED|Overall Study||34
8377448|NCT01120782|20650668|P1|STARTED|Overall Study||45
8377449|NCT01120756|20650674|P2|NOT COMPLETED|Overall Study||1
8377450|NCT01120756|20650675|P1|NOT COMPLETED|Overall Study||1
8377451|NCT01120756|20650674|P2|COMPLETED|Overall Study||13
8377452|NCT01120756|20650675|P1|COMPLETED|Overall Study||20
8377453|NCT01120756|20650674|P2|STARTED|Overall Study||14
8377454|NCT01120756|20650675|P1|STARTED|Overall Study||21
8377455|NCT01120717|20650685|P2|NOT COMPLETED|Overall Study||24
8377456|NCT01120717|20650686|P1|NOT COMPLETED|Overall Study||32
8377457|NCT01120717|20650685|P2|COMPLETED|Overall Study||89
8377458|NCT01120717|20650686|P1|COMPLETED|Overall Study||194
8377459|NCT01120717|20650685|P2|Safety Population: Received Study Drug|Overall Study||113
8377460|NCT01120717|20650686|P1|Safety Population: Received Study Drug|Overall Study||225
8377461|NCT01120717|20650685|P2|STARTED|Overall Study||113
8377462|NCT01120717|20650686|P1|STARTED|Overall Study||226
8377463|NCT01120704|20650734|P32|NOT COMPLETED|Overall Study||1
8377464|NCT01120704|20650735|P31|NOT COMPLETED|Overall Study||2
8377465|NCT01120704|20650736|P30|NOT COMPLETED|Overall Study||3
8377466|NCT01120704|20650737|P29|NOT COMPLETED|Overall Study||5
8377467|NCT01120704|20650738|P28|NOT COMPLETED|Overall Study||2
8377468|NCT01120704|20650739|P27|NOT COMPLETED|Overall Study||3
8377469|NCT01120704|20650740|P26|NOT COMPLETED|Overall Study||0
8377470|NCT01120704|20650741|P25|NOT COMPLETED|Overall Study||2
8377471|NCT01120704|20650742|P24|NOT COMPLETED|Overall Study||3
8377472|NCT01120704|20650743|P23|NOT COMPLETED|Overall Study||4
8377473|NCT01120704|20650744|P22|NOT COMPLETED|Overall Study||0
8377474|NCT01120704|20650745|P21|NOT COMPLETED|Overall Study||3
8377475|NCT01120704|20650746|P20|NOT COMPLETED|Overall Study||3
8377476|NCT01120704|20650747|P19|NOT COMPLETED|Overall Study||2
8377477|NCT01120704|20650748|P18|NOT COMPLETED|Overall Study||0
8377478|NCT01120704|20650749|P17|NOT COMPLETED|Overall Study||1
8377479|NCT01120704|20650750|P16|NOT COMPLETED|Overall Study||2
8377480|NCT01120704|20650751|P15|NOT COMPLETED|Overall Study||1
8377481|NCT01120704|20650752|P14|NOT COMPLETED|Overall Study||4
8377482|NCT01120704|20650753|P13|NOT COMPLETED|Overall Study||3
8377483|NCT01120704|20650754|P12|NOT COMPLETED|Overall Study||2
8377484|NCT01120704|20650755|P11|NOT COMPLETED|Overall Study||1
8377485|NCT01120704|20650756|P10|NOT COMPLETED|Overall Study||1
8377486|NCT01120704|20650757|P9|NOT COMPLETED|Overall Study||3
8377487|NCT01120704|20650758|P8|NOT COMPLETED|Overall Study||2
8377488|NCT01120704|20650759|P7|NOT COMPLETED|Overall Study||3
8377489|NCT01120704|20650760|P6|NOT COMPLETED|Overall Study||1
8377490|NCT01120704|20650761|P5|NOT COMPLETED|Overall Study||2
8377491|NCT01120704|20650762|P4|NOT COMPLETED|Overall Study||4
8377492|NCT01120704|20650763|P3|NOT COMPLETED|Overall Study||1
8377493|NCT01120704|20650764|P2|NOT COMPLETED|Overall Study||4
8377494|NCT01120704|20650765|P1|NOT COMPLETED|Overall Study||3
8377495|NCT01120704|20650734|P32|COMPLETED|Overall Study||17
8377496|NCT01120704|20650735|P31|COMPLETED|Overall Study||12
8377497|NCT01120704|20650736|P30|COMPLETED|Overall Study||12
8377498|NCT01120704|20650737|P29|COMPLETED|Overall Study||14
8377499|NCT01120704|20650738|P28|COMPLETED|Overall Study||16
8377500|NCT01120704|20650739|P27|COMPLETED|Overall Study||15
8377501|NCT01120704|20650740|P26|COMPLETED|Overall Study||14
8377502|NCT01120704|20650741|P25|COMPLETED|Overall Study||16
8377503|NCT01120704|20650742|P24|COMPLETED|Overall Study||13
8377504|NCT01120704|20650743|P23|COMPLETED|Overall Study||17
8377505|NCT01120704|20650744|P22|COMPLETED|Overall Study||16
8377506|NCT01120704|20650745|P21|COMPLETED|Overall Study||14
8377507|NCT01120704|20650746|P20|COMPLETED|Overall Study||15
8377508|NCT01120704|20650747|P19|COMPLETED|Overall Study||15
8377509|NCT01120704|20650748|P18|COMPLETED|Overall Study||16
8377510|NCT01120704|20650749|P17|COMPLETED|Overall Study||13
8377511|NCT01120704|20650750|P16|COMPLETED|Overall Study||16
8377512|NCT01120704|20650751|P15|COMPLETED|Overall Study||17
8377513|NCT01120704|20650752|P14|COMPLETED|Overall Study||15
8377514|NCT01120704|20650753|P13|COMPLETED|Overall Study||14
8377515|NCT01120704|20650754|P12|COMPLETED|Overall Study||14
8377516|NCT01120704|20650755|P11|COMPLETED|Overall Study||16
8377517|NCT01120704|20650756|P10|COMPLETED|Overall Study||19
8377518|NCT01120704|20650757|P9|COMPLETED|Overall Study||19
8377519|NCT01120704|20650758|P8|COMPLETED|Overall Study||13
8377520|NCT01120704|20650759|P7|COMPLETED|Overall Study||12
8377521|NCT01120704|20650760|P6|COMPLETED|Overall Study||18
8377522|NCT01120704|20650761|P5|COMPLETED|Overall Study||14
8377523|NCT01120704|20650762|P4|COMPLETED|Overall Study||15
8377524|NCT01120704|20650763|P3|COMPLETED|Overall Study||13
8377525|NCT01120704|20650764|P2|COMPLETED|Overall Study||13
8377526|NCT01120704|20650765|P1|COMPLETED|Overall Study||10
8377527|NCT01120704|20650734|P32|STARTED|Overall Study||18
8377528|NCT01120704|20650735|P31|STARTED|Overall Study||14
8377529|NCT01120704|20650736|P30|STARTED|Overall Study||15
8377530|NCT01120704|20650737|P29|STARTED|Overall Study||19
8377531|NCT01120704|20650738|P28|STARTED|Overall Study||18
8377532|NCT01120704|20650739|P27|STARTED|Overall Study||18
8377533|NCT01120704|20650740|P26|STARTED|Overall Study||14
8377534|NCT01120704|20650741|P25|STARTED|Overall Study||18
8377535|NCT01120704|20650742|P24|STARTED|Overall Study||16
8377536|NCT01120704|20650743|P23|STARTED|Overall Study||21
8377537|NCT01120704|20650744|P22|STARTED|Overall Study||16
8377538|NCT01120704|20650745|P21|STARTED|Overall Study||17
8377539|NCT01120704|20650746|P20|STARTED|Overall Study||18
8377540|NCT01120704|20650747|P19|STARTED|Overall Study||17
8377541|NCT01120704|20650748|P18|STARTED|Overall Study||16
8377542|NCT01120704|20650749|P17|STARTED|Overall Study||14
8377543|NCT01120704|20650750|P16|STARTED|Overall Study||18
8377544|NCT01120704|20650751|P15|STARTED|Overall Study||18
8377545|NCT01120704|20650752|P14|STARTED|Overall Study||19
8377546|NCT01120704|20650753|P13|STARTED|Overall Study||17
8377547|NCT01120704|20650754|P12|STARTED|Overall Study||16
8377548|NCT01120704|20650755|P11|STARTED|Overall Study||17
8377549|NCT01120704|20650756|P10|STARTED|Overall Study||20
8377550|NCT01120704|20650757|P9|STARTED|Overall Study||22
8377551|NCT01120704|20650758|P8|STARTED|Overall Study||15
8377552|NCT01120704|20650759|P7|STARTED|Overall Study||15
8377553|NCT01120704|20650760|P6|STARTED|Overall Study||19
8377554|NCT01120704|20650761|P5|STARTED|Overall Study||16
8377555|NCT01120704|20650762|P4|STARTED|Overall Study||19
8377556|NCT01120704|20650763|P3|STARTED|Overall Study||14
8377557|NCT01120704|20650764|P2|STARTED|Overall Study||17
8377558|NCT01120704|20650765|P1|STARTED|Overall Study||13
8377559|NCT01120691|20650792|P3|NOT COMPLETED|Overall Study||183
8377560|NCT01120691|20650793|P2|NOT COMPLETED|Overall Study||203
8377561|NCT01120691|20650794|P1|NOT COMPLETED|Overall Study||171
8377562|NCT01120691|20650792|P3|COMPLETED|Overall Study||559
8377563|NCT01120691|20650793|P2|COMPLETED|Overall Study||538
8377564|NCT01120691|20650794|P1|COMPLETED|Overall Study||570
8377565|NCT01120691|20650792|P3|Modified Full Analysis Set (mFAS)|Overall Study||737
8377566|NCT01120691|20650793|P2|Modified Full Analysis Set (mFAS)|Overall Study||739
8377567|NCT01120691|20650794|P1|Modified Full Analysis Set (mFAS)|Overall Study||729
8377568|NCT01120691|20650792|P3|Modified Safety Set (mSAF)|Overall Study||737
8377569|NCT01120691|20650793|P2|Modified Safety Set (mSAF)|Overall Study||740
8377570|NCT01120691|20650794|P1|Modified Safety Set (mSAF)|Overall Study||729
8377571|NCT01120691|20650792|P3|Safety Set (SAF)|Overall Study||739
8377572|NCT01120691|20650793|P2|Safety Set (SAF)|Overall Study||740
8377573|NCT01120691|20650794|P1|Safety Set (SAF)|Overall Study||736
8377574|NCT01120691|20650792|P3|Full Analysis Set (FAS)|Overall Study||739
8377575|NCT01120691|20650793|P2|Full Analysis Set (FAS)|Overall Study||739
8377576|NCT01120691|20650794|P1|Full Analysis Set (FAS)|Overall Study||736
8377577|NCT01120691|20650792|P3|STARTED|Overall Study||742
8377578|NCT01120691|20650793|P2|STARTED|Overall Study||741
8377579|NCT01120691|20650794|P1|STARTED|Overall Study||741
8377592|NCT01120626|20650891|P2|NOT COMPLETED|Overall Study||0
8377593|NCT01120626|20650892|P1|NOT COMPLETED|Overall Study||1
8377594|NCT01120626|20650891|P2|COMPLETED|Overall Study||22
8377595|NCT01120626|20650892|P1|COMPLETED|Overall Study||19
8377596|NCT01120626|20650891|P2|STARTED|Overall Study||22
8377597|NCT01120626|20650892|P1|STARTED|Overall Study||20
8377598|NCT01120600|20650902|P2|NOT COMPLETED|Overall Study||32
8377599|NCT01120600|20650903|P1|NOT COMPLETED|Overall Study||19
8377600|NCT01120600|20650902|P2|COMPLETED|Overall Study||115
8377601|NCT01120600|20650903|P1|COMPLETED|Overall Study||128
8377602|NCT01120600|20650902|P2|Treated|Overall Study||146
8377603|NCT01120600|20650903|P1|Treated|Overall Study||146
8377604|NCT01120600|20650902|P2|STARTED|Overall Study||147
8377605|NCT01120600|20650903|P1|STARTED|Overall Study||147
8377606|NCT01120405|20650929|P2|NOT COMPLETED|Overall Study||33
8377607|NCT01120405|20650930|P1|NOT COMPLETED|Overall Study||27
8377608|NCT01120405|20650929|P2|COMPLETED|Overall Study||269
8377609|NCT01120405|20650930|P1|COMPLETED|Overall Study||271
8377610|NCT01120405|20650929|P2|STARTED|Overall Study||302
8377611|NCT01120405|20650930|P1|STARTED|Overall Study||298
8377612|NCT01120379|20650958|P1|NOT COMPLETED|Four Year Timepoint||368
8377613|NCT01120379|20650958|P1|COMPLETED|Four Year Timepoint||3923
8377614|NCT01120379|20650958|P1|STARTED|Four Year Timepoint||4291
8377615|NCT01120379|20650958|P1|NOT COMPLETED|Three Year Timepoint||214
8377616|NCT01120379|20650958|P1|COMPLETED|Three Year Timepoint||4291
8377617|NCT01120379|20650958|P1|STARTED|Three Year Timepoint||4505
8377618|NCT01120379|20650958|P1|NOT COMPLETED|Two Year Timepoint||237
8377619|NCT01120379|20650958|P1|COMPLETED|Two Year Timepoint||4505
8377620|NCT01120379|20650958|P1|STARTED|Two Year Timepoint||4742
8377621|NCT01120379|20650958|P1|NOT COMPLETED|One Year Timepoint||278
8377622|NCT01120379|20650958|P1|COMPLETED|One Year Timepoint||4742
8377623|NCT01120379|20650958|P1|STARTED|One Year Timepoint||5020
8377624|NCT01120275|20650994|P1|NOT COMPLETED|Overall Study||36
8377625|NCT01120275|20650994|P1|COMPLETED|Overall Study||0
8377626|NCT01120275|20650994|P1|Eligible and Treated|Overall Study||32
8377627|NCT01120275|20650994|P1|STARTED|Overall Study||36
8377628|NCT01120236|20651003|P2|NOT COMPLETED|Overall Study||1
8377629|NCT01120236|20651004|P1|NOT COMPLETED|Overall Study||0
8377630|NCT01120236|20651003|P2|COMPLETED|Overall Study||105
8377631|NCT01120236|20651004|P1|COMPLETED|Overall Study||105
8377632|NCT01120236|20651003|P2|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
8377633|NCT01120236|20651004|P1|Ineligble|Overall Study||0
8377634|NCT01120236|20651003|P2|STARTED|Overall Study||106
8377635|NCT01120236|20651004|P1|STARTED|Overall Study||105
8377636|NCT01120223|20651031|P1|NOT COMPLETED|Overall Study||4
8377637|NCT01120223|20651031|P1|COMPLETED|Overall Study||74
8377638|NCT01120223|20651031|P1|STARTED|Overall Study||78
8377639|NCT01120210|20651061|P2|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
8377640|NCT01120210|20651062|P1|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
8377641|NCT01120210|20651061|P2|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
8377642|NCT01120210|20651062|P1|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
8377643|NCT01120210|20651061|P2|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
8377644|NCT01120210|20651062|P1|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
8377645|NCT01120210|20651061|P2|NOT COMPLETED|MAIN INFUSION||1
8377646|NCT01120210|20651062|P1|NOT COMPLETED|MAIN INFUSION||1
8377647|NCT01120210|20651061|P2|COMPLETED|MAIN INFUSION||45
8377648|NCT01120210|20651062|P1|COMPLETED|MAIN INFUSION||15
8377649|NCT01120210|20651061|P2|STARTED|MAIN INFUSION||46
8377650|NCT01120210|20651062|P1|STARTED|MAIN INFUSION||16
8377651|NCT01120197|20651094|P2|NOT COMPLETED|Overall Study||10
8377652|NCT01120197|20651095|P1|NOT COMPLETED|Overall Study||9
8377653|NCT01120197|20651094|P2|COMPLETED|Overall Study||32
8377654|NCT01120197|20651095|P1|COMPLETED|Overall Study||38
8377655|NCT01120197|20651094|P2|STARTED|Overall Study||42
8377656|NCT01120197|20651095|P1|STARTED|Overall Study||47
8377657|NCT01120184|20651112|P3|NOT COMPLETED|Overall Study||363
8377658|NCT01120184|20651113|P2|NOT COMPLETED|Overall Study||367
8377659|NCT01120184|20651114|P1|NOT COMPLETED|Overall Study||365
8377660|NCT01120184|20651112|P3|COMPLETED|Overall Study||0
8377661|NCT01120184|20651113|P2|COMPLETED|Overall Study||0
8377662|NCT01120184|20651114|P1|COMPLETED|Overall Study||0
8377663|NCT01120184|20651112|P3|Treated|Overall Study||360
8377664|NCT01120184|20651113|P2|Treated|Overall Study||365
8377665|NCT01120184|20651114|P1|Treated|Overall Study||355
8377666|NCT01120184|20651112|P3|STARTED|Overall Study||363
8377667|NCT01120184|20651113|P2|STARTED|Overall Study||367
8377668|NCT01120184|20651114|P1|STARTED|Overall Study||365
8377669|NCT01120093|20651236|P5|NOT COMPLETED|Treatment Period 5||0
8377670|NCT01120093|20651237|P4|NOT COMPLETED|Treatment Period 5||1
8377671|NCT01120093|20651238|P3|NOT COMPLETED|Treatment Period 5||0
8377672|NCT01120093|20651239|P2|NOT COMPLETED|Treatment Period 5||1
8377673|NCT01120093|20651240|P1|NOT COMPLETED|Treatment Period 5||0
8377674|NCT01120093|20651236|P5|COMPLETED|Treatment Period 5||13
8377675|NCT01120093|20651237|P4|COMPLETED|Treatment Period 5||11
8377676|NCT01120093|20651238|P3|COMPLETED|Treatment Period 5||15
8377677|NCT01120093|20651239|P2|COMPLETED|Treatment Period 5||12
8377678|NCT01120093|20651240|P1|COMPLETED|Treatment Period 5||17
8377679|NCT01120093|20651236|P5|STARTED|Treatment Period 5||13
8377680|NCT01120093|20651237|P4|STARTED|Treatment Period 5||12
8377681|NCT01120093|20651238|P3|STARTED|Treatment Period 5||15
8377682|NCT01120093|20651239|P2|STARTED|Treatment Period 5||13
8377683|NCT01120093|20651240|P1|STARTED|Treatment Period 5||17
8377684|NCT01120093|20651236|P5|NOT COMPLETED|Treatment Period 4||0
8377685|NCT01120093|20651237|P4|NOT COMPLETED|Treatment Period 4||0
8377686|NCT01120093|20651238|P3|NOT COMPLETED|Treatment Period 4||0
8377687|NCT01120093|20651239|P2|NOT COMPLETED|Treatment Period 4||0
8377688|NCT01120093|20651240|P1|NOT COMPLETED|Treatment Period 4||1
8377689|NCT01120093|20651236|P5|COMPLETED|Treatment Period 4||13
8377690|NCT01120093|20651237|P4|COMPLETED|Treatment Period 4||12
8377691|NCT01120093|20651238|P3|COMPLETED|Treatment Period 4||15
8377692|NCT01120093|20651239|P2|COMPLETED|Treatment Period 4||13
8377693|NCT01120093|20651240|P1|COMPLETED|Treatment Period 4||17
8377694|NCT01120093|20651236|P5|STARTED|Treatment Period 4||13
8377695|NCT01120093|20651237|P4|STARTED|Treatment Period 4||12
8377696|NCT01120093|20651238|P3|STARTED|Treatment Period 4||15
8377697|NCT01120093|20651239|P2|STARTED|Treatment Period 4||13
8377698|NCT01120093|20651240|P1|STARTED|Treatment Period 4||18
8377699|NCT01120093|20651236|P5|NOT COMPLETED|Treatment Period 3||1
8377700|NCT01120093|20651237|P4|NOT COMPLETED|Treatment Period 3||1
8377701|NCT01120093|20651238|P3|NOT COMPLETED|Treatment Period 3||1
8377702|NCT01120093|20651239|P2|NOT COMPLETED|Treatment Period 3||0
8377703|NCT01120093|20651240|P1|NOT COMPLETED|Treatment Period 3||0
8377704|NCT01120093|20651236|P5|COMPLETED|Treatment Period 3||13
8377705|NCT01120093|20651237|P4|COMPLETED|Treatment Period 3||12
8377706|NCT01120093|20651238|P3|COMPLETED|Treatment Period 3||15
8377707|NCT01120093|20651239|P2|COMPLETED|Treatment Period 3||13
8377708|NCT01120093|20651240|P1|COMPLETED|Treatment Period 3||18
8377709|NCT01120093|20651236|P5|STARTED|Treatment Period 3||14
8377710|NCT01120093|20651237|P4|STARTED|Treatment Period 3||13
8377711|NCT01120093|20651238|P3|STARTED|Treatment Period 3||16
8377712|NCT01120093|20651239|P2|STARTED|Treatment Period 3||13
8377713|NCT01120093|20651240|P1|STARTED|Treatment Period 3||18
8377714|NCT01120093|20651236|P5|NOT COMPLETED|Treatment Period 2||1
8377715|NCT01120093|20651237|P4|NOT COMPLETED|Treatment Period 2||1
8377716|NCT01120093|20651238|P3|NOT COMPLETED|Treatment Period 2||0
8377717|NCT01120093|20651239|P2|NOT COMPLETED|Treatment Period 2||0
8377718|NCT01120093|20651240|P1|NOT COMPLETED|Treatment Period 2||0
8377719|NCT01120093|20651236|P5|COMPLETED|Treatment Period 2||14
8377720|NCT01120093|20651237|P4|COMPLETED|Treatment Period 2||13
8377721|NCT01120093|20651238|P3|COMPLETED|Treatment Period 2||16
8377722|NCT01120093|20651239|P2|COMPLETED|Treatment Period 2||13
8377723|NCT01120093|20651240|P1|COMPLETED|Treatment Period 2||18
8377724|NCT01120093|20651236|P5|STARTED|Treatment Period 2||15
8377725|NCT01120093|20651237|P4|STARTED|Treatment Period 2||14
8377726|NCT01120093|20651238|P3|STARTED|Treatment Period 2||16
8377727|NCT01120093|20651239|P2|STARTED|Treatment Period 2||13
8377728|NCT01120093|20651240|P1|STARTED|Treatment Period 2||18
8377729|NCT01120093|20651236|P5|NOT COMPLETED|Treatment Period 1||1
8377730|NCT01120093|20651237|P4|NOT COMPLETED|Treatment Period 1||0
8377731|NCT01120093|20651238|P3|NOT COMPLETED|Treatment Period 1||1
8377732|NCT01120093|20651239|P2|NOT COMPLETED|Treatment Period 1||1
8377733|NCT01120093|20651240|P1|NOT COMPLETED|Treatment Period 1||0
8377734|NCT01120093|20651236|P5|COMPLETED|Treatment Period 1||15
8377735|NCT01120093|20651237|P4|COMPLETED|Treatment Period 1||14
8377736|NCT01120093|20651238|P3|COMPLETED|Treatment Period 1||16
8377737|NCT01120093|20651239|P2|COMPLETED|Treatment Period 1||13
8377738|NCT01120093|20651240|P1|COMPLETED|Treatment Period 1||18
8377739|NCT01120093|20651236|P5|STARTED|Treatment Period 1||16
8377740|NCT01120093|20651237|P4|STARTED|Treatment Period 1||14
8377741|NCT01120093|20651238|P3|STARTED|Treatment Period 1||17
8377742|NCT01120093|20651239|P2|STARTED|Treatment Period 1||14
8377743|NCT01120093|20651240|P1|STARTED|Treatment Period 1||18
8377744|NCT01120067|20651269|P2|NOT COMPLETED|Overall Study||1
8377745|NCT01120067|20651270|P1|NOT COMPLETED|Overall Study||5
8377746|NCT01120067|20651269|P2|COMPLETED|Overall Study||10
8377747|NCT01120067|20651270|P1|COMPLETED|Overall Study||7
8377748|NCT01120067|20651269|P2|STARTED|Overall Study||11
8377749|NCT01120067|20651270|P1|STARTED|Overall Study||12
8377750|NCT01120028|20651280|P4|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8377751|NCT01120028|20651281|P3|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8377752|NCT01120028|20651282|P2|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8377753|NCT01120028|20651283|P1|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8377754|NCT01120028|20651280|P4|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
8377755|NCT01120028|20651281|P3|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
8377756|NCT01120028|20651282|P2|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8377757|NCT01120028|20651283|P1|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
8377758|NCT01120028|20651280|P4|STARTED|Period 2: Tacrolimus or Sirolimus||197
8377759|NCT01120028|20651281|P3|STARTED|Period 2: Tacrolimus or Sirolimus||197
8377760|NCT01120028|20651282|P2|STARTED|Period 2: Tacrolimus or Sirolimus||0
8377761|NCT01120028|20651283|P1|STARTED|Period 2: Tacrolimus or Sirolimus||0
8377762|NCT01120028|20651280|P4|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
8377763|NCT01120028|20651281|P3|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
8377764|NCT01120028|20651282|P2|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23
8377765|NCT01120028|20651283|P1|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14
8377766|NCT01120028|20651280|P4|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
8377767|NCT01120028|20651281|P3|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
8377768|NCT01120028|20651282|P2|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403
8377769|NCT01120028|20651283|P1|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412
8377770|NCT01120028|20651280|P4|STARTED|Period 1: Alemtuzumab or Basiliximab||0
8377771|NCT01120028|20651281|P3|STARTED|Period 1: Alemtuzumab or Basiliximab||0
8377772|NCT01120028|20651282|P2|STARTED|Period 1: Alemtuzumab or Basiliximab||426
8377773|NCT01120028|20651283|P1|STARTED|Period 1: Alemtuzumab or Basiliximab||426
8377774|NCT01119963|20651307|P2|NOT COMPLETED|Overall Study||1
8377775|NCT01119963|20651308|P1|NOT COMPLETED|Overall Study||1
8377776|NCT01119963|20651307|P2|COMPLETED|Overall Study||77
8377777|NCT01119963|20651308|P1|COMPLETED|Overall Study||73
8377778|NCT01119963|20651307|P2|STARTED|Overall Study||78
8377779|NCT01119963|20651308|P1|STARTED|Overall Study||74
8377780|NCT01119950|20651318|P1|NOT COMPLETED|Overall Study||47
8377781|NCT01119950|20651318|P1|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
8377782|NCT01119950|20651318|P1|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
8377783|NCT01119950|20651318|P1|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
8377784|NCT01119950|20651318|P1|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
8377785|NCT01119950|20651318|P1|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
8377786|NCT01119950|20651318|P1|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
8377787|NCT01119950|20651318|P1|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
8377788|NCT01119950|20651318|P1|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
8377789|NCT01119950|20651318|P1|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
8377790|NCT01119950|20651318|P1|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
8377791|NCT01119937|20651565|P2|NOT COMPLETED|Overall Study||7
8377792|NCT01119937|20651566|P1|NOT COMPLETED|Overall Study||19
8377793|NCT01119937|20651565|P2|COMPLETED|Overall Study||33
8377794|NCT01119937|20651566|P1|COMPLETED|Overall Study||104
8377795|NCT01119937|20651565|P2|STARTED|Overall Study||40
8377796|NCT01119937|20651566|P1|STARTED|Overall Study||123
8377797|NCT01119898|20651594|P2|NOT COMPLETED|Overall Study||12
8377798|NCT01119898|20651595|P1|NOT COMPLETED|Overall Study||8
8377799|NCT01119898|20651594|P2|COMPLETED|Overall Study||117
8377800|NCT01119898|20651595|P1|COMPLETED|Overall Study||123
8377801|NCT01119898|20651594|P2|Received Study Drug (mITT)|Overall Study||129
8377802|NCT01119898|20651595|P1|Received Study Drug (mITT)|Overall Study||130
8377803|NCT01119898|20651594|P2|STARTED|Overall Study||129
8377804|NCT01119898|20651595|P1|STARTED|Overall Study||131
8377805|NCT01119859|20651621|P2|NOT COMPLETED|Overall Study||30
8377806|NCT01119859|20651622|P1|NOT COMPLETED|Overall Study||24
8377807|NCT01119859|20651621|P2|COMPLETED|Overall Study||133
8377808|NCT01119859|20651622|P1|COMPLETED|Overall Study||139
8377809|NCT01119859|20651621|P2|STARTED|Overall Study||163
8377810|NCT01119859|20651622|P1|STARTED|Overall Study||163
8377811|NCT01119846|20651641|P3|NOT COMPLETED|Overall Study||11
8377812|NCT01119846|20651642|P2|NOT COMPLETED|Overall Study||0
8377813|NCT01119846|20651643|P1|NOT COMPLETED|Overall Study||2
8377814|NCT01119846|20651641|P3|COMPLETED|Overall Study||72
8377815|NCT01119846|20651642|P2|COMPLETED|Overall Study||4
8377816|NCT01119846|20651643|P1|COMPLETED|Overall Study||11
8377817|NCT01119846|20651641|P3|STARTED|Overall Study||83
8377818|NCT01119846|20651642|P2|STARTED|Overall Study||4
8377819|NCT01119846|20651643|P1|STARTED|Overall Study||13
8377820|NCT01119794|20651851|P1|NOT COMPLETED|Overall Study||0
8377821|NCT01119794|20651851|P1|COMPLETED|Overall Study||10
8377822|NCT01119794|20651851|P1|STARTED|Overall Study||10
8377823|NCT01119768|20651857|P2|NOT COMPLETED|Follow-up||2
8377824|NCT01119768|20651858|P1|NOT COMPLETED|Follow-up||1
8377825|NCT01119768|20651857|P2|COMPLETED|Follow-up||122
8377826|NCT01119768|20651858|P1|COMPLETED|Follow-up||135
8377827|NCT01119768|20651857|P2|STARTED|Follow-up||124
8377828|NCT01119768|20651858|P1|STARTED|Follow-up||136
8377829|NCT01119768|20651857|P2|NOT COMPLETED|Treatment Period||25
8377830|NCT01119768|20651858|P1|NOT COMPLETED|Treatment Period||18
8377831|NCT01119768|20651857|P2|COMPLETED|Treatment Period||126
8377832|NCT01119768|20651858|P1|COMPLETED|Treatment Period||136
8377833|NCT01119768|20651857|P2|STARTED|Treatment Period||151
8377834|NCT01119768|20651858|P1|STARTED|Treatment Period||154
8377835|NCT01119755|20651880|P1|NOT COMPLETED|Overall Study||0
8377836|NCT01119755|20651880|P1|COMPLETED|Overall Study||80
8377837|NCT01119755|20651880|P1|STARTED|Overall Study||80
8377838|NCT01119716|20651891|P1|NOT COMPLETED|Overall Study||0
8377839|NCT01119716|20651891|P1|COMPLETED|Overall Study||4658
8377840|NCT01119716|20651891|P1|STARTED|Overall Study||4658
8377841|NCT01119703|20651914|P2|NOT COMPLETED|Overall Study||1
8377842|NCT01119703|20651915|P1|NOT COMPLETED|Overall Study||0
8377843|NCT01119703|20651914|P2|COMPLETED|Overall Study||143
8377844|NCT01119703|20651915|P1|COMPLETED|Overall Study||30
8377845|NCT01119703|20651914|P2|STARTED|Overall Study||144
8377846|NCT01119703|20651915|P1|STARTED|Overall Study||30
8377847|NCT01119625|20651929|P2|NOT COMPLETED|Overall Study||4
8377848|NCT01119625|20651930|P1|NOT COMPLETED|Overall Study||3
8377849|NCT01119625|20651929|P2|COMPLETED|Overall Study||116
8377850|NCT01119625|20651930|P1|COMPLETED|Overall Study||115
8377851|NCT01119625|20651929|P2|STARTED|Overall Study||120
8377852|NCT01119625|20651930|P1|STARTED|Overall Study||118
8377853|NCT01119508|20651970|P1|NOT COMPLETED|Overall Study||59
8377854|NCT01119508|20651970|P1|COMPLETED|Overall Study||5
8377855|NCT01119508|20651970|P1|Received Fifth Consolidation Dose week12|Overall Study||32
8377856|NCT01119508|20651970|P1|Received Four Induction Doses|Overall Study||45
8377857|NCT01119508|20651970|P1|STARTED|Overall Study||64
8377858|NCT01119456|20651982|P8|NOT COMPLETED|Overall Study||0
8377859|NCT01119456|20651983|P7|NOT COMPLETED|Overall Study||0
8377860|NCT01119456|20651984|P6|NOT COMPLETED|Overall Study||0
8377861|NCT01119456|20651985|P5|NOT COMPLETED|Overall Study||0
8377862|NCT01119456|20651986|P4|NOT COMPLETED|Overall Study||0
8377863|NCT01119456|20651987|P3|NOT COMPLETED|Overall Study||0
8377864|NCT01119456|20651988|P2|NOT COMPLETED|Overall Study||0
8377865|NCT01119456|20651989|P1|NOT COMPLETED|Overall Study||0
8377866|NCT01119456|20651982|P8|COMPLETED|Overall Study||3
8377867|NCT01119456|20651983|P7|COMPLETED|Overall Study||3
8377868|NCT01119456|20651984|P6|COMPLETED|Overall Study||3
8377869|NCT01119456|20651985|P5|COMPLETED|Overall Study||4
8377870|NCT01119456|20651986|P4|COMPLETED|Overall Study||13
8377871|NCT01119456|20651987|P3|COMPLETED|Overall Study||3
8377872|NCT01119456|20651988|P2|COMPLETED|Overall Study||3
8377873|NCT01119456|20651989|P1|COMPLETED|Overall Study||7
8377874|NCT01119456|20651982|P8|Received at Least 1 Dose of Study Drug|Overall Study||3
8377875|NCT01119456|20651983|P7|Received at Least 1 Dose of Study Drug|Overall Study||3
8377876|NCT01119456|20651984|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
8377877|NCT01119456|20651985|P5|Received at Least 1 Dose of Study Drug|Overall Study||4
8377878|NCT01119456|20651986|P4|Received at Least 1 Dose of Study Drug|Overall Study||13
8377879|NCT01119456|20651987|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8377880|NCT01119456|20651988|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8377881|NCT01119456|20651989|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
8377882|NCT01119456|20651982|P8|STARTED|Overall Study||3
8377883|NCT01119456|20651983|P7|STARTED|Overall Study||3
8377884|NCT01119456|20651984|P6|STARTED|Overall Study||3
8377885|NCT01119456|20651985|P5|STARTED|Overall Study||4
8377886|NCT01119456|20651986|P4|STARTED|Overall Study||13
8377887|NCT01119456|20651987|P3|STARTED|Overall Study||3
8377888|NCT01119456|20651988|P2|STARTED|Overall Study||3
8377889|NCT01119456|20651989|P1|STARTED|Overall Study||7
8377890|NCT01119443|20652050|P2|NOT COMPLETED|End of Study (All Patients)||0
8377891|NCT01119443|20652051|P1|NOT COMPLETED|End of Study (All Patients)||0
8377892|NCT01119443|20652050|P2|COMPLETED|End of Study (All Patients)||14
8377893|NCT01119443|20652051|P1|COMPLETED|End of Study (All Patients)||14
8377894|NCT01119443|20652050|P2|STARTED|End of Study (All Patients)||14
8377895|NCT01119443|20652051|P1|STARTED|End of Study (All Patients)||14
8377896|NCT01119443|20652050|P2|NOT COMPLETED|Down-titration Period (1 Day)||0
8377897|NCT01119443|20652051|P1|NOT COMPLETED|Down-titration Period (1 Day)||0
8377898|NCT01119443|20652050|P2|COMPLETED|Down-titration Period (1 Day)||13
8377899|NCT01119443|20652051|P1|COMPLETED|Down-titration Period (1 Day)||14
8377900|NCT01119443|20652050|P2|STARTED|Down-titration Period (1 Day)||13
8377901|NCT01119443|20652051|P1|STARTED|Down-titration Period (1 Day)||14
8377902|NCT01119443|20652050|P2|NOT COMPLETED|Crossover Period 4 (5 Days)||0
8377903|NCT01119443|20652051|P1|NOT COMPLETED|Crossover Period 4 (5 Days)||0
8377904|NCT01119443|20652050|P2|COMPLETED|Crossover Period 4 (5 Days)||13
8377905|NCT01119443|20652051|P1|COMPLETED|Crossover Period 4 (5 Days)||14
8377906|NCT01119443|20652050|P2|STARTED|Crossover Period 4 (5 Days)||13
8377907|NCT01119443|20652051|P1|STARTED|Crossover Period 4 (5 Days)||14
8377908|NCT01119443|20652050|P2|NOT COMPLETED|Crossover Period 3 (5 Days)||0
8377909|NCT01119443|20652051|P1|NOT COMPLETED|Crossover Period 3 (5 Days)||0
8377910|NCT01119443|20652050|P2|COMPLETED|Crossover Period 3 (5 Days)||13
8377911|NCT01119443|20652051|P1|COMPLETED|Crossover Period 3 (5 Days)||14
8377912|NCT01119443|20652050|P2|STARTED|Crossover Period 3 (5 Days)||13
8377913|NCT01119443|20652051|P1|STARTED|Crossover Period 3 (5 Days)||14
8377914|NCT01119443|20652050|P2|NOT COMPLETED|Crossover Period 2 (5 Days)||0
8377915|NCT01119443|20652051|P1|NOT COMPLETED|Crossover Period 2 (5 Days)||0
8377916|NCT01119443|20652050|P2|COMPLETED|Crossover Period 2 (5 Days)||13
8377917|NCT01119443|20652051|P1|COMPLETED|Crossover Period 2 (5 Days)||14
8377918|NCT01119443|20652050|P2|STARTED|Crossover Period 2 (5 Days)||13
8377919|NCT01119443|20652051|P1|STARTED|Crossover Period 2 (5 Days)||14
8377920|NCT01119443|20652050|P2|NOT COMPLETED|Crossover Period 1 (5 Days)||1
8377921|NCT01119443|20652051|P1|NOT COMPLETED|Crossover Period 1 (5 Days)||0
8377922|NCT01119443|20652050|P2|COMPLETED|Crossover Period 1 (5 Days)||13
8377923|NCT01119443|20652051|P1|COMPLETED|Crossover Period 1 (5 Days)||14
8377924|NCT01119443|20652050|P2|STARTED|Crossover Period 1 (5 Days)||14
8377925|NCT01119443|20652051|P1|STARTED|Crossover Period 1 (5 Days)||14
8377926|NCT01119443|20652050|P2|NOT COMPLETED|Up-titration Period (10 Days)||0
8377927|NCT01119443|20652051|P1|NOT COMPLETED|Up-titration Period (10 Days)||0
8377928|NCT01119443|20652050|P2|COMPLETED|Up-titration Period (10 Days)||14
8377929|NCT01119443|20652051|P1|COMPLETED|Up-titration Period (10 Days)||14
8377930|NCT01119443|20652050|P2|STARTED|Up-titration Period (10 Days)||14
8377931|NCT01119443|20652051|P1|STARTED|Up-titration Period (10 Days)||14
8377932|NCT01119287|20652094|P6|NOT COMPLETED|Overall Study||0
8377933|NCT01119287|20652095|P5|NOT COMPLETED|Overall Study||1
8377934|NCT01119287|20652096|P4|NOT COMPLETED|Overall Study||2
8377935|NCT01119287|20652097|P3|NOT COMPLETED|Overall Study||2
8377936|NCT01119287|20652098|P2|NOT COMPLETED|Overall Study||0
8377937|NCT01119287|20652099|P1|NOT COMPLETED|Overall Study||0
8377938|NCT01119287|20652094|P6|COMPLETED|Overall Study||32
8377939|NCT01119287|20652095|P5|COMPLETED|Overall Study||30
8377940|NCT01119287|20652096|P4|COMPLETED|Overall Study||29
8377941|NCT01119287|20652097|P3|COMPLETED|Overall Study||24
8377942|NCT01119287|20652098|P2|COMPLETED|Overall Study||24
8377943|NCT01119287|20652099|P1|COMPLETED|Overall Study||26
8377944|NCT01119287|20652094|P6|STARTED|Overall Study||32
8377945|NCT01119287|20652095|P5|STARTED|Overall Study||31
8377946|NCT01119287|20652096|P4|STARTED|Overall Study||31
8377947|NCT01119287|20652097|P3|STARTED|Overall Study||26
8377948|NCT01119287|20652098|P2|STARTED|Overall Study||24
8377949|NCT01119287|20652099|P1|STARTED|Overall Study||26
8377950|NCT01119248|20652112|P1|NOT COMPLETED|Overall Study||5
8377951|NCT01119248|20652112|P1|COMPLETED|Overall Study||115
8377952|NCT01119248|20652112|P1|STARTED|Overall Study||120
8377953|NCT01119222|20652118|P4|NOT COMPLETED|Overall Study||0
8377954|NCT01119222|20652119|P3|NOT COMPLETED|Overall Study||0
8377955|NCT01119222|20652120|P2|NOT COMPLETED|Overall Study||0
8377956|NCT01119222|20652121|P1|NOT COMPLETED|Overall Study||0
8377957|NCT01119222|20652118|P4|COMPLETED|Overall Study||4
8377958|NCT01119222|20652119|P3|COMPLETED|Overall Study||5
8377959|NCT01119222|20652120|P2|COMPLETED|Overall Study||5
8377960|NCT01119222|20652121|P1|COMPLETED|Overall Study||5
8377961|NCT01119222|20652118|P4|STARTED|Overall Study||4
8377962|NCT01119222|20652119|P3|STARTED|Overall Study||5
8377963|NCT01119222|20652120|P2|STARTED|Overall Study||5
8377964|NCT01119222|20652121|P1|STARTED|Overall Study||5
8377965|NCT01119131|20652162|P3|NOT COMPLETED|Overall Study||6
8377966|NCT01119131|20652163|P2|NOT COMPLETED|Overall Study||1
8377967|NCT01119131|20652164|P1|NOT COMPLETED|Overall Study||2
8377968|NCT01119131|20652162|P3|COMPLETED|Overall Study||24
8377969|NCT01119131|20652163|P2|COMPLETED|Overall Study||27
8377970|NCT01119131|20652164|P1|COMPLETED|Overall Study||8
8377971|NCT01119131|20652162|P3|STARTED|Overall Study||30
8377972|NCT01119131|20652163|P2|STARTED|Overall Study||28
8377973|NCT01119131|20652164|P1|STARTED|Overall Study||10
8377974|NCT01119118|20652193|P1|NOT COMPLETED|Overall Study||1
8377975|NCT01119118|20652193|P1|COMPLETED|Overall Study||5
8377976|NCT01119118|20652193|P1|STARTED|Overall Study||6
8377977|NCT01119105|20652204|P3|NOT COMPLETED|Overall Study||8
8377978|NCT01119105|20652205|P2|NOT COMPLETED|Overall Study||6
8377979|NCT01119105|20652206|P1|NOT COMPLETED|Overall Study||4
8377980|NCT01119105|20652204|P3|COMPLETED|Overall Study||60
8377981|NCT01119105|20652205|P2|COMPLETED|Overall Study||66
8377982|NCT01119105|20652206|P1|COMPLETED|Overall Study||66
8377983|NCT01119105|20652204|P3|STARTED|Overall Study||68
8377984|NCT01119105|20652205|P2|STARTED|Overall Study||72
8377985|NCT01119105|20652206|P1|STARTED|Overall Study||70
8377986|NCT01119040|20652217|P1|NOT COMPLETED|Overall Study||1
8377987|NCT01119040|20652217|P1|COMPLETED|Overall Study||0
8377988|NCT01119040|20652217|P1|STARTED|Overall Study||1
8377989|NCT01119001|20652221|P1|NOT COMPLETED|Overall Study||2
8377990|NCT01119001|20652221|P1|COMPLETED|Overall Study||11
8377991|NCT01119001|20652221|P1|STARTED|Overall Study||13
8377992|NCT01118988|20652230|P3|NOT COMPLETED|Overall Study||4
8377993|NCT01118988|20652231|P2|NOT COMPLETED|Overall Study||1
8377994|NCT01118988|20652232|P1|NOT COMPLETED|Overall Study||5
8377995|NCT01118988|20652230|P3|COMPLETED|Overall Study||3
8377996|NCT01118988|20652231|P2|COMPLETED|Overall Study||3
8377997|NCT01118988|20652232|P1|COMPLETED|Overall Study||11
8377998|NCT01118988|20652230|P3|STARTED|Overall Study||7
8377999|NCT01118988|20652231|P2|STARTED|Overall Study||4
8378000|NCT01118988|20652232|P1|STARTED|Overall Study||16
8378001|NCT01118975|20652265|P2|NOT COMPLETED|Overall Study||1
8378002|NCT01118975|20652266|P1|NOT COMPLETED|Overall Study||0
8378003|NCT01118975|20652265|P2|COMPLETED|Overall Study||2
8378004|NCT01118975|20652266|P1|COMPLETED|Overall Study||9
8378005|NCT01118975|20652265|P2|STARTED|Overall Study||3
8378006|NCT01118975|20652266|P1|STARTED|Overall Study||9
8378007|NCT01118962|20652272|P1|NOT COMPLETED|Overall Study||10
8378008|NCT01118962|20652272|P1|COMPLETED|Overall Study||29
8378009|NCT01118962|20652272|P1|STARTED|Overall Study||39
8378010|NCT01118949|20652277|P1|NOT COMPLETED|Overall Study||9
8378011|NCT01118949|20652277|P1|COMPLETED|Overall Study||40
8378012|NCT01118949|20652277|P1|STARTED|Overall Study||49
8378013|NCT01118845|20652286|P1|NOT COMPLETED|Overall Study||42
8378014|NCT01118845|20652286|P1|COMPLETED|Overall Study||17
8378015|NCT01118845|20652286|P1|STARTED|Overall Study||59
8378016|NCT01118780|20652307|P2|NOT COMPLETED|Overall Study||35
8378017|NCT01118780|20652308|P1|NOT COMPLETED|Overall Study||36
8378018|NCT01118780|20652307|P2|COMPLETED|Overall Study||105
8378019|NCT01118780|20652308|P1|COMPLETED|Overall Study||115
8378020|NCT01118780|20652307|P2|STARTED|Overall Study||140
8378021|NCT01118780|20652308|P1|STARTED|Overall Study||151
8378022|NCT01118741|20652357|P2|NOT COMPLETED|Overall Study||0
8378023|NCT01118741|20652358|P1|NOT COMPLETED|Overall Study||0
8378024|NCT01118741|20652357|P2|COMPLETED|Overall Study||10
8378025|NCT01118741|20652358|P1|COMPLETED|Overall Study||9
8378026|NCT01118741|20652357|P2|STARTED|Overall Study||10
8378027|NCT01118741|20652358|P1|STARTED|Overall Study||9
8378028|NCT01118728|20652366|P1|NOT COMPLETED|Overall Study||223
8378029|NCT01118728|20652366|P1|COMPLETED|Overall Study||0
8378030|NCT01118728|20652366|P1|STARTED|Overall Study||223
8378031|NCT01118715|20652373|P2|NOT COMPLETED|Overall Study||0
8378032|NCT01118715|20652374|P1|NOT COMPLETED|Overall Study||0
8378033|NCT01118715|20652373|P2|COMPLETED|Overall Study||60
8378034|NCT01118715|20652374|P1|COMPLETED|Overall Study||68
8378035|NCT01118715|20652373|P2|STARTED|Overall Study||60
8378036|NCT01118715|20652374|P1|STARTED|Overall Study||68
8378037|NCT01118663|20652403|P2|NOT COMPLETED|Overall Study||2
8378038|NCT01118663|20652404|P1|NOT COMPLETED|Overall Study||2
8378039|NCT01118663|20652403|P2|COMPLETED|Overall Study||8
8378040|NCT01118663|20652404|P1|COMPLETED|Overall Study||5
8378041|NCT01118663|20652403|P2|STARTED|Overall Study||10
8378042|NCT01118663|20652404|P1|STARTED|Overall Study||7
8378043|NCT01118624|20652418|P1|NOT COMPLETED|Overall Study||22
8378044|NCT01118624|20652418|P1|COMPLETED|Overall Study||0
8378045|NCT01118624|20652418|P1|STARTED|Overall Study||22
8378046|NCT01118520|20652428|P3|NOT COMPLETED|Overall Study||20
8378047|NCT01118520|20652429|P2|NOT COMPLETED|Overall Study||23
8378048|NCT01118520|20652430|P1|NOT COMPLETED|Overall Study||20
8378049|NCT01118520|20652428|P3|COMPLETED|Overall Study||59
8378050|NCT01118520|20652429|P2|COMPLETED|Overall Study||49
8378051|NCT01118520|20652430|P1|COMPLETED|Overall Study||53
8378052|NCT01118520|20652428|P3|STARTED|Overall Study||79
8378053|NCT01118520|20652429|P2|STARTED|Overall Study||72
8378054|NCT01118520|20652430|P1|STARTED|Overall Study||73
8378055|NCT01118455|20652443|P2|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
8378056|NCT01118455|20652444|P1|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
8378057|NCT01118455|20652443|P2|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
8378058|NCT01118455|20652444|P1|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
8378059|NCT01118455|20652443|P2|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
8378060|NCT01118455|20652444|P1|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
8378061|NCT01118455|20652443|P2|NOT COMPLETED|Baseline [Visits 1 & 2]||0
8378062|NCT01118455|20652444|P1|NOT COMPLETED|Baseline [Visits 1 & 2]||1
8378063|NCT01118455|20652443|P2|COMPLETED|Baseline [Visits 1 & 2]||69
8378064|NCT01118455|20652444|P1|COMPLETED|Baseline [Visits 1 & 2]||65
8378065|NCT01118455|20652443|P2|Actual Patients Treated|Baseline [Visits 1 & 2]||69
8378066|NCT01118455|20652444|P1|Actual Patients Treated|Baseline [Visits 1 & 2]||65
8378067|NCT01118455|20652443|P2|STARTED|Baseline [Visits 1 & 2]||69
8378068|NCT01118455|20652444|P1|STARTED|Baseline [Visits 1 & 2]||66
8378069|NCT01118377|20652472|P1|NOT COMPLETED|Overall Study||42
8378070|NCT01118377|20652472|P1|COMPLETED|Overall Study||3
8378071|NCT01118377|20652472|P1|STARTED|Overall Study||45
8378072|NCT01118351|20652478|P1|NOT COMPLETED|Overall Study||4
8378073|NCT01118351|20652478|P1|COMPLETED|Overall Study||15
8378074|NCT01118351|20652478|P1|STARTED|Overall Study||19
8378075|NCT01118338|20652488|P2|NOT COMPLETED|Overall Study||9
8378076|NCT01118338|20652489|P1|NOT COMPLETED|Overall Study||3
8378077|NCT01118338|20652488|P2|COMPLETED|Overall Study||174
8378078|NCT01118338|20652489|P1|COMPLETED|Overall Study||182
8378079|NCT01118338|20652488|P2|STARTED|Overall Study||183
8378080|NCT01118338|20652489|P1|STARTED|Overall Study||185
8378081|NCT01118325|20652502|P3|NOT COMPLETED|Overall Study||1
8378082|NCT01118325|20652503|P2|NOT COMPLETED|Overall Study||0
8378083|NCT01118325|20652504|P1|NOT COMPLETED|Overall Study||1
8378084|NCT01118325|20652502|P3|COMPLETED|Overall Study||45
8378085|NCT01118325|20652503|P2|COMPLETED|Overall Study||43
8378086|NCT01118325|20652504|P1|COMPLETED|Overall Study||49
8378087|NCT01118325|20652502|P3|STARTED|Overall Study||46
8378088|NCT01118325|20652503|P2|STARTED|Overall Study||43
8378089|NCT01118325|20652504|P1|STARTED|Overall Study||50
8378090|NCT01118312|20652550|P2|NOT COMPLETED|Overall Study||35
8378091|NCT01118312|20652551|P1|NOT COMPLETED|Overall Study||34
8378092|NCT01118312|20652550|P2|COMPLETED|Overall Study||164
8378093|NCT01118312|20652551|P1|COMPLETED|Overall Study||155
8378094|NCT01118312|20652550|P2|STARTED|Overall Study||199
8378095|NCT01118312|20652551|P1|STARTED|Overall Study||189
8378096|NCT01118299|20652561|P2|NOT COMPLETED|Overall Study||29
8378097|NCT01118299|20652562|P1|NOT COMPLETED|Overall Study||23
8378098|NCT01118299|20652561|P2|COMPLETED|Overall Study||0
8378099|NCT01118299|20652562|P1|COMPLETED|Overall Study||45
8378100|NCT01118299|20652561|P2|STARTED|Overall Study||29
8378101|NCT01118299|20652562|P1|STARTED|Overall Study||68
8378102|NCT01118273|20652575|P6|NOT COMPLETED|Overall Study||0
8378103|NCT01118273|20652576|P5|NOT COMPLETED|Overall Study||0
8378104|NCT01118273|20652577|P4|NOT COMPLETED|Overall Study||0
8378105|NCT01118273|20652578|P3|NOT COMPLETED|Overall Study||0
8378106|NCT01118273|20652579|P2|NOT COMPLETED|Overall Study||0
8378107|NCT01118273|20652580|P1|NOT COMPLETED|Overall Study||0
8378108|NCT01118273|20652575|P6|COMPLETED|Overall Study||27
8378109|NCT01118273|20652576|P5|COMPLETED|Overall Study||27
8378110|NCT01118273|20652577|P4|COMPLETED|Overall Study||27
8378111|NCT01118273|20652578|P3|COMPLETED|Overall Study||27
8378112|NCT01118273|20652579|P2|COMPLETED|Overall Study||27
8378113|NCT01118273|20652580|P1|COMPLETED|Overall Study||27
8378114|NCT01118273|20652575|P6|STARTED|Overall Study||27
8378115|NCT01118273|20652576|P5|STARTED|Overall Study||27
8378116|NCT01118273|20652577|P4|STARTED|Overall Study||27
8378117|NCT01118273|20652578|P3|STARTED|Overall Study||27
8378118|NCT01118273|20652579|P2|STARTED|Overall Study||27
8378119|NCT01118273|20652580|P1|STARTED|Overall Study||27
8378120|NCT01118221|20652746|P2|NOT COMPLETED|Overall Study||1
8378121|NCT01118221|20652747|P1|NOT COMPLETED|Overall Study||3
8378122|NCT01118221|20652746|P2|COMPLETED|Overall Study||10
8378123|NCT01118221|20652747|P1|COMPLETED|Overall Study||11
8378124|NCT01118221|20652746|P2|STARTED|Overall Study||11
8378125|NCT01118221|20652747|P1|STARTED|Overall Study||14
8378126|NCT01118143|20652759|P2|NOT COMPLETED|Overall Study||5
8378127|NCT01118143|20652760|P1|NOT COMPLETED|Overall Study||2
8378128|NCT01118143|20652759|P2|COMPLETED|Overall Study||64
8378129|NCT01118143|20652760|P1|COMPLETED|Overall Study||62
8378130|NCT01118143|20652759|P2|STARTED|Overall Study||69
8378131|NCT01118143|20652760|P1|STARTED|Overall Study||64
8378132|NCT01118117|20652770|P2|NOT COMPLETED|Overall Study||0
8378133|NCT01118117|20652771|P1|NOT COMPLETED|Overall Study||21
8378134|NCT01118117|20652770|P2|COMPLETED|Overall Study||15
8378135|NCT01118117|20652771|P1|COMPLETED|Overall Study||240
8378136|NCT01118117|20652770|P2|STARTED|Overall Study||15
8378137|NCT01118117|20652771|P1|STARTED|Overall Study||261
8378138|NCT01118091|20652792|P2|NOT COMPLETED|Overall Study||0
8378139|NCT01118091|20652793|P1|NOT COMPLETED|Overall Study||0
8378140|NCT01118091|20652792|P2|COMPLETED|Overall Study||5
8378141|NCT01118091|20652793|P1|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
8378142|NCT01118091|20652792|P2|STARTED|Overall Study||5
8378143|NCT01118091|20652793|P1|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
8378144|NCT01118052|20652803|P1|NOT COMPLETED|Overall Study||2
8378145|NCT01118052|20652803|P1|COMPLETED|Overall Study||20
8378146|NCT01118052|20652803|P1|STARTED|Overall Study||22
8378147|NCT01118013|20652816|P1|NOT COMPLETED|Overall Study||0
8378148|NCT01118013|20652816|P1|COMPLETED|Overall Study||6
8378149|NCT01118013|20652816|P1|STARTED|Overall Study||6
8378150|NCT01117987|20652826|P2|NOT COMPLETED|Overall Study||74
8378151|NCT01117987|20652827|P1|NOT COMPLETED|Overall Study||61
8378152|NCT01117987|20652826|P2|COMPLETED|Overall Study||4
8378153|NCT01117987|20652827|P1|COMPLETED|Overall Study||5
8378154|NCT01117987|20652826|P2|STARTED|Overall Study||78
8378155|NCT01117987|20652827|P1|STARTED|Overall Study||66
8378156|NCT01117948|20652839|P2|NOT COMPLETED|Open Label||47
8378157|NCT01117948|20652840|P1|NOT COMPLETED|Open Label||52
8378158|NCT01117948|20652839|P2|COMPLETED|Open Label||51
8378159|NCT01117948|20652840|P1|COMPLETED|Open Label||41
8378160|NCT01117948|20652839|P2|STARTED|Open Label||98
8378161|NCT01117948|20652840|P1|STARTED|Open Label||93
8378162|NCT01117948|20652839|P2|NOT COMPLETED|Double Blind||10
8378163|NCT01117948|20652840|P1|NOT COMPLETED|Double Blind||18
8378164|NCT01117948|20652839|P2|COMPLETED|Double Blind||98
8378165|NCT01117948|20652840|P1|COMPLETED|Double Blind||93
8378166|NCT01117948|20652839|P2|STARTED|Double Blind||108
8378167|NCT01117948|20652840|P1|STARTED|Double Blind||111
8378168|NCT01117870|20652848|P2|NOT COMPLETED|Overall Study||0
8378169|NCT01117870|20652849|P1|NOT COMPLETED|Overall Study||1
8378170|NCT01117870|20652848|P2|COMPLETED|Overall Study||16
8378171|NCT01117870|20652849|P1|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
8378172|NCT01117870|20652848|P2|STARTED|Overall Study||16
8378173|NCT01117870|20652849|P1|STARTED|Overall Study||15
8378174|NCT01117857|20652863|P1|NOT COMPLETED|Overall Study||9
8378175|NCT01117857|20652863|P1|COMPLETED|Overall Study||13
8378176|NCT01117857|20652863|P1|STARTED|Overall Study||22
8378177|NCT01117766|20652871|P2|NOT COMPLETED|Second Intervention||5
8378178|NCT01117766|20652872|P1|NOT COMPLETED|Second Intervention||2
8378179|NCT01117766|20652871|P2|COMPLETED|Second Intervention||9
8378180|NCT01117766|20652872|P1|COMPLETED|Second Intervention||11
8378181|NCT01117766|20652871|P2|STARTED|Second Intervention||14
8378182|NCT01117766|20652872|P1|STARTED|Second Intervention||13
8378183|NCT01117766|20652871|P2|NOT COMPLETED|Washout Period||2
8378184|NCT01117766|20652872|P1|NOT COMPLETED|Washout Period||0
8378185|NCT01117766|20652871|P2|COMPLETED|Washout Period||14
8378186|NCT01117766|20652872|P1|COMPLETED|Washout Period||13
8378187|NCT01117766|20652871|P2|STARTED|Washout Period||16
8378188|NCT01117766|20652872|P1|STARTED|Washout Period||13
8378189|NCT01117766|20652871|P2|NOT COMPLETED|First Intervention||1
8378190|NCT01117766|20652872|P1|NOT COMPLETED|First Intervention||1
8378191|NCT01117766|20652871|P2|COMPLETED|First Intervention||16
8378192|NCT01117766|20652872|P1|COMPLETED|First Intervention||13
8378193|NCT01117766|20652871|P2|Received Treatment|First Intervention||17
8378194|NCT01117766|20652872|P1|Received Treatment|First Intervention||14
8378195|NCT01117766|20652871|P2|STARTED|First Intervention||17
8378196|NCT01117766|20652872|P1|STARTED|First Intervention||14
8378197|NCT01117727|20652896|P1|NOT COMPLETED|Overall Study||0
8378198|NCT01117727|20652896|P1|COMPLETED|Overall Study||1
8378199|NCT01117727|20652896|P1|STARTED|Overall Study||1
8378200|NCT01117623|20652909|P8|NOT COMPLETED|Overall Study||26
8378201|NCT01117623|20652910|P7|NOT COMPLETED|Overall Study||6
8378202|NCT01117623|20652911|P6|NOT COMPLETED|Overall Study||16
8378203|NCT01117623|20652912|P5|NOT COMPLETED|Overall Study||10
8378204|NCT01117623|20652913|P4|NOT COMPLETED|Overall Study||6
8378205|NCT01117623|20652914|P3|NOT COMPLETED|Overall Study||11
8378206|NCT01117623|20652915|P2|NOT COMPLETED|Overall Study||8
8378207|NCT01117623|20652916|P1|NOT COMPLETED|Overall Study||3
8378208|NCT01117623|20652909|P8|COMPLETED|Overall Study||0
8378209|NCT01117623|20652910|P7|COMPLETED|Overall Study||0
8378210|NCT01117623|20652911|P6|COMPLETED|Overall Study||0
8378211|NCT01117623|20652912|P5|COMPLETED|Overall Study||0
8378212|NCT01117623|20652913|P4|COMPLETED|Overall Study||0
8378213|NCT01117623|20652914|P3|COMPLETED|Overall Study||0
8378214|NCT01117623|20652915|P2|COMPLETED|Overall Study||0
8378215|NCT01117623|20652916|P1|COMPLETED|Overall Study||0
8378216|NCT01117623|20652909|P8|PK Population|Overall Study||24
8378217|NCT01117623|20652910|P7|PK Population|Overall Study||6
8378218|NCT01117623|20652911|P6|PK Population|Overall Study||14
8378219|NCT01117623|20652912|P5|PK Population|Overall Study||10
8378220|NCT01117623|20652913|P4|PK Population|Overall Study||6
8378221|NCT01117623|20652914|P3|PK Population|Overall Study||10
8378222|NCT01117623|20652915|P2|PK Population|Overall Study||8
8378223|NCT01117623|20652916|P1|PK Population|Overall Study||3
8378224|NCT01117623|20652909|P8|ITT Efficacy Analysis Population|Overall Study||22
8378225|NCT01117623|20652910|P7|ITT Efficacy Analysis Population|Overall Study||6
8378226|NCT01117623|20652911|P6|ITT Efficacy Analysis Population|Overall Study||16
8378227|NCT01117623|20652912|P5|ITT Efficacy Analysis Population|Overall Study||10
8378228|NCT01117623|20652913|P4|ITT Efficacy Analysis Population|Overall Study||5
8378229|NCT01117623|20652914|P3|ITT Efficacy Analysis Population|Overall Study||11
8378230|NCT01117623|20652915|P2|ITT Efficacy Analysis Population|Overall Study||8
8378231|NCT01117623|20652916|P1|ITT Efficacy Analysis Population|Overall Study||3
8378232|NCT01117623|20652909|P8|STARTED|Overall Study||26
8378233|NCT01117623|20652910|P7|STARTED|Overall Study||6
8378234|NCT01117623|20652911|P6|STARTED|Overall Study||16
8378235|NCT01117623|20652912|P5|STARTED|Overall Study||10
8378236|NCT01117623|20652913|P4|STARTED|Overall Study||6
8378237|NCT01117623|20652914|P3|STARTED|Overall Study||11
8378238|NCT01117623|20652915|P2|STARTED|Overall Study||8
8378239|NCT01117623|20652916|P1|STARTED|Overall Study||3
8378240|NCT01117480|20653068|P1|NOT COMPLETED|Overall Study||28
8378241|NCT01117480|20653068|P1|COMPLETED|Overall Study||985
8378242|NCT01117480|20653068|P1|STARTED|Overall Study||1013
8378243|NCT01117454|20653076|P2|NOT COMPLETED|Overall Study||1
8378244|NCT01117454|20653077|P1|NOT COMPLETED|Overall Study||0
8378245|NCT01117454|20653076|P2|COMPLETED|Overall Study||7
8378246|NCT01117454|20653077|P1|COMPLETED|Overall Study||6
8378247|NCT01117454|20653076|P2|STARTED|Overall Study||8
8378248|NCT01117454|20653077|P1|STARTED|Overall Study||6
8378249|NCT01117428|20653089|P6|NOT COMPLETED|Overall Study||20
8378250|NCT01117428|20653090|P5|NOT COMPLETED|Overall Study||17
8378251|NCT01117428|20653091|P4|NOT COMPLETED|Overall Study||12
8378252|NCT01117428|20653092|P3|NOT COMPLETED|Overall Study||13
8378253|NCT01117428|20653093|P2|NOT COMPLETED|Overall Study||29
8378254|NCT01117428|20653094|P1|NOT COMPLETED|Overall Study||20
8378255|NCT01117428|20653089|P6|COMPLETED|Overall Study||0
8378256|NCT01117428|20653090|P5|COMPLETED|Overall Study||0
8378257|NCT01117428|20653091|P4|COMPLETED|Overall Study||0
8378258|NCT01117428|20653092|P3|COMPLETED|Overall Study||0
8378259|NCT01117428|20653093|P2|COMPLETED|Overall Study||0
8378260|NCT01117428|20653094|P1|COMPLETED|Overall Study||0
8378261|NCT01117428|20653089|P6|STARTED|Overall Study||20
8378262|NCT01117428|20653090|P5|STARTED|Overall Study||17
8378263|NCT01117428|20653091|P4|STARTED|Overall Study||12
8378264|NCT01117428|20653092|P3|STARTED|Overall Study||13
8378265|NCT01117428|20653093|P2|STARTED|Overall Study||29
8378266|NCT01117428|20653094|P1|STARTED|Overall Study|"0.4 mg/kg=1
~0.75 mg/kg=1
~1.5 mg/kg=3
~3 mg/kg=3
~6 mg/kg=3
~9 mg/kg=6
~12 mg/kg=3"|20
8378267|NCT01117350|20653128|P2|NOT COMPLETED|Extension Period||63
8378268|NCT01117350|20653129|P1|NOT COMPLETED|Extension Period||0
8378269|NCT01117350|20653128|P2|COMPLETED|Extension Period||147
8378270|NCT01117350|20653129|P1|COMPLETED|Extension Period||0
8378271|NCT01117350|20653128|P2|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
8378272|NCT01117350|20653129|P1|mITT Population (Extension)|Extension Period||0
8378273|NCT01117350|20653128|P2|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
8378274|NCT01117350|20653129|P1|TREATED = Safety Population (Extension)|Extension Period||0
8378275|NCT01117350|20653128|P2|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
8378276|NCT01117350|20653129|P1|STARTED|Extension Period||0
8378277|NCT01117350|20653128|P2|NOT COMPLETED|Comparative Period||75
8378278|NCT01117350|20653129|P1|NOT COMPLETED|Comparative Period||42
8378279|NCT01117350|20653128|P2|COMPLETED|Comparative Period||414
8378280|NCT01117350|20653129|P1|COMPLETED|Comparative Period||447
8378281|NCT01117350|20653128|P2|mITT Population|Comparative Period||470
8378282|NCT01117350|20653129|P1|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
8378283|NCT01117350|20653128|P2|TREATED = Safety Population|Comparative Period||481
8378284|NCT01117350|20653129|P1|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
8378285|NCT01117350|20653128|P2|STARTED|Comparative Period||489
8378286|NCT01117350|20653129|P1|STARTED|Comparative Period|STARTED: randomized|489
8378287|NCT01117337|20653161|P2|NOT COMPLETED|Overall Study||0
8378288|NCT01117337|20653162|P1|NOT COMPLETED|Overall Study||4
8378289|NCT01117337|20653161|P2|COMPLETED|Overall Study||52
8378290|NCT01117337|20653162|P1|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
8378291|NCT01117337|20653161|P2|Underwent Surgery|Overall Study||52
8378292|NCT01117337|20653162|P1|Underwent Surgery|Overall Study|52 patients underwent surgery|52
8378293|NCT01117337|20653161|P2|STARTED|Overall Study||52
8378294|NCT01117337|20653162|P1|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
8378295|NCT01117311|20653172|P2|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
8378296|NCT01117311|20653173|P1|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
8378297|NCT01117311|20653172|P2|COMPLETED|Second Intervention - Mixed Meal 3||4
8378298|NCT01117311|20653173|P1|COMPLETED|Second Intervention - Mixed Meal 3||3
8378299|NCT01117311|20653172|P2|STARTED|Second Intervention - Mixed Meal 3||4
8378300|NCT01117311|20653173|P1|STARTED|Second Intervention - Mixed Meal 3||3
8378301|NCT01117311|20653172|P2|NOT COMPLETED|First Intervention - Mixed Meal 2||0
8378302|NCT01117311|20653173|P1|NOT COMPLETED|First Intervention - Mixed Meal 2||0
8378303|NCT01117311|20653172|P2|COMPLETED|First Intervention - Mixed Meal 2||4
8378304|NCT01117311|20653173|P1|COMPLETED|First Intervention - Mixed Meal 2||3
8378305|NCT01117311|20653172|P2|STARTED|First Intervention - Mixed Meal 2||4
8378306|NCT01117311|20653173|P1|STARTED|First Intervention - Mixed Meal 2||3
8378307|NCT01117311|20653172|P2|NOT COMPLETED|Lead-in Mixed Meal 1||0
8378308|NCT01117311|20653173|P1|NOT COMPLETED|Lead-in Mixed Meal 1||0
8378309|NCT01117311|20653172|P2|COMPLETED|Lead-in Mixed Meal 1||4
8378310|NCT01117311|20653173|P1|COMPLETED|Lead-in Mixed Meal 1||3
8378311|NCT01117311|20653172|P2|STARTED|Lead-in Mixed Meal 1||4
8378312|NCT01117311|20653173|P1|STARTED|Lead-in Mixed Meal 1||3
8378313|NCT01117181|20653183|P2|NOT COMPLETED|Overall Study||2
8378314|NCT01117181|20653184|P1|NOT COMPLETED|Overall Study||1
8378315|NCT01117181|20653183|P2|COMPLETED|Overall Study||29
8378316|NCT01117181|20653184|P1|COMPLETED|Overall Study||28
8378317|NCT01117181|20653183|P2|STARTED|Overall Study||31
8378318|NCT01117181|20653184|P1|STARTED|Overall Study||29
8378319|NCT01117090|20653204|P1|NOT COMPLETED|Overall Study||0
8378320|NCT01117090|20653204|P1|COMPLETED|Overall Study||47
8378321|NCT01117090|20653204|P1|STARTED|Overall Study||47
8378328|NCT01117012|20653228|P2|NOT COMPLETED|Overall Study||5
8378329|NCT01117012|20653229|P1|NOT COMPLETED|Overall Study||8
8378330|NCT01117012|20653228|P2|COMPLETED|Overall Study||98
8378331|NCT01117012|20653229|P1|COMPLETED|Overall Study||81
8378332|NCT01117012|20653228|P2|STARTED|Overall Study||103
8378333|NCT01117012|20653229|P1|STARTED|Overall Study||89
8378334|NCT01116986|20653277|P32|NOT COMPLETED|Overall Study||3
8378335|NCT01116986|20653278|P31|NOT COMPLETED|Overall Study||1
8378336|NCT01116986|20653279|P30|NOT COMPLETED|Overall Study||0
8378337|NCT01116986|20653280|P29|NOT COMPLETED|Overall Study||0
8378338|NCT01116986|20653281|P28|NOT COMPLETED|Overall Study||1
8378339|NCT01116986|20653282|P27|NOT COMPLETED|Overall Study||4
8378340|NCT01116986|20653283|P26|NOT COMPLETED|Overall Study||0
8378341|NCT01116986|20653284|P25|NOT COMPLETED|Overall Study||3
8378342|NCT01116986|20653285|P24|NOT COMPLETED|Overall Study||2
8378343|NCT01116986|20653286|P23|NOT COMPLETED|Overall Study||4
8378344|NCT01116986|20653287|P22|NOT COMPLETED|Overall Study||2
8378345|NCT01116986|20653288|P21|NOT COMPLETED|Overall Study||2
8378346|NCT01116986|20653289|P20|NOT COMPLETED|Overall Study||2
8378347|NCT01116986|20653290|P19|NOT COMPLETED|Overall Study||3
8378348|NCT01116986|20653291|P18|NOT COMPLETED|Overall Study||5
8378349|NCT01116986|20653292|P17|NOT COMPLETED|Overall Study||3
8378350|NCT01116986|20653293|P16|NOT COMPLETED|Overall Study||6
8378351|NCT01116986|20653294|P15|NOT COMPLETED|Overall Study||0
8378352|NCT01116986|20653295|P14|NOT COMPLETED|Overall Study||3
8378353|NCT01116986|20653296|P13|NOT COMPLETED|Overall Study||1
8378354|NCT01116986|20653297|P12|NOT COMPLETED|Overall Study||0
8378355|NCT01116986|20653298|P11|NOT COMPLETED|Overall Study||1
8378356|NCT01116986|20653299|P10|NOT COMPLETED|Overall Study||4
8378357|NCT01116986|20653300|P9|NOT COMPLETED|Overall Study||1
8378358|NCT01116986|20653301|P8|NOT COMPLETED|Overall Study||2
8378359|NCT01116986|20653302|P7|NOT COMPLETED|Overall Study||2
8378360|NCT01116986|20653303|P6|NOT COMPLETED|Overall Study||2
8378361|NCT01116986|20653304|P5|NOT COMPLETED|Overall Study||4
8378362|NCT01116986|20653305|P4|NOT COMPLETED|Overall Study||2
8378363|NCT01116986|20653306|P3|NOT COMPLETED|Overall Study||2
8378364|NCT01116986|20653307|P2|NOT COMPLETED|Overall Study||3
8378365|NCT01116986|20653308|P1|NOT COMPLETED|Overall Study||2
8378366|NCT01116986|20653277|P32|COMPLETED|Overall Study||14
8378367|NCT01116986|20653278|P31|COMPLETED|Overall Study||16
8378368|NCT01116986|20653279|P30|COMPLETED|Overall Study||17
8378369|NCT01116986|20653280|P29|COMPLETED|Overall Study||17
8378370|NCT01116986|20653281|P28|COMPLETED|Overall Study||18
8378371|NCT01116986|20653282|P27|COMPLETED|Overall Study||14
8378372|NCT01116986|20653283|P26|COMPLETED|Overall Study||19
8378373|NCT01116986|20653284|P25|COMPLETED|Overall Study||15
8378374|NCT01116986|20653285|P24|COMPLETED|Overall Study||19
8378375|NCT01116986|20653286|P23|COMPLETED|Overall Study||19
8378376|NCT01116986|20653287|P22|COMPLETED|Overall Study||18
8378377|NCT01116986|20653288|P21|COMPLETED|Overall Study||22
8378378|NCT01116986|20653289|P20|COMPLETED|Overall Study||13
8378379|NCT01116986|20653290|P19|COMPLETED|Overall Study||20
8378380|NCT01116986|20653291|P18|COMPLETED|Overall Study||19
8378381|NCT01116986|20653292|P17|COMPLETED|Overall Study||13
8378382|NCT01116986|20653293|P16|COMPLETED|Overall Study||15
8378383|NCT01116986|20653294|P15|COMPLETED|Overall Study||17
8378384|NCT01116986|20653295|P14|COMPLETED|Overall Study||16
8378385|NCT01116986|20653296|P13|COMPLETED|Overall Study||16
8378386|NCT01116986|20653297|P12|COMPLETED|Overall Study||20
8378387|NCT01116986|20653298|P11|COMPLETED|Overall Study||18
8378388|NCT01116986|20653299|P10|COMPLETED|Overall Study||19
8378389|NCT01116986|20653300|P9|COMPLETED|Overall Study||19
8378390|NCT01116986|20653301|P8|COMPLETED|Overall Study||20
8378391|NCT01116986|20653302|P7|COMPLETED|Overall Study||20
8378392|NCT01116986|20653303|P6|COMPLETED|Overall Study||20
8378393|NCT01116986|20653304|P5|COMPLETED|Overall Study||20
8378394|NCT01116986|20653305|P4|COMPLETED|Overall Study||20
8378395|NCT01116986|20653306|P3|COMPLETED|Overall Study||16
8378396|NCT01116986|20653307|P2|COMPLETED|Overall Study||16
8378397|NCT01116986|20653308|P1|COMPLETED|Overall Study||22
8378398|NCT01116986|20653277|P32|STARTED|Overall Study||17
8378399|NCT01116986|20653278|P31|STARTED|Overall Study||17
8378400|NCT01116986|20653279|P30|STARTED|Overall Study||17
8378401|NCT01116986|20653280|P29|STARTED|Overall Study||17
8378402|NCT01116986|20653281|P28|STARTED|Overall Study||19
8378403|NCT01116986|20653282|P27|STARTED|Overall Study||18
8378404|NCT01116986|20653283|P26|STARTED|Overall Study||19
8378405|NCT01116986|20653284|P25|STARTED|Overall Study||18
8378406|NCT01116986|20653285|P24|STARTED|Overall Study||21
8378407|NCT01116986|20653286|P23|STARTED|Overall Study||23
8378408|NCT01116986|20653287|P22|STARTED|Overall Study||20
8378409|NCT01116986|20653288|P21|STARTED|Overall Study||24
8378410|NCT01116986|20653289|P20|STARTED|Overall Study||15
8378411|NCT01116986|20653290|P19|STARTED|Overall Study||23
8378412|NCT01116986|20653291|P18|STARTED|Overall Study||24
8378413|NCT01116986|20653292|P17|STARTED|Overall Study||16
8378414|NCT01116986|20653293|P16|STARTED|Overall Study||21
8378415|NCT01116986|20653294|P15|STARTED|Overall Study||17
8378416|NCT01116986|20653295|P14|STARTED|Overall Study||19
8378417|NCT01116986|20653296|P13|STARTED|Overall Study||17
8378418|NCT01116986|20653297|P12|STARTED|Overall Study||20
8378419|NCT01116986|20653298|P11|STARTED|Overall Study||19
8378420|NCT01116986|20653299|P10|STARTED|Overall Study||23
8378421|NCT01116986|20653300|P9|STARTED|Overall Study||20
8378422|NCT01116986|20653301|P8|STARTED|Overall Study||22
8378423|NCT01116986|20653302|P7|STARTED|Overall Study||22
8378424|NCT01116986|20653303|P6|STARTED|Overall Study||22
8378425|NCT01116986|20653304|P5|STARTED|Overall Study||24
8378426|NCT01116986|20653305|P4|STARTED|Overall Study||22
8378427|NCT01116986|20653306|P3|STARTED|Overall Study||18
8378428|NCT01116986|20653307|P2|STARTED|Overall Study||19
8378429|NCT01116986|20653308|P1|STARTED|Overall Study||24
8378430|NCT01116934|20653342|P2|NOT COMPLETED|Overall Study||0
8378431|NCT01116934|20653343|P1|NOT COMPLETED|Overall Study||0
8378432|NCT01116934|20653342|P2|COMPLETED|Overall Study||9
8378433|NCT01116934|20653343|P1|COMPLETED|Overall Study||8
8378434|NCT01116934|20653342|P2|STARTED|Overall Study||9
8378435|NCT01116934|20653343|P1|STARTED|Overall Study||8
8378436|NCT01116921|20653351|P2|NOT COMPLETED|Overall Study||0
8378437|NCT01116921|20653352|P1|NOT COMPLETED|Overall Study||0
8378438|NCT01116921|20653351|P2|COMPLETED|Overall Study||50
8378439|NCT01116921|20653352|P1|COMPLETED|Overall Study||53
8378440|NCT01116921|20653351|P2|STARTED|Overall Study||50
8378441|NCT01116921|20653352|P1|STARTED|Overall Study||53
8378442|NCT01116895|20653372|P4|NOT COMPLETED|Overall Study||3
8378443|NCT01116895|20653373|P3|NOT COMPLETED|Overall Study||4
8378444|NCT01116895|20653374|P2|NOT COMPLETED|Overall Study||7
8378445|NCT01116895|20653375|P1|NOT COMPLETED|Overall Study||4
8378446|NCT01116895|20653372|P4|COMPLETED|Overall Study||11
8378447|NCT01116895|20653373|P3|COMPLETED|Overall Study||14
8378448|NCT01116895|20653374|P2|COMPLETED|Overall Study||8
8378449|NCT01116895|20653375|P1|COMPLETED|Overall Study||12
8378450|NCT01116895|20653372|P4|STARTED|Overall Study||14
8378451|NCT01116895|20653373|P3|STARTED|Overall Study||18
8378452|NCT01116895|20653374|P2|STARTED|Overall Study||15
8378453|NCT01116895|20653375|P1|STARTED|Overall Study||16
8378454|NCT01116882|20653403|P2|NOT COMPLETED|12-month||99
8378455|NCT01116882|20653404|P1|NOT COMPLETED|12-month||267
8378456|NCT01116882|20653403|P2|COMPLETED|12-month||787
8378457|NCT01116882|20653404|P1|COMPLETED|12-month||2439
8378458|NCT01116882|20653403|P2|STARTED|12-month||886
8378459|NCT01116882|20653404|P1|STARTED|12-month||2706
8378460|NCT01116882|20653403|P2|NOT COMPLETED|30-day||31
8378461|NCT01116882|20653404|P1|NOT COMPLETED|30-day||68
8378462|NCT01116882|20653403|P2|COMPLETED|30-day||886
8378463|NCT01116882|20653404|P1|COMPLETED|30-day||2706
8378464|NCT01116882|20653403|P2|STARTED|30-day||917
8378465|NCT01116882|20653404|P1|STARTED|30-day||2774
8378466|NCT01116687|20653442|P1|NOT COMPLETED|Overall Study||4
8378467|NCT01116687|20653442|P1|COMPLETED|Overall Study||33
8378468|NCT01116687|20653442|P1|STARTED|Overall Study||37
8378469|NCT01116661|20653449|P1|NOT COMPLETED|Overall Study||2
8378470|NCT01116661|20653449|P1|COMPLETED|Overall Study||197
8378471|NCT01116661|20653449|P1|STARTED|Overall Study||199
8379102|NCT01116544|20653510|P2|NOT COMPLETED|Overall Study||1
8379103|NCT01116544|20653511|P1|NOT COMPLETED|Overall Study||2
8379104|NCT01116544|20653510|P2|COMPLETED|Overall Study||22
8379105|NCT01116544|20653511|P1|COMPLETED|Overall Study||21
8379106|NCT01116544|20653510|P2|STARTED|Overall Study||23
8379107|NCT01116544|20653511|P1|STARTED|Overall Study||23
8379111|NCT01116440|20653537|P2|NOT COMPLETED|Follow-up||2
8379112|NCT01116440|20653538|P1|NOT COMPLETED|Follow-up||0
8379113|NCT01116440|20653537|P2|COMPLETED|Follow-up||5
8379114|NCT01116440|20653538|P1|COMPLETED|Follow-up||8
8379115|NCT01116440|20653537|P2|STARTED|Follow-up||7
8379116|NCT01116440|20653538|P1|STARTED|Follow-up||8
8379117|NCT01116440|20653537|P2|NOT COMPLETED|Withdrawal||2
8379118|NCT01116440|20653538|P1|NOT COMPLETED|Withdrawal||0
8379119|NCT01116440|20653537|P2|COMPLETED|Withdrawal||7
8379120|NCT01116440|20653538|P1|COMPLETED|Withdrawal||8
8379121|NCT01116440|20653537|P2|STARTED|Withdrawal||9
8379122|NCT01116440|20653538|P1|STARTED|Withdrawal||8
8379123|NCT01116440|20653537|P2|NOT COMPLETED|Treatment||7
8379124|NCT01116440|20653538|P1|NOT COMPLETED|Treatment||3
8379125|NCT01116440|20653537|P2|COMPLETED|Treatment||9
8379126|NCT01116440|20653538|P1|COMPLETED|Treatment||8
8379127|NCT01116440|20653537|P2|STARTED|Treatment||16
8379128|NCT01116440|20653538|P1|STARTED|Treatment||11
8379129|NCT01116427|20653554|P2|NOT COMPLETED|Extension Phase||2
8379130|NCT01116427|20653555|P1|NOT COMPLETED|Extension Phase||9
8379131|NCT01116427|20653554|P2|COMPLETED|Extension Phase||18
8379132|NCT01116427|20653555|P1|COMPLETED|Extension Phase||29
8379133|NCT01116427|20653554|P2|STARTED|Extension Phase||20
8379134|NCT01116427|20653555|P1|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
8379135|NCT01116427|20653554|P2|NOT COMPLETED|Core Phase||1
8379136|NCT01116427|20653555|P1|NOT COMPLETED|Core Phase||5
8379137|NCT01116427|20653554|P2|COMPLETED|Core Phase||20
8379138|NCT01116427|20653555|P1|COMPLETED|Core Phase||39
8379139|NCT01116427|20653554|P2|STARTED|Core Phase||21
8379140|NCT01116427|20653555|P1|STARTED|Core Phase||44
8379141|NCT01116401|20653591|P1|NOT COMPLETED|Overall Study||0
8379142|NCT01116401|20653591|P1|COMPLETED|Overall Study||29
8379143|NCT01116401|20653591|P1|STARTED|Overall Study||29
8379144|NCT01116232|20653596|P1|NOT COMPLETED|Overall Study||4
8379145|NCT01116232|20653596|P1|COMPLETED|Overall Study||0
8379146|NCT01116232|20653596|P1|STARTED|Overall Study||4
8379147|NCT01116102|20653615|P8|NOT COMPLETED|Overall Study||0
8379148|NCT01116102|20653616|P7|NOT COMPLETED|Overall Study||0
8379149|NCT01116102|20653617|P6|NOT COMPLETED|Overall Study||0
8379150|NCT01116102|20653618|P5|NOT COMPLETED|Overall Study||0
8379151|NCT01116102|20653619|P4|NOT COMPLETED|Overall Study||0
8379152|NCT01116102|20653620|P3|NOT COMPLETED|Overall Study||0
8379153|NCT01116102|20653621|P2|NOT COMPLETED|Overall Study||0
8379154|NCT01116102|20653622|P1|NOT COMPLETED|Overall Study||0
8379155|NCT01116102|20653615|P8|COMPLETED|Overall Study||3
8379156|NCT01116102|20653616|P7|COMPLETED|Overall Study||2
8379157|NCT01116102|20653617|P6|COMPLETED|Overall Study||2
8379158|NCT01116102|20653618|P5|COMPLETED|Overall Study||2
8379159|NCT01116102|20653619|P4|COMPLETED|Overall Study||3
8379160|NCT01116102|20653620|P3|COMPLETED|Overall Study||3
8379161|NCT01116102|20653621|P2|COMPLETED|Overall Study||3
8379162|NCT01116102|20653622|P1|COMPLETED|Overall Study||2
8379163|NCT01116102|20653615|P8|STARTED|Overall Study||3
8379164|NCT01116102|20653616|P7|STARTED|Overall Study||2
8379165|NCT01116102|20653617|P6|STARTED|Overall Study||2
8379166|NCT01116102|20653618|P5|STARTED|Overall Study||2
8379167|NCT01116102|20653619|P4|STARTED|Overall Study||3
8379168|NCT01116102|20653620|P3|STARTED|Overall Study||3
8379169|NCT01116102|20653621|P2|STARTED|Overall Study||3
8379170|NCT01116102|20653622|P1|STARTED|Overall Study||2
8379171|NCT01116037|20653664|P1|NOT COMPLETED|Overall Study||25
8379172|NCT01116037|20653664|P1|COMPLETED|Overall Study||1
8379173|NCT01116037|20653664|P1|STARTED|Overall Study||26
8379174|NCT01116024|20653669|P1|NOT COMPLETED|Overall Study||52
8379175|NCT01116024|20653669|P1|COMPLETED|Overall Study|Patient Enrollment stop date|96
8379176|NCT01116024|20653669|P1|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
8379177|NCT01115998|20653710|P2|NOT COMPLETED|Overall Study||6
8379178|NCT01115998|20653711|P1|NOT COMPLETED|Overall Study||6
8379179|NCT01115998|20653710|P2|COMPLETED|Overall Study||11
8379180|NCT01115998|20653711|P1|COMPLETED|Overall Study||11
8379181|NCT01115998|20653710|P2|STARTED|Overall Study||17
8379182|NCT01115998|20653711|P1|STARTED|Overall Study||17
8379183|NCT01115933|20653721|P1|NOT COMPLETED|Overall Study||1
8379184|NCT01115933|20653721|P1|COMPLETED|Overall Study||64
8379185|NCT01115933|20653721|P1|STARTED|Overall Study||65
8379186|NCT01115855|20653818|P2|NOT COMPLETED|Overall Study||36
8379187|NCT01115855|20653819|P1|NOT COMPLETED|Overall Study||36
8379188|NCT01115855|20653818|P2|COMPLETED|Overall Study||74
8379189|NCT01115855|20653819|P1|COMPLETED|Overall Study||75
8379190|NCT01115855|20653818|P2|STARTED|Overall Study||110
8379191|NCT01115855|20653819|P1|STARTED|Overall Study||111
8379192|NCT01115803|20653874|P7|NOT COMPLETED|Overall Study||2
8379193|NCT01115803|20653875|P6|NOT COMPLETED|Overall Study||0
8379194|NCT01115803|20653876|P5|NOT COMPLETED|Overall Study||0
8379195|NCT01115803|20653877|P4|NOT COMPLETED|Overall Study||0
8379196|NCT01115803|20653878|P3|NOT COMPLETED|Overall Study||1
8379197|NCT01115803|20653879|P2|NOT COMPLETED|Overall Study||0
8379198|NCT01115803|20653880|P1|NOT COMPLETED|Overall Study||0
8379199|NCT01115803|20653874|P7|COMPLETED|Overall Study||4
8379200|NCT01115803|20653875|P6|COMPLETED|Overall Study||3
8379201|NCT01115803|20653876|P5|COMPLETED|Overall Study||3
8379202|NCT01115803|20653877|P4|COMPLETED|Overall Study||5
8379203|NCT01115803|20653878|P3|COMPLETED|Overall Study||2
8379204|NCT01115803|20653879|P2|COMPLETED|Overall Study||5
8379205|NCT01115803|20653880|P1|COMPLETED|Overall Study||4
8379206|NCT01115803|20653874|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
8379207|NCT01115803|20653875|P6|Received at Least 1 Dose of Study Drug|Overall Study||3
8379208|NCT01115803|20653876|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
8379209|NCT01115803|20653877|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
8379210|NCT01115803|20653878|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8379211|NCT01115803|20653879|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
8379212|NCT01115803|20653880|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
8379213|NCT01115803|20653874|P7|STARTED|Overall Study||6
8379214|NCT01115803|20653875|P6|STARTED|Overall Study||3
8379215|NCT01115803|20653876|P5|STARTED|Overall Study||3
8379216|NCT01115803|20653877|P4|STARTED|Overall Study||5
8379217|NCT01115803|20653878|P3|STARTED|Overall Study||3
8379218|NCT01115803|20653879|P2|STARTED|Overall Study||5
8379219|NCT01115803|20653880|P1|STARTED|Overall Study||4
8379220|NCT01115738|20653943|P3|NOT COMPLETED|Overall Study||27
8379221|NCT01115738|20653944|P2|NOT COMPLETED|Overall Study||21
8379222|NCT01115738|20653945|P1|NOT COMPLETED|Overall Study||25
8379223|NCT01115738|20653943|P3|COMPLETED|Overall Study||62
8379224|NCT01115738|20653944|P2|COMPLETED|Overall Study||62
8379225|NCT01115738|20653945|P1|COMPLETED|Overall Study||85
8379226|NCT01115738|20653943|P3|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
8379227|NCT01115738|20653944|P2|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
8379228|NCT01115738|20653945|P1|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
8379229|NCT01115738|20653943|P3|Received Any Treatment|Overall Study||88
8379230|NCT01115738|20653944|P2|Received Any Treatment|Overall Study||79
8379231|NCT01115738|20653945|P1|Received Any Treatment|Overall Study||109
8379232|NCT01115738|20653943|P3|STARTED|Overall Study||89
8379233|NCT01115738|20653944|P2|STARTED|Overall Study||83
8379234|NCT01115738|20653945|P1|STARTED|Overall Study||110
8379235|NCT01115699|20653979|P1|NOT COMPLETED|Overall Study||0
8379236|NCT01115699|20653979|P1|COMPLETED|Overall Study||2
8379237|NCT01115699|20653979|P1|STARTED|Overall Study||2
8379238|NCT01115673|20653987|P3|NOT COMPLETED|Overall Study||0
8379239|NCT01115673|20653988|P2|NOT COMPLETED|Overall Study||0
8379240|NCT01115673|20653989|P1|NOT COMPLETED|Overall Study||0
8379241|NCT01115673|20653987|P3|COMPLETED|Overall Study||60
8379242|NCT01115673|20653988|P2|COMPLETED|Overall Study||241
8379243|NCT01115673|20653989|P1|COMPLETED|Overall Study||239
8379244|NCT01115673|20653987|P3|STARTED|Overall Study||60
8379245|NCT01115673|20653988|P2|STARTED|Overall Study||241
8379246|NCT01115673|20653989|P1|STARTED|Overall Study||239
8379247|NCT01115660|20654125|P2|NOT COMPLETED|Overall Study||0
8379248|NCT01115660|20654126|P1|NOT COMPLETED|Overall Study||1
8379249|NCT01115660|20654125|P2|COMPLETED|Overall Study||10
8379250|NCT01115660|20654126|P1|COMPLETED|Overall Study||19
8379251|NCT01115660|20654125|P2|STARTED|Overall Study||10
8379252|NCT01115660|20654126|P1|STARTED|Overall Study||20
8379253|NCT01115582|20654134|P1|NOT COMPLETED|Overall Study||0
8379254|NCT01115582|20654134|P1|COMPLETED|Overall Study||16
8379255|NCT01115582|20654134|P1|STARTED|Overall Study||16
8379256|NCT01115569|20654143|P2|NOT COMPLETED|Maintenance Phase||139
8379257|NCT01115569|20654144|P1|NOT COMPLETED|Maintenance Phase||0
8379258|NCT01115569|20654143|P2|COMPLETED|Maintenance Phase||285
8379259|NCT01115569|20654144|P1|COMPLETED|Maintenance Phase||0
8379260|NCT01115569|20654143|P2|STARTED|Maintenance Phase||424
8379261|NCT01115569|20654144|P1|STARTED|Maintenance Phase||0
8379262|NCT01115569|20654143|P2|NOT COMPLETED|Conversion/Titration Phase||0
8379263|NCT01115569|20654144|P1|NOT COMPLETED|Conversion/Titration Phase||214
8379264|NCT01115569|20654143|P2|COMPLETED|Conversion/Titration Phase||0
8379265|NCT01115569|20654144|P1|COMPLETED|Conversion/Titration Phase||424
8379266|NCT01115569|20654143|P2|STARTED|Conversion/Titration Phase||0
8379267|NCT01115569|20654144|P1|STARTED|Conversion/Titration Phase||638
8379268|NCT01115556|20654151|P2|NOT COMPLETED|Overall Study||0
8379269|NCT01115556|20654152|P1|NOT COMPLETED|Overall Study||0
8379270|NCT01115556|20654151|P2|COMPLETED|Overall Study||2
8379271|NCT01115556|20654152|P1|COMPLETED|Overall Study||7
8379272|NCT01115556|20654151|P2|STARTED|Overall Study||2
8379273|NCT01115556|20654152|P1|STARTED|Overall Study||7
8379274|NCT01115517|20654162|P2|NOT COMPLETED|Overall Study||5
8379275|NCT01115517|20654163|P1|NOT COMPLETED|Overall Study||4
8379276|NCT01115517|20654162|P2|COMPLETED|Overall Study||16
8379277|NCT01115517|20654163|P1|COMPLETED|Overall Study||14
8379278|NCT01115517|20654162|P2|STARTED|Overall Study||21
8379279|NCT01115517|20654163|P1|STARTED|Overall Study||18
8379280|NCT01115491|20654173|P1|NOT COMPLETED|Overall Study||30
8379281|NCT01115491|20654173|P1|COMPLETED|Overall Study||2
8379282|NCT01115491|20654173|P1|STARTED|Overall Study||32
8379283|NCT01115452|20654182|P1|NOT COMPLETED|Overall Study||0
8379284|NCT01115452|20654182|P1|COMPLETED|Overall Study||32
8379285|NCT01115452|20654182|P1|STARTED|Overall Study||32
8379286|NCT01115309|20654232|P1|NOT COMPLETED|Long-term Follow-up||6
8379287|NCT01115309|20654232|P1|COMPLETED|Long-term Follow-up||44
8379288|NCT01115309|20654232|P1|12-Month Follow-up|Long-term Follow-up||44
8379289|NCT01115309|20654232|P1|6-Month Follow-up|Long-term Follow-up||46
8379290|NCT01115309|20654232|P1|STARTED|Long-term Follow-up||50
8379291|NCT01115309|20654232|P1|NOT COMPLETED|Procedure Safety (1-Month)||3
8379292|NCT01115309|20654232|P1|COMPLETED|Procedure Safety (1-Month)||172
8379293|NCT01115309|20654232|P1|STARTED|Procedure Safety (1-Month)||175
8379294|NCT01115244|20654242|P2|NOT COMPLETED|Overall Study||0
8379295|NCT01115244|20654243|P1|NOT COMPLETED|Overall Study||0
8379296|NCT01115244|20654242|P2|COMPLETED|Overall Study||0
8379297|NCT01115244|20654243|P1|COMPLETED|Overall Study||0
8379298|NCT01115244|20654242|P2|STARTED|Overall Study||0
8379299|NCT01115244|20654243|P1|STARTED|Overall Study||0
8379300|NCT01115231|20654255|P2|NOT COMPLETED|Overall Study||0
8379301|NCT01115231|20654256|P1|NOT COMPLETED|Overall Study||0
8379302|NCT01115231|20654255|P2|COMPLETED|Overall Study||90
8379303|NCT01115231|20654256|P1|COMPLETED|Overall Study||133
8379304|NCT01115231|20654255|P2|STARTED|Overall Study||90
8379305|NCT01115231|20654256|P1|STARTED|Overall Study||133
8379306|NCT01115166|20654268|P1|NOT COMPLETED|Overall Study||0
8379307|NCT01115166|20654268|P1|COMPLETED|Overall Study||10
8379308|NCT01115166|20654268|P1|STARTED|Overall Study||10
8379309|NCT01115101|20654276|P2|NOT COMPLETED|Overall Study||0
8379310|NCT01115101|20654277|P1|NOT COMPLETED|Overall Study||0
8379311|NCT01115101|20654276|P2|COMPLETED|Overall Study||126
8379312|NCT01115101|20654277|P1|COMPLETED|Overall Study||113
8379313|NCT01115101|20654276|P2|STARTED|Overall Study||126
8379314|NCT01115101|20654277|P1|STARTED|Overall Study||113
8379315|NCT01114997|20654286|P3|NOT COMPLETED|Overall Study||0
8379316|NCT01114997|20654287|P2|NOT COMPLETED|Overall Study||0
8379317|NCT01114997|20654288|P1|NOT COMPLETED|Overall Study||0
8379318|NCT01114997|20654286|P3|COMPLETED|Overall Study||11
8379319|NCT01114997|20654287|P2|COMPLETED|Overall Study||10
8379320|NCT01114997|20654288|P1|COMPLETED|Overall Study||11
8379321|NCT01114997|20654286|P3|STARTED|Overall Study||11
8379322|NCT01114997|20654287|P2|STARTED|Overall Study||10
8379323|NCT01114997|20654288|P1|STARTED|Overall Study||11
8379324|NCT01114971|20654317|P3|NOT COMPLETED|Overall Study||0
8379325|NCT01114971|20654318|P2|NOT COMPLETED|Overall Study||0
8379326|NCT01114971|20654319|P1|NOT COMPLETED|Overall Study||0
8379327|NCT01114971|20654317|P3|COMPLETED|Overall Study||25
8379328|NCT01114971|20654318|P2|COMPLETED|Overall Study||25
8379329|NCT01114971|20654319|P1|COMPLETED|Overall Study||25
8379330|NCT01114971|20654317|P3|STARTED|Overall Study||25
8379331|NCT01114971|20654318|P2|STARTED|Overall Study||25
8379332|NCT01114971|20654319|P1|STARTED|Overall Study||25
8379333|NCT01114945|20654346|P4|NOT COMPLETED|Overall Study||0
8379334|NCT01114945|20654347|P3|NOT COMPLETED|Overall Study||0
8379335|NCT01114945|20654348|P2|NOT COMPLETED|Overall Study||0
8379336|NCT01114945|20654349|P1|NOT COMPLETED|Overall Study||0
8379337|NCT01114945|20654346|P4|COMPLETED|Overall Study||31
8379338|NCT01114945|20654347|P3|COMPLETED|Overall Study||30
8379339|NCT01114945|20654348|P2|COMPLETED|Overall Study||30
8379340|NCT01114945|20654349|P1|COMPLETED|Overall Study||30
8379341|NCT01114945|20654346|P4|STARTED|Overall Study||31
8379342|NCT01114945|20654347|P3|STARTED|Overall Study||30
8379343|NCT01114945|20654348|P2|STARTED|Overall Study||30
8379344|NCT01114945|20654349|P1|STARTED|Overall Study||30
8379345|NCT01114893|20654376|P5|NOT COMPLETED|Overall Study||0
8379346|NCT01114893|20654377|P4|NOT COMPLETED|Overall Study||0
8379347|NCT01114893|20654378|P3|NOT COMPLETED|Overall Study||0
8379348|NCT01114893|20654379|P2|NOT COMPLETED|Overall Study||0
8379349|NCT01114893|20654380|P1|NOT COMPLETED|Overall Study||0
8379350|NCT01114893|20654376|P5|COMPLETED|Overall Study||12
8379351|NCT01114893|20654377|P4|COMPLETED|Overall Study||13
8379352|NCT01114893|20654378|P3|COMPLETED|Overall Study||14
8379353|NCT01114893|20654379|P2|COMPLETED|Overall Study||14
8379354|NCT01114893|20654380|P1|COMPLETED|Overall Study||14
8379355|NCT01114893|20654376|P5|STARTED|Overall Study||12
8379356|NCT01114893|20654377|P4|STARTED|Overall Study||13
8379357|NCT01114893|20654378|P3|STARTED|Overall Study||14
8379358|NCT01114893|20654379|P2|STARTED|Overall Study||14
8379359|NCT01114893|20654380|P1|STARTED|Overall Study||14
8379360|NCT01114880|20654399|P2|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
8379361|NCT01114880|20654400|P1|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
8379362|NCT01114880|20654399|P2|COMPLETED|Period 2 (Week 12 to Week 24)||111
8379363|NCT01114880|20654400|P1|COMPLETED|Period 2 (Week 12 to Week 24)||221
8379364|NCT01114880|20654399|P2|STARTED|Period 2 (Week 12 to Week 24)||113
8379365|NCT01114880|20654400|P1|STARTED|Period 2 (Week 12 to Week 24)||224
8379366|NCT01114880|20654399|P2|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
8379367|NCT01114880|20654400|P1|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
8379368|NCT01114880|20654399|P2|COMPLETED|Period 1 (Week 0 to Week 12)||113
8379369|NCT01114880|20654400|P1|COMPLETED|Period 1 (Week 0 to Week 12)||224
8379370|NCT01114880|20654399|P2|STARTED|Period 1 (Week 0 to Week 12)||115
8379371|NCT01114880|20654400|P1|STARTED|Period 1 (Week 0 to Week 12)||229
8379372|NCT01114828|20654452|P2|NOT COMPLETED|Overall Study||4
8379373|NCT01114828|20654453|P1|NOT COMPLETED|Overall Study||3
8379374|NCT01114828|20654452|P2|COMPLETED|Overall Study||17
8379375|NCT01114828|20654453|P1|COMPLETED|Overall Study||16
8379376|NCT01114828|20654452|P2|STARTED|Overall Study||21
8379377|NCT01114828|20654453|P1|STARTED|Overall Study||19
8379378|NCT01114737|20654463|P2|NOT COMPLETED|Open-Label Treatment Period||2
8379379|NCT01114737|20654464|P1|NOT COMPLETED|Open-Label Treatment Period||5
8379380|NCT01114737|20654463|P2|COMPLETED|Open-Label Treatment Period||95
8379381|NCT01114737|20654464|P1|COMPLETED|Open-Label Treatment Period||100
8379382|NCT01114737|20654463|P2|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
8379383|NCT01114737|20654464|P1|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
8379384|NCT01114737|20654463|P2|NOT COMPLETED|Randomized Treatment Period||1
8379385|NCT01114737|20654464|P1|NOT COMPLETED|Randomized Treatment Period||3
8379386|NCT01114737|20654463|P2|COMPLETED|Randomized Treatment Period||97
8379387|NCT01114737|20654464|P1|COMPLETED|Randomized Treatment Period||105
8379388|NCT01114737|20654463|P2|STARTED|Randomized Treatment Period||98
8379389|NCT01114737|20654464|P1|STARTED|Randomized Treatment Period||108
8379390|NCT01114724|20654512|P1|NOT COMPLETED|Overall Study||10
8379391|NCT01114724|20654512|P1|COMPLETED|Overall Study||40
8379392|NCT01114724|20654512|P1|STARTED|Overall Study||50
8379393|NCT01114672|20654532|P2|NOT COMPLETED|Overall Study||2
8379394|NCT01114672|20654533|P1|NOT COMPLETED|Overall Study||4
8379395|NCT01114672|20654532|P2|COMPLETED|Overall Study||23
8379396|NCT01114672|20654533|P1|COMPLETED|Overall Study||21
8379397|NCT01114672|20654532|P2|STARTED|Overall Study||25
8379398|NCT01114672|20654533|P1|STARTED|Overall Study||25
8379399|NCT01114646|20654541|P2|NOT COMPLETED|Overall Study||2
8379400|NCT01114646|20654542|P1|NOT COMPLETED|Overall Study||3
8379401|NCT01114646|20654541|P2|COMPLETED|Overall Study||62
8379402|NCT01114646|20654542|P1|COMPLETED|Overall Study||63
8379403|NCT01114646|20654541|P2|STARTED|Overall Study||64
8379404|NCT01114646|20654542|P1|STARTED|Overall Study||66
8379405|NCT01114620|20654548|P1|NOT COMPLETED|Overall Study||0
8379406|NCT01114620|20654548|P1|COMPLETED|Overall Study||50
8379407|NCT01114620|20654548|P1|STARTED|Overall Study||50
8379408|NCT01114581|20654581|P2|NOT COMPLETED|Overall Study||0
8379409|NCT01114581|20654582|P1|NOT COMPLETED|Overall Study||0
8379410|NCT01114581|20654581|P2|COMPLETED|Overall Study||19
8379411|NCT01114581|20654582|P1|COMPLETED|Overall Study||19
8379412|NCT01114581|20654581|P2|STARTED|Overall Study||19
8379413|NCT01114581|20654582|P1|STARTED|Overall Study||19
8379414|NCT01114555|20654592|P1|NOT COMPLETED|Overall Study||0
8379415|NCT01114555|20654592|P1|COMPLETED|Overall Study||34
8379416|NCT01114555|20654592|P1|STARTED|Overall Study||34
8379417|NCT01114529|20654602|P3|NOT COMPLETED|Completed Study Phase at Month 24||14
8379418|NCT01114529|20654603|P2|NOT COMPLETED|Completed Study Phase at Month 24||16
8379419|NCT01114529|20654604|P1|NOT COMPLETED|Completed Study Phase at Month 24||40
8379420|NCT01114529|20654602|P3|COMPLETED|Completed Study Phase at Month 24|at month 24|111
8379421|NCT01114529|20654603|P2|COMPLETED|Completed Study Phase at Month 24|at month 24|215
8379422|NCT01114529|20654604|P1|COMPLETED|Completed Study Phase at Month 24|at month 24|313
8379423|NCT01114529|20654602|P3|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
8379424|NCT01114529|20654603|P2|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
8379425|NCT01114529|20654604|P1|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
8379426|NCT01114529|20654602|P3|NOT COMPLETED|Completed Study Medication at Month 24||32
8379427|NCT01114529|20654603|P2|NOT COMPLETED|Completed Study Medication at Month 24||41
8379428|NCT01114529|20654604|P1|NOT COMPLETED|Completed Study Medication at Month 24||124
8379429|NCT01114529|20654602|P3|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
8379430|NCT01114529|20654603|P2|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
8379431|NCT01114529|20654604|P1|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
8379432|NCT01114529|20654602|P3|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
8379433|NCT01114529|20654603|P2|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
8379434|NCT01114529|20654604|P1|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
8379435|NCT01114516|20654623|P2|NOT COMPLETED|Overall Study||1
8379436|NCT01114516|20654624|P1|NOT COMPLETED|Overall Study||2
8379437|NCT01114516|20654623|P2|COMPLETED|Overall Study||26
8379438|NCT01114516|20654624|P1|COMPLETED|Overall Study||24
8379439|NCT01114516|20654623|P2|STARTED|Overall Study||27
8379440|NCT01114516|20654624|P1|STARTED|Overall Study||26
8379441|NCT01114503|20654638|P1|NOT COMPLETED|Overall Study||0
8379442|NCT01114503|20654638|P1|COMPLETED|Overall Study||2
8379443|NCT01114503|20654638|P1|STARTED|Overall Study||2
8379444|NCT01114438|20654659|P1|NOT COMPLETED|Overall Study||14
8379445|NCT01114438|20654659|P1|COMPLETED|Overall Study||31
8379446|NCT01114438|20654659|P1|STARTED|Overall Study||45
8379447|NCT01114373|20654669|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||1
8379448|NCT01114373|20654670|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
8379449|NCT01114373|20654669|P2|COMPLETED|Intervention 2 (4 Weeks)||18
8379450|NCT01114373|20654670|P1|COMPLETED|Intervention 2 (4 Weeks)||18
8379451|NCT01114373|20654669|P2|STARTED|Intervention 2 (4 Weeks)||19
8379452|NCT01114373|20654670|P1|STARTED|Intervention 2 (4 Weeks)||18
8379453|NCT01114373|20654669|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||0
8379454|NCT01114373|20654670|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||3
8379455|NCT01114373|20654669|P2|COMPLETED|Intervention 1 (4 Weeks)||19
8379456|NCT01114373|20654670|P1|COMPLETED|Intervention 1 (4 Weeks)||18
8379457|NCT01114373|20654669|P2|STARTED|Intervention 1 (4 Weeks)||19
8379458|NCT01114373|20654670|P1|STARTED|Intervention 1 (4 Weeks)||21
8379459|NCT01114360|20654702|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||0
8379460|NCT01114360|20654703|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
8379461|NCT01114360|20654702|P2|COMPLETED|Intervention 2 (4 Weeks)||18
8379462|NCT01114360|20654703|P1|COMPLETED|Intervention 2 (4 Weeks)||18
8379463|NCT01114360|20654702|P2|STARTED|Intervention 2 (4 Weeks)||18
8379464|NCT01114360|20654703|P1|STARTED|Intervention 2 (4 Weeks)||18
8379465|NCT01114360|20654702|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||1
8379466|NCT01114360|20654703|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||0
8379467|NCT01114360|20654702|P2|COMPLETED|Intervention 1 (4 Weeks)||18
8379468|NCT01114360|20654703|P1|COMPLETED|Intervention 1 (4 Weeks)||18
8379469|NCT01114360|20654702|P2|STARTED|Intervention 1 (4 Weeks)||19
8379470|NCT01114360|20654703|P1|STARTED|Intervention 1 (4 Weeks)||18
8379471|NCT01114334|20654741|P2|NOT COMPLETED|Overall Study||22
8379472|NCT01114334|20654742|P1|NOT COMPLETED|Overall Study||21
8379473|NCT01114334|20654741|P2|COMPLETED|Overall Study||58
8379474|NCT01114334|20654742|P1|COMPLETED|Overall Study||67
8379475|NCT01114334|20654741|P2|STARTED|Overall Study||80
8379476|NCT01114334|20654742|P1|STARTED|Overall Study||88
8379477|NCT01114217|20654754|P2|NOT COMPLETED|Overall Study||98
8379478|NCT01114217|20654755|P1|NOT COMPLETED|Overall Study||75
8379479|NCT01114217|20654754|P2|COMPLETED|Overall Study||199
8379480|NCT01114217|20654755|P1|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
8379481|NCT01114217|20654754|P2|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
8379482|NCT01114217|20654755|P1|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
8379483|NCT01114217|20654754|P2|STARTED|Overall Study||297
8379484|NCT01114217|20654755|P1|STARTED|Overall Study||337
8379485|NCT01114204|20654767|P2|NOT COMPLETED|Overall Study||8
8379486|NCT01114204|20654768|P1|NOT COMPLETED|Overall Study||21
8379487|NCT01114204|20654767|P2|COMPLETED|Overall Study||191
8379488|NCT01114204|20654768|P1|COMPLETED|Overall Study||385
8379489|NCT01114204|20654767|P2|Received at Least 1 Dose of Study Drug|Overall Study||199
8379490|NCT01114204|20654768|P1|Received at Least 1 Dose of Study Drug|Overall Study||406
8379491|NCT01114204|20654767|P2|STARTED|Overall Study||199
8379492|NCT01114204|20654768|P1|STARTED|Overall Study||406
8379493|NCT01114139|20654786|P2|NOT COMPLETED|Overall Study||16
8379494|NCT01114139|20654787|P1|NOT COMPLETED|Overall Study||40
8379495|NCT01114139|20654786|P2|COMPLETED|Overall Study||187
8379496|NCT01114139|20654787|P1|COMPLETED|Overall Study||569
8379497|NCT01114139|20654786|P2|Received at Least 1 Dose of Study Drug|Overall Study||200
8379498|NCT01114139|20654787|P1|Received at Least 1 Dose of Study Drug|Overall Study||608
8379499|NCT01114139|20654786|P2|STARTED|Overall Study||203
8379500|NCT01114139|20654787|P1|STARTED|Overall Study||609
8379501|NCT01113983|20654805|P2|NOT COMPLETED|Overall Study||17
8379502|NCT01113983|20654806|P1|NOT COMPLETED|Overall Study||25
8379503|NCT01113983|20654805|P2|COMPLETED|Overall Study||10
8379504|NCT01113983|20654806|P1|COMPLETED|Overall Study||12
8379505|NCT01113983|20654805|P2|STARTED|Overall Study||27
8379506|NCT01113983|20654806|P1|STARTED|Overall Study||37
8379507|NCT01113931|20654816|P2|NOT COMPLETED|Overall Study||17
8379508|NCT01113931|20654817|P1|NOT COMPLETED|Overall Study||19
8379509|NCT01113931|20654816|P2|COMPLETED|Overall Study||231
8379510|NCT01113931|20654817|P1|COMPLETED|Overall Study||228
8379511|NCT01113931|20654816|P2|mITT Population|Overall Study||190
8379512|NCT01113931|20654817|P1|mITT Population|Overall Study||188
8379513|NCT01113931|20654816|P2|Safety Population|Overall Study||248
8379514|NCT01113931|20654817|P1|Safety Population|Overall Study|1 subject did not take any study medication|246
8379515|NCT01113931|20654816|P2|STARTED|Overall Study||248
8379516|NCT01113931|20654817|P1|STARTED|Overall Study||247
8379517|NCT01113892|20654831|P2|NOT COMPLETED|Overall Study||16
8379518|NCT01113892|20654832|P1|NOT COMPLETED|Overall Study||14
8379519|NCT01113892|20654831|P2|COMPLETED|Overall Study||90
8379520|NCT01113892|20654832|P1|COMPLETED|Overall Study||87
8379521|NCT01113892|20654831|P2|STARTED|Overall Study||106
8379522|NCT01113892|20654832|P1|STARTED|Overall Study||101
8379523|NCT01113879|20654860|P2|NOT COMPLETED|Period 2: Block 2||0
8379524|NCT01113879|20654861|P1|NOT COMPLETED|Period 2: Block 2||0
8379525|NCT01113879|20654860|P2|COMPLETED|Period 2: Block 2||2
8379526|NCT01113879|20654861|P1|COMPLETED|Period 2: Block 2||5
8379527|NCT01113879|20654860|P2|STARTED|Period 2: Block 2||2
8379528|NCT01113879|20654861|P1|STARTED|Period 2: Block 2||5
8379529|NCT01113879|20654860|P2|NOT COMPLETED|Period 1: Block 1||0
8379530|NCT01113879|20654861|P1|NOT COMPLETED|Period 1: Block 1||2
8379531|NCT01113879|20654860|P2|COMPLETED|Period 1: Block 1||2
8379532|NCT01113879|20654861|P1|COMPLETED|Period 1: Block 1||5
8379533|NCT01113879|20654860|P2|STARTED|Period 1: Block 1||2
8379534|NCT01113879|20654861|P1|STARTED|Period 1: Block 1||7
8379535|NCT01113801|20654873|P4|NOT COMPLETED|Overall Study||41
8379536|NCT01113801|20654874|P3|NOT COMPLETED|Overall Study||37
8379537|NCT01113801|20654875|P2|NOT COMPLETED|Overall Study||40
8379538|NCT01113801|20654876|P1|NOT COMPLETED|Overall Study||41
8379539|NCT01113801|20654873|P4|COMPLETED|Overall Study||65
8379540|NCT01113801|20654874|P3|COMPLETED|Overall Study||66
8379541|NCT01113801|20654875|P2|COMPLETED|Overall Study||65
8379542|NCT01113801|20654876|P1|COMPLETED|Overall Study||62
8379543|NCT01113801|20654873|P4|Received at Least One Dose of Drug|Overall Study||105
8379544|NCT01113801|20654874|P3|Received at Least One Dose of Drug|Overall Study||103
8379545|NCT01113801|20654875|P2|Received at Least One Dose of Drug|Overall Study||105
8379546|NCT01113801|20654876|P1|Received at Least One Dose of Drug|Overall Study||103
8379547|NCT01113801|20654873|P4|STARTED|Overall Study||106
8379548|NCT01113801|20654874|P3|STARTED|Overall Study||103
8379549|NCT01113801|20654875|P2|STARTED|Overall Study||105
8379550|NCT01113801|20654876|P1|STARTED|Overall Study||103
8379551|NCT01113749|20654904|P2|NOT COMPLETED|Overall Study||2
8379552|NCT01113749|20654905|P1|NOT COMPLETED|Overall Study||1
8379553|NCT01113749|20654904|P2|COMPLETED|Overall Study||127
8379554|NCT01113749|20654905|P1|COMPLETED|Overall Study||126
8379555|NCT01113749|20654904|P2|STARTED|Overall Study||129
8379556|NCT01113749|20654905|P1|STARTED|Overall Study||127
8379557|NCT01113723|20654917|P2|NOT COMPLETED|Overall Study||0
8379558|NCT01113723|20654918|P1|NOT COMPLETED|Overall Study||0
8379559|NCT01113723|20654917|P2|COMPLETED|Overall Study||70
8379560|NCT01113723|20654918|P1|COMPLETED|Overall Study||70
8379561|NCT01113723|20654917|P2|STARTED|Overall Study||70
8379562|NCT01113723|20654918|P1|STARTED|Overall Study||70
8379563|NCT01113710|20654928|P1|NOT COMPLETED|Overall Study||269
8379564|NCT01113710|20654928|P1|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
8379565|NCT01113710|20654928|P1|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
8379566|NCT01113632|20654939|P2|NOT COMPLETED|Overall Study||25
8379567|NCT01113632|20654940|P1|NOT COMPLETED|Overall Study||31
8379568|NCT01113632|20654939|P2|COMPLETED|Overall Study||19
8379569|NCT01113632|20654940|P1|COMPLETED|Overall Study||2
8379570|NCT01113632|20654939|P2|STARTED|Overall Study||44
8379571|NCT01113632|20654940|P1|STARTED|Overall Study||33
8379572|NCT01113580|20654956|P2|NOT COMPLETED|Overall Study||0
8379573|NCT01113580|20654957|P1|NOT COMPLETED|Overall Study||1
8379574|NCT01113580|20654956|P2|COMPLETED|Overall Study||60
8379575|NCT01113580|20654957|P1|COMPLETED|Overall Study||59
8379576|NCT01113580|20654956|P2|STARTED|Overall Study||60
8379577|NCT01113580|20654957|P1|STARTED|Overall Study||60
8379581|NCT01113463|20655004|P1|NOT COMPLETED|Overall Study||5
8379582|NCT01113463|20655004|P1|COMPLETED|Overall Study||12
8379583|NCT01113463|20655004|P1|STARTED|Overall Study||17
8379584|NCT01113398|20655009|P1|NOT COMPLETED|Overall Study||0
8379585|NCT01113398|20655009|P1|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
8379586|NCT01113398|20655009|P1|STARTED|Overall Study||36
8379587|NCT01113385|20655016|P1|NOT COMPLETED|Overall Study||0
8379588|NCT01113385|20655016|P1|COMPLETED|Overall Study||7
8379589|NCT01113385|20655016|P1|STARTED|Overall Study||7
8379590|NCT01113008|20655023|P2|NOT COMPLETED|Overall Study||0
8379591|NCT01113008|20655024|P1|NOT COMPLETED|Overall Study||0
8379592|NCT01113008|20655023|P2|COMPLETED|Overall Study||133
8379593|NCT01113008|20655024|P1|COMPLETED|Overall Study||133
8379594|NCT01113008|20655023|P2|STARTED|Overall Study||133
8379595|NCT01113008|20655024|P1|STARTED|Overall Study||133
8379596|NCT01112982|20655034|P1|NOT COMPLETED|Overall Study||2
8379597|NCT01112982|20655034|P1|COMPLETED|Overall Study||72
8379598|NCT01112982|20655034|P1|STARTED|Overall Study||74
8379599|NCT01112917|20655046|P2|NOT COMPLETED|Overall Study||15
8379600|NCT01112917|20655047|P1|NOT COMPLETED|Overall Study||7
8379601|NCT01112917|20655046|P2|COMPLETED|Overall Study||38
8379602|NCT01112917|20655047|P1|COMPLETED|Overall Study||89
8379603|NCT01112917|20655046|P2|STARTED|Overall Study||53
8379604|NCT01112917|20655047|P1|STARTED|Overall Study||96
8379605|NCT01112865|20655052|P2|NOT COMPLETED|Second Intervention||0
8379606|NCT01112865|20655053|P1|NOT COMPLETED|Second Intervention||0
8379607|NCT01112865|20655052|P2|COMPLETED|Second Intervention||61
8379608|NCT01112865|20655053|P1|COMPLETED|Second Intervention||59
8379609|NCT01112865|20655052|P2|STARTED|Second Intervention||61
8379610|NCT01112865|20655053|P1|STARTED|Second Intervention||59
8379611|NCT01112865|20655052|P2|NOT COMPLETED|First Intervention||0
8379612|NCT01112865|20655053|P1|NOT COMPLETED|First Intervention||0
8379613|NCT01112865|20655052|P2|COMPLETED|First Intervention||61
8379614|NCT01112865|20655053|P1|COMPLETED|First Intervention||59
8379615|NCT01112865|20655052|P2|STARTED|First Intervention||61
8379616|NCT01112865|20655053|P1|STARTED|First Intervention||59
8379617|NCT01112735|20655065|P2|NOT COMPLETED|Overall Study||0
8379618|NCT01112735|20655066|P1|NOT COMPLETED|Overall Study||0
8379619|NCT01112735|20655065|P2|COMPLETED|Overall Study||20
8379620|NCT01112735|20655066|P1|COMPLETED|Overall Study||20
8379621|NCT01112735|20655065|P2|STARTED|Overall Study||20
8379622|NCT01112735|20655066|P1|STARTED|Overall Study||20
8379623|NCT01112696|20655090|P1|NOT COMPLETED|Overall Study||2
8379624|NCT01112696|20655090|P1|COMPLETED|Overall Study||98
8379625|NCT01112696|20655090|P1|STARTED|Overall Study||100
8379626|NCT01112683|20655097|P2|NOT COMPLETED|Overall Study||1
8379627|NCT01112683|20655098|P1|NOT COMPLETED|Overall Study||1
8379628|NCT01112683|20655097|P2|COMPLETED|Overall Study||19
8379629|NCT01112683|20655098|P1|COMPLETED|Overall Study||18
8379630|NCT01112683|20655097|P2|STARTED|Overall Study||20
8379631|NCT01112683|20655098|P1|STARTED|Overall Study||19
8379632|NCT01112670|20655108|P6|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379633|NCT01112670|20655109|P5|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379634|NCT01112670|20655110|P4|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379635|NCT01112670|20655111|P3|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379636|NCT01112670|20655112|P2|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379637|NCT01112670|20655113|P1|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379638|NCT01112670|20655108|P6|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
8379639|NCT01112670|20655109|P5|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379640|NCT01112670|20655110|P4|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
8379641|NCT01112670|20655111|P3|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379642|NCT01112670|20655112|P2|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
8379643|NCT01112670|20655113|P1|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379644|NCT01112670|20655108|P6|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
8379645|NCT01112670|20655109|P5|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379646|NCT01112670|20655110|P4|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
8379647|NCT01112670|20655111|P3|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379648|NCT01112670|20655112|P2|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
8379649|NCT01112670|20655113|P1|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
8379650|NCT01112670|20655108|P6|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379651|NCT01112670|20655109|P5|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
8379652|NCT01112670|20655110|P4|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379653|NCT01112670|20655111|P3|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
8379654|NCT01112670|20655112|P2|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379655|NCT01112670|20655113|P1|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
8379656|NCT01112670|20655108|P6|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379657|NCT01112670|20655109|P5|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
8379658|NCT01112670|20655110|P4|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379659|NCT01112670|20655111|P3|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
8379660|NCT01112670|20655112|P2|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379661|NCT01112670|20655113|P1|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
8379662|NCT01112670|20655108|P6|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379663|NCT01112670|20655109|P5|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
8379664|NCT01112670|20655110|P4|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379665|NCT01112670|20655111|P3|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
8379666|NCT01112670|20655112|P2|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
8379667|NCT01112670|20655113|P1|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
8379668|NCT01112579|20655151|P2|NOT COMPLETED|Overall Study||3
8379669|NCT01112579|20655152|P1|NOT COMPLETED|Overall Study||1
8379670|NCT01112579|20655151|P2|COMPLETED|Overall Study||21
8379671|NCT01112579|20655152|P1|COMPLETED|Overall Study||41
8379672|NCT01112579|20655151|P2|STARTED|Overall Study||24
8379673|NCT01112579|20655152|P1|STARTED|Overall Study||42
8379674|NCT01112514|20655162|P1|NOT COMPLETED|Overall Study||1
8379675|NCT01112514|20655162|P1|COMPLETED|Overall Study||3
8379676|NCT01112514|20655162|P1|STARTED|Overall Study||4
8379677|NCT01112358|20655168|P2|NOT COMPLETED|Overall Study||0
8379678|NCT01112358|20655169|P1|NOT COMPLETED|Overall Study||0
8379679|NCT01112358|20655168|P2|COMPLETED|Overall Study||33
8379680|NCT01112358|20655169|P1|COMPLETED|Overall Study||25
8379681|NCT01112358|20655168|P2|STARTED|Overall Study||33
8379682|NCT01112358|20655169|P1|STARTED|Overall Study||25
8379683|NCT01112293|20655205|P1|NOT COMPLETED|Overall Study||0
8379684|NCT01112293|20655205|P1|COMPLETED|Overall Study||14
8379685|NCT01112293|20655205|P1|STARTED|Overall Study||14
8379686|NCT01112267|20655218|P2|NOT COMPLETED|Overall Study||18
8379687|NCT01112267|20655219|P1|NOT COMPLETED|Overall Study||34
8379688|NCT01112267|20655218|P2|COMPLETED|Overall Study||104
8379689|NCT01112267|20655219|P1|COMPLETED|Overall Study||92
8379690|NCT01112267|20655218|P2|Treated|Overall Study||120
8379691|NCT01112267|20655219|P1|Treated|Overall Study||125
8379692|NCT01112267|20655218|P2|STARTED|Overall Study||122
8379693|NCT01112267|20655219|P1|STARTED|Overall Study||126
8379694|NCT01112241|20655237|P1|NOT COMPLETED|Overall Study||0
8379695|NCT01112241|20655237|P1|COMPLETED|Overall Study||17
8379696|NCT01112241|20655237|P1|STARTED|Overall Study||17
8379697|NCT01112228|20655250|P1|NOT COMPLETED|Overall Study||0
8379698|NCT01112228|20655250|P1|COMPLETED|Overall Study||600
8379699|NCT01112228|20655250|P1|STARTED|Overall Study||600
8379700|NCT01112059|20655258|P2|NOT COMPLETED|Overall Study||0
8379701|NCT01112059|20655259|P1|NOT COMPLETED|Overall Study||1
8379702|NCT01112059|20655258|P2|COMPLETED|Overall Study||20
8379703|NCT01112059|20655259|P1|COMPLETED|Overall Study||19
8379704|NCT01112059|20655258|P2|STARTED|Overall Study||20
8379705|NCT01112059|20655259|P1|STARTED|Overall Study||20
8379706|NCT01111851|20655273|P2|NOT COMPLETED|Overall Study||0
8379707|NCT01111851|20655274|P1|NOT COMPLETED|Overall Study||2
8379708|NCT01111851|20655273|P2|COMPLETED|Overall Study||8
8379709|NCT01111851|20655274|P1|COMPLETED|Overall Study||6
8379710|NCT01111851|20655273|P2|STARTED|Overall Study||8
8379711|NCT01111851|20655274|P1|STARTED|Overall Study||8
8379712|NCT01111838|20655286|P1|NOT COMPLETED|Overall Study||7
8379713|NCT01111838|20655286|P1|COMPLETED|Overall Study||15
8379714|NCT01111838|20655286|P1|STARTED|Overall Study||22
8379715|NCT01111825|20655294|P4|NOT COMPLETED|Overall Study||21
8379716|NCT01111825|20655295|P3|NOT COMPLETED|Overall Study||8
8379717|NCT01111825|20655296|P2|NOT COMPLETED|Overall Study||1
8379718|NCT01111825|20655297|P1|NOT COMPLETED|Overall Study||3
8379719|NCT01111825|20655294|P4|COMPLETED|Overall Study||27
8379720|NCT01111825|20655295|P3|COMPLETED|Overall Study||29
8379721|NCT01111825|20655296|P2|COMPLETED|Overall Study||5
8379722|NCT01111825|20655297|P1|COMPLETED|Overall Study||5
8379723|NCT01111825|20655294|P4|STARTED|Overall Study||48
8379724|NCT01111825|20655295|P3|STARTED|Overall Study||37
8379725|NCT01111825|20655296|P2|STARTED|Overall Study||6
8379726|NCT01111825|20655297|P1|STARTED|Overall Study||8
8379727|NCT01111604|20655319|P3|NOT COMPLETED|Overall Study||3
8379728|NCT01111604|20655320|P2|NOT COMPLETED|Overall Study||0
8379729|NCT01111604|20655321|P1|NOT COMPLETED|Overall Study||8
8379730|NCT01111604|20655319|P3|COMPLETED|Overall Study||49
8379731|NCT01111604|20655320|P2|COMPLETED|Overall Study||52
8379732|NCT01111604|20655321|P1|COMPLETED|Overall Study||46
8379733|NCT01111604|20655319|P3|Received at Least One Dose of Study Drug|Overall Study||52
8379734|NCT01111604|20655320|P2|Received at Least One Dose of Study Drug|Overall Study||52
8379735|NCT01111604|20655321|P1|Received at Least One Dose of Study Drug|Overall Study||49
8379736|NCT01111604|20655319|P3|STARTED|Overall Study||52
8379737|NCT01111604|20655320|P2|STARTED|Overall Study||52
8379738|NCT01111604|20655321|P1|STARTED|Overall Study||54
8379739|NCT01111526|20655359|P3|NOT COMPLETED|Overall Study||2
8379740|NCT01111526|20655360|P2|NOT COMPLETED|Overall Study||1
8379741|NCT01111526|20655361|P1|NOT COMPLETED|Overall Study||0
8379742|NCT01111526|20655359|P3|COMPLETED|Overall Study||8
8379743|NCT01111526|20655360|P2|COMPLETED|Overall Study||7
8379744|NCT01111526|20655361|P1|COMPLETED|Overall Study||4
8379745|NCT01111526|20655359|P3|STARTED|Overall Study||10
8379746|NCT01111526|20655360|P2|STARTED|Overall Study||8
8379747|NCT01111526|20655361|P1|STARTED|Overall Study||4
8379748|NCT01111474|20655373|P1|NOT COMPLETED|Overall Study||12
8379749|NCT01111474|20655373|P1|COMPLETED|Overall Study|434 teeth from 62 participants: 218 teeth teated with cyanoacrylate and 216 teeth with LILT|62
8379750|NCT01111474|20655373|P1|STARTED|Overall Study|593 teeth from 74 participants: 296 teeth treated with cyanoacrylate and 297 teeth with LILT|74
8379751|NCT01111461|20655381|P1|NOT COMPLETED|Overall Study||51
8379752|NCT01111461|20655381|P1|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
8379753|NCT01111461|20655381|P1|STARTED|Overall Study||133
8379754|NCT01111370|20655394|P1|NOT COMPLETED|Overall Study||2
8379755|NCT01111370|20655394|P1|COMPLETED|Overall Study||58
8379756|NCT01111370|20655394|P1|STARTED|Overall Study||60
8379757|NCT01111331|20655398|P2|NOT COMPLETED|Overall Study||0
8379758|NCT01111331|20655399|P1|NOT COMPLETED|Overall Study||0
8379759|NCT01111331|20655398|P2|COMPLETED|Overall Study||9
8379760|NCT01111331|20655399|P1|COMPLETED|Overall Study||9
8379761|NCT01111331|20655398|P2|STARTED|Overall Study||9
8379762|NCT01111331|20655399|P1|STARTED|Overall Study||9
8379763|NCT01111318|20655481|P4|NOT COMPLETED|Overall Study||0
8379764|NCT01111318|20655482|P3|NOT COMPLETED|Overall Study||0
8379765|NCT01111318|20655483|P2|NOT COMPLETED|Overall Study||0
8379766|NCT01111318|20655484|P1|NOT COMPLETED|Overall Study||0
8379767|NCT01111318|20655481|P4|COMPLETED|Overall Study||8
8379768|NCT01111318|20655482|P3|COMPLETED|Overall Study||8
8379769|NCT01111318|20655483|P2|COMPLETED|Overall Study||8
8379770|NCT01111318|20655484|P1|COMPLETED|Overall Study||12
8379771|NCT01111318|20655481|P4|STARTED|Overall Study||8
8379772|NCT01111318|20655482|P3|STARTED|Overall Study||8
8379773|NCT01111318|20655483|P2|STARTED|Overall Study||8
8379774|NCT01111318|20655484|P1|STARTED|Overall Study||12
8379781|NCT01111292|20655561|P2|NOT COMPLETED|Follow-Up||0
8379782|NCT01111292|20655562|P1|NOT COMPLETED|Follow-Up||0
8379783|NCT01111292|20655561|P2|COMPLETED|Follow-Up||1
8379784|NCT01111292|20655562|P1|COMPLETED|Follow-Up||2
8379785|NCT01111292|20655561|P2|STARTED|Follow-Up||1
8379786|NCT01111292|20655562|P1|STARTED|Follow-Up||2
8379787|NCT01111292|20655561|P2|NOT COMPLETED|Post Treatment Biopsy||0
8379788|NCT01111292|20655562|P1|NOT COMPLETED|Post Treatment Biopsy||0
8379789|NCT01111292|20655561|P2|COMPLETED|Post Treatment Biopsy||1
8379790|NCT01111292|20655562|P1|COMPLETED|Post Treatment Biopsy||2
8379791|NCT01111292|20655561|P2|STARTED|Post Treatment Biopsy||1
8379792|NCT01111292|20655562|P1|STARTED|Post Treatment Biopsy||2
8379793|NCT01111292|20655561|P2|NOT COMPLETED|Treatment||1
8379794|NCT01111292|20655562|P1|NOT COMPLETED|Treatment||1
8379795|NCT01111292|20655561|P2|COMPLETED|Treatment||1
8379796|NCT01111292|20655562|P1|COMPLETED|Treatment||2
8379797|NCT01111292|20655561|P2|STARTED|Treatment||2
8379798|NCT01111292|20655562|P1|STARTED|Treatment||3
8379799|NCT01111292|20655561|P2|NOT COMPLETED|Randomization||0
8379800|NCT01111292|20655562|P1|NOT COMPLETED|Randomization||0
8379801|NCT01111292|20655561|P2|COMPLETED|Randomization||2
8379802|NCT01111292|20655562|P1|COMPLETED|Randomization||3
8379803|NCT01111292|20655561|P2|STARTED|Randomization||2
8379804|NCT01111292|20655562|P1|STARTED|Randomization||3
8379805|NCT01111240|20655568|P1|NOT COMPLETED|Overall Study||1066
8379806|NCT01111240|20655568|P1|COMPLETED|Overall Study||3569
8379807|NCT01111240|20655568|P1|STARTED|Overall Study||4635
8379808|NCT01111162|20655590|P1|NOT COMPLETED|Overall Study||0
8379809|NCT01111162|20655590|P1|COMPLETED|Overall Study||120
8379810|NCT01111162|20655590|P1|STARTED|Overall Study||120
8379811|NCT01111149|20655598|P3|NOT COMPLETED|Overall Study||4
8379812|NCT01111149|20655599|P2|NOT COMPLETED|Overall Study||1
8379813|NCT01111149|20655600|P1|NOT COMPLETED|Overall Study||2
8379814|NCT01111149|20655598|P3|COMPLETED|Overall Study||5
8379815|NCT01111149|20655599|P2|COMPLETED|Overall Study||5
8379816|NCT01111149|20655600|P1|COMPLETED|Overall Study||7
8379817|NCT01111149|20655598|P3|STARTED|Overall Study||9
8379818|NCT01111149|20655599|P2|STARTED|Overall Study||6
8379819|NCT01111149|20655600|P1|STARTED|Overall Study||9
8379820|NCT01111123|20655676|P2|NOT COMPLETED|Maintenance Phase||2
8379821|NCT01111123|20655677|P1|NOT COMPLETED|Maintenance Phase||0
8379822|NCT01111123|20655676|P2|COMPLETED|Maintenance Phase||18
8379823|NCT01111123|20655677|P1|COMPLETED|Maintenance Phase||21
8379824|NCT01111123|20655676|P2|STARTED|Maintenance Phase||20
8379825|NCT01111123|20655677|P1|STARTED|Maintenance Phase||21
8379826|NCT01111123|20655676|P2|NOT COMPLETED|Open- Label Phase||0
8379827|NCT01111123|20655677|P1|NOT COMPLETED|Open- Label Phase||14
8379828|NCT01111123|20655676|P2|COMPLETED|Open- Label Phase||0
8379829|NCT01111123|20655677|P1|COMPLETED|Open- Label Phase||41
8379830|NCT01111123|20655676|P2|STARTED|Open- Label Phase||0
8379831|NCT01111123|20655677|P1|STARTED|Open- Label Phase||55
8379832|NCT01111110|20655687|P2|NOT COMPLETED|Overall Study||0
8379833|NCT01111110|20655688|P1|NOT COMPLETED|Overall Study||0
8379834|NCT01111110|20655687|P2|COMPLETED|Overall Study||4
8379835|NCT01111110|20655688|P1|COMPLETED|Overall Study||3
8379836|NCT01111110|20655687|P2|STARTED|Overall Study||4
8379837|NCT01111110|20655688|P1|STARTED|Overall Study||3
8379838|NCT01111058|20655700|P2|NOT COMPLETED|Overall Study||0
8379839|NCT01111058|20655701|P1|NOT COMPLETED|Overall Study||0
8379840|NCT01111058|20655700|P2|COMPLETED|Overall Study||24
8379841|NCT01111058|20655701|P1|COMPLETED|Overall Study||28
8379842|NCT01111058|20655700|P2|STARTED|Overall Study||24
8379843|NCT01111058|20655701|P1|STARTED|Overall Study||28
8379844|NCT01111019|20655723|P1|NOT COMPLETED|Overall Study||3
8379845|NCT01111019|20655723|P1|COMPLETED|Overall Study||16
8379846|NCT01111019|20655723|P1|STARTED|Overall Study||19
8379847|NCT01110967|20655742|P1|NOT COMPLETED|Overall Study||9
8379848|NCT01110967|20655742|P1|COMPLETED|Overall Study||31
8379849|NCT01110967|20655742|P1|12 Months Follow up|Overall Study||31
8379850|NCT01110967|20655742|P1|6 Months Follow up|Overall Study||24
8379851|NCT01110967|20655742|P1|3 Months Follow up|Overall Study||28
8379852|NCT01110967|20655742|P1|1 Month Follow up|Overall Study||26
8379853|NCT01110967|20655742|P1|Surgery|Overall Study||40
8379854|NCT01110967|20655742|P1|STARTED|Overall Study||40
8379855|NCT01110915|20655755|P2|NOT COMPLETED|Overall Study||2
8379856|NCT01110915|20655756|P1|NOT COMPLETED|Overall Study||10
8379857|NCT01110915|20655755|P2|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
8379858|NCT01110915|20655756|P1|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
8379859|NCT01110915|20655755|P2|STARTED|Overall Study|Subjects being randomized to the Control group.|86
8379860|NCT01110915|20655756|P1|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
8379861|NCT01110707|20655773|P2|NOT COMPLETED|Overall Study||3
8379862|NCT01110707|20655774|P1|NOT COMPLETED|Overall Study||0
8379863|NCT01110707|20655773|P2|COMPLETED|Overall Study||65
8379864|NCT01110707|20655774|P1|COMPLETED|Overall Study||63
8379865|NCT01110707|20655773|P2|STARTED|Overall Study||68
8379866|NCT01110707|20655774|P1|STARTED|Overall Study||63
8379867|NCT01110681|20655796|P1|NOT COMPLETED|Overall Study||32
8379868|NCT01110681|20655796|P1|COMPLETED|Overall Study||83
8379869|NCT01110681|20655796|P1|STARTED|Overall Study||115
8379870|NCT01110499|20655812|P8|NOT COMPLETED|Overall Study||0
8379871|NCT01110499|20655813|P7|NOT COMPLETED|Overall Study||0
8379872|NCT01110499|20655814|P6|NOT COMPLETED|Overall Study||0
8379873|NCT01110499|20655815|P5|NOT COMPLETED|Overall Study||0
8379874|NCT01110499|20655816|P4|NOT COMPLETED|Overall Study||0
8379875|NCT01110499|20655817|P3|NOT COMPLETED|Overall Study||0
8379876|NCT01110499|20655818|P2|NOT COMPLETED|Overall Study||0
8379877|NCT01110499|20655819|P1|NOT COMPLETED|Overall Study||0
8379878|NCT01110499|20655812|P8|COMPLETED|Overall Study||40
8379879|NCT01110499|20655813|P7|COMPLETED|Overall Study||39
8379880|NCT01110499|20655814|P6|COMPLETED|Overall Study||14
8379881|NCT01110499|20655815|P5|COMPLETED|Overall Study||14
8379882|NCT01110499|20655816|P4|COMPLETED|Overall Study||14
8379883|NCT01110499|20655817|P3|COMPLETED|Overall Study||14
8379884|NCT01110499|20655818|P2|COMPLETED|Overall Study||14
8379885|NCT01110499|20655819|P1|COMPLETED|Overall Study||14
8379886|NCT01110499|20655812|P8|STARTED|Overall Study||40
8379887|NCT01110499|20655813|P7|STARTED|Overall Study||39
8379888|NCT01110499|20655814|P6|STARTED|Overall Study||14
8379889|NCT01110499|20655815|P5|STARTED|Overall Study||14
8379890|NCT01110499|20655816|P4|STARTED|Overall Study||14
8379891|NCT01110499|20655817|P3|STARTED|Overall Study||14
8379892|NCT01110499|20655818|P2|STARTED|Overall Study||14
8379893|NCT01110499|20655819|P1|STARTED|Overall Study||14
8379894|NCT01110434|20655841|P2|NOT COMPLETED|Overall Study||6
8379895|NCT01110434|20655842|P1|NOT COMPLETED|Overall Study||11
8379896|NCT01110434|20655841|P2|COMPLETED|Overall Study||20
8379897|NCT01110434|20655842|P1|COMPLETED|Overall Study||29
8379898|NCT01110434|20655841|P2|STARTED|Overall Study||26
8379899|NCT01110434|20655842|P1|STARTED|Overall Study||40
8379900|NCT01110421|20655854|P2|NOT COMPLETED|Overall Study||0
8379901|NCT01110421|20655855|P1|NOT COMPLETED|Overall Study||0
8379902|NCT01110421|20655854|P2|COMPLETED|Overall Study||2
8379903|NCT01110421|20655855|P1|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
8379904|NCT01110421|20655854|P2|STARTED|Overall Study||2
8379905|NCT01110421|20655855|P1|STARTED|Overall Study||5
8379906|NCT01110408|20655875|P2|NOT COMPLETED|Overall Study||0
8379907|NCT01110408|20655876|P1|NOT COMPLETED|Overall Study||1
8379908|NCT01110408|20655875|P2|COMPLETED|Overall Study||10
8379909|NCT01110408|20655876|P1|COMPLETED|Overall Study||30
8379910|NCT01110408|20655875|P2|STARTED|Overall Study||10
8379911|NCT01110408|20655876|P1|STARTED|Overall Study||31
8379912|NCT01110395|20655894|P1|NOT COMPLETED|Overall Study||0
8379913|NCT01110395|20655894|P1|COMPLETED|Overall Study||15
8379914|NCT01110395|20655894|P1|STARTED|Overall Study||15
8379915|NCT01110382|20655900|P2|NOT COMPLETED|Overall Study||2
8379916|NCT01110382|20655901|P1|NOT COMPLETED|Overall Study||0
8379917|NCT01110382|20655900|P2|COMPLETED|Overall Study||8
8379918|NCT01110382|20655901|P1|COMPLETED|Overall Study||31
8379919|NCT01110382|20655900|P2|STARTED|Overall Study||10
8379920|NCT01110382|20655901|P1|STARTED|Overall Study||31
8379921|NCT01110330|20655922|P3|NOT COMPLETED|Overall Study||26
8379922|NCT01110330|20655923|P2|NOT COMPLETED|Overall Study||23
8379923|NCT01110330|20655924|P1|NOT COMPLETED|Overall Study||15
8379924|NCT01110330|20655922|P3|COMPLETED|Overall Study||208
8379925|NCT01110330|20655923|P2|COMPLETED|Overall Study||207
8379926|NCT01110330|20655924|P1|COMPLETED|Overall Study||104
8379927|NCT01110330|20655922|P3|Positive Baseline Culture Set|Overall Study||114
8379928|NCT01110330|20655923|P2|Positive Baseline Culture Set|Overall Study||111
8379929|NCT01110330|20655924|P1|Positive Baseline Culture Set|Overall Study||56
8379930|NCT01110330|20655922|P3|STARTED|Overall Study||234
8379931|NCT01110330|20655923|P2|STARTED|Overall Study||230
8379932|NCT01110330|20655924|P1|STARTED|Overall Study||119
8379933|NCT01110252|20655935|P1|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
8379934|NCT01110252|20655935|P1|COMPLETED|Post-procedure (Stem Cells Infusion)||4
8379935|NCT01110252|20655935|P1|STARTED|Post-procedure (Stem Cells Infusion)||4
8379936|NCT01110252|20655935|P1|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
8379937|NCT01110252|20655935|P1|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
8379938|NCT01110252|20655935|P1|STARTED|Pre-procedure (Stem Cells Infusion)||4
8379939|NCT01110239|20655952|P4|NOT COMPLETED|10 Min Ischemia||0
8379940|NCT01110239|20655953|P3|NOT COMPLETED|10 Min Ischemia||0
8379941|NCT01110239|20655954|P2|NOT COMPLETED|10 Min Ischemia||0
8379942|NCT01110239|20655955|P1|NOT COMPLETED|10 Min Ischemia||0
8379943|NCT01110239|20655952|P4|COMPLETED|10 Min Ischemia||6
8379944|NCT01110239|20655953|P3|COMPLETED|10 Min Ischemia||0
8379945|NCT01110239|20655954|P2|COMPLETED|10 Min Ischemia||0
8379946|NCT01110239|20655955|P1|COMPLETED|10 Min Ischemia||0
8379947|NCT01110239|20655952|P4|STARTED|10 Min Ischemia||6
8379948|NCT01110239|20655953|P3|STARTED|10 Min Ischemia||0
8379949|NCT01110239|20655954|P2|STARTED|10 Min Ischemia||0
8379950|NCT01110239|20655955|P1|STARTED|10 Min Ischemia||0
8379951|NCT01110239|20655952|P4|NOT COMPLETED|7.5 Min Ischemia||0
8379952|NCT01110239|20655953|P3|NOT COMPLETED|7.5 Min Ischemia||1
8379953|NCT01110239|20655954|P2|NOT COMPLETED|7.5 Min Ischemia||0
8379954|NCT01110239|20655955|P1|NOT COMPLETED|7.5 Min Ischemia||0
8379955|NCT01110239|20655952|P4|COMPLETED|7.5 Min Ischemia||0
8379956|NCT01110239|20655953|P3|COMPLETED|7.5 Min Ischemia||6
8379957|NCT01110239|20655954|P2|COMPLETED|7.5 Min Ischemia||0
8379958|NCT01110239|20655955|P1|COMPLETED|7.5 Min Ischemia||0
8379959|NCT01110239|20655952|P4|STARTED|7.5 Min Ischemia||0
8379960|NCT01110239|20655953|P3|STARTED|7.5 Min Ischemia||7
8379961|NCT01110239|20655954|P2|STARTED|7.5 Min Ischemia||0
8379962|NCT01110239|20655955|P1|STARTED|7.5 Min Ischemia||0
8379963|NCT01110239|20655952|P4|NOT COMPLETED|5 Min Ischemia||0
8379964|NCT01110239|20655953|P3|NOT COMPLETED|5 Min Ischemia||0
8379965|NCT01110239|20655954|P2|NOT COMPLETED|5 Min Ischemia||14
8379966|NCT01110239|20655955|P1|NOT COMPLETED|5 Min Ischemia||0
8379967|NCT01110239|20655952|P4|COMPLETED|5 Min Ischemia||0
8379968|NCT01110239|20655953|P3|COMPLETED|5 Min Ischemia||0
8379969|NCT01110239|20655954|P2|COMPLETED|5 Min Ischemia||0
8379970|NCT01110239|20655955|P1|COMPLETED|5 Min Ischemia||0
8379971|NCT01110239|20655952|P4|STARTED|5 Min Ischemia||0
8379972|NCT01110239|20655953|P3|STARTED|5 Min Ischemia||0
8379973|NCT01110239|20655954|P2|STARTED|5 Min Ischemia||14
8379974|NCT01110239|20655955|P1|STARTED|5 Min Ischemia||0
8379975|NCT01110239|20655952|P4|NOT COMPLETED|Sham Preconditioning||0
8379976|NCT01110239|20655953|P3|NOT COMPLETED|Sham Preconditioning||1
8379977|NCT01110239|20655954|P2|NOT COMPLETED|Sham Preconditioning||0
8379978|NCT01110239|20655955|P1|NOT COMPLETED|Sham Preconditioning||0
8379979|NCT01110239|20655952|P4|COMPLETED|Sham Preconditioning||6
8379980|NCT01110239|20655953|P3|COMPLETED|Sham Preconditioning||6
8379981|NCT01110239|20655954|P2|COMPLETED|Sham Preconditioning||14
8379982|NCT01110239|20655955|P1|COMPLETED|Sham Preconditioning||7
8379983|NCT01110239|20655952|P4|STARTED|Sham Preconditioning||6
8379984|NCT01110239|20655953|P3|STARTED|Sham Preconditioning||7
8379985|NCT01110239|20655954|P2|STARTED|Sham Preconditioning||14
8379986|NCT01110239|20655955|P1|STARTED|Sham Preconditioning||7
8379987|NCT01110200|20655971|P2|NOT COMPLETED|Overall Study||121
8379988|NCT01110200|20655972|P1|NOT COMPLETED|Overall Study||106
8379989|NCT01110200|20655971|P2|COMPLETED|Overall Study||204
8379990|NCT01110200|20655972|P1|COMPLETED|Overall Study||208
8379991|NCT01110200|20655971|P2|STARTED|Overall Study||325
8379992|NCT01110200|20655972|P1|STARTED|Overall Study||314
8379993|NCT01110187|20655988|P2|NOT COMPLETED|Overall Study||0
8379994|NCT01110187|20655989|P1|NOT COMPLETED|Overall Study||0
8379995|NCT01110187|20655988|P2|COMPLETED|Overall Study|completed 7 day treatment|4
8379996|NCT01110187|20655989|P1|COMPLETED|Overall Study|completed 7 day treatment|7
8379997|NCT01110187|20655988|P2|STARTED|Overall Study||4
8379998|NCT01110187|20655989|P1|STARTED|Overall Study||7
8379999|NCT01110174|20655997|P1|NOT COMPLETED|Overall Study||0
8380000|NCT01110174|20655997|P1|COMPLETED|Overall Study||8
8380001|NCT01110174|20655997|P1|STARTED|Overall Study||8
8380002|NCT01110135|20656002|P1|NOT COMPLETED|Overall Study||9
8380003|NCT01110135|20656002|P1|COMPLETED|Overall Study||34
8380004|NCT01110135|20656002|P1|STARTED|Overall Study||43
8380005|NCT01110005|20656008|P2|NOT COMPLETED|Overall Study||5
8380006|NCT01110005|20656009|P1|NOT COMPLETED|Overall Study||4
8380007|NCT01110005|20656008|P2|COMPLETED|Overall Study||156
8380008|NCT01110005|20656009|P1|COMPLETED|Overall Study||153
8380009|NCT01110005|20656008|P2|STARTED|Overall Study||161
8380010|NCT01110005|20656009|P1|STARTED|Overall Study||157
8380011|NCT01109992|20656021|P2|NOT COMPLETED|Overall Study||2
8380012|NCT01109992|20656022|P1|NOT COMPLETED|Overall Study||0
8380013|NCT01109992|20656021|P2|COMPLETED|Overall Study||30
8380014|NCT01109992|20656022|P1|COMPLETED|Overall Study||11
8380015|NCT01109992|20656021|P2|Subjects Enrolled|Overall Study||32
8380016|NCT01109992|20656022|P1|Subjects Enrolled|Overall Study||11
8380017|NCT01109992|20656021|P2|STARTED|Overall Study||32
8380018|NCT01109992|20656022|P1|STARTED|Overall Study||11
8380019|NCT01109979|20656036|P2|NOT COMPLETED|Overall Study||1
8380020|NCT01109979|20656037|P1|NOT COMPLETED|Overall Study||2
8380021|NCT01109979|20656036|P2|COMPLETED|Overall Study||11
8380022|NCT01109979|20656037|P1|COMPLETED|Overall Study||10
8380023|NCT01109979|20656036|P2|STARTED|Overall Study||12
8380024|NCT01109979|20656037|P1|STARTED|Overall Study||12
8380025|NCT01109849|20656045|P5|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
8380026|NCT01109849|20656046|P4|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
8380027|NCT01109849|20656047|P3|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
8380028|NCT01109849|20656048|P2|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
8380029|NCT01109849|20656049|P1|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
8380030|NCT01109849|20656045|P5|COMPLETED|Adaptive Randomization: Weight Recovery||24
8380031|NCT01109849|20656046|P4|COMPLETED|Adaptive Randomization: Weight Recovery||20
8380032|NCT01109849|20656047|P3|COMPLETED|Adaptive Randomization: Weight Recovery||23
8380033|NCT01109849|20656048|P2|COMPLETED|Adaptive Randomization: Weight Recovery||0
8380034|NCT01109849|20656049|P1|COMPLETED|Adaptive Randomization: Weight Recovery||0
8380035|NCT01109849|20656045|P5|STARTED|Adaptive Randomization: Weight Recovery||25
8380036|NCT01109849|20656046|P4|STARTED|Adaptive Randomization: Weight Recovery||23
8380037|NCT01109849|20656047|P3|STARTED|Adaptive Randomization: Weight Recovery||24
8380038|NCT01109849|20656048|P2|STARTED|Adaptive Randomization: Weight Recovery||0
8380039|NCT01109849|20656049|P1|STARTED|Adaptive Randomization: Weight Recovery||0
8380040|NCT01109849|20656045|P5|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
8380041|NCT01109849|20656046|P4|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
8380042|NCT01109849|20656047|P3|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
8380043|NCT01109849|20656048|P2|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
8380044|NCT01109849|20656049|P1|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
8380045|NCT01109849|20656045|P5|COMPLETED|Initial Randomization: ADHD Treatment||0
8380046|NCT01109849|20656046|P4|COMPLETED|Initial Randomization: ADHD Treatment||0
8380047|NCT01109849|20656047|P3|COMPLETED|Initial Randomization: ADHD Treatment||0
8380048|NCT01109849|20656048|P2|COMPLETED|Initial Randomization: ADHD Treatment||131
8380049|NCT01109849|20656049|P1|COMPLETED|Initial Randomization: ADHD Treatment||32
8380050|NCT01109849|20656045|P5|STARTED|Initial Randomization: ADHD Treatment||0
8380051|NCT01109849|20656046|P4|STARTED|Initial Randomization: ADHD Treatment||0
8380052|NCT01109849|20656047|P3|STARTED|Initial Randomization: ADHD Treatment||0
8380053|NCT01109849|20656048|P2|STARTED|Initial Randomization: ADHD Treatment||180
8380054|NCT01109849|20656049|P1|STARTED|Initial Randomization: ADHD Treatment||50
8380055|NCT01109602|20656101|P3|NOT COMPLETED|Overall Study||1
8380056|NCT01109602|20656102|P2|NOT COMPLETED|Overall Study||2
8380057|NCT01109602|20656103|P1|NOT COMPLETED|Overall Study||1
8380058|NCT01109602|20656101|P3|COMPLETED|Overall Study||9
8380059|NCT01109602|20656102|P2|COMPLETED|Overall Study||21
8380060|NCT01109602|20656103|P1|COMPLETED|Overall Study||13
8380061|NCT01109602|20656101|P3|STARTED|Overall Study||10
8380062|NCT01109602|20656102|P2|STARTED|Overall Study||23
8380063|NCT01109602|20656103|P1|STARTED|Overall Study||14
8380064|NCT01109576|20656114|P1|NOT COMPLETED|Overall Study||1
8380065|NCT01109576|20656114|P1|COMPLETED|Overall Study||12
8380066|NCT01109576|20656114|P1|STARTED|Overall Study||13
8380067|NCT01109524|20656118|P1|NOT COMPLETED|Overall Study||57
8380068|NCT01109524|20656118|P1|COMPLETED|Overall Study||3
8380069|NCT01109524|20656118|P1|STARTED|Overall Study||60
8380070|NCT01109381|20656128|P1|NOT COMPLETED|Overall Study||2
8380071|NCT01109381|20656128|P1|COMPLETED|Overall Study||31
8380072|NCT01109381|20656128|P1|STARTED|Overall Study||33
8380073|NCT01109316|20656140|P6|NOT COMPLETED|Study Period 3||0
8380074|NCT01109316|20656141|P5|NOT COMPLETED|Study Period 3||2
8380075|NCT01109316|20656142|P4|NOT COMPLETED|Study Period 3||0
8380076|NCT01109316|20656143|P3|NOT COMPLETED|Study Period 3||0
8380077|NCT01109316|20656144|P2|NOT COMPLETED|Study Period 3||0
8380078|NCT01109316|20656145|P1|NOT COMPLETED|Study Period 3||1
8380079|NCT01109316|20656140|P6|COMPLETED|Study Period 3||19
8380080|NCT01109316|20656141|P5|COMPLETED|Study Period 3||18
8380081|NCT01109316|20656142|P4|COMPLETED|Study Period 3||20
8380082|NCT01109316|20656143|P3|COMPLETED|Study Period 3||18
8380083|NCT01109316|20656144|P2|COMPLETED|Study Period 3||21
8380084|NCT01109316|20656145|P1|COMPLETED|Study Period 3||20
8380085|NCT01109316|20656140|P6|STARTED|Study Period 3||19
8380086|NCT01109316|20656141|P5|STARTED|Study Period 3||20
8380087|NCT01109316|20656142|P4|STARTED|Study Period 3||20
8380088|NCT01109316|20656143|P3|STARTED|Study Period 3||18
8380089|NCT01109316|20656144|P2|STARTED|Study Period 3||21
8380090|NCT01109316|20656145|P1|STARTED|Study Period 3||21
8380091|NCT01109316|20656140|P6|NOT COMPLETED|Study Period 2||1
8380092|NCT01109316|20656141|P5|NOT COMPLETED|Study Period 2||0
8380093|NCT01109316|20656142|P4|NOT COMPLETED|Study Period 2||1
8380094|NCT01109316|20656143|P3|NOT COMPLETED|Study Period 2||1
8380095|NCT01109316|20656144|P2|NOT COMPLETED|Study Period 2||1
8380096|NCT01109316|20656145|P1|NOT COMPLETED|Study Period 2||1
8380097|NCT01109316|20656140|P6|COMPLETED|Study Period 2||19
8380098|NCT01109316|20656141|P5|COMPLETED|Study Period 2||20
8380099|NCT01109316|20656142|P4|COMPLETED|Study Period 2||20
8380100|NCT01109316|20656143|P3|COMPLETED|Study Period 2||18
8380101|NCT01109316|20656144|P2|COMPLETED|Study Period 2||21
8380102|NCT01109316|20656145|P1|COMPLETED|Study Period 2||21
8380103|NCT01109316|20656140|P6|STARTED|Study Period 2||20
8380104|NCT01109316|20656141|P5|STARTED|Study Period 2||20
8380105|NCT01109316|20656142|P4|STARTED|Study Period 2||21
8380106|NCT01109316|20656143|P3|STARTED|Study Period 2||19
8380107|NCT01109316|20656144|P2|STARTED|Study Period 2||22
8380108|NCT01109316|20656145|P1|STARTED|Study Period 2||22
8380109|NCT01109316|20656140|P6|NOT COMPLETED|Study Period 1||2
8380110|NCT01109316|20656141|P5|NOT COMPLETED|Study Period 1||2
8380111|NCT01109316|20656142|P4|NOT COMPLETED|Study Period 1||1
8380112|NCT01109316|20656143|P3|NOT COMPLETED|Study Period 1||3
8380113|NCT01109316|20656144|P2|NOT COMPLETED|Study Period 1||0
8380114|NCT01109316|20656145|P1|NOT COMPLETED|Study Period 1||0
8380115|NCT01109316|20656140|P6|COMPLETED|Study Period 1||20
8380116|NCT01109316|20656141|P5|COMPLETED|Study Period 1||20
8380117|NCT01109316|20656142|P4|COMPLETED|Study Period 1||21
8380118|NCT01109316|20656143|P3|COMPLETED|Study Period 1||19
8380119|NCT01109316|20656144|P2|COMPLETED|Study Period 1||22
8380120|NCT01109316|20656145|P1|COMPLETED|Study Period 1||22
8380121|NCT01109316|20656140|P6|Received at Least One Dose of Study Drug|Study Period 1||20
8380122|NCT01109316|20656141|P5|Received at Least One Dose of Study Drug|Study Period 1||22
8380123|NCT01109316|20656142|P4|Received at Least One Dose of Study Drug|Study Period 1||22
8380124|NCT01109316|20656143|P3|Received at Least One Dose of Study Drug|Study Period 1||22
8380125|NCT01109316|20656144|P2|Received at Least One Dose of Study Drug|Study Period 1||22
8380126|NCT01109316|20656145|P1|Received at Least One Dose of Study Drug|Study Period 1||22
8380127|NCT01109316|20656140|P6|STARTED|Study Period 1||22
8380128|NCT01109316|20656141|P5|STARTED|Study Period 1||22
8380129|NCT01109316|20656142|P4|STARTED|Study Period 1||22
8380130|NCT01109316|20656143|P3|STARTED|Study Period 1||22
8380131|NCT01109316|20656144|P2|STARTED|Study Period 1||22
8380132|NCT01109316|20656145|P1|STARTED|Study Period 1||22
8380133|NCT01109173|20656193|P4|NOT COMPLETED|Overall Study||93
8380134|NCT01109173|20656194|P3|NOT COMPLETED|Overall Study||101
8380135|NCT01109173|20656195|P2|NOT COMPLETED|Overall Study||86
8380136|NCT01109173|20656196|P1|NOT COMPLETED|Overall Study||88
8380137|NCT01109173|20656193|P4|COMPLETED|Overall Study||120
8380138|NCT01109173|20656194|P3|COMPLETED|Overall Study||110
8380139|NCT01109173|20656195|P2|COMPLETED|Overall Study||759
8380140|NCT01109173|20656196|P1|COMPLETED|Overall Study||763
8380141|NCT01109173|20656193|P4|STARTED|Overall Study||213
8380142|NCT01109173|20656194|P3|STARTED|Overall Study||211
8380143|NCT01109173|20656195|P2|STARTED|Overall Study||845
8380144|NCT01109173|20656196|P1|STARTED|Overall Study||851
8380145|NCT01109147|20656213|P3|NOT COMPLETED|Overall Study||10
8380146|NCT01109147|20656214|P2|NOT COMPLETED|Overall Study||3
8380147|NCT01109147|20656215|P1|NOT COMPLETED|Overall Study||2
8380148|NCT01109147|20656213|P3|COMPLETED|Overall Study|10 have been excluded of the results|26
8380149|NCT01109147|20656214|P2|COMPLETED|Overall Study|3 have been excluded of the results|11
8380150|NCT01109147|20656215|P1|COMPLETED|Overall Study|2 have been excluded of the results|15
8380151|NCT01109147|20656213|P3|STARTED|Overall Study||36
8380152|NCT01109147|20656214|P2|STARTED|Overall Study||14
8380153|NCT01109147|20656215|P1|STARTED|Overall Study||17
8380154|NCT01109108|20656225|P2|NOT COMPLETED|Overall Study||0
8380155|NCT01109108|20656226|P1|NOT COMPLETED|Overall Study||0
8380156|NCT01109108|20656225|P2|COMPLETED|Overall Study||4755
8380157|NCT01109108|20656226|P1|COMPLETED|Overall Study||4035
8380158|NCT01109108|20656225|P2|STARTED|Overall Study||4755
8380159|NCT01109108|20656226|P1|STARTED|Overall Study||4035
8380160|NCT01109069|20656232|P1|NOT COMPLETED|Overall Study||93
8380161|NCT01109069|20656232|P1|COMPLETED|Overall Study||106
8380162|NCT01109069|20656232|P1|STARTED|Overall Study||199
8380163|NCT01109056|20656241|P2|NOT COMPLETED|Overall Study||5
8380164|NCT01109056|20656242|P1|NOT COMPLETED|Overall Study||7
8380165|NCT01109056|20656241|P2|COMPLETED|Overall Study||53
8380166|NCT01109056|20656242|P1|COMPLETED|Overall Study||50
8380167|NCT01109056|20656241|P2|STARTED|Overall Study||58
8380168|NCT01109056|20656242|P1|STARTED|Overall Study||57
8380169|NCT01109004|20656255|P3|NOT COMPLETED|Overall Study||0
8380170|NCT01109004|20656256|P2|NOT COMPLETED|Overall Study||0
8380171|NCT01109004|20656257|P1|NOT COMPLETED|Overall Study||0
8380172|NCT01109004|20656255|P3|COMPLETED|Overall Study||257
8380173|NCT01109004|20656256|P2|COMPLETED|Overall Study||254
8380174|NCT01109004|20656257|P1|COMPLETED|Overall Study||247
8380175|NCT01109004|20656255|P3|STARTED|Overall Study||257
8380176|NCT01109004|20656256|P2|STARTED|Overall Study||254
8380177|NCT01109004|20656257|P1|STARTED|Overall Study||247
8380178|NCT01108835|20656294|P2|NOT COMPLETED|Overall Study||21
8380179|NCT01108835|20656295|P1|NOT COMPLETED|Overall Study||17
8380180|NCT01108835|20656294|P2|COMPLETED|Overall Study||69
8380181|NCT01108835|20656295|P1|COMPLETED|Overall Study||73
8380182|NCT01108835|20656294|P2|STARTED|Overall Study||90
8380183|NCT01108835|20656295|P1|STARTED|Overall Study||90
8380184|NCT01108809|20656309|P1|NOT COMPLETED|Overall Study||4
8380185|NCT01108809|20656309|P1|COMPLETED|Overall Study||291
8380186|NCT01108809|20656309|P1|STARTED|Overall Study||295
8380187|NCT01108796|20656326|P2|NOT COMPLETED|Overall Study||7
8380188|NCT01108796|20656327|P1|NOT COMPLETED|Overall Study||7
8380189|NCT01108796|20656326|P2|COMPLETED|Overall Study||1060
8380190|NCT01108796|20656327|P1|COMPLETED|Overall Study||767
8380191|NCT01108796|20656326|P2|STARTED|Overall Study||1067
8380192|NCT01108796|20656327|P1|STARTED|Overall Study||774
8380193|NCT01108757|20656361|P2|NOT COMPLETED|Overall Study||0
8380194|NCT01108757|20656362|P1|NOT COMPLETED|Overall Study||0
8380195|NCT01108757|20656361|P2|COMPLETED|Overall Study||26
8380196|NCT01108757|20656362|P1|COMPLETED|Overall Study||26
8380197|NCT01108757|20656361|P2|STARTED|Overall Study||26
8380198|NCT01108757|20656362|P1|STARTED|Overall Study||26
8380199|NCT01108731|20656370|P2|NOT COMPLETED|Overall Study||4
8380200|NCT01108731|20656371|P1|NOT COMPLETED|Overall Study||4
8380201|NCT01108731|20656370|P2|COMPLETED|Overall Study||13
8380202|NCT01108731|20656371|P1|COMPLETED|Overall Study||13
8380203|NCT01108731|20656370|P2|STARTED|Overall Study||17
8380204|NCT01108731|20656371|P1|STARTED|Overall Study||17
8380205|NCT01108718|20656383|P2|NOT COMPLETED|Received Second Intervention (2 Months)||0
8380206|NCT01108718|20656384|P1|NOT COMPLETED|Received Second Intervention (2 Months)||1
8380207|NCT01108718|20656383|P2|COMPLETED|Received Second Intervention (2 Months)||7
8380208|NCT01108718|20656384|P1|COMPLETED|Received Second Intervention (2 Months)||4
8380209|NCT01108718|20656383|P2|STARTED|Received Second Intervention (2 Months)||7
8380210|NCT01108718|20656384|P1|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
8380211|NCT01108718|20656383|P2|NOT COMPLETED|Received First Intervention (2 Months)||0
8380212|NCT01108718|20656384|P1|NOT COMPLETED|Received First Intervention (2 Months)||0
8380213|NCT01108718|20656383|P2|COMPLETED|Received First Intervention (2 Months)||7
8380214|NCT01108718|20656384|P1|COMPLETED|Received First Intervention (2 Months)||5
8380215|NCT01108718|20656383|P2|STARTED|Received First Intervention (2 Months)||7
8380216|NCT01108718|20656384|P1|STARTED|Received First Intervention (2 Months)||5
8380220|NCT01108523|20656396|P1|NOT COMPLETED|Overall Study||4
8380221|NCT01108523|20656396|P1|COMPLETED|Overall Study||3
8380222|NCT01108523|20656396|P1|STARTED|Overall Study||7
8380223|NCT01108510|20656403|P2|NOT COMPLETED|Overall Study||268
8380224|NCT01108510|20656404|P1|NOT COMPLETED|Overall Study||279
8380225|NCT01108510|20656403|P2|COMPLETED|Overall Study||81
8380226|NCT01108510|20656404|P1|COMPLETED|Overall Study||70
8380227|NCT01108510|20656403|P2|STARTED|Overall Study||349
8380228|NCT01108510|20656404|P1|STARTED|Overall Study||349
8380229|NCT01108458|20656424|P1|NOT COMPLETED|Overall Study||1
8380230|NCT01108458|20656424|P1|COMPLETED|Overall Study||0
8380231|NCT01108458|20656424|P1|STARTED|Overall Study||1
8380232|NCT01108445|20656435|P2|NOT COMPLETED|Overall Study||49
8380233|NCT01108445|20656436|P1|NOT COMPLETED|Overall Study||56
8380234|NCT01108445|20656435|P2|COMPLETED|Overall Study||2
8380235|NCT01108445|20656436|P1|COMPLETED|Overall Study||1
8380236|NCT01108445|20656435|P2|STARTED|Overall Study||51
8380237|NCT01108445|20656436|P1|STARTED|Overall Study||57
8380238|NCT01108406|20656470|P1|NOT COMPLETED|Overall Study||0
8380239|NCT01108406|20656470|P1|COMPLETED|Overall Study||22
8380240|NCT01108406|20656470|P1|STARTED|Overall Study||22
8380241|NCT01108341|20656476|P1|NOT COMPLETED|Overall Study||5
8380242|NCT01108341|20656476|P1|COMPLETED|Overall Study||45
8380243|NCT01108341|20656476|P1|Safety Set (Enrolled and Treated)|Overall Study||49
8380244|NCT01108341|20656476|P1|STARTED|Overall Study||50
8380245|NCT01108263|20656483|P2|NOT COMPLETED|Overall Study||1
8380246|NCT01108263|20656484|P1|NOT COMPLETED|Overall Study||0
8380247|NCT01108263|20656483|P2|COMPLETED|Overall Study||2
8380248|NCT01108263|20656484|P1|COMPLETED|Overall Study||2
8380249|NCT01108263|20656483|P2|STARTED|Overall Study||3
8380250|NCT01108263|20656484|P1|STARTED|Overall Study||2
8380251|NCT01108237|20656494|P2|NOT COMPLETED|Overall Study||17
8380252|NCT01108237|20656495|P1|NOT COMPLETED|Overall Study||9
8380253|NCT01108237|20656494|P2|COMPLETED|Overall Study||84
8380254|NCT01108237|20656495|P1|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
8380255|NCT01108237|20656494|P2|STARTED|Overall Study||101
8380256|NCT01108237|20656495|P1|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
8380257|NCT01108185|20656501|P1|NOT COMPLETED|Overall Study||27
8380258|NCT01108185|20656501|P1|COMPLETED|Overall Study||3154
8380259|NCT01108185|20656501|P1|Per Protocol Population|Overall Study||3181
8380260|NCT01108185|20656501|P1|STARTED|Overall Study||3181
8380261|NCT01108094|20656518|P4|NOT COMPLETED|Overall Study||0
8380262|NCT01108094|20656519|P3|NOT COMPLETED|Overall Study||0
8380263|NCT01108094|20656520|P2|NOT COMPLETED|Overall Study||0
8380264|NCT01108094|20656521|P1|NOT COMPLETED|Overall Study||3
8380265|NCT01108094|20656518|P4|COMPLETED|Overall Study||10
8380266|NCT01108094|20656519|P3|COMPLETED|Overall Study||4
8380267|NCT01108094|20656520|P2|COMPLETED|Overall Study||3
8380268|NCT01108094|20656521|P1|COMPLETED|Overall Study||9
8380269|NCT01108094|20656518|P4|STARTED|Overall Study||10
8380270|NCT01108094|20656519|P3|STARTED|Overall Study||4
8380271|NCT01108094|20656520|P2|STARTED|Overall Study||3
8380272|NCT01108094|20656521|P1|STARTED|Overall Study||12
8380273|NCT01108081|20656546|P4|NOT COMPLETED|Overall Study||4
8380274|NCT01108081|20656547|P3|NOT COMPLETED|Overall Study||0
8380275|NCT01108081|20656548|P2|NOT COMPLETED|Overall Study||2
8380276|NCT01108081|20656549|P1|NOT COMPLETED|Overall Study||2
8380277|NCT01108081|20656546|P4|COMPLETED|Overall Study||39
8380278|NCT01108081|20656547|P3|COMPLETED|Overall Study||38
8380279|NCT01108081|20656548|P2|COMPLETED|Overall Study||40
8380280|NCT01108081|20656549|P1|COMPLETED|Overall Study||44
8380281|NCT01108081|20656546|P4|STARTED|Overall Study||43
8380282|NCT01108081|20656547|P3|STARTED|Overall Study||38
8380283|NCT01108081|20656548|P2|STARTED|Overall Study||42
8380284|NCT01108081|20656549|P1|STARTED|Overall Study||46
8380285|NCT01108068|20656565|P2|NOT COMPLETED|Overall Study||0
8380286|NCT01108068|20656566|P1|NOT COMPLETED|Overall Study||6
8380287|NCT01108068|20656565|P2|COMPLETED|Overall Study||16
8380288|NCT01108068|20656566|P1|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
8380289|NCT01108068|20656565|P2|STARTED|Overall Study||16
8380290|NCT01108068|20656566|P1|STARTED|Overall Study||10
8380291|NCT01108055|20656573|P1|NOT COMPLETED|Overall Study||15
8380292|NCT01108055|20656573|P1|COMPLETED|Overall Study||28
8380293|NCT01108055|20656573|P1|Eligible and Started Treatment|Overall Study||32
8380294|NCT01108055|20656573|P1|STARTED|Overall Study||43
8380295|NCT01108003|20656583|P2|NOT COMPLETED|Overall Study||0
8380296|NCT01108003|20656584|P1|NOT COMPLETED|Overall Study||0
8380297|NCT01108003|20656583|P2|COMPLETED|Overall Study||3
8380298|NCT01108003|20656584|P1|COMPLETED|Overall Study||4
8380299|NCT01108003|20656583|P2|STARTED|Overall Study||3
8380300|NCT01108003|20656584|P1|STARTED|Overall Study||4
8380301|NCT01107964|20656594|P2|NOT COMPLETED|Overall Study||1
8380302|NCT01107964|20656595|P1|NOT COMPLETED|Overall Study||1
8380303|NCT01107964|20656594|P2|COMPLETED|Overall Study||13
8380304|NCT01107964|20656595|P1|COMPLETED|Overall Study||12
8380305|NCT01107964|20656594|P2|STARTED|Overall Study||14
8380306|NCT01107964|20656595|P1|STARTED|Overall Study||13
8380307|NCT01107925|20656611|P6|NOT COMPLETED|Period 3||0
8380308|NCT01107925|20656612|P5|NOT COMPLETED|Period 3||0
8380309|NCT01107925|20656613|P4|NOT COMPLETED|Period 3||0
8380310|NCT01107925|20656614|P3|NOT COMPLETED|Period 3||0
8380311|NCT01107925|20656615|P2|NOT COMPLETED|Period 3||0
8380312|NCT01107925|20656616|P1|NOT COMPLETED|Period 3||0
8380313|NCT01107925|20656611|P6|COMPLETED|Period 3||20
8380314|NCT01107925|20656612|P5|COMPLETED|Period 3||0
8380315|NCT01107925|20656613|P4|COMPLETED|Period 3||16
8380316|NCT01107925|20656614|P3|COMPLETED|Period 3||15
8380317|NCT01107925|20656615|P2|COMPLETED|Period 3||17
8380318|NCT01107925|20656616|P1|COMPLETED|Period 3||0
8380319|NCT01107925|20656611|P6|Took at Least 1 Dose of Study Drug|Period 3||20
8380320|NCT01107925|20656612|P5|Took at Least 1 Dose of Study Drug|Period 3||0
8380321|NCT01107925|20656613|P4|Took at Least 1 Dose of Study Drug|Period 3||16
8380322|NCT01107925|20656614|P3|Took at Least 1 Dose of Study Drug|Period 3||15
8380323|NCT01107925|20656615|P2|Took at Least 1 Dose of Study Drug|Period 3||17
8380324|NCT01107925|20656616|P1|Took at Least 1 Dose of Study Drug|Period 3||0
8380325|NCT01107925|20656611|P6|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
8380326|NCT01107925|20656612|P5|STARTED|Period 3||0
8380327|NCT01107925|20656613|P4|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
8380328|NCT01107925|20656614|P3|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
8380329|NCT01107925|20656615|P2|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
8380330|NCT01107925|20656616|P1|STARTED|Period 3||0
8380331|NCT01107925|20656611|P6|NOT COMPLETED|Period 2||1
8380332|NCT01107925|20656612|P5|NOT COMPLETED|Period 2||0
8380333|NCT01107925|20656613|P4|NOT COMPLETED|Period 2||0
8380334|NCT01107925|20656614|P3|NOT COMPLETED|Period 2||0
8380335|NCT01107925|20656615|P2|NOT COMPLETED|Period 2||1
8380336|NCT01107925|20656616|P1|NOT COMPLETED|Period 2||0
8380337|NCT01107925|20656611|P6|COMPLETED|Period 2||16
8380338|NCT01107925|20656612|P5|COMPLETED|Period 2||0
8380339|NCT01107925|20656613|P4|COMPLETED|Period 2||20
8380340|NCT01107925|20656614|P3|COMPLETED|Period 2||17
8380341|NCT01107925|20656615|P2|COMPLETED|Period 2||15
8380342|NCT01107925|20656616|P1|COMPLETED|Period 2||0
8380343|NCT01107925|20656611|P6|Took at Least 1 Dose of Study Drug|Period 2||17
8380344|NCT01107925|20656612|P5|Took at Least 1 Dose of Study Drug|Period 2||0
8380345|NCT01107925|20656613|P4|Took at Least 1 Dose of Study Drug|Period 2||20
8380346|NCT01107925|20656614|P3|Took at Least 1 Dose of Study Drug|Period 2||17
8380347|NCT01107925|20656615|P2|Took at Least 1 Dose of Study Drug|Period 2||16
8380348|NCT01107925|20656616|P1|Took at Least 1 Dose of Study Drug|Period 2||0
8380349|NCT01107925|20656611|P6|STARTED|Period 2||17
8380350|NCT01107925|20656612|P5|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
8380351|NCT01107925|20656613|P4|STARTED|Period 2||20
8380352|NCT01107925|20656614|P3|STARTED|Period 2||17
8380353|NCT01107925|20656615|P2|STARTED|Period 2||16
8380354|NCT01107925|20656616|P1|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
8380355|NCT01107925|20656611|P6|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
8380356|NCT01107925|20656612|P5|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
8380357|NCT01107925|20656613|P4|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
8380358|NCT01107925|20656614|P3|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
8380359|NCT01107925|20656615|P2|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
8380360|NCT01107925|20656616|P1|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
8380361|NCT01107925|20656611|P6|COMPLETED|Period 1-Randomization up Through Day 12||0
8380362|NCT01107925|20656612|P5|COMPLETED|Period 1-Randomization up Through Day 12||37
8380363|NCT01107925|20656613|P4|COMPLETED|Period 1-Randomization up Through Day 12||0
8380364|NCT01107925|20656614|P3|COMPLETED|Period 1-Randomization up Through Day 12||0
8380365|NCT01107925|20656615|P2|COMPLETED|Period 1-Randomization up Through Day 12||0
8380366|NCT01107925|20656616|P1|COMPLETED|Period 1-Randomization up Through Day 12||33
8380367|NCT01107925|20656611|P6|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
8380368|NCT01107925|20656612|P5|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
8380369|NCT01107925|20656613|P4|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
8380370|NCT01107925|20656614|P3|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
8380371|NCT01107925|20656615|P2|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
8380372|NCT01107925|20656616|P1|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
8380373|NCT01107925|20656611|P6|STARTED|Period 1-Randomization up Through Day 12||0
8380374|NCT01107925|20656612|P5|STARTED|Period 1-Randomization up Through Day 12||38
8380375|NCT01107925|20656613|P4|STARTED|Period 1-Randomization up Through Day 12||0
8380376|NCT01107925|20656614|P3|STARTED|Period 1-Randomization up Through Day 12||0
8380377|NCT01107925|20656615|P2|STARTED|Period 1-Randomization up Through Day 12||0
8380378|NCT01107925|20656616|P1|STARTED|Period 1-Randomization up Through Day 12||34
8380379|NCT01107912|20656654|P6|NOT COMPLETED|Period 3||0
8380380|NCT01107912|20656655|P5|NOT COMPLETED|Period 3||0
8380381|NCT01107912|20656656|P4|NOT COMPLETED|Period 3||1
8380382|NCT01107912|20656657|P3|NOT COMPLETED|Period 3||1
8380383|NCT01107912|20656658|P2|NOT COMPLETED|Period 3||1
8380384|NCT01107912|20656659|P1|NOT COMPLETED|Period 3||0
8380385|NCT01107912|20656654|P6|COMPLETED|Period 3||41
8380386|NCT01107912|20656655|P5|COMPLETED|Period 3||0
8380387|NCT01107912|20656656|P4|COMPLETED|Period 3||37
8380388|NCT01107912|20656657|P3|COMPLETED|Period 3||35
8380389|NCT01107912|20656658|P2|COMPLETED|Period 3||34
8380390|NCT01107912|20656659|P1|COMPLETED|Period 3||0
8380391|NCT01107912|20656654|P6|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
8380392|NCT01107912|20656655|P5|STARTED|Period 3||0
8380393|NCT01107912|20656656|P4|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
8380394|NCT01107912|20656657|P3|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
8380395|NCT01107912|20656658|P2|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
8380396|NCT01107912|20656659|P1|STARTED|Period 3||0
8380397|NCT01107912|20656654|P6|NOT COMPLETED|Period 2||0
8380398|NCT01107912|20656655|P5|NOT COMPLETED|Period 2||0
8380399|NCT01107912|20656656|P4|NOT COMPLETED|Period 2||0
8380400|NCT01107912|20656657|P3|NOT COMPLETED|Period 2||1
8380401|NCT01107912|20656658|P2|NOT COMPLETED|Period 2||0
8380402|NCT01107912|20656659|P1|NOT COMPLETED|Period 2||0
8380403|NCT01107912|20656654|P6|COMPLETED|Period 2||38
8380404|NCT01107912|20656655|P5|COMPLETED|Period 2||0
8380405|NCT01107912|20656656|P4|COMPLETED|Period 2||41
8380406|NCT01107912|20656657|P3|COMPLETED|Period 2||35
8380407|NCT01107912|20656658|P2|COMPLETED|Period 2||36
8380408|NCT01107912|20656659|P1|COMPLETED|Period 2||0
8380409|NCT01107912|20656654|P6|STARTED|Period 2||38
8380410|NCT01107912|20656655|P5|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
8380411|NCT01107912|20656656|P4|STARTED|Period 2||41
8380412|NCT01107912|20656657|P3|STARTED|Period 2||36
8380413|NCT01107912|20656658|P2|STARTED|Period 2||36
8380414|NCT01107912|20656659|P1|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
8380415|NCT01107912|20656654|P6|NOT COMPLETED|Period 1||0
8380416|NCT01107912|20656655|P5|NOT COMPLETED|Period 1||3
8380417|NCT01107912|20656656|P4|NOT COMPLETED|Period 1||0
8380418|NCT01107912|20656657|P3|NOT COMPLETED|Period 1||0
8380419|NCT01107912|20656658|P2|NOT COMPLETED|Period 1||0
8380420|NCT01107912|20656659|P1|NOT COMPLETED|Period 1||1
8380421|NCT01107912|20656654|P6|COMPLETED|Period 1||0
8380422|NCT01107912|20656655|P5|COMPLETED|Period 1||79
8380423|NCT01107912|20656656|P4|COMPLETED|Period 1||0
8380424|NCT01107912|20656657|P3|COMPLETED|Period 1||0
8380425|NCT01107912|20656658|P2|COMPLETED|Period 1||0
8380426|NCT01107912|20656659|P1|COMPLETED|Period 1||72
8380427|NCT01107912|20656654|P6|Received at Least 1 Dose of Study Drug|Period 1||0
8380428|NCT01107912|20656655|P5|Received at Least 1 Dose of Study Drug|Period 1||82
8380429|NCT01107912|20656656|P4|Received at Least 1 Dose of Study Drug|Period 1||0
8380430|NCT01107912|20656657|P3|Received at Least 1 Dose of Study Drug|Period 1||0
8380431|NCT01107912|20656658|P2|Received at Least 1 Dose of Study Drug|Period 1||0
8380432|NCT01107912|20656659|P1|Received at Least 1 Dose of Study Drug|Period 1||73
8380433|NCT01107912|20656654|P6|STARTED|Period 1||0
8380434|NCT01107912|20656655|P5|STARTED|Period 1||82
8380435|NCT01107912|20656656|P4|STARTED|Period 1||0
8380436|NCT01107912|20656657|P3|STARTED|Period 1||0
8380437|NCT01107912|20656658|P2|STARTED|Period 1||0
8380438|NCT01107912|20656659|P1|STARTED|Period 1||73
8380439|NCT01107899|20656696|P3|NOT COMPLETED|Overall Study||4
8380440|NCT01107899|20656697|P2|NOT COMPLETED|Overall Study||0
8380441|NCT01107899|20656698|P1|NOT COMPLETED|Overall Study||5
8380442|NCT01107899|20656696|P3|COMPLETED|Overall Study||5
8380443|NCT01107899|20656697|P2|COMPLETED|Overall Study||10
8380444|NCT01107899|20656698|P1|COMPLETED|Overall Study||5
8380445|NCT01107899|20656696|P3|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
8380446|NCT01107899|20656697|P2|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
8380447|NCT01107899|20656698|P1|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
8380448|NCT01107899|20656696|P3|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
8380449|NCT01107899|20656697|P2|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
8380450|NCT01107899|20656698|P1|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
8380451|NCT01107899|20656696|P3|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
8380452|NCT01107899|20656697|P2|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
8380453|NCT01107899|20656698|P1|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
8380454|NCT01107899|20656696|P3|Received at Least One Dose of Study Drug|Overall Study||8
8380455|NCT01107899|20656697|P2|Received at Least One Dose of Study Drug|Overall Study||10
8380456|NCT01107899|20656698|P1|Received at Least One Dose of Study Drug|Overall Study||10
8380457|NCT01107899|20656696|P3|STARTED|Overall Study||9
8380458|NCT01107899|20656697|P2|STARTED|Overall Study||10
8380459|NCT01107899|20656698|P1|STARTED|Overall Study||10
8380460|NCT01107886|20656744|P2|NOT COMPLETED|Overall Study||214
8380461|NCT01107886|20656745|P1|NOT COMPLETED|Overall Study||202
8380462|NCT01107886|20656744|P2|COMPLETED|Overall Study|Completed subjects|7998
8380463|NCT01107886|20656745|P1|COMPLETED|Overall Study|Completed subjects|8078
8380464|NCT01107886|20656744|P2|STARTED|Overall Study|Randomized subjects|8212
8380465|NCT01107886|20656745|P1|STARTED|Overall Study|Randomized subjects|8280
8380466|NCT01107834|20656757|P2|NOT COMPLETED|Overall Study||0
8380467|NCT01107834|20656758|P1|NOT COMPLETED|Overall Study||0
8380468|NCT01107834|20656757|P2|COMPLETED|Overall Study||30
8380469|NCT01107834|20656758|P1|COMPLETED|Overall Study||30
8380470|NCT01107834|20656757|P2|STARTED|Overall Study||30
8380471|NCT01107834|20656758|P1|STARTED|Overall Study||30
8380472|NCT01107795|20656774|P1|NOT COMPLETED|Overall Study||0
8380473|NCT01107795|20656774|P1|COMPLETED|Overall Study||41
8380474|NCT01107795|20656774|P1|STARTED|Overall Study||41
8380475|NCT01107730|20656781|P3|NOT COMPLETED|Overall Study||0
8380476|NCT01107730|20656782|P2|NOT COMPLETED|Overall Study||0
8380477|NCT01107730|20656783|P1|NOT COMPLETED|Overall Study||0
8380478|NCT01107730|20656781|P3|COMPLETED|Overall Study||11
8380479|NCT01107730|20656782|P2|COMPLETED|Overall Study||11
8380480|NCT01107730|20656783|P1|COMPLETED|Overall Study||11
8380481|NCT01107730|20656781|P3|STARTED|Overall Study||11
8380482|NCT01107730|20656782|P2|STARTED|Overall Study||11
8380483|NCT01107730|20656783|P1|STARTED|Overall Study||11
8380484|NCT01107665|20656791|P1|NOT COMPLETED|Overall Study||49
8380485|NCT01107665|20656791|P1|COMPLETED|Overall Study||11
8380486|NCT01107665|20656791|P1|STARTED|Overall Study||60
8380487|NCT01107535|20656806|P1|NOT COMPLETED|Overall Study||5
8380488|NCT01107535|20656806|P1|COMPLETED|Overall Study||77
8380489|NCT01107535|20656806|P1|Number of Participants Analyzed|Overall Study||82
8380490|NCT01107535|20656806|P1|STARTED|Overall Study||82
8380491|NCT01107457|20656819|P6|NOT COMPLETED|Part B and C||120
8380492|NCT01107457|20656820|P5|NOT COMPLETED|Part B and C||0
8380493|NCT01107457|20656821|P4|NOT COMPLETED|Part B and C||0
8380494|NCT01107457|20656822|P3|NOT COMPLETED|Part B and C||0
8380495|NCT01107457|20656823|P2|NOT COMPLETED|Part B and C||0
8380496|NCT01107457|20656824|P1|NOT COMPLETED|Part B and C||0
8380497|NCT01107457|20656819|P6|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
8380498|NCT01107457|20656820|P5|COMPLETED|Part B and C||0
8380499|NCT01107457|20656821|P4|COMPLETED|Part B and C||0
8380500|NCT01107457|20656822|P3|COMPLETED|Part B and C||0
8380501|NCT01107457|20656823|P2|COMPLETED|Part B and C||0
8380502|NCT01107457|20656824|P1|COMPLETED|Part B and C||0
8380503|NCT01107457|20656819|P6|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
8380504|NCT01107457|20656820|P5|Post Treatment Safety Visits|Part B and C||0
8380505|NCT01107457|20656821|P4|Post Treatment Safety Visits|Part B and C||0
8380506|NCT01107457|20656822|P3|Post Treatment Safety Visits|Part B and C||0
8380507|NCT01107457|20656823|P2|Post Treatment Safety Visits|Part B and C||0
8380508|NCT01107457|20656824|P1|Post Treatment Safety Visits|Part B and C||0
8380509|NCT01107457|20656819|P6|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
8380510|NCT01107457|20656820|P5|Completed Part C|Part B and C||0
8380511|NCT01107457|20656821|P4|Completed Part C|Part B and C||0
8380512|NCT01107457|20656822|P3|Completed Part C|Part B and C||0
8380513|NCT01107457|20656823|P2|Completed Part C|Part B and C||0
8380514|NCT01107457|20656824|P1|Completed Part C|Part B and C||0
8380515|NCT01107457|20656819|P6|Completed Part B (Week 240)|Part B and C||74
8380516|NCT01107457|20656820|P5|Completed Part B (Week 240)|Part B and C||0
8380517|NCT01107457|20656821|P4|Completed Part B (Week 240)|Part B and C||0
8380518|NCT01107457|20656822|P3|Completed Part B (Week 240)|Part B and C||0
8380519|NCT01107457|20656823|P2|Completed Part B (Week 240)|Part B and C||0
8380520|NCT01107457|20656824|P1|Completed Part B (Week 240)|Part B and C||0
8380521|NCT01107457|20656819|P6|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
8380522|NCT01107457|20656820|P5|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8380523|NCT01107457|20656821|P4|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8380524|NCT01107457|20656822|P3|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8380525|NCT01107457|20656823|P2|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8380526|NCT01107457|20656824|P1|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
8380527|NCT01107457|20656819|P6|NOT COMPLETED|Part A||0
8380528|NCT01107457|20656820|P5|NOT COMPLETED|Part A||1
8380529|NCT01107457|20656821|P4|NOT COMPLETED|Part A||3
8380530|NCT01107457|20656822|P3|NOT COMPLETED|Part A||1
8380531|NCT01107457|20656823|P2|NOT COMPLETED|Part A||7
8380532|NCT01107457|20656824|P1|NOT COMPLETED|Part A||5
8380533|NCT01107457|20656819|P6|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
8380534|NCT01107457|20656820|P5|COMPLETED|Part A||27
8380535|NCT01107457|20656821|P4|COMPLETED|Part A||26
8380536|NCT01107457|20656822|P3|COMPLETED|Part A||29
8380537|NCT01107457|20656823|P2|COMPLETED|Part A||21
8380538|NCT01107457|20656824|P1|COMPLETED|Part A||22
8380539|NCT01107457|20656819|P6|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
8380540|NCT01107457|20656820|P5|Received at Least 1 Dose of Study Drug|Part A||28
8380541|NCT01107457|20656821|P4|Received at Least 1 Dose of Study Drug|Part A||29
8380542|NCT01107457|20656822|P3|Received at Least 1 Dose of Study Drug|Part A||30
8380543|NCT01107457|20656823|P2|Received at Least 1 Dose of Study Drug|Part A||28
8380544|NCT01107457|20656824|P1|Received at Least 1 Dose of Study Drug|Part A||27
8380545|NCT01107457|20656819|P6|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
8380546|NCT01107457|20656820|P5|STARTED|Part A||28
8380547|NCT01107457|20656821|P4|STARTED|Part A||29
8380548|NCT01107457|20656822|P3|STARTED|Part A||30
8380549|NCT01107457|20656823|P2|STARTED|Part A||28
8380550|NCT01107457|20656824|P1|STARTED|Part A||27
8380551|NCT01107444|20656952|P2|NOT COMPLETED|Overall Study||13
8380552|NCT01107444|20656953|P1|NOT COMPLETED|Overall Study||8
8380553|NCT01107444|20656952|P2|COMPLETED|Overall Study||47
8380554|NCT01107444|20656953|P1|COMPLETED|Overall Study||112
8380555|NCT01107444|20656952|P2|Received At Least 1 Dose of Study Drug|Overall Study||48
8380556|NCT01107444|20656953|P1|Received At Least 1 Dose of Study Drug|Overall Study||114
8380557|NCT01107444|20656952|P2|STARTED|Overall Study||60
8380558|NCT01107444|20656953|P1|STARTED|Overall Study||120
8380559|NCT01107418|20656987|P1|NOT COMPLETED|Overall Study||52
8380560|NCT01107418|20656987|P1|COMPLETED|Overall Study||0
8380561|NCT01107418|20656987|P1|STARTED|Overall Study||52
8380562|NCT01107405|20657060|P5|NOT COMPLETED|Overall Study||3
8380563|NCT01107405|20657061|P4|NOT COMPLETED|Overall Study||3
8380564|NCT01107405|20657062|P3|NOT COMPLETED|Overall Study||2
8380565|NCT01107405|20657063|P2|NOT COMPLETED|Overall Study||1
8380566|NCT01107405|20657064|P1|NOT COMPLETED|Overall Study||2
8380567|NCT01107405|20657060|P5|COMPLETED|Overall Study||17
8380568|NCT01107405|20657061|P4|COMPLETED|Overall Study||17
8380569|NCT01107405|20657062|P3|COMPLETED|Overall Study||18
8380570|NCT01107405|20657063|P2|COMPLETED|Overall Study||19
8380571|NCT01107405|20657064|P1|COMPLETED|Overall Study||19
8380572|NCT01107405|20657060|P5|STARTED|Overall Study||20
8380573|NCT01107405|20657061|P4|STARTED|Overall Study||20
8380574|NCT01107405|20657062|P3|STARTED|Overall Study||20
8380575|NCT01107405|20657063|P2|STARTED|Overall Study||20
8380576|NCT01107405|20657064|P1|STARTED|Overall Study||21
8380577|NCT01107392|20657103|P2|NOT COMPLETED|Overall Study||3
8380578|NCT01107392|20657104|P1|NOT COMPLETED|Overall Study||5
8380579|NCT01107392|20657103|P2|COMPLETED|Overall Study||154
8380580|NCT01107392|20657104|P1|COMPLETED|Overall Study||153
8380581|NCT01107392|20657103|P2|STARTED|Overall Study||157
8380582|NCT01107392|20657104|P1|STARTED|Overall Study||158
8380583|NCT01107379|20657116|P1|NOT COMPLETED|Overall Study||21
8380584|NCT01107379|20657116|P1|COMPLETED|Overall Study||182
8380585|NCT01107379|20657116|P1|STARTED|Overall Study||203
8380586|NCT01107353|20657127|P2|NOT COMPLETED|Overall Study||0
8380587|NCT01107353|20657128|P1|NOT COMPLETED|Overall Study||1
8380588|NCT01107353|20657127|P2|COMPLETED|Overall Study||20
8380589|NCT01107353|20657128|P1|COMPLETED|Overall Study||19
8380590|NCT01107353|20657127|P2|STARTED|Overall Study||20
8380591|NCT01107353|20657128|P1|STARTED|Overall Study||20
8380592|NCT01107197|20657136|P2|NOT COMPLETED|Overall Study||23
8380593|NCT01107197|20657137|P1|NOT COMPLETED|Overall Study||20
8380594|NCT01107197|20657136|P2|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
8380595|NCT01107197|20657137|P1|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
8380596|NCT01107197|20657136|P2|STARTED|Overall Study||101
8380597|NCT01107197|20657137|P1|STARTED|Overall Study||99
8380598|NCT01107015|20657159|P4|NOT COMPLETED|Overall Study||18
8380599|NCT01107015|20657160|P3|NOT COMPLETED|Overall Study||11
8380600|NCT01107015|20657161|P2|NOT COMPLETED|Overall Study||15
8380601|NCT01107015|20657162|P1|NOT COMPLETED|Overall Study||6
8380602|NCT01107015|20657159|P4|COMPLETED|Overall Study||62
8380603|NCT01107015|20657160|P3|COMPLETED|Overall Study||22
8380604|NCT01107015|20657161|P2|COMPLETED|Overall Study||23
8380605|NCT01107015|20657162|P1|COMPLETED|Overall Study||56
8380606|NCT01107015|20657159|P4|STARTED|Overall Study||80
8380607|NCT01107015|20657160|P3|STARTED|Overall Study||33
8380608|NCT01107015|20657161|P2|STARTED|Overall Study||38
8380609|NCT01107015|20657162|P1|STARTED|Overall Study||62
8380610|NCT01106976|20657172|P1|NOT COMPLETED|Overall Study||8
8380611|NCT01106976|20657172|P1|COMPLETED|Overall Study||59
8380612|NCT01106976|20657172|P1|STARTED|Overall Study||67
8380613|NCT01106950|20657176|P1|NOT COMPLETED|Overall Study||0
8380614|NCT01106950|20657176|P1|COMPLETED|Overall Study||15
8380615|NCT01106950|20657176|P1|STARTED|Overall Study||15
8380616|NCT01106911|20657186|P1|NOT COMPLETED|Overall Study||5
8380617|NCT01106911|20657186|P1|COMPLETED|Overall Study||1080
8380618|NCT01106911|20657186|P1|STARTED|Overall Study||1085
8380619|NCT01106898|20657190|P1|NOT COMPLETED|Overall Study||6
8380620|NCT01106898|20657190|P1|COMPLETED|Overall Study||94
8380621|NCT01106898|20657190|P1|STARTED|Overall Study||100
8380622|NCT01106859|20657194|P1|NOT COMPLETED|Overall Study||0
8380623|NCT01106859|20657194|P1|COMPLETED|Overall Study||40
8380624|NCT01106859|20657194|P1|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
8380625|NCT01106846|20657235|P2|NOT COMPLETED|Overall Study||1
8380626|NCT01106846|20657236|P1|NOT COMPLETED|Overall Study||0
8380627|NCT01106846|20657235|P2|COMPLETED|Overall Study||9
8380628|NCT01106846|20657236|P1|COMPLETED|Overall Study||12
8380629|NCT01106846|20657235|P2|STARTED|Overall Study||10
8380630|NCT01106846|20657236|P1|STARTED|Overall Study||12
8380631|NCT01106833|20657244|P2|NOT COMPLETED|Overall Study||0
8380632|NCT01106833|20657245|P1|NOT COMPLETED|Overall Study||0
8380633|NCT01106833|20657244|P2|COMPLETED|Overall Study||77
8380634|NCT01106833|20657245|P1|COMPLETED|Overall Study||74
8380635|NCT01106833|20657244|P2|STARTED|Overall Study||77
8380636|NCT01106833|20657245|P1|STARTED|Overall Study||74
8380637|NCT01106690|20657286|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
8380638|NCT01106690|20657287|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
8380639|NCT01106690|20657288|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
8380640|NCT01106690|20657286|P3|COMPLETED|Extension Period: Week 26 to Week 52||89
8380641|NCT01106690|20657287|P2|COMPLETED|Extension Period: Week 26 to Week 52||96
8380642|NCT01106690|20657288|P1|COMPLETED|Extension Period: Week 26 to Week 52||78
8380643|NCT01106690|20657286|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
8380644|NCT01106690|20657287|P2|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
8380645|NCT01106690|20657288|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
8380646|NCT01106690|20657286|P3|NOT COMPLETED|Core Period: Baseline to Week 26||13
8380647|NCT01106690|20657287|P2|NOT COMPLETED|Core Period: Baseline to Week 26||9
8380648|NCT01106690|20657288|P1|NOT COMPLETED|Core Period: Baseline to Week 26||24
8380649|NCT01106690|20657286|P3|COMPLETED|Core Period: Baseline to Week 26||101
8380650|NCT01106690|20657287|P2|COMPLETED|Core Period: Baseline to Week 26||104
8380651|NCT01106690|20657288|P1|COMPLETED|Core Period: Baseline to Week 26||91
8380652|NCT01106690|20657286|P3|STARTED|Core Period: Baseline to Week 26||114
8380653|NCT01106690|20657287|P2|STARTED|Core Period: Baseline to Week 26||113
8380654|NCT01106690|20657288|P1|STARTED|Core Period: Baseline to Week 26||115
8380655|NCT01106677|20657324|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
8380656|NCT01106677|20657325|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
8380657|NCT01106677|20657326|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
8380658|NCT01106677|20657327|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
8380659|NCT01106677|20657324|P4|COMPLETED|Extension Period: Week 26 to Week 52||285
8380660|NCT01106677|20657325|P3|COMPLETED|Extension Period: Week 26 to Week 52||299
8380661|NCT01106677|20657326|P2|COMPLETED|Extension Period: Week 26 to Week 52||298
8380662|NCT01106677|20657327|P1|COMPLETED|Extension Period: Week 26 to Week 52||138
8380663|NCT01106677|20657324|P4|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
8380664|NCT01106677|20657325|P3|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
8380665|NCT01106677|20657326|P2|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
8380666|NCT01106677|20657327|P1|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
8380667|NCT01106677|20657324|P4|NOT COMPLETED|Core Period: Baseline to Week 26||47
8380668|NCT01106677|20657325|P3|NOT COMPLETED|Core Period: Baseline to Week 26||44
8380669|NCT01106677|20657326|P2|NOT COMPLETED|Core Period: Baseline to Week 26||46
8380670|NCT01106677|20657327|P1|NOT COMPLETED|Core Period: Baseline to Week 26||28
8380671|NCT01106677|20657324|P4|COMPLETED|Core Period: Baseline to Week 26||319
8380672|NCT01106677|20657325|P3|COMPLETED|Core Period: Baseline to Week 26||323
8380673|NCT01106677|20657326|P2|COMPLETED|Core Period: Baseline to Week 26||322
8380674|NCT01106677|20657327|P1|COMPLETED|Core Period: Baseline to Week 26||155
8380675|NCT01106677|20657324|P4|STARTED|Core Period: Baseline to Week 26||366
8380676|NCT01106677|20657325|P3|STARTED|Core Period: Baseline to Week 26||367
8380677|NCT01106677|20657326|P2|STARTED|Core Period: Baseline to Week 26||368
8380678|NCT01106677|20657327|P1|STARTED|Core Period: Baseline to Week 26||183
8380679|NCT01106651|20657390|P3|NOT COMPLETED|Overall Study||58
8380680|NCT01106651|20657391|P2|NOT COMPLETED|Overall Study||57
8380681|NCT01106651|20657392|P1|NOT COMPLETED|Overall Study||79
8380682|NCT01106651|20657390|P3|COMPLETED|Overall Study||178
8380683|NCT01106651|20657391|P2|COMPLETED|Overall Study||184
8380684|NCT01106651|20657392|P1|COMPLETED|Overall Study||158
8380685|NCT01106651|20657390|P3|STARTED|Overall Study||236
8380686|NCT01106651|20657391|P2|STARTED|Overall Study||241
8380687|NCT01106651|20657392|P1|STARTED|Overall Study||237
8380688|NCT01106625|20657445|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
8380689|NCT01106625|20657446|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
8380690|NCT01106625|20657447|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
8380691|NCT01106625|20657445|P3|COMPLETED|Extension Period: Week 26 to Week 52||111
8380692|NCT01106625|20657446|P2|COMPLETED|Extension Period: Week 26 to Week 52||109
8380693|NCT01106625|20657447|P1|COMPLETED|Extension Period: Week 26 to Week 52||90
8380694|NCT01106625|20657445|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
8380695|NCT01106625|20657446|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
8380696|NCT01106625|20657447|P1|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
8380697|NCT01106625|20657445|P3|NOT COMPLETED|Core Period: Baseline to Week 26||27
8380698|NCT01106625|20657446|P2|NOT COMPLETED|Core Period: Baseline to Week 26||28
8380699|NCT01106625|20657447|P1|NOT COMPLETED|Core Period: Baseline to Week 26||33
8380700|NCT01106625|20657445|P3|COMPLETED|Core Period: Baseline to Week 26||129
8380701|NCT01106625|20657446|P2|COMPLETED|Core Period: Baseline to Week 26||129
8380702|NCT01106625|20657447|P1|COMPLETED|Core Period: Baseline to Week 26||123
8380703|NCT01106625|20657445|P3|STARTED|Core Period: Baseline to Week 26||156
8380704|NCT01106625|20657446|P2|STARTED|Core Period: Baseline to Week 26||157
8380705|NCT01106625|20657447|P1|STARTED|Core Period: Baseline to Week 26||156
8380706|NCT01106586|20657478|P2|NOT COMPLETED|Overall Study||285
8380707|NCT01106586|20657479|P1|NOT COMPLETED|Overall Study||285
8380708|NCT01106586|20657478|P2|COMPLETED|Overall Study||70
8380709|NCT01106586|20657479|P1|COMPLETED|Overall Study||68
8380710|NCT01106586|20657478|P2|STARTED|Overall Study||355
8380711|NCT01106586|20657479|P1|STARTED|Overall Study||353
8380712|NCT01106534|20657497|P1|NOT COMPLETED|Overall Study||37
8380713|NCT01106534|20657497|P1|COMPLETED|Overall Study||2960
8380714|NCT01106534|20657497|P1|STARTED|Overall Study||2997
8380715|NCT01106456|20657520|P2|NOT COMPLETED|Overall Study||124
8380716|NCT01106456|20657521|P1|NOT COMPLETED|Overall Study||103
8380717|NCT01106456|20657520|P2|COMPLETED|Overall Study||96
8380718|NCT01106456|20657521|P1|COMPLETED|Overall Study||140
8380719|NCT01106456|20657520|P2|STARTED|Overall Study||220
8380720|NCT01106456|20657521|P1|STARTED|Overall Study||243
8380727|NCT01106404|20657552|P2|NOT COMPLETED|Period II (Second 6 Weeks)||0
8380728|NCT01106404|20657553|P1|NOT COMPLETED|Period II (Second 6 Weeks)||0
8380729|NCT01106404|20657552|P2|COMPLETED|Period II (Second 6 Weeks)||38
8380730|NCT01106404|20657553|P1|COMPLETED|Period II (Second 6 Weeks)||33
8380731|NCT01106404|20657552|P2|STARTED|Period II (Second 6 Weeks)||38
8380732|NCT01106404|20657553|P1|STARTED|Period II (Second 6 Weeks)||33
8380733|NCT01106404|20657552|P2|NOT COMPLETED|Period I (First 6 Weeks)||2
8380734|NCT01106404|20657553|P1|NOT COMPLETED|Period I (First 6 Weeks)||3
8380735|NCT01106404|20657552|P2|COMPLETED|Period I (First 6 Weeks)||38
8380736|NCT01106404|20657553|P1|COMPLETED|Period I (First 6 Weeks)||33
8380737|NCT01106404|20657552|P2|STARTED|Period I (First 6 Weeks)||40
8380738|NCT01106404|20657553|P1|STARTED|Period I (First 6 Weeks)||36
8380739|NCT01106391|20657566|P1|NOT COMPLETED|Overall Study||0
8380740|NCT01106391|20657566|P1|COMPLETED|Overall Study||60
8380741|NCT01106391|20657566|P1|STARTED|Overall Study||60
8380742|NCT01106352|20657576|P5|NOT COMPLETED|Overall Study||8
8380743|NCT01106352|20657577|P4|NOT COMPLETED|Overall Study||13
8380744|NCT01106352|20657578|P3|NOT COMPLETED|Overall Study||2
8380745|NCT01106352|20657579|P2|NOT COMPLETED|Overall Study||0
8380746|NCT01106352|20657580|P1|NOT COMPLETED|Overall Study||1
8380747|NCT01106352|20657576|P5|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
8380748|NCT01106352|20657577|P4|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
8380749|NCT01106352|20657578|P3|COMPLETED|Overall Study||5
8380750|NCT01106352|20657579|P2|COMPLETED|Overall Study||3
8380751|NCT01106352|20657580|P1|COMPLETED|Overall Study||6
8380752|NCT01106352|20657576|P5|Completed Safety Cohort|Overall Study||9
8380753|NCT01106352|20657577|P4|Completed Safety Cohort|Overall Study||23
8380754|NCT01106352|20657578|P3|Completed Safety Cohort|Overall Study||0
8380755|NCT01106352|20657579|P2|Completed Safety Cohort|Overall Study||0
8380756|NCT01106352|20657580|P1|Completed Safety Cohort|Overall Study||0
8380757|NCT01106352|20657576|P5|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
8380758|NCT01106352|20657577|P4|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
8380759|NCT01106352|20657578|P3|Treated Safety Cohort|Overall Study||0
8380760|NCT01106352|20657579|P2|Treated Safety Cohort|Overall Study||0
8380761|NCT01106352|20657580|P1|Treated Safety Cohort|Overall Study||0
8380762|NCT01106352|20657576|P5|Started Safety Cohort|Overall Study||17
8380763|NCT01106352|20657577|P4|Started Safety Cohort|Overall Study||36
8380764|NCT01106352|20657578|P3|Started Safety Cohort|Overall Study||0
8380765|NCT01106352|20657579|P2|Started Safety Cohort|Overall Study||0
8380766|NCT01106352|20657580|P1|Started Safety Cohort|Overall Study||0
8380767|NCT01106352|20657576|P5|Completed Dose Escalation|Overall Study||0
8380768|NCT01106352|20657577|P4|Completed Dose Escalation|Overall Study||0
8380769|NCT01106352|20657578|P3|Completed Dose Escalation|Overall Study||5
8380770|NCT01106352|20657579|P2|Completed Dose Escalation|Overall Study||3
8380771|NCT01106352|20657580|P1|Completed Dose Escalation|Overall Study||6
8380772|NCT01106352|20657576|P5|Started Dose Escalation|Overall Study||0
8380773|NCT01106352|20657577|P4|Started Dose Escalation|Overall Study||0
8380774|NCT01106352|20657578|P3|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
8380775|NCT01106352|20657579|P2|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
8380776|NCT01106352|20657580|P1|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
8380777|NCT01106352|20657576|P5|STARTED|Overall Study||17
8380778|NCT01106352|20657577|P4|STARTED|Overall Study||36
8380779|NCT01106352|20657578|P3|STARTED|Overall Study||7
8380780|NCT01106352|20657579|P2|STARTED|Overall Study||3
8380781|NCT01106352|20657580|P1|STARTED|Overall Study||7
8380782|NCT01106326|20657666|P1|NOT COMPLETED|Overall Study||2
8380783|NCT01106326|20657666|P1|COMPLETED|Overall Study||28
8380784|NCT01106326|20657666|P1|STARTED|Overall Study||30
8380785|NCT01106287|20657676|P4|NOT COMPLETED|Overall Study||0
8380786|NCT01106287|20657677|P3|NOT COMPLETED|Overall Study||0
8380787|NCT01106287|20657678|P2|NOT COMPLETED|Overall Study||0
8380788|NCT01106287|20657679|P1|NOT COMPLETED|Overall Study||1
8380789|NCT01106287|20657676|P4|COMPLETED|Overall Study||3
8380790|NCT01106287|20657677|P3|COMPLETED|Overall Study||3
8380791|NCT01106287|20657678|P2|COMPLETED|Overall Study||3
8380792|NCT01106287|20657679|P1|COMPLETED|Overall Study||3
8380793|NCT01106287|20657676|P4|STARTED|Overall Study||3
8380794|NCT01106287|20657677|P3|STARTED|Overall Study||3
8380795|NCT01106287|20657678|P2|STARTED|Overall Study||3
8380796|NCT01106287|20657679|P1|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
8380797|NCT01106248|20657699|P1|NOT COMPLETED|Overall Study||3
8380798|NCT01106248|20657699|P1|COMPLETED|Overall Study||23
8380799|NCT01106248|20657699|P1|STARTED|Overall Study||26
8380800|NCT01106157|20657707|P2|NOT COMPLETED|Overall Study||0
8380801|NCT01106157|20657708|P1|NOT COMPLETED|Overall Study||1
8380802|NCT01106157|20657707|P2|COMPLETED|Overall Study||8
8380803|NCT01106157|20657708|P1|COMPLETED|Overall Study||16
8380804|NCT01106157|20657707|P2|STARTED|Overall Study||8
8380805|NCT01106157|20657708|P1|STARTED|Overall Study||17
8380806|NCT01106092|20657736|P4|NOT COMPLETED|Overall Study||1
8380807|NCT01106092|20657737|P3|NOT COMPLETED|Overall Study||0
8380808|NCT01106092|20657738|P2|NOT COMPLETED|Overall Study||0
8380809|NCT01106092|20657739|P1|NOT COMPLETED|Overall Study||0
8380810|NCT01106092|20657736|P4|COMPLETED|Overall Study||77
8380811|NCT01106092|20657737|P3|COMPLETED|Overall Study||78
8380812|NCT01106092|20657738|P2|COMPLETED|Overall Study||78
8380813|NCT01106092|20657739|P1|COMPLETED|Overall Study||78
8380814|NCT01106092|20657736|P4|STARTED|Overall Study||78
8380815|NCT01106092|20657737|P3|STARTED|Overall Study||78
8380816|NCT01106092|20657738|P2|STARTED|Overall Study||78
8380817|NCT01106092|20657739|P1|STARTED|Overall Study||78
8380818|NCT01106040|20657817|P1|NOT COMPLETED|Overall Study||11
8380819|NCT01106040|20657817|P1|COMPLETED|Overall Study||152
8380820|NCT01106040|20657817|P1|STARTED|Overall Study||163
8380821|NCT01106027|20657822|P1|NOT COMPLETED|Overall Study||1
8380822|NCT01106027|20657822|P1|COMPLETED|Overall Study||1
8380823|NCT01106027|20657822|P1|STARTED|Overall Study||2
8380824|NCT01106014|20657828|P2|NOT COMPLETED|Overall Study||330
8380825|NCT01106014|20657829|P1|NOT COMPLETED|Overall Study||285
8380826|NCT01106014|20657828|P2|COMPLETED|Overall Study||252
8380827|NCT01106014|20657829|P1|COMPLETED|Overall Study||289
8380828|NCT01106014|20657828|P2|STARTED|Overall Study||582
8380829|NCT01106014|20657829|P1|STARTED|Overall Study||574
8380830|NCT01105975|20657849|P10|NOT COMPLETED|Overall Study||9
8380831|NCT01105975|20657850|P9|NOT COMPLETED|Overall Study||6
8380832|NCT01105975|20657851|P8|NOT COMPLETED|Overall Study||7
8380833|NCT01105975|20657852|P7|NOT COMPLETED|Overall Study||8
8380834|NCT01105975|20657853|P6|NOT COMPLETED|Overall Study||5
8380835|NCT01105975|20657854|P5|NOT COMPLETED|Overall Study||6
8380836|NCT01105975|20657855|P4|NOT COMPLETED|Overall Study||2
8380837|NCT01105975|20657856|P3|NOT COMPLETED|Overall Study||10
8380838|NCT01105975|20657857|P2|NOT COMPLETED|Overall Study||5
8380839|NCT01105975|20657858|P1|NOT COMPLETED|Overall Study||5
8380840|NCT01105975|20657849|P10|COMPLETED|Overall Study||32
8380841|NCT01105975|20657850|P9|COMPLETED|Overall Study||34
8380842|NCT01105975|20657851|P8|COMPLETED|Overall Study||33
8380843|NCT01105975|20657852|P7|COMPLETED|Overall Study||34
8380844|NCT01105975|20657853|P6|COMPLETED|Overall Study||30
8380845|NCT01105975|20657854|P5|COMPLETED|Overall Study||35
8380846|NCT01105975|20657855|P4|COMPLETED|Overall Study||36
8380847|NCT01105975|20657856|P3|COMPLETED|Overall Study||32
8380848|NCT01105975|20657857|P2|COMPLETED|Overall Study||34
8380849|NCT01105975|20657858|P1|COMPLETED|Overall Study||35
8380850|NCT01105975|20657849|P10|Took at Least One Dose of Study Drug|Overall Study||41
8380851|NCT01105975|20657850|P9|Took at Least One Dose of Study Drug|Overall Study||39
8380852|NCT01105975|20657851|P8|Took at Least One Dose of Study Drug|Overall Study||40
8380853|NCT01105975|20657852|P7|Took at Least One Dose of Study Drug|Overall Study||41
8380854|NCT01105975|20657853|P6|Took at Least One Dose of Study Drug|Overall Study||35
8380855|NCT01105975|20657854|P5|Took at Least One Dose of Study Drug|Overall Study||41
8380856|NCT01105975|20657855|P4|Took at Least One Dose of Study Drug|Overall Study||38
8380857|NCT01105975|20657856|P3|Took at Least One Dose of Study Drug|Overall Study||40
8380858|NCT01105975|20657857|P2|Took at Least One Dose of Study Drug|Overall Study||38
8380859|NCT01105975|20657858|P1|Took at Least One Dose of Study Drug|Overall Study||40
8380860|NCT01105975|20657849|P10|STARTED|Overall Study||41
8380861|NCT01105975|20657850|P9|STARTED|Overall Study||40
8380862|NCT01105975|20657851|P8|STARTED|Overall Study||40
8380863|NCT01105975|20657852|P7|STARTED|Overall Study||42
8380864|NCT01105975|20657853|P6|STARTED|Overall Study||35
8380865|NCT01105975|20657854|P5|STARTED|Overall Study||41
8380866|NCT01105975|20657855|P4|STARTED|Overall Study||38
8380867|NCT01105975|20657856|P3|STARTED|Overall Study||42
8380868|NCT01105975|20657857|P2|STARTED|Overall Study||39
8380869|NCT01105975|20657858|P1|STARTED|Overall Study||40
8380870|NCT01105936|20658006|P4|NOT COMPLETED|Period 3||0
8380871|NCT01105936|20658007|P3|NOT COMPLETED|Period 3||0
8380872|NCT01105936|20658008|P2|NOT COMPLETED|Period 3||2
8380873|NCT01105936|20658009|P1|NOT COMPLETED|Period 3||0
8380874|NCT01105936|20658006|P4|COMPLETED|Period 3||7
8380875|NCT01105936|20658007|P3|COMPLETED|Period 3||7
8380876|NCT01105936|20658008|P2|COMPLETED|Period 3||6
8380877|NCT01105936|20658009|P1|COMPLETED|Period 3||7
8380878|NCT01105936|20658006|P4|STARTED|Period 3||7
8380879|NCT01105936|20658007|P3|STARTED|Period 3||7
8380880|NCT01105936|20658008|P2|STARTED|Period 3||8
8380881|NCT01105936|20658009|P1|STARTED|Period 3||7
8380882|NCT01105936|20658006|P4|NOT COMPLETED|Wash-out Period 2||0
8380883|NCT01105936|20658007|P3|NOT COMPLETED|Wash-out Period 2||0
8380884|NCT01105936|20658008|P2|NOT COMPLETED|Wash-out Period 2||0
8380885|NCT01105936|20658009|P1|NOT COMPLETED|Wash-out Period 2||0
8380886|NCT01105936|20658006|P4|COMPLETED|Wash-out Period 2||7
8380887|NCT01105936|20658007|P3|COMPLETED|Wash-out Period 2||7
8380888|NCT01105936|20658008|P2|COMPLETED|Wash-out Period 2||8
8380889|NCT01105936|20658009|P1|COMPLETED|Wash-out Period 2||7
8380890|NCT01105936|20658006|P4|STARTED|Wash-out Period 2||7
8380891|NCT01105936|20658007|P3|STARTED|Wash-out Period 2||7
8380892|NCT01105936|20658008|P2|STARTED|Wash-out Period 2||8
8380893|NCT01105936|20658009|P1|STARTED|Wash-out Period 2||7
8380894|NCT01105936|20658006|P4|NOT COMPLETED|Period 2||0
8380895|NCT01105936|20658007|P3|NOT COMPLETED|Period 2||0
8380896|NCT01105936|20658008|P2|NOT COMPLETED|Period 2||0
8380897|NCT01105936|20658009|P1|NOT COMPLETED|Period 2||1
8380898|NCT01105936|20658006|P4|COMPLETED|Period 2||7
8380899|NCT01105936|20658007|P3|COMPLETED|Period 2||7
8380900|NCT01105936|20658008|P2|COMPLETED|Period 2||8
8380901|NCT01105936|20658009|P1|COMPLETED|Period 2||7
8380902|NCT01105936|20658006|P4|STARTED|Period 2||7
8380903|NCT01105936|20658007|P3|STARTED|Period 2||7
8380904|NCT01105936|20658008|P2|STARTED|Period 2||8
8380905|NCT01105936|20658009|P1|STARTED|Period 2||8
8380906|NCT01105936|20658006|P4|NOT COMPLETED|Wash-out Period 1||0
8380907|NCT01105936|20658007|P3|NOT COMPLETED|Wash-out Period 1||0
8380908|NCT01105936|20658008|P2|NOT COMPLETED|Wash-out Period 1||0
8380909|NCT01105936|20658009|P1|NOT COMPLETED|Wash-out Period 1||0
8380910|NCT01105936|20658006|P4|COMPLETED|Wash-out Period 1||7
8380911|NCT01105936|20658007|P3|COMPLETED|Wash-out Period 1||7
8380912|NCT01105936|20658008|P2|COMPLETED|Wash-out Period 1||8
8380913|NCT01105936|20658009|P1|COMPLETED|Wash-out Period 1||8
8380914|NCT01105936|20658006|P4|STARTED|Wash-out Period 1||7
8380915|NCT01105936|20658007|P3|STARTED|Wash-out Period 1||7
8380916|NCT01105936|20658008|P2|STARTED|Wash-out Period 1||8
8380917|NCT01105936|20658009|P1|STARTED|Wash-out Period 1||8
8380918|NCT01105936|20658006|P4|NOT COMPLETED|Period 1||1
8380919|NCT01105936|20658007|P3|NOT COMPLETED|Period 1||0
8380920|NCT01105936|20658008|P2|NOT COMPLETED|Period 1||0
8380921|NCT01105936|20658009|P1|NOT COMPLETED|Period 1||0
8380922|NCT01105936|20658006|P4|COMPLETED|Period 1||7
8380923|NCT01105936|20658007|P3|COMPLETED|Period 1||7
8380924|NCT01105936|20658008|P2|COMPLETED|Period 1||8
8380925|NCT01105936|20658009|P1|COMPLETED|Period 1||8
8380926|NCT01105936|20658006|P4|STARTED|Period 1||8
8380927|NCT01105936|20658007|P3|STARTED|Period 1||7
8380928|NCT01105936|20658008|P2|STARTED|Period 1||8
8380929|NCT01105936|20658009|P1|STARTED|Period 1||8
8380930|NCT01105767|20658038|P3|NOT COMPLETED|Overall Study||1184
8380931|NCT01105767|20658039|P2|NOT COMPLETED|Overall Study||1614
8380932|NCT01105767|20658040|P1|NOT COMPLETED|Overall Study||1160
8380933|NCT01105767|20658038|P3|COMPLETED|Overall Study||8846
8380934|NCT01105767|20658039|P2|COMPLETED|Overall Study||9250
8380935|NCT01105767|20658040|P1|COMPLETED|Overall Study||8155
8380936|NCT01105767|20658038|P3|STARTED|Overall Study||10030
8380937|NCT01105767|20658039|P2|STARTED|Overall Study||10864
8380938|NCT01105767|20658040|P1|STARTED|Overall Study||9315
8380939|NCT01105754|20658053|P2|NOT COMPLETED|Overall Study||12
8380940|NCT01105754|20658054|P1|NOT COMPLETED|Overall Study||15
8380941|NCT01105754|20658053|P2|COMPLETED|Overall Study||307
8380942|NCT01105754|20658054|P1|COMPLETED|Overall Study||304
8380943|NCT01105754|20658053|P2|STARTED|Overall Study||319
8380944|NCT01105754|20658054|P1|STARTED|Overall Study||319
8380945|NCT01105702|20658062|P1|NOT COMPLETED|Overall Study||18
8380946|NCT01105702|20658062|P1|COMPLETED|Overall Study||10
8380947|NCT01105702|20658062|P1|STARTED|Overall Study||28
8380948|NCT01105650|20658072|P4|NOT COMPLETED|Overall Study||0
8380949|NCT01105650|20658073|P3|NOT COMPLETED|Overall Study||0
8380950|NCT01105650|20658074|P2|NOT COMPLETED|Overall Study||0
8380951|NCT01105650|20658075|P1|NOT COMPLETED|Overall Study||0
8380952|NCT01105650|20658072|P4|COMPLETED|Overall Study||0
8380953|NCT01105650|20658073|P3|COMPLETED|Overall Study||7
8380954|NCT01105650|20658074|P2|COMPLETED|Overall Study||3
8380955|NCT01105650|20658075|P1|COMPLETED|Overall Study||3
8380956|NCT01105650|20658072|P4|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
8380957|NCT01105650|20658073|P3|STARTED|Overall Study||7
8380958|NCT01105650|20658074|P2|STARTED|Overall Study||3
8380959|NCT01105650|20658075|P1|STARTED|Overall Study||3
8380960|NCT01105533|20658092|P9|NOT COMPLETED|Overall Study||12
8380961|NCT01105533|20658093|P8|NOT COMPLETED|Overall Study||4
8380962|NCT01105533|20658094|P7|NOT COMPLETED|Overall Study||8
8380963|NCT01105533|20658095|P6|NOT COMPLETED|Overall Study||7
8380964|NCT01105533|20658096|P5|NOT COMPLETED|Overall Study||7
8380965|NCT01105533|20658097|P4|NOT COMPLETED|Overall Study||3
8380966|NCT01105533|20658098|P3|NOT COMPLETED|Overall Study||3
8380967|NCT01105533|20658099|P2|NOT COMPLETED|Overall Study||1
8380968|NCT01105533|20658100|P1|NOT COMPLETED|Overall Study||1
8380969|NCT01105533|20658092|P9|COMPLETED|Overall Study||0
8380970|NCT01105533|20658093|P8|COMPLETED|Overall Study||0
8380971|NCT01105533|20658094|P7|COMPLETED|Overall Study||0
8380972|NCT01105533|20658095|P6|COMPLETED|Overall Study||0
8380973|NCT01105533|20658096|P5|COMPLETED|Overall Study||0
8380974|NCT01105533|20658097|P4|COMPLETED|Overall Study||0
8380975|NCT01105533|20658098|P3|COMPLETED|Overall Study||0
8380976|NCT01105533|20658099|P2|COMPLETED|Overall Study||0
8380977|NCT01105533|20658100|P1|COMPLETED|Overall Study||0
8380978|NCT01105533|20658092|P9|STARTED|Overall Study||12
8380979|NCT01105533|20658093|P8|STARTED|Overall Study||4
8380980|NCT01105533|20658094|P7|STARTED|Overall Study||8
8380981|NCT01105533|20658095|P6|STARTED|Overall Study||7
8380982|NCT01105533|20658096|P5|STARTED|Overall Study||7
8380983|NCT01105533|20658097|P4|STARTED|Overall Study||3
8380984|NCT01105533|20658098|P3|STARTED|Overall Study||3
8380985|NCT01105533|20658099|P2|STARTED|Overall Study||1
8380986|NCT01105533|20658100|P1|STARTED|Overall Study||1
8380987|NCT01105377|20658190|P2|NOT COMPLETED|Overall Study||1
8380988|NCT01105377|20658191|P1|NOT COMPLETED|Overall Study||0
8380989|NCT01105377|20658190|P2|COMPLETED|Overall Study||22
8380990|NCT01105377|20658191|P1|COMPLETED|Overall Study||24
8380991|NCT01105377|20658190|P2|STARTED|Overall Study||23
8380992|NCT01105377|20658191|P1|STARTED|Overall Study||24
8380993|NCT01105312|20658202|P3|NOT COMPLETED|Overall Study||0
8380994|NCT01105312|20658203|P2|NOT COMPLETED|Overall Study||0
8380995|NCT01105312|20658204|P1|NOT COMPLETED|Overall Study||3
8380996|NCT01105312|20658202|P3|COMPLETED|Overall Study||6
8380997|NCT01105312|20658203|P2|COMPLETED|Overall Study||6
8380998|NCT01105312|20658204|P1|COMPLETED|Overall Study||13
8380999|NCT01105312|20658202|P3|STARTED|Overall Study||6
8381000|NCT01105312|20658203|P2|STARTED|Overall Study||6
8381001|NCT01105312|20658204|P1|STARTED|Overall Study||16
8381002|NCT01105247|20658222|P2|NOT COMPLETED|Overall Study||0
8381003|NCT01105247|20658223|P1|NOT COMPLETED|Overall Study||37
8381004|NCT01105247|20658222|P2|COMPLETED|Overall Study||16
8381005|NCT01105247|20658223|P1|COMPLETED|Overall Study||79
8381006|NCT01105247|20658222|P2|STARTED|Overall Study||16
8381007|NCT01105247|20658223|P1|STARTED|Overall Study||116
8381008|NCT01105130|20658239|P3|NOT COMPLETED|Overall Study||10
8381009|NCT01105130|20658240|P2|NOT COMPLETED|Overall Study||11
8381010|NCT01105130|20658241|P1|NOT COMPLETED|Overall Study||10
8381011|NCT01105130|20658239|P3|COMPLETED|Overall Study||37
8381012|NCT01105130|20658240|P2|COMPLETED|Overall Study||34
8381013|NCT01105130|20658241|P1|COMPLETED|Overall Study||38
8381014|NCT01105130|20658239|P3|STARTED|Overall Study||47
8381015|NCT01105130|20658240|P2|STARTED|Overall Study||45
8381016|NCT01105130|20658241|P1|STARTED|Overall Study||48
8381017|NCT01105117|20658260|P2|NOT COMPLETED|Overall Study||0
8381018|NCT01105117|20658261|P1|NOT COMPLETED|Overall Study||0
8381019|NCT01105117|20658260|P2|COMPLETED|Overall Study||1
8381020|NCT01105117|20658261|P1|COMPLETED|Overall Study||1
8381021|NCT01105117|20658260|P2|STARTED|Overall Study||1
8381022|NCT01105117|20658261|P1|STARTED|Overall Study||1
8381023|NCT01105091|20658271|P2|NOT COMPLETED|Overall Study||0
8381024|NCT01105091|20658272|P1|NOT COMPLETED|Overall Study||2
8381025|NCT01105091|20658271|P2|COMPLETED|Overall Study||10
8381026|NCT01105091|20658272|P1|COMPLETED|Overall Study||18
8381027|NCT01105091|20658271|P2|STARTED|Overall Study||10
8381028|NCT01105091|20658272|P1|STARTED|Overall Study||20
8381029|NCT01105065|20658296|P1|NOT COMPLETED|Overall Study||6
8381030|NCT01105065|20658296|P1|COMPLETED|Overall Study||17
8381031|NCT01105065|20658296|P1|STARTED|Overall Study||23
8381032|NCT01104870|20658305|P3|NOT COMPLETED|Overall Study||2
8381033|NCT01104870|20658306|P2|NOT COMPLETED|Overall Study||1
8381034|NCT01104870|20658307|P1|NOT COMPLETED|Overall Study||1
8381035|NCT01104870|20658305|P3|COMPLETED|Overall Study||18
8381036|NCT01104870|20658306|P2|COMPLETED|Overall Study||18
8381037|NCT01104870|20658307|P1|COMPLETED|Overall Study||10
8381038|NCT01104870|20658305|P3|STARTED|Overall Study||20
8381039|NCT01104870|20658306|P2|STARTED|Overall Study||19
8381040|NCT01104870|20658307|P1|STARTED|Overall Study||11
8381041|NCT01104792|20658336|P1|NOT COMPLETED|Overall Study||526
8381042|NCT01104792|20658336|P1|COMPLETED|Overall Study||226
8381043|NCT01104792|20658336|P1|STARTED|Overall Study||752
8381044|NCT01104779|20658344|P3|NOT COMPLETED|Overall Study||62
8381045|NCT01104779|20658345|P2|NOT COMPLETED|Overall Study||55
8381046|NCT01104779|20658346|P1|NOT COMPLETED|Overall Study||59
8381047|NCT01104779|20658344|P3|COMPLETED|Overall Study||86
8381048|NCT01104779|20658345|P2|COMPLETED|Overall Study||96
8381049|NCT01104779|20658346|P1|COMPLETED|Overall Study||88
8381050|NCT01104779|20658344|P3|STARTED|Overall Study||148
8381051|NCT01104779|20658345|P2|STARTED|Overall Study||151
8381052|NCT01104779|20658346|P1|STARTED|Overall Study||147
8381053|NCT01104766|20658361|P4|NOT COMPLETED|Overall Study||38
8381054|NCT01104766|20658362|P3|NOT COMPLETED|Overall Study||60
8381055|NCT01104766|20658363|P2|NOT COMPLETED|Overall Study||51
8381056|NCT01104766|20658364|P1|NOT COMPLETED|Overall Study||58
8381057|NCT01104766|20658361|P4|COMPLETED|Overall Study||114
8381058|NCT01104766|20658362|P3|COMPLETED|Overall Study||97
8381059|NCT01104766|20658363|P2|COMPLETED|Overall Study||104
8381060|NCT01104766|20658364|P1|COMPLETED|Overall Study||95
8381061|NCT01104766|20658361|P4|STARTED|Overall Study||152
8381062|NCT01104766|20658362|P3|STARTED|Overall Study||157
8381063|NCT01104766|20658363|P2|STARTED|Overall Study||155
8381064|NCT01104766|20658364|P1|STARTED|Overall Study||153
8381065|NCT01104701|20658382|P4|NOT COMPLETED|Overall Study||2
8381066|NCT01104701|20658383|P3|NOT COMPLETED|Overall Study||2
8381067|NCT01104701|20658384|P2|NOT COMPLETED|Overall Study||3
8381068|NCT01104701|20658385|P1|NOT COMPLETED|Overall Study||0
8381069|NCT01104701|20658382|P4|COMPLETED|Overall Study||28
8381070|NCT01104701|20658383|P3|COMPLETED|Overall Study||29
8381071|NCT01104701|20658384|P2|COMPLETED|Overall Study||27
8381072|NCT01104701|20658385|P1|COMPLETED|Overall Study||30
8381073|NCT01104701|20658382|P4|STARTED|Overall Study||30
8381074|NCT01104701|20658383|P3|STARTED|Overall Study||31
8381075|NCT01104701|20658384|P2|STARTED|Overall Study||30
8381076|NCT01104701|20658385|P1|STARTED|Overall Study||30
8381077|NCT01104662|20658447|P8|NOT COMPLETED|Overall Study||0
8381078|NCT01104662|20658448|P7|NOT COMPLETED|Overall Study||0
8381079|NCT01104662|20658449|P6|NOT COMPLETED|Overall Study||4
8381080|NCT01104662|20658450|P5|NOT COMPLETED|Overall Study||1
8381081|NCT01104662|20658451|P4|NOT COMPLETED|Overall Study||1
8381082|NCT01104662|20658452|P3|NOT COMPLETED|Overall Study||1
8381083|NCT01104662|20658453|P2|NOT COMPLETED|Overall Study||10
8381084|NCT01104662|20658454|P1|NOT COMPLETED|Overall Study||10
8381085|NCT01104662|20658447|P8|COMPLETED|Overall Study||6
8381086|NCT01104662|20658448|P7|COMPLETED|Overall Study||5
8381087|NCT01104662|20658449|P6|COMPLETED|Overall Study||12
8381088|NCT01104662|20658450|P5|COMPLETED|Overall Study||14
8381089|NCT01104662|20658451|P4|COMPLETED|Overall Study||3
8381090|NCT01104662|20658452|P3|COMPLETED|Overall Study||4
8381091|NCT01104662|20658453|P2|COMPLETED|Overall Study||11
8381092|NCT01104662|20658454|P1|COMPLETED|Overall Study||10
8381093|NCT01104662|20658447|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
8381094|NCT01104662|20658448|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
8381095|NCT01104662|20658449|P6|Received at Least 1 Dose of Study Drug|Overall Study||15
8381096|NCT01104662|20658450|P5|Received at Least 1 Dose of Study Drug|Overall Study||15
8381097|NCT01104662|20658451|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
8381098|NCT01104662|20658452|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
8381099|NCT01104662|20658453|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
8381100|NCT01104662|20658454|P1|Received at Least 1 Dose of Study Drug|Overall Study||17
8381101|NCT01104662|20658447|P8|STARTED|Overall Study||6
8381102|NCT01104662|20658448|P7|STARTED|Overall Study||5
8381103|NCT01104662|20658449|P6|STARTED|Overall Study||16
8381104|NCT01104662|20658450|P5|STARTED|Overall Study||15
8381105|NCT01104662|20658451|P4|STARTED|Overall Study||4
8381106|NCT01104662|20658452|P3|STARTED|Overall Study||5
8381107|NCT01104662|20658453|P2|STARTED|Overall Study||21
8381108|NCT01104662|20658454|P1|STARTED|Overall Study||20
8381109|NCT01104636|20658480|P1|NOT COMPLETED|Overall Study||178
8381110|NCT01104636|20658480|P1|COMPLETED|Overall Study||999
8381111|NCT01104636|20658480|P1|STARTED|Overall Study||1177
8381112|NCT01104584|20658485|P1|NOT COMPLETED|Overall Study||23
8381113|NCT01104584|20658485|P1|COMPLETED|Overall Study|study course completed|437
8381114|NCT01104584|20658485|P1|Fulfilled Requirements of FAS Population|Overall Study||397
8381115|NCT01104584|20658485|P1|Received Treatment|Overall Study|treatment started|439
8381116|NCT01104584|20658485|P1|STARTED|Overall Study|screened and enrolled|460
8381117|NCT01104558|20658555|P1|NOT COMPLETED|Overall Study||17
8381118|NCT01104558|20658555|P1|COMPLETED|Overall Study||83
8381119|NCT01104558|20658555|P1|STARTED|Overall Study||100
8381120|NCT01104545|20658599|P3|NOT COMPLETED|Overall Study||2
8381121|NCT01104545|20658600|P2|NOT COMPLETED|Overall Study||1
8381122|NCT01104545|20658601|P1|NOT COMPLETED|Overall Study||0
8381123|NCT01104545|20658599|P3|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6
8381124|NCT01104545|20658600|P2|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7
8381125|NCT01104545|20658601|P1|COMPLETED|Overall Study||8
8381126|NCT01104545|20658599|P3|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8
8381127|NCT01104545|20658600|P2|STARTED|Overall Study||8
8381128|NCT01104545|20658601|P1|STARTED|Overall Study||8
8381129|NCT01104493|20658758|P2|NOT COMPLETED|Overall Study||2
8381130|NCT01104493|20658759|P1|NOT COMPLETED|Overall Study||0
8381131|NCT01104493|20658758|P2|COMPLETED|Overall Study||58
8381132|NCT01104493|20658759|P1|COMPLETED|Overall Study||240
8381133|NCT01104493|20658758|P2|STARTED|Overall Study||60
8381134|NCT01104493|20658759|P1|STARTED|Overall Study||240
8381135|NCT01104415|20658777|P2|NOT COMPLETED|Extension Period||11
8381136|NCT01104415|20658778|P1|NOT COMPLETED|Extension Period||0
8381137|NCT01104415|20658777|P2|COMPLETED|Extension Period||0
8381138|NCT01104415|20658778|P1|COMPLETED|Extension Period||0
8381139|NCT01104415|20658777|P2|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11
8381140|NCT01104415|20658778|P1|STARTED|Extension Period||0
8381141|NCT01104415|20658777|P2|NOT COMPLETED|Core Phase||0
8381142|NCT01104415|20658778|P1|NOT COMPLETED|Core Phase||1
8381143|NCT01104415|20658777|P2|COMPLETED|Core Phase||0
8381144|NCT01104415|20658778|P1|COMPLETED|Core Phase||14
8381145|NCT01104415|20658777|P2|STARTED|Core Phase||0
8381146|NCT01104415|20658778|P1|STARTED|Core Phase||15
8381147|NCT01104402|20658803|P2|NOT COMPLETED|Overall Study||33
8381148|NCT01104402|20658804|P1|NOT COMPLETED|Overall Study||21
8381149|NCT01104402|20658803|P2|COMPLETED|Overall Study||102
8381150|NCT01104402|20658804|P1|COMPLETED|Overall Study||111
8381151|NCT01104402|20658803|P2|STARTED|Overall Study||135
8381152|NCT01104402|20658804|P1|STARTED|Overall Study||132
8381153|NCT01104376|20658822|P1|NOT COMPLETED|Overall Study||28
8381154|NCT01104376|20658822|P1|COMPLETED|Overall Study||61
8381155|NCT01104376|20658822|P1|STARTED|Overall Study||89
8381156|NCT01104311|20658828|P2|NOT COMPLETED|Overall Study||12
8381157|NCT01104311|20658829|P1|NOT COMPLETED|Overall Study||10
8381158|NCT01104311|20658828|P2|COMPLETED|Overall Study||54
8381159|NCT01104311|20658829|P1|COMPLETED|Overall Study||56
8381160|NCT01104311|20658828|P2|STARTED|Overall Study||66
8381161|NCT01104311|20658829|P1|STARTED|Overall Study||66
8381162|NCT01104285|20658849|P2|NOT COMPLETED|Overall Study||0
8381163|NCT01104285|20658850|P1|NOT COMPLETED|Overall Study||0
8381164|NCT01104285|20658849|P2|COMPLETED|Overall Study||86
8381165|NCT01104285|20658850|P1|COMPLETED|Overall Study||112
8381166|NCT01104285|20658849|P2|STARTED|Overall Study||86
8381167|NCT01104285|20658850|P1|STARTED|Overall Study||112
8381168|NCT01104246|20658856|P1|NOT COMPLETED|Overall Study||5
8381169|NCT01104246|20658856|P1|COMPLETED|Overall Study||35
8381170|NCT01104246|20658856|P1|Baseline Characteristics Measured|Overall Study||35
8381171|NCT01104246|20658856|P1|STARTED|Overall Study||40
8381172|NCT01104207|20658862|P2|NOT COMPLETED|Overall Study||3
8381173|NCT01104207|20658863|P1|NOT COMPLETED|Overall Study||3
8381174|NCT01104207|20658862|P2|COMPLETED|Overall Study||32
8381175|NCT01104207|20658863|P1|COMPLETED|Overall Study||32
8381176|NCT01104207|20658862|P2|STARTED|Overall Study||35
8381177|NCT01104207|20658863|P1|STARTED|Overall Study||35
8381178|NCT01104155|20658871|P2|NOT COMPLETED|Overall Study||18
8381179|NCT01104155|20658872|P1|NOT COMPLETED|Overall Study||25
8381180|NCT01104155|20658871|P2|COMPLETED|Overall Study||42
8381181|NCT01104155|20658872|P1|COMPLETED|Overall Study||38
8381182|NCT01104155|20658871|P2|STARTED|Overall Study||60
8381183|NCT01104155|20658872|P1|STARTED|Overall Study||63
8381184|NCT01104116|20658886|P1|NOT COMPLETED|Overall Study||0
8381185|NCT01104116|20658886|P1|COMPLETED|Overall Study||1
8381186|NCT01104116|20658886|P1|STARTED|Overall Study||1
8381187|NCT01104103|20658893|P2|NOT COMPLETED|Overall Study||0
8381188|NCT01104103|20658894|P1|NOT COMPLETED|Overall Study||0
8381189|NCT01104103|20658893|P2|COMPLETED|Overall Study||224
8381190|NCT01104103|20658894|P1|COMPLETED|Overall Study||243
8381191|NCT01104103|20658893|P2|STARTED|Overall Study||224
8381192|NCT01104103|20658894|P1|STARTED|Overall Study||243
8381193|NCT01104025|20658902|P1|NOT COMPLETED|Follow up Until Day 100 Post BMT||2
8381194|NCT01104025|20658902|P1|COMPLETED|Follow up Until Day 100 Post BMT||9
8381195|NCT01104025|20658902|P1|STARTED|Follow up Until Day 100 Post BMT|only 11 participants proceeded to BMT; 14 did not|11
8381196|NCT01104025|20658902|P1|NOT COMPLETED|Follow up Until BMT OR 6 Months||3
8381197|NCT01104025|20658902|P1|COMPLETED|Follow up Until BMT OR 6 Months||22
8381198|NCT01104025|20658902|P1|STARTED|Follow up Until BMT OR 6 Months||25
8381199|NCT01104025|20658902|P1|NOT COMPLETED|Treatment Period||6
8381200|NCT01104025|20658902|P1|COMPLETED|Treatment Period||25
8381201|NCT01104025|20658902|P1|STARTED|Treatment Period||31
8381202|NCT01103973|20658913|P2|NOT COMPLETED|Overall Study||0
8381203|NCT01103973|20658914|P1|NOT COMPLETED|Overall Study||0
8381204|NCT01103973|20658913|P2|COMPLETED|Overall Study||46
8381205|NCT01103973|20658914|P1|COMPLETED|Overall Study||51
8381206|NCT01103973|20658913|P2|STARTED|Overall Study||46
8381207|NCT01103973|20658914|P1|STARTED|Overall Study||51
8381208|NCT01103960|20658924|P2|NOT COMPLETED|Overall Study||2
8381209|NCT01103960|20658925|P1|NOT COMPLETED|Overall Study||5
8381210|NCT01103960|20658924|P2|COMPLETED|Overall Study|Completed study medication.|158
8381211|NCT01103960|20658925|P1|COMPLETED|Overall Study|Completed study medication.|159
8381212|NCT01103960|20658924|P2|STARTED|Overall Study|Randomised and treated.|160
8381213|NCT01103960|20658925|P1|STARTED|Overall Study|Randomised and treated.|164
8381214|NCT01103934|20658951|P2|NOT COMPLETED|Overall Study||0
8381215|NCT01103934|20658952|P1|NOT COMPLETED|Overall Study||0
8381216|NCT01103934|20658951|P2|COMPLETED|Overall Study||18
8381217|NCT01103934|20658952|P1|COMPLETED|Overall Study||17
8381218|NCT01103934|20658951|P2|STARTED|Overall Study||18
8381219|NCT01103934|20658952|P1|STARTED|Overall Study||17
8381220|NCT01103778|20658960|P1|NOT COMPLETED|Overall Study||3
8381221|NCT01103778|20658960|P1|COMPLETED|Overall Study||8
8381222|NCT01103778|20658960|P1|STARTED|Overall Study||11
8381223|NCT01103713|20658967|P1|NOT COMPLETED|Overall Study||13
8381224|NCT01103713|20658967|P1|COMPLETED|Overall Study||155
8381225|NCT01103713|20658967|P1|STARTED|Overall Study||168
8381226|NCT01103505|20658995|P2|NOT COMPLETED|Overall Study||20
8381227|NCT01103505|20658996|P1|NOT COMPLETED|Overall Study||24
8381228|NCT01103505|20658995|P2|COMPLETED|Overall Study||737
8381229|NCT01103505|20658996|P1|COMPLETED|Overall Study||739
8381230|NCT01103505|20658995|P2|STARTED|Overall Study||757
8381231|NCT01103505|20658996|P1|STARTED|Overall Study||763
8381232|NCT01103492|20659010|P1|NOT COMPLETED|Overall Study||0
8381233|NCT01103492|20659010|P1|COMPLETED|Overall Study||1
8381234|NCT01103492|20659010|P1|STARTED|Overall Study||1
8381235|NCT01103479|20659017|P3|NOT COMPLETED|Overall Study||14
8381236|NCT01103479|20659018|P2|NOT COMPLETED|Overall Study||9
8381237|NCT01103479|20659019|P1|NOT COMPLETED|Overall Study||5
8381238|NCT01103479|20659017|P3|COMPLETED|Overall Study||174
8381239|NCT01103479|20659018|P2|COMPLETED|Overall Study||201
8381240|NCT01103479|20659019|P1|COMPLETED|Overall Study||163
8381241|NCT01103479|20659017|P3|STARTED|Overall Study||188
8381242|NCT01103479|20659018|P2|STARTED|Overall Study||210
8381243|NCT01103479|20659019|P1|STARTED|Overall Study||168
8381244|NCT01103466|20659032|P3|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
8381245|NCT01103466|20659033|P2|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
8381246|NCT01103466|20659034|P1|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
8381247|NCT01103466|20659032|P3|COMPLETED|Third Period (14 +/- 3 Days)||13
8381248|NCT01103466|20659033|P2|COMPLETED|Third Period (14 +/- 3 Days)||8
8381249|NCT01103466|20659034|P1|COMPLETED|Third Period (14 +/- 3 Days)||6
8381250|NCT01103466|20659032|P3|STARTED|Third Period (14 +/- 3 Days)||14
8381251|NCT01103466|20659033|P2|STARTED|Third Period (14 +/- 3 Days)||8
8381252|NCT01103466|20659034|P1|STARTED|Third Period (14 +/- 3 Days)||8
8381253|NCT01103466|20659032|P3|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
8381254|NCT01103466|20659033|P2|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
8381255|NCT01103466|20659034|P1|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
8381256|NCT01103466|20659032|P3|COMPLETED|Second Period (14 +/- 3 Days)||6
8381257|NCT01103466|20659033|P2|COMPLETED|Second Period (14 +/- 3 Days)||11
8381258|NCT01103466|20659034|P1|COMPLETED|Second Period (14 +/- 3 Days)||13
8381259|NCT01103466|20659032|P3|STARTED|Second Period (14 +/- 3 Days)||7
8381260|NCT01103466|20659033|P2|STARTED|Second Period (14 +/- 3 Days)||13
8381261|NCT01103466|20659034|P1|STARTED|Second Period (14 +/- 3 Days)||15
8381262|NCT01103466|20659032|P3|NOT COMPLETED|First Period (14 +/- 3 Days)||0
8381263|NCT01103466|20659033|P2|NOT COMPLETED|First Period (14 +/- 3 Days)||0
8381264|NCT01103466|20659034|P1|NOT COMPLETED|First Period (14 +/- 3 Days)||2
8381265|NCT01103466|20659032|P3|COMPLETED|First Period (14 +/- 3 Days)||13
8381266|NCT01103466|20659033|P2|COMPLETED|First Period (14 +/- 3 Days)||12
8381267|NCT01103466|20659034|P1|COMPLETED|First Period (14 +/- 3 Days)||10
8381268|NCT01103466|20659032|P3|STARTED|First Period (14 +/- 3 Days)||13
8381269|NCT01103466|20659033|P2|STARTED|First Period (14 +/- 3 Days)||12
8381270|NCT01103466|20659034|P1|STARTED|First Period (14 +/- 3 Days)||12
8381271|NCT01103440|20659044|P2|NOT COMPLETED|Overall Study||0
8381272|NCT01103440|20659045|P1|NOT COMPLETED|Overall Study||0
8381273|NCT01103440|20659044|P2|COMPLETED|Overall Study||18
8381274|NCT01103440|20659045|P1|COMPLETED|Overall Study||18
8381275|NCT01103440|20659044|P2|STARTED|Overall Study||18
8381276|NCT01103440|20659045|P1|STARTED|Overall Study||18
8381277|NCT01103414|20659058|P5|NOT COMPLETED|Overall Study||15
8381278|NCT01103414|20659059|P4|NOT COMPLETED|Overall Study||7
8381279|NCT01103414|20659060|P3|NOT COMPLETED|Overall Study||15
8381280|NCT01103414|20659061|P2|NOT COMPLETED|Overall Study||9
8381281|NCT01103414|20659062|P1|NOT COMPLETED|Overall Study||13
8381282|NCT01103414|20659058|P5|COMPLETED|Overall Study||56
8381283|NCT01103414|20659059|P4|COMPLETED|Overall Study||64
8381284|NCT01103414|20659060|P3|COMPLETED|Overall Study||56
8381285|NCT01103414|20659061|P2|COMPLETED|Overall Study||62
8381286|NCT01103414|20659062|P1|COMPLETED|Overall Study||59
8381287|NCT01103414|20659058|P5|STARTED|Overall Study||71
8381288|NCT01103414|20659059|P4|STARTED|Overall Study||71
8381289|NCT01103414|20659060|P3|STARTED|Overall Study||71
8381290|NCT01103414|20659061|P2|STARTED|Overall Study||71
8381291|NCT01103414|20659062|P1|STARTED|Overall Study||72
8381292|NCT01103362|20659124|P1|NOT COMPLETED|Overall Study||596
8381293|NCT01103362|20659124|P1|COMPLETED|Overall Study||0
8381294|NCT01103362|20659124|P1|STARTED|Overall Study||596
8381295|NCT01103323|20659130|P2|NOT COMPLETED|Switched From Placebo to Regorafenib||1
8381296|NCT01103323|20659131|P1|NOT COMPLETED|Switched From Placebo to Regorafenib||0
8381297|NCT01103323|20659130|P2|COMPLETED|Switched From Placebo to Regorafenib||3
8381298|NCT01103323|20659131|P1|COMPLETED|Switched From Placebo to Regorafenib||0
8381299|NCT01103323|20659130|P2|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
8381300|NCT01103323|20659131|P1|STARTED|Switched From Placebo to Regorafenib||0
8381301|NCT01103323|20659130|P2|NOT COMPLETED|Without/Before Drug Switch||18
8381302|NCT01103323|20659131|P1|NOT COMPLETED|Without/Before Drug Switch||76
8381303|NCT01103323|20659130|P2|COMPLETED|Without/Before Drug Switch||237
8381304|NCT01103323|20659131|P1|COMPLETED|Without/Before Drug Switch||429
8381305|NCT01103323|20659130|P2|Participants Received Treatment|Without/Before Drug Switch||253
8381306|NCT01103323|20659131|P1|Participants Received Treatment|Without/Before Drug Switch||500
8381307|NCT01103323|20659130|P2|STARTED|Without/Before Drug Switch||255
8381308|NCT01103323|20659131|P1|STARTED|Without/Before Drug Switch||505
8381309|NCT01103284|20659148|P2|NOT COMPLETED|Overall Study||44
8381310|NCT01103284|20659149|P1|NOT COMPLETED|Overall Study||42
8381311|NCT01103284|20659148|P2|COMPLETED|Overall Study||195
8381312|NCT01103284|20659149|P1|COMPLETED|Overall Study||194
8381313|NCT01103284|20659148|P2|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
8381404|NCT01102491|20659435|P1|STARTED|Overall Study||71
8381314|NCT01103284|20659149|P1|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
8381315|NCT01103284|20659148|P2|Treated|Overall Study||238
8381316|NCT01103284|20659149|P1|Treated|Overall Study||236
8381317|NCT01103284|20659148|P2|STARTED|Overall Study||239
8381318|NCT01103284|20659149|P1|STARTED|Overall Study||236
8381319|NCT01103271|20659165|P2|NOT COMPLETED|Overall Study||4
8381320|NCT01103271|20659166|P1|NOT COMPLETED|Overall Study||1
8381321|NCT01103271|20659165|P2|COMPLETED|Overall Study||5
8381322|NCT01103271|20659166|P1|COMPLETED|Overall Study||10
8381323|NCT01103271|20659165|P2|STARTED|Overall Study||9
8381324|NCT01103271|20659166|P1|STARTED|Overall Study||11
8381325|NCT01103245|20659177|P4|NOT COMPLETED|Overall Study||0
8381326|NCT01103245|20659178|P3|NOT COMPLETED|Overall Study||4
8381327|NCT01103245|20659179|P2|NOT COMPLETED|Overall Study||2
8381328|NCT01103245|20659180|P1|NOT COMPLETED|Overall Study||3
8381329|NCT01103245|20659177|P4|COMPLETED|Overall Study||6
8381330|NCT01103245|20659178|P3|COMPLETED|Overall Study||8
8381331|NCT01103245|20659179|P2|COMPLETED|Overall Study||5
8381332|NCT01103245|20659180|P1|COMPLETED|Overall Study||10
8381333|NCT01103245|20659177|P4|STARTED|Overall Study||6
8381334|NCT01103245|20659178|P3|STARTED|Overall Study||12
8381335|NCT01103245|20659179|P2|STARTED|Overall Study||7
8381336|NCT01103245|20659180|P1|STARTED|Overall Study||13
8381337|NCT01103232|20659196|P2|NOT COMPLETED|Overall Study||2
8381338|NCT01103232|20659197|P1|NOT COMPLETED|Overall Study||1
8381339|NCT01103232|20659196|P2|COMPLETED|Overall Study||11
8381340|NCT01103232|20659197|P1|COMPLETED|Overall Study||12
8381341|NCT01103232|20659196|P2|STARTED|Overall Study||13
8381342|NCT01103232|20659197|P1|STARTED|Overall Study||13
8381343|NCT01103180|20659205|P2|NOT COMPLETED|Overall Study||21
8381344|NCT01103180|20659206|P1|NOT COMPLETED|Overall Study||22
8381345|NCT01103180|20659205|P2|COMPLETED|Overall Study||14
8381346|NCT01103180|20659206|P1|COMPLETED|Overall Study||13
8381347|NCT01103180|20659205|P2|STARTED|Overall Study||35
8381348|NCT01103180|20659206|P1|STARTED|Overall Study||35
8381349|NCT01103141|20659216|P2|NOT COMPLETED|Overall Study||2
8381350|NCT01103141|20659217|P1|NOT COMPLETED|Overall Study||2
8381351|NCT01103141|20659216|P2|COMPLETED|Overall Study||74
8381352|NCT01103141|20659217|P1|COMPLETED|Overall Study||65
8381353|NCT01103141|20659216|P2|STARTED|Overall Study||76
8381354|NCT01103141|20659217|P1|STARTED|Overall Study||67
8381355|NCT01103063|20659225|P2|NOT COMPLETED|Overall Study||421
8381356|NCT01103063|20659226|P1|NOT COMPLETED|Overall Study||477
8381357|NCT01103063|20659225|P2|COMPLETED|Overall Study||1024
8381358|NCT01103063|20659226|P1|COMPLETED|Overall Study||969
8381359|NCT01103063|20659225|P2|STARTED|Overall Study||1445
8381360|NCT01103063|20659226|P1|STARTED|Overall Study||1446
8381361|NCT01102972|20659294|P2|NOT COMPLETED|Overall Study||14
8381362|NCT01102972|20659295|P1|NOT COMPLETED|Overall Study||29
8381363|NCT01102972|20659294|P2|COMPLETED|Overall Study|These participants completed Study Week 48.|83
8381364|NCT01102972|20659295|P1|COMPLETED|Overall Study|These participants completed Study Week 48.|170
8381365|NCT01102972|20659294|P2|Completed Week 24|Overall Study||88
8381366|NCT01102972|20659295|P1|Completed Week 24|Overall Study||180
8381367|NCT01102972|20659294|P2|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|97
8381368|NCT01102972|20659295|P1|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|199
8381369|NCT01102894|20659347|P1|NOT COMPLETED|Overall Study||0
8381370|NCT01102894|20659347|P1|COMPLETED|Overall Study||10
8381371|NCT01102894|20659347|P1|STARTED|Overall Study||10
8381372|NCT01102803|20659359|P2|NOT COMPLETED|Post to Follow-Up||3
8381373|NCT01102803|20659360|P1|NOT COMPLETED|Post to Follow-Up||1
8381374|NCT01102803|20659359|P2|COMPLETED|Post to Follow-Up||12
8381375|NCT01102803|20659360|P1|COMPLETED|Post to Follow-Up||10
8381376|NCT01102803|20659359|P2|STARTED|Post to Follow-Up||15
8381377|NCT01102803|20659360|P1|STARTED|Post to Follow-Up||11
8381378|NCT01102803|20659359|P2|NOT COMPLETED|Baseline to Post-Treatment||0
8381379|NCT01102803|20659360|P1|NOT COMPLETED|Baseline to Post-Treatment||3
8381380|NCT01102803|20659359|P2|COMPLETED|Baseline to Post-Treatment||15
8381381|NCT01102803|20659360|P1|COMPLETED|Baseline to Post-Treatment||11
8381382|NCT01102803|20659359|P2|STARTED|Baseline to Post-Treatment||15
8381383|NCT01102803|20659360|P1|STARTED|Baseline to Post-Treatment||14
8381384|NCT01102777|20659374|P2|NOT COMPLETED|Overall Study||16
8381385|NCT01102777|20659375|P1|NOT COMPLETED|Overall Study||9
8381386|NCT01102777|20659374|P2|COMPLETED|Overall Study||139
8381387|NCT01102777|20659375|P1|COMPLETED|Overall Study||75
8381388|NCT01102777|20659374|P2|STARTED|Overall Study||155
8381389|NCT01102777|20659375|P1|STARTED|Overall Study||84
8381390|NCT01102764|20659401|P2|NOT COMPLETED|Overall Study||13
8381391|NCT01102764|20659402|P1|NOT COMPLETED|Overall Study||21
8381392|NCT01102764|20659401|P2|COMPLETED|Overall Study||55
8381393|NCT01102764|20659402|P1|COMPLETED|Overall Study||43
8381394|NCT01102764|20659401|P2|STARTED|Overall Study||68
8381395|NCT01102764|20659402|P1|STARTED|Overall Study||64
8381396|NCT01102738|20659428|P1|NOT COMPLETED|Overall Study||0
8381397|NCT01102738|20659428|P1|COMPLETED|Overall Study||369
8381398|NCT01102738|20659428|P1|STARTED|Overall Study||369
8381399|NCT01102491|20659434|P2|NOT COMPLETED|Overall Study||12
8381400|NCT01102491|20659435|P1|NOT COMPLETED|Overall Study||11
8381401|NCT01102491|20659434|P2|COMPLETED|Overall Study|12 patients were excluded|59
8381402|NCT01102491|20659435|P1|COMPLETED|Overall Study|11 patient excluded|60
8381403|NCT01102491|20659434|P2|STARTED|Overall Study||71
8381405|NCT01102426|20659443|P2|NOT COMPLETED|Overall Study||81
8381406|NCT01102426|20659444|P1|NOT COMPLETED|Overall Study||165
8381407|NCT01102426|20659443|P2|COMPLETED|Overall Study||3
8381408|NCT01102426|20659444|P1|COMPLETED|Overall Study||6
8381409|NCT01102426|20659443|P2|STARTED|Overall Study||84
8381410|NCT01102426|20659444|P1|STARTED|Overall Study||171
8381411|NCT01102413|20659484|P2|NOT COMPLETED|Overall Study||12
8381412|NCT01102413|20659485|P1|NOT COMPLETED|Overall Study||25
8381413|NCT01102413|20659484|P2|COMPLETED|Overall Study||106
8381414|NCT01102413|20659485|P1|COMPLETED|Overall Study||208
8381415|NCT01102413|20659484|P2|STARTED|Overall Study||118
8381416|NCT01102413|20659485|P1|STARTED|Overall Study||233
8381417|NCT01102374|20659495|P2|NOT COMPLETED|Overall Study||19
8381418|NCT01102374|20659496|P1|NOT COMPLETED|Overall Study||16
8381419|NCT01102374|20659495|P2|COMPLETED|Overall Study||33
8381420|NCT01102374|20659496|P1|COMPLETED|Overall Study||39
8381421|NCT01102374|20659495|P2|STARTED|Overall Study||52
8381422|NCT01102374|20659496|P1|STARTED|Overall Study||55
8381423|NCT01102270|20659530|P2|NOT COMPLETED|Overall Study||0
8381424|NCT01102270|20659531|P1|NOT COMPLETED|Overall Study||0
8381425|NCT01102270|20659530|P2|COMPLETED|Overall Study||9
8381426|NCT01102270|20659531|P1|COMPLETED|Overall Study||8
8381427|NCT01102270|20659530|P2|STARTED|Overall Study||9
8381428|NCT01102270|20659531|P1|STARTED|Overall Study||8
8381429|NCT01102257|20659545|P2|NOT COMPLETED|Overall Study||0
8381430|NCT01102257|20659546|P1|NOT COMPLETED|Overall Study||2
8381431|NCT01102257|20659545|P2|COMPLETED|Overall Study||9
8381432|NCT01102257|20659546|P1|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
8381433|NCT01102257|20659545|P2|STARTED|Overall Study||9
8381434|NCT01102257|20659546|P1|STARTED|Overall Study||9
8381435|NCT01102218|20659554|P2|NOT COMPLETED|Overall Study||10
8381436|NCT01102218|20659555|P1|NOT COMPLETED|Overall Study||11
8381437|NCT01102218|20659554|P2|COMPLETED|Overall Study||14
8381438|NCT01102218|20659555|P1|COMPLETED|Overall Study||13
8381439|NCT01102218|20659554|P2|STARTED|Overall Study||24
8381440|NCT01102218|20659555|P1|STARTED|Overall Study||24
8381441|NCT01102140|20659563|P2|NOT COMPLETED|Overall Study||2
8381442|NCT01102140|20659564|P1|NOT COMPLETED|Overall Study||3
8381443|NCT01102140|20659563|P2|COMPLETED|Overall Study||5
8381444|NCT01102140|20659564|P1|COMPLETED|Overall Study||10
8381445|NCT01102140|20659563|P2|STARTED|Overall Study||7
8381446|NCT01102140|20659564|P1|STARTED|Overall Study||13
8381447|NCT01101997|20659576|P1|NOT COMPLETED|Overall Study||2
8381448|NCT01101997|20659576|P1|COMPLETED|Overall Study||58
8381449|NCT01101997|20659576|P1|STARTED|Overall Study||60
8381450|NCT01101971|20659582|P1|NOT COMPLETED|Overall Study||0
8381451|NCT01101971|20659582|P1|COMPLETED|Overall Study||45
8381452|NCT01101971|20659582|P1|STARTED|Overall Study||45
8381453|NCT01101958|20659588|P2|NOT COMPLETED|Overall Study||5
8381454|NCT01101958|20659589|P1|NOT COMPLETED|Overall Study||11
8381455|NCT01101958|20659588|P2|COMPLETED|Overall Study||29
8381456|NCT01101958|20659589|P1|COMPLETED|Overall Study||51
8381457|NCT01101958|20659588|P2|STARTED|Overall Study||34
8381458|NCT01101958|20659589|P1|STARTED|Overall Study||62
8381459|NCT01101880|20659595|P1|NOT COMPLETED|Overall Study||0
8381460|NCT01101880|20659595|P1|COMPLETED|Overall Study||50
8381461|NCT01101880|20659595|P1|STARTED|Overall Study||50
8381462|NCT01101867|20659606|P2|NOT COMPLETED|Overall Study||4
8381463|NCT01101867|20659607|P1|NOT COMPLETED|Overall Study||1
8381464|NCT01101867|20659606|P2|COMPLETED|Overall Study||59
8381465|NCT01101867|20659607|P1|COMPLETED|Overall Study||62
8381466|NCT01101867|20659606|P2|STARTED|Overall Study||63
8381467|NCT01101867|20659607|P1|STARTED|Overall Study||63
8381468|NCT01101841|20659625|P2|NOT COMPLETED|Overall Study||67
8381469|NCT01101841|20659626|P1|NOT COMPLETED|Overall Study||50
8381470|NCT01101841|20659625|P2|COMPLETED|Overall Study||218
8381471|NCT01101841|20659626|P1|COMPLETED|Overall Study||235
8381472|NCT01101841|20659625|P2|STARTED|Overall Study||285
8381473|NCT01101841|20659626|P1|STARTED|Overall Study||285
8381474|NCT01101750|20659664|P1|NOT COMPLETED|Overall Study||16
8381475|NCT01101750|20659664|P1|COMPLETED|Overall Study||9
8381476|NCT01101750|20659664|P1|STARTED|Overall Study||25
8381477|NCT01101542|20659668|P1|NOT COMPLETED|Year 6 Surveillance Period||991
8381478|NCT01101542|20659668|P1|COMPLETED|Year 6 Surveillance Period||2100
8381479|NCT01101542|20659668|P1|STARTED|Year 6 Surveillance Period||3091
8381480|NCT01101542|20659668|P1|NOT COMPLETED|Year 5 Surveillance Period||141
8381481|NCT01101542|20659668|P1|COMPLETED|Year 5 Surveillance Period||668
8381482|NCT01101542|20659668|P1|STARTED|Year 5 Surveillance Period||809
8381483|NCT01101542|20659668|P1|NOT COMPLETED|Year 4 Surveillance Period||287
8381484|NCT01101542|20659668|P1|COMPLETED|Year 4 Surveillance Period||282
8381485|NCT01101542|20659668|P1|STARTED|Year 4 Surveillance Period||569
8381486|NCT01101542|20659668|P1|NOT COMPLETED|Year 3 Surveillance Period||11
8381487|NCT01101542|20659668|P1|COMPLETED|Year 3 Surveillance Period||94
8381488|NCT01101542|20659668|P1|STARTED|Year 3 Surveillance Period||105
8381489|NCT01101477|20659684|P3|NOT COMPLETED|Overall Study||1
8381490|NCT01101477|20659685|P2|NOT COMPLETED|Overall Study||3
8381491|NCT01101477|20659686|P1|NOT COMPLETED|Overall Study||5
8381492|NCT01101477|20659684|P3|COMPLETED|Overall Study||45
8381493|NCT01101477|20659685|P2|COMPLETED|Overall Study||46
8381494|NCT01101477|20659686|P1|COMPLETED|Overall Study||44
8381495|NCT01101477|20659684|P3|STARTED|Overall Study||46
8381496|NCT01101477|20659685|P2|STARTED|Overall Study||49
8381497|NCT01101477|20659686|P1|STARTED|Overall Study||49
8381595|NCT01101061|20659793|P4|Received Study Drug|Overall Study||6
8381498|NCT01101464|20659696|P2|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
8381499|NCT01101464|20659697|P1|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
8381500|NCT01101464|20659696|P2|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
8381501|NCT01101464|20659697|P1|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
8381502|NCT01101464|20659696|P2|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
8381503|NCT01101464|20659697|P1|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
8381504|NCT01101464|20659696|P2|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
8381505|NCT01101464|20659697|P1|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
8381506|NCT01101464|20659696|P2|COMPLETED|Day 1 Through AM Dose of Day 5||4
8381507|NCT01101464|20659697|P1|COMPLETED|Day 1 Through AM Dose of Day 5||4
8381508|NCT01101464|20659696|P2|STARTED|Day 1 Through AM Dose of Day 5||4
8381509|NCT01101464|20659697|P1|STARTED|Day 1 Through AM Dose of Day 5||4
8381510|NCT01101334|20659709|P2|NOT COMPLETED|Overall Study||45
8381511|NCT01101334|20659710|P1|NOT COMPLETED|Overall Study||45
8381512|NCT01101334|20659709|P2|COMPLETED|Overall Study||0
8381513|NCT01101334|20659710|P1|COMPLETED|Overall Study||0
8381514|NCT01101334|20659709|P2|Received Study Treatment|Overall Study||45
8381515|NCT01101334|20659710|P1|Received Study Treatment|Overall Study||44
8381516|NCT01101334|20659709|P2|STARTED|Overall Study||45
8381517|NCT01101334|20659710|P1|STARTED|Overall Study||45
8381518|NCT01101321|20659722|P2|NOT COMPLETED|Period 2||0
8381519|NCT01101321|20659723|P1|NOT COMPLETED|Period 2||0
8381520|NCT01101321|20659722|P2|COMPLETED|Period 2||24
8381521|NCT01101321|20659723|P1|COMPLETED|Period 2||26
8381522|NCT01101321|20659722|P2|STARTED|Period 2||24
8381523|NCT01101321|20659723|P1|STARTED|Period 2||26
8381524|NCT01101321|20659722|P2|NOT COMPLETED|Period 1||4
8381525|NCT01101321|20659723|P1|NOT COMPLETED|Period 1||4
8381526|NCT01101321|20659722|P2|COMPLETED|Period 1||24
8381527|NCT01101321|20659723|P1|COMPLETED|Period 1||26
8381528|NCT01101321|20659722|P2|STARTED|Period 1||28
8381529|NCT01101321|20659723|P1|STARTED|Period 1||30
8381530|NCT01101308|20659733|P2|NOT COMPLETED|Period 2||0
8381531|NCT01101308|20659734|P1|NOT COMPLETED|Period 2||0
8381532|NCT01101308|20659733|P2|COMPLETED|Period 2||27
8381533|NCT01101308|20659734|P1|COMPLETED|Period 2||24
8381534|NCT01101308|20659733|P2|STARTED|Period 2||27
8381535|NCT01101308|20659734|P1|STARTED|Period 2||24
8381536|NCT01101308|20659733|P2|NOT COMPLETED|Period 1||1
8381537|NCT01101308|20659734|P1|NOT COMPLETED|Period 1||3
8381538|NCT01101308|20659733|P2|COMPLETED|Period 1||27
8381539|NCT01101308|20659734|P1|COMPLETED|Period 1||24
8381540|NCT01101308|20659733|P2|STARTED|Period 1||28
8381541|NCT01101308|20659734|P1|STARTED|Period 1||27
8381542|NCT01101191|20659745|P2|NOT COMPLETED|Period 2||0
8381543|NCT01101191|20659746|P1|NOT COMPLETED|Period 2||0
8381544|NCT01101191|20659745|P2|COMPLETED|Period 2||40
8381545|NCT01101191|20659746|P1|COMPLETED|Period 2||40
8381546|NCT01101191|20659745|P2|STARTED|Period 2||40
8381547|NCT01101191|20659746|P1|STARTED|Period 2||40
8381548|NCT01101191|20659745|P2|NOT COMPLETED|Period 1||2
8381549|NCT01101191|20659746|P1|NOT COMPLETED|Period 1||2
8381550|NCT01101191|20659745|P2|COMPLETED|Period 1||40
8381551|NCT01101191|20659746|P1|COMPLETED|Period 1||40
8381552|NCT01101191|20659745|P2|STARTED|Period 1||42
8381553|NCT01101191|20659746|P1|STARTED|Period 1||42
8381554|NCT01101178|20659757|P2|NOT COMPLETED|Period 2||1
8381555|NCT01101178|20659758|P1|NOT COMPLETED|Period 2||0
8381556|NCT01101178|20659757|P2|COMPLETED|Period 2||34
8381557|NCT01101178|20659758|P1|COMPLETED|Period 2||36
8381558|NCT01101178|20659757|P2|STARTED|Period 2||35
8381559|NCT01101178|20659758|P1|STARTED|Period 2||36
8381560|NCT01101178|20659757|P2|NOT COMPLETED|Period 1||4
8381561|NCT01101178|20659758|P1|NOT COMPLETED|Period 1||4
8381562|NCT01101178|20659757|P2|COMPLETED|Period 1||35
8381563|NCT01101178|20659758|P1|COMPLETED|Period 1||36
8381564|NCT01101178|20659757|P2|STARTED|Period 1||39
8381565|NCT01101178|20659758|P1|STARTED|Period 1||40
8381566|NCT01101165|20659769|P2|NOT COMPLETED|Period 2||1
8381567|NCT01101165|20659770|P1|NOT COMPLETED|Period 2||4
8381568|NCT01101165|20659769|P2|COMPLETED|Period 2||39
8381569|NCT01101165|20659770|P1|COMPLETED|Period 2||41
8381570|NCT01101165|20659769|P2|STARTED|Period 2||40
8381571|NCT01101165|20659770|P1|STARTED|Period 2||45
8381572|NCT01101165|20659769|P2|NOT COMPLETED|Period 1||5
8381573|NCT01101165|20659770|P1|NOT COMPLETED|Period 1||2
8381574|NCT01101165|20659769|P2|COMPLETED|Period 1||40
8381575|NCT01101165|20659770|P1|COMPLETED|Period 1||45
8381576|NCT01101165|20659769|P2|STARTED|Period 1||45
8381577|NCT01101165|20659770|P1|STARTED|Period 1||47
8381578|NCT01101100|20659780|P1|NOT COMPLETED|Overall Study||55
8381579|NCT01101100|20659780|P1|COMPLETED|Overall Study||126
8381580|NCT01101100|20659780|P1|STARTED|Overall Study||181
8381581|NCT01101061|20659791|P6|NOT COMPLETED|Overall Study||0
8381582|NCT01101061|20659792|P5|NOT COMPLETED|Overall Study||0
8381583|NCT01101061|20659793|P4|NOT COMPLETED|Overall Study||0
8381584|NCT01101061|20659794|P3|NOT COMPLETED|Overall Study||1
8381585|NCT01101061|20659795|P2|NOT COMPLETED|Overall Study||0
8381586|NCT01101061|20659796|P1|NOT COMPLETED|Overall Study||0
8381587|NCT01101061|20659791|P6|COMPLETED|Overall Study||4
8381588|NCT01101061|20659792|P5|COMPLETED|Overall Study||2
8381589|NCT01101061|20659793|P4|COMPLETED|Overall Study||6
8381590|NCT01101061|20659794|P3|COMPLETED|Overall Study||6
8381591|NCT01101061|20659795|P2|COMPLETED|Overall Study||6
8381592|NCT01101061|20659796|P1|COMPLETED|Overall Study||6
8381593|NCT01101061|20659791|P6|Received Study Drug|Overall Study||4
8381594|NCT01101061|20659792|P5|Received Study Drug|Overall Study||2
8381596|NCT01101061|20659794|P3|Received Study Drug|Overall Study||6
8381597|NCT01101061|20659795|P2|Received Study Drug|Overall Study||6
8381598|NCT01101061|20659796|P1|Received Study Drug|Overall Study||6
8381599|NCT01101061|20659791|P6|STARTED|Overall Study||4
8381600|NCT01101061|20659792|P5|STARTED|Overall Study||2
8381601|NCT01101061|20659793|P4|STARTED|Overall Study||6
8381602|NCT01101061|20659794|P3|STARTED|Overall Study||7
8381603|NCT01101061|20659795|P2|STARTED|Overall Study||6
8381604|NCT01101061|20659796|P1|STARTED|Overall Study||6
8381605|NCT01101035|20659876|P2|NOT COMPLETED|Overall Study||1391
8381606|NCT01101035|20659877|P1|NOT COMPLETED|Overall Study||1397
8381607|NCT01101035|20659876|P2|COMPLETED|Overall Study||1706
8381608|NCT01101035|20659877|P1|COMPLETED|Overall Study||1704
8381609|NCT01101035|20659876|P2|STARTED|Overall Study||3097
8381610|NCT01101035|20659877|P1|STARTED|Overall Study||3101
8381617|NCT01100944|20659932|P3|NOT COMPLETED|Expansion Phase - Phase 2||0
8381618|NCT01100944|20659933|P2|NOT COMPLETED|Expansion Phase - Phase 2||0
8381619|NCT01100944|20659934|P1|NOT COMPLETED|Expansion Phase - Phase 2||0
8381620|NCT01100944|20659932|P3|COMPLETED|Expansion Phase - Phase 2||18
8381621|NCT01100944|20659933|P2|COMPLETED|Expansion Phase - Phase 2||0
8381622|NCT01100944|20659934|P1|COMPLETED|Expansion Phase - Phase 2||0
8381623|NCT01100944|20659932|P3|STARTED|Expansion Phase - Phase 2||18
8381624|NCT01100944|20659933|P2|STARTED|Expansion Phase - Phase 2||0
8381625|NCT01100944|20659934|P1|STARTED|Expansion Phase - Phase 2||0
8381626|NCT01100944|20659932|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8381627|NCT01100944|20659933|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
8381628|NCT01100944|20659934|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8381629|NCT01100944|20659932|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8381630|NCT01100944|20659933|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8381631|NCT01100944|20659934|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
8381632|NCT01100944|20659932|P3|STARTED|Dose Escalation Phase 1 Dose Level 2||0
8381633|NCT01100944|20659933|P2|STARTED|Dose Escalation Phase 1 Dose Level 2||2
8381634|NCT01100944|20659934|P1|STARTED|Dose Escalation Phase 1 Dose Level 2||0
8381635|NCT01100944|20659932|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
8381636|NCT01100944|20659933|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
8381637|NCT01100944|20659934|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
8381638|NCT01100944|20659932|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
8381639|NCT01100944|20659933|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
8381640|NCT01100944|20659934|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
8381641|NCT01100944|20659932|P3|STARTED|Dose Escalation Phase 1 Dose Level 1||0
8381642|NCT01100944|20659933|P2|STARTED|Dose Escalation Phase 1 Dose Level 1||0
8381643|NCT01100944|20659934|P1|STARTED|Dose Escalation Phase 1 Dose Level 1||6
8381644|NCT01100931|20659981|P2|NOT COMPLETED|Phase II||0
8381645|NCT01100931|20659982|P1|NOT COMPLETED|Phase II||0
8381646|NCT01100931|20659981|P2|COMPLETED|Phase II||19
8381647|NCT01100931|20659982|P1|COMPLETED|Phase II||0
8381648|NCT01100931|20659981|P2|STARTED|Phase II||19
8381649|NCT01100931|20659982|P1|STARTED|Phase II||0
8381650|NCT01100931|20659981|P2|NOT COMPLETED|Phase I||0
8381651|NCT01100931|20659982|P1|NOT COMPLETED|Phase I||0
8381652|NCT01100931|20659981|P2|COMPLETED|Phase I||0
8381653|NCT01100931|20659982|P1|COMPLETED|Phase I||22
8381654|NCT01100931|20659981|P2|STARTED|Phase I||0
8381655|NCT01100931|20659982|P1|STARTED|Phase I||22
8381656|NCT01100853|20659992|P2|NOT COMPLETED|Overall Study||23
8381657|NCT01100853|20659993|P1|NOT COMPLETED|Overall Study||27
8381658|NCT01100853|20659992|P2|COMPLETED|Overall Study||26
8381659|NCT01100853|20659993|P1|COMPLETED|Overall Study||24
8381660|NCT01100853|20659992|P2|STARTED|Overall Study||49
8381661|NCT01100853|20659993|P1|STARTED|Overall Study||51
8381662|NCT01100762|20660009|P1|NOT COMPLETED|Overall Study||0
8381663|NCT01100762|20660009|P1|COMPLETED|Overall Study||10
8381664|NCT01100762|20660009|P1|STARTED|Overall Study||10
8381665|NCT01100723|20660030|P1|NOT COMPLETED|Overall Study||14
8381666|NCT01100723|20660030|P1|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
8381667|NCT01100723|20660030|P1|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
8381668|NCT01100723|20660030|P1|STARTED|Overall Study||92
8381669|NCT01100658|20660039|P1|NOT COMPLETED|Overall Study||1
8381670|NCT01100658|20660039|P1|COMPLETED|Overall Study||0
8381671|NCT01100658|20660039|P1|STARTED|Overall Study||1
8381672|NCT01100606|20660044|P2|NOT COMPLETED|Second Treatment Period||0
8381673|NCT01100606|20660045|P1|NOT COMPLETED|Second Treatment Period||0
8381674|NCT01100606|20660044|P2|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
8381675|NCT01100606|20660045|P1|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
8381676|NCT01100606|20660044|P2|STARTED|Second Treatment Period||7
8381677|NCT01100606|20660045|P1|STARTED|Second Treatment Period||8
8381678|NCT01100606|20660044|P2|NOT COMPLETED|First Treatment Period||0
8381679|NCT01100606|20660045|P1|NOT COMPLETED|First Treatment Period||0
8381680|NCT01100606|20660044|P2|COMPLETED|First Treatment Period||7
8381681|NCT01100606|20660045|P1|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
8381682|NCT01100606|20660044|P2|STARTED|First Treatment Period||7
8381683|NCT01100606|20660045|P1|STARTED|First Treatment Period||8
8381684|NCT01100567|20660071|P2|NOT COMPLETED|Overall Study||16
8381685|NCT01100567|20660072|P1|NOT COMPLETED|Overall Study||12
8381686|NCT01100567|20660071|P2|COMPLETED|Overall Study||35
8381687|NCT01100567|20660072|P1|COMPLETED|Overall Study||38
8381688|NCT01100567|20660071|P2|STARTED|Overall Study||51
8381689|NCT01100567|20660072|P1|STARTED|Overall Study||50
8381690|NCT01100528|20660080|P1|NOT COMPLETED|Overall Study||3
8381691|NCT01100528|20660080|P1|COMPLETED|Overall Study||35
8381692|NCT01100528|20660080|P1|STARTED|Overall Study||38
8381705|NCT01100437|20660099|P3|NOT COMPLETED|Treatment 2||0
8381706|NCT01100437|20660100|P2|NOT COMPLETED|Treatment 2||0
8381707|NCT01100437|20660101|P1|NOT COMPLETED|Treatment 2||0
8381708|NCT01100437|20660099|P3|COMPLETED|Treatment 2||0
8381709|NCT01100437|20660100|P2|COMPLETED|Treatment 2||2
8381710|NCT01100437|20660101|P1|COMPLETED|Treatment 2||4
8381711|NCT01100437|20660099|P3|STARTED|Treatment 2||0
8381712|NCT01100437|20660100|P2|STARTED|Treatment 2||2
8381713|NCT01100437|20660101|P1|STARTED|Treatment 2||4
8381714|NCT01100437|20660099|P3|NOT COMPLETED|Washout (4 Days)||0
8381715|NCT01100437|20660100|P2|NOT COMPLETED|Washout (4 Days)||0
8381716|NCT01100437|20660101|P1|NOT COMPLETED|Washout (4 Days)||0
8381717|NCT01100437|20660099|P3|COMPLETED|Washout (4 Days)||0
8381718|NCT01100437|20660100|P2|COMPLETED|Washout (4 Days)||2
8381719|NCT01100437|20660101|P1|COMPLETED|Washout (4 Days)||4
8381720|NCT01100437|20660099|P3|STARTED|Washout (4 Days)||0
8381721|NCT01100437|20660100|P2|STARTED|Washout (4 Days)||2
8381722|NCT01100437|20660101|P1|STARTED|Washout (4 Days)||4
8381723|NCT01100437|20660099|P3|NOT COMPLETED|Treatment 1||0
8381724|NCT01100437|20660100|P2|NOT COMPLETED|Treatment 1||0
8381725|NCT01100437|20660101|P1|NOT COMPLETED|Treatment 1||0
8381726|NCT01100437|20660099|P3|COMPLETED|Treatment 1||0
8381727|NCT01100437|20660100|P2|COMPLETED|Treatment 1||2
8381728|NCT01100437|20660101|P1|COMPLETED|Treatment 1||4
8381729|NCT01100437|20660099|P3|STARTED|Treatment 1||0
8381730|NCT01100437|20660100|P2|STARTED|Treatment 1||2
8381731|NCT01100437|20660101|P1|STARTED|Treatment 1||4
8381732|NCT01100437|20660099|P3|NOT COMPLETED|Maintenance||2
8381733|NCT01100437|20660100|P2|NOT COMPLETED|Maintenance||0
8381734|NCT01100437|20660101|P1|NOT COMPLETED|Maintenance||0
8381735|NCT01100437|20660099|P3|COMPLETED|Maintenance||0
8381736|NCT01100437|20660100|P2|COMPLETED|Maintenance||2
8381737|NCT01100437|20660101|P1|COMPLETED|Maintenance||4
8381738|NCT01100437|20660099|P3|STARTED|Maintenance||2
8381739|NCT01100437|20660100|P2|STARTED|Maintenance||2
8381740|NCT01100437|20660101|P1|STARTED|Maintenance||4
8381741|NCT01100437|20660099|P3|NOT COMPLETED|Titration/Stabilization||6
8381742|NCT01100437|20660100|P2|NOT COMPLETED|Titration/Stabilization||0
8381743|NCT01100437|20660101|P1|NOT COMPLETED|Titration/Stabilization||0
8381744|NCT01100437|20660099|P3|COMPLETED|Titration/Stabilization||2
8381745|NCT01100437|20660100|P2|COMPLETED|Titration/Stabilization||2
8381746|NCT01100437|20660101|P1|COMPLETED|Titration/Stabilization||4
8381747|NCT01100437|20660099|P3|STARTED|Titration/Stabilization||8
8381748|NCT01100437|20660100|P2|STARTED|Titration/Stabilization||2
8381749|NCT01100437|20660101|P1|STARTED|Titration/Stabilization||4
8381750|NCT01100437|20660099|P3|NOT COMPLETED|Screening||0
8381751|NCT01100437|20660100|P2|NOT COMPLETED|Screening||0
8381752|NCT01100437|20660101|P1|NOT COMPLETED|Screening||0
8381753|NCT01100437|20660099|P3|COMPLETED|Screening||8
8381754|NCT01100437|20660100|P2|COMPLETED|Screening||2
8381755|NCT01100437|20660101|P1|COMPLETED|Screening||4
8381756|NCT01100437|20660099|P3|STARTED|Screening||8
8381757|NCT01100437|20660100|P2|STARTED|Screening||2
8381758|NCT01100437|20660101|P1|STARTED|Screening||4
8381759|NCT01100320|20660138|P2|NOT COMPLETED|Period 2||1
8381760|NCT01100320|20660139|P1|NOT COMPLETED|Period 2||1
8381761|NCT01100320|20660138|P2|COMPLETED|Period 2||37
8381762|NCT01100320|20660139|P1|COMPLETED|Period 2||37
8381763|NCT01100320|20660138|P2|STARTED|Period 2||38
8381764|NCT01100320|20660139|P1|STARTED|Period 2||38
8381765|NCT01100320|20660138|P2|NOT COMPLETED|Period 1||7
8381766|NCT01100320|20660139|P1|NOT COMPLETED|Period 1||5
8381767|NCT01100320|20660138|P2|COMPLETED|Period 1||38
8381768|NCT01100320|20660139|P1|COMPLETED|Period 1||38
8381769|NCT01100320|20660138|P2|STARTED|Period 1||45
8381770|NCT01100320|20660139|P1|STARTED|Period 1||43
8381771|NCT01100307|20660151|P2|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
8381772|NCT01100307|20660152|P1|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
8381865|NCT01099631|20660368|P2|NOT COMPLETED|Overall Study||0
8381773|NCT01100307|20660151|P2|COMPLETED|Open Phase (Week 24 up to Week 54)||99
8381774|NCT01100307|20660152|P1|COMPLETED|Open Phase (Week 24 up to Week 54)||110
8381775|NCT01100307|20660151|P2|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
8381776|NCT01100307|20660152|P1|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
8381777|NCT01100307|20660151|P2|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
8381778|NCT01100307|20660152|P1|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
8381779|NCT01100307|20660151|P2|COMPLETED|Double Masked Phase (Up to Week 24)||116
8381780|NCT01100307|20660152|P1|COMPLETED|Double Masked Phase (Up to Week 24)||117
8381781|NCT01100307|20660151|P2|STARTED|Double Masked Phase (Up to Week 24)||120
8381782|NCT01100307|20660152|P1|STARTED|Double Masked Phase (Up to Week 24)||123
8381783|NCT01100268|20660194|P1|NOT COMPLETED|Overall Study||0
8381784|NCT01100268|20660194|P1|COMPLETED|Overall Study||4
8381785|NCT01100268|20660194|P1|STARTED|Overall Study||4
8381786|NCT01100255|20660201|P2|NOT COMPLETED|Overall Study||0
8381787|NCT01100255|20660202|P1|NOT COMPLETED|Overall Study||0
8381788|NCT01100255|20660201|P2|COMPLETED|Overall Study||7
8381789|NCT01100255|20660202|P1|COMPLETED|Overall Study||8
8381790|NCT01100255|20660201|P2|STARTED|Overall Study||7
8381791|NCT01100255|20660202|P1|STARTED|Overall Study||8
8381792|NCT01100242|20660208|P1|NOT COMPLETED|Overall Study||0
8381793|NCT01100242|20660208|P1|COMPLETED|Overall Study||17
8381794|NCT01100242|20660208|P1|STARTED|Overall Study||17
8381795|NCT01100112|20660214|P1|NOT COMPLETED|Overall Study||8
8381796|NCT01100112|20660214|P1|COMPLETED|Overall Study||52
8381797|NCT01100112|20660214|P1|STARTED|Overall Study||60
8381798|NCT01100086|20660221|P2|NOT COMPLETED|Period 2||0
8381799|NCT01100086|20660222|P1|NOT COMPLETED|Period 2||0
8381800|NCT01100086|20660221|P2|COMPLETED|Period 2||41
8381801|NCT01100086|20660222|P1|COMPLETED|Period 2||42
8381802|NCT01100086|20660221|P2|STARTED|Period 2||41
8381803|NCT01100086|20660222|P1|STARTED|Period 2||42
8381804|NCT01100086|20660221|P2|NOT COMPLETED|Period 1||0
8381805|NCT01100086|20660222|P1|NOT COMPLETED|Period 1||1
8381806|NCT01100086|20660221|P2|COMPLETED|Period 1||41
8381807|NCT01100086|20660222|P1|COMPLETED|Period 1||42
8381808|NCT01100086|20660221|P2|STARTED|Period 1||41
8381809|NCT01100086|20660222|P1|STARTED|Period 1||43
8381810|NCT01100073|20660232|P1|NOT COMPLETED|Overall Study||100
8381811|NCT01100073|20660232|P1|COMPLETED|Overall Study|End of study (Visit 3)|1599
8381812|NCT01100073|20660232|P1|STARTED|Overall Study|Baseline (Visit 1)|1699
8381813|NCT01100034|20660247|P1|NOT COMPLETED|Overall Study||43
8381814|NCT01100034|20660247|P1|COMPLETED|Overall Study||29
8381815|NCT01100034|20660247|P1|STARTED|Overall Study||72
8381816|NCT01099969|20660260|P4|NOT COMPLETED|Overall Study||0
8381817|NCT01099969|20660261|P3|NOT COMPLETED|Overall Study||0
8381818|NCT01099969|20660262|P2|NOT COMPLETED|Overall Study||0
8381819|NCT01099969|20660263|P1|NOT COMPLETED|Overall Study||0
8381820|NCT01099969|20660260|P4|COMPLETED|Overall Study||15
8381821|NCT01099969|20660261|P3|COMPLETED|Overall Study||15
8381822|NCT01099969|20660262|P2|COMPLETED|Overall Study||15
8381823|NCT01099969|20660263|P1|COMPLETED|Overall Study||15
8381824|NCT01099969|20660260|P4|STARTED|Overall Study||15
8381825|NCT01099969|20660261|P3|STARTED|Overall Study||15
8381826|NCT01099969|20660262|P2|STARTED|Overall Study||15
8381827|NCT01099969|20660263|P1|STARTED|Overall Study||15
8381828|NCT01099917|20660285|P1|NOT COMPLETED|Overall Study||27
8381829|NCT01099917|20660285|P1|COMPLETED|Overall Study||18
8381830|NCT01099917|20660285|P1|STARTED|Overall Study||45
8381831|NCT01099774|20660291|P2|NOT COMPLETED|Overall Study||6
8381832|NCT01099774|20660292|P1|NOT COMPLETED|Overall Study||6
8381833|NCT01099774|20660291|P2|COMPLETED|Overall Study||289
8381834|NCT01099774|20660292|P1|COMPLETED|Overall Study||296
8381835|NCT01099774|20660291|P2|STARTED|Overall Study||295
8381836|NCT01099774|20660292|P1|STARTED|Overall Study||302
8381837|NCT01099761|20660308|P4|NOT COMPLETED|Overall Study||0
8381838|NCT01099761|20660309|P3|NOT COMPLETED|Overall Study||0
8381839|NCT01099761|20660310|P2|NOT COMPLETED|Overall Study||0
8381840|NCT01099761|20660311|P1|NOT COMPLETED|Overall Study||0
8381841|NCT01099761|20660308|P4|COMPLETED|Overall Study||6
8381842|NCT01099761|20660309|P3|COMPLETED|Overall Study||0
8381843|NCT01099761|20660310|P2|COMPLETED|Overall Study||9
8381844|NCT01099761|20660311|P1|COMPLETED|Overall Study||9
8381845|NCT01099761|20660308|P4|STARTED|Overall Study||6
8381846|NCT01099761|20660309|P3|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
8381847|NCT01099761|20660310|P2|STARTED|Overall Study||9
8381848|NCT01099761|20660311|P1|STARTED|Overall Study||9
8381849|NCT01099709|20660347|P2|NOT COMPLETED|Period 2||0
8381850|NCT01099709|20660348|P1|NOT COMPLETED|Period 2||0
8381851|NCT01099709|20660347|P2|COMPLETED|Period 2||41
8381852|NCT01099709|20660348|P1|COMPLETED|Period 2||41
8381853|NCT01099709|20660347|P2|STARTED|Period 2||41
8381854|NCT01099709|20660348|P1|STARTED|Period 2||41
8381855|NCT01099709|20660347|P2|NOT COMPLETED|Period 1||2
8381856|NCT01099709|20660348|P1|NOT COMPLETED|Period 1||1
8381857|NCT01099709|20660347|P2|COMPLETED|Period 1||41
8381858|NCT01099709|20660348|P1|COMPLETED|Period 1||41
8381859|NCT01099709|20660347|P2|STARTED|Period 1||43
8381860|NCT01099709|20660348|P1|STARTED|Period 1||42
8381861|NCT01099631|20660364|P6|NOT COMPLETED|Overall Study||0
8381862|NCT01099631|20660365|P5|NOT COMPLETED|Overall Study||0
8381863|NCT01099631|20660366|P4|NOT COMPLETED|Overall Study||0
8381864|NCT01099631|20660367|P3|NOT COMPLETED|Overall Study||0
8381866|NCT01099631|20660369|P1|NOT COMPLETED|Overall Study||0
8381867|NCT01099631|20660364|P6|COMPLETED|Overall Study||4
8381868|NCT01099631|20660365|P5|COMPLETED|Overall Study||3
8381869|NCT01099631|20660366|P4|COMPLETED|Overall Study||3
8381870|NCT01099631|20660367|P3|COMPLETED|Overall Study||3
8381871|NCT01099631|20660368|P2|COMPLETED|Overall Study||3
8381872|NCT01099631|20660369|P1|COMPLETED|Overall Study||6
8381873|NCT01099631|20660364|P6|STARTED|Overall Study||4
8381874|NCT01099631|20660365|P5|STARTED|Overall Study||3
8381875|NCT01099631|20660366|P4|STARTED|Overall Study||3
8381876|NCT01099631|20660367|P3|STARTED|Overall Study||3
8381877|NCT01099631|20660368|P2|STARTED|Overall Study||3
8381878|NCT01099631|20660369|P1|STARTED|Overall Study||6
8381879|NCT01099618|20660404|P3|NOT COMPLETED|Overall Study||0
8381880|NCT01099618|20660405|P2|NOT COMPLETED|Overall Study||0
8381881|NCT01099618|20660406|P1|NOT COMPLETED|Overall Study||0
8381882|NCT01099618|20660404|P3|COMPLETED|Overall Study||15
8381883|NCT01099618|20660405|P2|COMPLETED|Overall Study||16
8381884|NCT01099618|20660406|P1|COMPLETED|Overall Study||17
8381885|NCT01099618|20660404|P3|STARTED|Overall Study||15
8381886|NCT01099618|20660405|P2|STARTED|Overall Study||16
8381887|NCT01099618|20660406|P1|STARTED|Overall Study||17
8381888|NCT01099579|20660417|P3|NOT COMPLETED|Stage 2 (ATV Capsule)||6
8381889|NCT01099579|20660418|P2|NOT COMPLETED|Stage 2 (ATV Capsule)||5
8381890|NCT01099579|20660419|P1|NOT COMPLETED|Stage 2 (ATV Capsule)||6
8381891|NCT01099579|20660417|P3|COMPLETED|Stage 2 (ATV Capsule)||9
8381892|NCT01099579|20660418|P2|COMPLETED|Stage 2 (ATV Capsule)||9
8381893|NCT01099579|20660419|P1|COMPLETED|Stage 2 (ATV Capsule)||10
8381894|NCT01099579|20660417|P3|STARTED|Stage 2 (ATV Capsule)||15
8381895|NCT01099579|20660418|P2|STARTED|Stage 2 (ATV Capsule)||14
8381896|NCT01099579|20660419|P1|STARTED|Stage 2 (ATV Capsule)||16
8381897|NCT01099579|20660417|P3|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
8381898|NCT01099579|20660418|P2|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
8381899|NCT01099579|20660419|P1|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
8381900|NCT01099579|20660417|P3|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
8381901|NCT01099579|20660418|P2|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
8381902|NCT01099579|20660419|P1|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
8381903|NCT01099579|20660417|P3|STARTED|Stage 1 (ATV Powder Formulation)||16
8381904|NCT01099579|20660418|P2|STARTED|Stage 1 (ATV Powder Formulation)||19
8381905|NCT01099579|20660419|P1|STARTED|Stage 1 (ATV Powder Formulation)||21
8381906|NCT01099475|20660475|P2|NOT COMPLETED|Overall Study||0
8381907|NCT01099475|20660476|P1|NOT COMPLETED|Overall Study||0
8381908|NCT01099475|20660475|P2|COMPLETED|Overall Study||10
8381909|NCT01099475|20660476|P1|COMPLETED|Overall Study||10
8381910|NCT01099475|20660475|P2|STARTED|Overall Study||10
8381911|NCT01099475|20660476|P1|STARTED|Overall Study||10
8381912|NCT01099449|20660491|P3|NOT COMPLETED|Overall Study||0
8381913|NCT01099449|20660492|P2|NOT COMPLETED|Overall Study||0
8381914|NCT01099449|20660493|P1|NOT COMPLETED|Overall Study||0
8381915|NCT01099449|20660491|P3|COMPLETED|Overall Study||116
8381916|NCT01099449|20660492|P2|COMPLETED|Overall Study||119
8381917|NCT01099449|20660493|P1|COMPLETED|Overall Study||118
8381918|NCT01099449|20660491|P3|STARTED|Overall Study||116
8381919|NCT01099449|20660492|P2|STARTED|Overall Study||119
8381920|NCT01099449|20660493|P1|STARTED|Overall Study||118
8381921|NCT01099397|20660528|P1|NOT COMPLETED|Overall Study||13
8381922|NCT01099397|20660528|P1|COMPLETED|Overall Study||26
8381923|NCT01099397|20660528|P1|STARTED|Overall Study||39
8381924|NCT01099358|20660533|P4|NOT COMPLETED|Overall Study||4
8381925|NCT01099358|20660534|P3|NOT COMPLETED|Overall Study||8
8381926|NCT01099358|20660535|P2|NOT COMPLETED|Overall Study||1
8381927|NCT01099358|20660536|P1|NOT COMPLETED|Overall Study||3
8381928|NCT01099358|20660533|P4|COMPLETED|Overall Study||12
8381929|NCT01099358|20660534|P3|COMPLETED|Overall Study||13
8381930|NCT01099358|20660535|P2|COMPLETED|Overall Study||5
8381931|NCT01099358|20660536|P1|COMPLETED|Overall Study||1
8381932|NCT01099358|20660533|P4|Received at Least One Dose of Study Drug|Overall Study||15
8381933|NCT01099358|20660534|P3|Received at Least One Dose of Study Drug|Overall Study||20
8381934|NCT01099358|20660535|P2|Received at Least One Dose of Study Drug|Overall Study||6
8381935|NCT01099358|20660536|P1|Received at Least One Dose of Study Drug|Overall Study||3
8381936|NCT01099358|20660533|P4|STARTED|Overall Study||16
8381937|NCT01099358|20660534|P3|STARTED|Overall Study||21
8381938|NCT01099358|20660535|P2|STARTED|Overall Study||6
8381939|NCT01099358|20660536|P1|STARTED|Overall Study||4
8381940|NCT01099267|20660555|P1|NOT COMPLETED|MDS-009 Extension Follow-up||0
8381941|NCT01099267|20660555|P1|COMPLETED|MDS-009 Extension Follow-up||54
8381942|NCT01099267|20660555|P1|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
8381943|NCT01099267|20660555|P1|Informed Consent Given|MDS-009 Extension Follow-up||33
8381944|NCT01099267|20660555|P1|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
8381945|NCT01099267|20660555|P1|NOT COMPLETED|MDS-003 Study||124
8381946|NCT01099267|20660555|P1|COMPLETED|MDS-003 Study||24
8381947|NCT01099267|20660555|P1|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
8381954|NCT01099202|20660604|P2|NOT COMPLETED|Overall Study||0
8381955|NCT01099202|20660605|P1|NOT COMPLETED|Overall Study||0
8381956|NCT01099202|20660604|P2|COMPLETED|Overall Study||54
8381957|NCT01099202|20660605|P1|COMPLETED|Overall Study||55
8381958|NCT01099202|20660604|P2|STARTED|Overall Study||54
8381959|NCT01099202|20660605|P1|STARTED|Overall Study||55
8381960|NCT01099111|20660618|P5|NOT COMPLETED|Overall Study||0
8381961|NCT01099111|20660619|P4|NOT COMPLETED|Overall Study||0
8381962|NCT01099111|20660620|P3|NOT COMPLETED|Overall Study||0
8381963|NCT01099111|20660621|P2|NOT COMPLETED|Overall Study||0
8381964|NCT01099111|20660622|P1|NOT COMPLETED|Overall Study||0
8381965|NCT01099111|20660618|P5|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
8381966|NCT01099111|20660619|P4|COMPLETED|Overall Study||29
8381967|NCT01099111|20660620|P3|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
8381968|NCT01099111|20660621|P2|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
8381969|NCT01099111|20660622|P1|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
8381970|NCT01099111|20660618|P5|STARTED|Overall Study||50
8381971|NCT01099111|20660619|P4|STARTED|Overall Study||29
8381972|NCT01099111|20660620|P3|STARTED|Overall Study||46
8381973|NCT01099111|20660621|P2|STARTED|Overall Study||50
8381974|NCT01099111|20660622|P1|STARTED|Overall Study||50
8381975|NCT01098851|20660636|P2|NOT COMPLETED|Overall Study||0
8381976|NCT01098851|20660637|P1|NOT COMPLETED|Overall Study||1
8381977|NCT01098851|20660636|P2|COMPLETED|Overall Study||10
8381978|NCT01098851|20660637|P1|COMPLETED|Overall Study||10
8381979|NCT01098851|20660636|P2|STARTED|Overall Study||10
8381980|NCT01098851|20660637|P1|STARTED|Overall Study||11
8381981|NCT01098812|20660648|P3|NOT COMPLETED|Overall Study||1
8381982|NCT01098812|20660649|P2|NOT COMPLETED|Overall Study||1
8381983|NCT01098812|20660650|P1|NOT COMPLETED|Overall Study||2
8381984|NCT01098812|20660648|P3|COMPLETED|Overall Study||71
8381985|NCT01098812|20660649|P2|COMPLETED|Overall Study||101
8381986|NCT01098812|20660650|P1|COMPLETED|Overall Study||93
8381987|NCT01098812|20660648|P3|STARTED|Overall Study||72
8381988|NCT01098812|20660649|P2|STARTED|Overall Study||102
8381989|NCT01098812|20660650|P1|STARTED|Overall Study||95
8381990|NCT01098747|20660664|P4|NOT COMPLETED|Overall Study||0
8381991|NCT01098747|20660665|P3|NOT COMPLETED|Overall Study||0
8381992|NCT01098747|20660666|P2|NOT COMPLETED|Overall Study||0
8381993|NCT01098747|20660667|P1|NOT COMPLETED|Overall Study||0
8381994|NCT01098747|20660664|P4|COMPLETED|Overall Study||87
8381995|NCT01098747|20660665|P3|COMPLETED|Overall Study||86
8381996|NCT01098747|20660666|P2|COMPLETED|Overall Study||95
8381997|NCT01098747|20660667|P1|COMPLETED|Overall Study||48
8381998|NCT01098747|20660664|P4|STARTED|Overall Study||87
8381999|NCT01098747|20660665|P3|STARTED|Overall Study||86
8382000|NCT01098747|20660666|P2|STARTED|Overall Study||95
8382001|NCT01098747|20660667|P1|STARTED|Overall Study||48
8382002|NCT01098578|20660717|P1|NOT COMPLETED|Overall Study||0
8382003|NCT01098578|20660717|P1|COMPLETED|Overall Study||20
8382004|NCT01098578|20660717|P1|STARTED|Overall Study||20
8382005|NCT01098539|20660726|P2|NOT COMPLETED|Overall Study||68
8382006|NCT01098539|20660727|P1|NOT COMPLETED|Overall Study||51
8382007|NCT01098539|20660726|P2|COMPLETED|Overall Study||178
8382008|NCT01098539|20660727|P1|COMPLETED|Overall Study||198
8382009|NCT01098539|20660726|P2|STARTED|Overall Study||246
8382010|NCT01098539|20660727|P1|STARTED|Overall Study||249
8382011|NCT01098500|20660763|P1|NOT COMPLETED|Overall Study||0
8382012|NCT01098500|20660763|P1|COMPLETED|Overall Study||3800
8382013|NCT01098500|20660763|P1|STARTED|Overall Study||3800
8382014|NCT01098487|20660778|P1|NOT COMPLETED|Overall Study||44
8382015|NCT01098487|20660778|P1|COMPLETED|Overall Study||118
8382016|NCT01098487|20660778|P1|STARTED|Overall Study||162
8382017|NCT01098474|20660796|P6|NOT COMPLETED|Follow Up Phase||5
8382018|NCT01098474|20660797|P5|NOT COMPLETED|Follow Up Phase||2
8382019|NCT01098474|20660798|P4|NOT COMPLETED|Follow Up Phase||2
8382020|NCT01098474|20660799|P3|NOT COMPLETED|Follow Up Phase||0
8382021|NCT01098474|20660800|P2|NOT COMPLETED|Follow Up Phase||0
8382022|NCT01098474|20660801|P1|NOT COMPLETED|Follow Up Phase||0
8382023|NCT01098474|20660796|P6|COMPLETED|Follow Up Phase||44
8382024|NCT01098474|20660797|P5|COMPLETED|Follow Up Phase||50
8382025|NCT01098474|20660798|P4|COMPLETED|Follow Up Phase||47
8382026|NCT01098474|20660799|P3|COMPLETED|Follow Up Phase||45
8382027|NCT01098474|20660800|P2|COMPLETED|Follow Up Phase||49
8382028|NCT01098474|20660801|P1|COMPLETED|Follow Up Phase||48
8382029|NCT01098474|20660796|P6|STARTED|Follow Up Phase||49
8382030|NCT01098474|20660797|P5|STARTED|Follow Up Phase||52
8382031|NCT01098474|20660798|P4|STARTED|Follow Up Phase||49
8382032|NCT01098474|20660799|P3|STARTED|Follow Up Phase||45
8382033|NCT01098474|20660800|P2|STARTED|Follow Up Phase||49
8382034|NCT01098474|20660801|P1|STARTED|Follow Up Phase||48
8382035|NCT01098474|20660796|P6|NOT COMPLETED|Active Phase||0
8382036|NCT01098474|20660797|P5|NOT COMPLETED|Active Phase||0
8382037|NCT01098474|20660798|P4|NOT COMPLETED|Active Phase||0
8382038|NCT01098474|20660799|P3|NOT COMPLETED|Active Phase||5
8382039|NCT01098474|20660800|P2|NOT COMPLETED|Active Phase||1
8382040|NCT01098474|20660801|P1|NOT COMPLETED|Active Phase||2
8382041|NCT01098474|20660796|P6|COMPLETED|Active Phase||49
8382042|NCT01098474|20660797|P5|COMPLETED|Active Phase||52
8382043|NCT01098474|20660798|P4|COMPLETED|Active Phase||49
8382044|NCT01098474|20660799|P3|COMPLETED|Active Phase||45
8382045|NCT01098474|20660800|P2|COMPLETED|Active Phase||49
8382046|NCT01098474|20660801|P1|COMPLETED|Active Phase||48
8382047|NCT01098474|20660796|P6|STARTED|Active Phase||49
8382048|NCT01098474|20660797|P5|STARTED|Active Phase||52
8382049|NCT01098474|20660798|P4|STARTED|Active Phase||49
8382050|NCT01098474|20660799|P3|STARTED|Active Phase||50
8382051|NCT01098474|20660800|P2|STARTED|Active Phase||50
8382052|NCT01098474|20660801|P1|STARTED|Active Phase||50
8382053|NCT01098461|20661035|P4|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
8382054|NCT01098461|20661036|P3|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
8382055|NCT01098461|20661037|P2|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
8382056|NCT01098461|20661038|P1|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
8382057|NCT01098461|20661035|P4|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
8382058|NCT01098461|20661036|P3|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
8382059|NCT01098461|20661037|P2|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
8382060|NCT01098461|20661038|P1|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
8382061|NCT01098461|20661035|P4|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
8382062|NCT01098461|20661036|P3|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
8382063|NCT01098461|20661037|P2|STARTED|Follow-up (FU) Period (8 Weeks)||52
8382064|NCT01098461|20661038|P1|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
8382065|NCT01098461|20661035|P4|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
8382066|NCT01098461|20661036|P3|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
8382067|NCT01098461|20661037|P2|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
8382068|NCT01098461|20661038|P1|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
8382069|NCT01098461|20661035|P4|COMPLETED|Treatment Period (TP) (16 Weeks)||50
8382070|NCT01098461|20661036|P3|COMPLETED|Treatment Period (TP) (16 Weeks)||53
8382071|NCT01098461|20661037|P2|COMPLETED|Treatment Period (TP) (16 Weeks)||45
8382072|NCT01098461|20661038|P1|COMPLETED|Treatment Period (TP) (16 Weeks)||41
8382073|NCT01098461|20661035|P4|STARTED|Treatment Period (TP) (16 Weeks)||53
8382074|NCT01098461|20661036|P3|STARTED|Treatment Period (TP) (16 Weeks)||54
8382075|NCT01098461|20661037|P2|STARTED|Treatment Period (TP) (16 Weeks)||52
8382076|NCT01098461|20661038|P1|STARTED|Treatment Period (TP) (16 Weeks)||53
8382077|NCT01098318|20661071|P3|NOT COMPLETED|Overall Study||3
8382078|NCT01098318|20661072|P2|NOT COMPLETED|Overall Study||7
8382079|NCT01098318|20661073|P1|NOT COMPLETED|Overall Study||3
8382080|NCT01098318|20661071|P3|COMPLETED|Overall Study||15
8382081|NCT01098318|20661072|P2|COMPLETED|Overall Study||12
8382082|NCT01098318|20661073|P1|COMPLETED|Overall Study||17
8382083|NCT01098318|20661071|P3|STARTED|Overall Study||18
8382084|NCT01098318|20661072|P2|STARTED|Overall Study||19
8382085|NCT01098318|20661073|P1|STARTED|Overall Study||20
8382086|NCT01098305|20661098|P2|NOT COMPLETED|Overall Study||33
8382087|NCT01098305|20661099|P1|NOT COMPLETED|Overall Study||31
8382088|NCT01098305|20661098|P2|COMPLETED|Overall Study||85
8382089|NCT01098305|20661099|P1|COMPLETED|Overall Study||88
8382090|NCT01098305|20661098|P2|STARTED|Overall Study||118
8382091|NCT01098305|20661099|P1|STARTED|Overall Study||119
8382092|NCT01098266|20661109|P2|NOT COMPLETED|Overall Study||7
8382093|NCT01098266|20661110|P1|NOT COMPLETED|Overall Study||7
8382094|NCT01098266|20661109|P2|COMPLETED|Overall Study||193
8382095|NCT01098266|20661110|P1|COMPLETED|Overall Study||193
8382096|NCT01098266|20661109|P2|STARTED|Overall Study||200
8382097|NCT01098266|20661110|P1|STARTED|Overall Study||200
8382098|NCT01098253|20661130|P2|NOT COMPLETED|Overall Study||0
8382099|NCT01098253|20661131|P1|NOT COMPLETED|Overall Study||2
8382100|NCT01098253|20661130|P2|COMPLETED|Overall Study||88
8382101|NCT01098253|20661131|P1|COMPLETED|Overall Study||92
8382102|NCT01098253|20661130|P2|STARTED|Overall Study||88
8382103|NCT01098253|20661131|P1|STARTED|Overall Study||94
8382122|NCT01098162|20661171|P1|NOT COMPLETED|Overall Study||112
8382123|NCT01098162|20661171|P1|COMPLETED|Overall Study||461
8382124|NCT01098162|20661171|P1|STARTED|Overall Study||573
8382125|NCT01098110|20661183|P3|NOT COMPLETED|Overall Study||94
8382126|NCT01098110|20661184|P2|NOT COMPLETED|Overall Study||73
8382127|NCT01098110|20661185|P1|NOT COMPLETED|Overall Study||62
8382128|NCT01098110|20661183|P3|COMPLETED|Overall Study||80
8382129|NCT01098110|20661184|P2|COMPLETED|Overall Study||109
8382130|NCT01098110|20661185|P1|COMPLETED|Overall Study||114
8382131|NCT01098110|20661183|P3|Treated|Overall Study|Received at least one dose of trial medication|174
8382132|NCT01098110|20661184|P2|Treated|Overall Study|Received at least one dose of trial medication|181
8382133|NCT01098110|20661185|P1|Treated|Overall Study|Received at least one dose of trial medication|175
8382134|NCT01098110|20661183|P3|STARTED|Overall Study|Randomized participants|174
8382135|NCT01098110|20661184|P2|STARTED|Overall Study|Randomized participants|182
8382136|NCT01098110|20661185|P1|STARTED|Overall Study|Randomized participants|176
8382137|NCT01098097|20661226|P1|NOT COMPLETED|Overall Study||82
8382138|NCT01098097|20661226|P1|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
8382139|NCT01098097|20661226|P1|STARTED|Overall Study||963
8382140|NCT01098071|20661235|P1|NOT COMPLETED|Overall Study||15
8382141|NCT01098071|20661235|P1|COMPLETED|Overall Study||19
8382142|NCT01098071|20661235|P1|STARTED|Overall Study||34
8382143|NCT01098032|20661248|P2|NOT COMPLETED|Overall Study||1
8382144|NCT01098032|20661249|P1|NOT COMPLETED|Overall Study||1
8382145|NCT01098032|20661248|P2|COMPLETED|Overall Study||146
8382146|NCT01098032|20661249|P1|COMPLETED|Overall Study||146
8382147|NCT01098032|20661248|P2|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
8382148|NCT01098032|20661249|P1|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
8382149|NCT01098006|20661259|P4|NOT COMPLETED|Overall Study||0
8382150|NCT01098006|20661260|P3|NOT COMPLETED|Overall Study||0
8382151|NCT01098006|20661261|P2|NOT COMPLETED|Overall Study||0
8382152|NCT01098006|20661262|P1|NOT COMPLETED|Overall Study||0
8382153|NCT01098006|20661259|P4|COMPLETED|Overall Study||21
8382154|NCT01098006|20661260|P3|COMPLETED|Overall Study||60
8382155|NCT01098006|20661261|P2|COMPLETED|Overall Study||11
8382156|NCT01098006|20661262|P1|COMPLETED|Overall Study||7
8382157|NCT01098006|20661259|P4|STARTED|Overall Study||21
8382158|NCT01098006|20661260|P3|STARTED|Overall Study||60
8382159|NCT01098006|20661261|P2|STARTED|Overall Study||11
8382160|NCT01098006|20661262|P1|STARTED|Overall Study||7
8382161|NCT01097915|20661339|P3|NOT COMPLETED|Overall Study||30
8382162|NCT01097915|20661340|P2|NOT COMPLETED|Overall Study||42
8382163|NCT01097915|20661341|P1|NOT COMPLETED|Overall Study||23
8382164|NCT01097915|20661339|P3|COMPLETED|Overall Study||20
8382165|NCT01097915|20661340|P2|COMPLETED|Overall Study||28
8382166|NCT01097915|20661341|P1|COMPLETED|Overall Study||27
8382167|NCT01097915|20661339|P3|STARTED|Overall Study||50
8382168|NCT01097915|20661340|P2|STARTED|Overall Study||70
8382169|NCT01097915|20661341|P1|STARTED|Overall Study||50
8382170|NCT01097863|20661366|P3|NOT COMPLETED|Overall Study||2
8382171|NCT01097863|20661367|P2|NOT COMPLETED|Overall Study||0
8382172|NCT01097863|20661368|P1|NOT COMPLETED|Overall Study||1
8382173|NCT01097863|20661366|P3|COMPLETED|Overall Study||89
8382174|NCT01097863|20661367|P2|COMPLETED|Overall Study||98
8382175|NCT01097863|20661368|P1|COMPLETED|Overall Study||89
8382176|NCT01097863|20661366|P3|STARTED|Overall Study||91
8382177|NCT01097863|20661367|P2|STARTED|Overall Study||98
8382178|NCT01097863|20661368|P1|STARTED|Overall Study||90
8382179|NCT01097785|20661378|P2|NOT COMPLETED|Cycle 3 (30 Days)||0
8382180|NCT01097785|20661379|P1|NOT COMPLETED|Cycle 3 (30 Days)||0
8382181|NCT01097785|20661378|P2|COMPLETED|Cycle 3 (30 Days)||6
8382182|NCT01097785|20661379|P1|COMPLETED|Cycle 3 (30 Days)||6
8382183|NCT01097785|20661378|P2|STARTED|Cycle 3 (30 Days)||6
8382184|NCT01097785|20661379|P1|STARTED|Cycle 3 (30 Days)||6
8382185|NCT01097785|20661378|P2|NOT COMPLETED|Washout (2 Weeks)||0
8382186|NCT01097785|20661379|P1|NOT COMPLETED|Washout (2 Weeks)||0
8382187|NCT01097785|20661378|P2|COMPLETED|Washout (2 Weeks)||6
8382188|NCT01097785|20661379|P1|COMPLETED|Washout (2 Weeks)||6
8382189|NCT01097785|20661378|P2|STARTED|Washout (2 Weeks)||6
8382190|NCT01097785|20661379|P1|STARTED|Washout (2 Weeks)||6
8382191|NCT01097785|20661378|P2|NOT COMPLETED|Cycle 1 (30 Days)||0
8382192|NCT01097785|20661379|P1|NOT COMPLETED|Cycle 1 (30 Days)||0
8382193|NCT01097785|20661378|P2|COMPLETED|Cycle 1 (30 Days)||6
8382194|NCT01097785|20661379|P1|COMPLETED|Cycle 1 (30 Days)||6
8382195|NCT01097785|20661378|P2|STARTED|Cycle 1 (30 Days)||6
8382196|NCT01097785|20661379|P1|STARTED|Cycle 1 (30 Days)||6
8382197|NCT01097707|20661392|P5|NOT COMPLETED|Overall Study||50
8382198|NCT01097707|20661393|P4|NOT COMPLETED|Overall Study||44
8382199|NCT01097707|20661394|P3|NOT COMPLETED|Overall Study||45
8382200|NCT01097707|20661395|P2|NOT COMPLETED|Overall Study||43
8382201|NCT01097707|20661396|P1|NOT COMPLETED|Overall Study||44
8382202|NCT01097707|20661392|P5|COMPLETED|Overall Study||35
8382203|NCT01097707|20661393|P4|COMPLETED|Overall Study||40
8382204|NCT01097707|20661394|P3|COMPLETED|Overall Study||37
8382205|NCT01097707|20661395|P2|COMPLETED|Overall Study||37
8382206|NCT01097707|20661396|P1|COMPLETED|Overall Study||39
8382207|NCT01097707|20661392|P5|STARTED|Overall Study||85
8382208|NCT01097707|20661393|P4|STARTED|Overall Study||84
8382209|NCT01097707|20661394|P3|STARTED|Overall Study||82
8382210|NCT01097707|20661395|P2|STARTED|Overall Study||80
8382211|NCT01097707|20661396|P1|STARTED|Overall Study||83
8382212|NCT01097694|20661445|P2|NOT COMPLETED|Overall Study||4
8382213|NCT01097694|20661446|P1|NOT COMPLETED|Overall Study||8
8382214|NCT01097694|20661445|P2|COMPLETED|Overall Study||26
8382215|NCT01097694|20661446|P1|COMPLETED|Overall Study||24
8382216|NCT01097694|20661445|P2|STARTED|Overall Study||30
8382217|NCT01097694|20661446|P1|STARTED|Overall Study||32
8382218|NCT01097668|20661508|P2|NOT COMPLETED|Overall Study||2
8382219|NCT01097668|20661509|P1|NOT COMPLETED|Overall Study||2
8382220|NCT01097668|20661508|P2|COMPLETED|Overall Study||20
8382221|NCT01097668|20661509|P1|COMPLETED|Overall Study||19
8382222|NCT01097668|20661508|P2|Week 48|Overall Study||20
8382223|NCT01097668|20661509|P1|Week 48|Overall Study||19
8382224|NCT01097668|20661508|P2|Week 20|Overall Study|Patient evaluability time point = week 20|22
8382225|NCT01097668|20661509|P1|Week 20|Overall Study|Patient evaluability time point = week 20|21
8382226|NCT01097668|20661508|P2|STARTED|Overall Study||22
8382227|NCT01097668|20661509|P1|STARTED|Overall Study||21
8382228|NCT01097655|20661519|P1|NOT COMPLETED|Overall Study||10
8382229|NCT01097655|20661519|P1|COMPLETED|Overall Study|participants included for analysis|3039
8382230|NCT01097655|20661519|P1|STARTED|Overall Study||3049
8382231|NCT01097629|20661529|P8|NOT COMPLETED|DB RO Phase||1
8382232|NCT01097629|20661530|P7|NOT COMPLETED|DB RO Phase||3
8382233|NCT01097629|20661531|P6|NOT COMPLETED|DB RO Phase||1
8382234|NCT01097629|20661532|P5|NOT COMPLETED|DB RO Phase||0
8382235|NCT01097629|20661533|P4|NOT COMPLETED|DB RO Phase||1
8382236|NCT01097629|20661534|P3|NOT COMPLETED|DB RO Phase||0
8382237|NCT01097629|20661535|P2|NOT COMPLETED|DB RO Phase||0
8382238|NCT01097629|20661536|P1|NOT COMPLETED|DB RO Phase||0
8382239|NCT01097629|20661529|P8|COMPLETED|DB RO Phase||326
8382240|NCT01097629|20661530|P7|COMPLETED|DB RO Phase||168
8382241|NCT01097629|20661531|P6|COMPLETED|DB RO Phase||172
8382242|NCT01097629|20661532|P5|COMPLETED|DB RO Phase||108
8382243|NCT01097629|20661533|P4|COMPLETED|DB RO Phase||96
8382244|NCT01097629|20661534|P3|COMPLETED|DB RO Phase||0
8382245|NCT01097629|20661535|P2|COMPLETED|DB RO Phase||0
8382246|NCT01097629|20661536|P1|COMPLETED|DB RO Phase||0
8382247|NCT01097629|20661529|P8|STARTED|DB RO Phase||327
8382248|NCT01097629|20661530|P7|STARTED|DB RO Phase||171
8382249|NCT01097629|20661531|P6|STARTED|DB RO Phase||173
8382250|NCT01097629|20661532|P5|STARTED|DB RO Phase||108
8382251|NCT01097629|20661533|P4|STARTED|DB RO Phase||97
8382252|NCT01097629|20661534|P3|STARTED|DB RO Phase||0
8382253|NCT01097629|20661535|P2|STARTED|DB RO Phase||0
8382254|NCT01097629|20661536|P1|STARTED|DB RO Phase||0
8382255|NCT01097629|20661529|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382256|NCT01097629|20661530|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382257|NCT01097629|20661531|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382258|NCT01097629|20661532|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382259|NCT01097629|20661533|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382260|NCT01097629|20661534|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
8382261|NCT01097629|20661535|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
8382262|NCT01097629|20661536|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
8382263|NCT01097629|20661529|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382264|NCT01097629|20661530|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382265|NCT01097629|20661531|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382266|NCT01097629|20661532|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382267|NCT01097629|20661533|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382268|NCT01097629|20661534|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
8382269|NCT01097629|20661535|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
8382270|NCT01097629|20661536|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
8382271|NCT01097629|20661529|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382272|NCT01097629|20661530|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382273|NCT01097629|20661531|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382274|NCT01097629|20661532|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382275|NCT01097629|20661533|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382276|NCT01097629|20661534|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
8382277|NCT01097629|20661535|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
8382278|NCT01097629|20661536|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
8382279|NCT01097629|20661529|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382280|NCT01097629|20661530|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382281|NCT01097629|20661531|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382282|NCT01097629|20661532|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382283|NCT01097629|20661533|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382284|NCT01097629|20661534|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
8382285|NCT01097629|20661535|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
8382286|NCT01097629|20661536|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
8382287|NCT01097616|20661587|P8|NOT COMPLETED|DB RO Phase||1
8382288|NCT01097616|20661588|P7|NOT COMPLETED|DB RO Phase||1
8382289|NCT01097616|20661589|P6|NOT COMPLETED|DB RO Phase||2
8382290|NCT01097616|20661590|P5|NOT COMPLETED|DB RO Phase||1
8382291|NCT01097616|20661591|P4|NOT COMPLETED|DB RO Phase||1
8382292|NCT01097616|20661592|P3|NOT COMPLETED|DB RO Phase||0
8382293|NCT01097616|20661593|P2|NOT COMPLETED|DB RO Phase||0
8382294|NCT01097616|20661594|P1|NOT COMPLETED|DB RO Phase||0
8382295|NCT01097616|20661587|P8|COMPLETED|DB RO Phase||326
8382296|NCT01097616|20661588|P7|COMPLETED|DB RO Phase||161
8382297|NCT01097616|20661589|P6|COMPLETED|DB RO Phase||159
8382298|NCT01097616|20661590|P5|COMPLETED|DB RO Phase||111
8382299|NCT01097616|20661591|P4|COMPLETED|DB RO Phase||100
8382300|NCT01097616|20661592|P3|COMPLETED|DB RO Phase||0
8382301|NCT01097616|20661593|P2|COMPLETED|DB RO Phase||0
8382302|NCT01097616|20661594|P1|COMPLETED|DB RO Phase||0
8382303|NCT01097616|20661587|P8|STARTED|DB RO Phase||327
8382304|NCT01097616|20661588|P7|STARTED|DB RO Phase||162
8382305|NCT01097616|20661589|P6|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
8382306|NCT01097616|20661590|P5|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
8382307|NCT01097616|20661591|P4|STARTED|DB RO Phase||101
8382308|NCT01097616|20661592|P3|STARTED|DB RO Phase||0
8382309|NCT01097616|20661593|P2|STARTED|DB RO Phase||0
8382310|NCT01097616|20661594|P1|STARTED|DB RO Phase||0
8382311|NCT01097616|20661587|P8|NOT COMPLETED|Optional DB EXT Phase||0
8382312|NCT01097616|20661588|P7|NOT COMPLETED|Optional DB EXT Phase||0
8382313|NCT01097616|20661589|P6|NOT COMPLETED|Optional DB EXT Phase||0
8382314|NCT01097616|20661590|P5|NOT COMPLETED|Optional DB EXT Phase||0
8382315|NCT01097616|20661591|P4|NOT COMPLETED|Optional DB EXT Phase||0
8382316|NCT01097616|20661592|P3|NOT COMPLETED|Optional DB EXT Phase||10
8382317|NCT01097616|20661593|P2|NOT COMPLETED|Optional DB EXT Phase||21
8382318|NCT01097616|20661594|P1|NOT COMPLETED|Optional DB EXT Phase||15
8382319|NCT01097616|20661587|P8|COMPLETED|Optional DB EXT Phase||0
8382320|NCT01097616|20661588|P7|COMPLETED|Optional DB EXT Phase||0
8382321|NCT01097616|20661589|P6|COMPLETED|Optional DB EXT Phase||0
8382322|NCT01097616|20661590|P5|COMPLETED|Optional DB EXT Phase||0
8382323|NCT01097616|20661591|P4|COMPLETED|Optional DB EXT Phase||0
8382324|NCT01097616|20661592|P3|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
8382325|NCT01097616|20661593|P2|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
8382326|NCT01097616|20661594|P1|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
8382327|NCT01097616|20661587|P8|STARTED|Optional DB EXT Phase||0
8382328|NCT01097616|20661588|P7|STARTED|Optional DB EXT Phase||0
8382329|NCT01097616|20661589|P6|STARTED|Optional DB EXT Phase||0
8382330|NCT01097616|20661590|P5|STARTED|Optional DB EXT Phase||0
8382331|NCT01097616|20661591|P4|STARTED|Optional DB EXT Phase||0
8382332|NCT01097616|20661592|P3|STARTED|Optional DB EXT Phase||151
8382333|NCT01097616|20661593|P2|STARTED|Optional DB EXT Phase||172
8382334|NCT01097616|20661594|P1|STARTED|Optional DB EXT Phase||100
8382335|NCT01097616|20661587|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382336|NCT01097616|20661588|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382337|NCT01097616|20661589|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382338|NCT01097616|20661590|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382339|NCT01097616|20661591|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382340|NCT01097616|20661592|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
8382341|NCT01097616|20661593|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
8382342|NCT01097616|20661594|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
8382343|NCT01097616|20661587|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382344|NCT01097616|20661588|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382345|NCT01097616|20661589|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382346|NCT01097616|20661590|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382347|NCT01097616|20661591|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
8382348|NCT01097616|20661592|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
8382349|NCT01097616|20661593|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
8382350|NCT01097616|20661594|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
8382351|NCT01097616|20661587|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382352|NCT01097616|20661588|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382353|NCT01097616|20661589|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382354|NCT01097616|20661590|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382355|NCT01097616|20661591|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
8382356|NCT01097616|20661592|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
8382357|NCT01097616|20661593|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
8382358|NCT01097616|20661594|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
8382359|NCT01097616|20661587|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382360|NCT01097616|20661588|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382361|NCT01097616|20661589|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382362|NCT01097616|20661590|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382363|NCT01097616|20661591|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
8382364|NCT01097616|20661592|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
8382365|NCT01097616|20661593|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
8382366|NCT01097616|20661594|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
8382367|NCT01097577|20661667|P2|NOT COMPLETED|Overall Study||1
8382368|NCT01097577|20661668|P1|NOT COMPLETED|Overall Study||0
8382369|NCT01097577|20661667|P2|COMPLETED|Overall Study||62
8382370|NCT01097577|20661668|P1|COMPLETED|Overall Study||67
8382371|NCT01097577|20661667|P2|STARTED|Overall Study||63
8382372|NCT01097577|20661668|P1|STARTED|Overall Study||67
8382373|NCT01097460|20661684|P1|NOT COMPLETED|Overall Study||0
8382374|NCT01097460|20661684|P1|COMPLETED|Overall Study||16
8382375|NCT01097460|20661684|P1|STARTED|Overall Study||16
8382376|NCT01097421|20661688|P1|NOT COMPLETED|Overall Study||14
8382377|NCT01097421|20661688|P1|COMPLETED|Overall Study||314
8382378|NCT01097421|20661688|P1|STARTED|Overall Study||328
8382379|NCT01097343|20661698|P2|NOT COMPLETED|Second Intervention- 30 Days||0
8382380|NCT01097343|20661699|P1|NOT COMPLETED|Second Intervention- 30 Days||0
8382381|NCT01097343|20661698|P2|COMPLETED|Second Intervention- 30 Days||25
8382382|NCT01097343|20661699|P1|COMPLETED|Second Intervention- 30 Days||25
8382383|NCT01097343|20661698|P2|STARTED|Second Intervention- 30 Days||25
8382384|NCT01097343|20661699|P1|STARTED|Second Intervention- 30 Days||25
8382385|NCT01097343|20661698|P2|NOT COMPLETED|First Intervention- 30 Days||0
8382386|NCT01097343|20661699|P1|NOT COMPLETED|First Intervention- 30 Days||0
8382387|NCT01097343|20661698|P2|COMPLETED|First Intervention- 30 Days||25
8382388|NCT01097343|20661699|P1|COMPLETED|First Intervention- 30 Days||25
8382389|NCT01097343|20661698|P2|STARTED|First Intervention- 30 Days||25
8382390|NCT01097343|20661699|P1|STARTED|First Intervention- 30 Days||25
8382391|NCT01097330|20661707|P2|NOT COMPLETED|Overall Study||5
8382392|NCT01097330|20661708|P1|NOT COMPLETED|Overall Study||7
8382393|NCT01097330|20661707|P2|COMPLETED|Overall Study||0
8382394|NCT01097330|20661708|P1|COMPLETED|Overall Study||0
8382395|NCT01097330|20661707|P2|STARTED|Overall Study||5
8382396|NCT01097330|20661708|P1|STARTED|Overall Study||7
8382397|NCT01097304|20661718|P1|NOT COMPLETED|Overall Study||7
8382398|NCT01097304|20661718|P1|COMPLETED|Overall Study||29
8382399|NCT01097304|20661718|P1|STARTED|Overall Study||36
8382400|NCT01097057|20661725|P1|NOT COMPLETED|Overall Study||3
8382401|NCT01097057|20661725|P1|COMPLETED|Overall Study||17
8382402|NCT01097057|20661725|P1|STARTED|Overall Study||20
8382403|NCT01097044|20661734|P2|NOT COMPLETED|Overall Study||5
8382404|NCT01097044|20661735|P1|NOT COMPLETED|Overall Study||5
8382405|NCT01097044|20661734|P2|COMPLETED|Overall Study||33
8382406|NCT01097044|20661735|P1|COMPLETED|Overall Study||34
8382407|NCT01097044|20661734|P2|STARTED|Overall Study||38
8382408|NCT01097044|20661735|P1|STARTED|Overall Study||39
8382409|NCT01097005|20661753|P1|NOT COMPLETED|Overall Study||365
8382410|NCT01097005|20661753|P1|COMPLETED|Overall Study||101
8382411|NCT01097005|20661753|P1|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
8382412|NCT01097005|20661753|P1|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
8382413|NCT01097005|20661753|P1|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
8382414|NCT01097005|20661753|P1|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
8382415|NCT01097005|20661753|P1|STARTED|Overall Study|number of participants who were enrolled for this study.|466
8382416|NCT01096992|20661764|P5|NOT COMPLETED|Overall Study||0
8382417|NCT01096992|20661765|P4|NOT COMPLETED|Overall Study||0
8382418|NCT01096992|20661766|P3|NOT COMPLETED|Overall Study||0
8382419|NCT01096992|20661767|P2|NOT COMPLETED|Overall Study||0
8382420|NCT01096992|20661768|P1|NOT COMPLETED|Overall Study||0
8382421|NCT01096992|20661764|P5|COMPLETED|Overall Study||30
8382422|NCT01096992|20661765|P4|COMPLETED|Overall Study||6
8382423|NCT01096992|20661766|P3|COMPLETED|Overall Study||6
8382424|NCT01096992|20661767|P2|COMPLETED|Overall Study||3
8382425|NCT01096992|20661768|P1|COMPLETED|Overall Study||6
8382426|NCT01096992|20661764|P5|STARTED|Overall Study||30
8382427|NCT01096992|20661765|P4|STARTED|Overall Study||6
8382428|NCT01096992|20661766|P3|STARTED|Overall Study||6
8382429|NCT01096992|20661767|P2|STARTED|Overall Study||3
8382430|NCT01096992|20661768|P1|STARTED|Overall Study||6
8382431|NCT01096875|20661783|P2|NOT COMPLETED|Overall Study||1
8382432|NCT01096875|20661784|P1|NOT COMPLETED|Overall Study||0
8382433|NCT01096875|20661783|P2|COMPLETED|Overall Study||29
8382434|NCT01096875|20661784|P1|COMPLETED|Overall Study||30
8382435|NCT01096875|20661783|P2|STARTED|Overall Study||30
8382436|NCT01096875|20661784|P1|STARTED|Overall Study||30
8382437|NCT01096849|20661799|P3|NOT COMPLETED|Overall Study||6
8382438|NCT01096849|20661800|P2|NOT COMPLETED|Overall Study||12
8382439|NCT01096849|20661801|P1|NOT COMPLETED|Overall Study||2
8382440|NCT01096849|20661799|P3|COMPLETED|Overall Study||41
8382441|NCT01096849|20661800|P2|COMPLETED|Overall Study||64
8382442|NCT01096849|20661801|P1|COMPLETED|Overall Study||20
8382443|NCT01096849|20661799|P3|STARTED|Overall Study||47
8382444|NCT01096849|20661800|P2|STARTED|Overall Study||76
8382445|NCT01096849|20661801|P1|STARTED|Overall Study||22
8382446|NCT01096823|20661856|P2|NOT COMPLETED|Overall Study||1
8382447|NCT01096823|20661857|P1|NOT COMPLETED|Overall Study||3
8382448|NCT01096823|20661856|P2|COMPLETED|Overall Study||15
8382449|NCT01096823|20661857|P1|COMPLETED|Overall Study||11
8382450|NCT01096823|20661856|P2|STARTED|Overall Study||16
8382451|NCT01096823|20661857|P1|STARTED|Overall Study||14
8382452|NCT01096810|20661869|P1|NOT COMPLETED|Overall Study||0
8382453|NCT01096810|20661869|P1|COMPLETED|Overall Study||20
8382454|NCT01096810|20661869|P1|STARTED|Overall Study||20
8382461|NCT01096771|20661912|P2|NOT COMPLETED|Overall Study||0
8382462|NCT01096771|20661913|P1|NOT COMPLETED|Overall Study||0
8382463|NCT01096771|20661912|P2|COMPLETED|Overall Study||7
8382464|NCT01096771|20661913|P1|COMPLETED|Overall Study||7
8382465|NCT01096771|20661912|P2|STARTED|Overall Study||7
8382466|NCT01096771|20661913|P1|STARTED|Overall Study||7
8382482|NCT01096667|20661983|P5|NOT COMPLETED|Overall Study||0
8382483|NCT01096667|20661984|P4|NOT COMPLETED|Overall Study||3
8382484|NCT01096667|20661985|P3|NOT COMPLETED|Overall Study||2
8382485|NCT01096667|20661986|P2|NOT COMPLETED|Overall Study||2
8382486|NCT01096667|20661987|P1|NOT COMPLETED|Overall Study||3
8382487|NCT01096667|20661983|P5|COMPLETED|Overall Study||39
8382488|NCT01096667|20661984|P4|COMPLETED|Overall Study||36
8382489|NCT01096667|20661985|P3|COMPLETED|Overall Study||36
8382490|NCT01096667|20661986|P2|COMPLETED|Overall Study||37
8382491|NCT01096667|20661987|P1|COMPLETED|Overall Study||36
8382492|NCT01096667|20661983|P5|Treated|Overall Study||39
8382493|NCT01096667|20661984|P4|Treated|Overall Study||39
8382494|NCT01096667|20661985|P3|Treated|Overall Study||38
8382495|NCT01096667|20661986|P2|Treated|Overall Study||39
8382496|NCT01096667|20661987|P1|Treated|Overall Study||38
8382497|NCT01096667|20661983|P5|STARTED|Overall Study||39
8382498|NCT01096667|20661984|P4|STARTED|Overall Study||39
8382499|NCT01096667|20661985|P3|STARTED|Overall Study||38
8382500|NCT01096667|20661986|P2|STARTED|Overall Study||39
8382501|NCT01096667|20661987|P1|STARTED|Overall Study||39
8382502|NCT01096589|20662129|P4|NOT COMPLETED|Overall Study||3
8382503|NCT01096589|20662130|P3|NOT COMPLETED|Overall Study||4
8382504|NCT01096589|20662131|P2|NOT COMPLETED|Overall Study||2
8382505|NCT01096589|20662132|P1|NOT COMPLETED|Overall Study||4
8382506|NCT01096589|20662129|P4|COMPLETED|Overall Study||15
8382507|NCT01096589|20662130|P3|COMPLETED|Overall Study||18
8382508|NCT01096589|20662131|P2|COMPLETED|Overall Study||18
8382509|NCT01096589|20662132|P1|COMPLETED|Overall Study||18
8382510|NCT01096589|20662129|P4|STARTED|Overall Study||18
8382511|NCT01096589|20662130|P3|STARTED|Overall Study||22
8382512|NCT01096589|20662131|P2|STARTED|Overall Study||20
8382513|NCT01096589|20662132|P1|STARTED|Overall Study||22
8382514|NCT01096550|20662148|P2|NOT COMPLETED|Overall Study||29
8382515|NCT01096550|20662149|P1|NOT COMPLETED|Overall Study||37
8382516|NCT01096550|20662148|P2|COMPLETED|Overall Study||146
8382517|NCT01096550|20662149|P1|COMPLETED|Overall Study||133
8382518|NCT01096550|20662148|P2|STARTED|Overall Study||175
8382519|NCT01096550|20662149|P1|STARTED|Overall Study||170
8382520|NCT01096446|20662157|P2|NOT COMPLETED|Overall Study||0
8382521|NCT01096446|20662158|P1|NOT COMPLETED|Overall Study||3
8382522|NCT01096446|20662157|P2|COMPLETED|Overall Study||10
8382523|NCT01096446|20662158|P1|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
8382524|NCT01096446|20662157|P2|STARTED|Overall Study||10
8382525|NCT01096446|20662158|P1|STARTED|Overall Study||12
8382526|NCT01096342|20662163|P1|NOT COMPLETED|Overall Study||1
8382527|NCT01096342|20662163|P1|COMPLETED|Overall Study||15
8382528|NCT01096342|20662163|P1|STARTED|Overall Study||16
8382529|NCT01096316|20662171|P2|NOT COMPLETED|Overall Study||9
8382530|NCT01096316|20662172|P1|NOT COMPLETED|Overall Study||15
8382531|NCT01096316|20662171|P2|COMPLETED|Overall Study||94
8382532|NCT01096316|20662172|P1|COMPLETED|Overall Study||87
8382533|NCT01096316|20662171|P2|STARTED|Overall Study||103
8382534|NCT01096316|20662172|P1|STARTED|Overall Study||102
8382535|NCT01096290|20662184|P2|NOT COMPLETED|Overall Study||0
8382536|NCT01096290|20662185|P1|NOT COMPLETED|Overall Study||0
8382537|NCT01096290|20662184|P2|COMPLETED|Overall Study||14
8382538|NCT01096290|20662185|P1|COMPLETED|Overall Study||9
8382539|NCT01096290|20662184|P2|STARTED|Overall Study||14
8382540|NCT01096290|20662185|P1|STARTED|Overall Study||9
8382541|NCT01096186|20662193|P1|NOT COMPLETED|Overall Study||50
8382542|NCT01096186|20662193|P1|COMPLETED|Overall Study||567
8382543|NCT01096186|20662193|P1|STARTED|Overall Study||617
8382544|NCT01096160|20662209|P10|NOT COMPLETED|Overall Study||1
8382545|NCT01096160|20662210|P9|NOT COMPLETED|Overall Study||2
8382546|NCT01096160|20662211|P8|NOT COMPLETED|Overall Study||0
8382547|NCT01096160|20662212|P7|NOT COMPLETED|Overall Study||2
8382548|NCT01096160|20662213|P6|NOT COMPLETED|Overall Study||0
8382549|NCT01096160|20662214|P5|NOT COMPLETED|Overall Study||1
8382550|NCT01096160|20662215|P4|NOT COMPLETED|Overall Study||0
8382551|NCT01096160|20662216|P3|NOT COMPLETED|Overall Study||1
8382552|NCT01096160|20662217|P2|NOT COMPLETED|Overall Study||0
8382553|NCT01096160|20662218|P1|NOT COMPLETED|Overall Study||0
8382554|NCT01096160|20662209|P10|COMPLETED|Overall Study||1
8382555|NCT01096160|20662210|P9|COMPLETED|Overall Study||4
8382556|NCT01096160|20662211|P8|COMPLETED|Overall Study||2
8382557|NCT01096160|20662212|P7|COMPLETED|Overall Study||4
8382558|NCT01096160|20662213|P6|COMPLETED|Overall Study||2
8382559|NCT01096160|20662214|P5|COMPLETED|Overall Study||5
8382560|NCT01096160|20662215|P4|COMPLETED|Overall Study||2
8382561|NCT01096160|20662216|P3|COMPLETED|Overall Study||5
8382562|NCT01096160|20662217|P2|COMPLETED|Overall Study||2
8382563|NCT01096160|20662218|P1|COMPLETED|Overall Study||6
8382564|NCT01096160|20662209|P10|STARTED|Overall Study||2
8382565|NCT01096160|20662210|P9|STARTED|Overall Study||6
8382566|NCT01096160|20662211|P8|STARTED|Overall Study||2
8382567|NCT01096160|20662212|P7|STARTED|Overall Study||6
8382568|NCT01096160|20662213|P6|STARTED|Overall Study||2
8382569|NCT01096160|20662214|P5|STARTED|Overall Study||6
8382570|NCT01096160|20662215|P4|STARTED|Overall Study||2
8382571|NCT01096160|20662216|P3|STARTED|Overall Study||6
8382572|NCT01096160|20662217|P2|STARTED|Overall Study||2
8382573|NCT01096160|20662218|P1|STARTED|Overall Study||6
8382574|NCT01096056|20662276|P2|NOT COMPLETED|Overall Study||1
8382575|NCT01096056|20662277|P1|NOT COMPLETED|Overall Study||0
8382576|NCT01096056|20662276|P2|COMPLETED|Overall Study||19
8382577|NCT01096056|20662277|P1|COMPLETED|Overall Study||20
8382578|NCT01096056|20662276|P2|Completed at Day 42|Overall Study||20
8382579|NCT01096056|20662277|P1|Completed at Day 42|Overall Study||20
8382580|NCT01096056|20662276|P2|STARTED|Overall Study||20
8382581|NCT01096056|20662277|P1|STARTED|Overall Study||20
8382582|NCT01096017|20662309|P2|NOT COMPLETED|Treatment Period 2||1
8382583|NCT01096017|20662310|P1|NOT COMPLETED|Treatment Period 2||1
8382584|NCT01096017|20662309|P2|COMPLETED|Treatment Period 2||11
8382585|NCT01096017|20662310|P1|COMPLETED|Treatment Period 2||11
8382586|NCT01096017|20662309|P2|STARTED|Treatment Period 2||12
8382587|NCT01096017|20662310|P1|STARTED|Treatment Period 2||12
8382588|NCT01096017|20662309|P2|NOT COMPLETED|Washout 1 - 14 Days||0
8382589|NCT01096017|20662310|P1|NOT COMPLETED|Washout 1 - 14 Days||0
8382590|NCT01096017|20662309|P2|COMPLETED|Washout 1 - 14 Days||12
8382591|NCT01096017|20662310|P1|COMPLETED|Washout 1 - 14 Days||12
8382592|NCT01096017|20662309|P2|STARTED|Washout 1 - 14 Days||12
8382593|NCT01096017|20662310|P1|STARTED|Washout 1 - 14 Days||12
8382594|NCT01096017|20662309|P2|NOT COMPLETED|Treatment Period 1||0
8382595|NCT01096017|20662310|P1|NOT COMPLETED|Treatment Period 1||0
8382596|NCT01096017|20662309|P2|COMPLETED|Treatment Period 1||12
8382597|NCT01096017|20662310|P1|COMPLETED|Treatment Period 1||12
8382598|NCT01096017|20662309|P2|STARTED|Treatment Period 1||12
8382599|NCT01096017|20662310|P1|STARTED|Treatment Period 1||12
8382600|NCT01095978|20662338|P1|NOT COMPLETED|Overall Study||3
8382601|NCT01095978|20662338|P1|COMPLETED|Overall Study||2819
8382602|NCT01095978|20662338|P1|STARTED|Overall Study||2822
8382603|NCT01095887|20662365|P1|NOT COMPLETED|Overall Study||0
8382604|NCT01095887|20662365|P1|COMPLETED|Overall Study||6
8382605|NCT01095887|20662365|P1|STARTED|Overall Study||6
8382606|NCT01095835|20662372|P3|NOT COMPLETED|Overall Study||8
8382607|NCT01095835|20662373|P2|NOT COMPLETED|Overall Study||12
8382608|NCT01095835|20662374|P1|NOT COMPLETED|Overall Study||10
8382609|NCT01095835|20662372|P3|COMPLETED|Overall Study||17
8382610|NCT01095835|20662373|P2|COMPLETED|Overall Study||40
8382611|NCT01095835|20662374|P1|COMPLETED|Overall Study||41
8382612|NCT01095835|20662372|P3|STARTED|Overall Study||25
8382613|NCT01095835|20662373|P2|STARTED|Overall Study||52
8382614|NCT01095835|20662374|P1|STARTED|Overall Study||51
8382615|NCT01095796|20662412|P2|NOT COMPLETED|Overall Study||289
8382616|NCT01095796|20662413|P1|NOT COMPLETED|Overall Study||295
8382617|NCT01095796|20662412|P2|COMPLETED|Overall Study||65
8382618|NCT01095796|20662413|P1|COMPLETED|Overall Study||58
8382619|NCT01095796|20662412|P2|STARTED|Overall Study||354
8382620|NCT01095796|20662413|P1|STARTED|Overall Study||353
8382621|NCT01095757|20662431|P1|NOT COMPLETED|Overall Study||0
8382622|NCT01095757|20662431|P1|COMPLETED|Overall Study||45
8382623|NCT01095757|20662431|P1|STARTED|Overall Study||45
8382624|NCT01095666|20662443|P3|NOT COMPLETED|Overall Study||7
8382625|NCT01095666|20662444|P2|NOT COMPLETED|Overall Study||11
8382626|NCT01095666|20662445|P1|NOT COMPLETED|Overall Study||17
8382627|NCT01095666|20662443|P3|COMPLETED|Overall Study||145
8382628|NCT01095666|20662444|P2|COMPLETED|Overall Study||136
8382629|NCT01095666|20662445|P1|COMPLETED|Overall Study||128
8382630|NCT01095666|20662443|P3|STARTED|Overall Study||152
8382631|NCT01095666|20662444|P2|STARTED|Overall Study||147
8382632|NCT01095666|20662445|P1|STARTED|Overall Study||145
8382633|NCT01095653|20662468|P3|NOT COMPLETED|Overall Study||16
8382634|NCT01095653|20662469|P2|NOT COMPLETED|Overall Study||15
8382635|NCT01095653|20662470|P1|NOT COMPLETED|Overall Study||19
8382636|NCT01095653|20662468|P3|COMPLETED|Overall Study||117
8382637|NCT01095653|20662469|P2|COMPLETED|Overall Study||113
8382638|NCT01095653|20662470|P1|COMPLETED|Overall Study||113
8382639|NCT01095653|20662468|P3|STARTED|Overall Study||133
8382640|NCT01095653|20662469|P2|STARTED|Overall Study||128
8382641|NCT01095653|20662470|P1|STARTED|Overall Study||132
8382666|NCT01095250|20662528|P4|NOT COMPLETED|Overall Study||5
8382667|NCT01095250|20662529|P3|NOT COMPLETED|Overall Study||8
8382668|NCT01095250|20662530|P2|NOT COMPLETED|Overall Study||10
8382669|NCT01095250|20662531|P1|NOT COMPLETED|Overall Study||8
8382670|NCT01095250|20662528|P4|COMPLETED|Overall Study||0
8382671|NCT01095250|20662529|P3|COMPLETED|Overall Study||0
8382672|NCT01095250|20662530|P2|COMPLETED|Overall Study||0
8382673|NCT01095250|20662531|P1|COMPLETED|Overall Study||0
8382674|NCT01095250|20662528|P4|STARTED|Overall Study||5
8382675|NCT01095250|20662529|P3|STARTED|Overall Study||8
8382676|NCT01095250|20662530|P2|STARTED|Overall Study||10
8382677|NCT01095250|20662531|P1|STARTED|Overall Study||8
8382678|NCT01095094|20662561|P1|NOT COMPLETED|Overall Study||3
8382679|NCT01095094|20662561|P1|COMPLETED|Overall Study||16
8382680|NCT01095094|20662561|P1|STARTED|Overall Study||19
8382681|NCT01095003|20662568|P2|NOT COMPLETED|Overall Study||386
8382682|NCT01095003|20662569|P1|NOT COMPLETED|Overall Study||384
8382683|NCT01095003|20662568|P2|COMPLETED|Overall Study||0
8382684|NCT01095003|20662569|P1|COMPLETED|Overall Study||0
8382685|NCT01095003|20662568|P2|STARTED|Overall Study||386
8382686|NCT01095003|20662569|P1|STARTED|Overall Study||384
8382687|NCT01094886|20662583|P1|NOT COMPLETED|Overall Study||7
8382688|NCT01094886|20662583|P1|COMPLETED|Overall Study||46
8382689|NCT01094886|20662583|P1|STARTED|Overall Study||53
8382690|NCT01094808|20662593|P3|NOT COMPLETED|Overall Study||0
8382691|NCT01094808|20662594|P2|NOT COMPLETED|Overall Study||1
8382692|NCT01094808|20662595|P1|NOT COMPLETED|Overall Study||1
8382693|NCT01094808|20662593|P3|COMPLETED|Overall Study||21
8382694|NCT01094808|20662594|P2|COMPLETED|Overall Study||19
8382695|NCT01094808|20662595|P1|COMPLETED|Overall Study||20
8382696|NCT01094808|20662593|P3|STARTED|Overall Study||21
8382697|NCT01094808|20662594|P2|STARTED|Overall Study||20
8382698|NCT01094808|20662595|P1|STARTED|Overall Study||21
8382699|NCT01094782|20662636|P6|NOT COMPLETED|Overall Study||8
8382700|NCT01094782|20662637|P5|NOT COMPLETED|Overall Study||11
8382701|NCT01094782|20662638|P4|NOT COMPLETED|Overall Study||11
8382702|NCT01094782|20662639|P3|NOT COMPLETED|Overall Study||3
8382703|NCT01094782|20662640|P2|NOT COMPLETED|Overall Study||10
8382704|NCT01094782|20662641|P1|NOT COMPLETED|Overall Study||8
8382705|NCT01094782|20662636|P6|COMPLETED|Overall Study||30
8382706|NCT01094782|20662637|P5|COMPLETED|Overall Study||31
8382707|NCT01094782|20662638|P4|COMPLETED|Overall Study||45
8382708|NCT01094782|20662639|P3|COMPLETED|Overall Study||31
8382709|NCT01094782|20662640|P2|COMPLETED|Overall Study||29
8382710|NCT01094782|20662641|P1|COMPLETED|Overall Study||31
8382711|NCT01094782|20662636|P6|STARTED|Overall Study||38
8382712|NCT01094782|20662637|P5|STARTED|Overall Study||42
8382713|NCT01094782|20662638|P4|STARTED|Overall Study||56
8382714|NCT01094782|20662639|P3|STARTED|Overall Study||34
8382715|NCT01094782|20662640|P2|STARTED|Overall Study||39
8382716|NCT01094782|20662641|P1|STARTED|Overall Study||39
8382717|NCT01094743|20662685|P1|NOT COMPLETED|Period 2||0
8382718|NCT01094743|20662685|P1|COMPLETED|Period 2||50
8382719|NCT01094743|20662685|P1|STARTED|Period 2||50
8382720|NCT01094743|20662685|P1|NOT COMPLETED|Period 1||2
8382721|NCT01094743|20662685|P1|COMPLETED|Period 1||50
8382722|NCT01094743|20662685|P1|STARTED|Period 1||52
8382723|NCT01094730|20662702|P2|NOT COMPLETED|Period 2 (14 Days)||2
8382724|NCT01094730|20662703|P1|NOT COMPLETED|Period 2 (14 Days)||3
8382725|NCT01094730|20662702|P2|COMPLETED|Period 2 (14 Days)||84
8382726|NCT01094730|20662703|P1|COMPLETED|Period 2 (14 Days)||87
8382727|NCT01094730|20662702|P2|STARTED|Period 2 (14 Days)||86
8382728|NCT01094730|20662703|P1|STARTED|Period 2 (14 Days)||90
8382729|NCT01094730|20662702|P2|NOT COMPLETED|Period 1 (14 Days)||2
8382730|NCT01094730|20662703|P1|NOT COMPLETED|Period 1 (14 Days)||2
8382731|NCT01094730|20662702|P2|COMPLETED|Period 1 (14 Days)||86
8382732|NCT01094730|20662703|P1|COMPLETED|Period 1 (14 Days)||90
8382733|NCT01094730|20662702|P2|STARTED|Period 1 (14 Days)||88
8382734|NCT01094730|20662703|P1|STARTED|Period 1 (14 Days)||92
8382735|NCT01094717|20662716|P2|NOT COMPLETED|Overall Study||0
8382736|NCT01094717|20662717|P1|NOT COMPLETED|Overall Study||0
8382737|NCT01094717|20662716|P2|COMPLETED|Overall Study||10
8382738|NCT01094717|20662717|P1|COMPLETED|Overall Study||3
8382739|NCT01094717|20662716|P2|STARTED|Overall Study||10
8382740|NCT01094717|20662717|P1|STARTED|Overall Study||3
8382741|NCT01094704|20662735|P2|NOT COMPLETED|Overall Study||0
8382742|NCT01094704|20662736|P1|NOT COMPLETED|Overall Study||0
8382743|NCT01094704|20662735|P2|COMPLETED|Overall Study||8
8382744|NCT01094704|20662736|P1|COMPLETED|Overall Study||8
8382745|NCT01094704|20662735|P2|STARTED|Overall Study||8
8382746|NCT01094704|20662736|P1|STARTED|Overall Study||8
8382747|NCT01094574|20662748|P6|NOT COMPLETED|Overall Study||0
8382748|NCT01094574|20662749|P5|NOT COMPLETED|Overall Study||0
8382749|NCT01094574|20662750|P4|NOT COMPLETED|Overall Study||0
8382750|NCT01094574|20662751|P3|NOT COMPLETED|Overall Study||0
8382751|NCT01094574|20662752|P2|NOT COMPLETED|Overall Study||0
8382752|NCT01094574|20662753|P1|NOT COMPLETED|Overall Study||0
8382753|NCT01094574|20662748|P6|COMPLETED|Overall Study||2
8382754|NCT01094574|20662749|P5|COMPLETED|Overall Study||2
8382755|NCT01094574|20662750|P4|COMPLETED|Overall Study||2
8382756|NCT01094574|20662751|P3|COMPLETED|Overall Study||2
8382757|NCT01094574|20662752|P2|COMPLETED|Overall Study||1
8382758|NCT01094574|20662753|P1|COMPLETED|Overall Study||1
8382759|NCT01094574|20662748|P6|STARTED|Overall Study||2
8382760|NCT01094574|20662749|P5|STARTED|Overall Study||2
8382761|NCT01094574|20662750|P4|STARTED|Overall Study||2
8382762|NCT01094574|20662751|P3|STARTED|Overall Study||2
8382763|NCT01094574|20662752|P2|STARTED|Overall Study||1
8382764|NCT01094574|20662753|P1|STARTED|Overall Study||1
8382765|NCT01094561|20662800|P1|NOT COMPLETED|Overall Study||6
8382766|NCT01094561|20662800|P1|COMPLETED|Overall Study||17
8382767|NCT01094561|20662800|P1|STARTED|Overall Study||23
8382768|NCT01094548|20662807|P2|NOT COMPLETED|Overall Study||0
8382769|NCT01094548|20662808|P1|NOT COMPLETED|Overall Study||0
8382770|NCT01094548|20662807|P2|COMPLETED|Overall Study||17
8382771|NCT01094548|20662808|P1|COMPLETED|Overall Study||17
8382772|NCT01094548|20662807|P2|STARTED|Overall Study||17
8382773|NCT01094548|20662808|P1|STARTED|Overall Study||17
8382774|NCT01094522|20662828|P2|NOT COMPLETED|Overall Study||0
8382775|NCT01094522|20662829|P1|NOT COMPLETED|Overall Study||0
8382776|NCT01094522|20662828|P2|COMPLETED|Overall Study||20
8382777|NCT01094522|20662829|P1|COMPLETED|Overall Study||20
8382778|NCT01094522|20662828|P2|STARTED|Overall Study||20
8382779|NCT01094522|20662829|P1|STARTED|Overall Study||20
8382780|NCT01094301|20662839|P1|NOT COMPLETED|Implant Stage||8
8382781|NCT01094301|20662839|P1|COMPLETED|Implant Stage||5
8382782|NCT01094301|20662839|P1|Subjects Who Received SPR IPG|Implant Stage||5
8382783|NCT01094301|20662839|P1|Met Criteria for Implant Stage|Implant Stage||7
8382784|NCT01094301|20662839|P1|STARTED|Implant Stage||13
8382785|NCT01094301|20662839|P1|NOT COMPLETED|Trial Stage||1
8382786|NCT01094301|20662839|P1|COMPLETED|Trial Stage||27
8382787|NCT01094301|20662839|P1|Subjects Who Received Smartpatch Lead|Trial Stage||28
8382788|NCT01094301|20662839|P1|STARTED|Trial Stage||28
8382789|NCT01094288|20662869|P8|NOT COMPLETED|Overall Study||2
8382790|NCT01094288|20662870|P7|NOT COMPLETED|Overall Study||0
8382791|NCT01094288|20662871|P6|NOT COMPLETED|Overall Study||0
8382792|NCT01094288|20662872|P5|NOT COMPLETED|Overall Study||0
8382793|NCT01094288|20662873|P4|NOT COMPLETED|Overall Study||2
8382794|NCT01094288|20662874|P3|NOT COMPLETED|Overall Study||4
8382795|NCT01094288|20662875|P2|NOT COMPLETED|Overall Study||10
8382796|NCT01094288|20662876|P1|NOT COMPLETED|Overall Study||2
8382797|NCT01094288|20662869|P8|COMPLETED|Overall Study||2
8382798|NCT01094288|20662870|P7|COMPLETED|Overall Study||2
8382799|NCT01094288|20662871|P6|COMPLETED|Overall Study||4
8382800|NCT01094288|20662872|P5|COMPLETED|Overall Study||2
8382801|NCT01094288|20662873|P4|COMPLETED|Overall Study||1
8382802|NCT01094288|20662874|P3|COMPLETED|Overall Study||1
8382803|NCT01094288|20662875|P2|COMPLETED|Overall Study||5
8382804|NCT01094288|20662876|P1|COMPLETED|Overall Study|Completed=Completed Treatment|4
8382805|NCT01094288|20662869|P8|STARTED|Overall Study||4
8382806|NCT01094288|20662870|P7|STARTED|Overall Study||2
8382807|NCT01094288|20662871|P6|STARTED|Overall Study||4
8382808|NCT01094288|20662872|P5|STARTED|Overall Study||2
8382809|NCT01094288|20662873|P4|STARTED|Overall Study||3
8382810|NCT01094288|20662874|P3|STARTED|Overall Study||5
8382811|NCT01094288|20662875|P2|STARTED|Overall Study||15
8382812|NCT01094288|20662876|P1|STARTED|Overall Study||6
8382813|NCT01094184|20662988|P2|NOT COMPLETED|Overall Study||11
8382814|NCT01094184|20662989|P1|NOT COMPLETED|Overall Study||35
8382815|NCT01094184|20662988|P2|COMPLETED|Overall Study||2
8382816|NCT01094184|20662989|P1|COMPLETED|Overall Study||1
8382817|NCT01094184|20662988|P2|STARTED|Overall Study||13
8382818|NCT01094184|20662989|P1|STARTED|Overall Study||36
8382819|NCT01094171|20663223|P1|NOT COMPLETED|Overall Study||10
8382820|NCT01094171|20663223|P1|COMPLETED|Overall Study||390
8382821|NCT01094171|20663223|P1|STARTED|Overall Study||400
8382822|NCT01094119|20663232|P2|NOT COMPLETED|Overall Study||4
8382823|NCT01094119|20663233|P1|NOT COMPLETED|Overall Study||2
8382824|NCT01094119|20663232|P2|COMPLETED|Overall Study||32
8382825|NCT01094119|20663233|P1|COMPLETED|Overall Study||32
8382826|NCT01094119|20663232|P2|STARTED|Overall Study||36
8382827|NCT01094119|20663233|P1|STARTED|Overall Study||34
8382828|NCT01094106|20663243|P2|NOT COMPLETED|Overall Study||0
8382829|NCT01094106|20663244|P1|NOT COMPLETED|Overall Study||0
8382830|NCT01094106|20663243|P2|COMPLETED|Overall Study||34
8382831|NCT01094106|20663244|P1|COMPLETED|Overall Study||33
8382832|NCT01094106|20663243|P2|STARTED|Overall Study||34
8382833|NCT01094106|20663244|P1|STARTED|Overall Study||33
8382834|NCT01093976|20663254|P1|NOT COMPLETED|Overall Study||0
8382835|NCT01093976|20663254|P1|COMPLETED|Overall Study||14
8382836|NCT01093976|20663254|P1|STARTED|Overall Study||14
8382837|NCT01093885|20663258|P1|NOT COMPLETED|Overall Study||5
8382838|NCT01093885|20663258|P1|COMPLETED|Overall Study||10
8382839|NCT01093885|20663258|P1|STARTED|Overall Study||15
8382840|NCT01093846|20663266|P3|NOT COMPLETED|Overall Study||21
8382841|NCT01093846|20663267|P2|NOT COMPLETED|Overall Study||18
8382842|NCT01093846|20663268|P1|NOT COMPLETED|Overall Study||19
8382843|NCT01093846|20663266|P3|COMPLETED|Overall Study||1
8382844|NCT01093846|20663267|P2|COMPLETED|Overall Study||0
8382845|NCT01093846|20663268|P1|COMPLETED|Overall Study||0
8382846|NCT01093846|20663266|P3|STARTED|Overall Study||22
8382847|NCT01093846|20663267|P2|STARTED|Overall Study||18
8382848|NCT01093846|20663268|P1|STARTED|Overall Study||19
8382849|NCT01093794|20663274|P4|NOT COMPLETED|Treatment Period 4||0
8382850|NCT01093794|20663275|P3|NOT COMPLETED|Treatment Period 4||0
8382851|NCT01093794|20663276|P2|NOT COMPLETED|Treatment Period 4||0
8382852|NCT01093794|20663277|P1|NOT COMPLETED|Treatment Period 4||0
8382853|NCT01093794|20663274|P4|COMPLETED|Treatment Period 4||7
8382854|NCT01093794|20663275|P3|COMPLETED|Treatment Period 4||6
8382855|NCT01093794|20663276|P2|COMPLETED|Treatment Period 4||7
8382856|NCT01093794|20663277|P1|COMPLETED|Treatment Period 4||7
8382857|NCT01093794|20663274|P4|STARTED|Treatment Period 4||7
8382858|NCT01093794|20663275|P3|STARTED|Treatment Period 4||6
8382859|NCT01093794|20663276|P2|STARTED|Treatment Period 4||7
8382860|NCT01093794|20663277|P1|STARTED|Treatment Period 4||7
8382861|NCT01093794|20663274|P4|NOT COMPLETED|Treatment Period 3||0
8382862|NCT01093794|20663275|P3|NOT COMPLETED|Treatment Period 3||0
8382863|NCT01093794|20663276|P2|NOT COMPLETED|Treatment Period 3||0
8382864|NCT01093794|20663277|P1|NOT COMPLETED|Treatment Period 3||0
8382865|NCT01093794|20663274|P4|COMPLETED|Treatment Period 3||7
8382866|NCT01093794|20663275|P3|COMPLETED|Treatment Period 3||6
8382867|NCT01093794|20663276|P2|COMPLETED|Treatment Period 3||7
8382868|NCT01093794|20663277|P1|COMPLETED|Treatment Period 3||7
8382869|NCT01093794|20663274|P4|STARTED|Treatment Period 3||7
8382870|NCT01093794|20663275|P3|STARTED|Treatment Period 3||6
8382871|NCT01093794|20663276|P2|STARTED|Treatment Period 3||7
8382872|NCT01093794|20663277|P1|STARTED|Treatment Period 3||7
8382873|NCT01093794|20663274|P4|NOT COMPLETED|Treatment Period 2||0
8382874|NCT01093794|20663275|P3|NOT COMPLETED|Treatment Period 2||0
8382875|NCT01093794|20663276|P2|NOT COMPLETED|Treatment Period 2||0
8382876|NCT01093794|20663277|P1|NOT COMPLETED|Treatment Period 2||0
8382877|NCT01093794|20663274|P4|COMPLETED|Treatment Period 2||7
8382878|NCT01093794|20663275|P3|COMPLETED|Treatment Period 2||6
8382879|NCT01093794|20663276|P2|COMPLETED|Treatment Period 2||7
8382880|NCT01093794|20663277|P1|COMPLETED|Treatment Period 2||7
8382881|NCT01093794|20663274|P4|STARTED|Treatment Period 2||7
8382882|NCT01093794|20663275|P3|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
8382883|NCT01093794|20663276|P2|STARTED|Treatment Period 2||7
8382884|NCT01093794|20663277|P1|STARTED|Treatment Period 2||7
8382885|NCT01093794|20663274|P4|NOT COMPLETED|Treatment Period 1||0
8382886|NCT01093794|20663275|P3|NOT COMPLETED|Treatment Period 1||0
8382887|NCT01093794|20663276|P2|NOT COMPLETED|Treatment Period 1||0
8382888|NCT01093794|20663277|P1|NOT COMPLETED|Treatment Period 1||0
8382889|NCT01093794|20663274|P4|COMPLETED|Treatment Period 1||7
8382890|NCT01093794|20663275|P3|COMPLETED|Treatment Period 1||7
8382891|NCT01093794|20663276|P2|COMPLETED|Treatment Period 1||7
8382892|NCT01093794|20663277|P1|COMPLETED|Treatment Period 1||7
8382893|NCT01093794|20663274|P4|STARTED|Treatment Period 1||7
8382894|NCT01093794|20663275|P3|STARTED|Treatment Period 1||7
8382895|NCT01093794|20663276|P2|STARTED|Treatment Period 1||7
8382896|NCT01093794|20663277|P1|STARTED|Treatment Period 1||7
8382897|NCT01093755|20663293|P2|NOT COMPLETED|Overall Study||4
8382898|NCT01093755|20663294|P1|NOT COMPLETED|Overall Study||3
8382899|NCT01093755|20663293|P2|COMPLETED|Overall Study||10
8382900|NCT01093755|20663294|P1|COMPLETED|Overall Study||13
8382901|NCT01093755|20663293|P2|STARTED|Overall Study||14
8382902|NCT01093755|20663294|P1|STARTED|Overall Study||16
8382903|NCT01093690|20663304|P2|NOT COMPLETED|Overall Study||0
8382904|NCT01093690|20663305|P1|NOT COMPLETED|Overall Study||0
8382905|NCT01093690|20663304|P2|COMPLETED|Overall Study||79
8382906|NCT01093690|20663305|P1|COMPLETED|Overall Study||83
8382907|NCT01093690|20663304|P2|STARTED|Overall Study||79
8382908|NCT01093690|20663305|P1|STARTED|Overall Study||83
8382909|NCT01093651|20663313|P2|NOT COMPLETED|Overall Study||0
8382910|NCT01093651|20663314|P1|NOT COMPLETED|Overall Study||0
8382911|NCT01093651|20663313|P2|COMPLETED|Overall Study||10
8382912|NCT01093651|20663314|P1|COMPLETED|Overall Study||10
8382913|NCT01093651|20663313|P2|STARTED|Overall Study||10
8382914|NCT01093651|20663314|P1|STARTED|Overall Study||10
8382915|NCT01093625|20663334|P2|NOT COMPLETED|1-Year Visit||3
8382916|NCT01093625|20663335|P1|NOT COMPLETED|1-Year Visit||5
8382917|NCT01093625|20663334|P2|COMPLETED|1-Year Visit||37
8382918|NCT01093625|20663335|P1|COMPLETED|1-Year Visit||29
8382919|NCT01093625|20663334|P2|STARTED|1-Year Visit||40
8382920|NCT01093625|20663335|P1|STARTED|1-Year Visit||34
8382921|NCT01093625|20663334|P2|NOT COMPLETED|6-Month Visit||9
8382922|NCT01093625|20663335|P1|NOT COMPLETED|6-Month Visit||8
8382923|NCT01093625|20663334|P2|COMPLETED|6-Month Visit||40
8382924|NCT01093625|20663335|P1|COMPLETED|6-Month Visit||34
8382925|NCT01093625|20663334|P2|STARTED|6-Month Visit||49
8382926|NCT01093625|20663335|P1|STARTED|6-Month Visit||42
8382927|NCT01093625|20663334|P2|NOT COMPLETED|3-Month Visit||0
8382928|NCT01093625|20663335|P1|NOT COMPLETED|3-Month Visit||2
8382929|NCT01093625|20663334|P2|COMPLETED|3-Month Visit||49
8382930|NCT01093625|20663335|P1|COMPLETED|3-Month Visit||42
8382931|NCT01093625|20663334|P2|STARTED|3-Month Visit||49
8382932|NCT01093625|20663335|P1|STARTED|3-Month Visit||44
8382933|NCT01093625|20663334|P2|NOT COMPLETED|1-Month Visit||0
8382934|NCT01093625|20663335|P1|NOT COMPLETED|1-Month Visit||2
8382935|NCT01093625|20663334|P2|COMPLETED|1-Month Visit||49
8382936|NCT01093625|20663335|P1|COMPLETED|1-Month Visit||44
8382937|NCT01093625|20663334|P2|STARTED|1-Month Visit||49
8382938|NCT01093625|20663335|P1|STARTED|1-Month Visit||46
8382939|NCT01093625|20663334|P2|NOT COMPLETED|2-Week Visit||0
8382940|NCT01093625|20663335|P1|NOT COMPLETED|2-Week Visit||1
8382941|NCT01093625|20663334|P2|COMPLETED|2-Week Visit||49
8382942|NCT01093625|20663335|P1|COMPLETED|2-Week Visit||46
8382943|NCT01093625|20663334|P2|STARTED|2-Week Visit||49
8382944|NCT01093625|20663335|P1|STARTED|2-Week Visit||47
8382945|NCT01093625|20663334|P2|NOT COMPLETED|Baseline and Dispensed||0
8382946|NCT01093625|20663335|P1|NOT COMPLETED|Baseline and Dispensed||2
8382947|NCT01093625|20663334|P2|COMPLETED|Baseline and Dispensed||49
8382948|NCT01093625|20663335|P1|COMPLETED|Baseline and Dispensed||47
8382949|NCT01093625|20663334|P2|STARTED|Baseline and Dispensed||49
8382950|NCT01093625|20663335|P1|STARTED|Baseline and Dispensed||49
8382951|NCT01093599|20663355|P2|NOT COMPLETED|Overall Study||46
8382952|NCT01093599|20663356|P1|NOT COMPLETED|Overall Study||32
8382953|NCT01093599|20663355|P2|COMPLETED|Overall Study||59
8382954|NCT01093599|20663356|P1|COMPLETED|Overall Study||59
8382955|NCT01093599|20663355|P2|STARTED|Overall Study||105
8382956|NCT01093599|20663356|P1|STARTED|Overall Study||91
8382957|NCT01093586|20663362|P1|NOT COMPLETED|Overall Study||3
8382958|NCT01093586|20663362|P1|COMPLETED|Overall Study||11
8382959|NCT01093586|20663362|P1|STARTED|Overall Study||14
8382960|NCT01093573|20663383|P3|NOT COMPLETED|Overall Study||2
8382961|NCT01093573|20663384|P2|NOT COMPLETED|Overall Study||0
8382962|NCT01093573|20663385|P1|NOT COMPLETED|Overall Study||0
8382963|NCT01093573|20663383|P3|COMPLETED|Overall Study||26
8382964|NCT01093573|20663384|P2|COMPLETED|Overall Study||3
8382965|NCT01093573|20663385|P1|COMPLETED|Overall Study||3
8382966|NCT01093573|20663383|P3|STARTED|Overall Study||28
8382967|NCT01093573|20663384|P2|STARTED|Overall Study||3
8382968|NCT01093573|20663385|P1|STARTED|Overall Study||3
8382969|NCT01093534|20663402|P3|NOT COMPLETED|Overall Study||9
8382970|NCT01093534|20663403|P2|NOT COMPLETED|Overall Study||16
8382971|NCT01093534|20663404|P1|NOT COMPLETED|Overall Study||10
8382972|NCT01093534|20663402|P3|COMPLETED|Overall Study||169
8382973|NCT01093534|20663403|P2|COMPLETED|Overall Study||167
8382974|NCT01093534|20663404|P1|COMPLETED|Overall Study||176
8382975|NCT01093534|20663402|P3|Received Study Treatment|Overall Study||175
8382976|NCT01093534|20663403|P2|Received Study Treatment|Overall Study||182
8382977|NCT01093534|20663404|P1|Received Study Treatment|Overall Study||186
8382978|NCT01093534|20663402|P3|STARTED|Overall Study||178
8382979|NCT01093534|20663403|P2|STARTED|Overall Study||183
8382980|NCT01093534|20663404|P1|STARTED|Overall Study||186
8382981|NCT01093521|20663509|P1|NOT COMPLETED|Overall Study||0
8382982|NCT01093521|20663509|P1|COMPLETED|Overall Study||20
8382983|NCT01093521|20663509|P1|STARTED|Overall Study||20
8382984|NCT01093482|20663524|P1|NOT COMPLETED|Overall Study||0
8382985|NCT01093482|20663524|P1|COMPLETED|Overall Study||8151
8382986|NCT01093482|20663524|P1|STARTED|Overall Study||8151
8382987|NCT01093469|20663531|P3|NOT COMPLETED|Overall Study||1
8382988|NCT01093469|20663532|P2|NOT COMPLETED|Overall Study||0
8382989|NCT01093469|20663533|P1|NOT COMPLETED|Overall Study||0
8382990|NCT01093469|20663531|P3|COMPLETED|Overall Study||12
8382991|NCT01093469|20663532|P2|COMPLETED|Overall Study||13
8382992|NCT01093469|20663533|P1|COMPLETED|Overall Study||13
8382993|NCT01093469|20663531|P3|STARTED|Overall Study||13
8382994|NCT01093469|20663532|P2|STARTED|Overall Study||13
8382995|NCT01093469|20663533|P1|STARTED|Overall Study||13
8382996|NCT01093417|20663543|P2|NOT COMPLETED|Overall Study||1
8382997|NCT01093417|20663544|P1|NOT COMPLETED|Overall Study||0
8382998|NCT01093417|20663543|P2|COMPLETED|Overall Study||29
8382999|NCT01093417|20663544|P1|COMPLETED|Overall Study||15
8383000|NCT01093417|20663543|P2|STARTED|Overall Study||30
8383001|NCT01093417|20663544|P1|STARTED|Overall Study||15
8383002|NCT01093222|20663552|P1|NOT COMPLETED|Overall Study||40
8383003|NCT01093222|20663552|P1|COMPLETED|Overall Study||0
8383004|NCT01093222|20663552|P1|Eligible and Began Protocol Therapy|Overall Study||34
8383005|NCT01093222|20663552|P1|STARTED|Overall Study||40
8383006|NCT01093183|20663559|P2|NOT COMPLETED|Overall Study||2
8383007|NCT01093183|20663560|P1|NOT COMPLETED|Overall Study||1
8383008|NCT01093183|20663559|P2|COMPLETED|Overall Study||4
8383009|NCT01093183|20663560|P1|COMPLETED|Overall Study||18
8383010|NCT01093183|20663559|P2|STARTED|Overall Study||6
8383011|NCT01093183|20663560|P1|STARTED|Overall Study||19
8383012|NCT01093027|20663570|P2|NOT COMPLETED|Visit 2||0
8383013|NCT01093027|20663571|P1|NOT COMPLETED|Visit 2||0
8383014|NCT01093027|20663570|P2|COMPLETED|Visit 2||10
8383015|NCT01093027|20663571|P1|COMPLETED|Visit 2||10
8383016|NCT01093027|20663570|P2|STARTED|Visit 2||10
8383017|NCT01093027|20663571|P1|STARTED|Visit 2||10
8383018|NCT01093027|20663570|P2|NOT COMPLETED|Visit 1||0
8383019|NCT01093027|20663571|P1|NOT COMPLETED|Visit 1||0
8383020|NCT01093027|20663570|P2|COMPLETED|Visit 1||10
8383021|NCT01093027|20663571|P1|COMPLETED|Visit 1||10
8383022|NCT01093027|20663570|P2|STARTED|Visit 1||10
8383023|NCT01093027|20663571|P1|STARTED|Visit 1||10
8383024|NCT01093014|20663582|P3|NOT COMPLETED|Overall Study||0
8383025|NCT01093014|20663583|P2|NOT COMPLETED|Overall Study||0
8383026|NCT01093014|20663584|P1|NOT COMPLETED|Overall Study||0
8383027|NCT01093014|20663582|P3|COMPLETED|Overall Study||12
8383028|NCT01093014|20663583|P2|COMPLETED|Overall Study||9
8383029|NCT01093014|20663584|P1|COMPLETED|Overall Study||12
8383030|NCT01093014|20663582|P3|STARTED|Overall Study||12
8383031|NCT01093014|20663583|P2|STARTED|Overall Study||9
8383032|NCT01093014|20663584|P1|STARTED|Overall Study||12
8383033|NCT01092923|20663603|P2|NOT COMPLETED|Overall Study||0
8383034|NCT01092923|20663604|P1|NOT COMPLETED|Overall Study||0
8383035|NCT01092923|20663603|P2|COMPLETED|Overall Study||10
8383036|NCT01092923|20663604|P1|COMPLETED|Overall Study||10
8383037|NCT01092923|20663603|P2|STARTED|Overall Study||10
8383038|NCT01092923|20663604|P1|STARTED|Overall Study||10
8383039|NCT01092910|20663613|P1|NOT COMPLETED|Overall Study||5
8383040|NCT01092910|20663613|P1|COMPLETED|Overall Study||52
8383041|NCT01092910|20663613|P1|10 Month Follow-up|Overall Study||52
8383042|NCT01092910|20663613|P1|4 Month Follow-up|Overall Study||54
8383043|NCT01092910|20663613|P1|STARTED|Overall Study||57
8383044|NCT01092832|20663628|P2|NOT COMPLETED|Overall Study||0
8383045|NCT01092832|20663629|P1|NOT COMPLETED|Overall Study||1
8383046|NCT01092832|20663628|P2|COMPLETED|Overall Study||8
8383047|NCT01092832|20663629|P1|COMPLETED|Overall Study||13
8383048|NCT01092832|20663628|P2|STARTED|Overall Study||8
8383049|NCT01092832|20663629|P1|STARTED|Overall Study||14
8383050|NCT01092780|20663641|P4|NOT COMPLETED|Treatment Period 4||0
8383051|NCT01092780|20663642|P3|NOT COMPLETED|Treatment Period 4||0
8383052|NCT01092780|20663643|P2|NOT COMPLETED|Treatment Period 4||0
8383053|NCT01092780|20663644|P1|NOT COMPLETED|Treatment Period 4||0
8383054|NCT01092780|20663641|P4|COMPLETED|Treatment Period 4||13
8383055|NCT01092780|20663642|P3|COMPLETED|Treatment Period 4||13
8383056|NCT01092780|20663643|P2|COMPLETED|Treatment Period 4||13
8383057|NCT01092780|20663644|P1|COMPLETED|Treatment Period 4||13
8383058|NCT01092780|20663641|P4|STARTED|Treatment Period 4||13
8383059|NCT01092780|20663642|P3|STARTED|Treatment Period 4||13
8383060|NCT01092780|20663643|P2|STARTED|Treatment Period 4||13
8383061|NCT01092780|20663644|P1|STARTED|Treatment Period 4||13
8383062|NCT01092780|20663641|P4|NOT COMPLETED|Washout Period 3||0
8383063|NCT01092780|20663642|P3|NOT COMPLETED|Washout Period 3||0
8383064|NCT01092780|20663643|P2|NOT COMPLETED|Washout Period 3||0
8383065|NCT01092780|20663644|P1|NOT COMPLETED|Washout Period 3||0
8383066|NCT01092780|20663641|P4|COMPLETED|Washout Period 3||13
8383067|NCT01092780|20663642|P3|COMPLETED|Washout Period 3||13
8383068|NCT01092780|20663643|P2|COMPLETED|Washout Period 3||13
8383069|NCT01092780|20663644|P1|COMPLETED|Washout Period 3||13
8383070|NCT01092780|20663641|P4|STARTED|Washout Period 3||13
8383071|NCT01092780|20663642|P3|STARTED|Washout Period 3||13
8383072|NCT01092780|20663643|P2|STARTED|Washout Period 3||13
8383073|NCT01092780|20663644|P1|STARTED|Washout Period 3||13
8383074|NCT01092780|20663641|P4|NOT COMPLETED|Treatment Period 3||0
8383075|NCT01092780|20663642|P3|NOT COMPLETED|Treatment Period 3||0
8383076|NCT01092780|20663643|P2|NOT COMPLETED|Treatment Period 3||0
8383077|NCT01092780|20663644|P1|NOT COMPLETED|Treatment Period 3||0
8383078|NCT01092780|20663641|P4|COMPLETED|Treatment Period 3||13
8383079|NCT01092780|20663642|P3|COMPLETED|Treatment Period 3||13
8383080|NCT01092780|20663643|P2|COMPLETED|Treatment Period 3||13
8383081|NCT01092780|20663644|P1|COMPLETED|Treatment Period 3||13
8383082|NCT01092780|20663641|P4|STARTED|Treatment Period 3||13
8383083|NCT01092780|20663642|P3|STARTED|Treatment Period 3||13
8383084|NCT01092780|20663643|P2|STARTED|Treatment Period 3||13
8383085|NCT01092780|20663644|P1|STARTED|Treatment Period 3||13
8383086|NCT01092780|20663641|P4|NOT COMPLETED|Washout Period 2||0
8383087|NCT01092780|20663642|P3|NOT COMPLETED|Washout Period 2||1
8383088|NCT01092780|20663643|P2|NOT COMPLETED|Washout Period 2||1
8383089|NCT01092780|20663644|P1|NOT COMPLETED|Washout Period 2||0
8383090|NCT01092780|20663641|P4|COMPLETED|Washout Period 2||13
8383091|NCT01092780|20663642|P3|COMPLETED|Washout Period 2||13
8383092|NCT01092780|20663643|P2|COMPLETED|Washout Period 2||13
8383093|NCT01092780|20663644|P1|COMPLETED|Washout Period 2||13
8383094|NCT01092780|20663641|P4|STARTED|Washout Period 2||13
8383095|NCT01092780|20663642|P3|STARTED|Washout Period 2||14
8383096|NCT01092780|20663643|P2|STARTED|Washout Period 2||14
8383097|NCT01092780|20663644|P1|STARTED|Washout Period 2||13
8383098|NCT01092780|20663641|P4|NOT COMPLETED|Treatment Period 2||0
8383099|NCT01092780|20663642|P3|NOT COMPLETED|Treatment Period 2||0
8383100|NCT01092780|20663643|P2|NOT COMPLETED|Treatment Period 2||0
8383101|NCT01092780|20663644|P1|NOT COMPLETED|Treatment Period 2||0
8383102|NCT01092780|20663641|P4|COMPLETED|Treatment Period 2||13
8383103|NCT01092780|20663642|P3|COMPLETED|Treatment Period 2||14
8383104|NCT01092780|20663643|P2|COMPLETED|Treatment Period 2||14
8383105|NCT01092780|20663644|P1|COMPLETED|Treatment Period 2||13
8383106|NCT01092780|20663641|P4|STARTED|Treatment Period 2||13
8383107|NCT01092780|20663642|P3|STARTED|Treatment Period 2||14
8383108|NCT01092780|20663643|P2|STARTED|Treatment Period 2||14
8383109|NCT01092780|20663644|P1|STARTED|Treatment Period 2||13
8383110|NCT01092780|20663641|P4|NOT COMPLETED|Washout Period 1||0
8383111|NCT01092780|20663642|P3|NOT COMPLETED|Washout Period 1||0
8383112|NCT01092780|20663643|P2|NOT COMPLETED|Washout Period 1||1
8383113|NCT01092780|20663644|P1|NOT COMPLETED|Washout Period 1||1
8383114|NCT01092780|20663641|P4|COMPLETED|Washout Period 1||13
8383115|NCT01092780|20663642|P3|COMPLETED|Washout Period 1||14
8383116|NCT01092780|20663643|P2|COMPLETED|Washout Period 1||14
8383117|NCT01092780|20663644|P1|COMPLETED|Washout Period 1||13
8383118|NCT01092780|20663641|P4|STARTED|Washout Period 1||13
8383119|NCT01092780|20663642|P3|STARTED|Washout Period 1||14
8383120|NCT01092780|20663643|P2|STARTED|Washout Period 1||15
8383121|NCT01092780|20663644|P1|STARTED|Washout Period 1||14
8383122|NCT01092780|20663641|P4|NOT COMPLETED|Treatment Period 1||0
8383123|NCT01092780|20663642|P3|NOT COMPLETED|Treatment Period 1||0
8383124|NCT01092780|20663643|P2|NOT COMPLETED|Treatment Period 1||0
8383125|NCT01092780|20663644|P1|NOT COMPLETED|Treatment Period 1||0
8383126|NCT01092780|20663641|P4|COMPLETED|Treatment Period 1||13
8383127|NCT01092780|20663642|P3|COMPLETED|Treatment Period 1||14
8383128|NCT01092780|20663643|P2|COMPLETED|Treatment Period 1||15
8383129|NCT01092780|20663644|P1|COMPLETED|Treatment Period 1||14
8383130|NCT01092780|20663641|P4|STARTED|Treatment Period 1||13
8383131|NCT01092780|20663642|P3|STARTED|Treatment Period 1||14
8383132|NCT01092780|20663643|P2|STARTED|Treatment Period 1||15
8383133|NCT01092780|20663644|P1|STARTED|Treatment Period 1||14
8383134|NCT01092767|20663674|P1|NOT COMPLETED|Overall Study||5
8383135|NCT01092767|20663674|P1|COMPLETED|Overall Study||45
8383136|NCT01092767|20663674|P1|STARTED|Overall Study||50
8383137|NCT01092728|20663680|P2|NOT COMPLETED|Overall Study||14
8383138|NCT01092728|20663681|P1|NOT COMPLETED|Overall Study||4
8383139|NCT01092728|20663680|P2|COMPLETED|Overall Study||0
8383140|NCT01092728|20663681|P1|COMPLETED|Overall Study||0
8383141|NCT01092728|20663680|P2|STARTED|Overall Study||14
8383142|NCT01092728|20663681|P1|STARTED|Overall Study||4
8383143|NCT01092702|20663689|P1|NOT COMPLETED|Overall Study||9
8383144|NCT01092702|20663689|P1|COMPLETED|Overall Study||23
8383145|NCT01092702|20663689|P1|STARTED|Overall Study||32
8383146|NCT01092676|20663695|P2|NOT COMPLETED|Overall Study||0
8383147|NCT01092676|20663696|P1|NOT COMPLETED|Overall Study||0
8383148|NCT01092676|20663695|P2|COMPLETED|Overall Study||49
8383149|NCT01092676|20663696|P1|COMPLETED|Overall Study||50
8383150|NCT01092676|20663695|P2|STARTED|Overall Study||49
8383151|NCT01092676|20663696|P1|STARTED|Overall Study||50
8383152|NCT01092663|20663706|P2|NOT COMPLETED|Overall Study||4
8383153|NCT01092663|20663707|P1|NOT COMPLETED|Overall Study||7
8383154|NCT01092663|20663706|P2|COMPLETED|Overall Study||26
8383155|NCT01092663|20663707|P1|COMPLETED|Overall Study||24
8383156|NCT01092663|20663706|P2|STARTED|Overall Study||30
8383157|NCT01092663|20663707|P1|STARTED|Overall Study||31
8383158|NCT01092637|20663755|P2|NOT COMPLETED|Overall Study||49
8383159|NCT01092637|20663756|P1|NOT COMPLETED|Overall Study||47
8383160|NCT01092637|20663755|P2|COMPLETED|Overall Study||86
8383161|NCT01092637|20663756|P1|COMPLETED|Overall Study||98
8383162|NCT01092637|20663755|P2|STARTED|Overall Study||135
8383163|NCT01092637|20663756|P1|STARTED|Overall Study||145
8383164|NCT01092559|20663766|P1|NOT COMPLETED|Overall Study||0
8383165|NCT01092559|20663766|P1|COMPLETED|Overall Study||10
8383166|NCT01092559|20663766|P1|STARTED|Overall Study||10
8383167|NCT01092546|20663771|P1|NOT COMPLETED|Overall Study||4
8383168|NCT01092546|20663771|P1|COMPLETED|Overall Study||12
8383169|NCT01092546|20663771|P1|STARTED|Overall Study||16
8383170|NCT01092507|20663778|P2|NOT COMPLETED|Overall Study||0
8383171|NCT01092507|20663779|P1|NOT COMPLETED|Overall Study||2
8383172|NCT01092507|20663778|P2|COMPLETED|Overall Study||150
8383173|NCT01092507|20663779|P1|COMPLETED|Overall Study||147
8383174|NCT01092507|20663778|P2|STARTED|Overall Study||150
8383175|NCT01092507|20663779|P1|STARTED|Overall Study||149
8383176|NCT01092442|20663799|P2|NOT COMPLETED|Overall Study||0
8383177|NCT01092442|20663800|P1|NOT COMPLETED|Overall Study||0
8383178|NCT01092442|20663799|P2|COMPLETED|Overall Study||60
8383179|NCT01092442|20663800|P1|COMPLETED|Overall Study||80
8383180|NCT01092442|20663799|P2|STARTED|Overall Study||60
8383181|NCT01092442|20663800|P1|STARTED|Overall Study||80
8383182|NCT01092416|20663814|P1|NOT COMPLETED|12-Month Follow-up||25
8383183|NCT01092416|20663814|P1|COMPLETED|12-Month Follow-up||413
8383184|NCT01092416|20663814|P1|STARTED|12-Month Follow-up||438
8383185|NCT01092416|20663814|P1|NOT COMPLETED|30-Day Follow-up||10
8383186|NCT01092416|20663814|P1|COMPLETED|30-Day Follow-up||430
8383187|NCT01092416|20663814|P1|STARTED|30-Day Follow-up||440
8383188|NCT01092416|20663814|P1|NOT COMPLETED|Enrollment||3
8383189|NCT01092416|20663814|P1|COMPLETED|Enrollment||440
8383190|NCT01092416|20663814|P1|STARTED|Enrollment||443
8383191|NCT01092364|20663826|P3|NOT COMPLETED|Overall Study||18
8383192|NCT01092364|20663827|P2|NOT COMPLETED|Overall Study||16
8383193|NCT01092364|20663828|P1|NOT COMPLETED|Overall Study||18
8383194|NCT01092364|20663826|P3|COMPLETED|Overall Study||105
8383195|NCT01092364|20663827|P2|COMPLETED|Overall Study||104
8383196|NCT01092364|20663828|P1|COMPLETED|Overall Study||104
8383197|NCT01092364|20663826|P3|STARTED|Overall Study||123
8383198|NCT01092364|20663827|P2|STARTED|Overall Study||120
8383199|NCT01092364|20663828|P1|STARTED|Overall Study||122
8383200|NCT01092338|20663838|P2|NOT COMPLETED|Overall Study||1
8383201|NCT01092338|20663839|P1|NOT COMPLETED|Overall Study||1
8383202|NCT01092338|20663838|P2|COMPLETED|Overall Study||21
8383203|NCT01092338|20663839|P1|COMPLETED|Overall Study||21
8383204|NCT01092338|20663838|P2|STARTED|Overall Study||22
8383205|NCT01092338|20663839|P1|STARTED|Overall Study||22
8383206|NCT01092195|20663850|P3|NOT COMPLETED|Overall Study||0
8383207|NCT01092195|20663851|P2|NOT COMPLETED|Overall Study||0
8383208|NCT01092195|20663852|P1|NOT COMPLETED|Overall Study||0
8383209|NCT01092195|20663850|P3|COMPLETED|Overall Study||20
8383210|NCT01092195|20663851|P2|COMPLETED|Overall Study||21
8383211|NCT01092195|20663852|P1|COMPLETED|Overall Study||23
8383212|NCT01092195|20663850|P3|STARTED|Overall Study||20
8383213|NCT01092195|20663851|P2|STARTED|Overall Study||21
8383214|NCT01092195|20663852|P1|STARTED|Overall Study||23
8383215|NCT01091974|20663864|P4|NOT COMPLETED|Overall Study||7
8383216|NCT01091974|20663865|P3|NOT COMPLETED|Overall Study||6
8383217|NCT01091974|20663866|P2|NOT COMPLETED|Overall Study||5
8383218|NCT01091974|20663867|P1|NOT COMPLETED|Overall Study||5
8383219|NCT01091974|20663864|P4|COMPLETED|Overall Study||17
8383220|NCT01091974|20663865|P3|COMPLETED|Overall Study||19
8383221|NCT01091974|20663866|P2|COMPLETED|Overall Study||18
8383222|NCT01091974|20663867|P1|COMPLETED|Overall Study||19
8383223|NCT01091974|20663864|P4|STARTED|Overall Study||24
8383224|NCT01091974|20663865|P3|STARTED|Overall Study||25
8383225|NCT01091974|20663866|P2|STARTED|Overall Study||23
8383226|NCT01091974|20663867|P1|STARTED|Overall Study||24
8383227|NCT01091948|20663883|P2|NOT COMPLETED|Overall Study||0
8383228|NCT01091948|20663884|P1|NOT COMPLETED|Overall Study||0
8383229|NCT01091948|20663883|P2|COMPLETED|Overall Study||38
8383230|NCT01091948|20663884|P1|COMPLETED|Overall Study||37
8383231|NCT01091948|20663883|P2|STARTED|Overall Study||38
8383232|NCT01091948|20663884|P1|STARTED|Overall Study||37
8383233|NCT01091675|20663902|P1|NOT COMPLETED|Overall Study||34
8383234|NCT01091675|20663902|P1|COMPLETED|Overall Study||23
8383235|NCT01091675|20663902|P1|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
8383236|NCT01091662|20663908|P2|NOT COMPLETED|Overall Study||34
8383237|NCT01091662|20663909|P1|NOT COMPLETED|Overall Study||17
8383238|NCT01091662|20663908|P2|COMPLETED|Overall Study||80
8383239|NCT01091662|20663909|P1|COMPLETED|Overall Study||41
8383240|NCT01091662|20663908|P2|STARTED|Overall Study||114
8383241|NCT01091662|20663909|P1|STARTED|Overall Study||58
8383242|NCT01091519|20663947|P2|NOT COMPLETED|Overall Study||73
8383243|NCT01091519|20663948|P1|NOT COMPLETED|Overall Study||55
8383244|NCT01091519|20663947|P2|COMPLETED|Overall Study||362
8383245|NCT01091519|20663948|P1|COMPLETED|Overall Study||291
8383246|NCT01091519|20663947|P2|Treated|Overall Study||431
8383247|NCT01091519|20663948|P1|Treated|Overall Study||342
8383248|NCT01091519|20663947|P2|STARTED|Overall Study||435
8383249|NCT01091519|20663948|P1|STARTED|Overall Study||346
8383250|NCT01091454|20663960|P1|NOT COMPLETED|Overall Study||1
8383251|NCT01091454|20663960|P1|COMPLETED|Overall Study||47
8383252|NCT01091454|20663960|P1|STARTED|Overall Study||48
8383253|NCT01091428|20663973|P4|NOT COMPLETED|Phase 2||69
8383254|NCT01091428|20663974|P3|NOT COMPLETED|Phase 2||73
8383255|NCT01091428|20663975|P2|NOT COMPLETED|Phase 2||0
8383256|NCT01091428|20663976|P1|NOT COMPLETED|Phase 2||0
8383257|NCT01091428|20663973|P4|COMPLETED|Phase 2||0
8383258|NCT01091428|20663974|P3|COMPLETED|Phase 2||0
8383259|NCT01091428|20663975|P2|COMPLETED|Phase 2||0
8383260|NCT01091428|20663976|P1|COMPLETED|Phase 2||0
8383261|NCT01091428|20663973|P4|STARTED|Phase 2||69
8383262|NCT01091428|20663974|P3|STARTED|Phase 2||73
8383263|NCT01091428|20663975|P2|STARTED|Phase 2||0
8383264|NCT01091428|20663976|P1|STARTED|Phase 2||0
8383265|NCT01091428|20663973|P4|NOT COMPLETED|Phase 1||0
8383266|NCT01091428|20663974|P3|NOT COMPLETED|Phase 1||0
8383267|NCT01091428|20663975|P2|NOT COMPLETED|Phase 1||11
8383268|NCT01091428|20663976|P1|NOT COMPLETED|Phase 1||38
8383269|NCT01091428|20663973|P4|COMPLETED|Phase 1||0
8383270|NCT01091428|20663974|P3|COMPLETED|Phase 1||0
8383271|NCT01091428|20663975|P2|COMPLETED|Phase 1||0
8383272|NCT01091428|20663976|P1|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
8383273|NCT01091428|20663973|P4|STARTED|Phase 1||0
8383274|NCT01091428|20663974|P3|STARTED|Phase 1||0
8383275|NCT01091428|20663975|P2|STARTED|Phase 1||11
8383276|NCT01091428|20663976|P1|STARTED|Phase 1||38
8383277|NCT01091363|20664079|P2|NOT COMPLETED|Overall Study||17
8383278|NCT01091363|20664080|P1|NOT COMPLETED|Overall Study||13
8383279|NCT01091363|20664079|P2|COMPLETED|Overall Study||37
8383280|NCT01091363|20664080|P1|COMPLETED|Overall Study||42
8383281|NCT01091363|20664079|P2|STARTED|Overall Study||54
8383282|NCT01091363|20664080|P1|STARTED|Overall Study||55
8383283|NCT01091259|20664090|P1|NOT COMPLETED|Overall Study||5
8383284|NCT01091259|20664090|P1|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
8383285|NCT01091259|20664090|P1|STARTED|Overall Study||29
8383286|NCT01091246|20664101|P3|NOT COMPLETED|Overall Study||13
8383287|NCT01091246|20664102|P2|NOT COMPLETED|Overall Study||16
8383288|NCT01091246|20664103|P1|NOT COMPLETED|Overall Study||35
8383289|NCT01091246|20664101|P3|COMPLETED|Overall Study||450
8383290|NCT01091246|20664102|P2|COMPLETED|Overall Study||448
8383291|NCT01091246|20664103|P1|COMPLETED|Overall Study||1350
8383292|NCT01091246|20664101|P3|STARTED|Overall Study||463
8383293|NCT01091246|20664102|P2|STARTED|Overall Study||464
8383294|NCT01091246|20664103|P1|STARTED|Overall Study||1385
8383295|NCT01091168|20664179|P2|NOT COMPLETED|Overall Study||296
8383296|NCT01091168|20664180|P1|NOT COMPLETED|Overall Study||298
8383297|NCT01091168|20664179|P2|COMPLETED|Overall Study||0
8383298|NCT01091168|20664180|P1|COMPLETED|Overall Study||0
8383299|NCT01091168|20664179|P2|STARTED|Overall Study||296
8383300|NCT01091168|20664180|P1|STARTED|Overall Study||298
8383301|NCT01091155|20664190|P1|NOT COMPLETED|Overall Study||9
8383302|NCT01091155|20664190|P1|COMPLETED|Overall Study||279
8383303|NCT01091155|20664190|P1|STARTED|Overall Study||288
8383304|NCT01091116|20664199|P5|NOT COMPLETED|Overall Study||11
8383305|NCT01091116|20664200|P4|NOT COMPLETED|Overall Study||4
8383306|NCT01091116|20664201|P3|NOT COMPLETED|Overall Study||11
8383307|NCT01091116|20664202|P2|NOT COMPLETED|Overall Study||8
8383308|NCT01091116|20664203|P1|NOT COMPLETED|Overall Study||6
8383309|NCT01091116|20664199|P5|COMPLETED|Overall Study||73
8383310|NCT01091116|20664200|P4|COMPLETED|Overall Study||80
8383311|NCT01091116|20664201|P3|COMPLETED|Overall Study||73
8383312|NCT01091116|20664202|P2|COMPLETED|Overall Study||80
8383313|NCT01091116|20664203|P1|COMPLETED|Overall Study||77
8383314|NCT01091116|20664199|P5|STARTED|Overall Study||84
8383315|NCT01091116|20664200|P4|STARTED|Overall Study||84
8383316|NCT01091116|20664201|P3|STARTED|Overall Study||84
8383317|NCT01091116|20664202|P2|STARTED|Overall Study||88
8383318|NCT01091116|20664203|P1|STARTED|Overall Study||83
8383319|NCT01091103|20664255|P1|NOT COMPLETED|Overall Study||4
8383320|NCT01091103|20664255|P1|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
8383321|NCT01091103|20664255|P1|STARTED|Overall Study||60
8383322|NCT01090973|20664275|P1|NOT COMPLETED|Overall Study||1
8383323|NCT01090973|20664275|P1|COMPLETED|Overall Study||0
8383324|NCT01090973|20664275|P1|STARTED|Overall Study||1
8383325|NCT01090921|20664285|P1|NOT COMPLETED|Overall Study||27
8383326|NCT01090921|20664285|P1|COMPLETED|Overall Study||23
8383327|NCT01090921|20664285|P1|STARTED|Overall Study||50
8383328|NCT01090765|20664296|P6|NOT COMPLETED|Overall Study||1
8383329|NCT01090765|20664297|P5|NOT COMPLETED|Overall Study||2
8383330|NCT01090765|20664298|P4|NOT COMPLETED|Overall Study||1
8383331|NCT01090765|20664299|P3|NOT COMPLETED|Overall Study||0
8383332|NCT01090765|20664300|P2|NOT COMPLETED|Overall Study||0
8383333|NCT01090765|20664301|P1|NOT COMPLETED|Overall Study||0
8383334|NCT01090765|20664296|P6|COMPLETED|Overall Study||3
8383335|NCT01090765|20664297|P5|COMPLETED|Overall Study||4
8383336|NCT01090765|20664298|P4|COMPLETED|Overall Study||1
8383337|NCT01090765|20664299|P3|COMPLETED|Overall Study||3
8383338|NCT01090765|20664300|P2|COMPLETED|Overall Study||3
8383339|NCT01090765|20664301|P1|COMPLETED|Overall Study||3
8383340|NCT01090765|20664296|P6|STARTED|Overall Study||4
8383341|NCT01090765|20664297|P5|STARTED|Overall Study||6
8383342|NCT01090765|20664298|P4|STARTED|Overall Study||2
8383343|NCT01090765|20664299|P3|STARTED|Overall Study||3
8383344|NCT01090765|20664300|P2|STARTED|Overall Study||3
8383345|NCT01090765|20664301|P1|STARTED|Overall Study||3
8383346|NCT01090752|20664336|P2|NOT COMPLETED|Overall Study||0
8383347|NCT01090752|20664337|P1|NOT COMPLETED|Overall Study||0
8383348|NCT01090752|20664336|P2|COMPLETED|Overall Study||8
8383349|NCT01090752|20664337|P1|COMPLETED|Overall Study||8
8383350|NCT01090752|20664336|P2|STARTED|Overall Study||8
8383351|NCT01090752|20664337|P1|STARTED|Overall Study||8
8383352|NCT01090739|20664347|P1|NOT COMPLETED|36 Month Follow-up||23
8383353|NCT01090739|20664347|P1|COMPLETED|36 Month Follow-up||115
8383354|NCT01090739|20664347|P1|STARTED|36 Month Follow-up||138
8383355|NCT01090739|20664347|P1|NOT COMPLETED|24 Month Follow-up||9
8383356|NCT01090739|20664347|P1|COMPLETED|24 Month Follow-up||138
8383357|NCT01090739|20664347|P1|STARTED|24 Month Follow-up||147
8383358|NCT01090739|20664347|P1|NOT COMPLETED|12 Month Follow-up||5
8383359|NCT01090739|20664347|P1|COMPLETED|12 Month Follow-up||147
8383360|NCT01090739|20664347|P1|STARTED|12 Month Follow-up||152
8383361|NCT01090739|20664347|P1|NOT COMPLETED|Enrollment||55
8383362|NCT01090739|20664347|P1|COMPLETED|Enrollment||152
8383363|NCT01090739|20664347|P1|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
8383364|NCT01090492|20664372|P8|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
8383365|NCT01090492|20664373|P7|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
8383366|NCT01090492|20664374|P6|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
8383367|NCT01090492|20664375|P5|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
8383368|NCT01090492|20664376|P4|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
8383369|NCT01090492|20664377|P3|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
8383370|NCT01090492|20664378|P2|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
8383371|NCT01090492|20664379|P1|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
8383372|NCT01090492|20664372|P8|COMPLETED|Second Intervention Period (4 Weeks)||25
8383373|NCT01090492|20664373|P7|COMPLETED|Second Intervention Period (4 Weeks)||22
8383374|NCT01090492|20664374|P6|COMPLETED|Second Intervention Period (4 Weeks)||29
8383375|NCT01090492|20664375|P5|COMPLETED|Second Intervention Period (4 Weeks)||27
8383376|NCT01090492|20664376|P4|COMPLETED|Second Intervention Period (4 Weeks)||22
8383377|NCT01090492|20664377|P3|COMPLETED|Second Intervention Period (4 Weeks)||24
8383378|NCT01090492|20664378|P2|COMPLETED|Second Intervention Period (4 Weeks)||22
8383379|NCT01090492|20664379|P1|COMPLETED|Second Intervention Period (4 Weeks)||25
8383380|NCT01090492|20664372|P8|STARTED|Second Intervention Period (4 Weeks)||27
8383381|NCT01090492|20664373|P7|STARTED|Second Intervention Period (4 Weeks)||31
8383382|NCT01090492|20664374|P6|STARTED|Second Intervention Period (4 Weeks)||30
8383383|NCT01090492|20664375|P5|STARTED|Second Intervention Period (4 Weeks)||29
8383384|NCT01090492|20664376|P4|STARTED|Second Intervention Period (4 Weeks)||22
8383385|NCT01090492|20664377|P3|STARTED|Second Intervention Period (4 Weeks)||26
8383386|NCT01090492|20664378|P2|STARTED|Second Intervention Period (4 Weeks)||24
8383387|NCT01090492|20664379|P1|STARTED|Second Intervention Period (4 Weeks)||26
8383388|NCT01090492|20664372|P8|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383389|NCT01090492|20664373|P7|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383390|NCT01090492|20664374|P6|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383391|NCT01090492|20664375|P5|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383392|NCT01090492|20664376|P4|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383393|NCT01090492|20664377|P3|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383394|NCT01090492|20664378|P2|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383395|NCT01090492|20664379|P1|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
8383396|NCT01090492|20664372|P8|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
8383397|NCT01090492|20664373|P7|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
8383398|NCT01090492|20664374|P6|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
8383399|NCT01090492|20664375|P5|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
8383400|NCT01090492|20664376|P4|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
8383401|NCT01090492|20664377|P3|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
8383402|NCT01090492|20664378|P2|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
8383403|NCT01090492|20664379|P1|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
8383404|NCT01090492|20664372|P8|STARTED|Placebo Washout Period ( 2 Weeks)||27
8383405|NCT01090492|20664373|P7|STARTED|Placebo Washout Period ( 2 Weeks)||31
8383406|NCT01090492|20664374|P6|STARTED|Placebo Washout Period ( 2 Weeks)||30
8383407|NCT01090492|20664375|P5|STARTED|Placebo Washout Period ( 2 Weeks)||29
8383408|NCT01090492|20664376|P4|STARTED|Placebo Washout Period ( 2 Weeks)||22
8383409|NCT01090492|20664377|P3|STARTED|Placebo Washout Period ( 2 Weeks)||26
8383410|NCT01090492|20664378|P2|STARTED|Placebo Washout Period ( 2 Weeks)||24
8383411|NCT01090492|20664379|P1|STARTED|Placebo Washout Period ( 2 Weeks)||26
8383412|NCT01090492|20664372|P8|NOT COMPLETED|First Intervention Period (4 Weeks)||6
8383413|NCT01090492|20664373|P7|NOT COMPLETED|First Intervention Period (4 Weeks)||1
8383414|NCT01090492|20664374|P6|NOT COMPLETED|First Intervention Period (4 Weeks)||2
8383415|NCT01090492|20664375|P5|NOT COMPLETED|First Intervention Period (4 Weeks)||4
8383416|NCT01090492|20664376|P4|NOT COMPLETED|First Intervention Period (4 Weeks)||6
8383417|NCT01090492|20664377|P3|NOT COMPLETED|First Intervention Period (4 Weeks)||3
8383418|NCT01090492|20664378|P2|NOT COMPLETED|First Intervention Period (4 Weeks)||5
8383419|NCT01090492|20664379|P1|NOT COMPLETED|First Intervention Period (4 Weeks)||1
8383420|NCT01090492|20664372|P8|COMPLETED|First Intervention Period (4 Weeks)||27
8383421|NCT01090492|20664373|P7|COMPLETED|First Intervention Period (4 Weeks)||31
8383422|NCT01090492|20664374|P6|COMPLETED|First Intervention Period (4 Weeks)||30
8383423|NCT01090492|20664375|P5|COMPLETED|First Intervention Period (4 Weeks)||29
8383424|NCT01090492|20664376|P4|COMPLETED|First Intervention Period (4 Weeks)||22
8383425|NCT01090492|20664377|P3|COMPLETED|First Intervention Period (4 Weeks)||26
8383426|NCT01090492|20664378|P2|COMPLETED|First Intervention Period (4 Weeks)||24
8383427|NCT01090492|20664379|P1|COMPLETED|First Intervention Period (4 Weeks)||26
8383428|NCT01090492|20664372|P8|STARTED|First Intervention Period (4 Weeks)||33
8383429|NCT01090492|20664373|P7|STARTED|First Intervention Period (4 Weeks)||32
8383430|NCT01090492|20664374|P6|STARTED|First Intervention Period (4 Weeks)||32
8383431|NCT01090492|20664375|P5|STARTED|First Intervention Period (4 Weeks)||33
8383432|NCT01090492|20664376|P4|STARTED|First Intervention Period (4 Weeks)||28
8383433|NCT01090492|20664377|P3|STARTED|First Intervention Period (4 Weeks)||29
8383434|NCT01090492|20664378|P2|STARTED|First Intervention Period (4 Weeks)||29
8383435|NCT01090492|20664379|P1|STARTED|First Intervention Period (4 Weeks)||27
8383436|NCT01090479|20664438|P2|NOT COMPLETED|Overall Study||0
8383437|NCT01090479|20664439|P1|NOT COMPLETED|Overall Study||0
8383438|NCT01090479|20664438|P2|COMPLETED|Overall Study||50
8383439|NCT01090479|20664439|P1|COMPLETED|Overall Study||50
8383440|NCT01090479|20664438|P2|STARTED|Overall Study||50
8383441|NCT01090479|20664439|P1|STARTED|Overall Study||50
8383442|NCT01090453|20664447|P2|NOT COMPLETED|Overall Study||14
8383443|NCT01090453|20664448|P1|NOT COMPLETED|Overall Study||13
8383444|NCT01090453|20664447|P2|COMPLETED|Overall Study||228
8383445|NCT01090453|20664448|P1|COMPLETED|Overall Study||225
8383446|NCT01090453|20664447|P2|STARTED|Overall Study||242
8383447|NCT01090453|20664448|P1|STARTED|Overall Study||238
8383448|NCT01090427|20664499|P7|NOT COMPLETED|After Controlled Period||2
8383449|NCT01090427|20664500|P6|NOT COMPLETED|After Controlled Period||5
8383450|NCT01090427|20664501|P5|NOT COMPLETED|After Controlled Period||0
8383451|NCT01090427|20664502|P4|NOT COMPLETED|After Controlled Period||2
8383452|NCT01090427|20664503|P3|NOT COMPLETED|After Controlled Period||0
8383453|NCT01090427|20664504|P2|NOT COMPLETED|After Controlled Period||0
8383454|NCT01090427|20664505|P1|NOT COMPLETED|After Controlled Period||0
8383455|NCT01090427|20664499|P7|COMPLETED|After Controlled Period||34
8383456|NCT01090427|20664500|P6|COMPLETED|After Controlled Period||32
8383457|NCT01090427|20664501|P5|COMPLETED|After Controlled Period||18
8383458|NCT01090427|20664502|P4|COMPLETED|After Controlled Period||17
8383459|NCT01090427|20664503|P3|COMPLETED|After Controlled Period||0
8383460|NCT01090427|20664504|P2|COMPLETED|After Controlled Period||0
8383461|NCT01090427|20664505|P1|COMPLETED|After Controlled Period||0
8383462|NCT01090427|20664499|P7|STARTED|After Controlled Period||36
8383463|NCT01090427|20664500|P6|STARTED|After Controlled Period||37
8383464|NCT01090427|20664501|P5|STARTED|After Controlled Period||18
8383465|NCT01090427|20664502|P4|STARTED|After Controlled Period||19
8383466|NCT01090427|20664503|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8383467|NCT01090427|20664504|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8383468|NCT01090427|20664505|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8383469|NCT01090427|20664499|P7|NOT COMPLETED|Controlled Period||0
8383470|NCT01090427|20664500|P6|NOT COMPLETED|Controlled Period||0
8383471|NCT01090427|20664501|P5|NOT COMPLETED|Controlled Period||0
8383472|NCT01090427|20664502|P4|NOT COMPLETED|Controlled Period||0
8383473|NCT01090427|20664503|P3|NOT COMPLETED|Controlled Period||0
8383474|NCT01090427|20664504|P2|NOT COMPLETED|Controlled Period||0
8383475|NCT01090427|20664505|P1|NOT COMPLETED|Controlled Period||0
8383476|NCT01090427|20664499|P7|COMPLETED|Controlled Period||0
8383477|NCT01090427|20664500|P6|COMPLETED|Controlled Period||0
8383478|NCT01090427|20664501|P5|COMPLETED|Controlled Period||0
8383479|NCT01090427|20664502|P4|COMPLETED|Controlled Period||0
8383480|NCT01090427|20664503|P3|COMPLETED|Controlled Period||36
8383481|NCT01090427|20664504|P2|COMPLETED|Controlled Period||37
8383482|NCT01090427|20664505|P1|COMPLETED|Controlled Period||37
8383483|NCT01090427|20664499|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8383484|NCT01090427|20664500|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8383485|NCT01090427|20664501|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8383486|NCT01090427|20664502|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8383487|NCT01090427|20664503|P3|STARTED|Controlled Period||36
8383488|NCT01090427|20664504|P2|STARTED|Controlled Period||37
8383489|NCT01090427|20664505|P1|STARTED|Controlled Period||37
8383490|NCT01090414|20664542|P4|NOT COMPLETED|Study 101-99||5
8383491|NCT01090414|20664543|P3|NOT COMPLETED|Study 101-99||41
8383492|NCT01090414|20664544|P2|NOT COMPLETED|Study 101-99||108
8383493|NCT01090414|20664545|P1|NOT COMPLETED|Study 101-99||48
8383494|NCT01090414|20664542|P4|COMPLETED|Study 101-99||0
8383495|NCT01090414|20664543|P3|COMPLETED|Study 101-99||0
8383496|NCT01090414|20664544|P2|COMPLETED|Study 101-99||0
8383497|NCT01090414|20664545|P1|COMPLETED|Study 101-99||0
8383498|NCT01090414|20664542|P4|STARTED|Study 101-99||5
8383499|NCT01090414|20664543|P3|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41
8383500|NCT01090414|20664544|P2|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108
8383501|NCT01090414|20664545|P1|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48
8383502|NCT01090414|20664542|P4|NOT COMPLETED|Parent Studies||13
8383503|NCT01090414|20664543|P3|NOT COMPLETED|Parent Studies||21
8383504|NCT01090414|20664544|P2|NOT COMPLETED|Parent Studies||127
8383505|NCT01090414|20664545|P1|NOT COMPLETED|Parent Studies||141
8383506|NCT01090414|20664542|P4|COMPLETED|Parent Studies||5
8383507|NCT01090414|20664543|P3|COMPLETED|Parent Studies||43
8383508|NCT01090414|20664544|P2|COMPLETED|Parent Studies||114
8383509|NCT01090414|20664545|P1|COMPLETED|Parent Studies||50
8383510|NCT01090414|20664542|P4|STARTED|Parent Studies||18
8383511|NCT01090414|20664543|P3|STARTED|Parent Studies||64
8383512|NCT01090414|20664544|P2|STARTED|Parent Studies||241
8383513|NCT01090414|20664545|P1|STARTED|Parent Studies||191
8383514|NCT01090323|20664612|P2|NOT COMPLETED|Overall Study||34
8383515|NCT01090323|20664613|P1|NOT COMPLETED|Overall Study||89
8383516|NCT01090323|20664612|P2|COMPLETED|Overall Study||19
8383517|NCT01090323|20664613|P1|COMPLETED|Overall Study||43
8383518|NCT01090323|20664612|P2|STARTED|Overall Study||53
8383519|NCT01090323|20664613|P1|STARTED|Overall Study||132
8383520|NCT01090310|20664625|P4|NOT COMPLETED|Extension Study||20
8383521|NCT01090310|20664626|P3|NOT COMPLETED|Extension Study||15
8383522|NCT01090310|20664627|P2|NOT COMPLETED|Extension Study||16
8383523|NCT01090310|20664628|P1|NOT COMPLETED|Extension Study||14
8383524|NCT01090310|20664625|P4|COMPLETED|Extension Study||1
8383525|NCT01090310|20664626|P3|COMPLETED|Extension Study||1
8383526|NCT01090310|20664627|P2|COMPLETED|Extension Study||0
8383527|NCT01090310|20664628|P1|COMPLETED|Extension Study||3
8383528|NCT01090310|20664625|P4|STARTED|Extension Study||21
8383529|NCT01090310|20664626|P3|STARTED|Extension Study||16
8383530|NCT01090310|20664627|P2|STARTED|Extension Study||16
8383531|NCT01090310|20664628|P1|STARTED|Extension Study||17
8383532|NCT01090310|20664625|P4|NOT COMPLETED|Core Study||7
8383533|NCT01090310|20664626|P3|NOT COMPLETED|Core Study||7
8383534|NCT01090310|20664627|P2|NOT COMPLETED|Core Study||11
8383535|NCT01090310|20664628|P1|NOT COMPLETED|Core Study||8
8383536|NCT01090310|20664625|P4|COMPLETED|Core Study||27
8383537|NCT01090310|20664626|P3|COMPLETED|Core Study||24
8383538|NCT01090310|20664627|P2|COMPLETED|Core Study||20
8383539|NCT01090310|20664628|P1|COMPLETED|Core Study||21
8383540|NCT01090310|20664625|P4|STARTED|Core Study||34
8383541|NCT01090310|20664626|P3|STARTED|Core Study||31
8383542|NCT01090310|20664627|P2|STARTED|Core Study||31
8383543|NCT01090310|20664628|P1|STARTED|Core Study||29
8383544|NCT01090180|20664656|P2|NOT COMPLETED|Overall Study||8
8383545|NCT01090180|20664657|P1|NOT COMPLETED|Overall Study||11
8383546|NCT01090180|20664656|P2|COMPLETED|Overall Study||21
8383547|NCT01090180|20664657|P1|COMPLETED|Overall Study||22
8383548|NCT01090180|20664656|P2|STARTED|Overall Study||29
8383549|NCT01090180|20664657|P1|STARTED|Overall Study||33
8383550|NCT01090141|20664667|P2|NOT COMPLETED|Overall Study||0
8383551|NCT01090141|20664668|P1|NOT COMPLETED|Overall Study||0
8383552|NCT01090141|20664667|P2|COMPLETED|Overall Study||0
8383553|NCT01090141|20664668|P1|COMPLETED|Overall Study||0
8383554|NCT01090141|20664667|P2|STARTED|Overall Study||0
8383555|NCT01090141|20664668|P1|STARTED|Overall Study||0
8383556|NCT01090102|20664676|P2|NOT COMPLETED|Second 12 Weeks||1
8383557|NCT01090102|20664677|P1|NOT COMPLETED|Second 12 Weeks||0
8383558|NCT01090102|20664676|P2|COMPLETED|Second 12 Weeks||15
8383559|NCT01090102|20664677|P1|COMPLETED|Second 12 Weeks||11
8383560|NCT01090102|20664676|P2|STARTED|Second 12 Weeks||16
8383561|NCT01090102|20664677|P1|STARTED|Second 12 Weeks||11
8383562|NCT01090102|20664676|P2|NOT COMPLETED|First 12 Weeks||2
8383563|NCT01090102|20664677|P1|NOT COMPLETED|First 12 Weeks||4
8383564|NCT01090102|20664676|P2|COMPLETED|First 12 Weeks||16
8383565|NCT01090102|20664677|P1|COMPLETED|First 12 Weeks||11
8383566|NCT01090102|20664676|P2|STARTED|First 12 Weeks||18
8383567|NCT01090102|20664677|P1|STARTED|First 12 Weeks||15
8383568|NCT01090076|20664687|P2|NOT COMPLETED|Overall Study||2
8383569|NCT01090076|20664688|P1|NOT COMPLETED|Overall Study||1
8383570|NCT01090076|20664687|P2|COMPLETED|Overall Study||12
8383571|NCT01090076|20664688|P1|COMPLETED|Overall Study||11
8383572|NCT01090076|20664687|P2|STARTED|Overall Study||14
8383573|NCT01090076|20664688|P1|STARTED|Overall Study||12
8383574|NCT01090063|20664698|P1|NOT COMPLETED|Treatment||4
8383575|NCT01090063|20664698|P1|COMPLETED|Treatment||20
8383576|NCT01090063|20664698|P1|STARTED|Treatment||24
8383577|NCT01090063|20664698|P1|NOT COMPLETED|Screen||4
8383578|NCT01090063|20664698|P1|COMPLETED|Screen||24
8383579|NCT01090063|20664698|P1|STARTED|Screen||28
8383580|NCT01090050|20664714|P2|NOT COMPLETED|Overall Study||7
8383581|NCT01090050|20664715|P1|NOT COMPLETED|Overall Study||1
8383582|NCT01090050|20664714|P2|COMPLETED|Overall Study||5
8383583|NCT01090050|20664715|P1|COMPLETED|Overall Study||15
8383584|NCT01090050|20664714|P2|STARTED|Overall Study||12
8383585|NCT01090050|20664715|P1|STARTED|Overall Study||16
8383586|NCT01090011|20664735|P1|NOT COMPLETED|Overall Study||171
8383587|NCT01090011|20664735|P1|COMPLETED|Overall Study||0
8383588|NCT01090011|20664735|P1|STARTED|Overall Study||171
8383589|NCT01089751|20664805|P2|NOT COMPLETED|Overall Study||27
8383590|NCT01089751|20664806|P1|NOT COMPLETED|Overall Study||34
8383591|NCT01089751|20664805|P2|COMPLETED|Overall Study||132
8383592|NCT01089751|20664806|P1|COMPLETED|Overall Study||129
8383593|NCT01089751|20664805|P2|STARTED|Overall Study||159
8383594|NCT01089751|20664806|P1|STARTED|Overall Study||163
8383595|NCT01089647|20664828|P2|NOT COMPLETED|Overall Study||4
8383596|NCT01089647|20664829|P1|NOT COMPLETED|Overall Study||4
8383597|NCT01089647|20664828|P2|COMPLETED|Overall Study||13
8383598|NCT01089647|20664829|P1|COMPLETED|Overall Study||13
8383599|NCT01089647|20664828|P2|STARTED|Overall Study||17
8383600|NCT01089647|20664829|P1|STARTED|Overall Study||17
8383601|NCT01089608|20664837|P2|NOT COMPLETED|Overall Study||6
8383602|NCT01089608|20664838|P1|NOT COMPLETED|Overall Study||0
8383603|NCT01089608|20664837|P2|COMPLETED|Overall Study||44
8383604|NCT01089608|20664838|P1|COMPLETED|Overall Study||43
8383605|NCT01089608|20664837|P2|STARTED|Overall Study||50
8383606|NCT01089608|20664838|P1|STARTED|Overall Study||43
8383607|NCT01089595|20664846|P2|NOT COMPLETED|Overall Study||0
8383608|NCT01089595|20664847|P1|NOT COMPLETED|Overall Study||0
8383609|NCT01089595|20664846|P2|COMPLETED|Overall Study||3
8383610|NCT01089595|20664847|P1|COMPLETED|Overall Study||2
8383611|NCT01089595|20664846|P2|STARTED|Overall Study||3
8383612|NCT01089595|20664847|P1|STARTED|Overall Study||2
8383613|NCT01089582|20664855|P1|NOT COMPLETED|Overall Study||30
8383614|NCT01089582|20664855|P1|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
8383615|NCT01089582|20664855|P1|STARTED|Overall Study||603
8383616|NCT01089569|20664868|P3|NOT COMPLETED|Overall Study||4
8383617|NCT01089569|20664869|P2|NOT COMPLETED|Overall Study||3
8383618|NCT01089569|20664870|P1|NOT COMPLETED|Overall Study||4
8383619|NCT01089569|20664868|P3|COMPLETED|Overall Study||16
8383620|NCT01089569|20664869|P2|COMPLETED|Overall Study||17
8383621|NCT01089569|20664870|P1|COMPLETED|Overall Study||16
8383622|NCT01089569|20664868|P3|STARTED|Overall Study||20
8383623|NCT01089569|20664869|P2|STARTED|Overall Study||20
8383624|NCT01089569|20664870|P1|STARTED|Overall Study||20
8383625|NCT01089556|20664898|P6|NOT COMPLETED|Study Period III (Weeks 9-16)||7
8383626|NCT01089556|20664899|P5|NOT COMPLETED|Study Period III (Weeks 9-16)||12
8383627|NCT01089556|20664900|P4|NOT COMPLETED|Study Period III (Weeks 9-16)||9
8383628|NCT01089556|20664901|P3|NOT COMPLETED|Study Period III (Weeks 9-16)||14
8383629|NCT01089556|20664902|P2|NOT COMPLETED|Study Period III (Weeks 9-16)||0
8383630|NCT01089556|20664903|P1|NOT COMPLETED|Study Period III (Weeks 9-16)||0
8383631|NCT01089556|20664898|P6|COMPLETED|Study Period III (Weeks 9-16)||92
8383632|NCT01089556|20664899|P5|COMPLETED|Study Period III (Weeks 9-16)||83
8383633|NCT01089556|20664900|P4|COMPLETED|Study Period III (Weeks 9-16)||66
8383634|NCT01089556|20664901|P3|COMPLETED|Study Period III (Weeks 9-16)||60
8383635|NCT01089556|20664902|P2|COMPLETED|Study Period III (Weeks 9-16)||0
8383636|NCT01089556|20664903|P1|COMPLETED|Study Period III (Weeks 9-16)||0
8383637|NCT01089556|20664898|P6|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
8383638|NCT01089556|20664899|P5|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
8383639|NCT01089556|20664900|P4|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
8383640|NCT01089556|20664901|P3|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
8383641|NCT01089556|20664902|P2|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
8383642|NCT01089556|20664903|P1|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
8383643|NCT01089556|20664898|P6|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
8383644|NCT01089556|20664899|P5|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
8383645|NCT01089556|20664900|P4|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
8383646|NCT01089556|20664901|P3|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
8383647|NCT01089556|20664902|P2|STARTED|Study Period III (Weeks 9-16)||0
8383648|NCT01089556|20664903|P1|STARTED|Study Period III (Weeks 9-16)||0
8383649|NCT01089556|20664898|P6|NOT COMPLETED|Study Period II (Weeks 1-8)||0
8383650|NCT01089556|20664899|P5|NOT COMPLETED|Study Period II (Weeks 1-8)||0
8383651|NCT01089556|20664900|P4|NOT COMPLETED|Study Period II (Weeks 1-8)||0
8383652|NCT01089556|20664901|P3|NOT COMPLETED|Study Period II (Weeks 1-8)||0
8383653|NCT01089556|20664902|P2|NOT COMPLETED|Study Period II (Weeks 1-8)||74
8383654|NCT01089556|20664903|P1|NOT COMPLETED|Study Period II (Weeks 1-8)||71
8383655|NCT01089556|20664898|P6|COMPLETED|Study Period II (Weeks 1-8)||0
8383656|NCT01089556|20664899|P5|COMPLETED|Study Period II (Weeks 1-8)||0
8383657|NCT01089556|20664900|P4|COMPLETED|Study Period II (Weeks 1-8)||0
8383658|NCT01089556|20664901|P3|COMPLETED|Study Period II (Weeks 1-8)||0
8383659|NCT01089556|20664902|P2|COMPLETED|Study Period II (Weeks 1-8)||333
8383660|NCT01089556|20664903|P1|COMPLETED|Study Period II (Weeks 1-8)||333
8383661|NCT01089556|20664898|P6|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
8383662|NCT01089556|20664899|P5|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
8383663|NCT01089556|20664900|P4|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
8383664|NCT01089556|20664901|P3|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
8383665|NCT01089556|20664902|P2|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
8383752|NCT01089062|20665129|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8383666|NCT01089556|20664903|P1|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
8383667|NCT01089556|20664898|P6|Safety Population|Study Period II (Weeks 1-8)||0
8383668|NCT01089556|20664899|P5|Safety Population|Study Period II (Weeks 1-8)||0
8383669|NCT01089556|20664900|P4|Safety Population|Study Period II (Weeks 1-8)||0
8383670|NCT01089556|20664901|P3|Safety Population|Study Period II (Weeks 1-8)||0
8383671|NCT01089556|20664902|P2|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
8383672|NCT01089556|20664903|P1|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
8383673|NCT01089556|20664898|P6|STARTED|Study Period II (Weeks 1-8)||0
8383674|NCT01089556|20664899|P5|STARTED|Study Period II (Weeks 1-8)||0
8383675|NCT01089556|20664900|P4|STARTED|Study Period II (Weeks 1-8)||0
8383676|NCT01089556|20664901|P3|STARTED|Study Period II (Weeks 1-8)||0
8383677|NCT01089556|20664902|P2|STARTED|Study Period II (Weeks 1-8)||407
8383678|NCT01089556|20664903|P1|STARTED|Study Period II (Weeks 1-8)||404
8383679|NCT01089543|20664977|P4|NOT COMPLETED|Overall Study||2
8383680|NCT01089543|20664978|P3|NOT COMPLETED|Overall Study||3
8383681|NCT01089543|20664979|P2|NOT COMPLETED|Overall Study||4
8383682|NCT01089543|20664980|P1|NOT COMPLETED|Overall Study||3
8383683|NCT01089543|20664977|P4|COMPLETED|Overall Study||83
8383684|NCT01089543|20664978|P3|COMPLETED|Overall Study||81
8383685|NCT01089543|20664979|P2|COMPLETED|Overall Study||81
8383686|NCT01089543|20664980|P1|COMPLETED|Overall Study||81
8383687|NCT01089543|20664977|P4|STARTED|Overall Study||85
8383688|NCT01089543|20664978|P3|STARTED|Overall Study||84
8383689|NCT01089543|20664979|P2|STARTED|Overall Study||85
8383690|NCT01089543|20664980|P1|STARTED|Overall Study||84
8383691|NCT01089517|20664997|P3|NOT COMPLETED|Overall Study||5
8383692|NCT01089517|20664998|P2|NOT COMPLETED|Overall Study||5
8383693|NCT01089517|20664999|P1|NOT COMPLETED|Overall Study||4
8383694|NCT01089517|20664997|P3|COMPLETED|Overall Study||147
8383695|NCT01089517|20664998|P2|COMPLETED|Overall Study||144
8383696|NCT01089517|20664999|P1|COMPLETED|Overall Study||144
8383697|NCT01089517|20664997|P3|STARTED|Overall Study||152
8383698|NCT01089517|20664998|P2|STARTED|Overall Study||149
8383699|NCT01089517|20664999|P1|STARTED|Overall Study||148
8383700|NCT01089504|20665015|P2|NOT COMPLETED|Overall Study||1
8383701|NCT01089504|20665016|P1|NOT COMPLETED|Overall Study||3
8383702|NCT01089504|20665015|P2|COMPLETED|Overall Study||4
8383703|NCT01089504|20665016|P1|COMPLETED|Overall Study||5
8383704|NCT01089504|20665015|P2|STARTED|Overall Study||5
8383705|NCT01089504|20665016|P1|STARTED|Overall Study||8
8383706|NCT01089413|20665029|P1|NOT COMPLETED|Overall Study||201
8383707|NCT01089413|20665029|P1|COMPLETED|Overall Study||0
8383708|NCT01089413|20665029|P1|Received Bevacizumab in First Line|Overall Study||199
8383709|NCT01089413|20665029|P1|STARTED|Overall Study||201
8383710|NCT01089361|20665048|P2|NOT COMPLETED|Overall Study||0
8383711|NCT01089361|20665049|P1|NOT COMPLETED|Overall Study||1
8383712|NCT01089361|20665048|P2|COMPLETED|Overall Study||10
8383713|NCT01089361|20665049|P1|COMPLETED|Overall Study||8
8383714|NCT01089361|20665048|P2|STARTED|Overall Study||10
8383715|NCT01089361|20665049|P1|STARTED|Overall Study||9
8383716|NCT01089231|20665071|P4|NOT COMPLETED|Overall Study||1
8383717|NCT01089231|20665072|P3|NOT COMPLETED|Overall Study||2
8383718|NCT01089231|20665073|P2|NOT COMPLETED|Overall Study||2
8383719|NCT01089231|20665074|P1|NOT COMPLETED|Overall Study||4
8383720|NCT01089231|20665071|P4|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
8383721|NCT01089231|20665072|P3|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
8383722|NCT01089231|20665073|P2|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
8383723|NCT01089231|20665074|P1|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
8383724|NCT01089231|20665071|P4|STARTED|Overall Study||10
8383725|NCT01089231|20665072|P3|STARTED|Overall Study||10
8383726|NCT01089231|20665073|P2|STARTED|Overall Study||10
8383727|NCT01089231|20665074|P1|STARTED|Overall Study||10
8383728|NCT01089127|20665098|P6|NOT COMPLETED|Overall Study||3
8383729|NCT01089127|20665099|P5|NOT COMPLETED|Overall Study||2
8383730|NCT01089127|20665100|P4|NOT COMPLETED|Overall Study||1
8383731|NCT01089127|20665101|P3|NOT COMPLETED|Overall Study||2
8383732|NCT01089127|20665102|P2|NOT COMPLETED|Overall Study||5
8383733|NCT01089127|20665103|P1|NOT COMPLETED|Overall Study||8
8383734|NCT01089127|20665098|P6|COMPLETED|Overall Study||88
8383735|NCT01089127|20665099|P5|COMPLETED|Overall Study||90
8383736|NCT01089127|20665100|P4|COMPLETED|Overall Study||91
8383737|NCT01089127|20665101|P3|COMPLETED|Overall Study||92
8383738|NCT01089127|20665102|P2|COMPLETED|Overall Study||86
8383739|NCT01089127|20665103|P1|COMPLETED|Overall Study||84
8383740|NCT01089127|20665098|P6|Exposed to Study Drug|Overall Study||91
8383741|NCT01089127|20665099|P5|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
8383742|NCT01089127|20665100|P4|Exposed to Study Drug|Overall Study||92
8383743|NCT01089127|20665101|P3|Exposed to Study Drug|Overall Study||94
8383744|NCT01089127|20665102|P2|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
8383745|NCT01089127|20665103|P1|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
8383746|NCT01089127|20665098|P6|STARTED|Overall Study||91
8383747|NCT01089127|20665099|P5|STARTED|Overall Study||92
8383748|NCT01089127|20665100|P4|STARTED|Overall Study||92
8383749|NCT01089127|20665101|P3|STARTED|Overall Study||94
8383750|NCT01089127|20665102|P2|STARTED|Overall Study||91
8383751|NCT01089127|20665103|P1|STARTED|Overall Study||92
8383753|NCT01089062|20665130|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8383754|NCT01089062|20665131|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8383755|NCT01089062|20665132|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8383756|NCT01089062|20665133|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8383757|NCT01089062|20665134|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8383758|NCT01089062|20665129|P6|COMPLETED|Follow-up Visit (Final Visit)||3
8383759|NCT01089062|20665130|P5|COMPLETED|Follow-up Visit (Final Visit)||3
8383760|NCT01089062|20665131|P4|COMPLETED|Follow-up Visit (Final Visit)||3
8383761|NCT01089062|20665132|P3|COMPLETED|Follow-up Visit (Final Visit)||3
8383762|NCT01089062|20665133|P2|COMPLETED|Follow-up Visit (Final Visit)||3
8383763|NCT01089062|20665134|P1|COMPLETED|Follow-up Visit (Final Visit)||3
8383764|NCT01089062|20665129|P6|STARTED|Follow-up Visit (Final Visit)||3
8383765|NCT01089062|20665130|P5|STARTED|Follow-up Visit (Final Visit)||3
8383766|NCT01089062|20665131|P4|STARTED|Follow-up Visit (Final Visit)||3
8383767|NCT01089062|20665132|P3|STARTED|Follow-up Visit (Final Visit)||3
8383768|NCT01089062|20665133|P2|STARTED|Follow-up Visit (Final Visit)||3
8383769|NCT01089062|20665134|P1|STARTED|Follow-up Visit (Final Visit)||3
8383770|NCT01089062|20665129|P6|NOT COMPLETED|Visit 4||0
8383771|NCT01089062|20665130|P5|NOT COMPLETED|Visit 4||0
8383772|NCT01089062|20665131|P4|NOT COMPLETED|Visit 4||0
8383773|NCT01089062|20665132|P3|NOT COMPLETED|Visit 4||0
8383774|NCT01089062|20665133|P2|NOT COMPLETED|Visit 4||0
8383775|NCT01089062|20665134|P1|NOT COMPLETED|Visit 4||0
8383776|NCT01089062|20665129|P6|COMPLETED|Visit 4||3
8383777|NCT01089062|20665130|P5|COMPLETED|Visit 4||3
8383778|NCT01089062|20665131|P4|COMPLETED|Visit 4||3
8383779|NCT01089062|20665132|P3|COMPLETED|Visit 4||3
8383780|NCT01089062|20665133|P2|COMPLETED|Visit 4||3
8383781|NCT01089062|20665134|P1|COMPLETED|Visit 4||3
8383782|NCT01089062|20665129|P6|STARTED|Visit 4||3
8383783|NCT01089062|20665130|P5|STARTED|Visit 4||3
8383784|NCT01089062|20665131|P4|STARTED|Visit 4||3
8383785|NCT01089062|20665132|P3|STARTED|Visit 4||3
8383786|NCT01089062|20665133|P2|STARTED|Visit 4||3
8383787|NCT01089062|20665134|P1|STARTED|Visit 4||3
8383788|NCT01089062|20665129|P6|NOT COMPLETED|Visit 3||0
8383789|NCT01089062|20665130|P5|NOT COMPLETED|Visit 3||0
8383790|NCT01089062|20665131|P4|NOT COMPLETED|Visit 3||1
8383791|NCT01089062|20665132|P3|NOT COMPLETED|Visit 3||0
8383792|NCT01089062|20665133|P2|NOT COMPLETED|Visit 3||0
8383793|NCT01089062|20665134|P1|NOT COMPLETED|Visit 3||0
8383794|NCT01089062|20665129|P6|COMPLETED|Visit 3||3
8383795|NCT01089062|20665130|P5|COMPLETED|Visit 3||3
8383796|NCT01089062|20665131|P4|COMPLETED|Visit 3||3
8383797|NCT01089062|20665132|P3|COMPLETED|Visit 3||3
8383798|NCT01089062|20665133|P2|COMPLETED|Visit 3||3
8383799|NCT01089062|20665134|P1|COMPLETED|Visit 3||3
8383800|NCT01089062|20665129|P6|STARTED|Visit 3||3
8383801|NCT01089062|20665130|P5|STARTED|Visit 3||3
8383802|NCT01089062|20665131|P4|STARTED|Visit 3||4
8383803|NCT01089062|20665132|P3|STARTED|Visit 3||3
8383804|NCT01089062|20665133|P2|STARTED|Visit 3||3
8383805|NCT01089062|20665134|P1|STARTED|Visit 3||3
8383806|NCT01089062|20665129|P6|NOT COMPLETED|Visit 2 (Randomization)||1
8383807|NCT01089062|20665130|P5|NOT COMPLETED|Visit 2 (Randomization)||1
8383808|NCT01089062|20665131|P4|NOT COMPLETED|Visit 2 (Randomization)||0
8383809|NCT01089062|20665132|P3|NOT COMPLETED|Visit 2 (Randomization)||1
8383810|NCT01089062|20665133|P2|NOT COMPLETED|Visit 2 (Randomization)||1
8383811|NCT01089062|20665134|P1|NOT COMPLETED|Visit 2 (Randomization)||1
8383812|NCT01089062|20665129|P6|COMPLETED|Visit 2 (Randomization)||3
8383813|NCT01089062|20665130|P5|COMPLETED|Visit 2 (Randomization)||3
8383814|NCT01089062|20665131|P4|COMPLETED|Visit 2 (Randomization)||4
8383815|NCT01089062|20665132|P3|COMPLETED|Visit 2 (Randomization)||3
8383816|NCT01089062|20665133|P2|COMPLETED|Visit 2 (Randomization)||3
8383817|NCT01089062|20665134|P1|COMPLETED|Visit 2 (Randomization)||3
8383818|NCT01089062|20665129|P6|STARTED|Visit 2 (Randomization)||4
8383819|NCT01089062|20665130|P5|STARTED|Visit 2 (Randomization)||4
8383820|NCT01089062|20665131|P4|STARTED|Visit 2 (Randomization)||4
8383821|NCT01089062|20665132|P3|STARTED|Visit 2 (Randomization)||4
8383822|NCT01089062|20665133|P2|STARTED|Visit 2 (Randomization)||4
8383823|NCT01089062|20665134|P1|STARTED|Visit 2 (Randomization)||4
8383824|NCT01089023|20665157|P1|NOT COMPLETED|Overall Study||7
8383825|NCT01089023|20665157|P1|COMPLETED|Overall Study||88
8383826|NCT01089023|20665157|P1|STARTED|Overall Study||95
8383827|NCT01088997|20665171|P2|NOT COMPLETED|Overall Study||3
8383828|NCT01088997|20665172|P1|NOT COMPLETED|Overall Study||3
8383829|NCT01088997|20665171|P2|COMPLETED|Overall Study||2
8383830|NCT01088997|20665172|P1|COMPLETED|Overall Study||4
8383831|NCT01088997|20665171|P2|STARTED|Overall Study||5
8383832|NCT01088997|20665172|P1|STARTED|Overall Study||7
8383833|NCT01088984|20665183|P2|NOT COMPLETED|Phase 2||32
8383834|NCT01088984|20665184|P1|NOT COMPLETED|Phase 2||0
8383835|NCT01088984|20665183|P2|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
8383836|NCT01088984|20665184|P1|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
8383837|NCT01088984|20665183|P2|STARTED|Phase 2||32
8383838|NCT01088984|20665184|P1|STARTED|Phase 2||0
8383839|NCT01088984|20665183|P2|NOT COMPLETED|Phase 1||6
8383840|NCT01088984|20665184|P1|NOT COMPLETED|Phase 1||5
8383841|NCT01088984|20665183|P2|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
8383842|NCT01088984|20665184|P1|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
8383843|NCT01088984|20665183|P2|STARTED|Phase 1||6
8383844|NCT01088984|20665184|P1|STARTED|Phase 1||5
8383845|NCT01088815|20665202|P1|NOT COMPLETED|Overall Study||0
8383846|NCT01088815|20665202|P1|COMPLETED|Overall Study||72
8383847|NCT01088815|20665202|P1|STARTED|Overall Study||72
8383848|NCT01088711|20665215|P4|NOT COMPLETED|Overall Study||0
8383849|NCT01088711|20665216|P3|NOT COMPLETED|Overall Study||0
8383850|NCT01088711|20665217|P2|NOT COMPLETED|Overall Study||0
8383851|NCT01088711|20665218|P1|NOT COMPLETED|Overall Study||0
8383852|NCT01088711|20665215|P4|COMPLETED|Overall Study||2
8383853|NCT01088711|20665216|P3|COMPLETED|Overall Study||6
8383854|NCT01088711|20665217|P2|COMPLETED|Overall Study||6
8383855|NCT01088711|20665218|P1|COMPLETED|Overall Study||18
8383856|NCT01088711|20665215|P4|STARTED|Overall Study||2
8383857|NCT01088711|20665216|P3|STARTED|Overall Study||6
8383858|NCT01088711|20665217|P2|STARTED|Overall Study||6
8383859|NCT01088711|20665218|P1|STARTED|Overall Study||18
8383860|NCT01088672|20665242|P1|NOT COMPLETED|Overall Study||0
8383861|NCT01088672|20665242|P1|COMPLETED|Overall Study||60
8383862|NCT01088672|20665242|P1|STARTED|Overall Study||60
8383863|NCT01088646|20665248|P1|NOT COMPLETED|Overall Study||0
8383864|NCT01088646|20665248|P1|COMPLETED|Overall Study||25
8383865|NCT01088646|20665248|P1|STARTED|Overall Study||25
8383866|NCT01088529|20665255|P2|NOT COMPLETED|Overall Study||1
8383867|NCT01088529|20665256|P1|NOT COMPLETED|Overall Study||0
8383868|NCT01088529|20665255|P2|COMPLETED|Overall Study||21
8383869|NCT01088529|20665256|P1|COMPLETED|Overall Study||44
8383870|NCT01088529|20665255|P2|Received Treatment|Overall Study||21
8383871|NCT01088529|20665256|P1|Received Treatment|Overall Study||44
8383872|NCT01088529|20665255|P2|STARTED|Overall Study||22
8383873|NCT01088529|20665256|P1|STARTED|Overall Study||44
8383874|NCT01088503|20665269|P3|NOT COMPLETED|Overall Study||17
8383875|NCT01088503|20665270|P2|NOT COMPLETED|Overall Study||685
8383876|NCT01088503|20665271|P1|NOT COMPLETED|Overall Study||182
8383877|NCT01088503|20665269|P3|COMPLETED|Overall Study||241
8383878|NCT01088503|20665270|P2|COMPLETED|Overall Study||8161
8383879|NCT01088503|20665271|P1|COMPLETED|Overall Study||2941
8383880|NCT01088503|20665269|P3|STARTED|Overall Study||258
8383881|NCT01088503|20665270|P2|STARTED|Overall Study||8846
8383882|NCT01088503|20665271|P1|STARTED|Overall Study||3123
8383883|NCT01088464|20665295|P3|NOT COMPLETED|Overall Study||0
8383884|NCT01088464|20665296|P2|NOT COMPLETED|Overall Study||0
8383885|NCT01088464|20665297|P1|NOT COMPLETED|Overall Study||0
8383886|NCT01088464|20665295|P3|COMPLETED|Overall Study||6
8383887|NCT01088464|20665296|P2|COMPLETED|Overall Study||6
8383888|NCT01088464|20665297|P1|COMPLETED|Overall Study||3
8383889|NCT01088464|20665295|P3|Received Any Quantity of Study Drug|Overall Study||6
8383890|NCT01088464|20665296|P2|Received Any Quantity of Study Drug|Overall Study||6
8383891|NCT01088464|20665297|P1|Received Any Quantity of Study Drug|Overall Study||3
8383892|NCT01088464|20665295|P3|STARTED|Overall Study||6
8383893|NCT01088464|20665296|P2|STARTED|Overall Study||6
8383894|NCT01088464|20665297|P1|STARTED|Overall Study||3
8383895|NCT01088438|20665349|P2|NOT COMPLETED|Overall Study||36
8383896|NCT01088438|20665350|P1|NOT COMPLETED|Overall Study||29
8383897|NCT01088438|20665349|P2|COMPLETED|Overall Study||59
8383898|NCT01088438|20665350|P1|COMPLETED|Overall Study||65
8383899|NCT01088438|20665349|P2|STARTED|Overall Study||95
8383900|NCT01088438|20665350|P1|STARTED|Overall Study||94
8383901|NCT01088412|20665363|P3|NOT COMPLETED|Overall Study||72
8383902|NCT01088412|20665364|P2|NOT COMPLETED|Overall Study||436
8383903|NCT01088412|20665365|P1|NOT COMPLETED|Overall Study||18017
8383904|NCT01088412|20665363|P3|COMPLETED|Overall Study||5
8383905|NCT01088412|20665364|P2|COMPLETED|Overall Study||21
8383906|NCT01088412|20665365|P1|COMPLETED|Overall Study||4294
8383907|NCT01088412|20665363|P3|SME+ >= 1 FU and Previous Cancer|Overall Study||0
8383908|NCT01088412|20665364|P2|SME+ >= 1 FU and Previous Cancer|Overall Study||114
8383909|NCT01088412|20665365|P1|SME+ >= 1 FU and Previous Cancer|Overall Study||622
8383910|NCT01088412|20665363|P3|SME+ >= 1 FU and No Previous Cancer|Overall Study||0
8383911|NCT01088412|20665364|P2|SME+ >= 1 FU and No Previous Cancer|Overall Study||192
8383912|NCT01088412|20665365|P1|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556
8383913|NCT01088412|20665363|P3|SME+ >= 1 FU and Unknown Arm|Overall Study||40
8383914|NCT01088412|20665364|P2|SME+ >= 1 FU and Unknown Arm|Overall Study||306
8383915|NCT01088412|20665365|P1|SME+ >= 1 FU and Unknown Arm|Overall Study||21177
8383916|NCT01088412|20665363|P3|SME With at Least 1 Follow Up (FU)|Overall Study||0
8383917|NCT01088412|20665364|P2|SME With at Least 1 Follow Up (FU)|Overall Study||306
8383918|NCT01088412|20665365|P1|SME With at Least 1 Follow Up (FU)|Overall Study||21178
8383919|NCT01088412|20665363|P3|Safety Modified Evaluable (SME)|Overall Study||0
8383920|NCT01088412|20665364|P2|Safety Modified Evaluable (SME)|Overall Study||456
8383921|NCT01088412|20665365|P1|Safety Modified Evaluable (SME)|Overall Study||22294
8383922|NCT01088412|20665363|P3|STARTED|Overall Study||77
8383923|NCT01088412|20665364|P2|STARTED|Overall Study||457
8383924|NCT01088412|20665365|P1|STARTED|Overall Study||22311
8383925|NCT01088399|20665384|P3|NOT COMPLETED|Overall Study||281
8383926|NCT01088399|20665385|P2|NOT COMPLETED|Overall Study||1347
8383927|NCT01088399|20665386|P1|NOT COMPLETED|Overall Study||7121
8383928|NCT01088399|20665384|P3|COMPLETED|Overall Study||21
8383929|NCT01088399|20665385|P2|COMPLETED|Overall Study||308
8383930|NCT01088399|20665386|P1|COMPLETED|Overall Study||1595
8383931|NCT01088399|20665384|P3|STARTED|Overall Study||302
8383932|NCT01088399|20665385|P2|STARTED|Overall Study||1655
8383933|NCT01088399|20665386|P1|STARTED|Overall Study||8716
8383934|NCT01088295|20665409|P1|NOT COMPLETED|Overall Study||1
8383935|NCT01088295|20665409|P1|COMPLETED|Overall Study||35
8383936|NCT01088295|20665409|P1|STARTED|Overall Study||36
8383937|NCT01088243|20665415|P2|NOT COMPLETED|Overall Study||0
8383938|NCT01088243|20665416|P1|NOT COMPLETED|Overall Study||1
8383939|NCT01088243|20665415|P2|COMPLETED|Overall Study||5
8383940|NCT01088243|20665416|P1|COMPLETED|Overall Study||12
8383941|NCT01088243|20665415|P2|STARTED|Overall Study||5
8383942|NCT01088243|20665416|P1|STARTED|Overall Study||13
8383943|NCT01087996|20665434|P2|NOT COMPLETED|Overall Study||0
8383944|NCT01087996|20665435|P1|NOT COMPLETED|Overall Study||0
8383945|NCT01087996|20665434|P2|COMPLETED|Overall Study||15
8383946|NCT01087996|20665435|P1|COMPLETED|Overall Study||15
8383947|NCT01087996|20665434|P2|STARTED|Overall Study||15
8383948|NCT01087996|20665435|P1|STARTED|Overall Study||15
8383949|NCT01087970|20665457|P1|NOT COMPLETED|Overall Study||2
8383950|NCT01087970|20665457|P1|COMPLETED|Overall Study||67
8383951|NCT01087970|20665457|P1|Received Carboplatin|Overall Study||63
8383952|NCT01087970|20665457|P1|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
8383953|NCT01087970|20665457|P1|Completed 6 Cycles|Overall Study||69
8383954|NCT01087970|20665457|P1|Received ≥1 Dose of Any Study Drug|Overall Study||69
8383955|NCT01087970|20665457|P1|STARTED|Overall Study||69
8383956|NCT01087957|20665469|P2|NOT COMPLETED|Overall Study||55
8383957|NCT01087957|20665470|P1|NOT COMPLETED|Overall Study||41
8383958|NCT01087957|20665469|P2|COMPLETED|Overall Study||187
8383959|NCT01087957|20665470|P1|COMPLETED|Overall Study||212
8383960|NCT01087957|20665469|P2|STARTED|Overall Study||242
8383961|NCT01087957|20665470|P1|STARTED|Overall Study||253
8383962|NCT01087944|20665496|P2|NOT COMPLETED|Period 2 (Week 4-6)||2
8383963|NCT01087944|20665497|P1|NOT COMPLETED|Period 2 (Week 4-6)||0
8383964|NCT01087944|20665496|P2|COMPLETED|Period 2 (Week 4-6)||28
8383965|NCT01087944|20665497|P1|COMPLETED|Period 2 (Week 4-6)||29
8383966|NCT01087944|20665496|P2|STARTED|Period 2 (Week 4-6)||30
8383967|NCT01087944|20665497|P1|STARTED|Period 2 (Week 4-6)||29
8383968|NCT01087944|20665496|P2|NOT COMPLETED|Period 1 (Week 1-3)||0
8383969|NCT01087944|20665497|P1|NOT COMPLETED|Period 1 (Week 1-3)||1
8383970|NCT01087944|20665496|P2|COMPLETED|Period 1 (Week 1-3)||30
8383971|NCT01087944|20665497|P1|COMPLETED|Period 1 (Week 1-3)||29
8383972|NCT01087944|20665496|P2|STARTED|Period 1 (Week 1-3)||30
8383973|NCT01087944|20665497|P1|STARTED|Period 1 (Week 1-3)||30
8383974|NCT01087931|20665527|P2|NOT COMPLETED|Overall Study||0
8383975|NCT01087931|20665528|P1|NOT COMPLETED|Overall Study||0
8383976|NCT01087931|20665527|P2|COMPLETED|Overall Study||20
8383977|NCT01087931|20665528|P1|COMPLETED|Overall Study||20
8383978|NCT01087931|20665527|P2|Final Follow up|Overall Study||17
8383979|NCT01087931|20665528|P1|Final Follow up|Overall Study||19
8383980|NCT01087931|20665527|P2|1st Follow up|Overall Study||19
8383981|NCT01087931|20665528|P1|1st Follow up|Overall Study||20
8383982|NCT01087931|20665527|P2|STARTED|Overall Study||20
8383983|NCT01087931|20665528|P1|STARTED|Overall Study||20
8383984|NCT01087918|20665542|P2|NOT COMPLETED|Overall Study||0
8383985|NCT01087918|20665543|P1|NOT COMPLETED|Overall Study||0
8383986|NCT01087918|20665542|P2|COMPLETED|Overall Study||4
8383987|NCT01087918|20665543|P1|COMPLETED|Overall Study||5
8383988|NCT01087918|20665542|P2|STARTED|Overall Study||4
8383989|NCT01087918|20665543|P1|STARTED|Overall Study||5
8383990|NCT01087905|20665577|P8|NOT COMPLETED|Overall Study||29
8383991|NCT01087905|20665578|P7|NOT COMPLETED|Overall Study||23
8383992|NCT01087905|20665579|P6|NOT COMPLETED|Overall Study||28
8383993|NCT01087905|20665580|P5|NOT COMPLETED|Overall Study||31
8383994|NCT01087905|20665581|P4|NOT COMPLETED|Overall Study||36
8383995|NCT01087905|20665582|P3|NOT COMPLETED|Overall Study||22
8383996|NCT01087905|20665583|P2|NOT COMPLETED|Overall Study||32
8383997|NCT01087905|20665584|P1|NOT COMPLETED|Overall Study||29
8383998|NCT01087905|20665577|P8|COMPLETED|Overall Study||98
8383999|NCT01087905|20665578|P7|COMPLETED|Overall Study||98
8384000|NCT01087905|20665579|P6|COMPLETED|Overall Study||99
8384001|NCT01087905|20665580|P5|COMPLETED|Overall Study||91
8384002|NCT01087905|20665581|P4|COMPLETED|Overall Study||86
8384003|NCT01087905|20665582|P3|COMPLETED|Overall Study||101
8384004|NCT01087905|20665583|P2|COMPLETED|Overall Study||94
8384005|NCT01087905|20665584|P1|COMPLETED|Overall Study||90
8384006|NCT01087905|20665577|P8|STARTED|Overall Study||127
8384007|NCT01087905|20665578|P7|STARTED|Overall Study||121
8384008|NCT01087905|20665579|P6|STARTED|Overall Study||127
8384009|NCT01087905|20665580|P5|STARTED|Overall Study||122
8384010|NCT01087905|20665581|P4|STARTED|Overall Study||122
8384011|NCT01087905|20665582|P3|STARTED|Overall Study||123
8384012|NCT01087905|20665583|P2|STARTED|Overall Study||126
8384013|NCT01087905|20665584|P1|STARTED|Overall Study||119
8384014|NCT01087814|20665606|P2|NOT COMPLETED|Second Intervention (5 Days)||0
8384015|NCT01087814|20665607|P1|NOT COMPLETED|Second Intervention (5 Days)||1
8384016|NCT01087814|20665606|P2|COMPLETED|Second Intervention (5 Days)||6
8384017|NCT01087814|20665607|P1|COMPLETED|Second Intervention (5 Days)||4
8384018|NCT01087814|20665606|P2|STARTED|Second Intervention (5 Days)||6
8384019|NCT01087814|20665607|P1|STARTED|Second Intervention (5 Days)||5
8384020|NCT01087814|20665606|P2|NOT COMPLETED|First Intervention (5 Days)||1
8384021|NCT01087814|20665607|P1|NOT COMPLETED|First Intervention (5 Days)||3
8384022|NCT01087814|20665606|P2|COMPLETED|First Intervention (5 Days)||6
8384023|NCT01087814|20665607|P1|COMPLETED|First Intervention (5 Days)||5
8384024|NCT01087814|20665606|P2|STARTED|First Intervention (5 Days)||7
8384025|NCT01087814|20665607|P1|STARTED|First Intervention (5 Days)||8
8384026|NCT01087801|20665615|P2|NOT COMPLETED|Overall Study||5
8384027|NCT01087801|20665616|P1|NOT COMPLETED|Overall Study||4
8384028|NCT01087801|20665615|P2|COMPLETED|Overall Study||29
8384029|NCT01087801|20665616|P1|COMPLETED|Overall Study||26
8384030|NCT01087801|20665615|P2|STARTED|Overall Study||34
8384031|NCT01087801|20665616|P1|STARTED|Overall Study||30
8384032|NCT01087788|20665625|P3|NOT COMPLETED|Open-Label Period (OL-P)||28
8384033|NCT01087788|20665626|P2|NOT COMPLETED|Open-Label Period (OL-P)||24
8384034|NCT01087788|20665627|P1|NOT COMPLETED|Open-Label Period (OL-P)||30
8384035|NCT01087788|20665625|P3|COMPLETED|Open-Label Period (OL-P)||86
8384036|NCT01087788|20665626|P2|COMPLETED|Open-Label Period (OL-P)||97
8384037|NCT01087788|20665627|P1|COMPLETED|Open-Label Period (OL-P)||81
8384038|NCT01087788|20665625|P3|STARTED|Open-Label Period (OL-P)||114
8384039|NCT01087788|20665626|P2|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
8384040|NCT01087788|20665627|P1|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
8384041|NCT01087788|20665625|P3|NOT COMPLETED|24-weeks Dose-blind Period||6
8384042|NCT01087788|20665626|P2|NOT COMPLETED|24-weeks Dose-blind Period||5
8384043|NCT01087788|20665627|P1|NOT COMPLETED|24-weeks Dose-blind Period||7
8384044|NCT01087788|20665625|P3|COMPLETED|24-weeks Dose-blind Period||114
8384045|NCT01087788|20665626|P2|COMPLETED|24-weeks Dose-blind Period||123
8384046|NCT01087788|20665627|P1|COMPLETED|24-weeks Dose-blind Period||113
8384047|NCT01087788|20665625|P3|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
8384048|NCT01087788|20665626|P2|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
8384049|NCT01087788|20665627|P1|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
8384050|NCT01087788|20665625|P3|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
8384051|NCT01087788|20665626|P2|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
8384052|NCT01087788|20665627|P1|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
8384053|NCT01087788|20665625|P3|STARTED|24-weeks Dose-blind Period||120
8384054|NCT01087788|20665626|P2|STARTED|24-weeks Dose-blind Period||128
8384055|NCT01087788|20665627|P1|STARTED|24-weeks Dose-blind Period||120
8384056|NCT01087788|20665625|P3|NOT COMPLETED|24-weeks Double-blind Period||15
8384057|NCT01087788|20665626|P2|NOT COMPLETED|24-weeks Double-blind Period||10
8384058|NCT01087788|20665627|P1|NOT COMPLETED|24-weeks Double-blind Period||16
8384059|NCT01087788|20665625|P3|COMPLETED|24-weeks Double-blind Period||120
8384060|NCT01087788|20665626|P2|COMPLETED|24-weeks Double-blind Period||128
8384061|NCT01087788|20665627|P1|COMPLETED|24-weeks Double-blind Period||120
8384062|NCT01087788|20665625|P3|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
8384063|NCT01087788|20665626|P2|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
8384064|NCT01087788|20665627|P1|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
8384065|NCT01087788|20665625|P3|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
8384066|NCT01087788|20665626|P2|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
8384067|NCT01087788|20665627|P1|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
8384068|NCT01087788|20665625|P3|STARTED|24-weeks Double-blind Period||135
8384069|NCT01087788|20665626|P2|STARTED|24-weeks Double-blind Period||138
8384070|NCT01087788|20665627|P1|STARTED|24-weeks Double-blind Period||136
8384071|NCT01087775|20665654|P1|NOT COMPLETED|Overall Study||2
8384072|NCT01087775|20665654|P1|COMPLETED|Overall Study|2 subjects were found to be ineligible for the study|23
8384073|NCT01087775|20665654|P1|STARTED|Overall Study||25
8384074|NCT01087762|20665662|P5|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
8384075|NCT01087762|20665663|P4|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
8384076|NCT01087762|20665664|P3|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
8384077|NCT01087762|20665665|P2|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
8384078|NCT01087762|20665666|P1|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
8384079|NCT01087762|20665662|P5|COMPLETED|Open-Label Period (Weeks 48-204)||100
8384080|NCT01087762|20665663|P4|COMPLETED|Open-Label Period (Weeks 48-204)||99
8384081|NCT01087762|20665664|P3|COMPLETED|Open-Label Period (Weeks 48-204)||0
8384082|NCT01087762|20665665|P2|COMPLETED|Open-Label Period (Weeks 48-204)||0
8384083|NCT01087762|20665666|P1|COMPLETED|Open-Label Period (Weeks 48-204)||0
8384084|NCT01087762|20665662|P5|STARTED|Open-Label Period (Weeks 48-204)||157
8384085|NCT01087762|20665663|P4|STARTED|Open-Label Period (Weeks 48-204)||158
8384086|NCT01087762|20665664|P3|STARTED|Open-Label Period (Weeks 48-204)||0
8384087|NCT01087762|20665665|P2|STARTED|Open-Label Period (Weeks 48-204)||0
8384088|NCT01087762|20665666|P1|STARTED|Open-Label Period (Weeks 48-204)||0
8384089|NCT01087762|20665662|P5|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
8384090|NCT01087762|20665663|P4|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
8384091|NCT01087762|20665664|P3|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
8384092|NCT01087762|20665665|P2|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
8384093|NCT01087762|20665666|P1|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
8384094|NCT01087762|20665662|P5|COMPLETED|Double Blind Period (Weeks 0-24)||0
8384095|NCT01087762|20665663|P4|COMPLETED|Double Blind Period (Weeks 0-24)||0
8384096|NCT01087762|20665664|P3|COMPLETED|Double Blind Period (Weeks 0-24)||98
8384097|NCT01087762|20665665|P2|COMPLETED|Double Blind Period (Weeks 0-24)||105
8384098|NCT01087762|20665666|P1|COMPLETED|Double Blind Period (Weeks 0-24)||95
8384099|NCT01087762|20665662|P5|STARTED|Double Blind Period (Weeks 0-24)||0
8384100|NCT01087762|20665663|P4|STARTED|Double Blind Period (Weeks 0-24)||0
8384101|NCT01087762|20665664|P3|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
8384102|NCT01087762|20665665|P2|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
8384103|NCT01087762|20665666|P1|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
8384104|NCT01087736|20665714|P2|NOT COMPLETED|Overall Study||2
8384105|NCT01087736|20665715|P1|NOT COMPLETED|Overall Study||1
8384106|NCT01087736|20665714|P2|COMPLETED|Overall Study||14
8384107|NCT01087736|20665715|P1|COMPLETED|Overall Study||13
8384108|NCT01087736|20665714|P2|STARTED|Overall Study||16
8384109|NCT01087736|20665715|P1|STARTED|Overall Study||14
8384110|NCT01087723|20665725|P2|NOT COMPLETED|Overall Study||20
8384111|NCT01087723|20665726|P1|NOT COMPLETED|Overall Study||14
8384112|NCT01087723|20665725|P2|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
8384113|NCT01087723|20665726|P1|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
8384114|NCT01087723|20665725|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
8384115|NCT01087723|20665726|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
8384116|NCT01087723|20665725|P2|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
8384117|NCT01087723|20665726|P1|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
8384118|NCT01087541|20665750|P2|NOT COMPLETED|Overall Study||0
8384119|NCT01087541|20665751|P1|NOT COMPLETED|Overall Study||0
8384120|NCT01087541|20665750|P2|COMPLETED|Overall Study||3523
8384121|NCT01087541|20665751|P1|COMPLETED|Overall Study||3307
8384122|NCT01087541|20665750|P2|STARTED|Overall Study||3523
8384123|NCT01087541|20665751|P1|STARTED|Overall Study||3307
8384124|NCT01087528|20665767|P1|NOT COMPLETED|Overall Study||7
8384125|NCT01087528|20665767|P1|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
8384126|NCT01087528|20665767|P1|STARTED|Overall Study||51
8384127|NCT01087502|20665779|P2|NOT COMPLETED|Up to Final Analysis (Week 52)||23
8384128|NCT01087502|20665780|P1|NOT COMPLETED|Up to Final Analysis (Week 52)||33
8384129|NCT01087502|20665779|P2|COMPLETED|Up to Final Analysis (Week 52)||95
8384130|NCT01087502|20665780|P1|COMPLETED|Up to Final Analysis (Week 52)||90
8384131|NCT01087502|20665779|P2|STARTED|Up to Final Analysis (Week 52)||118
8384132|NCT01087502|20665780|P1|STARTED|Up to Final Analysis (Week 52)||123
8384133|NCT01087502|20665779|P2|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
8384134|NCT01087502|20665780|P1|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
8384135|NCT01087502|20665779|P2|COMPLETED|Up to Interim Analysis (Week 12)||110
8384136|NCT01087502|20665780|P1|COMPLETED|Up to Interim Analysis (Week 12)||114
8384137|NCT01087502|20665779|P2|STARTED|Up to Interim Analysis (Week 12)||118
8384138|NCT01087502|20665780|P1|STARTED|Up to Interim Analysis (Week 12)||123
8384139|NCT01087489|20665799|P2|NOT COMPLETED|Overall Study||3
8384140|NCT01087489|20665800|P1|NOT COMPLETED|Overall Study||0
8384141|NCT01087489|20665799|P2|COMPLETED|Overall Study||31
8384142|NCT01087489|20665800|P1|COMPLETED|Overall Study||19
8384143|NCT01087489|20665799|P2|STARTED|Overall Study||34
8384144|NCT01087489|20665800|P1|STARTED|Overall Study||19
8384145|NCT01086969|20665813|P3|NOT COMPLETED|Overall Study||0
8384146|NCT01086969|20665814|P2|NOT COMPLETED|Overall Study||2
8384147|NCT01086969|20665815|P1|NOT COMPLETED|Overall Study||1
8384148|NCT01086969|20665813|P3|COMPLETED|Overall Study||100
8384149|NCT01086969|20665814|P2|COMPLETED|Overall Study||98
8384150|NCT01086969|20665815|P1|COMPLETED|Overall Study||99
8384151|NCT01086969|20665813|P3|STARTED|Overall Study||100
8384152|NCT01086969|20665814|P2|STARTED|Overall Study||100
8384153|NCT01086969|20665815|P1|STARTED|Overall Study||100
8384154|NCT01086852|20665832|P1|NOT COMPLETED|Overall Study||0
8384155|NCT01086852|20665832|P1|COMPLETED|Overall Study||4
8384156|NCT01086852|20665832|P1|STARTED|Overall Study||4
8384157|NCT01086761|20665848|P6|NOT COMPLETED|Overall Study||0
8384158|NCT01086761|20665849|P5|NOT COMPLETED|Overall Study||0
8384159|NCT01086761|20665850|P4|NOT COMPLETED|Overall Study||0
8384160|NCT01086761|20665851|P3|NOT COMPLETED|Overall Study||0
8384161|NCT01086761|20665852|P2|NOT COMPLETED|Overall Study||0
8384162|NCT01086761|20665853|P1|NOT COMPLETED|Overall Study||0
8384163|NCT01086761|20665848|P6|COMPLETED|Overall Study||0
8384164|NCT01086761|20665849|P5|COMPLETED|Overall Study||4
8384165|NCT01086761|20665850|P4|COMPLETED|Overall Study||6
8384166|NCT01086761|20665851|P3|COMPLETED|Overall Study||6
8384167|NCT01086761|20665852|P2|COMPLETED|Overall Study||7
8384168|NCT01086761|20665853|P1|COMPLETED|Overall Study||9
8384169|NCT01086761|20665848|P6|STARTED|Overall Study||0
8384170|NCT01086761|20665849|P5|STARTED|Overall Study||4
8384171|NCT01086761|20665850|P4|STARTED|Overall Study||6
8384172|NCT01086761|20665851|P3|STARTED|Overall Study||6
8384173|NCT01086761|20665852|P2|STARTED|Overall Study||7
8384174|NCT01086761|20665853|P1|STARTED|Overall Study||9
8384175|NCT01086605|20665893|P2|NOT COMPLETED|Overall Study||0
8384176|NCT01086605|20665894|P1|NOT COMPLETED|Overall Study||0
8384177|NCT01086605|20665893|P2|COMPLETED|Overall Study||22
8384178|NCT01086605|20665894|P1|COMPLETED|Overall Study||24
8384179|NCT01086605|20665893|P2|STARTED|Overall Study||22
8384180|NCT01086605|20665894|P1|STARTED|Overall Study||24
8384187|NCT01086475|20665956|P2|NOT COMPLETED|Overall Study||0
8384188|NCT01086475|20665957|P1|NOT COMPLETED|Overall Study||0
8384189|NCT01086475|20665956|P2|COMPLETED|Overall Study||33
8384190|NCT01086475|20665957|P1|COMPLETED|Overall Study||34
8384191|NCT01086475|20665956|P2|STARTED|Overall Study||33
8384192|NCT01086475|20665957|P1|STARTED|Overall Study||34
8384193|NCT01086423|20665970|P3|NOT COMPLETED|Overall Study||9
8384194|NCT01086423|20665971|P2|NOT COMPLETED|Overall Study||3
8384195|NCT01086423|20665972|P1|NOT COMPLETED|Overall Study||10
8384196|NCT01086423|20665970|P3|COMPLETED|Overall Study||321
8384197|NCT01086423|20665971|P2|COMPLETED|Overall Study||321
8384198|NCT01086423|20665972|P1|COMPLETED|Overall Study||320
8384199|NCT01086423|20665970|P3|STARTED|Overall Study||330
8384200|NCT01086423|20665971|P2|STARTED|Overall Study||324
8384201|NCT01086423|20665972|P1|STARTED|Overall Study||330
8384202|NCT01086410|20666017|P4|NOT COMPLETED|Overall Study||2
8384203|NCT01086410|20666018|P3|NOT COMPLETED|Overall Study||1
8384204|NCT01086410|20666019|P2|NOT COMPLETED|Overall Study||2
8384205|NCT01086410|20666020|P1|NOT COMPLETED|Overall Study||3
8384206|NCT01086410|20666017|P4|COMPLETED|Overall Study||13
8384207|NCT01086410|20666018|P3|COMPLETED|Overall Study||55
8384208|NCT01086410|20666019|P2|COMPLETED|Overall Study||54
8384209|NCT01086410|20666020|P1|COMPLETED|Overall Study||55
8384210|NCT01086410|20666017|P4|STARTED|Overall Study||15
8384211|NCT01086410|20666018|P3|STARTED|Overall Study||56
8384212|NCT01086410|20666019|P2|STARTED|Overall Study||56
8384213|NCT01086410|20666020|P1|STARTED|Overall Study||58
8384214|NCT01086384|20666116|P3|NOT COMPLETED|Treatment Period||124
8384215|NCT01086384|20666117|P2|NOT COMPLETED|Treatment Period||148
8384216|NCT01086384|20666118|P1|NOT COMPLETED|Treatment Period||0
8384217|NCT01086384|20666116|P3|COMPLETED|Treatment Period||885
8384218|NCT01086384|20666117|P2|COMPLETED|Treatment Period||863
8384219|NCT01086384|20666118|P1|COMPLETED|Treatment Period||0
8384220|NCT01086384|20666116|P3|STARTED|Treatment Period||1009
8384221|NCT01086384|20666117|P2|STARTED|Treatment Period||1011
8384222|NCT01086384|20666118|P1|STARTED|Treatment Period||0
8384223|NCT01086384|20666116|P3|NOT COMPLETED|2-week Run-in Period||0
8384224|NCT01086384|20666117|P2|NOT COMPLETED|2-week Run-in Period||0
8384225|NCT01086384|20666118|P1|NOT COMPLETED|2-week Run-in Period||163
8384226|NCT01086384|20666116|P3|COMPLETED|2-week Run-in Period||0
8384227|NCT01086384|20666117|P2|COMPLETED|2-week Run-in Period||0
8384228|NCT01086384|20666118|P1|COMPLETED|2-week Run-in Period||2020
8384229|NCT01086384|20666116|P3|STARTED|2-week Run-in Period||0
8384230|NCT01086384|20666117|P2|STARTED|2-week Run-in Period||0
8384231|NCT01086384|20666118|P1|STARTED|2-week Run-in Period||2183
8384232|NCT01086358|20666128|P2|NOT COMPLETED|Second Intervention||4
8384233|NCT01086358|20666129|P1|NOT COMPLETED|Second Intervention||4
8384234|NCT01086358|20666128|P2|COMPLETED|Second Intervention||20
8384235|NCT01086358|20666129|P1|COMPLETED|Second Intervention||17
8384236|NCT01086358|20666128|P2|STARTED|Second Intervention||24
8384237|NCT01086358|20666129|P1|STARTED|Second Intervention||21
8384238|NCT01086358|20666128|P2|NOT COMPLETED|First Intervention||5
8384239|NCT01086358|20666129|P1|NOT COMPLETED|First Intervention||9
8384240|NCT01086358|20666128|P2|COMPLETED|First Intervention||24
8384241|NCT01086358|20666129|P1|COMPLETED|First Intervention||21
8384242|NCT01086358|20666128|P2|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
8384243|NCT01086358|20666129|P1|STARTED|First Intervention|30 subjects enrolled.|30
8384244|NCT01086228|20666141|P1|NOT COMPLETED|5-year Follow-up||652
8384245|NCT01086228|20666141|P1|COMPLETED|5-year Follow-up||1012
8384246|NCT01086228|20666141|P1|STARTED|5-year Follow-up||1664
8384247|NCT01086228|20666141|P1|NOT COMPLETED|4-year Follow-up||103
8384248|NCT01086228|20666141|P1|COMPLETED|4-year Follow-up||1664
8384249|NCT01086228|20666141|P1|STARTED|4-year Follow-up||1767
8384250|NCT01086228|20666141|P1|NOT COMPLETED|3-year Follow-up||67
8384251|NCT01086228|20666141|P1|COMPLETED|3-year Follow-up||1767
8384252|NCT01086228|20666141|P1|STARTED|3-year Follow-up||1834
8384253|NCT01086228|20666141|P1|NOT COMPLETED|2-year Follow-up||60
8384254|NCT01086228|20666141|P1|COMPLETED|2-year Follow-up||1834
8384255|NCT01086228|20666141|P1|STARTED|2-year Follow-up||1894
8384256|NCT01086228|20666141|P1|NOT COMPLETED|1-year Follow-up||44
8384257|NCT01086228|20666141|P1|COMPLETED|1-year Follow-up||1894
8384258|NCT01086228|20666141|P1|STARTED|1-year Follow-up||1938
8384259|NCT01086228|20666141|P1|NOT COMPLETED|8 Month Follow-up||71
8384260|NCT01086228|20666141|P1|COMPLETED|8 Month Follow-up||1938
8384261|NCT01086228|20666141|P1|STARTED|8 Month Follow-up|Analysis population|2009
8384262|NCT01086215|20666199|P4|NOT COMPLETED|Overall Study||3
8384263|NCT01086215|20666200|P3|NOT COMPLETED|Overall Study||26
8384264|NCT01086215|20666201|P2|NOT COMPLETED|Overall Study||47
8384265|NCT01086215|20666202|P1|NOT COMPLETED|Overall Study||36
8384266|NCT01086215|20666199|P4|COMPLETED|Overall Study||11
8384267|NCT01086215|20666200|P3|COMPLETED|Overall Study||47
8384268|NCT01086215|20666201|P2|COMPLETED|Overall Study||154
8384269|NCT01086215|20666202|P1|COMPLETED|Overall Study||176
8384270|NCT01086215|20666199|P4|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
8384271|NCT01086215|20666200|P3|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
8384272|NCT01086215|20666201|P2|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
8384273|NCT01086215|20666202|P1|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
8384274|NCT01086215|20666199|P4|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
8384275|NCT01086215|20666200|P3|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
8384276|NCT01086215|20666201|P2|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
8384277|NCT01086215|20666202|P1|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
8384278|NCT01086215|20666199|P4|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
8384279|NCT01086215|20666200|P3|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
8384280|NCT01086215|20666201|P2|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
8384281|NCT01086215|20666202|P1|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
8384282|NCT01086215|20666199|P4|STARTED|Overall Study||14
8384283|NCT01086215|20666200|P3|STARTED|Overall Study||73
8384284|NCT01086215|20666201|P2|STARTED|Overall Study||201
8384285|NCT01086215|20666202|P1|STARTED|Overall Study||212
8384286|NCT01086150|20666223|P3|NOT COMPLETED|Overall Study||1
8384287|NCT01086150|20666224|P2|NOT COMPLETED|Overall Study||6
8384288|NCT01086150|20666225|P1|NOT COMPLETED|Overall Study||0
8384289|NCT01086150|20666223|P3|COMPLETED|Overall Study||12
8384290|NCT01086150|20666224|P2|COMPLETED|Overall Study||21
8384291|NCT01086150|20666225|P1|COMPLETED|Overall Study||11
8384292|NCT01086150|20666223|P3|STARTED|Overall Study||13
8384293|NCT01086150|20666224|P2|STARTED|Overall Study||27
8384294|NCT01086150|20666225|P1|STARTED|Overall Study||11
8384295|NCT01086033|20666236|P1|NOT COMPLETED|Overall Study||304
8384296|NCT01086033|20666236|P1|COMPLETED|Overall Study||262
8384297|NCT01086033|20666236|P1|STARTED|Overall Study||566
8384298|NCT01085968|20666250|P2|NOT COMPLETED|Overall Study||4
8384299|NCT01085968|20666251|P1|NOT COMPLETED|Overall Study||10
8384300|NCT01085968|20666250|P2|COMPLETED|Overall Study||21
8384301|NCT01085968|20666251|P1|COMPLETED|Overall Study||19
8384302|NCT01085968|20666250|P2|STARTED|Overall Study||25
8384303|NCT01085968|20666251|P1|STARTED|Overall Study||29
8384304|NCT01085903|20666267|P3|NOT COMPLETED|Overall Study||0
8384305|NCT01085903|20666268|P2|NOT COMPLETED|Overall Study||0
8384306|NCT01085903|20666269|P1|NOT COMPLETED|Overall Study||0
8384307|NCT01085903|20666267|P3|COMPLETED|Overall Study||3
8384308|NCT01085903|20666268|P2|COMPLETED|Overall Study||4
8384309|NCT01085903|20666269|P1|COMPLETED|Overall Study||21
8384310|NCT01085903|20666267|P3|STARTED|Overall Study||3
8384311|NCT01085903|20666268|P2|STARTED|Overall Study||4
8384312|NCT01085903|20666269|P1|STARTED|Overall Study||21
8384313|NCT01085825|20666295|P2|NOT COMPLETED|Overall Study||1
8384314|NCT01085825|20666296|P1|NOT COMPLETED|Overall Study||1
8384315|NCT01085825|20666295|P2|COMPLETED|Overall Study||247
8384316|NCT01085825|20666296|P1|COMPLETED|Overall Study||251
8384317|NCT01085825|20666295|P2|STARTED|Overall Study||248
8384318|NCT01085825|20666296|P1|STARTED|Overall Study|1st participant enrolled|252
8384319|NCT01085812|20666302|P2|NOT COMPLETED|Double-blind Intent-to-treat Population||56
8384320|NCT01085812|20666303|P1|NOT COMPLETED|Double-blind Intent-to-treat Population||20
8384321|NCT01085812|20666302|P2|COMPLETED|Double-blind Intent-to-treat Population||174
8384322|NCT01085812|20666303|P1|COMPLETED|Double-blind Intent-to-treat Population||92
8384323|NCT01085812|20666302|P2|STARTED|Double-blind Intent-to-treat Population||230
8384324|NCT01085812|20666303|P1|STARTED|Double-blind Intent-to-treat Population||112
8384325|NCT01085812|20666302|P2|NOT COMPLETED|Double-Blind Period||58
8384326|NCT01085812|20666303|P1|NOT COMPLETED|Double-Blind Period||21
8384327|NCT01085812|20666302|P2|COMPLETED|Double-Blind Period||177
8384328|NCT01085812|20666303|P1|COMPLETED|Double-Blind Period||92
8384329|NCT01085812|20666302|P2|STARTED|Double-Blind Period||235
8384330|NCT01085812|20666303|P1|STARTED|Double-Blind Period||113
8384331|NCT01085812|20666302|P2|NOT COMPLETED|Open-Label Period||240
8384332|NCT01085812|20666303|P1|NOT COMPLETED|Open-Label Period||0
8384333|NCT01085812|20666302|P2|COMPLETED|Open-Label Period||494
8384334|NCT01085812|20666303|P1|COMPLETED|Open-Label Period||0
8384335|NCT01085812|20666302|P2|STARTED|Open-Label Period||734
8384336|NCT01085812|20666303|P1|STARTED|Open-Label Period||0
8384337|NCT01085786|20666312|P2|NOT COMPLETED|Overall Study||0
8384338|NCT01085786|20666313|P1|NOT COMPLETED|Overall Study||0
8384339|NCT01085786|20666312|P2|COMPLETED|Overall Study||117
8384340|NCT01085786|20666313|P1|COMPLETED|Overall Study||123
8384341|NCT01085786|20666312|P2|STARTED|Overall Study||117
8384342|NCT01085786|20666313|P1|STARTED|Overall Study||123
8384343|NCT01085760|20666323|P4|NOT COMPLETED|Overall Study||3
8384344|NCT01085760|20666324|P3|NOT COMPLETED|Overall Study||2
8384345|NCT01085760|20666325|P2|NOT COMPLETED|Overall Study||1
8384346|NCT01085760|20666326|P1|NOT COMPLETED|Overall Study||1
8384347|NCT01085760|20666323|P4|COMPLETED|Overall Study||6
8384348|NCT01085760|20666324|P3|COMPLETED|Overall Study||7
8384349|NCT01085760|20666325|P2|COMPLETED|Overall Study||8
8384350|NCT01085760|20666326|P1|COMPLETED|Overall Study||7
8384351|NCT01085760|20666323|P4|STARTED|Overall Study||9
8384352|NCT01085760|20666324|P3|STARTED|Overall Study||9
8384353|NCT01085760|20666325|P2|STARTED|Overall Study||9
8384354|NCT01085760|20666326|P1|STARTED|Overall Study||8
8384355|NCT01085734|20666350|P2|NOT COMPLETED|Overall Study||4
8384356|NCT01085734|20666351|P1|NOT COMPLETED|Overall Study||1
8384357|NCT01085734|20666350|P2|COMPLETED|Overall Study||11
8384358|NCT01085734|20666351|P1|COMPLETED|Overall Study||14
8384359|NCT01085734|20666350|P2|STARTED|Overall Study||15
8384360|NCT01085734|20666351|P1|STARTED|Overall Study||15
8384361|NCT01085682|20666363|P2|NOT COMPLETED|Overall Study||25
8384362|NCT01085682|20666364|P1|NOT COMPLETED|Overall Study||25
8384363|NCT01085682|20666363|P2|COMPLETED|Overall Study||3
8384364|NCT01085682|20666364|P1|COMPLETED|Overall Study||6
8384365|NCT01085682|20666363|P2|STARTED|Overall Study||28
8384366|NCT01085682|20666364|P1|STARTED|Overall Study||31
8384367|NCT01085643|20666370|P1|NOT COMPLETED|Overall Study||0
8384368|NCT01085643|20666370|P1|COMPLETED|Overall Study||4
8384369|NCT01085643|20666370|P1|STARTED|Overall Study||4
8384376|NCT01085591|20666395|P3|NOT COMPLETED|Overall Study||7
8384377|NCT01085591|20666396|P2|NOT COMPLETED|Overall Study||6
8384378|NCT01085591|20666397|P1|NOT COMPLETED|Overall Study||3
8384379|NCT01085591|20666395|P3|COMPLETED|Overall Study||63
8384380|NCT01085591|20666396|P2|COMPLETED|Overall Study||65
8384381|NCT01085591|20666397|P1|COMPLETED|Overall Study||66
8384382|NCT01085591|20666395|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
8384383|NCT01085591|20666396|P2|Received at Least 1 Dose of Study Drug|Overall Study||69
8384384|NCT01085591|20666397|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
8384385|NCT01085591|20666395|P3|STARTED|Overall Study||70
8384386|NCT01085591|20666396|P2|STARTED|Overall Study||71
8384387|NCT01085591|20666397|P1|STARTED|Overall Study||69
8384388|NCT01085539|20666420|P1|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
8384389|NCT01085539|20666420|P1|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
8384390|NCT01085539|20666420|P1|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
8384391|NCT01085539|20666420|P1|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
8384392|NCT01085539|20666420|P1|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
8384393|NCT01085539|20666420|P1|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
8384394|NCT01085539|20666420|P1|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
8384395|NCT01085539|20666420|P1|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
8384396|NCT01085539|20666420|P1|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
8384397|NCT01085539|20666420|P1|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
8384398|NCT01085539|20666420|P1|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
8384399|NCT01085539|20666420|P1|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
8384400|NCT01085539|20666420|P1|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
8384401|NCT01085539|20666420|P1|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
8384402|NCT01085539|20666420|P1|STARTED|Sat Secs Off--No Alarm Evaluation||50
8384403|NCT01085513|20666426|P2|NOT COMPLETED|Phase II - Validation Phase||0
8384404|NCT01085513|20666427|P1|NOT COMPLETED|Phase II - Validation Phase||0
8384405|NCT01085513|20666426|P2|COMPLETED|Phase II - Validation Phase||16
8384406|NCT01085513|20666427|P1|COMPLETED|Phase II - Validation Phase||21
8384407|NCT01085513|20666426|P2|STARTED|Phase II - Validation Phase||16
8384408|NCT01085513|20666427|P1|STARTED|Phase II - Validation Phase||21
8384409|NCT01085513|20666426|P2|NOT COMPLETED|Phase I - Development Phase||0
8384410|NCT01085513|20666427|P1|NOT COMPLETED|Phase I - Development Phase||0
8384411|NCT01085513|20666426|P2|COMPLETED|Phase I - Development Phase||52
8384412|NCT01085513|20666427|P1|COMPLETED|Phase I - Development Phase|recruitment was premature terminated|54
8384413|NCT01085513|20666426|P2|STARTED|Phase I - Development Phase||52
8384414|NCT01085513|20666427|P1|STARTED|Phase I - Development Phase||54
8384415|NCT01085500|20666437|P2|NOT COMPLETED|Overall Study||0
8384416|NCT01085500|20666438|P1|NOT COMPLETED|Overall Study||0
8384417|NCT01085500|20666437|P2|COMPLETED|Overall Study||24
8384418|NCT01085500|20666438|P1|COMPLETED|Overall Study||26
8384419|NCT01085500|20666437|P2|STARTED|Overall Study||24
8384420|NCT01085500|20666438|P1|STARTED|Overall Study||26
8384421|NCT01085357|20666450|P2|NOT COMPLETED|Overall Study||6
8384422|NCT01085357|20666451|P1|NOT COMPLETED|Overall Study||19
8384423|NCT01085357|20666450|P2|COMPLETED|Overall Study||125
8384424|NCT01085357|20666451|P1|COMPLETED|Overall Study||355
8384425|NCT01085357|20666450|P2|STARTED|Overall Study||131
8384426|NCT01085357|20666451|P1|STARTED|Overall Study||374
8384427|NCT01085344|20666461|P1|NOT COMPLETED|Overall Study||6
8384428|NCT01085344|20666461|P1|COMPLETED|Overall Study||50
8384429|NCT01085344|20666461|P1|STARTED|Overall Study||56
8384430|NCT01085331|20666473|P2|NOT COMPLETED|Overall Study||0
8384431|NCT01085331|20666474|P1|NOT COMPLETED|Overall Study||0
8384432|NCT01085331|20666473|P2|COMPLETED|Overall Study||6
8384433|NCT01085331|20666474|P1|COMPLETED|Overall Study||10
8384434|NCT01085331|20666473|P2|STARTED|Overall Study||6
8384435|NCT01085331|20666474|P1|STARTED|Overall Study||10
8384436|NCT01085318|20666513|P2|NOT COMPLETED|Overall Study||0
8384437|NCT01085318|20666514|P1|NOT COMPLETED|Overall Study||2
8384438|NCT01085318|20666513|P2|COMPLETED|Overall Study||15
8384439|NCT01085318|20666514|P1|COMPLETED|Overall Study||21
8384440|NCT01085318|20666513|P2|STARTED|Overall Study||15
8384441|NCT01085318|20666514|P1|STARTED|Overall Study||23
8384442|NCT01085214|20666524|P1|NOT COMPLETED|Overall Study||1
8384443|NCT01085214|20666524|P1|COMPLETED|Overall Study||36
8384444|NCT01085214|20666524|P1|STARTED|Overall Study||37
8384445|NCT01085201|20666536|P5|NOT COMPLETED|Overall Study||0
8384446|NCT01085201|20666537|P4|NOT COMPLETED|Overall Study||0
8384447|NCT01085201|20666538|P3|NOT COMPLETED|Overall Study||2
8384448|NCT01085201|20666539|P2|NOT COMPLETED|Overall Study||1
8384449|NCT01085201|20666540|P1|NOT COMPLETED|Overall Study||3
8384450|NCT01085201|20666536|P5|COMPLETED|Overall Study||3
8384451|NCT01085201|20666537|P4|COMPLETED|Overall Study||6
8384452|NCT01085201|20666538|P3|COMPLETED|Overall Study||3
8384453|NCT01085201|20666539|P2|COMPLETED|Overall Study||6
8384454|NCT01085201|20666540|P1|COMPLETED|Overall Study||15
8384455|NCT01085201|20666536|P5|STARTED|Overall Study||3
8384456|NCT01085201|20666537|P4|STARTED|Overall Study||6
8384457|NCT01085201|20666538|P3|STARTED|Overall Study||5
8384458|NCT01085201|20666539|P2|STARTED|Overall Study||7
8384459|NCT01085201|20666540|P1|STARTED|Overall Study||18
8384460|NCT01085136|20666562|P3|NOT COMPLETED|Part B||26
8384461|NCT01085136|20666563|P2|NOT COMPLETED|Part B||51
8384462|NCT01085136|20666564|P1|NOT COMPLETED|Part B||0
8384463|NCT01085136|20666562|P3|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
8384464|NCT01085136|20666563|P2|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
8384465|NCT01085136|20666564|P1|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
8384466|NCT01085136|20666562|P3|STARTED|Part B||68
8384467|NCT01085136|20666563|P2|STARTED|Part B||138
8384468|NCT01085136|20666564|P1|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
8384469|NCT01085136|20666562|P3|NOT COMPLETED|Part A||0
8384470|NCT01085136|20666563|P2|NOT COMPLETED|Part A||0
8384471|NCT01085136|20666564|P1|NOT COMPLETED|Part A||323
8384472|NCT01085136|20666562|P3|COMPLETED|Part A||0
8384473|NCT01085136|20666563|P2|COMPLETED|Part A||0
8384474|NCT01085136|20666564|P1|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
8384475|NCT01085136|20666562|P3|Randomized to Part B|Part A||0
8384476|NCT01085136|20666563|P2|Randomized to Part B|Part A||0
8384477|NCT01085136|20666564|P1|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
8384478|NCT01085136|20666562|P3|STARTED|Part A||0
8384479|NCT01085136|20666563|P2|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
8384480|NCT01085136|20666564|P1|STARTED|Part A||1154
8384481|NCT01085045|20666580|P1|NOT COMPLETED|Part B||15
8384482|NCT01085045|20666580|P1|COMPLETED|Part B||89
8384483|NCT01085045|20666580|P1|GP MDI 36 µg (PT001)|Part B||0
8384484|NCT01085045|20666580|P1|Foradil 12 µg|Part B||41
8384485|NCT01085045|20666580|P1|Placebo MDI|Part B||47
8384486|NCT01085045|20666580|P1|FF MDI 7.2 µg (PT005)|Part B||43
8384487|NCT01085045|20666580|P1|FF MDI 9.6 µg (PT005)|Part B||43
8384488|NCT01085045|20666580|P1|Spiriva 18 µg|Part B||0
8384489|NCT01085045|20666580|P1|GFF MDI 36/9.6 µg|Part B||0
8384490|NCT01085045|20666580|P1|GFF MDI 72/9.6mcg (PT003)|Part B||0
8384491|NCT01085045|20666580|P1|STARTED|Part B||104
8384492|NCT01085045|20666580|P1|NOT COMPLETED|Part A||18
8384493|NCT01085045|20666580|P1|COMPLETED|Part A||104
8384494|NCT01085045|20666580|P1|Foradil 12 µg|Part A||14
8384495|NCT01085045|20666580|P1|Placebo MDI|Part A||5
8384496|NCT01085045|20666580|P1|FF MDI 7.2 µg (PT005)|Part A||21
8384497|NCT01085045|20666580|P1|FF MDI 9.6 µg (PT005)|Part A||20
8384498|NCT01085045|20666580|P1|Spiriva 18 µg|Part A||58
8384499|NCT01085045|20666580|P1|GP MDI 36 µg (PT001)|Part A||40
8384500|NCT01085045|20666580|P1|GFF MDI 36/9.6 µg (PT003)|Part A||42
8384501|NCT01085045|20666580|P1|GFF MDI 72/9.6mcg|Part A||40
8384502|NCT01085045|20666580|P1|STARTED|Part A||122
8384503|NCT01085006|20666682|P2|NOT COMPLETED|Overall Study||0
8384504|NCT01085006|20666683|P1|NOT COMPLETED|Overall Study||0
8384505|NCT01085006|20666682|P2|COMPLETED|Overall Study||50
8384506|NCT01085006|20666683|P1|COMPLETED|Overall Study||50
8384507|NCT01085006|20666682|P2|STARTED|Overall Study||50
8384508|NCT01085006|20666683|P1|STARTED|Overall Study||50
8384509|NCT01084772|20666691|P2|NOT COMPLETED|2 Years||4
8384510|NCT01084772|20666692|P1|NOT COMPLETED|2 Years||9
8384511|NCT01084772|20666691|P2|COMPLETED|2 Years||46
8384512|NCT01084772|20666692|P1|COMPLETED|2 Years||46
8384513|NCT01084772|20666691|P2|STARTED|2 Years||50
8384514|NCT01084772|20666692|P1|STARTED|2 Years||55
8384515|NCT01084772|20666691|P2|NOT COMPLETED|1 Year||8
8384516|NCT01084772|20666692|P1|NOT COMPLETED|1 Year||3
8384517|NCT01084772|20666691|P2|COMPLETED|1 Year||50
8384518|NCT01084772|20666692|P1|COMPLETED|1 Year||55
8384519|NCT01084772|20666691|P2|STARTED|1 Year||58
8384520|NCT01084772|20666692|P1|STARTED|1 Year||58
8384521|NCT01084772|20666691|P2|NOT COMPLETED|3 Months||2
8384522|NCT01084772|20666692|P1|NOT COMPLETED|3 Months||3
8384523|NCT01084772|20666691|P2|COMPLETED|3 Months||58
8384524|NCT01084772|20666692|P1|COMPLETED|3 Months||58
8384525|NCT01084772|20666691|P2|STARTED|3 Months||60
8384526|NCT01084772|20666692|P1|STARTED|3 Months||61
8384527|NCT01084772|20666691|P2|NOT COMPLETED|Baseline||6
8384528|NCT01084772|20666692|P1|NOT COMPLETED|Baseline||7
8384529|NCT01084772|20666691|P2|COMPLETED|Baseline||60
8384530|NCT01084772|20666692|P1|COMPLETED|Baseline||61
8384531|NCT01084772|20666691|P2|STARTED|Baseline||66
8384532|NCT01084772|20666692|P1|STARTED|Baseline||68
8384533|NCT01084759|20666722|P1|NOT COMPLETED|Overall Study||2
8384534|NCT01084759|20666722|P1|COMPLETED|Overall Study||14
8384535|NCT01084759|20666722|P1|STARTED|Overall Study||16
8384536|NCT01084707|20666728|P1|NOT COMPLETED|Overall Study||6
8384537|NCT01084707|20666728|P1|COMPLETED|Overall Study||34
8384538|NCT01084707|20666728|P1|STARTED|Overall Study||40
8384539|NCT01084694|20666764|P2|NOT COMPLETED|Overall Study||20
8384540|NCT01084694|20666765|P1|NOT COMPLETED|Overall Study||6
8384541|NCT01084694|20666764|P2|COMPLETED|Overall Study||30
8384542|NCT01084694|20666765|P1|COMPLETED|Overall Study||44
8384543|NCT01084694|20666764|P2|STARTED|Overall Study||50
8384544|NCT01084694|20666765|P1|STARTED|Overall Study||50
8384545|NCT01084668|20666781|P1|NOT COMPLETED|Overall Study||9
8384546|NCT01084668|20666781|P1|COMPLETED|Overall Study||33
8384547|NCT01084668|20666781|P1|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
8384548|NCT01084655|20666793|P3|NOT COMPLETED|Overall Study||19
8384549|NCT01084655|20666794|P2|NOT COMPLETED|Overall Study||6
8384550|NCT01084655|20666795|P1|NOT COMPLETED|Overall Study||6
8384551|NCT01084655|20666793|P3|COMPLETED|Overall Study||5
8384552|NCT01084655|20666794|P2|COMPLETED|Overall Study||2
8384553|NCT01084655|20666795|P1|COMPLETED|Overall Study||0
8384554|NCT01084655|20666793|P3|Treated|Overall Study||23
8384555|NCT01084655|20666794|P2|Treated|Overall Study||8
8384556|NCT01084655|20666795|P1|Treated|Overall Study||6
8384557|NCT01084655|20666793|P3|STARTED|Overall Study||24
8384558|NCT01084655|20666794|P2|STARTED|Overall Study||8
8384559|NCT01084655|20666795|P1|STARTED|Overall Study||6
8384560|NCT01084603|20666830|P1|NOT COMPLETED|Oral Nicotine 4||0
8384561|NCT01084603|20666830|P1|COMPLETED|Oral Nicotine 4||39
8384562|NCT01084603|20666830|P1|STARTED|Oral Nicotine 4||39
8384563|NCT01084603|20666830|P1|NOT COMPLETED|Washout Period 4||1
8384564|NCT01084603|20666830|P1|COMPLETED|Washout Period 4||39
8384565|NCT01084603|20666830|P1|STARTED|Washout Period 4||40
8384566|NCT01084603|20666830|P1|NOT COMPLETED|Oral Nicotine 2||0
8384567|NCT01084603|20666830|P1|COMPLETED|Oral Nicotine 2||40
8384568|NCT01084603|20666830|P1|STARTED|Oral Nicotine 2||40
8384569|NCT01084603|20666830|P1|NOT COMPLETED|Washout Period 3||0
8384570|NCT01084603|20666830|P1|COMPLETED|Washout Period 3||40
8384571|NCT01084603|20666830|P1|STARTED|Washout Period 3||40
8384572|NCT01084603|20666830|P1|NOT COMPLETED|Oral Nicotine 1||1
8384573|NCT01084603|20666830|P1|COMPLETED|Oral Nicotine 1||40
8384574|NCT01084603|20666830|P1|STARTED|Oral Nicotine 1||41
8384575|NCT01084603|20666830|P1|NOT COMPLETED|Washout Period 2||0
8384576|NCT01084603|20666830|P1|COMPLETED|Washout Period 2||41
8384577|NCT01084603|20666830|P1|STARTED|Washout Period 2||41
8384578|NCT01084603|20666830|P1|NOT COMPLETED|Nicorette® Gum||1
8384579|NCT01084603|20666830|P1|COMPLETED|Nicorette® Gum||41
8384580|NCT01084603|20666830|P1|STARTED|Nicorette® Gum||42
8384581|NCT01084603|20666830|P1|NOT COMPLETED|Washout Period 1||0
8384582|NCT01084603|20666830|P1|COMPLETED|Washout Period 1||42
8384583|NCT01084603|20666830|P1|STARTED|Washout Period 1||42
8384584|NCT01084603|20666830|P1|NOT COMPLETED|NiQuitinTM Lozenge||1
8384585|NCT01084603|20666830|P1|COMPLETED|NiQuitinTM Lozenge||42
8384586|NCT01084603|20666830|P1|STARTED|NiQuitinTM Lozenge||43
8384587|NCT01084603|20666830|P1|NOT COMPLETED|Baseline||2
8384588|NCT01084603|20666830|P1|COMPLETED|Baseline||43
8384589|NCT01084603|20666830|P1|STARTED|Baseline||45
8384590|NCT01084551|20666866|P3|NOT COMPLETED|Overall Study||8
8384591|NCT01084551|20666867|P2|NOT COMPLETED|Overall Study||14
8384592|NCT01084551|20666868|P1|NOT COMPLETED|Overall Study||9
8384593|NCT01084551|20666866|P3|COMPLETED|Overall Study||86
8384594|NCT01084551|20666867|P2|COMPLETED|Overall Study||81
8384595|NCT01084551|20666868|P1|COMPLETED|Overall Study||86
8384596|NCT01084551|20666866|P3|STARTED|Overall Study||94
8384597|NCT01084551|20666867|P2|STARTED|Overall Study||95
8384598|NCT01084551|20666868|P1|STARTED|Overall Study||95
8384599|NCT01084538|20666906|P1|NOT COMPLETED|Overall Study||68
8384600|NCT01084538|20666906|P1|COMPLETED|Overall Study||113
8384601|NCT01084538|20666906|P1|STARTED|Overall Study||181
8384602|NCT01084499|20666915|P2|NOT COMPLETED|Overall Study||0
8384603|NCT01084499|20666916|P1|NOT COMPLETED|Overall Study||0
8384604|NCT01084499|20666915|P2|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13
8384605|NCT01084499|20666916|P1|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13
8384606|NCT01084499|20666915|P2|Washout (5 Weeks)|Overall Study||13
8384607|NCT01084499|20666916|P1|Washout (5 Weeks)|Overall Study||13
8384608|NCT01084499|20666915|P2|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13
8384609|NCT01084499|20666916|P1|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13
8384610|NCT01084278|20666929|P5|NOT COMPLETED|Overall Study||0
8384611|NCT01084278|20666930|P4|NOT COMPLETED|Overall Study||0
8384612|NCT01084278|20666931|P3|NOT COMPLETED|Overall Study||0
8384613|NCT01084278|20666932|P2|NOT COMPLETED|Overall Study||0
8384614|NCT01084278|20666933|P1|NOT COMPLETED|Overall Study||0
8384615|NCT01084278|20666929|P5|COMPLETED|Overall Study||8
8384616|NCT01084278|20666930|P4|COMPLETED|Overall Study||8
8384617|NCT01084278|20666931|P3|COMPLETED|Overall Study||8
8384618|NCT01084278|20666932|P2|COMPLETED|Overall Study||8
8384619|NCT01084278|20666933|P1|COMPLETED|Overall Study||8
8384620|NCT01084278|20666929|P5|STARTED|Overall Study||8
8384621|NCT01084278|20666930|P4|STARTED|Overall Study||8
8384622|NCT01084278|20666931|P3|STARTED|Overall Study||8
8384623|NCT01084278|20666932|P2|STARTED|Overall Study||8
8384624|NCT01084278|20666933|P1|STARTED|Overall Study||8
8384625|NCT01084265|20667014|P1|NOT COMPLETED|Overall Study||0
8384626|NCT01084265|20667014|P1|COMPLETED|Overall Study||31
8384627|NCT01084265|20667014|P1|STARTED|Overall Study||31
8384796|NCT01084239|20667237|P2|NOT COMPLETED|28-Day Follow-up||9
8384797|NCT01084239|20667238|P1|NOT COMPLETED|28-Day Follow-up||4
8384798|NCT01084239|20667237|P2|COMPLETED|28-Day Follow-up||490
8384799|NCT01084239|20667238|P1|COMPLETED|28-Day Follow-up||497
8384800|NCT01084239|20667237|P2|STARTED|28-Day Follow-up||499
8384801|NCT01084239|20667238|P1|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
8384802|NCT01084239|20667237|P2|NOT COMPLETED|Randomization - Index Hospitalization||0
8384803|NCT01084239|20667238|P1|NOT COMPLETED|Randomization - Index Hospitalization||0
8384804|NCT01084239|20667237|P2|COMPLETED|Randomization - Index Hospitalization||499
8384805|NCT01084239|20667238|P1|COMPLETED|Randomization - Index Hospitalization||501
8384806|NCT01084239|20667237|P2|STARTED|Randomization - Index Hospitalization||499
8384807|NCT01084239|20667238|P1|STARTED|Randomization - Index Hospitalization||501
8384808|NCT01084174|20667256|P2|NOT COMPLETED|Overall Study||4
8384809|NCT01084174|20667257|P1|NOT COMPLETED|Overall Study||1
8384810|NCT01084174|20667256|P2|COMPLETED|Overall Study||7
8384811|NCT01084174|20667257|P1|COMPLETED|Overall Study||9
8384812|NCT01084174|20667256|P2|STARTED|Overall Study||11
8384813|NCT01084174|20667257|P1|STARTED|Overall Study||10
8384814|NCT01084148|20667277|P2|NOT COMPLETED|Overall Study||16
8384815|NCT01084148|20667278|P1|NOT COMPLETED|Overall Study||30
8384816|NCT01084148|20667277|P2|COMPLETED|Overall Study||102
8384817|NCT01084148|20667278|P1|COMPLETED|Overall Study||88
8384818|NCT01084148|20667277|P2|Treated Patients|Overall Study|Patients who received test product at least once|117
8384819|NCT01084148|20667278|P1|Treated Patients|Overall Study||118
8384820|NCT01084148|20667277|P2|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
8384821|NCT01084148|20667278|P1|STARTED|Overall Study||118
8384822|NCT01084135|20667290|P2|NOT COMPLETED|20 Week||1
8384823|NCT01084135|20667291|P1|NOT COMPLETED|20 Week||0
8384824|NCT01084135|20667290|P2|COMPLETED|20 Week||10
8384825|NCT01084135|20667291|P1|COMPLETED|20 Week||12
8384826|NCT01084135|20667290|P2|STARTED|20 Week||11
8384827|NCT01084135|20667291|P1|STARTED|20 Week||12
8384828|NCT01084135|20667290|P2|NOT COMPLETED|12 Week||0
8384829|NCT01084135|20667291|P1|NOT COMPLETED|12 Week||0
8384830|NCT01084135|20667290|P2|COMPLETED|12 Week||4
8384831|NCT01084135|20667291|P1|COMPLETED|12 Week||4
8384832|NCT01084135|20667290|P2|STARTED|12 Week||4
8384833|NCT01084135|20667291|P1|STARTED|12 Week||4
8384834|NCT01084083|20667301|P1|NOT COMPLETED|Overall Study||12
8384835|NCT01084083|20667301|P1|COMPLETED|Overall Study||78
8384836|NCT01084083|20667301|P1|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
8384837|NCT01084083|20667301|P1|CR to Induction Therapy|Overall Study||56
8384838|NCT01084083|20667301|P1|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
8384839|NCT01084083|20667301|P1|Eligible|Overall Study||81
8384840|NCT01084083|20667301|P1|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
8384841|NCT01084083|20667301|P1|STARTED|Overall Study||90
8384842|NCT01084005|20667309|P2|NOT COMPLETED|Overall Study||16
8384843|NCT01084005|20667310|P1|NOT COMPLETED|Overall Study||5
8384844|NCT01084005|20667309|P2|COMPLETED|Overall Study||146
8384845|NCT01084005|20667310|P1|COMPLETED|Overall Study||74
8384846|NCT01084005|20667309|P2|STARTED|Overall Study||162
8384847|NCT01084005|20667310|P1|STARTED|Overall Study||79
8384848|NCT01083979|20667338|P1|NOT COMPLETED|Overall Study||0
8384849|NCT01083979|20667338|P1|COMPLETED|Overall Study||1
8384850|NCT01083979|20667338|P1|STARTED|Overall Study||1
8384851|NCT01083901|20667346|P3|NOT COMPLETED|Overall Study||2
8384852|NCT01083901|20667347|P2|NOT COMPLETED|Overall Study||2
8384853|NCT01083901|20667348|P1|NOT COMPLETED|Overall Study||1
8384854|NCT01083901|20667346|P3|COMPLETED|Overall Study||11
8384855|NCT01083901|20667347|P2|COMPLETED|Overall Study||6
8384856|NCT01083901|20667348|P1|COMPLETED|Overall Study||12
8384857|NCT01083901|20667346|P3|STARTED|Overall Study||13
8384858|NCT01083901|20667347|P2|STARTED|Overall Study||8
8384859|NCT01083901|20667348|P1|STARTED|Overall Study||13
8384860|NCT01083849|20667367|P2|NOT COMPLETED|Overall Study||111
8384861|NCT01083849|20667368|P1|NOT COMPLETED|Overall Study||60
8384862|NCT01083849|20667367|P2|COMPLETED|Overall Study||527
8384863|NCT01083849|20667368|P1|COMPLETED|Overall Study||61
8384864|NCT01083849|20667367|P2|STARTED|Overall Study||638
8384865|NCT01083849|20667368|P1|STARTED|Overall Study||121
8384866|NCT01083810|20667391|P3|NOT COMPLETED|Overall Study||20
8384867|NCT01083810|20667392|P2|NOT COMPLETED|Overall Study||45
8384868|NCT01083810|20667393|P1|NOT COMPLETED|Overall Study||65
8384869|NCT01083810|20667391|P3|COMPLETED|Overall Study||35
8384870|NCT01083810|20667392|P2|COMPLETED|Overall Study||47
8384871|NCT01083810|20667393|P1|COMPLETED|Overall Study||72
8384872|NCT01083810|20667391|P3|STARTED|Overall Study||55
8384873|NCT01083810|20667392|P2|STARTED|Overall Study||92
8384874|NCT01083810|20667393|P1|STARTED|Overall Study||137
8384875|NCT01083771|20667414|P1|NOT COMPLETED|Overall Study||5
8384876|NCT01083771|20667414|P1|COMPLETED|Overall Study||16
8384877|NCT01083771|20667414|P1|STARTED|Overall Study||21
8384878|NCT01083758|20667419|P1|NOT COMPLETED|Overall Study||2
8384879|NCT01083758|20667419|P1|COMPLETED|Overall Study||29
8384880|NCT01083758|20667419|P1|STARTED|Overall Study||31
8384881|NCT01083732|20667453|P3|NOT COMPLETED|Overall Study||0
8384882|NCT01083732|20667454|P2|NOT COMPLETED|Overall Study||0
8384883|NCT01083732|20667455|P1|NOT COMPLETED|Overall Study||0
8384884|NCT01083732|20667453|P3|COMPLETED|Overall Study||3
8384885|NCT01083732|20667454|P2|COMPLETED|Overall Study||9
8384886|NCT01083732|20667455|P1|COMPLETED|Overall Study||6
8384887|NCT01083732|20667453|P3|STARTED|Overall Study||3
8384888|NCT01083732|20667454|P2|STARTED|Overall Study||9
8384889|NCT01083732|20667455|P1|STARTED|Overall Study||6
8384890|NCT01083706|20667506|P1|NOT COMPLETED|Overall Study||0
8384891|NCT01083706|20667506|P1|COMPLETED|Overall Study||39
8384892|NCT01083706|20667506|P1|STARTED|Overall Study||39
8384893|NCT01083693|20667515|P3|NOT COMPLETED|Overall Study||7
8384894|NCT01083693|20667516|P2|NOT COMPLETED|Overall Study||6
8384895|NCT01083693|20667517|P1|NOT COMPLETED|Overall Study||20
8384896|NCT01083693|20667515|P3|COMPLETED|Overall Study||33
8384897|NCT01083693|20667516|P2|COMPLETED|Overall Study||22
8384898|NCT01083693|20667517|P1|COMPLETED|Overall Study||73
8384899|NCT01083693|20667515|P3|STARTED|Overall Study||40
8384900|NCT01083693|20667516|P2|STARTED|Overall Study||28
8384901|NCT01083693|20667517|P1|STARTED|Overall Study||93
8384902|NCT01083680|20667552|P1|NOT COMPLETED|Overall Study||3844
8384903|NCT01083680|20667552|P1|COMPLETED|Overall Study||263
8384904|NCT01083680|20667552|P1|Full Analysis Set (FAS), Efficacy|Overall Study||1621
8384905|NCT01083680|20667552|P1|STARTED|Overall Study||4107
8384906|NCT01083667|20667561|P1|NOT COMPLETED|Overall Study||10
8384907|NCT01083667|20667561|P1|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
8384908|NCT01083667|20667561|P1|STARTED|Overall Study|enrolled|32
8384909|NCT01083654|20667568|P2|NOT COMPLETED|Overall Study||0
8384910|NCT01083654|20667569|P1|NOT COMPLETED|Overall Study||0
8384911|NCT01083654|20667568|P2|COMPLETED|Overall Study||50
8384912|NCT01083654|20667569|P1|COMPLETED|Overall Study||53
8384913|NCT01083654|20667568|P2|STARTED|Overall Study||50
8384914|NCT01083654|20667569|P1|STARTED|Overall Study||53
8384915|NCT01083641|20667575|P1|NOT COMPLETED|Overall Study||2
8384916|NCT01083641|20667575|P1|COMPLETED|Overall Study||15
8384917|NCT01083641|20667575|P1|STARTED|Overall Study||17
8384918|NCT01083628|20667584|P2|NOT COMPLETED|Overall Study||0
8384919|NCT01083628|20667585|P1|NOT COMPLETED|Overall Study||0
8384920|NCT01083628|20667584|P2|COMPLETED|Overall Study||40
8384921|NCT01083628|20667585|P1|COMPLETED|Overall Study||45
8384922|NCT01083628|20667584|P2|STARTED|Overall Study||40
8384923|NCT01083628|20667585|P1|STARTED|Overall Study||45
8384924|NCT01083602|20667595|P1|NOT COMPLETED|Overall Study||55
8384925|NCT01083602|20667595|P1|COMPLETED|Overall Study||0
8384926|NCT01083602|20667595|P1|STARTED|Overall Study||55
8384927|NCT01083576|20667606|P2|NOT COMPLETED|Overall Study||1
8384928|NCT01083576|20667607|P1|NOT COMPLETED|Overall Study||6
8384929|NCT01083576|20667606|P2|COMPLETED|Overall Study||14
8384930|NCT01083576|20667607|P1|COMPLETED|Overall Study||9
8384931|NCT01083576|20667606|P2|STARTED|Overall Study||15
8384932|NCT01083576|20667607|P1|STARTED|Overall Study||15
8384933|NCT01083485|20667637|P2|NOT COMPLETED|Overall Study||3
8384934|NCT01083485|20667638|P1|NOT COMPLETED|Overall Study||7
8384935|NCT01083485|20667637|P2|COMPLETED|Overall Study||64
8384936|NCT01083485|20667638|P1|COMPLETED|Overall Study||63
8384937|NCT01083485|20667637|P2|STARTED|Overall Study||67
8384938|NCT01083485|20667638|P1|STARTED|Overall Study||70
8384939|NCT01083472|20667648|P2|NOT COMPLETED|Overall Study||0
8384940|NCT01083472|20667649|P1|NOT COMPLETED|Overall Study||0
8384941|NCT01083472|20667648|P2|COMPLETED|Overall Study||19
8384942|NCT01083472|20667649|P1|COMPLETED|Overall Study||18
8384943|NCT01083472|20667648|P2|STARTED|Overall Study||19
8384944|NCT01083472|20667649|P1|STARTED|Overall Study||18
8384945|NCT01083368|20667657|P4|NOT COMPLETED|Phase II - Efficacy/Safety||0
8384946|NCT01083368|20667658|P3|NOT COMPLETED|Phase II - Efficacy/Safety||0
8384947|NCT01083368|20667659|P2|NOT COMPLETED|Phase II - Efficacy/Safety||0
8384948|NCT01083368|20667660|P1|NOT COMPLETED|Phase II - Efficacy/Safety||0
8384949|NCT01083368|20667657|P4|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20
8384950|NCT01083368|20667658|P3|COMPLETED|Phase II - Efficacy/Safety||0
8384951|NCT01083368|20667659|P2|COMPLETED|Phase II - Efficacy/Safety||0
8384952|NCT01083368|20667660|P1|COMPLETED|Phase II - Efficacy/Safety||0
8384953|NCT01083368|20667657|P4|STARTED|Phase II - Efficacy/Safety||20
8384954|NCT01083368|20667658|P3|STARTED|Phase II - Efficacy/Safety||0
8384955|NCT01083368|20667659|P2|STARTED|Phase II - Efficacy/Safety||0
8384956|NCT01083368|20667660|P1|STARTED|Phase II - Efficacy/Safety||0
8384957|NCT01083368|20667657|P4|NOT COMPLETED|Dose Escalation Weeks 5-9||0
8384958|NCT01083368|20667658|P3|NOT COMPLETED|Dose Escalation Weeks 5-9||0
8384959|NCT01083368|20667659|P2|NOT COMPLETED|Dose Escalation Weeks 5-9||0
8384960|NCT01083368|20667660|P1|NOT COMPLETED|Dose Escalation Weeks 5-9||0
8384961|NCT01083368|20667657|P4|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6
8384962|NCT01083368|20667658|P3|COMPLETED|Dose Escalation Weeks 5-9||1
8384963|NCT01083368|20667659|P2|COMPLETED|Dose Escalation Weeks 5-9||0
8384964|NCT01083368|20667660|P1|COMPLETED|Dose Escalation Weeks 5-9||0
8384965|NCT01083368|20667657|P4|STARTED|Dose Escalation Weeks 5-9||6
8384966|NCT01083368|20667658|P3|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1
8384967|NCT01083368|20667659|P2|STARTED|Dose Escalation Weeks 5-9||0
8384968|NCT01083368|20667660|P1|STARTED|Dose Escalation Weeks 5-9||0
8384969|NCT01083368|20667657|P4|NOT COMPLETED|Dose Escalation Weeks 1-4||0
8384970|NCT01083368|20667658|P3|NOT COMPLETED|Dose Escalation Weeks 1-4||0
8384971|NCT01083368|20667659|P2|NOT COMPLETED|Dose Escalation Weeks 1-4||0
8384972|NCT01083368|20667660|P1|NOT COMPLETED|Dose Escalation Weeks 1-4||0
8384973|NCT01083368|20667657|P4|COMPLETED|Dose Escalation Weeks 1-4||0
8384974|NCT01083368|20667658|P3|COMPLETED|Dose Escalation Weeks 1-4||4
8384975|NCT01083368|20667659|P2|COMPLETED|Dose Escalation Weeks 1-4||0
8384976|NCT01083368|20667660|P1|COMPLETED|Dose Escalation Weeks 1-4||0
8384977|NCT01083368|20667657|P4|Disease Progression|Dose Escalation Weeks 1-4||0
8384978|NCT01083368|20667658|P3|Disease Progression|Dose Escalation Weeks 1-4||1
8384979|NCT01083368|20667659|P2|Disease Progression|Dose Escalation Weeks 1-4||0
8384980|NCT01083368|20667660|P1|Disease Progression|Dose Escalation Weeks 1-4||0
8384981|NCT01083368|20667657|P4|STARTED|Dose Escalation Weeks 1-4||0
8384982|NCT01083368|20667658|P3|STARTED|Dose Escalation Weeks 1-4||4
8384983|NCT01083368|20667659|P2|STARTED|Dose Escalation Weeks 1-4||0
8384984|NCT01083368|20667660|P1|STARTED|Dose Escalation Weeks 1-4||0
8384985|NCT01083316|20667670|P1|NOT COMPLETED|Overall Study||3
8384986|NCT01083316|20667670|P1|COMPLETED|Overall Study||32
8384987|NCT01083316|20667670|P1|STARTED|Overall Study||35
8384988|NCT01083199|20667677|P1|NOT COMPLETED|Overall Study||0
8384989|NCT01083199|20667677|P1|COMPLETED|Overall Study||10
8384990|NCT01083199|20667677|P1|STARTED|Overall Study||10
8384991|NCT01083186|20667682|P1|NOT COMPLETED|Overall Study||94
8384992|NCT01083186|20667682|P1|COMPLETED|Overall Study||406
8384993|NCT01083186|20667682|P1|STARTED|Overall Study||500
8384994|NCT01083173|20667723|P2|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
8384995|NCT01083173|20667724|P1|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
8384996|NCT01083173|20667723|P2|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
8384997|NCT01083173|20667724|P1|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
8384998|NCT01083173|20667723|P2|STARTED|Long-term Surveillance: Effectiveness Gr||479
8384999|NCT01083173|20667724|P1|STARTED|Long-term Surveillance: Effectiveness Gr||0
8385000|NCT01083173|20667723|P2|NOT COMPLETED|Long-term Surveillance: Safety Group||116
8385001|NCT01083173|20667724|P1|NOT COMPLETED|Long-term Surveillance: Safety Group||0
8385002|NCT01083173|20667723|P2|COMPLETED|Long-term Surveillance: Safety Group||479
8385003|NCT01083173|20667724|P1|COMPLETED|Long-term Surveillance: Safety Group||0
8385004|NCT01083173|20667723|P2|STARTED|Long-term Surveillance: Safety Group||595
8385005|NCT01083173|20667724|P1|STARTED|Long-term Surveillance: Safety Group||0
8385006|NCT01083173|20667723|P2|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
8385007|NCT01083173|20667724|P1|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
8385008|NCT01083173|20667723|P2|COMPLETED|Main Surveillance: Effectiveness Group||0
8385009|NCT01083173|20667724|P1|COMPLETED|Main Surveillance: Effectiveness Group||198
8385010|NCT01083173|20667723|P2|STARTED|Main Surveillance: Effectiveness Group||0
8385011|NCT01083173|20667724|P1|STARTED|Main Surveillance: Effectiveness Group||580
8385012|NCT01083173|20667723|P2|NOT COMPLETED|Main Surveillance: Safety Group||0
8385013|NCT01083173|20667724|P1|NOT COMPLETED|Main Surveillance: Safety Group||15
8385014|NCT01083173|20667723|P2|COMPLETED|Main Surveillance: Safety Group||0
8385015|NCT01083173|20667724|P1|COMPLETED|Main Surveillance: Safety Group||580
8385016|NCT01083173|20667723|P2|STARTED|Main Surveillance: Safety Group||0
8385017|NCT01083173|20667724|P1|STARTED|Main Surveillance: Safety Group||595
8385018|NCT01083160|20667742|P1|NOT COMPLETED|Overall Study||1
8385019|NCT01083160|20667742|P1|COMPLETED|Overall Study||81
8385020|NCT01083160|20667742|P1|Evaluable Population|Overall Study||71
8385021|NCT01083160|20667742|P1|STARTED|Overall Study||82
8385022|NCT01083121|20667749|P1|NOT COMPLETED|Overall Study||81
8385023|NCT01083121|20667749|P1|COMPLETED|Overall Study|Participants included in the analysis|1698
8385024|NCT01083121|20667749|P1|STARTED|Overall Study|Participants who were enrolled in the study|1779
8385025|NCT01082965|20667759|P2|NOT COMPLETED|Overall Study||2
8385026|NCT01082965|20667760|P1|NOT COMPLETED|Overall Study||1
8385027|NCT01082965|20667759|P2|COMPLETED|Overall Study||6
8385028|NCT01082965|20667760|P1|COMPLETED|Overall Study||9
8385029|NCT01082965|20667759|P2|STARTED|Overall Study||8
8385030|NCT01082965|20667760|P1|STARTED|Overall Study||10
8385031|NCT01082952|20667780|P2|NOT COMPLETED|Overall Study||0
8385032|NCT01082952|20667781|P1|NOT COMPLETED|Overall Study||0
8385033|NCT01082952|20667780|P2|COMPLETED|Overall Study||6
8385034|NCT01082952|20667781|P1|COMPLETED|Overall Study||6
8385035|NCT01082952|20667780|P2|STARTED|Overall Study||6
8385036|NCT01082952|20667781|P1|STARTED|Overall Study||6
8385037|NCT01082939|20667789|P1|NOT COMPLETED|Overall Study||0
8385038|NCT01082939|20667789|P1|COMPLETED|Overall Study||80
8385039|NCT01082939|20667789|P1|STARTED|Overall Study||80
8385040|NCT01082874|20667797|P4|NOT COMPLETED|Overall Study||13
8385041|NCT01082874|20667798|P3|NOT COMPLETED|Overall Study||11
8385042|NCT01082874|20667799|P2|NOT COMPLETED|Overall Study||12
8385043|NCT01082874|20667800|P1|NOT COMPLETED|Overall Study||11
8385044|NCT01082874|20667797|P4|COMPLETED|Overall Study||2489
8385045|NCT01082874|20667798|P3|COMPLETED|Overall Study||2488
8385046|NCT01082874|20667799|P2|COMPLETED|Overall Study||2498
8385047|NCT01082874|20667800|P1|COMPLETED|Overall Study||2488
8385048|NCT01082874|20667797|P4|STARTED|Overall Study||2502
8385049|NCT01082874|20667798|P3|STARTED|Overall Study||2499
8385050|NCT01082874|20667799|P2|STARTED|Overall Study||2510
8385051|NCT01082874|20667800|P1|STARTED|Overall Study||2499
8385052|NCT01082640|20667813|P3|NOT COMPLETED|Overall Study||8
8385053|NCT01082640|20667814|P2|NOT COMPLETED|Overall Study||15
8385054|NCT01082640|20667815|P1|NOT COMPLETED|Overall Study||17
8385055|NCT01082640|20667813|P3|COMPLETED|Overall Study||24
8385056|NCT01082640|20667814|P2|COMPLETED|Overall Study||17
8385057|NCT01082640|20667815|P1|COMPLETED|Overall Study||15
8385058|NCT01082640|20667813|P3|STARTED|Overall Study||32
8385059|NCT01082640|20667814|P2|STARTED|Overall Study||32
8385060|NCT01082640|20667815|P1|STARTED|Overall Study||32
8385061|NCT01082614|20667837|P2|NOT COMPLETED|Overall Study||5
8385062|NCT01082614|20667838|P1|NOT COMPLETED|Overall Study||3
8385063|NCT01082614|20667837|P2|COMPLETED|Overall Study||18
8385064|NCT01082614|20667838|P1|COMPLETED|Overall Study||20
8385065|NCT01082614|20667837|P2|STARTED|Overall Study||23
8385066|NCT01082614|20667838|P1|STARTED|Overall Study||23
8385067|NCT01082588|20667850|P2|NOT COMPLETED|Overall Study||5
8385068|NCT01082588|20667851|P1|NOT COMPLETED|Overall Study||6
8385069|NCT01082588|20667850|P2|COMPLETED|Overall Study||25
8385070|NCT01082588|20667851|P1|COMPLETED|Overall Study||24
8385071|NCT01082588|20667850|P2|STARTED|Overall Study||30
8385072|NCT01082588|20667851|P1|STARTED|Overall Study||30
8385073|NCT01082575|20667869|P1|NOT COMPLETED|Overall Study||0
8385074|NCT01082575|20667869|P1|COMPLETED|Overall Study||100
8385075|NCT01082575|20667869|P1|STARTED|Overall Study||100
8385076|NCT01082380|20667874|P1|NOT COMPLETED|Overall Study||0
8385077|NCT01082380|20667874|P1|COMPLETED|Overall Study||6
8385078|NCT01082380|20667874|P1|STARTED|Overall Study||6
8385079|NCT01082367|20667909|P2|NOT COMPLETED|Follow-up (F-U) Period||1
8385080|NCT01082367|20667910|P1|NOT COMPLETED|Follow-up (F-U) Period||2
8385081|NCT01082367|20667909|P2|COMPLETED|Follow-up (F-U) Period||9
8385082|NCT01082367|20667910|P1|COMPLETED|Follow-up (F-U) Period||17
8385083|NCT01082367|20667909|P2|Treated in F-U|Follow-up (F-U) Period||5
8385084|NCT01082367|20667910|P1|Treated in F-U|Follow-up (F-U) Period||5
8385085|NCT01082367|20667909|P2|STARTED|Follow-up (F-U) Period||10
8385086|NCT01082367|20667910|P1|STARTED|Follow-up (F-U) Period||19
8385087|NCT01082367|20667909|P2|NOT COMPLETED|Double-blind Period||13
8385088|NCT01082367|20667910|P1|NOT COMPLETED|Double-blind Period||5
8385089|NCT01082367|20667909|P2|COMPLETED|Double-blind Period||12
8385090|NCT01082367|20667910|P1|COMPLETED|Double-blind Period||21
8385091|NCT01082367|20667909|P2|Stage 4:no tx for Patients Not in co|Double-blind Period||0
8385092|NCT01082367|20667910|P1|Stage 4:no tx for Patients Not in co|Double-blind Period||0
8385093|NCT01082367|20667909|P2|Stage 3: Cross-over (co) tx|Double-blind Period||6
8385094|NCT01082367|20667910|P1|Stage 3: Cross-over (co) tx|Double-blind Period||13
8385095|NCT01082367|20667909|P2|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
8385096|NCT01082367|20667910|P1|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
8385097|NCT01082367|20667909|P2|Entered OL TOBI|Double-blind Period||18
8385098|NCT01082367|20667910|P1|Entered OL TOBI|Double-blind Period||4
8385099|NCT01082367|20667909|P2|Stage 2:no tx|Double-blind Period||0
8385100|NCT01082367|20667910|P1|Stage 2:no tx|Double-blind Period||0
8385101|NCT01082367|20667909|P2|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
8385102|NCT01082367|20667910|P1|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
8385103|NCT01082367|20667909|P2|STARTED|Double-blind Period||25
8385104|NCT01082367|20667910|P1|STARTED|Double-blind Period||26
8385105|NCT01082328|20667924|P1|NOT COMPLETED|Overall Study||1
8385106|NCT01082328|20667924|P1|COMPLETED|Overall Study||58
8385107|NCT01082328|20667924|P1|STARTED|Overall Study||59
8385108|NCT01082211|20667933|P1|NOT COMPLETED|Overall Study||7
8385109|NCT01082211|20667933|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
8385110|NCT01082211|20667933|P1|All Eligible Patients|Overall Study||58
8385111|NCT01082211|20667933|P1|Has Baseline/36-Month MD QOL Data|Overall Study||27
8385112|NCT01082211|20667933|P1|Has Baseline/36-month PT QOL Data|Overall Study||32
8385113|NCT01082211|20667933|P1|Has Baseline/12-Month MD QOL Data|Overall Study||35
8385114|NCT01082211|20667933|P1|Has Baseline/12-month PT QOL Data|Overall Study||36
8385115|NCT01082211|20667933|P1|Has Baseline MD QOL Data|Overall Study||44
8385116|NCT01082211|20667933|P1|Has Baseline PT QOL Data|Overall Study||46
8385117|NCT01082211|20667933|P1|STARTED|Overall Study||65
8385118|NCT01082159|20667951|P1|NOT COMPLETED|Overall Study||9
8385119|NCT01082159|20667951|P1|COMPLETED|Overall Study||46
8385120|NCT01082159|20667951|P1|STARTED|Overall Study||55
8385121|NCT01082081|20667960|P3|NOT COMPLETED|Overall Study||2
8385122|NCT01082081|20667961|P2|NOT COMPLETED|Overall Study||1
8385123|NCT01082081|20667962|P1|NOT COMPLETED|Overall Study||0
8385124|NCT01082081|20667960|P3|COMPLETED|Overall Study||58
8385125|NCT01082081|20667961|P2|COMPLETED|Overall Study||118
8385126|NCT01082081|20667962|P1|COMPLETED|Overall Study||121
8385127|NCT01082081|20667960|P3|STARTED|Overall Study||60
8385128|NCT01082081|20667961|P2|STARTED|Overall Study||119
8385129|NCT01082081|20667962|P1|STARTED|Overall Study||121
8385142|NCT01081912|20668025|P3|NOT COMPLETED|Maintenance Treatment||92
8385143|NCT01081912|20668026|P2|NOT COMPLETED|Maintenance Treatment||27
8385144|NCT01081912|20668027|P1|NOT COMPLETED|Maintenance Treatment||0
8385145|NCT01081912|20668025|P3|COMPLETED|Maintenance Treatment||59
8385146|NCT01081912|20668026|P2|COMPLETED|Maintenance Treatment||124
8385147|NCT01081912|20668027|P1|COMPLETED|Maintenance Treatment||0
8385148|NCT01081912|20668025|P3|STARTED|Maintenance Treatment||151
8385149|NCT01081912|20668026|P2|STARTED|Maintenance Treatment||151
8385150|NCT01081912|20668027|P1|STARTED|Maintenance Treatment||0
8385151|NCT01081912|20668025|P3|NOT COMPLETED|Conversion/Titration||0
8385152|NCT01081912|20668026|P2|NOT COMPLETED|Conversion/Titration||0
8385153|NCT01081912|20668027|P1|NOT COMPLETED|Conversion/Titration||208
8385154|NCT01081912|20668025|P3|COMPLETED|Conversion/Titration||0
8385155|NCT01081912|20668026|P2|COMPLETED|Conversion/Titration||0
8385156|NCT01081912|20668027|P1|COMPLETED|Conversion/Titration||302
8385157|NCT01081912|20668025|P3|STARTED|Conversion/Titration||0
8385158|NCT01081912|20668026|P2|STARTED|Conversion/Titration||0
8385159|NCT01081912|20668027|P1|STARTED|Conversion/Titration||510
8385160|NCT01081886|20668036|P2|NOT COMPLETED|Overall Study||13
8385161|NCT01081886|20668037|P1|NOT COMPLETED|Overall Study||11
8385162|NCT01081886|20668036|P2|COMPLETED|Overall Study||0
8385163|NCT01081886|20668037|P1|COMPLETED|Overall Study||0
8385164|NCT01081886|20668036|P2|STARTED|Overall Study||13
8385165|NCT01081886|20668037|P1|STARTED|Overall Study||11
8385166|NCT01081873|20668045|P1|NOT COMPLETED|Overall Study||298
8385167|NCT01081873|20668045|P1|COMPLETED|Overall Study||2416
8385168|NCT01081873|20668045|P1|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
8385169|NCT01081834|20668117|P5|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
8385170|NCT01081834|20668118|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
8385171|NCT01081834|20668119|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
8385172|NCT01081834|20668120|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
8385173|NCT01081834|20668121|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
8385174|NCT01081834|20668117|P5|COMPLETED|Extension Period: Week 26 to Week 52||0
8385175|NCT01081834|20668118|P4|COMPLETED|Extension Period: Week 26 to Week 52||0
8385176|NCT01081834|20668119|P3|COMPLETED|Extension Period: Week 26 to Week 52||165
8385177|NCT01081834|20668120|P2|COMPLETED|Extension Period: Week 26 to Week 52||152
8385178|NCT01081834|20668121|P1|COMPLETED|Extension Period: Week 26 to Week 52||135
8385179|NCT01081834|20668117|P5|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
8385180|NCT01081834|20668118|P4|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
8385181|NCT01081834|20668119|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
8385182|NCT01081834|20668120|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
8385183|NCT01081834|20668121|P1|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
8385184|NCT01081834|20668117|P5|NOT COMPLETED|Core Period: Baseline to Week 26||4
8385185|NCT01081834|20668118|P4|NOT COMPLETED|Core Period: Baseline to Week 26||7
8385186|NCT01081834|20668119|P3|NOT COMPLETED|Core Period: Baseline to Week 26||22
8385187|NCT01081834|20668120|P2|NOT COMPLETED|Core Period: Baseline to Week 26||23
8385188|NCT01081834|20668121|P1|NOT COMPLETED|Core Period: Baseline to Week 26||32
8385189|NCT01081834|20668117|P5|COMPLETED|Core Period: Baseline to Week 26||40
8385190|NCT01081834|20668118|P4|COMPLETED|Core Period: Baseline to Week 26||40
8385191|NCT01081834|20668119|P3|COMPLETED|Core Period: Baseline to Week 26||175
8385192|NCT01081834|20668120|P2|COMPLETED|Core Period: Baseline to Week 26||172
8385193|NCT01081834|20668121|P1|COMPLETED|Core Period: Baseline to Week 26||160
8385194|NCT01081834|20668117|P5|STARTED|Core Period: Baseline to Week 26||44
8385195|NCT01081834|20668118|P4|STARTED|Core Period: Baseline to Week 26||47
8385196|NCT01081834|20668119|P3|STARTED|Core Period: Baseline to Week 26||197
8385197|NCT01081834|20668120|P2|STARTED|Core Period: Baseline to Week 26||195
8385198|NCT01081834|20668121|P1|STARTED|Core Period: Baseline to Week 26||192
8385199|NCT01081795|20668182|P3|NOT COMPLETED|Overall Study||30
8385200|NCT01081795|20668183|P2|NOT COMPLETED|Overall Study||35
8385201|NCT01081795|20668184|P1|NOT COMPLETED|Overall Study||33
8385202|NCT01081795|20668182|P3|COMPLETED|Overall Study||97
8385203|NCT01081795|20668183|P2|COMPLETED|Overall Study||95
8385204|NCT01081795|20668184|P1|COMPLETED|Overall Study||97
8385205|NCT01081795|20668182|P3|STARTED|Overall Study||127
8385206|NCT01081795|20668183|P2|STARTED|Overall Study||130
8385207|NCT01081795|20668184|P1|STARTED|Overall Study||130
8385208|NCT01081769|20668221|P2|NOT COMPLETED|CORE Intent-To-Treat||97
8385209|NCT01081769|20668222|P1|NOT COMPLETED|CORE Intent-To-Treat||80
8385210|NCT01081769|20668221|P2|COMPLETED|CORE Intent-To-Treat||266
8385211|NCT01081769|20668222|P1|COMPLETED|CORE Intent-To-Treat||272
8385212|NCT01081769|20668221|P2|STARTED|CORE Intent-To-Treat||363
8385213|NCT01081769|20668222|P1|STARTED|CORE Intent-To-Treat||352
8385214|NCT01081769|20668221|P2|NOT COMPLETED|Whole Intent-to-Treat||25
8385215|NCT01081769|20668222|P1|NOT COMPLETED|Whole Intent-to-Treat||24
8385216|NCT01081769|20668221|P2|COMPLETED|Whole Intent-to-Treat||363
8385217|NCT01081769|20668222|P1|COMPLETED|Whole Intent-to-Treat||352
8385218|NCT01081769|20668221|P2|STARTED|Whole Intent-to-Treat||388
8385219|NCT01081769|20668222|P1|STARTED|Whole Intent-to-Treat||376
8385220|NCT01081678|20668260|P4|NOT COMPLETED|Overall Study||29
8385221|NCT01081678|20668261|P3|NOT COMPLETED|Overall Study||31
8385222|NCT01081678|20668262|P2|NOT COMPLETED|Overall Study||16
8385223|NCT01081678|20668263|P1|NOT COMPLETED|Overall Study||27
8385224|NCT01081678|20668260|P4|COMPLETED|Overall Study||61
8385225|NCT01081678|20668261|P3|COMPLETED|Overall Study||62
8385226|NCT01081678|20668262|P2|COMPLETED|Overall Study||44
8385227|NCT01081678|20668263|P1|COMPLETED|Overall Study||62
8385228|NCT01081678|20668260|P4|Completed 24 Weeks of Study|Overall Study||68
8385229|NCT01081678|20668261|P3|Completed 24 Weeks of Study|Overall Study||72
8385230|NCT01081678|20668262|P2|Completed 24 Weeks of Study|Overall Study||50
8385231|NCT01081678|20668263|P1|Completed 24 Weeks of Study|Overall Study||73
8385232|NCT01081678|20668260|P4|Received Study Drug|Overall Study||89
8385233|NCT01081678|20668261|P3|Received Study Drug|Overall Study||89
8385234|NCT01081678|20668262|P2|Received Study Drug|Overall Study||60
8385235|NCT01081678|20668263|P1|Received Study Drug|Overall Study||87
8385236|NCT01081678|20668260|P4|STARTED|Overall Study||90
8385237|NCT01081678|20668261|P3|STARTED|Overall Study||93
8385238|NCT01081678|20668262|P2|STARTED|Overall Study||60
8385239|NCT01081678|20668263|P1|STARTED|Overall Study||89
8385240|NCT01081665|20668293|P1|NOT COMPLETED|Overall Study||95
8385241|NCT01081665|20668293|P1|COMPLETED|Overall Study||142
8385242|NCT01081665|20668293|P1|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
8385243|NCT01081665|20668293|P1|Full Analysis Set|Overall Study||237
8385244|NCT01081665|20668293|P1|STARTED|Overall Study||237
8385245|NCT01081626|20668305|P2|NOT COMPLETED|Overall Study||61
8385246|NCT01081626|20668306|P1|NOT COMPLETED|Overall Study||60
8385247|NCT01081626|20668305|P2|COMPLETED|Overall Study||94
8385248|NCT01081626|20668306|P1|COMPLETED|Overall Study||95
8385249|NCT01081626|20668305|P2|Assessed for Efficacy|Overall Study||125
8385250|NCT01081626|20668306|P1|Assessed for Efficacy|Overall Study||122
8385251|NCT01081626|20668305|P2|STARTED|Overall Study||155
8385252|NCT01081626|20668306|P1|STARTED|Overall Study||155
8385253|NCT01081301|20668332|P1|NOT COMPLETED|Overall Study||14
8385254|NCT01081301|20668332|P1|COMPLETED|Overall Study||22
8385255|NCT01081301|20668332|P1|STARTED|Overall Study||36
8385268|NCT01081249|20668407|P2|NOT COMPLETED|Overall Study||1
8385269|NCT01081249|20668408|P1|NOT COMPLETED|Overall Study||0
8385270|NCT01081249|20668407|P2|COMPLETED|Overall Study||6
8385271|NCT01081249|20668408|P1|COMPLETED|Overall Study||11
8385272|NCT01081249|20668407|P2|Second Psychotherapy Appointment (1 Day)|Overall Study||6
8385273|NCT01081249|20668408|P1|Second Psychotherapy Appointment (1 Day)|Overall Study||11
8385274|NCT01081249|20668407|P2|Washout (5-10 Days)|Overall Study||6
8385275|NCT01081249|20668408|P1|Washout (5-10 Days)|Overall Study||11
8385276|NCT01081249|20668407|P2|First Psychotherapy Appointment (1 Day)|Overall Study||6
8385277|NCT01081249|20668408|P1|First Psychotherapy Appointment (1 Day)|Overall Study||11
8385278|NCT01081249|20668407|P2|STARTED|Overall Study||7
8385279|NCT01081249|20668408|P1|STARTED|Overall Study||11
8385298|NCT01081041|20668485|P3|NOT COMPLETED|Overall Study||2
8385299|NCT01081041|20668486|P2|NOT COMPLETED|Overall Study||4
8385300|NCT01081041|20668487|P1|NOT COMPLETED|Overall Study||0
8385301|NCT01081041|20668485|P3|COMPLETED|Overall Study||71
8385302|NCT01081041|20668486|P2|COMPLETED|Overall Study||77
8385303|NCT01081041|20668487|P1|COMPLETED|Overall Study||33
8385304|NCT01081041|20668485|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
8385305|NCT01081041|20668486|P2|Received at Least 1 Dose of Study Drug|Overall Study||77
8385306|NCT01081041|20668487|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
8385307|NCT01081041|20668485|P3|STARTED|Overall Study||73
8385308|NCT01081041|20668486|P2|STARTED|Overall Study||81
8385309|NCT01081041|20668487|P1|STARTED|Overall Study||33
8385310|NCT01080976|20668517|P2|NOT COMPLETED|Overall Study||0
8385311|NCT01080976|20668518|P1|NOT COMPLETED|Overall Study||0
8385312|NCT01080976|20668517|P2|COMPLETED|Overall Study||5
8385313|NCT01080976|20668518|P1|COMPLETED|Overall Study||5
8385314|NCT01080976|20668517|P2|STARTED|Overall Study||5
8385315|NCT01080976|20668518|P1|STARTED|Overall Study||5
8385316|NCT01080807|20668528|P2|NOT COMPLETED|Overall Study||23
8385317|NCT01080807|20668529|P1|NOT COMPLETED|Overall Study||35
8385318|NCT01080807|20668528|P2|COMPLETED|Overall Study||167
8385319|NCT01080807|20668529|P1|COMPLETED|Overall Study||158
8385320|NCT01080807|20668528|P2|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
8385321|NCT01080807|20668529|P1|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
8385322|NCT01080794|20668587|P4|NOT COMPLETED|Overall Study||2
8385323|NCT01080794|20668588|P3|NOT COMPLETED|Overall Study||2
8385324|NCT01080794|20668589|P2|NOT COMPLETED|Overall Study||2
8385325|NCT01080794|20668590|P1|NOT COMPLETED|Overall Study||5
8385326|NCT01080794|20668587|P4|COMPLETED|Overall Study||13
8385327|NCT01080794|20668588|P3|COMPLETED|Overall Study||10
8385328|NCT01080794|20668589|P2|COMPLETED|Overall Study||12
8385329|NCT01080794|20668590|P1|COMPLETED|Overall Study||15
8385330|NCT01080794|20668587|P4|STARTED|Overall Study||15
8385331|NCT01080794|20668588|P3|STARTED|Overall Study||12
8385332|NCT01080794|20668589|P2|STARTED|Overall Study||14
8385333|NCT01080794|20668590|P1|STARTED|Overall Study||20
8385334|NCT01080768|20668638|P2|NOT COMPLETED|Overall Study||1
8385335|NCT01080768|20668639|P1|NOT COMPLETED|Overall Study||2
8385336|NCT01080768|20668638|P2|COMPLETED|Overall Study||16
8385337|NCT01080768|20668639|P1|COMPLETED|Overall Study||12
8385338|NCT01080768|20668638|P2|STARTED|Overall Study||17
8385339|NCT01080768|20668639|P1|STARTED|Overall Study||14
8385340|NCT01080716|20668649|P4|NOT COMPLETED|Part 2||0
8385341|NCT01080716|20668650|P3|NOT COMPLETED|Part 2||0
8385342|NCT01080716|20668651|P2|NOT COMPLETED|Part 2||0
8385343|NCT01080716|20668652|P1|NOT COMPLETED|Part 2||0
8385344|NCT01080716|20668649|P4|COMPLETED|Part 2||10
8385345|NCT01080716|20668650|P3|COMPLETED|Part 2||10
8385346|NCT01080716|20668651|P2|COMPLETED|Part 2||0
8385347|NCT01080716|20668652|P1|COMPLETED|Part 2||0
8385348|NCT01080716|20668649|P4|STARTED|Part 2||10
8385349|NCT01080716|20668650|P3|STARTED|Part 2||10
8385350|NCT01080716|20668651|P2|STARTED|Part 2||0
8385351|NCT01080716|20668652|P1|STARTED|Part 2||0
8385352|NCT01080716|20668649|P4|NOT COMPLETED|Part 1||0
8385353|NCT01080716|20668650|P3|NOT COMPLETED|Part 1||0
8385354|NCT01080716|20668651|P2|NOT COMPLETED|Part 1||0
8385355|NCT01080716|20668652|P1|NOT COMPLETED|Part 1||1
8385356|NCT01080716|20668649|P4|COMPLETED|Part 1||0
8385357|NCT01080716|20668650|P3|COMPLETED|Part 1||0
8385358|NCT01080716|20668651|P2|COMPLETED|Part 1||6
8385359|NCT01080716|20668652|P1|COMPLETED|Part 1||13
8385360|NCT01080716|20668649|P4|STARTED|Part 1||0
8385361|NCT01080716|20668650|P3|STARTED|Part 1||0
8385362|NCT01080716|20668651|P2|STARTED|Part 1||6
8385363|NCT01080716|20668652|P1|STARTED|Part 1||14
8385364|NCT01080677|20668669|P3|NOT COMPLETED|Overall Study||0
8385365|NCT01080677|20668670|P2|NOT COMPLETED|Overall Study||0
8385366|NCT01080677|20668671|P1|NOT COMPLETED|Overall Study||0
8385367|NCT01080677|20668669|P3|COMPLETED|Overall Study||20
8385368|NCT01080677|20668670|P2|COMPLETED|Overall Study||20
8385369|NCT01080677|20668671|P1|COMPLETED|Overall Study||20
8385370|NCT01080677|20668669|P3|STARTED|Overall Study||20
8385371|NCT01080677|20668670|P2|STARTED|Overall Study||20
8385372|NCT01080677|20668671|P1|STARTED|Overall Study||20
8385373|NCT01080625|20668691|P3|NOT COMPLETED|Overall Study||1
8385374|NCT01080625|20668692|P2|NOT COMPLETED|Overall Study||2
8385375|NCT01080625|20668693|P1|NOT COMPLETED|Overall Study||0
8385376|NCT01080625|20668691|P3|COMPLETED|Overall Study||31
8385377|NCT01080625|20668692|P2|COMPLETED|Overall Study||31
8385378|NCT01080625|20668693|P1|COMPLETED|Overall Study||31
8385379|NCT01080625|20668691|P3|STARTED|Overall Study||32
8385380|NCT01080625|20668692|P2|STARTED|Overall Study||33
8385381|NCT01080625|20668693|P1|STARTED|Overall Study||31
8385382|NCT01080391|20668703|P2|NOT COMPLETED|Overall Study||4
8385383|NCT01080391|20668704|P1|NOT COMPLETED|Overall Study||7
8385384|NCT01080391|20668703|P2|COMPLETED|Overall Study||392
8385385|NCT01080391|20668704|P1|COMPLETED|Overall Study||389
8385386|NCT01080391|20668703|P2|Treated|Overall Study||392
8385387|NCT01080391|20668704|P1|Treated|Overall Study||389
8385388|NCT01080391|20668703|P2|STARTED|Overall Study||396
8385389|NCT01080391|20668704|P1|STARTED|Overall Study||396
8385390|NCT01080326|20668722|P1|NOT COMPLETED|Overall Study||4
8385391|NCT01080326|20668722|P1|COMPLETED|Overall Study||3
8385392|NCT01080326|20668722|P1|STARTED|Overall Study||7
8385393|NCT01080300|20668728|P2|NOT COMPLETED|Overall Study||104
8385394|NCT01080300|20668729|P1|NOT COMPLETED|Overall Study||94
8385395|NCT01080300|20668728|P2|COMPLETED|Overall Study||191
8385396|NCT01080300|20668729|P1|COMPLETED|Overall Study||206
8385397|NCT01080300|20668728|P2|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
8385398|NCT01080300|20668729|P1|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
8385399|NCT01080261|20668757|P1|NOT COMPLETED|Overall Study||0
8385400|NCT01080261|20668757|P1|COMPLETED|Overall Study||60
8385401|NCT01080261|20668757|P1|STARTED|Overall Study||60
8385402|NCT01080248|20668772|P1|NOT COMPLETED|Overall Study||0
8385403|NCT01080248|20668772|P1|COMPLETED|Overall Study||2
8385404|NCT01080248|20668772|P1|STARTED|Overall Study||2
8385405|NCT01080209|20668786|P7|NOT COMPLETED|Overall Study||7
8385406|NCT01080209|20668787|P6|NOT COMPLETED|Overall Study||0
8385407|NCT01080209|20668788|P5|NOT COMPLETED|Overall Study||0
8385408|NCT01080209|20668789|P4|NOT COMPLETED|Overall Study||5
8385409|NCT01080209|20668790|P3|NOT COMPLETED|Overall Study||5
8385410|NCT01080209|20668791|P2|NOT COMPLETED|Overall Study||11
8385411|NCT01080209|20668792|P1|NOT COMPLETED|Overall Study||6
8385412|NCT01080209|20668786|P7|COMPLETED|Overall Study||44
8385413|NCT01080209|20668787|P6|COMPLETED|Overall Study||2
8385414|NCT01080209|20668788|P5|COMPLETED|Overall Study||6
8385415|NCT01080209|20668789|P4|COMPLETED|Overall Study||37
8385416|NCT01080209|20668790|P3|COMPLETED|Overall Study||28
8385417|NCT01080209|20668791|P2|COMPLETED|Overall Study||42
8385418|NCT01080209|20668792|P1|COMPLETED|Overall Study||22
8385419|NCT01080209|20668786|P7|STARTED|Overall Study||51
8385420|NCT01080209|20668787|P6|STARTED|Overall Study||2
8385421|NCT01080209|20668788|P5|STARTED|Overall Study||6
8385422|NCT01080209|20668789|P4|STARTED|Overall Study||42
8385423|NCT01080209|20668790|P3|STARTED|Overall Study||33
8385424|NCT01080209|20668791|P2|STARTED|Overall Study||53
8385425|NCT01080209|20668792|P1|STARTED|Overall Study||28
8385426|NCT01080196|20668817|P2|NOT COMPLETED|Overall Study||0
8385427|NCT01080196|20668818|P1|NOT COMPLETED|Overall Study||0
8385428|NCT01080196|20668817|P2|COMPLETED|Overall Study||66
8385429|NCT01080196|20668818|P1|COMPLETED|Overall Study||68
8385430|NCT01080196|20668817|P2|STARTED|Overall Study||66
8385431|NCT01080196|20668818|P1|STARTED|Overall Study||68
8385432|NCT01080131|20668834|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
8385433|NCT01080131|20668835|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
8385434|NCT01080131|20668834|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||54
8385435|NCT01080131|20668835|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||64
8385436|NCT01080131|20668834|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
8385437|NCT01080131|20668835|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
8385438|NCT01080131|20668834|P2|STARTED|Extension Study 2 (25-72 Weeks)||65
8385439|NCT01080131|20668835|P1|STARTED|Extension Study 2 (25-72 Weeks)||72
8385440|NCT01080131|20668834|P2|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
8385441|NCT01080131|20668835|P1|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
8385442|NCT01080131|20668834|P2|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
8385443|NCT01080131|20668835|P1|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
8385444|NCT01080131|20668834|P2|STARTED|Extension Study 1 (12 -24 Weeks)||76
8385445|NCT01080131|20668835|P1|STARTED|Extension Study 1 (12 -24 Weeks)||84
8385446|NCT01080131|20668834|P2|NOT COMPLETED|Core Study (0- 12 Weeks)||11
8385447|NCT01080131|20668835|P1|NOT COMPLETED|Core Study (0- 12 Weeks)||13
8385448|NCT01080131|20668834|P2|COMPLETED|Core Study (0- 12 Weeks)||103
8385449|NCT01080131|20668835|P1|COMPLETED|Core Study (0- 12 Weeks)||99
8385450|NCT01080131|20668834|P2|STARTED|Core Study (0- 12 Weeks)||114
8385451|NCT01080131|20668835|P1|STARTED|Core Study (0- 12 Weeks)||112
8385452|NCT01080118|20668914|P4|NOT COMPLETED|Overall Study||0
8385453|NCT01080118|20668915|P3|NOT COMPLETED|Overall Study||0
8385454|NCT01080118|20668916|P2|NOT COMPLETED|Overall Study||0
8385455|NCT01080118|20668917|P1|NOT COMPLETED|Overall Study||0
8385456|NCT01080118|20668914|P4|COMPLETED|Overall Study||30
8385457|NCT01080118|20668915|P3|COMPLETED|Overall Study||30
8385458|NCT01080118|20668916|P2|COMPLETED|Overall Study||15
8385459|NCT01080118|20668917|P1|COMPLETED|Overall Study||15
8385460|NCT01080118|20668914|P4|STARTED|Overall Study||30
8385461|NCT01080118|20668915|P3|STARTED|Overall Study||30
8385462|NCT01080118|20668916|P2|STARTED|Overall Study||15
8385463|NCT01080118|20668917|P1|STARTED|Overall Study||15
8385464|NCT01079988|20668930|P5|NOT COMPLETED|Overall Study||1
8385465|NCT01079988|20668931|P4|NOT COMPLETED|Overall Study||3
8385466|NCT01079988|20668932|P3|NOT COMPLETED|Overall Study||0
8385467|NCT01079988|20668933|P2|NOT COMPLETED|Overall Study||0
8385468|NCT01079988|20668934|P1|NOT COMPLETED|Overall Study||1
8385469|NCT01079988|20668930|P5|COMPLETED|Overall Study||1
8385470|NCT01079988|20668931|P4|COMPLETED|Overall Study||17
8385471|NCT01079988|20668932|P3|COMPLETED|Overall Study||8
8385472|NCT01079988|20668933|P2|COMPLETED|Overall Study||1
8385473|NCT01079988|20668934|P1|COMPLETED|Overall Study||9
8385474|NCT01079988|20668930|P5|STARTED|Overall Study||2
8385475|NCT01079988|20668931|P4|STARTED|Overall Study||20
8385476|NCT01079988|20668932|P3|STARTED|Overall Study||8
8385477|NCT01079988|20668933|P2|STARTED|Overall Study||1
8385478|NCT01079988|20668934|P1|STARTED|Overall Study||10
8385479|NCT01079962|20668953|P2|NOT COMPLETED|Overall Study||15
8385480|NCT01079962|20668954|P1|NOT COMPLETED|Overall Study||15
8385481|NCT01079962|20668953|P2|COMPLETED|Overall Study||89
8385482|NCT01079962|20668954|P1|COMPLETED|Overall Study||90
8385483|NCT01079962|20668953|P2|STARTED|Overall Study||104
8385484|NCT01079962|20668954|P1|STARTED|Overall Study||105
8385485|NCT01079949|20668982|P2|NOT COMPLETED|Overall Study||13
8385486|NCT01079949|20668983|P1|NOT COMPLETED|Overall Study||15
8385487|NCT01079949|20668982|P2|COMPLETED|Overall Study||34
8385488|NCT01079949|20668983|P1|COMPLETED|Overall Study||31
8385489|NCT01079949|20668982|P2|STARTED|Overall Study||47
8385490|NCT01079949|20668983|P1|STARTED|Overall Study||46
8385491|NCT01079936|20669029|P5|NOT COMPLETED|Phase II||1
8385492|NCT01079936|20669030|P4|NOT COMPLETED|Phase II||0
8385493|NCT01079936|20669031|P3|NOT COMPLETED|Phase II||1
8385494|NCT01079936|20669032|P2|NOT COMPLETED|Phase II||0
8385495|NCT01079936|20669033|P1|NOT COMPLETED|Phase II||0
8385496|NCT01079936|20669029|P5|COMPLETED|Phase II||25
8385497|NCT01079936|20669030|P4|COMPLETED|Phase II||24
8385498|NCT01079936|20669031|P3|COMPLETED|Phase II||5
8385499|NCT01079936|20669032|P2|COMPLETED|Phase II||3
8385500|NCT01079936|20669033|P1|COMPLETED|Phase II||0
8385501|NCT01079936|20669029|P5|STARTED|Phase II||26
8385502|NCT01079936|20669030|P4|STARTED|Phase II||24
8385503|NCT01079936|20669031|P3|STARTED|Phase II||6
8385504|NCT01079936|20669032|P2|STARTED|Phase II||3
8385505|NCT01079936|20669033|P1|STARTED|Phase II||0
8385506|NCT01079936|20669029|P5|NOT COMPLETED|Phase I: MTD||0
8385507|NCT01079936|20669030|P4|NOT COMPLETED|Phase I: MTD||0
8385508|NCT01079936|20669031|P3|NOT COMPLETED|Phase I: MTD||0
8385509|NCT01079936|20669032|P2|NOT COMPLETED|Phase I: MTD||0
8385510|NCT01079936|20669033|P1|NOT COMPLETED|Phase I: MTD||4
8385511|NCT01079936|20669029|P5|COMPLETED|Phase I: MTD||0
8385512|NCT01079936|20669030|P4|COMPLETED|Phase I: MTD||0
8385513|NCT01079936|20669031|P3|COMPLETED|Phase I: MTD||0
8385514|NCT01079936|20669032|P2|COMPLETED|Phase I: MTD||0
8385515|NCT01079936|20669033|P1|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
8385516|NCT01079936|20669029|P5|STARTED|Phase I: MTD||0
8385517|NCT01079936|20669030|P4|STARTED|Phase I: MTD||0
8385518|NCT01079936|20669031|P3|STARTED|Phase I: MTD||0
8385519|NCT01079936|20669032|P2|STARTED|Phase I: MTD||0
8385520|NCT01079936|20669033|P1|STARTED|Phase I: MTD||16
8385521|NCT01079832|20669052|P1|NOT COMPLETED|Overall Study||1
8385522|NCT01079832|20669052|P1|COMPLETED|Overall Study||49
8385523|NCT01079832|20669052|P1|STARTED|Overall Study||50
8385524|NCT01079806|20669062|P2|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15
8385525|NCT01079806|20669063|P1|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19
8385526|NCT01079806|20669062|P2|COMPLETED|Long-term Follow-up: Day 1-End of Study||43
8385527|NCT01079806|20669063|P1|COMPLETED|Long-term Follow-up: Day 1-End of Study||92
8385528|NCT01079806|20669062|P2|STARTED|Long-term Follow-up: Day 1-End of Study||58
8385529|NCT01079806|20669063|P1|STARTED|Long-term Follow-up: Day 1-End of Study||111
8385530|NCT01079806|20669062|P2|NOT COMPLETED|Day 1 to Week 96||7
8385531|NCT01079806|20669063|P1|NOT COMPLETED|Day 1 to Week 96||7
8385532|NCT01079806|20669062|P2|COMPLETED|Day 1 to Week 96||53
8385533|NCT01079806|20669063|P1|COMPLETED|Day 1 to Week 96||113
8385534|NCT01079806|20669062|P2|Primary Endpoint Cohort|Day 1 to Week 96||41
8385535|NCT01079806|20669063|P1|Primary Endpoint Cohort|Day 1 to Week 96||82
8385536|NCT01079806|20669062|P2|Received Treatment|Day 1 to Week 96||60
8385537|NCT01079806|20669063|P1|Received Treatment|Day 1 to Week 96||120
8385538|NCT01079806|20669062|P2|STARTED|Day 1 to Week 96||60
8385539|NCT01079806|20669063|P1|STARTED|Day 1 to Week 96||120
8385540|NCT01079741|20669098|P5|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
8385541|NCT01079741|20669099|P4|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
8385542|NCT01079741|20669100|P3|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
8385543|NCT01079741|20669101|P2|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
8385544|NCT01079741|20669102|P1|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
8385545|NCT01079741|20669098|P5|COMPLETED|Phase 2 (Weeks 37-48)||9
8385546|NCT01079741|20669099|P4|COMPLETED|Phase 2 (Weeks 37-48)||12
8385547|NCT01079741|20669100|P3|COMPLETED|Phase 2 (Weeks 37-48)||0
8385548|NCT01079741|20669101|P2|COMPLETED|Phase 2 (Weeks 37-48)||0
8385549|NCT01079741|20669102|P1|COMPLETED|Phase 2 (Weeks 37-48)||0
8385550|NCT01079741|20669098|P5|STARTED|Phase 2 (Weeks 37-48)||12
8385551|NCT01079741|20669099|P4|STARTED|Phase 2 (Weeks 37-48)||12
8385552|NCT01079741|20669100|P3|STARTED|Phase 2 (Weeks 37-48)||0
8385553|NCT01079741|20669101|P2|STARTED|Phase 2 (Weeks 37-48)||0
8385554|NCT01079741|20669102|P1|STARTED|Phase 2 (Weeks 37-48)||0
8385555|NCT01079741|20669098|P5|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385556|NCT01079741|20669099|P4|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385557|NCT01079741|20669100|P3|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
8385558|NCT01079741|20669101|P2|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385559|NCT01079741|20669102|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385560|NCT01079741|20669098|P5|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385561|NCT01079741|20669099|P4|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385562|NCT01079741|20669100|P3|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385563|NCT01079741|20669101|P2|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385564|NCT01079741|20669102|P1|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385565|NCT01079741|20669098|P5|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385566|NCT01079741|20669099|P4|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385567|NCT01079741|20669100|P3|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
8385568|NCT01079741|20669101|P2|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385569|NCT01079741|20669102|P1|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
8385570|NCT01079741|20669098|P5|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385571|NCT01079741|20669099|P4|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385572|NCT01079741|20669100|P3|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385573|NCT01079741|20669101|P2|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
8385574|NCT01079741|20669102|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385575|NCT01079741|20669098|P5|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385576|NCT01079741|20669099|P4|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385577|NCT01079741|20669100|P3|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385578|NCT01079741|20669101|P2|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
8385579|NCT01079741|20669102|P1|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385580|NCT01079741|20669098|P5|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385581|NCT01079741|20669099|P4|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385582|NCT01079741|20669100|P3|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385583|NCT01079741|20669101|P2|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
8385584|NCT01079741|20669102|P1|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
8385585|NCT01079741|20669098|P5|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385586|NCT01079741|20669099|P4|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385587|NCT01079741|20669100|P3|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385588|NCT01079741|20669101|P2|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385589|NCT01079741|20669102|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385590|NCT01079741|20669098|P5|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385591|NCT01079741|20669099|P4|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385592|NCT01079741|20669100|P3|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385593|NCT01079741|20669101|P2|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385594|NCT01079741|20669102|P1|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
8385595|NCT01079741|20669098|P5|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385596|NCT01079741|20669099|P4|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385597|NCT01079741|20669100|P3|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385598|NCT01079741|20669101|P2|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
8385599|NCT01079741|20669102|P1|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
8385600|NCT01079598|20669116|P1|NOT COMPLETED|Overall Study||0
8385601|NCT01079598|20669116|P1|COMPLETED|Overall Study||8
8385602|NCT01079598|20669116|P1|STARTED|Overall Study||8
8385603|NCT01079390|20669126|P3|NOT COMPLETED|Overall Study||4
8385604|NCT01079390|20669127|P2|NOT COMPLETED|Overall Study||5
8385605|NCT01079390|20669128|P1|NOT COMPLETED|Overall Study||5
8385606|NCT01079390|20669126|P3|COMPLETED|Overall Study||10
8385607|NCT01079390|20669127|P2|COMPLETED|Overall Study||10
8385608|NCT01079390|20669128|P1|COMPLETED|Overall Study||10
8385609|NCT01079390|20669126|P3|STARTED|Overall Study||14
8385610|NCT01079390|20669127|P2|STARTED|Overall Study||15
8385611|NCT01079390|20669128|P1|STARTED|Overall Study||15
8385612|NCT01079299|20669140|P2|NOT COMPLETED|Overall Study||0
8385613|NCT01079299|20669141|P1|NOT COMPLETED|Overall Study||0
8385614|NCT01079299|20669140|P2|COMPLETED|Overall Study||25
8385615|NCT01079299|20669141|P1|COMPLETED|Overall Study||27
8385616|NCT01079299|20669140|P2|STARTED|Overall Study||25
8385617|NCT01079299|20669141|P1|STARTED|Overall Study||27
8385618|NCT01079234|20669150|P4|NOT COMPLETED|Extension: Week 27 to 52||16
8385619|NCT01079234|20669151|P3|NOT COMPLETED|Extension: Week 27 to 52||11
8385620|NCT01079234|20669152|P2|NOT COMPLETED|Extension: Week 27 to 52||0
8385621|NCT01079234|20669153|P1|NOT COMPLETED|Extension: Week 27 to 52||0
8385622|NCT01079234|20669150|P4|COMPLETED|Extension: Week 27 to 52||223
8385623|NCT01079234|20669151|P3|COMPLETED|Extension: Week 27 to 52||122
8385624|NCT01079234|20669152|P2|COMPLETED|Extension: Week 27 to 52||0
8385625|NCT01079234|20669153|P1|COMPLETED|Extension: Week 27 to 52||0
8385626|NCT01079234|20669150|P4|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
8385627|NCT01079234|20669151|P3|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
8385628|NCT01079234|20669152|P2|STARTED|Extension: Week 27 to 52||0
8385629|NCT01079234|20669153|P1|STARTED|Extension: Week 27 to 52||0
8385630|NCT01079234|20669150|P4|NOT COMPLETED|Main: Week 0 to 26||0
8385631|NCT01079234|20669151|P3|NOT COMPLETED|Main: Week 0 to 26||12
8385632|NCT01079234|20669152|P2|NOT COMPLETED|Main: Week 0 to 26||26
8385633|NCT01079234|20669153|P1|NOT COMPLETED|Main: Week 0 to 26||26
8385634|NCT01079234|20669150|P4|COMPLETED|Main: Week 0 to 26||0
8385635|NCT01079234|20669151|P3|COMPLETED|Main: Week 0 to 26||152
8385636|NCT01079234|20669152|P2|COMPLETED|Main: Week 0 to 26||139
8385637|NCT01079234|20669153|P1|COMPLETED|Main: Week 0 to 26||138
8385638|NCT01079234|20669150|P4|Exposed|Main: Week 0 to 26||0
8385639|NCT01079234|20669151|P3|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
8385640|NCT01079234|20669152|P2|Exposed|Main: Week 0 to 26||165
8385641|NCT01079234|20669153|P1|Exposed|Main: Week 0 to 26||164
8385642|NCT01079234|20669150|P4|STARTED|Main: Week 0 to 26||0
8385643|NCT01079234|20669151|P3|STARTED|Main: Week 0 to 26||164
8385644|NCT01079234|20669152|P2|STARTED|Main: Week 0 to 26||165
8385645|NCT01079234|20669153|P1|STARTED|Main: Week 0 to 26||164
8385646|NCT01079195|20669171|P1|NOT COMPLETED|Overall Study||1431
8385647|NCT01079195|20669171|P1|COMPLETED|Overall Study||14442
8385648|NCT01079195|20669171|P1|STARTED|Overall Study||15873
8385649|NCT01079182|20669177|P1|NOT COMPLETED|Overall Study||2719
8385650|NCT01079182|20669177|P1|COMPLETED|Overall Study||1962
8385651|NCT01079182|20669177|P1|STARTED|Overall Study||4681
8385652|NCT01079143|20669208|P4|NOT COMPLETED|Overall Study||5
8385653|NCT01079143|20669209|P3|NOT COMPLETED|Overall Study||5
8385654|NCT01079143|20669210|P2|NOT COMPLETED|Overall Study||17
8385655|NCT01079143|20669211|P1|NOT COMPLETED|Overall Study||9
8385656|NCT01079143|20669208|P4|COMPLETED|Overall Study||54
8385657|NCT01079143|20669209|P3|COMPLETED|Overall Study||34
8385658|NCT01079143|20669210|P2|COMPLETED|Overall Study||43
8385659|NCT01079143|20669211|P1|COMPLETED|Overall Study||27
8385660|NCT01079143|20669208|P4|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
8385661|NCT01079143|20669209|P3|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
8385662|NCT01079143|20669210|P2|M3 and M12 Biopsies|Overall Study||43
8385663|NCT01079143|20669211|P1|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
8385664|NCT01079143|20669208|P4|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
8385665|NCT01079143|20669209|P3|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
8385666|NCT01079143|20669210|P2|Month 12 (M12) Biopsies|Overall Study||43
8385667|NCT01079143|20669211|P1|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
8385668|NCT01079143|20669208|P4|Month 3 (M3) Biopsies|Overall Study||59
8385669|NCT01079143|20669209|P3|Month 3 (M3) Biopsies|Overall Study||39
8385670|NCT01079143|20669210|P2|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
8385671|NCT01079143|20669211|P1|Month 3 (M3) Biopsies|Overall Study||36
8385672|NCT01079143|20669208|P4|Exposed|Overall Study||59
8385673|NCT01079143|20669209|P3|Exposed|Overall Study||39
8385674|NCT01079143|20669210|P2|Exposed|Overall Study||60
8385675|NCT01079143|20669211|P1|Exposed|Overall Study||36
8385676|NCT01079143|20669208|P4|STARTED|Overall Study||59
8385677|NCT01079143|20669209|P3|STARTED|Overall Study||39
8385678|NCT01079143|20669210|P2|STARTED|Overall Study||60
8385679|NCT01079143|20669211|P1|STARTED|Overall Study||36
8385680|NCT01079130|20669285|P6|NOT COMPLETED|Overall Study||5
8385681|NCT01079130|20669286|P5|NOT COMPLETED|Overall Study||8
8385682|NCT01079130|20669287|P4|NOT COMPLETED|Overall Study||5
8385683|NCT01079130|20669288|P3|NOT COMPLETED|Overall Study||1
8385684|NCT01079130|20669289|P2|NOT COMPLETED|Overall Study||7
8385685|NCT01079130|20669290|P1|NOT COMPLETED|Overall Study||2
8385686|NCT01079130|20669285|P6|COMPLETED|Overall Study||80
8385687|NCT01079130|20669286|P5|COMPLETED|Overall Study||78
8385688|NCT01079130|20669287|P4|COMPLETED|Overall Study||81
8385689|NCT01079130|20669288|P3|COMPLETED|Overall Study||83
8385690|NCT01079130|20669289|P2|COMPLETED|Overall Study||78
8385691|NCT01079130|20669290|P1|COMPLETED|Overall Study||83
8385692|NCT01079130|20669285|P6|Full Analysis Set (FAS)|Overall Study||84
8385693|NCT01079130|20669286|P5|Full Analysis Set (FAS)|Overall Study||84
8385694|NCT01079130|20669287|P4|Full Analysis Set (FAS)|Overall Study||85
8385695|NCT01079130|20669288|P3|Full Analysis Set (FAS)|Overall Study||83
8385696|NCT01079130|20669289|P2|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
8385697|NCT01079130|20669290|P1|Full Analysis Set (FAS)|Overall Study||84
8385698|NCT01079130|20669285|P6|Safety Set: Received Study Drug|Overall Study||84
8385699|NCT01079130|20669286|P5|Safety Set: Received Study Drug|Overall Study||84
8385700|NCT01079130|20669287|P4|Safety Set: Received Study Drug|Overall Study||85
8385701|NCT01079130|20669288|P3|Safety Set: Received Study Drug|Overall Study||84
8385702|NCT01079130|20669289|P2|Safety Set: Received Study Drug|Overall Study||81
8385703|NCT01079130|20669290|P1|Safety Set: Received Study Drug|Overall Study||84
8385704|NCT01079130|20669285|P6|STARTED|Overall Study||85
8385705|NCT01079130|20669286|P5|STARTED|Overall Study||86
8385706|NCT01079130|20669287|P4|STARTED|Overall Study||86
8385707|NCT01079130|20669288|P3|STARTED|Overall Study||84
8385708|NCT01079130|20669289|P2|STARTED|Overall Study||85
8385709|NCT01079130|20669290|P1|STARTED|Overall Study||85
8385710|NCT01078974|20669310|P1|NOT COMPLETED|Overall Study||3
8385711|NCT01078974|20669310|P1|COMPLETED|Overall Study||4
8385712|NCT01078974|20669310|P1|STARTED|Overall Study||7
8385713|NCT01078922|20669315|P1|NOT COMPLETED|Overall Study||1
8385714|NCT01078922|20669315|P1|COMPLETED|Overall Study||10
8385715|NCT01078922|20669315|P1|STARTED|Overall Study||11
8385716|NCT01078909|20669325|P5|NOT COMPLETED|Overall Study||2
8385717|NCT01078909|20669326|P4|NOT COMPLETED|Overall Study||1
8385718|NCT01078909|20669327|P3|NOT COMPLETED|Overall Study||1
8385719|NCT01078909|20669328|P2|NOT COMPLETED|Overall Study||4
8385720|NCT01078909|20669329|P1|NOT COMPLETED|Overall Study||2
8385721|NCT01078909|20669325|P5|COMPLETED|Overall Study||23
8385722|NCT01078909|20669326|P4|COMPLETED|Overall Study||24
8385723|NCT01078909|20669327|P3|COMPLETED|Overall Study||24
8385724|NCT01078909|20669328|P2|COMPLETED|Overall Study||21
8385725|NCT01078909|20669329|P1|COMPLETED|Overall Study||23
8385726|NCT01078909|20669325|P5|STARTED|Overall Study||25
8385727|NCT01078909|20669326|P4|STARTED|Overall Study||25
8385728|NCT01078909|20669327|P3|STARTED|Overall Study||25
8385729|NCT01078909|20669328|P2|STARTED|Overall Study||25
8385730|NCT01078909|20669329|P1|STARTED|Overall Study||25
8385731|NCT01078844|20669351|P1|NOT COMPLETED|Overall Study||4
8385732|NCT01078844|20669351|P1|COMPLETED|Overall Study||0
8385733|NCT01078844|20669351|P1|STARTED|Overall Study||4
8385734|NCT01078805|20669356|P1|NOT COMPLETED|Overall Study||2050
8385735|NCT01078805|20669356|P1|COMPLETED|Overall Study||2117
8385736|NCT01078805|20669356|P1|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
8385737|NCT01078805|20669356|P1|Took at Least 1 Dose of Study Drug|Overall Study||4085
8385738|NCT01078805|20669356|P1|STARTED|Overall Study||4167
8385739|NCT01078753|20669370|P2|NOT COMPLETED|Treatment Period II||0
8385740|NCT01078753|20669371|P1|NOT COMPLETED|Treatment Period II||0
8385741|NCT01078753|20669370|P2|COMPLETED|Treatment Period II||44
8385742|NCT01078753|20669371|P1|COMPLETED|Treatment Period II||45
8385743|NCT01078753|20669370|P2|Full Analysis Set|Treatment Period II||44
8385744|NCT01078753|20669371|P1|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
8385745|NCT01078753|20669370|P2|STARTED|Treatment Period II||44
8385746|NCT01078753|20669371|P1|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
8385747|NCT01078753|20669370|P2|NOT COMPLETED|Treatment Period I||0
8385748|NCT01078753|20669371|P1|NOT COMPLETED|Treatment Period I||0
8385749|NCT01078753|20669370|P2|COMPLETED|Treatment Period I||44
8385750|NCT01078753|20669371|P1|COMPLETED|Treatment Period I||45
8385751|NCT01078753|20669370|P2|Full Analysis Set|Treatment Period I||44
8385752|NCT01078753|20669371|P1|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
8385753|NCT01078753|20669370|P2|STARTED|Treatment Period I||44
8385754|NCT01078753|20669371|P1|STARTED|Treatment Period I||45
8385755|NCT01078675|20669383|P2|NOT COMPLETED|Overall Study||6
8385756|NCT01078675|20669384|P1|NOT COMPLETED|Overall Study||68
8385757|NCT01078675|20669383|P2|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
8385758|NCT01078675|20669384|P1|COMPLETED|Overall Study||182
8385759|NCT01078675|20669383|P2|Patients Treated|Overall Study||0
8385760|NCT01078675|20669384|P1|Patients Treated|Overall Study||198
8385761|NCT01078675|20669383|P2|STARTED|Overall Study||65
8385762|NCT01078675|20669384|P1|STARTED|Overall Study||250
8385778|NCT01078623|20669449|P20|NOT COMPLETED|Treatment Period 4||0
8385779|NCT01078623|20669450|P19|NOT COMPLETED|Treatment Period 4||0
8385780|NCT01078623|20669451|P18|NOT COMPLETED|Treatment Period 4||0
8385781|NCT01078623|20669452|P17|NOT COMPLETED|Treatment Period 4||0
8385782|NCT01078623|20669453|P16|NOT COMPLETED|Treatment Period 4||1
8385783|NCT01078623|20669454|P15|NOT COMPLETED|Treatment Period 4||0
8385784|NCT01078623|20669455|P14|NOT COMPLETED|Treatment Period 4||0
8385785|NCT01078623|20669456|P13|NOT COMPLETED|Treatment Period 4||0
8385786|NCT01078623|20669457|P12|NOT COMPLETED|Treatment Period 4||0
8385787|NCT01078623|20669458|P11|NOT COMPLETED|Treatment Period 4||0
8385788|NCT01078623|20669459|P10|NOT COMPLETED|Treatment Period 4||0
8385789|NCT01078623|20669460|P9|NOT COMPLETED|Treatment Period 4||0
8385790|NCT01078623|20669461|P8|NOT COMPLETED|Treatment Period 4||0
8385791|NCT01078623|20669462|P7|NOT COMPLETED|Treatment Period 4||0
8385792|NCT01078623|20669463|P6|NOT COMPLETED|Treatment Period 4||0
8385793|NCT01078623|20669464|P5|NOT COMPLETED|Treatment Period 4||0
8385794|NCT01078623|20669465|P4|NOT COMPLETED|Treatment Period 4||0
8385795|NCT01078623|20669466|P3|NOT COMPLETED|Treatment Period 4||1
8385796|NCT01078623|20669467|P2|NOT COMPLETED|Treatment Period 4||0
8385797|NCT01078623|20669468|P1|NOT COMPLETED|Treatment Period 4||0
8385798|NCT01078623|20669449|P20|COMPLETED|Treatment Period 4||7
8385799|NCT01078623|20669450|P19|COMPLETED|Treatment Period 4||6
8385800|NCT01078623|20669451|P18|COMPLETED|Treatment Period 4||7
8385801|NCT01078623|20669452|P17|COMPLETED|Treatment Period 4||7
8385802|NCT01078623|20669453|P16|COMPLETED|Treatment Period 4||6
8385803|NCT01078623|20669454|P15|COMPLETED|Treatment Period 4||7
8385804|NCT01078623|20669455|P14|COMPLETED|Treatment Period 4||6
8385805|NCT01078623|20669456|P13|COMPLETED|Treatment Period 4||7
8385806|NCT01078623|20669457|P12|COMPLETED|Treatment Period 4||7
8385807|NCT01078623|20669458|P11|COMPLETED|Treatment Period 4||6
8385808|NCT01078623|20669459|P10|COMPLETED|Treatment Period 4||6
8385809|NCT01078623|20669460|P9|COMPLETED|Treatment Period 4||5
8385810|NCT01078623|20669461|P8|COMPLETED|Treatment Period 4||6
8385811|NCT01078623|20669462|P7|COMPLETED|Treatment Period 4||5
8385812|NCT01078623|20669463|P6|COMPLETED|Treatment Period 4||4
8385813|NCT01078623|20669464|P5|COMPLETED|Treatment Period 4||6
8385814|NCT01078623|20669465|P4|COMPLETED|Treatment Period 4||6
8385815|NCT01078623|20669466|P3|COMPLETED|Treatment Period 4||5
8385816|NCT01078623|20669467|P2|COMPLETED|Treatment Period 4||5
8385817|NCT01078623|20669468|P1|COMPLETED|Treatment Period 4||5
8385818|NCT01078623|20669449|P20|STARTED|Treatment Period 4||7
8385819|NCT01078623|20669450|P19|STARTED|Treatment Period 4||6
8385820|NCT01078623|20669451|P18|STARTED|Treatment Period 4||7
8385821|NCT01078623|20669452|P17|STARTED|Treatment Period 4||7
8385822|NCT01078623|20669453|P16|STARTED|Treatment Period 4||7
8385823|NCT01078623|20669454|P15|STARTED|Treatment Period 4||7
8385824|NCT01078623|20669455|P14|STARTED|Treatment Period 4||6
8385825|NCT01078623|20669456|P13|STARTED|Treatment Period 4||7
8385826|NCT01078623|20669457|P12|STARTED|Treatment Period 4||7
8385827|NCT01078623|20669458|P11|STARTED|Treatment Period 4||6
8385828|NCT01078623|20669459|P10|STARTED|Treatment Period 4||6
8385829|NCT01078623|20669460|P9|STARTED|Treatment Period 4||5
8385830|NCT01078623|20669461|P8|STARTED|Treatment Period 4||6
8385831|NCT01078623|20669462|P7|STARTED|Treatment Period 4||5
8385832|NCT01078623|20669463|P6|STARTED|Treatment Period 4||4
8385833|NCT01078623|20669464|P5|STARTED|Treatment Period 4||6
8385834|NCT01078623|20669465|P4|STARTED|Treatment Period 4||6
8385835|NCT01078623|20669466|P3|STARTED|Treatment Period 4||6
8385836|NCT01078623|20669467|P2|STARTED|Treatment Period 4||5
8385837|NCT01078623|20669468|P1|STARTED|Treatment Period 4||5
8385838|NCT01078623|20669449|P20|NOT COMPLETED|Treatment Period 3||0
8385839|NCT01078623|20669450|P19|NOT COMPLETED|Treatment Period 3||0
8385840|NCT01078623|20669451|P18|NOT COMPLETED|Treatment Period 3||0
8385841|NCT01078623|20669452|P17|NOT COMPLETED|Treatment Period 3||0
8385842|NCT01078623|20669453|P16|NOT COMPLETED|Treatment Period 3||0
8385843|NCT01078623|20669454|P15|NOT COMPLETED|Treatment Period 3||0
8385844|NCT01078623|20669455|P14|NOT COMPLETED|Treatment Period 3||1
8385845|NCT01078623|20669456|P13|NOT COMPLETED|Treatment Period 3||0
8385846|NCT01078623|20669457|P12|NOT COMPLETED|Treatment Period 3||0
8385847|NCT01078623|20669458|P11|NOT COMPLETED|Treatment Period 3||0
8385848|NCT01078623|20669459|P10|NOT COMPLETED|Treatment Period 3||0
8385849|NCT01078623|20669460|P9|NOT COMPLETED|Treatment Period 3||0
8385850|NCT01078623|20669461|P8|NOT COMPLETED|Treatment Period 3||0
8385851|NCT01078623|20669462|P7|NOT COMPLETED|Treatment Period 3||0
8385852|NCT01078623|20669463|P6|NOT COMPLETED|Treatment Period 3||0
8385853|NCT01078623|20669464|P5|NOT COMPLETED|Treatment Period 3||1
8385854|NCT01078623|20669465|P4|NOT COMPLETED|Treatment Period 3||0
8385855|NCT01078623|20669466|P3|NOT COMPLETED|Treatment Period 3||0
8385856|NCT01078623|20669467|P2|NOT COMPLETED|Treatment Period 3||0
8385857|NCT01078623|20669468|P1|NOT COMPLETED|Treatment Period 3||0
8385858|NCT01078623|20669449|P20|COMPLETED|Treatment Period 3||7
8385859|NCT01078623|20669450|P19|COMPLETED|Treatment Period 3||6
8385860|NCT01078623|20669451|P18|COMPLETED|Treatment Period 3||7
8385861|NCT01078623|20669452|P17|COMPLETED|Treatment Period 3||7
8385862|NCT01078623|20669453|P16|COMPLETED|Treatment Period 3||7
8385863|NCT01078623|20669454|P15|COMPLETED|Treatment Period 3||7
8385864|NCT01078623|20669455|P14|COMPLETED|Treatment Period 3||6
8385865|NCT01078623|20669456|P13|COMPLETED|Treatment Period 3||7
8385866|NCT01078623|20669457|P12|COMPLETED|Treatment Period 3||7
8385867|NCT01078623|20669458|P11|COMPLETED|Treatment Period 3||6
8385868|NCT01078623|20669459|P10|COMPLETED|Treatment Period 3||6
8385869|NCT01078623|20669460|P9|COMPLETED|Treatment Period 3||5
8385870|NCT01078623|20669461|P8|COMPLETED|Treatment Period 3||6
8385871|NCT01078623|20669462|P7|COMPLETED|Treatment Period 3||5
8385872|NCT01078623|20669463|P6|COMPLETED|Treatment Period 3||4
8385873|NCT01078623|20669464|P5|COMPLETED|Treatment Period 3||6
8385874|NCT01078623|20669465|P4|COMPLETED|Treatment Period 3||6
8385875|NCT01078623|20669466|P3|COMPLETED|Treatment Period 3||6
8385876|NCT01078623|20669467|P2|COMPLETED|Treatment Period 3||5
8385877|NCT01078623|20669468|P1|COMPLETED|Treatment Period 3||5
8385878|NCT01078623|20669449|P20|STARTED|Treatment Period 3||7
8385879|NCT01078623|20669450|P19|STARTED|Treatment Period 3||6
8385880|NCT01078623|20669451|P18|STARTED|Treatment Period 3||7
8385881|NCT01078623|20669452|P17|STARTED|Treatment Period 3||7
8385882|NCT01078623|20669453|P16|STARTED|Treatment Period 3||7
8385883|NCT01078623|20669454|P15|STARTED|Treatment Period 3||7
8385884|NCT01078623|20669455|P14|STARTED|Treatment Period 3||7
8385885|NCT01078623|20669456|P13|STARTED|Treatment Period 3||7
8385886|NCT01078623|20669457|P12|STARTED|Treatment Period 3||7
8385887|NCT01078623|20669458|P11|STARTED|Treatment Period 3||6
8385888|NCT01078623|20669459|P10|STARTED|Treatment Period 3||6
8385889|NCT01078623|20669460|P9|STARTED|Treatment Period 3||5
8385890|NCT01078623|20669461|P8|STARTED|Treatment Period 3||6
8385891|NCT01078623|20669462|P7|STARTED|Treatment Period 3||5
8385892|NCT01078623|20669463|P6|STARTED|Treatment Period 3||4
8385893|NCT01078623|20669464|P5|STARTED|Treatment Period 3||7
8385894|NCT01078623|20669465|P4|STARTED|Treatment Period 3||6
8385895|NCT01078623|20669466|P3|STARTED|Treatment Period 3||6
8385896|NCT01078623|20669467|P2|STARTED|Treatment Period 3||5
8385897|NCT01078623|20669468|P1|STARTED|Treatment Period 3||5
8385898|NCT01078623|20669449|P20|NOT COMPLETED|Treatment Period 2||0
8385899|NCT01078623|20669450|P19|NOT COMPLETED|Treatment Period 2||1
8385900|NCT01078623|20669451|P18|NOT COMPLETED|Treatment Period 2||0
8385901|NCT01078623|20669452|P17|NOT COMPLETED|Treatment Period 2||0
8385902|NCT01078623|20669453|P16|NOT COMPLETED|Treatment Period 2||0
8385903|NCT01078623|20669454|P15|NOT COMPLETED|Treatment Period 2||0
8385904|NCT01078623|20669455|P14|NOT COMPLETED|Treatment Period 2||0
8385905|NCT01078623|20669456|P13|NOT COMPLETED|Treatment Period 2||0
8385906|NCT01078623|20669457|P12|NOT COMPLETED|Treatment Period 2||0
8385907|NCT01078623|20669458|P11|NOT COMPLETED|Treatment Period 2||0
8385908|NCT01078623|20669459|P10|NOT COMPLETED|Treatment Period 2||0
8385909|NCT01078623|20669460|P9|NOT COMPLETED|Treatment Period 2||0
8385910|NCT01078623|20669461|P8|NOT COMPLETED|Treatment Period 2||0
8385911|NCT01078623|20669462|P7|NOT COMPLETED|Treatment Period 2||1
8385912|NCT01078623|20669463|P6|NOT COMPLETED|Treatment Period 2||1
8385913|NCT01078623|20669464|P5|NOT COMPLETED|Treatment Period 2||0
8385914|NCT01078623|20669465|P4|NOT COMPLETED|Treatment Period 2||0
8385915|NCT01078623|20669466|P3|NOT COMPLETED|Treatment Period 2||0
8385916|NCT01078623|20669467|P2|NOT COMPLETED|Treatment Period 2||0
8385917|NCT01078623|20669468|P1|NOT COMPLETED|Treatment Period 2||0
8385918|NCT01078623|20669449|P20|COMPLETED|Treatment Period 2||7
8385919|NCT01078623|20669450|P19|COMPLETED|Treatment Period 2||6
8385920|NCT01078623|20669451|P18|COMPLETED|Treatment Period 2||7
8385921|NCT01078623|20669452|P17|COMPLETED|Treatment Period 2||7
8385922|NCT01078623|20669453|P16|COMPLETED|Treatment Period 2||7
8385923|NCT01078623|20669454|P15|COMPLETED|Treatment Period 2||7
8385924|NCT01078623|20669455|P14|COMPLETED|Treatment Period 2||7
8385925|NCT01078623|20669456|P13|COMPLETED|Treatment Period 2||7
8385926|NCT01078623|20669457|P12|COMPLETED|Treatment Period 2||7
8385927|NCT01078623|20669458|P11|COMPLETED|Treatment Period 2||6
8385928|NCT01078623|20669459|P10|COMPLETED|Treatment Period 2||6
8385929|NCT01078623|20669460|P9|COMPLETED|Treatment Period 2||5
8385930|NCT01078623|20669461|P8|COMPLETED|Treatment Period 2||6
8385931|NCT01078623|20669462|P7|COMPLETED|Treatment Period 2||5
8385932|NCT01078623|20669463|P6|COMPLETED|Treatment Period 2||4
8385933|NCT01078623|20669464|P5|COMPLETED|Treatment Period 2||7
8385934|NCT01078623|20669465|P4|COMPLETED|Treatment Period 2||6
8385935|NCT01078623|20669466|P3|COMPLETED|Treatment Period 2||6
8385936|NCT01078623|20669467|P2|COMPLETED|Treatment Period 2||5
8385937|NCT01078623|20669468|P1|COMPLETED|Treatment Period 2||5
8385938|NCT01078623|20669449|P20|STARTED|Treatment Period 2||7
8385939|NCT01078623|20669450|P19|STARTED|Treatment Period 2||7
8385940|NCT01078623|20669451|P18|STARTED|Treatment Period 2||7
8385941|NCT01078623|20669452|P17|STARTED|Treatment Period 2||7
8385942|NCT01078623|20669453|P16|STARTED|Treatment Period 2||7
8385943|NCT01078623|20669454|P15|STARTED|Treatment Period 2||7
8385944|NCT01078623|20669455|P14|STARTED|Treatment Period 2||7
8385945|NCT01078623|20669456|P13|STARTED|Treatment Period 2||7
8385946|NCT01078623|20669457|P12|STARTED|Treatment Period 2||7
8385947|NCT01078623|20669458|P11|STARTED|Treatment Period 2||6
8385948|NCT01078623|20669459|P10|STARTED|Treatment Period 2||6
8385949|NCT01078623|20669460|P9|STARTED|Treatment Period 2||5
8385950|NCT01078623|20669461|P8|STARTED|Treatment Period 2||6
8385951|NCT01078623|20669462|P7|STARTED|Treatment Period 2||6
8385952|NCT01078623|20669463|P6|STARTED|Treatment Period 2||5
8385953|NCT01078623|20669464|P5|STARTED|Treatment Period 2||7
8385954|NCT01078623|20669465|P4|STARTED|Treatment Period 2||6
8385955|NCT01078623|20669466|P3|STARTED|Treatment Period 2||6
8385956|NCT01078623|20669467|P2|STARTED|Treatment Period 2||5
8385957|NCT01078623|20669468|P1|STARTED|Treatment Period 2||5
8385958|NCT01078623|20669449|P20|NOT COMPLETED|Treatment Period 1||0
8385959|NCT01078623|20669450|P19|NOT COMPLETED|Treatment Period 1||0
8385960|NCT01078623|20669451|P18|NOT COMPLETED|Treatment Period 1||0
8385961|NCT01078623|20669452|P17|NOT COMPLETED|Treatment Period 1||0
8385962|NCT01078623|20669453|P16|NOT COMPLETED|Treatment Period 1||0
8385963|NCT01078623|20669454|P15|NOT COMPLETED|Treatment Period 1||0
8385964|NCT01078623|20669455|P14|NOT COMPLETED|Treatment Period 1||0
8385965|NCT01078623|20669456|P13|NOT COMPLETED|Treatment Period 1||0
8385966|NCT01078623|20669457|P12|NOT COMPLETED|Treatment Period 1||0
8385967|NCT01078623|20669458|P11|NOT COMPLETED|Treatment Period 1||1
8385968|NCT01078623|20669459|P10|NOT COMPLETED|Treatment Period 1||1
8385969|NCT01078623|20669460|P9|NOT COMPLETED|Treatment Period 1||1
8385970|NCT01078623|20669461|P8|NOT COMPLETED|Treatment Period 1||1
8385971|NCT01078623|20669462|P7|NOT COMPLETED|Treatment Period 1||1
8385972|NCT01078623|20669463|P6|NOT COMPLETED|Treatment Period 1||1
8385973|NCT01078623|20669464|P5|NOT COMPLETED|Treatment Period 1||0
8385974|NCT01078623|20669465|P4|NOT COMPLETED|Treatment Period 1||0
8385975|NCT01078623|20669466|P3|NOT COMPLETED|Treatment Period 1||1
8385976|NCT01078623|20669467|P2|NOT COMPLETED|Treatment Period 1||1
8385977|NCT01078623|20669468|P1|NOT COMPLETED|Treatment Period 1||1
8385978|NCT01078623|20669449|P20|COMPLETED|Treatment Period 1||7
8385979|NCT01078623|20669450|P19|COMPLETED|Treatment Period 1||7
8385980|NCT01078623|20669451|P18|COMPLETED|Treatment Period 1||7
8385981|NCT01078623|20669452|P17|COMPLETED|Treatment Period 1||7
8385982|NCT01078623|20669453|P16|COMPLETED|Treatment Period 1||7
8385983|NCT01078623|20669454|P15|COMPLETED|Treatment Period 1||7
8385984|NCT01078623|20669455|P14|COMPLETED|Treatment Period 1||7
8385985|NCT01078623|20669456|P13|COMPLETED|Treatment Period 1||7
8385986|NCT01078623|20669457|P12|COMPLETED|Treatment Period 1||7
8385987|NCT01078623|20669458|P11|COMPLETED|Treatment Period 1||6
8385988|NCT01078623|20669459|P10|COMPLETED|Treatment Period 1||6
8385989|NCT01078623|20669460|P9|COMPLETED|Treatment Period 1||5
8385990|NCT01078623|20669461|P8|COMPLETED|Treatment Period 1||6
8385991|NCT01078623|20669462|P7|COMPLETED|Treatment Period 1||6
8385992|NCT01078623|20669463|P6|COMPLETED|Treatment Period 1||5
8385993|NCT01078623|20669464|P5|COMPLETED|Treatment Period 1||7
8385994|NCT01078623|20669465|P4|COMPLETED|Treatment Period 1||6
8385995|NCT01078623|20669466|P3|COMPLETED|Treatment Period 1||6
8385996|NCT01078623|20669467|P2|COMPLETED|Treatment Period 1||5
8385997|NCT01078623|20669468|P1|COMPLETED|Treatment Period 1||5
8385998|NCT01078623|20669449|P20|STARTED|Treatment Period 1||7
8385999|NCT01078623|20669450|P19|STARTED|Treatment Period 1||7
8386000|NCT01078623|20669451|P18|STARTED|Treatment Period 1||7
8386001|NCT01078623|20669452|P17|STARTED|Treatment Period 1||7
8386002|NCT01078623|20669453|P16|STARTED|Treatment Period 1||7
8386003|NCT01078623|20669454|P15|STARTED|Treatment Period 1||7
8386004|NCT01078623|20669455|P14|STARTED|Treatment Period 1||7
8386005|NCT01078623|20669456|P13|STARTED|Treatment Period 1||7
8386006|NCT01078623|20669457|P12|STARTED|Treatment Period 1||7
8386007|NCT01078623|20669458|P11|STARTED|Treatment Period 1||7
8386008|NCT01078623|20669459|P10|STARTED|Treatment Period 1||7
8386009|NCT01078623|20669460|P9|STARTED|Treatment Period 1||6
8386010|NCT01078623|20669461|P8|STARTED|Treatment Period 1||7
8386011|NCT01078623|20669462|P7|STARTED|Treatment Period 1||7
8386012|NCT01078623|20669463|P6|STARTED|Treatment Period 1||6
8386013|NCT01078623|20669464|P5|STARTED|Treatment Period 1||7
8386014|NCT01078623|20669465|P4|STARTED|Treatment Period 1||6
8386015|NCT01078623|20669466|P3|STARTED|Treatment Period 1||7
8386016|NCT01078623|20669467|P2|STARTED|Treatment Period 1||6
8386017|NCT01078623|20669468|P1|STARTED|Treatment Period 1||6
8386018|NCT01078584|20669490|P1|NOT COMPLETED|Overall Study||3010
8386019|NCT01078584|20669490|P1|COMPLETED|Overall Study||4983
8386020|NCT01078584|20669490|P1|Participants Conducted Visit 4(12-month)|Overall Study||4983
8386021|NCT01078584|20669490|P1|Participants Conducted Visit 3 (6-month)|Overall Study||5833
8386022|NCT01078584|20669490|P1|Participants Conducted Visit 2 (3-month)|Overall Study||7125
8386023|NCT01078584|20669490|P1|STARTED|Overall Study||7993
8386024|NCT01078571|20669571|P1|NOT COMPLETED|Overall Study||115
8386025|NCT01078571|20669571|P1|COMPLETED|Overall Study||590
8386026|NCT01078571|20669571|P1|Intent-to-treat (ITT) Population|Overall Study||591
8386027|NCT01078571|20669571|P1|Safety Population|Overall Study||675
8386028|NCT01078571|20669571|P1|STARTED|Overall Study||705
8386029|NCT01078558|20669590|P3|NOT COMPLETED|Overall Study||1361
8386030|NCT01078558|20669591|P2|NOT COMPLETED|Overall Study||755
8386031|NCT01078558|20669592|P1|NOT COMPLETED|Overall Study||2018
8386032|NCT01078558|20669590|P3|COMPLETED|Overall Study||596
8386033|NCT01078558|20669591|P2|COMPLETED|Overall Study||372
8386034|NCT01078558|20669592|P1|COMPLETED|Overall Study||818
8386035|NCT01078558|20669590|P3|Oligoarticular PsA|Overall Study||0
8386036|NCT01078558|20669591|P2|Oligoarticular PsA|Overall Study||197
8386037|NCT01078558|20669592|P1|Oligoarticular PsA|Overall Study||0
8386038|NCT01078558|20669590|P3|STARTED|Overall Study||1957
8386039|NCT01078558|20669591|P2|STARTED|Overall Study||1127
8386040|NCT01078558|20669592|P1|STARTED|Overall Study||2836
8386041|NCT01078545|20669622|P1|NOT COMPLETED|Overall Study||26
8386042|NCT01078545|20669622|P1|COMPLETED|Overall Study||703
8386043|NCT01078545|20669622|P1|Per Protocol Population|Overall Study||661
8386044|NCT01078545|20669622|P1|Intent-to-treat Population|Overall Study||729
8386045|NCT01078545|20669622|P1|STARTED|Overall Study||729
8386046|NCT01078454|20669632|P2|NOT COMPLETED|Overall Study||2
8386047|NCT01078454|20669633|P1|NOT COMPLETED|Overall Study||1
8386048|NCT01078454|20669632|P2|COMPLETED|Overall Study||3
8386049|NCT01078454|20669633|P1|COMPLETED|Overall Study||5
8386050|NCT01078454|20669632|P2|STARTED|Overall Study||5
8386051|NCT01078454|20669633|P1|STARTED|Overall Study||6
8386052|NCT01078441|20669639|P1|NOT COMPLETED|Overall Study||1
8386053|NCT01078441|20669639|P1|COMPLETED|Overall Study||1
8386054|NCT01078441|20669639|P1|STARTED|Overall Study||2
8386055|NCT01078402|20669646|P3|NOT COMPLETED|Overall Study||68
8386056|NCT01078402|20669647|P2|NOT COMPLETED|Overall Study||29
8386057|NCT01078402|20669648|P1|NOT COMPLETED|Overall Study||107
8386058|NCT01078402|20669646|P3|COMPLETED|Overall Study||166
8386059|NCT01078402|20669647|P2|COMPLETED|Overall Study||95
8386060|NCT01078402|20669648|P1|COMPLETED|Overall Study||324
8386061|NCT01078402|20669646|P3|STARTED|Overall Study||234
8386062|NCT01078402|20669647|P2|STARTED|Overall Study||124
8386063|NCT01078402|20669648|P1|STARTED|Overall Study||431
8386064|NCT01078389|20669679|P2|NOT COMPLETED|Overall Study||67
8386065|NCT01078389|20669680|P1|NOT COMPLETED|Overall Study||64
8386066|NCT01078389|20669679|P2|COMPLETED|Overall Study||90
8386067|NCT01078389|20669680|P1|COMPLETED|Overall Study||93
8386068|NCT01078389|20669679|P2|STARTED|Overall Study||157
8386069|NCT01078389|20669680|P1|STARTED|Overall Study||157
8386070|NCT01078376|20669698|P4|NOT COMPLETED|Overall Study||0
8386071|NCT01078376|20669699|P3|NOT COMPLETED|Overall Study||0
8386072|NCT01078376|20669700|P2|NOT COMPLETED|Overall Study||0
8386073|NCT01078376|20669701|P1|NOT COMPLETED|Overall Study||0
8386074|NCT01078376|20669698|P4|COMPLETED|Overall Study||3
8386075|NCT01078376|20669699|P3|COMPLETED|Overall Study||8
8386076|NCT01078376|20669700|P2|COMPLETED|Overall Study||9
8386077|NCT01078376|20669701|P1|COMPLETED|Overall Study||9
8386078|NCT01078376|20669698|P4|STARTED|Overall Study||3
8386079|NCT01078376|20669699|P3|STARTED|Overall Study||8
8386080|NCT01078376|20669700|P2|STARTED|Overall Study||9
8386081|NCT01078376|20669701|P1|STARTED|Overall Study||9
8386082|NCT01078363|20669822|P2|NOT COMPLETED|Overall Study||0
8386083|NCT01078363|20669823|P1|NOT COMPLETED|Overall Study||0
8386084|NCT01078363|20669822|P2|COMPLETED|Overall Study||49
8386085|NCT01078363|20669823|P1|COMPLETED|Overall Study||47
8386086|NCT01078363|20669822|P2|STARTED|Overall Study||49
8386087|NCT01078363|20669823|P1|STARTED|Overall Study||47
8386088|NCT01078298|20669841|P2|NOT COMPLETED|Overall Study||90
8386089|NCT01078298|20669842|P1|NOT COMPLETED|Overall Study||81
8386090|NCT01078298|20669841|P2|COMPLETED|Overall Study||179
8386091|NCT01078298|20669842|P1|COMPLETED|Overall Study||175
8386092|NCT01078298|20669841|P2|STARTED|Overall Study||269
8386093|NCT01078298|20669842|P1|STARTED|Overall Study||256
8386094|NCT01078246|20669875|P7|NOT COMPLETED|Overall Study||0
8386095|NCT01078246|20669876|P6|NOT COMPLETED|Overall Study||0
8386096|NCT01078246|20669877|P5|NOT COMPLETED|Overall Study||0
8386097|NCT01078246|20669878|P4|NOT COMPLETED|Overall Study||0
8386098|NCT01078246|20669879|P3|NOT COMPLETED|Overall Study||0
8386099|NCT01078246|20669880|P2|NOT COMPLETED|Overall Study||0
8386100|NCT01078246|20669881|P1|NOT COMPLETED|Overall Study||0
8386101|NCT01078246|20669875|P7|COMPLETED|Overall Study||22
8386102|NCT01078246|20669876|P6|COMPLETED|Overall Study||231
8386103|NCT01078246|20669877|P5|COMPLETED|Overall Study||3310
8386104|NCT01078246|20669878|P4|COMPLETED|Overall Study||152
8386105|NCT01078246|20669879|P3|COMPLETED|Overall Study||1963
8386106|NCT01078246|20669880|P2|COMPLETED|Overall Study||405
8386107|NCT01078246|20669881|P1|COMPLETED|Overall Study||1041
8386108|NCT01078246|20669875|P7|STARTED|Overall Study||22
8386109|NCT01078246|20669876|P6|STARTED|Overall Study||231
8386110|NCT01078246|20669877|P5|STARTED|Overall Study||3310
8386111|NCT01078246|20669878|P4|STARTED|Overall Study||152
8386112|NCT01078246|20669879|P3|STARTED|Overall Study||1963
8386113|NCT01078246|20669880|P2|STARTED|Overall Study||405
8386114|NCT01078246|20669881|P1|STARTED|Overall Study||1041
8386115|NCT01078233|20669913|P6|NOT COMPLETED|Overall Study||0
8386116|NCT01078233|20669914|P5|NOT COMPLETED|Overall Study||0
8386117|NCT01078233|20669915|P4|NOT COMPLETED|Overall Study||0
8386118|NCT01078233|20669916|P3|NOT COMPLETED|Overall Study||0
8386119|NCT01078233|20669917|P2|NOT COMPLETED|Overall Study||0
8386120|NCT01078233|20669918|P1|NOT COMPLETED|Overall Study||0
8386121|NCT01078233|20669913|P6|COMPLETED|Overall Study||154
8386122|NCT01078233|20669914|P5|COMPLETED|Overall Study||3199
8386123|NCT01078233|20669915|P4|COMPLETED|Overall Study||631
8386124|NCT01078233|20669916|P3|COMPLETED|Overall Study||1681
8386125|NCT01078233|20669917|P2|COMPLETED|Overall Study||296
8386126|NCT01078233|20669918|P1|COMPLETED|Overall Study||656
8386127|NCT01078233|20669913|P6|STARTED|Overall Study||154
8386128|NCT01078233|20669914|P5|STARTED|Overall Study||3199
8386129|NCT01078233|20669915|P4|STARTED|Overall Study||631
8386130|NCT01078233|20669916|P3|STARTED|Overall Study||1681
8386131|NCT01078233|20669917|P2|STARTED|Overall Study||296
8386132|NCT01078233|20669918|P1|STARTED|Overall Study||656
8386133|NCT01078220|20669935|P1|NOT COMPLETED|Overall Study||0
8386134|NCT01078220|20669935|P1|COMPLETED|Overall Study||189629
8386135|NCT01078220|20669935|P1|STARTED|Overall Study||189629
8386136|NCT01078207|20669945|P1|NOT COMPLETED|Overall Study||0
8386137|NCT01078207|20669945|P1|COMPLETED|Overall Study||100
8386138|NCT01078207|20669945|P1|STARTED|Overall Study||100
8386139|NCT01078168|20669952|P2|NOT COMPLETED|Overall Study||1
8386140|NCT01078168|20669953|P1|NOT COMPLETED|Overall Study||0
8386141|NCT01078168|20669952|P2|COMPLETED|Overall Study||10
8386142|NCT01078168|20669953|P1|COMPLETED|Overall Study||11
8386143|NCT01078168|20669952|P2|STARTED|Overall Study||11
8386144|NCT01078168|20669953|P1|STARTED|Overall Study||11
8386145|NCT01078155|20669959|P1|NOT COMPLETED|Overall Study||44
8386146|NCT01078155|20669959|P1|COMPLETED|Overall Study||87
8386147|NCT01078155|20669959|P1|STARTED|Overall Study||131
8386148|NCT01078116|20669975|P1|NOT COMPLETED|Overall Study||48
8386149|NCT01078116|20669975|P1|COMPLETED|Overall Study||76
8386150|NCT01078116|20669975|P1|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
8386151|NCT01078090|20669983|P1|NOT COMPLETED|Overall Study||4593
8386152|NCT01078090|20669983|P1|COMPLETED|Overall Study||1152
8386153|NCT01078090|20669983|P1|STARTED|Overall Study||5745
8386154|NCT01077973|20670027|P3|NOT COMPLETED|Overall Study||0
8386155|NCT01077973|20670028|P2|NOT COMPLETED|Overall Study||0
8386156|NCT01077973|20670029|P1|NOT COMPLETED|Overall Study||0
8386157|NCT01077973|20670027|P3|COMPLETED|Overall Study||80
8386158|NCT01077973|20670028|P2|COMPLETED|Overall Study||79
8386159|NCT01077973|20670029|P1|COMPLETED|Overall Study||41
8386160|NCT01077973|20670027|P3|STARTED|Overall Study||80
8386161|NCT01077973|20670028|P2|STARTED|Overall Study||79
8386162|NCT01077973|20670029|P1|STARTED|Overall Study||41
8386163|NCT01077960|20670077|P1|NOT COMPLETED|Overall Study||16
8386164|NCT01077960|20670077|P1|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
8386165|NCT01077960|20670077|P1|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
8386166|NCT01077921|20670088|P2|NOT COMPLETED|Second Intervention||1
8386167|NCT01077921|20670089|P1|NOT COMPLETED|Second Intervention||0
8386168|NCT01077921|20670088|P2|COMPLETED|Second Intervention||9
8386169|NCT01077921|20670089|P1|COMPLETED|Second Intervention||13
8386170|NCT01077921|20670088|P2|STARTED|Second Intervention||10
8386171|NCT01077921|20670089|P1|STARTED|Second Intervention||13
8386172|NCT01077921|20670088|P2|NOT COMPLETED|Washout||2
8386173|NCT01077921|20670089|P1|NOT COMPLETED|Washout||0
8386174|NCT01077921|20670088|P2|COMPLETED|Washout||10
8386175|NCT01077921|20670089|P1|COMPLETED|Washout||13
8386176|NCT01077921|20670088|P2|STARTED|Washout||12
8386177|NCT01077921|20670089|P1|STARTED|Washout||13
8386178|NCT01077921|20670088|P2|NOT COMPLETED|First Intervention||1
8386179|NCT01077921|20670089|P1|NOT COMPLETED|First Intervention||1
8386180|NCT01077921|20670088|P2|COMPLETED|First Intervention||12
8386181|NCT01077921|20670089|P1|COMPLETED|First Intervention||13
8386182|NCT01077921|20670088|P2|STARTED|First Intervention||13
8386183|NCT01077921|20670089|P1|STARTED|First Intervention||14
8386184|NCT01077856|20670122|P3|NOT COMPLETED|Overall Study||0
8386185|NCT01077856|20670123|P2|NOT COMPLETED|Overall Study||0
8386186|NCT01077856|20670124|P1|NOT COMPLETED|Overall Study||0
8386187|NCT01077856|20670122|P3|COMPLETED|Overall Study||15713
8386188|NCT01077856|20670123|P2|COMPLETED|Overall Study||16604
8386189|NCT01077856|20670124|P1|COMPLETED|Overall Study||22199
8386190|NCT01077856|20670122|P3|STARTED|Overall Study||15713
8386191|NCT01077856|20670123|P2|STARTED|Overall Study||16604
8386192|NCT01077856|20670124|P1|STARTED|Overall Study||22199
8386193|NCT01077830|20670305|P2|NOT COMPLETED|Overall Study||0
8386194|NCT01077830|20670306|P1|NOT COMPLETED|Overall Study||0
8386195|NCT01077830|20670305|P2|COMPLETED|Overall Study||682
8386196|NCT01077830|20670306|P1|COMPLETED|Overall Study||677
8386197|NCT01077830|20670305|P2|STARTED|Overall Study||682
8386198|NCT01077830|20670306|P1|STARTED|Overall Study||677
8386199|NCT01077817|20670316|P1|NOT COMPLETED|Overall Study||0
8386200|NCT01077817|20670316|P1|COMPLETED|Overall Study||684815
8386201|NCT01077817|20670316|P1|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
8386202|NCT01077804|20670327|P1|NOT COMPLETED|Overall Study||199
8386203|NCT01077804|20670327|P1|COMPLETED|Overall Study||7386
8386204|NCT01077804|20670327|P1|STARTED|Overall Study||7585
8386205|NCT01077739|20670336|P2|NOT COMPLETED|Overall Study||10
8386206|NCT01077739|20670337|P1|NOT COMPLETED|Overall Study||5
8386207|NCT01077739|20670336|P2|COMPLETED|Overall Study||40
8386208|NCT01077739|20670337|P1|COMPLETED|Overall Study||20
8386209|NCT01077739|20670336|P2|STARTED|Overall Study||50
8386210|NCT01077739|20670337|P1|STARTED|Overall Study||25
8386211|NCT01077713|20670351|P2|NOT COMPLETED|Overall Study||36
8386212|NCT01077713|20670352|P1|NOT COMPLETED|Overall Study||36
8386213|NCT01077713|20670351|P2|COMPLETED|Overall Study||6
8386214|NCT01077713|20670352|P1|COMPLETED|Overall Study||8
8386215|NCT01077713|20670351|P2|STARTED|Overall Study||42
8386216|NCT01077713|20670352|P1|STARTED|Overall Study||44
8386217|NCT01077622|20670376|P1|NOT COMPLETED|Overall Study||3
8386218|NCT01077622|20670376|P1|COMPLETED|Overall Study||7
8386219|NCT01077622|20670376|P1|STARTED|Overall Study||10
8386220|NCT01077596|20670434|P12|NOT COMPLETED|Overall Study||0
8386221|NCT01077596|20670435|P11|NOT COMPLETED|Overall Study||0
8386222|NCT01077596|20670436|P10|NOT COMPLETED|Overall Study||0
8386223|NCT01077596|20670437|P9|NOT COMPLETED|Overall Study||0
8386224|NCT01077596|20670438|P8|NOT COMPLETED|Overall Study||0
8386225|NCT01077596|20670439|P7|NOT COMPLETED|Overall Study||0
8386226|NCT01077596|20670440|P6|NOT COMPLETED|Overall Study||0
8386227|NCT01077596|20670441|P5|NOT COMPLETED|Overall Study||0
8386228|NCT01077596|20670442|P4|NOT COMPLETED|Overall Study||0
8386229|NCT01077596|20670443|P3|NOT COMPLETED|Overall Study||0
8386230|NCT01077596|20670444|P2|NOT COMPLETED|Overall Study||0
8386231|NCT01077596|20670445|P1|NOT COMPLETED|Overall Study||0
8386232|NCT01077596|20670434|P12|COMPLETED|Overall Study||22150
8386233|NCT01077596|20670435|P11|COMPLETED|Overall Study||2215
8386234|NCT01077596|20670436|P10|COMPLETED|Overall Study||28420
8386235|NCT01077596|20670437|P9|COMPLETED|Overall Study||2842
8386236|NCT01077596|20670438|P8|COMPLETED|Overall Study||837
8386237|NCT01077596|20670439|P7|COMPLETED|Overall Study||308
8386238|NCT01077596|20670440|P6|COMPLETED|Overall Study||882
8386239|NCT01077596|20670441|P5|COMPLETED|Overall Study||294
8386240|NCT01077596|20670442|P4|COMPLETED|Overall Study||1370
8386241|NCT01077596|20670443|P3|COMPLETED|Overall Study||457
8386242|NCT01077596|20670444|P2|COMPLETED|Overall Study||1050
8386243|NCT01077596|20670445|P1|COMPLETED|Overall Study||350
8386244|NCT01077596|20670434|P12|STARTED|Overall Study||22150
8386245|NCT01077596|20670435|P11|STARTED|Overall Study||2215
8386246|NCT01077596|20670436|P10|STARTED|Overall Study||28420
8386247|NCT01077596|20670437|P9|STARTED|Overall Study||2842
8386248|NCT01077596|20670438|P8|STARTED|Overall Study||837
8386249|NCT01077596|20670439|P7|STARTED|Overall Study||308
8386250|NCT01077596|20670440|P6|STARTED|Overall Study||882
8386251|NCT01077596|20670441|P5|STARTED|Overall Study||294
8386252|NCT01077596|20670442|P4|STARTED|Overall Study||1370
8386253|NCT01077596|20670443|P3|STARTED|Overall Study||457
8386254|NCT01077596|20670444|P2|STARTED|Overall Study||1050
8386255|NCT01077596|20670445|P1|STARTED|Overall Study||350
8386256|NCT01077544|20670496|P2|NOT COMPLETED|Overall Study||5
8386257|NCT01077544|20670497|P1|NOT COMPLETED|Overall Study||3
8386258|NCT01077544|20670496|P2|COMPLETED|Overall Study||2
8386259|NCT01077544|20670497|P1|COMPLETED|Overall Study||5
8386260|NCT01077544|20670496|P2|STARTED|Overall Study||7
8386261|NCT01077544|20670497|P1|STARTED|Overall Study||8
8386262|NCT01077518|20670525|P3|NOT COMPLETED|Optional Ofa Phase||16
8386263|NCT01077518|20670526|P2|NOT COMPLETED|Optional Ofa Phase||0
8386264|NCT01077518|20670527|P1|NOT COMPLETED|Optional Ofa Phase||0
8386265|NCT01077518|20670525|P3|COMPLETED|Optional Ofa Phase||16
8386266|NCT01077518|20670526|P2|COMPLETED|Optional Ofa Phase||0
8386267|NCT01077518|20670527|P1|COMPLETED|Optional Ofa Phase||0
8386268|NCT01077518|20670525|P3|Completed 5-year Follow-up|Optional Ofa Phase||12
8386269|NCT01077518|20670526|P2|Completed 5-year Follow-up|Optional Ofa Phase||0
8386270|NCT01077518|20670527|P1|Completed 5-year Follow-up|Optional Ofa Phase||0
8386271|NCT01077518|20670525|P3|STARTED|Optional Ofa Phase||32
8386272|NCT01077518|20670526|P2|STARTED|Optional Ofa Phase||0
8386273|NCT01077518|20670527|P1|STARTED|Optional Ofa Phase||0
8386274|NCT01077518|20670525|P3|NOT COMPLETED|Treatment Phase - no Optional Ofa||0
8386275|NCT01077518|20670526|P2|NOT COMPLETED|Treatment Phase - no Optional Ofa||65
8386276|NCT01077518|20670527|P1|NOT COMPLETED|Treatment Phase - no Optional Ofa||78
8386277|NCT01077518|20670525|P3|COMPLETED|Treatment Phase - no Optional Ofa||0
8386278|NCT01077518|20670526|P2|COMPLETED|Treatment Phase - no Optional Ofa||108
8386279|NCT01077518|20670527|P1|COMPLETED|Treatment Phase - no Optional Ofa||95
8386280|NCT01077518|20670525|P3|Safety Population|Treatment Phase - no Optional Ofa||0
8386281|NCT01077518|20670526|P2|Safety Population|Treatment Phase - no Optional Ofa||170
8386282|NCT01077518|20670527|P1|Safety Population|Treatment Phase - no Optional Ofa||172
8386283|NCT01077518|20670525|P3|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||0
8386284|NCT01077518|20670526|P2|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
8386285|NCT01077518|20670527|P1|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
8386286|NCT01077518|20670525|P3|STARTED|Treatment Phase - no Optional Ofa||0
8386287|NCT01077518|20670526|P2|STARTED|Treatment Phase - no Optional Ofa||173
8386288|NCT01077518|20670527|P1|STARTED|Treatment Phase - no Optional Ofa||173
8386289|NCT01077401|20670587|P2|NOT COMPLETED|Overall Study||21
8386290|NCT01077401|20670588|P1|NOT COMPLETED|Overall Study||18
8386291|NCT01077401|20670587|P2|COMPLETED|Overall Study||54
8386292|NCT01077401|20670588|P1|COMPLETED|Overall Study||59
8386293|NCT01077401|20670587|P2|STARTED|Overall Study||75
8386294|NCT01077401|20670588|P1|STARTED|Overall Study||77
8386295|NCT01077375|20670600|P2|NOT COMPLETED|Overall Study||35
8386296|NCT01077375|20670601|P1|NOT COMPLETED|Overall Study||10
8386297|NCT01077375|20670600|P2|COMPLETED|Overall Study||51
8386298|NCT01077375|20670601|P1|COMPLETED|Overall Study||11
8386299|NCT01077375|20670600|P2|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
8386300|NCT01077375|20670601|P1|STARTED|Overall Study||21
8386301|NCT01077362|20670612|P3|NOT COMPLETED|Overall Study||24
8386302|NCT01077362|20670613|P2|NOT COMPLETED|Overall Study||19
8386303|NCT01077362|20670614|P1|NOT COMPLETED|Overall Study||31
8386304|NCT01077362|20670612|P3|COMPLETED|Overall Study||81
8386305|NCT01077362|20670613|P2|COMPLETED|Overall Study||84
8386306|NCT01077362|20670614|P1|COMPLETED|Overall Study||73
8386307|NCT01077362|20670612|P3|STARTED|Overall Study||105
8386308|NCT01077362|20670613|P2|STARTED|Overall Study||103
8386309|NCT01077362|20670614|P1|STARTED|Overall Study||104
8386310|NCT01077323|20670650|P3|NOT COMPLETED|Overall Study||11912089
8386311|NCT01077323|20670651|P2|NOT COMPLETED|Overall Study||386263
8386312|NCT01077323|20670652|P1|NOT COMPLETED|Overall Study||11378
8386313|NCT01077323|20670650|P3|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
8386314|NCT01077323|20670651|P2|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
8386315|NCT01077323|20670652|P1|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
8386316|NCT01077323|20670650|P3|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
8386317|NCT01077323|20670651|P2|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
8386318|NCT01077323|20670652|P1|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
8386319|NCT01077310|20670671|P2|NOT COMPLETED|Overall Study||0
8386320|NCT01077310|20670672|P1|NOT COMPLETED|Overall Study||0
8386321|NCT01077310|20670671|P2|COMPLETED|Overall Study||33
8386322|NCT01077310|20670672|P1|COMPLETED|Overall Study||67
8386323|NCT01077310|20670671|P2|STARTED|Overall Study||33
8386324|NCT01077310|20670672|P1|STARTED|Overall Study||67
8386325|NCT01077284|20670695|P3|NOT COMPLETED|Overall Study||3
8386326|NCT01077284|20670696|P2|NOT COMPLETED|Overall Study||5
8386327|NCT01077284|20670697|P1|NOT COMPLETED|Overall Study||5
8386328|NCT01077284|20670695|P3|COMPLETED|Overall Study||30
8386329|NCT01077284|20670696|P2|COMPLETED|Overall Study||28
8386330|NCT01077284|20670697|P1|COMPLETED|Overall Study||28
8386331|NCT01077284|20670695|P3|STARTED|Overall Study||33
8386332|NCT01077284|20670696|P2|STARTED|Overall Study||33
8386333|NCT01077284|20670697|P1|STARTED|Overall Study||33
8386334|NCT01077271|20670718|P1|NOT COMPLETED|Overall Study||22
8386335|NCT01077271|20670718|P1|COMPLETED|Overall Study||102
8386336|NCT01077271|20670718|P1|Number of Participants Analyzed|Overall Study||120
8386337|NCT01077271|20670718|P1|Participants Treated With Palivizumab|Overall Study||120
8386338|NCT01077271|20670718|P1|STARTED|Overall Study||124
8386339|NCT01077258|20670756|P1|NOT COMPLETED|Overall Study||2568
8386340|NCT01077258|20670756|P1|COMPLETED|Overall Study||1640
8386341|NCT01077258|20670756|P1|STARTED|Overall Study||4208
8386342|NCT01077193|20670792|P1|NOT COMPLETED|Overall Study||44
8386343|NCT01077193|20670792|P1|COMPLETED|Overall Study||0
8386344|NCT01077193|20670792|P1|STARTED|Overall Study||44
8386345|NCT01077154|20670798|P2|NOT COMPLETED|Overall Study||2228
8386346|NCT01077154|20670799|P1|NOT COMPLETED|Overall Study||2226
8386347|NCT01077154|20670798|P2|COMPLETED|Overall Study||28
8386348|NCT01077154|20670799|P1|COMPLETED|Overall Study||27
8386349|NCT01077154|20670798|P2|Received Study Drug|Overall Study||2230
8386350|NCT01077154|20670799|P1|Received Study Drug|Overall Study||2229
8386351|NCT01077154|20670798|P2|STARTED|Overall Study||2256
8386352|NCT01077154|20670799|P1|STARTED|Overall Study||2253
8386353|NCT01077128|20670813|P1|NOT COMPLETED|Overall Study||67
8386354|NCT01077128|20670813|P1|COMPLETED|Overall Study||433
8386355|NCT01077128|20670813|P1|STARTED|Overall Study||500
8386356|NCT01077076|20670871|P6|NOT COMPLETED|Third Intervention||1
8386357|NCT01077076|20670872|P5|NOT COMPLETED|Third Intervention||0
8386358|NCT01077076|20670873|P4|NOT COMPLETED|Third Intervention||0
8386359|NCT01077076|20670874|P3|NOT COMPLETED|Third Intervention||0
8386360|NCT01077076|20670875|P2|NOT COMPLETED|Third Intervention||0
8386361|NCT01077076|20670876|P1|NOT COMPLETED|Third Intervention||0
8386362|NCT01077076|20670871|P6|COMPLETED|Third Intervention||4
8386363|NCT01077076|20670872|P5|COMPLETED|Third Intervention||5
8386364|NCT01077076|20670873|P4|COMPLETED|Third Intervention||5
8386365|NCT01077076|20670874|P3|COMPLETED|Third Intervention||5
8386366|NCT01077076|20670875|P2|COMPLETED|Third Intervention||5
8386367|NCT01077076|20670876|P1|COMPLETED|Third Intervention||4
8386368|NCT01077076|20670871|P6|STARTED|Third Intervention||5
8386369|NCT01077076|20670872|P5|STARTED|Third Intervention||5
8386370|NCT01077076|20670873|P4|STARTED|Third Intervention||5
8386371|NCT01077076|20670874|P3|STARTED|Third Intervention||5
8386372|NCT01077076|20670875|P2|STARTED|Third Intervention||5
8386373|NCT01077076|20670876|P1|STARTED|Third Intervention||4
8386374|NCT01077076|20670871|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
8386375|NCT01077076|20670872|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
8386376|NCT01077076|20670873|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
8386377|NCT01077076|20670874|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
8386378|NCT01077076|20670875|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8386379|NCT01077076|20670876|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8386380|NCT01077076|20670871|P6|COMPLETED|Washout Period of 2 Weeks||5
8386381|NCT01077076|20670872|P5|COMPLETED|Washout Period of 2 Weeks||5
8386382|NCT01077076|20670873|P4|COMPLETED|Washout Period of 2 Weeks||5
8386383|NCT01077076|20670874|P3|COMPLETED|Washout Period of 2 Weeks||5
8386384|NCT01077076|20670875|P2|COMPLETED|Washout Period of 2 Weeks||5
8386385|NCT01077076|20670876|P1|COMPLETED|Washout Period of 2 Weeks||4
8386386|NCT01077076|20670871|P6|STARTED|Washout Period of 2 Weeks||5
8386387|NCT01077076|20670872|P5|STARTED|Washout Period of 2 Weeks||5
8386388|NCT01077076|20670873|P4|STARTED|Washout Period of 2 Weeks||5
8386389|NCT01077076|20670874|P3|STARTED|Washout Period of 2 Weeks||5
8386390|NCT01077076|20670875|P2|STARTED|Washout Period of 2 Weeks||5
8386391|NCT01077076|20670876|P1|STARTED|Washout Period of 2 Weeks||4
8386392|NCT01077076|20670871|P6|NOT COMPLETED|Second Intervention||0
8386393|NCT01077076|20670872|P5|NOT COMPLETED|Second Intervention||0
8386394|NCT01077076|20670873|P4|NOT COMPLETED|Second Intervention||0
8386395|NCT01077076|20670874|P3|NOT COMPLETED|Second Intervention||0
8386396|NCT01077076|20670875|P2|NOT COMPLETED|Second Intervention||0
8386397|NCT01077076|20670876|P1|NOT COMPLETED|Second Intervention||0
8386398|NCT01077076|20670871|P6|COMPLETED|Second Intervention||5
8386399|NCT01077076|20670872|P5|COMPLETED|Second Intervention||5
8386400|NCT01077076|20670873|P4|COMPLETED|Second Intervention||5
8386401|NCT01077076|20670874|P3|COMPLETED|Second Intervention||5
8386402|NCT01077076|20670875|P2|COMPLETED|Second Intervention||5
8386403|NCT01077076|20670876|P1|COMPLETED|Second Intervention||4
8386404|NCT01077076|20670871|P6|STARTED|Second Intervention||5
8386405|NCT01077076|20670872|P5|STARTED|Second Intervention||5
8386406|NCT01077076|20670873|P4|STARTED|Second Intervention||5
8386407|NCT01077076|20670874|P3|STARTED|Second Intervention||5
8386408|NCT01077076|20670875|P2|STARTED|Second Intervention||5
8386409|NCT01077076|20670876|P1|STARTED|Second Intervention||4
8386410|NCT01077076|20670871|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
8386411|NCT01077076|20670872|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
8386412|NCT01077076|20670873|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
8386413|NCT01077076|20670874|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
8386414|NCT01077076|20670875|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8386415|NCT01077076|20670876|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8386416|NCT01077076|20670871|P6|COMPLETED|Washout Period of 2 Weeks||5
8386417|NCT01077076|20670872|P5|COMPLETED|Washout Period of 2 Weeks||5
8386418|NCT01077076|20670873|P4|COMPLETED|Washout Period of 2 Weeks||5
8386419|NCT01077076|20670874|P3|COMPLETED|Washout Period of 2 Weeks||5
8386420|NCT01077076|20670875|P2|COMPLETED|Washout Period of 2 Weeks||5
8386421|NCT01077076|20670876|P1|COMPLETED|Washout Period of 2 Weeks||4
8386422|NCT01077076|20670871|P6|STARTED|Washout Period of 2 Weeks||5
8386423|NCT01077076|20670872|P5|STARTED|Washout Period of 2 Weeks||5
8386424|NCT01077076|20670873|P4|STARTED|Washout Period of 2 Weeks||5
8386425|NCT01077076|20670874|P3|STARTED|Washout Period of 2 Weeks||5
8386426|NCT01077076|20670875|P2|STARTED|Washout Period of 2 Weeks||5
8386427|NCT01077076|20670876|P1|STARTED|Washout Period of 2 Weeks||4
8386428|NCT01077076|20670871|P6|NOT COMPLETED|First Intervention||0
8386429|NCT01077076|20670872|P5|NOT COMPLETED|First Intervention||0
8386430|NCT01077076|20670873|P4|NOT COMPLETED|First Intervention||0
8386431|NCT01077076|20670874|P3|NOT COMPLETED|First Intervention||0
8386432|NCT01077076|20670875|P2|NOT COMPLETED|First Intervention||0
8386433|NCT01077076|20670876|P1|NOT COMPLETED|First Intervention||1
8386434|NCT01077076|20670871|P6|COMPLETED|First Intervention||5
8386435|NCT01077076|20670872|P5|COMPLETED|First Intervention||5
8386436|NCT01077076|20670873|P4|COMPLETED|First Intervention||5
8386437|NCT01077076|20670874|P3|COMPLETED|First Intervention||5
8386438|NCT01077076|20670875|P2|COMPLETED|First Intervention||5
8386439|NCT01077076|20670876|P1|COMPLETED|First Intervention||4
8386440|NCT01077076|20670871|P6|STARTED|First Intervention||5
8386441|NCT01077076|20670872|P5|STARTED|First Intervention||5
8386442|NCT01077076|20670873|P4|STARTED|First Intervention||5
8386443|NCT01077076|20670874|P3|STARTED|First Intervention||5
8386444|NCT01077076|20670875|P2|STARTED|First Intervention||5
8386445|NCT01077076|20670876|P1|STARTED|First Intervention||5
8386446|NCT01077063|20670886|P2|NOT COMPLETED|Overall Study||3
8386447|NCT01077063|20670887|P1|NOT COMPLETED|Overall Study||4
8386448|NCT01077063|20670886|P2|COMPLETED|Overall Study||0
8386449|NCT01077063|20670887|P1|COMPLETED|Overall Study||0
8386450|NCT01077063|20670886|P2|STARTED|Overall Study||3
8386451|NCT01077063|20670887|P1|STARTED|Overall Study||4
8386452|NCT01077050|20670893|P1|NOT COMPLETED|Overall Study||9
8386453|NCT01077050|20670893|P1|COMPLETED|Overall Study||1942
8386454|NCT01077050|20670893|P1|STARTED|Overall Study||1951
8386461|NCT01076985|20670918|P1|NOT COMPLETED|Overall Study||0
8386462|NCT01076985|20670918|P1|COMPLETED|Overall Study||24
8386463|NCT01076985|20670918|P1|STARTED|Overall Study||24
8386464|NCT01076972|20670924|P1|NOT COMPLETED|Overall Study||0
8386465|NCT01076972|20670924|P1|COMPLETED|Overall Study||1184
8386466|NCT01076972|20670924|P1|STARTED|Overall Study||1184
8386467|NCT01076959|20670939|P1|NOT COMPLETED|Overall Study||2250
8386468|NCT01076959|20670939|P1|COMPLETED|Overall Study||5490
8386469|NCT01076959|20670939|P1|STARTED|Overall Study||7740
8386470|NCT01076686|20670960|P4|NOT COMPLETED|Overall Study||0
8386471|NCT01076686|20670961|P3|NOT COMPLETED|Overall Study||0
8386472|NCT01076686|20670962|P2|NOT COMPLETED|Overall Study||0
8386473|NCT01076686|20670963|P1|NOT COMPLETED|Overall Study||0
8386474|NCT01076686|20670960|P4|COMPLETED|Overall Study||31
8386475|NCT01076686|20670961|P3|COMPLETED|Overall Study||32
8386476|NCT01076686|20670962|P2|COMPLETED|Overall Study||14
8386477|NCT01076686|20670963|P1|COMPLETED|Overall Study||17
8386478|NCT01076686|20670960|P4|STARTED|Overall Study||31
8386479|NCT01076686|20670961|P3|STARTED|Overall Study||32
8386480|NCT01076686|20670962|P2|STARTED|Overall Study||14
8386481|NCT01076686|20670963|P1|STARTED|Overall Study||17
8386482|NCT01076647|20670975|P2|NOT COMPLETED|Overall Study||25
8386483|NCT01076647|20670976|P1|NOT COMPLETED|Overall Study||25
8386484|NCT01076647|20670975|P2|COMPLETED|Overall Study||209
8386485|NCT01076647|20670976|P1|COMPLETED|Overall Study||208
8386486|NCT01076647|20670975|P2|STARTED|Overall Study||234
8386487|NCT01076647|20670976|P1|STARTED|Overall Study||233
8386488|NCT01076543|20670990|P6|NOT COMPLETED|Overall Study||0
8386489|NCT01076543|20670991|P5|NOT COMPLETED|Overall Study||0
8386490|NCT01076543|20670992|P4|NOT COMPLETED|Overall Study||0
8386491|NCT01076543|20670993|P3|NOT COMPLETED|Overall Study||0
8386492|NCT01076543|20670994|P2|NOT COMPLETED|Overall Study||0
8386493|NCT01076543|20670995|P1|NOT COMPLETED|Overall Study||2
8386494|NCT01076543|20670990|P6|COMPLETED|Overall Study||39
8386495|NCT01076543|20670991|P5|COMPLETED|Overall Study||15
8386496|NCT01076543|20670992|P4|COMPLETED|Overall Study||39
8386497|NCT01076543|20670993|P3|COMPLETED|Overall Study||6
8386498|NCT01076543|20670994|P2|COMPLETED|Overall Study||3
8386499|NCT01076543|20670995|P1|COMPLETED|Overall Study||6
8386500|NCT01076543|20670990|P6|STARTED|Overall Study||39
8386501|NCT01076543|20670991|P5|STARTED|Overall Study||15
8386502|NCT01076543|20670992|P4|STARTED|Overall Study||39
8386503|NCT01076543|20670993|P3|STARTED|Overall Study||6
8386504|NCT01076543|20670994|P2|STARTED|Overall Study||3
8386505|NCT01076543|20670995|P1|STARTED|Overall Study||8
8386506|NCT01076504|20671033|P1|NOT COMPLETED|Overall Study||80
8386507|NCT01076504|20671033|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
8386508|NCT01076504|20671033|P1|STARTED|Overall Study||80
8386509|NCT01076452|20671043|P2|NOT COMPLETED|Overall Study||14
8386510|NCT01076452|20671044|P1|NOT COMPLETED|Overall Study||24
8386511|NCT01076452|20671043|P2|COMPLETED|Overall Study||138
8386512|NCT01076452|20671044|P1|COMPLETED|Overall Study||123
8386513|NCT01076452|20671043|P2|STARTED|Overall Study||152
8386514|NCT01076452|20671044|P1|STARTED|Overall Study||147
8386515|NCT01076400|20671056|P3|NOT COMPLETED|Overall Study||0
8386516|NCT01076400|20671057|P2|NOT COMPLETED|Overall Study||0
8386517|NCT01076400|20671058|P1|NOT COMPLETED|Overall Study||7
8386518|NCT01076400|20671056|P3|COMPLETED|Overall Study||0
8386519|NCT01076400|20671057|P2|COMPLETED|Overall Study||0
8386520|NCT01076400|20671058|P1|COMPLETED|Overall Study||0
8386521|NCT01076400|20671056|P3|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
8386522|NCT01076400|20671057|P2|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
8386523|NCT01076400|20671058|P1|STARTED|Overall Study||7
8386524|NCT01076361|20671064|P1|NOT COMPLETED|Overall Study||21
8386525|NCT01076361|20671064|P1|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
8386526|NCT01076361|20671064|P1|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
8386527|NCT01076348|20671068|P1|NOT COMPLETED|Overall Study||22
8386528|NCT01076348|20671068|P1|COMPLETED|Overall Study||51
8386529|NCT01076348|20671068|P1|STARTED|Overall Study||73
8386530|NCT01076335|20671072|P1|NOT COMPLETED|Overall Study||4
8386531|NCT01076335|20671072|P1|COMPLETED|Overall Study||36
8386532|NCT01076335|20671072|P1|STARTED|Overall Study||40
8386533|NCT01076296|20671076|P8|NOT COMPLETED|Overall Study||0
8386534|NCT01076296|20671077|P7|NOT COMPLETED|Overall Study||0
8386535|NCT01076296|20671078|P6|NOT COMPLETED|Overall Study||0
8386536|NCT01076296|20671079|P5|NOT COMPLETED|Overall Study||0
8386537|NCT01076296|20671080|P4|NOT COMPLETED|Overall Study||0
8386538|NCT01076296|20671081|P3|NOT COMPLETED|Overall Study||0
8386539|NCT01076296|20671082|P2|NOT COMPLETED|Overall Study||0
8386540|NCT01076296|20671083|P1|NOT COMPLETED|Overall Study||0
8386541|NCT01076296|20671076|P8|COMPLETED|Overall Study||199
8386542|NCT01076296|20671077|P7|COMPLETED|Overall Study||51
8386543|NCT01076296|20671078|P6|COMPLETED|Overall Study||191
8386544|NCT01076296|20671079|P5|COMPLETED|Overall Study||59
8386545|NCT01076296|20671080|P4|COMPLETED|Overall Study||199
8386546|NCT01076296|20671081|P3|COMPLETED|Overall Study||51
8386547|NCT01076296|20671082|P2|COMPLETED|Overall Study||196
8386548|NCT01076296|20671083|P1|COMPLETED|Overall Study||54
8386549|NCT01076296|20671076|P8|STARTED|Overall Study||199
8386550|NCT01076296|20671077|P7|STARTED|Overall Study||51
8386551|NCT01076296|20671078|P6|STARTED|Overall Study||191
8386552|NCT01076296|20671079|P5|STARTED|Overall Study||59
8386553|NCT01076296|20671080|P4|STARTED|Overall Study||199
8386554|NCT01076296|20671081|P3|STARTED|Overall Study||51
8386555|NCT01076296|20671082|P2|STARTED|Overall Study||196
8386556|NCT01076296|20671083|P1|STARTED|Overall Study||54
8386557|NCT01076283|20671103|P2|NOT COMPLETED|Overall Study||0
8386558|NCT01076283|20671104|P1|NOT COMPLETED|Overall Study||1
8386559|NCT01076283|20671103|P2|COMPLETED|Overall Study||7
8386560|NCT01076283|20671104|P1|COMPLETED|Overall Study||6
8386561|NCT01076283|20671103|P2|STARTED|Overall Study||7
8386562|NCT01076283|20671104|P1|STARTED|Overall Study||7
8386563|NCT01076270|20671112|P1|NOT COMPLETED|Overall Study||0
8386564|NCT01076270|20671112|P1|COMPLETED|Overall Study||1
8386565|NCT01076270|20671112|P1|STARTED|Overall Study||1
8386566|NCT01076244|20671117|P1|NOT COMPLETED|Overall Study||4
8386567|NCT01076244|20671117|P1|COMPLETED|Overall Study||42
8386568|NCT01076244|20671117|P1|STARTED|Overall Study||46
8386569|NCT01076205|20671124|P1|NOT COMPLETED|Overall Study||6019
8386570|NCT01076205|20671124|P1|COMPLETED|Overall Study||1210
8386571|NCT01076205|20671124|P1|STARTED|Overall Study||7229
8386572|NCT01076192|20671177|P1|NOT COMPLETED|Overall Study||197
8386573|NCT01076192|20671177|P1|COMPLETED|Overall Study||350
8386574|NCT01076192|20671177|P1|STARTED|Overall Study||547
8386575|NCT01076179|20671192|P1|NOT COMPLETED|Overall Study||1
8386576|NCT01076179|20671192|P1|COMPLETED|Overall Study||501
8386577|NCT01076179|20671192|P1|STARTED|Overall Study||502
8386578|NCT01076166|20671215|P1|NOT COMPLETED|Overall Study||9
8386579|NCT01076166|20671215|P1|COMPLETED|Overall Study||328
8386580|NCT01076166|20671215|P1|STARTED|Overall Study||337
8386581|NCT01076153|20671222|P1|NOT COMPLETED|Overall Study||11
8386582|NCT01076153|20671222|P1|COMPLETED|Overall Study||749
8386583|NCT01076153|20671222|P1|STARTED|Overall Study||760
8386584|NCT01076088|20671236|P6|NOT COMPLETED|Overall Study||23
8386585|NCT01076088|20671237|P5|NOT COMPLETED|Overall Study||16
8386586|NCT01076088|20671238|P4|NOT COMPLETED|Overall Study||15
8386587|NCT01076088|20671239|P3|NOT COMPLETED|Overall Study||17
8386588|NCT01076088|20671240|P2|NOT COMPLETED|Overall Study||18
8386589|NCT01076088|20671241|P1|NOT COMPLETED|Overall Study||11
8386590|NCT01076088|20671236|P6|COMPLETED|Overall Study||104
8386591|NCT01076088|20671237|P5|COMPLETED|Overall Study||104
8386592|NCT01076088|20671238|P4|COMPLETED|Overall Study||109
8386593|NCT01076088|20671239|P3|COMPLETED|Overall Study||109
8386594|NCT01076088|20671240|P2|COMPLETED|Overall Study||107
8386595|NCT01076088|20671241|P1|COMPLETED|Overall Study||111
8386596|NCT01076088|20671236|P6|STARTED|Overall Study||127
8386597|NCT01076088|20671237|P5|STARTED|Overall Study||120
8386598|NCT01076088|20671238|P4|STARTED|Overall Study||124
8386599|NCT01076088|20671239|P3|STARTED|Overall Study||126
8386600|NCT01076088|20671240|P2|STARTED|Overall Study||125
8386601|NCT01076088|20671241|P1|STARTED|Overall Study||122
8386602|NCT01076075|20671269|P2|NOT COMPLETED|Overall Study||47
8386603|NCT01076075|20671270|P1|NOT COMPLETED|Overall Study||41
8386604|NCT01076075|20671269|P2|COMPLETED|Overall Study||167
8386605|NCT01076075|20671270|P1|COMPLETED|Overall Study||172
8386606|NCT01076075|20671269|P2|Completed Phase A|Overall Study||189
8386607|NCT01076075|20671270|P1|Completed Phase A|Overall Study||199
8386608|NCT01076075|20671269|P2|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
8386609|NCT01076075|20671270|P1|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
8386610|NCT01076036|20671284|P1|NOT COMPLETED|Overall Study||2
8386611|NCT01076036|20671284|P1|COMPLETED|Overall Study||8
8386612|NCT01076036|20671284|P1|Complete CorPath Procedures|Overall Study||8
8386613|NCT01076036|20671284|P1|# of Procedures|Overall Study||8
8386614|NCT01076036|20671284|P1|STARTED|Overall Study||10
8386615|NCT01076010|20671292|P3|NOT COMPLETED|Overall Study||2
8386616|NCT01076010|20671293|P2|NOT COMPLETED|Overall Study||39
8386617|NCT01076010|20671294|P1|NOT COMPLETED|Overall Study||125
8386618|NCT01076010|20671292|P3|COMPLETED|Overall Study||26
8386619|NCT01076010|20671293|P2|COMPLETED|Overall Study||49
8386620|NCT01076010|20671294|P1|COMPLETED|Overall Study||36
8386621|NCT01076010|20671292|P3|STARTED|Overall Study||28
8386622|NCT01076010|20671293|P2|STARTED|Overall Study||88
8386623|NCT01076010|20671294|P1|STARTED|Overall Study||161
8386624|NCT01075984|20671334|P5|NOT COMPLETED|Follow-up Phase||47
8386625|NCT01075984|20671335|P4|NOT COMPLETED|Follow-up Phase||2
8386626|NCT01075984|20671336|P3|NOT COMPLETED|Follow-up Phase||1
8386627|NCT01075984|20671337|P2|NOT COMPLETED|Follow-up Phase||0
8386628|NCT01075984|20671338|P1|NOT COMPLETED|Follow-up Phase||0
8386629|NCT01075984|20671334|P5|COMPLETED|Follow-up Phase||165
8386630|NCT01075984|20671335|P4|COMPLETED|Follow-up Phase||19
8386631|NCT01075984|20671336|P3|COMPLETED|Follow-up Phase||19
8386632|NCT01075984|20671337|P2|COMPLETED|Follow-up Phase||10
8386633|NCT01075984|20671338|P1|COMPLETED|Follow-up Phase||10
8386634|NCT01075984|20671334|P5|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
8386635|NCT01075984|20671335|P4|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
8386636|NCT01075984|20671336|P3|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
8386637|NCT01075984|20671337|P2|STARTED|Follow-up Phase||10
8386638|NCT01075984|20671338|P1|STARTED|Follow-up Phase||10
8386639|NCT01075984|20671334|P5|NOT COMPLETED|Treatment Phase||60
8386640|NCT01075984|20671335|P4|NOT COMPLETED|Treatment Phase||7
8386641|NCT01075984|20671336|P3|NOT COMPLETED|Treatment Phase||7
8386642|NCT01075984|20671337|P2|NOT COMPLETED|Treatment Phase||1
8386643|NCT01075984|20671338|P1|NOT COMPLETED|Treatment Phase||0
8386644|NCT01075984|20671334|P5|COMPLETED|Treatment Phase||153
8386645|NCT01075984|20671335|P4|COMPLETED|Treatment Phase||17
8386646|NCT01075984|20671336|P3|COMPLETED|Treatment Phase||14
8386647|NCT01075984|20671337|P2|COMPLETED|Treatment Phase||10
8386648|NCT01075984|20671338|P1|COMPLETED|Treatment Phase||10
8386649|NCT01075984|20671334|P5|STARTED|Treatment Phase||213
8386650|NCT01075984|20671335|P4|STARTED|Treatment Phase||24
8386651|NCT01075984|20671336|P3|STARTED|Treatment Phase||21
8386652|NCT01075984|20671337|P2|STARTED|Treatment Phase||11
8386653|NCT01075984|20671338|P1|STARTED|Treatment Phase||10
8386654|NCT01075971|20671392|P1|NOT COMPLETED|Overall Study||0
8386655|NCT01075971|20671392|P1|COMPLETED|Overall Study||52
8386656|NCT01075971|20671392|P1|STARTED|Overall Study||52
8386657|NCT01075958|20671396|P1|NOT COMPLETED|Overall Study||44
8386658|NCT01075958|20671396|P1|COMPLETED|Overall Study||239
8386659|NCT01075958|20671396|P1|STARTED|Overall Study||283
8386660|NCT01075815|20671412|P2|NOT COMPLETED|Overall Study||4
8386661|NCT01075815|20671413|P1|NOT COMPLETED|Overall Study||10
8386662|NCT01075815|20671412|P2|COMPLETED|Overall Study||31
8386663|NCT01075815|20671413|P1|COMPLETED|Overall Study||30
8386664|NCT01075815|20671412|P2|STARTED|Overall Study|Number of participants treated.|35
8386665|NCT01075815|20671413|P1|STARTED|Overall Study|Number of participants treated.|40
8386666|NCT01075763|20671451|P2|NOT COMPLETED|Overall Study||4
8386667|NCT01075763|20671452|P1|NOT COMPLETED|Overall Study||4
8386668|NCT01075763|20671451|P2|COMPLETED|Overall Study||15
8386669|NCT01075763|20671452|P1|COMPLETED|Overall Study||19
8386670|NCT01075763|20671451|P2|STARTED|Overall Study||19
8386671|NCT01075763|20671452|P1|STARTED|Overall Study||23
8386672|NCT01075685|20671476|P2|NOT COMPLETED|Overall Study||226
8386673|NCT01075685|20671477|P1|NOT COMPLETED|Overall Study||592
8386674|NCT01075685|20671476|P2|COMPLETED|Overall Study||188
8386675|NCT01075685|20671477|P1|COMPLETED|Overall Study||151
8386676|NCT01075685|20671476|P2|Completed Baseline Measures|Overall Study||263
8386677|NCT01075685|20671477|P1|Completed Baseline Measures|Overall Study||225
8386678|NCT01075685|20671476|P2|Met Inclusion Criteria|Overall Study||413
8386679|NCT01075685|20671477|P1|Met Inclusion Criteria|Overall Study||734
8386680|NCT01075685|20671476|P2|STARTED|Overall Study||414
8386681|NCT01075685|20671477|P1|STARTED|Overall Study||743
8386682|NCT01075646|20671493|P4|NOT COMPLETED|Overall Study||2
8386683|NCT01075646|20671494|P3|NOT COMPLETED|Overall Study||1
8386684|NCT01075646|20671495|P2|NOT COMPLETED|Overall Study||3
8386685|NCT01075646|20671496|P1|NOT COMPLETED|Overall Study||4
8386686|NCT01075646|20671493|P4|COMPLETED|Overall Study||44
8386687|NCT01075646|20671494|P3|COMPLETED|Overall Study||52
8386688|NCT01075646|20671495|P2|COMPLETED|Overall Study||31
8386689|NCT01075646|20671496|P1|COMPLETED|Overall Study||29
8386690|NCT01075646|20671493|P4|STARTED|Overall Study||46
8386691|NCT01075646|20671494|P3|STARTED|Overall Study||53
8386692|NCT01075646|20671495|P2|STARTED|Overall Study||34
8386693|NCT01075646|20671496|P1|STARTED|Overall Study||33
8386694|NCT01075412|20671528|P2|NOT COMPLETED|Overall Study||1
8386695|NCT01075412|20671529|P1|NOT COMPLETED|Overall Study||0
8386696|NCT01075412|20671528|P2|COMPLETED|Overall Study||1
8386697|NCT01075412|20671529|P1|COMPLETED|Overall Study||4
8386698|NCT01075412|20671528|P2|STARTED|Overall Study||2
8386699|NCT01075412|20671529|P1|STARTED|Overall Study||4
8386700|NCT01075399|20671539|P1|NOT COMPLETED|Overall Study||8
8386701|NCT01075399|20671539|P1|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
8386702|NCT01075399|20671539|P1|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
8386703|NCT01075347|20671545|P2|NOT COMPLETED|Overall Study||0
8386704|NCT01075347|20671546|P1|NOT COMPLETED|Overall Study||0
8386705|NCT01075347|20671545|P2|COMPLETED|Overall Study||83
8386706|NCT01075347|20671546|P1|COMPLETED|Overall Study||82
8386707|NCT01075347|20671545|P2|STARTED|Overall Study||83
8386708|NCT01075347|20671546|P1|STARTED|Overall Study||82
8386709|NCT01075321|20671554|P4|NOT COMPLETED|Overall Study||2
8386710|NCT01075321|20671555|P3|NOT COMPLETED|Overall Study||2
8386711|NCT01075321|20671556|P2|NOT COMPLETED|Overall Study||0
8386712|NCT01075321|20671557|P1|NOT COMPLETED|Overall Study||1
8386713|NCT01075321|20671554|P4|COMPLETED|Overall Study||31
8386714|NCT01075321|20671555|P3|COMPLETED|Overall Study||7
8386715|NCT01075321|20671556|P2|COMPLETED|Overall Study||9
8386716|NCT01075321|20671557|P1|COMPLETED|Overall Study||6
8386717|NCT01075321|20671554|P4|STARTED|Overall Study||33
8386718|NCT01075321|20671555|P3|STARTED|Overall Study||9
8386719|NCT01075321|20671556|P2|STARTED|Overall Study||9
8386720|NCT01075321|20671557|P1|STARTED|Overall Study||7
8386721|NCT01075282|20671575|P3|NOT COMPLETED|Overall Study||27
8386722|NCT01075282|20671576|P2|NOT COMPLETED|Overall Study||29
8386723|NCT01075282|20671577|P1|NOT COMPLETED|Overall Study||31
8386724|NCT01075282|20671575|P3|COMPLETED|Overall Study||238
8386725|NCT01075282|20671576|P2|COMPLETED|Overall Study||243
8386726|NCT01075282|20671577|P1|COMPLETED|Overall Study||242
8386727|NCT01075282|20671575|P3|Received at Least One Dose of Study Drug|Overall Study||262
8386728|NCT01075282|20671576|P2|Received at Least One Dose of Study Drug|Overall Study||272
8386729|NCT01075282|20671577|P1|Received at Least One Dose of Study Drug|Overall Study||273
8386730|NCT01075282|20671575|P3|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
8386731|NCT01075282|20671576|P2|STARTED|Overall Study||272
8386732|NCT01075282|20671577|P1|STARTED|Overall Study||273
8386733|NCT01075256|20671660|P3|NOT COMPLETED|Overall Study||0
8386734|NCT01075256|20671661|P2|NOT COMPLETED|Overall Study||0
8386735|NCT01075256|20671662|P1|NOT COMPLETED|Overall Study||1
8386736|NCT01075256|20671660|P3|COMPLETED|Overall Study||65
8386737|NCT01075256|20671661|P2|COMPLETED|Overall Study||66
8386738|NCT01075256|20671662|P1|COMPLETED|Overall Study||63
8386739|NCT01075256|20671660|P3|STARTED|Overall Study||65
8386740|NCT01075256|20671661|P2|STARTED|Overall Study||66
8386741|NCT01075256|20671662|P1|STARTED|Overall Study||64
8386742|NCT01075243|20671694|P3|NOT COMPLETED|Overall Study||0
8386743|NCT01075243|20671695|P2|NOT COMPLETED|Overall Study||3
8386744|NCT01075243|20671696|P1|NOT COMPLETED|Overall Study||6
8386745|NCT01075243|20671694|P3|COMPLETED|Overall Study||80
8386746|NCT01075243|20671695|P2|COMPLETED|Overall Study||155
8386747|NCT01075243|20671696|P1|COMPLETED|Overall Study||157
8386748|NCT01075243|20671694|P3|STARTED|Overall Study||80
8386749|NCT01075243|20671695|P2|STARTED|Overall Study||158
8386750|NCT01075243|20671696|P1|STARTED|Overall Study||163
8386751|NCT01075217|20671748|P2|NOT COMPLETED|Overall Study||1
8386752|NCT01075217|20671749|P1|NOT COMPLETED|Overall Study||2
8386753|NCT01075217|20671748|P2|COMPLETED|Overall Study||84
8386754|NCT01075217|20671749|P1|COMPLETED|Overall Study||82
8386755|NCT01075217|20671748|P2|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
8386756|NCT01075217|20671749|P1|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
8386757|NCT01075204|20671765|P1|NOT COMPLETED|Overall Study||0
8386758|NCT01075204|20671765|P1|COMPLETED|Overall Study||335
8386759|NCT01075204|20671765|P1|STARTED|Overall Study||335
8386760|NCT01075191|20671782|P1|NOT COMPLETED|Overall Study||18
8386761|NCT01075191|20671782|P1|COMPLETED|Overall Study||42
8386762|NCT01075191|20671782|P1|Discontinued Year 3|Overall Study||5
8386763|NCT01075191|20671782|P1|Discontinued Year 2|Overall Study||6
8386764|NCT01075191|20671782|P1|Discontinued Year 1|Overall Study||7
8386765|NCT01075191|20671782|P1|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
8386766|NCT01075178|20671793|P2|NOT COMPLETED|Subject Chart Review||9
8386767|NCT01075178|20671794|P1|NOT COMPLETED|Subject Chart Review||9
8386768|NCT01075178|20671793|P2|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
8386769|NCT01075178|20671794|P1|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
8386770|NCT01075178|20671793|P2|STARTED|Subject Chart Review|subjects matched|1018
8386771|NCT01075178|20671794|P1|STARTED|Subject Chart Review|subjects matched|1018
8386772|NCT01075178|20671793|P2|NOT COMPLETED|Subject Matching||403
8386773|NCT01075178|20671794|P1|NOT COMPLETED|Subject Matching||130
8386774|NCT01075178|20671793|P2|COMPLETED|Subject Matching|subjects matched|1018
8386775|NCT01075178|20671794|P1|COMPLETED|Subject Matching|subjects matched|1018
8386776|NCT01075178|20671793|P2|STARTED|Subject Matching|eligible for matching|1421
8386777|NCT01075178|20671794|P1|STARTED|Subject Matching|eligible for matching|1148
8386778|NCT01075152|20671808|P2|NOT COMPLETED|Overall Study||0
8386779|NCT01075152|20671809|P1|NOT COMPLETED|Overall Study||1
8386780|NCT01075152|20671808|P2|COMPLETED|Overall Study||89
8386781|NCT01075152|20671809|P1|COMPLETED|Overall Study||87
8386782|NCT01075152|20671808|P2|STARTED|Overall Study|randomized|89
8386783|NCT01075152|20671809|P1|STARTED|Overall Study|randomized|88
8386784|NCT01075100|20671835|P2|NOT COMPLETED|Overall Study||53
8386785|NCT01075100|20671836|P1|NOT COMPLETED|Overall Study||49
8386786|NCT01075100|20671835|P2|COMPLETED|Overall Study||1
8386787|NCT01075100|20671836|P1|COMPLETED|Overall Study||0
8386788|NCT01075100|20671835|P2|STARTED|Overall Study||54
8386789|NCT01075100|20671836|P1|STARTED|Overall Study||49
8386790|NCT01075087|20671854|P2|NOT COMPLETED|Overall Study||0
8386791|NCT01075087|20671855|P1|NOT COMPLETED|Overall Study||0
8386792|NCT01075087|20671854|P2|COMPLETED|Overall Study||10
8386793|NCT01075087|20671855|P1|COMPLETED|Overall Study||9
8386794|NCT01075087|20671854|P2|STARTED|Overall Study||10
8386795|NCT01075087|20671855|P1|STARTED|Overall Study||9
8386796|NCT01075074|20671866|P3|NOT COMPLETED|Overall Study||2
8386797|NCT01075074|20671867|P2|NOT COMPLETED|Overall Study||2
8386798|NCT01075074|20671868|P1|NOT COMPLETED|Overall Study||1
8386799|NCT01075074|20671866|P3|COMPLETED|Overall Study||23
8386800|NCT01075074|20671867|P2|COMPLETED|Overall Study||23
8386801|NCT01075074|20671868|P1|COMPLETED|Overall Study||24
8386802|NCT01075074|20671866|P3|STARTED|Overall Study||25
8386803|NCT01075074|20671867|P2|STARTED|Overall Study||25
8386804|NCT01075074|20671868|P1|STARTED|Overall Study||25
8386817|NCT01074944|20671913|P5|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
8386818|NCT01074944|20671914|P4|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
8386819|NCT01074944|20671915|P3|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
8386820|NCT01074944|20671916|P2|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
8386821|NCT01074944|20671917|P1|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
8386822|NCT01074944|20671913|P5|COMPLETED|Extended Treatment (up to 42 Months)||20
8386823|NCT01074944|20671914|P4|COMPLETED|Extended Treatment (up to 42 Months)||0
8386824|NCT01074944|20671915|P3|COMPLETED|Extended Treatment (up to 42 Months)||0
8386825|NCT01074944|20671916|P2|COMPLETED|Extended Treatment (up to 42 Months)||0
8386826|NCT01074944|20671917|P1|COMPLETED|Extended Treatment (up to 42 Months)||0
8386827|NCT01074944|20671913|P5|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
8386828|NCT01074944|20671914|P4|STARTED|Extended Treatment (up to 42 Months)||0
8386829|NCT01074944|20671915|P3|STARTED|Extended Treatment (up to 42 Months)||0
8386830|NCT01074944|20671916|P2|STARTED|Extended Treatment (up to 42 Months)||0
8386831|NCT01074944|20671917|P1|STARTED|Extended Treatment (up to 42 Months)||0
8386832|NCT01074944|20671913|P5|NOT COMPLETED|Long Term Treatment||0
8386833|NCT01074944|20671914|P4|NOT COMPLETED|Long Term Treatment||26
8386834|NCT01074944|20671915|P3|NOT COMPLETED|Long Term Treatment||0
8386835|NCT01074944|20671916|P2|NOT COMPLETED|Long Term Treatment||0
8386836|NCT01074944|20671917|P1|NOT COMPLETED|Long Term Treatment||0
8386837|NCT01074944|20671913|P5|COMPLETED|Long Term Treatment||0
8386838|NCT01074944|20671914|P4|COMPLETED|Long Term Treatment||95
8386839|NCT01074944|20671915|P3|COMPLETED|Long Term Treatment||0
8386840|NCT01074944|20671916|P2|COMPLETED|Long Term Treatment||0
8386841|NCT01074944|20671917|P1|COMPLETED|Long Term Treatment||0
8386842|NCT01074944|20671913|P5|STARTED|Long Term Treatment||0
8386843|NCT01074944|20671914|P4|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
8386844|NCT01074944|20671915|P3|STARTED|Long Term Treatment||0
8386845|NCT01074944|20671916|P2|STARTED|Long Term Treatment||0
8386846|NCT01074944|20671917|P1|STARTED|Long Term Treatment||0
8386847|NCT01074944|20671913|P5|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8386848|NCT01074944|20671914|P4|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8386849|NCT01074944|20671915|P3|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
8386850|NCT01074944|20671916|P2|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
8386851|NCT01074944|20671917|P1|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8386852|NCT01074944|20671913|P5|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8386853|NCT01074944|20671914|P4|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8386854|NCT01074944|20671915|P3|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
8386855|NCT01074944|20671916|P2|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
8386856|NCT01074944|20671917|P1|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
8386857|NCT01074944|20671913|P5|STARTED|Primary Analysis Period (up to 52 Weeks)||0
8386858|NCT01074944|20671914|P4|STARTED|Primary Analysis Period (up to 52 Weeks)||0
8386859|NCT01074944|20671915|P3|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
8386860|NCT01074944|20671916|P2|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
8386861|NCT01074944|20671917|P1|STARTED|Primary Analysis Period (up to 52 Weeks)||0
8386862|NCT01074944|20671913|P5|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386863|NCT01074944|20671914|P4|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386864|NCT01074944|20671915|P3|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386865|NCT01074944|20671916|P2|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386866|NCT01074944|20671917|P1|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
8386867|NCT01074944|20671913|P5|COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386868|NCT01074944|20671914|P4|COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386869|NCT01074944|20671915|P3|COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386870|NCT01074944|20671916|P2|COMPLETED|Lead-in Period (up to 78 Weeks)||0
8386871|NCT01074944|20671917|P1|COMPLETED|Lead-in Period (up to 78 Weeks)||157
8386872|NCT01074944|20671913|P5|STARTED|Lead-in Period (up to 78 Weeks)||0
8386873|NCT01074944|20671914|P4|STARTED|Lead-in Period (up to 78 Weeks)||0
8386874|NCT01074944|20671915|P3|STARTED|Lead-in Period (up to 78 Weeks)||0
8386875|NCT01074944|20671916|P2|STARTED|Lead-in Period (up to 78 Weeks)||0
8386876|NCT01074944|20671917|P1|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
8386877|NCT01074931|20671971|P1|NOT COMPLETED|Overall Study||6
8386878|NCT01074931|20671971|P1|COMPLETED|Overall Study||92
8386879|NCT01074931|20671971|P1|STARTED|Overall Study||98
8386880|NCT01074658|20671983|P1|NOT COMPLETED|Overall Study||19
8386881|NCT01074658|20671983|P1|COMPLETED|Overall Study||996
8386882|NCT01074658|20671983|P1|Attempted Implant|Overall Study||996
8386883|NCT01074658|20671983|P1|STARTED|Overall Study||1015
8386884|NCT01074554|20671991|P2|NOT COMPLETED|Overall Study||4
8386885|NCT01074554|20671992|P1|NOT COMPLETED|Overall Study||3
8386886|NCT01074554|20671991|P2|COMPLETED|Overall Study||11
8386887|NCT01074554|20671992|P1|COMPLETED|Overall Study||11
8386888|NCT01074554|20671991|P2|STARTED|Overall Study||15
8386889|NCT01074554|20671992|P1|STARTED|Overall Study||14
8386890|NCT01074502|20672002|P1|NOT COMPLETED|Overall Study||1
8386891|NCT01074502|20672002|P1|COMPLETED|Overall Study||2
8386892|NCT01074502|20672002|P1|STARTED|Overall Study||3
8386893|NCT01074463|20672013|P2|NOT COMPLETED|Second Intervention||0
8386894|NCT01074463|20672014|P1|NOT COMPLETED|Second Intervention||0
8386895|NCT01074463|20672013|P2|COMPLETED|Second Intervention||12
8386896|NCT01074463|20672014|P1|COMPLETED|Second Intervention||12
8386897|NCT01074463|20672013|P2|STARTED|Second Intervention||12
8386898|NCT01074463|20672014|P1|STARTED|Second Intervention||12
8386899|NCT01074463|20672013|P2|NOT COMPLETED|Washout of 7 Days||0
8386900|NCT01074463|20672014|P1|NOT COMPLETED|Washout of 7 Days||0
8386901|NCT01074463|20672013|P2|COMPLETED|Washout of 7 Days||12
8386902|NCT01074463|20672014|P1|COMPLETED|Washout of 7 Days||12
8386903|NCT01074463|20672013|P2|STARTED|Washout of 7 Days||12
8386904|NCT01074463|20672014|P1|STARTED|Washout of 7 Days||12
8386905|NCT01074463|20672013|P2|NOT COMPLETED|First Intervention||0
8386906|NCT01074463|20672014|P1|NOT COMPLETED|First Intervention||0
8386907|NCT01074463|20672013|P2|COMPLETED|First Intervention||12
8386908|NCT01074463|20672014|P1|COMPLETED|First Intervention||12
8386909|NCT01074463|20672013|P2|STARTED|First Intervention||12
8386910|NCT01074463|20672014|P1|STARTED|First Intervention||12
8386911|NCT01074450|20672026|P2|NOT COMPLETED|Second Intervention||1
8386912|NCT01074450|20672027|P1|NOT COMPLETED|Second Intervention||1
8386913|NCT01074450|20672026|P2|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
8386914|NCT01074450|20672027|P1|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
8386915|NCT01074450|20672026|P2|STARTED|Second Intervention||10
8386916|NCT01074450|20672027|P1|STARTED|Second Intervention||12
8386917|NCT01074450|20672026|P2|NOT COMPLETED|Washout of 7 Days||0
8386918|NCT01074450|20672027|P1|NOT COMPLETED|Washout of 7 Days||0
8386919|NCT01074450|20672026|P2|COMPLETED|Washout of 7 Days||10
8386920|NCT01074450|20672027|P1|COMPLETED|Washout of 7 Days||12
8386921|NCT01074450|20672026|P2|STARTED|Washout of 7 Days||10
8386922|NCT01074450|20672027|P1|STARTED|Washout of 7 Days||12
8386923|NCT01074450|20672026|P2|NOT COMPLETED|First Intervention||2
8386924|NCT01074450|20672027|P1|NOT COMPLETED|First Intervention||0
8386925|NCT01074450|20672026|P2|COMPLETED|First Intervention||10
8386926|NCT01074450|20672027|P1|COMPLETED|First Intervention||12
8386927|NCT01074450|20672026|P2|STARTED|First Intervention||12
8386928|NCT01074450|20672027|P1|STARTED|First Intervention||12
8386929|NCT01074437|20672039|P2|NOT COMPLETED|Overall Study||0
8386930|NCT01074437|20672040|P1|NOT COMPLETED|Overall Study||0
8386931|NCT01074437|20672039|P2|COMPLETED|Overall Study||5
8386932|NCT01074437|20672040|P1|COMPLETED|Overall Study||4
8386933|NCT01074437|20672039|P2|STARTED|Overall Study||5
8386934|NCT01074437|20672040|P1|STARTED|Overall Study||4
8386935|NCT01074307|20672056|P2|NOT COMPLETED|Overall Study||12
8386936|NCT01074307|20672057|P1|NOT COMPLETED|Overall Study||22
8386937|NCT01074307|20672056|P2|COMPLETED|Overall Study||102
8386938|NCT01074307|20672057|P1|COMPLETED|Overall Study||44
8386939|NCT01074307|20672056|P2|STARTED|Overall Study||114
8386940|NCT01074307|20672057|P1|STARTED|Overall Study||66
8386941|NCT01074268|20672079|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
8386942|NCT01074268|20672080|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
8386943|NCT01074268|20672079|P2|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
8386944|NCT01074268|20672080|P1|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
8386945|NCT01074268|20672079|P2|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
8386946|NCT01074268|20672080|P1|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
8386947|NCT01074268|20672079|P2|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
8386948|NCT01074268|20672080|P1|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
8386949|NCT01074268|20672079|P2|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
8386950|NCT01074268|20672080|P1|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
8386951|NCT01074268|20672079|P2|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
8386952|NCT01074268|20672080|P1|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
8386953|NCT01074268|20672079|P2|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
8386954|NCT01074268|20672080|P1|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
8386955|NCT01074268|20672079|P2|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
8386956|NCT01074268|20672080|P1|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
8386957|NCT01074255|20672106|P1|NOT COMPLETED|Overall Study||2
8386958|NCT01074255|20672106|P1|COMPLETED|Overall Study||3139
8386959|NCT01074255|20672106|P1|Treated|Overall Study||3139
8386960|NCT01074255|20672106|P1|STARTED|Overall Study||3141
8386961|NCT01074242|20672110|P1|NOT COMPLETED|Overall Study||403
8386962|NCT01074242|20672110|P1|COMPLETED|Overall Study||3395
8386963|NCT01074242|20672110|P1|Received at Least 1 Dose of Vaccine|Overall Study||3395
8386964|NCT01074242|20672110|P1|STARTED|Overall Study||3798
8386965|NCT01074229|20672118|P3|NOT COMPLETED|Overall Study||4
8386966|NCT01074229|20672119|P2|NOT COMPLETED|Overall Study||3
8386967|NCT01074229|20672120|P1|NOT COMPLETED|Overall Study||2
8386968|NCT01074229|20672118|P3|COMPLETED|Overall Study||21
8386969|NCT01074229|20672119|P2|COMPLETED|Overall Study||22
8386970|NCT01074229|20672120|P1|COMPLETED|Overall Study||23
8386971|NCT01074229|20672118|P3|STARTED|Overall Study||25
8386972|NCT01074229|20672119|P2|STARTED|Overall Study||25
8386973|NCT01074229|20672120|P1|STARTED|Overall Study||25
8386974|NCT01074216|20672131|P1|NOT COMPLETED|Overall Study||13
8386975|NCT01074216|20672131|P1|COMPLETED|Overall Study||41
8386976|NCT01074216|20672131|P1|STARTED|Overall Study||54
8386977|NCT01074177|20672135|P1|NOT COMPLETED|Overall Study||0
8386978|NCT01074177|20672135|P1|COMPLETED|Overall Study||24
8386979|NCT01074177|20672135|P1|STARTED|Overall Study||24
8386980|NCT01074164|20672144|P2|NOT COMPLETED|Overall Study||1
8386981|NCT01074164|20672145|P1|NOT COMPLETED|Overall Study||3
8386982|NCT01074164|20672144|P2|COMPLETED|Overall Study||7
8386983|NCT01074164|20672145|P1|COMPLETED|Overall Study||4
8386984|NCT01074164|20672144|P2|STARTED|Overall Study||8
8386985|NCT01074164|20672145|P1|STARTED|Overall Study||7
8386986|NCT01074125|20672166|P3|NOT COMPLETED|Overall Study||12
8386987|NCT01074125|20672167|P2|NOT COMPLETED|Overall Study||5
8386988|NCT01074125|20672168|P1|NOT COMPLETED|Overall Study||12
8386989|NCT01074125|20672166|P3|COMPLETED|Overall Study||36
8386990|NCT01074125|20672167|P2|COMPLETED|Overall Study||47
8386991|NCT01074125|20672168|P1|COMPLETED|Overall Study||39
8386992|NCT01074125|20672166|P3|STARTED|Overall Study||48
8386993|NCT01074125|20672167|P2|STARTED|Overall Study||52
8386994|NCT01074125|20672168|P1|STARTED|Overall Study||51
8386995|NCT01074099|20672184|P2|NOT COMPLETED|Overall Study||0
8386996|NCT01074099|20672185|P1|NOT COMPLETED|Overall Study||0
8386997|NCT01074099|20672184|P2|COMPLETED|Overall Study||3
8386998|NCT01074099|20672185|P1|COMPLETED|Overall Study||2
8386999|NCT01074099|20672184|P2|STARTED|Overall Study||3
8387000|NCT01074099|20672185|P1|STARTED|Overall Study||2
8387001|NCT01074047|20672195|P2|NOT COMPLETED|Extension Phase||0
8387002|NCT01074047|20672196|P1|NOT COMPLETED|Extension Phase||22
8387003|NCT01074047|20672195|P2|COMPLETED|Extension Phase||0
8387004|NCT01074047|20672196|P1|COMPLETED|Extension Phase||0
8387005|NCT01074047|20672195|P2|Safety Population|Extension Phase||0
8387006|NCT01074047|20672196|P1|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
8387007|NCT01074047|20672195|P2|STARTED|Extension Phase||0
8387008|NCT01074047|20672196|P1|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
8387009|NCT01074047|20672195|P2|NOT COMPLETED|Survival Follow-Up Phase||136
8387010|NCT01074047|20672196|P1|NOT COMPLETED|Survival Follow-Up Phase||124
8387011|NCT01074047|20672195|P2|COMPLETED|Survival Follow-Up Phase||27
8387012|NCT01074047|20672196|P1|COMPLETED|Survival Follow-Up Phase||16
8387013|NCT01074047|20672195|P2|STARTED|Survival Follow-Up Phase||163
8387014|NCT01074047|20672196|P1|STARTED|Survival Follow-Up Phase||140
8387015|NCT01074047|20672195|P2|NOT COMPLETED|Treatment Phase||234
8387016|NCT01074047|20672196|P1|NOT COMPLETED|Treatment Phase||217
8387017|NCT01074047|20672195|P2|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
8387018|NCT01074047|20672196|P1|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
8387019|NCT01074047|20672195|P2|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
8387020|NCT01074047|20672196|P1|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
8387021|NCT01074047|20672195|P2|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
8387022|NCT01074047|20672196|P1|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
8387023|NCT01074047|20672195|P2|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
8387024|NCT01074047|20672196|P1|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
8387025|NCT01074047|20672195|P2|STARTED|Treatment Phase||247
8387026|NCT01074047|20672196|P1|STARTED|Treatment Phase||241
8387027|NCT01074034|20672270|P1|NOT COMPLETED|Overall Study||6
8387028|NCT01074034|20672270|P1|COMPLETED|Overall Study||205
8387029|NCT01074034|20672270|P1|STARTED|Overall Study||211
8387030|NCT01074008|20672284|P9|NOT COMPLETED|Overall Study||4
8387031|NCT01074008|20672285|P8|NOT COMPLETED|Overall Study||0
8387032|NCT01074008|20672286|P7|NOT COMPLETED|Overall Study||1
8387033|NCT01074008|20672287|P6|NOT COMPLETED|Overall Study||0
8387034|NCT01074008|20672288|P5|NOT COMPLETED|Overall Study||2
8387035|NCT01074008|20672289|P4|NOT COMPLETED|Overall Study||1
8387036|NCT01074008|20672290|P3|NOT COMPLETED|Overall Study||2
8387037|NCT01074008|20672291|P2|NOT COMPLETED|Overall Study||3
8387038|NCT01074008|20672292|P1|NOT COMPLETED|Overall Study||1
8387039|NCT01074008|20672284|P9|COMPLETED|Overall Study||7
8387040|NCT01074008|20672285|P8|COMPLETED|Overall Study||8
8387041|NCT01074008|20672286|P7|COMPLETED|Overall Study||7
8387042|NCT01074008|20672287|P6|COMPLETED|Overall Study||7
8387043|NCT01074008|20672288|P5|COMPLETED|Overall Study||6
8387044|NCT01074008|20672289|P4|COMPLETED|Overall Study||7
8387045|NCT01074008|20672290|P3|COMPLETED|Overall Study||6
8387046|NCT01074008|20672291|P2|COMPLETED|Overall Study||5
8387047|NCT01074008|20672292|P1|COMPLETED|Overall Study||7
8387048|NCT01074008|20672284|P9|Completed Direct-acting Antiviral Agent|Overall Study||5
8387049|NCT01074008|20672285|P8|Completed Direct-acting Antiviral Agent|Overall Study||7
8387050|NCT01074008|20672286|P7|Completed Direct-acting Antiviral Agent|Overall Study||8
8387051|NCT01074008|20672287|P6|Completed Direct-acting Antiviral Agent|Overall Study||5
8387052|NCT01074008|20672288|P5|Completed Direct-acting Antiviral Agent|Overall Study||8
8387053|NCT01074008|20672289|P4|Completed Direct-acting Antiviral Agent|Overall Study||8
8387054|NCT01074008|20672290|P3|Completed Direct-acting Antiviral Agent|Overall Study||7
8387055|NCT01074008|20672291|P2|Completed Direct-acting Antiviral Agent|Overall Study||7
8387056|NCT01074008|20672292|P1|Completed Direct-acting Antiviral Agent|Overall Study||8
8387057|NCT01074008|20672284|P9|STARTED|Overall Study||11
8387058|NCT01074008|20672285|P8|STARTED|Overall Study||8
8387059|NCT01074008|20672286|P7|STARTED|Overall Study||8
8387060|NCT01074008|20672287|P6|STARTED|Overall Study||7
8387061|NCT01074008|20672288|P5|STARTED|Overall Study||8
8387062|NCT01074008|20672289|P4|STARTED|Overall Study||8
8387063|NCT01074008|20672290|P3|STARTED|Overall Study||8
8387064|NCT01074008|20672291|P2|STARTED|Overall Study||8
8387065|NCT01074008|20672292|P1|STARTED|Overall Study||8
8387066|NCT01073943|20672402|P2|NOT COMPLETED|Overall Study||8
8387067|NCT01073943|20672403|P1|NOT COMPLETED|Overall Study||13
8387068|NCT01073943|20672402|P2|COMPLETED|Overall Study||295
8387069|NCT01073943|20672403|P1|COMPLETED|Overall Study||287
8387070|NCT01073943|20672402|P2|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
8387071|NCT01073943|20672403|P1|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
8387072|NCT01073943|20672402|P2|Safety Population (Treated)|Overall Study||302
8387073|NCT01073943|20672403|P1|Safety Population (Treated)|Overall Study||296
8387074|NCT01073943|20672402|P2|STARTED|Overall Study||303
8387075|NCT01073943|20672403|P1|STARTED|Overall Study||300
8387076|NCT01073930|20672429|P2|NOT COMPLETED|Overall Study||6
8387077|NCT01073930|20672430|P1|NOT COMPLETED|Overall Study||3
8387078|NCT01073930|20672429|P2|COMPLETED|Overall Study||295
8387079|NCT01073930|20672430|P1|COMPLETED|Overall Study||304
8387080|NCT01073930|20672429|P2|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
8387081|NCT01073930|20672430|P1|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
8387082|NCT01073930|20672429|P2|Safety Population (Treated)|Overall Study||298
8387083|NCT01073930|20672430|P1|Safety Population (Treated)|Overall Study||305
8387084|NCT01073930|20672429|P2|STARTED|Overall Study||301
8387085|NCT01073930|20672430|P1|STARTED|Overall Study||307
8387086|NCT01073865|20672454|P2|NOT COMPLETED|Overall Study||39
8387087|NCT01073865|20672455|P1|NOT COMPLETED|Overall Study||28
8387088|NCT01073865|20672454|P2|COMPLETED|Overall Study|Number of patients completed the study|74
8387089|NCT01073865|20672455|P1|COMPLETED|Overall Study|Number of patients completed the study|81
8387090|NCT01073865|20672454|P2|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
8387091|NCT01073865|20672455|P1|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
8387092|NCT01073865|20672454|P2|STARTED|Overall Study|Number of patients randomised|113
8387093|NCT01073865|20672455|P1|STARTED|Overall Study|Number of patients randomised|109
8387094|NCT01073657|20672467|P2|NOT COMPLETED|Overall Study||0
8387095|NCT01073657|20672468|P1|NOT COMPLETED|Overall Study||0
8387096|NCT01073657|20672467|P2|COMPLETED|Overall Study||16
8387097|NCT01073657|20672468|P1|COMPLETED|Overall Study||17
8387098|NCT01073657|20672467|P2|STARTED|Overall Study||16
8387099|NCT01073657|20672468|P1|STARTED|Overall Study||17
8387100|NCT01073631|20672474|P1|NOT COMPLETED|Overall Study||169
8387101|NCT01073631|20672474|P1|COMPLETED|Overall Study||374
8387102|NCT01073631|20672474|P1|STARTED|Overall Study||543
8387103|NCT01073618|20672479|P1|NOT COMPLETED|Overall Study||307
8387104|NCT01073618|20672479|P1|COMPLETED|Overall Study||385
8387105|NCT01073618|20672479|P1|STARTED|Overall Study||692
8387106|NCT01073605|20672487|P3|NOT COMPLETED|Overall Study||61
8387107|NCT01073605|20672488|P2|NOT COMPLETED|Overall Study||67
8387108|NCT01073605|20672489|P1|NOT COMPLETED|Overall Study||62
8387109|NCT01073605|20672487|P3|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
8387110|NCT01073605|20672488|P2|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
8387111|NCT01073605|20672489|P1|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
8387112|NCT01073605|20672487|P3|Received Treatment|Overall Study||68
8387113|NCT01073605|20672488|P2|Received Treatment|Overall Study||70
8387114|NCT01073605|20672489|P1|Received Treatment|Overall Study||68
8387115|NCT01073605|20672487|P3|STARTED|Overall Study||69
8387116|NCT01073605|20672488|P2|STARTED|Overall Study||71
8387117|NCT01073605|20672489|P1|STARTED|Overall Study||68
8387118|NCT01073566|20672535|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
8387119|NCT01073566|20672536|P1|NOT COMPLETED|Period 2 (6 Weeks)||1
8387120|NCT01073566|20672535|P2|COMPLETED|Period 2 (6 Weeks)||19
8387121|NCT01073566|20672536|P1|COMPLETED|Period 2 (6 Weeks)||18
8387122|NCT01073566|20672535|P2|STARTED|Period 2 (6 Weeks)||19
8387123|NCT01073566|20672536|P1|STARTED|Period 2 (6 Weeks)||19
8387124|NCT01073566|20672535|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
8387125|NCT01073566|20672536|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
8387126|NCT01073566|20672535|P2|COMPLETED|Period 1 (6 Weeks)||19
8387127|NCT01073566|20672536|P1|COMPLETED|Period 1 (6 Weeks)||19
8387128|NCT01073566|20672535|P2|STARTED|Period 1 (6 Weeks)||19
8387129|NCT01073566|20672536|P1|STARTED|Period 1 (6 Weeks)||19
8387130|NCT01073462|20672548|P1|NOT COMPLETED|Overall Study||41
8387131|NCT01073462|20672548|P1|COMPLETED|Overall Study||26
8387132|NCT01073462|20672548|P1|STARTED|Overall Study||67
8387133|NCT01073449|20672559|P1|NOT COMPLETED|Overall Study||0
8387134|NCT01073449|20672559|P1|COMPLETED|Overall Study||3362
8387135|NCT01073449|20672559|P1|STARTED|Overall Study||3362
8387136|NCT01073293|20672567|P2|NOT COMPLETED|Overall Study||11
8387137|NCT01073293|20672568|P1|NOT COMPLETED|Overall Study||5
8387138|NCT01073293|20672567|P2|COMPLETED|Overall Study||517
8387139|NCT01073293|20672568|P1|COMPLETED|Overall Study||521
8387140|NCT01073293|20672567|P2|STARTED|Overall Study||528
8387141|NCT01073293|20672568|P1|STARTED|Overall Study||526
8387142|NCT01073267|20672590|P1|NOT COMPLETED|Overall Study||3
8387143|NCT01073267|20672590|P1|COMPLETED|Overall Study||1
8387144|NCT01073267|20672590|P1|STARTED|Overall Study||4
8387145|NCT01073163|20672594|P1|NOT COMPLETED|Overall Study||3
8387146|NCT01073163|20672594|P1|COMPLETED|Overall Study|Patients completed study|51
8387147|NCT01073163|20672594|P1|Treated With >=6 Cycles|Overall Study||49
8387148|NCT01073163|20672594|P1|Treated With <6 Cycles|Overall Study||4
8387149|NCT01073163|20672594|P1|Enrolled But Not Treated|Overall Study||1
8387150|NCT01073163|20672594|P1|STARTED|Overall Study||54
8387151|NCT01072929|20672617|P3|NOT COMPLETED|Overall Study||9
8387152|NCT01072929|20672618|P2|NOT COMPLETED|Overall Study||51
8387153|NCT01072929|20672619|P1|NOT COMPLETED|Overall Study||44
8387154|NCT01072929|20672617|P3|COMPLETED|Overall Study||24
8387155|NCT01072929|20672618|P2|COMPLETED|Overall Study||150
8387156|NCT01072929|20672619|P1|COMPLETED|Overall Study||155
8387157|NCT01072929|20672617|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
8387158|NCT01072929|20672618|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
8387159|NCT01072929|20672619|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
8387160|NCT01072929|20672617|P3|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
8387161|NCT01072929|20672618|P2|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
8387162|NCT01072929|20672619|P1|Safety Population|Overall Study|Treated participants|199
8387163|NCT01072929|20672617|P3|STARTED|Overall Study||33
8387164|NCT01072929|20672618|P2|STARTED|Overall Study||201
8387165|NCT01072929|20672619|P1|STARTED|Overall Study||199
8387181|NCT01072773|20672724|P1|NOT COMPLETED|Overall Study||0
8387182|NCT01072773|20672724|P1|COMPLETED|Overall Study||2
8387183|NCT01072773|20672724|P1|STARTED|Overall Study||2
8387184|NCT01072669|20672735|P2|NOT COMPLETED|Overall Study||0
8387185|NCT01072669|20672736|P1|NOT COMPLETED|Overall Study||0
8387186|NCT01072669|20672735|P2|COMPLETED|Overall Study||5
8387187|NCT01072669|20672736|P1|COMPLETED|Overall Study||15
8387188|NCT01072669|20672735|P2|STARTED|Overall Study||5
8387189|NCT01072669|20672736|P1|STARTED|Overall Study||15
8387190|NCT01072656|20672744|P2|NOT COMPLETED|Second Intervention||0
8387191|NCT01072656|20672745|P1|NOT COMPLETED|Second Intervention||0
8387192|NCT01072656|20672744|P2|COMPLETED|Second Intervention||4
8387193|NCT01072656|20672745|P1|COMPLETED|Second Intervention||5
8387194|NCT01072656|20672744|P2|STARTED|Second Intervention||4
8387195|NCT01072656|20672745|P1|STARTED|Second Intervention||5
8387196|NCT01072656|20672744|P2|NOT COMPLETED|First Intervention||0
8387197|NCT01072656|20672745|P1|NOT COMPLETED|First Intervention||0
8387198|NCT01072656|20672744|P2|COMPLETED|First Intervention||4
8387199|NCT01072656|20672745|P1|COMPLETED|First Intervention||5
8387200|NCT01072656|20672744|P2|STARTED|First Intervention||4
8387201|NCT01072656|20672745|P1|STARTED|First Intervention||5
8387202|NCT01072643|20672755|P1|NOT COMPLETED|Overall Study||0
8387203|NCT01072643|20672755|P1|COMPLETED|Overall Study||4
8387204|NCT01072643|20672755|P1|STARTED|Overall Study||4
8387205|NCT01072630|20672781|P3|NOT COMPLETED|Overall Study||13
8387206|NCT01072630|20672782|P2|NOT COMPLETED|Overall Study||60
8387207|NCT01072630|20672783|P1|NOT COMPLETED|Overall Study||55
8387208|NCT01072630|20672781|P3|COMPLETED|Overall Study||17
8387209|NCT01072630|20672782|P2|COMPLETED|Overall Study||172
8387210|NCT01072630|20672783|P1|COMPLETED|Overall Study||175
8387211|NCT01072630|20672781|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
8387212|NCT01072630|20672782|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
8387213|NCT01072630|20672783|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
8387214|NCT01072630|20672781|P3|Safety Population|Overall Study|Treated participants.|30
8387215|NCT01072630|20672782|P2|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
8387216|NCT01072630|20672783|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
8387217|NCT01072630|20672781|P3|STARTED|Overall Study||30
8387218|NCT01072630|20672782|P2|STARTED|Overall Study||232
8387219|NCT01072630|20672783|P1|STARTED|Overall Study||230
8387220|NCT01072617|20672857|P1|NOT COMPLETED|Overall Study||0
8387221|NCT01072617|20672857|P1|COMPLETED|Overall Study||8
8387222|NCT01072617|20672857|P1|STARTED|Overall Study||8
8387223|NCT01072539|20672864|P1|NOT COMPLETED|Overall Study||3
8387224|NCT01072539|20672864|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
8387225|NCT01072539|20672864|P1|STARTED|Overall Study||3172
8387226|NCT01072526|20672872|P2|NOT COMPLETED|Overall Study||0
8387227|NCT01072526|20672873|P1|NOT COMPLETED|Overall Study||0
8387228|NCT01072526|20672872|P2|COMPLETED|Overall Study||0
8387229|NCT01072526|20672873|P1|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
8387230|NCT01072526|20672872|P2|STARTED|Overall Study||0
8387231|NCT01072526|20672873|P1|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
8387232|NCT01072500|20672888|P2|NOT COMPLETED|Overall Study||14
8387233|NCT01072500|20672889|P1|NOT COMPLETED|Overall Study||24
8387234|NCT01072500|20672888|P2|COMPLETED|Overall Study||803
8387235|NCT01072500|20672889|P1|COMPLETED|Overall Study||794
8387236|NCT01072500|20672888|P2|STARTED|Overall Study||817
8387237|NCT01072500|20672889|P1|STARTED|Overall Study||818
8387238|NCT01072448|20672899|P2|NOT COMPLETED|Overall Study||30
8387239|NCT01072448|20672900|P1|NOT COMPLETED|Overall Study||19
8387240|NCT01072448|20672899|P2|COMPLETED|Overall Study||130
8387241|NCT01072448|20672900|P1|COMPLETED|Overall Study||144
8387242|NCT01072448|20672899|P2|STARTED|Overall Study||160
8387243|NCT01072448|20672900|P1|STARTED|Overall Study||163
8387244|NCT01072409|20672908|P1|NOT COMPLETED|Overall Study||7
8387245|NCT01072409|20672908|P1|COMPLETED|Overall Study||38
8387246|NCT01072409|20672908|P1|STARTED|Overall Study||45
8387247|NCT01072396|20672914|P2|NOT COMPLETED|Period Two||3
8387248|NCT01072396|20672915|P1|NOT COMPLETED|Period Two||1
8387249|NCT01072396|20672914|P2|COMPLETED|Period Two||57
8387250|NCT01072396|20672915|P1|COMPLETED|Period Two||57
8387251|NCT01072396|20672914|P2|STARTED|Period Two||60
8387252|NCT01072396|20672915|P1|STARTED|Period Two||58
8387253|NCT01072396|20672914|P2|NOT COMPLETED|Washout Period||1
8387254|NCT01072396|20672915|P1|NOT COMPLETED|Washout Period||0
8387255|NCT01072396|20672914|P2|COMPLETED|Washout Period||60
8387256|NCT01072396|20672915|P1|COMPLETED|Washout Period||58
8387257|NCT01072396|20672914|P2|STARTED|Washout Period||61
8387258|NCT01072396|20672915|P1|STARTED|Washout Period||58
8387259|NCT01072396|20672914|P2|NOT COMPLETED|Period One||2
8387260|NCT01072396|20672915|P1|NOT COMPLETED|Period One||5
8387261|NCT01072396|20672914|P2|COMPLETED|Period One||61
8387262|NCT01072396|20672915|P1|COMPLETED|Period One||58
8387263|NCT01072396|20672914|P2|STARTED|Period One||63
8387264|NCT01072396|20672915|P1|STARTED|Period One||63
8387265|NCT01072357|20672927|P2|NOT COMPLETED|Overall Study||1
8387266|NCT01072357|20672928|P1|NOT COMPLETED|Overall Study||0
8387267|NCT01072357|20672927|P2|COMPLETED|Overall Study||14
8387268|NCT01072357|20672928|P1|COMPLETED|Overall Study||15
8387269|NCT01072357|20672927|P2|STARTED|Overall Study||15
8387270|NCT01072357|20672928|P1|STARTED|Overall Study||15
8387271|NCT01072344|20672938|P2|NOT COMPLETED|Overall Study||18
8387272|NCT01072344|20672939|P1|NOT COMPLETED|Overall Study||11
8387273|NCT01072344|20672938|P2|COMPLETED|Overall Study||29
8387274|NCT01072344|20672939|P1|COMPLETED|Overall Study||35
8387275|NCT01072344|20672938|P2|STARTED|Overall Study||47
8387276|NCT01072344|20672939|P1|STARTED|Overall Study||46
8387277|NCT01072331|20672956|P3|NOT COMPLETED|Overall Study||0
8387278|NCT01072331|20672957|P2|NOT COMPLETED|Overall Study||0
8387279|NCT01072331|20672958|P1|NOT COMPLETED|Overall Study||0
8387280|NCT01072331|20672956|P3|COMPLETED|Overall Study||32
8387281|NCT01072331|20672957|P2|COMPLETED|Overall Study||33
8387282|NCT01072331|20672958|P1|COMPLETED|Overall Study||34
8387283|NCT01072331|20672956|P3|STARTED|Overall Study||32
8387284|NCT01072331|20672957|P2|STARTED|Overall Study||33
8387285|NCT01072331|20672958|P1|STARTED|Overall Study||34
8387286|NCT01072201|20672977|P2|NOT COMPLETED|Overall Study||1
8387287|NCT01072201|20672978|P1|NOT COMPLETED|Overall Study||0
8387288|NCT01072201|20672977|P2|COMPLETED|Overall Study||29
8387289|NCT01072201|20672978|P1|COMPLETED|Overall Study||30
8387290|NCT01072201|20672977|P2|STARTED|Overall Study||30
8387291|NCT01072201|20672978|P1|STARTED|Overall Study||30
8387292|NCT01072188|20672990|P2|NOT COMPLETED|Overall Study||0
8387293|NCT01072188|20672991|P1|NOT COMPLETED|Overall Study||0
8387294|NCT01072188|20672990|P2|COMPLETED|Overall Study||23
8387295|NCT01072188|20672991|P1|COMPLETED|Overall Study||22
8387296|NCT01072188|20672990|P2|STARTED|Overall Study||23
8387297|NCT01072188|20672991|P1|STARTED|Overall Study||22
8387298|NCT01072175|20673011|P13|NOT COMPLETED|Part D (HPMC Capsules)||39
8387299|NCT01072175|20673012|P12|NOT COMPLETED|Part D (HPMC Capsules)||43
8387300|NCT01072175|20673013|P11|NOT COMPLETED|Part D (HPMC Capsules)||16
8387301|NCT01072175|20673014|P10|NOT COMPLETED|Part D (HPMC Capsules)||12
8387302|NCT01072175|20673015|P9|NOT COMPLETED|Part D (HPMC Capsules)||0
8387303|NCT01072175|20673016|P8|NOT COMPLETED|Part D (HPMC Capsules)||0
8387304|NCT01072175|20673017|P7|NOT COMPLETED|Part D (HPMC Capsules)||0
8387305|NCT01072175|20673018|P6|NOT COMPLETED|Part D (HPMC Capsules)||0
8387306|NCT01072175|20673019|P5|NOT COMPLETED|Part D (HPMC Capsules)||0
8387307|NCT01072175|20673020|P4|NOT COMPLETED|Part D (HPMC Capsules)||0
8387308|NCT01072175|20673021|P3|NOT COMPLETED|Part D (HPMC Capsules)||0
8387309|NCT01072175|20673022|P2|NOT COMPLETED|Part D (HPMC Capsules)||0
8387310|NCT01072175|20673023|P1|NOT COMPLETED|Part D (HPMC Capsules)||0
8387311|NCT01072175|20673011|P13|COMPLETED|Part D (HPMC Capsules)||0
8387312|NCT01072175|20673012|P12|COMPLETED|Part D (HPMC Capsules)||0
8387313|NCT01072175|20673013|P11|COMPLETED|Part D (HPMC Capsules)||0
8387314|NCT01072175|20673014|P10|COMPLETED|Part D (HPMC Capsules)||0
8387315|NCT01072175|20673015|P9|COMPLETED|Part D (HPMC Capsules)||0
8387316|NCT01072175|20673016|P8|COMPLETED|Part D (HPMC Capsules)||0
8387317|NCT01072175|20673017|P7|COMPLETED|Part D (HPMC Capsules)||0
8387318|NCT01072175|20673018|P6|COMPLETED|Part D (HPMC Capsules)||0
8387319|NCT01072175|20673019|P5|COMPLETED|Part D (HPMC Capsules)||0
8387320|NCT01072175|20673020|P4|COMPLETED|Part D (HPMC Capsules)||0
8387321|NCT01072175|20673021|P3|COMPLETED|Part D (HPMC Capsules)||0
8387322|NCT01072175|20673022|P2|COMPLETED|Part D (HPMC Capsules)||0
8387323|NCT01072175|20673023|P1|COMPLETED|Part D (HPMC Capsules)||0
8387324|NCT01072175|20673011|P13|STARTED|Part D (HPMC Capsules)||39
8387325|NCT01072175|20673012|P12|STARTED|Part D (HPMC Capsules)||43
8387326|NCT01072175|20673013|P11|STARTED|Part D (HPMC Capsules)||16
8387327|NCT01072175|20673014|P10|STARTED|Part D (HPMC Capsules)||12
8387328|NCT01072175|20673015|P9|STARTED|Part D (HPMC Capsules)||0
8387329|NCT01072175|20673016|P8|STARTED|Part D (HPMC Capsules)||0
8387330|NCT01072175|20673017|P7|STARTED|Part D (HPMC Capsules)||0
8387331|NCT01072175|20673018|P6|STARTED|Part D (HPMC Capsules)||0
8387332|NCT01072175|20673019|P5|STARTED|Part D (HPMC Capsules)||0
8387333|NCT01072175|20673020|P4|STARTED|Part D (HPMC Capsules)||0
8387334|NCT01072175|20673021|P3|STARTED|Part D (HPMC Capsules)||0
8387335|NCT01072175|20673022|P2|STARTED|Part D (HPMC Capsules)||0
8387336|NCT01072175|20673023|P1|STARTED|Part D (HPMC Capsules)||0
8387337|NCT01072175|20673011|P13|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387338|NCT01072175|20673012|P12|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387339|NCT01072175|20673013|P11|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387340|NCT01072175|20673014|P10|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387341|NCT01072175|20673015|P9|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45
8387342|NCT01072175|20673016|P8|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387343|NCT01072175|20673017|P7|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387344|NCT01072175|20673018|P6|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387345|NCT01072175|20673019|P5|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387346|NCT01072175|20673020|P4|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387347|NCT01072175|20673021|P3|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387500|NCT01072149|20673239|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387348|NCT01072175|20673022|P2|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387349|NCT01072175|20673023|P1|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387350|NCT01072175|20673011|P13|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387351|NCT01072175|20673012|P12|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387352|NCT01072175|20673013|P11|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387353|NCT01072175|20673014|P10|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387354|NCT01072175|20673015|P9|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387355|NCT01072175|20673016|P8|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387356|NCT01072175|20673017|P7|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387357|NCT01072175|20673018|P6|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387358|NCT01072175|20673019|P5|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387359|NCT01072175|20673020|P4|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387360|NCT01072175|20673021|P3|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387361|NCT01072175|20673022|P2|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387362|NCT01072175|20673023|P1|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
8387363|NCT01072175|20673011|P13|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387364|NCT01072175|20673012|P12|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387365|NCT01072175|20673013|P11|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387366|NCT01072175|20673014|P10|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387367|NCT01072175|20673015|P9|STARTED|Part C (Phase II: Crossover Phase [CP])||45
8387368|NCT01072175|20673016|P8|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387369|NCT01072175|20673017|P7|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387370|NCT01072175|20673018|P6|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387371|NCT01072175|20673019|P5|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387372|NCT01072175|20673020|P4|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387373|NCT01072175|20673021|P3|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387374|NCT01072175|20673022|P2|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387375|NCT01072175|20673023|P1|STARTED|Part C (Phase II: Crossover Phase [CP])||0
8387376|NCT01072175|20673011|P13|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387377|NCT01072175|20673012|P12|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387378|NCT01072175|20673013|P11|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387379|NCT01072175|20673014|P10|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387380|NCT01072175|20673015|P9|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387381|NCT01072175|20673016|P8|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
8387382|NCT01072175|20673017|P7|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
8387383|NCT01072175|20673018|P6|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
8387384|NCT01072175|20673019|P5|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387385|NCT01072175|20673020|P4|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387386|NCT01072175|20673021|P3|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387387|NCT01072175|20673022|P2|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387388|NCT01072175|20673023|P1|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
8387389|NCT01072175|20673011|P13|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387390|NCT01072175|20673012|P12|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387391|NCT01072175|20673013|P11|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387392|NCT01072175|20673014|P10|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387393|NCT01072175|20673015|P9|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387394|NCT01072175|20673016|P8|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387395|NCT01072175|20673017|P7|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387396|NCT01072175|20673018|P6|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387397|NCT01072175|20673019|P5|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387398|NCT01072175|20673020|P4|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387399|NCT01072175|20673021|P3|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387400|NCT01072175|20673022|P2|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387401|NCT01072175|20673023|P1|COMPLETED|Part C (Phase II: Randomized Phase)||0
8387402|NCT01072175|20673011|P13|STARTED|Part C (Phase II: Randomized Phase)||0
8387403|NCT01072175|20673012|P12|STARTED|Part C (Phase II: Randomized Phase)||0
8387404|NCT01072175|20673013|P11|STARTED|Part C (Phase II: Randomized Phase)||0
8387405|NCT01072175|20673014|P10|STARTED|Part C (Phase II: Randomized Phase)||0
8387406|NCT01072175|20673015|P9|STARTED|Part C (Phase II: Randomized Phase)||0
8387407|NCT01072175|20673016|P8|STARTED|Part C (Phase II: Randomized Phase)||54
8387408|NCT01072175|20673017|P7|STARTED|Part C (Phase II: Randomized Phase)||54
8387409|NCT01072175|20673018|P6|STARTED|Part C (Phase II: Randomized Phase)||54
8387410|NCT01072175|20673019|P5|STARTED|Part C (Phase II: Randomized Phase)||0
8387411|NCT01072175|20673020|P4|STARTED|Part C (Phase II: Randomized Phase)||0
8387412|NCT01072175|20673021|P3|STARTED|Part C (Phase II: Randomized Phase)||0
8387413|NCT01072175|20673022|P2|STARTED|Part C (Phase II: Randomized Phase)||0
8387414|NCT01072175|20673023|P1|STARTED|Part C (Phase II: Randomized Phase)||0
8387415|NCT01072175|20673011|P13|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387416|NCT01072175|20673012|P12|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387417|NCT01072175|20673013|P11|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387418|NCT01072175|20673014|P10|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387419|NCT01072175|20673015|P9|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387420|NCT01072175|20673016|P8|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387421|NCT01072175|20673017|P7|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387422|NCT01072175|20673018|P6|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387423|NCT01072175|20673019|P5|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94
8387424|NCT01072175|20673020|P4|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
8387425|NCT01072175|20673021|P3|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
8387426|NCT01072175|20673022|P2|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
8387427|NCT01072175|20673023|P1|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
8387428|NCT01072175|20673011|P13|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387429|NCT01072175|20673012|P12|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387430|NCT01072175|20673013|P11|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387431|NCT01072175|20673014|P10|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387432|NCT01072175|20673015|P9|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387433|NCT01072175|20673016|P8|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387434|NCT01072175|20673017|P7|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387435|NCT01072175|20673018|P6|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387436|NCT01072175|20673019|P5|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387437|NCT01072175|20673020|P4|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387438|NCT01072175|20673021|P3|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387439|NCT01072175|20673022|P2|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387440|NCT01072175|20673023|P1|COMPLETED|Part B (Dose Escalation and Expansion)||0
8387441|NCT01072175|20673011|P13|STARTED|Part B (Dose Escalation and Expansion)||0
8387442|NCT01072175|20673012|P12|STARTED|Part B (Dose Escalation and Expansion)||0
8387443|NCT01072175|20673013|P11|STARTED|Part B (Dose Escalation and Expansion)||0
8387444|NCT01072175|20673014|P10|STARTED|Part B (Dose Escalation and Expansion)||0
8387445|NCT01072175|20673015|P9|STARTED|Part B (Dose Escalation and Expansion)||0
8387446|NCT01072175|20673016|P8|STARTED|Part B (Dose Escalation and Expansion)||0
8387447|NCT01072175|20673017|P7|STARTED|Part B (Dose Escalation and Expansion)||0
8387448|NCT01072175|20673018|P6|STARTED|Part B (Dose Escalation and Expansion)||0
8387449|NCT01072175|20673019|P5|STARTED|Part B (Dose Escalation and Expansion)||94
8387450|NCT01072175|20673020|P4|STARTED|Part B (Dose Escalation and Expansion)||27
8387451|NCT01072175|20673021|P3|STARTED|Part B (Dose Escalation and Expansion)||23
8387452|NCT01072175|20673022|P2|STARTED|Part B (Dose Escalation and Expansion)||6
8387453|NCT01072175|20673023|P1|STARTED|Part B (Dose Escalation and Expansion)||0
8387454|NCT01072175|20673011|P13|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387455|NCT01072175|20673012|P12|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387456|NCT01072175|20673013|P11|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387457|NCT01072175|20673014|P10|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387458|NCT01072175|20673015|P9|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387459|NCT01072175|20673016|P8|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387460|NCT01072175|20673017|P7|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387461|NCT01072175|20673018|P6|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387462|NCT01072175|20673019|P5|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387463|NCT01072175|20673020|P4|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387464|NCT01072175|20673021|P3|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387465|NCT01072175|20673022|P2|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
8387466|NCT01072175|20673023|P1|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
8387467|NCT01072175|20673011|P13|COMPLETED|Part A (Drug-Drug Interaction)||0
8387468|NCT01072175|20673012|P12|COMPLETED|Part A (Drug-Drug Interaction)||0
8387469|NCT01072175|20673013|P11|COMPLETED|Part A (Drug-Drug Interaction)||0
8387470|NCT01072175|20673014|P10|COMPLETED|Part A (Drug-Drug Interaction)||0
8387471|NCT01072175|20673015|P9|COMPLETED|Part A (Drug-Drug Interaction)||0
8387472|NCT01072175|20673016|P8|COMPLETED|Part A (Drug-Drug Interaction)||0
8387473|NCT01072175|20673017|P7|COMPLETED|Part A (Drug-Drug Interaction)||0
8387474|NCT01072175|20673018|P6|COMPLETED|Part A (Drug-Drug Interaction)||0
8387475|NCT01072175|20673019|P5|COMPLETED|Part A (Drug-Drug Interaction)||0
8387476|NCT01072175|20673020|P4|COMPLETED|Part A (Drug-Drug Interaction)||0
8387477|NCT01072175|20673021|P3|COMPLETED|Part A (Drug-Drug Interaction)||0
8387478|NCT01072175|20673022|P2|COMPLETED|Part A (Drug-Drug Interaction)||0
8387479|NCT01072175|20673023|P1|COMPLETED|Part A (Drug-Drug Interaction)||0
8387480|NCT01072175|20673011|P13|STARTED|Part A (Drug-Drug Interaction)||0
8387481|NCT01072175|20673012|P12|STARTED|Part A (Drug-Drug Interaction)||0
8387482|NCT01072175|20673013|P11|STARTED|Part A (Drug-Drug Interaction)||0
8387483|NCT01072175|20673014|P10|STARTED|Part A (Drug-Drug Interaction)||0
8387484|NCT01072175|20673015|P9|STARTED|Part A (Drug-Drug Interaction)||0
8387485|NCT01072175|20673016|P8|STARTED|Part A (Drug-Drug Interaction)||0
8387486|NCT01072175|20673017|P7|STARTED|Part A (Drug-Drug Interaction)||0
8387487|NCT01072175|20673018|P6|STARTED|Part A (Drug-Drug Interaction)||0
8387488|NCT01072175|20673019|P5|STARTED|Part A (Drug-Drug Interaction)||0
8387489|NCT01072175|20673020|P4|STARTED|Part A (Drug-Drug Interaction)||0
8387490|NCT01072175|20673021|P3|STARTED|Part A (Drug-Drug Interaction)||0
8387491|NCT01072175|20673022|P2|STARTED|Part A (Drug-Drug Interaction)||0
8387492|NCT01072175|20673023|P1|STARTED|Part A (Drug-Drug Interaction)||8
8387493|NCT01072149|20673232|P18|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387494|NCT01072149|20673233|P17|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387495|NCT01072149|20673234|P16|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387496|NCT01072149|20673235|P15|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387497|NCT01072149|20673236|P14|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8387498|NCT01072149|20673237|P13|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387499|NCT01072149|20673238|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387501|NCT01072149|20673240|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387502|NCT01072149|20673241|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387503|NCT01072149|20673242|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387504|NCT01072149|20673243|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387505|NCT01072149|20673244|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387506|NCT01072149|20673245|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387507|NCT01072149|20673246|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387508|NCT01072149|20673247|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8387509|NCT01072149|20673248|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387510|NCT01072149|20673249|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8387511|NCT01072149|20673232|P18|COMPLETED|Treatment Period 3 (28 Days)||2
8387512|NCT01072149|20673233|P17|COMPLETED|Treatment Period 3 (28 Days)||3
8387513|NCT01072149|20673234|P16|COMPLETED|Treatment Period 3 (28 Days)||1
8387514|NCT01072149|20673235|P15|COMPLETED|Treatment Period 3 (28 Days)||3
8387515|NCT01072149|20673236|P14|COMPLETED|Treatment Period 3 (28 Days)||2
8387516|NCT01072149|20673237|P13|COMPLETED|Treatment Period 3 (28 Days)||2
8387517|NCT01072149|20673238|P12|COMPLETED|Treatment Period 3 (28 Days)||3
8387518|NCT01072149|20673239|P11|COMPLETED|Treatment Period 3 (28 Days)||2
8387519|NCT01072149|20673240|P10|COMPLETED|Treatment Period 3 (28 Days)||3
8387520|NCT01072149|20673241|P9|COMPLETED|Treatment Period 3 (28 Days)||3
8387521|NCT01072149|20673242|P8|COMPLETED|Treatment Period 3 (28 Days)||2
8387522|NCT01072149|20673243|P7|COMPLETED|Treatment Period 3 (28 Days)||3
8387523|NCT01072149|20673244|P6|COMPLETED|Treatment Period 3 (28 Days)||3
8387524|NCT01072149|20673245|P5|COMPLETED|Treatment Period 3 (28 Days)||3
8387525|NCT01072149|20673246|P4|COMPLETED|Treatment Period 3 (28 Days)||3
8387526|NCT01072149|20673247|P3|COMPLETED|Treatment Period 3 (28 Days)||0
8387527|NCT01072149|20673248|P2|COMPLETED|Treatment Period 3 (28 Days)||2
8387528|NCT01072149|20673249|P1|COMPLETED|Treatment Period 3 (28 Days)||2
8387529|NCT01072149|20673232|P18|STARTED|Treatment Period 3 (28 Days)||2
8387530|NCT01072149|20673233|P17|STARTED|Treatment Period 3 (28 Days)||3
8387531|NCT01072149|20673234|P16|STARTED|Treatment Period 3 (28 Days)||1
8387532|NCT01072149|20673235|P15|STARTED|Treatment Period 3 (28 Days)||3
8387533|NCT01072149|20673236|P14|STARTED|Treatment Period 3 (28 Days)||3
8387534|NCT01072149|20673237|P13|STARTED|Treatment Period 3 (28 Days)||2
8387535|NCT01072149|20673238|P12|STARTED|Treatment Period 3 (28 Days)||3
8387536|NCT01072149|20673239|P11|STARTED|Treatment Period 3 (28 Days)||2
8387537|NCT01072149|20673240|P10|STARTED|Treatment Period 3 (28 Days)||3
8387538|NCT01072149|20673241|P9|STARTED|Treatment Period 3 (28 Days)||3
8387539|NCT01072149|20673242|P8|STARTED|Treatment Period 3 (28 Days)||2
8387540|NCT01072149|20673243|P7|STARTED|Treatment Period 3 (28 Days)||3
8387541|NCT01072149|20673244|P6|STARTED|Treatment Period 3 (28 Days)||3
8387542|NCT01072149|20673245|P5|STARTED|Treatment Period 3 (28 Days)||3
8387543|NCT01072149|20673246|P4|STARTED|Treatment Period 3 (28 Days)||3
8387544|NCT01072149|20673247|P3|STARTED|Treatment Period 3 (28 Days)||1
8387545|NCT01072149|20673248|P2|STARTED|Treatment Period 3 (28 Days)||2
8387546|NCT01072149|20673249|P1|STARTED|Treatment Period 3 (28 Days)||2
8387547|NCT01072149|20673232|P18|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387548|NCT01072149|20673233|P17|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387549|NCT01072149|20673234|P16|NOT COMPLETED|Washout Period 2 (14 Days)||2
8387550|NCT01072149|20673235|P15|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387551|NCT01072149|20673236|P14|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387552|NCT01072149|20673237|P13|NOT COMPLETED|Washout Period 2 (14 Days)||1
8387553|NCT01072149|20673238|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387554|NCT01072149|20673239|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387555|NCT01072149|20673240|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387556|NCT01072149|20673241|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387557|NCT01072149|20673242|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387558|NCT01072149|20673243|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387559|NCT01072149|20673244|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387560|NCT01072149|20673245|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387561|NCT01072149|20673246|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387562|NCT01072149|20673247|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387563|NCT01072149|20673248|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
8387564|NCT01072149|20673249|P1|NOT COMPLETED|Washout Period 2 (14 Days)||1
8387565|NCT01072149|20673232|P18|COMPLETED|Washout Period 2 (14 Days)||2
8387566|NCT01072149|20673233|P17|COMPLETED|Washout Period 2 (14 Days)||3
8387567|NCT01072149|20673234|P16|COMPLETED|Washout Period 2 (14 Days)||1
8387568|NCT01072149|20673235|P15|COMPLETED|Washout Period 2 (14 Days)||3
8387569|NCT01072149|20673236|P14|COMPLETED|Washout Period 2 (14 Days)||3
8387570|NCT01072149|20673237|P13|COMPLETED|Washout Period 2 (14 Days)||2
8387571|NCT01072149|20673238|P12|COMPLETED|Washout Period 2 (14 Days)||3
8387572|NCT01072149|20673239|P11|COMPLETED|Washout Period 2 (14 Days)||2
8387573|NCT01072149|20673240|P10|COMPLETED|Washout Period 2 (14 Days)||3
8387574|NCT01072149|20673241|P9|COMPLETED|Washout Period 2 (14 Days)||3
8387575|NCT01072149|20673242|P8|COMPLETED|Washout Period 2 (14 Days)||2
8387576|NCT01072149|20673243|P7|COMPLETED|Washout Period 2 (14 Days)||3
8387577|NCT01072149|20673244|P6|COMPLETED|Washout Period 2 (14 Days)||3
8387578|NCT01072149|20673245|P5|COMPLETED|Washout Period 2 (14 Days)||3
8387579|NCT01072149|20673246|P4|COMPLETED|Washout Period 2 (14 Days)||3
8387580|NCT01072149|20673247|P3|COMPLETED|Washout Period 2 (14 Days)||1
8387581|NCT01072149|20673248|P2|COMPLETED|Washout Period 2 (14 Days)||2
8387582|NCT01072149|20673249|P1|COMPLETED|Washout Period 2 (14 Days)||2
8387583|NCT01072149|20673232|P18|STARTED|Washout Period 2 (14 Days)||2
8387584|NCT01072149|20673233|P17|STARTED|Washout Period 2 (14 Days)||3
8387585|NCT01072149|20673234|P16|STARTED|Washout Period 2 (14 Days)||3
8387586|NCT01072149|20673235|P15|STARTED|Washout Period 2 (14 Days)||3
8387587|NCT01072149|20673236|P14|STARTED|Washout Period 2 (14 Days)||3
8387588|NCT01072149|20673237|P13|STARTED|Washout Period 2 (14 Days)||3
8387589|NCT01072149|20673238|P12|STARTED|Washout Period 2 (14 Days)||3
8387590|NCT01072149|20673239|P11|STARTED|Washout Period 2 (14 Days)||2
8387591|NCT01072149|20673240|P10|STARTED|Washout Period 2 (14 Days)||3
8387592|NCT01072149|20673241|P9|STARTED|Washout Period 2 (14 Days)||3
8387593|NCT01072149|20673242|P8|STARTED|Washout Period 2 (14 Days)||2
8387594|NCT01072149|20673243|P7|STARTED|Washout Period 2 (14 Days)||3
8387595|NCT01072149|20673244|P6|STARTED|Washout Period 2 (14 Days)||3
8387596|NCT01072149|20673245|P5|STARTED|Washout Period 2 (14 Days)||3
8387597|NCT01072149|20673246|P4|STARTED|Washout Period 2 (14 Days)||3
8387598|NCT01072149|20673247|P3|STARTED|Washout Period 2 (14 Days)||1
8387599|NCT01072149|20673248|P2|STARTED|Washout Period 2 (14 Days)||2
8387600|NCT01072149|20673249|P1|STARTED|Washout Period 2 (14 Days)||3
8387601|NCT01072149|20673232|P18|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387602|NCT01072149|20673233|P17|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387603|NCT01072149|20673234|P16|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387604|NCT01072149|20673235|P15|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387605|NCT01072149|20673236|P14|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387606|NCT01072149|20673237|P13|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387607|NCT01072149|20673238|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387608|NCT01072149|20673239|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387609|NCT01072149|20673240|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387610|NCT01072149|20673241|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387611|NCT01072149|20673242|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8387612|NCT01072149|20673243|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387613|NCT01072149|20673244|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387614|NCT01072149|20673245|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387615|NCT01072149|20673246|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387616|NCT01072149|20673247|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8387617|NCT01072149|20673248|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8387618|NCT01072149|20673249|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8387619|NCT01072149|20673232|P18|COMPLETED|Treatment Period 2 (28 Days)||2
8387620|NCT01072149|20673233|P17|COMPLETED|Treatment Period 2 (28 Days)||3
8387621|NCT01072149|20673234|P16|COMPLETED|Treatment Period 2 (28 Days)||3
8387622|NCT01072149|20673235|P15|COMPLETED|Treatment Period 2 (28 Days)||3
8387623|NCT01072149|20673236|P14|COMPLETED|Treatment Period 2 (28 Days)||3
8387624|NCT01072149|20673237|P13|COMPLETED|Treatment Period 2 (28 Days)||3
8387625|NCT01072149|20673238|P12|COMPLETED|Treatment Period 2 (28 Days)||3
8387626|NCT01072149|20673239|P11|COMPLETED|Treatment Period 2 (28 Days)||2
8387627|NCT01072149|20673240|P10|COMPLETED|Treatment Period 2 (28 Days)||3
8387628|NCT01072149|20673241|P9|COMPLETED|Treatment Period 2 (28 Days)||3
8387629|NCT01072149|20673242|P8|COMPLETED|Treatment Period 2 (28 Days)||2
8387630|NCT01072149|20673243|P7|COMPLETED|Treatment Period 2 (28 Days)||3
8387631|NCT01072149|20673244|P6|COMPLETED|Treatment Period 2 (28 Days)||3
8387632|NCT01072149|20673245|P5|COMPLETED|Treatment Period 2 (28 Days)||3
8387633|NCT01072149|20673246|P4|COMPLETED|Treatment Period 2 (28 Days)||3
8387634|NCT01072149|20673247|P3|COMPLETED|Treatment Period 2 (28 Days)||1
8387635|NCT01072149|20673248|P2|COMPLETED|Treatment Period 2 (28 Days)||2
8387636|NCT01072149|20673249|P1|COMPLETED|Treatment Period 2 (28 Days)||3
8387637|NCT01072149|20673232|P18|STARTED|Treatment Period 2 (28 Days)||2
8387638|NCT01072149|20673233|P17|STARTED|Treatment Period 2 (28 Days)||3
8387639|NCT01072149|20673234|P16|STARTED|Treatment Period 2 (28 Days)||3
8387640|NCT01072149|20673235|P15|STARTED|Treatment Period 2 (28 Days)||3
8387641|NCT01072149|20673236|P14|STARTED|Treatment Period 2 (28 Days)||3
8387642|NCT01072149|20673237|P13|STARTED|Treatment Period 2 (28 Days)||3
8387643|NCT01072149|20673238|P12|STARTED|Treatment Period 2 (28 Days)||3
8387644|NCT01072149|20673239|P11|STARTED|Treatment Period 2 (28 Days)||2
8387645|NCT01072149|20673240|P10|STARTED|Treatment Period 2 (28 Days)||3
8387646|NCT01072149|20673241|P9|STARTED|Treatment Period 2 (28 Days)||3
8387647|NCT01072149|20673242|P8|STARTED|Treatment Period 2 (28 Days)||3
8387648|NCT01072149|20673243|P7|STARTED|Treatment Period 2 (28 Days)||3
8387649|NCT01072149|20673244|P6|STARTED|Treatment Period 2 (28 Days)||3
8387650|NCT01072149|20673245|P5|STARTED|Treatment Period 2 (28 Days)||3
8387651|NCT01072149|20673246|P4|STARTED|Treatment Period 2 (28 Days)||3
8387652|NCT01072149|20673247|P3|STARTED|Treatment Period 2 (28 Days)||2
8387653|NCT01072149|20673248|P2|STARTED|Treatment Period 2 (28 Days)||3
8387654|NCT01072149|20673249|P1|STARTED|Treatment Period 2 (28 Days)||3
8387655|NCT01072149|20673232|P18|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387656|NCT01072149|20673233|P17|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387657|NCT01072149|20673234|P16|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387658|NCT01072149|20673235|P15|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387659|NCT01072149|20673236|P14|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387660|NCT01072149|20673237|P13|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387661|NCT01072149|20673238|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387662|NCT01072149|20673239|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387663|NCT01072149|20673240|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387664|NCT01072149|20673241|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387665|NCT01072149|20673242|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387666|NCT01072149|20673243|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387667|NCT01072149|20673244|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387668|NCT01072149|20673245|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387669|NCT01072149|20673246|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387670|NCT01072149|20673247|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387671|NCT01072149|20673248|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387672|NCT01072149|20673249|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
8387673|NCT01072149|20673232|P18|COMPLETED|Washout Period 1 (14 Days)||2
8387674|NCT01072149|20673233|P17|COMPLETED|Washout Period 1 (14 Days)||3
8387675|NCT01072149|20673234|P16|COMPLETED|Washout Period 1 (14 Days)||3
8387676|NCT01072149|20673235|P15|COMPLETED|Washout Period 1 (14 Days)||3
8387677|NCT01072149|20673236|P14|COMPLETED|Washout Period 1 (14 Days)||3
8387678|NCT01072149|20673237|P13|COMPLETED|Washout Period 1 (14 Days)||3
8387679|NCT01072149|20673238|P12|COMPLETED|Washout Period 1 (14 Days)||3
8387680|NCT01072149|20673239|P11|COMPLETED|Washout Period 1 (14 Days)||2
8387681|NCT01072149|20673240|P10|COMPLETED|Washout Period 1 (14 Days)||3
8387682|NCT01072149|20673241|P9|COMPLETED|Washout Period 1 (14 Days)||3
8387683|NCT01072149|20673242|P8|COMPLETED|Washout Period 1 (14 Days)||3
8387684|NCT01072149|20673243|P7|COMPLETED|Washout Period 1 (14 Days)||3
8387685|NCT01072149|20673244|P6|COMPLETED|Washout Period 1 (14 Days)||3
8387686|NCT01072149|20673245|P5|COMPLETED|Washout Period 1 (14 Days)||3
8387687|NCT01072149|20673246|P4|COMPLETED|Washout Period 1 (14 Days)||3
8387688|NCT01072149|20673247|P3|COMPLETED|Washout Period 1 (14 Days)||2
8387689|NCT01072149|20673248|P2|COMPLETED|Washout Period 1 (14 Days)||3
8387690|NCT01072149|20673249|P1|COMPLETED|Washout Period 1 (14 Days)||3
8387691|NCT01072149|20673232|P18|STARTED|Washout Period 1 (14 Days)||2
8387692|NCT01072149|20673233|P17|STARTED|Washout Period 1 (14 Days)||3
8387693|NCT01072149|20673234|P16|STARTED|Washout Period 1 (14 Days)||3
8387694|NCT01072149|20673235|P15|STARTED|Washout Period 1 (14 Days)||3
8387695|NCT01072149|20673236|P14|STARTED|Washout Period 1 (14 Days)||3
8387696|NCT01072149|20673237|P13|STARTED|Washout Period 1 (14 Days)||3
8387697|NCT01072149|20673238|P12|STARTED|Washout Period 1 (14 Days)||3
8387698|NCT01072149|20673239|P11|STARTED|Washout Period 1 (14 Days)||2
8387699|NCT01072149|20673240|P10|STARTED|Washout Period 1 (14 Days)||3
8387700|NCT01072149|20673241|P9|STARTED|Washout Period 1 (14 Days)||3
8387701|NCT01072149|20673242|P8|STARTED|Washout Period 1 (14 Days)||3
8387702|NCT01072149|20673243|P7|STARTED|Washout Period 1 (14 Days)||3
8387703|NCT01072149|20673244|P6|STARTED|Washout Period 1 (14 Days)||3
8387704|NCT01072149|20673245|P5|STARTED|Washout Period 1 (14 Days)||3
8387705|NCT01072149|20673246|P4|STARTED|Washout Period 1 (14 Days)||3
8387706|NCT01072149|20673247|P3|STARTED|Washout Period 1 (14 Days)||2
8387707|NCT01072149|20673248|P2|STARTED|Washout Period 1 (14 Days)||3
8387708|NCT01072149|20673249|P1|STARTED|Washout Period 1 (14 Days)||3
8387709|NCT01072149|20673232|P18|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8387710|NCT01072149|20673233|P17|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387711|NCT01072149|20673234|P16|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387712|NCT01072149|20673235|P15|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387713|NCT01072149|20673236|P14|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387714|NCT01072149|20673237|P13|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387715|NCT01072149|20673238|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387716|NCT01072149|20673239|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8387717|NCT01072149|20673240|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387718|NCT01072149|20673241|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387719|NCT01072149|20673242|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387720|NCT01072149|20673243|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387721|NCT01072149|20673244|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387722|NCT01072149|20673245|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387723|NCT01072149|20673246|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387724|NCT01072149|20673247|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8387725|NCT01072149|20673248|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387726|NCT01072149|20673249|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8387727|NCT01072149|20673232|P18|COMPLETED|Treatment Period 1 (28 Days)||2
8387728|NCT01072149|20673233|P17|COMPLETED|Treatment Period 1 (28 Days)||3
8387729|NCT01072149|20673234|P16|COMPLETED|Treatment Period 1 (28 Days)||3
8387730|NCT01072149|20673235|P15|COMPLETED|Treatment Period 1 (28 Days)||3
8387731|NCT01072149|20673236|P14|COMPLETED|Treatment Period 1 (28 Days)||3
8387732|NCT01072149|20673237|P13|COMPLETED|Treatment Period 1 (28 Days)||3
8387733|NCT01072149|20673238|P12|COMPLETED|Treatment Period 1 (28 Days)||3
8387734|NCT01072149|20673239|P11|COMPLETED|Treatment Period 1 (28 Days)||2
8387735|NCT01072149|20673240|P10|COMPLETED|Treatment Period 1 (28 Days)||3
8387736|NCT01072149|20673241|P9|COMPLETED|Treatment Period 1 (28 Days)||3
8387737|NCT01072149|20673242|P8|COMPLETED|Treatment Period 1 (28 Days)||3
8387738|NCT01072149|20673243|P7|COMPLETED|Treatment Period 1 (28 Days)||3
8387739|NCT01072149|20673244|P6|COMPLETED|Treatment Period 1 (28 Days)||3
8387740|NCT01072149|20673245|P5|COMPLETED|Treatment Period 1 (28 Days)||3
8387741|NCT01072149|20673246|P4|COMPLETED|Treatment Period 1 (28 Days)||3
8387742|NCT01072149|20673247|P3|COMPLETED|Treatment Period 1 (28 Days)||2
8387743|NCT01072149|20673248|P2|COMPLETED|Treatment Period 1 (28 Days)||3
8387744|NCT01072149|20673249|P1|COMPLETED|Treatment Period 1 (28 Days)||3
8387745|NCT01072149|20673232|P18|STARTED|Treatment Period 1 (28 Days)||3
8387746|NCT01072149|20673233|P17|STARTED|Treatment Period 1 (28 Days)||3
8387747|NCT01072149|20673234|P16|STARTED|Treatment Period 1 (28 Days)||3
8387748|NCT01072149|20673235|P15|STARTED|Treatment Period 1 (28 Days)||3
8387749|NCT01072149|20673236|P14|STARTED|Treatment Period 1 (28 Days)||3
8387750|NCT01072149|20673237|P13|STARTED|Treatment Period 1 (28 Days)||3
8387751|NCT01072149|20673238|P12|STARTED|Treatment Period 1 (28 Days)||3
8387752|NCT01072149|20673239|P11|STARTED|Treatment Period 1 (28 Days)||3
8387753|NCT01072149|20673240|P10|STARTED|Treatment Period 1 (28 Days)||3
8387754|NCT01072149|20673241|P9|STARTED|Treatment Period 1 (28 Days)||3
8387755|NCT01072149|20673242|P8|STARTED|Treatment Period 1 (28 Days)||3
8387756|NCT01072149|20673243|P7|STARTED|Treatment Period 1 (28 Days)||3
8387757|NCT01072149|20673244|P6|STARTED|Treatment Period 1 (28 Days)||3
8387758|NCT01072149|20673245|P5|STARTED|Treatment Period 1 (28 Days)||3
8387759|NCT01072149|20673246|P4|STARTED|Treatment Period 1 (28 Days)||3
8387760|NCT01072149|20673247|P3|STARTED|Treatment Period 1 (28 Days)||3
8387761|NCT01072149|20673248|P2|STARTED|Treatment Period 1 (28 Days)||3
8387762|NCT01072149|20673249|P1|STARTED|Treatment Period 1 (28 Days)||3
8387763|NCT01072136|20673269|P2|NOT COMPLETED|Overall Study||31
8387764|NCT01072136|20673270|P1|NOT COMPLETED|Overall Study||23
8387765|NCT01072136|20673269|P2|COMPLETED|Overall Study||12
8387766|NCT01072136|20673270|P1|COMPLETED|Overall Study||21
8387767|NCT01072136|20673269|P2|Met All Enrollment Criteria|Overall Study||25
8387768|NCT01072136|20673270|P1|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
8387769|NCT01072136|20673269|P2|STARTED|Overall Study||43
8387770|NCT01072136|20673270|P1|STARTED|Overall Study||44
8387771|NCT01072032|20673294|P2|NOT COMPLETED|Overall Study||9
8387772|NCT01072032|20673295|P1|NOT COMPLETED|Overall Study||8
8387773|NCT01072032|20673294|P2|COMPLETED|Overall Study||5
8387774|NCT01072032|20673295|P1|COMPLETED|Overall Study||5
8387775|NCT01072032|20673294|P2|STARTED|Overall Study||14
8387776|NCT01072032|20673295|P1|STARTED|Overall Study||13
8387777|NCT01072006|20673309|P4|NOT COMPLETED|Overall Study||0
8387778|NCT01072006|20673310|P3|NOT COMPLETED|Overall Study||0
8387779|NCT01072006|20673311|P2|NOT COMPLETED|Overall Study||0
8387780|NCT01072006|20673312|P1|NOT COMPLETED|Overall Study||0
8387781|NCT01072006|20673309|P4|COMPLETED|Overall Study||11
8387782|NCT01072006|20673310|P3|COMPLETED|Overall Study||0
8387783|NCT01072006|20673311|P2|COMPLETED|Overall Study||5
8387784|NCT01072006|20673312|P1|COMPLETED|Overall Study||14
8387785|NCT01072006|20673309|P4|STARTED|Overall Study||11
8387786|NCT01072006|20673310|P3|STARTED|Overall Study||0
8387787|NCT01072006|20673311|P2|STARTED|Overall Study||5
8387788|NCT01072006|20673312|P1|STARTED|Overall Study||14
8387789|NCT01071993|20673331|P2|NOT COMPLETED|Overall Study||0
8387790|NCT01071993|20673332|P1|NOT COMPLETED|Overall Study||0
8387791|NCT01071993|20673331|P2|COMPLETED|Overall Study||0
8387792|NCT01071993|20673332|P1|COMPLETED|Overall Study||0
8387793|NCT01071993|20673331|P2|STARTED|Overall Study||0
8387794|NCT01071993|20673332|P1|STARTED|Overall Study||0
8387795|NCT01071954|20673338|P1|NOT COMPLETED|Overall Study||27
8387796|NCT01071954|20673338|P1|COMPLETED|Overall Study||39
8387797|NCT01071954|20673338|P1|Received Treatment|Overall Study||65
8387798|NCT01071954|20673338|P1|STARTED|Overall Study||66
8387799|NCT01071915|20673347|P1|NOT COMPLETED|Overall Study||9
8387800|NCT01071915|20673347|P1|COMPLETED|Overall Study||148
8387801|NCT01071915|20673347|P1|Safety Analysis Set|Overall Study||156
8387802|NCT01071915|20673347|P1|Full Analysis Set (FAS)|Overall Study||155
8387803|NCT01071915|20673347|P1|STARTED|Overall Study|Intention to Treat Analysis Set|157
8387804|NCT01071798|20673357|P1|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
8387805|NCT01071798|20673357|P1|COMPLETED|Subpopulation Who Received Two Cycles||805
8387806|NCT01071798|20673357|P1|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
8387807|NCT01071798|20673357|P1|STARTED|Subpopulation Who Received Two Cycles||820
8387808|NCT01071798|20673357|P1|NOT COMPLETED|Participants Who Received One Cycle||65
8387809|NCT01071798|20673357|P1|COMPLETED|Participants Who Received One Cycle||1588
8387810|NCT01071798|20673357|P1|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
8387811|NCT01071798|20673357|P1|STARTED|Participants Who Received One Cycle||1653
8387812|NCT01071538|20673377|P1|NOT COMPLETED|Overall Study||2
8387813|NCT01071538|20673377|P1|COMPLETED|Overall Study||13
8387814|NCT01071538|20673377|P1|STARTED|Overall Study||15
8387815|NCT01071512|20673387|P1|NOT COMPLETED|Overall Study||5
8387816|NCT01071512|20673387|P1|COMPLETED|Overall Study||15
8387817|NCT01071512|20673387|P1|STARTED|Overall Study||20
8387818|NCT01071395|20673397|P2|NOT COMPLETED|Overall Study||2
8387819|NCT01071395|20673398|P1|NOT COMPLETED|Overall Study||5
8387820|NCT01071395|20673397|P2|COMPLETED|Overall Study||30
8387821|NCT01071395|20673398|P1|COMPLETED|Overall Study||31
8387822|NCT01071395|20673397|P2|STARTED|Overall Study||32
8387823|NCT01071395|20673398|P1|STARTED|Overall Study||36
8387824|NCT01071356|20673406|P2|NOT COMPLETED|Overall Study||9
8387825|NCT01071356|20673407|P1|NOT COMPLETED|Overall Study||7
8387826|NCT01071356|20673406|P2|COMPLETED|Overall Study||97
8387827|NCT01071356|20673407|P1|COMPLETED|Overall Study||104
8387828|NCT01071356|20673406|P2|STARTED|Overall Study||106
8387829|NCT01071356|20673407|P1|STARTED|Overall Study||111
8387830|NCT01071317|20673417|P2|NOT COMPLETED|Overall Study||2
8387831|NCT01071317|20673418|P1|NOT COMPLETED|Overall Study||2
8387832|NCT01071317|20673417|P2|COMPLETED|Overall Study||23
8387833|NCT01071317|20673418|P1|COMPLETED|Overall Study||23
8387834|NCT01071317|20673417|P2|STARTED|Overall Study||25
8387835|NCT01071317|20673418|P1|STARTED|Overall Study||25
8387836|NCT01071278|20673430|P1|NOT COMPLETED|Overall Study||713
8387837|NCT01071278|20673430|P1|COMPLETED|Overall Study||1677
8387838|NCT01071278|20673430|P1|STARTED|Overall Study||2390
8387839|NCT01071252|20673441|P5|NOT COMPLETED|Overall Study||11
8387840|NCT01071252|20673442|P4|NOT COMPLETED|Overall Study||7
8387841|NCT01071252|20673443|P3|NOT COMPLETED|Overall Study||4
8387842|NCT01071252|20673444|P2|NOT COMPLETED|Overall Study||10
8387843|NCT01071252|20673445|P1|NOT COMPLETED|Overall Study||15
8387844|NCT01071252|20673441|P5|COMPLETED|Overall Study||11
8387845|NCT01071252|20673442|P4|COMPLETED|Overall Study||20
8387846|NCT01071252|20673443|P3|COMPLETED|Overall Study||17
8387847|NCT01071252|20673444|P2|COMPLETED|Overall Study||16
8387848|NCT01071252|20673445|P1|COMPLETED|Overall Study||14
8387849|NCT01071252|20673441|P5|STARTED|Overall Study||22
8387850|NCT01071252|20673442|P4|STARTED|Overall Study||27
8387851|NCT01071252|20673443|P3|STARTED|Overall Study||21
8387852|NCT01071252|20673444|P2|STARTED|Overall Study||26
8387853|NCT01071252|20673445|P1|STARTED|Overall Study||29
8387854|NCT01071200|20673473|P2|NOT COMPLETED|Overall Study||3
8387855|NCT01071200|20673474|P1|NOT COMPLETED|Overall Study||7
8387856|NCT01071200|20673473|P2|COMPLETED|Overall Study||63
8387857|NCT01071200|20673474|P1|COMPLETED|Overall Study||60
8387858|NCT01071200|20673473|P2|STARTED|Overall Study||66
8387859|NCT01071200|20673474|P1|STARTED|Overall Study||67
8387860|NCT01071096|20673506|P2|NOT COMPLETED|Second Intervention (90 Days)||0
8387861|NCT01071096|20673507|P1|NOT COMPLETED|Second Intervention (90 Days)||0
8387862|NCT01071096|20673506|P2|COMPLETED|Second Intervention (90 Days)||10
8387863|NCT01071096|20673507|P1|COMPLETED|Second Intervention (90 Days)||9
8387864|NCT01071096|20673506|P2|STARTED|Second Intervention (90 Days)||10
8387865|NCT01071096|20673507|P1|STARTED|Second Intervention (90 Days)||9
8387866|NCT01071096|20673506|P2|NOT COMPLETED|Washout Period (30 Days)||0
8387867|NCT01071096|20673507|P1|NOT COMPLETED|Washout Period (30 Days)||0
8387868|NCT01071096|20673506|P2|COMPLETED|Washout Period (30 Days)||10
8387869|NCT01071096|20673507|P1|COMPLETED|Washout Period (30 Days)||9
8387870|NCT01071096|20673506|P2|STARTED|Washout Period (30 Days)||10
8387871|NCT01071096|20673507|P1|STARTED|Washout Period (30 Days)||9
8387872|NCT01071096|20673506|P2|NOT COMPLETED|First Intervention (90 Days)||0
8387873|NCT01071096|20673507|P1|NOT COMPLETED|First Intervention (90 Days)||1
8387874|NCT01071096|20673506|P2|COMPLETED|First Intervention (90 Days)||10
8387875|NCT01071096|20673507|P1|COMPLETED|First Intervention (90 Days)||9
8387876|NCT01071096|20673506|P2|STARTED|First Intervention (90 Days)||10
8387877|NCT01071096|20673507|P1|STARTED|First Intervention (90 Days)||10
8387878|NCT01071083|20673531|P5|NOT COMPLETED|Overall Study||8
8387879|NCT01071083|20673532|P4|NOT COMPLETED|Overall Study||2
8387880|NCT01071083|20673533|P3|NOT COMPLETED|Overall Study||5
8387881|NCT01071083|20673534|P2|NOT COMPLETED|Overall Study||2
8387882|NCT01071083|20673535|P1|NOT COMPLETED|Overall Study||7
8387883|NCT01071083|20673531|P5|COMPLETED|Overall Study||46
8387884|NCT01071083|20673532|P4|COMPLETED|Overall Study||15
8387885|NCT01071083|20673533|P3|COMPLETED|Overall Study||12
8387886|NCT01071083|20673534|P2|COMPLETED|Overall Study||43
8387887|NCT01071083|20673535|P1|COMPLETED|Overall Study||35
8387888|NCT01071083|20673531|P5|STARTED|Overall Study||54
8387889|NCT01071083|20673532|P4|STARTED|Overall Study||17
8387890|NCT01071083|20673533|P3|STARTED|Overall Study||17
8387891|NCT01071083|20673534|P2|STARTED|Overall Study||45
8387892|NCT01071083|20673535|P1|STARTED|Overall Study||42
8387893|NCT01071070|20673554|P2|NOT COMPLETED|Overall Study||3
8387894|NCT01071070|20673555|P1|NOT COMPLETED|Overall Study||4
8387895|NCT01071070|20673554|P2|COMPLETED|Overall Study||105
8387896|NCT01071070|20673555|P1|COMPLETED|Overall Study||104
8387897|NCT01071070|20673554|P2|STARTED|Overall Study||108
8387898|NCT01071070|20673555|P1|STARTED|Overall Study||108
8387899|NCT01071044|20673579|P2|NOT COMPLETED|Overall Study||0
8387900|NCT01071044|20673580|P1|NOT COMPLETED|Overall Study||2
8387901|NCT01071044|20673579|P2|COMPLETED|Overall Study||11
8387902|NCT01071044|20673580|P1|COMPLETED|Overall Study||13
8387903|NCT01071044|20673579|P2|STARTED|Overall Study||11
8387904|NCT01071044|20673580|P1|STARTED|Overall Study||15
8387905|NCT01070979|20673601|P3|NOT COMPLETED|Overall Study||13
8387906|NCT01070979|20673602|P2|NOT COMPLETED|Overall Study||12
8387907|NCT01070979|20673603|P1|NOT COMPLETED|Overall Study||11
8387908|NCT01070979|20673601|P3|COMPLETED|Overall Study||72
8387909|NCT01070979|20673602|P2|COMPLETED|Overall Study||73
8387910|NCT01070979|20673603|P1|COMPLETED|Overall Study||68
8387911|NCT01070979|20673601|P3|STARTED|Overall Study||85
8387912|NCT01070979|20673602|P2|STARTED|Overall Study||85
8387913|NCT01070979|20673603|P1|STARTED|Overall Study||79
8387914|NCT01070966|20673629|P1|NOT COMPLETED|Participants for Efficacy Evaluation||82
8387915|NCT01070966|20673629|P1|COMPLETED|Participants for Efficacy Evaluation||1929
8387916|NCT01070966|20673629|P1|STARTED|Participants for Efficacy Evaluation||2011
8387917|NCT01070966|20673629|P1|NOT COMPLETED|Participants for Safety Evaluation||78
8387918|NCT01070966|20673629|P1|COMPLETED|Participants for Safety Evaluation||2011
8387919|NCT01070966|20673629|P1|STARTED|Participants for Safety Evaluation||2089
8387920|NCT01070953|20673640|P1|NOT COMPLETED|Participants for Efficacy Evaluation||227
8387921|NCT01070953|20673640|P1|COMPLETED|Participants for Efficacy Evaluation||3309
8387922|NCT01070953|20673640|P1|STARTED|Participants for Efficacy Evaluation||3536
8387923|NCT01070953|20673640|P1|NOT COMPLETED|Participants for Safety Evaluation||931
8387924|NCT01070953|20673640|P1|COMPLETED|Participants for Safety Evaluation||3536
8387925|NCT01070953|20673640|P1|STARTED|Participants for Safety Evaluation||4467
8387944|NCT01070810|20673662|P2|NOT COMPLETED|Overall Study||0
8387945|NCT01070810|20673663|P1|NOT COMPLETED|Overall Study||0
8387946|NCT01070810|20673662|P2|COMPLETED|Overall Study||43
8387947|NCT01070810|20673663|P1|COMPLETED|Overall Study||45
8387948|NCT01070810|20673662|P2|STARTED|Overall Study||43
8387949|NCT01070810|20673663|P1|STARTED|Overall Study||45
8387950|NCT01070784|20673679|P2|NOT COMPLETED|Overall Study||18
8387951|NCT01070784|20673680|P1|NOT COMPLETED|Overall Study||20
8387952|NCT01070784|20673679|P2|COMPLETED|Overall Study||112
8387953|NCT01070784|20673680|P1|COMPLETED|Overall Study||110
8387954|NCT01070784|20673679|P2|STARTED|Overall Study||130
8387955|NCT01070784|20673680|P1|STARTED|Overall Study||130
8387956|NCT01070771|20673768|P1|NOT COMPLETED|Overall Study||3
8387957|NCT01070771|20673768|P1|COMPLETED|Overall Study|August 2012|200
8387958|NCT01070771|20673768|P1|STARTED|Overall Study|September 2008|203
8387959|NCT01070693|20673775|P2|NOT COMPLETED|Overall Study||39
8387960|NCT01070693|20673776|P1|NOT COMPLETED|Overall Study||28
8387961|NCT01070693|20673775|P2|COMPLETED|Overall Study||110
8387962|NCT01070693|20673776|P1|COMPLETED|Overall Study||122
8387963|NCT01070693|20673775|P2|STARTED|Overall Study||149
8387964|NCT01070693|20673776|P1|STARTED|Overall Study||150
8387965|NCT01070550|20673788|P6|NOT COMPLETED|Overall Study||7
8387966|NCT01070550|20673789|P5|NOT COMPLETED|Overall Study||1
8387967|NCT01070550|20673790|P4|NOT COMPLETED|Overall Study||77
8387968|NCT01070550|20673791|P3|NOT COMPLETED|Overall Study||216
8387969|NCT01070550|20673792|P2|NOT COMPLETED|Overall Study||62
8387970|NCT01070550|20673793|P1|NOT COMPLETED|Overall Study||1285
8387971|NCT01070550|20673788|P6|COMPLETED|Overall Study||35
8387972|NCT01070550|20673789|P5|COMPLETED|Overall Study||20
8387973|NCT01070550|20673790|P4|COMPLETED|Overall Study||124
8387974|NCT01070550|20673791|P3|COMPLETED|Overall Study||528
8387975|NCT01070550|20673792|P2|COMPLETED|Overall Study||254
8387976|NCT01070550|20673793|P1|COMPLETED|Overall Study||2071
8387977|NCT01070550|20673788|P6|STARTED|Overall Study||42
8387978|NCT01070550|20673789|P5|STARTED|Overall Study||21
8387979|NCT01070550|20673790|P4|STARTED|Overall Study||201
8387980|NCT01070550|20673791|P3|STARTED|Overall Study||744
8387981|NCT01070550|20673792|P2|STARTED|Overall Study||316
8387982|NCT01070550|20673793|P1|STARTED|Overall Study||3356
8387983|NCT01070394|20673933|P1|NOT COMPLETED|Overall Study||7
8387984|NCT01070394|20673933|P1|COMPLETED|Overall Study||33
8387985|NCT01070394|20673933|P1|STARTED|Overall Study||40
8387986|NCT01070381|20673944|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
8387987|NCT01070381|20673945|P1|NOT COMPLETED|Period 2, 1 Week of Wear||1
8387988|NCT01070381|20673944|P2|COMPLETED|Period 2, 1 Week of Wear||106
8387989|NCT01070381|20673945|P1|COMPLETED|Period 2, 1 Week of Wear||108
8387990|NCT01070381|20673944|P2|STARTED|Period 2, 1 Week of Wear||107
8387991|NCT01070381|20673945|P1|STARTED|Period 2, 1 Week of Wear||109
8387992|NCT01070381|20673944|P2|NOT COMPLETED|Period 1, 1 Week of Wear||0
8387993|NCT01070381|20673945|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
8387994|NCT01070381|20673944|P2|COMPLETED|Period 1, 1 Week of Wear||107
8387995|NCT01070381|20673945|P1|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
8387996|NCT01070381|20673944|P2|STARTED|Period 1, 1 Week of Wear||107
8387997|NCT01070381|20673945|P1|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
8387998|NCT01070329|20673953|P2|NOT COMPLETED|Overall Study||49
8387999|NCT01070329|20673954|P1|NOT COMPLETED|Overall Study||52
8388000|NCT01070329|20673953|P2|COMPLETED|Overall Study||217
8388001|NCT01070329|20673954|P1|COMPLETED|Overall Study||209
8388002|NCT01070329|20673953|P2|STARTED|Overall Study||266
8388003|NCT01070329|20673954|P1|STARTED|Overall Study||261
8388004|NCT01070316|20673986|P1|NOT COMPLETED|Extension Phase||4
8388005|NCT01070316|20673986|P1|COMPLETED|Extension Phase||14
8388006|NCT01070316|20673986|P1|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
8388007|NCT01070316|20673986|P1|NOT COMPLETED|Main Phase||0
8388008|NCT01070316|20673986|P1|COMPLETED|Main Phase||20
8388009|NCT01070316|20673986|P1|STARTED|Main Phase||20
8388010|NCT01070303|20673993|P1|NOT COMPLETED|Overall Study||89
8388011|NCT01070303|20673993|P1|COMPLETED|Overall Study||88
8388012|NCT01070303|20673993|P1|STARTED|Overall Study||177
8388013|NCT01070173|20674052|P3|NOT COMPLETED|Overall Study||0
8388014|NCT01070173|20674053|P2|NOT COMPLETED|Overall Study||0
8388015|NCT01070173|20674054|P1|NOT COMPLETED|Overall Study||0
8388016|NCT01070173|20674052|P3|COMPLETED|Overall Study||11
8388017|NCT01070173|20674053|P2|COMPLETED|Overall Study||8
8388018|NCT01070173|20674054|P1|COMPLETED|Overall Study||33
8388019|NCT01070173|20674052|P3|STARTED|Overall Study||11
8388020|NCT01070173|20674053|P2|STARTED|Overall Study||8
8388021|NCT01070173|20674054|P1|STARTED|Overall Study||33
8388022|NCT01070095|20674065|P2|NOT COMPLETED|Intervention Period||0
8388023|NCT01070095|20674066|P1|NOT COMPLETED|Intervention Period||0
8388024|NCT01070095|20674065|P2|COMPLETED|Intervention Period||890
8388025|NCT01070095|20674066|P1|COMPLETED|Intervention Period||18
8388026|NCT01070095|20674065|P2|STARTED|Intervention Period||890
8388027|NCT01070095|20674066|P1|STARTED|Intervention Period||18
8388028|NCT01070095|20674065|P2|NOT COMPLETED|Baseline Period||0
8388029|NCT01070095|20674066|P1|NOT COMPLETED|Baseline Period||1
8388030|NCT01070095|20674065|P2|COMPLETED|Baseline Period||830
8388031|NCT01070095|20674066|P1|COMPLETED|Baseline Period||18
8388032|NCT01070095|20674065|P2|STARTED|Baseline Period||830
8388033|NCT01070095|20674066|P1|STARTED|Baseline Period||19
8388034|NCT01070043|20674088|P3|NOT COMPLETED|Double-Blind Treatment||2
8388035|NCT01070043|20674089|P2|NOT COMPLETED|Double-Blind Treatment||0
8388036|NCT01070043|20674090|P1|NOT COMPLETED|Double-Blind Treatment||0
8388037|NCT01070043|20674088|P3|COMPLETED|Double-Blind Treatment||19
8388038|NCT01070043|20674089|P2|COMPLETED|Double-Blind Treatment||21
8388039|NCT01070043|20674090|P1|COMPLETED|Double-Blind Treatment||0
8388040|NCT01070043|20674088|P3|STARTED|Double-Blind Treatment||21
8388041|NCT01070043|20674089|P2|STARTED|Double-Blind Treatment||21
8388042|NCT01070043|20674090|P1|STARTED|Double-Blind Treatment||0
8388043|NCT01070043|20674088|P3|NOT COMPLETED|Run-In Phase||0
8388044|NCT01070043|20674089|P2|NOT COMPLETED|Run-In Phase||0
8388045|NCT01070043|20674090|P1|NOT COMPLETED|Run-In Phase||18
8388046|NCT01070043|20674088|P3|COMPLETED|Run-In Phase||0
8388047|NCT01070043|20674089|P2|COMPLETED|Run-In Phase||0
8388048|NCT01070043|20674090|P1|COMPLETED|Run-In Phase||42
8388049|NCT01070043|20674088|P3|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
8388050|NCT01070043|20674089|P2|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
8388051|NCT01070043|20674090|P1|STARTED|Run-In Phase||60
8388052|NCT01069939|20674106|P2|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
8388053|NCT01069939|20674107|P1|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
8388054|NCT01069939|20674106|P2|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
8388055|NCT01069939|20674107|P1|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
8388056|NCT01069939|20674106|P2|STARTED|At Data Cut Off Date (26 Feb 2011)||214
8388057|NCT01069939|20674107|P1|STARTED|At Data Cut Off Date (26 Feb 2011)||213
8388058|NCT01069939|20674106|P2|NOT COMPLETED|Randomised and Included in the Analyses||77
8388059|NCT01069939|20674107|P1|NOT COMPLETED|Randomised and Included in the Analyses||49
8388060|NCT01069939|20674106|P2|COMPLETED|Randomised and Included in the Analyses||137
8388061|NCT01069939|20674107|P1|COMPLETED|Randomised and Included in the Analyses||164
8388062|NCT01069939|20674106|P2|STARTED|Randomised and Included in the Analyses||214
8388063|NCT01069939|20674107|P1|STARTED|Randomised and Included in the Analyses||213
8388064|NCT01069900|20674133|P2|NOT COMPLETED|Overall Study||4
8388065|NCT01069900|20674134|P1|NOT COMPLETED|Overall Study||18
8388066|NCT01069900|20674133|P2|COMPLETED|Overall Study||149
8388067|NCT01069900|20674134|P1|COMPLETED|Overall Study||287
8388068|NCT01069900|20674133|P2|Treated|Overall Study||150
8388069|NCT01069900|20674134|P1|Treated|Overall Study||301
8388070|NCT01069900|20674133|P2|STARTED|Overall Study||153
8388071|NCT01069900|20674134|P1|STARTED|Overall Study||305
8388075|NCT01069627|20674191|P1|NOT COMPLETED|Overall Study||20
8388076|NCT01069627|20674191|P1|COMPLETED|Overall Study||0
8388077|NCT01069627|20674191|P1|STARTED|Overall Study||20
8388078|NCT01069562|20674214|P2|NOT COMPLETED|Overall Study||0
8388079|NCT01069562|20674215|P1|NOT COMPLETED|Overall Study||0
8388080|NCT01069562|20674214|P2|COMPLETED|Overall Study||20
8388081|NCT01069562|20674215|P1|COMPLETED|Overall Study||20
8388082|NCT01069562|20674214|P2|STARTED|Overall Study||20
8388083|NCT01069562|20674215|P1|STARTED|Overall Study||20
8388084|NCT01069523|20674241|P2|NOT COMPLETED|Overall Study||7
8388085|NCT01069523|20674242|P1|NOT COMPLETED|Overall Study||4
8388086|NCT01069523|20674241|P2|COMPLETED|Overall Study||9
8388087|NCT01069523|20674242|P1|COMPLETED|Overall Study||9
8388088|NCT01069523|20674241|P2|STARTED|Overall Study||16
8388089|NCT01069523|20674242|P1|STARTED|Overall Study||13
8388090|NCT01069510|20674252|P2|NOT COMPLETED|Overall Study||0
8388091|NCT01069510|20674253|P1|NOT COMPLETED|Overall Study||0
8388092|NCT01069510|20674252|P2|COMPLETED|Overall Study||7
8388093|NCT01069510|20674253|P1|COMPLETED|Overall Study||8
8388094|NCT01069510|20674252|P2|STARTED|Overall Study||7
8388095|NCT01069510|20674253|P1|STARTED|Overall Study||8
8388096|NCT01069484|20674265|P2|NOT COMPLETED|Overall Study||3
8388097|NCT01069484|20674266|P1|NOT COMPLETED|Overall Study||12
8388098|NCT01069484|20674265|P2|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
8388099|NCT01069484|20674266|P1|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
8388100|NCT01069484|20674265|P2|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
8388101|NCT01069484|20674266|P1|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
8388102|NCT01069419|20674274|P1|NOT COMPLETED|Overall Study||715
8388103|NCT01069419|20674274|P1|COMPLETED|Overall Study||402
8388104|NCT01069419|20674274|P1|Full Analysis Set|Overall Study||851
8388105|NCT01069419|20674274|P1|Safety Set|Overall Study||1111
8388106|NCT01069419|20674274|P1|STARTED|Overall Study||1117
8388107|NCT01069354|20674281|P1|NOT COMPLETED|Overall Study||1
8388108|NCT01069354|20674281|P1|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
8388109|NCT01069354|20674281|P1|STARTED|Overall Study||102
8388110|NCT01069341|20674303|P1|NOT COMPLETED|Overall Study||1
8388111|NCT01069341|20674303|P1|COMPLETED|Overall Study||3
8388112|NCT01069341|20674303|P1|STARTED|Overall Study||4
8388113|NCT01069315|20674318|P4|NOT COMPLETED|Overall Study||7
8388114|NCT01069315|20674319|P3|NOT COMPLETED|Overall Study||5
8388115|NCT01069315|20674320|P2|NOT COMPLETED|Overall Study||6
8388116|NCT01069315|20674321|P1|NOT COMPLETED|Overall Study||4
8388117|NCT01069315|20674318|P4|COMPLETED|Overall Study||19
8388118|NCT01069315|20674319|P3|COMPLETED|Overall Study||23
8388119|NCT01069315|20674320|P2|COMPLETED|Overall Study||24
8388120|NCT01069315|20674321|P1|COMPLETED|Overall Study||23
8388121|NCT01069315|20674318|P4|STARTED|Overall Study||26
8388122|NCT01069315|20674319|P3|STARTED|Overall Study||28
8388123|NCT01069315|20674320|P2|STARTED|Overall Study||30
8388124|NCT01069315|20674321|P1|STARTED|Overall Study||27
8388125|NCT01069289|20674345|P2|NOT COMPLETED|Overall Study||56
8388126|NCT01069289|20674346|P1|NOT COMPLETED|Overall Study||42
8388127|NCT01069289|20674345|P2|COMPLETED|Overall Study||601
8388128|NCT01069289|20674346|P1|COMPLETED|Overall Study||594
8388129|NCT01069289|20674345|P2|STARTED|Overall Study||657
8388130|NCT01069289|20674346|P1|STARTED|Overall Study||636
8388131|NCT01069185|20674386|P2|NOT COMPLETED|Overall Study||0
8388132|NCT01069185|20674387|P1|NOT COMPLETED|Overall Study||0
8388133|NCT01069185|20674386|P2|COMPLETED|Overall Study||45
8388134|NCT01069185|20674387|P1|COMPLETED|Overall Study||47
8388135|NCT01069185|20674386|P2|STARTED|Overall Study||45
8388136|NCT01069185|20674387|P1|STARTED|Overall Study||47
8388137|NCT01069172|20674395|P2|NOT COMPLETED|Overall Study||0
8388138|NCT01069172|20674396|P1|NOT COMPLETED|Overall Study||1
8388139|NCT01069172|20674395|P2|COMPLETED|Overall Study|30 eyes|30
8388140|NCT01069172|20674396|P1|COMPLETED|Overall Study|29 eyes|29
8388141|NCT01069172|20674395|P2|STARTED|Overall Study|30 eyes|30
8388142|NCT01069172|20674396|P1|STARTED|Overall Study|30 eyes|30
8388143|NCT01069120|20674406|P1|NOT COMPLETED|Overall Study||27
8388144|NCT01069120|20674406|P1|COMPLETED|Overall Study||0
8388145|NCT01069120|20674406|P1|STARTED|Overall Study||27
8388146|NCT01069003|20674415|P3|NOT COMPLETED|Overall Study||475
8388147|NCT01069003|20674416|P2|NOT COMPLETED|Overall Study||54
8388148|NCT01069003|20674417|P1|NOT COMPLETED|Overall Study||46
8388149|NCT01069003|20674415|P3|COMPLETED|Overall Study||976
8388150|NCT01069003|20674416|P2|COMPLETED|Overall Study||358
8388151|NCT01069003|20674417|P1|COMPLETED|Overall Study||353
8388152|NCT01069003|20674415|P3|STARTED|Overall Study||1451
8388153|NCT01069003|20674416|P2|STARTED|Overall Study||412
8388154|NCT01069003|20674417|P1|STARTED|Overall Study||399
8388155|NCT01068964|20674433|P2|NOT COMPLETED|Overall Study||10
8388156|NCT01068964|20674434|P1|NOT COMPLETED|Overall Study||8
8388157|NCT01068964|20674433|P2|COMPLETED|Overall Study||104
8388158|NCT01068964|20674434|P1|COMPLETED|Overall Study||113
8388159|NCT01068964|20674433|P2|STARTED|Overall Study||114
8388160|NCT01068964|20674434|P1|STARTED|Overall Study||121
8388161|NCT01068912|20674443|P3|NOT COMPLETED|Overall Study||15
8388162|NCT01068912|20674444|P2|NOT COMPLETED|Overall Study||22
8388163|NCT01068912|20674445|P1|NOT COMPLETED|Overall Study||11
8388164|NCT01068912|20674443|P3|COMPLETED|Overall Study||186
8388165|NCT01068912|20674444|P2|COMPLETED|Overall Study||173
8388166|NCT01068912|20674445|P1|COMPLETED|Overall Study||123
8388167|NCT01068912|20674443|P3|STARTED|Overall Study||201
8388168|NCT01068912|20674444|P2|STARTED|Overall Study||195
8388169|NCT01068912|20674445|P1|STARTED|Overall Study||134
8388170|NCT01068873|20674453|P1|NOT COMPLETED|Overall Study||0
8388171|NCT01068873|20674453|P1|COMPLETED|Overall Study||1
8388172|NCT01068873|20674453|P1|STARTED|Overall Study||1
8388173|NCT01068860|20674473|P10|NOT COMPLETED|Overall Study||4
8388174|NCT01068860|20674474|P9|NOT COMPLETED|Overall Study||0
8388175|NCT01068860|20674475|P8|NOT COMPLETED|Overall Study||0
8388176|NCT01068860|20674476|P7|NOT COMPLETED|Overall Study||0
8388177|NCT01068860|20674477|P6|NOT COMPLETED|Overall Study||2
8388178|NCT01068860|20674478|P5|NOT COMPLETED|Overall Study||0
8388179|NCT01068860|20674479|P4|NOT COMPLETED|Overall Study||1
8388180|NCT01068860|20674480|P3|NOT COMPLETED|Overall Study||0
8388181|NCT01068860|20674481|P2|NOT COMPLETED|Overall Study||1
8388182|NCT01068860|20674482|P1|NOT COMPLETED|Overall Study||0
8388183|NCT01068860|20674473|P10|COMPLETED|Overall Study||23
8388184|NCT01068860|20674474|P9|COMPLETED|Overall Study||28
8388185|NCT01068860|20674475|P8|COMPLETED|Overall Study||15
8388186|NCT01068860|20674476|P7|COMPLETED|Overall Study||28
8388187|NCT01068860|20674477|P6|COMPLETED|Overall Study||14
8388188|NCT01068860|20674478|P5|COMPLETED|Overall Study||32
8388189|NCT01068860|20674479|P4|COMPLETED|Overall Study||16
8388190|NCT01068860|20674480|P3|COMPLETED|Overall Study||33
8388191|NCT01068860|20674481|P2|COMPLETED|Overall Study||16
8388192|NCT01068860|20674482|P1|COMPLETED|Overall Study||33
8388193|NCT01068860|20674473|P10|STARTED|Overall Study||27
8388194|NCT01068860|20674474|P9|STARTED|Overall Study||28
8388195|NCT01068860|20674475|P8|STARTED|Overall Study||15
8388196|NCT01068860|20674476|P7|STARTED|Overall Study||28
8388197|NCT01068860|20674477|P6|STARTED|Overall Study||16
8388198|NCT01068860|20674478|P5|STARTED|Overall Study||32
8388199|NCT01068860|20674479|P4|STARTED|Overall Study||17
8388200|NCT01068860|20674480|P3|STARTED|Overall Study||33
8388201|NCT01068860|20674481|P2|STARTED|Overall Study||17
8388202|NCT01068860|20674482|P1|STARTED|Overall Study||33
8388203|NCT01068821|20674656|P2|NOT COMPLETED|Overall Study||0
8388204|NCT01068821|20674657|P1|NOT COMPLETED|Overall Study||1
8388205|NCT01068821|20674656|P2|COMPLETED|Overall Study||29
8388206|NCT01068821|20674657|P1|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
8388207|NCT01068821|20674656|P2|STARTED|Overall Study||29
8388208|NCT01068821|20674657|P1|STARTED|Overall Study||31
8388209|NCT01068769|20674665|P1|NOT COMPLETED|Overall Study||1
8388210|NCT01068769|20674665|P1|COMPLETED|Overall Study||33
8388211|NCT01068769|20674665|P1|STARTED|Overall Study||34
8388212|NCT01068743|20674670|P4|NOT COMPLETED|Period 4||0
8388213|NCT01068743|20674671|P3|NOT COMPLETED|Period 4||0
8388214|NCT01068743|20674672|P2|NOT COMPLETED|Period 4||0
8388215|NCT01068743|20674673|P1|NOT COMPLETED|Period 4||0
8388216|NCT01068743|20674670|P4|COMPLETED|Period 4||6
8388217|NCT01068743|20674671|P3|COMPLETED|Period 4||6
8388218|NCT01068743|20674672|P2|COMPLETED|Period 4||5
8388219|NCT01068743|20674673|P1|COMPLETED|Period 4||6
8388220|NCT01068743|20674670|P4|STARTED|Period 4||6
8388221|NCT01068743|20674671|P3|STARTED|Period 4||6
8388222|NCT01068743|20674672|P2|STARTED|Period 4||5
8388223|NCT01068743|20674673|P1|STARTED|Period 4||6
8388224|NCT01068743|20674670|P4|NOT COMPLETED|Period 3||0
8388225|NCT01068743|20674671|P3|NOT COMPLETED|Period 3||0
8388226|NCT01068743|20674672|P2|NOT COMPLETED|Period 3||1
8388227|NCT01068743|20674673|P1|NOT COMPLETED|Period 3||0
8388228|NCT01068743|20674670|P4|COMPLETED|Period 3||6
8388229|NCT01068743|20674671|P3|COMPLETED|Period 3||6
8388230|NCT01068743|20674672|P2|COMPLETED|Period 3||5
8388231|NCT01068743|20674673|P1|COMPLETED|Period 3||6
8388232|NCT01068743|20674670|P4|STARTED|Period 3||6
8388233|NCT01068743|20674671|P3|STARTED|Period 3||6
8388234|NCT01068743|20674672|P2|STARTED|Period 3||6
8388235|NCT01068743|20674673|P1|STARTED|Period 3||6
8388236|NCT01068743|20674670|P4|NOT COMPLETED|Period 2||0
8388237|NCT01068743|20674671|P3|NOT COMPLETED|Period 2||0
8388238|NCT01068743|20674672|P2|NOT COMPLETED|Period 2||0
8388239|NCT01068743|20674673|P1|NOT COMPLETED|Period 2||0
8388240|NCT01068743|20674670|P4|COMPLETED|Period 2||6
8388241|NCT01068743|20674671|P3|COMPLETED|Period 2||6
8388242|NCT01068743|20674672|P2|COMPLETED|Period 2||6
8388243|NCT01068743|20674673|P1|COMPLETED|Period 2||6
8388244|NCT01068743|20674670|P4|STARTED|Period 2||6
8388245|NCT01068743|20674671|P3|STARTED|Period 2||6
8388246|NCT01068743|20674672|P2|STARTED|Period 2||6
8388247|NCT01068743|20674673|P1|STARTED|Period 2||6
8388248|NCT01068743|20674670|P4|NOT COMPLETED|Period 1||0
8388249|NCT01068743|20674671|P3|NOT COMPLETED|Period 1||0
8388250|NCT01068743|20674672|P2|NOT COMPLETED|Period 1||0
8388251|NCT01068743|20674673|P1|NOT COMPLETED|Period 1||0
8388252|NCT01068743|20674670|P4|COMPLETED|Period 1||6
8388253|NCT01068743|20674671|P3|COMPLETED|Period 1||6
8388254|NCT01068743|20674672|P2|COMPLETED|Period 1||6
8388255|NCT01068743|20674673|P1|COMPLETED|Period 1||6
8388256|NCT01068743|20674670|P4|STARTED|Period 1||6
8388257|NCT01068743|20674671|P3|STARTED|Period 1||6
8388258|NCT01068743|20674672|P2|STARTED|Period 1||6
8388259|NCT01068743|20674673|P1|STARTED|Period 1||6
8388260|NCT01068730|20674747|P4|NOT COMPLETED|Period 4||0
8388261|NCT01068730|20674748|P3|NOT COMPLETED|Period 4||0
8388262|NCT01068730|20674749|P2|NOT COMPLETED|Period 4||1
8388263|NCT01068730|20674750|P1|NOT COMPLETED|Period 4||0
8388264|NCT01068730|20674747|P4|COMPLETED|Period 4||7
8388265|NCT01068730|20674748|P3|COMPLETED|Period 4||7
8388266|NCT01068730|20674749|P2|COMPLETED|Period 4||6
8388267|NCT01068730|20674750|P1|COMPLETED|Period 4||6
8388268|NCT01068730|20674747|P4|STARTED|Period 4||7
8388269|NCT01068730|20674748|P3|STARTED|Period 4||7
8388270|NCT01068730|20674749|P2|STARTED|Period 4||7
8388271|NCT01068730|20674750|P1|STARTED|Period 4||6
8388272|NCT01068730|20674747|P4|NOT COMPLETED|Period 3||0
8388273|NCT01068730|20674748|P3|NOT COMPLETED|Period 3||0
8388274|NCT01068730|20674749|P2|NOT COMPLETED|Period 3||0
8388275|NCT01068730|20674750|P1|NOT COMPLETED|Period 3||1
8388276|NCT01068730|20674747|P4|COMPLETED|Period 3||7
8388277|NCT01068730|20674748|P3|COMPLETED|Period 3||7
8388278|NCT01068730|20674749|P2|COMPLETED|Period 3||7
8388279|NCT01068730|20674750|P1|COMPLETED|Period 3||6
8388280|NCT01068730|20674747|P4|STARTED|Period 3||7
8388281|NCT01068730|20674748|P3|STARTED|Period 3||7
8388282|NCT01068730|20674749|P2|STARTED|Period 3||7
8388283|NCT01068730|20674750|P1|STARTED|Period 3||7
8388284|NCT01068730|20674747|P4|NOT COMPLETED|Period 2||0
8388285|NCT01068730|20674748|P3|NOT COMPLETED|Period 2||0
8388286|NCT01068730|20674749|P2|NOT COMPLETED|Period 2||0
8388287|NCT01068730|20674750|P1|NOT COMPLETED|Period 2||0
8388288|NCT01068730|20674747|P4|COMPLETED|Period 2||7
8388289|NCT01068730|20674748|P3|COMPLETED|Period 2||7
8388290|NCT01068730|20674749|P2|COMPLETED|Period 2||7
8388291|NCT01068730|20674750|P1|COMPLETED|Period 2||7
8388292|NCT01068730|20674747|P4|STARTED|Period 2||7
8388293|NCT01068730|20674748|P3|STARTED|Period 2||7
8388294|NCT01068730|20674749|P2|STARTED|Period 2||7
8388295|NCT01068730|20674750|P1|STARTED|Period 2||7
8388296|NCT01068730|20674747|P4|NOT COMPLETED|Period 1||0
8388297|NCT01068730|20674748|P3|NOT COMPLETED|Period 1||0
8388298|NCT01068730|20674749|P2|NOT COMPLETED|Period 1||0
8388299|NCT01068730|20674750|P1|NOT COMPLETED|Period 1||0
8388300|NCT01068730|20674747|P4|COMPLETED|Period 1||7
8388301|NCT01068730|20674748|P3|COMPLETED|Period 1||7
8388302|NCT01068730|20674749|P2|COMPLETED|Period 1||7
8388303|NCT01068730|20674750|P1|COMPLETED|Period 1||7
8388304|NCT01068730|20674747|P4|STARTED|Period 1||7
8388305|NCT01068730|20674748|P3|STARTED|Period 1||7
8388306|NCT01068730|20674749|P2|STARTED|Period 1||7
8388307|NCT01068730|20674750|P1|STARTED|Period 1||7
8388308|NCT01068717|20674804|P4|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
8388309|NCT01068717|20674805|P3|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
8388310|NCT01068717|20674806|P2|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
8388311|NCT01068717|20674807|P1|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
8388312|NCT01068717|20674804|P4|COMPLETED|Period 4: Treatment Schedule Phase 4||7
8388313|NCT01068717|20674805|P3|COMPLETED|Period 4: Treatment Schedule Phase 4||7
8388314|NCT01068717|20674806|P2|COMPLETED|Period 4: Treatment Schedule Phase 4||6
8388315|NCT01068717|20674807|P1|COMPLETED|Period 4: Treatment Schedule Phase 4||7
8388316|NCT01068717|20674804|P4|STARTED|Period 4: Treatment Schedule Phase 4||7
8388317|NCT01068717|20674805|P3|STARTED|Period 4: Treatment Schedule Phase 4||7
8388318|NCT01068717|20674806|P2|STARTED|Period 4: Treatment Schedule Phase 4||6
8388319|NCT01068717|20674807|P1|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
8388320|NCT01068717|20674804|P4|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
8388321|NCT01068717|20674805|P3|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
8388322|NCT01068717|20674806|P2|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
8388323|NCT01068717|20674807|P1|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
8388324|NCT01068717|20674804|P4|COMPLETED|Period 3: Treatment Schedule Phase 3||7
8388325|NCT01068717|20674805|P3|COMPLETED|Period 3: Treatment Schedule Phase 3||7
8388326|NCT01068717|20674806|P2|COMPLETED|Period 3: Treatment Schedule Phase 3||6
8388327|NCT01068717|20674807|P1|COMPLETED|Period 3: Treatment Schedule Phase 3||7
8388328|NCT01068717|20674804|P4|STARTED|Period 3: Treatment Schedule Phase 3||7
8388329|NCT01068717|20674805|P3|STARTED|Period 3: Treatment Schedule Phase 3||7
8388330|NCT01068717|20674806|P2|STARTED|Period 3: Treatment Schedule Phase 3||6
8388331|NCT01068717|20674807|P1|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
8388332|NCT01068717|20674804|P4|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
8388333|NCT01068717|20674805|P3|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
8388334|NCT01068717|20674806|P2|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
8388335|NCT01068717|20674807|P1|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
8388336|NCT01068717|20674804|P4|COMPLETED|Period 2: Treatment Schedule Phase 2||7
8388337|NCT01068717|20674805|P3|COMPLETED|Period 2: Treatment Schedule Phase 2||7
8388338|NCT01068717|20674806|P2|COMPLETED|Period 2: Treatment Schedule Phase 2||6
8388339|NCT01068717|20674807|P1|COMPLETED|Period 2: Treatment Schedule Phase 2||6
8388340|NCT01068717|20674804|P4|STARTED|Period 2: Treatment Schedule Phase 2||7
8388341|NCT01068717|20674805|P3|STARTED|Period 2: Treatment Schedule Phase 2||7
8388342|NCT01068717|20674806|P2|STARTED|Period 2: Treatment Schedule Phase 2||6
8388343|NCT01068717|20674807|P1|STARTED|Period 2: Treatment Schedule Phase 2||6
8388344|NCT01068717|20674804|P4|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
8388345|NCT01068717|20674805|P3|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
8388346|NCT01068717|20674806|P2|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
8388347|NCT01068717|20674807|P1|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
8388348|NCT01068717|20674804|P4|COMPLETED|Period 1: Treatment Schedule Phase 1||7
8388349|NCT01068717|20674805|P3|COMPLETED|Period 1: Treatment Schedule Phase 1||7
8388350|NCT01068717|20674806|P2|COMPLETED|Period 1: Treatment Schedule Phase 1||6
8388351|NCT01068717|20674807|P1|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
8388352|NCT01068717|20674804|P4|STARTED|Period 1: Treatment Schedule Phase 1||7
8388353|NCT01068717|20674805|P3|STARTED|Period 1: Treatment Schedule Phase 1||7
8388354|NCT01068717|20674806|P2|STARTED|Period 1: Treatment Schedule Phase 1||6
8388355|NCT01068717|20674807|P1|STARTED|Period 1: Treatment Schedule Phase 1||7
8388356|NCT01068678|20674863|P2|NOT COMPLETED|Overall Study||24
8388357|NCT01068678|20674864|P1|NOT COMPLETED|Overall Study||38
8388358|NCT01068678|20674863|P2|COMPLETED|Overall Study||206
8388359|NCT01068678|20674864|P1|COMPLETED|Overall Study||192
8388360|NCT01068678|20674863|P2|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
8388361|NCT01068678|20674864|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
8388362|NCT01068678|20674863|P2|STARTED|Overall Study||230
8388363|NCT01068678|20674864|P1|STARTED|Overall Study||230
8388364|NCT01068665|20674874|P2|NOT COMPLETED|Overall Study||29
8388365|NCT01068665|20674875|P1|NOT COMPLETED|Overall Study||30
8388366|NCT01068665|20674874|P2|COMPLETED|Overall Study||201
8388367|NCT01068665|20674875|P1|COMPLETED|Overall Study||200
8388368|NCT01068665|20674874|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
8388369|NCT01068665|20674875|P1|Exposed|Overall Study||228
8388370|NCT01068665|20674874|P2|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
8388371|NCT01068665|20674875|P1|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
8388372|NCT01068665|20674874|P2|STARTED|Overall Study||230
8388373|NCT01068665|20674875|P1|STARTED|Overall Study||230
8388374|NCT01068652|20674885|P2|NOT COMPLETED|Overall Study||15
8388375|NCT01068652|20674886|P1|NOT COMPLETED|Overall Study||18
8388376|NCT01068652|20674885|P2|COMPLETED|Overall Study||188
8388377|NCT01068652|20674886|P1|COMPLETED|Overall Study||182
8388378|NCT01068652|20674885|P2|STARTED|Overall Study||203
8388379|NCT01068652|20674886|P1|STARTED|Overall Study||200
8388380|NCT01068626|20674926|P2|NOT COMPLETED|Overall Study||2
8388381|NCT01068626|20674927|P1|NOT COMPLETED|Overall Study||3
8388382|NCT01068626|20674926|P2|COMPLETED|Overall Study||27
8388383|NCT01068626|20674927|P1|COMPLETED|Overall Study||27
8388384|NCT01068626|20674926|P2|STARTED|Overall Study||29
8388385|NCT01068626|20674927|P1|STARTED|Overall Study||30
8388386|NCT01068600|20674945|P2|NOT COMPLETED|Overall Study||17
8388387|NCT01068600|20674946|P1|NOT COMPLETED|Overall Study||11
8388388|NCT01068600|20674945|P2|COMPLETED|Overall Study||142
8388389|NCT01068600|20674946|P1|COMPLETED|Overall Study||148
8388390|NCT01068600|20674945|P2|STARTED|Overall Study||159
8388391|NCT01068600|20674946|P1|STARTED|Overall Study||159
8388392|NCT01068548|20674956|P2|NOT COMPLETED|Overall Study||0
8388393|NCT01068548|20674957|P1|NOT COMPLETED|Overall Study||0
8388394|NCT01068548|20674956|P2|COMPLETED|Overall Study||63
8388395|NCT01068548|20674957|P1|COMPLETED|Overall Study||66
8388396|NCT01068548|20674956|P2|STARTED|Overall Study||63
8388397|NCT01068548|20674957|P1|STARTED|Overall Study||66
8388398|NCT01068509|20674968|P3|NOT COMPLETED|Overall Study||21
8388399|NCT01068509|20674969|P2|NOT COMPLETED|Overall Study||22
8388400|NCT01068509|20674970|P1|NOT COMPLETED|Overall Study||6
8388401|NCT01068509|20674968|P3|COMPLETED|Overall Study||6
8388402|NCT01068509|20674969|P2|COMPLETED|Overall Study||7
8388403|NCT01068509|20674970|P1|COMPLETED|Overall Study||1
8388404|NCT01068509|20674968|P3|STARTED|Overall Study||27
8388405|NCT01068509|20674969|P2|STARTED|Overall Study||29
8388406|NCT01068509|20674970|P1|STARTED|Overall Study||7
8388407|NCT01068418|20674983|P1|NOT COMPLETED|Overall Study||12
8388408|NCT01068418|20674983|P1|COMPLETED|Overall Study|14 participants completed all study procedures.|14
8388409|NCT01068418|20674983|P1|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
8388410|NCT01068418|20674983|P1|STARTED|Overall Study|26 participants found to be eligible|26
8388411|NCT01068262|20674992|P4|NOT COMPLETED|Overall Study||0
8388412|NCT01068262|20674993|P3|NOT COMPLETED|Overall Study||1
8388413|NCT01068262|20674994|P2|NOT COMPLETED|Overall Study||1
8388414|NCT01068262|20674995|P1|NOT COMPLETED|Overall Study||3
8388415|NCT01068262|20674992|P4|COMPLETED|Overall Study||2
8388416|NCT01068262|20674993|P3|COMPLETED|Overall Study||9
8388417|NCT01068262|20674994|P2|COMPLETED|Overall Study||8
8388418|NCT01068262|20674995|P1|COMPLETED|Overall Study||20
8388419|NCT01068262|20674992|P4|STARTED|Overall Study||2
8388420|NCT01068262|20674993|P3|STARTED|Overall Study||10
8388421|NCT01068262|20674994|P2|STARTED|Overall Study||9
8388422|NCT01068262|20674995|P1|STARTED|Overall Study||23
8388423|NCT01068158|20675025|P2|NOT COMPLETED|Overall Study||4
8388424|NCT01068158|20675026|P1|NOT COMPLETED|Overall Study||8
8388425|NCT01068158|20675025|P2|COMPLETED|Overall Study||198
8388426|NCT01068158|20675026|P1|COMPLETED|Overall Study||161
8388427|NCT01068158|20675025|P2|STARTED|Overall Study||202
8388428|NCT01068158|20675026|P1|STARTED|Overall Study||169
8388429|NCT01067976|20675038|P1|NOT COMPLETED|Overall Study||22
8388430|NCT01067976|20675038|P1|COMPLETED|Overall Study|study course completed|424
8388431|NCT01067976|20675038|P1|Fulfilled Requirements of FAS Population|Overall Study||390
8388432|NCT01067976|20675038|P1|Received Treatment|Overall Study|treatment started|426
8388433|NCT01067976|20675038|P1|STARTED|Overall Study|screened and enrolled|446
8388434|NCT01067846|20675099|P2|NOT COMPLETED|Overall Study||19
8388435|NCT01067846|20675100|P1|NOT COMPLETED|Overall Study||19
8388436|NCT01067846|20675099|P2|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
8388437|NCT01067846|20675100|P1|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
8388438|NCT01067846|20675099|P2|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
8388439|NCT01067846|20675100|P1|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
8388440|NCT01067846|20675099|P2|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
8388441|NCT01067846|20675100|P1|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
8388442|NCT01067781|20675112|P4|NOT COMPLETED|180 to Day 720||89
8388443|NCT01067781|20675113|P3|NOT COMPLETED|180 to Day 720||89
8388444|NCT01067781|20675114|P2|NOT COMPLETED|180 to Day 720||164
8388445|NCT01067781|20675115|P1|NOT COMPLETED|180 to Day 720||170
8388446|NCT01067781|20675112|P4|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
8388447|NCT01067781|20675113|P3|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
8388448|NCT01067781|20675114|P2|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
8388449|NCT01067781|20675115|P1|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
8388450|NCT01067781|20675112|P4|STARTED|180 to Day 720||89
8388451|NCT01067781|20675113|P3|STARTED|180 to Day 720||89
8388452|NCT01067781|20675114|P2|STARTED|180 to Day 720||168
8388453|NCT01067781|20675115|P1|STARTED|180 to Day 720||173
8388454|NCT01067781|20675112|P4|NOT COMPLETED|Up to Day 180||12
8388455|NCT01067781|20675113|P3|NOT COMPLETED|Up to Day 180||8
8388456|NCT01067781|20675114|P2|NOT COMPLETED|Up to Day 180||31
8388457|NCT01067781|20675115|P1|NOT COMPLETED|Up to Day 180||30
8388458|NCT01067781|20675112|P4|COMPLETED|Up to Day 180||89
8388459|NCT01067781|20675113|P3|COMPLETED|Up to Day 180||89
8388460|NCT01067781|20675114|P2|COMPLETED|Up to Day 180||168
8388461|NCT01067781|20675115|P1|COMPLETED|Up to Day 180||173
8388462|NCT01067781|20675112|P4|STARTED|Up to Day 180||101
8388463|NCT01067781|20675113|P3|STARTED|Up to Day 180||97
8388464|NCT01067781|20675114|P2|STARTED|Up to Day 180||199
8388465|NCT01067781|20675115|P1|STARTED|Up to Day 180||203
8388466|NCT01067768|20675137|P2|NOT COMPLETED|Overall Study||0
8388467|NCT01067768|20675138|P1|NOT COMPLETED|Overall Study||0
8388468|NCT01067768|20675137|P2|COMPLETED|Overall Study||605
8388469|NCT01067768|20675138|P1|COMPLETED|Overall Study||604
8388470|NCT01067768|20675137|P2|STARTED|Overall Study||605
8388471|NCT01067768|20675138|P1|STARTED|Overall Study||604
8388472|NCT01067716|20675149|P3|NOT COMPLETED|Overall Study||0
8388473|NCT01067716|20675150|P2|NOT COMPLETED|Overall Study||0
8388474|NCT01067716|20675151|P1|NOT COMPLETED|Overall Study||0
8388475|NCT01067716|20675149|P3|COMPLETED|Overall Study|15 eyes|9
8388476|NCT01067716|20675150|P2|COMPLETED|Overall Study|25 eyes|13
8388477|NCT01067716|20675151|P1|COMPLETED|Overall Study|110 eyes|57
8388478|NCT01067716|20675149|P3|STARTED|Overall Study|15 eyes|9
8388479|NCT01067716|20675150|P2|STARTED|Overall Study|25 eyes|13
8388480|NCT01067716|20675151|P1|STARTED|Overall Study|110 eyes|57
8388481|NCT01067521|20675170|P2|NOT COMPLETED|Open-Label Period||158
8388482|NCT01067521|20675171|P1|NOT COMPLETED|Open-Label Period||254
8388483|NCT01067521|20675170|P2|COMPLETED|Open-Label Period||261
8388484|NCT01067521|20675171|P1|COMPLETED|Open-Label Period||580
8388485|NCT01067521|20675170|P2|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
8388486|NCT01067521|20675171|P1|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
8388487|NCT01067521|20675170|P2|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
8388488|NCT01067521|20675171|P1|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
8388489|NCT01067521|20675170|P2|COMPLETED|Double-Blind Placebo-Controlled Period||430
8388490|NCT01067521|20675171|P1|COMPLETED|Double-Blind Placebo-Controlled Period||859
8388491|NCT01067521|20675170|P2|STARTED|Double-Blind Placebo-Controlled Period||461
8388492|NCT01067521|20675171|P1|STARTED|Double-Blind Placebo-Controlled Period||943
8388493|NCT01067508|20675197|P2|NOT COMPLETED|Overall Study||2
8388494|NCT01067508|20675198|P1|NOT COMPLETED|Overall Study||0
8388495|NCT01067508|20675197|P2|COMPLETED|Overall Study||7
8388496|NCT01067508|20675198|P1|COMPLETED|Overall Study||10
8388497|NCT01067508|20675197|P2|STARTED|Overall Study||9
8388498|NCT01067508|20675198|P1|STARTED|Overall Study||10
8388499|NCT01067469|20675206|P2|NOT COMPLETED|Overall Study||2
8388500|NCT01067469|20675207|P1|NOT COMPLETED|Overall Study||0
8388501|NCT01067469|20675206|P2|COMPLETED|Overall Study||33
8388502|NCT01067469|20675207|P1|COMPLETED|Overall Study||36
8388503|NCT01067469|20675206|P2|75 mg/m^2|Overall Study||21
8388504|NCT01067469|20675207|P1|75 mg/m^2|Overall Study||0
8388505|NCT01067469|20675206|P2|90 mg/m^2|Overall Study||12
8388506|NCT01067469|20675207|P1|90 mg/m^2|Overall Study||0
8388507|NCT01067469|20675206|P2|STARTED|Overall Study||35
8388508|NCT01067469|20675207|P1|STARTED|Overall Study||36
8388509|NCT01067456|20675225|P2|NOT COMPLETED|Overall Study||0
8388510|NCT01067456|20675226|P1|NOT COMPLETED|Overall Study||0
8388511|NCT01067456|20675225|P2|COMPLETED|Overall Study||29
8388512|NCT01067456|20675226|P1|COMPLETED|Overall Study||30
8388513|NCT01067456|20675225|P2|STARTED|Overall Study||29
8388514|NCT01067456|20675226|P1|STARTED|Overall Study||30
8388515|NCT01067352|20675239|P3|NOT COMPLETED|Overall Study||1
8388516|NCT01067352|20675240|P2|NOT COMPLETED|Overall Study||3
8388517|NCT01067352|20675241|P1|NOT COMPLETED|Overall Study||1
8388518|NCT01067352|20675239|P3|COMPLETED|Overall Study||9
8388519|NCT01067352|20675240|P2|COMPLETED|Overall Study||3
8388520|NCT01067352|20675241|P1|COMPLETED|Overall Study||8
8388521|NCT01067352|20675239|P3|STARTED|Overall Study||10
8388522|NCT01067352|20675240|P2|STARTED|Overall Study||6
8388523|NCT01067352|20675241|P1|STARTED|Overall Study||9
8388524|NCT01067339|20675257|P2|NOT COMPLETED|Overall Study||5
8388525|NCT01067339|20675258|P1|NOT COMPLETED|Overall Study||6
8388526|NCT01067339|20675257|P2|COMPLETED|Overall Study||29
8388527|NCT01067339|20675258|P1|COMPLETED|Overall Study||25
8388528|NCT01067339|20675257|P2|STARTED|Overall Study||34
8388529|NCT01067339|20675258|P1|STARTED|Overall Study||31
8388530|NCT01067326|20675268|P2|NOT COMPLETED|Overall Study||3
8388531|NCT01067326|20675269|P1|NOT COMPLETED|Overall Study||2
8388532|NCT01067326|20675268|P2|COMPLETED|Overall Study||5
8388533|NCT01067326|20675269|P1|COMPLETED|Overall Study||12
8388534|NCT01067326|20675268|P2|STARTED|Overall Study||8
8388535|NCT01067326|20675269|P1|STARTED|Overall Study||14
8388536|NCT01067144|20675283|P2|NOT COMPLETED|Follow-up||56
8388537|NCT01067144|20675284|P1|NOT COMPLETED|Follow-up||59
8388538|NCT01067144|20675283|P2|COMPLETED|Follow-up||152
8388539|NCT01067144|20675284|P1|COMPLETED|Follow-up||144
8388540|NCT01067144|20675283|P2|Intention-to-Treat Analysis Set|Follow-up||208
8388541|NCT01067144|20675284|P1|Intention-to-Treat Analysis Set|Follow-up||202
8388542|NCT01067144|20675283|P2|STARTED|Follow-up||208
8388543|NCT01067144|20675284|P1|STARTED|Follow-up||203
8388544|NCT01067144|20675283|P2|NOT COMPLETED|Treatment||7
8388545|NCT01067144|20675284|P1|NOT COMPLETED|Treatment||4
8388546|NCT01067144|20675283|P2|COMPLETED|Treatment||208
8388547|NCT01067144|20675284|P1|COMPLETED|Treatment||203
8388548|NCT01067144|20675283|P2|STARTED|Treatment||215
8388549|NCT01067144|20675284|P1|STARTED|Treatment||207
8388550|NCT01067105|20675300|P1|NOT COMPLETED|Overall Study||141
8388551|NCT01067105|20675300|P1|COMPLETED|Overall Study||683
8388552|NCT01067105|20675300|P1|STARTED|Overall Study||824
8388553|NCT01066936|20675317|P1|NOT COMPLETED|Overall Study||10
8388554|NCT01066936|20675317|P1|COMPLETED|Overall Study||10
8388555|NCT01066936|20675317|P1|STARTED|Overall Study||20
8388556|NCT01066923|20675353|P4|NOT COMPLETED|Overall Study||8
8388557|NCT01066923|20675354|P3|NOT COMPLETED|Overall Study||8
8388558|NCT01066923|20675355|P2|NOT COMPLETED|Overall Study||3
8388559|NCT01066923|20675356|P1|NOT COMPLETED|Overall Study||3
8388560|NCT01066923|20675353|P4|COMPLETED|Overall Study||23
8388561|NCT01066923|20675354|P3|COMPLETED|Overall Study||25
8388562|NCT01066923|20675355|P2|COMPLETED|Overall Study||29
8388563|NCT01066923|20675356|P1|COMPLETED|Overall Study||25
8388564|NCT01066923|20675353|P4|Retinal Imaging|Overall Study||0
8388565|NCT01066923|20675354|P3|Retinal Imaging|Overall Study||0
8388566|NCT01066923|20675355|P2|Retinal Imaging|Overall Study||0
8388567|NCT01066923|20675356|P1|Retinal Imaging|Overall Study||0
8388568|NCT01066923|20675353|P4|Activation of Coagulation|Overall Study||0
8388569|NCT01066923|20675354|P3|Activation of Coagulation|Overall Study||0
8388570|NCT01066923|20675355|P2|Activation of Coagulation|Overall Study||0
8388571|NCT01066923|20675356|P1|Activation of Coagulation|Overall Study||0
8388572|NCT01066923|20675353|P4|Vascular Function|Overall Study||13
8388573|NCT01066923|20675354|P3|Vascular Function|Overall Study||12
8388574|NCT01066923|20675355|P2|Vascular Function|Overall Study||14
8388575|NCT01066923|20675356|P1|Vascular Function|Overall Study||13
8388576|NCT01066923|20675353|P4|Platelet Closure Time|Overall Study||23
8388577|NCT01066923|20675354|P3|Platelet Closure Time|Overall Study||25
8388578|NCT01066923|20675355|P2|Platelet Closure Time|Overall Study||29
8388579|NCT01066923|20675356|P1|Platelet Closure Time|Overall Study||25
8388580|NCT01066923|20675353|P4|STARTED|Overall Study||31
8388581|NCT01066923|20675354|P3|STARTED|Overall Study||33
8388582|NCT01066923|20675355|P2|STARTED|Overall Study||32
8388583|NCT01066923|20675356|P1|STARTED|Overall Study||28
8388584|NCT01066897|20675380|P2|NOT COMPLETED|Overall Study||0
8388585|NCT01066897|20675381|P1|NOT COMPLETED|Overall Study||2
8388586|NCT01066897|20675380|P2|COMPLETED|Overall Study||9
8388587|NCT01066897|20675381|P1|COMPLETED|Overall Study||5
8388588|NCT01066897|20675380|P2|STARTED|Overall Study||9
8388589|NCT01066897|20675381|P1|STARTED|Overall Study||7
8388590|NCT01066871|20675395|P4|NOT COMPLETED|Overall Study||5
8388591|NCT01066871|20675396|P3|NOT COMPLETED|Overall Study||6
8388592|NCT01066871|20675397|P2|NOT COMPLETED|Overall Study||5
8388593|NCT01066871|20675398|P1|NOT COMPLETED|Overall Study||4
8388594|NCT01066871|20675395|P4|COMPLETED|Overall Study||13
8388595|NCT01066871|20675396|P3|COMPLETED|Overall Study||12
8388596|NCT01066871|20675397|P2|COMPLETED|Overall Study||13
8388597|NCT01066871|20675398|P1|COMPLETED|Overall Study||16
8388598|NCT01066871|20675395|P4|STARTED|Overall Study||18
8388599|NCT01066871|20675396|P3|STARTED|Overall Study||18
8388600|NCT01066871|20675397|P2|STARTED|Overall Study||18
8388601|NCT01066871|20675398|P1|STARTED|Overall Study||20
8388602|NCT01066819|20675462|P6|NOT COMPLETED|Overall Study||6
8388603|NCT01066819|20675463|P5|NOT COMPLETED|Overall Study||4
8388604|NCT01066819|20675464|P4|NOT COMPLETED|Overall Study||17
8388605|NCT01066819|20675465|P3|NOT COMPLETED|Overall Study||146
8388606|NCT01066819|20675466|P2|NOT COMPLETED|Overall Study||171
8388607|NCT01066819|20675467|P1|NOT COMPLETED|Overall Study||689
8388608|NCT01066819|20675462|P6|COMPLETED|Overall Study||7
8388609|NCT01066819|20675463|P5|COMPLETED|Overall Study||3
8388610|NCT01066819|20675464|P4|COMPLETED|Overall Study||8
8388611|NCT01066819|20675465|P3|COMPLETED|Overall Study||111
8388612|NCT01066819|20675466|P2|COMPLETED|Overall Study||177
8388613|NCT01066819|20675467|P1|COMPLETED|Overall Study||317
8388614|NCT01066819|20675462|P6|STARTED|Overall Study||13
8388615|NCT01066819|20675463|P5|STARTED|Overall Study||7
8388616|NCT01066819|20675464|P4|STARTED|Overall Study||25
8388617|NCT01066819|20675465|P3|STARTED|Overall Study||257
8388618|NCT01066819|20675466|P2|STARTED|Overall Study||348
8388619|NCT01066819|20675467|P1|STARTED|Overall Study||1006
8388620|NCT01066793|20675608|P6|NOT COMPLETED|Overall Study||1
8388621|NCT01066793|20675609|P5|NOT COMPLETED|Overall Study||0
8388622|NCT01066793|20675610|P4|NOT COMPLETED|Overall Study||49
8388623|NCT01066793|20675611|P3|NOT COMPLETED|Overall Study||115
8388624|NCT01066793|20675612|P2|NOT COMPLETED|Overall Study||77
8388625|NCT01066793|20675613|P1|NOT COMPLETED|Overall Study||374
8388626|NCT01066793|20675608|P6|COMPLETED|Overall Study||4
8388627|NCT01066793|20675609|P5|COMPLETED|Overall Study||11
8388628|NCT01066793|20675610|P4|COMPLETED|Overall Study||94
8388629|NCT01066793|20675611|P3|COMPLETED|Overall Study||369
8388630|NCT01066793|20675612|P2|COMPLETED|Overall Study||495
8388631|NCT01066793|20675613|P1|COMPLETED|Overall Study||754
8388632|NCT01066793|20675608|P6|STARTED|Overall Study||5
8388633|NCT01066793|20675609|P5|STARTED|Overall Study||11
8388634|NCT01066793|20675610|P4|STARTED|Overall Study||143
8388635|NCT01066793|20675611|P3|STARTED|Overall Study||484
8388636|NCT01066793|20675612|P2|STARTED|Overall Study||572
8388637|NCT01066793|20675613|P1|STARTED|Overall Study||1128
8388638|NCT01066780|20675753|P2|NOT COMPLETED|Overall Study||1
8388639|NCT01066780|20675754|P1|NOT COMPLETED|Overall Study||1
8388640|NCT01066780|20675753|P2|COMPLETED|Overall Study||23
8388641|NCT01066780|20675754|P1|COMPLETED|Overall Study||23
8388642|NCT01066780|20675753|P2|STARTED|Overall Study||24
8388643|NCT01066780|20675754|P1|STARTED|Overall Study||24
8388644|NCT01066637|20675760|P2|NOT COMPLETED|Overall Study||0
8388645|NCT01066637|20675761|P1|NOT COMPLETED|Overall Study||0
8388646|NCT01066637|20675760|P2|COMPLETED|Overall Study||10
8388647|NCT01066637|20675761|P1|COMPLETED|Overall Study||16
8388648|NCT01066637|20675760|P2|STARTED|Overall Study||10
8388649|NCT01066637|20675761|P1|STARTED|Overall Study||16
8388650|NCT01066624|20675772|P3|NOT COMPLETED|Overall Study||0
8388651|NCT01066624|20675773|P2|NOT COMPLETED|Overall Study||0
8388652|NCT01066624|20675774|P1|NOT COMPLETED|Overall Study||0
8388653|NCT01066624|20675772|P3|COMPLETED|Overall Study||39
8388654|NCT01066624|20675773|P2|COMPLETED|Overall Study||40
8388655|NCT01066624|20675774|P1|COMPLETED|Overall Study||38
8388656|NCT01066624|20675772|P3|STARTED|Overall Study||39
8388657|NCT01066624|20675773|P2|STARTED|Overall Study||40
8388658|NCT01066624|20675774|P1|STARTED|Overall Study||38
8388659|NCT01066585|20675784|P2|NOT COMPLETED|Overall Study||3
8388660|NCT01066585|20675785|P1|NOT COMPLETED|Overall Study||1
8388661|NCT01066585|20675784|P2|COMPLETED|Overall Study||196
8388662|NCT01066585|20675785|P1|COMPLETED|Overall Study||210
8388663|NCT01066585|20675784|P2|STARTED|Overall Study||199
8388664|NCT01066585|20675785|P1|STARTED|Overall Study||211
8388665|NCT01066546|20675797|P1|NOT COMPLETED|Overall Study||5
8388666|NCT01066546|20675797|P1|COMPLETED|Overall Study||0
8388667|NCT01066546|20675797|P1|STARTED|Overall Study||5
8388668|NCT01066520|20675811|P3|NOT COMPLETED|Overall Study||0
8388669|NCT01066520|20675812|P2|NOT COMPLETED|Overall Study||0
8388670|NCT01066520|20675813|P1|NOT COMPLETED|Overall Study||0
8388671|NCT01066520|20675811|P3|COMPLETED|Overall Study||137
8388672|NCT01066520|20675812|P2|COMPLETED|Overall Study||140
8388673|NCT01066520|20675813|P1|COMPLETED|Overall Study||143
8388674|NCT01066520|20675811|P3|STARTED|Overall Study||137
8388675|NCT01066520|20675812|P2|STARTED|Overall Study||140
8388676|NCT01066520|20675813|P1|STARTED|Overall Study||143
8388677|NCT01066364|20675829|P2|NOT COMPLETED|Overall Study||2
8388678|NCT01066364|20675830|P1|NOT COMPLETED|Overall Study||3
8388679|NCT01066364|20675829|P2|COMPLETED|Overall Study||23
8388680|NCT01066364|20675830|P1|COMPLETED|Overall Study||22
8388681|NCT01066364|20675829|P2|STARTED|Overall Study||25
8388682|NCT01066364|20675830|P1|STARTED|Overall Study||25
8388683|NCT01066156|20675842|P1|NOT COMPLETED|Overall Study||10
8388684|NCT01066156|20675842|P1|COMPLETED|Overall Study||24
8388685|NCT01066156|20675842|P1|STARTED|Overall Study||34
8388686|NCT01066143|20675846|P1|NOT COMPLETED|Overall Study||8
8388687|NCT01066143|20675846|P1|COMPLETED|Overall Study||0
8388688|NCT01066143|20675846|P1|STARTED|Overall Study||8
8388689|NCT01066104|20675852|P2|NOT COMPLETED|Overall Study||1
8388690|NCT01066104|20675853|P1|NOT COMPLETED|Overall Study||2
8388691|NCT01066104|20675852|P2|COMPLETED|Overall Study||12
8388692|NCT01066104|20675853|P1|COMPLETED|Overall Study||12
8388693|NCT01066104|20675852|P2|STARTED|Overall Study||13
8388694|NCT01066104|20675853|P1|STARTED|Overall Study||14
8388695|NCT01066052|20675863|P2|NOT COMPLETED|Overall Study||0
8388696|NCT01066052|20675864|P1|NOT COMPLETED|Overall Study||3
8388697|NCT01066052|20675863|P2|COMPLETED|Overall Study||51
8388698|NCT01066052|20675864|P1|COMPLETED|Overall Study||61
8388699|NCT01066052|20675863|P2|Treated|Overall Study||0
8388700|NCT01066052|20675864|P1|Treated|Overall Study||61
8388701|NCT01066052|20675863|P2|STARTED|Overall Study||51
8388702|NCT01066052|20675864|P1|STARTED|Overall Study||64
8388703|NCT01066039|20675875|P1|NOT COMPLETED|Overall Study||44
8388704|NCT01066039|20675875|P1|COMPLETED|Overall Study||158
8388705|NCT01066039|20675875|P1|Treated|Overall Study||200
8388706|NCT01066039|20675875|P1|STARTED|Overall Study||202
8388707|NCT01066026|20675888|P1|NOT COMPLETED|Overall Study||2
8388708|NCT01066026|20675888|P1|COMPLETED|Overall Study||23
8388709|NCT01066026|20675888|P1|STARTED|Overall Study|Each patient was injected with hyaluronic acid in each nasolabial fold (total: 2 injections)|25
8388710|NCT01066000|20675900|P1|NOT COMPLETED|Overall Study||9
8388711|NCT01066000|20675900|P1|COMPLETED|Overall Study||24
8388712|NCT01066000|20675900|P1|STARTED|Overall Study||33
8388713|NCT01065844|20675911|P1|NOT COMPLETED|Overall Study||5
8388714|NCT01065844|20675911|P1|COMPLETED|Overall Study||10
8388715|NCT01065844|20675911|P1|STARTED|Overall Study||15
8388716|NCT01065818|20675915|P1|NOT COMPLETED|Overall Study||2
8388717|NCT01065818|20675915|P1|COMPLETED|Overall Study||4
8388718|NCT01065818|20675915|P1|STARTED|Overall Study||6
8388719|NCT01065779|20675919|P1|NOT COMPLETED|Overall Study||82
8388720|NCT01065779|20675919|P1|COMPLETED|Overall Study||798
8388721|NCT01065779|20675919|P1|STARTED|Overall Study||880
8388722|NCT01065766|20675930|P1|NOT COMPLETED|Overall Study||32
8388723|NCT01065766|20675930|P1|COMPLETED|Overall Study||4033
8388724|NCT01065766|20675930|P1|STARTED|Overall Study||4065
8388725|NCT01065714|20675942|P1|NOT COMPLETED|Overall Study||0
8388726|NCT01065714|20675942|P1|COMPLETED|Overall Study||20
8388727|NCT01065714|20675942|P1|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
8388728|NCT01065597|20675949|P1|NOT COMPLETED|Overall Study||1
8388729|NCT01065597|20675949|P1|COMPLETED|Overall Study||12
8388730|NCT01065597|20675949|P1|STARTED|Overall Study||13
8388731|NCT01065571|20675958|P2|NOT COMPLETED|Overall Study||0
8388732|NCT01065571|20675959|P1|NOT COMPLETED|Overall Study||3
8388733|NCT01065571|20675958|P2|COMPLETED|Overall Study||5
8388734|NCT01065571|20675959|P1|COMPLETED|Overall Study||7
8388735|NCT01065571|20675958|P2|STARTED|Overall Study||5
8388736|NCT01065571|20675959|P1|STARTED|Overall Study||10
8388737|NCT01065558|20675969|P1|NOT COMPLETED|Overall Study||0
8388738|NCT01065558|20675969|P1|COMPLETED|Overall Study||5
8388739|NCT01065558|20675969|P1|STARTED|Overall Study||5
8388740|NCT01065506|20675976|P2|NOT COMPLETED|Overall Study||38
8388741|NCT01065506|20675977|P1|NOT COMPLETED|Overall Study||32
8388742|NCT01065506|20675976|P2|COMPLETED|Overall Study||34
8388743|NCT01065506|20675977|P1|COMPLETED|Overall Study||32
8388744|NCT01065506|20675976|P2|4-Month Follow-Up|Overall Study||34
8388745|NCT01065506|20675977|P1|4-Month Follow-Up|Overall Study||35
8388746|NCT01065506|20675976|P2|End of Treatment|Overall Study||37
8388747|NCT01065506|20675977|P1|End of Treatment|Overall Study||44
8388748|NCT01065506|20675976|P2|STARTED|Overall Study||72
8388749|NCT01065506|20675977|P1|STARTED|Overall Study||64
8388750|NCT01065480|20675985|P2|NOT COMPLETED|Overall Study||0
8388751|NCT01065480|20675986|P1|NOT COMPLETED|Overall Study||0
8388752|NCT01065480|20675985|P2|COMPLETED|Overall Study||43
8388753|NCT01065480|20675986|P1|COMPLETED|Overall Study||48
8388754|NCT01065480|20675985|P2|STARTED|Overall Study||43
8388755|NCT01065480|20675986|P1|STARTED|Overall Study||48
8388784|NCT01065428|20676111|P2|NOT COMPLETED|Overall Study||0
8388785|NCT01065428|20676112|P1|NOT COMPLETED|Overall Study||0
8388786|NCT01065428|20676111|P2|COMPLETED|Overall Study||35
8388787|NCT01065428|20676112|P1|COMPLETED|Overall Study||17
8388788|NCT01065428|20676111|P2|STARTED|Overall Study||35
8388789|NCT01065428|20676112|P1|STARTED|Overall Study||17
8388790|NCT01065350|20676122|P2|NOT COMPLETED|Overall Study||1
8388791|NCT01065350|20676123|P1|NOT COMPLETED|Overall Study||0
8388792|NCT01065350|20676122|P2|COMPLETED|Overall Study||41
8388793|NCT01065350|20676123|P1|COMPLETED|Overall Study||43
8388794|NCT01065350|20676122|P2|STARTED|Overall Study||42
8388795|NCT01065350|20676123|P1|STARTED|Overall Study||43
8388796|NCT01065051|20676157|P2|NOT COMPLETED|Overall Study||0
8388797|NCT01065051|20676158|P1|NOT COMPLETED|Overall Study||0
8388798|NCT01065051|20676157|P2|COMPLETED|Overall Study||0
8388799|NCT01065051|20676158|P1|COMPLETED|Overall Study||1
8388800|NCT01065051|20676157|P2|STARTED|Overall Study||0
8388801|NCT01065051|20676158|P1|STARTED|Overall Study||1
8388802|NCT01064947|20676184|P1|NOT COMPLETED|Overall Study||41
8388803|NCT01064947|20676184|P1|COMPLETED|Overall Study||29
8388804|NCT01064947|20676184|P1|STARTED|Overall Study||70
8388805|NCT01064882|20676195|P3|NOT COMPLETED|Overall Study||2
8388806|NCT01064882|20676196|P2|NOT COMPLETED|Overall Study||2
8388807|NCT01064882|20676197|P1|NOT COMPLETED|Overall Study||2
8388808|NCT01064882|20676195|P3|COMPLETED|Overall Study||32
8388809|NCT01064882|20676196|P2|COMPLETED|Overall Study||32
8388810|NCT01064882|20676197|P1|COMPLETED|Overall Study||34
8388811|NCT01064882|20676195|P3|STARTED|Overall Study||34
8388812|NCT01064882|20676196|P2|STARTED|Overall Study||34
8388813|NCT01064882|20676197|P1|STARTED|Overall Study||36
8388838|NCT01064830|20676261|P2|NOT COMPLETED|Overall Study||4
8388839|NCT01064830|20676262|P1|NOT COMPLETED|Overall Study||2
8388840|NCT01064830|20676261|P2|COMPLETED|Overall Study||7
8388841|NCT01064830|20676262|P1|COMPLETED|Overall Study||8
8388842|NCT01064830|20676261|P2|STARTED|Overall Study||11
8388843|NCT01064830|20676262|P1|STARTED|Overall Study||10
8388856|NCT01064739|20676285|P1|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
8388857|NCT01064739|20676285|P1|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
8388858|NCT01064739|20676285|P1|STARTED|Fixed Sodium Diet + Fava Beans||14
8388859|NCT01064739|20676285|P1|NOT COMPLETED|Fixed Sodium Study Diet||0
8388860|NCT01064739|20676285|P1|COMPLETED|Fixed Sodium Study Diet||14
8388861|NCT01064739|20676285|P1|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
8388862|NCT01064713|20676343|P2|NOT COMPLETED|Overall Study||0
8388863|NCT01064713|20676344|P1|NOT COMPLETED|Overall Study||0
8388864|NCT01064713|20676343|P2|COMPLETED|Overall Study||4
8388865|NCT01064713|20676344|P1|COMPLETED|Overall Study||13
8388866|NCT01064713|20676343|P2|STARTED|Overall Study||4
8388867|NCT01064713|20676344|P1|STARTED|Overall Study||13
8388868|NCT01064687|20676356|P4|NOT COMPLETED|Overall Study||17
8388869|NCT01064687|20676357|P3|NOT COMPLETED|Overall Study||41
8388870|NCT01064687|20676358|P2|NOT COMPLETED|Overall Study||26
8388871|NCT01064687|20676359|P1|NOT COMPLETED|Overall Study||34
8388872|NCT01064687|20676356|P4|COMPLETED|Overall Study||124
8388873|NCT01064687|20676357|P3|COMPLETED|Overall Study||237
8388874|NCT01064687|20676358|P2|COMPLETED|Overall Study||254
8388875|NCT01064687|20676359|P1|COMPLETED|Overall Study||245
8388876|NCT01064687|20676356|P4|Completed 26 Weeks|Overall Study||124
8388877|NCT01064687|20676357|P3|Completed 26 Weeks|Overall Study||252
8388878|NCT01064687|20676358|P2|Completed 26 Weeks|Overall Study||263
8388879|NCT01064687|20676359|P1|Completed 26 Weeks|Overall Study||260
8388880|NCT01064687|20676356|P4|Received at Least 1 Dose of Study Drug|Overall Study||141
8388881|NCT01064687|20676357|P3|Received at Least 1 Dose of Study Drug|Overall Study||276
8388882|NCT01064687|20676358|P2|Received at Least 1 Dose of Study Drug|Overall Study||280
8388883|NCT01064687|20676359|P1|Received at Least 1 Dose of Study Drug|Overall Study||279
8388884|NCT01064687|20676356|P4|STARTED|Overall Study||141
8388885|NCT01064687|20676357|P3|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
8388886|NCT01064687|20676358|P2|STARTED|Overall Study||280
8388887|NCT01064687|20676359|P1|STARTED|Overall Study||279
8388924|NCT01064622|20676568|P2|NOT COMPLETED|Crossover of Arm I||0
8388925|NCT01064622|20676569|P1|NOT COMPLETED|Crossover of Arm I||0
8388926|NCT01064622|20676568|P2|COMPLETED|Crossover of Arm I||0
8388927|NCT01064622|20676569|P1|COMPLETED|Crossover of Arm I||22
8388928|NCT01064622|20676568|P2|STARTED|Crossover of Arm I||0
8388929|NCT01064622|20676569|P1|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
8388930|NCT01064622|20676568|P2|NOT COMPLETED|Randomized Phase II||3
8388931|NCT01064622|20676569|P1|NOT COMPLETED|Randomized Phase II||2
8388932|NCT01064622|20676568|P2|COMPLETED|Randomized Phase II||53
8388933|NCT01064622|20676569|P1|COMPLETED|Randomized Phase II||53
8388934|NCT01064622|20676568|P2|STARTED|Randomized Phase II||56
8388935|NCT01064622|20676569|P1|STARTED|Randomized Phase II||55
8388936|NCT01064622|20676568|P2|NOT COMPLETED|Lead-in Phase I||0
8388937|NCT01064622|20676569|P1|NOT COMPLETED|Lead-in Phase I||0
8388938|NCT01064622|20676568|P2|COMPLETED|Lead-in Phase I||7
8388939|NCT01064622|20676569|P1|COMPLETED|Lead-in Phase I||0
8388940|NCT01064622|20676568|P2|STARTED|Lead-in Phase I||7
8388941|NCT01064622|20676569|P1|STARTED|Lead-in Phase I||0
8388942|NCT01064531|20676592|P2|NOT COMPLETED|Overall Study||7
8388943|NCT01064531|20676593|P1|NOT COMPLETED|Overall Study||3
8388944|NCT01064531|20676592|P2|COMPLETED|Overall Study||13
8388945|NCT01064531|20676593|P1|COMPLETED|Overall Study||18
8388946|NCT01064531|20676592|P2|STARTED|Overall Study||20
8388947|NCT01064531|20676593|P1|STARTED|Overall Study||21
8388948|NCT01064414|20676640|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
8388949|NCT01064414|20676641|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
8388950|NCT01064414|20676642|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
8388951|NCT01064414|20676640|P3|COMPLETED|Extension Period: Week 26 to Week 52||76
8388952|NCT01064414|20676641|P2|COMPLETED|Extension Period: Week 26 to Week 52||67
8388953|NCT01064414|20676642|P1|COMPLETED|Extension Period: Week 26 to Week 52||64
8388954|NCT01064414|20676640|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
8388955|NCT01064414|20676641|P2|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
8388956|NCT01064414|20676642|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
8388957|NCT01064414|20676640|P3|NOT COMPLETED|Core Period: Baseline to Week 26||7
8388958|NCT01064414|20676641|P2|NOT COMPLETED|Core Period: Baseline to Week 26||15
8388959|NCT01064414|20676642|P1|NOT COMPLETED|Core Period: Baseline to Week 26||13
8388960|NCT01064414|20676640|P3|COMPLETED|Core Period: Baseline to Week 26||82
8388961|NCT01064414|20676641|P2|COMPLETED|Core Period: Baseline to Week 26||75
8388962|NCT01064414|20676642|P1|COMPLETED|Core Period: Baseline to Week 26||77
8388963|NCT01064414|20676640|P3|STARTED|Core Period: Baseline to Week 26||89
8388964|NCT01064414|20676641|P2|STARTED|Core Period: Baseline to Week 26||90
8388965|NCT01064414|20676642|P1|STARTED|Core Period: Baseline to Week 26||90
8388966|NCT01064401|20676661|P2|NOT COMPLETED|Overall Study||195
8388967|NCT01064401|20676662|P1|NOT COMPLETED|Overall Study||228
8388968|NCT01064401|20676661|P2|COMPLETED|Overall Study||724
8388969|NCT01064401|20676662|P1|COMPLETED|Overall Study||694
8388970|NCT01064401|20676661|P2|STARTED|Overall Study||919
8388971|NCT01064401|20676662|P1|STARTED|Overall Study||922
8388972|NCT01064362|20676678|P2|NOT COMPLETED|Overall Study||0
8388973|NCT01064362|20676679|P1|NOT COMPLETED|Overall Study||0
8388974|NCT01064362|20676678|P2|COMPLETED|Overall Study||11883
8388975|NCT01064362|20676679|P1|COMPLETED|Overall Study||1559
8388976|NCT01064362|20676678|P2|STARTED|Overall Study||11883
8388977|NCT01064362|20676679|P1|STARTED|Overall Study||1559
8388978|NCT01064323|20676687|P1|NOT COMPLETED|Overall Study||0
8388979|NCT01064323|20676687|P1|COMPLETED|Overall Study||10
8388980|NCT01064323|20676687|P1|STARTED|Overall Study||10
8388981|NCT01064310|20676711|P3|NOT COMPLETED|Open Label Pazopinib||84
8388982|NCT01064310|20676712|P2|NOT COMPLETED|Open Label Pazopinib||0
8388983|NCT01064310|20676713|P1|NOT COMPLETED|Open Label Pazopinib||0
8388984|NCT01064310|20676711|P3|COMPLETED|Open Label Pazopinib||0
8388985|NCT01064310|20676712|P2|COMPLETED|Open Label Pazopinib||0
8388986|NCT01064310|20676713|P1|COMPLETED|Open Label Pazopinib||0
8388987|NCT01064310|20676711|P3|STARTED|Open Label Pazopinib||84
8388988|NCT01064310|20676712|P2|STARTED|Open Label Pazopinib||0
8388989|NCT01064310|20676713|P1|STARTED|Open Label Pazopinib||0
8388990|NCT01064310|20676711|P3|NOT COMPLETED|Period 2||0
8388991|NCT01064310|20676712|P2|NOT COMPLETED|Period 2||6
8388992|NCT01064310|20676713|P1|NOT COMPLETED|Period 2||4
8388993|NCT01064310|20676711|P3|COMPLETED|Period 2||0
8388994|NCT01064310|20676712|P2|COMPLETED|Period 2||62
8388995|NCT01064310|20676713|P1|COMPLETED|Period 2||64
8388996|NCT01064310|20676711|P3|STARTED|Period 2||0
8388997|NCT01064310|20676712|P2|STARTED|Period 2||68
8388998|NCT01064310|20676713|P1|STARTED|Period 2||68
8388999|NCT01064310|20676711|P3|NOT COMPLETED|Period 1||0
8389000|NCT01064310|20676712|P2|NOT COMPLETED|Period 1||18
8389001|NCT01064310|20676713|P1|NOT COMPLETED|Period 1||14
8389002|NCT01064310|20676711|P3|COMPLETED|Period 1||0
8389003|NCT01064310|20676712|P2|COMPLETED|Period 1||68
8389004|NCT01064310|20676713|P1|COMPLETED|Period 1||68
8389005|NCT01064310|20676711|P3|STARTED|Period 1||0
8389006|NCT01064310|20676712|P2|STARTED|Period 1||86
8389007|NCT01064310|20676713|P1|STARTED|Period 1||82
8389008|NCT01064297|20676743|P3|NOT COMPLETED|Overall Study||133
8389009|NCT01064297|20676744|P2|NOT COMPLETED|Overall Study||48
8389010|NCT01064297|20676745|P1|NOT COMPLETED|Overall Study||791
8389011|NCT01064297|20676743|P3|COMPLETED|Overall Study||497
8389012|NCT01064297|20676744|P2|COMPLETED|Overall Study||171
8389013|NCT01064297|20676745|P1|COMPLETED|Overall Study||1776
8389014|NCT01064297|20676743|P3|STARTED|Overall Study||630
8389015|NCT01064297|20676744|P2|STARTED|Overall Study||219
8389016|NCT01064297|20676745|P1|STARTED|Overall Study||2567
8389017|NCT01064284|20676791|P2|NOT COMPLETED|Overall Study||17
8389018|NCT01064284|20676792|P1|NOT COMPLETED|Overall Study||18
8389019|NCT01064284|20676791|P2|COMPLETED|Overall Study||109
8389020|NCT01064284|20676792|P1|COMPLETED|Overall Study||107
8389021|NCT01064284|20676791|P2|STARTED|Overall Study|Taking into account the analyzed patients only|126
8389022|NCT01064284|20676792|P1|STARTED|Overall Study|Taking into account the analyzed patients only|125
8389023|NCT01064167|20676814|P2|NOT COMPLETED|Overall Study||15
8389024|NCT01064167|20676815|P1|NOT COMPLETED|Overall Study||14
8389025|NCT01064167|20676814|P2|COMPLETED|Overall Study||115
8389026|NCT01064167|20676815|P1|COMPLETED|Overall Study||116
8389027|NCT01064167|20676814|P2|STARTED|Overall Study||130
8389028|NCT01064167|20676815|P1|STARTED|Overall Study||130
8389029|NCT01064076|20676823|P1|NOT COMPLETED|Overall Study||18
8389030|NCT01064076|20676823|P1|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
8389031|NCT01064076|20676823|P1|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
8389032|NCT01063972|20676830|P2|NOT COMPLETED|Overall Study||12
8389033|NCT01063972|20676831|P1|NOT COMPLETED|Overall Study||14
8389034|NCT01063972|20676830|P2|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284
8389035|NCT01063972|20676831|P1|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296
8389036|NCT01063972|20676830|P2|STARTED|Overall Study||296
8389037|NCT01063972|20676831|P1|STARTED|Overall Study||310
8389038|NCT01063907|20676847|P2|NOT COMPLETED|Overall Study||0
8389039|NCT01063907|20676848|P1|NOT COMPLETED|Overall Study||0
8389040|NCT01063907|20676847|P2|COMPLETED|Overall Study||80
8389041|NCT01063907|20676848|P1|COMPLETED|Overall Study||15
8389042|NCT01063907|20676847|P2|STARTED|Overall Study||80
8389043|NCT01063907|20676848|P1|STARTED|Overall Study||15
8389044|NCT01063881|20676881|P3|NOT COMPLETED|Overall Study||1
8389045|NCT01063881|20676882|P2|NOT COMPLETED|Overall Study||11
8389046|NCT01063881|20676883|P1|NOT COMPLETED|Overall Study||55
8389047|NCT01063881|20676881|P3|COMPLETED|Overall Study||12
8389048|NCT01063881|20676882|P2|COMPLETED|Overall Study||114
8389049|NCT01063881|20676883|P1|COMPLETED|Overall Study||92
8389050|NCT01063881|20676881|P3|STARTED|Overall Study||13
8389051|NCT01063881|20676882|P2|STARTED|Overall Study||125
8389052|NCT01063881|20676883|P1|STARTED|Overall Study||147
8389053|NCT01063868|20676907|P2|NOT COMPLETED|Overall Study||12
8389054|NCT01063868|20676908|P1|NOT COMPLETED|Overall Study||35
8389055|NCT01063868|20676907|P2|COMPLETED|Overall Study||0
8389056|NCT01063868|20676908|P1|COMPLETED|Overall Study||0
8389057|NCT01063868|20676907|P2|STARTED|Overall Study||12
8389058|NCT01063868|20676908|P1|STARTED|Overall Study||35
8389059|NCT01063855|20676916|P2|NOT COMPLETED|Overall Study||29
8389060|NCT01063855|20676917|P1|NOT COMPLETED|Overall Study||37
8389061|NCT01063855|20676916|P2|COMPLETED|Overall Study||221
8389062|NCT01063855|20676917|P1|COMPLETED|Overall Study||208
8389063|NCT01063855|20676916|P2|STARTED|Overall Study||250
8389064|NCT01063855|20676917|P1|STARTED|Overall Study||245
8389065|NCT01063829|20676943|P4|NOT COMPLETED|Overall Study||21
8389066|NCT01063829|20676944|P3|NOT COMPLETED|Overall Study||10
8389067|NCT01063829|20676945|P2|NOT COMPLETED|Overall Study||10
8389068|NCT01063829|20676946|P1|NOT COMPLETED|Overall Study||16
8389069|NCT01063829|20676943|P4|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
8389070|NCT01063829|20676944|P3|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
8389071|NCT01063829|20676945|P2|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
8389072|NCT01063829|20676946|P1|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
8389073|NCT01063829|20676943|P4|STARTED|Overall Study||33
8389074|NCT01063829|20676944|P3|STARTED|Overall Study||34
8389075|NCT01063829|20676945|P2|STARTED|Overall Study||31
8389076|NCT01063829|20676946|P1|STARTED|Overall Study||33
8389077|NCT01063764|20676964|P1|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
8389078|NCT01063764|20676964|P1|COMPLETED|2nd Period (Week 22 to the End of Study)||35
8389079|NCT01063764|20676964|P1|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
8389080|NCT01063764|20676964|P1|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
8389081|NCT01063764|20676964|P1|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
8389082|NCT01063764|20676964|P1|STARTED|1st Period (From Week 8 to Week 22)||73
8389083|NCT01063712|20676978|P1|NOT COMPLETED|Overall Study||0
8389084|NCT01063712|20676978|P1|COMPLETED|Overall Study||29
8389085|NCT01063712|20676978|P1|STARTED|Overall Study||29
8389086|NCT01063595|20676983|P2|NOT COMPLETED|Second Intervention||0
8389087|NCT01063595|20676984|P1|NOT COMPLETED|Second Intervention||0
8389088|NCT01063595|20676983|P2|COMPLETED|Second Intervention||24
8389089|NCT01063595|20676984|P1|COMPLETED|Second Intervention||29
8389090|NCT01063595|20676983|P2|STARTED|Second Intervention||24
8389091|NCT01063595|20676984|P1|STARTED|Second Intervention||29
8389092|NCT01063595|20676983|P2|NOT COMPLETED|First Intervention||5
8389093|NCT01063595|20676984|P1|NOT COMPLETED|First Intervention||2
8389094|NCT01063595|20676983|P2|COMPLETED|First Intervention||24
8389095|NCT01063595|20676984|P1|COMPLETED|First Intervention||29
8389096|NCT01063595|20676983|P2|STARTED|First Intervention||29
8389097|NCT01063595|20676984|P1|STARTED|First Intervention||31
8389098|NCT01063595|20676983|P2|NOT COMPLETED|Enrolled in Study and Randomized||2
8389099|NCT01063595|20676984|P1|NOT COMPLETED|Enrolled in Study and Randomized||1
8389100|NCT01063595|20676983|P2|COMPLETED|Enrolled in Study and Randomized||29
8389101|NCT01063595|20676984|P1|COMPLETED|Enrolled in Study and Randomized||31
8389102|NCT01063595|20676983|P2|Received Treatment|Enrolled in Study and Randomized||29
8389103|NCT01063595|20676984|P1|Received Treatment|Enrolled in Study and Randomized||31
8389104|NCT01063595|20676983|P2|STARTED|Enrolled in Study and Randomized||31
8389105|NCT01063595|20676984|P1|STARTED|Enrolled in Study and Randomized||32
8389114|NCT01063348|20677037|P2|NOT COMPLETED|Overall Study||10
8389115|NCT01063348|20677038|P1|NOT COMPLETED|Overall Study||3
8389116|NCT01063348|20677037|P2|COMPLETED|Overall Study||21
8389117|NCT01063348|20677038|P1|COMPLETED|Overall Study||32
8389118|NCT01063348|20677037|P2|STARTED|Overall Study||31
8389119|NCT01063348|20677038|P1|STARTED|Overall Study||35
8389120|NCT01063283|20677048|P3|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
8389121|NCT01063283|20677049|P2|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
8389122|NCT01063283|20677050|P1|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
8389123|NCT01063283|20677048|P3|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11
8389124|NCT01063283|20677049|P2|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6
8389125|NCT01063283|20677050|P1|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
8389126|NCT01063283|20677048|P3|STARTED|Randomized Phase (Cycle 2 and Beyond)||11
8389127|NCT01063283|20677049|P2|STARTED|Randomized Phase (Cycle 2 and Beyond)||6
8389128|NCT01063283|20677050|P1|STARTED|Randomized Phase (Cycle 2 and Beyond)||0
8389129|NCT01063283|20677048|P3|NOT COMPLETED|Cycle 1||0
8389130|NCT01063283|20677049|P2|NOT COMPLETED|Cycle 1||0
8389131|NCT01063283|20677050|P1|NOT COMPLETED|Cycle 1||3
8389132|NCT01063283|20677048|P3|COMPLETED|Cycle 1||0
8389133|NCT01063283|20677049|P2|COMPLETED|Cycle 1||0
8389134|NCT01063283|20677050|P1|COMPLETED|Cycle 1||17
8389135|NCT01063283|20677048|P3|STARTED|Cycle 1||0
8389136|NCT01063283|20677049|P2|STARTED|Cycle 1||0
8389137|NCT01063283|20677050|P1|STARTED|Cycle 1||20
8389138|NCT01063153|20677064|P2|NOT COMPLETED|Overall Study||12
8389139|NCT01063153|20677065|P1|NOT COMPLETED|Overall Study||2
8389140|NCT01063153|20677064|P2|COMPLETED|Overall Study||26
8389141|NCT01063153|20677065|P1|COMPLETED|Overall Study||31
8389142|NCT01063153|20677064|P2|STARTED|Overall Study||38
8389143|NCT01063153|20677065|P1|STARTED|Overall Study||33
8389144|NCT01063075|20677075|P4|NOT COMPLETED|Overall Study||1
8389145|NCT01063075|20677076|P3|NOT COMPLETED|Overall Study||5
8389146|NCT01063075|20677077|P2|NOT COMPLETED|Overall Study||2
8389147|NCT01063075|20677078|P1|NOT COMPLETED|Overall Study||1
8389148|NCT01063075|20677075|P4|COMPLETED|Overall Study||14
8389149|NCT01063075|20677076|P3|COMPLETED|Overall Study||9
8389150|NCT01063075|20677077|P2|COMPLETED|Overall Study||1
8389151|NCT01063075|20677078|P1|COMPLETED|Overall Study||1
8389152|NCT01063075|20677075|P4|STARTED|Overall Study||15
8389153|NCT01063075|20677076|P3|STARTED|Overall Study||14
8389154|NCT01063075|20677077|P2|STARTED|Overall Study||3
8389155|NCT01063075|20677078|P1|STARTED|Overall Study||2
8389156|NCT01063062|20677096|P2|NOT COMPLETED|Overall Study||12
8389157|NCT01063062|20677097|P1|NOT COMPLETED|Overall Study||8
8389158|NCT01063062|20677096|P2|COMPLETED|Overall Study||65
8389159|NCT01063062|20677097|P1|COMPLETED|Overall Study||22
8389160|NCT01063062|20677096|P2|Received Study Drug|Overall Study||76
8389161|NCT01063062|20677097|P1|Received Study Drug|Overall Study||29
8389162|NCT01063062|20677096|P2|STARTED|Overall Study||77
8389163|NCT01063062|20677097|P1|STARTED|Overall Study||30
8389164|NCT01063049|20677138|P3|NOT COMPLETED|Overall Study||0
8389165|NCT01063049|20677139|P2|NOT COMPLETED|Overall Study||0
8389166|NCT01063049|20677140|P1|NOT COMPLETED|Overall Study||0
8389167|NCT01063049|20677138|P3|COMPLETED|Overall Study||200
8389168|NCT01063049|20677139|P2|COMPLETED|Overall Study||200
8389169|NCT01063049|20677140|P1|COMPLETED|Overall Study||200
8389170|NCT01063049|20677138|P3|STARTED|Overall Study||200
8389171|NCT01063049|20677139|P2|STARTED|Overall Study||200
8389172|NCT01063049|20677140|P1|STARTED|Overall Study||200
8389173|NCT01063036|20677151|P1|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
8389174|NCT01063036|20677151|P1|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
8389175|NCT01063036|20677151|P1|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
8389176|NCT01063036|20677151|P1|NOT COMPLETED|Participants Treated With Study Drug||6
8389177|NCT01063036|20677151|P1|COMPLETED|Participants Treated With Study Drug||86
8389178|NCT01063036|20677151|P1|STARTED|Participants Treated With Study Drug||92
8389179|NCT01062971|20677167|P2|NOT COMPLETED|Overall Study||7
8389180|NCT01062971|20677168|P1|NOT COMPLETED|Overall Study||4
8389181|NCT01062971|20677167|P2|COMPLETED|Overall Study||56
8389182|NCT01062971|20677168|P1|COMPLETED|Overall Study||56
8389183|NCT01062971|20677167|P2|STARTED|Overall Study||63
8389184|NCT01062971|20677168|P1|STARTED|Overall Study||60
8389185|NCT01062893|20677178|P2|NOT COMPLETED|Overall Study||13
8389186|NCT01062893|20677179|P1|NOT COMPLETED|Overall Study||14
8389187|NCT01062893|20677178|P2|COMPLETED|Overall Study||28
8389188|NCT01062893|20677179|P1|COMPLETED|Overall Study||27
8389189|NCT01062893|20677178|P2|STARTED|Overall Study||41
8389190|NCT01062893|20677179|P1|STARTED|Overall Study||41
8389191|NCT01062841|20677207|P2|NOT COMPLETED|Overall Study||53
8389192|NCT01062841|20677208|P1|NOT COMPLETED|Overall Study||49
8389193|NCT01062841|20677207|P2|COMPLETED|Overall Study||162
8389194|NCT01062841|20677208|P1|COMPLETED|Overall Study||154
8389195|NCT01062841|20677207|P2|STARTED|Overall Study||215
8389196|NCT01062841|20677208|P1|STARTED|Overall Study||203
8389197|NCT01062763|20677238|P2|NOT COMPLETED|Overall Study||4
8389198|NCT01062763|20677239|P1|NOT COMPLETED|Overall Study||3
8389199|NCT01062763|20677238|P2|COMPLETED|Overall Study||57
8389200|NCT01062763|20677239|P1|COMPLETED|Overall Study||55
8389201|NCT01062763|20677238|P2|STARTED|Overall Study||61
8389202|NCT01062763|20677239|P1|STARTED|Overall Study|119 randomized.|58
8389203|NCT01062568|20677251|P2|NOT COMPLETED|Overall Study||0
8389204|NCT01062568|20677252|P1|NOT COMPLETED|Overall Study||0
8389205|NCT01062568|20677251|P2|COMPLETED|Overall Study||40
8389206|NCT01062568|20677252|P1|COMPLETED|Overall Study||10
8389207|NCT01062568|20677251|P2|STARTED|Overall Study||40
8389208|NCT01062568|20677252|P1|STARTED|Overall Study||10
8389209|NCT01062555|20677265|P4|NOT COMPLETED|Phase 2||34
8389210|NCT01062555|20677266|P3|NOT COMPLETED|Phase 2||15
8389211|NCT01062555|20677267|P2|NOT COMPLETED|Phase 2||0
8389212|NCT01062555|20677268|P1|NOT COMPLETED|Phase 2||0
8389213|NCT01062555|20677265|P4|COMPLETED|Phase 2||53
8389214|NCT01062555|20677266|P3|COMPLETED|Phase 2||71
8389215|NCT01062555|20677267|P2|COMPLETED|Phase 2||0
8389216|NCT01062555|20677268|P1|COMPLETED|Phase 2||0
8389217|NCT01062555|20677265|P4|STARTED|Phase 2||87
8389218|NCT01062555|20677266|P3|STARTED|Phase 2||86
8389219|NCT01062555|20677267|P2|STARTED|Phase 2||0
8389220|NCT01062555|20677268|P1|STARTED|Phase 2||0
8389221|NCT01062555|20677265|P4|NOT COMPLETED|Phase 1||0
8389222|NCT01062555|20677266|P3|NOT COMPLETED|Phase 1||0
8389223|NCT01062555|20677267|P2|NOT COMPLETED|Phase 1||26
8389224|NCT01062555|20677268|P1|NOT COMPLETED|Phase 1||23
8389225|NCT01062555|20677265|P4|COMPLETED|Phase 1||0
8389226|NCT01062555|20677266|P3|COMPLETED|Phase 1||0
8389227|NCT01062555|20677267|P2|COMPLETED|Phase 1||235
8389228|NCT01062555|20677268|P1|COMPLETED|Phase 1||243
8389229|NCT01062555|20677265|P4|STARTED|Phase 1||0
8389230|NCT01062555|20677266|P3|STARTED|Phase 1||0
8389231|NCT01062555|20677267|P2|STARTED|Phase 1||261
8389232|NCT01062555|20677268|P1|STARTED|Phase 1||266
8389239|NCT01062399|20677306|P5|NOT COMPLETED|Overall Study||4
8389240|NCT01062399|20677307|P4|NOT COMPLETED|Overall Study||6
8389241|NCT01062399|20677308|P3|NOT COMPLETED|Overall Study||0
8389242|NCT01062399|20677309|P2|NOT COMPLETED|Overall Study||1
8389243|NCT01062399|20677310|P1|NOT COMPLETED|Overall Study||0
8389244|NCT01062399|20677306|P5|COMPLETED|Overall Study||88
8389245|NCT01062399|20677307|P4|COMPLETED|Overall Study||83
8389246|NCT01062399|20677308|P3|COMPLETED|Overall Study||8
8389247|NCT01062399|20677309|P2|COMPLETED|Overall Study||9
8389248|NCT01062399|20677310|P1|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
8389249|NCT01062399|20677306|P5|STARTED|Overall Study||92
8389250|NCT01062399|20677307|P4|STARTED|Overall Study||89
8389251|NCT01062399|20677308|P3|STARTED|Overall Study||8
8389252|NCT01062399|20677309|P2|STARTED|Overall Study||10
8389253|NCT01062399|20677310|P1|STARTED|Overall Study||8
8389254|NCT01062308|20677331|P2|NOT COMPLETED|Overall Study||10
8389255|NCT01062308|20677332|P1|NOT COMPLETED|Overall Study||16
8389256|NCT01062308|20677331|P2|COMPLETED|Overall Study||72
8389257|NCT01062308|20677332|P1|COMPLETED|Overall Study||64
8389258|NCT01062308|20677331|P2|STARTED|Overall Study||82
8389259|NCT01062308|20677332|P1|STARTED|Overall Study||80
8389260|NCT01062269|20677340|P1|NOT COMPLETED|Overall Study||0
8389261|NCT01062269|20677340|P1|COMPLETED|Overall Study||42
8389262|NCT01062269|20677340|P1|STARTED|Overall Study||42
8389263|NCT01062256|20677354|P3|NOT COMPLETED|Overall Study||4
8389264|NCT01062256|20677355|P2|NOT COMPLETED|Overall Study||7
8389265|NCT01062256|20677356|P1|NOT COMPLETED|Overall Study||3
8389266|NCT01062256|20677354|P3|COMPLETED|Overall Study||103
8389267|NCT01062256|20677355|P2|COMPLETED|Overall Study||96
8389268|NCT01062256|20677356|P1|COMPLETED|Overall Study||52
8389269|NCT01062256|20677354|P3|STARTED|Overall Study||107
8389270|NCT01062256|20677355|P2|STARTED|Overall Study||103
8389271|NCT01062256|20677356|P1|STARTED|Overall Study||55
8389272|NCT01062230|20677379|P1|NOT COMPLETED|Overall Study||0
8389273|NCT01062230|20677379|P1|COMPLETED|Overall Study||6
8389274|NCT01062230|20677379|P1|STARTED|Overall Study||6
8389275|NCT01062165|20677383|P1|NOT COMPLETED|Overall Study||0
8389276|NCT01062165|20677383|P1|COMPLETED|Overall Study||18
8389277|NCT01062165|20677383|P1|STARTED|Overall Study||18
8389278|NCT01062126|20677387|P1|NOT COMPLETED|Overall Study||533
8389279|NCT01062126|20677387|P1|COMPLETED|Overall Study||2856
8389280|NCT01062126|20677387|P1|STARTED|Overall Study||3389
8389290|NCT01062074|20677409|P1|NOT COMPLETED|Overall Study||0
8389291|NCT01062074|20677409|P1|COMPLETED|Overall Study||3605
8389292|NCT01062074|20677409|P1|STARTED|Overall Study||3605
8389293|NCT01062061|20677414|P1|NOT COMPLETED|Overall Study||27
8389294|NCT01062061|20677414|P1|COMPLETED|Overall Study||727
8389295|NCT01062061|20677414|P1|STARTED|Overall Study||754
8389296|NCT01062009|20677432|P4|NOT COMPLETED|Overall Study||0
8389297|NCT01062009|20677433|P3|NOT COMPLETED|Overall Study||0
8389298|NCT01062009|20677434|P2|NOT COMPLETED|Overall Study||0
8389299|NCT01062009|20677435|P1|NOT COMPLETED|Overall Study||1
8389300|NCT01062009|20677432|P4|COMPLETED|Overall Study||6
8389301|NCT01062009|20677433|P3|COMPLETED|Overall Study||6
8389302|NCT01062009|20677434|P2|COMPLETED|Overall Study||6
8389303|NCT01062009|20677435|P1|COMPLETED|Overall Study||6
8389304|NCT01062009|20677432|P4|STARTED|Overall Study||6
8389305|NCT01062009|20677433|P3|STARTED|Overall Study||6
8389306|NCT01062009|20677434|P2|STARTED|Overall Study||6
8389307|NCT01062009|20677435|P1|STARTED|Overall Study||7
8389308|NCT01061866|20677453|P1|NOT COMPLETED|Overall Study||2
8389309|NCT01061866|20677453|P1|COMPLETED|Overall Study||5
8389310|NCT01061866|20677453|P1|STARTED|Overall Study||7
8389311|NCT01061775|20677457|P1|NOT COMPLETED|Overall Study||3
8389312|NCT01061775|20677457|P1|COMPLETED|Overall Study||16
8389313|NCT01061775|20677457|P1|STARTED|Overall Study||19
8389314|NCT01061736|20677474|P10|NOT COMPLETED|Overall Study||74
8389315|NCT01061736|20677475|P9|NOT COMPLETED|Overall Study||97
8389316|NCT01061736|20677476|P8|NOT COMPLETED|Overall Study||94
8389317|NCT01061736|20677477|P7|NOT COMPLETED|Overall Study||84
8389318|NCT01061736|20677478|P6|NOT COMPLETED|Overall Study||3
8389319|NCT01061736|20677479|P5|NOT COMPLETED|Overall Study||7
8389320|NCT01061736|20677480|P4|NOT COMPLETED|Overall Study||3
8389321|NCT01061736|20677481|P3|NOT COMPLETED|Overall Study||6
8389322|NCT01061736|20677482|P2|NOT COMPLETED|Overall Study||4
8389323|NCT01061736|20677483|P1|NOT COMPLETED|Overall Study||13
8389324|NCT01061736|20677474|P10|COMPLETED|Overall Study||354
8389325|NCT01061736|20677475|P9|COMPLETED|Overall Study||330
8389326|NCT01061736|20677476|P8|COMPLETED|Overall Study||336
8389327|NCT01061736|20677477|P7|COMPLETED|Overall Study||0
8389328|NCT01061736|20677478|P6|COMPLETED|Overall Study||49
8389329|NCT01061736|20677479|P5|COMPLETED|Overall Study||45
8389330|NCT01061736|20677480|P4|COMPLETED|Overall Study||48
8389331|NCT01061736|20677481|P3|COMPLETED|Overall Study||45
8389332|NCT01061736|20677482|P2|COMPLETED|Overall Study||46
8389333|NCT01061736|20677483|P1|COMPLETED|Overall Study||37
8389334|NCT01061736|20677474|P10|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
8389335|NCT01061736|20677475|P9|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
8389336|NCT01061736|20677476|P8|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
8389337|NCT01061736|20677477|P7|Rescued|Overall Study||0
8389338|NCT01061736|20677478|P6|Rescued|Overall Study||0
8389339|NCT01061736|20677479|P5|Rescued|Overall Study||0
8389340|NCT01061736|20677480|P4|Rescued|Overall Study||0
8389341|NCT01061736|20677481|P3|Rescued|Overall Study||0
8389342|NCT01061736|20677482|P2|Rescued|Overall Study||0
8389343|NCT01061736|20677483|P1|Rescued|Overall Study||0
8389344|NCT01061736|20677474|P10|Treated|Overall Study||428
8389345|NCT01061736|20677475|P9|Treated|Overall Study||426
8389346|NCT01061736|20677476|P8|Treated|Overall Study||428
8389347|NCT01061736|20677477|P7|Treated|Overall Study||84
8389348|NCT01061736|20677478|P6|Treated|Overall Study||52
8389349|NCT01061736|20677479|P5|Treated|Overall Study||51
8389350|NCT01061736|20677480|P4|Treated|Overall Study||51
8389351|NCT01061736|20677481|P3|Treated|Overall Study||51
8389352|NCT01061736|20677482|P2|Treated|Overall Study||50
8389353|NCT01061736|20677483|P1|Treated|Overall Study||50
8389354|NCT01061736|20677474|P10|STARTED|Overall Study||428
8389355|NCT01061736|20677475|P9|STARTED|Overall Study||427
8389356|NCT01061736|20677476|P8|STARTED|Overall Study||430
8389357|NCT01061736|20677477|P7|STARTED|Overall Study||84
8389358|NCT01061736|20677478|P6|STARTED|Overall Study||52
8389359|NCT01061736|20677479|P5|STARTED|Overall Study||52
8389360|NCT01061736|20677480|P4|STARTED|Overall Study||51
8389361|NCT01061736|20677481|P3|STARTED|Overall Study||51
8389362|NCT01061736|20677482|P2|STARTED|Overall Study||50
8389363|NCT01061736|20677483|P1|STARTED|Overall Study||50
8389364|NCT01061723|20677522|P6|NOT COMPLETED|Overall Study||9
8389365|NCT01061723|20677523|P5|NOT COMPLETED|Overall Study||3
8389366|NCT01061723|20677524|P4|NOT COMPLETED|Overall Study||8
8389367|NCT01061723|20677525|P3|NOT COMPLETED|Overall Study||10
8389368|NCT01061723|20677526|P2|NOT COMPLETED|Overall Study||6
8389369|NCT01061723|20677527|P1|NOT COMPLETED|Overall Study||4
8389370|NCT01061723|20677522|P6|COMPLETED|Overall Study||41
8389371|NCT01061723|20677523|P5|COMPLETED|Overall Study||47
8389372|NCT01061723|20677524|P4|COMPLETED|Overall Study||44
8389373|NCT01061723|20677525|P3|COMPLETED|Overall Study||40
8389374|NCT01061723|20677526|P2|COMPLETED|Overall Study||43
8389375|NCT01061723|20677527|P1|COMPLETED|Overall Study||46
8389376|NCT01061723|20677522|P6|Treated|Overall Study||49
8389377|NCT01061723|20677523|P5|Treated|Overall Study||50
8389378|NCT01061723|20677524|P4|Treated|Overall Study||52
8389379|NCT01061723|20677525|P3|Treated|Overall Study||50
8389380|NCT01061723|20677526|P2|Treated|Overall Study||49
8389381|NCT01061723|20677527|P1|Treated|Overall Study||50
8389382|NCT01061723|20677522|P6|STARTED|Overall Study||50
8389383|NCT01061723|20677523|P5|STARTED|Overall Study||50
8389384|NCT01061723|20677524|P4|STARTED|Overall Study||52
8389385|NCT01061723|20677525|P3|STARTED|Overall Study||50
8389386|NCT01061723|20677526|P2|STARTED|Overall Study||49
8389387|NCT01061723|20677527|P1|STARTED|Overall Study||50
8389388|NCT01061710|20677607|P1|NOT COMPLETED|Overall Study||14
8389389|NCT01061710|20677607|P1|COMPLETED|Overall Study||6
8389390|NCT01061710|20677607|P1|STARTED|Overall Study||20
8389391|NCT01061671|20677617|P2|NOT COMPLETED|Overall Study||55
8389392|NCT01061671|20677618|P1|NOT COMPLETED|Overall Study||47
8389393|NCT01061671|20677617|P2|COMPLETED|Overall Study||397
8389394|NCT01061671|20677618|P1|COMPLETED|Overall Study||386
8389395|NCT01061671|20677617|P2|STARTED|Overall Study||452
8389396|NCT01061671|20677618|P1|STARTED|Overall Study||433
8389397|NCT01061606|20677630|P1|NOT COMPLETED|Overall Study||8
8389398|NCT01061606|20677630|P1|COMPLETED|Overall Study||0
8389399|NCT01061606|20677630|P1|STARTED|Overall Study||8
8389400|NCT01061567|20677639|P1|NOT COMPLETED|Overall Study||76
8389401|NCT01061567|20677639|P1|COMPLETED|Overall Study||1738
8389402|NCT01061567|20677639|P1|STARTED|Overall Study||1814
8389403|NCT01061528|20677650|P2|NOT COMPLETED|Overall Study||2
8389404|NCT01061528|20677651|P1|NOT COMPLETED|Overall Study||3
8389405|NCT01061528|20677650|P2|COMPLETED|Overall Study||52
8389406|NCT01061528|20677651|P1|COMPLETED|Overall Study||59
8389407|NCT01061528|20677650|P2|STARTED|Overall Study||54
8389408|NCT01061528|20677651|P1|STARTED|Overall Study||62
8389409|NCT01061476|20677657|P1|NOT COMPLETED|Overall Study||0
8389410|NCT01061476|20677657|P1|COMPLETED|Overall Study||12
8389411|NCT01061476|20677657|P1|STARTED|Overall Study||12
8389412|NCT01061385|20677663|P2|NOT COMPLETED|Overall Study||1
8389413|NCT01061385|20677664|P1|NOT COMPLETED|Overall Study||1
8389414|NCT01061385|20677663|P2|COMPLETED|Overall Study||8
8389415|NCT01061385|20677664|P1|COMPLETED|Overall Study||20
8389416|NCT01061385|20677663|P2|STARTED|Overall Study||9
8389417|NCT01061385|20677664|P1|STARTED|Overall Study||21
8389418|NCT01061359|20677672|P1|NOT COMPLETED|Overall Study||1302
8389419|NCT01061359|20677672|P1|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
8389420|NCT01061359|20677672|P1|STARTED|Overall Study||1972
8389421|NCT01061333|20677678|P2|NOT COMPLETED|Period 7: Mometasone||0
8389422|NCT01061333|20677679|P1|NOT COMPLETED|Period 7: Mometasone||0
8389423|NCT01061333|20677678|P2|COMPLETED|Period 7: Mometasone||7
8389424|NCT01061333|20677679|P1|COMPLETED|Period 7: Mometasone||8
8389425|NCT01061333|20677678|P2|STARTED|Period 7: Mometasone||7
8389426|NCT01061333|20677679|P1|STARTED|Period 7: Mometasone||8
8389427|NCT01061333|20677678|P2|NOT COMPLETED|Period 6: 20-day Washout||0
8389428|NCT01061333|20677679|P1|NOT COMPLETED|Period 6: 20-day Washout||0
8389429|NCT01061333|20677678|P2|COMPLETED|Period 6: 20-day Washout||7
8389430|NCT01061333|20677679|P1|COMPLETED|Period 6: 20-day Washout||8
8389431|NCT01061333|20677678|P2|STARTED|Period 6: 20-day Washout||7
8389432|NCT01061333|20677679|P1|STARTED|Period 6: 20-day Washout||8
8389433|NCT01061333|20677678|P2|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
8389434|NCT01061333|20677679|P1|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
8389435|NCT01061333|20677678|P2|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
8389436|NCT01061333|20677679|P1|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
8389437|NCT01061333|20677678|P2|STARTED|Period 5: Nedocromil-Montelukast X-over||7
8389438|NCT01061333|20677679|P1|STARTED|Period 5: Nedocromil-Montelukast X-over||8
8389439|NCT01061333|20677678|P2|NOT COMPLETED|Period 4: 20-day Washout||1
8389440|NCT01061333|20677679|P1|NOT COMPLETED|Period 4: 20-day Washout||0
8389441|NCT01061333|20677678|P2|COMPLETED|Period 4: 20-day Washout||7
8389442|NCT01061333|20677679|P1|COMPLETED|Period 4: 20-day Washout||8
8389443|NCT01061333|20677678|P2|STARTED|Period 4: 20-day Washout||8
8389444|NCT01061333|20677679|P1|STARTED|Period 4: 20-day Washout||8
8389445|NCT01061333|20677678|P2|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
8389446|NCT01061333|20677679|P1|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
8389447|NCT01061333|20677678|P2|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
8389448|NCT01061333|20677679|P1|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
8389449|NCT01061333|20677678|P2|STARTED|Period 3: Nedocromil-Montelukast X-over||8
8389450|NCT01061333|20677679|P1|STARTED|Period 3: Nedocromil-Montelukast X-over||8
8389451|NCT01061333|20677678|P2|NOT COMPLETED|Period 2: 20-day Washout||0
8389452|NCT01061333|20677679|P1|NOT COMPLETED|Period 2: 20-day Washout||0
8389453|NCT01061333|20677678|P2|COMPLETED|Period 2: 20-day Washout||8
8389454|NCT01061333|20677679|P1|COMPLETED|Period 2: 20-day Washout||8
8389455|NCT01061333|20677678|P2|STARTED|Period 2: 20-day Washout||8
8389456|NCT01061333|20677679|P1|STARTED|Period 2: 20-day Washout||8
8389457|NCT01061333|20677678|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
8389458|NCT01061333|20677679|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
8389459|NCT01061333|20677678|P2|COMPLETED|Period 1: Placebo Run-in||8
8389460|NCT01061333|20677679|P1|COMPLETED|Period 1: Placebo Run-in||8
8389461|NCT01061333|20677678|P2|STARTED|Period 1: Placebo Run-in||8
8389462|NCT01061333|20677679|P1|STARTED|Period 1: Placebo Run-in||8
8389463|NCT01061177|20677717|P1|NOT COMPLETED|Overall Study||208
8389464|NCT01061177|20677717|P1|COMPLETED|Overall Study||881
8389465|NCT01061177|20677717|P1|ITT_CyR (Ph+ Patients Only)|Overall Study||983
8389466|NCT01061177|20677717|P1|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
8389467|NCT01061177|20677717|P1|STARTED|Overall Study||1089
8389468|NCT01061151|20677740|P4|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
8389469|NCT01061151|20677741|P3|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
8389470|NCT01061151|20677742|P2|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
8389471|NCT01061151|20677743|P1|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
8389472|NCT01061151|20677740|P4|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
8389473|NCT01061151|20677741|P3|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
8389474|NCT01061151|20677742|P2|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
8389475|NCT01061151|20677743|P1|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
8389476|NCT01061151|20677740|P4|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
8389477|NCT01061151|20677741|P3|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
8389478|NCT01061151|20677742|P2|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
8389479|NCT01061151|20677743|P1|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
8389480|NCT01061151|20677740|P4|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
8389481|NCT01061151|20677741|P3|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
8389482|NCT01061151|20677742|P2|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
8389483|NCT01061151|20677743|P1|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
8389484|NCT01061151|20677740|P4|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
8389485|NCT01061151|20677741|P3|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
8389486|NCT01061151|20677742|P2|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
8389487|NCT01061151|20677743|P1|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
8389488|NCT01061151|20677740|P4|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
8389489|NCT01061151|20677741|P3|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
8389490|NCT01061151|20677742|P2|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
8389491|NCT01061151|20677743|P1|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
8389492|NCT01061151|20677740|P4|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
8389493|NCT01061151|20677741|P3|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
8389494|NCT01061151|20677742|P2|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
8389495|NCT01061151|20677743|P1|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
8389496|NCT01061151|20677740|P4|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
8389497|NCT01061151|20677741|P3|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
8389498|NCT01061151|20677742|P2|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
8389499|NCT01061151|20677743|P1|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
8389500|NCT01061034|20677795|P1|NOT COMPLETED|Aspirin Plus Omeprazole||0
8389501|NCT01061034|20677795|P1|COMPLETED|Aspirin Plus Omeprazole||9
8389502|NCT01061034|20677795|P1|STARTED|Aspirin Plus Omeprazole||9
8389503|NCT01061034|20677795|P1|NOT COMPLETED|Aspirin||0
8389504|NCT01061034|20677795|P1|COMPLETED|Aspirin||9
8389505|NCT01061034|20677795|P1|STARTED|Aspirin||9
8389506|NCT01061008|20677802|P2|NOT COMPLETED|Overall Study||6
8389507|NCT01061008|20677803|P1|NOT COMPLETED|Overall Study||6
8389508|NCT01061008|20677802|P2|COMPLETED|Overall Study||9
8389509|NCT01061008|20677803|P1|COMPLETED|Overall Study||10
8389510|NCT01061008|20677802|P2|STARTED|Overall Study||15
8389511|NCT01061008|20677803|P1|STARTED|Overall Study||16
8389512|NCT01060670|20677811|P2|NOT COMPLETED|Follow up Phase||35
8389513|NCT01060670|20677812|P1|NOT COMPLETED|Follow up Phase||22
8389514|NCT01060670|20677811|P2|COMPLETED|Follow up Phase||82
8389515|NCT01060670|20677812|P1|COMPLETED|Follow up Phase||106
8389516|NCT01060670|20677811|P2|Withdrew From Follow up Phase|Follow up Phase||35
8389517|NCT01060670|20677812|P1|Withdrew From Follow up Phase|Follow up Phase||22
8389518|NCT01060670|20677811|P2|Recurrence|Follow up Phase||9
8389519|NCT01060670|20677812|P1|Recurrence|Follow up Phase||14
8389520|NCT01060670|20677811|P2|STARTED|Follow up Phase||117
8389521|NCT01060670|20677812|P1|STARTED|Follow up Phase||128
8389522|NCT01060670|20677811|P2|NOT COMPLETED|Treatment Phase||36
8389523|NCT01060670|20677812|P1|NOT COMPLETED|Treatment Phase||26
8389524|NCT01060670|20677811|P2|COMPLETED|Treatment Phase||117
8389525|NCT01060670|20677812|P1|COMPLETED|Treatment Phase||128
8389526|NCT01060670|20677811|P2|Withdrew From Treatment|Treatment Phase||36
8389527|NCT01060670|20677812|P1|Withdrew From Treatment|Treatment Phase||26
8389528|NCT01060670|20677811|P2|Did Not Heal by Treatment Visit 17|Treatment Phase||68
8389529|NCT01060670|20677812|P1|Did Not Heal by Treatment Visit 17|Treatment Phase||49
8389530|NCT01060670|20677811|P2|Healed at End of Treatment Phase|Treatment Phase||49
8389531|NCT01060670|20677812|P1|Healed at End of Treatment Phase|Treatment Phase||79
8389532|NCT01060670|20677811|P2|STARTED|Treatment Phase||153
8389533|NCT01060670|20677812|P1|STARTED|Treatment Phase||154
8389534|NCT01060670|20677811|P2|NOT COMPLETED|Run In||238
8389535|NCT01060670|20677812|P1|NOT COMPLETED|Run In||0
8389536|NCT01060670|20677811|P2|COMPLETED|Run In||307
8389537|NCT01060670|20677812|P1|COMPLETED|Run In||0
8389538|NCT01060670|20677811|P2|STARTED|Run In||545
8389539|NCT01060670|20677812|P1|STARTED|Run In||0
8389540|NCT01060592|20677832|P2|NOT COMPLETED|12m||18
8389541|NCT01060592|20677833|P1|NOT COMPLETED|12m||0
8389542|NCT01060592|20677832|P2|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
8389543|NCT01060592|20677833|P1|COMPLETED|12m||35
8389544|NCT01060592|20677832|P2|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
8389545|NCT01060592|20677833|P1|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
8389546|NCT01060592|20677832|P2|NOT COMPLETED|4-6w||10
8389547|NCT01060592|20677833|P1|NOT COMPLETED|4-6w||12
8389548|NCT01060592|20677832|P2|COMPLETED|4-6w||39
8389549|NCT01060592|20677833|P1|COMPLETED|4-6w||23
8389550|NCT01060592|20677832|P2|STARTED|4-6w||49
8389551|NCT01060592|20677833|P1|STARTED|4-6w||35
8389552|NCT01060553|20677847|P2|NOT COMPLETED|Overall Study||10
8389553|NCT01060553|20677848|P1|NOT COMPLETED|Overall Study||9
8389554|NCT01060553|20677847|P2|COMPLETED|Overall Study||5
8389555|NCT01060553|20677848|P1|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
8389556|NCT01060553|20677847|P2|STARTED|Overall Study||15
8389557|NCT01060553|20677848|P1|STARTED|Overall Study||15
8389558|NCT01060540|20677855|P2|NOT COMPLETED|Overall Study||65
8389559|NCT01060540|20677856|P1|NOT COMPLETED|Overall Study||64
8389560|NCT01060540|20677855|P2|COMPLETED|Overall Study||233
8389561|NCT01060540|20677856|P1|COMPLETED|Overall Study||239
8389562|NCT01060540|20677855|P2|STARTED|Overall Study||298
8389563|NCT01060540|20677856|P1|STARTED|Overall Study||303
8389564|NCT01060384|20677870|P5|NOT COMPLETED|Overall Study||2
8389565|NCT01060384|20677871|P4|NOT COMPLETED|Overall Study||0
8389566|NCT01060384|20677872|P3|NOT COMPLETED|Overall Study||0
8389567|NCT01060384|20677873|P2|NOT COMPLETED|Overall Study||1
8389568|NCT01060384|20677874|P1|NOT COMPLETED|Overall Study||0
8389569|NCT01060384|20677870|P5|COMPLETED|Overall Study||34
8389570|NCT01060384|20677871|P4|COMPLETED|Overall Study||0
8389571|NCT01060384|20677872|P3|COMPLETED|Overall Study||0
8389572|NCT01060384|20677873|P2|COMPLETED|Overall Study||3
8389573|NCT01060384|20677874|P1|COMPLETED|Overall Study||6
8389574|NCT01060384|20677870|P5|STARTED|Overall Study||36
8389575|NCT01060384|20677871|P4|STARTED|Overall Study||0
8389576|NCT01060384|20677872|P3|STARTED|Overall Study||0
8389577|NCT01060384|20677873|P2|STARTED|Overall Study||4
8389578|NCT01060384|20677874|P1|STARTED|Overall Study||6
8389579|NCT01060345|20677883|P1|NOT COMPLETED|Overall Study||0
8389580|NCT01060345|20677883|P1|COMPLETED|Overall Study||20
8389581|NCT01060345|20677883|P1|STARTED|Overall Study||20
8389582|NCT01060150|20677893|P1|NOT COMPLETED|Overall Study||23
8389583|NCT01060150|20677893|P1|COMPLETED|Overall Study||92
8389584|NCT01060150|20677893|P1|Treated|Overall Study||113
8389585|NCT01060150|20677893|P1|STARTED|Overall Study||115
8389586|NCT01060124|20677908|P1|NOT COMPLETED|Overall Study||37
8389587|NCT01060124|20677908|P1|COMPLETED|Overall Study||66
8389588|NCT01060124|20677908|P1|STARTED|Overall Study||103
8389589|NCT01060111|20677919|P3|NOT COMPLETED|Overall Study||35
8389590|NCT01060111|20677920|P2|NOT COMPLETED|Overall Study||23
8389591|NCT01060111|20677921|P1|NOT COMPLETED|Overall Study||27
8389592|NCT01060111|20677919|P3|COMPLETED|Overall Study||45
8389593|NCT01060111|20677920|P2|COMPLETED|Overall Study||61
8389594|NCT01060111|20677921|P1|COMPLETED|Overall Study||54
8389595|NCT01060111|20677919|P3|Treated|Overall Study||79
8389596|NCT01060111|20677920|P2|Treated|Overall Study||83
8389597|NCT01060111|20677921|P1|Treated|Overall Study||81
8389598|NCT01060111|20677919|P3|STARTED|Overall Study||80
8389599|NCT01060111|20677920|P2|STARTED|Overall Study||84
8389600|NCT01060111|20677921|P1|STARTED|Overall Study||81
8389601|NCT01060098|20677941|P3|NOT COMPLETED|Overall Study||0
8389602|NCT01060098|20677942|P2|NOT COMPLETED|Overall Study||0
8389603|NCT01060098|20677943|P1|NOT COMPLETED|Overall Study||0
8389604|NCT01060098|20677941|P3|COMPLETED|Overall Study||8
8389605|NCT01060098|20677942|P2|COMPLETED|Overall Study||15
8389606|NCT01060098|20677943|P1|COMPLETED|Overall Study||25
8389607|NCT01060098|20677941|P3|STARTED|Overall Study||8
8389608|NCT01060098|20677942|P2|STARTED|Overall Study||15
8389609|NCT01060098|20677943|P1|STARTED|Overall Study||25
8389610|NCT01060072|20677953|P2|NOT COMPLETED|Overall Study||5
8389611|NCT01060072|20677954|P1|NOT COMPLETED|Overall Study||2
8389612|NCT01060072|20677953|P2|COMPLETED|Overall Study||196
8389613|NCT01060072|20677954|P1|COMPLETED|Overall Study||204
8389614|NCT01060072|20677953|P2|STARTED|Overall Study||201
8389615|NCT01060072|20677954|P1|STARTED|Overall Study||206
8389616|NCT01060059|20677970|P2|NOT COMPLETED|Overall Study||67
8389617|NCT01060059|20677971|P1|NOT COMPLETED|Overall Study||67
8389618|NCT01060059|20677970|P2|COMPLETED|Overall Study||371
8389619|NCT01060059|20677971|P1|COMPLETED|Overall Study||377
8389620|NCT01060059|20677970|P2|STARTED|Overall Study||438
8389621|NCT01060059|20677971|P1|STARTED|Overall Study||444
8389622|NCT01060020|20678021|P1|NOT COMPLETED|Overall Study||0
8389623|NCT01060020|20678021|P1|COMPLETED|Overall Study||20
8389624|NCT01060020|20678021|P1|STARTED|Overall Study||20
8389625|NCT01060007|20678029|P1|NOT COMPLETED|Overall Study||4
8389626|NCT01060007|20678029|P1|COMPLETED|Overall Study||76
8389627|NCT01060007|20678029|P1|STARTED|Overall Study||80
8389628|NCT01059994|20678047|P4|NOT COMPLETED|Overall Study||1
8389629|NCT01059994|20678048|P3|NOT COMPLETED|Overall Study||0
8389630|NCT01059994|20678049|P2|NOT COMPLETED|Overall Study||0
8389631|NCT01059994|20678050|P1|NOT COMPLETED|Overall Study||0
8389632|NCT01059994|20678047|P4|COMPLETED|Overall Study||3
8389633|NCT01059994|20678048|P3|COMPLETED|Overall Study||3
8389634|NCT01059994|20678049|P2|COMPLETED|Overall Study||2
8389635|NCT01059994|20678050|P1|COMPLETED|Overall Study||3
8389636|NCT01059994|20678047|P4|STARTED|Overall Study||4
8389637|NCT01059994|20678048|P3|STARTED|Overall Study||3
8389638|NCT01059994|20678049|P2|STARTED|Overall Study||2
8389639|NCT01059994|20678050|P1|STARTED|Overall Study||3
8389640|NCT01059929|20678066|P2|NOT COMPLETED|Overall Study||0
8389641|NCT01059929|20678067|P1|NOT COMPLETED|Overall Study||0
8389642|NCT01059929|20678066|P2|COMPLETED|Overall Study||21
8389643|NCT01059929|20678067|P1|COMPLETED|Overall Study||20
8389644|NCT01059929|20678066|P2|STARTED|Overall Study||21
8389645|NCT01059929|20678067|P1|STARTED|Overall Study||20
8389646|NCT01059903|20678097|P2|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
8389647|NCT01059903|20678098|P1|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
8389648|NCT01059903|20678097|P2|COMPLETED|Period 3: Second Intervention- 24 Hours||24
8389649|NCT01059903|20678098|P1|COMPLETED|Period 3: Second Intervention- 24 Hours||24
8389650|NCT01059903|20678097|P2|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
8389651|NCT01059903|20678098|P1|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
8389652|NCT01059903|20678097|P2|STARTED|Period 3: Second Intervention- 24 Hours||24
8389653|NCT01059903|20678098|P1|STARTED|Period 3: Second Intervention- 24 Hours||24
8389654|NCT01059903|20678097|P2|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
8389655|NCT01059903|20678098|P1|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
8389656|NCT01059903|20678097|P2|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
8389657|NCT01059903|20678098|P1|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
8389658|NCT01059903|20678097|P2|STARTED|Period 2: Washout Period (>= 5 Days)||24
8389659|NCT01059903|20678098|P1|STARTED|Period 2: Washout Period (>= 5 Days)||24
8389660|NCT01059903|20678097|P2|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
8389661|NCT01059903|20678098|P1|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
8389662|NCT01059903|20678097|P2|COMPLETED|Period 1: First Intervention- 24 Hours||24
8389663|NCT01059903|20678098|P1|COMPLETED|Period 1: First Intervention- 24 Hours||24
8389664|NCT01059903|20678097|P2|STARTED|Period 1: First Intervention- 24 Hours||25
8389665|NCT01059903|20678098|P1|STARTED|Period 1: First Intervention- 24 Hours||25
8389666|NCT01059877|20678134|P2|NOT COMPLETED|Overall Study||2
8389667|NCT01059877|20678135|P1|NOT COMPLETED|Overall Study||0
8389668|NCT01059877|20678134|P2|COMPLETED|Overall Study||3
8389669|NCT01059877|20678135|P1|COMPLETED|Overall Study||6
8389670|NCT01059877|20678134|P2|STARTED|Overall Study||5
8389671|NCT01059877|20678135|P1|STARTED|Overall Study||6
8389672|NCT01059864|20678141|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
8389673|NCT01059864|20678142|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
8389674|NCT01059864|20678143|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
8389675|NCT01059864|20678141|P3|COMPLETED|Double-Blind Treatment Phase||45
8389676|NCT01059864|20678142|P2|COMPLETED|Double-Blind Treatment Phase||47
8389677|NCT01059864|20678143|P1|COMPLETED|Double-Blind Treatment Phase||0
8389678|NCT01059864|20678141|P3|Treated|Double-Blind Treatment Phase||47
8389679|NCT01059864|20678142|P2|Treated|Double-Blind Treatment Phase||50
8389680|NCT01059864|20678143|P1|Treated|Double-Blind Treatment Phase||0
8389681|NCT01059864|20678141|P3|STARTED|Double-Blind Treatment Phase||48
8389682|NCT01059864|20678142|P2|STARTED|Double-Blind Treatment Phase||50
8389683|NCT01059864|20678143|P1|STARTED|Double-Blind Treatment Phase||0
8389684|NCT01059864|20678141|P3|NOT COMPLETED|Open-Label Run-In Phase||0
8389685|NCT01059864|20678142|P2|NOT COMPLETED|Open-Label Run-In Phase||0
8389686|NCT01059864|20678143|P1|NOT COMPLETED|Open-Label Run-In Phase||13
8389687|NCT01059864|20678141|P3|COMPLETED|Open-Label Run-In Phase||0
8389688|NCT01059864|20678142|P2|COMPLETED|Open-Label Run-In Phase||0
8389689|NCT01059864|20678143|P1|COMPLETED|Open-Label Run-In Phase||98
8389690|NCT01059864|20678141|P3|STARTED|Open-Label Run-In Phase||0
8389691|NCT01059864|20678142|P2|STARTED|Open-Label Run-In Phase||0
8389692|NCT01059864|20678143|P1|STARTED|Open-Label Run-In Phase||111
8389693|NCT01059851|20678192|P6|NOT COMPLETED|Overall Study||0
8389694|NCT01059851|20678193|P5|NOT COMPLETED|Overall Study||0
8389695|NCT01059851|20678194|P4|NOT COMPLETED|Overall Study||0
8389696|NCT01059851|20678195|P3|NOT COMPLETED|Overall Study||0
8389697|NCT01059851|20678196|P2|NOT COMPLETED|Overall Study||0
8389698|NCT01059851|20678197|P1|NOT COMPLETED|Overall Study||0
8389699|NCT01059851|20678192|P6|COMPLETED|Overall Study||0
8389700|NCT01059851|20678193|P5|COMPLETED|Overall Study||0
8389701|NCT01059851|20678194|P4|COMPLETED|Overall Study||0
8389702|NCT01059851|20678195|P3|COMPLETED|Overall Study||0
8389703|NCT01059851|20678196|P2|COMPLETED|Overall Study||8
8389704|NCT01059851|20678197|P1|COMPLETED|Overall Study||8
8389705|NCT01059851|20678192|P6|STARTED|Overall Study||0
8389706|NCT01059851|20678193|P5|STARTED|Overall Study||0
8389707|NCT01059851|20678194|P4|STARTED|Overall Study||0
8389708|NCT01059851|20678195|P3|STARTED|Overall Study||0
8389709|NCT01059851|20678196|P2|STARTED|Overall Study||8
8389710|NCT01059851|20678197|P1|STARTED|Overall Study||8
8389711|NCT01059825|20678217|P7|NOT COMPLETED|Treatment Period||0
8389712|NCT01059825|20678218|P6|NOT COMPLETED|Treatment Period||3
8389713|NCT01059825|20678219|P5|NOT COMPLETED|Treatment Period||8
8389714|NCT01059825|20678220|P4|NOT COMPLETED|Treatment Period||11
8389715|NCT01059825|20678221|P3|NOT COMPLETED|Treatment Period||6
8389716|NCT01059825|20678222|P2|NOT COMPLETED|Treatment Period||4
8389717|NCT01059825|20678223|P1|NOT COMPLETED|Treatment Period||10
8389718|NCT01059825|20678217|P7|COMPLETED|Treatment Period||0
8389719|NCT01059825|20678218|P6|COMPLETED|Treatment Period||52
8389720|NCT01059825|20678219|P5|COMPLETED|Treatment Period||47
8389721|NCT01059825|20678220|P4|COMPLETED|Treatment Period||44
8389722|NCT01059825|20678221|P3|COMPLETED|Treatment Period||49
8389723|NCT01059825|20678222|P2|COMPLETED|Treatment Period||50
8389724|NCT01059825|20678223|P1|COMPLETED|Treatment Period||44
8389725|NCT01059825|20678217|P7|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
8389726|NCT01059825|20678218|P6|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
8389727|NCT01059825|20678219|P5|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
8389728|NCT01059825|20678220|P4|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
8389729|NCT01059825|20678221|P3|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
8389730|NCT01059825|20678222|P2|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
8389731|NCT01059825|20678223|P1|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
8389732|NCT01059825|20678217|P7|NOT COMPLETED|Enrolled, Run-in Period||47
8389733|NCT01059825|20678218|P6|NOT COMPLETED|Enrolled, Run-in Period||0
8389734|NCT01059825|20678219|P5|NOT COMPLETED|Enrolled, Run-in Period||0
8389735|NCT01059825|20678220|P4|NOT COMPLETED|Enrolled, Run-in Period||0
8389736|NCT01059825|20678221|P3|NOT COMPLETED|Enrolled, Run-in Period||0
8389737|NCT01059825|20678222|P2|NOT COMPLETED|Enrolled, Run-in Period||0
8389738|NCT01059825|20678223|P1|NOT COMPLETED|Enrolled, Run-in Period||0
8389739|NCT01059825|20678217|P7|COMPLETED|Enrolled, Run-in Period||328
8389740|NCT01059825|20678218|P6|COMPLETED|Enrolled, Run-in Period||0
8389741|NCT01059825|20678219|P5|COMPLETED|Enrolled, Run-in Period||0
8389742|NCT01059825|20678220|P4|COMPLETED|Enrolled, Run-in Period||0
8389743|NCT01059825|20678221|P3|COMPLETED|Enrolled, Run-in Period||0
8389744|NCT01059825|20678222|P2|COMPLETED|Enrolled, Run-in Period||0
8389745|NCT01059825|20678223|P1|COMPLETED|Enrolled, Run-in Period||0
8389746|NCT01059825|20678217|P7|STARTED|Enrolled, Run-in Period||375
8389747|NCT01059825|20678218|P6|STARTED|Enrolled, Run-in Period||0
8389748|NCT01059825|20678219|P5|STARTED|Enrolled, Run-in Period||0
8389749|NCT01059825|20678220|P4|STARTED|Enrolled, Run-in Period||0
8389750|NCT01059825|20678221|P3|STARTED|Enrolled, Run-in Period||0
8389751|NCT01059825|20678222|P2|STARTED|Enrolled, Run-in Period||0
8389752|NCT01059825|20678223|P1|STARTED|Enrolled, Run-in Period||0
8389753|NCT01059812|20678410|P2|NOT COMPLETED|Overall Study||16
8389754|NCT01059812|20678411|P1|NOT COMPLETED|Overall Study||37
8389755|NCT01059812|20678410|P2|COMPLETED|Overall Study||126
8389756|NCT01059812|20678411|P1|COMPLETED|Overall Study||245
8389757|NCT01059812|20678410|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
8389758|NCT01059812|20678411|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
8389759|NCT01059812|20678410|P2|STARTED|Overall Study||142
8389760|NCT01059812|20678411|P1|STARTED|Overall Study||282
8389761|NCT01059799|20678427|P2|NOT COMPLETED|Overall Study||10
8389762|NCT01059799|20678428|P1|NOT COMPLETED|Overall Study||31
8389763|NCT01059799|20678427|P2|COMPLETED|Overall Study||136
8389764|NCT01059799|20678428|P1|COMPLETED|Overall Study||258
8389765|NCT01059799|20678427|P2|Exposed|Overall Study||146
8389766|NCT01059799|20678428|P1|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
8389767|NCT01059799|20678427|P2|STARTED|Overall Study||146
8389768|NCT01059799|20678428|P1|STARTED|Overall Study||289
8389769|NCT01059773|20678442|P2|NOT COMPLETED|Overall Study||24
8389770|NCT01059773|20678443|P1|NOT COMPLETED|Overall Study||20
8389771|NCT01059773|20678442|P2|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
8389772|NCT01059773|20678443|P1|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
8389773|NCT01059773|20678442|P2|STARTED|Overall Study||245
8389774|NCT01059773|20678443|P1|STARTED|Overall Study||244
8389775|NCT01059760|20678475|P2|NOT COMPLETED|Overall Study||0
8389776|NCT01059760|20678476|P1|NOT COMPLETED|Overall Study||0
8389777|NCT01059760|20678475|P2|COMPLETED|Overall Study||14
8389778|NCT01059760|20678476|P1|COMPLETED|Overall Study||16
8389779|NCT01059760|20678475|P2|STARTED|Overall Study||14
8389780|NCT01059760|20678476|P1|STARTED|Overall Study||16
8389781|NCT01059682|20678584|P2|NOT COMPLETED|Overall Study||18
8389782|NCT01059682|20678585|P1|NOT COMPLETED|Overall Study||10
8389783|NCT01059682|20678584|P2|COMPLETED|Overall Study||444
8389784|NCT01059682|20678585|P1|COMPLETED|Overall Study||464
8389785|NCT01059682|20678584|P2|STARTED|Overall Study||462
8389786|NCT01059682|20678585|P1|STARTED|Overall Study||474
8389787|NCT01059643|20678599|P1|NOT COMPLETED|Overall Study||6
8389788|NCT01059643|20678599|P1|COMPLETED|Overall Study||97
8389789|NCT01059643|20678599|P1|Received at Least 1 Dose of Study Drug|Overall Study||103
8389790|NCT01059643|20678599|P1|STARTED|Overall Study||103
8389791|NCT01059630|20678614|P2|NOT COMPLETED|Overall Study||103
8389792|NCT01059630|20678615|P1|NOT COMPLETED|Overall Study||127
8389793|NCT01059630|20678614|P2|COMPLETED|Overall Study||101
8389794|NCT01059630|20678615|P1|COMPLETED|Overall Study||82
8389795|NCT01059630|20678614|P2|STARTED|Overall Study||204
8389796|NCT01059630|20678615|P1|STARTED|Overall Study||209
8389797|NCT01059617|20678689|P4|NOT COMPLETED|Overall Study||6
8389798|NCT01059617|20678690|P3|NOT COMPLETED|Overall Study||8
8389799|NCT01059617|20678691|P2|NOT COMPLETED|Overall Study||1
8389800|NCT01059617|20678692|P1|NOT COMPLETED|Overall Study||7
8389801|NCT01059617|20678689|P4|COMPLETED|Overall Study||27
8389802|NCT01059617|20678690|P3|COMPLETED|Overall Study||25
8389803|NCT01059617|20678691|P2|COMPLETED|Overall Study||33
8389804|NCT01059617|20678692|P1|COMPLETED|Overall Study||26
8389805|NCT01059617|20678689|P4|STARTED|Overall Study||33
8389806|NCT01059617|20678690|P3|STARTED|Overall Study||33
8389807|NCT01059617|20678691|P2|STARTED|Overall Study||34
8389808|NCT01059617|20678692|P1|STARTED|Overall Study||33
8389809|NCT01059565|20678862|P2|NOT COMPLETED|24-Week Open-Label Phase||3
8389810|NCT01059565|20678863|P1|NOT COMPLETED|24-Week Open-Label Phase||5
8389811|NCT01059565|20678862|P2|COMPLETED|24-Week Open-Label Phase||42
8389812|NCT01059565|20678863|P1|COMPLETED|24-Week Open-Label Phase||34
8389813|NCT01059565|20678862|P2|STARTED|24-Week Open-Label Phase||45
8389814|NCT01059565|20678863|P1|STARTED|24-Week Open-Label Phase||39
8389815|NCT01059565|20678862|P2|NOT COMPLETED|24-Week Randomized Phase||7
8389816|NCT01059565|20678863|P1|NOT COMPLETED|24-Week Randomized Phase||10
8389817|NCT01059565|20678862|P2|COMPLETED|24-Week Randomized Phase||45
8389818|NCT01059565|20678863|P1|COMPLETED|24-Week Randomized Phase||39
8389819|NCT01059565|20678862|P2|Randomized and Treated|24-Week Randomized Phase||52
8389820|NCT01059565|20678863|P1|Randomized and Treated|24-Week Randomized Phase||48
8389821|NCT01059565|20678862|P2|STARTED|24-Week Randomized Phase||52
8389822|NCT01059565|20678863|P1|STARTED|24-Week Randomized Phase||49
8389823|NCT01059539|20678897|P1|NOT COMPLETED|Overall Study||271
8389824|NCT01059539|20678897|P1|COMPLETED|Overall Study||132
8389825|NCT01059539|20678897|P1|STARTED|Overall Study||403
8389834|NCT01059435|20678923|P10|NOT COMPLETED|Overall Study||0
8389835|NCT01059435|20678924|P9|NOT COMPLETED|Overall Study||0
8389836|NCT01059435|20678925|P8|NOT COMPLETED|Overall Study||0
8389837|NCT01059435|20678926|P7|NOT COMPLETED|Overall Study||0
8389838|NCT01059435|20678927|P6|NOT COMPLETED|Overall Study||0
8389839|NCT01059435|20678928|P5|NOT COMPLETED|Overall Study||0
8389840|NCT01059435|20678929|P4|NOT COMPLETED|Overall Study||0
8389841|NCT01059435|20678930|P3|NOT COMPLETED|Overall Study||2
8389842|NCT01059435|20678931|P2|NOT COMPLETED|Overall Study||0
8389843|NCT01059435|20678932|P1|NOT COMPLETED|Overall Study||0
8389844|NCT01059435|20678923|P10|COMPLETED|Overall Study||6
8389845|NCT01059435|20678924|P9|COMPLETED|Overall Study||6
8389846|NCT01059435|20678925|P8|COMPLETED|Overall Study||4
8389847|NCT01059435|20678926|P7|COMPLETED|Overall Study||6
8389848|NCT01059435|20678927|P6|COMPLETED|Overall Study||9
8389849|NCT01059435|20678928|P5|COMPLETED|Overall Study||6
8389850|NCT01059435|20678929|P4|COMPLETED|Overall Study||9
8389851|NCT01059435|20678930|P3|COMPLETED|Overall Study||6
8389852|NCT01059435|20678931|P2|COMPLETED|Overall Study||6
8389853|NCT01059435|20678932|P1|COMPLETED|Overall Study||14
8389854|NCT01059435|20678923|P10|Received Study Drug|Overall Study||6
8389855|NCT01059435|20678924|P9|Received Study Drug|Overall Study||6
8389856|NCT01059435|20678925|P8|Received Study Drug|Overall Study||4
8389857|NCT01059435|20678926|P7|Received Study Drug|Overall Study||6
8389858|NCT01059435|20678927|P6|Received Study Drug|Overall Study||9
8389859|NCT01059435|20678928|P5|Received Study Drug|Overall Study||6
8389860|NCT01059435|20678929|P4|Received Study Drug|Overall Study||9
8389861|NCT01059435|20678930|P3|Received Study Drug|Overall Study||6
8389862|NCT01059435|20678931|P2|Received Study Drug|Overall Study||6
8389863|NCT01059435|20678932|P1|Received Study Drug|Overall Study||14
8389864|NCT01059435|20678923|P10|STARTED|Overall Study||6
8389865|NCT01059435|20678924|P9|STARTED|Overall Study||6
8389866|NCT01059435|20678925|P8|STARTED|Overall Study||4
8389867|NCT01059435|20678926|P7|STARTED|Overall Study||6
8389868|NCT01059435|20678927|P6|STARTED|Overall Study||9
8389869|NCT01059435|20678928|P5|STARTED|Overall Study||6
8389870|NCT01059435|20678929|P4|STARTED|Overall Study||9
8389871|NCT01059435|20678930|P3|STARTED|Overall Study||8
8389872|NCT01059435|20678931|P2|STARTED|Overall Study||6
8389873|NCT01059435|20678932|P1|STARTED|Overall Study||14
8389874|NCT01059357|20679240|P1|NOT COMPLETED|Overall Study||4
8389875|NCT01059357|20679240|P1|COMPLETED|Overall Study||54
8389876|NCT01059357|20679240|P1|STARTED|Overall Study||58
8389877|NCT01059344|20679251|P2|NOT COMPLETED|Overall Study||46
8389878|NCT01059344|20679252|P1|NOT COMPLETED|Overall Study||22
8389879|NCT01059344|20679251|P2|COMPLETED|Overall Study||95
8389880|NCT01059344|20679252|P1|COMPLETED|Overall Study||118
8389881|NCT01059344|20679251|P2|STARTED|Overall Study||141
8389882|NCT01059344|20679252|P1|STARTED|Overall Study||140
8389883|NCT01059318|20679270|P1|NOT COMPLETED|Extension (36 Week)||3
8389884|NCT01059318|20679270|P1|COMPLETED|Extension (36 Week)||17
8389885|NCT01059318|20679270|P1|STARTED|Extension (36 Week)||20
8389886|NCT01059318|20679270|P1|NOT COMPLETED|Core Study (26 Week)||4
8389887|NCT01059318|20679270|P1|COMPLETED|Core Study (26 Week)||20
8389888|NCT01059318|20679270|P1|Pharmacokinetics (PK) Analysis Set|Core Study (26 Week)|For 8 patients plasma rather than whole blood sample was collected, hence excluded from PK set.|16
8389889|NCT01059318|20679270|P1|Everolimus 10 mg for 18 Weeks|Core Study (26 Week)||24
8389890|NCT01059318|20679270|P1|Everolimus 5 mg for 4 Weeks|Core Study (26 Week)||24
8389891|NCT01059318|20679270|P1|Everolimus 2.5 mg for 4 Weeks|Core Study (26 Week)||24
8389892|NCT01059318|20679270|P1|STARTED|Core Study (26 Week)|This is safety set and Pharmacodynamic set|24
8389893|NCT01059305|20679285|P1|NOT COMPLETED|Overall Study||0
8389894|NCT01059305|20679285|P1|COMPLETED|Overall Study||10
8389895|NCT01059305|20679285|P1|STARTED|Overall Study||10
8389896|NCT01059175|20679291|P2|NOT COMPLETED|Overall Study||20
8389897|NCT01059175|20679292|P1|NOT COMPLETED|Overall Study||21
8389898|NCT01059175|20679291|P2|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
8389899|NCT01059175|20679292|P1|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
8389900|NCT01059175|20679291|P2|STARTED|Overall Study||41
8389901|NCT01059175|20679292|P1|STARTED|Overall Study||43
8389902|NCT01059071|20679314|P4|NOT COMPLETED|Overall Study||6
8389903|NCT01059071|20679315|P3|NOT COMPLETED|Overall Study||2
8389904|NCT01059071|20679316|P2|NOT COMPLETED|Overall Study||4
8389905|NCT01059071|20679317|P1|NOT COMPLETED|Overall Study||2
8389906|NCT01059071|20679314|P4|COMPLETED|Overall Study||3
8389907|NCT01059071|20679315|P3|COMPLETED|Overall Study||1
8389908|NCT01059071|20679316|P2|COMPLETED|Overall Study||1
8389909|NCT01059071|20679317|P1|COMPLETED|Overall Study||2
8389910|NCT01059071|20679314|P4|STARTED|Overall Study||9
8389911|NCT01059071|20679315|P3|STARTED|Overall Study||3
8389912|NCT01059071|20679316|P2|STARTED|Overall Study||5
8389913|NCT01059071|20679317|P1|STARTED|Overall Study||4
8389914|NCT01058993|20679329|P1|NOT COMPLETED|Overall Study||0
8389915|NCT01058993|20679329|P1|COMPLETED|Overall Study||6
8389916|NCT01058993|20679329|P1|STARTED|Overall Study||6
8389917|NCT01058941|20679335|P2|NOT COMPLETED|Overall Study||11
8389918|NCT01058941|20679336|P1|NOT COMPLETED|Overall Study||9
8389919|NCT01058941|20679335|P2|COMPLETED|Overall Study||22
8389920|NCT01058941|20679336|P1|COMPLETED|Overall Study||25
8389921|NCT01058941|20679335|P2|STARTED|Overall Study||33
8389922|NCT01058941|20679336|P1|STARTED|Overall Study||34
8389923|NCT01058863|20679344|P1|NOT COMPLETED|Overall Study||4
8389924|NCT01058863|20679344|P1|COMPLETED|Overall Study||68
8389925|NCT01058863|20679344|P1|Treated With Placebo Inhaler|Overall Study||69
8389926|NCT01058863|20679344|P1|Treated With ProAir® HFA 180 mcg|Overall Study||68
8389927|NCT01058863|20679344|P1|Treated With ProAir® HFA 90 mcg|Overall Study||70
8389928|NCT01058863|20679344|P1|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
8389929|NCT01058863|20679344|P1|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
8389930|NCT01058863|20679344|P1|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
8389931|NCT01058863|20679344|P1|STARTED|Overall Study||72
8389932|NCT01058707|20679369|P7|NOT COMPLETED|Overall Study||26
8389933|NCT01058707|20679370|P6|NOT COMPLETED|Overall Study||17
8389934|NCT01058707|20679371|P5|NOT COMPLETED|Overall Study||39
8389935|NCT01058707|20679372|P4|NOT COMPLETED|Overall Study||22
8389936|NCT01058707|20679373|P3|NOT COMPLETED|Overall Study||33
8389937|NCT01058707|20679374|P2|NOT COMPLETED|Overall Study||30
8389938|NCT01058707|20679375|P1|NOT COMPLETED|Overall Study||31
8389939|NCT01058707|20679369|P7|COMPLETED|Overall Study||0
8389940|NCT01058707|20679370|P6|COMPLETED|Overall Study||0
8389941|NCT01058707|20679371|P5|COMPLETED|Overall Study||0
8389942|NCT01058707|20679372|P4|COMPLETED|Overall Study||0
8389943|NCT01058707|20679373|P3|COMPLETED|Overall Study||0
8389944|NCT01058707|20679374|P2|COMPLETED|Overall Study||0
8389945|NCT01058707|20679375|P1|COMPLETED|Overall Study||0
8389946|NCT01058707|20679369|P7|STARTED|Overall Study||26
8389947|NCT01058707|20679370|P6|STARTED|Overall Study||17
8389948|NCT01058707|20679371|P5|STARTED|Overall Study||39
8389949|NCT01058707|20679372|P4|STARTED|Overall Study||22
8389950|NCT01058707|20679373|P3|STARTED|Overall Study||33
8389951|NCT01058707|20679374|P2|STARTED|Overall Study||30
8389952|NCT01058707|20679375|P1|STARTED|Overall Study||31
8389953|NCT01058668|20679541|P3|NOT COMPLETED|Safety Follow-up||7
8389954|NCT01058668|20679542|P2|NOT COMPLETED|Safety Follow-up||0
8389955|NCT01058668|20679543|P1|NOT COMPLETED|Safety Follow-up||5
8389956|NCT01058668|20679541|P3|COMPLETED|Safety Follow-up||141
8389957|NCT01058668|20679542|P2|COMPLETED|Safety Follow-up||146
8389958|NCT01058668|20679543|P1|COMPLETED|Safety Follow-up||139
8389959|NCT01058668|20679541|P3|STARTED|Safety Follow-up||148
8389960|NCT01058668|20679542|P2|STARTED|Safety Follow-up||146
8389961|NCT01058668|20679543|P1|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
8389962|NCT01058668|20679541|P3|NOT COMPLETED|Double-blind Treatment Phase||50
8389963|NCT01058668|20679542|P2|NOT COMPLETED|Double-blind Treatment Phase||38
8389964|NCT01058668|20679543|P1|NOT COMPLETED|Double-blind Treatment Phase||39
8389965|NCT01058668|20679541|P3|COMPLETED|Double-blind Treatment Phase||119
8389966|NCT01058668|20679542|P2|COMPLETED|Double-blind Treatment Phase||129
8389967|NCT01058668|20679543|P1|COMPLETED|Double-blind Treatment Phase||122
8389968|NCT01058668|20679541|P3|STARTED|Double-blind Treatment Phase||169
8389969|NCT01058668|20679542|P2|STARTED|Double-blind Treatment Phase||167
8389970|NCT01058668|20679543|P1|STARTED|Double-blind Treatment Phase||161
8389971|NCT01058655|20679558|P4|NOT COMPLETED|Overall Study||42
8389972|NCT01058655|20679559|P3|NOT COMPLETED|Overall Study||8
8389973|NCT01058655|20679560|P2|NOT COMPLETED|Overall Study||3
8389974|NCT01058655|20679561|P1|NOT COMPLETED|Overall Study||3
8389975|NCT01058655|20679558|P4|COMPLETED|Overall Study||0
8389976|NCT01058655|20679559|P3|COMPLETED|Overall Study||0
8389977|NCT01058655|20679560|P2|COMPLETED|Overall Study||0
8389978|NCT01058655|20679561|P1|COMPLETED|Overall Study||0
8389979|NCT01058655|20679558|P4|Evaluable|Overall Study||40
8389980|NCT01058655|20679559|P3|Evaluable|Overall Study||6
8389981|NCT01058655|20679560|P2|Evaluable|Overall Study||3
8389982|NCT01058655|20679561|P1|Evaluable|Overall Study||3
8389983|NCT01058655|20679558|P4|STARTED|Overall Study||42
8389984|NCT01058655|20679559|P3|STARTED|Overall Study||8
8389985|NCT01058655|20679560|P2|STARTED|Overall Study||3
8389986|NCT01058655|20679561|P1|STARTED|Overall Study||3
8389987|NCT01058642|20679579|P4|NOT COMPLETED|Treatment Period 2||0
8389988|NCT01058642|20679580|P3|NOT COMPLETED|Treatment Period 2||0
8389989|NCT01058642|20679581|P2|NOT COMPLETED|Treatment Period 2||0
8389990|NCT01058642|20679582|P1|NOT COMPLETED|Treatment Period 2||0
8389991|NCT01058642|20679579|P4|COMPLETED|Treatment Period 2||7
8389992|NCT01058642|20679580|P3|COMPLETED|Treatment Period 2||9
8389993|NCT01058642|20679581|P2|COMPLETED|Treatment Period 2||11
8389994|NCT01058642|20679582|P1|COMPLETED|Treatment Period 2||7
8389995|NCT01058642|20679579|P4|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
8389996|NCT01058642|20679580|P3|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
8389997|NCT01058642|20679581|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
8389998|NCT01058642|20679582|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
8389999|NCT01058642|20679579|P4|STARTED|Treatment Period 2||7
8390000|NCT01058642|20679580|P3|STARTED|Treatment Period 2||9
8390001|NCT01058642|20679581|P2|STARTED|Treatment Period 2||11
8390002|NCT01058642|20679582|P1|STARTED|Treatment Period 2||7
8390003|NCT01058642|20679579|P4|NOT COMPLETED|Washout Period||0
8390004|NCT01058642|20679580|P3|NOT COMPLETED|Washout Period||0
8390005|NCT01058642|20679581|P2|NOT COMPLETED|Washout Period||0
8390006|NCT01058642|20679582|P1|NOT COMPLETED|Washout Period||0
8390007|NCT01058642|20679579|P4|COMPLETED|Washout Period||7
8390008|NCT01058642|20679580|P3|COMPLETED|Washout Period||9
8390009|NCT01058642|20679581|P2|COMPLETED|Washout Period||11
8390010|NCT01058642|20679582|P1|COMPLETED|Washout Period||7
8390011|NCT01058642|20679579|P4|STARTED|Washout Period||7
8390012|NCT01058642|20679580|P3|STARTED|Washout Period||9
8390013|NCT01058642|20679581|P2|STARTED|Washout Period||11
8390014|NCT01058642|20679582|P1|STARTED|Washout Period||7
8390015|NCT01058642|20679579|P4|NOT COMPLETED|Treatment Period 1||2
8390016|NCT01058642|20679580|P3|NOT COMPLETED|Treatment Period 1||2
8390017|NCT01058642|20679581|P2|NOT COMPLETED|Treatment Period 1||1
8390018|NCT01058642|20679582|P1|NOT COMPLETED|Treatment Period 1||2
8390019|NCT01058642|20679579|P4|COMPLETED|Treatment Period 1||7
8390020|NCT01058642|20679580|P3|COMPLETED|Treatment Period 1||9
8390021|NCT01058642|20679581|P2|COMPLETED|Treatment Period 1||11
8390022|NCT01058642|20679582|P1|COMPLETED|Treatment Period 1||7
8390023|NCT01058642|20679579|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
8390024|NCT01058642|20679580|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
8390025|NCT01058642|20679581|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
8390026|NCT01058642|20679582|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
8390027|NCT01058642|20679579|P4|STARTED|Treatment Period 1||9
8390028|NCT01058642|20679580|P3|STARTED|Treatment Period 1||11
8390029|NCT01058642|20679581|P2|STARTED|Treatment Period 1||12
8390030|NCT01058642|20679582|P1|STARTED|Treatment Period 1||9
8390031|NCT01058421|20679592|P2|NOT COMPLETED|6 Month Outcomes||26
8390032|NCT01058421|20679593|P1|NOT COMPLETED|6 Month Outcomes||19
8390033|NCT01058421|20679592|P2|COMPLETED|6 Month Outcomes||24
8390034|NCT01058421|20679593|P1|COMPLETED|6 Month Outcomes||27
8390035|NCT01058421|20679592|P2|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
8390036|NCT01058421|20679593|P1|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
8390037|NCT01058421|20679592|P2|NOT COMPLETED|3 Month Outcomes||26
8390038|NCT01058421|20679593|P1|NOT COMPLETED|3 Month Outcomes||20
8390039|NCT01058421|20679592|P2|COMPLETED|3 Month Outcomes||29
8390040|NCT01058421|20679593|P1|COMPLETED|3 Month Outcomes||29
8390041|NCT01058421|20679592|P2|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
8390042|NCT01058421|20679593|P1|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
8390043|NCT01058421|20679592|P2|NOT COMPLETED|1 Month Outcomes||42
8390044|NCT01058421|20679593|P1|NOT COMPLETED|1 Month Outcomes||39
8390045|NCT01058421|20679592|P2|COMPLETED|1 Month Outcomes||19
8390046|NCT01058421|20679593|P1|COMPLETED|1 Month Outcomes||20
8390047|NCT01058421|20679592|P2|STARTED|1 Month Outcomes||61
8390048|NCT01058421|20679593|P1|STARTED|1 Month Outcomes||59
8390049|NCT01058395|20679617|P2|NOT COMPLETED|Overall Study||1
8390050|NCT01058395|20679618|P1|NOT COMPLETED|Overall Study||3
8390051|NCT01058395|20679617|P2|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
8390052|NCT01058395|20679618|P1|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
8390053|NCT01058395|20679617|P2|STARTED|Overall Study||8
8390054|NCT01058395|20679618|P1|STARTED|Overall Study||7
8390055|NCT01058369|20679627|P1|NOT COMPLETED|Overall Study||2
8390056|NCT01058369|20679627|P1|COMPLETED|Overall Study||0
8390057|NCT01058369|20679627|P1|STARTED|Overall Study||2
8390058|NCT01058356|20679631|P1|NOT COMPLETED|Overall Study||42
8390059|NCT01058356|20679631|P1|COMPLETED|Overall Study||172
8390060|NCT01058356|20679631|P1|STARTED|Overall Study||214
8390061|NCT01058304|20679638|P2|NOT COMPLETED|Overall Study||33
8390062|NCT01058304|20679639|P1|NOT COMPLETED|Overall Study||27
8390063|NCT01058304|20679638|P2|COMPLETED|Overall Study||128
8390064|NCT01058304|20679639|P1|COMPLETED|Overall Study||132
8390065|NCT01058304|20679638|P2|STARTED|Overall Study||161
8390066|NCT01058304|20679639|P1|STARTED|Overall Study||159
8390067|NCT01058265|20679649|P2|NOT COMPLETED|Overall Study||12
8390068|NCT01058265|20679650|P1|NOT COMPLETED|Overall Study||11
8390069|NCT01058265|20679649|P2|COMPLETED|Overall Study||13
8390070|NCT01058265|20679650|P1|COMPLETED|Overall Study||11
8390071|NCT01058265|20679649|P2|STARTED|Overall Study||25
8390072|NCT01058265|20679650|P1|STARTED|Overall Study||22
8390073|NCT01058239|20679658|P1|NOT COMPLETED|Overall Study||0
8390074|NCT01058239|20679658|P1|COMPLETED|Overall Study||7
8390075|NCT01058239|20679658|P1|STARTED|Overall Study||7
8390076|NCT01058096|20679669|P2|NOT COMPLETED|Safety Follow-up||4
8390077|NCT01058096|20679670|P1|NOT COMPLETED|Safety Follow-up||4
8390078|NCT01058096|20679669|P2|COMPLETED|Safety Follow-up||130
8390079|NCT01058096|20679670|P1|COMPLETED|Safety Follow-up||129
8390080|NCT01058096|20679669|P2|STARTED|Safety Follow-up||134
8390081|NCT01058096|20679670|P1|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
8390082|NCT01058096|20679669|P2|NOT COMPLETED|Double-blind Treatment Phase||50
8390083|NCT01058096|20679670|P1|NOT COMPLETED|Double-blind Treatment Phase||48
8390084|NCT01058096|20679669|P2|COMPLETED|Double-blind Treatment Phase||108
8390085|NCT01058096|20679670|P1|COMPLETED|Double-blind Treatment Phase||106
8390086|NCT01058096|20679669|P2|STARTED|Double-blind Treatment Phase||158
8390087|NCT01058096|20679670|P1|STARTED|Double-blind Treatment Phase||154
8390091|NCT01058005|20679686|P3|NOT COMPLETED|Overall Study||20
8390092|NCT01058005|20679687|P2|NOT COMPLETED|Overall Study||25
8390093|NCT01058005|20679688|P1|NOT COMPLETED|Overall Study||38
8390094|NCT01058005|20679686|P3|COMPLETED|Overall Study||1
8390095|NCT01058005|20679687|P2|COMPLETED|Overall Study||0
8390096|NCT01058005|20679688|P1|COMPLETED|Overall Study||0
8390097|NCT01058005|20679686|P3|Dosed With Study Treatment|Overall Study||17
8390098|NCT01058005|20679687|P2|Dosed With Study Treatment|Overall Study||22
8390099|NCT01058005|20679688|P1|Dosed With Study Treatment|Overall Study||36
8390100|NCT01058005|20679686|P3|STARTED|Overall Study||21
8390101|NCT01058005|20679687|P2|STARTED|Overall Study||25
8390102|NCT01058005|20679688|P1|STARTED|Overall Study||38
8390103|NCT01057901|20679698|P2|NOT COMPLETED|Overall Study||246
8390104|NCT01057901|20679699|P1|NOT COMPLETED|Overall Study||260
8390105|NCT01057901|20679698|P2|COMPLETED|Overall Study||126
8390106|NCT01057901|20679699|P1|COMPLETED|Overall Study||116
8390107|NCT01057901|20679698|P2|STARTED|Overall Study||372
8390108|NCT01057901|20679699|P1|STARTED|Overall Study||376
8390109|NCT01057888|20679710|P3|NOT COMPLETED|Overall Study||0
8390110|NCT01057888|20679711|P2|NOT COMPLETED|Overall Study||0
8390111|NCT01057888|20679712|P1|NOT COMPLETED|Overall Study||0
8390112|NCT01057888|20679710|P3|COMPLETED|Overall Study||2494
8390113|NCT01057888|20679711|P2|COMPLETED|Overall Study||2406
8390114|NCT01057888|20679712|P1|COMPLETED|Overall Study||2504
8390115|NCT01057888|20679710|P3|STARTED|Overall Study||2494
8390116|NCT01057888|20679711|P2|STARTED|Overall Study||2406
8390117|NCT01057888|20679712|P1|STARTED|Overall Study||2504
8390118|NCT01057862|20679723|P2|NOT COMPLETED|Overall Study||2
8390119|NCT01057862|20679724|P1|NOT COMPLETED|Overall Study||1
8390120|NCT01057862|20679723|P2|COMPLETED|Overall Study||2
8390121|NCT01057862|20679724|P1|COMPLETED|Overall Study||4
8390122|NCT01057862|20679723|P2|STARTED|Overall Study||4
8390123|NCT01057862|20679724|P1|STARTED|Overall Study||5
8390124|NCT01057810|20679734|P2|NOT COMPLETED|Overall Study||398
8390125|NCT01057810|20679735|P1|NOT COMPLETED|Overall Study||198
8390126|NCT01057810|20679734|P2|COMPLETED|Overall Study||1
8390127|NCT01057810|20679735|P1|COMPLETED|Overall Study||1
8390128|NCT01057810|20679734|P2|STARTED|Overall Study||399
8390129|NCT01057810|20679735|P1|STARTED|Overall Study||199
8390130|NCT01057693|20679751|P3|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
8390131|NCT01057693|20679752|P2|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
8390132|NCT01057693|20679753|P1|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
8390133|NCT01057693|20679751|P3|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
8390134|NCT01057693|20679752|P2|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
8390135|NCT01057693|20679753|P1|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
8390136|NCT01057693|20679751|P3|Treated|Double-Blind Phase (Week 7 to Week 19)||147
8390137|NCT01057693|20679752|P2|Treated|Double-Blind Phase (Week 7 to Week 19)||147
8390138|NCT01057693|20679753|P1|Treated|Double-Blind Phase (Week 7 to Week 19)||0
8390139|NCT01057693|20679751|P3|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
8390140|NCT01057693|20679752|P2|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
8390141|NCT01057693|20679753|P1|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
8390142|NCT01057693|20679751|P3|NOT COMPLETED|Between Single-Blind and Double-Blind||0
8390143|NCT01057693|20679752|P2|NOT COMPLETED|Between Single-Blind and Double-Blind||0
8390144|NCT01057693|20679753|P1|NOT COMPLETED|Between Single-Blind and Double-Blind||270
8390145|NCT01057693|20679751|P3|COMPLETED|Between Single-Blind and Double-Blind||0
8390146|NCT01057693|20679752|P2|COMPLETED|Between Single-Blind and Double-Blind||0
8390147|NCT01057693|20679753|P1|COMPLETED|Between Single-Blind and Double-Blind||296
8390148|NCT01057693|20679751|P3|STARTED|Between Single-Blind and Double-Blind||0
8390149|NCT01057693|20679752|P2|STARTED|Between Single-Blind and Double-Blind||0
8390150|NCT01057693|20679753|P1|STARTED|Between Single-Blind and Double-Blind||566
8390151|NCT01057693|20679751|P3|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
8390152|NCT01057693|20679752|P2|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
8390153|NCT01057693|20679753|P1|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
8390154|NCT01057693|20679751|P3|COMPLETED|Single-Blind Phase (Up to Week 6)||0
8390155|NCT01057693|20679752|P2|COMPLETED|Single-Blind Phase (Up to Week 6)||0
8390156|NCT01057693|20679753|P1|COMPLETED|Single-Blind Phase (Up to Week 6)||566
8390157|NCT01057693|20679751|P3|STARTED|Single-Blind Phase (Up to Week 6)||0
8390158|NCT01057693|20679752|P2|STARTED|Single-Blind Phase (Up to Week 6)||0
8390159|NCT01057693|20679753|P1|STARTED|Single-Blind Phase (Up to Week 6)||665
8390160|NCT01057589|20679799|P1|NOT COMPLETED|Overall Study||66
8390161|NCT01057589|20679799|P1|COMPLETED|Overall Study||0
8390162|NCT01057589|20679799|P1|STARTED|Overall Study||66
8390166|NCT01057394|20679812|P2|NOT COMPLETED|Overall Study||2
8390167|NCT01057394|20679813|P1|NOT COMPLETED|Overall Study||0
8390168|NCT01057394|20679812|P2|COMPLETED|Overall Study|19 treated participants|19
8390169|NCT01057394|20679813|P1|COMPLETED|Overall Study||0
8390170|NCT01057394|20679812|P2|STARTED|Overall Study|21 enrolled participants|21
8390171|NCT01057394|20679813|P1|STARTED|Overall Study||0
8390172|NCT01057277|20679817|P1|NOT COMPLETED|Overall Study||0
8390173|NCT01057277|20679817|P1|COMPLETED|Overall Study||3
8390174|NCT01057277|20679817|P1|STARTED|Overall Study||3
8390175|NCT01057251|20679823|P2|NOT COMPLETED|Overall Study||29
8390176|NCT01057251|20679824|P1|NOT COMPLETED|Overall Study||28
8390177|NCT01057251|20679823|P2|COMPLETED|Overall Study||114
8390178|NCT01057251|20679824|P1|COMPLETED|Overall Study||262
8390179|NCT01057251|20679823|P2|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
8390180|NCT01057251|20679824|P1|STARTED|Overall Study||290
8390181|NCT01057225|20679832|P6|NOT COMPLETED|Overall Study||0
8390182|NCT01057225|20679833|P5|NOT COMPLETED|Overall Study||0
8390183|NCT01057225|20679834|P4|NOT COMPLETED|Overall Study||0
8390184|NCT01057225|20679835|P3|NOT COMPLETED|Overall Study||0
8390185|NCT01057225|20679836|P2|NOT COMPLETED|Overall Study||0
8390186|NCT01057225|20679837|P1|NOT COMPLETED|Overall Study||0
8390187|NCT01057225|20679832|P6|COMPLETED|Overall Study||23
8390188|NCT01057225|20679833|P5|COMPLETED|Overall Study||22
8390189|NCT01057225|20679834|P4|COMPLETED|Overall Study||7
8390190|NCT01057225|20679835|P3|COMPLETED|Overall Study||6
8390191|NCT01057225|20679836|P2|COMPLETED|Overall Study||3
8390192|NCT01057225|20679837|P1|COMPLETED|Overall Study||3
8390193|NCT01057225|20679832|P6|STARTED|Overall Study||23
8390194|NCT01057225|20679833|P5|STARTED|Overall Study||22
8390195|NCT01057225|20679834|P4|STARTED|Overall Study||7
8390196|NCT01057225|20679835|P3|STARTED|Overall Study||6
8390197|NCT01057225|20679836|P2|STARTED|Overall Study||3
8390198|NCT01057225|20679837|P1|STARTED|Overall Study||3
8390199|NCT01057121|20679859|P5|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390200|NCT01057121|20679860|P4|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390201|NCT01057121|20679861|P3|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390202|NCT01057121|20679862|P2|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390203|NCT01057121|20679863|P1|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390204|NCT01057121|20679859|P5|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
8390205|NCT01057121|20679860|P4|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390206|NCT01057121|20679861|P3|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390207|NCT01057121|20679862|P2|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390208|NCT01057121|20679863|P1|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
8390209|NCT01057121|20679859|P5|STARTED|Phase II: 25 mg/Day Lenalidomide||23
8390210|NCT01057121|20679860|P4|STARTED|Phase II: 25 mg/Day Lenalidomide||0
8390211|NCT01057121|20679861|P3|STARTED|Phase II: 25 mg/Day Lenalidomide||0
8390212|NCT01057121|20679862|P2|STARTED|Phase II: 25 mg/Day Lenalidomide||0
8390213|NCT01057121|20679863|P1|STARTED|Phase II: 25 mg/Day Lenalidomide||0
8390214|NCT01057121|20679859|P5|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390215|NCT01057121|20679860|P4|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390216|NCT01057121|20679861|P3|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390217|NCT01057121|20679862|P2|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390218|NCT01057121|20679863|P1|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390219|NCT01057121|20679859|P5|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390220|NCT01057121|20679860|P4|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
8390221|NCT01057121|20679861|P3|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390222|NCT01057121|20679862|P2|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390223|NCT01057121|20679863|P1|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
8390224|NCT01057121|20679859|P5|STARTED|Phase I: 25 mg/Day Lenalidomide||0
8390225|NCT01057121|20679860|P4|STARTED|Phase I: 25 mg/Day Lenalidomide||6
8390226|NCT01057121|20679861|P3|STARTED|Phase I: 25 mg/Day Lenalidomide||0
8390227|NCT01057121|20679862|P2|STARTED|Phase I: 25 mg/Day Lenalidomide||0
8390228|NCT01057121|20679863|P1|STARTED|Phase I: 25 mg/Day Lenalidomide||0
8390229|NCT01057121|20679859|P5|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390230|NCT01057121|20679860|P4|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390231|NCT01057121|20679861|P3|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390232|NCT01057121|20679862|P2|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390233|NCT01057121|20679863|P1|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390234|NCT01057121|20679859|P5|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390235|NCT01057121|20679860|P4|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390236|NCT01057121|20679861|P3|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
8390237|NCT01057121|20679862|P2|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390238|NCT01057121|20679863|P1|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
8390239|NCT01057121|20679859|P5|STARTED|Phase I: 20 mg/Day Lenalidomide||0
8390240|NCT01057121|20679860|P4|STARTED|Phase I: 20 mg/Day Lenalidomide||0
8390241|NCT01057121|20679861|P3|STARTED|Phase I: 20 mg/Day Lenalidomide||3
8390242|NCT01057121|20679862|P2|STARTED|Phase I: 20 mg/Day Lenalidomide||0
8390243|NCT01057121|20679863|P1|STARTED|Phase I: 20 mg/Day Lenalidomide||0
8390244|NCT01057121|20679859|P5|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390245|NCT01057121|20679860|P4|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390246|NCT01057121|20679861|P3|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390247|NCT01057121|20679862|P2|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390248|NCT01057121|20679863|P1|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390249|NCT01057121|20679859|P5|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390250|NCT01057121|20679860|P4|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390251|NCT01057121|20679861|P3|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390252|NCT01057121|20679862|P2|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
8390253|NCT01057121|20679863|P1|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
8390254|NCT01057121|20679859|P5|STARTED|Phase I: 15 mg/Day Lenolidomide||0
8390255|NCT01057121|20679860|P4|STARTED|Phase I: 15 mg/Day Lenolidomide||0
8390256|NCT01057121|20679861|P3|STARTED|Phase I: 15 mg/Day Lenolidomide||0
8390257|NCT01057121|20679862|P2|STARTED|Phase I: 15 mg/Day Lenolidomide||3
8390258|NCT01057121|20679863|P1|STARTED|Phase I: 15 mg/Day Lenolidomide||0
8390259|NCT01057121|20679859|P5|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390260|NCT01057121|20679860|P4|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390261|NCT01057121|20679861|P3|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390262|NCT01057121|20679862|P2|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390263|NCT01057121|20679863|P1|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390264|NCT01057121|20679859|P5|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390265|NCT01057121|20679860|P4|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390266|NCT01057121|20679861|P3|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390267|NCT01057121|20679862|P2|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
8390268|NCT01057121|20679863|P1|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
8390269|NCT01057121|20679859|P5|STARTED|Phase I: 10 mg/Day Lenalidomide||0
8390270|NCT01057121|20679860|P4|STARTED|Phase I: 10 mg/Day Lenalidomide||0
8390271|NCT01057121|20679861|P3|STARTED|Phase I: 10 mg/Day Lenalidomide||0
8390272|NCT01057121|20679862|P2|STARTED|Phase I: 10 mg/Day Lenalidomide||0
8390273|NCT01057121|20679863|P1|STARTED|Phase I: 10 mg/Day Lenalidomide||3
8390274|NCT01057017|20679892|P1|NOT COMPLETED|Overall Study||0
8390275|NCT01057017|20679892|P1|COMPLETED|Overall Study||5
8390276|NCT01057017|20679892|P1|STARTED|Overall Study||5
8390277|NCT01056913|20679896|P1|NOT COMPLETED|Overall Study||0
8390278|NCT01056913|20679896|P1|COMPLETED|Overall Study||62
8390279|NCT01056913|20679896|P1|STARTED|Overall Study||62
8390280|NCT01056822|20679902|P2|NOT COMPLETED|Overall Study||7
8390281|NCT01056822|20679903|P1|NOT COMPLETED|Overall Study||8
8390282|NCT01056822|20679902|P2|COMPLETED|Overall Study||35
8390283|NCT01056822|20679903|P1|COMPLETED|Overall Study||39
8390284|NCT01056822|20679902|P2|Safety (SAF) Population: NO|Overall Study||2
8390285|NCT01056822|20679903|P1|Safety (SAF) Population: NO|Overall Study||1
8390286|NCT01056822|20679902|P2|Safety (SAF) Population: YES|Overall Study||40
8390287|NCT01056822|20679903|P1|Safety (SAF) Population: YES|Overall Study||46
8390288|NCT01056822|20679902|P2|Per-protocol (PP) Population: NO|Overall Study||17
8390289|NCT01056822|20679903|P1|Per-protocol (PP) Population: NO|Overall Study||18
8390290|NCT01056822|20679902|P2|Per-protocol (PP) Population: YES|Overall Study||25
8390291|NCT01056822|20679903|P1|Per-protocol (PP) Population: YES|Overall Study||29
8390292|NCT01056822|20679902|P2|Intention-to-treat (ITT) Population: NO|Overall Study||4
8390293|NCT01056822|20679903|P1|Intention-to-treat (ITT) Population: NO|Overall Study||4
8390294|NCT01056822|20679902|P2|Intention-to-treat (ITT) Population: YES|Overall Study||38
8390295|NCT01056822|20679903|P1|Intention-to-treat (ITT) Population: YES|Overall Study||43
8390296|NCT01056822|20679902|P2|STARTED|Overall Study||42
8390297|NCT01056822|20679903|P1|STARTED|Overall Study||47
8390298|NCT01056718|20679952|P1|NOT COMPLETED|Overall Study||3
8390299|NCT01056718|20679952|P1|COMPLETED|Overall Study||50
8390300|NCT01056718|20679952|P1|STARTED|Overall Study||53
8390301|NCT01056653|20679985|P3|NOT COMPLETED|Overall Study||2
8390302|NCT01056653|20679986|P2|NOT COMPLETED|Overall Study||0
8390303|NCT01056653|20679987|P1|NOT COMPLETED|Overall Study||0
8390304|NCT01056653|20679985|P3|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
8390305|NCT01056653|20679986|P2|COMPLETED|Overall Study||23
8390306|NCT01056653|20679987|P1|COMPLETED|Overall Study||46
8390307|NCT01056653|20679985|P3|STARTED|Overall Study||44
8390308|NCT01056653|20679986|P2|STARTED|Overall Study||23
8390309|NCT01056653|20679987|P1|STARTED|Overall Study||46
8390310|NCT01056640|20680003|P2|NOT COMPLETED|Overall Study||12
8390311|NCT01056640|20680004|P1|NOT COMPLETED|Overall Study||26
8390312|NCT01056640|20680003|P2|COMPLETED|Overall Study||91
8390313|NCT01056640|20680004|P1|COMPLETED|Overall Study||76
8390314|NCT01056640|20680003|P2|STARTED|Overall Study||103
8390315|NCT01056640|20680004|P1|STARTED|Overall Study||102
8390316|NCT01056601|20680010|P1|NOT COMPLETED|Overall Study||0
8390317|NCT01056601|20680010|P1|COMPLETED|Overall Study||7
8390318|NCT01056601|20680010|P1|STARTED|Overall Study||7
8390319|NCT01056536|20680019|P3|NOT COMPLETED|Overall Study||248
8390320|NCT01056536|20680020|P2|NOT COMPLETED|Overall Study||116
8390321|NCT01056536|20680021|P1|NOT COMPLETED|Overall Study||202
8390322|NCT01056536|20680019|P3|COMPLETED|Overall Study||481
8390323|NCT01056536|20680020|P2|COMPLETED|Overall Study||240
8390324|NCT01056536|20680021|P1|COMPLETED|Overall Study||394
8390325|NCT01056536|20680019|P3|STARTED|Overall Study||729
8390326|NCT01056536|20680020|P2|STARTED|Overall Study||356
8390327|NCT01056536|20680021|P1|STARTED|Overall Study||596
8390328|NCT01056523|20680032|P7|NOT COMPLETED|Overall Study||1
8390329|NCT01056523|20680033|P6|NOT COMPLETED|Overall Study||0
8390330|NCT01056523|20680034|P5|NOT COMPLETED|Overall Study||0
8390331|NCT01056523|20680035|P4|NOT COMPLETED|Overall Study||3
8390332|NCT01056523|20680036|P3|NOT COMPLETED|Overall Study||2
8390333|NCT01056523|20680037|P2|NOT COMPLETED|Overall Study||0
8390334|NCT01056523|20680038|P1|NOT COMPLETED|Overall Study||1
8390335|NCT01056523|20680032|P7|COMPLETED|Overall Study||4
8390336|NCT01056523|20680033|P6|COMPLETED|Overall Study||3
8390337|NCT01056523|20680034|P5|COMPLETED|Overall Study||3
8390338|NCT01056523|20680035|P4|COMPLETED|Overall Study||3
8390339|NCT01056523|20680036|P3|COMPLETED|Overall Study||3
8390340|NCT01056523|20680037|P2|COMPLETED|Overall Study||3
8390341|NCT01056523|20680038|P1|COMPLETED|Overall Study||3
8390342|NCT01056523|20680032|P7|STARTED|Overall Study||5
8390343|NCT01056523|20680033|P6|STARTED|Overall Study||3
8390344|NCT01056523|20680034|P5|STARTED|Overall Study||3
8390345|NCT01056523|20680035|P4|STARTED|Overall Study||6
8390346|NCT01056523|20680036|P3|STARTED|Overall Study||5
8390347|NCT01056523|20680037|P2|STARTED|Overall Study||3
8390348|NCT01056523|20680038|P1|STARTED|Overall Study||4
8390349|NCT01056510|20680048|P2|NOT COMPLETED|Overall Study||64
8390350|NCT01056510|20680049|P1|NOT COMPLETED|Overall Study||54
8390351|NCT01056510|20680048|P2|COMPLETED|Overall Study||115
8390352|NCT01056510|20680049|P1|COMPLETED|Overall Study||124
8390353|NCT01056510|20680048|P2|STARTED|Overall Study||179
8390354|NCT01056510|20680049|P1|STARTED|Overall Study||178
8390355|NCT01056484|20680095|P2|NOT COMPLETED|Follow up - Non-randomized||2
8390356|NCT01056484|20680096|P1|NOT COMPLETED|Follow up - Non-randomized||0
8390357|NCT01056484|20680095|P2|COMPLETED|Follow up - Non-randomized||56
8390358|NCT01056484|20680096|P1|COMPLETED|Follow up - Non-randomized||57
8390359|NCT01056484|20680095|P2|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
8390360|NCT01056484|20680096|P1|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
8390361|NCT01056484|20680095|P2|NOT COMPLETED|Randomized Controlled Trial||1
8390362|NCT01056484|20680096|P1|NOT COMPLETED|Randomized Controlled Trial||7
8390363|NCT01056484|20680095|P2|COMPLETED|Randomized Controlled Trial||58
8390364|NCT01056484|20680096|P1|COMPLETED|Randomized Controlled Trial||57
8390365|NCT01056484|20680095|P2|STARTED|Randomized Controlled Trial||59
8390366|NCT01056484|20680096|P1|STARTED|Randomized Controlled Trial||64
8390367|NCT01056380|20680112|P2|NOT COMPLETED|Overall Study||3
8390368|NCT01056380|20680113|P1|NOT COMPLETED|Overall Study||2
8390369|NCT01056380|20680112|P2|COMPLETED|Overall Study||39
8390370|NCT01056380|20680113|P1|COMPLETED|Overall Study||35
8390371|NCT01056380|20680112|P2|STARTED|Overall Study||42
8390372|NCT01056380|20680113|P1|STARTED|Overall Study||37
8390373|NCT01056341|20680140|P5|NOT COMPLETED|Overall Study||14
8390374|NCT01056341|20680141|P4|NOT COMPLETED|Overall Study||36
8390375|NCT01056341|20680142|P3|NOT COMPLETED|Overall Study||15
8390376|NCT01056341|20680143|P2|NOT COMPLETED|Overall Study||36
8390377|NCT01056341|20680144|P1|NOT COMPLETED|Overall Study||36
8390378|NCT01056341|20680140|P5|COMPLETED|Overall Study||88
8390379|NCT01056341|20680141|P4|COMPLETED|Overall Study||65
8390380|NCT01056341|20680142|P3|COMPLETED|Overall Study||88
8390381|NCT01056341|20680143|P2|COMPLETED|Overall Study||63
8390382|NCT01056341|20680144|P1|COMPLETED|Overall Study||19
8390383|NCT01056341|20680140|P5|Interim Analysis|Overall Study||43
8390384|NCT01056341|20680141|P4|Interim Analysis|Overall Study||40
8390385|NCT01056341|20680142|P3|Interim Analysis|Overall Study||41
8390386|NCT01056341|20680143|P2|Interim Analysis|Overall Study||41
8390387|NCT01056341|20680144|P1|Interim Analysis|Overall Study||25
8390388|NCT01056341|20680140|P5|STARTED|Overall Study||102
8390389|NCT01056341|20680141|P4|STARTED|Overall Study||101
8390390|NCT01056341|20680142|P3|STARTED|Overall Study||103
8390391|NCT01056341|20680143|P2|STARTED|Overall Study||99
8390392|NCT01056341|20680144|P1|STARTED|Overall Study||55
8390393|NCT01056328|20680165|P2|NOT COMPLETED|Overall Study||16
8390394|NCT01056328|20680166|P1|NOT COMPLETED|Overall Study||17
8390395|NCT01056328|20680165|P2|COMPLETED|Overall Study||144
8390396|NCT01056328|20680166|P1|COMPLETED|Overall Study||147
8390397|NCT01056328|20680165|P2|STARTED|Overall Study||160
8390398|NCT01056328|20680166|P1|STARTED|Overall Study||164
8390399|NCT01056315|20680182|P2|NOT COMPLETED|Overall Study||11
8390400|NCT01056315|20680183|P1|NOT COMPLETED|Overall Study||14
8390401|NCT01056315|20680182|P2|COMPLETED|Overall Study||12
8390402|NCT01056315|20680183|P1|COMPLETED|Overall Study||13
8390403|NCT01056315|20680182|P2|STARTED|Overall Study||23
8390404|NCT01056315|20680183|P1|STARTED|Overall Study||27
8390405|NCT01056302|20680217|P1|NOT COMPLETED|Overall Study||0
8390406|NCT01056302|20680217|P1|COMPLETED|Overall Study|The study was completed with 3 datasets from patients who had maxillofacial trauma and were treated|3
8390407|NCT01056302|20680217|P1|STARTED|Overall Study||3
8390408|NCT01056289|20680223|P4|NOT COMPLETED|Double-blind Phase||10
8390409|NCT01056289|20680224|P3|NOT COMPLETED|Double-blind Phase||13
8390410|NCT01056289|20680225|P2|NOT COMPLETED|Double-blind Phase||4
8390411|NCT01056289|20680226|P1|NOT COMPLETED|Double-blind Phase||0
8390412|NCT01056289|20680223|P4|COMPLETED|Double-blind Phase||138
8390413|NCT01056289|20680224|P3|COMPLETED|Double-blind Phase||127
8390414|NCT01056289|20680225|P2|COMPLETED|Double-blind Phase||69
8390415|NCT01056289|20680226|P1|COMPLETED|Double-blind Phase||0
8390416|NCT01056289|20680223|P4|STARTED|Double-blind Phase||148
8390417|NCT01056289|20680224|P3|STARTED|Double-blind Phase||140
8390418|NCT01056289|20680225|P2|STARTED|Double-blind Phase||73
8390419|NCT01056289|20680226|P1|STARTED|Double-blind Phase||0
8390420|NCT01056289|20680223|P4|NOT COMPLETED|Open-label Phase||0
8390421|NCT01056289|20680224|P3|NOT COMPLETED|Open-label Phase||0
8390422|NCT01056289|20680225|P2|NOT COMPLETED|Open-label Phase||0
8390423|NCT01056289|20680226|P1|NOT COMPLETED|Open-label Phase||119
8390424|NCT01056289|20680223|P4|COMPLETED|Open-label Phase||0
8390425|NCT01056289|20680224|P3|COMPLETED|Open-label Phase||0
8390426|NCT01056289|20680225|P2|COMPLETED|Open-label Phase||0
8390427|NCT01056289|20680226|P1|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
8390428|NCT01056289|20680223|P4|STARTED|Open-label Phase||0
8390429|NCT01056289|20680224|P3|STARTED|Open-label Phase||0
8390430|NCT01056289|20680225|P2|STARTED|Open-label Phase||0
8390431|NCT01056289|20680226|P1|STARTED|Open-label Phase||480
8390432|NCT01056276|20680243|P2|NOT COMPLETED|Maintenance Therapy||28
8390433|NCT01056276|20680244|P1|NOT COMPLETED|Maintenance Therapy||0
8390434|NCT01056276|20680243|P2|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
8390435|NCT01056276|20680244|P1|COMPLETED|Maintenance Therapy||0
8390436|NCT01056276|20680243|P2|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
8390437|NCT01056276|20680244|P1|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
8390438|NCT01056276|20680243|P2|NOT COMPLETED|Treatment Period-Cycles 1-8||8
8390439|NCT01056276|20680244|P1|NOT COMPLETED|Treatment Period-Cycles 1-8||13
8390440|NCT01056276|20680243|P2|COMPLETED|Treatment Period-Cycles 1-8||33
8390441|NCT01056276|20680244|P1|COMPLETED|Treatment Period-Cycles 1-8||5
8390442|NCT01056276|20680243|P2|STARTED|Treatment Period-Cycles 1-8||41
8390443|NCT01056276|20680244|P1|STARTED|Treatment Period-Cycles 1-8||18
8390444|NCT01056263|20680258|P1|NOT COMPLETED|Overall Study||52
8390445|NCT01056263|20680258|P1|COMPLETED|Overall Study||0
8390446|NCT01056263|20680258|P1|STARTED|Overall Study||52
8390447|NCT01056198|20680264|P2|NOT COMPLETED|Overall Study||0
8390448|NCT01056198|20680265|P1|NOT COMPLETED|Overall Study||0
8390449|NCT01056198|20680264|P2|COMPLETED|Overall Study||24
8390450|NCT01056198|20680265|P1|COMPLETED|Overall Study||24
8390451|NCT01056198|20680264|P2|STARTED|Overall Study||24
8390452|NCT01056198|20680265|P1|STARTED|Overall Study||24
8390453|NCT01056107|20680281|P4|NOT COMPLETED|Overall Study||0
8390454|NCT01056107|20680282|P3|NOT COMPLETED|Overall Study||3
8390455|NCT01056107|20680283|P2|NOT COMPLETED|Overall Study||1
8390456|NCT01056107|20680284|P1|NOT COMPLETED|Overall Study||0
8390457|NCT01056107|20680281|P4|COMPLETED|Overall Study||12
8390458|NCT01056107|20680282|P3|COMPLETED|Overall Study||9
8390459|NCT01056107|20680283|P2|COMPLETED|Overall Study||10
8390460|NCT01056107|20680284|P1|COMPLETED|Overall Study||11
8390461|NCT01056107|20680281|P4|STARTED|Overall Study||12
8390462|NCT01056107|20680282|P3|STARTED|Overall Study||12
8390463|NCT01056107|20680283|P2|STARTED|Overall Study||11
8390464|NCT01056107|20680284|P1|STARTED|Overall Study||11
8390465|NCT01056016|20680332|P2|NOT COMPLETED|Overall Study||1
8390466|NCT01056016|20680333|P1|NOT COMPLETED|Overall Study||2
8390467|NCT01056016|20680332|P2|COMPLETED|Overall Study||26
8390468|NCT01056016|20680333|P1|COMPLETED|Overall Study||20
8390469|NCT01056016|20680332|P2|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
8390470|NCT01056016|20680333|P1|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
8390471|NCT01055886|20680341|P2|NOT COMPLETED|Overall Study||11
8390472|NCT01055886|20680342|P1|NOT COMPLETED|Overall Study||5
8390473|NCT01055886|20680341|P2|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
8390474|NCT01055886|20680342|P1|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
8390475|NCT01055886|20680341|P2|Reached Pre-quit Period|Overall Study|1 lost to contact|31
8390476|NCT01055886|20680342|P1|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
8390477|NCT01055886|20680341|P2|STARTED|Overall Study||32
8390478|NCT01055886|20680342|P1|STARTED|Overall Study||33
8390479|NCT01055834|20680354|P2|NOT COMPLETED|Treatment Period III||0
8390480|NCT01055834|20680355|P1|NOT COMPLETED|Treatment Period III||0
8390481|NCT01055834|20680354|P2|COMPLETED|Treatment Period III||14
8390482|NCT01055834|20680355|P1|COMPLETED|Treatment Period III||0
8390483|NCT01055834|20680354|P2|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
8390484|NCT01055834|20680355|P1|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
8390485|NCT01055834|20680354|P2|NOT COMPLETED|Treatment Period II||0
8390486|NCT01055834|20680355|P1|NOT COMPLETED|Treatment Period II||0
8390487|NCT01055834|20680354|P2|COMPLETED|Treatment Period II||21
8390488|NCT01055834|20680355|P1|COMPLETED|Treatment Period II||20
8390489|NCT01055834|20680354|P2|STARTED|Treatment Period II||21
8390490|NCT01055834|20680355|P1|STARTED|Treatment Period II||20
8390491|NCT01055834|20680354|P2|NOT COMPLETED|Treatment Period I||0
8390492|NCT01055834|20680355|P1|NOT COMPLETED|Treatment Period I||1
8390493|NCT01055834|20680354|P2|COMPLETED|Treatment Period I||21
8390494|NCT01055834|20680355|P1|COMPLETED|Treatment Period I||20
8390495|NCT01055834|20680354|P2|STARTED|Treatment Period I||21
8390496|NCT01055834|20680355|P1|STARTED|Treatment Period I||21
8390497|NCT01055782|20680369|P2|NOT COMPLETED|Overall Study||0
8390498|NCT01055782|20680370|P1|NOT COMPLETED|Overall Study||0
8390499|NCT01055782|20680369|P2|COMPLETED|Overall Study||449
8390500|NCT01055782|20680370|P1|COMPLETED|Overall Study||555
8390501|NCT01055782|20680369|P2|STARTED|Overall Study||449
8390502|NCT01055782|20680370|P1|STARTED|Overall Study||555
8390503|NCT01055769|20680378|P2|NOT COMPLETED|Second Intervention||0
8390504|NCT01055769|20680379|P1|NOT COMPLETED|Second Intervention||0
8390505|NCT01055769|20680378|P2|COMPLETED|Second Intervention||10
8390506|NCT01055769|20680379|P1|COMPLETED|Second Intervention||10
8390507|NCT01055769|20680378|P2|STARTED|Second Intervention||10
8390508|NCT01055769|20680379|P1|STARTED|Second Intervention||10
8390509|NCT01055769|20680378|P2|NOT COMPLETED|Washout Period of Atleast 4 Days||0
8390510|NCT01055769|20680379|P1|NOT COMPLETED|Washout Period of Atleast 4 Days||0
8390511|NCT01055769|20680378|P2|COMPLETED|Washout Period of Atleast 4 Days||10
8390512|NCT01055769|20680379|P1|COMPLETED|Washout Period of Atleast 4 Days||10
8390513|NCT01055769|20680378|P2|STARTED|Washout Period of Atleast 4 Days||10
8390514|NCT01055769|20680379|P1|STARTED|Washout Period of Atleast 4 Days||10
8390515|NCT01055769|20680378|P2|NOT COMPLETED|First Intervention||0
8390516|NCT01055769|20680379|P1|NOT COMPLETED|First Intervention||0
8390517|NCT01055769|20680378|P2|COMPLETED|First Intervention||10
8390518|NCT01055769|20680379|P1|COMPLETED|First Intervention||10
8390519|NCT01055769|20680378|P2|STARTED|First Intervention||10
8390520|NCT01055769|20680379|P1|STARTED|First Intervention||10
8390521|NCT01055704|20680397|P4|NOT COMPLETED|Overall Study||0
8390522|NCT01055704|20680398|P3|NOT COMPLETED|Overall Study||0
8390523|NCT01055704|20680399|P2|NOT COMPLETED|Overall Study||0
8390524|NCT01055704|20680400|P1|NOT COMPLETED|Overall Study||0
8390525|NCT01055704|20680397|P4|COMPLETED|Overall Study||8
8390526|NCT01055704|20680398|P3|COMPLETED|Overall Study||16
8390527|NCT01055704|20680399|P2|COMPLETED|Overall Study||8
8390528|NCT01055704|20680400|P1|COMPLETED|Overall Study||16
8390529|NCT01055704|20680397|P4|STARTED|Overall Study||8
8390530|NCT01055704|20680398|P3|STARTED|Overall Study||16
8390531|NCT01055704|20680399|P2|STARTED|Overall Study||8
8390532|NCT01055704|20680400|P1|STARTED|Overall Study||16
8390533|NCT01055639|20680440|P2|NOT COMPLETED|Overall Study||29
8390534|NCT01055639|20680441|P1|NOT COMPLETED|Overall Study||21
8390535|NCT01055639|20680440|P2|COMPLETED|Overall Study||31
8390536|NCT01055639|20680441|P1|COMPLETED|Overall Study||45
8390537|NCT01055639|20680440|P2|STARTED|Overall Study||60
8390538|NCT01055639|20680441|P1|STARTED|Overall Study||66
8390539|NCT01055613|20680465|P2|NOT COMPLETED|Overall Study||4
8390540|NCT01055613|20680466|P1|NOT COMPLETED|Overall Study||9
8390541|NCT01055613|20680465|P2|COMPLETED|Overall Study||96
8390542|NCT01055613|20680466|P1|COMPLETED|Overall Study||191
8390543|NCT01055613|20680465|P2|STARTED|Overall Study||100
8390544|NCT01055613|20680466|P1|STARTED|Overall Study||200
8390545|NCT01055496|20680476|P2|NOT COMPLETED|Overall Study||30
8390546|NCT01055496|20680477|P1|NOT COMPLETED|Overall Study||15
8390547|NCT01055496|20680476|P2|COMPLETED|Overall Study||25
8390548|NCT01055496|20680477|P1|COMPLETED|Overall Study||33
8390549|NCT01055496|20680476|P2|STARTED|Overall Study||55
8390550|NCT01055496|20680477|P1|STARTED|Overall Study||48
8390551|NCT01055457|20680534|P10|NOT COMPLETED|Overall Study||1
8390552|NCT01055457|20680535|P9|NOT COMPLETED|Overall Study||0
8390553|NCT01055457|20680536|P8|NOT COMPLETED|Overall Study||1
8390554|NCT01055457|20680537|P7|NOT COMPLETED|Overall Study||1
8390555|NCT01055457|20680538|P6|NOT COMPLETED|Overall Study||3
8390556|NCT01055457|20680539|P5|NOT COMPLETED|Overall Study||3
8390557|NCT01055457|20680540|P4|NOT COMPLETED|Overall Study||3
8390558|NCT01055457|20680541|P3|NOT COMPLETED|Overall Study||2
8390559|NCT01055457|20680542|P2|NOT COMPLETED|Overall Study||1
8390560|NCT01055457|20680543|P1|NOT COMPLETED|Overall Study||1
8390561|NCT01055457|20680534|P10|COMPLETED|Overall Study||19
8390562|NCT01055457|20680535|P9|COMPLETED|Overall Study||20
8390563|NCT01055457|20680536|P8|COMPLETED|Overall Study||18
8390564|NCT01055457|20680537|P7|COMPLETED|Overall Study||18
8390565|NCT01055457|20680538|P6|COMPLETED|Overall Study||15
8390566|NCT01055457|20680539|P5|COMPLETED|Overall Study||38
8390567|NCT01055457|20680540|P4|COMPLETED|Overall Study||37
8390568|NCT01055457|20680541|P3|COMPLETED|Overall Study||36
8390569|NCT01055457|20680542|P2|COMPLETED|Overall Study||39
8390570|NCT01055457|20680543|P1|COMPLETED|Overall Study||39
8390571|NCT01055457|20680534|P10|STARTED|Overall Study||20
8390572|NCT01055457|20680535|P9|STARTED|Overall Study||20
8390573|NCT01055457|20680536|P8|STARTED|Overall Study||19
8390574|NCT01055457|20680537|P7|STARTED|Overall Study||19
8390575|NCT01055457|20680538|P6|STARTED|Overall Study||18
8390576|NCT01055457|20680539|P5|STARTED|Overall Study||41
8390577|NCT01055457|20680540|P4|STARTED|Overall Study||40
8390578|NCT01055457|20680541|P3|STARTED|Overall Study||38
8390579|NCT01055457|20680542|P2|STARTED|Overall Study||40
8390580|NCT01055457|20680543|P1|STARTED|Overall Study||40
8390581|NCT01055314|20680577|P2|NOT COMPLETED|Overall Study||38
8390582|NCT01055314|20680578|P1|NOT COMPLETED|Overall Study||45
8390583|NCT01055314|20680577|P2|COMPLETED|Overall Study||37
8390584|NCT01055314|20680578|P1|COMPLETED|Overall Study||55
8390585|NCT01055314|20680577|P2|STARTED|Overall Study||75
8390586|NCT01055314|20680578|P1|STARTED|Overall Study||100
8390587|NCT01055262|20680590|P1|NOT COMPLETED|Overall Study||9
8390588|NCT01055262|20680590|P1|COMPLETED|Overall Study||160
8390589|NCT01055262|20680590|P1|STARTED|Overall Study||169
8390590|NCT01055223|20680601|P1|NOT COMPLETED|Overall Study||0
8390591|NCT01055223|20680601|P1|COMPLETED|Overall Study||98483
8390592|NCT01055223|20680601|P1|STARTED|Overall Study||98483
8390593|NCT01055197|20680631|P2|NOT COMPLETED|Overall Study||2
8390594|NCT01055197|20680632|P1|NOT COMPLETED|Overall Study||9
8390595|NCT01055197|20680631|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
8390596|NCT01055197|20680632|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
8390597|NCT01055197|20680631|P2|STARTED|Overall Study||46
8390598|NCT01055197|20680632|P1|STARTED|Overall Study||51
8390599|NCT01055184|20680646|P1|NOT COMPLETED|Overall Study||0
8390600|NCT01055184|20680646|P1|COMPLETED|Overall Study||34
8390601|NCT01055184|20680646|P1|STARTED|Overall Study||34
8390602|NCT01055171|20680652|P2|NOT COMPLETED|Overall Study||7
8390603|NCT01055171|20680653|P1|NOT COMPLETED|Overall Study||11
8390604|NCT01055171|20680652|P2|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
8390605|NCT01055171|20680653|P1|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
8390606|NCT01055171|20680652|P2|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
8390607|NCT01055171|20680653|P1|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
8390608|NCT01055171|20680652|P2|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
8390609|NCT01055171|20680653|P1|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
8390610|NCT01055171|20680652|P2|STARTED|Overall Study|Randomized to receive placebo.|28
8390611|NCT01055171|20680653|P1|STARTED|Overall Study|Randomized to receive medication.|29
8390612|NCT01055132|20680667|P2|NOT COMPLETED|Period 2 (5-9 Days)||1
8390613|NCT01055132|20680668|P1|NOT COMPLETED|Period 2 (5-9 Days)||0
8390614|NCT01055132|20680667|P2|COMPLETED|Period 2 (5-9 Days)||32
8390615|NCT01055132|20680668|P1|COMPLETED|Period 2 (5-9 Days)||35
8390616|NCT01055132|20680667|P2|STARTED|Period 2 (5-9 Days)||33
8390617|NCT01055132|20680668|P1|STARTED|Period 2 (5-9 Days)||35
8390618|NCT01055132|20680667|P2|NOT COMPLETED|Period 1 (5-9 Days)||0
8390619|NCT01055132|20680668|P1|NOT COMPLETED|Period 1 (5-9 Days)||1
8390620|NCT01055132|20680667|P2|COMPLETED|Period 1 (5-9 Days)||33
8390621|NCT01055132|20680668|P1|COMPLETED|Period 1 (5-9 Days)||35
8390622|NCT01055132|20680667|P2|STARTED|Period 1 (5-9 Days)||33
8390623|NCT01055132|20680668|P1|STARTED|Period 1 (5-9 Days)||36
8390627|NCT01055028|20680693|P2|NOT COMPLETED|Treatment Cycles 4 to 6||0
8390628|NCT01055028|20680694|P1|NOT COMPLETED|Treatment Cycles 4 to 6||0
8390629|NCT01055028|20680693|P2|COMPLETED|Treatment Cycles 4 to 6||2
8390630|NCT01055028|20680694|P1|COMPLETED|Treatment Cycles 4 to 6||6
8390631|NCT01055028|20680693|P2|STARTED|Treatment Cycles 4 to 6||2
8390632|NCT01055028|20680694|P1|STARTED|Treatment Cycles 4 to 6||6
8390633|NCT01055028|20680693|P2|NOT COMPLETED|Inter-treatment Period||3
8390634|NCT01055028|20680694|P1|NOT COMPLETED|Inter-treatment Period||0
8390635|NCT01055028|20680693|P2|COMPLETED|Inter-treatment Period||2
8390636|NCT01055028|20680694|P1|COMPLETED|Inter-treatment Period||6
8390637|NCT01055028|20680693|P2|STARTED|Inter-treatment Period||5
8390638|NCT01055028|20680694|P1|STARTED|Inter-treatment Period||6
8390639|NCT01055028|20680693|P2|NOT COMPLETED|Treatment Cycles 1 to 3||3
8390640|NCT01055028|20680694|P1|NOT COMPLETED|Treatment Cycles 1 to 3||2
8390641|NCT01055028|20680693|P2|COMPLETED|Treatment Cycles 1 to 3||5
8390642|NCT01055028|20680694|P1|COMPLETED|Treatment Cycles 1 to 3||6
8390643|NCT01055028|20680693|P2|STARTED|Treatment Cycles 1 to 3||8
8390644|NCT01055028|20680694|P1|STARTED|Treatment Cycles 1 to 3||8
8390645|NCT01055028|20680693|P2|NOT COMPLETED|Screening||1
8390646|NCT01055028|20680694|P1|NOT COMPLETED|Screening||1
8390647|NCT01055028|20680693|P2|COMPLETED|Screening||8
8390648|NCT01055028|20680694|P1|COMPLETED|Screening||8
8390649|NCT01055028|20680693|P2|STARTED|Screening||9
8390650|NCT01055028|20680694|P1|STARTED|Screening||9
8390651|NCT01054976|20680708|P1|NOT COMPLETED|Overall Study||35
8390652|NCT01054976|20680708|P1|COMPLETED|Overall Study||57
8390653|NCT01054976|20680708|P1|STARTED|Overall Study||92
8390654|NCT01054911|20680716|P1|NOT COMPLETED|Overall Study||0
8390655|NCT01054911|20680716|P1|COMPLETED|Overall Study||5
8390656|NCT01054911|20680716|P1|STARTED|Overall Study||5
8390657|NCT01054885|20680729|P7|NOT COMPLETED|24-week, Double-blind Treatment Period||47
8390658|NCT01054885|20680730|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||60
8390659|NCT01054885|20680731|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||42
8390660|NCT01054885|20680732|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||43
8390661|NCT01054885|20680733|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||49
8390662|NCT01054885|20680734|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||59
8390663|NCT01054885|20680735|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
8390664|NCT01054885|20680729|P7|COMPLETED|24-week, Double-blind Treatment Period||158
8390665|NCT01054885|20680730|P6|COMPLETED|24-week, Double-blind Treatment Period||144
8390666|NCT01054885|20680731|P5|COMPLETED|24-week, Double-blind Treatment Period||161
8390667|NCT01054885|20680732|P4|COMPLETED|24-week, Double-blind Treatment Period||160
8390668|NCT01054885|20680733|P3|COMPLETED|24-week, Double-blind Treatment Period||155
8390669|NCT01054885|20680734|P2|COMPLETED|24-week, Double-blind Treatment Period||146
8390670|NCT01054885|20680735|P1|COMPLETED|24-week, Double-blind Treatment Period||0
8390671|NCT01054885|20680729|P7|STARTED|24-week, Double-blind Treatment Period||205
8390672|NCT01054885|20680730|P6|STARTED|24-week, Double-blind Treatment Period||204
8390673|NCT01054885|20680731|P5|STARTED|24-week, Double-blind Treatment Period||203
8390674|NCT01054885|20680732|P4|STARTED|24-week, Double-blind Treatment Period||203
8390675|NCT01054885|20680733|P3|STARTED|24-week, Double-blind Treatment Period||204
8390676|NCT01054885|20680734|P2|STARTED|24-week, Double-blind Treatment Period||205
8390677|NCT01054885|20680735|P1|STARTED|24-week, Double-blind Treatment Period||0
8390678|NCT01054885|20680729|P7|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390679|NCT01054885|20680730|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390680|NCT01054885|20680731|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390681|NCT01054885|20680732|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390682|NCT01054885|20680733|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390683|NCT01054885|20680734|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390684|NCT01054885|20680735|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||351
8390685|NCT01054885|20680729|P7|COMPLETED|2-week, Single-blind Run-In Period||0
8390686|NCT01054885|20680730|P6|COMPLETED|2-week, Single-blind Run-In Period||0
8390687|NCT01054885|20680731|P5|COMPLETED|2-week, Single-blind Run-In Period||0
8390688|NCT01054885|20680732|P4|COMPLETED|2-week, Single-blind Run-In Period||0
8390689|NCT01054885|20680733|P3|COMPLETED|2-week, Single-blind Run-In Period||0
8390690|NCT01054885|20680734|P2|COMPLETED|2-week, Single-blind Run-In Period||0
8390691|NCT01054885|20680735|P1|COMPLETED|2-week, Single-blind Run-In Period||1226
8390692|NCT01054885|20680729|P7|STARTED|2-week, Single-blind Run-In Period||0
8390693|NCT01054885|20680730|P6|STARTED|2-week, Single-blind Run-In Period||0
8390694|NCT01054885|20680731|P5|STARTED|2-week, Single-blind Run-In Period||0
8390695|NCT01054885|20680732|P4|STARTED|2-week, Single-blind Run-In Period||0
8390696|NCT01054885|20680733|P3|STARTED|2-week, Single-blind Run-In Period||0
8390697|NCT01054885|20680734|P2|STARTED|2-week, Single-blind Run-In Period||0
8390698|NCT01054885|20680735|P1|STARTED|2-week, Single-blind Run-In Period||1577
8390699|NCT01054846|20680775|P2|NOT COMPLETED|Overall Study||17
8390700|NCT01054846|20680776|P1|NOT COMPLETED|Overall Study||76
8390701|NCT01054846|20680775|P2|COMPLETED|Overall Study||51
8390702|NCT01054846|20680776|P1|COMPLETED|Overall Study||246
8390703|NCT01054846|20680775|P2|STARTED|Overall Study||68
8390704|NCT01054846|20680776|P1|STARTED|Overall Study||322
8390705|NCT01054820|20680783|P1|NOT COMPLETED|Overall Study||2
8390706|NCT01054820|20680783|P1|COMPLETED|Overall Study||121
8390707|NCT01054820|20680783|P1|STARTED|Overall Study||123
8390708|NCT01054742|20680797|P1|NOT COMPLETED|Overall Study||0
8390709|NCT01054742|20680797|P1|COMPLETED|Overall Study||2
8390710|NCT01054742|20680797|P1|STARTED|Overall Study||2
8390711|NCT01054729|20680805|P4|NOT COMPLETED|Overall Study||3
8390712|NCT01054729|20680806|P3|NOT COMPLETED|Overall Study||6
8390713|NCT01054729|20680807|P2|NOT COMPLETED|Overall Study||5
8390714|NCT01054729|20680808|P1|NOT COMPLETED|Overall Study||4
8390715|NCT01054729|20680805|P4|COMPLETED|Overall Study||11
8390716|NCT01054729|20680806|P3|COMPLETED|Overall Study||9
8390717|NCT01054729|20680807|P2|COMPLETED|Overall Study||14
8390718|NCT01054729|20680808|P1|COMPLETED|Overall Study||12
8390719|NCT01054729|20680805|P4|Randomized and Treated|Overall Study||14
8390720|NCT01054729|20680806|P3|Randomized and Treated|Overall Study||15
8390721|NCT01054729|20680807|P2|Randomized and Treated|Overall Study||18
8390722|NCT01054729|20680808|P1|Randomized and Treated|Overall Study||16
8390723|NCT01054729|20680805|P4|STARTED|Overall Study||14
8390724|NCT01054729|20680806|P3|STARTED|Overall Study||15
8390725|NCT01054729|20680807|P2|STARTED|Overall Study||19
8390726|NCT01054729|20680808|P1|STARTED|Overall Study||16
8390727|NCT01054703|20680869|P1|NOT COMPLETED|Overall Study||0
8390728|NCT01054703|20680869|P1|COMPLETED|Overall Study||14
8390729|NCT01054703|20680869|P1|STARTED|Overall Study||14
8390730|NCT01054625|20680876|P3|NOT COMPLETED|Overall Study||1
8390731|NCT01054625|20680877|P2|NOT COMPLETED|Overall Study||3
8390732|NCT01054625|20680878|P1|NOT COMPLETED|Overall Study||2
8390733|NCT01054625|20680876|P3|COMPLETED|Overall Study||9
8390734|NCT01054625|20680877|P2|COMPLETED|Overall Study||9
8390735|NCT01054625|20680878|P1|COMPLETED|Overall Study||6
8390736|NCT01054625|20680876|P3|STARTED|Overall Study||10
8390737|NCT01054625|20680877|P2|STARTED|Overall Study||12
8390738|NCT01054625|20680878|P1|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
8390739|NCT01054599|20680906|P2|NOT COMPLETED|Overall Study||7
8390740|NCT01054599|20680907|P1|NOT COMPLETED|Overall Study||4
8390741|NCT01054599|20680906|P2|COMPLETED|Overall Study||9
8390742|NCT01054599|20680907|P1|COMPLETED|Overall Study||9
8390743|NCT01054599|20680906|P2|STARTED|Overall Study||16
8390744|NCT01054599|20680907|P1|STARTED|Overall Study||13
8390745|NCT01054586|20680919|P4|NOT COMPLETED|Overall Study||0
8390746|NCT01054586|20680920|P3|NOT COMPLETED|Overall Study||0
8390747|NCT01054586|20680921|P2|NOT COMPLETED|Overall Study||0
8390748|NCT01054586|20680922|P1|NOT COMPLETED|Overall Study||0
8390749|NCT01054586|20680919|P4|COMPLETED|Overall Study||101
8390750|NCT01054586|20680920|P3|COMPLETED|Overall Study||8
8390751|NCT01054586|20680921|P2|COMPLETED|Overall Study||15
8390752|NCT01054586|20680922|P1|COMPLETED|Overall Study||43
8390753|NCT01054586|20680919|P4|STARTED|Overall Study||101
8390754|NCT01054586|20680920|P3|STARTED|Overall Study||8
8390755|NCT01054586|20680921|P2|STARTED|Overall Study||15
8390756|NCT01054586|20680922|P1|STARTED|Overall Study||43
8390757|NCT01054573|20681014|P4|NOT COMPLETED|Overall Study||2
8390758|NCT01054573|20681015|P3|NOT COMPLETED|Overall Study||3
8390759|NCT01054573|20681016|P2|NOT COMPLETED|Overall Study||4
8390760|NCT01054573|20681017|P1|NOT COMPLETED|Overall Study||1
8390761|NCT01054573|20681014|P4|COMPLETED|Overall Study||25
8390762|NCT01054573|20681015|P3|COMPLETED|Overall Study||19
8390763|NCT01054573|20681016|P2|COMPLETED|Overall Study||28
8390764|NCT01054573|20681017|P1|COMPLETED|Overall Study||8
8390765|NCT01054573|20681014|P4|STARTED|Overall Study||27
8390766|NCT01054573|20681015|P3|STARTED|Overall Study||22
8390767|NCT01054573|20681016|P2|STARTED|Overall Study||32
8390768|NCT01054573|20681017|P1|STARTED|Overall Study||9
8390769|NCT01054560|20681063|P2|NOT COMPLETED|Overall Study||28
8390770|NCT01054560|20681064|P1|NOT COMPLETED|Overall Study||13
8390771|NCT01054560|20681063|P2|COMPLETED|Overall Study||27
8390772|NCT01054560|20681064|P1|COMPLETED|Overall Study||45
8390773|NCT01054560|20681063|P2|STARTED|Overall Study||55
8390774|NCT01054560|20681064|P1|STARTED|Overall Study||58
8390775|NCT01054456|20681086|P1|NOT COMPLETED|Overall Study||1
8390776|NCT01054456|20681086|P1|COMPLETED|Overall Study||35
8390777|NCT01054456|20681086|P1|STARTED|Overall Study||36
8390778|NCT01054404|20681106|P2|NOT COMPLETED|Overall Study||0
8390779|NCT01054404|20681107|P1|NOT COMPLETED|Overall Study||0
8390780|NCT01054404|20681106|P2|COMPLETED|Overall Study||13
8390781|NCT01054404|20681107|P1|COMPLETED|Overall Study||10
8390782|NCT01054404|20681106|P2|STARTED|Overall Study||13
8390783|NCT01054404|20681107|P1|STARTED|Overall Study||10
8390784|NCT01054339|20681116|P3|NOT COMPLETED|Overall Study||0
8390785|NCT01054339|20681117|P2|NOT COMPLETED|Overall Study||0
8390786|NCT01054339|20681118|P1|NOT COMPLETED|Overall Study||0
8390787|NCT01054339|20681116|P3|COMPLETED|Overall Study||3
8390788|NCT01054339|20681117|P2|COMPLETED|Overall Study||3
8390789|NCT01054339|20681118|P1|COMPLETED|Overall Study||3
8390790|NCT01054339|20681116|P3|STARTED|Overall Study||3
8390791|NCT01054339|20681117|P2|STARTED|Overall Study||3
8390792|NCT01054339|20681118|P1|STARTED|Overall Study||3
8390793|NCT01054300|20681134|P4|NOT COMPLETED|Period 2||0
8390794|NCT01054300|20681135|P3|NOT COMPLETED|Period 2||1
8390795|NCT01054300|20681136|P2|NOT COMPLETED|Period 2||0
8390796|NCT01054300|20681137|P1|NOT COMPLETED|Period 2||0
8390797|NCT01054300|20681134|P4|COMPLETED|Period 2||13
8390798|NCT01054300|20681135|P3|COMPLETED|Period 2||12
8390799|NCT01054300|20681136|P2|COMPLETED|Period 2||13
8390800|NCT01054300|20681137|P1|COMPLETED|Period 2||12
8390801|NCT01054300|20681134|P4|STARTED|Period 2||13
8390802|NCT01054300|20681135|P3|STARTED|Period 2||13
8390803|NCT01054300|20681136|P2|STARTED|Period 2||13
8390804|NCT01054300|20681137|P1|STARTED|Period 2||12
8390805|NCT01054300|20681134|P4|NOT COMPLETED|Period 1||0
8390806|NCT01054300|20681135|P3|NOT COMPLETED|Period 1||0
8390807|NCT01054300|20681136|P2|NOT COMPLETED|Period 1||0
8390808|NCT01054300|20681137|P1|NOT COMPLETED|Period 1||1
8390809|NCT01054300|20681134|P4|COMPLETED|Period 1||13
8390810|NCT01054300|20681135|P3|COMPLETED|Period 1||13
8390811|NCT01054300|20681136|P2|COMPLETED|Period 1||13
8390812|NCT01054300|20681137|P1|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
8390813|NCT01054300|20681134|P4|STARTED|Period 1||13
8390814|NCT01054300|20681135|P3|STARTED|Period 1||13
8390815|NCT01054300|20681136|P2|STARTED|Period 1||13
8390816|NCT01054300|20681137|P1|STARTED|Period 1||13
8390817|NCT01054222|20681187|P1|NOT COMPLETED|Overall Study||11
8390818|NCT01054222|20681187|P1|COMPLETED|Overall Study||20
8390819|NCT01054222|20681187|P1|STARTED|Overall Study||31
8390820|NCT01054209|20681208|P2|NOT COMPLETED|Overall Study||0
8390821|NCT01054209|20681209|P1|NOT COMPLETED|Overall Study||0
8390822|NCT01054209|20681208|P2|COMPLETED|Overall Study||58
8390823|NCT01054209|20681209|P1|COMPLETED|Overall Study||58
8390824|NCT01054209|20681208|P2|STARTED|Overall Study||58
8390825|NCT01054209|20681209|P1|STARTED|Overall Study||58
8390826|NCT01054183|20681217|P2|NOT COMPLETED|Overall Study||0
8390827|NCT01054183|20681218|P1|NOT COMPLETED|Overall Study||0
8390828|NCT01054183|20681217|P2|COMPLETED|Overall Study||12
8390829|NCT01054183|20681218|P1|COMPLETED|Overall Study||10
8390830|NCT01054183|20681217|P2|STARTED|Overall Study||12
8390831|NCT01054183|20681218|P1|STARTED|Overall Study||10
8390832|NCT01054170|20681228|P2|NOT COMPLETED|Overall Study||6
8390833|NCT01054170|20681229|P1|NOT COMPLETED|Overall Study||4
8390834|NCT01054170|20681228|P2|COMPLETED|Overall Study||21
8390835|NCT01054170|20681229|P1|COMPLETED|Overall Study||21
8390836|NCT01054170|20681228|P2|STARTED|Overall Study||27
8390837|NCT01054170|20681229|P1|STARTED|Overall Study||25
8390838|NCT01054079|20681281|P1|NOT COMPLETED|Overall Study||0
8390839|NCT01054079|20681281|P1|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
8390840|NCT01054079|20681281|P1|# Recieved Proper PSA Testing|Overall Study||10
8390841|NCT01054079|20681281|P1|STARTED|Overall Study||20
8390842|NCT01053988|20681294|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||55
8390843|NCT01053988|20681295|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||59
8390844|NCT01053988|20681296|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||63
8390845|NCT01053988|20681297|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||61
8390846|NCT01053988|20681298|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||69
8390847|NCT01053988|20681299|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
8390848|NCT01053988|20681294|P6|COMPLETED|24-week, Double-blind Treatment Period||151
8390849|NCT01053988|20681295|P5|COMPLETED|24-week, Double-blind Treatment Period||147
8390850|NCT01053988|20681296|P4|COMPLETED|24-week, Double-blind Treatment Period||142
8390851|NCT01053988|20681297|P3|COMPLETED|24-week, Double-blind Treatment Period||145
8390852|NCT01053988|20681298|P2|COMPLETED|24-week, Double-blind Treatment Period||138
8390853|NCT01053988|20681299|P1|COMPLETED|24-week, Double-blind Treatment Period||0
8390854|NCT01053988|20681294|P6|STARTED|24-week, Double-blind Treatment Period||206
8390855|NCT01053988|20681295|P5|STARTED|24-week, Double-blind Treatment Period||206
8390856|NCT01053988|20681296|P4|STARTED|24-week, Double-blind Treatment Period||205
8390857|NCT01053988|20681297|P3|STARTED|24-week, Double-blind Treatment Period||206
8390858|NCT01053988|20681298|P2|STARTED|24-week, Double-blind Treatment Period||207
8390859|NCT01053988|20681299|P1|STARTED|24-week, Double-blind Treatment Period||0
8390860|NCT01053988|20681294|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390861|NCT01053988|20681295|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390862|NCT01053988|20681296|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390863|NCT01053988|20681297|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390864|NCT01053988|20681298|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
8390865|NCT01053988|20681299|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||360
8390866|NCT01053988|20681294|P6|COMPLETED|2-week, Single-blind Run-In Period||0
8390867|NCT01053988|20681295|P5|COMPLETED|2-week, Single-blind Run-In Period||0
8390868|NCT01053988|20681296|P4|COMPLETED|2-week, Single-blind Run-In Period||0
8390869|NCT01053988|20681297|P3|COMPLETED|2-week, Single-blind Run-In Period||0
8390870|NCT01053988|20681298|P2|COMPLETED|2-week, Single-blind Run-In Period||0
8390871|NCT01053988|20681299|P1|COMPLETED|2-week, Single-blind Run-In Period||1030
8390872|NCT01053988|20681294|P6|STARTED|2-week, Single-blind Run-In Period||0
8390873|NCT01053988|20681295|P5|STARTED|2-week, Single-blind Run-In Period||0
8390874|NCT01053988|20681296|P4|STARTED|2-week, Single-blind Run-In Period||0
8390875|NCT01053988|20681297|P3|STARTED|2-week, Single-blind Run-In Period||0
8390876|NCT01053988|20681298|P2|STARTED|2-week, Single-blind Run-In Period||0
8390877|NCT01053988|20681299|P1|STARTED|2-week, Single-blind Run-In Period||1390
8390878|NCT01053962|20681336|P5|NOT COMPLETED|Follow-up Period||0
8390879|NCT01053962|20681337|P4|NOT COMPLETED|Follow-up Period||0
8390880|NCT01053962|20681338|P3|NOT COMPLETED|Follow-up Period||0
8390881|NCT01053962|20681339|P2|NOT COMPLETED|Follow-up Period||0
8390882|NCT01053962|20681340|P1|NOT COMPLETED|Follow-up Period||0
8390883|NCT01053962|20681336|P5|COMPLETED|Follow-up Period||17
8390884|NCT01053962|20681337|P4|COMPLETED|Follow-up Period||15
8390885|NCT01053962|20681338|P3|COMPLETED|Follow-up Period||15
8390886|NCT01053962|20681339|P2|COMPLETED|Follow-up Period||14
8390887|NCT01053962|20681340|P1|COMPLETED|Follow-up Period||13
8390888|NCT01053962|20681336|P5|STARTED|Follow-up Period||17
8390889|NCT01053962|20681337|P4|STARTED|Follow-up Period||15
8390890|NCT01053962|20681338|P3|STARTED|Follow-up Period||15
8390891|NCT01053962|20681339|P2|STARTED|Follow-up Period||14
8390892|NCT01053962|20681340|P1|STARTED|Follow-up Period||13
8390893|NCT01053962|20681336|P5|NOT COMPLETED|Treatment Period||3
8390894|NCT01053962|20681337|P4|NOT COMPLETED|Treatment Period||0
8390895|NCT01053962|20681338|P3|NOT COMPLETED|Treatment Period||0
8390896|NCT01053962|20681339|P2|NOT COMPLETED|Treatment Period||0
8390897|NCT01053962|20681340|P1|NOT COMPLETED|Treatment Period||1
8390898|NCT01053962|20681336|P5|COMPLETED|Treatment Period||17
8390899|NCT01053962|20681337|P4|COMPLETED|Treatment Period||15
8390900|NCT01053962|20681338|P3|COMPLETED|Treatment Period||15
8390901|NCT01053962|20681339|P2|COMPLETED|Treatment Period||14
8390902|NCT01053962|20681340|P1|COMPLETED|Treatment Period||13
8390903|NCT01053962|20681336|P5|STARTED|Treatment Period||20
8390904|NCT01053962|20681337|P4|STARTED|Treatment Period||15
8390905|NCT01053962|20681338|P3|STARTED|Treatment Period||15
8390906|NCT01053962|20681339|P2|STARTED|Treatment Period||14
8390907|NCT01053962|20681340|P1|STARTED|Treatment Period||14
8390908|NCT01053962|20681336|P5|NOT COMPLETED|Pretreatment Period||2
8390909|NCT01053962|20681337|P4|NOT COMPLETED|Pretreatment Period||2
8390910|NCT01053962|20681338|P3|NOT COMPLETED|Pretreatment Period||1
8390911|NCT01053962|20681339|P2|NOT COMPLETED|Pretreatment Period||1
8390912|NCT01053962|20681340|P1|NOT COMPLETED|Pretreatment Period||0
8390913|NCT01053962|20681336|P5|COMPLETED|Pretreatment Period||20
8390914|NCT01053962|20681337|P4|COMPLETED|Pretreatment Period||15
8390915|NCT01053962|20681338|P3|COMPLETED|Pretreatment Period||15
8390916|NCT01053962|20681339|P2|COMPLETED|Pretreatment Period||14
8390917|NCT01053962|20681340|P1|COMPLETED|Pretreatment Period||14
8390918|NCT01053962|20681336|P5|STARTED|Pretreatment Period||22
8390919|NCT01053962|20681337|P4|STARTED|Pretreatment Period||17
8390920|NCT01053962|20681338|P3|STARTED|Pretreatment Period||16
8390921|NCT01053962|20681339|P2|STARTED|Pretreatment Period||15
8390922|NCT01053962|20681340|P1|STARTED|Pretreatment Period||14
8390923|NCT01053897|20681372|P1|NOT COMPLETED|Overall Study||0
8390924|NCT01053897|20681372|P1|COMPLETED|Overall Study||5
8390925|NCT01053897|20681372|P1|STARTED|Overall Study||5
8390926|NCT01053819|20681384|P1|NOT COMPLETED|Overall Study||0
8390927|NCT01053819|20681384|P1|COMPLETED|Overall Study||6
8390928|NCT01053819|20681384|P1|STARTED|Overall Study||6
8390929|NCT01053741|20681391|P2|NOT COMPLETED|2nd Study Intervention||1
8390930|NCT01053741|20681392|P1|NOT COMPLETED|2nd Study Intervention||0
8390931|NCT01053741|20681391|P2|COMPLETED|2nd Study Intervention||5
8390932|NCT01053741|20681392|P1|COMPLETED|2nd Study Intervention||5
8390933|NCT01053741|20681391|P2|STARTED|2nd Study Intervention||6
8390934|NCT01053741|20681392|P1|STARTED|2nd Study Intervention||5
8390935|NCT01053741|20681391|P2|NOT COMPLETED|14 Day Washout||0
8390936|NCT01053741|20681392|P1|NOT COMPLETED|14 Day Washout||0
8390937|NCT01053741|20681391|P2|COMPLETED|14 Day Washout||6
8390938|NCT01053741|20681392|P1|COMPLETED|14 Day Washout||5
8390939|NCT01053741|20681391|P2|STARTED|14 Day Washout||6
8390940|NCT01053741|20681392|P1|STARTED|14 Day Washout||5
8390941|NCT01053741|20681391|P2|NOT COMPLETED|1st Intervention||0
8390942|NCT01053741|20681392|P1|NOT COMPLETED|1st Intervention||0
8390943|NCT01053741|20681391|P2|COMPLETED|1st Intervention||6
8390944|NCT01053741|20681392|P1|COMPLETED|1st Intervention||5
8390945|NCT01053741|20681391|P2|STARTED|1st Intervention||6
8390946|NCT01053741|20681392|P1|STARTED|1st Intervention||5
8390947|NCT01053663|20681401|P1|NOT COMPLETED|Overall Study||6
8390948|NCT01053663|20681401|P1|COMPLETED|Overall Study||3
8390949|NCT01053663|20681401|P1|STARTED|Overall Study||9
8390950|NCT01053507|20681444|P2|NOT COMPLETED|Overall Study||1
8390951|NCT01053507|20681445|P1|NOT COMPLETED|Overall Study||3
8390952|NCT01053507|20681444|P2|COMPLETED|Overall Study||11
8390953|NCT01053507|20681445|P1|COMPLETED|Overall Study||8
8390954|NCT01053507|20681444|P2|STARTED|Overall Study||12
8390955|NCT01053507|20681445|P1|STARTED|Overall Study||11
8390959|NCT01053312|20681468|P1|NOT COMPLETED|Overall Study||0
8390960|NCT01053312|20681468|P1|COMPLETED|Overall Study||7
8390961|NCT01053312|20681468|P1|STARTED|Overall Study||7
8390962|NCT01053247|20681489|P3|NOT COMPLETED|Overall Study||28
8390963|NCT01053247|20681490|P2|NOT COMPLETED|Overall Study||19
8390964|NCT01053247|20681491|P1|NOT COMPLETED|Overall Study||20
8390965|NCT01053247|20681489|P3|COMPLETED|Overall Study||236
8390966|NCT01053247|20681490|P2|COMPLETED|Overall Study||241
8390967|NCT01053247|20681491|P1|COMPLETED|Overall Study||249
8390968|NCT01053247|20681489|P3|STARTED|Overall Study||264
8390969|NCT01053247|20681490|P2|STARTED|Overall Study||260
8390970|NCT01053247|20681491|P1|STARTED|Overall Study||269
8390971|NCT01053221|20681501|P2|NOT COMPLETED|Overall Study||9
8390972|NCT01053221|20681502|P1|NOT COMPLETED|Overall Study||5
8390973|NCT01053221|20681501|P2|COMPLETED|Overall Study||0
8390974|NCT01053221|20681502|P1|COMPLETED|Overall Study||0
8390975|NCT01053221|20681501|P2|STARTED|Overall Study||9
8390976|NCT01053221|20681502|P1|STARTED|Overall Study||5
8390977|NCT01053156|20681518|P2|NOT COMPLETED|Second Intervention (Week 13-24)||5
8390978|NCT01053156|20681519|P1|NOT COMPLETED|Second Intervention (Week 13-24)||2
8390979|NCT01053156|20681518|P2|COMPLETED|Second Intervention (Week 13-24)||22
8390980|NCT01053156|20681519|P1|COMPLETED|Second Intervention (Week 13-24)||26
8390981|NCT01053156|20681518|P2|STARTED|Second Intervention (Week 13-24)||27
8390982|NCT01053156|20681519|P1|STARTED|Second Intervention (Week 13-24)||28
8390983|NCT01053156|20681518|P2|NOT COMPLETED|First Intervention (Week 1-12)||6
8390984|NCT01053156|20681519|P1|NOT COMPLETED|First Intervention (Week 1-12)||5
8390985|NCT01053156|20681518|P2|COMPLETED|First Intervention (Week 1-12)||27
8390986|NCT01053156|20681519|P1|COMPLETED|First Intervention (Week 1-12)||28
8390987|NCT01053156|20681518|P2|STARTED|First Intervention (Week 1-12)||33
8390988|NCT01053156|20681519|P1|STARTED|First Intervention (Week 1-12)||33
8390989|NCT01053078|20681557|P2|NOT COMPLETED|Overall Study||3
8390990|NCT01053078|20681558|P1|NOT COMPLETED|Overall Study||4
8390991|NCT01053078|20681557|P2|COMPLETED|Overall Study||12
8390992|NCT01053078|20681558|P1|COMPLETED|Overall Study||10
8390993|NCT01053078|20681557|P2|STARTED|Overall Study||15
8390994|NCT01053078|20681558|P1|STARTED|Overall Study||14
8390995|NCT01053000|20681566|P2|NOT COMPLETED|Overall Study||0
8390996|NCT01053000|20681567|P1|NOT COMPLETED|Overall Study||0
8390997|NCT01053000|20681566|P2|COMPLETED|Overall Study||5
8390998|NCT01053000|20681567|P1|COMPLETED|Overall Study||5
8390999|NCT01053000|20681566|P2|STARTED|Overall Study||5
8391000|NCT01053000|20681567|P1|STARTED|Overall Study||5
8391001|NCT01052948|20681577|P4|NOT COMPLETED|Overall Study||0
8391002|NCT01052948|20681578|P3|NOT COMPLETED|Overall Study||0
8391003|NCT01052948|20681579|P2|NOT COMPLETED|Overall Study||0
8391004|NCT01052948|20681580|P1|NOT COMPLETED|Overall Study||0
8391005|NCT01052948|20681577|P4|COMPLETED|Overall Study||29311
8391006|NCT01052948|20681578|P3|COMPLETED|Overall Study||15147
8391007|NCT01052948|20681579|P2|COMPLETED|Overall Study||14669
8391008|NCT01052948|20681580|P1|COMPLETED|Overall Study||27812
8391009|NCT01052948|20681577|P4|STARTED|Overall Study||29311
8391010|NCT01052948|20681578|P3|STARTED|Overall Study||15147
8391011|NCT01052948|20681579|P2|STARTED|Overall Study||14669
8391012|NCT01052948|20681580|P1|STARTED|Overall Study||27812
8391013|NCT01052844|20681604|P2|NOT COMPLETED|Overall Study||1
8391014|NCT01052844|20681605|P1|NOT COMPLETED|Overall Study||0
8391015|NCT01052844|20681604|P2|COMPLETED|Overall Study||39
8391016|NCT01052844|20681605|P1|COMPLETED|Overall Study||40
8391017|NCT01052844|20681604|P2|STARTED|Overall Study||40
8391018|NCT01052844|20681605|P1|STARTED|Overall Study||40
8391019|NCT01052831|20681615|P2|NOT COMPLETED|Overall Study||1
8391020|NCT01052831|20681616|P1|NOT COMPLETED|Overall Study||4
8391021|NCT01052831|20681615|P2|COMPLETED|Overall Study||23
8391022|NCT01052831|20681616|P1|COMPLETED|Overall Study||22
8391023|NCT01052831|20681615|P2|STARTED|Overall Study||24
8391024|NCT01052831|20681616|P1|STARTED|Overall Study||26
8391025|NCT01052779|20681626|P2|NOT COMPLETED|Overall Study||9
8391026|NCT01052779|20681627|P1|NOT COMPLETED|Overall Study||5
8391027|NCT01052779|20681626|P2|COMPLETED|Overall Study||73
8391028|NCT01052779|20681627|P1|COMPLETED|Overall Study||75
8391029|NCT01052779|20681626|P2|Received at Least 1 Dose of Study Drug|Overall Study||81
8391030|NCT01052779|20681627|P1|Received at Least 1 Dose of Study Drug|Overall Study||80
8391031|NCT01052779|20681626|P2|STARTED|Overall Study||82
8391032|NCT01052779|20681627|P1|STARTED|Overall Study||80
8391033|NCT01052714|20681637|P3|NOT COMPLETED|Overall Study||2
8391034|NCT01052714|20681638|P2|NOT COMPLETED|Overall Study||29
8391035|NCT01052714|20681639|P1|NOT COMPLETED|Overall Study||25
8391036|NCT01052714|20681637|P3|COMPLETED|Overall Study||15
8391037|NCT01052714|20681638|P2|COMPLETED|Overall Study||33
8391038|NCT01052714|20681639|P1|COMPLETED|Overall Study||17
8391039|NCT01052714|20681637|P3|STARTED|Overall Study||17
8391040|NCT01052714|20681638|P2|STARTED|Overall Study||62
8391041|NCT01052714|20681639|P1|STARTED|Overall Study||42
8391042|NCT01052701|20681681|P2|NOT COMPLETED|Overall Study||0
8391043|NCT01052701|20681682|P1|NOT COMPLETED|Overall Study||0
8391044|NCT01052701|20681681|P2|COMPLETED|Overall Study||12
8391045|NCT01052701|20681682|P1|COMPLETED|Overall Study||14
8391046|NCT01052701|20681681|P2|STARTED|Overall Study||12
8391047|NCT01052701|20681682|P1|STARTED|Overall Study||14
8391048|NCT01052662|20681693|P3|NOT COMPLETED|Overall Study||22
8391049|NCT01052662|20681694|P2|NOT COMPLETED|Overall Study||22
8391050|NCT01052662|20681695|P1|NOT COMPLETED|Overall Study||22
8391051|NCT01052662|20681693|P3|COMPLETED|Overall Study||10
8391052|NCT01052662|20681694|P2|COMPLETED|Overall Study||5
8391053|NCT01052662|20681695|P1|COMPLETED|Overall Study||6
8391054|NCT01052662|20681693|P3|Discontinuation Phase|Overall Study||10
8391055|NCT01052662|20681694|P2|Discontinuation Phase|Overall Study||5
8391056|NCT01052662|20681695|P1|Discontinuation Phase|Overall Study||6
8391057|NCT01052662|20681693|P3|Stabilization Phase|Overall Study||26
8391058|NCT01052662|20681694|P2|Stabilization Phase|Overall Study||21
8391059|NCT01052662|20681695|P1|Stabilization Phase|Overall Study||21
8391060|NCT01052662|20681693|P3|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
8391061|NCT01052662|20681694|P2|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
8391062|NCT01052662|20681695|P1|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
8391063|NCT01052545|20681711|P2|NOT COMPLETED|Overall Study||0
8391064|NCT01052545|20681712|P1|NOT COMPLETED|Overall Study||0
8391065|NCT01052545|20681711|P2|COMPLETED|Overall Study||731
8391066|NCT01052545|20681712|P1|COMPLETED|Overall Study||867
8391067|NCT01052545|20681711|P2|STARTED|Overall Study||731
8391068|NCT01052545|20681712|P1|STARTED|Overall Study||867
8391069|NCT01052480|20681736|P2|NOT COMPLETED|Overall Study||17
8391070|NCT01052480|20681737|P1|NOT COMPLETED|Overall Study||8
8391071|NCT01052480|20681736|P2|COMPLETED|Overall Study||32
8391072|NCT01052480|20681737|P1|COMPLETED|Overall Study||41
8391073|NCT01052480|20681736|P2|STARTED|Overall Study||49
8391074|NCT01052480|20681737|P1|STARTED|Overall Study||49
8391075|NCT01052428|20681787|P2|NOT COMPLETED|Overall Study||1
8391076|NCT01052428|20681788|P1|NOT COMPLETED|Overall Study||1
8391077|NCT01052428|20681787|P2|COMPLETED|Overall Study||18
8391078|NCT01052428|20681788|P1|COMPLETED|Overall Study||18
8391079|NCT01052428|20681787|P2|STARTED|Overall Study||19
8391080|NCT01052428|20681788|P1|STARTED|Overall Study||19
8391081|NCT01052272|20681810|P4|NOT COMPLETED|Overall Study||7
8391082|NCT01052272|20681811|P3|NOT COMPLETED|Overall Study||8
8391083|NCT01052272|20681812|P2|NOT COMPLETED|Overall Study||7
8391084|NCT01052272|20681813|P1|NOT COMPLETED|Overall Study||5
8391085|NCT01052272|20681810|P4|COMPLETED|Overall Study||11
8391086|NCT01052272|20681811|P3|COMPLETED|Overall Study||10
8391087|NCT01052272|20681812|P2|COMPLETED|Overall Study||11
8391088|NCT01052272|20681813|P1|COMPLETED|Overall Study||13
8391089|NCT01052272|20681810|P4|STARTED|Overall Study||18
8391090|NCT01052272|20681811|P3|STARTED|Overall Study||18
8391091|NCT01052272|20681812|P2|STARTED|Overall Study||18
8391092|NCT01052272|20681813|P1|STARTED|Overall Study||18
8391093|NCT01052207|20681849|P2|NOT COMPLETED|Overall Study||0
8391094|NCT01052207|20681850|P1|NOT COMPLETED|Overall Study||0
8391095|NCT01052207|20681849|P2|COMPLETED|Overall Study||42
8391096|NCT01052207|20681850|P1|COMPLETED|Overall Study||60
8391097|NCT01052207|20681849|P2|STARTED|Overall Study||42
8391098|NCT01052207|20681850|P1|STARTED|Overall Study||60
8391099|NCT01052116|20681858|P2|NOT COMPLETED|Overall Study||27
8391100|NCT01052116|20681859|P1|NOT COMPLETED|Overall Study||14
8391101|NCT01052116|20681858|P2|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
8391102|NCT01052116|20681859|P1|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
8391103|NCT01052116|20681858|P2|STARTED|Overall Study||193
8391104|NCT01052116|20681859|P1|STARTED|Overall Study||193
8391105|NCT01052077|20681867|P4|NOT COMPLETED|Phase A+||21
8391106|NCT01052077|20681868|P3|NOT COMPLETED|Phase A+||0
8391107|NCT01052077|20681869|P2|NOT COMPLETED|Phase A+||0
8391108|NCT01052077|20681870|P1|NOT COMPLETED|Phase A+||0
8391109|NCT01052077|20681867|P4|COMPLETED|Phase A+||230
8391110|NCT01052077|20681868|P3|COMPLETED|Phase A+||0
8391111|NCT01052077|20681869|P2|COMPLETED|Phase A+||0
8391112|NCT01052077|20681870|P1|COMPLETED|Phase A+||0
8391113|NCT01052077|20681867|P4|STARTED|Phase A+||251
8391114|NCT01052077|20681868|P3|STARTED|Phase A+||0
8391115|NCT01052077|20681869|P2|STARTED|Phase A+||0
8391116|NCT01052077|20681870|P1|STARTED|Phase A+||0
8391117|NCT01052077|20681867|P4|NOT COMPLETED|Phase B||0
8391118|NCT01052077|20681868|P3|NOT COMPLETED|Phase B||16
8391119|NCT01052077|20681869|P2|NOT COMPLETED|Phase B||18
8391120|NCT01052077|20681870|P1|NOT COMPLETED|Phase B||0
8391121|NCT01052077|20681867|P4|COMPLETED|Phase B||0
8391122|NCT01052077|20681868|P3|COMPLETED|Phase B||171
8391123|NCT01052077|20681869|P2|COMPLETED|Phase B||167
8391124|NCT01052077|20681870|P1|COMPLETED|Phase B||0
8391125|NCT01052077|20681867|P4|STARTED|Phase B||0
8391126|NCT01052077|20681868|P3|STARTED|Phase B||187
8391127|NCT01052077|20681869|P2|STARTED|Phase B||185
8391128|NCT01052077|20681870|P1|STARTED|Phase B||0
8391129|NCT01052077|20681867|P4|NOT COMPLETED|Phase A||0
8391130|NCT01052077|20681868|P3|NOT COMPLETED|Phase A||0
8391131|NCT01052077|20681869|P2|NOT COMPLETED|Phase A||0
8391132|NCT01052077|20681870|P1|NOT COMPLETED|Phase A||146
8391133|NCT01052077|20681867|P4|COMPLETED|Phase A||0
8391134|NCT01052077|20681868|P3|COMPLETED|Phase A||0
8391135|NCT01052077|20681869|P2|COMPLETED|Phase A||0
8391136|NCT01052077|20681870|P1|COMPLETED|Phase A||623
8391137|NCT01052077|20681867|P4|STARTED|Phase A||0
8391138|NCT01052077|20681868|P3|STARTED|Phase A||0
8391139|NCT01052077|20681869|P2|STARTED|Phase A||0
8391140|NCT01052077|20681870|P1|STARTED|Phase A||769
8391141|NCT01052038|20681897|P3|NOT COMPLETED|Overall Study||4
8391142|NCT01052038|20681898|P2|NOT COMPLETED|Overall Study||6
8391143|NCT01052038|20681899|P1|NOT COMPLETED|Overall Study||4
8391144|NCT01052038|20681897|P3|COMPLETED|Overall Study||36
8391145|NCT01052038|20681898|P2|COMPLETED|Overall Study||34
8391146|NCT01052038|20681899|P1|COMPLETED|Overall Study||36
8391147|NCT01052038|20681897|P3|STARTED|Overall Study||40
8391148|NCT01052038|20681898|P2|STARTED|Overall Study||40
8391149|NCT01052038|20681899|P1|STARTED|Overall Study||40
8391150|NCT01051986|20681921|P2|NOT COMPLETED|Overall Study||4
8391151|NCT01051986|20681922|P1|NOT COMPLETED|Overall Study||5
8391152|NCT01051986|20681921|P2|COMPLETED|Overall Study||108
8391153|NCT01051986|20681922|P1|COMPLETED|Overall Study||107
8391154|NCT01051986|20681921|P2|STARTED|Overall Study||112
8391155|NCT01051986|20681922|P1|STARTED|Overall Study||112
8391156|NCT01051960|20681936|P1|NOT COMPLETED|Overall Study||1
8391157|NCT01051960|20681936|P1|COMPLETED|Overall Study||11
8391158|NCT01051960|20681936|P1|STARTED|Overall Study||12
8391159|NCT01051921|20681944|P1|NOT COMPLETED|Overall Study||30
8391160|NCT01051921|20681944|P1|COMPLETED|Overall Study||37
8391161|NCT01051921|20681944|P1|STARTED|Overall Study||67
8391162|NCT01051856|20681951|P2|NOT COMPLETED|Overall Study||0
8391163|NCT01051856|20681952|P1|NOT COMPLETED|Overall Study||1
8391164|NCT01051856|20681951|P2|COMPLETED|Overall Study||35
8391165|NCT01051856|20681952|P1|COMPLETED|Overall Study||32
8391166|NCT01051856|20681951|P2|STARTED|Overall Study||35
8391167|NCT01051856|20681952|P1|STARTED|Overall Study||33
8391168|NCT01051817|20681962|P2|NOT COMPLETED|Overall Study||9
8391169|NCT01051817|20681963|P1|NOT COMPLETED|Overall Study||3
8391170|NCT01051817|20681962|P2|COMPLETED|Overall Study||26
8391171|NCT01051817|20681963|P1|COMPLETED|Overall Study||35
8391172|NCT01051817|20681962|P2|STARTED|Overall Study||35
8391173|NCT01051817|20681963|P1|STARTED|Overall Study||38
8391174|NCT01051791|20681973|P1|NOT COMPLETED|Overall Study||4
8391175|NCT01051791|20681973|P1|COMPLETED|Overall Study||9
8391176|NCT01051791|20681973|P1|STARTED|Overall Study||13
8391177|NCT01051778|20681982|P2|NOT COMPLETED|Overall Study||0
8391178|NCT01051778|20681983|P1|NOT COMPLETED|Overall Study||0
8391179|NCT01051778|20681982|P2|COMPLETED|Overall Study|November 2009|30
8391180|NCT01051778|20681983|P1|COMPLETED|Overall Study|November 2009|30
8391181|NCT01051778|20681982|P2|STARTED|Overall Study|June 2006|30
8391182|NCT01051778|20681983|P1|STARTED|Overall Study|June 2006|30
8391183|NCT01051739|20681991|P2|NOT COMPLETED|Overall Study||13
8391184|NCT01051739|20681992|P1|NOT COMPLETED|Overall Study||28
8391185|NCT01051739|20681991|P2|COMPLETED|Overall Study||47
8391186|NCT01051739|20681992|P1|COMPLETED|Overall Study||92
8391187|NCT01051739|20681991|P2|STARTED|Overall Study||60
8391188|NCT01051739|20681992|P1|STARTED|Overall Study||120
8391207|NCT01051596|20682188|P1|NOT COMPLETED|Overall Study||0
8391208|NCT01051596|20682188|P1|COMPLETED|Overall Study||75
8391209|NCT01051596|20682188|P1|STARTED|Overall Study||75
8391210|NCT01051570|20682195|P1|NOT COMPLETED|Overall Study||0
8391211|NCT01051570|20682195|P1|COMPLETED|Overall Study||26
8391212|NCT01051570|20682195|P1|STARTED|Overall Study||26
8391234|NCT01051518|20682236|P1|NOT COMPLETED|Overall Study||73
8391235|NCT01051518|20682236|P1|COMPLETED|Overall Study||53
8391236|NCT01051518|20682236|P1|STARTED|Overall Study||126
8391237|NCT01051466|20682248|P2|NOT COMPLETED|Overall Study||5
8391238|NCT01051466|20682249|P1|NOT COMPLETED|Overall Study||8
8391239|NCT01051466|20682248|P2|COMPLETED|Overall Study||23
8391240|NCT01051466|20682249|P1|COMPLETED|Overall Study||24
8391241|NCT01051466|20682248|P2|STARTED|Overall Study||28
8391242|NCT01051466|20682249|P1|STARTED|Overall Study||32
8391243|NCT01051440|20682283|P2|NOT COMPLETED|Overall Study||0
8391244|NCT01051440|20682284|P1|NOT COMPLETED|Overall Study||0
8391245|NCT01051440|20682283|P2|COMPLETED|Overall Study||1
8391246|NCT01051440|20682284|P1|COMPLETED|Overall Study||1
8391247|NCT01051440|20682283|P2|STARTED|Overall Study||1
8391248|NCT01051440|20682284|P1|STARTED|Overall Study||1
8391249|NCT01051349|20682294|P1|NOT COMPLETED|Overall Study||173
8391250|NCT01051349|20682294|P1|COMPLETED|Overall Study||237
8391251|NCT01051349|20682294|P1|STARTED|Overall Study||410
8391252|NCT01051323|20682323|P1|NOT COMPLETED|Overall Study||539
8391253|NCT01051323|20682323|P1|COMPLETED|Overall Study||1041
8391254|NCT01051323|20682323|P1|Received at Least One Dose|Overall Study||1547
8391255|NCT01051323|20682323|P1|STARTED|Overall Study||1580
8391256|NCT01051310|20682345|P1|NOT COMPLETED|Overall Study||5
8391257|NCT01051310|20682345|P1|COMPLETED|Overall Study||13
8391258|NCT01051310|20682345|P1|STARTED|Overall Study||18
8391259|NCT01051063|20682352|P2|NOT COMPLETED|Overall Study||4
8391260|NCT01051063|20682353|P1|NOT COMPLETED|Overall Study||10
8391261|NCT01051063|20682352|P2|COMPLETED|Overall Study||1
8391262|NCT01051063|20682353|P1|COMPLETED|Overall Study||2
8391263|NCT01051063|20682352|P2|STARTED|Overall Study||5
8391264|NCT01051063|20682353|P1|STARTED|Overall Study||12
8391265|NCT01050998|20682373|P5|NOT COMPLETED|Overall Study||14
8391266|NCT01050998|20682374|P4|NOT COMPLETED|Overall Study||3
8391267|NCT01050998|20682375|P3|NOT COMPLETED|Overall Study||3
8391268|NCT01050998|20682376|P2|NOT COMPLETED|Overall Study||2
8391269|NCT01050998|20682377|P1|NOT COMPLETED|Overall Study||4
8391270|NCT01050998|20682373|P5|COMPLETED|Overall Study||82
8391271|NCT01050998|20682374|P4|COMPLETED|Overall Study||45
8391272|NCT01050998|20682375|P3|COMPLETED|Overall Study||46
8391273|NCT01050998|20682376|P2|COMPLETED|Overall Study||47
8391274|NCT01050998|20682377|P1|COMPLETED|Overall Study||44
8391275|NCT01050998|20682373|P5|STARTED|Overall Study||96
8391276|NCT01050998|20682374|P4|STARTED|Overall Study||48
8391277|NCT01050998|20682375|P3|STARTED|Overall Study||49
8391278|NCT01050998|20682376|P2|STARTED|Overall Study||49
8391279|NCT01050998|20682377|P1|STARTED|Overall Study||48
8391280|NCT01050946|20682701|P1|NOT COMPLETED|Overall Study||0
8391281|NCT01050946|20682701|P1|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
8391282|NCT01050946|20682701|P1|STARTED|Overall Study||1
8391283|NCT01050907|20682711|P1|NOT COMPLETED|Overall Study||0
8391284|NCT01050907|20682711|P1|COMPLETED|Overall Study||4
8391285|NCT01050907|20682711|P1|STARTED|Overall Study||4
8391286|NCT01050816|20682716|P1|NOT COMPLETED|Overall Study||4
8391287|NCT01050816|20682716|P1|COMPLETED|Overall Study||26
8391288|NCT01050816|20682716|P1|STARTED|Overall Study||30
8391289|NCT01050790|20682722|P1|NOT COMPLETED|Overall Study||1
8391290|NCT01050790|20682722|P1|COMPLETED|Overall Study||16
8391291|NCT01050790|20682722|P1|STARTED|Overall Study||17
8391292|NCT01050764|20682732|P1|NOT COMPLETED|Overall Study||3
8391293|NCT01050764|20682732|P1|COMPLETED|Overall Study||7
8391294|NCT01050764|20682732|P1|Received Infusion of T-con Cells|Overall Study||7
8391295|NCT01050764|20682732|P1|Received Infusion of T-reg Cells|Overall Study||7
8391296|NCT01050764|20682732|P1|Received HSCT Graft|Overall Study||8
8391297|NCT01050764|20682732|P1|STARTED|Overall Study||10
8391298|NCT01050673|20682743|P2|NOT COMPLETED|Overall Study||5
8391299|NCT01050673|20682744|P1|NOT COMPLETED|Overall Study||4
8391300|NCT01050673|20682743|P2|COMPLETED|Overall Study||14
8391301|NCT01050673|20682744|P1|COMPLETED|Overall Study||17
8391302|NCT01050673|20682743|P2|STARTED|Overall Study||19
8391303|NCT01050673|20682744|P1|STARTED|Overall Study||21
8391304|NCT01050660|20682768|P2|NOT COMPLETED|Overall Study||0
8391305|NCT01050660|20682769|P1|NOT COMPLETED|Overall Study||0
8391306|NCT01050660|20682768|P2|COMPLETED|Overall Study||69
8391307|NCT01050660|20682769|P1|COMPLETED|Overall Study||67
8391308|NCT01050660|20682768|P2|STARTED|Overall Study||69
8391309|NCT01050660|20682769|P1|STARTED|Overall Study||67
8391310|NCT01050647|20682795|P2|NOT COMPLETED|Overall Study||0
8391311|NCT01050647|20682796|P1|NOT COMPLETED|Overall Study||0
8391312|NCT01050647|20682795|P2|COMPLETED|Overall Study||11
8391313|NCT01050647|20682796|P1|COMPLETED|Overall Study||10
8391314|NCT01050647|20682795|P2|STARTED|Overall Study||11
8391315|NCT01050647|20682796|P1|STARTED|Overall Study||10
8391316|NCT01050634|20682812|P1|NOT COMPLETED|Overall Study||128
8391317|NCT01050634|20682812|P1|COMPLETED|Overall Study||852
8391318|NCT01050634|20682812|P1|Received Treatment|Overall Study||924
8391319|NCT01050634|20682812|P1|STARTED|Overall Study||980
8391320|NCT01050582|20682822|P2|NOT COMPLETED|Overall Study||0
8391321|NCT01050582|20682823|P1|NOT COMPLETED|Overall Study||0
8391322|NCT01050582|20682822|P2|COMPLETED|Overall Study||51
8391323|NCT01050582|20682823|P1|COMPLETED|Overall Study||133
8391324|NCT01050582|20682822|P2|STARTED|Overall Study||51
8391325|NCT01050582|20682823|P1|STARTED|Overall Study||133
8391326|NCT01050569|20682836|P3|NOT COMPLETED|Overall Study||33
8391327|NCT01050569|20682837|P2|NOT COMPLETED|Overall Study||24
8391328|NCT01050569|20682838|P1|NOT COMPLETED|Overall Study||38
8391329|NCT01050569|20682836|P3|COMPLETED|Overall Study||47
8391330|NCT01050569|20682837|P2|COMPLETED|Overall Study||52
8391331|NCT01050569|20682838|P1|COMPLETED|Overall Study||41
8391332|NCT01050569|20682836|P3|STARTED|Overall Study||80
8391333|NCT01050569|20682837|P2|STARTED|Overall Study||76
8391334|NCT01050569|20682838|P1|STARTED|Overall Study||79
8391335|NCT01050543|20682857|P2|NOT COMPLETED|Overall Study||4
8391336|NCT01050543|20682858|P1|NOT COMPLETED|Overall Study||4
8391337|NCT01050543|20682857|P2|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
8391338|NCT01050543|20682858|P1|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
8391339|NCT01050543|20682857|P2|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
8391340|NCT01050543|20682858|P1|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
8391341|NCT01050530|20682866|P2|NOT COMPLETED|Overall Study||10
8391342|NCT01050530|20682867|P1|NOT COMPLETED|Overall Study||8
8391343|NCT01050530|20682866|P2|COMPLETED|Overall Study||70
8391344|NCT01050530|20682867|P1|COMPLETED|Overall Study||74
8391345|NCT01050530|20682866|P2|STARTED|Overall Study||80
8391346|NCT01050530|20682867|P1|STARTED|Overall Study||82
8391347|NCT01050257|20682878|P3|NOT COMPLETED|Overall Study||7
8391348|NCT01050257|20682879|P2|NOT COMPLETED|Overall Study||13
8391349|NCT01050257|20682880|P1|NOT COMPLETED|Overall Study||11
8391350|NCT01050257|20682878|P3|COMPLETED|Overall Study||8
8391351|NCT01050257|20682879|P2|COMPLETED|Overall Study||40
8391352|NCT01050257|20682880|P1|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
8391353|NCT01050257|20682878|P3|Switched to Oral Treatment|Overall Study||3
8391354|NCT01050257|20682879|P2|Switched to Oral Treatment|Overall Study||31
8391355|NCT01050257|20682880|P1|Switched to Oral Treatment|Overall Study||28
8391356|NCT01050257|20682878|P3|Intent-to-treat Infected Confirmed|Overall Study||10
8391357|NCT01050257|20682879|P2|Intent-to-treat Infected Confirmed|Overall Study||32
8391358|NCT01050257|20682880|P1|Intent-to-treat Infected Confirmed|Overall Study||30
8391359|NCT01050257|20682878|P3|Safety Population: Actual Dose Received|Overall Study||14
8391360|NCT01050257|20682879|P2|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
8391361|NCT01050257|20682880|P1|Safety Population: Actual Dose Received|Overall Study||48
8391362|NCT01050257|20682878|P3|Received Treatment|Overall Study||14
8391363|NCT01050257|20682879|P2|Received Treatment|Overall Study||50
8391364|NCT01050257|20682880|P1|Received Treatment|Overall Study||49
8391365|NCT01050257|20682878|P3|STARTED|Overall Study||15
8391366|NCT01050257|20682879|P2|STARTED|Overall Study||53
8391367|NCT01050257|20682880|P1|STARTED|Overall Study||50
8391368|NCT01050218|20682915|P1|NOT COMPLETED|Overall Study||95
8391369|NCT01050218|20682915|P1|COMPLETED|Overall Study||142
8391370|NCT01050218|20682915|P1|STARTED|Overall Study||237
8391371|NCT01050205|20682921|P2|NOT COMPLETED|Overall Study||4
8391372|NCT01050205|20682922|P1|NOT COMPLETED|Overall Study||11
8391373|NCT01050205|20682921|P2|COMPLETED|Overall Study||71
8391374|NCT01050205|20682922|P1|COMPLETED|Overall Study||137
8391375|NCT01050205|20682921|P2|STARTED|Overall Study||75
8391376|NCT01050205|20682922|P1|STARTED|Overall Study||148
8391377|NCT01050153|20682952|P2|NOT COMPLETED|Overall Study||0
8391378|NCT01050153|20682953|P1|NOT COMPLETED|Overall Study||0
8391379|NCT01050153|20682952|P2|COMPLETED|Overall Study||25
8391380|NCT01050153|20682953|P1|COMPLETED|Overall Study||25
8391381|NCT01050153|20682952|P2|STARTED|Overall Study||25
8391382|NCT01050153|20682953|P1|STARTED|Overall Study||25
8391383|NCT01050062|20682979|P2|NOT COMPLETED|Overall Study||112
8391384|NCT01050062|20682980|P1|NOT COMPLETED|Overall Study||271
8391385|NCT01050062|20682979|P2|COMPLETED|Overall Study||243
8391386|NCT01050062|20682980|P1|COMPLETED|Overall Study||799
8391387|NCT01050062|20682979|P2|STARTED|Overall Study||355
8391388|NCT01050062|20682980|P1|STARTED|Overall Study||1070
8391389|NCT01049984|20683002|P2|NOT COMPLETED|Overall Study||19
8391390|NCT01049984|20683003|P1|NOT COMPLETED|Overall Study||19
8391391|NCT01049984|20683002|P2|COMPLETED|Overall Study||146
8391392|NCT01049984|20683003|P1|COMPLETED|Overall Study||144
8391393|NCT01049984|20683002|P2|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
8391394|NCT01049984|20683003|P1|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
8391395|NCT01049984|20683002|P2|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
8391396|NCT01049984|20683003|P1|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
8391397|NCT01049984|20683002|P2|STARTED|Overall Study||165
8391398|NCT01049984|20683003|P1|STARTED|Overall Study||163
8391399|NCT01049945|20683021|P6|NOT COMPLETED|Overall Study||0
8391400|NCT01049945|20683022|P5|NOT COMPLETED|Overall Study||0
8391401|NCT01049945|20683023|P4|NOT COMPLETED|Overall Study||0
8391402|NCT01049945|20683024|P3|NOT COMPLETED|Overall Study||0
8391403|NCT01049945|20683025|P2|NOT COMPLETED|Overall Study||0
8391404|NCT01049945|20683026|P1|NOT COMPLETED|Overall Study||0
8391405|NCT01049945|20683021|P6|COMPLETED|Overall Study||49
8391406|NCT01049945|20683022|P5|COMPLETED|Overall Study||3
8391407|NCT01049945|20683023|P4|COMPLETED|Overall Study||6
8391408|NCT01049945|20683024|P3|COMPLETED|Overall Study||3
8391409|NCT01049945|20683025|P2|COMPLETED|Overall Study||6
8391410|NCT01049945|20683026|P1|COMPLETED|Overall Study||3
8391411|NCT01049945|20683021|P6|STARTED|Overall Study||49
8391412|NCT01049945|20683022|P5|STARTED|Overall Study||3
8391413|NCT01049945|20683023|P4|STARTED|Overall Study||6
8391414|NCT01049945|20683024|P3|STARTED|Overall Study||3
8391415|NCT01049945|20683025|P2|STARTED|Overall Study||6
8391416|NCT01049945|20683026|P1|STARTED|Overall Study||3
8391417|NCT01049802|20683046|P2|NOT COMPLETED|Overall Study||0
8391418|NCT01049802|20683047|P1|NOT COMPLETED|Overall Study||0
8391419|NCT01049802|20683046|P2|COMPLETED|Overall Study||10
8391420|NCT01049802|20683047|P1|COMPLETED|Overall Study||20
8391421|NCT01049802|20683046|P2|STARTED|Overall Study||10
8391422|NCT01049802|20683047|P1|STARTED|Overall Study||20
8391423|NCT01049776|20683061|P1|NOT COMPLETED|Overall Study||20
8391424|NCT01049776|20683061|P1|COMPLETED|Overall Study||12
8391425|NCT01049776|20683061|P1|STARTED|Overall Study||32
8391426|NCT01049581|20683067|P2|NOT COMPLETED|Overall Study||1
8391427|NCT01049581|20683068|P1|NOT COMPLETED|Overall Study||2
8391428|NCT01049581|20683067|P2|COMPLETED|Overall Study||13
8391429|NCT01049581|20683068|P1|COMPLETED|Overall Study||11
8391430|NCT01049581|20683067|P2|STARTED|Overall Study||14
8391431|NCT01049581|20683068|P1|STARTED|Overall Study||13
8391432|NCT01049503|20683083|P6|NOT COMPLETED|Overall Study||8
8391433|NCT01049503|20683084|P5|NOT COMPLETED|Overall Study||27
8391434|NCT01049503|20683085|P4|NOT COMPLETED|Overall Study||26
8391435|NCT01049503|20683086|P3|NOT COMPLETED|Overall Study||24
8391436|NCT01049503|20683087|P2|NOT COMPLETED|Overall Study||12
8391437|NCT01049503|20683088|P1|NOT COMPLETED|Overall Study||11
8391438|NCT01049503|20683083|P6|COMPLETED|Overall Study||40
8391439|NCT01049503|20683084|P5|COMPLETED|Overall Study||29
8391440|NCT01049503|20683085|P4|COMPLETED|Overall Study||29
8391441|NCT01049503|20683086|P3|COMPLETED|Overall Study||32
8391442|NCT01049503|20683087|P2|COMPLETED|Overall Study||36
8391443|NCT01049503|20683088|P1|COMPLETED|Overall Study||41
8391444|NCT01049503|20683083|P6|STARTED|Overall Study||48
8391445|NCT01049503|20683084|P5|STARTED|Overall Study||56
8391446|NCT01049503|20683085|P4|STARTED|Overall Study||55
8391447|NCT01049503|20683086|P3|STARTED|Overall Study||56
8391448|NCT01049503|20683087|P2|STARTED|Overall Study||48
8391449|NCT01049503|20683088|P1|STARTED|Overall Study||52
8391450|NCT01049412|20683119|P2|NOT COMPLETED|Period II||3
8391451|NCT01049412|20683120|P1|NOT COMPLETED|Period II||4
8391452|NCT01049412|20683119|P2|COMPLETED|Period II||52
8391453|NCT01049412|20683120|P1|COMPLETED|Period II||58
8391454|NCT01049412|20683119|P2|STARTED|Period II||55
8391455|NCT01049412|20683120|P1|STARTED|Period II||62
8391456|NCT01049412|20683119|P2|NOT COMPLETED|Period I||13
8391457|NCT01049412|20683120|P1|NOT COMPLETED|Period I||8
8391458|NCT01049412|20683119|P2|COMPLETED|Period I||55
8391459|NCT01049412|20683120|P1|COMPLETED|Period I||62
8391460|NCT01049412|20683119|P2|Took at Least One Dose of Study Drug|Period I||68
8391461|NCT01049412|20683120|P1|Took at Least One Dose of Study Drug|Period I||69
8391462|NCT01049412|20683119|P2|STARTED|Period I||68
8391463|NCT01049412|20683120|P1|STARTED|Period I||70
8391464|NCT01049373|20683149|P2|NOT COMPLETED|Overall Study||44
8391465|NCT01049373|20683150|P1|NOT COMPLETED|Overall Study||39
8391466|NCT01049373|20683149|P2|COMPLETED|Overall Study||65
8391467|NCT01049373|20683150|P1|COMPLETED|Overall Study||73
8391468|NCT01049373|20683149|P2|STARTED|Overall Study||109
8391469|NCT01049373|20683150|P1|STARTED|Overall Study||112
8391470|NCT01049360|20683164|P20|NOT COMPLETED|Period 4||0
8391471|NCT01049360|20683165|P19|NOT COMPLETED|Period 4||0
8391472|NCT01049360|20683166|P18|NOT COMPLETED|Period 4||1
8391473|NCT01049360|20683167|P17|NOT COMPLETED|Period 4||0
8391474|NCT01049360|20683168|P16|NOT COMPLETED|Period 4||0
8391475|NCT01049360|20683169|P15|NOT COMPLETED|Period 4||0
8391476|NCT01049360|20683170|P14|NOT COMPLETED|Period 4||0
8391477|NCT01049360|20683171|P13|NOT COMPLETED|Period 4||0
8391478|NCT01049360|20683172|P12|NOT COMPLETED|Period 4||0
8391479|NCT01049360|20683173|P11|NOT COMPLETED|Period 4||0
8391480|NCT01049360|20683174|P10|NOT COMPLETED|Period 4||0
8391481|NCT01049360|20683175|P9|NOT COMPLETED|Period 4||0
8391482|NCT01049360|20683176|P8|NOT COMPLETED|Period 4||0
8391483|NCT01049360|20683177|P7|NOT COMPLETED|Period 4||0
8391484|NCT01049360|20683178|P6|NOT COMPLETED|Period 4||0
8391485|NCT01049360|20683179|P5|NOT COMPLETED|Period 4||0
8391486|NCT01049360|20683180|P4|NOT COMPLETED|Period 4||1
8391487|NCT01049360|20683181|P3|NOT COMPLETED|Period 4||0
8391488|NCT01049360|20683182|P2|NOT COMPLETED|Period 4||0
8391489|NCT01049360|20683183|P1|NOT COMPLETED|Period 4||0
8391490|NCT01049360|20683164|P20|COMPLETED|Period 4||5
8391491|NCT01049360|20683165|P19|COMPLETED|Period 4||5
8391492|NCT01049360|20683166|P18|COMPLETED|Period 4||5
8391493|NCT01049360|20683167|P17|COMPLETED|Period 4||5
8391494|NCT01049360|20683168|P16|COMPLETED|Period 4||6
8391495|NCT01049360|20683169|P15|COMPLETED|Period 4||5
8391496|NCT01049360|20683170|P14|COMPLETED|Period 4||6
8391497|NCT01049360|20683171|P13|COMPLETED|Period 4||4
8391498|NCT01049360|20683172|P12|COMPLETED|Period 4||6
8391499|NCT01049360|20683173|P11|COMPLETED|Period 4||5
8391500|NCT01049360|20683174|P10|COMPLETED|Period 4||6
8391501|NCT01049360|20683175|P9|COMPLETED|Period 4||4
8391502|NCT01049360|20683176|P8|COMPLETED|Period 4||4
8391503|NCT01049360|20683177|P7|COMPLETED|Period 4||6
8391504|NCT01049360|20683178|P6|COMPLETED|Period 4||5
8391505|NCT01049360|20683179|P5|COMPLETED|Period 4||7
8391506|NCT01049360|20683180|P4|COMPLETED|Period 4||3
8391507|NCT01049360|20683181|P3|COMPLETED|Period 4||7
8391508|NCT01049360|20683182|P2|COMPLETED|Period 4||4
8391509|NCT01049360|20683183|P1|COMPLETED|Period 4||6
8391510|NCT01049360|20683164|P20|STARTED|Period 4||5
8391511|NCT01049360|20683165|P19|STARTED|Period 4||5
8391512|NCT01049360|20683166|P18|STARTED|Period 4||6
8391513|NCT01049360|20683167|P17|STARTED|Period 4||5
8391514|NCT01049360|20683168|P16|STARTED|Period 4||6
8391515|NCT01049360|20683169|P15|STARTED|Period 4||5
8391516|NCT01049360|20683170|P14|STARTED|Period 4||6
8391517|NCT01049360|20683171|P13|STARTED|Period 4||4
8391518|NCT01049360|20683172|P12|STARTED|Period 4||6
8391519|NCT01049360|20683173|P11|STARTED|Period 4||5
8391520|NCT01049360|20683174|P10|STARTED|Period 4||6
8391521|NCT01049360|20683175|P9|STARTED|Period 4||4
8391522|NCT01049360|20683176|P8|STARTED|Period 4||4
8391523|NCT01049360|20683177|P7|STARTED|Period 4||6
8391524|NCT01049360|20683178|P6|STARTED|Period 4||5
8391525|NCT01049360|20683179|P5|STARTED|Period 4||7
8391526|NCT01049360|20683180|P4|STARTED|Period 4||4
8391527|NCT01049360|20683181|P3|STARTED|Period 4||7
8391528|NCT01049360|20683182|P2|STARTED|Period 4||4
8391529|NCT01049360|20683183|P1|STARTED|Period 4||6
8391530|NCT01049360|20683164|P20|NOT COMPLETED|Period 3||0
8391531|NCT01049360|20683165|P19|NOT COMPLETED|Period 3||0
8391532|NCT01049360|20683166|P18|NOT COMPLETED|Period 3||0
8391533|NCT01049360|20683167|P17|NOT COMPLETED|Period 3||0
8391534|NCT01049360|20683168|P16|NOT COMPLETED|Period 3||0
8391535|NCT01049360|20683169|P15|NOT COMPLETED|Period 3||0
8391536|NCT01049360|20683170|P14|NOT COMPLETED|Period 3||0
8391537|NCT01049360|20683171|P13|NOT COMPLETED|Period 3||0
8391538|NCT01049360|20683172|P12|NOT COMPLETED|Period 3||0
8391539|NCT01049360|20683173|P11|NOT COMPLETED|Period 3||0
8391540|NCT01049360|20683174|P10|NOT COMPLETED|Period 3||0
8391541|NCT01049360|20683175|P9|NOT COMPLETED|Period 3||0
8391542|NCT01049360|20683176|P8|NOT COMPLETED|Period 3||0
8391543|NCT01049360|20683177|P7|NOT COMPLETED|Period 3||0
8391544|NCT01049360|20683178|P6|NOT COMPLETED|Period 3||0
8391545|NCT01049360|20683179|P5|NOT COMPLETED|Period 3||0
8391546|NCT01049360|20683180|P4|NOT COMPLETED|Period 3||0
8391547|NCT01049360|20683181|P3|NOT COMPLETED|Period 3||0
8391548|NCT01049360|20683182|P2|NOT COMPLETED|Period 3||0
8391549|NCT01049360|20683183|P1|NOT COMPLETED|Period 3||0
8391550|NCT01049360|20683164|P20|COMPLETED|Period 3||5
8391551|NCT01049360|20683165|P19|COMPLETED|Period 3||5
8391552|NCT01049360|20683166|P18|COMPLETED|Period 3||6
8391553|NCT01049360|20683167|P17|COMPLETED|Period 3||5
8391554|NCT01049360|20683168|P16|COMPLETED|Period 3||6
8391555|NCT01049360|20683169|P15|COMPLETED|Period 3||5
8391556|NCT01049360|20683170|P14|COMPLETED|Period 3||6
8391557|NCT01049360|20683171|P13|COMPLETED|Period 3||4
8391558|NCT01049360|20683172|P12|COMPLETED|Period 3||6
8391559|NCT01049360|20683173|P11|COMPLETED|Period 3||5
8391560|NCT01049360|20683174|P10|COMPLETED|Period 3||6
8391561|NCT01049360|20683175|P9|COMPLETED|Period 3||4
8391562|NCT01049360|20683176|P8|COMPLETED|Period 3||4
8391563|NCT01049360|20683177|P7|COMPLETED|Period 3||6
8391564|NCT01049360|20683178|P6|COMPLETED|Period 3||5
8391565|NCT01049360|20683179|P5|COMPLETED|Period 3||7
8391566|NCT01049360|20683180|P4|COMPLETED|Period 3||4
8391567|NCT01049360|20683181|P3|COMPLETED|Period 3||7
8391568|NCT01049360|20683182|P2|COMPLETED|Period 3||4
8391569|NCT01049360|20683183|P1|COMPLETED|Period 3||6
8391570|NCT01049360|20683164|P20|STARTED|Period 3||5
8391571|NCT01049360|20683165|P19|STARTED|Period 3||5
8391572|NCT01049360|20683166|P18|STARTED|Period 3||6
8391573|NCT01049360|20683167|P17|STARTED|Period 3||5
8391574|NCT01049360|20683168|P16|STARTED|Period 3||6
8391575|NCT01049360|20683169|P15|STARTED|Period 3||5
8391576|NCT01049360|20683170|P14|STARTED|Period 3||6
8391577|NCT01049360|20683171|P13|STARTED|Period 3||4
8391578|NCT01049360|20683172|P12|STARTED|Period 3||6
8391579|NCT01049360|20683173|P11|STARTED|Period 3||5
8391580|NCT01049360|20683174|P10|STARTED|Period 3||6
8391581|NCT01049360|20683175|P9|STARTED|Period 3||4
8391582|NCT01049360|20683176|P8|STARTED|Period 3||4
8391583|NCT01049360|20683177|P7|STARTED|Period 3||6
8391584|NCT01049360|20683178|P6|STARTED|Period 3||5
8391585|NCT01049360|20683179|P5|STARTED|Period 3||7
8391586|NCT01049360|20683180|P4|STARTED|Period 3||4
8391587|NCT01049360|20683181|P3|STARTED|Period 3||7
8391588|NCT01049360|20683182|P2|STARTED|Period 3||4
8391589|NCT01049360|20683183|P1|STARTED|Period 3||6
8391590|NCT01049360|20683164|P20|NOT COMPLETED|Period 2||2
8391591|NCT01049360|20683165|P19|NOT COMPLETED|Period 2||0
8391592|NCT01049360|20683166|P18|NOT COMPLETED|Period 2||0
8391593|NCT01049360|20683167|P17|NOT COMPLETED|Period 2||0
8391594|NCT01049360|20683168|P16|NOT COMPLETED|Period 2||1
8391595|NCT01049360|20683169|P15|NOT COMPLETED|Period 2||2
8391596|NCT01049360|20683170|P14|NOT COMPLETED|Period 2||0
8391597|NCT01049360|20683171|P13|NOT COMPLETED|Period 2||0
8391598|NCT01049360|20683172|P12|NOT COMPLETED|Period 2||0
8391599|NCT01049360|20683173|P11|NOT COMPLETED|Period 2||0
8391600|NCT01049360|20683174|P10|NOT COMPLETED|Period 2||0
8391601|NCT01049360|20683175|P9|NOT COMPLETED|Period 2||1
8391602|NCT01049360|20683176|P8|NOT COMPLETED|Period 2||0
8391603|NCT01049360|20683177|P7|NOT COMPLETED|Period 2||0
8391604|NCT01049360|20683178|P6|NOT COMPLETED|Period 2||1
8391605|NCT01049360|20683179|P5|NOT COMPLETED|Period 2||0
8391606|NCT01049360|20683180|P4|NOT COMPLETED|Period 2||2
8391607|NCT01049360|20683181|P3|NOT COMPLETED|Period 2||0
8391608|NCT01049360|20683182|P2|NOT COMPLETED|Period 2||1
8391609|NCT01049360|20683183|P1|NOT COMPLETED|Period 2||0
8391610|NCT01049360|20683164|P20|COMPLETED|Period 2||5
8391611|NCT01049360|20683165|P19|COMPLETED|Period 2||5
8391612|NCT01049360|20683166|P18|COMPLETED|Period 2||6
8391613|NCT01049360|20683167|P17|COMPLETED|Period 2||5
8391614|NCT01049360|20683168|P16|COMPLETED|Period 2||6
8391615|NCT01049360|20683169|P15|COMPLETED|Period 2||5
8391616|NCT01049360|20683170|P14|COMPLETED|Period 2||6
8391617|NCT01049360|20683171|P13|COMPLETED|Period 2||4
8391618|NCT01049360|20683172|P12|COMPLETED|Period 2||6
8391619|NCT01049360|20683173|P11|COMPLETED|Period 2||5
8391620|NCT01049360|20683174|P10|COMPLETED|Period 2||6
8391621|NCT01049360|20683175|P9|COMPLETED|Period 2||4
8391622|NCT01049360|20683176|P8|COMPLETED|Period 2||4
8391623|NCT01049360|20683177|P7|COMPLETED|Period 2||6
8391624|NCT01049360|20683178|P6|COMPLETED|Period 2||5
8391625|NCT01049360|20683179|P5|COMPLETED|Period 2||7
8391626|NCT01049360|20683180|P4|COMPLETED|Period 2||4
8391627|NCT01049360|20683181|P3|COMPLETED|Period 2||7
8391628|NCT01049360|20683182|P2|COMPLETED|Period 2||4
8391629|NCT01049360|20683183|P1|COMPLETED|Period 2||6
8391630|NCT01049360|20683164|P20|STARTED|Period 2||7
8391631|NCT01049360|20683165|P19|STARTED|Period 2||5
8391632|NCT01049360|20683166|P18|STARTED|Period 2||6
8391633|NCT01049360|20683167|P17|STARTED|Period 2||5
8391634|NCT01049360|20683168|P16|STARTED|Period 2||7
8391635|NCT01049360|20683169|P15|STARTED|Period 2||7
8391636|NCT01049360|20683170|P14|STARTED|Period 2||6
8391637|NCT01049360|20683171|P13|STARTED|Period 2||4
8391638|NCT01049360|20683172|P12|STARTED|Period 2||6
8391639|NCT01049360|20683173|P11|STARTED|Period 2||5
8391640|NCT01049360|20683174|P10|STARTED|Period 2||6
8391641|NCT01049360|20683175|P9|STARTED|Period 2||5
8391642|NCT01049360|20683176|P8|STARTED|Period 2||4
8391643|NCT01049360|20683177|P7|STARTED|Period 2||6
8391644|NCT01049360|20683178|P6|STARTED|Period 2||6
8391645|NCT01049360|20683179|P5|STARTED|Period 2||7
8391646|NCT01049360|20683180|P4|STARTED|Period 2||6
8391647|NCT01049360|20683181|P3|STARTED|Period 2||7
8391648|NCT01049360|20683182|P2|STARTED|Period 2||5
8391649|NCT01049360|20683183|P1|STARTED|Period 2||6
8391650|NCT01049360|20683164|P20|NOT COMPLETED|Period 1||0
8391651|NCT01049360|20683165|P19|NOT COMPLETED|Period 1||1
8391652|NCT01049360|20683166|P18|NOT COMPLETED|Period 1||0
8391653|NCT01049360|20683167|P17|NOT COMPLETED|Period 1||1
8391654|NCT01049360|20683168|P16|NOT COMPLETED|Period 1||0
8391655|NCT01049360|20683169|P15|NOT COMPLETED|Period 1||0
8391656|NCT01049360|20683170|P14|NOT COMPLETED|Period 1||1
8391657|NCT01049360|20683171|P13|NOT COMPLETED|Period 1||2
8391658|NCT01049360|20683172|P12|NOT COMPLETED|Period 1||0
8391659|NCT01049360|20683173|P11|NOT COMPLETED|Period 1||1
8391660|NCT01049360|20683174|P10|NOT COMPLETED|Period 1||0
8391661|NCT01049360|20683175|P9|NOT COMPLETED|Period 1||2
8391662|NCT01049360|20683176|P8|NOT COMPLETED|Period 1||2
8391663|NCT01049360|20683177|P7|NOT COMPLETED|Period 1||0
8391664|NCT01049360|20683178|P6|NOT COMPLETED|Period 1||0
8391665|NCT01049360|20683179|P5|NOT COMPLETED|Period 1||0
8391666|NCT01049360|20683180|P4|NOT COMPLETED|Period 1||1
8391667|NCT01049360|20683181|P3|NOT COMPLETED|Period 1||0
8391668|NCT01049360|20683182|P2|NOT COMPLETED|Period 1||1
8391669|NCT01049360|20683183|P1|NOT COMPLETED|Period 1||0
8391670|NCT01049360|20683164|P20|COMPLETED|Period 1||7
8391671|NCT01049360|20683165|P19|COMPLETED|Period 1||5
8391672|NCT01049360|20683166|P18|COMPLETED|Period 1||6
8391673|NCT01049360|20683167|P17|COMPLETED|Period 1||5
8391674|NCT01049360|20683168|P16|COMPLETED|Period 1||7
8391675|NCT01049360|20683169|P15|COMPLETED|Period 1||7
8391676|NCT01049360|20683170|P14|COMPLETED|Period 1||6
8391677|NCT01049360|20683171|P13|COMPLETED|Period 1||4
8391678|NCT01049360|20683172|P12|COMPLETED|Period 1||6
8391679|NCT01049360|20683173|P11|COMPLETED|Period 1||5
8391680|NCT01049360|20683174|P10|COMPLETED|Period 1||6
8391681|NCT01049360|20683175|P9|COMPLETED|Period 1||5
8391682|NCT01049360|20683176|P8|COMPLETED|Period 1||4
8391683|NCT01049360|20683177|P7|COMPLETED|Period 1||6
8391684|NCT01049360|20683178|P6|COMPLETED|Period 1||6
8391685|NCT01049360|20683179|P5|COMPLETED|Period 1||7
8391686|NCT01049360|20683180|P4|COMPLETED|Period 1||6
8391687|NCT01049360|20683181|P3|COMPLETED|Period 1||7
8391688|NCT01049360|20683182|P2|COMPLETED|Period 1||5
8391689|NCT01049360|20683183|P1|COMPLETED|Period 1||6
8391690|NCT01049360|20683164|P20|STARTED|Period 1||7
8391691|NCT01049360|20683165|P19|STARTED|Period 1||6
8391692|NCT01049360|20683166|P18|STARTED|Period 1||6
8391693|NCT01049360|20683167|P17|STARTED|Period 1||6
8391694|NCT01049360|20683168|P16|STARTED|Period 1||7
8391695|NCT01049360|20683169|P15|STARTED|Period 1||7
8391696|NCT01049360|20683170|P14|STARTED|Period 1||7
8391697|NCT01049360|20683171|P13|STARTED|Period 1||6
8391698|NCT01049360|20683172|P12|STARTED|Period 1||6
8391699|NCT01049360|20683173|P11|STARTED|Period 1||6
8391700|NCT01049360|20683174|P10|STARTED|Period 1||6
8391701|NCT01049360|20683175|P9|STARTED|Period 1||7
8391702|NCT01049360|20683176|P8|STARTED|Period 1||6
8391703|NCT01049360|20683177|P7|STARTED|Period 1||6
8391704|NCT01049360|20683178|P6|STARTED|Period 1||6
8391705|NCT01049360|20683179|P5|STARTED|Period 1||7
8391706|NCT01049360|20683180|P4|STARTED|Period 1||7
8391707|NCT01049360|20683181|P3|STARTED|Period 1||7
8391708|NCT01049360|20683182|P2|STARTED|Period 1||6
8391709|NCT01049360|20683183|P1|STARTED|Period 1||6
8391710|NCT01049334|20683207|P2|NOT COMPLETED|Overall Study||7
8391711|NCT01049334|20683208|P1|NOT COMPLETED|Overall Study||9
8391712|NCT01049334|20683207|P2|COMPLETED|Overall Study||95
8391713|NCT01049334|20683208|P1|COMPLETED|Overall Study||93
8391714|NCT01049334|20683207|P2|STARTED|Overall Study||102
8391715|NCT01049334|20683208|P1|STARTED|Overall Study||102
8391716|NCT01049308|20683244|P1|NOT COMPLETED|Pill Counts||83
8391717|NCT01049308|20683244|P1|COMPLETED|Pill Counts||168
8391718|NCT01049308|20683244|P1|STARTED|Pill Counts||251
8391719|NCT01049308|20683244|P1|NOT COMPLETED|Evaluation of Cognitive Impairment||0
8391720|NCT01049308|20683244|P1|COMPLETED|Evaluation of Cognitive Impairment||251
8391721|NCT01049308|20683244|P1|STARTED|Evaluation of Cognitive Impairment||251
8391722|NCT01049243|20683251|P1|NOT COMPLETED|Overall Study||2
8391723|NCT01049243|20683251|P1|COMPLETED|Overall Study||18
8391724|NCT01049243|20683251|P1|STARTED|Overall Study||20
8391725|NCT01049035|20683263|P7|NOT COMPLETED|Overall Study||15
8391726|NCT01049035|20683264|P6|NOT COMPLETED|Overall Study||12
8391727|NCT01049035|20683265|P5|NOT COMPLETED|Overall Study||4
8391728|NCT01049035|20683266|P4|NOT COMPLETED|Overall Study||11
8391729|NCT01049035|20683267|P3|NOT COMPLETED|Overall Study||27
8391730|NCT01049035|20683268|P2|NOT COMPLETED|Overall Study||21
8391731|NCT01049035|20683269|P1|NOT COMPLETED|Overall Study||33
8391732|NCT01049035|20683263|P7|COMPLETED|Overall Study||39
8391733|NCT01049035|20683264|P6|COMPLETED|Overall Study||42
8391734|NCT01049035|20683265|P5|COMPLETED|Overall Study||71
8391735|NCT01049035|20683266|P4|COMPLETED|Overall Study||64
8391736|NCT01049035|20683267|P3|COMPLETED|Overall Study||80
8391737|NCT01049035|20683268|P2|COMPLETED|Overall Study||87
8391738|NCT01049035|20683269|P1|COMPLETED|Overall Study||74
8391739|NCT01049035|20683263|P7|Safety Population|Overall Study||49
8391740|NCT01049035|20683264|P6|Safety Population|Overall Study||52
8391741|NCT01049035|20683265|P5|Safety Population|Overall Study||70
8391742|NCT01049035|20683266|P4|Safety Population|Overall Study||74
8391743|NCT01049035|20683267|P3|Safety Population|Overall Study||100
8391744|NCT01049035|20683268|P2|Safety Population|Overall Study||102
8391745|NCT01049035|20683269|P1|Safety Population|Overall Study||104
8391746|NCT01049035|20683263|P7|STARTED|Overall Study||54
8391747|NCT01049035|20683264|P6|STARTED|Overall Study||54
8391748|NCT01049035|20683265|P5|STARTED|Overall Study||75
8391749|NCT01049035|20683266|P4|STARTED|Overall Study||75
8391750|NCT01049035|20683267|P3|STARTED|Overall Study||107
8391751|NCT01049035|20683268|P2|STARTED|Overall Study||108
8391752|NCT01049035|20683269|P1|STARTED|Overall Study||107
8391753|NCT01049009|20683428|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
8391754|NCT01049009|20683429|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
8391755|NCT01049009|20683428|P2|COMPLETED|Treatment Period 2 (12 Weeks)||8
8391756|NCT01049009|20683429|P1|COMPLETED|Treatment Period 2 (12 Weeks)||11
8391757|NCT01049009|20683428|P2|STARTED|Treatment Period 2 (12 Weeks)||18
8391758|NCT01049009|20683429|P1|STARTED|Treatment Period 2 (12 Weeks)||21
8391759|NCT01049009|20683428|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
8391760|NCT01049009|20683429|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
8391761|NCT01049009|20683428|P2|COMPLETED|Treatment Period 1 (12 Weeks)||18
8391762|NCT01049009|20683429|P1|COMPLETED|Treatment Period 1 (12 Weeks)||21
8391763|NCT01049009|20683428|P2|STARTED|Treatment Period 1 (12 Weeks)||21
8391764|NCT01049009|20683429|P1|STARTED|Treatment Period 1 (12 Weeks)||23
8391765|NCT01048944|20683441|P4|NOT COMPLETED|Overall Study||2
8391766|NCT01048944|20683442|P3|NOT COMPLETED|Overall Study||10
8391767|NCT01048944|20683443|P2|NOT COMPLETED|Overall Study||10
8391768|NCT01048944|20683444|P1|NOT COMPLETED|Overall Study||8
8391769|NCT01048944|20683441|P4|COMPLETED|Overall Study||19
8391770|NCT01048944|20683442|P3|COMPLETED|Overall Study||25
8391771|NCT01048944|20683443|P2|COMPLETED|Overall Study||28
8391772|NCT01048944|20683444|P1|COMPLETED|Overall Study||24
8391773|NCT01048944|20683441|P4|STARTED|Overall Study||21
8391774|NCT01048944|20683442|P3|STARTED|Overall Study||35
8391775|NCT01048944|20683443|P2|STARTED|Overall Study||38
8391776|NCT01048944|20683444|P1|STARTED|Overall Study||32
8391777|NCT01048879|20683461|P3|NOT COMPLETED|Overall Study||0
8391778|NCT01048879|20683462|P2|NOT COMPLETED|Overall Study||0
8391779|NCT01048879|20683463|P1|NOT COMPLETED|Overall Study||0
8391780|NCT01048879|20683461|P3|COMPLETED|Overall Study||5
8391781|NCT01048879|20683462|P2|COMPLETED|Overall Study||9
8391782|NCT01048879|20683463|P1|COMPLETED|Overall Study||1
8391783|NCT01048879|20683461|P3|STARTED|Overall Study||5
8391784|NCT01048879|20683462|P2|STARTED|Overall Study||9
8391785|NCT01048879|20683463|P1|STARTED|Overall Study||1
8391786|NCT01048866|20683476|P2|NOT COMPLETED|Overall Study||5
8391787|NCT01048866|20683477|P1|NOT COMPLETED|Overall Study||4
8391788|NCT01048866|20683476|P2|COMPLETED|Overall Study||92
8391789|NCT01048866|20683477|P1|COMPLETED|Overall Study||97
8391790|NCT01048866|20683476|P2|STARTED|Overall Study||97
8391791|NCT01048866|20683477|P1|STARTED|Overall Study||101
8391792|NCT01048788|20683522|P3|NOT COMPLETED|Overall Study||2
8391793|NCT01048788|20683523|P2|NOT COMPLETED|Overall Study||2
8391794|NCT01048788|20683524|P1|NOT COMPLETED|Overall Study||5
8391795|NCT01048788|20683522|P3|COMPLETED|Overall Study||11
8391796|NCT01048788|20683523|P2|COMPLETED|Overall Study||28
8391797|NCT01048788|20683524|P1|COMPLETED|Overall Study||3
8391798|NCT01048788|20683522|P3|STARTED|Overall Study||13
8391799|NCT01048788|20683523|P2|STARTED|Overall Study||30
8391800|NCT01048788|20683524|P1|STARTED|Overall Study||8
8391801|NCT01048723|20683532|P1|NOT COMPLETED|Overall Study||0
8391802|NCT01048723|20683532|P1|COMPLETED|Overall Study||2
8391803|NCT01048723|20683532|P1|STARTED|Overall Study||2
8391804|NCT01048697|20683539|P1|NOT COMPLETED|Overall Study||0
8391805|NCT01048697|20683539|P1|COMPLETED|Overall Study||18
8391806|NCT01048697|20683539|P1|STARTED|Overall Study||18
8391807|NCT01048671|20683546|P3|NOT COMPLETED|Overall Study||1
8391808|NCT01048671|20683547|P2|NOT COMPLETED|Overall Study||1
8391809|NCT01048671|20683548|P1|NOT COMPLETED|Overall Study||0
8391810|NCT01048671|20683546|P3|COMPLETED|Overall Study||151
8391811|NCT01048671|20683547|P2|COMPLETED|Overall Study||263
8391812|NCT01048671|20683548|P1|COMPLETED|Overall Study||66
8391813|NCT01048671|20683546|P3|STARTED|Overall Study||152
8391814|NCT01048671|20683547|P2|STARTED|Overall Study||264
8391815|NCT01048671|20683548|P1|STARTED|Overall Study||66
8391816|NCT01048658|20683571|P2|NOT COMPLETED|Overall Study||0
8391817|NCT01048658|20683572|P1|NOT COMPLETED|Overall Study||0
8391818|NCT01048658|20683571|P2|COMPLETED|Overall Study||80
8391819|NCT01048658|20683572|P1|COMPLETED|Overall Study||80
8391820|NCT01048658|20683571|P2|STARTED|Overall Study||80
8391821|NCT01048658|20683572|P1|STARTED|Overall Study||80
8391822|NCT01048606|20683590|P4|NOT COMPLETED|Overall Study||5
8391823|NCT01048606|20683591|P3|NOT COMPLETED|Overall Study||10
8391824|NCT01048606|20683592|P2|NOT COMPLETED|Overall Study||7
8391825|NCT01048606|20683593|P1|NOT COMPLETED|Overall Study||12
8391826|NCT01048606|20683590|P4|COMPLETED|Overall Study||5
8391827|NCT01048606|20683591|P3|COMPLETED|Overall Study||16
8391828|NCT01048606|20683592|P2|COMPLETED|Overall Study||8
8391829|NCT01048606|20683593|P1|COMPLETED|Overall Study||16
8391830|NCT01048606|20683590|P4|STARTED|Overall Study||10
8391831|NCT01048606|20683591|P3|STARTED|Overall Study||26
8391832|NCT01048606|20683592|P2|STARTED|Overall Study||15
8391833|NCT01048606|20683593|P1|STARTED|Overall Study||28
8391834|NCT01048593|20683606|P3|NOT COMPLETED|Overall Study||0
8391835|NCT01048593|20683607|P2|NOT COMPLETED|Overall Study||0
8391836|NCT01048593|20683608|P1|NOT COMPLETED|Overall Study||0
8391837|NCT01048593|20683606|P3|COMPLETED|Overall Study||1
8391838|NCT01048593|20683607|P2|COMPLETED|Overall Study||2
8391839|NCT01048593|20683608|P1|COMPLETED|Overall Study||3
8391840|NCT01048593|20683606|P3|STARTED|Overall Study||1
8391841|NCT01048593|20683607|P2|STARTED|Overall Study||2
8391842|NCT01048593|20683608|P1|STARTED|Overall Study||3
8391843|NCT01048541|20683628|P2|NOT COMPLETED|Overall Study||0
8391844|NCT01048541|20683629|P1|NOT COMPLETED|Overall Study||1
8391845|NCT01048541|20683628|P2|COMPLETED|Overall Study||19
8391846|NCT01048541|20683629|P1|COMPLETED|Overall Study||17
8391847|NCT01048541|20683628|P2|STARTED|Overall Study||19
8391848|NCT01048541|20683629|P1|STARTED|Overall Study||18
8391849|NCT01048502|20683639|P4|NOT COMPLETED|Overall Study||4
8391850|NCT01048502|20683640|P3|NOT COMPLETED|Overall Study||5
8391851|NCT01048502|20683641|P2|NOT COMPLETED|Overall Study||7
8391852|NCT01048502|20683642|P1|NOT COMPLETED|Overall Study||4
8391853|NCT01048502|20683639|P4|COMPLETED|Overall Study||21
8391854|NCT01048502|20683640|P3|COMPLETED|Overall Study||23
8391855|NCT01048502|20683641|P2|COMPLETED|Overall Study||16
8391856|NCT01048502|20683642|P1|COMPLETED|Overall Study||20
8391857|NCT01048502|20683639|P4|STARTED|Overall Study||25
8391858|NCT01048502|20683640|P3|STARTED|Overall Study||28
8391859|NCT01048502|20683641|P2|STARTED|Overall Study||23
8391860|NCT01048502|20683642|P1|STARTED|Overall Study||24
8391861|NCT01048424|20683655|P2|NOT COMPLETED|Overall Study||0
8391862|NCT01048424|20683656|P1|NOT COMPLETED|Overall Study||2
8391863|NCT01048424|20683655|P2|COMPLETED|Overall Study||10
8391864|NCT01048424|20683656|P1|COMPLETED|Overall Study||8
8391865|NCT01048424|20683655|P2|STARTED|Overall Study||10
8391866|NCT01048424|20683656|P1|STARTED|Overall Study||10
8391867|NCT01048333|20683678|P6|NOT COMPLETED|Treatment Period 3||0
8391868|NCT01048333|20683679|P5|NOT COMPLETED|Treatment Period 3||0
8391869|NCT01048333|20683680|P4|NOT COMPLETED|Treatment Period 3||0
8391870|NCT01048333|20683681|P3|NOT COMPLETED|Treatment Period 3||0
8391871|NCT01048333|20683682|P2|NOT COMPLETED|Treatment Period 3||0
8391872|NCT01048333|20683683|P1|NOT COMPLETED|Treatment Period 3||0
8391873|NCT01048333|20683678|P6|COMPLETED|Treatment Period 3||18
8391874|NCT01048333|20683679|P5|COMPLETED|Treatment Period 3||17
8391875|NCT01048333|20683680|P4|COMPLETED|Treatment Period 3||18
8391876|NCT01048333|20683681|P3|COMPLETED|Treatment Period 3||16
8391877|NCT01048333|20683682|P2|COMPLETED|Treatment Period 3||18
8391878|NCT01048333|20683683|P1|COMPLETED|Treatment Period 3||21
8391879|NCT01048333|20683678|P6|STARTED|Treatment Period 3||18
8391880|NCT01048333|20683679|P5|STARTED|Treatment Period 3||17
8391881|NCT01048333|20683680|P4|STARTED|Treatment Period 3||18
8391882|NCT01048333|20683681|P3|STARTED|Treatment Period 3||16
8391883|NCT01048333|20683682|P2|STARTED|Treatment Period 3||18
8391884|NCT01048333|20683683|P1|STARTED|Treatment Period 3||21
8391885|NCT01048333|20683678|P6|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8391886|NCT01048333|20683679|P5|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8391887|NCT01048333|20683680|P4|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8391888|NCT01048333|20683681|P3|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8391889|NCT01048333|20683682|P2|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
8391890|NCT01048333|20683683|P1|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
8391891|NCT01048333|20683678|P6|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
8391892|NCT01048333|20683679|P5|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
8391893|NCT01048333|20683680|P4|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
8391894|NCT01048333|20683681|P3|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
8391895|NCT01048333|20683682|P2|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
8391896|NCT01048333|20683683|P1|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
8391897|NCT01048333|20683678|P6|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
8391898|NCT01048333|20683679|P5|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
8391899|NCT01048333|20683680|P4|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
8391900|NCT01048333|20683681|P3|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
8391901|NCT01048333|20683682|P2|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
8391902|NCT01048333|20683683|P1|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
8391903|NCT01048333|20683678|P6|NOT COMPLETED|Treatment Period 2||0
8391904|NCT01048333|20683679|P5|NOT COMPLETED|Treatment Period 2||0
8391905|NCT01048333|20683680|P4|NOT COMPLETED|Treatment Period 2||0
8391906|NCT01048333|20683681|P3|NOT COMPLETED|Treatment Period 2||0
8391907|NCT01048333|20683682|P2|NOT COMPLETED|Treatment Period 2||0
8391908|NCT01048333|20683683|P1|NOT COMPLETED|Treatment Period 2||0
8391909|NCT01048333|20683678|P6|COMPLETED|Treatment Period 2||18
8391910|NCT01048333|20683679|P5|COMPLETED|Treatment Period 2||17
8391911|NCT01048333|20683680|P4|COMPLETED|Treatment Period 2||18
8391912|NCT01048333|20683681|P3|COMPLETED|Treatment Period 2||16
8391913|NCT01048333|20683682|P2|COMPLETED|Treatment Period 2||19
8391914|NCT01048333|20683683|P1|COMPLETED|Treatment Period 2||21
8391915|NCT01048333|20683678|P6|STARTED|Treatment Period 2||18
8391916|NCT01048333|20683679|P5|STARTED|Treatment Period 2||17
8391917|NCT01048333|20683680|P4|STARTED|Treatment Period 2||18
8391918|NCT01048333|20683681|P3|STARTED|Treatment Period 2||16
8391919|NCT01048333|20683682|P2|STARTED|Treatment Period 2||19
8391920|NCT01048333|20683683|P1|STARTED|Treatment Period 2||21
8391921|NCT01048333|20683678|P6|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8391922|NCT01048333|20683679|P5|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8391923|NCT01048333|20683680|P4|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8391924|NCT01048333|20683681|P3|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8391925|NCT01048333|20683682|P2|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8391926|NCT01048333|20683683|P1|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
8391927|NCT01048333|20683678|P6|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
8391928|NCT01048333|20683679|P5|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
8391929|NCT01048333|20683680|P4|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
8391930|NCT01048333|20683681|P3|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
8391931|NCT01048333|20683682|P2|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
8391932|NCT01048333|20683683|P1|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
8391933|NCT01048333|20683678|P6|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
8391934|NCT01048333|20683679|P5|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
8391935|NCT01048333|20683680|P4|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
8391936|NCT01048333|20683681|P3|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
8391937|NCT01048333|20683682|P2|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
8391938|NCT01048333|20683683|P1|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
8391939|NCT01048333|20683678|P6|NOT COMPLETED|Treatment Period 1||0
8391940|NCT01048333|20683679|P5|NOT COMPLETED|Treatment Period 1||0
8391941|NCT01048333|20683680|P4|NOT COMPLETED|Treatment Period 1||0
8391942|NCT01048333|20683681|P3|NOT COMPLETED|Treatment Period 1||0
8391943|NCT01048333|20683682|P2|NOT COMPLETED|Treatment Period 1||0
8391944|NCT01048333|20683683|P1|NOT COMPLETED|Treatment Period 1||0
8391945|NCT01048333|20683678|P6|COMPLETED|Treatment Period 1||18
8391946|NCT01048333|20683679|P5|COMPLETED|Treatment Period 1||17
8391947|NCT01048333|20683680|P4|COMPLETED|Treatment Period 1||18
8391948|NCT01048333|20683681|P3|COMPLETED|Treatment Period 1||16
8391949|NCT01048333|20683682|P2|COMPLETED|Treatment Period 1||19
8391950|NCT01048333|20683683|P1|COMPLETED|Treatment Period 1||21
8391951|NCT01048333|20683678|P6|STARTED|Treatment Period 1||18
8391952|NCT01048333|20683679|P5|STARTED|Treatment Period 1||17
8391953|NCT01048333|20683680|P4|STARTED|Treatment Period 1||18
8391954|NCT01048333|20683681|P3|STARTED|Treatment Period 1||16
8391955|NCT01048333|20683682|P2|STARTED|Treatment Period 1||19
8391956|NCT01048333|20683683|P1|STARTED|Treatment Period 1||21
8391957|NCT01048242|20683705|P2|NOT COMPLETED|Overall Study||2
8391958|NCT01048242|20683706|P1|NOT COMPLETED|Overall Study||4
8391959|NCT01048242|20683705|P2|COMPLETED|Overall Study||13
8391960|NCT01048242|20683706|P1|COMPLETED|Overall Study||8
8391961|NCT01048242|20683705|P2|STARTED|Overall Study||15
8391962|NCT01048242|20683706|P1|STARTED|Overall Study||12
8391963|NCT01048125|20683714|P2|NOT COMPLETED|Overall Study||0
8391964|NCT01048125|20683715|P1|NOT COMPLETED|Overall Study||0
8391965|NCT01048125|20683714|P2|COMPLETED|Overall Study||0
8391966|NCT01048125|20683715|P1|COMPLETED|Overall Study||0
8391967|NCT01048125|20683714|P2|STARTED|Overall Study||0
8391968|NCT01048125|20683715|P1|STARTED|Overall Study||0
8391969|NCT01048099|20683721|P1|NOT COMPLETED|Treatment Per Protocol||14
8391970|NCT01048099|20683721|P1|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
8391971|NCT01048099|20683721|P1|STARTED|Treatment Per Protocol||14
8391972|NCT01048099|20683721|P1|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
8391973|NCT01048099|20683721|P1|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
8391974|NCT01048099|20683721|P1|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
8391975|NCT01048099|20683721|P1|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
8391976|NCT01048099|20683721|P1|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
8391977|NCT01048099|20683721|P1|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
8391978|NCT01048099|20683721|P1|NOT COMPLETED|Patients Enrolled and Blood Collected||57
8391979|NCT01048099|20683721|P1|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
8391980|NCT01048099|20683721|P1|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
8391981|NCT01047839|20683732|P3|NOT COMPLETED|Overall Study||6
8391982|NCT01047839|20683733|P2|NOT COMPLETED|Overall Study||0
8391983|NCT01047839|20683734|P1|NOT COMPLETED|Overall Study||2
8391984|NCT01047839|20683732|P3|COMPLETED|Overall Study||53
8391985|NCT01047839|20683733|P2|COMPLETED|Overall Study||29
8391986|NCT01047839|20683734|P1|COMPLETED|Overall Study||10
8391987|NCT01047839|20683732|P3|STARTED|Overall Study||59
8391988|NCT01047839|20683733|P2|STARTED|Overall Study||29
8391989|NCT01047839|20683734|P1|STARTED|Overall Study||12
8391990|NCT01047709|20683760|P2|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
8391991|NCT01047709|20683761|P1|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
8391992|NCT01047709|20683760|P2|COMPLETED|Control/Positioning ad Lib (1 Night)||9
8391993|NCT01047709|20683761|P1|COMPLETED|Control/Positioning ad Lib (1 Night)||9
8391994|NCT01047709|20683760|P2|STARTED|Control/Positioning ad Lib (1 Night)||9
8391995|NCT01047709|20683761|P1|STARTED|Control/Positioning ad Lib (1 Night)||9
8391996|NCT01047709|20683760|P2|NOT COMPLETED|Positional Therapy (1 Night)||0
8391997|NCT01047709|20683761|P1|NOT COMPLETED|Positional Therapy (1 Night)||0
8391998|NCT01047709|20683760|P2|COMPLETED|Positional Therapy (1 Night)||9
8391999|NCT01047709|20683761|P1|COMPLETED|Positional Therapy (1 Night)||9
8392000|NCT01047709|20683760|P2|STARTED|Positional Therapy (1 Night)||9
8392001|NCT01047709|20683761|P1|STARTED|Positional Therapy (1 Night)||9
8392002|NCT01047553|20683769|P2|NOT COMPLETED|Overall Study||9
8392003|NCT01047553|20683770|P1|NOT COMPLETED|Overall Study||17
8392004|NCT01047553|20683769|P2|COMPLETED|Overall Study||117
8392005|NCT01047553|20683770|P1|COMPLETED|Overall Study||108
8392006|NCT01047553|20683769|P2|STARTED|Overall Study||126
8392007|NCT01047553|20683770|P1|STARTED|Overall Study||125
8392008|NCT01047527|20683855|P3|NOT COMPLETED|Overall Study||65
8392009|NCT01047527|20683856|P2|NOT COMPLETED|Overall Study||61
8392010|NCT01047527|20683857|P1|NOT COMPLETED|Overall Study||85
8392011|NCT01047527|20683855|P3|COMPLETED|Overall Study||107
8392012|NCT01047527|20683856|P2|COMPLETED|Overall Study||112
8392013|NCT01047527|20683857|P1|COMPLETED|Overall Study||95
8392014|NCT01047527|20683855|P3|24 Weeks|Overall Study||119
8392015|NCT01047527|20683856|P2|24 Weeks|Overall Study||123
8392016|NCT01047527|20683857|P1|24 Weeks|Overall Study||111
8392017|NCT01047527|20683855|P3|8 Weeks|Overall Study||138
8392018|NCT01047527|20683856|P2|8 Weeks|Overall Study||142
8392019|NCT01047527|20683857|P1|8 Weeks|Overall Study||148
8392020|NCT01047527|20683855|P3|STARTED|Overall Study||172
8392021|NCT01047527|20683856|P2|STARTED|Overall Study||173
8392022|NCT01047527|20683857|P1|STARTED|Overall Study||180
8392023|NCT01047475|20683868|P2|NOT COMPLETED|Overall Study||7
8392024|NCT01047475|20683869|P1|NOT COMPLETED|Overall Study||5
8392025|NCT01047475|20683868|P2|COMPLETED|Overall Study||31
8392026|NCT01047475|20683869|P1|COMPLETED|Overall Study||29
8392027|NCT01047475|20683868|P2|STARTED|Overall Study||38
8392028|NCT01047475|20683869|P1|STARTED|Overall Study||34
8392029|NCT01047436|20683877|P2|NOT COMPLETED|Overall Study||0
8392030|NCT01047436|20683878|P1|NOT COMPLETED|Overall Study||1
8392031|NCT01047436|20683877|P2|COMPLETED|Overall Study||15
8392032|NCT01047436|20683878|P1|COMPLETED|Overall Study||15
8392033|NCT01047436|20683877|P2|STARTED|Overall Study||15
8392034|NCT01047436|20683878|P1|STARTED|Overall Study||16
8392035|NCT01047358|20683894|P1|NOT COMPLETED|Overall Study||0
8392036|NCT01047358|20683894|P1|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
8392037|NCT01047358|20683894|P1|STARTED|Overall Study||206
8392038|NCT01047345|20683903|P3|NOT COMPLETED|Extension||6
8392039|NCT01047345|20683904|P2|NOT COMPLETED|Extension||0
8392040|NCT01047345|20683905|P1|NOT COMPLETED|Extension||0
8392041|NCT01047345|20683903|P3|COMPLETED|Extension||96
8392042|NCT01047345|20683904|P2|COMPLETED|Extension||0
8392043|NCT01047345|20683905|P1|COMPLETED|Extension||0
8392044|NCT01047345|20683903|P3|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
8392045|NCT01047345|20683904|P2|Vaccination 6|Extension||0
8392046|NCT01047345|20683905|P1|Vaccination 6|Extension||0
8392047|NCT01047345|20683903|P3|Vaccination 5|Extension||99
8392048|NCT01047345|20683904|P2|Vaccination 5|Extension||0
8392049|NCT01047345|20683905|P1|Vaccination 5|Extension||0
8392050|NCT01047345|20683903|P3|Vaccination 4|Extension||102
8392051|NCT01047345|20683904|P2|Vaccination 4|Extension||0
8392052|NCT01047345|20683905|P1|Vaccination 4|Extension||0
8392053|NCT01047345|20683903|P3|STARTED|Extension|Not all eligible participants elected to participate in extension|102
8392054|NCT01047345|20683904|P2|STARTED|Extension||0
8392055|NCT01047345|20683905|P1|STARTED|Extension||0
8392056|NCT01047345|20683903|P3|NOT COMPLETED|Base Study||0
8392057|NCT01047345|20683904|P2|NOT COMPLETED|Base Study||6
8392058|NCT01047345|20683905|P1|NOT COMPLETED|Base Study||22
8392059|NCT01047345|20683903|P3|COMPLETED|Base Study||0
8392060|NCT01047345|20683904|P2|COMPLETED|Base Study||300
8392061|NCT01047345|20683905|P1|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
8392062|NCT01047345|20683903|P3|Vaccination 3|Base Study||0
8392063|NCT01047345|20683904|P2|Vaccination 3|Base Study||300
8392064|NCT01047345|20683905|P1|Vaccination 3|Base Study||597
8392065|NCT01047345|20683903|P3|Vaccination 2|Base Study||0
8392066|NCT01047345|20683904|P2|Vaccination 2|Base Study||304
8392067|NCT01047345|20683905|P1|Vaccination 2|Base Study||604
8392068|NCT01047345|20683903|P3|Vaccination 1|Base Study||0
8392069|NCT01047345|20683904|P2|Vaccination 1|Base Study||306
8392070|NCT01047345|20683905|P1|Vaccination 1|Base Study||615
8392071|NCT01047345|20683903|P3|STARTED|Base Study||0
8392072|NCT01047345|20683904|P2|STARTED|Base Study||306
8392073|NCT01047345|20683905|P1|STARTED|Base Study||618
8392074|NCT01047332|20683927|P2|NOT COMPLETED|Overall Study||64
8392075|NCT01047332|20683928|P1|NOT COMPLETED|Overall Study||57
8392076|NCT01047332|20683927|P2|COMPLETED|Overall Study|Alive at final follow-up|4
8392077|NCT01047332|20683928|P1|COMPLETED|Overall Study|Alive at final follow-up|4
8392078|NCT01047332|20683927|P2|STARTED|Overall Study||68
8392079|NCT01047332|20683928|P1|STARTED|Overall Study||61
8392080|NCT01047319|20683943|P3|NOT COMPLETED|Overall Study||352
8392081|NCT01047319|20683944|P2|NOT COMPLETED|Overall Study||350
8392082|NCT01047319|20683945|P1|NOT COMPLETED|Overall Study||345
8392083|NCT01047319|20683943|P3|COMPLETED|Overall Study||0
8392084|NCT01047319|20683944|P2|COMPLETED|Overall Study||0
8392085|NCT01047319|20683945|P1|COMPLETED|Overall Study||0
8392086|NCT01047319|20683943|P3|STARTED|Overall Study||352
8392087|NCT01047319|20683944|P2|STARTED|Overall Study||350
8392088|NCT01047319|20683945|P1|STARTED|Overall Study||345
8392097|NCT01047293|20684042|P4|NOT COMPLETED|Overall Study||0
8392098|NCT01047293|20684043|P3|NOT COMPLETED|Overall Study||0
8392099|NCT01047293|20684044|P2|NOT COMPLETED|Overall Study||1
8392100|NCT01047293|20684045|P1|NOT COMPLETED|Overall Study||1
8392101|NCT01047293|20684042|P4|COMPLETED|Overall Study||26
8392102|NCT01047293|20684043|P3|COMPLETED|Overall Study||9
8392103|NCT01047293|20684044|P2|COMPLETED|Overall Study||7
8392104|NCT01047293|20684045|P1|COMPLETED|Overall Study||3
8392105|NCT01047293|20684042|P4|STARTED|Overall Study||26
8392106|NCT01047293|20684043|P3|STARTED|Overall Study||9
8392107|NCT01047293|20684044|P2|STARTED|Overall Study||8
8392108|NCT01047293|20684045|P1|STARTED|Overall Study||4
8392109|NCT01047241|20684052|P1|NOT COMPLETED|Overall Study||0
8392110|NCT01047241|20684052|P1|COMPLETED|Overall Study||50
8392111|NCT01047241|20684052|P1|STARTED|Overall Study||50
8392112|NCT01047189|20684063|P2|NOT COMPLETED|Overall Study||0
8392113|NCT01047189|20684064|P1|NOT COMPLETED|Overall Study||4
8392114|NCT01047189|20684063|P2|COMPLETED|Overall Study||13
8392115|NCT01047189|20684064|P1|COMPLETED|Overall Study||9
8392116|NCT01047189|20684063|P2|STARTED|Overall Study||13
8392117|NCT01047189|20684064|P1|STARTED|Overall Study||13
8392118|NCT01047007|20684076|P4|NOT COMPLETED|Overall Study||0
8392119|NCT01047007|20684077|P3|NOT COMPLETED|Overall Study||2
8392120|NCT01047007|20684078|P2|NOT COMPLETED|Overall Study||6
8392121|NCT01047007|20684079|P1|NOT COMPLETED|Overall Study||2
8392122|NCT01047007|20684076|P4|COMPLETED|Overall Study||0
8392123|NCT01047007|20684077|P3|COMPLETED|Overall Study||0
8392124|NCT01047007|20684078|P2|COMPLETED|Overall Study||0
8392125|NCT01047007|20684079|P1|COMPLETED|Overall Study||1
8392126|NCT01047007|20684076|P4|Treated|Overall Study||0
8392127|NCT01047007|20684077|P3|Treated|Overall Study||2
8392128|NCT01047007|20684078|P2|Treated|Overall Study||6
8392129|NCT01047007|20684079|P1|Treated|Overall Study||3
8392130|NCT01047007|20684076|P4|STARTED|Overall Study||0
8392131|NCT01047007|20684077|P3|STARTED|Overall Study||2
8392132|NCT01047007|20684078|P2|STARTED|Overall Study||6
8392133|NCT01047007|20684079|P1|STARTED|Overall Study||3
8392134|NCT01046903|20684090|P1|NOT COMPLETED|Overall Study||28
8392135|NCT01046903|20684090|P1|COMPLETED|Overall Study||475
8392136|NCT01046903|20684090|P1|STARTED|Overall Study||503
8392137|NCT01046877|20684103|P1|NOT COMPLETED|Overall Study||18
8392138|NCT01046877|20684103|P1|COMPLETED|Overall Study||7
8392139|NCT01046877|20684103|P1|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
8392140|NCT01046877|20684103|P1|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
8392141|NCT01046877|20684103|P1|STARTED|Overall Study||25
8392142|NCT01046695|20684119|P2|NOT COMPLETED|Overall Study||2
8392143|NCT01046695|20684120|P1|NOT COMPLETED|Overall Study||0
8392144|NCT01046695|20684119|P2|COMPLETED|Overall Study||20
8392145|NCT01046695|20684120|P1|COMPLETED|Overall Study||20
8392146|NCT01046695|20684119|P2|STARTED|Overall Study||22
8392147|NCT01046695|20684120|P1|STARTED|Overall Study||20
8392148|NCT01046682|20684132|P2|NOT COMPLETED|Overall Study||0
8392149|NCT01046682|20684133|P1|NOT COMPLETED|Overall Study||2
8392150|NCT01046682|20684132|P2|COMPLETED|Overall Study||20
8392151|NCT01046682|20684133|P1|COMPLETED|Overall Study||18
8392152|NCT01046682|20684132|P2|STARTED|Overall Study||20
8392153|NCT01046682|20684133|P1|STARTED|Overall Study||20
8392154|NCT01046669|20684141|P2|NOT COMPLETED|Overall Study||1
8392155|NCT01046669|20684142|P1|NOT COMPLETED|Overall Study||0
8392156|NCT01046669|20684141|P2|COMPLETED|Overall Study||223
8392157|NCT01046669|20684142|P1|COMPLETED|Overall Study||226
8392158|NCT01046669|20684141|P2|STARTED|Overall Study||224
8392159|NCT01046669|20684142|P1|STARTED|Overall Study||226
8392160|NCT01046643|20684150|P4|NOT COMPLETED|Second Period Treatment or Placebo||0
8392161|NCT01046643|20684151|P3|NOT COMPLETED|Second Period Treatment or Placebo||0
8392162|NCT01046643|20684152|P2|NOT COMPLETED|Second Period Treatment or Placebo||0
8392163|NCT01046643|20684153|P1|NOT COMPLETED|Second Period Treatment or Placebo||0
8392164|NCT01046643|20684150|P4|COMPLETED|Second Period Treatment or Placebo||7
8392165|NCT01046643|20684151|P3|COMPLETED|Second Period Treatment or Placebo||7
8392166|NCT01046643|20684152|P2|COMPLETED|Second Period Treatment or Placebo||6
8392167|NCT01046643|20684153|P1|COMPLETED|Second Period Treatment or Placebo||9
8392168|NCT01046643|20684150|P4|STARTED|Second Period Treatment or Placebo||7
8392169|NCT01046643|20684151|P3|STARTED|Second Period Treatment or Placebo||7
8392170|NCT01046643|20684152|P2|STARTED|Second Period Treatment or Placebo||6
8392171|NCT01046643|20684153|P1|STARTED|Second Period Treatment or Placebo||9
8392172|NCT01046643|20684150|P4|NOT COMPLETED|Washout Period||0
8392173|NCT01046643|20684151|P3|NOT COMPLETED|Washout Period||0
8392174|NCT01046643|20684152|P2|NOT COMPLETED|Washout Period||0
8392175|NCT01046643|20684153|P1|NOT COMPLETED|Washout Period||0
8392176|NCT01046643|20684150|P4|COMPLETED|Washout Period||7
8392177|NCT01046643|20684151|P3|COMPLETED|Washout Period||7
8392178|NCT01046643|20684152|P2|COMPLETED|Washout Period||6
8392179|NCT01046643|20684153|P1|COMPLETED|Washout Period||9
8392180|NCT01046643|20684150|P4|STARTED|Washout Period||7
8392181|NCT01046643|20684151|P3|STARTED|Washout Period||7
8392182|NCT01046643|20684152|P2|STARTED|Washout Period||6
8392183|NCT01046643|20684153|P1|STARTED|Washout Period||9
8392184|NCT01046643|20684150|P4|NOT COMPLETED|First Period Treatment or Placebo||0
8392185|NCT01046643|20684151|P3|NOT COMPLETED|First Period Treatment or Placebo||0
8392186|NCT01046643|20684152|P2|NOT COMPLETED|First Period Treatment or Placebo||1
8392187|NCT01046643|20684153|P1|NOT COMPLETED|First Period Treatment or Placebo||0
8392188|NCT01046643|20684150|P4|COMPLETED|First Period Treatment or Placebo||7
8392189|NCT01046643|20684151|P3|COMPLETED|First Period Treatment or Placebo||7
8392190|NCT01046643|20684152|P2|COMPLETED|First Period Treatment or Placebo||6
8392191|NCT01046643|20684153|P1|COMPLETED|First Period Treatment or Placebo||9
8392192|NCT01046643|20684150|P4|STARTED|First Period Treatment or Placebo||7
8392193|NCT01046643|20684151|P3|STARTED|First Period Treatment or Placebo||7
8392194|NCT01046643|20684152|P2|STARTED|First Period Treatment or Placebo||7
8392195|NCT01046643|20684153|P1|STARTED|First Period Treatment or Placebo||9
8392196|NCT01046565|20684175|P1|NOT COMPLETED|Overall Study||9
8392197|NCT01046565|20684175|P1|COMPLETED|Overall Study||66
8392198|NCT01046565|20684175|P1|STARTED|Overall Study||75
8392199|NCT01046396|20684184|P1|NOT COMPLETED|Overall Study||5
8392200|NCT01046396|20684184|P1|COMPLETED|Overall Study||64
8392201|NCT01046396|20684184|P1|STARTED|Overall Study||69
8392202|NCT01046253|20684195|P2|NOT COMPLETED|Fourth Intervention||0
8392203|NCT01046253|20684196|P1|NOT COMPLETED|Fourth Intervention||0
8392204|NCT01046253|20684195|P2|COMPLETED|Fourth Intervention||23
8392205|NCT01046253|20684196|P1|COMPLETED|Fourth Intervention||25
8392206|NCT01046253|20684195|P2|STARTED|Fourth Intervention||23
8392207|NCT01046253|20684196|P1|STARTED|Fourth Intervention||25
8392208|NCT01046253|20684195|P2|NOT COMPLETED|Third Washout of 7 Days||0
8392209|NCT01046253|20684196|P1|NOT COMPLETED|Third Washout of 7 Days||0
8392210|NCT01046253|20684195|P2|COMPLETED|Third Washout of 7 Days||23
8392211|NCT01046253|20684196|P1|COMPLETED|Third Washout of 7 Days||25
8392212|NCT01046253|20684195|P2|STARTED|Third Washout of 7 Days||23
8392213|NCT01046253|20684196|P1|STARTED|Third Washout of 7 Days||25
8392214|NCT01046253|20684195|P2|NOT COMPLETED|Third Intervention||0
8392215|NCT01046253|20684196|P1|NOT COMPLETED|Third Intervention||0
8392216|NCT01046253|20684195|P2|COMPLETED|Third Intervention||23
8392217|NCT01046253|20684196|P1|COMPLETED|Third Intervention||25
8392218|NCT01046253|20684195|P2|STARTED|Third Intervention||23
8392219|NCT01046253|20684196|P1|STARTED|Third Intervention||25
8392220|NCT01046253|20684195|P2|NOT COMPLETED|Second Washout of 7 Days||0
8392221|NCT01046253|20684196|P1|NOT COMPLETED|Second Washout of 7 Days||0
8392222|NCT01046253|20684195|P2|COMPLETED|Second Washout of 7 Days||23
8392223|NCT01046253|20684196|P1|COMPLETED|Second Washout of 7 Days||25
8392224|NCT01046253|20684195|P2|STARTED|Second Washout of 7 Days||23
8392225|NCT01046253|20684196|P1|STARTED|Second Washout of 7 Days||25
8392226|NCT01046253|20684195|P2|NOT COMPLETED|Second Intervention||2
8392227|NCT01046253|20684196|P1|NOT COMPLETED|Second Intervention||0
8392228|NCT01046253|20684195|P2|COMPLETED|Second Intervention||23
8392229|NCT01046253|20684196|P1|COMPLETED|Second Intervention||25
8392230|NCT01046253|20684195|P2|STARTED|Second Intervention||25
8392231|NCT01046253|20684196|P1|STARTED|Second Intervention||25
8392232|NCT01046253|20684195|P2|NOT COMPLETED|First Washout of 7 Days||0
8392233|NCT01046253|20684196|P1|NOT COMPLETED|First Washout of 7 Days||0
8392234|NCT01046253|20684195|P2|COMPLETED|First Washout of 7 Days||25
8392235|NCT01046253|20684196|P1|COMPLETED|First Washout of 7 Days||25
8392236|NCT01046253|20684195|P2|STARTED|First Washout of 7 Days||25
8392237|NCT01046253|20684196|P1|STARTED|First Washout of 7 Days||25
8392238|NCT01046253|20684195|P2|NOT COMPLETED|First Intervention||0
8392239|NCT01046253|20684196|P1|NOT COMPLETED|First Intervention||0
8392240|NCT01046253|20684195|P2|COMPLETED|First Intervention||25
8392241|NCT01046253|20684196|P1|COMPLETED|First Intervention||25
8392242|NCT01046253|20684195|P2|STARTED|First Intervention||25
8392243|NCT01046253|20684196|P1|STARTED|First Intervention||25
8392244|NCT01046136|20684208|P2|NOT COMPLETED|Overall Study||8
8392245|NCT01046136|20684209|P1|NOT COMPLETED|Overall Study||4
8392246|NCT01046136|20684208|P2|COMPLETED|Overall Study||182
8392247|NCT01046136|20684209|P1|COMPLETED|Overall Study||184
8392248|NCT01046136|20684208|P2|STARTED|Overall Study||190
8392249|NCT01046136|20684209|P1|STARTED|Overall Study||188
8392250|NCT01046110|20684221|P2|NOT COMPLETED|Overall Study||55
8392251|NCT01046110|20684222|P1|NOT COMPLETED|Overall Study||55
8392252|NCT01046110|20684221|P2|COMPLETED|Overall Study||174
8392253|NCT01046110|20684222|P1|COMPLETED|Overall Study||174
8392254|NCT01046110|20684221|P2|Exposed|Overall Study|1 subject was randomised in error|228
8392255|NCT01046110|20684222|P1|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
8392256|NCT01046110|20684221|P2|STARTED|Overall Study||229
8392257|NCT01046110|20684222|P1|STARTED|Overall Study||229
8392258|NCT01046084|20684232|P2|NOT COMPLETED|Fourth Intervention||0
8392259|NCT01046084|20684233|P1|NOT COMPLETED|Fourth Intervention||0
8392260|NCT01046084|20684232|P2|COMPLETED|Fourth Intervention||25
8392261|NCT01046084|20684233|P1|COMPLETED|Fourth Intervention||23
8392262|NCT01046084|20684232|P2|STARTED|Fourth Intervention||25
8392263|NCT01046084|20684233|P1|STARTED|Fourth Intervention||23
8392264|NCT01046084|20684232|P2|NOT COMPLETED|Third Washout of 7 Days||0
8392265|NCT01046084|20684233|P1|NOT COMPLETED|Third Washout of 7 Days||2
8392266|NCT01046084|20684232|P2|COMPLETED|Third Washout of 7 Days||25
8392267|NCT01046084|20684233|P1|COMPLETED|Third Washout of 7 Days||23
8392268|NCT01046084|20684232|P2|STARTED|Third Washout of 7 Days||25
8392269|NCT01046084|20684233|P1|STARTED|Third Washout of 7 Days||25
8392270|NCT01046084|20684232|P2|NOT COMPLETED|Third Intervention||0
8392271|NCT01046084|20684233|P1|NOT COMPLETED|Third Intervention||0
8392272|NCT01046084|20684232|P2|COMPLETED|Third Intervention||25
8392273|NCT01046084|20684233|P1|COMPLETED|Third Intervention||25
8392274|NCT01046084|20684232|P2|STARTED|Third Intervention||25
8392275|NCT01046084|20684233|P1|STARTED|Third Intervention||25
8392276|NCT01046084|20684232|P2|NOT COMPLETED|Second Washout of 7 Days||0
8392277|NCT01046084|20684233|P1|NOT COMPLETED|Second Washout of 7 Days||0
8392278|NCT01046084|20684232|P2|COMPLETED|Second Washout of 7 Days||25
8392279|NCT01046084|20684233|P1|COMPLETED|Second Washout of 7 Days||25
8392280|NCT01046084|20684232|P2|STARTED|Second Washout of 7 Days||25
8392281|NCT01046084|20684233|P1|STARTED|Second Washout of 7 Days||25
8392282|NCT01046084|20684232|P2|NOT COMPLETED|Second Intervention||0
8392283|NCT01046084|20684233|P1|NOT COMPLETED|Second Intervention||0
8392284|NCT01046084|20684232|P2|COMPLETED|Second Intervention||25
8392285|NCT01046084|20684233|P1|COMPLETED|Second Intervention||25
8392286|NCT01046084|20684232|P2|STARTED|Second Intervention||25
8392287|NCT01046084|20684233|P1|STARTED|Second Intervention||25
8392288|NCT01046084|20684232|P2|NOT COMPLETED|First Washout of 7 Days||0
8392289|NCT01046084|20684233|P1|NOT COMPLETED|First Washout of 7 Days||0
8392290|NCT01046084|20684232|P2|COMPLETED|First Washout of 7 Days||25
8392291|NCT01046084|20684233|P1|COMPLETED|First Washout of 7 Days||25
8392292|NCT01046084|20684232|P2|STARTED|First Washout of 7 Days||25
8392293|NCT01046084|20684233|P1|STARTED|First Washout of 7 Days||25
8392294|NCT01046084|20684232|P2|NOT COMPLETED|First Intervention||0
8392295|NCT01046084|20684233|P1|NOT COMPLETED|First Intervention||0
8392296|NCT01046084|20684232|P2|COMPLETED|First Intervention||25
8392297|NCT01046084|20684233|P1|COMPLETED|First Intervention||25
8392298|NCT01046084|20684232|P2|STARTED|First Intervention||25
8392299|NCT01046084|20684233|P1|STARTED|First Intervention||25
8392300|NCT01045993|20684247|P4|NOT COMPLETED|Overall Study||0
8392301|NCT01045993|20684248|P3|NOT COMPLETED|Overall Study||0
8392302|NCT01045993|20684249|P2|NOT COMPLETED|Overall Study||1
8392303|NCT01045993|20684250|P1|NOT COMPLETED|Overall Study||0
8392304|NCT01045993|20684247|P4|COMPLETED|Overall Study||25
8392305|NCT01045993|20684248|P3|COMPLETED|Overall Study||5
8392306|NCT01045993|20684249|P2|COMPLETED|Overall Study||4
8392307|NCT01045993|20684250|P1|COMPLETED|Overall Study||26
8392308|NCT01045993|20684247|P4|STARTED|Overall Study||25
8392309|NCT01045993|20684248|P3|STARTED|Overall Study||5
8392310|NCT01045993|20684249|P2|STARTED|Overall Study||5
8392311|NCT01045993|20684250|P1|STARTED|Overall Study||26
8392312|NCT01045967|20684326|P2|NOT COMPLETED|Second Intervention||1
8392313|NCT01045967|20684327|P1|NOT COMPLETED|Second Intervention||0
8392314|NCT01045967|20684326|P2|COMPLETED|Second Intervention||27
8392315|NCT01045967|20684327|P1|COMPLETED|Second Intervention||28
8392316|NCT01045967|20684326|P2|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
8392317|NCT01045967|20684327|P1|STARTED|Second Intervention||28
8392318|NCT01045967|20684326|P2|NOT COMPLETED|Washout of 7 Days||0
8392319|NCT01045967|20684327|P1|NOT COMPLETED|Washout of 7 Days||0
8392320|NCT01045967|20684326|P2|COMPLETED|Washout of 7 Days||28
8392321|NCT01045967|20684327|P1|COMPLETED|Washout of 7 Days||28
8392322|NCT01045967|20684326|P2|STARTED|Washout of 7 Days||28
8392323|NCT01045967|20684327|P1|STARTED|Washout of 7 Days||28
8392324|NCT01045967|20684326|P2|NOT COMPLETED|First Intervention||0
8392325|NCT01045967|20684327|P1|NOT COMPLETED|First Intervention||0
8392326|NCT01045967|20684326|P2|COMPLETED|First Intervention||28
8392327|NCT01045967|20684327|P1|COMPLETED|First Intervention||28
8392328|NCT01045967|20684326|P2|STARTED|First Intervention||28
8392329|NCT01045967|20684327|P1|STARTED|First Intervention||28
8392330|NCT01045798|20684339|P2|NOT COMPLETED|Overall Study||4
8392331|NCT01045798|20684340|P1|NOT COMPLETED|Overall Study||2
8392332|NCT01045798|20684339|P2|COMPLETED|Overall Study||5
8392333|NCT01045798|20684340|P1|COMPLETED|Overall Study||4
8392334|NCT01045798|20684339|P2|STARTED|Overall Study||9
8392335|NCT01045798|20684340|P1|STARTED|Overall Study||6
8392429|NCT01045421|20684415|P10|STARTED|Phase 1||0
8392336|NCT01045707|20684348|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
8392337|NCT01045707|20684349|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
8392338|NCT01045707|20684348|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
8392339|NCT01045707|20684349|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
8392340|NCT01045707|20684348|P2|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
8392341|NCT01045707|20684349|P1|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
8392342|NCT01045707|20684348|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
8392343|NCT01045707|20684349|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
8392344|NCT01045707|20684348|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
8392345|NCT01045707|20684349|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
8392346|NCT01045707|20684348|P2|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
8392347|NCT01045707|20684349|P1|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
8392348|NCT01045707|20684348|P2|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
8392349|NCT01045707|20684349|P1|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
8392350|NCT01045694|20684365|P1|NOT COMPLETED|Overall Study||2
8392351|NCT01045694|20684365|P1|COMPLETED|Overall Study||6
8392352|NCT01045694|20684365|P1|STARTED|Overall Study||8
8392353|NCT01045551|20684371|P1|NOT COMPLETED|Overall Study||0
8392354|NCT01045551|20684371|P1|COMPLETED|Overall Study||10
8392355|NCT01045551|20684371|P1|STARTED|Overall Study||10
8392356|NCT01045499|20684379|P1|NOT COMPLETED|Overall Study||10
8392357|NCT01045499|20684379|P1|COMPLETED|Overall Study||127
8392358|NCT01045499|20684379|P1|STARTED|Overall Study||137
8392365|NCT01045447|20684399|P2|NOT COMPLETED|Overall Study||28
8392366|NCT01045447|20684400|P1|NOT COMPLETED|Overall Study||36
8392367|NCT01045447|20684399|P2|COMPLETED|Overall Study||205
8392368|NCT01045447|20684400|P1|COMPLETED|Overall Study||196
8392369|NCT01045447|20684399|P2|Exposed|Overall Study||233
8392370|NCT01045447|20684400|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
8392371|NCT01045447|20684399|P2|STARTED|Overall Study||233
8392372|NCT01045447|20684400|P1|STARTED|Overall Study||232
8392373|NCT01045421|20684414|P11|NOT COMPLETED|Phase 2||2
8392374|NCT01045421|20684415|P10|NOT COMPLETED|Phase 2||3
8392375|NCT01045421|20684416|P9|NOT COMPLETED|Phase 2||2
8392376|NCT01045421|20684417|P8|NOT COMPLETED|Phase 2||5
8392377|NCT01045421|20684418|P7|NOT COMPLETED|Phase 2||0
8392378|NCT01045421|20684419|P6|NOT COMPLETED|Phase 2||0
8392379|NCT01045421|20684420|P5|NOT COMPLETED|Phase 2||0
8392380|NCT01045421|20684421|P4|NOT COMPLETED|Phase 2||0
8392381|NCT01045421|20684422|P3|NOT COMPLETED|Phase 2||0
8392382|NCT01045421|20684423|P2|NOT COMPLETED|Phase 2||0
8392383|NCT01045421|20684424|P1|NOT COMPLETED|Phase 2||0
8392384|NCT01045421|20684414|P11|COMPLETED|Phase 2||58
8392385|NCT01045421|20684415|P10|COMPLETED|Phase 2||23
8392386|NCT01045421|20684416|P9|COMPLETED|Phase 2||53
8392387|NCT01045421|20684417|P8|COMPLETED|Phase 2||50
8392388|NCT01045421|20684418|P7|COMPLETED|Phase 2||53
8392389|NCT01045421|20684419|P6|COMPLETED|Phase 2||0
8392390|NCT01045421|20684420|P5|COMPLETED|Phase 2||0
8392391|NCT01045421|20684421|P4|COMPLETED|Phase 2||0
8392392|NCT01045421|20684422|P3|COMPLETED|Phase 2||0
8392393|NCT01045421|20684423|P2|COMPLETED|Phase 2||0
8392394|NCT01045421|20684424|P1|COMPLETED|Phase 2||0
8392395|NCT01045421|20684414|P11|STARTED|Phase 2||60
8392396|NCT01045421|20684415|P10|STARTED|Phase 2||26
8392397|NCT01045421|20684416|P9|STARTED|Phase 2||55
8392398|NCT01045421|20684417|P8|STARTED|Phase 2||55
8392399|NCT01045421|20684418|P7|STARTED|Phase 2||53
8392400|NCT01045421|20684419|P6|STARTED|Phase 2||0
8392401|NCT01045421|20684420|P5|STARTED|Phase 2||0
8392402|NCT01045421|20684421|P4|STARTED|Phase 2||0
8392403|NCT01045421|20684422|P3|STARTED|Phase 2||0
8392404|NCT01045421|20684423|P2|STARTED|Phase 2||0
8392405|NCT01045421|20684424|P1|STARTED|Phase 2||0
8392406|NCT01045421|20684414|P11|NOT COMPLETED|Phase 1||0
8392407|NCT01045421|20684415|P10|NOT COMPLETED|Phase 1||0
8392408|NCT01045421|20684416|P9|NOT COMPLETED|Phase 1||0
8392409|NCT01045421|20684417|P8|NOT COMPLETED|Phase 1||0
8392410|NCT01045421|20684418|P7|NOT COMPLETED|Phase 1||0
8392411|NCT01045421|20684419|P6|NOT COMPLETED|Phase 1||0
8392412|NCT01045421|20684420|P5|NOT COMPLETED|Phase 1||1
8392413|NCT01045421|20684421|P4|NOT COMPLETED|Phase 1||1
8392414|NCT01045421|20684422|P3|NOT COMPLETED|Phase 1||0
8392415|NCT01045421|20684423|P2|NOT COMPLETED|Phase 1||0
8392416|NCT01045421|20684424|P1|NOT COMPLETED|Phase 1||0
8392417|NCT01045421|20684414|P11|COMPLETED|Phase 1||0
8392418|NCT01045421|20684415|P10|COMPLETED|Phase 1||0
8392419|NCT01045421|20684416|P9|COMPLETED|Phase 1||0
8392420|NCT01045421|20684417|P8|COMPLETED|Phase 1||0
8392421|NCT01045421|20684418|P7|COMPLETED|Phase 1||0
8392422|NCT01045421|20684419|P6|COMPLETED|Phase 1||1
8392423|NCT01045421|20684420|P5|COMPLETED|Phase 1||2
8392424|NCT01045421|20684421|P4|COMPLETED|Phase 1||11
8392425|NCT01045421|20684422|P3|COMPLETED|Phase 1||4
8392426|NCT01045421|20684423|P2|COMPLETED|Phase 1||3
8392427|NCT01045421|20684424|P1|COMPLETED|Phase 1||1
8392428|NCT01045421|20684414|P11|STARTED|Phase 1||0
8392430|NCT01045421|20684416|P9|STARTED|Phase 1||0
8392431|NCT01045421|20684417|P8|STARTED|Phase 1||0
8392432|NCT01045421|20684418|P7|STARTED|Phase 1||0
8392433|NCT01045421|20684419|P6|STARTED|Phase 1||1
8392434|NCT01045421|20684420|P5|STARTED|Phase 1||3
8392435|NCT01045421|20684421|P4|STARTED|Phase 1||12
8392436|NCT01045421|20684422|P3|STARTED|Phase 1||4
8392437|NCT01045421|20684423|P2|STARTED|Phase 1||3
8392438|NCT01045421|20684424|P1|STARTED|Phase 1||1
8392439|NCT01045265|20684504|P1|NOT COMPLETED|Overall Study||0
8392440|NCT01045265|20684504|P1|COMPLETED|Overall Study||16
8392441|NCT01045265|20684504|P1|STARTED|Overall Study||16
8392442|NCT01045187|20684511|P1|NOT COMPLETED|Overall Study||0
8392443|NCT01045187|20684511|P1|COMPLETED|Overall Study||15
8392444|NCT01045187|20684511|P1|STARTED|Overall Study||15
8392445|NCT01045174|20684517|P2|NOT COMPLETED|Overall Study||0
8392446|NCT01045174|20684518|P1|NOT COMPLETED|Overall Study||0
8392447|NCT01045174|20684517|P2|COMPLETED|Overall Study||90
8392448|NCT01045174|20684518|P1|COMPLETED|Overall Study||90
8392449|NCT01045174|20684517|P2|STARTED|Overall Study||90
8392450|NCT01045174|20684518|P1|STARTED|Overall Study||90
8392451|NCT01045161|20684533|P3|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
8392452|NCT01045161|20684534|P2|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
8392453|NCT01045161|20684535|P1|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
8392454|NCT01045161|20684533|P3|COMPLETED|Part B - 40 Additional Weeks Open Label||115
8392455|NCT01045161|20684534|P2|COMPLETED|Part B - 40 Additional Weeks Open Label||118
8392456|NCT01045161|20684535|P1|COMPLETED|Part B - 40 Additional Weeks Open Label||111
8392457|NCT01045161|20684533|P3|STARTED|Part B - 40 Additional Weeks Open Label||147
8392458|NCT01045161|20684534|P2|STARTED|Part B - 40 Additional Weeks Open Label||154
8392459|NCT01045161|20684535|P1|STARTED|Part B - 40 Additional Weeks Open Label||147
8392460|NCT01045161|20684533|P3|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
8392461|NCT01045161|20684534|P2|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
8392462|NCT01045161|20684535|P1|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
8392463|NCT01045161|20684533|P3|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
8392464|NCT01045161|20684534|P2|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
8392465|NCT01045161|20684535|P1|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
8392466|NCT01045161|20684533|P3|STARTED|Part A - 12 Weeks Double Blind Treatment||178
8392467|NCT01045161|20684534|P2|STARTED|Part A - 12 Weeks Double Blind Treatment||184
8392468|NCT01045161|20684535|P1|STARTED|Part A - 12 Weeks Double Blind Treatment||182
8392469|NCT01045135|20684555|P1|NOT COMPLETED|Overall Study||26
8392470|NCT01045135|20684555|P1|COMPLETED|Overall Study||274
8392471|NCT01045135|20684555|P1|STARTED|Overall Study||300
8392472|NCT01045122|20684562|P2|NOT COMPLETED|Propofol Then Dexmedetomidine||0
8392473|NCT01045122|20684563|P1|NOT COMPLETED|Propofol Then Dexmedetomidine||0
8392474|NCT01045122|20684562|P2|COMPLETED|Propofol Then Dexmedetomidine||6
8392475|NCT01045122|20684563|P1|COMPLETED|Propofol Then Dexmedetomidine||5
8392476|NCT01045122|20684562|P2|STARTED|Propofol Then Dexmedetomidine||6
8392477|NCT01045122|20684563|P1|STARTED|Propofol Then Dexmedetomidine||5
8392478|NCT01045122|20684562|P2|NOT COMPLETED|Dexmedetomidine Then Propofol||0
8392479|NCT01045122|20684563|P1|NOT COMPLETED|Dexmedetomidine Then Propofol||0
8392480|NCT01045122|20684562|P2|COMPLETED|Dexmedetomidine Then Propofol||6
8392481|NCT01045122|20684563|P1|COMPLETED|Dexmedetomidine Then Propofol||5
8392482|NCT01045122|20684562|P2|STARTED|Dexmedetomidine Then Propofol||6
8392483|NCT01045122|20684563|P1|STARTED|Dexmedetomidine Then Propofol||5
8392484|NCT01045096|20684572|P3|NOT COMPLETED|Overall Study||0
8392485|NCT01045096|20684573|P2|NOT COMPLETED|Overall Study||0
8392486|NCT01045096|20684574|P1|NOT COMPLETED|Overall Study||3
8392487|NCT01045096|20684572|P3|COMPLETED|Overall Study||12
8392488|NCT01045096|20684573|P2|COMPLETED|Overall Study||12
8392489|NCT01045096|20684574|P1|COMPLETED|Overall Study||9
8392490|NCT01045096|20684572|P3|Pharmacokinetic Set|Overall Study||11
8392491|NCT01045096|20684573|P2|Pharmacokinetic Set|Overall Study||11
8392492|NCT01045096|20684574|P1|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
8392493|NCT01045096|20684572|P3|STARTED|Overall Study||12
8392494|NCT01045096|20684573|P2|STARTED|Overall Study||12
8392495|NCT01045096|20684574|P1|STARTED|Overall Study||12
8392499|NCT01045031|20684609|P2|NOT COMPLETED|Overall Study||6
8392500|NCT01045031|20684610|P1|NOT COMPLETED|Overall Study||9
8392501|NCT01045031|20684609|P2|COMPLETED|Overall Study||50
8392502|NCT01045031|20684610|P1|COMPLETED|Overall Study||49
8392503|NCT01045031|20684609|P2|STARTED|Overall Study||56
8392504|NCT01045031|20684610|P1|STARTED|Overall Study||58
8392505|NCT01044966|20684620|P1|NOT COMPLETED|Consolidation Phase||10
8392506|NCT01044966|20684620|P1|COMPLETED|Consolidation Phase||2
8392507|NCT01044966|20684620|P1|STARTED|Consolidation Phase||12
8392508|NCT01044966|20684620|P1|NOT COMPLETED|Induction Phase||0
8392509|NCT01044966|20684620|P1|COMPLETED|Induction Phase||12
8392510|NCT01044966|20684620|P1|STARTED|Induction Phase||12
8392511|NCT01044862|20684631|P3|NOT COMPLETED|Overall Study||52
8392512|NCT01044862|20684632|P2|NOT COMPLETED|Overall Study||49
8392513|NCT01044862|20684633|P1|NOT COMPLETED|Overall Study||53
8392514|NCT01044862|20684631|P3|COMPLETED|Overall Study||249
8392515|NCT01044862|20684632|P2|COMPLETED|Overall Study||251
8392516|NCT01044862|20684633|P1|COMPLETED|Overall Study||246
8392517|NCT01044862|20684631|P3|STARTED|Overall Study||301
8392518|NCT01044862|20684632|P2|STARTED|Overall Study||300
8392519|NCT01044862|20684633|P1|STARTED|Overall Study||299
8392520|NCT01044771|20684650|P1|NOT COMPLETED|Overall Study||0
8392521|NCT01044771|20684650|P1|COMPLETED|Overall Study||20
8392522|NCT01044771|20684650|P1|STARTED|Overall Study||20
8392523|NCT01044758|20684662|P7|NOT COMPLETED|Overall Study||10
8392524|NCT01044758|20684663|P6|NOT COMPLETED|Overall Study||3
8392525|NCT01044758|20684664|P5|NOT COMPLETED|Overall Study||2
8392526|NCT01044758|20684665|P4|NOT COMPLETED|Overall Study||2
8392527|NCT01044758|20684666|P3|NOT COMPLETED|Overall Study||4
8392528|NCT01044758|20684667|P2|NOT COMPLETED|Overall Study||0
8392529|NCT01044758|20684668|P1|NOT COMPLETED|Overall Study||4
8392530|NCT01044758|20684662|P7|COMPLETED|Overall Study||17
8392531|NCT01044758|20684663|P6|COMPLETED|Overall Study||8
8392532|NCT01044758|20684664|P5|COMPLETED|Overall Study||9
8392533|NCT01044758|20684665|P4|COMPLETED|Overall Study||10
8392534|NCT01044758|20684666|P3|COMPLETED|Overall Study||7
8392535|NCT01044758|20684667|P2|COMPLETED|Overall Study||12
8392536|NCT01044758|20684668|P1|COMPLETED|Overall Study||8
8392537|NCT01044758|20684662|P7|STARTED|Overall Study||27
8392538|NCT01044758|20684663|P6|STARTED|Overall Study||11
8392539|NCT01044758|20684664|P5|STARTED|Overall Study||11
8392540|NCT01044758|20684665|P4|STARTED|Overall Study||12
8392541|NCT01044758|20684666|P3|STARTED|Overall Study||11
8392542|NCT01044758|20684667|P2|STARTED|Overall Study||12
8392543|NCT01044758|20684668|P1|STARTED|Overall Study||12
8392544|NCT01044745|20684691|P1|NOT COMPLETED|Overall Study||2
8392545|NCT01044745|20684691|P1|COMPLETED|Overall Study||18
8392546|NCT01044745|20684691|P1|STARTED|Overall Study||20
8392547|NCT01044732|20684700|P2|NOT COMPLETED|Overall Study||50
8392548|NCT01044732|20684701|P1|NOT COMPLETED|Overall Study||49
8392549|NCT01044732|20684700|P2|COMPLETED|Overall Study||176
8392550|NCT01044732|20684701|P1|COMPLETED|Overall Study||173
8392551|NCT01044732|20684700|P2|STARTED|Overall Study||226
8392552|NCT01044732|20684701|P1|STARTED|Overall Study||222
8392553|NCT01044706|20684711|P2|NOT COMPLETED|Overall Study||0
8392554|NCT01044706|20684712|P1|NOT COMPLETED|Overall Study||0
8392555|NCT01044706|20684711|P2|COMPLETED|Overall Study||30
8392556|NCT01044706|20684712|P1|COMPLETED|Overall Study||30
8392557|NCT01044706|20684711|P2|STARTED|Overall Study||30
8392558|NCT01044706|20684712|P1|STARTED|Overall Study||30
8392559|NCT01044693|20684720|P16|NOT COMPLETED|Overall Study||0
8392560|NCT01044693|20684721|P15|NOT COMPLETED|Overall Study||0
8392561|NCT01044693|20684722|P14|NOT COMPLETED|Overall Study||0
8392562|NCT01044693|20684723|P13|NOT COMPLETED|Overall Study||0
8392563|NCT01044693|20684724|P12|NOT COMPLETED|Overall Study||0
8392564|NCT01044693|20684725|P11|NOT COMPLETED|Overall Study||0
8392565|NCT01044693|20684726|P10|NOT COMPLETED|Overall Study||0
8392566|NCT01044693|20684727|P9|NOT COMPLETED|Overall Study||0
8392567|NCT01044693|20684728|P8|NOT COMPLETED|Overall Study||0
8392568|NCT01044693|20684729|P7|NOT COMPLETED|Overall Study||0
8392569|NCT01044693|20684730|P6|NOT COMPLETED|Overall Study||0
8392570|NCT01044693|20684731|P5|NOT COMPLETED|Overall Study||0
8392571|NCT01044693|20684732|P4|NOT COMPLETED|Overall Study||0
8392572|NCT01044693|20684733|P3|NOT COMPLETED|Overall Study||0
8392573|NCT01044693|20684734|P2|NOT COMPLETED|Overall Study||0
8392574|NCT01044693|20684735|P1|NOT COMPLETED|Overall Study||0
8392575|NCT01044693|20684720|P16|COMPLETED|Overall Study||1
8392576|NCT01044693|20684721|P15|COMPLETED|Overall Study||1
8392577|NCT01044693|20684722|P14|COMPLETED|Overall Study||1
8392578|NCT01044693|20684723|P13|COMPLETED|Overall Study||2
8392579|NCT01044693|20684724|P12|COMPLETED|Overall Study||1
8392580|NCT01044693|20684725|P11|COMPLETED|Overall Study||1
8392581|NCT01044693|20684726|P10|COMPLETED|Overall Study||1
8392582|NCT01044693|20684727|P9|COMPLETED|Overall Study||1
8392583|NCT01044693|20684728|P8|COMPLETED|Overall Study||1
8392584|NCT01044693|20684729|P7|COMPLETED|Overall Study||1
8392585|NCT01044693|20684730|P6|COMPLETED|Overall Study||2
8392586|NCT01044693|20684731|P5|COMPLETED|Overall Study||1
8392587|NCT01044693|20684732|P4|COMPLETED|Overall Study||1
8392588|NCT01044693|20684733|P3|COMPLETED|Overall Study||1
8392589|NCT01044693|20684734|P2|COMPLETED|Overall Study||1
8392590|NCT01044693|20684735|P1|COMPLETED|Overall Study||3
8392591|NCT01044693|20684720|P16|STARTED|Overall Study||1
8392592|NCT01044693|20684721|P15|STARTED|Overall Study||1
8392593|NCT01044693|20684722|P14|STARTED|Overall Study||1
8392594|NCT01044693|20684723|P13|STARTED|Overall Study||2
8392595|NCT01044693|20684724|P12|STARTED|Overall Study||1
8392596|NCT01044693|20684725|P11|STARTED|Overall Study||1
8392597|NCT01044693|20684726|P10|STARTED|Overall Study||1
8392598|NCT01044693|20684727|P9|STARTED|Overall Study||1
8392599|NCT01044693|20684728|P8|STARTED|Overall Study||1
8392600|NCT01044693|20684729|P7|STARTED|Overall Study||1
8392601|NCT01044693|20684730|P6|STARTED|Overall Study||2
8392602|NCT01044693|20684731|P5|STARTED|Overall Study||1
8392603|NCT01044693|20684732|P4|STARTED|Overall Study||1
8392604|NCT01044693|20684733|P3|STARTED|Overall Study||1
8392605|NCT01044693|20684734|P2|STARTED|Overall Study||1
8392606|NCT01044693|20684735|P1|STARTED|Overall Study||3
8392607|NCT01044589|20684759|P2|NOT COMPLETED|Overall Study||5
8392608|NCT01044589|20684760|P1|NOT COMPLETED|Overall Study||3
8392609|NCT01044589|20684759|P2|COMPLETED|Overall Study||2
8392610|NCT01044589|20684760|P1|COMPLETED|Overall Study||3
8392611|NCT01044589|20684759|P2|STARTED|Overall Study||7
8392612|NCT01044589|20684760|P1|STARTED|Overall Study||6
8392613|NCT01044537|20684775|P7|NOT COMPLETED|Overall Study||0
8392614|NCT01044537|20684776|P6|NOT COMPLETED|Overall Study||0
8392615|NCT01044537|20684777|P5|NOT COMPLETED|Overall Study||0
8392616|NCT01044537|20684778|P4|NOT COMPLETED|Overall Study||0
8392617|NCT01044537|20684779|P3|NOT COMPLETED|Overall Study||0
8392618|NCT01044537|20684780|P2|NOT COMPLETED|Overall Study||0
8392619|NCT01044537|20684781|P1|NOT COMPLETED|Overall Study||0
8392620|NCT01044537|20684775|P7|COMPLETED|Overall Study||16
8392621|NCT01044537|20684776|P6|COMPLETED|Overall Study||5
8392622|NCT01044537|20684777|P5|COMPLETED|Overall Study||5
8392623|NCT01044537|20684778|P4|COMPLETED|Overall Study||6
8392624|NCT01044537|20684779|P3|COMPLETED|Overall Study||6
8392625|NCT01044537|20684780|P2|COMPLETED|Overall Study||6
8392626|NCT01044537|20684781|P1|COMPLETED|Overall Study||6
8392627|NCT01044537|20684775|P7|STARTED|Overall Study||16
8392628|NCT01044537|20684776|P6|STARTED|Overall Study||5
8392629|NCT01044537|20684777|P5|STARTED|Overall Study||5
8392630|NCT01044537|20684778|P4|STARTED|Overall Study||6
8392631|NCT01044537|20684779|P3|STARTED|Overall Study||6
8392632|NCT01044537|20684780|P2|STARTED|Overall Study||6
8392633|NCT01044537|20684781|P1|STARTED|Overall Study||6
8392634|NCT01044498|20684890|P2|NOT COMPLETED|Overall Study||2
8392635|NCT01044498|20684891|P1|NOT COMPLETED|Overall Study||3
8392636|NCT01044498|20684890|P2|COMPLETED|Overall Study||21
8392637|NCT01044498|20684891|P1|COMPLETED|Overall Study||20
8392638|NCT01044498|20684890|P2|STARTED|Overall Study||23
8392639|NCT01044498|20684891|P1|STARTED|Overall Study||23
8392640|NCT01044459|20684917|P2|NOT COMPLETED|Overall Study||131
8392641|NCT01044459|20684918|P1|NOT COMPLETED|Overall Study||133
8392642|NCT01044459|20684917|P2|COMPLETED|Overall Study||162
8392643|NCT01044459|20684918|P1|COMPLETED|Overall Study||179
8392644|NCT01044459|20684917|P2|STARTED|Overall Study||293
8392645|NCT01044459|20684918|P1|STARTED|Overall Study||312
8392646|NCT01044433|20684926|P1|NOT COMPLETED|Overall Study||6
8392647|NCT01044433|20684926|P1|COMPLETED|Overall Study||38
8392648|NCT01044433|20684926|P1|STARTED|Overall Study||44
8392649|NCT01044303|20684934|P1|NOT COMPLETED|Overall Study||2
8392650|NCT01044303|20684934|P1|COMPLETED|Overall Study||30
8392651|NCT01044303|20684934|P1|STARTED|Overall Study||32
8392652|NCT01044290|20684944|P3|NOT COMPLETED|Follow-Up 2||2
8392653|NCT01044290|20684945|P2|NOT COMPLETED|Follow-Up 2||2
8392654|NCT01044290|20684946|P1|NOT COMPLETED|Follow-Up 2||0
8392655|NCT01044290|20684944|P3|COMPLETED|Follow-Up 2||69
8392656|NCT01044290|20684945|P2|COMPLETED|Follow-Up 2||67
8392657|NCT01044290|20684946|P1|COMPLETED|Follow-Up 2||70
8392658|NCT01044290|20684944|P3|Completed F2 Interview|Follow-Up 2||64
8392659|NCT01044290|20684945|P2|Completed F2 Interview|Follow-Up 2||57
8392660|NCT01044290|20684946|P1|Completed F2 Interview|Follow-Up 2||64
8392661|NCT01044290|20684944|P3|STARTED|Follow-Up 2||71
8392662|NCT01044290|20684945|P2|STARTED|Follow-Up 2||69
8392663|NCT01044290|20684946|P1|STARTED|Follow-Up 2||70
8392664|NCT01044290|20684944|P3|NOT COMPLETED|Follow-up 1||1
8392665|NCT01044290|20684945|P2|NOT COMPLETED|Follow-up 1||5
8392666|NCT01044290|20684946|P1|NOT COMPLETED|Follow-up 1||5
8392667|NCT01044290|20684944|P3|COMPLETED|Follow-up 1||71
8392668|NCT01044290|20684945|P2|COMPLETED|Follow-up 1||69
8392669|NCT01044290|20684946|P1|COMPLETED|Follow-up 1||70
8392670|NCT01044290|20684944|P3|Completed F1 Interview|Follow-up 1||61
8392671|NCT01044290|20684945|P2|Completed F1 Interview|Follow-up 1||60
8392672|NCT01044290|20684946|P1|Completed F1 Interview|Follow-up 1||61
8392673|NCT01044290|20684944|P3|STARTED|Follow-up 1||72
8392674|NCT01044290|20684945|P2|STARTED|Follow-up 1||74
8392675|NCT01044290|20684946|P1|STARTED|Follow-up 1||75
8392676|NCT01044290|20684944|P3|NOT COMPLETED|Randomization||0
8392677|NCT01044290|20684945|P2|NOT COMPLETED|Randomization||0
8392678|NCT01044290|20684946|P1|NOT COMPLETED|Randomization||0
8392679|NCT01044290|20684944|P3|COMPLETED|Randomization||72
8392680|NCT01044290|20684945|P2|COMPLETED|Randomization||74
8392681|NCT01044290|20684946|P1|COMPLETED|Randomization||75
8392682|NCT01044290|20684944|P3|Randomized|Randomization||72
8392683|NCT01044290|20684945|P2|Randomized|Randomization||74
8392684|NCT01044290|20684946|P1|Randomized|Randomization||75
8392685|NCT01044290|20684944|P3|STARTED|Randomization||72
8392686|NCT01044290|20684945|P2|STARTED|Randomization||74
8392687|NCT01044290|20684946|P1|STARTED|Randomization||75
8392688|NCT01044264|20684972|P3|NOT COMPLETED|Overall Study||92
8392689|NCT01044264|20684973|P2|NOT COMPLETED|Overall Study||94
8392690|NCT01044264|20684974|P1|NOT COMPLETED|Overall Study||90
8392691|NCT01044264|20684972|P3|COMPLETED|Overall Study||108
8392692|NCT01044264|20684973|P2|COMPLETED|Overall Study||108
8392693|NCT01044264|20684974|P1|COMPLETED|Overall Study||110
8392694|NCT01044264|20684972|P3|STARTED|Overall Study||200
8392695|NCT01044264|20684973|P2|STARTED|Overall Study||202
8392696|NCT01044264|20684974|P1|STARTED|Overall Study||200
8392697|NCT01044212|20684984|P2|NOT COMPLETED|Overall Study||7
8392698|NCT01044212|20684985|P1|NOT COMPLETED|Overall Study||5
8392699|NCT01044212|20684984|P2|COMPLETED|Overall Study||30
8392700|NCT01044212|20684985|P1|COMPLETED|Overall Study||30
8392701|NCT01044212|20684984|P2|STARTED|Overall Study||37
8392702|NCT01044212|20684985|P1|STARTED|Overall Study||35
8392703|NCT01044056|20684998|P3|NOT COMPLETED|Overall Study||0
8392704|NCT01044056|20684999|P2|NOT COMPLETED|Overall Study||0
8392705|NCT01044056|20685000|P1|NOT COMPLETED|Overall Study||0
8392706|NCT01044056|20684998|P3|COMPLETED|Overall Study||8
8392707|NCT01044056|20684999|P2|COMPLETED|Overall Study||8
8392708|NCT01044056|20685000|P1|COMPLETED|Overall Study||8
8392709|NCT01044056|20684998|P3|STARTED|Overall Study||8
8392710|NCT01044056|20684999|P2|STARTED|Overall Study||8
8392711|NCT01044056|20685000|P1|STARTED|Overall Study||8
8392712|NCT01044030|20685019|P2|NOT COMPLETED|Overall Study||20
8392713|NCT01044030|20685020|P1|NOT COMPLETED|Overall Study||19
8392714|NCT01044030|20685019|P2|COMPLETED|Overall Study||146
8392715|NCT01044030|20685020|P1|COMPLETED|Overall Study||141
8392716|NCT01044030|20685019|P2|STARTED|Overall Study||166
8392717|NCT01044030|20685020|P1|STARTED|Overall Study||160
8392718|NCT01043939|20685034|P2|NOT COMPLETED|Second Intervention||0
8392719|NCT01043939|20685035|P1|NOT COMPLETED|Second Intervention||0
8392720|NCT01043939|20685034|P2|COMPLETED|Second Intervention||12
8392721|NCT01043939|20685035|P1|COMPLETED|Second Intervention||12
8392722|NCT01043939|20685034|P2|STARTED|Second Intervention||12
8392723|NCT01043939|20685035|P1|STARTED|Second Intervention||12
8392724|NCT01043939|20685034|P2|NOT COMPLETED|Washout Period||0
8392725|NCT01043939|20685035|P1|NOT COMPLETED|Washout Period||0
8392726|NCT01043939|20685034|P2|COMPLETED|Washout Period||12
8392727|NCT01043939|20685035|P1|COMPLETED|Washout Period||12
8392728|NCT01043939|20685034|P2|STARTED|Washout Period||12
8392729|NCT01043939|20685035|P1|STARTED|Washout Period||12
8392730|NCT01043939|20685034|P2|NOT COMPLETED|First Intervention||0
8392731|NCT01043939|20685035|P1|NOT COMPLETED|First Intervention||0
8392732|NCT01043939|20685034|P2|COMPLETED|First Intervention||12
8392733|NCT01043939|20685035|P1|COMPLETED|First Intervention||12
8392734|NCT01043939|20685034|P2|STARTED|First Intervention||12
8392735|NCT01043939|20685035|P1|STARTED|First Intervention||12
8392736|NCT01043926|20685049|P4|NOT COMPLETED|Overall Study||0
8392737|NCT01043926|20685050|P3|NOT COMPLETED|Overall Study||0
8392738|NCT01043926|20685051|P2|NOT COMPLETED|Overall Study||0
8392739|NCT01043926|20685052|P1|NOT COMPLETED|Overall Study||0
8392740|NCT01043926|20685049|P4|COMPLETED|Overall Study||0
8392741|NCT01043926|20685050|P3|COMPLETED|Overall Study||0
8392742|NCT01043926|20685051|P2|COMPLETED|Overall Study||8
8392743|NCT01043926|20685052|P1|COMPLETED|Overall Study||8
8392744|NCT01043926|20685049|P4|STARTED|Overall Study||0
8392745|NCT01043926|20685050|P3|STARTED|Overall Study||0
8392746|NCT01043926|20685051|P2|STARTED|Overall Study||8
8392747|NCT01043926|20685052|P1|STARTED|Overall Study||8
8392748|NCT01043874|20685066|P1|NOT COMPLETED|Overall Study||6
8392749|NCT01043874|20685066|P1|COMPLETED|Overall Study||39
8392750|NCT01043874|20685066|P1|STARTED|Overall Study||45
8392751|NCT01043705|20685076|P3|NOT COMPLETED|Overall Study||80
8392752|NCT01043705|20685077|P2|NOT COMPLETED|Overall Study||131
8392753|NCT01043705|20685078|P1|NOT COMPLETED|Overall Study||107
8392754|NCT01043705|20685076|P3|COMPLETED|Overall Study||498
8392755|NCT01043705|20685077|P2|COMPLETED|Overall Study||447
8392756|NCT01043705|20685078|P1|COMPLETED|Overall Study||352
8392757|NCT01043705|20685076|P3|STARTED|Overall Study||578
8392758|NCT01043705|20685077|P2|STARTED|Overall Study||578
8392759|NCT01043705|20685078|P1|STARTED|Overall Study||459
8392760|NCT01043653|20685088|P1|NOT COMPLETED|Overall Study||64
8392761|NCT01043653|20685088|P1|COMPLETED|Overall Study||186
8392762|NCT01043653|20685088|P1|STARTED|Overall Study||250
8392763|NCT01043640|20685093|P1|NOT COMPLETED|Overall Study||0
8392764|NCT01043640|20685093|P1|COMPLETED|Overall Study||46
8392765|NCT01043640|20685093|P1|STARTED|Overall Study||46
8392766|NCT01043562|20685108|P1|NOT COMPLETED|Overall Study||0
8392767|NCT01043562|20685108|P1|COMPLETED|Overall Study||20
8392768|NCT01043562|20685108|P1|STARTED|Overall Study||20
8392769|NCT01043523|20685115|P1|NOT COMPLETED|Overall Study||0
8392770|NCT01043523|20685115|P1|COMPLETED|Overall Study||52
8392771|NCT01043523|20685115|P1|Participants With Unenhanced Images|Overall Study||51
8392772|NCT01043523|20685115|P1|STARTED|Overall Study||52
8392773|NCT01043432|20685144|P4|NOT COMPLETED|Overall Study||0
8392774|NCT01043432|20685145|P3|NOT COMPLETED|Overall Study||0
8392775|NCT01043432|20685146|P2|NOT COMPLETED|Overall Study||0
8392776|NCT01043432|20685147|P1|NOT COMPLETED|Overall Study||0
8392777|NCT01043432|20685144|P4|COMPLETED|Overall Study||48
8392778|NCT01043432|20685145|P3|COMPLETED|Overall Study||12
8392779|NCT01043432|20685146|P2|COMPLETED|Overall Study||51
8392780|NCT01043432|20685147|P1|COMPLETED|Overall Study||22
8392781|NCT01043432|20685144|P4|STARTED|Overall Study||48
8392782|NCT01043432|20685145|P3|STARTED|Overall Study||12
8392783|NCT01043432|20685146|P2|STARTED|Overall Study||51
8392784|NCT01043432|20685147|P1|STARTED|Overall Study||22
8392785|NCT01043393|20685156|P2|NOT COMPLETED|Overall Study||0
8392786|NCT01043393|20685157|P1|NOT COMPLETED|Overall Study||0
8392787|NCT01043393|20685156|P2|COMPLETED|Overall Study||12
8392788|NCT01043393|20685157|P1|COMPLETED|Overall Study||12
8392789|NCT01043393|20685156|P2|STARTED|Overall Study||12
8392790|NCT01043393|20685157|P1|STARTED|Overall Study||12
8392791|NCT01043185|20685167|P10|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392792|NCT01043185|20685168|P9|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392793|NCT01043185|20685169|P8|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392794|NCT01043185|20685170|P7|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392795|NCT01043185|20685171|P6|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392796|NCT01043185|20685172|P5|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392797|NCT01043185|20685173|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392798|NCT01043185|20685174|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392799|NCT01043185|20685175|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392800|NCT01043185|20685176|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
8392801|NCT01043185|20685167|P10|COMPLETED|Period 7 - Fourth Intervention||3
8392802|NCT01043185|20685168|P9|COMPLETED|Period 7 - Fourth Intervention||2
8392803|NCT01043185|20685169|P8|COMPLETED|Period 7 - Fourth Intervention||3
8392804|NCT01043185|20685170|P7|COMPLETED|Period 7 - Fourth Intervention||3
8392805|NCT01043185|20685171|P6|COMPLETED|Period 7 - Fourth Intervention||3
8392806|NCT01043185|20685172|P5|COMPLETED|Period 7 - Fourth Intervention||2
8392807|NCT01043185|20685173|P4|COMPLETED|Period 7 - Fourth Intervention||2
8392808|NCT01043185|20685174|P3|COMPLETED|Period 7 - Fourth Intervention||3
8392809|NCT01043185|20685175|P2|COMPLETED|Period 7 - Fourth Intervention||2
8392810|NCT01043185|20685176|P1|COMPLETED|Period 7 - Fourth Intervention||3
8392811|NCT01043185|20685167|P10|STARTED|Period 7 - Fourth Intervention||3
8392812|NCT01043185|20685168|P9|STARTED|Period 7 - Fourth Intervention||2
8392813|NCT01043185|20685169|P8|STARTED|Period 7 - Fourth Intervention||3
8392814|NCT01043185|20685170|P7|STARTED|Period 7 - Fourth Intervention||3
8392815|NCT01043185|20685171|P6|STARTED|Period 7 - Fourth Intervention||3
8392816|NCT01043185|20685172|P5|STARTED|Period 7 - Fourth Intervention||2
8392817|NCT01043185|20685173|P4|STARTED|Period 7 - Fourth Intervention||2
8392818|NCT01043185|20685174|P3|STARTED|Period 7 - Fourth Intervention||3
8392819|NCT01043185|20685175|P2|STARTED|Period 7 - Fourth Intervention||2
8392820|NCT01043185|20685176|P1|STARTED|Period 7 - Fourth Intervention||3
8392821|NCT01043185|20685167|P10|NOT COMPLETED|Period 6 - Third Washout Period||0
8392822|NCT01043185|20685168|P9|NOT COMPLETED|Period 6 - Third Washout Period||1
8392823|NCT01043185|20685169|P8|NOT COMPLETED|Period 6 - Third Washout Period||0
8392824|NCT01043185|20685170|P7|NOT COMPLETED|Period 6 - Third Washout Period||0
8392825|NCT01043185|20685171|P6|NOT COMPLETED|Period 6 - Third Washout Period||0
8392826|NCT01043185|20685172|P5|NOT COMPLETED|Period 6 - Third Washout Period||0
8392827|NCT01043185|20685173|P4|NOT COMPLETED|Period 6 - Third Washout Period||0
8392828|NCT01043185|20685174|P3|NOT COMPLETED|Period 6 - Third Washout Period||0
8392829|NCT01043185|20685175|P2|NOT COMPLETED|Period 6 - Third Washout Period||0
8392830|NCT01043185|20685176|P1|NOT COMPLETED|Period 6 - Third Washout Period||0
8392831|NCT01043185|20685167|P10|COMPLETED|Period 6 - Third Washout Period||3
8392832|NCT01043185|20685168|P9|COMPLETED|Period 6 - Third Washout Period||2
8392833|NCT01043185|20685169|P8|COMPLETED|Period 6 - Third Washout Period||3
8392834|NCT01043185|20685170|P7|COMPLETED|Period 6 - Third Washout Period||3
8392835|NCT01043185|20685171|P6|COMPLETED|Period 6 - Third Washout Period||3
8392836|NCT01043185|20685172|P5|COMPLETED|Period 6 - Third Washout Period||2
8392837|NCT01043185|20685173|P4|COMPLETED|Period 6 - Third Washout Period||2
8392838|NCT01043185|20685174|P3|COMPLETED|Period 6 - Third Washout Period||3
8392839|NCT01043185|20685175|P2|COMPLETED|Period 6 - Third Washout Period||2
8392840|NCT01043185|20685176|P1|COMPLETED|Period 6 - Third Washout Period||3
8392841|NCT01043185|20685167|P10|STARTED|Period 6 - Third Washout Period||3
8392842|NCT01043185|20685168|P9|STARTED|Period 6 - Third Washout Period||3
8392843|NCT01043185|20685169|P8|STARTED|Period 6 - Third Washout Period||3
8392844|NCT01043185|20685170|P7|STARTED|Period 6 - Third Washout Period||3
8392845|NCT01043185|20685171|P6|STARTED|Period 6 - Third Washout Period||3
8392846|NCT01043185|20685172|P5|STARTED|Period 6 - Third Washout Period||2
8392847|NCT01043185|20685173|P4|STARTED|Period 6 - Third Washout Period||2
8392848|NCT01043185|20685174|P3|STARTED|Period 6 - Third Washout Period||3
8392849|NCT01043185|20685175|P2|STARTED|Period 6 - Third Washout Period||2
8392850|NCT01043185|20685176|P1|STARTED|Period 6 - Third Washout Period||3
8392851|NCT01043185|20685167|P10|NOT COMPLETED|Period 5 - Third Intervention||0
8392852|NCT01043185|20685168|P9|NOT COMPLETED|Period 5 - Third Intervention||0
8392853|NCT01043185|20685169|P8|NOT COMPLETED|Period 5 - Third Intervention||0
8392854|NCT01043185|20685170|P7|NOT COMPLETED|Period 5 - Third Intervention||0
8392855|NCT01043185|20685171|P6|NOT COMPLETED|Period 5 - Third Intervention||0
8392856|NCT01043185|20685172|P5|NOT COMPLETED|Period 5 - Third Intervention||0
8392857|NCT01043185|20685173|P4|NOT COMPLETED|Period 5 - Third Intervention||0
8392858|NCT01043185|20685174|P3|NOT COMPLETED|Period 5 - Third Intervention||0
8392859|NCT01043185|20685175|P2|NOT COMPLETED|Period 5 - Third Intervention||0
8392860|NCT01043185|20685176|P1|NOT COMPLETED|Period 5 - Third Intervention||0
8392861|NCT01043185|20685167|P10|COMPLETED|Period 5 - Third Intervention||3
8392862|NCT01043185|20685168|P9|COMPLETED|Period 5 - Third Intervention||3
8392863|NCT01043185|20685169|P8|COMPLETED|Period 5 - Third Intervention||3
8392864|NCT01043185|20685170|P7|COMPLETED|Period 5 - Third Intervention||3
8392865|NCT01043185|20685171|P6|COMPLETED|Period 5 - Third Intervention||3
8392866|NCT01043185|20685172|P5|COMPLETED|Period 5 - Third Intervention||2
8392867|NCT01043185|20685173|P4|COMPLETED|Period 5 - Third Intervention||2
8392868|NCT01043185|20685174|P3|COMPLETED|Period 5 - Third Intervention||3
8392869|NCT01043185|20685175|P2|COMPLETED|Period 5 - Third Intervention||2
8392870|NCT01043185|20685176|P1|COMPLETED|Period 5 - Third Intervention||3
8392871|NCT01043185|20685167|P10|STARTED|Period 5 - Third Intervention||3
8392872|NCT01043185|20685168|P9|STARTED|Period 5 - Third Intervention||3
8392873|NCT01043185|20685169|P8|STARTED|Period 5 - Third Intervention||3
8392874|NCT01043185|20685170|P7|STARTED|Period 5 - Third Intervention||3
8392875|NCT01043185|20685171|P6|STARTED|Period 5 - Third Intervention||3
8392876|NCT01043185|20685172|P5|STARTED|Period 5 - Third Intervention||2
8392877|NCT01043185|20685173|P4|STARTED|Period 5 - Third Intervention||2
8392878|NCT01043185|20685174|P3|STARTED|Period 5 - Third Intervention||3
8392879|NCT01043185|20685175|P2|STARTED|Period 5 - Third Intervention||2
8392880|NCT01043185|20685176|P1|STARTED|Period 5 - Third Intervention||3
8392881|NCT01043185|20685167|P10|NOT COMPLETED|Period 4 - Second Washout Period||0
8392882|NCT01043185|20685168|P9|NOT COMPLETED|Period 4 - Second Washout Period||0
8392883|NCT01043185|20685169|P8|NOT COMPLETED|Period 4 - Second Washout Period||0
8392884|NCT01043185|20685170|P7|NOT COMPLETED|Period 4 - Second Washout Period||0
8392885|NCT01043185|20685171|P6|NOT COMPLETED|Period 4 - Second Washout Period||0
8392886|NCT01043185|20685172|P5|NOT COMPLETED|Period 4 - Second Washout Period||0
8392887|NCT01043185|20685173|P4|NOT COMPLETED|Period 4 - Second Washout Period||0
8392888|NCT01043185|20685174|P3|NOT COMPLETED|Period 4 - Second Washout Period||0
8392889|NCT01043185|20685175|P2|NOT COMPLETED|Period 4 - Second Washout Period||0
8392890|NCT01043185|20685176|P1|NOT COMPLETED|Period 4 - Second Washout Period||0
8392891|NCT01043185|20685167|P10|COMPLETED|Period 4 - Second Washout Period||3
8392892|NCT01043185|20685168|P9|COMPLETED|Period 4 - Second Washout Period||3
8392893|NCT01043185|20685169|P8|COMPLETED|Period 4 - Second Washout Period||3
8392894|NCT01043185|20685170|P7|COMPLETED|Period 4 - Second Washout Period||3
8392895|NCT01043185|20685171|P6|COMPLETED|Period 4 - Second Washout Period||3
8392896|NCT01043185|20685172|P5|COMPLETED|Period 4 - Second Washout Period||2
8392897|NCT01043185|20685173|P4|COMPLETED|Period 4 - Second Washout Period||2
8392898|NCT01043185|20685174|P3|COMPLETED|Period 4 - Second Washout Period||3
8392899|NCT01043185|20685175|P2|COMPLETED|Period 4 - Second Washout Period||2
8392900|NCT01043185|20685176|P1|COMPLETED|Period 4 - Second Washout Period||3
8392901|NCT01043185|20685167|P10|STARTED|Period 4 - Second Washout Period||3
8392902|NCT01043185|20685168|P9|STARTED|Period 4 - Second Washout Period||3
8392903|NCT01043185|20685169|P8|STARTED|Period 4 - Second Washout Period||3
8392904|NCT01043185|20685170|P7|STARTED|Period 4 - Second Washout Period||3
8392905|NCT01043185|20685171|P6|STARTED|Period 4 - Second Washout Period||3
8392906|NCT01043185|20685172|P5|STARTED|Period 4 - Second Washout Period||2
8392907|NCT01043185|20685173|P4|STARTED|Period 4 - Second Washout Period||2
8392908|NCT01043185|20685174|P3|STARTED|Period 4 - Second Washout Period||3
8392909|NCT01043185|20685175|P2|STARTED|Period 4 - Second Washout Period||2
8392910|NCT01043185|20685176|P1|STARTED|Period 4 - Second Washout Period||3
8392911|NCT01043185|20685167|P10|NOT COMPLETED|Period 3 - Second Intervention||0
8392912|NCT01043185|20685168|P9|NOT COMPLETED|Period 3 - Second Intervention||0
8392913|NCT01043185|20685169|P8|NOT COMPLETED|Period 3 - Second Intervention||0
8392914|NCT01043185|20685170|P7|NOT COMPLETED|Period 3 - Second Intervention||0
8392915|NCT01043185|20685171|P6|NOT COMPLETED|Period 3 - Second Intervention||0
8392916|NCT01043185|20685172|P5|NOT COMPLETED|Period 3 - Second Intervention||0
8392917|NCT01043185|20685173|P4|NOT COMPLETED|Period 3 - Second Intervention||0
8392918|NCT01043185|20685174|P3|NOT COMPLETED|Period 3 - Second Intervention||0
8392919|NCT01043185|20685175|P2|NOT COMPLETED|Period 3 - Second Intervention||0
8392920|NCT01043185|20685176|P1|NOT COMPLETED|Period 3 - Second Intervention||0
8392921|NCT01043185|20685167|P10|COMPLETED|Period 3 - Second Intervention||3
8392922|NCT01043185|20685168|P9|COMPLETED|Period 3 - Second Intervention||3
8392923|NCT01043185|20685169|P8|COMPLETED|Period 3 - Second Intervention||3
8392924|NCT01043185|20685170|P7|COMPLETED|Period 3 - Second Intervention||3
8392925|NCT01043185|20685171|P6|COMPLETED|Period 3 - Second Intervention||3
8392926|NCT01043185|20685172|P5|COMPLETED|Period 3 - Second Intervention||2
8392927|NCT01043185|20685173|P4|COMPLETED|Period 3 - Second Intervention||2
8392928|NCT01043185|20685174|P3|COMPLETED|Period 3 - Second Intervention||3
8392929|NCT01043185|20685175|P2|COMPLETED|Period 3 - Second Intervention||2
8392930|NCT01043185|20685176|P1|COMPLETED|Period 3 - Second Intervention||3
8392931|NCT01043185|20685167|P10|STARTED|Period 3 - Second Intervention||3
8392932|NCT01043185|20685168|P9|STARTED|Period 3 - Second Intervention||3
8392933|NCT01043185|20685169|P8|STARTED|Period 3 - Second Intervention||3
8392934|NCT01043185|20685170|P7|STARTED|Period 3 - Second Intervention||3
8392935|NCT01043185|20685171|P6|STARTED|Period 3 - Second Intervention||3
8392936|NCT01043185|20685172|P5|STARTED|Period 3 - Second Intervention||2
8392937|NCT01043185|20685173|P4|STARTED|Period 3 - Second Intervention||2
8392938|NCT01043185|20685174|P3|STARTED|Period 3 - Second Intervention||3
8392939|NCT01043185|20685175|P2|STARTED|Period 3 - Second Intervention||2
8392940|NCT01043185|20685176|P1|STARTED|Period 3 - Second Intervention||3
8392941|NCT01043185|20685167|P10|NOT COMPLETED|Period 2 - First Washout Period||0
8392942|NCT01043185|20685168|P9|NOT COMPLETED|Period 2 - First Washout Period||0
8392943|NCT01043185|20685169|P8|NOT COMPLETED|Period 2 - First Washout Period||0
8392944|NCT01043185|20685170|P7|NOT COMPLETED|Period 2 - First Washout Period||0
8392945|NCT01043185|20685171|P6|NOT COMPLETED|Period 2 - First Washout Period||0
8392946|NCT01043185|20685172|P5|NOT COMPLETED|Period 2 - First Washout Period||0
8392947|NCT01043185|20685173|P4|NOT COMPLETED|Period 2 - First Washout Period||0
8392948|NCT01043185|20685174|P3|NOT COMPLETED|Period 2 - First Washout Period||0
8392949|NCT01043185|20685175|P2|NOT COMPLETED|Period 2 - First Washout Period||0
8392950|NCT01043185|20685176|P1|NOT COMPLETED|Period 2 - First Washout Period||0
8392951|NCT01043185|20685167|P10|COMPLETED|Period 2 - First Washout Period||3
8392952|NCT01043185|20685168|P9|COMPLETED|Period 2 - First Washout Period||3
8392953|NCT01043185|20685169|P8|COMPLETED|Period 2 - First Washout Period||3
8392954|NCT01043185|20685170|P7|COMPLETED|Period 2 - First Washout Period||3
8392955|NCT01043185|20685171|P6|COMPLETED|Period 2 - First Washout Period||3
8392956|NCT01043185|20685172|P5|COMPLETED|Period 2 - First Washout Period||2
8392957|NCT01043185|20685173|P4|COMPLETED|Period 2 - First Washout Period||2
8392958|NCT01043185|20685174|P3|COMPLETED|Period 2 - First Washout Period||3
8392959|NCT01043185|20685175|P2|COMPLETED|Period 2 - First Washout Period||2
8392960|NCT01043185|20685176|P1|COMPLETED|Period 2 - First Washout Period||3
8392961|NCT01043185|20685167|P10|STARTED|Period 2 - First Washout Period||3
8392962|NCT01043185|20685168|P9|STARTED|Period 2 - First Washout Period||3
8392963|NCT01043185|20685169|P8|STARTED|Period 2 - First Washout Period||3
8392964|NCT01043185|20685170|P7|STARTED|Period 2 - First Washout Period||3
8392965|NCT01043185|20685171|P6|STARTED|Period 2 - First Washout Period||3
8392966|NCT01043185|20685172|P5|STARTED|Period 2 - First Washout Period||2
8392967|NCT01043185|20685173|P4|STARTED|Period 2 - First Washout Period||2
8392968|NCT01043185|20685174|P3|STARTED|Period 2 - First Washout Period||3
8392969|NCT01043185|20685175|P2|STARTED|Period 2 - First Washout Period||2
8392970|NCT01043185|20685176|P1|STARTED|Period 2 - First Washout Period||3
8392971|NCT01043185|20685167|P10|NOT COMPLETED|Period 1 - First Intervention||0
8392972|NCT01043185|20685168|P9|NOT COMPLETED|Period 1 - First Intervention||0
8392973|NCT01043185|20685169|P8|NOT COMPLETED|Period 1 - First Intervention||0
8392974|NCT01043185|20685170|P7|NOT COMPLETED|Period 1 - First Intervention||0
8392975|NCT01043185|20685171|P6|NOT COMPLETED|Period 1 - First Intervention||0
8392976|NCT01043185|20685172|P5|NOT COMPLETED|Period 1 - First Intervention||0
8392977|NCT01043185|20685173|P4|NOT COMPLETED|Period 1 - First Intervention||0
8392978|NCT01043185|20685174|P3|NOT COMPLETED|Period 1 - First Intervention||0
8392979|NCT01043185|20685175|P2|NOT COMPLETED|Period 1 - First Intervention||0
8392980|NCT01043185|20685176|P1|NOT COMPLETED|Period 1 - First Intervention||0
8392981|NCT01043185|20685167|P10|COMPLETED|Period 1 - First Intervention||3
8392982|NCT01043185|20685168|P9|COMPLETED|Period 1 - First Intervention||3
8392983|NCT01043185|20685169|P8|COMPLETED|Period 1 - First Intervention||3
8392984|NCT01043185|20685170|P7|COMPLETED|Period 1 - First Intervention||3
8392985|NCT01043185|20685171|P6|COMPLETED|Period 1 - First Intervention||3
8392986|NCT01043185|20685172|P5|COMPLETED|Period 1 - First Intervention||2
8392987|NCT01043185|20685173|P4|COMPLETED|Period 1 - First Intervention||2
8392988|NCT01043185|20685174|P3|COMPLETED|Period 1 - First Intervention||3
8392989|NCT01043185|20685175|P2|COMPLETED|Period 1 - First Intervention||2
8392990|NCT01043185|20685176|P1|COMPLETED|Period 1 - First Intervention||3
8392991|NCT01043185|20685167|P10|STARTED|Period 1 - First Intervention||3
8392992|NCT01043185|20685168|P9|STARTED|Period 1 - First Intervention||3
8392993|NCT01043185|20685169|P8|STARTED|Period 1 - First Intervention||3
8392994|NCT01043185|20685170|P7|STARTED|Period 1 - First Intervention||3
8392995|NCT01043185|20685171|P6|STARTED|Period 1 - First Intervention||3
8392996|NCT01043185|20685172|P5|STARTED|Period 1 - First Intervention||2
8392997|NCT01043185|20685173|P4|STARTED|Period 1 - First Intervention||2
8392998|NCT01043185|20685174|P3|STARTED|Period 1 - First Intervention||3
8392999|NCT01043185|20685175|P2|STARTED|Period 1 - First Intervention||2
8393000|NCT01043185|20685176|P1|STARTED|Period 1 - First Intervention||3
8393001|NCT01043146|20685209|P6|NOT COMPLETED|Overall Study||0
8393002|NCT01043146|20685210|P5|NOT COMPLETED|Overall Study||0
8393003|NCT01043146|20685211|P4|NOT COMPLETED|Overall Study||0
8393004|NCT01043146|20685212|P3|NOT COMPLETED|Overall Study||0
8393005|NCT01043146|20685213|P2|NOT COMPLETED|Overall Study||0
8393006|NCT01043146|20685214|P1|NOT COMPLETED|Overall Study||0
8393007|NCT01043146|20685209|P6|COMPLETED|Overall Study||8
8393008|NCT01043146|20685210|P5|COMPLETED|Overall Study||8
8393009|NCT01043146|20685211|P4|COMPLETED|Overall Study||8
8393010|NCT01043146|20685212|P3|COMPLETED|Overall Study||8
8393011|NCT01043146|20685213|P2|COMPLETED|Overall Study||8
8393012|NCT01043146|20685214|P1|COMPLETED|Overall Study||10
8393013|NCT01043146|20685209|P6|STARTED|Overall Study||8
8393014|NCT01043146|20685210|P5|STARTED|Overall Study||8
8393015|NCT01043146|20685211|P4|STARTED|Overall Study||8
8393016|NCT01043146|20685212|P3|STARTED|Overall Study||8
8393017|NCT01043146|20685213|P2|STARTED|Overall Study||8
8393018|NCT01043146|20685214|P1|STARTED|Overall Study||10
8393019|NCT01043133|20685230|P2|NOT COMPLETED|Overall Study||2
8393020|NCT01043133|20685231|P1|NOT COMPLETED|Overall Study||1
8393021|NCT01043133|20685230|P2|COMPLETED|Overall Study||78
8393022|NCT01043133|20685231|P1|COMPLETED|Overall Study||74
8393023|NCT01043133|20685230|P2|STARTED|Overall Study||80
8393024|NCT01043133|20685231|P1|STARTED|Overall Study||75
8393025|NCT01043094|20685241|P2|NOT COMPLETED|Overall Study||0
8393026|NCT01043094|20685242|P1|NOT COMPLETED|Overall Study||0
8393027|NCT01043094|20685241|P2|COMPLETED|Overall Study||8
8393028|NCT01043094|20685242|P1|COMPLETED|Overall Study||8
8393029|NCT01043094|20685241|P2|STARTED|Overall Study||8
8393030|NCT01043094|20685242|P1|STARTED|Overall Study||8
8393031|NCT01042977|20685252|P2|NOT COMPLETED|Overall Study||55
8393032|NCT01042977|20685253|P1|NOT COMPLETED|Overall Study||41
8393033|NCT01042977|20685252|P2|COMPLETED|Overall Study||428
8393034|NCT01042977|20685253|P1|COMPLETED|Overall Study||441
8393035|NCT01042977|20685252|P2|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
8393036|NCT01042977|20685253|P1|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
8393037|NCT01042938|20685273|P2|NOT COMPLETED|Overall Study||2
8393038|NCT01042938|20685274|P1|NOT COMPLETED|Overall Study||3
8393039|NCT01042938|20685273|P2|COMPLETED|Overall Study||16
8393040|NCT01042938|20685274|P1|COMPLETED|Overall Study||14
8393041|NCT01042938|20685273|P2|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
8393042|NCT01042938|20685274|P1|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
8393043|NCT01042795|20685286|P1|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
8393044|NCT01042795|20685286|P1|COMPLETED|Follow up - 22 Months After Drug Start||0
8393045|NCT01042795|20685286|P1|STARTED|Follow up - 22 Months After Drug Start||2
8393127|NCT01042366|20685424|P2|COMPLETED|Overall Study||6
8393046|NCT01042795|20685286|P1|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
8393047|NCT01042795|20685286|P1|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
8393048|NCT01042795|20685286|P1|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
8393049|NCT01042678|20685293|P6|NOT COMPLETED|Overall Study||0
8393050|NCT01042678|20685294|P5|NOT COMPLETED|Overall Study||0
8393051|NCT01042678|20685295|P4|NOT COMPLETED|Overall Study||0
8393052|NCT01042678|20685296|P3|NOT COMPLETED|Overall Study||0
8393053|NCT01042678|20685297|P2|NOT COMPLETED|Overall Study||0
8393054|NCT01042678|20685298|P1|NOT COMPLETED|Overall Study||1
8393055|NCT01042678|20685293|P6|COMPLETED|Overall Study||0
8393056|NCT01042678|20685294|P5|COMPLETED|Overall Study||0
8393057|NCT01042678|20685295|P4|COMPLETED|Overall Study||0
8393058|NCT01042678|20685296|P3|COMPLETED|Overall Study||6
8393059|NCT01042678|20685297|P2|COMPLETED|Overall Study||6
8393060|NCT01042678|20685298|P1|COMPLETED|Overall Study||5
8393061|NCT01042678|20685293|P6|STARTED|Overall Study||0
8393062|NCT01042678|20685294|P5|STARTED|Overall Study||0
8393063|NCT01042678|20685295|P4|STARTED|Overall Study||0
8393064|NCT01042678|20685296|P3|STARTED|Overall Study||6
8393065|NCT01042678|20685297|P2|STARTED|Overall Study||6
8393066|NCT01042678|20685298|P1|STARTED|Overall Study||6
8393067|NCT01042613|20685323|P2|NOT COMPLETED|Overall Study||0
8393068|NCT01042613|20685324|P1|NOT COMPLETED|Overall Study||0
8393069|NCT01042613|20685323|P2|COMPLETED|Overall Study||74
8393070|NCT01042613|20685324|P1|COMPLETED|Overall Study||72
8393071|NCT01042613|20685323|P2|STARTED|Overall Study||74
8393072|NCT01042613|20685324|P1|STARTED|Overall Study||72
8393073|NCT01042600|20685336|P2|NOT COMPLETED|Overall Study||0
8393074|NCT01042600|20685337|P1|NOT COMPLETED|Overall Study||1
8393075|NCT01042600|20685336|P2|COMPLETED|Overall Study||30
8393076|NCT01042600|20685337|P1|COMPLETED|Overall Study||30
8393077|NCT01042600|20685336|P2|STARTED|Overall Study||30
8393078|NCT01042600|20685337|P1|STARTED|Overall Study||31
8393079|NCT01042535|20685357|P1|NOT COMPLETED|Overall Study||8
8393080|NCT01042535|20685357|P1|COMPLETED|Overall Study||36
8393081|NCT01042535|20685357|P1|STARTED|Overall Study||44
8393082|NCT01042509|20685365|P1|NOT COMPLETED|Overall Study||0
8393083|NCT01042509|20685365|P1|COMPLETED|Overall Study||15
8393084|NCT01042509|20685365|P1|STARTED|Overall Study||15
8393085|NCT01042496|20685372|P2|NOT COMPLETED|Overall Study||0
8393086|NCT01042496|20685373|P1|NOT COMPLETED|Overall Study||0
8393087|NCT01042496|20685372|P2|COMPLETED|Overall Study||33
8393088|NCT01042496|20685373|P1|COMPLETED|Overall Study||29
8393089|NCT01042496|20685372|P2|STARTED|Overall Study||33
8393090|NCT01042496|20685373|P1|STARTED|Overall Study||29
8393091|NCT01042392|20685391|P4|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
8393092|NCT01042392|20685392|P3|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
8393093|NCT01042392|20685393|P2|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
8393094|NCT01042392|20685394|P1|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
8393095|NCT01042392|20685391|P4|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
8393096|NCT01042392|20685392|P3|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
8393097|NCT01042392|20685393|P2|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
8393098|NCT01042392|20685394|P1|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
8393099|NCT01042392|20685391|P4|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
8393100|NCT01042392|20685392|P3|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
8393101|NCT01042392|20685393|P2|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
8393102|NCT01042392|20685394|P1|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
8393103|NCT01042392|20685391|P4|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
8393104|NCT01042392|20685392|P3|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
8393105|NCT01042392|20685393|P2|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
8393106|NCT01042392|20685394|P1|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
8393107|NCT01042392|20685391|P4|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
8393108|NCT01042392|20685392|P3|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
8393109|NCT01042392|20685393|P2|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
8393110|NCT01042392|20685394|P1|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
8393111|NCT01042392|20685391|P4|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
8393112|NCT01042392|20685392|P3|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
8393113|NCT01042392|20685393|P2|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
8393114|NCT01042392|20685394|P1|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
8393115|NCT01042392|20685391|P4|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
8393116|NCT01042392|20685392|P3|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
8393117|NCT01042392|20685393|P2|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
8393118|NCT01042392|20685394|P1|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
8393119|NCT01042392|20685391|P4|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
8393120|NCT01042392|20685392|P3|STARTED|Period II(Randomized,Double Blinded,8wk)||249
8393121|NCT01042392|20685393|P2|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
8393122|NCT01042392|20685394|P1|STARTED|Period II(Randomized,Double Blinded,8wk)||257
8393123|NCT01042366|20685423|P3|NOT COMPLETED|Overall Study||0
8393124|NCT01042366|20685424|P2|NOT COMPLETED|Overall Study||0
8393125|NCT01042366|20685425|P1|NOT COMPLETED|Overall Study||0
8393126|NCT01042366|20685423|P3|COMPLETED|Overall Study||4
8393128|NCT01042366|20685425|P1|COMPLETED|Overall Study||5
8393129|NCT01042366|20685423|P3|STARTED|Overall Study||4
8393130|NCT01042366|20685424|P2|STARTED|Overall Study||6
8393131|NCT01042366|20685425|P1|STARTED|Overall Study||5
8393132|NCT01042288|20685434|P1|NOT COMPLETED|Overall Study||69
8393133|NCT01042288|20685434|P1|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
8393134|NCT01042288|20685434|P1|Maintenance|Overall Study||27
8393135|NCT01042288|20685434|P1|STARTED|Overall Study||69
8393136|NCT01042236|20685442|P6|NOT COMPLETED|Treatment Period 3||0
8393137|NCT01042236|20685443|P5|NOT COMPLETED|Treatment Period 3||0
8393138|NCT01042236|20685444|P4|NOT COMPLETED|Treatment Period 3||2
8393139|NCT01042236|20685445|P3|NOT COMPLETED|Treatment Period 3||0
8393140|NCT01042236|20685446|P2|NOT COMPLETED|Treatment Period 3||0
8393141|NCT01042236|20685447|P1|NOT COMPLETED|Treatment Period 3||0
8393142|NCT01042236|20685442|P6|COMPLETED|Treatment Period 3||3
8393143|NCT01042236|20685443|P5|COMPLETED|Treatment Period 3||3
8393144|NCT01042236|20685444|P4|COMPLETED|Treatment Period 3||3
8393145|NCT01042236|20685445|P3|COMPLETED|Treatment Period 3||3
8393146|NCT01042236|20685446|P2|COMPLETED|Treatment Period 3||3
8393147|NCT01042236|20685447|P1|COMPLETED|Treatment Period 3||3
8393148|NCT01042236|20685442|P6|STARTED|Treatment Period 3||3
8393149|NCT01042236|20685443|P5|STARTED|Treatment Period 3||3
8393150|NCT01042236|20685444|P4|STARTED|Treatment Period 3||5
8393151|NCT01042236|20685445|P3|STARTED|Treatment Period 3||3
8393152|NCT01042236|20685446|P2|STARTED|Treatment Period 3||3
8393153|NCT01042236|20685447|P1|STARTED|Treatment Period 3||3
8393154|NCT01042236|20685442|P6|NOT COMPLETED|Treatment Period 2||0
8393155|NCT01042236|20685443|P5|NOT COMPLETED|Treatment Period 2||0
8393156|NCT01042236|20685444|P4|NOT COMPLETED|Treatment Period 2||0
8393157|NCT01042236|20685445|P3|NOT COMPLETED|Treatment Period 2||0
8393158|NCT01042236|20685446|P2|NOT COMPLETED|Treatment Period 2||0
8393159|NCT01042236|20685447|P1|NOT COMPLETED|Treatment Period 2||0
8393160|NCT01042236|20685442|P6|COMPLETED|Treatment Period 2||3
8393161|NCT01042236|20685443|P5|COMPLETED|Treatment Period 2||3
8393162|NCT01042236|20685444|P4|COMPLETED|Treatment Period 2||5
8393163|NCT01042236|20685445|P3|COMPLETED|Treatment Period 2||3
8393164|NCT01042236|20685446|P2|COMPLETED|Treatment Period 2||3
8393165|NCT01042236|20685447|P1|COMPLETED|Treatment Period 2||3
8393166|NCT01042236|20685442|P6|STARTED|Treatment Period 2||3
8393167|NCT01042236|20685443|P5|STARTED|Treatment Period 2||3
8393168|NCT01042236|20685444|P4|STARTED|Treatment Period 2||5
8393169|NCT01042236|20685445|P3|STARTED|Treatment Period 2||3
8393170|NCT01042236|20685446|P2|STARTED|Treatment Period 2||3
8393171|NCT01042236|20685447|P1|STARTED|Treatment Period 2||3
8393172|NCT01042236|20685442|P6|NOT COMPLETED|Treatment Period 1||0
8393173|NCT01042236|20685443|P5|NOT COMPLETED|Treatment Period 1||1
8393174|NCT01042236|20685444|P4|NOT COMPLETED|Treatment Period 1||0
8393175|NCT01042236|20685445|P3|NOT COMPLETED|Treatment Period 1||0
8393176|NCT01042236|20685446|P2|NOT COMPLETED|Treatment Period 1||1
8393177|NCT01042236|20685447|P1|NOT COMPLETED|Treatment Period 1||0
8393178|NCT01042236|20685442|P6|COMPLETED|Treatment Period 1||3
8393179|NCT01042236|20685443|P5|COMPLETED|Treatment Period 1||3
8393180|NCT01042236|20685444|P4|COMPLETED|Treatment Period 1||5
8393181|NCT01042236|20685445|P3|COMPLETED|Treatment Period 1||3
8393182|NCT01042236|20685446|P2|COMPLETED|Treatment Period 1||3
8393183|NCT01042236|20685447|P1|COMPLETED|Treatment Period 1||3
8393184|NCT01042236|20685442|P6|STARTED|Treatment Period 1||3
8393185|NCT01042236|20685443|P5|STARTED|Treatment Period 1||4
8393186|NCT01042236|20685444|P4|STARTED|Treatment Period 1||5
8393187|NCT01042236|20685445|P3|STARTED|Treatment Period 1||3
8393188|NCT01042236|20685446|P2|STARTED|Treatment Period 1||4
8393189|NCT01042236|20685447|P1|STARTED|Treatment Period 1||3
8393190|NCT01042158|20685484|P1|NOT COMPLETED|Overall Study||1
8393191|NCT01042158|20685484|P1|COMPLETED|Overall Study||24
8393192|NCT01042158|20685484|P1|STARTED|Overall Study||25
8393193|NCT01042145|20685493|P2|NOT COMPLETED|Overall Study||1
8393194|NCT01042145|20685494|P1|NOT COMPLETED|Overall Study||1
8393195|NCT01042145|20685493|P2|COMPLETED|Overall Study||45
8393196|NCT01042145|20685494|P1|COMPLETED|Overall Study||40
8393197|NCT01042145|20685493|P2|STARTED|Overall Study||46
8393198|NCT01042145|20685494|P1|STARTED|Overall Study||41
8393199|NCT01042093|20685514|P4|NOT COMPLETED|Overall Study||4
8393200|NCT01042093|20685515|P3|NOT COMPLETED|Overall Study||2
8393201|NCT01042093|20685516|P2|NOT COMPLETED|Overall Study||2
8393202|NCT01042093|20685517|P1|NOT COMPLETED|Overall Study||2
8393203|NCT01042093|20685514|P4|COMPLETED|Overall Study||36
8393204|NCT01042093|20685515|P3|COMPLETED|Overall Study||38
8393205|NCT01042093|20685516|P2|COMPLETED|Overall Study||38
8393206|NCT01042093|20685517|P1|COMPLETED|Overall Study||38
8393207|NCT01042093|20685514|P4|STARTED|Overall Study||40
8393208|NCT01042093|20685515|P3|STARTED|Overall Study||40
8393209|NCT01042093|20685516|P2|STARTED|Overall Study||40
8393210|NCT01042093|20685517|P1|STARTED|Overall Study||40
8393211|NCT01041976|20685537|P2|NOT COMPLETED|Overall Study||4
8393212|NCT01041976|20685538|P1|NOT COMPLETED|Overall Study||5
8393213|NCT01041976|20685537|P2|COMPLETED|Overall Study||38
8393214|NCT01041976|20685538|P1|COMPLETED|Overall Study||37
8393215|NCT01041976|20685537|P2|18 Month Follow-up|Overall Study||38
8393216|NCT01041976|20685538|P1|18 Month Follow-up|Overall Study||37
8393217|NCT01041976|20685537|P2|12 Month Follow-up|Overall Study||38
8393218|NCT01041976|20685538|P1|12 Month Follow-up|Overall Study||37
8393219|NCT01041976|20685537|P2|6 Month Follow-up|Overall Study||41
8393220|NCT01041976|20685538|P1|6 Month Follow-up|Overall Study||39
8393221|NCT01041976|20685537|P2|STARTED|Overall Study||42
8393222|NCT01041976|20685538|P1|STARTED|Overall Study||42
8393223|NCT01041859|20685548|P3|NOT COMPLETED|Double-Blind Maintenance||45
8393224|NCT01041859|20685549|P2|NOT COMPLETED|Double-Blind Maintenance||46
8393225|NCT01041859|20685550|P1|NOT COMPLETED|Double-Blind Maintenance||0
8393226|NCT01041859|20685548|P3|COMPLETED|Double-Blind Maintenance||107
8393227|NCT01041859|20685549|P2|COMPLETED|Double-Blind Maintenance||120
8393228|NCT01041859|20685550|P1|COMPLETED|Double-Blind Maintenance||0
8393229|NCT01041859|20685548|P3|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
8393230|NCT01041859|20685549|P2|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
8393231|NCT01041859|20685550|P1|STARTED|Double-Blind Maintenance||0
8393232|NCT01041859|20685548|P3|NOT COMPLETED|Open-Label Titration||0
8393233|NCT01041859|20685549|P2|NOT COMPLETED|Open-Label Titration||0
8393234|NCT01041859|20685550|P1|NOT COMPLETED|Open-Label Titration||101
8393235|NCT01041859|20685548|P3|COMPLETED|Open-Label Titration||0
8393236|NCT01041859|20685549|P2|COMPLETED|Open-Label Titration||0
8393237|NCT01041859|20685550|P1|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
8393238|NCT01041859|20685548|P3|STARTED|Open-Label Titration||0
8393239|NCT01041859|20685549|P2|STARTED|Open-Label Titration||0
8393240|NCT01041859|20685550|P1|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
8393241|NCT01041781|20685567|P2|NOT COMPLETED|Overall Study||0
8393242|NCT01041781|20685568|P1|NOT COMPLETED|Overall Study||0
8393243|NCT01041781|20685567|P2|COMPLETED|Overall Study||158
8393244|NCT01041781|20685568|P1|COMPLETED|Overall Study||154
8393245|NCT01041781|20685567|P2|STARTED|Overall Study||158
8393246|NCT01041781|20685568|P1|STARTED|Overall Study||154
8393262|NCT01041521|20685611|P2|NOT COMPLETED|Overall Study||16
8393263|NCT01041521|20685612|P1|NOT COMPLETED|Overall Study||17
8393264|NCT01041521|20685611|P2|COMPLETED|Overall Study||40
8393265|NCT01041521|20685612|P1|COMPLETED|Overall Study||44
8393266|NCT01041521|20685611|P2|STARTED|Overall Study||56
8393267|NCT01041521|20685612|P1|STARTED|Overall Study||61
8393268|NCT01041417|20685622|P2|NOT COMPLETED|Overall Study||3
8393269|NCT01041417|20685623|P1|NOT COMPLETED|Overall Study||7
8393270|NCT01041417|20685622|P2|COMPLETED|Overall Study||76
8393271|NCT01041417|20685623|P1|COMPLETED|Overall Study||73
8393272|NCT01041417|20685622|P2|STARTED|Overall Study||79
8393273|NCT01041417|20685623|P1|STARTED|Overall Study||80
8393274|NCT01041404|20685661|P2|NOT COMPLETED|Overall Study||294
8393275|NCT01041404|20685662|P1|NOT COMPLETED|Overall Study||290
8393276|NCT01041404|20685661|P2|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
8393277|NCT01041404|20685662|P1|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
8393278|NCT01041404|20685661|P2|Alive in Follow-up|Overall Study||41
8393279|NCT01041404|20685662|P1|Alive in Follow-up|Overall Study||40
8393280|NCT01041404|20685661|P2|Lost to Follow-up|Overall Study||10
8393281|NCT01041404|20685662|P1|Lost to Follow-up|Overall Study||12
8393282|NCT01041404|20685661|P2|Died in Follow-up|Overall Study||200
8393283|NCT01041404|20685662|P1|Died in Follow-up|Overall Study||199
8393284|NCT01041404|20685661|P2|Entered Follow-Up|Overall Study||251
8393285|NCT01041404|20685662|P1|Entered Follow-Up|Overall Study||251
8393286|NCT01041404|20685661|P2|STARTED|Overall Study||294
8393287|NCT01041404|20685662|P1|STARTED|Overall Study||290
8393288|NCT01041287|20685703|P2|NOT COMPLETED|Treatment Period 2 (3 Months)||5
8393289|NCT01041287|20685704|P1|NOT COMPLETED|Treatment Period 2 (3 Months)||3
8393290|NCT01041287|20685703|P2|COMPLETED|Treatment Period 2 (3 Months)||14
8393291|NCT01041287|20685704|P1|COMPLETED|Treatment Period 2 (3 Months)||16
8393292|NCT01041287|20685703|P2|STARTED|Treatment Period 2 (3 Months)||19
8393293|NCT01041287|20685704|P1|STARTED|Treatment Period 2 (3 Months)||19
8393294|NCT01041287|20685703|P2|NOT COMPLETED|Treatment Period 1 (3 Months)||0
8393295|NCT01041287|20685704|P1|NOT COMPLETED|Treatment Period 1 (3 Months)||0
8393296|NCT01041287|20685703|P2|COMPLETED|Treatment Period 1 (3 Months)||19
8393297|NCT01041287|20685704|P1|COMPLETED|Treatment Period 1 (3 Months)||19
8393298|NCT01041287|20685703|P2|STARTED|Treatment Period 1 (3 Months)||19
8393299|NCT01041287|20685704|P1|STARTED|Treatment Period 1 (3 Months)||19
8393300|NCT01041274|20685716|P2|NOT COMPLETED|Overall Study||21
8393301|NCT01041274|20685717|P1|NOT COMPLETED|Overall Study||23
8393302|NCT01041274|20685716|P2|COMPLETED|Overall Study||25
8393303|NCT01041274|20685717|P1|COMPLETED|Overall Study||26
8393304|NCT01041274|20685716|P2|STARTED|Overall Study||46
8393305|NCT01041274|20685717|P1|STARTED|Overall Study||49
8393306|NCT01041209|20685733|P2|NOT COMPLETED|Overall Study||0
8393307|NCT01041209|20685734|P1|NOT COMPLETED|Overall Study||0
8393308|NCT01041209|20685733|P2|COMPLETED|Overall Study||60
8393309|NCT01041209|20685734|P1|COMPLETED|Overall Study||60
8393310|NCT01041209|20685733|P2|STARTED|Overall Study||60
8393311|NCT01041209|20685734|P1|STARTED|Overall Study||60
8393312|NCT01040871|20685744|P2|NOT COMPLETED|Overall Study||7
8393313|NCT01040871|20685745|P1|NOT COMPLETED|Overall Study||13
8393314|NCT01040871|20685744|P2|COMPLETED|Overall Study||73
8393315|NCT01040871|20685745|P1|COMPLETED|Overall Study||71
8393316|NCT01040871|20685744|P2|STARTED|Overall Study|Intent to Treat, Randomized|80
8393317|NCT01040871|20685745|P1|STARTED|Overall Study|Intent to Treat, Randomized|84
8393318|NCT01040858|20685765|P2|NOT COMPLETED|Overall Study||0
8393319|NCT01040858|20685766|P1|NOT COMPLETED|Overall Study||9
8393320|NCT01040858|20685765|P2|COMPLETED|Overall Study||69
8393321|NCT01040858|20685766|P1|COMPLETED|Overall Study||50
8393322|NCT01040858|20685765|P2|STARTED|Overall Study||69
8393323|NCT01040858|20685766|P1|STARTED|Overall Study||59
8393324|NCT01040845|20685796|P2|NOT COMPLETED|Overall Study||1
8393325|NCT01040845|20685797|P1|NOT COMPLETED|Overall Study||2
8393326|NCT01040845|20685796|P2|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
8393327|NCT01040845|20685797|P1|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
8393328|NCT01040845|20685796|P2|STARTED|Overall Study||15
8393329|NCT01040845|20685797|P1|STARTED|Overall Study||15
8393330|NCT01040832|20685812|P2|NOT COMPLETED|Overall Study||37
8393331|NCT01040832|20685813|P1|NOT COMPLETED|Overall Study||46
8393332|NCT01040832|20685812|P2|COMPLETED|Overall Study||16
8393333|NCT01040832|20685813|P1|COMPLETED|Overall Study||8
8393334|NCT01040832|20685812|P2|STARTED|Overall Study||53
8393335|NCT01040832|20685813|P1|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
8393336|NCT01040819|20685829|P2|NOT COMPLETED|Overall Study||0
8393337|NCT01040819|20685830|P1|NOT COMPLETED|Overall Study||0
8393338|NCT01040819|20685829|P2|COMPLETED|Overall Study||12
8393339|NCT01040819|20685830|P1|COMPLETED|Overall Study||13
8393340|NCT01040819|20685829|P2|STARTED|Overall Study||12
8393341|NCT01040819|20685830|P1|STARTED|Overall Study||13
8393342|NCT01040793|20685836|P6|NOT COMPLETED|Overall Study||1
8393343|NCT01040793|20685837|P5|NOT COMPLETED|Overall Study||4
8393344|NCT01040793|20685838|P4|NOT COMPLETED|Overall Study||4
8393345|NCT01040793|20685839|P3|NOT COMPLETED|Overall Study||3
8393346|NCT01040793|20685840|P2|NOT COMPLETED|Overall Study||5
8393347|NCT01040793|20685841|P1|NOT COMPLETED|Overall Study||6
8393348|NCT01040793|20685836|P6|COMPLETED|Overall Study||26
8393349|NCT01040793|20685837|P5|COMPLETED|Overall Study||22
8393350|NCT01040793|20685838|P4|COMPLETED|Overall Study||22
8393351|NCT01040793|20685839|P3|COMPLETED|Overall Study||23
8393352|NCT01040793|20685840|P2|COMPLETED|Overall Study||21
8393353|NCT01040793|20685841|P1|COMPLETED|Overall Study||20
8393354|NCT01040793|20685836|P6|STARTED|Overall Study||27
8393355|NCT01040793|20685837|P5|STARTED|Overall Study||26
8393356|NCT01040793|20685838|P4|STARTED|Overall Study||26
8393357|NCT01040793|20685839|P3|STARTED|Overall Study||26
8393358|NCT01040793|20685840|P2|STARTED|Overall Study||26
8393359|NCT01040793|20685841|P1|STARTED|Overall Study|Entered and treated|26
8393360|NCT01040780|20685920|P2|NOT COMPLETED|Overall Study||3
8393361|NCT01040780|20685921|P1|NOT COMPLETED|Overall Study||1
8393362|NCT01040780|20685920|P2|COMPLETED|Overall Study||196
8393363|NCT01040780|20685921|P1|COMPLETED|Overall Study||199
8393364|NCT01040780|20685920|P2|STARTED|Overall Study||199
8393365|NCT01040780|20685921|P1|STARTED|Overall Study||200
8393366|NCT01040728|20685935|P4|NOT COMPLETED|Overall Study||6
8393367|NCT01040728|20685936|P3|NOT COMPLETED|Overall Study||1
8393368|NCT01040728|20685937|P2|NOT COMPLETED|Overall Study||11
8393369|NCT01040728|20685938|P1|NOT COMPLETED|Overall Study||4
8393370|NCT01040728|20685935|P4|COMPLETED|Overall Study||24
8393371|NCT01040728|20685936|P3|COMPLETED|Overall Study||30
8393372|NCT01040728|20685937|P2|COMPLETED|Overall Study||19
8393373|NCT01040728|20685938|P1|COMPLETED|Overall Study||27
8393374|NCT01040728|20685935|P4|STARTED|Overall Study||30
8393375|NCT01040728|20685936|P3|STARTED|Overall Study||31
8393376|NCT01040728|20685937|P2|STARTED|Overall Study||30
8393377|NCT01040728|20685938|P1|STARTED|Overall Study||31
8393378|NCT01040689|20686008|P4|NOT COMPLETED|Overall Study||4
8393379|NCT01040689|20686009|P3|NOT COMPLETED|Overall Study||4
8393380|NCT01040689|20686010|P2|NOT COMPLETED|Overall Study||2
8393381|NCT01040689|20686011|P1|NOT COMPLETED|Overall Study||3
8393382|NCT01040689|20686008|P4|COMPLETED|Overall Study||23
8393383|NCT01040689|20686009|P3|COMPLETED|Overall Study||23
8393384|NCT01040689|20686010|P2|COMPLETED|Overall Study||25
8393385|NCT01040689|20686011|P1|COMPLETED|Overall Study||24
8393386|NCT01040689|20686008|P4|STARTED|Overall Study||27
8393387|NCT01040689|20686009|P3|STARTED|Overall Study||27
8393388|NCT01040689|20686010|P2|STARTED|Overall Study||27
8393389|NCT01040689|20686011|P1|STARTED|Overall Study||27
8393390|NCT01040624|20686083|P2|NOT COMPLETED|Overall Study||0
8393391|NCT01040624|20686084|P1|NOT COMPLETED|Overall Study||0
8393392|NCT01040624|20686083|P2|COMPLETED|Overall Study||19
8393393|NCT01040624|20686084|P1|COMPLETED|Overall Study||58
8393394|NCT01040624|20686083|P2|STARTED|Overall Study||19
8393395|NCT01040624|20686084|P1|STARTED|Overall Study||58
8393396|NCT01040403|20686090|P1|NOT COMPLETED|Overall Study||20
8393397|NCT01040403|20686090|P1|COMPLETED|Overall Study|All treatment periods|213
8393398|NCT01040403|20686090|P1|Completed T+O 5/10|Overall Study||107
8393399|NCT01040403|20686090|P1|Completed T+O 2.5/10|Overall Study||110
8393400|NCT01040403|20686090|P1|Completed T+O 1.25/10|Overall Study||106
8393401|NCT01040403|20686090|P1|Completed Olo 10|Overall Study||109
8393402|NCT01040403|20686090|P1|Completed T+O 5/5|Overall Study||106
8393403|NCT01040403|20686090|P1|Completed T+O 2.5/5|Overall Study||111
8393404|NCT01040403|20686090|P1|Completed T+O 1.25/5|Overall Study||105
8393405|NCT01040403|20686090|P1|Completed Olo 5|Overall Study||106
8393406|NCT01040403|20686090|P1|STARTED|Overall Study||233
8393407|NCT01040351|20686278|P2|NOT COMPLETED|Overall Study||2
8393408|NCT01040351|20686279|P1|NOT COMPLETED|Overall Study||1
8393409|NCT01040351|20686278|P2|COMPLETED|Overall Study|May 2010|53
8393410|NCT01040351|20686279|P1|COMPLETED|Overall Study|May 2010|54
8393411|NCT01040351|20686278|P2|STARTED|Overall Study|October 2006|55
8393412|NCT01040351|20686279|P1|STARTED|Overall Study|October 2006|55
8393413|NCT01040260|20686289|P2|NOT COMPLETED|Overall Study||11
8393414|NCT01040260|20686290|P1|NOT COMPLETED|Overall Study||15
8393415|NCT01040260|20686289|P2|COMPLETED|Overall Study||39
8393416|NCT01040260|20686290|P1|COMPLETED|Overall Study||38
8393417|NCT01040260|20686289|P2|STARTED|Overall Study||50
8393418|NCT01040260|20686290|P1|STARTED|Overall Study||53
8393419|NCT01040208|20686299|P3|NOT COMPLETED|Overall Study||3
8393420|NCT01040208|20686300|P2|NOT COMPLETED|Overall Study||13
8393421|NCT01040208|20686301|P1|NOT COMPLETED|Overall Study||6
8393422|NCT01040208|20686299|P3|COMPLETED|Overall Study||35
8393423|NCT01040208|20686300|P2|COMPLETED|Overall Study||15
8393424|NCT01040208|20686301|P1|COMPLETED|Overall Study||39
8393425|NCT01040208|20686299|P3|STARTED|Overall Study||38
8393426|NCT01040208|20686300|P2|STARTED|Overall Study||28
8393427|NCT01040208|20686301|P1|STARTED|Overall Study||45
8393428|NCT01040169|20686317|P2|NOT COMPLETED|Overall Study||8
8393429|NCT01040169|20686318|P1|NOT COMPLETED|Overall Study||3
8393430|NCT01040169|20686317|P2|COMPLETED|Overall Study||36
8393431|NCT01040169|20686318|P1|COMPLETED|Overall Study||32
8393432|NCT01040169|20686317|P2|STARTED|Overall Study||44
8393433|NCT01040169|20686318|P1|STARTED|Overall Study||35
8393434|NCT01040130|20686326|P6|NOT COMPLETED|Overall Study||4
8393435|NCT01040130|20686327|P5|NOT COMPLETED|Overall Study||0
8393436|NCT01040130|20686328|P4|NOT COMPLETED|Overall Study||5
8393437|NCT01040130|20686329|P3|NOT COMPLETED|Overall Study||2
8393438|NCT01040130|20686330|P2|NOT COMPLETED|Overall Study||3
8393439|NCT01040130|20686331|P1|NOT COMPLETED|Overall Study||3
8393440|NCT01040130|20686326|P6|COMPLETED|Overall Study||22
8393441|NCT01040130|20686327|P5|COMPLETED|Overall Study||25
8393442|NCT01040130|20686328|P4|COMPLETED|Overall Study||20
8393443|NCT01040130|20686329|P3|COMPLETED|Overall Study||23
8393444|NCT01040130|20686330|P2|COMPLETED|Overall Study||22
8393445|NCT01040130|20686331|P1|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
8393446|NCT01040130|20686326|P6|STARTED|Overall Study||26
8393447|NCT01040130|20686327|P5|STARTED|Overall Study||25
8393448|NCT01040130|20686328|P4|STARTED|Overall Study||25
8393449|NCT01040130|20686329|P3|STARTED|Overall Study||25
8393450|NCT01040130|20686330|P2|STARTED|Overall Study||25
8393451|NCT01040130|20686331|P1|STARTED|Overall Study|Number of patients entered and treated|25
8393452|NCT01040052|20686408|P1|NOT COMPLETED|Overall Study||0
8393453|NCT01040052|20686408|P1|COMPLETED|Overall Study||30
8393454|NCT01040052|20686408|P1|STARTED|Overall Study||30
8393455|NCT01039792|20686414|P2|NOT COMPLETED|Overall Study||1
8393456|NCT01039792|20686415|P1|NOT COMPLETED|Overall Study||6
8393457|NCT01039792|20686414|P2|COMPLETED|Overall Study||27
8393458|NCT01039792|20686415|P1|COMPLETED|Overall Study||23
8393459|NCT01039792|20686414|P2|STARTED|Overall Study||28
8393460|NCT01039792|20686415|P1|STARTED|Overall Study||29
8393461|NCT01039688|20686424|P3|NOT COMPLETED|Overall Study||80
8393462|NCT01039688|20686425|P2|NOT COMPLETED|Overall Study||111
8393463|NCT01039688|20686426|P1|NOT COMPLETED|Overall Study||107
8393464|NCT01039688|20686424|P3|COMPLETED|Overall Study||106
8393465|NCT01039688|20686425|P2|COMPLETED|Overall Study||286
8393466|NCT01039688|20686426|P1|COMPLETED|Overall Study||266
8393467|NCT01039688|20686424|P3|STARTED|Overall Study||186
8393468|NCT01039688|20686425|P2|STARTED|Overall Study||397
8393469|NCT01039688|20686426|P1|STARTED|Overall Study||373
8393470|NCT01039675|20686697|P2|NOT COMPLETED|Overall Study||7
8393471|NCT01039675|20686698|P1|NOT COMPLETED|Overall Study||0
8393472|NCT01039675|20686697|P2|COMPLETED|Overall Study||35
8393473|NCT01039675|20686698|P1|COMPLETED|Overall Study||9
8393474|NCT01039675|20686697|P2|STARTED|Overall Study||42
8393475|NCT01039675|20686698|P1|STARTED|Overall Study||9
8393476|NCT01039584|20686711|P3|NOT COMPLETED|Overall Study||57
8393477|NCT01039584|20686712|P2|NOT COMPLETED|Overall Study||97
8393478|NCT01039584|20686713|P1|NOT COMPLETED|Overall Study||103
8393479|NCT01039584|20686711|P3|COMPLETED|Overall Study||65
8393480|NCT01039584|20686712|P2|COMPLETED|Overall Study||146
8393481|NCT01039584|20686713|P1|COMPLETED|Overall Study||143
8393482|NCT01039584|20686711|P3|STARTED|Overall Study||122
8393483|NCT01039584|20686712|P2|STARTED|Overall Study||243
8393484|NCT01039584|20686713|P1|STARTED|Overall Study||246
8393485|NCT01039519|20686727|P1|NOT COMPLETED|Survival Follow-up||27
8393486|NCT01039519|20686727|P1|COMPLETED|Survival Follow-up||0
8393487|NCT01039519|20686727|P1|STARTED|Survival Follow-up||27
8393488|NCT01039519|20686727|P1|NOT COMPLETED|Treatment||27
8393489|NCT01039519|20686727|P1|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
8393490|NCT01039519|20686727|P1|STARTED|Treatment||27
8393491|NCT01039467|20686738|P2|NOT COMPLETED|Overall Study||49
8393492|NCT01039467|20686739|P1|NOT COMPLETED|Overall Study||40
8393493|NCT01039467|20686738|P2|COMPLETED|Overall Study||140
8393494|NCT01039467|20686739|P1|COMPLETED|Overall Study||156
8393495|NCT01039467|20686738|P2|STARTED|Overall Study||189
8393496|NCT01039467|20686739|P1|STARTED|Overall Study||196
8393497|NCT01039428|20686763|P2|NOT COMPLETED|Overall Study||0
8393498|NCT01039428|20686764|P1|NOT COMPLETED|Overall Study||2
8393499|NCT01039428|20686763|P2|COMPLETED|Overall Study||28
8393500|NCT01039428|20686764|P1|COMPLETED|Overall Study||33
8393501|NCT01039428|20686763|P2|STARTED|Overall Study||28
8393502|NCT01039428|20686764|P1|STARTED|Overall Study||35
8393503|NCT01039376|20686788|P2|NOT COMPLETED|Overall Study||126
8393504|NCT01039376|20686789|P1|NOT COMPLETED|Overall Study||130
8393505|NCT01039376|20686788|P2|COMPLETED|Overall Study||114
8393506|NCT01039376|20686789|P1|COMPLETED|Overall Study||110
8393507|NCT01039376|20686788|P2|STARTED|Overall Study||240
8393508|NCT01039376|20686789|P1|STARTED|Overall Study||240
8393509|NCT01039207|20686848|P1|NOT COMPLETED|Overall Study||0
8393510|NCT01039207|20686848|P1|COMPLETED|Overall Study||31
8393511|NCT01039207|20686848|P1|STARTED|Overall Study||31
8393512|NCT01038921|20686858|P2|NOT COMPLETED|Overall Study||0
8393513|NCT01038921|20686859|P1|NOT COMPLETED|Overall Study||2
8393514|NCT01038921|20686858|P2|COMPLETED|Overall Study||20
8393515|NCT01038921|20686859|P1|COMPLETED|Overall Study|2 subjects withdrew|17
8393516|NCT01038921|20686858|P2|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
8393517|NCT01038921|20686859|P1|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
8393518|NCT01038869|20686865|P1|NOT COMPLETED|Overall Study||7
8393519|NCT01038869|20686865|P1|COMPLETED|Overall Study||13
8393520|NCT01038869|20686865|P1|STARTED|Overall Study||20
8393521|NCT01038856|20686873|P1|NOT COMPLETED|Overall Study||2
8393522|NCT01038856|20686873|P1|COMPLETED|Overall Study||3
8393523|NCT01038856|20686873|P1|STARTED|Overall Study||5
8393524|NCT01038752|20686882|P2|NOT COMPLETED|Overall Study||5
8393525|NCT01038752|20686883|P1|NOT COMPLETED|Overall Study||5
8393526|NCT01038752|20686882|P2|COMPLETED|Overall Study||1
8393527|NCT01038752|20686883|P1|COMPLETED|Overall Study||3
8393528|NCT01038752|20686882|P2|STARTED|Overall Study||6
8393529|NCT01038752|20686883|P1|STARTED|Overall Study||8
8393530|NCT01038713|20686906|P3|NOT COMPLETED|Overall Study||1
8393531|NCT01038713|20686907|P2|NOT COMPLETED|Overall Study||3
8393532|NCT01038713|20686908|P1|NOT COMPLETED|Overall Study||5
8393533|NCT01038713|20686906|P3|COMPLETED|Overall Study||16
8393534|NCT01038713|20686907|P2|COMPLETED|Overall Study||17
8393535|NCT01038713|20686908|P1|COMPLETED|Overall Study||21
8393536|NCT01038713|20686906|P3|STARTED|Overall Study||17
8393537|NCT01038713|20686907|P2|STARTED|Overall Study||20
8393538|NCT01038713|20686908|P1|STARTED|Overall Study||26
8393539|NCT01038687|20686931|P3|NOT COMPLETED|Overall Study||1
8393540|NCT01038687|20686932|P2|NOT COMPLETED|Overall Study||2
8393541|NCT01038687|20686933|P1|NOT COMPLETED|Overall Study||0
8393542|NCT01038687|20686931|P3|COMPLETED|Overall Study||12
8393543|NCT01038687|20686932|P2|COMPLETED|Overall Study||9
8393544|NCT01038687|20686933|P1|COMPLETED|Overall Study||12
8393545|NCT01038687|20686931|P3|STARTED|Overall Study||13
8393546|NCT01038687|20686932|P2|STARTED|Overall Study||11
8393547|NCT01038687|20686933|P1|STARTED|Overall Study||12
8393548|NCT01038635|20686974|P9|NOT COMPLETED|Overall Study||2
8393549|NCT01038635|20686975|P8|NOT COMPLETED|Overall Study||5
8393550|NCT01038635|20686976|P7|NOT COMPLETED|Overall Study||2
8393551|NCT01038635|20686977|P6|NOT COMPLETED|Overall Study||0
8393552|NCT01038635|20686978|P5|NOT COMPLETED|Overall Study||1
8393553|NCT01038635|20686979|P4|NOT COMPLETED|Overall Study||0
8393554|NCT01038635|20686980|P3|NOT COMPLETED|Overall Study||0
8393555|NCT01038635|20686981|P2|NOT COMPLETED|Overall Study||0
8393556|NCT01038635|20686982|P1|NOT COMPLETED|Overall Study||2
8393557|NCT01038635|20686974|P9|COMPLETED|Overall Study||38
8393558|NCT01038635|20686975|P8|COMPLETED|Overall Study||15
8393559|NCT01038635|20686976|P7|COMPLETED|Overall Study||5
8393560|NCT01038635|20686977|P6|COMPLETED|Overall Study||3
8393561|NCT01038635|20686978|P5|COMPLETED|Overall Study||3
8393562|NCT01038635|20686979|P4|COMPLETED|Overall Study||3
8393563|NCT01038635|20686980|P3|COMPLETED|Overall Study||3
8393564|NCT01038635|20686981|P2|COMPLETED|Overall Study||3
8393565|NCT01038635|20686982|P1|COMPLETED|Overall Study||3
8393566|NCT01038635|20686974|P9|STARTED|Overall Study||40
8393567|NCT01038635|20686975|P8|STARTED|Overall Study||20
8393568|NCT01038635|20686976|P7|STARTED|Overall Study||7
8393569|NCT01038635|20686977|P6|STARTED|Overall Study||3
8393570|NCT01038635|20686978|P5|STARTED|Overall Study||4
8393571|NCT01038635|20686979|P4|STARTED|Overall Study||3
8393572|NCT01038635|20686980|P3|STARTED|Overall Study||3
8393573|NCT01038635|20686981|P2|STARTED|Overall Study||3
8393574|NCT01038635|20686982|P1|STARTED|Overall Study||5
8393575|NCT01038609|20687008|P5|NOT COMPLETED|Overall Study||1
8393576|NCT01038609|20687009|P4|NOT COMPLETED|Overall Study||1
8393577|NCT01038609|20687010|P3|NOT COMPLETED|Overall Study||1
8393578|NCT01038609|20687011|P2|NOT COMPLETED|Overall Study||1
8393579|NCT01038609|20687012|P1|NOT COMPLETED|Overall Study||1
8393580|NCT01038609|20687008|P5|COMPLETED|Overall Study||50
8393581|NCT01038609|20687009|P4|COMPLETED|Overall Study||47
8393582|NCT01038609|20687010|P3|COMPLETED|Overall Study||48
8393583|NCT01038609|20687011|P2|COMPLETED|Overall Study||51
8393584|NCT01038609|20687012|P1|COMPLETED|Overall Study||49
8393585|NCT01038609|20687008|P5|STARTED|Overall Study||51
8393586|NCT01038609|20687009|P4|STARTED|Overall Study||48
8393587|NCT01038609|20687010|P3|STARTED|Overall Study||49
8393588|NCT01038609|20687011|P2|STARTED|Overall Study||52
8393589|NCT01038609|20687012|P1|STARTED|Overall Study||50
8393590|NCT01038557|20687057|P3|NOT COMPLETED|Overall Study||0
8393591|NCT01038557|20687058|P2|NOT COMPLETED|Overall Study||0
8393592|NCT01038557|20687059|P1|NOT COMPLETED|Overall Study||0
8393593|NCT01038557|20687057|P3|COMPLETED|Overall Study||86
8393594|NCT01038557|20687058|P2|COMPLETED|Overall Study||86
8393595|NCT01038557|20687059|P1|COMPLETED|Overall Study||82
8393596|NCT01038557|20687057|P3|STARTED|Overall Study||86
8393597|NCT01038557|20687058|P2|STARTED|Overall Study||86
8393598|NCT01038557|20687059|P1|STARTED|Overall Study||82
8393599|NCT01038336|20687097|P3|NOT COMPLETED|Overall Study||0
8393600|NCT01038336|20687098|P2|NOT COMPLETED|Overall Study||0
8393601|NCT01038336|20687099|P1|NOT COMPLETED|Overall Study||0
8393602|NCT01038336|20687097|P3|COMPLETED|Overall Study||44
8393603|NCT01038336|20687098|P2|COMPLETED|Overall Study||42
8393604|NCT01038336|20687099|P1|COMPLETED|Overall Study||43
8393605|NCT01038336|20687097|P3|STARTED|Overall Study||44
8393606|NCT01038336|20687098|P2|STARTED|Overall Study||42
8393607|NCT01038336|20687099|P1|STARTED|Overall Study||43
8393608|NCT01038323|20687131|P3|NOT COMPLETED|Overall Study||4
8393609|NCT01038323|20687132|P2|NOT COMPLETED|Overall Study||2
8393610|NCT01038323|20687133|P1|NOT COMPLETED|Overall Study||3
8393611|NCT01038323|20687131|P3|COMPLETED|Overall Study||15
8393612|NCT01038323|20687132|P2|COMPLETED|Overall Study||17
8393613|NCT01038323|20687133|P1|COMPLETED|Overall Study||17
8393614|NCT01038323|20687131|P3|STARTED|Overall Study||19
8393615|NCT01038323|20687132|P2|STARTED|Overall Study||19
8393616|NCT01038323|20687133|P1|STARTED|Overall Study||20
8393617|NCT01038128|20687147|P1|NOT COMPLETED|Overall Study||4
8393618|NCT01038128|20687147|P1|COMPLETED|Overall Study||1
8393619|NCT01038128|20687147|P1|Baseline Visit|Overall Study||3
8393620|NCT01038128|20687147|P1|STARTED|Overall Study||5
8393621|NCT01037881|20687162|P7|NOT COMPLETED|Overall Study||2
8393622|NCT01037881|20687163|P6|NOT COMPLETED|Overall Study||3
8393623|NCT01037881|20687164|P5|NOT COMPLETED|Overall Study||3
8393624|NCT01037881|20687165|P4|NOT COMPLETED|Overall Study||1
8393625|NCT01037881|20687166|P3|NOT COMPLETED|Overall Study||3
8393626|NCT01037881|20687167|P2|NOT COMPLETED|Overall Study||2
8393627|NCT01037881|20687168|P1|NOT COMPLETED|Overall Study||6
8393628|NCT01037881|20687162|P7|COMPLETED|Overall Study||23
8393629|NCT01037881|20687163|P6|COMPLETED|Overall Study||27
8393630|NCT01037881|20687164|P5|COMPLETED|Overall Study||26
8393631|NCT01037881|20687165|P4|COMPLETED|Overall Study||24
8393632|NCT01037881|20687166|P3|COMPLETED|Overall Study||22
8393633|NCT01037881|20687167|P2|COMPLETED|Overall Study||22
8393634|NCT01037881|20687168|P1|COMPLETED|Overall Study||19
8393635|NCT01037881|20687162|P7|STARTED|Overall Study||25
8393636|NCT01037881|20687163|P6|STARTED|Overall Study||30
8393637|NCT01037881|20687164|P5|STARTED|Overall Study||29
8393638|NCT01037881|20687165|P4|STARTED|Overall Study||25
8393639|NCT01037881|20687166|P3|STARTED|Overall Study||25
8393640|NCT01037881|20687167|P2|STARTED|Overall Study||24
8393641|NCT01037881|20687168|P1|STARTED|Overall Study||25
8393642|NCT01037452|20687230|P4|NOT COMPLETED|Overall Study||0
8393643|NCT01037452|20687231|P3|NOT COMPLETED|Overall Study||0
8393644|NCT01037452|20687232|P2|NOT COMPLETED|Overall Study||0
8393645|NCT01037452|20687233|P1|NOT COMPLETED|Overall Study||0
8393646|NCT01037452|20687230|P4|COMPLETED|Overall Study||30
8393647|NCT01037452|20687231|P3|COMPLETED|Overall Study||30
8393648|NCT01037452|20687232|P2|COMPLETED|Overall Study||30
8393649|NCT01037452|20687233|P1|COMPLETED|Overall Study||30
8393650|NCT01037452|20687230|P4|STARTED|Overall Study||30
8393651|NCT01037452|20687231|P3|STARTED|Overall Study||30
8393652|NCT01037452|20687232|P2|STARTED|Overall Study||30
8393653|NCT01037452|20687233|P1|STARTED|Overall Study||30
8393654|NCT01037309|20687261|P9|NOT COMPLETED|Intravenous Period 7 - 9||0
8393655|NCT01037309|20687262|P8|NOT COMPLETED|Intravenous Period 7 - 9||0
8393656|NCT01037309|20687263|P7|NOT COMPLETED|Intravenous Period 7 - 9||0
8393657|NCT01037309|20687264|P6|NOT COMPLETED|Intravenous Period 7 - 9||0
8393658|NCT01037309|20687265|P5|NOT COMPLETED|Intravenous Period 7 - 9||0
8393659|NCT01037309|20687266|P4|NOT COMPLETED|Intravenous Period 7 - 9||0
8393660|NCT01037309|20687267|P3|NOT COMPLETED|Intravenous Period 7 - 9||0
8393661|NCT01037309|20687268|P2|NOT COMPLETED|Intravenous Period 7 - 9||0
8393662|NCT01037309|20687269|P1|NOT COMPLETED|Intravenous Period 7 - 9||0
8393663|NCT01037309|20687261|P9|COMPLETED|Intravenous Period 7 - 9||3
8393664|NCT01037309|20687262|P8|COMPLETED|Intravenous Period 7 - 9||3
8393665|NCT01037309|20687263|P7|COMPLETED|Intravenous Period 7 - 9||3
8393666|NCT01037309|20687264|P6|COMPLETED|Intravenous Period 7 - 9||0
8393667|NCT01037309|20687265|P5|COMPLETED|Intravenous Period 7 - 9||0
8393668|NCT01037309|20687266|P4|COMPLETED|Intravenous Period 7 - 9||0
8393669|NCT01037309|20687267|P3|COMPLETED|Intravenous Period 7 - 9||0
8393670|NCT01037309|20687268|P2|COMPLETED|Intravenous Period 7 - 9||0
8393671|NCT01037309|20687269|P1|COMPLETED|Intravenous Period 7 - 9||0
8393672|NCT01037309|20687261|P9|STARTED|Intravenous Period 7 - 9||3
8393673|NCT01037309|20687262|P8|STARTED|Intravenous Period 7 - 9||3
8393674|NCT01037309|20687263|P7|STARTED|Intravenous Period 7 - 9||3
8393675|NCT01037309|20687264|P6|STARTED|Intravenous Period 7 - 9||0
8393676|NCT01037309|20687265|P5|STARTED|Intravenous Period 7 - 9||0
8393677|NCT01037309|20687266|P4|STARTED|Intravenous Period 7 - 9||0
8393678|NCT01037309|20687267|P3|STARTED|Intravenous Period 7 - 9||0
8393679|NCT01037309|20687268|P2|STARTED|Intravenous Period 7 - 9||0
8393680|NCT01037309|20687269|P1|STARTED|Intravenous Period 7 - 9||0
8393681|NCT01037309|20687261|P9|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393682|NCT01037309|20687262|P8|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393683|NCT01037309|20687263|P7|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393684|NCT01037309|20687264|P6|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393685|NCT01037309|20687265|P5|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393686|NCT01037309|20687266|P4|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393687|NCT01037309|20687267|P3|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393688|NCT01037309|20687268|P2|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393689|NCT01037309|20687269|P1|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
8393690|NCT01037309|20687261|P9|COMPLETED|Subcutaneous Cohort 1 - 6||0
8393691|NCT01037309|20687262|P8|COMPLETED|Subcutaneous Cohort 1 - 6||0
8393692|NCT01037309|20687263|P7|COMPLETED|Subcutaneous Cohort 1 - 6||0
8393693|NCT01037309|20687264|P6|COMPLETED|Subcutaneous Cohort 1 - 6||3
8393694|NCT01037309|20687265|P5|COMPLETED|Subcutaneous Cohort 1 - 6||3
8393695|NCT01037309|20687266|P4|COMPLETED|Subcutaneous Cohort 1 - 6||3
8393696|NCT01037309|20687267|P3|COMPLETED|Subcutaneous Cohort 1 - 6||3
8393697|NCT01037309|20687268|P2|COMPLETED|Subcutaneous Cohort 1 - 6||3
8393698|NCT01037309|20687269|P1|COMPLETED|Subcutaneous Cohort 1 - 6||3
8393699|NCT01037309|20687261|P9|STARTED|Subcutaneous Cohort 1 - 6||0
8393700|NCT01037309|20687262|P8|STARTED|Subcutaneous Cohort 1 - 6||0
8393701|NCT01037309|20687263|P7|STARTED|Subcutaneous Cohort 1 - 6||0
8393702|NCT01037309|20687264|P6|STARTED|Subcutaneous Cohort 1 - 6||3
8393703|NCT01037309|20687265|P5|STARTED|Subcutaneous Cohort 1 - 6||3
8393704|NCT01037309|20687266|P4|STARTED|Subcutaneous Cohort 1 - 6||3
8393705|NCT01037309|20687267|P3|STARTED|Subcutaneous Cohort 1 - 6||3
8393706|NCT01037309|20687268|P2|STARTED|Subcutaneous Cohort 1 - 6||3
8393707|NCT01037309|20687269|P1|STARTED|Subcutaneous Cohort 1 - 6||3
8393708|NCT01037244|20687311|P4|NOT COMPLETED|Overall Study||14
8393709|NCT01037244|20687312|P3|NOT COMPLETED|Overall Study||14
8393710|NCT01037244|20687313|P2|NOT COMPLETED|Overall Study||14
8393711|NCT01037244|20687314|P1|NOT COMPLETED|Overall Study||13
8393712|NCT01037244|20687311|P4|COMPLETED|Overall Study||140
8393713|NCT01037244|20687312|P3|COMPLETED|Overall Study||144
8393714|NCT01037244|20687313|P2|COMPLETED|Overall Study||138
8393715|NCT01037244|20687314|P1|COMPLETED|Overall Study||141
8393716|NCT01037244|20687311|P4|Safety Population|Overall Study||152
8393717|NCT01037244|20687312|P3|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
8393718|NCT01037244|20687313|P2|Safety Population|Overall Study||150
8393719|NCT01037244|20687314|P1|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
8393720|NCT01037244|20687311|P4|mITT (Modified Intent-to-Treat)|Overall Study||153
8393721|NCT01037244|20687312|P3|mITT (Modified Intent-to-Treat)|Overall Study||154
8393722|NCT01037244|20687313|P2|mITT (Modified Intent-to-Treat)|Overall Study||148
8393723|NCT01037244|20687314|P1|mITT (Modified Intent-to-Treat)|Overall Study||150
8393724|NCT01037244|20687311|P4|STARTED|Overall Study||154
8393725|NCT01037244|20687312|P3|STARTED|Overall Study||158
8393726|NCT01037244|20687313|P2|STARTED|Overall Study||152
8393727|NCT01037244|20687314|P1|STARTED|Overall Study||154
8393728|NCT01037218|20687376|P4|NOT COMPLETED|Overall Study||16
8393729|NCT01037218|20687377|P3|NOT COMPLETED|Overall Study||21
8393730|NCT01037218|20687378|P2|NOT COMPLETED|Overall Study||21
8393731|NCT01037218|20687379|P1|NOT COMPLETED|Overall Study||16
8393732|NCT01037218|20687376|P4|COMPLETED|Overall Study||134
8393733|NCT01037218|20687377|P3|COMPLETED|Overall Study||134
8393734|NCT01037218|20687378|P2|COMPLETED|Overall Study||128
8393735|NCT01037218|20687379|P1|COMPLETED|Overall Study||131
8393736|NCT01037218|20687376|P4|mITT Population|Overall Study||141
8393737|NCT01037218|20687377|P3|mITT Population|Overall Study||147
8393738|NCT01037218|20687378|P2|mITT Population|Overall Study||140
8393739|NCT01037218|20687379|P1|mITT Population|Overall Study||141
8393740|NCT01037218|20687376|P4|Safety Population|Overall Study||150
8393741|NCT01037218|20687377|P3|Safety Population|Overall Study||154
8393742|NCT01037218|20687378|P2|Safety Population|Overall Study||148
8393743|NCT01037218|20687379|P1|Safety Population|Overall Study||147
8393744|NCT01037218|20687376|P4|STARTED|Overall Study||150
8393745|NCT01037218|20687377|P3|STARTED|Overall Study||155
8393746|NCT01037218|20687378|P2|STARTED|Overall Study||149
8393747|NCT01037218|20687379|P1|STARTED|Overall Study||147
8393748|NCT01037192|20687439|P2|NOT COMPLETED|Overall Study||0
8393749|NCT01037192|20687440|P1|NOT COMPLETED|Overall Study||0
8393750|NCT01037192|20687439|P2|COMPLETED|Overall Study||1
8393751|NCT01037192|20687440|P1|COMPLETED|Overall Study||3
8393752|NCT01037192|20687439|P2|STARTED|Overall Study||1
8393753|NCT01037192|20687440|P1|STARTED|Overall Study||3
8393754|NCT01037127|20687450|P2|NOT COMPLETED|Overall Study||21
8393755|NCT01037127|20687451|P1|NOT COMPLETED|Overall Study||5
8393756|NCT01037127|20687450|P2|COMPLETED|Overall Study||36
8393757|NCT01037127|20687451|P1|COMPLETED|Overall Study||35
8393758|NCT01037127|20687450|P2|STARTED|Overall Study||57
8393759|NCT01037127|20687451|P1|STARTED|Overall Study||40
8393760|NCT01037114|20687483|P1|NOT COMPLETED|Year 20||1
8393761|NCT01037114|20687483|P1|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
8393762|NCT01037114|20687483|P1|STARTED|Year 20||45
8393763|NCT01037114|20687483|P1|NOT COMPLETED|Year 19||0
8393764|NCT01037114|20687483|P1|COMPLETED|Year 19||45
8393765|NCT01037114|20687483|P1|STARTED|Year 19||45
8393766|NCT01037114|20687483|P1|NOT COMPLETED|Year 18||0
8393767|NCT01037114|20687483|P1|COMPLETED|Year 18||44
8393768|NCT01037114|20687483|P1|STARTED|Year 18||44
8393769|NCT01037114|20687483|P1|NOT COMPLETED|Year 17||0
8393770|NCT01037114|20687483|P1|COMPLETED|Year 17||48
8393771|NCT01037114|20687483|P1|STARTED|Year 17||48
8393772|NCT01037114|20687483|P1|NOT COMPLETED|Year 16||0
8393773|NCT01037114|20687483|P1|COMPLETED|Year 16||49
8393774|NCT01037114|20687483|P1|STARTED|Year 16||49
8393775|NCT01037088|20687496|P1|NOT COMPLETED|Overall Study||3
8393776|NCT01037088|20687496|P1|COMPLETED|Overall Study||36
8393777|NCT01037088|20687496|P1|Received Placebo|Overall Study||38
8393778|NCT01037088|20687496|P1|Received 1.29% THC|Overall Study||37
8393779|NCT01037088|20687496|P1|Received 3.53% THC|Overall Study||36
8393780|NCT01037088|20687496|P1|STARTED|Overall Study||39
8393781|NCT01036802|20687509|P2|NOT COMPLETED|Overall Study||0
8393782|NCT01036802|20687510|P1|NOT COMPLETED|Overall Study||0
8393783|NCT01036802|20687509|P2|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
8393784|NCT01036802|20687510|P1|COMPLETED|Overall Study||2
8393785|NCT01036802|20687509|P2|STARTED|Overall Study||1
8393786|NCT01036802|20687510|P1|STARTED|Overall Study||2
8393787|NCT01036763|20687528|P1|NOT COMPLETED|Overall Study||93
8393788|NCT01036763|20687528|P1|COMPLETED|Overall Study||1171
8393789|NCT01036763|20687528|P1|STARTED|Overall Study||1264
8393790|NCT01036724|20687540|P2|NOT COMPLETED|Overall Study||8
8393791|NCT01036724|20687541|P1|NOT COMPLETED|Overall Study||6
8393792|NCT01036724|20687540|P2|COMPLETED|Overall Study||47
8393793|NCT01036724|20687541|P1|COMPLETED|Overall Study||46
8393794|NCT01036724|20687540|P2|STARTED|Overall Study||55
8393795|NCT01036724|20687541|P1|STARTED|Overall Study||52
8393796|NCT01036594|20687549|P2|NOT COMPLETED|Treatment Regiments Post Week 12||4
8393797|NCT01036594|20687550|P1|NOT COMPLETED|Treatment Regiments Post Week 12||2
8393798|NCT01036594|20687549|P2|COMPLETED|Treatment Regiments Post Week 12||5
8393799|NCT01036594|20687550|P1|COMPLETED|Treatment Regiments Post Week 12||13
8393800|NCT01036594|20687549|P2|STARTED|Treatment Regiments Post Week 12||9
8393801|NCT01036594|20687550|P1|STARTED|Treatment Regiments Post Week 12||15
8393802|NCT01036594|20687549|P2|NOT COMPLETED|Week 12 Evaluation||0
8393803|NCT01036594|20687550|P1|NOT COMPLETED|Week 12 Evaluation||6
8393804|NCT01036594|20687549|P2|COMPLETED|Week 12 Evaluation||0
8393805|NCT01036594|20687550|P1|COMPLETED|Week 12 Evaluation||24
8393806|NCT01036594|20687549|P2|STARTED|Week 12 Evaluation|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
8393807|NCT01036594|20687550|P1|STARTED|Week 12 Evaluation||30
8393808|NCT01036594|20687549|P2|NOT COMPLETED|First Treatment Regimen||0
8393809|NCT01036594|20687550|P1|NOT COMPLETED|First Treatment Regimen||1
8393810|NCT01036594|20687549|P2|COMPLETED|First Treatment Regimen||0
8393811|NCT01036594|20687550|P1|COMPLETED|First Treatment Regimen||30
8393812|NCT01036594|20687549|P2|STARTED|First Treatment Regimen|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
8393813|NCT01036594|20687550|P1|STARTED|First Treatment Regimen||31
8393814|NCT01036594|20687549|P2|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
8393815|NCT01036594|20687550|P1|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||1
8393816|NCT01036594|20687549|P2|COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
8393817|NCT01036594|20687550|P1|COMPLETED|Run-In: Ketoconazole Only (200 mg)||31
8393818|NCT01036594|20687549|P2|STARTED|Run-In: Ketoconazole Only (200 mg)|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
8393819|NCT01036594|20687550|P1|STARTED|Run-In: Ketoconazole Only (200 mg)||32
8393820|NCT01036529|20687574|P2|NOT COMPLETED|Overall Study||15
8393821|NCT01036529|20687575|P1|NOT COMPLETED|Overall Study||13
8393822|NCT01036529|20687574|P2|COMPLETED|Overall Study||0
8393823|NCT01036529|20687575|P1|COMPLETED|Overall Study||0
8393824|NCT01036529|20687574|P2|Crossover to Other Group|Overall Study||1
8393825|NCT01036529|20687575|P1|Crossover to Other Group|Overall Study||1
8393826|NCT01036529|20687574|P2|Requested Crossover|Overall Study||2
8393827|NCT01036529|20687575|P1|Requested Crossover|Overall Study||1
8393828|NCT01036529|20687574|P2|12 Month Follow-up|Overall Study||3
8393829|NCT01036529|20687575|P1|12 Month Follow-up|Overall Study||4
8393830|NCT01036529|20687574|P2|6 Month Follow-up|Overall Study||7
8393831|NCT01036529|20687575|P1|6 Month Follow-up|Overall Study||6
8393832|NCT01036529|20687574|P2|3 Month Follow-up|Overall Study||9
8393833|NCT01036529|20687575|P1|3 Month Follow-up|Overall Study||7
8393834|NCT01036529|20687574|P2|Index Procedure|Overall Study|Index Procedure: Surgery|11
8393835|NCT01036529|20687575|P1|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
8393836|NCT01036529|20687574|P2|Baseline Visit|Overall Study||13
8393837|NCT01036529|20687575|P1|Baseline Visit|Overall Study||10
8393838|NCT01036529|20687574|P2|STARTED|Overall Study||15
8393839|NCT01036529|20687575|P1|STARTED|Overall Study||13
8393840|NCT01036490|20687583|P2|NOT COMPLETED|Overall Study||0
8393841|NCT01036490|20687584|P1|NOT COMPLETED|Overall Study||4
8393842|NCT01036490|20687583|P2|COMPLETED|Overall Study||18
8393843|NCT01036490|20687584|P1|COMPLETED|Overall Study||14
8393844|NCT01036490|20687583|P2|STARTED|Overall Study||18
8393845|NCT01036490|20687584|P1|STARTED|Overall Study||18
8393846|NCT01036438|20687602|P2|NOT COMPLETED|Overall Study||10
8393847|NCT01036438|20687603|P1|NOT COMPLETED|Overall Study||10
8393848|NCT01036438|20687602|P2|COMPLETED|Overall Study||90
8393849|NCT01036438|20687603|P1|COMPLETED|Overall Study||91
8393850|NCT01036438|20687602|P2|STARTED|Overall Study||100
8393851|NCT01036438|20687603|P1|STARTED|Overall Study||101
8393852|NCT01036321|20687611|P2|NOT COMPLETED|Overall Study||4
8393853|NCT01036321|20687612|P1|NOT COMPLETED|Overall Study||5
8393854|NCT01036321|20687611|P2|COMPLETED|Overall Study||31
8393855|NCT01036321|20687612|P1|COMPLETED|Overall Study||31
8393856|NCT01036321|20687611|P2|STARTED|Overall Study||35
8393857|NCT01036321|20687612|P1|STARTED|Overall Study||36
8393858|NCT01036165|20687636|P1|NOT COMPLETED|Overall Study||15
8393859|NCT01036165|20687636|P1|COMPLETED|Overall Study||88
8393860|NCT01036165|20687636|P1|STARTED|Overall Study||103
8393861|NCT01036022|20687647|P6|NOT COMPLETED|Overall Study||3
8393862|NCT01036022|20687648|P5|NOT COMPLETED|Overall Study||3
8393863|NCT01036022|20687649|P4|NOT COMPLETED|Overall Study||2
8393864|NCT01036022|20687650|P3|NOT COMPLETED|Overall Study||4
8393865|NCT01036022|20687651|P2|NOT COMPLETED|Overall Study||4
8393866|NCT01036022|20687652|P1|NOT COMPLETED|Overall Study||2
8393867|NCT01036022|20687647|P6|COMPLETED|Overall Study||13
8393868|NCT01036022|20687648|P5|COMPLETED|Overall Study||9
8393869|NCT01036022|20687649|P4|COMPLETED|Overall Study||10
8393870|NCT01036022|20687650|P3|COMPLETED|Overall Study||8
8393871|NCT01036022|20687651|P2|COMPLETED|Overall Study||7
8393872|NCT01036022|20687652|P1|COMPLETED|Overall Study||13
8393873|NCT01036022|20687647|P6|STARTED|Overall Study||16
8393874|NCT01036022|20687648|P5|STARTED|Overall Study||12
8393875|NCT01036022|20687649|P4|STARTED|Overall Study||12
8393876|NCT01036022|20687650|P3|STARTED|Overall Study||12
8393877|NCT01036022|20687651|P2|STARTED|Overall Study||11
8393878|NCT01036022|20687652|P1|STARTED|Overall Study||15
8393879|NCT01036009|20687754|P2|NOT COMPLETED|Overall Study||0
8393880|NCT01036009|20687755|P1|NOT COMPLETED|Overall Study||0
8393881|NCT01036009|20687754|P2|COMPLETED|Overall Study||26
8393882|NCT01036009|20687755|P1|COMPLETED|Overall Study||17
8393883|NCT01036009|20687754|P2|STARTED|Overall Study||26
8393884|NCT01036009|20687755|P1|STARTED|Overall Study||17
8393885|NCT01035944|20687773|P4|NOT COMPLETED|Overall Study||0
8393886|NCT01035944|20687774|P3|NOT COMPLETED|Overall Study||1
8393887|NCT01035944|20687775|P2|NOT COMPLETED|Overall Study||1
8393888|NCT01035944|20687776|P1|NOT COMPLETED|Overall Study||3
8393889|NCT01035944|20687773|P4|COMPLETED|Overall Study||4
8393890|NCT01035944|20687774|P3|COMPLETED|Overall Study||4
8393891|NCT01035944|20687775|P2|COMPLETED|Overall Study||13
8393892|NCT01035944|20687776|P1|COMPLETED|Overall Study||11
8393893|NCT01035944|20687773|P4|STARTED|Overall Study||4
8393894|NCT01035944|20687774|P3|STARTED|Overall Study||5
8393895|NCT01035944|20687775|P2|STARTED|Overall Study||14
8393896|NCT01035944|20687776|P1|STARTED|Overall Study||14
8393897|NCT01035905|20687788|P2|NOT COMPLETED|Overall Study||1
8393898|NCT01035905|20687789|P1|NOT COMPLETED|Overall Study||1
8393899|NCT01035905|20687788|P2|COMPLETED|Overall Study||30
8393900|NCT01035905|20687789|P1|COMPLETED|Overall Study||31
8393901|NCT01035905|20687788|P2|STARTED|Overall Study||31
8393902|NCT01035905|20687789|P1|STARTED|Overall Study||32
8393903|NCT01035788|20687797|P2|NOT COMPLETED|Overall Study||14
8393904|NCT01035788|20687798|P1|NOT COMPLETED|Overall Study||6
8393905|NCT01035788|20687797|P2|COMPLETED|Overall Study||9
8393906|NCT01035788|20687798|P1|COMPLETED|Overall Study||17
8393907|NCT01035788|20687797|P2|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
8393908|NCT01035788|20687798|P1|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
8393909|NCT01035749|20687808|P4|NOT COMPLETED|Overall Study||0
8393910|NCT01035749|20687809|P3|NOT COMPLETED|Overall Study||0
8393911|NCT01035749|20687810|P2|NOT COMPLETED|Overall Study||0
8393912|NCT01035749|20687811|P1|NOT COMPLETED|Overall Study||0
8393913|NCT01035749|20687808|P4|COMPLETED|Overall Study||110
8393914|NCT01035749|20687809|P3|COMPLETED|Overall Study||68
8393915|NCT01035749|20687810|P2|COMPLETED|Overall Study||66
8393916|NCT01035749|20687811|P1|COMPLETED|Overall Study||66
8393917|NCT01035749|20687808|P4|STARTED|Overall Study||110
8393918|NCT01035749|20687809|P3|STARTED|Overall Study||68
8393919|NCT01035749|20687810|P2|STARTED|Overall Study||66
8393920|NCT01035749|20687811|P1|STARTED|Overall Study||66
8393921|NCT01035658|20687933|P4|NOT COMPLETED|Overall Study||0
8393922|NCT01035658|20687934|P3|NOT COMPLETED|Overall Study||0
8393923|NCT01035658|20687935|P2|NOT COMPLETED|Overall Study||0
8393924|NCT01035658|20687936|P1|NOT COMPLETED|Overall Study||0
8393925|NCT01035658|20687933|P4|COMPLETED|Overall Study||6
8393926|NCT01035658|20687934|P3|COMPLETED|Overall Study||3
8393927|NCT01035658|20687935|P2|COMPLETED|Overall Study||8
8393928|NCT01035658|20687936|P1|COMPLETED|Overall Study||5
8393929|NCT01035658|20687933|P4|STARTED|Overall Study||6
8393930|NCT01035658|20687934|P3|STARTED|Overall Study||3
8393931|NCT01035658|20687935|P2|STARTED|Overall Study||8
8393932|NCT01035658|20687936|P1|STARTED|Overall Study||5
8393933|NCT01035606|20687962|P3|NOT COMPLETED|Overall Study||4
8393934|NCT01035606|20687963|P2|NOT COMPLETED|Overall Study||3
8393935|NCT01035606|20687964|P1|NOT COMPLETED|Overall Study||3
8393936|NCT01035606|20687962|P3|COMPLETED|Overall Study||7
8393937|NCT01035606|20687963|P2|COMPLETED|Overall Study||16
8393938|NCT01035606|20687964|P1|COMPLETED|Overall Study||16
8393939|NCT01035606|20687962|P3|STARTED|Overall Study||11
8393940|NCT01035606|20687963|P2|STARTED|Overall Study||19
8393941|NCT01035606|20687964|P1|STARTED|Overall Study||19
8393942|NCT01035463|20687980|P6|NOT COMPLETED|Overall Study||18
8393943|NCT01035463|20687981|P5|NOT COMPLETED|Overall Study||6
8393944|NCT01035463|20687982|P4|NOT COMPLETED|Overall Study||2
8393945|NCT01035463|20687983|P3|NOT COMPLETED|Overall Study||5
8393946|NCT01035463|20687984|P2|NOT COMPLETED|Overall Study||2
8393947|NCT01035463|20687985|P1|NOT COMPLETED|Overall Study||0
8393948|NCT01035463|20687980|P6|COMPLETED|Overall Study||15
8393949|NCT01035463|20687981|P5|COMPLETED|Overall Study||1
8393950|NCT01035463|20687982|P4|COMPLETED|Overall Study||2
8393951|NCT01035463|20687983|P3|COMPLETED|Overall Study||1
8393952|NCT01035463|20687984|P2|COMPLETED|Overall Study||1
8393953|NCT01035463|20687985|P1|COMPLETED|Overall Study||6
8393954|NCT01035463|20687980|P6|STARTED|Overall Study||33
8393955|NCT01035463|20687981|P5|STARTED|Overall Study||7
8393956|NCT01035463|20687982|P4|STARTED|Overall Study||4
8393957|NCT01035463|20687983|P3|STARTED|Overall Study||6
8393958|NCT01035463|20687984|P2|STARTED|Overall Study||3
8393959|NCT01035463|20687985|P1|STARTED|Overall Study||6
8393960|NCT01035346|20687996|P2|NOT COMPLETED|Overall Study||0
8393961|NCT01035346|20687997|P1|NOT COMPLETED|Overall Study||0
8393962|NCT01035346|20687996|P2|COMPLETED|Overall Study||9
8393963|NCT01035346|20687997|P1|COMPLETED|Overall Study||7
8393964|NCT01035346|20687996|P2|STARTED|Overall Study||9
8393965|NCT01035346|20687997|P1|STARTED|Overall Study||7
8393966|NCT01035333|20688015|P1|NOT COMPLETED|Overall Study||10
8393967|NCT01035333|20688015|P1|COMPLETED|Overall Study||9
8393968|NCT01035333|20688015|P1|STARTED|Overall Study||19
8393969|NCT01035255|20688022|P2|NOT COMPLETED|Overall Study||862
8393970|NCT01035255|20688023|P1|NOT COMPLETED|Overall Study||741
8393971|NCT01035255|20688022|P2|COMPLETED|Overall Study||3371
8393972|NCT01035255|20688023|P1|COMPLETED|Overall Study||3468
8393973|NCT01035255|20688022|P2|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
8393974|NCT01035255|20688023|P1|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
8393975|NCT01035255|20688022|P2|Mis-randomized|Overall Study||2
8393976|NCT01035255|20688023|P1|Mis-randomized|Overall Study||4
8393977|NCT01035255|20688022|P2|GCP Violations|Overall Study||19
8393978|NCT01035255|20688023|P1|GCP Violations|Overall Study||18
8393979|NCT01035255|20688022|P2|STARTED|Overall Study||4233
8393980|NCT01035255|20688023|P1|STARTED|Overall Study||4209
8393981|NCT01035229|20688041|P2|NOT COMPLETED|Overall Study||184
8393982|NCT01035229|20688042|P1|NOT COMPLETED|Overall Study||362
8393983|NCT01035229|20688041|P2|COMPLETED|Overall Study||0
8393984|NCT01035229|20688042|P1|COMPLETED|Overall Study||0
8393985|NCT01035229|20688041|P2|STARTED|Overall Study||184
8393986|NCT01035229|20688042|P1|STARTED|Overall Study||362
8393987|NCT01035151|20688062|P2|NOT COMPLETED|Overall Study||15
8393988|NCT01035151|20688063|P1|NOT COMPLETED|Overall Study||21
8393989|NCT01035151|20688062|P2|COMPLETED|Overall Study||185
8393990|NCT01035151|20688063|P1|COMPLETED|Overall Study||188
8393991|NCT01035151|20688062|P2|STARTED|Overall Study||200
8393992|NCT01035151|20688063|P1|STARTED|Overall Study||209
8393993|NCT01035138|20688072|P3|NOT COMPLETED|Overall Study||47
8393994|NCT01035138|20688073|P2|NOT COMPLETED|Overall Study||60
8393995|NCT01035138|20688074|P1|NOT COMPLETED|Overall Study||73
8393996|NCT01035138|20688072|P3|COMPLETED|Overall Study||0
8393997|NCT01035138|20688073|P2|COMPLETED|Overall Study||0
8393998|NCT01035138|20688074|P1|COMPLETED|Overall Study||0
8393999|NCT01035138|20688072|P3|STARTED|Overall Study||47
8394000|NCT01035138|20688073|P2|STARTED|Overall Study||60
8394001|NCT01035138|20688074|P1|STARTED|Overall Study||73
8394008|NCT01035073|20688167|P1|NOT COMPLETED|Overall Study||0
8394009|NCT01035073|20688167|P1|COMPLETED|Overall Study||0
8394010|NCT01035073|20688167|P1|STARTED|Overall Study||0
8394011|NCT01035060|20688174|P2|NOT COMPLETED|Overall Study||14
8394012|NCT01035060|20688175|P1|NOT COMPLETED|Overall Study||24
8394013|NCT01035060|20688174|P2|COMPLETED|Overall Study||15
8394014|NCT01035060|20688175|P1|COMPLETED|Overall Study||15
8394015|NCT01035060|20688174|P2|STARTED|Overall Study||29
8394016|NCT01035060|20688175|P1|STARTED|Overall Study||39
8394017|NCT01035047|20688183|P2|NOT COMPLETED|Overall Study||0
8394018|NCT01035047|20688184|P1|NOT COMPLETED|Overall Study||0
8394019|NCT01035047|20688183|P2|COMPLETED|Overall Study||53
8394020|NCT01035047|20688184|P1|COMPLETED|Overall Study||52
8394021|NCT01035047|20688183|P2|STARTED|Overall Study||53
8394022|NCT01035047|20688184|P1|STARTED|Overall Study||52
8394023|NCT01034709|20688200|P2|NOT COMPLETED|Overall Study||16
8394024|NCT01034709|20688201|P1|NOT COMPLETED|Overall Study||9
8394025|NCT01034709|20688200|P2|COMPLETED|Overall Study||42
8394026|NCT01034709|20688201|P1|COMPLETED|Overall Study||44
8394027|NCT01034709|20688200|P2|STARTED|Overall Study||58
8394028|NCT01034709|20688201|P1|STARTED|Overall Study||53
8394029|NCT01034657|20688207|P3|NOT COMPLETED|Randomized Phase||1
8394030|NCT01034657|20688208|P2|NOT COMPLETED|Randomized Phase||6
8394031|NCT01034657|20688209|P1|NOT COMPLETED|Randomized Phase||5
8394032|NCT01034657|20688207|P3|COMPLETED|Randomized Phase||0
8394033|NCT01034657|20688208|P2|COMPLETED|Randomized Phase||0
8394034|NCT01034657|20688209|P1|COMPLETED|Randomized Phase||1
8394035|NCT01034657|20688207|P3|STARTED|Randomized Phase||1
8394036|NCT01034657|20688208|P2|STARTED|Randomized Phase||6
8394037|NCT01034657|20688209|P1|STARTED|Randomized Phase||6
8394038|NCT01034657|20688207|P3|NOT COMPLETED|Core Phase||0
8394039|NCT01034657|20688208|P2|NOT COMPLETED|Core Phase||0
8394040|NCT01034657|20688209|P1|NOT COMPLETED|Core Phase||14
8394041|NCT01034657|20688207|P3|COMPLETED|Core Phase||0
8394042|NCT01034657|20688208|P2|COMPLETED|Core Phase||0
8394043|NCT01034657|20688209|P1|COMPLETED|Core Phase||20
8394044|NCT01034657|20688207|P3|STARTED|Core Phase||0
8394045|NCT01034657|20688208|P2|STARTED|Core Phase||0
8394046|NCT01034657|20688209|P1|STARTED|Core Phase||34
8394047|NCT01034631|20688250|P3|NOT COMPLETED|Phase II||2
8394048|NCT01034631|20688251|P2|NOT COMPLETED|Phase II||1
8394049|NCT01034631|20688252|P1|NOT COMPLETED|Phase II||0
8394050|NCT01034631|20688250|P3|COMPLETED|Phase II||67
8394051|NCT01034631|20688251|P2|COMPLETED|Phase II||69
8394052|NCT01034631|20688252|P1|COMPLETED|Phase II||0
8394053|NCT01034631|20688250|P3|STARTED|Phase II||69
8394054|NCT01034631|20688251|P2|STARTED|Phase II||70
8394055|NCT01034631|20688252|P1|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
8394056|NCT01034631|20688250|P3|NOT COMPLETED|Phase I||0
8394057|NCT01034631|20688251|P2|NOT COMPLETED|Phase I||0
8394058|NCT01034631|20688252|P1|NOT COMPLETED|Phase I||3
8394059|NCT01034631|20688250|P3|COMPLETED|Phase I||0
8394060|NCT01034631|20688251|P2|COMPLETED|Phase I||0
8394061|NCT01034631|20688252|P1|COMPLETED|Phase I||12
8394062|NCT01034631|20688250|P3|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
8394063|NCT01034631|20688251|P2|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
8394064|NCT01034631|20688252|P1|STARTED|Phase I||15
8394065|NCT01034592|20688271|P1|NOT COMPLETED|Overall Study||0
8394066|NCT01034592|20688271|P1|COMPLETED|Overall Study||2
8394067|NCT01034592|20688271|P1|STARTED|Overall Study||2
8394068|NCT01034579|20688283|P2|NOT COMPLETED|Overall Study||0
8394069|NCT01034579|20688284|P1|NOT COMPLETED|Overall Study||0
8394070|NCT01034579|20688283|P2|COMPLETED|Overall Study||166
8394071|NCT01034579|20688284|P1|COMPLETED|Overall Study||158
8394072|NCT01034579|20688283|P2|STARTED|Overall Study||166
8394073|NCT01034579|20688284|P1|STARTED|Overall Study||158
8394074|NCT01034553|20688298|P6|NOT COMPLETED|Overall Study||0
8394075|NCT01034553|20688299|P5|NOT COMPLETED|Overall Study||0
8394076|NCT01034553|20688300|P4|NOT COMPLETED|Overall Study||0
8394077|NCT01034553|20688301|P3|NOT COMPLETED|Overall Study||0
8394078|NCT01034553|20688302|P2|NOT COMPLETED|Overall Study||0
8394079|NCT01034553|20688303|P1|NOT COMPLETED|Overall Study||0
8394080|NCT01034553|20688298|P6|COMPLETED|Overall Study||7
8394081|NCT01034553|20688299|P5|COMPLETED|Overall Study||6
8394082|NCT01034553|20688300|P4|COMPLETED|Overall Study||3
8394083|NCT01034553|20688301|P3|COMPLETED|Overall Study||3
8394084|NCT01034553|20688302|P2|COMPLETED|Overall Study||4
8394085|NCT01034553|20688303|P1|COMPLETED|Overall Study||3
8394086|NCT01034553|20688298|P6|STARTED|Overall Study||7
8394087|NCT01034553|20688299|P5|STARTED|Overall Study||6
8394088|NCT01034553|20688300|P4|STARTED|Overall Study||3
8394089|NCT01034553|20688301|P3|STARTED|Overall Study||3
8394090|NCT01034553|20688302|P2|STARTED|Overall Study||4
8394091|NCT01034553|20688303|P1|STARTED|Overall Study||3
8394092|NCT01034540|20688319|P2|NOT COMPLETED|Overall Study||1
8394093|NCT01034540|20688320|P1|NOT COMPLETED|Overall Study||0
8394094|NCT01034540|20688319|P2|COMPLETED|Overall Study||11
8394095|NCT01034540|20688320|P1|COMPLETED|Overall Study||11
8394096|NCT01034540|20688319|P2|Completed 1st Treatment Intervention|Overall Study||11
8394097|NCT01034540|20688320|P1|Completed 1st Treatment Intervention|Overall Study||11
8394098|NCT01034540|20688319|P2|STARTED|Overall Study||12
8394099|NCT01034540|20688320|P1|STARTED|Overall Study||11
8394100|NCT01034527|20688330|P2|NOT COMPLETED|Overall Study||0
8394101|NCT01034527|20688331|P1|NOT COMPLETED|Overall Study||0
8394102|NCT01034527|20688330|P2|COMPLETED|Overall Study||216
8394103|NCT01034527|20688331|P1|COMPLETED|Overall Study||307
8394104|NCT01034527|20688330|P2|STARTED|Overall Study||216
8394105|NCT01034527|20688331|P1|STARTED|Overall Study||307
8394106|NCT01034462|20688339|P2|NOT COMPLETED|Overall Study||54
8394107|NCT01034462|20688340|P1|NOT COMPLETED|Overall Study||45
8394108|NCT01034462|20688339|P2|COMPLETED|Overall Study||163
8394109|NCT01034462|20688340|P1|COMPLETED|Overall Study||172
8394110|NCT01034462|20688339|P2|STARTED|Overall Study||217
8394111|NCT01034462|20688340|P1|STARTED|Overall Study||217
8394112|NCT01034397|20688350|P2|NOT COMPLETED|Overall Study||2
8394113|NCT01034397|20688351|P1|NOT COMPLETED|Overall Study||7
8394114|NCT01034397|20688350|P2|COMPLETED|Overall Study||17
8394115|NCT01034397|20688351|P1|COMPLETED|Overall Study||28
8394116|NCT01034397|20688350|P2|STARTED|Overall Study||19
8394117|NCT01034397|20688351|P1|STARTED|Overall Study||35
8394118|NCT01034358|20688500|P1|NOT COMPLETED|Overall Study||2
8394119|NCT01034358|20688500|P1|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
8394120|NCT01034358|20688500|P1|STARTED|Overall Study||15
8394121|NCT01034306|20688506|P2|NOT COMPLETED|Overall Study||3
8394122|NCT01034306|20688507|P1|NOT COMPLETED|Overall Study||5
8394123|NCT01034306|20688506|P2|COMPLETED|Overall Study||34
8394124|NCT01034306|20688507|P1|COMPLETED|Overall Study||37
8394125|NCT01034306|20688506|P2|STARTED|Overall Study||37
8394126|NCT01034306|20688507|P1|STARTED|Overall Study||42
8394127|NCT01034176|20688515|P2|NOT COMPLETED|Overall Study||2
8394128|NCT01034176|20688516|P1|NOT COMPLETED|Overall Study||2
8394129|NCT01034176|20688515|P2|COMPLETED|Overall Study||19
8394130|NCT01034176|20688516|P1|COMPLETED|Overall Study||20
8394131|NCT01034176|20688515|P2|STARTED|Overall Study||21
8394132|NCT01034176|20688516|P1|STARTED|Overall Study||22
8394133|NCT01034163|20688526|P2|NOT COMPLETED|Overall Study||14
8394134|NCT01034163|20688527|P1|NOT COMPLETED|Overall Study||27
8394135|NCT01034163|20688526|P2|COMPLETED|Overall Study||0
8394136|NCT01034163|20688527|P1|COMPLETED|Overall Study||0
8394137|NCT01034163|20688526|P2|In Open Label Phase After Unblinding|Overall Study||0
8394138|NCT01034163|20688527|P1|In Open Label Phase After Unblinding|Overall Study||5
8394139|NCT01034163|20688526|P2|Safety Set|Overall Study||12
8394140|NCT01034163|20688527|P1|Safety Set|Overall Study||26
8394141|NCT01034163|20688526|P2|Untreated (Not in Safety Set)|Overall Study||2
8394142|NCT01034163|20688527|P1|Untreated (Not in Safety Set)|Overall Study||1
8394143|NCT01034163|20688526|P2|STARTED|Overall Study||14
8394144|NCT01034163|20688527|P1|STARTED|Overall Study||27
8394145|NCT01034137|20688536|P3|NOT COMPLETED|Overall Study||30
8394146|NCT01034137|20688537|P2|NOT COMPLETED|Overall Study||22
8394147|NCT01034137|20688538|P1|NOT COMPLETED|Overall Study||28
8394148|NCT01034137|20688536|P3|COMPLETED|Overall Study||78
8394149|NCT01034137|20688537|P2|COMPLETED|Overall Study||81
8394150|NCT01034137|20688538|P1|COMPLETED|Overall Study||78
8394151|NCT01034137|20688536|P3|STARTED|Overall Study||108
8394152|NCT01034137|20688537|P2|STARTED|Overall Study||103
8394153|NCT01034137|20688538|P1|STARTED|Overall Study||106
8394154|NCT01034111|20688669|P1|NOT COMPLETED|Overall Study||0
8394155|NCT01034111|20688669|P1|COMPLETED|Overall Study||30
8394156|NCT01034111|20688669|P1|STARTED|Overall Study||30
8394157|NCT01033942|20688677|P3|NOT COMPLETED|Overall Study||1
8394158|NCT01033942|20688678|P2|NOT COMPLETED|Overall Study||4
8394159|NCT01033942|20688679|P1|NOT COMPLETED|Overall Study||2
8394160|NCT01033942|20688677|P3|COMPLETED|Overall Study||18
8394161|NCT01033942|20688678|P2|COMPLETED|Overall Study||15
8394162|NCT01033942|20688679|P1|COMPLETED|Overall Study||18
8394163|NCT01033942|20688677|P3|STARTED|Overall Study||19
8394164|NCT01033942|20688678|P2|STARTED|Overall Study||19
8394165|NCT01033942|20688679|P1|STARTED|Overall Study||20
8394166|NCT01033864|20688951|P2|NOT COMPLETED|Overall Study||0
8394167|NCT01033864|20688952|P1|NOT COMPLETED|Overall Study||0
8394168|NCT01033864|20688951|P2|COMPLETED|Overall Study||11
8394169|NCT01033864|20688952|P1|COMPLETED|Overall Study||12
8394170|NCT01033864|20688951|P2|STARTED|Overall Study||11
8394171|NCT01033864|20688952|P1|STARTED|Overall Study||12
8394172|NCT01033851|20688977|P2|NOT COMPLETED|Overall Study||7
8394173|NCT01033851|20688978|P1|NOT COMPLETED|Overall Study||3
8394174|NCT01033851|20688977|P2|COMPLETED|Overall Study||34
8394175|NCT01033851|20688978|P1|COMPLETED|Overall Study||45
8394176|NCT01033851|20688977|P2|STARTED|Overall Study||41
8394177|NCT01033851|20688978|P1|STARTED|Overall Study||48
8394178|NCT01033825|20688993|P7|NOT COMPLETED|Overall Study||0
8394179|NCT01033825|20688994|P6|NOT COMPLETED|Overall Study||0
8394180|NCT01033825|20688995|P5|NOT COMPLETED|Overall Study||2
8394181|NCT01033825|20688996|P4|NOT COMPLETED|Overall Study||2
8394182|NCT01033825|20688997|P3|NOT COMPLETED|Overall Study||2
8394183|NCT01033825|20688998|P2|NOT COMPLETED|Overall Study||3
8394184|NCT01033825|20688999|P1|NOT COMPLETED|Overall Study||3
8394185|NCT01033825|20688993|P7|COMPLETED|Overall Study||18
8394186|NCT01033825|20688994|P6|COMPLETED|Overall Study||18
8394187|NCT01033825|20688995|P5|COMPLETED|Overall Study||56
8394188|NCT01033825|20688996|P4|COMPLETED|Overall Study||46
8394189|NCT01033825|20688997|P3|COMPLETED|Overall Study||55
8394190|NCT01033825|20688998|P2|COMPLETED|Overall Study||57
8394191|NCT01033825|20688999|P1|COMPLETED|Overall Study||48
8394192|NCT01033825|20688993|P7|STARTED|Overall Study||18
8394193|NCT01033825|20688994|P6|STARTED|Overall Study||18
8394194|NCT01033825|20688995|P5|STARTED|Overall Study||58
8394195|NCT01033825|20688996|P4|STARTED|Overall Study||48
8394196|NCT01033825|20688997|P3|STARTED|Overall Study||57
8394197|NCT01033825|20688998|P2|STARTED|Overall Study||60
8394198|NCT01033825|20688999|P1|STARTED|Overall Study||51
8394199|NCT01033773|20689218|P1|NOT COMPLETED|Overall Study||35
8394200|NCT01033773|20689218|P1|COMPLETED|Overall Study||51
8394201|NCT01033773|20689218|P1|STARTED|Overall Study||86
8394202|NCT01033747|20689226|P2|NOT COMPLETED|Overall Study||15
8394203|NCT01033747|20689227|P1|NOT COMPLETED|Overall Study||37
8394204|NCT01033747|20689226|P2|COMPLETED|Overall Study||4
8394205|NCT01033747|20689227|P1|COMPLETED|Overall Study||14
8394206|NCT01033747|20689226|P2|STARTED|Overall Study||19
8394207|NCT01033747|20689227|P1|STARTED|Overall Study||51
8394208|NCT01033734|20689235|P1|NOT COMPLETED|Overall Study||1
8394209|NCT01033734|20689235|P1|COMPLETED|Overall Study||7
8394210|NCT01033734|20689235|P1|STARTED|Overall Study||8
8394211|NCT01033565|20689287|P1|NOT COMPLETED|Overall Study||0
8394212|NCT01033565|20689287|P1|COMPLETED|Overall Study||1
8394213|NCT01033565|20689287|P1|STARTED|Overall Study||1
8394214|NCT01033487|20689291|P10|NOT COMPLETED|Fifth Intervention Period||0
8394215|NCT01033487|20689292|P9|NOT COMPLETED|Fifth Intervention Period||0
8394216|NCT01033487|20689293|P8|NOT COMPLETED|Fifth Intervention Period||0
8394217|NCT01033487|20689294|P7|NOT COMPLETED|Fifth Intervention Period||0
8394218|NCT01033487|20689295|P6|NOT COMPLETED|Fifth Intervention Period||0
8394219|NCT01033487|20689296|P5|NOT COMPLETED|Fifth Intervention Period||0
8394220|NCT01033487|20689297|P4|NOT COMPLETED|Fifth Intervention Period||0
8394221|NCT01033487|20689298|P3|NOT COMPLETED|Fifth Intervention Period||0
8394222|NCT01033487|20689299|P2|NOT COMPLETED|Fifth Intervention Period||0
8394223|NCT01033487|20689300|P1|NOT COMPLETED|Fifth Intervention Period||0
8394224|NCT01033487|20689291|P10|COMPLETED|Fifth Intervention Period||2
8394225|NCT01033487|20689292|P9|COMPLETED|Fifth Intervention Period||1
8394226|NCT01033487|20689293|P8|COMPLETED|Fifth Intervention Period||3
8394227|NCT01033487|20689294|P7|COMPLETED|Fifth Intervention Period||2
8394228|NCT01033487|20689295|P6|COMPLETED|Fifth Intervention Period||2
8394229|NCT01033487|20689296|P5|COMPLETED|Fifth Intervention Period||2
8394230|NCT01033487|20689297|P4|COMPLETED|Fifth Intervention Period||2
8394231|NCT01033487|20689298|P3|COMPLETED|Fifth Intervention Period||2
8394232|NCT01033487|20689299|P2|COMPLETED|Fifth Intervention Period||3
8394233|NCT01033487|20689300|P1|COMPLETED|Fifth Intervention Period||2
8394234|NCT01033487|20689291|P10|STARTED|Fifth Intervention Period||2
8394235|NCT01033487|20689292|P9|STARTED|Fifth Intervention Period||1
8394236|NCT01033487|20689293|P8|STARTED|Fifth Intervention Period||3
8394237|NCT01033487|20689294|P7|STARTED|Fifth Intervention Period||2
8394238|NCT01033487|20689295|P6|STARTED|Fifth Intervention Period||2
8394239|NCT01033487|20689296|P5|STARTED|Fifth Intervention Period||2
8394240|NCT01033487|20689297|P4|STARTED|Fifth Intervention Period||2
8394241|NCT01033487|20689298|P3|STARTED|Fifth Intervention Period||2
8394242|NCT01033487|20689299|P2|STARTED|Fifth Intervention Period||3
8394243|NCT01033487|20689300|P1|STARTED|Fifth Intervention Period||2
8394244|NCT01033487|20689291|P10|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394245|NCT01033487|20689292|P9|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394246|NCT01033487|20689293|P8|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394247|NCT01033487|20689294|P7|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394248|NCT01033487|20689295|P6|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394249|NCT01033487|20689296|P5|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394250|NCT01033487|20689297|P4|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394251|NCT01033487|20689298|P3|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394252|NCT01033487|20689299|P2|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394253|NCT01033487|20689300|P1|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
8394254|NCT01033487|20689291|P10|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8394255|NCT01033487|20689292|P9|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
8394256|NCT01033487|20689293|P8|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
8394257|NCT01033487|20689294|P7|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8394258|NCT01033487|20689295|P6|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8394259|NCT01033487|20689296|P5|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8394260|NCT01033487|20689297|P4|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8394261|NCT01033487|20689298|P3|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8394262|NCT01033487|20689299|P2|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
8394263|NCT01033487|20689300|P1|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
8394264|NCT01033487|20689291|P10|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8394265|NCT01033487|20689292|P9|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
8394266|NCT01033487|20689293|P8|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
8394267|NCT01033487|20689294|P7|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8394268|NCT01033487|20689295|P6|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8394269|NCT01033487|20689296|P5|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8394270|NCT01033487|20689297|P4|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8394271|NCT01033487|20689298|P3|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8394272|NCT01033487|20689299|P2|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
8394273|NCT01033487|20689300|P1|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
8394274|NCT01033487|20689291|P10|NOT COMPLETED|Fourth Intervention Period||0
8394275|NCT01033487|20689292|P9|NOT COMPLETED|Fourth Intervention Period||1
8394276|NCT01033487|20689293|P8|NOT COMPLETED|Fourth Intervention Period||0
8394277|NCT01033487|20689294|P7|NOT COMPLETED|Fourth Intervention Period||0
8394278|NCT01033487|20689295|P6|NOT COMPLETED|Fourth Intervention Period||0
8394279|NCT01033487|20689296|P5|NOT COMPLETED|Fourth Intervention Period||0
8394280|NCT01033487|20689297|P4|NOT COMPLETED|Fourth Intervention Period||0
8394281|NCT01033487|20689298|P3|NOT COMPLETED|Fourth Intervention Period||0
8394282|NCT01033487|20689299|P2|NOT COMPLETED|Fourth Intervention Period||0
8394283|NCT01033487|20689300|P1|NOT COMPLETED|Fourth Intervention Period||0
8394284|NCT01033487|20689291|P10|COMPLETED|Fourth Intervention Period||2
8394285|NCT01033487|20689292|P9|COMPLETED|Fourth Intervention Period||1
8394286|NCT01033487|20689293|P8|COMPLETED|Fourth Intervention Period||3
8394287|NCT01033487|20689294|P7|COMPLETED|Fourth Intervention Period||2
8394288|NCT01033487|20689295|P6|COMPLETED|Fourth Intervention Period||2
8394289|NCT01033487|20689296|P5|COMPLETED|Fourth Intervention Period||2
8394290|NCT01033487|20689297|P4|COMPLETED|Fourth Intervention Period||2
8394291|NCT01033487|20689298|P3|COMPLETED|Fourth Intervention Period||2
8394292|NCT01033487|20689299|P2|COMPLETED|Fourth Intervention Period||3
8394293|NCT01033487|20689300|P1|COMPLETED|Fourth Intervention Period||2
8394294|NCT01033487|20689291|P10|STARTED|Fourth Intervention Period||2
8394295|NCT01033487|20689292|P9|STARTED|Fourth Intervention Period||2
8394296|NCT01033487|20689293|P8|STARTED|Fourth Intervention Period||3
8394297|NCT01033487|20689294|P7|STARTED|Fourth Intervention Period||2
8394298|NCT01033487|20689295|P6|STARTED|Fourth Intervention Period||2
8394299|NCT01033487|20689296|P5|STARTED|Fourth Intervention Period||2
8394300|NCT01033487|20689297|P4|STARTED|Fourth Intervention Period||2
8394301|NCT01033487|20689298|P3|STARTED|Fourth Intervention Period||2
8394302|NCT01033487|20689299|P2|STARTED|Fourth Intervention Period||3
8394303|NCT01033487|20689300|P1|STARTED|Fourth Intervention Period||2
8394304|NCT01033487|20689291|P10|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394305|NCT01033487|20689292|P9|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394306|NCT01033487|20689293|P8|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394307|NCT01033487|20689294|P7|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394308|NCT01033487|20689295|P6|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394309|NCT01033487|20689296|P5|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394310|NCT01033487|20689297|P4|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394311|NCT01033487|20689298|P3|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394312|NCT01033487|20689299|P2|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394313|NCT01033487|20689300|P1|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
8394314|NCT01033487|20689291|P10|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394315|NCT01033487|20689292|P9|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394316|NCT01033487|20689293|P8|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
8394317|NCT01033487|20689294|P7|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394318|NCT01033487|20689295|P6|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394319|NCT01033487|20689296|P5|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394320|NCT01033487|20689297|P4|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394321|NCT01033487|20689298|P3|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394322|NCT01033487|20689299|P2|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
8394323|NCT01033487|20689300|P1|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
8394324|NCT01033487|20689291|P10|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394325|NCT01033487|20689292|P9|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394326|NCT01033487|20689293|P8|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
8394327|NCT01033487|20689294|P7|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394328|NCT01033487|20689295|P6|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394329|NCT01033487|20689296|P5|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394330|NCT01033487|20689297|P4|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394331|NCT01033487|20689298|P3|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394332|NCT01033487|20689299|P2|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
8394333|NCT01033487|20689300|P1|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
8394334|NCT01033487|20689291|P10|NOT COMPLETED|Third Intervention Period||0
8394335|NCT01033487|20689292|P9|NOT COMPLETED|Third Intervention Period||0
8394336|NCT01033487|20689293|P8|NOT COMPLETED|Third Intervention Period||0
8394337|NCT01033487|20689294|P7|NOT COMPLETED|Third Intervention Period||0
8394338|NCT01033487|20689295|P6|NOT COMPLETED|Third Intervention Period||0
8394339|NCT01033487|20689296|P5|NOT COMPLETED|Third Intervention Period||0
8394340|NCT01033487|20689297|P4|NOT COMPLETED|Third Intervention Period||0
8394341|NCT01033487|20689298|P3|NOT COMPLETED|Third Intervention Period||0
8394342|NCT01033487|20689299|P2|NOT COMPLETED|Third Intervention Period||0
8394343|NCT01033487|20689300|P1|NOT COMPLETED|Third Intervention Period||0
8394344|NCT01033487|20689291|P10|COMPLETED|Third Intervention Period||2
8394345|NCT01033487|20689292|P9|COMPLETED|Third Intervention Period||2
8394346|NCT01033487|20689293|P8|COMPLETED|Third Intervention Period||3
8394347|NCT01033487|20689294|P7|COMPLETED|Third Intervention Period||2
8394348|NCT01033487|20689295|P6|COMPLETED|Third Intervention Period||2
8394349|NCT01033487|20689296|P5|COMPLETED|Third Intervention Period||2
8394350|NCT01033487|20689297|P4|COMPLETED|Third Intervention Period||2
8394351|NCT01033487|20689298|P3|COMPLETED|Third Intervention Period||2
8394352|NCT01033487|20689299|P2|COMPLETED|Third Intervention Period||3
8394353|NCT01033487|20689300|P1|COMPLETED|Third Intervention Period||2
8394354|NCT01033487|20689291|P10|STARTED|Third Intervention Period||2
8394355|NCT01033487|20689292|P9|STARTED|Third Intervention Period||2
8394356|NCT01033487|20689293|P8|STARTED|Third Intervention Period||3
8394357|NCT01033487|20689294|P7|STARTED|Third Intervention Period||2
8394358|NCT01033487|20689295|P6|STARTED|Third Intervention Period||2
8394359|NCT01033487|20689296|P5|STARTED|Third Intervention Period||2
8394360|NCT01033487|20689297|P4|STARTED|Third Intervention Period||2
8394361|NCT01033487|20689298|P3|STARTED|Third Intervention Period||2
8394362|NCT01033487|20689299|P2|STARTED|Third Intervention Period||3
8394363|NCT01033487|20689300|P1|STARTED|Third Intervention Period||2
8394364|NCT01033487|20689291|P10|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394365|NCT01033487|20689292|P9|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394366|NCT01033487|20689293|P8|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394367|NCT01033487|20689294|P7|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394368|NCT01033487|20689295|P6|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394369|NCT01033487|20689296|P5|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394370|NCT01033487|20689297|P4|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394371|NCT01033487|20689298|P3|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394372|NCT01033487|20689299|P2|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394373|NCT01033487|20689300|P1|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
8394374|NCT01033487|20689291|P10|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394375|NCT01033487|20689292|P9|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394376|NCT01033487|20689293|P8|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
8394377|NCT01033487|20689294|P7|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394378|NCT01033487|20689295|P6|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394379|NCT01033487|20689296|P5|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394380|NCT01033487|20689297|P4|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394381|NCT01033487|20689298|P3|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394382|NCT01033487|20689299|P2|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
8394383|NCT01033487|20689300|P1|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
8394384|NCT01033487|20689291|P10|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394385|NCT01033487|20689292|P9|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394386|NCT01033487|20689293|P8|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
8394387|NCT01033487|20689294|P7|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394388|NCT01033487|20689295|P6|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394389|NCT01033487|20689296|P5|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394390|NCT01033487|20689297|P4|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394391|NCT01033487|20689298|P3|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394392|NCT01033487|20689299|P2|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
8394393|NCT01033487|20689300|P1|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
8394394|NCT01033487|20689291|P10|NOT COMPLETED|Second Intervention Period||0
8394395|NCT01033487|20689292|P9|NOT COMPLETED|Second Intervention Period||0
8394396|NCT01033487|20689293|P8|NOT COMPLETED|Second Intervention Period||0
8394397|NCT01033487|20689294|P7|NOT COMPLETED|Second Intervention Period||0
8394398|NCT01033487|20689295|P6|NOT COMPLETED|Second Intervention Period||0
8394399|NCT01033487|20689296|P5|NOT COMPLETED|Second Intervention Period||0
8394400|NCT01033487|20689297|P4|NOT COMPLETED|Second Intervention Period||0
8394401|NCT01033487|20689298|P3|NOT COMPLETED|Second Intervention Period||0
8394402|NCT01033487|20689299|P2|NOT COMPLETED|Second Intervention Period||0
8394403|NCT01033487|20689300|P1|NOT COMPLETED|Second Intervention Period||0
8394404|NCT01033487|20689291|P10|COMPLETED|Second Intervention Period||2
8394405|NCT01033487|20689292|P9|COMPLETED|Second Intervention Period||2
8394406|NCT01033487|20689293|P8|COMPLETED|Second Intervention Period||3
8394407|NCT01033487|20689294|P7|COMPLETED|Second Intervention Period||2
8394408|NCT01033487|20689295|P6|COMPLETED|Second Intervention Period||2
8394409|NCT01033487|20689296|P5|COMPLETED|Second Intervention Period||2
8394410|NCT01033487|20689297|P4|COMPLETED|Second Intervention Period||2
8394411|NCT01033487|20689298|P3|COMPLETED|Second Intervention Period||2
8394412|NCT01033487|20689299|P2|COMPLETED|Second Intervention Period||3
8394413|NCT01033487|20689300|P1|COMPLETED|Second Intervention Period||2
8394414|NCT01033487|20689291|P10|STARTED|Second Intervention Period||2
8394415|NCT01033487|20689292|P9|STARTED|Second Intervention Period||2
8394416|NCT01033487|20689293|P8|STARTED|Second Intervention Period||3
8394417|NCT01033487|20689294|P7|STARTED|Second Intervention Period||2
8394418|NCT01033487|20689295|P6|STARTED|Second Intervention Period||2
8394419|NCT01033487|20689296|P5|STARTED|Second Intervention Period||2
8394420|NCT01033487|20689297|P4|STARTED|Second Intervention Period||2
8394421|NCT01033487|20689298|P3|STARTED|Second Intervention Period||2
8394422|NCT01033487|20689299|P2|STARTED|Second Intervention Period||3
8394423|NCT01033487|20689300|P1|STARTED|Second Intervention Period||2
8394424|NCT01033487|20689291|P10|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394425|NCT01033487|20689292|P9|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394426|NCT01033487|20689293|P8|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394427|NCT01033487|20689294|P7|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394428|NCT01033487|20689295|P6|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394429|NCT01033487|20689296|P5|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394430|NCT01033487|20689297|P4|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394431|NCT01033487|20689298|P3|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394432|NCT01033487|20689299|P2|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394433|NCT01033487|20689300|P1|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
8394434|NCT01033487|20689291|P10|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394435|NCT01033487|20689292|P9|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394436|NCT01033487|20689293|P8|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
8394437|NCT01033487|20689294|P7|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394438|NCT01033487|20689295|P6|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394439|NCT01033487|20689296|P5|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394440|NCT01033487|20689297|P4|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394441|NCT01033487|20689298|P3|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394442|NCT01033487|20689299|P2|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
8394443|NCT01033487|20689300|P1|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
8394444|NCT01033487|20689291|P10|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394445|NCT01033487|20689292|P9|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394446|NCT01033487|20689293|P8|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
8394447|NCT01033487|20689294|P7|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394448|NCT01033487|20689295|P6|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394449|NCT01033487|20689296|P5|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394450|NCT01033487|20689297|P4|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394451|NCT01033487|20689298|P3|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394452|NCT01033487|20689299|P2|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
8394453|NCT01033487|20689300|P1|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
8394454|NCT01033487|20689291|P10|NOT COMPLETED|First Intervention Period||0
8394455|NCT01033487|20689292|P9|NOT COMPLETED|First Intervention Period||0
8394456|NCT01033487|20689293|P8|NOT COMPLETED|First Intervention Period||0
8394457|NCT01033487|20689294|P7|NOT COMPLETED|First Intervention Period||0
8394458|NCT01033487|20689295|P6|NOT COMPLETED|First Intervention Period||0
8394459|NCT01033487|20689296|P5|NOT COMPLETED|First Intervention Period||0
8394460|NCT01033487|20689297|P4|NOT COMPLETED|First Intervention Period||0
8394461|NCT01033487|20689298|P3|NOT COMPLETED|First Intervention Period||0
8394462|NCT01033487|20689299|P2|NOT COMPLETED|First Intervention Period||0
8394463|NCT01033487|20689300|P1|NOT COMPLETED|First Intervention Period||0
8394464|NCT01033487|20689291|P10|COMPLETED|First Intervention Period||2
8394465|NCT01033487|20689292|P9|COMPLETED|First Intervention Period||2
8394466|NCT01033487|20689293|P8|COMPLETED|First Intervention Period||3
8394467|NCT01033487|20689294|P7|COMPLETED|First Intervention Period||2
8394468|NCT01033487|20689295|P6|COMPLETED|First Intervention Period||2
8394469|NCT01033487|20689296|P5|COMPLETED|First Intervention Period||2
8394470|NCT01033487|20689297|P4|COMPLETED|First Intervention Period||2
8394471|NCT01033487|20689298|P3|COMPLETED|First Intervention Period||2
8394472|NCT01033487|20689299|P2|COMPLETED|First Intervention Period||3
8394473|NCT01033487|20689300|P1|COMPLETED|First Intervention Period||2
8394474|NCT01033487|20689291|P10|STARTED|First Intervention Period||2
8394475|NCT01033487|20689292|P9|STARTED|First Intervention Period||2
8394476|NCT01033487|20689293|P8|STARTED|First Intervention Period||3
8394477|NCT01033487|20689294|P7|STARTED|First Intervention Period||2
8394478|NCT01033487|20689295|P6|STARTED|First Intervention Period||2
8394479|NCT01033487|20689296|P5|STARTED|First Intervention Period||2
8394480|NCT01033487|20689297|P4|STARTED|First Intervention Period||2
8394481|NCT01033487|20689298|P3|STARTED|First Intervention Period||2
8394482|NCT01033487|20689299|P2|STARTED|First Intervention Period||3
8394483|NCT01033487|20689300|P1|STARTED|First Intervention Period||2
8394484|NCT01033448|20689354|P1|NOT COMPLETED|Overall Study||12
8394485|NCT01033448|20689354|P1|COMPLETED|Overall Study||47
8394486|NCT01033448|20689354|P1|STARTED|Overall Study||59
8394487|NCT01033422|20689365|P3|NOT COMPLETED|Overall Study||1
8394488|NCT01033422|20689366|P2|NOT COMPLETED|Overall Study||4
8394489|NCT01033422|20689367|P1|NOT COMPLETED|Overall Study||1
8394490|NCT01033422|20689365|P3|COMPLETED|Overall Study||22
8394491|NCT01033422|20689366|P2|COMPLETED|Overall Study||28
8394492|NCT01033422|20689367|P1|COMPLETED|Overall Study||33
8394493|NCT01033422|20689365|P3|STARTED|Overall Study||23
8394494|NCT01033422|20689366|P2|STARTED|Overall Study||32
8394495|NCT01033422|20689367|P1|STARTED|Overall Study||34
8394496|NCT01033383|20689379|P4|NOT COMPLETED|Overall Study||0
8394497|NCT01033383|20689380|P3|NOT COMPLETED|Overall Study||0
8394498|NCT01033383|20689381|P2|NOT COMPLETED|Overall Study||0
8394499|NCT01033383|20689382|P1|NOT COMPLETED|Overall Study||0
8394500|NCT01033383|20689379|P4|COMPLETED|Overall Study||20
8394501|NCT01033383|20689380|P3|COMPLETED|Overall Study||20
8394502|NCT01033383|20689381|P2|COMPLETED|Overall Study||20
8394503|NCT01033383|20689382|P1|COMPLETED|Overall Study||20
8394504|NCT01033383|20689379|P4|STARTED|Overall Study||20
8394505|NCT01033383|20689380|P3|STARTED|Overall Study||20
8394506|NCT01033383|20689381|P2|STARTED|Overall Study||20
8394507|NCT01033383|20689382|P1|STARTED|Overall Study||20
8394508|NCT01033227|20689402|P2|NOT COMPLETED|Overall Study||0
8394509|NCT01033227|20689403|P1|NOT COMPLETED|Overall Study||0
8394510|NCT01033227|20689402|P2|COMPLETED|Overall Study||2
8394511|NCT01033227|20689403|P1|COMPLETED|Overall Study||3
8394512|NCT01033227|20689402|P2|STARTED|Overall Study||2
8394513|NCT01033227|20689403|P1|STARTED|Overall Study||3
8394514|NCT01033136|20689413|P2|NOT COMPLETED|Follow-Up (3 Month)||2
8394515|NCT01033136|20689414|P1|NOT COMPLETED|Follow-Up (3 Month)||2
8394516|NCT01033136|20689413|P2|COMPLETED|Follow-Up (3 Month)||13
8394517|NCT01033136|20689414|P1|COMPLETED|Follow-Up (3 Month)||14
8394518|NCT01033136|20689413|P2|STARTED|Follow-Up (3 Month)||15
8394519|NCT01033136|20689414|P1|STARTED|Follow-Up (3 Month)||16
8394520|NCT01033136|20689413|P2|NOT COMPLETED|Post-Treatment (1 Week)||11
8394521|NCT01033136|20689414|P1|NOT COMPLETED|Post-Treatment (1 Week)||14
8394522|NCT01033136|20689413|P2|COMPLETED|Post-Treatment (1 Week)||15
8394523|NCT01033136|20689414|P1|COMPLETED|Post-Treatment (1 Week)||16
8394524|NCT01033136|20689413|P2|STARTED|Post-Treatment (1 Week)||26
8394525|NCT01033136|20689414|P1|STARTED|Post-Treatment (1 Week)||30
8394526|NCT01033136|20689413|P2|NOT COMPLETED|Baseline Assessment||6
8394527|NCT01033136|20689414|P1|NOT COMPLETED|Baseline Assessment||6
8394528|NCT01033136|20689413|P2|COMPLETED|Baseline Assessment||26
8394529|NCT01033136|20689414|P1|COMPLETED|Baseline Assessment||30
8394530|NCT01033136|20689413|P2|STARTED|Baseline Assessment||32
8394531|NCT01033136|20689414|P1|STARTED|Baseline Assessment||36
8394532|NCT01033071|20689425|P3|NOT COMPLETED|Overall Study||47
8394533|NCT01033071|20689426|P2|NOT COMPLETED|Overall Study||77
8394534|NCT01033071|20689427|P1|NOT COMPLETED|Overall Study||55
8394535|NCT01033071|20689425|P3|COMPLETED|Overall Study||317
8394536|NCT01033071|20689426|P2|COMPLETED|Overall Study||275
8394537|NCT01033071|20689427|P1|COMPLETED|Overall Study||300
8394538|NCT01033071|20689425|P3|STARTED|Overall Study||364
8394539|NCT01033071|20689426|P2|STARTED|Overall Study||352
8394540|NCT01033071|20689427|P1|STARTED|Overall Study||355
8394541|NCT01033032|20689486|P4|NOT COMPLETED|Phase II||0
8394542|NCT01033032|20689487|P3|NOT COMPLETED|Phase II||66
8394543|NCT01033032|20689488|P2|NOT COMPLETED|Phase II||0
8394544|NCT01033032|20689489|P1|NOT COMPLETED|Phase II||0
8394545|NCT01033032|20689486|P4|COMPLETED|Phase II||0
8394546|NCT01033032|20689487|P3|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
8394547|NCT01033032|20689488|P2|COMPLETED|Phase II||0
8394548|NCT01033032|20689489|P1|COMPLETED|Phase II||0
8394549|NCT01033032|20689486|P4|STARTED|Phase II||0
8394550|NCT01033032|20689487|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
8394551|NCT01033032|20689488|P2|STARTED|Phase II||0
8394552|NCT01033032|20689489|P1|STARTED|Phase II||0
8394553|NCT01033032|20689486|P4|NOT COMPLETED|Phase I||6
8394554|NCT01033032|20689487|P3|NOT COMPLETED|Phase I||0
8394555|NCT01033032|20689488|P2|NOT COMPLETED|Phase I||3
8394556|NCT01033032|20689489|P1|NOT COMPLETED|Phase I||3
8394557|NCT01033032|20689486|P4|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8394558|NCT01033032|20689487|P3|COMPLETED|Phase I||3
8394559|NCT01033032|20689488|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8394560|NCT01033032|20689489|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8394561|NCT01033032|20689486|P4|STARTED|Phase I||6
8394562|NCT01033032|20689487|P3|STARTED|Phase I||3
8394563|NCT01033032|20689488|P2|STARTED|Phase I||3
8394564|NCT01033032|20689489|P1|STARTED|Phase I||3
8394565|NCT01033019|20689498|P2|NOT COMPLETED|Overall Study||0
8394566|NCT01033019|20689499|P1|NOT COMPLETED|Overall Study||1
8394567|NCT01033019|20689498|P2|COMPLETED|Overall Study||8
8394568|NCT01033019|20689499|P1|COMPLETED|Overall Study||15
8394569|NCT01033019|20689498|P2|STARTED|Overall Study||8
8394570|NCT01033019|20689499|P1|STARTED|Overall Study||16
8394571|NCT01032993|20689508|P2|NOT COMPLETED|Overall Study||0
8394572|NCT01032993|20689509|P1|NOT COMPLETED|Overall Study||0
8394573|NCT01032993|20689508|P2|COMPLETED|Overall Study||20
8394574|NCT01032993|20689509|P1|COMPLETED|Overall Study||19
8394575|NCT01032993|20689508|P2|STARTED|Overall Study||20
8394576|NCT01032993|20689509|P1|STARTED|Overall Study||19
8394577|NCT01032954|20689524|P3|NOT COMPLETED|Overall Study||0
8394578|NCT01032954|20689525|P2|NOT COMPLETED|Overall Study||1
8394579|NCT01032954|20689526|P1|NOT COMPLETED|Overall Study||4
8394580|NCT01032954|20689524|P3|COMPLETED|Overall Study||30
8394581|NCT01032954|20689525|P2|COMPLETED|Overall Study||29
8394582|NCT01032954|20689526|P1|COMPLETED|Overall Study||26
8394583|NCT01032954|20689524|P3|STARTED|Overall Study||30
8394584|NCT01032954|20689525|P2|STARTED|Overall Study||30
8394585|NCT01032954|20689526|P1|STARTED|Overall Study||30
8394586|NCT01032928|20689540|P1|NOT COMPLETED|Overall Study||0
8394587|NCT01032928|20689540|P1|COMPLETED|Overall Study||30
8394588|NCT01032928|20689540|P1|STARTED|Overall Study||30
8394589|NCT01032915|20689556|P4|NOT COMPLETED|Overall Study||7
8394590|NCT01032915|20689557|P3|NOT COMPLETED|Overall Study||7
8394591|NCT01032915|20689558|P2|NOT COMPLETED|Overall Study||11
8394592|NCT01032915|20689559|P1|NOT COMPLETED|Overall Study||8
8394593|NCT01032915|20689556|P4|COMPLETED|Overall Study||27
8394594|NCT01032915|20689557|P3|COMPLETED|Overall Study||24
8394595|NCT01032915|20689558|P2|COMPLETED|Overall Study||20
8394596|NCT01032915|20689559|P1|COMPLETED|Overall Study||21
8394597|NCT01032915|20689556|P4|STARTED|Overall Study||34
8394598|NCT01032915|20689557|P3|STARTED|Overall Study||31
8394599|NCT01032915|20689558|P2|STARTED|Overall Study||31
8394600|NCT01032915|20689559|P1|STARTED|Overall Study||29
8394601|NCT01032889|20689584|P3|NOT COMPLETED|Overall Study||3
8394602|NCT01032889|20689585|P2|NOT COMPLETED|Overall Study||15
8394603|NCT01032889|20689586|P1|NOT COMPLETED|Overall Study||8
8394604|NCT01032889|20689584|P3|COMPLETED|Overall Study||42
8394605|NCT01032889|20689585|P2|COMPLETED|Overall Study||28
8394606|NCT01032889|20689586|P1|COMPLETED|Overall Study||33
8394607|NCT01032889|20689584|P3|Received Treatment|Overall Study||45
8394608|NCT01032889|20689585|P2|Received Treatment|Overall Study||43
8394609|NCT01032889|20689586|P1|Received Treatment|Overall Study||41
8394610|NCT01032889|20689584|P3|STARTED|Overall Study||45
8394611|NCT01032889|20689585|P2|STARTED|Overall Study||43
8394612|NCT01032889|20689586|P1|STARTED|Overall Study||41
8394616|NCT01032837|20689617|P4|NOT COMPLETED|Overall Study||3
8394617|NCT01032837|20689618|P3|NOT COMPLETED|Overall Study||1
8394618|NCT01032837|20689619|P2|NOT COMPLETED|Overall Study||3
8394619|NCT01032837|20689620|P1|NOT COMPLETED|Overall Study||0
8394620|NCT01032837|20689617|P4|COMPLETED|Overall Study|Represents patients who completed treatment.|22
8394621|NCT01032837|20689618|P3|COMPLETED|Overall Study|Represents patients who completed treatment.|24
8394622|NCT01032837|20689619|P2|COMPLETED|Overall Study|Represents patients who completed treatment.|23
8394623|NCT01032837|20689620|P1|COMPLETED|Overall Study|Represents patients who completed treatment.|26
8394624|NCT01032837|20689617|P4|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
8394625|NCT01032837|20689618|P3|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
8394626|NCT01032837|20689619|P2|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
8394627|NCT01032837|20689620|P1|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
8394628|NCT01032837|20689617|P4|STARTED|Overall Study||25
8394629|NCT01032837|20689618|P3|STARTED|Overall Study||25
8394630|NCT01032837|20689619|P2|STARTED|Overall Study||26
8394631|NCT01032837|20689620|P1|STARTED|Overall Study||26
8394632|NCT01032759|20689668|P2|NOT COMPLETED|Overall Study||3
8394633|NCT01032759|20689669|P1|NOT COMPLETED|Overall Study||1
8394634|NCT01032759|20689668|P2|COMPLETED|Overall Study||28
8394635|NCT01032759|20689669|P1|COMPLETED|Overall Study||31
8394636|NCT01032759|20689668|P2|Completed 48 Hour Assessment|Overall Study||28
8394637|NCT01032759|20689669|P1|Completed 48 Hour Assessment|Overall Study||31
8394638|NCT01032759|20689668|P2|Completed 24 Hour Assessment|Overall Study||30
8394639|NCT01032759|20689669|P1|Completed 24 Hour Assessment|Overall Study||32
8394640|NCT01032759|20689668|P2|STARTED|Overall Study||31
8394641|NCT01032759|20689669|P1|STARTED|Overall Study||32
8394642|NCT01032733|20689689|P2|NOT COMPLETED|Overall Study||1
8394643|NCT01032733|20689690|P1|NOT COMPLETED|Overall Study||1
8394644|NCT01032733|20689689|P2|COMPLETED|Overall Study||16
8394645|NCT01032733|20689690|P1|COMPLETED|Overall Study||16
8394646|NCT01032733|20689689|P2|STARTED|Overall Study||17
8394647|NCT01032733|20689690|P1|STARTED|Overall Study||17
8394648|NCT01032694|20689706|P2|NOT COMPLETED|Overall Study||0
8394649|NCT01032694|20689707|P1|NOT COMPLETED|Overall Study||0
8394650|NCT01032694|20689706|P2|COMPLETED|Overall Study||10
8394651|NCT01032694|20689707|P1|COMPLETED|Overall Study||20
8394652|NCT01032694|20689706|P2|STARTED|Overall Study||10
8394653|NCT01032694|20689707|P1|STARTED|Overall Study||20
8394654|NCT01032629|20689720|P3|NOT COMPLETED|Overall Study||88
8394655|NCT01032629|20689721|P2|NOT COMPLETED|Overall Study||101
8394656|NCT01032629|20689722|P1|NOT COMPLETED|Overall Study||145
8394657|NCT01032629|20689720|P3|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
8394658|NCT01032629|20689721|P2|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
8394659|NCT01032629|20689722|P1|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
8394660|NCT01032629|20689720|P3|Treated|Overall Study||1441
8394661|NCT01032629|20689721|P2|Treated|Overall Study||1445
8394662|NCT01032629|20689722|P1|Treated|Overall Study||1441
8394663|NCT01032629|20689720|P3|STARTED|Overall Study||1443
8394664|NCT01032629|20689721|P2|STARTED|Overall Study||1445
8394665|NCT01032629|20689722|P1|STARTED|Overall Study||1442
8394672|NCT01032538|20689826|P1|NOT COMPLETED|Overall Study||0
8394673|NCT01032538|20689826|P1|COMPLETED|Overall Study|Knees|99
8394674|NCT01032538|20689826|P1|STARTED|Overall Study|Knees|99
8394675|NCT01032382|20689834|P2|NOT COMPLETED|Overall Study||5
8394676|NCT01032382|20689835|P1|NOT COMPLETED|Overall Study||5
8394677|NCT01032382|20689834|P2|COMPLETED|Overall Study||9
8394678|NCT01032382|20689835|P1|COMPLETED|Overall Study||11
8394679|NCT01032382|20689834|P2|STARTED|Overall Study||14
8394680|NCT01032382|20689835|P1|STARTED|Overall Study||16
8394681|NCT01032330|20689865|P4|NOT COMPLETED|Overall Study||14
8394682|NCT01032330|20689866|P3|NOT COMPLETED|Overall Study||10
8394683|NCT01032330|20689867|P2|NOT COMPLETED|Overall Study||24
8394684|NCT01032330|20689868|P1|NOT COMPLETED|Overall Study||18
8394685|NCT01032330|20689865|P4|COMPLETED|Overall Study||90
8394686|NCT01032330|20689866|P3|COMPLETED|Overall Study||87
8394687|NCT01032330|20689867|P2|COMPLETED|Overall Study||151
8394688|NCT01032330|20689868|P1|COMPLETED|Overall Study||165
8394689|NCT01032330|20689865|P4|STARTED|Overall Study||104
8394690|NCT01032330|20689866|P3|STARTED|Overall Study||97
8394691|NCT01032330|20689867|P2|STARTED|Overall Study||175
8394692|NCT01032330|20689868|P1|STARTED|Overall Study||183
8394693|NCT01032291|20689923|P3|NOT COMPLETED|Proof of Concept||3
8394694|NCT01032291|20689924|P2|NOT COMPLETED|Proof of Concept||8
8394695|NCT01032291|20689925|P1|NOT COMPLETED|Proof of Concept||0
8394696|NCT01032291|20689923|P3|COMPLETED|Proof of Concept|Participants with disease progression|18
8394697|NCT01032291|20689924|P2|COMPLETED|Proof of Concept|Participants with disease progression|14
8394698|NCT01032291|20689925|P1|COMPLETED|Proof of Concept||0
8394699|NCT01032291|20689923|P3|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
8394700|NCT01032291|20689924|P2|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
8394701|NCT01032291|20689925|P1|Intent to Treat and Safety Populations|Proof of Concept||0
8394702|NCT01032291|20689923|P3|STARTED|Proof of Concept||21
8394703|NCT01032291|20689924|P2|STARTED|Proof of Concept||22
8394704|NCT01032291|20689925|P1|STARTED|Proof of Concept||0
8394705|NCT01032291|20689923|P3|NOT COMPLETED|Safety Lead-in||0
8394706|NCT01032291|20689924|P2|NOT COMPLETED|Safety Lead-in||0
8394707|NCT01032291|20689925|P1|NOT COMPLETED|Safety Lead-in||2
8394708|NCT01032291|20689923|P3|COMPLETED|Safety Lead-in||0
8394709|NCT01032291|20689924|P2|COMPLETED|Safety Lead-in||0
8394710|NCT01032291|20689925|P1|COMPLETED|Safety Lead-in|Participants with disease progression|6
8394711|NCT01032291|20689923|P3|STARTED|Safety Lead-in||0
8394712|NCT01032291|20689924|P2|STARTED|Safety Lead-in||0
8394713|NCT01032291|20689925|P1|STARTED|Safety Lead-in||8
8394714|NCT01032265|20689951|P2|NOT COMPLETED|Overall Study||17
8394715|NCT01032265|20689952|P1|NOT COMPLETED|Overall Study||13
8394716|NCT01032265|20689951|P2|COMPLETED|Overall Study||107
8394717|NCT01032265|20689952|P1|COMPLETED|Overall Study||113
8394718|NCT01032265|20689951|P2|STARTED|Overall Study||124
8394719|NCT01032265|20689952|P1|STARTED|Overall Study||126
8394720|NCT01032239|20689972|P2|NOT COMPLETED|Overall Study||5
8394721|NCT01032239|20689973|P1|NOT COMPLETED|Overall Study||7
8394722|NCT01032239|20689972|P2|COMPLETED|Overall Study||24
8394723|NCT01032239|20689973|P1|COMPLETED|Overall Study||24
8394724|NCT01032239|20689972|P2|Implant|Overall Study||0
8394725|NCT01032239|20689973|P1|Implant|Overall Study|implanted|25
8394726|NCT01032239|20689972|P2|STARTED|Overall Study|randomized to BMT arm|29
8394727|NCT01032239|20689973|P1|STARTED|Overall Study|randomized to ITB arm|31
8394728|NCT01032200|20690003|P2|NOT COMPLETED|Overall Study||7
8394729|NCT01032200|20690004|P1|NOT COMPLETED|Overall Study||4
8394730|NCT01032200|20690003|P2|COMPLETED|Overall Study||21
8394731|NCT01032200|20690004|P1|COMPLETED|Overall Study||22
8394732|NCT01032200|20690003|P2|STARTED|Overall Study||28
8394733|NCT01032200|20690004|P1|STARTED|Overall Study||26
8394734|NCT01032174|20690020|P2|NOT COMPLETED|Overall Study||1
8394735|NCT01032174|20690021|P1|NOT COMPLETED|Overall Study||0
8394736|NCT01032174|20690020|P2|COMPLETED|Overall Study||59
8394737|NCT01032174|20690021|P1|COMPLETED|Overall Study||63
8394738|NCT01032174|20690020|P2|STARTED|Overall Study||60
8394739|NCT01032174|20690021|P1|STARTED|Overall Study||63
8394740|NCT01032135|20690036|P7|NOT COMPLETED|8 Week Randomization||18
8394741|NCT01032135|20690037|P6|NOT COMPLETED|8 Week Randomization||17
8394742|NCT01032135|20690038|P5|NOT COMPLETED|8 Week Randomization||9
8394743|NCT01032135|20690039|P4|NOT COMPLETED|8 Week Randomization||11
8394744|NCT01032135|20690040|P3|NOT COMPLETED|8 Week Randomization||0
8394745|NCT01032135|20690041|P2|NOT COMPLETED|8 Week Randomization||0
8394746|NCT01032135|20690042|P1|NOT COMPLETED|8 Week Randomization||26
8394747|NCT01032135|20690036|P7|COMPLETED|8 Week Randomization||36
8394748|NCT01032135|20690037|P6|COMPLETED|8 Week Randomization||31
8394749|NCT01032135|20690038|P5|COMPLETED|8 Week Randomization||34
8394750|NCT01032135|20690039|P4|COMPLETED|8 Week Randomization||30
8394751|NCT01032135|20690040|P3|COMPLETED|8 Week Randomization||0
8394752|NCT01032135|20690041|P2|COMPLETED|8 Week Randomization||0
8394753|NCT01032135|20690042|P1|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
8394754|NCT01032135|20690036|P7|12 Week Follow up|8 Week Randomization||41
8394755|NCT01032135|20690037|P6|12 Week Follow up|8 Week Randomization||36
8394756|NCT01032135|20690038|P5|12 Week Follow up|8 Week Randomization||38
8394757|NCT01032135|20690039|P4|12 Week Follow up|8 Week Randomization||34
8394758|NCT01032135|20690040|P3|12 Week Follow up|8 Week Randomization||0
8394759|NCT01032135|20690041|P2|12 Week Follow up|8 Week Randomization||0
8394760|NCT01032135|20690042|P1|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
8394761|NCT01032135|20690036|P7|STARTED|8 Week Randomization||54
8394762|NCT01032135|20690037|P6|STARTED|8 Week Randomization||48
8394763|NCT01032135|20690038|P5|STARTED|8 Week Randomization||43
8394764|NCT01032135|20690039|P4|STARTED|8 Week Randomization||41
8394765|NCT01032135|20690040|P3|STARTED|8 Week Randomization||0
8394766|NCT01032135|20690041|P2|STARTED|8 Week Randomization||0
8394767|NCT01032135|20690042|P1|STARTED|8 Week Randomization||227
8394768|NCT01032135|20690036|P7|NOT COMPLETED|2 Week Randomization||0
8394769|NCT01032135|20690037|P6|NOT COMPLETED|2 Week Randomization||0
8394770|NCT01032135|20690038|P5|NOT COMPLETED|2 Week Randomization||0
8394771|NCT01032135|20690039|P4|NOT COMPLETED|2 Week Randomization||0
8394772|NCT01032135|20690040|P3|NOT COMPLETED|2 Week Randomization||0
8394773|NCT01032135|20690041|P2|NOT COMPLETED|2 Week Randomization||0
8394774|NCT01032135|20690042|P1|NOT COMPLETED|2 Week Randomization||0
8394775|NCT01032135|20690036|P7|COMPLETED|2 Week Randomization||0
8394776|NCT01032135|20690037|P6|COMPLETED|2 Week Randomization||0
8394777|NCT01032135|20690038|P5|COMPLETED|2 Week Randomization||0
8394778|NCT01032135|20690039|P4|COMPLETED|2 Week Randomization||0
8394779|NCT01032135|20690040|P3|COMPLETED|2 Week Randomization||96
8394780|NCT01032135|20690041|P2|COMPLETED|2 Week Randomization||93
8394781|NCT01032135|20690042|P1|COMPLETED|2 Week Randomization||311
8394782|NCT01032135|20690036|P7|STARTED|2 Week Randomization||0
8394783|NCT01032135|20690037|P6|STARTED|2 Week Randomization||0
8394784|NCT01032135|20690038|P5|STARTED|2 Week Randomization||0
8394785|NCT01032135|20690039|P4|STARTED|2 Week Randomization||0
8394786|NCT01032135|20690040|P3|STARTED|2 Week Randomization||96
8394787|NCT01032135|20690041|P2|STARTED|2 Week Randomization||93
8394788|NCT01032135|20690042|P1|STARTED|2 Week Randomization||311
8394789|NCT01032070|20690261|P2|NOT COMPLETED|Overall Study||12
8394790|NCT01032070|20690262|P1|NOT COMPLETED|Overall Study||13
8394791|NCT01032070|20690261|P2|COMPLETED|Overall Study||0
8394792|NCT01032070|20690262|P1|COMPLETED|Overall Study||0
8394793|NCT01032070|20690261|P2|STARTED|Overall Study||12
8394794|NCT01032070|20690262|P1|STARTED|Overall Study||13
8394795|NCT01032044|20690291|P2|NOT COMPLETED|Overall Study||20
8394796|NCT01032044|20690292|P1|NOT COMPLETED|Overall Study||25
8394797|NCT01032044|20690291|P2|COMPLETED|Overall Study||62
8394798|NCT01032044|20690292|P1|COMPLETED|Overall Study||57
8394799|NCT01032044|20690291|P2|Procedure|Overall Study||75
8394800|NCT01032044|20690292|P1|Procedure|Overall Study||74
8394801|NCT01032044|20690291|P2|STARTED|Overall Study||82
8394802|NCT01032044|20690292|P1|STARTED|Overall Study||82
8394803|NCT01032018|20690300|P2|NOT COMPLETED|Overall Study||6
8394804|NCT01032018|20690301|P1|NOT COMPLETED|Overall Study||6
8394805|NCT01032018|20690300|P2|COMPLETED|Overall Study||67
8394806|NCT01032018|20690301|P1|COMPLETED|Overall Study||71
8394807|NCT01032018|20690300|P2|STARTED|Overall Study||73
8394808|NCT01032018|20690301|P1|STARTED|Overall Study||77
8394809|NCT01031979|20690311|P2|NOT COMPLETED|Overall Study||4
8394810|NCT01031979|20690312|P1|NOT COMPLETED|Overall Study||5
8394811|NCT01031979|20690311|P2|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
8394812|NCT01031979|20690312|P1|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
8394813|NCT01031979|20690311|P2|Completed Primary Outcome Measure|Overall Study||12
8394814|NCT01031979|20690312|P1|Completed Primary Outcome Measure|Overall Study||12
8394815|NCT01031979|20690311|P2|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
8394816|NCT01031979|20690312|P1|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
8394817|NCT01031953|20690324|P1|NOT COMPLETED|Overall Study||0
8394818|NCT01031953|20690324|P1|COMPLETED|Overall Study||11
8394819|NCT01031953|20690324|P1|STARTED|Overall Study||11
8394820|NCT01031914|20690335|P1|NOT COMPLETED|Overall Study||0
8394821|NCT01031914|20690335|P1|COMPLETED|Overall Study||36
8394822|NCT01031914|20690335|P1|STARTED|Overall Study||36
8394823|NCT01031836|20690345|P6|NOT COMPLETED|Stage II||1
8394824|NCT01031836|20690346|P5|NOT COMPLETED|Stage II||2
8394825|NCT01031836|20690347|P4|NOT COMPLETED|Stage II||3
8394826|NCT01031836|20690348|P3|NOT COMPLETED|Stage II||2
8394827|NCT01031836|20690349|P2|NOT COMPLETED|Stage II||0
8394828|NCT01031836|20690350|P1|NOT COMPLETED|Stage II||2
8394829|NCT01031836|20690345|P6|COMPLETED|Stage II||3
8394830|NCT01031836|20690346|P5|COMPLETED|Stage II||3
8394831|NCT01031836|20690347|P4|COMPLETED|Stage II||1
8394832|NCT01031836|20690348|P3|COMPLETED|Stage II||2
8394833|NCT01031836|20690349|P2|COMPLETED|Stage II||1
8394834|NCT01031836|20690350|P1|COMPLETED|Stage II||1
8394835|NCT01031836|20690345|P6|STARTED|Stage II||4
8394836|NCT01031836|20690346|P5|STARTED|Stage II||5
8394837|NCT01031836|20690347|P4|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
8394838|NCT01031836|20690348|P3|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
8394839|NCT01031836|20690349|P2|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
8394840|NCT01031836|20690350|P1|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
8394841|NCT01031836|20690345|P6|NOT COMPLETED|Stage I||1
8394842|NCT01031836|20690346|P5|NOT COMPLETED|Stage I||0
8394843|NCT01031836|20690347|P4|NOT COMPLETED|Stage I||0
8394844|NCT01031836|20690348|P3|NOT COMPLETED|Stage I||0
8394845|NCT01031836|20690349|P2|NOT COMPLETED|Stage I||2
8394846|NCT01031836|20690350|P1|NOT COMPLETED|Stage I||1
8394847|NCT01031836|20690345|P6|COMPLETED|Stage I||4
8394848|NCT01031836|20690346|P5|COMPLETED|Stage I||5
8394849|NCT01031836|20690347|P4|COMPLETED|Stage I||5
8394850|NCT01031836|20690348|P3|COMPLETED|Stage I||5
8394851|NCT01031836|20690349|P2|COMPLETED|Stage I||3
8394852|NCT01031836|20690350|P1|COMPLETED|Stage I||4
8394853|NCT01031836|20690345|P6|STARTED|Stage I||5
8394854|NCT01031836|20690346|P5|STARTED|Stage I||5
8394855|NCT01031836|20690347|P4|STARTED|Stage I||5
8394856|NCT01031836|20690348|P3|STARTED|Stage I||5
8394857|NCT01031836|20690349|P2|STARTED|Stage I||5
8394858|NCT01031836|20690350|P1|STARTED|Stage I||5
8394859|NCT01031810|20690400|P1|NOT COMPLETED|Overall Study||4
8394860|NCT01031810|20690400|P1|COMPLETED|Overall Study||9
8394861|NCT01031810|20690400|P1|STARTED|Overall Study||13
8394862|NCT01031706|20690411|P2|NOT COMPLETED|Overall Study||1
8394863|NCT01031706|20690412|P1|NOT COMPLETED|Overall Study||2
8394864|NCT01031706|20690411|P2|COMPLETED|Overall Study||8
8394865|NCT01031706|20690412|P1|COMPLETED|Overall Study||12
8394866|NCT01031706|20690411|P2|STARTED|Overall Study||9
8394867|NCT01031706|20690412|P1|STARTED|Overall Study||14
8394868|NCT01031680|20690422|P2|NOT COMPLETED|Overall Study||58
8394869|NCT01031680|20690423|P1|NOT COMPLETED|Overall Study||57
8394870|NCT01031680|20690422|P2|COMPLETED|Overall Study||404
8394871|NCT01031680|20690423|P1|COMPLETED|Overall Study||403
8394872|NCT01031680|20690422|P2|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
8394873|NCT01031680|20690423|P1|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
8394874|NCT01031628|20690443|P4|NOT COMPLETED|Overall Study||0
8394875|NCT01031628|20690444|P3|NOT COMPLETED|Overall Study||3
8394876|NCT01031628|20690445|P2|NOT COMPLETED|Overall Study||1
8394877|NCT01031628|20690446|P1|NOT COMPLETED|Overall Study||0
8394878|NCT01031628|20690443|P4|COMPLETED|Overall Study||0
8394879|NCT01031628|20690444|P3|COMPLETED|Overall Study||0
8394880|NCT01031628|20690445|P2|COMPLETED|Overall Study||0
8394881|NCT01031628|20690446|P1|COMPLETED|Overall Study||0
8394882|NCT01031628|20690443|P4|STARTED|Overall Study||0
8394883|NCT01031628|20690444|P3|STARTED|Overall Study||3
8394884|NCT01031628|20690445|P2|STARTED|Overall Study||1
8394885|NCT01031628|20690446|P1|STARTED|Overall Study||0
8394886|NCT01031550|20690458|P2|NOT COMPLETED|Overall Study||0
8394887|NCT01031550|20690459|P1|NOT COMPLETED|Overall Study||0
8394888|NCT01031550|20690458|P2|COMPLETED|Overall Study||3
8394889|NCT01031550|20690459|P1|COMPLETED|Overall Study||5
8394890|NCT01031550|20690458|P2|STARTED|Overall Study||3
8394891|NCT01031550|20690459|P1|STARTED|Overall Study||5
8394892|NCT01031537|20690471|P1|NOT COMPLETED|Overall Study||32
8394893|NCT01031537|20690471|P1|COMPLETED|Overall Study||34
8394894|NCT01031537|20690471|P1|STARTED|Overall Study||66
8394895|NCT01031498|20690479|P3|NOT COMPLETED|Overall Study||2
8394896|NCT01031498|20690480|P2|NOT COMPLETED|Overall Study||3
8394897|NCT01031498|20690481|P1|NOT COMPLETED|Overall Study||2
8394898|NCT01031498|20690479|P3|COMPLETED|Overall Study||48
8394899|NCT01031498|20690480|P2|COMPLETED|Overall Study||48
8394900|NCT01031498|20690481|P1|COMPLETED|Overall Study||47
8394901|NCT01031498|20690479|P3|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
8394902|NCT01031498|20690480|P2|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
8394903|NCT01031498|20690481|P1|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
8394904|NCT01031446|20690489|P1|NOT COMPLETED|Overall Study||55
8394905|NCT01031446|20690489|P1|COMPLETED|Overall Study||0
8394906|NCT01031446|20690489|P1|STARTED|Overall Study||55
8394907|NCT01031420|20690498|P1|NOT COMPLETED|Overall Study||10
8394908|NCT01031420|20690498|P1|COMPLETED|Overall Study||44
8394909|NCT01031420|20690498|P1|STARTED|Overall Study||54
8394910|NCT01031381|20690503|P1|NOT COMPLETED|Overall Study||9
8394911|NCT01031381|20690503|P1|COMPLETED|Overall Study||50
8394912|NCT01031381|20690503|P1|STARTED|Overall Study||59
8394913|NCT01031134|20690510|P2|NOT COMPLETED|Overall Study||10
8394914|NCT01031134|20690511|P1|NOT COMPLETED|Overall Study||11
8394915|NCT01031134|20690510|P2|COMPLETED|Overall Study||78
8394916|NCT01031134|20690511|P1|COMPLETED|Overall Study||103
8394917|NCT01031134|20690510|P2|STARTED|Overall Study||88
8394918|NCT01031134|20690511|P1|STARTED|Overall Study||114
8394919|NCT01031095|20690521|P2|NOT COMPLETED|Overall Study||0
8394920|NCT01031095|20690522|P1|NOT COMPLETED|Overall Study||0
8394921|NCT01031095|20690521|P2|COMPLETED|Overall Study||100
8394922|NCT01031095|20690522|P1|COMPLETED|Overall Study||100
8394923|NCT01031095|20690521|P2|STARTED|Overall Study||100
8394924|NCT01031095|20690522|P1|STARTED|Overall Study||100
8394925|NCT01031069|20690532|P4|NOT COMPLETED|Overall Study||34
8394926|NCT01031069|20690533|P3|NOT COMPLETED|Overall Study||41
8394927|NCT01031069|20690534|P2|NOT COMPLETED|Overall Study||11
8394928|NCT01031069|20690535|P1|NOT COMPLETED|Overall Study||12
8394929|NCT01031069|20690532|P4|COMPLETED|Overall Study||111
8394930|NCT01031069|20690533|P3|COMPLETED|Overall Study||103
8394931|NCT01031069|20690534|P2|COMPLETED|Overall Study||117
8394932|NCT01031069|20690535|P1|COMPLETED|Overall Study||117
8394933|NCT01031069|20690532|P4|STARTED|Overall Study||145
8394934|NCT01031069|20690533|P3|STARTED|Overall Study||144
8394935|NCT01031069|20690534|P2|STARTED|Overall Study||128
8394936|NCT01031069|20690535|P1|STARTED|Overall Study||129
8394937|NCT01031043|20690631|P1|NOT COMPLETED|Overall Study||1
8394938|NCT01031043|20690631|P1|COMPLETED|Overall Study||4
8394939|NCT01031043|20690631|P1|STARTED|Overall Study||5
8394940|NCT01031004|20690637|P2|NOT COMPLETED|Overall Study||1
8394941|NCT01031004|20690638|P1|NOT COMPLETED|Overall Study||1
8394942|NCT01031004|20690637|P2|COMPLETED|Overall Study||24
8394943|NCT01031004|20690638|P1|COMPLETED|Overall Study||24
8394944|NCT01031004|20690637|P2|STARTED|Overall Study||25
8394945|NCT01031004|20690638|P1|STARTED|Overall Study||25
8394946|NCT01030965|20690682|P4|NOT COMPLETED|Overall Study||7
8394947|NCT01030965|20690683|P3|NOT COMPLETED|Overall Study||4
8394948|NCT01030965|20690684|P2|NOT COMPLETED|Overall Study||6
8394949|NCT01030965|20690685|P1|NOT COMPLETED|Overall Study||4
8394950|NCT01030965|20690682|P4|COMPLETED|Overall Study||64
8394951|NCT01030965|20690683|P3|COMPLETED|Overall Study||68
8394952|NCT01030965|20690684|P2|COMPLETED|Overall Study||65
8394953|NCT01030965|20690685|P1|COMPLETED|Overall Study||67
8394954|NCT01030965|20690682|P4|STARTED|Overall Study||71
8394955|NCT01030965|20690683|P3|STARTED|Overall Study||72
8394956|NCT01030965|20690684|P2|STARTED|Overall Study||71
8394957|NCT01030965|20690685|P1|STARTED|Overall Study||71
8394958|NCT01030952|20690705|P2|NOT COMPLETED|Overall Study||3
8394959|NCT01030952|20690706|P1|NOT COMPLETED|Overall Study||2
8394960|NCT01030952|20690705|P2|COMPLETED|Overall Study||49
8394961|NCT01030952|20690706|P1|COMPLETED|Overall Study||49
8394962|NCT01030952|20690705|P2|STARTED|Overall Study||52
8394963|NCT01030952|20690706|P1|STARTED|Overall Study||51
8394964|NCT01030861|20690742|P2|NOT COMPLETED|Overall Study||0
8394965|NCT01030861|20690743|P1|NOT COMPLETED|Overall Study||0
8394966|NCT01030861|20690742|P2|COMPLETED|Overall Study||32
8394967|NCT01030861|20690743|P1|COMPLETED|Overall Study||44
8394968|NCT01030861|20690742|P2|STARTED|Overall Study||32
8394969|NCT01030861|20690743|P1|STARTED|Overall Study||44
8394970|NCT01030822|20690754|P3|NOT COMPLETED|Overall Study||26
8394971|NCT01030822|20690755|P2|NOT COMPLETED|Overall Study||24
8394972|NCT01030822|20690756|P1|NOT COMPLETED|Overall Study||31
8394973|NCT01030822|20690754|P3|COMPLETED|Overall Study||61
8394974|NCT01030822|20690755|P2|COMPLETED|Overall Study||71
8394975|NCT01030822|20690756|P1|COMPLETED|Overall Study||69
8394976|NCT01030822|20690754|P3|STARTED|Overall Study||87
8394977|NCT01030822|20690755|P2|STARTED|Overall Study||95
8394978|NCT01030822|20690756|P1|STARTED|Overall Study||100
8394979|NCT01030783|20690805|P2|NOT COMPLETED|Overall Study||26
8394980|NCT01030783|20690806|P1|NOT COMPLETED|Overall Study||49
8394981|NCT01030783|20690805|P2|COMPLETED|Overall Study||231
8394982|NCT01030783|20690806|P1|COMPLETED|Overall Study||211
8394983|NCT01030783|20690805|P2|STARTED|Overall Study||257
8394984|NCT01030783|20690806|P1|STARTED|Overall Study||260
8394985|NCT01030757|20690823|P1|NOT COMPLETED|Overall Study||0
8394986|NCT01030757|20690823|P1|COMPLETED|Overall Study||2
8394987|NCT01030757|20690823|P1|STARTED|Overall Study||2
8394988|NCT01030718|20690831|P3|NOT COMPLETED|Study CA180-036 Only||5
8394989|NCT01030718|20690832|P2|NOT COMPLETED|Study CA180-036 Only||7
8394990|NCT01030718|20690833|P1|NOT COMPLETED|Study CA180-036 Only||3
8394991|NCT01030718|20690831|P3|COMPLETED|Study CA180-036 Only||1
8394992|NCT01030718|20690832|P2|COMPLETED|Study CA180-036 Only||2
8394993|NCT01030718|20690833|P1|COMPLETED|Study CA180-036 Only||26
8394994|NCT01030718|20690831|P3|STARTED|Study CA180-036 Only||6
8394995|NCT01030718|20690832|P2|STARTED|Study CA180-036 Only||9
8394996|NCT01030718|20690833|P1|STARTED|Study CA180-036 Only||29
8394997|NCT01030718|20690831|P3|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
8394998|NCT01030718|20690832|P2|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
8394999|NCT01030718|20690833|P1|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
8395000|NCT01030718|20690831|P3|COMPLETED|Studies CA180-031 and -036 Combined||1
8395001|NCT01030718|20690832|P2|COMPLETED|Studies CA180-031 and -036 Combined||2
8395002|NCT01030718|20690833|P1|COMPLETED|Studies CA180-031 and -036 Combined||26
8395003|NCT01030718|20690831|P3|STARTED|Studies CA180-031 and -036 Combined||13
8395004|NCT01030718|20690832|P2|STARTED|Studies CA180-031 and -036 Combined||11
8395005|NCT01030718|20690833|P1|STARTED|Studies CA180-031 and -036 Combined||30
8395006|NCT01030666|20690894|P2|NOT COMPLETED|Overall Study||2
8395007|NCT01030666|20690895|P1|NOT COMPLETED|Overall Study||3
8395008|NCT01030666|20690894|P2|COMPLETED|Overall Study||31
8395009|NCT01030666|20690895|P1|COMPLETED|Overall Study||25
8395010|NCT01030666|20690894|P2|STARTED|Overall Study||33
8395011|NCT01030666|20690895|P1|STARTED|Overall Study||28
8395012|NCT01030653|20690905|P2|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
8395013|NCT01030653|20690906|P1|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
8395014|NCT01030653|20690905|P2|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
8395015|NCT01030653|20690906|P1|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
8395016|NCT01030653|20690905|P2|STARTED|Loading Dose & 2nd Maintenance Regimen||4
8395017|NCT01030653|20690906|P1|STARTED|Loading Dose & 2nd Maintenance Regimen||4
8395018|NCT01030653|20690905|P2|NOT COMPLETED|7-Day Washout Period||0
8395019|NCT01030653|20690906|P1|NOT COMPLETED|7-Day Washout Period||0
8395020|NCT01030653|20690905|P2|COMPLETED|7-Day Washout Period||4
8395021|NCT01030653|20690906|P1|COMPLETED|7-Day Washout Period||4
8395022|NCT01030653|20690905|P2|STARTED|7-Day Washout Period||4
8395023|NCT01030653|20690906|P1|STARTED|7-Day Washout Period||4
8395024|NCT01030653|20690905|P2|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
8395025|NCT01030653|20690906|P1|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
8395026|NCT01030653|20690905|P2|COMPLETED|Loading Dose & First Maintenance Regimen||4
8395027|NCT01030653|20690906|P1|COMPLETED|Loading Dose & First Maintenance Regimen||4
8395028|NCT01030653|20690905|P2|STARTED|Loading Dose & First Maintenance Regimen||4
8395029|NCT01030653|20690906|P1|STARTED|Loading Dose & First Maintenance Regimen||4
8395030|NCT01030536|20690920|P5|NOT COMPLETED|Overall Study||1
8395031|NCT01030536|20690921|P4|NOT COMPLETED|Overall Study||3
8395032|NCT01030536|20690922|P3|NOT COMPLETED|Overall Study||6
8395033|NCT01030536|20690923|P2|NOT COMPLETED|Overall Study||6
8395034|NCT01030536|20690924|P1|NOT COMPLETED|Overall Study||7
8395035|NCT01030536|20690920|P5|COMPLETED|Overall Study||0
8395036|NCT01030536|20690921|P4|COMPLETED|Overall Study||0
8395037|NCT01030536|20690922|P3|COMPLETED|Overall Study||0
8395038|NCT01030536|20690923|P2|COMPLETED|Overall Study||0
8395039|NCT01030536|20690924|P1|COMPLETED|Overall Study||0
8395040|NCT01030536|20690920|P5|STARTED|Overall Study||1
8395041|NCT01030536|20690921|P4|STARTED|Overall Study||3
8395042|NCT01030536|20690922|P3|STARTED|Overall Study||6
8395043|NCT01030536|20690923|P2|STARTED|Overall Study||6
8395044|NCT01030536|20690924|P1|STARTED|Overall Study||7
8395045|NCT01030523|20691029|P2|NOT COMPLETED|Overall Study||5
8395046|NCT01030523|20691030|P1|NOT COMPLETED|Overall Study||6
8395047|NCT01030523|20691029|P2|COMPLETED|Overall Study||46
8395048|NCT01030523|20691030|P1|COMPLETED|Overall Study||44
8395049|NCT01030523|20691029|P2|STARTED|Overall Study||51
8395050|NCT01030523|20691030|P1|STARTED|Overall Study||50
8395051|NCT01030458|20691044|P2|NOT COMPLETED|Overall Study||32
8395052|NCT01030458|20691045|P1|NOT COMPLETED|Overall Study||27
8395053|NCT01030458|20691044|P2|COMPLETED|Overall Study||57
8395054|NCT01030458|20691045|P1|COMPLETED|Overall Study||67
8395055|NCT01030458|20691044|P2|STARTED|Overall Study||89
8395056|NCT01030458|20691045|P1|STARTED|Overall Study||94
8395057|NCT01030406|20691062|P5|NOT COMPLETED|Overall Study||0
8395058|NCT01030406|20691063|P4|NOT COMPLETED|Overall Study||1
8395059|NCT01030406|20691064|P3|NOT COMPLETED|Overall Study||1
8395060|NCT01030406|20691065|P2|NOT COMPLETED|Overall Study||0
8395061|NCT01030406|20691066|P1|NOT COMPLETED|Overall Study||0
8395062|NCT01030406|20691062|P5|COMPLETED|Overall Study||9
8395063|NCT01030406|20691063|P4|COMPLETED|Overall Study||9
8395064|NCT01030406|20691064|P3|COMPLETED|Overall Study||9
8395065|NCT01030406|20691065|P2|COMPLETED|Overall Study||10
8395066|NCT01030406|20691066|P1|COMPLETED|Overall Study||10
8395067|NCT01030406|20691062|P5|STARTED|Overall Study||9
8395068|NCT01030406|20691063|P4|STARTED|Overall Study||10
8395069|NCT01030406|20691064|P3|STARTED|Overall Study||10
8395070|NCT01030406|20691065|P2|STARTED|Overall Study||10
8395071|NCT01030406|20691066|P1|STARTED|Overall Study||10
8395072|NCT01030341|20691078|P1|NOT COMPLETED|Overall Study||3
8395073|NCT01030341|20691078|P1|COMPLETED|Overall Study|42 participants completed the study|42
8395074|NCT01030341|20691078|P1|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
8395075|NCT01030289|20691083|P2|NOT COMPLETED|Overall Study||0
8395076|NCT01030289|20691084|P1|NOT COMPLETED|Overall Study||0
8395077|NCT01030289|20691083|P2|COMPLETED|Overall Study||10
8395078|NCT01030289|20691084|P1|COMPLETED|Overall Study||9
8395079|NCT01030289|20691083|P2|STARTED|Overall Study||10
8395080|NCT01030289|20691084|P1|STARTED|Overall Study||9
8395081|NCT01030198|20691101|P2|NOT COMPLETED|Overall Study||7
8395082|NCT01030198|20691102|P1|NOT COMPLETED|Overall Study||0
8395083|NCT01030198|20691101|P2|COMPLETED|Overall Study|Study terminated due to poor results and lack of enrollment|0
8395084|NCT01030198|20691102|P1|COMPLETED|Overall Study|None recruited|0
8395085|NCT01030198|20691101|P2|STARTED|Overall Study||7
8395086|NCT01030198|20691102|P1|STARTED|Overall Study|None recruited|0
8395087|NCT01030133|20691110|P2|NOT COMPLETED|Overall Study||2
8395088|NCT01030133|20691111|P1|NOT COMPLETED|Overall Study||2
8395089|NCT01030133|20691110|P2|COMPLETED|Overall Study||12
8395090|NCT01030133|20691111|P1|COMPLETED|Overall Study||12
8395091|NCT01030133|20691110|P2|STARTED|Overall Study||14
8395092|NCT01030133|20691111|P1|STARTED|Overall Study||14
8395093|NCT01029925|20691123|P1|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
8395094|NCT01029925|20691123|P1|COMPLETED|Completion of Cycle 2 (56 Days)||2
8395095|NCT01029925|20691123|P1|STARTED|Completion of Cycle 2 (56 Days)||3
8395096|NCT01029925|20691123|P1|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
8395097|NCT01029925|20691123|P1|COMPLETED|Completion of Cycle 1 (28 Days)||3
8395098|NCT01029925|20691123|P1|STARTED|Completion of Cycle 1 (28 Days)||7
8395099|NCT01029912|20691129|P2|NOT COMPLETED|Overall Study||0
8395100|NCT01029912|20691130|P1|NOT COMPLETED|Overall Study||2
8395101|NCT01029912|20691129|P2|COMPLETED|Overall Study||12
8395102|NCT01029912|20691130|P1|COMPLETED|Overall Study||12
8395103|NCT01029912|20691129|P2|STARTED|Overall Study||12
8395104|NCT01029912|20691130|P1|STARTED|Overall Study||14
8395105|NCT01029886|20691142|P2|NOT COMPLETED|Overall Study||60
8395106|NCT01029886|20691143|P1|NOT COMPLETED|Overall Study||61
8395107|NCT01029886|20691142|P2|COMPLETED|Overall Study||391
8395108|NCT01029886|20691143|P1|COMPLETED|Overall Study||400
8395109|NCT01029886|20691142|P2|Intent to Treat (ITT)|Overall Study||450
8395110|NCT01029886|20691143|P1|Intent to Treat (ITT)|Overall Study||461
8395111|NCT01029886|20691142|P2|STARTED|Overall Study||451
8395112|NCT01029886|20691143|P1|STARTED|Overall Study||461
8395113|NCT01029795|20691171|P2|NOT COMPLETED|Overall Study||22
8395114|NCT01029795|20691172|P1|NOT COMPLETED|Overall Study||16
8395115|NCT01029795|20691171|P2|COMPLETED|Overall Study||0
8395116|NCT01029795|20691172|P1|COMPLETED|Overall Study||0
8395117|NCT01029795|20691171|P2|STARTED|Overall Study||22
8395118|NCT01029795|20691172|P1|STARTED|Overall Study||16
8395119|NCT01029782|20691226|P2|NOT COMPLETED|Overall Study||8
8395120|NCT01029782|20691227|P1|NOT COMPLETED|Overall Study||3
8395121|NCT01029782|20691226|P2|COMPLETED|Overall Study||96
8395122|NCT01029782|20691227|P1|COMPLETED|Overall Study||99
8395123|NCT01029782|20691226|P2|STARTED|Overall Study||104
8395124|NCT01029782|20691227|P1|STARTED|Overall Study||102
8395125|NCT01029730|20691233|P1|NOT COMPLETED|Maintenance Therapy||23
8395126|NCT01029730|20691233|P1|COMPLETED|Maintenance Therapy||14
8395127|NCT01029730|20691233|P1|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
8395128|NCT01029730|20691233|P1|NOT COMPLETED|Combination Therapy||16
8395129|NCT01029730|20691233|P1|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
8395130|NCT01029730|20691233|P1|STARTED|Combination Therapy||55
8395146|NCT01029691|20691279|P3|NOT COMPLETED|Continued APAP to Delivery||1
8395147|NCT01029691|20691280|P2|NOT COMPLETED|Continued APAP to Delivery||0
8395148|NCT01029691|20691281|P1|NOT COMPLETED|Continued APAP to Delivery||0
8395149|NCT01029691|20691279|P3|COMPLETED|Continued APAP to Delivery||76
8395150|NCT01029691|20691280|P2|COMPLETED|Continued APAP to Delivery||16
8395151|NCT01029691|20691281|P1|COMPLETED|Continued APAP to Delivery||20
8395152|NCT01029691|20691279|P3|STARTED|Continued APAP to Delivery||77
8395153|NCT01029691|20691280|P2|STARTED|Continued APAP to Delivery||16
8395154|NCT01029691|20691281|P1|STARTED|Continued APAP to Delivery||20
8395155|NCT01029691|20691279|P3|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
8395156|NCT01029691|20691280|P2|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
8395157|NCT01029691|20691281|P1|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
8395158|NCT01029691|20691279|P3|COMPLETED|APAP Initiation to Week 1 or Delivery||77
8395159|NCT01029691|20691280|P2|COMPLETED|APAP Initiation to Week 1 or Delivery||16
8395160|NCT01029691|20691281|P1|COMPLETED|APAP Initiation to Week 1 or Delivery||20
8395161|NCT01029691|20691279|P3|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
8395162|NCT01029691|20691280|P2|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
8395163|NCT01029691|20691281|P1|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
8395164|NCT01029691|20691279|P3|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
8395165|NCT01029691|20691280|P2|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
8395166|NCT01029691|20691281|P1|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
8395167|NCT01029691|20691279|P3|STARTED|APAP Initiation to Week 1 or Delivery||77
8395168|NCT01029691|20691280|P2|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
8395169|NCT01029691|20691281|P1|STARTED|APAP Initiation to Week 1 or Delivery||20
8395170|NCT01029652|20691306|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
8395171|NCT01029652|20691307|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
8395172|NCT01029652|20691306|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||63
8395173|NCT01029652|20691307|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||68
8395174|NCT01029652|20691306|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
8395175|NCT01029652|20691307|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
8395176|NCT01029652|20691306|P2|STARTED|Extension Study 2 (25-72 Weeks)||66
8395177|NCT01029652|20691307|P1|STARTED|Extension Study 2 (25-72 Weeks)||69
8395178|NCT01029652|20691306|P2|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
8395179|NCT01029652|20691307|P1|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
8395180|NCT01029652|20691306|P2|COMPLETED|Extension Study 1 (12-24 Weeks)||80
8395181|NCT01029652|20691307|P1|COMPLETED|Extension Study 1 (12-24 Weeks)||87
8395182|NCT01029652|20691306|P2|STARTED|Extension Study 1 (12-24 Weeks)||85
8395183|NCT01029652|20691307|P1|STARTED|Extension Study 1 (12-24 Weeks)||90
8395184|NCT01029652|20691306|P2|NOT COMPLETED|Core Study (0-12 Weeks)||10
8395185|NCT01029652|20691307|P1|NOT COMPLETED|Core Study (0-12 Weeks)||6
8395186|NCT01029652|20691306|P2|COMPLETED|Core Study (0-12 Weeks)||105
8395187|NCT01029652|20691307|P1|COMPLETED|Core Study (0-12 Weeks)||109
8395188|NCT01029652|20691306|P2|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
8395189|NCT01029652|20691307|P1|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
8395190|NCT01029652|20691306|P2|STARTED|Core Study (0-12 Weeks)||115
8395191|NCT01029652|20691307|P1|STARTED|Core Study (0-12 Weeks)||115
8395192|NCT01029587|20691385|P1|NOT COMPLETED|Overall Study||0
8395193|NCT01029587|20691385|P1|COMPLETED|Overall Study||1
8395194|NCT01029587|20691385|P1|STARTED|Overall Study||1
8395195|NCT01029535|20691391|P1|NOT COMPLETED|Overall Study||31
8395196|NCT01029535|20691391|P1|COMPLETED|Overall Study||72
8395197|NCT01029535|20691391|P1|STARTED|Overall Study||103
8395198|NCT01029405|20691420|P4|NOT COMPLETED|Overall Study||5
8395199|NCT01029405|20691421|P3|NOT COMPLETED|Overall Study||4
8395200|NCT01029405|20691422|P2|NOT COMPLETED|Overall Study||3
8395201|NCT01029405|20691423|P1|NOT COMPLETED|Overall Study||2
8395202|NCT01029405|20691420|P4|COMPLETED|Overall Study||32
8395203|NCT01029405|20691421|P3|COMPLETED|Overall Study||31
8395204|NCT01029405|20691422|P2|COMPLETED|Overall Study||34
8395205|NCT01029405|20691423|P1|COMPLETED|Overall Study||34
8395206|NCT01029405|20691420|P4|STARTED|Overall Study||37
8395207|NCT01029405|20691421|P3|STARTED|Overall Study||35
8395208|NCT01029405|20691422|P2|STARTED|Overall Study||37
8395209|NCT01029405|20691423|P1|STARTED|Overall Study||36
8395210|NCT01029392|20691435|P2|NOT COMPLETED|Overall Study||11
8395211|NCT01029392|20691436|P1|NOT COMPLETED|Overall Study||20
8395212|NCT01029392|20691435|P2|COMPLETED|Overall Study||27
8395213|NCT01029392|20691436|P1|COMPLETED|Overall Study||17
8395214|NCT01029392|20691435|P2|STARTED|Overall Study||38
8395215|NCT01029392|20691436|P1|STARTED|Overall Study||37
8395216|NCT01029366|20691446|P2|NOT COMPLETED|Overall Study||2
8395217|NCT01029366|20691447|P1|NOT COMPLETED|Overall Study||4
8395218|NCT01029366|20691446|P2|COMPLETED|Overall Study||6
8395219|NCT01029366|20691447|P1|COMPLETED|Overall Study||14
8395220|NCT01029366|20691446|P2|STARTED|Overall Study||8
8395221|NCT01029366|20691447|P1|STARTED|Overall Study||18
8395222|NCT01029340|20691459|P6|NOT COMPLETED|Part C Follow up Period||0
8395223|NCT01029340|20691460|P5|NOT COMPLETED|Part C Follow up Period||0
8395224|NCT01029340|20691461|P4|NOT COMPLETED|Part C Follow up Period||0
8395225|NCT01029340|20691462|P3|NOT COMPLETED|Part C Follow up Period||0
8395226|NCT01029340|20691463|P2|NOT COMPLETED|Part C Follow up Period||0
8395227|NCT01029340|20691464|P1|NOT COMPLETED|Part C Follow up Period||0
8395228|NCT01029340|20691459|P6|COMPLETED|Part C Follow up Period||0
8395229|NCT01029340|20691460|P5|COMPLETED|Part C Follow up Period||5
8395230|NCT01029340|20691461|P4|COMPLETED|Part C Follow up Period||0
8395231|NCT01029340|20691462|P3|COMPLETED|Part C Follow up Period||0
8395232|NCT01029340|20691463|P2|COMPLETED|Part C Follow up Period||0
8395233|NCT01029340|20691464|P1|COMPLETED|Part C Follow up Period||0
8395234|NCT01029340|20691459|P6|STARTED|Part C Follow up Period||0
8395235|NCT01029340|20691460|P5|STARTED|Part C Follow up Period||5
8395236|NCT01029340|20691461|P4|STARTED|Part C Follow up Period||0
8395237|NCT01029340|20691462|P3|STARTED|Part C Follow up Period||0
8395238|NCT01029340|20691463|P2|STARTED|Part C Follow up Period||0
8395239|NCT01029340|20691464|P1|STARTED|Part C Follow up Period||0
8395240|NCT01029340|20691459|P6|NOT COMPLETED|Part C Treatment Period||0
8395241|NCT01029340|20691460|P5|NOT COMPLETED|Part C Treatment Period||0
8395242|NCT01029340|20691461|P4|NOT COMPLETED|Part C Treatment Period||0
8395243|NCT01029340|20691462|P3|NOT COMPLETED|Part C Treatment Period||0
8395244|NCT01029340|20691463|P2|NOT COMPLETED|Part C Treatment Period||0
8395245|NCT01029340|20691464|P1|NOT COMPLETED|Part C Treatment Period||0
8395246|NCT01029340|20691459|P6|COMPLETED|Part C Treatment Period||0
8395247|NCT01029340|20691460|P5|COMPLETED|Part C Treatment Period||5
8395248|NCT01029340|20691461|P4|COMPLETED|Part C Treatment Period||0
8395249|NCT01029340|20691462|P3|COMPLETED|Part C Treatment Period||0
8395250|NCT01029340|20691463|P2|COMPLETED|Part C Treatment Period||0
8395251|NCT01029340|20691464|P1|COMPLETED|Part C Treatment Period||0
8395252|NCT01029340|20691459|P6|Participants Received Treatment|Part C Treatment Period||0
8395253|NCT01029340|20691460|P5|Participants Received Treatment|Part C Treatment Period||5
8395254|NCT01029340|20691461|P4|Participants Received Treatment|Part C Treatment Period||0
8395255|NCT01029340|20691462|P3|Participants Received Treatment|Part C Treatment Period||0
8395256|NCT01029340|20691463|P2|Participants Received Treatment|Part C Treatment Period||0
8395257|NCT01029340|20691464|P1|Participants Received Treatment|Part C Treatment Period||0
8395258|NCT01029340|20691459|P6|STARTED|Part C Treatment Period||0
8395259|NCT01029340|20691460|P5|STARTED|Part C Treatment Period||5
8395260|NCT01029340|20691461|P4|STARTED|Part C Treatment Period||0
8395261|NCT01029340|20691462|P3|STARTED|Part C Treatment Period||0
8395262|NCT01029340|20691463|P2|STARTED|Part C Treatment Period||0
8395263|NCT01029340|20691464|P1|STARTED|Part C Treatment Period||0
8395264|NCT01029340|20691459|P6|NOT COMPLETED|Extension Period||12
8395265|NCT01029340|20691460|P5|NOT COMPLETED|Extension Period||0
8395266|NCT01029340|20691461|P4|NOT COMPLETED|Extension Period||0
8395267|NCT01029340|20691462|P3|NOT COMPLETED|Extension Period||0
8395268|NCT01029340|20691463|P2|NOT COMPLETED|Extension Period||0
8395269|NCT01029340|20691464|P1|NOT COMPLETED|Extension Period||0
8395270|NCT01029340|20691459|P6|COMPLETED|Extension Period||43
8395271|NCT01029340|20691460|P5|COMPLETED|Extension Period||0
8395272|NCT01029340|20691461|P4|COMPLETED|Extension Period||0
8395273|NCT01029340|20691462|P3|COMPLETED|Extension Period||0
8395274|NCT01029340|20691463|P2|COMPLETED|Extension Period||0
8395275|NCT01029340|20691464|P1|COMPLETED|Extension Period||0
8395276|NCT01029340|20691459|P6|STARTED|Extension Period||55
8395277|NCT01029340|20691460|P5|STARTED|Extension Period||0
8395278|NCT01029340|20691461|P4|STARTED|Extension Period||0
8395279|NCT01029340|20691462|P3|STARTED|Extension Period||0
8395280|NCT01029340|20691463|P2|STARTED|Extension Period||0
8395281|NCT01029340|20691464|P1|STARTED|Extension Period||0
8395282|NCT01029340|20691459|P6|NOT COMPLETED|Part B Follow up Period||0
8395283|NCT01029340|20691460|P5|NOT COMPLETED|Part B Follow up Period||0
8395284|NCT01029340|20691461|P4|NOT COMPLETED|Part B Follow up Period||0
8395285|NCT01029340|20691462|P3|NOT COMPLETED|Part B Follow up Period||0
8395286|NCT01029340|20691463|P2|NOT COMPLETED|Part B Follow up Period||0
8395287|NCT01029340|20691464|P1|NOT COMPLETED|Part B Follow up Period||0
8395288|NCT01029340|20691459|P6|COMPLETED|Part B Follow up Period||0
8395289|NCT01029340|20691460|P5|COMPLETED|Part B Follow up Period||0
8395290|NCT01029340|20691461|P4|COMPLETED|Part B Follow up Period||32
8395291|NCT01029340|20691462|P3|COMPLETED|Part B Follow up Period||29
8395292|NCT01029340|20691463|P2|COMPLETED|Part B Follow up Period||0
8395293|NCT01029340|20691464|P1|COMPLETED|Part B Follow up Period||0
8395294|NCT01029340|20691459|P6|STARTED|Part B Follow up Period||0
8395295|NCT01029340|20691460|P5|STARTED|Part B Follow up Period||0
8395296|NCT01029340|20691461|P4|STARTED|Part B Follow up Period||32
8395297|NCT01029340|20691462|P3|STARTED|Part B Follow up Period||29
8395298|NCT01029340|20691463|P2|STARTED|Part B Follow up Period||0
8395299|NCT01029340|20691464|P1|STARTED|Part B Follow up Period||0
8395300|NCT01029340|20691459|P6|NOT COMPLETED|Part B Treatment Period||0
8395301|NCT01029340|20691460|P5|NOT COMPLETED|Part B Treatment Period||0
8395302|NCT01029340|20691461|P4|NOT COMPLETED|Part B Treatment Period||0
8395303|NCT01029340|20691462|P3|NOT COMPLETED|Part B Treatment Period||2
8395304|NCT01029340|20691463|P2|NOT COMPLETED|Part B Treatment Period||0
8395305|NCT01029340|20691464|P1|NOT COMPLETED|Part B Treatment Period||0
8395306|NCT01029340|20691459|P6|COMPLETED|Part B Treatment Period||0
8395307|NCT01029340|20691460|P5|COMPLETED|Part B Treatment Period||0
8395308|NCT01029340|20691461|P4|COMPLETED|Part B Treatment Period||32
8395309|NCT01029340|20691462|P3|COMPLETED|Part B Treatment Period||29
8395310|NCT01029340|20691463|P2|COMPLETED|Part B Treatment Period||0
8395311|NCT01029340|20691464|P1|COMPLETED|Part B Treatment Period||0
8395312|NCT01029340|20691459|P6|Participants Received Treatment|Part B Treatment Period||0
8395313|NCT01029340|20691460|P5|Participants Received Treatment|Part B Treatment Period||0
8395314|NCT01029340|20691461|P4|Participants Received Treatment|Part B Treatment Period||32
8395315|NCT01029340|20691462|P3|Participants Received Treatment|Part B Treatment Period||30
8395316|NCT01029340|20691463|P2|Participants Received Treatment|Part B Treatment Period||0
8395317|NCT01029340|20691464|P1|Participants Received Treatment|Part B Treatment Period||0
8395318|NCT01029340|20691459|P6|STARTED|Part B Treatment Period||0
8395319|NCT01029340|20691460|P5|STARTED|Part B Treatment Period||0
8395320|NCT01029340|20691461|P4|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
8395321|NCT01029340|20691462|P3|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
8395322|NCT01029340|20691463|P2|STARTED|Part B Treatment Period||0
8395323|NCT01029340|20691464|P1|STARTED|Part B Treatment Period||0
8395324|NCT01029340|20691459|P6|NOT COMPLETED|Part A Follow up Period||0
8395325|NCT01029340|20691460|P5|NOT COMPLETED|Part A Follow up Period||0
8395326|NCT01029340|20691461|P4|NOT COMPLETED|Part A Follow up Period||0
8395327|NCT01029340|20691462|P3|NOT COMPLETED|Part A Follow up Period||0
8395328|NCT01029340|20691463|P2|NOT COMPLETED|Part A Follow up Period||0
8395329|NCT01029340|20691464|P1|NOT COMPLETED|Part A Follow up Period||0
8395330|NCT01029340|20691459|P6|COMPLETED|Part A Follow up Period||0
8395331|NCT01029340|20691460|P5|COMPLETED|Part A Follow up Period||0
8395332|NCT01029340|20691461|P4|COMPLETED|Part A Follow up Period||0
8395333|NCT01029340|20691462|P3|COMPLETED|Part A Follow up Period||0
8395334|NCT01029340|20691463|P2|COMPLETED|Part A Follow up Period||14
8395335|NCT01029340|20691464|P1|COMPLETED|Part A Follow up Period||14
8395336|NCT01029340|20691459|P6|STARTED|Part A Follow up Period||0
8395337|NCT01029340|20691460|P5|STARTED|Part A Follow up Period||0
8395338|NCT01029340|20691461|P4|STARTED|Part A Follow up Period||0
8395339|NCT01029340|20691462|P3|STARTED|Part A Follow up Period||0
8395340|NCT01029340|20691463|P2|STARTED|Part A Follow up Period||14
8395341|NCT01029340|20691464|P1|STARTED|Part A Follow up Period||14
8395342|NCT01029340|20691459|P6|NOT COMPLETED|Part A Treatment Period||0
8395343|NCT01029340|20691460|P5|NOT COMPLETED|Part A Treatment Period||0
8395344|NCT01029340|20691461|P4|NOT COMPLETED|Part A Treatment Period||0
8395345|NCT01029340|20691462|P3|NOT COMPLETED|Part A Treatment Period||0
8395346|NCT01029340|20691463|P2|NOT COMPLETED|Part A Treatment Period||0
8395347|NCT01029340|20691464|P1|NOT COMPLETED|Part A Treatment Period||0
8395348|NCT01029340|20691459|P6|COMPLETED|Part A Treatment Period||0
8395349|NCT01029340|20691460|P5|COMPLETED|Part A Treatment Period||0
8395350|NCT01029340|20691461|P4|COMPLETED|Part A Treatment Period||0
8395351|NCT01029340|20691462|P3|COMPLETED|Part A Treatment Period||0
8395352|NCT01029340|20691463|P2|COMPLETED|Part A Treatment Period||14
8395353|NCT01029340|20691464|P1|COMPLETED|Part A Treatment Period||14
8395354|NCT01029340|20691459|P6|Safety Population|Part A Treatment Period||0
8395355|NCT01029340|20691460|P5|Safety Population|Part A Treatment Period||0
8395356|NCT01029340|20691461|P4|Safety Population|Part A Treatment Period||0
8395357|NCT01029340|20691462|P3|Safety Population|Part A Treatment Period||0
8395358|NCT01029340|20691463|P2|Safety Population|Part A Treatment Period||14
8395359|NCT01029340|20691464|P1|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
8395360|NCT01029340|20691459|P6|Participants Received Treatment|Part A Treatment Period||0
8395361|NCT01029340|20691460|P5|Participants Received Treatment|Part A Treatment Period||0
8395362|NCT01029340|20691461|P4|Participants Received Treatment|Part A Treatment Period||0
8395363|NCT01029340|20691462|P3|Participants Received Treatment|Part A Treatment Period||0
8395364|NCT01029340|20691463|P2|Participants Received Treatment|Part A Treatment Period||14
8395365|NCT01029340|20691464|P1|Participants Received Treatment|Part A Treatment Period||14
8395366|NCT01029340|20691459|P6|STARTED|Part A Treatment Period||0
8395367|NCT01029340|20691460|P5|STARTED|Part A Treatment Period||0
8395368|NCT01029340|20691461|P4|STARTED|Part A Treatment Period||0
8395369|NCT01029340|20691462|P3|STARTED|Part A Treatment Period||0
8395370|NCT01029340|20691463|P2|STARTED|Part A Treatment Period||14
8395371|NCT01029340|20691464|P1|STARTED|Part A Treatment Period||14
8395372|NCT01029262|20691495|P2|NOT COMPLETED|Overall Study||160
8395373|NCT01029262|20691496|P1|NOT COMPLETED|Overall Study||79
8395374|NCT01029262|20691495|P2|COMPLETED|Overall Study||0
8395375|NCT01029262|20691496|P1|COMPLETED|Overall Study||0
8395376|NCT01029262|20691495|P2|STARTED|Overall Study||160
8395377|NCT01029262|20691496|P1|STARTED|Overall Study||79
8395378|NCT01029054|20691558|P3|NOT COMPLETED|Phase II||0
8395379|NCT01029054|20691559|P2|NOT COMPLETED|Phase II||0
8395380|NCT01029054|20691560|P1|NOT COMPLETED|Phase II||0
8395381|NCT01029054|20691558|P3|COMPLETED|Phase II||18
8395382|NCT01029054|20691559|P2|COMPLETED|Phase II||0
8395383|NCT01029054|20691560|P1|COMPLETED|Phase II||0
8395384|NCT01029054|20691558|P3|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
8395385|NCT01029054|20691559|P2|STARTED|Phase II||0
8395386|NCT01029054|20691560|P1|STARTED|Phase II||0
8395387|NCT01029054|20691558|P3|NOT COMPLETED|Phase I||0
8395388|NCT01029054|20691559|P2|NOT COMPLETED|Phase I||0
8395389|NCT01029054|20691560|P1|NOT COMPLETED|Phase I||0
8395390|NCT01029054|20691558|P3|COMPLETED|Phase I||18
8395391|NCT01029054|20691559|P2|COMPLETED|Phase I||13
8395392|NCT01029054|20691560|P1|COMPLETED|Phase I||4
8395393|NCT01029054|20691558|P3|STARTED|Phase I||18
8395394|NCT01029054|20691559|P2|STARTED|Phase I||13
8395395|NCT01029054|20691560|P1|STARTED|Phase I||4
8395396|NCT01028937|20691566|P1|NOT COMPLETED|Overall Study||0
8395397|NCT01028937|20691566|P1|COMPLETED|Overall Study||6
8395398|NCT01028937|20691566|P1|STARTED|Overall Study||6
8395399|NCT01028911|20691573|P2|NOT COMPLETED|Overall Study||0
8395400|NCT01028911|20691574|P1|NOT COMPLETED|Overall Study||0
8395401|NCT01028911|20691573|P2|COMPLETED|Overall Study||2
8395402|NCT01028911|20691574|P1|COMPLETED|Overall Study||7
8395403|NCT01028911|20691573|P2|STARTED|Overall Study||2
8395404|NCT01028911|20691574|P1|STARTED|Overall Study||7
8395405|NCT01028820|20691639|P1|NOT COMPLETED|Overall Study||1
8395406|NCT01028820|20691639|P1|COMPLETED|Overall Study||12
8395407|NCT01028820|20691639|P1|STARTED|Overall Study||13
8395408|NCT01028677|20691648|P2|NOT COMPLETED|Overall Study||1
8395409|NCT01028677|20691649|P1|NOT COMPLETED|Overall Study||2
8395410|NCT01028677|20691648|P2|COMPLETED|Overall Study||6
8395411|NCT01028677|20691649|P1|COMPLETED|Overall Study||8
8395412|NCT01028677|20691648|P2|STARTED|Overall Study||7
8395413|NCT01028677|20691649|P1|STARTED|Overall Study||10
8395414|NCT01028651|20691665|P1|NOT COMPLETED|Overall Study||3
8395415|NCT01028651|20691665|P1|COMPLETED|Overall Study||10
8395416|NCT01028651|20691665|P1|STARTED|Overall Study||13
8395417|NCT01028560|20691688|P2|NOT COMPLETED|Overall Study||18
8395418|NCT01028560|20691689|P1|NOT COMPLETED|Overall Study||10
8395419|NCT01028560|20691688|P2|COMPLETED|Overall Study||13
8395420|NCT01028560|20691689|P1|COMPLETED|Overall Study||17
8395421|NCT01028560|20691688|P2|Started Study Protocol|Overall Study||27
8395422|NCT01028560|20691689|P1|Started Study Protocol|Overall Study||23
8395423|NCT01028560|20691688|P2|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31
8395424|NCT01028560|20691689|P1|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27
8395425|NCT01028391|20691703|P2|NOT COMPLETED|Overall Study||11
8395426|NCT01028391|20691704|P1|NOT COMPLETED|Overall Study||14
8395427|NCT01028391|20691703|P2|COMPLETED|Overall Study||142
8395428|NCT01028391|20691704|P1|COMPLETED|Overall Study||150
8395429|NCT01028391|20691703|P2|STARTED|Overall Study||153
8395430|NCT01028391|20691704|P1|STARTED|Overall Study||164
8395431|NCT01028378|20691712|P1|NOT COMPLETED|Overall Study||17
8395432|NCT01028378|20691712|P1|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
8395433|NCT01028378|20691712|P1|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
8395434|NCT01028352|20691724|P1|NOT COMPLETED|Overall Study||6
8395435|NCT01028352|20691724|P1|COMPLETED|Overall Study||29
8395436|NCT01028352|20691724|P1|STARTED|Overall Study||35
8395437|NCT01028300|20691729|P1|NOT COMPLETED|Overall Study||4
8395438|NCT01028300|20691729|P1|COMPLETED|Overall Study||0
8395439|NCT01028300|20691729|P1|STARTED|Overall Study||4
8395440|NCT01028222|20691738|P2|NOT COMPLETED|Overall Study||13
8395441|NCT01028222|20691739|P1|NOT COMPLETED|Overall Study||38
8395442|NCT01028222|20691738|P2|COMPLETED|Overall Study||0
8395443|NCT01028222|20691739|P1|COMPLETED|Overall Study||4
8395444|NCT01028222|20691738|P2|Cross Over From DTIC to Nilotinib|Overall Study||10
8395445|NCT01028222|20691739|P1|Cross Over From DTIC to Nilotinib|Overall Study||0
8395446|NCT01028222|20691738|P2|STARTED|Overall Study||13
8395447|NCT01028222|20691739|P1|STARTED|Overall Study||42
8395448|NCT01028131|20691764|P4|NOT COMPLETED|Overall Study||4
8395449|NCT01028131|20691765|P3|NOT COMPLETED|Overall Study||6
8395450|NCT01028131|20691766|P2|NOT COMPLETED|Overall Study||3
8395451|NCT01028131|20691767|P1|NOT COMPLETED|Overall Study||3
8395452|NCT01028131|20691764|P4|COMPLETED|Overall Study||26
8395453|NCT01028131|20691765|P3|COMPLETED|Overall Study||22
8395454|NCT01028131|20691766|P2|COMPLETED|Overall Study||23
8395455|NCT01028131|20691767|P1|COMPLETED|Overall Study||23
8395456|NCT01028131|20691764|P4|Completed Intervention/Control Session|Overall Study||30
8395457|NCT01028131|20691765|P3|Completed Intervention/Control Session|Overall Study||28
8395458|NCT01028131|20691766|P2|Completed Intervention/Control Session|Overall Study||26
8395459|NCT01028131|20691767|P1|Completed Intervention/Control Session|Overall Study||26
8395460|NCT01028131|20691764|P4|STARTED|Overall Study||30
8395461|NCT01028131|20691765|P3|STARTED|Overall Study||28
8395462|NCT01028131|20691766|P2|STARTED|Overall Study||26
8395463|NCT01028131|20691767|P1|STARTED|Overall Study||26
8395464|NCT01028053|20691781|P1|NOT COMPLETED|Overall Study||133
8395465|NCT01028053|20691781|P1|COMPLETED|Overall Study||232
8395466|NCT01028053|20691781|P1|STARTED|Overall Study||365
8395467|NCT01028027|20691789|P2|NOT COMPLETED|Overall Study||13
8395468|NCT01028027|20691790|P1|NOT COMPLETED|Overall Study||16
8395469|NCT01028027|20691789|P2|COMPLETED|Overall Study||164
8395470|NCT01028027|20691790|P1|COMPLETED|Overall Study||164
8395471|NCT01028027|20691789|P2|STARTED|Overall Study||177
8395472|NCT01028027|20691790|P1|STARTED|Overall Study||180
8395473|NCT01028014|20691812|P6|NOT COMPLETED|Overall Study||2
8395474|NCT01028014|20691813|P5|NOT COMPLETED|Overall Study||1
8395475|NCT01028014|20691814|P4|NOT COMPLETED|Overall Study||1
8395476|NCT01028014|20691815|P3|NOT COMPLETED|Overall Study||0
8395477|NCT01028014|20691816|P2|NOT COMPLETED|Overall Study||2
8395478|NCT01028014|20691817|P1|NOT COMPLETED|Overall Study||1
8395479|NCT01028014|20691812|P6|COMPLETED|Overall Study||4
8395480|NCT01028014|20691813|P5|COMPLETED|Overall Study||9
8395481|NCT01028014|20691814|P4|COMPLETED|Overall Study||9
8395482|NCT01028014|20691815|P3|COMPLETED|Overall Study||10
8395483|NCT01028014|20691816|P2|COMPLETED|Overall Study||8
8395484|NCT01028014|20691817|P1|COMPLETED|Overall Study||9
8395485|NCT01028014|20691812|P6|STARTED|Overall Study||6
8395486|NCT01028014|20691813|P5|STARTED|Overall Study||10
8395487|NCT01028014|20691814|P4|STARTED|Overall Study||10
8395488|NCT01028014|20691815|P3|STARTED|Overall Study||10
8395489|NCT01028014|20691816|P2|STARTED|Overall Study||10
8395490|NCT01028014|20691817|P1|STARTED|Overall Study||10
8395491|NCT01027910|20691845|P2|NOT COMPLETED|Overall Study||0
8395492|NCT01027910|20691846|P1|NOT COMPLETED|Overall Study||0
8395493|NCT01027910|20691845|P2|COMPLETED|Overall Study||14
8395494|NCT01027910|20691846|P1|COMPLETED|Overall Study||6
8395495|NCT01027910|20691845|P2|STARTED|Overall Study||14
8395496|NCT01027910|20691846|P1|STARTED|Overall Study||6
8395497|NCT01027897|20691858|P1|NOT COMPLETED|Overall Study||2
8395498|NCT01027897|20691858|P1|COMPLETED|Overall Study||28
8395499|NCT01027897|20691858|P1|STARTED|Overall Study||30
8395500|NCT01027884|20691866|P2|NOT COMPLETED|Overall Study||7
8395501|NCT01027884|20691867|P1|NOT COMPLETED|Overall Study||4
8395502|NCT01027884|20691866|P2|COMPLETED|Overall Study||25
8395503|NCT01027884|20691867|P1|COMPLETED|Overall Study||30
8395504|NCT01027884|20691866|P2|STARTED|Overall Study||32
8395505|NCT01027884|20691867|P1|STARTED|Overall Study||34
8395506|NCT01027871|20691884|P3|NOT COMPLETED|Overall Study||7
8395507|NCT01027871|20691885|P2|NOT COMPLETED|Overall Study||13
8395508|NCT01027871|20691886|P1|NOT COMPLETED|Overall Study||2
8395509|NCT01027871|20691884|P3|COMPLETED|Overall Study||91
8395510|NCT01027871|20691885|P2|COMPLETED|Overall Study||85
8395511|NCT01027871|20691886|P1|COMPLETED|Overall Study||91
8395512|NCT01027871|20691884|P3|Received at Least One Dose of Study Drug|Overall Study||97
8395513|NCT01027871|20691885|P2|Received at Least One Dose of Study Drug|Overall Study||98
8395514|NCT01027871|20691886|P1|Received at Least One Dose of Study Drug|Overall Study||93
8395515|NCT01027871|20691884|P3|STARTED|Overall Study||98
8395516|NCT01027871|20691885|P2|STARTED|Overall Study||98
8395517|NCT01027871|20691886|P1|STARTED|Overall Study||93
8395518|NCT01027845|20691945|P4|NOT COMPLETED|Booster Vaccination Phase||0
8395519|NCT01027845|20691946|P3|NOT COMPLETED|Booster Vaccination Phase||0
8395520|NCT01027845|20691947|P2|NOT COMPLETED|Booster Vaccination Phase||0
8395521|NCT01027845|20691948|P1|NOT COMPLETED|Booster Vaccination Phase||2
8395522|NCT01027845|20691945|P4|COMPLETED|Booster Vaccination Phase||1
8395523|NCT01027845|20691946|P3|COMPLETED|Booster Vaccination Phase||119
8395524|NCT01027845|20691947|P2|COMPLETED|Booster Vaccination Phase||0
8395525|NCT01027845|20691948|P1|COMPLETED|Booster Vaccination Phase||226
8395526|NCT01027845|20691945|P4|STARTED|Booster Vaccination Phase||1
8395527|NCT01027845|20691946|P3|STARTED|Booster Vaccination Phase||119
8395528|NCT01027845|20691947|P2|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0
8395529|NCT01027845|20691948|P1|STARTED|Booster Vaccination Phase||228
8395530|NCT01027845|20691945|P4|NOT COMPLETED|Primary Vaccination Phase||0
8395531|NCT01027845|20691946|P3|NOT COMPLETED|Primary Vaccination Phase||0
8395532|NCT01027845|20691947|P2|NOT COMPLETED|Primary Vaccination Phase||1
8395533|NCT01027845|20691948|P1|NOT COMPLETED|Primary Vaccination Phase||4
8395534|NCT01027845|20691945|P4|COMPLETED|Primary Vaccination Phase||0
8395535|NCT01027845|20691946|P3|COMPLETED|Primary Vaccination Phase||0
8395536|NCT01027845|20691947|P2|COMPLETED|Primary Vaccination Phase||122
8395537|NCT01027845|20691948|P1|COMPLETED|Primary Vaccination Phase||233
8395538|NCT01027845|20691945|P4|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
8395539|NCT01027845|20691946|P3|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
8395540|NCT01027845|20691947|P2|STARTED|Primary Vaccination Phase||123
8395541|NCT01027845|20691948|P1|STARTED|Primary Vaccination Phase||237
8395542|NCT01027819|20692000|P2|NOT COMPLETED|Overall Study||0
8395543|NCT01027819|20692001|P1|NOT COMPLETED|Overall Study||0
8395544|NCT01027819|20692000|P2|COMPLETED|Overall Study||40
8395545|NCT01027819|20692001|P1|COMPLETED|Overall Study||40
8395546|NCT01027819|20692000|P2|STARTED|Overall Study||40
8395547|NCT01027819|20692001|P1|STARTED|Overall Study||40
8395548|NCT01027806|20692009|P2|NOT COMPLETED|Overall Study||3
8395549|NCT01027806|20692010|P1|NOT COMPLETED|Overall Study||4
8395550|NCT01027806|20692009|P2|COMPLETED|Overall Study||29
8395551|NCT01027806|20692010|P1|COMPLETED|Overall Study||28
8395552|NCT01027806|20692009|P2|STARTED|Overall Study||32
8395553|NCT01027806|20692010|P1|STARTED|Overall Study||32
8395554|NCT01027793|20692018|P2|NOT COMPLETED|Overall Study||3
8395555|NCT01027793|20692019|P1|NOT COMPLETED|Overall Study||7
8395556|NCT01027793|20692018|P2|COMPLETED|Overall Study||12
8395557|NCT01027793|20692019|P1|COMPLETED|Overall Study||10
8395558|NCT01027793|20692018|P2|STARTED|Overall Study||15
8395559|NCT01027793|20692019|P1|STARTED|Overall Study||17
8395560|NCT01027780|20692033|P2|NOT COMPLETED|Overall Study||1
8395561|NCT01027780|20692034|P1|NOT COMPLETED|Overall Study||0
8395562|NCT01027780|20692033|P2|COMPLETED|Overall Study||102
8395563|NCT01027780|20692034|P1|COMPLETED|Overall Study||105
8395564|NCT01027780|20692033|P2|STARTED|Overall Study||103
8395565|NCT01027780|20692034|P1|STARTED|Overall Study||105
8395572|NCT01027702|20692081|P7|NOT COMPLETED|Overall Study||1
8395573|NCT01027702|20692082|P6|NOT COMPLETED|Overall Study||0
8395574|NCT01027702|20692083|P5|NOT COMPLETED|Overall Study||1
8395575|NCT01027702|20692084|P4|NOT COMPLETED|Overall Study||4
8395576|NCT01027702|20692085|P3|NOT COMPLETED|Overall Study||1
8395577|NCT01027702|20692086|P2|NOT COMPLETED|Overall Study||2
8395578|NCT01027702|20692087|P1|NOT COMPLETED|Overall Study||1
8395579|NCT01027702|20692081|P7|COMPLETED|Overall Study||1
8395580|NCT01027702|20692082|P6|COMPLETED|Overall Study||1
8395581|NCT01027702|20692083|P5|COMPLETED|Overall Study||9
8395582|NCT01027702|20692084|P4|COMPLETED|Overall Study||10
8395583|NCT01027702|20692085|P3|COMPLETED|Overall Study||2
8395584|NCT01027702|20692086|P2|COMPLETED|Overall Study||2
8395585|NCT01027702|20692087|P1|COMPLETED|Overall Study||3
8395586|NCT01027702|20692081|P7|STARTED|Overall Study||2
8395587|NCT01027702|20692082|P6|STARTED|Overall Study||1
8395588|NCT01027702|20692083|P5|STARTED|Overall Study||10
8395589|NCT01027702|20692084|P4|STARTED|Overall Study||14
8395590|NCT01027702|20692085|P3|STARTED|Overall Study||3
8395591|NCT01027702|20692086|P2|STARTED|Overall Study||4
8395592|NCT01027702|20692087|P1|STARTED|Overall Study||4
8395593|NCT01027650|20692113|P8|NOT COMPLETED|Overall Study||0
8395594|NCT01027650|20692114|P7|NOT COMPLETED|Overall Study||1
8395595|NCT01027650|20692115|P6|NOT COMPLETED|Overall Study||2
8395596|NCT01027650|20692116|P5|NOT COMPLETED|Overall Study||2
8395597|NCT01027650|20692117|P4|NOT COMPLETED|Overall Study||0
8395598|NCT01027650|20692118|P3|NOT COMPLETED|Overall Study||0
8395599|NCT01027650|20692119|P2|NOT COMPLETED|Overall Study||0
8395600|NCT01027650|20692120|P1|NOT COMPLETED|Overall Study||0
8395601|NCT01027650|20692113|P8|COMPLETED|Overall Study||24
8395602|NCT01027650|20692114|P7|COMPLETED|Overall Study||24
8395603|NCT01027650|20692115|P6|COMPLETED|Overall Study||24
8395604|NCT01027650|20692116|P5|COMPLETED|Overall Study||23
8395605|NCT01027650|20692117|P4|COMPLETED|Overall Study||3
8395606|NCT01027650|20692118|P3|COMPLETED|Overall Study||6
8395607|NCT01027650|20692119|P2|COMPLETED|Overall Study||6
8395608|NCT01027650|20692120|P1|COMPLETED|Overall Study||6
8395609|NCT01027650|20692113|P8|STARTED|Overall Study||24
8395610|NCT01027650|20692114|P7|STARTED|Overall Study||25
8395611|NCT01027650|20692115|P6|STARTED|Overall Study||26
8395612|NCT01027650|20692116|P5|STARTED|Overall Study||25
8395613|NCT01027650|20692117|P4|STARTED|Overall Study||3
8395614|NCT01027650|20692118|P3|STARTED|Overall Study||6
8395615|NCT01027650|20692119|P2|STARTED|Overall Study||6
8395616|NCT01027650|20692120|P1|STARTED|Overall Study||6
8395617|NCT01027598|20692164|P2|NOT COMPLETED|Overall Study||67
8395618|NCT01027598|20692165|P1|NOT COMPLETED|Overall Study||134
8395706|NCT01027195|20692439|P1|COMPLETED|Overall Study||71
8395619|NCT01027598|20692164|P2|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
8395620|NCT01027598|20692165|P1|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
8395621|NCT01027598|20692164|P2|STARTED|Overall Study||67
8395622|NCT01027598|20692165|P1|STARTED|Overall Study|One patient was enrolled but not treated|134
8395623|NCT01027559|20692178|P3|NOT COMPLETED|Overall Study||9
8395624|NCT01027559|20692179|P2|NOT COMPLETED|Overall Study||8
8395625|NCT01027559|20692180|P1|NOT COMPLETED|Overall Study||6
8395626|NCT01027559|20692178|P3|COMPLETED|Overall Study||22
8395627|NCT01027559|20692179|P2|COMPLETED|Overall Study||26
8395628|NCT01027559|20692180|P1|COMPLETED|Overall Study||20
8395629|NCT01027559|20692178|P3|STARTED|Overall Study||31
8395630|NCT01027559|20692179|P2|STARTED|Overall Study||34
8395631|NCT01027559|20692180|P1|STARTED|Overall Study||26
8395632|NCT01027468|20692190|P1|NOT COMPLETED|Overall Study||0
8395633|NCT01027468|20692190|P1|COMPLETED|Overall Study||160
8395634|NCT01027468|20692190|P1|STARTED|Overall Study||160
8395635|NCT01027416|20692198|P2|NOT COMPLETED|Overall Study||5
8395636|NCT01027416|20692199|P1|NOT COMPLETED|Overall Study||1
8395637|NCT01027416|20692198|P2|COMPLETED|Overall Study||23
8395638|NCT01027416|20692199|P1|COMPLETED|Overall Study||30
8395639|NCT01027416|20692198|P2|STARTED|Overall Study||28
8395640|NCT01027416|20692199|P1|STARTED|Overall Study||31
8395641|NCT01027364|20692211|P4|NOT COMPLETED|Overall Study||1
8395642|NCT01027364|20692212|P3|NOT COMPLETED|Overall Study||1
8395643|NCT01027364|20692213|P2|NOT COMPLETED|Overall Study||2
8395644|NCT01027364|20692214|P1|NOT COMPLETED|Overall Study||4
8395645|NCT01027364|20692211|P4|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
8395646|NCT01027364|20692212|P3|COMPLETED|Overall Study||26
8395647|NCT01027364|20692213|P2|COMPLETED|Overall Study||27
8395648|NCT01027364|20692214|P1|COMPLETED|Overall Study||59
8395649|NCT01027364|20692211|P4|Started Arm 4 Then Joined Another Arm|Overall Study||0
8395650|NCT01027364|20692212|P3|Started Arm 4 Then Joined Another Arm|Overall Study||0
8395651|NCT01027364|20692213|P2|Started Arm 4 Then Joined Another Arm|Overall Study||0
8395652|NCT01027364|20692214|P1|Started Arm 4 Then Joined Another Arm|Overall Study||2
8395653|NCT01027364|20692211|P4|Joined Arm 4 for Surgery Then Returned|Overall Study||0
8395654|NCT01027364|20692212|P3|Joined Arm 4 for Surgery Then Returned|Overall Study||1
8395655|NCT01027364|20692213|P2|Joined Arm 4 for Surgery Then Returned|Overall Study||0
8395656|NCT01027364|20692214|P1|Joined Arm 4 for Surgery Then Returned|Overall Study||5
8395657|NCT01027364|20692211|P4|Enrolled in Sequential PK Subgroup|Overall Study||0
8395658|NCT01027364|20692212|P3|Enrolled in Sequential PK Subgroup|Overall Study||0
8395659|NCT01027364|20692213|P2|Enrolled in Sequential PK Subgroup|Overall Study||0
8395660|NCT01027364|20692214|P1|Enrolled in Sequential PK Subgroup|Overall Study||22
8395661|NCT01027364|20692211|P4|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
8395662|NCT01027364|20692212|P3|STARTED|Overall Study||27
8395663|NCT01027364|20692213|P2|STARTED|Overall Study||29
8395664|NCT01027364|20692214|P1|STARTED|Overall Study||63
8395665|NCT01027351|20692309|P6|NOT COMPLETED|Overall Study||5
8395666|NCT01027351|20692310|P5|NOT COMPLETED|Overall Study||11
8395667|NCT01027351|20692311|P4|NOT COMPLETED|Overall Study||2
8395668|NCT01027351|20692312|P3|NOT COMPLETED|Overall Study||1
8395669|NCT01027351|20692313|P2|NOT COMPLETED|Overall Study||1
8395670|NCT01027351|20692314|P1|NOT COMPLETED|Overall Study||3
8395671|NCT01027351|20692309|P6|COMPLETED|Overall Study||45
8395672|NCT01027351|20692310|P5|COMPLETED|Overall Study||32
8395673|NCT01027351|20692311|P4|COMPLETED|Overall Study||6
8395674|NCT01027351|20692312|P3|COMPLETED|Overall Study||13
8395675|NCT01027351|20692313|P2|COMPLETED|Overall Study||18
8395676|NCT01027351|20692314|P1|COMPLETED|Overall Study||26
8395677|NCT01027351|20692309|P6|STARTED|Overall Study||50
8395678|NCT01027351|20692310|P5|STARTED|Overall Study||43
8395679|NCT01027351|20692311|P4|STARTED|Overall Study||8
8395680|NCT01027351|20692312|P3|STARTED|Overall Study||14
8395681|NCT01027351|20692313|P2|STARTED|Overall Study||19
8395682|NCT01027351|20692314|P1|STARTED|Overall Study||29
8395683|NCT01027286|20692398|P2|NOT COMPLETED|Overall Study||1
8395684|NCT01027286|20692399|P1|NOT COMPLETED|Overall Study||1
8395685|NCT01027286|20692398|P2|COMPLETED|Overall Study||49
8395686|NCT01027286|20692399|P1|COMPLETED|Overall Study||49
8395687|NCT01027286|20692398|P2|12 Week Postoperative|Overall Study||49
8395688|NCT01027286|20692399|P1|12 Week Postoperative|Overall Study||49
8395689|NCT01027286|20692398|P2|4 Week Postoperative|Overall Study||50
8395690|NCT01027286|20692399|P1|4 Week Postoperative|Overall Study||49
8395691|NCT01027286|20692398|P2|Day of Surgery|Overall Study||50
8395692|NCT01027286|20692399|P1|Day of Surgery|Overall Study||50
8395693|NCT01027286|20692398|P2|Preoperative|Overall Study||50
8395694|NCT01027286|20692399|P1|Preoperative|Overall Study||50
8395695|NCT01027286|20692398|P2|STARTED|Overall Study||50
8395696|NCT01027286|20692399|P1|STARTED|Overall Study||50
8395697|NCT01027273|20692419|P2|NOT COMPLETED|Overall Study||33
8395698|NCT01027273|20692420|P1|NOT COMPLETED|Overall Study||59
8395699|NCT01027273|20692419|P2|COMPLETED|Overall Study||266
8395700|NCT01027273|20692420|P1|COMPLETED|Overall Study||242
8395701|NCT01027273|20692419|P2|STARTED|Overall Study||299
8395702|NCT01027273|20692420|P1|STARTED|Overall Study||301
8395703|NCT01027195|20692438|P2|NOT COMPLETED|Overall Study||0
8395704|NCT01027195|20692439|P1|NOT COMPLETED|Overall Study||0
8395705|NCT01027195|20692438|P2|COMPLETED|Overall Study||69
8395707|NCT01027195|20692438|P2|STARTED|Overall Study||69
8395708|NCT01027195|20692439|P1|STARTED|Overall Study||71
8395712|NCT01026974|20692467|P4|NOT COMPLETED|Overall Study||3
8395713|NCT01026974|20692468|P3|NOT COMPLETED|Overall Study||12
8395714|NCT01026974|20692469|P2|NOT COMPLETED|Overall Study||2
8395715|NCT01026974|20692470|P1|NOT COMPLETED|Overall Study||1
8395716|NCT01026974|20692467|P4|COMPLETED|Overall Study||46
8395717|NCT01026974|20692468|P3|COMPLETED|Overall Study||29
8395718|NCT01026974|20692469|P2|COMPLETED|Overall Study||12
8395719|NCT01026974|20692470|P1|COMPLETED|Overall Study||15
8395720|NCT01026974|20692467|P4|STARTED|Overall Study||49
8395721|NCT01026974|20692468|P3|STARTED|Overall Study||41
8395722|NCT01026974|20692469|P2|STARTED|Overall Study||14
8395723|NCT01026974|20692470|P1|STARTED|Overall Study||16
8395724|NCT01026948|20692527|P1|NOT COMPLETED|Overall Study||8
8395725|NCT01026948|20692527|P1|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
8395726|NCT01026948|20692527|P1|STARTED|Overall Study||70
8395727|NCT01026909|20692534|P2|NOT COMPLETED|Overall Study||0
8395728|NCT01026909|20692535|P1|NOT COMPLETED|Overall Study||0
8395729|NCT01026909|20692534|P2|COMPLETED|Overall Study||2
8395730|NCT01026909|20692535|P1|COMPLETED|Overall Study||1
8395731|NCT01026909|20692534|P2|STARTED|Overall Study||2
8395732|NCT01026909|20692535|P1|STARTED|Overall Study||1
8395733|NCT01026844|20692545|P2|NOT COMPLETED|Overall Study||0
8395734|NCT01026844|20692546|P1|NOT COMPLETED|Overall Study||0
8395735|NCT01026844|20692545|P2|COMPLETED|Overall Study||8
8395736|NCT01026844|20692546|P1|COMPLETED|Overall Study||19
8395737|NCT01026844|20692545|P2|STARTED|Overall Study||8
8395738|NCT01026844|20692546|P1|STARTED|Overall Study||19
8395739|NCT01026831|20692560|P2|NOT COMPLETED|Overall Study||11
8395740|NCT01026831|20692561|P1|NOT COMPLETED|Overall Study||14
8395741|NCT01026831|20692560|P2|COMPLETED|Overall Study||312
8395742|NCT01026831|20692561|P1|COMPLETED|Overall Study||306
8395743|NCT01026831|20692560|P2|STARTED|Overall Study|randomized|323
8395744|NCT01026831|20692561|P1|STARTED|Overall Study|randomized|320
8395745|NCT01026818|20692572|P4|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
8395746|NCT01026818|20692573|P3|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
8395747|NCT01026818|20692574|P2|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
8395748|NCT01026818|20692575|P1|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
8395749|NCT01026818|20692572|P4|COMPLETED|OL Period (Month 10.5 - 13.5)||105
8395750|NCT01026818|20692573|P3|COMPLETED|OL Period (Month 10.5 - 13.5)||112
8395751|NCT01026818|20692574|P2|COMPLETED|OL Period (Month 10.5 - 13.5)||98
8395752|NCT01026818|20692575|P1|COMPLETED|OL Period (Month 10.5 - 13.5)||0
8395753|NCT01026818|20692572|P4|STARTED|OL Period (Month 10.5 - 13.5)||108
8395754|NCT01026818|20692573|P3|STARTED|OL Period (Month 10.5 - 13.5)||117
8395755|NCT01026818|20692574|P2|STARTED|OL Period (Month 10.5 - 13.5)||105
8395756|NCT01026818|20692575|P1|STARTED|OL Period (Month 10.5 - 13.5)||0
8395757|NCT01026818|20692572|P4|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
8395758|NCT01026818|20692573|P3|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
8395759|NCT01026818|20692574|P2|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
8395760|NCT01026818|20692575|P1|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
8395761|NCT01026818|20692572|P4|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
8395762|NCT01026818|20692573|P3|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
8395763|NCT01026818|20692574|P2|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
8395764|NCT01026818|20692575|P1|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
8395765|NCT01026818|20692572|P4|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
8395766|NCT01026818|20692573|P3|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
8395767|NCT01026818|20692574|P2|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
8395768|NCT01026818|20692575|P1|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
8395769|NCT01026818|20692572|P4|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
8395770|NCT01026818|20692573|P3|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
8395771|NCT01026818|20692574|P2|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
8395772|NCT01026818|20692575|P1|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
8395773|NCT01026818|20692572|P4|COMPLETED|DB Treatment Period (Month 0 - 9)||115
8395774|NCT01026818|20692573|P3|COMPLETED|DB Treatment Period (Month 0 - 9)||122
8395775|NCT01026818|20692574|P2|COMPLETED|DB Treatment Period (Month 0 - 9)||114
8395776|NCT01026818|20692575|P1|COMPLETED|DB Treatment Period (Month 0 - 9)||0
8395777|NCT01026818|20692572|P4|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
8395778|NCT01026818|20692573|P3|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
8395779|NCT01026818|20692574|P2|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
8395780|NCT01026818|20692575|P1|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
8395781|NCT01026818|20692572|P4|STARTED|DB Treatment Period (Month 0 - 9)||141
8395782|NCT01026818|20692573|P3|STARTED|DB Treatment Period (Month 0 - 9)||143
8395783|NCT01026818|20692574|P2|STARTED|DB Treatment Period (Month 0 - 9)||139
8395784|NCT01026818|20692575|P1|STARTED|DB Treatment Period (Month 0 - 9)||0
8395785|NCT01026818|20692572|P4|NOT COMPLETED|Screening Period||0
8395786|NCT01026818|20692573|P3|NOT COMPLETED|Screening Period||0
8395787|NCT01026818|20692574|P2|NOT COMPLETED|Screening Period||0
8395788|NCT01026818|20692575|P1|NOT COMPLETED|Screening Period||160
8395789|NCT01026818|20692572|P4|COMPLETED|Screening Period||0
8395790|NCT01026818|20692573|P3|COMPLETED|Screening Period||0
8395791|NCT01026818|20692574|P2|COMPLETED|Screening Period||0
8395792|NCT01026818|20692575|P1|COMPLETED|Screening Period||423
8395793|NCT01026818|20692572|P4|STARTED|Screening Period||0
8395794|NCT01026818|20692573|P3|STARTED|Screening Period||0
8395795|NCT01026818|20692574|P2|STARTED|Screening Period||0
8395796|NCT01026818|20692575|P1|STARTED|Screening Period||583
8395797|NCT01026805|20692653|P1|NOT COMPLETED|Overall Study||0
8395798|NCT01026805|20692653|P1|COMPLETED|Overall Study||11
8395799|NCT01026805|20692653|P1|STARTED|Overall Study||11
8395800|NCT01026792|20692663|P1|NOT COMPLETED|Overall Study||1
8395801|NCT01026792|20692663|P1|COMPLETED|Overall Study||37
8395802|NCT01026792|20692663|P1|STARTED|Overall Study||38
8395803|NCT01026623|20692670|P3|NOT COMPLETED|Overall Study||0
8395804|NCT01026623|20692671|P2|NOT COMPLETED|Overall Study||0
8395805|NCT01026623|20692672|P1|NOT COMPLETED|Overall Study||0
8395806|NCT01026623|20692670|P3|COMPLETED|Overall Study||5
8395807|NCT01026623|20692671|P2|COMPLETED|Overall Study||5
8395808|NCT01026623|20692672|P1|COMPLETED|Overall Study||6
8395809|NCT01026623|20692670|P3|STARTED|Overall Study||5
8395810|NCT01026623|20692671|P2|STARTED|Overall Study||5
8395811|NCT01026623|20692672|P1|STARTED|Overall Study||6
8395812|NCT01026493|20692706|P8|NOT COMPLETED|Overall Study||1
8395813|NCT01026493|20692707|P7|NOT COMPLETED|Overall Study||4
8395814|NCT01026493|20692708|P6|NOT COMPLETED|Overall Study||3
8395815|NCT01026493|20692709|P5|NOT COMPLETED|Overall Study||2
8395816|NCT01026493|20692710|P4|NOT COMPLETED|Overall Study||0
8395817|NCT01026493|20692711|P3|NOT COMPLETED|Overall Study||0
8395818|NCT01026493|20692712|P2|NOT COMPLETED|Overall Study||1
8395819|NCT01026493|20692713|P1|NOT COMPLETED|Overall Study||0
8395820|NCT01026493|20692706|P8|COMPLETED|Overall Study||37
8395821|NCT01026493|20692707|P7|COMPLETED|Overall Study||32
8395822|NCT01026493|20692708|P6|COMPLETED|Overall Study||73
8395823|NCT01026493|20692709|P5|COMPLETED|Overall Study||73
8395824|NCT01026493|20692710|P4|COMPLETED|Overall Study||8
8395825|NCT01026493|20692711|P3|COMPLETED|Overall Study||9
8395826|NCT01026493|20692712|P2|COMPLETED|Overall Study||6
8395827|NCT01026493|20692713|P1|COMPLETED|Overall Study||8
8395828|NCT01026493|20692706|P8|STARTED|Overall Study||38
8395829|NCT01026493|20692707|P7|STARTED|Overall Study||36
8395830|NCT01026493|20692708|P6|STARTED|Overall Study||76
8395831|NCT01026493|20692709|P5|STARTED|Overall Study||75
8395832|NCT01026493|20692710|P4|STARTED|Overall Study||8
8395833|NCT01026493|20692711|P3|STARTED|Overall Study||9
8395834|NCT01026493|20692712|P2|STARTED|Overall Study||7
8395835|NCT01026493|20692713|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
8395836|NCT01026454|20692741|P2|NOT COMPLETED|Second Intervention||1
8395837|NCT01026454|20692742|P1|NOT COMPLETED|Second Intervention||1
8395838|NCT01026454|20692741|P2|COMPLETED|Second Intervention||13
8395839|NCT01026454|20692742|P1|COMPLETED|Second Intervention||16
8395840|NCT01026454|20692741|P2|STARTED|Second Intervention||14
8395841|NCT01026454|20692742|P1|STARTED|Second Intervention||17
8395842|NCT01026454|20692741|P2|NOT COMPLETED|Washout||0
8395843|NCT01026454|20692742|P1|NOT COMPLETED|Washout||0
8395844|NCT01026454|20692741|P2|COMPLETED|Washout||14
8395845|NCT01026454|20692742|P1|COMPLETED|Washout||18
8395846|NCT01026454|20692741|P2|STARTED|Washout||14
8395847|NCT01026454|20692742|P1|STARTED|Washout||18
8395848|NCT01026454|20692741|P2|NOT COMPLETED|First Intervention||0
8395849|NCT01026454|20692742|P1|NOT COMPLETED|First Intervention||0
8395850|NCT01026454|20692741|P2|COMPLETED|First Intervention||14
8395851|NCT01026454|20692742|P1|COMPLETED|First Intervention||18
8395852|NCT01026454|20692741|P2|STARTED|First Intervention||14
8395853|NCT01026454|20692742|P1|STARTED|First Intervention||18
8395854|NCT01026402|20692765|P17|NOT COMPLETED|Overall Study||0
8395855|NCT01026402|20692766|P16|NOT COMPLETED|Overall Study||0
8395856|NCT01026402|20692767|P15|NOT COMPLETED|Overall Study||0
8395857|NCT01026402|20692768|P14|NOT COMPLETED|Overall Study||0
8395858|NCT01026402|20692769|P13|NOT COMPLETED|Overall Study||0
8395859|NCT01026402|20692770|P12|NOT COMPLETED|Overall Study||0
8395860|NCT01026402|20692771|P11|NOT COMPLETED|Overall Study||0
8395861|NCT01026402|20692772|P10|NOT COMPLETED|Overall Study||0
8395862|NCT01026402|20692773|P9|NOT COMPLETED|Overall Study||0
8395863|NCT01026402|20692774|P8|NOT COMPLETED|Overall Study||0
8395864|NCT01026402|20692775|P7|NOT COMPLETED|Overall Study||0
8395865|NCT01026402|20692776|P6|NOT COMPLETED|Overall Study||0
8395866|NCT01026402|20692777|P5|NOT COMPLETED|Overall Study||0
8395867|NCT01026402|20692778|P4|NOT COMPLETED|Overall Study||0
8395868|NCT01026402|20692779|P3|NOT COMPLETED|Overall Study||0
8395869|NCT01026402|20692780|P2|NOT COMPLETED|Overall Study||0
8395870|NCT01026402|20692781|P1|NOT COMPLETED|Overall Study||0
8395871|NCT01026402|20692765|P17|COMPLETED|Overall Study||4
8395872|NCT01026402|20692766|P16|COMPLETED|Overall Study||5
8395873|NCT01026402|20692767|P15|COMPLETED|Overall Study||3
8395874|NCT01026402|20692768|P14|COMPLETED|Overall Study||6
8395875|NCT01026402|20692769|P13|COMPLETED|Overall Study||8
8395876|NCT01026402|20692770|P12|COMPLETED|Overall Study||8
8395877|NCT01026402|20692771|P11|COMPLETED|Overall Study||7
8395878|NCT01026402|20692772|P10|COMPLETED|Overall Study||3
8395879|NCT01026402|20692773|P9|COMPLETED|Overall Study||7
8395880|NCT01026402|20692774|P8|COMPLETED|Overall Study||3
8395881|NCT01026402|20692775|P7|COMPLETED|Overall Study||8
8395882|NCT01026402|20692776|P6|COMPLETED|Overall Study||5
8395883|NCT01026402|20692777|P5|COMPLETED|Overall Study||3
8395884|NCT01026402|20692778|P4|COMPLETED|Overall Study||18
8395885|NCT01026402|20692779|P3|COMPLETED|Overall Study||33
8395886|NCT01026402|20692780|P2|COMPLETED|Overall Study||8
8395887|NCT01026402|20692781|P1|COMPLETED|Overall Study||6
8395888|NCT01026402|20692765|P17|STARTED|Overall Study||4
8395889|NCT01026402|20692766|P16|STARTED|Overall Study||5
8395890|NCT01026402|20692767|P15|STARTED|Overall Study||3
8395891|NCT01026402|20692768|P14|STARTED|Overall Study||6
8395892|NCT01026402|20692769|P13|STARTED|Overall Study||8
8395893|NCT01026402|20692770|P12|STARTED|Overall Study||8
8395894|NCT01026402|20692771|P11|STARTED|Overall Study||7
8395895|NCT01026402|20692772|P10|STARTED|Overall Study||3
8395896|NCT01026402|20692773|P9|STARTED|Overall Study||7
8395897|NCT01026402|20692774|P8|STARTED|Overall Study||3
8395898|NCT01026402|20692775|P7|STARTED|Overall Study||8
8395899|NCT01026402|20692776|P6|STARTED|Overall Study||5
8395900|NCT01026402|20692777|P5|STARTED|Overall Study||3
8395901|NCT01026402|20692778|P4|STARTED|Overall Study||18
8395902|NCT01026402|20692779|P3|STARTED|Overall Study||33
8395903|NCT01026402|20692780|P2|STARTED|Overall Study||8
8395904|NCT01026402|20692781|P1|STARTED|Overall Study||6
8395905|NCT01026389|20693091|P2|NOT COMPLETED|Overall Study||5
8395906|NCT01026389|20693092|P1|NOT COMPLETED|Overall Study||5
8395907|NCT01026389|20693091|P2|COMPLETED|Overall Study||88
8395908|NCT01026389|20693092|P1|COMPLETED|Overall Study||88
8395909|NCT01026389|20693091|P2|STARTED|Overall Study||93
8395910|NCT01026389|20693092|P1|STARTED|Overall Study||93
8395911|NCT01026324|20693107|P3|NOT COMPLETED|Follow up/Survival||0
8395912|NCT01026324|20693108|P2|NOT COMPLETED|Follow up/Survival||0
8395913|NCT01026324|20693109|P1|NOT COMPLETED|Follow up/Survival||1
8395914|NCT01026324|20693107|P3|COMPLETED|Follow up/Survival||4
8395915|NCT01026324|20693108|P2|COMPLETED|Follow up/Survival||3
8395916|NCT01026324|20693109|P1|COMPLETED|Follow up/Survival||4
8395917|NCT01026324|20693107|P3|Follow up Discontinuation (Death)|Follow up/Survival||4
8395918|NCT01026324|20693108|P2|Follow up Discontinuation (Death)|Follow up/Survival||3
8395919|NCT01026324|20693109|P1|Follow up Discontinuation (Death)|Follow up/Survival||4
8395920|NCT01026324|20693107|P3|STARTED|Follow up/Survival||4
8395921|NCT01026324|20693108|P2|STARTED|Follow up/Survival||3
8395922|NCT01026324|20693109|P1|STARTED|Follow up/Survival||5
8395923|NCT01026324|20693107|P3|NOT COMPLETED|Treatment Allocation||0
8395924|NCT01026324|20693108|P2|NOT COMPLETED|Treatment Allocation||0
8395925|NCT01026324|20693109|P1|NOT COMPLETED|Treatment Allocation||0
8395926|NCT01026324|20693107|P3|COMPLETED|Treatment Allocation||4
8395927|NCT01026324|20693108|P2|COMPLETED|Treatment Allocation||3
8395928|NCT01026324|20693109|P1|COMPLETED|Treatment Allocation||5
8395929|NCT01026324|20693107|P3|Discontinued Intervention (Withdrew)|Treatment Allocation||0
8395930|NCT01026324|20693108|P2|Discontinued Intervention (Withdrew)|Treatment Allocation||0
8395931|NCT01026324|20693109|P1|Discontinued Intervention (Withdrew)|Treatment Allocation||1
8395932|NCT01026324|20693107|P3|Discontinuted Intervention (Progression)|Treatment Allocation||4
8395933|NCT01026324|20693108|P2|Discontinuted Intervention (Progression)|Treatment Allocation||3
8395934|NCT01026324|20693109|P1|Discontinuted Intervention (Progression)|Treatment Allocation||3
8395935|NCT01026324|20693107|P3|Discontinued Intervention (Toxicity)|Treatment Allocation||0
8395936|NCT01026324|20693108|P2|Discontinued Intervention (Toxicity)|Treatment Allocation||0
8395937|NCT01026324|20693109|P1|Discontinued Intervention (Toxicity)|Treatment Allocation||1
8395938|NCT01026324|20693107|P3|STARTED|Treatment Allocation||4
8395939|NCT01026324|20693108|P2|STARTED|Treatment Allocation||3
8395940|NCT01026324|20693109|P1|STARTED|Treatment Allocation||5
8395941|NCT01026220|20693119|P3|NOT COMPLETED|Consolidation Maintenance||14
8395942|NCT01026220|20693120|P2|NOT COMPLETED|Consolidation Maintenance||6
8395943|NCT01026220|20693121|P1|NOT COMPLETED|Consolidation Maintenance||0
8395944|NCT01026220|20693119|P3|COMPLETED|Consolidation Maintenance||66
8395945|NCT01026220|20693120|P2|COMPLETED|Consolidation Maintenance||75
8395946|NCT01026220|20693121|P1|COMPLETED|Consolidation Maintenance||0
8395947|NCT01026220|20693119|P3|STARTED|Consolidation Maintenance||80
8395948|NCT01026220|20693120|P2|STARTED|Consolidation Maintenance||81
8395949|NCT01026220|20693121|P1|STARTED|Consolidation Maintenance||0
8395950|NCT01026220|20693119|P3|NOT COMPLETED|Induction||0
8395951|NCT01026220|20693120|P2|NOT COMPLETED|Induction||0
8395952|NCT01026220|20693121|P1|NOT COMPLETED|Induction||25
8395953|NCT01026220|20693119|P3|COMPLETED|Induction||0
8395954|NCT01026220|20693120|P2|COMPLETED|Induction||0
8395955|NCT01026220|20693121|P1|COMPLETED|Induction||141
8395956|NCT01026220|20693119|P3|STARTED|Induction||0
8395957|NCT01026220|20693120|P2|STARTED|Induction||0
8395958|NCT01026220|20693121|P1|STARTED|Induction||166
8395959|NCT01026194|20693145|P2|NOT COMPLETED|Period 2：Open-label Period||10
8395960|NCT01026194|20693146|P1|NOT COMPLETED|Period 2：Open-label Period||7
8395961|NCT01026194|20693145|P2|COMPLETED|Period 2：Open-label Period||88
8395962|NCT01026194|20693146|P1|COMPLETED|Period 2：Open-label Period||91
8395963|NCT01026194|20693145|P2|STARTED|Period 2：Open-label Period||98
8395964|NCT01026194|20693146|P1|STARTED|Period 2：Open-label Period||98
8395965|NCT01026194|20693145|P2|NOT COMPLETED|Period 1：Double Blind Period||5
8395966|NCT01026194|20693146|P1|NOT COMPLETED|Period 1：Double Blind Period||3
8395967|NCT01026194|20693145|P2|COMPLETED|Period 1：Double Blind Period||98
8395968|NCT01026194|20693146|P1|COMPLETED|Period 1：Double Blind Period||98
8395969|NCT01026194|20693145|P2|STARTED|Period 1：Double Blind Period||103
8395970|NCT01026194|20693146|P1|STARTED|Period 1：Double Blind Period||101
8395971|NCT01026181|20693163|P3|NOT COMPLETED|Overall Study||0
8395972|NCT01026181|20693164|P2|NOT COMPLETED|Overall Study||0
8395973|NCT01026181|20693165|P1|NOT COMPLETED|Overall Study||0
8395974|NCT01026181|20693163|P3|COMPLETED|Overall Study||48
8395975|NCT01026181|20693164|P2|COMPLETED|Overall Study||51
8395976|NCT01026181|20693165|P1|COMPLETED|Overall Study||51
8395977|NCT01026181|20693163|P3|STARTED|Overall Study||48
8395978|NCT01026181|20693164|P2|STARTED|Overall Study||51
8395979|NCT01026181|20693165|P1|STARTED|Overall Study||51
8395980|NCT01026142|20693178|P2|NOT COMPLETED|Overall Study||163
8395981|NCT01026142|20693179|P1|NOT COMPLETED|Overall Study||172
8395982|NCT01026142|20693178|P2|COMPLETED|Overall Study||65
8395983|NCT01026142|20693179|P1|COMPLETED|Overall Study||52
8395984|NCT01026142|20693178|P2|STARTED|Overall Study||228
8395985|NCT01026142|20693179|P1|STARTED|Overall Study||224
8395986|NCT01026103|20693201|P1|NOT COMPLETED|Overall Study||2
8395987|NCT01026103|20693201|P1|COMPLETED|Overall Study||28
8395988|NCT01026103|20693201|P1|Consented|Overall Study||30
8395989|NCT01026103|20693201|P1|STARTED|Overall Study||30
8395990|NCT01026038|20693211|P3|NOT COMPLETED|Overall Study||0
8395991|NCT01026038|20693212|P2|NOT COMPLETED|Overall Study||1
8395992|NCT01026038|20693213|P1|NOT COMPLETED|Overall Study||1
8395993|NCT01026038|20693211|P3|COMPLETED|Overall Study||67
8395994|NCT01026038|20693212|P2|COMPLETED|Overall Study||64
8395995|NCT01026038|20693213|P1|COMPLETED|Overall Study||129
8395996|NCT01026038|20693211|P3|STARTED|Overall Study||67
8395997|NCT01026038|20693212|P2|STARTED|Overall Study||65
8395998|NCT01026038|20693213|P1|STARTED|Overall Study||130
8395999|NCT01026012|20693248|P1|NOT COMPLETED|Overall Study||0
8396000|NCT01026012|20693248|P1|COMPLETED|Overall Study||40
8396001|NCT01026012|20693248|P1|STARTED|Overall Study||40
8396002|NCT01025843|20693262|P10|NOT COMPLETED|Period 5||0
8396003|NCT01025843|20693263|P9|NOT COMPLETED|Period 5||0
8396004|NCT01025843|20693264|P8|NOT COMPLETED|Period 5||0
8396005|NCT01025843|20693265|P7|NOT COMPLETED|Period 5||0
8396006|NCT01025843|20693266|P6|NOT COMPLETED|Period 5||0
8396007|NCT01025843|20693267|P5|NOT COMPLETED|Period 5||0
8396008|NCT01025843|20693268|P4|NOT COMPLETED|Period 5||0
8396009|NCT01025843|20693269|P3|NOT COMPLETED|Period 5||0
8396010|NCT01025843|20693270|P2|NOT COMPLETED|Period 5||0
8396011|NCT01025843|20693271|P1|NOT COMPLETED|Period 5||0
8396012|NCT01025843|20693262|P10|COMPLETED|Period 5||2
8396013|NCT01025843|20693263|P9|COMPLETED|Period 5||2
8396014|NCT01025843|20693264|P8|COMPLETED|Period 5||2
8396015|NCT01025843|20693265|P7|COMPLETED|Period 5||2
8396016|NCT01025843|20693266|P6|COMPLETED|Period 5||2
8396017|NCT01025843|20693267|P5|COMPLETED|Period 5||2
8396018|NCT01025843|20693268|P4|COMPLETED|Period 5||1
8396019|NCT01025843|20693269|P3|COMPLETED|Period 5||1
8396020|NCT01025843|20693270|P2|COMPLETED|Period 5||2
8396021|NCT01025843|20693271|P1|COMPLETED|Period 5||2
8396022|NCT01025843|20693262|P10|STARTED|Period 5||2
8396023|NCT01025843|20693263|P9|STARTED|Period 5||2
8396024|NCT01025843|20693264|P8|STARTED|Period 5||2
8396025|NCT01025843|20693265|P7|STARTED|Period 5||2
8396026|NCT01025843|20693266|P6|STARTED|Period 5||2
8396027|NCT01025843|20693267|P5|STARTED|Period 5||2
8396028|NCT01025843|20693268|P4|STARTED|Period 5||1
8396029|NCT01025843|20693269|P3|STARTED|Period 5||1
8396030|NCT01025843|20693270|P2|STARTED|Period 5||2
8396031|NCT01025843|20693271|P1|STARTED|Period 5||2
8396032|NCT01025843|20693262|P10|NOT COMPLETED|Washout 4||0
8396033|NCT01025843|20693263|P9|NOT COMPLETED|Washout 4||0
8396034|NCT01025843|20693264|P8|NOT COMPLETED|Washout 4||0
8396035|NCT01025843|20693265|P7|NOT COMPLETED|Washout 4||0
8396036|NCT01025843|20693266|P6|NOT COMPLETED|Washout 4||0
8396037|NCT01025843|20693267|P5|NOT COMPLETED|Washout 4||0
8396038|NCT01025843|20693268|P4|NOT COMPLETED|Washout 4||1
8396039|NCT01025843|20693269|P3|NOT COMPLETED|Washout 4||1
8396040|NCT01025843|20693270|P2|NOT COMPLETED|Washout 4||0
8396041|NCT01025843|20693271|P1|NOT COMPLETED|Washout 4||0
8396042|NCT01025843|20693262|P10|COMPLETED|Washout 4||2
8396043|NCT01025843|20693263|P9|COMPLETED|Washout 4||2
8396044|NCT01025843|20693264|P8|COMPLETED|Washout 4||2
8396045|NCT01025843|20693265|P7|COMPLETED|Washout 4||2
8396046|NCT01025843|20693266|P6|COMPLETED|Washout 4||2
8396047|NCT01025843|20693267|P5|COMPLETED|Washout 4||2
8396048|NCT01025843|20693268|P4|COMPLETED|Washout 4||1
8396049|NCT01025843|20693269|P3|COMPLETED|Washout 4||1
8396050|NCT01025843|20693270|P2|COMPLETED|Washout 4||2
8396051|NCT01025843|20693271|P1|COMPLETED|Washout 4||2
8396052|NCT01025843|20693262|P10|STARTED|Washout 4||2
8396053|NCT01025843|20693263|P9|STARTED|Washout 4||2
8396054|NCT01025843|20693264|P8|STARTED|Washout 4||2
8396055|NCT01025843|20693265|P7|STARTED|Washout 4||2
8396056|NCT01025843|20693266|P6|STARTED|Washout 4||2
8396057|NCT01025843|20693267|P5|STARTED|Washout 4||2
8396058|NCT01025843|20693268|P4|STARTED|Washout 4||2
8396059|NCT01025843|20693269|P3|STARTED|Washout 4||2
8396060|NCT01025843|20693270|P2|STARTED|Washout 4||2
8396061|NCT01025843|20693271|P1|STARTED|Washout 4||2
8396062|NCT01025843|20693262|P10|NOT COMPLETED|Period 4||0
8396063|NCT01025843|20693263|P9|NOT COMPLETED|Period 4||0
8396064|NCT01025843|20693264|P8|NOT COMPLETED|Period 4||0
8396065|NCT01025843|20693265|P7|NOT COMPLETED|Period 4||0
8396066|NCT01025843|20693266|P6|NOT COMPLETED|Period 4||0
8396067|NCT01025843|20693267|P5|NOT COMPLETED|Period 4||0
8396068|NCT01025843|20693268|P4|NOT COMPLETED|Period 4||0
8396069|NCT01025843|20693269|P3|NOT COMPLETED|Period 4||0
8396070|NCT01025843|20693270|P2|NOT COMPLETED|Period 4||0
8396071|NCT01025843|20693271|P1|NOT COMPLETED|Period 4||0
8396072|NCT01025843|20693262|P10|COMPLETED|Period 4||2
8396073|NCT01025843|20693263|P9|COMPLETED|Period 4||2
8396074|NCT01025843|20693264|P8|COMPLETED|Period 4||2
8396075|NCT01025843|20693265|P7|COMPLETED|Period 4||2
8396076|NCT01025843|20693266|P6|COMPLETED|Period 4||2
8396077|NCT01025843|20693267|P5|COMPLETED|Period 4||2
8396078|NCT01025843|20693268|P4|COMPLETED|Period 4||2
8396079|NCT01025843|20693269|P3|COMPLETED|Period 4||2
8396080|NCT01025843|20693270|P2|COMPLETED|Period 4||2
8396081|NCT01025843|20693271|P1|COMPLETED|Period 4||2
8396082|NCT01025843|20693262|P10|STARTED|Period 4||2
8396083|NCT01025843|20693263|P9|STARTED|Period 4||2
8396084|NCT01025843|20693264|P8|STARTED|Period 4||2
8396085|NCT01025843|20693265|P7|STARTED|Period 4||2
8396086|NCT01025843|20693266|P6|STARTED|Period 4||2
8396087|NCT01025843|20693267|P5|STARTED|Period 4||2
8396088|NCT01025843|20693268|P4|STARTED|Period 4||2
8396089|NCT01025843|20693269|P3|STARTED|Period 4||2
8396090|NCT01025843|20693270|P2|STARTED|Period 4||2
8396091|NCT01025843|20693271|P1|STARTED|Period 4||2
8396092|NCT01025843|20693262|P10|NOT COMPLETED|Washout 3||0
8396093|NCT01025843|20693263|P9|NOT COMPLETED|Washout 3||0
8396094|NCT01025843|20693264|P8|NOT COMPLETED|Washout 3||0
8396095|NCT01025843|20693265|P7|NOT COMPLETED|Washout 3||0
8396096|NCT01025843|20693266|P6|NOT COMPLETED|Washout 3||0
8396097|NCT01025843|20693267|P5|NOT COMPLETED|Washout 3||0
8396098|NCT01025843|20693268|P4|NOT COMPLETED|Washout 3||0
8396099|NCT01025843|20693269|P3|NOT COMPLETED|Washout 3||0
8396100|NCT01025843|20693270|P2|NOT COMPLETED|Washout 3||0
8396101|NCT01025843|20693271|P1|NOT COMPLETED|Washout 3||0
8396102|NCT01025843|20693262|P10|COMPLETED|Washout 3||2
8396103|NCT01025843|20693263|P9|COMPLETED|Washout 3||2
8396104|NCT01025843|20693264|P8|COMPLETED|Washout 3||2
8396105|NCT01025843|20693265|P7|COMPLETED|Washout 3||2
8396106|NCT01025843|20693266|P6|COMPLETED|Washout 3||2
8396107|NCT01025843|20693267|P5|COMPLETED|Washout 3||2
8396108|NCT01025843|20693268|P4|COMPLETED|Washout 3||2
8396109|NCT01025843|20693269|P3|COMPLETED|Washout 3||2
8396110|NCT01025843|20693270|P2|COMPLETED|Washout 3||2
8396111|NCT01025843|20693271|P1|COMPLETED|Washout 3||2
8396112|NCT01025843|20693262|P10|STARTED|Washout 3||2
8396113|NCT01025843|20693263|P9|STARTED|Washout 3||2
8396114|NCT01025843|20693264|P8|STARTED|Washout 3||2
8396115|NCT01025843|20693265|P7|STARTED|Washout 3||2
8396116|NCT01025843|20693266|P6|STARTED|Washout 3||2
8396117|NCT01025843|20693267|P5|STARTED|Washout 3||2
8396118|NCT01025843|20693268|P4|STARTED|Washout 3||2
8396119|NCT01025843|20693269|P3|STARTED|Washout 3||2
8396120|NCT01025843|20693270|P2|STARTED|Washout 3||2
8396121|NCT01025843|20693271|P1|STARTED|Washout 3||2
8396122|NCT01025843|20693262|P10|NOT COMPLETED|Period 3||0
8396123|NCT01025843|20693263|P9|NOT COMPLETED|Period 3||0
8396124|NCT01025843|20693264|P8|NOT COMPLETED|Period 3||0
8396125|NCT01025843|20693265|P7|NOT COMPLETED|Period 3||0
8396126|NCT01025843|20693266|P6|NOT COMPLETED|Period 3||0
8396127|NCT01025843|20693267|P5|NOT COMPLETED|Period 3||0
8396128|NCT01025843|20693268|P4|NOT COMPLETED|Period 3||0
8396129|NCT01025843|20693269|P3|NOT COMPLETED|Period 3||0
8396130|NCT01025843|20693270|P2|NOT COMPLETED|Period 3||0
8396131|NCT01025843|20693271|P1|NOT COMPLETED|Period 3||0
8396132|NCT01025843|20693262|P10|COMPLETED|Period 3||2
8396133|NCT01025843|20693263|P9|COMPLETED|Period 3||2
8396134|NCT01025843|20693264|P8|COMPLETED|Period 3||2
8396135|NCT01025843|20693265|P7|COMPLETED|Period 3||2
8396136|NCT01025843|20693266|P6|COMPLETED|Period 3||2
8396137|NCT01025843|20693267|P5|COMPLETED|Period 3||2
8396138|NCT01025843|20693268|P4|COMPLETED|Period 3||2
8396139|NCT01025843|20693269|P3|COMPLETED|Period 3||2
8396140|NCT01025843|20693270|P2|COMPLETED|Period 3||2
8396141|NCT01025843|20693271|P1|COMPLETED|Period 3||2
8396142|NCT01025843|20693262|P10|STARTED|Period 3||2
8396143|NCT01025843|20693263|P9|STARTED|Period 3||2
8396144|NCT01025843|20693264|P8|STARTED|Period 3||2
8396145|NCT01025843|20693265|P7|STARTED|Period 3||2
8396146|NCT01025843|20693266|P6|STARTED|Period 3||2
8396147|NCT01025843|20693267|P5|STARTED|Period 3||2
8396148|NCT01025843|20693268|P4|STARTED|Period 3||2
8396149|NCT01025843|20693269|P3|STARTED|Period 3||2
8396150|NCT01025843|20693270|P2|STARTED|Period 3||2
8396151|NCT01025843|20693271|P1|STARTED|Period 3||2
8396152|NCT01025843|20693262|P10|NOT COMPLETED|Washout 2||0
8396153|NCT01025843|20693263|P9|NOT COMPLETED|Washout 2||0
8396154|NCT01025843|20693264|P8|NOT COMPLETED|Washout 2||0
8396155|NCT01025843|20693265|P7|NOT COMPLETED|Washout 2||0
8396156|NCT01025843|20693266|P6|NOT COMPLETED|Washout 2||0
8396157|NCT01025843|20693267|P5|NOT COMPLETED|Washout 2||0
8396158|NCT01025843|20693268|P4|NOT COMPLETED|Washout 2||0
8396159|NCT01025843|20693269|P3|NOT COMPLETED|Washout 2||0
8396160|NCT01025843|20693270|P2|NOT COMPLETED|Washout 2||0
8396161|NCT01025843|20693271|P1|NOT COMPLETED|Washout 2||0
8396162|NCT01025843|20693262|P10|COMPLETED|Washout 2||2
8396163|NCT01025843|20693263|P9|COMPLETED|Washout 2||2
8396164|NCT01025843|20693264|P8|COMPLETED|Washout 2||2
8396165|NCT01025843|20693265|P7|COMPLETED|Washout 2||2
8396166|NCT01025843|20693266|P6|COMPLETED|Washout 2||2
8396167|NCT01025843|20693267|P5|COMPLETED|Washout 2||2
8396168|NCT01025843|20693268|P4|COMPLETED|Washout 2||2
8396169|NCT01025843|20693269|P3|COMPLETED|Washout 2||2
8396170|NCT01025843|20693270|P2|COMPLETED|Washout 2||2
8396171|NCT01025843|20693271|P1|COMPLETED|Washout 2||2
8396172|NCT01025843|20693262|P10|STARTED|Washout 2||2
8396173|NCT01025843|20693263|P9|STARTED|Washout 2||2
8396174|NCT01025843|20693264|P8|STARTED|Washout 2||2
8396175|NCT01025843|20693265|P7|STARTED|Washout 2||2
8396176|NCT01025843|20693266|P6|STARTED|Washout 2||2
8396177|NCT01025843|20693267|P5|STARTED|Washout 2||2
8396178|NCT01025843|20693268|P4|STARTED|Washout 2||2
8396179|NCT01025843|20693269|P3|STARTED|Washout 2||2
8396180|NCT01025843|20693270|P2|STARTED|Washout 2||2
8396181|NCT01025843|20693271|P1|STARTED|Washout 2||2
8396182|NCT01025843|20693262|P10|NOT COMPLETED|Period 2||0
8396183|NCT01025843|20693263|P9|NOT COMPLETED|Period 2||0
8396184|NCT01025843|20693264|P8|NOT COMPLETED|Period 2||0
8396185|NCT01025843|20693265|P7|NOT COMPLETED|Period 2||0
8396186|NCT01025843|20693266|P6|NOT COMPLETED|Period 2||0
8396187|NCT01025843|20693267|P5|NOT COMPLETED|Period 2||0
8396188|NCT01025843|20693268|P4|NOT COMPLETED|Period 2||0
8396189|NCT01025843|20693269|P3|NOT COMPLETED|Period 2||0
8396190|NCT01025843|20693270|P2|NOT COMPLETED|Period 2||0
8396191|NCT01025843|20693271|P1|NOT COMPLETED|Period 2||0
8396192|NCT01025843|20693262|P10|COMPLETED|Period 2||2
8396193|NCT01025843|20693263|P9|COMPLETED|Period 2||2
8396194|NCT01025843|20693264|P8|COMPLETED|Period 2||2
8396195|NCT01025843|20693265|P7|COMPLETED|Period 2||2
8396196|NCT01025843|20693266|P6|COMPLETED|Period 2||2
8396197|NCT01025843|20693267|P5|COMPLETED|Period 2||2
8396198|NCT01025843|20693268|P4|COMPLETED|Period 2||2
8396199|NCT01025843|20693269|P3|COMPLETED|Period 2||2
8396200|NCT01025843|20693270|P2|COMPLETED|Period 2||2
8396201|NCT01025843|20693271|P1|COMPLETED|Period 2||2
8396202|NCT01025843|20693262|P10|STARTED|Period 2||2
8396203|NCT01025843|20693263|P9|STARTED|Period 2||2
8396204|NCT01025843|20693264|P8|STARTED|Period 2||2
8396205|NCT01025843|20693265|P7|STARTED|Period 2||2
8396206|NCT01025843|20693266|P6|STARTED|Period 2||2
8396207|NCT01025843|20693267|P5|STARTED|Period 2||2
8396208|NCT01025843|20693268|P4|STARTED|Period 2||2
8396209|NCT01025843|20693269|P3|STARTED|Period 2||2
8396210|NCT01025843|20693270|P2|STARTED|Period 2||2
8396211|NCT01025843|20693271|P1|STARTED|Period 2||2
8396212|NCT01025843|20693262|P10|NOT COMPLETED|Washout 1||0
8396213|NCT01025843|20693263|P9|NOT COMPLETED|Washout 1||0
8396214|NCT01025843|20693264|P8|NOT COMPLETED|Washout 1||0
8396215|NCT01025843|20693265|P7|NOT COMPLETED|Washout 1||0
8396216|NCT01025843|20693266|P6|NOT COMPLETED|Washout 1||0
8396217|NCT01025843|20693267|P5|NOT COMPLETED|Washout 1||0
8396218|NCT01025843|20693268|P4|NOT COMPLETED|Washout 1||0
8396219|NCT01025843|20693269|P3|NOT COMPLETED|Washout 1||0
8396220|NCT01025843|20693270|P2|NOT COMPLETED|Washout 1||0
8396221|NCT01025843|20693271|P1|NOT COMPLETED|Washout 1||0
8396222|NCT01025843|20693262|P10|COMPLETED|Washout 1||2
8396223|NCT01025843|20693263|P9|COMPLETED|Washout 1||2
8396224|NCT01025843|20693264|P8|COMPLETED|Washout 1||2
8396225|NCT01025843|20693265|P7|COMPLETED|Washout 1||2
8396226|NCT01025843|20693266|P6|COMPLETED|Washout 1||2
8396227|NCT01025843|20693267|P5|COMPLETED|Washout 1||2
8396228|NCT01025843|20693268|P4|COMPLETED|Washout 1||2
8396229|NCT01025843|20693269|P3|COMPLETED|Washout 1||2
8396230|NCT01025843|20693270|P2|COMPLETED|Washout 1||2
8396231|NCT01025843|20693271|P1|COMPLETED|Washout 1||2
8396232|NCT01025843|20693262|P10|STARTED|Washout 1||2
8396233|NCT01025843|20693263|P9|STARTED|Washout 1||2
8396234|NCT01025843|20693264|P8|STARTED|Washout 1||2
8396235|NCT01025843|20693265|P7|STARTED|Washout 1||2
8396236|NCT01025843|20693266|P6|STARTED|Washout 1||2
8396237|NCT01025843|20693267|P5|STARTED|Washout 1||2
8396238|NCT01025843|20693268|P4|STARTED|Washout 1||2
8396239|NCT01025843|20693269|P3|STARTED|Washout 1||2
8396240|NCT01025843|20693270|P2|STARTED|Washout 1||2
8396241|NCT01025843|20693271|P1|STARTED|Washout 1||2
8396242|NCT01025843|20693262|P10|NOT COMPLETED|Period 1||0
8396243|NCT01025843|20693263|P9|NOT COMPLETED|Period 1||0
8396244|NCT01025843|20693264|P8|NOT COMPLETED|Period 1||0
8396245|NCT01025843|20693265|P7|NOT COMPLETED|Period 1||0
8396246|NCT01025843|20693266|P6|NOT COMPLETED|Period 1||0
8396247|NCT01025843|20693267|P5|NOT COMPLETED|Period 1||0
8396248|NCT01025843|20693268|P4|NOT COMPLETED|Period 1||0
8396249|NCT01025843|20693269|P3|NOT COMPLETED|Period 1||0
8396250|NCT01025843|20693270|P2|NOT COMPLETED|Period 1||0
8396251|NCT01025843|20693271|P1|NOT COMPLETED|Period 1||0
8396252|NCT01025843|20693262|P10|COMPLETED|Period 1||2
8396253|NCT01025843|20693263|P9|COMPLETED|Period 1||2
8396254|NCT01025843|20693264|P8|COMPLETED|Period 1||2
8396255|NCT01025843|20693265|P7|COMPLETED|Period 1||2
8396256|NCT01025843|20693266|P6|COMPLETED|Period 1||2
8396257|NCT01025843|20693267|P5|COMPLETED|Period 1||2
8396258|NCT01025843|20693268|P4|COMPLETED|Period 1||2
8396259|NCT01025843|20693269|P3|COMPLETED|Period 1||2
8396260|NCT01025843|20693270|P2|COMPLETED|Period 1||2
8396261|NCT01025843|20693271|P1|COMPLETED|Period 1||2
8396262|NCT01025843|20693262|P10|STARTED|Period 1||2
8396263|NCT01025843|20693263|P9|STARTED|Period 1||2
8396264|NCT01025843|20693264|P8|STARTED|Period 1||2
8396265|NCT01025843|20693265|P7|STARTED|Period 1||2
8396266|NCT01025843|20693266|P6|STARTED|Period 1||2
8396267|NCT01025843|20693267|P5|STARTED|Period 1||2
8396268|NCT01025843|20693268|P4|STARTED|Period 1||2
8396269|NCT01025843|20693269|P3|STARTED|Period 1||2
8396270|NCT01025843|20693270|P2|STARTED|Period 1||2
8396271|NCT01025843|20693271|P1|STARTED|Period 1||2
8396272|NCT01025830|20693345|P2|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
8396273|NCT01025830|20693346|P1|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
8396274|NCT01025830|20693345|P2|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
8396275|NCT01025830|20693346|P1|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
8396276|NCT01025830|20693345|P2|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
8396277|NCT01025830|20693346|P1|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
8396278|NCT01025830|20693345|P2|NOT COMPLETED|Washout Period of 30 Days||0
8396279|NCT01025830|20693346|P1|NOT COMPLETED|Washout Period of 30 Days||0
8396280|NCT01025830|20693345|P2|COMPLETED|Washout Period of 30 Days||12
8396281|NCT01025830|20693346|P1|COMPLETED|Washout Period of 30 Days||8
8396282|NCT01025830|20693345|P2|STARTED|Washout Period of 30 Days||12
8396283|NCT01025830|20693346|P1|STARTED|Washout Period of 30 Days||8
8396284|NCT01025830|20693345|P2|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
8396285|NCT01025830|20693346|P1|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
8396286|NCT01025830|20693345|P2|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
8396287|NCT01025830|20693346|P1|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
8396288|NCT01025830|20693345|P2|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
8396289|NCT01025830|20693346|P1|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
8396290|NCT01025817|20693365|P2|NOT COMPLETED|Completed Study||22
8396291|NCT01025817|20693366|P1|NOT COMPLETED|Completed Study||16
8396292|NCT01025817|20693365|P2|COMPLETED|Completed Study|Completed study phase|282
8396293|NCT01025817|20693366|P1|COMPLETED|Completed Study|Completed study phase|293
8396294|NCT01025817|20693365|P2|STARTED|Completed Study||304
8396295|NCT01025817|20693366|P1|STARTED|Completed Study||309
8396296|NCT01025817|20693365|P2|NOT COMPLETED|Completed Study Medication||72
8396297|NCT01025817|20693366|P1|NOT COMPLETED|Completed Study Medication||105
8396298|NCT01025817|20693365|P2|COMPLETED|Completed Study Medication||232
8396299|NCT01025817|20693366|P1|COMPLETED|Completed Study Medication||204
8396300|NCT01025817|20693365|P2|STARTED|Completed Study Medication||304
8396301|NCT01025817|20693366|P1|STARTED|Completed Study Medication||309
8396302|NCT01025791|20693387|P14|NOT COMPLETED|Period 5||0
8396303|NCT01025791|20693388|P13|NOT COMPLETED|Period 5||0
8396304|NCT01025791|20693389|P12|NOT COMPLETED|Period 5||0
8396305|NCT01025791|20693390|P11|NOT COMPLETED|Period 5||0
8396306|NCT01025791|20693391|P10|NOT COMPLETED|Period 5||0
8396307|NCT01025791|20693392|P9|NOT COMPLETED|Period 5||0
8396308|NCT01025791|20693393|P8|NOT COMPLETED|Period 5||0
8396309|NCT01025791|20693394|P7|NOT COMPLETED|Period 5||0
8396310|NCT01025791|20693395|P6|NOT COMPLETED|Period 5||0
8396311|NCT01025791|20693396|P5|NOT COMPLETED|Period 5||0
8396312|NCT01025791|20693397|P4|NOT COMPLETED|Period 5||0
8396313|NCT01025791|20693398|P3|NOT COMPLETED|Period 5||0
8396314|NCT01025791|20693399|P2|NOT COMPLETED|Period 5||0
8396315|NCT01025791|20693400|P1|NOT COMPLETED|Period 5||0
8396316|NCT01025791|20693387|P14|COMPLETED|Period 5||0
8396317|NCT01025791|20693388|P13|COMPLETED|Period 5||0
8396318|NCT01025791|20693389|P12|COMPLETED|Period 5||0
8396319|NCT01025791|20693390|P11|COMPLETED|Period 5||0
8396320|NCT01025791|20693391|P10|COMPLETED|Period 5||0
8396321|NCT01025791|20693392|P9|COMPLETED|Period 5||0
8396322|NCT01025791|20693393|P8|COMPLETED|Period 5||0
8396323|NCT01025791|20693394|P7|COMPLETED|Period 5||0
8396324|NCT01025791|20693395|P6|COMPLETED|Period 5||0
8396325|NCT01025791|20693396|P5|COMPLETED|Period 5||0
8396326|NCT01025791|20693397|P4|COMPLETED|Period 5||2
8396327|NCT01025791|20693398|P3|COMPLETED|Period 5||2
8396328|NCT01025791|20693399|P2|COMPLETED|Period 5||2
8396329|NCT01025791|20693400|P1|COMPLETED|Period 5||2
8396330|NCT01025791|20693387|P14|STARTED|Period 5||0
8396331|NCT01025791|20693388|P13|STARTED|Period 5||0
8396332|NCT01025791|20693389|P12|STARTED|Period 5||0
8396333|NCT01025791|20693390|P11|STARTED|Period 5||0
8396334|NCT01025791|20693391|P10|STARTED|Period 5||0
8396335|NCT01025791|20693392|P9|STARTED|Period 5||0
8396336|NCT01025791|20693393|P8|STARTED|Period 5||0
8396337|NCT01025791|20693394|P7|STARTED|Period 5||0
8396338|NCT01025791|20693395|P6|STARTED|Period 5||0
8396339|NCT01025791|20693396|P5|STARTED|Period 5||0
8396340|NCT01025791|20693397|P4|STARTED|Period 5||2
8396341|NCT01025791|20693398|P3|STARTED|Period 5||2
8396342|NCT01025791|20693399|P2|STARTED|Period 5||2
8396343|NCT01025791|20693400|P1|STARTED|Period 5||2
8396344|NCT01025791|20693387|P14|NOT COMPLETED|Period 4||0
8396345|NCT01025791|20693388|P13|NOT COMPLETED|Period 4||0
8396346|NCT01025791|20693389|P12|NOT COMPLETED|Period 4||0
8396347|NCT01025791|20693390|P11|NOT COMPLETED|Period 4||0
8396348|NCT01025791|20693391|P10|NOT COMPLETED|Period 4||0
8396349|NCT01025791|20693392|P9|NOT COMPLETED|Period 4||0
8396350|NCT01025791|20693393|P8|NOT COMPLETED|Period 4||0
8396351|NCT01025791|20693394|P7|NOT COMPLETED|Period 4||0
8396352|NCT01025791|20693395|P6|NOT COMPLETED|Period 4||0
8396353|NCT01025791|20693396|P5|NOT COMPLETED|Period 4||0
8396354|NCT01025791|20693397|P4|NOT COMPLETED|Period 4||0
8396355|NCT01025791|20693398|P3|NOT COMPLETED|Period 4||0
8396356|NCT01025791|20693399|P2|NOT COMPLETED|Period 4||0
8396357|NCT01025791|20693400|P1|NOT COMPLETED|Period 4||0
8396358|NCT01025791|20693387|P14|COMPLETED|Period 4||1
8396359|NCT01025791|20693388|P13|COMPLETED|Period 4||2
8396360|NCT01025791|20693389|P12|COMPLETED|Period 4||1
8396361|NCT01025791|20693390|P11|COMPLETED|Period 4||2
8396362|NCT01025791|20693391|P10|COMPLETED|Period 4||1
8396363|NCT01025791|20693392|P9|COMPLETED|Period 4||2
8396364|NCT01025791|20693393|P8|COMPLETED|Period 4||2
8396365|NCT01025791|20693394|P7|COMPLETED|Period 4||2
8396366|NCT01025791|20693395|P6|COMPLETED|Period 4||2
8396367|NCT01025791|20693396|P5|COMPLETED|Period 4||2
8396368|NCT01025791|20693397|P4|COMPLETED|Period 4||2
8396369|NCT01025791|20693398|P3|COMPLETED|Period 4||2
8396370|NCT01025791|20693399|P2|COMPLETED|Period 4||2
8396371|NCT01025791|20693400|P1|COMPLETED|Period 4||2
8396372|NCT01025791|20693387|P14|STARTED|Period 4||1
8396373|NCT01025791|20693388|P13|STARTED|Period 4||2
8396374|NCT01025791|20693389|P12|STARTED|Period 4||1
8396375|NCT01025791|20693390|P11|STARTED|Period 4||2
8396376|NCT01025791|20693391|P10|STARTED|Period 4||1
8396377|NCT01025791|20693392|P9|STARTED|Period 4||2
8396378|NCT01025791|20693393|P8|STARTED|Period 4||2
8396379|NCT01025791|20693394|P7|STARTED|Period 4||2
8396380|NCT01025791|20693395|P6|STARTED|Period 4||2
8396381|NCT01025791|20693396|P5|STARTED|Period 4||2
8396382|NCT01025791|20693397|P4|STARTED|Period 4||2
8396383|NCT01025791|20693398|P3|STARTED|Period 4||2
8396384|NCT01025791|20693399|P2|STARTED|Period 4||2
8396385|NCT01025791|20693400|P1|STARTED|Period 4||2
8396386|NCT01025791|20693387|P14|NOT COMPLETED|Period 3||0
8396387|NCT01025791|20693388|P13|NOT COMPLETED|Period 3||0
8396388|NCT01025791|20693389|P12|NOT COMPLETED|Period 3||0
8396389|NCT01025791|20693390|P11|NOT COMPLETED|Period 3||0
8396390|NCT01025791|20693391|P10|NOT COMPLETED|Period 3||0
8396391|NCT01025791|20693392|P9|NOT COMPLETED|Period 3||0
8396392|NCT01025791|20693393|P8|NOT COMPLETED|Period 3||0
8396393|NCT01025791|20693394|P7|NOT COMPLETED|Period 3||0
8396394|NCT01025791|20693395|P6|NOT COMPLETED|Period 3||0
8396395|NCT01025791|20693396|P5|NOT COMPLETED|Period 3||0
8396396|NCT01025791|20693397|P4|NOT COMPLETED|Period 3||0
8396397|NCT01025791|20693398|P3|NOT COMPLETED|Period 3||0
8396398|NCT01025791|20693399|P2|NOT COMPLETED|Period 3||0
8396399|NCT01025791|20693400|P1|NOT COMPLETED|Period 3||0
8396400|NCT01025791|20693387|P14|COMPLETED|Period 3||1
8396401|NCT01025791|20693388|P13|COMPLETED|Period 3||2
8396402|NCT01025791|20693389|P12|COMPLETED|Period 3||1
8396403|NCT01025791|20693390|P11|COMPLETED|Period 3||2
8396404|NCT01025791|20693391|P10|COMPLETED|Period 3||1
8396405|NCT01025791|20693392|P9|COMPLETED|Period 3||2
8396406|NCT01025791|20693393|P8|COMPLETED|Period 3||2
8396407|NCT01025791|20693394|P7|COMPLETED|Period 3||2
8396408|NCT01025791|20693395|P6|COMPLETED|Period 3||2
8396409|NCT01025791|20693396|P5|COMPLETED|Period 3||2
8396410|NCT01025791|20693397|P4|COMPLETED|Period 3||2
8396411|NCT01025791|20693398|P3|COMPLETED|Period 3||2
8396412|NCT01025791|20693399|P2|COMPLETED|Period 3||2
8396413|NCT01025791|20693400|P1|COMPLETED|Period 3||2
8396414|NCT01025791|20693387|P14|STARTED|Period 3||1
8396415|NCT01025791|20693388|P13|STARTED|Period 3||2
8396416|NCT01025791|20693389|P12|STARTED|Period 3||1
8396417|NCT01025791|20693390|P11|STARTED|Period 3||2
8396418|NCT01025791|20693391|P10|STARTED|Period 3||1
8396419|NCT01025791|20693392|P9|STARTED|Period 3||2
8396420|NCT01025791|20693393|P8|STARTED|Period 3||2
8396421|NCT01025791|20693394|P7|STARTED|Period 3||2
8396422|NCT01025791|20693395|P6|STARTED|Period 3||2
8396423|NCT01025791|20693396|P5|STARTED|Period 3||2
8396424|NCT01025791|20693397|P4|STARTED|Period 3||2
8396425|NCT01025791|20693398|P3|STARTED|Period 3||2
8396426|NCT01025791|20693399|P2|STARTED|Period 3||2
8396427|NCT01025791|20693400|P1|STARTED|Period 3||2
8396428|NCT01025791|20693387|P14|NOT COMPLETED|Period 2||0
8396429|NCT01025791|20693388|P13|NOT COMPLETED|Period 2||0
8396430|NCT01025791|20693389|P12|NOT COMPLETED|Period 2||0
8396431|NCT01025791|20693390|P11|NOT COMPLETED|Period 2||0
8396432|NCT01025791|20693391|P10|NOT COMPLETED|Period 2||0
8396433|NCT01025791|20693392|P9|NOT COMPLETED|Period 2||0
8396434|NCT01025791|20693393|P8|NOT COMPLETED|Period 2||0
8396435|NCT01025791|20693394|P7|NOT COMPLETED|Period 2||0
8396436|NCT01025791|20693395|P6|NOT COMPLETED|Period 2||0
8396437|NCT01025791|20693396|P5|NOT COMPLETED|Period 2||0
8396438|NCT01025791|20693397|P4|NOT COMPLETED|Period 2||0
8396439|NCT01025791|20693398|P3|NOT COMPLETED|Period 2||0
8396440|NCT01025791|20693399|P2|NOT COMPLETED|Period 2||0
8396441|NCT01025791|20693400|P1|NOT COMPLETED|Period 2||0
8396442|NCT01025791|20693387|P14|COMPLETED|Period 2||1
8396443|NCT01025791|20693388|P13|COMPLETED|Period 2||2
8396444|NCT01025791|20693389|P12|COMPLETED|Period 2||1
8396445|NCT01025791|20693390|P11|COMPLETED|Period 2||2
8396446|NCT01025791|20693391|P10|COMPLETED|Period 2||1
8396447|NCT01025791|20693392|P9|COMPLETED|Period 2||2
8396448|NCT01025791|20693393|P8|COMPLETED|Period 2||2
8396449|NCT01025791|20693394|P7|COMPLETED|Period 2||2
8396450|NCT01025791|20693395|P6|COMPLETED|Period 2||2
8396451|NCT01025791|20693396|P5|COMPLETED|Period 2||2
8396452|NCT01025791|20693397|P4|COMPLETED|Period 2||2
8396453|NCT01025791|20693398|P3|COMPLETED|Period 2||2
8396454|NCT01025791|20693399|P2|COMPLETED|Period 2||2
8396455|NCT01025791|20693400|P1|COMPLETED|Period 2||2
8396456|NCT01025791|20693387|P14|STARTED|Period 2||1
8396457|NCT01025791|20693388|P13|STARTED|Period 2||2
8396458|NCT01025791|20693389|P12|STARTED|Period 2||1
8396459|NCT01025791|20693390|P11|STARTED|Period 2||2
8396460|NCT01025791|20693391|P10|STARTED|Period 2||1
8396461|NCT01025791|20693392|P9|STARTED|Period 2||2
8396462|NCT01025791|20693393|P8|STARTED|Period 2||2
8396463|NCT01025791|20693394|P7|STARTED|Period 2||2
8396464|NCT01025791|20693395|P6|STARTED|Period 2||2
8396465|NCT01025791|20693396|P5|STARTED|Period 2||2
8396466|NCT01025791|20693397|P4|STARTED|Period 2||2
8396467|NCT01025791|20693398|P3|STARTED|Period 2||2
8396468|NCT01025791|20693399|P2|STARTED|Period 2||2
8396469|NCT01025791|20693400|P1|STARTED|Period 2||2
8396470|NCT01025791|20693387|P14|NOT COMPLETED|Period 1||0
8396471|NCT01025791|20693388|P13|NOT COMPLETED|Period 1||0
8396472|NCT01025791|20693389|P12|NOT COMPLETED|Period 1||0
8396473|NCT01025791|20693390|P11|NOT COMPLETED|Period 1||0
8396474|NCT01025791|20693391|P10|NOT COMPLETED|Period 1||0
8396475|NCT01025791|20693392|P9|NOT COMPLETED|Period 1||0
8396476|NCT01025791|20693393|P8|NOT COMPLETED|Period 1||0
8396477|NCT01025791|20693394|P7|NOT COMPLETED|Period 1||0
8396478|NCT01025791|20693395|P6|NOT COMPLETED|Period 1||0
8396479|NCT01025791|20693396|P5|NOT COMPLETED|Period 1||0
8396480|NCT01025791|20693397|P4|NOT COMPLETED|Period 1||0
8396481|NCT01025791|20693398|P3|NOT COMPLETED|Period 1||0
8396482|NCT01025791|20693399|P2|NOT COMPLETED|Period 1||0
8396483|NCT01025791|20693400|P1|NOT COMPLETED|Period 1||0
8396484|NCT01025791|20693387|P14|COMPLETED|Period 1||1
8396485|NCT01025791|20693388|P13|COMPLETED|Period 1||2
8396486|NCT01025791|20693389|P12|COMPLETED|Period 1||1
8396487|NCT01025791|20693390|P11|COMPLETED|Period 1||2
8396488|NCT01025791|20693391|P10|COMPLETED|Period 1||1
8396489|NCT01025791|20693392|P9|COMPLETED|Period 1||2
8396490|NCT01025791|20693393|P8|COMPLETED|Period 1||2
8396491|NCT01025791|20693394|P7|COMPLETED|Period 1||2
8396492|NCT01025791|20693395|P6|COMPLETED|Period 1||2
8396493|NCT01025791|20693396|P5|COMPLETED|Period 1||2
8396494|NCT01025791|20693397|P4|COMPLETED|Period 1||2
8396495|NCT01025791|20693398|P3|COMPLETED|Period 1||2
8396496|NCT01025791|20693399|P2|COMPLETED|Period 1||2
8396497|NCT01025791|20693400|P1|COMPLETED|Period 1||2
8396498|NCT01025791|20693387|P14|STARTED|Period 1||1
8396499|NCT01025791|20693388|P13|STARTED|Period 1||2
8396500|NCT01025791|20693389|P12|STARTED|Period 1||1
8396501|NCT01025791|20693390|P11|STARTED|Period 1||2
8396502|NCT01025791|20693391|P10|STARTED|Period 1||1
8396503|NCT01025791|20693392|P9|STARTED|Period 1||2
8396504|NCT01025791|20693393|P8|STARTED|Period 1||2
8396505|NCT01025791|20693394|P7|STARTED|Period 1||2
8396506|NCT01025791|20693395|P6|STARTED|Period 1||2
8396507|NCT01025791|20693396|P5|STARTED|Period 1||2
8396508|NCT01025791|20693397|P4|STARTED|Period 1||2
8396509|NCT01025791|20693398|P3|STARTED|Period 1||2
8396510|NCT01025791|20693399|P2|STARTED|Period 1||2
8396511|NCT01025791|20693400|P1|STARTED|Period 1||2
8396512|NCT01025752|20693532|P2|NOT COMPLETED|Overall Study||13
8396513|NCT01025752|20693533|P1|NOT COMPLETED|Overall Study||8
8396514|NCT01025752|20693532|P2|COMPLETED|Overall Study||50
8396515|NCT01025752|20693533|P1|COMPLETED|Overall Study||54
8396516|NCT01025752|20693532|P2|STARTED|Overall Study||63
8396517|NCT01025752|20693533|P1|STARTED|Overall Study||62
8396518|NCT01025635|20693553|P2|NOT COMPLETED|Overall Study||25
8396519|NCT01025635|20693554|P1|NOT COMPLETED|Overall Study||23
8396520|NCT01025635|20693553|P2|COMPLETED|Overall Study||178
8396521|NCT01025635|20693554|P1|COMPLETED|Overall Study||175
8396522|NCT01025635|20693553|P2|STARTED|Overall Study||203
8396523|NCT01025635|20693554|P1|STARTED|Overall Study||198
8396524|NCT01025492|20693566|P1|NOT COMPLETED|Overall Study||0
8396525|NCT01025492|20693566|P1|COMPLETED|Overall Study||24
8396526|NCT01025492|20693566|P1|STARTED|Overall Study||24
8396527|NCT01025453|20693570|P1|NOT COMPLETED|Overall Study||0
8396528|NCT01025453|20693570|P1|COMPLETED|Overall Study||37
8396529|NCT01025453|20693570|P1|STARTED|Overall Study||37
8396530|NCT01025427|20693577|P1|NOT COMPLETED|Overall Study||0
8396531|NCT01025427|20693577|P1|COMPLETED|Overall Study||16
8396532|NCT01025427|20693577|P1|STARTED|Overall Study||16
8396533|NCT01025336|20693586|P5|NOT COMPLETED|Overall Study||0
8396534|NCT01025336|20693587|P4|NOT COMPLETED|Overall Study||2
8396535|NCT01025336|20693588|P3|NOT COMPLETED|Overall Study||0
8396536|NCT01025336|20693589|P2|NOT COMPLETED|Overall Study||0
8396537|NCT01025336|20693590|P1|NOT COMPLETED|Overall Study||0
8396538|NCT01025336|20693586|P5|COMPLETED|Overall Study||222
8396539|NCT01025336|20693587|P4|COMPLETED|Overall Study||219
8396540|NCT01025336|20693588|P3|COMPLETED|Overall Study||179
8396541|NCT01025336|20693589|P2|COMPLETED|Overall Study||210
8396542|NCT01025336|20693590|P1|COMPLETED|Overall Study||130
8396543|NCT01025336|20693586|P5|STARTED|Overall Study||222
8396544|NCT01025336|20693587|P4|STARTED|Overall Study||221
8396545|NCT01025336|20693588|P3|STARTED|Overall Study||179
8396546|NCT01025336|20693589|P2|STARTED|Overall Study||210
8396547|NCT01025336|20693590|P1|STARTED|Overall Study||130
8396548|NCT01025284|20693645|P3|NOT COMPLETED|Overall Study||0
8396549|NCT01025284|20693646|P2|NOT COMPLETED|Overall Study||2
8396550|NCT01025284|20693647|P1|NOT COMPLETED|Overall Study||0
8396551|NCT01025284|20693645|P3|COMPLETED|Overall Study||8
8396552|NCT01025284|20693646|P2|COMPLETED|Overall Study||16
8396553|NCT01025284|20693647|P1|COMPLETED|Overall Study||38
8396554|NCT01025284|20693645|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
8396555|NCT01025284|20693646|P2|Received at Least 1 Dose of Study Drug|Overall Study||18
8396556|NCT01025284|20693647|P1|Received at Least 1 Dose of Study Drug|Overall Study||38
8396557|NCT01025284|20693645|P3|STARTED|Overall Study||8
8396558|NCT01025284|20693646|P2|STARTED|Overall Study||18
8396559|NCT01025284|20693647|P1|STARTED|Overall Study||38
8396560|NCT01025271|20693665|P1|NOT COMPLETED|Overall Study||0
8396561|NCT01025271|20693665|P1|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
8396562|NCT01025271|20693665|P1|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
8396563|NCT01025232|20693672|P2|NOT COMPLETED|Overall Study||6
8396564|NCT01025232|20693673|P1|NOT COMPLETED|Overall Study||3
8396565|NCT01025232|20693672|P2|COMPLETED|Overall Study||36
8396566|NCT01025232|20693673|P1|COMPLETED|Overall Study||43
8396567|NCT01025232|20693672|P2|STARTED|Overall Study||42
8396568|NCT01025232|20693673|P1|STARTED|Overall Study||46
8396569|NCT01025193|20693691|P1|NOT COMPLETED|Overall Study||4
8396570|NCT01025193|20693691|P1|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
8396571|NCT01025193|20693691|P1|STARTED|Overall Study||8
8396572|NCT01025154|20693701|P1|NOT COMPLETED|Overall Study||2
8396573|NCT01025154|20693701|P1|COMPLETED|Overall Study||57
8396574|NCT01025154|20693701|P1|STARTED|Overall Study||59
8396575|NCT01025076|20693706|P1|NOT COMPLETED|Overall Study||0
8396576|NCT01025076|20693706|P1|COMPLETED|Overall Study||14
8396577|NCT01025076|20693706|P1|STARTED|Overall Study||14
8396578|NCT01025037|20693710|P1|NOT COMPLETED|Overall Study||11
8396579|NCT01025037|20693710|P1|COMPLETED|Overall Study||50
8396580|NCT01025037|20693710|P1|STARTED|Overall Study||61
8396581|NCT01024972|20693721|P2|NOT COMPLETED|Overall Study||0
8396582|NCT01024972|20693722|P1|NOT COMPLETED|Overall Study||0
8396583|NCT01024972|20693721|P2|COMPLETED|Overall Study||15
8396584|NCT01024972|20693722|P1|COMPLETED|Overall Study||16
8396585|NCT01024972|20693721|P2|STARTED|Overall Study||15
8396586|NCT01024972|20693722|P1|STARTED|Overall Study||16
8396587|NCT01024959|20693732|P1|NOT COMPLETED|Overall Study||41
8396588|NCT01024959|20693732|P1|COMPLETED|Overall Study||466
8396589|NCT01024959|20693732|P1|STARTED|Overall Study||507
8396590|NCT01024946|20693741|P1|NOT COMPLETED|Overall Study||5
8396591|NCT01024946|20693741|P1|COMPLETED|Overall Study||6
8396592|NCT01024946|20693741|P1|STARTED|Overall Study||11
8396601|NCT01024855|20693766|P1|NOT COMPLETED|Overall Study||1
8396602|NCT01024855|20693766|P1|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
8396603|NCT01024855|20693766|P1|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
8396604|NCT01024751|20693773|P2|NOT COMPLETED|Eligible Participants||3
8396605|NCT01024751|20693774|P1|NOT COMPLETED|Eligible Participants||0
8396606|NCT01024751|20693773|P2|COMPLETED|Eligible Participants||149
8396607|NCT01024751|20693774|P1|COMPLETED|Eligible Participants||153
8396608|NCT01024751|20693773|P2|STARTED|Eligible Participants||152
8396609|NCT01024751|20693774|P1|STARTED|Eligible Participants||153
8396610|NCT01024751|20693773|P2|NOT COMPLETED|Enrolled Participants||4
8396611|NCT01024751|20693774|P1|NOT COMPLETED|Enrolled Participants||3
8396612|NCT01024751|20693773|P2|COMPLETED|Enrolled Participants||152
8396613|NCT01024751|20693774|P1|COMPLETED|Enrolled Participants||153
8396614|NCT01024751|20693773|P2|STARTED|Enrolled Participants||156
8396615|NCT01024751|20693774|P1|STARTED|Enrolled Participants||156
8396616|NCT01024738|20693785|P3|NOT COMPLETED|Third Intervention:||0
8396617|NCT01024738|20693786|P2|NOT COMPLETED|Third Intervention:||0
8396618|NCT01024738|20693787|P1|NOT COMPLETED|Third Intervention:||0
8396619|NCT01024738|20693785|P3|COMPLETED|Third Intervention:||8
8396620|NCT01024738|20693786|P2|COMPLETED|Third Intervention:||7
8396621|NCT01024738|20693787|P1|COMPLETED|Third Intervention:||7
8396622|NCT01024738|20693785|P3|STARTED|Third Intervention:||8
8396623|NCT01024738|20693786|P2|STARTED|Third Intervention:||7
8396624|NCT01024738|20693787|P1|STARTED|Third Intervention:||7
8396625|NCT01024738|20693785|P3|NOT COMPLETED|Washout After 2nd Intervention||0
8396626|NCT01024738|20693786|P2|NOT COMPLETED|Washout After 2nd Intervention||0
8396627|NCT01024738|20693787|P1|NOT COMPLETED|Washout After 2nd Intervention||0
8396628|NCT01024738|20693785|P3|COMPLETED|Washout After 2nd Intervention||8
8396629|NCT01024738|20693786|P2|COMPLETED|Washout After 2nd Intervention||7
8396630|NCT01024738|20693787|P1|COMPLETED|Washout After 2nd Intervention||7
8396631|NCT01024738|20693785|P3|STARTED|Washout After 2nd Intervention||8
8396632|NCT01024738|20693786|P2|STARTED|Washout After 2nd Intervention||7
8396633|NCT01024738|20693787|P1|STARTED|Washout After 2nd Intervention||7
8396634|NCT01024738|20693785|P3|NOT COMPLETED|Second Intervention:||0
8396635|NCT01024738|20693786|P2|NOT COMPLETED|Second Intervention:||0
8396636|NCT01024738|20693787|P1|NOT COMPLETED|Second Intervention:||0
8396637|NCT01024738|20693785|P3|COMPLETED|Second Intervention:||8
8396638|NCT01024738|20693786|P2|COMPLETED|Second Intervention:||7
8396639|NCT01024738|20693787|P1|COMPLETED|Second Intervention:||7
8396640|NCT01024738|20693785|P3|STARTED|Second Intervention:||8
8396641|NCT01024738|20693786|P2|STARTED|Second Intervention:||7
8396642|NCT01024738|20693787|P1|STARTED|Second Intervention:||7
8396643|NCT01024738|20693785|P3|NOT COMPLETED|Washout After 1st Intervention||0
8396644|NCT01024738|20693786|P2|NOT COMPLETED|Washout After 1st Intervention||0
8396645|NCT01024738|20693787|P1|NOT COMPLETED|Washout After 1st Intervention||0
8396646|NCT01024738|20693785|P3|COMPLETED|Washout After 1st Intervention||8
8396647|NCT01024738|20693786|P2|COMPLETED|Washout After 1st Intervention||7
8396648|NCT01024738|20693787|P1|COMPLETED|Washout After 1st Intervention||7
8396649|NCT01024738|20693785|P3|STARTED|Washout After 1st Intervention||8
8396650|NCT01024738|20693786|P2|STARTED|Washout After 1st Intervention||7
8396651|NCT01024738|20693787|P1|STARTED|Washout After 1st Intervention||7
8396652|NCT01024738|20693785|P3|NOT COMPLETED|First Intervention:||0
8396653|NCT01024738|20693786|P2|NOT COMPLETED|First Intervention:||0
8396654|NCT01024738|20693787|P1|NOT COMPLETED|First Intervention:||0
8396655|NCT01024738|20693785|P3|COMPLETED|First Intervention:||8
8396656|NCT01024738|20693786|P2|COMPLETED|First Intervention:||7
8396657|NCT01024738|20693787|P1|COMPLETED|First Intervention:||7
8396658|NCT01024738|20693785|P3|STARTED|First Intervention:||8
8396659|NCT01024738|20693786|P2|STARTED|First Intervention:||7
8396660|NCT01024738|20693787|P1|STARTED|First Intervention:||7
8396661|NCT01024686|20693798|P3|NOT COMPLETED|Overall Study||0
8396662|NCT01024686|20693799|P2|NOT COMPLETED|Overall Study||0
8396663|NCT01024686|20693800|P1|NOT COMPLETED|Overall Study||0
8396664|NCT01024686|20693798|P3|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
8396665|NCT01024686|20693799|P2|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
8396666|NCT01024686|20693800|P1|COMPLETED|Overall Study||6
8396667|NCT01024686|20693798|P3|STARTED|Overall Study||0
8396668|NCT01024686|20693799|P2|STARTED|Overall Study||0
8396669|NCT01024686|20693800|P1|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6
8396670|NCT01024608|20693831|P2|NOT COMPLETED|Overall Study||4
8396671|NCT01024608|20693832|P1|NOT COMPLETED|Overall Study||4
8396672|NCT01024608|20693831|P2|COMPLETED|Overall Study||167
8396673|NCT01024608|20693832|P1|COMPLETED|Overall Study||165
8396674|NCT01024608|20693831|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
8396675|NCT01024608|20693832|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
8396676|NCT01024608|20693831|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
8396677|NCT01024608|20693832|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
8396678|NCT01024608|20693831|P2|STARTED|Overall Study||171
8396679|NCT01024608|20693832|P1|STARTED|Overall Study||169
8396680|NCT01024569|20693846|P2|NOT COMPLETED|Overall Study||11
8396681|NCT01024569|20693847|P1|NOT COMPLETED|Overall Study||25
8396682|NCT01024569|20693846|P2|COMPLETED|Overall Study||268
8396683|NCT01024569|20693847|P1|COMPLETED|Overall Study||251
8396684|NCT01024569|20693846|P2|STARTED|Overall Study||279
8396685|NCT01024569|20693847|P1|STARTED|Overall Study||276
8396686|NCT01024465|20693861|P1|NOT COMPLETED|Overall Study||3
8396687|NCT01024465|20693861|P1|COMPLETED|Overall Study||23
8396688|NCT01024465|20693861|P1|STARTED|Overall Study||26
8396689|NCT01024387|20693865|P1|NOT COMPLETED|Overall Study||60
8396690|NCT01024387|20693865|P1|COMPLETED|Overall Study||0
8396691|NCT01024387|20693865|P1|Evaluable for Response|Overall Study||53
8396692|NCT01024387|20693865|P1|Evaluable for PFS|Overall Study||54
8396693|NCT01024387|20693865|P1|STARTED|Overall Study||60
8396694|NCT01024335|20693875|P2|NOT COMPLETED|Overall Study||26
8396695|NCT01024335|20693876|P1|NOT COMPLETED|Overall Study||13
8396696|NCT01024335|20693875|P2|COMPLETED|Overall Study||14
8396697|NCT01024335|20693876|P1|COMPLETED|Overall Study||7
8396698|NCT01024335|20693875|P2|STARTED|Overall Study||40
8396699|NCT01024335|20693876|P1|STARTED|Overall Study||20
8396700|NCT01024309|20693886|P2|NOT COMPLETED|Overall Study||4
8396701|NCT01024309|20693887|P1|NOT COMPLETED|Overall Study||8
8396702|NCT01024309|20693886|P2|COMPLETED|Overall Study||27
8396703|NCT01024309|20693887|P1|COMPLETED|Overall Study||27
8396704|NCT01024309|20693886|P2|STARTED|Overall Study||31
8396705|NCT01024309|20693887|P1|STARTED|Overall Study||35
8396706|NCT01024296|20693909|P1|NOT COMPLETED|Overall Study||0
8396707|NCT01024296|20693909|P1|COMPLETED|Overall Study||4
8396708|NCT01024296|20693909|P1|STARTED|Overall Study||4
8396709|NCT01024244|20693919|P5|NOT COMPLETED|Overall Study||14
8396710|NCT01024244|20693920|P4|NOT COMPLETED|Overall Study||13
8396711|NCT01024244|20693921|P3|NOT COMPLETED|Overall Study||14
8396712|NCT01024244|20693922|P2|NOT COMPLETED|Overall Study||11
8396713|NCT01024244|20693923|P1|NOT COMPLETED|Overall Study||17
8396714|NCT01024244|20693919|P5|COMPLETED|Overall Study||1
8396715|NCT01024244|20693920|P4|COMPLETED|Overall Study||1
8396716|NCT01024244|20693921|P3|COMPLETED|Overall Study||1
8396717|NCT01024244|20693922|P2|COMPLETED|Overall Study||1
8396718|NCT01024244|20693923|P1|COMPLETED|Overall Study||5
8396719|NCT01024244|20693919|P5|STARTED|Overall Study||15
8396720|NCT01024244|20693920|P4|STARTED|Overall Study||14
8396721|NCT01024244|20693921|P3|STARTED|Overall Study||15
8396722|NCT01024244|20693922|P2|STARTED|Overall Study||12
8396723|NCT01024244|20693923|P1|STARTED|Overall Study||22
8396724|NCT01024036|20694037|P2|NOT COMPLETED|Follow-Up Period||3
8396725|NCT01024036|20694038|P1|NOT COMPLETED|Follow-Up Period||5
8396726|NCT01024036|20694037|P2|COMPLETED|Follow-Up Period||3
8396727|NCT01024036|20694038|P1|COMPLETED|Follow-Up Period||9
8396728|NCT01024036|20694037|P2|STARTED|Follow-Up Period||6
8396729|NCT01024036|20694038|P1|STARTED|Follow-Up Period||14
8396730|NCT01024036|20694037|P2|NOT COMPLETED|Unblinded Treatment||3
8396731|NCT01024036|20694038|P1|NOT COMPLETED|Unblinded Treatment||0
8396732|NCT01024036|20694037|P2|COMPLETED|Unblinded Treatment||10
8396733|NCT01024036|20694038|P1|COMPLETED|Unblinded Treatment||0
8396734|NCT01024036|20694037|P2|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
8396735|NCT01024036|20694038|P1|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
8396736|NCT01024036|20694037|P2|NOT COMPLETED|Blinded Treatment||20
8396737|NCT01024036|20694038|P1|NOT COMPLETED|Blinded Treatment||22
8396738|NCT01024036|20694037|P2|COMPLETED|Blinded Treatment||6
8396739|NCT01024036|20694038|P1|COMPLETED|Blinded Treatment||31
8396740|NCT01024036|20694037|P2|STARTED|Blinded Treatment||26
8396741|NCT01024036|20694038|P1|STARTED|Blinded Treatment||53
8396742|NCT01024010|20694071|P2|NOT COMPLETED|Overall Study||0
8396743|NCT01024010|20694072|P1|NOT COMPLETED|Overall Study||0
8396744|NCT01024010|20694071|P2|COMPLETED|Overall Study||34
8396745|NCT01024010|20694072|P1|COMPLETED|Overall Study||48
8396746|NCT01024010|20694071|P2|STARTED|Overall Study||34
8396747|NCT01024010|20694072|P1|STARTED|Overall Study||48
8396748|NCT01023958|20694085|P1|NOT COMPLETED|Overall Study||50
8396749|NCT01023958|20694085|P1|COMPLETED|Overall Study||0
8396750|NCT01023958|20694085|P1|STARTED|Overall Study||50
8396751|NCT01023841|20694114|P2|NOT COMPLETED|Overall Study||0
8396752|NCT01023841|20694115|P1|NOT COMPLETED|Overall Study||1
8396753|NCT01023841|20694114|P2|COMPLETED|Overall Study||23
8396754|NCT01023841|20694115|P1|COMPLETED|Overall Study||47
8396755|NCT01023841|20694114|P2|STARTED|Overall Study||23
8396756|NCT01023841|20694115|P1|STARTED|Overall Study||48
8396757|NCT01023815|20694133|P4|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
8396758|NCT01023815|20694134|P3|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
8396759|NCT01023815|20694135|P2|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
8396760|NCT01023815|20694136|P1|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
8396761|NCT01023815|20694133|P4|COMPLETED|Randomized Period (Day 90 to Month 12)||68
8396762|NCT01023815|20694134|P3|COMPLETED|Randomized Period (Day 90 to Month 12)||60
8396763|NCT01023815|20694135|P2|COMPLETED|Randomized Period (Day 90 to Month 12)||42
8396764|NCT01023815|20694136|P1|COMPLETED|Randomized Period (Day 90 to Month 12)||0
8396765|NCT01023815|20694133|P4|STARTED|Randomized Period (Day 90 to Month 12)||71
8396766|NCT01023815|20694134|P3|STARTED|Randomized Period (Day 90 to Month 12)||68
8396767|NCT01023815|20694135|P2|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
8396768|NCT01023815|20694136|P1|STARTED|Randomized Period (Day 90 to Month 12)||0
8396769|NCT01023815|20694133|P4|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8396770|NCT01023815|20694134|P3|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8396771|NCT01023815|20694135|P2|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8396772|NCT01023815|20694136|P1|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
8396773|NCT01023815|20694133|P4|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8396774|NCT01023815|20694134|P3|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8396775|NCT01023815|20694135|P2|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
8396776|NCT01023815|20694136|P1|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
8396777|NCT01023815|20694133|P4|STARTED|Pre-randomization Period (Day 1 to 90)||0
8396778|NCT01023815|20694134|P3|STARTED|Pre-randomization Period (Day 1 to 90)||0
8396779|NCT01023815|20694135|P2|STARTED|Pre-randomization Period (Day 1 to 90)||0
8396780|NCT01023815|20694136|P1|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
8396781|NCT01023789|20694155|P1|NOT COMPLETED|3 - Year Visit||43
8396782|NCT01023789|20694155|P1|COMPLETED|3 - Year Visit||769
8396783|NCT01023789|20694155|P1|STARTED|3 - Year Visit||812
8396784|NCT01023789|20694155|P1|NOT COMPLETED|2 - Year Visit||0
8396785|NCT01023789|20694155|P1|COMPLETED|2 - Year Visit||812
8396786|NCT01023789|20694155|P1|STARTED|2 - Year Visit||812
8396787|NCT01023789|20694155|P1|NOT COMPLETED|1 - Year Visit||0
8396788|NCT01023789|20694155|P1|COMPLETED|1 - Year Visit||812
8396789|NCT01023789|20694155|P1|STARTED|1 - Year Visit||812
8396790|NCT01023789|20694155|P1|NOT COMPLETED|180-day Clinical Follow-up||0
8396791|NCT01023789|20694155|P1|COMPLETED|180-day Clinical Follow-up||812
8396792|NCT01023789|20694155|P1|STARTED|180-day Clinical Follow-up||812
8396793|NCT01023789|20694155|P1|NOT COMPLETED|30-day Follow-up Visit||0
8396794|NCT01023789|20694155|P1|COMPLETED|30-day Follow-up Visit||812
8396795|NCT01023789|20694155|P1|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
8396796|NCT01023776|20694222|P1|NOT COMPLETED|Overall Study||0
8396797|NCT01023776|20694222|P1|COMPLETED|Overall Study||20
8396798|NCT01023776|20694222|P1|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
8396799|NCT01023724|20694229|P2|NOT COMPLETED|Overall Study||3
8396800|NCT01023724|20694230|P1|NOT COMPLETED|Overall Study||4
8396801|NCT01023724|20694229|P2|COMPLETED|Overall Study||22
8396802|NCT01023724|20694230|P1|COMPLETED|Overall Study||21
8396803|NCT01023724|20694229|P2|STARTED|Overall Study||25
8396804|NCT01023724|20694230|P1|STARTED|Overall Study||25
8396805|NCT01023711|20694236|P1|NOT COMPLETED|Overall Study||0
8396806|NCT01023711|20694236|P1|COMPLETED|Overall Study||107
8396807|NCT01023711|20694236|P1|STARTED|Overall Study||107
8396808|NCT01023672|20694241|P1|NOT COMPLETED|Overall Study||3
8396809|NCT01023672|20694241|P1|COMPLETED|Overall Study||17
8396810|NCT01023672|20694241|P1|STARTED|Overall Study||20
8396811|NCT01023659|20694248|P3|NOT COMPLETED|Overall Study||99
8396812|NCT01023659|20694249|P2|NOT COMPLETED|Overall Study||228
8396813|NCT01023659|20694250|P1|NOT COMPLETED|Overall Study||73
8396814|NCT01023659|20694248|P3|COMPLETED|Overall Study||165
8396815|NCT01023659|20694249|P2|COMPLETED|Overall Study||137
8396816|NCT01023659|20694250|P1|COMPLETED|Overall Study||185
8396817|NCT01023659|20694248|P3|STARTED|Overall Study||264
8396818|NCT01023659|20694249|P2|STARTED|Overall Study||365
8396819|NCT01023659|20694250|P1|STARTED|Overall Study||258
8396820|NCT01023620|20694261|P2|NOT COMPLETED|Overall Study||0
8396821|NCT01023620|20694262|P1|NOT COMPLETED|Overall Study||0
8396822|NCT01023620|20694261|P2|COMPLETED|Overall Study||0
8396823|NCT01023620|20694262|P1|COMPLETED|Overall Study||0
8396824|NCT01023620|20694261|P2|STARTED|Overall Study||0
8396825|NCT01023620|20694262|P1|STARTED|Overall Study||0
8396826|NCT01023581|20694277|P7|NOT COMPLETED|Overall Study||20
8396827|NCT01023581|20694278|P6|NOT COMPLETED|Overall Study||19
8396828|NCT01023581|20694279|P5|NOT COMPLETED|Overall Study||16
8396829|NCT01023581|20694280|P4|NOT COMPLETED|Overall Study||20
8396830|NCT01023581|20694281|P3|NOT COMPLETED|Overall Study||42
8396831|NCT01023581|20694282|P2|NOT COMPLETED|Overall Study||23
8396832|NCT01023581|20694283|P1|NOT COMPLETED|Overall Study||35
8396833|NCT01023581|20694277|P7|COMPLETED|Overall Study||94
8396834|NCT01023581|20694278|P6|COMPLETED|Overall Study||92
8396835|NCT01023581|20694279|P5|COMPLETED|Overall Study||95
8396836|NCT01023581|20694280|P4|COMPLETED|Overall Study||94
8396837|NCT01023581|20694281|P3|COMPLETED|Overall Study||71
8396838|NCT01023581|20694282|P2|COMPLETED|Overall Study||89
8396839|NCT01023581|20694283|P1|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
8396840|NCT01023581|20694277|P7|Received Study Treatment|Overall Study||114
8396841|NCT01023581|20694278|P6|Received Study Treatment|Overall Study||106
8396842|NCT01023581|20694279|P5|Received Study Treatment|Overall Study||111
8396843|NCT01023581|20694280|P4|Received Study Treatment|Overall Study||109
8396844|NCT01023581|20694281|P3|Received Study Treatment|Overall Study||110
8396845|NCT01023581|20694282|P2|Received Study Treatment|Overall Study||112
8396846|NCT01023581|20694283|P1|Received Study Treatment|Overall Study||106
8396847|NCT01023581|20694277|P7|STARTED|Overall Study||114
8396848|NCT01023581|20694278|P6|STARTED|Overall Study||111
8396849|NCT01023581|20694279|P5|STARTED|Overall Study||111
8396850|NCT01023581|20694280|P4|STARTED|Overall Study||114
8396851|NCT01023581|20694281|P3|STARTED|Overall Study||113
8396852|NCT01023581|20694282|P2|STARTED|Overall Study||112
8396853|NCT01023581|20694283|P1|STARTED|Overall Study||109
8396854|NCT01023568|20694316|P3|NOT COMPLETED|Overall Study||0
8396855|NCT01023568|20694317|P2|NOT COMPLETED|Overall Study||0
8396856|NCT01023568|20694318|P1|NOT COMPLETED|Overall Study||0
8396857|NCT01023568|20694316|P3|COMPLETED|Overall Study||45
8396858|NCT01023568|20694317|P2|COMPLETED|Overall Study||44
8396859|NCT01023568|20694318|P1|COMPLETED|Overall Study||45
8396860|NCT01023568|20694316|P3|STARTED|Overall Study||45
8396861|NCT01023568|20694317|P2|STARTED|Overall Study||44
8396862|NCT01023568|20694318|P1|STARTED|Overall Study||45
8396863|NCT01023516|20694340|P2|NOT COMPLETED|Overall Study||18
8396864|NCT01023516|20694341|P1|NOT COMPLETED|Overall Study||24
8396865|NCT01023516|20694340|P2|COMPLETED|Overall Study||284
8396866|NCT01023516|20694341|P1|COMPLETED|Overall Study||289
8396867|NCT01023516|20694340|P2|STARTED|Overall Study||302
8396868|NCT01023516|20694341|P1|STARTED|Overall Study||313
8396869|NCT01023308|20694423|P2|NOT COMPLETED|Overall Study||279
8396870|NCT01023308|20694424|P1|NOT COMPLETED|Overall Study||285
8396871|NCT01023308|20694423|P2|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
8396872|NCT01023308|20694424|P1|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
8396873|NCT01023308|20694423|P2|STARTED|Overall Study||381
8396874|NCT01023308|20694424|P1|STARTED|Overall Study||387
8396875|NCT01023269|20694450|P2|NOT COMPLETED|Overall Study||0
8396876|NCT01023269|20694451|P1|NOT COMPLETED|Overall Study||2
8396877|NCT01023269|20694450|P2|COMPLETED|Overall Study||2
8396878|NCT01023269|20694451|P1|COMPLETED|Overall Study||1
8396879|NCT01023269|20694450|P2|STARTED|Overall Study||2
8396880|NCT01023269|20694451|P1|STARTED|Overall Study||3
8396881|NCT01023256|20694459|P4|NOT COMPLETED|Overall Study||5
8396882|NCT01023256|20694460|P3|NOT COMPLETED|Overall Study||1
8396883|NCT01023256|20694461|P2|NOT COMPLETED|Overall Study||3
8396884|NCT01023256|20694462|P1|NOT COMPLETED|Overall Study||4
8396885|NCT01023256|20694459|P4|COMPLETED|Overall Study||22
8396886|NCT01023256|20694460|P3|COMPLETED|Overall Study||23
8396887|NCT01023256|20694461|P2|COMPLETED|Overall Study||19
8396888|NCT01023256|20694462|P1|COMPLETED|Overall Study||21
8396889|NCT01023256|20694459|P4|STARTED|Overall Study||27
8396890|NCT01023256|20694460|P3|STARTED|Overall Study||24
8396891|NCT01023256|20694461|P2|STARTED|Overall Study||22
8396892|NCT01023256|20694462|P1|STARTED|Overall Study||25
8396893|NCT01023217|20694504|P2|NOT COMPLETED|Overall Study||0
8396894|NCT01023217|20694505|P1|NOT COMPLETED|Overall Study||1
8396895|NCT01023217|20694504|P2|COMPLETED|Overall Study||45
8396896|NCT01023217|20694505|P1|COMPLETED|Overall Study||44
8396897|NCT01023217|20694504|P2|STARTED|Overall Study||45
8396898|NCT01023217|20694505|P1|STARTED|Overall Study||45
8396899|NCT01023178|20694514|P3|NOT COMPLETED|Overall Study||3
8396900|NCT01023178|20694515|P2|NOT COMPLETED|Overall Study||2
8396901|NCT01023178|20694516|P1|NOT COMPLETED|Overall Study||2
8396902|NCT01023178|20694514|P3|COMPLETED|Overall Study||4
8396903|NCT01023178|20694515|P2|COMPLETED|Overall Study||6
8396904|NCT01023178|20694516|P1|COMPLETED|Overall Study||3
8396905|NCT01023178|20694514|P3|STARTED|Overall Study||7
8396906|NCT01023178|20694515|P2|STARTED|Overall Study||8
8396907|NCT01023178|20694516|P1|STARTED|Overall Study||5
8396908|NCT01023074|20694527|P3|NOT COMPLETED|Overall Study||0
8396909|NCT01023074|20694528|P2|NOT COMPLETED|Overall Study||0
8396910|NCT01023074|20694529|P1|NOT COMPLETED|Overall Study||0
8396911|NCT01023074|20694527|P3|COMPLETED|Overall Study||13
8396912|NCT01023074|20694528|P2|COMPLETED|Overall Study||13
8396913|NCT01023074|20694529|P1|COMPLETED|Overall Study||26
8396914|NCT01023074|20694527|P3|STARTED|Overall Study||13
8396915|NCT01023074|20694528|P2|STARTED|Overall Study||13
8396916|NCT01023074|20694529|P1|STARTED|Overall Study||26
8396917|NCT01023061|20694543|P1|NOT COMPLETED|Overall Study||2
8396918|NCT01023061|20694543|P1|COMPLETED|Overall Study||22
8396919|NCT01023061|20694543|P1|STARTED|Overall Study||24
8396938|NCT01023022|20694564|P1|NOT COMPLETED|Overall Study||14
8396939|NCT01023022|20694564|P1|COMPLETED|Overall Study||162
8396940|NCT01023022|20694564|P1|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
8396941|NCT01022996|20694570|P1|NOT COMPLETED|Overall Study||57
8396942|NCT01022996|20694570|P1|COMPLETED|Overall Study||0
8396943|NCT01022996|20694570|P1|STARTED|Overall Study||57
8396944|NCT01022853|20694584|P5|NOT COMPLETED|Overall Study||2
8396945|NCT01022853|20694585|P4|NOT COMPLETED|Overall Study||8
8396946|NCT01022853|20694586|P3|NOT COMPLETED|Overall Study||13
8396947|NCT01022853|20694587|P2|NOT COMPLETED|Overall Study||4
8396948|NCT01022853|20694588|P1|NOT COMPLETED|Overall Study||3
8396949|NCT01022853|20694584|P5|COMPLETED|Overall Study||0
8396950|NCT01022853|20694585|P4|COMPLETED|Overall Study||0
8396951|NCT01022853|20694586|P3|COMPLETED|Overall Study||0
8396952|NCT01022853|20694587|P2|COMPLETED|Overall Study||0
8396953|NCT01022853|20694588|P1|COMPLETED|Overall Study||0
8396954|NCT01022853|20694584|P5|STARTED|Overall Study|entered and treated|2
8396955|NCT01022853|20694585|P4|STARTED|Overall Study|entered and treated|8
8396956|NCT01022853|20694586|P3|STARTED|Overall Study|entered and treated|13
8396957|NCT01022853|20694587|P2|STARTED|Overall Study|entered and treated|4
8396958|NCT01022853|20694588|P1|STARTED|Overall Study|entered and treated|3
8396959|NCT01022762|20694667|P2|NOT COMPLETED|Overall Study||28
8396960|NCT01022762|20694668|P1|NOT COMPLETED|Overall Study||22
8396961|NCT01022762|20694667|P2|COMPLETED|Overall Study||194
8396962|NCT01022762|20694668|P1|COMPLETED|Overall Study||196
8396963|NCT01022762|20694667|P2|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
8396964|NCT01022762|20694668|P1|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
8396965|NCT01022762|20694667|P2|STARTED|Overall Study||222
8396966|NCT01022762|20694668|P1|STARTED|Overall Study||218
8396967|NCT01022567|20694696|P2|NOT COMPLETED|Overall Study||15
8396968|NCT01022567|20694697|P1|NOT COMPLETED|Overall Study||1
8396969|NCT01022567|20694696|P2|COMPLETED|Overall Study||242
8396970|NCT01022567|20694697|P1|COMPLETED|Overall Study||272
8396971|NCT01022567|20694696|P2|STARTED|Overall Study||257
8396972|NCT01022567|20694697|P1|STARTED|Overall Study||273
8396973|NCT01022502|20694703|P1|NOT COMPLETED|Overall Study||3
8396974|NCT01022502|20694703|P1|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
8396975|NCT01022502|20694703|P1|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
8396976|NCT01022424|20694717|P1|NOT COMPLETED|Overall Study||4
8396977|NCT01022424|20694717|P1|COMPLETED|Overall Study||9
8396978|NCT01022424|20694717|P1|STARTED|Overall Study||13
8396979|NCT01022398|20694732|P2|NOT COMPLETED|Overall Study||2
8396980|NCT01022398|20694733|P1|NOT COMPLETED|Overall Study||2
8396981|NCT01022398|20694732|P2|COMPLETED|Overall Study||0
8396982|NCT01022398|20694733|P1|COMPLETED|Overall Study||0
8396983|NCT01022398|20694732|P2|STARTED|Overall Study||2
8396984|NCT01022398|20694733|P1|STARTED|Overall Study||2
8396985|NCT01022307|20694740|P2|NOT COMPLETED|Overall Study||4
8396986|NCT01022307|20694741|P1|NOT COMPLETED|Overall Study||0
8396987|NCT01022307|20694740|P2|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
8396988|NCT01022307|20694741|P1|COMPLETED|Overall Study||184
8396989|NCT01022307|20694740|P2|STARTED|Overall Study||28
8396990|NCT01022307|20694741|P1|STARTED|Overall Study||184
8396991|NCT01022242|20694749|P2|NOT COMPLETED|Overall Study||19
8396992|NCT01022242|20694750|P1|NOT COMPLETED|Overall Study||21
8396993|NCT01022242|20694749|P2|COMPLETED|Overall Study||46
8396994|NCT01022242|20694750|P1|COMPLETED|Overall Study||49
8396995|NCT01022242|20694749|P2|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
8396996|NCT01022242|20694750|P1|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
8396997|NCT01022203|20694758|P2|NOT COMPLETED|Follow-Up Assessment||2
8396998|NCT01022203|20694759|P1|NOT COMPLETED|Follow-Up Assessment||2
8396999|NCT01022203|20694758|P2|COMPLETED|Follow-Up Assessment||40
8397000|NCT01022203|20694759|P1|COMPLETED|Follow-Up Assessment||42
8397001|NCT01022203|20694758|P2|STARTED|Follow-Up Assessment||42
8397002|NCT01022203|20694759|P1|STARTED|Follow-Up Assessment||44
8397003|NCT01022203|20694758|P2|NOT COMPLETED|Post Treatment Assessment||14
8397004|NCT01022203|20694759|P1|NOT COMPLETED|Post Treatment Assessment||14
8397005|NCT01022203|20694758|P2|COMPLETED|Post Treatment Assessment||42
8397006|NCT01022203|20694759|P1|COMPLETED|Post Treatment Assessment||44
8397007|NCT01022203|20694758|P2|STARTED|Post Treatment Assessment||56
8397008|NCT01022203|20694759|P1|STARTED|Post Treatment Assessment||58
8397009|NCT01022203|20694758|P2|NOT COMPLETED|PreTreatment Assessment||0
8397010|NCT01022203|20694759|P1|NOT COMPLETED|PreTreatment Assessment||0
8397011|NCT01022203|20694758|P2|COMPLETED|PreTreatment Assessment||56
8397012|NCT01022203|20694759|P1|COMPLETED|PreTreatment Assessment||58
8397013|NCT01022203|20694758|P2|STARTED|PreTreatment Assessment||56
8397014|NCT01022203|20694759|P1|STARTED|PreTreatment Assessment||58
8397015|NCT01022190|20694769|P1|NOT COMPLETED|Overall Study||0
8397016|NCT01022190|20694769|P1|COMPLETED|Overall Study||42
8397017|NCT01022190|20694769|P1|STARTED|Overall Study||42
8397018|NCT01022112|20694778|P5|NOT COMPLETED|Overall Study||10
8397019|NCT01022112|20694779|P4|NOT COMPLETED|Overall Study||3
8397020|NCT01022112|20694780|P3|NOT COMPLETED|Overall Study||3
8397021|NCT01022112|20694781|P2|NOT COMPLETED|Overall Study||3
8397022|NCT01022112|20694782|P1|NOT COMPLETED|Overall Study||3
8397023|NCT01022112|20694778|P5|COMPLETED|Overall Study||65
8397024|NCT01022112|20694779|P4|COMPLETED|Overall Study||72
8397025|NCT01022112|20694780|P3|COMPLETED|Overall Study||74
8397026|NCT01022112|20694781|P2|COMPLETED|Overall Study||71
8397027|NCT01022112|20694782|P1|COMPLETED|Overall Study||79
8397028|NCT01022112|20694778|P5|STARTED|Overall Study||75
8397029|NCT01022112|20694779|P4|STARTED|Overall Study||75
8397030|NCT01022112|20694780|P3|STARTED|Overall Study||77
8397031|NCT01022112|20694781|P2|STARTED|Overall Study||74
8397032|NCT01022112|20694782|P1|STARTED|Overall Study||82
8397033|NCT01022073|20694796|P2|NOT COMPLETED|Overall Study||18
8397034|NCT01022073|20694797|P1|NOT COMPLETED|Overall Study||19
8397035|NCT01022073|20694796|P2|COMPLETED|Overall Study||52
8397036|NCT01022073|20694797|P1|COMPLETED|Overall Study||67
8397037|NCT01022073|20694796|P2|STARTED|Overall Study||70
8397038|NCT01022073|20694797|P1|STARTED|Overall Study||86
8397039|NCT01021956|20694807|P4|NOT COMPLETED|Overall Study||0
8397040|NCT01021956|20694808|P3|NOT COMPLETED|Overall Study||0
8397041|NCT01021956|20694809|P2|NOT COMPLETED|Overall Study||0
8397042|NCT01021956|20694810|P1|NOT COMPLETED|Overall Study||0
8397043|NCT01021956|20694807|P4|COMPLETED|Overall Study||1
8397044|NCT01021956|20694808|P3|COMPLETED|Overall Study||3
8397045|NCT01021956|20694809|P2|COMPLETED|Overall Study||3
8397046|NCT01021956|20694810|P1|COMPLETED|Overall Study||3
8397047|NCT01021956|20694807|P4|STARTED|Overall Study||1
8397048|NCT01021956|20694808|P3|STARTED|Overall Study||3
8397049|NCT01021956|20694809|P2|STARTED|Overall Study||3
8397050|NCT01021956|20694810|P1|STARTED|Overall Study||3
8397051|NCT01021878|20694831|P2|NOT COMPLETED|Overall Study||10
8397052|NCT01021878|20694832|P1|NOT COMPLETED|Overall Study||16
8397053|NCT01021878|20694831|P2|COMPLETED|Overall Study||17
8397054|NCT01021878|20694832|P1|COMPLETED|Overall Study||17
8397055|NCT01021878|20694831|P2|Completed Follow-up|Overall Study||17
8397056|NCT01021878|20694832|P1|Completed Follow-up|Overall Study||17
8397057|NCT01021878|20694831|P2|STARTED|Overall Study||27
8397058|NCT01021878|20694832|P1|STARTED|Overall Study||33
8397059|NCT01021852|20694854|P8|NOT COMPLETED|Treatment Period 2||2
8397060|NCT01021852|20694855|P7|NOT COMPLETED|Treatment Period 2||3
8397061|NCT01021852|20694856|P6|NOT COMPLETED|Treatment Period 2||1
8397062|NCT01021852|20694857|P5|NOT COMPLETED|Treatment Period 2||2
8397063|NCT01021852|20694858|P4|NOT COMPLETED|Treatment Period 2||0
8397064|NCT01021852|20694859|P3|NOT COMPLETED|Treatment Period 2||1
8397065|NCT01021852|20694860|P2|NOT COMPLETED|Treatment Period 2||1
8397066|NCT01021852|20694861|P1|NOT COMPLETED|Treatment Period 2||0
8397067|NCT01021852|20694854|P8|COMPLETED|Treatment Period 2||38
8397068|NCT01021852|20694855|P7|COMPLETED|Treatment Period 2||37
8397069|NCT01021852|20694856|P6|COMPLETED|Treatment Period 2||37
8397070|NCT01021852|20694857|P5|COMPLETED|Treatment Period 2||37
8397071|NCT01021852|20694858|P4|COMPLETED|Treatment Period 2||37
8397072|NCT01021852|20694859|P3|COMPLETED|Treatment Period 2||38
8397073|NCT01021852|20694860|P2|COMPLETED|Treatment Period 2||38
8397074|NCT01021852|20694861|P1|COMPLETED|Treatment Period 2||37
8397075|NCT01021852|20694854|P8|STARTED|Treatment Period 2||40
8397076|NCT01021852|20694855|P7|STARTED|Treatment Period 2||40
8397077|NCT01021852|20694856|P6|STARTED|Treatment Period 2||38
8397078|NCT01021852|20694857|P5|STARTED|Treatment Period 2||39
8397079|NCT01021852|20694858|P4|STARTED|Treatment Period 2||37
8397080|NCT01021852|20694859|P3|STARTED|Treatment Period 2||39
8397081|NCT01021852|20694860|P2|STARTED|Treatment Period 2||39
8397082|NCT01021852|20694861|P1|STARTED|Treatment Period 2||37
8397083|NCT01021852|20694854|P8|NOT COMPLETED|Washout Period-No Drug||0
8397084|NCT01021852|20694855|P7|NOT COMPLETED|Washout Period-No Drug||0
8397085|NCT01021852|20694856|P6|NOT COMPLETED|Washout Period-No Drug||1
8397086|NCT01021852|20694857|P5|NOT COMPLETED|Washout Period-No Drug||0
8397087|NCT01021852|20694858|P4|NOT COMPLETED|Washout Period-No Drug||0
8397088|NCT01021852|20694859|P3|NOT COMPLETED|Washout Period-No Drug||0
8397089|NCT01021852|20694860|P2|NOT COMPLETED|Washout Period-No Drug||0
8397090|NCT01021852|20694861|P1|NOT COMPLETED|Washout Period-No Drug||1
8397091|NCT01021852|20694854|P8|COMPLETED|Washout Period-No Drug||40
8397092|NCT01021852|20694855|P7|COMPLETED|Washout Period-No Drug||40
8397093|NCT01021852|20694856|P6|COMPLETED|Washout Period-No Drug||38
8397094|NCT01021852|20694857|P5|COMPLETED|Washout Period-No Drug||39
8397095|NCT01021852|20694858|P4|COMPLETED|Washout Period-No Drug||37
8397096|NCT01021852|20694859|P3|COMPLETED|Washout Period-No Drug||39
8397097|NCT01021852|20694860|P2|COMPLETED|Washout Period-No Drug||39
8397098|NCT01021852|20694861|P1|COMPLETED|Washout Period-No Drug||37
8397099|NCT01021852|20694854|P8|STARTED|Washout Period-No Drug||40
8397100|NCT01021852|20694855|P7|STARTED|Washout Period-No Drug||40
8397101|NCT01021852|20694856|P6|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
8397102|NCT01021852|20694857|P5|STARTED|Washout Period-No Drug||39
8397103|NCT01021852|20694858|P4|STARTED|Washout Period-No Drug||37
8397104|NCT01021852|20694859|P3|STARTED|Washout Period-No Drug||39
8397105|NCT01021852|20694860|P2|STARTED|Washout Period-No Drug||39
8397106|NCT01021852|20694861|P1|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
8397107|NCT01021852|20694854|P8|NOT COMPLETED|Washout Period-Placebo||0
8397108|NCT01021852|20694855|P7|NOT COMPLETED|Washout Period-Placebo||1
8397109|NCT01021852|20694856|P6|NOT COMPLETED|Washout Period-Placebo||1
8397110|NCT01021852|20694857|P5|NOT COMPLETED|Washout Period-Placebo||1
8397111|NCT01021852|20694858|P4|NOT COMPLETED|Washout Period-Placebo||1
8397112|NCT01021852|20694859|P3|NOT COMPLETED|Washout Period-Placebo||0
8397113|NCT01021852|20694860|P2|NOT COMPLETED|Washout Period-Placebo||0
8397114|NCT01021852|20694861|P1|NOT COMPLETED|Washout Period-Placebo||0
8397115|NCT01021852|20694854|P8|COMPLETED|Washout Period-Placebo||40
8397116|NCT01021852|20694855|P7|COMPLETED|Washout Period-Placebo||40
8397117|NCT01021852|20694856|P6|COMPLETED|Washout Period-Placebo||38
8397118|NCT01021852|20694857|P5|COMPLETED|Washout Period-Placebo||39
8397119|NCT01021852|20694858|P4|COMPLETED|Washout Period-Placebo||37
8397120|NCT01021852|20694859|P3|COMPLETED|Washout Period-Placebo||39
8397121|NCT01021852|20694860|P2|COMPLETED|Washout Period-Placebo||39
8397122|NCT01021852|20694861|P1|COMPLETED|Washout Period-Placebo||37
8397123|NCT01021852|20694854|P8|STARTED|Washout Period-Placebo||40
8397124|NCT01021852|20694855|P7|STARTED|Washout Period-Placebo||41
8397125|NCT01021852|20694856|P6|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
8397126|NCT01021852|20694857|P5|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
8397127|NCT01021852|20694858|P4|STARTED|Washout Period-Placebo||38
8397128|NCT01021852|20694859|P3|STARTED|Washout Period-Placebo||39
8397129|NCT01021852|20694860|P2|STARTED|Washout Period-Placebo||39
8397130|NCT01021852|20694861|P1|STARTED|Washout Period-Placebo||37
8397131|NCT01021852|20694854|P8|NOT COMPLETED|Treatment Period 1||1
8397132|NCT01021852|20694855|P7|NOT COMPLETED|Treatment Period 1||0
8397133|NCT01021852|20694856|P6|NOT COMPLETED|Treatment Period 1||2
8397134|NCT01021852|20694857|P5|NOT COMPLETED|Treatment Period 1||3
8397135|NCT01021852|20694858|P4|NOT COMPLETED|Treatment Period 1||2
8397136|NCT01021852|20694859|P3|NOT COMPLETED|Treatment Period 1||2
8397137|NCT01021852|20694860|P2|NOT COMPLETED|Treatment Period 1||1
8397138|NCT01021852|20694861|P1|NOT COMPLETED|Treatment Period 1||3
8397139|NCT01021852|20694854|P8|COMPLETED|Treatment Period 1||40
8397140|NCT01021852|20694855|P7|COMPLETED|Treatment Period 1||41
8397141|NCT01021852|20694856|P6|COMPLETED|Treatment Period 1||39
8397142|NCT01021852|20694857|P5|COMPLETED|Treatment Period 1||39
8397143|NCT01021852|20694858|P4|COMPLETED|Treatment Period 1||38
8397144|NCT01021852|20694859|P3|COMPLETED|Treatment Period 1||39
8397145|NCT01021852|20694860|P2|COMPLETED|Treatment Period 1||39
8397146|NCT01021852|20694861|P1|COMPLETED|Treatment Period 1||37
8397147|NCT01021852|20694854|P8|Treated|Treatment Period 1||41
8397148|NCT01021852|20694855|P7|Treated|Treatment Period 1||41
8397149|NCT01021852|20694856|P6|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
8397150|NCT01021852|20694857|P5|Treated|Treatment Period 1||42
8397151|NCT01021852|20694858|P4|Treated|Treatment Period 1||38
8397152|NCT01021852|20694859|P3|Treated|Treatment Period 1||41
8397153|NCT01021852|20694860|P2|Treated|Treatment Period 1||40
8397154|NCT01021852|20694861|P1|Treated|Treatment Period 1||40
8397155|NCT01021852|20694854|P8|STARTED|Treatment Period 1||41
8397156|NCT01021852|20694855|P7|STARTED|Treatment Period 1||41
8397157|NCT01021852|20694856|P6|STARTED|Treatment Period 1||41
8397158|NCT01021852|20694857|P5|STARTED|Treatment Period 1||42
8397159|NCT01021852|20694858|P4|STARTED|Treatment Period 1||40
8397160|NCT01021852|20694859|P3|STARTED|Treatment Period 1||41
8397161|NCT01021852|20694860|P2|STARTED|Treatment Period 1||40
8397162|NCT01021852|20694861|P1|STARTED|Treatment Period 1||40
8397163|NCT01021813|20694897|P5|NOT COMPLETED|DB Randomized Discontinuation Phase||5
8397164|NCT01021813|20694898|P4|NOT COMPLETED|DB Randomized Discontinuation Phase||5
8397165|NCT01021813|20694899|P3|NOT COMPLETED|DB Randomized Discontinuation Phase||4
8397166|NCT01021813|20694900|P2|NOT COMPLETED|DB Randomized Discontinuation Phase||0
8397167|NCT01021813|20694901|P1|NOT COMPLETED|DB Randomized Discontinuation Phase||0
8397168|NCT01021813|20694897|P5|COMPLETED|DB Randomized Discontinuation Phase||157
8397169|NCT01021813|20694898|P4|COMPLETED|DB Randomized Discontinuation Phase||161
8397170|NCT01021813|20694899|P3|COMPLETED|DB Randomized Discontinuation Phase||152
8397171|NCT01021813|20694900|P2|COMPLETED|DB Randomized Discontinuation Phase||0
8397172|NCT01021813|20694901|P1|COMPLETED|DB Randomized Discontinuation Phase||0
8397173|NCT01021813|20694897|P5|STARTED|DB Randomized Discontinuation Phase||162
8397174|NCT01021813|20694898|P4|STARTED|DB Randomized Discontinuation Phase||166
8397175|NCT01021813|20694899|P3|STARTED|DB Randomized Discontinuation Phase||156
8397176|NCT01021813|20694900|P2|STARTED|DB Randomized Discontinuation Phase||0
8397177|NCT01021813|20694901|P1|STARTED|DB Randomized Discontinuation Phase||0
8397178|NCT01021813|20694897|P5|NOT COMPLETED|DB Treatment Phase||0
8397179|NCT01021813|20694898|P4|NOT COMPLETED|DB Treatment Phase||0
8397180|NCT01021813|20694899|P3|NOT COMPLETED|DB Treatment Phase||0
8397181|NCT01021813|20694900|P2|NOT COMPLETED|DB Treatment Phase||97
8397182|NCT01021813|20694901|P1|NOT COMPLETED|DB Treatment Phase||200
8397183|NCT01021813|20694897|P5|COMPLETED|DB Treatment Phase||0
8397184|NCT01021813|20694898|P4|COMPLETED|DB Treatment Phase||0
8397185|NCT01021813|20694899|P3|COMPLETED|DB Treatment Phase||0
8397186|NCT01021813|20694900|P2|COMPLETED|DB Treatment Phase||162
8397187|NCT01021813|20694901|P1|COMPLETED|DB Treatment Phase||322
8397188|NCT01021813|20694897|P5|Treated|DB Treatment Phase||0
8397189|NCT01021813|20694898|P4|Treated|DB Treatment Phase||0
8397190|NCT01021813|20694899|P3|Treated|DB Treatment Phase||0
8397191|NCT01021813|20694900|P2|Treated|DB Treatment Phase||258
8397192|NCT01021813|20694901|P1|Treated|DB Treatment Phase||521
8397193|NCT01021813|20694897|P5|STARTED|DB Treatment Phase||0
8397194|NCT01021813|20694898|P4|STARTED|DB Treatment Phase||0
8397195|NCT01021813|20694899|P3|STARTED|DB Treatment Phase||0
8397196|NCT01021813|20694900|P2|STARTED|DB Treatment Phase||259
8397197|NCT01021813|20694901|P1|STARTED|DB Treatment Phase||522
8397198|NCT01021761|20694943|P3|NOT COMPLETED|Overall Study||0
8397199|NCT01021761|20694944|P2|NOT COMPLETED|Overall Study||4
8397200|NCT01021761|20694945|P1|NOT COMPLETED|Overall Study||1
8397201|NCT01021761|20694943|P3|COMPLETED|Overall Study||42
8397202|NCT01021761|20694944|P2|COMPLETED|Overall Study||38
8397203|NCT01021761|20694945|P1|COMPLETED|Overall Study||41
8397204|NCT01021761|20694943|P3|STARTED|Overall Study||42
8397205|NCT01021761|20694944|P2|STARTED|Overall Study||42
8397206|NCT01021761|20694945|P1|STARTED|Overall Study||42
8397207|NCT01021748|20694962|P9|NOT COMPLETED|Overall Study||16
8397208|NCT01021748|20694963|P8|NOT COMPLETED|Overall Study||6
8397209|NCT01021748|20694964|P7|NOT COMPLETED|Overall Study||3
8397210|NCT01021748|20694965|P6|NOT COMPLETED|Overall Study||3
8397211|NCT01021748|20694966|P5|NOT COMPLETED|Overall Study||9
8397212|NCT01021748|20694967|P4|NOT COMPLETED|Overall Study||7
8397213|NCT01021748|20694968|P3|NOT COMPLETED|Overall Study||7
8397214|NCT01021748|20694969|P2|NOT COMPLETED|Overall Study||5
8397215|NCT01021748|20694970|P1|NOT COMPLETED|Overall Study||6
8397216|NCT01021748|20694962|P9|COMPLETED|Overall Study||1
8397217|NCT01021748|20694963|P8|COMPLETED|Overall Study||0
8397218|NCT01021748|20694964|P7|COMPLETED|Overall Study||0
8397219|NCT01021748|20694965|P6|COMPLETED|Overall Study||0
8397220|NCT01021748|20694966|P5|COMPLETED|Overall Study||0
8397221|NCT01021748|20694967|P4|COMPLETED|Overall Study||0
8397222|NCT01021748|20694968|P3|COMPLETED|Overall Study||0
8397223|NCT01021748|20694969|P2|COMPLETED|Overall Study||0
8397224|NCT01021748|20694970|P1|COMPLETED|Overall Study||0
8397225|NCT01021748|20694962|P9|Treated|Overall Study||17
8397226|NCT01021748|20694963|P8|Treated|Overall Study||6
8397227|NCT01021748|20694964|P7|Treated|Overall Study||3
8397228|NCT01021748|20694965|P6|Treated|Overall Study||3
8397229|NCT01021748|20694966|P5|Treated|Overall Study||9
8397230|NCT01021748|20694967|P4|Treated|Overall Study||7
8397231|NCT01021748|20694968|P3|Treated|Overall Study||7
8397232|NCT01021748|20694969|P2|Treated|Overall Study|One participant was allocated, but not treated.|4
8397233|NCT01021748|20694970|P1|Treated|Overall Study||6
8397234|NCT01021748|20694962|P9|STARTED|Overall Study||17
8397235|NCT01021748|20694963|P8|STARTED|Overall Study||6
8397236|NCT01021748|20694964|P7|STARTED|Overall Study||3
8397237|NCT01021748|20694965|P6|STARTED|Overall Study||3
8397238|NCT01021748|20694966|P5|STARTED|Overall Study||9
8397239|NCT01021748|20694967|P4|STARTED|Overall Study||7
8397240|NCT01021748|20694968|P3|STARTED|Overall Study||7
8397241|NCT01021748|20694969|P2|STARTED|Overall Study||5
8397242|NCT01021748|20694970|P1|STARTED|Overall Study||6
8397243|NCT01021683|20695017|P1|NOT COMPLETED|Overall Study||71
8397244|NCT01021683|20695017|P1|COMPLETED|Overall Study||132
8397245|NCT01021683|20695017|P1|STARTED|Overall Study||203
8397246|NCT01021618|20695031|P2|NOT COMPLETED|Overall Study||0
8397247|NCT01021618|20695032|P1|NOT COMPLETED|Overall Study||0
8397248|NCT01021618|20695031|P2|COMPLETED|Overall Study||96
8397249|NCT01021618|20695032|P1|COMPLETED|Overall Study||44
8397250|NCT01021618|20695031|P2|STARTED|Overall Study||96
8397251|NCT01021618|20695032|P1|STARTED|Overall Study||44
8397252|NCT01021553|20695043|P3|NOT COMPLETED|Overall Study||3
8397253|NCT01021553|20695044|P2|NOT COMPLETED|Overall Study||5
8397254|NCT01021553|20695045|P1|NOT COMPLETED|Overall Study||4
8397255|NCT01021553|20695043|P3|COMPLETED|Overall Study||25
8397256|NCT01021553|20695044|P2|COMPLETED|Overall Study||17
8397257|NCT01021553|20695045|P1|COMPLETED|Overall Study||23
8397258|NCT01021553|20695043|P3|STARTED|Overall Study||28
8397259|NCT01021553|20695044|P2|STARTED|Overall Study||22
8397260|NCT01021553|20695045|P1|STARTED|Overall Study||27
8397261|NCT01021423|20695099|P2|NOT COMPLETED|Overall Study||5
8397262|NCT01021423|20695100|P1|NOT COMPLETED|Overall Study||4
8397263|NCT01021423|20695099|P2|COMPLETED|Overall Study||0
8397264|NCT01021423|20695100|P1|COMPLETED|Overall Study||0
8397265|NCT01021423|20695099|P2|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
8397266|NCT01021423|20695100|P1|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
8397267|NCT01021332|20695116|P1|NOT COMPLETED|Overall Study||106
8397268|NCT01021332|20695116|P1|COMPLETED|Overall Study||960
8397269|NCT01021332|20695116|P1|Full Analysis Set (FAS)|Overall Study||1009
8397270|NCT01021332|20695116|P1|Safety Analysis Set (SAF)|Overall Study||1066
8397271|NCT01021332|20695116|P1|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
8397272|NCT01021306|20695154|P4|NOT COMPLETED|6 Month (Follow-up)||3
8397273|NCT01021306|20695155|P3|NOT COMPLETED|6 Month (Follow-up)||0
8397274|NCT01021306|20695156|P2|NOT COMPLETED|6 Month (Follow-up)||1
8397275|NCT01021306|20695157|P1|NOT COMPLETED|6 Month (Follow-up)||3
8397276|NCT01021306|20695154|P4|COMPLETED|6 Month (Follow-up)||14
8397277|NCT01021306|20695155|P3|COMPLETED|6 Month (Follow-up)||14
8397278|NCT01021306|20695156|P2|COMPLETED|6 Month (Follow-up)||13
8397279|NCT01021306|20695157|P1|COMPLETED|6 Month (Follow-up)||11
8397280|NCT01021306|20695154|P4|STARTED|6 Month (Follow-up)||17
8397281|NCT01021306|20695155|P3|STARTED|6 Month (Follow-up)||14
8397282|NCT01021306|20695156|P2|STARTED|6 Month (Follow-up)||14
8397283|NCT01021306|20695157|P1|STARTED|6 Month (Follow-up)||14
8397284|NCT01021306|20695154|P4|NOT COMPLETED|2 Month (Primary Outcome)||4
8397285|NCT01021306|20695155|P3|NOT COMPLETED|2 Month (Primary Outcome)||5
8397286|NCT01021306|20695156|P2|NOT COMPLETED|2 Month (Primary Outcome)||6
8397287|NCT01021306|20695157|P1|NOT COMPLETED|2 Month (Primary Outcome)||6
8397288|NCT01021306|20695154|P4|COMPLETED|2 Month (Primary Outcome)||17
8397289|NCT01021306|20695155|P3|COMPLETED|2 Month (Primary Outcome)||14
8397290|NCT01021306|20695156|P2|COMPLETED|2 Month (Primary Outcome)||14
8397291|NCT01021306|20695157|P1|COMPLETED|2 Month (Primary Outcome)||14
8397292|NCT01021306|20695154|P4|STARTED|2 Month (Primary Outcome)||21
8397293|NCT01021306|20695155|P3|STARTED|2 Month (Primary Outcome)||19
8397294|NCT01021306|20695156|P2|STARTED|2 Month (Primary Outcome)||20
8397295|NCT01021306|20695157|P1|STARTED|2 Month (Primary Outcome)||20
8397296|NCT01021293|20695177|P2|NOT COMPLETED|Overall Study||24
8397297|NCT01021293|20695178|P1|NOT COMPLETED|Overall Study||12
8397298|NCT01021293|20695177|P2|COMPLETED|Overall Study||526
8397299|NCT01021293|20695178|P1|COMPLETED|Overall Study||538
8397300|NCT01021293|20695177|P2|STARTED|Overall Study||550
8397301|NCT01021293|20695178|P1|STARTED|Overall Study||550
8397302|NCT01021215|20695197|P2|NOT COMPLETED|Overall Study||0
8397303|NCT01021215|20695198|P1|NOT COMPLETED|Overall Study||3
8397304|NCT01021215|20695197|P2|COMPLETED|Overall Study||20
8397305|NCT01021215|20695198|P1|COMPLETED|Overall Study||57
8397306|NCT01021215|20695197|P2|Received Allocated Intervention|Overall Study||20
8397307|NCT01021215|20695198|P1|Received Allocated Intervention|Overall Study||60
8397308|NCT01021215|20695197|P2|STARTED|Overall Study||20
8397309|NCT01021215|20695198|P1|STARTED|Overall Study||60
8397310|NCT01021137|20695212|P4|NOT COMPLETED|Overall Study||9
8397311|NCT01021137|20695213|P3|NOT COMPLETED|Overall Study||2
8397312|NCT01021137|20695214|P2|NOT COMPLETED|Overall Study||4
8397313|NCT01021137|20695215|P1|NOT COMPLETED|Overall Study||10
8397314|NCT01021137|20695212|P4|COMPLETED|Overall Study||32
8397315|NCT01021137|20695213|P3|COMPLETED|Overall Study||9
8397316|NCT01021137|20695214|P2|COMPLETED|Overall Study||16
8397317|NCT01021137|20695215|P1|COMPLETED|Overall Study||52
8397318|NCT01021137|20695212|P4|STARTED|Overall Study||41
8397319|NCT01021137|20695213|P3|STARTED|Overall Study||11
8397320|NCT01021137|20695214|P2|STARTED|Overall Study||20
8397321|NCT01021137|20695215|P1|STARTED|Overall Study||62
8397322|NCT01021111|20695253|P1|NOT COMPLETED|Overall Study||0
8397323|NCT01021111|20695253|P1|COMPLETED|Overall Study||17
8397324|NCT01021111|20695253|P1|STARTED|Overall Study||17
8397325|NCT01021020|20695258|P1|NOT COMPLETED|Period III||0
8397326|NCT01021020|20695258|P1|COMPLETED|Period III||25
8397327|NCT01021020|20695258|P1|STARTED|Period III||25
8397328|NCT01021020|20695258|P1|NOT COMPLETED|14 Day Washout Period B||0
8397329|NCT01021020|20695258|P1|COMPLETED|14 Day Washout Period B||25
8397330|NCT01021020|20695258|P1|STARTED|14 Day Washout Period B||25
8397331|NCT01021020|20695258|P1|NOT COMPLETED|Period II||0
8397332|NCT01021020|20695258|P1|COMPLETED|Period II||25
8397333|NCT01021020|20695258|P1|STARTED|Period II||25
8397334|NCT01021020|20695258|P1|NOT COMPLETED|14 Day Washout Period A||1
8397335|NCT01021020|20695258|P1|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
8397336|NCT01021020|20695258|P1|STARTED|14 Day Washout Period A||26
8397337|NCT01021020|20695258|P1|NOT COMPLETED|Period I||2
8397338|NCT01021020|20695258|P1|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
8397339|NCT01021020|20695258|P1|STARTED|Period I||28
8397340|NCT01021007|20695274|P2|NOT COMPLETED|Overall Study||4
8397341|NCT01021007|20695275|P1|NOT COMPLETED|Overall Study||2
8397342|NCT01021007|20695274|P2|COMPLETED|Overall Study||33
8397343|NCT01021007|20695275|P1|COMPLETED|Overall Study||34
8397344|NCT01021007|20695274|P2|STARTED|Overall Study||37
8397345|NCT01021007|20695275|P1|STARTED|Overall Study||36
8397346|NCT01020981|20695287|P2|NOT COMPLETED|Overall Study||90
8397347|NCT01020981|20695288|P1|NOT COMPLETED|Overall Study||84
8397348|NCT01020981|20695287|P2|COMPLETED|Overall Study||60
8397349|NCT01020981|20695288|P1|COMPLETED|Overall Study||66
8397350|NCT01020981|20695287|P2|STARTED|Overall Study||150
8397351|NCT01020981|20695288|P1|STARTED|Overall Study||150
8397352|NCT01020903|20695300|P2|NOT COMPLETED|Overall Study||0
8397353|NCT01020903|20695301|P1|NOT COMPLETED|Overall Study||0
8397354|NCT01020903|20695300|P2|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
8397355|NCT01020903|20695301|P1|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
8397356|NCT01020903|20695300|P2|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
8397357|NCT01020903|20695301|P1|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
8397358|NCT01020877|20695309|P2|NOT COMPLETED|Second Intervention||0
8397359|NCT01020877|20695310|P1|NOT COMPLETED|Second Intervention||1
8397360|NCT01020877|20695309|P2|COMPLETED|Second Intervention||19
8397361|NCT01020877|20695310|P1|COMPLETED|Second Intervention||18
8397362|NCT01020877|20695309|P2|STARTED|Second Intervention||19
8397363|NCT01020877|20695310|P1|STARTED|Second Intervention||19
8397364|NCT01020877|20695309|P2|NOT COMPLETED|Washout of 7 Days||0
8397365|NCT01020877|20695310|P1|NOT COMPLETED|Washout of 7 Days||0
8397366|NCT01020877|20695309|P2|COMPLETED|Washout of 7 Days||19
8397367|NCT01020877|20695310|P1|COMPLETED|Washout of 7 Days||19
8397368|NCT01020877|20695309|P2|STARTED|Washout of 7 Days||19
8397369|NCT01020877|20695310|P1|STARTED|Washout of 7 Days||19
8397370|NCT01020877|20695309|P2|NOT COMPLETED|First Intervention||0
8397371|NCT01020877|20695310|P1|NOT COMPLETED|First Intervention||0
8397372|NCT01020877|20695309|P2|COMPLETED|First Intervention||19
8397373|NCT01020877|20695310|P1|COMPLETED|First Intervention||19
8397374|NCT01020877|20695309|P2|STARTED|First Intervention||19
8397375|NCT01020877|20695310|P1|STARTED|First Intervention||19
8397376|NCT01020838|20695320|P1|NOT COMPLETED|Overall Study||183
8397377|NCT01020838|20695320|P1|COMPLETED|Overall Study||35
8397378|NCT01020838|20695320|P1|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
8397379|NCT01020838|20695320|P1|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
8397380|NCT01020838|20695320|P1|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
8397381|NCT01020838|20695320|P1|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
8397382|NCT01020838|20695320|P1|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
8397383|NCT01020838|20695320|P1|STARTED|Overall Study||218
8397384|NCT01020812|20695335|P1|NOT COMPLETED|Overall Study||3
8397385|NCT01020812|20695335|P1|COMPLETED|Overall Study||8
8397386|NCT01020812|20695335|P1|STARTED|Overall Study||11
8397387|NCT01020799|20695345|P3|NOT COMPLETED|Overall Study||7
8397388|NCT01020799|20695346|P2|NOT COMPLETED|Overall Study||14
8397389|NCT01020799|20695347|P1|NOT COMPLETED|Overall Study||19
8397390|NCT01020799|20695345|P3|COMPLETED|Overall Study||43
8397391|NCT01020799|20695346|P2|COMPLETED|Overall Study||85
8397392|NCT01020799|20695347|P1|COMPLETED|Overall Study||79
8397393|NCT01020799|20695345|P3|Full Analysis Set|Overall Study||49
8397394|NCT01020799|20695346|P2|Full Analysis Set|Overall Study||94
8397395|NCT01020799|20695347|P1|Full Analysis Set|Overall Study||91
8397396|NCT01020799|20695345|P3|Patients Received Treatment|Overall Study||50
8397397|NCT01020799|20695346|P2|Patients Received Treatment|Overall Study||99
8397398|NCT01020799|20695347|P1|Patients Received Treatment|Overall Study||96
8397399|NCT01020799|20695345|P3|STARTED|Overall Study||50
8397400|NCT01020799|20695346|P2|STARTED|Overall Study||99
8397401|NCT01020799|20695347|P1|STARTED|Overall Study||98
8397402|NCT01020786|20695370|P1|NOT COMPLETED|Maintenance Period||60
8397403|NCT01020786|20695370|P1|COMPLETED|Maintenance Period||0
8397404|NCT01020786|20695370|P1|STARTED|Maintenance Period||60
8397405|NCT01020786|20695370|P1|NOT COMPLETED|Induction Period||49
8397406|NCT01020786|20695370|P1|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
8397407|NCT01020786|20695370|P1|STARTED|Induction Period||109
8397408|NCT01020773|20695384|P2|NOT COMPLETED|Overall Study||3
8397409|NCT01020773|20695385|P1|NOT COMPLETED|Overall Study||4
8397410|NCT01020773|20695384|P2|COMPLETED|Overall Study||29
8397411|NCT01020773|20695385|P1|COMPLETED|Overall Study||31
8397412|NCT01020773|20695384|P2|STARTED|Overall Study||32
8397413|NCT01020773|20695385|P1|STARTED|Overall Study||35
8397414|NCT01020747|20695391|P1|NOT COMPLETED|Overall Study||1
8397415|NCT01020747|20695391|P1|COMPLETED|Overall Study||19
8397416|NCT01020747|20695391|P1|STARTED|Overall Study||20
8397417|NCT01020591|20695398|P2|NOT COMPLETED|Overall Study||0
8397418|NCT01020591|20695399|P1|NOT COMPLETED|Overall Study||0
8397419|NCT01020591|20695398|P2|COMPLETED|Overall Study||15
8397420|NCT01020591|20695399|P1|COMPLETED|Overall Study||15
8397421|NCT01020591|20695398|P2|STARTED|Overall Study||15
8397422|NCT01020591|20695399|P1|STARTED|Overall Study||15
8397423|NCT01020448|20695407|P1|NOT COMPLETED|Treatment||26
8397424|NCT01020448|20695407|P1|COMPLETED|Treatment||299
8397425|NCT01020448|20695407|P1|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
8397426|NCT01020448|20695407|P1|NOT COMPLETED|Pre-assignment||13
8397427|NCT01020448|20695407|P1|COMPLETED|Pre-assignment||326
8397428|NCT01020448|20695407|P1|STARTED|Pre-assignment||339
8397429|NCT01020435|20695418|P2|NOT COMPLETED|Overall Study||1
8397430|NCT01020435|20695419|P1|NOT COMPLETED|Overall Study||0
8397431|NCT01020435|20695418|P2|COMPLETED|Overall Study||26
8397432|NCT01020435|20695419|P1|COMPLETED|Overall Study||24
8397433|NCT01020435|20695418|P2|STARTED|Overall Study||27
8397434|NCT01020435|20695419|P1|STARTED|Overall Study||24
8397435|NCT01020305|20695427|P1|NOT COMPLETED|Overall Study||2
8397436|NCT01020305|20695427|P1|COMPLETED|Overall Study||3
8397437|NCT01020305|20695427|P1|STARTED|Overall Study||5
8397438|NCT01020123|20695438|P7|NOT COMPLETED|Extention Period||1
8397439|NCT01020123|20695439|P6|NOT COMPLETED|Extention Period||2
8397440|NCT01020123|20695440|P5|NOT COMPLETED|Extention Period||0
8397441|NCT01020123|20695441|P4|NOT COMPLETED|Extention Period||1
8397442|NCT01020123|20695442|P3|NOT COMPLETED|Extention Period||2
8397443|NCT01020123|20695443|P2|NOT COMPLETED|Extention Period||2
8397444|NCT01020123|20695444|P1|NOT COMPLETED|Extention Period||3
8397445|NCT01020123|20695438|P7|COMPLETED|Extention Period||18
8397446|NCT01020123|20695439|P6|COMPLETED|Extention Period||36
8397447|NCT01020123|20695440|P5|COMPLETED|Extention Period||31
8397448|NCT01020123|20695441|P4|COMPLETED|Extention Period||12
8397449|NCT01020123|20695442|P3|COMPLETED|Extention Period||17
8397450|NCT01020123|20695443|P2|COMPLETED|Extention Period||33
8397451|NCT01020123|20695444|P1|COMPLETED|Extention Period||37
8397452|NCT01020123|20695438|P7|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
8397453|NCT01020123|20695439|P6|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
8397454|NCT01020123|20695440|P5|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
8397455|NCT01020123|20695441|P4|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
8397456|NCT01020123|20695442|P3|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
8397457|NCT01020123|20695443|P2|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
8397458|NCT01020123|20695444|P1|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
8397459|NCT01020123|20695438|P7|NOT COMPLETED|Main Period||11
8397460|NCT01020123|20695439|P6|NOT COMPLETED|Main Period||11
8397461|NCT01020123|20695440|P5|NOT COMPLETED|Main Period||11
8397462|NCT01020123|20695441|P4|NOT COMPLETED|Main Period||7
8397463|NCT01020123|20695442|P3|NOT COMPLETED|Main Period||8
8397464|NCT01020123|20695443|P2|NOT COMPLETED|Main Period||14
8397465|NCT01020123|20695444|P1|NOT COMPLETED|Main Period||17
8397466|NCT01020123|20695438|P7|COMPLETED|Main Period||61
8397467|NCT01020123|20695439|P6|COMPLETED|Main Period||83
8397468|NCT01020123|20695440|P5|COMPLETED|Main Period||77
8397469|NCT01020123|20695441|P4|COMPLETED|Main Period||33
8397470|NCT01020123|20695442|P3|COMPLETED|Main Period||44
8397471|NCT01020123|20695443|P2|COMPLETED|Main Period||77
8397472|NCT01020123|20695444|P1|COMPLETED|Main Period||76
8397473|NCT01020123|20695438|P7|STARTED|Main Period||72
8397474|NCT01020123|20695439|P6|STARTED|Main Period||94
8397475|NCT01020123|20695440|P5|STARTED|Main Period||88
8397476|NCT01020123|20695441|P4|STARTED|Main Period||40
8397477|NCT01020123|20695442|P3|STARTED|Main Period||52
8397478|NCT01020123|20695443|P2|STARTED|Main Period||91
8397479|NCT01020123|20695444|P1|STARTED|Main Period||93
8397480|NCT01020019|20695639|P2|NOT COMPLETED|Overall Study||29
8397481|NCT01020019|20695640|P1|NOT COMPLETED|Overall Study||26
8397482|NCT01020019|20695639|P2|COMPLETED|Overall Study||32
8397483|NCT01020019|20695640|P1|COMPLETED|Overall Study||35
8397484|NCT01020019|20695639|P2|STARTED|Overall Study||61
8397485|NCT01020019|20695640|P1|STARTED|Overall Study||61
8397486|NCT01020006|20695649|P3|NOT COMPLETED|Overall Study||16
8397487|NCT01020006|20695650|P2|NOT COMPLETED|Overall Study||18
8397488|NCT01020006|20695651|P1|NOT COMPLETED|Overall Study||8
8397489|NCT01020006|20695649|P3|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
8397490|NCT01020006|20695650|P2|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
8397491|NCT01020006|20695651|P1|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
8397492|NCT01020006|20695649|P3|STARTED|Overall Study||16
8397493|NCT01020006|20695650|P2|STARTED|Overall Study||18
8397494|NCT01020006|20695651|P1|STARTED|Overall Study||8
8397495|NCT01019980|20695661|P2|NOT COMPLETED|Overall Study||0
8397496|NCT01019980|20695662|P1|NOT COMPLETED|Overall Study||2
8397497|NCT01019980|20695661|P2|COMPLETED|Overall Study||0
8397498|NCT01019980|20695662|P1|COMPLETED|Overall Study||0
8397499|NCT01019980|20695661|P2|Discontinued|Overall Study||0
8397500|NCT01019980|20695662|P1|Discontinued|Overall Study||2
8397501|NCT01019980|20695661|P2|STARTED|Overall Study||0
8397502|NCT01019980|20695662|P1|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
8397503|NCT01019928|20695670|P2|NOT COMPLETED|Period 3||0
8397504|NCT01019928|20695671|P1|NOT COMPLETED|Period 3||0
8397505|NCT01019928|20695670|P2|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
8397506|NCT01019928|20695671|P1|COMPLETED|Period 3||7
8397507|NCT01019928|20695670|P2|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
8397508|NCT01019928|20695671|P1|STARTED|Period 3||7
8397509|NCT01019928|20695670|P2|NOT COMPLETED|Period 2||1
8397510|NCT01019928|20695671|P1|NOT COMPLETED|Period 2||0
8397511|NCT01019928|20695670|P2|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
8397512|NCT01019928|20695671|P1|COMPLETED|Period 2||7
8397513|NCT01019928|20695670|P2|STARTED|Period 2||7
8397514|NCT01019928|20695671|P1|STARTED|Period 2||7
8397515|NCT01019928|20695670|P2|NOT COMPLETED|Period 1||0
8397516|NCT01019928|20695671|P1|NOT COMPLETED|Period 1||0
8397517|NCT01019928|20695670|P2|COMPLETED|Period 1||7
8397518|NCT01019928|20695671|P1|COMPLETED|Period 1||7
8397519|NCT01019928|20695670|P2|STARTED|Period 1||7
8397520|NCT01019928|20695671|P1|STARTED|Period 1||7
8397521|NCT01019707|20695711|P2|NOT COMPLETED|Second Phase||0
8397522|NCT01019707|20695712|P1|NOT COMPLETED|Second Phase||0
8397523|NCT01019707|20695711|P2|COMPLETED|Second Phase||1
8397524|NCT01019707|20695712|P1|COMPLETED|Second Phase||3
8397525|NCT01019707|20695711|P2|STARTED|Second Phase||1
8397526|NCT01019707|20695712|P1|STARTED|Second Phase||3
8397527|NCT01019707|20695711|P2|NOT COMPLETED|Washout||2
8397528|NCT01019707|20695712|P1|NOT COMPLETED|Washout||0
8397529|NCT01019707|20695711|P2|COMPLETED|Washout||1
8397530|NCT01019707|20695712|P1|COMPLETED|Washout||3
8397531|NCT01019707|20695711|P2|STARTED|Washout||3
8397532|NCT01019707|20695712|P1|STARTED|Washout||3
8397533|NCT01019707|20695711|P2|NOT COMPLETED|First Phase||0
8397534|NCT01019707|20695712|P1|NOT COMPLETED|First Phase||0
8397535|NCT01019707|20695711|P2|COMPLETED|First Phase||3
8397536|NCT01019707|20695712|P1|COMPLETED|First Phase||3
8397537|NCT01019707|20695711|P2|STARTED|First Phase||3
8397538|NCT01019707|20695712|P1|STARTED|First Phase||3
8397539|NCT01019694|20695725|P3|NOT COMPLETED|Overall Study||47
8397540|NCT01019694|20695726|P2|NOT COMPLETED|Overall Study||38
8397541|NCT01019694|20695727|P1|NOT COMPLETED|Overall Study||24
8397542|NCT01019694|20695725|P3|COMPLETED|Overall Study||110
8397543|NCT01019694|20695726|P2|COMPLETED|Overall Study||118
8397544|NCT01019694|20695727|P1|COMPLETED|Overall Study||133
8397545|NCT01019694|20695725|P3|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
8397546|NCT01019694|20695726|P2|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
8397547|NCT01019694|20695727|P1|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
8397548|NCT01019486|20695852|P3|NOT COMPLETED|Overall Study||1
8397549|NCT01019486|20695853|P2|NOT COMPLETED|Overall Study||1
8397550|NCT01019486|20695854|P1|NOT COMPLETED|Overall Study||1
8397551|NCT01019486|20695852|P3|COMPLETED|Overall Study||15
8397552|NCT01019486|20695853|P2|COMPLETED|Overall Study||4
8397553|NCT01019486|20695854|P1|COMPLETED|Overall Study||4
8397554|NCT01019486|20695852|P3|STARTED|Overall Study||16
8397555|NCT01019486|20695853|P2|STARTED|Overall Study||5
8397556|NCT01019486|20695854|P1|STARTED|Overall Study||5
8397557|NCT01019369|20695868|P2|NOT COMPLETED|Overall Study||7
8397558|NCT01019369|20695869|P1|NOT COMPLETED|Overall Study||10
8397559|NCT01019369|20695868|P2|COMPLETED|Overall Study||39
8397560|NCT01019369|20695869|P1|COMPLETED|Overall Study||76
8397561|NCT01019369|20695868|P2|STARTED|Overall Study||46
8397562|NCT01019369|20695869|P1|STARTED|Overall Study||86
8397563|NCT01019317|20695885|P1|NOT COMPLETED|Overall Study||4
8397564|NCT01019317|20695885|P1|COMPLETED|Overall Study||147
8397565|NCT01019317|20695885|P1|STARTED|Overall Study||151
8397566|NCT01019252|20695891|P2|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
8397567|NCT01019252|20695892|P1|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
8397568|NCT01019252|20695891|P2|COMPLETED|Wait List Cross-over to CBT for ADHD||15
8397569|NCT01019252|20695892|P1|COMPLETED|Wait List Cross-over to CBT for ADHD||21
8397570|NCT01019252|20695891|P2|STARTED|Wait List Cross-over to CBT for ADHD||22
8397571|NCT01019252|20695892|P1|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
8397572|NCT01019252|20695891|P2|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
8397573|NCT01019252|20695892|P1|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
8397574|NCT01019252|20695891|P2|COMPLETED|Initial CBT for ADHD vs. Wait List||22
8397575|NCT01019252|20695892|P1|COMPLETED|Initial CBT for ADHD vs. Wait List||21
8397576|NCT01019252|20695891|P2|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
8397577|NCT01019252|20695892|P1|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
8397578|NCT01019135|20695905|P3|NOT COMPLETED|Overall Study||31
8397579|NCT01019135|20695906|P2|NOT COMPLETED|Overall Study||19
8397580|NCT01019135|20695907|P1|NOT COMPLETED|Overall Study||20
8397581|NCT01019135|20695905|P3|COMPLETED|Overall Study||24
8397582|NCT01019135|20695906|P2|COMPLETED|Overall Study||40
8397583|NCT01019135|20695907|P1|COMPLETED|Overall Study||35
8397584|NCT01019135|20695905|P3|STARTED|Overall Study||55
8397585|NCT01019135|20695906|P2|STARTED|Overall Study||59
8397586|NCT01019135|20695907|P1|STARTED|Overall Study||55
8397587|NCT01018992|20695935|P2|NOT COMPLETED|Overall Study||16
8397588|NCT01018992|20695936|P1|NOT COMPLETED|Overall Study||16
8397589|NCT01018992|20695935|P2|COMPLETED|Overall Study||49
8397590|NCT01018992|20695936|P1|COMPLETED|Overall Study||47
8397591|NCT01018992|20695935|P2|STARTED|Overall Study||65
8397592|NCT01018992|20695936|P1|STARTED|Overall Study||63
8397601|NCT01018953|20695981|P1|NOT COMPLETED|Overall Study||8
8397602|NCT01018953|20695981|P1|COMPLETED|Overall Study||0
8397603|NCT01018953|20695981|P1|BIM 23A760 4 mg|Overall Study||3
8397604|NCT01018953|20695981|P1|BIM 23A760 2 mg|Overall Study||2
8397605|NCT01018953|20695981|P1|BIM 23A760 1 mg|Overall Study||3
8397606|NCT01018953|20695981|P1|STARTED|Overall Study||8
8397607|NCT01018862|20695994|P3|NOT COMPLETED|Overall Study||16
8397608|NCT01018862|20695995|P2|NOT COMPLETED|Overall Study||10
8397609|NCT01018862|20695996|P1|NOT COMPLETED|Overall Study||13
8397610|NCT01018862|20695994|P3|COMPLETED|Overall Study||146
8397611|NCT01018862|20695995|P2|COMPLETED|Overall Study||156
8397612|NCT01018862|20695996|P1|COMPLETED|Overall Study||148
8397613|NCT01018862|20695994|P3|STARTED|Overall Study||162
8397614|NCT01018862|20695995|P2|STARTED|Overall Study||166
8397615|NCT01018862|20695996|P1|STARTED|Overall Study||161
8397616|NCT01018810|20696018|P5|NOT COMPLETED|Overall Study||1
8397617|NCT01018810|20696019|P4|NOT COMPLETED|Overall Study||1
8397618|NCT01018810|20696020|P3|NOT COMPLETED|Overall Study||1
8397619|NCT01018810|20696021|P2|NOT COMPLETED|Overall Study||1
8397620|NCT01018810|20696022|P1|NOT COMPLETED|Overall Study||2
8397621|NCT01018810|20696018|P5|COMPLETED|Overall Study||0
8397622|NCT01018810|20696019|P4|COMPLETED|Overall Study||0
8397623|NCT01018810|20696020|P3|COMPLETED|Overall Study||0
8397624|NCT01018810|20696021|P2|COMPLETED|Overall Study||0
8397625|NCT01018810|20696022|P1|COMPLETED|Overall Study||2
8397626|NCT01018810|20696018|P5|STARTED|Overall Study||1
8397627|NCT01018810|20696019|P4|STARTED|Overall Study||1
8397628|NCT01018810|20696020|P3|STARTED|Overall Study||1
8397629|NCT01018810|20696021|P2|STARTED|Overall Study||1
8397630|NCT01018810|20696022|P1|STARTED|Overall Study||4
8397631|NCT01018732|20696082|P3|NOT COMPLETED|Overall Study||4
8397632|NCT01018732|20696083|P2|NOT COMPLETED|Overall Study||2
8397633|NCT01018732|20696084|P1|NOT COMPLETED|Overall Study||1
8397634|NCT01018732|20696082|P3|COMPLETED|Overall Study||50
8397635|NCT01018732|20696083|P2|COMPLETED|Overall Study||49
8397636|NCT01018732|20696084|P1|COMPLETED|Overall Study||49
8397637|NCT01018732|20696082|P3|STARTED|Overall Study||54
8397638|NCT01018732|20696083|P2|STARTED|Overall Study||51
8397639|NCT01018732|20696084|P1|STARTED|Overall Study||50
8397640|NCT01018680|20696118|P2|NOT COMPLETED|Overall Study||75
8397641|NCT01018680|20696119|P1|NOT COMPLETED|Overall Study||61
8397642|NCT01018680|20696118|P2|COMPLETED|Overall Study||189
8397643|NCT01018680|20696119|P1|COMPLETED|Overall Study||199
8397644|NCT01018680|20696118|P2|STARTED|Overall Study||264
8397645|NCT01018680|20696119|P1|STARTED|Overall Study||260
8397646|NCT01020487|20696162|P3|NOT COMPLETED|Part 2 Open-label Period||1
8397647|NCT01020487|20696163|P2|NOT COMPLETED|Part 2 Open-label Period||4
8397648|NCT01020487|20696164|P1|NOT COMPLETED|Part 2 Open-label Period||0
8397649|NCT01020487|20696162|P3|COMPLETED|Part 2 Open-label Period||12
8397650|NCT01020487|20696163|P2|COMPLETED|Part 2 Open-label Period||12
8397651|NCT01020487|20696164|P1|COMPLETED|Part 2 Open-label Period||0
8397652|NCT01020487|20696162|P3|STARTED|Part 2 Open-label Period||13
8397653|NCT01020487|20696163|P2|STARTED|Part 2 Open-label Period||16
8397654|NCT01020487|20696164|P1|STARTED|Part 2 Open-label Period||0
8397655|NCT01020487|20696162|P3|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
8397656|NCT01020487|20696163|P2|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
8397657|NCT01020487|20696164|P1|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
8397658|NCT01020487|20696162|P3|COMPLETED|Part 2 Double-blind Treatment Period||13
8397659|NCT01020487|20696163|P2|COMPLETED|Part 2 Double-blind Treatment Period||16
8397660|NCT01020487|20696164|P1|COMPLETED|Part 2 Double-blind Treatment Period||0
8397661|NCT01020487|20696162|P3|Received Treatment|Part 2 Double-blind Treatment Period||18
8397662|NCT01020487|20696163|P2|Received Treatment|Part 2 Double-blind Treatment Period||18
8397663|NCT01020487|20696164|P1|Received Treatment|Part 2 Double-blind Treatment Period||0
8397664|NCT01020487|20696162|P3|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
8397665|NCT01020487|20696163|P2|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
8397666|NCT01020487|20696164|P1|STARTED|Part 2 Double-blind Treatment Period||0
8397667|NCT01020487|20696162|P3|NOT COMPLETED|Part 1||0
8397668|NCT01020487|20696163|P2|NOT COMPLETED|Part 1||0
8397669|NCT01020487|20696164|P1|NOT COMPLETED|Part 1||0
8397670|NCT01020487|20696162|P3|COMPLETED|Part 1||0
8397671|NCT01020487|20696163|P2|COMPLETED|Part 1||0
8397672|NCT01020487|20696164|P1|COMPLETED|Part 1||12
8397673|NCT01020487|20696162|P3|STARTED|Part 1||0
8397674|NCT01020487|20696163|P2|STARTED|Part 1||0
8397675|NCT01020487|20696164|P1|STARTED|Part 1||12
8397676|NCT01018511|20696189|P4|NOT COMPLETED|Overall Study||33
8397677|NCT01018511|20696190|P3|NOT COMPLETED|Overall Study||40
8397678|NCT01018511|20696191|P2|NOT COMPLETED|Overall Study||32
8397679|NCT01018511|20696192|P1|NOT COMPLETED|Overall Study||26
8397680|NCT01018511|20696189|P4|COMPLETED|Overall Study||294
8397681|NCT01018511|20696190|P3|COMPLETED|Overall Study||299
8397682|NCT01018511|20696191|P2|COMPLETED|Overall Study||295
8397683|NCT01018511|20696192|P1|COMPLETED|Overall Study||315
8397684|NCT01018511|20696189|P4|Randomized and Treated|Overall Study||324
8397685|NCT01018511|20696190|P3|Randomized and Treated|Overall Study||338
8397686|NCT01018511|20696191|P2|Randomized and Treated|Overall Study||326
8397687|NCT01018511|20696192|P1|Randomized and Treated|Overall Study||341
8397688|NCT01018511|20696189|P4|STARTED|Overall Study||327
8397689|NCT01018511|20696190|P3|STARTED|Overall Study||339
8397690|NCT01018511|20696191|P2|STARTED|Overall Study||327
8397691|NCT01018511|20696192|P1|STARTED|Overall Study||341
8397692|NCT01018420|20696361|P2|NOT COMPLETED|Overall Study||0
8397693|NCT01018420|20696362|P1|NOT COMPLETED|Overall Study||0
8397694|NCT01018420|20696361|P2|COMPLETED|Overall Study||3
8397695|NCT01018420|20696362|P1|COMPLETED|Overall Study||15
8397696|NCT01018420|20696361|P2|STARTED|Overall Study||3
8397697|NCT01018420|20696362|P1|STARTED|Overall Study||15
8397698|NCT01018394|20696389|P2|NOT COMPLETED|Overall Study||8
8397699|NCT01018394|20696390|P1|NOT COMPLETED|Overall Study||9
8397700|NCT01018394|20696389|P2|COMPLETED|Overall Study||33
8397701|NCT01018394|20696390|P1|COMPLETED|Overall Study||31
8397702|NCT01018394|20696389|P2|STARTED|Overall Study||41
8397703|NCT01018394|20696390|P1|STARTED|Overall Study||40
8397704|NCT01018264|20696400|P2|NOT COMPLETED|Overall Study||1
8397705|NCT01018264|20696401|P1|NOT COMPLETED|Overall Study||1
8397706|NCT01018264|20696400|P2|COMPLETED|Overall Study||12
8397707|NCT01018264|20696401|P1|COMPLETED|Overall Study||9
8397708|NCT01018264|20696400|P2|STARTED|Overall Study||13
8397709|NCT01018264|20696401|P1|STARTED|Overall Study||10
8397710|NCT01018186|20696418|P4|NOT COMPLETED|52-week Double-blind Treatment Period||29
8397711|NCT01018186|20696419|P3|NOT COMPLETED|52-week Double-blind Treatment Period||41
8397712|NCT01018186|20696420|P2|NOT COMPLETED|52-week Double-blind Treatment Period||40
8397713|NCT01018186|20696421|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
8397714|NCT01018186|20696418|P4|COMPLETED|52-week Double-blind Treatment Period||71
8397715|NCT01018186|20696419|P3|COMPLETED|52-week Double-blind Treatment Period||161
8397716|NCT01018186|20696420|P2|COMPLETED|52-week Double-blind Treatment Period||161
8397717|NCT01018186|20696421|P1|COMPLETED|52-week Double-blind Treatment Period||0
8397718|NCT01018186|20696418|P4|STARTED|52-week Double-blind Treatment Period||100
8397719|NCT01018186|20696419|P3|STARTED|52-week Double-blind Treatment Period||202
8397720|NCT01018186|20696420|P2|STARTED|52-week Double-blind Treatment Period||201
8397721|NCT01018186|20696421|P1|STARTED|52-week Double-blind Treatment Period||0
8397722|NCT01018186|20696418|P4|NOT COMPLETED|2-week Run-in Period||0
8397723|NCT01018186|20696419|P3|NOT COMPLETED|2-week Run-in Period||0
8397724|NCT01018186|20696420|P2|NOT COMPLETED|2-week Run-in Period||0
8397725|NCT01018186|20696421|P1|NOT COMPLETED|2-week Run-in Period||114
8397726|NCT01018186|20696418|P4|COMPLETED|2-week Run-in Period||0
8397727|NCT01018186|20696419|P3|COMPLETED|2-week Run-in Period||0
8397728|NCT01018186|20696420|P2|COMPLETED|2-week Run-in Period||0
8397729|NCT01018186|20696421|P1|COMPLETED|2-week Run-in Period||503
8397730|NCT01018186|20696418|P4|STARTED|2-week Run-in Period||0
8397731|NCT01018186|20696419|P3|STARTED|2-week Run-in Period||0
8397732|NCT01018186|20696420|P2|STARTED|2-week Run-in Period||0
8397733|NCT01018186|20696421|P1|STARTED|2-week Run-in Period||617
8397734|NCT01018134|20696513|P6|NOT COMPLETED|Overall Study||0
8397735|NCT01018134|20696514|P5|NOT COMPLETED|Overall Study||0
8397736|NCT01018134|20696515|P4|NOT COMPLETED|Overall Study||0
8397737|NCT01018134|20696516|P3|NOT COMPLETED|Overall Study||1
8397738|NCT01018134|20696517|P2|NOT COMPLETED|Overall Study||1
8397739|NCT01018134|20696518|P1|NOT COMPLETED|Overall Study||0
8397740|NCT01018134|20696513|P6|COMPLETED|Overall Study||15
8397741|NCT01018134|20696514|P5|COMPLETED|Overall Study||15
8397742|NCT01018134|20696515|P4|COMPLETED|Overall Study||29
8397743|NCT01018134|20696516|P3|COMPLETED|Overall Study||29
8397744|NCT01018134|20696517|P2|COMPLETED|Overall Study||30
8397745|NCT01018134|20696518|P1|COMPLETED|Overall Study||30
8397746|NCT01018134|20696513|P6|STARTED|Overall Study||15
8397747|NCT01018134|20696514|P5|STARTED|Overall Study||15
8397748|NCT01018134|20696515|P4|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
8397749|NCT01018134|20696516|P3|STARTED|Overall Study||30
8397750|NCT01018134|20696517|P2|STARTED|Overall Study||31
8397751|NCT01018134|20696518|P1|STARTED|Overall Study||30
8397752|NCT01018095|20696558|P2|NOT COMPLETED|Overall Study||62
8397753|NCT01018095|20696559|P1|NOT COMPLETED|Overall Study||56
8397754|NCT01018095|20696558|P2|COMPLETED|Overall Study||73
8397755|NCT01018095|20696559|P1|COMPLETED|Overall Study||79
8397756|NCT01018095|20696558|P2|STARTED|Overall Study||135
8397757|NCT01018095|20696559|P1|STARTED|Overall Study||135
8397758|NCT01018056|20696570|P3|NOT COMPLETED|Overall Study||1
8397759|NCT01018056|20696571|P2|NOT COMPLETED|Overall Study||2
8397760|NCT01018056|20696572|P1|NOT COMPLETED|Overall Study||3
8397761|NCT01018056|20696570|P3|COMPLETED|Overall Study||5
8397762|NCT01018056|20696571|P2|COMPLETED|Overall Study||10
8397763|NCT01018056|20696572|P1|COMPLETED|Overall Study||9
8397764|NCT01018056|20696570|P3|STARTED|Overall Study||6
8397765|NCT01018056|20696571|P2|STARTED|Overall Study||12
8397766|NCT01018056|20696572|P1|STARTED|Overall Study||12
8397767|NCT01018030|20696622|P3|NOT COMPLETED|Overall Study||13
8397768|NCT01018030|20696623|P2|NOT COMPLETED|Overall Study||11
8397769|NCT01018030|20696624|P1|NOT COMPLETED|Overall Study||19
8397770|NCT01018030|20696622|P3|COMPLETED|Overall Study||239
8397771|NCT01018030|20696623|P2|COMPLETED|Overall Study||232
8397772|NCT01018030|20696624|P1|COMPLETED|Overall Study||227
8397773|NCT01018030|20696622|P3|STARTED|Overall Study||252
8397774|NCT01018030|20696623|P2|STARTED|Overall Study||243
8397775|NCT01018030|20696624|P1|STARTED|Overall Study||246
8397776|NCT01017952|20696675|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||103
8397777|NCT01017952|20696676|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||112
8397778|NCT01017952|20696677|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||109
8397779|NCT01017952|20696678|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||125
8397780|NCT01017952|20696679|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
8397781|NCT01017952|20696675|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
8397782|NCT01017952|20696676|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
8397783|NCT01017952|20696677|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
8397784|NCT01017952|20696678|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
8397785|NCT01017952|20696679|P1|COMPLETED|52-week, Double-blind Treatment Period||0
8397786|NCT01017952|20696675|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
8397787|NCT01017952|20696676|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
8397788|NCT01017952|20696677|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
8397873|NCT01017237|20696878|P1|NOT COMPLETED|Overall Study||5
8397874|NCT01017237|20696877|P2|COMPLETED|Overall Study||6
8397789|NCT01017952|20696678|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
8397790|NCT01017952|20696679|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
8397791|NCT01017952|20696675|P5|STARTED|52-week, Double-blind Treatment Period||409
8397792|NCT01017952|20696676|P4|STARTED|52-week, Double-blind Treatment Period||403
8397793|NCT01017952|20696677|P3|STARTED|52-week, Double-blind Treatment Period||412
8397794|NCT01017952|20696678|P2|STARTED|52-week, Double-blind Treatment Period||409
8397795|NCT01017952|20696679|P1|STARTED|52-week, Double-blind Treatment Period||0
8397796|NCT01017952|20696675|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
8397797|NCT01017952|20696676|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
8397798|NCT01017952|20696677|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
8397799|NCT01017952|20696678|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
8397800|NCT01017952|20696679|P1|NOT COMPLETED|4-week, Open-label Run-In Period||459
8397801|NCT01017952|20696675|P5|COMPLETED|4-week, Open-label Run-In Period||0
8397802|NCT01017952|20696676|P4|COMPLETED|4-week, Open-label Run-In Period||0
8397803|NCT01017952|20696677|P3|COMPLETED|4-week, Open-label Run-In Period||0
8397804|NCT01017952|20696678|P2|COMPLETED|4-week, Open-label Run-In Period||0
8397805|NCT01017952|20696679|P1|COMPLETED|4-week, Open-label Run-In Period||1633
8397806|NCT01017952|20696675|P5|STARTED|4-week, Open-label Run-In Period||0
8397807|NCT01017952|20696676|P4|STARTED|4-week, Open-label Run-In Period||0
8397808|NCT01017952|20696677|P3|STARTED|4-week, Open-label Run-In Period||0
8397809|NCT01017952|20696678|P2|STARTED|4-week, Open-label Run-In Period||0
8397810|NCT01017952|20696679|P1|STARTED|4-week, Open-label Run-In Period||2092
8397811|NCT01017874|20696703|P2|NOT COMPLETED|Overall Study||26
8397812|NCT01017874|20696704|P1|NOT COMPLETED|Overall Study||30
8397813|NCT01017874|20696703|P2|COMPLETED|Overall Study||92
8397814|NCT01017874|20696704|P1|COMPLETED|Overall Study||88
8397815|NCT01017874|20696703|P2|Received at Least 1 Dose of Study Drug|Overall Study||118
8397816|NCT01017874|20696704|P1|Received at Least 1 Dose of Study Drug|Overall Study||114
8397817|NCT01017874|20696703|P2|STARTED|Overall Study||118
8397818|NCT01017874|20696704|P1|STARTED|Overall Study||118
8397819|NCT01017731|20696722|P1|NOT COMPLETED|Overall Study||8
8397820|NCT01017731|20696722|P1|COMPLETED|Overall Study||60
8397821|NCT01017731|20696722|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
8397822|NCT01017731|20696722|P1|STARTED|Overall Study||68
8397823|NCT01017653|20696739|P1|NOT COMPLETED|Overall Study||0
8397824|NCT01017653|20696739|P1|COMPLETED|Overall Study||16
8397825|NCT01017653|20696739|P1|STARTED|Overall Study||16
8397826|NCT01017601|20696751|P2|NOT COMPLETED|Overall Study||13
8397827|NCT01017601|20696752|P1|NOT COMPLETED|Overall Study||12
8397828|NCT01017601|20696751|P2|COMPLETED|Overall Study||11
8397829|NCT01017601|20696752|P1|COMPLETED|Overall Study||14
8397830|NCT01017601|20696751|P2|STARTED|Overall Study||24
8397831|NCT01017601|20696752|P1|STARTED|Overall Study||26
8397832|NCT01017575|20696779|P5|NOT COMPLETED|Overall Study||3
8397833|NCT01017575|20696780|P4|NOT COMPLETED|Overall Study||1
8397834|NCT01017575|20696781|P3|NOT COMPLETED|Overall Study||0
8397835|NCT01017575|20696782|P2|NOT COMPLETED|Overall Study||2
8397836|NCT01017575|20696783|P1|NOT COMPLETED|Overall Study||1
8397837|NCT01017575|20696779|P5|COMPLETED|Overall Study||6
8397838|NCT01017575|20696780|P4|COMPLETED|Overall Study||7
8397839|NCT01017575|20696781|P3|COMPLETED|Overall Study||8
8397840|NCT01017575|20696782|P2|COMPLETED|Overall Study||7
8397841|NCT01017575|20696783|P1|COMPLETED|Overall Study||7
8397842|NCT01017575|20696779|P5|STARTED|Overall Study||9
8397843|NCT01017575|20696780|P4|STARTED|Overall Study||8
8397844|NCT01017575|20696781|P3|STARTED|Overall Study||8
8397845|NCT01017575|20696782|P2|STARTED|Overall Study||9
8397846|NCT01017575|20696783|P1|STARTED|Overall Study||8
8397847|NCT01017549|20696820|P1|NOT COMPLETED|5 Year Follow-up||12
8397848|NCT01017549|20696820|P1|COMPLETED|5 Year Follow-up||24
8397849|NCT01017549|20696820|P1|STARTED|5 Year Follow-up||36
8397850|NCT01017549|20696820|P1|NOT COMPLETED|One-year Follow-up||7
8397851|NCT01017549|20696820|P1|COMPLETED|One-year Follow-up||36
8397852|NCT01017549|20696820|P1|STARTED|One-year Follow-up||43
8397853|NCT01017549|20696820|P1|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
8397854|NCT01017549|20696820|P1|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
8397855|NCT01017549|20696820|P1|STARTED|Eligibility Through 6 Month Follow-up||44
8397856|NCT01017536|20696827|P2|NOT COMPLETED|Overall Study||0
8397857|NCT01017536|20696828|P1|NOT COMPLETED|Overall Study||0
8397858|NCT01017536|20696827|P2|COMPLETED|Overall Study||13
8397859|NCT01017536|20696828|P1|COMPLETED|Overall Study||13
8397860|NCT01017536|20696827|P2|STARTED|Overall Study||13
8397861|NCT01017536|20696828|P1|STARTED|Overall Study||13
8397862|NCT01017497|20696838|P1|NOT COMPLETED|Overall Study||0
8397863|NCT01017497|20696838|P1|COMPLETED|Overall Study||49
8397864|NCT01017497|20696838|P1|STARTED|Overall Study||49
8397865|NCT01017263|20696851|P1|NOT COMPLETED|Overall Study||12
8397866|NCT01017263|20696851|P1|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
8397867|NCT01017263|20696851|P1|STARTED|Overall Study||14
8397868|NCT01017250|20696855|P1|NOT COMPLETED|Overall Study||0
8397869|NCT01017250|20696855|P1|COMPLETED|Overall Study||15
8397870|NCT01017250|20696855|P1|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
8397871|NCT01017250|20696855|P1|STARTED|Overall Study||15
8397872|NCT01017237|20696877|P2|NOT COMPLETED|Overall Study||2
8397875|NCT01017237|20696878|P1|COMPLETED|Overall Study||5
8397876|NCT01017237|20696877|P2|STARTED|Overall Study||8
8397877|NCT01017237|20696878|P1|STARTED|Overall Study||10
8397878|NCT01017146|20696932|P2|NOT COMPLETED|Overall Study||39
8397879|NCT01017146|20696933|P1|NOT COMPLETED|Overall Study||66
8397880|NCT01017146|20696932|P2|COMPLETED|Overall Study||333
8397881|NCT01017146|20696933|P1|COMPLETED|Overall Study||306
8397882|NCT01017146|20696932|P2|STARTED|Overall Study||372
8397883|NCT01017146|20696933|P1|STARTED|Overall Study||372
8397884|NCT01017120|20696971|P2|NOT COMPLETED|Overall Study||35
8397885|NCT01017120|20696972|P1|NOT COMPLETED|Overall Study||66
8397886|NCT01017120|20696971|P2|COMPLETED|Overall Study||334
8397887|NCT01017120|20696972|P1|COMPLETED|Overall Study||307
8397888|NCT01017120|20696971|P2|STARTED|Overall Study||369
8397889|NCT01017120|20696972|P1|STARTED|Overall Study||373
8397890|NCT01017042|20697020|P1|NOT COMPLETED|Overall Study||0
8397891|NCT01017042|20697020|P1|COMPLETED|Overall Study||13
8397892|NCT01017042|20697020|P1|STARTED|Overall Study||13
8397893|NCT01017029|20697033|P2|NOT COMPLETED|Overall Study||2
8397894|NCT01017029|20697034|P1|NOT COMPLETED|Overall Study||4
8397895|NCT01017029|20697033|P2|COMPLETED|Overall Study||90
8397896|NCT01017029|20697034|P1|COMPLETED|Overall Study||85
8397897|NCT01017029|20697033|P2|STARTED|Overall Study||92
8397898|NCT01017029|20697034|P1|STARTED|Overall Study||89
8397899|NCT01017003|20697050|P1|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
8397900|NCT01017003|20697050|P1|COMPLETED|Colchicine 0.6 mg Final Dose||13
8397901|NCT01017003|20697050|P1|STARTED|Colchicine 0.6 mg Final Dose||13
8397902|NCT01017003|20697050|P1|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
8397903|NCT01017003|20697050|P1|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
8397904|NCT01017003|20697050|P1|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
8397905|NCT01017003|20697050|P1|NOT COMPLETED|14 Day Washout Period||0
8397906|NCT01017003|20697050|P1|COMPLETED|14 Day Washout Period||13
8397907|NCT01017003|20697050|P1|STARTED|14 Day Washout Period||13
8397908|NCT01017003|20697050|P1|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
8397909|NCT01017003|20697050|P1|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
8397910|NCT01017003|20697050|P1|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
8397911|NCT01016977|20697062|P2|NOT COMPLETED|Overall Study||2
8397912|NCT01016977|20697063|P1|NOT COMPLETED|Overall Study||3
8397913|NCT01016977|20697062|P2|COMPLETED|Overall Study||18
8397914|NCT01016977|20697063|P1|COMPLETED|Overall Study||17
8397915|NCT01016977|20697062|P2|STARTED|Overall Study||20
8397916|NCT01016977|20697063|P1|STARTED|Overall Study||20
8397917|NCT01016964|20697099|P2|NOT COMPLETED|Overall Study||3
8397918|NCT01016964|20697100|P1|NOT COMPLETED|Overall Study||3
8397919|NCT01016964|20697099|P2|COMPLETED|Overall Study||39
8397920|NCT01016964|20697100|P1|COMPLETED|Overall Study||18
8397921|NCT01016964|20697099|P2|STARTED|Overall Study||42
8397922|NCT01016964|20697100|P1|STARTED|Overall Study||21
8397923|NCT01016938|20697106|P1|NOT COMPLETED|Overall Study||9
8397924|NCT01016938|20697106|P1|COMPLETED|Overall Study||7
8397925|NCT01016938|20697106|P1|STARTED|Overall Study||16
8397926|NCT01016912|20697116|P5|NOT COMPLETED|Follow-up Period||0
8397927|NCT01016912|20697117|P4|NOT COMPLETED|Follow-up Period||1
8397928|NCT01016912|20697118|P3|NOT COMPLETED|Follow-up Period||1
8397929|NCT01016912|20697119|P2|NOT COMPLETED|Follow-up Period||0
8397930|NCT01016912|20697120|P1|NOT COMPLETED|Follow-up Period||0
8397931|NCT01016912|20697116|P5|COMPLETED|Follow-up Period||9
8397932|NCT01016912|20697117|P4|COMPLETED|Follow-up Period||8
8397933|NCT01016912|20697118|P3|COMPLETED|Follow-up Period||9
8397934|NCT01016912|20697119|P2|COMPLETED|Follow-up Period||9
8397935|NCT01016912|20697120|P1|COMPLETED|Follow-up Period||8
8397936|NCT01016912|20697116|P5|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
8397937|NCT01016912|20697117|P4|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
8397938|NCT01016912|20697118|P3|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
8397939|NCT01016912|20697119|P2|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
8397940|NCT01016912|20697120|P1|STARTED|Follow-up Period||8
8397941|NCT01016912|20697116|P5|NOT COMPLETED|End of Treatment Period||4
8397942|NCT01016912|20697117|P4|NOT COMPLETED|End of Treatment Period||4
8397943|NCT01016912|20697118|P3|NOT COMPLETED|End of Treatment Period||1
8397944|NCT01016912|20697119|P2|NOT COMPLETED|End of Treatment Period||3
8397945|NCT01016912|20697120|P1|NOT COMPLETED|End of Treatment Period||0
8397946|NCT01016912|20697116|P5|COMPLETED|End of Treatment Period||5
8397947|NCT01016912|20697117|P4|COMPLETED|End of Treatment Period||5
8397948|NCT01016912|20697118|P3|COMPLETED|End of Treatment Period||9
8397949|NCT01016912|20697119|P2|COMPLETED|End of Treatment Period||6
8397950|NCT01016912|20697120|P1|COMPLETED|End of Treatment Period||8
8397951|NCT01016912|20697116|P5|Received Treatment|End of Treatment Period||9
8397952|NCT01016912|20697117|P4|Received Treatment|End of Treatment Period||9
8397953|NCT01016912|20697118|P3|Received Treatment|End of Treatment Period||10
8397954|NCT01016912|20697119|P2|Received Treatment|End of Treatment Period||9
8397955|NCT01016912|20697120|P1|Received Treatment|End of Treatment Period||8
8397956|NCT01016912|20697116|P5|STARTED|End of Treatment Period||9
8397957|NCT01016912|20697117|P4|STARTED|End of Treatment Period||9
8397958|NCT01016912|20697118|P3|STARTED|End of Treatment Period||10
8397959|NCT01016912|20697119|P2|STARTED|End of Treatment Period||9
8397960|NCT01016912|20697120|P1|STARTED|End of Treatment Period||8
8397961|NCT01016873|20697165|P3|NOT COMPLETED|36 Months||6
8397962|NCT01016873|20697166|P2|NOT COMPLETED|36 Months||4
8397963|NCT01016873|20697167|P1|NOT COMPLETED|36 Months||11
8397964|NCT01016873|20697165|P3|COMPLETED|36 Months||67
8397965|NCT01016873|20697166|P2|COMPLETED|36 Months||64
8397966|NCT01016873|20697167|P1|COMPLETED|36 Months||58
8397967|NCT01016873|20697165|P3|STARTED|36 Months||73
8397968|NCT01016873|20697166|P2|STARTED|36 Months||68
8397969|NCT01016873|20697167|P1|STARTED|36 Months||69
8397970|NCT01016873|20697165|P3|NOT COMPLETED|24 Months||6
8397971|NCT01016873|20697166|P2|NOT COMPLETED|24 Months||4
8397972|NCT01016873|20697167|P1|NOT COMPLETED|24 Months||5
8397973|NCT01016873|20697165|P3|COMPLETED|24 Months||73
8397974|NCT01016873|20697166|P2|COMPLETED|24 Months||68
8397975|NCT01016873|20697167|P1|COMPLETED|24 Months||69
8397976|NCT01016873|20697165|P3|STARTED|24 Months||79
8397977|NCT01016873|20697166|P2|STARTED|24 Months||72
8397978|NCT01016873|20697167|P1|STARTED|24 Months||74
8397979|NCT01016873|20697165|P3|NOT COMPLETED|12 Months||1
8397980|NCT01016873|20697166|P2|NOT COMPLETED|12 Months||3
8397981|NCT01016873|20697167|P1|NOT COMPLETED|12 Months||1
8397982|NCT01016873|20697165|P3|COMPLETED|12 Months||79
8397983|NCT01016873|20697166|P2|COMPLETED|12 Months||72
8397984|NCT01016873|20697167|P1|COMPLETED|12 Months||74
8397985|NCT01016873|20697165|P3|STARTED|12 Months||80
8397986|NCT01016873|20697166|P2|STARTED|12 Months||75
8397987|NCT01016873|20697167|P1|STARTED|12 Months||75
8397988|NCT01016847|20697198|P2|NOT COMPLETED|Overall Study||0
8397989|NCT01016847|20697199|P1|NOT COMPLETED|Overall Study||0
8397990|NCT01016847|20697198|P2|COMPLETED|Overall Study||2
8397991|NCT01016847|20697199|P1|COMPLETED|Overall Study||1
8397992|NCT01016847|20697198|P2|STARTED|Overall Study||2
8397993|NCT01016847|20697199|P1|STARTED|Overall Study||1
8397994|NCT01016834|20697215|P1|NOT COMPLETED|Overall Study||22
8397995|NCT01016834|20697215|P1|COMPLETED|Overall Study||220
8397996|NCT01016834|20697215|P1|STARTED|Overall Study||242
8397997|NCT01016769|20697225|P4|NOT COMPLETED|Overall Study||0
8397998|NCT01016769|20697226|P3|NOT COMPLETED|Overall Study||1
8397999|NCT01016769|20697227|P2|NOT COMPLETED|Overall Study||1
8398000|NCT01016769|20697228|P1|NOT COMPLETED|Overall Study||1
8398001|NCT01016769|20697225|P4|COMPLETED|Overall Study||30
8398002|NCT01016769|20697226|P3|COMPLETED|Overall Study||6
8398003|NCT01016769|20697227|P2|COMPLETED|Overall Study||6
8398004|NCT01016769|20697228|P1|COMPLETED|Overall Study||3
8398005|NCT01016769|20697225|P4|STARTED|Overall Study||30
8398006|NCT01016769|20697226|P3|STARTED|Overall Study||7
8398007|NCT01016769|20697227|P2|STARTED|Overall Study||7
8398008|NCT01016769|20697228|P1|STARTED|Overall Study||4
8398009|NCT01016691|20697242|P3|NOT COMPLETED|Overall Study||0
8398010|NCT01016691|20697243|P2|NOT COMPLETED|Overall Study||0
8398011|NCT01016691|20697244|P1|NOT COMPLETED|Overall Study||0
8398012|NCT01016691|20697242|P3|COMPLETED|Overall Study||18
8398013|NCT01016691|20697243|P2|COMPLETED|Overall Study||12
8398014|NCT01016691|20697244|P1|COMPLETED|Overall Study||17
8398015|NCT01016691|20697242|P3|STARTED|Overall Study||18
8398016|NCT01016691|20697243|P2|STARTED|Overall Study||12
8398017|NCT01016691|20697244|P1|STARTED|Overall Study||17
8398018|NCT01016678|20697252|P5|NOT COMPLETED|Overall Study||6
8398019|NCT01016678|20697253|P4|NOT COMPLETED|Overall Study||0
8398020|NCT01016678|20697254|P3|NOT COMPLETED|Overall Study||4
8398021|NCT01016678|20697255|P2|NOT COMPLETED|Overall Study||3
8398022|NCT01016678|20697256|P1|NOT COMPLETED|Overall Study||2
8398023|NCT01016678|20697252|P5|COMPLETED|Overall Study||13
8398024|NCT01016678|20697253|P4|COMPLETED|Overall Study||19
8398025|NCT01016678|20697254|P3|COMPLETED|Overall Study||15
8398026|NCT01016678|20697255|P2|COMPLETED|Overall Study||14
8398027|NCT01016678|20697256|P1|COMPLETED|Overall Study||18
8398028|NCT01016678|20697252|P5|STARTED|Overall Study||19
8398029|NCT01016678|20697253|P4|STARTED|Overall Study||19
8398030|NCT01016678|20697254|P3|STARTED|Overall Study||19
8398031|NCT01016678|20697255|P2|STARTED|Overall Study||17
8398032|NCT01016678|20697256|P1|STARTED|Overall Study||20
8398033|NCT01016652|20697278|P2|NOT COMPLETED|Period 2||0
8398034|NCT01016652|20697279|P1|NOT COMPLETED|Period 2||0
8398035|NCT01016652|20697278|P2|COMPLETED|Period 2||24
8398036|NCT01016652|20697279|P1|COMPLETED|Period 2||25
8398037|NCT01016652|20697278|P2|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
8398038|NCT01016652|20697279|P1|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
8398039|NCT01016652|20697278|P2|NOT COMPLETED|Period 1||0
8398040|NCT01016652|20697279|P1|NOT COMPLETED|Period 1||0
8398041|NCT01016652|20697278|P2|COMPLETED|Period 1||24
8398042|NCT01016652|20697279|P1|COMPLETED|Period 1||25
8398043|NCT01016652|20697278|P2|STARTED|Period 1||24
8398044|NCT01016652|20697279|P1|STARTED|Period 1||25
8398045|NCT01016600|20697299|P4|NOT COMPLETED|Overall Study||0
8398046|NCT01016600|20697300|P3|NOT COMPLETED|Overall Study||0
8398047|NCT01016600|20697301|P2|NOT COMPLETED|Overall Study||0
8398048|NCT01016600|20697302|P1|NOT COMPLETED|Overall Study||1
8398049|NCT01016600|20697299|P4|COMPLETED|Overall Study||12
8398050|NCT01016600|20697300|P3|COMPLETED|Overall Study||6
8398051|NCT01016600|20697301|P2|COMPLETED|Overall Study||4
8398052|NCT01016600|20697302|P1|COMPLETED|Overall Study||8
8398053|NCT01016600|20697299|P4|STARTED|Overall Study||12
8398054|NCT01016600|20697300|P3|STARTED|Overall Study||6
8398055|NCT01016600|20697301|P2|STARTED|Overall Study||4
8398056|NCT01016600|20697302|P1|STARTED|Overall Study||9
8398057|NCT01016483|20697369|P4|NOT COMPLETED|Phase II||0
8398058|NCT01016483|20697370|P3|NOT COMPLETED|Phase II||0
8398059|NCT01016483|20697371|P2|NOT COMPLETED|Phase II||0
8398060|NCT01016483|20697372|P1|NOT COMPLETED|Phase II||0
8398061|NCT01016483|20697369|P4|COMPLETED|Phase II||44
8398062|NCT01016483|20697370|P3|COMPLETED|Phase II||44
8398063|NCT01016483|20697371|P2|COMPLETED|Phase II||0
8398064|NCT01016483|20697372|P1|COMPLETED|Phase II||0
8398065|NCT01016483|20697369|P4|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
8398066|NCT01016483|20697370|P3|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
8398067|NCT01016483|20697371|P2|Treated (Safety Analysis Set [SAF])|Phase II||0
8398068|NCT01016483|20697372|P1|Treated (Safety Analysis Set [SAF])|Phase II||0
8398069|NCT01016483|20697369|P4|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
8398070|NCT01016483|20697370|P3|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
8398071|NCT01016483|20697371|P2|STARTED|Phase II||0
8398072|NCT01016483|20697372|P1|STARTED|Phase II||0
8398073|NCT01016483|20697369|P4|NOT COMPLETED|Safety Run-in Part||0
8398074|NCT01016483|20697370|P3|NOT COMPLETED|Safety Run-in Part||0
8398075|NCT01016483|20697371|P2|NOT COMPLETED|Safety Run-in Part||0
8398076|NCT01016483|20697372|P1|NOT COMPLETED|Safety Run-in Part||0
8398077|NCT01016483|20697369|P4|COMPLETED|Safety Run-in Part||0
8398078|NCT01016483|20697370|P3|COMPLETED|Safety Run-in Part||0
8398079|NCT01016483|20697371|P2|COMPLETED|Safety Run-in Part||26
8398080|NCT01016483|20697372|P1|COMPLETED|Safety Run-in Part||27
8398081|NCT01016483|20697369|P4|STARTED|Safety Run-in Part||0
8398082|NCT01016483|20697370|P3|STARTED|Safety Run-in Part||0
8398083|NCT01016483|20697371|P2|STARTED|Safety Run-in Part||26
8398084|NCT01016483|20697372|P1|STARTED|Safety Run-in Part||27
8398085|NCT01016353|20697480|P2|NOT COMPLETED|Overall Study||1
8398086|NCT01016353|20697481|P1|NOT COMPLETED|Overall Study||2
8398087|NCT01016353|20697480|P2|COMPLETED|Overall Study||102
8398088|NCT01016353|20697481|P1|COMPLETED|Overall Study||178
8398089|NCT01016353|20697480|P2|STARTED|Overall Study||103
8398090|NCT01016353|20697481|P1|STARTED|Overall Study||180
8398091|NCT01016262|20697490|P6|NOT COMPLETED|Open-Label Phase||0
8398092|NCT01016262|20697491|P5|NOT COMPLETED|Open-Label Phase||2
8398093|NCT01016262|20697492|P4|NOT COMPLETED|Open-Label Phase||2
8398094|NCT01016262|20697493|P3|NOT COMPLETED|Open-Label Phase||0
8398095|NCT01016262|20697494|P2|NOT COMPLETED|Open-Label Phase||0
8398096|NCT01016262|20697495|P1|NOT COMPLETED|Open-Label Phase||0
8398097|NCT01016262|20697490|P6|COMPLETED|Open-Label Phase||20
8398098|NCT01016262|20697491|P5|COMPLETED|Open-Label Phase||50
8398099|NCT01016262|20697492|P4|COMPLETED|Open-Label Phase||42
8398100|NCT01016262|20697493|P3|COMPLETED|Open-Label Phase||0
8398101|NCT01016262|20697494|P2|COMPLETED|Open-Label Phase||0
8398102|NCT01016262|20697495|P1|COMPLETED|Open-Label Phase||0
8398103|NCT01016262|20697490|P6|STARTED|Open-Label Phase||20
8398104|NCT01016262|20697491|P5|STARTED|Open-Label Phase||52
8398105|NCT01016262|20697492|P4|STARTED|Open-Label Phase||44
8398106|NCT01016262|20697493|P3|STARTED|Open-Label Phase||0
8398107|NCT01016262|20697494|P2|STARTED|Open-Label Phase||0
8398108|NCT01016262|20697495|P1|STARTED|Open-Label Phase||0
8398109|NCT01016262|20697490|P6|NOT COMPLETED|Double-blind Phase||0
8398110|NCT01016262|20697491|P5|NOT COMPLETED|Double-blind Phase||0
8398111|NCT01016262|20697492|P4|NOT COMPLETED|Double-blind Phase||0
8398112|NCT01016262|20697493|P3|NOT COMPLETED|Double-blind Phase||9
8398113|NCT01016262|20697494|P2|NOT COMPLETED|Double-blind Phase||1
8398114|NCT01016262|20697495|P1|NOT COMPLETED|Double-blind Phase||1
8398115|NCT01016262|20697490|P6|COMPLETED|Double-blind Phase||0
8398116|NCT01016262|20697491|P5|COMPLETED|Double-blind Phase||0
8398117|NCT01016262|20697492|P4|COMPLETED|Double-blind Phase||0
8398118|NCT01016262|20697493|P3|COMPLETED|Double-blind Phase||30
8398119|NCT01016262|20697494|P2|COMPLETED|Double-blind Phase||38
8398120|NCT01016262|20697495|P1|COMPLETED|Double-blind Phase||40
8398121|NCT01016262|20697490|P6|STARTED|Double-blind Phase||0
8398122|NCT01016262|20697491|P5|STARTED|Double-blind Phase||0
8398123|NCT01016262|20697492|P4|STARTED|Double-blind Phase||0
8398124|NCT01016262|20697493|P3|STARTED|Double-blind Phase||39
8398125|NCT01016262|20697494|P2|STARTED|Double-blind Phase||39
8398126|NCT01016262|20697495|P1|STARTED|Double-blind Phase||41
8398127|NCT01016132|20697518|P1|NOT COMPLETED|Overall Study||1
8398128|NCT01016132|20697518|P1|COMPLETED|Overall Study||151
8398129|NCT01016132|20697518|P1|STARTED|Overall Study||152
8398130|NCT01016106|20697524|P2|NOT COMPLETED|Overall Study||0
8398131|NCT01016106|20697525|P1|NOT COMPLETED|Overall Study||0
8398132|NCT01016106|20697524|P2|COMPLETED|Overall Study||18
8398133|NCT01016106|20697525|P1|COMPLETED|Overall Study||17
8398134|NCT01016106|20697524|P2|STARTED|Overall Study||18
8398135|NCT01016106|20697525|P1|STARTED|Overall Study||17
8398136|NCT01016067|20697533|P2|NOT COMPLETED|Overall Study||4
8398137|NCT01016067|20697534|P1|NOT COMPLETED|Overall Study||2
8398138|NCT01016067|20697533|P2|COMPLETED|Overall Study||8
8398139|NCT01016067|20697534|P1|COMPLETED|Overall Study||9
8398140|NCT01016067|20697533|P2|STARTED|Overall Study||12
8398141|NCT01016067|20697534|P1|STARTED|Overall Study||11
8398142|NCT01016015|20697552|P1|NOT COMPLETED|Overall Study||19
8398143|NCT01016015|20697552|P1|COMPLETED|Overall Study||159
8398144|NCT01016015|20697552|P1|STARTED|Overall Study||178
8398145|NCT01015976|20697556|P2|NOT COMPLETED|Overall Study||0
8398146|NCT01015976|20697557|P1|NOT COMPLETED|Overall Study||0
8398147|NCT01015976|20697556|P2|COMPLETED|Overall Study||5
8398148|NCT01015976|20697557|P1|COMPLETED|Overall Study||5
8398149|NCT01015976|20697556|P2|STARTED|Overall Study||5
8398150|NCT01015976|20697557|P1|STARTED|Overall Study||5
8398157|NCT01015820|20697580|P2|NOT COMPLETED|Overall Study||0
8398158|NCT01015820|20697581|P1|NOT COMPLETED|Overall Study||1
8398159|NCT01015820|20697580|P2|COMPLETED|Overall Study||15
8398160|NCT01015820|20697581|P1|COMPLETED|Overall Study||14
8398161|NCT01015820|20697580|P2|STARTED|Overall Study||15
8398162|NCT01015820|20697581|P1|STARTED|Overall Study||15
8398163|NCT01015807|20697592|P3|NOT COMPLETED|Overall Study||0
8398164|NCT01015807|20697593|P2|NOT COMPLETED|Overall Study||0
8398165|NCT01015807|20697594|P1|NOT COMPLETED|Overall Study||0
8398166|NCT01015807|20697592|P3|COMPLETED|Overall Study||30
8398167|NCT01015807|20697593|P2|COMPLETED|Overall Study||30
8398168|NCT01015807|20697594|P1|COMPLETED|Overall Study||30
8398169|NCT01015807|20697592|P3|STARTED|Overall Study||30
8398170|NCT01015807|20697593|P2|STARTED|Overall Study||30
8398171|NCT01015807|20697594|P1|STARTED|Overall Study||30
8398172|NCT01015781|20697604|P2|NOT COMPLETED|Overall Study||29
8398173|NCT01015781|20697605|P1|NOT COMPLETED|Overall Study||37
8398174|NCT01015781|20697604|P2|COMPLETED|Overall Study||121
8398175|NCT01015781|20697605|P1|COMPLETED|Overall Study||113
8398176|NCT01015781|20697604|P2|STARTED|Overall Study||150
8398177|NCT01015781|20697605|P1|STARTED|Overall Study||150
8398178|NCT01015768|20697611|P2|NOT COMPLETED|Overall Study||4
8398179|NCT01015768|20697612|P1|NOT COMPLETED|Overall Study||4
8398180|NCT01015768|20697611|P2|COMPLETED|Overall Study||26
8398181|NCT01015768|20697612|P1|COMPLETED|Overall Study||26
8398182|NCT01015768|20697611|P2|STARTED|Overall Study||30
8398183|NCT01015768|20697612|P1|STARTED|Overall Study||30
8398184|NCT01015703|20697627|P5|NOT COMPLETED|Overall Study||0
8398185|NCT01015703|20697628|P4|NOT COMPLETED|Overall Study||0
8398186|NCT01015703|20697629|P3|NOT COMPLETED|Overall Study||0
8398187|NCT01015703|20697630|P2|NOT COMPLETED|Overall Study||1
8398188|NCT01015703|20697631|P1|NOT COMPLETED|Overall Study||2
8398189|NCT01015703|20697627|P5|COMPLETED|Overall Study||10
8398190|NCT01015703|20697628|P4|COMPLETED|Overall Study||10
8398191|NCT01015703|20697629|P3|COMPLETED|Overall Study||10
8398192|NCT01015703|20697630|P2|COMPLETED|Overall Study||9
8398193|NCT01015703|20697631|P1|COMPLETED|Overall Study||8
8398194|NCT01015703|20697627|P5|STARTED|Overall Study||10
8398195|NCT01015703|20697628|P4|STARTED|Overall Study||10
8398196|NCT01015703|20697629|P3|STARTED|Overall Study||10
8398197|NCT01015703|20697630|P2|STARTED|Overall Study||10
8398198|NCT01015703|20697631|P1|STARTED|Overall Study||10
8398199|NCT01015677|20697646|P3|NOT COMPLETED|Overall Study||0
8398200|NCT01015677|20697647|P2|NOT COMPLETED|Overall Study||4
8398201|NCT01015677|20697648|P1|NOT COMPLETED|Overall Study||1
8398202|NCT01015677|20697646|P3|COMPLETED|Overall Study||33
8398203|NCT01015677|20697647|P2|COMPLETED|Overall Study||28
8398204|NCT01015677|20697648|P1|COMPLETED|Overall Study||33
8398205|NCT01015677|20697646|P3|STARTED|Overall Study||33
8398206|NCT01015677|20697647|P2|STARTED|Overall Study||32
8398207|NCT01015677|20697648|P1|STARTED|Overall Study||34
8398208|NCT01015638|20697670|P2|NOT COMPLETED|Overall Study||0
8398209|NCT01015638|20697671|P1|NOT COMPLETED|Overall Study||1
8398210|NCT01015638|20697670|P2|COMPLETED|Overall Study||19
8398211|NCT01015638|20697671|P1|COMPLETED|Overall Study||16
8398212|NCT01015638|20697670|P2|STARTED|Overall Study||19
8398213|NCT01015638|20697671|P1|STARTED|Overall Study||17
8398214|NCT01015612|20697699|P1|NOT COMPLETED|Overall Study||153
8398215|NCT01015612|20697699|P1|COMPLETED|Overall Study||481
8398216|NCT01015612|20697699|P1|STARTED|Overall Study||634
8398217|NCT01015586|20697711|P2|NOT COMPLETED|Overall Study||11
8398218|NCT01015586|20697712|P1|NOT COMPLETED|Overall Study||7
8398219|NCT01015586|20697711|P2|COMPLETED|Overall Study||11
8398220|NCT01015586|20697712|P1|COMPLETED|Overall Study||14
8398221|NCT01015586|20697711|P2|STARTED|Overall Study||22
8398222|NCT01015586|20697712|P1|STARTED|Overall Study||21
8398223|NCT01015560|20697730|P1|NOT COMPLETED|Overall Study||3
8398224|NCT01015560|20697730|P1|COMPLETED|Overall Study||41
8398225|NCT01015560|20697730|P1|Eligible and Analyzable|Overall Study||43
8398226|NCT01015560|20697730|P1|STARTED|Overall Study||44
8398227|NCT01015534|20697736|P2|NOT COMPLETED|Overall Study||0
8398228|NCT01015534|20697737|P1|NOT COMPLETED|Overall Study||1
8398229|NCT01015534|20697736|P2|COMPLETED|Overall Study||27
8398230|NCT01015534|20697737|P1|COMPLETED|Overall Study||27
8398231|NCT01015534|20697736|P2|STARTED|Overall Study||27
8398232|NCT01015534|20697737|P1|STARTED|Overall Study||28
8398233|NCT01015443|20697751|P2|NOT COMPLETED|Overall Study||0
8398234|NCT01015443|20697752|P1|NOT COMPLETED|Overall Study||0
8398235|NCT01015443|20697751|P2|COMPLETED|Overall Study||94
8398236|NCT01015443|20697752|P1|COMPLETED|Overall Study||191
8398237|NCT01015443|20697751|P2|Treated|Overall Study||93
8398238|NCT01015443|20697752|P1|Treated|Overall Study||191
8398239|NCT01015443|20697751|P2|STARTED|Overall Study||94
8398240|NCT01015443|20697752|P1|STARTED|Overall Study||191
8398241|NCT01015326|20697770|P2|NOT COMPLETED|Overall Study||2
8398242|NCT01015326|20697771|P1|NOT COMPLETED|Overall Study||1
8398243|NCT01015326|20697770|P2|COMPLETED|Overall Study||18
8398244|NCT01015326|20697771|P1|COMPLETED|Overall Study||11
8398245|NCT01015326|20697770|P2|STARTED|Overall Study||20
8398246|NCT01015326|20697771|P1|STARTED|Overall Study||12
8398247|NCT01015287|20697779|P2|NOT COMPLETED|Overall Study||79
8398248|NCT01015287|20697780|P1|NOT COMPLETED|Overall Study||72
8398249|NCT01015287|20697779|P2|COMPLETED|Overall Study||1958
8398250|NCT01015287|20697780|P1|COMPLETED|Overall Study||1924
8398251|NCT01015287|20697779|P2|Received at Least 1 Dose of Study Drug|Overall Study||2037
8398252|NCT01015287|20697780|P1|Received at Least 1 Dose of Study Drug|Overall Study||1996
8398253|NCT01015287|20697779|P2|STARTED|Overall Study||2037
8398254|NCT01015287|20697780|P1|STARTED|Overall Study||1996
8398255|NCT01015170|20697806|P1|NOT COMPLETED|Overall Study||239
8398256|NCT01015170|20697806|P1|COMPLETED|Overall Study||215
8398257|NCT01015170|20697806|P1|STARTED|Overall Study||454
8398261|NCT01015118|20697828|P2|NOT COMPLETED|Overall Study||327
8398262|NCT01015118|20697829|P1|NOT COMPLETED|Overall Study||669
8398263|NCT01015118|20697828|P2|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
8398264|NCT01015118|20697829|P1|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
8398265|NCT01015118|20697828|P2|STARTED|Overall Study||455
8398266|NCT01015118|20697829|P1|STARTED|Overall Study||911
8398267|NCT01014988|20697857|P6|NOT COMPLETED|Overall Study||3
8398268|NCT01014988|20697858|P5|NOT COMPLETED|Overall Study||1
8398269|NCT01014988|20697859|P4|NOT COMPLETED|Overall Study||0
8398270|NCT01014988|20697860|P3|NOT COMPLETED|Overall Study||2
8398271|NCT01014988|20697861|P2|NOT COMPLETED|Overall Study||0
8398272|NCT01014988|20697862|P1|NOT COMPLETED|Overall Study||23
8398273|NCT01014988|20697857|P6|COMPLETED|Overall Study||11
8398274|NCT01014988|20697858|P5|COMPLETED|Overall Study||26
8398275|NCT01014988|20697859|P4|COMPLETED|Overall Study||12
8398276|NCT01014988|20697860|P3|COMPLETED|Overall Study||9
8398277|NCT01014988|20697861|P2|COMPLETED|Overall Study||7
8398278|NCT01014988|20697862|P1|COMPLETED|Overall Study||107
8398279|NCT01014988|20697857|P6|STARTED|Overall Study||14
8398280|NCT01014988|20697858|P5|STARTED|Overall Study||27
8398281|NCT01014988|20697859|P4|STARTED|Overall Study||12
8398282|NCT01014988|20697860|P3|STARTED|Overall Study||11
8398283|NCT01014988|20697861|P2|STARTED|Overall Study||7
8398284|NCT01014988|20697862|P1|STARTED|Overall Study||130
8398285|NCT01014975|20698034|P3|NOT COMPLETED|Overall Study||6
8398286|NCT01014975|20698035|P2|NOT COMPLETED|Overall Study||3
8398287|NCT01014975|20698036|P1|NOT COMPLETED|Overall Study||4
8398288|NCT01014975|20698034|P3|COMPLETED|Overall Study||10
8398289|NCT01014975|20698035|P2|COMPLETED|Overall Study||13
8398290|NCT01014975|20698036|P1|COMPLETED|Overall Study||4
8398291|NCT01014975|20698034|P3|STARTED|Overall Study||16
8398292|NCT01014975|20698035|P2|STARTED|Overall Study||16
8398293|NCT01014975|20698036|P1|STARTED|Overall Study||8
8398294|NCT01014936|20698047|P3|NOT COMPLETED|Overall Study||0
8398295|NCT01014936|20698048|P2|NOT COMPLETED|Overall Study||0
8398296|NCT01014936|20698049|P1|NOT COMPLETED|Overall Study||0
8398297|NCT01014936|20698047|P3|COMPLETED|Overall Study||62
8398298|NCT01014936|20698048|P2|COMPLETED|Overall Study||45
8398299|NCT01014936|20698049|P1|COMPLETED|Overall Study||42
8398300|NCT01014936|20698047|P3|STARTED|Overall Study||62
8398301|NCT01014936|20698048|P2|STARTED|Overall Study||45
8398302|NCT01014936|20698049|P1|STARTED|Overall Study||42
8398303|NCT01014910|20698541|P2|NOT COMPLETED|Overall Study||2
8398304|NCT01014910|20698542|P1|NOT COMPLETED|Overall Study||0
8398305|NCT01014910|20698541|P2|COMPLETED|Overall Study||79
8398306|NCT01014910|20698542|P1|COMPLETED|Overall Study||80
8398307|NCT01014910|20698541|P2|STARTED|Overall Study||81
8398308|NCT01014910|20698542|P1|STARTED|Overall Study||80
8398312|NCT01014767|20698560|P4|NOT COMPLETED|Overall Study||1
8398313|NCT01014767|20698561|P3|NOT COMPLETED|Overall Study||4
8398314|NCT01014767|20698562|P2|NOT COMPLETED|Overall Study||1
8398315|NCT01014767|20698563|P1|NOT COMPLETED|Overall Study||12
8398316|NCT01014767|20698560|P4|COMPLETED|Overall Study||0
8398317|NCT01014767|20698561|P3|COMPLETED|Overall Study||0
8398318|NCT01014767|20698562|P2|COMPLETED|Overall Study||0
8398319|NCT01014767|20698563|P1|COMPLETED|Overall Study||0
8398320|NCT01014767|20698560|P4|STARTED|Overall Study||1
8398321|NCT01014767|20698561|P3|STARTED|Overall Study||4
8398322|NCT01014767|20698562|P2|STARTED|Overall Study||1
8398323|NCT01014767|20698563|P1|STARTED|Overall Study||12
8398324|NCT01014741|20698579|P2|NOT COMPLETED|Overall Study||5
8398325|NCT01014741|20698580|P1|NOT COMPLETED|Overall Study||11
8398326|NCT01014741|20698579|P2|COMPLETED|Overall Study||90
8398327|NCT01014741|20698580|P1|COMPLETED|Overall Study||94
8398328|NCT01014741|20698579|P2|STARTED|Overall Study||95
8398329|NCT01014741|20698580|P1|STARTED|Overall Study||105
8398330|NCT01014728|20698594|P2|NOT COMPLETED|Overall Study||0
8398331|NCT01014728|20698595|P1|NOT COMPLETED|Overall Study||0
8398332|NCT01014728|20698594|P2|COMPLETED|Overall Study||15
8398333|NCT01014728|20698595|P1|COMPLETED|Overall Study||18
8398334|NCT01014728|20698594|P2|STARTED|Overall Study||15
8398335|NCT01014728|20698595|P1|STARTED|Overall Study||18
8398348|NCT01014585|20698643|P4|NOT COMPLETED|Overall Study||30
8398349|NCT01014585|20698644|P3|NOT COMPLETED|Overall Study||23
8398350|NCT01014585|20698645|P2|NOT COMPLETED|Overall Study||25
8398351|NCT01014585|20698646|P1|NOT COMPLETED|Overall Study||20
8398352|NCT01014585|20698643|P4|COMPLETED|Overall Study||99
8398353|NCT01014585|20698644|P3|COMPLETED|Overall Study||37
8398354|NCT01014585|20698645|P2|COMPLETED|Overall Study||75
8398355|NCT01014585|20698646|P1|COMPLETED|Overall Study||31
8398356|NCT01014585|20698643|P4|STARTED|Overall Study||129
8398357|NCT01014585|20698644|P3|STARTED|Overall Study||60
8398358|NCT01014585|20698645|P2|STARTED|Overall Study||100
8398359|NCT01014585|20698646|P1|STARTED|Overall Study||51
8398360|NCT01014533|20698666|P2|NOT COMPLETED|Overall Study||5
8398361|NCT01014533|20698667|P1|NOT COMPLETED|Overall Study||5
8398362|NCT01014533|20698666|P2|COMPLETED|Overall Study||25
8398363|NCT01014533|20698667|P1|COMPLETED|Overall Study||24
8398364|NCT01014533|20698666|P2|STARTED|Overall Study||30
8398365|NCT01014533|20698667|P1|STARTED|Overall Study||29
8398366|NCT01014455|20698679|P2|NOT COMPLETED|Overall Study||0
8398367|NCT01014455|20698680|P1|NOT COMPLETED|Overall Study||0
8398368|NCT01014455|20698679|P2|COMPLETED|Overall Study||87
8398369|NCT01014455|20698680|P1|COMPLETED|Overall Study||82
8398370|NCT01014455|20698679|P2|STARTED|Overall Study||87
8398371|NCT01014455|20698680|P1|STARTED|Overall Study||82
8398372|NCT01014442|20698688|P2|NOT COMPLETED|Overall Study||19
8398373|NCT01014442|20698689|P1|NOT COMPLETED|Overall Study||7
8398374|NCT01014442|20698688|P2|COMPLETED|Overall Study||16
8398375|NCT01014442|20698689|P1|COMPLETED|Overall Study||26
8398376|NCT01014442|20698688|P2|STARTED|Overall Study||35
8398377|NCT01014442|20698689|P1|STARTED|Overall Study||33
8398378|NCT01014403|20698803|P2|NOT COMPLETED|Overall Study||0
8398379|NCT01014403|20698804|P1|NOT COMPLETED|Overall Study||0
8398380|NCT01014403|20698803|P2|COMPLETED|Overall Study||28
8398381|NCT01014403|20698804|P1|COMPLETED|Overall Study||34
8398382|NCT01014403|20698803|P2|STARTED|Overall Study||28
8398383|NCT01014403|20698804|P1|STARTED|Overall Study||34
8398384|NCT01014390|20698814|P1|NOT COMPLETED|Overall Study||10
8398385|NCT01014390|20698814|P1|COMPLETED|Overall Study||177
8398386|NCT01014390|20698814|P1|STARTED|Overall Study||187
8398387|NCT01014351|20698818|P1|NOT COMPLETED|Overall Study||37
8398388|NCT01014351|20698818|P1|COMPLETED|Overall Study||33
8398389|NCT01014351|20698818|P1|STARTED|Overall Study||70
8398390|NCT01014208|20698826|P2|NOT COMPLETED|Overall Study||100
8398391|NCT01014208|20698827|P1|NOT COMPLETED|Overall Study||94
8398392|NCT01014208|20698826|P2|COMPLETED|Overall Study||122
8398393|NCT01014208|20698827|P1|COMPLETED|Overall Study||131
8398394|NCT01014208|20698826|P2|Intent-to-Treat Population|Overall Study||222
8398395|NCT01014208|20698827|P1|Intent-to-Treat Population|Overall Study||223
8398396|NCT01014208|20698826|P2|STARTED|Overall Study||222
8398397|NCT01014208|20698827|P1|STARTED|Overall Study||225
8398398|NCT01014169|20698855|P2|NOT COMPLETED|Overall Study||13
8398399|NCT01014169|20698856|P1|NOT COMPLETED|Overall Study||7
8398400|NCT01014169|20698855|P2|COMPLETED|Overall Study||48
8398401|NCT01014169|20698856|P1|COMPLETED|Overall Study||58
8398402|NCT01014169|20698855|P2|STARTED|Overall Study||61
8398403|NCT01014169|20698856|P1|STARTED|Overall Study||65
8398404|NCT01014143|20698869|P3|NOT COMPLETED|Third Intervention||0
8398405|NCT01014143|20698870|P2|NOT COMPLETED|Third Intervention||0
8398406|NCT01014143|20698871|P1|NOT COMPLETED|Third Intervention||0
8398407|NCT01014143|20698869|P3|COMPLETED|Third Intervention||9
8398408|NCT01014143|20698870|P2|COMPLETED|Third Intervention||9
8398409|NCT01014143|20698871|P1|COMPLETED|Third Intervention||8
8398410|NCT01014143|20698869|P3|STARTED|Third Intervention||9
8398411|NCT01014143|20698870|P2|STARTED|Third Intervention||9
8398412|NCT01014143|20698871|P1|STARTED|Third Intervention||8
8398413|NCT01014143|20698869|P3|NOT COMPLETED|Washout After 2nd Intervention||0
8398414|NCT01014143|20698870|P2|NOT COMPLETED|Washout After 2nd Intervention||0
8398415|NCT01014143|20698871|P1|NOT COMPLETED|Washout After 2nd Intervention||0
8398416|NCT01014143|20698869|P3|COMPLETED|Washout After 2nd Intervention||9
8398417|NCT01014143|20698870|P2|COMPLETED|Washout After 2nd Intervention||9
8398418|NCT01014143|20698871|P1|COMPLETED|Washout After 2nd Intervention||8
8398419|NCT01014143|20698869|P3|STARTED|Washout After 2nd Intervention||9
8398420|NCT01014143|20698870|P2|STARTED|Washout After 2nd Intervention||9
8398421|NCT01014143|20698871|P1|STARTED|Washout After 2nd Intervention||8
8398422|NCT01014143|20698869|P3|NOT COMPLETED|Second Intervention||0
8398423|NCT01014143|20698870|P2|NOT COMPLETED|Second Intervention||0
8398424|NCT01014143|20698871|P1|NOT COMPLETED|Second Intervention||2
8398425|NCT01014143|20698869|P3|COMPLETED|Second Intervention||9
8398426|NCT01014143|20698870|P2|COMPLETED|Second Intervention||9
8398427|NCT01014143|20698871|P1|COMPLETED|Second Intervention||8
8398428|NCT01014143|20698869|P3|STARTED|Second Intervention||9
8398429|NCT01014143|20698870|P2|STARTED|Second Intervention||9
8398430|NCT01014143|20698871|P1|STARTED|Second Intervention||10
8398431|NCT01014143|20698869|P3|NOT COMPLETED|Washout Period After 1st Intervention||0
8398432|NCT01014143|20698870|P2|NOT COMPLETED|Washout Period After 1st Intervention||0
8398433|NCT01014143|20698871|P1|NOT COMPLETED|Washout Period After 1st Intervention||0
8398434|NCT01014143|20698869|P3|COMPLETED|Washout Period After 1st Intervention||9
8398435|NCT01014143|20698870|P2|COMPLETED|Washout Period After 1st Intervention||9
8398436|NCT01014143|20698871|P1|COMPLETED|Washout Period After 1st Intervention||10
8398437|NCT01014143|20698869|P3|STARTED|Washout Period After 1st Intervention||9
8398438|NCT01014143|20698870|P2|STARTED|Washout Period After 1st Intervention||9
8398439|NCT01014143|20698871|P1|STARTED|Washout Period After 1st Intervention||10
8398440|NCT01014143|20698869|P3|NOT COMPLETED|First Intervention||0
8398441|NCT01014143|20698870|P2|NOT COMPLETED|First Intervention||0
8398442|NCT01014143|20698871|P1|NOT COMPLETED|First Intervention||0
8398443|NCT01014143|20698869|P3|COMPLETED|First Intervention||9
8398444|NCT01014143|20698870|P2|COMPLETED|First Intervention||9
8398445|NCT01014143|20698871|P1|COMPLETED|First Intervention||10
8398446|NCT01014143|20698869|P3|STARTED|First Intervention||9
8398447|NCT01014143|20698870|P2|STARTED|First Intervention||9
8398448|NCT01014143|20698871|P1|STARTED|First Intervention||10
8398449|NCT01014091|20698885|P6|NOT COMPLETED|Overall Study||0
8398450|NCT01014091|20698886|P5|NOT COMPLETED|Overall Study||0
8398451|NCT01014091|20698887|P4|NOT COMPLETED|Overall Study||0
8398452|NCT01014091|20698888|P3|NOT COMPLETED|Overall Study||0
8398453|NCT01014091|20698889|P2|NOT COMPLETED|Overall Study||0
8398454|NCT01014091|20698890|P1|NOT COMPLETED|Overall Study||0
8398455|NCT01014091|20698885|P6|COMPLETED|Overall Study||12
8398456|NCT01014091|20698886|P5|COMPLETED|Overall Study||6
8398457|NCT01014091|20698887|P4|COMPLETED|Overall Study||15
8398458|NCT01014091|20698888|P3|COMPLETED|Overall Study||5
8398459|NCT01014091|20698889|P2|COMPLETED|Overall Study||13
8398460|NCT01014091|20698890|P1|COMPLETED|Overall Study||7
8398461|NCT01014091|20698885|P6|STARTED|Overall Study||12
8398462|NCT01014091|20698886|P5|STARTED|Overall Study||6
8398463|NCT01014091|20698887|P4|STARTED|Overall Study||15
8398464|NCT01014091|20698888|P3|STARTED|Overall Study||5
8398465|NCT01014091|20698889|P2|STARTED|Overall Study||13
8398466|NCT01014091|20698890|P1|STARTED|Overall Study||7
8398467|NCT01014013|20698966|P2|NOT COMPLETED|Overall Study||56
8398468|NCT01014013|20698967|P1|NOT COMPLETED|Overall Study||51
8398469|NCT01014013|20698966|P2|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
8398470|NCT01014013|20698967|P1|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
8398471|NCT01014013|20698966|P2|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
8398472|NCT01014013|20698967|P1|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous
~infusion at least 3 days"|87
8398473|NCT01014013|20698966|P2|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
8398474|NCT01014013|20698967|P1|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
8398475|NCT01014013|20698966|P2|STARTED|Overall Study||136
8398476|NCT01014013|20698967|P1|STARTED|Overall Study||135
8398477|NCT01013961|20698979|P2|NOT COMPLETED|Overall Study||3
8398478|NCT01013961|20698980|P1|NOT COMPLETED|Overall Study||3
8398479|NCT01013961|20698979|P2|COMPLETED|Overall Study||12
8398480|NCT01013961|20698980|P1|COMPLETED|Overall Study||13
8398481|NCT01013961|20698979|P2|STARTED|Overall Study||15
8398482|NCT01013961|20698980|P1|STARTED|Overall Study||16
8398483|NCT01013883|20698998|P2|NOT COMPLETED|Overall Study||2
8398484|NCT01013883|20698999|P1|NOT COMPLETED|Overall Study||2
8398485|NCT01013883|20698998|P2|COMPLETED|Overall Study||241
8398486|NCT01013883|20698999|P1|COMPLETED|Overall Study||268
8398487|NCT01013883|20698998|P2|STARTED|Overall Study||243
8398488|NCT01013883|20698999|P1|STARTED|Overall Study||270
8398489|NCT01013870|20699011|P2|NOT COMPLETED|Overall Study||3
8398490|NCT01013870|20699012|P1|NOT COMPLETED|Overall Study||1
8398491|NCT01013870|20699011|P2|COMPLETED|Overall Study||21
8398492|NCT01013870|20699012|P1|COMPLETED|Overall Study||27
8398493|NCT01013870|20699011|P2|STARTED|Overall Study||24
8398494|NCT01013870|20699012|P1|STARTED|Overall Study||28
8398495|NCT01013844|20699036|P2|NOT COMPLETED|Overall Study||0
8398496|NCT01013844|20699037|P1|NOT COMPLETED|Overall Study||0
8398497|NCT01013844|20699036|P2|COMPLETED|Overall Study||65
8398498|NCT01013844|20699037|P1|COMPLETED|Overall Study||65
8398499|NCT01013844|20699036|P2|STARTED|Overall Study||65
8398500|NCT01013844|20699037|P1|STARTED|Overall Study||65
8398501|NCT01013792|20699061|P2|NOT COMPLETED|Overall Study||5
8398502|NCT01013792|20699062|P1|NOT COMPLETED|Overall Study||2
8398503|NCT01013792|20699061|P2|COMPLETED|Overall Study||11
8398504|NCT01013792|20699062|P1|COMPLETED|Overall Study||12
8398505|NCT01013792|20699061|P2|STARTED|Overall Study||16
8398506|NCT01013792|20699062|P1|STARTED|Overall Study||14
8398507|NCT01013753|20699068|P1|NOT COMPLETED|Overall Study||16
8398508|NCT01013753|20699068|P1|COMPLETED|Overall Study||182
8398509|NCT01013753|20699068|P1|Received Form 12 mcg Bid|Overall Study||125
8398510|NCT01013753|20699068|P1|Received Olo 20 mcg qd|Overall Study||124
8398511|NCT01013753|20699068|P1|Received Olo 10 mcg qd|Overall Study||127
8398512|NCT01013753|20699068|P1|Received Olo 5 mcg qd|Overall Study||130
8398513|NCT01013753|20699068|P1|Received Olo 2 mcg qd|Overall Study||121
8398514|NCT01013753|20699068|P1|Received Placebo|Overall Study||125
8398515|NCT01013753|20699068|P1|STARTED|Overall Study|Entered and treated|198
8398516|NCT01013740|20699264|P2|NOT COMPLETED|Overall Study||19
8398517|NCT01013740|20699265|P1|NOT COMPLETED|Overall Study||11
8398518|NCT01013740|20699264|P2|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
8398519|NCT01013740|20699265|P1|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
8398520|NCT01013740|20699264|P2|Ongoing|Overall Study||0
8398521|NCT01013740|20699265|P1|Ongoing|Overall Study||0
8398522|NCT01013740|20699264|P2|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
8398523|NCT01013740|20699265|P1|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
8398524|NCT01013701|20699289|P1|NOT COMPLETED|Overall Study||7
8398525|NCT01013701|20699289|P1|COMPLETED|Overall Study||0
8398526|NCT01013701|20699289|P1|STARTED|Overall Study||7
8398527|NCT01013597|20699296|P1|NOT COMPLETED|Overall Study||1
8398528|NCT01013597|20699296|P1|COMPLETED|Overall Study||12
8398529|NCT01013597|20699296|P1|STARTED|Overall Study||13
8398530|NCT01013350|20699308|P2|NOT COMPLETED|Overall Study||192
8398531|NCT01013350|20699309|P1|NOT COMPLETED|Overall Study||38
8398532|NCT01013350|20699308|P2|COMPLETED|Overall Study||771
8398533|NCT01013350|20699309|P1|COMPLETED|Overall Study||160
8398534|NCT01013350|20699308|P2|Safety Analysis Set|Overall Study||950
8398535|NCT01013350|20699309|P1|Safety Analysis Set|Overall Study||198
8398536|NCT01013350|20699308|P2|STARTED|Overall Study||963
8398537|NCT01013350|20699309|P1|STARTED|Overall Study||198
8398538|NCT01013285|20699322|P2|NOT COMPLETED|Overall Study||89
8398539|NCT01013285|20699323|P1|NOT COMPLETED|Overall Study||48
8398540|NCT01013285|20699322|P2|COMPLETED|Overall Study||21
8398541|NCT01013285|20699323|P1|COMPLETED|Overall Study||22
8398542|NCT01013285|20699322|P2|STARTED|Overall Study||110
8398543|NCT01013285|20699323|P1|STARTED|Overall Study||70
8398544|NCT01013207|20699336|P1|NOT COMPLETED|CPAP Post Nexus (S9)||6
8398545|NCT01013207|20699336|P1|COMPLETED|CPAP Post Nexus (S9)||44
8398546|NCT01013207|20699336|P1|STARTED|CPAP Post Nexus (S9)||50
8398547|NCT01013207|20699336|P1|NOT COMPLETED|Nexus (S9)||0
8398548|NCT01013207|20699336|P1|COMPLETED|Nexus (S9)||50
8398549|NCT01013207|20699336|P1|STARTED|Nexus (S9)||50
8398550|NCT01013207|20699336|P1|NOT COMPLETED|CPAP Pre Nexus (S9)||0
8398551|NCT01013207|20699336|P1|COMPLETED|CPAP Pre Nexus (S9)||50
8398552|NCT01013207|20699336|P1|STARTED|CPAP Pre Nexus (S9)||50
8398553|NCT01013194|20699343|P2|NOT COMPLETED|Overall Study||0
8398554|NCT01013194|20699344|P1|NOT COMPLETED|Overall Study||0
8398555|NCT01013194|20699343|P2|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
8398556|NCT01013194|20699344|P1|COMPLETED|Overall Study|Consecutive patients|9
8398557|NCT01013194|20699343|P2|STARTED|Overall Study||16
8398558|NCT01013194|20699344|P1|STARTED|Overall Study||9
8398559|NCT01012999|20699354|P1|NOT COMPLETED|Overall Study||1
8398560|NCT01012999|20699354|P1|COMPLETED|Overall Study||15
8398561|NCT01012999|20699354|P1|STARTED|Overall Study||16
8398562|NCT01012973|20699360|P2|NOT COMPLETED|Overall Study||19
8398563|NCT01012973|20699361|P1|NOT COMPLETED|Overall Study||16
8398564|NCT01012973|20699360|P2|COMPLETED|Overall Study||52
8398565|NCT01012973|20699361|P1|COMPLETED|Overall Study||90
8398566|NCT01012973|20699360|P2|Completed Week 52, From FAS|Overall Study||52
8398567|NCT01012973|20699361|P1|Completed Week 52, From FAS|Overall Study||91
8398568|NCT01012973|20699360|P2|Completed Week 24, From FAS|Overall Study||57
8398569|NCT01012973|20699361|P1|Completed Week 24, From FAS|Overall Study||97
8398570|NCT01012973|20699360|P2|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
8398571|NCT01012973|20699361|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
8398572|NCT01012973|20699360|P2|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
8398573|NCT01012973|20699361|P1|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
8398574|NCT01012973|20699360|P2|STARTED|Overall Study||71
8398575|NCT01012973|20699361|P1|STARTED|Overall Study||106
8398576|NCT01012947|20699386|P5|NOT COMPLETED|Overall Study||142
8398577|NCT01012947|20699387|P4|NOT COMPLETED|Overall Study||118
8398578|NCT01012947|20699388|P3|NOT COMPLETED|Overall Study||130
8398579|NCT01012947|20699389|P2|NOT COMPLETED|Overall Study||135
8398580|NCT01012947|20699390|P1|NOT COMPLETED|Overall Study||131
8398581|NCT01012947|20699386|P5|COMPLETED|Overall Study||94
8398582|NCT01012947|20699387|P4|COMPLETED|Overall Study||93
8398583|NCT01012947|20699388|P3|COMPLETED|Overall Study||111
8398584|NCT01012947|20699389|P2|COMPLETED|Overall Study||80
8398585|NCT01012947|20699390|P1|COMPLETED|Overall Study||81
8398586|NCT01012947|20699386|P5|STARTED|Overall Study||236
8398587|NCT01012947|20699387|P4|STARTED|Overall Study||211
8398588|NCT01012947|20699388|P3|STARTED|Overall Study||241
8398589|NCT01012947|20699389|P2|STARTED|Overall Study||215
8398590|NCT01012947|20699390|P1|STARTED|Overall Study||212
8398591|NCT01012921|20699404|P2|NOT COMPLETED|Overall Study||13
8398592|NCT01012921|20699405|P1|NOT COMPLETED|Overall Study||10
8398593|NCT01012921|20699404|P2|COMPLETED|Overall Study||47
8398594|NCT01012921|20699405|P1|COMPLETED|Overall Study||47
8398595|NCT01012921|20699404|P2|STARTED|Overall Study||60
8398596|NCT01012921|20699405|P1|STARTED|Overall Study||57
8398597|NCT01012765|20699411|P6|NOT COMPLETED|Treatment Period 3||0
8398598|NCT01012765|20699412|P5|NOT COMPLETED|Treatment Period 3||0
8398599|NCT01012765|20699413|P4|NOT COMPLETED|Treatment Period 3||0
8398600|NCT01012765|20699414|P3|NOT COMPLETED|Treatment Period 3||0
8398601|NCT01012765|20699415|P2|NOT COMPLETED|Treatment Period 3||0
8398602|NCT01012765|20699416|P1|NOT COMPLETED|Treatment Period 3||0
8398603|NCT01012765|20699411|P6|COMPLETED|Treatment Period 3||24
8398604|NCT01012765|20699412|P5|COMPLETED|Treatment Period 3||18
8398605|NCT01012765|20699413|P4|COMPLETED|Treatment Period 3||15
8398606|NCT01012765|20699414|P3|COMPLETED|Treatment Period 3||18
8398607|NCT01012765|20699415|P2|COMPLETED|Treatment Period 3||19
8398608|NCT01012765|20699416|P1|COMPLETED|Treatment Period 3||16
8398609|NCT01012765|20699411|P6|STARTED|Treatment Period 3||24
8398610|NCT01012765|20699412|P5|STARTED|Treatment Period 3||18
8398611|NCT01012765|20699413|P4|STARTED|Treatment Period 3||15
8398612|NCT01012765|20699414|P3|STARTED|Treatment Period 3||18
8398613|NCT01012765|20699415|P2|STARTED|Treatment Period 3||19
8398614|NCT01012765|20699416|P1|STARTED|Treatment Period 3||16
8398615|NCT01012765|20699411|P6|NOT COMPLETED|Treatment Period 2||1
8398616|NCT01012765|20699412|P5|NOT COMPLETED|Treatment Period 2||1
8398617|NCT01012765|20699413|P4|NOT COMPLETED|Treatment Period 2||0
8398618|NCT01012765|20699414|P3|NOT COMPLETED|Treatment Period 2||3
8398619|NCT01012765|20699415|P2|NOT COMPLETED|Treatment Period 2||2
8398620|NCT01012765|20699416|P1|NOT COMPLETED|Treatment Period 2||1
8398621|NCT01012765|20699411|P6|COMPLETED|Treatment Period 2||24
8398622|NCT01012765|20699412|P5|COMPLETED|Treatment Period 2||18
8398623|NCT01012765|20699413|P4|COMPLETED|Treatment Period 2||15
8398624|NCT01012765|20699414|P3|COMPLETED|Treatment Period 2||18
8398625|NCT01012765|20699415|P2|COMPLETED|Treatment Period 2||19
8398626|NCT01012765|20699416|P1|COMPLETED|Treatment Period 2||16
8398627|NCT01012765|20699411|P6|STARTED|Treatment Period 2||25
8398628|NCT01012765|20699412|P5|STARTED|Treatment Period 2||19
8398629|NCT01012765|20699413|P4|STARTED|Treatment Period 2||15
8398630|NCT01012765|20699414|P3|STARTED|Treatment Period 2||21
8398631|NCT01012765|20699415|P2|STARTED|Treatment Period 2||21
8398632|NCT01012765|20699416|P1|STARTED|Treatment Period 2||17
8398633|NCT01012765|20699411|P6|NOT COMPLETED|Treatment Period 1||0
8398634|NCT01012765|20699412|P5|NOT COMPLETED|Treatment Period 1||3
8398635|NCT01012765|20699413|P4|NOT COMPLETED|Treatment Period 1||3
8398636|NCT01012765|20699414|P3|NOT COMPLETED|Treatment Period 1||2
8398637|NCT01012765|20699415|P2|NOT COMPLETED|Treatment Period 1||0
8398638|NCT01012765|20699416|P1|NOT COMPLETED|Treatment Period 1||3
8398639|NCT01012765|20699411|P6|COMPLETED|Treatment Period 1||25
8398640|NCT01012765|20699412|P5|COMPLETED|Treatment Period 1||19
8398641|NCT01012765|20699413|P4|COMPLETED|Treatment Period 1||15
8398642|NCT01012765|20699414|P3|COMPLETED|Treatment Period 1||21
8398643|NCT01012765|20699415|P2|COMPLETED|Treatment Period 1||21
8398644|NCT01012765|20699416|P1|COMPLETED|Treatment Period 1||17
8398645|NCT01012765|20699411|P6|STARTED|Treatment Period 1||25
8398646|NCT01012765|20699412|P5|STARTED|Treatment Period 1||22
8398647|NCT01012765|20699413|P4|STARTED|Treatment Period 1||18
8398648|NCT01012765|20699414|P3|STARTED|Treatment Period 1||23
8398649|NCT01012765|20699415|P2|STARTED|Treatment Period 1||21
8398650|NCT01012765|20699416|P1|STARTED|Treatment Period 1||20
8398651|NCT01012739|20699445|P4|NOT COMPLETED|Treatment Period 4||0
8398652|NCT01012739|20699446|P3|NOT COMPLETED|Treatment Period 4||0
8398653|NCT01012739|20699447|P2|NOT COMPLETED|Treatment Period 4||0
8398654|NCT01012739|20699448|P1|NOT COMPLETED|Treatment Period 4||0
8398655|NCT01012739|20699445|P4|COMPLETED|Treatment Period 4||7
8398656|NCT01012739|20699446|P3|COMPLETED|Treatment Period 4||9
8398657|NCT01012739|20699447|P2|COMPLETED|Treatment Period 4||8
8398658|NCT01012739|20699448|P1|COMPLETED|Treatment Period 4||9
8398659|NCT01012739|20699445|P4|STARTED|Treatment Period 4||7
8398660|NCT01012739|20699446|P3|STARTED|Treatment Period 4||9
8398661|NCT01012739|20699447|P2|STARTED|Treatment Period 4||8
8398662|NCT01012739|20699448|P1|STARTED|Treatment Period 4||9
8398663|NCT01012739|20699445|P4|NOT COMPLETED|Treatment Period 3||0
8398664|NCT01012739|20699446|P3|NOT COMPLETED|Treatment Period 3||0
8398665|NCT01012739|20699447|P2|NOT COMPLETED|Treatment Period 3||0
8398666|NCT01012739|20699448|P1|NOT COMPLETED|Treatment Period 3||0
8398667|NCT01012739|20699445|P4|COMPLETED|Treatment Period 3||7
8398668|NCT01012739|20699446|P3|COMPLETED|Treatment Period 3||9
8398669|NCT01012739|20699447|P2|COMPLETED|Treatment Period 3||8
8398670|NCT01012739|20699448|P1|COMPLETED|Treatment Period 3||9
8398671|NCT01012739|20699445|P4|STARTED|Treatment Period 3||7
8398672|NCT01012739|20699446|P3|STARTED|Treatment Period 3||9
8398673|NCT01012739|20699447|P2|STARTED|Treatment Period 3||8
8398674|NCT01012739|20699448|P1|STARTED|Treatment Period 3||9
8398675|NCT01012739|20699445|P4|NOT COMPLETED|Treatment Period 2||1
8398676|NCT01012739|20699446|P3|NOT COMPLETED|Treatment Period 2||0
8398677|NCT01012739|20699447|P2|NOT COMPLETED|Treatment Period 2||0
8398678|NCT01012739|20699448|P1|NOT COMPLETED|Treatment Period 2||0
8398679|NCT01012739|20699445|P4|COMPLETED|Treatment Period 2||7
8398680|NCT01012739|20699446|P3|COMPLETED|Treatment Period 2||9
8398681|NCT01012739|20699447|P2|COMPLETED|Treatment Period 2||8
8398682|NCT01012739|20699448|P1|COMPLETED|Treatment Period 2||9
8398683|NCT01012739|20699445|P4|STARTED|Treatment Period 2||8
8398684|NCT01012739|20699446|P3|STARTED|Treatment Period 2||9
8398685|NCT01012739|20699447|P2|STARTED|Treatment Period 2||8
8398686|NCT01012739|20699448|P1|STARTED|Treatment Period 2||9
8398687|NCT01012739|20699445|P4|NOT COMPLETED|Treatment Period 1||1
8398688|NCT01012739|20699446|P3|NOT COMPLETED|Treatment Period 1||0
8398689|NCT01012739|20699447|P2|NOT COMPLETED|Treatment Period 1||0
8398690|NCT01012739|20699448|P1|NOT COMPLETED|Treatment Period 1||0
8398691|NCT01012739|20699445|P4|COMPLETED|Treatment Period 1||8
8398692|NCT01012739|20699446|P3|COMPLETED|Treatment Period 1||9
8398693|NCT01012739|20699447|P2|COMPLETED|Treatment Period 1||8
8398694|NCT01012739|20699448|P1|COMPLETED|Treatment Period 1||9
8398695|NCT01012739|20699445|P4|STARTED|Treatment Period 1||9
8398696|NCT01012739|20699446|P3|STARTED|Treatment Period 1||9
8398697|NCT01012739|20699447|P2|STARTED|Treatment Period 1||8
8398698|NCT01012739|20699448|P1|STARTED|Treatment Period 1||9
8398699|NCT01012713|20699476|P1|NOT COMPLETED|Overall Study||3
8398700|NCT01012713|20699476|P1|COMPLETED|Overall Study||27
8398701|NCT01012713|20699476|P1|STARTED|Overall Study||30
8398702|NCT01012674|20699482|P1|NOT COMPLETED|Overall Study||24
8398703|NCT01012674|20699482|P1|COMPLETED|Overall Study||187
8398704|NCT01012674|20699482|P1|STARTED|Overall Study||211
8398705|NCT01012661|20699494|P1|NOT COMPLETED|Overall Study||0
8398706|NCT01012661|20699494|P1|COMPLETED|Overall Study||50
8398707|NCT01012661|20699494|P1|STARTED|Overall Study||50
8398708|NCT01012622|20699502|P1|NOT COMPLETED|Overall Study||31
8398709|NCT01012622|20699502|P1|COMPLETED|Overall Study||111
8398710|NCT01012622|20699502|P1|STARTED|Overall Study||142
8398711|NCT01012492|20699521|P1|NOT COMPLETED|Overall Study||0
8398712|NCT01012492|20699521|P1|COMPLETED|Overall Study||10
8398713|NCT01012492|20699521|P1|STARTED|Overall Study||10
8398714|NCT01012440|20699528|P1|NOT COMPLETED|Overall Study||2
8398715|NCT01012440|20699528|P1|COMPLETED|Overall Study||3
8398716|NCT01012440|20699528|P1|STARTED|Overall Study||5
8398717|NCT01012414|20699532|P1|NOT COMPLETED|Overall Study||10
8398718|NCT01012414|20699532|P1|COMPLETED|Overall Study|No subjects completed the study.|0
8398719|NCT01012414|20699532|P1|STARTED|Overall Study||10
8398720|NCT01012388|20699539|P1|NOT COMPLETED|Overall Study||0
8398721|NCT01012388|20699539|P1|COMPLETED|Overall Study||100
8398722|NCT01012388|20699539|P1|STARTED|Overall Study||100
8398723|NCT01012362|20699549|P5|NOT COMPLETED|Overall Study||0
8398724|NCT01012362|20699550|P4|NOT COMPLETED|Overall Study||0
8398725|NCT01012362|20699551|P3|NOT COMPLETED|Overall Study||0
8398726|NCT01012362|20699552|P2|NOT COMPLETED|Overall Study||0
8398727|NCT01012362|20699553|P1|NOT COMPLETED|Overall Study||0
8398728|NCT01012362|20699549|P5|COMPLETED|Overall Study||9
8398729|NCT01012362|20699550|P4|COMPLETED|Overall Study||4
8398730|NCT01012362|20699551|P3|COMPLETED|Overall Study||3
8398731|NCT01012362|20699552|P2|COMPLETED|Overall Study||6
8398732|NCT01012362|20699553|P1|COMPLETED|Overall Study||9
8398733|NCT01012362|20699549|P5|STARTED|Overall Study||9
8398734|NCT01012362|20699550|P4|STARTED|Overall Study||4
8398735|NCT01012362|20699551|P3|STARTED|Overall Study||3
8398736|NCT01012362|20699552|P2|STARTED|Overall Study||6
8398737|NCT01012362|20699553|P1|STARTED|Overall Study||9
8398738|NCT01012336|20699569|P1|NOT COMPLETED|Overall Study||0
8398739|NCT01012336|20699569|P1|COMPLETED|Overall Study||85
8398740|NCT01012336|20699569|P1|STARTED|Overall Study||85
8398741|NCT01012323|20699573|P1|NOT COMPLETED|Overall Study||1
8398742|NCT01012323|20699573|P1|COMPLETED|Overall Study||50
8398743|NCT01012323|20699573|P1|STARTED|Overall Study||51
8398744|NCT01012297|20699597|P2|NOT COMPLETED|Overall Study||0
8398745|NCT01012297|20699598|P1|NOT COMPLETED|Overall Study||0
8398746|NCT01012297|20699597|P2|COMPLETED|Overall Study||53
8398747|NCT01012297|20699598|P1|COMPLETED|Overall Study||54
8398748|NCT01012297|20699597|P2|STARTED|Overall Study||53
8398749|NCT01012297|20699598|P1|STARTED|Overall Study||54
8398750|NCT01012258|20699610|P1|NOT COMPLETED|Overall Study||66
8398751|NCT01012258|20699610|P1|COMPLETED|Overall Study||0
8398752|NCT01012258|20699610|P1|STARTED|Overall Study||66
8398756|NCT01012219|20699657|P1|NOT COMPLETED|Period 3||0
8398757|NCT01012219|20699657|P1|COMPLETED|Period 3||20
8398758|NCT01012219|20699657|P1|STARTED|Period 3|of the 36 who started Period 1|20
8398759|NCT01012219|20699657|P1|NOT COMPLETED|Period 2||1
8398760|NCT01012219|20699657|P1|COMPLETED|Period 2||34
8398761|NCT01012219|20699657|P1|STARTED|Period 2|Number who completed Period 1|35
8398762|NCT01012219|20699657|P1|NOT COMPLETED|Period 1||1
8398763|NCT01012219|20699657|P1|COMPLETED|Period 1||35
8398764|NCT01012219|20699657|P1|STARTED|Period 1|Number randomized|36
8398765|NCT01012167|20699667|P3|NOT COMPLETED|Overall Study||4
8398766|NCT01012167|20699668|P2|NOT COMPLETED|Overall Study||2
8398767|NCT01012167|20699669|P1|NOT COMPLETED|Overall Study||2
8398768|NCT01012167|20699667|P3|COMPLETED|Overall Study||17
8398769|NCT01012167|20699668|P2|COMPLETED|Overall Study||18
8398770|NCT01012167|20699669|P1|COMPLETED|Overall Study||15
8398771|NCT01012167|20699667|P3|Exposed to Study Drug|Overall Study||20
8398772|NCT01012167|20699668|P2|Exposed to Study Drug|Overall Study||20
8398773|NCT01012167|20699669|P1|Exposed to Study Drug|Overall Study||16
8398774|NCT01012167|20699667|P3|Withdrawn Prior to Study Drug Exposure|Overall Study||1
8398775|NCT01012167|20699668|P2|Withdrawn Prior to Study Drug Exposure|Overall Study||0
8398776|NCT01012167|20699669|P1|Withdrawn Prior to Study Drug Exposure|Overall Study||1
8398777|NCT01012167|20699667|P3|STARTED|Overall Study||21
8398778|NCT01012167|20699668|P2|STARTED|Overall Study||20
8398779|NCT01012167|20699669|P1|STARTED|Overall Study||17
8398780|NCT01012089|20699925|P1|NOT COMPLETED|Overall Study||0
8398781|NCT01012089|20699925|P1|COMPLETED|Overall Study||6
8398782|NCT01012089|20699925|P1|STARTED|Overall Study||6
8398783|NCT01012037|20699948|P3|NOT COMPLETED|Overall Study||10
8398784|NCT01012037|20699949|P2|NOT COMPLETED|Overall Study||16
8398785|NCT01012037|20699950|P1|NOT COMPLETED|Overall Study||1
8398786|NCT01012037|20699948|P3|COMPLETED|Overall Study||214
8398787|NCT01012037|20699949|P2|COMPLETED|Overall Study||207
8398788|NCT01012037|20699950|P1|COMPLETED|Overall Study||43
8398789|NCT01012037|20699948|P3|STARTED|Overall Study||224
8398790|NCT01012037|20699949|P2|STARTED|Overall Study||223
8398791|NCT01012037|20699950|P1|STARTED|Overall Study||44
8398792|NCT01011946|20699985|P1|NOT COMPLETED|Overall Study||3
8398793|NCT01011946|20699985|P1|COMPLETED|Overall Study||33
8398794|NCT01011946|20699985|P1|STARTED|Overall Study||36
8398795|NCT01011933|20699989|P1|NOT COMPLETED|Overall Study||4
8398796|NCT01011933|20699989|P1|COMPLETED|Overall Study|total eligible and evaluable|50
8398797|NCT01011933|20699989|P1|STARTED|Overall Study|total enrolled|54
8398798|NCT01011907|20700006|P2|NOT COMPLETED|Overall Study||15
8398799|NCT01011907|20700007|P1|NOT COMPLETED|Overall Study||14
8398800|NCT01011907|20700006|P2|COMPLETED|Overall Study||18
8398801|NCT01011907|20700007|P1|COMPLETED|Overall Study||17
8398802|NCT01011907|20700006|P2|STARTED|Overall Study||33
8398803|NCT01011907|20700007|P1|STARTED|Overall Study||31
8398804|NCT01011894|20700017|P1|NOT COMPLETED|Overall Study||0
8398805|NCT01011894|20700017|P1|COMPLETED|Overall Study||26
8398806|NCT01011894|20700017|P1|STARTED|Overall Study||26
8398807|NCT01011868|20700024|P3|NOT COMPLETED|After Week 78 Follow-up||44
8398808|NCT01011868|20700025|P2|NOT COMPLETED|After Week 78 Follow-up||38
8398809|NCT01011868|20700026|P1|NOT COMPLETED|After Week 78 Follow-up||52
8398810|NCT01011868|20700024|P3|COMPLETED|After Week 78 Follow-up||111
8398811|NCT01011868|20700025|P2|COMPLETED|After Week 78 Follow-up||131
8398812|NCT01011868|20700026|P1|COMPLETED|After Week 78 Follow-up||118
8398813|NCT01011868|20700024|P3|STARTED|After Week 78 Follow-up||155
8398814|NCT01011868|20700025|P2|STARTED|After Week 78 Follow-up||169
8398815|NCT01011868|20700026|P1|STARTED|After Week 78 Follow-up||170
8398816|NCT01011868|20700024|P3|NOT COMPLETED|After Week 18 Follow-up||26
8398817|NCT01011868|20700025|P2|NOT COMPLETED|After Week 18 Follow-up||16
8398818|NCT01011868|20700026|P1|NOT COMPLETED|After Week 18 Follow-up||23
8398819|NCT01011868|20700024|P3|COMPLETED|After Week 18 Follow-up||129
8398820|NCT01011868|20700025|P2|COMPLETED|After Week 18 Follow-up||153
8398821|NCT01011868|20700026|P1|COMPLETED|After Week 18 Follow-up||147
8398822|NCT01011868|20700024|P3|STARTED|After Week 18 Follow-up||155
8398823|NCT01011868|20700025|P2|STARTED|After Week 18 Follow-up||169
8398824|NCT01011868|20700026|P1|STARTED|After Week 18 Follow-up||170
8398825|NCT01011829|20700063|P2|NOT COMPLETED|Overall Study||9
8398826|NCT01011829|20700064|P1|NOT COMPLETED|Overall Study||4
8398827|NCT01011829|20700063|P2|COMPLETED|Overall Study||1
8398828|NCT01011829|20700064|P1|COMPLETED|Overall Study||6
8398829|NCT01011829|20700063|P2|STARTED|Overall Study||10
8398830|NCT01011829|20700064|P1|STARTED|Overall Study||10
8398831|NCT01011816|20700074|P2|NOT COMPLETED|78-Week Extended Follow-up||28
8398832|NCT01011816|20700075|P1|NOT COMPLETED|78-Week Extended Follow-up||72
8398833|NCT01011816|20700074|P2|COMPLETED|78-Week Extended Follow-up||26
8398834|NCT01011816|20700075|P1|COMPLETED|78-Week Extended Follow-up||85
8398835|NCT01011816|20700074|P2|STARTED|78-Week Extended Follow-up||54
8398836|NCT01011816|20700075|P1|STARTED|78-Week Extended Follow-up||157
8398837|NCT01011816|20700074|P2|NOT COMPLETED|26-Week Primary Endpoint||2
8398838|NCT01011816|20700075|P1|NOT COMPLETED|26-Week Primary Endpoint||7
8398839|NCT01011816|20700074|P2|COMPLETED|26-Week Primary Endpoint||54
8398840|NCT01011816|20700075|P1|COMPLETED|26-Week Primary Endpoint||157
8398841|NCT01011816|20700074|P2|STARTED|26-Week Primary Endpoint||56
8398842|NCT01011816|20700075|P1|STARTED|26-Week Primary Endpoint||164
8398843|NCT01011738|20700088|P3|NOT COMPLETED|Overall Study||17
8398844|NCT01011738|20700089|P2|NOT COMPLETED|Overall Study||294
8398845|NCT01011738|20700090|P1|NOT COMPLETED|Overall Study||324
8398846|NCT01011738|20700088|P3|COMPLETED|Overall Study||36
8398847|NCT01011738|20700089|P2|COMPLETED|Overall Study||618
8398848|NCT01011738|20700090|P1|COMPLETED|Overall Study||553
8398849|NCT01011738|20700088|P3|STARTED|Overall Study||53
8398850|NCT01011738|20700089|P2|STARTED|Overall Study||912
8398851|NCT01011738|20700090|P1|STARTED|Overall Study||877
8398852|NCT01011673|20700130|P2|NOT COMPLETED|24 Hour Follow-up||3
8398853|NCT01011673|20700131|P1|NOT COMPLETED|24 Hour Follow-up||3
8398854|NCT01011673|20700130|P2|COMPLETED|24 Hour Follow-up||57
8398855|NCT01011673|20700131|P1|COMPLETED|24 Hour Follow-up||57
8398856|NCT01011673|20700130|P2|STARTED|24 Hour Follow-up||60
8398857|NCT01011673|20700131|P1|STARTED|24 Hour Follow-up||60
8398858|NCT01011673|20700130|P2|NOT COMPLETED|Emergency Department Portion||0
8398859|NCT01011673|20700131|P1|NOT COMPLETED|Emergency Department Portion||0
8398860|NCT01011673|20700130|P2|COMPLETED|Emergency Department Portion||60
8398861|NCT01011673|20700131|P1|COMPLETED|Emergency Department Portion||60
8398862|NCT01011673|20700130|P2|STARTED|Emergency Department Portion||60
8398863|NCT01011673|20700131|P1|STARTED|Emergency Department Portion||60
8398864|NCT01011673|20700130|P2|NOT COMPLETED|Randomized||1
8398865|NCT01011673|20700131|P1|NOT COMPLETED|Randomized||2
8398866|NCT01011673|20700130|P2|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
8398867|NCT01011673|20700131|P1|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
8398868|NCT01011673|20700130|P2|STARTED|Randomized||61
8398869|NCT01011673|20700131|P1|STARTED|Randomized||62
8398870|NCT01011634|20700141|P2|NOT COMPLETED|Overall Study||1
8398871|NCT01011634|20700142|P1|NOT COMPLETED|Overall Study||0
8398872|NCT01011634|20700141|P2|COMPLETED|Overall Study||8
8398873|NCT01011634|20700142|P1|COMPLETED|Overall Study||9
8398874|NCT01011634|20700141|P2|STARTED|Overall Study||9
8398875|NCT01011634|20700142|P1|STARTED|Overall Study||9
8398876|NCT01011556|20700154|P4|NOT COMPLETED|Overall Study||13
8398877|NCT01011556|20700155|P3|NOT COMPLETED|Overall Study||10
8398878|NCT01011556|20700156|P2|NOT COMPLETED|Overall Study||8
8398879|NCT01011556|20700157|P1|NOT COMPLETED|Overall Study||6
8398880|NCT01011556|20700154|P4|COMPLETED|Overall Study||51
8398881|NCT01011556|20700155|P3|COMPLETED|Overall Study||45
8398882|NCT01011556|20700156|P2|COMPLETED|Overall Study||48
8398883|NCT01011556|20700157|P1|COMPLETED|Overall Study||52
8398884|NCT01011556|20700154|P4|Received at Least 1 Dose of Study Drug|Overall Study||64
8398885|NCT01011556|20700155|P3|Received at Least 1 Dose of Study Drug|Overall Study||54
8398886|NCT01011556|20700156|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
8398887|NCT01011556|20700157|P1|Received at Least 1 Dose of Study Drug|Overall Study||57
8398888|NCT01011556|20700154|P4|STARTED|Overall Study||64
8398889|NCT01011556|20700155|P3|STARTED|Overall Study||55
8398890|NCT01011556|20700156|P2|STARTED|Overall Study||56
8398891|NCT01011556|20700157|P1|STARTED|Overall Study||58
8398892|NCT01011465|20700235|P8|NOT COMPLETED|Overall Study||0
8398893|NCT01011465|20700236|P7|NOT COMPLETED|Overall Study||1
8398894|NCT01011465|20700237|P6|NOT COMPLETED|Overall Study||0
8398895|NCT01011465|20700238|P5|NOT COMPLETED|Overall Study||1
8398896|NCT01011465|20700239|P4|NOT COMPLETED|Overall Study||0
8398897|NCT01011465|20700240|P3|NOT COMPLETED|Overall Study||0
8398898|NCT01011465|20700241|P2|NOT COMPLETED|Overall Study||1
8398899|NCT01011465|20700242|P1|NOT COMPLETED|Overall Study||2
8398900|NCT01011465|20700235|P8|COMPLETED|Overall Study||32
8398901|NCT01011465|20700236|P7|COMPLETED|Overall Study||51
8398902|NCT01011465|20700237|P6|COMPLETED|Overall Study||29
8398903|NCT01011465|20700238|P5|COMPLETED|Overall Study||46
8398904|NCT01011465|20700239|P4|COMPLETED|Overall Study||18
8398905|NCT01011465|20700240|P3|COMPLETED|Overall Study||36
8398906|NCT01011465|20700241|P2|COMPLETED|Overall Study||19
8398907|NCT01011465|20700242|P1|COMPLETED|Overall Study||34
8398908|NCT01011465|20700235|P8|STARTED|Overall Study||32
8398909|NCT01011465|20700236|P7|STARTED|Overall Study||52
8398910|NCT01011465|20700237|P6|STARTED|Overall Study||29
8398911|NCT01011465|20700238|P5|STARTED|Overall Study||47
8398912|NCT01011465|20700239|P4|STARTED|Overall Study||18
8398913|NCT01011465|20700240|P3|STARTED|Overall Study||36
8398914|NCT01011465|20700241|P2|STARTED|Overall Study||20
8398915|NCT01011465|20700242|P1|STARTED|Overall Study||36
8398916|NCT01011439|20700270|P1|NOT COMPLETED|Overall Study||57
8398917|NCT01011439|20700270|P1|COMPLETED|Overall Study||15
8398918|NCT01011439|20700270|P1|STARTED|Overall Study||72
8398919|NCT01011413|20700282|P2|NOT COMPLETED|Overall Study||25
8398920|NCT01011413|20700283|P1|NOT COMPLETED|Overall Study||26
8398921|NCT01011413|20700282|P2|COMPLETED|Overall Study||299
8398922|NCT01011413|20700283|P1|COMPLETED|Overall Study||286
8398923|NCT01011413|20700282|P2|Lost to Follow-up Between Week 48 and 96|Overall Study||4
8398924|NCT01011413|20700283|P1|Lost to Follow-up Between Week 48 and 96|Overall Study||10
8398925|NCT01011413|20700282|P2|Withdrew Consent Between Week 48 and 96|Overall Study||6
8398926|NCT01011413|20700283|P1|Withdrew Consent Between Week 48 and 96|Overall Study||2
8398927|NCT01011413|20700282|P2|Died Between Week 48 and 96|Overall Study||3
8398928|NCT01011413|20700283|P1|Died Between Week 48 and 96|Overall Study||2
8398929|NCT01011413|20700282|P2|Attended w48 Visit|Overall Study||311
8398930|NCT01011413|20700283|P1|Attended w48 Visit|Overall Study||295
8398931|NCT01011413|20700282|P2|Withdrew Consent Before w48|Overall Study||3
8398932|NCT01011413|20700283|P1|Withdrew Consent Before w48|Overall Study||3
8398933|NCT01011413|20700282|P2|Lost to Follow up Before w48|Overall Study||4
8398934|NCT01011413|20700283|P1|Lost to Follow up Before w48|Overall Study||3
8398935|NCT01011413|20700282|P2|Died Before Week 48|Overall Study||2
8398936|NCT01011413|20700283|P1|Died Before Week 48|Overall Study||3
8398937|NCT01011413|20700282|P2|In Modified ITT|Overall Study||321
8398938|NCT01011413|20700283|P1|In Modified ITT|Overall Study||309
8398939|NCT01011413|20700282|P2|Did Not Start Study Drug|Overall Study||3
8398940|NCT01011413|20700283|P1|Did Not Start Study Drug|Overall Study||3
8398941|NCT01011413|20700282|P2|STARTED|Overall Study|324 randomised|324
8398942|NCT01011413|20700283|P1|STARTED|Overall Study|312 randomised|312
8398943|NCT01011387|20700307|P1|NOT COMPLETED|Overall Study||6
8398944|NCT01011387|20700307|P1|COMPLETED|Overall Study||10
8398945|NCT01011387|20700307|P1|STARTED|Overall Study||16
8398946|NCT01011335|20700315|P13|NOT COMPLETED|Overall Study||3
8398947|NCT01011335|20700316|P12|NOT COMPLETED|Overall Study||1
8398948|NCT01011335|20700317|P11|NOT COMPLETED|Overall Study||6
8398949|NCT01011335|20700318|P10|NOT COMPLETED|Overall Study||0
8398950|NCT01011335|20700319|P9|NOT COMPLETED|Overall Study||2
8398951|NCT01011335|20700320|P8|NOT COMPLETED|Overall Study||2
8398952|NCT01011335|20700321|P7|NOT COMPLETED|Overall Study||3
8398953|NCT01011335|20700322|P6|NOT COMPLETED|Overall Study||1
8398954|NCT01011335|20700323|P5|NOT COMPLETED|Overall Study||1
8398955|NCT01011335|20700324|P4|NOT COMPLETED|Overall Study||2
8398956|NCT01011335|20700325|P3|NOT COMPLETED|Overall Study||1
8398957|NCT01011335|20700326|P2|NOT COMPLETED|Overall Study||1
8398958|NCT01011335|20700327|P1|NOT COMPLETED|Overall Study||1
8398959|NCT01011335|20700315|P13|COMPLETED|Overall Study||19
8398960|NCT01011335|20700316|P12|COMPLETED|Overall Study||21
8398961|NCT01011335|20700317|P11|COMPLETED|Overall Study||6
8398962|NCT01011335|20700318|P10|COMPLETED|Overall Study||12
8398963|NCT01011335|20700319|P9|COMPLETED|Overall Study||10
8398964|NCT01011335|20700320|P8|COMPLETED|Overall Study||10
8398965|NCT01011335|20700321|P7|COMPLETED|Overall Study||9
8398966|NCT01011335|20700322|P6|COMPLETED|Overall Study||11
8398967|NCT01011335|20700323|P5|COMPLETED|Overall Study||12
8398968|NCT01011335|20700324|P4|COMPLETED|Overall Study||10
8398969|NCT01011335|20700325|P3|COMPLETED|Overall Study||11
8398970|NCT01011335|20700326|P2|COMPLETED|Overall Study||11
8398971|NCT01011335|20700327|P1|COMPLETED|Overall Study||10
8398972|NCT01011335|20700315|P13|STARTED|Overall Study||22
8398973|NCT01011335|20700316|P12|STARTED|Overall Study||22
8398974|NCT01011335|20700317|P11|STARTED|Overall Study||12
8398975|NCT01011335|20700318|P10|STARTED|Overall Study||12
8398976|NCT01011335|20700319|P9|STARTED|Overall Study||12
8398977|NCT01011335|20700320|P8|STARTED|Overall Study||12
8398978|NCT01011335|20700321|P7|STARTED|Overall Study||12
8398979|NCT01011335|20700322|P6|STARTED|Overall Study||12
8398980|NCT01011335|20700323|P5|STARTED|Overall Study||13
8398981|NCT01011335|20700324|P4|STARTED|Overall Study||12
8398982|NCT01011335|20700325|P3|STARTED|Overall Study||12
8398983|NCT01011335|20700326|P2|STARTED|Overall Study||12
8398984|NCT01011335|20700327|P1|STARTED|Overall Study||11
8398985|NCT01011309|20700367|P3|NOT COMPLETED|Overall Study||5
8398986|NCT01011309|20700368|P2|NOT COMPLETED|Overall Study||3
8398987|NCT01011309|20700369|P1|NOT COMPLETED|Overall Study||2
8398988|NCT01011309|20700367|P3|COMPLETED|Overall Study||16
8398989|NCT01011309|20700368|P2|COMPLETED|Overall Study||7
8398990|NCT01011309|20700369|P1|COMPLETED|Overall Study||12
8398991|NCT01011309|20700367|P3|STARTED|Overall Study||21
8398992|NCT01011309|20700368|P2|STARTED|Overall Study||10
8398993|NCT01011309|20700369|P1|STARTED|Overall Study||14
8398994|NCT01011283|20700385|P2|NOT COMPLETED|Overall Study||11
8398995|NCT01011283|20700386|P1|NOT COMPLETED|Overall Study||11
8398996|NCT01011283|20700385|P2|COMPLETED|Overall Study||2
8398997|NCT01011283|20700386|P1|COMPLETED|Overall Study||2
8398998|NCT01011283|20700385|P2|STARTED|Overall Study||13
8398999|NCT01011283|20700386|P1|STARTED|Overall Study||13
8399000|NCT01011218|20700398|P4|NOT COMPLETED|Overall Study||0
8399001|NCT01011218|20700399|P3|NOT COMPLETED|Overall Study||0
8399002|NCT01011218|20700400|P2|NOT COMPLETED|Overall Study||0
8399003|NCT01011218|20700401|P1|NOT COMPLETED|Overall Study||0
8399004|NCT01011218|20700398|P4|COMPLETED|Overall Study||26
8399005|NCT01011218|20700399|P3|COMPLETED|Overall Study||26
8399006|NCT01011218|20700400|P2|COMPLETED|Overall Study||9
8399007|NCT01011218|20700401|P1|COMPLETED|Overall Study||9
8399008|NCT01011218|20700398|P4|STARTED|Overall Study||26
8399009|NCT01011218|20700399|P3|STARTED|Overall Study||26
8399010|NCT01011218|20700400|P2|STARTED|Overall Study||9
8399011|NCT01011218|20700401|P1|STARTED|Overall Study||9
8399018|NCT01011153|20700435|P3|NOT COMPLETED|Overall Study||9
8399019|NCT01011153|20700436|P2|NOT COMPLETED|Overall Study||11
8399020|NCT01011153|20700437|P1|NOT COMPLETED|Overall Study||8
8399021|NCT01011153|20700435|P3|COMPLETED|Overall Study||45
8399022|NCT01011153|20700436|P2|COMPLETED|Overall Study||64
8399023|NCT01011153|20700437|P1|COMPLETED|Overall Study||46
8399024|NCT01011153|20700435|P3|STARTED|Overall Study||54
8399025|NCT01011153|20700436|P2|STARTED|Overall Study||75
8399026|NCT01011153|20700437|P1|STARTED|Overall Study||54
8399027|NCT01011075|20700455|P1|NOT COMPLETED|Overall Study||0
8399028|NCT01011075|20700455|P1|COMPLETED|Overall Study||34
8399029|NCT01011075|20700455|P1|STARTED|Overall Study||34
8399030|NCT01011049|20700466|P4|NOT COMPLETED|Overall Study||0
8399031|NCT01011049|20700467|P3|NOT COMPLETED|Overall Study||4
8399032|NCT01011049|20700468|P2|NOT COMPLETED|Overall Study||2
8399033|NCT01011049|20700469|P1|NOT COMPLETED|Overall Study||1
8399034|NCT01011049|20700466|P4|COMPLETED|Overall Study||246
8399035|NCT01011049|20700467|P3|COMPLETED|Overall Study||239
8399036|NCT01011049|20700468|P2|COMPLETED|Overall Study||250
8399037|NCT01011049|20700469|P1|COMPLETED|Overall Study||506
8399038|NCT01011049|20700466|P4|STARTED|Overall Study||246
8399039|NCT01011049|20700467|P3|STARTED|Overall Study||243
8399040|NCT01011049|20700468|P2|STARTED|Overall Study||252
8399041|NCT01011049|20700469|P1|STARTED|Overall Study||507
8399042|NCT01010984|20700491|P1|NOT COMPLETED|Overall Study||0
8399043|NCT01010984|20700491|P1|COMPLETED|Overall Study||20
8399044|NCT01010984|20700491|P1|STARTED|Overall Study||20
8399045|NCT01010971|20700499|P3|NOT COMPLETED|Overall Study||13
8399046|NCT01010971|20700500|P2|NOT COMPLETED|Overall Study||8
8399047|NCT01010971|20700501|P1|NOT COMPLETED|Overall Study||3
8399048|NCT01010971|20700499|P3|COMPLETED|Overall Study||207
8399049|NCT01010971|20700500|P2|COMPLETED|Overall Study||218
8399050|NCT01010971|20700501|P1|COMPLETED|Overall Study||222
8399051|NCT01010971|20700499|P3|STARTED|Overall Study||220
8399052|NCT01010971|20700500|P2|STARTED|Overall Study||226
8399053|NCT01010971|20700501|P1|STARTED|Overall Study||225
8399054|NCT01010932|20700586|P1|NOT COMPLETED|Overall Study||22
8399055|NCT01010932|20700586|P1|COMPLETED|Overall Study||200
8399056|NCT01010932|20700586|P1|STARTED|Overall Study||222
8399057|NCT01010906|20700604|P6|NOT COMPLETED|Overall Study||0
8399058|NCT01010906|20700605|P5|NOT COMPLETED|Overall Study||0
8399059|NCT01010906|20700606|P4|NOT COMPLETED|Overall Study||0
8399060|NCT01010906|20700607|P3|NOT COMPLETED|Overall Study||0
8399061|NCT01010906|20700608|P2|NOT COMPLETED|Overall Study||0
8399062|NCT01010906|20700609|P1|NOT COMPLETED|Overall Study||0
8399063|NCT01010906|20700604|P6|COMPLETED|Overall Study||10
8399064|NCT01010906|20700605|P5|COMPLETED|Overall Study||10
8399065|NCT01010906|20700606|P4|COMPLETED|Overall Study||10
8399066|NCT01010906|20700607|P3|COMPLETED|Overall Study||10
8399067|NCT01010906|20700608|P2|COMPLETED|Overall Study||10
8399068|NCT01010906|20700609|P1|COMPLETED|Overall Study||10
8399069|NCT01010906|20700604|P6|STARTED|Overall Study||10
8399070|NCT01010906|20700605|P5|STARTED|Overall Study||10
8399071|NCT01010906|20700606|P4|STARTED|Overall Study||10
8399072|NCT01010906|20700607|P3|STARTED|Overall Study||10
8399073|NCT01010906|20700608|P2|STARTED|Overall Study||10
8399074|NCT01010906|20700609|P1|STARTED|Overall Study||10
8399075|NCT01010867|20700629|P1|NOT COMPLETED|Overall Study||1
8399076|NCT01010867|20700629|P1|COMPLETED|Overall Study||30
8399077|NCT01010867|20700629|P1|STARTED|Overall Study||31
8399078|NCT01010854|20700636|P1|NOT COMPLETED|Overall Study||0
8399079|NCT01010854|20700636|P1|COMPLETED|Overall Study||6
8399080|NCT01010854|20700636|P1|STARTED|Overall Study||6
8399081|NCT01010776|20700641|P1|NOT COMPLETED|Extension Phase||3
8399082|NCT01010776|20700641|P1|COMPLETED|Extension Phase||156
8399083|NCT01010776|20700641|P1|STARTED|Extension Phase||159
8399084|NCT01010776|20700641|P1|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
8399085|NCT01010776|20700641|P1|COMPLETED|In-Between Main Phase & Extension Phase||159
8399086|NCT01010776|20700641|P1|STARTED|In-Between Main Phase & Extension Phase||174
8399087|NCT01010776|20700641|P1|NOT COMPLETED|Main Phase||49
8399088|NCT01010776|20700641|P1|COMPLETED|Main Phase||174
8399089|NCT01010776|20700641|P1|Treated|Main Phase||218
8399090|NCT01010776|20700641|P1|STARTED|Main Phase||223
8399091|NCT01010763|20700665|P2|NOT COMPLETED|Overall Study||30
8399092|NCT01010763|20700666|P1|NOT COMPLETED|Overall Study||35
8399093|NCT01010763|20700665|P2|COMPLETED|Overall Study||54
8399094|NCT01010763|20700666|P1|COMPLETED|Overall Study||61
8399095|NCT01010763|20700665|P2|STARTED|Overall Study||84
8399096|NCT01010763|20700666|P1|STARTED|Overall Study||96
8399151|NCT01010633|20700728|P2|NOT COMPLETED|Overall Study||5
8399152|NCT01010633|20700729|P1|NOT COMPLETED|Overall Study||4
8399153|NCT01010633|20700728|P2|COMPLETED|Overall Study||198
8399154|NCT01010633|20700729|P1|COMPLETED|Overall Study||199
8399155|NCT01010633|20700728|P2|STARTED|Overall Study||203
8399156|NCT01010633|20700729|P1|STARTED|Overall Study||203
8399157|NCT01010568|20700739|P1|NOT COMPLETED|Overall Study||5
8399158|NCT01010568|20700739|P1|COMPLETED|Overall Study||5
8399159|NCT01010568|20700739|P1|STARTED|Overall Study||10
8399160|NCT01010555|20700745|P2|NOT COMPLETED|Second Four Weeks of Wear||0
8399161|NCT01010555|20700746|P1|NOT COMPLETED|Second Four Weeks of Wear||0
8399162|NCT01010555|20700745|P2|COMPLETED|Second Four Weeks of Wear||9
8399163|NCT01010555|20700746|P1|COMPLETED|Second Four Weeks of Wear||10
8399164|NCT01010555|20700745|P2|STARTED|Second Four Weeks of Wear||9
8399165|NCT01010555|20700746|P1|STARTED|Second Four Weeks of Wear||10
8399166|NCT01010555|20700745|P2|NOT COMPLETED|First Four Weeks of Wear||0
8399167|NCT01010555|20700746|P1|NOT COMPLETED|First Four Weeks of Wear||0
8399168|NCT01010555|20700745|P2|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
8399169|NCT01010555|20700746|P1|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
8399170|NCT01010555|20700745|P2|STARTED|First Four Weeks of Wear||10
8399171|NCT01010555|20700746|P1|STARTED|First Four Weeks of Wear||11
8399172|NCT01010503|20700756|P1|NOT COMPLETED|Overall Study||2
8399173|NCT01010503|20700756|P1|COMPLETED|Overall Study||30
8399174|NCT01010503|20700756|P1|STARTED|Overall Study||32
8399175|NCT01010477|20700776|P2|NOT COMPLETED|Overall Study||3
8399176|NCT01010477|20700777|P1|NOT COMPLETED|Overall Study||6
8399177|NCT01010477|20700776|P2|COMPLETED|Overall Study||22
8399178|NCT01010477|20700777|P1|COMPLETED|Overall Study||21
8399179|NCT01010477|20700776|P2|STARTED|Overall Study||25
8399180|NCT01010477|20700777|P1|STARTED|Overall Study||27
8399181|NCT01010399|20700783|P1|NOT COMPLETED|Overall Study||5
8399182|NCT01010399|20700783|P1|COMPLETED|Overall Study||31
8399183|NCT01010399|20700783|P1|STARTED|Overall Study||36
8399184|NCT01010282|20700791|P3|NOT COMPLETED|Overall Study||19
8399185|NCT01010282|20700792|P2|NOT COMPLETED|Overall Study||7
8399186|NCT01010282|20700793|P1|NOT COMPLETED|Overall Study||6
8399187|NCT01010282|20700791|P3|COMPLETED|Overall Study||77
8399188|NCT01010282|20700792|P2|COMPLETED|Overall Study||88
8399189|NCT01010282|20700793|P1|COMPLETED|Overall Study||91
8399190|NCT01010282|20700791|P3|STARTED|Overall Study||96
8399191|NCT01010282|20700792|P2|STARTED|Overall Study||95
8399192|NCT01010282|20700793|P1|STARTED|Overall Study||97
8399193|NCT01010230|20700815|P2|NOT COMPLETED|Overall Study||7
8399194|NCT01010230|20700816|P1|NOT COMPLETED|Overall Study||10
8399195|NCT01010230|20700815|P2|COMPLETED|Overall Study||26
8399196|NCT01010230|20700816|P1|COMPLETED|Overall Study||22
8399197|NCT01010230|20700815|P2|STARTED|Overall Study||33
8399198|NCT01010230|20700816|P1|STARTED|Overall Study||32
8399199|NCT01010217|20700851|P5|NOT COMPLETED|Overall Study||3
8399200|NCT01010217|20700852|P4|NOT COMPLETED|Overall Study||6
8399201|NCT01010217|20700853|P3|NOT COMPLETED|Overall Study||1
8399202|NCT01010217|20700854|P2|NOT COMPLETED|Overall Study||5
8399203|NCT01010217|20700855|P1|NOT COMPLETED|Overall Study||5
8399204|NCT01010217|20700851|P5|COMPLETED|Overall Study||0
8399205|NCT01010217|20700852|P4|COMPLETED|Overall Study||0
8399206|NCT01010217|20700853|P3|COMPLETED|Overall Study||21
8399207|NCT01010217|20700854|P2|COMPLETED|Overall Study||51
8399208|NCT01010217|20700855|P1|COMPLETED|Overall Study||84
8399209|NCT01010217|20700851|P5|STARTED|Overall Study||3
8399210|NCT01010217|20700852|P4|STARTED|Overall Study||6
8399211|NCT01010217|20700853|P3|STARTED|Overall Study||22
8399212|NCT01010217|20700854|P2|STARTED|Overall Study||56
8399213|NCT01010217|20700855|P1|STARTED|Overall Study||89
8399214|NCT01010204|20700894|P2|NOT COMPLETED|Overall Study||9
8399215|NCT01010204|20700895|P1|NOT COMPLETED|Overall Study||7
8399216|NCT01010204|20700894|P2|COMPLETED|Overall Study||20
8399217|NCT01010204|20700895|P1|COMPLETED|Overall Study||24
8399218|NCT01010204|20700894|P2|STARTED|Overall Study||29
8399219|NCT01010204|20700895|P1|STARTED|Overall Study||31
8399220|NCT01010126|20700911|P6|NOT COMPLETED|Overall Study||0
8399221|NCT01010126|20700912|P5|NOT COMPLETED|Overall Study||3
8399222|NCT01010126|20700913|P4|NOT COMPLETED|Overall Study||0
8399223|NCT01010126|20700914|P3|NOT COMPLETED|Overall Study||1
8399224|NCT01010126|20700915|P2|NOT COMPLETED|Overall Study||0
8399225|NCT01010126|20700916|P1|NOT COMPLETED|Overall Study||1
8399226|NCT01010126|20700911|P6|COMPLETED|Overall Study||24
8399227|NCT01010126|20700912|P5|COMPLETED|Overall Study||55
8399228|NCT01010126|20700913|P4|COMPLETED|Overall Study||57
8399229|NCT01010126|20700914|P3|COMPLETED|Overall Study||27
8399230|NCT01010126|20700915|P2|COMPLETED|Overall Study||58
8399231|NCT01010126|20700916|P1|COMPLETED|Overall Study||26
8399232|NCT01010126|20700911|P6|STARTED|Overall Study||24
8399233|NCT01010126|20700912|P5|STARTED|Overall Study||58
8399234|NCT01010126|20700913|P4|STARTED|Overall Study||57
8399235|NCT01010126|20700914|P3|STARTED|Overall Study||28
8399236|NCT01010126|20700915|P2|STARTED|Overall Study||58
8399237|NCT01010126|20700916|P1|STARTED|Overall Study||27
8399238|NCT01010061|20700968|P2|NOT COMPLETED|Overall Study||40
8399239|NCT01010061|20700969|P1|NOT COMPLETED|Overall Study||48
8399240|NCT01010061|20700968|P2|COMPLETED|Overall Study||78
8399241|NCT01010061|20700969|P1|COMPLETED|Overall Study|Completed=Completed treatment.|190
8399242|NCT01010061|20700968|P2|Received Study Drug|Overall Study||116
8399243|NCT01010061|20700969|P1|Received Study Drug|Overall Study||236
8399244|NCT01010061|20700968|P2|STARTED|Overall Study||118
8399245|NCT01010061|20700969|P1|STARTED|Overall Study||238
8399246|NCT01010009|20701004|P3|NOT COMPLETED|Overall Study||0
8399247|NCT01010009|20701005|P2|NOT COMPLETED|Overall Study||0
8399248|NCT01010009|20701006|P1|NOT COMPLETED|Overall Study||0
8399249|NCT01010009|20701004|P3|COMPLETED|Overall Study||8
8399250|NCT01010009|20701005|P2|COMPLETED|Overall Study||8
8399251|NCT01010009|20701006|P1|COMPLETED|Overall Study||8
8399252|NCT01010009|20701004|P3|STARTED|Overall Study||8
8399253|NCT01010009|20701005|P2|STARTED|Overall Study||8
8399254|NCT01010009|20701006|P1|STARTED|Overall Study||8
8399255|NCT01009983|20701020|P1|NOT COMPLETED|Overall Study||1
8399256|NCT01009983|20701020|P1|COMPLETED|Overall Study||13
8399257|NCT01009983|20701020|P1|STARTED|Overall Study||14
8399258|NCT01009931|20701027|P1|NOT COMPLETED|Overall Study||1
8399259|NCT01009931|20701027|P1|COMPLETED|Overall Study||0
8399260|NCT01009931|20701027|P1|STARTED|Overall Study||1
8399261|NCT01009840|20701033|P1|NOT COMPLETED|Overall Study||14
8399262|NCT01009840|20701033|P1|COMPLETED|Overall Study||16
8399263|NCT01009840|20701033|P1|STARTED|Overall Study||30
8399264|NCT01009814|20701051|P5|NOT COMPLETED|Overall Study||0
8399265|NCT01009814|20701052|P4|NOT COMPLETED|Overall Study||0
8399266|NCT01009814|20701053|P3|NOT COMPLETED|Overall Study||0
8399267|NCT01009814|20701054|P2|NOT COMPLETED|Overall Study||1
8399268|NCT01009814|20701055|P1|NOT COMPLETED|Overall Study||1
8399269|NCT01009814|20701051|P5|COMPLETED|Overall Study||10
8399270|NCT01009814|20701052|P4|COMPLETED|Overall Study||10
8399271|NCT01009814|20701053|P3|COMPLETED|Overall Study||10
8399272|NCT01009814|20701054|P2|COMPLETED|Overall Study||9
8399273|NCT01009814|20701055|P1|COMPLETED|Overall Study||9
8399274|NCT01009814|20701051|P5|STARTED|Overall Study||10
8399275|NCT01009814|20701052|P4|STARTED|Overall Study||10
8399276|NCT01009814|20701053|P3|STARTED|Overall Study||10
8399277|NCT01009814|20701054|P2|STARTED|Overall Study||10
8399278|NCT01009814|20701055|P1|STARTED|Overall Study||10
8399279|NCT01009762|20701164|P2|NOT COMPLETED|Overall Study||0
8399280|NCT01009762|20701165|P1|NOT COMPLETED|Overall Study||0
8399281|NCT01009762|20701164|P2|COMPLETED|Overall Study|10 participants received vaccine|10
8399282|NCT01009762|20701165|P1|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
8399283|NCT01009762|20701164|P2|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
8399284|NCT01009762|20701165|P1|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
8399285|NCT01009762|20701164|P2|STARTED|Overall Study||10
8399286|NCT01009762|20701165|P1|STARTED|Overall Study||1
8399287|NCT01009645|20701179|P4|NOT COMPLETED|Overall Study||5
8399288|NCT01009645|20701180|P3|NOT COMPLETED|Overall Study||4
8399289|NCT01009645|20701181|P2|NOT COMPLETED|Overall Study||8
8399290|NCT01009645|20701182|P1|NOT COMPLETED|Overall Study||2
8399291|NCT01009645|20701179|P4|COMPLETED|Overall Study||26
8399292|NCT01009645|20701180|P3|COMPLETED|Overall Study||28
8399293|NCT01009645|20701181|P2|COMPLETED|Overall Study||23
8399294|NCT01009645|20701182|P1|COMPLETED|Overall Study||29
8399295|NCT01009645|20701179|P4|STARTED|Overall Study||31
8399296|NCT01009645|20701180|P3|STARTED|Overall Study||32
8399297|NCT01009645|20701181|P2|STARTED|Overall Study||31
8399298|NCT01009645|20701182|P1|STARTED|Overall Study||31
8399299|NCT01009619|20701198|P2|NOT COMPLETED|Overall Study||0
8399300|NCT01009619|20701199|P1|NOT COMPLETED|Overall Study||0
8399301|NCT01009619|20701198|P2|COMPLETED|Overall Study||43
8399302|NCT01009619|20701199|P1|COMPLETED|Overall Study||40
8399303|NCT01009619|20701198|P2|STARTED|Overall Study||43
8399304|NCT01009619|20701199|P1|STARTED|Overall Study||40
8399305|NCT01009580|20701219|P2|NOT COMPLETED|Overall Study||35
8399306|NCT01009580|20701220|P1|NOT COMPLETED|Overall Study||27
8399307|NCT01009580|20701219|P2|COMPLETED|Overall Study||188
8399308|NCT01009580|20701220|P1|COMPLETED|Overall Study||197
8399309|NCT01009580|20701219|P2|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
8399310|NCT01009580|20701220|P1|Exposed|Overall Study||224
8399311|NCT01009580|20701219|P2|STARTED|Overall Study||223
8399312|NCT01009580|20701220|P1|STARTED|Overall Study||224
8399313|NCT01009554|20701234|P2|NOT COMPLETED|Overall Study||7
8399314|NCT01009554|20701235|P1|NOT COMPLETED|Overall Study||2
8399315|NCT01009554|20701234|P2|COMPLETED|Overall Study||41
8399316|NCT01009554|20701235|P1|COMPLETED|Overall Study||46
8399317|NCT01009554|20701234|P2|STARTED|Overall Study||48
8399318|NCT01009554|20701235|P1|STARTED|Overall Study||48
8399319|NCT01009515|20701367|P1|NOT COMPLETED|Overall Study||3
8399320|NCT01009515|20701367|P1|COMPLETED|Overall Study||16
8399321|NCT01009515|20701367|P1|STARTED|Overall Study||19
8399322|NCT01009463|20701378|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||101
8399323|NCT01009463|20701379|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||91
8399324|NCT01009463|20701380|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||93
8399325|NCT01009463|20701381|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||115
8399326|NCT01009463|20701382|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
8399327|NCT01009463|20701378|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
8399328|NCT01009463|20701379|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
8399329|NCT01009463|20701380|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
8399330|NCT01009463|20701381|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
8399331|NCT01009463|20701382|P1|COMPLETED|52-week, Double-blind Treatment Period||0
8399332|NCT01009463|20701378|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
8399333|NCT01009463|20701379|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
8399334|NCT01009463|20701380|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
8399335|NCT01009463|20701381|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
8399336|NCT01009463|20701382|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
8399337|NCT01009463|20701378|P5|STARTED|52-week, Double-blind Treatment Period||402
8399338|NCT01009463|20701379|P4|STARTED|52-week, Double-blind Treatment Period||403
8399339|NCT01009463|20701380|P3|STARTED|52-week, Double-blind Treatment Period||408
8399340|NCT01009463|20701381|P2|STARTED|52-week, Double-blind Treatment Period||409
8399341|NCT01009463|20701382|P1|STARTED|52-week, Double-blind Treatment Period||0
8399342|NCT01009463|20701378|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
8399343|NCT01009463|20701379|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
8399344|NCT01009463|20701380|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
8399345|NCT01009463|20701381|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
8399346|NCT01009463|20701382|P1|NOT COMPLETED|4-week, Open-label Run-In Period||449
8399347|NCT01009463|20701378|P5|COMPLETED|4-week, Open-label Run-In Period||0
8399348|NCT01009463|20701379|P4|COMPLETED|4-week, Open-label Run-In Period||0
8399349|NCT01009463|20701380|P3|COMPLETED|4-week, Open-label Run-In Period||0
8399350|NCT01009463|20701381|P2|COMPLETED|4-week, Open-label Run-In Period||0
8399351|NCT01009463|20701382|P1|COMPLETED|4-week, Open-label Run-In Period||1622
8399352|NCT01009463|20701378|P5|STARTED|4-week, Open-label Run-In Period||0
8399353|NCT01009463|20701379|P4|STARTED|4-week, Open-label Run-In Period||0
8399354|NCT01009463|20701380|P3|STARTED|4-week, Open-label Run-In Period||0
8399355|NCT01009463|20701381|P2|STARTED|4-week, Open-label Run-In Period||0
8399356|NCT01009463|20701382|P1|STARTED|4-week, Open-label Run-In Period||2071
8399357|NCT01009346|20701404|P1|NOT COMPLETED|Overall Study||4
8399358|NCT01009346|20701404|P1|COMPLETED|Overall Study||5
8399359|NCT01009346|20701404|P1|STARTED|Overall Study||9
8399360|NCT01009333|20701409|P6|NOT COMPLETED|Week 3||0
8399361|NCT01009333|20701410|P5|NOT COMPLETED|Week 3||0
8399362|NCT01009333|20701411|P4|NOT COMPLETED|Week 3||0
8399363|NCT01009333|20701412|P3|NOT COMPLETED|Week 3||0
8399364|NCT01009333|20701413|P2|NOT COMPLETED|Week 3||0
8399365|NCT01009333|20701414|P1|NOT COMPLETED|Week 3||0
8399366|NCT01009333|20701409|P6|COMPLETED|Week 3||2
8399367|NCT01009333|20701410|P5|COMPLETED|Week 3||2
8399368|NCT01009333|20701411|P4|COMPLETED|Week 3||2
8399369|NCT01009333|20701412|P3|COMPLETED|Week 3||2
8399370|NCT01009333|20701413|P2|COMPLETED|Week 3||2
8399371|NCT01009333|20701414|P1|COMPLETED|Week 3||2
8399372|NCT01009333|20701409|P6|STARTED|Week 3||2
8399373|NCT01009333|20701410|P5|STARTED|Week 3||2
8399374|NCT01009333|20701411|P4|STARTED|Week 3||2
8399375|NCT01009333|20701412|P3|STARTED|Week 3||2
8399376|NCT01009333|20701413|P2|STARTED|Week 3||2
8399377|NCT01009333|20701414|P1|STARTED|Week 3||2
8399378|NCT01009333|20701409|P6|NOT COMPLETED|Week 2||0
8399379|NCT01009333|20701410|P5|NOT COMPLETED|Week 2||0
8399380|NCT01009333|20701411|P4|NOT COMPLETED|Week 2||0
8399381|NCT01009333|20701412|P3|NOT COMPLETED|Week 2||0
8399382|NCT01009333|20701413|P2|NOT COMPLETED|Week 2||0
8399383|NCT01009333|20701414|P1|NOT COMPLETED|Week 2||0
8399384|NCT01009333|20701409|P6|COMPLETED|Week 2||2
8399385|NCT01009333|20701410|P5|COMPLETED|Week 2||2
8399386|NCT01009333|20701411|P4|COMPLETED|Week 2||2
8399387|NCT01009333|20701412|P3|COMPLETED|Week 2||2
8399388|NCT01009333|20701413|P2|COMPLETED|Week 2||2
8399389|NCT01009333|20701414|P1|COMPLETED|Week 2||2
8399390|NCT01009333|20701409|P6|STARTED|Week 2||2
8399391|NCT01009333|20701410|P5|STARTED|Week 2||2
8399392|NCT01009333|20701411|P4|STARTED|Week 2||2
8399393|NCT01009333|20701412|P3|STARTED|Week 2||2
8399394|NCT01009333|20701413|P2|STARTED|Week 2||2
8399395|NCT01009333|20701414|P1|STARTED|Week 2||2
8399396|NCT01009333|20701409|P6|NOT COMPLETED|Week 1||0
8399397|NCT01009333|20701410|P5|NOT COMPLETED|Week 1||0
8399398|NCT01009333|20701411|P4|NOT COMPLETED|Week 1||0
8399399|NCT01009333|20701412|P3|NOT COMPLETED|Week 1||0
8399400|NCT01009333|20701413|P2|NOT COMPLETED|Week 1||0
8399401|NCT01009333|20701414|P1|NOT COMPLETED|Week 1||0
8399402|NCT01009333|20701409|P6|COMPLETED|Week 1||2
8399403|NCT01009333|20701410|P5|COMPLETED|Week 1||2
8399404|NCT01009333|20701411|P4|COMPLETED|Week 1||2
8399405|NCT01009333|20701412|P3|COMPLETED|Week 1||2
8399406|NCT01009333|20701413|P2|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
8399407|NCT01009333|20701414|P1|COMPLETED|Week 1||2
8399408|NCT01009333|20701409|P6|STARTED|Week 1||2
8399409|NCT01009333|20701410|P5|STARTED|Week 1||2
8399410|NCT01009333|20701411|P4|STARTED|Week 1||2
8399411|NCT01009333|20701412|P3|STARTED|Week 1||2
8399412|NCT01009333|20701413|P2|STARTED|Week 1||3
8399413|NCT01009333|20701414|P1|STARTED|Week 1||2
8399414|NCT01009294|20701428|P1|NOT COMPLETED|Overall Study||6
8399415|NCT01009294|20701428|P1|COMPLETED|Overall Study||0
8399416|NCT01009294|20701428|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
8399417|NCT01009294|20701428|P1|STARTED|Overall Study||6
8399418|NCT01009203|20701449|P1|NOT COMPLETED|Overall Study||7
8399419|NCT01009203|20701449|P1|COMPLETED|Overall Study||6
8399420|NCT01009203|20701449|P1|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
8399421|NCT01009203|20701449|P1|STARTED|Overall Study||13
8399422|NCT01009138|20701458|P2|NOT COMPLETED|Overall Study||20
8399423|NCT01009138|20701459|P1|NOT COMPLETED|Overall Study||13
8399424|NCT01009138|20701458|P2|COMPLETED|Overall Study||88
8399425|NCT01009138|20701459|P1|COMPLETED|Overall Study||93
8399426|NCT01009138|20701458|P2|STARTED|Overall Study||108
8399427|NCT01009138|20701459|P1|STARTED|Overall Study||106
8399428|NCT01009099|20701489|P2|NOT COMPLETED|Overall Study||4
8399429|NCT01009099|20701490|P1|NOT COMPLETED|Overall Study||5
8399430|NCT01009099|20701489|P2|COMPLETED|Overall Study||57
8399431|NCT01009099|20701490|P1|COMPLETED|Overall Study||53
8399432|NCT01009099|20701489|P2|STARTED|Overall Study||61
8399433|NCT01009099|20701490|P1|STARTED|Overall Study||58
8399434|NCT01009086|20701499|P3|NOT COMPLETED|Overall Study||34
8399435|NCT01009086|20701500|P2|NOT COMPLETED|Overall Study||47
8399436|NCT01009086|20701501|P1|NOT COMPLETED|Overall Study||44
8399437|NCT01009086|20701499|P3|COMPLETED|Overall Study||170
8399438|NCT01009086|20701500|P2|COMPLETED|Overall Study||158
8399439|NCT01009086|20701501|P1|COMPLETED|Overall Study||162
8399440|NCT01009086|20701499|P3|STARTED|Overall Study||204
8399441|NCT01009086|20701500|P2|STARTED|Overall Study||205
8399442|NCT01009086|20701501|P1|STARTED|Overall Study||206
8399443|NCT01009060|20701536|P2|NOT COMPLETED|Overall Study||5
8399444|NCT01009060|20701537|P1|NOT COMPLETED|Overall Study||4
8399445|NCT01009060|20701536|P2|COMPLETED|Overall Study||20
8399446|NCT01009060|20701537|P1|COMPLETED|Overall Study||21
8399447|NCT01009060|20701536|P2|STARTED|Overall Study||25
8399448|NCT01009060|20701537|P1|STARTED|Overall Study||25
8399449|NCT01009047|20701575|P2|NOT COMPLETED|Overall Study||26
8399450|NCT01009047|20701576|P1|NOT COMPLETED|Overall Study||28
8399451|NCT01009047|20701575|P2|COMPLETED|Overall Study||89
8399452|NCT01009047|20701576|P1|COMPLETED|Overall Study||85
8399453|NCT01009047|20701575|P2|STARTED|Overall Study||115
8399454|NCT01009047|20701576|P1|STARTED|Overall Study||113
8399455|NCT01009034|20701598|P1|NOT COMPLETED|Overall Study||4
8399456|NCT01009034|20701598|P1|COMPLETED|Overall Study||10
8399457|NCT01009034|20701598|P1|STARTED|Overall Study||14
8399458|NCT01008995|20701606|P4|NOT COMPLETED|After Controlled Period||1
8399459|NCT01008995|20701607|P3|NOT COMPLETED|After Controlled Period||2
8399460|NCT01008995|20701608|P2|NOT COMPLETED|After Controlled Period||0
8399461|NCT01008995|20701609|P1|NOT COMPLETED|After Controlled Period||0
8399462|NCT01008995|20701606|P4|COMPLETED|After Controlled Period||156
8399463|NCT01008995|20701607|P3|COMPLETED|After Controlled Period||156
8399464|NCT01008995|20701608|P2|COMPLETED|After Controlled Period||0
8399465|NCT01008995|20701609|P1|COMPLETED|After Controlled Period||0
8399466|NCT01008995|20701606|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
8399467|NCT01008995|20701607|P3|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
8399468|NCT01008995|20701608|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8399469|NCT01008995|20701609|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8399470|NCT01008995|20701606|P4|NOT COMPLETED|Controlled Period||0
8399471|NCT01008995|20701607|P3|NOT COMPLETED|Controlled Period||0
8399472|NCT01008995|20701608|P2|NOT COMPLETED|Controlled Period||3
8399473|NCT01008995|20701609|P1|NOT COMPLETED|Controlled Period||3
8399474|NCT01008995|20701606|P4|COMPLETED|Controlled Period||0
8399475|NCT01008995|20701607|P3|COMPLETED|Controlled Period||0
8399476|NCT01008995|20701608|P2|COMPLETED|Controlled Period||157
8399477|NCT01008995|20701609|P1|COMPLETED|Controlled Period||159
8399478|NCT01008995|20701606|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8399479|NCT01008995|20701607|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8399480|NCT01008995|20701608|P2|STARTED|Controlled Period||160
8399481|NCT01008995|20701609|P1|STARTED|Controlled Period||162
8399482|NCT01008969|20701621|P1|NOT COMPLETED|Overall Study||0
8399483|NCT01008969|20701621|P1|COMPLETED|Overall Study||10
8399484|NCT01008969|20701621|P1|STARTED|Overall Study||10
8399488|NCT01008904|20701633|P1|NOT COMPLETED|Overall Study||4
8399489|NCT01008904|20701633|P1|COMPLETED|Overall Study||25
8399490|NCT01008904|20701633|P1|STARTED|Overall Study||29
8399491|NCT01008748|20701638|P1|NOT COMPLETED|Overall Study||81
8399492|NCT01008748|20701638|P1|COMPLETED|Overall Study||119
8399493|NCT01008748|20701638|P1|Week 26|Overall Study||119
8399494|NCT01008748|20701638|P1|Week 3|Overall Study||168
8399495|NCT01008748|20701638|P1|Week 0|Overall Study||182
8399496|NCT01008748|20701638|P1|Baseline|Overall Study||188
8399497|NCT01008748|20701638|P1|STARTED|Overall Study||200
8399498|NCT01008722|20701652|P2|NOT COMPLETED|Overall Study||0
8399499|NCT01008722|20701653|P1|NOT COMPLETED|Overall Study||0
8399500|NCT01008722|20701652|P2|COMPLETED|Overall Study||71
8399501|NCT01008722|20701653|P1|COMPLETED|Overall Study||36
8399502|NCT01008722|20701652|P2|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
8399503|NCT01008722|20701653|P1|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
8399504|NCT01008696|20701663|P2|NOT COMPLETED|Overall Study||17
8399505|NCT01008696|20701664|P1|NOT COMPLETED|Overall Study||17
8399506|NCT01008696|20701663|P2|COMPLETED|Overall Study||92
8399507|NCT01008696|20701664|P1|COMPLETED|Overall Study||91
8399508|NCT01008696|20701663|P2|STARTED|Overall Study||109
8399509|NCT01008696|20701664|P1|STARTED|Overall Study||108
8399510|NCT01008618|20701674|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||38
8399511|NCT01008618|20701675|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||36
8399512|NCT01008618|20701676|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
8399513|NCT01008618|20701674|P3|COMPLETED|Period 2 (Double-Blind Period)||39
8399514|NCT01008618|20701675|P2|COMPLETED|Period 2 (Double-Blind Period)||37
8399515|NCT01008618|20701676|P1|COMPLETED|Period 2 (Double-Blind Period)||0
8399516|NCT01008618|20701674|P3|STARTED|Period 2 (Double-Blind Period)||77
8399517|NCT01008618|20701675|P2|STARTED|Period 2 (Double-Blind Period)||73
8399518|NCT01008618|20701676|P1|STARTED|Period 2 (Double-Blind Period)||0
8399519|NCT01008618|20701674|P3|NOT COMPLETED|Period 1 (Titration Period)||0
8399520|NCT01008618|20701675|P2|NOT COMPLETED|Period 1 (Titration Period)||0
8399521|NCT01008618|20701676|P1|NOT COMPLETED|Period 1 (Titration Period)||68
8399522|NCT01008618|20701674|P3|COMPLETED|Period 1 (Titration Period)||0
8399523|NCT01008618|20701675|P2|COMPLETED|Period 1 (Titration Period)||0
8399524|NCT01008618|20701676|P1|COMPLETED|Period 1 (Titration Period)||150
8399525|NCT01008618|20701674|P3|STARTED|Period 1 (Titration Period)||0
8399526|NCT01008618|20701675|P2|STARTED|Period 1 (Titration Period)||0
8399527|NCT01008618|20701676|P1|STARTED|Period 1 (Titration Period)||218
8399528|NCT01008605|20701701|P1|NOT COMPLETED|Overall Study||0
8399529|NCT01008605|20701701|P1|COMPLETED|Overall Study||48
8399530|NCT01008605|20701701|P1|STARTED|Overall Study||48
8399531|NCT01008553|20701725|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||51
8399532|NCT01008553|20701726|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||37
8399533|NCT01008553|20701727|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
8399534|NCT01008553|20701725|P3|COMPLETED|Period 2 (Double-Blind Period)||28
8399535|NCT01008553|20701726|P2|COMPLETED|Period 2 (Double-Blind Period)||47
8399536|NCT01008553|20701727|P1|COMPLETED|Period 2 (Double-Blind Period)||0
8399537|NCT01008553|20701725|P3|STARTED|Period 2 (Double-Blind Period)||79
8399538|NCT01008553|20701726|P2|STARTED|Period 2 (Double-Blind Period)||84
8399539|NCT01008553|20701727|P1|STARTED|Period 2 (Double-Blind Period)||0
8399540|NCT01008553|20701725|P3|NOT COMPLETED|Period 1 (Titration Period)||0
8399541|NCT01008553|20701726|P2|NOT COMPLETED|Period 1 (Titration Period)||0
8399542|NCT01008553|20701727|P1|NOT COMPLETED|Period 1 (Titration Period)||95
8399543|NCT01008553|20701725|P3|COMPLETED|Period 1 (Titration Period)||0
8399544|NCT01008553|20701726|P2|COMPLETED|Period 1 (Titration Period)||0
8399545|NCT01008553|20701727|P1|COMPLETED|Period 1 (Titration Period)||163
8399546|NCT01008553|20701725|P3|STARTED|Period 1 (Titration Period)||0
8399547|NCT01008553|20701726|P2|STARTED|Period 1 (Titration Period)||0
8399548|NCT01008553|20701727|P1|STARTED|Period 1 (Titration Period)||258
8399549|NCT01008475|20701759|P7|NOT COMPLETED|Overall Study||4
8399550|NCT01008475|20701760|P6|NOT COMPLETED|Overall Study||6
8399551|NCT01008475|20701761|P5|NOT COMPLETED|Overall Study||5
8399552|NCT01008475|20701762|P4|NOT COMPLETED|Overall Study||0
8399553|NCT01008475|20701763|P3|NOT COMPLETED|Overall Study||0
8399554|NCT01008475|20701764|P2|NOT COMPLETED|Overall Study||0
8399555|NCT01008475|20701765|P1|NOT COMPLETED|Overall Study||0
8399556|NCT01008475|20701759|P7|COMPLETED|Overall Study||67
8399557|NCT01008475|20701760|P6|COMPLETED|Overall Study||67
8399558|NCT01008475|20701761|P5|COMPLETED|Overall Study||67
8399559|NCT01008475|20701762|P4|COMPLETED|Overall Study||3
8399560|NCT01008475|20701763|P3|COMPLETED|Overall Study||7
8399561|NCT01008475|20701764|P2|COMPLETED|Overall Study||3
8399562|NCT01008475|20701765|P1|COMPLETED|Overall Study||3
8399563|NCT01008475|20701759|P7|Safety Analysis Set|Overall Study||69
8399564|NCT01008475|20701760|P6|Safety Analysis Set|Overall Study||72
8399565|NCT01008475|20701761|P5|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
8399566|NCT01008475|20701762|P4|Safety Analysis Set|Overall Study||3
8399567|NCT01008475|20701763|P3|Safety Analysis Set|Overall Study||7
8399568|NCT01008475|20701764|P2|Safety Analysis Set|Overall Study||3
8399569|NCT01008475|20701765|P1|Safety Analysis Set|Overall Study||3
8399570|NCT01008475|20701759|P7|STARTED|Overall Study||71
8399571|NCT01008475|20701760|P6|STARTED|Overall Study||73
8399572|NCT01008475|20701761|P5|STARTED|Overall Study||72
8399573|NCT01008475|20701762|P4|STARTED|Overall Study||3
8399574|NCT01008475|20701763|P3|STARTED|Overall Study||7
8399575|NCT01008475|20701764|P2|STARTED|Overall Study||3
8399576|NCT01008475|20701765|P1|STARTED|Overall Study||3
8399577|NCT01008462|20701793|P1|NOT COMPLETED|Overall Study||0
8399578|NCT01008462|20701793|P1|COMPLETED|Overall Study||16
8399579|NCT01008462|20701793|P1|STARTED|Overall Study||16
8399580|NCT01008449|20701805|P2|NOT COMPLETED|Overall Study||19
8399581|NCT01008449|20701806|P1|NOT COMPLETED|Overall Study||29
8399582|NCT01008449|20701805|P2|COMPLETED|Overall Study||179
8399583|NCT01008449|20701806|P1|COMPLETED|Overall Study||171
8399584|NCT01008449|20701805|P2|STARTED|Overall Study||198
8399585|NCT01008449|20701806|P1|STARTED|Overall Study||200
8399586|NCT01008423|20701828|P2|NOT COMPLETED|Overall Study||22
8399587|NCT01008423|20701829|P1|NOT COMPLETED|Overall Study||19
8399588|NCT01008423|20701828|P2|COMPLETED|Overall Study||125
8399589|NCT01008423|20701829|P1|COMPLETED|Overall Study||115
8399590|NCT01008423|20701828|P2|Received at Least 1 Dose of Study Drug|Overall Study||147
8399591|NCT01008423|20701829|P1|Received at Least 1 Dose of Study Drug|Overall Study||134
8399592|NCT01008423|20701828|P2|STARTED|Overall Study||147
8399593|NCT01008423|20701829|P1|STARTED|Overall Study||134
8399594|NCT01008410|20701855|P2|NOT COMPLETED|Overall Study||16
8399595|NCT01008410|20701856|P1|NOT COMPLETED|Overall Study||25
8399596|NCT01008410|20701855|P2|COMPLETED|Overall Study||116
8399597|NCT01008410|20701856|P1|COMPLETED|Overall Study||108
8399598|NCT01008410|20701855|P2|Received at Least 1 Dose of Study Drug|Overall Study||132
8399599|NCT01008410|20701856|P1|Received at Least 1 Dose of Study Drug|Overall Study||133
8399600|NCT01008410|20701855|P2|STARTED|Overall Study||132
8399601|NCT01008410|20701856|P1|STARTED|Overall Study||133
8399602|NCT01008319|20701882|P2|NOT COMPLETED|Overall Study||0
8399603|NCT01008319|20701883|P1|NOT COMPLETED|Overall Study||0
8399604|NCT01008319|20701882|P2|COMPLETED|Overall Study||60
8399605|NCT01008319|20701883|P1|COMPLETED|Overall Study||60
8399606|NCT01008319|20701882|P2|STARTED|Overall Study||60
8399607|NCT01008319|20701883|P1|STARTED|Overall Study||60
8399608|NCT01008280|20701895|P2|NOT COMPLETED|Overall Study||19
8399609|NCT01008280|20701896|P1|NOT COMPLETED|Overall Study||21
8399610|NCT01008280|20701895|P2|COMPLETED|Overall Study||73
8399611|NCT01008280|20701896|P1|COMPLETED|Overall Study||67
8399612|NCT01008280|20701895|P2|STARTED|Overall Study||92
8399613|NCT01008280|20701896|P1|STARTED|Overall Study||88
8399614|NCT01008150|20701910|P4|NOT COMPLETED|Overall Study||0
8399615|NCT01008150|20701911|P3|NOT COMPLETED|Overall Study||1
8399616|NCT01008150|20701912|P2|NOT COMPLETED|Overall Study||1
8399617|NCT01008150|20701913|P1|NOT COMPLETED|Overall Study||1
8399618|NCT01008150|20701910|P4|COMPLETED|Overall Study||12
8399619|NCT01008150|20701911|P3|COMPLETED|Overall Study||42
8399620|NCT01008150|20701912|P2|COMPLETED|Overall Study||42
8399621|NCT01008150|20701913|P1|COMPLETED|Overall Study||42
8399622|NCT01008150|20701910|P4|STARTED|Overall Study||12
8399623|NCT01008150|20701911|P3|STARTED|Overall Study||43
8399624|NCT01008150|20701912|P2|STARTED|Overall Study||43
8399625|NCT01008150|20701913|P1|STARTED|Overall Study||43
8399626|NCT01008059|20701943|P8|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399627|NCT01008059|20701944|P7|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399628|NCT01008059|20701945|P6|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399629|NCT01008059|20701946|P5|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399630|NCT01008059|20701947|P4|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399631|NCT01008059|20701948|P3|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399632|NCT01008059|20701949|P2|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399633|NCT01008059|20701950|P1|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399634|NCT01008059|20701943|P8|COMPLETED|Ketoconazole Simultaneous Alfentanil||6
8399635|NCT01008059|20701944|P7|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399636|NCT01008059|20701945|P6|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399637|NCT01008059|20701946|P5|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399638|NCT01008059|20701947|P4|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399639|NCT01008059|20701948|P3|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399640|NCT01008059|20701949|P2|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399641|NCT01008059|20701950|P1|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
8399642|NCT01008059|20701943|P8|STARTED|Ketoconazole Simultaneous Alfentanil||6
8399643|NCT01008059|20701944|P7|STARTED|Ketoconazole Simultaneous Alfentanil||0
8399644|NCT01008059|20701945|P6|STARTED|Ketoconazole Simultaneous Alfentanil||0
8399645|NCT01008059|20701946|P5|STARTED|Ketoconazole Simultaneous Alfentanil||0
8399646|NCT01008059|20701947|P4|STARTED|Ketoconazole Simultaneous Alfentanil||0
8399647|NCT01008059|20701948|P3|STARTED|Ketoconazole Simultaneous Alfentanil||0
8399648|NCT01008059|20701949|P2|STARTED|Ketoconazole Simultaneous Alfentanil||0
8399649|NCT01008059|20701950|P1|STARTED|Ketoconazole Simultaneous Alfentanil||0
8399650|NCT01008059|20701943|P8|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399651|NCT01008059|20701944|P7|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399652|NCT01008059|20701945|P6|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399653|NCT01008059|20701946|P5|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399654|NCT01008059|20701947|P4|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399655|NCT01008059|20701948|P3|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399656|NCT01008059|20701949|P2|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399657|NCT01008059|20701950|P1|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399658|NCT01008059|20701943|P8|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399659|NCT01008059|20701944|P7|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6
8399660|NCT01008059|20701945|P6|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399661|NCT01008059|20701946|P5|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399662|NCT01008059|20701947|P4|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399663|NCT01008059|20701948|P3|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399664|NCT01008059|20701949|P2|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399665|NCT01008059|20701950|P1|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
8399666|NCT01008059|20701943|P8|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8399667|NCT01008059|20701944|P7|STARTED|Grapefruit Juice Simultaneous Alfentanil||6
8399668|NCT01008059|20701945|P6|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8399669|NCT01008059|20701946|P5|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8399670|NCT01008059|20701947|P4|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8399671|NCT01008059|20701948|P3|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8399672|NCT01008059|20701949|P2|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8399673|NCT01008059|20701950|P1|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
8399674|NCT01008059|20701943|P8|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399675|NCT01008059|20701944|P7|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399676|NCT01008059|20701945|P6|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399677|NCT01008059|20701946|P5|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399678|NCT01008059|20701947|P4|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399679|NCT01008059|20701948|P3|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399680|NCT01008059|20701949|P2|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399681|NCT01008059|20701950|P1|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
8399682|NCT01008059|20701943|P8|COMPLETED|Rifampin Simultaneous Alfentanil||0
8399683|NCT01008059|20701944|P7|COMPLETED|Rifampin Simultaneous Alfentanil||0
8399684|NCT01008059|20701945|P6|COMPLETED|Rifampin Simultaneous Alfentanil||6
8399685|NCT01008059|20701946|P5|COMPLETED|Rifampin Simultaneous Alfentanil||0
8399686|NCT01008059|20701947|P4|COMPLETED|Rifampin Simultaneous Alfentanil||0
8399687|NCT01008059|20701948|P3|COMPLETED|Rifampin Simultaneous Alfentanil||0
8399688|NCT01008059|20701949|P2|COMPLETED|Rifampin Simultaneous Alfentanil||0
8399689|NCT01008059|20701950|P1|COMPLETED|Rifampin Simultaneous Alfentanil||0
8399690|NCT01008059|20701943|P8|STARTED|Rifampin Simultaneous Alfentanil||0
8399691|NCT01008059|20701944|P7|STARTED|Rifampin Simultaneous Alfentanil||0
8399692|NCT01008059|20701945|P6|STARTED|Rifampin Simultaneous Alfentanil||6
8399693|NCT01008059|20701946|P5|STARTED|Rifampin Simultaneous Alfentanil||0
8399694|NCT01008059|20701947|P4|STARTED|Rifampin Simultaneous Alfentanil||0
8399695|NCT01008059|20701948|P3|STARTED|Rifampin Simultaneous Alfentanil||0
8399696|NCT01008059|20701949|P2|STARTED|Rifampin Simultaneous Alfentanil||0
8399697|NCT01008059|20701950|P1|STARTED|Rifampin Simultaneous Alfentanil||0
8399698|NCT01008059|20701943|P8|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399699|NCT01008059|20701944|P7|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399700|NCT01008059|20701945|P6|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399701|NCT01008059|20701946|P5|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399702|NCT01008059|20701947|P4|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399703|NCT01008059|20701948|P3|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399704|NCT01008059|20701949|P2|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399705|NCT01008059|20701950|P1|NOT COMPLETED|Control Simultaneous Alfentanil||0
8399706|NCT01008059|20701943|P8|COMPLETED|Control Simultaneous Alfentanil||0
8399707|NCT01008059|20701944|P7|COMPLETED|Control Simultaneous Alfentanil||0
8399708|NCT01008059|20701945|P6|COMPLETED|Control Simultaneous Alfentanil||0
8399709|NCT01008059|20701946|P5|COMPLETED|Control Simultaneous Alfentanil||6
8399710|NCT01008059|20701947|P4|COMPLETED|Control Simultaneous Alfentanil||0
8399711|NCT01008059|20701948|P3|COMPLETED|Control Simultaneous Alfentanil||0
8399712|NCT01008059|20701949|P2|COMPLETED|Control Simultaneous Alfentanil||0
8399713|NCT01008059|20701950|P1|COMPLETED|Control Simultaneous Alfentanil||0
8399714|NCT01008059|20701943|P8|STARTED|Control Simultaneous Alfentanil||0
8399715|NCT01008059|20701944|P7|STARTED|Control Simultaneous Alfentanil||0
8399716|NCT01008059|20701945|P6|STARTED|Control Simultaneous Alfentanil||0
8399717|NCT01008059|20701946|P5|STARTED|Control Simultaneous Alfentanil||6
8399718|NCT01008059|20701947|P4|STARTED|Control Simultaneous Alfentanil||0
8399719|NCT01008059|20701948|P3|STARTED|Control Simultaneous Alfentanil||0
8399720|NCT01008059|20701949|P2|STARTED|Control Simultaneous Alfentanil||0
8399721|NCT01008059|20701950|P1|STARTED|Control Simultaneous Alfentanil||0
8399722|NCT01008059|20701943|P8|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399723|NCT01008059|20701944|P7|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399724|NCT01008059|20701945|P6|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399725|NCT01008059|20701946|P5|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399726|NCT01008059|20701947|P4|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399727|NCT01008059|20701948|P3|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399728|NCT01008059|20701949|P2|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399729|NCT01008059|20701950|P1|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
8399730|NCT01008059|20701943|P8|COMPLETED|Ketoconazole Sequential Alfentanil||0
8399731|NCT01008059|20701944|P7|COMPLETED|Ketoconazole Sequential Alfentanil||0
8399732|NCT01008059|20701945|P6|COMPLETED|Ketoconazole Sequential Alfentanil||0
8399733|NCT01008059|20701946|P5|COMPLETED|Ketoconazole Sequential Alfentanil||0
8399734|NCT01008059|20701947|P4|COMPLETED|Ketoconazole Sequential Alfentanil||6
8399735|NCT01008059|20701948|P3|COMPLETED|Ketoconazole Sequential Alfentanil||0
8399736|NCT01008059|20701949|P2|COMPLETED|Ketoconazole Sequential Alfentanil||0
8399737|NCT01008059|20701950|P1|COMPLETED|Ketoconazole Sequential Alfentanil||0
8399738|NCT01008059|20701943|P8|STARTED|Ketoconazole Sequential Alfentanil||0
8399739|NCT01008059|20701944|P7|STARTED|Ketoconazole Sequential Alfentanil||0
8399740|NCT01008059|20701945|P6|STARTED|Ketoconazole Sequential Alfentanil||0
8399741|NCT01008059|20701946|P5|STARTED|Ketoconazole Sequential Alfentanil||0
8399742|NCT01008059|20701947|P4|STARTED|Ketoconazole Sequential Alfentanil||6
8399743|NCT01008059|20701948|P3|STARTED|Ketoconazole Sequential Alfentanil||0
8399744|NCT01008059|20701949|P2|STARTED|Ketoconazole Sequential Alfentanil||0
8399745|NCT01008059|20701950|P1|STARTED|Ketoconazole Sequential Alfentanil||0
8399746|NCT01008059|20701943|P8|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399747|NCT01008059|20701944|P7|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399748|NCT01008059|20701945|P6|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399749|NCT01008059|20701946|P5|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399750|NCT01008059|20701947|P4|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399751|NCT01008059|20701948|P3|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399752|NCT01008059|20701949|P2|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399753|NCT01008059|20701950|P1|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399754|NCT01008059|20701943|P8|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399755|NCT01008059|20701944|P7|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399756|NCT01008059|20701945|P6|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399757|NCT01008059|20701946|P5|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399758|NCT01008059|20701947|P4|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399759|NCT01008059|20701948|P3|COMPLETED|Grapefruit Juice Sequential Alfentanil||6
8399760|NCT01008059|20701949|P2|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399761|NCT01008059|20701950|P1|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
8399762|NCT01008059|20701943|P8|STARTED|Grapefruit Juice Sequential Alfentanil||0
8399763|NCT01008059|20701944|P7|STARTED|Grapefruit Juice Sequential Alfentanil||0
8399764|NCT01008059|20701945|P6|STARTED|Grapefruit Juice Sequential Alfentanil||0
8399765|NCT01008059|20701946|P5|STARTED|Grapefruit Juice Sequential Alfentanil||0
8399766|NCT01008059|20701947|P4|STARTED|Grapefruit Juice Sequential Alfentanil||0
8399767|NCT01008059|20701948|P3|STARTED|Grapefruit Juice Sequential Alfentanil||6
8399768|NCT01008059|20701949|P2|STARTED|Grapefruit Juice Sequential Alfentanil||0
8399769|NCT01008059|20701950|P1|STARTED|Grapefruit Juice Sequential Alfentanil||0
8399770|NCT01008059|20701943|P8|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399771|NCT01008059|20701944|P7|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399772|NCT01008059|20701945|P6|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399773|NCT01008059|20701946|P5|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399774|NCT01008059|20701947|P4|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399775|NCT01008059|20701948|P3|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399776|NCT01008059|20701949|P2|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399777|NCT01008059|20701950|P1|NOT COMPLETED|Rifampin Sequential Alfentanil||0
8399778|NCT01008059|20701943|P8|COMPLETED|Rifampin Sequential Alfentanil||0
8399779|NCT01008059|20701944|P7|COMPLETED|Rifampin Sequential Alfentanil||0
8399780|NCT01008059|20701945|P6|COMPLETED|Rifampin Sequential Alfentanil||0
8399781|NCT01008059|20701946|P5|COMPLETED|Rifampin Sequential Alfentanil||0
8399782|NCT01008059|20701947|P4|COMPLETED|Rifampin Sequential Alfentanil||0
8399783|NCT01008059|20701948|P3|COMPLETED|Rifampin Sequential Alfentanil||0
8399784|NCT01008059|20701949|P2|COMPLETED|Rifampin Sequential Alfentanil||6
8399785|NCT01008059|20701950|P1|COMPLETED|Rifampin Sequential Alfentanil||0
8399786|NCT01008059|20701943|P8|STARTED|Rifampin Sequential Alfentanil||0
8399787|NCT01008059|20701944|P7|STARTED|Rifampin Sequential Alfentanil||0
8399788|NCT01008059|20701945|P6|STARTED|Rifampin Sequential Alfentanil||0
8399789|NCT01008059|20701946|P5|STARTED|Rifampin Sequential Alfentanil||0
8399790|NCT01008059|20701947|P4|STARTED|Rifampin Sequential Alfentanil||0
8399791|NCT01008059|20701948|P3|STARTED|Rifampin Sequential Alfentanil||0
8399792|NCT01008059|20701949|P2|STARTED|Rifampin Sequential Alfentanil||6
8399793|NCT01008059|20701950|P1|STARTED|Rifampin Sequential Alfentanil||0
8399794|NCT01008059|20701943|P8|NOT COMPLETED|Control Sequential Alfentanil||0
8399795|NCT01008059|20701944|P7|NOT COMPLETED|Control Sequential Alfentanil||0
8399796|NCT01008059|20701945|P6|NOT COMPLETED|Control Sequential Alfentanil||0
8399797|NCT01008059|20701946|P5|NOT COMPLETED|Control Sequential Alfentanil||0
8399798|NCT01008059|20701947|P4|NOT COMPLETED|Control Sequential Alfentanil||0
8399799|NCT01008059|20701948|P3|NOT COMPLETED|Control Sequential Alfentanil||0
8399800|NCT01008059|20701949|P2|NOT COMPLETED|Control Sequential Alfentanil||0
8399801|NCT01008059|20701950|P1|NOT COMPLETED|Control Sequential Alfentanil||0
8399802|NCT01008059|20701943|P8|COMPLETED|Control Sequential Alfentanil||0
8399803|NCT01008059|20701944|P7|COMPLETED|Control Sequential Alfentanil||0
8399804|NCT01008059|20701945|P6|COMPLETED|Control Sequential Alfentanil||0
8399805|NCT01008059|20701946|P5|COMPLETED|Control Sequential Alfentanil||0
8399806|NCT01008059|20701947|P4|COMPLETED|Control Sequential Alfentanil||0
8399807|NCT01008059|20701948|P3|COMPLETED|Control Sequential Alfentanil||0
8399808|NCT01008059|20701949|P2|COMPLETED|Control Sequential Alfentanil||0
8399809|NCT01008059|20701950|P1|COMPLETED|Control Sequential Alfentanil||6
8399810|NCT01008059|20701943|P8|STARTED|Control Sequential Alfentanil||0
8399811|NCT01008059|20701944|P7|STARTED|Control Sequential Alfentanil||0
8399812|NCT01008059|20701945|P6|STARTED|Control Sequential Alfentanil||0
8399813|NCT01008059|20701946|P5|STARTED|Control Sequential Alfentanil||0
8399814|NCT01008059|20701947|P4|STARTED|Control Sequential Alfentanil||0
8399815|NCT01008059|20701948|P3|STARTED|Control Sequential Alfentanil||0
8399816|NCT01008059|20701949|P2|STARTED|Control Sequential Alfentanil||0
8399817|NCT01008059|20701950|P1|STARTED|Control Sequential Alfentanil||6
8399818|NCT01007916|20701961|P2|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
8399819|NCT01007916|20701962|P1|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
8399820|NCT01007916|20701961|P2|COMPLETED|Period 2, 4 Weeks of Wear||25
8399821|NCT01007916|20701962|P1|COMPLETED|Period 2, 4 Weeks of Wear||21
8399822|NCT01007916|20701961|P2|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
8399823|NCT01007916|20701962|P1|STARTED|Period 2, 4 Weeks of Wear||22
8399824|NCT01007916|20701961|P2|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
8399825|NCT01007916|20701962|P1|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
8399826|NCT01007916|20701961|P2|COMPLETED|Period 1, 4 Weeks of Wear||26
8399827|NCT01007916|20701962|P1|COMPLETED|Period 1, 4 Weeks of Wear||22
8399828|NCT01007916|20701961|P2|STARTED|Period 1, 4 Weeks of Wear||26
8399829|NCT01007916|20701962|P1|STARTED|Period 1, 4 Weeks of Wear||23
8399830|NCT01007942|20701970|P2|NOT COMPLETED|Overall Study||278
8399831|NCT01007942|20701971|P1|NOT COMPLETED|Overall Study||281
8399832|NCT01007942|20701970|P2|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
8399833|NCT01007942|20701971|P1|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
8399834|NCT01007942|20701970|P2|STARTED|Overall Study||285
8399835|NCT01007942|20701971|P1|STARTED|Overall Study||284
8399836|NCT01007838|20701997|P4|NOT COMPLETED|Overall Study||0
8399837|NCT01007838|20701998|P3|NOT COMPLETED|Overall Study||0
8399838|NCT01007838|20701999|P2|NOT COMPLETED|Overall Study||0
8399839|NCT01007838|20702000|P1|NOT COMPLETED|Overall Study||3
8399840|NCT01007838|20701997|P4|COMPLETED|Overall Study||4
8399841|NCT01007838|20701998|P3|COMPLETED|Overall Study||5
8399842|NCT01007838|20701999|P2|COMPLETED|Overall Study||11
8399843|NCT01007838|20702000|P1|COMPLETED|Overall Study||9
8399844|NCT01007838|20701997|P4|STARTED|Overall Study||4
8399845|NCT01007838|20701998|P3|STARTED|Overall Study||5
8399846|NCT01007838|20701999|P2|STARTED|Overall Study||11
8399847|NCT01007838|20702000|P1|STARTED|Overall Study||12
8399848|NCT01007812|20702010|P2|NOT COMPLETED|Period 2, One Week||0
8399849|NCT01007812|20702011|P1|NOT COMPLETED|Period 2, One Week||0
8399850|NCT01007812|20702010|P2|COMPLETED|Period 2, One Week||24
8399851|NCT01007812|20702011|P1|COMPLETED|Period 2, One Week||24
8399852|NCT01007812|20702010|P2|STARTED|Period 2, One Week||24
8399853|NCT01007812|20702011|P1|STARTED|Period 2, One Week||24
8399854|NCT01007812|20702010|P2|NOT COMPLETED|Period 1, One Week||1
8399855|NCT01007812|20702011|P1|NOT COMPLETED|Period 1, One Week||1
8399856|NCT01007812|20702010|P2|COMPLETED|Period 1, One Week||24
8399857|NCT01007812|20702011|P1|COMPLETED|Period 1, One Week||24
8399858|NCT01007812|20702010|P2|STARTED|Period 1, One Week||25
8399859|NCT01007812|20702011|P1|STARTED|Period 1, One Week||25
8399860|NCT01007656|20702017|P1|NOT COMPLETED|Overall Study||0
8399861|NCT01007656|20702017|P1|COMPLETED|Overall Study||31
8399862|NCT01007656|20702017|P1|STARTED|Overall Study||31
8399863|NCT01007643|20702037|P2|NOT COMPLETED|Overall Study||0
8399864|NCT01007643|20702038|P1|NOT COMPLETED|Overall Study||0
8399865|NCT01007643|20702037|P2|COMPLETED|Overall Study||14
8399866|NCT01007643|20702038|P1|COMPLETED|Overall Study||8
8399867|NCT01007643|20702037|P2|STARTED|Overall Study||14
8399868|NCT01007643|20702038|P1|STARTED|Overall Study||8
8399869|NCT01007591|20702046|P2|NOT COMPLETED|Overall Study||1
8399870|NCT01007591|20702047|P1|NOT COMPLETED|Overall Study||1
8399871|NCT01007591|20702046|P2|COMPLETED|Overall Study||12
8399872|NCT01007591|20702047|P1|COMPLETED|Overall Study||26
8399873|NCT01007591|20702046|P2|STARTED|Overall Study||13
8399874|NCT01007591|20702047|P1|STARTED|Overall Study||27
8399875|NCT01007552|20702061|P1|NOT COMPLETED|Overall Study||1
8399876|NCT01007552|20702061|P1|COMPLETED|Overall Study||49
8399877|NCT01007552|20702061|P1|STARTED|Overall Study||50
8399878|NCT01007526|20702071|P1|NOT COMPLETED|Overall Study||0
8399879|NCT01007526|20702071|P1|COMPLETED|Overall Study||31
8399880|NCT01007526|20702071|P1|STARTED|Overall Study||31
8399881|NCT01007448|20702077|P2|NOT COMPLETED|Overall Study||9
8399882|NCT01007448|20702078|P1|NOT COMPLETED|Overall Study||10
8399883|NCT01007448|20702077|P2|COMPLETED|Overall Study||20
8399884|NCT01007448|20702078|P1|COMPLETED|Overall Study||20
8399885|NCT01007448|20702077|P2|Safety Population|Overall Study||29
8399886|NCT01007448|20702078|P1|Safety Population|Overall Study||30
8399887|NCT01007448|20702077|P2|Full Analysis Population|Overall Study||29
8399888|NCT01007448|20702078|P1|Full Analysis Population|Overall Study||30
8399889|NCT01007448|20702077|P2|STARTED|Overall Study||29
8399890|NCT01007448|20702078|P1|STARTED|Overall Study||30
8399891|NCT01007435|20702110|P4|NOT COMPLETED|Overall Study||56
8399892|NCT01007435|20702111|P3|NOT COMPLETED|Overall Study||64
8399893|NCT01007435|20702112|P2|NOT COMPLETED|Overall Study||59
8399894|NCT01007435|20702113|P1|NOT COMPLETED|Overall Study||63
8399895|NCT01007435|20702110|P4|COMPLETED|Overall Study||236
8399896|NCT01007435|20702111|P3|COMPLETED|Overall Study||227
8399897|NCT01007435|20702112|P2|COMPLETED|Overall Study||231
8399898|NCT01007435|20702113|P1|COMPLETED|Overall Study||226
8399899|NCT01007435|20702110|P4|STARTED|Overall Study||292
8399900|NCT01007435|20702111|P3|STARTED|Overall Study||291
8399901|NCT01007435|20702112|P2|STARTED|Overall Study||290
8399902|NCT01007435|20702113|P1|STARTED|Overall Study||289
8399903|NCT01007396|20702155|P1|NOT COMPLETED|Overall Study||47
8399904|NCT01007396|20702155|P1|COMPLETED|Overall Study||275
8399905|NCT01007396|20702155|P1|STARTED|Overall Study||322
8399906|NCT01007253|20702160|P4|NOT COMPLETED|Fourth Intervention||0
8399907|NCT01007253|20702161|P3|NOT COMPLETED|Fourth Intervention||0
8399908|NCT01007253|20702162|P2|NOT COMPLETED|Fourth Intervention||0
8399909|NCT01007253|20702163|P1|NOT COMPLETED|Fourth Intervention||0
8399910|NCT01007253|20702160|P4|COMPLETED|Fourth Intervention||5
8399911|NCT01007253|20702161|P3|COMPLETED|Fourth Intervention||5
8399912|NCT01007253|20702162|P2|COMPLETED|Fourth Intervention||5
8399913|NCT01007253|20702163|P1|COMPLETED|Fourth Intervention||5
8399914|NCT01007253|20702160|P4|STARTED|Fourth Intervention||5
8399915|NCT01007253|20702161|P3|STARTED|Fourth Intervention||5
8399916|NCT01007253|20702162|P2|STARTED|Fourth Intervention||5
8399917|NCT01007253|20702163|P1|STARTED|Fourth Intervention||5
8399918|NCT01007253|20702160|P4|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
8399919|NCT01007253|20702161|P3|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
8399920|NCT01007253|20702162|P2|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
8399921|NCT01007253|20702163|P1|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
8399922|NCT01007253|20702160|P4|COMPLETED|Washout Period (2 Weeks) # 3||5
8399923|NCT01007253|20702161|P3|COMPLETED|Washout Period (2 Weeks) # 3||5
8399924|NCT01007253|20702162|P2|COMPLETED|Washout Period (2 Weeks) # 3||5
8399925|NCT01007253|20702163|P1|COMPLETED|Washout Period (2 Weeks) # 3||5
8399926|NCT01007253|20702160|P4|STARTED|Washout Period (2 Weeks) # 3||5
8399927|NCT01007253|20702161|P3|STARTED|Washout Period (2 Weeks) # 3||5
8399928|NCT01007253|20702162|P2|STARTED|Washout Period (2 Weeks) # 3||5
8399929|NCT01007253|20702163|P1|STARTED|Washout Period (2 Weeks) # 3||6
8399930|NCT01007253|20702160|P4|NOT COMPLETED|Third Intervention||0
8399931|NCT01007253|20702161|P3|NOT COMPLETED|Third Intervention||0
8399932|NCT01007253|20702162|P2|NOT COMPLETED|Third Intervention||0
8399933|NCT01007253|20702163|P1|NOT COMPLETED|Third Intervention||0
8399934|NCT01007253|20702160|P4|COMPLETED|Third Intervention||5
8399935|NCT01007253|20702161|P3|COMPLETED|Third Intervention||5
8399936|NCT01007253|20702162|P2|COMPLETED|Third Intervention||5
8399937|NCT01007253|20702163|P1|COMPLETED|Third Intervention||6
8399938|NCT01007253|20702160|P4|STARTED|Third Intervention||5
8399939|NCT01007253|20702161|P3|STARTED|Third Intervention||5
8399940|NCT01007253|20702162|P2|STARTED|Third Intervention||5
8399941|NCT01007253|20702163|P1|STARTED|Third Intervention||6
8399942|NCT01007253|20702160|P4|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
8399943|NCT01007253|20702161|P3|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
8399944|NCT01007253|20702162|P2|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
8399945|NCT01007253|20702163|P1|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
8399946|NCT01007253|20702160|P4|COMPLETED|Washout Period (2 Weeks) # 2||5
8399947|NCT01007253|20702161|P3|COMPLETED|Washout Period (2 Weeks) # 2||5
8399948|NCT01007253|20702162|P2|COMPLETED|Washout Period (2 Weeks) # 2||5
8399949|NCT01007253|20702163|P1|COMPLETED|Washout Period (2 Weeks) # 2||6
8399950|NCT01007253|20702160|P4|STARTED|Washout Period (2 Weeks) # 2||5
8399951|NCT01007253|20702161|P3|STARTED|Washout Period (2 Weeks) # 2||5
8399952|NCT01007253|20702162|P2|STARTED|Washout Period (2 Weeks) # 2||5
8399953|NCT01007253|20702163|P1|STARTED|Washout Period (2 Weeks) # 2||6
8399954|NCT01007253|20702160|P4|NOT COMPLETED|Second Intervention||0
8399955|NCT01007253|20702161|P3|NOT COMPLETED|Second Intervention||0
8399956|NCT01007253|20702162|P2|NOT COMPLETED|Second Intervention||0
8399957|NCT01007253|20702163|P1|NOT COMPLETED|Second Intervention||0
8399958|NCT01007253|20702160|P4|COMPLETED|Second Intervention||5
8399959|NCT01007253|20702161|P3|COMPLETED|Second Intervention||5
8399960|NCT01007253|20702162|P2|COMPLETED|Second Intervention||5
8399961|NCT01007253|20702163|P1|COMPLETED|Second Intervention||6
8399962|NCT01007253|20702160|P4|STARTED|Second Intervention||5
8399963|NCT01007253|20702161|P3|STARTED|Second Intervention||5
8399964|NCT01007253|20702162|P2|STARTED|Second Intervention||5
8399965|NCT01007253|20702163|P1|STARTED|Second Intervention||6
8399966|NCT01007253|20702160|P4|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
8399967|NCT01007253|20702161|P3|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
8399968|NCT01007253|20702162|P2|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
8399969|NCT01007253|20702163|P1|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
8399970|NCT01007253|20702160|P4|COMPLETED|Washout Period (2 Weeks) # 1||5
8399971|NCT01007253|20702161|P3|COMPLETED|Washout Period (2 Weeks) # 1||5
8399972|NCT01007253|20702162|P2|COMPLETED|Washout Period (2 Weeks) # 1||5
8399973|NCT01007253|20702163|P1|COMPLETED|Washout Period (2 Weeks) # 1||6
8399974|NCT01007253|20702160|P4|STARTED|Washout Period (2 Weeks) # 1||5
8399975|NCT01007253|20702161|P3|STARTED|Washout Period (2 Weeks) # 1||5
8399976|NCT01007253|20702162|P2|STARTED|Washout Period (2 Weeks) # 1||5
8399977|NCT01007253|20702163|P1|STARTED|Washout Period (2 Weeks) # 1||6
8399978|NCT01007253|20702160|P4|NOT COMPLETED|First Intervention||0
8399979|NCT01007253|20702161|P3|NOT COMPLETED|First Intervention||0
8399980|NCT01007253|20702162|P2|NOT COMPLETED|First Intervention||0
8399981|NCT01007253|20702163|P1|NOT COMPLETED|First Intervention||0
8399982|NCT01007253|20702160|P4|COMPLETED|First Intervention||5
8399983|NCT01007253|20702161|P3|COMPLETED|First Intervention||5
8399984|NCT01007253|20702162|P2|COMPLETED|First Intervention||5
8399985|NCT01007253|20702163|P1|COMPLETED|First Intervention||6
8399986|NCT01007253|20702160|P4|STARTED|First Intervention||5
8399987|NCT01007253|20702161|P3|STARTED|First Intervention||5
8399988|NCT01007253|20702162|P2|STARTED|First Intervention||5
8399989|NCT01007253|20702163|P1|STARTED|First Intervention||6
8399990|NCT01007149|20702195|P2|NOT COMPLETED|Overall Study||1
8399991|NCT01007149|20702196|P1|NOT COMPLETED|Overall Study||0
8399992|NCT01007149|20702195|P2|COMPLETED|Overall Study||20
8399993|NCT01007149|20702196|P1|COMPLETED|Overall Study||20
8399994|NCT01007149|20702195|P2|STARTED|Overall Study||21
8399995|NCT01007149|20702196|P1|STARTED|Overall Study||20
8399996|NCT01007136|20702223|P5|NOT COMPLETED|Overall Study||0
8399997|NCT01007136|20702224|P4|NOT COMPLETED|Overall Study||0
8399998|NCT01007136|20702225|P3|NOT COMPLETED|Overall Study||0
8399999|NCT01007136|20702226|P2|NOT COMPLETED|Overall Study||4
8400000|NCT01007136|20702227|P1|NOT COMPLETED|Overall Study||4
8400001|NCT01007136|20702223|P5|COMPLETED|Overall Study||4
8400002|NCT01007136|20702224|P4|COMPLETED|Overall Study||6
8400003|NCT01007136|20702225|P3|COMPLETED|Overall Study||15
8400004|NCT01007136|20702226|P2|COMPLETED|Overall Study||13
8400005|NCT01007136|20702227|P1|COMPLETED|Overall Study||15
8400006|NCT01007136|20702223|P5|STARTED|Overall Study||4
8400007|NCT01007136|20702224|P4|STARTED|Overall Study||6
8400008|NCT01007136|20702225|P3|STARTED|Overall Study||15
8400009|NCT01007136|20702226|P2|STARTED|Overall Study|One additional subject was excluded prior to randomization due to illicit drug use.|17
8400010|NCT01007136|20702227|P1|STARTED|Overall Study||19
8400011|NCT01007123|20702270|P4|NOT COMPLETED|Overall Study||6
8400012|NCT01007123|20702271|P3|NOT COMPLETED|Overall Study||11
8400013|NCT01007123|20702272|P2|NOT COMPLETED|Overall Study||6
8400014|NCT01007123|20702273|P1|NOT COMPLETED|Overall Study||6
8400015|NCT01007123|20702270|P4|COMPLETED|Overall Study||41
8400016|NCT01007123|20702271|P3|COMPLETED|Overall Study||37
8400017|NCT01007123|20702272|P2|COMPLETED|Overall Study||41
8400018|NCT01007123|20702273|P1|COMPLETED|Overall Study||42
8400019|NCT01007123|20702270|P4|STARTED|Overall Study||47
8400020|NCT01007123|20702271|P3|STARTED|Overall Study||48
8400021|NCT01007123|20702272|P2|STARTED|Overall Study||47
8400022|NCT01007123|20702273|P1|STARTED|Overall Study||48
8400023|NCT01007110|20702304|P2|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
8400024|NCT01007110|20702305|P1|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
8400025|NCT01007110|20702304|P2|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
8400026|NCT01007110|20702305|P1|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
8400027|NCT01007110|20702304|P2|STARTED|Neonatal Behavioral Assessment Scale (NB||20
8400028|NCT01007110|20702305|P1|STARTED|Neonatal Behavioral Assessment Scale (NB||24
8400029|NCT01007110|20702304|P2|NOT COMPLETED|Follow-Up at 36 Weeks||2
8400030|NCT01007110|20702305|P1|NOT COMPLETED|Follow-Up at 36 Weeks||0
8400031|NCT01007110|20702304|P2|COMPLETED|Follow-Up at 36 Weeks||20
8400032|NCT01007110|20702305|P1|COMPLETED|Follow-Up at 36 Weeks||24
8400033|NCT01007110|20702304|P2|STARTED|Follow-Up at 36 Weeks||22
8400034|NCT01007110|20702305|P1|STARTED|Follow-Up at 36 Weeks||24
8400035|NCT01007110|20702304|P2|NOT COMPLETED|Follow-Up at 32 Weeks||1
8400036|NCT01007110|20702305|P1|NOT COMPLETED|Follow-Up at 32 Weeks||1
8400037|NCT01007110|20702304|P2|COMPLETED|Follow-Up at 32 Weeks||22
8400038|NCT01007110|20702305|P1|COMPLETED|Follow-Up at 32 Weeks||24
8400039|NCT01007110|20702304|P2|STARTED|Follow-Up at 32 Weeks||23
8400040|NCT01007110|20702305|P1|STARTED|Follow-Up at 32 Weeks||25
8400041|NCT01007110|20702304|P2|NOT COMPLETED|Follow-Up at 24 Weeks||4
8400042|NCT01007110|20702305|P1|NOT COMPLETED|Follow-Up at 24 Weeks||0
8400043|NCT01007110|20702304|P2|COMPLETED|Follow-Up at 24 Weeks||23
8400044|NCT01007110|20702305|P1|COMPLETED|Follow-Up at 24 Weeks||25
8400045|NCT01007110|20702304|P2|STARTED|Follow-Up at 24 Weeks||27
8400046|NCT01007110|20702305|P1|STARTED|Follow-Up at 24 Weeks||25
8400047|NCT01007110|20702304|P2|NOT COMPLETED|Allocation||8
8400048|NCT01007110|20702305|P1|NOT COMPLETED|Allocation||7
8400049|NCT01007110|20702304|P2|COMPLETED|Allocation||27
8400050|NCT01007110|20702305|P1|COMPLETED|Allocation||25
8400051|NCT01007110|20702304|P2|STARTED|Allocation||35
8400052|NCT01007110|20702305|P1|STARTED|Allocation||32
8400053|NCT01007071|20702321|P2|NOT COMPLETED|Overall Study||0
8400054|NCT01007071|20702322|P1|NOT COMPLETED|Overall Study||0
8400055|NCT01007071|20702321|P2|COMPLETED|Overall Study||5
8400056|NCT01007071|20702322|P1|COMPLETED|Overall Study||6
8400057|NCT01007071|20702321|P2|STARTED|Overall Study||5
8400058|NCT01007071|20702322|P1|STARTED|Overall Study||6
8400059|NCT01007032|20702334|P4|NOT COMPLETED|Overall Study||1
8400060|NCT01007032|20702335|P3|NOT COMPLETED|Overall Study||1
8400061|NCT01007032|20702336|P2|NOT COMPLETED|Overall Study||1
8400062|NCT01007032|20702337|P1|NOT COMPLETED|Overall Study||0
8400063|NCT01007032|20702334|P4|COMPLETED|Overall Study||6
8400064|NCT01007032|20702335|P3|COMPLETED|Overall Study||2
8400065|NCT01007032|20702336|P2|COMPLETED|Overall Study||6
8400066|NCT01007032|20702337|P1|COMPLETED|Overall Study||4
8400067|NCT01007032|20702334|P4|Received at Least 1 Dose of Study Drug|Overall Study||7
8400068|NCT01007032|20702335|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8400069|NCT01007032|20702336|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
8400070|NCT01007032|20702337|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
8400071|NCT01007032|20702334|P4|STARTED|Overall Study||7
8400072|NCT01007032|20702335|P3|STARTED|Overall Study||3
8400073|NCT01007032|20702336|P2|STARTED|Overall Study||7
8400074|NCT01007032|20702337|P1|STARTED|Overall Study||4
8400075|NCT01006980|20702381|P2|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
8400076|NCT01006980|20702382|P1|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
8400077|NCT01006980|20702381|P2|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
8400078|NCT01006980|20702382|P1|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
8400079|NCT01006980|20702381|P2|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
8400080|NCT01006980|20702382|P1|STARTED|Crossover: Dacarbazine to Vemurafenib||0
8400081|NCT01006980|20702381|P2|NOT COMPLETED|Vemurafenib and Dacarbazine||338
8400082|NCT01006980|20702382|P1|NOT COMPLETED|Vemurafenib and Dacarbazine||337
8400083|NCT01006980|20702381|P2|COMPLETED|Vemurafenib and Dacarbazine||0
8400084|NCT01006980|20702382|P1|COMPLETED|Vemurafenib and Dacarbazine||0
8400085|NCT01006980|20702381|P2|Treated|Vemurafenib and Dacarbazine||293
8400086|NCT01006980|20702382|P1|Treated|Vemurafenib and Dacarbazine||336
8400087|NCT01006980|20702381|P2|STARTED|Vemurafenib and Dacarbazine||338
8400088|NCT01006980|20702382|P1|STARTED|Vemurafenib and Dacarbazine||337
8400089|NCT01006967|20702404|P2|NOT COMPLETED|Overall Study||63
8400090|NCT01006967|20702405|P1|NOT COMPLETED|Overall Study||66
8400091|NCT01006967|20702404|P2|COMPLETED|Overall Study||190
8400092|NCT01006967|20702405|P1|COMPLETED|Overall Study||187
8400093|NCT01006967|20702404|P2|3 Month Follow-up|Overall Study||210
8400094|NCT01006967|20702405|P1|3 Month Follow-up|Overall Study||212
8400095|NCT01006967|20702404|P2|Received Treatment|Overall Study||245
8400096|NCT01006967|20702405|P1|Received Treatment|Overall Study||245
8400097|NCT01006967|20702404|P2|STARTED|Overall Study||253
8400098|NCT01006967|20702405|P1|STARTED|Overall Study||253
8400099|NCT01006889|20702421|P1|NOT COMPLETED|Overall Study||3
8400100|NCT01006889|20702421|P1|COMPLETED|Overall Study||17
8400101|NCT01006889|20702421|P1|STARTED|Overall Study||20
8400102|NCT01006707|20702432|P3|NOT COMPLETED|Study Session 3||0
8400103|NCT01006707|20702433|P2|NOT COMPLETED|Study Session 3||0
8400104|NCT01006707|20702434|P1|NOT COMPLETED|Study Session 3||0
8400105|NCT01006707|20702432|P3|COMPLETED|Study Session 3||6
8400106|NCT01006707|20702433|P2|COMPLETED|Study Session 3||4
8400107|NCT01006707|20702434|P1|COMPLETED|Study Session 3||0
8400108|NCT01006707|20702432|P3|STARTED|Study Session 3||6
8400109|NCT01006707|20702433|P2|STARTED|Study Session 3||4
8400110|NCT01006707|20702434|P1|STARTED|Study Session 3||0
8400111|NCT01006707|20702432|P3|NOT COMPLETED|Study Session 2||0
8400112|NCT01006707|20702433|P2|NOT COMPLETED|Study Session 2||0
8400113|NCT01006707|20702434|P1|NOT COMPLETED|Study Session 2||0
8400114|NCT01006707|20702432|P3|COMPLETED|Study Session 2||6
8400115|NCT01006707|20702433|P2|COMPLETED|Study Session 2||4
8400116|NCT01006707|20702434|P1|COMPLETED|Study Session 2||0
8400117|NCT01006707|20702432|P3|STARTED|Study Session 2||6
8400118|NCT01006707|20702433|P2|STARTED|Study Session 2||4
8400119|NCT01006707|20702434|P1|STARTED|Study Session 2||0
8400120|NCT01006707|20702432|P3|NOT COMPLETED|Study Session 1||0
8400121|NCT01006707|20702433|P2|NOT COMPLETED|Study Session 1||0
8400122|NCT01006707|20702434|P1|NOT COMPLETED|Study Session 1||5
8400123|NCT01006707|20702432|P3|COMPLETED|Study Session 1||0
8400124|NCT01006707|20702433|P2|COMPLETED|Study Session 1||0
8400125|NCT01006707|20702434|P1|COMPLETED|Study Session 1||10
8400126|NCT01006707|20702432|P3|STARTED|Study Session 1||0
8400127|NCT01006707|20702433|P2|STARTED|Study Session 1||0
8400128|NCT01006707|20702434|P1|STARTED|Study Session 1||15
8400129|NCT01006655|20702447|P2|NOT COMPLETED|Second Intervention||0
8400130|NCT01006655|20702448|P1|NOT COMPLETED|Second Intervention||0
8400131|NCT01006655|20702447|P2|COMPLETED|Second Intervention||10
8400132|NCT01006655|20702448|P1|COMPLETED|Second Intervention||11
8400133|NCT01006655|20702447|P2|STARTED|Second Intervention||10
8400134|NCT01006655|20702448|P1|STARTED|Second Intervention||11
8400135|NCT01006655|20702447|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8400136|NCT01006655|20702448|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8400137|NCT01006655|20702447|P2|COMPLETED|Washout Period of 2 Weeks||10
8400138|NCT01006655|20702448|P1|COMPLETED|Washout Period of 2 Weeks||11
8400139|NCT01006655|20702447|P2|STARTED|Washout Period of 2 Weeks||10
8400140|NCT01006655|20702448|P1|STARTED|Washout Period of 2 Weeks||11
8400141|NCT01006655|20702447|P2|NOT COMPLETED|First Intervention||0
8400142|NCT01006655|20702448|P1|NOT COMPLETED|First Intervention||0
8400143|NCT01006655|20702447|P2|COMPLETED|First Intervention||10
8400144|NCT01006655|20702448|P1|COMPLETED|First Intervention||11
8400145|NCT01006655|20702447|P2|STARTED|First Intervention||10
8400146|NCT01006655|20702448|P1|STARTED|First Intervention||11
8400147|NCT01006629|20702454|P1|NOT COMPLETED|Overall Study||6
8400148|NCT01006629|20702454|P1|COMPLETED|Overall Study||94
8400149|NCT01006629|20702454|P1|STARTED|Overall Study||100
8400150|NCT01006616|20702469|P4|NOT COMPLETED|Period 2 (18 Months)||82
8400151|NCT01006616|20702470|P3|NOT COMPLETED|Period 2 (18 Months)||55
8400152|NCT01006616|20702471|P2|NOT COMPLETED|Period 2 (18 Months)||63
8400153|NCT01006616|20702472|P1|NOT COMPLETED|Period 2 (18 Months)||75
8400154|NCT01006616|20702469|P4|COMPLETED|Period 2 (18 Months)||0
8400155|NCT01006616|20702470|P3|COMPLETED|Period 2 (18 Months)||0
8400156|NCT01006616|20702471|P2|COMPLETED|Period 2 (18 Months)||0
8400157|NCT01006616|20702472|P1|COMPLETED|Period 2 (18 Months)||0
8400158|NCT01006616|20702469|P4|Treated|Period 2 (18 Months)||82
8400159|NCT01006616|20702470|P3|Treated|Period 2 (18 Months)||55
8400160|NCT01006616|20702471|P2|Treated|Period 2 (18 Months)||63
8400161|NCT01006616|20702472|P1|Treated|Period 2 (18 Months)||75
8400162|NCT01006616|20702469|P4|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
8400163|NCT01006616|20702470|P3|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
8400164|NCT01006616|20702471|P2|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
8400165|NCT01006616|20702472|P1|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
8400166|NCT01006616|20702469|P4|NOT COMPLETED|Period 1 (6 Months)||27
8400167|NCT01006616|20702470|P3|NOT COMPLETED|Period 1 (6 Months)||51
8400168|NCT01006616|20702471|P2|NOT COMPLETED|Period 1 (6 Months)||54
8400169|NCT01006616|20702472|P1|NOT COMPLETED|Period 1 (6 Months)||26
8400170|NCT01006616|20702469|P4|COMPLETED|Period 1 (6 Months)||128
8400171|NCT01006616|20702470|P3|COMPLETED|Period 1 (6 Months)||102
8400172|NCT01006616|20702471|P2|COMPLETED|Period 1 (6 Months)||102
8400173|NCT01006616|20702472|P1|COMPLETED|Period 1 (6 Months)||126
8400174|NCT01006616|20702469|P4|Treated|Period 1 (6 Months)||154
8400175|NCT01006616|20702470|P3|Treated|Period 1 (6 Months)||152
8400176|NCT01006616|20702471|P2|Treated|Period 1 (6 Months)||156
8400177|NCT01006616|20702472|P1|Treated|Period 1 (6 Months)||152
8400178|NCT01006616|20702469|P4|STARTED|Period 1 (6 Months)||155
8400179|NCT01006616|20702470|P3|STARTED|Period 1 (6 Months)||153
8400180|NCT01006616|20702471|P2|STARTED|Period 1 (6 Months)||156
8400181|NCT01006616|20702472|P1|STARTED|Period 1 (6 Months)||152
8400182|NCT01006603|20702608|P2|NOT COMPLETED|Overall Study||75
8400183|NCT01006603|20702609|P1|NOT COMPLETED|Overall Study||71
8400184|NCT01006603|20702608|P2|COMPLETED|Overall Study||285
8400185|NCT01006603|20702609|P1|COMPLETED|Overall Study||289
8400337|NCT01005966|20702799|P1|COMPLETED|Washout Period 2 (4 Days)||13
8400186|NCT01006603|20702608|P2|STARTED|Overall Study|Completed lead-in period and were randomised|360
8400187|NCT01006603|20702609|P1|STARTED|Overall Study|Completed lead-in period and were randomised|360
8400188|NCT01006590|20702629|P2|NOT COMPLETED|Overall Study||32
8400189|NCT01006590|20702630|P1|NOT COMPLETED|Overall Study||28
8400190|NCT01006590|20702629|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
8400191|NCT01006590|20702630|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
8400192|NCT01006590|20702629|P2|STARTED|Overall Study|Randomised and treated|139
8400193|NCT01006590|20702630|P1|STARTED|Overall Study|Randomised and treated|147
8400194|NCT01006538|20702648|P2|NOT COMPLETED|Overall Study||4
8400195|NCT01006538|20702649|P1|NOT COMPLETED|Overall Study||11
8400196|NCT01006538|20702648|P2|COMPLETED|Overall Study||115
8400197|NCT01006538|20702649|P1|COMPLETED|Overall Study||233
8400198|NCT01006538|20702648|P2|STARTED|Overall Study||119
8400199|NCT01006538|20702649|P1|STARTED|Overall Study||244
8400200|NCT01006356|20702669|P1|NOT COMPLETED|Overall Study||42
8400201|NCT01006356|20702669|P1|COMPLETED|Overall Study||99
8400202|NCT01006356|20702669|P1|STARTED|Overall Study||141
8400203|NCT01006291|20702684|P3|NOT COMPLETED|Overall Study||27
8400204|NCT01006291|20702685|P2|NOT COMPLETED|Overall Study||24
8400205|NCT01006291|20702686|P1|NOT COMPLETED|Overall Study||26
8400206|NCT01006291|20702684|P3|COMPLETED|Overall Study||203
8400207|NCT01006291|20702685|P2|COMPLETED|Overall Study||204
8400208|NCT01006291|20702686|P1|COMPLETED|Overall Study||203
8400209|NCT01006291|20702684|P3|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
8400210|NCT01006291|20702685|P2|Exposed|Overall Study|2 subjects received IDeg OD FF|226
8400211|NCT01006291|20702686|P1|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
8400212|NCT01006291|20702684|P3|STARTED|Overall Study||230
8400213|NCT01006291|20702685|P2|STARTED|Overall Study||228
8400214|NCT01006291|20702686|P1|STARTED|Overall Study||229
8400215|NCT01006252|20702705|P2|NOT COMPLETED|Overall Study||0
8400216|NCT01006252|20702706|P1|NOT COMPLETED|Overall Study||0
8400217|NCT01006252|20702705|P2|COMPLETED|Overall Study||168
8400218|NCT01006252|20702706|P1|COMPLETED|Overall Study||168
8400219|NCT01006252|20702705|P2|Received Treatment|Overall Study||161
8400220|NCT01006252|20702706|P1|Received Treatment|Overall Study||164
8400221|NCT01006252|20702705|P2|STARTED|Overall Study||168
8400222|NCT01006252|20702706|P1|STARTED|Overall Study||168
8400223|NCT01006135|20702736|P1|NOT COMPLETED|Overall Study||140
8400224|NCT01006135|20702736|P1|COMPLETED|Overall Study||4712
8400225|NCT01006135|20702736|P1|STARTED|Overall Study||4852
8400226|NCT01006122|20702743|P2|NOT COMPLETED|Second Double-blind Intervention Period||7
8400227|NCT01006122|20702744|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
8400228|NCT01006122|20702743|P2|COMPLETED|Second Double-blind Intervention Period||24
8400229|NCT01006122|20702744|P1|COMPLETED|Second Double-blind Intervention Period||29
8400230|NCT01006122|20702743|P2|STARTED|Second Double-blind Intervention Period||31
8400231|NCT01006122|20702744|P1|STARTED|Second Double-blind Intervention Period||31
8400232|NCT01006122|20702743|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8400233|NCT01006122|20702744|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8400234|NCT01006122|20702743|P2|COMPLETED|Wash-out Period (at Least 7 Days)||31
8400235|NCT01006122|20702744|P1|COMPLETED|Wash-out Period (at Least 7 Days)||31
8400236|NCT01006122|20702743|P2|STARTED|Wash-out Period (at Least 7 Days)||31
8400237|NCT01006122|20702744|P1|STARTED|Wash-out Period (at Least 7 Days)||31
8400238|NCT01006122|20702743|P2|NOT COMPLETED|First Double-blind Intervention Period||17
8400239|NCT01006122|20702744|P1|NOT COMPLETED|First Double-blind Intervention Period||16
8400240|NCT01006122|20702743|P2|COMPLETED|First Double-blind Intervention Period||31
8400241|NCT01006122|20702744|P1|COMPLETED|First Double-blind Intervention Period||31
8400242|NCT01006122|20702743|P2|STARTED|First Double-blind Intervention Period||48
8400243|NCT01006122|20702744|P1|STARTED|First Double-blind Intervention Period||47
8400244|NCT01006018|20702785|P3|NOT COMPLETED|Overall Study||0
8400245|NCT01006018|20702786|P2|NOT COMPLETED|Overall Study||0
8400246|NCT01006018|20702787|P1|NOT COMPLETED|Overall Study||0
8400247|NCT01006018|20702785|P3|COMPLETED|Overall Study||0
8400248|NCT01006018|20702786|P2|COMPLETED|Overall Study||0
8400249|NCT01006018|20702787|P1|COMPLETED|Overall Study||0
8400250|NCT01006018|20702785|P3|STARTED|Overall Study||0
8400251|NCT01006018|20702786|P2|STARTED|Overall Study||0
8400252|NCT01006018|20702787|P1|STARTED|Overall Study||0
8400253|NCT01005966|20702795|P5|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8400254|NCT01005966|20702796|P4|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8400255|NCT01005966|20702797|P3|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8400256|NCT01005966|20702798|P2|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8400257|NCT01005966|20702799|P1|NOT COMPLETED|Treatment Period 5 (14 Days)||0
8400258|NCT01005966|20702795|P5|COMPLETED|Treatment Period 5 (14 Days)||10
8400259|NCT01005966|20702796|P4|COMPLETED|Treatment Period 5 (14 Days)||11
8400260|NCT01005966|20702797|P3|COMPLETED|Treatment Period 5 (14 Days)||11
8400261|NCT01005966|20702798|P2|COMPLETED|Treatment Period 5 (14 Days)||12
8400262|NCT01005966|20702799|P1|COMPLETED|Treatment Period 5 (14 Days)||9
8400263|NCT01005966|20702795|P5|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
8400264|NCT01005966|20702796|P4|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
8400265|NCT01005966|20702797|P3|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
8400338|NCT01005966|20702795|P5|STARTED|Washout Period 2 (4 Days)||11
8400266|NCT01005966|20702798|P2|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
8400267|NCT01005966|20702799|P1|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
8400268|NCT01005966|20702795|P5|NOT COMPLETED|Washout Period 4 (4 Days)||0
8400269|NCT01005966|20702796|P4|NOT COMPLETED|Washout Period 4 (4 Days)||0
8400270|NCT01005966|20702797|P3|NOT COMPLETED|Washout Period 4 (4 Days)||0
8400271|NCT01005966|20702798|P2|NOT COMPLETED|Washout Period 4 (4 Days)||0
8400272|NCT01005966|20702799|P1|NOT COMPLETED|Washout Period 4 (4 Days)||0
8400273|NCT01005966|20702795|P5|COMPLETED|Washout Period 4 (4 Days)||12
8400274|NCT01005966|20702796|P4|COMPLETED|Washout Period 4 (4 Days)||10
8400275|NCT01005966|20702797|P3|COMPLETED|Washout Period 4 (4 Days)||11
8400276|NCT01005966|20702798|P2|COMPLETED|Washout Period 4 (4 Days)||10
8400277|NCT01005966|20702799|P1|COMPLETED|Washout Period 4 (4 Days)||10
8400278|NCT01005966|20702795|P5|STARTED|Washout Period 4 (4 Days)||12
8400279|NCT01005966|20702796|P4|STARTED|Washout Period 4 (4 Days)||10
8400280|NCT01005966|20702797|P3|STARTED|Washout Period 4 (4 Days)||11
8400281|NCT01005966|20702798|P2|STARTED|Washout Period 4 (4 Days)||10
8400282|NCT01005966|20702799|P1|STARTED|Washout Period 4 (4 Days)||10
8400283|NCT01005966|20702795|P5|NOT COMPLETED|Treatment Period 4 (14 Days)||1
8400284|NCT01005966|20702796|P4|NOT COMPLETED|Treatment Period 4 (14 Days)||0
8400285|NCT01005966|20702797|P3|NOT COMPLETED|Treatment Period 4 (14 Days)||0
8400286|NCT01005966|20702798|P2|NOT COMPLETED|Treatment Period 4 (14 Days)||1
8400287|NCT01005966|20702799|P1|NOT COMPLETED|Treatment Period 4 (14 Days)||0
8400288|NCT01005966|20702795|P5|COMPLETED|Treatment Period 4 (14 Days)||12
8400289|NCT01005966|20702796|P4|COMPLETED|Treatment Period 4 (14 Days)||10
8400290|NCT01005966|20702797|P3|COMPLETED|Treatment Period 4 (14 Days)||11
8400291|NCT01005966|20702798|P2|COMPLETED|Treatment Period 4 (14 Days)||10
8400292|NCT01005966|20702799|P1|COMPLETED|Treatment Period 4 (14 Days)||10
8400293|NCT01005966|20702795|P5|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
8400294|NCT01005966|20702796|P4|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
8400295|NCT01005966|20702797|P3|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
8400296|NCT01005966|20702798|P2|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
8400297|NCT01005966|20702799|P1|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
8400298|NCT01005966|20702795|P5|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8400299|NCT01005966|20702796|P4|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8400300|NCT01005966|20702797|P3|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8400301|NCT01005966|20702798|P2|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8400302|NCT01005966|20702799|P1|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
8400303|NCT01005966|20702795|P5|COMPLETED|Washout Period 3 ( 4 Days)||11
8400304|NCT01005966|20702796|P4|COMPLETED|Washout Period 3 ( 4 Days)||13
8400305|NCT01005966|20702797|P3|COMPLETED|Washout Period 3 ( 4 Days)||12
8400306|NCT01005966|20702798|P2|COMPLETED|Washout Period 3 ( 4 Days)||7
8400307|NCT01005966|20702799|P1|COMPLETED|Washout Period 3 ( 4 Days)||12
8400308|NCT01005966|20702795|P5|STARTED|Washout Period 3 ( 4 Days)||11
8400309|NCT01005966|20702796|P4|STARTED|Washout Period 3 ( 4 Days)||13
8400310|NCT01005966|20702797|P3|STARTED|Washout Period 3 ( 4 Days)||12
8400311|NCT01005966|20702798|P2|STARTED|Washout Period 3 ( 4 Days)||7
8400312|NCT01005966|20702799|P1|STARTED|Washout Period 3 ( 4 Days)||12
8400313|NCT01005966|20702795|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8400314|NCT01005966|20702796|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8400315|NCT01005966|20702797|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8400316|NCT01005966|20702798|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
8400317|NCT01005966|20702799|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
8400318|NCT01005966|20702795|P5|COMPLETED|Treatment Period 3 (14 Days)||11
8400319|NCT01005966|20702796|P4|COMPLETED|Treatment Period 3 (14 Days)||13
8400320|NCT01005966|20702797|P3|COMPLETED|Treatment Period 3 (14 Days)||12
8400321|NCT01005966|20702798|P2|COMPLETED|Treatment Period 3 (14 Days)||7
8400322|NCT01005966|20702799|P1|COMPLETED|Treatment Period 3 (14 Days)||12
8400323|NCT01005966|20702795|P5|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8400324|NCT01005966|20702796|P4|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
8400325|NCT01005966|20702797|P3|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8400326|NCT01005966|20702798|P2|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
8400327|NCT01005966|20702799|P1|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
8400328|NCT01005966|20702795|P5|NOT COMPLETED|Washout Period 2 (4 Days)||0
8400329|NCT01005966|20702796|P4|NOT COMPLETED|Washout Period 2 (4 Days)||0
8400330|NCT01005966|20702797|P3|NOT COMPLETED|Washout Period 2 (4 Days)||0
8400331|NCT01005966|20702798|P2|NOT COMPLETED|Washout Period 2 (4 Days)||0
8400332|NCT01005966|20702799|P1|NOT COMPLETED|Washout Period 2 (4 Days)||0
8400333|NCT01005966|20702795|P5|COMPLETED|Washout Period 2 (4 Days)||11
8400334|NCT01005966|20702796|P4|COMPLETED|Washout Period 2 (4 Days)||11
8400335|NCT01005966|20702797|P3|COMPLETED|Washout Period 2 (4 Days)||10
8400336|NCT01005966|20702798|P2|COMPLETED|Washout Period 2 (4 Days)||12
8400339|NCT01005966|20702796|P4|STARTED|Washout Period 2 (4 Days)||11
8400340|NCT01005966|20702797|P3|STARTED|Washout Period 2 (4 Days)||10
8400341|NCT01005966|20702798|P2|STARTED|Washout Period 2 (4 Days)||12
8400342|NCT01005966|20702799|P1|STARTED|Washout Period 2 (4 Days)||13
8400343|NCT01005966|20702795|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8400344|NCT01005966|20702796|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8400345|NCT01005966|20702797|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
8400346|NCT01005966|20702798|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
8400347|NCT01005966|20702799|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8400348|NCT01005966|20702795|P5|COMPLETED|Treatment Period 2 (14 Days)||11
8400349|NCT01005966|20702796|P4|COMPLETED|Treatment Period 2 (14 Days)||11
8400350|NCT01005966|20702797|P3|COMPLETED|Treatment Period 2 (14 Days)||10
8400351|NCT01005966|20702798|P2|COMPLETED|Treatment Period 2 (14 Days)||12
8400352|NCT01005966|20702799|P1|COMPLETED|Treatment Period 2 (14 Days)||13
8400353|NCT01005966|20702795|P5|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
8400354|NCT01005966|20702796|P4|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
8400355|NCT01005966|20702797|P3|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
8400356|NCT01005966|20702798|P2|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
8400357|NCT01005966|20702799|P1|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
8400358|NCT01005966|20702795|P5|NOT COMPLETED|Washout Period 1 (4 Days)||0
8400359|NCT01005966|20702796|P4|NOT COMPLETED|Washout Period 1 (4 Days)||1
8400360|NCT01005966|20702797|P3|NOT COMPLETED|Washout Period 1 (4 Days)||0
8400361|NCT01005966|20702798|P2|NOT COMPLETED|Washout Period 1 (4 Days)||0
8400362|NCT01005966|20702799|P1|NOT COMPLETED|Washout Period 1 (4 Days)||0
8400363|NCT01005966|20702795|P5|COMPLETED|Washout Period 1 (4 Days)||13
8400364|NCT01005966|20702796|P4|COMPLETED|Washout Period 1 (4 Days)||12
8400365|NCT01005966|20702797|P3|COMPLETED|Washout Period 1 (4 Days)||12
8400366|NCT01005966|20702798|P2|COMPLETED|Washout Period 1 (4 Days)||13
8400367|NCT01005966|20702799|P1|COMPLETED|Washout Period 1 (4 Days)||11
8400368|NCT01005966|20702795|P5|STARTED|Washout Period 1 (4 Days)||13
8400369|NCT01005966|20702796|P4|STARTED|Washout Period 1 (4 Days)||13
8400370|NCT01005966|20702797|P3|STARTED|Washout Period 1 (4 Days)||12
8400371|NCT01005966|20702798|P2|STARTED|Washout Period 1 (4 Days)||13
8400372|NCT01005966|20702799|P1|STARTED|Washout Period 1 (4 Days)||11
8400373|NCT01005966|20702795|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8400374|NCT01005966|20702796|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8400375|NCT01005966|20702797|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
8400376|NCT01005966|20702798|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||0
8400377|NCT01005966|20702799|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
8400378|NCT01005966|20702795|P5|COMPLETED|Treatment Period 1 (14 Days)||13
8400379|NCT01005966|20702796|P4|COMPLETED|Treatment Period 1 (14 Days)||13
8400380|NCT01005966|20702797|P3|COMPLETED|Treatment Period 1 (14 Days)||12
8400381|NCT01005966|20702798|P2|COMPLETED|Treatment Period 1 (14 Days)||13
8400382|NCT01005966|20702799|P1|COMPLETED|Treatment Period 1 (14 Days)||11
8400383|NCT01005966|20702795|P5|STARTED|Treatment Period 1 (14 Days)||13
8400384|NCT01005966|20702796|P4|STARTED|Treatment Period 1 (14 Days)||13
8400385|NCT01005966|20702797|P3|STARTED|Treatment Period 1 (14 Days)||13
8400386|NCT01005966|20702798|P2|STARTED|Treatment Period 1 (14 Days)||13
8400387|NCT01005966|20702799|P1|STARTED|Treatment Period 1 (14 Days)||13
8400388|NCT01005914|20702819|P1|NOT COMPLETED|Overall Study||10
8400389|NCT01005914|20702819|P1|COMPLETED|Overall Study||1
8400390|NCT01005914|20702819|P1|STARTED|Overall Study||11
8400391|NCT01005901|20702825|P2|NOT COMPLETED|Overall Study||58
8400392|NCT01005901|20702826|P1|NOT COMPLETED|Overall Study||102
8400393|NCT01005901|20702825|P2|COMPLETED|Overall Study||212
8400394|NCT01005901|20702826|P1|COMPLETED|Overall Study||450
8400395|NCT01005901|20702825|P2|Full Analysis Set|Overall Study||260
8400396|NCT01005901|20702826|P1|Full Analysis Set|Overall Study||534
8400397|NCT01005901|20702825|P2|Safety Population|Overall Study||267
8400398|NCT01005901|20702826|P1|Safety Population|Overall Study||550
8400399|NCT01005901|20702825|P2|STARTED|Overall Study||270
8400400|NCT01005901|20702826|P1|STARTED|Overall Study||552
8400413|NCT01005875|20702889|P1|NOT COMPLETED|Overall Study||3
8400414|NCT01005875|20702889|P1|COMPLETED|Overall Study||2
8400415|NCT01005875|20702889|P1|STARTED|Overall Study||5
8400416|NCT01005810|20702899|P2|NOT COMPLETED|Overall Study||25
8400417|NCT01005810|20702900|P1|NOT COMPLETED|Overall Study||21
8400418|NCT01005810|20702899|P2|COMPLETED|Overall Study||33
8400419|NCT01005810|20702900|P1|COMPLETED|Overall Study||37
8400420|NCT01005810|20702899|P2|STARTED|Overall Study||58
8400421|NCT01005810|20702900|P1|STARTED|Overall Study||58
8400425|NCT01005732|20702911|P1|NOT COMPLETED|Overall Study||11
8400426|NCT01005732|20702911|P1|COMPLETED|Overall Study||43
8400427|NCT01005732|20702911|P1|STARTED|Overall Study||54
8400428|NCT01005719|20702927|P6|NOT COMPLETED|Period 3||0
8400429|NCT01005719|20702928|P5|NOT COMPLETED|Period 3||0
8400430|NCT01005719|20702929|P4|NOT COMPLETED|Period 3||0
8400431|NCT01005719|20702930|P3|NOT COMPLETED|Period 3||0
8400432|NCT01005719|20702931|P2|NOT COMPLETED|Period 3||0
8400433|NCT01005719|20702932|P1|NOT COMPLETED|Period 3||0
8400434|NCT01005719|20702927|P6|COMPLETED|Period 3||9
8400435|NCT01005719|20702928|P5|COMPLETED|Period 3||10
8400436|NCT01005719|20702929|P4|COMPLETED|Period 3||10
8400437|NCT01005719|20702930|P3|COMPLETED|Period 3||10
8400438|NCT01005719|20702931|P2|COMPLETED|Period 3||10
8400439|NCT01005719|20702932|P1|COMPLETED|Period 3||10
8400440|NCT01005719|20702927|P6|STARTED|Period 3||9
8400441|NCT01005719|20702928|P5|STARTED|Period 3||10
8400442|NCT01005719|20702929|P4|STARTED|Period 3||10
8400443|NCT01005719|20702930|P3|STARTED|Period 3||10
8400444|NCT01005719|20702931|P2|STARTED|Period 3||10
8400445|NCT01005719|20702932|P1|STARTED|Period 3||10
8400446|NCT01005719|20702927|P6|NOT COMPLETED|Period 2||1
8400447|NCT01005719|20702928|P5|NOT COMPLETED|Period 2||1
8400448|NCT01005719|20702929|P4|NOT COMPLETED|Period 2||0
8400449|NCT01005719|20702930|P3|NOT COMPLETED|Period 2||0
8400450|NCT01005719|20702931|P2|NOT COMPLETED|Period 2||0
8400451|NCT01005719|20702932|P1|NOT COMPLETED|Period 2||0
8400452|NCT01005719|20702927|P6|COMPLETED|Period 2||9
8400453|NCT01005719|20702928|P5|COMPLETED|Period 2||10
8400454|NCT01005719|20702929|P4|COMPLETED|Period 2||10
8400455|NCT01005719|20702930|P3|COMPLETED|Period 2||10
8400456|NCT01005719|20702931|P2|COMPLETED|Period 2||10
8400457|NCT01005719|20702932|P1|COMPLETED|Period 2||10
8400458|NCT01005719|20702927|P6|STARTED|Period 2||10
8400459|NCT01005719|20702928|P5|STARTED|Period 2||11
8400460|NCT01005719|20702929|P4|STARTED|Period 2||10
8400461|NCT01005719|20702930|P3|STARTED|Period 2||10
8400462|NCT01005719|20702931|P2|STARTED|Period 2||10
8400463|NCT01005719|20702932|P1|STARTED|Period 2||10
8400464|NCT01005719|20702927|P6|NOT COMPLETED|Period 1||1
8400465|NCT01005719|20702928|P5|NOT COMPLETED|Period 1||0
8400466|NCT01005719|20702929|P4|NOT COMPLETED|Period 1||1
8400467|NCT01005719|20702930|P3|NOT COMPLETED|Period 1||0
8400468|NCT01005719|20702931|P2|NOT COMPLETED|Period 1||0
8400469|NCT01005719|20702932|P1|NOT COMPLETED|Period 1||0
8400470|NCT01005719|20702927|P6|COMPLETED|Period 1||10
8400471|NCT01005719|20702928|P5|COMPLETED|Period 1||11
8400472|NCT01005719|20702929|P4|COMPLETED|Period 1||10
8400473|NCT01005719|20702930|P3|COMPLETED|Period 1||10
8400474|NCT01005719|20702931|P2|COMPLETED|Period 1||10
8400475|NCT01005719|20702932|P1|COMPLETED|Period 1||10
8400476|NCT01005719|20702927|P6|STARTED|Period 1||11
8400477|NCT01005719|20702928|P5|STARTED|Period 1||11
8400478|NCT01005719|20702929|P4|STARTED|Period 1||11
8400479|NCT01005719|20702930|P3|STARTED|Period 1||10
8400480|NCT01005719|20702931|P2|STARTED|Period 1||10
8400481|NCT01005719|20702932|P1|STARTED|Period 1||10
8400482|NCT01005706|20702990|P2|NOT COMPLETED|Overall Study||0
8400483|NCT01005706|20702991|P1|NOT COMPLETED|Overall Study||0
8400484|NCT01005706|20702990|P2|COMPLETED|Overall Study||17
8400485|NCT01005706|20702991|P1|COMPLETED|Overall Study||23
8400486|NCT01005706|20702990|P2|STARTED|Overall Study||17
8400487|NCT01005706|20702991|P1|STARTED|Overall Study||23
8400488|NCT01005680|20702999|P2|NOT COMPLETED|Overall Study||11
8400489|NCT01005680|20703000|P1|NOT COMPLETED|Overall Study||6
8400490|NCT01005680|20702999|P2|COMPLETED|Overall Study||119
8400491|NCT01005680|20703000|P1|COMPLETED|Overall Study||120
8400492|NCT01005680|20702999|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
8400493|NCT01005680|20703000|P1|Received at Least 1 Dose of Study Drug|Overall Study||125
8400494|NCT01005680|20702999|P2|STARTED|Overall Study||130
8400495|NCT01005680|20703000|P1|STARTED|Overall Study||126
8400496|NCT01005602|20703024|P2|NOT COMPLETED|Overall Study||0
8400497|NCT01005602|20703025|P1|NOT COMPLETED|Overall Study||1
8400498|NCT01005602|20703024|P2|COMPLETED|Overall Study||66
8400499|NCT01005602|20703025|P1|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
8400500|NCT01005602|20703024|P2|STARTED|Overall Study||66
8400501|NCT01005602|20703025|P1|STARTED|Overall Study||66
8400502|NCT01005576|20703045|P1|NOT COMPLETED|Overall Study||0
8400503|NCT01005576|20703045|P1|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
8400504|NCT01005576|20703045|P1|STARTED|Overall Study||21
8400505|NCT01005459|20703055|P2|NOT COMPLETED|Overall Study||0
8400506|NCT01005459|20703056|P1|NOT COMPLETED|Overall Study||0
8400507|NCT01005459|20703055|P2|COMPLETED|Overall Study||23
8400508|NCT01005459|20703056|P1|COMPLETED|Overall Study||23
8400509|NCT01005459|20703055|P2|STARTED|Overall Study||23
8400510|NCT01005459|20703056|P1|STARTED|Overall Study||23
8400511|NCT01005407|20703064|P2|NOT COMPLETED|Overall Study||32
8400512|NCT01005407|20703065|P1|NOT COMPLETED|Overall Study||151
8400513|NCT01005407|20703064|P2|COMPLETED|Overall Study||451
8400514|NCT01005407|20703065|P1|COMPLETED|Overall Study||1818
8400515|NCT01005407|20703064|P2|STARTED|Overall Study||483
8400516|NCT01005407|20703065|P1|STARTED|Overall Study||1969
8400517|NCT01005355|20703076|P3|NOT COMPLETED|Overall Study||0
8400518|NCT01005355|20703077|P2|NOT COMPLETED|Overall Study||0
8400519|NCT01005355|20703078|P1|NOT COMPLETED|Overall Study||0
8400520|NCT01005355|20703076|P3|COMPLETED|Overall Study||6
8400521|NCT01005355|20703077|P2|COMPLETED|Overall Study||6
8400522|NCT01005355|20703078|P1|COMPLETED|Overall Study||3
8400523|NCT01005355|20703076|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8400524|NCT01005355|20703077|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8400525|NCT01005355|20703078|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8400526|NCT01005355|20703076|P3|STARTED|Overall Study||6
8400527|NCT01005355|20703077|P2|STARTED|Overall Study||6
8400528|NCT01005355|20703078|P1|STARTED|Overall Study||3
8400529|NCT01005329|20703113|P1|NOT COMPLETED|Overall Study||4
8400530|NCT01005329|20703113|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
8400531|NCT01005329|20703113|P1|STARTED|Overall Study||34
8400532|NCT01005316|20703126|P4|NOT COMPLETED|Overall Study||108
8400533|NCT01005316|20703127|P3|NOT COMPLETED|Overall Study||11
8400534|NCT01005316|20703128|P2|NOT COMPLETED|Overall Study||76
8400535|NCT01005316|20703129|P1|NOT COMPLETED|Overall Study||50
8400536|NCT01005316|20703126|P4|COMPLETED|Overall Study||19
8400537|NCT01005316|20703127|P3|COMPLETED|Overall Study||5
8400538|NCT01005316|20703128|P2|COMPLETED|Overall Study||21
8400539|NCT01005316|20703129|P1|COMPLETED|Overall Study||0
8400540|NCT01005316|20703126|P4|STARTED|Overall Study||127
8400541|NCT01005316|20703127|P3|STARTED|Overall Study||16
8400542|NCT01005316|20703128|P2|STARTED|Overall Study||97
8400543|NCT01005316|20703129|P1|STARTED|Overall Study||50
8400544|NCT01005290|20703181|P3|NOT COMPLETED|Period 2 (5 Weeks)||2
8400545|NCT01005290|20703182|P2|NOT COMPLETED|Period 2 (5 Weeks)||0
8400546|NCT01005290|20703183|P1|NOT COMPLETED|Period 2 (5 Weeks)||0
8400547|NCT01005290|20703181|P3|COMPLETED|Period 2 (5 Weeks)||7
8400548|NCT01005290|20703182|P2|COMPLETED|Period 2 (5 Weeks)||13
8400549|NCT01005290|20703183|P1|COMPLETED|Period 2 (5 Weeks)||0
8400550|NCT01005290|20703181|P3|STARTED|Period 2 (5 Weeks)||9
8400551|NCT01005290|20703182|P2|STARTED|Period 2 (5 Weeks)||13
8400552|NCT01005290|20703183|P1|STARTED|Period 2 (5 Weeks)||0
8400553|NCT01005290|20703181|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
8400554|NCT01005290|20703182|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
8400555|NCT01005290|20703183|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
8400556|NCT01005290|20703181|P3|COMPLETED|Washout Period (2 Weeks)||9
8400557|NCT01005290|20703182|P2|COMPLETED|Washout Period (2 Weeks)||13
8400558|NCT01005290|20703183|P1|COMPLETED|Washout Period (2 Weeks)||0
8400559|NCT01005290|20703181|P3|STARTED|Washout Period (2 Weeks)||9
8400560|NCT01005290|20703182|P2|STARTED|Washout Period (2 Weeks)||13
8400561|NCT01005290|20703183|P1|STARTED|Washout Period (2 Weeks)||0
8400562|NCT01005290|20703181|P3|NOT COMPLETED|Period 1 (5 Weeks)||9
8400563|NCT01005290|20703182|P2|NOT COMPLETED|Period 1 (5 Weeks)||7
8400564|NCT01005290|20703183|P1|NOT COMPLETED|Period 1 (5 Weeks)||0
8400565|NCT01005290|20703181|P3|COMPLETED|Period 1 (5 Weeks)||9
8400566|NCT01005290|20703182|P2|COMPLETED|Period 1 (5 Weeks)||13
8400567|NCT01005290|20703183|P1|COMPLETED|Period 1 (5 Weeks)||0
8400568|NCT01005290|20703181|P3|STARTED|Period 1 (5 Weeks)||18
8400569|NCT01005290|20703182|P2|STARTED|Period 1 (5 Weeks)||20
8400570|NCT01005290|20703183|P1|STARTED|Period 1 (5 Weeks)||0
8400571|NCT01005290|20703181|P3|NOT COMPLETED|Run-In||0
8400572|NCT01005290|20703182|P2|NOT COMPLETED|Run-In||0
8400573|NCT01005290|20703183|P1|NOT COMPLETED|Run-In||14
8400574|NCT01005290|20703181|P3|COMPLETED|Run-In||0
8400575|NCT01005290|20703182|P2|COMPLETED|Run-In||0
8400576|NCT01005290|20703183|P1|COMPLETED|Run-In||38
8400577|NCT01005290|20703181|P3|STARTED|Run-In||0
8400578|NCT01005290|20703182|P2|STARTED|Run-In||0
8400579|NCT01005290|20703183|P1|STARTED|Run-In||52
8400580|NCT01005251|20703196|P5|NOT COMPLETED|Overall Study||18
8400581|NCT01005251|20703197|P4|NOT COMPLETED|Overall Study||12
8400582|NCT01005251|20703198|P3|NOT COMPLETED|Overall Study||22
8400583|NCT01005251|20703199|P2|NOT COMPLETED|Overall Study||16
8400584|NCT01005251|20703200|P1|NOT COMPLETED|Overall Study||13
8400585|NCT01005251|20703196|P5|COMPLETED|Overall Study||122
8400586|NCT01005251|20703197|P4|COMPLETED|Overall Study||114
8400587|NCT01005251|20703198|P3|COMPLETED|Overall Study||114
8400588|NCT01005251|20703199|P2|COMPLETED|Overall Study||109
8400589|NCT01005251|20703200|P1|COMPLETED|Overall Study||121
8400590|NCT01005251|20703196|P5|STARTED|Overall Study||140
8400591|NCT01005251|20703197|P4|STARTED|Overall Study||126
8400592|NCT01005251|20703198|P3|STARTED|Overall Study||136
8400593|NCT01005251|20703199|P2|STARTED|Overall Study||125
8400594|NCT01005251|20703200|P1|STARTED|Overall Study||134
8400595|NCT01004991|20703217|P1|NOT COMPLETED|Overall Study||0
8400596|NCT01004991|20703217|P1|COMPLETED|Overall Study||12
8400597|NCT01004991|20703217|P1|STARTED|Overall Study||12
8400598|NCT01004939|20703221|P1|NOT COMPLETED|Overall Study||0
8400599|NCT01004939|20703221|P1|COMPLETED|Overall Study||120
8400600|NCT01004939|20703221|P1|STARTED|Overall Study||120
8400643|NCT01004848|20703362|P2|NOT COMPLETED|Overall Study||45
8400644|NCT01004848|20703363|P1|NOT COMPLETED|Overall Study||55
8400645|NCT01004848|20703362|P2|COMPLETED|Overall Study||147
8400646|NCT01004848|20703363|P1|COMPLETED|Overall Study||155
8400647|NCT01004848|20703362|P2|STARTED|Overall Study||192
8400648|NCT01004848|20703363|P1|STARTED|Overall Study||210
8400649|NCT01004822|20703401|P8|NOT COMPLETED|Overall Study||5
8400650|NCT01004822|20703402|P7|NOT COMPLETED|Overall Study||4
8400651|NCT01004822|20703403|P6|NOT COMPLETED|Overall Study||4
8400652|NCT01004822|20703404|P5|NOT COMPLETED|Overall Study||4
8400653|NCT01004822|20703405|P4|NOT COMPLETED|Overall Study||4
8400654|NCT01004822|20703406|P3|NOT COMPLETED|Overall Study||4
8400655|NCT01004822|20703407|P2|NOT COMPLETED|Overall Study||3
8400656|NCT01004822|20703408|P1|NOT COMPLETED|Overall Study||3
8400657|NCT01004822|20703401|P8|COMPLETED|Overall Study||0
8400658|NCT01004822|20703402|P7|COMPLETED|Overall Study||0
8400659|NCT01004822|20703403|P6|COMPLETED|Overall Study||0
8400660|NCT01004822|20703404|P5|COMPLETED|Overall Study||0
8400661|NCT01004822|20703405|P4|COMPLETED|Overall Study||0
8400662|NCT01004822|20703406|P3|COMPLETED|Overall Study||0
8400663|NCT01004822|20703407|P2|COMPLETED|Overall Study||0
8400664|NCT01004822|20703408|P1|COMPLETED|Overall Study||0
8400665|NCT01004822|20703401|P8|Treated|Overall Study||5
8400666|NCT01004822|20703402|P7|Treated|Overall Study||4
8400667|NCT01004822|20703403|P6|Treated|Overall Study||4
8400668|NCT01004822|20703404|P5|Treated|Overall Study||4
8400669|NCT01004822|20703405|P4|Treated|Overall Study||4
8400670|NCT01004822|20703406|P3|Treated|Overall Study||3
8400671|NCT01004822|20703407|P2|Treated|Overall Study||3
8400672|NCT01004822|20703408|P1|Treated|Overall Study||3
8400673|NCT01004822|20703401|P8|STARTED|Overall Study||5
8400674|NCT01004822|20703402|P7|STARTED|Overall Study||4
8400675|NCT01004822|20703403|P6|STARTED|Overall Study||4
8400676|NCT01004822|20703404|P5|STARTED|Overall Study||4
8400677|NCT01004822|20703405|P4|STARTED|Overall Study||4
8400678|NCT01004822|20703406|P3|STARTED|Overall Study||4
8400679|NCT01004822|20703407|P2|STARTED|Overall Study||3
8400680|NCT01004822|20703408|P1|STARTED|Overall Study||3
8400681|NCT01004770|20703522|P5|NOT COMPLETED|Overall Study||0
8400682|NCT01004770|20703523|P4|NOT COMPLETED|Overall Study||0
8400683|NCT01004770|20703524|P3|NOT COMPLETED|Overall Study||0
8400684|NCT01004770|20703525|P2|NOT COMPLETED|Overall Study||0
8400685|NCT01004770|20703526|P1|NOT COMPLETED|Overall Study||0
8400686|NCT01004770|20703522|P5|COMPLETED|Overall Study||10
8400687|NCT01004770|20703523|P4|COMPLETED|Overall Study||10
8400688|NCT01004770|20703524|P3|COMPLETED|Overall Study||10
8400689|NCT01004770|20703525|P2|COMPLETED|Overall Study||10
8400690|NCT01004770|20703526|P1|COMPLETED|Overall Study||10
8400691|NCT01004770|20703522|P5|STARTED|Overall Study||10
8400692|NCT01004770|20703523|P4|STARTED|Overall Study||10
8400693|NCT01004770|20703524|P3|STARTED|Overall Study||10
8400694|NCT01004770|20703525|P2|STARTED|Overall Study||10
8400695|NCT01004770|20703526|P1|STARTED|Overall Study||10
8400696|NCT01004744|20703558|P1|NOT COMPLETED|Overall Study||0
8400697|NCT01004744|20703558|P1|COMPLETED|Overall Study||10
8400698|NCT01004744|20703558|P1|STARTED|Overall Study||10
8400699|NCT01004705|20703562|P3|NOT COMPLETED|Period 2 (12 Weeks)||4
8400700|NCT01004705|20703563|P2|NOT COMPLETED|Period 2 (12 Weeks)||0
8400701|NCT01004705|20703564|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
8400702|NCT01004705|20703562|P3|COMPLETED|Period 2 (12 Weeks)||9
8400703|NCT01004705|20703563|P2|COMPLETED|Period 2 (12 Weeks)||13
8400704|NCT01004705|20703564|P1|COMPLETED|Period 2 (12 Weeks)||0
8400705|NCT01004705|20703562|P3|STARTED|Period 2 (12 Weeks)||13
8400706|NCT01004705|20703563|P2|STARTED|Period 2 (12 Weeks)||13
8400707|NCT01004705|20703564|P1|STARTED|Period 2 (12 Weeks)||0
8400708|NCT01004705|20703562|P3|NOT COMPLETED|Washout Period (6 Weeks)||0
8400709|NCT01004705|20703563|P2|NOT COMPLETED|Washout Period (6 Weeks)||0
8400710|NCT01004705|20703564|P1|NOT COMPLETED|Washout Period (6 Weeks)||0
8400711|NCT01004705|20703562|P3|COMPLETED|Washout Period (6 Weeks)||13
8400712|NCT01004705|20703563|P2|COMPLETED|Washout Period (6 Weeks)||13
8400713|NCT01004705|20703564|P1|COMPLETED|Washout Period (6 Weeks)||0
8400714|NCT01004705|20703562|P3|STARTED|Washout Period (6 Weeks)||13
8400715|NCT01004705|20703563|P2|STARTED|Washout Period (6 Weeks)||13
8400716|NCT01004705|20703564|P1|STARTED|Washout Period (6 Weeks)||0
8400717|NCT01004705|20703562|P3|NOT COMPLETED|Period 1 (12 Weeks)||5
8400718|NCT01004705|20703563|P2|NOT COMPLETED|Period 1 (12 Weeks)||5
8400719|NCT01004705|20703564|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
8400720|NCT01004705|20703562|P3|COMPLETED|Period 1 (12 Weeks)||13
8400721|NCT01004705|20703563|P2|COMPLETED|Period 1 (12 Weeks)||13
8400722|NCT01004705|20703564|P1|COMPLETED|Period 1 (12 Weeks)||0
8400723|NCT01004705|20703562|P3|STARTED|Period 1 (12 Weeks)||18
8400724|NCT01004705|20703563|P2|STARTED|Period 1 (12 Weeks)||18
8400725|NCT01004705|20703564|P1|STARTED|Period 1 (12 Weeks)||0
8400726|NCT01004705|20703562|P3|NOT COMPLETED|Run-In||0
8400727|NCT01004705|20703563|P2|NOT COMPLETED|Run-In||0
8400728|NCT01004705|20703564|P1|NOT COMPLETED|Run-In||8
8400729|NCT01004705|20703562|P3|COMPLETED|Run-In||0
8400730|NCT01004705|20703563|P2|COMPLETED|Run-In||0
8400731|NCT01004705|20703564|P1|COMPLETED|Run-In||36
8400732|NCT01004705|20703562|P3|STARTED|Run-In||0
8400733|NCT01004705|20703563|P2|STARTED|Run-In||0
8400734|NCT01004705|20703564|P1|STARTED|Run-In||44
8400735|NCT01004510|20703573|P1|NOT COMPLETED|Overall Study||1
8400736|NCT01004510|20703573|P1|COMPLETED|Overall Study||2
8400737|NCT01004510|20703573|P1|STARTED|Overall Study||3
8400738|NCT01004432|20703577|P5|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
8400739|NCT01004432|20703578|P4|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
8400740|NCT01004432|20703579|P3|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
8400741|NCT01004432|20703580|P2|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
8400742|NCT01004432|20703581|P1|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
8400743|NCT01004432|20703577|P5|COMPLETED|OL Study Extension (Week 52 - 76)||194
8400744|NCT01004432|20703578|P4|COMPLETED|OL Study Extension (Week 52 - 76)||0
8400745|NCT01004432|20703579|P3|COMPLETED|OL Study Extension (Week 52 - 76)||0
8400746|NCT01004432|20703580|P2|COMPLETED|OL Study Extension (Week 52 - 76)||0
8400747|NCT01004432|20703581|P1|COMPLETED|OL Study Extension (Week 52 - 76)||0
8400748|NCT01004432|20703577|P5|STARTED|OL Study Extension (Week 52 - 76)||212
8400749|NCT01004432|20703578|P4|STARTED|OL Study Extension (Week 52 - 76)||0
8400750|NCT01004432|20703579|P3|STARTED|OL Study Extension (Week 52 - 76)||0
8400751|NCT01004432|20703580|P2|STARTED|OL Study Extension (Week 52 - 76)||0
8400752|NCT01004432|20703581|P1|STARTED|OL Study Extension (Week 52 - 76)||0
8400753|NCT01004432|20703577|P5|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
8400754|NCT01004432|20703578|P4|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
8400755|NCT01004432|20703579|P3|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
8400756|NCT01004432|20703580|P2|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
8400757|NCT01004432|20703581|P1|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
8400758|NCT01004432|20703577|P5|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
8400759|NCT01004432|20703578|P4|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
8400760|NCT01004432|20703579|P3|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
8400761|NCT01004432|20703580|P2|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
8400762|NCT01004432|20703581|P1|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
8400763|NCT01004432|20703577|P5|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
8400764|NCT01004432|20703578|P4|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
8400765|NCT01004432|20703579|P3|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
8400766|NCT01004432|20703580|P2|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
8400767|NCT01004432|20703581|P1|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
8400768|NCT01004432|20703577|P5|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400769|NCT01004432|20703578|P4|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400770|NCT01004432|20703579|P3|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400771|NCT01004432|20703580|P2|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400772|NCT01004432|20703581|P1|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||83
8400773|NCT01004432|20703577|P5|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400774|NCT01004432|20703578|P4|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400775|NCT01004432|20703579|P3|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400776|NCT01004432|20703580|P2|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
8400777|NCT01004432|20703581|P1|COMPLETED|Open-label (OL) Period (Week 0 - 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
8400778|NCT01004432|20703577|P5|STARTED|Open-label (OL) Period (Week 0 - 16)||0
8400779|NCT01004432|20703578|P4|STARTED|Open-label (OL) Period (Week 0 - 16)||0
8400780|NCT01004432|20703579|P3|STARTED|Open-label (OL) Period (Week 0 - 16)||0
8400781|NCT01004432|20703580|P2|STARTED|Open-label (OL) Period (Week 0 - 16)||0
8400782|NCT01004432|20703581|P1|STARTED|Open-label (OL) Period (Week 0 - 16)||433
8400783|NCT01004406|20703603|P2|NOT COMPLETED|Overall Study||0
8400784|NCT01004406|20703604|P1|NOT COMPLETED|Overall Study||3
8400785|NCT01004406|20703603|P2|COMPLETED|Overall Study||10
8400786|NCT01004406|20703604|P1|COMPLETED|Overall Study||18
8400787|NCT01004406|20703603|P2|STARTED|Overall Study||10
8400788|NCT01004406|20703604|P1|STARTED|Overall Study||21
8400789|NCT01004393|20703616|P1|NOT COMPLETED|Overall Study||0
8400790|NCT01004393|20703616|P1|COMPLETED|Overall Study||12
8400791|NCT01004393|20703616|P1|STARTED|Overall Study||12
8400792|NCT01004354|20703627|P1|NOT COMPLETED|Overall Study||0
8400793|NCT01004354|20703627|P1|COMPLETED|Overall Study||12
8400794|NCT01004354|20703627|P1|STARTED|Overall Study||12
8400795|NCT01004263|20703639|P1|NOT COMPLETED|Overall Study||179
8400796|NCT01004263|20703639|P1|COMPLETED|Overall Study||427
8400797|NCT01004263|20703639|P1|STARTED|Overall Study|Participants who took study drug|606
8400798|NCT01004250|20703647|P1|NOT COMPLETED|Follow-Up (FU) Period||1
8400799|NCT01004250|20703647|P1|COMPLETED|Follow-Up (FU) Period||100
8400800|NCT01004250|20703647|P1|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
8400801|NCT01004250|20703647|P1|NOT COMPLETED|Maintenance Therapy Period||26
8400802|NCT01004250|20703647|P1|COMPLETED|Maintenance Therapy Period||46
8400803|NCT01004250|20703647|P1|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
8400804|NCT01004250|20703647|P1|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
8400805|NCT01004250|20703647|P1|NOT COMPLETED|Induction Therapy Period||15
8400806|NCT01004250|20703647|P1|COMPLETED|Induction Therapy Period||94
8400807|NCT01004250|20703647|P1|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
8400808|NCT01004250|20703647|P1|Received at Least One Dose of Study Drug|Induction Therapy Period||109
8400809|NCT01004250|20703647|P1|STARTED|Induction Therapy Period||109
8400810|NCT01004185|20703659|P2|NOT COMPLETED|Overall Study||9
8400811|NCT01004185|20703660|P1|NOT COMPLETED|Overall Study||9
8400812|NCT01004185|20703659|P2|COMPLETED|Overall Study||11
8400813|NCT01004185|20703660|P1|COMPLETED|Overall Study||10
8400814|NCT01004185|20703659|P2|STARTED|Overall Study||20
8400815|NCT01004185|20703660|P1|STARTED|Overall Study||19
8400816|NCT01004172|20703668|P1|NOT COMPLETED|Overall Study||38
8400817|NCT01004172|20703668|P1|COMPLETED|Overall Study||0
8400818|NCT01004172|20703668|P1|STARTED|Overall Study||38
8400819|NCT01004159|20703676|P1|NOT COMPLETED|Overall Study||20
8400820|NCT01004159|20703676|P1|COMPLETED|Overall Study||0
8400821|NCT01004159|20703676|P1|STARTED|Overall Study||20
8400822|NCT01004146|20703683|P2|NOT COMPLETED|Overall Study||5
8400823|NCT01004146|20703684|P1|NOT COMPLETED|Overall Study||4
8400824|NCT01004146|20703683|P2|COMPLETED|Overall Study||20
8400825|NCT01004146|20703684|P1|COMPLETED|Overall Study||21
8400826|NCT01004146|20703683|P2|Have Incentive Spirometry Data|Overall Study||20
8400827|NCT01004146|20703684|P1|Have Incentive Spirometry Data|Overall Study||21
8400828|NCT01004146|20703683|P2|STARTED|Overall Study||25
8400829|NCT01004146|20703684|P1|STARTED|Overall Study||25
8400830|NCT01004107|20703692|P2|NOT COMPLETED|Overall Study||2
8400831|NCT01004107|20703693|P1|NOT COMPLETED|Overall Study||1
8400832|NCT01004107|20703692|P2|COMPLETED|Overall Study||23
8400833|NCT01004107|20703693|P1|COMPLETED|Overall Study||75
8400834|NCT01004107|20703692|P2|STARTED|Overall Study||25
8400835|NCT01004107|20703693|P1|STARTED|Overall Study||76
8400836|NCT01004042|20703771|P2|NOT COMPLETED|Overall Study||0
8400837|NCT01004042|20703772|P1|NOT COMPLETED|Overall Study||4
8400838|NCT01004042|20703771|P2|COMPLETED|Overall Study||25
8400839|NCT01004042|20703772|P1|COMPLETED|Overall Study||21
8400840|NCT01004042|20703771|P2|STARTED|Overall Study||25
8400841|NCT01004042|20703772|P1|STARTED|Overall Study||25
8400842|NCT01004003|20703795|P9|NOT COMPLETED|Overall Study||30
8400843|NCT01004003|20703796|P8|NOT COMPLETED|Overall Study||60
8400844|NCT01004003|20703797|P7|NOT COMPLETED|Overall Study||8
8400845|NCT01004003|20703798|P6|NOT COMPLETED|Overall Study||4
8400846|NCT01004003|20703799|P5|NOT COMPLETED|Overall Study||4
8400847|NCT01004003|20703800|P4|NOT COMPLETED|Overall Study||3
8400848|NCT01004003|20703801|P3|NOT COMPLETED|Overall Study||4
8400849|NCT01004003|20703802|P2|NOT COMPLETED|Overall Study||3
8400850|NCT01004003|20703803|P1|NOT COMPLETED|Overall Study||6
8400851|NCT01004003|20703795|P9|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
8400852|NCT01004003|20703796|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
8400853|NCT01004003|20703797|P7|COMPLETED|Overall Study||0
8400854|NCT01004003|20703798|P6|COMPLETED|Overall Study||0
8400855|NCT01004003|20703799|P5|COMPLETED|Overall Study||0
8400856|NCT01004003|20703800|P4|COMPLETED|Overall Study||0
8400857|NCT01004003|20703801|P3|COMPLETED|Overall Study||0
8400858|NCT01004003|20703802|P2|COMPLETED|Overall Study||0
8400859|NCT01004003|20703803|P1|COMPLETED|Overall Study||0
8400860|NCT01004003|20703795|P9|STARTED|Overall Study||31
8400861|NCT01004003|20703796|P8|STARTED|Overall Study||62
8400862|NCT01004003|20703797|P7|STARTED|Overall Study||8
8400863|NCT01004003|20703798|P6|STARTED|Overall Study||4
8400864|NCT01004003|20703799|P5|STARTED|Overall Study||4
8400865|NCT01004003|20703800|P4|STARTED|Overall Study||3
8400866|NCT01004003|20703801|P3|STARTED|Overall Study||4
8400867|NCT01004003|20703802|P2|STARTED|Overall Study||3
8400868|NCT01004003|20703803|P1|STARTED|Overall Study||6
8400869|NCT01003990|20703834|P3|NOT COMPLETED|Overall Study||43
8400870|NCT01003990|20703835|P2|NOT COMPLETED|Overall Study||51
8400871|NCT01003990|20703836|P1|NOT COMPLETED|Overall Study||92
8400872|NCT01003990|20703834|P3|COMPLETED|Overall Study||53
8400873|NCT01003990|20703835|P2|COMPLETED|Overall Study||103
8400874|NCT01003990|20703836|P1|COMPLETED|Overall Study||367
8400875|NCT01003990|20703834|P3|STARTED|Overall Study||96
8400876|NCT01003990|20703835|P2|STARTED|Overall Study||154
8400877|NCT01003990|20703836|P1|STARTED|Overall Study||459
8400878|NCT01003938|20703844|P1|NOT COMPLETED|Overall Study||0
8400879|NCT01003938|20703844|P1|COMPLETED|Overall Study||6
8400880|NCT01003938|20703844|P1|STARTED|Overall Study||6
8400881|NCT01003899|20703853|P1|NOT COMPLETED|Overall Study||47
8400882|NCT01003899|20703853|P1|COMPLETED|Overall Study||0
8400883|NCT01003899|20703853|P1|STARTED|Overall Study|enrolled|47
8400884|NCT01003769|20703862|P1|NOT COMPLETED|Overall Study||0
8400885|NCT01003769|20703862|P1|COMPLETED|Overall Study||5
8400886|NCT01003769|20703862|P1|STARTED|Overall Study||5
8400887|NCT01003639|20703874|P2|NOT COMPLETED|Overall Study||22
8400888|NCT01003639|20703875|P1|NOT COMPLETED|Overall Study||17
8400889|NCT01003639|20703874|P2|COMPLETED|Overall Study||57
8400890|NCT01003639|20703875|P1|COMPLETED|Overall Study||69
8400891|NCT01003639|20703874|P2|STARTED|Overall Study||79
8400892|NCT01003639|20703875|P1|STARTED|Overall Study||86
8400893|NCT01003418|20703889|P2|NOT COMPLETED|Overall Study||0
8400894|NCT01003418|20703890|P1|NOT COMPLETED|Overall Study||0
8400895|NCT01003418|20703889|P2|COMPLETED|Overall Study||3
8400896|NCT01003418|20703890|P1|COMPLETED|Overall Study||5
8400897|NCT01003418|20703889|P2|STARTED|Overall Study||3
8400898|NCT01003418|20703890|P1|STARTED|Overall Study||5
8400899|NCT01003301|20703908|P2|NOT COMPLETED|Overall Study||0
8400900|NCT01003301|20703909|P1|NOT COMPLETED|Overall Study||0
8400901|NCT01003301|20703908|P2|COMPLETED|Overall Study||9
8400902|NCT01003301|20703909|P1|COMPLETED|Overall Study||10
8400903|NCT01003301|20703908|P2|STARTED|Overall Study||9
8400904|NCT01003301|20703909|P1|STARTED|Overall Study||10
8400905|NCT01003288|20703917|P1|NOT COMPLETED|Overall Study||0
8400906|NCT01003288|20703917|P1|COMPLETED|Overall Study||255
8400907|NCT01003288|20703917|P1|STARTED|Overall Study||255
8400908|NCT01003275|20703924|P2|NOT COMPLETED|Overall Study||0
8400909|NCT01003275|20703925|P1|NOT COMPLETED|Overall Study||1
8400910|NCT01003275|20703924|P2|COMPLETED|Overall Study||11
8400911|NCT01003275|20703925|P1|COMPLETED|Overall Study||10
8400912|NCT01003275|20703924|P2|STARTED|Overall Study||11
8400913|NCT01003275|20703925|P1|STARTED|Overall Study||11
8400914|NCT01003249|20703931|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
8400915|NCT01003249|20703932|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
8400916|NCT01003249|20703931|P2|COMPLETED|Second Intervention (4 Weeks)||2
8400917|NCT01003249|20703932|P1|COMPLETED|Second Intervention (4 Weeks)||3
8400918|NCT01003249|20703931|P2|STARTED|Second Intervention (4 Weeks)||3
8400919|NCT01003249|20703932|P1|STARTED|Second Intervention (4 Weeks)||4
8400920|NCT01003249|20703931|P2|NOT COMPLETED|Washout (3 Weeks)||0
8400921|NCT01003249|20703932|P1|NOT COMPLETED|Washout (3 Weeks)||0
8400922|NCT01003249|20703931|P2|COMPLETED|Washout (3 Weeks)||3
8400923|NCT01003249|20703932|P1|COMPLETED|Washout (3 Weeks)||4
8400924|NCT01003249|20703931|P2|STARTED|Washout (3 Weeks)||3
8400925|NCT01003249|20703932|P1|STARTED|Washout (3 Weeks)||4
8400926|NCT01003249|20703931|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
8400927|NCT01003249|20703932|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
8400928|NCT01003249|20703931|P2|COMPLETED|First Intervention (4 Weeks)||3
8400929|NCT01003249|20703932|P1|COMPLETED|First Intervention (4 Weeks)||5
8400930|NCT01003249|20703931|P2|Received Intervention|First Intervention (4 Weeks)||5
8400931|NCT01003249|20703932|P1|Received Intervention|First Intervention (4 Weeks)||7
8400932|NCT01003249|20703931|P2|STARTED|First Intervention (4 Weeks)||5
8400933|NCT01003249|20703932|P1|STARTED|First Intervention (4 Weeks)||7
8400934|NCT01003210|20703950|P2|NOT COMPLETED|Overall Study||3
8400935|NCT01003210|20703951|P1|NOT COMPLETED|Overall Study||1
8400936|NCT01003210|20703950|P2|COMPLETED|Overall Study||102
8400937|NCT01003210|20703951|P1|COMPLETED|Overall Study||104
8400938|NCT01003210|20703950|P2|STARTED|Overall Study||105
8400939|NCT01003210|20703951|P1|STARTED|Overall Study||105
8400940|NCT01003184|20703963|P2|NOT COMPLETED|Overall Study||12
8400941|NCT01003184|20703964|P1|NOT COMPLETED|Overall Study||19
8400942|NCT01003184|20703963|P2|COMPLETED|Overall Study||99
8400943|NCT01003184|20703964|P1|COMPLETED|Overall Study||92
8400944|NCT01003184|20703963|P2|Full Analysis Set (FAS)|Overall Study||105
8400945|NCT01003184|20703964|P1|Full Analysis Set (FAS)|Overall Study||111
8400946|NCT01003184|20703963|P2|STARTED|Overall Study||111
8400947|NCT01003184|20703964|P1|STARTED|Overall Study||111
8400948|NCT01003106|20704000|P8|NOT COMPLETED|Month 6-Month 36||0
8400949|NCT01003106|20704001|P7|NOT COMPLETED|Month 6-Month 36||1
8400950|NCT01003106|20704002|P6|NOT COMPLETED|Month 6-Month 36||0
8400951|NCT01003106|20704003|P5|NOT COMPLETED|Month 6-Month 36||0
8400952|NCT01003106|20704004|P4|NOT COMPLETED|Month 6-Month 36||0
8400953|NCT01003106|20704005|P3|NOT COMPLETED|Month 6-Month 36||1
8400954|NCT01003106|20704006|P2|NOT COMPLETED|Month 6-Month 36||0
8400955|NCT01003106|20704007|P1|NOT COMPLETED|Month 6-Month 36||0
8400956|NCT01003106|20704000|P8|COMPLETED|Month 6-Month 36||18
8400957|NCT01003106|20704001|P7|COMPLETED|Month 6-Month 36||19
8400958|NCT01003106|20704002|P6|COMPLETED|Month 6-Month 36||0
8400959|NCT01003106|20704003|P5|COMPLETED|Month 6-Month 36||0
8400960|NCT01003106|20704004|P4|COMPLETED|Month 6-Month 36||20
8400961|NCT01003106|20704005|P3|COMPLETED|Month 6-Month 36||18
8400962|NCT01003106|20704006|P2|COMPLETED|Month 6-Month 36||0
8400963|NCT01003106|20704007|P1|COMPLETED|Month 6-Month 36||0
8400964|NCT01003106|20704000|P8|STARTED|Month 6-Month 36||18
8400965|NCT01003106|20704001|P7|STARTED|Month 6-Month 36||20
8400966|NCT01003106|20704002|P6|STARTED|Month 6-Month 36||0
8400967|NCT01003106|20704003|P5|STARTED|Month 6-Month 36||0
8400968|NCT01003106|20704004|P4|STARTED|Month 6-Month 36||20
8400969|NCT01003106|20704005|P3|STARTED|Month 6-Month 36||19
8400970|NCT01003106|20704006|P2|STARTED|Month 6-Month 36||0
8400971|NCT01003106|20704007|P1|STARTED|Month 6-Month 36||0
8400972|NCT01003106|20704000|P8|NOT COMPLETED|Baseline to Month 6||0
8400973|NCT01003106|20704001|P7|NOT COMPLETED|Baseline to Month 6||0
8400974|NCT01003106|20704002|P6|NOT COMPLETED|Baseline to Month 6||0
8400975|NCT01003106|20704003|P5|NOT COMPLETED|Baseline to Month 6||0
8400976|NCT01003106|20704004|P4|NOT COMPLETED|Baseline to Month 6||0
8400977|NCT01003106|20704005|P3|NOT COMPLETED|Baseline to Month 6||0
8400978|NCT01003106|20704006|P2|NOT COMPLETED|Baseline to Month 6||0
8400979|NCT01003106|20704007|P1|NOT COMPLETED|Baseline to Month 6||0
8400980|NCT01003106|20704000|P8|COMPLETED|Baseline to Month 6||0
8400981|NCT01003106|20704001|P7|COMPLETED|Baseline to Month 6||0
8400982|NCT01003106|20704002|P6|COMPLETED|Baseline to Month 6||20
8400983|NCT01003106|20704003|P5|COMPLETED|Baseline to Month 6||19
8400984|NCT01003106|20704004|P4|COMPLETED|Baseline to Month 6||0
8400985|NCT01003106|20704005|P3|COMPLETED|Baseline to Month 6||0
8400986|NCT01003106|20704006|P2|COMPLETED|Baseline to Month 6||20
8400987|NCT01003106|20704007|P1|COMPLETED|Baseline to Month 6||22
8400988|NCT01003106|20704000|P8|STARTED|Baseline to Month 6||0
8400989|NCT01003106|20704001|P7|STARTED|Baseline to Month 6||0
8400990|NCT01003106|20704002|P6|STARTED|Baseline to Month 6||20
8400991|NCT01003106|20704003|P5|STARTED|Baseline to Month 6||19
8400992|NCT01003106|20704004|P4|STARTED|Baseline to Month 6||0
8400993|NCT01003106|20704005|P3|STARTED|Baseline to Month 6||0
8400994|NCT01003106|20704006|P2|STARTED|Baseline to Month 6||20
8400995|NCT01003106|20704007|P1|STARTED|Baseline to Month 6||22
8400996|NCT01003080|20704031|P2|NOT COMPLETED|Overall Study||0
8400997|NCT01003080|20704032|P1|NOT COMPLETED|Overall Study||0
8400998|NCT01003080|20704031|P2|COMPLETED|Overall Study||61
8400999|NCT01003080|20704032|P1|COMPLETED|Overall Study||50
8401000|NCT01003080|20704031|P2|STARTED|Overall Study||61
8401001|NCT01003080|20704032|P1|STARTED|Overall Study||50
8401002|NCT01003067|20704040|P2|NOT COMPLETED|Overall Study||24
8401003|NCT01003067|20704041|P1|NOT COMPLETED|Overall Study||33
8401004|NCT01003067|20704040|P2|COMPLETED|Overall Study||107
8401005|NCT01003067|20704041|P1|COMPLETED|Overall Study||103
8401006|NCT01003067|20704040|P2|STARTED|Overall Study||131
8401007|NCT01003067|20704041|P1|STARTED|Overall Study||136
8401008|NCT01002989|20704047|P1|NOT COMPLETED|Overall Study||5
8401009|NCT01002989|20704047|P1|COMPLETED|Overall Study||93
8401010|NCT01002989|20704047|P1|STARTED|Overall Study||98
8401011|NCT01002755|20704054|P1|NOT COMPLETED|Overall Study||0
8401012|NCT01002755|20704054|P1|COMPLETED|Overall Study||36
8401013|NCT01002755|20704054|P1|STARTED|Overall Study||36
8401014|NCT01002742|20704062|P2|NOT COMPLETED|Overall Study||1
8401015|NCT01002742|20704063|P1|NOT COMPLETED|Overall Study||0
8401016|NCT01002742|20704062|P2|COMPLETED|Overall Study||116
8401017|NCT01002742|20704063|P1|COMPLETED|Overall Study||119
8401018|NCT01002742|20704062|P2|STARTED|Overall Study||117
8401019|NCT01002742|20704063|P1|STARTED|Overall Study||119
8401020|NCT01002573|20704099|P2|NOT COMPLETED|Overall Study||7
8401021|NCT01002573|20704100|P1|NOT COMPLETED|Overall Study||11
8401022|NCT01002573|20704099|P2|COMPLETED|Overall Study||53
8401023|NCT01002573|20704100|P1|COMPLETED|Overall Study||47
8401024|NCT01002573|20704099|P2|STARTED|Overall Study||60
8401025|NCT01002573|20704100|P1|STARTED|Overall Study||58
8401026|NCT01002547|20704121|P3|NOT COMPLETED|Overall Study||8
8401027|NCT01002547|20704122|P2|NOT COMPLETED|Overall Study||3
8401028|NCT01002547|20704123|P1|NOT COMPLETED|Overall Study||8
8401029|NCT01002547|20704121|P3|COMPLETED|Overall Study||29
8401030|NCT01002547|20704122|P2|COMPLETED|Overall Study||33
8401031|NCT01002547|20704123|P1|COMPLETED|Overall Study||24
8401032|NCT01002547|20704121|P3|STARTED|Overall Study||37
8401033|NCT01002547|20704122|P2|STARTED|Overall Study||36
8401034|NCT01002547|20704123|P1|STARTED|Overall Study||32
8401035|NCT01002482|20704181|P2|NOT COMPLETED|Overall Study||21
8401036|NCT01002482|20704182|P1|NOT COMPLETED|Overall Study||15
8401037|NCT01002482|20704181|P2|COMPLETED|Overall Study||1312
8401038|NCT01002482|20704182|P1|COMPLETED|Overall Study||1336
8401039|NCT01002482|20704181|P2|STARTED|Overall Study||1333
8401040|NCT01002482|20704182|P1|STARTED|Overall Study||1351
8401041|NCT01002456|20704204|P2|NOT COMPLETED|Overall Study||0
8401042|NCT01002456|20704205|P1|NOT COMPLETED|Overall Study||0
8401043|NCT01002456|20704204|P2|COMPLETED|Overall Study||122
8401044|NCT01002456|20704205|P1|COMPLETED|Overall Study||98
8401045|NCT01002456|20704204|P2|STARTED|Overall Study||122
8401046|NCT01002456|20704205|P1|STARTED|Overall Study||98
8401047|NCT01002339|20704216|P3|NOT COMPLETED|Overall Study||5
8401048|NCT01002339|20704217|P2|NOT COMPLETED|Overall Study||1
8401049|NCT01002339|20704218|P1|NOT COMPLETED|Overall Study||0
8401050|NCT01002339|20704216|P3|COMPLETED|Overall Study||42
8401051|NCT01002339|20704217|P2|COMPLETED|Overall Study||42
8401052|NCT01002339|20704218|P1|COMPLETED|Overall Study||44
8401053|NCT01002339|20704216|P3|STARTED|Overall Study||47
8401054|NCT01002339|20704217|P2|STARTED|Overall Study||43
8401055|NCT01002339|20704218|P1|STARTED|Overall Study||44
8401056|NCT01002287|20704273|P2|NOT COMPLETED|Overall Study||0
8401057|NCT01002287|20704274|P1|NOT COMPLETED|Overall Study||0
8401058|NCT01002287|20704273|P2|COMPLETED|Overall Study||3
8401059|NCT01002287|20704274|P1|COMPLETED|Overall Study||8
8401060|NCT01002287|20704273|P2|STARTED|Overall Study||3
8401061|NCT01002287|20704274|P1|STARTED|Overall Study||8
8401062|NCT01002118|20704286|P1|NOT COMPLETED|Overall Study||0
8401063|NCT01002118|20704286|P1|COMPLETED|Overall Study||1
8401064|NCT01002118|20704286|P1|Randomized Only Patient|Overall Study||1
8401065|NCT01002118|20704286|P1|STARTED|Overall Study||1
8401066|NCT01002105|20704294|P2|NOT COMPLETED|Overall Study||21
8401067|NCT01002105|20704295|P1|NOT COMPLETED|Overall Study||19
8401068|NCT01002105|20704294|P2|COMPLETED|Overall Study||11
8401069|NCT01002105|20704295|P1|COMPLETED|Overall Study||13
8401070|NCT01002105|20704294|P2|STARTED|Overall Study||32
8401071|NCT01002105|20704295|P1|STARTED|Overall Study||32
8401072|NCT01001988|20704311|P1|NOT COMPLETED|Overall Study||117
8401073|NCT01001988|20704311|P1|COMPLETED|Overall Study||479
8401074|NCT01001988|20704311|P1|STARTED|Overall Study||596
8401075|NCT01001975|20704318|P2|NOT COMPLETED|Overall Study||0
8401076|NCT01001975|20704319|P1|NOT COMPLETED|Overall Study||0
8401077|NCT01001975|20704318|P2|COMPLETED|Overall Study||5
8401078|NCT01001975|20704319|P1|COMPLETED|Overall Study||5
8401079|NCT01001975|20704318|P2|STARTED|Overall Study||5
8401080|NCT01001975|20704319|P1|STARTED|Overall Study||5
8401081|NCT01001832|20704329|P2|NOT COMPLETED|Follow-up Period||21
8401082|NCT01001832|20704330|P1|NOT COMPLETED|Follow-up Period||18
8401083|NCT01001832|20704329|P2|COMPLETED|Follow-up Period||30
8401084|NCT01001832|20704330|P1|COMPLETED|Follow-up Period||34
8401085|NCT01001832|20704329|P2|STARTED|Follow-up Period||51
8401086|NCT01001832|20704330|P1|STARTED|Follow-up Period||52
8401087|NCT01001832|20704329|P2|NOT COMPLETED|Long-term Period||5
8401088|NCT01001832|20704330|P1|NOT COMPLETED|Long-term Period||4
8401089|NCT01001832|20704329|P2|COMPLETED|Long-term Period||51
8401090|NCT01001832|20704330|P1|COMPLETED|Long-term Period||52
8401091|NCT01001832|20704329|P2|STARTED|Long-term Period||56
8401092|NCT01001832|20704330|P1|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
8401093|NCT01001832|20704329|P2|NOT COMPLETED|Short-term Period||3
8401094|NCT01001832|20704330|P1|NOT COMPLETED|Short-term Period||2
8401095|NCT01001832|20704329|P2|COMPLETED|Short-term Period||56
8401096|NCT01001832|20704330|P1|COMPLETED|Short-term Period||57
8401097|NCT01001832|20704329|P2|STARTED|Short-term Period||59
8401098|NCT01001832|20704330|P1|STARTED|Short-term Period||59
8401099|NCT01001806|20704376|P3|NOT COMPLETED|Overall Study||4
8401100|NCT01001806|20704377|P2|NOT COMPLETED|Overall Study||1
8401101|NCT01001806|20704378|P1|NOT COMPLETED|Overall Study||0
8401102|NCT01001806|20704376|P3|COMPLETED|Overall Study||38
8401103|NCT01001806|20704377|P2|COMPLETED|Overall Study||41
8401104|NCT01001806|20704378|P1|COMPLETED|Overall Study||42
8401105|NCT01001806|20704376|P3|STARTED|Overall Study||42
8401106|NCT01001806|20704377|P2|STARTED|Overall Study||42
8401107|NCT01001806|20704378|P1|STARTED|Overall Study||42
8401108|NCT01001767|20704388|P2|NOT COMPLETED|Overall Study||0
8401109|NCT01001767|20704389|P1|NOT COMPLETED|Overall Study||4
8401110|NCT01001767|20704388|P2|COMPLETED|Overall Study||17
8401111|NCT01001767|20704389|P1|COMPLETED|Overall Study||14
8401112|NCT01001767|20704388|P2|STARTED|Overall Study||17
8401113|NCT01001767|20704389|P1|STARTED|Overall Study||18
8401114|NCT01001702|20704395|P1|NOT COMPLETED|Overall Study||72
8401115|NCT01001702|20704395|P1|COMPLETED|Overall Study||13
8401116|NCT01001702|20704395|P1|STARTED|Overall Study||85
8401117|NCT01001598|20704406|P1|NOT COMPLETED|Overall Study||2
8401118|NCT01001598|20704406|P1|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3
8401119|NCT01001598|20704406|P1|STARTED|Overall Study||5
8401120|NCT01001572|20704414|P3|NOT COMPLETED|Double-Blind Treatment Phase||19
8401121|NCT01001572|20704415|P2|NOT COMPLETED|Double-Blind Treatment Phase||10
8401122|NCT01001572|20704416|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
8401123|NCT01001572|20704414|P3|COMPLETED|Double-Blind Treatment Phase||306
8401124|NCT01001572|20704415|P2|COMPLETED|Double-Blind Treatment Phase||319
8401125|NCT01001572|20704416|P1|COMPLETED|Double-Blind Treatment Phase||0
8401126|NCT01001572|20704414|P3|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
8401127|NCT01001572|20704415|P2|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
8401128|NCT01001572|20704416|P1|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
8401129|NCT01001572|20704414|P3|STARTED|Double-Blind Treatment Phase||325
8401130|NCT01001572|20704415|P2|STARTED|Double-Blind Treatment Phase||329
8401131|NCT01001572|20704416|P1|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
8401132|NCT01001572|20704414|P3|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
8401133|NCT01001572|20704415|P2|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
8401134|NCT01001572|20704416|P1|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
8401135|NCT01001572|20704414|P3|COMPLETED|Single-Blind Valsartan 160 mg||0
8401136|NCT01001572|20704415|P2|COMPLETED|Single-Blind Valsartan 160 mg||0
8401137|NCT01001572|20704416|P1|COMPLETED|Single-Blind Valsartan 160 mg||654
8401138|NCT01001572|20704414|P3|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
8401139|NCT01001572|20704415|P2|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
8401140|NCT01001572|20704416|P1|STARTED|Single-Blind Valsartan 160 mg||932
8401141|NCT01001559|20704432|P2|NOT COMPLETED|Overall Study||0
8401142|NCT01001559|20704433|P1|NOT COMPLETED|Overall Study||0
8401143|NCT01001559|20704432|P2|COMPLETED|Overall Study||147
8401144|NCT01001559|20704433|P1|COMPLETED|Overall Study||95
8401145|NCT01001559|20704432|P2|STARTED|Overall Study||147
8401146|NCT01001559|20704433|P1|STARTED|Overall Study||95
8401147|NCT01001546|20704447|P2|NOT COMPLETED|Overall Study||0
8401148|NCT01001546|20704448|P1|NOT COMPLETED|Overall Study||0
8401149|NCT01001546|20704447|P2|COMPLETED|Overall Study||207
8401150|NCT01001546|20704448|P1|COMPLETED|Overall Study||206
8401151|NCT01001546|20704447|P2|STARTED|Overall Study||207
8401152|NCT01001546|20704448|P1|STARTED|Overall Study||206
8401153|NCT01001520|20704454|P2|NOT COMPLETED|Medication Period 2||3
8401154|NCT01001520|20704455|P1|NOT COMPLETED|Medication Period 2||0
8401155|NCT01001520|20704454|P2|COMPLETED|Medication Period 2||13
8401156|NCT01001520|20704455|P1|COMPLETED|Medication Period 2||16
8401157|NCT01001520|20704454|P2|STARTED|Medication Period 2||16
8401158|NCT01001520|20704455|P1|STARTED|Medication Period 2||16
8401159|NCT01001520|20704454|P2|NOT COMPLETED|Washout Period||1
8401160|NCT01001520|20704455|P1|NOT COMPLETED|Washout Period||2
8401161|NCT01001520|20704454|P2|COMPLETED|Washout Period||16
8401162|NCT01001520|20704455|P1|COMPLETED|Washout Period||16
8401163|NCT01001520|20704454|P2|STARTED|Washout Period||17
8401164|NCT01001520|20704455|P1|STARTED|Washout Period||18
8401165|NCT01001520|20704454|P2|NOT COMPLETED|Medication Period 1||7
8401166|NCT01001520|20704455|P1|NOT COMPLETED|Medication Period 1||4
8401167|NCT01001520|20704454|P2|COMPLETED|Medication Period 1||17
8401168|NCT01001520|20704455|P1|COMPLETED|Medication Period 1||18
8401169|NCT01001520|20704454|P2|STARTED|Medication Period 1||24
8401170|NCT01001520|20704455|P1|STARTED|Medication Period 1||22
8401171|NCT01001494|20704482|P3|NOT COMPLETED|Overall Study||41
8401172|NCT01001494|20704483|P2|NOT COMPLETED|Overall Study||17
8401173|NCT01001494|20704484|P1|NOT COMPLETED|Overall Study||24
8401174|NCT01001494|20704482|P3|COMPLETED|Overall Study||232
8401175|NCT01001494|20704483|P2|COMPLETED|Overall Study||252
8401176|NCT01001494|20704484|P1|COMPLETED|Overall Study||253
8401177|NCT01001494|20704482|P3|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
8401178|NCT01001494|20704483|P2|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
8401179|NCT01001494|20704484|P1|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
8401180|NCT01001442|20704512|P8|NOT COMPLETED|Overall Study||2
8401181|NCT01001442|20704513|P7|NOT COMPLETED|Overall Study||4
8401182|NCT01001442|20704514|P6|NOT COMPLETED|Overall Study||0
8401183|NCT01001442|20704515|P5|NOT COMPLETED|Overall Study||2
8401184|NCT01001442|20704516|P4|NOT COMPLETED|Overall Study||0
8401185|NCT01001442|20704517|P3|NOT COMPLETED|Overall Study||0
8401186|NCT01001442|20704518|P2|NOT COMPLETED|Overall Study||0
8401187|NCT01001442|20704519|P1|NOT COMPLETED|Overall Study||0
8401188|NCT01001442|20704512|P8|COMPLETED|Overall Study||2
8401189|NCT01001442|20704513|P7|COMPLETED|Overall Study||6
8401190|NCT01001442|20704514|P6|COMPLETED|Overall Study||3
8401191|NCT01001442|20704515|P5|COMPLETED|Overall Study||2
8401192|NCT01001442|20704516|P4|COMPLETED|Overall Study||3
8401193|NCT01001442|20704517|P3|COMPLETED|Overall Study||4
8401194|NCT01001442|20704518|P2|COMPLETED|Overall Study||3
8401195|NCT01001442|20704519|P1|COMPLETED|Overall Study||4
8401196|NCT01001442|20704512|P8|STARTED|Overall Study||4
8401197|NCT01001442|20704513|P7|STARTED|Overall Study||10
8401198|NCT01001442|20704514|P6|STARTED|Overall Study||3
8401199|NCT01001442|20704515|P5|STARTED|Overall Study||4
8401200|NCT01001442|20704516|P4|STARTED|Overall Study||3
8401201|NCT01001442|20704517|P3|STARTED|Overall Study||4
8401202|NCT01001442|20704518|P2|STARTED|Overall Study||3
8401203|NCT01001442|20704519|P1|STARTED|Overall Study||4
8401204|NCT01001429|20704569|P2|NOT COMPLETED|Overall Study||1
8401205|NCT01001429|20704570|P1|NOT COMPLETED|Overall Study||0
8401206|NCT01001429|20704569|P2|COMPLETED|Overall Study||37
8401207|NCT01001429|20704570|P1|COMPLETED|Overall Study||39
8401208|NCT01001429|20704569|P2|STARTED|Overall Study||38
8401209|NCT01001429|20704570|P1|STARTED|Overall Study||39
8401210|NCT01001403|20704602|P2|NOT COMPLETED|Overall Study||0
8401211|NCT01001403|20704603|P1|NOT COMPLETED|Overall Study||0
8401212|NCT01001403|20704602|P2|COMPLETED|Overall Study||31
8401213|NCT01001403|20704603|P1|COMPLETED|Overall Study||31
8401214|NCT01001403|20704602|P2|STARTED|Overall Study||31
8401215|NCT01001403|20704603|P1|STARTED|Overall Study||31
8401216|NCT01001390|20704609|P2|NOT COMPLETED|Overall Study||0
8401217|NCT01001390|20704610|P1|NOT COMPLETED|Overall Study||2
8401218|NCT01001390|20704609|P2|COMPLETED|Overall Study||0
8401219|NCT01001390|20704610|P1|COMPLETED|Overall Study||0
8401220|NCT01001390|20704609|P2|STARTED|Overall Study||0
8401221|NCT01001390|20704610|P1|STARTED|Overall Study||2
8401222|NCT01001377|20704618|P2|NOT COMPLETED|Overall Study||421
8401223|NCT01001377|20704619|P1|NOT COMPLETED|Overall Study||426
8401224|NCT01001377|20704618|P2|COMPLETED|Overall Study|Indicates participants continuing in study|85
8401225|NCT01001377|20704619|P1|COMPLETED|Overall Study|Indicates participants continuing in study|78
8401226|NCT01001377|20704618|P2|Received Treatment|Overall Study||499
8401227|NCT01001377|20704619|P1|Received Treatment|Overall Study||500
8401228|NCT01001377|20704618|P2|STARTED|Overall Study||506
8401229|NCT01001377|20704619|P1|STARTED|Overall Study||504
8401230|NCT01001325|20704649|P2|NOT COMPLETED|Overall Study||10
8401231|NCT01001325|20704650|P1|NOT COMPLETED|Overall Study||18
8401232|NCT01001325|20704649|P2|COMPLETED|Overall Study||224
8401233|NCT01001325|20704650|P1|COMPLETED|Overall Study||216
8401234|NCT01001325|20704649|P2|STARTED|Overall Study||234
8401235|NCT01001325|20704650|P1|STARTED|Overall Study||234
8401236|NCT01001299|20704656|P1|NOT COMPLETED|Overall Study||25
8401237|NCT01001299|20704656|P1|COMPLETED|Overall Study||0
8401238|NCT01001299|20704656|P1|STARTED|Overall Study||25
8401239|NCT01001234|20704685|P5|NOT COMPLETED|Overall Study||0
8401240|NCT01001234|20704686|P4|NOT COMPLETED|Overall Study||25
8401241|NCT01001234|20704687|P3|NOT COMPLETED|Overall Study||32
8401242|NCT01001234|20704688|P2|NOT COMPLETED|Overall Study||26
8401243|NCT01001234|20704689|P1|NOT COMPLETED|Overall Study||405
8401244|NCT01001234|20704685|P5|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
8401245|NCT01001234|20704686|P4|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
8401246|NCT01001234|20704687|P3|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
8401247|NCT01001234|20704688|P2|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
8401248|NCT01001234|20704689|P1|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
8401249|NCT01001234|20704685|P5|Participants Not Treated|Overall Study|Participants who did not take study drug|0
8401250|NCT01001234|20704686|P4|Participants Not Treated|Overall Study|Participants who did not take study drug|5
8401251|NCT01001234|20704687|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|9
8401252|NCT01001234|20704688|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|23
8401253|NCT01001234|20704689|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|368
8401254|NCT01001234|20704685|P5|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
8401255|NCT01001234|20704686|P4|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
8401256|NCT01001234|20704687|P3|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
8401257|NCT01001234|20704688|P2|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
8401258|NCT01001234|20704689|P1|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
8401259|NCT01001234|20704685|P5|STARTED|Overall Study|Participants who were randomized to study drug|40
8401260|NCT01001234|20704686|P4|STARTED|Overall Study|Participants who were randomized to study drug|410
8401261|NCT01001234|20704687|P3|STARTED|Overall Study|Participants who were randomized to study drug|409
8401262|NCT01001234|20704688|P2|STARTED|Overall Study|Participants who were randomized to study drug|31
8401263|NCT01001234|20704689|P1|STARTED|Overall Study|Participants who were randomized to study drug|492
8401264|NCT01001221|20704705|P5|NOT COMPLETED|Overall Study||0
8401265|NCT01001221|20704706|P4|NOT COMPLETED|Overall Study||6
8401266|NCT01001221|20704707|P3|NOT COMPLETED|Overall Study||3
8401267|NCT01001221|20704708|P2|NOT COMPLETED|Overall Study||5
8401268|NCT01001221|20704709|P1|NOT COMPLETED|Overall Study||5
8401269|NCT01001221|20704705|P5|COMPLETED|Overall Study||0
8401270|NCT01001221|20704706|P4|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
8401271|NCT01001221|20704707|P3|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
8401272|NCT01001221|20704708|P2|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
8401273|NCT01001221|20704709|P1|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
8401274|NCT01001221|20704705|P5|Completed 1st Treatment Cycle|Overall Study||0
8401275|NCT01001221|20704706|P4|Completed 1st Treatment Cycle|Overall Study||6
8401276|NCT01001221|20704707|P3|Completed 1st Treatment Cycle|Overall Study||2
8401277|NCT01001221|20704708|P2|Completed 1st Treatment Cycle|Overall Study||5
8401278|NCT01001221|20704709|P1|Completed 1st Treatment Cycle|Overall Study||5
8401279|NCT01001221|20704705|P5|Treated|Overall Study||0
8401280|NCT01001221|20704706|P4|Treated|Overall Study||6
8401281|NCT01001221|20704707|P3|Treated|Overall Study||2
8401282|NCT01001221|20704708|P2|Treated|Overall Study||5
8401283|NCT01001221|20704709|P1|Treated|Overall Study||5
8401284|NCT01001221|20704705|P5|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
8401285|NCT01001221|20704706|P4|STARTED|Overall Study||6
8401286|NCT01001221|20704707|P3|STARTED|Overall Study||3
8401287|NCT01001221|20704708|P2|STARTED|Overall Study||5
8401288|NCT01001221|20704709|P1|STARTED|Overall Study||5
8401289|NCT01001208|20704884|P2|NOT COMPLETED|Overall Study||33
8401290|NCT01001208|20704885|P1|NOT COMPLETED|Overall Study||28
8401291|NCT01001208|20704884|P2|COMPLETED|Overall Study||206
8401292|NCT01001208|20704885|P1|COMPLETED|Overall Study||211
8401293|NCT01001208|20704884|P2|STARTED|Overall Study||239
8401294|NCT01001208|20704885|P1|STARTED|Overall Study||239
8401295|NCT01001195|20704913|P4|NOT COMPLETED|Overall Study||0
8401296|NCT01001195|20704914|P3|NOT COMPLETED|Overall Study||0
8401297|NCT01001195|20704915|P2|NOT COMPLETED|Overall Study||2
8401298|NCT01001195|20704916|P1|NOT COMPLETED|Overall Study||2
8401299|NCT01001195|20704913|P4|COMPLETED|Overall Study||41
8401300|NCT01001195|20704914|P3|COMPLETED|Overall Study||44
8401301|NCT01001195|20704915|P2|COMPLETED|Overall Study||39
8401302|NCT01001195|20704916|P1|COMPLETED|Overall Study||37
8401303|NCT01001195|20704913|P4|STARTED|Overall Study||41
8401304|NCT01001195|20704914|P3|STARTED|Overall Study||44
8401305|NCT01001195|20704915|P2|STARTED|Overall Study||41
8401306|NCT01001195|20704916|P1|STARTED|Overall Study||39
8401307|NCT01001169|20704928|P2|NOT COMPLETED|Overall Study||1
8401308|NCT01001169|20704929|P1|NOT COMPLETED|Overall Study||2
8401309|NCT01001169|20704928|P2|COMPLETED|Overall Study||29
8401310|NCT01001169|20704929|P1|COMPLETED|Overall Study||28
8401311|NCT01001169|20704928|P2|STARTED|Overall Study||30
8401312|NCT01001169|20704929|P1|STARTED|Overall Study||30
8401313|NCT01001104|20705037|P4|NOT COMPLETED|Overall Study||3
8401314|NCT01001104|20705038|P3|NOT COMPLETED|Overall Study||1
8401315|NCT01001104|20705039|P2|NOT COMPLETED|Overall Study||1
8401316|NCT01001104|20705040|P1|NOT COMPLETED|Overall Study||2
8401317|NCT01001104|20705037|P4|COMPLETED|Overall Study||34
8401318|NCT01001104|20705038|P3|COMPLETED|Overall Study||35
8401319|NCT01001104|20705039|P2|COMPLETED|Overall Study||36
8401320|NCT01001104|20705040|P1|COMPLETED|Overall Study||33
8401321|NCT01001104|20705037|P4|STARTED|Overall Study||37
8401322|NCT01001104|20705038|P3|STARTED|Overall Study||36
8401323|NCT01001104|20705039|P2|STARTED|Overall Study||37
8401324|NCT01001104|20705040|P1|STARTED|Overall Study||35
8401325|NCT01001078|20705087|P2|NOT COMPLETED|Overall Study||0
8401326|NCT01001078|20705088|P1|NOT COMPLETED|Overall Study||0
8401327|NCT01001078|20705087|P2|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
8401328|NCT01001078|20705088|P1|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
8401329|NCT01001078|20705087|P2|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
8401330|NCT01001078|20705088|P1|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
8401331|NCT01001078|20705087|P2|Intubated|Overall Study||1
8401332|NCT01001078|20705088|P1|Intubated|Overall Study||2
8401333|NCT01001078|20705087|P2|Received Crossover|Overall Study||3
8401334|NCT01001078|20705088|P1|Received Crossover|Overall Study||2
8401335|NCT01001078|20705087|P2|Received Allocated Intervention|Overall Study||46
8401336|NCT01001078|20705088|P1|Received Allocated Intervention|Overall Study||46
8401337|NCT01001078|20705087|P2|STARTED|Overall Study||50
8401338|NCT01001078|20705088|P1|STARTED|Overall Study||50
8401339|NCT01001052|20705104|P2|NOT COMPLETED|Overall Study||0
8401340|NCT01001052|20705105|P1|NOT COMPLETED|Overall Study||0
8401341|NCT01001052|20705104|P2|COMPLETED|Overall Study||18
8401342|NCT01001052|20705105|P1|COMPLETED|Overall Study||20
8401343|NCT01001052|20705104|P2|STARTED|Overall Study||18
8401344|NCT01001052|20705105|P1|STARTED|Overall Study||20
8401345|NCT01000987|20705118|P3|NOT COMPLETED|Overall Study||0
8401346|NCT01000987|20705119|P2|NOT COMPLETED|Overall Study||0
8401347|NCT01000987|20705120|P1|NOT COMPLETED|Overall Study||0
8401348|NCT01000987|20705118|P3|COMPLETED|Overall Study||17
8401349|NCT01000987|20705119|P2|COMPLETED|Overall Study||15
8401350|NCT01000987|20705120|P1|COMPLETED|Overall Study||12
8401351|NCT01000987|20705118|P3|STARTED|Overall Study||17
8401352|NCT01000987|20705119|P2|STARTED|Overall Study||15
8401353|NCT01000987|20705120|P1|STARTED|Overall Study||12
8401354|NCT01000974|20705131|P3|NOT COMPLETED|Booster Vaccination Phase||14
8401355|NCT01000974|20705132|P2|NOT COMPLETED|Booster Vaccination Phase||12
8401356|NCT01000974|20705133|P1|NOT COMPLETED|Booster Vaccination Phase||67
8401357|NCT01000974|20705131|P3|COMPLETED|Booster Vaccination Phase||386
8401358|NCT01000974|20705132|P2|COMPLETED|Booster Vaccination Phase||423
8401359|NCT01000974|20705133|P1|COMPLETED|Booster Vaccination Phase||2270
8401360|NCT01000974|20705131|P3|STARTED|Booster Vaccination Phase||400
8401361|NCT01000974|20705132|P2|STARTED|Booster Vaccination Phase||435
8401362|NCT01000974|20705133|P1|STARTED|Booster Vaccination Phase||2337
8401363|NCT01000974|20705131|P3|NOT COMPLETED|Primary Vaccination Phase||63
8401364|NCT01000974|20705132|P2|NOT COMPLETED|Primary Vaccination Phase||50
8401365|NCT01000974|20705133|P1|NOT COMPLETED|Primary Vaccination Phase||338
8401366|NCT01000974|20705131|P3|COMPLETED|Primary Vaccination Phase||457
8401367|NCT01000974|20705132|P2|COMPLETED|Primary Vaccination Phase||470
8401368|NCT01000974|20705133|P1|COMPLETED|Primary Vaccination Phase||2625
8401369|NCT01000974|20705131|P3|STARTED|Primary Vaccination Phase||520
8401370|NCT01000974|20705132|P2|STARTED|Primary Vaccination Phase||520
8401371|NCT01000974|20705133|P1|STARTED|Primary Vaccination Phase||2963
8401372|NCT01000961|20705240|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8401373|NCT01000961|20705241|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8401374|NCT01000961|20705240|P2|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
8401375|NCT01000961|20705241|P1|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
8401376|NCT01000961|20705240|P2|STARTED|Second Intervention (3 Weeks)||20
8401377|NCT01000961|20705241|P1|STARTED|Second Intervention (3 Weeks)||21
8401378|NCT01000961|20705240|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
8401379|NCT01000961|20705241|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
8401380|NCT01000961|20705240|P2|COMPLETED|First Intervention (3 Weeks)||20
8401381|NCT01000961|20705241|P1|COMPLETED|First Intervention (3 Weeks)||21
8401382|NCT01000961|20705240|P2|STARTED|First Intervention (3 Weeks)||22
8401383|NCT01000961|20705241|P1|STARTED|First Intervention (3 Weeks)||21
8401384|NCT01000961|20705240|P2|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
8401385|NCT01000961|20705241|P1|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
8401386|NCT01000961|20705240|P2|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
8401387|NCT01000961|20705241|P1|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
8401388|NCT01000961|20705240|P2|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
8401389|NCT01000961|20705241|P1|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
8401390|NCT01000818|20705253|P1|NOT COMPLETED|Omeprazole + Raltegravir||0
8401391|NCT01000818|20705253|P1|COMPLETED|Omeprazole + Raltegravir||18
8401392|NCT01000818|20705253|P1|STARTED|Omeprazole + Raltegravir||18
8401393|NCT01000818|20705253|P1|NOT COMPLETED|Famotidine + Raltegravir||0
8401394|NCT01000818|20705253|P1|COMPLETED|Famotidine + Raltegravir||18
8401395|NCT01000818|20705253|P1|STARTED|Famotidine + Raltegravir||18
8401396|NCT01000818|20705253|P1|NOT COMPLETED|Raltegravir||0
8401397|NCT01000818|20705253|P1|COMPLETED|Raltegravir||18
8401398|NCT01000818|20705253|P1|STARTED|Raltegravir||18
8401399|NCT01000805|20705264|P2|NOT COMPLETED|Overall Study||62
8401400|NCT01000805|20705265|P1|NOT COMPLETED|Overall Study||70
8401401|NCT01000805|20705264|P2|COMPLETED|Overall Study||204
8401402|NCT01000805|20705265|P1|COMPLETED|Overall Study||192
8401403|NCT01000805|20705264|P2|STARTED|Overall Study||266
8401404|NCT01000805|20705265|P1|STARTED|Overall Study||262
8401405|NCT01000727|20705299|P2|NOT COMPLETED|Overall Study||176
8401406|NCT01000727|20705300|P1|NOT COMPLETED|Overall Study||175
8401407|NCT01000727|20705299|P2|COMPLETED|Overall Study||6328
8401408|NCT01000727|20705300|P1|COMPLETED|Overall Study||6347
8401409|NCT01000727|20705299|P2|STARTED|Overall Study||6504
8401410|NCT01000727|20705300|P1|STARTED|Overall Study||6522
8401411|NCT01000662|20705330|P2|NOT COMPLETED|Overall Study||8
8401412|NCT01000662|20705331|P1|NOT COMPLETED|Overall Study||4
8401413|NCT01000662|20705330|P2|COMPLETED|Overall Study||198
8401414|NCT01000662|20705331|P1|COMPLETED|Overall Study||202
8401415|NCT01000662|20705330|P2|STARTED|Overall Study||206
8401416|NCT01000662|20705331|P1|STARTED|Overall Study||206
8401417|NCT01000649|20705365|P4|NOT COMPLETED|Overall Study||6
8401418|NCT01000649|20705366|P3|NOT COMPLETED|Overall Study||2
8401419|NCT01000649|20705367|P2|NOT COMPLETED|Overall Study||3
8401420|NCT01000649|20705368|P1|NOT COMPLETED|Overall Study||5
8401421|NCT01000649|20705365|P4|COMPLETED|Overall Study||15
8401422|NCT01000649|20705366|P3|COMPLETED|Overall Study||0
8401423|NCT01000649|20705367|P2|COMPLETED|Overall Study||16
8401424|NCT01000649|20705368|P1|COMPLETED|Overall Study||5
8401425|NCT01000649|20705365|P4|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
8401426|NCT01000649|20705366|P3|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
8401427|NCT01000649|20705367|P2|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
8401428|NCT01000649|20705368|P1|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
8401429|NCT01000649|20705365|P4|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
8401430|NCT01000649|20705366|P3|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
8401431|NCT01000649|20705367|P2|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
8401432|NCT01000649|20705368|P1|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
8401433|NCT01000610|20705449|P1|NOT COMPLETED|Overall Study||6
8401434|NCT01000610|20705449|P1|COMPLETED|Overall Study||12
8401435|NCT01000610|20705449|P1|STARTED|Overall Study||18
8401436|NCT01000506|20705460|P4|NOT COMPLETED|Overall Study||23
8401437|NCT01000506|20705461|P3|NOT COMPLETED|Overall Study||21
8401438|NCT01000506|20705462|P2|NOT COMPLETED|Overall Study||24
8401439|NCT01000506|20705463|P1|NOT COMPLETED|Overall Study||28
8401440|NCT01000506|20705460|P4|COMPLETED|Overall Study||133
8401441|NCT01000506|20705461|P3|COMPLETED|Overall Study||131
8401442|NCT01000506|20705462|P2|COMPLETED|Overall Study||129
8401443|NCT01000506|20705463|P1|COMPLETED|Overall Study||127
8401444|NCT01000506|20705460|P4|STARTED|Overall Study||156
8401445|NCT01000506|20705461|P3|STARTED|Overall Study||152
8401446|NCT01000506|20705462|P2|STARTED|Overall Study||153
8401447|NCT01000506|20705463|P1|STARTED|Overall Study||155
8401448|NCT01000493|20705507|P2|NOT COMPLETED|Overall Study||55
8401449|NCT01000493|20705508|P1|NOT COMPLETED|Overall Study||39
8401450|NCT01000493|20705507|P2|COMPLETED|Overall Study||14
8401451|NCT01000493|20705508|P1|COMPLETED|Overall Study||21
8401452|NCT01000493|20705507|P2|STARTED|Overall Study||69
8401453|NCT01000493|20705508|P1|STARTED|Overall Study||60
8401454|NCT01000480|20705558|P1|NOT COMPLETED|Follow-Up Period||0
8401455|NCT01000480|20705558|P1|COMPLETED|Follow-Up Period||88
8401456|NCT01000480|20705558|P1|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
8401457|NCT01000480|20705558|P1|NOT COMPLETED|Concurrent Therapy Phase||10
8401458|NCT01000480|20705558|P1|COMPLETED|Concurrent Therapy Phase||65
8401459|NCT01000480|20705558|P1|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
8401460|NCT01000480|20705558|P1|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
8401461|NCT01000480|20705558|P1|NOT COMPLETED|Induction Phase||7
8401462|NCT01000480|20705558|P1|COMPLETED|Induction Phase||83
8401463|NCT01000480|20705558|P1|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
8401464|NCT01000480|20705558|P1|Received at Least 1 Dose of Either Drug|Induction Phase||90
8401465|NCT01000480|20705558|P1|STARTED|Induction Phase||90
8401466|NCT01000376|20705566|P2|NOT COMPLETED|Cycle 1 Day 15||0
8401467|NCT01000376|20705567|P1|NOT COMPLETED|Cycle 1 Day 15||0
8401468|NCT01000376|20705566|P2|COMPLETED|Cycle 1 Day 15||6
8401469|NCT01000376|20705567|P1|COMPLETED|Cycle 1 Day 15||4
8401470|NCT01000376|20705566|P2|STARTED|Cycle 1 Day 15||6
8401471|NCT01000376|20705567|P1|STARTED|Cycle 1 Day 15||4
8401472|NCT01000376|20705566|P2|NOT COMPLETED|Cycle 1 Day 1||0
8401473|NCT01000376|20705567|P1|NOT COMPLETED|Cycle 1 Day 1||2
8401474|NCT01000376|20705566|P2|COMPLETED|Cycle 1 Day 1||6
8401475|NCT01000376|20705567|P1|COMPLETED|Cycle 1 Day 1||4
8401476|NCT01000376|20705566|P2|STARTED|Cycle 1 Day 1||6
8401477|NCT01000376|20705567|P1|STARTED|Cycle 1 Day 1||6
8401478|NCT01000337|20705577|P2|NOT COMPLETED|Overall Study||3
8401479|NCT01000337|20705578|P1|NOT COMPLETED|Overall Study||4
8401480|NCT01000337|20705577|P2|COMPLETED|Overall Study||30
8401481|NCT01000337|20705578|P1|COMPLETED|Overall Study||30
8401482|NCT01000337|20705577|P2|STARTED|Overall Study||33
8401483|NCT01000337|20705578|P1|STARTED|Overall Study||34
8401484|NCT01000324|20705584|P1|NOT COMPLETED|Year 20||0
8401485|NCT01000324|20705584|P1|COMPLETED|Year 20||28
8401486|NCT01000324|20705584|P1|STARTED|Year 20||28
8401487|NCT01000324|20705584|P1|NOT COMPLETED|Year 19||0
8401488|NCT01000324|20705584|P1|COMPLETED|Year 19||28
8401489|NCT01000324|20705584|P1|STARTED|Year 19||28
8401490|NCT01000324|20705584|P1|NOT COMPLETED|Year 18||0
8401491|NCT01000324|20705584|P1|COMPLETED|Year 18||29
8401492|NCT01000324|20705584|P1|STARTED|Year 18||29
8401493|NCT01000324|20705584|P1|NOT COMPLETED|Year 17||0
8401494|NCT01000324|20705584|P1|COMPLETED|Year 17||32
8401495|NCT01000324|20705584|P1|STARTED|Year 17||32
8401496|NCT01000324|20705584|P1|NOT COMPLETED|Year 16||0
8401497|NCT01000324|20705584|P1|COMPLETED|Year 16||40
8401498|NCT01000324|20705584|P1|STARTED|Year 16||40
8401499|NCT01000311|20705596|P2|NOT COMPLETED|Overall Study||70
8401500|NCT01000311|20705597|P1|NOT COMPLETED|Overall Study||45
8401501|NCT01000311|20705596|P2|COMPLETED|Overall Study||201
8401502|NCT01000311|20705597|P1|COMPLETED|Overall Study||213
8401503|NCT01000311|20705596|P2|STARTED|Overall Study||271
8401504|NCT01000311|20705597|P1|STARTED|Overall Study||258
8401505|NCT01000285|20705627|P1|NOT COMPLETED|Overall Study||0
8401506|NCT01000285|20705627|P1|COMPLETED|Overall Study||18
8401507|NCT01000285|20705627|P1|STARTED|Overall Study||18
8401508|NCT01000155|20705647|P1|NOT COMPLETED|Overall Study||2
8401509|NCT01000155|20705647|P1|COMPLETED|Overall Study||3
8401510|NCT01000155|20705647|P1|STARTED|Overall Study||5
8401511|NCT01000064|20705653|P2|NOT COMPLETED|Overall Study||1
8401512|NCT01000064|20705654|P1|NOT COMPLETED|Overall Study||1
8401513|NCT01000064|20705653|P2|COMPLETED|Overall Study||5
8401514|NCT01000064|20705654|P1|COMPLETED|Overall Study||6
8401515|NCT01000064|20705653|P2|STARTED|Overall Study||6
8401516|NCT01000064|20705654|P1|STARTED|Overall Study||7
8401517|NCT01000051|20705677|P2|NOT COMPLETED|Overall Study||1
8401518|NCT01000051|20705678|P1|NOT COMPLETED|Overall Study||3
8401519|NCT01000051|20705677|P2|COMPLETED|Overall Study||17
8401520|NCT01000051|20705678|P1|COMPLETED|Overall Study||39
8401521|NCT01000051|20705677|P2|STARTED|Overall Study||18
8401522|NCT01000051|20705678|P1|STARTED|Overall Study||42
8401523|NCT01000025|20705686|P2|NOT COMPLETED|Overall Study||238
8401524|NCT01000025|20705687|P1|NOT COMPLETED|Overall Study||468
8401525|NCT01000025|20705686|P2|COMPLETED|Overall Study||2
8401526|NCT01000025|20705687|P1|COMPLETED|Overall Study||12
8401527|NCT01000025|20705686|P2|STARTED|Overall Study||240
8401528|NCT01000025|20705687|P1|STARTED|Overall Study||480
8401529|NCT00999921|20705705|P2|NOT COMPLETED|Overall Study||19
8401530|NCT00999921|20705706|P1|NOT COMPLETED|Overall Study||10
8401531|NCT00999921|20705705|P2|COMPLETED|Overall Study||110
8401532|NCT00999921|20705706|P1|COMPLETED|Overall Study||117
8401533|NCT00999921|20705705|P2|STARTED|Overall Study||129
8401534|NCT00999921|20705706|P1|STARTED|Overall Study||127
8401535|NCT00999908|20705716|P3|NOT COMPLETED|Treatment Period 3||0
8401536|NCT00999908|20705717|P2|NOT COMPLETED|Treatment Period 3||0
8401537|NCT00999908|20705718|P1|NOT COMPLETED|Treatment Period 3||0
8401538|NCT00999908|20705716|P3|COMPLETED|Treatment Period 3||19
8401539|NCT00999908|20705717|P2|COMPLETED|Treatment Period 3||16
8401540|NCT00999908|20705718|P1|COMPLETED|Treatment Period 3||16
8401541|NCT00999908|20705716|P3|STARTED|Treatment Period 3||19
8401542|NCT00999908|20705717|P2|STARTED|Treatment Period 3||16
8401543|NCT00999908|20705718|P1|STARTED|Treatment Period 3||16
8401544|NCT00999908|20705716|P3|NOT COMPLETED|Treatment Period 2||0
8401545|NCT00999908|20705717|P2|NOT COMPLETED|Treatment Period 2||0
8401546|NCT00999908|20705718|P1|NOT COMPLETED|Treatment Period 2||1
8401547|NCT00999908|20705716|P3|COMPLETED|Treatment Period 2||19
8401548|NCT00999908|20705717|P2|COMPLETED|Treatment Period 2||16
8401549|NCT00999908|20705718|P1|COMPLETED|Treatment Period 2||16
8401550|NCT00999908|20705716|P3|STARTED|Treatment Period 2||19
8401551|NCT00999908|20705717|P2|STARTED|Treatment Period 2||16
8401552|NCT00999908|20705718|P1|STARTED|Treatment Period 2||17
8401553|NCT00999908|20705716|P3|NOT COMPLETED|Treatment Period 1||0
8401554|NCT00999908|20705717|P2|NOT COMPLETED|Treatment Period 1||0
8401555|NCT00999908|20705718|P1|NOT COMPLETED|Treatment Period 1||2
8401556|NCT00999908|20705716|P3|COMPLETED|Treatment Period 1||19
8401557|NCT00999908|20705717|P2|COMPLETED|Treatment Period 1||16
8401558|NCT00999908|20705718|P1|COMPLETED|Treatment Period 1||17
8401559|NCT00999908|20705716|P3|STARTED|Treatment Period 1||19
8401560|NCT00999908|20705717|P2|STARTED|Treatment Period 1||16
8401561|NCT00999908|20705718|P1|STARTED|Treatment Period 1||19
8401562|NCT00999830|20705734|P2|NOT COMPLETED|Overall Study||0
8401563|NCT00999830|20705735|P1|NOT COMPLETED|Overall Study||0
8401564|NCT00999830|20705734|P2|COMPLETED|Overall Study||13
8401565|NCT00999830|20705735|P1|COMPLETED|Overall Study||14
8401566|NCT00999830|20705734|P2|STARTED|Overall Study||13
8401567|NCT00999830|20705735|P1|STARTED|Overall Study||14
8401574|NCT00999713|20705762|P2|NOT COMPLETED|Overall Study||0
8401575|NCT00999713|20705763|P1|NOT COMPLETED|Overall Study||2
8401576|NCT00999713|20705762|P2|COMPLETED|Overall Study||17
8401577|NCT00999713|20705763|P1|COMPLETED|Overall Study||24
8401578|NCT00999713|20705762|P2|STARTED|Overall Study||17
8401579|NCT00999713|20705763|P1|STARTED|Overall Study||26
8401580|NCT00999687|20705777|P1|NOT COMPLETED|Second Intervention||3
8401581|NCT00999687|20705777|P1|COMPLETED|Second Intervention||27
8401582|NCT00999687|20705777|P1|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
8401583|NCT00999687|20705777|P1|NOT COMPLETED|First Intervention||1
8401584|NCT00999687|20705777|P1|COMPLETED|First Intervention||30
8401585|NCT00999687|20705777|P1|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
8401586|NCT00999661|20705784|P1|NOT COMPLETED|Overall Study||70
8401587|NCT00999661|20705784|P1|COMPLETED|Overall Study||161
8401588|NCT00999661|20705784|P1|STARTED|Overall Study||231
8401589|NCT00999609|20705792|P2|NOT COMPLETED|Overall Study||1
8401590|NCT00999609|20705793|P1|NOT COMPLETED|Overall Study||1
8401591|NCT00999609|20705792|P2|COMPLETED|Overall Study|1 year post intervention|9
8401592|NCT00999609|20705793|P1|COMPLETED|Overall Study|1 year post intervention|20
8401593|NCT00999609|20705792|P2|STARTED|Overall Study||10
8401594|NCT00999609|20705793|P1|STARTED|Overall Study|Before intervention|21
8401595|NCT00999596|20705805|P1|NOT COMPLETED|Overall Study||101
8401596|NCT00999596|20705805|P1|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
8401597|NCT00999596|20705805|P1|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
8401598|NCT00999596|20705805|P1|STARTED|Overall Study||107
8401599|NCT00999544|20705810|P1|NOT COMPLETED|Overall Study||1
8401600|NCT00999544|20705810|P1|COMPLETED|Overall Study||8
8401601|NCT00999544|20705810|P1|STARTED|Overall Study||9
8401602|NCT00999466|20705846|P3|NOT COMPLETED|Main Part||4
8401603|NCT00999466|20705847|P2|NOT COMPLETED|Main Part||4
8401604|NCT00999466|20705848|P1|NOT COMPLETED|Main Part||0
8401605|NCT00999466|20705846|P3|COMPLETED|Main Part||21
8401606|NCT00999466|20705847|P2|COMPLETED|Main Part||22
8401607|NCT00999466|20705848|P1|COMPLETED|Main Part||0
8401608|NCT00999466|20705846|P3|STARTED|Main Part||25
8401609|NCT00999466|20705847|P2|STARTED|Main Part||26
8401610|NCT00999466|20705848|P1|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
8401611|NCT00999466|20705846|P3|NOT COMPLETED|Pilot Part||0
8401612|NCT00999466|20705847|P2|NOT COMPLETED|Pilot Part||0
8401613|NCT00999466|20705848|P1|NOT COMPLETED|Pilot Part||0
8401614|NCT00999466|20705846|P3|COMPLETED|Pilot Part||3
8401615|NCT00999466|20705847|P2|COMPLETED|Pilot Part||0
8401616|NCT00999466|20705848|P1|COMPLETED|Pilot Part||6
8401617|NCT00999466|20705846|P3|STARTED|Pilot Part||3
8401618|NCT00999466|20705847|P2|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
8401619|NCT00999466|20705848|P1|STARTED|Pilot Part||6
8401620|NCT00999167|20706125|P3|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
8401621|NCT00999167|20706126|P2|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
8401622|NCT00999167|20706127|P1|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
8401623|NCT00999167|20706125|P3|COMPLETED|Part B: Randomized, Placebo Controlled||67
8401624|NCT00999167|20706126|P2|COMPLETED|Part B: Randomized, Placebo Controlled||55
8401625|NCT00999167|20706127|P1|COMPLETED|Part B: Randomized, Placebo Controlled||0
8401626|NCT00999167|20706125|P3|STARTED|Part B: Randomized, Placebo Controlled||88
8401627|NCT00999167|20706126|P2|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
8401628|NCT00999167|20706127|P1|STARTED|Part B: Randomized, Placebo Controlled||0
8401629|NCT00999167|20706125|P3|NOT COMPLETED|Part A: Open Label Safety run-in||0
8401630|NCT00999167|20706126|P2|NOT COMPLETED|Part A: Open Label Safety run-in||0
8401631|NCT00999167|20706127|P1|NOT COMPLETED|Part A: Open Label Safety run-in||7
8401632|NCT00999167|20706125|P3|COMPLETED|Part A: Open Label Safety run-in||0
8401633|NCT00999167|20706126|P2|COMPLETED|Part A: Open Label Safety run-in||0
8401634|NCT00999167|20706127|P1|COMPLETED|Part A: Open Label Safety run-in||8
8401635|NCT00999167|20706125|P3|Received 9 mL BID|Part A: Open Label Safety run-in||0
8401636|NCT00999167|20706126|P2|Received 9 mL BID|Part A: Open Label Safety run-in||0
8401637|NCT00999167|20706127|P1|Received 9 mL BID|Part A: Open Label Safety run-in||15
8401638|NCT00999167|20706125|P3|STARTED|Part A: Open Label Safety run-in||0
8401639|NCT00999167|20706126|P2|STARTED|Part A: Open Label Safety run-in||0
8401640|NCT00999167|20706127|P1|STARTED|Part A: Open Label Safety run-in||15
8401641|NCT00999141|20706141|P1|NOT COMPLETED|Overall Study||0
8401642|NCT00999141|20706141|P1|COMPLETED|Overall Study||75
8401643|NCT00999141|20706141|P1|STARTED|Overall Study|Randomized and treated|75
8401644|NCT00999102|20706223|P2|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
8401645|NCT00999102|20706224|P1|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
8401646|NCT00999102|20706223|P2|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
8401647|NCT00999102|20706224|P1|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
8401648|NCT00999102|20706223|P2|STARTED|4 Weeks at Higher Dose of Second Drug||16
8401649|NCT00999102|20706224|P1|STARTED|4 Weeks at Higher Dose of Second Drug||15
8401650|NCT00999102|20706223|P2|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
8401651|NCT00999102|20706224|P1|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
8401652|NCT00999102|20706223|P2|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
8401653|NCT00999102|20706224|P1|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
8401654|NCT00999102|20706223|P2|STARTED|4 Weeks at Lower Dose of Second Drug||16
8401655|NCT00999102|20706224|P1|STARTED|4 Weeks at Lower Dose of Second Drug||15
8401656|NCT00999102|20706223|P2|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
8401657|NCT00999102|20706224|P1|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
8401658|NCT00999102|20706223|P2|COMPLETED|4 Weeks at Higher Dose of First Drug||16
8401659|NCT00999102|20706224|P1|COMPLETED|4 Weeks at Higher Dose of First Drug||15
8401660|NCT00999102|20706223|P2|STARTED|4 Weeks at Higher Dose of First Drug||16
8401661|NCT00999102|20706224|P1|STARTED|4 Weeks at Higher Dose of First Drug||15
8401662|NCT00999102|20706223|P2|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
8401663|NCT00999102|20706224|P1|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
8401664|NCT00999102|20706223|P2|COMPLETED|4 Weeks at Lower Dose of First Drug||16
8401665|NCT00999102|20706224|P1|COMPLETED|4 Weeks at Lower Dose of First Drug||15
8401666|NCT00999102|20706223|P2|STARTED|4 Weeks at Lower Dose of First Drug||17
8401667|NCT00999102|20706224|P1|STARTED|4 Weeks at Lower Dose of First Drug||16
8401668|NCT00999037|20706240|P2|NOT COMPLETED|Overall Study||0
8401669|NCT00999037|20706241|P1|NOT COMPLETED|Overall Study||0
8401670|NCT00999037|20706240|P2|COMPLETED|Overall Study||9
8401671|NCT00999037|20706241|P1|COMPLETED|Overall Study||9
8401672|NCT00999037|20706240|P2|STARTED|Overall Study|20|9
8401673|NCT00999037|20706241|P1|STARTED|Overall Study||9
8401674|NCT00998985|20706265|P14|NOT COMPLETED|Overall Study||0
8401675|NCT00998985|20706266|P13|NOT COMPLETED|Overall Study||0
8401676|NCT00998985|20706267|P12|NOT COMPLETED|Overall Study||0
8401677|NCT00998985|20706268|P11|NOT COMPLETED|Overall Study||0
8401678|NCT00998985|20706269|P10|NOT COMPLETED|Overall Study||0
8401679|NCT00998985|20706270|P9|NOT COMPLETED|Overall Study||1
8401680|NCT00998985|20706271|P8|NOT COMPLETED|Overall Study||0
8401681|NCT00998985|20706272|P7|NOT COMPLETED|Overall Study||0
8401682|NCT00998985|20706273|P6|NOT COMPLETED|Overall Study||1
8401683|NCT00998985|20706274|P5|NOT COMPLETED|Overall Study||0
8401684|NCT00998985|20706275|P4|NOT COMPLETED|Overall Study||0
8401685|NCT00998985|20706276|P3|NOT COMPLETED|Overall Study||0
8401686|NCT00998985|20706277|P2|NOT COMPLETED|Overall Study||0
8401687|NCT00998985|20706278|P1|NOT COMPLETED|Overall Study||0
8401688|NCT00998985|20706265|P14|COMPLETED|Overall Study||15
8401689|NCT00998985|20706266|P13|COMPLETED|Overall Study||5
8401690|NCT00998985|20706267|P12|COMPLETED|Overall Study||5
8401691|NCT00998985|20706268|P11|COMPLETED|Overall Study||5
8401692|NCT00998985|20706269|P10|COMPLETED|Overall Study||5
8401693|NCT00998985|20706270|P9|COMPLETED|Overall Study||5
8401694|NCT00998985|20706271|P8|COMPLETED|Overall Study||5
8401695|NCT00998985|20706272|P7|COMPLETED|Overall Study||5
8401696|NCT00998985|20706273|P6|COMPLETED|Overall Study||4
8401697|NCT00998985|20706274|P5|COMPLETED|Overall Study||5
8401698|NCT00998985|20706275|P4|COMPLETED|Overall Study||5
8401699|NCT00998985|20706276|P3|COMPLETED|Overall Study||15
8401700|NCT00998985|20706277|P2|COMPLETED|Overall Study||5
8401701|NCT00998985|20706278|P1|COMPLETED|Overall Study||5
8401702|NCT00998985|20706265|P14|STARTED|Overall Study||15
8401703|NCT00998985|20706266|P13|STARTED|Overall Study||5
8401704|NCT00998985|20706267|P12|STARTED|Overall Study||5
8401705|NCT00998985|20706268|P11|STARTED|Overall Study||5
8401706|NCT00998985|20706269|P10|STARTED|Overall Study||5
8401707|NCT00998985|20706270|P9|STARTED|Overall Study||6
8401708|NCT00998985|20706271|P8|STARTED|Overall Study||5
8401709|NCT00998985|20706272|P7|STARTED|Overall Study||5
8401710|NCT00998985|20706273|P6|STARTED|Overall Study||5
8401711|NCT00998985|20706274|P5|STARTED|Overall Study||5
8401712|NCT00998985|20706275|P4|STARTED|Overall Study||5
8401713|NCT00998985|20706276|P3|STARTED|Overall Study||15
8401714|NCT00998985|20706277|P2|STARTED|Overall Study||5
8401715|NCT00998985|20706278|P1|STARTED|Overall Study||5
8401716|NCT00998881|20706346|P2|NOT COMPLETED|Overall Study||2
8401717|NCT00998881|20706347|P1|NOT COMPLETED|Overall Study||8
8401718|NCT00998881|20706346|P2|COMPLETED|Overall Study||97
8401719|NCT00998881|20706347|P1|COMPLETED|Overall Study||96
8401720|NCT00998881|20706346|P2|STARTED|Overall Study||99
8401721|NCT00998881|20706347|P1|STARTED|Overall Study||104
8401722|NCT00998868|20706359|P1|NOT COMPLETED|Overall Study||0
8401723|NCT00998868|20706359|P1|COMPLETED|Overall Study||51
8401724|NCT00998868|20706359|P1|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
8401725|NCT00998790|20706366|P1|NOT COMPLETED|Overall Study||21
8401726|NCT00998790|20706366|P1|COMPLETED|Overall Study||93
8401727|NCT00998790|20706366|P1|Participants Who Were Treated|Overall Study||113
8401728|NCT00998790|20706366|P1|STARTED|Overall Study||114
8401729|NCT00998764|20706376|P2|NOT COMPLETED|Overall Study||274
8401730|NCT00998764|20706377|P1|NOT COMPLETED|Overall Study||216
8401731|NCT00998764|20706376|P2|COMPLETED|Overall Study||2
8401732|NCT00998764|20706377|P1|COMPLETED|Overall Study||0
8401733|NCT00998764|20706376|P2|Treated|Overall Study||275
8401734|NCT00998764|20706377|P1|Treated|Overall Study||215
8401735|NCT00998764|20706376|P2|STARTED|Overall Study||276
8401736|NCT00998764|20706377|P1|STARTED|Overall Study||216
8401737|NCT00998738|20706399|P1|NOT COMPLETED|Overall Study||1
8401738|NCT00998738|20706399|P1|COMPLETED|Overall Study||0
8401739|NCT00998738|20706399|P1|STARTED|Overall Study||1
8401740|NCT00998660|20706414|P1|NOT COMPLETED|Overall Study||13
8401741|NCT00998660|20706414|P1|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
8401742|NCT00998660|20706414|P1|Month 3 Visit|Overall Study||87
8401743|NCT00998660|20706414|P1|Implanted|Overall Study||93
8401744|NCT00998660|20706414|P1|STARTED|Overall Study||100
8401745|NCT00998582|20706420|P2|NOT COMPLETED|Overall Study||0
8401746|NCT00998582|20706421|P1|NOT COMPLETED|Overall Study||0
8401747|NCT00998582|20706420|P2|COMPLETED|Overall Study||14
8401748|NCT00998582|20706421|P1|COMPLETED|Overall Study||13
8401749|NCT00998582|20706420|P2|STARTED|Overall Study||14
8401750|NCT00998582|20706421|P1|STARTED|Overall Study||13
8401751|NCT00998517|20706432|P3|NOT COMPLETED|Overall Study||0
8401752|NCT00998517|20706433|P2|NOT COMPLETED|Overall Study||0
8401753|NCT00998517|20706434|P1|NOT COMPLETED|Overall Study||0
8401754|NCT00998517|20706432|P3|COMPLETED|Overall Study||918
8401755|NCT00998517|20706433|P2|COMPLETED|Overall Study||906
8401756|NCT00998517|20706434|P1|COMPLETED|Overall Study||888
8401757|NCT00998517|20706432|P3|STARTED|Overall Study||918
8401758|NCT00998517|20706433|P2|STARTED|Overall Study||906
8401759|NCT00998517|20706434|P1|STARTED|Overall Study||888
8401760|NCT00998426|20706460|P1|NOT COMPLETED|Overall Study||0
8401761|NCT00998426|20706460|P1|COMPLETED|Overall Study||5
8401762|NCT00998426|20706460|P1|Blood Glucose Monitoring|Overall Study||5
8401763|NCT00998426|20706460|P1|STARTED|Overall Study||5
8401764|NCT00998400|20706467|P2|NOT COMPLETED|Overall Study||2
8401765|NCT00998400|20706468|P1|NOT COMPLETED|Overall Study||2
8401766|NCT00998400|20706467|P2|COMPLETED|Overall Study||48
8401767|NCT00998400|20706468|P1|COMPLETED|Overall Study||48
8401768|NCT00998400|20706467|P2|STARTED|Overall Study||50
8401769|NCT00998400|20706468|P1|STARTED|Overall Study||50
8401770|NCT00998374|20706498|P2|NOT COMPLETED|Overall Study||11
8401771|NCT00998374|20706499|P1|NOT COMPLETED|Overall Study||12
8401772|NCT00998374|20706498|P2|COMPLETED|Overall Study||12
8401773|NCT00998374|20706499|P1|COMPLETED|Overall Study||27
8401774|NCT00998374|20706498|P2|STARTED|Overall Study||23
8401775|NCT00998374|20706499|P1|STARTED|Overall Study||39
8401776|NCT00998335|20706513|P2|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
8401777|NCT00998335|20706514|P1|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
8401778|NCT00998335|20706513|P2|COMPLETED|Randomized Period (Months 3 to 6)||20
8401779|NCT00998335|20706514|P1|COMPLETED|Randomized Period (Months 3 to 6)||8
8401780|NCT00998335|20706513|P2|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
8401781|NCT00998335|20706514|P1|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
8401782|NCT00998335|20706513|P2|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
8401783|NCT00998335|20706514|P1|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
8401784|NCT00998335|20706513|P2|COMPLETED|Initial Treatment (Months 0 - 3)||0
8401785|NCT00998335|20706514|P1|COMPLETED|Initial Treatment (Months 0 - 3)||30
8401786|NCT00998335|20706513|P2|STARTED|Initial Treatment (Months 0 - 3)||0
8401787|NCT00998335|20706514|P1|STARTED|Initial Treatment (Months 0 - 3)||30
8401788|NCT00998309|20706542|P1|NOT COMPLETED|Overall Study||4
8401789|NCT00998309|20706542|P1|COMPLETED|Overall Study||498
8401790|NCT00998309|20706542|P1|STARTED|Overall Study||502
8401791|NCT00998296|20706609|P11|NOT COMPLETED|Overall Study||7
8401792|NCT00998296|20706610|P10|NOT COMPLETED|Overall Study||18
8401793|NCT00998296|20706611|P9|NOT COMPLETED|Overall Study||2
8401794|NCT00998296|20706612|P8|NOT COMPLETED|Overall Study||2
8401795|NCT00998296|20706613|P7|NOT COMPLETED|Overall Study||1
8401796|NCT00998296|20706614|P6|NOT COMPLETED|Overall Study||0
8401797|NCT00998296|20706615|P5|NOT COMPLETED|Overall Study||2
8401798|NCT00998296|20706616|P4|NOT COMPLETED|Overall Study||0
8401799|NCT00998296|20706617|P3|NOT COMPLETED|Overall Study||0
8401800|NCT00998296|20706618|P2|NOT COMPLETED|Overall Study||1
8401801|NCT00998296|20706619|P1|NOT COMPLETED|Overall Study||0
8401802|NCT00998296|20706609|P11|COMPLETED|Overall Study||0
8401803|NCT00998296|20706610|P10|COMPLETED|Overall Study||0
8401804|NCT00998296|20706611|P9|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
8401805|NCT00998296|20706612|P8|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
8401806|NCT00998296|20706613|P7|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
8401807|NCT00998296|20706614|P6|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
8401808|NCT00998296|20706615|P5|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
8401809|NCT00998296|20706616|P4|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
8401810|NCT00998296|20706617|P3|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
8401811|NCT00998296|20706618|P2|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
8401812|NCT00998296|20706619|P1|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
8401813|NCT00998296|20706609|P11|STARTED|Overall Study||7
8401814|NCT00998296|20706610|P10|STARTED|Overall Study||18
8401815|NCT00998296|20706611|P9|STARTED|Overall Study||6
8401816|NCT00998296|20706612|P8|STARTED|Overall Study||6
8401817|NCT00998296|20706613|P7|STARTED|Overall Study||7
8401818|NCT00998296|20706614|P6|STARTED|Overall Study||3
8401819|NCT00998296|20706615|P5|STARTED|Overall Study||8
8401820|NCT00998296|20706616|P4|STARTED|Overall Study||3
8401821|NCT00998296|20706617|P3|STARTED|Overall Study||3
8401822|NCT00998296|20706618|P2|STARTED|Overall Study||3
8401823|NCT00998296|20706619|P1|STARTED|Overall Study||6
8401824|NCT00998205|20706686|P1|NOT COMPLETED|Overall Study||0
8401825|NCT00998205|20706686|P1|COMPLETED|Overall Study||16
8401826|NCT00998205|20706686|P1|STARTED|Overall Study||16
8401827|NCT00998049|20706691|P1|NOT COMPLETED|Overall Study||0
8401828|NCT00998049|20706691|P1|COMPLETED|Overall Study||39
8401829|NCT00998049|20706691|P1|STARTED|Overall Study||39
8401830|NCT00998023|20706702|P2|NOT COMPLETED|Overall Study||0
8401831|NCT00998023|20706703|P1|NOT COMPLETED|Overall Study||0
8401832|NCT00998023|20706702|P2|COMPLETED|Overall Study||32
8401833|NCT00998023|20706703|P1|COMPLETED|Overall Study||32
8401834|NCT00998023|20706702|P2|STARTED|Overall Study||32
8401835|NCT00998023|20706703|P1|STARTED|Overall Study||32
8401836|NCT00998010|20706711|P1|NOT COMPLETED|Overall Study||0
8401837|NCT00998010|20706711|P1|COMPLETED|Overall Study||24
8401838|NCT00998010|20706711|P1|STARTED|Overall Study||24
8401848|NCT00997932|20706790|P1|NOT COMPLETED|Overall Study||2
8401849|NCT00997932|20706790|P1|COMPLETED|Overall Study||27
8401850|NCT00997932|20706790|P1|STARTED|Overall Study||29
8401851|NCT00997893|20706798|P3|NOT COMPLETED|Overall Study||0
8401852|NCT00997893|20706799|P2|NOT COMPLETED|Overall Study||1
8401853|NCT00997893|20706800|P1|NOT COMPLETED|Overall Study||2
8401854|NCT00997893|20706798|P3|COMPLETED|Overall Study||13
8401855|NCT00997893|20706799|P2|COMPLETED|Overall Study||12
8401856|NCT00997893|20706800|P1|COMPLETED|Overall Study||12
8401857|NCT00997893|20706798|P3|STARTED|Overall Study||13
8401858|NCT00997893|20706799|P2|STARTED|Overall Study||13
8401859|NCT00997893|20706800|P1|STARTED|Overall Study||14
8401860|NCT00997672|20706822|P2|NOT COMPLETED|Overall Study||4
8401861|NCT00997672|20706823|P1|NOT COMPLETED|Overall Study||4
8401862|NCT00997672|20706822|P2|COMPLETED|Overall Study||1
8401863|NCT00997672|20706823|P1|COMPLETED|Overall Study||0
8401864|NCT00997672|20706822|P2|STARTED|Overall Study||5
8401865|NCT00997672|20706823|P1|STARTED|Overall Study||4
8401866|NCT00997620|20706831|P2|NOT COMPLETED|Overall Study||0
8401867|NCT00997620|20706832|P1|NOT COMPLETED|Overall Study||0
8401868|NCT00997620|20706831|P2|COMPLETED|Overall Study||21
8401869|NCT00997620|20706832|P1|COMPLETED|Overall Study||19
8401870|NCT00997620|20706831|P2|STARTED|Overall Study||21
8401871|NCT00997620|20706832|P1|STARTED|Overall Study||19
8401872|NCT00997594|20706850|P2|NOT COMPLETED|Overall Study||0
8401873|NCT00997594|20706851|P1|NOT COMPLETED|Overall Study||0
8401874|NCT00997594|20706850|P2|COMPLETED|Overall Study||9
8401875|NCT00997594|20706851|P1|COMPLETED|Overall Study||9
8401876|NCT00997594|20706850|P2|Completion of Ablation Procedure|Overall Study||9
8401877|NCT00997594|20706851|P1|Completion of Ablation Procedure|Overall Study||9
8401878|NCT00997594|20706850|P2|STARTED|Overall Study||9
8401879|NCT00997594|20706851|P1|STARTED|Overall Study||9
8401880|NCT00997555|20706859|P2|NOT COMPLETED|Overall Study||0
8401881|NCT00997555|20706860|P1|NOT COMPLETED|Overall Study||0
8401882|NCT00997555|20706859|P2|COMPLETED|Overall Study||15
8401883|NCT00997555|20706860|P1|COMPLETED|Overall Study||13
8401884|NCT00997555|20706859|P2|STARTED|Overall Study||15
8401885|NCT00997555|20706860|P1|STARTED|Overall Study||13
8401886|NCT00997516|20706878|P2|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
8401887|NCT00997516|20706879|P1|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
8401888|NCT00997516|20706878|P2|COMPLETED|Long-term Follow-up (After 6 Months)||36
8401889|NCT00997516|20706879|P1|COMPLETED|Long-term Follow-up (After 6 Months)||31
8401890|NCT00997516|20706878|P2|STARTED|Long-term Follow-up (After 6 Months)||38
8401891|NCT00997516|20706879|P1|STARTED|Long-term Follow-up (After 6 Months)||37
8401892|NCT00997516|20706878|P2|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
8401893|NCT00997516|20706879|P1|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
8401894|NCT00997516|20706878|P2|COMPLETED|Short-term Follow-up (Post Operative)||38
8401895|NCT00997516|20706879|P1|COMPLETED|Short-term Follow-up (Post Operative)||37
8401896|NCT00997516|20706878|P2|STARTED|Short-term Follow-up (Post Operative)||38
8401897|NCT00997516|20706879|P1|STARTED|Short-term Follow-up (Post Operative)||37
8401898|NCT00997503|20706907|P1|NOT COMPLETED|Overall Study||273
8401899|NCT00997503|20706907|P1|COMPLETED|Overall Study||3926
8401900|NCT00997503|20706907|P1|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
8401901|NCT00997503|20706907|P1|STARTED|Overall Study||4199
8401902|NCT00997438|20706950|P3|NOT COMPLETED|Overall Study||4
8401903|NCT00997438|20706951|P2|NOT COMPLETED|Overall Study||3
8401904|NCT00997438|20706952|P1|NOT COMPLETED|Overall Study||5
8401905|NCT00997438|20706950|P3|COMPLETED|Overall Study||20
8401906|NCT00997438|20706951|P2|COMPLETED|Overall Study||21
8401907|NCT00997438|20706952|P1|COMPLETED|Overall Study||16
8401908|NCT00997438|20706950|P3|STARTED|Overall Study||24
8401909|NCT00997438|20706951|P2|STARTED|Overall Study||24
8401910|NCT00997438|20706952|P1|STARTED|Overall Study||21
8401911|NCT00997425|20706987|P1|NOT COMPLETED|Overall Study||0
8401912|NCT00997425|20706987|P1|COMPLETED|Overall Study||19
8401913|NCT00997425|20706987|P1|STARTED|Overall Study||19
8401914|NCT00997386|20706992|P1|NOT COMPLETED|Overall Study||7
8401915|NCT00997386|20706992|P1|COMPLETED|Overall Study||9
8401916|NCT00997386|20706992|P1|STARTED|Overall Study||16
8401917|NCT00997373|20707001|P2|NOT COMPLETED|Overall Study||0
8401918|NCT00997373|20707002|P1|NOT COMPLETED|Overall Study||15
8401919|NCT00997373|20707001|P2|COMPLETED|Overall Study||15
8401920|NCT00997373|20707002|P1|COMPLETED|Overall Study||13
8401921|NCT00997373|20707001|P2|Completed Hysterectomy|Overall Study||15
8401922|NCT00997373|20707002|P1|Completed Hysterectomy|Overall Study||17
8401923|NCT00997373|20707001|P2|Received Letrozole|Overall Study||0
8401924|NCT00997373|20707002|P1|Received Letrozole|Overall Study||23
8401925|NCT00997373|20707001|P2|STARTED|Overall Study||15
8401926|NCT00997373|20707002|P1|STARTED|Overall Study||28
8401927|NCT00997334|20707008|P1|NOT COMPLETED|Overall Study||25
8401928|NCT00997334|20707008|P1|COMPLETED|Overall Study||35
8402016|NCT00996918|20707206|P3|STARTED|Overall Study||37
8401929|NCT00997334|20707008|P1|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
8401930|NCT00997334|20707008|P1|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
8401931|NCT00997334|20707008|P1|STARTED|Overall Study||60
8401932|NCT00997321|20707017|P2|NOT COMPLETED|Overall Study||3
8401933|NCT00997321|20707018|P1|NOT COMPLETED|Overall Study||0
8401934|NCT00997321|20707017|P2|COMPLETED|Overall Study||47
8401935|NCT00997321|20707018|P1|COMPLETED|Overall Study||50
8401936|NCT00997321|20707017|P2|STARTED|Overall Study||50
8401937|NCT00997321|20707018|P1|STARTED|Overall Study||50
8401938|NCT00997243|20707030|P1|NOT COMPLETED|Overall Study||7
8401939|NCT00997243|20707030|P1|COMPLETED|Overall Study||0
8401940|NCT00997243|20707030|P1|STARTED|Overall Study||7
8401953|NCT00997139|20707054|P1|NOT COMPLETED|Overall Study||186
8401954|NCT00997139|20707054|P1|COMPLETED|Overall Study||30
8401955|NCT00997139|20707054|P1|Treated for Positive Baseline Culture|Overall Study||30
8401956|NCT00997139|20707054|P1|STARTED|Overall Study||216
8401957|NCT00997126|20707062|P2|NOT COMPLETED|Overall Study||11
8401958|NCT00997126|20707063|P1|NOT COMPLETED|Overall Study||7
8401959|NCT00997126|20707062|P2|COMPLETED|Overall Study||52
8401960|NCT00997126|20707063|P1|COMPLETED|Overall Study||56
8401961|NCT00997126|20707062|P2|STARTED|Overall Study||63
8401962|NCT00997126|20707063|P1|STARTED|Overall Study||63
8401963|NCT00997113|20707079|P2|NOT COMPLETED|Overall Study||0
8401964|NCT00997113|20707080|P1|NOT COMPLETED|Overall Study||0
8401965|NCT00997113|20707079|P2|COMPLETED|Overall Study||10
8401966|NCT00997113|20707080|P1|COMPLETED|Overall Study||10
8401967|NCT00997113|20707079|P2|STARTED|Overall Study||10
8401968|NCT00997113|20707080|P1|STARTED|Overall Study||10
8401969|NCT00997035|20707092|P2|NOT COMPLETED|3-month Follow-up Visit||6
8401970|NCT00997035|20707093|P1|NOT COMPLETED|3-month Follow-up Visit||12
8401971|NCT00997035|20707092|P2|COMPLETED|3-month Follow-up Visit||107
8401972|NCT00997035|20707093|P1|COMPLETED|3-month Follow-up Visit||100
8401973|NCT00997035|20707092|P2|STARTED|3-month Follow-up Visit||113
8401974|NCT00997035|20707093|P1|STARTED|3-month Follow-up Visit||112
8401975|NCT00997035|20707092|P2|NOT COMPLETED|3-week Followup Visit||6
8401976|NCT00997035|20707093|P1|NOT COMPLETED|3-week Followup Visit||9
8401977|NCT00997035|20707092|P2|COMPLETED|3-week Followup Visit||113
8401978|NCT00997035|20707093|P1|COMPLETED|3-week Followup Visit||112
8401979|NCT00997035|20707092|P2|STARTED|3-week Followup Visit||119
8401980|NCT00997035|20707093|P1|STARTED|3-week Followup Visit||121
8401981|NCT00996996|20707117|P1|NOT COMPLETED|Overall Study||33
8401982|NCT00996996|20707117|P1|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
8401983|NCT00996996|20707117|P1|STARTED|Overall Study||77
8401984|NCT00996944|20707151|P2|NOT COMPLETED|Long-term Treatment Period||5
8401985|NCT00996944|20707152|P1|NOT COMPLETED|Long-term Treatment Period||12
8401986|NCT00996944|20707151|P2|COMPLETED|Long-term Treatment Period||0
8401987|NCT00996944|20707152|P1|COMPLETED|Long-term Treatment Period||0
8401988|NCT00996944|20707151|P2|STARTED|Long-term Treatment Period||5
8401989|NCT00996944|20707152|P1|STARTED|Long-term Treatment Period||12
8401990|NCT00996944|20707151|P2|NOT COMPLETED|Double-blind Treatment Period||7
8401991|NCT00996944|20707152|P1|NOT COMPLETED|Double-blind Treatment Period||10
8401992|NCT00996944|20707151|P2|COMPLETED|Double-blind Treatment Period||5
8401993|NCT00996944|20707152|P1|COMPLETED|Double-blind Treatment Period||12
8401994|NCT00996944|20707151|P2|STARTED|Double-blind Treatment Period||12
8401995|NCT00996944|20707152|P1|STARTED|Double-blind Treatment Period||22
8401996|NCT00996931|20707194|P1|NOT COMPLETED|Overall Study||0
8401997|NCT00996931|20707194|P1|COMPLETED|Overall Study||6
8401998|NCT00996931|20707194|P1|STARTED|Overall Study||6
8401999|NCT00996918|20707204|P5|NOT COMPLETED|Overall Study||4
8402000|NCT00996918|20707205|P4|NOT COMPLETED|Overall Study||56
8402001|NCT00996918|20707206|P3|NOT COMPLETED|Overall Study||37
8402002|NCT00996918|20707207|P2|NOT COMPLETED|Overall Study||66
8402003|NCT00996918|20707208|P1|NOT COMPLETED|Overall Study||39
8402004|NCT00996918|20707204|P5|COMPLETED|Overall Study||0
8402005|NCT00996918|20707205|P4|COMPLETED|Overall Study||0
8402006|NCT00996918|20707206|P3|COMPLETED|Overall Study||0
8402007|NCT00996918|20707207|P2|COMPLETED|Overall Study||0
8402008|NCT00996918|20707208|P1|COMPLETED|Overall Study||0
8402009|NCT00996918|20707204|P5|Treated|Overall Study||4
8402010|NCT00996918|20707205|P4|Treated|Overall Study||56
8402011|NCT00996918|20707206|P3|Treated|Overall Study||37
8402012|NCT00996918|20707207|P2|Treated|Overall Study||66
8402013|NCT00996918|20707208|P1|Treated|Overall Study||39
8402014|NCT00996918|20707204|P5|STARTED|Overall Study||4
8402015|NCT00996918|20707205|P4|STARTED|Overall Study||56
8402017|NCT00996918|20707207|P2|STARTED|Overall Study||66
8402018|NCT00996918|20707208|P1|STARTED|Overall Study||39
8402019|NCT00996892|20707252|P20|NOT COMPLETED|Expansion Stage 2A||45
8402020|NCT00996892|20707253|P19|NOT COMPLETED|Expansion Stage 2A||0
8402021|NCT00996892|20707254|P18|NOT COMPLETED|Expansion Stage 2A||0
8402022|NCT00996892|20707255|P17|NOT COMPLETED|Expansion Stage 2A||0
8402023|NCT00996892|20707256|P16|NOT COMPLETED|Expansion Stage 2A||0
8402024|NCT00996892|20707257|P15|NOT COMPLETED|Expansion Stage 2A||0
8402025|NCT00996892|20707258|P14|NOT COMPLETED|Expansion Stage 2A||0
8402026|NCT00996892|20707259|P13|NOT COMPLETED|Expansion Stage 2A||0
8402027|NCT00996892|20707260|P12|NOT COMPLETED|Expansion Stage 2A||0
8402028|NCT00996892|20707261|P11|NOT COMPLETED|Expansion Stage 2A||0
8402029|NCT00996892|20707262|P10|NOT COMPLETED|Expansion Stage 2A||0
8402030|NCT00996892|20707263|P9|NOT COMPLETED|Expansion Stage 2A||0
8402031|NCT00996892|20707264|P8|NOT COMPLETED|Expansion Stage 2A||0
8402032|NCT00996892|20707265|P7|NOT COMPLETED|Expansion Stage 2A||0
8402033|NCT00996892|20707266|P6|NOT COMPLETED|Expansion Stage 2A||0
8402034|NCT00996892|20707267|P5|NOT COMPLETED|Expansion Stage 2A||0
8402035|NCT00996892|20707268|P4|NOT COMPLETED|Expansion Stage 2A||0
8402036|NCT00996892|20707269|P3|NOT COMPLETED|Expansion Stage 2A||0
8402037|NCT00996892|20707270|P2|NOT COMPLETED|Expansion Stage 2A||0
8402038|NCT00996892|20707271|P1|NOT COMPLETED|Expansion Stage 2A||0
8402039|NCT00996892|20707252|P20|COMPLETED|Expansion Stage 2A||0
8402040|NCT00996892|20707253|P19|COMPLETED|Expansion Stage 2A||0
8402041|NCT00996892|20707254|P18|COMPLETED|Expansion Stage 2A||0
8402042|NCT00996892|20707255|P17|COMPLETED|Expansion Stage 2A||0
8402043|NCT00996892|20707256|P16|COMPLETED|Expansion Stage 2A||0
8402044|NCT00996892|20707257|P15|COMPLETED|Expansion Stage 2A||0
8402045|NCT00996892|20707258|P14|COMPLETED|Expansion Stage 2A||0
8402046|NCT00996892|20707259|P13|COMPLETED|Expansion Stage 2A||0
8402047|NCT00996892|20707260|P12|COMPLETED|Expansion Stage 2A||0
8402048|NCT00996892|20707261|P11|COMPLETED|Expansion Stage 2A||0
8402049|NCT00996892|20707262|P10|COMPLETED|Expansion Stage 2A||0
8402050|NCT00996892|20707263|P9|COMPLETED|Expansion Stage 2A||0
8402051|NCT00996892|20707264|P8|COMPLETED|Expansion Stage 2A||0
8402052|NCT00996892|20707265|P7|COMPLETED|Expansion Stage 2A||0
8402053|NCT00996892|20707266|P6|COMPLETED|Expansion Stage 2A||0
8402054|NCT00996892|20707267|P5|COMPLETED|Expansion Stage 2A||0
8402055|NCT00996892|20707268|P4|COMPLETED|Expansion Stage 2A||0
8402056|NCT00996892|20707269|P3|COMPLETED|Expansion Stage 2A||0
8402057|NCT00996892|20707270|P2|COMPLETED|Expansion Stage 2A||0
8402058|NCT00996892|20707271|P1|COMPLETED|Expansion Stage 2A||0
8402059|NCT00996892|20707252|P20|STARTED|Expansion Stage 2A||45
8402060|NCT00996892|20707253|P19|STARTED|Expansion Stage 2A||0
8402061|NCT00996892|20707254|P18|STARTED|Expansion Stage 2A||0
8402062|NCT00996892|20707255|P17|STARTED|Expansion Stage 2A||0
8402063|NCT00996892|20707256|P16|STARTED|Expansion Stage 2A||0
8402064|NCT00996892|20707257|P15|STARTED|Expansion Stage 2A||0
8402065|NCT00996892|20707258|P14|STARTED|Expansion Stage 2A||0
8402066|NCT00996892|20707259|P13|STARTED|Expansion Stage 2A||0
8402067|NCT00996892|20707260|P12|STARTED|Expansion Stage 2A||0
8402068|NCT00996892|20707261|P11|STARTED|Expansion Stage 2A||0
8402069|NCT00996892|20707262|P10|STARTED|Expansion Stage 2A||0
8402070|NCT00996892|20707263|P9|STARTED|Expansion Stage 2A||0
8402071|NCT00996892|20707264|P8|STARTED|Expansion Stage 2A||0
8402072|NCT00996892|20707265|P7|STARTED|Expansion Stage 2A||0
8402073|NCT00996892|20707266|P6|STARTED|Expansion Stage 2A||0
8402074|NCT00996892|20707267|P5|STARTED|Expansion Stage 2A||0
8402075|NCT00996892|20707268|P4|STARTED|Expansion Stage 2A||0
8402076|NCT00996892|20707269|P3|STARTED|Expansion Stage 2A||0
8402077|NCT00996892|20707270|P2|STARTED|Expansion Stage 2A||0
8402078|NCT00996892|20707271|P1|STARTED|Expansion Stage 2A||0
8402079|NCT00996892|20707252|P20|NOT COMPLETED|Expansion Stage 2||0
8402080|NCT00996892|20707253|P19|NOT COMPLETED|Expansion Stage 2||35
8402081|NCT00996892|20707254|P18|NOT COMPLETED|Expansion Stage 2||0
8402082|NCT00996892|20707255|P17|NOT COMPLETED|Expansion Stage 2||0
8402083|NCT00996892|20707256|P16|NOT COMPLETED|Expansion Stage 2||0
8402084|NCT00996892|20707257|P15|NOT COMPLETED|Expansion Stage 2||0
8402085|NCT00996892|20707258|P14|NOT COMPLETED|Expansion Stage 2||0
8402086|NCT00996892|20707259|P13|NOT COMPLETED|Expansion Stage 2||0
8402087|NCT00996892|20707260|P12|NOT COMPLETED|Expansion Stage 2||0
8402088|NCT00996892|20707261|P11|NOT COMPLETED|Expansion Stage 2||0
8402089|NCT00996892|20707262|P10|NOT COMPLETED|Expansion Stage 2||0
8402090|NCT00996892|20707263|P9|NOT COMPLETED|Expansion Stage 2||0
8402091|NCT00996892|20707264|P8|NOT COMPLETED|Expansion Stage 2||0
8402092|NCT00996892|20707265|P7|NOT COMPLETED|Expansion Stage 2||0
8402093|NCT00996892|20707266|P6|NOT COMPLETED|Expansion Stage 2||0
8402094|NCT00996892|20707267|P5|NOT COMPLETED|Expansion Stage 2||0
8402095|NCT00996892|20707268|P4|NOT COMPLETED|Expansion Stage 2||0
8402096|NCT00996892|20707269|P3|NOT COMPLETED|Expansion Stage 2||0
8402097|NCT00996892|20707270|P2|NOT COMPLETED|Expansion Stage 2||0
8402098|NCT00996892|20707271|P1|NOT COMPLETED|Expansion Stage 2||0
8402099|NCT00996892|20707252|P20|COMPLETED|Expansion Stage 2||0
8402100|NCT00996892|20707253|P19|COMPLETED|Expansion Stage 2||0
8402101|NCT00996892|20707254|P18|COMPLETED|Expansion Stage 2||0
8402102|NCT00996892|20707255|P17|COMPLETED|Expansion Stage 2||0
8402103|NCT00996892|20707256|P16|COMPLETED|Expansion Stage 2||0
8402104|NCT00996892|20707257|P15|COMPLETED|Expansion Stage 2||0
8402105|NCT00996892|20707258|P14|COMPLETED|Expansion Stage 2||0
8402106|NCT00996892|20707259|P13|COMPLETED|Expansion Stage 2||0
8402107|NCT00996892|20707260|P12|COMPLETED|Expansion Stage 2||0
8402108|NCT00996892|20707261|P11|COMPLETED|Expansion Stage 2||0
8402109|NCT00996892|20707262|P10|COMPLETED|Expansion Stage 2||0
8402110|NCT00996892|20707263|P9|COMPLETED|Expansion Stage 2||0
8402111|NCT00996892|20707264|P8|COMPLETED|Expansion Stage 2||0
8402112|NCT00996892|20707265|P7|COMPLETED|Expansion Stage 2||0
8402113|NCT00996892|20707266|P6|COMPLETED|Expansion Stage 2||0
8402114|NCT00996892|20707267|P5|COMPLETED|Expansion Stage 2||0
8402115|NCT00996892|20707268|P4|COMPLETED|Expansion Stage 2||0
8402116|NCT00996892|20707269|P3|COMPLETED|Expansion Stage 2||0
8402117|NCT00996892|20707270|P2|COMPLETED|Expansion Stage 2||0
8402118|NCT00996892|20707271|P1|COMPLETED|Expansion Stage 2||0
8402119|NCT00996892|20707252|P20|STARTED|Expansion Stage 2||0
8402120|NCT00996892|20707253|P19|STARTED|Expansion Stage 2||35
8402121|NCT00996892|20707254|P18|STARTED|Expansion Stage 2||0
8402122|NCT00996892|20707255|P17|STARTED|Expansion Stage 2||0
8402123|NCT00996892|20707256|P16|STARTED|Expansion Stage 2||0
8402124|NCT00996892|20707257|P15|STARTED|Expansion Stage 2||0
8402125|NCT00996892|20707258|P14|STARTED|Expansion Stage 2||0
8402126|NCT00996892|20707259|P13|STARTED|Expansion Stage 2||0
8402127|NCT00996892|20707260|P12|STARTED|Expansion Stage 2||0
8402128|NCT00996892|20707261|P11|STARTED|Expansion Stage 2||0
8402129|NCT00996892|20707262|P10|STARTED|Expansion Stage 2||0
8402130|NCT00996892|20707263|P9|STARTED|Expansion Stage 2||0
8402131|NCT00996892|20707264|P8|STARTED|Expansion Stage 2||0
8402132|NCT00996892|20707265|P7|STARTED|Expansion Stage 2||0
8402133|NCT00996892|20707266|P6|STARTED|Expansion Stage 2||0
8402134|NCT00996892|20707267|P5|STARTED|Expansion Stage 2||0
8402135|NCT00996892|20707268|P4|STARTED|Expansion Stage 2||0
8402136|NCT00996892|20707269|P3|STARTED|Expansion Stage 2||0
8402137|NCT00996892|20707270|P2|STARTED|Expansion Stage 2||0
8402138|NCT00996892|20707271|P1|STARTED|Expansion Stage 2||0
8402139|NCT00996892|20707252|P20|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402140|NCT00996892|20707253|P19|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402141|NCT00996892|20707254|P18|NOT COMPLETED|Dose-Escalation Stage 1B||5
8402142|NCT00996892|20707255|P17|NOT COMPLETED|Dose-Escalation Stage 1B||3
8402143|NCT00996892|20707256|P16|NOT COMPLETED|Dose-Escalation Stage 1B||3
8402144|NCT00996892|20707257|P15|NOT COMPLETED|Dose-Escalation Stage 1B||4
8402145|NCT00996892|20707258|P14|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402146|NCT00996892|20707259|P13|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402147|NCT00996892|20707260|P12|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402148|NCT00996892|20707261|P11|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402149|NCT00996892|20707262|P10|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402150|NCT00996892|20707263|P9|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402151|NCT00996892|20707264|P8|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402152|NCT00996892|20707265|P7|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402153|NCT00996892|20707266|P6|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402154|NCT00996892|20707267|P5|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402155|NCT00996892|20707268|P4|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402156|NCT00996892|20707269|P3|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402157|NCT00996892|20707270|P2|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402158|NCT00996892|20707271|P1|NOT COMPLETED|Dose-Escalation Stage 1B||0
8402159|NCT00996892|20707252|P20|COMPLETED|Dose-Escalation Stage 1B||0
8402160|NCT00996892|20707253|P19|COMPLETED|Dose-Escalation Stage 1B||0
8402161|NCT00996892|20707254|P18|COMPLETED|Dose-Escalation Stage 1B||0
8402162|NCT00996892|20707255|P17|COMPLETED|Dose-Escalation Stage 1B||0
8402163|NCT00996892|20707256|P16|COMPLETED|Dose-Escalation Stage 1B||0
8402164|NCT00996892|20707257|P15|COMPLETED|Dose-Escalation Stage 1B||0
8402165|NCT00996892|20707258|P14|COMPLETED|Dose-Escalation Stage 1B||0
8402166|NCT00996892|20707259|P13|COMPLETED|Dose-Escalation Stage 1B||0
8402167|NCT00996892|20707260|P12|COMPLETED|Dose-Escalation Stage 1B||0
8402168|NCT00996892|20707261|P11|COMPLETED|Dose-Escalation Stage 1B||0
8402169|NCT00996892|20707262|P10|COMPLETED|Dose-Escalation Stage 1B||0
8402170|NCT00996892|20707263|P9|COMPLETED|Dose-Escalation Stage 1B||0
8402171|NCT00996892|20707264|P8|COMPLETED|Dose-Escalation Stage 1B||0
8402172|NCT00996892|20707265|P7|COMPLETED|Dose-Escalation Stage 1B||0
8402173|NCT00996892|20707266|P6|COMPLETED|Dose-Escalation Stage 1B||0
8402174|NCT00996892|20707267|P5|COMPLETED|Dose-Escalation Stage 1B||0
8402175|NCT00996892|20707268|P4|COMPLETED|Dose-Escalation Stage 1B||0
8402176|NCT00996892|20707269|P3|COMPLETED|Dose-Escalation Stage 1B||0
8402177|NCT00996892|20707270|P2|COMPLETED|Dose-Escalation Stage 1B||0
8402178|NCT00996892|20707271|P1|COMPLETED|Dose-Escalation Stage 1B||0
8402179|NCT00996892|20707252|P20|STARTED|Dose-Escalation Stage 1B||0
8402180|NCT00996892|20707253|P19|STARTED|Dose-Escalation Stage 1B||0
8402181|NCT00996892|20707254|P18|STARTED|Dose-Escalation Stage 1B||5
8402182|NCT00996892|20707255|P17|STARTED|Dose-Escalation Stage 1B||3
8402183|NCT00996892|20707256|P16|STARTED|Dose-Escalation Stage 1B||3
8402184|NCT00996892|20707257|P15|STARTED|Dose-Escalation Stage 1B||4
8402185|NCT00996892|20707258|P14|STARTED|Dose-Escalation Stage 1B||0
8402186|NCT00996892|20707259|P13|STARTED|Dose-Escalation Stage 1B||0
8402187|NCT00996892|20707260|P12|STARTED|Dose-Escalation Stage 1B||0
8402188|NCT00996892|20707261|P11|STARTED|Dose-Escalation Stage 1B||0
8402189|NCT00996892|20707262|P10|STARTED|Dose-Escalation Stage 1B||0
8402190|NCT00996892|20707263|P9|STARTED|Dose-Escalation Stage 1B||0
8402191|NCT00996892|20707264|P8|STARTED|Dose-Escalation Stage 1B||0
8402192|NCT00996892|20707265|P7|STARTED|Dose-Escalation Stage 1B||0
8402193|NCT00996892|20707266|P6|STARTED|Dose-Escalation Stage 1B||0
8402194|NCT00996892|20707267|P5|STARTED|Dose-Escalation Stage 1B||0
8402195|NCT00996892|20707268|P4|STARTED|Dose-Escalation Stage 1B||0
8402196|NCT00996892|20707269|P3|STARTED|Dose-Escalation Stage 1B||0
8402197|NCT00996892|20707270|P2|STARTED|Dose-Escalation Stage 1B||0
8402198|NCT00996892|20707271|P1|STARTED|Dose-Escalation Stage 1B||0
8402199|NCT00996892|20707252|P20|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402200|NCT00996892|20707253|P19|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402201|NCT00996892|20707254|P18|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402202|NCT00996892|20707255|P17|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402203|NCT00996892|20707256|P16|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402204|NCT00996892|20707257|P15|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402205|NCT00996892|20707258|P14|NOT COMPLETED|Dose-Escalation Stage 1A||5
8402206|NCT00996892|20707259|P13|NOT COMPLETED|Dose-Escalation Stage 1A||8
8402207|NCT00996892|20707260|P12|NOT COMPLETED|Dose-Escalation Stage 1A||9
8402208|NCT00996892|20707261|P11|NOT COMPLETED|Dose-Escalation Stage 1A||7
8402209|NCT00996892|20707262|P10|NOT COMPLETED|Dose-Escalation Stage 1A||4
8402210|NCT00996892|20707263|P9|NOT COMPLETED|Dose-Escalation Stage 1A||3
8402211|NCT00996892|20707264|P8|NOT COMPLETED|Dose-Escalation Stage 1A||3
8402212|NCT00996892|20707265|P7|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402213|NCT00996892|20707266|P6|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402214|NCT00996892|20707267|P5|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402215|NCT00996892|20707268|P4|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402216|NCT00996892|20707269|P3|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402217|NCT00996892|20707270|P2|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402218|NCT00996892|20707271|P1|NOT COMPLETED|Dose-Escalation Stage 1A||0
8402219|NCT00996892|20707252|P20|COMPLETED|Dose-Escalation Stage 1A||0
8402220|NCT00996892|20707253|P19|COMPLETED|Dose-Escalation Stage 1A||0
8402221|NCT00996892|20707254|P18|COMPLETED|Dose-Escalation Stage 1A||0
8402222|NCT00996892|20707255|P17|COMPLETED|Dose-Escalation Stage 1A||0
8402223|NCT00996892|20707256|P16|COMPLETED|Dose-Escalation Stage 1A||0
8402224|NCT00996892|20707257|P15|COMPLETED|Dose-Escalation Stage 1A||0
8402225|NCT00996892|20707258|P14|COMPLETED|Dose-Escalation Stage 1A||0
8402226|NCT00996892|20707259|P13|COMPLETED|Dose-Escalation Stage 1A||0
8402227|NCT00996892|20707260|P12|COMPLETED|Dose-Escalation Stage 1A||0
8402228|NCT00996892|20707261|P11|COMPLETED|Dose-Escalation Stage 1A||0
8402229|NCT00996892|20707262|P10|COMPLETED|Dose-Escalation Stage 1A||0
8402230|NCT00996892|20707263|P9|COMPLETED|Dose-Escalation Stage 1A||0
8402231|NCT00996892|20707264|P8|COMPLETED|Dose-Escalation Stage 1A||0
8402232|NCT00996892|20707265|P7|COMPLETED|Dose-Escalation Stage 1A||0
8402233|NCT00996892|20707266|P6|COMPLETED|Dose-Escalation Stage 1A||0
8402234|NCT00996892|20707267|P5|COMPLETED|Dose-Escalation Stage 1A||0
8402235|NCT00996892|20707268|P4|COMPLETED|Dose-Escalation Stage 1A||0
8402236|NCT00996892|20707269|P3|COMPLETED|Dose-Escalation Stage 1A||0
8402237|NCT00996892|20707270|P2|COMPLETED|Dose-Escalation Stage 1A||0
8402238|NCT00996892|20707271|P1|COMPLETED|Dose-Escalation Stage 1A||0
8402239|NCT00996892|20707252|P20|STARTED|Dose-Escalation Stage 1A||0
8402240|NCT00996892|20707253|P19|STARTED|Dose-Escalation Stage 1A||0
8402241|NCT00996892|20707254|P18|STARTED|Dose-Escalation Stage 1A||0
8402242|NCT00996892|20707255|P17|STARTED|Dose-Escalation Stage 1A||0
8402243|NCT00996892|20707256|P16|STARTED|Dose-Escalation Stage 1A||0
8402244|NCT00996892|20707257|P15|STARTED|Dose-Escalation Stage 1A||0
8402245|NCT00996892|20707258|P14|STARTED|Dose-Escalation Stage 1A||5
8402246|NCT00996892|20707259|P13|STARTED|Dose-Escalation Stage 1A||8
8402247|NCT00996892|20707260|P12|STARTED|Dose-Escalation Stage 1A||9
8402248|NCT00996892|20707261|P11|STARTED|Dose-Escalation Stage 1A||7
8402249|NCT00996892|20707262|P10|STARTED|Dose-Escalation Stage 1A||4
8402250|NCT00996892|20707263|P9|STARTED|Dose-Escalation Stage 1A||3
8402251|NCT00996892|20707264|P8|STARTED|Dose-Escalation Stage 1A||3
8402252|NCT00996892|20707265|P7|STARTED|Dose-Escalation Stage 1A||0
8402253|NCT00996892|20707266|P6|STARTED|Dose-Escalation Stage 1A||0
8402254|NCT00996892|20707267|P5|STARTED|Dose-Escalation Stage 1A||0
8402255|NCT00996892|20707268|P4|STARTED|Dose-Escalation Stage 1A||0
8402256|NCT00996892|20707269|P3|STARTED|Dose-Escalation Stage 1A||0
8402257|NCT00996892|20707270|P2|STARTED|Dose-Escalation Stage 1A||0
8402258|NCT00996892|20707271|P1|STARTED|Dose-Escalation Stage 1A||0
8402259|NCT00996892|20707252|P20|NOT COMPLETED|Dose-Escalation Stage 1||0
8402260|NCT00996892|20707253|P19|NOT COMPLETED|Dose-Escalation Stage 1||0
8402261|NCT00996892|20707254|P18|NOT COMPLETED|Dose-Escalation Stage 1||0
8402262|NCT00996892|20707255|P17|NOT COMPLETED|Dose-Escalation Stage 1||0
8402263|NCT00996892|20707256|P16|NOT COMPLETED|Dose-Escalation Stage 1||0
8402264|NCT00996892|20707257|P15|NOT COMPLETED|Dose-Escalation Stage 1||0
8402265|NCT00996892|20707258|P14|NOT COMPLETED|Dose-Escalation Stage 1||0
8402266|NCT00996892|20707259|P13|NOT COMPLETED|Dose-Escalation Stage 1||0
8402267|NCT00996892|20707260|P12|NOT COMPLETED|Dose-Escalation Stage 1||0
8402268|NCT00996892|20707261|P11|NOT COMPLETED|Dose-Escalation Stage 1||0
8402269|NCT00996892|20707262|P10|NOT COMPLETED|Dose-Escalation Stage 1||0
8402270|NCT00996892|20707263|P9|NOT COMPLETED|Dose-Escalation Stage 1||0
8402271|NCT00996892|20707264|P8|NOT COMPLETED|Dose-Escalation Stage 1||0
8402272|NCT00996892|20707265|P7|NOT COMPLETED|Dose-Escalation Stage 1||4
8402273|NCT00996892|20707266|P6|NOT COMPLETED|Dose-Escalation Stage 1||10
8402274|NCT00996892|20707267|P5|NOT COMPLETED|Dose-Escalation Stage 1||11
8402275|NCT00996892|20707268|P4|NOT COMPLETED|Dose-Escalation Stage 1||9
8402276|NCT00996892|20707269|P3|NOT COMPLETED|Dose-Escalation Stage 1||3
8402277|NCT00996892|20707270|P2|NOT COMPLETED|Dose-Escalation Stage 1||3
8402278|NCT00996892|20707271|P1|NOT COMPLETED|Dose-Escalation Stage 1||4
8402279|NCT00996892|20707252|P20|COMPLETED|Dose-Escalation Stage 1||0
8402280|NCT00996892|20707253|P19|COMPLETED|Dose-Escalation Stage 1||0
8402281|NCT00996892|20707254|P18|COMPLETED|Dose-Escalation Stage 1||0
8402282|NCT00996892|20707255|P17|COMPLETED|Dose-Escalation Stage 1||0
8402283|NCT00996892|20707256|P16|COMPLETED|Dose-Escalation Stage 1||0
8402284|NCT00996892|20707257|P15|COMPLETED|Dose-Escalation Stage 1||0
8402285|NCT00996892|20707258|P14|COMPLETED|Dose-Escalation Stage 1||0
8402286|NCT00996892|20707259|P13|COMPLETED|Dose-Escalation Stage 1||0
8402287|NCT00996892|20707260|P12|COMPLETED|Dose-Escalation Stage 1||0
8402288|NCT00996892|20707261|P11|COMPLETED|Dose-Escalation Stage 1||0
8402289|NCT00996892|20707262|P10|COMPLETED|Dose-Escalation Stage 1||0
8402290|NCT00996892|20707263|P9|COMPLETED|Dose-Escalation Stage 1||0
8402291|NCT00996892|20707264|P8|COMPLETED|Dose-Escalation Stage 1||0
8402292|NCT00996892|20707265|P7|COMPLETED|Dose-Escalation Stage 1||0
8402293|NCT00996892|20707266|P6|COMPLETED|Dose-Escalation Stage 1||0
8402294|NCT00996892|20707267|P5|COMPLETED|Dose-Escalation Stage 1||0
8402295|NCT00996892|20707268|P4|COMPLETED|Dose-Escalation Stage 1||0
8402296|NCT00996892|20707269|P3|COMPLETED|Dose-Escalation Stage 1||0
8402297|NCT00996892|20707270|P2|COMPLETED|Dose-Escalation Stage 1||0
8402298|NCT00996892|20707271|P1|COMPLETED|Dose-Escalation Stage 1||0
8402299|NCT00996892|20707252|P20|STARTED|Dose-Escalation Stage 1||0
8402300|NCT00996892|20707253|P19|STARTED|Dose-Escalation Stage 1||0
8402301|NCT00996892|20707254|P18|STARTED|Dose-Escalation Stage 1||0
8402302|NCT00996892|20707255|P17|STARTED|Dose-Escalation Stage 1||0
8402303|NCT00996892|20707256|P16|STARTED|Dose-Escalation Stage 1||0
8402304|NCT00996892|20707257|P15|STARTED|Dose-Escalation Stage 1||0
8402305|NCT00996892|20707258|P14|STARTED|Dose-Escalation Stage 1||0
8402306|NCT00996892|20707259|P13|STARTED|Dose-Escalation Stage 1||0
8402307|NCT00996892|20707260|P12|STARTED|Dose-Escalation Stage 1||0
8402308|NCT00996892|20707261|P11|STARTED|Dose-Escalation Stage 1||0
8402309|NCT00996892|20707262|P10|STARTED|Dose-Escalation Stage 1||0
8402310|NCT00996892|20707263|P9|STARTED|Dose-Escalation Stage 1||0
8402311|NCT00996892|20707264|P8|STARTED|Dose-Escalation Stage 1||0
8402312|NCT00996892|20707265|P7|STARTED|Dose-Escalation Stage 1||4
8402313|NCT00996892|20707266|P6|STARTED|Dose-Escalation Stage 1||10
8402314|NCT00996892|20707267|P5|STARTED|Dose-Escalation Stage 1||11
8402315|NCT00996892|20707268|P4|STARTED|Dose-Escalation Stage 1||9
8402316|NCT00996892|20707269|P3|STARTED|Dose-Escalation Stage 1||3
8402317|NCT00996892|20707270|P2|STARTED|Dose-Escalation Stage 1||3
8402318|NCT00996892|20707271|P1|STARTED|Dose-Escalation Stage 1||4
8402319|NCT00996840|20707865|P5|NOT COMPLETED|Overall Study||2
8402320|NCT00996840|20707866|P4|NOT COMPLETED|Overall Study||1
8402321|NCT00996840|20707867|P3|NOT COMPLETED|Overall Study||1
8402322|NCT00996840|20707868|P2|NOT COMPLETED|Overall Study||2
8402323|NCT00996840|20707869|P1|NOT COMPLETED|Overall Study||1
8402324|NCT00996840|20707865|P5|COMPLETED|Overall Study||16
8402325|NCT00996840|20707866|P4|COMPLETED|Overall Study||17
8402326|NCT00996840|20707867|P3|COMPLETED|Overall Study||11
8402327|NCT00996840|20707868|P2|COMPLETED|Overall Study||7
8402328|NCT00996840|20707869|P1|COMPLETED|Overall Study||19
8402329|NCT00996840|20707865|P5|STARTED|Overall Study||18
8402330|NCT00996840|20707866|P4|STARTED|Overall Study||18
8402331|NCT00996840|20707867|P3|STARTED|Overall Study||12
8402332|NCT00996840|20707868|P2|STARTED|Overall Study||9
8402333|NCT00996840|20707869|P1|STARTED|Overall Study||20
8402334|NCT00996801|20708019|P6|NOT COMPLETED|Overall Study||19
8402335|NCT00996801|20708020|P5|NOT COMPLETED|Overall Study||88
8402336|NCT00996801|20708021|P4|NOT COMPLETED|Overall Study||31
8402337|NCT00996801|20708022|P3|NOT COMPLETED|Overall Study||23
8402338|NCT00996801|20708023|P2|NOT COMPLETED|Overall Study||16
8402339|NCT00996801|20708024|P1|NOT COMPLETED|Overall Study||20
8402340|NCT00996801|20708019|P6|COMPLETED|Overall Study||68
8402341|NCT00996801|20708020|P5|COMPLETED|Overall Study||0
8402342|NCT00996801|20708021|P4|COMPLETED|Overall Study||56
8402343|NCT00996801|20708022|P3|COMPLETED|Overall Study||65
8402344|NCT00996801|20708023|P2|COMPLETED|Overall Study||72
8402345|NCT00996801|20708024|P1|COMPLETED|Overall Study||68
8402346|NCT00996801|20708019|P6|STARTED|Overall Study||87
8402347|NCT00996801|20708020|P5|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
8402348|NCT00996801|20708021|P4|STARTED|Overall Study||87
8402349|NCT00996801|20708022|P3|STARTED|Overall Study||88
8402350|NCT00996801|20708023|P2|STARTED|Overall Study||88
8402351|NCT00996801|20708024|P1|STARTED|Overall Study||88
8402352|NCT00996775|20708127|P2|NOT COMPLETED|Overall Study||14
8402353|NCT00996775|20708128|P1|NOT COMPLETED|Overall Study||11
8402354|NCT00996775|20708127|P2|COMPLETED|Overall Study||75
8402355|NCT00996775|20708128|P1|COMPLETED|Overall Study||67
8402356|NCT00996775|20708127|P2|STARTED|Overall Study||89
8402357|NCT00996775|20708128|P1|STARTED|Overall Study||78
8402358|NCT00996736|20708136|P2|NOT COMPLETED|Overall Study||18
8402359|NCT00996736|20708137|P1|NOT COMPLETED|Overall Study||21
8402360|NCT00996736|20708136|P2|COMPLETED|Overall Study||143
8402361|NCT00996736|20708137|P1|COMPLETED|Overall Study||141
8402362|NCT00996736|20708136|P2|3-month Visit|Overall Study||146
8402363|NCT00996736|20708137|P1|3-month Visit|Overall Study||146
8402364|NCT00996736|20708136|P2|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
8402365|NCT00996736|20708137|P1|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
8402366|NCT00996736|20708136|P2|STARTED|Overall Study||161
8402367|NCT00996736|20708137|P1|STARTED|Overall Study||162
8402368|NCT00996658|20708157|P2|NOT COMPLETED|Overall Study||21
8402369|NCT00996658|20708158|P1|NOT COMPLETED|Overall Study||16
8402370|NCT00996658|20708157|P2|COMPLETED|Overall Study||165
8402371|NCT00996658|20708158|P1|COMPLETED|Overall Study||76
8402372|NCT00996658|20708157|P2|STARTED|Overall Study||186
8402373|NCT00996658|20708158|P1|STARTED|Overall Study||92
8402374|NCT00996632|20708186|P2|NOT COMPLETED|Overall Study||0
8402375|NCT00996632|20708187|P1|NOT COMPLETED|Overall Study||0
8402376|NCT00996632|20708186|P2|COMPLETED|Overall Study||56
8402377|NCT00996632|20708187|P1|COMPLETED|Overall Study||38
8402378|NCT00996632|20708186|P2|STARTED|Overall Study||56
8402379|NCT00996632|20708187|P1|STARTED|Overall Study||38
8402380|NCT00996606|20708195|P1|NOT COMPLETED|Overall Study||8
8402381|NCT00996606|20708195|P1|COMPLETED|Overall Study||50
8402382|NCT00996606|20708195|P1|STARTED|Overall Study||58
8402383|NCT00996593|20708289|P1|NOT COMPLETED|Long-Term Follow-Up||3
8402384|NCT00996593|20708289|P1|COMPLETED|Long-Term Follow-Up||6
8402385|NCT00996593|20708289|P1|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
8402386|NCT00996593|20708289|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
8402387|NCT00996593|20708289|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
8402388|NCT00996593|20708289|P1|STARTED|Dosimetric and Therapeutic Treatment||43
8402389|NCT00996580|20708317|P1|NOT COMPLETED|Overall Study||1453
8402390|NCT00996580|20708317|P1|COMPLETED|Overall Study||2144
8402391|NCT00996580|20708317|P1|Pregnancy Intent-to-Treat Population|Overall Study||3019
8402392|NCT00996580|20708317|P1|STARTED|Overall Study||3597
8402393|NCT00996502|20708345|P1|NOT COMPLETED|Overall Study||0
8402394|NCT00996502|20708345|P1|COMPLETED|Overall Study||4
8402395|NCT00996502|20708345|P1|STARTED|Overall Study||4
8402396|NCT00996489|20708352|P1|NOT COMPLETED|Overall Study||161
8402397|NCT00996489|20708352|P1|COMPLETED|Overall Study||298
8402398|NCT00996489|20708352|P1|STARTED|Overall Study||459
8402399|NCT00996476|20708372|P5|NOT COMPLETED|Overall Study||2
8402400|NCT00996476|20708373|P4|NOT COMPLETED|Overall Study||0
8402401|NCT00996476|20708374|P3|NOT COMPLETED|Overall Study||1
8402402|NCT00996476|20708375|P2|NOT COMPLETED|Overall Study||3
8402403|NCT00996476|20708376|P1|NOT COMPLETED|Overall Study||1
8402404|NCT00996476|20708372|P5|COMPLETED|Overall Study||11
8402405|NCT00996476|20708373|P4|COMPLETED|Overall Study||13
8402406|NCT00996476|20708374|P3|COMPLETED|Overall Study||12
8402407|NCT00996476|20708375|P2|COMPLETED|Overall Study||23
8402408|NCT00996476|20708376|P1|COMPLETED|Overall Study||26
8402409|NCT00996476|20708372|P5|STARTED|Overall Study||13
8402410|NCT00996476|20708373|P4|STARTED|Overall Study||13
8402411|NCT00996476|20708374|P3|STARTED|Overall Study||13
8402412|NCT00996476|20708375|P2|STARTED|Overall Study||26
8402413|NCT00996476|20708376|P1|STARTED|Overall Study||27
8402414|NCT00996437|20708444|P2|NOT COMPLETED|Overall Study||7
8402415|NCT00996437|20708445|P1|NOT COMPLETED|Overall Study||5
8402416|NCT00996437|20708444|P2|COMPLETED|Overall Study||129
8402417|NCT00996437|20708445|P1|COMPLETED|Overall Study||120
8402418|NCT00996437|20708444|P2|STARTED|Overall Study||136
8402419|NCT00996437|20708445|P1|STARTED|Overall Study||125
8402420|NCT00996372|20708467|P2|NOT COMPLETED|Overall Study||84
8402421|NCT00996372|20708468|P1|NOT COMPLETED|Overall Study||103
8402422|NCT00996372|20708467|P2|COMPLETED|Overall Study||397
8402423|NCT00996372|20708468|P1|COMPLETED|Overall Study||365
8402424|NCT00996372|20708467|P2|STARTED|Overall Study||481
8402425|NCT00996372|20708468|P1|STARTED|Overall Study||468
8402426|NCT00996346|20708481|P3|NOT COMPLETED|Overall Study||0
8402427|NCT00996346|20708482|P2|NOT COMPLETED|Overall Study||0
8402428|NCT00996346|20708483|P1|NOT COMPLETED|Overall Study||0
8402429|NCT00996346|20708481|P3|COMPLETED|Overall Study||3
8402430|NCT00996346|20708482|P2|COMPLETED|Overall Study||8
8402431|NCT00996346|20708483|P1|COMPLETED|Overall Study||6
8402432|NCT00996346|20708481|P3|STARTED|Overall Study||3
8402433|NCT00996346|20708482|P2|STARTED|Overall Study||8
8402434|NCT00996346|20708483|P1|STARTED|Overall Study||6
8402435|NCT00996333|20708490|P1|NOT COMPLETED|Overall Study||13
8402436|NCT00996333|20708490|P1|COMPLETED|Overall Study||33
8402437|NCT00996333|20708490|P1|STARTED|Overall Study||46
8402438|NCT00996307|20708500|P4|NOT COMPLETED|Overall Study||21
8402439|NCT00996307|20708501|P3|NOT COMPLETED|Overall Study||14
8402440|NCT00996307|20708502|P2|NOT COMPLETED|Overall Study||17
8402441|NCT00996307|20708503|P1|NOT COMPLETED|Overall Study||20
8402442|NCT00996307|20708500|P4|COMPLETED|Overall Study||144
8402443|NCT00996307|20708501|P3|COMPLETED|Overall Study||146
8402444|NCT00996307|20708502|P2|COMPLETED|Overall Study||148
8402445|NCT00996307|20708503|P1|COMPLETED|Overall Study||144
8402446|NCT00996307|20708500|P4|STARTED|Overall Study||165
8402447|NCT00996307|20708501|P3|STARTED|Overall Study||160
8402448|NCT00996307|20708502|P2|STARTED|Overall Study||165
8402449|NCT00996307|20708503|P1|STARTED|Overall Study||164
8402450|NCT00996281|20708563|P2|NOT COMPLETED|Overall Study||89
8402451|NCT00996281|20708564|P1|NOT COMPLETED|Overall Study||131
8402452|NCT00996281|20708563|P2|COMPLETED|Overall Study||330
8402453|NCT00996281|20708564|P1|COMPLETED|Overall Study||287
8402454|NCT00996281|20708563|P2|STARTED|Overall Study||419
8402455|NCT00996281|20708564|P1|STARTED|Overall Study||418
8402456|NCT00996216|20708572|P1|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
8402457|NCT00996216|20708572|P1|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
8402458|NCT00996216|20708572|P1|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn't qualify to begin antiviral treatment in Part 2.|25
8402459|NCT00996216|20708572|P1|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
8402460|NCT00996216|20708572|P1|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
8402461|NCT00996216|20708572|P1|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
8402462|NCT00996203|20708588|P1|NOT COMPLETED|Overall Study||7
8402463|NCT00996203|20708588|P1|COMPLETED|Overall Study||194
8402464|NCT00996203|20708588|P1|STARTED|Overall Study||201
8402465|NCT00996164|20708609|P2|NOT COMPLETED|Overall Study||101
8402466|NCT00996164|20708610|P1|NOT COMPLETED|Overall Study||135
8402467|NCT00996164|20708609|P2|COMPLETED|Overall Study||446
8402468|NCT00996164|20708610|P1|COMPLETED|Overall Study||408
8402469|NCT00996164|20708609|P2|STARTED|Overall Study||547
8402470|NCT00996164|20708610|P1|STARTED|Overall Study||543
8402471|NCT00996125|20708620|P2|NOT COMPLETED|Overall Study||11
8402472|NCT00996125|20708621|P1|NOT COMPLETED|Overall Study||5
8402473|NCT00996125|20708620|P2|COMPLETED|Overall Study||365
8402474|NCT00996125|20708621|P1|COMPLETED|Overall Study||369
8402475|NCT00996125|20708620|P2|STARTED|Overall Study||376
8402476|NCT00996125|20708621|P1|STARTED|Overall Study||374
8402477|NCT00996034|20708641|P1|NOT COMPLETED|Overall Study||3
8402478|NCT00996034|20708641|P1|COMPLETED|Overall Study||11
8402479|NCT00996034|20708641|P1|STARTED|Overall Study||14
8402480|NCT00995930|20708647|P2|NOT COMPLETED|Overall Study||28
8402481|NCT00995930|20708648|P1|NOT COMPLETED|Overall Study||21
8402482|NCT00995930|20708647|P2|COMPLETED|Overall Study||67
8402483|NCT00995930|20708648|P1|COMPLETED|Overall Study||73
8402484|NCT00995930|20708647|P2|Imaging Analysis Set|Overall Study||92
8402485|NCT00995930|20708648|P1|Imaging Analysis Set|Overall Study||92
8402486|NCT00995930|20708647|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||92
8402487|NCT00995930|20708648|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||92
8402488|NCT00995930|20708647|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||95
8402489|NCT00995930|20708648|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
8402490|NCT00995930|20708647|P2|Safety Analysis Set|Overall Study||95
8402491|NCT00995930|20708648|P1|Safety Analysis Set|Overall Study||94
8402492|NCT00995930|20708647|P2|STARTED|Overall Study||95
8402493|NCT00995930|20708648|P1|STARTED|Overall Study||94
8402494|NCT00995904|20708677|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8402495|NCT00995904|20708678|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8402496|NCT00995904|20708679|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8402497|NCT00995904|20708680|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8402498|NCT00995904|20708681|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8402499|NCT00995904|20708682|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
8402500|NCT00995904|20708677|P6|COMPLETED|Follow-up Visit (Final Visit)||3
8402501|NCT00995904|20708678|P5|COMPLETED|Follow-up Visit (Final Visit)||5
8402502|NCT00995904|20708679|P4|COMPLETED|Follow-up Visit (Final Visit)||5
8402503|NCT00995904|20708680|P3|COMPLETED|Follow-up Visit (Final Visit)||4
8402504|NCT00995904|20708681|P2|COMPLETED|Follow-up Visit (Final Visit)||3
8402505|NCT00995904|20708682|P1|COMPLETED|Follow-up Visit (Final Visit)||4
8402506|NCT00995904|20708677|P6|STARTED|Follow-up Visit (Final Visit)||3
8402507|NCT00995904|20708678|P5|STARTED|Follow-up Visit (Final Visit)||5
8402508|NCT00995904|20708679|P4|STARTED|Follow-up Visit (Final Visit)||5
8402509|NCT00995904|20708680|P3|STARTED|Follow-up Visit (Final Visit)||4
8402510|NCT00995904|20708681|P2|STARTED|Follow-up Visit (Final Visit)||3
8402511|NCT00995904|20708682|P1|STARTED|Follow-up Visit (Final Visit)||4
8402512|NCT00995904|20708677|P6|NOT COMPLETED|Visit 4||0
8402513|NCT00995904|20708678|P5|NOT COMPLETED|Visit 4||0
8402514|NCT00995904|20708679|P4|NOT COMPLETED|Visit 4||0
8402515|NCT00995904|20708680|P3|NOT COMPLETED|Visit 4||0
8402516|NCT00995904|20708681|P2|NOT COMPLETED|Visit 4||0
8402517|NCT00995904|20708682|P1|NOT COMPLETED|Visit 4||0
8402518|NCT00995904|20708677|P6|COMPLETED|Visit 4||3
8402519|NCT00995904|20708678|P5|COMPLETED|Visit 4||5
8402520|NCT00995904|20708679|P4|COMPLETED|Visit 4||5
8402521|NCT00995904|20708680|P3|COMPLETED|Visit 4||4
8402522|NCT00995904|20708681|P2|COMPLETED|Visit 4||3
8402523|NCT00995904|20708682|P1|COMPLETED|Visit 4||4
8402524|NCT00995904|20708677|P6|STARTED|Visit 4||3
8402525|NCT00995904|20708678|P5|STARTED|Visit 4||5
8402526|NCT00995904|20708679|P4|STARTED|Visit 4||5
8402527|NCT00995904|20708680|P3|STARTED|Visit 4||4
8402528|NCT00995904|20708681|P2|STARTED|Visit 4||3
8402529|NCT00995904|20708682|P1|STARTED|Visit 4||4
8402530|NCT00995904|20708677|P6|NOT COMPLETED|Visit 3||0
8402531|NCT00995904|20708678|P5|NOT COMPLETED|Visit 3||0
8402532|NCT00995904|20708679|P4|NOT COMPLETED|Visit 3||0
8402533|NCT00995904|20708680|P3|NOT COMPLETED|Visit 3||0
8402534|NCT00995904|20708681|P2|NOT COMPLETED|Visit 3||0
8402535|NCT00995904|20708682|P1|NOT COMPLETED|Visit 3||0
8402536|NCT00995904|20708677|P6|COMPLETED|Visit 3||3
8402537|NCT00995904|20708678|P5|COMPLETED|Visit 3||5
8402538|NCT00995904|20708679|P4|COMPLETED|Visit 3||5
8402539|NCT00995904|20708680|P3|COMPLETED|Visit 3||4
8402540|NCT00995904|20708681|P2|COMPLETED|Visit 3||3
8402541|NCT00995904|20708682|P1|COMPLETED|Visit 3||4
8402542|NCT00995904|20708677|P6|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
8402543|NCT00995904|20708678|P5|STARTED|Visit 3||5
8402544|NCT00995904|20708679|P4|STARTED|Visit 3||5
8402545|NCT00995904|20708680|P3|STARTED|Visit 3||4
8402546|NCT00995904|20708681|P2|STARTED|Visit 3||3
8402547|NCT00995904|20708682|P1|STARTED|Visit 3||4
8402548|NCT00995904|20708677|P6|NOT COMPLETED|Visit 2 (Randomization)||0
8402549|NCT00995904|20708678|P5|NOT COMPLETED|Visit 2 (Randomization)||0
8402550|NCT00995904|20708679|P4|NOT COMPLETED|Visit 2 (Randomization)||0
8402551|NCT00995904|20708680|P3|NOT COMPLETED|Visit 2 (Randomization)||0
8402552|NCT00995904|20708681|P2|NOT COMPLETED|Visit 2 (Randomization)||0
8402553|NCT00995904|20708682|P1|NOT COMPLETED|Visit 2 (Randomization)||0
8402554|NCT00995904|20708677|P6|COMPLETED|Visit 2 (Randomization)||4
8402555|NCT00995904|20708678|P5|COMPLETED|Visit 2 (Randomization)||5
8402556|NCT00995904|20708679|P4|COMPLETED|Visit 2 (Randomization)||5
8402557|NCT00995904|20708680|P3|COMPLETED|Visit 2 (Randomization)||4
8402558|NCT00995904|20708681|P2|COMPLETED|Visit 2 (Randomization)||3
8402559|NCT00995904|20708682|P1|COMPLETED|Visit 2 (Randomization)||4
8402560|NCT00995904|20708677|P6|STARTED|Visit 2 (Randomization)||4
8402561|NCT00995904|20708678|P5|STARTED|Visit 2 (Randomization)||5
8402562|NCT00995904|20708679|P4|STARTED|Visit 2 (Randomization)||5
8402563|NCT00995904|20708680|P3|STARTED|Visit 2 (Randomization)||4
8402564|NCT00995904|20708681|P2|STARTED|Visit 2 (Randomization)||3
8402565|NCT00995904|20708682|P1|STARTED|Visit 2 (Randomization)||4
8402566|NCT00995865|20708699|P3|NOT COMPLETED|Overall Study||1
8402567|NCT00995865|20708700|P2|NOT COMPLETED|Overall Study||0
8402568|NCT00995865|20708701|P1|NOT COMPLETED|Overall Study||2
8402569|NCT00995865|20708699|P3|COMPLETED|Overall Study||11
8402570|NCT00995865|20708700|P2|COMPLETED|Overall Study||24
8402571|NCT00995865|20708701|P1|COMPLETED|Overall Study||22
8402572|NCT00995865|20708699|P3|STARTED|Overall Study||12
8402573|NCT00995865|20708700|P2|STARTED|Overall Study||24
8402574|NCT00995865|20708701|P1|STARTED|Overall Study||24
8402575|NCT00995774|20708723|P2|NOT COMPLETED|Training Period 2||0
8402576|NCT00995774|20708724|P1|NOT COMPLETED|Training Period 2||2
8402577|NCT00995774|20708723|P2|COMPLETED|Training Period 2||5
8402578|NCT00995774|20708724|P1|COMPLETED|Training Period 2||5
8402579|NCT00995774|20708723|P2|STARTED|Training Period 2||5
8402580|NCT00995774|20708724|P1|STARTED|Training Period 2||7
8402581|NCT00995774|20708723|P2|NOT COMPLETED|Washout Period||0
8402582|NCT00995774|20708724|P1|NOT COMPLETED|Washout Period||0
8402583|NCT00995774|20708723|P2|COMPLETED|Washout Period||5
8402584|NCT00995774|20708724|P1|COMPLETED|Washout Period||7
8402585|NCT00995774|20708723|P2|STARTED|Washout Period||5
8402586|NCT00995774|20708724|P1|STARTED|Washout Period||7
8402587|NCT00995774|20708723|P2|NOT COMPLETED|Training Period 1||0
8402588|NCT00995774|20708724|P1|NOT COMPLETED|Training Period 1||0
8402589|NCT00995774|20708723|P2|COMPLETED|Training Period 1||5
8402590|NCT00995774|20708724|P1|COMPLETED|Training Period 1||7
8402591|NCT00995774|20708723|P2|STARTED|Training Period 1||5
8402592|NCT00995774|20708724|P1|STARTED|Training Period 1||7
8402593|NCT00995761|20708734|P1|NOT COMPLETED|Overall Study||0
8402594|NCT00995761|20708734|P1|COMPLETED|Overall Study||48
8402595|NCT00995761|20708734|P1|STARTED|Overall Study||48
8402596|NCT00995722|20708740|P2|NOT COMPLETED|Overall Study: 36 Weeks||2
8402597|NCT00995722|20708741|P1|NOT COMPLETED|Overall Study: 36 Weeks||2
8402598|NCT00995722|20708740|P2|COMPLETED|Overall Study: 36 Weeks||2
8402599|NCT00995722|20708741|P1|COMPLETED|Overall Study: 36 Weeks||3
8402600|NCT00995722|20708740|P2|STARTED|Overall Study: 36 Weeks||4
8402601|NCT00995722|20708741|P1|STARTED|Overall Study: 36 Weeks||5
8402602|NCT00995722|20708740|P2|NOT COMPLETED|Double Blinded: 16 Weeks||1
8402603|NCT00995722|20708741|P1|NOT COMPLETED|Double Blinded: 16 Weeks||1
8402604|NCT00995722|20708740|P2|COMPLETED|Double Blinded: 16 Weeks||4
8402605|NCT00995722|20708741|P1|COMPLETED|Double Blinded: 16 Weeks||5
8402606|NCT00995722|20708740|P2|STARTED|Double Blinded: 16 Weeks||5
8402607|NCT00995722|20708741|P1|STARTED|Double Blinded: 16 Weeks||6
8402608|NCT00995709|20708758|P3|NOT COMPLETED|Overall Study||5
8402609|NCT00995709|20708759|P2|NOT COMPLETED|Overall Study||9
8402610|NCT00995709|20708760|P1|NOT COMPLETED|Overall Study||7
8402611|NCT00995709|20708758|P3|COMPLETED|Overall Study||34
8402612|NCT00995709|20708759|P2|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
8402613|NCT00995709|20708760|P1|COMPLETED|Overall Study||32
8402614|NCT00995709|20708758|P3|STARTED|Overall Study||39
8402615|NCT00995709|20708759|P2|STARTED|Overall Study||40
8402616|NCT00995709|20708760|P1|STARTED|Overall Study||39
8402617|NCT00995670|20708786|P3|NOT COMPLETED|Overall Study||3
8402618|NCT00995670|20708787|P2|NOT COMPLETED|Overall Study||0
8402619|NCT00995670|20708788|P1|NOT COMPLETED|Overall Study||1
8402620|NCT00995670|20708786|P3|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
8402621|NCT00995670|20708787|P2|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
8402622|NCT00995670|20708788|P1|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
8402623|NCT00995670|20708786|P3|STARTED|Overall Study||17
8402624|NCT00995670|20708787|P2|STARTED|Overall Study||16
8402625|NCT00995670|20708788|P1|STARTED|Overall Study||26
8402626|NCT00995566|20708796|P1|NOT COMPLETED|Overall Study||54
8402627|NCT00995566|20708796|P1|COMPLETED|Overall Study||0
8402628|NCT00995566|20708796|P1|STARTED|Overall Study||54
8402629|NCT00995553|20708810|P2|NOT COMPLETED|Overall Study||6
8402630|NCT00995553|20708811|P1|NOT COMPLETED|Overall Study||2
8402631|NCT00995553|20708810|P2|COMPLETED|Overall Study||35
8402632|NCT00995553|20708811|P1|COMPLETED|Overall Study||38
8402633|NCT00995553|20708810|P2|STARTED|Overall Study||41
8402634|NCT00995553|20708811|P1|STARTED|Overall Study||40
8402635|NCT00995501|20708827|P8|NOT COMPLETED|Overall Study||0
8402636|NCT00995501|20708828|P7|NOT COMPLETED|Overall Study||0
8402637|NCT00995501|20708829|P6|NOT COMPLETED|Overall Study||0
8402638|NCT00995501|20708830|P5|NOT COMPLETED|Overall Study||0
8402639|NCT00995501|20708831|P4|NOT COMPLETED|Overall Study||0
8402640|NCT00995501|20708832|P3|NOT COMPLETED|Overall Study||0
8402641|NCT00995501|20708833|P2|NOT COMPLETED|Overall Study||0
8402642|NCT00995501|20708834|P1|NOT COMPLETED|Overall Study||0
8402643|NCT00995501|20708827|P8|COMPLETED|Overall Study||46
8402644|NCT00995501|20708828|P7|COMPLETED|Overall Study||49
8402645|NCT00995501|20708829|P6|COMPLETED|Overall Study||44
8402646|NCT00995501|20708830|P5|COMPLETED|Overall Study||46
8402647|NCT00995501|20708831|P4|COMPLETED|Overall Study||46
8402648|NCT00995501|20708832|P3|COMPLETED|Overall Study||47
8402649|NCT00995501|20708833|P2|COMPLETED|Overall Study||51
8402650|NCT00995501|20708834|P1|COMPLETED|Overall Study||52
8402651|NCT00995501|20708827|P8|STARTED|Overall Study||46
8402652|NCT00995501|20708828|P7|STARTED|Overall Study||49
8402653|NCT00995501|20708829|P6|STARTED|Overall Study||44
8402654|NCT00995501|20708830|P5|STARTED|Overall Study||46
8402655|NCT00995501|20708831|P4|STARTED|Overall Study||46
8402656|NCT00995501|20708832|P3|STARTED|Overall Study||47
8402657|NCT00995501|20708833|P2|STARTED|Overall Study||51
8402658|NCT00995501|20708834|P1|STARTED|Overall Study||52
8402659|NCT00995488|20708860|P1|NOT COMPLETED|Overall Study||1
8402660|NCT00995488|20708860|P1|COMPLETED|Overall Study||15
8402661|NCT00995488|20708860|P1|STARTED|Overall Study||16
8402662|NCT00995475|20708865|P2|NOT COMPLETED|Second Intervention||0
8402663|NCT00995475|20708866|P1|NOT COMPLETED|Second Intervention||0
8402664|NCT00995475|20708865|P2|COMPLETED|Second Intervention||9
8402665|NCT00995475|20708866|P1|COMPLETED|Second Intervention||9
8402666|NCT00995475|20708865|P2|STARTED|Second Intervention||9
8402667|NCT00995475|20708866|P1|STARTED|Second Intervention||9
8402668|NCT00995475|20708865|P2|NOT COMPLETED|Wash-out Two Week||0
8402669|NCT00995475|20708866|P1|NOT COMPLETED|Wash-out Two Week||0
8402670|NCT00995475|20708865|P2|COMPLETED|Wash-out Two Week||9
8402671|NCT00995475|20708866|P1|COMPLETED|Wash-out Two Week||9
8402672|NCT00995475|20708865|P2|STARTED|Wash-out Two Week||9
8402673|NCT00995475|20708866|P1|STARTED|Wash-out Two Week||9
8402674|NCT00995475|20708865|P2|NOT COMPLETED|First Intervention||0
8402675|NCT00995475|20708866|P1|NOT COMPLETED|First Intervention||0
8402676|NCT00995475|20708865|P2|COMPLETED|First Intervention||9
8402677|NCT00995475|20708866|P1|COMPLETED|First Intervention||9
8402678|NCT00995475|20708865|P2|STARTED|First Intervention||9
8402679|NCT00995475|20708866|P1|STARTED|First Intervention||9
8402680|NCT00995449|20708880|P4|NOT COMPLETED|Overall Study||0
8402681|NCT00995449|20708881|P3|NOT COMPLETED|Overall Study||2
8402682|NCT00995449|20708882|P2|NOT COMPLETED|Overall Study||0
8402683|NCT00995449|20708883|P1|NOT COMPLETED|Overall Study||0
8402684|NCT00995449|20708880|P4|COMPLETED|Overall Study||2
8402685|NCT00995449|20708881|P3|COMPLETED|Overall Study||5
8402686|NCT00995449|20708882|P2|COMPLETED|Overall Study||0
8402687|NCT00995449|20708883|P1|COMPLETED|Overall Study||0
8402688|NCT00995449|20708880|P4|STARTED|Overall Study||2
8402689|NCT00995449|20708881|P3|STARTED|Overall Study||7
8402690|NCT00995449|20708882|P2|STARTED|Overall Study||0
8402691|NCT00995449|20708883|P1|STARTED|Overall Study||0
8402692|NCT00995436|20708894|P3|NOT COMPLETED|Overall Study||0
8402693|NCT00995436|20708895|P2|NOT COMPLETED|Overall Study||5
8402694|NCT00995436|20708896|P1|NOT COMPLETED|Overall Study||2
8402695|NCT00995436|20708894|P3|COMPLETED|Overall Study||26
8402696|NCT00995436|20708895|P2|COMPLETED|Overall Study||22
8402697|NCT00995436|20708896|P1|COMPLETED|Overall Study||23
8402698|NCT00995436|20708894|P3|STARTED|Overall Study||26
8402699|NCT00995436|20708895|P2|STARTED|Overall Study||27
8402700|NCT00995436|20708896|P1|STARTED|Overall Study|25|25
8402701|NCT00995410|20708904|P1|NOT COMPLETED|Overall Study||88
8402702|NCT00995410|20708904|P1|COMPLETED|Overall Study||292
8402703|NCT00995410|20708904|P1|Treated|Overall Study||379
8402704|NCT00995410|20708904|P1|STARTED|Overall Study||380
8402705|NCT00995371|20708911|P2|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
8402706|NCT00995371|20708912|P1|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
8402707|NCT00995371|20708911|P2|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
8402708|NCT00995371|20708912|P1|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
8402709|NCT00995371|20708911|P2|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
8402710|NCT00995371|20708912|P1|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
8402711|NCT00995371|20708911|P2|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
8402712|NCT00995371|20708912|P1|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
8402713|NCT00995371|20708911|P2|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
8402714|NCT00995371|20708912|P1|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
8402715|NCT00995371|20708911|P2|STARTED|Prior to ESI Cross-over, 6 Weeks||17
8402716|NCT00995371|20708912|P1|STARTED|Prior to ESI Cross-over, 6 Weeks||21
8402717|NCT00995345|20708930|P5|NOT COMPLETED|Overall Study||5
8402718|NCT00995345|20708931|P4|NOT COMPLETED|Overall Study||5
8402719|NCT00995345|20708932|P3|NOT COMPLETED|Overall Study||7
8402720|NCT00995345|20708933|P2|NOT COMPLETED|Overall Study||7
8402721|NCT00995345|20708934|P1|NOT COMPLETED|Overall Study||11
8402722|NCT00995345|20708930|P5|COMPLETED|Overall Study||75
8402723|NCT00995345|20708931|P4|COMPLETED|Overall Study||76
8402724|NCT00995345|20708932|P3|COMPLETED|Overall Study||73
8402725|NCT00995345|20708933|P2|COMPLETED|Overall Study||74
8402726|NCT00995345|20708934|P1|COMPLETED|Overall Study||70
8402727|NCT00995345|20708930|P5|STARTED|Overall Study||80
8402728|NCT00995345|20708931|P4|STARTED|Overall Study||81
8402729|NCT00995345|20708932|P3|STARTED|Overall Study||80
8402730|NCT00995345|20708933|P2|STARTED|Overall Study||81
8402731|NCT00995345|20708934|P1|STARTED|Overall Study||81
8402732|NCT00995215|20708961|P1|NOT COMPLETED|Overall Study||0
8402733|NCT00995215|20708961|P1|COMPLETED|Overall Study||6
8402734|NCT00995215|20708961|P1|STARTED|Overall Study||6
8402735|NCT00995085|20708966|P1|NOT COMPLETED|Overall Study||5
8402736|NCT00995085|20708966|P1|COMPLETED|Overall Study||38
8402737|NCT00995085|20708966|P1|STARTED|Overall Study||43
8402738|NCT00995072|20708972|P2|NOT COMPLETED|Overall Study||3
8402739|NCT00995072|20708973|P1|NOT COMPLETED|Overall Study||1
8402740|NCT00995072|20708972|P2|COMPLETED|Overall Study||12
8402741|NCT00995072|20708973|P1|COMPLETED|Overall Study||9
8402742|NCT00995072|20708972|P2|STARTED|Overall Study||15
8402743|NCT00995072|20708973|P1|STARTED|Overall Study||10
8402744|NCT00995020|20708983|P2|NOT COMPLETED|Overall Study||7
8402745|NCT00995020|20708984|P1|NOT COMPLETED|Overall Study||3
8402746|NCT00995020|20708983|P2|COMPLETED|Overall Study|"Reasons for not completed:
~margin analysis not performed specimen fragmentation thermal damage"|45
8402747|NCT00995020|20708984|P1|COMPLETED|Overall Study|"Reasons for not completed:
~margin analysis not performed specimen fragmentation thermal damage"|48
8402748|NCT00995020|20708983|P2|STARTED|Overall Study||52
8402749|NCT00995020|20708984|P1|STARTED|Overall Study||51
8402750|NCT00995007|20708994|P2|NOT COMPLETED|Overall Study||2
8402751|NCT00995007|20708995|P1|NOT COMPLETED|Overall Study||17
8402752|NCT00995007|20708994|P2|COMPLETED|Overall Study||54
8402753|NCT00995007|20708995|P1|COMPLETED|Overall Study||39
8402754|NCT00995007|20708994|P2|Crossover to Vandetanib|Overall Study||0
8402755|NCT00995007|20708995|P1|Crossover to Vandetanib|Overall Study||42
8402756|NCT00995007|20708994|P2|STARTED|Overall Study||56
8402757|NCT00995007|20708995|P1|STARTED|Overall Study||56
8402758|NCT00994929|20709011|P1|NOT COMPLETED|Overall Study||0
8402759|NCT00994929|20709011|P1|COMPLETED|Overall Study||9
8402760|NCT00994929|20709011|P1|STARTED|Overall Study||9
8402761|NCT00994760|20709017|P1|NOT COMPLETED|Overall Study||24
8402762|NCT00994760|20709017|P1|COMPLETED|Overall Study||107
8402763|NCT00994760|20709017|P1|STARTED|Overall Study||131
8402764|NCT00994682|20709058|P2|NOT COMPLETED|Pioglitazone Open Label||7
8402765|NCT00994682|20709059|P1|NOT COMPLETED|Pioglitazone Open Label||13
8402766|NCT00994682|20709058|P2|COMPLETED|Pioglitazone Open Label||34
8402767|NCT00994682|20709059|P1|COMPLETED|Pioglitazone Open Label||29
8402768|NCT00994682|20709058|P2|STARTED|Pioglitazone Open Label||41
8402769|NCT00994682|20709059|P1|STARTED|Pioglitazone Open Label||42
8402770|NCT00994682|20709058|P2|NOT COMPLETED|Double Bilnd||9
8402771|NCT00994682|20709059|P1|NOT COMPLETED|Double Bilnd||9
8402772|NCT00994682|20709058|P2|COMPLETED|Double Bilnd||41
8402773|NCT00994682|20709059|P1|COMPLETED|Double Bilnd||42
8402774|NCT00994682|20709058|P2|STARTED|Double Bilnd||50
8402775|NCT00994682|20709059|P1|STARTED|Double Bilnd||51
8402776|NCT00994643|20709103|P1|NOT COMPLETED|Overall Study||1
8402777|NCT00994643|20709103|P1|COMPLETED|Overall Study||10
8402778|NCT00994643|20709103|P1|STARTED|Overall Study||11
8402779|NCT00994604|20709107|P1|NOT COMPLETED|Overall Study||6
8402780|NCT00994604|20709107|P1|COMPLETED|Overall Study||45
8402781|NCT00994604|20709107|P1|STARTED|Overall Study||51
8402791|NCT00994448|20709147|P2|NOT COMPLETED|Overall Study||2
8402792|NCT00994448|20709148|P1|NOT COMPLETED|Overall Study||8
8402793|NCT00994448|20709147|P2|COMPLETED|Overall Study||5
8402794|NCT00994448|20709148|P1|COMPLETED|Overall Study||4
8402795|NCT00994448|20709147|P2|STARTED|Overall Study||7
8402796|NCT00994448|20709148|P1|STARTED|Overall Study||12
8402797|NCT00994422|20709156|P2|NOT COMPLETED|Overall Study||1
8402798|NCT00994422|20709157|P1|NOT COMPLETED|Overall Study||7
8402799|NCT00994422|20709156|P2|COMPLETED|Overall Study||54
8402800|NCT00994422|20709157|P1|COMPLETED|Overall Study||185
8402801|NCT00994422|20709156|P2|STARTED|Overall Study||55
8402802|NCT00994422|20709157|P1|STARTED|Overall Study||192
8402803|NCT00994318|20709170|P3|NOT COMPLETED|Overall Study||67
8402804|NCT00994318|20709171|P2|NOT COMPLETED|Overall Study||18
8402805|NCT00994318|20709172|P1|NOT COMPLETED|Overall Study||22
8402806|NCT00994318|20709170|P3|COMPLETED|Overall Study||250
8402807|NCT00994318|20709171|P2|COMPLETED|Overall Study||136
8402808|NCT00994318|20709172|P1|COMPLETED|Overall Study||133
8402809|NCT00994318|20709170|P3|STARTED|Overall Study||317
8402810|NCT00994318|20709171|P2|STARTED|Overall Study||154
8402811|NCT00994318|20709172|P1|STARTED|Overall Study||155
8402812|NCT00994279|20709182|P2|NOT COMPLETED|Overall Study||5
8402813|NCT00994279|20709183|P1|NOT COMPLETED|Overall Study||4
8402814|NCT00994279|20709182|P2|COMPLETED|Overall Study||13
8402815|NCT00994279|20709183|P1|COMPLETED|Overall Study||18
8402816|NCT00994279|20709182|P2|STARTED|Overall Study||18
8402817|NCT00994279|20709183|P1|STARTED|Overall Study||22
8402818|NCT00994240|20709193|P2|NOT COMPLETED|Overall Study||5
8402819|NCT00994240|20709194|P1|NOT COMPLETED|Overall Study||6
8402820|NCT00994240|20709193|P2|COMPLETED|Overall Study||39
8402821|NCT00994240|20709194|P1|COMPLETED|Overall Study||35
8402822|NCT00994240|20709193|P2|STARTED|Overall Study||44
8402823|NCT00994240|20709194|P1|STARTED|Overall Study||41
8402824|NCT00994214|20709204|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
8402825|NCT00994214|20709205|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
8402826|NCT00994214|20709206|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
8402827|NCT00994214|20709207|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
8402828|NCT00994214|20709204|P4|COMPLETED|ITT (Intention-to-Treat) - Part B||0
8402829|NCT00994214|20709205|P3|COMPLETED|ITT (Intention-to-Treat) - Part B||0
8402830|NCT00994214|20709206|P2|COMPLETED|ITT (Intention-to-Treat) - Part B||0
8402831|NCT00994214|20709207|P1|COMPLETED|ITT (Intention-to-Treat) - Part B||0
8402832|NCT00994214|20709204|P4|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
8402833|NCT00994214|20709205|P3|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
8402834|NCT00994214|20709206|P2|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
8402835|NCT00994214|20709207|P1|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
8402836|NCT00994214|20709204|P4|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
8402837|NCT00994214|20709205|P3|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
8402838|NCT00994214|20709206|P2|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
8402839|NCT00994214|20709207|P1|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
8402840|NCT00994214|20709204|P4|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
8402841|NCT00994214|20709205|P3|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
8402842|NCT00994214|20709206|P2|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
8402843|NCT00994214|20709207|P1|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
8402844|NCT00994214|20709204|P4|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
8402845|NCT00994214|20709205|P3|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
8402846|NCT00994214|20709206|P2|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
8402847|NCT00994214|20709207|P1|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
8402848|NCT00994214|20709204|P4|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
8402849|NCT00994214|20709205|P3|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
8402850|NCT00994214|20709206|P2|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
8402851|NCT00994214|20709207|P1|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
8402852|NCT00994214|20709204|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
8402853|NCT00994214|20709205|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
8402854|NCT00994214|20709206|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
8402855|NCT00994214|20709207|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
8402856|NCT00994214|20709204|P4|COMPLETED|ITT (Intention-to-Treat) - Part A||5
8402857|NCT00994214|20709205|P3|COMPLETED|ITT (Intention-to-Treat) - Part A||5
8402858|NCT00994214|20709206|P2|COMPLETED|ITT (Intention-to-Treat) - Part A||6
8402859|NCT00994214|20709207|P1|COMPLETED|ITT (Intention-to-Treat) - Part A||5
8402860|NCT00994214|20709204|P4|STARTED|ITT (Intention-to-Treat) - Part A||20
8402861|NCT00994214|20709205|P3|STARTED|ITT (Intention-to-Treat) - Part A||18
8402862|NCT00994214|20709206|P2|STARTED|ITT (Intention-to-Treat) - Part A||19
8402863|NCT00994214|20709207|P1|STARTED|ITT (Intention-to-Treat) - Part A||19
8402864|NCT00994175|20709251|P2|NOT COMPLETED|Second Intervention||0
8402865|NCT00994175|20709252|P1|NOT COMPLETED|Second Intervention||0
8402866|NCT00994175|20709251|P2|COMPLETED|Second Intervention||8
8402867|NCT00994175|20709252|P1|COMPLETED|Second Intervention||4
8402868|NCT00994175|20709251|P2|STARTED|Second Intervention||8
8402869|NCT00994175|20709252|P1|STARTED|Second Intervention||4
8402870|NCT00994175|20709251|P2|NOT COMPLETED|First Intervention||1
8402871|NCT00994175|20709252|P1|NOT COMPLETED|First Intervention||2
8402872|NCT00994175|20709251|P2|COMPLETED|First Intervention||8
8402873|NCT00994175|20709252|P1|COMPLETED|First Intervention||4
8402874|NCT00994175|20709251|P2|STARTED|First Intervention||9
8402875|NCT00994175|20709252|P1|STARTED|First Intervention||6
8402876|NCT00994123|20709263|P3|NOT COMPLETED|Overall Study||0
8402877|NCT00994123|20709264|P2|NOT COMPLETED|Overall Study||0
8402878|NCT00994123|20709265|P1|NOT COMPLETED|Overall Study||0
8402879|NCT00994123|20709263|P3|COMPLETED|Overall Study||44
8402880|NCT00994123|20709264|P2|COMPLETED|Overall Study||85
8402881|NCT00994123|20709265|P1|COMPLETED|Overall Study||33
8402882|NCT00994123|20709263|P3|STARTED|Overall Study||44
8402883|NCT00994123|20709264|P2|STARTED|Overall Study||85
8402884|NCT00994123|20709265|P1|STARTED|Overall Study||33
8402885|NCT00994110|20709286|P2|NOT COMPLETED|Overall Study||74
8402886|NCT00994110|20709287|P1|NOT COMPLETED|Overall Study||65
8402887|NCT00994110|20709286|P2|COMPLETED|Overall Study||148
8402888|NCT00994110|20709287|P1|COMPLETED|Overall Study||152
8402889|NCT00994110|20709286|P2|STARTED|Overall Study||222
8402890|NCT00994110|20709287|P1|STARTED|Overall Study||217
8402891|NCT00993967|20709293|P1|NOT COMPLETED|Overall Study||61
8402892|NCT00993967|20709293|P1|COMPLETED|Overall Study||139
8402893|NCT00993967|20709293|P1|STARTED|Overall Study||200
8402894|NCT00993954|20709300|P2|NOT COMPLETED|Overall Study||2
8402895|NCT00993954|20709301|P1|NOT COMPLETED|Overall Study||21
8402896|NCT00993954|20709300|P2|COMPLETED|Overall Study||121
8402897|NCT00993954|20709301|P1|COMPLETED|Overall Study||124
8402898|NCT00993954|20709300|P2|STARTED|Overall Study||123
8402899|NCT00993954|20709301|P1|STARTED|Overall Study||145
8402900|NCT00993928|20709314|P2|NOT COMPLETED|Overall Study||7
8402901|NCT00993928|20709315|P1|NOT COMPLETED|Overall Study||5
8402902|NCT00993928|20709314|P2|COMPLETED|Overall Study||38
8402903|NCT00993928|20709315|P1|COMPLETED|Overall Study||43
8402904|NCT00993928|20709314|P2|STARTED|Overall Study||45
8402905|NCT00993928|20709315|P1|STARTED|Overall Study||48
8402909|NCT00993824|20709340|P2|NOT COMPLETED|Overall Study||0
8402910|NCT00993824|20709341|P1|NOT COMPLETED|Overall Study||0
8402911|NCT00993824|20709340|P2|COMPLETED|Overall Study||10
8402912|NCT00993824|20709341|P1|COMPLETED|Overall Study||11
8402913|NCT00993824|20709340|P2|STARTED|Overall Study||10
8402914|NCT00993824|20709341|P1|STARTED|Overall Study||11
8402915|NCT00993668|20709355|P2|NOT COMPLETED|Open-Label Period||15
8402916|NCT00993668|20709356|P1|NOT COMPLETED|Open-Label Period||23
8402917|NCT00993668|20709355|P2|COMPLETED|Open-Label Period||91
8402918|NCT00993668|20709356|P1|COMPLETED|Open-Label Period||86
8402919|NCT00993668|20709355|P2|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
8402920|NCT00993668|20709356|P1|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
8402921|NCT00993668|20709355|P2|NOT COMPLETED|Single-Blind Period||3
8402922|NCT00993668|20709356|P1|NOT COMPLETED|Single-Blind Period||4
8402923|NCT00993668|20709355|P2|COMPLETED|Single-Blind Period||107
8402924|NCT00993668|20709356|P1|COMPLETED|Single-Blind Period||110
8402925|NCT00993668|20709355|P2|STARTED|Single-Blind Period||110
8402926|NCT00993668|20709356|P1|STARTED|Single-Blind Period||114
8402927|NCT00993655|20709384|P3|NOT COMPLETED|Overall Study||0
8402928|NCT00993655|20709385|P2|NOT COMPLETED|Overall Study||0
8402929|NCT00993655|20709386|P1|NOT COMPLETED|Overall Study||0
8402930|NCT00993655|20709384|P3|COMPLETED|Overall Study||102
8402931|NCT00993655|20709385|P2|COMPLETED|Overall Study||72
8402932|NCT00993655|20709386|P1|COMPLETED|Overall Study||101
8402933|NCT00993655|20709384|P3|STARTED|Overall Study||102
8402934|NCT00993655|20709385|P2|STARTED|Overall Study||72
8402935|NCT00993655|20709386|P1|STARTED|Overall Study||101
8402936|NCT00993616|20709400|P1|NOT COMPLETED|Overall Study||2
8402937|NCT00993616|20709400|P1|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
8402938|NCT00993616|20709400|P1|STARTED|Overall Study||29
8402939|NCT00993499|20709418|P6|NOT COMPLETED|Discontinued After Starting Course 3||3
8402940|NCT00993499|20709419|P5|NOT COMPLETED|Discontinued After Starting Course 3||3
8402941|NCT00993499|20709420|P4|NOT COMPLETED|Discontinued After Starting Course 3||2
8402942|NCT00993499|20709421|P3|NOT COMPLETED|Discontinued After Starting Course 3||6
8402943|NCT00993499|20709422|P2|NOT COMPLETED|Discontinued After Starting Course 3||5
8402944|NCT00993499|20709423|P1|NOT COMPLETED|Discontinued After Starting Course 3||8
8402945|NCT00993499|20709418|P6|COMPLETED|Discontinued After Starting Course 3||0
8402946|NCT00993499|20709419|P5|COMPLETED|Discontinued After Starting Course 3||0
8402947|NCT00993499|20709420|P4|COMPLETED|Discontinued After Starting Course 3||1
8402948|NCT00993499|20709421|P3|COMPLETED|Discontinued After Starting Course 3||3
8402949|NCT00993499|20709422|P2|COMPLETED|Discontinued After Starting Course 3||4
8402950|NCT00993499|20709423|P1|COMPLETED|Discontinued After Starting Course 3||4
8402951|NCT00993499|20709418|P6|STARTED|Discontinued After Starting Course 3||3
8402952|NCT00993499|20709419|P5|STARTED|Discontinued After Starting Course 3||3
8402953|NCT00993499|20709420|P4|STARTED|Discontinued After Starting Course 3||3
8402954|NCT00993499|20709421|P3|STARTED|Discontinued After Starting Course 3||9
8402955|NCT00993499|20709422|P2|STARTED|Discontinued After Starting Course 3||9
8402956|NCT00993499|20709423|P1|STARTED|Discontinued After Starting Course 3||12
8402957|NCT00993499|20709418|P6|NOT COMPLETED|Discontinued Before Starting Course 3||0
8402958|NCT00993499|20709419|P5|NOT COMPLETED|Discontinued Before Starting Course 3||0
8402959|NCT00993499|20709420|P4|NOT COMPLETED|Discontinued Before Starting Course 3||1
8402960|NCT00993499|20709421|P3|NOT COMPLETED|Discontinued Before Starting Course 3||3
8402961|NCT00993499|20709422|P2|NOT COMPLETED|Discontinued Before Starting Course 3||4
8402962|NCT00993499|20709423|P1|NOT COMPLETED|Discontinued Before Starting Course 3||4
8402963|NCT00993499|20709418|P6|COMPLETED|Discontinued Before Starting Course 3||3
8402964|NCT00993499|20709419|P5|COMPLETED|Discontinued Before Starting Course 3||3
8402965|NCT00993499|20709420|P4|COMPLETED|Discontinued Before Starting Course 3||2
8402966|NCT00993499|20709421|P3|COMPLETED|Discontinued Before Starting Course 3||6
8402967|NCT00993499|20709422|P2|COMPLETED|Discontinued Before Starting Course 3||5
8402968|NCT00993499|20709423|P1|COMPLETED|Discontinued Before Starting Course 3||8
8402969|NCT00993499|20709418|P6|STARTED|Discontinued Before Starting Course 3||3
8402970|NCT00993499|20709419|P5|STARTED|Discontinued Before Starting Course 3||3
8402971|NCT00993499|20709420|P4|STARTED|Discontinued Before Starting Course 3||3
8402972|NCT00993499|20709421|P3|STARTED|Discontinued Before Starting Course 3||9
8402973|NCT00993499|20709422|P2|STARTED|Discontinued Before Starting Course 3||9
8402974|NCT00993499|20709423|P1|STARTED|Discontinued Before Starting Course 3||12
8402975|NCT00993499|20709418|P6|NOT COMPLETED|Run-in Period (8 Days)||0
8402976|NCT00993499|20709419|P5|NOT COMPLETED|Run-in Period (8 Days)||0
8402977|NCT00993499|20709420|P4|NOT COMPLETED|Run-in Period (8 Days)||0
8402978|NCT00993499|20709421|P3|NOT COMPLETED|Run-in Period (8 Days)||1
8402979|NCT00993499|20709422|P2|NOT COMPLETED|Run-in Period (8 Days)||3
8402980|NCT00993499|20709423|P1|NOT COMPLETED|Run-in Period (8 Days)||1
8402981|NCT00993499|20709418|P6|COMPLETED|Run-in Period (8 Days)||3
8402982|NCT00993499|20709419|P5|COMPLETED|Run-in Period (8 Days)||3
8402983|NCT00993499|20709420|P4|COMPLETED|Run-in Period (8 Days)||3
8402984|NCT00993499|20709421|P3|COMPLETED|Run-in Period (8 Days)||9
8402985|NCT00993499|20709422|P2|COMPLETED|Run-in Period (8 Days)||9
8402986|NCT00993499|20709423|P1|COMPLETED|Run-in Period (8 Days)||12
8402987|NCT00993499|20709418|P6|STARTED|Run-in Period (8 Days)||3
8402988|NCT00993499|20709419|P5|STARTED|Run-in Period (8 Days)||3
8402989|NCT00993499|20709420|P4|STARTED|Run-in Period (8 Days)||3
8402990|NCT00993499|20709421|P3|STARTED|Run-in Period (8 Days)||10
8402991|NCT00993499|20709422|P2|STARTED|Run-in Period (8 Days)||12
8402992|NCT00993499|20709423|P1|STARTED|Run-in Period (8 Days)||13
8402993|NCT00993473|20709505|P2|NOT COMPLETED|Overall Study||10
8402994|NCT00993473|20709506|P1|NOT COMPLETED|Overall Study||4
8402995|NCT00993473|20709505|P2|COMPLETED|Overall Study||54
8402996|NCT00993473|20709506|P1|COMPLETED|Overall Study||57
8402997|NCT00993473|20709505|P2|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
8402998|NCT00993473|20709506|P1|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
8402999|NCT00993447|20709544|P2|NOT COMPLETED|Overall Study||19
8403000|NCT00993447|20709545|P1|NOT COMPLETED|Overall Study||37
8403001|NCT00993447|20709544|P2|COMPLETED|Overall Study||180
8403002|NCT00993447|20709545|P1|COMPLETED|Overall Study||364
8403003|NCT00993447|20709544|P2|STARTED|Overall Study||199
8403004|NCT00993447|20709545|P1|STARTED|Overall Study||401
8403005|NCT00993421|20709582|P7|NOT COMPLETED|Overall Study||42
8403006|NCT00993421|20709583|P6|NOT COMPLETED|Overall Study||46
8403007|NCT00993421|20709584|P5|NOT COMPLETED|Overall Study||46
8403008|NCT00993421|20709585|P4|NOT COMPLETED|Overall Study||45
8403009|NCT00993421|20709586|P3|NOT COMPLETED|Overall Study||43
8403010|NCT00993421|20709587|P2|NOT COMPLETED|Overall Study||45
8403011|NCT00993421|20709588|P1|NOT COMPLETED|Overall Study||44
8403012|NCT00993421|20709582|P7|COMPLETED|Overall Study||4
8403013|NCT00993421|20709583|P6|COMPLETED|Overall Study||4
8403014|NCT00993421|20709584|P5|COMPLETED|Overall Study||6
8403015|NCT00993421|20709585|P4|COMPLETED|Overall Study||4
8403016|NCT00993421|20709586|P3|COMPLETED|Overall Study||5
8403017|NCT00993421|20709587|P2|COMPLETED|Overall Study||4
8403018|NCT00993421|20709588|P1|COMPLETED|Overall Study||5
8403019|NCT00993421|20709582|P7|STARTED|Overall Study||46
8403020|NCT00993421|20709583|P6|STARTED|Overall Study||50
8403021|NCT00993421|20709584|P5|STARTED|Overall Study||52
8403022|NCT00993421|20709585|P4|STARTED|Overall Study||49
8403023|NCT00993421|20709586|P3|STARTED|Overall Study||48
8403024|NCT00993421|20709587|P2|STARTED|Overall Study||49
8403025|NCT00993421|20709588|P1|STARTED|Overall Study||49
8403026|NCT00993317|20709739|P2|NOT COMPLETED|Overall Study||25
8403027|NCT00993317|20709740|P1|NOT COMPLETED|Overall Study||21
8403028|NCT00993317|20709739|P2|COMPLETED|Overall Study||60
8403029|NCT00993317|20709740|P1|COMPLETED|Overall Study||21
8403030|NCT00993317|20709739|P2|STARTED|Overall Study||85
8403031|NCT00993317|20709740|P1|STARTED|Overall Study||42
8403032|NCT00993291|20709758|P1|NOT COMPLETED|Overall Study||1
8403033|NCT00993291|20709758|P1|COMPLETED|Overall Study||19
8403034|NCT00993291|20709758|P1|STARTED|Overall Study||20
8403035|NCT00993265|20709764|P2|NOT COMPLETED|Overall Study||0
8403036|NCT00993265|20709765|P1|NOT COMPLETED|Overall Study||4
8403037|NCT00993265|20709764|P2|COMPLETED|Overall Study||19
8403038|NCT00993265|20709765|P1|COMPLETED|Overall Study||16
8403039|NCT00993265|20709764|P2|STARTED|Overall Study||19
8403040|NCT00993265|20709765|P1|STARTED|Overall Study||20
8403041|NCT00993200|20709785|P2|NOT COMPLETED|Overall Study||0
8403042|NCT00993200|20709786|P1|NOT COMPLETED|Overall Study||0
8403043|NCT00993200|20709785|P2|COMPLETED|Overall Study||13
8403044|NCT00993200|20709786|P1|COMPLETED|Overall Study||13
8403045|NCT00993200|20709785|P2|STARTED|Overall Study||13
8403046|NCT00993200|20709786|P1|STARTED|Overall Study||13
8403047|NCT00993187|20709798|P2|NOT COMPLETED|Overall Study||37
8403048|NCT00993187|20709799|P1|NOT COMPLETED|Overall Study||26
8403049|NCT00993187|20709798|P2|COMPLETED|Overall Study||108
8403050|NCT00993187|20709799|P1|COMPLETED|Overall Study||121
8403051|NCT00993187|20709798|P2|Received at Least 1 Dose of Study Drug|Overall Study||144
8403052|NCT00993187|20709799|P1|Received at Least 1 Dose of Study Drug|Overall Study||146
8403053|NCT00993187|20709798|P2|STARTED|Overall Study||145
8403054|NCT00993187|20709799|P1|STARTED|Overall Study||147
8403055|NCT00993148|20709817|P1|NOT COMPLETED|Overall Study||3
8403056|NCT00993148|20709817|P1|COMPLETED|Overall Study||22
8403057|NCT00993148|20709817|P1|STARTED|Overall Study||25
8403058|NCT00993044|20709829|P1|NOT COMPLETED|Irinotecan 50 mg||1
8403059|NCT00993044|20709829|P1|COMPLETED|Irinotecan 50 mg||6
8403060|NCT00993044|20709829|P1|STARTED|Irinotecan 50 mg||7
8403061|NCT00993044|20709829|P1|NOT COMPLETED|Irinotecan 30 mg||0
8403062|NCT00993044|20709829|P1|COMPLETED|Irinotecan 30 mg||6
8403063|NCT00993044|20709829|P1|STARTED|Irinotecan 30 mg||6
8403064|NCT00993031|20709836|P2|NOT COMPLETED|Overall Study||19
8403065|NCT00993031|20709837|P1|NOT COMPLETED|Overall Study||22
8403066|NCT00993031|20709836|P2|COMPLETED|Overall Study||175
8403067|NCT00993031|20709837|P1|COMPLETED|Overall Study||173
8403068|NCT00993031|20709836|P2|Delivered|Overall Study||190
8403069|NCT00993031|20709837|P1|Delivered|Overall Study||187
8403070|NCT00993031|20709836|P2|STARTED|Overall Study||194
8403071|NCT00993031|20709837|P1|STARTED|Overall Study||195
8403072|NCT00992992|20709869|P1|NOT COMPLETED|Overall Study||25
8403073|NCT00992992|20709869|P1|COMPLETED|Overall Study||0
8403074|NCT00992992|20709869|P1|STARTED|Overall Study||25
8403075|NCT00992927|20709891|P2|NOT COMPLETED|Overall Study||0
8403076|NCT00992927|20709892|P1|NOT COMPLETED|Overall Study||0
8403077|NCT00992927|20709891|P2|COMPLETED|Overall Study||22
8403078|NCT00992927|20709892|P1|COMPLETED|Overall Study||32
8403079|NCT00992927|20709891|P2|STARTED|Overall Study||22
8403080|NCT00992927|20709892|P1|STARTED|Overall Study||32
8403081|NCT00992836|20709900|P1|NOT COMPLETED|Overall Study||5
8403082|NCT00992836|20709900|P1|COMPLETED|Overall Study||150
8403083|NCT00992836|20709900|P1|Received Both Study Vaccinations|Overall Study||150
8403084|NCT00992836|20709900|P1|STARTED|Overall Study||155
8403085|NCT00992784|20709915|P3|NOT COMPLETED|Overall Study||1
8403086|NCT00992784|20709916|P2|NOT COMPLETED|Overall Study||2
8403087|NCT00992784|20709917|P1|NOT COMPLETED|Overall Study||3
8403088|NCT00992784|20709915|P3|COMPLETED|Overall Study||85
8403089|NCT00992784|20709916|P2|COMPLETED|Overall Study||102
8403090|NCT00992784|20709917|P1|COMPLETED|Overall Study||177
8403091|NCT00992784|20709915|P3|STARTED|Overall Study||86
8403092|NCT00992784|20709916|P2|STARTED|Overall Study||104
8403093|NCT00992784|20709917|P1|STARTED|Overall Study||180
8403094|NCT00992719|20709988|P3|NOT COMPLETED|Overall Study||0
8403095|NCT00992719|20709989|P2|NOT COMPLETED|Overall Study||1
8403096|NCT00992719|20709990|P1|NOT COMPLETED|Overall Study||1
8403097|NCT00992719|20709988|P3|COMPLETED|Overall Study||28
8403098|NCT00992719|20709989|P2|COMPLETED|Overall Study||27
8403099|NCT00992719|20709990|P1|COMPLETED|Overall Study||27
8403100|NCT00992719|20709988|P3|STARTED|Overall Study||28
8403101|NCT00992719|20709989|P2|STARTED|Overall Study||28
8403102|NCT00992719|20709990|P1|STARTED|Overall Study||28
8403103|NCT00992602|20710024|P1|NOT COMPLETED|Overall Study||3
8403104|NCT00992602|20710024|P1|COMPLETED|Overall Study||0
8403105|NCT00992602|20710024|P1|STARTED|Overall Study||3
8403106|NCT00992589|20710029|P4|NOT COMPLETED|Double-Blind Phase||10
8403107|NCT00992589|20710030|P3|NOT COMPLETED|Double-Blind Phase||13
8403108|NCT00992589|20710031|P2|NOT COMPLETED|Double-Blind Phase||13
8403109|NCT00992589|20710032|P1|NOT COMPLETED|Double-Blind Phase||0
8403110|NCT00992589|20710029|P4|COMPLETED|Double-Blind Phase||78
8403111|NCT00992589|20710030|P3|COMPLETED|Double-Blind Phase||77
8403112|NCT00992589|20710031|P2|COMPLETED|Double-Blind Phase||76
8403113|NCT00992589|20710032|P1|COMPLETED|Double-Blind Phase||0
8403114|NCT00992589|20710029|P4|STARTED|Double-Blind Phase||88
8403115|NCT00992589|20710030|P3|STARTED|Double-Blind Phase||90
8403116|NCT00992589|20710031|P2|STARTED|Double-Blind Phase||89
8403117|NCT00992589|20710032|P1|STARTED|Double-Blind Phase||0
8403118|NCT00992589|20710029|P4|NOT COMPLETED|Open-Label Phase||0
8403119|NCT00992589|20710030|P3|NOT COMPLETED|Open-Label Phase||0
8403120|NCT00992589|20710031|P2|NOT COMPLETED|Open-Label Phase||0
8403121|NCT00992589|20710032|P1|NOT COMPLETED|Open-Label Phase||77
8403122|NCT00992589|20710029|P4|COMPLETED|Open-Label Phase||0
8403123|NCT00992589|20710030|P3|COMPLETED|Open-Label Phase||0
8403124|NCT00992589|20710031|P2|COMPLETED|Open-Label Phase||0
8403125|NCT00992589|20710032|P1|COMPLETED|Open-Label Phase||267
8403126|NCT00992589|20710029|P4|STARTED|Open-Label Phase||0
8403127|NCT00992589|20710030|P3|STARTED|Open-Label Phase||0
8403128|NCT00992589|20710031|P2|STARTED|Open-Label Phase||0
8403129|NCT00992589|20710032|P1|STARTED|Open-Label Phase||344
8403130|NCT00992511|20710078|P4|NOT COMPLETED|Overall Study||5
8403131|NCT00992511|20710079|P3|NOT COMPLETED|Overall Study||2
8403132|NCT00992511|20710080|P2|NOT COMPLETED|Overall Study||0
8403133|NCT00992511|20710081|P1|NOT COMPLETED|Overall Study||2
8403134|NCT00992511|20710078|P4|COMPLETED|Overall Study||70
8403135|NCT00992511|20710079|P3|COMPLETED|Overall Study||74
8403136|NCT00992511|20710080|P2|COMPLETED|Overall Study||73
8403137|NCT00992511|20710081|P1|COMPLETED|Overall Study||74
8403138|NCT00992511|20710078|P4|STARTED|Overall Study||75
8403139|NCT00992511|20710079|P3|STARTED|Overall Study||76
8403140|NCT00992511|20710080|P2|STARTED|Overall Study||73
8403141|NCT00992511|20710081|P1|STARTED|Overall Study||76
8403142|NCT00992459|20710165|P2|NOT COMPLETED|Overall Study||1
8403143|NCT00992459|20710166|P1|NOT COMPLETED|Overall Study||1
8403144|NCT00992459|20710165|P2|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
8403145|NCT00992459|20710166|P1|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
8403146|NCT00992459|20710165|P2|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
8403147|NCT00992459|20710166|P1|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
8403148|NCT00992446|20710190|P1|NOT COMPLETED|Overall Study||8
8403149|NCT00992446|20710190|P1|COMPLETED|Overall Study||19
8403150|NCT00992446|20710190|P1|STARTED|Overall Study||27
8403151|NCT00992433|20710200|P2|NOT COMPLETED|Overall Study||7
8403152|NCT00992433|20710201|P1|NOT COMPLETED|Overall Study||4
8403153|NCT00992433|20710200|P2|COMPLETED|Overall Study||90
8403154|NCT00992433|20710201|P1|COMPLETED|Overall Study||91
8403155|NCT00992433|20710200|P2|STARTED|Overall Study||97
8403156|NCT00992433|20710201|P1|STARTED|Overall Study||95
8403157|NCT00992407|20710265|P2|NOT COMPLETED|Overall Study||24
8403158|NCT00992407|20710266|P1|NOT COMPLETED|Overall Study||31
8403159|NCT00992407|20710265|P2|COMPLETED|Overall Study||14
8403160|NCT00992407|20710266|P1|COMPLETED|Overall Study||6
8403161|NCT00992407|20710265|P2|Treated|Overall Study||25
8403162|NCT00992407|20710266|P1|Treated|Overall Study||20
8403163|NCT00992407|20710265|P2|STARTED|Overall Study||38
8403164|NCT00992407|20710266|P1|STARTED|Overall Study||37
8403165|NCT00992394|20710316|P2|NOT COMPLETED|Overall Study||14
8403166|NCT00992394|20710317|P1|NOT COMPLETED|Overall Study||24
8403167|NCT00992394|20710316|P2|COMPLETED|Overall Study||72
8403168|NCT00992394|20710317|P1|COMPLETED|Overall Study||64
8403169|NCT00992394|20710316|P2|mITT Population|Overall Study||84
8403170|NCT00992394|20710317|P1|mITT Population|Overall Study||86
8403171|NCT00992394|20710316|P2|Safety Population|Overall Study||84
8403172|NCT00992394|20710317|P1|Safety Population|Overall Study||87
8403173|NCT00992394|20710316|P2|STARTED|Overall Study||86
8403174|NCT00992394|20710317|P1|STARTED|Overall Study||88
8403175|NCT00992264|20710375|P16|NOT COMPLETED|Overall Study||0
8403176|NCT00992264|20710376|P15|NOT COMPLETED|Overall Study||0
8403177|NCT00992264|20710377|P14|NOT COMPLETED|Overall Study||0
8403178|NCT00992264|20710378|P13|NOT COMPLETED|Overall Study||0
8403179|NCT00992264|20710379|P12|NOT COMPLETED|Overall Study||0
8403180|NCT00992264|20710380|P11|NOT COMPLETED|Overall Study||0
8403181|NCT00992264|20710381|P10|NOT COMPLETED|Overall Study||0
8403182|NCT00992264|20710382|P9|NOT COMPLETED|Overall Study||0
8403183|NCT00992264|20710383|P8|NOT COMPLETED|Overall Study||0
8403184|NCT00992264|20710384|P7|NOT COMPLETED|Overall Study||0
8403185|NCT00992264|20710385|P6|NOT COMPLETED|Overall Study||0
8403186|NCT00992264|20710386|P5|NOT COMPLETED|Overall Study||0
8403187|NCT00992264|20710387|P4|NOT COMPLETED|Overall Study||0
8403188|NCT00992264|20710388|P3|NOT COMPLETED|Overall Study||0
8403189|NCT00992264|20710389|P2|NOT COMPLETED|Overall Study||0
8403190|NCT00992264|20710390|P1|NOT COMPLETED|Overall Study||0
8403191|NCT00992264|20710375|P16|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8403192|NCT00992264|20710376|P15|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403193|NCT00992264|20710377|P14|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403194|NCT00992264|20710378|P13|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8403195|NCT00992264|20710379|P12|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403196|NCT00992264|20710380|P11|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403197|NCT00992264|20710381|P10|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8403198|NCT00992264|20710382|P9|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8403199|NCT00992264|20710383|P8|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403200|NCT00992264|20710384|P7|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8403201|NCT00992264|20710385|P6|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403202|NCT00992264|20710386|P5|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403203|NCT00992264|20710387|P4|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403204|NCT00992264|20710388|P3|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
8403205|NCT00992264|20710389|P2|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8403206|NCT00992264|20710390|P1|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
8403207|NCT00992264|20710375|P16|STARTED|Overall Study||116
8403208|NCT00992264|20710376|P15|STARTED|Overall Study||117
8403209|NCT00992264|20710377|P14|STARTED|Overall Study||117
8403210|NCT00992264|20710378|P13|STARTED|Overall Study||116
8403211|NCT00992264|20710379|P12|STARTED|Overall Study||117
8403212|NCT00992264|20710380|P11|STARTED|Overall Study||117
8403213|NCT00992264|20710381|P10|STARTED|Overall Study||116
8403214|NCT00992264|20710382|P9|STARTED|Overall Study||116
8403215|NCT00992264|20710383|P8|STARTED|Overall Study||117
8403216|NCT00992264|20710384|P7|STARTED|Overall Study||116
8403217|NCT00992264|20710385|P6|STARTED|Overall Study||117
8403218|NCT00992264|20710386|P5|STARTED|Overall Study||117
8403219|NCT00992264|20710387|P4|STARTED|Overall Study||117
8403220|NCT00992264|20710388|P3|STARTED|Overall Study||117
8403221|NCT00992264|20710389|P2|STARTED|Overall Study||116
8403222|NCT00992264|20710390|P1|STARTED|Overall Study||116
8403223|NCT00992225|20710404|P1|NOT COMPLETED|Overall Study||10
8403224|NCT00992225|20710404|P1|COMPLETED|Overall Study||33
8403225|NCT00992225|20710404|P1|Received at Least One Dose of Study Drug|Overall Study||33
8403226|NCT00992225|20710404|P1|STARTED|Overall Study||43
8403227|NCT00992186|20710414|P1|NOT COMPLETED|Overall Study||46
8403228|NCT00992186|20710414|P1|COMPLETED|Overall Study||0
8403229|NCT00992186|20710414|P1|STARTED|Overall Study||46
8403230|NCT00992108|20710433|P2|NOT COMPLETED|Overall Study||1
8403231|NCT00992108|20710434|P1|NOT COMPLETED|Overall Study||0
8403232|NCT00992108|20710433|P2|COMPLETED|Overall Study||9
8403233|NCT00992108|20710434|P1|COMPLETED|Overall Study||7
8403234|NCT00992108|20710433|P2|STARTED|Overall Study||10
8403235|NCT00992108|20710434|P1|STARTED|Overall Study||7
8403236|NCT00992056|20710448|P2|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
8403237|NCT00992056|20710449|P1|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
8403238|NCT00992056|20710448|P2|COMPLETED|Treatment Period 2 (6 Weeks)||10
8403239|NCT00992056|20710449|P1|COMPLETED|Treatment Period 2 (6 Weeks)||10
8403240|NCT00992056|20710448|P2|STARTED|Treatment Period 2 (6 Weeks)||10
8403241|NCT00992056|20710449|P1|STARTED|Treatment Period 2 (6 Weeks)||10
8403242|NCT00992056|20710448|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
8403243|NCT00992056|20710449|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
8403244|NCT00992056|20710448|P2|COMPLETED|Washout Period (2 Weeks)||10
8403245|NCT00992056|20710449|P1|COMPLETED|Washout Period (2 Weeks)||10
8403246|NCT00992056|20710448|P2|STARTED|Washout Period (2 Weeks)||10
8403247|NCT00992056|20710449|P1|STARTED|Washout Period (2 Weeks)||11
8403248|NCT00992056|20710448|P2|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
8403249|NCT00992056|20710449|P1|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
8403250|NCT00992056|20710448|P2|COMPLETED|Treatment Period 1 (6 Weeks)||10
8403251|NCT00992056|20710449|P1|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
8403252|NCT00992056|20710448|P2|STARTED|Treatment Period 1 (6 Weeks)||12
8403253|NCT00992056|20710449|P1|STARTED|Treatment Period 1 (6 Weeks)||12
8403254|NCT00992017|20710455|P1|NOT COMPLETED|Overall Study||10
8403255|NCT00992017|20710455|P1|COMPLETED|Overall Study||118
8403256|NCT00992017|20710455|P1|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
8403257|NCT00992017|20710455|P1|Received Both Study Vaccinations|Overall Study||124
8403258|NCT00992017|20710455|P1|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
8403259|NCT00991952|20710470|P2|NOT COMPLETED|Overall Study||1
8403260|NCT00991952|20710471|P1|NOT COMPLETED|Overall Study||0
8403261|NCT00991952|20710470|P2|COMPLETED|Overall Study||5
8403262|NCT00991952|20710471|P1|COMPLETED|Overall Study||13
8403263|NCT00991952|20710470|P2|STARTED|Overall Study||6
8403264|NCT00991952|20710471|P1|STARTED|Overall Study||13
8403265|NCT00991939|20710479|P2|NOT COMPLETED|Overall Study||2
8403266|NCT00991939|20710480|P1|NOT COMPLETED|Overall Study||5
8403267|NCT00991939|20710479|P2|COMPLETED|Overall Study||1
8403268|NCT00991939|20710480|P1|COMPLETED|Overall Study||0
8403269|NCT00991939|20710479|P2|STARTED|Overall Study||3
8403270|NCT00991939|20710480|P1|STARTED|Overall Study||5
8403271|NCT00991887|20710514|P2|NOT COMPLETED|Overall Study||1
8403272|NCT00991887|20710515|P1|NOT COMPLETED|Overall Study||2
8403273|NCT00991887|20710514|P2|COMPLETED|Overall Study||21
8403274|NCT00991887|20710515|P1|COMPLETED|Overall Study||24
8403275|NCT00991887|20710514|P2|STARTED|Overall Study||22
8403276|NCT00991887|20710515|P1|STARTED|Overall Study||26
8403277|NCT00991809|20710523|P2|NOT COMPLETED|Overall Study||6
8403278|NCT00991809|20710524|P1|NOT COMPLETED|Overall Study||4
8403279|NCT00991809|20710523|P2|COMPLETED|Overall Study||4
8403280|NCT00991809|20710524|P1|COMPLETED|Overall Study||8
8403281|NCT00991809|20710523|P2|STARTED|Overall Study||10
8403282|NCT00991809|20710524|P1|STARTED|Overall Study||12
8403283|NCT00991510|20710534|P2|NOT COMPLETED|Period III (Days 29-112)||1
8403284|NCT00991510|20710535|P1|NOT COMPLETED|Period III (Days 29-112)||1
8403285|NCT00991510|20710534|P2|COMPLETED|Period III (Days 29-112)||20
8403286|NCT00991510|20710535|P1|COMPLETED|Period III (Days 29-112)||20
8403287|NCT00991510|20710534|P2|STARTED|Period III (Days 29-112)||21
8403288|NCT00991510|20710535|P1|STARTED|Period III (Days 29-112)||21
8403289|NCT00991510|20710534|P2|NOT COMPLETED|Period II (Days 15-28)||0
8403290|NCT00991510|20710535|P1|NOT COMPLETED|Period II (Days 15-28)||0
8403291|NCT00991510|20710534|P2|COMPLETED|Period II (Days 15-28)||21
8403292|NCT00991510|20710535|P1|COMPLETED|Period II (Days 15-28)||21
8403293|NCT00991510|20710534|P2|STARTED|Period II (Days 15-28)||21
8403294|NCT00991510|20710535|P1|STARTED|Period II (Days 15-28)||21
8403295|NCT00991510|20710534|P2|NOT COMPLETED|Period I (Days 1-14)||0
8403296|NCT00991510|20710535|P1|NOT COMPLETED|Period I (Days 1-14)||1
8403297|NCT00991510|20710534|P2|COMPLETED|Period I (Days 1-14)||21
8403298|NCT00991510|20710535|P1|COMPLETED|Period I (Days 1-14)||21
8403299|NCT00991510|20710534|P2|STARTED|Period I (Days 1-14)||21
8403300|NCT00991510|20710535|P1|STARTED|Period I (Days 1-14)||22
8403301|NCT00991458|20710560|P3|NOT COMPLETED|Overall Study||25
8403302|NCT00991458|20710561|P2|NOT COMPLETED|Overall Study||28
8403303|NCT00991458|20710562|P1|NOT COMPLETED|Overall Study||20
8403304|NCT00991458|20710560|P3|COMPLETED|Overall Study||180
8403305|NCT00991458|20710561|P2|COMPLETED|Overall Study||181
8403306|NCT00991458|20710562|P1|COMPLETED|Overall Study||187
8403307|NCT00991458|20710560|P3|STARTED|Overall Study||205
8403308|NCT00991458|20710561|P2|STARTED|Overall Study||209
8403309|NCT00991458|20710562|P1|STARTED|Overall Study||207
8403310|NCT00991406|20710579|P1|NOT COMPLETED|Overall Study||1
8403311|NCT00991406|20710579|P1|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8
8403312|NCT00991406|20710579|P1|STARTED|Overall Study||9
8403313|NCT00991341|20710588|P2|NOT COMPLETED|Overall Study||179
8403314|NCT00991341|20710589|P1|NOT COMPLETED|Overall Study||204
8403315|NCT00991341|20710588|P2|COMPLETED|Overall Study||560
8403316|NCT00991341|20710589|P1|COMPLETED|Overall Study||538
8403317|NCT00991341|20710588|P2|STARTED|Overall Study||739
8403318|NCT00991341|20710589|P1|STARTED|Overall Study||742
8403319|NCT00991302|20710627|P2|NOT COMPLETED|Overall Study||13
8403320|NCT00991302|20710628|P1|NOT COMPLETED|Overall Study||14
8403321|NCT00991302|20710627|P2|COMPLETED|Overall Study||73
8403322|NCT00991302|20710628|P1|COMPLETED|Overall Study||72
8403323|NCT00991302|20710627|P2|STARTED|Overall Study||86
8403324|NCT00991302|20710628|P1|STARTED|Overall Study||86
8403325|NCT00991289|20710644|P1|NOT COMPLETED|Overall Study||12
8403326|NCT00991289|20710644|P1|COMPLETED|Overall Study|Completed study.|55
8403327|NCT00991289|20710644|P1|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
8403328|NCT00991289|20710644|P1|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
8403419|NCT00991185|20710767|P1|NOT COMPLETED|Overall Study||0
8403420|NCT00991185|20710767|P1|COMPLETED|Overall Study||8
8403421|NCT00991185|20710767|P1|STARTED|Overall Study||8
8403422|NCT00991081|20710773|P3|NOT COMPLETED|Phase II, Randomized Control Trial||4
8403423|NCT00991081|20710774|P2|NOT COMPLETED|Phase II, Randomized Control Trial||2
8403424|NCT00991081|20710775|P1|NOT COMPLETED|Phase II, Randomized Control Trial||0
8403425|NCT00991081|20710773|P3|COMPLETED|Phase II, Randomized Control Trial||15
8403426|NCT00991081|20710774|P2|COMPLETED|Phase II, Randomized Control Trial||15
8403427|NCT00991081|20710775|P1|COMPLETED|Phase II, Randomized Control Trial||0
8403428|NCT00991081|20710773|P3|Received First Clinical Call|Phase II, Randomized Control Trial||17
8403429|NCT00991081|20710774|P2|Received First Clinical Call|Phase II, Randomized Control Trial||16
8403430|NCT00991081|20710775|P1|Received First Clinical Call|Phase II, Randomized Control Trial||0
8403431|NCT00991081|20710773|P3|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
8403432|NCT00991081|20710774|P2|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
8403433|NCT00991081|20710775|P1|STARTED|Phase II, Randomized Control Trial||0
8403434|NCT00991081|20710773|P3|NOT COMPLETED|Phase I, Formative Research||0
8403435|NCT00991081|20710774|P2|NOT COMPLETED|Phase I, Formative Research||0
8403436|NCT00991081|20710775|P1|NOT COMPLETED|Phase I, Formative Research||0
8403437|NCT00991081|20710773|P3|COMPLETED|Phase I, Formative Research||0
8403438|NCT00991081|20710774|P2|COMPLETED|Phase I, Formative Research||0
8403439|NCT00991081|20710775|P1|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
8403440|NCT00991081|20710773|P3|STARTED|Phase I, Formative Research||0
8403441|NCT00991081|20710774|P2|STARTED|Phase I, Formative Research||0
8403442|NCT00991081|20710775|P1|STARTED|Phase I, Formative Research||20
8403443|NCT00991029|20710809|P2|NOT COMPLETED|Overall Study||168
8403444|NCT00991029|20710810|P1|NOT COMPLETED|Overall Study||156
8403445|NCT00991029|20710809|P2|COMPLETED|Overall Study||2281
8403446|NCT00991029|20710810|P1|COMPLETED|Overall Study||2276
8403447|NCT00991029|20710809|P2|STARTED|Overall Study||2449
8403448|NCT00991029|20710810|P1|STARTED|Overall Study||2432
8403449|NCT00990964|20710840|P1|NOT COMPLETED|Overall Study||212
8403450|NCT00990964|20710840|P1|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
8403451|NCT00990964|20710840|P1|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
8403452|NCT00990964|20710840|P1|STARTED|Overall Study|Total number of subjects enrolled|2014
8403453|NCT00990938|20710851|P6|NOT COMPLETED|Overall Study||0
8403454|NCT00990938|20710852|P5|NOT COMPLETED|Overall Study||0
8403455|NCT00990938|20710853|P4|NOT COMPLETED|Overall Study||0
8403456|NCT00990938|20710854|P3|NOT COMPLETED|Overall Study||0
8403457|NCT00990938|20710855|P2|NOT COMPLETED|Overall Study||0
8403458|NCT00990938|20710856|P1|NOT COMPLETED|Overall Study||0
8403459|NCT00990938|20710851|P6|COMPLETED|Overall Study||12
8403460|NCT00990938|20710852|P5|COMPLETED|Overall Study||12
8403461|NCT00990938|20710853|P4|COMPLETED|Overall Study||12
8403462|NCT00990938|20710854|P3|COMPLETED|Overall Study||12
8403463|NCT00990938|20710855|P2|COMPLETED|Overall Study||12
8403464|NCT00990938|20710856|P1|COMPLETED|Overall Study||3
8403465|NCT00990938|20710851|P6|STARTED|Overall Study||12
8403466|NCT00990938|20710852|P5|STARTED|Overall Study||12
8403467|NCT00990938|20710853|P4|STARTED|Overall Study||12
8403468|NCT00990938|20710854|P3|STARTED|Overall Study||12
8403469|NCT00990938|20710855|P2|STARTED|Overall Study||12
8403470|NCT00990938|20710856|P1|STARTED|Overall Study||3
8403471|NCT00990821|20710884|P14|NOT COMPLETED|Overall Study||1
8403472|NCT00990821|20710885|P13|NOT COMPLETED|Overall Study||2
8403473|NCT00990821|20710886|P12|NOT COMPLETED|Overall Study||5
8403474|NCT00990821|20710887|P11|NOT COMPLETED|Overall Study||3
8403475|NCT00990821|20710888|P10|NOT COMPLETED|Overall Study||1
8403476|NCT00990821|20710889|P9|NOT COMPLETED|Overall Study||0
8403477|NCT00990821|20710890|P8|NOT COMPLETED|Overall Study||0
8403478|NCT00990821|20710891|P7|NOT COMPLETED|Overall Study||1
8403479|NCT00990821|20710892|P6|NOT COMPLETED|Overall Study||3
8403480|NCT00990821|20710893|P5|NOT COMPLETED|Overall Study||3
8403481|NCT00990821|20710894|P4|NOT COMPLETED|Overall Study||0
8403482|NCT00990821|20710895|P3|NOT COMPLETED|Overall Study||0
8403483|NCT00990821|20710896|P2|NOT COMPLETED|Overall Study||2
8403484|NCT00990821|20710897|P1|NOT COMPLETED|Overall Study||0
8403485|NCT00990821|20710884|P14|COMPLETED|Overall Study||11
8403486|NCT00990821|20710885|P13|COMPLETED|Overall Study||10
8403487|NCT00990821|20710886|P12|COMPLETED|Overall Study||9
8403488|NCT00990821|20710887|P11|COMPLETED|Overall Study||9
8403489|NCT00990821|20710888|P10|COMPLETED|Overall Study||13
8403490|NCT00990821|20710889|P9|COMPLETED|Overall Study||12
8403491|NCT00990821|20710890|P8|COMPLETED|Overall Study||14
8403492|NCT00990821|20710891|P7|COMPLETED|Overall Study||11
8403493|NCT00990821|20710892|P6|COMPLETED|Overall Study||14
8403494|NCT00990821|20710893|P5|COMPLETED|Overall Study||14
8403495|NCT00990821|20710894|P4|COMPLETED|Overall Study||8
8403496|NCT00990821|20710895|P3|COMPLETED|Overall Study||14
8403497|NCT00990821|20710896|P2|COMPLETED|Overall Study||14
8403498|NCT00990821|20710897|P1|COMPLETED|Overall Study||14
8403499|NCT00990821|20710884|P14|STARTED|Overall Study||12
8403500|NCT00990821|20710885|P13|STARTED|Overall Study||12
8403501|NCT00990821|20710886|P12|STARTED|Overall Study||14
8403502|NCT00990821|20710887|P11|STARTED|Overall Study||12
8403503|NCT00990821|20710888|P10|STARTED|Overall Study||14
8403504|NCT00990821|20710889|P9|STARTED|Overall Study||12
8403505|NCT00990821|20710890|P8|STARTED|Overall Study||14
8403506|NCT00990821|20710891|P7|STARTED|Overall Study||12
8403507|NCT00990821|20710892|P6|STARTED|Overall Study||17
8403508|NCT00990821|20710893|P5|STARTED|Overall Study||17
8403509|NCT00990821|20710894|P4|STARTED|Overall Study||8
8403510|NCT00990821|20710895|P3|STARTED|Overall Study||14
8403511|NCT00990821|20710896|P2|STARTED|Overall Study||16
8403512|NCT00990821|20710897|P1|STARTED|Overall Study||14
8403513|NCT00990782|20710914|P1|NOT COMPLETED|Overall Study||5
8403514|NCT00990782|20710914|P1|COMPLETED|Overall Study||88
8403515|NCT00990782|20710914|P1|STARTED|Overall Study||93
8403516|NCT00990769|20710921|P2|NOT COMPLETED|Overall Study||0
8403517|NCT00990769|20710922|P1|NOT COMPLETED|Overall Study||0
8403518|NCT00990769|20710921|P2|COMPLETED|Overall Study||18
8403519|NCT00990769|20710922|P1|COMPLETED|Overall Study||22
8403520|NCT00990769|20710921|P2|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
8403521|NCT00990769|20710922|P1|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
8403522|NCT00990704|20710934|P2|NOT COMPLETED|Overall Study||2
8403523|NCT00990704|20710935|P1|NOT COMPLETED|Overall Study||1
8403524|NCT00990704|20710934|P2|COMPLETED|Overall Study||31
8403525|NCT00990704|20710935|P1|COMPLETED|Overall Study||13
8403526|NCT00990704|20710934|P2|STARTED|Overall Study||33
8403527|NCT00990704|20710935|P1|STARTED|Overall Study||14
8403528|NCT00990665|20710955|P1|NOT COMPLETED|Overall Study||48
8403529|NCT00990665|20710955|P1|COMPLETED|Overall Study||130
8403530|NCT00990665|20710955|P1|STARTED|Overall Study||178
8403531|NCT00990652|20710962|P1|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
8403532|NCT00990652|20710962|P1|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
8403533|NCT00990652|20710962|P1|STARTED|Post-sugery Bortezomib + Temozolomide||9
8403534|NCT00990652|20710962|P1|NOT COMPLETED|Surgical Resection||0
8403535|NCT00990652|20710962|P1|COMPLETED|Surgical Resection||9
8403536|NCT00990652|20710962|P1|STARTED|Surgical Resection||9
8403537|NCT00990652|20710962|P1|NOT COMPLETED|Pre-surgical Bortezomib||1
8403538|NCT00990652|20710962|P1|COMPLETED|Pre-surgical Bortezomib||9
8403539|NCT00990652|20710962|P1|STARTED|Pre-surgical Bortezomib||10
8403540|NCT00990561|20710972|P4|NOT COMPLETED|Period 2||2
8403541|NCT00990561|20710973|P3|NOT COMPLETED|Period 2||0
8403542|NCT00990561|20710974|P2|NOT COMPLETED|Period 2||0
8403543|NCT00990561|20710975|P1|NOT COMPLETED|Period 2||0
8403544|NCT00990561|20710972|P4|COMPLETED|Period 2||17
8403545|NCT00990561|20710973|P3|COMPLETED|Period 2||20
8403546|NCT00990561|20710974|P2|COMPLETED|Period 2||0
8403547|NCT00990561|20710975|P1|COMPLETED|Period 2||0
8403548|NCT00990561|20710972|P4|STARTED|Period 2||19
8403549|NCT00990561|20710973|P3|STARTED|Period 2||20
8403550|NCT00990561|20710974|P2|STARTED|Period 2||0
8403551|NCT00990561|20710975|P1|STARTED|Period 2||0
8403552|NCT00990561|20710972|P4|NOT COMPLETED|Period 1||0
8403553|NCT00990561|20710973|P3|NOT COMPLETED|Period 1||0
8403554|NCT00990561|20710974|P2|NOT COMPLETED|Period 1||1
8403555|NCT00990561|20710975|P1|NOT COMPLETED|Period 1||0
8403556|NCT00990561|20710972|P4|COMPLETED|Period 1||0
8403557|NCT00990561|20710973|P3|COMPLETED|Period 1||0
8403558|NCT00990561|20710974|P2|COMPLETED|Period 1||19
8403559|NCT00990561|20710975|P1|COMPLETED|Period 1||20
8403560|NCT00990561|20710972|P4|STARTED|Period 1||0
8403561|NCT00990561|20710973|P3|STARTED|Period 1||0
8403562|NCT00990561|20710974|P2|STARTED|Period 1||20
8403563|NCT00990561|20710975|P1|STARTED|Period 1||20
8403564|NCT00990509|20710983|P2|NOT COMPLETED|Overall Study||1
8403565|NCT00990509|20710984|P1|NOT COMPLETED|Overall Study||0
8403566|NCT00990509|20710983|P2|COMPLETED|Overall Study||8
8403567|NCT00990509|20710984|P1|COMPLETED|Overall Study||5
8403568|NCT00990509|20710983|P2|STARTED|Overall Study||9
8403569|NCT00990509|20710984|P1|STARTED|Overall Study||5
8403570|NCT00990340|20710996|P2|NOT COMPLETED|Second 14-day Treatment||0
8403571|NCT00990340|20710997|P1|NOT COMPLETED|Second 14-day Treatment||0
8403572|NCT00990340|20710996|P2|COMPLETED|Second 14-day Treatment||21
8403573|NCT00990340|20710997|P1|COMPLETED|Second 14-day Treatment||21
8403574|NCT00990340|20710996|P2|STARTED|Second 14-day Treatment||21
8403575|NCT00990340|20710997|P1|STARTED|Second 14-day Treatment||21
8403576|NCT00990340|20710996|P2|NOT COMPLETED|First 14-day Treatment||4
8403577|NCT00990340|20710997|P1|NOT COMPLETED|First 14-day Treatment||6
8403578|NCT00990340|20710996|P2|COMPLETED|First 14-day Treatment||21
8403579|NCT00990340|20710997|P1|COMPLETED|First 14-day Treatment||21
8403580|NCT00990340|20710996|P2|STARTED|First 14-day Treatment||25
8403581|NCT00990340|20710997|P1|STARTED|First 14-day Treatment||27
8403582|NCT00990314|20711011|P1|NOT COMPLETED|Overall Study||12
8403583|NCT00990314|20711011|P1|COMPLETED|Overall Study||19
8403584|NCT00990314|20711011|P1|STARTED|Overall Study||31
8403585|NCT00990288|20711022|P2|NOT COMPLETED|Overall Study||0
8403586|NCT00990288|20711023|P1|NOT COMPLETED|Overall Study||0
8403587|NCT00990288|20711022|P2|COMPLETED|Overall Study||99
8403588|NCT00990288|20711023|P1|COMPLETED|Overall Study||97
8403589|NCT00990288|20711022|P2|STARTED|Overall Study||99
8403590|NCT00990288|20711023|P1|STARTED|Overall Study||97
8403591|NCT00990249|20711053|P1|NOT COMPLETED|Overall Study||13
8403592|NCT00990249|20711053|P1|COMPLETED|Overall Study||107
8403593|NCT00990249|20711053|P1|STARTED|Overall Study||120
8403594|NCT00990236|20711059|P2|NOT COMPLETED|Overall Study||0
8403595|NCT00990236|20711060|P1|NOT COMPLETED|Overall Study||0
8403596|NCT00990236|20711059|P2|COMPLETED|Overall Study||96
8403597|NCT00990236|20711060|P1|COMPLETED|Overall Study||89
8403598|NCT00990236|20711059|P2|STARTED|Overall Study||96
8403599|NCT00990236|20711060|P1|STARTED|Overall Study||89
8403600|NCT00990184|20711068|P1|NOT COMPLETED|Overall Study||1
8403601|NCT00990184|20711068|P1|COMPLETED|Overall Study||20
8403602|NCT00990184|20711068|P1|STARTED|Overall Study||21
8403603|NCT00990106|20711076|P2|NOT COMPLETED|Overall Study||12
8403604|NCT00990106|20711077|P1|NOT COMPLETED|Overall Study||9
8403605|NCT00990106|20711076|P2|COMPLETED|Overall Study||23
8403606|NCT00990106|20711077|P1|COMPLETED|Overall Study||23
8403607|NCT00990106|20711076|P2|STARTED|Overall Study||35
8403608|NCT00990106|20711077|P1|STARTED|Overall Study||32
8403609|NCT00990093|20711087|P2|NOT COMPLETED|Test Period 2 (15-28 Days)||1
8403610|NCT00990093|20711088|P1|NOT COMPLETED|Test Period 2 (15-28 Days)||2
8403611|NCT00990093|20711087|P2|COMPLETED|Test Period 2 (15-28 Days)||14
8403612|NCT00990093|20711088|P1|COMPLETED|Test Period 2 (15-28 Days)||13
8403613|NCT00990093|20711087|P2|STARTED|Test Period 2 (15-28 Days)||15
8403614|NCT00990093|20711088|P1|STARTED|Test Period 2 (15-28 Days)||15
8403615|NCT00990093|20711087|P2|NOT COMPLETED|Test Period 1 (1-14 Days)||2
8403616|NCT00990093|20711088|P1|NOT COMPLETED|Test Period 1 (1-14 Days)||4
8403617|NCT00990093|20711087|P2|COMPLETED|Test Period 1 (1-14 Days)||15
8403618|NCT00990093|20711088|P1|COMPLETED|Test Period 1 (1-14 Days)||15
8403619|NCT00990093|20711087|P2|STARTED|Test Period 1 (1-14 Days)||17
8403620|NCT00990093|20711088|P1|STARTED|Test Period 1 (1-14 Days)||19
8403621|NCT00989989|20711097|P3|NOT COMPLETED|Overall Study||23
8403622|NCT00989989|20711098|P2|NOT COMPLETED|Overall Study||10
8403623|NCT00989989|20711099|P1|NOT COMPLETED|Overall Study||18
8403624|NCT00989989|20711097|P3|COMPLETED|Overall Study||108
8403625|NCT00989989|20711098|P2|COMPLETED|Overall Study||123
8403626|NCT00989989|20711099|P1|COMPLETED|Overall Study||114
8403627|NCT00989989|20711097|P3|STARTED|Overall Study||131
8403628|NCT00989989|20711098|P2|STARTED|Overall Study||133
8403629|NCT00989989|20711099|P1|STARTED|Overall Study||132
8403630|NCT00989963|20711140|P3|NOT COMPLETED|Overall Study||1
8403631|NCT00989963|20711141|P2|NOT COMPLETED|Overall Study||1
8403632|NCT00989963|20711142|P1|NOT COMPLETED|Overall Study||1
8403633|NCT00989963|20711140|P3|COMPLETED|Overall Study||11
8403634|NCT00989963|20711141|P2|COMPLETED|Overall Study||11
8403635|NCT00989963|20711142|P1|COMPLETED|Overall Study||11
8403636|NCT00989963|20711140|P3|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|10
8403637|NCT00989963|20711141|P2|Per-Protocol Population|Overall Study||11
8403638|NCT00989963|20711142|P1|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|12
8403639|NCT00989963|20711140|P3|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|11
8403640|NCT00989963|20711141|P2|Safety Population|Overall Study||12
8403641|NCT00989963|20711142|P1|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|13
8403642|NCT00989963|20711140|P3|STARTED|Overall Study||12
8403643|NCT00989963|20711141|P2|STARTED|Overall Study||12
8403644|NCT00989963|20711142|P1|STARTED|Overall Study||12
8403645|NCT00989950|20711178|P4|NOT COMPLETED|Randomized Phase||0
8403646|NCT00989950|20711179|P3|NOT COMPLETED|Randomized Phase||0
8403647|NCT00989950|20711180|P2|NOT COMPLETED|Randomized Phase||1
8403648|NCT00989950|20711181|P1|NOT COMPLETED|Randomized Phase||1
8403649|NCT00989950|20711178|P4|COMPLETED|Randomized Phase||7
8403650|NCT00989950|20711179|P3|COMPLETED|Randomized Phase||4
8403651|NCT00989950|20711180|P2|COMPLETED|Randomized Phase||8
8403652|NCT00989950|20711181|P1|COMPLETED|Randomized Phase||5
8403653|NCT00989950|20711178|P4|STARTED|Randomized Phase||7
8403654|NCT00989950|20711179|P3|STARTED|Randomized Phase||4
8403655|NCT00989950|20711180|P2|STARTED|Randomized Phase||9
8403656|NCT00989950|20711181|P1|STARTED|Randomized Phase||6
8403657|NCT00989950|20711178|P4|NOT COMPLETED|Open Label Dose Optimization||0
8403658|NCT00989950|20711179|P3|NOT COMPLETED|Open Label Dose Optimization||0
8403659|NCT00989950|20711180|P2|NOT COMPLETED|Open Label Dose Optimization||0
8403660|NCT00989950|20711181|P1|NOT COMPLETED|Open Label Dose Optimization||0
8403661|NCT00989950|20711178|P4|COMPLETED|Open Label Dose Optimization||7
8403662|NCT00989950|20711179|P3|COMPLETED|Open Label Dose Optimization||4
8403663|NCT00989950|20711180|P2|COMPLETED|Open Label Dose Optimization||9
8403664|NCT00989950|20711181|P1|COMPLETED|Open Label Dose Optimization||6
8403665|NCT00989950|20711178|P4|STARTED|Open Label Dose Optimization||7
8403666|NCT00989950|20711179|P3|STARTED|Open Label Dose Optimization||4
8403667|NCT00989950|20711180|P2|STARTED|Open Label Dose Optimization||9
8403668|NCT00989950|20711181|P1|STARTED|Open Label Dose Optimization||6
8403669|NCT00989937|20711191|P1|NOT COMPLETED|Overall Study||0
8403670|NCT00989937|20711191|P1|COMPLETED|Overall Study||0
8403671|NCT00989937|20711191|P1|STARTED|Overall Study||0
8403672|NCT00989911|20711206|P1|NOT COMPLETED|Overall Study||3
8403673|NCT00989911|20711206|P1|COMPLETED|Overall Study||7
8403674|NCT00989911|20711206|P1|STARTED|Overall Study||10
8403675|NCT00989833|20711213|P3|NOT COMPLETED|Overall Study||2
8403676|NCT00989833|20711214|P2|NOT COMPLETED|Overall Study||3
8403677|NCT00989833|20711215|P1|NOT COMPLETED|Overall Study||2
8403678|NCT00989833|20711213|P3|COMPLETED|Overall Study||21
8403679|NCT00989833|20711214|P2|COMPLETED|Overall Study||19
8403680|NCT00989833|20711215|P1|COMPLETED|Overall Study||19
8403681|NCT00989833|20711213|P3|STARTED|Overall Study||23
8403682|NCT00989833|20711214|P2|STARTED|Overall Study||22
8403683|NCT00989833|20711215|P1|STARTED|Overall Study||21
8403684|NCT00989781|20711246|P2|NOT COMPLETED|Adrenal Response ot ACTH||3
8403685|NCT00989781|20711247|P1|NOT COMPLETED|Adrenal Response ot ACTH||5
8403686|NCT00989781|20711246|P2|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
8403687|NCT00989781|20711247|P1|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
8403688|NCT00989781|20711246|P2|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
8403689|NCT00989781|20711247|P1|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
8403690|NCT00989781|20711246|P2|NOT COMPLETED|Ovarian Response to hCG||2
8403691|NCT00989781|20711247|P1|NOT COMPLETED|Ovarian Response to hCG||3
8403692|NCT00989781|20711246|P2|COMPLETED|Ovarian Response to hCG||18
8403693|NCT00989781|20711247|P1|COMPLETED|Ovarian Response to hCG||18
8403694|NCT00989781|20711246|P2|STARTED|Ovarian Response to hCG||20
8403695|NCT00989781|20711247|P1|STARTED|Ovarian Response to hCG||21
8403696|NCT00989768|20711266|P1|NOT COMPLETED|Overall Study||1
8403697|NCT00989768|20711266|P1|COMPLETED|Overall Study||28
8403698|NCT00989768|20711266|P1|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
8403699|NCT00989664|20711277|P1|NOT COMPLETED|Long-Term Follow-Up||3
8403700|NCT00989664|20711277|P1|COMPLETED|Long-Term Follow-Up||11
8403701|NCT00989664|20711277|P1|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
8403702|NCT00989664|20711277|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
8403703|NCT00989664|20711277|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
8403704|NCT00989664|20711277|P1|STARTED|Dosimetric and Therapeutic Treatment||61
8403705|NCT00989612|20711305|P1|NOT COMPLETED|Overall Study||0
8403706|NCT00989612|20711305|P1|COMPLETED|Overall Study||100
8403707|NCT00989612|20711305|P1|STARTED|Overall Study||100
8403708|NCT00989586|20711346|P2|NOT COMPLETED|Overall Study||0
8403709|NCT00989586|20711347|P1|NOT COMPLETED|Overall Study||0
8403710|NCT00989586|20711346|P2|COMPLETED|Overall Study||17
8403711|NCT00989586|20711347|P1|COMPLETED|Overall Study||18
8403712|NCT00989586|20711346|P2|STARTED|Overall Study||17
8403713|NCT00989586|20711347|P1|STARTED|Overall Study||18
8403714|NCT00989287|20711362|P2|NOT COMPLETED|Overall Study||1
8403715|NCT00989287|20711363|P1|NOT COMPLETED|Overall Study||1
8403716|NCT00989287|20711362|P2|COMPLETED|Overall Study||65
8403717|NCT00989287|20711363|P1|COMPLETED|Overall Study||64
8403718|NCT00989287|20711362|P2|STARTED|Overall Study||66
8403719|NCT00989287|20711363|P1|STARTED|Overall Study||65
8403720|NCT00989261|20711465|P2|NOT COMPLETED|Overall Study||22
8403721|NCT00989261|20711466|P1|NOT COMPLETED|Overall Study||15
8403722|NCT00989261|20711465|P2|COMPLETED|Overall Study||154
8403723|NCT00989261|20711466|P1|COMPLETED|Overall Study||142
8403724|NCT00989261|20711465|P2|STARTED|Overall Study||176
8403725|NCT00989261|20711466|P1|STARTED|Overall Study||157
8403726|NCT00989235|20711496|P2|NOT COMPLETED|Overall Study||6
8403727|NCT00989235|20711497|P1|NOT COMPLETED|Overall Study||3
8403728|NCT00989235|20711496|P2|COMPLETED|Overall Study||44
8403729|NCT00989235|20711497|P1|COMPLETED|Overall Study||55
8403730|NCT00989235|20711496|P2|Number Completing Double-Blind Treatment|Overall Study||41
8403731|NCT00989235|20711497|P1|Number Completing Double-Blind Treatment|Overall Study||51
8403732|NCT00989235|20711496|P2|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
8403733|NCT00989235|20711497|P1|Number Rescued to Open-Label Treatment|Overall Study||4
8403734|NCT00989235|20711496|P2|STARTED|Overall Study||50
8403735|NCT00989235|20711497|P1|STARTED|Overall Study||58
8403736|NCT00989196|20711542|P2|NOT COMPLETED|Treatment Period||0
8403737|NCT00989196|20711543|P1|NOT COMPLETED|Treatment Period||1
8403738|NCT00989196|20711542|P2|COMPLETED|Treatment Period||12
8403739|NCT00989196|20711543|P1|COMPLETED|Treatment Period||9
8403740|NCT00989196|20711542|P2|STARTED|Treatment Period||12
8403741|NCT00989196|20711543|P1|STARTED|Treatment Period||10
8403742|NCT00989196|20711542|P2|NOT COMPLETED|PK Crossover Period||0
8403743|NCT00989196|20711543|P1|NOT COMPLETED|PK Crossover Period||0
8403744|NCT00989196|20711542|P2|COMPLETED|PK Crossover Period||12
8403745|NCT00989196|20711543|P1|COMPLETED|PK Crossover Period||10
8403746|NCT00989196|20711542|P2|STARTED|PK Crossover Period||12
8403747|NCT00989196|20711543|P1|STARTED|PK Crossover Period||10
8403748|NCT00989157|20711564|P2|NOT COMPLETED|Overall Study||0
8403749|NCT00989157|20711565|P1|NOT COMPLETED|Overall Study||0
8403750|NCT00989157|20711564|P2|COMPLETED|Overall Study||10
8403751|NCT00989157|20711565|P1|COMPLETED|Overall Study||10
8403752|NCT00989157|20711564|P2|STARTED|Overall Study||10
8403753|NCT00989157|20711565|P1|STARTED|Overall Study||10
8403754|NCT00989092|20711581|P2|NOT COMPLETED|Overall Study||28
8403755|NCT00989092|20711582|P1|NOT COMPLETED|Overall Study||90
8403756|NCT00989092|20711581|P2|COMPLETED|Overall Study||31
8403757|NCT00989092|20711582|P1|COMPLETED|Overall Study||138
8403758|NCT00989092|20711581|P2|Treated With Darbepoetin Alfa|Overall Study||33
8403759|NCT00989092|20711582|P1|Treated With Darbepoetin Alfa|Overall Study||226
8403760|NCT00989092|20711581|P2|STARTED|Overall Study||59
8403761|NCT00989092|20711582|P1|STARTED|Overall Study||228
8403774|NCT00988884|20711634|P2|NOT COMPLETED|Overall Study||36
8403775|NCT00988884|20711635|P1|NOT COMPLETED|Overall Study||35
8403776|NCT00988884|20711634|P2|COMPLETED|Overall Study||584
8403777|NCT00988884|20711635|P1|COMPLETED|Overall Study||586
8403778|NCT00988884|20711634|P2|STARTED|Overall Study||620
8403779|NCT00988884|20711635|P1|STARTED|Overall Study||621
8403780|NCT00988858|20711657|P1|NOT COMPLETED|Overall Study||10
8403781|NCT00988858|20711657|P1|COMPLETED|Overall Study||45
8403782|NCT00988858|20711657|P1|STARTED|Overall Study||55
8403783|NCT00988832|20711669|P1|NOT COMPLETED|Overall Study||0
8403784|NCT00988832|20711669|P1|COMPLETED|Overall Study||380
8403785|NCT00988832|20711669|P1|STARTED|Overall Study||380
8403786|NCT00988637|20711706|P2|NOT COMPLETED|Overall Study||3
8403787|NCT00988637|20711707|P1|NOT COMPLETED|Overall Study||3
8403788|NCT00988637|20711706|P2|COMPLETED|Overall Study||65
8403789|NCT00988637|20711707|P1|COMPLETED|Overall Study||67
8403790|NCT00988637|20711706|P2|STARTED|Overall Study||68
8403791|NCT00988637|20711707|P1|STARTED|Overall Study||70
8403792|NCT00988598|20711739|P2|NOT COMPLETED|Overall Study||0
8403793|NCT00988598|20711740|P1|NOT COMPLETED|Overall Study||2
8403794|NCT00988598|20711739|P2|COMPLETED|Overall Study||5
8403795|NCT00988598|20711740|P1|COMPLETED|Overall Study||8
8403796|NCT00988598|20711739|P2|STARTED|Overall Study||5
8403797|NCT00988598|20711740|P1|STARTED|Overall Study||10
8403798|NCT00988559|20711768|P4|NOT COMPLETED|Overall Study||1
8403799|NCT00988559|20711769|P3|NOT COMPLETED|Overall Study||2
8403800|NCT00988559|20711770|P2|NOT COMPLETED|Overall Study||2
8403801|NCT00988559|20711771|P1|NOT COMPLETED|Overall Study||1
8403802|NCT00988559|20711768|P4|COMPLETED|Overall Study||6
8403803|NCT00988559|20711769|P3|COMPLETED|Overall Study||9
8403804|NCT00988559|20711770|P2|COMPLETED|Overall Study||9
8403805|NCT00988559|20711771|P1|COMPLETED|Overall Study||9
8403806|NCT00988559|20711768|P4|STARTED|Overall Study||7
8403807|NCT00988559|20711769|P3|STARTED|Overall Study||11
8403808|NCT00988559|20711770|P2|STARTED|Overall Study||11
8403809|NCT00988559|20711771|P1|STARTED|Overall Study||10
8403810|NCT00988533|20711785|P1|NOT COMPLETED|Overall Study||3
8403811|NCT00988533|20711785|P1|COMPLETED|Overall Study||27
8403812|NCT00988533|20711785|P1|STARTED|Overall Study||30
8403813|NCT00988442|20711799|P2|NOT COMPLETED|Overall Study||28
8403814|NCT00988442|20711800|P1|NOT COMPLETED|Overall Study||30
8403815|NCT00988442|20711799|P2|COMPLETED|Overall Study||1
8403816|NCT00988442|20711800|P1|COMPLETED|Overall Study||0
8403817|NCT00988442|20711799|P2|STARTED|Overall Study||29
8403818|NCT00988442|20711800|P1|STARTED|Overall Study||30
8403834|NCT00988351|20711878|P2|NOT COMPLETED|Overall Study||12
8403835|NCT00988351|20711879|P1|NOT COMPLETED|Overall Study||19
8403836|NCT00988351|20711878|P2|COMPLETED|Overall Study||66
8403837|NCT00988351|20711879|P1|COMPLETED|Overall Study||59
8403838|NCT00988351|20711878|P2|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
8403839|NCT00988351|20711879|P1|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
8403840|NCT00988351|20711878|P2|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
8403841|NCT00988351|20711879|P1|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
8403842|NCT00988351|20711878|P2|PAP Setup|Overall Study|APAP treatment started|78
8403843|NCT00988351|20711879|P1|PAP Setup|Overall Study|CPAP treatment started|70
8403844|NCT00988351|20711878|P2|CPAP Titration|Overall Study|no titration needed|78
8403845|NCT00988351|20711879|P1|CPAP Titration|Overall Study|8 declined CPAP treatment|78
8403846|NCT00988351|20711878|P2|STARTED|Overall Study||78
8403847|NCT00988351|20711879|P1|STARTED|Overall Study||78
8403848|NCT00988325|20711896|P3|NOT COMPLETED|Overall Study||0
8403849|NCT00988325|20711897|P2|NOT COMPLETED|Overall Study||0
8403850|NCT00988325|20711898|P1|NOT COMPLETED|Overall Study||0
8403851|NCT00988325|20711896|P3|COMPLETED|Overall Study||5
8403852|NCT00988325|20711897|P2|COMPLETED|Overall Study||20
8403853|NCT00988325|20711898|P1|COMPLETED|Overall Study||40
8403854|NCT00988325|20711896|P3|STARTED|Overall Study||5
8403855|NCT00988325|20711897|P2|STARTED|Overall Study||20
8403856|NCT00988325|20711898|P1|STARTED|Overall Study||40
8403857|NCT00988247|20711956|P2|NOT COMPLETED|Overall Study||26
8403858|NCT00988247|20711957|P1|NOT COMPLETED|Overall Study||83
8403859|NCT00988247|20711956|P2|COMPLETED|Overall Study||85
8403860|NCT00988247|20711957|P1|COMPLETED|Overall Study||335
8403861|NCT00988247|20711956|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
8403947|NCT00988091|20712232|P2|NOT COMPLETED|Double-blind Period||47
8403862|NCT00988247|20711957|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
8403863|NCT00988247|20711956|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
8403864|NCT00988247|20711957|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
8403865|NCT00988247|20711956|P2|STARTED|Overall Study||111
8403866|NCT00988247|20711957|P1|STARTED|Overall Study||418
8403867|NCT00988221|20711976|P4|NOT COMPLETED|Part III||0
8403868|NCT00988221|20711977|P3|NOT COMPLETED|Part III||3
8403869|NCT00988221|20711978|P2|NOT COMPLETED|Part III||1
8403870|NCT00988221|20711979|P1|NOT COMPLETED|Part III||1
8403871|NCT00988221|20711976|P4|COMPLETED|Part III||0
8403872|NCT00988221|20711977|P3|COMPLETED|Part III||103
8403873|NCT00988221|20711978|P2|COMPLETED|Part III||23
8403874|NCT00988221|20711979|P1|COMPLETED|Part III||29
8403875|NCT00988221|20711976|P4|STARTED|Part III|No patients received placebo in Part III of this study.|0
8403876|NCT00988221|20711977|P3|STARTED|Part III||106
8403877|NCT00988221|20711978|P2|STARTED|Part III||24
8403878|NCT00988221|20711979|P1|STARTED|Part III||30
8403879|NCT00988221|20711976|P4|NOT COMPLETED|Part II||3
8403880|NCT00988221|20711977|P3|NOT COMPLETED|Part II||3
8403881|NCT00988221|20711978|P2|NOT COMPLETED|Part II||0
8403882|NCT00988221|20711979|P1|NOT COMPLETED|Part II||1
8403883|NCT00988221|20711976|P4|COMPLETED|Part II||81
8403884|NCT00988221|20711977|P3|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
8403885|NCT00988221|20711978|P2|COMPLETED|Part II||11
8403886|NCT00988221|20711979|P1|COMPLETED|Part II||15
8403887|NCT00988221|20711976|P4|STARTED|Part II||84
8403888|NCT00988221|20711977|P3|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
8403889|NCT00988221|20711978|P2|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
8403890|NCT00988221|20711979|P1|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
8403891|NCT00988221|20711976|P4|NOT COMPLETED|Part I||0
8403892|NCT00988221|20711977|P3|NOT COMPLETED|Part I||8
8403893|NCT00988221|20711978|P2|NOT COMPLETED|Part I||10
8403894|NCT00988221|20711979|P1|NOT COMPLETED|Part I||4
8403895|NCT00988221|20711976|P4|COMPLETED|Part I||0
8403896|NCT00988221|20711977|P3|COMPLETED|Part I||111
8403897|NCT00988221|20711978|P2|COMPLETED|Part I||24
8403898|NCT00988221|20711979|P1|COMPLETED|Part I||31
8403899|NCT00988221|20711976|P4|STARTED|Part I|No patients received placebo in Part I of this study.|0
8403900|NCT00988221|20711977|P3|STARTED|Part I||119
8403901|NCT00988221|20711978|P2|STARTED|Part I||34
8403902|NCT00988221|20711979|P1|STARTED|Part I||35
8403903|NCT00988208|20712152|P2|NOT COMPLETED|Overall Study||438
8403904|NCT00988208|20712153|P1|NOT COMPLETED|Overall Study||431
8403905|NCT00988208|20712152|P2|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
8403906|NCT00988208|20712153|P1|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
8403907|NCT00988208|20712152|P2|Treated|Overall Study||525
8403908|NCT00988208|20712153|P1|Treated|Overall Study||521
8403909|NCT00988208|20712152|P2|STARTED|Overall Study||533
8403910|NCT00988208|20712153|P1|STARTED|Overall Study||526
8403911|NCT00988169|20712171|P1|NOT COMPLETED|Overall Study||1
8403912|NCT00988169|20712171|P1|COMPLETED|Overall Study||5
8403913|NCT00988169|20712171|P1|STARTED|Overall Study||6
8403914|NCT00988156|20712177|P2|NOT COMPLETED|Overall Study||20
8403915|NCT00988156|20712178|P1|NOT COMPLETED|Overall Study||17
8403916|NCT00988156|20712177|P2|COMPLETED|Overall Study||135
8403917|NCT00988156|20712178|P1|COMPLETED|Overall Study||132
8403918|NCT00988156|20712177|P2|Safety Set|Overall Study||134
8403919|NCT00988156|20712178|P1|Safety Set|Overall Study||129
8403920|NCT00988156|20712177|P2|Per Protocol Set (PP)|Overall Study||97
8403921|NCT00988156|20712178|P1|Per Protocol Set (PP)|Overall Study||101
8403922|NCT00988156|20712177|P2|Intention-to-Treat Set (ITT)|Overall Study||134
8403923|NCT00988156|20712178|P1|Intention-to-Treat Set (ITT)|Overall Study||129
8403924|NCT00988156|20712177|P2|STARTED|Overall Study||155
8403925|NCT00988156|20712178|P1|STARTED|Overall Study||149
8403926|NCT00988143|20712189|P3|NOT COMPLETED|Overall Study||0
8403927|NCT00988143|20712190|P2|NOT COMPLETED|Overall Study||0
8403928|NCT00988143|20712191|P1|NOT COMPLETED|Overall Study||0
8403929|NCT00988143|20712189|P3|COMPLETED|Overall Study||190
8403930|NCT00988143|20712190|P2|COMPLETED|Overall Study||190
8403931|NCT00988143|20712191|P1|COMPLETED|Overall Study||220
8403932|NCT00988143|20712189|P3|STARTED|Overall Study||190
8403933|NCT00988143|20712190|P2|STARTED|Overall Study||190
8403934|NCT00988143|20712191|P1|STARTED|Overall Study||220
8403935|NCT00988117|20712223|P1|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
8403936|NCT00988117|20712223|P1|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
8403937|NCT00988117|20712223|P1|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
8403938|NCT00988117|20712223|P1|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
8403939|NCT00988117|20712223|P1|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
8403940|NCT00988117|20712223|P1|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
8403941|NCT00988091|20712232|P2|NOT COMPLETED|Open-label Period||33
8403942|NCT00988091|20712233|P1|NOT COMPLETED|Open-label Period||21
8403943|NCT00988091|20712232|P2|COMPLETED|Open-label Period||192
8403944|NCT00988091|20712233|P1|COMPLETED|Open-label Period||208
8403945|NCT00988091|20712232|P2|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
8403946|NCT00988091|20712233|P1|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
8403948|NCT00988091|20712233|P1|NOT COMPLETED|Double-blind Period||43
8403949|NCT00988091|20712232|P2|COMPLETED|Double-blind Period||251
8403950|NCT00988091|20712233|P1|COMPLETED|Double-blind Period||255
8403951|NCT00988091|20712232|P2|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
8403952|NCT00988091|20712233|P1|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
8403953|NCT00988091|20712232|P2|STARTED|Double-blind Period||298
8403954|NCT00988091|20712233|P1|STARTED|Double-blind Period||298
8403955|NCT00988065|20712255|P3|NOT COMPLETED|Overall Study||15
8403956|NCT00988065|20712256|P2|NOT COMPLETED|Overall Study||23
8403957|NCT00988065|20712257|P1|NOT COMPLETED|Overall Study||13
8403958|NCT00988065|20712255|P3|COMPLETED|Overall Study||135
8403959|NCT00988065|20712256|P2|COMPLETED|Overall Study||127
8403960|NCT00988065|20712257|P1|COMPLETED|Overall Study||135
8403961|NCT00988065|20712255|P3|Received Third Randomized Dose|Overall Study||135
8403962|NCT00988065|20712256|P2|Received Third Randomized Dose|Overall Study||127
8403963|NCT00988065|20712257|P1|Received Third Randomized Dose|Overall Study||135
8403964|NCT00988065|20712255|P3|Received Second Randomized Dose|Overall Study||145
8403965|NCT00988065|20712256|P2|Received Second Randomized Dose|Overall Study||135
8403966|NCT00988065|20712257|P1|Received Second Randomized Dose|Overall Study||139
8403967|NCT00988065|20712255|P3|Received First Randomized Dose|Overall Study||150
8403968|NCT00988065|20712256|P2|Received First Randomized Dose|Overall Study||150
8403969|NCT00988065|20712257|P1|Received First Randomized Dose|Overall Study||148
8403970|NCT00988065|20712255|P3|STARTED|Overall Study|Randomized to double-blind treatment|150
8403971|NCT00988065|20712256|P2|STARTED|Overall Study|Randomized to double-blind treatment|150
8403972|NCT00988065|20712257|P1|STARTED|Overall Study|Randomized to double-blind treatment|148
8403973|NCT00988052|20712279|P2|NOT COMPLETED|Overall Study||416
8403974|NCT00988052|20712280|P1|NOT COMPLETED|Overall Study||423
8403975|NCT00988052|20712279|P2|COMPLETED|Overall Study||0
8403976|NCT00988052|20712280|P1|COMPLETED|Overall Study||0
8403977|NCT00988052|20712279|P2|STARTED|Overall Study||416
8403978|NCT00988052|20712280|P1|STARTED|Overall Study||423
8403979|NCT00988000|20712297|P3|NOT COMPLETED|Overall Study||0
8403980|NCT00988000|20712298|P2|NOT COMPLETED|Overall Study||0
8403981|NCT00988000|20712299|P1|NOT COMPLETED|Overall Study||0
8403982|NCT00988000|20712297|P3|COMPLETED|Overall Study||57
8403983|NCT00988000|20712298|P2|COMPLETED|Overall Study||51
8403984|NCT00988000|20712299|P1|COMPLETED|Overall Study||49
8403985|NCT00988000|20712297|P3|STARTED|Overall Study||57
8403986|NCT00988000|20712298|P2|STARTED|Overall Study||51
8403987|NCT00988000|20712299|P1|STARTED|Overall Study||49
8403988|NCT00987948|20712310|P1|NOT COMPLETED|Overall Study||3
8403989|NCT00987948|20712310|P1|COMPLETED|Overall Study||12
8403990|NCT00987948|20712310|P1|STARTED|Overall Study||15
8403991|NCT00987935|20712324|P9|NOT COMPLETED|Overall Study||32
8403992|NCT00987935|20712325|P8|NOT COMPLETED|Overall Study||62
8403993|NCT00987935|20712326|P7|NOT COMPLETED|Overall Study||15
8403994|NCT00987935|20712327|P6|NOT COMPLETED|Overall Study||3
8403995|NCT00987935|20712328|P5|NOT COMPLETED|Overall Study||7
8403996|NCT00987935|20712329|P4|NOT COMPLETED|Overall Study||3
8403997|NCT00987935|20712330|P3|NOT COMPLETED|Overall Study||3
8403998|NCT00987935|20712331|P2|NOT COMPLETED|Overall Study||3
8403999|NCT00987935|20712332|P1|NOT COMPLETED|Overall Study||4
8404000|NCT00987935|20712324|P9|COMPLETED|Overall Study||0
8404001|NCT00987935|20712325|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
8404002|NCT00987935|20712326|P7|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
8404003|NCT00987935|20712327|P6|COMPLETED|Overall Study||0
8404004|NCT00987935|20712328|P5|COMPLETED|Overall Study||0
8404005|NCT00987935|20712329|P4|COMPLETED|Overall Study||0
8404006|NCT00987935|20712330|P3|COMPLETED|Overall Study||0
8404007|NCT00987935|20712331|P2|COMPLETED|Overall Study||0
8404008|NCT00987935|20712332|P1|COMPLETED|Overall Study||0
8404009|NCT00987935|20712324|P9|STARTED|Overall Study||32
8404010|NCT00987935|20712325|P8|STARTED|Overall Study||63
8404011|NCT00987935|20712326|P7|STARTED|Overall Study||16
8404012|NCT00987935|20712327|P6|STARTED|Overall Study||3
8404013|NCT00987935|20712328|P5|STARTED|Overall Study||7
8404014|NCT00987935|20712329|P4|STARTED|Overall Study||3
8404015|NCT00987935|20712330|P3|STARTED|Overall Study||3
8404016|NCT00987935|20712331|P2|STARTED|Overall Study||3
8404017|NCT00987935|20712332|P1|STARTED|Overall Study||4
8404018|NCT00987831|20712388|P3|NOT COMPLETED|Overall Study||0
8404019|NCT00987831|20712389|P2|NOT COMPLETED|Overall Study||3
8404020|NCT00987831|20712390|P1|NOT COMPLETED|Overall Study||1
8404021|NCT00987831|20712388|P3|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
8404022|NCT00987831|20712389|P2|COMPLETED|Overall Study|all controls returned for two visits|52
8404023|NCT00987831|20712390|P1|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
8404024|NCT00987831|20712388|P3|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
8404025|NCT00987831|20712389|P2|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
8404026|NCT00987831|20712390|P1|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
8404027|NCT00987727|20712401|P2|NOT COMPLETED|Overall Study||7
8404028|NCT00987727|20712402|P1|NOT COMPLETED|Overall Study||5
8404029|NCT00987727|20712401|P2|COMPLETED|Overall Study||34
8404030|NCT00987727|20712402|P1|COMPLETED|Overall Study||36
8404031|NCT00987727|20712401|P2|STARTED|Overall Study||41
8404032|NCT00987727|20712402|P1|STARTED|Overall Study||41
8404033|NCT00987623|20712412|P2|NOT COMPLETED|Overall Study||3
8404034|NCT00987623|20712413|P1|NOT COMPLETED|Overall Study||5
8404035|NCT00987623|20712412|P2|COMPLETED|Overall Study||151
8404036|NCT00987623|20712413|P1|COMPLETED|Overall Study||140
8404037|NCT00987623|20712412|P2|STARTED|Overall Study||154
8404038|NCT00987623|20712413|P1|STARTED|Overall Study||145
8404039|NCT00987558|20712419|P2|NOT COMPLETED|Overall Study||5
8404040|NCT00987558|20712420|P1|NOT COMPLETED|Overall Study||1
8404041|NCT00987558|20712419|P2|COMPLETED|Overall Study||12
8404042|NCT00987558|20712420|P1|COMPLETED|Overall Study||12
8404043|NCT00987558|20712419|P2|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
8404044|NCT00987558|20712420|P1|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
8404045|NCT00987558|20712419|P2|Washout|Overall Study||12
8404046|NCT00987558|20712420|P1|Washout|Overall Study||13
8404047|NCT00987558|20712419|P2|Simvastatin|Overall Study||12
8404048|NCT00987558|20712420|P1|Simvastatin|Overall Study||13
8404049|NCT00987558|20712419|P2|STARTED|Overall Study||17
8404050|NCT00987558|20712420|P1|STARTED|Overall Study||13
8404051|NCT00987480|20712433|P1|NOT COMPLETED|Overall Study||0
8404052|NCT00987480|20712433|P1|COMPLETED|Overall Study||45
8404053|NCT00987480|20712433|P1|STARTED|Overall Study||45
8404054|NCT00987467|20712442|P1|NOT COMPLETED|Overall Study||2
8404055|NCT00987467|20712442|P1|COMPLETED|Overall Study||10
8404056|NCT00987467|20712442|P1|STARTED|Overall Study||12
8404057|NCT00987415|20712449|P2|NOT COMPLETED|Overall Study||9
8404058|NCT00987415|20712450|P1|NOT COMPLETED|Overall Study||9
8404059|NCT00987415|20712449|P2|COMPLETED|Overall Study||116
8404060|NCT00987415|20712450|P1|COMPLETED|Overall Study||119
8404061|NCT00987415|20712449|P2|STARTED|Overall Study||125
8404062|NCT00987415|20712450|P1|STARTED|Overall Study||128
8404063|NCT00987402|20712466|P2|NOT COMPLETED|Overall Study||98
8404064|NCT00987402|20712467|P1|NOT COMPLETED|Overall Study||86
8404065|NCT00987402|20712466|P2|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
8404066|NCT00987402|20712467|P1|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
8404067|NCT00987402|20712466|P2|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
8404068|NCT00987402|20712467|P1|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
8404069|NCT00987389|20712475|P4|NOT COMPLETED|Overall Study||3
8404070|NCT00987389|20712476|P3|NOT COMPLETED|Overall Study||8
8404071|NCT00987389|20712477|P2|NOT COMPLETED|Overall Study||8
8404072|NCT00987389|20712478|P1|NOT COMPLETED|Overall Study||9
8404073|NCT00987389|20712475|P4|COMPLETED|Overall Study||174
8404074|NCT00987389|20712476|P3|COMPLETED|Overall Study||167
8404075|NCT00987389|20712477|P2|COMPLETED|Overall Study||168
8404076|NCT00987389|20712478|P1|COMPLETED|Overall Study||167
8404077|NCT00987389|20712475|P4|STARTED|Overall Study||177
8404078|NCT00987389|20712476|P3|STARTED|Overall Study||175
8404079|NCT00987389|20712477|P2|STARTED|Overall Study||176
8404080|NCT00987389|20712478|P1|STARTED|Overall Study||176
8404081|NCT00987337|20712497|P3|NOT COMPLETED|Overall Study||51
8404082|NCT00987337|20712498|P2|NOT COMPLETED|Overall Study||55
8404083|NCT00987337|20712499|P1|NOT COMPLETED|Overall Study||57
8404084|NCT00987337|20712497|P3|COMPLETED|Overall Study||45
8404085|NCT00987337|20712498|P2|COMPLETED|Overall Study||41
8404086|NCT00987337|20712499|P1|COMPLETED|Overall Study||39
8404087|NCT00987337|20712497|P3|STARTED|Overall Study||96
8404088|NCT00987337|20712498|P2|STARTED|Overall Study||96
8404089|NCT00987337|20712499|P1|STARTED|Overall Study||96
8404090|NCT00986999|20712543|P1|NOT COMPLETED|Overall Study||1
8404091|NCT00986999|20712543|P1|COMPLETED|Overall Study||6
8404092|NCT00986999|20712543|P1|STARTED|Overall Study||7
8404093|NCT00986986|20712554|P2|NOT COMPLETED|Overall Study||1
8404094|NCT00986986|20712555|P1|NOT COMPLETED|Overall Study||0
8404095|NCT00986986|20712554|P2|COMPLETED|Overall Study||9
8404096|NCT00986986|20712555|P1|COMPLETED|Overall Study||10
8404097|NCT00986986|20712554|P2|STARTED|Overall Study||10
8404098|NCT00986986|20712555|P1|STARTED|Overall Study||10
8404099|NCT00986973|20712565|P1|NOT COMPLETED|Overall Study||1
8404100|NCT00986973|20712565|P1|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
8404101|NCT00986973|20712565|P1|STARTED|Overall Study||6
8404102|NCT00986947|20712575|P1|NOT COMPLETED|Overall Study||20
8404103|NCT00986947|20712575|P1|COMPLETED|Overall Study||0
8404104|NCT00986947|20712575|P1|STARTED|Overall Study||20
8404105|NCT00986921|20712582|P2|NOT COMPLETED|Overall Study||0
8404106|NCT00986921|20712583|P1|NOT COMPLETED|Overall Study||1
8404107|NCT00986921|20712582|P2|COMPLETED|Overall Study||25
8404108|NCT00986921|20712583|P1|COMPLETED|Overall Study||24
8404109|NCT00986921|20712582|P2|STARTED|Overall Study||25
8404110|NCT00986921|20712583|P1|STARTED|Overall Study||25
8404111|NCT00986856|20712595|P2|NOT COMPLETED|Overall Study||0
8404112|NCT00986856|20712596|P1|NOT COMPLETED|Overall Study||0
8404113|NCT00986856|20712595|P2|COMPLETED|Overall Study||16
8404114|NCT00986856|20712596|P1|COMPLETED|Overall Study||42
8404115|NCT00986856|20712595|P2|STARTED|Overall Study||16
8404116|NCT00986856|20712596|P1|STARTED|Overall Study||42
8404117|NCT00986830|20712616|P1|NOT COMPLETED|Overall Study||8
8404118|NCT00986830|20712616|P1|COMPLETED|Overall Study||66
8404119|NCT00986830|20712616|P1|Treated|Overall Study||69
8404120|NCT00986830|20712616|P1|STARTED|Overall Study||74
8404121|NCT00986674|20712631|P3|NOT COMPLETED|Overall Study||48
8404122|NCT00986674|20712632|P2|NOT COMPLETED|Overall Study||45
8404123|NCT00986674|20712633|P1|NOT COMPLETED|Overall Study||47
8404124|NCT00986674|20712631|P3|COMPLETED|Overall Study||0
8404125|NCT00986674|20712632|P2|COMPLETED|Overall Study||0
8404126|NCT00986674|20712633|P1|COMPLETED|Overall Study||0
8404127|NCT00986674|20712631|P3|Eligible and Treated|Overall Study||47
8404128|NCT00986674|20712632|P2|Eligible and Treated|Overall Study||41
8404129|NCT00986674|20712633|P1|Eligible and Treated|Overall Study||39
8404130|NCT00986674|20712631|P3|Treated|Overall Study||47
8404131|NCT00986674|20712632|P2|Treated|Overall Study||42
8404132|NCT00986674|20712633|P1|Treated|Overall Study||43
8404133|NCT00986674|20712631|P3|STARTED|Overall Study||48
8404134|NCT00986674|20712632|P2|STARTED|Overall Study||45
8404135|NCT00986674|20712633|P1|STARTED|Overall Study||47
8404136|NCT00986583|20712649|P2|NOT COMPLETED|Overall Study||0
8404137|NCT00986583|20712650|P1|NOT COMPLETED|Overall Study||0
8404138|NCT00986583|20712649|P2|COMPLETED|Overall Study||32
8404139|NCT00986583|20712650|P1|COMPLETED|Overall Study||38
8404140|NCT00986583|20712649|P2|STARTED|Overall Study||32
8404141|NCT00986583|20712650|P1|STARTED|Overall Study||38
8404142|NCT00986570|20712666|P1|NOT COMPLETED|Overall Study||7
8404143|NCT00986570|20712666|P1|COMPLETED|Overall Study||114
8404144|NCT00986570|20712666|P1|STARTED|Overall Study||121
8404145|NCT00986544|20712672|P2|NOT COMPLETED|Overall Study||0
8404146|NCT00986544|20712673|P1|NOT COMPLETED|Overall Study||0
8404147|NCT00986544|20712672|P2|COMPLETED|Overall Study||53
8404148|NCT00986544|20712673|P1|COMPLETED|Overall Study||53
8404149|NCT00986544|20712672|P2|STARTED|Overall Study||53
8404150|NCT00986544|20712673|P1|STARTED|Overall Study||53
8404151|NCT00986479|20712683|P2|NOT COMPLETED|Period 2||0
8404152|NCT00986479|20712684|P1|NOT COMPLETED|Period 2||0
8404153|NCT00986479|20712683|P2|COMPLETED|Period 2||10
8404154|NCT00986479|20712684|P1|COMPLETED|Period 2||10
8404155|NCT00986479|20712683|P2|STARTED|Period 2||10
8404156|NCT00986479|20712684|P1|STARTED|Period 2||10
8404157|NCT00986479|20712683|P2|NOT COMPLETED|Period 1||0
8404158|NCT00986479|20712684|P1|NOT COMPLETED|Period 1||2
8404159|NCT00986479|20712683|P2|COMPLETED|Period 1||10
8404160|NCT00986479|20712684|P1|COMPLETED|Period 1||10
8404161|NCT00986479|20712683|P2|STARTED|Period 1||10
8404162|NCT00986479|20712684|P1|STARTED|Period 1||12
8404163|NCT00986453|20712714|P1|NOT COMPLETED|Overall Study||2
8404164|NCT00986453|20712714|P1|COMPLETED|Overall Study||43
8404165|NCT00986453|20712714|P1|STARTED|Overall Study||45
8404166|NCT00986440|20712730|P2|NOT COMPLETED|Overall Study||43
8404167|NCT00986440|20712731|P1|NOT COMPLETED|Overall Study||41
8404168|NCT00986440|20712730|P2|COMPLETED|Overall Study||0
8404169|NCT00986440|20712731|P1|COMPLETED|Overall Study||0
8404170|NCT00986440|20712730|P2|Randomized, But Not Dosed|Overall Study||1
8404171|NCT00986440|20712731|P1|Randomized, But Not Dosed|Overall Study||0
8404172|NCT00986440|20712730|P2|STARTED|Overall Study||43
8404173|NCT00986440|20712731|P1|STARTED|Overall Study||41
8404174|NCT00986427|20712749|P2|NOT COMPLETED|Overall Study||0
8404175|NCT00986427|20712750|P1|NOT COMPLETED|Overall Study||4
8404176|NCT00986427|20712749|P2|COMPLETED|Overall Study||12
8404177|NCT00986427|20712750|P1|COMPLETED|Overall Study||8
8404178|NCT00986427|20712749|P2|STARTED|Overall Study||12
8404179|NCT00986427|20712750|P1|STARTED|Overall Study||12
8404180|NCT00986401|20712766|P2|NOT COMPLETED|Period 2||0
8404181|NCT00986401|20712767|P1|NOT COMPLETED|Period 2||0
8404182|NCT00986401|20712766|P2|COMPLETED|Period 2||21
8404183|NCT00986401|20712767|P1|COMPLETED|Period 2||22
8404184|NCT00986401|20712766|P2|STARTED|Period 2||21
8404185|NCT00986401|20712767|P1|STARTED|Period 2||22
8404186|NCT00986401|20712766|P2|NOT COMPLETED|Period 1||1
8404187|NCT00986401|20712767|P1|NOT COMPLETED|Period 1||0
8404188|NCT00986401|20712766|P2|COMPLETED|Period 1||21
8404189|NCT00986401|20712767|P1|COMPLETED|Period 1||22
8404190|NCT00986401|20712766|P2|STARTED|Period 1||22
8404191|NCT00986401|20712767|P1|STARTED|Period 1||22
8404192|NCT00986362|20712778|P2|NOT COMPLETED|Overall Study||1
8404193|NCT00986362|20712779|P1|NOT COMPLETED|Overall Study||2
8404194|NCT00986362|20712778|P2|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
8404195|NCT00986362|20712779|P1|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
8404196|NCT00986362|20712778|P2|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
8404197|NCT00986362|20712779|P1|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
8404198|NCT00986349|20712785|P1|NOT COMPLETED|Overall Study||7
8404199|NCT00986349|20712785|P1|COMPLETED|Overall Study||16
8404200|NCT00986349|20712785|P1|Early Explant|Overall Study||4
8404201|NCT00986349|20712785|P1|Successful Implant Procedure|Overall Study|successful device implant procedure|20
8404202|NCT00986349|20712785|P1|STARTED|Overall Study|attempted implant procedures|23
8404203|NCT00986310|20712800|P2|NOT COMPLETED|Overall Study||0
8404204|NCT00986310|20712801|P1|NOT COMPLETED|Overall Study||0
8404205|NCT00986310|20712800|P2|COMPLETED|Overall Study||0
8404206|NCT00986310|20712801|P1|COMPLETED|Overall Study||0
8404207|NCT00986310|20712800|P2|STARTED|Overall Study||0
8404208|NCT00986310|20712801|P1|STARTED|Overall Study||0
8404209|NCT00986258|20712809|P1|NOT COMPLETED|Maintenance Period||9
8404210|NCT00986258|20712809|P1|COMPLETED|Maintenance Period||93
8404211|NCT00986258|20712809|P1|STARTED|Maintenance Period||102
8404212|NCT00986258|20712809|P1|NOT COMPLETED|Titration and Optimal Dose Period||23
8404213|NCT00986258|20712809|P1|COMPLETED|Titration and Optimal Dose Period||102
8404214|NCT00986258|20712809|P1|STARTED|Titration and Optimal Dose Period||125
8404215|NCT00986258|20712809|P1|NOT COMPLETED|Observation Period||11
8404216|NCT00986258|20712809|P1|COMPLETED|Observation Period||125
8404217|NCT00986258|20712809|P1|STARTED|Observation Period||136
8404218|NCT00986245|20712837|P2|NOT COMPLETED|Second Intervention||1
8404219|NCT00986245|20712838|P1|NOT COMPLETED|Second Intervention||2
8404220|NCT00986245|20712837|P2|COMPLETED|Second Intervention||32
8404221|NCT00986245|20712838|P1|COMPLETED|Second Intervention||29
8404222|NCT00986245|20712837|P2|STARTED|Second Intervention||33
8404223|NCT00986245|20712838|P1|STARTED|Second Intervention||31
8404224|NCT00986245|20712837|P2|NOT COMPLETED|First Intervention||8
8404225|NCT00986245|20712838|P1|NOT COMPLETED|First Intervention||10
8404226|NCT00986245|20712837|P2|COMPLETED|First Intervention||33
8404227|NCT00986245|20712838|P1|COMPLETED|First Intervention||31
8404228|NCT00986245|20712837|P2|STARTED|First Intervention||41
8404229|NCT00986245|20712838|P1|STARTED|First Intervention||41
8404230|NCT00986232|20712875|P4|NOT COMPLETED|Overall Study||20
8404231|NCT00986232|20712876|P3|NOT COMPLETED|Overall Study||35
8404232|NCT00986232|20712877|P2|NOT COMPLETED|Overall Study||50
8404233|NCT00986232|20712878|P1|NOT COMPLETED|Overall Study||51
8404234|NCT00986232|20712875|P4|COMPLETED|Overall Study||370
8404235|NCT00986232|20712876|P3|COMPLETED|Overall Study||346
8404236|NCT00986232|20712877|P2|COMPLETED|Overall Study||343
8404237|NCT00986232|20712878|P1|COMPLETED|Overall Study||336
8404238|NCT00986232|20712875|P4|Vaccination Visit 2|Overall Study||0
8404239|NCT00986232|20712876|P3|Vaccination Visit 2|Overall Study||360
8404240|NCT00986232|20712877|P2|Vaccination Visit 2|Overall Study||365
8404241|NCT00986232|20712878|P1|Vaccination Visit 2|Overall Study||360
8404242|NCT00986232|20712875|P4|Vaccination Visit 1|Overall Study||390
8404243|NCT00986232|20712876|P3|Vaccination Visit 1|Overall Study||381
8404244|NCT00986232|20712877|P2|Vaccination Visit 1|Overall Study||393
8404245|NCT00986232|20712878|P1|Vaccination Visit 1|Overall Study||387
8404246|NCT00986232|20712875|P4|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
8404247|NCT00986232|20712876|P3|STARTED|Overall Study||381
8404248|NCT00986232|20712877|P2|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
8404249|NCT00986232|20712878|P1|STARTED|Overall Study||387
8404250|NCT00986180|20712952|P2|NOT COMPLETED|Overall Study||56
8404251|NCT00986180|20712953|P1|NOT COMPLETED|Overall Study||44
8404252|NCT00986180|20712952|P2|COMPLETED|Overall Study||268
8404253|NCT00986180|20712953|P1|COMPLETED|Overall Study||277
8404254|NCT00986180|20712952|P2|STARTED|Overall Study||324
8404255|NCT00986180|20712953|P1|STARTED|Overall Study||321
8404256|NCT00986154|20713031|P2|NOT COMPLETED|Overall Study||194
8404257|NCT00986154|20713032|P1|NOT COMPLETED|Overall Study||206
8404258|NCT00986154|20713031|P2|COMPLETED|Overall Study||3955
8404259|NCT00986154|20713032|P1|COMPLETED|Overall Study||3937
8404260|NCT00986154|20713031|P2|Safety Analysis Set (Received Drug)|Overall Study||4122
8404261|NCT00986154|20713032|P1|Safety Analysis Set (Received Drug)|Overall Study||4118
8404262|NCT00986154|20713031|P2|STARTED|Overall Study||4149
8404263|NCT00986154|20713032|P1|STARTED|Overall Study||4143
8404264|NCT00986102|20713046|P4|NOT COMPLETED|Overall Study||1
8404265|NCT00986102|20713047|P3|NOT COMPLETED|Overall Study||0
8404266|NCT00986102|20713048|P2|NOT COMPLETED|Overall Study||2
8404267|NCT00986102|20713049|P1|NOT COMPLETED|Overall Study||1
8404268|NCT00986102|20713046|P4|COMPLETED|Overall Study||66
8404269|NCT00986102|20713047|P3|COMPLETED|Overall Study||19
8404270|NCT00986102|20713048|P2|COMPLETED|Overall Study||75
8404271|NCT00986102|20713049|P1|COMPLETED|Overall Study||52
8404272|NCT00986102|20713046|P4|STARTED|Overall Study|Number of participants who received study medication|67
8404273|NCT00986102|20713047|P3|STARTED|Overall Study|Number of participants who received study medication|19
8404274|NCT00986102|20713048|P2|STARTED|Overall Study|Number of participants who received study medication|77
8404275|NCT00986102|20713049|P1|STARTED|Overall Study|Number of participants who received study medication|53
8404276|NCT00985985|20713099|P4|NOT COMPLETED|Overall Study||13
8404277|NCT00985985|20713100|P3|NOT COMPLETED|Overall Study||11
8404278|NCT00985985|20713101|P2|NOT COMPLETED|Overall Study||24
8404279|NCT00985985|20713102|P1|NOT COMPLETED|Overall Study||24
8404280|NCT00985985|20713099|P4|COMPLETED|Overall Study||107
8404281|NCT00985985|20713100|P3|COMPLETED|Overall Study||109
8404282|NCT00985985|20713101|P2|COMPLETED|Overall Study||218
8404283|NCT00985985|20713102|P1|COMPLETED|Overall Study||217
8404284|NCT00985985|20713099|P4|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
8404285|NCT00985985|20713100|P3|Full Analysis Set (FAS) Population|Overall Study||120
8404286|NCT00985985|20713101|P2|Full Analysis Set (FAS) Population|Overall Study||242
8404287|NCT00985985|20713102|P1|Full Analysis Set (FAS) Population|Overall Study||241
8404288|NCT00985985|20713099|P4|Safety Population|Overall Study||118
8404289|NCT00985985|20713100|P3|Safety Population|Overall Study||119
8404290|NCT00985985|20713101|P2|Safety Population|Overall Study||242
8404291|NCT00985985|20713102|P1|Safety Population|Overall Study||241
8404292|NCT00985985|20713099|P4|STARTED|Overall Study||120
8404293|NCT00985985|20713100|P3|STARTED|Overall Study||120
8404294|NCT00985985|20713101|P2|STARTED|Overall Study||242
8404295|NCT00985985|20713102|P1|STARTED|Overall Study||241
8404296|NCT00985959|20713143|P3|NOT COMPLETED|Overall Study||59
8404297|NCT00985959|20713144|P2|NOT COMPLETED|Overall Study||3
8404298|NCT00985959|20713145|P1|NOT COMPLETED|Overall Study||3
8404299|NCT00985959|20713143|P3|COMPLETED|Overall Study||28
8404300|NCT00985959|20713144|P2|COMPLETED|Overall Study|Completed all 9 cycles|3
8404301|NCT00985959|20713145|P1|COMPLETED|Overall Study|Completed all 9 cycles|3
8404302|NCT00985959|20713143|P3|STARTED|Overall Study|Number of participants treated|87
8404303|NCT00985959|20713144|P2|STARTED|Overall Study|Number of participants treated|6
8404304|NCT00985959|20713145|P1|STARTED|Overall Study|Number of participants treated|6
8404305|NCT00985946|20713168|P1|NOT COMPLETED|Overall Study||7
8404306|NCT00985946|20713168|P1|COMPLETED|Overall Study||8
8404307|NCT00985946|20713168|P1|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
8404308|NCT00985907|20713176|P1|NOT COMPLETED|Overall Study||13
8404309|NCT00985907|20713176|P1|COMPLETED|Overall Study||0
8404310|NCT00985907|20713176|P1|STARTED|Overall Study||13
8404311|NCT00985829|20713186|P1|NOT COMPLETED|Overall Study||0
8404312|NCT00985829|20713186|P1|COMPLETED|Overall Study||28
8404313|NCT00985829|20713186|P1|STARTED|Overall Study||28
8404314|NCT00985790|20713197|P2|NOT COMPLETED|Overall Study||8
8404315|NCT00985790|20713198|P1|NOT COMPLETED|Overall Study||7
8404316|NCT00985790|20713197|P2|COMPLETED|Overall Study||293
8404317|NCT00985790|20713198|P1|COMPLETED|Overall Study||291
8404318|NCT00985790|20713197|P2|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
8404319|NCT00985790|20713198|P1|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
8404320|NCT00985751|20713239|P5|NOT COMPLETED|Overall Study||1
8404321|NCT00985751|20713240|P4|NOT COMPLETED|Overall Study||0
8404322|NCT00985751|20713241|P3|NOT COMPLETED|Overall Study||0
8404323|NCT00985751|20713242|P2|NOT COMPLETED|Overall Study||0
8404324|NCT00985751|20713243|P1|NOT COMPLETED|Overall Study||0
8404325|NCT00985751|20713239|P5|COMPLETED|Overall Study||50
8404326|NCT00985751|20713240|P4|COMPLETED|Overall Study||51
8404327|NCT00985751|20713241|P3|COMPLETED|Overall Study||52
8404328|NCT00985751|20713242|P2|COMPLETED|Overall Study||52
8404329|NCT00985751|20713243|P1|COMPLETED|Overall Study||51
8404330|NCT00985751|20713239|P5|STARTED|Overall Study||51
8404331|NCT00985751|20713240|P4|STARTED|Overall Study||51
8404332|NCT00985751|20713241|P3|STARTED|Overall Study||52
8404333|NCT00985751|20713242|P2|STARTED|Overall Study||52
8404334|NCT00985751|20713243|P1|STARTED|Overall Study||51
8404335|NCT00985738|20713306|P2|NOT COMPLETED|Overall Study||8
8404336|NCT00985738|20713307|P1|NOT COMPLETED|Overall Study||8
8404337|NCT00985738|20713306|P2|COMPLETED|Overall Study||0
8404338|NCT00985738|20713307|P1|COMPLETED|Overall Study||0
8404339|NCT00985738|20713306|P2|STARTED|Overall Study||8
8404340|NCT00985738|20713307|P1|STARTED|Overall Study||8
8404347|NCT00985712|20713352|P2|NOT COMPLETED|Overall Study||7
8404348|NCT00985712|20713353|P1|NOT COMPLETED|Overall Study||6
8404349|NCT00985712|20713352|P2|COMPLETED|Overall Study||123
8404350|NCT00985712|20713353|P1|COMPLETED|Overall Study||127
8404351|NCT00985712|20713352|P2|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
8404352|NCT00985712|20713353|P1|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
8404353|NCT00985712|20713352|P2|Received at Least One Dose of Study Drug|Overall Study||130
8404354|NCT00985712|20713353|P1|Received at Least One Dose of Study Drug|Overall Study||131
8404355|NCT00985712|20713352|P2|STARTED|Overall Study||130
8404356|NCT00985712|20713353|P1|STARTED|Overall Study||133
8404357|NCT00985686|20713371|P4|NOT COMPLETED|Overall Study||2
8404358|NCT00985686|20713372|P3|NOT COMPLETED|Overall Study||0
8404359|NCT00985686|20713373|P2|NOT COMPLETED|Overall Study||1
8404360|NCT00985686|20713374|P1|NOT COMPLETED|Overall Study||1
8404361|NCT00985686|20713371|P4|COMPLETED|Overall Study||14
8404362|NCT00985686|20713372|P3|COMPLETED|Overall Study||13
8404363|NCT00985686|20713373|P2|COMPLETED|Overall Study||15
8404364|NCT00985686|20713374|P1|COMPLETED|Overall Study||17
8404365|NCT00985686|20713371|P4|Visit 4: Data Collection at 24 Weeks|Overall Study||14
8404366|NCT00985686|20713372|P3|Visit 4: Data Collection at 24 Weeks|Overall Study||13
8404367|NCT00985686|20713373|P2|Visit 4: Data Collection at 24 Weeks|Overall Study||15
8404368|NCT00985686|20713374|P1|Visit 4: Data Collection at 24 Weeks|Overall Study||17
8404369|NCT00985686|20713371|P4|Visit 3: Data Collection at 16 Weeks|Overall Study||16
8404370|NCT00985686|20713372|P3|Visit 3: Data Collection at 16 Weeks|Overall Study||13
8404371|NCT00985686|20713373|P2|Visit 3: Data Collection at 16 Weeks|Overall Study||15
8404372|NCT00985686|20713374|P1|Visit 3: Data Collection at 16 Weeks|Overall Study||17
8404373|NCT00985686|20713371|P4|Visit 2: Data Collection at 8 Weeks|Overall Study||16
8404374|NCT00985686|20713372|P3|Visit 2: Data Collection at 8 Weeks|Overall Study||13
8404375|NCT00985686|20713373|P2|Visit 2: Data Collection at 8 Weeks|Overall Study||15
8404376|NCT00985686|20713374|P1|Visit 2: Data Collection at 8 Weeks|Overall Study||18
8404377|NCT00985686|20713371|P4|Visit 1: Baseline Data Collection|Overall Study||16
8404378|NCT00985686|20713372|P3|Visit 1: Baseline Data Collection|Overall Study||13
8404379|NCT00985686|20713373|P2|Visit 1: Baseline Data Collection|Overall Study||15
8404380|NCT00985686|20713374|P1|Visit 1: Baseline Data Collection|Overall Study||18
8404381|NCT00985686|20713371|P4|STARTED|Overall Study||16
8404382|NCT00985686|20713372|P3|STARTED|Overall Study||13
8404383|NCT00985686|20713373|P2|STARTED|Overall Study||16
8404384|NCT00985686|20713374|P1|STARTED|Overall Study||18
8404385|NCT00985673|20713388|P6|NOT COMPLETED|Overall Study||6
8404386|NCT00985673|20713389|P5|NOT COMPLETED|Overall Study||8
8404387|NCT00985673|20713390|P4|NOT COMPLETED|Overall Study||12
8404388|NCT00985673|20713391|P3|NOT COMPLETED|Overall Study||12
8404389|NCT00985673|20713392|P2|NOT COMPLETED|Overall Study||11
8404390|NCT00985673|20713393|P1|NOT COMPLETED|Overall Study||7
8404391|NCT00985673|20713388|P6|COMPLETED|Overall Study||96
8404392|NCT00985673|20713389|P5|COMPLETED|Overall Study||93
8404393|NCT00985673|20713390|P4|COMPLETED|Overall Study||88
8404394|NCT00985673|20713391|P3|COMPLETED|Overall Study||90
8404395|NCT00985673|20713392|P2|COMPLETED|Overall Study||93
8404396|NCT00985673|20713393|P1|COMPLETED|Overall Study||95
8404397|NCT00985673|20713388|P6|STARTED|Overall Study||102
8404398|NCT00985673|20713389|P5|STARTED|Overall Study||101
8404399|NCT00985673|20713390|P4|STARTED|Overall Study||100
8404400|NCT00985673|20713391|P3|STARTED|Overall Study||102
8404401|NCT00985673|20713392|P2|STARTED|Overall Study||104
8404402|NCT00985673|20713393|P1|STARTED|Overall Study||102
8404403|NCT00985543|20713644|P1|NOT COMPLETED|Overall Study||0
8404404|NCT00985543|20713644|P1|COMPLETED|Overall Study||22
8404405|NCT00985543|20713644|P1|STARTED|Overall Study||22
8404406|NCT00985517|20713657|P4|NOT COMPLETED|Overall Study||3
8404407|NCT00985517|20713658|P3|NOT COMPLETED|Overall Study||1
8404408|NCT00985517|20713659|P2|NOT COMPLETED|Overall Study||0
8404409|NCT00985517|20713660|P1|NOT COMPLETED|Overall Study||0
8404410|NCT00985517|20713657|P4|COMPLETED|Overall Study||24
8404411|NCT00985517|20713658|P3|COMPLETED|Overall Study||23
8404412|NCT00985517|20713659|P2|COMPLETED|Overall Study||3
8404413|NCT00985517|20713660|P1|COMPLETED|Overall Study||3
8404414|NCT00985517|20713657|P4|STARTED|Overall Study||27
8404415|NCT00985517|20713658|P3|STARTED|Overall Study||24
8404416|NCT00985517|20713659|P2|STARTED|Overall Study||3
8404417|NCT00985517|20713660|P1|STARTED|Overall Study||3
8404418|NCT00985504|20713676|P2|NOT COMPLETED|Optimization Period||23
8404419|NCT00985504|20713677|P1|NOT COMPLETED|Optimization Period||26
8404420|NCT00985504|20713676|P2|COMPLETED|Optimization Period||204
8404421|NCT00985504|20713677|P1|COMPLETED|Optimization Period||203
8404422|NCT00985504|20713676|P2|STARTED|Optimization Period||227
8404423|NCT00985504|20713677|P1|STARTED|Optimization Period||229
8404424|NCT00985504|20713676|P2|NOT COMPLETED|Acute Treatment Period||12
8404425|NCT00985504|20713677|P1|NOT COMPLETED|Acute Treatment Period||15
8404426|NCT00985504|20713676|P2|COMPLETED|Acute Treatment Period||227
8404427|NCT00985504|20713677|P1|COMPLETED|Acute Treatment Period||229
8404428|NCT00985504|20713676|P2|STARTED|Acute Treatment Period||239
8404429|NCT00985504|20713677|P1|STARTED|Acute Treatment Period||244
8404430|NCT00985491|20713703|P1|NOT COMPLETED|Overall Study||19
8404431|NCT00985491|20713703|P1|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
8404432|NCT00985491|20713703|P1|Received Device|Overall Study||43
8404433|NCT00985491|20713703|P1|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
8404434|NCT00985465|20713710|P2|NOT COMPLETED|Overall Study||3
8404435|NCT00985465|20713711|P1|NOT COMPLETED|Overall Study||1
8404436|NCT00985465|20713710|P2|COMPLETED|Overall Study||66
8404437|NCT00985465|20713711|P1|COMPLETED|Overall Study||140
8404438|NCT00985465|20713710|P2|STARTED|Overall Study||69
8404439|NCT00985465|20713711|P1|STARTED|Overall Study||141
8404440|NCT00985439|20713738|P4|NOT COMPLETED|Overall Study||0
8404441|NCT00985439|20713739|P3|NOT COMPLETED|Overall Study||1
8404442|NCT00985439|20713740|P2|NOT COMPLETED|Overall Study||0
8404443|NCT00985439|20713741|P1|NOT COMPLETED|Overall Study||0
8404444|NCT00985439|20713738|P4|COMPLETED|Overall Study||51
8404445|NCT00985439|20713739|P3|COMPLETED|Overall Study||50
8404446|NCT00985439|20713740|P2|COMPLETED|Overall Study||51
8404447|NCT00985439|20713741|P1|COMPLETED|Overall Study||49
8404448|NCT00985439|20713738|P4|STARTED|Overall Study||51
8404449|NCT00985439|20713739|P3|STARTED|Overall Study||51
8404450|NCT00985439|20713740|P2|STARTED|Overall Study||51
8404451|NCT00985439|20713741|P1|STARTED|Overall Study||49
8404458|NCT00985257|20713770|P1|NOT COMPLETED|Overall Study||0
8404459|NCT00985257|20713770|P1|COMPLETED|Overall Study||123
8404460|NCT00985257|20713770|P1|STARTED|Overall Study||123
8404461|NCT00985231|20713776|P2|NOT COMPLETED|Overall Study||3
8404462|NCT00985231|20713777|P1|NOT COMPLETED|Overall Study||3
8404463|NCT00985231|20713776|P2|COMPLETED|Overall Study||129
8404464|NCT00985231|20713777|P1|COMPLETED|Overall Study||130
8404465|NCT00985231|20713776|P2|STARTED|Overall Study||132
8404466|NCT00985231|20713777|P1|STARTED|Overall Study||133
8404467|NCT00985192|20713785|P1|NOT COMPLETED|Overall Study||4
8404468|NCT00985192|20713785|P1|COMPLETED|Overall Study||45
8404469|NCT00985192|20713785|P1|STARTED|Overall Study||49
8404470|NCT00985166|20713797|P3|NOT COMPLETED|Overall Study||7
8404471|NCT00985166|20713798|P2|NOT COMPLETED|Overall Study||4
8404472|NCT00985166|20713799|P1|NOT COMPLETED|Overall Study||9
8404473|NCT00985166|20713797|P3|COMPLETED|Overall Study||188
8404474|NCT00985166|20713798|P2|COMPLETED|Overall Study||201
8404475|NCT00985166|20713799|P1|COMPLETED|Overall Study||392
8404476|NCT00985166|20713797|P3|Vaccinated at Visit 1|Overall Study||195
8404477|NCT00985166|20713798|P2|Vaccinated at Visit 1|Overall Study||205
8404478|NCT00985166|20713799|P1|Vaccinated at Visit 1|Overall Study||399
8404479|NCT00985166|20713797|P3|STARTED|Overall Study||195
8404480|NCT00985166|20713798|P2|STARTED|Overall Study||205
8404481|NCT00985166|20713799|P1|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
8404482|NCT00985153|20713819|P4|NOT COMPLETED|Overall Study||47
8404483|NCT00985153|20713820|P3|NOT COMPLETED|Overall Study||44
8404484|NCT00985153|20713821|P2|NOT COMPLETED|Overall Study||44
8404485|NCT00985153|20713822|P1|NOT COMPLETED|Overall Study||35
8404486|NCT00985153|20713819|P4|COMPLETED|Overall Study||965
8404487|NCT00985153|20713820|P3|COMPLETED|Overall Study||918
8404488|NCT00985153|20713821|P2|COMPLETED|Overall Study||924
8404489|NCT00985153|20713822|P1|COMPLETED|Overall Study||950
8404490|NCT00985153|20713819|P4|Vaccinated at Visit 1|Overall Study||1012
8404491|NCT00985153|20713820|P3|Vaccinated at Visit 1|Overall Study||962
8404492|NCT00985153|20713821|P2|Vaccinated at Visit 1|Overall Study||968
8404493|NCT00985153|20713822|P1|Vaccinated at Visit 1|Overall Study||985
8404494|NCT00985153|20713819|P4|STARTED|Overall Study||1012
8404495|NCT00985153|20713820|P3|STARTED|Overall Study||962
8404496|NCT00985153|20713821|P2|STARTED|Overall Study||968
8404497|NCT00985153|20713822|P1|STARTED|Overall Study||985
8404498|NCT00985140|20713864|P1|NOT COMPLETED|Overall Study||0
8404499|NCT00985140|20713864|P1|COMPLETED|Overall Study||15
8404500|NCT00985140|20713864|P1|STARTED|Overall Study||15
8404501|NCT00985114|20713870|P2|NOT COMPLETED|Overall Study||2
8404502|NCT00985114|20713871|P1|NOT COMPLETED|Overall Study||1
8404503|NCT00985114|20713870|P2|COMPLETED|Overall Study||37
8404504|NCT00985114|20713871|P1|COMPLETED|Overall Study||33
8404505|NCT00985114|20713870|P2|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
8404506|NCT00985114|20713871|P1|Diet + Lifestyle Counseling Cross-over|Overall Study||0
8404507|NCT00985114|20713870|P2|STARTED|Overall Study||39
8404508|NCT00985114|20713871|P1|STARTED|Overall Study|38 randomized, 34 received the device|34
8404509|NCT00985088|20713885|P8|NOT COMPLETED|Overall Study||6
8404510|NCT00985088|20713886|P7|NOT COMPLETED|Overall Study||4
8404511|NCT00985088|20713887|P6|NOT COMPLETED|Overall Study||7
8404512|NCT00985088|20713888|P5|NOT COMPLETED|Overall Study||9
8404513|NCT00985088|20713889|P4|NOT COMPLETED|Overall Study||7
8404514|NCT00985088|20713890|P3|NOT COMPLETED|Overall Study||4
8404515|NCT00985088|20713891|P2|NOT COMPLETED|Overall Study||2
8404516|NCT00985088|20713892|P1|NOT COMPLETED|Overall Study||11
8404517|NCT00985088|20713885|P8|COMPLETED|Overall Study||216
8404518|NCT00985088|20713886|P7|COMPLETED|Overall Study||107
8404519|NCT00985088|20713887|P6|COMPLETED|Overall Study||108
8404520|NCT00985088|20713888|P5|COMPLETED|Overall Study||214
8404521|NCT00985088|20713889|P4|COMPLETED|Overall Study||214
8404522|NCT00985088|20713890|P3|COMPLETED|Overall Study||108
8404523|NCT00985088|20713891|P2|COMPLETED|Overall Study||112
8404524|NCT00985088|20713892|P1|COMPLETED|Overall Study||211
8404525|NCT00985088|20713885|P8|STARTED|Overall Study||222
8404526|NCT00985088|20713886|P7|STARTED|Overall Study||111
8404527|NCT00985088|20713887|P6|STARTED|Overall Study||115
8404528|NCT00985088|20713888|P5|STARTED|Overall Study||223
8404529|NCT00985088|20713889|P4|STARTED|Overall Study||221
8404530|NCT00985088|20713890|P3|STARTED|Overall Study||112
8404531|NCT00985088|20713891|P2|STARTED|Overall Study||114
8404532|NCT00985088|20713892|P1|STARTED|Overall Study||222
8404533|NCT00985010|20714150|P2|NOT COMPLETED|Overall Study||0
8404534|NCT00985010|20714151|P1|NOT COMPLETED|Overall Study||0
8404535|NCT00985010|20714150|P2|COMPLETED|Overall Study||5
8404536|NCT00985010|20714151|P1|COMPLETED|Overall Study||4
8404537|NCT00985010|20714150|P2|STARTED|Overall Study||5
8404538|NCT00985010|20714151|P1|STARTED|Overall Study||4
8404539|NCT00984867|20714161|P2|NOT COMPLETED|Overall Study||17
8404540|NCT00984867|20714162|P1|NOT COMPLETED|Overall Study||23
8404541|NCT00984867|20714161|P2|COMPLETED|Overall Study||208
8404542|NCT00984867|20714162|P1|COMPLETED|Overall Study||203
8404543|NCT00984867|20714161|P2|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
8404544|NCT00984867|20714162|P1|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
8404545|NCT00984815|20714180|P1|NOT COMPLETED|Overall Study||30
8404546|NCT00984815|20714180|P1|COMPLETED|Overall Study||56
8404547|NCT00984815|20714180|P1|STARTED|Overall Study||86
8404548|NCT00984698|20714189|P2|NOT COMPLETED|Overall Study||8
8404549|NCT00984698|20714190|P1|NOT COMPLETED|Overall Study||3
8404550|NCT00984698|20714189|P2|COMPLETED|Overall Study||14
8404551|NCT00984698|20714190|P1|COMPLETED|Overall Study||18
8404552|NCT00984698|20714189|P2|STARTED|Overall Study||22
8404553|NCT00984698|20714190|P1|STARTED|Overall Study||21
8404554|NCT00984659|20714202|P4|NOT COMPLETED|6-week Double-blind Treatment Period||13
8404555|NCT00984659|20714203|P3|NOT COMPLETED|6-week Double-blind Treatment Period||11
8404556|NCT00984659|20714204|P2|NOT COMPLETED|6-week Double-blind Treatment Period||6
8404557|NCT00984659|20714205|P1|NOT COMPLETED|6-week Double-blind Treatment Period||0
8404558|NCT00984659|20714202|P4|COMPLETED|6-week Double-blind Treatment Period||126
8404559|NCT00984659|20714203|P3|COMPLETED|6-week Double-blind Treatment Period||141
8404560|NCT00984659|20714204|P2|COMPLETED|6-week Double-blind Treatment Period||69
8404561|NCT00984659|20714205|P1|COMPLETED|6-week Double-blind Treatment Period||0
8404562|NCT00984659|20714202|P4|STARTED|6-week Double-blind Treatment Period||139
8404563|NCT00984659|20714203|P3|STARTED|6-week Double-blind Treatment Period||152
8404564|NCT00984659|20714204|P2|STARTED|6-week Double-blind Treatment Period||75
8404565|NCT00984659|20714205|P1|STARTED|6-week Double-blind Treatment Period||0
8404566|NCT00984659|20714202|P4|NOT COMPLETED|2-week Run-in Period||0
8404567|NCT00984659|20714203|P3|NOT COMPLETED|2-week Run-in Period||0
8404568|NCT00984659|20714204|P2|NOT COMPLETED|2-week Run-in Period||0
8404569|NCT00984659|20714205|P1|NOT COMPLETED|2-week Run-in Period||52
8404570|NCT00984659|20714202|P4|COMPLETED|2-week Run-in Period||0
8404571|NCT00984659|20714203|P3|COMPLETED|2-week Run-in Period||0
8404572|NCT00984659|20714204|P2|COMPLETED|2-week Run-in Period||0
8404573|NCT00984659|20714205|P1|COMPLETED|2-week Run-in Period||366
8404574|NCT00984659|20714202|P4|STARTED|2-week Run-in Period||0
8404575|NCT00984659|20714203|P3|STARTED|2-week Run-in Period||0
8404576|NCT00984659|20714204|P2|STARTED|2-week Run-in Period||0
8404577|NCT00984659|20714205|P1|STARTED|2-week Run-in Period||418
8404578|NCT00984620|20714232|P2|NOT COMPLETED|Overall Study||12
8404579|NCT00984620|20714233|P1|NOT COMPLETED|Overall Study||6
8404580|NCT00984620|20714232|P2|COMPLETED|Overall Study||67
8404581|NCT00984620|20714233|P1|COMPLETED|Overall Study||75
8404582|NCT00984620|20714232|P2|STARTED|Overall Study||79
8404583|NCT00984620|20714233|P1|STARTED|Overall Study||81
8404584|NCT00984594|20714271|P2|NOT COMPLETED|Overall Study||1
8404585|NCT00984594|20714272|P1|NOT COMPLETED|Overall Study||1
8404586|NCT00984594|20714271|P2|COMPLETED|Overall Study||1
8404587|NCT00984594|20714272|P1|COMPLETED|Overall Study||1
8404588|NCT00984594|20714271|P2|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
8404589|NCT00984594|20714272|P1|STARTED|Overall Study||2
8404590|NCT00984568|20714288|P2|NOT COMPLETED|Overall Study||6
8404591|NCT00984568|20714289|P1|NOT COMPLETED|Overall Study||8
8404592|NCT00984568|20714288|P2|COMPLETED|Overall Study||7
8404593|NCT00984568|20714289|P1|COMPLETED|Overall Study||7
8404594|NCT00984568|20714288|P2|STARTED|Overall Study||13
8404595|NCT00984568|20714289|P1|STARTED|Overall Study||15
8404596|NCT00984542|20714297|P1|NOT COMPLETED|Overall Study||41
8404597|NCT00984542|20714297|P1|COMPLETED|Overall Study||9
8404598|NCT00984542|20714297|P1|STARTED|Overall Study||50
8404599|NCT00984490|20714305|P1|NOT COMPLETED|Overall Study||0
8404600|NCT00984490|20714305|P1|COMPLETED|Overall Study||5
8404601|NCT00984490|20714305|P1|STARTED|Overall Study||5
8404602|NCT00984334|20714315|P5|NOT COMPLETED|Overall Study||1
8404603|NCT00984334|20714316|P4|NOT COMPLETED|Overall Study||1
8404604|NCT00984334|20714317|P3|NOT COMPLETED|Overall Study||0
8404605|NCT00984334|20714318|P2|NOT COMPLETED|Overall Study||1
8404606|NCT00984334|20714319|P1|NOT COMPLETED|Overall Study||1
8404607|NCT00984334|20714315|P5|COMPLETED|Overall Study||7
8404608|NCT00984334|20714316|P4|COMPLETED|Overall Study||7
8404609|NCT00984334|20714317|P3|COMPLETED|Overall Study||8
8404610|NCT00984334|20714318|P2|COMPLETED|Overall Study||7
8404611|NCT00984334|20714319|P1|COMPLETED|Overall Study||7
8404612|NCT00984334|20714315|P5|STARTED|Overall Study||8
8404613|NCT00984334|20714316|P4|STARTED|Overall Study||8
8404614|NCT00984334|20714317|P3|STARTED|Overall Study||8
8404615|NCT00984334|20714318|P2|STARTED|Overall Study||8
8404616|NCT00984334|20714319|P1|STARTED|Overall Study||8
8404617|NCT00984308|20714333|P2|NOT COMPLETED|Overall Study||6
8404618|NCT00984308|20714334|P1|NOT COMPLETED|Overall Study||18
8404619|NCT00984308|20714333|P2|COMPLETED|Overall Study||109
8404620|NCT00984308|20714334|P1|COMPLETED|Overall Study||92
8404621|NCT00984308|20714333|P2|STARTED|Overall Study||115
8404622|NCT00984308|20714334|P1|STARTED|Overall Study||110
8404623|NCT00984295|20714347|P3|NOT COMPLETED|Overall Study||37
8404624|NCT00984295|20714348|P2|NOT COMPLETED|Overall Study||32
8404625|NCT00984295|20714349|P1|NOT COMPLETED|Overall Study||65
8404626|NCT00984295|20714347|P3|COMPLETED|Overall Study||442
8404627|NCT00984295|20714348|P2|COMPLETED|Overall Study||453
8404628|NCT00984295|20714349|P1|COMPLETED|Overall Study||884
8404629|NCT00984295|20714347|P3|Visit 2|Overall Study||453
8404630|NCT00984295|20714348|P2|Visit 2|Overall Study||468
8404631|NCT00984295|20714349|P1|Visit 2|Overall Study||909
8404632|NCT00984295|20714347|P3|Visit 1|Overall Study||479
8404633|NCT00984295|20714348|P2|Visit 1|Overall Study||485
8404634|NCT00984295|20714349|P1|Visit 1|Overall Study||949
8404635|NCT00984295|20714347|P3|STARTED|Overall Study||479
8404636|NCT00984295|20714348|P2|STARTED|Overall Study||485
8404637|NCT00984295|20714349|P1|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
8404638|NCT00984282|20714416|P2|NOT COMPLETED|Long Term Follow-up||120
8404639|NCT00984282|20714417|P1|NOT COMPLETED|Long Term Follow-up||69
8404640|NCT00984282|20714416|P2|COMPLETED|Long Term Follow-up||4
8404641|NCT00984282|20714417|P1|COMPLETED|Long Term Follow-up||3
8404642|NCT00984282|20714416|P2|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
8404643|NCT00984282|20714417|P1|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
8404644|NCT00984282|20714416|P2|NOT COMPLETED|Open-label Treatment||161
8404645|NCT00984282|20714417|P1|NOT COMPLETED|Open-label Treatment||86
8404646|NCT00984282|20714416|P2|COMPLETED|Open-label Treatment||0
8404647|NCT00984282|20714417|P1|COMPLETED|Open-label Treatment||0
8404648|NCT00984282|20714416|P2|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
8404649|NCT00984282|20714417|P1|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
8404650|NCT00984282|20714416|P2|STARTED|Open-label Treatment||161
8404651|NCT00984282|20714417|P1|STARTED|Open-label Treatment||86
8404652|NCT00984282|20714416|P2|NOT COMPLETED|Double Blind Treatment||38
8404653|NCT00984282|20714417|P1|NOT COMPLETED|Double Blind Treatment||104
8404654|NCT00984282|20714416|P2|COMPLETED|Double Blind Treatment||172
8404655|NCT00984282|20714417|P1|COMPLETED|Double Blind Treatment||103
8404656|NCT00984282|20714416|P2|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
8404657|NCT00984282|20714417|P1|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
8404658|NCT00984282|20714416|P2|STARTED|Double Blind Treatment||210
8404659|NCT00984282|20714417|P1|STARTED|Double Blind Treatment||207
8404660|NCT00984256|20714440|P2|NOT COMPLETED|Overall Study||1
8404661|NCT00984256|20714441|P1|NOT COMPLETED|Overall Study||0
8404662|NCT00984256|20714440|P2|COMPLETED|Overall Study||29
8404663|NCT00984256|20714441|P1|COMPLETED|Overall Study||6
8404664|NCT00984256|20714440|P2|STARTED|Overall Study||30
8404665|NCT00984256|20714441|P1|STARTED|Overall Study||6
8404666|NCT00984204|20714461|P1|NOT COMPLETED|Overall Study||15
8404667|NCT00984204|20714461|P1|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
8404668|NCT00984204|20714461|P1|STARTED|Overall Study||188
8404669|NCT00984165|20714471|P4|NOT COMPLETED|Overall Study||4
8404670|NCT00984165|20714472|P3|NOT COMPLETED|Overall Study||0
8404671|NCT00984165|20714473|P2|NOT COMPLETED|Overall Study||1
8404672|NCT00984165|20714474|P1|NOT COMPLETED|Overall Study||7
8404673|NCT00984165|20714471|P4|COMPLETED|Overall Study||0
8404674|NCT00984165|20714472|P3|COMPLETED|Overall Study||4
8404675|NCT00984165|20714473|P2|COMPLETED|Overall Study||0
8404676|NCT00984165|20714474|P1|COMPLETED|Overall Study||2
8404677|NCT00984165|20714471|P4|STARTED|Overall Study||4
8404678|NCT00984165|20714472|P3|STARTED|Overall Study||4
8404679|NCT00984165|20714473|P2|STARTED|Overall Study||1
8404680|NCT00984165|20714474|P1|STARTED|Overall Study||9
8404681|NCT00984139|20714487|P1|NOT COMPLETED|Overall Study||0
8404682|NCT00984139|20714487|P1|COMPLETED|Overall Study||306
8404683|NCT00984139|20714487|P1|STARTED|Overall Study||306
8404684|NCT00984126|20714503|P4|NOT COMPLETED|Overall Study||59
8404685|NCT00984126|20714504|P3|NOT COMPLETED|Overall Study||7
8404686|NCT00984126|20714505|P2|NOT COMPLETED|Overall Study||8
8404687|NCT00984126|20714506|P1|NOT COMPLETED|Overall Study||7
8404688|NCT00984126|20714503|P4|COMPLETED|Overall Study||76
8404689|NCT00984126|20714504|P3|COMPLETED|Overall Study||16
8404690|NCT00984126|20714505|P2|COMPLETED|Overall Study||20
8404691|NCT00984126|20714506|P1|COMPLETED|Overall Study||20
8404692|NCT00984126|20714503|P4|STARTED|Overall Study||135
8404693|NCT00984126|20714504|P3|STARTED|Overall Study||23
8404694|NCT00984126|20714505|P2|STARTED|Overall Study||28
8404695|NCT00984126|20714506|P1|STARTED|Overall Study||27
8404696|NCT00984061|20714531|P1|NOT COMPLETED|Colchicine With Clarithromycin||0
8404697|NCT00984061|20714531|P1|COMPLETED|Colchicine With Clarithromycin||23
8404698|NCT00984061|20714531|P1|STARTED|Colchicine With Clarithromycin||23
8404699|NCT00984061|20714531|P1|NOT COMPLETED|Clarithromycin Alone||1
8404700|NCT00984061|20714531|P1|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
8404701|NCT00984061|20714531|P1|STARTED|Clarithromycin Alone||24
8404702|NCT00984061|20714531|P1|NOT COMPLETED|21 Day Washout Period||0
8404703|NCT00984061|20714531|P1|COMPLETED|21 Day Washout Period||24
8404704|NCT00984061|20714531|P1|STARTED|21 Day Washout Period||24
8404705|NCT00984061|20714531|P1|NOT COMPLETED|Colchicine Alone||0
8404706|NCT00984061|20714531|P1|COMPLETED|Colchicine Alone||24
8404707|NCT00984061|20714531|P1|STARTED|Colchicine Alone||24
8404708|NCT00984022|20714544|P2|NOT COMPLETED|Overall Study||14
8404709|NCT00984022|20714545|P1|NOT COMPLETED|Overall Study||10
8404710|NCT00984022|20714544|P2|COMPLETED|Overall Study||35
8404711|NCT00984022|20714545|P1|COMPLETED|Overall Study||33
8404712|NCT00984022|20714544|P2|STARTED|Overall Study||49
8404713|NCT00984022|20714545|P1|STARTED|Overall Study||43
8404714|NCT00984009|20714555|P1|NOT COMPLETED|Colchicine With Grapefruit Juice||0
8404715|NCT00984009|20714555|P1|COMPLETED|Colchicine With Grapefruit Juice||21
8404716|NCT00984009|20714555|P1|STARTED|Colchicine With Grapefruit Juice||21
8404717|NCT00984009|20714555|P1|NOT COMPLETED|Grapefruit Juice Alone||1
8404718|NCT00984009|20714555|P1|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
8404719|NCT00984009|20714555|P1|STARTED|Grapefruit Juice Alone||22
8404720|NCT00984009|20714555|P1|NOT COMPLETED|14 Day Washout Period||0
8404721|NCT00984009|20714555|P1|COMPLETED|14 Day Washout Period||22
8404722|NCT00984009|20714555|P1|STARTED|14 Day Washout Period||22
8404723|NCT00984009|20714555|P1|NOT COMPLETED|Colchicine Alone||0
8404724|NCT00984009|20714555|P1|COMPLETED|Colchicine Alone||22
8404725|NCT00984009|20714555|P1|STARTED|Colchicine Alone||22
8404726|NCT00983983|20714569|P3|NOT COMPLETED|Overall Study||1
8404727|NCT00983983|20714570|P2|NOT COMPLETED|Overall Study||1
8404728|NCT00983983|20714571|P1|NOT COMPLETED|Overall Study||2
8404729|NCT00983983|20714569|P3|COMPLETED|Overall Study||6
8404730|NCT00983983|20714570|P2|COMPLETED|Overall Study||8
8404731|NCT00983983|20714571|P1|COMPLETED|Overall Study||6
8404732|NCT00983983|20714569|P3|STARTED|Overall Study||7
8404733|NCT00983983|20714570|P2|STARTED|Overall Study||9
8404734|NCT00983983|20714571|P1|STARTED|Overall Study||8
8404735|NCT00983957|20714588|P1|NOT COMPLETED|Overall Study||2
8404736|NCT00983957|20714588|P1|COMPLETED|Overall Study||18
8404737|NCT00983957|20714588|P1|Treatment C|Overall Study||18
8404738|NCT00983957|20714588|P1|Treatment B|Overall Study||20
8404739|NCT00983957|20714588|P1|Treatment A|Overall Study||20
8404740|NCT00983957|20714588|P1|STARTED|Overall Study||20
8404741|NCT00983931|20714622|P1|NOT COMPLETED|Colchicine With Cyclosporine||0
8404742|NCT00983931|20714622|P1|COMPLETED|Colchicine With Cyclosporine||23
8404743|NCT00983931|20714622|P1|STARTED|Colchicine With Cyclosporine||23
8404744|NCT00983931|20714622|P1|NOT COMPLETED|14 Day Washout Period||1
8404745|NCT00983931|20714622|P1|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
8404746|NCT00983931|20714622|P1|STARTED|14 Day Washout Period||24
8404747|NCT00983931|20714622|P1|NOT COMPLETED|Colchicine Alone||0
8404748|NCT00983931|20714622|P1|COMPLETED|Colchicine Alone||24
8404749|NCT00983931|20714622|P1|STARTED|Colchicine Alone||24
8404750|NCT00983918|20714636|P4|NOT COMPLETED|Overall Study||2
8404751|NCT00983918|20714637|P3|NOT COMPLETED|Overall Study||2
8404752|NCT00983918|20714638|P2|NOT COMPLETED|Overall Study||2
8404753|NCT00983918|20714639|P1|NOT COMPLETED|Overall Study||0
8404754|NCT00983918|20714636|P4|COMPLETED|Overall Study||18
8404755|NCT00983918|20714637|P3|COMPLETED|Overall Study||18
8404756|NCT00983918|20714638|P2|COMPLETED|Overall Study||18
8404757|NCT00983918|20714639|P1|COMPLETED|Overall Study||20
8404758|NCT00983918|20714636|P4|STARTED|Overall Study||20
8404759|NCT00983918|20714637|P3|STARTED|Overall Study||20
8404760|NCT00983918|20714638|P2|STARTED|Overall Study||20
8404761|NCT00983918|20714639|P1|STARTED|Overall Study||20
8404762|NCT00983905|20714649|P1|NOT COMPLETED|Theophylline With Colchicine||0
8404763|NCT00983905|20714649|P1|COMPLETED|Theophylline With Colchicine||27
8404764|NCT00983905|20714649|P1|STARTED|Theophylline With Colchicine||27
8404765|NCT00983905|20714649|P1|NOT COMPLETED|Colchicine Alone||2
8404766|NCT00983905|20714649|P1|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
8404767|NCT00983905|20714649|P1|STARTED|Colchicine Alone||29
8404768|NCT00983905|20714649|P1|NOT COMPLETED|4 Day Washout Period||0
8404769|NCT00983905|20714649|P1|COMPLETED|4 Day Washout Period||29
8404770|NCT00983905|20714649|P1|STARTED|4 Day Washout Period||29
8404771|NCT00983905|20714649|P1|NOT COMPLETED|Theophylline Alone||1
8404772|NCT00983905|20714649|P1|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
8404773|NCT00983905|20714649|P1|STARTED|Theophylline Alone||30
8404774|NCT00983892|20714662|P2|NOT COMPLETED|Overall Study||12
8404775|NCT00983892|20714663|P1|NOT COMPLETED|Overall Study||10
8404776|NCT00983892|20714662|P2|COMPLETED|Overall Study||56
8404777|NCT00983892|20714663|P1|COMPLETED|Overall Study||56
8404778|NCT00983892|20714662|P2|STARTED|Overall Study||68
8404779|NCT00983892|20714663|P1|STARTED|Overall Study||66
8404780|NCT00983853|20714675|P6|NOT COMPLETED|Overall Study||1
8404781|NCT00983853|20714676|P5|NOT COMPLETED|Overall Study||3
8404782|NCT00983853|20714677|P4|NOT COMPLETED|Overall Study||2
8404783|NCT00983853|20714678|P3|NOT COMPLETED|Overall Study||3
8404784|NCT00983853|20714679|P2|NOT COMPLETED|Overall Study||2
8404785|NCT00983853|20714680|P1|NOT COMPLETED|Overall Study||1
8404786|NCT00983853|20714675|P6|COMPLETED|Overall Study||7
8404787|NCT00983853|20714676|P5|COMPLETED|Overall Study||12
8404788|NCT00983853|20714677|P4|COMPLETED|Overall Study||6
8404789|NCT00983853|20714678|P3|COMPLETED|Overall Study||14
8404790|NCT00983853|20714679|P2|COMPLETED|Overall Study||5
8404791|NCT00983853|20714680|P1|COMPLETED|Overall Study||6
8404792|NCT00983853|20714675|P6|STARTED|Overall Study||8
8404793|NCT00983853|20714676|P5|STARTED|Overall Study||15
8404794|NCT00983853|20714677|P4|STARTED|Overall Study||8
8404795|NCT00983853|20714678|P3|STARTED|Overall Study|1 subject was randomized but not dosed|17
8404796|NCT00983853|20714679|P2|STARTED|Overall Study|1 subject was randomized but not dosed|7
8404797|NCT00983853|20714680|P1|STARTED|Overall Study||7
8404798|NCT00983827|20714708|P1|NOT COMPLETED|Overall Study||1
8404799|NCT00983827|20714708|P1|COMPLETED|Overall Study||7
8404800|NCT00983827|20714708|P1|STARTED|Overall Study||8
8404801|NCT00983801|20714712|P1|NOT COMPLETED|Overall Study||0
8404802|NCT00983801|20714712|P1|COMPLETED|Overall Study|Participants who were taken off treatment.|52
8404803|NCT00983801|20714712|P1|STARTED|Overall Study|Participants who received treatment.|52
8404804|NCT00983749|20714726|P2|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
8404805|NCT00983749|20714727|P1|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
8404806|NCT00983749|20714726|P2|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
8404807|NCT00983749|20714727|P1|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
8404808|NCT00983749|20714726|P2|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
8404809|NCT00983749|20714727|P1|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
8404810|NCT00983749|20714726|P2|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
8404811|NCT00983749|20714727|P1|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
8404812|NCT00983749|20714726|P2|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
8404813|NCT00983749|20714727|P1|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
8404814|NCT00983749|20714726|P2|STARTED|Acute Phase (Enrollment to Hospital DC)||10
8404815|NCT00983749|20714727|P1|STARTED|Acute Phase (Enrollment to Hospital DC)||13
8404816|NCT00983645|20714737|P2|NOT COMPLETED|Overall Study||0
8404817|NCT00983645|20714738|P1|NOT COMPLETED|Overall Study||0
8404818|NCT00983645|20714737|P2|COMPLETED|Overall Study||7
8404819|NCT00983645|20714738|P1|COMPLETED|Overall Study||8
8404820|NCT00983645|20714737|P2|STARTED|Overall Study||7
8404821|NCT00983645|20714738|P1|STARTED|Overall Study||8
8404822|NCT00983619|20714762|P12|NOT COMPLETED|Overall Study||11
8404823|NCT00983619|20714763|P11|NOT COMPLETED|Overall Study||11
8404824|NCT00983619|20714764|P10|NOT COMPLETED|Overall Study||3
8404825|NCT00983619|20714765|P9|NOT COMPLETED|Overall Study||1
8404826|NCT00983619|20714766|P8|NOT COMPLETED|Overall Study||2
8404827|NCT00983619|20714767|P7|NOT COMPLETED|Overall Study||3
8404828|NCT00983619|20714768|P6|NOT COMPLETED|Overall Study||67
8404829|NCT00983619|20714769|P5|NOT COMPLETED|Overall Study||3
8404830|NCT00983619|20714770|P4|NOT COMPLETED|Overall Study||5
8404831|NCT00983619|20714771|P3|NOT COMPLETED|Overall Study||3
8404832|NCT00983619|20714772|P2|NOT COMPLETED|Overall Study||4
8404833|NCT00983619|20714773|P1|NOT COMPLETED|Overall Study||3
8404834|NCT00983619|20714762|P12|COMPLETED|Overall Study||3
8404835|NCT00983619|20714763|P11|COMPLETED|Overall Study||6
8404836|NCT00983619|20714764|P10|COMPLETED|Overall Study||0
8404837|NCT00983619|20714765|P9|COMPLETED|Overall Study||0
8404838|NCT00983619|20714766|P8|COMPLETED|Overall Study||1
8404839|NCT00983619|20714767|P7|COMPLETED|Overall Study||0
8404840|NCT00983619|20714768|P6|COMPLETED|Overall Study||9
8404841|NCT00983619|20714769|P5|COMPLETED|Overall Study||0
8404842|NCT00983619|20714770|P4|COMPLETED|Overall Study||1
8404843|NCT00983619|20714771|P3|COMPLETED|Overall Study||0
8404844|NCT00983619|20714772|P2|COMPLETED|Overall Study||0
8404845|NCT00983619|20714773|P1|COMPLETED|Overall Study||0
8404846|NCT00983619|20714762|P12|STARTED|Overall Study||14
8404847|NCT00983619|20714763|P11|STARTED|Overall Study||17
8404848|NCT00983619|20714764|P10|STARTED|Overall Study||3
8404849|NCT00983619|20714765|P9|STARTED|Overall Study||1
8404850|NCT00983619|20714766|P8|STARTED|Overall Study||3
8404851|NCT00983619|20714767|P7|STARTED|Overall Study||3
8404852|NCT00983619|20714768|P6|STARTED|Overall Study||76
8404853|NCT00983619|20714769|P5|STARTED|Overall Study||3
8404854|NCT00983619|20714770|P4|STARTED|Overall Study||6
8404855|NCT00983619|20714771|P3|STARTED|Overall Study||3
8404856|NCT00983619|20714772|P2|STARTED|Overall Study||4
8404857|NCT00983619|20714773|P1|STARTED|Overall Study||3
8404858|NCT00983580|20715078|P2|NOT COMPLETED|Overall Study||4
8404859|NCT00983580|20715079|P1|NOT COMPLETED|Overall Study||5
8404860|NCT00983580|20715078|P2|COMPLETED|Overall Study||49
8404861|NCT00983580|20715079|P1|COMPLETED|Overall Study||49
8404862|NCT00983580|20715078|P2|STARTED|Overall Study||53
8404863|NCT00983580|20715079|P1|STARTED|Overall Study||54
8404864|NCT00983541|20715095|P1|NOT COMPLETED|Overall Study||0
8404865|NCT00983541|20715095|P1|COMPLETED|Overall Study||1
8404866|NCT00983541|20715095|P1|STARTED|Overall Study||1
8404867|NCT00983528|20715105|P1|NOT COMPLETED|Overall Study||6
8404868|NCT00983528|20715105|P1|COMPLETED|Overall Study||0
8404869|NCT00983528|20715105|P1|STARTED|Overall Study||6
8404870|NCT00983515|20715110|P1|NOT COMPLETED|Colchicine With Ritonavir||1
8404871|NCT00983515|20715110|P1|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
8404872|NCT00983515|20715110|P1|STARTED|Colchicine With Ritonavir||18
8404873|NCT00983515|20715110|P1|NOT COMPLETED|Ritonavir Alone||6
8404874|NCT00983515|20715110|P1|COMPLETED|Ritonavir Alone||18
8404875|NCT00983515|20715110|P1|STARTED|Ritonavir Alone||24
8404876|NCT00983515|20715110|P1|NOT COMPLETED|14 Day Washout Period||0
8404877|NCT00983515|20715110|P1|COMPLETED|14 Day Washout Period||24
8404878|NCT00983515|20715110|P1|STARTED|14 Day Washout Period||24
8404879|NCT00983515|20715110|P1|NOT COMPLETED|Colchicine Alone||0
8404880|NCT00983515|20715110|P1|COMPLETED|Colchicine Alone||24
8404881|NCT00983515|20715110|P1|STARTED|Colchicine Alone||24
8404882|NCT00983489|20715124|P3|NOT COMPLETED|Overall Study||312
8404883|NCT00983489|20715125|P2|NOT COMPLETED|Overall Study||285
8404884|NCT00983489|20715126|P1|NOT COMPLETED|Overall Study||185
8404885|NCT00983489|20715124|P3|COMPLETED|Overall Study||135
8404886|NCT00983489|20715125|P2|COMPLETED|Overall Study||168
8404887|NCT00983489|20715126|P1|COMPLETED|Overall Study||326
8404888|NCT00983489|20715124|P3|STARTED|Overall Study||447
8404889|NCT00983489|20715125|P2|STARTED|Overall Study||453
8404890|NCT00983489|20715126|P1|STARTED|Overall Study||511
8404891|NCT00983476|20715137|P3|NOT COMPLETED|Overall Study||0
8404892|NCT00983476|20715138|P2|NOT COMPLETED|Overall Study||22
8404893|NCT00983476|20715139|P1|NOT COMPLETED|Overall Study||17
8404894|NCT00983476|20715137|P3|COMPLETED|Overall Study||88
8404895|NCT00983476|20715138|P2|COMPLETED|Overall Study||71
8404896|NCT00983476|20715139|P1|COMPLETED|Overall Study||78
8404897|NCT00983476|20715137|P3|6 Month Follow up Assessment|Overall Study||74
8404898|NCT00983476|20715138|P2|6 Month Follow up Assessment|Overall Study||62
8404899|NCT00983476|20715139|P1|6 Month Follow up Assessment|Overall Study||71
8404900|NCT00983476|20715137|P3|STARTED|Overall Study||88
8404901|NCT00983476|20715138|P2|STARTED|Overall Study||93
8404902|NCT00983476|20715139|P1|STARTED|Overall Study||95
8404903|NCT00983437|20715171|P1|NOT COMPLETED|Overall Study||47
8404904|NCT00983437|20715171|P1|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
8404905|NCT00983437|20715171|P1|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
8404906|NCT00983437|20715171|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
8404907|NCT00983437|20715171|P1|STARTED|Overall Study||47
8404908|NCT00983385|20715190|P1|NOT COMPLETED|Maintenance Period||23
8404909|NCT00983385|20715190|P1|COMPLETED|Maintenance Period||117
8404910|NCT00983385|20715190|P1|STARTED|Maintenance Period||140
8404911|NCT00983385|20715190|P1|NOT COMPLETED|Titration and Optimal Dose Period||36
8404912|NCT00983385|20715190|P1|COMPLETED|Titration and Optimal Dose Period||140
8404913|NCT00983385|20715190|P1|STARTED|Titration and Optimal Dose Period||176
8404914|NCT00983385|20715190|P1|NOT COMPLETED|Observation Period||32
8404915|NCT00983385|20715190|P1|COMPLETED|Observation Period||176
8404916|NCT00983385|20715190|P1|STARTED|Observation Period||208
8404917|NCT00983372|20715235|P1|NOT COMPLETED|Colchicine With Diltiazem ER||0
8404918|NCT00983372|20715235|P1|COMPLETED|Colchicine With Diltiazem ER||20
8404919|NCT00983372|20715235|P1|STARTED|Colchicine With Diltiazem ER||20
8404920|NCT00983372|20715235|P1|NOT COMPLETED|Diltiazem ER Alone||3
8404921|NCT00983372|20715235|P1|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
8404922|NCT00983372|20715235|P1|STARTED|Diltiazem ER Alone||23
8404923|NCT00983372|20715235|P1|NOT COMPLETED|14 Day Washout Period||1
8404924|NCT00983372|20715235|P1|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
8404925|NCT00983372|20715235|P1|STARTED|14 Day Washout Period||24
8404926|NCT00983372|20715235|P1|NOT COMPLETED|Colchicine Alone||0
8404927|NCT00983372|20715235|P1|COMPLETED|Colchicine Alone||24
8404928|NCT00983372|20715235|P1|STARTED|Colchicine Alone||24
8404929|NCT00983359|20715246|P1|NOT COMPLETED|Overall Study||1
8404930|NCT00983359|20715246|P1|COMPLETED|Overall Study||39
8404931|NCT00983359|20715246|P1|Not Eligible for Analysis|Overall Study||1
8404932|NCT00983359|20715246|P1|STARTED|Overall Study||40
8404933|NCT00983346|20715254|P1|NOT COMPLETED|Overall Study||0
8404934|NCT00983346|20715254|P1|COMPLETED|Overall Study||17
8404935|NCT00983346|20715254|P1|STARTED|Overall Study||17
8404936|NCT00983307|20715258|P1|NOT COMPLETED|Overall Study||0
8404937|NCT00983307|20715258|P1|COMPLETED|Overall Study||17
8404938|NCT00983307|20715258|P1|STARTED|Overall Study||17
8404939|NCT00983294|20715262|P1|NOT COMPLETED|Colchicine With Azithromycin||1
8404940|NCT00983294|20715262|P1|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
8404941|NCT00983294|20715262|P1|STARTED|Colchicine With Azithromycin||22
8404942|NCT00983294|20715262|P1|NOT COMPLETED|Azithromycin Alone||0
8404943|NCT00983294|20715262|P1|COMPLETED|Azithromycin Alone||22
8404944|NCT00983294|20715262|P1|STARTED|Azithromycin Alone||22
8404945|NCT00983294|20715262|P1|NOT COMPLETED|14 Day Washout Period||2
8404946|NCT00983294|20715262|P1|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
8404947|NCT00983294|20715262|P1|STARTED|14 Day Washout Period||24
8404948|NCT00983294|20715262|P1|NOT COMPLETED|Colchicine Alone||0
8404949|NCT00983294|20715262|P1|COMPLETED|Colchicine Alone||24
8404950|NCT00983294|20715262|P1|STARTED|Colchicine Alone||24
8404951|NCT00983281|20715275|P2|NOT COMPLETED|Overall Study||0
8404952|NCT00983281|20715276|P1|NOT COMPLETED|Overall Study||0
8404953|NCT00983281|20715275|P2|COMPLETED|Overall Study||909
8404954|NCT00983281|20715276|P1|COMPLETED|Overall Study||805
8404955|NCT00983281|20715275|P2|STARTED|Overall Study||909
8404956|NCT00983281|20715276|P1|STARTED|Overall Study||805
8404957|NCT00983242|20715282|P1|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
8404958|NCT00983242|20715282|P1|COMPLETED|Colchicine With Verapamil HCl ER||24
8404959|NCT00983242|20715282|P1|STARTED|Colchicine With Verapamil HCl ER||24
8404960|NCT00983242|20715282|P1|NOT COMPLETED|Verapamil HCl ER Alone||0
8404961|NCT00983242|20715282|P1|COMPLETED|Verapamil HCl ER Alone||24
8404962|NCT00983242|20715282|P1|STARTED|Verapamil HCl ER Alone||24
8404963|NCT00983242|20715282|P1|NOT COMPLETED|14 Day Washout Period||0
8404964|NCT00983242|20715282|P1|COMPLETED|14 Day Washout Period||24
8404965|NCT00983242|20715282|P1|STARTED|14 Day Washout Period||24
8404966|NCT00983242|20715282|P1|NOT COMPLETED|Colchicine Alone||0
8404967|NCT00983242|20715282|P1|COMPLETED|Colchicine Alone||24
8404968|NCT00983242|20715282|P1|STARTED|Colchicine Alone||24
8404969|NCT00983216|20715293|P1|NOT COMPLETED|Colchicine With Ketoconazole||0
8404970|NCT00983216|20715293|P1|COMPLETED|Colchicine With Ketoconazole||24
8404971|NCT00983216|20715293|P1|STARTED|Colchicine With Ketoconazole||24
8404972|NCT00983216|20715293|P1|NOT COMPLETED|Ketoconazole Alone||0
8404973|NCT00983216|20715293|P1|COMPLETED|Ketoconazole Alone||24
8404974|NCT00983216|20715293|P1|STARTED|Ketoconazole Alone||24
8404975|NCT00983216|20715293|P1|NOT COMPLETED|14 Day Washout Period||0
8404976|NCT00983216|20715293|P1|COMPLETED|14 Day Washout Period||24
8404977|NCT00983216|20715293|P1|STARTED|14 Day Washout Period||24
8404978|NCT00983216|20715293|P1|NOT COMPLETED|Colchicine Alone||0
8404979|NCT00983216|20715293|P1|COMPLETED|Colchicine Alone||24
8404980|NCT00983216|20715293|P1|STARTED|Colchicine Alone||24
8404981|NCT00983073|20715304|P1|NOT COMPLETED|Maintenance Period||16
8404982|NCT00983073|20715304|P1|COMPLETED|Maintenance Period||144
8404983|NCT00983073|20715304|P1|STARTED|Maintenance Period||160
8404984|NCT00983073|20715304|P1|NOT COMPLETED|Titration and Optimal Dose Period||40
8404985|NCT00983073|20715304|P1|COMPLETED|Titration and Optimal Dose Period||160
8404986|NCT00983073|20715304|P1|STARTED|Titration and Optimal Dose Period||200
8404987|NCT00983073|20715304|P1|NOT COMPLETED|Observation Period||24
8404988|NCT00983073|20715304|P1|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
8404989|NCT00983073|20715304|P1|STARTED|Observation Period||224
8404990|NCT00982995|20715325|P1|NOT COMPLETED|Overall Study||0
8404991|NCT00982995|20715325|P1|COMPLETED|Overall Study||3
8404992|NCT00982995|20715325|P1|STARTED|Overall Study||3
8404993|NCT00982878|20715330|P1|NOT COMPLETED|Overall Study||1
8404994|NCT00982878|20715330|P1|COMPLETED|Overall Study||12
8404995|NCT00982878|20715330|P1|STARTED|Overall Study||13
8404996|NCT00982865|20715339|P4|NOT COMPLETED|Overall Study||0
8404997|NCT00982865|20715340|P3|NOT COMPLETED|Overall Study||0
8404998|NCT00982865|20715341|P2|NOT COMPLETED|Overall Study||0
8404999|NCT00982865|20715342|P1|NOT COMPLETED|Overall Study||0
8405000|NCT00982865|20715339|P4|COMPLETED|Overall Study||34
8405001|NCT00982865|20715340|P3|COMPLETED|Overall Study||15
8405002|NCT00982865|20715341|P2|COMPLETED|Overall Study||82
8405003|NCT00982865|20715342|P1|COMPLETED|Overall Study||49
8405004|NCT00982865|20715339|P4|STARTED|Overall Study||34
8405005|NCT00982865|20715340|P3|STARTED|Overall Study||15
8405006|NCT00982865|20715341|P2|STARTED|Overall Study||82
8405007|NCT00982865|20715342|P1|STARTED|Overall Study||49
8405008|NCT00982735|20715628|P1|NOT COMPLETED|Overall Study||230
8405009|NCT00982735|20715628|P1|COMPLETED|Overall Study||757
8405010|NCT00982735|20715628|P1|STARTED|Overall Study||987
8405011|NCT00982657|20715638|P4|NOT COMPLETED|Overall Study||9
8405012|NCT00982657|20715639|P3|NOT COMPLETED|Overall Study||2
8405013|NCT00982657|20715640|P2|NOT COMPLETED|Overall Study||0
8405014|NCT00982657|20715641|P1|NOT COMPLETED|Overall Study||1
8405015|NCT00982657|20715638|P4|COMPLETED|Overall Study||7
8405016|NCT00982657|20715639|P3|COMPLETED|Overall Study||1
8405017|NCT00982657|20715640|P2|COMPLETED|Overall Study||3
8405018|NCT00982657|20715641|P1|COMPLETED|Overall Study||11
8405019|NCT00982657|20715638|P4|STARTED|Overall Study||16
8405020|NCT00982657|20715639|P3|STARTED|Overall Study||3
8405021|NCT00982657|20715640|P2|STARTED|Overall Study||3
8405022|NCT00982657|20715641|P1|STARTED|Overall Study||12
8405023|NCT00982644|20715682|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
8405024|NCT00982644|20715683|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
8405025|NCT00982644|20715682|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
8405026|NCT00982644|20715683|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
8405027|NCT00982644|20715682|P2|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
8405028|NCT00982644|20715683|P1|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
8405029|NCT00982644|20715682|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
8405030|NCT00982644|20715683|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
8405031|NCT00982644|20715682|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
8405032|NCT00982644|20715683|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
8405033|NCT00982644|20715682|P2|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
8405034|NCT00982644|20715683|P1|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
8405035|NCT00982644|20715682|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
8405036|NCT00982644|20715683|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
8405037|NCT00982644|20715682|P2|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
8405038|NCT00982644|20715683|P1|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
8405039|NCT00982592|20715707|P2|NOT COMPLETED|Overall Study||33
8405040|NCT00982592|20715708|P1|NOT COMPLETED|Overall Study||31
8405041|NCT00982592|20715707|P2|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
8405042|NCT00982592|20715708|P1|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
8405043|NCT00982592|20715707|P2|Treatment Received|Overall Study||52
8405044|NCT00982592|20715708|P1|Treatment Received|Overall Study||63
8405045|NCT00982592|20715707|P2|STARTED|Overall Study||60
8405046|NCT00982592|20715708|P1|STARTED|Overall Study||64
8405047|NCT00982553|20715722|P1|NOT COMPLETED|Phase3||0
8405048|NCT00982553|20715722|P1|COMPLETED|Phase3||14
8405049|NCT00982553|20715722|P1|STARTED|Phase3||14
8405050|NCT00982553|20715722|P1|NOT COMPLETED|Phase2||0
8405051|NCT00982553|20715722|P1|COMPLETED|Phase2||14
8405052|NCT00982553|20715722|P1|STARTED|Phase2||14
8405053|NCT00982553|20715722|P1|NOT COMPLETED|Phase1||0
8405054|NCT00982553|20715722|P1|COMPLETED|Phase1||14
8405055|NCT00982553|20715722|P1|STARTED|Phase1||14
8405056|NCT00982488|20715738|P5|NOT COMPLETED|Overall Study||1
8405057|NCT00982488|20715739|P4|NOT COMPLETED|Overall Study||3
8405058|NCT00982488|20715740|P3|NOT COMPLETED|Overall Study||34
8405059|NCT00982488|20715741|P2|NOT COMPLETED|Overall Study||14
8405060|NCT00982488|20715742|P1|NOT COMPLETED|Overall Study||185
8405061|NCT00982488|20715738|P5|COMPLETED|Overall Study|Still receiving treatment|0
8405062|NCT00982488|20715739|P4|COMPLETED|Overall Study|Still receiving treatment|0
8405063|NCT00982488|20715740|P3|COMPLETED|Overall Study|Still receiving treatment|0
8405064|NCT00982488|20715741|P2|COMPLETED|Overall Study|Still receiving treatment|0
8405065|NCT00982488|20715742|P1|COMPLETED|Overall Study|Still receiving treatment|0
8405066|NCT00982488|20715738|P5|STARTED|Overall Study|Received treatment|1
8405067|NCT00982488|20715739|P4|STARTED|Overall Study|Received treatment|3
8405068|NCT00982488|20715740|P3|STARTED|Overall Study|Received treatment|34
8405069|NCT00982488|20715741|P2|STARTED|Overall Study|Received treatment|14
8405070|NCT00982488|20715742|P1|STARTED|Overall Study|Received treatment|185
8405071|NCT00982423|20715756|P2|NOT COMPLETED|Overall Study||0
8405072|NCT00982423|20715757|P1|NOT COMPLETED|Overall Study||0
8405073|NCT00982423|20715756|P2|COMPLETED|Overall Study||19
8405074|NCT00982423|20715757|P1|COMPLETED|Overall Study||13
8405075|NCT00982423|20715756|P2|STARTED|Overall Study||19
8405076|NCT00982423|20715757|P1|STARTED|Overall Study||13
8405077|NCT00982410|20715775|P2|NOT COMPLETED|12-month Follow-up Assessment||9
8405078|NCT00982410|20715776|P1|NOT COMPLETED|12-month Follow-up Assessment||9
8405079|NCT00982410|20715775|P2|COMPLETED|12-month Follow-up Assessment||55
8405080|NCT00982410|20715776|P1|COMPLETED|12-month Follow-up Assessment||56
8405081|NCT00982410|20715775|P2|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
8405082|NCT00982410|20715776|P1|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
8405083|NCT00982410|20715775|P2|NOT COMPLETED|6-month Follow-up Assessment||11
8405084|NCT00982410|20715776|P1|NOT COMPLETED|6-month Follow-up Assessment||6
8405085|NCT00982410|20715775|P2|COMPLETED|6-month Follow-up Assessment||53
8405086|NCT00982410|20715776|P1|COMPLETED|6-month Follow-up Assessment||59
8405087|NCT00982410|20715775|P2|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
8405088|NCT00982410|20715776|P1|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
8405089|NCT00982410|20715775|P2|NOT COMPLETED|3-month Follow-up Assessment||13
8405090|NCT00982410|20715776|P1|NOT COMPLETED|3-month Follow-up Assessment||9
8405091|NCT00982410|20715775|P2|COMPLETED|3-month Follow-up Assessment||53
8405092|NCT00982410|20715776|P1|COMPLETED|3-month Follow-up Assessment||56
8405093|NCT00982410|20715775|P2|STARTED|3-month Follow-up Assessment||66
8405094|NCT00982410|20715776|P1|STARTED|3-month Follow-up Assessment||65
8405095|NCT00982397|20715800|P2|NOT COMPLETED|Phase II/Overall Study||0
8405096|NCT00982397|20715801|P1|NOT COMPLETED|Phase II/Overall Study||0
8405097|NCT00982397|20715800|P2|COMPLETED|Phase II/Overall Study||751
8405098|NCT00982397|20715801|P1|COMPLETED|Phase II/Overall Study||2019
8405099|NCT00982397|20715800|P2|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
8405100|NCT00982397|20715801|P1|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
8405101|NCT00982397|20715800|P2|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
8405102|NCT00982397|20715801|P1|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
8405103|NCT00982397|20715800|P2|STARTED|Phase II/Overall Study||751
8405104|NCT00982397|20715801|P1|STARTED|Phase II/Overall Study||2019
8405105|NCT00982397|20715800|P2|NOT COMPLETED|Phase I||0
8405106|NCT00982397|20715801|P1|NOT COMPLETED|Phase I||0
8405107|NCT00982397|20715800|P2|COMPLETED|Phase I||0
8405108|NCT00982397|20715801|P1|COMPLETED|Phase I||236
8405109|NCT00982397|20715800|P2|STARTED|Phase I||0
8405110|NCT00982397|20715801|P1|STARTED|Phase I||236
8405111|NCT00982345|20715811|P1|NOT COMPLETED|Overall Study||2
8405112|NCT00982345|20715811|P1|COMPLETED|Overall Study||18
8405113|NCT00982345|20715811|P1|STARTED|Overall Study||20
8405114|NCT00982319|20715817|P2|NOT COMPLETED|Overall Study||2
8405115|NCT00982319|20715818|P1|NOT COMPLETED|Overall Study||2
8405116|NCT00982319|20715817|P2|COMPLETED|Overall Study||15
8405117|NCT00982319|20715818|P1|COMPLETED|Overall Study||15
8405118|NCT00982319|20715817|P2|STARTED|Overall Study||17
8405119|NCT00982319|20715818|P1|STARTED|Overall Study||17
8405120|NCT00982280|20715826|P1|NOT COMPLETED|Maintenance Period||1
8405121|NCT00982280|20715826|P1|COMPLETED|Maintenance Period||54
8405122|NCT00982280|20715826|P1|STARTED|Maintenance Period||55
8405123|NCT00982280|20715826|P1|NOT COMPLETED|Titration and Optimal Dose Period||8
8405124|NCT00982280|20715826|P1|COMPLETED|Titration and Optimal Dose Period||55
8405125|NCT00982280|20715826|P1|STARTED|Titration and Optimal Dose Period||63
8405126|NCT00982280|20715826|P1|NOT COMPLETED|Observation Period||19
8405127|NCT00982280|20715826|P1|COMPLETED|Observation Period||63
8405128|NCT00982280|20715826|P1|STARTED|Observation Period||82
8405129|NCT00982228|20715851|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
8405130|NCT00982228|20715852|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
8405131|NCT00982228|20715851|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
8405132|NCT00982228|20715852|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
8405133|NCT00982228|20715851|P2|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
8405134|NCT00982228|20715852|P1|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
8405135|NCT00982228|20715851|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
8405136|NCT00982228|20715852|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
8405137|NCT00982228|20715851|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
8405138|NCT00982228|20715852|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
8405139|NCT00982228|20715851|P2|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
8405140|NCT00982228|20715852|P1|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
8405141|NCT00982228|20715851|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
8405142|NCT00982228|20715852|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
8405143|NCT00982228|20715851|P2|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
8405144|NCT00982228|20715852|P1|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
8405145|NCT00982189|20715880|P4|NOT COMPLETED|Overall Study||0
8405146|NCT00982189|20715881|P3|NOT COMPLETED|Overall Study||0
8405147|NCT00982189|20715882|P2|NOT COMPLETED|Overall Study||0
8405148|NCT00982189|20715883|P1|NOT COMPLETED|Overall Study||0
8405149|NCT00982189|20715880|P4|COMPLETED|Overall Study||9
8405150|NCT00982189|20715881|P3|COMPLETED|Overall Study||9
8405151|NCT00982189|20715882|P2|COMPLETED|Overall Study||9
8405152|NCT00982189|20715883|P1|COMPLETED|Overall Study||10
8405153|NCT00982189|20715880|P4|STARTED|Overall Study||9
8405154|NCT00982189|20715881|P3|STARTED|Overall Study||9
8405155|NCT00982189|20715882|P2|STARTED|Overall Study||9
8405156|NCT00982189|20715883|P1|STARTED|Overall Study||10
8405157|NCT00982137|20715911|P4|NOT COMPLETED|Overall Study||1
8405158|NCT00982137|20715912|P3|NOT COMPLETED|Overall Study||0
8405159|NCT00982137|20715913|P2|NOT COMPLETED|Overall Study||1
8405160|NCT00982137|20715914|P1|NOT COMPLETED|Overall Study||0
8405161|NCT00982137|20715911|P4|COMPLETED|Overall Study||17
8405162|NCT00982137|20715912|P3|COMPLETED|Overall Study||18
8405163|NCT00982137|20715913|P2|COMPLETED|Overall Study||35
8405164|NCT00982137|20715914|P1|COMPLETED|Overall Study||36
8405165|NCT00982137|20715911|P4|STARTED|Overall Study||18
8405166|NCT00982137|20715912|P3|STARTED|Overall Study||18
8405167|NCT00982137|20715913|P2|STARTED|Overall Study||36
8405168|NCT00982137|20715914|P1|STARTED|Overall Study||36
8405169|NCT00982111|20715946|P2|NOT COMPLETED|Overall Study||66
8405170|NCT00982111|20715947|P1|NOT COMPLETED|Overall Study||75
8405171|NCT00982111|20715946|P2|COMPLETED|Overall Study||252
8405172|NCT00982111|20715947|P1|COMPLETED|Overall Study||240
8405173|NCT00982111|20715946|P2|On Study at Conclusion, Off Treatment|Overall Study||6
8405174|NCT00982111|20715947|P1|On Study at Conclusion, Off Treatment|Overall Study||4
8405175|NCT00982111|20715946|P2|Death Due to Any Cause|Overall Study||246
8405176|NCT00982111|20715947|P1|Death Due to Any Cause|Overall Study||236
8405177|NCT00982111|20715946|P2|Received at Least 1 Dose of Study Drug|Overall Study||312
8405178|NCT00982111|20715947|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
8405179|NCT00982111|20715946|P2|STARTED|Overall Study||318
8405180|NCT00982111|20715947|P1|STARTED|Overall Study||315
8405181|NCT00982033|20715971|P2|NOT COMPLETED|Overall Study||0
8405182|NCT00982033|20715972|P1|NOT COMPLETED|Overall Study||0
8405183|NCT00982033|20715971|P2|COMPLETED|Overall Study||27
8405184|NCT00982033|20715972|P1|COMPLETED|Overall Study||25
8405185|NCT00982033|20715971|P2|STARTED|Overall Study||27
8405186|NCT00982033|20715972|P1|STARTED|Overall Study||25
8405187|NCT00982020|20715980|P2|NOT COMPLETED|Overall Study||64
8405188|NCT00982020|20715981|P1|NOT COMPLETED|Overall Study||57
8405189|NCT00982020|20715980|P2|COMPLETED|Overall Study||37
8405190|NCT00982020|20715981|P1|COMPLETED|Overall Study||45
8405191|NCT00982020|20715980|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
8405192|NCT00982020|20715981|P1|Received at Least 1 Dose of Study Drug|Overall Study||102
8405193|NCT00982020|20715980|P2|STARTED|Overall Study||101
8405194|NCT00982020|20715981|P1|STARTED|Overall Study||102
8405195|NCT00982007|20716005|P4|NOT COMPLETED|Overall Study||6
8405196|NCT00982007|20716006|P3|NOT COMPLETED|Overall Study||0
8405197|NCT00982007|20716007|P2|NOT COMPLETED|Overall Study||4
8405198|NCT00982007|20716008|P1|NOT COMPLETED|Overall Study||4
8405199|NCT00982007|20716005|P4|COMPLETED|Overall Study||245
8405200|NCT00982007|20716006|P3|COMPLETED|Overall Study||253
8405201|NCT00982007|20716007|P2|COMPLETED|Overall Study||253
8405202|NCT00982007|20716008|P1|COMPLETED|Overall Study||246
8405203|NCT00982007|20716005|P4|STARTED|Overall Study||251
8405204|NCT00982007|20716006|P3|STARTED|Overall Study||253
8405205|NCT00982007|20716007|P2|STARTED|Overall Study||257
8405206|NCT00982007|20716008|P1|STARTED|Overall Study||250
8405207|NCT00981825|20716020|P2|NOT COMPLETED|Second Intervention||0
8405208|NCT00981825|20716021|P1|NOT COMPLETED|Second Intervention||0
8405209|NCT00981825|20716020|P2|COMPLETED|Second Intervention||11
8405210|NCT00981825|20716021|P1|COMPLETED|Second Intervention||11
8405211|NCT00981825|20716020|P2|STARTED|Second Intervention||11
8405212|NCT00981825|20716021|P1|STARTED|Second Intervention||11
8405213|NCT00981825|20716020|P2|NOT COMPLETED|Washout After 1st Intervention||0
8405214|NCT00981825|20716021|P1|NOT COMPLETED|Washout After 1st Intervention||0
8405215|NCT00981825|20716020|P2|COMPLETED|Washout After 1st Intervention||11
8405216|NCT00981825|20716021|P1|COMPLETED|Washout After 1st Intervention||11
8405217|NCT00981825|20716020|P2|STARTED|Washout After 1st Intervention||11
8405218|NCT00981825|20716021|P1|STARTED|Washout After 1st Intervention||11
8405219|NCT00981825|20716020|P2|NOT COMPLETED|First Intervention||0
8405220|NCT00981825|20716021|P1|NOT COMPLETED|First Intervention||0
8405221|NCT00981825|20716020|P2|COMPLETED|First Intervention||11
8405222|NCT00981825|20716021|P1|COMPLETED|First Intervention||11
8405223|NCT00981825|20716020|P2|STARTED|First Intervention||11
8405224|NCT00981825|20716021|P1|STARTED|First Intervention||11
8405225|NCT00981812|20716027|P1|NOT COMPLETED|Overall Study||0
8405226|NCT00981812|20716027|P1|COMPLETED|Overall Study||20
8405227|NCT00981812|20716027|P1|STARTED|Overall Study||20
8405228|NCT00981799|20716035|P4|NOT COMPLETED|Overall Study||0
8405229|NCT00981799|20716036|P3|NOT COMPLETED|Overall Study||0
8405230|NCT00981799|20716037|P2|NOT COMPLETED|Overall Study||1
8405231|NCT00981799|20716038|P1|NOT COMPLETED|Overall Study||1
8405232|NCT00981799|20716035|P4|COMPLETED|Overall Study||0
8405233|NCT00981799|20716036|P3|COMPLETED|Overall Study||10
8405234|NCT00981799|20716037|P2|COMPLETED|Overall Study||6
8405235|NCT00981799|20716038|P1|COMPLETED|Overall Study||5
8405236|NCT00981799|20716035|P4|STARTED|Overall Study||0
8405237|NCT00981799|20716036|P3|STARTED|Overall Study||10
8405238|NCT00981799|20716037|P2|STARTED|Overall Study||7
8405239|NCT00981799|20716038|P1|STARTED|Overall Study||6
8405240|NCT00981747|20716052|P1|NOT COMPLETED|Sildenafil and Losartan||0
8405241|NCT00981747|20716052|P1|COMPLETED|Sildenafil and Losartan||9
8405242|NCT00981747|20716052|P1|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
8405243|NCT00981747|20716052|P1|Started Sildenafil and Losartan|Sildenafil and Losartan||9
8405244|NCT00981747|20716052|P1|STARTED|Sildenafil and Losartan||9
8405245|NCT00981747|20716052|P1|NOT COMPLETED|Sildenafil||0
8405246|NCT00981747|20716052|P1|COMPLETED|Sildenafil||9
8405247|NCT00981747|20716052|P1|Completed Sildenafil|Sildenafil||9
8405248|NCT00981747|20716052|P1|Started Sildenafil|Sildenafil||9
8405249|NCT00981747|20716052|P1|STARTED|Sildenafil||9
8405250|NCT00981747|20716052|P1|NOT COMPLETED|Placebo Oral Tablet||1
8405251|NCT00981747|20716052|P1|COMPLETED|Placebo Oral Tablet||9
8405252|NCT00981747|20716052|P1|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
8405253|NCT00981747|20716052|P1|Started Placebo Oral Tablet|Placebo Oral Tablet||10
8405254|NCT00981747|20716052|P1|STARTED|Placebo Oral Tablet||10
8405255|NCT00981747|20716052|P1|NOT COMPLETED|Losartan||2
8405256|NCT00981747|20716052|P1|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
8405257|NCT00981747|20716052|P1|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
8405258|NCT00981747|20716052|P1|Started Losartan|Losartan||12
8405259|NCT00981747|20716052|P1|STARTED|Losartan||12
8405260|NCT00981682|20716070|P1|NOT COMPLETED|Overall Study||142
8405261|NCT00981682|20716070|P1|COMPLETED|Overall Study||234
8405262|NCT00981682|20716070|P1|STARTED|Overall Study||376
8405263|NCT00981669|20716076|P2|NOT COMPLETED|Overall Study||0
8405264|NCT00981669|20716077|P1|NOT COMPLETED|Overall Study||1
8405265|NCT00981669|20716076|P2|COMPLETED|Overall Study||40
8405266|NCT00981669|20716077|P1|COMPLETED|Overall Study||39
8405267|NCT00981669|20716076|P2|STARTED|Overall Study||40
8405268|NCT00981669|20716077|P1|STARTED|Overall Study||40
8405269|NCT00981630|20716089|P4|NOT COMPLETED|Overall Study||0
8405270|NCT00981630|20716090|P3|NOT COMPLETED|Overall Study||0
8405271|NCT00981630|20716091|P2|NOT COMPLETED|Overall Study||0
8405272|NCT00981630|20716092|P1|NOT COMPLETED|Overall Study||0
8405273|NCT00981630|20716089|P4|COMPLETED|Overall Study||32
8405274|NCT00981630|20716090|P3|COMPLETED|Overall Study||32
8405275|NCT00981630|20716091|P2|COMPLETED|Overall Study||32
8405276|NCT00981630|20716092|P1|COMPLETED|Overall Study||32
8405277|NCT00981630|20716089|P4|STARTED|Overall Study||32
8405278|NCT00981630|20716090|P3|STARTED|Overall Study||32
8405279|NCT00981630|20716091|P2|STARTED|Overall Study||32
8405280|NCT00981630|20716092|P1|STARTED|Overall Study||32
8405281|NCT00981578|20716122|P1|NOT COMPLETED|Overall Study||3
8405282|NCT00981578|20716122|P1|COMPLETED|Overall Study||14
8405283|NCT00981578|20716122|P1|STARTED|Overall Study||17
8405284|NCT00981526|20716130|P2|NOT COMPLETED|Overall Study||6
8405285|NCT00981526|20716131|P1|NOT COMPLETED|Overall Study||4
8405286|NCT00981526|20716130|P2|COMPLETED|Overall Study||22
8405287|NCT00981526|20716131|P1|COMPLETED|Overall Study||22
8405288|NCT00981526|20716130|P2|STARTED|Overall Study||28
8405289|NCT00981526|20716131|P1|STARTED|Overall Study||26
8405290|NCT00981461|20716149|P2|NOT COMPLETED|Overall Study||2
8405291|NCT00981461|20716150|P1|NOT COMPLETED|Overall Study||5
8405292|NCT00981461|20716149|P2|COMPLETED|Overall Study||22
8405293|NCT00981461|20716150|P1|COMPLETED|Overall Study||43
8405294|NCT00981461|20716149|P2|STARTED|Overall Study||24
8405295|NCT00981461|20716150|P1|STARTED|Overall Study||48
8405296|NCT00981435|20716159|P3|NOT COMPLETED|Overall Study||0
8405297|NCT00981435|20716160|P2|NOT COMPLETED|Overall Study||0
8405298|NCT00981435|20716161|P1|NOT COMPLETED|Overall Study||0
8405299|NCT00981435|20716159|P3|COMPLETED|Overall Study||37
8405300|NCT00981435|20716160|P2|COMPLETED|Overall Study||29
8405301|NCT00981435|20716161|P1|COMPLETED|Overall Study||31
8405302|NCT00981435|20716159|P3|STARTED|Overall Study||37
8405303|NCT00981435|20716160|P2|STARTED|Overall Study||29
8405304|NCT00981435|20716161|P1|STARTED|Overall Study||31
8405305|NCT00981409|20716174|P2|NOT COMPLETED|Overall Study||1
8405306|NCT00981409|20716175|P1|NOT COMPLETED|Overall Study||6
8405307|NCT00981409|20716174|P2|COMPLETED|Overall Study||10
8405308|NCT00981409|20716175|P1|COMPLETED|Overall Study||24
8405309|NCT00981409|20716174|P2|STARTED|Overall Study||11
8405310|NCT00981409|20716175|P1|STARTED|Overall Study||30
8405311|NCT00981370|20716189|P1|NOT COMPLETED|Overall Study||0
8405312|NCT00981370|20716189|P1|COMPLETED|Overall Study||0
8405313|NCT00981370|20716189|P1|STARTED|Overall Study||0
8405314|NCT00981305|20716195|P2|NOT COMPLETED|Overall Study||10
8405315|NCT00981305|20716196|P1|NOT COMPLETED|Overall Study||19
8405316|NCT00981305|20716195|P2|COMPLETED|Overall Study||57
8405317|NCT00981305|20716196|P1|COMPLETED|Overall Study||50
8405318|NCT00981305|20716195|P2|STARTED|Overall Study||67
8405319|NCT00981305|20716196|P1|STARTED|Overall Study||69
8405320|NCT00981292|20716214|P6|NOT COMPLETED|Day 3||1
8405321|NCT00981292|20716215|P5|NOT COMPLETED|Day 3||0
8405322|NCT00981292|20716216|P4|NOT COMPLETED|Day 3||0
8405323|NCT00981292|20716217|P3|NOT COMPLETED|Day 3||0
8405324|NCT00981292|20716218|P2|NOT COMPLETED|Day 3||0
8405325|NCT00981292|20716219|P1|NOT COMPLETED|Day 3||0
8405326|NCT00981292|20716214|P6|COMPLETED|Day 3||4
8405327|NCT00981292|20716215|P5|COMPLETED|Day 3||4
8405328|NCT00981292|20716216|P4|COMPLETED|Day 3||4
8405329|NCT00981292|20716217|P3|COMPLETED|Day 3||6
8405330|NCT00981292|20716218|P2|COMPLETED|Day 3||4
8405331|NCT00981292|20716219|P1|COMPLETED|Day 3||4
8405332|NCT00981292|20716214|P6|STARTED|Day 3||5
8405333|NCT00981292|20716215|P5|STARTED|Day 3||4
8405334|NCT00981292|20716216|P4|STARTED|Day 3||4
8405335|NCT00981292|20716217|P3|STARTED|Day 3||6
8405336|NCT00981292|20716218|P2|STARTED|Day 3||4
8405337|NCT00981292|20716219|P1|STARTED|Day 3||4
8405338|NCT00981292|20716214|P6|NOT COMPLETED|Day 2||0
8405339|NCT00981292|20716215|P5|NOT COMPLETED|Day 2||0
8405340|NCT00981292|20716216|P4|NOT COMPLETED|Day 2||0
8405341|NCT00981292|20716217|P3|NOT COMPLETED|Day 2||0
8405342|NCT00981292|20716218|P2|NOT COMPLETED|Day 2||0
8405343|NCT00981292|20716219|P1|NOT COMPLETED|Day 2||2
8405344|NCT00981292|20716214|P6|COMPLETED|Day 2||5
8405345|NCT00981292|20716215|P5|COMPLETED|Day 2||4
8405346|NCT00981292|20716216|P4|COMPLETED|Day 2||4
8405347|NCT00981292|20716217|P3|COMPLETED|Day 2||6
8405348|NCT00981292|20716218|P2|COMPLETED|Day 2||4
8405349|NCT00981292|20716219|P1|COMPLETED|Day 2||4
8405350|NCT00981292|20716214|P6|STARTED|Day 2||5
8405351|NCT00981292|20716215|P5|STARTED|Day 2||4
8405352|NCT00981292|20716216|P4|STARTED|Day 2||4
8405353|NCT00981292|20716217|P3|STARTED|Day 2||6
8405354|NCT00981292|20716218|P2|STARTED|Day 2||4
8405355|NCT00981292|20716219|P1|STARTED|Day 2||6
8405356|NCT00981292|20716214|P6|NOT COMPLETED|Day 1||2
8405357|NCT00981292|20716215|P5|NOT COMPLETED|Day 1||0
8405358|NCT00981292|20716216|P4|NOT COMPLETED|Day 1||0
8405359|NCT00981292|20716217|P3|NOT COMPLETED|Day 1||0
8405360|NCT00981292|20716218|P2|NOT COMPLETED|Day 1||0
8405361|NCT00981292|20716219|P1|NOT COMPLETED|Day 1||1
8405362|NCT00981292|20716214|P6|COMPLETED|Day 1||5
8405363|NCT00981292|20716215|P5|COMPLETED|Day 1||4
8405364|NCT00981292|20716216|P4|COMPLETED|Day 1||4
8405365|NCT00981292|20716217|P3|COMPLETED|Day 1||6
8405366|NCT00981292|20716218|P2|COMPLETED|Day 1||4
8405367|NCT00981292|20716219|P1|COMPLETED|Day 1||6
8405368|NCT00981292|20716214|P6|STARTED|Day 1||7
8405369|NCT00981292|20716215|P5|STARTED|Day 1||4
8405370|NCT00981292|20716216|P4|STARTED|Day 1||4
8405371|NCT00981292|20716217|P3|STARTED|Day 1||6
8405372|NCT00981292|20716218|P2|STARTED|Day 1||4
8405373|NCT00981292|20716219|P1|STARTED|Day 1||7
8405374|NCT00981253|20716238|P2|NOT COMPLETED|Overall Study||3
8405375|NCT00981253|20716239|P1|NOT COMPLETED|Overall Study||3
8405376|NCT00981253|20716238|P2|COMPLETED|Overall Study||72
8405377|NCT00981253|20716239|P1|COMPLETED|Overall Study||73
8405378|NCT00981253|20716238|P2|STARTED|Overall Study||75
8405379|NCT00981253|20716239|P1|STARTED|Overall Study||76
8405380|NCT00981227|20716263|P6|NOT COMPLETED|Overall Study||18
8405381|NCT00981227|20716264|P5|NOT COMPLETED|Overall Study||30
8405382|NCT00981227|20716265|P4|NOT COMPLETED|Overall Study||21
8405383|NCT00981227|20716266|P3|NOT COMPLETED|Overall Study||21
8405384|NCT00981227|20716267|P2|NOT COMPLETED|Overall Study||19
8405385|NCT00981227|20716268|P1|NOT COMPLETED|Overall Study||22
8405386|NCT00981227|20716263|P6|COMPLETED|Overall Study||75
8405387|NCT00981227|20716264|P5|COMPLETED|Overall Study||60
8405388|NCT00981227|20716265|P4|COMPLETED|Overall Study||73
8405389|NCT00981227|20716266|P3|COMPLETED|Overall Study||73
8405390|NCT00981227|20716267|P2|COMPLETED|Overall Study||75
8405391|NCT00981227|20716268|P1|COMPLETED|Overall Study||80
8405392|NCT00981227|20716263|P6|Per-Protocol|Overall Study||70
8405393|NCT00981227|20716264|P5|Per-Protocol|Overall Study||50
8405394|NCT00981227|20716265|P4|Per-Protocol|Overall Study||68
8405395|NCT00981227|20716266|P3|Per-Protocol|Overall Study||67
8405396|NCT00981227|20716267|P2|Per-Protocol|Overall Study||72
8405397|NCT00981227|20716268|P1|Per-Protocol|Overall Study||69
8405398|NCT00981227|20716263|P6|Safety Population|Overall Study||93
8405399|NCT00981227|20716264|P5|Safety Population|Overall Study||90
8405400|NCT00981227|20716265|P4|Safety Population|Overall Study||94
8405401|NCT00981227|20716266|P3|Safety Population|Overall Study||94
8405402|NCT00981227|20716267|P2|Safety Population|Overall Study||94
8405403|NCT00981227|20716268|P1|Safety Population|Overall Study||102
8405404|NCT00981227|20716263|P6|Randomized|Overall Study||93
8405405|NCT00981227|20716264|P5|Randomized|Overall Study||90
8405406|NCT00981227|20716265|P4|Randomized|Overall Study||94
8405407|NCT00981227|20716266|P3|Randomized|Overall Study||94
8405408|NCT00981227|20716267|P2|Randomized|Overall Study||94
8405409|NCT00981227|20716268|P1|Randomized|Overall Study||102
8405410|NCT00981227|20716263|P6|STARTED|Overall Study||93
8405411|NCT00981227|20716264|P5|STARTED|Overall Study||90
8405412|NCT00981227|20716265|P4|STARTED|Overall Study||94
8405413|NCT00981227|20716266|P3|STARTED|Overall Study||94
8405414|NCT00981227|20716267|P2|STARTED|Overall Study||94
8405415|NCT00981227|20716268|P1|STARTED|Overall Study||102
8405416|NCT00981214|20716286|P1|NOT COMPLETED|Overall Study||0
8405417|NCT00981214|20716286|P1|COMPLETED|Overall Study||19
8405418|NCT00981214|20716286|P1|STARTED|Overall Study||19
8405419|NCT00981175|20716303|P2|NOT COMPLETED|Booster Dose Vaccination||3
8405420|NCT00981175|20716304|P1|NOT COMPLETED|Booster Dose Vaccination||2
8405421|NCT00981175|20716303|P2|COMPLETED|Booster Dose Vaccination||40
8405422|NCT00981175|20716304|P1|COMPLETED|Booster Dose Vaccination||53
8405423|NCT00981175|20716303|P2|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
8405424|NCT00981175|20716304|P1|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
8405425|NCT00981175|20716303|P2|NOT COMPLETED|Primary Dose Vaccination||2
8405426|NCT00981175|20716304|P1|NOT COMPLETED|Primary Dose Vaccination||3
8405427|NCT00981175|20716303|P2|COMPLETED|Primary Dose Vaccination||99
8405428|NCT00981175|20716304|P1|COMPLETED|Primary Dose Vaccination||98
8405429|NCT00981175|20716303|P2|STARTED|Primary Dose Vaccination||101
8405430|NCT00981175|20716304|P1|STARTED|Primary Dose Vaccination||101
8405437|NCT00981084|20716340|P2|NOT COMPLETED|Post Intervention (Data Analysis)||1
8405438|NCT00981084|20716341|P1|NOT COMPLETED|Post Intervention (Data Analysis)||2
8405439|NCT00981084|20716340|P2|COMPLETED|Post Intervention (Data Analysis)||16
8405440|NCT00981084|20716341|P1|COMPLETED|Post Intervention (Data Analysis)||14
8405441|NCT00981084|20716340|P2|STARTED|Post Intervention (Data Analysis)||17
8405442|NCT00981084|20716341|P1|STARTED|Post Intervention (Data Analysis)||16
8405443|NCT00981084|20716340|P2|NOT COMPLETED|Second Intervention (One Day)||0
8405444|NCT00981084|20716341|P1|NOT COMPLETED|Second Intervention (One Day)||0
8405445|NCT00981084|20716340|P2|COMPLETED|Second Intervention (One Day)||17
8405446|NCT00981084|20716341|P1|COMPLETED|Second Intervention (One Day)||16
8405447|NCT00981084|20716340|P2|STARTED|Second Intervention (One Day)||17
8405448|NCT00981084|20716341|P1|STARTED|Second Intervention (One Day)||16
8405449|NCT00981084|20716340|P2|NOT COMPLETED|Washout Period (7 Days)||0
8405450|NCT00981084|20716341|P1|NOT COMPLETED|Washout Period (7 Days)||0
8405451|NCT00981084|20716340|P2|COMPLETED|Washout Period (7 Days)||17
8405452|NCT00981084|20716341|P1|COMPLETED|Washout Period (7 Days)||16
8405453|NCT00981084|20716340|P2|STARTED|Washout Period (7 Days)||17
8405454|NCT00981084|20716341|P1|STARTED|Washout Period (7 Days)||16
8405455|NCT00981084|20716340|P2|NOT COMPLETED|First Intervention (One Day)||0
8405456|NCT00981084|20716341|P1|NOT COMPLETED|First Intervention (One Day)||0
8405457|NCT00981084|20716340|P2|COMPLETED|First Intervention (One Day)||17
8405458|NCT00981084|20716341|P1|COMPLETED|First Intervention (One Day)||16
8405459|NCT00981084|20716340|P2|STARTED|First Intervention (One Day)||17
8405460|NCT00981084|20716341|P1|STARTED|First Intervention (One Day)||16
8405471|NCT00981045|20716380|P2|NOT COMPLETED|Overall Study||9
8405472|NCT00981045|20716381|P1|NOT COMPLETED|Overall Study||14
8405473|NCT00981045|20716380|P2|COMPLETED|Overall Study||1285
8405474|NCT00981045|20716381|P1|COMPLETED|Overall Study||1276
8405475|NCT00981045|20716380|P2|STARTED|Overall Study||1294
8405476|NCT00981045|20716381|P1|STARTED|Overall Study||1290
8405477|NCT00981019|20716389|P1|NOT COMPLETED|Overall Study||477
8405478|NCT00981019|20716389|P1|COMPLETED|Overall Study||301
8405479|NCT00981019|20716389|P1|STARTED|Overall Study||778
8405480|NCT00980980|20716396|P3|NOT COMPLETED|Overall Study||0
8405481|NCT00980980|20716397|P2|NOT COMPLETED|Overall Study||1
8405482|NCT00980980|20716398|P1|NOT COMPLETED|Overall Study||0
8405483|NCT00980980|20716396|P3|COMPLETED|Overall Study||13
8405484|NCT00980980|20716397|P2|COMPLETED|Overall Study||13
8405485|NCT00980980|20716398|P1|COMPLETED|Overall Study||16
8405486|NCT00980980|20716396|P3|STARTED|Overall Study||13
8405487|NCT00980980|20716397|P2|STARTED|Overall Study||14
8405488|NCT00980980|20716398|P1|STARTED|Overall Study||16
8405489|NCT00980798|20716429|P2|NOT COMPLETED|Overall Study||55
8405490|NCT00980798|20716430|P1|NOT COMPLETED|Overall Study||33
8405491|NCT00980798|20716429|P2|COMPLETED|Overall Study||84
8405492|NCT00980798|20716430|P1|COMPLETED|Overall Study||116
8405493|NCT00980798|20716429|P2|STARTED|Overall Study||139
8405494|NCT00980798|20716430|P1|STARTED|Overall Study||149
8405495|NCT00980785|20716440|P2|NOT COMPLETED|Overall Study||0
8405496|NCT00980785|20716441|P1|NOT COMPLETED|Overall Study||0
8405497|NCT00980785|20716440|P2|COMPLETED|Overall Study||8
8405498|NCT00980785|20716441|P1|COMPLETED|Overall Study||6
8405499|NCT00980785|20716440|P2|STARTED|Overall Study||8
8405500|NCT00980785|20716441|P1|STARTED|Overall Study||6
8405501|NCT00980746|20716459|P6|NOT COMPLETED|Overall Study||18
8405502|NCT00980746|20716460|P5|NOT COMPLETED|Overall Study||17
8405503|NCT00980746|20716461|P4|NOT COMPLETED|Overall Study||36
8405504|NCT00980746|20716462|P3|NOT COMPLETED|Overall Study||20
8405505|NCT00980746|20716463|P2|NOT COMPLETED|Overall Study||22
8405506|NCT00980746|20716464|P1|NOT COMPLETED|Overall Study||27
8405507|NCT00980746|20716459|P6|COMPLETED|Overall Study||78
8405508|NCT00980746|20716460|P5|COMPLETED|Overall Study||75
8405509|NCT00980746|20716461|P4|COMPLETED|Overall Study||64
8405510|NCT00980746|20716462|P3|COMPLETED|Overall Study||75
8405511|NCT00980746|20716463|P2|COMPLETED|Overall Study||67
8405512|NCT00980746|20716464|P1|COMPLETED|Overall Study||58
8405513|NCT00980746|20716459|P6|Per-protocol|Overall Study||74
8405514|NCT00980746|20716460|P5|Per-protocol|Overall Study||73
8405515|NCT00980746|20716461|P4|Per-protocol|Overall Study||62
8405516|NCT00980746|20716462|P3|Per-protocol|Overall Study||73
8405517|NCT00980746|20716463|P2|Per-protocol|Overall Study||66
8405518|NCT00980746|20716464|P1|Per-protocol|Overall Study||55
8405519|NCT00980746|20716459|P6|Safety Population|Overall Study||96
8405520|NCT00980746|20716460|P5|Safety Population|Overall Study||92
8405521|NCT00980746|20716461|P4|Safety Population|Overall Study||100
8405522|NCT00980746|20716462|P3|Safety Population|Overall Study||95
8405523|NCT00980746|20716463|P2|Safety Population|Overall Study||89
8405524|NCT00980746|20716464|P1|Safety Population|Overall Study||85
8405525|NCT00980746|20716459|P6|Randomized|Overall Study||96
8405526|NCT00980746|20716460|P5|Randomized|Overall Study||92
8405527|NCT00980746|20716461|P4|Randomized|Overall Study||100
8405528|NCT00980746|20716462|P3|Randomized|Overall Study||95
8405529|NCT00980746|20716463|P2|Randomized|Overall Study||89
8405530|NCT00980746|20716464|P1|Randomized|Overall Study||85
8405531|NCT00980746|20716459|P6|STARTED|Overall Study||96
8405532|NCT00980746|20716460|P5|STARTED|Overall Study||92
8405533|NCT00980746|20716461|P4|STARTED|Overall Study||100
8405534|NCT00980746|20716462|P3|STARTED|Overall Study||95
8405535|NCT00980746|20716463|P2|STARTED|Overall Study||89
8405536|NCT00980746|20716464|P1|STARTED|Overall Study||85
8405537|NCT00980681|20716478|P1|NOT COMPLETED|Dotarem MRA||0
8405538|NCT00980681|20716478|P1|COMPLETED|Dotarem MRA||10
8405539|NCT00980681|20716478|P1|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
8405540|NCT00980681|20716478|P1|NOT COMPLETED|TOF MRA||0
8405541|NCT00980681|20716478|P1|COMPLETED|TOF MRA||10
8405542|NCT00980681|20716478|P1|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
8405543|NCT00980655|20716486|P2|NOT COMPLETED|Overall Study||51
8405544|NCT00980655|20716487|P1|NOT COMPLETED|Overall Study||16
8405545|NCT00980655|20716486|P2|COMPLETED|Overall Study||139
8405546|NCT00980655|20716487|P1|COMPLETED|Overall Study||45
8405547|NCT00980655|20716486|P2|Vaccinated 23vPS Dose|Overall Study||140
8405548|NCT00980655|20716487|P1|Vaccinated 23vPS Dose|Overall Study||45
8405549|NCT00980655|20716486|P2|Vaccinated 13vPnC Dose 4|Overall Study||146
8405550|NCT00980655|20716487|P1|Vaccinated 13vPnC Dose 4|Overall Study||46
8405551|NCT00980655|20716486|P2|Vaccinated 13vPnC Dose 3|Overall Study||167
8405552|NCT00980655|20716487|P1|Vaccinated 13vPnC Dose 3|Overall Study||54
8405553|NCT00980655|20716486|P2|Vaccinated 13vPnC Dose 2|Overall Study||176
8405554|NCT00980655|20716487|P1|Vaccinated 13vPnC Dose 2|Overall Study||55
8405555|NCT00980655|20716486|P2|Vaccinated 13vPnC Dose 1|Overall Study||188
8405556|NCT00980655|20716487|P1|Vaccinated 13vPnC Dose 1|Overall Study||59
8405557|NCT00980655|20716486|P2|STARTED|Overall Study||190
8405558|NCT00980655|20716487|P1|STARTED|Overall Study||61
8405559|NCT00980642|20716535|P2|NOT COMPLETED|Overall Study||0
8405560|NCT00980642|20716536|P1|NOT COMPLETED|Overall Study||0
8405561|NCT00980642|20716535|P2|COMPLETED|Overall Study||20
8405562|NCT00980642|20716536|P1|COMPLETED|Overall Study||36
8405563|NCT00980642|20716535|P2|STARTED|Overall Study||20
8405564|NCT00980642|20716536|P1|STARTED|Overall Study||36
8405565|NCT00980590|20716548|P2|NOT COMPLETED|Overall Study||0
8405566|NCT00980590|20716549|P1|NOT COMPLETED|Overall Study||0
8405567|NCT00980590|20716548|P2|COMPLETED|Overall Study||50
8405568|NCT00980590|20716549|P1|COMPLETED|Overall Study||50
8405569|NCT00980590|20716548|P2|STARTED|Overall Study||50
8405570|NCT00980590|20716549|P1|STARTED|Overall Study||50
8405571|NCT00980395|20716561|P1|NOT COMPLETED|Overall Study||0
8405572|NCT00980395|20716561|P1|COMPLETED|Overall Study||24
8405573|NCT00980395|20716561|P1|STARTED|Overall Study||24
8405574|NCT00980343|20716570|P2|NOT COMPLETED|Overall Study||3
8405575|NCT00980343|20716571|P1|NOT COMPLETED|Overall Study||1
8405576|NCT00980343|20716570|P2|COMPLETED|Overall Study||20
8405577|NCT00980343|20716571|P1|COMPLETED|Overall Study||20
8405578|NCT00980343|20716570|P2|STARTED|Overall Study||23
8405579|NCT00980343|20716571|P1|STARTED|Overall Study||21
8405580|NCT00980330|20716595|P7|NOT COMPLETED|Overall Study||7
8405581|NCT00980330|20716596|P6|NOT COMPLETED|Overall Study||4
8405582|NCT00980330|20716597|P5|NOT COMPLETED|Overall Study||5
8405583|NCT00980330|20716598|P4|NOT COMPLETED|Overall Study||5
8405584|NCT00980330|20716599|P3|NOT COMPLETED|Overall Study||8
8405585|NCT00980330|20716600|P2|NOT COMPLETED|Overall Study||5
8405586|NCT00980330|20716601|P1|NOT COMPLETED|Overall Study||5
8405587|NCT00980330|20716595|P7|COMPLETED|Overall Study||59
8405588|NCT00980330|20716596|P6|COMPLETED|Overall Study||61
8405589|NCT00980330|20716597|P5|COMPLETED|Overall Study||63
8405590|NCT00980330|20716598|P4|COMPLETED|Overall Study||61
8405591|NCT00980330|20716599|P3|COMPLETED|Overall Study||58
8405592|NCT00980330|20716600|P2|COMPLETED|Overall Study||60
8405593|NCT00980330|20716601|P1|COMPLETED|Overall Study||61
8405594|NCT00980330|20716595|P7|STARTED|Overall Study||66
8405595|NCT00980330|20716596|P6|STARTED|Overall Study||65
8405596|NCT00980330|20716597|P5|STARTED|Overall Study||68
8405597|NCT00980330|20716598|P4|STARTED|Overall Study||66
8405598|NCT00980330|20716599|P3|STARTED|Overall Study||66
8405599|NCT00980330|20716600|P2|STARTED|Overall Study||65
8405600|NCT00980330|20716601|P1|STARTED|Overall Study||66
8405601|NCT00980278|20716701|P2|NOT COMPLETED|Overall Study||0
8405602|NCT00980278|20716702|P1|NOT COMPLETED|Overall Study||2
8405603|NCT00980278|20716701|P2|COMPLETED|Overall Study||13
8405604|NCT00980278|20716702|P1|COMPLETED|Overall Study||11
8405605|NCT00980278|20716701|P2|STARTED|Overall Study||13
8405606|NCT00980278|20716702|P1|STARTED|Overall Study||13
8405607|NCT00980200|20716716|P5|NOT COMPLETED|7-day Treatment Period 5||0
8405608|NCT00980200|20716717|P4|NOT COMPLETED|7-day Treatment Period 5||0
8405609|NCT00980200|20716718|P3|NOT COMPLETED|7-day Treatment Period 5||0
8405610|NCT00980200|20716719|P2|NOT COMPLETED|7-day Treatment Period 5||0
8405611|NCT00980200|20716720|P1|NOT COMPLETED|7-day Treatment Period 5||0
8405612|NCT00980200|20716716|P5|COMPLETED|7-day Treatment Period 5||14
8405613|NCT00980200|20716717|P4|COMPLETED|7-day Treatment Period 5||16
8405614|NCT00980200|20716718|P3|COMPLETED|7-day Treatment Period 5||15
8405615|NCT00980200|20716719|P2|COMPLETED|7-day Treatment Period 5||12
8405616|NCT00980200|20716720|P1|COMPLETED|7-day Treatment Period 5||15
8405617|NCT00980200|20716716|P5|STARTED|7-day Treatment Period 5||14
8405618|NCT00980200|20716717|P4|STARTED|7-day Treatment Period 5||16
8405619|NCT00980200|20716718|P3|STARTED|7-day Treatment Period 5||15
8405620|NCT00980200|20716719|P2|STARTED|7-day Treatment Period 5||12
8405621|NCT00980200|20716720|P1|STARTED|7-day Treatment Period 5||15
8405622|NCT00980200|20716716|P5|NOT COMPLETED|7-day Washout Period 4||0
8405623|NCT00980200|20716717|P4|NOT COMPLETED|7-day Washout Period 4||0
8405624|NCT00980200|20716718|P3|NOT COMPLETED|7-day Washout Period 4||0
8405625|NCT00980200|20716719|P2|NOT COMPLETED|7-day Washout Period 4||0
8405626|NCT00980200|20716720|P1|NOT COMPLETED|7-day Washout Period 4||0
8405627|NCT00980200|20716716|P5|COMPLETED|7-day Washout Period 4||14
8405628|NCT00980200|20716717|P4|COMPLETED|7-day Washout Period 4||16
8405629|NCT00980200|20716718|P3|COMPLETED|7-day Washout Period 4||15
8405630|NCT00980200|20716719|P2|COMPLETED|7-day Washout Period 4||12
8405631|NCT00980200|20716720|P1|COMPLETED|7-day Washout Period 4||15
8405632|NCT00980200|20716716|P5|STARTED|7-day Washout Period 4||14
8405633|NCT00980200|20716717|P4|STARTED|7-day Washout Period 4||16
8405634|NCT00980200|20716718|P3|STARTED|7-day Washout Period 4||15
8405635|NCT00980200|20716719|P2|STARTED|7-day Washout Period 4||12
8405636|NCT00980200|20716720|P1|STARTED|7-day Washout Period 4||15
8405637|NCT00980200|20716716|P5|NOT COMPLETED|7-day Treatment Period 4||0
8405638|NCT00980200|20716717|P4|NOT COMPLETED|7-day Treatment Period 4||0
8405639|NCT00980200|20716718|P3|NOT COMPLETED|7-day Treatment Period 4||0
8405640|NCT00980200|20716719|P2|NOT COMPLETED|7-day Treatment Period 4||0
8405641|NCT00980200|20716720|P1|NOT COMPLETED|7-day Treatment Period 4||0
8405642|NCT00980200|20716716|P5|COMPLETED|7-day Treatment Period 4||14
8405643|NCT00980200|20716717|P4|COMPLETED|7-day Treatment Period 4||16
8405644|NCT00980200|20716718|P3|COMPLETED|7-day Treatment Period 4||15
8405645|NCT00980200|20716719|P2|COMPLETED|7-day Treatment Period 4||12
8405646|NCT00980200|20716720|P1|COMPLETED|7-day Treatment Period 4||15
8405647|NCT00980200|20716716|P5|STARTED|7-day Treatment Period 4||14
8405648|NCT00980200|20716717|P4|STARTED|7-day Treatment Period 4||16
8405649|NCT00980200|20716718|P3|STARTED|7-day Treatment Period 4||15
8405650|NCT00980200|20716719|P2|STARTED|7-day Treatment Period 4||12
8405651|NCT00980200|20716720|P1|STARTED|7-day Treatment Period 4||15
8405652|NCT00980200|20716716|P5|NOT COMPLETED|7-day Washout Period 3||0
8405653|NCT00980200|20716717|P4|NOT COMPLETED|7-day Washout Period 3||0
8405654|NCT00980200|20716718|P3|NOT COMPLETED|7-day Washout Period 3||0
8405655|NCT00980200|20716719|P2|NOT COMPLETED|7-day Washout Period 3||0
8405656|NCT00980200|20716720|P1|NOT COMPLETED|7-day Washout Period 3||0
8405657|NCT00980200|20716716|P5|COMPLETED|7-day Washout Period 3||14
8405658|NCT00980200|20716717|P4|COMPLETED|7-day Washout Period 3||16
8405659|NCT00980200|20716718|P3|COMPLETED|7-day Washout Period 3||15
8405660|NCT00980200|20716719|P2|COMPLETED|7-day Washout Period 3||12
8405661|NCT00980200|20716720|P1|COMPLETED|7-day Washout Period 3||15
8405662|NCT00980200|20716716|P5|STARTED|7-day Washout Period 3||14
8405663|NCT00980200|20716717|P4|STARTED|7-day Washout Period 3||16
8405664|NCT00980200|20716718|P3|STARTED|7-day Washout Period 3||15
8405665|NCT00980200|20716719|P2|STARTED|7-day Washout Period 3||12
8405666|NCT00980200|20716720|P1|STARTED|7-day Washout Period 3||15
8405667|NCT00980200|20716716|P5|NOT COMPLETED|7-day Treatment Period 3||1
8405668|NCT00980200|20716717|P4|NOT COMPLETED|7-day Treatment Period 3||0
8405669|NCT00980200|20716718|P3|NOT COMPLETED|7-day Treatment Period 3||0
8405670|NCT00980200|20716719|P2|NOT COMPLETED|7-day Treatment Period 3||1
8405671|NCT00980200|20716720|P1|NOT COMPLETED|7-day Treatment Period 3||0
8405672|NCT00980200|20716716|P5|COMPLETED|7-day Treatment Period 3||14
8405673|NCT00980200|20716717|P4|COMPLETED|7-day Treatment Period 3||16
8405674|NCT00980200|20716718|P3|COMPLETED|7-day Treatment Period 3||15
8405675|NCT00980200|20716719|P2|COMPLETED|7-day Treatment Period 3||12
8405676|NCT00980200|20716720|P1|COMPLETED|7-day Treatment Period 3||15
8405677|NCT00980200|20716716|P5|STARTED|7-day Treatment Period 3||15
8405678|NCT00980200|20716717|P4|STARTED|7-day Treatment Period 3||16
8405679|NCT00980200|20716718|P3|STARTED|7-day Treatment Period 3||15
8405680|NCT00980200|20716719|P2|STARTED|7-day Treatment Period 3||13
8405681|NCT00980200|20716720|P1|STARTED|7-day Treatment Period 3||15
8405682|NCT00980200|20716716|P5|NOT COMPLETED|7-day Washout Period 2||0
8405683|NCT00980200|20716717|P4|NOT COMPLETED|7-day Washout Period 2||0
8405684|NCT00980200|20716718|P3|NOT COMPLETED|7-day Washout Period 2||0
8405685|NCT00980200|20716719|P2|NOT COMPLETED|7-day Washout Period 2||0
8405686|NCT00980200|20716720|P1|NOT COMPLETED|7-day Washout Period 2||0
8405687|NCT00980200|20716716|P5|COMPLETED|7-day Washout Period 2||15
8405688|NCT00980200|20716717|P4|COMPLETED|7-day Washout Period 2||16
8405689|NCT00980200|20716718|P3|COMPLETED|7-day Washout Period 2||15
8405690|NCT00980200|20716719|P2|COMPLETED|7-day Washout Period 2||13
8405691|NCT00980200|20716720|P1|COMPLETED|7-day Washout Period 2||15
8405692|NCT00980200|20716716|P5|STARTED|7-day Washout Period 2||15
8405693|NCT00980200|20716717|P4|STARTED|7-day Washout Period 2||16
8405694|NCT00980200|20716718|P3|STARTED|7-day Washout Period 2||15
8405695|NCT00980200|20716719|P2|STARTED|7-day Washout Period 2||13
8405696|NCT00980200|20716720|P1|STARTED|7-day Washout Period 2||15
8405697|NCT00980200|20716716|P5|NOT COMPLETED|7-day Treatment Period 2||0
8405698|NCT00980200|20716717|P4|NOT COMPLETED|7-day Treatment Period 2||0
8405699|NCT00980200|20716718|P3|NOT COMPLETED|7-day Treatment Period 2||0
8405700|NCT00980200|20716719|P2|NOT COMPLETED|7-day Treatment Period 2||0
8405701|NCT00980200|20716720|P1|NOT COMPLETED|7-day Treatment Period 2||0
8405702|NCT00980200|20716716|P5|COMPLETED|7-day Treatment Period 2||15
8405703|NCT00980200|20716717|P4|COMPLETED|7-day Treatment Period 2||16
8405704|NCT00980200|20716718|P3|COMPLETED|7-day Treatment Period 2||15
8405705|NCT00980200|20716719|P2|COMPLETED|7-day Treatment Period 2||13
8405706|NCT00980200|20716720|P1|COMPLETED|7-day Treatment Period 2||15
8405707|NCT00980200|20716716|P5|STARTED|7-day Treatment Period 2||15
8405708|NCT00980200|20716717|P4|STARTED|7-day Treatment Period 2||16
8405709|NCT00980200|20716718|P3|STARTED|7-day Treatment Period 2||15
8405710|NCT00980200|20716719|P2|STARTED|7-day Treatment Period 2||13
8405711|NCT00980200|20716720|P1|STARTED|7-day Treatment Period 2||15
8405712|NCT00980200|20716716|P5|NOT COMPLETED|7-day Washout Period 1||0
8405713|NCT00980200|20716717|P4|NOT COMPLETED|7-day Washout Period 1||0
8405714|NCT00980200|20716718|P3|NOT COMPLETED|7-day Washout Period 1||0
8405715|NCT00980200|20716719|P2|NOT COMPLETED|7-day Washout Period 1||0
8405716|NCT00980200|20716720|P1|NOT COMPLETED|7-day Washout Period 1||0
8405717|NCT00980200|20716716|P5|COMPLETED|7-day Washout Period 1||15
8405718|NCT00980200|20716717|P4|COMPLETED|7-day Washout Period 1||16
8405719|NCT00980200|20716718|P3|COMPLETED|7-day Washout Period 1||15
8405720|NCT00980200|20716719|P2|COMPLETED|7-day Washout Period 1||13
8405721|NCT00980200|20716720|P1|COMPLETED|7-day Washout Period 1||15
8405722|NCT00980200|20716716|P5|STARTED|7-day Washout Period 1||15
8405723|NCT00980200|20716717|P4|STARTED|7-day Washout Period 1||16
8405724|NCT00980200|20716718|P3|STARTED|7-day Washout Period 1||15
8405725|NCT00980200|20716719|P2|STARTED|7-day Washout Period 1||13
8405726|NCT00980200|20716720|P1|STARTED|7-day Washout Period 1||15
8405727|NCT00980200|20716716|P5|NOT COMPLETED|7-day Treatment Period 1||0
8405728|NCT00980200|20716717|P4|NOT COMPLETED|7-day Treatment Period 1||0
8405729|NCT00980200|20716718|P3|NOT COMPLETED|7-day Treatment Period 1||0
8405730|NCT00980200|20716719|P2|NOT COMPLETED|7-day Treatment Period 1||1
8405731|NCT00980200|20716720|P1|NOT COMPLETED|7-day Treatment Period 1||0
8405732|NCT00980200|20716716|P5|COMPLETED|7-day Treatment Period 1||15
8405733|NCT00980200|20716717|P4|COMPLETED|7-day Treatment Period 1||16
8405734|NCT00980200|20716718|P3|COMPLETED|7-day Treatment Period 1||15
8405735|NCT00980200|20716719|P2|COMPLETED|7-day Treatment Period 1||13
8405736|NCT00980200|20716720|P1|COMPLETED|7-day Treatment Period 1||15
8405737|NCT00980200|20716716|P5|STARTED|7-day Treatment Period 1||15
8405738|NCT00980200|20716717|P4|STARTED|7-day Treatment Period 1||16
8405739|NCT00980200|20716718|P3|STARTED|7-day Treatment Period 1||15
8405740|NCT00980200|20716719|P2|STARTED|7-day Treatment Period 1||14
8405741|NCT00980200|20716720|P1|STARTED|7-day Treatment Period 1||15
8405742|NCT00980174|20716739|P2|NOT COMPLETED|Overall Study||10
8405743|NCT00980174|20716740|P1|NOT COMPLETED|Overall Study||4
8405744|NCT00980174|20716739|P2|COMPLETED|Overall Study||111
8405745|NCT00980174|20716740|P1|COMPLETED|Overall Study||117
8405746|NCT00980174|20716739|P2|STARTED|Overall Study||121
8405747|NCT00980174|20716740|P1|STARTED|Overall Study||121
8405748|NCT00980148|20716758|P2|NOT COMPLETED|Overall Study||128
8405749|NCT00980148|20716759|P1|NOT COMPLETED|Overall Study||129
8405750|NCT00980148|20716758|P2|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
8405751|NCT00980148|20716759|P1|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
8405752|NCT00980148|20716758|P2|STARTED|Overall Study||283
8405753|NCT00980148|20716759|P1|STARTED|Overall Study||284
8405754|NCT00980057|20716767|P2|NOT COMPLETED|Overall Study||5
8405755|NCT00980057|20716768|P1|NOT COMPLETED|Overall Study||19
8405756|NCT00980057|20716767|P2|COMPLETED|Overall Study||155
8405757|NCT00980057|20716768|P1|COMPLETED|Overall Study||299
8405758|NCT00980057|20716767|P2|STARTED|Overall Study||160
8405759|NCT00980057|20716768|P1|STARTED|Overall Study||318
8405760|NCT00980044|20716791|P3|NOT COMPLETED|Overall Study||5
8405761|NCT00980044|20716792|P2|NOT COMPLETED|Overall Study||7
8405762|NCT00980044|20716793|P1|NOT COMPLETED|Overall Study||5
8405763|NCT00980044|20716791|P3|COMPLETED|Overall Study||12
8405764|NCT00980044|20716792|P2|COMPLETED|Overall Study||12
8405765|NCT00980044|20716793|P1|COMPLETED|Overall Study||12
8405766|NCT00980044|20716791|P3|STARTED|Overall Study||17
8405767|NCT00980044|20716792|P2|STARTED|Overall Study||19
8405768|NCT00980044|20716793|P1|STARTED|Overall Study||17
8405769|NCT00980005|20716812|P2|NOT COMPLETED|Overall Study||63
8405770|NCT00980005|20716813|P1|NOT COMPLETED|Overall Study||47
8405771|NCT00980005|20716812|P2|COMPLETED|Overall Study||998
8405772|NCT00980005|20716813|P1|COMPLETED|Overall Study||1008
8405773|NCT00980005|20716812|P2|STARTED|Overall Study||1061
8405774|NCT00980005|20716813|P1|STARTED|Overall Study||1055
8405775|NCT00979992|20716853|P1|NOT COMPLETED|Overall Study||5
8405776|NCT00979992|20716853|P1|COMPLETED|Overall Study||30
8405777|NCT00979992|20716853|P1|STARTED|Overall Study||35
8405778|NCT00979953|20716865|P4|NOT COMPLETED|Overall Study||7
8405779|NCT00979953|20716866|P3|NOT COMPLETED|Overall Study||22
8405780|NCT00979953|20716867|P2|NOT COMPLETED|Overall Study||5
8405781|NCT00979953|20716868|P1|NOT COMPLETED|Overall Study||8
8405782|NCT00979953|20716865|P4|COMPLETED|Overall Study||97
8405783|NCT00979953|20716866|P3|COMPLETED|Overall Study||82
8405784|NCT00979953|20716867|P2|COMPLETED|Overall Study||94
8405785|NCT00979953|20716868|P1|COMPLETED|Overall Study||93
8405786|NCT00979953|20716865|P4|Received at Least 1 Dose of Study Drug|Overall Study||104
8405787|NCT00979953|20716866|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
8405788|NCT00979953|20716867|P2|Received at Least 1 Dose of Study Drug|Overall Study||99
8405789|NCT00979953|20716868|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
8405790|NCT00979953|20716865|P4|STARTED|Overall Study||104
8405791|NCT00979953|20716866|P3|STARTED|Overall Study||104
8405792|NCT00979953|20716867|P2|STARTED|Overall Study||99
8405793|NCT00979953|20716868|P1|STARTED|Overall Study||101
8405794|NCT00979940|20716880|P2|NOT COMPLETED|Overall Study||0
8405795|NCT00979940|20716881|P1|NOT COMPLETED|Overall Study||0
8405796|NCT00979940|20716880|P2|COMPLETED|Overall Study||28
8405797|NCT00979940|20716881|P1|COMPLETED|Overall Study||32
8405798|NCT00979940|20716880|P2|STARTED|Overall Study||28
8405799|NCT00979940|20716881|P1|STARTED|Overall Study||32
8405800|NCT00979901|20716891|P4|NOT COMPLETED|Overall Study||116
8405801|NCT00979901|20716892|P3|NOT COMPLETED|Overall Study||29
8405802|NCT00979901|20716893|P2|NOT COMPLETED|Overall Study||12
8405803|NCT00979901|20716894|P1|NOT COMPLETED|Overall Study||18
8405804|NCT00979901|20716891|P4|COMPLETED|Overall Study||159
8405805|NCT00979901|20716892|P3|COMPLETED|Overall Study||573
8405806|NCT00979901|20716893|P2|COMPLETED|Overall Study||336
8405807|NCT00979901|20716894|P1|COMPLETED|Overall Study||334
8405808|NCT00979901|20716891|P4|STARTED|Overall Study||275
8405809|NCT00979901|20716892|P3|STARTED|Overall Study||602
8405810|NCT00979901|20716893|P2|STARTED|Overall Study||348
8405811|NCT00979901|20716894|P1|STARTED|Overall Study||352
8405812|NCT00979875|20716918|P6|NOT COMPLETED|Intervention 3||0
8405813|NCT00979875|20716919|P5|NOT COMPLETED|Intervention 3||0
8405814|NCT00979875|20716920|P4|NOT COMPLETED|Intervention 3||0
8405815|NCT00979875|20716921|P3|NOT COMPLETED|Intervention 3||0
8405816|NCT00979875|20716922|P2|NOT COMPLETED|Intervention 3||0
8405817|NCT00979875|20716923|P1|NOT COMPLETED|Intervention 3||0
8405818|NCT00979875|20716918|P6|COMPLETED|Intervention 3||2
8405819|NCT00979875|20716919|P5|COMPLETED|Intervention 3||3
8405820|NCT00979875|20716920|P4|COMPLETED|Intervention 3||2
8405821|NCT00979875|20716921|P3|COMPLETED|Intervention 3||3
8405822|NCT00979875|20716922|P2|COMPLETED|Intervention 3||2
8405823|NCT00979875|20716923|P1|COMPLETED|Intervention 3||2
8405824|NCT00979875|20716918|P6|STARTED|Intervention 3||2
8405825|NCT00979875|20716919|P5|STARTED|Intervention 3||3
8405826|NCT00979875|20716920|P4|STARTED|Intervention 3||2
8405827|NCT00979875|20716921|P3|STARTED|Intervention 3||3
8405828|NCT00979875|20716922|P2|STARTED|Intervention 3||2
8405829|NCT00979875|20716923|P1|STARTED|Intervention 3||2
8405830|NCT00979875|20716918|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8405831|NCT00979875|20716919|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8405832|NCT00979875|20716920|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8405833|NCT00979875|20716921|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8405834|NCT00979875|20716922|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8405835|NCT00979875|20716923|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8405836|NCT00979875|20716918|P6|COMPLETED|Washout 2 (3 to 14 Days)||2
8405837|NCT00979875|20716919|P5|COMPLETED|Washout 2 (3 to 14 Days)||3
8405838|NCT00979875|20716920|P4|COMPLETED|Washout 2 (3 to 14 Days)||2
8405839|NCT00979875|20716921|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
8405840|NCT00979875|20716922|P2|COMPLETED|Washout 2 (3 to 14 Days)||2
8405841|NCT00979875|20716923|P1|COMPLETED|Washout 2 (3 to 14 Days)||2
8405842|NCT00979875|20716918|P6|STARTED|Washout 2 (3 to 14 Days)||2
8405843|NCT00979875|20716919|P5|STARTED|Washout 2 (3 to 14 Days)||3
8405844|NCT00979875|20716920|P4|STARTED|Washout 2 (3 to 14 Days)||2
8405845|NCT00979875|20716921|P3|STARTED|Washout 2 (3 to 14 Days)||3
8405846|NCT00979875|20716922|P2|STARTED|Washout 2 (3 to 14 Days)||2
8405847|NCT00979875|20716923|P1|STARTED|Washout 2 (3 to 14 Days)||2
8405848|NCT00979875|20716918|P6|NOT COMPLETED|Intervention 2||0
8405849|NCT00979875|20716919|P5|NOT COMPLETED|Intervention 2||0
8405850|NCT00979875|20716920|P4|NOT COMPLETED|Intervention 2||0
8405851|NCT00979875|20716921|P3|NOT COMPLETED|Intervention 2||0
8405852|NCT00979875|20716922|P2|NOT COMPLETED|Intervention 2||0
8405853|NCT00979875|20716923|P1|NOT COMPLETED|Intervention 2||0
8405854|NCT00979875|20716918|P6|COMPLETED|Intervention 2||2
8405855|NCT00979875|20716919|P5|COMPLETED|Intervention 2||3
8405856|NCT00979875|20716920|P4|COMPLETED|Intervention 2||2
8405857|NCT00979875|20716921|P3|COMPLETED|Intervention 2||3
8405858|NCT00979875|20716922|P2|COMPLETED|Intervention 2||2
8405859|NCT00979875|20716923|P1|COMPLETED|Intervention 2||2
8405860|NCT00979875|20716918|P6|STARTED|Intervention 2||2
8405861|NCT00979875|20716919|P5|STARTED|Intervention 2||3
8405862|NCT00979875|20716920|P4|STARTED|Intervention 2||2
8405863|NCT00979875|20716921|P3|STARTED|Intervention 2||3
8405864|NCT00979875|20716922|P2|STARTED|Intervention 2||2
8405865|NCT00979875|20716923|P1|STARTED|Intervention 2||2
8405866|NCT00979875|20716918|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8405867|NCT00979875|20716919|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8405868|NCT00979875|20716920|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8405869|NCT00979875|20716921|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8405870|NCT00979875|20716922|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8405871|NCT00979875|20716923|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8405872|NCT00979875|20716918|P6|COMPLETED|Washout 1 (3 to 14 Days)||2
8405873|NCT00979875|20716919|P5|COMPLETED|Washout 1 (3 to 14 Days)||3
8405874|NCT00979875|20716920|P4|COMPLETED|Washout 1 (3 to 14 Days)||2
8405875|NCT00979875|20716921|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
8405876|NCT00979875|20716922|P2|COMPLETED|Washout 1 (3 to 14 Days)||2
8405877|NCT00979875|20716923|P1|COMPLETED|Washout 1 (3 to 14 Days)||2
8405878|NCT00979875|20716918|P6|STARTED|Washout 1 (3 to 14 Days)||2
8405879|NCT00979875|20716919|P5|STARTED|Washout 1 (3 to 14 Days)||3
8405880|NCT00979875|20716920|P4|STARTED|Washout 1 (3 to 14 Days)||2
8405881|NCT00979875|20716921|P3|STARTED|Washout 1 (3 to 14 Days)||3
8405882|NCT00979875|20716922|P2|STARTED|Washout 1 (3 to 14 Days)||2
8405883|NCT00979875|20716923|P1|STARTED|Washout 1 (3 to 14 Days)||2
8405884|NCT00979875|20716918|P6|NOT COMPLETED|Intervention 1||0
8405885|NCT00979875|20716919|P5|NOT COMPLETED|Intervention 1||0
8405886|NCT00979875|20716920|P4|NOT COMPLETED|Intervention 1||0
8405887|NCT00979875|20716921|P3|NOT COMPLETED|Intervention 1||0
8405888|NCT00979875|20716922|P2|NOT COMPLETED|Intervention 1||0
8405889|NCT00979875|20716923|P1|NOT COMPLETED|Intervention 1||0
8405890|NCT00979875|20716918|P6|COMPLETED|Intervention 1||2
8405891|NCT00979875|20716919|P5|COMPLETED|Intervention 1||3
8405892|NCT00979875|20716920|P4|COMPLETED|Intervention 1||2
8405893|NCT00979875|20716921|P3|COMPLETED|Intervention 1||3
8405894|NCT00979875|20716922|P2|COMPLETED|Intervention 1||2
8405895|NCT00979875|20716923|P1|COMPLETED|Intervention 1||2
8405896|NCT00979875|20716918|P6|Received at Least 1 Dose of Study Drug|Intervention 1||2
8405897|NCT00979875|20716919|P5|Received at Least 1 Dose of Study Drug|Intervention 1||3
8405898|NCT00979875|20716920|P4|Received at Least 1 Dose of Study Drug|Intervention 1||2
8405899|NCT00979875|20716921|P3|Received at Least 1 Dose of Study Drug|Intervention 1||3
8405900|NCT00979875|20716922|P2|Received at Least 1 Dose of Study Drug|Intervention 1||2
8405901|NCT00979875|20716923|P1|Received at Least 1 Dose of Study Drug|Intervention 1||2
8405902|NCT00979875|20716918|P6|STARTED|Intervention 1||2
8405903|NCT00979875|20716919|P5|STARTED|Intervention 1||3
8405904|NCT00979875|20716920|P4|STARTED|Intervention 1||2
8405905|NCT00979875|20716921|P3|STARTED|Intervention 1||3
8405906|NCT00979875|20716922|P2|STARTED|Intervention 1||2
8405907|NCT00979875|20716923|P1|STARTED|Intervention 1||2
8405908|NCT00979810|20716967|P1|NOT COMPLETED|Overall Study||0
8405909|NCT00979810|20716967|P1|COMPLETED|Overall Study||11
8405910|NCT00979810|20716967|P1|STARTED|Overall Study||11
8405911|NCT00979654|20716974|P1|NOT COMPLETED|Overall Study||36
8405912|NCT00979654|20716974|P1|COMPLETED|Overall Study||67
8405913|NCT00979654|20716974|P1|STARTED|Overall Study||103
8405914|NCT00979628|20716989|P3|NOT COMPLETED|Overall Study||6
8405915|NCT00979628|20716990|P2|NOT COMPLETED|Overall Study||9
8405916|NCT00979628|20716991|P1|NOT COMPLETED|Overall Study||9
8405917|NCT00979628|20716989|P3|COMPLETED|Overall Study||74
8405918|NCT00979628|20716990|P2|COMPLETED|Overall Study||133
8405919|NCT00979628|20716991|P1|COMPLETED|Overall Study||144
8405920|NCT00979628|20716989|P3|STARTED|Overall Study||80
8405921|NCT00979628|20716990|P2|STARTED|Overall Study||142
8405922|NCT00979628|20716991|P1|STARTED|Overall Study||153
8405923|NCT00979615|20717004|P2|NOT COMPLETED|Overall Study||8
8405924|NCT00979615|20717005|P1|NOT COMPLETED|Overall Study||6
8405925|NCT00979615|20717004|P2|COMPLETED|Overall Study||58
8405926|NCT00979615|20717005|P1|COMPLETED|Overall Study||57
8405927|NCT00979615|20717004|P2|STARTED|Overall Study||66
8405928|NCT00979615|20717005|P1|STARTED|Overall Study||63
8405929|NCT00979602|20717021|P2|NOT COMPLETED|Overall Study||133
8405930|NCT00979602|20717022|P1|NOT COMPLETED|Overall Study||145
8405931|NCT00979602|20717021|P2|COMPLETED|Overall Study||1890
8405932|NCT00979602|20717022|P1|COMPLETED|Overall Study||1880
8405933|NCT00979602|20717021|P2|STARTED|Overall Study||2023
8405934|NCT00979602|20717022|P1|STARTED|Overall Study||2025
8405935|NCT00979576|20717193|P3|NOT COMPLETED|Combination Followed by Monotherapy||1
8405936|NCT00979576|20717194|P2|NOT COMPLETED|Combination Followed by Monotherapy||2
8405937|NCT00979576|20717195|P1|NOT COMPLETED|Combination Followed by Monotherapy||0
8405938|NCT00979576|20717193|P3|COMPLETED|Combination Followed by Monotherapy||0
8405939|NCT00979576|20717194|P2|COMPLETED|Combination Followed by Monotherapy||0
8405940|NCT00979576|20717195|P1|COMPLETED|Combination Followed by Monotherapy||0
8405941|NCT00979576|20717193|P3|STARTED|Combination Followed by Monotherapy||1
8405942|NCT00979576|20717194|P2|STARTED|Combination Followed by Monotherapy||2
8405943|NCT00979576|20717195|P1|STARTED|Combination Followed by Monotherapy||0
8405944|NCT00979576|20717193|P3|NOT COMPLETED|Combination Treatment Phase||9
8405945|NCT00979576|20717194|P2|NOT COMPLETED|Combination Treatment Phase||6
8405946|NCT00979576|20717195|P1|NOT COMPLETED|Combination Treatment Phase||3
8405947|NCT00979576|20717193|P3|COMPLETED|Combination Treatment Phase||0
8405948|NCT00979576|20717194|P2|COMPLETED|Combination Treatment Phase||0
8405949|NCT00979576|20717195|P1|COMPLETED|Combination Treatment Phase||0
8405950|NCT00979576|20717193|P3|STARTED|Combination Treatment Phase||9
8405951|NCT00979576|20717194|P2|STARTED|Combination Treatment Phase||6
8405952|NCT00979576|20717195|P1|STARTED|Combination Treatment Phase||3
8405953|NCT00979550|20717228|P2|NOT COMPLETED|Overall Study||0
8405954|NCT00979550|20717229|P1|NOT COMPLETED|Overall Study||0
8405955|NCT00979550|20717228|P2|COMPLETED|Overall Study||3
8405956|NCT00979550|20717229|P1|COMPLETED|Overall Study||4
8405957|NCT00979550|20717228|P2|STARTED|Overall Study||3
8405958|NCT00979550|20717229|P1|STARTED|Overall Study||4
8405959|NCT00979459|20717235|P2|NOT COMPLETED|Second Intervention||0
8405960|NCT00979459|20717236|P1|NOT COMPLETED|Second Intervention||0
8405961|NCT00979459|20717235|P2|COMPLETED|Second Intervention||6
8405962|NCT00979459|20717236|P1|COMPLETED|Second Intervention||6
8405963|NCT00979459|20717235|P2|STARTED|Second Intervention||6
8405964|NCT00979459|20717236|P1|STARTED|Second Intervention||6
8405965|NCT00979459|20717235|P2|NOT COMPLETED|7-day Washout Period||0
8405966|NCT00979459|20717236|P1|NOT COMPLETED|7-day Washout Period||0
8405967|NCT00979459|20717235|P2|COMPLETED|7-day Washout Period||6
8405968|NCT00979459|20717236|P1|COMPLETED|7-day Washout Period||6
8405969|NCT00979459|20717235|P2|STARTED|7-day Washout Period||6
8405970|NCT00979459|20717236|P1|STARTED|7-day Washout Period||6
8405971|NCT00979459|20717235|P2|NOT COMPLETED|First Intervention||0
8405972|NCT00979459|20717236|P1|NOT COMPLETED|First Intervention||0
8405973|NCT00979459|20717235|P2|COMPLETED|First Intervention||6
8405974|NCT00979459|20717236|P1|COMPLETED|First Intervention||6
8405975|NCT00979459|20717235|P2|STARTED|First Intervention||6
8405976|NCT00979459|20717236|P1|STARTED|First Intervention||6
8405977|NCT00979420|20717252|P4|NOT COMPLETED|Overall Study||2
8405978|NCT00979420|20717253|P3|NOT COMPLETED|Overall Study||1
8405979|NCT00979420|20717254|P2|NOT COMPLETED|Overall Study||0
8405980|NCT00979420|20717255|P1|NOT COMPLETED|Overall Study||7
8405981|NCT00979420|20717252|P4|COMPLETED|Overall Study||59
8405982|NCT00979420|20717253|P3|COMPLETED|Overall Study||59
8405983|NCT00979420|20717254|P2|COMPLETED|Overall Study||57
8405984|NCT00979420|20717255|P1|COMPLETED|Overall Study||171
8405985|NCT00979420|20717252|P4|STARTED|Overall Study||61
8405986|NCT00979420|20717253|P3|STARTED|Overall Study||60
8405987|NCT00979420|20717254|P2|STARTED|Overall Study||57
8405988|NCT00979420|20717255|P1|STARTED|Overall Study||178
8405989|NCT00979407|20717325|P2|NOT COMPLETED|Overall Study||7
8405990|NCT00979407|20717326|P1|NOT COMPLETED|Overall Study||6
8405991|NCT00979407|20717325|P2|COMPLETED|Overall Study||160
8405992|NCT00979407|20717326|P1|COMPLETED|Overall Study||161
8405993|NCT00979407|20717325|P2|STARTED|Overall Study||167
8405994|NCT00979407|20717326|P1|STARTED|Overall Study||167
8405995|NCT00979303|20717368|P2|NOT COMPLETED|Overall Study||0
8405996|NCT00979303|20717369|P1|NOT COMPLETED|Overall Study||0
8405997|NCT00979303|20717368|P2|COMPLETED|Overall Study||37
8405998|NCT00979303|20717369|P1|COMPLETED|Overall Study||37
8405999|NCT00979303|20717368|P2|STARTED|Overall Study||37
8406000|NCT00979303|20717369|P1|STARTED|Overall Study||37
8406001|NCT00979212|20717379|P2|NOT COMPLETED|Overall Study||8
8406002|NCT00979212|20717380|P1|NOT COMPLETED|Overall Study||2
8406003|NCT00979212|20717379|P2|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
8406004|NCT00979212|20717380|P1|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
8406005|NCT00979212|20717379|P2|STARTED|Overall Study||47
8406006|NCT00979212|20717380|P1|STARTED|Overall Study||24
8406007|NCT00979199|20717398|P1|NOT COMPLETED|Overall Study||222
8406008|NCT00979199|20717398|P1|COMPLETED|Overall Study||475
8406009|NCT00979199|20717398|P1|STARTED|Overall Study||697
8406010|NCT00979147|20717404|P2|NOT COMPLETED|Overall Study||0
8406011|NCT00979147|20717405|P1|NOT COMPLETED|Overall Study||0
8406012|NCT00979147|20717404|P2|COMPLETED|Overall Study||0
8406013|NCT00979147|20717405|P1|COMPLETED|Overall Study||0
8406014|NCT00979147|20717404|P2|STARTED|Overall Study||0
8406015|NCT00979147|20717405|P1|STARTED|Overall Study||0
8406016|NCT00979134|20717417|P3|NOT COMPLETED|Overall Study||40
8406017|NCT00979134|20717418|P2|NOT COMPLETED|Overall Study||6
8406018|NCT00979134|20717419|P1|NOT COMPLETED|Overall Study||33
8406019|NCT00979134|20717417|P3|COMPLETED|Overall Study|At DCO|5
8406020|NCT00979134|20717418|P2|COMPLETED|Overall Study|At DCO|0
8406021|NCT00979134|20717419|P1|COMPLETED|Overall Study|At DCO|10
8406022|NCT00979134|20717417|P3|STARTED|Overall Study||45
8406023|NCT00979134|20717418|P2|STARTED|Overall Study||6
8406024|NCT00979134|20717419|P1|STARTED|Overall Study||43
8406025|NCT00979121|20717471|P2|NOT COMPLETED|Overall Study||0
8406026|NCT00979121|20717472|P1|NOT COMPLETED|Overall Study||0
8406027|NCT00979121|20717471|P2|COMPLETED|Overall Study||366
8406028|NCT00979121|20717472|P1|COMPLETED|Overall Study||379
8406029|NCT00979121|20717471|P2|STARTED|Overall Study||366
8406030|NCT00979121|20717472|P1|STARTED|Overall Study||379
8406031|NCT00979069|20717490|P2|NOT COMPLETED|Overall Study||2
8406032|NCT00979069|20717491|P1|NOT COMPLETED|Overall Study||0
8406033|NCT00979069|20717490|P2|COMPLETED|Overall Study||8
8406034|NCT00979069|20717491|P1|COMPLETED|Overall Study||10
8406035|NCT00979069|20717490|P2|STARTED|Overall Study||10
8406036|NCT00979069|20717491|P1|STARTED|Overall Study||10
8406037|NCT00979017|20717497|P1|NOT COMPLETED|Overall Study||0
8406038|NCT00979017|20717497|P1|COMPLETED|Overall Study||41
8406039|NCT00979017|20717497|P1|STARTED|Overall Study||41
8406040|NCT00978757|20717507|P2|NOT COMPLETED|Overall Study||3
8406041|NCT00978757|20717508|P1|NOT COMPLETED|Overall Study||1
8406042|NCT00978757|20717507|P2|COMPLETED|Overall Study|June 2008|17
8406043|NCT00978757|20717508|P1|COMPLETED|Overall Study|June 2008|21
8406044|NCT00978757|20717507|P2|STARTED|Overall Study|June 2001|20
8406045|NCT00978757|20717508|P1|STARTED|Overall Study|June 2001|22
8406046|NCT00978731|20717518|P4|NOT COMPLETED|Overall Study||4
8406047|NCT00978731|20717519|P3|NOT COMPLETED|Overall Study||5
8406048|NCT00978731|20717520|P2|NOT COMPLETED|Overall Study||15
8406049|NCT00978731|20717521|P1|NOT COMPLETED|Overall Study||22
8406050|NCT00978731|20717518|P4|COMPLETED|Overall Study||0
8406051|NCT00978731|20717519|P3|COMPLETED|Overall Study||0
8406052|NCT00978731|20717520|P2|COMPLETED|Overall Study||0
8406053|NCT00978731|20717521|P1|COMPLETED|Overall Study||0
8406054|NCT00978731|20717518|P4|STARTED|Overall Study||4
8406055|NCT00978731|20717519|P3|STARTED|Overall Study||5
8406056|NCT00978731|20717520|P2|STARTED|Overall Study||15
8406057|NCT00978731|20717521|P1|STARTED|Overall Study||22
8406058|NCT00978627|20717561|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
8406059|NCT00978627|20717562|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
8406060|NCT00978627|20717561|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
8406061|NCT00978627|20717562|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
8406062|NCT00978627|20717561|P2|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
8406063|NCT00978627|20717562|P1|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
8406064|NCT00978627|20717561|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
8406065|NCT00978627|20717562|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
8406066|NCT00978627|20717561|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
8406067|NCT00978627|20717562|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
8406068|NCT00978627|20717561|P2|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
8406069|NCT00978627|20717562|P1|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
8406070|NCT00978627|20717561|P2|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
8406071|NCT00978627|20717562|P1|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
8406072|NCT00978562|20717584|P1|NOT COMPLETED|Overall Study||0
8406073|NCT00978562|20717584|P1|COMPLETED|Overall Study||7
8406074|NCT00978562|20717584|P1|STARTED|Overall Study||7
8406075|NCT00978445|20717589|P2|NOT COMPLETED|Overall Study||1
8406076|NCT00978445|20717590|P1|NOT COMPLETED|Overall Study||2
8406077|NCT00978445|20717589|P2|COMPLETED|Overall Study||12
8406078|NCT00978445|20717590|P1|COMPLETED|Overall Study||10
8406079|NCT00978445|20717589|P2|STARTED|Overall Study||13
8406080|NCT00978445|20717590|P1|STARTED|Overall Study||12
8406081|NCT00978432|20717600|P3|NOT COMPLETED|Overall Study||5
8406082|NCT00978432|20717601|P2|NOT COMPLETED|Overall Study||1
8406083|NCT00978432|20717602|P1|NOT COMPLETED|Overall Study||3
8406084|NCT00978432|20717600|P3|COMPLETED|Overall Study||13
8406085|NCT00978432|20717601|P2|COMPLETED|Overall Study||4
8406086|NCT00978432|20717602|P1|COMPLETED|Overall Study||7
8406087|NCT00978432|20717600|P3|STARTED|Overall Study||18
8406088|NCT00978432|20717601|P2|STARTED|Overall Study||5
8406089|NCT00978432|20717602|P1|STARTED|Overall Study||10
8406090|NCT00978419|20717624|P2|NOT COMPLETED|Overall Study||0
8406091|NCT00978419|20717625|P1|NOT COMPLETED|Overall Study||0
8406092|NCT00978419|20717624|P2|COMPLETED|Overall Study||0
8406093|NCT00978419|20717625|P1|COMPLETED|Overall Study||0
8406094|NCT00978419|20717624|P2|STARTED|Overall Study||0
8406095|NCT00978419|20717625|P1|STARTED|Overall Study||0
8406096|NCT00978380|20717653|P1|NOT COMPLETED|Overall Study||19
8406097|NCT00978380|20717653|P1|COMPLETED|Overall Study||44
8406098|NCT00978380|20717653|P1|STARTED|Overall Study||63
8406099|NCT00978341|20717659|P2|NOT COMPLETED|Second Intervention||0
8406100|NCT00978341|20717660|P1|NOT COMPLETED|Second Intervention||0
8406101|NCT00978341|20717659|P2|COMPLETED|Second Intervention||7
8406102|NCT00978341|20717660|P1|COMPLETED|Second Intervention||7
8406103|NCT00978341|20717659|P2|STARTED|Second Intervention||7
8406104|NCT00978341|20717660|P1|STARTED|Second Intervention||7
8406105|NCT00978341|20717659|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8406106|NCT00978341|20717660|P1|NOT COMPLETED|Washout Period of 2 Weeks||1
8406107|NCT00978341|20717659|P2|COMPLETED|Washout Period of 2 Weeks||7
8406108|NCT00978341|20717660|P1|COMPLETED|Washout Period of 2 Weeks||7
8406109|NCT00978341|20717659|P2|STARTED|Washout Period of 2 Weeks||7
8406110|NCT00978341|20717660|P1|STARTED|Washout Period of 2 Weeks||8
8406111|NCT00978341|20717659|P2|NOT COMPLETED|First Intervention||0
8406112|NCT00978341|20717660|P1|NOT COMPLETED|First Intervention||0
8406113|NCT00978341|20717659|P2|COMPLETED|First Intervention||7
8406114|NCT00978341|20717660|P1|COMPLETED|First Intervention||8
8406115|NCT00978341|20717659|P2|STARTED|First Intervention||7
8406116|NCT00978341|20717660|P1|STARTED|First Intervention||8
8406117|NCT00978250|20717682|P4|NOT COMPLETED|Overall Study||1
8406118|NCT00978250|20717683|P3|NOT COMPLETED|Overall Study||0
8406119|NCT00978250|20717684|P2|NOT COMPLETED|Overall Study||1
8406120|NCT00978250|20717685|P1|NOT COMPLETED|Overall Study||0
8406121|NCT00978250|20717682|P4|COMPLETED|Overall Study||21
8406122|NCT00978250|20717683|P3|COMPLETED|Overall Study||18
8406123|NCT00978250|20717684|P2|COMPLETED|Overall Study||29
8406124|NCT00978250|20717685|P1|COMPLETED|Overall Study||25
8406125|NCT00978250|20717682|P4|STARTED|Overall Study||22
8406126|NCT00978250|20717683|P3|STARTED|Overall Study||18
8406127|NCT00978250|20717684|P2|STARTED|Overall Study||30
8406128|NCT00978250|20717685|P1|STARTED|Overall Study||25
8406129|NCT00978120|20717701|P4|NOT COMPLETED|Overall Study||2
8406130|NCT00978120|20717702|P3|NOT COMPLETED|Overall Study||3
8406131|NCT00978120|20717703|P2|NOT COMPLETED|Overall Study||0
8406132|NCT00978120|20717704|P1|NOT COMPLETED|Overall Study||2
8406133|NCT00978120|20717701|P4|COMPLETED|Overall Study||84
8406134|NCT00978120|20717702|P3|COMPLETED|Overall Study||84
8406135|NCT00978120|20717703|P2|COMPLETED|Overall Study||107
8406136|NCT00978120|20717704|P1|COMPLETED|Overall Study||108
8406137|NCT00978120|20717701|P4|STARTED|Overall Study||86
8406138|NCT00978120|20717702|P3|STARTED|Overall Study||87
8406139|NCT00978120|20717703|P2|STARTED|Overall Study||107
8406140|NCT00978120|20717704|P1|STARTED|Overall Study||110
8406141|NCT00978068|20717756|P2|NOT COMPLETED|Overall Study||9
8406142|NCT00978068|20717757|P1|NOT COMPLETED|Overall Study||4
8406143|NCT00978068|20717756|P2|COMPLETED|Overall Study||80
8406144|NCT00978068|20717757|P1|COMPLETED|Overall Study||83
8406145|NCT00978068|20717756|P2|Initiated Study Drugs|Overall Study||86
8406146|NCT00978068|20717757|P1|Initiated Study Drugs|Overall Study||84
8406147|NCT00978068|20717756|P2|STARTED|Overall Study||89
8406148|NCT00978068|20717757|P1|STARTED|Overall Study||87
8406149|NCT00978042|20717775|P2|NOT COMPLETED|Received Repeat Treatment||3
8406150|NCT00978042|20717776|P1|NOT COMPLETED|Received Repeat Treatment||43
8406151|NCT00978042|20717775|P2|COMPLETED|Received Repeat Treatment||23
8406152|NCT00978042|20717776|P1|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
8406153|NCT00978042|20717775|P2|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
8406154|NCT00978042|20717776|P1|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
8406155|NCT00978042|20717775|P2|NOT COMPLETED|Initial Treatment Period||15
8406156|NCT00978042|20717776|P1|NOT COMPLETED|Initial Treatment Period||61
8406157|NCT00978042|20717775|P2|COMPLETED|Initial Treatment Period||32
8406158|NCT00978042|20717776|P1|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
8406159|NCT00978042|20717775|P2|MITT_treated With VOLUMA XC|Initial Treatment Period||35
8406160|NCT00978042|20717776|P1|MITT_treated With VOLUMA XC|Initial Treatment Period||235
8406161|NCT00978042|20717775|P2|STARTED|Initial Treatment Period||47
8406162|NCT00978042|20717776|P1|STARTED|Initial Treatment Period||235
8406163|NCT00978029|20717789|P3|NOT COMPLETED|Overall Study||6
8406164|NCT00978029|20717790|P2|NOT COMPLETED|Overall Study||3
8406165|NCT00978029|20717791|P1|NOT COMPLETED|Overall Study||1
8406166|NCT00978029|20717789|P3|COMPLETED|Overall Study||59
8406167|NCT00978029|20717790|P2|COMPLETED|Overall Study||63
8406168|NCT00978029|20717791|P1|COMPLETED|Overall Study||64
8406169|NCT00978029|20717789|P3|STARTED|Overall Study||65
8406170|NCT00978029|20717790|P2|STARTED|Overall Study||66
8406171|NCT00978029|20717791|P1|STARTED|Overall Study||65
8406172|NCT00977938|20717818|P4|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
8406173|NCT00977938|20717819|P3|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
8406174|NCT00977938|20717820|P2|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
8406175|NCT00977938|20717821|P1|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
8406176|NCT00977938|20717818|P4|COMPLETED|Observation (30-33 mo. Post Procedure)||781
8406177|NCT00977938|20717819|P3|COMPLETED|Observation (30-33 mo. Post Procedure)||784
8406178|NCT00977938|20717820|P2|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
8406179|NCT00977938|20717821|P1|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
8406180|NCT00977938|20717818|P4|STARTED|Observation (30-33 mo. Post Procedure)||784
8406181|NCT00977938|20717819|P3|STARTED|Observation (30-33 mo. Post Procedure)||796
8406182|NCT00977938|20717820|P2|STARTED|Observation (30-33 mo. Post Procedure)||4716
8406183|NCT00977938|20717821|P1|STARTED|Observation (30-33 mo. Post Procedure)||4783
8406184|NCT00977938|20717818|P4|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
8406185|NCT00977938|20717819|P3|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
8406186|NCT00977938|20717820|P2|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
8406187|NCT00977938|20717821|P1|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
8406188|NCT00977938|20717818|P4|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
8406189|NCT00977938|20717819|P3|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
8406190|NCT00977938|20717820|P2|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
8406191|NCT00977938|20717821|P1|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
8406192|NCT00977938|20717818|P4|STARTED|Treatment (12-30 mo. Post Procedure)||845
8406193|NCT00977938|20717819|P3|STARTED|Treatment (12-30 mo. Post Procedure)||842
8406194|NCT00977938|20717820|P2|STARTED|Treatment (12-30 mo. Post Procedure)||4941
8406195|NCT00977938|20717821|P1|STARTED|Treatment (12-30 mo. Post Procedure)||5020
8406196|NCT00977808|20717855|P1|NOT COMPLETED|Overall Study||1
8406197|NCT00977808|20717855|P1|COMPLETED|Overall Study||11
8406198|NCT00977808|20717855|P1|Completion of Closed-Loop Admission|Overall Study||11
8406199|NCT00977808|20717855|P1|Completion of Open-Loop Admission|Overall Study||12
8406200|NCT00977808|20717855|P1|STARTED|Overall Study||12
8406201|NCT00977769|20717863|P3|NOT COMPLETED|Overall Study||0
8406202|NCT00977769|20717864|P2|NOT COMPLETED|Overall Study||0
8406203|NCT00977769|20717865|P1|NOT COMPLETED|Overall Study||0
8406204|NCT00977769|20717863|P3|COMPLETED|Overall Study||25
8406205|NCT00977769|20717864|P2|COMPLETED|Overall Study||26
8406206|NCT00977769|20717865|P1|COMPLETED|Overall Study||25
8406207|NCT00977769|20717863|P3|STARTED|Overall Study||25
8406208|NCT00977769|20717864|P2|STARTED|Overall Study||26
8406209|NCT00977769|20717865|P1|STARTED|Overall Study||25
8406210|NCT00977704|20717879|P1|NOT COMPLETED|Overall Study||0
8406211|NCT00977704|20717879|P1|COMPLETED|Overall Study||20
8406212|NCT00977704|20717879|P1|STARTED|Overall Study||20
8406222|NCT00977665|20717898|P2|NOT COMPLETED|Overall Study||15
8406223|NCT00977665|20717899|P1|NOT COMPLETED|Overall Study||21
8406224|NCT00977665|20717898|P2|COMPLETED|Overall Study||75
8406225|NCT00977665|20717899|P1|COMPLETED|Overall Study||63
8406226|NCT00977665|20717898|P2|STARTED|Overall Study||90
8406227|NCT00977665|20717899|P1|STARTED|Overall Study||84
8406228|NCT00977613|20717931|P1|NOT COMPLETED|Overall Study||16
8406229|NCT00977613|20717931|P1|COMPLETED|Overall Study||34
8406230|NCT00977613|20717931|P1|STARTED|Overall Study||50
8406240|NCT00977561|20717959|P2|NOT COMPLETED|Overall Study||4
8406241|NCT00977561|20717960|P1|NOT COMPLETED|Overall Study||5
8406242|NCT00977561|20717959|P2|COMPLETED|Overall Study||0
8406243|NCT00977561|20717960|P1|COMPLETED|Overall Study||0
8406244|NCT00977561|20717959|P2|STARTED|Overall Study||4
8406245|NCT00977561|20717960|P1|STARTED|Overall Study||5
8406246|NCT00977548|20717987|P1|NOT COMPLETED|Overall Study||13
8406247|NCT00977548|20717987|P1|COMPLETED|Overall Study||26
8406248|NCT00977548|20717987|P1|STARTED|Overall Study||39
8406249|NCT00977470|20717996|P2|NOT COMPLETED|Overall Study||38
8406250|NCT00977470|20717997|P1|NOT COMPLETED|Overall Study||38
8406251|NCT00977470|20717996|P2|COMPLETED|Overall Study||0
8406252|NCT00977470|20717997|P1|COMPLETED|Overall Study||0
8406253|NCT00977470|20717996|P2|STARTED|Overall Study||38
8406254|NCT00977470|20717997|P1|STARTED|Overall Study||38
8406255|NCT00977431|20718020|P5|NOT COMPLETED|Overall Study||13
8406256|NCT00977431|20718021|P4|NOT COMPLETED|Overall Study||3
8406257|NCT00977431|20718022|P3|NOT COMPLETED|Overall Study||7
8406258|NCT00977431|20718023|P2|NOT COMPLETED|Overall Study||6
8406259|NCT00977431|20718024|P1|NOT COMPLETED|Overall Study||7
8406260|NCT00977431|20718020|P5|COMPLETED|Overall Study||0
8406261|NCT00977431|20718021|P4|COMPLETED|Overall Study||0
8406262|NCT00977431|20718022|P3|COMPLETED|Overall Study||0
8406263|NCT00977431|20718023|P2|COMPLETED|Overall Study||0
8406264|NCT00977431|20718024|P1|COMPLETED|Overall Study||0
8406265|NCT00977431|20718020|P5|Discontinued Afatinib Before/on Day 42|Overall Study||3
8406266|NCT00977431|20718021|P4|Discontinued Afatinib Before/on Day 42|Overall Study||0
8406267|NCT00977431|20718022|P3|Discontinued Afatinib Before/on Day 42|Overall Study||4
8406268|NCT00977431|20718023|P2|Discontinued Afatinib Before/on Day 42|Overall Study||0
8406269|NCT00977431|20718024|P1|Discontinued Afatinib Before/on Day 42|Overall Study||1
8406270|NCT00977431|20718020|P5|STARTED|Overall Study||13
8406271|NCT00977431|20718021|P4|STARTED|Overall Study||3
8406272|NCT00977431|20718022|P3|STARTED|Overall Study||7
8406273|NCT00977431|20718023|P2|STARTED|Overall Study||6
8406274|NCT00977431|20718024|P1|STARTED|Overall Study||7
8406275|NCT00977379|20718057|P2|NOT COMPLETED|Overall Study||12
8406276|NCT00977379|20718058|P1|NOT COMPLETED|Overall Study||12
8406277|NCT00977379|20718057|P2|COMPLETED|Overall Study||0
8406278|NCT00977379|20718058|P1|COMPLETED|Overall Study||0
8406279|NCT00977379|20718057|P2|Treated|Overall Study||11
8406280|NCT00977379|20718058|P1|Treated|Overall Study||12
8406281|NCT00977379|20718057|P2|STARTED|Overall Study|Randomized|12
8406282|NCT00977379|20718058|P1|STARTED|Overall Study|Randomized|12
8406283|NCT00977314|20718094|P2|NOT COMPLETED|Overall Study||0
8406284|NCT00977314|20718095|P1|NOT COMPLETED|Overall Study||2
8406285|NCT00977314|20718094|P2|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
8406286|NCT00977314|20718095|P1|COMPLETED|Overall Study||28
8406287|NCT00977314|20718094|P2|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
8406288|NCT00977314|20718095|P1|STARTED|Overall Study||30
8406289|NCT00977197|20718103|P2|NOT COMPLETED|Overall Study||9
8406290|NCT00977197|20718104|P1|NOT COMPLETED|Overall Study||9
8406291|NCT00977197|20718103|P2|COMPLETED|Overall Study||35
8406292|NCT00977197|20718104|P1|COMPLETED|Overall Study||32
8406293|NCT00977197|20718103|P2|STARTED|Overall Study||44
8406294|NCT00977197|20718104|P1|STARTED|Overall Study||41
8406295|NCT00977184|20718134|P2|NOT COMPLETED|Overall Study||0
8406296|NCT00977184|20718135|P1|NOT COMPLETED|Overall Study||0
8406297|NCT00977184|20718134|P2|COMPLETED|Overall Study||13
8406298|NCT00977184|20718135|P1|COMPLETED|Overall Study||13
8406299|NCT00977184|20718134|P2|STARTED|Overall Study||13
8406300|NCT00977184|20718135|P1|STARTED|Overall Study||13
8406301|NCT00977171|20718161|P1|NOT COMPLETED|Overall Study||0
8406302|NCT00977171|20718161|P1|COMPLETED|Overall Study||3
8406303|NCT00977171|20718161|P1|STARTED|Overall Study||3
8406304|NCT00977106|20718167|P2|NOT COMPLETED|Overall Study||11
8406305|NCT00977106|20718168|P1|NOT COMPLETED|Overall Study||10
8406306|NCT00977106|20718167|P2|COMPLETED|Overall Study||45
8406307|NCT00977106|20718168|P1|COMPLETED|Overall Study||37
8406308|NCT00977106|20718167|P2|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
8406309|NCT00977106|20718168|P1|STARTED|Overall Study||47
8406310|NCT00977080|20718260|P4|NOT COMPLETED|Overall Study||17
8406311|NCT00977080|20718261|P3|NOT COMPLETED|Overall Study||16
8406312|NCT00977080|20718262|P2|NOT COMPLETED|Overall Study||20
8406313|NCT00977080|20718263|P1|NOT COMPLETED|Overall Study||12
8406314|NCT00977080|20718260|P4|COMPLETED|Overall Study||53
8406315|NCT00977080|20718261|P3|COMPLETED|Overall Study||56
8406316|NCT00977080|20718262|P2|COMPLETED|Overall Study||44
8406317|NCT00977080|20718263|P1|COMPLETED|Overall Study||50
8406318|NCT00977080|20718260|P4|STARTED|Overall Study||70
8406319|NCT00977080|20718261|P3|STARTED|Overall Study||72
8406320|NCT00977080|20718262|P2|STARTED|Overall Study||64
8406321|NCT00977080|20718263|P1|STARTED|Overall Study||62
8406322|NCT00976989|20718296|P3|NOT COMPLETED|Overall Study||17
8406323|NCT00976989|20718297|P2|NOT COMPLETED|Overall Study||12
8406324|NCT00976989|20718298|P1|NOT COMPLETED|Overall Study||13
8406325|NCT00976989|20718296|P3|COMPLETED|Overall Study||60
8406326|NCT00976989|20718297|P2|COMPLETED|Overall Study||63
8406327|NCT00976989|20718298|P1|COMPLETED|Overall Study||60
8406328|NCT00976989|20718296|P3|STARTED|Overall Study||77
8406329|NCT00976989|20718297|P2|STARTED|Overall Study||75
8406330|NCT00976989|20718298|P1|STARTED|Overall Study||73
8406331|NCT00976950|20718339|P1|NOT COMPLETED|Overall Study||6
8406332|NCT00976950|20718339|P1|COMPLETED|Overall Study||36
8406333|NCT00976950|20718339|P1|STARTED|Overall Study||42
8406334|NCT00976937|20718347|P2|NOT COMPLETED|Overall Study||11
8406335|NCT00976937|20718348|P1|NOT COMPLETED|Overall Study||16
8406336|NCT00976937|20718347|P2|COMPLETED|Overall Study||150
8406337|NCT00976937|20718348|P1|COMPLETED|Overall Study||142
8406338|NCT00976937|20718347|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||161
8406339|NCT00976937|20718348|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
8406340|NCT00976937|20718347|P2|Treated/Safety Population|Overall Study||161
8406341|NCT00976937|20718348|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
8406342|NCT00976937|20718347|P2|STARTED|Overall Study||161
8406343|NCT00976937|20718348|P1|STARTED|Overall Study|Randomized|158
8406344|NCT00976911|20718390|P2|NOT COMPLETED|Overall Study||179
8406345|NCT00976911|20718391|P1|NOT COMPLETED|Overall Study||182
8406346|NCT00976911|20718390|P2|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
8406347|NCT00976911|20718391|P1|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
8406348|NCT00976911|20718390|P2|STARTED|Overall Study||179
8406349|NCT00976911|20718391|P1|STARTED|Overall Study||182
8406350|NCT00976898|20718409|P1|NOT COMPLETED|Overall Study||5
8406351|NCT00976898|20718409|P1|COMPLETED|Overall Study||78
8406352|NCT00976898|20718409|P1|STARTED|Overall Study||83
8406353|NCT00976820|20718420|P4|NOT COMPLETED|Overall Study||7
8406354|NCT00976820|20718421|P3|NOT COMPLETED|Overall Study||4
8406355|NCT00976820|20718422|P2|NOT COMPLETED|Overall Study||20
8406356|NCT00976820|20718423|P1|NOT COMPLETED|Overall Study||8
8406357|NCT00976820|20718420|P4|COMPLETED|Overall Study||56
8406358|NCT00976820|20718421|P3|COMPLETED|Overall Study||60
8406359|NCT00976820|20718422|P2|COMPLETED|Overall Study||108
8406360|NCT00976820|20718423|P1|COMPLETED|Overall Study||59
8406361|NCT00976820|20718420|P4|STARTED|Overall Study||63
8406362|NCT00976820|20718421|P3|STARTED|Overall Study||64
8406363|NCT00976820|20718422|P2|STARTED|Overall Study||128
8406364|NCT00976820|20718423|P1|STARTED|Overall Study||67
8406368|NCT00976703|20718777|P2|NOT COMPLETED|Overall Study||3
8406369|NCT00976703|20718778|P1|NOT COMPLETED|Overall Study||3
8406370|NCT00976703|20718777|P2|COMPLETED|Overall Study||95
8406371|NCT00976703|20718778|P1|COMPLETED|Overall Study||96
8406372|NCT00976703|20718777|P2|STARTED|Overall Study||98
8406373|NCT00976703|20718778|P1|STARTED|Overall Study||99
8406374|NCT00976677|20718792|P2|NOT COMPLETED|Overall Study||5
8406375|NCT00976677|20718793|P1|NOT COMPLETED|Overall Study||5
8406376|NCT00976677|20718792|P2|COMPLETED|Overall Study||0
8406377|NCT00976677|20718793|P1|COMPLETED|Overall Study||0
8406378|NCT00976677|20718792|P2|STARTED|Overall Study||5
8406379|NCT00976677|20718793|P1|STARTED|Overall Study||5
8406380|NCT00976664|20718801|P2|NOT COMPLETED|Overall Study||1
8406381|NCT00976664|20718802|P1|NOT COMPLETED|Overall Study||3
8406382|NCT00976664|20718801|P2|COMPLETED|Overall Study||24
8406383|NCT00976664|20718802|P1|COMPLETED|Overall Study||22
8406384|NCT00976664|20718801|P2|STARTED|Overall Study||25
8406385|NCT00976664|20718802|P1|STARTED|Overall Study||25
8406386|NCT00976599|20718812|P2|NOT COMPLETED|Overall Study||0
8406387|NCT00976599|20718813|P1|NOT COMPLETED|Overall Study||0
8406388|NCT00976599|20718812|P2|COMPLETED|Overall Study||14
8406389|NCT00976599|20718813|P1|COMPLETED|Overall Study||15
8406390|NCT00976599|20718812|P2|STARTED|Overall Study||14
8406391|NCT00976599|20718813|P1|STARTED|Overall Study||15
8406392|NCT00976573|20719001|P2|NOT COMPLETED|Overall Study||3
8406393|NCT00976573|20719002|P1|NOT COMPLETED|Overall Study||4
8406394|NCT00976573|20719001|P2|COMPLETED|Overall Study||71
8406395|NCT00976573|20719002|P1|COMPLETED|Overall Study||71
8406396|NCT00976573|20719001|P2|STARTED|Overall Study||74
8406397|NCT00976573|20719002|P1|STARTED|Overall Study||75
8406398|NCT00976560|20719016|P2|NOT COMPLETED|Overall Study||13
8406399|NCT00976560|20719017|P1|NOT COMPLETED|Overall Study||14
8406400|NCT00976560|20719016|P2|COMPLETED|Overall Study||51
8406401|NCT00976560|20719017|P1|COMPLETED|Overall Study||50
8406402|NCT00976560|20719016|P2|STARTED|Overall Study||64
8406403|NCT00976560|20719017|P1|STARTED|Overall Study||64
8406404|NCT00976521|20719069|P4|NOT COMPLETED|Overall Study||19
8406405|NCT00976521|20719070|P3|NOT COMPLETED|Overall Study||9
8406406|NCT00976521|20719071|P2|NOT COMPLETED|Overall Study||12
8406407|NCT00976521|20719072|P1|NOT COMPLETED|Overall Study||9
8406408|NCT00976521|20719069|P4|COMPLETED|Overall Study||93
8406409|NCT00976521|20719070|P3|COMPLETED|Overall Study||102
8406410|NCT00976521|20719071|P2|COMPLETED|Overall Study||99
8406411|NCT00976521|20719072|P1|COMPLETED|Overall Study||109
8406412|NCT00976521|20719069|P4|STARTED|Overall Study||112
8406413|NCT00976521|20719070|P3|STARTED|Overall Study||111
8406414|NCT00976521|20719071|P2|STARTED|Overall Study||111
8406415|NCT00976521|20719072|P1|STARTED|Overall Study||118
8406416|NCT00976508|20719086|P2|NOT COMPLETED|Overall Study||6
8406417|NCT00976508|20719087|P1|NOT COMPLETED|Overall Study||14
8406418|NCT00976508|20719086|P2|COMPLETED|Overall Study||0
8406419|NCT00976508|20719087|P1|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
8406420|NCT00976508|20719086|P2|STARTED|Overall Study||6
8406421|NCT00976508|20719087|P1|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
8406422|NCT00976495|20719120|P3|NOT COMPLETED|Overall Study||0
8406423|NCT00976495|20719121|P2|NOT COMPLETED|Overall Study||1
8406424|NCT00976495|20719122|P1|NOT COMPLETED|Overall Study||0
8406425|NCT00976495|20719120|P3|COMPLETED|Overall Study||26
8406426|NCT00976495|20719121|P2|COMPLETED|Overall Study||23
8406427|NCT00976495|20719122|P1|COMPLETED|Overall Study||25
8406428|NCT00976495|20719120|P3|STARTED|Overall Study||26
8406429|NCT00976495|20719121|P2|STARTED|Overall Study||24
8406430|NCT00976495|20719122|P1|STARTED|Overall Study||25
8406431|NCT00976482|20719139|P1|NOT COMPLETED|Overall Study||259
8406432|NCT00976482|20719139|P1|COMPLETED|Overall Study||1486
8406433|NCT00976482|20719139|P1|Eligible for Last Follow up|Overall Study||1487
8406434|NCT00976482|20719139|P1|STARTED|Overall Study||1745
8406435|NCT00976456|20719145|P2|NOT COMPLETED|Overall Study||38
8406436|NCT00976456|20719146|P1|NOT COMPLETED|Overall Study||43
8406437|NCT00976456|20719145|P2|COMPLETED|Overall Study||98
8406438|NCT00976456|20719146|P1|COMPLETED|Overall Study||92
8406439|NCT00976456|20719145|P2|STARTED|Overall Study||136
8406440|NCT00976456|20719146|P1|STARTED|Overall Study||135
8406441|NCT00976404|20719156|P2|NOT COMPLETED|Overall Study||0
8406442|NCT00976404|20719157|P1|NOT COMPLETED|Overall Study||0
8406443|NCT00976404|20719156|P2|COMPLETED|Overall Study||14
8406444|NCT00976404|20719157|P1|COMPLETED|Overall Study||14
8406445|NCT00976404|20719156|P2|STARTED|Overall Study||14
8406446|NCT00976404|20719157|P1|STARTED|Overall Study||14
8406447|NCT00976391|20719173|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||34
8406448|NCT00976391|20719174|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||29
8406449|NCT00976391|20719173|P2|COMPLETED|Follow-up Period (8 Weeks)||247
8406450|NCT00976391|20719174|P1|COMPLETED|Follow-up Period (8 Weeks)||256
8406451|NCT00976391|20719173|P2|STARTED|Follow-up Period (8 Weeks)||281
8406452|NCT00976391|20719174|P1|STARTED|Follow-up Period (8 Weeks)||285
8406453|NCT00976391|20719173|P2|NOT COMPLETED|Treatment Period (52 Weeks)||39
8406454|NCT00976391|20719174|P1|NOT COMPLETED|Treatment Period (52 Weeks)||42
8406455|NCT00976391|20719173|P2|COMPLETED|Treatment Period (52 Weeks)||242
8406456|NCT00976391|20719174|P1|COMPLETED|Treatment Period (52 Weeks)||243
8406457|NCT00976391|20719173|P2|STARTED|Treatment Period (52 Weeks)||281
8406458|NCT00976391|20719174|P1|STARTED|Treatment Period (52 Weeks)||285
8406459|NCT00976352|20719196|P2|NOT COMPLETED|Overall Study||4
8406460|NCT00976352|20719197|P1|NOT COMPLETED|Overall Study||0
8406461|NCT00976352|20719196|P2|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
8406462|NCT00976352|20719197|P1|COMPLETED|Overall Study||3
8406463|NCT00976352|20719196|P2|STARTED|Overall Study||10
8406464|NCT00976352|20719197|P1|STARTED|Overall Study||3
8406465|NCT00976339|20719211|P2|NOT COMPLETED|Overall Study||0
8406466|NCT00976339|20719212|P1|NOT COMPLETED|Overall Study||0
8406467|NCT00976339|20719211|P2|COMPLETED|Overall Study||10
8406468|NCT00976339|20719212|P1|COMPLETED|Overall Study||10
8406469|NCT00976339|20719211|P2|STARTED|Overall Study||10
8406470|NCT00976339|20719212|P1|STARTED|Overall Study||10
8406471|NCT00976274|20719222|P2|NOT COMPLETED|Overall Study||8
8406472|NCT00976274|20719223|P1|NOT COMPLETED|Overall Study||7
8406473|NCT00976274|20719222|P2|COMPLETED|Overall Study||21
8406474|NCT00976274|20719223|P1|COMPLETED|Overall Study||24
8406475|NCT00976274|20719222|P2|STARTED|Overall Study||29
8406476|NCT00976274|20719223|P1|STARTED|Overall Study||31
8406477|NCT00976248|20719231|P1|NOT COMPLETED|Overall Study||0
8406478|NCT00976248|20719231|P1|COMPLETED|Overall Study||33
8406479|NCT00976248|20719231|P1|STARTED|Overall Study||33
8406480|NCT00976209|20719239|P2|NOT COMPLETED|Treatment Period 2||2
8406481|NCT00976209|20719240|P1|NOT COMPLETED|Treatment Period 2||0
8406482|NCT00976209|20719239|P2|COMPLETED|Treatment Period 2||161
8406483|NCT00976209|20719240|P1|COMPLETED|Treatment Period 2||158
8406484|NCT00976209|20719239|P2|STARTED|Treatment Period 2||163
8406485|NCT00976209|20719240|P1|STARTED|Treatment Period 2||158
8406486|NCT00976209|20719239|P2|NOT COMPLETED|Wash-out Period||2
8406487|NCT00976209|20719240|P1|NOT COMPLETED|Wash-out Period||4
8406488|NCT00976209|20719239|P2|COMPLETED|Wash-out Period||163
8406489|NCT00976209|20719240|P1|COMPLETED|Wash-out Period||158
8406490|NCT00976209|20719239|P2|STARTED|Wash-out Period||165
8406491|NCT00976209|20719240|P1|STARTED|Wash-out Period||162
8406492|NCT00976209|20719239|P2|NOT COMPLETED|Treatment Period 1||1
8406493|NCT00976209|20719240|P1|NOT COMPLETED|Treatment Period 1||3
8406494|NCT00976209|20719239|P2|COMPLETED|Treatment Period 1||165
8406495|NCT00976209|20719240|P1|COMPLETED|Treatment Period 1||162
8406496|NCT00976209|20719239|P2|STARTED|Treatment Period 1||166
8406497|NCT00976209|20719240|P1|STARTED|Treatment Period 1||165
8406498|NCT00976183|20719246|P1|NOT COMPLETED|Overall Study||0
8406499|NCT00976183|20719246|P1|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
8406500|NCT00976183|20719246|P1|STARTED|Overall Study||18
8406501|NCT00976027|20719253|P2|NOT COMPLETED|Overall Study||215
8406502|NCT00976027|20719254|P1|NOT COMPLETED|Overall Study||411
8406503|NCT00976027|20719253|P2|COMPLETED|Overall Study||2835
8406504|NCT00976027|20719254|P1|COMPLETED|Overall Study||5697
8406505|NCT00976027|20719253|P2|STARTED|Overall Study||3050
8406506|NCT00976027|20719254|P1|STARTED|Overall Study||6108
8406507|NCT00975975|20719266|P1|NOT COMPLETED|Overall Study||6
8406508|NCT00975975|20719266|P1|COMPLETED|Overall Study||11
8406509|NCT00975975|20719266|P1|STARTED|Overall Study||17
8406510|NCT00975923|20719274|P2|NOT COMPLETED|Overall Study||1
8406511|NCT00975923|20719275|P1|NOT COMPLETED|Overall Study||0
8406512|NCT00975923|20719274|P2|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
8406513|NCT00975923|20719275|P1|COMPLETED|Overall Study||30
8406514|NCT00975923|20719274|P2|STARTED|Overall Study||30
8406515|NCT00975923|20719275|P1|STARTED|Overall Study||30
8406516|NCT00975884|20719285|P2|NOT COMPLETED|Overall Study||15
8406517|NCT00975884|20719286|P1|NOT COMPLETED|Overall Study||16
8406518|NCT00975884|20719285|P2|COMPLETED|Overall Study||107
8406519|NCT00975884|20719286|P1|COMPLETED|Overall Study||168
8406520|NCT00975884|20719285|P2|STARTED|Overall Study||122
8406521|NCT00975884|20719286|P1|STARTED|Overall Study||184
8406522|NCT00975806|20719443|P3|NOT COMPLETED|Overall Study||4
8406523|NCT00975806|20719444|P2|NOT COMPLETED|Overall Study||7
8406524|NCT00975806|20719445|P1|NOT COMPLETED|Overall Study||5
8406525|NCT00975806|20719443|P3|COMPLETED|Overall Study|Participants were prematurely discontinued|0
8406526|NCT00975806|20719444|P2|COMPLETED|Overall Study|Participants were prematurely discontinued|0
8406527|NCT00975806|20719445|P1|COMPLETED|Overall Study|Participants were prematurely discontinued|0
8406528|NCT00975806|20719443|P3|STARTED|Overall Study||4
8406529|NCT00975806|20719444|P2|STARTED|Overall Study||7
8406530|NCT00975806|20719445|P1|STARTED|Overall Study||5
8406531|NCT00975780|20719469|P2|NOT COMPLETED|Follow Up||157
8406532|NCT00975780|20719470|P1|NOT COMPLETED|Follow Up||102
8406533|NCT00975780|20719469|P2|COMPLETED|Follow Up||277
8406534|NCT00975780|20719470|P1|COMPLETED|Follow Up||298
8406535|NCT00975780|20719469|P2|STARTED|Follow Up||434
8406536|NCT00975780|20719470|P1|STARTED|Follow Up||400
8406537|NCT00975780|20719469|P2|NOT COMPLETED|Allocation||0
8406538|NCT00975780|20719470|P1|NOT COMPLETED|Allocation||0
8406539|NCT00975780|20719469|P2|COMPLETED|Allocation||434
8406540|NCT00975780|20719470|P1|COMPLETED|Allocation||400
8406541|NCT00975780|20719469|P2|STARTED|Allocation||434
8406542|NCT00975780|20719470|P1|STARTED|Allocation||400
8406543|NCT00975715|20719480|P2|NOT COMPLETED|Maintenance Period||1
8406544|NCT00975715|20719481|P1|NOT COMPLETED|Maintenance Period||2
8406545|NCT00975715|20719480|P2|COMPLETED|Maintenance Period||50
8406546|NCT00975715|20719481|P1|COMPLETED|Maintenance Period||39
8406547|NCT00975715|20719480|P2|STARTED|Maintenance Period||51
8406548|NCT00975715|20719481|P1|STARTED|Maintenance Period||41
8406549|NCT00975715|20719480|P2|NOT COMPLETED|Titration Period||0
8406550|NCT00975715|20719481|P1|NOT COMPLETED|Titration Period||7
8406551|NCT00975715|20719480|P2|COMPLETED|Titration Period||51
8406552|NCT00975715|20719481|P1|COMPLETED|Titration Period||41
8406553|NCT00975715|20719480|P2|STARTED|Titration Period||51
8406554|NCT00975715|20719481|P1|STARTED|Titration Period||48
8406555|NCT00975689|20719497|P2|NOT COMPLETED|Overall Study||3
8406556|NCT00975689|20719498|P1|NOT COMPLETED|Overall Study||2
8406557|NCT00975689|20719497|P2|COMPLETED|Overall Study||15
8406558|NCT00975689|20719498|P1|COMPLETED|Overall Study||15
8406559|NCT00975689|20719497|P2|STARTED|Overall Study||18
8406560|NCT00975689|20719498|P1|STARTED|Overall Study||17
8406561|NCT00975650|20719504|P4|NOT COMPLETED|Period 4||0
8406562|NCT00975650|20719505|P3|NOT COMPLETED|Period 4||0
8406563|NCT00975650|20719506|P2|NOT COMPLETED|Period 4||0
8406564|NCT00975650|20719507|P1|NOT COMPLETED|Period 4||0
8406565|NCT00975650|20719504|P4|COMPLETED|Period 4||14
8406566|NCT00975650|20719505|P3|COMPLETED|Period 4||14
8406567|NCT00975650|20719506|P2|COMPLETED|Period 4||14
8406568|NCT00975650|20719507|P1|COMPLETED|Period 4||12
8406569|NCT00975650|20719504|P4|STARTED|Period 4||14
8406570|NCT00975650|20719505|P3|STARTED|Period 4||14
8406571|NCT00975650|20719506|P2|STARTED|Period 4||14
8406572|NCT00975650|20719507|P1|STARTED|Period 4||12
8406573|NCT00975650|20719504|P4|NOT COMPLETED|Period 3||0
8406574|NCT00975650|20719505|P3|NOT COMPLETED|Period 3||0
8406575|NCT00975650|20719506|P2|NOT COMPLETED|Period 3||0
8406576|NCT00975650|20719507|P1|NOT COMPLETED|Period 3||0
8406577|NCT00975650|20719504|P4|COMPLETED|Period 3||14
8406578|NCT00975650|20719505|P3|COMPLETED|Period 3||14
8406579|NCT00975650|20719506|P2|COMPLETED|Period 3||14
8406580|NCT00975650|20719507|P1|COMPLETED|Period 3||12
8406581|NCT00975650|20719504|P4|STARTED|Period 3||14
8406582|NCT00975650|20719505|P3|STARTED|Period 3||14
8406583|NCT00975650|20719506|P2|STARTED|Period 3||14
8406584|NCT00975650|20719507|P1|STARTED|Period 3||12
8406585|NCT00975650|20719504|P4|NOT COMPLETED|Period 2||0
8406586|NCT00975650|20719505|P3|NOT COMPLETED|Period 2||0
8406587|NCT00975650|20719506|P2|NOT COMPLETED|Period 2||2
8406588|NCT00975650|20719507|P1|NOT COMPLETED|Period 2||1
8406589|NCT00975650|20719504|P4|COMPLETED|Period 2||14
8406590|NCT00975650|20719505|P3|COMPLETED|Period 2||14
8406591|NCT00975650|20719506|P2|COMPLETED|Period 2||14
8406592|NCT00975650|20719507|P1|COMPLETED|Period 2||12
8406593|NCT00975650|20719504|P4|STARTED|Period 2||14
8406594|NCT00975650|20719505|P3|STARTED|Period 2||14
8406595|NCT00975650|20719506|P2|STARTED|Period 2||16
8406596|NCT00975650|20719507|P1|STARTED|Period 2||13
8406597|NCT00975650|20719504|P4|NOT COMPLETED|Period 1||0
8406598|NCT00975650|20719505|P3|NOT COMPLETED|Period 1||0
8406599|NCT00975650|20719506|P2|NOT COMPLETED|Period 1||0
8406600|NCT00975650|20719507|P1|NOT COMPLETED|Period 1||0
8406601|NCT00975650|20719504|P4|COMPLETED|Period 1||14
8406602|NCT00975650|20719505|P3|COMPLETED|Period 1||14
8406603|NCT00975650|20719506|P2|COMPLETED|Period 1||16
8406604|NCT00975650|20719507|P1|COMPLETED|Period 1||13
8406605|NCT00975650|20719504|P4|STARTED|Period 1||14
8406606|NCT00975650|20719505|P3|STARTED|Period 1||14
8406607|NCT00975650|20719506|P2|STARTED|Period 1||16
8406608|NCT00975650|20719507|P1|STARTED|Period 1||13
8406609|NCT00975637|20719546|P5|NOT COMPLETED|Overall Study||2
8406610|NCT00975637|20719547|P4|NOT COMPLETED|Overall Study||6
8406611|NCT00975637|20719548|P3|NOT COMPLETED|Overall Study||2
8406612|NCT00975637|20719549|P2|NOT COMPLETED|Overall Study||1
8406613|NCT00975637|20719550|P1|NOT COMPLETED|Overall Study||3
8406614|NCT00975637|20719546|P5|COMPLETED|Overall Study||37
8406615|NCT00975637|20719547|P4|COMPLETED|Overall Study||32
8406616|NCT00975637|20719548|P3|COMPLETED|Overall Study||40
8406617|NCT00975637|20719549|P2|COMPLETED|Overall Study||38
8406618|NCT00975637|20719550|P1|COMPLETED|Overall Study||37
8406619|NCT00975637|20719546|P5|STARTED|Overall Study||39
8406620|NCT00975637|20719547|P4|STARTED|Overall Study||38
8406621|NCT00975637|20719548|P3|STARTED|Overall Study||42
8406622|NCT00975637|20719549|P2|STARTED|Overall Study||39
8406623|NCT00975637|20719550|P1|STARTED|Overall Study||40
8406624|NCT00975611|20719567|P1|NOT COMPLETED|Overall Study||17
8406625|NCT00975611|20719567|P1|COMPLETED|Overall Study||5
8406626|NCT00975611|20719567|P1|STARTED|Overall Study||22
8406627|NCT00975585|20719573|P2|NOT COMPLETED|Overall Study||12
8406628|NCT00975585|20719574|P1|NOT COMPLETED|Overall Study||7
8406629|NCT00975585|20719573|P2|COMPLETED|Overall Study||183
8406630|NCT00975585|20719574|P1|COMPLETED|Overall Study||177
8406631|NCT00975585|20719573|P2|STARTED|Overall Study||195
8406632|NCT00975585|20719574|P1|STARTED|Overall Study||184
8406633|NCT00975507|20719594|P2|NOT COMPLETED|Overall Study||4
8406634|NCT00975507|20719595|P1|NOT COMPLETED|Overall Study||20
8406635|NCT00975507|20719594|P2|COMPLETED|Overall Study||153
8406636|NCT00975507|20719595|P1|COMPLETED|Overall Study||303
8406637|NCT00975507|20719594|P2|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
8406638|NCT00975507|20719595|P1|Vaccinated at Visit 2|Overall Study||310
8406639|NCT00975507|20719594|P2|Vaccinated at Visit 1|Overall Study||157
8406640|NCT00975507|20719595|P1|Vaccinated at Visit 1|Overall Study||323
8406641|NCT00975507|20719594|P2|STARTED|Overall Study||157
8406642|NCT00975507|20719595|P1|STARTED|Overall Study||323
8406643|NCT00975481|20719615|P6|NOT COMPLETED|Sixth Intervention Period||0
8406644|NCT00975481|20719616|P5|NOT COMPLETED|Sixth Intervention Period||0
8406645|NCT00975481|20719617|P4|NOT COMPLETED|Sixth Intervention Period||0
8406646|NCT00975481|20719618|P3|NOT COMPLETED|Sixth Intervention Period||0
8406647|NCT00975481|20719619|P2|NOT COMPLETED|Sixth Intervention Period||0
8406648|NCT00975481|20719620|P1|NOT COMPLETED|Sixth Intervention Period||0
8406649|NCT00975481|20719615|P6|COMPLETED|Sixth Intervention Period||6
8406650|NCT00975481|20719616|P5|COMPLETED|Sixth Intervention Period||5
8406651|NCT00975481|20719617|P4|COMPLETED|Sixth Intervention Period||5
8406652|NCT00975481|20719618|P3|COMPLETED|Sixth Intervention Period||4
8406653|NCT00975481|20719619|P2|COMPLETED|Sixth Intervention Period||5
8406654|NCT00975481|20719620|P1|COMPLETED|Sixth Intervention Period||4
8406655|NCT00975481|20719615|P6|STARTED|Sixth Intervention Period||6
8406656|NCT00975481|20719616|P5|STARTED|Sixth Intervention Period||5
8406657|NCT00975481|20719617|P4|STARTED|Sixth Intervention Period||5
8406658|NCT00975481|20719618|P3|STARTED|Sixth Intervention Period||4
8406659|NCT00975481|20719619|P2|STARTED|Sixth Intervention Period||5
8406660|NCT00975481|20719620|P1|STARTED|Sixth Intervention Period||4
8406661|NCT00975481|20719615|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406662|NCT00975481|20719616|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406663|NCT00975481|20719617|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406664|NCT00975481|20719618|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406665|NCT00975481|20719619|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406666|NCT00975481|20719620|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406667|NCT00975481|20719615|P6|COMPLETED|Washout Period (at Least 7 Days)||6
8406668|NCT00975481|20719616|P5|COMPLETED|Washout Period (at Least 7 Days)||5
8406669|NCT00975481|20719617|P4|COMPLETED|Washout Period (at Least 7 Days)||5
8406670|NCT00975481|20719618|P3|COMPLETED|Washout Period (at Least 7 Days)||4
8406671|NCT00975481|20719619|P2|COMPLETED|Washout Period (at Least 7 Days)||5
8406672|NCT00975481|20719620|P1|COMPLETED|Washout Period (at Least 7 Days)||4
8406673|NCT00975481|20719615|P6|STARTED|Washout Period (at Least 7 Days)||6
8406674|NCT00975481|20719616|P5|STARTED|Washout Period (at Least 7 Days)||5
8406675|NCT00975481|20719617|P4|STARTED|Washout Period (at Least 7 Days)||5
8406676|NCT00975481|20719618|P3|STARTED|Washout Period (at Least 7 Days)||4
8406677|NCT00975481|20719619|P2|STARTED|Washout Period (at Least 7 Days)||5
8406678|NCT00975481|20719620|P1|STARTED|Washout Period (at Least 7 Days)||4
8406679|NCT00975481|20719615|P6|NOT COMPLETED|Fifth Intervention Period||0
8406680|NCT00975481|20719616|P5|NOT COMPLETED|Fifth Intervention Period||1
8406681|NCT00975481|20719617|P4|NOT COMPLETED|Fifth Intervention Period||0
8406682|NCT00975481|20719618|P3|NOT COMPLETED|Fifth Intervention Period||0
8406683|NCT00975481|20719619|P2|NOT COMPLETED|Fifth Intervention Period||0
8406684|NCT00975481|20719620|P1|NOT COMPLETED|Fifth Intervention Period||0
8406685|NCT00975481|20719615|P6|COMPLETED|Fifth Intervention Period||6
8406686|NCT00975481|20719616|P5|COMPLETED|Fifth Intervention Period||5
8406687|NCT00975481|20719617|P4|COMPLETED|Fifth Intervention Period||5
8406688|NCT00975481|20719618|P3|COMPLETED|Fifth Intervention Period||4
8406689|NCT00975481|20719619|P2|COMPLETED|Fifth Intervention Period||5
8406690|NCT00975481|20719620|P1|COMPLETED|Fifth Intervention Period||4
8406691|NCT00975481|20719615|P6|STARTED|Fifth Intervention Period||6
8406692|NCT00975481|20719616|P5|STARTED|Fifth Intervention Period||6
8406693|NCT00975481|20719617|P4|STARTED|Fifth Intervention Period||5
8406694|NCT00975481|20719618|P3|STARTED|Fifth Intervention Period||4
8406695|NCT00975481|20719619|P2|STARTED|Fifth Intervention Period||5
8406696|NCT00975481|20719620|P1|STARTED|Fifth Intervention Period||4
8406697|NCT00975481|20719615|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406698|NCT00975481|20719616|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406699|NCT00975481|20719617|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406700|NCT00975481|20719618|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406701|NCT00975481|20719619|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406702|NCT00975481|20719620|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406703|NCT00975481|20719615|P6|COMPLETED|Washout Period (at Least 7 Days)||6
8406704|NCT00975481|20719616|P5|COMPLETED|Washout Period (at Least 7 Days)||6
8406705|NCT00975481|20719617|P4|COMPLETED|Washout Period (at Least 7 Days)||5
8406706|NCT00975481|20719618|P3|COMPLETED|Washout Period (at Least 7 Days)||4
8406707|NCT00975481|20719619|P2|COMPLETED|Washout Period (at Least 7 Days)||5
8406708|NCT00975481|20719620|P1|COMPLETED|Washout Period (at Least 7 Days)||4
8406709|NCT00975481|20719615|P6|STARTED|Washout Period (at Least 7 Days)||6
8406710|NCT00975481|20719616|P5|STARTED|Washout Period (at Least 7 Days)||6
8406711|NCT00975481|20719617|P4|STARTED|Washout Period (at Least 7 Days)||5
8406712|NCT00975481|20719618|P3|STARTED|Washout Period (at Least 7 Days)||4
8406713|NCT00975481|20719619|P2|STARTED|Washout Period (at Least 7 Days)||5
8406714|NCT00975481|20719620|P1|STARTED|Washout Period (at Least 7 Days)||4
8406715|NCT00975481|20719615|P6|NOT COMPLETED|Fourth Intervention Period||0
8406716|NCT00975481|20719616|P5|NOT COMPLETED|Fourth Intervention Period||0
8406717|NCT00975481|20719617|P4|NOT COMPLETED|Fourth Intervention Period||1
8406718|NCT00975481|20719618|P3|NOT COMPLETED|Fourth Intervention Period||1
8406719|NCT00975481|20719619|P2|NOT COMPLETED|Fourth Intervention Period||0
8406720|NCT00975481|20719620|P1|NOT COMPLETED|Fourth Intervention Period||0
8406721|NCT00975481|20719615|P6|COMPLETED|Fourth Intervention Period||6
8406722|NCT00975481|20719616|P5|COMPLETED|Fourth Intervention Period||6
8406723|NCT00975481|20719617|P4|COMPLETED|Fourth Intervention Period||5
8406724|NCT00975481|20719618|P3|COMPLETED|Fourth Intervention Period||4
8406725|NCT00975481|20719619|P2|COMPLETED|Fourth Intervention Period||5
8406726|NCT00975481|20719620|P1|COMPLETED|Fourth Intervention Period||4
8406727|NCT00975481|20719615|P6|STARTED|Fourth Intervention Period||6
8406728|NCT00975481|20719616|P5|STARTED|Fourth Intervention Period||6
8406729|NCT00975481|20719617|P4|STARTED|Fourth Intervention Period||6
8406730|NCT00975481|20719618|P3|STARTED|Fourth Intervention Period||5
8406731|NCT00975481|20719619|P2|STARTED|Fourth Intervention Period||5
8406732|NCT00975481|20719620|P1|STARTED|Fourth Intervention Period||4
8406733|NCT00975481|20719615|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406734|NCT00975481|20719616|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406735|NCT00975481|20719617|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406736|NCT00975481|20719618|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406737|NCT00975481|20719619|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406738|NCT00975481|20719620|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406739|NCT00975481|20719615|P6|COMPLETED|Washout Period (at Least 7 Days)||6
8406740|NCT00975481|20719616|P5|COMPLETED|Washout Period (at Least 7 Days)||6
8406741|NCT00975481|20719617|P4|COMPLETED|Washout Period (at Least 7 Days)||6
8406742|NCT00975481|20719618|P3|COMPLETED|Washout Period (at Least 7 Days)||5
8406743|NCT00975481|20719619|P2|COMPLETED|Washout Period (at Least 7 Days)||5
8406744|NCT00975481|20719620|P1|COMPLETED|Washout Period (at Least 7 Days)||4
8406745|NCT00975481|20719615|P6|STARTED|Washout Period (at Least 7 Days)||6
8406746|NCT00975481|20719616|P5|STARTED|Washout Period (at Least 7 Days)||6
8406747|NCT00975481|20719617|P4|STARTED|Washout Period (at Least 7 Days)||6
8406748|NCT00975481|20719618|P3|STARTED|Washout Period (at Least 7 Days)||5
8406749|NCT00975481|20719619|P2|STARTED|Washout Period (at Least 7 Days)||5
8406750|NCT00975481|20719620|P1|STARTED|Washout Period (at Least 7 Days)||4
8406751|NCT00975481|20719615|P6|NOT COMPLETED|Third Intervention Period||0
8406752|NCT00975481|20719616|P5|NOT COMPLETED|Third Intervention Period||0
8406753|NCT00975481|20719617|P4|NOT COMPLETED|Third Intervention Period||0
8406754|NCT00975481|20719618|P3|NOT COMPLETED|Third Intervention Period||0
8406755|NCT00975481|20719619|P2|NOT COMPLETED|Third Intervention Period||0
8406756|NCT00975481|20719620|P1|NOT COMPLETED|Third Intervention Period||0
8406757|NCT00975481|20719615|P6|COMPLETED|Third Intervention Period||6
8406758|NCT00975481|20719616|P5|COMPLETED|Third Intervention Period||6
8406759|NCT00975481|20719617|P4|COMPLETED|Third Intervention Period||6
8406760|NCT00975481|20719618|P3|COMPLETED|Third Intervention Period||5
8406761|NCT00975481|20719619|P2|COMPLETED|Third Intervention Period||5
8406762|NCT00975481|20719620|P1|COMPLETED|Third Intervention Period||4
8406763|NCT00975481|20719615|P6|STARTED|Third Intervention Period||6
8406764|NCT00975481|20719616|P5|STARTED|Third Intervention Period||6
8406765|NCT00975481|20719617|P4|STARTED|Third Intervention Period||6
8406766|NCT00975481|20719618|P3|STARTED|Third Intervention Period||5
8406767|NCT00975481|20719619|P2|STARTED|Third Intervention Period||5
8406768|NCT00975481|20719620|P1|STARTED|Third Intervention Period||4
8406769|NCT00975481|20719615|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406770|NCT00975481|20719616|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406771|NCT00975481|20719617|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406772|NCT00975481|20719618|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406773|NCT00975481|20719619|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406774|NCT00975481|20719620|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406775|NCT00975481|20719615|P6|COMPLETED|Washout Period (at Least 7 Days)||6
8406776|NCT00975481|20719616|P5|COMPLETED|Washout Period (at Least 7 Days)||6
8406777|NCT00975481|20719617|P4|COMPLETED|Washout Period (at Least 7 Days)||6
8406778|NCT00975481|20719618|P3|COMPLETED|Washout Period (at Least 7 Days)||5
8406779|NCT00975481|20719619|P2|COMPLETED|Washout Period (at Least 7 Days)||5
8406780|NCT00975481|20719620|P1|COMPLETED|Washout Period (at Least 7 Days)||4
8406781|NCT00975481|20719615|P6|STARTED|Washout Period (at Least 7 Days)||6
8406782|NCT00975481|20719616|P5|STARTED|Washout Period (at Least 7 Days)||6
8406783|NCT00975481|20719617|P4|STARTED|Washout Period (at Least 7 Days)||6
8406784|NCT00975481|20719618|P3|STARTED|Washout Period (at Least 7 Days)||5
8406785|NCT00975481|20719619|P2|STARTED|Washout Period (at Least 7 Days)||5
8406786|NCT00975481|20719620|P1|STARTED|Washout Period (at Least 7 Days)||4
8406787|NCT00975481|20719615|P6|NOT COMPLETED|Second Intervention Period||0
8406788|NCT00975481|20719616|P5|NOT COMPLETED|Second Intervention Period||0
8406789|NCT00975481|20719617|P4|NOT COMPLETED|Second Intervention Period||0
8406790|NCT00975481|20719618|P3|NOT COMPLETED|Second Intervention Period||1
8406791|NCT00975481|20719619|P2|NOT COMPLETED|Second Intervention Period||1
8406792|NCT00975481|20719620|P1|NOT COMPLETED|Second Intervention Period||2
8406793|NCT00975481|20719615|P6|COMPLETED|Second Intervention Period||6
8406794|NCT00975481|20719616|P5|COMPLETED|Second Intervention Period||6
8406795|NCT00975481|20719617|P4|COMPLETED|Second Intervention Period||6
8406796|NCT00975481|20719618|P3|COMPLETED|Second Intervention Period||5
8406797|NCT00975481|20719619|P2|COMPLETED|Second Intervention Period||5
8406798|NCT00975481|20719620|P1|COMPLETED|Second Intervention Period||4
8406799|NCT00975481|20719615|P6|STARTED|Second Intervention Period||6
8406800|NCT00975481|20719616|P5|STARTED|Second Intervention Period||6
8406801|NCT00975481|20719617|P4|STARTED|Second Intervention Period||6
8406802|NCT00975481|20719618|P3|STARTED|Second Intervention Period||6
8406803|NCT00975481|20719619|P2|STARTED|Second Intervention Period||6
8406804|NCT00975481|20719620|P1|STARTED|Second Intervention Period||6
8406805|NCT00975481|20719615|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406806|NCT00975481|20719616|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406807|NCT00975481|20719617|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406808|NCT00975481|20719618|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406809|NCT00975481|20719619|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406810|NCT00975481|20719620|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8406811|NCT00975481|20719615|P6|COMPLETED|Washout Period (at Least 7 Days)||6
8406812|NCT00975481|20719616|P5|COMPLETED|Washout Period (at Least 7 Days)||6
8406813|NCT00975481|20719617|P4|COMPLETED|Washout Period (at Least 7 Days)||6
8406814|NCT00975481|20719618|P3|COMPLETED|Washout Period (at Least 7 Days)||6
8406815|NCT00975481|20719619|P2|COMPLETED|Washout Period (at Least 7 Days)||6
8406816|NCT00975481|20719620|P1|COMPLETED|Washout Period (at Least 7 Days)||6
8406817|NCT00975481|20719615|P6|STARTED|Washout Period (at Least 7 Days)||6
8406818|NCT00975481|20719616|P5|STARTED|Washout Period (at Least 7 Days)||6
8406819|NCT00975481|20719617|P4|STARTED|Washout Period (at Least 7 Days)||6
8406820|NCT00975481|20719618|P3|STARTED|Washout Period (at Least 7 Days)||6
8406821|NCT00975481|20719619|P2|STARTED|Washout Period (at Least 7 Days)||6
8406822|NCT00975481|20719620|P1|STARTED|Washout Period (at Least 7 Days)||6
8406823|NCT00975481|20719615|P6|NOT COMPLETED|First Intervention Period||0
8406824|NCT00975481|20719616|P5|NOT COMPLETED|First Intervention Period||0
8406825|NCT00975481|20719617|P4|NOT COMPLETED|First Intervention Period||0
8406826|NCT00975481|20719618|P3|NOT COMPLETED|First Intervention Period||0
8406827|NCT00975481|20719619|P2|NOT COMPLETED|First Intervention Period||0
8406828|NCT00975481|20719620|P1|NOT COMPLETED|First Intervention Period||0
8406829|NCT00975481|20719615|P6|COMPLETED|First Intervention Period||6
8406830|NCT00975481|20719616|P5|COMPLETED|First Intervention Period||6
8406831|NCT00975481|20719617|P4|COMPLETED|First Intervention Period||6
8406832|NCT00975481|20719618|P3|COMPLETED|First Intervention Period||6
8406833|NCT00975481|20719619|P2|COMPLETED|First Intervention Period||6
8406834|NCT00975481|20719620|P1|COMPLETED|First Intervention Period||6
8406835|NCT00975481|20719615|P6|STARTED|First Intervention Period||6
8406836|NCT00975481|20719616|P5|STARTED|First Intervention Period||6
8406837|NCT00975481|20719617|P4|STARTED|First Intervention Period||6
8406838|NCT00975481|20719618|P3|STARTED|First Intervention Period||6
8406839|NCT00975481|20719619|P2|STARTED|First Intervention Period||6
8406840|NCT00975481|20719620|P1|STARTED|First Intervention Period||6
8406841|NCT00975416|20719720|P2|NOT COMPLETED|Overall Study||5
8406842|NCT00975416|20719721|P1|NOT COMPLETED|Overall Study||3
8406843|NCT00975416|20719720|P2|COMPLETED|Overall Study||11
8406844|NCT00975416|20719721|P1|COMPLETED|Overall Study||11
8406845|NCT00975416|20719720|P2|STARTED|Overall Study||16
8406846|NCT00975416|20719721|P1|STARTED|Overall Study||14
8406847|NCT00975286|20719730|P2|NOT COMPLETED|Overall Study||29
8406848|NCT00975286|20719731|P1|NOT COMPLETED|Overall Study||12
8406849|NCT00975286|20719730|P2|COMPLETED|Overall Study||194
8406850|NCT00975286|20719731|P1|COMPLETED|Overall Study||211
8406851|NCT00975286|20719730|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||223
8406852|NCT00975286|20719731|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
8406853|NCT00975286|20719730|P2|Safety Population|Overall Study||223
8406854|NCT00975286|20719731|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
8406855|NCT00975286|20719730|P2|STARTED|Overall Study||223
8406856|NCT00975286|20719731|P1|STARTED|Overall Study|Randomized.|223
8406857|NCT00975221|20719763|P2|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
8406858|NCT00975221|20719764|P1|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
8406859|NCT00975221|20719763|P2|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
8406860|NCT00975221|20719764|P1|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
8406861|NCT00975221|20719763|P2|STARTED|Open-label Extension Phase (Weeks 29-52)||28
8406862|NCT00975221|20719764|P1|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
8406863|NCT00975221|20719763|P2|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
8406864|NCT00975221|20719764|P1|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
8406865|NCT00975221|20719763|P2|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
8406866|NCT00975221|20719764|P1|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
8406867|NCT00975221|20719763|P2|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
8406868|NCT00975221|20719764|P1|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
8406869|NCT00975221|20719763|P2|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
8406870|NCT00975221|20719764|P1|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
8406871|NCT00975221|20719763|P2|COMPLETED|Titration Phase (Weeks 1-12)||29
8406872|NCT00975221|20719764|P1|COMPLETED|Titration Phase (Weeks 1-12)||31
8406873|NCT00975221|20719763|P2|Received Study Drug|Titration Phase (Weeks 1-12)||33
8406874|NCT00975221|20719764|P1|Received Study Drug|Titration Phase (Weeks 1-12)||34
8406875|NCT00975221|20719763|P2|STARTED|Titration Phase (Weeks 1-12)||33
8406876|NCT00975221|20719764|P1|STARTED|Titration Phase (Weeks 1-12)||34
8406877|NCT00975195|20719780|P2|NOT COMPLETED|Overall Study||233
8406878|NCT00975195|20719781|P1|NOT COMPLETED|Overall Study||228
8406879|NCT00975195|20719780|P2|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
8406880|NCT00975195|20719781|P1|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
8406881|NCT00975195|20719780|P2|STARTED|Overall Study||1244
8406882|NCT00975195|20719781|P1|STARTED|Overall Study||1244
8406883|NCT00975156|20719841|P2|NOT COMPLETED|Overall Study||1
8406884|NCT00975156|20719842|P1|NOT COMPLETED|Overall Study||0
8406885|NCT00975156|20719841|P2|COMPLETED|Overall Study||9
8406886|NCT00975156|20719842|P1|COMPLETED|Overall Study||11
8406887|NCT00975156|20719841|P2|STARTED|Overall Study||10
8406888|NCT00975156|20719842|P1|STARTED|Overall Study||11
8406889|NCT00975143|20719854|P2|NOT COMPLETED|Overall Study||60
8406890|NCT00975143|20719855|P1|NOT COMPLETED|Overall Study||70
8406891|NCT00975143|20719854|P2|COMPLETED|Overall Study||401
8406892|NCT00975143|20719855|P1|COMPLETED|Overall Study||394
8406893|NCT00975143|20719854|P2|Completed Treatment (Week 20)|Overall Study||410
8406894|NCT00975143|20719855|P1|Completed Treatment (Week 20)|Overall Study||403
8406895|NCT00975143|20719854|P2|STARTED|Overall Study||461
8406896|NCT00975143|20719855|P1|STARTED|Overall Study||464
8406897|NCT00975130|20719865|P3|NOT COMPLETED|Study Part 2||17
8406898|NCT00975130|20719866|P2|NOT COMPLETED|Study Part 2||38
8406899|NCT00975130|20719867|P1|NOT COMPLETED|Study Part 2||0
8406900|NCT00975130|20719865|P3|COMPLETED|Study Part 2||238
8406901|NCT00975130|20719866|P2|COMPLETED|Study Part 2||212
8406902|NCT00975130|20719867|P1|COMPLETED|Study Part 2||0
8406903|NCT00975130|20719865|P3|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
8406904|NCT00975130|20719866|P2|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
8406905|NCT00975130|20719867|P1|STARTED|Study Part 2||0
8406906|NCT00975130|20719865|P3|NOT COMPLETED|Study Part 1||0
8406907|NCT00975130|20719866|P2|NOT COMPLETED|Study Part 1||0
8406908|NCT00975130|20719867|P1|NOT COMPLETED|Study Part 1||280
8406909|NCT00975130|20719865|P3|COMPLETED|Study Part 1||0
8406910|NCT00975130|20719866|P2|COMPLETED|Study Part 1||0
8406911|NCT00975130|20719867|P1|COMPLETED|Study Part 1||3086
8406912|NCT00975130|20719865|P3|STARTED|Study Part 1||0
8406913|NCT00975130|20719866|P2|STARTED|Study Part 1||0
8406914|NCT00975130|20719867|P1|STARTED|Study Part 1||3366
8406915|NCT00975000|20720051|P2|NOT COMPLETED|Overall Study||5
8406916|NCT00975000|20720052|P1|NOT COMPLETED|Overall Study||5
8406917|NCT00975000|20720051|P2|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
8406918|NCT00975000|20720052|P1|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
8406919|NCT00975000|20720051|P2|Completed Maintenance Phase|Overall Study||52
8406920|NCT00975000|20720052|P1|Completed Maintenance Phase|Overall Study||52
8406921|NCT00975000|20720051|P2|Completed Efficacy Assessment Phase|Overall Study||54
8406922|NCT00975000|20720052|P1|Completed Efficacy Assessment Phase|Overall Study||54
8406923|NCT00975000|20720051|P2|Completed Titration Phase|Overall Study||55
8406924|NCT00975000|20720052|P1|Completed Titration Phase|Overall Study||54
8406925|NCT00975000|20720051|P2|STARTED|Overall Study||57
8406926|NCT00975000|20720052|P1|STARTED|Overall Study||57
8406927|NCT00974974|20720076|P2|NOT COMPLETED|Maintenance - Double Blind Treatment||10
8406928|NCT00974974|20720077|P1|NOT COMPLETED|Maintenance - Double Blind Treatment||15
8406929|NCT00974974|20720076|P2|COMPLETED|Maintenance - Double Blind Treatment||182
8406930|NCT00974974|20720077|P1|COMPLETED|Maintenance - Double Blind Treatment||186
8406931|NCT00974974|20720076|P2|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
8406932|NCT00974974|20720077|P1|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
8406933|NCT00974974|20720076|P2|NOT COMPLETED|IPX066 Dose Conversion||0
8406934|NCT00974974|20720077|P1|NOT COMPLETED|IPX066 Dose Conversion||57
8406935|NCT00974974|20720076|P2|COMPLETED|IPX066 Dose Conversion||0
8406936|NCT00974974|20720077|P1|COMPLETED|IPX066 Dose Conversion||393
8406937|NCT00974974|20720076|P2|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
8406938|NCT00974974|20720077|P1|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
8406939|NCT00974974|20720076|P2|NOT COMPLETED|IR CD-LD Dose Adjustment||21
8406940|NCT00974974|20720077|P1|NOT COMPLETED|IR CD-LD Dose Adjustment||0
8406941|NCT00974974|20720076|P2|COMPLETED|IR CD-LD Dose Adjustment||450
8406942|NCT00974974|20720077|P1|COMPLETED|IR CD-LD Dose Adjustment||0
8406943|NCT00974974|20720076|P2|STARTED|IR CD-LD Dose Adjustment||471
8406944|NCT00974974|20720077|P1|STARTED|IR CD-LD Dose Adjustment||0
8406945|NCT00974922|20720087|P1|NOT COMPLETED|Overall Study||24
8406946|NCT00974922|20720087|P1|COMPLETED|Overall Study||16
8406947|NCT00974922|20720087|P1|STARTED|Overall Study||40
8406948|NCT00974818|20720094|P2|NOT COMPLETED|Overall Study||0
8406949|NCT00974818|20720095|P1|NOT COMPLETED|Overall Study||0
8406950|NCT00974818|20720094|P2|COMPLETED|Overall Study||25
8406951|NCT00974818|20720095|P1|COMPLETED|Overall Study||25
8406952|NCT00974818|20720094|P2|STARTED|Overall Study||25
8406953|NCT00974818|20720095|P1|STARTED|Overall Study||25
8406954|NCT00974675|20720105|P4|NOT COMPLETED|Overall Study||2
8406955|NCT00974675|20720106|P3|NOT COMPLETED|Overall Study||2
8406956|NCT00974675|20720107|P2|NOT COMPLETED|Overall Study||1
8406957|NCT00974675|20720108|P1|NOT COMPLETED|Overall Study||2
8406958|NCT00974675|20720105|P4|COMPLETED|Overall Study||2
8406959|NCT00974675|20720106|P3|COMPLETED|Overall Study||1
8406960|NCT00974675|20720107|P2|COMPLETED|Overall Study||7
8406961|NCT00974675|20720108|P1|COMPLETED|Overall Study||6
8406962|NCT00974675|20720105|P4|STARTED|Overall Study||4
8406963|NCT00974675|20720106|P3|STARTED|Overall Study||3
8406964|NCT00974675|20720107|P2|STARTED|Overall Study||8
8406965|NCT00974675|20720108|P1|STARTED|Overall Study||8
8406966|NCT00974571|20720157|P3|NOT COMPLETED|Overall Study||83
8406967|NCT00974571|20720158|P2|NOT COMPLETED|Overall Study||16
8406968|NCT00974571|20720159|P1|NOT COMPLETED|Overall Study||68
8406969|NCT00974571|20720157|P3|COMPLETED|Overall Study||530
8406970|NCT00974571|20720158|P2|COMPLETED|Overall Study||106
8406971|NCT00974571|20720159|P1|COMPLETED|Overall Study||562
8406972|NCT00974571|20720157|P3|STARTED|Overall Study||613
8406973|NCT00974571|20720158|P2|STARTED|Overall Study||122
8406974|NCT00974571|20720159|P1|STARTED|Overall Study||630
8406975|NCT00974493|20720181|P2|NOT COMPLETED|Overall Study||21
8406976|NCT00974493|20720182|P1|NOT COMPLETED|Overall Study||18
8406977|NCT00974493|20720181|P2|COMPLETED|Overall Study||506
8406978|NCT00974493|20720182|P1|COMPLETED|Overall Study||509
8406979|NCT00974493|20720181|P2|STARTED|Overall Study||527
8406980|NCT00974493|20720182|P1|STARTED|Overall Study||527
8406981|NCT00974480|20720191|P3|NOT COMPLETED|Overall Study||10
8406982|NCT00974480|20720192|P2|NOT COMPLETED|Overall Study||7
8406983|NCT00974480|20720193|P1|NOT COMPLETED|Overall Study||11
8406984|NCT00974480|20720191|P3|COMPLETED|Overall Study||30
8406985|NCT00974480|20720192|P2|COMPLETED|Overall Study||33
8406986|NCT00974480|20720193|P1|COMPLETED|Overall Study||29
8406987|NCT00974480|20720191|P3|STARTED|Overall Study||40
8406988|NCT00974480|20720192|P2|STARTED|Overall Study||40
8406989|NCT00974480|20720193|P1|STARTED|Overall Study||40
8406990|NCT00974376|20720233|P2|NOT COMPLETED|Overall Study||33
8406991|NCT00974376|20720234|P1|NOT COMPLETED|Overall Study||34
8406992|NCT00974376|20720233|P2|COMPLETED|Overall Study||42
8406993|NCT00974376|20720234|P1|COMPLETED|Overall Study||41
8406994|NCT00974376|20720233|P2|STARTED|Overall Study||75
8406995|NCT00974376|20720234|P1|STARTED|Overall Study||75
8406996|NCT00974363|20720242|P2|NOT COMPLETED|Overall Study||0
8406997|NCT00974363|20720243|P1|NOT COMPLETED|Overall Study||0
8406998|NCT00974363|20720242|P2|COMPLETED|Overall Study||168
8406999|NCT00974363|20720243|P1|COMPLETED|Overall Study||521
8407000|NCT00974363|20720242|P2|STARTED|Overall Study||168
8407001|NCT00974363|20720243|P1|STARTED|Overall Study||521
8407002|NCT00974311|20720265|P2|NOT COMPLETED|OLE Phase (up to 77 Months)||50
8407003|NCT00974311|20720266|P1|NOT COMPLETED|OLE Phase (up to 77 Months)||109
8407004|NCT00974311|20720265|P2|COMPLETED|OLE Phase (up to 77 Months)||0
8407005|NCT00974311|20720266|P1|COMPLETED|OLE Phase (up to 77 Months)||0
8407006|NCT00974311|20720265|P2|STARTED|OLE Phase (up to 77 Months)||50
8407007|NCT00974311|20720266|P1|STARTED|OLE Phase (up to 77 Months)||109
8407008|NCT00974311|20720265|P2|NOT COMPLETED|DB Phase (up to 24 Months)||349
8407009|NCT00974311|20720266|P1|NOT COMPLETED|DB Phase (up to 24 Months)||691
8407010|NCT00974311|20720265|P2|COMPLETED|DB Phase (up to 24 Months)||50
8407011|NCT00974311|20720266|P1|COMPLETED|DB Phase (up to 24 Months)||109
8407012|NCT00974311|20720265|P2|STARTED|DB Phase (up to 24 Months)||399
8407013|NCT00974311|20720266|P1|STARTED|DB Phase (up to 24 Months)||800
8407014|NCT00974259|20720304|P2|NOT COMPLETED|Overall Study||1
8407015|NCT00974259|20720305|P1|NOT COMPLETED|Overall Study||2
8407016|NCT00974259|20720304|P2|COMPLETED|Overall Study||62
8407017|NCT00974259|20720305|P1|COMPLETED|Overall Study||57
8407018|NCT00974259|20720304|P2|STARTED|Overall Study||63
8407019|NCT00974259|20720305|P1|STARTED|Overall Study||59
8407020|NCT00974246|20720317|P1|NOT COMPLETED|Overall Study||0
8407021|NCT00974246|20720317|P1|COMPLETED|Overall Study||27
8407022|NCT00974246|20720317|P1|STARTED|Overall Study||27
8407023|NCT00974233|20720323|P1|NOT COMPLETED|Maintenance Lenalidomide||13
8407024|NCT00974233|20720323|P1|COMPLETED|Maintenance Lenalidomide||6
8407025|NCT00974233|20720323|P1|STARTED|Maintenance Lenalidomide||19
8407026|NCT00974233|20720323|P1|NOT COMPLETED|Induction Chemoimmunotherapy||15
8407027|NCT00974233|20720323|P1|COMPLETED|Induction Chemoimmunotherapy||19
8407028|NCT00974233|20720323|P1|STARTED|Induction Chemoimmunotherapy||34
8407029|NCT00974220|20720338|P2|NOT COMPLETED|Treatment Period 2||0
8407030|NCT00974220|20720339|P1|NOT COMPLETED|Treatment Period 2||0
8407031|NCT00974220|20720338|P2|COMPLETED|Treatment Period 2||5
8407032|NCT00974220|20720339|P1|COMPLETED|Treatment Period 2||7
8407033|NCT00974220|20720338|P2|STARTED|Treatment Period 2||5
8407034|NCT00974220|20720339|P1|STARTED|Treatment Period 2||7
8407035|NCT00974220|20720338|P2|NOT COMPLETED|Treatment Period 1||2
8407036|NCT00974220|20720339|P1|NOT COMPLETED|Treatment Period 1||2
8407037|NCT00974220|20720338|P2|COMPLETED|Treatment Period 1||5
8407038|NCT00974220|20720339|P1|COMPLETED|Treatment Period 1||7
8407039|NCT00974220|20720338|P2|STARTED|Treatment Period 1||7
8407040|NCT00974220|20720339|P1|STARTED|Treatment Period 1||9
8407041|NCT00974142|20720349|P2|NOT COMPLETED|Overall Study||0
8407042|NCT00974142|20720350|P1|NOT COMPLETED|Overall Study||0
8407043|NCT00974142|20720349|P2|COMPLETED|Overall Study||9
8407044|NCT00974142|20720350|P1|COMPLETED|Overall Study||8
8407045|NCT00974142|20720349|P2|STARTED|Overall Study||9
8407046|NCT00974142|20720350|P1|STARTED|Overall Study||8
8407047|NCT00974090|20720384|P2|NOT COMPLETED|Period 2: Open-label Period||10
8407048|NCT00974090|20720385|P1|NOT COMPLETED|Period 2: Open-label Period||8
8407049|NCT00974090|20720384|P2|COMPLETED|Period 2: Open-label Period||85
8407050|NCT00974090|20720385|P1|COMPLETED|Period 2: Open-label Period||87
8407051|NCT00974090|20720384|P2|STARTED|Period 2: Open-label Period||95
8407052|NCT00974090|20720385|P1|STARTED|Period 2: Open-label Period||95
8407053|NCT00974090|20720384|P2|NOT COMPLETED|Period 1: Double Blind Period||1
8407054|NCT00974090|20720385|P1|NOT COMPLETED|Period 1: Double Blind Period||3
8407055|NCT00974090|20720384|P2|COMPLETED|Period 1: Double Blind Period||95
8407056|NCT00974090|20720385|P1|COMPLETED|Period 1: Double Blind Period||95
8407057|NCT00974090|20720384|P2|STARTED|Period 1: Double Blind Period||96
8407058|NCT00974090|20720385|P1|STARTED|Period 1: Double Blind Period||98
8407059|NCT00974051|20720399|P3|NOT COMPLETED|Overall Study||0
8407060|NCT00974051|20720400|P2|NOT COMPLETED|Overall Study||0
8407061|NCT00974051|20720401|P1|NOT COMPLETED|Overall Study||0
8407062|NCT00974051|20720399|P3|COMPLETED|Overall Study||6
8407063|NCT00974051|20720400|P2|COMPLETED|Overall Study||4
8407064|NCT00974051|20720401|P1|COMPLETED|Overall Study||6
8407065|NCT00974051|20720399|P3|STARTED|Overall Study||6
8407066|NCT00974051|20720400|P2|STARTED|Overall Study||4
8407067|NCT00974051|20720401|P1|STARTED|Overall Study||6
8407068|NCT00973973|20720421|P2|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
8407069|NCT00973973|20720422|P1|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
8407070|NCT00973973|20720421|P2|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
8407071|NCT00973973|20720422|P1|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
8407072|NCT00973973|20720421|P2|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
8407073|NCT00973973|20720422|P1|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
8407074|NCT00973973|20720421|P2|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
8407075|NCT00973973|20720422|P1|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
8407076|NCT00973973|20720421|P2|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
8407077|NCT00973973|20720422|P1|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
8407078|NCT00973973|20720421|P2|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
8407079|NCT00973973|20720422|P1|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
8407080|NCT00973973|20720421|P2|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
8407081|NCT00973973|20720422|P1|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
8407082|NCT00973921|20720482|P1|NOT COMPLETED|Overall Study||9
8407083|NCT00973921|20720482|P1|COMPLETED|Overall Study||31
8407084|NCT00973921|20720482|P1|STARTED|Overall Study||40
8407085|NCT00973856|20720491|P2|NOT COMPLETED|Overall Study||0
8407086|NCT00973856|20720492|P1|NOT COMPLETED|Overall Study||0
8407087|NCT00973856|20720491|P2|COMPLETED|Overall Study||2
8407088|NCT00973856|20720492|P1|COMPLETED|Overall Study||3
8407089|NCT00973856|20720491|P2|STARTED|Overall Study||2
8407090|NCT00973856|20720492|P1|STARTED|Overall Study||3
8407091|NCT00973765|20720499|P2|NOT COMPLETED|Overall Study||14
8407092|NCT00973765|20720500|P1|NOT COMPLETED|Overall Study||8
8407093|NCT00973765|20720499|P2|COMPLETED|Overall Study|102|102
8407094|NCT00973765|20720500|P1|COMPLETED|Overall Study|88|88
8407095|NCT00973765|20720499|P2|STARTED|Overall Study|116|116
8407096|NCT00973765|20720500|P1|STARTED|Overall Study|96|96
8407097|NCT00973752|20720506|P1|NOT COMPLETED|Overall Study||0
8407098|NCT00973752|20720506|P1|COMPLETED|Overall Study||30
8407099|NCT00973752|20720506|P1|STARTED|Overall Study||30
8407100|NCT00973739|20720510|P1|NOT COMPLETED|Overall Study||4
8407101|NCT00973739|20720510|P1|COMPLETED|Overall Study||17
8407102|NCT00973739|20720510|P1|STARTED|Overall Study||21
8407103|NCT00973700|20720522|P5|NOT COMPLETED|Overall Study||10
8407104|NCT00973700|20720523|P4|NOT COMPLETED|Overall Study||18
8407105|NCT00973700|20720524|P3|NOT COMPLETED|Overall Study||10
8407106|NCT00973700|20720525|P2|NOT COMPLETED|Overall Study||2
8407107|NCT00973700|20720526|P1|NOT COMPLETED|Overall Study||7
8407108|NCT00973700|20720522|P5|COMPLETED|Overall Study||158
8407109|NCT00973700|20720523|P4|COMPLETED|Overall Study||318
8407110|NCT00973700|20720524|P3|COMPLETED|Overall Study||158
8407111|NCT00973700|20720525|P2|COMPLETED|Overall Study||54
8407112|NCT00973700|20720526|P1|COMPLETED|Overall Study||49
8407113|NCT00973700|20720522|P5|STARTED|Overall Study||168
8407114|NCT00973700|20720523|P4|STARTED|Overall Study||336
8407115|NCT00973700|20720524|P3|STARTED|Overall Study||168
8407116|NCT00973700|20720525|P2|STARTED|Overall Study||56
8407117|NCT00973700|20720526|P1|STARTED|Overall Study||56
8407118|NCT00973674|20720575|P2|NOT COMPLETED|Overall Study||0
8407119|NCT00973674|20720576|P1|NOT COMPLETED|Overall Study||2
8407120|NCT00973674|20720575|P2|COMPLETED|Overall Study||26
8407121|NCT00973674|20720576|P1|COMPLETED|Overall Study||22
8407122|NCT00973674|20720575|P2|STARTED|Overall Study||26
8407123|NCT00973674|20720576|P1|STARTED|Overall Study||24
8407124|NCT00973622|20720590|P2|NOT COMPLETED|Overall Study||5
8407125|NCT00973622|20720591|P1|NOT COMPLETED|Overall Study||31
8407126|NCT00973622|20720590|P2|COMPLETED|Overall Study|Completed three sessions of rTMS|14
8407127|NCT00973622|20720591|P1|COMPLETED|Overall Study|Completed three sessions of rTMS|16
8407128|NCT00973622|20720590|P2|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
8407129|NCT00973622|20720591|P1|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
8407130|NCT00973479|20720599|P2|NOT COMPLETED|Overall Study||69
8407131|NCT00973479|20720600|P1|NOT COMPLETED|Overall Study||37
8407132|NCT00973479|20720599|P2|COMPLETED|Overall Study||326
8407133|NCT00973479|20720600|P1|COMPLETED|Overall Study||160
8407134|NCT00973479|20720599|P2|STARTED|Overall Study||395
8407135|NCT00973479|20720600|P1|STARTED|Overall Study||197
8407136|NCT00973362|20720618|P2|NOT COMPLETED|3-Year Follow-up||0
8407137|NCT00973362|20720619|P1|NOT COMPLETED|3-Year Follow-up||17
8407138|NCT00973362|20720618|P2|COMPLETED|3-Year Follow-up||0
8407139|NCT00973362|20720619|P1|COMPLETED|3-Year Follow-up||10854
8407140|NCT00973362|20720618|P2|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
8407141|NCT00973362|20720619|P1|STARTED|3-Year Follow-up||10871
8407142|NCT00973362|20720618|P2|NOT COMPLETED|Baseline Evaluation||223
8407143|NCT00973362|20720619|P1|NOT COMPLETED|Baseline Evaluation||773
8407144|NCT00973362|20720618|P2|COMPLETED|Baseline Evaluation||1029
8407145|NCT00973362|20720619|P1|COMPLETED|Baseline Evaluation||10871
8407146|NCT00973362|20720618|P2|Conclusive Disease Status|Baseline Evaluation||939
8407147|NCT00973362|20720619|P1|Conclusive Disease Status|Baseline Evaluation||819
8407148|NCT00973362|20720618|P2|Evaluable for Analysis|Baseline Evaluation||958
8407149|NCT00973362|20720619|P1|Evaluable for Analysis|Baseline Evaluation||10871
8407150|NCT00973362|20720618|P2|STARTED|Baseline Evaluation||1252
8407151|NCT00973362|20720619|P1|STARTED|Baseline Evaluation||11644
8407152|NCT00973349|20720644|P16|NOT COMPLETED|Overall Study||2
8407153|NCT00973349|20720645|P15|NOT COMPLETED|Overall Study||2
8407154|NCT00973349|20720646|P14|NOT COMPLETED|Overall Study||0
8407155|NCT00973349|20720647|P13|NOT COMPLETED|Overall Study||1
8407156|NCT00973349|20720648|P12|NOT COMPLETED|Overall Study||2
8407157|NCT00973349|20720649|P11|NOT COMPLETED|Overall Study||0
8407158|NCT00973349|20720650|P10|NOT COMPLETED|Overall Study||6
8407159|NCT00973349|20720651|P9|NOT COMPLETED|Overall Study||4
8407160|NCT00973349|20720652|P8|NOT COMPLETED|Overall Study||3
8407161|NCT00973349|20720653|P7|NOT COMPLETED|Overall Study||2
8407162|NCT00973349|20720654|P6|NOT COMPLETED|Overall Study||4
8407163|NCT00973349|20720655|P5|NOT COMPLETED|Overall Study||5
8407164|NCT00973349|20720656|P4|NOT COMPLETED|Overall Study||5
8407165|NCT00973349|20720657|P3|NOT COMPLETED|Overall Study||5
8407166|NCT00973349|20720658|P2|NOT COMPLETED|Overall Study||3
8407167|NCT00973349|20720659|P1|NOT COMPLETED|Overall Study||4
8407168|NCT00973349|20720644|P16|COMPLETED|Overall Study||165
8407169|NCT00973349|20720645|P15|COMPLETED|Overall Study||168
8407170|NCT00973349|20720646|P14|COMPLETED|Overall Study||171
8407171|NCT00973349|20720647|P13|COMPLETED|Overall Study||168
8407172|NCT00973349|20720648|P12|COMPLETED|Overall Study||167
8407173|NCT00973349|20720649|P11|COMPLETED|Overall Study||174
8407174|NCT00973349|20720650|P10|COMPLETED|Overall Study||163
8407175|NCT00973349|20720651|P9|COMPLETED|Overall Study||167
8407176|NCT00973349|20720652|P8|COMPLETED|Overall Study||166
8407177|NCT00973349|20720653|P7|COMPLETED|Overall Study||172
8407178|NCT00973349|20720654|P6|COMPLETED|Overall Study||165
8407179|NCT00973349|20720655|P5|COMPLETED|Overall Study||165
8407180|NCT00973349|20720656|P4|COMPLETED|Overall Study||163
8407181|NCT00973349|20720657|P3|COMPLETED|Overall Study||166
8407182|NCT00973349|20720658|P2|COMPLETED|Overall Study||165
8407183|NCT00973349|20720659|P1|COMPLETED|Overall Study||166
8407184|NCT00973349|20720644|P16|STARTED|Overall Study||167
8407185|NCT00973349|20720645|P15|STARTED|Overall Study||170
8407186|NCT00973349|20720646|P14|STARTED|Overall Study||171
8407187|NCT00973349|20720647|P13|STARTED|Overall Study||169
8407188|NCT00973349|20720648|P12|STARTED|Overall Study||169
8407189|NCT00973349|20720649|P11|STARTED|Overall Study||174
8407190|NCT00973349|20720650|P10|STARTED|Overall Study||169
8407191|NCT00973349|20720651|P9|STARTED|Overall Study||171
8407192|NCT00973349|20720652|P8|STARTED|Overall Study||169
8407193|NCT00973349|20720653|P7|STARTED|Overall Study||174
8407194|NCT00973349|20720654|P6|STARTED|Overall Study||169
8407195|NCT00973349|20720655|P5|STARTED|Overall Study||170
8407196|NCT00973349|20720656|P4|STARTED|Overall Study||168
8407197|NCT00973349|20720657|P3|STARTED|Overall Study||171
8407198|NCT00973349|20720658|P2|STARTED|Overall Study||168
8407199|NCT00973349|20720659|P1|STARTED|Overall Study||170
8407200|NCT00973102|20720759|P2|NOT COMPLETED|Overall Study||1
8407201|NCT00973102|20720760|P1|NOT COMPLETED|Overall Study||1
8407202|NCT00973102|20720759|P2|COMPLETED|Overall Study||25
8407203|NCT00973102|20720760|P1|COMPLETED|Overall Study||23
8407204|NCT00973102|20720759|P2|STARTED|Overall Study||26
8407205|NCT00973102|20720760|P1|STARTED|Overall Study||24
8407206|NCT00972959|20720768|P1|NOT COMPLETED|Overall Study||0
8407207|NCT00972959|20720768|P1|COMPLETED|Overall Study||17
8407208|NCT00972959|20720768|P1|STARTED|Overall Study||17
8407209|NCT00972816|20720791|P8|NOT COMPLETED|Overall Study||9
8407210|NCT00972816|20720792|P7|NOT COMPLETED|Overall Study||10
8407211|NCT00972816|20720793|P6|NOT COMPLETED|Overall Study||11
8407212|NCT00972816|20720794|P5|NOT COMPLETED|Overall Study||12
8407213|NCT00972816|20720795|P4|NOT COMPLETED|Overall Study||8
8407214|NCT00972816|20720796|P3|NOT COMPLETED|Overall Study||9
8407215|NCT00972816|20720797|P2|NOT COMPLETED|Overall Study||11
8407216|NCT00972816|20720798|P1|NOT COMPLETED|Overall Study||17
8407217|NCT00972816|20720791|P8|COMPLETED|Overall Study||161
8407218|NCT00972816|20720792|P7|COMPLETED|Overall Study||159
8407219|NCT00972816|20720793|P6|COMPLETED|Overall Study||158
8407220|NCT00972816|20720794|P5|COMPLETED|Overall Study||157
8407221|NCT00972816|20720795|P4|COMPLETED|Overall Study||161
8407222|NCT00972816|20720796|P3|COMPLETED|Overall Study||160
8407223|NCT00972816|20720797|P2|COMPLETED|Overall Study||158
8407224|NCT00972816|20720798|P1|COMPLETED|Overall Study||156
8407225|NCT00972816|20720791|P8|STARTED|Overall Study||170
8407226|NCT00972816|20720792|P7|STARTED|Overall Study||169
8407227|NCT00972816|20720793|P6|STARTED|Overall Study||169
8407228|NCT00972816|20720794|P5|STARTED|Overall Study||169
8407229|NCT00972816|20720795|P4|STARTED|Overall Study||169
8407230|NCT00972816|20720796|P3|STARTED|Overall Study||169
8407231|NCT00972816|20720797|P2|STARTED|Overall Study||169
8407232|NCT00972816|20720798|P1|STARTED|Overall Study||173
8407233|NCT00972777|20720882|P2|NOT COMPLETED|Overall Study||14
8407234|NCT00972777|20720883|P1|NOT COMPLETED|Overall Study||14
8407235|NCT00972777|20720882|P2|COMPLETED|Overall Study||229
8407236|NCT00972777|20720883|P1|COMPLETED|Overall Study||217
8407237|NCT00972777|20720882|P2|STARTED|Overall Study||243
8407238|NCT00972777|20720883|P1|STARTED|Overall Study||231
8407239|NCT00972738|20720898|P3|NOT COMPLETED|Overall Study||29
8407240|NCT00972738|20720899|P2|NOT COMPLETED|Overall Study||6
8407241|NCT00972738|20720900|P1|NOT COMPLETED|Overall Study||21
8407242|NCT00972738|20720898|P3|COMPLETED|Overall Study||492
8407243|NCT00972738|20720899|P2|COMPLETED|Overall Study||165
8407244|NCT00972738|20720900|P1|COMPLETED|Overall Study||501
8407245|NCT00972738|20720898|P3|STARTED|Overall Study||521
8407246|NCT00972738|20720899|P2|STARTED|Overall Study||171
8407247|NCT00972738|20720900|P1|STARTED|Overall Study||522
8407248|NCT00972725|20720925|P2|NOT COMPLETED|Overall Study||0
8407249|NCT00972725|20720926|P1|NOT COMPLETED|Overall Study||0
8407250|NCT00972725|20720925|P2|COMPLETED|Overall Study||15
8407251|NCT00972725|20720926|P1|COMPLETED|Overall Study||13
8407252|NCT00972725|20720925|P2|STARTED|Overall Study||15
8407253|NCT00972725|20720926|P1|STARTED|Overall Study||13
8407254|NCT00972621|20721008|P2|NOT COMPLETED|Overall Study||1
8407255|NCT00972621|20721009|P1|NOT COMPLETED|Overall Study||0
8407256|NCT00972621|20721008|P2|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
8407257|NCT00972621|20721009|P1|COMPLETED|Overall Study||200
8407258|NCT00972621|20721008|P2|STARTED|Overall Study||200
8407259|NCT00972621|20721009|P1|STARTED|Overall Study||200
8407260|NCT00972595|20721017|P2|NOT COMPLETED|Period 2||0
8407261|NCT00972595|20721018|P1|NOT COMPLETED|Period 2||0
8407262|NCT00972595|20721017|P2|COMPLETED|Period 2||22
8407263|NCT00972595|20721018|P1|COMPLETED|Period 2||22
8407264|NCT00972595|20721017|P2|STARTED|Period 2||22
8407265|NCT00972595|20721018|P1|STARTED|Period 2||22
8407266|NCT00972595|20721017|P2|NOT COMPLETED|Period 1||0
8407267|NCT00972595|20721018|P1|NOT COMPLETED|Period 1||1
8407268|NCT00972595|20721017|P2|COMPLETED|Period 1||22
8407269|NCT00972595|20721018|P1|COMPLETED|Period 1||22
8407270|NCT00972595|20721017|P2|STARTED|Period 1||22
8407271|NCT00972595|20721018|P1|STARTED|Period 1||23
8407272|NCT00972543|20721028|P2|NOT COMPLETED|Overall Study||1
8407273|NCT00972543|20721029|P1|NOT COMPLETED|Overall Study||5
8407274|NCT00972543|20721028|P2|COMPLETED|Overall Study||0
8407275|NCT00972543|20721029|P1|COMPLETED|Overall Study||0
8407276|NCT00972543|20721028|P2|STARTED|Overall Study||1
8407277|NCT00972543|20721029|P1|STARTED|Overall Study||5
8407278|NCT00972530|20721105|P2|NOT COMPLETED|Overall Study||0
8407279|NCT00972530|20721106|P1|NOT COMPLETED|Overall Study||0
8407280|NCT00972530|20721105|P2|COMPLETED|Overall Study||46
8407281|NCT00972530|20721106|P1|COMPLETED|Overall Study||44
8407282|NCT00972530|20721105|P2|STARTED|Overall Study||46
8407283|NCT00972530|20721106|P1|STARTED|Overall Study||44
8407284|NCT00972517|20721112|P6|NOT COMPLETED|Overall Study||0
8407285|NCT00972517|20721113|P5|NOT COMPLETED|Overall Study||1
8407286|NCT00972517|20721114|P4|NOT COMPLETED|Overall Study||3
8407287|NCT00972517|20721115|P3|NOT COMPLETED|Overall Study||0
8407288|NCT00972517|20721116|P2|NOT COMPLETED|Overall Study||1
8407289|NCT00972517|20721117|P1|NOT COMPLETED|Overall Study||0
8407290|NCT00972517|20721112|P6|COMPLETED|Overall Study||58
8407291|NCT00972517|20721113|P5|COMPLETED|Overall Study||33
8407292|NCT00972517|20721114|P4|COMPLETED|Overall Study||27
8407293|NCT00972517|20721115|P3|COMPLETED|Overall Study||60
8407294|NCT00972517|20721116|P2|COMPLETED|Overall Study||30
8407295|NCT00972517|20721117|P1|COMPLETED|Overall Study||31
8407296|NCT00972517|20721112|P6|STARTED|Overall Study||58
8407297|NCT00972517|20721113|P5|STARTED|Overall Study||34
8407298|NCT00972517|20721114|P4|STARTED|Overall Study||30
8407299|NCT00972517|20721115|P3|STARTED|Overall Study||60
8407300|NCT00972517|20721116|P2|STARTED|Overall Study||31
8407301|NCT00972517|20721117|P1|STARTED|Overall Study||31
8407302|NCT00972504|20721212|P1|NOT COMPLETED|Overall Study||3
8407303|NCT00972504|20721212|P1|COMPLETED|Overall Study||51
8407304|NCT00972504|20721212|P1|STARTED|Overall Study||54
8407313|NCT00972439|20721257|P2|NOT COMPLETED|Overall Study||0
8407314|NCT00972439|20721258|P1|NOT COMPLETED|Overall Study||0
8407315|NCT00972439|20721257|P2|COMPLETED|Overall Study||16
8407316|NCT00972439|20721258|P1|COMPLETED|Overall Study||17
8407317|NCT00972439|20721257|P2|STARTED|Overall Study||16
8407318|NCT00972439|20721258|P1|STARTED|Overall Study||17
8407319|NCT00972374|20721267|P3|NOT COMPLETED|Overall Study||1
8407320|NCT00972374|20721268|P2|NOT COMPLETED|Overall Study||0
8407321|NCT00972374|20721269|P1|NOT COMPLETED|Overall Study||2
8407322|NCT00972374|20721267|P3|COMPLETED|Overall Study||13
8407323|NCT00972374|20721268|P2|COMPLETED|Overall Study||15
8407324|NCT00972374|20721269|P1|COMPLETED|Overall Study||13
8407325|NCT00972374|20721267|P3|STARTED|Overall Study||14
8407326|NCT00972374|20721268|P2|STARTED|Overall Study||15
8407327|NCT00972374|20721269|P1|STARTED|Overall Study||15
8407328|NCT00972335|20721283|P1|NOT COMPLETED|Overall Study||17
8407329|NCT00972335|20721283|P1|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
8407330|NCT00972335|20721283|P1|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
8407331|NCT00972322|20721290|P2|NOT COMPLETED|Overall Study||3
8407332|NCT00972322|20721291|P1|NOT COMPLETED|Overall Study||3
8407333|NCT00972322|20721290|P2|COMPLETED|Overall Study||25
8407334|NCT00972322|20721291|P1|COMPLETED|Overall Study||25
8407335|NCT00972322|20721290|P2|STARTED|Overall Study||28
8407336|NCT00972322|20721291|P1|STARTED|Overall Study||28
8407337|NCT00972283|20721303|P2|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
8407338|NCT00972283|20721304|P1|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
8407339|NCT00972283|20721303|P2|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
8407340|NCT00972283|20721304|P1|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
8407341|NCT00972283|20721303|P2|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
8407342|NCT00972283|20721304|P1|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
8407343|NCT00972283|20721303|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
8407344|NCT00972283|20721304|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
8407345|NCT00972283|20721303|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
8407346|NCT00972283|20721304|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
8407347|NCT00972283|20721303|P2|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
8407348|NCT00972283|20721304|P1|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
8407349|NCT00972283|20721303|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
8407350|NCT00972283|20721304|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
8407351|NCT00972283|20721303|P2|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
8407352|NCT00972283|20721304|P1|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
8407353|NCT00972244|20721331|P5|NOT COMPLETED|Overall Study||9
8407354|NCT00972244|20721332|P4|NOT COMPLETED|Overall Study||0
8407355|NCT00972244|20721333|P3|NOT COMPLETED|Overall Study||2
8407356|NCT00972244|20721334|P2|NOT COMPLETED|Overall Study||5
8407357|NCT00972244|20721335|P1|NOT COMPLETED|Overall Study||5
8407358|NCT00972244|20721331|P5|COMPLETED|Overall Study||45
8407359|NCT00972244|20721332|P4|COMPLETED|Overall Study||52
8407360|NCT00972244|20721333|P3|COMPLETED|Overall Study||56
8407361|NCT00972244|20721334|P2|COMPLETED|Overall Study||51
8407362|NCT00972244|20721335|P1|COMPLETED|Overall Study||54
8407363|NCT00972244|20721331|P5|STARTED|Overall Study||54
8407364|NCT00972244|20721332|P4|STARTED|Overall Study||52
8407365|NCT00972244|20721333|P3|STARTED|Overall Study||58
8407366|NCT00972244|20721334|P2|STARTED|Overall Study||56
8407367|NCT00972244|20721335|P1|STARTED|Overall Study||59
8407368|NCT00972205|20721357|P1|NOT COMPLETED|Overall Study||0
8407369|NCT00972205|20721357|P1|COMPLETED|Overall Study||12
8407370|NCT00972205|20721357|P1|STARTED|Overall Study||12
8407371|NCT00972153|20721367|P3|NOT COMPLETED|Overall Study||0
8407372|NCT00972153|20721368|P2|NOT COMPLETED|Overall Study||1
8407373|NCT00972153|20721369|P1|NOT COMPLETED|Overall Study||0
8407374|NCT00972153|20721367|P3|COMPLETED|Overall Study||12
8407375|NCT00972153|20721368|P2|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
8407376|NCT00972153|20721369|P1|COMPLETED|Overall Study||12
8407377|NCT00972153|20721367|P3|STARTED|Overall Study||12
8407378|NCT00972153|20721368|P2|STARTED|Overall Study||12
8407379|NCT00972153|20721369|P1|STARTED|Overall Study||12
8407380|NCT00972088|20721380|P1|NOT COMPLETED|Overall Study||0
8407381|NCT00972088|20721380|P1|COMPLETED|Overall Study||26
8407382|NCT00972088|20721380|P1|STARTED|Overall Study||26
8407383|NCT00972023|20721384|P1|NOT COMPLETED|Overall Study||1
8407384|NCT00972023|20721384|P1|COMPLETED|Overall Study||0
8407385|NCT00972023|20721384|P1|STARTED|Overall Study||1
8407386|NCT00971997|20721391|P1|NOT COMPLETED|Overall Study||19
8407387|NCT00971997|20721391|P1|COMPLETED|Overall Study||116
8407388|NCT00971997|20721391|P1|STARTED|Overall Study||135
8407389|NCT00971932|20721409|P1|NOT COMPLETED|Overall Study||7
8407390|NCT00971932|20721409|P1|COMPLETED|Overall Study||26
8407391|NCT00971932|20721409|P1|STARTED|Overall Study|Number of participants treated.|33
8407392|NCT00971841|20721419|P1|NOT COMPLETED|Overall Study||0
8407393|NCT00971841|20721419|P1|COMPLETED|Overall Study||1
8407394|NCT00971841|20721419|P1|STARTED|Overall Study||1
8407395|NCT00971789|20721424|P1|NOT COMPLETED|Overall Study||0
8407396|NCT00971789|20721424|P1|COMPLETED|Overall Study||18
8407397|NCT00971789|20721424|P1|STARTED|Overall Study||18
8407398|NCT00971750|20721429|P1|NOT COMPLETED|Overall Study||0
8407399|NCT00971750|20721429|P1|COMPLETED|Overall Study||253
8407400|NCT00971750|20721429|P1|STARTED|Overall Study||253
8407401|NCT00971737|20721440|P2|NOT COMPLETED|Overall Study||0
8407402|NCT00971737|20721441|P1|NOT COMPLETED|Overall Study||0
8407403|NCT00971737|20721440|P2|COMPLETED|Overall Study||30
8407404|NCT00971737|20721441|P1|COMPLETED|Overall Study||30
8407405|NCT00971737|20721440|P2|STARTED|Overall Study||30
8407406|NCT00971737|20721441|P1|STARTED|Overall Study||30
8407407|NCT00971633|20721459|P6|NOT COMPLETED|Period 3||0
8407408|NCT00971633|20721460|P5|NOT COMPLETED|Period 3||0
8407409|NCT00971633|20721461|P4|NOT COMPLETED|Period 3||0
8407410|NCT00971633|20721462|P3|NOT COMPLETED|Period 3||0
8407411|NCT00971633|20721463|P2|NOT COMPLETED|Period 3||0
8407412|NCT00971633|20721464|P1|NOT COMPLETED|Period 3||0
8407413|NCT00971633|20721459|P6|COMPLETED|Period 3||2
8407414|NCT00971633|20721460|P5|COMPLETED|Period 3||2
8407415|NCT00971633|20721461|P4|COMPLETED|Period 3||2
8407416|NCT00971633|20721462|P3|COMPLETED|Period 3||2
8407417|NCT00971633|20721463|P2|COMPLETED|Period 3||2
8407418|NCT00971633|20721464|P1|COMPLETED|Period 3||2
8407419|NCT00971633|20721459|P6|STARTED|Period 3||2
8407420|NCT00971633|20721460|P5|STARTED|Period 3||2
8407421|NCT00971633|20721461|P4|STARTED|Period 3||2
8407422|NCT00971633|20721462|P3|STARTED|Period 3||2
8407423|NCT00971633|20721463|P2|STARTED|Period 3||2
8407424|NCT00971633|20721464|P1|STARTED|Period 3||2
8407425|NCT00971633|20721459|P6|NOT COMPLETED|Period 2||0
8407426|NCT00971633|20721460|P5|NOT COMPLETED|Period 2||0
8407427|NCT00971633|20721461|P4|NOT COMPLETED|Period 2||0
8407428|NCT00971633|20721462|P3|NOT COMPLETED|Period 2||0
8407429|NCT00971633|20721463|P2|NOT COMPLETED|Period 2||0
8407430|NCT00971633|20721464|P1|NOT COMPLETED|Period 2||0
8407431|NCT00971633|20721459|P6|COMPLETED|Period 2||2
8407432|NCT00971633|20721460|P5|COMPLETED|Period 2||2
8407433|NCT00971633|20721461|P4|COMPLETED|Period 2||2
8407434|NCT00971633|20721462|P3|COMPLETED|Period 2||2
8407435|NCT00971633|20721463|P2|COMPLETED|Period 2||2
8407436|NCT00971633|20721464|P1|COMPLETED|Period 2||2
8407437|NCT00971633|20721459|P6|STARTED|Period 2||2
8407438|NCT00971633|20721460|P5|STARTED|Period 2||2
8407439|NCT00971633|20721461|P4|STARTED|Period 2||2
8407440|NCT00971633|20721462|P3|STARTED|Period 2||2
8407441|NCT00971633|20721463|P2|STARTED|Period 2||2
8407442|NCT00971633|20721464|P1|STARTED|Period 2||2
8407443|NCT00971633|20721459|P6|NOT COMPLETED|Period 1||0
8407444|NCT00971633|20721460|P5|NOT COMPLETED|Period 1||0
8407445|NCT00971633|20721461|P4|NOT COMPLETED|Period 1||0
8407446|NCT00971633|20721462|P3|NOT COMPLETED|Period 1||0
8407447|NCT00971633|20721463|P2|NOT COMPLETED|Period 1||0
8407448|NCT00971633|20721464|P1|NOT COMPLETED|Period 1||0
8407449|NCT00971633|20721459|P6|COMPLETED|Period 1||2
8407450|NCT00971633|20721460|P5|COMPLETED|Period 1||2
8407451|NCT00971633|20721461|P4|COMPLETED|Period 1||2
8407452|NCT00971633|20721462|P3|COMPLETED|Period 1||2
8407453|NCT00971633|20721463|P2|COMPLETED|Period 1||2
8407454|NCT00971633|20721464|P1|COMPLETED|Period 1||2
8407455|NCT00971633|20721459|P6|STARTED|Period 1||2
8407456|NCT00971633|20721460|P5|STARTED|Period 1||2
8407457|NCT00971633|20721461|P4|STARTED|Period 1||2
8407458|NCT00971633|20721462|P3|STARTED|Period 1||2
8407459|NCT00971633|20721463|P2|STARTED|Period 1||2
8407460|NCT00971633|20721464|P1|STARTED|Period 1||2
8407461|NCT00971620|20721477|P2|NOT COMPLETED|Overall Study||0
8407462|NCT00971620|20721478|P1|NOT COMPLETED|Overall Study||0
8407463|NCT00971620|20721477|P2|COMPLETED|Overall Study||9
8407464|NCT00971620|20721478|P1|COMPLETED|Overall Study||9
8407465|NCT00971620|20721477|P2|STARTED|Overall Study||9
8407466|NCT00971620|20721478|P1|STARTED|Overall Study||9
8407467|NCT00971425|20721510|P2|NOT COMPLETED|Overall Study||2
8407468|NCT00971425|20721511|P1|NOT COMPLETED|Overall Study||1
8407469|NCT00971425|20721510|P2|COMPLETED|Overall Study||71
8407470|NCT00971425|20721511|P1|COMPLETED|Overall Study||71
8407471|NCT00971425|20721510|P2|STARTED|Overall Study||73
8407472|NCT00971425|20721511|P1|STARTED|Overall Study||72
8407473|NCT00971321|20721547|P2|NOT COMPLETED|Up to Month 11-12||3
8407474|NCT00971321|20721548|P1|NOT COMPLETED|Up to Month 11-12||5
8407475|NCT00971321|20721547|P2|COMPLETED|Up to Month 11-12||50
8407476|NCT00971321|20721548|P1|COMPLETED|Up to Month 11-12||99
8407477|NCT00971321|20721547|P2|STARTED|Up to Month 11-12||53
8407478|NCT00971321|20721548|P1|STARTED|Up to Month 11-12||104
8407479|NCT00971321|20721547|P2|NOT COMPLETED|Up to Month 7||2
8407480|NCT00971321|20721548|P1|NOT COMPLETED|Up to Month 7||4
8407481|NCT00971321|20721547|P2|COMPLETED|Up to Month 7||51
8407482|NCT00971321|20721548|P1|COMPLETED|Up to Month 7||100
8407483|NCT00971321|20721547|P2|STARTED|Up to Month 7||53
8407484|NCT00971321|20721548|P1|STARTED|Up to Month 7||104
8407485|NCT00971321|20721547|P2|NOT COMPLETED|Up to Day 42||0
8407486|NCT00971321|20721548|P1|NOT COMPLETED|Up to Day 42||0
8407487|NCT00971321|20721547|P2|COMPLETED|Up to Day 42||53
8407488|NCT00971321|20721548|P1|COMPLETED|Up to Day 42||104
8407489|NCT00971321|20721547|P2|STARTED|Up to Day 42||53
8407490|NCT00971321|20721548|P1|STARTED|Up to Day 42||104
8407491|NCT00971295|20721598|P2|NOT COMPLETED|Overall Study||1
8407492|NCT00971295|20721599|P1|NOT COMPLETED|Overall Study||0
8407493|NCT00971295|20721598|P2|COMPLETED|Overall Study||9
8407494|NCT00971295|20721599|P1|COMPLETED|Overall Study||10
8407495|NCT00971295|20721598|P2|STARTED|Overall Study||10
8407496|NCT00971295|20721599|P1|STARTED|Overall Study||10
8407500|NCT00971243|20721628|P5|NOT COMPLETED|Open-label Period||6
8407501|NCT00971243|20721629|P4|NOT COMPLETED|Open-label Period||10
8407502|NCT00971243|20721630|P3|NOT COMPLETED|Open-label Period||5
8407503|NCT00971243|20721631|P2|NOT COMPLETED|Open-label Period||10
8407504|NCT00971243|20721632|P1|NOT COMPLETED|Open-label Period||8
8407505|NCT00971243|20721628|P5|COMPLETED|Open-label Period||64
8407506|NCT00971243|20721629|P4|COMPLETED|Open-label Period||64
8407507|NCT00971243|20721630|P3|COMPLETED|Open-label Period||66
8407508|NCT00971243|20721631|P2|COMPLETED|Open-label Period||71
8407509|NCT00971243|20721632|P1|COMPLETED|Open-label Period||60
8407510|NCT00971243|20721628|P5|STARTED|Open-label Period||70
8407511|NCT00971243|20721629|P4|STARTED|Open-label Period||74
8407512|NCT00971243|20721630|P3|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
8407513|NCT00971243|20721631|P2|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
8407514|NCT00971243|20721632|P1|STARTED|Open-label Period||68
8407515|NCT00971243|20721628|P5|NOT COMPLETED|Double Blind Period||18
8407516|NCT00971243|20721629|P4|NOT COMPLETED|Double Blind Period||14
8407517|NCT00971243|20721630|P3|NOT COMPLETED|Double Blind Period||19
8407518|NCT00971243|20721631|P2|NOT COMPLETED|Double Blind Period||11
8407519|NCT00971243|20721632|P1|NOT COMPLETED|Double Blind Period||19
8407520|NCT00971243|20721628|P5|COMPLETED|Double Blind Period||70
8407521|NCT00971243|20721629|P4|COMPLETED|Double Blind Period||74
8407522|NCT00971243|20721630|P3|COMPLETED|Double Blind Period||72
8407523|NCT00971243|20721631|P2|COMPLETED|Double Blind Period||82
8407524|NCT00971243|20721632|P1|COMPLETED|Double Blind Period||68
8407525|NCT00971243|20721628|P5|STARTED|Double Blind Period||88
8407526|NCT00971243|20721629|P4|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
8407527|NCT00971243|20721630|P3|STARTED|Double Blind Period||91
8407528|NCT00971243|20721631|P2|STARTED|Double Blind Period||93
8407529|NCT00971243|20721632|P1|STARTED|Double Blind Period||87
8407530|NCT00971204|20721649|P1|NOT COMPLETED|Overall Study||24
8407531|NCT00971204|20721649|P1|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
8407532|NCT00971204|20721649|P1|Treated|Overall Study||86
8407533|NCT00971204|20721649|P1|STARTED|Overall Study|100 enrolled participants|100
8407534|NCT00971178|20721656|P3|NOT COMPLETED|Overall Study||2
8407535|NCT00971178|20721657|P2|NOT COMPLETED|Overall Study||2
8407536|NCT00971178|20721658|P1|NOT COMPLETED|Overall Study||2
8407537|NCT00971178|20721656|P3|COMPLETED|Overall Study||33
8407538|NCT00971178|20721657|P2|COMPLETED|Overall Study||33
8407539|NCT00971178|20721658|P1|COMPLETED|Overall Study||33
8407540|NCT00971178|20721656|P3|STARTED|Overall Study||35
8407541|NCT00971178|20721657|P2|STARTED|Overall Study||35
8407542|NCT00971178|20721658|P1|STARTED|Overall Study||35
8407543|NCT00971048|20721670|P4|NOT COMPLETED|Overall Study||2
8407544|NCT00971048|20721671|P3|NOT COMPLETED|Overall Study||1
8407545|NCT00971048|20721672|P2|NOT COMPLETED|Overall Study||2
8407546|NCT00971048|20721673|P1|NOT COMPLETED|Overall Study||1
8407547|NCT00971048|20721670|P4|COMPLETED|Overall Study||11
8407548|NCT00971048|20721671|P3|COMPLETED|Overall Study||11
8407549|NCT00971048|20721672|P2|COMPLETED|Overall Study||31
8407550|NCT00971048|20721673|P1|COMPLETED|Overall Study||29
8407551|NCT00971048|20721670|P4|STARTED|Overall Study||13
8407552|NCT00971048|20721671|P3|STARTED|Overall Study||12
8407553|NCT00971048|20721672|P2|STARTED|Overall Study||33
8407554|NCT00971048|20721673|P1|STARTED|Overall Study||30
8407555|NCT00970944|20721697|P2|NOT COMPLETED|Overall Study||2
8407556|NCT00970944|20721698|P1|NOT COMPLETED|Overall Study||1
8407557|NCT00970944|20721697|P2|COMPLETED|Overall Study||95
8407558|NCT00970944|20721698|P1|COMPLETED|Overall Study||86
8407559|NCT00970944|20721697|P2|STARTED|Overall Study||97
8407560|NCT00970944|20721698|P1|STARTED|Overall Study||87
8407561|NCT00970853|20721708|P2|NOT COMPLETED|Overall Study||0
8407562|NCT00970853|20721709|P1|NOT COMPLETED|Overall Study||0
8407563|NCT00970853|20721708|P2|COMPLETED|Overall Study||98
8407564|NCT00970853|20721709|P1|COMPLETED|Overall Study||89
8407565|NCT00970853|20721708|P2|STARTED|Overall Study||98
8407566|NCT00970853|20721709|P1|STARTED|Overall Study||89
8407567|NCT00970814|20721733|P2|NOT COMPLETED|Overall Study||14
8407568|NCT00970814|20721734|P1|NOT COMPLETED|Overall Study||8
8407569|NCT00970814|20721733|P2|COMPLETED|Overall Study||50
8407570|NCT00970814|20721734|P1|COMPLETED|Overall Study||58
8407571|NCT00970814|20721733|P2|STARTED|Overall Study||64
8407572|NCT00970814|20721734|P1|STARTED|Overall Study||66
8407573|NCT00970736|20721744|P1|NOT COMPLETED|Overall Study||2
8407574|NCT00970736|20721744|P1|COMPLETED|Overall Study||18
8407575|NCT00970736|20721744|P1|STARTED|Overall Study||20
8407576|NCT00970684|20721750|P1|NOT COMPLETED|Overall Study||10
8407577|NCT00970684|20721750|P1|COMPLETED|Overall Study||3
8407578|NCT00970684|20721750|P1|STARTED|Overall Study||13
8407579|NCT00970632|20721759|P3|NOT COMPLETED|Overall Study||18
8407580|NCT00970632|20721760|P2|NOT COMPLETED|Overall Study||15
8407581|NCT00970632|20721761|P1|NOT COMPLETED|Overall Study||24
8407582|NCT00970632|20721759|P3|COMPLETED|Overall Study||150
8407583|NCT00970632|20721760|P2|COMPLETED|Overall Study||156
8407584|NCT00970632|20721761|P1|COMPLETED|Overall Study||148
8407585|NCT00970632|20721759|P3|STARTED|Overall Study||168
8407586|NCT00970632|20721760|P2|STARTED|Overall Study||171
8407587|NCT00970632|20721761|P1|STARTED|Overall Study||172
8407588|NCT00970606|20721819|P2|NOT COMPLETED|Overall Study||0
8407589|NCT00970606|20721820|P1|NOT COMPLETED|Overall Study||0
8407590|NCT00970606|20721819|P2|COMPLETED|Overall Study||3
8407591|NCT00970606|20721820|P1|COMPLETED|Overall Study||4
8407592|NCT00970606|20721819|P2|STARTED|Overall Study||3
8407593|NCT00970606|20721820|P1|STARTED|Overall Study||4
8407594|NCT00970593|20721833|P7|NOT COMPLETED|Overall Study||2
8407595|NCT00970593|20721834|P6|NOT COMPLETED|Overall Study||0
8407596|NCT00970593|20721835|P5|NOT COMPLETED|Overall Study||0
8407597|NCT00970593|20721836|P4|NOT COMPLETED|Overall Study||0
8407598|NCT00970593|20721837|P3|NOT COMPLETED|Overall Study||6
8407599|NCT00970593|20721838|P2|NOT COMPLETED|Overall Study||1
8407600|NCT00970593|20721839|P1|NOT COMPLETED|Overall Study||1
8407601|NCT00970593|20721833|P7|COMPLETED|Overall Study||14
8407602|NCT00970593|20721834|P6|COMPLETED|Overall Study||5
8407603|NCT00970593|20721835|P5|COMPLETED|Overall Study||20
8407604|NCT00970593|20721836|P4|COMPLETED|Overall Study||12
8407605|NCT00970593|20721837|P3|COMPLETED|Overall Study||7
8407606|NCT00970593|20721838|P2|COMPLETED|Overall Study||14
8407607|NCT00970593|20721839|P1|COMPLETED|Overall Study||10
8407608|NCT00970593|20721833|P7|STARTED|Overall Study||16
8407609|NCT00970593|20721834|P6|STARTED|Overall Study||5
8407610|NCT00970593|20721835|P5|STARTED|Overall Study||20
8407611|NCT00970593|20721836|P4|STARTED|Overall Study||12
8407612|NCT00970593|20721837|P3|STARTED|Overall Study||13
8407613|NCT00970593|20721838|P2|STARTED|Overall Study||15
8407614|NCT00970593|20721839|P1|STARTED|Overall Study||11
8407615|NCT00970502|20721921|P1|NOT COMPLETED|Overall Study||1
8407616|NCT00970502|20721921|P1|COMPLETED|Overall Study||14
8407617|NCT00970502|20721921|P1|STARTED|Overall Study||15
8407618|NCT00970489|20721932|P2|NOT COMPLETED|Overall Study||41
8407619|NCT00970489|20721933|P1|NOT COMPLETED|Overall Study||54
8407620|NCT00970489|20721932|P2|COMPLETED|Overall Study||717
8407621|NCT00970489|20721933|P1|COMPLETED|Overall Study||704
8407622|NCT00970489|20721932|P2|STARTED|Overall Study||758
8407623|NCT00970489|20721933|P1|STARTED|Overall Study||758
8407624|NCT00970359|20721945|P1|NOT COMPLETED|Overall Study||4
8407625|NCT00970359|20721945|P1|COMPLETED|Overall Study||20
8407626|NCT00970359|20721945|P1|STARTED|Overall Study||24
8407627|NCT00970320|20721956|P5|NOT COMPLETED|Overall Study||540
8407628|NCT00970320|20721957|P4|NOT COMPLETED|Overall Study||14
8407629|NCT00970320|20721958|P3|NOT COMPLETED|Overall Study||13
8407630|NCT00970320|20721959|P2|NOT COMPLETED|Overall Study||11
8407631|NCT00970320|20721960|P1|NOT COMPLETED|Overall Study||0
8407632|NCT00970320|20721956|P5|COMPLETED|Overall Study||1031
8407633|NCT00970320|20721957|P4|COMPLETED|Overall Study||36
8407634|NCT00970320|20721958|P3|COMPLETED|Overall Study||35
8407635|NCT00970320|20721959|P2|COMPLETED|Overall Study||13
8407636|NCT00970320|20721960|P1|COMPLETED|Overall Study||25
8407637|NCT00970320|20721956|P5|STARTED|Overall Study||1571
8407638|NCT00970320|20721957|P4|STARTED|Overall Study||50
8407639|NCT00970320|20721958|P3|STARTED|Overall Study||48
8407640|NCT00970320|20721959|P2|STARTED|Overall Study||24
8407641|NCT00970320|20721960|P1|STARTED|Overall Study||25
8407642|NCT00970307|20721975|P3|NOT COMPLETED|Overall Study||2
8407643|NCT00970307|20721976|P2|NOT COMPLETED|Overall Study||3
8407644|NCT00970307|20721977|P1|NOT COMPLETED|Overall Study||3
8407645|NCT00970307|20721975|P3|COMPLETED|Overall Study||139
8407646|NCT00970307|20721976|P2|COMPLETED|Overall Study||136
8407647|NCT00970307|20721977|P1|COMPLETED|Overall Study||138
8407648|NCT00970307|20721975|P3|STARTED|Overall Study||141
8407649|NCT00970307|20721976|P2|STARTED|Overall Study||139
8407650|NCT00970307|20721977|P1|STARTED|Overall Study||141
8407651|NCT00970294|20722051|P1|NOT COMPLETED|Overall Study||5
8407652|NCT00970294|20722051|P1|COMPLETED|Overall Study||6
8407653|NCT00970294|20722051|P1|STARTED|Overall Study||11
8407654|NCT00970281|20722059|P2|NOT COMPLETED|Overall Study||16
8407655|NCT00970281|20722060|P1|NOT COMPLETED|Overall Study||2
8407656|NCT00970281|20722059|P2|COMPLETED|Overall Study||29
8407657|NCT00970281|20722060|P1|COMPLETED|Overall Study||44
8407658|NCT00970281|20722059|P2|Full Analysis Set|Overall Study||45
8407659|NCT00970281|20722060|P1|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
8407660|NCT00970281|20722059|P2|STARTED|Overall Study||45
8407661|NCT00970281|20722060|P1|STARTED|Overall Study||46
8407662|NCT00970268|20722078|P2|NOT COMPLETED|Overall Study||49
8407663|NCT00970268|20722079|P1|NOT COMPLETED|Overall Study||43
8407664|NCT00970268|20722078|P2|COMPLETED|Overall Study||103
8407665|NCT00970268|20722079|P1|COMPLETED|Overall Study||96
8407666|NCT00970268|20722078|P2|STARTED|Overall Study||152
8407667|NCT00970268|20722079|P1|STARTED|Overall Study||139
8407668|NCT00970216|20722093|P1|NOT COMPLETED|Overall Study||80
8407669|NCT00970216|20722093|P1|COMPLETED|Overall Study||80
8407670|NCT00970216|20722093|P1|STARTED|Overall Study||160
8407671|NCT00970203|20722099|P2|NOT COMPLETED|Overall Study||0
8407672|NCT00970203|20722100|P1|NOT COMPLETED|Overall Study||0
8407673|NCT00970203|20722099|P2|COMPLETED|Overall Study||6
8407674|NCT00970203|20722100|P1|COMPLETED|Overall Study||7
8407675|NCT00970203|20722099|P2|STARTED|Overall Study||6
8407676|NCT00970203|20722100|P1|STARTED|Overall Study||7
8407677|NCT00970073|20722123|P3|NOT COMPLETED|Overall Study||0
8407678|NCT00970073|20722124|P2|NOT COMPLETED|Overall Study||0
8407679|NCT00970073|20722125|P1|NOT COMPLETED|Overall Study||0
8407680|NCT00970073|20722123|P3|COMPLETED|Overall Study||10
8407681|NCT00970073|20722124|P2|COMPLETED|Overall Study||10
8407682|NCT00970073|20722125|P1|COMPLETED|Overall Study||10
8407683|NCT00970073|20722123|P3|STARTED|Overall Study||10
8407684|NCT00970073|20722124|P2|STARTED|Overall Study||10
8407685|NCT00970073|20722125|P1|STARTED|Overall Study||10
8407686|NCT00969878|20722144|P2|NOT COMPLETED|Overall Study||26
8407687|NCT00969878|20722145|P1|NOT COMPLETED|Overall Study||30
8407688|NCT00969878|20722144|P2|COMPLETED|Overall Study||126
8407689|NCT00969878|20722145|P1|COMPLETED|Overall Study||118
8407690|NCT00969878|20722144|P2|STARTED|Overall Study||152
8407691|NCT00969878|20722145|P1|STARTED|Overall Study||148
8407692|NCT00969761|20722165|P12|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8407693|NCT00969761|20722166|P11|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8407694|NCT00969761|20722167|P10|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
8407695|NCT00969761|20722168|P9|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11
8407696|NCT00969761|20722169|P8|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6
8407697|NCT00969761|20722170|P7|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8407698|NCT00969761|20722171|P6|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8407699|NCT00969761|20722172|P5|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8407700|NCT00969761|20722173|P4|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5
8407701|NCT00969761|20722174|P3|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10
8407702|NCT00969761|20722175|P2|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
8407703|NCT00969761|20722176|P1|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
8407704|NCT00969761|20722165|P12|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407705|NCT00969761|20722166|P11|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407706|NCT00969761|20722167|P10|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407707|NCT00969761|20722168|P9|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407708|NCT00969761|20722169|P8|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407709|NCT00969761|20722170|P7|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407710|NCT00969761|20722171|P6|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407711|NCT00969761|20722172|P5|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407712|NCT00969761|20722173|P4|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407713|NCT00969761|20722174|P3|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407714|NCT00969761|20722175|P2|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407715|NCT00969761|20722176|P1|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
8407716|NCT00969761|20722165|P12|STARTED|Treated in and Beyond Treat. Cycle 2||3
8407717|NCT00969761|20722166|P11|STARTED|Treated in and Beyond Treat. Cycle 2||3
8407718|NCT00969761|20722167|P10|STARTED|Treated in and Beyond Treat. Cycle 2||2
8407719|NCT00969761|20722168|P9|STARTED|Treated in and Beyond Treat. Cycle 2||11
8407720|NCT00969761|20722169|P8|STARTED|Treated in and Beyond Treat. Cycle 2||6
8407721|NCT00969761|20722170|P7|STARTED|Treated in and Beyond Treat. Cycle 2||3
8407722|NCT00969761|20722171|P6|STARTED|Treated in and Beyond Treat. Cycle 2||3
8407723|NCT00969761|20722172|P5|STARTED|Treated in and Beyond Treat. Cycle 2||3
8407724|NCT00969761|20722173|P4|STARTED|Treated in and Beyond Treat. Cycle 2||5
8407725|NCT00969761|20722174|P3|STARTED|Treated in and Beyond Treat. Cycle 2||10
8407726|NCT00969761|20722175|P2|STARTED|Treated in and Beyond Treat. Cycle 2||3
8407727|NCT00969761|20722176|P1|STARTED|Treated in and Beyond Treat. Cycle 2||2
8407728|NCT00969761|20722165|P12|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8407729|NCT00969761|20722166|P11|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8407730|NCT00969761|20722167|P10|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
8407731|NCT00969761|20722168|P9|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
8407732|NCT00969761|20722169|P8|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8407733|NCT00969761|20722170|P7|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8407734|NCT00969761|20722171|P6|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8407735|NCT00969761|20722172|P5|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8407736|NCT00969761|20722173|P4|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
8407737|NCT00969761|20722174|P3|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
8407738|NCT00969761|20722175|P2|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
8407739|NCT00969761|20722176|P1|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
8407740|NCT00969761|20722165|P12|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8407741|NCT00969761|20722166|P11|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8407742|NCT00969761|20722167|P10|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
8407743|NCT00969761|20722168|P9|COMPLETED|Discont. Before Start of Treat. Cycle 2||11
8407744|NCT00969761|20722169|P8|COMPLETED|Discont. Before Start of Treat. Cycle 2||6
8407745|NCT00969761|20722170|P7|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8407746|NCT00969761|20722171|P6|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8407747|NCT00969761|20722172|P5|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8407748|NCT00969761|20722173|P4|COMPLETED|Discont. Before Start of Treat. Cycle 2||5
8407749|NCT00969761|20722174|P3|COMPLETED|Discont. Before Start of Treat. Cycle 2||10
8407750|NCT00969761|20722175|P2|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
8407751|NCT00969761|20722176|P1|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
8407752|NCT00969761|20722165|P12|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407753|NCT00969761|20722166|P11|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407754|NCT00969761|20722167|P10|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407755|NCT00969761|20722168|P9|STARTED|Discont. Before Start of Treat. Cycle 2||13
8407756|NCT00969761|20722169|P8|STARTED|Discont. Before Start of Treat. Cycle 2||6
8407757|NCT00969761|20722170|P7|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407758|NCT00969761|20722171|P6|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407759|NCT00969761|20722172|P5|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407760|NCT00969761|20722173|P4|STARTED|Discont. Before Start of Treat. Cycle 2||6
8407761|NCT00969761|20722174|P3|STARTED|Discont. Before Start of Treat. Cycle 2||12
8407762|NCT00969761|20722175|P2|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407763|NCT00969761|20722176|P1|STARTED|Discont. Before Start of Treat. Cycle 2||3
8407764|NCT00969709|20722482|P4|NOT COMPLETED|Overall Study||63
8407765|NCT00969709|20722483|P3|NOT COMPLETED|Overall Study||58
8407766|NCT00969709|20722484|P2|NOT COMPLETED|Overall Study||48
8407767|NCT00969709|20722485|P1|NOT COMPLETED|Overall Study||38
8407768|NCT00969709|20722482|P4|COMPLETED|Overall Study||117
8407769|NCT00969709|20722483|P3|COMPLETED|Overall Study||121
8407770|NCT00969709|20722484|P2|COMPLETED|Overall Study||130
8407771|NCT00969709|20722485|P1|COMPLETED|Overall Study||138
8407772|NCT00969709|20722482|P4|STARTED|Overall Study||180
8407773|NCT00969709|20722483|P3|STARTED|Overall Study||179
8407774|NCT00969709|20722484|P2|STARTED|Overall Study||178
8407775|NCT00969709|20722485|P1|STARTED|Overall Study||176
8407776|NCT00969618|20722499|P1|NOT COMPLETED|Overall Study||78
8407777|NCT00969618|20722499|P1|COMPLETED|Overall Study||133
8407778|NCT00969618|20722499|P1|STARTED|Overall Study||211
8407779|NCT00969553|20722519|P9|NOT COMPLETED|Overall Study||3
8407780|NCT00969553|20722520|P8|NOT COMPLETED|Overall Study||14
8407781|NCT00969553|20722521|P7|NOT COMPLETED|Overall Study||4
8407782|NCT00969553|20722522|P6|NOT COMPLETED|Overall Study||4
8407783|NCT00969553|20722523|P5|NOT COMPLETED|Overall Study||3
8407784|NCT00969553|20722524|P4|NOT COMPLETED|Overall Study||16
8407785|NCT00969553|20722525|P3|NOT COMPLETED|Overall Study||6
8407786|NCT00969553|20722526|P2|NOT COMPLETED|Overall Study||3
8407787|NCT00969553|20722527|P1|NOT COMPLETED|Overall Study||3
8407788|NCT00969553|20722519|P9|COMPLETED|Overall Study||0
8407789|NCT00969553|20722520|P8|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2
8407790|NCT00969553|20722521|P7|COMPLETED|Overall Study||0
8407791|NCT00969553|20722522|P6|COMPLETED|Overall Study||0
8407792|NCT00969553|20722523|P5|COMPLETED|Overall Study||0
8407793|NCT00969553|20722524|P4|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1
8407794|NCT00969553|20722525|P3|COMPLETED|Overall Study||0
8407795|NCT00969553|20722526|P2|COMPLETED|Overall Study||0
8407796|NCT00969553|20722527|P1|COMPLETED|Overall Study||0
8407797|NCT00969553|20722519|P9|STARTED|Overall Study||3
8407798|NCT00969553|20722520|P8|STARTED|Overall Study||16
8407799|NCT00969553|20722521|P7|STARTED|Overall Study||4
8407800|NCT00969553|20722522|P6|STARTED|Overall Study||4
8407801|NCT00969553|20722523|P5|STARTED|Overall Study||3
8407802|NCT00969553|20722524|P4|STARTED|Overall Study||17
8407803|NCT00969553|20722525|P3|STARTED|Overall Study||6
8407804|NCT00969553|20722526|P2|STARTED|Overall Study||3
8407805|NCT00969553|20722527|P1|STARTED|Overall Study||3
8407806|NCT00969540|20722670|P2|NOT COMPLETED|Overall Study||1
8407807|NCT00969540|20722671|P1|NOT COMPLETED|Overall Study||1
8407808|NCT00969540|20722670|P2|COMPLETED|Overall Study||3
8407809|NCT00969540|20722671|P1|COMPLETED|Overall Study||3
8407810|NCT00969540|20722670|P2|STARTED|Overall Study||4
8407811|NCT00969540|20722671|P1|STARTED|Overall Study||4
8407812|NCT00969501|20722689|P1|NOT COMPLETED|Overall Study||5
8407813|NCT00969501|20722689|P1|COMPLETED|Overall Study||27
8407814|NCT00969501|20722689|P1|STARTED|Overall Study||32
8407815|NCT00969436|20722696|P3|NOT COMPLETED|Overall Study||11
8407816|NCT00969436|20722697|P2|NOT COMPLETED|Overall Study||21
8407817|NCT00969436|20722698|P1|NOT COMPLETED|Overall Study||25
8407818|NCT00969436|20722696|P3|COMPLETED|Overall Study||79
8407819|NCT00969436|20722697|P2|COMPLETED|Overall Study||159
8407820|NCT00969436|20722698|P1|COMPLETED|Overall Study||155
8407821|NCT00969436|20722696|P3|STARTED|Overall Study||90
8407822|NCT00969436|20722697|P2|STARTED|Overall Study||180
8407823|NCT00969436|20722698|P1|STARTED|Overall Study||180
8407824|NCT00969332|20722730|P1|NOT COMPLETED|Overall Study||11
8407825|NCT00969332|20722730|P1|COMPLETED|Overall Study||51
8407826|NCT00969332|20722730|P1|STARTED|Overall Study||62
8407827|NCT00969280|20722746|P2|NOT COMPLETED|Overall Study||3
8407828|NCT00969280|20722747|P1|NOT COMPLETED|Overall Study||2
8407829|NCT00969280|20722746|P2|COMPLETED|Overall Study||18
8407830|NCT00969280|20722747|P1|COMPLETED|Overall Study||19
8407831|NCT00969280|20722746|P2|STARTED|Overall Study||21
8407832|NCT00969280|20722747|P1|STARTED|Overall Study||21
8407833|NCT00969228|20722755|P2|NOT COMPLETED|Overall Study||14
8407834|NCT00969228|20722756|P1|NOT COMPLETED|Overall Study||43
8407835|NCT00969228|20722755|P2|COMPLETED|Overall Study||162
8407836|NCT00969228|20722756|P1|COMPLETED|Overall Study||465
8407837|NCT00969228|20722755|P2|STARTED|Overall Study||176
8407838|NCT00969228|20722756|P1|STARTED|Overall Study||508
8407839|NCT00969150|20722774|P2|NOT COMPLETED|Overall Study||40
8407840|NCT00969150|20722775|P1|NOT COMPLETED|Overall Study||33
8407841|NCT00969150|20722774|P2|COMPLETED|Overall Study||135
8407842|NCT00969150|20722775|P1|COMPLETED|Overall Study||149
8407843|NCT00969150|20722774|P2|STARTED|Overall Study||175
8407844|NCT00969150|20722775|P1|STARTED|Overall Study||182
8407845|NCT00969124|20722783|P1|NOT COMPLETED|Overall Study||30
8407846|NCT00969124|20722783|P1|COMPLETED|Overall Study||298
8407847|NCT00969124|20722783|P1|STARTED|Overall Study||328
8407848|NCT00968981|20722792|P3|NOT COMPLETED|Overall Study||22
8407849|NCT00968981|20722793|P2|NOT COMPLETED|Overall Study||22
8407850|NCT00968981|20722794|P1|NOT COMPLETED|Overall Study||22
8407851|NCT00968981|20722792|P3|COMPLETED|Overall Study||0
8407852|NCT00968981|20722793|P2|COMPLETED|Overall Study||0
8407853|NCT00968981|20722794|P1|COMPLETED|Overall Study||1
8407854|NCT00968981|20722792|P3|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
8407855|NCT00968981|20722793|P2|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
8407856|NCT00968981|20722794|P1|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
8407857|NCT00968981|20722792|P3|STARTED|Overall Study||22
8407858|NCT00968981|20722793|P2|STARTED|Overall Study||22
8407859|NCT00968981|20722794|P1|STARTED|Overall Study||23
8407860|NCT00968968|20722832|P2|NOT COMPLETED|Overall Study||14
8407861|NCT00968968|20722833|P1|NOT COMPLETED|Overall Study||16
8407862|NCT00968968|20722832|P2|COMPLETED|Overall Study||3
8407863|NCT00968968|20722833|P1|COMPLETED|Overall Study||4
8407864|NCT00968968|20722832|P2|STARTED|Overall Study||17
8407865|NCT00968968|20722833|P1|STARTED|Overall Study||20
8407866|NCT00968890|20722850|P2|NOT COMPLETED|Overall Study||0
8407867|NCT00968890|20722851|P1|NOT COMPLETED|Overall Study||0
8407868|NCT00968890|20722850|P2|COMPLETED|Overall Study||84
8407869|NCT00968890|20722851|P1|COMPLETED|Overall Study||84
8407870|NCT00968890|20722850|P2|STARTED|Overall Study||84
8407871|NCT00968890|20722851|P1|STARTED|Overall Study||84
8407872|NCT00968864|20722879|P1|NOT COMPLETED|Overall Study||1
8407873|NCT00968864|20722879|P1|COMPLETED|Overall Study||52
8407874|NCT00968864|20722879|P1|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
8407875|NCT00968838|20722897|P2|NOT COMPLETED|Overall Study||0
8407876|NCT00968838|20722898|P1|NOT COMPLETED|Overall Study||0
8407877|NCT00968838|20722897|P2|COMPLETED|Overall Study||58
8407878|NCT00968838|20722898|P1|COMPLETED|Overall Study||50
8407879|NCT00968838|20722897|P2|STARTED|Overall Study||58
8407880|NCT00968838|20722898|P1|STARTED|Overall Study||50
8407881|NCT00968812|20722907|P3|NOT COMPLETED|Overall Study||168
8407882|NCT00968812|20722908|P2|NOT COMPLETED|Overall Study||162
8407883|NCT00968812|20722909|P1|NOT COMPLETED|Overall Study||140
8407884|NCT00968812|20722907|P3|COMPLETED|Overall Study||314
8407885|NCT00968812|20722908|P2|COMPLETED|Overall Study||323
8407886|NCT00968812|20722909|P1|COMPLETED|Overall Study||343
8407887|NCT00968812|20722907|P3|STARTED|Overall Study||482
8407888|NCT00968812|20722908|P2|STARTED|Overall Study||485
8407889|NCT00968812|20722909|P1|STARTED|Overall Study||483
8407890|NCT00968799|20722929|P1|NOT COMPLETED|Overall Study||2
8407891|NCT00968799|20722929|P1|COMPLETED|Overall Study||4
8407892|NCT00968799|20722929|P1|STARTED|Overall Study||6
8407893|NCT00968708|20722939|P2|NOT COMPLETED|Overall Study||298
8407894|NCT00968708|20722940|P1|NOT COMPLETED|Overall Study||318
8407895|NCT00968708|20722939|P2|COMPLETED|Overall Study||2403
8407896|NCT00968708|20722940|P1|COMPLETED|Overall Study||2361
8407897|NCT00968708|20722939|P2|Treated|Overall Study||2698
8407898|NCT00968708|20722940|P1|Treated|Overall Study||2676
8407899|NCT00968708|20722939|P2|STARTED|Overall Study||2701
8407900|NCT00968708|20722940|P1|STARTED|Overall Study||2679
8407901|NCT00968669|20722952|P4|NOT COMPLETED|Overall Study||9
8407902|NCT00968669|20722953|P3|NOT COMPLETED|Overall Study||11
8407903|NCT00968669|20722954|P2|NOT COMPLETED|Overall Study||18
8407904|NCT00968669|20722955|P1|NOT COMPLETED|Overall Study||18
8407905|NCT00968669|20722952|P4|COMPLETED|Overall Study||72
8407906|NCT00968669|20722953|P3|COMPLETED|Overall Study||72
8407907|NCT00968669|20722954|P2|COMPLETED|Overall Study||63
8407908|NCT00968669|20722955|P1|COMPLETED|Overall Study||64
8407909|NCT00968669|20722952|P4|STARTED|Overall Study||81
8407910|NCT00968669|20722953|P3|STARTED|Overall Study||83
8407911|NCT00968669|20722954|P2|STARTED|Overall Study||81
8407912|NCT00968669|20722955|P1|STARTED|Overall Study||82
8407913|NCT00968617|20723045|P1|NOT COMPLETED|Overall Study||6
8407914|NCT00968617|20723045|P1|COMPLETED|Overall Study||1
8407915|NCT00968617|20723045|P1|STARTED|Overall Study||7
8407916|NCT00968539|20723059|P2|NOT COMPLETED|Overall Study||0
8407917|NCT00968539|20723060|P1|NOT COMPLETED|Overall Study||1
8407918|NCT00968539|20723059|P2|COMPLETED|Overall Study||66
8407919|NCT00968539|20723060|P1|COMPLETED|Overall Study||63
8407920|NCT00968539|20723059|P2|STARTED|Overall Study||66
8407921|NCT00968539|20723060|P1|STARTED|Overall Study||64
8407922|NCT00968526|20723120|P2|NOT COMPLETED|Overall Study||0
8407923|NCT00968526|20723121|P1|NOT COMPLETED|Overall Study||3
8407924|NCT00968526|20723120|P2|COMPLETED|Overall Study||102
8407925|NCT00968526|20723121|P1|COMPLETED|Overall Study||135
8407926|NCT00968526|20723120|P2|STARTED|Overall Study||102
8407927|NCT00968526|20723121|P1|STARTED|Overall Study||138
8407928|NCT00968344|20723213|P2|NOT COMPLETED|Overall Study||11
8407929|NCT00968344|20723214|P1|NOT COMPLETED|Overall Study||10
8407930|NCT00968344|20723213|P2|COMPLETED|Overall Study||9
8407931|NCT00968344|20723214|P1|COMPLETED|Overall Study||10
8407932|NCT00968344|20723213|P2|STARTED|Overall Study|Includes screen fails|20
8407933|NCT00968344|20723214|P1|STARTED|Overall Study|Includes screen fails|20
8407934|NCT00968253|20723223|P3|NOT COMPLETED|Overall Study||7
8407935|NCT00968253|20723224|P2|NOT COMPLETED|Overall Study||3
8407936|NCT00968253|20723225|P1|NOT COMPLETED|Overall Study||0
8407937|NCT00968253|20723223|P3|COMPLETED|Overall Study||5
8407938|NCT00968253|20723224|P2|COMPLETED|Overall Study||6
8407939|NCT00968253|20723225|P1|COMPLETED|Overall Study||3
8407940|NCT00968253|20723223|P3|STARTED|Overall Study||12
8407941|NCT00968253|20723224|P2|STARTED|Overall Study||9
8407942|NCT00968253|20723225|P1|STARTED|Overall Study||3
8407943|NCT00968227|20723239|P1|NOT COMPLETED|Overall Study||0
8407944|NCT00968227|20723239|P1|COMPLETED|Overall Study||56
8407945|NCT00968227|20723239|P1|STARTED|Overall Study||56
8407946|NCT00968201|20723246|P3|NOT COMPLETED|Extension Study - (Period III)||280
8407947|NCT00968201|20723247|P2|NOT COMPLETED|Extension Study - (Period III)||124
8407948|NCT00968201|20723248|P1|NOT COMPLETED|Extension Study - (Period III)||0
8407949|NCT00968201|20723246|P3|COMPLETED|Extension Study - (Period III)||84
8407950|NCT00968201|20723247|P2|COMPLETED|Extension Study - (Period III)||33
8407951|NCT00968201|20723248|P1|COMPLETED|Extension Study - (Period III)||0
8407952|NCT00968201|20723246|P3|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
8407953|NCT00968201|20723247|P2|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
8407954|NCT00968201|20723248|P1|STARTED|Extension Study - (Period III)||0
8407955|NCT00968201|20723246|P3|NOT COMPLETED|Base Study - (Period II)||45
8407956|NCT00968201|20723247|P2|NOT COMPLETED|Base Study - (Period II)||0
8407957|NCT00968201|20723248|P1|NOT COMPLETED|Base Study - (Period II)||26
8407958|NCT00968201|20723246|P3|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
8407959|NCT00968201|20723247|P2|COMPLETED|Base Study - (Period II)||0
8407960|NCT00968201|20723248|P1|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
8407961|NCT00968201|20723246|P3|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
8407962|NCT00968201|20723247|P2|STARTED|Base Study - (Period II)||0
8407963|NCT00968201|20723248|P1|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
8407964|NCT00968149|20723309|P2|NOT COMPLETED|Overall Study||6
8407965|NCT00968149|20723310|P1|NOT COMPLETED|Overall Study||11
8407966|NCT00968149|20723309|P2|COMPLETED|Overall Study||127
8407967|NCT00968149|20723310|P1|COMPLETED|Overall Study||269
8407968|NCT00968149|20723309|P2|STARTED|Overall Study||133
8407969|NCT00968149|20723310|P1|STARTED|Overall Study||280
8407970|NCT00968071|20723330|P1|NOT COMPLETED|Overall Study||0
8407971|NCT00968071|20723330|P1|COMPLETED|Overall Study||71
8407972|NCT00968071|20723330|P1|STARTED|Overall Study||71
8407973|NCT00968032|20723334|P1|NOT COMPLETED|Overall Study||2
8407974|NCT00968032|20723334|P1|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage
~1 patient denied latest FU"|61
8407975|NCT00968032|20723334|P1|STARTED|Overall Study||63
8407976|NCT00968019|20723338|P1|NOT COMPLETED|Overall Study||15
8407977|NCT00968019|20723338|P1|COMPLETED|Overall Study||303
8407978|NCT00968019|20723338|P1|STARTED|Overall Study||318
8407979|NCT00967993|20723359|P1|NOT COMPLETED|Overall Study||4
8407980|NCT00967993|20723359|P1|COMPLETED|Overall Study||18
8407981|NCT00967993|20723359|P1|STARTED|Overall Study||22
8407982|NCT00967941|20723366|P3|NOT COMPLETED|Overall Study||4
8407983|NCT00967941|20723367|P2|NOT COMPLETED|Overall Study||3
8407984|NCT00967941|20723368|P1|NOT COMPLETED|Overall Study||5
8407985|NCT00967941|20723366|P3|COMPLETED|Overall Study||56
8407986|NCT00967941|20723367|P2|COMPLETED|Overall Study||51
8407987|NCT00967941|20723368|P1|COMPLETED|Overall Study||62
8407988|NCT00967941|20723366|P3|STARTED|Overall Study||60
8407989|NCT00967941|20723367|P2|STARTED|Overall Study||54
8407990|NCT00967941|20723368|P1|STARTED|Overall Study||67
8407991|NCT00967798|20723378|P2|NOT COMPLETED|Overall Study||3
8407992|NCT00967798|20723379|P1|NOT COMPLETED|Overall Study||9
8407993|NCT00967798|20723378|P2|COMPLETED|Overall Study||13
8407994|NCT00967798|20723379|P1|COMPLETED|Overall Study||8
8407995|NCT00967798|20723378|P2|STARTED|Overall Study||16
8407996|NCT00967798|20723379|P1|STARTED|Overall Study||17
8407997|NCT00967694|20723393|P1|NOT COMPLETED|Overall Study||6
8407998|NCT00967694|20723393|P1|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
8407999|NCT00967694|20723393|P1|STARTED|Overall Study||26
8408000|NCT00967668|20723400|P3|NOT COMPLETED|Overall Study||69
8408001|NCT00967668|20723401|P2|NOT COMPLETED|Overall Study||56
8408002|NCT00967668|20723402|P1|NOT COMPLETED|Overall Study||71
8408003|NCT00967668|20723400|P3|COMPLETED|Overall Study||90
8408004|NCT00967668|20723401|P2|COMPLETED|Overall Study||104
8408005|NCT00967668|20723402|P1|COMPLETED|Overall Study||91
8408006|NCT00967668|20723400|P3|18-mo Assessment|Overall Study||92
8408007|NCT00967668|20723401|P2|18-mo Assessment|Overall Study||102
8408008|NCT00967668|20723402|P1|18-mo Assessment|Overall Study||95
8408009|NCT00967668|20723400|P3|Completed Year 1 - 12-mo Assessment|Overall Study||119
8408010|NCT00967668|20723401|P2|Completed Year 1 - 12-mo Assessment|Overall Study||122
8408011|NCT00967668|20723402|P1|Completed Year 1 - 12-mo Assessment|Overall Study||120
8408012|NCT00967668|20723400|P3|3-mo Assessment|Overall Study||115
8408013|NCT00967668|20723401|P2|3-mo Assessment|Overall Study||127
8408014|NCT00967668|20723402|P1|3-mo Assessment|Overall Study||131
8408015|NCT00967668|20723400|P3|STARTED|Overall Study||159
8408016|NCT00967668|20723401|P2|STARTED|Overall Study||160
8408017|NCT00967668|20723402|P1|STARTED|Overall Study||162
8408018|NCT00967616|20723415|P2|NOT COMPLETED|Overall Study||50
8408019|NCT00967616|20723416|P1|NOT COMPLETED|Overall Study||50
8408020|NCT00967616|20723415|P2|COMPLETED|Overall Study||0
8408021|NCT00967616|20723416|P1|COMPLETED|Overall Study||0
8408022|NCT00967616|20723415|P2|STARTED|Overall Study||50
8408023|NCT00967616|20723416|P1|STARTED|Overall Study||50
8408024|NCT00967551|20723432|P2|NOT COMPLETED|Overall Study||0
8408025|NCT00967551|20723433|P1|NOT COMPLETED|Overall Study||0
8408026|NCT00967551|20723432|P2|COMPLETED|Overall Study||75
8408027|NCT00967551|20723433|P1|COMPLETED|Overall Study||68
8408028|NCT00967551|20723432|P2|STARTED|Overall Study||75
8408029|NCT00967551|20723433|P1|STARTED|Overall Study||68
8408030|NCT00967499|20723443|P2|NOT COMPLETED|Overall Study||60
8408031|NCT00967499|20723444|P1|NOT COMPLETED|Overall Study||65
8408032|NCT00967499|20723443|P2|COMPLETED|Overall Study||49
8408033|NCT00967499|20723444|P1|COMPLETED|Overall Study||46
8408034|NCT00967499|20723443|P2|Treated (Full Analysis Set)|Overall Study||50
8408035|NCT00967499|20723444|P1|Treated (Full Analysis Set)|Overall Study||48
8408036|NCT00967499|20723443|P2|STARTED|Overall Study||109
8408037|NCT00967499|20723444|P1|STARTED|Overall Study||111
8408038|NCT00967486|20723462|P2|NOT COMPLETED|Overall Study||0
8408039|NCT00967486|20723463|P1|NOT COMPLETED|Overall Study||0
8408040|NCT00967486|20723462|P2|COMPLETED|Overall Study||102
8408041|NCT00967486|20723463|P1|COMPLETED|Overall Study||98
8408042|NCT00967486|20723462|P2|STARTED|Overall Study||102
8408043|NCT00967486|20723463|P1|STARTED|Overall Study||98
8408044|NCT00967473|20723469|P1|NOT COMPLETED|Overall Study||0
8408045|NCT00967473|20723469|P1|COMPLETED|Overall Study||15
8408046|NCT00967473|20723469|P1|STARTED|Overall Study||15
8408047|NCT00967447|20723475|P1|NOT COMPLETED|Overall Study||0
8408048|NCT00967447|20723475|P1|COMPLETED|Overall Study|there are no collected data in CRF|2
8408049|NCT00967447|20723475|P1|STARTED|Overall Study|there are no collected data in CRF|2
8408050|NCT00967369|20723484|P2|NOT COMPLETED|Overall Study||0
8408051|NCT00967369|20723485|P1|NOT COMPLETED|Overall Study||0
8408052|NCT00967369|20723484|P2|COMPLETED|Overall Study||10
8408053|NCT00967369|20723485|P1|COMPLETED|Overall Study||10
8408054|NCT00967369|20723484|P2|Refractory|Overall Study||3
8408055|NCT00967369|20723485|P1|Refractory|Overall Study||6
8408056|NCT00967369|20723484|P2|Relapsed|Overall Study||7
8408057|NCT00967369|20723485|P1|Relapsed|Overall Study||4
8408058|NCT00967369|20723484|P2|STARTED|Overall Study||10
8408059|NCT00967369|20723485|P1|STARTED|Overall Study||10
8408063|NCT00967330|20723507|P2|NOT COMPLETED|Overall Study||60
8408064|NCT00967330|20723508|P1|NOT COMPLETED|Overall Study||122
8408065|NCT00967330|20723507|P2|COMPLETED|Overall Study||0
8408066|NCT00967330|20723508|P1|COMPLETED|Overall Study||0
8408067|NCT00967330|20723507|P2|STARTED|Overall Study||60
8408068|NCT00967330|20723508|P1|STARTED|Overall Study||122
8408069|NCT00967226|20723538|P2|NOT COMPLETED|Overall Study||6
8408070|NCT00967226|20723539|P1|NOT COMPLETED|Overall Study||2
8408071|NCT00967226|20723538|P2|COMPLETED|Overall Study||2
8408072|NCT00967226|20723539|P1|COMPLETED|Overall Study||9
8408073|NCT00967226|20723538|P2|STARTED|Overall Study||8
8408074|NCT00967226|20723539|P1|STARTED|Overall Study||11
8408075|NCT00967044|20723569|P1|NOT COMPLETED|Overall Study||0
8408076|NCT00967044|20723569|P1|COMPLETED|Overall Study||30
8408077|NCT00967044|20723569|P1|STARTED|Overall Study||30
8408078|NCT00967018|20723573|P1|NOT COMPLETED|Overall Study||21
8408079|NCT00967018|20723573|P1|COMPLETED|Overall Study||56
8408080|NCT00967018|20723573|P1|STARTED|Overall Study||77
8408081|NCT00967005|20723582|P2|NOT COMPLETED|Overall Study||10
8408082|NCT00967005|20723583|P1|NOT COMPLETED|Overall Study||7
8408083|NCT00967005|20723582|P2|COMPLETED|Overall Study||5
8408084|NCT00967005|20723583|P1|COMPLETED|Overall Study||6
8408085|NCT00967005|20723582|P2|Treatment Completion|Overall Study||10
8408086|NCT00967005|20723583|P1|Treatment Completion|Overall Study||10
8408087|NCT00967005|20723582|P2|STARTED|Overall Study||15
8408088|NCT00967005|20723583|P1|STARTED|Overall Study||13
8408089|NCT00966992|20723637|P2|NOT COMPLETED|Overall Study||0
8408090|NCT00966992|20723638|P1|NOT COMPLETED|Overall Study||0
8408091|NCT00966992|20723637|P2|COMPLETED|Overall Study||0
8408092|NCT00966992|20723638|P1|COMPLETED|Overall Study||3
8408093|NCT00966992|20723637|P2|STARTED|Overall Study||0
8408094|NCT00966992|20723638|P1|STARTED|Overall Study||3
8408095|NCT00966953|20723658|P4|NOT COMPLETED|4th Intervention Order||0
8408096|NCT00966953|20723659|P3|NOT COMPLETED|4th Intervention Order||0
8408097|NCT00966953|20723660|P2|NOT COMPLETED|4th Intervention Order||0
8408098|NCT00966953|20723661|P1|NOT COMPLETED|4th Intervention Order||0
8408099|NCT00966953|20723658|P4|COMPLETED|4th Intervention Order||7
8408100|NCT00966953|20723659|P3|COMPLETED|4th Intervention Order||6
8408101|NCT00966953|20723660|P2|COMPLETED|4th Intervention Order||6
8408102|NCT00966953|20723661|P1|COMPLETED|4th Intervention Order||6
8408103|NCT00966953|20723658|P4|STARTED|4th Intervention Order||7
8408104|NCT00966953|20723659|P3|STARTED|4th Intervention Order||6
8408105|NCT00966953|20723660|P2|STARTED|4th Intervention Order||6
8408106|NCT00966953|20723661|P1|STARTED|4th Intervention Order||6
8408107|NCT00966953|20723658|P4|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
8408108|NCT00966953|20723659|P3|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
8408109|NCT00966953|20723660|P2|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
8408110|NCT00966953|20723661|P1|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
8408111|NCT00966953|20723658|P4|COMPLETED|1 Week Washout After 3rd Intervention||7
8408112|NCT00966953|20723659|P3|COMPLETED|1 Week Washout After 3rd Intervention||6
8408113|NCT00966953|20723660|P2|COMPLETED|1 Week Washout After 3rd Intervention||6
8408114|NCT00966953|20723661|P1|COMPLETED|1 Week Washout After 3rd Intervention||6
8408115|NCT00966953|20723658|P4|STARTED|1 Week Washout After 3rd Intervention||7
8408116|NCT00966953|20723659|P3|STARTED|1 Week Washout After 3rd Intervention||6
8408117|NCT00966953|20723660|P2|STARTED|1 Week Washout After 3rd Intervention||6
8408118|NCT00966953|20723661|P1|STARTED|1 Week Washout After 3rd Intervention||6
8408119|NCT00966953|20723658|P4|NOT COMPLETED|3rd Intervention Order||0
8408120|NCT00966953|20723659|P3|NOT COMPLETED|3rd Intervention Order||0
8408121|NCT00966953|20723660|P2|NOT COMPLETED|3rd Intervention Order||0
8408122|NCT00966953|20723661|P1|NOT COMPLETED|3rd Intervention Order||0
8408123|NCT00966953|20723658|P4|COMPLETED|3rd Intervention Order||7
8408124|NCT00966953|20723659|P3|COMPLETED|3rd Intervention Order||6
8408125|NCT00966953|20723660|P2|COMPLETED|3rd Intervention Order||6
8408126|NCT00966953|20723661|P1|COMPLETED|3rd Intervention Order||6
8408127|NCT00966953|20723658|P4|STARTED|3rd Intervention Order||7
8408128|NCT00966953|20723659|P3|STARTED|3rd Intervention Order||6
8408129|NCT00966953|20723660|P2|STARTED|3rd Intervention Order||6
8408130|NCT00966953|20723661|P1|STARTED|3rd Intervention Order||6
8408131|NCT00966953|20723658|P4|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
8408132|NCT00966953|20723659|P3|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
8408133|NCT00966953|20723660|P2|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
8408134|NCT00966953|20723661|P1|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
8408135|NCT00966953|20723658|P4|COMPLETED|1 Week Washout After 2nd Intervention||7
8408136|NCT00966953|20723659|P3|COMPLETED|1 Week Washout After 2nd Intervention||6
8408137|NCT00966953|20723660|P2|COMPLETED|1 Week Washout After 2nd Intervention||6
8408138|NCT00966953|20723661|P1|COMPLETED|1 Week Washout After 2nd Intervention||6
8408139|NCT00966953|20723658|P4|STARTED|1 Week Washout After 2nd Intervention||7
8408140|NCT00966953|20723659|P3|STARTED|1 Week Washout After 2nd Intervention||6
8408141|NCT00966953|20723660|P2|STARTED|1 Week Washout After 2nd Intervention||6
8408142|NCT00966953|20723661|P1|STARTED|1 Week Washout After 2nd Intervention||6
8408143|NCT00966953|20723658|P4|NOT COMPLETED|2nd Intervention||0
8408144|NCT00966953|20723659|P3|NOT COMPLETED|2nd Intervention||0
8408145|NCT00966953|20723660|P2|NOT COMPLETED|2nd Intervention||0
8408146|NCT00966953|20723661|P1|NOT COMPLETED|2nd Intervention||0
8408147|NCT00966953|20723658|P4|COMPLETED|2nd Intervention||7
8408148|NCT00966953|20723659|P3|COMPLETED|2nd Intervention||6
8408149|NCT00966953|20723660|P2|COMPLETED|2nd Intervention||6
8408150|NCT00966953|20723661|P1|COMPLETED|2nd Intervention||6
8408151|NCT00966953|20723658|P4|STARTED|2nd Intervention||7
8408152|NCT00966953|20723659|P3|STARTED|2nd Intervention||6
8408153|NCT00966953|20723660|P2|STARTED|2nd Intervention||6
8408154|NCT00966953|20723661|P1|STARTED|2nd Intervention||6
8408155|NCT00966953|20723658|P4|NOT COMPLETED|1 Week Washout After 1st Intervention||0
8408156|NCT00966953|20723659|P3|NOT COMPLETED|1 Week Washout After 1st Intervention||0
8408157|NCT00966953|20723660|P2|NOT COMPLETED|1 Week Washout After 1st Intervention||0
8408158|NCT00966953|20723661|P1|NOT COMPLETED|1 Week Washout After 1st Intervention||0
8408159|NCT00966953|20723658|P4|COMPLETED|1 Week Washout After 1st Intervention||7
8408160|NCT00966953|20723659|P3|COMPLETED|1 Week Washout After 1st Intervention||6
8408161|NCT00966953|20723660|P2|COMPLETED|1 Week Washout After 1st Intervention||6
8408162|NCT00966953|20723661|P1|COMPLETED|1 Week Washout After 1st Intervention||6
8408163|NCT00966953|20723658|P4|STARTED|1 Week Washout After 1st Intervention||7
8408164|NCT00966953|20723659|P3|STARTED|1 Week Washout After 1st Intervention||6
8408165|NCT00966953|20723660|P2|STARTED|1 Week Washout After 1st Intervention||6
8408166|NCT00966953|20723661|P1|STARTED|1 Week Washout After 1st Intervention||6
8408167|NCT00966953|20723658|P4|NOT COMPLETED|1st Intervention||0
8408168|NCT00966953|20723659|P3|NOT COMPLETED|1st Intervention||0
8408169|NCT00966953|20723660|P2|NOT COMPLETED|1st Intervention||0
8408170|NCT00966953|20723661|P1|NOT COMPLETED|1st Intervention||0
8408171|NCT00966953|20723658|P4|COMPLETED|1st Intervention||7
8408172|NCT00966953|20723659|P3|COMPLETED|1st Intervention||6
8408173|NCT00966953|20723660|P2|COMPLETED|1st Intervention||6
8408174|NCT00966953|20723661|P1|COMPLETED|1st Intervention||6
8408175|NCT00966953|20723658|P4|STARTED|1st Intervention||7
8408176|NCT00966953|20723659|P3|STARTED|1st Intervention||6
8408177|NCT00966953|20723660|P2|STARTED|1st Intervention||6
8408178|NCT00966953|20723661|P1|STARTED|1st Intervention||6
8408179|NCT00966940|20723669|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
8408180|NCT00966940|20723670|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
8408181|NCT00966940|20723669|P2|COMPLETED|Period 2, Second 6 Weeks||23
8408182|NCT00966940|20723670|P1|COMPLETED|Period 2, Second 6 Weeks||25
8408183|NCT00966940|20723669|P2|STARTED|Period 2, Second 6 Weeks||23
8408184|NCT00966940|20723670|P1|STARTED|Period 2, Second 6 Weeks||25
8408185|NCT00966940|20723669|P2|NOT COMPLETED|Period 1, First 6 Weeks||0
8408186|NCT00966940|20723670|P1|NOT COMPLETED|Period 1, First 6 Weeks||3
8408187|NCT00966940|20723669|P2|COMPLETED|Period 1, First 6 Weeks||23
8408188|NCT00966940|20723670|P1|COMPLETED|Period 1, First 6 Weeks||25
8408189|NCT00966940|20723669|P2|STARTED|Period 1, First 6 Weeks||23
8408190|NCT00966940|20723670|P1|STARTED|Period 1, First 6 Weeks||28
8408191|NCT00966875|20723697|P9|NOT COMPLETED|Part B||18
8408192|NCT00966875|20723698|P8|NOT COMPLETED|Part B||19
8408193|NCT00966875|20723699|P7|NOT COMPLETED|Part B||22
8408194|NCT00966875|20723700|P6|NOT COMPLETED|Part B||6
8408195|NCT00966875|20723701|P5|NOT COMPLETED|Part B||7
8408196|NCT00966875|20723702|P4|NOT COMPLETED|Part B||3
8408197|NCT00966875|20723703|P3|NOT COMPLETED|Part B||6
8408198|NCT00966875|20723704|P2|NOT COMPLETED|Part B||3
8408199|NCT00966875|20723705|P1|NOT COMPLETED|Part B||5
8408200|NCT00966875|20723697|P9|COMPLETED|Part B||32
8408201|NCT00966875|20723698|P8|COMPLETED|Part B||38
8408202|NCT00966875|20723699|P7|COMPLETED|Part B||29
8408203|NCT00966875|20723700|P6|COMPLETED|Part B||26
8408204|NCT00966875|20723701|P5|COMPLETED|Part B||44
8408205|NCT00966875|20723702|P4|COMPLETED|Part B||31
8408206|NCT00966875|20723703|P3|COMPLETED|Part B||27
8408207|NCT00966875|20723704|P2|COMPLETED|Part B||33
8408208|NCT00966875|20723705|P1|COMPLETED|Part B||41
8408209|NCT00966875|20723697|P9|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
8408210|NCT00966875|20723698|P8|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
8408211|NCT00966875|20723699|P7|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
8408212|NCT00966875|20723700|P6|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
8408213|NCT00966875|20723701|P5|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
8408214|NCT00966875|20723702|P4|STARTED|Part B||34
8408215|NCT00966875|20723703|P3|STARTED|Part B||33
8408216|NCT00966875|20723704|P2|STARTED|Part B||36
8408217|NCT00966875|20723705|P1|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
8408218|NCT00966875|20723697|P9|NOT COMPLETED|Part A||8
8408219|NCT00966875|20723698|P8|NOT COMPLETED|Part A||7
8408220|NCT00966875|20723699|P7|NOT COMPLETED|Part A||12
8408221|NCT00966875|20723700|P6|NOT COMPLETED|Part A||4
8408222|NCT00966875|20723701|P5|NOT COMPLETED|Part A||5
8408223|NCT00966875|20723702|P4|NOT COMPLETED|Part A||3
8408224|NCT00966875|20723703|P3|NOT COMPLETED|Part A||2
8408225|NCT00966875|20723704|P2|NOT COMPLETED|Part A||4
8408226|NCT00966875|20723705|P1|NOT COMPLETED|Part A||6
8408227|NCT00966875|20723697|P9|COMPLETED|Part A||51
8408228|NCT00966875|20723698|P8|COMPLETED|Part A||58
8408229|NCT00966875|20723699|P7|COMPLETED|Part A||52
8408230|NCT00966875|20723700|P6|COMPLETED|Part A||33
8408231|NCT00966875|20723701|P5|COMPLETED|Part A||52
8408232|NCT00966875|20723702|P4|COMPLETED|Part A||34
8408233|NCT00966875|20723703|P3|COMPLETED|Part A||33
8408234|NCT00966875|20723704|P2|COMPLETED|Part A||36
8408235|NCT00966875|20723705|P1|COMPLETED|Part A||48
8408236|NCT00966875|20723697|P9|Received ≥1 Doses of Study Drug|Part A||59
8408237|NCT00966875|20723698|P8|Received ≥1 Doses of Study Drug|Part A||65
8408238|NCT00966875|20723699|P7|Received ≥1 Doses of Study Drug|Part A||64
8408239|NCT00966875|20723700|P6|Received ≥1 Doses of Study Drug|Part A||37
8408240|NCT00966875|20723701|P5|Received ≥1 Doses of Study Drug|Part A||57
8408241|NCT00966875|20723702|P4|Received ≥1 Doses of Study Drug|Part A||37
8408242|NCT00966875|20723703|P3|Received ≥1 Doses of Study Drug|Part A||35
8408243|NCT00966875|20723704|P2|Received ≥1 Doses of Study Drug|Part A||40
8408244|NCT00966875|20723705|P1|Received ≥1 Doses of Study Drug|Part A||54
8408245|NCT00966875|20723697|P9|STARTED|Part A||59
8408246|NCT00966875|20723698|P8|STARTED|Part A||65
8408247|NCT00966875|20723699|P7|STARTED|Part A||64
8408248|NCT00966875|20723700|P6|STARTED|Part A||37
8408249|NCT00966875|20723701|P5|STARTED|Part A||57
8408250|NCT00966875|20723702|P4|STARTED|Part A||37
8408251|NCT00966875|20723703|P3|STARTED|Part A||35
8408252|NCT00966875|20723704|P2|STARTED|Part A||40
8408253|NCT00966875|20723705|P1|STARTED|Part A||54
8408254|NCT00966849|20724027|P3|NOT COMPLETED|Overall Study||1293
8408255|NCT00966849|20724028|P2|NOT COMPLETED|Overall Study||1478
8408256|NCT00966849|20724029|P1|NOT COMPLETED|Overall Study||1541
8408257|NCT00966849|20724027|P3|COMPLETED|Overall Study||1876
8408258|NCT00966849|20724028|P2|COMPLETED|Overall Study||2498
8408259|NCT00966849|20724029|P1|COMPLETED|Overall Study||2119
8408260|NCT00966849|20724027|P3|STARTED|Overall Study||3169
8408261|NCT00966849|20724028|P2|STARTED|Overall Study||3976
8408262|NCT00966849|20724029|P1|STARTED|Overall Study||3660
8408263|NCT00966823|20724046|P1|NOT COMPLETED|Overall Study||1
8408264|NCT00966823|20724046|P1|COMPLETED|Overall Study||2
8408265|NCT00966823|20724046|P1|STARTED|Overall Study||3
8408266|NCT00966719|20724056|P2|NOT COMPLETED|Overall Study||11
8408267|NCT00966719|20724057|P1|NOT COMPLETED|Overall Study||6
8408268|NCT00966719|20724056|P2|COMPLETED|Overall Study||38
8408269|NCT00966719|20724057|P1|COMPLETED|Overall Study||44
8408270|NCT00966719|20724056|P2|STARTED|Overall Study||49
8408271|NCT00966719|20724057|P1|STARTED|Overall Study||50
8408272|NCT00966693|20724081|P4|NOT COMPLETED|Overall Study||23
8408273|NCT00966693|20724082|P3|NOT COMPLETED|Overall Study||3
8408274|NCT00966693|20724083|P2|NOT COMPLETED|Overall Study||0
8408275|NCT00966693|20724084|P1|NOT COMPLETED|Overall Study||1
8408276|NCT00966693|20724081|P4|COMPLETED|Overall Study||26
8408277|NCT00966693|20724082|P3|COMPLETED|Overall Study||6
8408278|NCT00966693|20724083|P2|COMPLETED|Overall Study||3
8408279|NCT00966693|20724084|P1|COMPLETED|Overall Study||2
8408280|NCT00966693|20724081|P4|Phase 2 Completed|Overall Study||46
8408281|NCT00966693|20724082|P3|Phase 2 Completed|Overall Study||0
8408282|NCT00966693|20724083|P2|Phase 2 Completed|Overall Study||0
8408283|NCT00966693|20724084|P1|Phase 2 Completed|Overall Study||0
8408284|NCT00966693|20724081|P4|Phase 1 Completed|Overall Study||0
8408285|NCT00966693|20724082|P3|Phase 1 Completed|Overall Study||6
8408286|NCT00966693|20724083|P2|Phase 1 Completed|Overall Study||3
8408287|NCT00966693|20724084|P1|Phase 1 Completed|Overall Study||2
8408288|NCT00966693|20724081|P4|STARTED|Overall Study||49
8408289|NCT00966693|20724082|P3|STARTED|Overall Study||9
8408290|NCT00966693|20724083|P2|STARTED|Overall Study||3
8408291|NCT00966693|20724084|P1|STARTED|Overall Study||3
8408292|NCT00966654|20724118|P1|NOT COMPLETED|Overall Study||12
8408293|NCT00966654|20724118|P1|COMPLETED|Overall Study||0
8408294|NCT00966654|20724118|P1|STARTED|Overall Study||12
8408295|NCT00966641|20724126|P2|NOT COMPLETED|Second Intervention||0
8408296|NCT00966641|20724127|P1|NOT COMPLETED|Second Intervention||0
8408297|NCT00966641|20724126|P2|COMPLETED|Second Intervention||17
8408298|NCT00966641|20724127|P1|COMPLETED|Second Intervention||17
8408299|NCT00966641|20724126|P2|STARTED|Second Intervention||17
8408300|NCT00966641|20724127|P1|STARTED|Second Intervention||17
8408301|NCT00966641|20724126|P2|NOT COMPLETED|First Intervention||0
8408302|NCT00966641|20724127|P1|NOT COMPLETED|First Intervention||0
8408303|NCT00966641|20724126|P2|COMPLETED|First Intervention||17
8408304|NCT00966641|20724127|P1|COMPLETED|First Intervention||17
8408305|NCT00966641|20724126|P2|STARTED|First Intervention||17
8408306|NCT00966641|20724127|P1|STARTED|First Intervention||17
8408307|NCT00966550|20724135|P2|NOT COMPLETED|Overall Study||0
8408308|NCT00966550|20724136|P1|NOT COMPLETED|Overall Study||0
8408309|NCT00966550|20724135|P2|COMPLETED|Overall Study||12
8408310|NCT00966550|20724136|P1|COMPLETED|Overall Study||13
8408311|NCT00966550|20724135|P2|STARTED|Overall Study||12
8408312|NCT00966550|20724136|P1|STARTED|Overall Study||13
8408313|NCT00966446|20724145|P3|NOT COMPLETED|Overall Study||21
8408314|NCT00966446|20724146|P2|NOT COMPLETED|Overall Study||25
8408315|NCT00966446|20724147|P1|NOT COMPLETED|Overall Study||28
8408316|NCT00966446|20724145|P3|COMPLETED|Overall Study||52
8408317|NCT00966446|20724146|P2|COMPLETED|Overall Study||49
8408318|NCT00966446|20724147|P1|COMPLETED|Overall Study||48
8408319|NCT00966446|20724145|P3|STARTED|Overall Study||73
8408320|NCT00966446|20724146|P2|STARTED|Overall Study||74
8408321|NCT00966446|20724147|P1|STARTED|Overall Study||76
8408322|NCT00966433|20724164|P3|NOT COMPLETED|Overall Study||0
8408323|NCT00966433|20724165|P2|NOT COMPLETED|Overall Study||1
8408324|NCT00966433|20724166|P1|NOT COMPLETED|Overall Study||1
8408325|NCT00966433|20724164|P3|COMPLETED|Overall Study||11
8408326|NCT00966433|20724165|P2|COMPLETED|Overall Study||10
8408327|NCT00966433|20724166|P1|COMPLETED|Overall Study||10
8408328|NCT00966433|20724164|P3|STARTED|Overall Study||11
8408329|NCT00966433|20724165|P2|STARTED|Overall Study||11
8408330|NCT00966433|20724166|P1|STARTED|Overall Study||11
8408331|NCT00966355|20724192|P3|NOT COMPLETED|Overall Study||84
8408332|NCT00966355|20724193|P2|NOT COMPLETED|Overall Study||86
8408333|NCT00966355|20724194|P1|NOT COMPLETED|Overall Study||84
8408334|NCT00966355|20724192|P3|COMPLETED|Overall Study||261
8408335|NCT00966355|20724193|P2|COMPLETED|Overall Study||259
8408336|NCT00966355|20724194|P1|COMPLETED|Overall Study||260
8408337|NCT00966355|20724192|P3|STARTED|Overall Study||345
8408338|NCT00966355|20724193|P2|STARTED|Overall Study||345
8408339|NCT00966355|20724194|P1|STARTED|Overall Study||344
8408340|NCT00966277|20724207|P2|NOT COMPLETED|Overall Study||4
8408341|NCT00966277|20724208|P1|NOT COMPLETED|Overall Study||4
8408342|NCT00966277|20724207|P2|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
8408343|NCT00966277|20724208|P1|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
8408344|NCT00966277|20724207|P2|STARTED|Overall Study||37
8408345|NCT00966277|20724208|P1|STARTED|Overall Study||38
8408346|NCT00966264|20724216|P2|NOT COMPLETED|Overall Study||3
8408347|NCT00966264|20724217|P1|NOT COMPLETED|Overall Study||4
8408348|NCT00966264|20724216|P2|COMPLETED|Overall Study|5 years results|114
8408349|NCT00966264|20724217|P1|COMPLETED|Overall Study|5 years results|115
8408350|NCT00966264|20724216|P2|STARTED|Overall Study||117
8408351|NCT00966264|20724217|P1|STARTED|Overall Study||119
8408352|NCT00966238|20724229|P6|NOT COMPLETED|Overall Study||0
8408353|NCT00966238|20724230|P5|NOT COMPLETED|Overall Study||0
8408354|NCT00966238|20724231|P4|NOT COMPLETED|Overall Study||0
8408355|NCT00966238|20724232|P3|NOT COMPLETED|Overall Study||0
8408356|NCT00966238|20724233|P2|NOT COMPLETED|Overall Study||0
8408357|NCT00966238|20724234|P1|NOT COMPLETED|Overall Study||0
8408358|NCT00966238|20724229|P6|COMPLETED|Overall Study||20
8408359|NCT00966238|20724230|P5|COMPLETED|Overall Study||20
8408360|NCT00966238|20724231|P4|COMPLETED|Overall Study||20
8408361|NCT00966238|20724232|P3|COMPLETED|Overall Study||20
8408362|NCT00966238|20724233|P2|COMPLETED|Overall Study||20
8408363|NCT00966238|20724234|P1|COMPLETED|Overall Study||20
8408364|NCT00966238|20724229|P6|STARTED|Overall Study||20
8408365|NCT00966238|20724230|P5|STARTED|Overall Study||20
8408366|NCT00966238|20724231|P4|STARTED|Overall Study||20
8408367|NCT00966238|20724232|P3|STARTED|Overall Study||20
8408368|NCT00966238|20724233|P2|STARTED|Overall Study||20
8408369|NCT00966238|20724234|P1|STARTED|Overall Study||20
8408370|NCT00966186|20724256|P2|NOT COMPLETED|Overall Study||0
8408371|NCT00966186|20724257|P1|NOT COMPLETED|Overall Study||0
8408372|NCT00966186|20724256|P2|COMPLETED|Overall Study||60
8408373|NCT00966186|20724257|P1|COMPLETED|Overall Study||60
8408374|NCT00966186|20724256|P2|STARTED|Overall Study||60
8408375|NCT00966186|20724257|P1|STARTED|Overall Study||60
8408376|NCT00965848|20724263|P3|NOT COMPLETED|Overall Study||10
8408377|NCT00965848|20724264|P2|NOT COMPLETED|Overall Study||2
8408378|NCT00965848|20724265|P1|NOT COMPLETED|Overall Study||29
8408379|NCT00965848|20724263|P3|COMPLETED|Overall Study||117
8408380|NCT00965848|20724264|P2|COMPLETED|Overall Study||32
8408381|NCT00965848|20724265|P1|COMPLETED|Overall Study||78
8408382|NCT00965848|20724263|P3|STARTED|Overall Study||127
8408383|NCT00965848|20724264|P2|STARTED|Overall Study||34
8408384|NCT00965848|20724265|P1|STARTED|Overall Study||107
8408385|NCT00965757|20724284|P4|NOT COMPLETED|Extension Phase||24
8408386|NCT00965757|20724285|P3|NOT COMPLETED|Extension Phase||33
8408387|NCT00965757|20724286|P2|NOT COMPLETED|Extension Phase||0
8408388|NCT00965757|20724287|P1|NOT COMPLETED|Extension Phase||0
8408389|NCT00965757|20724284|P4|COMPLETED|Extension Phase||64
8408390|NCT00965757|20724285|P3|COMPLETED|Extension Phase||132
8408391|NCT00965757|20724286|P2|COMPLETED|Extension Phase||0
8408392|NCT00965757|20724287|P1|COMPLETED|Extension Phase||0
8408393|NCT00965757|20724284|P4|STARTED|Extension Phase||88
8408394|NCT00965757|20724285|P3|STARTED|Extension Phase||165
8408395|NCT00965757|20724286|P2|STARTED|Extension Phase||0
8408396|NCT00965757|20724287|P1|STARTED|Extension Phase||0
8408397|NCT00965757|20724284|P4|NOT COMPLETED|Double-blind Phase||0
8408398|NCT00965757|20724285|P3|NOT COMPLETED|Double-blind Phase||0
8408399|NCT00965757|20724286|P2|NOT COMPLETED|Double-blind Phase||18
8408400|NCT00965757|20724287|P1|NOT COMPLETED|Double-blind Phase||17
8408401|NCT00965757|20724284|P4|COMPLETED|Double-blind Phase||0
8408402|NCT00965757|20724285|P3|COMPLETED|Double-blind Phase||0
8408403|NCT00965757|20724286|P2|COMPLETED|Double-blind Phase||70
8408404|NCT00965757|20724287|P1|COMPLETED|Double-blind Phase||148
8408405|NCT00965757|20724284|P4|STARTED|Double-blind Phase||0
8408406|NCT00965757|20724285|P3|STARTED|Double-blind Phase||0
8408407|NCT00965757|20724286|P2|STARTED|Double-blind Phase||88
8408408|NCT00965757|20724287|P1|STARTED|Double-blind Phase||165
8408409|NCT00965731|20724321|P2|NOT COMPLETED|Overall Study||20
8408410|NCT00965731|20724322|P1|NOT COMPLETED|Overall Study||7
8408411|NCT00965731|20724321|P2|COMPLETED|Overall Study||0
8408412|NCT00965731|20724322|P1|COMPLETED|Overall Study||0
8408413|NCT00965731|20724321|P2|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
8408414|NCT00965731|20724322|P1|STARTED|Overall Study||7
8408415|NCT00965718|20724386|P1|NOT COMPLETED|Overall Study||4
8408416|NCT00965718|20724386|P1|COMPLETED|Overall Study||16
8408417|NCT00965718|20724386|P1|STARTED|Overall Study||20
8408418|NCT00965575|20724398|P2|NOT COMPLETED|Overall Study||0
8408419|NCT00965575|20724399|P1|NOT COMPLETED|Overall Study||1
8408420|NCT00965575|20724398|P2|COMPLETED|Overall Study||5
8408421|NCT00965575|20724399|P1|COMPLETED|Overall Study||5
8408422|NCT00965575|20724398|P2|STARTED|Overall Study|cross over, total enrolled 11|5
8408423|NCT00965575|20724399|P1|STARTED|Overall Study|cross over, total enrolled 11|6
8408424|NCT00965562|20724410|P3|NOT COMPLETED|Overall Study||3
8408425|NCT00965562|20724411|P2|NOT COMPLETED|Overall Study||4
8408426|NCT00965562|20724412|P1|NOT COMPLETED|Overall Study||3
8408427|NCT00965562|20724410|P3|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
8408428|NCT00965562|20724411|P2|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
8408429|NCT00965562|20724412|P1|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
8408430|NCT00965562|20724410|P3|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
8408431|NCT00965562|20724411|P2|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
8408432|NCT00965562|20724412|P1|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
8408433|NCT00965562|20724410|P3|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
8408434|NCT00965562|20724411|P2|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
8408435|NCT00965562|20724412|P1|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
8408436|NCT00965562|20724410|P3|STARTED|Overall Study||16
8408437|NCT00965562|20724411|P2|STARTED|Overall Study||17
8408438|NCT00965562|20724412|P1|STARTED|Overall Study||16
8408439|NCT00965523|20724450|P1|NOT COMPLETED|Study 224||6
8408440|NCT00965523|20724450|P1|COMPLETED|Study 224||0
8408441|NCT00965523|20724450|P1|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
8408442|NCT00965523|20724450|P1|NOT COMPLETED|Study 221||7
8408443|NCT00965523|20724450|P1|COMPLETED|Study 221||74
8408444|NCT00965523|20724450|P1|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
8408445|NCT00965497|20724455|P1|NOT COMPLETED|Overall Study||1
8408446|NCT00965497|20724455|P1|COMPLETED|Overall Study||13
8408447|NCT00965497|20724455|P1|STARTED|Overall Study||14
8408448|NCT00965484|20724460|P1|NOT COMPLETED|Overall Study||2
8408449|NCT00965484|20724460|P1|COMPLETED|Overall Study||134
8408450|NCT00965484|20724460|P1|STARTED|Overall Study||136
8408451|NCT00965458|20724469|P2|NOT COMPLETED|Overall Study||4
8408452|NCT00965458|20724470|P1|NOT COMPLETED|Overall Study||2
8408453|NCT00965458|20724469|P2|COMPLETED|Overall Study||12
8408454|NCT00965458|20724470|P1|COMPLETED|Overall Study||31
8408455|NCT00965458|20724469|P2|STARTED|Overall Study||16
8408456|NCT00965458|20724470|P1|STARTED|Overall Study||33
8408457|NCT00965419|20724486|P1|NOT COMPLETED|Follow-up Phase||62
8408458|NCT00965419|20724486|P1|COMPLETED|Follow-up Phase||18
8408459|NCT00965419|20724486|P1|STARTED|Follow-up Phase||80
8408460|NCT00965419|20724486|P1|NOT COMPLETED|Open Label Treatment for Responders||247
8408461|NCT00965419|20724486|P1|COMPLETED|Open Label Treatment for Responders||20
8408462|NCT00965419|20724486|P1|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
8408463|NCT00965419|20724486|P1|STARTED|Open Label Treatment for Responders||267
8408464|NCT00965341|20724532|P2|NOT COMPLETED|Overall Study||8
8408465|NCT00965341|20724533|P1|NOT COMPLETED|Overall Study||6
8408466|NCT00965341|20724532|P2|COMPLETED|Overall Study||16
8408467|NCT00965341|20724533|P1|COMPLETED|Overall Study||13
8408468|NCT00965341|20724532|P2|STARTED|Overall Study||24
8408469|NCT00965341|20724533|P1|STARTED|Overall Study||19
8408470|NCT00965263|20724543|P2|NOT COMPLETED|Overall Study||3
8408471|NCT00965263|20724544|P1|NOT COMPLETED|Overall Study||2
8408472|NCT00965263|20724543|P2|COMPLETED|Overall Study||6
8408473|NCT00965263|20724544|P1|COMPLETED|Overall Study||4
8408474|NCT00965263|20724543|P2|STARTED|Overall Study||9
8408475|NCT00965263|20724544|P1|STARTED|Overall Study||6
8408476|NCT00965250|20724576|P2|NOT COMPLETED|Overall Study||0
8408477|NCT00965250|20724577|P1|NOT COMPLETED|Overall Study||0
8408478|NCT00965250|20724576|P2|COMPLETED|Overall Study||12
8408479|NCT00965250|20724577|P1|COMPLETED|Overall Study||37
8408480|NCT00965250|20724576|P2|STARTED|Overall Study||12
8408481|NCT00965250|20724577|P1|STARTED|Overall Study||37
8408482|NCT00965237|20724595|P2|NOT COMPLETED|Period 2, One Week of Wear||0
8408483|NCT00965237|20724596|P1|NOT COMPLETED|Period 2, One Week of Wear||0
8408484|NCT00965237|20724595|P2|COMPLETED|Period 2, One Week of Wear||8
8408485|NCT00965237|20724596|P1|COMPLETED|Period 2, One Week of Wear||8
8408486|NCT00965237|20724595|P2|STARTED|Period 2, One Week of Wear||8
8408487|NCT00965237|20724596|P1|STARTED|Period 2, One Week of Wear||8
8408488|NCT00965237|20724595|P2|NOT COMPLETED|Period 1, One Week of Wear||0
8408489|NCT00965237|20724596|P1|NOT COMPLETED|Period 1, One Week of Wear||0
8408490|NCT00965237|20724595|P2|COMPLETED|Period 1, One Week of Wear||8
8408491|NCT00965237|20724596|P1|COMPLETED|Period 1, One Week of Wear||8
8408492|NCT00965237|20724595|P2|STARTED|Period 1, One Week of Wear||8
8408493|NCT00965237|20724596|P1|STARTED|Period 1, One Week of Wear||8
8408494|NCT00965185|20724604|P2|NOT COMPLETED|Overall Study||1
8408495|NCT00965185|20724605|P1|NOT COMPLETED|Overall Study||2
8408496|NCT00965185|20724604|P2|COMPLETED|Overall Study||20
8408497|NCT00965185|20724605|P1|COMPLETED|Overall Study||17
8408498|NCT00965185|20724604|P2|9 Month Visit|Overall Study||21
8408499|NCT00965185|20724605|P1|9 Month Visit|Overall Study||18
8408500|NCT00965185|20724604|P2|6 Month Visit|Overall Study||21
8408501|NCT00965185|20724605|P1|6 Month Visit|Overall Study||18
8408502|NCT00965185|20724604|P2|3 Month Visit|Overall Study||21
8408503|NCT00965185|20724605|P1|3 Month Visit|Overall Study||18
8408504|NCT00965185|20724604|P2|1 Month Visit|Overall Study||21
8408505|NCT00965185|20724605|P1|1 Month Visit|Overall Study||18
8408506|NCT00965185|20724604|P2|STARTED|Overall Study||21
8408507|NCT00965185|20724605|P1|STARTED|Overall Study||19
8408508|NCT00965146|20724625|P1|NOT COMPLETED|Overall Study||210
8408509|NCT00965146|20724625|P1|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
8408510|NCT00965146|20724625|P1|STARTED|Overall Study||210
8408511|NCT00965094|20724632|P2|NOT COMPLETED|Overall Study||1
8408512|NCT00965094|20724633|P1|NOT COMPLETED|Overall Study||5
8408513|NCT00965094|20724632|P2|COMPLETED|Overall Study||16
8408514|NCT00965094|20724633|P1|COMPLETED|Overall Study||14
8408515|NCT00965094|20724632|P2|STARTED|Overall Study||17
8408516|NCT00965094|20724633|P1|STARTED|Overall Study||19
8408517|NCT00965081|20724649|P2|NOT COMPLETED|Overall Study||43
8408518|NCT00965081|20724650|P1|NOT COMPLETED|Overall Study||34
8408519|NCT00965081|20724649|P2|COMPLETED|Overall Study||110
8408520|NCT00965081|20724650|P1|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
8408521|NCT00965081|20724649|P2|STARTED|Overall Study||153
8408522|NCT00965081|20724650|P1|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
8408523|NCT00965055|20724673|P1|NOT COMPLETED|Overall Study||0
8408524|NCT00965055|20724673|P1|COMPLETED|Overall Study||2
8408525|NCT00965055|20724673|P1|STARTED|Overall Study||2
8408526|NCT00964886|20724682|P4|NOT COMPLETED|Overall Study||9
8408527|NCT00964886|20724683|P3|NOT COMPLETED|Overall Study||16
8408528|NCT00964886|20724684|P2|NOT COMPLETED|Overall Study||7
8408529|NCT00964886|20724685|P1|NOT COMPLETED|Overall Study||11
8408530|NCT00964886|20724682|P4|COMPLETED|Overall Study||24
8408531|NCT00964886|20724683|P3|COMPLETED|Overall Study||21
8408532|NCT00964886|20724684|P2|COMPLETED|Overall Study||27
8408533|NCT00964886|20724685|P1|COMPLETED|Overall Study||27
8408534|NCT00964886|20724682|P4|STARTED|Overall Study||33
8408535|NCT00964886|20724683|P3|STARTED|Overall Study||37
8408536|NCT00964886|20724684|P2|STARTED|Overall Study||34
8408537|NCT00964886|20724685|P1|STARTED|Overall Study||38
8408538|NCT00964860|20724701|P2|NOT COMPLETED|Overall Study||1
8408539|NCT00964860|20724702|P1|NOT COMPLETED|Overall Study||0
8408540|NCT00964860|20724701|P2|COMPLETED|Overall Study||29
8408541|NCT00964860|20724702|P1|COMPLETED|Overall Study||30
8408542|NCT00964860|20724701|P2|STARTED|Overall Study||30
8408543|NCT00964860|20724702|P1|STARTED|Overall Study||30
8408544|NCT00964795|20724710|P1|NOT COMPLETED|Overall Study||307
8408545|NCT00964795|20724710|P1|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
8408546|NCT00964795|20724710|P1|Number of Participants Treated|Overall Study||320
8408547|NCT00964795|20724710|P1|STARTED|Overall Study|randomized|323
8408548|NCT00964782|20724719|P2|NOT COMPLETED|Overall Study||0
8408549|NCT00964782|20724720|P1|NOT COMPLETED|Overall Study||1
8408550|NCT00964782|20724719|P2|COMPLETED|Overall Study||8
8408551|NCT00964782|20724720|P1|COMPLETED|Overall Study||7
8408552|NCT00964782|20724719|P2|STARTED|Overall Study||8
8408553|NCT00964782|20724720|P1|STARTED|Overall Study||8
8408554|NCT00964743|20724734|P1|NOT COMPLETED|Overall Study||2
8408555|NCT00964743|20724734|P1|COMPLETED|Overall Study||0
8408556|NCT00964743|20724734|P1|STARTED|Overall Study||2
8408557|NCT00964678|20724742|P1|NOT COMPLETED|Overall Study||4
8408558|NCT00964678|20724742|P1|COMPLETED|Overall Study||6
8408559|NCT00964678|20724742|P1|STARTED|Overall Study||10
8408560|NCT00964548|20724751|P2|NOT COMPLETED|Overall Study||0
8408561|NCT00964548|20724752|P1|NOT COMPLETED|Overall Study||0
8408562|NCT00964548|20724751|P2|COMPLETED|Overall Study||5
8408563|NCT00964548|20724752|P1|COMPLETED|Overall Study||5
8408564|NCT00964548|20724751|P2|STARTED|Overall Study||5
8408565|NCT00964548|20724752|P1|STARTED|Overall Study||5
8408566|NCT00964496|20724764|P2|NOT COMPLETED|Overall Study||1
8408567|NCT00964496|20724765|P1|NOT COMPLETED|Overall Study||2
8408568|NCT00964496|20724764|P2|COMPLETED|Overall Study||26
8408569|NCT00964496|20724765|P1|COMPLETED|Overall Study||26
8408570|NCT00964496|20724764|P2|STARTED|Overall Study||27
8408571|NCT00964496|20724765|P1|STARTED|Overall Study||28
8408572|NCT00964444|20724783|P1|NOT COMPLETED|Overall Study||0
8408573|NCT00964444|20724783|P1|COMPLETED|Overall Study||10
8408574|NCT00964444|20724783|P1|STARTED|Overall Study||10
8408575|NCT00964431|20724791|P4|NOT COMPLETED|Overall Study||0
8408576|NCT00964431|20724792|P3|NOT COMPLETED|Overall Study||0
8408577|NCT00964431|20724793|P2|NOT COMPLETED|Overall Study||0
8408578|NCT00964431|20724794|P1|NOT COMPLETED|Overall Study||0
8408579|NCT00964431|20724791|P4|COMPLETED|Overall Study||51
8408580|NCT00964431|20724792|P3|COMPLETED|Overall Study||51
8408581|NCT00964431|20724793|P2|COMPLETED|Overall Study||51
8408582|NCT00964431|20724794|P1|COMPLETED|Overall Study||50
8408583|NCT00964431|20724791|P4|STARTED|Overall Study||51
8408584|NCT00964431|20724792|P3|STARTED|Overall Study||51
8408585|NCT00964431|20724793|P2|STARTED|Overall Study||51
8408586|NCT00964431|20724794|P1|STARTED|Overall Study||50
8408587|NCT00964392|20724806|P2|NOT COMPLETED|Overall Study||190
8408588|NCT00964392|20724807|P1|NOT COMPLETED|Overall Study||53
8408589|NCT00964392|20724806|P2|COMPLETED|Overall Study||92
8408590|NCT00964392|20724807|P1|COMPLETED|Overall Study||72
8408591|NCT00964392|20724806|P2|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
8408592|NCT00964392|20724807|P1|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
8408593|NCT00964366|20724817|P2|NOT COMPLETED|Overall Study||1
8408594|NCT00964366|20724818|P1|NOT COMPLETED|Overall Study||1
8408595|NCT00964366|20724817|P2|COMPLETED|Overall Study||24
8408596|NCT00964366|20724818|P1|COMPLETED|Overall Study||27
8408597|NCT00964366|20724817|P2|STARTED|Overall Study||25
8408598|NCT00964366|20724818|P1|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
8408599|NCT00964353|20724834|P2|NOT COMPLETED|Overall Study||0
8408600|NCT00964353|20724835|P1|NOT COMPLETED|Overall Study||0
8408601|NCT00964353|20724834|P2|COMPLETED|Overall Study||178
8408602|NCT00964353|20724835|P1|COMPLETED|Overall Study||181
8408603|NCT00964353|20724834|P2|STARTED|Overall Study||178
8408604|NCT00964353|20724835|P1|STARTED|Overall Study||181
8408605|NCT00964223|20724843|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
8408606|NCT00964223|20724843|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
8408607|NCT00964223|20724843|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||28
8408608|NCT00964223|20724843|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
8408609|NCT00964223|20724843|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
8408610|NCT00964223|20724843|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||28
8408611|NCT00964158|20724911|P3|NOT COMPLETED|Overall Study||8
8408612|NCT00964158|20724912|P2|NOT COMPLETED|Overall Study||1
8408613|NCT00964158|20724913|P1|NOT COMPLETED|Overall Study||0
8408614|NCT00964158|20724911|P3|COMPLETED|Overall Study||92
8408615|NCT00964158|20724912|P2|COMPLETED|Overall Study||56
8408616|NCT00964158|20724913|P1|COMPLETED|Overall Study||53
8408617|NCT00964158|20724911|P3|STARTED|Overall Study||100
8408618|NCT00964158|20724912|P2|STARTED|Overall Study||57
8408619|NCT00964158|20724913|P1|STARTED|Overall Study||53
8408620|NCT00964119|20724982|P1|NOT COMPLETED|Overall Study||0
8408621|NCT00964119|20724982|P1|COMPLETED|Overall Study||15
8408622|NCT00964119|20724982|P1|STARTED|Overall Study||15
8408623|NCT00964028|20724988|P2|NOT COMPLETED|Overall Study||1
8408624|NCT00964028|20724989|P1|NOT COMPLETED|Overall Study||0
8408625|NCT00964028|20724988|P2|COMPLETED|Overall Study||24
8408626|NCT00964028|20724989|P1|COMPLETED|Overall Study||25
8408627|NCT00964028|20724988|P2|STARTED|Overall Study||25
8408628|NCT00964028|20724989|P1|STARTED|Overall Study||25
8408629|NCT00963937|20725004|P3|NOT COMPLETED|Overall Study||4
8408630|NCT00963937|20725005|P2|NOT COMPLETED|Overall Study||11
8408631|NCT00963937|20725006|P1|NOT COMPLETED|Overall Study||19
8408632|NCT00963937|20725004|P3|COMPLETED|Overall Study||41
8408633|NCT00963937|20725005|P2|COMPLETED|Overall Study||33
8408634|NCT00963937|20725006|P1|COMPLETED|Overall Study||70
8408635|NCT00963937|20725004|P3|STARTED|Overall Study||45
8408636|NCT00963937|20725005|P2|STARTED|Overall Study||44
8408637|NCT00963937|20725006|P1|STARTED|Overall Study||89
8408638|NCT00963924|20725044|P2|NOT COMPLETED|Overall Study||3
8408639|NCT00963924|20725045|P1|NOT COMPLETED|Overall Study||1
8408640|NCT00963924|20725044|P2|COMPLETED|Overall Study||15
8408641|NCT00963924|20725045|P1|COMPLETED|Overall Study||17
8408642|NCT00963924|20725044|P2|STARTED|Overall Study||18
8408643|NCT00963924|20725045|P1|STARTED|Overall Study||18
8408647|NCT00963872|20725078|P2|NOT COMPLETED|Overall Study||1
8408648|NCT00963872|20725079|P1|NOT COMPLETED|Overall Study||1
8408649|NCT00963872|20725078|P2|COMPLETED|Overall Study||5
8408650|NCT00963872|20725079|P1|COMPLETED|Overall Study||24
8408651|NCT00963872|20725078|P2|STARTED|Overall Study||6
8408652|NCT00963872|20725079|P1|STARTED|Overall Study||25
8408653|NCT00963859|20725123|P1|NOT COMPLETED|Overall Study||0
8408654|NCT00963859|20725123|P1|COMPLETED|Overall Study||11
8408655|NCT00963859|20725123|P1|STARTED|Overall Study||11
8408656|NCT00963820|20725128|P12|NOT COMPLETED|Expansion Phase||4
8408657|NCT00963820|20725129|P11|NOT COMPLETED|Expansion Phase||5
8408658|NCT00963820|20725130|P10|NOT COMPLETED|Expansion Phase||9
8408659|NCT00963820|20725131|P9|NOT COMPLETED|Expansion Phase||10
8408660|NCT00963820|20725132|P8|NOT COMPLETED|Expansion Phase||0
8408661|NCT00963820|20725133|P7|NOT COMPLETED|Expansion Phase||0
8408662|NCT00963820|20725134|P6|NOT COMPLETED|Expansion Phase||0
8408663|NCT00963820|20725135|P5|NOT COMPLETED|Expansion Phase||0
8408664|NCT00963820|20725136|P4|NOT COMPLETED|Expansion Phase||0
8408665|NCT00963820|20725137|P3|NOT COMPLETED|Expansion Phase||0
8408666|NCT00963820|20725138|P2|NOT COMPLETED|Expansion Phase||0
8408667|NCT00963820|20725139|P1|NOT COMPLETED|Expansion Phase||0
8408668|NCT00963820|20725128|P12|COMPLETED|Expansion Phase||0
8408669|NCT00963820|20725129|P11|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
8408670|NCT00963820|20725130|P10|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
8408671|NCT00963820|20725131|P9|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
8408672|NCT00963820|20725132|P8|COMPLETED|Expansion Phase||0
8408673|NCT00963820|20725133|P7|COMPLETED|Expansion Phase||0
8408674|NCT00963820|20725134|P6|COMPLETED|Expansion Phase||0
8408675|NCT00963820|20725135|P5|COMPLETED|Expansion Phase||0
8408676|NCT00963820|20725136|P4|COMPLETED|Expansion Phase||0
8408677|NCT00963820|20725137|P3|COMPLETED|Expansion Phase||0
8408678|NCT00963820|20725138|P2|COMPLETED|Expansion Phase||0
8408679|NCT00963820|20725139|P1|COMPLETED|Expansion Phase||0
8408680|NCT00963820|20725128|P12|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
8408681|NCT00963820|20725129|P11|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
8408682|NCT00963820|20725130|P10|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
8408683|NCT00963820|20725131|P9|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
8408684|NCT00963820|20725132|P8|STARTED|Expansion Phase||0
8408685|NCT00963820|20725133|P7|STARTED|Expansion Phase||0
8408686|NCT00963820|20725134|P6|STARTED|Expansion Phase||0
8408687|NCT00963820|20725135|P5|STARTED|Expansion Phase||0
8408688|NCT00963820|20725136|P4|STARTED|Expansion Phase||0
8408689|NCT00963820|20725137|P3|STARTED|Expansion Phase||0
8408690|NCT00963820|20725138|P2|STARTED|Expansion Phase||0
8408691|NCT00963820|20725139|P1|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
8408692|NCT00963820|20725128|P12|NOT COMPLETED|Dose Escalation Phase||0
8408693|NCT00963820|20725129|P11|NOT COMPLETED|Dose Escalation Phase||0
8408694|NCT00963820|20725130|P10|NOT COMPLETED|Dose Escalation Phase||0
8408695|NCT00963820|20725131|P9|NOT COMPLETED|Dose Escalation Phase||0
8408696|NCT00963820|20725132|P8|NOT COMPLETED|Dose Escalation Phase||5
8408697|NCT00963820|20725133|P7|NOT COMPLETED|Dose Escalation Phase||8
8408698|NCT00963820|20725134|P6|NOT COMPLETED|Dose Escalation Phase||3
8408699|NCT00963820|20725135|P5|NOT COMPLETED|Dose Escalation Phase||4
8408700|NCT00963820|20725136|P4|NOT COMPLETED|Dose Escalation Phase||3
8408701|NCT00963820|20725137|P3|NOT COMPLETED|Dose Escalation Phase||3
8408702|NCT00963820|20725138|P2|NOT COMPLETED|Dose Escalation Phase||3
8408703|NCT00963820|20725139|P1|NOT COMPLETED|Dose Escalation Phase||3
8408704|NCT00963820|20725128|P12|COMPLETED|Dose Escalation Phase||0
8408705|NCT00963820|20725129|P11|COMPLETED|Dose Escalation Phase||0
8408706|NCT00963820|20725130|P10|COMPLETED|Dose Escalation Phase||0
8408707|NCT00963820|20725131|P9|COMPLETED|Dose Escalation Phase||0
8408708|NCT00963820|20725132|P8|COMPLETED|Dose Escalation Phase||0
8408709|NCT00963820|20725133|P7|COMPLETED|Dose Escalation Phase||0
8408710|NCT00963820|20725134|P6|COMPLETED|Dose Escalation Phase||0
8408711|NCT00963820|20725135|P5|COMPLETED|Dose Escalation Phase||0
8408712|NCT00963820|20725136|P4|COMPLETED|Dose Escalation Phase||0
8408713|NCT00963820|20725137|P3|COMPLETED|Dose Escalation Phase||0
8408714|NCT00963820|20725138|P2|COMPLETED|Dose Escalation Phase||0
8408715|NCT00963820|20725139|P1|COMPLETED|Dose Escalation Phase||0
8408716|NCT00963820|20725128|P12|STARTED|Dose Escalation Phase||0
8408717|NCT00963820|20725129|P11|STARTED|Dose Escalation Phase||0
8408718|NCT00963820|20725130|P10|STARTED|Dose Escalation Phase||0
8408719|NCT00963820|20725131|P9|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
8408720|NCT00963820|20725132|P8|STARTED|Dose Escalation Phase||5
8408721|NCT00963820|20725133|P7|STARTED|Dose Escalation Phase||8
8408722|NCT00963820|20725134|P6|STARTED|Dose Escalation Phase||3
8408723|NCT00963820|20725135|P5|STARTED|Dose Escalation Phase||4
8408724|NCT00963820|20725136|P4|STARTED|Dose Escalation Phase||3
8408725|NCT00963820|20725137|P3|STARTED|Dose Escalation Phase||3
8408726|NCT00963820|20725138|P2|STARTED|Dose Escalation Phase||3
8408727|NCT00963820|20725139|P1|STARTED|Dose Escalation Phase||3
8408728|NCT00963807|20725275|P1|NOT COMPLETED|Overall Study||18
8408729|NCT00963807|20725275|P1|COMPLETED|Overall Study||8
8408730|NCT00963807|20725275|P1|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
8408731|NCT00963807|20725275|P1|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
8408732|NCT00963807|20725275|P1|Completed Post-Cycle 1 Imaging|Overall Study||9
8408733|NCT00963807|20725275|P1|Completed Baseline Imaging|Overall Study||11
8408734|NCT00963807|20725275|P1|STARTED|Overall Study||26
8408735|NCT00963677|20725286|P2|NOT COMPLETED|Overall Study||2
8408736|NCT00963677|20725287|P1|NOT COMPLETED|Overall Study||0
8408737|NCT00963677|20725286|P2|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
8408738|NCT00963677|20725287|P1|COMPLETED|Overall Study||35
8408739|NCT00963677|20725286|P2|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
8408740|NCT00963677|20725287|P1|STARTED|Overall Study|Patients without predicted difficult intubation|35
8408741|NCT00963638|20725297|P2|NOT COMPLETED|Overall Study||0
8408742|NCT00963638|20725298|P1|NOT COMPLETED|Overall Study||0
8408743|NCT00963638|20725297|P2|COMPLETED|Overall Study||20
8408744|NCT00963638|20725298|P1|COMPLETED|Overall Study||20
8408745|NCT00963638|20725297|P2|STARTED|Overall Study||20
8408746|NCT00963638|20725298|P1|STARTED|Overall Study||20
8408747|NCT00963599|20725308|P4|NOT COMPLETED|Overall Study||14
8408748|NCT00963599|20725309|P3|NOT COMPLETED|Overall Study||9
8408749|NCT00963599|20725310|P2|NOT COMPLETED|Overall Study||6
8408750|NCT00963599|20725311|P1|NOT COMPLETED|Overall Study||6
8408751|NCT00963599|20725308|P4|COMPLETED|Overall Study||288
8408752|NCT00963599|20725309|P3|COMPLETED|Overall Study||292
8408753|NCT00963599|20725310|P2|COMPLETED|Overall Study||149
8408754|NCT00963599|20725311|P1|COMPLETED|Overall Study||143
8408755|NCT00963599|20725308|P4|STARTED|Overall Study||302
8408756|NCT00963599|20725309|P3|STARTED|Overall Study||301
8408757|NCT00963599|20725310|P2|STARTED|Overall Study||155
8408758|NCT00963599|20725311|P1|STARTED|Overall Study||149
8408759|NCT00963560|20725368|P3|NOT COMPLETED|Overall Study||0
8408760|NCT00963560|20725369|P2|NOT COMPLETED|Overall Study||3
8408761|NCT00963560|20725370|P1|NOT COMPLETED|Overall Study||3
8408762|NCT00963560|20725368|P3|COMPLETED|Overall Study||41
8408763|NCT00963560|20725369|P2|COMPLETED|Overall Study||41
8408764|NCT00963560|20725370|P1|COMPLETED|Overall Study||44
8408765|NCT00963560|20725368|P3|STARTED|Overall Study||41
8408766|NCT00963560|20725369|P2|STARTED|Overall Study||44
8408767|NCT00963560|20725370|P1|STARTED|Overall Study||47
8408768|NCT00963547|20725382|P7|NOT COMPLETED|Overall Study||0
8408769|NCT00963547|20725383|P6|NOT COMPLETED|Overall Study||0
8408770|NCT00963547|20725384|P5|NOT COMPLETED|Overall Study||0
8408771|NCT00963547|20725385|P4|NOT COMPLETED|Overall Study||6
8408772|NCT00963547|20725386|P3|NOT COMPLETED|Overall Study||12
8408773|NCT00963547|20725387|P2|NOT COMPLETED|Overall Study||11
8408774|NCT00963547|20725388|P1|NOT COMPLETED|Overall Study||4
8408775|NCT00963547|20725382|P7|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
8408776|NCT00963547|20725383|P6|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
8408777|NCT00963547|20725384|P5|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
8408778|NCT00963547|20725385|P4|COMPLETED|Overall Study||0
8408779|NCT00963547|20725386|P3|COMPLETED|Overall Study||0
8408780|NCT00963547|20725387|P2|COMPLETED|Overall Study||0
8408781|NCT00963547|20725388|P1|COMPLETED|Overall Study||0
8408782|NCT00963547|20725382|P7|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
8408783|NCT00963547|20725383|P6|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
8408784|NCT00963547|20725384|P5|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
8408785|NCT00963547|20725385|P4|Treated|Overall Study||6
8408786|NCT00963547|20725386|P3|Treated|Overall Study||11
8408787|NCT00963547|20725387|P2|Treated|Overall Study||11
8408788|NCT00963547|20725388|P1|Treated|Overall Study||3
8408789|NCT00963547|20725382|P7|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
8408790|NCT00963547|20725383|P6|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
8408791|NCT00963547|20725384|P5|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
8408792|NCT00963547|20725385|P4|STARTED|Overall Study||6
8408793|NCT00963547|20725386|P3|STARTED|Overall Study||12
8408794|NCT00963547|20725387|P2|STARTED|Overall Study||11
8408795|NCT00963547|20725388|P1|STARTED|Overall Study||4
8408796|NCT00963508|20725414|P2|NOT COMPLETED|Overall Study||28
8408797|NCT00963508|20725415|P1|NOT COMPLETED|Overall Study||10
8408798|NCT00963508|20725414|P2|COMPLETED|Overall Study||169
8408799|NCT00963508|20725415|P1|COMPLETED|Overall Study||196
8408800|NCT00963508|20725414|P2|STARTED|Overall Study||197
8408801|NCT00963508|20725415|P1|STARTED|Overall Study||206
8408802|NCT00963482|20725425|P2|NOT COMPLETED|Overall Study||17
8408803|NCT00963482|20725426|P1|NOT COMPLETED|Overall Study||28
8408804|NCT00963482|20725425|P2|COMPLETED|Overall Study||33
8408805|NCT00963482|20725426|P1|COMPLETED|Overall Study||25
8408806|NCT00963482|20725425|P2|STARTED|Overall Study||50
8408807|NCT00963482|20725426|P1|STARTED|Overall Study||53
8408808|NCT00963469|20725435|P3|NOT COMPLETED|Overall Study||10
8408809|NCT00963469|20725436|P2|NOT COMPLETED|Overall Study||28
8408810|NCT00963469|20725437|P1|NOT COMPLETED|Overall Study||41
8408811|NCT00963469|20725435|P3|COMPLETED|Overall Study||170
8408812|NCT00963469|20725436|P2|COMPLETED|Overall Study||420
8408813|NCT00963469|20725437|P1|COMPLETED|Overall Study||410
8408814|NCT00963469|20725435|P3|STARTED|Overall Study||180
8408815|NCT00963469|20725436|P2|STARTED|Overall Study||448
8408816|NCT00963469|20725437|P1|STARTED|Overall Study||451
8408817|NCT00963430|20725465|P2|NOT COMPLETED|Overall Study||3
8408818|NCT00963430|20725466|P1|NOT COMPLETED|Overall Study||1
8408819|NCT00963430|20725465|P2|COMPLETED|Overall Study||57
8408820|NCT00963430|20725466|P1|COMPLETED|Overall Study||59
8408821|NCT00963430|20725465|P2|STARTED|Overall Study||60
8408822|NCT00963430|20725466|P1|STARTED|Overall Study||60
8408823|NCT00963235|20725504|P1|NOT COMPLETED|Overall Study||60
8408824|NCT00963235|20725504|P1|COMPLETED|Overall Study||271
8408825|NCT00963235|20725504|P1|Completed Dose 3 1-month Blood Draw|Overall Study||277
8408826|NCT00963235|20725504|P1|Vaccinated Dose 3|Overall Study||279
8408827|NCT00963235|20725504|P1|Vaccinated Dose 2|Overall Study||300
8408828|NCT00963235|20725504|P1|Vaccinated Dose 1|Overall Study||329
8408829|NCT00963235|20725504|P1|STARTED|Overall Study||331
8408830|NCT00963157|20725528|P5|NOT COMPLETED|Overall Study||2
8408831|NCT00963157|20725529|P4|NOT COMPLETED|Overall Study||7
8408832|NCT00963157|20725530|P3|NOT COMPLETED|Overall Study||5
8408833|NCT00963157|20725531|P2|NOT COMPLETED|Overall Study||4
8408834|NCT00963157|20725532|P1|NOT COMPLETED|Overall Study||5
8408835|NCT00963157|20725528|P5|COMPLETED|Overall Study||151
8408836|NCT00963157|20725529|P4|COMPLETED|Overall Study||150
8408837|NCT00963157|20725530|P3|COMPLETED|Overall Study||155
8408838|NCT00963157|20725531|P2|COMPLETED|Overall Study||159
8408839|NCT00963157|20725532|P1|COMPLETED|Overall Study||151
8408840|NCT00963157|20725528|P5|STARTED|Overall Study||153
8408841|NCT00963157|20725529|P4|STARTED|Overall Study||157
8408842|NCT00963157|20725530|P3|STARTED|Overall Study||160
8408843|NCT00963157|20725531|P2|STARTED|Overall Study||163
8408844|NCT00963157|20725532|P1|STARTED|Overall Study||156
8408845|NCT00963105|20725727|P3|NOT COMPLETED|Overall Study||0
8408846|NCT00963105|20725728|P2|NOT COMPLETED|Overall Study||0
8408847|NCT00963105|20725729|P1|NOT COMPLETED|Overall Study||0
8408848|NCT00963105|20725727|P3|COMPLETED|Overall Study||35
8408849|NCT00963105|20725728|P2|COMPLETED|Overall Study||35
8408850|NCT00963105|20725729|P1|COMPLETED|Overall Study||34
8408851|NCT00963105|20725727|P3|Received Treatment|Overall Study||35
8408852|NCT00963105|20725728|P2|Received Treatment|Overall Study||34
8408853|NCT00963105|20725729|P1|Received Treatment|Overall Study||34
8408854|NCT00963105|20725727|P3|STARTED|Overall Study||35
8408855|NCT00963105|20725728|P2|STARTED|Overall Study||35
8408856|NCT00963105|20725729|P1|STARTED|Overall Study||34
8408857|NCT00962949|20725760|P2|NOT COMPLETED|Overall Study||0
8408858|NCT00962949|20725761|P1|NOT COMPLETED|Overall Study||0
8408859|NCT00962949|20725760|P2|COMPLETED|Overall Study||15
8408860|NCT00962949|20725761|P1|COMPLETED|Overall Study||13
8408861|NCT00962949|20725760|P2|STARTED|Overall Study||15
8408862|NCT00962949|20725761|P1|STARTED|Overall Study||13
8408863|NCT00962871|20725777|P4|NOT COMPLETED|Overall Study||0
8408864|NCT00962871|20725778|P3|NOT COMPLETED|Overall Study||0
8408865|NCT00962871|20725779|P2|NOT COMPLETED|Overall Study||0
8408866|NCT00962871|20725780|P1|NOT COMPLETED|Overall Study||0
8408867|NCT00962871|20725777|P4|COMPLETED|Overall Study||6
8408868|NCT00962871|20725778|P3|COMPLETED|Overall Study||12
8408869|NCT00962871|20725779|P2|COMPLETED|Overall Study||6
8408870|NCT00962871|20725780|P1|COMPLETED|Overall Study||6
8408871|NCT00962871|20725777|P4|STARTED|Overall Study||6
8408872|NCT00962871|20725778|P3|STARTED|Overall Study||12
8408873|NCT00962871|20725779|P2|STARTED|Overall Study||6
8408874|NCT00962871|20725780|P1|STARTED|Overall Study||6
8408875|NCT00962780|20725796|P2|NOT COMPLETED|Overall Study||14
8408876|NCT00962780|20725797|P1|NOT COMPLETED|Overall Study||10
8408877|NCT00962780|20725796|P2|COMPLETED|Overall Study||138
8408878|NCT00962780|20725797|P1|COMPLETED|Overall Study||141
8408879|NCT00962780|20725796|P2|Vaccinated 23vPS Dose|Overall Study||139
8408880|NCT00962780|20725797|P1|Vaccinated 23vPS Dose|Overall Study||143
8408881|NCT00962780|20725796|P2|Vaccinated 13vPnC Dose 3|Overall Study||142
8408882|NCT00962780|20725797|P1|Vaccinated 13vPnC Dose 3|Overall Study||144
8408883|NCT00962780|20725796|P2|Vaccinated 13vPnC Dose 2|Overall Study||145
8408884|NCT00962780|20725797|P1|Vaccinated 13vPnC Dose 2|Overall Study||145
8408885|NCT00962780|20725796|P2|Vaccinated 13vPnC Dose 1|Overall Study||151
8408886|NCT00962780|20725797|P1|Vaccinated 13vPnC Dose 1|Overall Study||150
8408887|NCT00962780|20725796|P2|STARTED|Overall Study||152
8408888|NCT00962780|20725797|P1|STARTED|Overall Study||151
8408889|NCT00962754|20725861|P2|NOT COMPLETED|Overall Study||0
8408890|NCT00962754|20725862|P1|NOT COMPLETED|Overall Study||0
8408891|NCT00962754|20725861|P2|COMPLETED|Overall Study||84
8408892|NCT00962754|20725862|P1|COMPLETED|Overall Study||86
8408893|NCT00962754|20725861|P2|STARTED|Overall Study||84
8408894|NCT00962754|20725862|P1|STARTED|Overall Study||86
8408895|NCT00962741|20725872|P1|NOT COMPLETED|Overall Study||8
8408896|NCT00962741|20725872|P1|COMPLETED|Overall Study||119
8408897|NCT00962741|20725872|P1|STARTED|Overall Study||127
8408898|NCT00962650|20725963|P1|NOT COMPLETED|Overall Study||2
8408899|NCT00962650|20725963|P1|COMPLETED|Overall Study||8
8408900|NCT00962650|20725963|P1|STARTED|Overall Study||10
8408901|NCT00962598|20725969|P2|NOT COMPLETED|Overall Study||0
8408902|NCT00962598|20725970|P1|NOT COMPLETED|Overall Study||0
8408903|NCT00962598|20725969|P2|COMPLETED|Overall Study||9
8408904|NCT00962598|20725970|P1|COMPLETED|Overall Study||7
8408905|NCT00962598|20725969|P2|STARTED|Overall Study||9
8408906|NCT00962598|20725970|P1|STARTED|Overall Study||7
8408907|NCT00962585|20725982|P4|NOT COMPLETED|Overall Study||0
8408908|NCT00962585|20725983|P3|NOT COMPLETED|Overall Study||3
8408909|NCT00962585|20725984|P2|NOT COMPLETED|Overall Study||2
8408910|NCT00962585|20725985|P1|NOT COMPLETED|Overall Study||6
8408911|NCT00962585|20725982|P4|COMPLETED|Overall Study||42
8408912|NCT00962585|20725983|P3|COMPLETED|Overall Study||39
8408913|NCT00962585|20725984|P2|COMPLETED|Overall Study||40
8408914|NCT00962585|20725985|P1|COMPLETED|Overall Study||37
8408915|NCT00962585|20725982|P4|STARTED|Overall Study||42
8408916|NCT00962585|20725983|P3|STARTED|Overall Study||42
8408917|NCT00962585|20725984|P2|STARTED|Overall Study||42
8408918|NCT00962585|20725985|P1|STARTED|Overall Study||43
8408919|NCT00962429|20726045|P2|NOT COMPLETED|Overall Study||0
8408920|NCT00962429|20726046|P1|NOT COMPLETED|Overall Study||0
8408921|NCT00962429|20726045|P2|COMPLETED|Overall Study||0
8408922|NCT00962429|20726046|P1|COMPLETED|Overall Study||0
8408923|NCT00962429|20726045|P2|STARTED|Overall Study||0
8408924|NCT00962429|20726046|P1|STARTED|Overall Study||0
8408925|NCT00962390|20726062|P4|NOT COMPLETED|Overall Study||1
8408926|NCT00962390|20726063|P3|NOT COMPLETED|Overall Study||4
8408927|NCT00962390|20726064|P2|NOT COMPLETED|Overall Study||3
8408928|NCT00962390|20726065|P1|NOT COMPLETED|Overall Study||4
8408929|NCT00962390|20726062|P4|COMPLETED|Overall Study||28
8408930|NCT00962390|20726063|P3|COMPLETED|Overall Study||25
8408931|NCT00962390|20726064|P2|COMPLETED|Overall Study||26
8408932|NCT00962390|20726065|P1|COMPLETED|Overall Study||25
8408933|NCT00962390|20726062|P4|STARTED|Overall Study||29
8408934|NCT00962390|20726063|P3|STARTED|Overall Study||29
8408935|NCT00962390|20726064|P2|STARTED|Overall Study||29
8408936|NCT00962390|20726065|P1|STARTED|Overall Study||29
8408937|NCT00962247|20726127|P1|NOT COMPLETED|50% Reduction of Sedentary Activity||0
8408938|NCT00962247|20726127|P1|COMPLETED|50% Reduction of Sedentary Activity||56
8408939|NCT00962247|20726127|P1|STARTED|50% Reduction of Sedentary Activity||56
8408940|NCT00962247|20726127|P1|NOT COMPLETED|25% Reduction of Sedentary Activity||5
8408941|NCT00962247|20726127|P1|COMPLETED|25% Reduction of Sedentary Activity||56
8408942|NCT00962247|20726127|P1|STARTED|25% Reduction of Sedentary Activity||61
8408943|NCT00962247|20726127|P1|NOT COMPLETED|Usual Sedentary||0
8408944|NCT00962247|20726127|P1|COMPLETED|Usual Sedentary||61
8408945|NCT00962247|20726127|P1|STARTED|Usual Sedentary||61
8408946|NCT00962208|20726138|P2|NOT COMPLETED|Overall Study||10
8408947|NCT00962208|20726139|P1|NOT COMPLETED|Overall Study||14
8408948|NCT00962208|20726138|P2|COMPLETED|Overall Study||41
8408949|NCT00962208|20726139|P1|COMPLETED|Overall Study||37
8408950|NCT00962208|20726138|P2|STARTED|Overall Study||51
8408951|NCT00962208|20726139|P1|STARTED|Overall Study||51
8408952|NCT00962104|20726147|P2|NOT COMPLETED|Overall Study||25
8408953|NCT00962104|20726148|P1|NOT COMPLETED|Overall Study||40
8408954|NCT00962104|20726147|P2|COMPLETED|Overall Study||171
8408955|NCT00962104|20726148|P1|COMPLETED|Overall Study||155
8408956|NCT00962104|20726147|P2|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
8408957|NCT00962104|20726148|P1|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
8408958|NCT00962104|20726147|P2|STARTED|Overall Study||196
8408959|NCT00962104|20726148|P1|STARTED|Overall Study||195
8408960|NCT00962091|20726181|P7|NOT COMPLETED|Overall Study||1
8408961|NCT00962091|20726182|P6|NOT COMPLETED|Overall Study||1
8408962|NCT00962091|20726183|P5|NOT COMPLETED|Overall Study||0
8408963|NCT00962091|20726184|P4|NOT COMPLETED|Overall Study||1
8408964|NCT00962091|20726185|P3|NOT COMPLETED|Overall Study||1
8408965|NCT00962091|20726186|P2|NOT COMPLETED|Overall Study||2
8408966|NCT00962091|20726187|P1|NOT COMPLETED|Overall Study||1
8408967|NCT00962091|20726181|P7|COMPLETED|Overall Study||11
8408968|NCT00962091|20726182|P6|COMPLETED|Overall Study||11
8408969|NCT00962091|20726183|P5|COMPLETED|Overall Study||3
8408970|NCT00962091|20726184|P4|COMPLETED|Overall Study||2
8408971|NCT00962091|20726185|P3|COMPLETED|Overall Study||9
8408972|NCT00962091|20726186|P2|COMPLETED|Overall Study||7
8408973|NCT00962091|20726187|P1|COMPLETED|Overall Study||3
8408974|NCT00962091|20726181|P7|STARTED|Overall Study||12
8408975|NCT00962091|20726182|P6|STARTED|Overall Study||12
8408976|NCT00962091|20726183|P5|STARTED|Overall Study||3
8408977|NCT00962091|20726184|P4|STARTED|Overall Study||3
8408978|NCT00962091|20726185|P3|STARTED|Overall Study||10
8408979|NCT00962091|20726186|P2|STARTED|Overall Study||9
8408980|NCT00962091|20726187|P1|STARTED|Overall Study||4
8408981|NCT00962078|20726234|P2|NOT COMPLETED|Overall Study||6
8408982|NCT00962078|20726235|P1|NOT COMPLETED|Overall Study||5
8408983|NCT00962078|20726234|P2|COMPLETED|Overall Study||30
8408984|NCT00962078|20726235|P1|COMPLETED|Overall Study||30
8408985|NCT00962078|20726234|P2|STARTED|Overall Study||36
8408986|NCT00962078|20726235|P1|STARTED|Overall Study||35
8408987|NCT00962065|20726246|P3|NOT COMPLETED|Overall Study||0
8408988|NCT00962065|20726247|P2|NOT COMPLETED|Overall Study||0
8408989|NCT00962065|20726248|P1|NOT COMPLETED|Overall Study||0
8408990|NCT00962065|20726246|P3|COMPLETED|Overall Study||12
8408991|NCT00962065|20726247|P2|COMPLETED|Overall Study||12
8408992|NCT00962065|20726248|P1|COMPLETED|Overall Study||12
8408993|NCT00962065|20726246|P3|STARTED|Overall Study||12
8408994|NCT00962065|20726247|P2|STARTED|Overall Study||12
8408995|NCT00962065|20726248|P1|STARTED|Overall Study||12
8408996|NCT00962039|20726273|P2|NOT COMPLETED|Overall Study||4
8408997|NCT00962039|20726274|P1|NOT COMPLETED|Overall Study||5
8408998|NCT00962039|20726273|P2|COMPLETED|Overall Study||37
8408999|NCT00962039|20726274|P1|COMPLETED|Overall Study||35
8409000|NCT00962039|20726273|P2|STARTED|Overall Study||41
8409001|NCT00962039|20726274|P1|STARTED|Overall Study||40
8409002|NCT00962013|20726290|P1|NOT COMPLETED|Overall Study||68
8409003|NCT00962013|20726290|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
8409004|NCT00962013|20726290|P1|STARTED|Overall Study||120
8409005|NCT00962000|20726299|P2|NOT COMPLETED|Period 4 - 1 Week||0
8409006|NCT00962000|20726300|P1|NOT COMPLETED|Period 4 - 1 Week||0
8409007|NCT00962000|20726299|P2|COMPLETED|Period 4 - 1 Week||21
8409008|NCT00962000|20726300|P1|COMPLETED|Period 4 - 1 Week||21
8409009|NCT00962000|20726299|P2|STARTED|Period 4 - 1 Week||21
8409010|NCT00962000|20726300|P1|STARTED|Period 4 - 1 Week||21
8409011|NCT00962000|20726299|P2|NOT COMPLETED|Period 3 - 1 Week||0
8409012|NCT00962000|20726300|P1|NOT COMPLETED|Period 3 - 1 Week||0
8409013|NCT00962000|20726299|P2|COMPLETED|Period 3 - 1 Week||21
8409014|NCT00962000|20726300|P1|COMPLETED|Period 3 - 1 Week||21
8409015|NCT00962000|20726299|P2|STARTED|Period 3 - 1 Week||21
8409016|NCT00962000|20726300|P1|STARTED|Period 3 - 1 Week||21
8409017|NCT00962000|20726299|P2|NOT COMPLETED|Period 2 - 1 Week||0
8409018|NCT00962000|20726300|P1|NOT COMPLETED|Period 2 - 1 Week||0
8409019|NCT00962000|20726299|P2|COMPLETED|Period 2 - 1 Week||21
8409020|NCT00962000|20726300|P1|COMPLETED|Period 2 - 1 Week||21
8409021|NCT00962000|20726299|P2|STARTED|Period 2 - 1 Week||21
8409022|NCT00962000|20726300|P1|STARTED|Period 2 - 1 Week||21
8409023|NCT00962000|20726299|P2|NOT COMPLETED|Period 1 - 1 Week||0
8409024|NCT00962000|20726300|P1|NOT COMPLETED|Period 1 - 1 Week||0
8409025|NCT00962000|20726299|P2|COMPLETED|Period 1 - 1 Week||21
8409026|NCT00962000|20726300|P1|COMPLETED|Period 1 - 1 Week||21
8409027|NCT00962000|20726299|P2|STARTED|Period 1 - 1 Week||21
8409028|NCT00962000|20726300|P1|STARTED|Period 1 - 1 Week||21
8409029|NCT00961961|20726314|P4|NOT COMPLETED|Phase II||8
8409030|NCT00961961|20726315|P3|NOT COMPLETED|Phase II||12
8409031|NCT00961961|20726316|P2|NOT COMPLETED|Phase II||0
8409032|NCT00961961|20726317|P1|NOT COMPLETED|Phase II||0
8409033|NCT00961961|20726314|P4|COMPLETED|Phase II||14
8409034|NCT00961961|20726315|P3|COMPLETED|Phase II||17
8409035|NCT00961961|20726316|P2|COMPLETED|Phase II||0
8409036|NCT00961961|20726317|P1|COMPLETED|Phase II||0
8409037|NCT00961961|20726314|P4|STARTED|Phase II||22
8409038|NCT00961961|20726315|P3|STARTED|Phase II||29
8409039|NCT00961961|20726316|P2|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
8409040|NCT00961961|20726317|P1|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
8409041|NCT00961961|20726314|P4|NOT COMPLETED|Phase I||0
8409042|NCT00961961|20726315|P3|NOT COMPLETED|Phase I||0
8409043|NCT00961961|20726316|P2|NOT COMPLETED|Phase I||0
8409044|NCT00961961|20726317|P1|NOT COMPLETED|Phase I||126
8409045|NCT00961961|20726314|P4|COMPLETED|Phase I||0
8409046|NCT00961961|20726315|P3|COMPLETED|Phase I||0
8409047|NCT00961961|20726316|P2|COMPLETED|Phase I||0
8409048|NCT00961961|20726317|P1|COMPLETED|Phase I||51
8409049|NCT00961961|20726314|P4|STARTED|Phase I||0
8409050|NCT00961961|20726315|P3|STARTED|Phase I||0
8409051|NCT00961961|20726316|P2|STARTED|Phase I||0
8409052|NCT00961961|20726317|P1|STARTED|Phase I||177
8409053|NCT00961896|20726342|P3|NOT COMPLETED|Overall Study||1
8409054|NCT00961896|20726343|P2|NOT COMPLETED|Overall Study||0
8409055|NCT00961896|20726344|P1|NOT COMPLETED|Overall Study||0
8409056|NCT00961896|20726342|P3|COMPLETED|Overall Study||6
8409057|NCT00961896|20726343|P2|COMPLETED|Overall Study||3
8409058|NCT00961896|20726344|P1|COMPLETED|Overall Study||8
8409059|NCT00961896|20726342|P3|STARTED|Overall Study||7
8409060|NCT00961896|20726343|P2|STARTED|Overall Study||3
8409061|NCT00961896|20726344|P1|STARTED|Overall Study||8
8409062|NCT00961805|20726365|P2|NOT COMPLETED|Overall Study||0
8409063|NCT00961805|20726366|P1|NOT COMPLETED|Overall Study||0
8409064|NCT00961805|20726365|P2|COMPLETED|Overall Study||40
8409065|NCT00961805|20726366|P1|COMPLETED|Overall Study||40
8409066|NCT00961805|20726365|P2|STARTED|Overall Study||40
8409067|NCT00961805|20726366|P1|STARTED|Overall Study||40
8409068|NCT00961662|20726397|P3|NOT COMPLETED|Overall Study||19
8409069|NCT00961662|20726398|P2|NOT COMPLETED|Overall Study||19
8409070|NCT00961662|20726399|P1|NOT COMPLETED|Overall Study||22
8409071|NCT00961662|20726397|P3|COMPLETED|Overall Study||34
8409072|NCT00961662|20726398|P2|COMPLETED|Overall Study||32
8409073|NCT00961662|20726399|P1|COMPLETED|Overall Study||35
8409074|NCT00961662|20726397|P3|STARTED|Overall Study||53
8409075|NCT00961662|20726398|P2|STARTED|Overall Study||51
8409076|NCT00961662|20726399|P1|STARTED|Overall Study||57
8409077|NCT00961649|20726411|P4|NOT COMPLETED|Overall Study||4
8409078|NCT00961649|20726412|P3|NOT COMPLETED|Overall Study||5
8409079|NCT00961649|20726413|P2|NOT COMPLETED|Overall Study||4
8409080|NCT00961649|20726414|P1|NOT COMPLETED|Overall Study||9
8409081|NCT00961649|20726411|P4|COMPLETED|Overall Study||37
8409082|NCT00961649|20726412|P3|COMPLETED|Overall Study||39
8409083|NCT00961649|20726413|P2|COMPLETED|Overall Study||40
8409084|NCT00961649|20726414|P1|COMPLETED|Overall Study||32
8409085|NCT00961649|20726411|P4|STARTED|Overall Study||41
8409086|NCT00961649|20726412|P3|STARTED|Overall Study||44
8409087|NCT00961649|20726413|P2|STARTED|Overall Study||44
8409088|NCT00961649|20726414|P1|STARTED|Overall Study||41
8409089|NCT00961636|20726428|P3|NOT COMPLETED|Overall Study||32
8409090|NCT00961636|20726429|P2|NOT COMPLETED|Overall Study||131
8409091|NCT00961636|20726430|P1|NOT COMPLETED|Overall Study||107
8409092|NCT00961636|20726428|P3|COMPLETED|Overall Study||201
8409093|NCT00961636|20726429|P2|COMPLETED|Overall Study||325
8409094|NCT00961636|20726430|P1|COMPLETED|Overall Study||356
8409095|NCT00961636|20726428|P3|STARTED|Overall Study||233
8409096|NCT00961636|20726429|P2|STARTED|Overall Study||456
8409097|NCT00961636|20726430|P1|STARTED|Overall Study||463
8409098|NCT00961571|20726441|P1|NOT COMPLETED|Overall Study||39
8409099|NCT00961571|20726441|P1|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
8409100|NCT00961571|20726441|P1|STARTED|Overall Study||50
8409101|NCT00961532|20726445|P1|NOT COMPLETED|Overall Study||0
8409102|NCT00961532|20726445|P1|COMPLETED|Overall Study||14
8409103|NCT00961532|20726445|P1|STARTED|Overall Study||14
8409104|NCT00961441|20726452|P2|NOT COMPLETED|Overall Study||0
8409105|NCT00961441|20726453|P1|NOT COMPLETED|Overall Study||0
8409106|NCT00961441|20726452|P2|COMPLETED|Overall Study||13
8409107|NCT00961441|20726453|P1|COMPLETED|Overall Study||12
8409108|NCT00961441|20726452|P2|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
8409109|NCT00961441|20726453|P1|Pharmacokinetic (PK-PP) Population|Overall Study||12
8409110|NCT00961441|20726452|P2|STARTED|Overall Study||13
8409111|NCT00961441|20726453|P1|STARTED|Overall Study||12
8409112|NCT00961415|20726469|P3|NOT COMPLETED|Maintenance Treatment Phase||45
8409113|NCT00961415|20726470|P2|NOT COMPLETED|Maintenance Treatment Phase||48
8409114|NCT00961415|20726471|P1|NOT COMPLETED|Maintenance Treatment Phase||0
8409115|NCT00961415|20726469|P3|COMPLETED|Maintenance Treatment Phase||83
8409116|NCT00961415|20726470|P2|COMPLETED|Maintenance Treatment Phase||77
8409117|NCT00961415|20726471|P1|COMPLETED|Maintenance Treatment Phase||0
8409118|NCT00961415|20726469|P3|STARTED|Maintenance Treatment Phase||128
8409119|NCT00961415|20726470|P2|STARTED|Maintenance Treatment Phase||125
8409120|NCT00961415|20726471|P1|STARTED|Maintenance Treatment Phase||0
8409121|NCT00961415|20726469|P3|NOT COMPLETED|Induction Treatment Phase||0
8409122|NCT00961415|20726470|P2|NOT COMPLETED|Induction Treatment Phase||0
8409123|NCT00961415|20726471|P1|NOT COMPLETED|Induction Treatment Phase||123
8409124|NCT00961415|20726469|P3|COMPLETED|Induction Treatment Phase||0
8409125|NCT00961415|20726470|P2|COMPLETED|Induction Treatment Phase||0
8409126|NCT00961415|20726471|P1|COMPLETED|Induction Treatment Phase||253
8409127|NCT00961415|20726469|P3|STARTED|Induction Treatment Phase||0
8409128|NCT00961415|20726470|P2|STARTED|Induction Treatment Phase||0
8409129|NCT00961415|20726471|P1|STARTED|Induction Treatment Phase||376
8409130|NCT00961402|20726496|P2|NOT COMPLETED|Overall Study||5
8409131|NCT00961402|20726497|P1|NOT COMPLETED|Overall Study||1
8409132|NCT00961402|20726496|P2|COMPLETED|Overall Study||61
8409133|NCT00961402|20726497|P1|COMPLETED|Overall Study||63
8409134|NCT00961402|20726496|P2|Randomized|Overall Study||66
8409135|NCT00961402|20726497|P1|Randomized|Overall Study||64
8409136|NCT00961402|20726496|P2|STARTED|Overall Study||66
8409137|NCT00961402|20726497|P1|STARTED|Overall Study||64
8409138|NCT00961350|20726511|P2|NOT COMPLETED|Overall Study||67
8409139|NCT00961350|20726512|P1|NOT COMPLETED|Overall Study||47
8409140|NCT00961350|20726511|P2|COMPLETED|Overall Study||198
8409141|NCT00961350|20726512|P1|COMPLETED|Overall Study||218
8409142|NCT00961350|20726511|P2|Safety Population|Overall Study||265
8409143|NCT00961350|20726512|P1|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
8409144|NCT00961350|20726511|P2|Intent-to-Treat Population (ITT)|Overall Study||265
8409145|NCT00961350|20726512|P1|Intent-to-Treat Population (ITT)|Overall Study||265
8409146|NCT00961350|20726511|P2|STARTED|Overall Study||265
8409147|NCT00961350|20726512|P1|STARTED|Overall Study||265
8409148|NCT00961311|20726526|P1|NOT COMPLETED|Overall Study||0
8409149|NCT00961311|20726526|P1|COMPLETED|Overall Study||51
8409150|NCT00961311|20726526|P1|STARTED|Overall Study||51
8409151|NCT00961298|20726533|P1|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
8409152|NCT00961298|20726533|P1|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
8409153|NCT00961298|20726533|P1|STARTED|12 Weeks Duloxetine Treatment Phase||14
8409154|NCT00961298|20726533|P1|NOT COMPLETED|Two Week Placebo Run in||1
8409155|NCT00961298|20726533|P1|COMPLETED|Two Week Placebo Run in||14
8409156|NCT00961298|20726533|P1|STARTED|Two Week Placebo Run in||15
8409157|NCT00961259|20726540|P3|NOT COMPLETED|Third Intervention||0
8409158|NCT00961259|20726541|P2|NOT COMPLETED|Third Intervention||0
8409159|NCT00961259|20726542|P1|NOT COMPLETED|Third Intervention||0
8409160|NCT00961259|20726540|P3|COMPLETED|Third Intervention||18
8409161|NCT00961259|20726541|P2|COMPLETED|Third Intervention||17
8409162|NCT00961259|20726542|P1|COMPLETED|Third Intervention||18
8409163|NCT00961259|20726540|P3|STARTED|Third Intervention||18
8409164|NCT00961259|20726541|P2|STARTED|Third Intervention||17
8409165|NCT00961259|20726542|P1|STARTED|Third Intervention||18
8409166|NCT00961259|20726540|P3|NOT COMPLETED|Washout Period of 7 Days||0
8409167|NCT00961259|20726541|P2|NOT COMPLETED|Washout Period of 7 Days||0
8409168|NCT00961259|20726542|P1|NOT COMPLETED|Washout Period of 7 Days||0
8409169|NCT00961259|20726540|P3|COMPLETED|Washout Period of 7 Days||18
8409170|NCT00961259|20726541|P2|COMPLETED|Washout Period of 7 Days||17
8409171|NCT00961259|20726542|P1|COMPLETED|Washout Period of 7 Days||18
8409172|NCT00961259|20726540|P3|STARTED|Washout Period of 7 Days||18
8409173|NCT00961259|20726541|P2|STARTED|Washout Period of 7 Days||17
8409174|NCT00961259|20726542|P1|STARTED|Washout Period of 7 Days||18
8409175|NCT00961259|20726540|P3|NOT COMPLETED|Second Intervention||0
8409176|NCT00961259|20726541|P2|NOT COMPLETED|Second Intervention||0
8409177|NCT00961259|20726542|P1|NOT COMPLETED|Second Intervention||0
8409178|NCT00961259|20726540|P3|COMPLETED|Second Intervention||18
8409179|NCT00961259|20726541|P2|COMPLETED|Second Intervention||17
8409180|NCT00961259|20726542|P1|COMPLETED|Second Intervention||18
8409181|NCT00961259|20726540|P3|STARTED|Second Intervention||18
8409182|NCT00961259|20726541|P2|STARTED|Second Intervention||17
8409183|NCT00961259|20726542|P1|STARTED|Second Intervention||18
8409184|NCT00961259|20726540|P3|NOT COMPLETED|Washout Period of 7 Days||0
8409185|NCT00961259|20726541|P2|NOT COMPLETED|Washout Period of 7 Days||1
8409186|NCT00961259|20726542|P1|NOT COMPLETED|Washout Period of 7 Days||0
8409187|NCT00961259|20726540|P3|COMPLETED|Washout Period of 7 Days||18
8409188|NCT00961259|20726541|P2|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
8409189|NCT00961259|20726542|P1|COMPLETED|Washout Period of 7 Days||18
8409190|NCT00961259|20726540|P3|STARTED|Washout Period of 7 Days||18
8409191|NCT00961259|20726541|P2|STARTED|Washout Period of 7 Days||18
8409192|NCT00961259|20726542|P1|STARTED|Washout Period of 7 Days||18
8409193|NCT00961259|20726540|P3|NOT COMPLETED|First Intervention||0
8409194|NCT00961259|20726541|P2|NOT COMPLETED|First Intervention||0
8409195|NCT00961259|20726542|P1|NOT COMPLETED|First Intervention||0
8409196|NCT00961259|20726540|P3|COMPLETED|First Intervention||18
8409197|NCT00961259|20726541|P2|COMPLETED|First Intervention||18
8409198|NCT00961259|20726542|P1|COMPLETED|First Intervention||18
8409199|NCT00961259|20726540|P3|STARTED|First Intervention||18
8409200|NCT00961259|20726541|P2|STARTED|First Intervention||18
8409201|NCT00961259|20726542|P1|STARTED|First Intervention||18
8409202|NCT00961233|20726561|P2|NOT COMPLETED|Overall Study||1
8409203|NCT00961233|20726562|P1|NOT COMPLETED|Overall Study||2
8409204|NCT00961233|20726561|P2|COMPLETED|Overall Study||11
8409205|NCT00961233|20726562|P1|COMPLETED|Overall Study||11
8409206|NCT00961233|20726561|P2|STARTED|Overall Study||12
8409207|NCT00961233|20726562|P1|STARTED|Overall Study||13
8409208|NCT00961220|20726570|P1|NOT COMPLETED|Overall Study||7
8409209|NCT00961220|20726570|P1|COMPLETED|Overall Study||10
8409210|NCT00961220|20726570|P1|STARTED|Overall Study||17
8409211|NCT00961181|20726586|P1|NOT COMPLETED|Overall Study||5
8409212|NCT00961181|20726586|P1|COMPLETED|Overall Study||76
8409213|NCT00961181|20726586|P1|STARTED|Overall Study||81
8409214|NCT00961116|20726599|P2|NOT COMPLETED|Second Intervention||0
8409215|NCT00961116|20726600|P1|NOT COMPLETED|Second Intervention||0
8409216|NCT00961116|20726599|P2|COMPLETED|Second Intervention||24
8409217|NCT00961116|20726600|P1|COMPLETED|Second Intervention||25
8409218|NCT00961116|20726599|P2|STARTED|Second Intervention||24
8409219|NCT00961116|20726600|P1|STARTED|Second Intervention||25
8409220|NCT00961116|20726599|P2|NOT COMPLETED|Washout Period of 7 Days||3
8409221|NCT00961116|20726600|P1|NOT COMPLETED|Washout Period of 7 Days||2
8409222|NCT00961116|20726599|P2|COMPLETED|Washout Period of 7 Days||24
8409223|NCT00961116|20726600|P1|COMPLETED|Washout Period of 7 Days||25
8409224|NCT00961116|20726599|P2|STARTED|Washout Period of 7 Days||27
8409225|NCT00961116|20726600|P1|STARTED|Washout Period of 7 Days||27
8409226|NCT00961116|20726599|P2|NOT COMPLETED|First Intervention||0
8409227|NCT00961116|20726600|P1|NOT COMPLETED|First Intervention||0
8409228|NCT00961116|20726599|P2|COMPLETED|First Intervention||27
8409229|NCT00961116|20726600|P1|COMPLETED|First Intervention||27
8409230|NCT00961116|20726599|P2|STARTED|First Intervention||27
8409231|NCT00961116|20726600|P1|STARTED|First Intervention||27
8409235|NCT00961051|20726616|P2|NOT COMPLETED|Overall Study||14
8409236|NCT00961051|20726617|P1|NOT COMPLETED|Overall Study||12
8409237|NCT00961051|20726616|P2|COMPLETED|Overall Study||79
8409238|NCT00961051|20726617|P1|COMPLETED|Overall Study||165
8409239|NCT00961051|20726616|P2|STARTED|Overall Study||93
8409240|NCT00961051|20726617|P1|STARTED|Overall Study||177
8409241|NCT00960999|20726627|P2|NOT COMPLETED|Overall Study||2
8409242|NCT00960999|20726628|P1|NOT COMPLETED|Overall Study||8
8409243|NCT00960999|20726627|P2|COMPLETED|Overall Study||45
8409244|NCT00960999|20726628|P1|COMPLETED|Overall Study||39
8409245|NCT00960999|20726627|P2|DLCO by Best Response|Overall Study||28
8409246|NCT00960999|20726628|P1|DLCO by Best Response|Overall Study||23
8409247|NCT00960999|20726627|P2|FEV1 by Best Response|Overall Study||33
8409248|NCT00960999|20726628|P1|FEV1 by Best Response|Overall Study||26
8409249|NCT00960999|20726627|P2|Normalized SUV at 1 Year|Overall Study||7
8409250|NCT00960999|20726628|P1|Normalized SUV at 1 Year|Overall Study||4
8409251|NCT00960999|20726627|P2|Normalized SUV at 8 Weeks|Overall Study||9
8409252|NCT00960999|20726628|P1|Normalized SUV at 8 Weeks|Overall Study||3
8409253|NCT00960999|20726627|P2|Peak SUV at 1 Year|Overall Study||7
8409254|NCT00960999|20726628|P1|Peak SUV at 1 Year|Overall Study||4
8409255|NCT00960999|20726627|P2|Peak SUV at 8 Weeks|Overall Study||11
8409256|NCT00960999|20726628|P1|Peak SUV at 8 Weeks|Overall Study||3
8409257|NCT00960999|20726627|P2|Primary Endpoint Population|Overall Study||38
8409258|NCT00960999|20726628|P1|Primary Endpoint Population|Overall Study||38
8409259|NCT00960999|20726627|P2|Started Protocol Treatment|Overall Study||45
8409260|NCT00960999|20726628|P1|Started Protocol Treatment|Overall Study||39
8409261|NCT00960999|20726627|P2|Eligible|Overall Study||45
8409262|NCT00960999|20726628|P1|Eligible|Overall Study||39
8409263|NCT00960999|20726627|P2|STARTED|Overall Study||47
8409264|NCT00960999|20726628|P1|STARTED|Overall Study||47
8409265|NCT00960986|20726660|P4|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
8409266|NCT00960986|20726661|P3|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
8409267|NCT00960986|20726662|P2|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
8409268|NCT00960986|20726663|P1|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
8409269|NCT00960986|20726660|P4|COMPLETED|Period 3 (7-week Therapy Period)||36
8409270|NCT00960986|20726661|P3|COMPLETED|Period 3 (7-week Therapy Period)||39
8409271|NCT00960986|20726662|P2|COMPLETED|Period 3 (7-week Therapy Period)||36
8409272|NCT00960986|20726663|P1|COMPLETED|Period 3 (7-week Therapy Period)||26
8409273|NCT00960986|20726660|P4|STARTED|Period 3 (7-week Therapy Period)||61
8409274|NCT00960986|20726661|P3|STARTED|Period 3 (7-week Therapy Period)||59
8409275|NCT00960986|20726662|P2|STARTED|Period 3 (7-week Therapy Period)||59
8409276|NCT00960986|20726663|P1|STARTED|Period 3 (7-week Therapy Period)||56
8409277|NCT00960986|20726660|P4|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
8409278|NCT00960986|20726661|P3|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
8409279|NCT00960986|20726662|P2|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
8409280|NCT00960986|20726663|P1|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
8409281|NCT00960986|20726660|P4|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
8409282|NCT00960986|20726661|P3|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
8409283|NCT00960986|20726662|P2|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
8409284|NCT00960986|20726663|P1|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
8409285|NCT00960986|20726660|P4|STARTED|Period 2 (1-week Initial Dosing Period)||61
8409286|NCT00960986|20726661|P3|STARTED|Period 2 (1-week Initial Dosing Period)||59
8409287|NCT00960986|20726662|P2|STARTED|Period 2 (1-week Initial Dosing Period)||59
8409288|NCT00960986|20726663|P1|STARTED|Period 2 (1-week Initial Dosing Period)||56
8409289|NCT00960986|20726660|P4|NOT COMPLETED|Period 1 (Screening and Washout)||3
8409290|NCT00960986|20726661|P3|NOT COMPLETED|Period 1 (Screening and Washout)||4
8409291|NCT00960986|20726662|P2|NOT COMPLETED|Period 1 (Screening and Washout)||4
8409292|NCT00960986|20726663|P1|NOT COMPLETED|Period 1 (Screening and Washout)||3
8409293|NCT00960986|20726660|P4|COMPLETED|Period 1 (Screening and Washout)||61
8409294|NCT00960986|20726661|P3|COMPLETED|Period 1 (Screening and Washout)||59
8409295|NCT00960986|20726662|P2|COMPLETED|Period 1 (Screening and Washout)||59
8409296|NCT00960986|20726663|P1|COMPLETED|Period 1 (Screening and Washout)||56
8409297|NCT00960986|20726660|P4|STARTED|Period 1 (Screening and Washout)||64
8409298|NCT00960986|20726661|P3|STARTED|Period 1 (Screening and Washout)||63
8409299|NCT00960986|20726662|P2|STARTED|Period 1 (Screening and Washout)||63
8409300|NCT00960986|20726663|P1|STARTED|Period 1 (Screening and Washout)||59
8409301|NCT00960934|20726739|P6|NOT COMPLETED|Overall Study||64
8409302|NCT00960934|20726740|P5|NOT COMPLETED|Overall Study||64
8409303|NCT00960934|20726741|P4|NOT COMPLETED|Overall Study||64
8409304|NCT00960934|20726742|P3|NOT COMPLETED|Overall Study||64
8409305|NCT00960934|20726743|P2|NOT COMPLETED|Overall Study||63
8409306|NCT00960934|20726744|P1|NOT COMPLETED|Overall Study||64
8409307|NCT00960934|20726739|P6|COMPLETED|Overall Study||0
8409308|NCT00960934|20726740|P5|COMPLETED|Overall Study||0
8409309|NCT00960934|20726741|P4|COMPLETED|Overall Study||0
8409310|NCT00960934|20726742|P3|COMPLETED|Overall Study||0
8409311|NCT00960934|20726743|P2|COMPLETED|Overall Study||0
8409312|NCT00960934|20726744|P1|COMPLETED|Overall Study||0
8409313|NCT00960934|20726739|P6|Number Treated|Overall Study|1 participant was randomized but not treated|63
8409314|NCT00960934|20726740|P5|Number Treated|Overall Study|1 participant was randomized but not treated|63
8409315|NCT00960934|20726741|P4|Number Treated|Overall Study||64
8409316|NCT00960934|20726742|P3|Number Treated|Overall Study||64
8409317|NCT00960934|20726743|P2|Number Treated|Overall Study|1 participant was randomized but not treated|62
8409318|NCT00960934|20726744|P1|Number Treated|Overall Study||64
8409319|NCT00960934|20726739|P6|STARTED|Overall Study||64
8409320|NCT00960934|20726740|P5|STARTED|Overall Study||64
8409321|NCT00960934|20726741|P4|STARTED|Overall Study||64
8409322|NCT00960934|20726742|P3|STARTED|Overall Study||64
8409323|NCT00960934|20726743|P2|STARTED|Overall Study||63
8409324|NCT00960934|20726744|P1|STARTED|Overall Study||64
8409325|NCT00960869|20726856|P2|NOT COMPLETED|Overall Study||62
8409326|NCT00960869|20726857|P1|NOT COMPLETED|Overall Study||53
8409327|NCT00960869|20726856|P2|COMPLETED|Overall Study||198
8409328|NCT00960869|20726857|P1|COMPLETED|Overall Study||206
8409329|NCT00960869|20726856|P2|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
8409330|NCT00960869|20726857|P1|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
8409331|NCT00960869|20726856|P2|Intent-to-Treat Population (ITT)|Overall Study||260
8409332|NCT00960869|20726857|P1|Intent-to-Treat Population (ITT)|Overall Study||259
8409333|NCT00960869|20726856|P2|STARTED|Overall Study||260
8409334|NCT00960869|20726857|P1|STARTED|Overall Study||259
8409335|NCT00960856|20726871|P4|NOT COMPLETED|Period IV||0
8409336|NCT00960856|20726872|P3|NOT COMPLETED|Period IV||0
8409337|NCT00960856|20726873|P2|NOT COMPLETED|Period IV||0
8409338|NCT00960856|20726874|P1|NOT COMPLETED|Period IV||0
8409339|NCT00960856|20726871|P4|COMPLETED|Period IV||9
8409340|NCT00960856|20726872|P3|COMPLETED|Period IV||8
8409341|NCT00960856|20726873|P2|COMPLETED|Period IV||7
8409342|NCT00960856|20726874|P1|COMPLETED|Period IV||10
8409343|NCT00960856|20726871|P4|STARTED|Period IV||9
8409344|NCT00960856|20726872|P3|STARTED|Period IV||8
8409345|NCT00960856|20726873|P2|STARTED|Period IV||7
8409346|NCT00960856|20726874|P1|STARTED|Period IV||10
8409347|NCT00960856|20726871|P4|NOT COMPLETED|Washout Period of 7 Days||0
8409348|NCT00960856|20726872|P3|NOT COMPLETED|Washout Period of 7 Days||1
8409349|NCT00960856|20726873|P2|NOT COMPLETED|Washout Period of 7 Days||0
8409350|NCT00960856|20726874|P1|NOT COMPLETED|Washout Period of 7 Days||0
8409351|NCT00960856|20726871|P4|COMPLETED|Washout Period of 7 Days||9
8409352|NCT00960856|20726872|P3|COMPLETED|Washout Period of 7 Days||8
8409353|NCT00960856|20726873|P2|COMPLETED|Washout Period of 7 Days||7
8409354|NCT00960856|20726874|P1|COMPLETED|Washout Period of 7 Days||10
8409355|NCT00960856|20726871|P4|STARTED|Washout Period of 7 Days||9
8409356|NCT00960856|20726872|P3|STARTED|Washout Period of 7 Days||9
8409357|NCT00960856|20726873|P2|STARTED|Washout Period of 7 Days||7
8409358|NCT00960856|20726874|P1|STARTED|Washout Period of 7 Days||10
8409359|NCT00960856|20726871|P4|NOT COMPLETED|Period III||0
8409360|NCT00960856|20726872|P3|NOT COMPLETED|Period III||0
8409361|NCT00960856|20726873|P2|NOT COMPLETED|Period III||0
8409362|NCT00960856|20726874|P1|NOT COMPLETED|Period III||0
8409363|NCT00960856|20726871|P4|COMPLETED|Period III||9
8409364|NCT00960856|20726872|P3|COMPLETED|Period III||9
8409365|NCT00960856|20726873|P2|COMPLETED|Period III||7
8409366|NCT00960856|20726874|P1|COMPLETED|Period III||10
8409367|NCT00960856|20726871|P4|STARTED|Period III||9
8409368|NCT00960856|20726872|P3|STARTED|Period III||9
8409369|NCT00960856|20726873|P2|STARTED|Period III||7
8409370|NCT00960856|20726874|P1|STARTED|Period III||10
8409371|NCT00960856|20726871|P4|NOT COMPLETED|Washout Period of 7 Days||0
8409372|NCT00960856|20726872|P3|NOT COMPLETED|Washout Period of 7 Days||0
8409373|NCT00960856|20726873|P2|NOT COMPLETED|Washout Period of 7 Days||0
8409374|NCT00960856|20726874|P1|NOT COMPLETED|Washout Period of 7 Days||0
8409375|NCT00960856|20726871|P4|COMPLETED|Washout Period of 7 Days||9
8409376|NCT00960856|20726872|P3|COMPLETED|Washout Period of 7 Days||9
8409377|NCT00960856|20726873|P2|COMPLETED|Washout Period of 7 Days||7
8409378|NCT00960856|20726874|P1|COMPLETED|Washout Period of 7 Days||10
8409379|NCT00960856|20726871|P4|STARTED|Washout Period of 7 Days||9
8409380|NCT00960856|20726872|P3|STARTED|Washout Period of 7 Days||9
8409381|NCT00960856|20726873|P2|STARTED|Washout Period of 7 Days||7
8409382|NCT00960856|20726874|P1|STARTED|Washout Period of 7 Days||10
8409383|NCT00960856|20726871|P4|NOT COMPLETED|Period II||0
8409384|NCT00960856|20726872|P3|NOT COMPLETED|Period II||0
8409385|NCT00960856|20726873|P2|NOT COMPLETED|Period II||0
8409386|NCT00960856|20726874|P1|NOT COMPLETED|Period II||0
8409387|NCT00960856|20726871|P4|COMPLETED|Period II||9
8409388|NCT00960856|20726872|P3|COMPLETED|Period II||9
8409389|NCT00960856|20726873|P2|COMPLETED|Period II||7
8409390|NCT00960856|20726874|P1|COMPLETED|Period II||10
8409391|NCT00960856|20726871|P4|STARTED|Period II||9
8409392|NCT00960856|20726872|P3|STARTED|Period II||9
8409393|NCT00960856|20726873|P2|STARTED|Period II||7
8409394|NCT00960856|20726874|P1|STARTED|Period II||10
8409395|NCT00960856|20726871|P4|NOT COMPLETED|Washout Period of 7 Days||0
8409396|NCT00960856|20726872|P3|NOT COMPLETED|Washout Period of 7 Days||0
8409397|NCT00960856|20726873|P2|NOT COMPLETED|Washout Period of 7 Days||2
8409398|NCT00960856|20726874|P1|NOT COMPLETED|Washout Period of 7 Days||0
8409399|NCT00960856|20726871|P4|COMPLETED|Washout Period of 7 Days||9
8409400|NCT00960856|20726872|P3|COMPLETED|Washout Period of 7 Days||9
8409401|NCT00960856|20726873|P2|COMPLETED|Washout Period of 7 Days|personal reasons|7
8409402|NCT00960856|20726874|P1|COMPLETED|Washout Period of 7 Days||10
8409403|NCT00960856|20726871|P4|STARTED|Washout Period of 7 Days||9
8409404|NCT00960856|20726872|P3|STARTED|Washout Period of 7 Days||9
8409405|NCT00960856|20726873|P2|STARTED|Washout Period of 7 Days||9
8409406|NCT00960856|20726874|P1|STARTED|Washout Period of 7 Days||10
8409407|NCT00960856|20726871|P4|NOT COMPLETED|Period I||0
8409408|NCT00960856|20726872|P3|NOT COMPLETED|Period I||0
8409409|NCT00960856|20726873|P2|NOT COMPLETED|Period I||0
8409410|NCT00960856|20726874|P1|NOT COMPLETED|Period I||0
8409411|NCT00960856|20726871|P4|COMPLETED|Period I||9
8409412|NCT00960856|20726872|P3|COMPLETED|Period I||9
8409413|NCT00960856|20726873|P2|COMPLETED|Period I||9
8409414|NCT00960856|20726874|P1|COMPLETED|Period I||10
8409415|NCT00960856|20726871|P4|STARTED|Period I||9
8409416|NCT00960856|20726872|P3|STARTED|Period I||9
8409417|NCT00960856|20726873|P2|STARTED|Period I||9
8409418|NCT00960856|20726874|P1|STARTED|Period I||10
8409419|NCT00960843|20726894|P2|NOT COMPLETED|Overall Study||5
8409420|NCT00960843|20726895|P1|NOT COMPLETED|Overall Study||2
8409421|NCT00960843|20726894|P2|COMPLETED|Overall Study||21
8409422|NCT00960843|20726895|P1|COMPLETED|Overall Study||23
8409423|NCT00960843|20726894|P2|STARTED|Overall Study||26
8409424|NCT00960843|20726895|P1|STARTED|Overall Study||25
8409425|NCT00960778|20726907|P2|NOT COMPLETED|Overall Study||3
8409426|NCT00960778|20726908|P1|NOT COMPLETED|Overall Study||9
8409427|NCT00960778|20726907|P2|COMPLETED|Overall Study||13
8409428|NCT00960778|20726908|P1|COMPLETED|Overall Study||8
8409429|NCT00960778|20726907|P2|STARTED|Overall Study||16
8409430|NCT00960778|20726908|P1|STARTED|Overall Study||17
8409431|NCT00960687|20726916|P2|NOT COMPLETED|Second Intervention||0
8409432|NCT00960687|20726917|P1|NOT COMPLETED|Second Intervention||0
8409433|NCT00960687|20726916|P2|COMPLETED|Second Intervention||24
8409434|NCT00960687|20726917|P1|COMPLETED|Second Intervention||23
8409435|NCT00960687|20726916|P2|STARTED|Second Intervention||24
8409436|NCT00960687|20726917|P1|STARTED|Second Intervention||23
8409437|NCT00960687|20726916|P2|NOT COMPLETED|Washout Period of 7 Days||3
8409438|NCT00960687|20726917|P1|NOT COMPLETED|Washout Period of 7 Days||4
8409439|NCT00960687|20726916|P2|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
8409440|NCT00960687|20726917|P1|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
8409441|NCT00960687|20726916|P2|STARTED|Washout Period of 7 Days||27
8409442|NCT00960687|20726917|P1|STARTED|Washout Period of 7 Days||27
8409443|NCT00960687|20726916|P2|NOT COMPLETED|First Intervention||0
8409444|NCT00960687|20726917|P1|NOT COMPLETED|First Intervention||0
8409445|NCT00960687|20726916|P2|COMPLETED|First Intervention||27
8409446|NCT00960687|20726917|P1|COMPLETED|First Intervention||27
8409447|NCT00960687|20726916|P2|STARTED|First Intervention||27
8409448|NCT00960687|20726917|P1|STARTED|First Intervention||27
8409449|NCT00960661|20726929|P3|NOT COMPLETED|Interventional Phase||46
8409450|NCT00960661|20726930|P2|NOT COMPLETED|Interventional Phase||52
8409451|NCT00960661|20726931|P1|NOT COMPLETED|Interventional Phase||0
8409452|NCT00960661|20726929|P3|COMPLETED|Interventional Phase||275
8409453|NCT00960661|20726930|P2|COMPLETED|Interventional Phase||264
8409454|NCT00960661|20726931|P1|COMPLETED|Interventional Phase||0
8409455|NCT00960661|20726929|P3|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
8409456|NCT00960661|20726930|P2|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
8409457|NCT00960661|20726931|P1|Per Protocol Population|Interventional Phase||0
8409458|NCT00960661|20726929|P3|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
8409459|NCT00960661|20726930|P2|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
8409460|NCT00960661|20726931|P1|Intent to Treat Population|Interventional Phase||0
8409461|NCT00960661|20726929|P3|STARTED|Interventional Phase||321
8409462|NCT00960661|20726930|P2|STARTED|Interventional Phase||316
8409463|NCT00960661|20726931|P1|STARTED|Interventional Phase||0
8409464|NCT00960661|20726929|P3|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
8409465|NCT00960661|20726930|P2|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
8409466|NCT00960661|20726931|P1|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
8409467|NCT00960661|20726929|P3|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
8409468|NCT00960661|20726930|P2|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
8409469|NCT00960661|20726931|P1|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
8409470|NCT00960661|20726929|P3|STARTED|Basal Insulin Optimization Phase (BIO)||0
8409471|NCT00960661|20726930|P2|STARTED|Basal Insulin Optimization Phase (BIO)||0
8409472|NCT00960661|20726931|P1|STARTED|Basal Insulin Optimization Phase (BIO)||1036
8409473|NCT00960622|20726963|P2|NOT COMPLETED|Overall Study||3
8409474|NCT00960622|20726964|P1|NOT COMPLETED|Overall Study||0
8409475|NCT00960622|20726963|P2|COMPLETED|Overall Study||7
8409476|NCT00960622|20726964|P1|COMPLETED|Overall Study||10
8409477|NCT00960622|20726963|P2|STARTED|Overall Study||10
8409478|NCT00960622|20726964|P1|STARTED|Overall Study||10
8409479|NCT00960570|20726970|P1|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
8409480|NCT00960570|20726970|P1|COMPLETED|Efavirenz and Fenofibric Acid||25
8409481|NCT00960570|20726970|P1|STARTED|Efavirenz and Fenofibric Acid||25
8409482|NCT00960570|20726970|P1|NOT COMPLETED|1 Day Period Between Dosing||3
8409483|NCT00960570|20726970|P1|COMPLETED|1 Day Period Between Dosing||25
8409484|NCT00960570|20726970|P1|STARTED|1 Day Period Between Dosing||28
8409485|NCT00960570|20726970|P1|NOT COMPLETED|Fenofibric Acid Alone||0
8409486|NCT00960570|20726970|P1|COMPLETED|Fenofibric Acid Alone||28
8409487|NCT00960570|20726970|P1|STARTED|Fenofibric Acid Alone||28
8409488|NCT00960570|20726970|P1|NOT COMPLETED|21 Day Washout Period||2
8409489|NCT00960570|20726970|P1|COMPLETED|21 Day Washout Period||28
8409490|NCT00960570|20726970|P1|STARTED|21 Day Washout Period||30
8409491|NCT00960570|20726970|P1|NOT COMPLETED|Efavirenz Alone||0
8409492|NCT00960570|20726970|P1|COMPLETED|Efavirenz Alone||30
8409493|NCT00960570|20726970|P1|STARTED|Efavirenz Alone||30
8409494|NCT00960531|20726991|P10|NOT COMPLETED|Overall Study||1
8409495|NCT00960531|20726992|P9|NOT COMPLETED|Overall Study||14
8409496|NCT00960531|20726993|P8|NOT COMPLETED|Overall Study||4
8409497|NCT00960531|20726994|P7|NOT COMPLETED|Overall Study||24
8409498|NCT00960531|20726995|P6|NOT COMPLETED|Overall Study||3
8409499|NCT00960531|20726996|P5|NOT COMPLETED|Overall Study||2
8409500|NCT00960531|20726997|P4|NOT COMPLETED|Overall Study||8
8409501|NCT00960531|20726998|P3|NOT COMPLETED|Overall Study||26
8409502|NCT00960531|20726999|P2|NOT COMPLETED|Overall Study||1
8409503|NCT00960531|20727000|P1|NOT COMPLETED|Overall Study||10
8409504|NCT00960531|20726991|P10|COMPLETED|Overall Study|Completed study|3
8409505|NCT00960531|20726992|P9|COMPLETED|Overall Study|Completed study|2
8409506|NCT00960531|20726993|P8|COMPLETED|Overall Study|Completed study|2
8409507|NCT00960531|20726994|P7|COMPLETED|Overall Study|Completed study|3
8409508|NCT00960531|20726995|P6|COMPLETED|Overall Study|Completed study|6
8409509|NCT00960531|20726996|P5|COMPLETED|Overall Study|Completed study|3
8409510|NCT00960531|20726997|P4|COMPLETED|Overall Study|Completed study|17
8409511|NCT00960531|20726998|P3|COMPLETED|Overall Study|Completed study|15
8409512|NCT00960531|20726999|P2|COMPLETED|Overall Study|Completed study|5
8409513|NCT00960531|20727000|P1|COMPLETED|Overall Study|Completed study|11
8409514|NCT00960531|20726991|P10|Completed Treatment|Overall Study||4
8409515|NCT00960531|20726992|P9|Completed Treatment|Overall Study||2
8409516|NCT00960531|20726993|P8|Completed Treatment|Overall Study||3
8409517|NCT00960531|20726994|P7|Completed Treatment|Overall Study||4
8409518|NCT00960531|20726995|P6|Completed Treatment|Overall Study||7
8409519|NCT00960531|20726996|P5|Completed Treatment|Overall Study||3
8409520|NCT00960531|20726997|P4|Completed Treatment|Overall Study||17
8409521|NCT00960531|20726998|P3|Completed Treatment|Overall Study||15
8409522|NCT00960531|20726999|P2|Completed Treatment|Overall Study||5
8409523|NCT00960531|20727000|P1|Completed Treatment|Overall Study||12
8409524|NCT00960531|20726991|P10|Treated|Overall Study||4
8409525|NCT00960531|20726992|P9|Treated|Overall Study||16
8409526|NCT00960531|20726993|P8|Treated|Overall Study||6
8409527|NCT00960531|20726994|P7|Treated|Overall Study||27
8409528|NCT00960531|20726995|P6|Treated|Overall Study||9
8409529|NCT00960531|20726996|P5|Treated|Overall Study||5
8409530|NCT00960531|20726997|P4|Treated|Overall Study||24
8409531|NCT00960531|20726998|P3|Treated|Overall Study||41
8409532|NCT00960531|20726999|P2|Treated|Overall Study||6
8409533|NCT00960531|20727000|P1|Treated|Overall Study||21
8409534|NCT00960531|20726991|P10|STARTED|Overall Study|Started=Randomized|4
8409535|NCT00960531|20726992|P9|STARTED|Overall Study|Started=Randomized|16
8409536|NCT00960531|20726993|P8|STARTED|Overall Study|Started=Randomized|6
8409537|NCT00960531|20726994|P7|STARTED|Overall Study|Started=Randomized|27
8409538|NCT00960531|20726995|P6|STARTED|Overall Study|Started=Randomized|9
8409539|NCT00960531|20726996|P5|STARTED|Overall Study|Started=Randomized|5
8409540|NCT00960531|20726997|P4|STARTED|Overall Study|Started=Randomized.|25
8409541|NCT00960531|20726998|P3|STARTED|Overall Study|Started=Randomized|41
8409542|NCT00960531|20726999|P2|STARTED|Overall Study|Started=Randomized|6
8409543|NCT00960531|20727000|P1|STARTED|Overall Study|Started=Randomized|21
8409544|NCT00960505|20727047|P3|NOT COMPLETED|Overall Study||8
8409545|NCT00960505|20727048|P2|NOT COMPLETED|Overall Study||10
8409546|NCT00960505|20727049|P1|NOT COMPLETED|Overall Study||13
8409547|NCT00960505|20727047|P3|COMPLETED|Overall Study||23
8409548|NCT00960505|20727048|P2|COMPLETED|Overall Study||25
8409549|NCT00960505|20727049|P1|COMPLETED|Overall Study||21
8409550|NCT00960505|20727047|P3|STARTED|Overall Study||31
8409551|NCT00960505|20727048|P2|STARTED|Overall Study||35
8409552|NCT00960505|20727049|P1|STARTED|Overall Study||34
8409553|NCT00960440|20727082|P4|NOT COMPLETED|Overall Study||18
8409554|NCT00960440|20727083|P3|NOT COMPLETED|Overall Study||13
8409555|NCT00960440|20727084|P2|NOT COMPLETED|Overall Study||31
8409556|NCT00960440|20727085|P1|NOT COMPLETED|Overall Study||26
8409557|NCT00960440|20727082|P4|COMPLETED|Overall Study||48
8409558|NCT00960440|20727083|P3|COMPLETED|Overall Study||53
8409559|NCT00960440|20727084|P2|COMPLETED|Overall Study||103
8409560|NCT00960440|20727085|P1|COMPLETED|Overall Study||107
8409561|NCT00960440|20727082|P4|STARTED|Overall Study||66
8409562|NCT00960440|20727083|P3|STARTED|Overall Study||66
8409563|NCT00960440|20727084|P2|STARTED|Overall Study||134
8409564|NCT00960440|20727085|P1|STARTED|Overall Study||133
8409565|NCT00960375|20727257|P2|NOT COMPLETED|Overall Study||22
8409566|NCT00960375|20727258|P1|NOT COMPLETED|Overall Study||20
8409567|NCT00960375|20727257|P2|COMPLETED|Overall Study||65
8409568|NCT00960375|20727258|P1|COMPLETED|Overall Study||72
8409569|NCT00960375|20727257|P2|STARTED|Overall Study||87
8409570|NCT00960375|20727258|P1|STARTED|Overall Study||92
8409571|NCT00960323|20727266|P1|NOT COMPLETED|Colchicine and Atorvastatin||0
8409572|NCT00960323|20727266|P1|COMPLETED|Colchicine and Atorvastatin||23
8409573|NCT00960323|20727266|P1|STARTED|Colchicine and Atorvastatin||23
8409574|NCT00960323|20727266|P1|NOT COMPLETED|Atorvastatin Alone||1
8409575|NCT00960323|20727266|P1|COMPLETED|Atorvastatin Alone||23
8409576|NCT00960323|20727266|P1|STARTED|Atorvastatin Alone||24
8409577|NCT00960323|20727266|P1|NOT COMPLETED|14 Day Washout Period||0
8409578|NCT00960323|20727266|P1|COMPLETED|14 Day Washout Period||24
8409579|NCT00960323|20727266|P1|STARTED|14 Day Washout Period||24
8409580|NCT00960323|20727266|P1|NOT COMPLETED|Colchicine Alone||0
8409581|NCT00960323|20727266|P1|COMPLETED|Colchicine Alone||24
8409582|NCT00960323|20727266|P1|STARTED|Colchicine Alone||24
8409583|NCT00960297|20727277|P1|NOT COMPLETED|Overall Study||3
8409584|NCT00960297|20727277|P1|COMPLETED|Overall Study||1
8409585|NCT00960297|20727277|P1|STARTED|Overall Study||4
8409586|NCT00960206|20727284|P3|NOT COMPLETED|Overall Study||12
8409587|NCT00960206|20727285|P2|NOT COMPLETED|Overall Study||27
8409588|NCT00960206|20727286|P1|NOT COMPLETED|Overall Study||40
8409589|NCT00960206|20727284|P3|COMPLETED|Overall Study||77
8409590|NCT00960206|20727285|P2|COMPLETED|Overall Study||158
8409591|NCT00960206|20727286|P1|COMPLETED|Overall Study||150
8409592|NCT00960206|20727284|P3|STARTED|Overall Study||89
8409593|NCT00960206|20727285|P2|STARTED|Overall Study||185
8409594|NCT00960206|20727286|P1|STARTED|Overall Study||190
8409595|NCT00960193|20727304|P1|NOT COMPLETED|Colchicine With Seville Orange Juice||0
8409596|NCT00960193|20727304|P1|COMPLETED|Colchicine With Seville Orange Juice||23
8409597|NCT00960193|20727304|P1|STARTED|Colchicine With Seville Orange Juice||23
8409598|NCT00960193|20727304|P1|NOT COMPLETED|Seville Orange Juice Alone||0
8409599|NCT00960193|20727304|P1|COMPLETED|Seville Orange Juice Alone||23
8409600|NCT00960193|20727304|P1|STARTED|Seville Orange Juice Alone||23
8409601|NCT00960193|20727304|P1|NOT COMPLETED|14 Day Washout Period||1
8409602|NCT00960193|20727304|P1|COMPLETED|14 Day Washout Period||23
8409603|NCT00960193|20727304|P1|STARTED|14 Day Washout Period||24
8409604|NCT00960193|20727304|P1|NOT COMPLETED|Colchicine Alone||0
8409605|NCT00960193|20727304|P1|COMPLETED|Colchicine Alone||24
8409606|NCT00960193|20727304|P1|STARTED|Colchicine Alone||24
8409607|NCT00960154|20727317|P2|NOT COMPLETED|Overall Study||25
8409608|NCT00960154|20727318|P1|NOT COMPLETED|Overall Study||25
8409609|NCT00960154|20727317|P2|COMPLETED|Overall Study||0
8409610|NCT00960154|20727318|P1|COMPLETED|Overall Study||0
8409611|NCT00960154|20727317|P2|STARTED|Overall Study||25
8409612|NCT00960154|20727318|P1|STARTED|Overall Study||25
8409613|NCT00960141|20727329|P3|NOT COMPLETED|Overall Study||7
8409614|NCT00960141|20727330|P2|NOT COMPLETED|Overall Study||17
8409615|NCT00960141|20727331|P1|NOT COMPLETED|Overall Study||10
8409616|NCT00960141|20727329|P3|COMPLETED|Overall Study||163
8409617|NCT00960141|20727330|P2|COMPLETED|Overall Study||309
8409618|NCT00960141|20727331|P1|COMPLETED|Overall Study||323
8409619|NCT00960141|20727329|P3|STARTED|Overall Study||170
8409620|NCT00960141|20727330|P2|STARTED|Overall Study||326
8409621|NCT00960141|20727331|P1|STARTED|Overall Study||333
8409622|NCT00960115|20727356|P2|NOT COMPLETED|Overall Study||15
8409623|NCT00960115|20727357|P1|NOT COMPLETED|Overall Study||19
8409624|NCT00960115|20727356|P2|COMPLETED|Overall Study||43
8409625|NCT00960115|20727357|P1|COMPLETED|Overall Study||95
8409626|NCT00960115|20727356|P2|STARTED|Overall Study||58
8409627|NCT00960115|20727357|P1|STARTED|Overall Study||114
8409628|NCT00960076|20727371|P2|NOT COMPLETED|Overall Study||25
8409629|NCT00960076|20727372|P1|NOT COMPLETED|Overall Study||8
8409630|NCT00960076|20727371|P2|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
8409631|NCT00960076|20727372|P1|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
8409632|NCT00960076|20727371|P2|STARTED|Overall Study|Randomized and treated|144
8409633|NCT00960076|20727372|P1|STARTED|Overall Study|Randomized and treated|138
8409634|NCT00960063|20727387|P3|NOT COMPLETED|Overall Study||3
8409635|NCT00960063|20727388|P2|NOT COMPLETED|Overall Study||0
8409636|NCT00960063|20727389|P1|NOT COMPLETED|Overall Study||1
8409637|NCT00960063|20727387|P3|COMPLETED|Overall Study||0
8409638|NCT00960063|20727388|P2|COMPLETED|Overall Study||0
8409639|NCT00960063|20727389|P1|COMPLETED|Overall Study||0
8409640|NCT00960063|20727387|P3|STARTED|Overall Study||3
8409641|NCT00960063|20727388|P2|STARTED|Overall Study||0
8409642|NCT00960063|20727389|P1|STARTED|Overall Study||1
8409643|NCT00960011|20727429|P2|NOT COMPLETED|Overall Study||2
8409644|NCT00960011|20727430|P1|NOT COMPLETED|Overall Study||11
8409645|NCT00960011|20727429|P2|COMPLETED|Overall Study||23
8409646|NCT00960011|20727430|P1|COMPLETED|Overall Study||22
8409647|NCT00960011|20727429|P2|STARTED|Overall Study||25
8409648|NCT00960011|20727430|P1|STARTED|Overall Study||33
8409649|NCT00959985|20727474|P4|NOT COMPLETED|Overall Study||0
8409650|NCT00959985|20727475|P3|NOT COMPLETED|Overall Study||0
8409651|NCT00959985|20727476|P2|NOT COMPLETED|Overall Study||0
8409652|NCT00959985|20727477|P1|NOT COMPLETED|Overall Study||0
8409653|NCT00959985|20727474|P4|COMPLETED|Overall Study||4
8409654|NCT00959985|20727475|P3|COMPLETED|Overall Study||4
8409655|NCT00959985|20727476|P2|COMPLETED|Overall Study||7
8409656|NCT00959985|20727477|P1|COMPLETED|Overall Study||8
8409657|NCT00959985|20727474|P4|STARTED|Overall Study||4
8409658|NCT00959985|20727475|P3|STARTED|Overall Study||4
8409659|NCT00959985|20727476|P2|STARTED|Overall Study||7
8409660|NCT00959985|20727477|P1|STARTED|Overall Study||8
8409661|NCT00959946|20727523|P8|NOT COMPLETED|Overall Study||2
8409662|NCT00959946|20727524|P7|NOT COMPLETED|Overall Study||2
8409663|NCT00959946|20727525|P6|NOT COMPLETED|Overall Study||9
8409664|NCT00959946|20727526|P5|NOT COMPLETED|Overall Study||4
8409665|NCT00959946|20727527|P4|NOT COMPLETED|Overall Study||5
8409666|NCT00959946|20727528|P3|NOT COMPLETED|Overall Study||4
8409667|NCT00959946|20727529|P2|NOT COMPLETED|Overall Study||4
8409668|NCT00959946|20727530|P1|NOT COMPLETED|Overall Study||2
8409669|NCT00959946|20727523|P8|COMPLETED|Overall Study||0
8409670|NCT00959946|20727524|P7|COMPLETED|Overall Study||0
8409671|NCT00959946|20727525|P6|COMPLETED|Overall Study||0
8409672|NCT00959946|20727526|P5|COMPLETED|Overall Study||0
8409673|NCT00959946|20727527|P4|COMPLETED|Overall Study||0
8409674|NCT00959946|20727528|P3|COMPLETED|Overall Study||0
8409675|NCT00959946|20727529|P2|COMPLETED|Overall Study||0
8409676|NCT00959946|20727530|P1|COMPLETED|Overall Study||0
8409677|NCT00959946|20727523|P8|STARTED|Overall Study||2
8409678|NCT00959946|20727524|P7|STARTED|Overall Study||2
8409679|NCT00959946|20727525|P6|STARTED|Overall Study||9
8409680|NCT00959946|20727526|P5|STARTED|Overall Study||4
8409681|NCT00959946|20727527|P4|STARTED|Overall Study||5
8409682|NCT00959946|20727528|P3|STARTED|Overall Study||4
8409683|NCT00959946|20727529|P2|STARTED|Overall Study||4
8409684|NCT00959946|20727530|P1|STARTED|Overall Study||2
8409685|NCT00959920|20727583|P2|NOT COMPLETED|Overall Study||1
8409686|NCT00959920|20727584|P1|NOT COMPLETED|Overall Study||0
8409687|NCT00959920|20727583|P2|COMPLETED|Overall Study||66
8409688|NCT00959920|20727584|P1|COMPLETED|Overall Study||72
8409689|NCT00959920|20727583|P2|STARTED|Overall Study||67
8409690|NCT00959920|20727584|P1|STARTED|Overall Study||72
8409691|NCT00959907|20727594|P2|NOT COMPLETED|Overall Study||1
8409692|NCT00959907|20727595|P1|NOT COMPLETED|Overall Study||3
8409693|NCT00959907|20727594|P2|COMPLETED|Overall Study||28
8409694|NCT00959907|20727595|P1|COMPLETED|Overall Study||27
8409695|NCT00959907|20727594|P2|STARTED|Overall Study||29
8409696|NCT00959907|20727595|P1|STARTED|Overall Study||30
8409697|NCT00959894|20727605|P1|NOT COMPLETED|Overall Study||16
8409698|NCT00959894|20727605|P1|COMPLETED|Overall Study||63
8409699|NCT00959894|20727605|P1|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
8409700|NCT00959764|20727636|P3|NOT COMPLETED|Overall Study||36
8409701|NCT00959764|20727637|P2|NOT COMPLETED|Overall Study||57
8409702|NCT00959764|20727638|P1|NOT COMPLETED|Overall Study||95
8409703|NCT00959764|20727636|P3|COMPLETED|Overall Study||73
8409704|NCT00959764|20727637|P2|COMPLETED|Overall Study||128
8409705|NCT00959764|20727638|P1|COMPLETED|Overall Study||176
8409706|NCT00959764|20727636|P3|STARTED|Overall Study||109
8409707|NCT00959764|20727637|P2|STARTED|Overall Study||185
8409708|NCT00959764|20727638|P1|STARTED|Overall Study||271
8409709|NCT00959751|20727654|P2|NOT COMPLETED|Overall Study||12
8409710|NCT00959751|20727655|P1|NOT COMPLETED|Overall Study||9
8409711|NCT00959751|20727654|P2|COMPLETED|Overall Study||86
8409712|NCT00959751|20727655|P1|COMPLETED|Overall Study||88
8409713|NCT00959751|20727654|P2|STARTED|Overall Study||98
8409714|NCT00959751|20727655|P1|STARTED|Overall Study||97
8409715|NCT00959699|20727677|P2|NOT COMPLETED|Follow-up Period||6
8409716|NCT00959699|20727678|P1|NOT COMPLETED|Follow-up Period||6
8409717|NCT00959699|20727677|P2|COMPLETED|Follow-up Period||56
8409718|NCT00959699|20727678|P1|COMPLETED|Follow-up Period||27
8409719|NCT00959699|20727677|P2|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
8409720|NCT00959699|20727678|P1|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
8409721|NCT00959699|20727677|P2|NOT COMPLETED|Treatment Period||25
8409722|NCT00959699|20727678|P1|NOT COMPLETED|Treatment Period||23
8409723|NCT00959699|20727677|P2|COMPLETED|Treatment Period||40
8409724|NCT00959699|20727678|P1|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
8409725|NCT00959699|20727677|P2|Treated|Treatment Period||64
8409726|NCT00959699|20727678|P1|Treated|Treatment Period||34
8409727|NCT00959699|20727677|P2|STARTED|Treatment Period||65
8409728|NCT00959699|20727678|P1|STARTED|Treatment Period||34
8409729|NCT00959660|20727699|P4|NOT COMPLETED|Overall Study||3
8409730|NCT00959660|20727700|P3|NOT COMPLETED|Overall Study||3
8409731|NCT00959660|20727701|P2|NOT COMPLETED|Overall Study||0
8409732|NCT00959660|20727702|P1|NOT COMPLETED|Overall Study||2
8409733|NCT00959660|20727699|P4|COMPLETED|Overall Study||22
8409734|NCT00959660|20727700|P3|COMPLETED|Overall Study||22
8409735|NCT00959660|20727701|P2|COMPLETED|Overall Study||24
8409736|NCT00959660|20727702|P1|COMPLETED|Overall Study||24
8409737|NCT00959660|20727699|P4|STARTED|Overall Study||25
8409738|NCT00959660|20727700|P3|STARTED|Overall Study||25
8409739|NCT00959660|20727701|P2|STARTED|Overall Study||24
8409740|NCT00959660|20727702|P1|STARTED|Overall Study||26
8409741|NCT00959647|20727724|P1|NOT COMPLETED|Overall Study||19
8409742|NCT00959647|20727724|P1|COMPLETED|Overall Study||0
8409743|NCT00959647|20727724|P1|STARTED|Overall Study||19
8409744|NCT00959374|20727729|P1|NOT COMPLETED|Overall Study||23
8409745|NCT00959374|20727729|P1|COMPLETED|Overall Study||218
8409746|NCT00959374|20727729|P1|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
8409747|NCT00959192|20727743|P4|NOT COMPLETED|Overall Study||1
8409748|NCT00959192|20727744|P3|NOT COMPLETED|Overall Study||3
8409749|NCT00959192|20727745|P2|NOT COMPLETED|Overall Study||1
8409750|NCT00959192|20727746|P1|NOT COMPLETED|Overall Study||2
8409751|NCT00959192|20727743|P4|COMPLETED|Overall Study||7
8409752|NCT00959192|20727744|P3|COMPLETED|Overall Study||6
8409753|NCT00959192|20727745|P2|COMPLETED|Overall Study||8
8409754|NCT00959192|20727746|P1|COMPLETED|Overall Study||4
8409755|NCT00959192|20727743|P4|STARTED|Overall Study||8
8409756|NCT00959192|20727744|P3|STARTED|Overall Study||9
8409757|NCT00959192|20727745|P2|STARTED|Overall Study||9
8409758|NCT00959192|20727746|P1|STARTED|Overall Study||6
8409759|NCT00959166|20727790|P2|NOT COMPLETED|Overall Study||0
8409760|NCT00959166|20727791|P1|NOT COMPLETED|Overall Study||0
8409761|NCT00959166|20727790|P2|COMPLETED|Overall Study||57
8409762|NCT00959166|20727791|P1|COMPLETED|Overall Study||24
8409763|NCT00959166|20727790|P2|STARTED|Overall Study||57
8409764|NCT00959166|20727791|P1|STARTED|Overall Study||24
8409765|NCT00959049|20727805|P6|NOT COMPLETED|Overall Study||1
8409766|NCT00959049|20727806|P5|NOT COMPLETED|Overall Study||9
8409767|NCT00959049|20727807|P4|NOT COMPLETED|Overall Study||11
8409768|NCT00959049|20727808|P3|NOT COMPLETED|Overall Study||1
8409769|NCT00959049|20727809|P2|NOT COMPLETED|Overall Study||7
8409770|NCT00959049|20727810|P1|NOT COMPLETED|Overall Study||18
8409771|NCT00959049|20727805|P6|COMPLETED|Overall Study||249
8409772|NCT00959049|20727806|P5|COMPLETED|Overall Study||248
8409773|NCT00959049|20727807|P4|COMPLETED|Overall Study||217
8409774|NCT00959049|20727808|P3|COMPLETED|Overall Study||253
8409775|NCT00959049|20727809|P2|COMPLETED|Overall Study||247
8409776|NCT00959049|20727810|P1|COMPLETED|Overall Study||213
8409777|NCT00959049|20727805|P6|STARTED|Overall Study||250
8409778|NCT00959049|20727806|P5|STARTED|Overall Study||257
8409779|NCT00959049|20727807|P4|STARTED|Overall Study||228
8409780|NCT00959049|20727808|P3|STARTED|Overall Study||254
8409781|NCT00959049|20727809|P2|STARTED|Overall Study||254
8409782|NCT00959049|20727810|P1|STARTED|Overall Study||231
8409783|NCT00958919|20727860|P2|NOT COMPLETED|Second Intervention||0
8409784|NCT00958919|20727861|P1|NOT COMPLETED|Second Intervention||0
8409785|NCT00958919|20727860|P2|COMPLETED|Second Intervention||7
8409786|NCT00958919|20727861|P1|COMPLETED|Second Intervention||7
8409787|NCT00958919|20727860|P2|STARTED|Second Intervention||7
8409788|NCT00958919|20727861|P1|STARTED|Second Intervention||7
8409789|NCT00958919|20727860|P2|NOT COMPLETED|First Intervention||0
8409790|NCT00958919|20727861|P1|NOT COMPLETED|First Intervention||0
8409791|NCT00958919|20727860|P2|COMPLETED|First Intervention||7
8409792|NCT00958919|20727861|P1|COMPLETED|First Intervention||7
8409793|NCT00958919|20727860|P2|STARTED|First Intervention||7
8409794|NCT00958919|20727861|P1|STARTED|First Intervention||7
8409795|NCT00958893|20727875|P1|NOT COMPLETED|Overall Study||4
8409796|NCT00958893|20727875|P1|COMPLETED|Overall Study||0
8409797|NCT00958893|20727875|P1|STARTED|Overall Study||4
8409798|NCT00958880|20727881|P2|NOT COMPLETED|Overall Study||2
8409799|NCT00958880|20727882|P1|NOT COMPLETED|Overall Study||2
8409800|NCT00958880|20727881|P2|COMPLETED|Overall Study||18
8409801|NCT00958880|20727882|P1|COMPLETED|Overall Study||18
8409802|NCT00958880|20727881|P2|STARTED|Overall Study||20
8409803|NCT00958880|20727882|P1|STARTED|Overall Study||20
8409804|NCT00958841|20727890|P1|NOT COMPLETED|Overall Study||96
8409805|NCT00958841|20727890|P1|COMPLETED|Overall Study|Completed = Completed extension|22
8409806|NCT00958841|20727890|P1|Entered in Extension|Overall Study||63
8409807|NCT00958841|20727890|P1|Completed Month 6 (M6)|Overall Study||90
8409808|NCT00958841|20727890|P1|STARTED|Overall Study||118
8409809|NCT00958828|20727908|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
8409810|NCT00958828|20727909|P1|NOT COMPLETED|Period 2, 1 Week of Wear||0
8409811|NCT00958828|20727908|P2|COMPLETED|Period 2, 1 Week of Wear||87
8409812|NCT00958828|20727909|P1|COMPLETED|Period 2, 1 Week of Wear||89
8409813|NCT00958828|20727908|P2|STARTED|Period 2, 1 Week of Wear||88
8409814|NCT00958828|20727909|P1|STARTED|Period 2, 1 Week of Wear||89
8409815|NCT00958828|20727908|P2|NOT COMPLETED|Period 1, 1 Week of Wear||1
8409816|NCT00958828|20727909|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
8409817|NCT00958828|20727908|P2|COMPLETED|Period 1, 1 Week of Wear||88
8409818|NCT00958828|20727909|P1|COMPLETED|Period 1, 1 Week of Wear||89
8409819|NCT00958828|20727908|P2|STARTED|Period 1, 1 Week of Wear||89
8409820|NCT00958828|20727909|P1|STARTED|Period 1, 1 Week of Wear||89
8409821|NCT00958789|20727915|P1|NOT COMPLETED|Overall Study||50
8409822|NCT00958789|20727915|P1|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
8409823|NCT00958789|20727915|P1|STARTED|Overall Study||180
8409824|NCT00958776|20727935|P2|NOT COMPLETED|Overall Study||29
8409825|NCT00958776|20727936|P1|NOT COMPLETED|Overall Study||16
8409826|NCT00958776|20727935|P2|COMPLETED|Overall Study||239
8409827|NCT00958776|20727936|P1|COMPLETED|Overall Study||121
8409828|NCT00958776|20727935|P2|STARTED|Overall Study||268
8409829|NCT00958776|20727936|P1|STARTED|Overall Study||137
8409830|NCT00958724|20727966|P1|NOT COMPLETED|Overall Study||6
8409831|NCT00958724|20727966|P1|COMPLETED|Overall Study||0
8409832|NCT00958724|20727966|P1|STARTED|Overall Study||6
8409833|NCT00958711|20727978|P2|NOT COMPLETED|Overall Study||21
8409834|NCT00958711|20727979|P1|NOT COMPLETED|Overall Study||13
8409835|NCT00958711|20727978|P2|COMPLETED|Overall Study||27
8409836|NCT00958711|20727979|P1|COMPLETED|Overall Study||29
8409837|NCT00958711|20727978|P2|STARTED|Overall Study||48
8409838|NCT00958711|20727979|P1|STARTED|Overall Study||42
8409839|NCT00958581|20728008|P3|NOT COMPLETED|Overall Study||0
8409840|NCT00958581|20728009|P2|NOT COMPLETED|Overall Study||0
8409841|NCT00958581|20728010|P1|NOT COMPLETED|Overall Study||0
8409842|NCT00958581|20728008|P3|COMPLETED|Overall Study||55
8409843|NCT00958581|20728009|P2|COMPLETED|Overall Study||61
8409844|NCT00958581|20728010|P1|COMPLETED|Overall Study||61
8409845|NCT00958581|20728008|P3|STARTED|Overall Study||55
8409846|NCT00958581|20728009|P2|STARTED|Overall Study||61
8409847|NCT00958581|20728010|P1|STARTED|Overall Study||61
8409848|NCT00958568|20728024|P4|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
8409849|NCT00958568|20728025|P3|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
8409850|NCT00958568|20728026|P2|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8409851|NCT00958568|20728027|P1|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8409852|NCT00958568|20728024|P4|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
8409853|NCT00958568|20728025|P3|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
8409854|NCT00958568|20728026|P2|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8409855|NCT00958568|20728027|P1|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8409856|NCT00958568|20728024|P4|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
8409857|NCT00958568|20728025|P3|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
8409858|NCT00958568|20728026|P2|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8409859|NCT00958568|20728027|P1|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
8409860|NCT00958568|20728024|P4|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409861|NCT00958568|20728025|P3|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409862|NCT00958568|20728026|P2|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
8409863|NCT00958568|20728027|P1|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409864|NCT00958568|20728024|P4|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409865|NCT00958568|20728025|P3|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409866|NCT00958568|20728026|P2|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
8409867|NCT00958568|20728027|P1|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409868|NCT00958568|20728024|P4|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409869|NCT00958568|20728025|P3|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409870|NCT00958568|20728026|P2|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
8409871|NCT00958568|20728027|P1|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
8409872|NCT00958568|20728024|P4|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8409873|NCT00958568|20728025|P3|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8409874|NCT00958568|20728026|P2|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8409875|NCT00958568|20728027|P1|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
8409876|NCT00958568|20728024|P4|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8409877|NCT00958568|20728025|P3|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8409878|NCT00958568|20728026|P2|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
8409879|NCT00958568|20728027|P1|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
8409880|NCT00958568|20728024|P4|STARTED|SPII (Wk 0-8, Acute Open-label)||0
8409881|NCT00958568|20728025|P3|STARTED|SPII (Wk 0-8, Acute Open-label)||0
8409882|NCT00958568|20728026|P2|STARTED|SPII (Wk 0-8, Acute Open-label)||0
8409883|NCT00958568|20728027|P1|STARTED|SPII (Wk 0-8, Acute Open-label)||892
8409884|NCT00958477|20728112|P4|NOT COMPLETED|Overall Study||0
8409885|NCT00958477|20728113|P3|NOT COMPLETED|Overall Study||0
8409886|NCT00958477|20728114|P2|NOT COMPLETED|Overall Study||0
8409887|NCT00958477|20728115|P1|NOT COMPLETED|Overall Study||0
8409888|NCT00958477|20728112|P4|COMPLETED|Overall Study||6
8409889|NCT00958477|20728113|P3|COMPLETED|Overall Study||6
8409890|NCT00958477|20728114|P2|COMPLETED|Overall Study||6
8409891|NCT00958477|20728115|P1|COMPLETED|Overall Study||8
8409892|NCT00958477|20728112|P4|STARTED|Overall Study||6
8409893|NCT00958477|20728113|P3|STARTED|Overall Study||6
8409894|NCT00958477|20728114|P2|STARTED|Overall Study||6
8409895|NCT00958477|20728115|P1|STARTED|Overall Study||8
8409896|NCT00958438|20728264|P3|NOT COMPLETED|Overall Study||6
8409897|NCT00958438|20728265|P2|NOT COMPLETED|Overall Study||10
8409898|NCT00958438|20728266|P1|NOT COMPLETED|Overall Study||10
8409899|NCT00958438|20728264|P3|COMPLETED|Overall Study||78
8409900|NCT00958438|20728265|P2|COMPLETED|Overall Study||72
8409901|NCT00958438|20728266|P1|COMPLETED|Overall Study||72
8409902|NCT00958438|20728264|P3|STARTED|Overall Study||84
8409903|NCT00958438|20728265|P2|STARTED|Overall Study||82
8409904|NCT00958438|20728266|P1|STARTED|Overall Study||82
8409905|NCT00958412|20728289|P1|NOT COMPLETED|Overall Study||18
8409906|NCT00958412|20728289|P1|COMPLETED|Overall Study||0
8409907|NCT00958412|20728289|P1|STARTED|Overall Study||18
8409908|NCT00958360|20728295|P2|NOT COMPLETED|Overall Study||10
8409909|NCT00958360|20728296|P1|NOT COMPLETED|Overall Study||11
8409910|NCT00958360|20728295|P2|COMPLETED|Overall Study||150
8409911|NCT00958360|20728296|P1|COMPLETED|Overall Study||152
8409912|NCT00958360|20728295|P2|STARTED|Overall Study||160
8409913|NCT00958360|20728296|P1|STARTED|Overall Study||163
8409914|NCT00958347|20728310|P1|NOT COMPLETED|Overall Study||226
8409915|NCT00958347|20728310|P1|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
8409916|NCT00958347|20728310|P1|STARTED|Overall Study||226
8409917|NCT00958334|20728317|P3|NOT COMPLETED|Overall Study||13
8409918|NCT00958334|20728318|P2|NOT COMPLETED|Overall Study||17
8409919|NCT00958334|20728319|P1|NOT COMPLETED|Overall Study||14
8409920|NCT00958334|20728317|P3|COMPLETED|Overall Study||8
8409921|NCT00958334|20728318|P2|COMPLETED|Overall Study||5
8409922|NCT00958334|20728319|P1|COMPLETED|Overall Study||8
8409923|NCT00958334|20728317|P3|STARTED|Overall Study||21
8409924|NCT00958334|20728318|P2|STARTED|Overall Study||22
8409925|NCT00958334|20728319|P1|STARTED|Overall Study||22
8409926|NCT00958308|20728333|P3|NOT COMPLETED|Overall Study||0
8409927|NCT00958308|20728334|P2|NOT COMPLETED|Overall Study||0
8409928|NCT00958308|20728335|P1|NOT COMPLETED|Overall Study||0
8409929|NCT00958308|20728333|P3|COMPLETED|Overall Study||86
8409930|NCT00958308|20728334|P2|COMPLETED|Overall Study||85
8409931|NCT00958308|20728335|P1|COMPLETED|Overall Study||84
8409932|NCT00958308|20728333|P3|STARTED|Overall Study||86
8409933|NCT00958308|20728334|P2|STARTED|Overall Study||85
8409934|NCT00958308|20728335|P1|STARTED|Overall Study||84
8409935|NCT00958282|20728345|P2|NOT COMPLETED|Overall Study||6
8409936|NCT00958282|20728346|P1|NOT COMPLETED|Overall Study||10
8409937|NCT00958282|20728345|P2|COMPLETED|Overall Study||15
8409938|NCT00958282|20728346|P1|COMPLETED|Overall Study||12
8409939|NCT00958282|20728345|P2|STARTED|Overall Study||21
8409940|NCT00958282|20728346|P1|STARTED|Overall Study||22
8409941|NCT00958256|20728354|P1|NOT COMPLETED|Overall Study||3
8409942|NCT00958256|20728354|P1|COMPLETED|Overall Study||18
8409943|NCT00958256|20728354|P1|STARTED|Overall Study||21
8409944|NCT00958243|20728364|P6|NOT COMPLETED|Overall Study||10
8409945|NCT00958243|20728365|P5|NOT COMPLETED|Overall Study||9
8409946|NCT00958243|20728366|P4|NOT COMPLETED|Overall Study||3
8409947|NCT00958243|20728367|P3|NOT COMPLETED|Overall Study||14
8409948|NCT00958243|20728368|P2|NOT COMPLETED|Overall Study||6
8409949|NCT00958243|20728369|P1|NOT COMPLETED|Overall Study||2
8409950|NCT00958243|20728364|P6|COMPLETED|Overall Study||99
8409951|NCT00958243|20728365|P5|COMPLETED|Overall Study||100
8409952|NCT00958243|20728366|P4|COMPLETED|Overall Study||25
8409953|NCT00958243|20728367|P3|COMPLETED|Overall Study||82
8409954|NCT00958243|20728368|P2|COMPLETED|Overall Study||99
8409955|NCT00958243|20728369|P1|COMPLETED|Overall Study||24
8409956|NCT00958243|20728364|P6|STARTED|Overall Study||109
8409957|NCT00958243|20728365|P5|STARTED|Overall Study||109
8409958|NCT00958243|20728366|P4|STARTED|Overall Study||28
8409959|NCT00958243|20728367|P3|STARTED|Overall Study||96
8409960|NCT00958243|20728368|P2|STARTED|Overall Study||105
8409961|NCT00958243|20728369|P1|STARTED|Overall Study||26
8409962|NCT00958217|20728427|P2|NOT COMPLETED|Overall Study||25
8409963|NCT00958217|20728428|P1|NOT COMPLETED|Overall Study||24
8409964|NCT00958217|20728427|P2|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
8409965|NCT00958217|20728428|P1|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
8409966|NCT00958217|20728427|P2|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
8409967|NCT00958217|20728428|P1|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
8409968|NCT00958217|20728427|P2|STARTED|Overall Study||62
8409969|NCT00958217|20728428|P1|STARTED|Overall Study||61
8409970|NCT00958191|20728439|P1|NOT COMPLETED|Overall Study||111
8409971|NCT00958191|20728439|P1|COMPLETED|Overall Study||110
8409972|NCT00958191|20728439|P1|STARTED|Overall Study||221
8409973|NCT00958165|20728454|P1|NOT COMPLETED|Overall Study||14
8409974|NCT00958165|20728454|P1|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
8409975|NCT00958165|20728454|P1|Treated|Overall Study||72
8409976|NCT00958165|20728454|P1|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
8409977|NCT00958126|20728466|P8|NOT COMPLETED|Overall Study||0
8409978|NCT00958126|20728467|P7|NOT COMPLETED|Overall Study||1
8409979|NCT00958126|20728468|P6|NOT COMPLETED|Overall Study||1
8409980|NCT00958126|20728469|P5|NOT COMPLETED|Overall Study||0
8409981|NCT00958126|20728470|P4|NOT COMPLETED|Overall Study||11
8409982|NCT00958126|20728471|P3|NOT COMPLETED|Overall Study||10
8409983|NCT00958126|20728472|P2|NOT COMPLETED|Overall Study||9
8409984|NCT00958126|20728473|P1|NOT COMPLETED|Overall Study||1
8409985|NCT00958126|20728466|P8|COMPLETED|Overall Study||202
8409986|NCT00958126|20728467|P7|COMPLETED|Overall Study||199
8409987|NCT00958126|20728468|P6|COMPLETED|Overall Study||202
8409988|NCT00958126|20728469|P5|COMPLETED|Overall Study||50
8409989|NCT00958126|20728470|P4|COMPLETED|Overall Study||192
8409990|NCT00958126|20728471|P3|COMPLETED|Overall Study||191
8409991|NCT00958126|20728472|P2|COMPLETED|Overall Study||196
8409992|NCT00958126|20728473|P1|COMPLETED|Overall Study||48
8409993|NCT00958126|20728466|P8|STARTED|Overall Study||202
8409994|NCT00958126|20728467|P7|STARTED|Overall Study||200
8409995|NCT00958126|20728468|P6|STARTED|Overall Study||203
8409996|NCT00958126|20728469|P5|STARTED|Overall Study||50
8409997|NCT00958126|20728470|P4|STARTED|Overall Study||203
8409998|NCT00958126|20728471|P3|STARTED|Overall Study||201
8409999|NCT00958126|20728472|P2|STARTED|Overall Study||205
8410000|NCT00958126|20728473|P1|STARTED|Overall Study||49
8410001|NCT00958074|20728545|P2|NOT COMPLETED|Overall Study||1
8410002|NCT00958074|20728546|P1|NOT COMPLETED|Overall Study||0
8410003|NCT00958074|20728545|P2|COMPLETED|Overall Study||6
8410004|NCT00958074|20728546|P1|COMPLETED|Overall Study||4
8410005|NCT00958074|20728545|P2|STARTED|Overall Study||7
8410006|NCT00958074|20728546|P1|STARTED|Overall Study||4
8410007|NCT00958035|20728562|P2|NOT COMPLETED|Overall Study||4
8410008|NCT00958035|20728563|P1|NOT COMPLETED|Overall Study||3
8410009|NCT00958035|20728562|P2|COMPLETED|Overall Study||39
8410010|NCT00958035|20728563|P1|COMPLETED|Overall Study||43
8410011|NCT00958035|20728562|P2|STARTED|Overall Study||43
8410012|NCT00958035|20728563|P1|STARTED|Overall Study||46
8410013|NCT00958009|20728569|P1|NOT COMPLETED|Overall Study||2
8410014|NCT00958009|20728569|P1|COMPLETED|Overall Study||107
8410015|NCT00958009|20728569|P1|STARTED|Overall Study||109
8410016|NCT00957996|20728576|P2|NOT COMPLETED|Overall Study||28
8410017|NCT00957996|20728577|P1|NOT COMPLETED|Overall Study||26
8410018|NCT00957996|20728576|P2|COMPLETED|Overall Study||89
8410019|NCT00957996|20728577|P1|COMPLETED|Overall Study||91
8410020|NCT00957996|20728576|P2|STARTED|Overall Study||117
8410021|NCT00957996|20728577|P1|STARTED|Overall Study||117
8410022|NCT00957944|20728609|P2|NOT COMPLETED|Second Intervention- 24 Hours||0
8410023|NCT00957944|20728610|P1|NOT COMPLETED|Second Intervention- 24 Hours||0
8410024|NCT00957944|20728609|P2|COMPLETED|Second Intervention- 24 Hours||19
8410025|NCT00957944|20728610|P1|COMPLETED|Second Intervention- 24 Hours||20
8410026|NCT00957944|20728609|P2|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
8410027|NCT00957944|20728610|P1|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
8410028|NCT00957944|20728609|P2|STARTED|Second Intervention- 24 Hours||19
8410029|NCT00957944|20728610|P1|STARTED|Second Intervention- 24 Hours||20
8410030|NCT00957944|20728609|P2|NOT COMPLETED|Washout Period of at Least 5 Days||0
8410031|NCT00957944|20728610|P1|NOT COMPLETED|Washout Period of at Least 5 Days||0
8410032|NCT00957944|20728609|P2|COMPLETED|Washout Period of at Least 5 Days||19
8410033|NCT00957944|20728610|P1|COMPLETED|Washout Period of at Least 5 Days||20
8410034|NCT00957944|20728609|P2|STARTED|Washout Period of at Least 5 Days||19
8410035|NCT00957944|20728610|P1|STARTED|Washout Period of at Least 5 Days||20
8410036|NCT00957944|20728609|P2|NOT COMPLETED|First Intervention- 24 Hours||1
8410037|NCT00957944|20728610|P1|NOT COMPLETED|First Intervention- 24 Hours||0
8410038|NCT00957944|20728609|P2|COMPLETED|First Intervention- 24 Hours||19
8410039|NCT00957944|20728610|P1|COMPLETED|First Intervention- 24 Hours||20
8410040|NCT00957944|20728609|P2|STARTED|First Intervention- 24 Hours||20
8410041|NCT00957944|20728610|P1|STARTED|First Intervention- 24 Hours||20
8410042|NCT00957931|20728644|P1|NOT COMPLETED|Overall Study||4
8410043|NCT00957931|20728644|P1|COMPLETED|Overall Study||2
8410044|NCT00957931|20728644|P1|STARTED|Overall Study||6
8410045|NCT00957905|20728654|P2|NOT COMPLETED|Part B||4
8410046|NCT00957905|20728655|P1|NOT COMPLETED|Part B||0
8410047|NCT00957905|20728654|P2|COMPLETED|Part B||25
8410048|NCT00957905|20728655|P1|COMPLETED|Part B||0
8410049|NCT00957905|20728654|P2|STARTED|Part B||29
8410050|NCT00957905|20728655|P1|STARTED|Part B||0
8410051|NCT00957905|20728654|P2|NOT COMPLETED|Part A||0
8410052|NCT00957905|20728655|P1|NOT COMPLETED|Part A||0
8410053|NCT00957905|20728654|P2|COMPLETED|Part A||0
8410054|NCT00957905|20728655|P1|COMPLETED|Part A||7
8410055|NCT00957905|20728654|P2|STARTED|Part A||0
8410056|NCT00957905|20728655|P1|STARTED|Part A||7
8410057|NCT00957853|20728664|P3|NOT COMPLETED|Overall Study||0
8410058|NCT00957853|20728665|P2|NOT COMPLETED|Overall Study||0
8410059|NCT00957853|20728666|P1|NOT COMPLETED|Overall Study||1
8410060|NCT00957853|20728664|P3|COMPLETED|Overall Study||5
8410061|NCT00957853|20728665|P2|COMPLETED|Overall Study||6
8410062|NCT00957853|20728666|P1|COMPLETED|Overall Study||3
8410063|NCT00957853|20728664|P3|Neoadjuvant Tx Completion|Overall Study||5
8410064|NCT00957853|20728665|P2|Neoadjuvant Tx Completion|Overall Study||6
8410065|NCT00957853|20728666|P1|Neoadjuvant Tx Completion|Overall Study||3
8410066|NCT00957853|20728664|P3|Randomization|Overall Study||5
8410067|NCT00957853|20728665|P2|Randomization|Overall Study||6
8410068|NCT00957853|20728666|P1|Randomization|Overall Study||4
8410069|NCT00957853|20728664|P3|STARTED|Overall Study||5
8410070|NCT00957853|20728665|P2|STARTED|Overall Study||6
8410071|NCT00957853|20728666|P1|STARTED|Overall Study||4
8410072|NCT00957827|20728679|P2|NOT COMPLETED|Overall Study||0
8410073|NCT00957827|20728680|P1|NOT COMPLETED|Overall Study||0
8410074|NCT00957827|20728679|P2|COMPLETED|Overall Study||2
8410075|NCT00957827|20728680|P1|COMPLETED|Overall Study||2
8410076|NCT00957827|20728679|P2|STARTED|Overall Study||2
8410077|NCT00957827|20728680|P1|STARTED|Overall Study||2
8410078|NCT00957801|20728690|P4|NOT COMPLETED|Overall Study||1
8410079|NCT00957801|20728691|P3|NOT COMPLETED|Overall Study||0
8410080|NCT00957801|20728692|P2|NOT COMPLETED|Overall Study||0
8410081|NCT00957801|20728693|P1|NOT COMPLETED|Overall Study||0
8410082|NCT00957801|20728690|P4|COMPLETED|Overall Study||7
8410083|NCT00957801|20728691|P3|COMPLETED|Overall Study||7
8410084|NCT00957801|20728692|P2|COMPLETED|Overall Study||7
8410085|NCT00957801|20728693|P1|COMPLETED|Overall Study||7
8410086|NCT00957801|20728690|P4|STARTED|Overall Study||8
8410087|NCT00957801|20728691|P3|STARTED|Overall Study||7
8410088|NCT00957801|20728692|P2|STARTED|Overall Study||7
8410089|NCT00957801|20728693|P1|STARTED|Overall Study||7
8410090|NCT00957723|20728859|P1|NOT COMPLETED|Overall Study||113
8410091|NCT00957723|20728859|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
8410092|NCT00957723|20728859|P1|STARTED|Overall Study||411
8410093|NCT00957684|20728877|P5|NOT COMPLETED|PART II||75
8410094|NCT00957684|20728878|P4|NOT COMPLETED|PART II||0
8410095|NCT00957684|20728879|P3|NOT COMPLETED|PART II||0
8410096|NCT00957684|20728880|P2|NOT COMPLETED|PART II||0
8410097|NCT00957684|20728881|P1|NOT COMPLETED|PART II||0
8410098|NCT00957684|20728877|P5|COMPLETED|PART II||239
8410099|NCT00957684|20728878|P4|COMPLETED|PART II||0
8410100|NCT00957684|20728879|P3|COMPLETED|PART II||0
8410101|NCT00957684|20728880|P2|COMPLETED|PART II||0
8410102|NCT00957684|20728881|P1|COMPLETED|PART II||0
8410103|NCT00957684|20728877|P5|Patients Entered Part II|PART II||314
8410104|NCT00957684|20728878|P4|Patients Entered Part II|PART II||0
8410105|NCT00957684|20728879|P3|Patients Entered Part II|PART II||0
8410106|NCT00957684|20728880|P2|Patients Entered Part II|PART II||0
8410107|NCT00957684|20728881|P1|Patients Entered Part II|PART II||0
8410108|NCT00957684|20728877|P5|STARTED|PART II||314
8410109|NCT00957684|20728878|P4|STARTED|PART II||0
8410110|NCT00957684|20728879|P3|STARTED|PART II||0
8410111|NCT00957684|20728880|P2|STARTED|PART II||0
8410112|NCT00957684|20728881|P1|STARTED|PART II||0
8410113|NCT00957684|20728877|P5|NOT COMPLETED|PART I||0
8410114|NCT00957684|20728878|P4|NOT COMPLETED|PART I||18
8410115|NCT00957684|20728879|P3|NOT COMPLETED|PART I||10
8410116|NCT00957684|20728880|P2|NOT COMPLETED|PART I||13
8410117|NCT00957684|20728881|P1|NOT COMPLETED|PART I||31
8410118|NCT00957684|20728877|P5|COMPLETED|PART I||0
8410119|NCT00957684|20728878|P4|COMPLETED|PART I||84
8410120|NCT00957684|20728879|P3|COMPLETED|PART I||90
8410121|NCT00957684|20728880|P2|COMPLETED|PART I||85
8410122|NCT00957684|20728881|P1|COMPLETED|PART I||71
8410123|NCT00957684|20728877|P5|Per-protocol (PP)Population|PART I||0
8410124|NCT00957684|20728878|P4|Per-protocol (PP)Population|PART I||91
8410125|NCT00957684|20728879|P3|Per-protocol (PP)Population|PART I||94
8410126|NCT00957684|20728880|P2|Per-protocol (PP)Population|PART I||86
8410127|NCT00957684|20728881|P1|Per-protocol (PP)Population|PART I||72
8410128|NCT00957684|20728877|P5|Intention-to-treat (ITT) Population|PART I||0
8410129|NCT00957684|20728878|P4|Intention-to-treat (ITT) Population|PART I||102
8410130|NCT00957684|20728879|P3|Intention-to-treat (ITT) Population|PART I||99
8410131|NCT00957684|20728880|P2|Intention-to-treat (ITT) Population|PART I||98
8410132|NCT00957684|20728881|P1|Intention-to-treat (ITT) Population|PART I||98
8410133|NCT00957684|20728877|P5|Randomised (Safety Population)|PART I||0
8410134|NCT00957684|20728878|P4|Randomised (Safety Population)|PART I||102
8410135|NCT00957684|20728879|P3|Randomised (Safety Population)|PART I||100
8410136|NCT00957684|20728880|P2|Randomised (Safety Population)|PART I||98
8410137|NCT00957684|20728881|P1|Randomised (Safety Population)|PART I||102
8410138|NCT00957684|20728877|P5|STARTED|PART I||0
8410139|NCT00957684|20728878|P4|STARTED|PART I||102
8410140|NCT00957684|20728879|P3|STARTED|PART I||100
8410141|NCT00957684|20728880|P2|STARTED|PART I||98
8410142|NCT00957684|20728881|P1|STARTED|PART I||102
8410143|NCT00957671|20728891|P1|NOT COMPLETED|Overall Study||0
8410144|NCT00957671|20728891|P1|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
8410145|NCT00957671|20728891|P1|STARTED|Overall Study|15 subjects began the treatment phase.|15
8410146|NCT00957658|20728948|P1|NOT COMPLETED|Overall Study||65
8410147|NCT00957658|20728948|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
8410148|NCT00957658|20728948|P1|STARTED|Overall Study||234
8410149|NCT00957593|20728963|P2|NOT COMPLETED|Overall Study||0
8410150|NCT00957593|20728964|P1|NOT COMPLETED|Overall Study||0
8410151|NCT00957593|20728963|P2|COMPLETED|Overall Study||125
8410152|NCT00957593|20728964|P1|COMPLETED|Overall Study||127
8410153|NCT00957593|20728963|P2|STARTED|Overall Study||125
8410154|NCT00957593|20728964|P1|STARTED|Overall Study||127
8410155|NCT00957580|20728975|P3|NOT COMPLETED|Overall Study||0
8410156|NCT00957580|20728976|P2|NOT COMPLETED|Overall Study||2
8410157|NCT00957580|20728977|P1|NOT COMPLETED|Overall Study||0
8410158|NCT00957580|20728975|P3|COMPLETED|Overall Study||15
8410159|NCT00957580|20728976|P2|COMPLETED|Overall Study||31
8410160|NCT00957580|20728977|P1|COMPLETED|Overall Study||33
8410161|NCT00957580|20728975|P3|Treated|Overall Study||15
8410162|NCT00957580|20728976|P2|Treated|Overall Study||32
8410163|NCT00957580|20728977|P1|Treated|Overall Study||33
8410164|NCT00957580|20728975|P3|STARTED|Overall Study||15
8410165|NCT00957580|20728976|P2|STARTED|Overall Study||33
8410166|NCT00957580|20728977|P1|STARTED|Overall Study||33
8410167|NCT00957528|20729124|P3|NOT COMPLETED|Overall Study||1
8410168|NCT00957528|20729125|P2|NOT COMPLETED|Overall Study||1
8410169|NCT00957528|20729126|P1|NOT COMPLETED|Overall Study||0
8410170|NCT00957528|20729124|P3|COMPLETED|Overall Study||8
8410171|NCT00957528|20729125|P2|COMPLETED|Overall Study||8
8410172|NCT00957528|20729126|P1|COMPLETED|Overall Study||8
8410173|NCT00957528|20729124|P3|STARTED|Overall Study||9
8410174|NCT00957528|20729125|P2|STARTED|Overall Study||9
8410175|NCT00957528|20729126|P1|STARTED|Overall Study||8
8410176|NCT00957424|20729149|P1|NOT COMPLETED|Overall Study||23
8410177|NCT00957424|20729149|P1|COMPLETED|Overall Study||44
8410178|NCT00957424|20729149|P1|Follow-up #2|Overall Study||50
8410179|NCT00957424|20729149|P1|Follow-up #1|Overall Study||59
8410180|NCT00957424|20729149|P1|STARTED|Overall Study||67
8410181|NCT00957372|20729159|P4|NOT COMPLETED|PART II||44
8410182|NCT00957372|20729160|P3|NOT COMPLETED|PART II||0
8410183|NCT00957372|20729161|P2|NOT COMPLETED|PART II||0
8410184|NCT00957372|20729162|P1|NOT COMPLETED|PART II||0
8410185|NCT00957372|20729159|P4|COMPLETED|PART II||150
8410186|NCT00957372|20729160|P3|COMPLETED|PART II||0
8410187|NCT00957372|20729161|P2|COMPLETED|PART II||0
8410188|NCT00957372|20729162|P1|COMPLETED|PART II||0
8410189|NCT00957372|20729159|P4|Per-Protocol Population|PART II||108
8410190|NCT00957372|20729160|P3|Per-Protocol Population|PART II||0
8410191|NCT00957372|20729161|P2|Per-Protocol Population|PART II||0
8410192|NCT00957372|20729162|P1|Per-Protocol Population|PART II||0
8410193|NCT00957372|20729159|P4|Intention-to-treat (ITT) Population|PART II||191
8410194|NCT00957372|20729160|P3|Intention-to-treat (ITT) Population|PART II||0
8410195|NCT00957372|20729161|P2|Intention-to-treat (ITT) Population|PART II||0
8410196|NCT00957372|20729162|P1|Intention-to-treat (ITT) Population|PART II||0
8410197|NCT00957372|20729159|P4|Safety Population|PART II||194
8410198|NCT00957372|20729160|P3|Safety Population|PART II||0
8410199|NCT00957372|20729161|P2|Safety Population|PART II||0
8410200|NCT00957372|20729162|P1|Safety Population|PART II||0
8410201|NCT00957372|20729159|P4|STARTED|PART II||194
8410202|NCT00957372|20729160|P3|STARTED|PART II||0
8410203|NCT00957372|20729161|P2|STARTED|PART II||0
8410204|NCT00957372|20729162|P1|STARTED|PART II||0
8410205|NCT00957372|20729159|P4|NOT COMPLETED|PART I||0
8410206|NCT00957372|20729160|P3|NOT COMPLETED|PART I||1
8410207|NCT00957372|20729161|P2|NOT COMPLETED|PART I||0
8410208|NCT00957372|20729162|P1|NOT COMPLETED|PART I||0
8410209|NCT00957372|20729159|P4|COMPLETED|PART I||0
8410210|NCT00957372|20729160|P3|COMPLETED|PART I||87
8410211|NCT00957372|20729161|P2|COMPLETED|PART I||85
8410212|NCT00957372|20729162|P1|COMPLETED|PART I||80
8410213|NCT00957372|20729159|P4|Randomized But Not Treated|PART I||0
8410214|NCT00957372|20729160|P3|Randomized But Not Treated|PART I||1
8410215|NCT00957372|20729161|P2|Randomized But Not Treated|PART I||0
8410216|NCT00957372|20729162|P1|Randomized But Not Treated|PART I||0
8410217|NCT00957372|20729159|P4|Per-Protocol Population|PART I||0
8410218|NCT00957372|20729160|P3|Per-Protocol Population|PART I||51
8410219|NCT00957372|20729161|P2|Per-Protocol Population|PART I||47
8410220|NCT00957372|20729162|P1|Per-Protocol Population|PART I||35
8410221|NCT00957372|20729159|P4|Intention-to-Treat Population|PART I||0
8410222|NCT00957372|20729160|P3|Intention-to-Treat Population|PART I||84
8410223|NCT00957372|20729161|P2|Intention-to-Treat Population|PART I||84
8410224|NCT00957372|20729162|P1|Intention-to-Treat Population|PART I||77
8410225|NCT00957372|20729159|P4|Safety Population|PART I||0
8410226|NCT00957372|20729160|P3|Safety Population|PART I||87
8410227|NCT00957372|20729161|P2|Safety Population|PART I||85
8410228|NCT00957372|20729162|P1|Safety Population|PART I||80
8410229|NCT00957372|20729159|P4|STARTED|PART I||0
8410230|NCT00957372|20729160|P3|STARTED|PART I||88
8410231|NCT00957372|20729161|P2|STARTED|PART I||85
8410232|NCT00957372|20729162|P1|STARTED|PART I||80
8410233|NCT00957359|20729180|P2|NOT COMPLETED|Overall Study||0
8410234|NCT00957359|20729181|P1|NOT COMPLETED|Overall Study||0
8410235|NCT00957359|20729180|P2|COMPLETED|Overall Study||15
8410236|NCT00957359|20729181|P1|COMPLETED|Overall Study||14
8410237|NCT00957359|20729180|P2|STARTED|Overall Study||15
8410238|NCT00957359|20729181|P1|STARTED|Overall Study||14
8410239|NCT00957333|20729293|P1|NOT COMPLETED|Overall Study||0
8410240|NCT00957333|20729293|P1|COMPLETED|Overall Study||44
8410241|NCT00957333|20729293|P1|STARTED|Overall Study||44
8410242|NCT00957268|20729302|P5|NOT COMPLETED|Overall Study||0
8410243|NCT00957268|20729303|P4|NOT COMPLETED|Overall Study||0
8410244|NCT00957268|20729304|P3|NOT COMPLETED|Overall Study||1
8410245|NCT00957268|20729305|P2|NOT COMPLETED|Overall Study||0
8410246|NCT00957268|20729306|P1|NOT COMPLETED|Overall Study||0
8410247|NCT00957268|20729302|P5|COMPLETED|Overall Study||22
8410248|NCT00957268|20729303|P4|COMPLETED|Overall Study||7
8410249|NCT00957268|20729304|P3|COMPLETED|Overall Study||7
8410250|NCT00957268|20729305|P2|COMPLETED|Overall Study||4
8410251|NCT00957268|20729306|P1|COMPLETED|Overall Study||5
8410252|NCT00957268|20729302|P5|STARTED|Overall Study||22
8410253|NCT00957268|20729303|P4|STARTED|Overall Study||7
8410254|NCT00957268|20729304|P3|STARTED|Overall Study||8
8410255|NCT00957268|20729305|P2|STARTED|Overall Study||4
8410256|NCT00957268|20729306|P1|STARTED|Overall Study||5
8410257|NCT00957242|20729370|P2|NOT COMPLETED|Overall Study||0
8410258|NCT00957242|20729371|P1|NOT COMPLETED|Overall Study||0
8410259|NCT00957242|20729370|P2|COMPLETED|Overall Study||72
8410260|NCT00957242|20729371|P1|COMPLETED|Overall Study||73
8410261|NCT00957242|20729370|P2|STARTED|Overall Study||72
8410262|NCT00957242|20729371|P1|STARTED|Overall Study||73
8410263|NCT00957229|20729401|P2|NOT COMPLETED|Reallocated to or Continued Vismodegib||2
8410264|NCT00957229|20729402|P1|NOT COMPLETED|Reallocated to or Continued Vismodegib||3
8410265|NCT00957229|20729401|P2|COMPLETED|Reallocated to or Continued Vismodegib||21
8410266|NCT00957229|20729402|P1|COMPLETED|Reallocated to or Continued Vismodegib||11
8410267|NCT00957229|20729401|P2|STARTED|Reallocated to or Continued Vismodegib||23
8410268|NCT00957229|20729402|P1|STARTED|Reallocated to or Continued Vismodegib||14
8410269|NCT00957229|20729401|P2|NOT COMPLETED|Study Start||3
8410270|NCT00957229|20729402|P1|NOT COMPLETED|Study Start||1
8410271|NCT00957229|20729401|P2|COMPLETED|Study Start||23
8410272|NCT00957229|20729402|P1|COMPLETED|Study Start||14
8410273|NCT00957229|20729401|P2|STARTED|Study Start||26
8410274|NCT00957229|20729402|P1|STARTED|Study Start||15
8410275|NCT00957047|20729416|P5|NOT COMPLETED|PART II||102
8410276|NCT00957047|20729417|P4|NOT COMPLETED|PART II||0
8410277|NCT00957047|20729418|P3|NOT COMPLETED|PART II||0
8410278|NCT00957047|20729419|P2|NOT COMPLETED|PART II||0
8410279|NCT00957047|20729420|P1|NOT COMPLETED|PART II||0
8410280|NCT00957047|20729416|P5|COMPLETED|PART II||223
8410281|NCT00957047|20729417|P4|COMPLETED|PART II||0
8410282|NCT00957047|20729418|P3|COMPLETED|PART II||0
8410283|NCT00957047|20729419|P2|COMPLETED|PART II||0
8410284|NCT00957047|20729420|P1|COMPLETED|PART II||0
8410285|NCT00957047|20729416|P5|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
8410286|NCT00957047|20729417|P4|Terminated Prematurely|PART II||0
8410287|NCT00957047|20729418|P3|Terminated Prematurely|PART II||0
8410288|NCT00957047|20729419|P2|Terminated Prematurely|PART II||0
8410289|NCT00957047|20729420|P1|Terminated Prematurely|PART II||0
8410290|NCT00957047|20729416|P5|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
8410291|NCT00957047|20729417|P4|STARTED|PART II||0
8410292|NCT00957047|20729418|P3|STARTED|PART II||0
8410293|NCT00957047|20729419|P2|STARTED|PART II||0
8410294|NCT00957047|20729420|P1|STARTED|PART II||0
8410295|NCT00957047|20729416|P5|NOT COMPLETED|PART I||0
8410296|NCT00957047|20729417|P4|NOT COMPLETED|PART I||30
8410297|NCT00957047|20729418|P3|NOT COMPLETED|PART I||21
8410298|NCT00957047|20729419|P2|NOT COMPLETED|PART I||13
8410299|NCT00957047|20729420|P1|NOT COMPLETED|PART I||6
8410300|NCT00957047|20729416|P5|COMPLETED|PART I||0
8410301|NCT00957047|20729417|P4|COMPLETED|PART I||68
8410302|NCT00957047|20729418|P3|COMPLETED|PART I||80
8410303|NCT00957047|20729419|P2|COMPLETED|PART I||83
8410304|NCT00957047|20729420|P1|COMPLETED|PART I||94
8410305|NCT00957047|20729416|P5|Per-Protocol Population|PART I||0
8410306|NCT00957047|20729417|P4|Per-Protocol Population|PART I||54
8410307|NCT00957047|20729418|P3|Per-Protocol Population|PART I||75
8410308|NCT00957047|20729419|P2|Per-Protocol Population|PART I||70
8410309|NCT00957047|20729420|P1|Per-Protocol Population|PART I||81
8410310|NCT00957047|20729416|P5|Intention-to-treat (ITT) Population|PART I||0
8410311|NCT00957047|20729417|P4|Intention-to-treat (ITT) Population|PART I||97
8410312|NCT00957047|20729418|P3|Intention-to-treat (ITT) Population|PART I||100
8410313|NCT00957047|20729419|P2|Intention-to-treat (ITT) Population|PART I||96
8410314|NCT00957047|20729420|P1|Intention-to-treat (ITT) Population|PART I||100
8410315|NCT00957047|20729416|P5|Randomized/Safety Population|PART I||0
8410316|NCT00957047|20729417|P4|Randomized/Safety Population|PART I||98
8410317|NCT00957047|20729418|P3|Randomized/Safety Population|PART I||101
8410318|NCT00957047|20729419|P2|Randomized/Safety Population|PART I||96
8410319|NCT00957047|20729420|P1|Randomized/Safety Population|PART I||100
8410320|NCT00957047|20729416|P5|STARTED|PART I||0
8410321|NCT00957047|20729417|P4|STARTED|PART I||98
8410322|NCT00957047|20729418|P3|STARTED|PART I||101
8410323|NCT00957047|20729419|P2|STARTED|PART I||96
8410324|NCT00957047|20729420|P1|STARTED|PART I||100
8410325|NCT00957034|20729441|P3|NOT COMPLETED|Overall Study||6
8410326|NCT00957034|20729442|P2|NOT COMPLETED|Overall Study||4
8410327|NCT00957034|20729443|P1|NOT COMPLETED|Overall Study||6
8410328|NCT00957034|20729441|P3|COMPLETED|Overall Study||1
8410329|NCT00957034|20729442|P2|COMPLETED|Overall Study||0
8410330|NCT00957034|20729443|P1|COMPLETED|Overall Study||0
8410331|NCT00957034|20729441|P3|STARTED|Overall Study||7
8410332|NCT00957034|20729442|P2|STARTED|Overall Study||4
8410333|NCT00957034|20729443|P1|STARTED|Overall Study||6
8410334|NCT00957021|20729466|P1|NOT COMPLETED|Overall Study||117
8410335|NCT00957021|20729466|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
8410336|NCT00957021|20729466|P1|STARTED|Overall Study||354
8410337|NCT00957008|20729479|P4|NOT COMPLETED|Overall Study||24
8410338|NCT00957008|20729480|P3|NOT COMPLETED|Overall Study||17
8410339|NCT00957008|20729481|P2|NOT COMPLETED|Overall Study||12
8410340|NCT00957008|20729482|P1|NOT COMPLETED|Overall Study||21
8410341|NCT00957008|20729479|P4|COMPLETED|Overall Study||26
8410342|NCT00957008|20729480|P3|COMPLETED|Overall Study||32
8410343|NCT00957008|20729481|P2|COMPLETED|Overall Study||37
8410344|NCT00957008|20729482|P1|COMPLETED|Overall Study||28
8410345|NCT00957008|20729479|P4|STARTED|Overall Study||50
8410346|NCT00957008|20729480|P3|STARTED|Overall Study||49
8410347|NCT00957008|20729481|P2|STARTED|Overall Study||49
8410348|NCT00957008|20729482|P1|STARTED|Overall Study||49
8410349|NCT00956943|20729510|P2|NOT COMPLETED|Overall Study||10
8410350|NCT00956943|20729511|P1|NOT COMPLETED|Overall Study||9
8410351|NCT00956943|20729510|P2|COMPLETED|Overall Study||34
8410352|NCT00956943|20729511|P1|COMPLETED|Overall Study||34
8410353|NCT00956943|20729510|P2|Baseline|Overall Study||44
8410354|NCT00956943|20729511|P1|Baseline|Overall Study||43
8410355|NCT00956943|20729510|P2|STARTED|Overall Study||44
8410356|NCT00956943|20729511|P1|STARTED|Overall Study||43
8410357|NCT00956930|20729521|P2|NOT COMPLETED|Overall Study||0
8410358|NCT00956930|20729522|P1|NOT COMPLETED|Overall Study||0
8410359|NCT00956930|20729521|P2|COMPLETED|Overall Study||21
8410360|NCT00956930|20729522|P1|COMPLETED|Overall Study||24
8410361|NCT00956930|20729521|P2|STARTED|Overall Study||21
8410362|NCT00956930|20729522|P1|STARTED|Overall Study||24
8410363|NCT00956839|20729535|P3|NOT COMPLETED|Overall Study||3
8410364|NCT00956839|20729536|P2|NOT COMPLETED|Overall Study||0
8410365|NCT00956839|20729537|P1|NOT COMPLETED|Overall Study||3
8410366|NCT00956839|20729535|P3|COMPLETED|Overall Study||10
8410367|NCT00956839|20729536|P2|COMPLETED|Overall Study||13
8410368|NCT00956839|20729537|P1|COMPLETED|Overall Study||11
8410369|NCT00956839|20729535|P3|STARTED|Overall Study||13
8410370|NCT00956839|20729536|P2|STARTED|Overall Study||13
8410371|NCT00956839|20729537|P1|STARTED|Overall Study||14
8410372|NCT00956813|20729550|P2|NOT COMPLETED|Continuation Phase||0
8410373|NCT00956813|20729551|P1|NOT COMPLETED|Continuation Phase||0
8410374|NCT00956813|20729550|P2|COMPLETED|Continuation Phase||0
8410375|NCT00956813|20729551|P1|COMPLETED|Continuation Phase||80
8410376|NCT00956813|20729550|P2|STARTED|Continuation Phase||0
8410377|NCT00956813|20729551|P1|STARTED|Continuation Phase||80
8410378|NCT00956813|20729550|P2|NOT COMPLETED|Flaxseed and Placebo||5
8410379|NCT00956813|20729551|P1|NOT COMPLETED|Flaxseed and Placebo||8
8410380|NCT00956813|20729550|P2|COMPLETED|Flaxseed and Placebo||100
8410381|NCT00956813|20729551|P1|COMPLETED|Flaxseed and Placebo||97
8410382|NCT00956813|20729550|P2|STARTED|Flaxseed and Placebo||105
8410383|NCT00956813|20729551|P1|STARTED|Flaxseed and Placebo||105
8410384|NCT00956761|20729566|P1|NOT COMPLETED|Overall Study||0
8410385|NCT00956761|20729566|P1|COMPLETED|Overall Study||63
8410386|NCT00956761|20729566|P1|STARTED|Overall Study||63
8410387|NCT00956709|20729575|P2|NOT COMPLETED|Overall Study||0
8410388|NCT00956709|20729576|P1|NOT COMPLETED|Overall Study||0
8410389|NCT00956709|20729575|P2|COMPLETED|Overall Study||19
8410390|NCT00956709|20729576|P1|COMPLETED|Overall Study||16
8410391|NCT00956709|20729575|P2|STARTED|Overall Study||19
8410392|NCT00956709|20729576|P1|STARTED|Overall Study||16
8410393|NCT00956657|20729588|P2|NOT COMPLETED|Overall Study||0
8410394|NCT00956657|20729589|P1|NOT COMPLETED|Overall Study||0
8410395|NCT00956657|20729588|P2|COMPLETED|Overall Study||13
8410396|NCT00956657|20729589|P1|COMPLETED|Overall Study||18
8410397|NCT00956657|20729588|P2|STARTED|Overall Study||13
8410398|NCT00956657|20729589|P1|STARTED|Overall Study||18
8410399|NCT00956631|20729595|P1|NOT COMPLETED|Overall Study||16
8410400|NCT00956631|20729595|P1|COMPLETED|Overall Study||62
8410401|NCT00956631|20729595|P1|STARTED|Overall Study||78
8410402|NCT00956592|20729603|P2|NOT COMPLETED|Overall Study||3
8410403|NCT00956592|20729604|P1|NOT COMPLETED|Overall Study||1
8410404|NCT00956592|20729603|P2|COMPLETED|Overall Study||147
8410405|NCT00956592|20729604|P1|COMPLETED|Overall Study||149
8410406|NCT00956592|20729603|P2|STARTED|Overall Study||150
8410407|NCT00956592|20729604|P1|STARTED|Overall Study||150
8410408|NCT00956540|20729624|P4|NOT COMPLETED|Overall Study||4
8410409|NCT00956540|20729625|P3|NOT COMPLETED|Overall Study||3
8410410|NCT00956540|20729626|P2|NOT COMPLETED|Overall Study||4
8410411|NCT00956540|20729627|P1|NOT COMPLETED|Overall Study||3
8410412|NCT00956540|20729624|P4|COMPLETED|Overall Study||41
8410413|NCT00956540|20729625|P3|COMPLETED|Overall Study||43
8410414|NCT00956540|20729626|P2|COMPLETED|Overall Study||46
8410415|NCT00956540|20729627|P1|COMPLETED|Overall Study||51
8410416|NCT00956540|20729624|P4|STARTED|Overall Study||45
8410417|NCT00956540|20729625|P3|STARTED|Overall Study||46
8410418|NCT00956540|20729626|P2|STARTED|Overall Study||50
8410419|NCT00956540|20729627|P1|STARTED|Overall Study||54
8410420|NCT00956293|20729639|P3|NOT COMPLETED|Follow-up Period||0
8410421|NCT00956293|20729640|P2|NOT COMPLETED|Follow-up Period||32
8410422|NCT00956293|20729641|P1|NOT COMPLETED|Follow-up Period||20
8410423|NCT00956293|20729639|P3|COMPLETED|Follow-up Period||0
8410424|NCT00956293|20729640|P2|COMPLETED|Follow-up Period||0
8410425|NCT00956293|20729641|P1|COMPLETED|Follow-up Period||0
8410426|NCT00956293|20729639|P3|STARTED|Follow-up Period||0
8410427|NCT00956293|20729640|P2|STARTED|Follow-up Period||32
8410428|NCT00956293|20729641|P1|STARTED|Follow-up Period||20
8410429|NCT00956293|20729639|P3|NOT COMPLETED|Main Period (Randomization)||0
8410430|NCT00956293|20729640|P2|NOT COMPLETED|Main Period (Randomization)||27
8410431|NCT00956293|20729641|P1|NOT COMPLETED|Main Period (Randomization)||1
8410432|NCT00956293|20729639|P3|COMPLETED|Main Period (Randomization)||0
8410433|NCT00956293|20729640|P2|COMPLETED|Main Period (Randomization)||26
8410434|NCT00956293|20729641|P1|COMPLETED|Main Period (Randomization)||23
8410435|NCT00956293|20729639|P3|Randomized Safety Set|Main Period (Randomization)||0
8410436|NCT00956293|20729640|P2|Randomized Safety Set|Main Period (Randomization)||51
8410437|NCT00956293|20729641|P1|Randomized Safety Set|Main Period (Randomization)||24
8410438|NCT00956293|20729639|P3|Full Analysis Set|Main Period (Randomization)||0
8410439|NCT00956293|20729640|P2|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
8410440|NCT00956293|20729641|P1|Full Analysis Set|Main Period (Randomization)||24
8410441|NCT00956293|20729639|P3|STARTED|Main Period (Randomization)||0
8410442|NCT00956293|20729640|P2|STARTED|Main Period (Randomization)||53
8410443|NCT00956293|20729641|P1|STARTED|Main Period (Randomization)||24
8410444|NCT00956293|20729639|P3|NOT COMPLETED|Main Period (Pre-randomization)||130
8410445|NCT00956293|20729640|P2|NOT COMPLETED|Main Period (Pre-randomization)||0
8410446|NCT00956293|20729641|P1|NOT COMPLETED|Main Period (Pre-randomization)||0
8410447|NCT00956293|20729639|P3|COMPLETED|Main Period (Pre-randomization)||77
8410448|NCT00956293|20729640|P2|COMPLETED|Main Period (Pre-randomization)||0
8410449|NCT00956293|20729641|P1|COMPLETED|Main Period (Pre-randomization)||0
8410450|NCT00956293|20729639|P3|Enrolled Safety Set|Main Period (Pre-randomization)||203
8410451|NCT00956293|20729640|P2|Enrolled Safety Set|Main Period (Pre-randomization)||0
8410452|NCT00956293|20729641|P1|Enrolled Safety Set|Main Period (Pre-randomization)||0
8410453|NCT00956293|20729639|P3|STARTED|Main Period (Pre-randomization)||207
8410454|NCT00956293|20729640|P2|STARTED|Main Period (Pre-randomization)||0
8410455|NCT00956293|20729641|P1|STARTED|Main Period (Pre-randomization)||0
8410456|NCT00956254|20729665|P1|NOT COMPLETED|Overall Study||0
8410457|NCT00956254|20729665|P1|COMPLETED|Overall Study||18
8410458|NCT00956254|20729665|P1|STARTED|Overall Study||18
8410459|NCT00956085|20729675|P1|NOT COMPLETED|Overall Study||0
8410460|NCT00956085|20729675|P1|COMPLETED|Overall Study||12
8410461|NCT00956085|20729675|P1|STARTED|Overall Study||12
8410462|NCT00956020|20729679|P1|NOT COMPLETED|Overall Study||0
8410463|NCT00956020|20729679|P1|COMPLETED|Overall Study||4
8410464|NCT00956020|20729679|P1|STARTED|Overall Study||4
8410465|NCT00955968|20729696|P2|NOT COMPLETED|Overall Study||126
8410466|NCT00955968|20729697|P1|NOT COMPLETED|Overall Study||137
8410467|NCT00955968|20729696|P2|COMPLETED|Overall Study||699
8410468|NCT00955968|20729697|P1|COMPLETED|Overall Study||691
8410469|NCT00955968|20729696|P2|STARTED|Overall Study||825
8410470|NCT00955968|20729697|P1|STARTED|Overall Study||828
8410471|NCT00955955|20729739|P3|NOT COMPLETED|Overall Study||0
8410472|NCT00955955|20729740|P2|NOT COMPLETED|Overall Study||0
8410473|NCT00955955|20729741|P1|NOT COMPLETED|Overall Study||2
8410474|NCT00955955|20729739|P3|COMPLETED|Overall Study||28
8410475|NCT00955955|20729740|P2|COMPLETED|Overall Study||28
8410476|NCT00955955|20729741|P1|COMPLETED|Overall Study||17
8410477|NCT00955955|20729739|P3|STARTED|Overall Study||28
8410478|NCT00955955|20729740|P2|STARTED|Overall Study||28
8410479|NCT00955955|20729741|P1|STARTED|Overall Study||19
8410480|NCT00955916|20729755|P1|NOT COMPLETED|Overall Study||0
8410481|NCT00955916|20729755|P1|COMPLETED|Overall Study||38
8410482|NCT00955916|20729755|P1|STARTED|Overall Study||38
8410483|NCT00955903|20729764|P3|NOT COMPLETED|Overall Study||7
8410484|NCT00955903|20729765|P2|NOT COMPLETED|Overall Study||3
8410485|NCT00955903|20729766|P1|NOT COMPLETED|Overall Study||6
8410486|NCT00955903|20729764|P3|COMPLETED|Overall Study||48
8410487|NCT00955903|20729765|P2|COMPLETED|Overall Study||51
8410488|NCT00955903|20729766|P1|COMPLETED|Overall Study||49
8410489|NCT00955903|20729764|P3|STARTED|Overall Study||55
8410490|NCT00955903|20729765|P2|STARTED|Overall Study||54
8410491|NCT00955903|20729766|P1|STARTED|Overall Study||55
8410492|NCT00955877|20729783|P3|NOT COMPLETED|Overall Study||0
8410493|NCT00955877|20729784|P2|NOT COMPLETED|Overall Study||0
8410494|NCT00955877|20729785|P1|NOT COMPLETED|Overall Study||0
8410495|NCT00955877|20729783|P3|COMPLETED|Overall Study||7
8410496|NCT00955877|20729784|P2|COMPLETED|Overall Study||0
8410497|NCT00955877|20729785|P1|COMPLETED|Overall Study||6
8410498|NCT00955877|20729783|P3|STARTED|Overall Study||7
8410499|NCT00955877|20729784|P2|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
8410500|NCT00955877|20729785|P1|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
8410501|NCT00955825|20729825|P2|NOT COMPLETED|Overall Study||17
8410502|NCT00955825|20729826|P1|NOT COMPLETED|Overall Study||26
8410503|NCT00955825|20729825|P2|COMPLETED|Overall Study||223
8410504|NCT00955825|20729826|P1|COMPLETED|Overall Study||207
8410505|NCT00955825|20729825|P2|STARTED|Overall Study||240
8410506|NCT00955825|20729826|P1|STARTED|Overall Study||233
8410507|NCT00955747|20729834|P2|NOT COMPLETED|Overall Study||69
8410508|NCT00955747|20729835|P1|NOT COMPLETED|Overall Study||69
8410509|NCT00955747|20729834|P2|COMPLETED|Overall Study||172
8410510|NCT00955747|20729835|P1|COMPLETED|Overall Study||184
8410511|NCT00955747|20729834|P2|STARTED|Overall Study||241
8410512|NCT00955747|20729835|P1|STARTED|Overall Study||253
8410513|NCT00955721|20729843|P2|NOT COMPLETED|Overall Study||0
8410514|NCT00955721|20729844|P1|NOT COMPLETED|Overall Study||3
8410515|NCT00955721|20729843|P2|COMPLETED|Overall Study||0
8410516|NCT00955721|20729844|P1|COMPLETED|Overall Study||6
8410517|NCT00955721|20729843|P2|STARTED|Overall Study||0
8410518|NCT00955721|20729844|P1|STARTED|Overall Study||9
8410519|NCT00955708|20729854|P1|NOT COMPLETED|Overall Study||1058
8410520|NCT00955708|20729854|P1|COMPLETED|Overall Study||250
8410521|NCT00955708|20729854|P1|STARTED|Overall Study||1308
8410552|NCT00955617|20729971|P2|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
8410553|NCT00955617|20729972|P1|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
8410554|NCT00955617|20729971|P2|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
8410555|NCT00955617|20729972|P1|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
8410556|NCT00955617|20729971|P2|STARTED|Second MRA (Between Day 1 and Day 51)||10
8410557|NCT00955617|20729972|P1|STARTED|Second MRA (Between Day 1 and Day 51)||10
8410558|NCT00955617|20729971|P2|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
8410559|NCT00955617|20729972|P1|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
8410560|NCT00955617|20729971|P2|COMPLETED|First MRA (Between Day0 and Day21)||10
8410561|NCT00955617|20729972|P1|COMPLETED|First MRA (Between Day0 and Day21)||10
8410562|NCT00955617|20729971|P2|STARTED|First MRA (Between Day0 and Day21)||10
8410563|NCT00955617|20729972|P1|STARTED|First MRA (Between Day0 and Day21)||10
8410564|NCT00955513|20729985|P3|NOT COMPLETED|Overall Study||3
8410565|NCT00955513|20729986|P2|NOT COMPLETED|Overall Study||2
8410566|NCT00955513|20729987|P1|NOT COMPLETED|Overall Study||1
8410567|NCT00955513|20729985|P3|COMPLETED|Overall Study||79
8410568|NCT00955513|20729986|P2|COMPLETED|Overall Study||78
8410569|NCT00955513|20729987|P1|COMPLETED|Overall Study||79
8410570|NCT00955513|20729985|P3|STARTED|Overall Study||82
8410571|NCT00955513|20729986|P2|STARTED|Overall Study||80
8410572|NCT00955513|20729987|P1|STARTED|Overall Study||80
8410573|NCT00955487|20729997|P6|NOT COMPLETED|Overall Study||0
8410574|NCT00955487|20729998|P5|NOT COMPLETED|Overall Study||0
8410575|NCT00955487|20729999|P4|NOT COMPLETED|Overall Study||0
8410576|NCT00955487|20730000|P3|NOT COMPLETED|Overall Study||0
8410577|NCT00955487|20730001|P2|NOT COMPLETED|Overall Study||0
8410578|NCT00955487|20730002|P1|NOT COMPLETED|Overall Study||0
8410579|NCT00955487|20729997|P6|COMPLETED|Overall Study||35
8410580|NCT00955487|20729998|P5|COMPLETED|Overall Study||32
8410581|NCT00955487|20729999|P4|COMPLETED|Overall Study||21
8410582|NCT00955487|20730000|P3|COMPLETED|Overall Study||17
8410583|NCT00955487|20730001|P2|COMPLETED|Overall Study||9
8410584|NCT00955487|20730002|P1|COMPLETED|Overall Study||10
8410585|NCT00955487|20729997|P6|STARTED|Overall Study||35
8410586|NCT00955487|20729998|P5|STARTED|Overall Study||32
8410587|NCT00955487|20729999|P4|STARTED|Overall Study||21
8410588|NCT00955487|20730000|P3|STARTED|Overall Study||17
8410589|NCT00955487|20730001|P2|STARTED|Overall Study||9
8410590|NCT00955487|20730002|P1|STARTED|Overall Study||10
8410591|NCT00955474|20730036|P2|NOT COMPLETED|Overall Study||5
8410592|NCT00955474|20730037|P1|NOT COMPLETED|Overall Study||7
8410593|NCT00955474|20730036|P2|COMPLETED|Overall Study||8
8410594|NCT00955474|20730037|P1|COMPLETED|Overall Study||5
8410595|NCT00955474|20730036|P2|STARTED|Overall Study||13
8410596|NCT00955474|20730037|P1|STARTED|Overall Study||12
8410597|NCT00955357|20730073|P2|NOT COMPLETED|Maintenance Phase||45
8410598|NCT00955357|20730074|P1|NOT COMPLETED|Maintenance Phase||12
8410599|NCT00955357|20730073|P2|COMPLETED|Maintenance Phase||249
8410600|NCT00955357|20730074|P1|COMPLETED|Maintenance Phase||68
8410601|NCT00955357|20730073|P2|STARTED|Maintenance Phase||294
8410602|NCT00955357|20730074|P1|STARTED|Maintenance Phase||80
8410603|NCT00955357|20730073|P2|NOT COMPLETED|Titration Phase||66
8410604|NCT00955357|20730074|P1|NOT COMPLETED|Titration Phase||16
8410605|NCT00955357|20730073|P2|COMPLETED|Titration Phase||294
8410606|NCT00955357|20730074|P1|COMPLETED|Titration Phase||80
8410607|NCT00955357|20730073|P2|STARTED|Titration Phase||360
8410608|NCT00955357|20730074|P1|STARTED|Titration Phase||96
8410609|NCT00955305|20730082|P2|NOT COMPLETED|Overall Study||87
8410610|NCT00955305|20730083|P1|NOT COMPLETED|Overall Study||88
8410611|NCT00955305|20730082|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
8410612|NCT00955305|20730083|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
8410613|NCT00955305|20730082|P2|Eligible and Treated|Overall Study||75
8410614|NCT00955305|20730083|P1|Eligible and Treated|Overall Study||78
8410615|NCT00955305|20730082|P2|Treated|Overall Study||82
8410616|NCT00955305|20730083|P1|Treated|Overall Study||83
8410617|NCT00955305|20730082|P2|STARTED|Overall Study||87
8410618|NCT00955305|20730083|P1|STARTED|Overall Study||88
8410619|NCT00955279|20730096|P3|NOT COMPLETED|Overall Study||8
8410620|NCT00955279|20730097|P2|NOT COMPLETED|Overall Study||4
8410621|NCT00955279|20730098|P1|NOT COMPLETED|Overall Study||3
8410622|NCT00955279|20730096|P3|COMPLETED|Overall Study||52
8410623|NCT00955279|20730097|P2|COMPLETED|Overall Study||51
8410624|NCT00955279|20730098|P1|COMPLETED|Overall Study||55
8410625|NCT00955279|20730096|P3|STARTED|Overall Study||60
8410626|NCT00955279|20730097|P2|STARTED|Overall Study||55
8410627|NCT00955279|20730098|P1|STARTED|Overall Study||58
8410628|NCT00955266|20730120|P2|NOT COMPLETED|Overall Study||0
8410629|NCT00955266|20730121|P1|NOT COMPLETED|Overall Study||0
8410630|NCT00955266|20730120|P2|COMPLETED|Overall Study||4
8410631|NCT00955266|20730121|P1|COMPLETED|Overall Study||4
8410632|NCT00955266|20730120|P2|STARTED|Overall Study||4
8410633|NCT00955266|20730121|P1|STARTED|Overall Study||4
8410634|NCT00955253|20730135|P2|NOT COMPLETED|Second Intervention (Day 4)||0
8410635|NCT00955253|20730136|P1|NOT COMPLETED|Second Intervention (Day 4)||0
8410636|NCT00955253|20730135|P2|COMPLETED|Second Intervention (Day 4)||6
8410637|NCT00955253|20730136|P1|COMPLETED|Second Intervention (Day 4)||7
8410638|NCT00955253|20730135|P2|STARTED|Second Intervention (Day 4)||6
8410639|NCT00955253|20730136|P1|STARTED|Second Intervention (Day 4)||7
8410640|NCT00955253|20730135|P2|NOT COMPLETED|First Intervention (Day 2)||0
8410641|NCT00955253|20730136|P1|NOT COMPLETED|First Intervention (Day 2)||0
8410642|NCT00955253|20730135|P2|COMPLETED|First Intervention (Day 2)||6
8410643|NCT00955253|20730136|P1|COMPLETED|First Intervention (Day 2)||7
8410644|NCT00955253|20730135|P2|STARTED|First Intervention (Day 2)||6
8410645|NCT00955253|20730136|P1|STARTED|First Intervention (Day 2)||7
8410646|NCT00955201|20730145|P4|NOT COMPLETED|Overall Study||4
8410647|NCT00955201|20730146|P3|NOT COMPLETED|Overall Study||1
8410648|NCT00955201|20730147|P2|NOT COMPLETED|Overall Study||0
8410649|NCT00955201|20730148|P1|NOT COMPLETED|Overall Study||4
8410650|NCT00955201|20730145|P4|COMPLETED|Overall Study||7
8410651|NCT00955201|20730146|P3|COMPLETED|Overall Study||10
8410652|NCT00955201|20730147|P2|COMPLETED|Overall Study||11
8410653|NCT00955201|20730148|P1|COMPLETED|Overall Study||8
8410654|NCT00955201|20730145|P4|STARTED|Overall Study||11
8410655|NCT00955201|20730146|P3|STARTED|Overall Study||11
8410656|NCT00955201|20730147|P2|STARTED|Overall Study||11
8410657|NCT00955201|20730148|P1|STARTED|Overall Study||12
8410658|NCT00955110|20730306|P1|NOT COMPLETED|Treatment Phase||6
8410659|NCT00955110|20730306|P1|COMPLETED|Treatment Phase||35
8410660|NCT00955110|20730306|P1|Oxycodone CR 60 mg|Treatment Phase||40
8410661|NCT00955110|20730306|P1|Oxycodone CR 30 mg|Treatment Phase||40
8410662|NCT00955110|20730306|P1|Oxymorphone ER 30 mg|Treatment Phase||38
8410663|NCT00955110|20730306|P1|Oxymorphone ER 15 mg|Treatment Phase||37
8410664|NCT00955110|20730306|P1|Placebo|Treatment Phase||38
8410665|NCT00955110|20730306|P1|STARTED|Treatment Phase||41
8410666|NCT00955110|20730306|P1|NOT COMPLETED|Qualification Phase||24
8410667|NCT00955110|20730306|P1|COMPLETED|Qualification Phase||54
8410668|NCT00955110|20730306|P1|STARTED|Qualification Phase||78
8410669|NCT00955032|20730320|P2|NOT COMPLETED|Overall Study||0
8410670|NCT00955032|20730321|P1|NOT COMPLETED|Overall Study||0
8410671|NCT00955032|20730320|P2|COMPLETED|Overall Study||8
8410672|NCT00955032|20730321|P1|COMPLETED|Overall Study||16
8410673|NCT00955032|20730320|P2|STARTED|Overall Study||8
8410674|NCT00955032|20730321|P1|STARTED|Overall Study||16
8410675|NCT00954993|20730341|P1|NOT COMPLETED|Period 2||0
8410676|NCT00954993|20730341|P1|COMPLETED|Period 2||3
8410677|NCT00954993|20730341|P1|STARTED|Period 2||3
8410678|NCT00954993|20730341|P1|NOT COMPLETED|Washout||0
8410679|NCT00954993|20730341|P1|COMPLETED|Washout||3
8410680|NCT00954993|20730341|P1|STARTED|Washout||3
8410681|NCT00954993|20730341|P1|NOT COMPLETED|Period 1||0
8410682|NCT00954993|20730341|P1|COMPLETED|Period 1||3
8410683|NCT00954993|20730341|P1|STARTED|Period 1||3
8410684|NCT00954941|20730353|P2|NOT COMPLETED|Overall Study||7
8410685|NCT00954941|20730354|P1|NOT COMPLETED|Overall Study||8
8410686|NCT00954941|20730353|P2|COMPLETED|Overall Study||41
8410687|NCT00954941|20730354|P1|COMPLETED|Overall Study||42
8410688|NCT00954941|20730353|P2|STARTED|Overall Study||48
8410689|NCT00954941|20730354|P1|STARTED|Overall Study||50
8410690|NCT00954915|20730362|P1|NOT COMPLETED|Overall Study||0
8410691|NCT00954915|20730362|P1|COMPLETED|Overall Study||1
8410692|NCT00954915|20730362|P1|STARTED|Overall Study||1
8410693|NCT00954824|20730366|P1|NOT COMPLETED|Overall Study||50
8410694|NCT00954824|20730366|P1|COMPLETED|Overall Study||50
8410695|NCT00954824|20730366|P1|STARTED|Overall Study||100
8410696|NCT00954733|20730370|P1|NOT COMPLETED|Overall Study||1
8410697|NCT00954733|20730370|P1|COMPLETED|Overall Study||39
8410698|NCT00954733|20730370|P1|STARTED|Overall Study||40
8410699|NCT00954707|20730374|P1|NOT COMPLETED|Overall Study||167
8410700|NCT00954707|20730374|P1|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
8410701|NCT00954707|20730374|P1|STARTED|Overall Study||2509
8410702|NCT00954681|20730390|P1|NOT COMPLETED|Overall Study||5
8410703|NCT00954681|20730390|P1|COMPLETED|Overall Study||10
8410704|NCT00954681|20730390|P1|STARTED|Overall Study||15
8410705|NCT00954538|20730396|P6|NOT COMPLETED|Part III||0
8410706|NCT00954538|20730397|P5|NOT COMPLETED|Part III||1
8410707|NCT00954538|20730398|P4|NOT COMPLETED|Part III||0
8410708|NCT00954538|20730399|P3|NOT COMPLETED|Part III||0
8410709|NCT00954538|20730400|P2|NOT COMPLETED|Part III||0
8410710|NCT00954538|20730401|P1|NOT COMPLETED|Part III||0
8410711|NCT00954538|20730396|P6|COMPLETED|Part III||2
8410712|NCT00954538|20730397|P5|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
8410713|NCT00954538|20730398|P4|COMPLETED|Part III||4
8410714|NCT00954538|20730399|P3|COMPLETED|Part III||0
8410715|NCT00954538|20730400|P2|COMPLETED|Part III||0
8410716|NCT00954538|20730401|P1|COMPLETED|Part III||0
8410717|NCT00954538|20730396|P6|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
8410718|NCT00954538|20730397|P5|STARTED|Part III|These subjects did not participate in Part I or II|6
8410719|NCT00954538|20730398|P4|STARTED|Part III|These subjects did not participate in Part I or II|4
8410720|NCT00954538|20730399|P3|STARTED|Part III||0
8410721|NCT00954538|20730400|P2|STARTED|Part III||0
8410722|NCT00954538|20730401|P1|STARTED|Part III||0
8410723|NCT00954538|20730396|P6|NOT COMPLETED|Part II||0
8410724|NCT00954538|20730397|P5|NOT COMPLETED|Part II||0
8410725|NCT00954538|20730398|P4|NOT COMPLETED|Part II||0
8410726|NCT00954538|20730399|P3|NOT COMPLETED|Part II||0
8410727|NCT00954538|20730400|P2|NOT COMPLETED|Part II||0
8410728|NCT00954538|20730401|P1|NOT COMPLETED|Part II||0
8410729|NCT00954538|20730396|P6|COMPLETED|Part II||2
8410730|NCT00954538|20730397|P5|COMPLETED|Part II||0
8410731|NCT00954538|20730398|P4|COMPLETED|Part II||0
8410732|NCT00954538|20730399|P3|COMPLETED|Part II||3
8410733|NCT00954538|20730400|P2|COMPLETED|Part II||1
8410734|NCT00954538|20730401|P1|COMPLETED|Part II||0
8410735|NCT00954538|20730396|P6|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
8410736|NCT00954538|20730397|P5|STARTED|Part II||0
8410737|NCT00954538|20730398|P4|STARTED|Part II||0
8410738|NCT00954538|20730399|P3|STARTED|Part II|These subjects did not participate in Part I or III|3
8410739|NCT00954538|20730400|P2|STARTED|Part II|This subject did not participate in Part I or III|1
8410740|NCT00954538|20730401|P1|STARTED|Part II||0
8410741|NCT00954538|20730396|P6|NOT COMPLETED|Part I||0
8410742|NCT00954538|20730397|P5|NOT COMPLETED|Part I||0
8410743|NCT00954538|20730398|P4|NOT COMPLETED|Part I||0
8410744|NCT00954538|20730399|P3|NOT COMPLETED|Part I||0
8410745|NCT00954538|20730400|P2|NOT COMPLETED|Part I||0
8410746|NCT00954538|20730401|P1|NOT COMPLETED|Part I||0
8410747|NCT00954538|20730396|P6|COMPLETED|Part I||0
8410748|NCT00954538|20730397|P5|COMPLETED|Part I||0
8410749|NCT00954538|20730398|P4|COMPLETED|Part I||0
8410750|NCT00954538|20730399|P3|COMPLETED|Part I||0
8410751|NCT00954538|20730400|P2|COMPLETED|Part I||0
8410752|NCT00954538|20730401|P1|COMPLETED|Part I||3
8410753|NCT00954538|20730396|P6|STARTED|Part I||0
8410754|NCT00954538|20730397|P5|STARTED|Part I||0
8410755|NCT00954538|20730398|P4|STARTED|Part I||0
8410756|NCT00954538|20730399|P3|STARTED|Part I||0
8410757|NCT00954538|20730400|P2|STARTED|Part I||0
8410758|NCT00954538|20730401|P1|STARTED|Part I|These subjects did not participate in Part II or III|3
8410759|NCT00954512|20730418|P6|NOT COMPLETED|Overall Study||4
8410760|NCT00954512|20730419|P5|NOT COMPLETED|Overall Study||4
8410761|NCT00954512|20730420|P4|NOT COMPLETED|Overall Study||2
8410762|NCT00954512|20730421|P3|NOT COMPLETED|Overall Study||0
8410763|NCT00954512|20730422|P2|NOT COMPLETED|Overall Study||3
8410764|NCT00954512|20730423|P1|NOT COMPLETED|Overall Study||2
8410765|NCT00954512|20730418|P6|COMPLETED|Overall Study||0
8410766|NCT00954512|20730419|P5|COMPLETED|Overall Study||0
8410767|NCT00954512|20730420|P4|COMPLETED|Overall Study||0
8410768|NCT00954512|20730421|P3|COMPLETED|Overall Study||0
8410769|NCT00954512|20730422|P2|COMPLETED|Overall Study||0
8410770|NCT00954512|20730423|P1|COMPLETED|Overall Study||0
8410771|NCT00954512|20730418|P6|STARTED|Overall Study||4
8410772|NCT00954512|20730419|P5|STARTED|Overall Study||4
8410773|NCT00954512|20730420|P4|STARTED|Overall Study||2
8410774|NCT00954512|20730421|P3|STARTED|Overall Study||0
8410775|NCT00954512|20730422|P2|STARTED|Overall Study||3
8410776|NCT00954512|20730423|P1|STARTED|Overall Study||2
8410777|NCT00954447|20730444|P2|NOT COMPLETED|Overall Study||88
8410778|NCT00954447|20730445|P1|NOT COMPLETED|Overall Study||110
8410779|NCT00954447|20730444|P2|COMPLETED|Overall Study||543
8410780|NCT00954447|20730445|P1|COMPLETED|Overall Study||520
8410781|NCT00954447|20730444|P2|STARTED|Overall Study||631
8410782|NCT00954447|20730445|P1|STARTED|Overall Study||630
8410783|NCT00954421|20730481|P1|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
8410784|NCT00954421|20730481|P1|COMPLETED|VIM=ON VO=OFF at 6 Months||11
8410785|NCT00954421|20730481|P1|STARTED|VIM=ON VO=OFF at 6 Months||12
8410786|NCT00954421|20730481|P1|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
8410787|NCT00954421|20730481|P1|COMPLETED|VIM=OFF VO=ON at 6 Months||12
8410788|NCT00954421|20730481|P1|STARTED|VIM=OFF VO=ON at 6 Months||12
8410789|NCT00954421|20730481|P1|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
8410790|NCT00954421|20730481|P1|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
8410791|NCT00954421|20730481|P1|STARTED|VIM=OFF VO=OFF at 6 Months||12
8410792|NCT00954421|20730481|P1|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
8410793|NCT00954421|20730481|P1|COMPLETED|VIM=ON VO=ON at 6 Months||12
8410794|NCT00954421|20730481|P1|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
8410795|NCT00954421|20730481|P1|NOT COMPLETED|6 Months of DBS||1
8410796|NCT00954421|20730481|P1|COMPLETED|6 Months of DBS||12
8410797|NCT00954421|20730481|P1|STARTED|6 Months of DBS||13
8410798|NCT00954421|20730481|P1|NOT COMPLETED|Baseline||0
8410799|NCT00954421|20730481|P1|COMPLETED|Baseline||13
8410800|NCT00954421|20730481|P1|STARTED|Baseline||13
8410801|NCT00954421|20730481|P1|NOT COMPLETED|Screening||3
8410802|NCT00954421|20730481|P1|COMPLETED|Screening||13
8410803|NCT00954421|20730481|P1|STARTED|Screening||16
8410804|NCT00954356|20730489|P2|NOT COMPLETED|Overall Study||0
8410805|NCT00954356|20730490|P1|NOT COMPLETED|Overall Study||0
8410806|NCT00954356|20730489|P2|COMPLETED|Overall Study||20
8410807|NCT00954356|20730490|P1|COMPLETED|Overall Study||41
8410808|NCT00954356|20730489|P2|STARTED|Overall Study||20
8410809|NCT00954356|20730490|P1|STARTED|Overall Study||41
8410810|NCT00954187|20730520|P2|NOT COMPLETED|Overall Study||0
8410811|NCT00954187|20730521|P1|NOT COMPLETED|Overall Study||0
8410812|NCT00954187|20730520|P2|COMPLETED|Overall Study||0
8410813|NCT00954187|20730521|P1|COMPLETED|Overall Study||0
8410814|NCT00954187|20730520|P2|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
8410815|NCT00954187|20730521|P1|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
8410816|NCT00954174|20730531|P4|NOT COMPLETED|Overall Study||25
8410817|NCT00954174|20730532|P3|NOT COMPLETED|Overall Study||24
8410818|NCT00954174|20730533|P2|NOT COMPLETED|Overall Study||123
8410819|NCT00954174|20730534|P1|NOT COMPLETED|Overall Study||126
8410820|NCT00954174|20730531|P4|COMPLETED|Overall Study||25
8410821|NCT00954174|20730532|P3|COMPLETED|Overall Study||27
8410822|NCT00954174|20730533|P2|COMPLETED|Overall Study||145
8410823|NCT00954174|20730534|P1|COMPLETED|Overall Study||142
8410824|NCT00954174|20730531|P4|STARTED|Overall Study||50
8410825|NCT00954174|20730532|P3|STARTED|Overall Study||51
8410826|NCT00954174|20730533|P2|STARTED|Overall Study||268
8410827|NCT00954174|20730534|P1|STARTED|Overall Study||268
8410828|NCT00954122|20730554|P1|NOT COMPLETED|Overall Study||7
8410829|NCT00954122|20730554|P1|COMPLETED|Overall Study||28
8410830|NCT00954122|20730554|P1|STARTED|Overall Study||35
8410831|NCT00954109|20730564|P1|NOT COMPLETED|Overall Study||0
8410832|NCT00954109|20730564|P1|COMPLETED|Overall Study||11
8410833|NCT00954109|20730564|P1|STARTED|Overall Study||11
8410834|NCT00953927|20730571|P2|NOT COMPLETED|Overall Study||95
8410835|NCT00953927|20730572|P1|NOT COMPLETED|Overall Study||105
8410836|NCT00953927|20730571|P2|COMPLETED|Overall Study||1303
8410837|NCT00953927|20730572|P1|COMPLETED|Overall Study||1294
8410838|NCT00953927|20730571|P2|STARTED|Overall Study||1398
8410839|NCT00953927|20730572|P1|STARTED|Overall Study||1399
8410840|NCT00953862|20730590|P1|NOT COMPLETED|Overall Study||6
8410841|NCT00953862|20730590|P1|COMPLETED|Overall Study||12
8410842|NCT00953862|20730590|P1|STARTED|Overall Study||18
8410843|NCT00953849|20730600|P4|NOT COMPLETED|Overall Study||0
8410844|NCT00953849|20730601|P3|NOT COMPLETED|Overall Study||0
8410845|NCT00953849|20730602|P2|NOT COMPLETED|Overall Study||0
8410846|NCT00953849|20730603|P1|NOT COMPLETED|Overall Study||0
8410847|NCT00953849|20730600|P4|COMPLETED|Overall Study||5
8410848|NCT00953849|20730601|P3|COMPLETED|Overall Study||4
8410849|NCT00953849|20730602|P2|COMPLETED|Overall Study||6
8410850|NCT00953849|20730603|P1|COMPLETED|Overall Study||6
8410851|NCT00953849|20730600|P4|STARTED|Overall Study||5
8410852|NCT00953849|20730601|P3|STARTED|Overall Study||4
8410853|NCT00953849|20730602|P2|STARTED|Overall Study||6
8410854|NCT00953849|20730603|P1|STARTED|Overall Study||6
8410855|NCT00953745|20730627|P2|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
8410856|NCT00953745|20730628|P1|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
8410857|NCT00953745|20730627|P2|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
8410858|NCT00953745|20730628|P1|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
8410859|NCT00953745|20730627|P2|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
8410860|NCT00953745|20730628|P1|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
8410861|NCT00953745|20730627|P2|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
8410862|NCT00953745|20730628|P1|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
8410863|NCT00953745|20730627|P2|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
8410864|NCT00953745|20730628|P1|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
8410865|NCT00953745|20730627|P2|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
8410866|NCT00953745|20730628|P1|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
8410867|NCT00953745|20730627|P2|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
8410868|NCT00953745|20730628|P1|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
8410869|NCT00953745|20730627|P2|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
8410870|NCT00953745|20730628|P1|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
8410871|NCT00953745|20730627|P2|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
8410872|NCT00953745|20730628|P1|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
8410873|NCT00953719|20730638|P2|NOT COMPLETED|Overall Study||5
8410874|NCT00953719|20730639|P1|NOT COMPLETED|Overall Study||19
8410875|NCT00953719|20730638|P2|COMPLETED|Overall Study||69
8410876|NCT00953719|20730639|P1|COMPLETED|Overall Study||150
8410877|NCT00953719|20730638|P2|STARTED|Overall Study||74
8410878|NCT00953719|20730639|P1|STARTED|Overall Study||169
8410879|NCT00953706|20730661|P4|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
8410880|NCT00953706|20730662|P3|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
8410881|NCT00953706|20730663|P2|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
8410882|NCT00953706|20730664|P1|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
8410883|NCT00953706|20730661|P4|COMPLETED|Part B (96-Week Open-Label Extension)||0
8410884|NCT00953706|20730662|P3|COMPLETED|Part B (96-Week Open-Label Extension)||0
8410885|NCT00953706|20730663|P2|COMPLETED|Part B (96-Week Open-Label Extension)||0
8410886|NCT00953706|20730664|P1|COMPLETED|Part B (96-Week Open-Label Extension)||0
8410887|NCT00953706|20730661|P4|STARTED|Part B (96-Week Open-Label Extension)||33
8410888|NCT00953706|20730662|P3|STARTED|Part B (96-Week Open-Label Extension)||5
8410889|NCT00953706|20730663|P2|STARTED|Part B (96-Week Open-Label Extension)||0
8410890|NCT00953706|20730664|P1|STARTED|Part B (96-Week Open-Label Extension)||0
8410891|NCT00953706|20730661|P4|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
8410892|NCT00953706|20730662|P3|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
8410893|NCT00953706|20730663|P2|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
8410894|NCT00953706|20730664|P1|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
8410895|NCT00953706|20730661|P4|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
8410896|NCT00953706|20730662|P3|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
8410897|NCT00953706|20730663|P2|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
8410898|NCT00953706|20730664|P1|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
8410899|NCT00953706|20730661|P4|STARTED|Part A (16-Week Double-Blind Treatment)||0
8410900|NCT00953706|20730662|P3|STARTED|Part A (16-Week Double-Blind Treatment)||0
8410901|NCT00953706|20730663|P2|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
8410902|NCT00953706|20730664|P1|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
8410903|NCT00953680|20730696|P2|NOT COMPLETED|Period 2||0
8410904|NCT00953680|20730697|P1|NOT COMPLETED|Period 2||0
8410905|NCT00953680|20730696|P2|COMPLETED|Period 2||38
8410906|NCT00953680|20730697|P1|COMPLETED|Period 2||38
8410907|NCT00953680|20730696|P2|STARTED|Period 2||38
8410908|NCT00953680|20730697|P1|STARTED|Period 2||38
8410909|NCT00953680|20730696|P2|NOT COMPLETED|Period 1||1
8410910|NCT00953680|20730697|P1|NOT COMPLETED|Period 1||0
8410911|NCT00953680|20730696|P2|COMPLETED|Period 1||38
8410912|NCT00953680|20730697|P1|COMPLETED|Period 1||38
8410913|NCT00953680|20730696|P2|STARTED|Period 1||39
8410914|NCT00953680|20730697|P1|STARTED|Period 1||38
8410915|NCT00953667|20730709|P1|NOT COMPLETED|Overall Study||123
8410916|NCT00953667|20730709|P1|COMPLETED|Overall Study||277
8410917|NCT00953667|20730709|P1|STARTED|Overall Study||400
8410918|NCT00953654|20730717|P3|NOT COMPLETED|Overall Study||0
8410919|NCT00953654|20730718|P2|NOT COMPLETED|Overall Study||0
8410920|NCT00953654|20730719|P1|NOT COMPLETED|Overall Study||0
8410921|NCT00953654|20730717|P3|COMPLETED|Overall Study||10
8410922|NCT00953654|20730718|P2|COMPLETED|Overall Study||10
8410923|NCT00953654|20730719|P1|COMPLETED|Overall Study||10
8410924|NCT00953654|20730717|P3|STARTED|Overall Study||10
8410925|NCT00953654|20730718|P2|STARTED|Overall Study||10
8410926|NCT00953654|20730719|P1|STARTED|Overall Study||10
8410927|NCT00953615|20730730|P1|NOT COMPLETED|Overall Study||1
8410928|NCT00953615|20730730|P1|COMPLETED|Overall Study||0
8410929|NCT00953615|20730730|P1|STARTED|Overall Study||1
8410930|NCT00953576|20730739|P2|NOT COMPLETED|Overall Study||1
8410931|NCT00953576|20730740|P1|NOT COMPLETED|Overall Study||2
8410932|NCT00953576|20730739|P2|COMPLETED|Overall Study||4
8410933|NCT00953576|20730740|P1|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
8410934|NCT00953576|20730739|P2|Pharmacokinetic (PK) Evaluable|Overall Study||3
8410935|NCT00953576|20730740|P1|Pharmacokinetic (PK) Evaluable|Overall Study||4
8410936|NCT00953576|20730739|P2|Treated|Overall Study||5
8410937|NCT00953576|20730740|P1|Treated|Overall Study||4
8410938|NCT00953576|20730739|P2|DLT Evaluable|Overall Study||5
8410939|NCT00953576|20730740|P1|DLT Evaluable|Overall Study||3
8410940|NCT00953576|20730739|P2|STARTED|Overall Study||5
8410941|NCT00953576|20730740|P1|STARTED|Overall Study||6
8410942|NCT00953524|20730755|P4|NOT COMPLETED|Overall Study||8
8410943|NCT00953524|20730756|P3|NOT COMPLETED|Overall Study||14
8410944|NCT00953524|20730757|P2|NOT COMPLETED|Overall Study||15
8410945|NCT00953524|20730758|P1|NOT COMPLETED|Overall Study||22
8410946|NCT00953524|20730755|P4|COMPLETED|Overall Study||91
8410947|NCT00953524|20730756|P3|COMPLETED|Overall Study||233
8410948|NCT00953524|20730757|P2|COMPLETED|Overall Study||239
8410949|NCT00953524|20730758|P1|COMPLETED|Overall Study||227
8410950|NCT00953524|20730755|P4|STARTED|Overall Study||99
8410951|NCT00953524|20730756|P3|STARTED|Overall Study||247
8410952|NCT00953524|20730757|P2|STARTED|Overall Study||254
8410953|NCT00953524|20730758|P1|STARTED|Overall Study||249
8410954|NCT00953407|20730801|P5|NOT COMPLETED|Overall Study||1
8410955|NCT00953407|20730802|P4|NOT COMPLETED|Overall Study||2
8410956|NCT00953407|20730803|P3|NOT COMPLETED|Overall Study||1
8410957|NCT00953407|20730804|P2|NOT COMPLETED|Overall Study||1
8410958|NCT00953407|20730805|P1|NOT COMPLETED|Overall Study||1
8410959|NCT00953407|20730801|P5|COMPLETED|Overall Study||23
8410960|NCT00953407|20730802|P4|COMPLETED|Overall Study||23
8410961|NCT00953407|20730803|P3|COMPLETED|Overall Study||25
8410962|NCT00953407|20730804|P2|COMPLETED|Overall Study||24
8410963|NCT00953407|20730805|P1|COMPLETED|Overall Study||25
8410964|NCT00953407|20730801|P5|STARTED|Overall Study||24
8410965|NCT00953407|20730802|P4|STARTED|Overall Study||25
8410966|NCT00953407|20730803|P3|STARTED|Overall Study||26
8410967|NCT00953407|20730804|P2|STARTED|Overall Study||25
8410968|NCT00953407|20730805|P1|STARTED|Overall Study||26
8410969|NCT00953329|20730817|P1|NOT COMPLETED|Overall Study||1
8410970|NCT00953329|20730817|P1|COMPLETED|Overall Study||0
8410971|NCT00953329|20730817|P1|STARTED|Overall Study||1
8410972|NCT00953290|20730821|P1|NOT COMPLETED|Overall Study||0
8410973|NCT00953290|20730821|P1|COMPLETED|Overall Study||4
8410974|NCT00953290|20730821|P1|STARTED|Overall Study||4
8410975|NCT00953225|20730830|P2|NOT COMPLETED|Overall Study||0
8410976|NCT00953225|20730831|P1|NOT COMPLETED|Overall Study||2
8410977|NCT00953225|20730830|P2|COMPLETED|Overall Study||37
8410978|NCT00953225|20730831|P1|COMPLETED|Overall Study||44
8410979|NCT00953225|20730830|P2|STARTED|Overall Study||37
8410980|NCT00953225|20730831|P1|STARTED|Overall Study||46
8410981|NCT00953212|20730843|P4|NOT COMPLETED|Overall Study||0
8410982|NCT00953212|20730844|P3|NOT COMPLETED|Overall Study||0
8410983|NCT00953212|20730845|P2|NOT COMPLETED|Overall Study||0
8410984|NCT00953212|20730846|P1|NOT COMPLETED|Overall Study||0
8410985|NCT00953212|20730843|P4|COMPLETED|Overall Study||76
8410986|NCT00953212|20730844|P3|COMPLETED|Overall Study||78
8410987|NCT00953212|20730845|P2|COMPLETED|Overall Study||74
8410988|NCT00953212|20730846|P1|COMPLETED|Overall Study||76
8410989|NCT00953212|20730843|P4|STARTED|Overall Study||76
8410990|NCT00953212|20730844|P3|STARTED|Overall Study||78
8410991|NCT00953212|20730845|P2|STARTED|Overall Study||74
8410992|NCT00953212|20730846|P1|STARTED|Overall Study||76
8410993|NCT00953199|20730902|P2|NOT COMPLETED|Overall Study||0
8410994|NCT00953199|20730903|P1|NOT COMPLETED|Overall Study||0
8410995|NCT00953199|20730902|P2|COMPLETED|Overall Study||252
8410996|NCT00953199|20730903|P1|COMPLETED|Overall Study||254
8410997|NCT00953199|20730902|P2|STARTED|Overall Study||252
8410998|NCT00953199|20730903|P1|STARTED|Overall Study||254
8410999|NCT00953173|20730911|P1|NOT COMPLETED|Overall Study||282
8411000|NCT00953173|20730911|P1|COMPLETED|Overall Study||389
8411001|NCT00953173|20730911|P1|STARTED|Overall Study||671
8411002|NCT00953160|20730915|P1|NOT COMPLETED|Overall Study||27
8411003|NCT00953160|20730915|P1|COMPLETED|Overall Study||49
8411004|NCT00953160|20730915|P1|STARTED|Overall Study||76
8411005|NCT00953147|20730924|P3|NOT COMPLETED|Overall Study||42
8411006|NCT00953147|20730925|P2|NOT COMPLETED|Overall Study||66
8411007|NCT00953147|20730926|P1|NOT COMPLETED|Overall Study||37
8411008|NCT00953147|20730924|P3|COMPLETED|Overall Study||265
8411009|NCT00953147|20730925|P2|COMPLETED|Overall Study||439
8411010|NCT00953147|20730926|P1|COMPLETED|Overall Study||261
8411011|NCT00953147|20730924|P3|STARTED|Overall Study||307
8411012|NCT00953147|20730925|P2|STARTED|Overall Study||505
8411013|NCT00953147|20730926|P1|STARTED|Overall Study||298
8411014|NCT00953121|20730976|P3|NOT COMPLETED|Overall Study||0
8411015|NCT00953121|20730977|P2|NOT COMPLETED|Overall Study||0
8411016|NCT00953121|20730978|P1|NOT COMPLETED|Overall Study||0
8411017|NCT00953121|20730976|P3|COMPLETED|Overall Study||25
8411018|NCT00953121|20730977|P2|COMPLETED|Overall Study||39
8411019|NCT00953121|20730978|P1|COMPLETED|Overall Study||40
8411020|NCT00953121|20730976|P3|STARTED|Overall Study||25
8411021|NCT00953121|20730977|P2|STARTED|Overall Study||39
8411022|NCT00953121|20730978|P1|STARTED|Overall Study||40
8411023|NCT00953056|20731004|P6|NOT COMPLETED|Overall Study||4
8411024|NCT00953056|20731005|P5|NOT COMPLETED|Overall Study||2
8411025|NCT00953056|20731006|P4|NOT COMPLETED|Overall Study||0
8411026|NCT00953056|20731007|P3|NOT COMPLETED|Overall Study||0
8411027|NCT00953056|20731008|P2|NOT COMPLETED|Overall Study||0
8411028|NCT00953056|20731009|P1|NOT COMPLETED|Overall Study||0
8411029|NCT00953056|20731004|P6|COMPLETED|Overall Study||20
8411030|NCT00953056|20731005|P5|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
8411031|NCT00953056|20731006|P4|COMPLETED|Overall Study||24
8411032|NCT00953056|20731007|P3|COMPLETED|Overall Study||24
8411033|NCT00953056|20731008|P2|COMPLETED|Overall Study||24
8411034|NCT00953056|20731009|P1|COMPLETED|Overall Study||24
8411035|NCT00953056|20731004|P6|STARTED|Overall Study||24
8411036|NCT00953056|20731005|P5|STARTED|Overall Study||24
8411037|NCT00953056|20731006|P4|STARTED|Overall Study||24
8411038|NCT00953056|20731007|P3|STARTED|Overall Study||24
8411039|NCT00953056|20731008|P2|STARTED|Overall Study||24
8411040|NCT00953056|20731009|P1|STARTED|Overall Study||24
8411041|NCT00953043|20731033|P2|NOT COMPLETED|Overall Study||2
8411042|NCT00953043|20731034|P1|NOT COMPLETED|Overall Study||4
8411043|NCT00953043|20731033|P2|COMPLETED|Overall Study||28
8411044|NCT00953043|20731034|P1|COMPLETED|Overall Study||26
8411045|NCT00953043|20731033|P2|STARTED|Overall Study||30
8411046|NCT00953043|20731034|P1|STARTED|Overall Study||30
8411047|NCT00953017|20731058|P4|NOT COMPLETED|Overall Study||5
8411048|NCT00953017|20731059|P3|NOT COMPLETED|Overall Study||6
8411049|NCT00953017|20731060|P2|NOT COMPLETED|Overall Study||6
8411050|NCT00953017|20731061|P1|NOT COMPLETED|Overall Study||5
8411051|NCT00953017|20731058|P4|COMPLETED|Overall Study||101
8411052|NCT00953017|20731059|P3|COMPLETED|Overall Study||100
8411053|NCT00953017|20731060|P2|COMPLETED|Overall Study||101
8411054|NCT00953017|20731061|P1|COMPLETED|Overall Study||101
8411055|NCT00953017|20731058|P4|STARTED|Overall Study||106
8411056|NCT00953017|20731059|P3|STARTED|Overall Study||106
8411057|NCT00953017|20731060|P2|STARTED|Overall Study||107
8411058|NCT00953017|20731061|P1|STARTED|Overall Study||106
8411059|NCT00952848|20731083|P1|NOT COMPLETED|Overall Study||4
8411060|NCT00952848|20731083|P1|COMPLETED|Overall Study||14
8411061|NCT00952848|20731083|P1|STARTED|Overall Study||18
8411086|NCT00952731|20731125|P2|NOT COMPLETED|Overall Study||0
8411087|NCT00952731|20731126|P1|NOT COMPLETED|Overall Study||1
8411088|NCT00952731|20731125|P2|COMPLETED|Overall Study||14
8411089|NCT00952731|20731126|P1|COMPLETED|Overall Study||12
8411090|NCT00952731|20731125|P2|Follow-up|Overall Study||14
8411091|NCT00952731|20731126|P1|Follow-up|Overall Study||12
8411092|NCT00952731|20731125|P2|Surgery|Overall Study||14
8411093|NCT00952731|20731126|P1|Surgery|Overall Study||12
8411094|NCT00952731|20731125|P2|Treatment & Pre-Surgery|Overall Study||14
8411095|NCT00952731|20731126|P1|Treatment & Pre-Surgery|Overall Study||12
8411096|NCT00952731|20731125|P2|Randomization|Overall Study||14
8411097|NCT00952731|20731126|P1|Randomization|Overall Study||13
8411098|NCT00952731|20731125|P2|STARTED|Overall Study||14
8411099|NCT00952731|20731126|P1|STARTED|Overall Study||13
8411106|NCT00952705|20731158|P3|NOT COMPLETED|Overall Study||10
8411107|NCT00952705|20731159|P2|NOT COMPLETED|Overall Study||10
8411108|NCT00952705|20731160|P1|NOT COMPLETED|Overall Study||33
8411109|NCT00952705|20731158|P3|COMPLETED|Overall Study||288
8411110|NCT00952705|20731159|P2|COMPLETED|Overall Study||290
8411111|NCT00952705|20731160|P1|COMPLETED|Overall Study||1169
8411112|NCT00952705|20731158|P3|STARTED|Overall Study||298
8411113|NCT00952705|20731159|P2|STARTED|Overall Study||300
8411114|NCT00952705|20731160|P1|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
8411115|NCT00952653|20731222|P1|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
8411116|NCT00952653|20731222|P1|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
8411117|NCT00952653|20731222|P1|STARTED|Period 2: Coadministration DVS SR, MDZ||28
8411118|NCT00952653|20731222|P1|NOT COMPLETED|Period 1: MDZ Alone||0
8411119|NCT00952653|20731222|P1|COMPLETED|Period 1: MDZ Alone||28
8411120|NCT00952653|20731222|P1|STARTED|Period 1: MDZ Alone||28
8411121|NCT00952614|20731247|P1|NOT COMPLETED|Overall Study||7
8411122|NCT00952614|20731247|P1|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
8411123|NCT00952614|20731247|P1|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
8411124|NCT00952614|20731247|P1|STARTED|Overall Study||30
8411125|NCT00952588|20731254|P2|NOT COMPLETED|Overall Study||24
8411126|NCT00952588|20731255|P1|NOT COMPLETED|Overall Study||36
8411127|NCT00952588|20731254|P2|COMPLETED|Overall Study||2
8411128|NCT00952588|20731255|P1|COMPLETED|Overall Study||12
8411129|NCT00952588|20731254|P2|STARTED|Overall Study||26
8411130|NCT00952588|20731255|P1|STARTED|Overall Study||48
8411131|NCT00952523|20731273|P1|NOT COMPLETED|Overall Study||7
8411132|NCT00952523|20731273|P1|COMPLETED|Overall Study||155
8411133|NCT00952523|20731273|P1|STARTED|Overall Study||162
8411134|NCT00952484|20731282|P3|NOT COMPLETED|Overall Study||0
8411135|NCT00952484|20731283|P2|NOT COMPLETED|Overall Study||1
8411136|NCT00952484|20731284|P1|NOT COMPLETED|Overall Study||0
8411137|NCT00952484|20731282|P3|COMPLETED|Overall Study||16
8411138|NCT00952484|20731283|P2|COMPLETED|Overall Study||6
8411139|NCT00952484|20731284|P1|COMPLETED|Overall Study||6
8411140|NCT00952484|20731282|P3|STARTED|Overall Study||16
8411141|NCT00952484|20731283|P2|STARTED|Overall Study||7
8411142|NCT00952484|20731284|P1|STARTED|Overall Study||6
8411143|NCT00952419|20731311|P3|NOT COMPLETED|Overall Study||0
8411144|NCT00952419|20731312|P2|NOT COMPLETED|Overall Study||10
8411145|NCT00952419|20731313|P1|NOT COMPLETED|Overall Study||6
8411146|NCT00952419|20731311|P3|COMPLETED|Overall Study||51
8411147|NCT00952419|20731312|P2|COMPLETED|Overall Study||198
8411148|NCT00952419|20731313|P1|COMPLETED|Overall Study||209
8411149|NCT00952419|20731311|P3|STARTED|Overall Study||51
8411150|NCT00952419|20731312|P2|STARTED|Overall Study||208
8411151|NCT00952419|20731313|P1|STARTED|Overall Study||215
8411152|NCT00952393|20731345|P1|NOT COMPLETED|Overall Study||0
8411153|NCT00952393|20731345|P1|COMPLETED|Overall Study||10
8411154|NCT00952393|20731345|P1|STARTED|Overall Study|10|10
8411155|NCT00952380|20731354|P5|NOT COMPLETED|Overall Study||6
8411156|NCT00952380|20731355|P4|NOT COMPLETED|Overall Study||3
8411157|NCT00952380|20731356|P3|NOT COMPLETED|Overall Study||2
8411158|NCT00952380|20731357|P2|NOT COMPLETED|Overall Study||1
8411159|NCT00952380|20731358|P1|NOT COMPLETED|Overall Study||0
8411160|NCT00952380|20731354|P5|COMPLETED|Overall Study||14
8411161|NCT00952380|20731355|P4|COMPLETED|Overall Study||4
8411162|NCT00952380|20731356|P3|COMPLETED|Overall Study||6
8411163|NCT00952380|20731357|P2|COMPLETED|Overall Study||1
8411164|NCT00952380|20731358|P1|COMPLETED|Overall Study||1
8411165|NCT00952380|20731354|P5|STARTED|Overall Study||20
8411166|NCT00952380|20731355|P4|STARTED|Overall Study||7
8411167|NCT00952380|20731356|P3|STARTED|Overall Study||8
8411168|NCT00952380|20731357|P2|STARTED|Overall Study||2
8411169|NCT00952380|20731358|P1|STARTED|Overall Study||1
8411170|NCT00952367|20731459|P1|NOT COMPLETED|Overall Study||6
8411171|NCT00952367|20731459|P1|COMPLETED|Overall Study||3635
8411172|NCT00952367|20731459|P1|STARTED|Overall Study||3641
8411173|NCT00952341|20731474|P2|NOT COMPLETED|Cycle 2||12
8411174|NCT00952341|20731475|P1|NOT COMPLETED|Cycle 2||9
8411175|NCT00952341|20731474|P2|COMPLETED|Cycle 2||118
8411176|NCT00952341|20731475|P1|COMPLETED|Cycle 2||101
8411177|NCT00952341|20731474|P2|STARTED|Cycle 2||130
8411178|NCT00952341|20731475|P1|STARTED|Cycle 2||110
8411179|NCT00952341|20731474|P2|NOT COMPLETED|Cycle 1||13
8411180|NCT00952341|20731475|P1|NOT COMPLETED|Cycle 1||20
8411181|NCT00952341|20731474|P2|COMPLETED|Cycle 1||199
8411182|NCT00952341|20731475|P1|COMPLETED|Cycle 1||189
8411183|NCT00952341|20731474|P2|STARTED|Cycle 1||212
8411184|NCT00952341|20731475|P1|STARTED|Cycle 1||209
8411185|NCT00952315|20731498|P3|NOT COMPLETED|Overall Study||19
8411186|NCT00952315|20731499|P2|NOT COMPLETED|Overall Study||24
8411187|NCT00952315|20731500|P1|NOT COMPLETED|Overall Study||26
8411188|NCT00952315|20731498|P3|COMPLETED|Overall Study||71
8411189|NCT00952315|20731499|P2|COMPLETED|Overall Study||66
8411190|NCT00952315|20731500|P1|COMPLETED|Overall Study||64
8411191|NCT00952315|20731498|P3|STARTED|Overall Study||90
8411192|NCT00952315|20731499|P2|STARTED|Overall Study||90
8411193|NCT00952315|20731500|P1|STARTED|Overall Study||90
8411194|NCT00952289|20731537|P2|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
8411195|NCT00952289|20731538|P1|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
8411196|NCT00952289|20731537|P2|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
8411197|NCT00952289|20731538|P1|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
8411198|NCT00952289|20731537|P2|STARTED|Patients Who Crossed Over to Ruxolitinib||111
8411199|NCT00952289|20731538|P1|STARTED|Patients Who Crossed Over to Ruxolitinib||0
8411200|NCT00952289|20731537|P2|NOT COMPLETED|All Participants||40
8411201|NCT00952289|20731538|P1|NOT COMPLETED|All Participants||21
8411202|NCT00952289|20731537|P2|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
8411203|NCT00952289|20731538|P1|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
8411204|NCT00952289|20731537|P2|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
8411205|NCT00952289|20731538|P1|Safety Population|All Participants||155
8411206|NCT00952289|20731537|P2|STARTED|All Participants||154
8411207|NCT00952289|20731538|P1|STARTED|All Participants||155
8411208|NCT00952276|20731567|P5|NOT COMPLETED|Overall Study||0
8411209|NCT00952276|20731568|P4|NOT COMPLETED|Overall Study||1
8411210|NCT00952276|20731569|P3|NOT COMPLETED|Overall Study||0
8411211|NCT00952276|20731570|P2|NOT COMPLETED|Overall Study||0
8411212|NCT00952276|20731571|P1|NOT COMPLETED|Overall Study||1
8411213|NCT00952276|20731567|P5|COMPLETED|Overall Study||63
8411214|NCT00952276|20731568|P4|COMPLETED|Overall Study||120
8411215|NCT00952276|20731569|P3|COMPLETED|Overall Study||122
8411216|NCT00952276|20731570|P2|COMPLETED|Overall Study||115
8411217|NCT00952276|20731571|P1|COMPLETED|Overall Study||126
8411218|NCT00952276|20731567|P5|STARTED|Overall Study||63
8411219|NCT00952276|20731568|P4|STARTED|Overall Study||121
8411220|NCT00952276|20731569|P3|STARTED|Overall Study||122
8411221|NCT00952276|20731570|P2|STARTED|Overall Study||115
8411222|NCT00952276|20731571|P1|STARTED|Overall Study||127
8411223|NCT00952211|20731620|P2|NOT COMPLETED|Overall Study||0
8411224|NCT00952211|20731621|P1|NOT COMPLETED|Overall Study||0
8411225|NCT00952211|20731620|P2|COMPLETED|Overall Study||0
8411226|NCT00952211|20731621|P1|COMPLETED|Overall Study||3
8411227|NCT00952211|20731620|P2|STARTED|Overall Study||0
8411228|NCT00952211|20731621|P1|STARTED|Overall Study||3
8411229|NCT00952133|20731631|P2|NOT COMPLETED|Overall Study||0
8411230|NCT00952133|20731632|P1|NOT COMPLETED|Overall Study||0
8411231|NCT00952133|20731631|P2|COMPLETED|Overall Study||59
8411232|NCT00952133|20731632|P1|COMPLETED|Overall Study||59
8411233|NCT00952133|20731631|P2|STARTED|Overall Study||59
8411234|NCT00952133|20731632|P1|STARTED|Overall Study||59
8411235|NCT00952120|20731643|P3|NOT COMPLETED|Overall Study||0
8411236|NCT00952120|20731644|P2|NOT COMPLETED|Overall Study||0
8411237|NCT00952120|20731645|P1|NOT COMPLETED|Overall Study||0
8411238|NCT00952120|20731643|P3|COMPLETED|Overall Study||5
8411239|NCT00952120|20731644|P2|COMPLETED|Overall Study||47
8411240|NCT00952120|20731645|P1|COMPLETED|Overall Study||52
8411241|NCT00952120|20731643|P3|STARTED|Overall Study||5
8411242|NCT00952120|20731644|P2|STARTED|Overall Study||47
8411243|NCT00952120|20731645|P1|STARTED|Overall Study||52
8411244|NCT00952081|20731653|P1|NOT COMPLETED|Overall Study||0
8411245|NCT00952081|20731653|P1|COMPLETED|Overall Study||22
8411246|NCT00952081|20731653|P1|STARTED|Overall Study||22
8411247|NCT00952068|20731657|P1|NOT COMPLETED|Overall Study||7
8411248|NCT00952068|20731657|P1|COMPLETED|Overall Study||40
8411249|NCT00952068|20731657|P1|STARTED|Overall Study||47
8411250|NCT00951912|20731668|P3|NOT COMPLETED|Overall Study||2
8411251|NCT00951912|20731669|P2|NOT COMPLETED|Overall Study||5
8411252|NCT00951912|20731670|P1|NOT COMPLETED|Overall Study||7
8411253|NCT00951912|20731668|P3|COMPLETED|Overall Study||54
8411254|NCT00951912|20731669|P2|COMPLETED|Overall Study||50
8411255|NCT00951912|20731670|P1|COMPLETED|Overall Study||47
8411256|NCT00951912|20731668|P3|STARTED|Overall Study||56
8411257|NCT00951912|20731669|P2|STARTED|Overall Study||55
8411258|NCT00951912|20731670|P1|STARTED|Overall Study||54
8411259|NCT00951899|20731722|P2|NOT COMPLETED|Overall Study||0
8411260|NCT00951899|20731723|P1|NOT COMPLETED|Overall Study||0
8411261|NCT00951899|20731722|P2|COMPLETED|Overall Study||19
8411262|NCT00951899|20731723|P1|COMPLETED|Overall Study||19
8411263|NCT00951899|20731722|P2|STARTED|Overall Study||19
8411264|NCT00951899|20731723|P1|STARTED|Overall Study||19
8411265|NCT00951821|20731747|P2|NOT COMPLETED|Overall Study||0
8411266|NCT00951821|20731748|P1|NOT COMPLETED|Overall Study||0
8411267|NCT00951821|20731747|P2|COMPLETED|Overall Study||8
8411268|NCT00951821|20731748|P1|COMPLETED|Overall Study||16
8411269|NCT00951821|20731747|P2|STARTED|Overall Study||8
8411270|NCT00951821|20731748|P1|STARTED|Overall Study||16
8411271|NCT00951808|20731756|P3|NOT COMPLETED|Overall Study||4
8411272|NCT00951808|20731757|P2|NOT COMPLETED|Overall Study||0
8411273|NCT00951808|20731758|P1|NOT COMPLETED|Overall Study||0
8411274|NCT00951808|20731756|P3|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
8411275|NCT00951808|20731757|P2|COMPLETED|Overall Study||6
8411276|NCT00951808|20731758|P1|COMPLETED|Overall Study||4
8411277|NCT00951808|20731756|P3|STARTED|Overall Study||227
8411278|NCT00951808|20731757|P2|STARTED|Overall Study||6
8411279|NCT00951808|20731758|P1|STARTED|Overall Study||4
8411280|NCT00951665|20731770|P6|NOT COMPLETED|Phase 2a||7
8411281|NCT00951665|20731771|P5|NOT COMPLETED|Phase 2a||12
8411282|NCT00951665|20731772|P4|NOT COMPLETED|Phase 2a||0
8411283|NCT00951665|20731773|P3|NOT COMPLETED|Phase 2a||0
8411284|NCT00951665|20731774|P2|NOT COMPLETED|Phase 2a||0
8411285|NCT00951665|20731775|P1|NOT COMPLETED|Phase 2a||0
8411286|NCT00951665|20731770|P6|COMPLETED|Phase 2a||15
8411287|NCT00951665|20731771|P5|COMPLETED|Phase 2a||10
8411288|NCT00951665|20731772|P4|COMPLETED|Phase 2a||0
8411289|NCT00951665|20731773|P3|COMPLETED|Phase 2a||0
8411290|NCT00951665|20731774|P2|COMPLETED|Phase 2a||0
8411291|NCT00951665|20731775|P1|COMPLETED|Phase 2a||0
8411292|NCT00951665|20731770|P6|STARTED|Phase 2a||22
8411293|NCT00951665|20731771|P5|STARTED|Phase 2a||22
8411294|NCT00951665|20731772|P4|STARTED|Phase 2a||0
8411295|NCT00951665|20731773|P3|STARTED|Phase 2a||0
8411296|NCT00951665|20731774|P2|STARTED|Phase 2a||0
8411297|NCT00951665|20731775|P1|STARTED|Phase 2a||0
8411298|NCT00951665|20731770|P6|NOT COMPLETED|Phase 1b||0
8411299|NCT00951665|20731771|P5|NOT COMPLETED|Phase 1b||0
8411300|NCT00951665|20731772|P4|NOT COMPLETED|Phase 1b||1
8411301|NCT00951665|20731773|P3|NOT COMPLETED|Phase 1b||17
8411302|NCT00951665|20731774|P2|NOT COMPLETED|Phase 1b||4
8411303|NCT00951665|20731775|P1|NOT COMPLETED|Phase 1b||22
8411304|NCT00951665|20731770|P6|COMPLETED|Phase 1b||0
8411305|NCT00951665|20731771|P5|COMPLETED|Phase 1b||0
8411306|NCT00951665|20731772|P4|COMPLETED|Phase 1b||2
8411307|NCT00951665|20731773|P3|COMPLETED|Phase 1b||4
8411308|NCT00951665|20731774|P2|COMPLETED|Phase 1b||6
8411309|NCT00951665|20731775|P1|COMPLETED|Phase 1b||7
8411310|NCT00951665|20731770|P6|Started Treatment|Phase 1b||0
8411311|NCT00951665|20731771|P5|Started Treatment|Phase 1b||0
8411312|NCT00951665|20731772|P4|Started Treatment|Phase 1b||3
8411313|NCT00951665|20731773|P3|Started Treatment|Phase 1b||21
8411314|NCT00951665|20731774|P2|Started Treatment|Phase 1b||10
8411315|NCT00951665|20731775|P1|Started Treatment|Phase 1b||26
8411316|NCT00951665|20731770|P6|STARTED|Phase 1b||0
8411317|NCT00951665|20731771|P5|STARTED|Phase 1b||0
8411318|NCT00951665|20731772|P4|STARTED|Phase 1b||3
8411319|NCT00951665|20731773|P3|STARTED|Phase 1b||21
8411320|NCT00951665|20731774|P2|STARTED|Phase 1b||10
8411321|NCT00951665|20731775|P1|STARTED|Phase 1b||29
8411322|NCT00951561|20731876|P4|NOT COMPLETED|Overall Study||1
8411323|NCT00951561|20731877|P3|NOT COMPLETED|Overall Study||3
8411324|NCT00951561|20731878|P2|NOT COMPLETED|Overall Study||0
8411325|NCT00951561|20731879|P1|NOT COMPLETED|Overall Study||0
8411326|NCT00951561|20731876|P4|COMPLETED|Overall Study|1 subject dropped after period 2|26
8411327|NCT00951561|20731877|P3|COMPLETED|Overall Study|3 subjects dropped after period 2|18
8411328|NCT00951561|20731878|P2|COMPLETED|Overall Study||29
8411329|NCT00951561|20731879|P1|COMPLETED|Overall Study||25
8411330|NCT00951561|20731876|P4|STARTED|Overall Study||27
8411331|NCT00951561|20731877|P3|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
8411332|NCT00951561|20731878|P2|STARTED|Overall Study||29
8411333|NCT00951561|20731879|P1|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
8411334|NCT00951509|20731884|P1|NOT COMPLETED|Overall Study||2
8411335|NCT00951509|20731884|P1|COMPLETED|Overall Study||29
8411336|NCT00951509|20731884|P1|Driving Condition 5|Overall Study||30
8411337|NCT00951509|20731884|P1|Driving Condition 4|Overall Study||28
8411338|NCT00951509|20731884|P1|Driving Condition 3|Overall Study||25
8411339|NCT00951509|20731884|P1|Driving Condition 2|Overall Study||29
8411340|NCT00951509|20731884|P1|Driving Condition 1|Overall Study||29
8411341|NCT00951509|20731884|P1|STARTED|Overall Study||31
8411351|NCT00951483|20731925|P2|NOT COMPLETED|Overall Study||0
8411352|NCT00951483|20731926|P1|NOT COMPLETED|Overall Study||19
8411353|NCT00951483|20731925|P2|COMPLETED|Overall Study||44
8411354|NCT00951483|20731926|P1|COMPLETED|Overall Study||28
8411355|NCT00951483|20731925|P2|STARTED|Overall Study||44
8411356|NCT00951483|20731926|P1|STARTED|Overall Study||47
8411357|NCT00951379|20731946|P2|NOT COMPLETED|Overall Study||2
8411358|NCT00951379|20731947|P1|NOT COMPLETED|Overall Study||6
8411359|NCT00951379|20731946|P2|COMPLETED|Overall Study||23
8411360|NCT00951379|20731947|P1|COMPLETED|Overall Study||21
8411361|NCT00951379|20731946|P2|STARTED|Overall Study||25
8411362|NCT00951379|20731947|P1|STARTED|Overall Study||27
8411363|NCT00951275|20731989|P1|NOT COMPLETED|Overall Study||13
8411364|NCT00951275|20731989|P1|COMPLETED|Overall Study||92
8411365|NCT00951275|20731989|P1|STARTED|Overall Study||105
8411366|NCT00951171|20732021|P2|NOT COMPLETED|Overall Study||0
8411367|NCT00951171|20732022|P1|NOT COMPLETED|Overall Study||2
8411368|NCT00951171|20732021|P2|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
8411369|NCT00951171|20732022|P1|COMPLETED|Overall Study||38
8411370|NCT00951171|20732021|P2|Pregnancy|Overall Study||7
8411371|NCT00951171|20732022|P1|Pregnancy|Overall Study||1
8411372|NCT00951171|20732021|P2|STARTED|Overall Study||55
8411373|NCT00951171|20732022|P1|STARTED|Overall Study||40
8411374|NCT00951093|20732028|P1|NOT COMPLETED|6 Months After GBP||0
8411375|NCT00951093|20732028|P1|COMPLETED|6 Months After GBP||53
8411376|NCT00951093|20732028|P1|STARTED|6 Months After GBP||53
8411377|NCT00951093|20732028|P1|NOT COMPLETED|Before GBP||0
8411378|NCT00951093|20732028|P1|COMPLETED|Before GBP||53
8411379|NCT00951093|20732028|P1|STARTED|Before GBP||53
8411380|NCT00951080|20732054|P2|NOT COMPLETED|Overall Study||27
8411381|NCT00951080|20732055|P1|NOT COMPLETED|Overall Study||26
8411382|NCT00951080|20732054|P2|COMPLETED|Overall Study||41
8411383|NCT00951080|20732055|P1|COMPLETED|Overall Study||38
8411384|NCT00951080|20732054|P2|STARTED|Overall Study||68
8411385|NCT00951080|20732055|P1|STARTED|Overall Study||64
8411386|NCT00951041|20732063|P2|NOT COMPLETED|Overall Study||1
8411387|NCT00951041|20732064|P1|NOT COMPLETED|Overall Study||5
8411388|NCT00951041|20732063|P2|COMPLETED|Overall Study||65
8411389|NCT00951041|20732064|P1|COMPLETED|Overall Study||59
8411390|NCT00951041|20732063|P2|STARTED|Overall Study||66
8411391|NCT00951041|20732064|P1|STARTED|Overall Study||64
8411392|NCT00951015|20732119|P5|NOT COMPLETED|Open-label Phase||50
8411393|NCT00951015|20732120|P4|NOT COMPLETED|Open-label Phase||0
8411394|NCT00951015|20732121|P3|NOT COMPLETED|Open-label Phase||0
8411395|NCT00951015|20732122|P2|NOT COMPLETED|Open-label Phase||0
8411396|NCT00951015|20732123|P1|NOT COMPLETED|Open-label Phase||0
8411397|NCT00951015|20732119|P5|COMPLETED|Open-label Phase||88
8411398|NCT00951015|20732120|P4|COMPLETED|Open-label Phase||0
8411399|NCT00951015|20732121|P3|COMPLETED|Open-label Phase||0
8411400|NCT00951015|20732122|P2|COMPLETED|Open-label Phase||0
8411401|NCT00951015|20732123|P1|COMPLETED|Open-label Phase||0
8411402|NCT00951015|20732119|P5|STARTED|Open-label Phase||138
8411403|NCT00951015|20732120|P4|STARTED|Open-label Phase||0
8411404|NCT00951015|20732121|P3|STARTED|Open-label Phase||0
8411405|NCT00951015|20732122|P2|STARTED|Open-label Phase||0
8411406|NCT00951015|20732123|P1|STARTED|Open-label Phase||0
8411407|NCT00951015|20732119|P5|NOT COMPLETED|Randomization Phase 96 Week||0
8411408|NCT00951015|20732120|P4|NOT COMPLETED|Randomization Phase 96 Week||10
8411409|NCT00951015|20732121|P3|NOT COMPLETED|Randomization Phase 96 Week||5
8411410|NCT00951015|20732122|P2|NOT COMPLETED|Randomization Phase 96 Week||7
8411411|NCT00951015|20732123|P1|NOT COMPLETED|Randomization Phase 96 Week||5
8411412|NCT00951015|20732119|P5|COMPLETED|Randomization Phase 96 Week||0
8411413|NCT00951015|20732120|P4|COMPLETED|Randomization Phase 96 Week||40
8411414|NCT00951015|20732121|P3|COMPLETED|Randomization Phase 96 Week||46
8411415|NCT00951015|20732122|P2|COMPLETED|Randomization Phase 96 Week||44
8411416|NCT00951015|20732123|P1|COMPLETED|Randomization Phase 96 Week||48
8411417|NCT00951015|20732119|P5|STARTED|Randomization Phase 96 Week||0
8411418|NCT00951015|20732120|P4|STARTED|Randomization Phase 96 Week||50
8411419|NCT00951015|20732121|P3|STARTED|Randomization Phase 96 Week||51
8411420|NCT00951015|20732122|P2|STARTED|Randomization Phase 96 Week||51
8411421|NCT00951015|20732123|P1|STARTED|Randomization Phase 96 Week||53
8411422|NCT00950963|20732220|P2|NOT COMPLETED|Overall Study||24
8411423|NCT00950963|20732221|P1|NOT COMPLETED|Overall Study||29
8411424|NCT00950963|20732220|P2|COMPLETED|Overall Study||357
8411425|NCT00950963|20732221|P1|COMPLETED|Overall Study||352
8411426|NCT00950963|20732220|P2|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
8411427|NCT00950963|20732221|P1|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
8411428|NCT00950950|20732237|P2|NOT COMPLETED|Overall Study||1
8411429|NCT00950950|20732238|P1|NOT COMPLETED|Overall Study||1
8411430|NCT00950950|20732237|P2|COMPLETED|Overall Study||11
8411431|NCT00950950|20732238|P1|COMPLETED|Overall Study||11
8411432|NCT00950950|20732237|P2|STARTED|Overall Study||12
8411433|NCT00950950|20732238|P1|STARTED|Overall Study||12
8411434|NCT00950937|20732301|P2|NOT COMPLETED|Overall Study||0
8411435|NCT00950937|20732302|P1|NOT COMPLETED|Overall Study||0
8411436|NCT00950937|20732301|P2|COMPLETED|Overall Study||14
8411437|NCT00950937|20732302|P1|COMPLETED|Overall Study||14
8411438|NCT00950937|20732301|P2|STARTED|Overall Study||14
8411439|NCT00950937|20732302|P1|STARTED|Overall Study||14
8411440|NCT00950911|20732320|P2|NOT COMPLETED|Overall Study||15
8411441|NCT00950911|20732321|P1|NOT COMPLETED|Overall Study||12
8411442|NCT00950911|20732320|P2|COMPLETED|Overall Study||3
8411443|NCT00950911|20732321|P1|COMPLETED|Overall Study||5
8411444|NCT00950911|20732320|P2|STARTED|Overall Study||18
8411445|NCT00950911|20732321|P1|STARTED|Overall Study||17
8411446|NCT00950872|20732327|P1|NOT COMPLETED|Overall Study||3
8411447|NCT00950872|20732327|P1|COMPLETED|Overall Study||26
8411448|NCT00950872|20732327|P1|STARTED|Overall Study||29
8411449|NCT00950859|20732336|P2|NOT COMPLETED|Overall Study||10
8411450|NCT00950859|20732337|P1|NOT COMPLETED|Overall Study||16
8411451|NCT00950859|20732336|P2|COMPLETED|Overall Study||14
8411452|NCT00950859|20732337|P1|COMPLETED|Overall Study||11
8411453|NCT00950859|20732336|P2|STARTED|Overall Study||24
8411454|NCT00950859|20732337|P1|STARTED|Overall Study||27
8411455|NCT00950833|20732380|P3|NOT COMPLETED|Overall Study||0
8411456|NCT00950833|20732381|P2|NOT COMPLETED|Overall Study||0
8411457|NCT00950833|20732382|P1|NOT COMPLETED|Overall Study||0
8411458|NCT00950833|20732380|P3|COMPLETED|Overall Study||223
8411459|NCT00950833|20732381|P2|COMPLETED|Overall Study||108
8411460|NCT00950833|20732382|P1|COMPLETED|Overall Study||112
8411461|NCT00950833|20732380|P3|STARTED|Overall Study||223
8411462|NCT00950833|20732381|P2|STARTED|Overall Study||108
8411463|NCT00950833|20732382|P1|STARTED|Overall Study||112
8411464|NCT00950807|20732436|P10|NOT COMPLETED|Treatment Period 3||1
8411465|NCT00950807|20732437|P9|NOT COMPLETED|Treatment Period 3||0
8411466|NCT00950807|20732438|P8|NOT COMPLETED|Treatment Period 3||1
8411467|NCT00950807|20732439|P7|NOT COMPLETED|Treatment Period 3||1
8411468|NCT00950807|20732440|P6|NOT COMPLETED|Treatment Period 3||0
8411469|NCT00950807|20732441|P5|NOT COMPLETED|Treatment Period 3||0
8411470|NCT00950807|20732442|P4|NOT COMPLETED|Treatment Period 3||0
8411471|NCT00950807|20732443|P3|NOT COMPLETED|Treatment Period 3||0
8411472|NCT00950807|20732444|P2|NOT COMPLETED|Treatment Period 3||0
8411473|NCT00950807|20732445|P1|NOT COMPLETED|Treatment Period 3||1
8411474|NCT00950807|20732436|P10|COMPLETED|Treatment Period 3||10
8411475|NCT00950807|20732437|P9|COMPLETED|Treatment Period 3||9
8411476|NCT00950807|20732438|P8|COMPLETED|Treatment Period 3||9
8411477|NCT00950807|20732439|P7|COMPLETED|Treatment Period 3||11
8411478|NCT00950807|20732440|P6|COMPLETED|Treatment Period 3||9
8411479|NCT00950807|20732441|P5|COMPLETED|Treatment Period 3||12
8411480|NCT00950807|20732442|P4|COMPLETED|Treatment Period 3||11
8411481|NCT00950807|20732443|P3|COMPLETED|Treatment Period 3||10
8411482|NCT00950807|20732444|P2|COMPLETED|Treatment Period 3||9
8411483|NCT00950807|20732445|P1|COMPLETED|Treatment Period 3||45
8411484|NCT00950807|20732436|P10|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
8411485|NCT00950807|20732437|P9|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
8411486|NCT00950807|20732438|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
8411487|NCT00950807|20732439|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
8411488|NCT00950807|20732440|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
8411489|NCT00950807|20732441|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
8411490|NCT00950807|20732442|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
8411491|NCT00950807|20732443|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
8411492|NCT00950807|20732444|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
8411493|NCT00950807|20732445|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
8411494|NCT00950807|20732436|P10|NOT COMPLETED|Washout Period 2||0
8411495|NCT00950807|20732437|P9|NOT COMPLETED|Washout Period 2||0
8411496|NCT00950807|20732438|P8|NOT COMPLETED|Washout Period 2||1
8411497|NCT00950807|20732439|P7|NOT COMPLETED|Washout Period 2||1
8411498|NCT00950807|20732440|P6|NOT COMPLETED|Washout Period 2||0
8411499|NCT00950807|20732441|P5|NOT COMPLETED|Washout Period 2||1
8411500|NCT00950807|20732442|P4|NOT COMPLETED|Washout Period 2||1
8411501|NCT00950807|20732443|P3|NOT COMPLETED|Washout Period 2||0
8411502|NCT00950807|20732444|P2|NOT COMPLETED|Washout Period 2||1
8411503|NCT00950807|20732445|P1|NOT COMPLETED|Washout Period 2||4
8411504|NCT00950807|20732436|P10|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
8411505|NCT00950807|20732437|P9|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
8411506|NCT00950807|20732438|P8|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
8411507|NCT00950807|20732439|P7|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
8411508|NCT00950807|20732440|P6|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
8411509|NCT00950807|20732441|P5|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
8411510|NCT00950807|20732442|P4|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
8411511|NCT00950807|20732443|P3|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
8411512|NCT00950807|20732444|P2|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
8411513|NCT00950807|20732445|P1|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
8411514|NCT00950807|20732436|P10|STARTED|Washout Period 2||11
8411515|NCT00950807|20732437|P9|STARTED|Washout Period 2||11
8411516|NCT00950807|20732438|P8|STARTED|Washout Period 2||10
8411517|NCT00950807|20732439|P7|STARTED|Washout Period 2||9
8411518|NCT00950807|20732440|P6|STARTED|Washout Period 2||9
8411519|NCT00950807|20732441|P5|STARTED|Washout Period 2||13
8411520|NCT00950807|20732442|P4|STARTED|Washout Period 2||12
8411521|NCT00950807|20732443|P3|STARTED|Washout Period 2||10
8411522|NCT00950807|20732444|P2|STARTED|Washout Period 2||12
8411523|NCT00950807|20732445|P1|STARTED|Washout Period 2||51
8411524|NCT00950807|20732436|P10|NOT COMPLETED|Treatment Period 2||0
8411525|NCT00950807|20732437|P9|NOT COMPLETED|Treatment Period 2||0
8411526|NCT00950807|20732438|P8|NOT COMPLETED|Treatment Period 2||3
8411527|NCT00950807|20732439|P7|NOT COMPLETED|Treatment Period 2||1
8411528|NCT00950807|20732440|P6|NOT COMPLETED|Treatment Period 2||1
8411529|NCT00950807|20732441|P5|NOT COMPLETED|Treatment Period 2||0
8411530|NCT00950807|20732442|P4|NOT COMPLETED|Treatment Period 2||1
8411531|NCT00950807|20732443|P3|NOT COMPLETED|Treatment Period 2||0
8411532|NCT00950807|20732444|P2|NOT COMPLETED|Treatment Period 2||1
8411533|NCT00950807|20732445|P1|NOT COMPLETED|Treatment Period 2||2
8411534|NCT00950807|20732436|P10|COMPLETED|Treatment Period 2||11
8411535|NCT00950807|20732437|P9|COMPLETED|Treatment Period 2||11
8411536|NCT00950807|20732438|P8|COMPLETED|Treatment Period 2||10
8411537|NCT00950807|20732439|P7|COMPLETED|Treatment Period 2||9
8411538|NCT00950807|20732440|P6|COMPLETED|Treatment Period 2||9
8411539|NCT00950807|20732441|P5|COMPLETED|Treatment Period 2||13
8411540|NCT00950807|20732442|P4|COMPLETED|Treatment Period 2||12
8411541|NCT00950807|20732443|P3|COMPLETED|Treatment Period 2||10
8411542|NCT00950807|20732444|P2|COMPLETED|Treatment Period 2||12
8411543|NCT00950807|20732445|P1|COMPLETED|Treatment Period 2||51
8411544|NCT00950807|20732436|P10|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
8411545|NCT00950807|20732437|P9|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
8411546|NCT00950807|20732438|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
8411547|NCT00950807|20732439|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
8411548|NCT00950807|20732440|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
8411549|NCT00950807|20732441|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
8411626|NCT00950729|20732530|P1|NOT COMPLETED|Driving With Aircast||0
8411550|NCT00950807|20732442|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
8411551|NCT00950807|20732443|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
8411552|NCT00950807|20732444|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
8411553|NCT00950807|20732445|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
8411554|NCT00950807|20732436|P10|NOT COMPLETED|Washout Period 1||0
8411555|NCT00950807|20732437|P9|NOT COMPLETED|Washout Period 1||1
8411556|NCT00950807|20732438|P8|NOT COMPLETED|Washout Period 1||1
8411557|NCT00950807|20732439|P7|NOT COMPLETED|Washout Period 1||2
8411558|NCT00950807|20732440|P6|NOT COMPLETED|Washout Period 1||0
8411559|NCT00950807|20732441|P5|NOT COMPLETED|Washout Period 1||1
8411560|NCT00950807|20732442|P4|NOT COMPLETED|Washout Period 1||1
8411561|NCT00950807|20732443|P3|NOT COMPLETED|Washout Period 1||0
8411562|NCT00950807|20732444|P2|NOT COMPLETED|Washout Period 1||0
8411563|NCT00950807|20732445|P1|NOT COMPLETED|Washout Period 1||5
8411564|NCT00950807|20732436|P10|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
8411565|NCT00950807|20732437|P9|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
8411566|NCT00950807|20732438|P8|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
8411567|NCT00950807|20732439|P7|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
8411568|NCT00950807|20732440|P6|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
8411569|NCT00950807|20732441|P5|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
8411570|NCT00950807|20732442|P4|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
8411571|NCT00950807|20732443|P3|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
8411572|NCT00950807|20732444|P2|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
8411573|NCT00950807|20732445|P1|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
8411574|NCT00950807|20732436|P10|STARTED|Washout Period 1||13
8411575|NCT00950807|20732437|P9|STARTED|Washout Period 1||12
8411576|NCT00950807|20732438|P8|STARTED|Washout Period 1||14
8411577|NCT00950807|20732439|P7|STARTED|Washout Period 1||12
8411578|NCT00950807|20732440|P6|STARTED|Washout Period 1||11
8411579|NCT00950807|20732441|P5|STARTED|Washout Period 1||12
8411580|NCT00950807|20732442|P4|STARTED|Washout Period 1||12
8411581|NCT00950807|20732443|P3|STARTED|Washout Period 1||13
8411582|NCT00950807|20732444|P2|STARTED|Washout Period 1||13
8411583|NCT00950807|20732445|P1|STARTED|Washout Period 1||56
8411584|NCT00950807|20732436|P10|NOT COMPLETED|Treatment Period 1||0
8411585|NCT00950807|20732437|P9|NOT COMPLETED|Treatment Period 1||1
8411586|NCT00950807|20732438|P8|NOT COMPLETED|Treatment Period 1||0
8411587|NCT00950807|20732439|P7|NOT COMPLETED|Treatment Period 1||0
8411588|NCT00950807|20732440|P6|NOT COMPLETED|Treatment Period 1||2
8411589|NCT00950807|20732441|P5|NOT COMPLETED|Treatment Period 1||1
8411590|NCT00950807|20732442|P4|NOT COMPLETED|Treatment Period 1||0
8411591|NCT00950807|20732443|P3|NOT COMPLETED|Treatment Period 1||1
8411592|NCT00950807|20732444|P2|NOT COMPLETED|Treatment Period 1||0
8411593|NCT00950807|20732445|P1|NOT COMPLETED|Treatment Period 1||3
8411594|NCT00950807|20732436|P10|COMPLETED|Treatment Period 1||13
8411595|NCT00950807|20732437|P9|COMPLETED|Treatment Period 1||12
8411596|NCT00950807|20732438|P8|COMPLETED|Treatment Period 1||14
8411597|NCT00950807|20732439|P7|COMPLETED|Treatment Period 1||12
8411598|NCT00950807|20732440|P6|COMPLETED|Treatment Period 1||11
8411599|NCT00950807|20732441|P5|COMPLETED|Treatment Period 1||12
8411600|NCT00950807|20732442|P4|COMPLETED|Treatment Period 1||12
8411601|NCT00950807|20732443|P3|COMPLETED|Treatment Period 1||13
8411602|NCT00950807|20732444|P2|COMPLETED|Treatment Period 1||13
8411603|NCT00950807|20732445|P1|COMPLETED|Treatment Period 1||56
8411604|NCT00950807|20732436|P10|STARTED|Treatment Period 1||13
8411605|NCT00950807|20732437|P9|STARTED|Treatment Period 1||13
8411606|NCT00950807|20732438|P8|STARTED|Treatment Period 1||14
8411607|NCT00950807|20732439|P7|STARTED|Treatment Period 1||12
8411608|NCT00950807|20732440|P6|STARTED|Treatment Period 1||13
8411609|NCT00950807|20732441|P5|STARTED|Treatment Period 1||13
8411610|NCT00950807|20732442|P4|STARTED|Treatment Period 1||12
8411611|NCT00950807|20732443|P3|STARTED|Treatment Period 1||14
8411612|NCT00950807|20732444|P2|STARTED|Treatment Period 1||13
8411613|NCT00950807|20732445|P1|STARTED|Treatment Period 1||59
8411614|NCT00950755|20732487|P1|NOT COMPLETED|Long-Term Follow-Up||9
8411615|NCT00950755|20732487|P1|COMPLETED|Long-Term Follow-Up||9
8411616|NCT00950755|20732487|P1|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
8411617|NCT00950755|20732487|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
8411618|NCT00950755|20732487|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
8411619|NCT00950755|20732487|P1|STARTED|Dosimetric and Therapeutic Treatment||41
8411620|NCT00950742|20732513|P2|NOT COMPLETED|Overall Study||2
8411621|NCT00950742|20732514|P1|NOT COMPLETED|Overall Study||16
8411622|NCT00950742|20732513|P2|COMPLETED|Overall Study||0
8411623|NCT00950742|20732514|P1|COMPLETED|Overall Study||0
8411624|NCT00950742|20732513|P2|STARTED|Overall Study|entered and treated|2
8411625|NCT00950742|20732514|P1|STARTED|Overall Study|entered and treated|16
8411627|NCT00950729|20732530|P1|COMPLETED|Driving With Aircast||48
8411628|NCT00950729|20732530|P1|STARTED|Driving With Aircast||48
8411629|NCT00950729|20732530|P1|NOT COMPLETED|Driving With Plaster Cast||0
8411630|NCT00950729|20732530|P1|COMPLETED|Driving With Plaster Cast||48
8411631|NCT00950729|20732530|P1|STARTED|Driving With Plaster Cast||48
8411632|NCT00950729|20732530|P1|NOT COMPLETED|Driving With Running Shoes||0
8411633|NCT00950729|20732530|P1|COMPLETED|Driving With Running Shoes|June 2007|48
8411634|NCT00950729|20732530|P1|STARTED|Driving With Running Shoes|March 2007|48
8411638|NCT00950664|20732542|P2|NOT COMPLETED|Second Intervention||48
8411639|NCT00950664|20732543|P1|NOT COMPLETED|Second Intervention||46
8411640|NCT00950664|20732542|P2|COMPLETED|Second Intervention||0
8411641|NCT00950664|20732543|P1|COMPLETED|Second Intervention||0
8411642|NCT00950664|20732542|P2|STARTED|Second Intervention||48
8411643|NCT00950664|20732543|P1|STARTED|Second Intervention||46
8411644|NCT00950664|20732542|P2|NOT COMPLETED|Washout Period of 4 Weeks||0
8411645|NCT00950664|20732543|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
8411646|NCT00950664|20732542|P2|COMPLETED|Washout Period of 4 Weeks||48
8411647|NCT00950664|20732543|P1|COMPLETED|Washout Period of 4 Weeks||46
8411648|NCT00950664|20732542|P2|STARTED|Washout Period of 4 Weeks||48
8411649|NCT00950664|20732543|P1|STARTED|Washout Period of 4 Weeks||46
8411650|NCT00950664|20732542|P2|NOT COMPLETED|First Intervention||5
8411651|NCT00950664|20732543|P1|NOT COMPLETED|First Intervention||3
8411652|NCT00950664|20732542|P2|COMPLETED|First Intervention||48
8411653|NCT00950664|20732543|P1|COMPLETED|First Intervention||46
8411654|NCT00950664|20732542|P2|STARTED|First Intervention||53
8411655|NCT00950664|20732543|P1|STARTED|First Intervention||49
8411656|NCT00950651|20732563|P2|NOT COMPLETED|Overall Study||35
8411657|NCT00950651|20732564|P1|NOT COMPLETED|Overall Study||31
8411658|NCT00950651|20732563|P2|COMPLETED|Overall Study||181
8411659|NCT00950651|20732564|P1|COMPLETED|Overall Study||184
8411660|NCT00950651|20732563|P2|STARTED|Overall Study|216 patients randomized but one never took study medication|216
8411661|NCT00950651|20732564|P1|STARTED|Overall Study||215
8411662|NCT00950612|20732612|P2|NOT COMPLETED|Overall Study||0
8411663|NCT00950612|20732613|P1|NOT COMPLETED|Overall Study||0
8411664|NCT00950612|20732612|P2|COMPLETED|Overall Study||20
8411665|NCT00950612|20732613|P1|COMPLETED|Overall Study||40
8411666|NCT00950612|20732612|P2|STARTED|Overall Study||20
8411667|NCT00950612|20732613|P1|STARTED|Overall Study||40
8411668|NCT00950599|20732657|P10|NOT COMPLETED|Follow-Up Period||2
8411669|NCT00950599|20732658|P9|NOT COMPLETED|Follow-Up Period||13
8411670|NCT00950599|20732659|P8|NOT COMPLETED|Follow-Up Period||0
8411671|NCT00950599|20732660|P7|NOT COMPLETED|Follow-Up Period||0
8411672|NCT00950599|20732661|P6|NOT COMPLETED|Follow-Up Period||0
8411673|NCT00950599|20732662|P5|NOT COMPLETED|Follow-Up Period||0
8411674|NCT00950599|20732663|P4|NOT COMPLETED|Follow-Up Period||0
8411675|NCT00950599|20732664|P3|NOT COMPLETED|Follow-Up Period||0
8411676|NCT00950599|20732665|P2|NOT COMPLETED|Follow-Up Period||0
8411677|NCT00950599|20732666|P1|NOT COMPLETED|Follow-Up Period||0
8411678|NCT00950599|20732657|P10|COMPLETED|Follow-Up Period||78
8411679|NCT00950599|20732658|P9|COMPLETED|Follow-Up Period||296
8411680|NCT00950599|20732659|P8|COMPLETED|Follow-Up Period||0
8411681|NCT00950599|20732660|P7|COMPLETED|Follow-Up Period||0
8411682|NCT00950599|20732661|P6|COMPLETED|Follow-Up Period||0
8411683|NCT00950599|20732662|P5|COMPLETED|Follow-Up Period||0
8411684|NCT00950599|20732663|P4|COMPLETED|Follow-Up Period||0
8411685|NCT00950599|20732664|P3|COMPLETED|Follow-Up Period||0
8411686|NCT00950599|20732665|P2|COMPLETED|Follow-Up Period||0
8411687|NCT00950599|20732666|P1|COMPLETED|Follow-Up Period||0
8411688|NCT00950599|20732657|P10|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
8411689|NCT00950599|20732658|P9|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
8411690|NCT00950599|20732659|P8|STARTED|Follow-Up Period||0
8411691|NCT00950599|20732660|P7|STARTED|Follow-Up Period||0
8411692|NCT00950599|20732661|P6|STARTED|Follow-Up Period||0
8411693|NCT00950599|20732662|P5|STARTED|Follow-Up Period||0
8411694|NCT00950599|20732663|P4|STARTED|Follow-Up Period||0
8411695|NCT00950599|20732664|P3|STARTED|Follow-Up Period||0
8411696|NCT00950599|20732665|P2|STARTED|Follow-Up Period||0
8411697|NCT00950599|20732666|P1|STARTED|Follow-Up Period||0
8411698|NCT00950599|20732657|P10|NOT COMPLETED|Double-Blind Treatment Period||0
8411699|NCT00950599|20732658|P9|NOT COMPLETED|Double-Blind Treatment Period||0
8411700|NCT00950599|20732659|P8|NOT COMPLETED|Double-Blind Treatment Period||6
8411701|NCT00950599|20732660|P7|NOT COMPLETED|Double-Blind Treatment Period||0
8411702|NCT00950599|20732661|P6|NOT COMPLETED|Double-Blind Treatment Period||12
8411703|NCT00950599|20732662|P5|NOT COMPLETED|Double-Blind Treatment Period||7
8411704|NCT00950599|20732663|P4|NOT COMPLETED|Double-Blind Treatment Period||11
8411705|NCT00950599|20732664|P3|NOT COMPLETED|Double-Blind Treatment Period||9
8411706|NCT00950599|20732665|P2|NOT COMPLETED|Double-Blind Treatment Period||10
8411707|NCT00950599|20732666|P1|NOT COMPLETED|Double-Blind Treatment Period||7
8411708|NCT00950599|20732657|P10|COMPLETED|Double-Blind Treatment Period||0
8411709|NCT00950599|20732658|P9|COMPLETED|Double-Blind Treatment Period||0
8411710|NCT00950599|20732659|P8|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
8411711|NCT00950599|20732660|P7|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
8411712|NCT00950599|20732661|P6|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
8411713|NCT00950599|20732662|P5|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
8411714|NCT00950599|20732663|P4|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
8411715|NCT00950599|20732664|P3|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
8411716|NCT00950599|20732665|P2|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
8411717|NCT00950599|20732666|P1|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
8411718|NCT00950599|20732657|P10|STARTED|Double-Blind Treatment Period||0
8411719|NCT00950599|20732658|P9|STARTED|Double-Blind Treatment Period||0
8411720|NCT00950599|20732659|P8|STARTED|Double-Blind Treatment Period||41
8411721|NCT00950599|20732660|P7|STARTED|Double-Blind Treatment Period||44
8411722|NCT00950599|20732661|P6|STARTED|Double-Blind Treatment Period||67
8411723|NCT00950599|20732662|P5|STARTED|Double-Blind Treatment Period||52
8411724|NCT00950599|20732663|P4|STARTED|Double-Blind Treatment Period||54
8411725|NCT00950599|20732664|P3|STARTED|Double-Blind Treatment Period||63
8411726|NCT00950599|20732665|P2|STARTED|Double-Blind Treatment Period||47
8411727|NCT00950599|20732666|P1|STARTED|Double-Blind Treatment Period||55
8411728|NCT00950365|20733230|P2|NOT COMPLETED|Overall Study||2
8411729|NCT00950365|20733231|P1|NOT COMPLETED|Overall Study||2
8411730|NCT00950365|20733230|P2|COMPLETED|Overall Study||50
8411731|NCT00950365|20733231|P1|COMPLETED|Overall Study||25
8411732|NCT00950365|20733230|P2|STARTED|Overall Study||52
8411733|NCT00950365|20733231|P1|STARTED|Overall Study||27
8411734|NCT00950352|20733243|P2|NOT COMPLETED|Overall Study||11
8411735|NCT00950352|20733244|P1|NOT COMPLETED|Overall Study||42
8411736|NCT00950352|20733243|P2|COMPLETED|Overall Study||21
8411737|NCT00950352|20733244|P1|COMPLETED|Overall Study||30
8411738|NCT00950352|20733243|P2|STARTED|Overall Study||32
8411739|NCT00950352|20733244|P1|STARTED|Overall Study||72
8411740|NCT00950300|20733252|P2|NOT COMPLETED|SFU Period||78
8411741|NCT00950300|20733253|P1|NOT COMPLETED|SFU Period||78
8411742|NCT00950300|20733252|P2|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
8411743|NCT00950300|20733253|P1|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
8411744|NCT00950300|20733252|P2|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
8411745|NCT00950300|20733253|P1|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
8411746|NCT00950300|20733252|P2|NOT COMPLETED|TFFU Period||107
8411747|NCT00950300|20733253|P1|NOT COMPLETED|TFFU Period||100
8411748|NCT00950300|20733252|P2|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
8411749|NCT00950300|20733253|P1|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
8411750|NCT00950300|20733252|P2|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
8411751|NCT00950300|20733253|P1|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
8411752|NCT00950300|20733252|P2|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
8411753|NCT00950300|20733253|P1|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
8411754|NCT00950300|20733252|P2|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
8411755|NCT00950300|20733253|P1|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
8411756|NCT00950300|20733252|P2|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
8411757|NCT00950300|20733253|P1|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
8411758|NCT00950300|20733252|P2|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
8411759|NCT00950300|20733253|P1|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
8411760|NCT00950300|20733252|P2|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
8411761|NCT00950300|20733253|P1|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
8411762|NCT00950300|20733252|P2|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
8411763|NCT00950300|20733253|P1|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
8411764|NCT00950248|20733302|P3|NOT COMPLETED|Year 2&3 Treatment Randomization||5
8411765|NCT00950248|20733303|P2|NOT COMPLETED|Year 2&3 Treatment Randomization||6
8411766|NCT00950248|20733304|P1|NOT COMPLETED|Year 2&3 Treatment Randomization||0
8411767|NCT00950248|20733302|P3|COMPLETED|Year 2&3 Treatment Randomization||33
8411768|NCT00950248|20733303|P2|COMPLETED|Year 2&3 Treatment Randomization||33
8411769|NCT00950248|20733304|P1|COMPLETED|Year 2&3 Treatment Randomization||0
8411770|NCT00950248|20733302|P3|STARTED|Year 2&3 Treatment Randomization||38
8411771|NCT00950248|20733303|P2|STARTED|Year 2&3 Treatment Randomization||39
8411772|NCT00950248|20733304|P1|STARTED|Year 2&3 Treatment Randomization||0
8411773|NCT00950248|20733302|P3|NOT COMPLETED|Year 1: Baseline||0
8411774|NCT00950248|20733303|P2|NOT COMPLETED|Year 1: Baseline||0
8411775|NCT00950248|20733304|P1|NOT COMPLETED|Year 1: Baseline||8
8411776|NCT00950248|20733302|P3|COMPLETED|Year 1: Baseline||0
8411777|NCT00950248|20733303|P2|COMPLETED|Year 1: Baseline||0
8411778|NCT00950248|20733304|P1|COMPLETED|Year 1: Baseline||77
8411779|NCT00950248|20733302|P3|STARTED|Year 1: Baseline||0
8411780|NCT00950248|20733303|P2|STARTED|Year 1: Baseline||0
8411781|NCT00950248|20733304|P1|STARTED|Year 1: Baseline||85
8411782|NCT00950235|20733325|P2|NOT COMPLETED|Overall Study||4
8411783|NCT00950235|20733326|P1|NOT COMPLETED|Overall Study||2
8411784|NCT00950235|20733325|P2|COMPLETED|Overall Study||54
8411785|NCT00950235|20733326|P1|COMPLETED|Overall Study||58
8411786|NCT00950235|20733325|P2|STARTED|Overall Study||58
8411787|NCT00950235|20733326|P1|STARTED|Overall Study||60
8411788|NCT00950183|20733336|P1|NOT COMPLETED|Overall Study||36
8411789|NCT00950183|20733336|P1|COMPLETED|Overall Study||0
8411790|NCT00950183|20733336|P1|STARTED|Overall Study||36
8411791|NCT00950170|20733344|P1|NOT COMPLETED|Overall Study||4
8411792|NCT00950170|20733344|P1|COMPLETED|Overall Study||19
8411793|NCT00950170|20733344|P1|STARTED|Overall Study||23
8411794|NCT00949988|20733395|P1|NOT COMPLETED|Overall Study||3
8411795|NCT00949988|20733395|P1|COMPLETED|Overall Study||0
8411796|NCT00949988|20733395|P1|STARTED|Overall Study||3
8411797|NCT00949975|20733410|P4|NOT COMPLETED|Overall Study||28
8411798|NCT00949975|20733411|P3|NOT COMPLETED|Overall Study||19
8411799|NCT00949975|20733412|P2|NOT COMPLETED|Overall Study||29
8411800|NCT00949975|20733413|P1|NOT COMPLETED|Overall Study||27
8411801|NCT00949975|20733410|P4|COMPLETED|Overall Study||190
8411802|NCT00949975|20733411|P3|COMPLETED|Overall Study||183
8411803|NCT00949975|20733412|P2|COMPLETED|Overall Study||177
8411804|NCT00949975|20733413|P1|COMPLETED|Overall Study||185
8411805|NCT00949975|20733410|P4|STARTED|Overall Study||218
8411806|NCT00949975|20733411|P3|STARTED|Overall Study||202
8411807|NCT00949975|20733412|P2|STARTED|Overall Study||206
8411808|NCT00949975|20733413|P1|STARTED|Overall Study||212
8411809|NCT00949910|20733531|P1|NOT COMPLETED|Overall Study||6576
8411810|NCT00949910|20733531|P1|COMPLETED|Overall Study||10
8411811|NCT00949910|20733531|P1|STARTED|Overall Study||6586
8411812|NCT00949884|20733544|P3|NOT COMPLETED|Overall Study||58
8411813|NCT00949884|20733545|P2|NOT COMPLETED|Overall Study||15
8411814|NCT00949884|20733546|P1|NOT COMPLETED|Overall Study||50
8411815|NCT00949884|20733544|P3|COMPLETED|Overall Study||411
8411816|NCT00949884|20733545|P2|COMPLETED|Overall Study||37
8411817|NCT00949884|20733546|P1|COMPLETED|Overall Study||370
8411818|NCT00949884|20733544|P3|STARTED|Overall Study||469
8411819|NCT00949884|20733545|P2|STARTED|Overall Study||52
8411820|NCT00949884|20733546|P1|STARTED|Overall Study||420
8411821|NCT00949715|20733601|P2|NOT COMPLETED|Overall Study||0
8411822|NCT00949715|20733602|P1|NOT COMPLETED|Overall Study||4
8411823|NCT00949715|20733601|P2|COMPLETED|Overall Study||33
8411824|NCT00949715|20733602|P1|COMPLETED|Overall Study||28
8411825|NCT00949715|20733601|P2|STARTED|Overall Study||33
8411826|NCT00949715|20733602|P1|STARTED|Overall Study||32
8411827|NCT00949702|20733613|P1|NOT COMPLETED|Overall Study||48
8411828|NCT00949702|20733613|P1|COMPLETED|Overall Study||84
8411829|NCT00949702|20733613|P1|STARTED|Overall Study||132
8411830|NCT00949650|20733630|P2|NOT COMPLETED|Overall Study||115
8411831|NCT00949650|20733631|P1|NOT COMPLETED|Overall Study||230
8411832|NCT00949650|20733630|P2|COMPLETED|Overall Study||0
8411833|NCT00949650|20733631|P1|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
8411834|NCT00949650|20733630|P2|STARTED|Overall Study|Treated patients.|115
8411835|NCT00949650|20733631|P1|STARTED|Overall Study|Treated patients.|230
8411836|NCT00949533|20733669|P2|NOT COMPLETED|Overall Study||1
8411837|NCT00949533|20733670|P1|NOT COMPLETED|Overall Study||0
8411838|NCT00949533|20733669|P2|COMPLETED|Overall Study||17
8411839|NCT00949533|20733670|P1|COMPLETED|Overall Study||19
8411840|NCT00949533|20733669|P2|STARTED|Overall Study||18
8411841|NCT00949533|20733670|P1|STARTED|Overall Study||19
8411842|NCT00949403|20733682|P1|NOT COMPLETED|Overall Study||0
8411843|NCT00949403|20733682|P1|COMPLETED|Overall Study||9
8411844|NCT00949403|20733682|P1|STARTED|Overall Study||9
8411845|NCT00949325|20733686|P3|NOT COMPLETED|Overall Study||0
8411846|NCT00949325|20733687|P2|NOT COMPLETED|Overall Study||2
8411847|NCT00949325|20733688|P1|NOT COMPLETED|Overall Study||0
8411848|NCT00949325|20733686|P3|COMPLETED|Overall Study||3
8411849|NCT00949325|20733687|P2|COMPLETED|Overall Study||16
8411850|NCT00949325|20733688|P1|COMPLETED|Overall Study||3
8411851|NCT00949325|20733686|P3|STARTED|Overall Study||3
8411852|NCT00949325|20733687|P2|STARTED|Overall Study||18
8411853|NCT00949325|20733688|P1|STARTED|Overall Study||3
8411854|NCT00949234|20733706|P1|NOT COMPLETED|Overall Study||42
8411855|NCT00949234|20733706|P1|COMPLETED|Overall Study||225
8411856|NCT00949234|20733706|P1|STARTED|Overall Study||267
8411857|NCT00949117|20733712|P2|NOT COMPLETED|Overall Study||5
8411858|NCT00949117|20733713|P1|NOT COMPLETED|Overall Study||3
8411859|NCT00949117|20733712|P2|COMPLETED|Overall Study||0
8411860|NCT00949117|20733713|P1|COMPLETED|Overall Study||1
8411861|NCT00949117|20733712|P2|STARTED|Overall Study||5
8411862|NCT00949117|20733713|P1|STARTED|Overall Study||4
8411863|NCT00949078|20733729|P2|NOT COMPLETED|Overall Study||0
8411864|NCT00949078|20733730|P1|NOT COMPLETED|Overall Study||0
8411865|NCT00949078|20733729|P2|COMPLETED|Overall Study||9
8411866|NCT00949078|20733730|P1|COMPLETED|Overall Study||5
8411867|NCT00949078|20733729|P2|STARTED|Overall Study||9
8411868|NCT00949078|20733730|P1|STARTED|Overall Study||5
8411869|NCT00948974|20733754|P2|NOT COMPLETED|Overall Study||20
8411870|NCT00948974|20733755|P1|NOT COMPLETED|Overall Study||23
8411871|NCT00948974|20733754|P2|COMPLETED|Overall Study||28
8411872|NCT00948974|20733755|P1|COMPLETED|Overall Study||17
8411873|NCT00948974|20733754|P2|STARTED|Overall Study||48
8411874|NCT00948974|20733755|P1|STARTED|Overall Study||40
8411875|NCT00948935|20733765|P1|NOT COMPLETED|Overall Study||0
8411876|NCT00948935|20733765|P1|COMPLETED|Overall Study||35
8411877|NCT00948935|20733765|P1|STARTED|Overall Study||35
8411878|NCT00948922|20733773|P3|NOT COMPLETED|Overall Study||1
8411879|NCT00948922|20733774|P2|NOT COMPLETED|Overall Study||14
8411880|NCT00948922|20733775|P1|NOT COMPLETED|Overall Study||8
8411881|NCT00948922|20733773|P3|COMPLETED|Overall Study||38
8411882|NCT00948922|20733774|P2|COMPLETED|Overall Study||37
8411883|NCT00948922|20733775|P1|COMPLETED|Overall Study||26
8411884|NCT00948922|20733773|P3|STARTED|Overall Study||39
8411885|NCT00948922|20733774|P2|STARTED|Overall Study||51
8411886|NCT00948922|20733775|P1|STARTED|Overall Study||34
8411887|NCT00948896|20733798|P8|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
8411888|NCT00948896|20733799|P7|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
8411889|NCT00948896|20733800|P6|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
8411890|NCT00948896|20733801|P5|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
8411891|NCT00948896|20733802|P4|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
8411892|NCT00948896|20733803|P3|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
8411893|NCT00948896|20733804|P2|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
8411894|NCT00948896|20733805|P1|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
8411895|NCT00948896|20733798|P8|COMPLETED|24 Months of Age to 36 Months of Age||45
8411896|NCT00948896|20733799|P7|COMPLETED|24 Months of Age to 36 Months of Age||43
8411897|NCT00948896|20733800|P6|COMPLETED|24 Months of Age to 36 Months of Age||40
8411898|NCT00948896|20733801|P5|COMPLETED|24 Months of Age to 36 Months of Age||43
8411899|NCT00948896|20733802|P4|COMPLETED|24 Months of Age to 36 Months of Age||85
8411900|NCT00948896|20733803|P3|COMPLETED|24 Months of Age to 36 Months of Age||85
8411901|NCT00948896|20733804|P2|COMPLETED|24 Months of Age to 36 Months of Age||83
8411902|NCT00948896|20733805|P1|COMPLETED|24 Months of Age to 36 Months of Age||87
8411903|NCT00948896|20733798|P8|STARTED|24 Months of Age to 36 Months of Age||45
8411904|NCT00948896|20733799|P7|STARTED|24 Months of Age to 36 Months of Age||43
8411905|NCT00948896|20733800|P6|STARTED|24 Months of Age to 36 Months of Age||42
8411906|NCT00948896|20733801|P5|STARTED|24 Months of Age to 36 Months of Age||44
8411907|NCT00948896|20733802|P4|STARTED|24 Months of Age to 36 Months of Age||87
8411908|NCT00948896|20733803|P3|STARTED|24 Months of Age to 36 Months of Age||90
8411909|NCT00948896|20733804|P2|STARTED|24 Months of Age to 36 Months of Age||85
8411910|NCT00948896|20733805|P1|STARTED|24 Months of Age to 36 Months of Age||90
8411911|NCT00948896|20733798|P8|NOT COMPLETED|Randomization to 24 Months of Age||2
8411912|NCT00948896|20733799|P7|NOT COMPLETED|Randomization to 24 Months of Age||4
8411913|NCT00948896|20733800|P6|NOT COMPLETED|Randomization to 24 Months of Age||4
8411914|NCT00948896|20733801|P5|NOT COMPLETED|Randomization to 24 Months of Age||2
8411915|NCT00948896|20733802|P4|NOT COMPLETED|Randomization to 24 Months of Age||11
8411916|NCT00948896|20733803|P3|NOT COMPLETED|Randomization to 24 Months of Age||9
8411917|NCT00948896|20733804|P2|NOT COMPLETED|Randomization to 24 Months of Age||13
8411918|NCT00948896|20733805|P1|NOT COMPLETED|Randomization to 24 Months of Age||8
8411919|NCT00948896|20733798|P8|COMPLETED|Randomization to 24 Months of Age||45
8411920|NCT00948896|20733799|P7|COMPLETED|Randomization to 24 Months of Age||43
8411921|NCT00948896|20733800|P6|COMPLETED|Randomization to 24 Months of Age||42
8411922|NCT00948896|20733801|P5|COMPLETED|Randomization to 24 Months of Age||44
8411923|NCT00948896|20733802|P4|COMPLETED|Randomization to 24 Months of Age||87
8411924|NCT00948896|20733803|P3|COMPLETED|Randomization to 24 Months of Age||90
8411925|NCT00948896|20733804|P2|COMPLETED|Randomization to 24 Months of Age||85
8411926|NCT00948896|20733805|P1|COMPLETED|Randomization to 24 Months of Age||90
8411927|NCT00948896|20733798|P8|STARTED|Randomization to 24 Months of Age||47
8411928|NCT00948896|20733799|P7|STARTED|Randomization to 24 Months of Age||47
8411929|NCT00948896|20733800|P6|STARTED|Randomization to 24 Months of Age||46
8411930|NCT00948896|20733801|P5|STARTED|Randomization to 24 Months of Age||46
8411931|NCT00948896|20733802|P4|STARTED|Randomization to 24 Months of Age||98
8411932|NCT00948896|20733803|P3|STARTED|Randomization to 24 Months of Age||99
8411933|NCT00948896|20733804|P2|STARTED|Randomization to 24 Months of Age||98
8411934|NCT00948896|20733805|P1|STARTED|Randomization to 24 Months of Age||98
8411935|NCT00948857|20733841|P2|NOT COMPLETED|Overall Study||0
8411936|NCT00948857|20733842|P1|NOT COMPLETED|Overall Study||1
8411937|NCT00948857|20733841|P2|COMPLETED|Overall Study||2
8411938|NCT00948857|20733842|P1|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
8411939|NCT00948857|20733841|P2|STARTED|Overall Study||2
8411940|NCT00948857|20733842|P1|STARTED|Overall Study||3
8411941|NCT00948818|20733850|P2|NOT COMPLETED|Overall Study||94
8411942|NCT00948818|20733851|P1|NOT COMPLETED|Overall Study||62
8411943|NCT00948818|20733850|P2|COMPLETED|Overall Study||312
8411944|NCT00948818|20733851|P1|COMPLETED|Overall Study||335
8411945|NCT00948818|20733850|P2|STARTED|Overall Study||406
8411946|NCT00948818|20733851|P1|STARTED|Overall Study||397
8411947|NCT00948792|20733886|P1|NOT COMPLETED|Overall Study||0
8411948|NCT00948792|20733886|P1|COMPLETED|Overall Study||21
8411949|NCT00948792|20733886|P1|STARTED|Overall Study||21
8411950|NCT00948766|20733898|P2|NOT COMPLETED|Extension Study||0
8411951|NCT00948766|20733899|P1|NOT COMPLETED|Extension Study||91
8411952|NCT00948766|20733898|P2|COMPLETED|Extension Study||0
8411953|NCT00948766|20733899|P1|COMPLETED|Extension Study||306
8411954|NCT00948766|20733898|P2|Exposed to Study Medication|Extension Study||0
8411955|NCT00948766|20733899|P1|Exposed to Study Medication|Extension Study||396
8411956|NCT00948766|20733898|P2|STARTED|Extension Study|No patients received this treatment in the extension study.|0
8411957|NCT00948766|20733899|P1|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
8411958|NCT00948766|20733898|P2|NOT COMPLETED|Core Study||126
8411959|NCT00948766|20733899|P1|NOT COMPLETED|Core Study||127
8411960|NCT00948766|20733898|P2|COMPLETED|Core Study||234
8411961|NCT00948766|20733899|P1|COMPLETED|Core Study||229
8411962|NCT00948766|20733898|P2|Exposed to Study Medication|Core Study||359
8411963|NCT00948766|20733899|P1|Exposed to Study Medication|Core Study||355
8411964|NCT00948766|20733898|P2|STARTED|Core Study||360
8411965|NCT00948766|20733899|P1|STARTED|Core Study||356
8411966|NCT00948688|20733915|P2|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
8411967|NCT00948688|20733916|P1|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
8411968|NCT00948688|20733915|P2|COMPLETED|Period 2: 100 mg Vorinostat||5
8411969|NCT00948688|20733916|P1|COMPLETED|Period 2: 100 mg Vorinostat||0
8411970|NCT00948688|20733915|P2|STARTED|Period 2: 100 mg Vorinostat||6
8411971|NCT00948688|20733916|P1|STARTED|Period 2: 100 mg Vorinostat||0
8411972|NCT00948688|20733915|P2|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
8411973|NCT00948688|20733916|P1|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
8411974|NCT00948688|20733915|P2|COMPLETED|Period 1: 200 mg Vorinostat||0
8411975|NCT00948688|20733916|P1|COMPLETED|Period 1: 200 mg Vorinostat||2
8411976|NCT00948688|20733915|P2|STARTED|Period 1: 200 mg Vorinostat||0
8411977|NCT00948688|20733916|P1|STARTED|Period 1: 200 mg Vorinostat||4
8411984|NCT00948610|20733947|P2|NOT COMPLETED|Overall Study||1
8411985|NCT00948610|20733948|P1|NOT COMPLETED|Overall Study||1
8411986|NCT00948610|20733947|P2|COMPLETED|Overall Study||9
8411987|NCT00948610|20733948|P1|COMPLETED|Overall Study||9
8411988|NCT00948610|20733947|P2|STARTED|Overall Study||10
8411989|NCT00948610|20733948|P1|STARTED|Overall Study||10
8411990|NCT00948506|20733958|P2|NOT COMPLETED|Overall Study||1
8411991|NCT00948506|20733959|P1|NOT COMPLETED|Overall Study||3
8411992|NCT00948506|20733958|P2|COMPLETED|Overall Study||8
8411993|NCT00948506|20733959|P1|COMPLETED|Overall Study||8
8411994|NCT00948506|20733958|P2|STARTED|Overall Study||9
8411995|NCT00948506|20733959|P1|STARTED|Overall Study||11
8411996|NCT00948441|20733970|P2|NOT COMPLETED|Overall Study||4
8411997|NCT00948441|20733971|P1|NOT COMPLETED|Overall Study||1
8411998|NCT00948441|20733970|P2|COMPLETED|Overall Study||4
8411999|NCT00948441|20733971|P1|COMPLETED|Overall Study||7
8412000|NCT00948441|20733970|P2|STARTED|Overall Study||8
8412001|NCT00948441|20733971|P1|STARTED|Overall Study||8
8412002|NCT00948428|20733982|P3|NOT COMPLETED|Overall Study||8
8412003|NCT00948428|20733983|P2|NOT COMPLETED|Overall Study||18
8412004|NCT00948428|20733984|P1|NOT COMPLETED|Overall Study||18
8412005|NCT00948428|20733982|P3|COMPLETED|Overall Study||84
8412006|NCT00948428|20733983|P2|COMPLETED|Overall Study||167
8412007|NCT00948428|20733984|P1|COMPLETED|Overall Study||167
8412008|NCT00948428|20733982|P3|STARTED|Overall Study||92
8412009|NCT00948428|20733983|P2|STARTED|Overall Study||185
8412010|NCT00948428|20733984|P1|STARTED|Overall Study||185
8412011|NCT00948389|20734003|P5|NOT COMPLETED|Overall Study||1
8412012|NCT00948389|20734004|P4|NOT COMPLETED|Overall Study||9
8412013|NCT00948389|20734005|P3|NOT COMPLETED|Overall Study||7
8412014|NCT00948389|20734006|P2|NOT COMPLETED|Overall Study||3
8412015|NCT00948389|20734007|P1|NOT COMPLETED|Overall Study||6
8412016|NCT00948389|20734003|P5|COMPLETED|Overall Study||0
8412017|NCT00948389|20734004|P4|COMPLETED|Overall Study||0
8412018|NCT00948389|20734005|P3|COMPLETED|Overall Study||0
8412019|NCT00948389|20734006|P2|COMPLETED|Overall Study||0
8412020|NCT00948389|20734007|P1|COMPLETED|Overall Study||0
8412021|NCT00948389|20734003|P5|STARTED|Overall Study||1
8412022|NCT00948389|20734004|P4|STARTED|Overall Study||9
8412023|NCT00948389|20734005|P3|STARTED|Overall Study||7
8412024|NCT00948389|20734006|P2|STARTED|Overall Study||3
8412025|NCT00948389|20734007|P1|STARTED|Overall Study||6
8412026|NCT00948298|20734046|P2|NOT COMPLETED|Overall Study||5
8412027|NCT00948298|20734047|P1|NOT COMPLETED|Overall Study||10
8412028|NCT00948298|20734046|P2|COMPLETED|Overall Study||60
8412029|NCT00948298|20734047|P1|COMPLETED|Overall Study||55
8412030|NCT00948298|20734046|P2|STARTED|Overall Study||65
8412031|NCT00948298|20734047|P1|STARTED|Overall Study||65
8412032|NCT00948246|20734055|P1|NOT COMPLETED|Overall Study||24
8412033|NCT00948246|20734055|P1|COMPLETED|Overall Study||86
8412034|NCT00948246|20734055|P1|STARTED|Overall Study||110
8412035|NCT00948155|20734064|P2|NOT COMPLETED|Second Intervention 21 Days||3
8412036|NCT00948155|20734065|P1|NOT COMPLETED|Second Intervention 21 Days||2
8412037|NCT00948155|20734064|P2|COMPLETED|Second Intervention 21 Days||8
8412038|NCT00948155|20734065|P1|COMPLETED|Second Intervention 21 Days||9
8412039|NCT00948155|20734064|P2|STARTED|Second Intervention 21 Days||11
8412040|NCT00948155|20734065|P1|STARTED|Second Intervention 21 Days||11
8412041|NCT00948155|20734064|P2|NOT COMPLETED|Washout 14 Days||2
8412042|NCT00948155|20734065|P1|NOT COMPLETED|Washout 14 Days||1
8412043|NCT00948155|20734064|P2|COMPLETED|Washout 14 Days||11
8412044|NCT00948155|20734065|P1|COMPLETED|Washout 14 Days||11
8412045|NCT00948155|20734064|P2|STARTED|Washout 14 Days||13
8412046|NCT00948155|20734065|P1|STARTED|Washout 14 Days||12
8412047|NCT00948155|20734064|P2|NOT COMPLETED|First Intervention 21 Days||2
8412048|NCT00948155|20734065|P1|NOT COMPLETED|First Intervention 21 Days||2
8412049|NCT00948155|20734064|P2|COMPLETED|First Intervention 21 Days||13
8412050|NCT00948155|20734065|P1|COMPLETED|First Intervention 21 Days||12
8412051|NCT00948155|20734064|P2|STARTED|First Intervention 21 Days||15
8412052|NCT00948155|20734065|P1|STARTED|First Intervention 21 Days||14
8412053|NCT00948090|20734087|P4|NOT COMPLETED|Overall Study||11
8412054|NCT00948090|20734088|P3|NOT COMPLETED|Overall Study||56
8412055|NCT00948090|20734089|P2|NOT COMPLETED|Overall Study||1
8412056|NCT00948090|20734090|P1|NOT COMPLETED|Overall Study||43
8412057|NCT00948090|20734087|P4|COMPLETED|Overall Study||7
8412058|NCT00948090|20734088|P3|COMPLETED|Overall Study||67
8412059|NCT00948090|20734089|P2|COMPLETED|Overall Study||0
8412060|NCT00948090|20734090|P1|COMPLETED|Overall Study||22
8412061|NCT00948090|20734087|P4|STARTED|Overall Study||18
8412062|NCT00948090|20734088|P3|STARTED|Overall Study||123
8412063|NCT00948090|20734089|P2|STARTED|Overall Study||1
8412064|NCT00948090|20734090|P1|STARTED|Overall Study||65
8412065|NCT00948064|20734112|P3|NOT COMPLETED|Phase II||1
8412066|NCT00948064|20734113|P2|NOT COMPLETED|Phase II||1
8412067|NCT00948064|20734114|P1|NOT COMPLETED|Phase II||0
8412068|NCT00948064|20734112|P3|COMPLETED|Phase II||26
8412069|NCT00948064|20734113|P2|COMPLETED|Phase II||51
8412070|NCT00948064|20734114|P1|COMPLETED|Phase II||0
8412071|NCT00948064|20734112|P3|STARTED|Phase II||27
8412072|NCT00948064|20734113|P2|STARTED|Phase II||52
8412073|NCT00948064|20734114|P1|STARTED|Phase II||0
8412074|NCT00948064|20734112|P3|NOT COMPLETED|Phase I||0
8412075|NCT00948064|20734113|P2|NOT COMPLETED|Phase I||0
8412076|NCT00948064|20734114|P1|NOT COMPLETED|Phase I||1
8412077|NCT00948064|20734112|P3|COMPLETED|Phase I||0
8412078|NCT00948064|20734113|P2|COMPLETED|Phase I||0
8412079|NCT00948064|20734114|P1|COMPLETED|Phase I||30
8412080|NCT00948064|20734112|P3|STARTED|Phase I||0
8412081|NCT00948064|20734113|P2|STARTED|Phase I||0
8412082|NCT00948064|20734114|P1|STARTED|Phase I||31
8412083|NCT00948025|20734127|P2|NOT COMPLETED|Phase 2 (Comparative Phase)||0
8412084|NCT00948025|20734128|P1|NOT COMPLETED|Phase 2 (Comparative Phase)||0
8412085|NCT00948025|20734127|P2|COMPLETED|Phase 2 (Comparative Phase)||0
8412086|NCT00948025|20734128|P1|COMPLETED|Phase 2 (Comparative Phase)||0
8412087|NCT00948025|20734127|P2|STARTED|Phase 2 (Comparative Phase)||0
8412088|NCT00948025|20734128|P1|STARTED|Phase 2 (Comparative Phase)||0
8412089|NCT00948025|20734127|P2|NOT COMPLETED|Phase 1 (Pilot Phase)||3
8412090|NCT00948025|20734128|P1|NOT COMPLETED|Phase 1 (Pilot Phase)||9
8412091|NCT00948025|20734127|P2|COMPLETED|Phase 1 (Pilot Phase)||6
8412092|NCT00948025|20734128|P1|COMPLETED|Phase 1 (Pilot Phase)||5
8412093|NCT00948025|20734127|P2|STARTED|Phase 1 (Pilot Phase)||9
8412094|NCT00948025|20734128|P1|STARTED|Phase 1 (Pilot Phase)||14
8412095|NCT00947882|20734156|P4|NOT COMPLETED|Overall Study||82
8412096|NCT00947882|20734157|P3|NOT COMPLETED|Overall Study||79
8412097|NCT00947882|20734158|P2|NOT COMPLETED|Overall Study||77
8412098|NCT00947882|20734159|P1|NOT COMPLETED|Overall Study||74
8412099|NCT00947882|20734156|P4|COMPLETED|Overall Study||20
8412100|NCT00947882|20734157|P3|COMPLETED|Overall Study||22
8412101|NCT00947882|20734158|P2|COMPLETED|Overall Study||24
8412102|NCT00947882|20734159|P1|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
8412103|NCT00947882|20734156|P4|Visit 12, Month 6|Overall Study||95
8412104|NCT00947882|20734157|P3|Visit 12, Month 6|Overall Study||90
8412105|NCT00947882|20734158|P2|Visit 12, Month 6|Overall Study||91
8412106|NCT00947882|20734159|P1|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
8412107|NCT00947882|20734156|P4|Safety Analysis Set|Overall Study||105
8412108|NCT00947882|20734157|P3|Safety Analysis Set|Overall Study||100
8412109|NCT00947882|20734158|P2|Safety Analysis Set|Overall Study||101
8412110|NCT00947882|20734159|P1|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
8412111|NCT00947882|20734156|P4|Actual Treatment|Overall Study||105
8412112|NCT00947882|20734157|P3|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
8412113|NCT00947882|20734158|P2|Actual Treatment|Overall Study||101
8412114|NCT00947882|20734159|P1|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
8412115|NCT00947882|20734156|P4|Full Analysis Set (FAS)|Overall Study||102
8412116|NCT00947882|20734157|P3|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
8412117|NCT00947882|20734158|P2|Full Analysis Set (FAS)|Overall Study||101
8412118|NCT00947882|20734159|P1|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
8412119|NCT00947882|20734156|P4|STARTED|Overall Study||102
8412120|NCT00947882|20734157|P3|STARTED|Overall Study||101
8412121|NCT00947882|20734158|P2|STARTED|Overall Study||101
8412122|NCT00947882|20734159|P1|STARTED|Overall Study|Started: Randomised.|100
8412123|NCT00947856|20734187|P2|NOT COMPLETED|Follow-up Period||23
8412124|NCT00947856|20734188|P1|NOT COMPLETED|Follow-up Period||51
8412125|NCT00947856|20734187|P2|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
8412126|NCT00947856|20734188|P1|COMPLETED|Follow-up Period||27
8412127|NCT00947856|20734187|P2|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
8412128|NCT00947856|20734188|P1|STARTED|Follow-up Period||78
8412129|NCT00947856|20734187|P2|NOT COMPLETED|Treatment Period||32
8412130|NCT00947856|20734188|P1|NOT COMPLETED|Treatment Period||78
8412131|NCT00947856|20734187|P2|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
8412132|NCT00947856|20734188|P1|COMPLETED|Treatment Period||0
8412133|NCT00947856|20734187|P2|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
8412134|NCT00947856|20734188|P1|STARTED|Treatment Period||78
8412135|NCT00947791|20734217|P2|NOT COMPLETED|Overall Study||0
8412136|NCT00947791|20734218|P1|NOT COMPLETED|Overall Study||0
8412137|NCT00947791|20734217|P2|COMPLETED|Overall Study||1
8412138|NCT00947791|20734218|P1|COMPLETED|Overall Study||0
8412139|NCT00947791|20734217|P2|STARTED|Overall Study||1
8412140|NCT00947791|20734218|P1|STARTED|Overall Study||0
8412141|NCT00947765|20734236|P2|NOT COMPLETED|Overall Study||0
8412142|NCT00947765|20734237|P1|NOT COMPLETED|Overall Study||0
8412143|NCT00947765|20734236|P2|COMPLETED|Overall Study||30
8412144|NCT00947765|20734237|P1|COMPLETED|Overall Study||30
8412145|NCT00947765|20734236|P2|STARTED|Overall Study||30
8412146|NCT00947765|20734237|P1|STARTED|Overall Study||30
8412147|NCT00947752|20734259|P2|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
8412148|NCT00947752|20734260|P1|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
8412149|NCT00947752|20734259|P2|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
8412150|NCT00947752|20734260|P1|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
8412151|NCT00947752|20734259|P2|STARTED|Crossover to 2nd 14-day Treatment Period||76
8412152|NCT00947752|20734260|P1|STARTED|Crossover to 2nd 14-day Treatment Period||71
8412153|NCT00947752|20734259|P2|NOT COMPLETED|1st 14-day Treatment Period||0
8412154|NCT00947752|20734260|P1|NOT COMPLETED|1st 14-day Treatment Period||0
8412155|NCT00947752|20734259|P2|COMPLETED|1st 14-day Treatment Period||71
8412156|NCT00947752|20734260|P1|COMPLETED|1st 14-day Treatment Period||76
8412157|NCT00947752|20734259|P2|STARTED|1st 14-day Treatment Period||71
8412158|NCT00947752|20734260|P1|STARTED|1st 14-day Treatment Period||76
8412159|NCT00947752|20734259|P2|NOT COMPLETED|7-Day Run-in Treatment Period||0
8412160|NCT00947752|20734260|P1|NOT COMPLETED|7-Day Run-in Treatment Period||0
8412161|NCT00947752|20734259|P2|COMPLETED|7-Day Run-in Treatment Period||0
8412162|NCT00947752|20734260|P1|COMPLETED|7-Day Run-in Treatment Period||147
8412163|NCT00947752|20734259|P2|STARTED|7-Day Run-in Treatment Period||0
8412164|NCT00947752|20734260|P1|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
8412171|NCT00947544|20734277|P2|NOT COMPLETED|Safety-Extension Period (12 Months)||0
8412172|NCT00947544|20734278|P1|NOT COMPLETED|Safety-Extension Period (12 Months)||1
8412173|NCT00947544|20734277|P2|COMPLETED|Safety-Extension Period (12 Months)||6
8412174|NCT00947544|20734278|P1|COMPLETED|Safety-Extension Period (12 Months)||10
8412175|NCT00947544|20734277|P2|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
8412176|NCT00947544|20734278|P1|STARTED|Safety-Extension Period (12 Months)||11
8412177|NCT00947544|20734277|P2|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
8412178|NCT00947544|20734278|P1|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
8412179|NCT00947544|20734277|P2|COMPLETED|Switch-Over Period (2 Weeks)||0
8412180|NCT00947544|20734278|P1|COMPLETED|Switch-Over Period (2 Weeks)||11
8412181|NCT00947544|20734277|P2|STARTED|Switch-Over Period (2 Weeks)||0
8412182|NCT00947544|20734278|P1|STARTED|Switch-Over Period (2 Weeks)||11
8412183|NCT00947531|20734304|P2|NOT COMPLETED|Overall Study||11
8412184|NCT00947531|20734305|P1|NOT COMPLETED|Overall Study||14
8412185|NCT00947531|20734304|P2|COMPLETED|Overall Study||110
8412186|NCT00947531|20734305|P1|COMPLETED|Overall Study||107
8412187|NCT00947531|20734304|P2|STARTED|Overall Study||121
8412188|NCT00947531|20734305|P1|STARTED|Overall Study||121
8412189|NCT00947518|20734316|P3|NOT COMPLETED|Overall Study||0
8412190|NCT00947518|20734317|P2|NOT COMPLETED|Overall Study||0
8412191|NCT00947518|20734318|P1|NOT COMPLETED|Overall Study||0
8412192|NCT00947518|20734316|P3|COMPLETED|Overall Study||20
8412193|NCT00947518|20734317|P2|COMPLETED|Overall Study||20
8412194|NCT00947518|20734318|P1|COMPLETED|Overall Study||20
8412195|NCT00947518|20734316|P3|STARTED|Overall Study||20
8412196|NCT00947518|20734317|P2|STARTED|Overall Study||20
8412197|NCT00947518|20734318|P1|STARTED|Overall Study||20
8412198|NCT00947505|20734334|P2|NOT COMPLETED|Overall Study||2
8412199|NCT00947505|20734335|P1|NOT COMPLETED|Overall Study||9
8412200|NCT00947505|20734334|P2|COMPLETED|Overall Study||14
8412201|NCT00947505|20734335|P1|COMPLETED|Overall Study||24
8412202|NCT00947505|20734334|P2|STARTED|Overall Study||16
8412203|NCT00947505|20734335|P1|STARTED|Overall Study||33
8412204|NCT00947427|20734343|P2|NOT COMPLETED|Overall Study||4
8412205|NCT00947427|20734344|P1|NOT COMPLETED|Overall Study||1
8412206|NCT00947427|20734343|P2|COMPLETED|Overall Study||45
8412207|NCT00947427|20734344|P1|COMPLETED|Overall Study||21
8412208|NCT00947427|20734343|P2|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
8412209|NCT00947427|20734344|P1|STARTED|Overall Study||22
8412210|NCT00947349|20734354|P4|NOT COMPLETED|Overall Study Standard of Care||2
8412211|NCT00947349|20734355|P3|NOT COMPLETED|Overall Study Standard of Care||2
8412212|NCT00947349|20734356|P2|NOT COMPLETED|Overall Study Standard of Care||0
8412213|NCT00947349|20734357|P1|NOT COMPLETED|Overall Study Standard of Care||0
8412214|NCT00947349|20734354|P4|COMPLETED|Overall Study Standard of Care||4
8412215|NCT00947349|20734355|P3|COMPLETED|Overall Study Standard of Care||4
8412216|NCT00947349|20734356|P2|COMPLETED|Overall Study Standard of Care||5
8412217|NCT00947349|20734357|P1|COMPLETED|Overall Study Standard of Care||4
8412218|NCT00947349|20734354|P4|STARTED|Overall Study Standard of Care||6
8412219|NCT00947349|20734355|P3|STARTED|Overall Study Standard of Care||6
8412220|NCT00947349|20734356|P2|STARTED|Overall Study Standard of Care||5
8412221|NCT00947349|20734357|P1|STARTED|Overall Study Standard of Care||4
8412222|NCT00947349|20734354|P4|NOT COMPLETED|Triple Treatment Combination Period||0
8412223|NCT00947349|20734355|P3|NOT COMPLETED|Triple Treatment Combination Period||0
8412224|NCT00947349|20734356|P2|NOT COMPLETED|Triple Treatment Combination Period||1
8412225|NCT00947349|20734357|P1|NOT COMPLETED|Triple Treatment Combination Period||0
8412226|NCT00947349|20734354|P4|COMPLETED|Triple Treatment Combination Period||6
8412227|NCT00947349|20734355|P3|COMPLETED|Triple Treatment Combination Period||6
8412228|NCT00947349|20734356|P2|COMPLETED|Triple Treatment Combination Period||5
8412229|NCT00947349|20734357|P1|COMPLETED|Triple Treatment Combination Period||4
8412230|NCT00947349|20734354|P4|STARTED|Triple Treatment Combination Period||6
8412231|NCT00947349|20734355|P3|STARTED|Triple Treatment Combination Period||6
8412232|NCT00947349|20734356|P2|STARTED|Triple Treatment Combination Period||6
8412233|NCT00947349|20734357|P1|STARTED|Triple Treatment Combination Period||4
8412234|NCT00947310|20734492|P3|NOT COMPLETED|Overall Study||0
8412235|NCT00947310|20734493|P2|NOT COMPLETED|Overall Study||0
8412236|NCT00947310|20734494|P1|NOT COMPLETED|Overall Study||0
8412237|NCT00947310|20734492|P3|COMPLETED|Overall Study||486
8412238|NCT00947310|20734493|P2|COMPLETED|Overall Study||500
8412239|NCT00947310|20734494|P1|COMPLETED|Overall Study||514
8412240|NCT00947310|20734492|P3|STARTED|Overall Study||486
8412241|NCT00947310|20734493|P2|STARTED|Overall Study||500
8412242|NCT00947310|20734494|P1|STARTED|Overall Study||514
8412243|NCT00947297|20734508|P1|NOT COMPLETED|Overall Study||7
8412244|NCT00947297|20734508|P1|COMPLETED|Overall Study||53
8412245|NCT00947297|20734508|P1|STARTED|Overall Study||60
8412246|NCT00947284|20734515|P2|NOT COMPLETED|Overall Study||3
8412247|NCT00947284|20734516|P1|NOT COMPLETED|Overall Study||0
8412248|NCT00947284|20734515|P2|COMPLETED|Overall Study||0
8412249|NCT00947284|20734516|P1|COMPLETED|Overall Study||0
8412250|NCT00947284|20734515|P2|STARTED|Overall Study||3
8412251|NCT00947284|20734516|P1|STARTED|Overall Study||0
8412252|NCT00947271|20734524|P4|NOT COMPLETED|12 Months Post Intervention||62
8412253|NCT00947271|20734525|P3|NOT COMPLETED|12 Months Post Intervention||59
8412254|NCT00947271|20734526|P2|NOT COMPLETED|12 Months Post Intervention||60
8412255|NCT00947271|20734527|P1|NOT COMPLETED|12 Months Post Intervention||71
8412256|NCT00947271|20734524|P4|COMPLETED|12 Months Post Intervention||188
8412257|NCT00947271|20734525|P3|COMPLETED|12 Months Post Intervention||195
8412258|NCT00947271|20734526|P2|COMPLETED|12 Months Post Intervention||192
8412259|NCT00947271|20734527|P1|COMPLETED|12 Months Post Intervention||183
8412260|NCT00947271|20734524|P4|STARTED|12 Months Post Intervention||250
8412261|NCT00947271|20734525|P3|STARTED|12 Months Post Intervention||254
8412262|NCT00947271|20734526|P2|STARTED|12 Months Post Intervention||252
8412263|NCT00947271|20734527|P1|STARTED|12 Months Post Intervention||254
8412264|NCT00947271|20734524|P4|NOT COMPLETED|9 Months Post Intervention||59
8412265|NCT00947271|20734525|P3|NOT COMPLETED|9 Months Post Intervention||61
8412266|NCT00947271|20734526|P2|NOT COMPLETED|9 Months Post Intervention||60
8412267|NCT00947271|20734527|P1|NOT COMPLETED|9 Months Post Intervention||70
8412268|NCT00947271|20734524|P4|COMPLETED|9 Months Post Intervention||191
8412269|NCT00947271|20734525|P3|COMPLETED|9 Months Post Intervention||193
8412270|NCT00947271|20734526|P2|COMPLETED|9 Months Post Intervention||192
8412271|NCT00947271|20734527|P1|COMPLETED|9 Months Post Intervention||184
8412272|NCT00947271|20734524|P4|STARTED|9 Months Post Intervention||250
8412273|NCT00947271|20734525|P3|STARTED|9 Months Post Intervention||254
8412274|NCT00947271|20734526|P2|STARTED|9 Months Post Intervention||252
8412275|NCT00947271|20734527|P1|STARTED|9 Months Post Intervention||254
8412276|NCT00947271|20734524|P4|NOT COMPLETED|6 Months Post Intervention||54
8412277|NCT00947271|20734525|P3|NOT COMPLETED|6 Months Post Intervention||58
8412278|NCT00947271|20734526|P2|NOT COMPLETED|6 Months Post Intervention||53
8412279|NCT00947271|20734527|P1|NOT COMPLETED|6 Months Post Intervention||55
8412280|NCT00947271|20734524|P4|COMPLETED|6 Months Post Intervention||196
8412281|NCT00947271|20734525|P3|COMPLETED|6 Months Post Intervention||196
8412282|NCT00947271|20734526|P2|COMPLETED|6 Months Post Intervention||199
8412283|NCT00947271|20734527|P1|COMPLETED|6 Months Post Intervention||199
8412284|NCT00947271|20734524|P4|STARTED|6 Months Post Intervention||250
8412285|NCT00947271|20734525|P3|STARTED|6 Months Post Intervention||254
8412286|NCT00947271|20734526|P2|STARTED|6 Months Post Intervention||252
8412287|NCT00947271|20734527|P1|STARTED|6 Months Post Intervention||254
8412288|NCT00947271|20734524|P4|NOT COMPLETED|3 Months Post Intervention||44
8412289|NCT00947271|20734525|P3|NOT COMPLETED|3 Months Post Intervention||36
8412290|NCT00947271|20734526|P2|NOT COMPLETED|3 Months Post Intervention||48
8412291|NCT00947271|20734527|P1|NOT COMPLETED|3 Months Post Intervention||52
8412292|NCT00947271|20734524|P4|COMPLETED|3 Months Post Intervention||206
8412293|NCT00947271|20734525|P3|COMPLETED|3 Months Post Intervention||218
8412294|NCT00947271|20734526|P2|COMPLETED|3 Months Post Intervention||204
8412295|NCT00947271|20734527|P1|COMPLETED|3 Months Post Intervention||202
8412296|NCT00947271|20734524|P4|STARTED|3 Months Post Intervention||250
8412297|NCT00947271|20734525|P3|STARTED|3 Months Post Intervention||254
8412298|NCT00947271|20734526|P2|STARTED|3 Months Post Intervention||252
8412299|NCT00947271|20734527|P1|STARTED|3 Months Post Intervention||254
8412300|NCT00947219|20734556|P3|NOT COMPLETED|Overall Study||4
8412301|NCT00947219|20734557|P2|NOT COMPLETED|Overall Study||4
8412302|NCT00947219|20734558|P1|NOT COMPLETED|Overall Study||6
8412303|NCT00947219|20734556|P3|COMPLETED|Overall Study||22
8412304|NCT00947219|20734557|P2|COMPLETED|Overall Study||21
8412305|NCT00947219|20734558|P1|COMPLETED|Overall Study||22
8412306|NCT00947219|20734556|P3|STARTED|Overall Study||26
8412307|NCT00947219|20734557|P2|STARTED|Overall Study||25
8412308|NCT00947219|20734558|P1|STARTED|Overall Study||28
8412309|NCT00947193|20734566|P2|NOT COMPLETED|Overall Study||0
8412310|NCT00947193|20734567|P1|NOT COMPLETED|Overall Study||3
8412311|NCT00947193|20734566|P2|COMPLETED|Overall Study||10
8412312|NCT00947193|20734567|P1|COMPLETED|Overall Study||0
8412313|NCT00947193|20734566|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
8412314|NCT00947193|20734567|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8412315|NCT00947193|20734566|P2|STARTED|Overall Study||10
8412316|NCT00947193|20734567|P1|STARTED|Overall Study||3
8412317|NCT00947167|20734577|P1|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
8412318|NCT00947167|20734577|P1|COMPLETED|Erlotinib Added to Pertuzumab||3
8412319|NCT00947167|20734577|P1|STARTED|Erlotinib Added to Pertuzumab||3
8412320|NCT00947167|20734577|P1|NOT COMPLETED|Pertuzumab Alone||0
8412321|NCT00947167|20734577|P1|COMPLETED|Pertuzumab Alone||4
8412322|NCT00947167|20734577|P1|STARTED|Pertuzumab Alone||4
8412323|NCT00947154|20734582|P1|NOT COMPLETED|Overall Study||1
8412324|NCT00947154|20734582|P1|COMPLETED|Overall Study||11
8412325|NCT00947154|20734582|P1|STARTED|Overall Study||12
8412326|NCT00947115|20734592|P3|NOT COMPLETED|Overall Study||15
8412327|NCT00947115|20734593|P2|NOT COMPLETED|Overall Study||22
8412328|NCT00947115|20734594|P1|NOT COMPLETED|Overall Study||17
8412329|NCT00947115|20734592|P3|COMPLETED|Overall Study||156
8412330|NCT00947115|20734593|P2|COMPLETED|Overall Study||172
8412331|NCT00947115|20734594|P1|COMPLETED|Overall Study||142
8412332|NCT00947115|20734592|P3|STARTED|Overall Study||171
8412333|NCT00947115|20734593|P2|STARTED|Overall Study||194
8412334|NCT00947115|20734594|P1|STARTED|Overall Study||159
8412335|NCT00947011|20734656|P1|NOT COMPLETED|Overall Study||12
8412336|NCT00947011|20734656|P1|COMPLETED|Overall Study||0
8412337|NCT00947011|20734656|P1|STARTED|Overall Study||12
8412338|NCT00946998|20734666|P2|NOT COMPLETED|Overall Study||3
8412339|NCT00946998|20734667|P1|NOT COMPLETED|Overall Study||5
8412340|NCT00946998|20734666|P2|COMPLETED|Overall Study||96
8412341|NCT00946998|20734667|P1|COMPLETED|Overall Study||97
8412342|NCT00946998|20734666|P2|Received Treatment as Randomized|Overall Study||99
8412343|NCT00946998|20734667|P1|Received Treatment as Randomized|Overall Study||102
8412344|NCT00946998|20734666|P2|STARTED|Overall Study||99
8412345|NCT00946998|20734667|P1|STARTED|Overall Study||102
8412346|NCT00946985|20734681|P1|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
8412347|NCT00946985|20734681|P1|COMPLETED|Relapse Prevention Phase (24 Months)||0
8412348|NCT00946985|20734681|P1|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
8412349|NCT00946985|20734681|P1|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
8412350|NCT00946985|20734681|P1|COMPLETED|Stabilization Phase (25 Weeks)||2
8412351|NCT00946985|20734681|P1|STARTED|Stabilization Phase (25 Weeks)||162
8412352|NCT00946920|20734687|P2|NOT COMPLETED|Overall Study||44
8412353|NCT00946920|20734688|P1|NOT COMPLETED|Overall Study||110
8412354|NCT00946920|20734687|P2|COMPLETED|Overall Study||239
8412355|NCT00946920|20734688|P1|COMPLETED|Overall Study||455
8412356|NCT00946920|20734687|P2|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
8412357|NCT00946920|20734688|P1|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
8412358|NCT00946920|20734687|P2|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
8412359|NCT00946920|20734688|P1|STARTED|Overall Study|Received at least one dose of degarelix.|565
8412360|NCT00946881|20734703|P1|NOT COMPLETED|Retreatment||1
8412361|NCT00946881|20734703|P1|COMPLETED|Retreatment||7
8412362|NCT00946881|20734703|P1|STARTED|Retreatment||8
8412363|NCT00946881|20734703|P1|NOT COMPLETED|First Treatment||2
8412364|NCT00946881|20734703|P1|COMPLETED|First Treatment||28
8412365|NCT00946881|20734703|P1|STARTED|First Treatment||30
8412372|NCT00946647|20734754|P5|NOT COMPLETED|Phase ll Part||42
8412373|NCT00946647|20734755|P4|NOT COMPLETED|Phase ll Part||40
8412374|NCT00946647|20734756|P3|NOT COMPLETED|Phase ll Part||0
8412375|NCT00946647|20734757|P2|NOT COMPLETED|Phase ll Part||0
8412376|NCT00946647|20734758|P1|NOT COMPLETED|Phase ll Part||0
8412377|NCT00946647|20734754|P5|COMPLETED|Phase ll Part||0
8412378|NCT00946647|20734755|P4|COMPLETED|Phase ll Part||0
8412379|NCT00946647|20734756|P3|COMPLETED|Phase ll Part||0
8412380|NCT00946647|20734757|P2|COMPLETED|Phase ll Part||0
8412381|NCT00946647|20734758|P1|COMPLETED|Phase ll Part||0
8412382|NCT00946647|20734754|P5|Safety Set|Phase ll Part|2 pts rand. to PAN+5AZA, did not receive PAN but received 5AZA|42
8412383|NCT00946647|20734755|P4|Safety Set|Phase ll Part|2 pts rand. to this grp did not receive PAN|38
8412384|NCT00946647|20734756|P3|Safety Set|Phase ll Part||0
8412385|NCT00946647|20734757|P2|Safety Set|Phase ll Part||0
8412386|NCT00946647|20734758|P1|Safety Set|Phase ll Part||0
8412387|NCT00946647|20734754|P5|STARTED|Phase ll Part||42
8412388|NCT00946647|20734755|P4|STARTED|Phase ll Part||40
8412389|NCT00946647|20734756|P3|STARTED|Phase ll Part||0
8412390|NCT00946647|20734757|P2|STARTED|Phase ll Part||0
8412391|NCT00946647|20734758|P1|STARTED|Phase ll Part||0
8412392|NCT00946647|20734754|P5|NOT COMPLETED|Phase 1 Part||0
8412393|NCT00946647|20734755|P4|NOT COMPLETED|Phase 1 Part||0
8412394|NCT00946647|20734756|P3|NOT COMPLETED|Phase 1 Part||7
8412395|NCT00946647|20734757|P2|NOT COMPLETED|Phase 1 Part||18
8412396|NCT00946647|20734758|P1|NOT COMPLETED|Phase 1 Part||6
8412397|NCT00946647|20734754|P5|COMPLETED|Phase 1 Part||0
8412398|NCT00946647|20734755|P4|COMPLETED|Phase 1 Part||0
8412399|NCT00946647|20734756|P3|COMPLETED|Phase 1 Part||0
8412400|NCT00946647|20734757|P2|COMPLETED|Phase 1 Part||0
8412401|NCT00946647|20734758|P1|COMPLETED|Phase 1 Part||0
8412402|NCT00946647|20734754|P5|STARTED|Phase 1 Part||0
8412403|NCT00946647|20734755|P4|STARTED|Phase 1 Part||0
8412404|NCT00946647|20734756|P3|STARTED|Phase 1 Part||7
8412405|NCT00946647|20734757|P2|STARTED|Phase 1 Part||18
8412406|NCT00946647|20734758|P1|STARTED|Phase 1 Part||6
8412407|NCT00946530|20734792|P4|NOT COMPLETED|Overall Study||4
8412408|NCT00946530|20734793|P3|NOT COMPLETED|Overall Study||1
8412409|NCT00946530|20734794|P2|NOT COMPLETED|Overall Study||4
8412410|NCT00946530|20734795|P1|NOT COMPLETED|Overall Study||1
8412411|NCT00946530|20734792|P4|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
8412412|NCT00946530|20734793|P3|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
8412413|NCT00946530|20734794|P2|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
8412414|NCT00946530|20734795|P1|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
8412415|NCT00946530|20734792|P4|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
8412416|NCT00946530|20734793|P3|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
8412417|NCT00946530|20734794|P2|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
8412418|NCT00946530|20734795|P1|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
8412419|NCT00946478|20734811|P2|NOT COMPLETED|Overall Study||0
8412420|NCT00946478|20734812|P1|NOT COMPLETED|Overall Study||0
8412421|NCT00946478|20734811|P2|COMPLETED|Overall Study||20
8412422|NCT00946478|20734812|P1|COMPLETED|Overall Study||20
8412423|NCT00946478|20734811|P2|STARTED|Overall Study||20
8412424|NCT00946478|20734812|P1|STARTED|Overall Study||20
8412431|NCT00946322|20734827|P1|NOT COMPLETED|Post-treatment||2
8412432|NCT00946322|20734827|P1|COMPLETED|Post-treatment||9
8412433|NCT00946322|20734827|P1|STARTED|Post-treatment||11
8412434|NCT00946322|20734827|P1|NOT COMPLETED|Pre-treatment||1
8412435|NCT00946322|20734827|P1|COMPLETED|Pre-treatment||11
8412436|NCT00946322|20734827|P1|STARTED|Pre-treatment||12
8412437|NCT00946309|20734840|P2|NOT COMPLETED|Overall Study||4
8412438|NCT00946309|20734841|P1|NOT COMPLETED|Overall Study||1
8412439|NCT00946309|20734840|P2|COMPLETED|Overall Study||19
8412440|NCT00946309|20734841|P1|COMPLETED|Overall Study||21
8412441|NCT00946309|20734840|P2|STARTED|Overall Study||23
8412442|NCT00946309|20734841|P1|STARTED|Overall Study||22
8412443|NCT00946296|20734859|P2|NOT COMPLETED|Overall Study||0
8412444|NCT00946296|20734860|P1|NOT COMPLETED|Overall Study||3
8412445|NCT00946296|20734859|P2|COMPLETED|Overall Study||15
8412446|NCT00946296|20734860|P1|COMPLETED|Overall Study||18
8412447|NCT00946296|20734859|P2|STARTED|Overall Study||15
8412448|NCT00946296|20734860|P1|STARTED|Overall Study||21
8412449|NCT00946270|20734869|P3|NOT COMPLETED|Overall Study||0
8412450|NCT00946270|20734870|P2|NOT COMPLETED|Overall Study||0
8412451|NCT00946270|20734871|P1|NOT COMPLETED|Overall Study||0
8412452|NCT00946270|20734869|P3|COMPLETED|Overall Study||29
8412453|NCT00946270|20734870|P2|COMPLETED|Overall Study||20
8412454|NCT00946270|20734871|P1|COMPLETED|Overall Study||21
8412455|NCT00946270|20734869|P3|STARTED|Overall Study||29
8412456|NCT00946270|20734870|P2|STARTED|Overall Study||20
8412457|NCT00946270|20734871|P1|STARTED|Overall Study||21
8412467|NCT00946153|20734900|P5|NOT COMPLETED|Phase 2||13
8412468|NCT00946153|20734901|P4|NOT COMPLETED|Phase 2||0
8412469|NCT00946153|20734902|P3|NOT COMPLETED|Phase 2||0
8412470|NCT00946153|20734903|P2|NOT COMPLETED|Phase 2||0
8412471|NCT00946153|20734904|P1|NOT COMPLETED|Phase 2||0
8412472|NCT00946153|20734900|P5|COMPLETED|Phase 2||33
8412473|NCT00946153|20734901|P4|COMPLETED|Phase 2||0
8412474|NCT00946153|20734902|P3|COMPLETED|Phase 2||0
8412475|NCT00946153|20734903|P2|COMPLETED|Phase 2||0
8412476|NCT00946153|20734904|P1|COMPLETED|Phase 2||0
8412477|NCT00946153|20734900|P5|STARTED|Phase 2||46
8412478|NCT00946153|20734901|P4|STARTED|Phase 2||0
8412479|NCT00946153|20734902|P3|STARTED|Phase 2||0
8412480|NCT00946153|20734903|P2|STARTED|Phase 2||0
8412481|NCT00946153|20734904|P1|STARTED|Phase 2||0
8412482|NCT00946153|20734900|P5|NOT COMPLETED|Phase 1||0
8412483|NCT00946153|20734901|P4|NOT COMPLETED|Phase 1||0
8412484|NCT00946153|20734902|P3|NOT COMPLETED|Phase 1||0
8412485|NCT00946153|20734903|P2|NOT COMPLETED|Phase 1||0
8412486|NCT00946153|20734904|P1|NOT COMPLETED|Phase 1||0
8412487|NCT00946153|20734900|P5|COMPLETED|Phase 1||0
8412488|NCT00946153|20734901|P4|COMPLETED|Phase 1||5
8412489|NCT00946153|20734902|P3|COMPLETED|Phase 1||6
8412490|NCT00946153|20734903|P2|COMPLETED|Phase 1||3
8412491|NCT00946153|20734904|P1|COMPLETED|Phase 1||6
8412492|NCT00946153|20734900|P5|STARTED|Phase 1||0
8412493|NCT00946153|20734901|P4|STARTED|Phase 1||5
8412494|NCT00946153|20734902|P3|STARTED|Phase 1||6
8412495|NCT00946153|20734903|P2|STARTED|Phase 1||3
8412496|NCT00946153|20734904|P1|STARTED|Phase 1||6
8412503|NCT00946101|20734941|P2|NOT COMPLETED|Overall Study||2
8412504|NCT00946101|20734942|P1|NOT COMPLETED|Overall Study||4
8412505|NCT00946101|20734941|P2|COMPLETED|Overall Study||63
8412506|NCT00946101|20734942|P1|COMPLETED|Overall Study||257
8412507|NCT00946101|20734941|P2|Day 15 Post Dose 2|Overall Study||63
8412508|NCT00946101|20734942|P1|Day 15 Post Dose 2|Overall Study||254
8412509|NCT00946101|20734941|P2|Day 15 Post Dose 1|Overall Study||64
8412510|NCT00946101|20734942|P1|Day 15 Post Dose 1|Overall Study||260
8412511|NCT00946101|20734941|P2|STARTED|Overall Study||65
8412512|NCT00946101|20734942|P1|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
8412513|NCT00946088|20735008|P2|NOT COMPLETED|Overall Study||1
8412514|NCT00946088|20735009|P1|NOT COMPLETED|Overall Study||0
8412515|NCT00946088|20735008|P2|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
8412516|NCT00946088|20735009|P1|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
8412517|NCT00946088|20735008|P2|STARTED|Overall Study||3
8412518|NCT00946088|20735009|P1|STARTED|Overall Study||4
8412519|NCT00946023|20735031|P1|NOT COMPLETED|Overall Study||0
8412520|NCT00946023|20735031|P1|COMPLETED|Overall Study||83
8412521|NCT00946023|20735031|P1|STARTED|Overall Study||83
8412525|NCT00945945|20735053|P2|NOT COMPLETED|Overall Study||55
8412526|NCT00945945|20735054|P1|NOT COMPLETED|Overall Study||36
8412527|NCT00945945|20735053|P2|COMPLETED|Overall Study||162
8412528|NCT00945945|20735054|P1|COMPLETED|Overall Study||171
8412529|NCT00945945|20735053|P2|STARTED|Overall Study||217
8412530|NCT00945945|20735054|P1|STARTED|Overall Study||207
8412531|NCT00945906|20735080|P1|NOT COMPLETED|Overall Study||7
8412532|NCT00945906|20735080|P1|COMPLETED|Overall Study||54
8412533|NCT00945906|20735080|P1|STARTED|Overall Study||61
8412534|NCT00945893|20735091|P2|NOT COMPLETED|Overall Study||10
8412535|NCT00945893|20735092|P1|NOT COMPLETED|Overall Study||3
8412536|NCT00945893|20735091|P2|COMPLETED|Overall Study||230
8412537|NCT00945893|20735092|P1|COMPLETED|Overall Study||57
8412538|NCT00945893|20735091|P2|Day 15 Post Dose 2|Overall Study||226
8412539|NCT00945893|20735092|P1|Day 15 Post Dose 2|Overall Study||54
8412540|NCT00945893|20735091|P2|Day 15 Post Dose 1|Overall Study||238
8412541|NCT00945893|20735092|P1|Day 15 Post Dose 1|Overall Study||60
8412542|NCT00945893|20735091|P2|STARTED|Overall Study||240
8412543|NCT00945893|20735092|P1|STARTED|Overall Study||60
8412544|NCT00945854|20735158|P2|NOT COMPLETED|Overall Study||4
8412545|NCT00945854|20735159|P1|NOT COMPLETED|Overall Study||2
8412546|NCT00945854|20735158|P2|COMPLETED|Overall Study||26
8412547|NCT00945854|20735159|P1|COMPLETED|Overall Study||28
8412548|NCT00945854|20735158|P2|STARTED|Overall Study||30
8412549|NCT00945854|20735159|P1|STARTED|Overall Study||30
8412550|NCT00945815|20735169|P1|NOT COMPLETED|Overall Study||8
8412551|NCT00945815|20735169|P1|COMPLETED|Overall Study||27
8412552|NCT00945815|20735169|P1|Eligible and Began Protocol Therapy|Overall Study||31
8412553|NCT00945815|20735169|P1|Eligible|Overall Study||32
8412554|NCT00945815|20735169|P1|STARTED|Overall Study||35
8412555|NCT00945750|20735180|P6|NOT COMPLETED|Period III||0
8412556|NCT00945750|20735181|P5|NOT COMPLETED|Period III||0
8412557|NCT00945750|20735182|P4|NOT COMPLETED|Period III||0
8412558|NCT00945750|20735183|P3|NOT COMPLETED|Period III||0
8412559|NCT00945750|20735184|P2|NOT COMPLETED|Period III||0
8412560|NCT00945750|20735185|P1|NOT COMPLETED|Period III||0
8412561|NCT00945750|20735180|P6|COMPLETED|Period III||5
8412562|NCT00945750|20735181|P5|COMPLETED|Period III||5
8412563|NCT00945750|20735182|P4|COMPLETED|Period III||5
8412564|NCT00945750|20735183|P3|COMPLETED|Period III||5
8412565|NCT00945750|20735184|P2|COMPLETED|Period III||5
8412566|NCT00945750|20735185|P1|COMPLETED|Period III||5
8412567|NCT00945750|20735180|P6|STARTED|Period III||5
8412568|NCT00945750|20735181|P5|STARTED|Period III||5
8412569|NCT00945750|20735182|P4|STARTED|Period III||5
8412570|NCT00945750|20735183|P3|STARTED|Period III||5
8412571|NCT00945750|20735184|P2|STARTED|Period III||5
8412572|NCT00945750|20735185|P1|STARTED|Period III||5
8412573|NCT00945750|20735180|P6|NOT COMPLETED|Period II||0
8412574|NCT00945750|20735181|P5|NOT COMPLETED|Period II||0
8412575|NCT00945750|20735182|P4|NOT COMPLETED|Period II||0
8412576|NCT00945750|20735183|P3|NOT COMPLETED|Period II||0
8412577|NCT00945750|20735184|P2|NOT COMPLETED|Period II||0
8412578|NCT00945750|20735185|P1|NOT COMPLETED|Period II||0
8412579|NCT00945750|20735180|P6|COMPLETED|Period II||5
8412580|NCT00945750|20735181|P5|COMPLETED|Period II||5
8412581|NCT00945750|20735182|P4|COMPLETED|Period II||5
8412582|NCT00945750|20735183|P3|COMPLETED|Period II||5
8412583|NCT00945750|20735184|P2|COMPLETED|Period II||5
8412584|NCT00945750|20735185|P1|COMPLETED|Period II||5
8412585|NCT00945750|20735180|P6|STARTED|Period II||5
8412586|NCT00945750|20735181|P5|STARTED|Period II||5
8412587|NCT00945750|20735182|P4|STARTED|Period II||5
8412588|NCT00945750|20735183|P3|STARTED|Period II||5
8412589|NCT00945750|20735184|P2|STARTED|Period II||5
8412590|NCT00945750|20735185|P1|STARTED|Period II||5
8412591|NCT00945750|20735180|P6|NOT COMPLETED|Period I||0
8412592|NCT00945750|20735181|P5|NOT COMPLETED|Period I||0
8412593|NCT00945750|20735182|P4|NOT COMPLETED|Period I||0
8412594|NCT00945750|20735183|P3|NOT COMPLETED|Period I||0
8412595|NCT00945750|20735184|P2|NOT COMPLETED|Period I||0
8412596|NCT00945750|20735185|P1|NOT COMPLETED|Period I||0
8412597|NCT00945750|20735180|P6|COMPLETED|Period I||5
8412598|NCT00945750|20735181|P5|COMPLETED|Period I||5
8412599|NCT00945750|20735182|P4|COMPLETED|Period I||5
8412600|NCT00945750|20735183|P3|COMPLETED|Period I||5
8412601|NCT00945750|20735184|P2|COMPLETED|Period I||5
8412602|NCT00945750|20735185|P1|COMPLETED|Period I||5
8412603|NCT00945750|20735180|P6|STARTED|Period I||5
8412604|NCT00945750|20735181|P5|STARTED|Period I||5
8412605|NCT00945750|20735182|P4|STARTED|Period I||5
8412606|NCT00945750|20735183|P3|STARTED|Period I||5
8412607|NCT00945750|20735184|P2|STARTED|Period I||5
8412608|NCT00945750|20735185|P1|STARTED|Period I||5
8412609|NCT00945659|20735201|P3|NOT COMPLETED|Overall Study||17
8412610|NCT00945659|20735202|P2|NOT COMPLETED|Overall Study||20
8412611|NCT00945659|20735203|P1|NOT COMPLETED|Overall Study||7
8412612|NCT00945659|20735201|P3|COMPLETED|Overall Study||20
8412613|NCT00945659|20735202|P2|COMPLETED|Overall Study||20
8412614|NCT00945659|20735203|P1|COMPLETED|Overall Study||32
8412615|NCT00945659|20735201|P3|12-Months|Overall Study||20
8412616|NCT00945659|20735202|P2|12-Months|Overall Study||20
8412617|NCT00945659|20735203|P1|12-Months|Overall Study||32
8412618|NCT00945659|20735201|P3|9-Months|Overall Study||20
8412619|NCT00945659|20735202|P2|9-Months|Overall Study||20
8412620|NCT00945659|20735203|P1|9-Months|Overall Study||32
8412621|NCT00945659|20735201|P3|6-Months|Overall Study||25
8412622|NCT00945659|20735202|P2|6-Months|Overall Study||29
8412623|NCT00945659|20735203|P1|6-Months|Overall Study||31
8412624|NCT00945659|20735201|P3|3-Months|Overall Study||35
8412625|NCT00945659|20735202|P2|3-Months|Overall Study||39
8412626|NCT00945659|20735203|P1|3-Months|Overall Study||38
8412627|NCT00945659|20735201|P3|Baseline|Overall Study||37
8412628|NCT00945659|20735202|P2|Baseline|Overall Study||40
8412629|NCT00945659|20735203|P1|Baseline|Overall Study||39
8412630|NCT00945659|20735201|P3|STARTED|Overall Study||37
8412631|NCT00945659|20735202|P2|STARTED|Overall Study||40
8412632|NCT00945659|20735203|P1|STARTED|Overall Study||39
8412633|NCT00945594|20735249|P2|NOT COMPLETED|Overall Study||0
8412634|NCT00945594|20735250|P1|NOT COMPLETED|Overall Study||0
8412635|NCT00945594|20735249|P2|COMPLETED|Overall Study||50
8412636|NCT00945594|20735250|P1|COMPLETED|Overall Study||50
8412637|NCT00945594|20735249|P2|STARTED|Overall Study||50
8412638|NCT00945594|20735250|P1|STARTED|Overall Study||50
8412639|NCT00945555|20735260|P1|NOT COMPLETED|Overall Study||28
8412640|NCT00945555|20735260|P1|COMPLETED|Overall Study||236
8412641|NCT00945555|20735260|P1|STARTED|Overall Study||264
8412642|NCT00945477|20735271|P1|NOT COMPLETED|Overall Study||6
8412643|NCT00945477|20735271|P1|COMPLETED|Overall Study||5
8412644|NCT00945477|20735271|P1|STARTED|Overall Study||11
8412645|NCT00945334|20735278|P2|NOT COMPLETED|Overall Study||3
8412646|NCT00945334|20735279|P1|NOT COMPLETED|Overall Study||3
8412647|NCT00945334|20735278|P2|COMPLETED|Overall Study||15
8412648|NCT00945334|20735279|P1|COMPLETED|Overall Study||16
8412649|NCT00945334|20735278|P2|STARTED|Overall Study||18
8412650|NCT00945334|20735279|P1|STARTED|Overall Study||19
8412651|NCT00945321|20735287|P6|NOT COMPLETED|Period 4||1
8412652|NCT00945321|20735288|P5|NOT COMPLETED|Period 4||0
8412653|NCT00945321|20735289|P4|NOT COMPLETED|Period 4||0
8412654|NCT00945321|20735290|P3|NOT COMPLETED|Period 4||0
8412655|NCT00945321|20735291|P2|NOT COMPLETED|Period 4||0
8412656|NCT00945321|20735292|P1|NOT COMPLETED|Period 4||0
8412657|NCT00945321|20735287|P6|COMPLETED|Period 4||6
8412658|NCT00945321|20735288|P5|COMPLETED|Period 4||6
8412659|NCT00945321|20735289|P4|COMPLETED|Period 4||7
8412660|NCT00945321|20735290|P3|COMPLETED|Period 4||7
8412661|NCT00945321|20735291|P2|COMPLETED|Period 4||7
8412662|NCT00945321|20735292|P1|COMPLETED|Period 4||7
8412663|NCT00945321|20735287|P6|STARTED|Period 4||7
8412664|NCT00945321|20735288|P5|STARTED|Period 4||6
8412665|NCT00945321|20735289|P4|STARTED|Period 4||7
8412666|NCT00945321|20735290|P3|STARTED|Period 4||7
8412667|NCT00945321|20735291|P2|STARTED|Period 4||7
8412668|NCT00945321|20735292|P1|STARTED|Period 4||7
8412669|NCT00945321|20735287|P6|NOT COMPLETED|Period 3||0
8412670|NCT00945321|20735288|P5|NOT COMPLETED|Period 3||0
8412671|NCT00945321|20735289|P4|NOT COMPLETED|Period 3||0
8412672|NCT00945321|20735290|P3|NOT COMPLETED|Period 3||0
8412673|NCT00945321|20735291|P2|NOT COMPLETED|Period 3||0
8412674|NCT00945321|20735292|P1|NOT COMPLETED|Period 3||0
8412675|NCT00945321|20735287|P6|COMPLETED|Period 3||7
8412676|NCT00945321|20735288|P5|COMPLETED|Period 3||6
8412677|NCT00945321|20735289|P4|COMPLETED|Period 3||7
8412678|NCT00945321|20735290|P3|COMPLETED|Period 3||7
8412679|NCT00945321|20735291|P2|COMPLETED|Period 3||7
8412680|NCT00945321|20735292|P1|COMPLETED|Period 3||7
8412681|NCT00945321|20735287|P6|STARTED|Period 3||7
8412682|NCT00945321|20735288|P5|STARTED|Period 3||6
8412683|NCT00945321|20735289|P4|STARTED|Period 3||7
8412684|NCT00945321|20735290|P3|STARTED|Period 3||7
8412685|NCT00945321|20735291|P2|STARTED|Period 3||7
8412686|NCT00945321|20735292|P1|STARTED|Period 3||7
8412687|NCT00945321|20735287|P6|NOT COMPLETED|Period 2||0
8412688|NCT00945321|20735288|P5|NOT COMPLETED|Period 2||0
8412689|NCT00945321|20735289|P4|NOT COMPLETED|Period 2||0
8412690|NCT00945321|20735290|P3|NOT COMPLETED|Period 2||0
8412691|NCT00945321|20735291|P2|NOT COMPLETED|Period 2||0
8412692|NCT00945321|20735292|P1|NOT COMPLETED|Period 2||0
8412693|NCT00945321|20735287|P6|COMPLETED|Period 2||7
8412694|NCT00945321|20735288|P5|COMPLETED|Period 2||6
8412695|NCT00945321|20735289|P4|COMPLETED|Period 2||7
8412696|NCT00945321|20735290|P3|COMPLETED|Period 2||7
8412697|NCT00945321|20735291|P2|COMPLETED|Period 2||7
8412698|NCT00945321|20735292|P1|COMPLETED|Period 2||7
8412699|NCT00945321|20735287|P6|STARTED|Period 2||7
8412700|NCT00945321|20735288|P5|STARTED|Period 2||6
8412701|NCT00945321|20735289|P4|STARTED|Period 2||7
8412702|NCT00945321|20735290|P3|STARTED|Period 2||7
8412703|NCT00945321|20735291|P2|STARTED|Period 2||7
8412704|NCT00945321|20735292|P1|STARTED|Period 2||7
8412705|NCT00945321|20735287|P6|NOT COMPLETED|Period 1||0
8412706|NCT00945321|20735288|P5|NOT COMPLETED|Period 1||1
8412707|NCT00945321|20735289|P4|NOT COMPLETED|Period 1||0
8412708|NCT00945321|20735290|P3|NOT COMPLETED|Period 1||0
8412709|NCT00945321|20735291|P2|NOT COMPLETED|Period 1||0
8412710|NCT00945321|20735292|P1|NOT COMPLETED|Period 1||0
8412711|NCT00945321|20735287|P6|COMPLETED|Period 1||7
8412712|NCT00945321|20735288|P5|COMPLETED|Period 1||6
8412713|NCT00945321|20735289|P4|COMPLETED|Period 1||7
8412714|NCT00945321|20735290|P3|COMPLETED|Period 1||7
8412715|NCT00945321|20735291|P2|COMPLETED|Period 1||7
8412716|NCT00945321|20735292|P1|COMPLETED|Period 1||7
8412717|NCT00945321|20735287|P6|STARTED|Period 1||7
8412718|NCT00945321|20735288|P5|STARTED|Period 1||7
8412719|NCT00945321|20735289|P4|STARTED|Period 1||7
8412720|NCT00945321|20735290|P3|STARTED|Period 1||7
8412721|NCT00945321|20735291|P2|STARTED|Period 1||7
8412722|NCT00945321|20735292|P1|STARTED|Period 1||7
8412723|NCT00945295|20735314|P2|NOT COMPLETED|Overall Study||2
8412724|NCT00945295|20735315|P1|NOT COMPLETED|Overall Study||0
8412725|NCT00945295|20735314|P2|COMPLETED|Overall Study||14
8412726|NCT00945295|20735315|P1|COMPLETED|Overall Study||15
8412727|NCT00945295|20735314|P2|STARTED|Overall Study||16
8412728|NCT00945295|20735315|P1|STARTED|Overall Study||15
8412729|NCT00945282|20735325|P2|NOT COMPLETED|Overall Study||0
8412730|NCT00945282|20735326|P1|NOT COMPLETED|Overall Study||0
8412731|NCT00945282|20735325|P2|COMPLETED|Overall Study||2
8412732|NCT00945282|20735326|P1|COMPLETED|Overall Study||6
8412733|NCT00945282|20735325|P2|STARTED|Overall Study||2
8412734|NCT00945282|20735326|P1|STARTED|Overall Study||6
8412735|NCT00945256|20735409|P5|NOT COMPLETED|Overall Study||1
8412736|NCT00945256|20735410|P4|NOT COMPLETED|Overall Study||9
8412737|NCT00945256|20735411|P3|NOT COMPLETED|Overall Study||8
8412738|NCT00945256|20735412|P2|NOT COMPLETED|Overall Study||2
8412739|NCT00945256|20735413|P1|NOT COMPLETED|Overall Study||4
8412740|NCT00945256|20735409|P5|COMPLETED|Overall Study||7
8412741|NCT00945256|20735410|P4|COMPLETED|Overall Study||7
8412742|NCT00945256|20735411|P3|COMPLETED|Overall Study||7
8412743|NCT00945256|20735412|P2|COMPLETED|Overall Study||8
8412744|NCT00945256|20735413|P1|COMPLETED|Overall Study||9
8412745|NCT00945256|20735409|P5|STARTED|Overall Study||8
8412746|NCT00945256|20735410|P4|STARTED|Overall Study||16
8412747|NCT00945256|20735411|P3|STARTED|Overall Study||15
8412748|NCT00945256|20735412|P2|STARTED|Overall Study||10
8412749|NCT00945256|20735413|P1|STARTED|Overall Study||13
8412750|NCT00945243|20735425|P1|NOT COMPLETED|Overall Study||3
8412751|NCT00945243|20735425|P1|COMPLETED|Overall Study||8
8412752|NCT00945243|20735425|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
8412756|NCT00945139|20735437|P1|NOT COMPLETED|Overall Study||0
8412757|NCT00945139|20735437|P1|COMPLETED|Overall Study||46
8412758|NCT00945139|20735437|P1|STARTED|Overall Study||46
8412759|NCT00945100|20735448|P2|NOT COMPLETED|Post-10 Week Primary Outcome||7
8412760|NCT00945100|20735449|P1|NOT COMPLETED|Post-10 Week Primary Outcome||4
8412761|NCT00945100|20735448|P2|COMPLETED|Post-10 Week Primary Outcome||56
8412762|NCT00945100|20735449|P1|COMPLETED|Post-10 Week Primary Outcome||51
8412763|NCT00945100|20735448|P2|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
8412764|NCT00945100|20735449|P1|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
8412765|NCT00945100|20735448|P2|NOT COMPLETED|10-week Primary Outcome||3
8412766|NCT00945100|20735449|P1|NOT COMPLETED|10-week Primary Outcome||1
8412767|NCT00945100|20735448|P2|COMPLETED|10-week Primary Outcome||83
8412768|NCT00945100|20735449|P1|COMPLETED|10-week Primary Outcome||82
8412769|NCT00945100|20735448|P2|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
8412770|NCT00945100|20735449|P1|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
8412771|NCT00945100|20735448|P2|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
8412772|NCT00945100|20735449|P1|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
8412773|NCT00945100|20735448|P2|STARTED|10-week Primary Outcome||86
8412774|NCT00945100|20735449|P1|STARTED|10-week Primary Outcome||83
8412775|NCT00945061|20735515|P2|NOT COMPLETED|Overall Study||0
8412776|NCT00945061|20735516|P1|NOT COMPLETED|Overall Study||0
8412777|NCT00945061|20735515|P2|COMPLETED|Overall Study||1
8412778|NCT00945061|20735516|P1|COMPLETED|Overall Study||12
8412779|NCT00945061|20735515|P2|STARTED|Overall Study||1
8412780|NCT00945061|20735516|P1|STARTED|Overall Study||12
8412781|NCT00945035|20735615|P2|NOT COMPLETED|Period 2||0
8412782|NCT00945035|20735616|P1|NOT COMPLETED|Period 2||0
8412783|NCT00945035|20735615|P2|COMPLETED|Period 2||18
8412784|NCT00945035|20735616|P1|COMPLETED|Period 2||18
8412785|NCT00945035|20735615|P2|STARTED|Period 2||18
8412786|NCT00945035|20735616|P1|STARTED|Period 2||18
8412787|NCT00945035|20735615|P2|NOT COMPLETED|Period 1||0
8412788|NCT00945035|20735616|P1|NOT COMPLETED|Period 1||0
8412789|NCT00945035|20735615|P2|COMPLETED|Period 1||18
8412790|NCT00945035|20735616|P1|COMPLETED|Period 1||18
8412791|NCT00945035|20735615|P2|STARTED|Period 1||18
8412792|NCT00945035|20735616|P1|STARTED|Period 1||18
8412805|NCT00944710|20735646|P2|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
8412806|NCT00944710|20735647|P1|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
8412807|NCT00944710|20735646|P2|COMPLETED|Additional Post 10-week Primary Outcome||22
8412808|NCT00944710|20735647|P1|COMPLETED|Additional Post 10-week Primary Outcome||23
8412809|NCT00944710|20735646|P2|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
8412810|NCT00944710|20735647|P1|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
8412811|NCT00944710|20735646|P2|STARTED|Additional Post 10-week Primary Outcome||33
8412812|NCT00944710|20735647|P1|STARTED|Additional Post 10-week Primary Outcome||40
8412813|NCT00944710|20735646|P2|NOT COMPLETED|12-week Visit (Off-treatment)||0
8412814|NCT00944710|20735647|P1|NOT COMPLETED|12-week Visit (Off-treatment)||0
8412815|NCT00944710|20735646|P2|COMPLETED|12-week Visit (Off-treatment)||33
8412816|NCT00944710|20735647|P1|COMPLETED|12-week Visit (Off-treatment)||40
8412817|NCT00944710|20735646|P2|STARTED|12-week Visit (Off-treatment)||33
8412818|NCT00944710|20735647|P1|STARTED|12-week Visit (Off-treatment)||40
8412819|NCT00944710|20735646|P2|NOT COMPLETED|10-week Primary Outcome||0
8412820|NCT00944710|20735647|P1|NOT COMPLETED|10-week Primary Outcome||0
8412821|NCT00944710|20735646|P2|COMPLETED|10-week Primary Outcome||33
8412822|NCT00944710|20735647|P1|COMPLETED|10-week Primary Outcome||40
8412823|NCT00944710|20735646|P2|STARTED|10-week Primary Outcome||33
8412824|NCT00944710|20735647|P1|STARTED|10-week Primary Outcome||40
8412825|NCT00944697|20735705|P2|NOT COMPLETED|Overall Study||5
8412826|NCT00944697|20735706|P1|NOT COMPLETED|Overall Study||2
8412827|NCT00944697|20735705|P2|COMPLETED|Overall Study||43
8412828|NCT00944697|20735706|P1|COMPLETED|Overall Study||48
8412829|NCT00944697|20735705|P2|STARTED|Overall Study||48
8412830|NCT00944697|20735706|P1|STARTED|Overall Study||50
8412831|NCT00944671|20735718|P6|NOT COMPLETED|Period III||0
8412832|NCT00944671|20735719|P5|NOT COMPLETED|Period III||0
8412833|NCT00944671|20735720|P4|NOT COMPLETED|Period III||0
8412834|NCT00944671|20735721|P3|NOT COMPLETED|Period III||0
8412835|NCT00944671|20735722|P2|NOT COMPLETED|Period III||0
8412836|NCT00944671|20735723|P1|NOT COMPLETED|Period III||0
8412837|NCT00944671|20735718|P6|COMPLETED|Period III||4
8412838|NCT00944671|20735719|P5|COMPLETED|Period III||4
8412839|NCT00944671|20735720|P4|COMPLETED|Period III||4
8412840|NCT00944671|20735721|P3|COMPLETED|Period III||4
8412841|NCT00944671|20735722|P2|COMPLETED|Period III||4
8412842|NCT00944671|20735723|P1|COMPLETED|Period III||4
8412843|NCT00944671|20735718|P6|STARTED|Period III||4
8412844|NCT00944671|20735719|P5|STARTED|Period III||4
8412845|NCT00944671|20735720|P4|STARTED|Period III||4
8412846|NCT00944671|20735721|P3|STARTED|Period III||4
8412847|NCT00944671|20735722|P2|STARTED|Period III||4
8412848|NCT00944671|20735723|P1|STARTED|Period III||4
8412849|NCT00944671|20735718|P6|NOT COMPLETED|Period II||0
8412850|NCT00944671|20735719|P5|NOT COMPLETED|Period II||0
8412851|NCT00944671|20735720|P4|NOT COMPLETED|Period II||0
8412852|NCT00944671|20735721|P3|NOT COMPLETED|Period II||0
8412853|NCT00944671|20735722|P2|NOT COMPLETED|Period II||0
8412854|NCT00944671|20735723|P1|NOT COMPLETED|Period II||0
8412855|NCT00944671|20735718|P6|COMPLETED|Period II||4
8412856|NCT00944671|20735719|P5|COMPLETED|Period II||4
8412857|NCT00944671|20735720|P4|COMPLETED|Period II||4
8412858|NCT00944671|20735721|P3|COMPLETED|Period II||4
8412859|NCT00944671|20735722|P2|COMPLETED|Period II||4
8412860|NCT00944671|20735723|P1|COMPLETED|Period II||4
8412861|NCT00944671|20735718|P6|STARTED|Period II||4
8412862|NCT00944671|20735719|P5|STARTED|Period II||4
8412863|NCT00944671|20735720|P4|STARTED|Period II||4
8412864|NCT00944671|20735721|P3|STARTED|Period II||4
8412865|NCT00944671|20735722|P2|STARTED|Period II||4
8412866|NCT00944671|20735723|P1|STARTED|Period II||4
8412867|NCT00944671|20735718|P6|NOT COMPLETED|Period I||0
8412868|NCT00944671|20735719|P5|NOT COMPLETED|Period I||0
8412869|NCT00944671|20735720|P4|NOT COMPLETED|Period I||0
8412870|NCT00944671|20735721|P3|NOT COMPLETED|Period I||0
8412871|NCT00944671|20735722|P2|NOT COMPLETED|Period I||0
8412872|NCT00944671|20735723|P1|NOT COMPLETED|Period I||0
8412873|NCT00944671|20735718|P6|COMPLETED|Period I||4
8412874|NCT00944671|20735719|P5|COMPLETED|Period I||4
8412875|NCT00944671|20735720|P4|COMPLETED|Period I||4
8412876|NCT00944671|20735721|P3|COMPLETED|Period I||4
8412877|NCT00944671|20735722|P2|COMPLETED|Period I||4
8412878|NCT00944671|20735723|P1|COMPLETED|Period I||4
8412879|NCT00944671|20735718|P6|STARTED|Period I||4
8412880|NCT00944671|20735719|P5|STARTED|Period I||4
8412881|NCT00944671|20735720|P4|STARTED|Period I||4
8412882|NCT00944671|20735721|P3|STARTED|Period I||4
8412883|NCT00944671|20735722|P2|STARTED|Period I||4
8412884|NCT00944671|20735723|P1|STARTED|Period I||4
8412885|NCT00944658|20735738|P2|NOT COMPLETED|Follow up 4 Weeks||0
8412886|NCT00944658|20735739|P1|NOT COMPLETED|Follow up 4 Weeks||0
8412887|NCT00944658|20735738|P2|COMPLETED|Follow up 4 Weeks||17
8412888|NCT00944658|20735739|P1|COMPLETED|Follow up 4 Weeks||19
8412889|NCT00944658|20735738|P2|STARTED|Follow up 4 Weeks||17
8412890|NCT00944658|20735739|P1|STARTED|Follow up 4 Weeks||19
8412891|NCT00944658|20735738|P2|NOT COMPLETED|Treatment 12 Weeks||2
8412892|NCT00944658|20735739|P1|NOT COMPLETED|Treatment 12 Weeks||0
8412893|NCT00944658|20735738|P2|COMPLETED|Treatment 12 Weeks||17
8412894|NCT00944658|20735739|P1|COMPLETED|Treatment 12 Weeks||19
8412895|NCT00944658|20735738|P2|STARTED|Treatment 12 Weeks||19
8412896|NCT00944658|20735739|P1|STARTED|Treatment 12 Weeks||19
8412897|NCT00944645|20735751|P2|NOT COMPLETED|Period 2||9
8412898|NCT00944645|20735752|P1|NOT COMPLETED|Period 2||8
8412899|NCT00944645|20735751|P2|COMPLETED|Period 2||85
8412900|NCT00944645|20735752|P1|COMPLETED|Period 2||86
8412901|NCT00944645|20735751|P2|STARTED|Period 2||94
8412902|NCT00944645|20735752|P1|STARTED|Period 2||94
8412903|NCT00944645|20735751|P2|NOT COMPLETED|Period 1||0
8412904|NCT00944645|20735752|P1|NOT COMPLETED|Period 1||0
8412905|NCT00944645|20735751|P2|COMPLETED|Period 1||94
8412906|NCT00944645|20735752|P1|COMPLETED|Period 1||94
8412907|NCT00944645|20735751|P2|STARTED|Period 1||94
8412908|NCT00944645|20735752|P1|STARTED|Period 1||94
8412909|NCT00944554|20735766|P2|NOT COMPLETED|Overall Study||29
8412910|NCT00944554|20735767|P1|NOT COMPLETED|Overall Study||28
8412911|NCT00944554|20735766|P2|COMPLETED|Overall Study||25
8412912|NCT00944554|20735767|P1|COMPLETED|Overall Study||22
8412913|NCT00944554|20735766|P2|STARTED|Overall Study||54
8412914|NCT00944554|20735767|P1|STARTED|Overall Study||50
8412924|NCT00944450|20735790|P2|NOT COMPLETED|Period 2||0
8412925|NCT00944450|20735791|P1|NOT COMPLETED|Period 2||0
8412926|NCT00944450|20735790|P2|COMPLETED|Period 2||6
8412927|NCT00944450|20735791|P1|COMPLETED|Period 2||6
8412928|NCT00944450|20735790|P2|STARTED|Period 2||6
8412929|NCT00944450|20735791|P1|STARTED|Period 2||6
8412930|NCT00944450|20735790|P2|NOT COMPLETED|Period 1||0
8412931|NCT00944450|20735791|P1|NOT COMPLETED|Period 1||0
8412932|NCT00944450|20735790|P2|COMPLETED|Period 1||6
8412933|NCT00944450|20735791|P1|COMPLETED|Period 1||6
8412934|NCT00944450|20735790|P2|STARTED|Period 1||6
8412935|NCT00944450|20735791|P1|STARTED|Period 1||6
8412936|NCT00944229|20735799|P1|NOT COMPLETED|Overall Study||25
8412937|NCT00944229|20735799|P1|COMPLETED|Overall Study||33
8412938|NCT00944229|20735799|P1|STARTED|Overall Study||58
8412939|NCT00944125|20735805|P2|NOT COMPLETED|6 Months to Study Completion||2
8412940|NCT00944125|20735806|P1|NOT COMPLETED|6 Months to Study Completion||0
8412941|NCT00944125|20735805|P2|COMPLETED|6 Months to Study Completion||18
8412942|NCT00944125|20735806|P1|COMPLETED|6 Months to Study Completion||19
8412943|NCT00944125|20735805|P2|STARTED|6 Months to Study Completion||20
8412944|NCT00944125|20735806|P1|STARTED|6 Months to Study Completion||19
8412945|NCT00944125|20735805|P2|NOT COMPLETED|3 to 6 Months||2
8412946|NCT00944125|20735806|P1|NOT COMPLETED|3 to 6 Months||0
8412947|NCT00944125|20735805|P2|COMPLETED|3 to 6 Months||20
8412948|NCT00944125|20735806|P1|COMPLETED|3 to 6 Months||19
8412949|NCT00944125|20735805|P2|STARTED|3 to 6 Months||22
8412950|NCT00944125|20735806|P1|STARTED|3 to 6 Months||19
8412951|NCT00944125|20735805|P2|NOT COMPLETED|Baseline to 3 Months||0
8412952|NCT00944125|20735806|P1|NOT COMPLETED|Baseline to 3 Months||0
8412953|NCT00944125|20735805|P2|COMPLETED|Baseline to 3 Months||22
8412954|NCT00944125|20735806|P1|COMPLETED|Baseline to 3 Months||19
8412955|NCT00944125|20735805|P2|STARTED|Baseline to 3 Months||22
8412956|NCT00944125|20735806|P1|STARTED|Baseline to 3 Months||19
8412957|NCT00944073|20735814|P2|NOT COMPLETED|Overall Study||4
8412958|NCT00944073|20735815|P1|NOT COMPLETED|Overall Study||5
8412959|NCT00944073|20735814|P2|COMPLETED|Overall Study||287
8412960|NCT00944073|20735815|P1|COMPLETED|Overall Study||287
8412961|NCT00944073|20735814|P2|STARTED|Overall Study||291
8412962|NCT00944073|20735815|P1|STARTED|Overall Study||292
8412963|NCT00944047|20735893|P1|NOT COMPLETED|Overall Study||5
8412964|NCT00944047|20735893|P1|COMPLETED|Overall Study||27
8412965|NCT00944047|20735893|P1|STARTED|Overall Study||32
8412966|NCT00944034|20735909|P12|NOT COMPLETED|Overall Study||4
8412967|NCT00944034|20735910|P11|NOT COMPLETED|Overall Study||1
8412968|NCT00944034|20735911|P10|NOT COMPLETED|Overall Study||10
8412969|NCT00944034|20735912|P9|NOT COMPLETED|Overall Study||10
8412970|NCT00944034|20735913|P8|NOT COMPLETED|Overall Study||5
8412971|NCT00944034|20735914|P7|NOT COMPLETED|Overall Study||4
8412972|NCT00944034|20735915|P6|NOT COMPLETED|Overall Study||20
8412973|NCT00944034|20735916|P5|NOT COMPLETED|Overall Study||14
8412974|NCT00944034|20735917|P4|NOT COMPLETED|Overall Study||4
8412975|NCT00944034|20735918|P3|NOT COMPLETED|Overall Study||9
8412976|NCT00944034|20735919|P2|NOT COMPLETED|Overall Study||7
8412977|NCT00944034|20735920|P1|NOT COMPLETED|Overall Study||5
8412978|NCT00944034|20735909|P12|COMPLETED|Overall Study||52
8412979|NCT00944034|20735910|P11|COMPLETED|Overall Study||50
8412980|NCT00944034|20735911|P10|COMPLETED|Overall Study||236
8412981|NCT00944034|20735912|P9|COMPLETED|Overall Study||63
8412982|NCT00944034|20735913|P8|COMPLETED|Overall Study||73
8412983|NCT00944034|20735914|P7|COMPLETED|Overall Study||102
8412984|NCT00944034|20735915|P6|COMPLETED|Overall Study||123
8412985|NCT00944034|20735916|P5|COMPLETED|Overall Study||150
8412986|NCT00944034|20735917|P4|COMPLETED|Overall Study||170
8412987|NCT00944034|20735918|P3|COMPLETED|Overall Study||143
8412988|NCT00944034|20735919|P2|COMPLETED|Overall Study||150
8412989|NCT00944034|20735920|P1|COMPLETED|Overall Study||183
8412990|NCT00944034|20735909|P12|STARTED|Overall Study||56
8412991|NCT00944034|20735910|P11|STARTED|Overall Study||51
8412992|NCT00944034|20735911|P10|STARTED|Overall Study||246
8412993|NCT00944034|20735912|P9|STARTED|Overall Study||73
8412994|NCT00944034|20735913|P8|STARTED|Overall Study||78
8412995|NCT00944034|20735914|P7|STARTED|Overall Study||106
8412996|NCT00944034|20735915|P6|STARTED|Overall Study||143
8412997|NCT00944034|20735916|P5|STARTED|Overall Study||164
8412998|NCT00944034|20735917|P4|STARTED|Overall Study||174
8412999|NCT00944034|20735918|P3|STARTED|Overall Study||152
8413000|NCT00944034|20735919|P2|STARTED|Overall Study||157
8413001|NCT00944034|20735920|P1|STARTED|Overall Study||188
8413002|NCT00944021|20735990|P5|NOT COMPLETED|Overall Study||0
8413003|NCT00944021|20735991|P4|NOT COMPLETED|Overall Study||0
8413004|NCT00944021|20735992|P3|NOT COMPLETED|Overall Study||0
8413005|NCT00944021|20735993|P2|NOT COMPLETED|Overall Study||0
8413006|NCT00944021|20735994|P1|NOT COMPLETED|Overall Study||1
8413007|NCT00944021|20735990|P5|COMPLETED|Overall Study||8
8413008|NCT00944021|20735991|P4|COMPLETED|Overall Study||16
8413009|NCT00944021|20735992|P3|COMPLETED|Overall Study||15
8413010|NCT00944021|20735993|P2|COMPLETED|Overall Study||15
8413011|NCT00944021|20735994|P1|COMPLETED|Overall Study||14
8413012|NCT00944021|20735990|P5|STARTED|Overall Study||8
8413013|NCT00944021|20735991|P4|STARTED|Overall Study||16
8413014|NCT00944021|20735992|P3|STARTED|Overall Study||15
8413015|NCT00944021|20735993|P2|STARTED|Overall Study||15
8413016|NCT00944021|20735994|P1|STARTED|Overall Study||15
8413017|NCT00943917|20736066|P15|NOT COMPLETED|Stage II Continuation||4
8413018|NCT00943917|20736067|P14|NOT COMPLETED|Stage II Continuation||3
8413019|NCT00943917|20736068|P13|NOT COMPLETED|Stage II Continuation||3
8413020|NCT00943917|20736069|P12|NOT COMPLETED|Stage II Continuation||2
8413021|NCT00943917|20736070|P11|NOT COMPLETED|Stage II Continuation||0
8413022|NCT00943917|20736071|P10|NOT COMPLETED|Stage II Continuation||1
8413023|NCT00943917|20736072|P9|NOT COMPLETED|Stage II Continuation||0
8413024|NCT00943917|20736073|P8|NOT COMPLETED|Stage II Continuation||0
8413025|NCT00943917|20736074|P7|NOT COMPLETED|Stage II Continuation||0
8413026|NCT00943917|20736075|P6|NOT COMPLETED|Stage II Continuation||0
8413027|NCT00943917|20736076|P5|NOT COMPLETED|Stage II Continuation||0
8413028|NCT00943917|20736077|P4|NOT COMPLETED|Stage II Continuation||0
8413029|NCT00943917|20736078|P3|NOT COMPLETED|Stage II Continuation||0
8413030|NCT00943917|20736079|P2|NOT COMPLETED|Stage II Continuation||0
8413031|NCT00943917|20736080|P1|NOT COMPLETED|Stage II Continuation||0
8413032|NCT00943917|20736066|P15|COMPLETED|Stage II Continuation||8
8413033|NCT00943917|20736067|P14|COMPLETED|Stage II Continuation||12
8413034|NCT00943917|20736068|P13|COMPLETED|Stage II Continuation||13
8413035|NCT00943917|20736069|P12|COMPLETED|Stage II Continuation||11
8413036|NCT00943917|20736070|P11|COMPLETED|Stage II Continuation||15
8413037|NCT00943917|20736071|P10|COMPLETED|Stage II Continuation||14
8413038|NCT00943917|20736072|P9|COMPLETED|Stage II Continuation||0
8413039|NCT00943917|20736073|P8|COMPLETED|Stage II Continuation||0
8413040|NCT00943917|20736074|P7|COMPLETED|Stage II Continuation||0
8413041|NCT00943917|20736075|P6|COMPLETED|Stage II Continuation||0
8413042|NCT00943917|20736076|P5|COMPLETED|Stage II Continuation||0
8413043|NCT00943917|20736077|P4|COMPLETED|Stage II Continuation||0
8413044|NCT00943917|20736078|P3|COMPLETED|Stage II Continuation||0
8413045|NCT00943917|20736079|P2|COMPLETED|Stage II Continuation||0
8413046|NCT00943917|20736080|P1|COMPLETED|Stage II Continuation||0
8413047|NCT00943917|20736066|P15|STARTED|Stage II Continuation||12
8413048|NCT00943917|20736067|P14|STARTED|Stage II Continuation||15
8413049|NCT00943917|20736068|P13|STARTED|Stage II Continuation||16
8413050|NCT00943917|20736069|P12|STARTED|Stage II Continuation||13
8413051|NCT00943917|20736070|P11|STARTED|Stage II Continuation||15
8413052|NCT00943917|20736071|P10|STARTED|Stage II Continuation||15
8413053|NCT00943917|20736072|P9|STARTED|Stage II Continuation||0
8413054|NCT00943917|20736073|P8|STARTED|Stage II Continuation||0
8413055|NCT00943917|20736074|P7|STARTED|Stage II Continuation||0
8413056|NCT00943917|20736075|P6|STARTED|Stage II Continuation||0
8413057|NCT00943917|20736076|P5|STARTED|Stage II Continuation||0
8413058|NCT00943917|20736077|P4|STARTED|Stage II Continuation||0
8413059|NCT00943917|20736078|P3|STARTED|Stage II Continuation||0
8413060|NCT00943917|20736079|P2|STARTED|Stage II Continuation||0
8413061|NCT00943917|20736080|P1|STARTED|Stage II Continuation||0
8413062|NCT00943917|20736066|P15|NOT COMPLETED|Stage II||0
8413063|NCT00943917|20736067|P14|NOT COMPLETED|Stage II||0
8413064|NCT00943917|20736068|P13|NOT COMPLETED|Stage II||0
8413065|NCT00943917|20736069|P12|NOT COMPLETED|Stage II||0
8413066|NCT00943917|20736070|P11|NOT COMPLETED|Stage II||0
8413067|NCT00943917|20736071|P10|NOT COMPLETED|Stage II||0
8413068|NCT00943917|20736072|P9|NOT COMPLETED|Stage II||1
8413069|NCT00943917|20736073|P8|NOT COMPLETED|Stage II||0
8413070|NCT00943917|20736074|P7|NOT COMPLETED|Stage II||3
8413071|NCT00943917|20736075|P6|NOT COMPLETED|Stage II||3
8413072|NCT00943917|20736076|P5|NOT COMPLETED|Stage II||0
8413073|NCT00943917|20736077|P4|NOT COMPLETED|Stage II||0
8413074|NCT00943917|20736078|P3|NOT COMPLETED|Stage II||0
8413075|NCT00943917|20736079|P2|NOT COMPLETED|Stage II||0
8413076|NCT00943917|20736080|P1|NOT COMPLETED|Stage II||0
8413077|NCT00943917|20736066|P15|COMPLETED|Stage II||0
8413078|NCT00943917|20736067|P14|COMPLETED|Stage II||0
8413079|NCT00943917|20736068|P13|COMPLETED|Stage II||0
8413080|NCT00943917|20736069|P12|COMPLETED|Stage II||0
8413081|NCT00943917|20736070|P11|COMPLETED|Stage II||0
8413082|NCT00943917|20736071|P10|COMPLETED|Stage II||0
8413083|NCT00943917|20736072|P9|COMPLETED|Stage II||20
8413084|NCT00943917|20736073|P8|COMPLETED|Stage II||23
8413085|NCT00943917|20736074|P7|COMPLETED|Stage II||20
8413086|NCT00943917|20736075|P6|COMPLETED|Stage II||20
8413087|NCT00943917|20736076|P5|COMPLETED|Stage II||21
8413088|NCT00943917|20736077|P4|COMPLETED|Stage II||20
8413089|NCT00943917|20736078|P3|COMPLETED|Stage II||0
8413090|NCT00943917|20736079|P2|COMPLETED|Stage II||0
8413091|NCT00943917|20736080|P1|COMPLETED|Stage II||0
8413092|NCT00943917|20736066|P15|STARTED|Stage II||0
8413093|NCT00943917|20736067|P14|STARTED|Stage II||0
8413094|NCT00943917|20736068|P13|STARTED|Stage II||0
8413095|NCT00943917|20736069|P12|STARTED|Stage II||0
8413096|NCT00943917|20736070|P11|STARTED|Stage II||0
8413097|NCT00943917|20736071|P10|STARTED|Stage II||0
8413098|NCT00943917|20736072|P9|STARTED|Stage II||21
8413099|NCT00943917|20736073|P8|STARTED|Stage II||23
8413100|NCT00943917|20736074|P7|STARTED|Stage II||23
8413101|NCT00943917|20736075|P6|STARTED|Stage II||23
8413102|NCT00943917|20736076|P5|STARTED|Stage II||21
8413103|NCT00943917|20736077|P4|STARTED|Stage II||20
8413104|NCT00943917|20736078|P3|STARTED|Stage II||0
8413105|NCT00943917|20736079|P2|STARTED|Stage II||0
8413106|NCT00943917|20736080|P1|STARTED|Stage II||0
8413107|NCT00943917|20736066|P15|NOT COMPLETED|Stage I||0
8413108|NCT00943917|20736067|P14|NOT COMPLETED|Stage I||0
8413109|NCT00943917|20736068|P13|NOT COMPLETED|Stage I||0
8413110|NCT00943917|20736069|P12|NOT COMPLETED|Stage I||0
8413111|NCT00943917|20736070|P11|NOT COMPLETED|Stage I||0
8413112|NCT00943917|20736071|P10|NOT COMPLETED|Stage I||0
8413113|NCT00943917|20736072|P9|NOT COMPLETED|Stage I||0
8413114|NCT00943917|20736073|P8|NOT COMPLETED|Stage I||0
8413115|NCT00943917|20736074|P7|NOT COMPLETED|Stage I||0
8413116|NCT00943917|20736075|P6|NOT COMPLETED|Stage I||0
8413117|NCT00943917|20736076|P5|NOT COMPLETED|Stage I||0
8413118|NCT00943917|20736077|P4|NOT COMPLETED|Stage I||0
8413119|NCT00943917|20736078|P3|NOT COMPLETED|Stage I||6
8413120|NCT00943917|20736079|P2|NOT COMPLETED|Stage I||3
8413121|NCT00943917|20736080|P1|NOT COMPLETED|Stage I||4
8413122|NCT00943917|20736066|P15|COMPLETED|Stage I||0
8413123|NCT00943917|20736067|P14|COMPLETED|Stage I||0
8413124|NCT00943917|20736068|P13|COMPLETED|Stage I||0
8413125|NCT00943917|20736069|P12|COMPLETED|Stage I||0
8413126|NCT00943917|20736070|P11|COMPLETED|Stage I||0
8413127|NCT00943917|20736071|P10|COMPLETED|Stage I||0
8413128|NCT00943917|20736072|P9|COMPLETED|Stage I||0
8413129|NCT00943917|20736073|P8|COMPLETED|Stage I||0
8413130|NCT00943917|20736074|P7|COMPLETED|Stage I||0
8413131|NCT00943917|20736075|P6|COMPLETED|Stage I||0
8413132|NCT00943917|20736076|P5|COMPLETED|Stage I||0
8413133|NCT00943917|20736077|P4|COMPLETED|Stage I||0
8413134|NCT00943917|20736078|P3|COMPLETED|Stage I||47
8413135|NCT00943917|20736079|P2|COMPLETED|Stage I||48
8413136|NCT00943917|20736080|P1|COMPLETED|Stage I||47
8413137|NCT00943917|20736066|P15|STARTED|Stage I||0
8413138|NCT00943917|20736067|P14|STARTED|Stage I||0
8413139|NCT00943917|20736068|P13|STARTED|Stage I||0
8413140|NCT00943917|20736069|P12|STARTED|Stage I||0
8413141|NCT00943917|20736070|P11|STARTED|Stage I||0
8413142|NCT00943917|20736071|P10|STARTED|Stage I||0
8413143|NCT00943917|20736072|P9|STARTED|Stage I||0
8413144|NCT00943917|20736073|P8|STARTED|Stage I||0
8413145|NCT00943917|20736074|P7|STARTED|Stage I||0
8413146|NCT00943917|20736075|P6|STARTED|Stage I||0
8413147|NCT00943917|20736076|P5|STARTED|Stage I||0
8413148|NCT00943917|20736077|P4|STARTED|Stage I||0
8413149|NCT00943917|20736078|P3|STARTED|Stage I||53
8413150|NCT00943917|20736079|P2|STARTED|Stage I||51
8413151|NCT00943917|20736080|P1|STARTED|Stage I||51
8413152|NCT00943878|20736131|P4|NOT COMPLETED|Overall Study||2
8413153|NCT00943878|20736132|P3|NOT COMPLETED|Overall Study||6
8413154|NCT00943878|20736133|P2|NOT COMPLETED|Overall Study||2
8413155|NCT00943878|20736134|P1|NOT COMPLETED|Overall Study||2
8413156|NCT00943878|20736131|P4|COMPLETED|Overall Study||198
8413157|NCT00943878|20736132|P3|COMPLETED|Overall Study||197
8413158|NCT00943878|20736133|P2|COMPLETED|Overall Study||198
8413159|NCT00943878|20736134|P1|COMPLETED|Overall Study||200
8413160|NCT00943878|20736131|P4|STARTED|Overall Study||200
8413161|NCT00943878|20736132|P3|STARTED|Overall Study||203
8413162|NCT00943878|20736133|P2|STARTED|Overall Study||200
8413163|NCT00943878|20736134|P1|STARTED|Overall Study||202
8413164|NCT00943852|20736256|P10|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413165|NCT00943852|20736257|P9|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413166|NCT00943852|20736258|P8|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413167|NCT00943852|20736259|P7|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413168|NCT00943852|20736260|P6|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413169|NCT00943852|20736261|P5|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413170|NCT00943852|20736262|P4|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413171|NCT00943852|20736263|P3|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413172|NCT00943852|20736264|P2|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413173|NCT00943852|20736265|P1|NOT COMPLETED|Fifth Period of Treatment Intervention||0
8413174|NCT00943852|20736256|P10|COMPLETED|Fifth Period of Treatment Intervention||1
8413175|NCT00943852|20736257|P9|COMPLETED|Fifth Period of Treatment Intervention||1
8413176|NCT00943852|20736258|P8|COMPLETED|Fifth Period of Treatment Intervention||0
8413177|NCT00943852|20736259|P7|COMPLETED|Fifth Period of Treatment Intervention||0
8413178|NCT00943852|20736260|P6|COMPLETED|Fifth Period of Treatment Intervention||0
8413179|NCT00943852|20736261|P5|COMPLETED|Fifth Period of Treatment Intervention||1
8413180|NCT00943852|20736262|P4|COMPLETED|Fifth Period of Treatment Intervention||0
8413181|NCT00943852|20736263|P3|COMPLETED|Fifth Period of Treatment Intervention||0
8413182|NCT00943852|20736264|P2|COMPLETED|Fifth Period of Treatment Intervention||1
8413183|NCT00943852|20736265|P1|COMPLETED|Fifth Period of Treatment Intervention||1
8413184|NCT00943852|20736256|P10|STARTED|Fifth Period of Treatment Intervention||1
8413185|NCT00943852|20736257|P9|STARTED|Fifth Period of Treatment Intervention||1
8413186|NCT00943852|20736258|P8|STARTED|Fifth Period of Treatment Intervention||0
8413187|NCT00943852|20736259|P7|STARTED|Fifth Period of Treatment Intervention||0
8413188|NCT00943852|20736260|P6|STARTED|Fifth Period of Treatment Intervention||0
8413189|NCT00943852|20736261|P5|STARTED|Fifth Period of Treatment Intervention||1
8413190|NCT00943852|20736262|P4|STARTED|Fifth Period of Treatment Intervention||0
8413191|NCT00943852|20736263|P3|STARTED|Fifth Period of Treatment Intervention||0
8413192|NCT00943852|20736264|P2|STARTED|Fifth Period of Treatment Intervention||1
8413193|NCT00943852|20736265|P1|STARTED|Fifth Period of Treatment Intervention||1
8413194|NCT00943852|20736256|P10|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8413195|NCT00943852|20736257|P9|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8413196|NCT00943852|20736258|P8|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8413197|NCT00943852|20736259|P7|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8413198|NCT00943852|20736260|P6|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8413199|NCT00943852|20736261|P5|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8413200|NCT00943852|20736262|P4|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8413201|NCT00943852|20736263|P3|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8413202|NCT00943852|20736264|P2|NOT COMPLETED|Washout Period After Period 4 Treatment||0
8413203|NCT00943852|20736265|P1|NOT COMPLETED|Washout Period After Period 4 Treatment||1
8413204|NCT00943852|20736256|P10|COMPLETED|Washout Period After Period 4 Treatment||1
8413205|NCT00943852|20736257|P9|COMPLETED|Washout Period After Period 4 Treatment||1
8413206|NCT00943852|20736258|P8|COMPLETED|Washout Period After Period 4 Treatment||0
8413207|NCT00943852|20736259|P7|COMPLETED|Washout Period After Period 4 Treatment||0
8413208|NCT00943852|20736260|P6|COMPLETED|Washout Period After Period 4 Treatment||0
8413209|NCT00943852|20736261|P5|COMPLETED|Washout Period After Period 4 Treatment||1
8413210|NCT00943852|20736262|P4|COMPLETED|Washout Period After Period 4 Treatment||0
8413211|NCT00943852|20736263|P3|COMPLETED|Washout Period After Period 4 Treatment||0
8413212|NCT00943852|20736264|P2|COMPLETED|Washout Period After Period 4 Treatment||1
8413213|NCT00943852|20736265|P1|COMPLETED|Washout Period After Period 4 Treatment||1
8413214|NCT00943852|20736256|P10|STARTED|Washout Period After Period 4 Treatment||1
8413215|NCT00943852|20736257|P9|STARTED|Washout Period After Period 4 Treatment||1
8413216|NCT00943852|20736258|P8|STARTED|Washout Period After Period 4 Treatment||1
8413217|NCT00943852|20736259|P7|STARTED|Washout Period After Period 4 Treatment||1
8413218|NCT00943852|20736260|P6|STARTED|Washout Period After Period 4 Treatment||0
8413219|NCT00943852|20736261|P5|STARTED|Washout Period After Period 4 Treatment||1
8413220|NCT00943852|20736262|P4|STARTED|Washout Period After Period 4 Treatment||1
8413221|NCT00943852|20736263|P3|STARTED|Washout Period After Period 4 Treatment||1
8413222|NCT00943852|20736264|P2|STARTED|Washout Period After Period 4 Treatment||1
8413223|NCT00943852|20736265|P1|STARTED|Washout Period After Period 4 Treatment||2
8413224|NCT00943852|20736256|P10|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413225|NCT00943852|20736257|P9|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413226|NCT00943852|20736258|P8|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413227|NCT00943852|20736259|P7|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413228|NCT00943852|20736260|P6|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413229|NCT00943852|20736261|P5|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413230|NCT00943852|20736262|P4|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413231|NCT00943852|20736263|P3|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413232|NCT00943852|20736264|P2|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413233|NCT00943852|20736265|P1|NOT COMPLETED|Fourth Period of Treatment Intervention||0
8413234|NCT00943852|20736256|P10|COMPLETED|Fourth Period of Treatment Intervention||1
8413235|NCT00943852|20736257|P9|COMPLETED|Fourth Period of Treatment Intervention||1
8413236|NCT00943852|20736258|P8|COMPLETED|Fourth Period of Treatment Intervention||1
8413237|NCT00943852|20736259|P7|COMPLETED|Fourth Period of Treatment Intervention||1
8413238|NCT00943852|20736260|P6|COMPLETED|Fourth Period of Treatment Intervention||0
8413239|NCT00943852|20736261|P5|COMPLETED|Fourth Period of Treatment Intervention||1
8413240|NCT00943852|20736262|P4|COMPLETED|Fourth Period of Treatment Intervention||1
8413241|NCT00943852|20736263|P3|COMPLETED|Fourth Period of Treatment Intervention||1
8413242|NCT00943852|20736264|P2|COMPLETED|Fourth Period of Treatment Intervention||1
8413243|NCT00943852|20736265|P1|COMPLETED|Fourth Period of Treatment Intervention||2
8413244|NCT00943852|20736256|P10|STARTED|Fourth Period of Treatment Intervention||1
8413245|NCT00943852|20736257|P9|STARTED|Fourth Period of Treatment Intervention||1
8413246|NCT00943852|20736258|P8|STARTED|Fourth Period of Treatment Intervention||1
8413247|NCT00943852|20736259|P7|STARTED|Fourth Period of Treatment Intervention||1
8413248|NCT00943852|20736260|P6|STARTED|Fourth Period of Treatment Intervention||0
8413249|NCT00943852|20736261|P5|STARTED|Fourth Period of Treatment Intervention||1
8413250|NCT00943852|20736262|P4|STARTED|Fourth Period of Treatment Intervention||1
8413251|NCT00943852|20736263|P3|STARTED|Fourth Period of Treatment Intervention||1
8413252|NCT00943852|20736264|P2|STARTED|Fourth Period of Treatment Intervention||1
8413253|NCT00943852|20736265|P1|STARTED|Fourth Period of Treatment Intervention||2
8413254|NCT00943852|20736256|P10|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413255|NCT00943852|20736257|P9|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413256|NCT00943852|20736258|P8|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413257|NCT00943852|20736259|P7|NOT COMPLETED|Washout Period After Period 3 Treatment||1
8413258|NCT00943852|20736260|P6|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413259|NCT00943852|20736261|P5|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413260|NCT00943852|20736262|P4|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413261|NCT00943852|20736263|P3|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413262|NCT00943852|20736264|P2|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413263|NCT00943852|20736265|P1|NOT COMPLETED|Washout Period After Period 3 Treatment||0
8413264|NCT00943852|20736256|P10|COMPLETED|Washout Period After Period 3 Treatment||1
8413265|NCT00943852|20736257|P9|COMPLETED|Washout Period After Period 3 Treatment||1
8413266|NCT00943852|20736258|P8|COMPLETED|Washout Period After Period 3 Treatment||1
8413267|NCT00943852|20736259|P7|COMPLETED|Washout Period After Period 3 Treatment||1
8413268|NCT00943852|20736260|P6|COMPLETED|Washout Period After Period 3 Treatment||0
8413269|NCT00943852|20736261|P5|COMPLETED|Washout Period After Period 3 Treatment||1
8413270|NCT00943852|20736262|P4|COMPLETED|Washout Period After Period 3 Treatment||1
8413271|NCT00943852|20736263|P3|COMPLETED|Washout Period After Period 3 Treatment||1
8413272|NCT00943852|20736264|P2|COMPLETED|Washout Period After Period 3 Treatment||1
8413273|NCT00943852|20736265|P1|COMPLETED|Washout Period After Period 3 Treatment||2
8413274|NCT00943852|20736256|P10|STARTED|Washout Period After Period 3 Treatment||1
8413275|NCT00943852|20736257|P9|STARTED|Washout Period After Period 3 Treatment||1
8413276|NCT00943852|20736258|P8|STARTED|Washout Period After Period 3 Treatment||1
8413277|NCT00943852|20736259|P7|STARTED|Washout Period After Period 3 Treatment||2
8413278|NCT00943852|20736260|P6|STARTED|Washout Period After Period 3 Treatment||0
8413279|NCT00943852|20736261|P5|STARTED|Washout Period After Period 3 Treatment||1
8413280|NCT00943852|20736262|P4|STARTED|Washout Period After Period 3 Treatment||1
8413281|NCT00943852|20736263|P3|STARTED|Washout Period After Period 3 Treatment||1
8413282|NCT00943852|20736264|P2|STARTED|Washout Period After Period 3 Treatment||1
8413283|NCT00943852|20736265|P1|STARTED|Washout Period After Period 3 Treatment||2
8413284|NCT00943852|20736256|P10|NOT COMPLETED|Third Period of Treatment Intervention||0
8413285|NCT00943852|20736257|P9|NOT COMPLETED|Third Period of Treatment Intervention||0
8413286|NCT00943852|20736258|P8|NOT COMPLETED|Third Period of Treatment Intervention||0
8413287|NCT00943852|20736259|P7|NOT COMPLETED|Third Period of Treatment Intervention||0
8413288|NCT00943852|20736260|P6|NOT COMPLETED|Third Period of Treatment Intervention||0
8413289|NCT00943852|20736261|P5|NOT COMPLETED|Third Period of Treatment Intervention||0
8413290|NCT00943852|20736262|P4|NOT COMPLETED|Third Period of Treatment Intervention||0
8413291|NCT00943852|20736263|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
8413292|NCT00943852|20736264|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
8413293|NCT00943852|20736265|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
8413294|NCT00943852|20736256|P10|COMPLETED|Third Period of Treatment Intervention||1
8413295|NCT00943852|20736257|P9|COMPLETED|Third Period of Treatment Intervention||1
8413296|NCT00943852|20736258|P8|COMPLETED|Third Period of Treatment Intervention||1
8413297|NCT00943852|20736259|P7|COMPLETED|Third Period of Treatment Intervention||2
8413298|NCT00943852|20736260|P6|COMPLETED|Third Period of Treatment Intervention||0
8413299|NCT00943852|20736261|P5|COMPLETED|Third Period of Treatment Intervention||1
8413300|NCT00943852|20736262|P4|COMPLETED|Third Period of Treatment Intervention||1
8413301|NCT00943852|20736263|P3|COMPLETED|Third Period of Treatment Intervention||1
8413302|NCT00943852|20736264|P2|COMPLETED|Third Period of Treatment Intervention||1
8413303|NCT00943852|20736265|P1|COMPLETED|Third Period of Treatment Intervention||2
8413304|NCT00943852|20736256|P10|STARTED|Third Period of Treatment Intervention||1
8413305|NCT00943852|20736257|P9|STARTED|Third Period of Treatment Intervention||1
8413306|NCT00943852|20736258|P8|STARTED|Third Period of Treatment Intervention||1
8413307|NCT00943852|20736259|P7|STARTED|Third Period of Treatment Intervention||2
8413308|NCT00943852|20736260|P6|STARTED|Third Period of Treatment Intervention||0
8413309|NCT00943852|20736261|P5|STARTED|Third Period of Treatment Intervention||1
8413310|NCT00943852|20736262|P4|STARTED|Third Period of Treatment Intervention||1
8413311|NCT00943852|20736263|P3|STARTED|Third Period of Treatment Intervention||1
8413312|NCT00943852|20736264|P2|STARTED|Third Period of Treatment Intervention||1
8413313|NCT00943852|20736265|P1|STARTED|Third Period of Treatment Intervention||2
8413314|NCT00943852|20736256|P10|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413315|NCT00943852|20736257|P9|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413316|NCT00943852|20736258|P8|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413317|NCT00943852|20736259|P7|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413318|NCT00943852|20736260|P6|NOT COMPLETED|Washout Period After Period 2 Treatment||1
8413319|NCT00943852|20736261|P5|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413320|NCT00943852|20736262|P4|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413321|NCT00943852|20736263|P3|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413322|NCT00943852|20736264|P2|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413323|NCT00943852|20736265|P1|NOT COMPLETED|Washout Period After Period 2 Treatment||0
8413324|NCT00943852|20736256|P10|COMPLETED|Washout Period After Period 2 Treatment||1
8413325|NCT00943852|20736257|P9|COMPLETED|Washout Period After Period 2 Treatment||1
8413326|NCT00943852|20736258|P8|COMPLETED|Washout Period After Period 2 Treatment||1
8413327|NCT00943852|20736259|P7|COMPLETED|Washout Period After Period 2 Treatment||2
8413328|NCT00943852|20736260|P6|COMPLETED|Washout Period After Period 2 Treatment||0
8413329|NCT00943852|20736261|P5|COMPLETED|Washout Period After Period 2 Treatment||1
8413330|NCT00943852|20736262|P4|COMPLETED|Washout Period After Period 2 Treatment||1
8413331|NCT00943852|20736263|P3|COMPLETED|Washout Period After Period 2 Treatment||1
8413332|NCT00943852|20736264|P2|COMPLETED|Washout Period After Period 2 Treatment||1
8413333|NCT00943852|20736265|P1|COMPLETED|Washout Period After Period 2 Treatment||2
8413334|NCT00943852|20736256|P10|STARTED|Washout Period After Period 2 Treatment||1
8413335|NCT00943852|20736257|P9|STARTED|Washout Period After Period 2 Treatment||1
8413336|NCT00943852|20736258|P8|STARTED|Washout Period After Period 2 Treatment||1
8413337|NCT00943852|20736259|P7|STARTED|Washout Period After Period 2 Treatment||2
8413338|NCT00943852|20736260|P6|STARTED|Washout Period After Period 2 Treatment||1
8413339|NCT00943852|20736261|P5|STARTED|Washout Period After Period 2 Treatment||1
8413340|NCT00943852|20736262|P4|STARTED|Washout Period After Period 2 Treatment||1
8413341|NCT00943852|20736263|P3|STARTED|Washout Period After Period 2 Treatment||1
8413342|NCT00943852|20736264|P2|STARTED|Washout Period After Period 2 Treatment||1
8413343|NCT00943852|20736265|P1|STARTED|Washout Period After Period 2 Treatment||2
8413344|NCT00943852|20736256|P10|NOT COMPLETED|Second Period of Treatment Intervention||0
8413345|NCT00943852|20736257|P9|NOT COMPLETED|Second Period of Treatment Intervention||0
8413346|NCT00943852|20736258|P8|NOT COMPLETED|Second Period of Treatment Intervention||0
8413347|NCT00943852|20736259|P7|NOT COMPLETED|Second Period of Treatment Intervention||0
8413348|NCT00943852|20736260|P6|NOT COMPLETED|Second Period of Treatment Intervention||0
8413349|NCT00943852|20736261|P5|NOT COMPLETED|Second Period of Treatment Intervention||0
8413350|NCT00943852|20736262|P4|NOT COMPLETED|Second Period of Treatment Intervention||0
8413351|NCT00943852|20736263|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
8413352|NCT00943852|20736264|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
8413353|NCT00943852|20736265|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
8413354|NCT00943852|20736256|P10|COMPLETED|Second Period of Treatment Intervention||1
8413355|NCT00943852|20736257|P9|COMPLETED|Second Period of Treatment Intervention||1
8413356|NCT00943852|20736258|P8|COMPLETED|Second Period of Treatment Intervention||1
8413357|NCT00943852|20736259|P7|COMPLETED|Second Period of Treatment Intervention||2
8413358|NCT00943852|20736260|P6|COMPLETED|Second Period of Treatment Intervention||1
8413359|NCT00943852|20736261|P5|COMPLETED|Second Period of Treatment Intervention||1
8413360|NCT00943852|20736262|P4|COMPLETED|Second Period of Treatment Intervention||1
8413361|NCT00943852|20736263|P3|COMPLETED|Second Period of Treatment Intervention||1
8413362|NCT00943852|20736264|P2|COMPLETED|Second Period of Treatment Intervention||1
8413363|NCT00943852|20736265|P1|COMPLETED|Second Period of Treatment Intervention||2
8413364|NCT00943852|20736256|P10|STARTED|Second Period of Treatment Intervention||1
8413365|NCT00943852|20736257|P9|STARTED|Second Period of Treatment Intervention||1
8413366|NCT00943852|20736258|P8|STARTED|Second Period of Treatment Intervention||1
8413367|NCT00943852|20736259|P7|STARTED|Second Period of Treatment Intervention||2
8413368|NCT00943852|20736260|P6|STARTED|Second Period of Treatment Intervention||1
8413369|NCT00943852|20736261|P5|STARTED|Second Period of Treatment Intervention||1
8413370|NCT00943852|20736262|P4|STARTED|Second Period of Treatment Intervention||1
8413371|NCT00943852|20736263|P3|STARTED|Second Period of Treatment Intervention||1
8413372|NCT00943852|20736264|P2|STARTED|Second Period of Treatment Intervention||1
8413373|NCT00943852|20736265|P1|STARTED|Second Period of Treatment Intervention||2
8413374|NCT00943852|20736256|P10|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413375|NCT00943852|20736257|P9|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413376|NCT00943852|20736258|P8|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413377|NCT00943852|20736259|P7|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413378|NCT00943852|20736260|P6|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413379|NCT00943852|20736261|P5|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413380|NCT00943852|20736262|P4|NOT COMPLETED|Washout Period After Period 1 Treatment||1
8413381|NCT00943852|20736263|P3|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413382|NCT00943852|20736264|P2|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413383|NCT00943852|20736265|P1|NOT COMPLETED|Washout Period After Period 1 Treatment||0
8413384|NCT00943852|20736256|P10|COMPLETED|Washout Period After Period 1 Treatment||1
8413385|NCT00943852|20736257|P9|COMPLETED|Washout Period After Period 1 Treatment||1
8413386|NCT00943852|20736258|P8|COMPLETED|Washout Period After Period 1 Treatment||1
8413387|NCT00943852|20736259|P7|COMPLETED|Washout Period After Period 1 Treatment||2
8413388|NCT00943852|20736260|P6|COMPLETED|Washout Period After Period 1 Treatment||1
8413389|NCT00943852|20736261|P5|COMPLETED|Washout Period After Period 1 Treatment||1
8413390|NCT00943852|20736262|P4|COMPLETED|Washout Period After Period 1 Treatment||1
8413391|NCT00943852|20736263|P3|COMPLETED|Washout Period After Period 1 Treatment||1
8413392|NCT00943852|20736264|P2|COMPLETED|Washout Period After Period 1 Treatment||1
8413393|NCT00943852|20736265|P1|COMPLETED|Washout Period After Period 1 Treatment||2
8413394|NCT00943852|20736256|P10|STARTED|Washout Period After Period 1 Treatment||1
8413395|NCT00943852|20736257|P9|STARTED|Washout Period After Period 1 Treatment||1
8413396|NCT00943852|20736258|P8|STARTED|Washout Period After Period 1 Treatment||1
8413397|NCT00943852|20736259|P7|STARTED|Washout Period After Period 1 Treatment||2
8413398|NCT00943852|20736260|P6|STARTED|Washout Period After Period 1 Treatment||1
8413399|NCT00943852|20736261|P5|STARTED|Washout Period After Period 1 Treatment||1
8413400|NCT00943852|20736262|P4|STARTED|Washout Period After Period 1 Treatment||2
8413401|NCT00943852|20736263|P3|STARTED|Washout Period After Period 1 Treatment||1
8413402|NCT00943852|20736264|P2|STARTED|Washout Period After Period 1 Treatment||1
8413403|NCT00943852|20736265|P1|STARTED|Washout Period After Period 1 Treatment||2
8413404|NCT00943852|20736256|P10|NOT COMPLETED|First Period of Treatment Intervention||0
8413405|NCT00943852|20736257|P9|NOT COMPLETED|First Period of Treatment Intervention||0
8413406|NCT00943852|20736258|P8|NOT COMPLETED|First Period of Treatment Intervention||0
8413407|NCT00943852|20736259|P7|NOT COMPLETED|First Period of Treatment Intervention||0
8413408|NCT00943852|20736260|P6|NOT COMPLETED|First Period of Treatment Intervention||0
8413409|NCT00943852|20736261|P5|NOT COMPLETED|First Period of Treatment Intervention||0
8413410|NCT00943852|20736262|P4|NOT COMPLETED|First Period of Treatment Intervention||0
8413411|NCT00943852|20736263|P3|NOT COMPLETED|First Period of Treatment Intervention||0
8413412|NCT00943852|20736264|P2|NOT COMPLETED|First Period of Treatment Intervention||0
8413413|NCT00943852|20736265|P1|NOT COMPLETED|First Period of Treatment Intervention||0
8413414|NCT00943852|20736256|P10|COMPLETED|First Period of Treatment Intervention||1
8413415|NCT00943852|20736257|P9|COMPLETED|First Period of Treatment Intervention||1
8413416|NCT00943852|20736258|P8|COMPLETED|First Period of Treatment Intervention||1
8413417|NCT00943852|20736259|P7|COMPLETED|First Period of Treatment Intervention||2
8413418|NCT00943852|20736260|P6|COMPLETED|First Period of Treatment Intervention||1
8413419|NCT00943852|20736261|P5|COMPLETED|First Period of Treatment Intervention||1
8413420|NCT00943852|20736262|P4|COMPLETED|First Period of Treatment Intervention||2
8413421|NCT00943852|20736263|P3|COMPLETED|First Period of Treatment Intervention||1
8413422|NCT00943852|20736264|P2|COMPLETED|First Period of Treatment Intervention||1
8413423|NCT00943852|20736265|P1|COMPLETED|First Period of Treatment Intervention||2
8413424|NCT00943852|20736256|P10|STARTED|First Period of Treatment Intervention||1
8413425|NCT00943852|20736257|P9|STARTED|First Period of Treatment Intervention||1
8413426|NCT00943852|20736258|P8|STARTED|First Period of Treatment Intervention||1
8413427|NCT00943852|20736259|P7|STARTED|First Period of Treatment Intervention||2
8413428|NCT00943852|20736260|P6|STARTED|First Period of Treatment Intervention||1
8413429|NCT00943852|20736261|P5|STARTED|First Period of Treatment Intervention||1
8413430|NCT00943852|20736262|P4|STARTED|First Period of Treatment Intervention||2
8413431|NCT00943852|20736263|P3|STARTED|First Period of Treatment Intervention||1
8413432|NCT00943852|20736264|P2|STARTED|First Period of Treatment Intervention||1
8413433|NCT00943852|20736265|P1|STARTED|First Period of Treatment Intervention||2
8413434|NCT00943826|20736278|P2|NOT COMPLETED|After Primary Overall Survival Analysis||20
8413435|NCT00943826|20736279|P1|NOT COMPLETED|After Primary Overall Survival Analysis||27
8413436|NCT00943826|20736278|P2|COMPLETED|After Primary Overall Survival Analysis||0
8413437|NCT00943826|20736279|P1|COMPLETED|After Primary Overall Survival Analysis||0
8413438|NCT00943826|20736278|P2|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
8413439|NCT00943826|20736279|P1|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
8413440|NCT00943826|20736278|P2|NOT COMPLETED|Monotherapy Phase||16
8413441|NCT00943826|20736279|P1|NOT COMPLETED|Monotherapy Phase||65
8413442|NCT00943826|20736278|P2|COMPLETED|Monotherapy Phase||143
8413443|NCT00943826|20736279|P1|COMPLETED|Monotherapy Phase||204
8413444|NCT00943826|20736278|P2|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
8413445|NCT00943826|20736279|P1|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
8413446|NCT00943826|20736278|P2|NOT COMPLETED|Maintenance Phase||39
8413447|NCT00943826|20736279|P1|NOT COMPLETED|Maintenance Phase||43
8413448|NCT00943826|20736278|P2|COMPLETED|Maintenance Phase||331
8413449|NCT00943826|20736279|P1|COMPLETED|Maintenance Phase||353
8413450|NCT00943826|20736278|P2|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
8413451|NCT00943826|20736279|P1|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
8413452|NCT00943826|20736278|P2|NOT COMPLETED|Concurrent Phase||42
8413453|NCT00943826|20736279|P1|NOT COMPLETED|Concurrent Phase||61
8413454|NCT00943826|20736278|P2|COMPLETED|Concurrent Phase||421
8413455|NCT00943826|20736279|P1|COMPLETED|Concurrent Phase||397
8413456|NCT00943826|20736278|P2|Treated|Concurrent Phase||459
8413457|NCT00943826|20736279|P1|Treated|Concurrent Phase||452
8413458|NCT00943826|20736278|P2|STARTED|Concurrent Phase||463
8413459|NCT00943826|20736279|P1|STARTED|Concurrent Phase||458
8413460|NCT00943800|20736297|P1|NOT COMPLETED|Overall Study||0
8413461|NCT00943800|20736297|P1|COMPLETED|Overall Study||87
8413462|NCT00943800|20736297|P1|STARTED|Overall Study||87
8413463|NCT00943787|20736303|P1|NOT COMPLETED|Overall Study||7
8413464|NCT00943787|20736303|P1|COMPLETED|Overall Study||34
8413465|NCT00943787|20736303|P1|STARTED|Overall Study||41
8413472|NCT00943735|20736323|P1|NOT COMPLETED|Overall Study||32
8413473|NCT00943735|20736323|P1|COMPLETED|Overall Study||742
8413474|NCT00943735|20736323|P1|Per Protocol Population|Overall Study||500
8413475|NCT00943735|20736323|P1|STARTED|Overall Study||774
8413506|NCT00943683|20736395|P2|NOT COMPLETED|Overall Study||6
8413507|NCT00943683|20736396|P1|NOT COMPLETED|Overall Study||7
8413508|NCT00943683|20736395|P2|COMPLETED|Overall Study||169
8413509|NCT00943683|20736396|P1|COMPLETED|Overall Study||74
8413510|NCT00943683|20736395|P2|STARTED|Overall Study||175
8413511|NCT00943683|20736396|P1|STARTED|Overall Study||81
8413512|NCT00943670|20736402|P1|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
8413513|NCT00943670|20736402|P1|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
8413514|NCT00943670|20736402|P1|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
8413515|NCT00943670|20736402|P1|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
8413516|NCT00943670|20736402|P1|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
8413517|NCT00943670|20736402|P1|Treated|Single-agent Trastuzumab Emtansine||51
8413518|NCT00943670|20736402|P1|STARTED|Single-agent Trastuzumab Emtansine||51
8413519|NCT00943631|20736438|P2|NOT COMPLETED|Overall Study||2
8413520|NCT00943631|20736439|P1|NOT COMPLETED|Overall Study||4
8413521|NCT00943631|20736438|P2|COMPLETED|Overall Study||202
8413522|NCT00943631|20736439|P1|COMPLETED|Overall Study||198
8413523|NCT00943631|20736438|P2|STARTED|Overall Study||204
8413524|NCT00943631|20736439|P1|STARTED|Overall Study||202
8413525|NCT00943605|20736491|P2|NOT COMPLETED|Overall Study||30
8413526|NCT00943605|20736492|P1|NOT COMPLETED|Overall Study||30
8413527|NCT00943605|20736491|P2|COMPLETED|Overall Study||0
8413528|NCT00943605|20736492|P1|COMPLETED|Overall Study||0
8413529|NCT00943605|20736491|P2|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
8413530|NCT00943605|20736492|P1|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
8413531|NCT00943592|20736502|P1|NOT COMPLETED|Overall Study||3
8413532|NCT00943592|20736502|P1|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
8413533|NCT00943592|20736502|P1|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
8413534|NCT00943592|20736502|P1|STARTED|Overall Study||82
8413535|NCT00943579|20736515|P2|NOT COMPLETED|Overall Study||5
8413536|NCT00943579|20736516|P1|NOT COMPLETED|Overall Study||6
8413537|NCT00943579|20736515|P2|COMPLETED|Overall Study||15
8413538|NCT00943579|20736516|P1|COMPLETED|Overall Study||15
8413539|NCT00943579|20736515|P2|STARTED|Overall Study||20
8413540|NCT00943579|20736516|P1|STARTED|Overall Study||21
8413541|NCT00943488|20736537|P2|NOT COMPLETED|Overall Study||2
8413542|NCT00943488|20736538|P1|NOT COMPLETED|Overall Study||1
8413543|NCT00943488|20736537|P2|COMPLETED|Overall Study||202
8413544|NCT00943488|20736538|P1|COMPLETED|Overall Study||203
8413545|NCT00943488|20736537|P2|STARTED|Overall Study||204
8413546|NCT00943488|20736538|P1|STARTED|Overall Study||204
8413547|NCT00943436|20736594|P2|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
8413548|NCT00943436|20736595|P1|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
8413549|NCT00943436|20736594|P2|COMPLETED|Rest Session: 45 Minutes of Reading||10
8413550|NCT00943436|20736595|P1|COMPLETED|Rest Session: 45 Minutes of Reading||10
8413551|NCT00943436|20736594|P2|STARTED|Rest Session: 45 Minutes of Reading||10
8413552|NCT00943436|20736595|P1|STARTED|Rest Session: 45 Minutes of Reading||10
8413553|NCT00943436|20736594|P2|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
8413554|NCT00943436|20736595|P1|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
8413555|NCT00943436|20736594|P2|COMPLETED|Exercise Session: 45 Minutes of Activity||10
8413556|NCT00943436|20736595|P1|COMPLETED|Exercise Session: 45 Minutes of Activity||10
8413557|NCT00943436|20736594|P2|STARTED|Exercise Session: 45 Minutes of Activity||10
8413558|NCT00943436|20736595|P1|STARTED|Exercise Session: 45 Minutes of Activity||10
8413559|NCT00943397|20736617|P2|NOT COMPLETED|Overall Study||72
8413560|NCT00943397|20736618|P1|NOT COMPLETED|Overall Study||15
8413561|NCT00943397|20736617|P2|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
8413562|NCT00943397|20736618|P1|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
8413563|NCT00943397|20736617|P2|STARTED|Overall Study||158
8413564|NCT00943397|20736618|P1|STARTED|Overall Study||32
8413565|NCT00943384|20736624|P1|NOT COMPLETED|Overall Study||49
8413566|NCT00943384|20736624|P1|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
8413567|NCT00943384|20736624|P1|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
8413568|NCT00943384|20736624|P1|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
8413569|NCT00943384|20736624|P1|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
8413570|NCT00943319|20736638|P1|NOT COMPLETED|Overall Study||1
8413571|NCT00943319|20736638|P1|COMPLETED|Overall Study||49
8413572|NCT00943319|20736638|P1|STARTED|Overall Study||50
8413573|NCT00943306|20736644|P1|NOT COMPLETED|Overall Study||3
8413574|NCT00943306|20736644|P1|COMPLETED|Overall Study||16
8413575|NCT00943306|20736644|P1|STARTED|Overall Study||19
8413576|NCT00943202|20736705|P4|NOT COMPLETED|Overall Study||1
8413577|NCT00943202|20736706|P3|NOT COMPLETED|Overall Study||0
8413578|NCT00943202|20736707|P2|NOT COMPLETED|Overall Study||2
8413579|NCT00943202|20736708|P1|NOT COMPLETED|Overall Study||1
8413580|NCT00943202|20736705|P4|COMPLETED|Overall Study||131
8413581|NCT00943202|20736706|P3|COMPLETED|Overall Study||133
8413582|NCT00943202|20736707|P2|COMPLETED|Overall Study||131
8413583|NCT00943202|20736708|P1|COMPLETED|Overall Study||132
8413584|NCT00943202|20736705|P4|STARTED|Overall Study||132
8413585|NCT00943202|20736706|P3|STARTED|Overall Study||133
8413586|NCT00943202|20736707|P2|STARTED|Overall Study||133
8413587|NCT00943202|20736708|P1|STARTED|Overall Study||133
8413588|NCT00943150|20736924|P2|NOT COMPLETED|Overall Study||0
8413589|NCT00943150|20736925|P1|NOT COMPLETED|Overall Study||0
8413590|NCT00943150|20736924|P2|COMPLETED|Overall Study||10
8413591|NCT00943150|20736925|P1|COMPLETED|Overall Study||10
8413592|NCT00943150|20736924|P2|STARTED|Overall Study||10
8413593|NCT00943150|20736925|P1|STARTED|Overall Study||10
8413594|NCT00943124|20736946|P2|NOT COMPLETED|Period 2||0
8413595|NCT00943124|20736947|P1|NOT COMPLETED|Period 2||0
8413596|NCT00943124|20736946|P2|COMPLETED|Period 2||108
8413597|NCT00943124|20736947|P1|COMPLETED|Period 2||108
8413598|NCT00943124|20736946|P2|STARTED|Period 2||108
8413599|NCT00943124|20736947|P1|STARTED|Period 2||108
8413600|NCT00943124|20736946|P2|NOT COMPLETED|Period 1||2
8413601|NCT00943124|20736947|P1|NOT COMPLETED|Period 1||2
8413602|NCT00943124|20736946|P2|COMPLETED|Period 1||108
8413603|NCT00943124|20736947|P1|COMPLETED|Period 1||108
8413604|NCT00943124|20736946|P2|STARTED|Period 1||110
8413605|NCT00943124|20736947|P1|STARTED|Period 1||110
8413606|NCT00943111|20736969|P3|NOT COMPLETED|5 Years Long-term Treatment Period||75
8413607|NCT00943111|20736970|P2|NOT COMPLETED|5 Years Long-term Treatment Period||0
8413608|NCT00943111|20736971|P1|NOT COMPLETED|5 Years Long-term Treatment Period||0
8413609|NCT00943111|20736969|P3|COMPLETED|5 Years Long-term Treatment Period||77
8413610|NCT00943111|20736970|P2|COMPLETED|5 Years Long-term Treatment Period||0
8413611|NCT00943111|20736971|P1|COMPLETED|5 Years Long-term Treatment Period||0
8413612|NCT00943111|20736969|P3|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
8413613|NCT00943111|20736970|P2|STARTED|5 Years Long-term Treatment Period||0
8413614|NCT00943111|20736971|P1|STARTED|5 Years Long-term Treatment Period||0
8413615|NCT00943111|20736969|P3|NOT COMPLETED|52-Weeks Primary Analysis Period||0
8413616|NCT00943111|20736970|P2|NOT COMPLETED|52-Weeks Primary Analysis Period||2
8413617|NCT00943111|20736971|P1|NOT COMPLETED|52-Weeks Primary Analysis Period||2
8413618|NCT00943111|20736969|P3|COMPLETED|52-Weeks Primary Analysis Period||0
8413619|NCT00943111|20736970|P2|COMPLETED|52-Weeks Primary Analysis Period||52
8413620|NCT00943111|20736971|P1|COMPLETED|52-Weeks Primary Analysis Period||104
8413621|NCT00943111|20736969|P3|Treated|52-Weeks Primary Analysis Period||0
8413622|NCT00943111|20736970|P2|Treated|52-Weeks Primary Analysis Period||53
8413623|NCT00943111|20736971|P1|Treated|52-Weeks Primary Analysis Period||106
8413624|NCT00943111|20736969|P3|STARTED|52-Weeks Primary Analysis Period||0
8413625|NCT00943111|20736970|P2|STARTED|52-Weeks Primary Analysis Period||54
8413626|NCT00943111|20736971|P1|STARTED|52-Weeks Primary Analysis Period||106
8413627|NCT00943098|20737004|P2|NOT COMPLETED|Overall Study||0
8413628|NCT00943098|20737005|P1|NOT COMPLETED|Overall Study||0
8413629|NCT00943098|20737004|P2|COMPLETED|Overall Study||72
8413630|NCT00943098|20737005|P1|COMPLETED|Overall Study||70
8413631|NCT00943098|20737004|P2|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
8413632|NCT00943098|20737005|P1|STARTED|Overall Study||70
8413633|NCT00943072|20737039|P2|NOT COMPLETED|Overall Study||14
8413634|NCT00943072|20737040|P1|NOT COMPLETED|Overall Study||5
8413635|NCT00943072|20737039|P2|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
8413636|NCT00943072|20737040|P1|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
8413637|NCT00943072|20737039|P2|Full Analysis Set (FAS) Population|Overall Study||73
8413638|NCT00943072|20737040|P1|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
8413639|NCT00943072|20737039|P2|Participants Received Treatment|Overall Study||74
8413640|NCT00943072|20737040|P1|Participants Received Treatment|Overall Study|Safety population (SAF)|114
8413641|NCT00943072|20737039|P2|STARTED|Overall Study||74
8413642|NCT00943072|20737040|P1|STARTED|Overall Study||115
8413643|NCT00942994|20737058|P2|NOT COMPLETED|Overall Study||19
8413644|NCT00942994|20737059|P1|NOT COMPLETED|Overall Study||16
8413645|NCT00942994|20737058|P2|COMPLETED|Overall Study||190
8413646|NCT00942994|20737059|P1|COMPLETED|Overall Study||187
8413647|NCT00942994|20737058|P2|STARTED|Overall Study||209
8413648|NCT00942994|20737059|P1|STARTED|Overall Study||203
8413649|NCT00942968|20737075|P1|NOT COMPLETED|Overall Study||229
8413650|NCT00942968|20737075|P1|COMPLETED|Overall Study||109
8413651|NCT00942968|20737075|P1|Treated|Overall Study||334
8413652|NCT00942968|20737075|P1|STARTED|Overall Study||338
8413653|NCT00942903|20737096|P1|NOT COMPLETED|Overall Study||0
8413654|NCT00942903|20737096|P1|COMPLETED|Overall Study||20
8413655|NCT00942903|20737096|P1|STARTED|Overall Study||20
8413656|NCT00942890|20737103|P2|NOT COMPLETED|Overall Study||0
8413657|NCT00942890|20737104|P1|NOT COMPLETED|Overall Study||0
8413658|NCT00942890|20737103|P2|COMPLETED|Overall Study||23
8413659|NCT00942890|20737104|P1|COMPLETED|Overall Study||21
8413660|NCT00942890|20737103|P2|STARTED|Overall Study||23
8413661|NCT00942890|20737104|P1|STARTED|Overall Study||21
8413662|NCT00942851|20737126|P2|NOT COMPLETED|Overall Study||1
8413663|NCT00942851|20737127|P1|NOT COMPLETED|Overall Study||0
8413664|NCT00942851|20737126|P2|COMPLETED|Overall Study||11
8413665|NCT00942851|20737127|P1|COMPLETED|Overall Study||12
8413666|NCT00942851|20737126|P2|STARTED|Overall Study||12
8413667|NCT00942851|20737127|P1|STARTED|Overall Study||12
8413668|NCT00942825|20737139|P2|NOT COMPLETED|Overall Study||0
8413669|NCT00942825|20737140|P1|NOT COMPLETED|Overall Study||0
8413670|NCT00942825|20737139|P2|COMPLETED|Overall Study||98
8413671|NCT00942825|20737140|P1|COMPLETED|Overall Study||97
8413672|NCT00942825|20737139|P2|STARTED|Overall Study||98
8413673|NCT00942825|20737140|P1|STARTED|Overall Study||97
8413674|NCT00942786|20737146|P1|NOT COMPLETED|Overall Study||0
8413675|NCT00942786|20737146|P1|COMPLETED|Overall Study|date of last follow-up|297
8413676|NCT00942786|20737146|P1|STARTED|Overall Study||297
8413677|NCT00942734|20737153|P1|NOT COMPLETED|Overall Study||8
8413678|NCT00942734|20737153|P1|COMPLETED|Overall Study||35
8413679|NCT00942734|20737153|P1|STARTED|Overall Study||43
8413680|NCT00942708|20737157|P1|NOT COMPLETED|Overall Study||1
8413681|NCT00942708|20737157|P1|COMPLETED|Overall Study||5
8413682|NCT00942708|20737157|P1|STARTED|Overall Study||6
8413683|NCT00942604|20737165|P2|NOT COMPLETED|Overall Study||4
8413684|NCT00942604|20737166|P1|NOT COMPLETED|Overall Study||2
8413685|NCT00942604|20737165|P2|COMPLETED|Overall Study||99
8413686|NCT00942604|20737166|P1|COMPLETED|Overall Study||98
8413687|NCT00942604|20737165|P2|STARTED|Overall Study||103
8413688|NCT00942604|20737166|P1|STARTED|Overall Study||100
8413689|NCT00942578|20737177|P3|NOT COMPLETED|Expansion Phase||0
8413690|NCT00942578|20737178|P2|NOT COMPLETED|Expansion Phase||0
8413691|NCT00942578|20737179|P1|NOT COMPLETED|Expansion Phase||0
8413692|NCT00942578|20737177|P3|COMPLETED|Expansion Phase||43
8413693|NCT00942578|20737178|P2|COMPLETED|Expansion Phase||0
8413694|NCT00942578|20737179|P1|COMPLETED|Expansion Phase||11
8413695|NCT00942578|20737177|P3|STARTED|Expansion Phase||43
8413696|NCT00942578|20737178|P2|STARTED|Expansion Phase||0
8413697|NCT00942578|20737179|P1|STARTED|Expansion Phase||11
8413698|NCT00942578|20737177|P3|NOT COMPLETED|Dose Escalation Phase||0
8413699|NCT00942578|20737178|P2|NOT COMPLETED|Dose Escalation Phase||0
8413700|NCT00942578|20737179|P1|NOT COMPLETED|Dose Escalation Phase||0
8413701|NCT00942578|20737177|P3|COMPLETED|Dose Escalation Phase||3
8413702|NCT00942578|20737178|P2|COMPLETED|Dose Escalation Phase||3
8413703|NCT00942578|20737179|P1|COMPLETED|Dose Escalation Phase||3
8413704|NCT00942578|20737177|P3|STARTED|Dose Escalation Phase||3
8413705|NCT00942578|20737178|P2|STARTED|Dose Escalation Phase||3
8413706|NCT00942578|20737179|P1|STARTED|Dose Escalation Phase||3
8413707|NCT00942448|20737209|P4|NOT COMPLETED|Overall Study||0
8413708|NCT00942448|20737210|P3|NOT COMPLETED|Overall Study||0
8413709|NCT00942448|20737211|P2|NOT COMPLETED|Overall Study||0
8413710|NCT00942448|20737212|P1|NOT COMPLETED|Overall Study||0
8413711|NCT00942448|20737209|P4|COMPLETED|Overall Study||75
8413712|NCT00942448|20737210|P3|COMPLETED|Overall Study||78
8413713|NCT00942448|20737211|P2|COMPLETED|Overall Study||76
8413714|NCT00942448|20737212|P1|COMPLETED|Overall Study||77
8413715|NCT00942448|20737209|P4|STARTED|Overall Study||75
8413716|NCT00942448|20737210|P3|STARTED|Overall Study||78
8413717|NCT00942448|20737211|P2|STARTED|Overall Study||76
8413718|NCT00942448|20737212|P1|STARTED|Overall Study||77
8413719|NCT00942422|20737274|P1|NOT COMPLETED|Overall Study||3
8413720|NCT00942422|20737274|P1|COMPLETED|Overall Study||5
8413721|NCT00942422|20737274|P1|STARTED|Overall Study||8
8413722|NCT00942409|20737278|P1|NOT COMPLETED|Overall Study||3
8413723|NCT00942409|20737278|P1|COMPLETED|Overall Study||2
8413724|NCT00942409|20737278|P1|STARTED|Overall Study||5
8413725|NCT00942357|20737284|P2|NOT COMPLETED|Overall Study||40
8413726|NCT00942357|20737285|P1|NOT COMPLETED|Overall Study||37
8413727|NCT00942357|20737284|P2|COMPLETED|Overall Study||366
8413728|NCT00942357|20737285|P1|COMPLETED|Overall Study||370
8413729|NCT00942357|20737284|P2|STARTED|Overall Study||406
8413730|NCT00942357|20737285|P1|STARTED|Overall Study||407
8413737|NCT00942266|20737314|P2|NOT COMPLETED|Overall Study||15
8413738|NCT00942266|20737315|P1|NOT COMPLETED|Overall Study||43
8413739|NCT00942266|20737314|P2|COMPLETED|Overall Study||0
8413740|NCT00942266|20737315|P1|COMPLETED|Overall Study||0
8413741|NCT00942266|20737314|P2|STARTED|Overall Study||15
8413742|NCT00942266|20737315|P1|STARTED|Overall Study||43
8413743|NCT00942188|20737337|P4|NOT COMPLETED|Overall Study||4
8413744|NCT00942188|20737338|P3|NOT COMPLETED|Overall Study||9
8413745|NCT00942188|20737339|P2|NOT COMPLETED|Overall Study||10
8413746|NCT00942188|20737340|P1|NOT COMPLETED|Overall Study||4
8413747|NCT00942188|20737337|P4|COMPLETED|Overall Study||23
8413748|NCT00942188|20737338|P3|COMPLETED|Overall Study||18
8413749|NCT00942188|20737339|P2|COMPLETED|Overall Study||16
8413750|NCT00942188|20737340|P1|COMPLETED|Overall Study||22
8413751|NCT00942188|20737337|P4|STARTED|Overall Study||27
8413752|NCT00942188|20737338|P3|STARTED|Overall Study||27
8413753|NCT00942188|20737339|P2|STARTED|Overall Study||26
8413754|NCT00942188|20737340|P1|STARTED|Overall Study||26
8413755|NCT00942175|20737379|P4|NOT COMPLETED|Overall Study||2
8413756|NCT00942175|20737380|P3|NOT COMPLETED|Overall Study||2
8413757|NCT00942175|20737381|P2|NOT COMPLETED|Overall Study||4
8413758|NCT00942175|20737382|P1|NOT COMPLETED|Overall Study||2
8413759|NCT00942175|20737379|P4|COMPLETED|Overall Study||38
8413760|NCT00942175|20737380|P3|COMPLETED|Overall Study||38
8413761|NCT00942175|20737381|P2|COMPLETED|Overall Study||36
8413762|NCT00942175|20737382|P1|COMPLETED|Overall Study||38
8413763|NCT00942175|20737379|P4|STARTED|Overall Study||40
8413764|NCT00942175|20737380|P3|STARTED|Overall Study||40
8413765|NCT00942175|20737381|P2|STARTED|Overall Study||40
8413766|NCT00942175|20737382|P1|STARTED|Overall Study||40
8413767|NCT00942162|20737435|P3|NOT COMPLETED|Overall Study||2
8413768|NCT00942162|20737436|P2|NOT COMPLETED|Overall Study||50
8413769|NCT00942162|20737437|P1|NOT COMPLETED|Overall Study||70
8413770|NCT00942162|20737435|P3|COMPLETED|Overall Study||0
8413771|NCT00942162|20737436|P2|COMPLETED|Overall Study||0
8413772|NCT00942162|20737437|P1|COMPLETED|Overall Study||1
8413773|NCT00942162|20737435|P3|STARTED|Overall Study||2
8413774|NCT00942162|20737436|P2|STARTED|Overall Study||50
8413775|NCT00942162|20737437|P1|STARTED|Overall Study||71
8413776|NCT00942149|20737504|P1|NOT COMPLETED|Overall Study||0
8413777|NCT00942149|20737504|P1|COMPLETED|Overall Study||20
8413778|NCT00942149|20737504|P1|STARTED|Overall Study||20
8413779|NCT00942084|20737508|P1|NOT COMPLETED|Overall Study||2
8413780|NCT00942084|20737508|P1|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
8413781|NCT00942084|20737508|P1|STARTED|Overall Study||32
8413782|NCT00941993|20737517|P1|NOT COMPLETED|Overall Study||0
8413783|NCT00941993|20737517|P1|COMPLETED|Overall Study||109
8413784|NCT00941993|20737517|P1|STARTED|Overall Study||109
8413785|NCT00941928|20737525|P1|NOT COMPLETED|Overall Study||2
8413786|NCT00941928|20737525|P1|COMPLETED|Overall Study||0
8413787|NCT00941928|20737525|P1|STARTED|Overall Study||2
8413788|NCT00941889|20737531|P2|NOT COMPLETED|Overall Study||12
8413789|NCT00941889|20737532|P1|NOT COMPLETED|Overall Study||12
8413790|NCT00941889|20737531|P2|COMPLETED|Overall Study||3
8413791|NCT00941889|20737532|P1|COMPLETED|Overall Study||5
8413792|NCT00941889|20737531|P2|STARTED|Overall Study||15
8413793|NCT00941889|20737532|P1|STARTED|Overall Study||17
8413794|NCT00941863|20737543|P5|NOT COMPLETED|Continued After PCD||19
8413795|NCT00941863|20737544|P4|NOT COMPLETED|Continued After PCD||0
8413796|NCT00941863|20737545|P3|NOT COMPLETED|Continued After PCD||0
8413797|NCT00941863|20737546|P2|NOT COMPLETED|Continued After PCD||0
8413798|NCT00941863|20737547|P1|NOT COMPLETED|Continued After PCD||0
8413799|NCT00941863|20737543|P5|COMPLETED|Continued After PCD||6
8413800|NCT00941863|20737544|P4|COMPLETED|Continued After PCD||0
8413801|NCT00941863|20737545|P3|COMPLETED|Continued After PCD||0
8413802|NCT00941863|20737546|P2|COMPLETED|Continued After PCD||0
8413803|NCT00941863|20737547|P1|COMPLETED|Continued After PCD||0
8413804|NCT00941863|20737543|P5|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
8413805|NCT00941863|20737544|P4|STARTED|Continued After PCD||0
8413806|NCT00941863|20737545|P3|STARTED|Continued After PCD||0
8413807|NCT00941863|20737546|P2|STARTED|Continued After PCD||0
8413808|NCT00941863|20737547|P1|STARTED|Continued After PCD||0
8413809|NCT00941863|20737543|P5|NOT COMPLETED|Until Primary Completion Date (PCD)||94
8413810|NCT00941863|20737544|P4|NOT COMPLETED|Until Primary Completion Date (PCD)||17
8413811|NCT00941863|20737545|P3|NOT COMPLETED|Until Primary Completion Date (PCD)||12
8413812|NCT00941863|20737546|P2|NOT COMPLETED|Until Primary Completion Date (PCD)||3
8413813|NCT00941863|20737547|P1|NOT COMPLETED|Until Primary Completion Date (PCD)||7
8413814|NCT00941863|20737543|P5|COMPLETED|Until Primary Completion Date (PCD)||25
8413815|NCT00941863|20737544|P4|COMPLETED|Until Primary Completion Date (PCD)||0
8413816|NCT00941863|20737545|P3|COMPLETED|Until Primary Completion Date (PCD)||0
8413817|NCT00941863|20737546|P2|COMPLETED|Until Primary Completion Date (PCD)||0
8413818|NCT00941863|20737547|P1|COMPLETED|Until Primary Completion Date (PCD)||0
8413819|NCT00941863|20737543|P5|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
8413820|NCT00941863|20737544|P4|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
8413821|NCT00941863|20737545|P3|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
8413822|NCT00941863|20737546|P2|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
8413823|NCT00941863|20737547|P1|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
8413824|NCT00941863|20737543|P5|STARTED|Until Primary Completion Date (PCD)||119
8413825|NCT00941863|20737544|P4|STARTED|Until Primary Completion Date (PCD)||17
8413826|NCT00941863|20737545|P3|STARTED|Until Primary Completion Date (PCD)||12
8413827|NCT00941863|20737546|P2|STARTED|Until Primary Completion Date (PCD)||3
8413828|NCT00941863|20737547|P1|STARTED|Until Primary Completion Date (PCD)||7
8413829|NCT00941798|20737574|P2|NOT COMPLETED|Overall Study||185
8413830|NCT00941798|20737575|P1|NOT COMPLETED|Overall Study||194
8413831|NCT00941798|20737574|P2|COMPLETED|Overall Study||578
8413832|NCT00941798|20737575|P1|COMPLETED|Overall Study||561
8413833|NCT00941798|20737574|P2|Full Analysis Set|Overall Study||759
8413834|NCT00941798|20737575|P1|Full Analysis Set|Overall Study||749
8413835|NCT00941798|20737574|P2|STARTED|Overall Study||763
8413836|NCT00941798|20737575|P1|STARTED|Overall Study||755
8413837|NCT00941733|20737605|P2|NOT COMPLETED|Overall Study||28
8413838|NCT00941733|20737606|P1|NOT COMPLETED|Overall Study||74
8413839|NCT00941733|20737605|P2|COMPLETED|Overall Study|1 year follow-up|91
8413840|NCT00941733|20737606|P1|COMPLETED|Overall Study|1 year follow-up|165
8413841|NCT00941733|20737605|P2|STARTED|Overall Study||119
8413842|NCT00941733|20737606|P1|STARTED|Overall Study||239
8413843|NCT00941720|20737646|P1|NOT COMPLETED|Overall Study||14
8413844|NCT00941720|20737646|P1|COMPLETED|Overall Study||57
8413845|NCT00941720|20737646|P1|STARTED|Overall Study||71
8413846|NCT00941681|20737655|P3|NOT COMPLETED|Overall Study||0
8413847|NCT00941681|20737656|P2|NOT COMPLETED|Overall Study||1
8413848|NCT00941681|20737657|P1|NOT COMPLETED|Overall Study||0
8413849|NCT00941681|20737655|P3|COMPLETED|Overall Study||12
8413850|NCT00941681|20737656|P2|COMPLETED|Overall Study||10
8413851|NCT00941681|20737657|P1|COMPLETED|Overall Study||12
8413852|NCT00941681|20737655|P3|STARTED|Overall Study||12
8413853|NCT00941681|20737656|P2|STARTED|Overall Study||11
8413854|NCT00941681|20737657|P1|STARTED|Overall Study||12
8413855|NCT00941668|20737682|P2|NOT COMPLETED|Overall Study||25
8413856|NCT00941668|20737683|P1|NOT COMPLETED|Overall Study||24
8413857|NCT00941668|20737682|P2|COMPLETED|Overall Study||0
8413858|NCT00941668|20737683|P1|COMPLETED|Overall Study||0
8413859|NCT00941668|20737682|P2|STARTED|Overall Study||25
8413860|NCT00941668|20737683|P1|STARTED|Overall Study||24
8413861|NCT00941655|20737693|P2|NOT COMPLETED|Overall Study||5
8413862|NCT00941655|20737694|P1|NOT COMPLETED|Overall Study||5
8413863|NCT00941655|20737693|P2|COMPLETED|Overall Study||2
8413864|NCT00941655|20737694|P1|COMPLETED|Overall Study||3
8413865|NCT00941655|20737693|P2|STARTED|Overall Study||7
8413866|NCT00941655|20737694|P1|STARTED|Overall Study||8
8413867|NCT00941603|20737719|P6|NOT COMPLETED|Overall Study||3
8413868|NCT00941603|20737720|P5|NOT COMPLETED|Overall Study||4
8413869|NCT00941603|20737721|P4|NOT COMPLETED|Overall Study||4
8413870|NCT00941603|20737722|P3|NOT COMPLETED|Overall Study||5
8413871|NCT00941603|20737723|P2|NOT COMPLETED|Overall Study||16
8413872|NCT00941603|20737724|P1|NOT COMPLETED|Overall Study||11
8413873|NCT00941603|20737719|P6|COMPLETED|Overall Study||94
8413874|NCT00941603|20737720|P5|COMPLETED|Overall Study||101
8413875|NCT00941603|20737721|P4|COMPLETED|Overall Study||100
8413876|NCT00941603|20737722|P3|COMPLETED|Overall Study||99
8413877|NCT00941603|20737723|P2|COMPLETED|Overall Study||89
8413878|NCT00941603|20737724|P1|COMPLETED|Overall Study||93
8413879|NCT00941603|20737719|P6|STARTED|Overall Study||97
8413880|NCT00941603|20737720|P5|STARTED|Overall Study||105
8413881|NCT00941603|20737721|P4|STARTED|Overall Study||104
8413882|NCT00941603|20737722|P3|STARTED|Overall Study||104
8413883|NCT00941603|20737723|P2|STARTED|Overall Study||105
8413884|NCT00941603|20737724|P1|STARTED|Overall Study||104
8413885|NCT00941330|20737746|P2|NOT COMPLETED|Overall Study||2
8413886|NCT00941330|20737747|P1|NOT COMPLETED|Overall Study||1
8413887|NCT00941330|20737746|P2|COMPLETED|Overall Study||9
8413888|NCT00941330|20737747|P1|COMPLETED|Overall Study||14
8413889|NCT00941330|20737746|P2|STARTED|Overall Study||11
8413890|NCT00941330|20737747|P1|STARTED|Overall Study||15
8413891|NCT00941304|20737760|P5|NOT COMPLETED|Overall Study||0
8413892|NCT00941304|20737761|P4|NOT COMPLETED|Overall Study||0
8413893|NCT00941304|20737762|P3|NOT COMPLETED|Overall Study||0
8413894|NCT00941304|20737763|P2|NOT COMPLETED|Overall Study||0
8413895|NCT00941304|20737764|P1|NOT COMPLETED|Overall Study||1
8413896|NCT00941304|20737760|P5|COMPLETED|Overall Study||31
8413897|NCT00941304|20737761|P4|COMPLETED|Overall Study||30
8413898|NCT00941304|20737762|P3|COMPLETED|Overall Study||31
8413899|NCT00941304|20737763|P2|COMPLETED|Overall Study||30
8413900|NCT00941304|20737764|P1|COMPLETED|Overall Study||30
8413901|NCT00941304|20737760|P5|STARTED|Overall Study||31
8413902|NCT00941304|20737761|P4|STARTED|Overall Study||30
8413903|NCT00941304|20737762|P3|STARTED|Overall Study||31
8413904|NCT00941304|20737763|P2|STARTED|Overall Study||30
8413905|NCT00941304|20737764|P1|STARTED|Overall Study||31
8413906|NCT00941070|20737826|P1|NOT COMPLETED|Overall Study||1
8413907|NCT00941070|20737826|P1|COMPLETED|Overall Study||25
8413908|NCT00941070|20737826|P1|STARTED|Overall Study||26
8413909|NCT00941031|20737846|P7|NOT COMPLETED|Maintenance Period||43
8413910|NCT00941031|20737847|P6|NOT COMPLETED|Maintenance Period||6
8413911|NCT00941031|20737848|P5|NOT COMPLETED|Maintenance Period||9
8413912|NCT00941031|20737849|P4|NOT COMPLETED|Maintenance Period||0
8413913|NCT00941031|20737850|P3|NOT COMPLETED|Maintenance Period||0
8413914|NCT00941031|20737851|P2|NOT COMPLETED|Maintenance Period||0
8413915|NCT00941031|20737852|P1|NOT COMPLETED|Maintenance Period||0
8413916|NCT00941031|20737846|P7|COMPLETED|Maintenance Period||204
8413917|NCT00941031|20737847|P6|COMPLETED|Maintenance Period||61
8413918|NCT00941031|20737848|P5|COMPLETED|Maintenance Period||56
8413919|NCT00941031|20737849|P4|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
8413920|NCT00941031|20737850|P3|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8413921|NCT00941031|20737851|P2|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8413922|NCT00941031|20737852|P1|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8413923|NCT00941031|20737846|P7|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
8413924|NCT00941031|20737847|P6|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
8413925|NCT00941031|20737848|P5|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
8413926|NCT00941031|20737849|P4|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
8413927|NCT00941031|20737850|P3|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8413928|NCT00941031|20737851|P2|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8413929|NCT00941031|20737852|P1|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
8413930|NCT00941031|20737846|P7|NOT COMPLETED|Induction Period||0
8413931|NCT00941031|20737847|P6|NOT COMPLETED|Induction Period||0
8413932|NCT00941031|20737848|P5|NOT COMPLETED|Induction Period||0
8413933|NCT00941031|20737849|P4|NOT COMPLETED|Induction Period||9
8413934|NCT00941031|20737850|P3|NOT COMPLETED|Induction Period||6
8413935|NCT00941031|20737851|P2|NOT COMPLETED|Induction Period||4
8413936|NCT00941031|20737852|P1|NOT COMPLETED|Induction Period||5
8413937|NCT00941031|20737846|P7|COMPLETED|Induction Period||0
8413938|NCT00941031|20737847|P6|COMPLETED|Induction Period||0
8413939|NCT00941031|20737848|P5|COMPLETED|Induction Period||0
8413940|NCT00941031|20737849|P4|COMPLETED|Induction Period||58
8413941|NCT00941031|20737850|P3|COMPLETED|Induction Period||127
8413942|NCT00941031|20737851|P2|COMPLETED|Induction Period||134
8413943|NCT00941031|20737852|P1|COMPLETED|Induction Period||61
8413944|NCT00941031|20737846|P7|STARTED|Induction Period||0
8413945|NCT00941031|20737847|P6|STARTED|Induction Period||0
8413946|NCT00941031|20737848|P5|STARTED|Induction Period||0
8413947|NCT00941031|20737849|P4|STARTED|Induction Period||67
8413948|NCT00941031|20737850|P3|STARTED|Induction Period||133
8413949|NCT00941031|20737851|P2|STARTED|Induction Period||138
8413950|NCT00941031|20737852|P1|STARTED|Induction Period||66
8413951|NCT00941005|20737877|P2|NOT COMPLETED|Overall Study||0
8413952|NCT00941005|20737878|P1|NOT COMPLETED|Overall Study||0
8413953|NCT00941005|20737877|P2|COMPLETED|Overall Study||61
8413954|NCT00941005|20737878|P1|COMPLETED|Overall Study||61
8413955|NCT00941005|20737877|P2|STARTED|Overall Study||61
8413956|NCT00941005|20737878|P1|STARTED|Overall Study||61
8413957|NCT00940992|20737899|P3|NOT COMPLETED|Overall Study||2
8413958|NCT00940992|20737900|P2|NOT COMPLETED|Overall Study||2
8413959|NCT00940992|20737901|P1|NOT COMPLETED|Overall Study||4
8413960|NCT00940992|20737899|P3|COMPLETED|Overall Study||28
8413961|NCT00940992|20737900|P2|COMPLETED|Overall Study||28
8413962|NCT00940992|20737901|P1|COMPLETED|Overall Study||28
8413963|NCT00940992|20737899|P3|STARTED|Overall Study||30
8413964|NCT00940992|20737900|P2|STARTED|Overall Study||30
8413965|NCT00940992|20737901|P1|STARTED|Overall Study||32
8413966|NCT00940927|20737912|P1|NOT COMPLETED|Overall Study||0
8413967|NCT00940927|20737912|P1|COMPLETED|Overall Study||81
8413968|NCT00940927|20737912|P1|STARTED|Overall Study||81
8413969|NCT00940901|20737919|P2|NOT COMPLETED|Week 9-16 (Phase 2)||3
8413970|NCT00940901|20737920|P1|NOT COMPLETED|Week 9-16 (Phase 2)||2
8413971|NCT00940901|20737919|P2|COMPLETED|Week 9-16 (Phase 2)||4
8413972|NCT00940901|20737920|P1|COMPLETED|Week 9-16 (Phase 2)||4
8413973|NCT00940901|20737919|P2|STARTED|Week 9-16 (Phase 2)||7
8413974|NCT00940901|20737920|P1|STARTED|Week 9-16 (Phase 2)||6
8413975|NCT00940901|20737919|P2|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
8413976|NCT00940901|20737920|P1|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
8413977|NCT00940901|20737919|P2|COMPLETED|Weeks 1-8 (Phase 1)||7
8413978|NCT00940901|20737920|P1|COMPLETED|Weeks 1-8 (Phase 1)||6
8413979|NCT00940901|20737919|P2|STARTED|Weeks 1-8 (Phase 1)||7
8413980|NCT00940901|20737920|P1|STARTED|Weeks 1-8 (Phase 1)||6
8413981|NCT00940888|20737930|P1|NOT COMPLETED|Overall Study||835
8413982|NCT00940888|20737930|P1|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
8413983|NCT00940888|20737930|P1|STARTED|Overall Study|Total number of subjects consented|1701
8413984|NCT00940875|20737937|P2|NOT COMPLETED|Post-Study Treatment||3
8413985|NCT00940875|20737938|P1|NOT COMPLETED|Post-Study Treatment||0
8413986|NCT00940875|20737937|P2|COMPLETED|Post-Study Treatment||1
8413987|NCT00940875|20737938|P1|COMPLETED|Post-Study Treatment||0
8413988|NCT00940875|20737937|P2|STARTED|Post-Study Treatment||4
8413989|NCT00940875|20737938|P1|STARTED|Post-Study Treatment||0
8413990|NCT00940875|20737937|P2|NOT COMPLETED|Treatment Phase||19
8413991|NCT00940875|20737938|P1|NOT COMPLETED|Treatment Phase||26
8413992|NCT00940875|20737937|P2|COMPLETED|Treatment Phase||4
8413993|NCT00940875|20737938|P1|COMPLETED|Treatment Phase||5
8413994|NCT00940875|20737937|P2|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
8413995|NCT00940875|20737938|P1|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
8413996|NCT00940823|20737958|P2|NOT COMPLETED|Overall Study||32
8413997|NCT00940823|20737959|P1|NOT COMPLETED|Overall Study||35
8413998|NCT00940823|20737958|P2|COMPLETED|Overall Study||82
8413999|NCT00940823|20737959|P1|COMPLETED|Overall Study||89
8414000|NCT00940823|20737958|P2|STARTED|Overall Study||114
8414001|NCT00940823|20737959|P1|STARTED|Overall Study||124
8414002|NCT00940771|20737975|P1|NOT COMPLETED|24 Weeks||0
8414003|NCT00940771|20737975|P1|COMPLETED|24 Weeks||10
8414004|NCT00940771|20737975|P1|STARTED|24 Weeks||10
8414005|NCT00940771|20737975|P1|NOT COMPLETED|12 Weeks||0
8414006|NCT00940771|20737975|P1|COMPLETED|12 Weeks||10
8414007|NCT00940771|20737975|P1|STARTED|12 Weeks||10
8414008|NCT00940771|20737975|P1|NOT COMPLETED|4 Weeks||0
8414009|NCT00940771|20737975|P1|COMPLETED|4 Weeks||10
8414010|NCT00940771|20737975|P1|STARTED|4 Weeks||10
8414011|NCT00940771|20737975|P1|NOT COMPLETED|Pre-Entry||0
8414012|NCT00940771|20737975|P1|COMPLETED|Pre-Entry||10
8414013|NCT00940771|20737975|P1|STARTED|Pre-Entry||10
8414014|NCT00940602|20737984|P2|NOT COMPLETED|Overall Study||76
8414015|NCT00940602|20737985|P1|NOT COMPLETED|Overall Study||149
8414016|NCT00940602|20737984|P2|COMPLETED|Overall Study||0
8414017|NCT00940602|20737985|P1|COMPLETED|Overall Study||0
8414018|NCT00940602|20737984|P2|Untreated|Overall Study||0
8414019|NCT00940602|20737985|P1|Untreated|Overall Study||1
8414020|NCT00940602|20737984|P2|Treated|Overall Study||76
8414021|NCT00940602|20737985|P1|Treated|Overall Study||148
8414022|NCT00940602|20737984|P2|Full Analysis Set|Overall Study||76
8414023|NCT00940602|20737985|P1|Full Analysis Set|Overall Study||149
8414024|NCT00940602|20737984|P2|Safety Analysis Set|Overall Study||76
8414025|NCT00940602|20737985|P1|Safety Analysis Set|Overall Study||148
8414026|NCT00940602|20737984|P2|STARTED|Overall Study||76
8414027|NCT00940602|20737985|P1|STARTED|Overall Study||149
8414028|NCT00940589|20738024|P2|NOT COMPLETED|Overall Study||5
8414029|NCT00940589|20738025|P1|NOT COMPLETED|Overall Study||8
8414030|NCT00940589|20738024|P2|COMPLETED|Overall Study||29
8414031|NCT00940589|20738025|P1|COMPLETED|Overall Study||31
8414032|NCT00940589|20738024|P2|STARTED|Overall Study||34
8414033|NCT00940589|20738025|P1|STARTED|Overall Study||39
8414034|NCT00940576|20738035|P2|NOT COMPLETED|Overall Study||0
8414035|NCT00940576|20738036|P1|NOT COMPLETED|Overall Study||0
8414036|NCT00940576|20738035|P2|COMPLETED|Overall Study||9
8414037|NCT00940576|20738036|P1|COMPLETED|Overall Study||8
8414038|NCT00940576|20738035|P2|STARTED|Overall Study||9
8414039|NCT00940576|20738036|P1|STARTED|Overall Study||8
8414040|NCT00940537|20738045|P2|NOT COMPLETED|Overall Study||0
8414041|NCT00940537|20738046|P1|NOT COMPLETED|Overall Study||0
8414042|NCT00940537|20738045|P2|COMPLETED|Overall Study||9
8414043|NCT00940537|20738046|P1|COMPLETED|Overall Study||5
8414044|NCT00940537|20738045|P2|STARTED|Overall Study||9
8414045|NCT00940537|20738046|P1|STARTED|Overall Study||5
8414046|NCT00940498|20738063|P8|NOT COMPLETED|Overall Study||1
8414047|NCT00940498|20738064|P7|NOT COMPLETED|Overall Study||1
8414048|NCT00940498|20738065|P6|NOT COMPLETED|Overall Study||1
8414049|NCT00940498|20738066|P5|NOT COMPLETED|Overall Study||9
8414050|NCT00940498|20738067|P4|NOT COMPLETED|Overall Study||2
8414051|NCT00940498|20738068|P3|NOT COMPLETED|Overall Study||3
8414052|NCT00940498|20738069|P2|NOT COMPLETED|Overall Study||1
8414053|NCT00940498|20738070|P1|NOT COMPLETED|Overall Study||3
8414054|NCT00940498|20738063|P8|COMPLETED|Overall Study||3
8414055|NCT00940498|20738064|P7|COMPLETED|Overall Study||7
8414056|NCT00940498|20738065|P6|COMPLETED|Overall Study||6
8414057|NCT00940498|20738066|P5|COMPLETED|Overall Study||34
8414058|NCT00940498|20738067|P4|COMPLETED|Overall Study||2
8414059|NCT00940498|20738068|P3|COMPLETED|Overall Study||1
8414060|NCT00940498|20738069|P2|COMPLETED|Overall Study||3
8414061|NCT00940498|20738070|P1|COMPLETED|Overall Study||1
8414062|NCT00940498|20738063|P8|STARTED|Overall Study||4
8414063|NCT00940498|20738064|P7|STARTED|Overall Study||8
8414064|NCT00940498|20738065|P6|STARTED|Overall Study||7
8414065|NCT00940498|20738066|P5|STARTED|Overall Study||43
8414066|NCT00940498|20738067|P4|STARTED|Overall Study||4
8414067|NCT00940498|20738068|P3|STARTED|Overall Study||4
8414068|NCT00940498|20738069|P2|STARTED|Overall Study||4
8414069|NCT00940498|20738070|P1|STARTED|Overall Study||4
8414070|NCT00940485|20738188|P2|NOT COMPLETED|Overall Study||7
8414071|NCT00940485|20738189|P1|NOT COMPLETED|Overall Study||15
8414072|NCT00940485|20738188|P2|COMPLETED|Overall Study||93
8414073|NCT00940485|20738189|P1|COMPLETED|Overall Study||82
8414074|NCT00940485|20738188|P2|STARTED|Overall Study||100
8414075|NCT00940485|20738189|P1|STARTED|Overall Study||97
8414076|NCT00940446|20738215|P2|NOT COMPLETED|Overall Study||0
8414077|NCT00940446|20738216|P1|NOT COMPLETED|Overall Study||0
8414078|NCT00940446|20738215|P2|COMPLETED|Overall Study||30
8414079|NCT00940446|20738216|P1|COMPLETED|Overall Study||30
8414080|NCT00940446|20738215|P2|STARTED|Overall Study||30
8414081|NCT00940446|20738216|P1|STARTED|Overall Study||30
8414082|NCT00940342|20738227|P3|NOT COMPLETED|Overall Study||1
8414083|NCT00940342|20738228|P2|NOT COMPLETED|Overall Study||2
8414084|NCT00940342|20738229|P1|NOT COMPLETED|Overall Study||0
8414085|NCT00940342|20738227|P3|COMPLETED|Overall Study||39
8414086|NCT00940342|20738228|P2|COMPLETED|Overall Study||38
8414087|NCT00940342|20738229|P1|COMPLETED|Overall Study||50
8414088|NCT00940342|20738227|P3|STARTED|Overall Study||40
8414089|NCT00940342|20738228|P2|STARTED|Overall Study||40
8414090|NCT00940342|20738229|P1|STARTED|Overall Study||50
8414091|NCT00940316|20738240|P3|NOT COMPLETED|Follow up Every 3 Months||0
8414092|NCT00940316|20738241|P2|NOT COMPLETED|Follow up Every 3 Months||0
8414093|NCT00940316|20738242|P1|NOT COMPLETED|Follow up Every 3 Months||0
8414094|NCT00940316|20738240|P3|COMPLETED|Follow up Every 3 Months||2
8414095|NCT00940316|20738241|P2|COMPLETED|Follow up Every 3 Months||13
8414096|NCT00940316|20738242|P1|COMPLETED|Follow up Every 3 Months||13
8414097|NCT00940316|20738240|P3|STARTED|Follow up Every 3 Months||2
8414098|NCT00940316|20738241|P2|STARTED|Follow up Every 3 Months||13
8414099|NCT00940316|20738242|P1|STARTED|Follow up Every 3 Months||13
8414100|NCT00940316|20738240|P3|NOT COMPLETED|Crossed Over to Arm A After Progression||0
8414101|NCT00940316|20738241|P2|NOT COMPLETED|Crossed Over to Arm A After Progression||0
8414102|NCT00940316|20738242|P1|NOT COMPLETED|Crossed Over to Arm A After Progression||0
8414103|NCT00940316|20738240|P3|COMPLETED|Crossed Over to Arm A After Progression||0
8414104|NCT00940316|20738241|P2|COMPLETED|Crossed Over to Arm A After Progression||3
8414105|NCT00940316|20738242|P1|COMPLETED|Crossed Over to Arm A After Progression||0
8414106|NCT00940316|20738240|P3|Treated for Cycle One|Crossed Over to Arm A After Progression||0
8414107|NCT00940316|20738241|P2|Treated for Cycle One|Crossed Over to Arm A After Progression||3
8414108|NCT00940316|20738242|P1|Treated for Cycle One|Crossed Over to Arm A After Progression||0
8414109|NCT00940316|20738240|P3|STARTED|Crossed Over to Arm A After Progression||0
8414110|NCT00940316|20738241|P2|STARTED|Crossed Over to Arm A After Progression||3
8414111|NCT00940316|20738242|P1|STARTED|Crossed Over to Arm A After Progression||0
8414112|NCT00940316|20738240|P3|NOT COMPLETED|Treated After Cycle 5||1
8414113|NCT00940316|20738241|P2|NOT COMPLETED|Treated After Cycle 5||1
8414114|NCT00940316|20738242|P1|NOT COMPLETED|Treated After Cycle 5||0
8414115|NCT00940316|20738240|P3|COMPLETED|Treated After Cycle 5||1
8414116|NCT00940316|20738241|P2|COMPLETED|Treated After Cycle 5||8
8414117|NCT00940316|20738242|P1|COMPLETED|Treated After Cycle 5||8
8414118|NCT00940316|20738240|P3|STARTED|Treated After Cycle 5||2
8414119|NCT00940316|20738241|P2|STARTED|Treated After Cycle 5||9
8414120|NCT00940316|20738242|P1|STARTED|Treated After Cycle 5||8
8414121|NCT00940316|20738240|P3|NOT COMPLETED|Moved on to be Treated Cycle 5||0
8414122|NCT00940316|20738241|P2|NOT COMPLETED|Moved on to be Treated Cycle 5||0
8414123|NCT00940316|20738242|P1|NOT COMPLETED|Moved on to be Treated Cycle 5||2
8414124|NCT00940316|20738240|P3|COMPLETED|Moved on to be Treated Cycle 5||2
8414125|NCT00940316|20738241|P2|COMPLETED|Moved on to be Treated Cycle 5||9
8414126|NCT00940316|20738242|P1|COMPLETED|Moved on to be Treated Cycle 5||8
8414127|NCT00940316|20738240|P3|STARTED|Moved on to be Treated Cycle 5||2
8414128|NCT00940316|20738241|P2|STARTED|Moved on to be Treated Cycle 5||9
8414129|NCT00940316|20738242|P1|STARTED|Moved on to be Treated Cycle 5||10
8414130|NCT00940316|20738240|P3|NOT COMPLETED|Reached First Response at 8 Weeks||0
8414131|NCT00940316|20738241|P2|NOT COMPLETED|Reached First Response at 8 Weeks||4
8414132|NCT00940316|20738242|P1|NOT COMPLETED|Reached First Response at 8 Weeks||3
8414133|NCT00940316|20738240|P3|COMPLETED|Reached First Response at 8 Weeks||2
8414134|NCT00940316|20738241|P2|COMPLETED|Reached First Response at 8 Weeks||9
8414135|NCT00940316|20738242|P1|COMPLETED|Reached First Response at 8 Weeks||10
8414136|NCT00940316|20738240|P3|STARTED|Reached First Response at 8 Weeks||2
8414137|NCT00940316|20738241|P2|STARTED|Reached First Response at 8 Weeks||13
8414138|NCT00940316|20738242|P1|STARTED|Reached First Response at 8 Weeks||13
8414139|NCT00940290|20738268|P4|NOT COMPLETED|Overall Study||0
8414140|NCT00940290|20738269|P3|NOT COMPLETED|Overall Study||0
8414141|NCT00940290|20738270|P2|NOT COMPLETED|Overall Study||0
8414142|NCT00940290|20738271|P1|NOT COMPLETED|Overall Study||0
8414143|NCT00940290|20738268|P4|COMPLETED|Overall Study||54
8414144|NCT00940290|20738269|P3|COMPLETED|Overall Study||55
8414145|NCT00940290|20738270|P2|COMPLETED|Overall Study||53
8414146|NCT00940290|20738271|P1|COMPLETED|Overall Study||54
8414147|NCT00940290|20738268|P4|STARTED|Overall Study||54
8414148|NCT00940290|20738269|P3|STARTED|Overall Study||55
8414149|NCT00940290|20738270|P2|STARTED|Overall Study||53
8414150|NCT00940290|20738271|P1|STARTED|Overall Study||54
8414151|NCT00940108|20738285|P4|NOT COMPLETED|Overall Study||5
8414152|NCT00940108|20738286|P3|NOT COMPLETED|Overall Study||3
8414153|NCT00940108|20738287|P2|NOT COMPLETED|Overall Study||9
8414154|NCT00940108|20738288|P1|NOT COMPLETED|Overall Study||5
8414155|NCT00940108|20738285|P4|COMPLETED|Overall Study||99
8414156|NCT00940108|20738286|P3|COMPLETED|Overall Study||100
8414157|NCT00940108|20738287|P2|COMPLETED|Overall Study||71
8414158|NCT00940108|20738288|P1|COMPLETED|Overall Study||77
8414159|NCT00940108|20738285|P4|STARTED|Overall Study||104
8414160|NCT00940108|20738286|P3|STARTED|Overall Study||103
8414161|NCT00940108|20738287|P2|STARTED|Overall Study||80
8414162|NCT00940108|20738288|P1|STARTED|Overall Study||82
8414163|NCT00940017|20738338|P1|NOT COMPLETED|Overall Study||4
8414164|NCT00940017|20738338|P1|COMPLETED|Overall Study||20
8414165|NCT00940017|20738338|P1|Subjects Treated|Overall Study||21
8414166|NCT00940017|20738338|P1|STARTED|Overall Study||24
8414167|NCT00939991|20738359|P2|NOT COMPLETED|Overall Study||0
8414168|NCT00939991|20738360|P1|NOT COMPLETED|Overall Study||0
8414169|NCT00939991|20738359|P2|COMPLETED|Overall Study||39
8414170|NCT00939991|20738360|P1|COMPLETED|Overall Study||9
8414171|NCT00939991|20738359|P2|STARTED|Overall Study||39
8414172|NCT00939991|20738360|P1|STARTED|Overall Study||9
8414173|NCT00939952|20738370|P1|NOT COMPLETED|Overall Study||0
8414174|NCT00939952|20738370|P1|COMPLETED|Overall Study||7
8414175|NCT00939952|20738370|P1|STARTED|Overall Study||7
8414176|NCT00939900|20738382|P2|NOT COMPLETED|Overall Study||7
8414177|NCT00939900|20738383|P1|NOT COMPLETED|Overall Study||2
8414178|NCT00939900|20738382|P2|COMPLETED|Overall Study||48
8414179|NCT00939900|20738383|P1|COMPLETED|Overall Study||53
8414180|NCT00939900|20738382|P2|STARTED|Overall Study||55
8414181|NCT00939900|20738383|P1|STARTED|Overall Study||55
8414182|NCT00939874|20738389|P1|NOT COMPLETED|Overall Study||20
8414183|NCT00939874|20738389|P1|COMPLETED|Overall Study||32
8414184|NCT00939874|20738389|P1|Completed Week 48|Overall Study||37
8414185|NCT00939874|20738389|P1|STARTED|Overall Study||52
8414186|NCT00939822|20738396|P2|NOT COMPLETED|Overall Study||3
8414187|NCT00939822|20738397|P1|NOT COMPLETED|Overall Study||2
8414188|NCT00939822|20738396|P2|COMPLETED|Overall Study||41
8414189|NCT00939822|20738397|P1|COMPLETED|Overall Study||42
8414190|NCT00939822|20738396|P2|STARTED|Overall Study||44
8414191|NCT00939822|20738397|P1|STARTED|Overall Study||44
8414192|NCT00939809|20738409|P1|NOT COMPLETED|Overall Study||3
8414193|NCT00939809|20738409|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
8414194|NCT00939809|20738409|P1|STARTED|Overall Study||31
8414195|NCT00939796|20738418|P1|NOT COMPLETED|Overall Study||0
8414196|NCT00939796|20738418|P1|COMPLETED|Overall Study||16
8414197|NCT00939796|20738418|P1|STARTED|Overall Study||16
8414198|NCT00939783|20738424|P1|NOT COMPLETED|Overall Study||649
8414199|NCT00939783|20738424|P1|COMPLETED|Overall Study||0
8414200|NCT00939783|20738424|P1|Treated|Overall Study||648
8414201|NCT00939783|20738424|P1|STARTED|Overall Study||649
8414202|NCT00939770|20738439|P8|NOT COMPLETED|Overall Study||10
8414203|NCT00939770|20738440|P7|NOT COMPLETED|Overall Study||14
8414204|NCT00939770|20738441|P6|NOT COMPLETED|Overall Study||11
8414205|NCT00939770|20738442|P5|NOT COMPLETED|Overall Study||37
8414206|NCT00939770|20738443|P4|NOT COMPLETED|Overall Study||11
8414207|NCT00939770|20738444|P3|NOT COMPLETED|Overall Study||20
8414208|NCT00939770|20738445|P2|NOT COMPLETED|Overall Study||8
8414209|NCT00939770|20738446|P1|NOT COMPLETED|Overall Study||5
8414210|NCT00939770|20738439|P8|COMPLETED|Overall Study||0
8414211|NCT00939770|20738440|P7|COMPLETED|Overall Study||0
8414212|NCT00939770|20738441|P6|COMPLETED|Overall Study||0
8414213|NCT00939770|20738442|P5|COMPLETED|Overall Study||1
8414214|NCT00939770|20738443|P4|COMPLETED|Overall Study||1
8414215|NCT00939770|20738444|P3|COMPLETED|Overall Study||3
8414216|NCT00939770|20738445|P2|COMPLETED|Overall Study||0
8414217|NCT00939770|20738446|P1|COMPLETED|Overall Study||1
8414218|NCT00939770|20738439|P8|STARTED|Overall Study||10
8414219|NCT00939770|20738440|P7|STARTED|Overall Study||14
8414220|NCT00939770|20738441|P6|STARTED|Overall Study||11
8414221|NCT00939770|20738442|P5|STARTED|Overall Study||38
8414222|NCT00939770|20738443|P4|STARTED|Overall Study||12
8414223|NCT00939770|20738444|P3|STARTED|Overall Study||23
8414224|NCT00939770|20738445|P2|STARTED|Overall Study||8
8414225|NCT00939770|20738446|P1|STARTED|Overall Study||6
8414226|NCT00939731|20738497|P2|NOT COMPLETED|Second Intervention Period||0
8414227|NCT00939731|20738498|P1|NOT COMPLETED|Second Intervention Period||0
8414228|NCT00939731|20738497|P2|COMPLETED|Second Intervention Period||12
8414229|NCT00939731|20738498|P1|COMPLETED|Second Intervention Period||12
8414230|NCT00939731|20738497|P2|STARTED|Second Intervention Period||12
8414231|NCT00939731|20738498|P1|STARTED|Second Intervention Period||12
8414232|NCT00939731|20738497|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8414233|NCT00939731|20738498|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8414234|NCT00939731|20738497|P2|COMPLETED|Washout Period (at Least 14 Days)||12
8414235|NCT00939731|20738498|P1|COMPLETED|Washout Period (at Least 14 Days)||12
8414236|NCT00939731|20738497|P2|STARTED|Washout Period (at Least 14 Days)||12
8414237|NCT00939731|20738498|P1|STARTED|Washout Period (at Least 14 Days)||12
8414238|NCT00939731|20738497|P2|NOT COMPLETED|First Intervention Period||0
8414239|NCT00939731|20738498|P1|NOT COMPLETED|First Intervention Period||0
8414240|NCT00939731|20738497|P2|COMPLETED|First Intervention Period||12
8414241|NCT00939731|20738498|P1|COMPLETED|First Intervention Period||12
8414242|NCT00939731|20738497|P2|STARTED|First Intervention Period||12
8414243|NCT00939731|20738498|P1|STARTED|First Intervention Period||12
8414244|NCT00939705|20738518|P2|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
8414245|NCT00939705|20738519|P1|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
8414246|NCT00939705|20738518|P2|COMPLETED|Period 3 - Second Intervent - 5 Days||9
8414247|NCT00939705|20738519|P1|COMPLETED|Period 3 - Second Intervent - 5 Days||9
8414248|NCT00939705|20738518|P2|STARTED|Period 3 - Second Intervent - 5 Days||9
8414249|NCT00939705|20738519|P1|STARTED|Period 3 - Second Intervent - 5 Days||9
8414250|NCT00939705|20738518|P2|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
8414251|NCT00939705|20738519|P1|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
8414252|NCT00939705|20738518|P2|COMPLETED|Period 2 - Washout Period - 21 Days||9
8414253|NCT00939705|20738519|P1|COMPLETED|Period 2 - Washout Period - 21 Days||9
8414254|NCT00939705|20738518|P2|STARTED|Period 2 - Washout Period - 21 Days||9
8414255|NCT00939705|20738519|P1|STARTED|Period 2 - Washout Period - 21 Days||9
8414256|NCT00939705|20738518|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
8414257|NCT00939705|20738519|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
8414258|NCT00939705|20738518|P2|COMPLETED|Period 1 - First Intervention - 5 Days||9
8414259|NCT00939705|20738519|P1|COMPLETED|Period 1 - First Intervention - 5 Days||9
8414260|NCT00939705|20738518|P2|STARTED|Period 1 - First Intervention - 5 Days||9
8414261|NCT00939705|20738519|P1|STARTED|Period 1 - First Intervention - 5 Days||9
8414262|NCT00939692|20738531|P2|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
8414263|NCT00939692|20738532|P1|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
8414264|NCT00939692|20738531|P2|COMPLETED|Period 2 - Second Intervent - 5 Days||12
8414265|NCT00939692|20738532|P1|COMPLETED|Period 2 - Second Intervent - 5 Days||12
8414266|NCT00939692|20738531|P2|STARTED|Period 2 - Second Intervent - 5 Days||13
8414267|NCT00939692|20738532|P1|STARTED|Period 2 - Second Intervent - 5 Days||12
8414268|NCT00939692|20738531|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
8414269|NCT00939692|20738532|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
8414270|NCT00939692|20738531|P2|COMPLETED|Period 1 - First Intervention - 5 Days||13
8414271|NCT00939692|20738532|P1|COMPLETED|Period 1 - First Intervention - 5 Days||12
8414272|NCT00939692|20738531|P2|STARTED|Period 1 - First Intervention - 5 Days||13
8414273|NCT00939692|20738532|P1|STARTED|Period 1 - First Intervention - 5 Days||13
8414274|NCT00939653|20738542|P1|NOT COMPLETED|Treatment Course 4||0
8414275|NCT00939653|20738542|P1|COMPLETED|Treatment Course 4||0
8414276|NCT00939653|20738542|P1|STARTED|Treatment Course 4||0
8414277|NCT00939653|20738542|P1|NOT COMPLETED|Treatment Course 3||0
8414278|NCT00939653|20738542|P1|COMPLETED|Treatment Course 3||0
8414279|NCT00939653|20738542|P1|STARTED|Treatment Course 3||0
8414280|NCT00939653|20738542|P1|NOT COMPLETED|Treatment Course 2||0
8414281|NCT00939653|20738542|P1|COMPLETED|Treatment Course 2||2
8414282|NCT00939653|20738542|P1|STARTED|Treatment Course 2||2
8414283|NCT00939653|20738542|P1|NOT COMPLETED|Treatment Course 1||0
8414284|NCT00939653|20738542|P1|COMPLETED|Treatment Course 1||6
8414285|NCT00939653|20738542|P1|STARTED|Treatment Course 1||6
8414286|NCT00939640|20738547|P1|NOT COMPLETED|Overall Study||1
8414287|NCT00939640|20738547|P1|COMPLETED|Overall Study||13
8414288|NCT00939640|20738547|P1|STARTED|Overall Study||14
8414289|NCT00939627|20738568|P3|NOT COMPLETED|Overall Study||0
8414290|NCT00939627|20738569|P2|NOT COMPLETED|Overall Study||28
8414291|NCT00939627|20738570|P1|NOT COMPLETED|Overall Study||27
8414292|NCT00939627|20738568|P3|COMPLETED|Overall Study||0
8414293|NCT00939627|20738569|P2|COMPLETED|Overall Study||0
8414294|NCT00939627|20738570|P1|COMPLETED|Overall Study||0
8414295|NCT00939627|20738568|P3|STARTED|Overall Study||0
8414296|NCT00939627|20738569|P2|STARTED|Overall Study||28
8414297|NCT00939627|20738570|P1|STARTED|Overall Study||27
8414298|NCT00939562|20738588|P2|NOT COMPLETED|Period 2||0
8414299|NCT00939562|20738589|P1|NOT COMPLETED|Period 2||0
8414300|NCT00939562|20738588|P2|COMPLETED|Period 2||12
8414301|NCT00939562|20738589|P1|COMPLETED|Period 2||12
8414302|NCT00939562|20738588|P2|STARTED|Period 2||12
8414303|NCT00939562|20738589|P1|STARTED|Period 2||12
8414304|NCT00939562|20738588|P2|NOT COMPLETED|Period 1||0
8414305|NCT00939562|20738589|P1|NOT COMPLETED|Period 1||0
8414306|NCT00939562|20738588|P2|COMPLETED|Period 1||12
8414307|NCT00939562|20738589|P1|COMPLETED|Period 1||12
8414308|NCT00939562|20738588|P2|STARTED|Period 1||12
8414309|NCT00939562|20738589|P1|STARTED|Period 1||12
8414310|NCT00939536|20738599|P2|NOT COMPLETED|Second Intervention||0
8414311|NCT00939536|20738600|P1|NOT COMPLETED|Second Intervention||0
8414312|NCT00939536|20738599|P2|COMPLETED|Second Intervention||12
8414313|NCT00939536|20738600|P1|COMPLETED|Second Intervention||12
8414314|NCT00939536|20738599|P2|STARTED|Second Intervention||12
8414315|NCT00939536|20738600|P1|STARTED|Second Intervention||12
8414316|NCT00939536|20738599|P2|NOT COMPLETED|First Intervention||0
8414317|NCT00939536|20738600|P1|NOT COMPLETED|First Intervention||0
8414318|NCT00939536|20738599|P2|COMPLETED|First Intervention||12
8414319|NCT00939536|20738600|P1|COMPLETED|First Intervention||12
8414320|NCT00939536|20738599|P2|STARTED|First Intervention||12
8414321|NCT00939536|20738600|P1|STARTED|First Intervention||12
8414322|NCT00939523|20738610|P1|NOT COMPLETED|Overall Study||3
8414323|NCT00939523|20738610|P1|COMPLETED|Overall Study||6
8414324|NCT00939523|20738610|P1|STARTED|Overall Study||9
8414325|NCT00939510|20738617|P1|NOT COMPLETED|Overall Study||1
8414326|NCT00939510|20738617|P1|COMPLETED|Overall Study||31
8414327|NCT00939510|20738617|P1|STARTED|Overall Study||32
8414328|NCT00939484|20738626|P3|NOT COMPLETED|Overall Study||3
8414329|NCT00939484|20738627|P2|NOT COMPLETED|Overall Study||20
8414330|NCT00939484|20738628|P1|NOT COMPLETED|Overall Study||8
8414331|NCT00939484|20738626|P3|COMPLETED|Overall Study||0
8414332|NCT00939484|20738627|P2|COMPLETED|Overall Study||0
8414333|NCT00939484|20738628|P1|COMPLETED|Overall Study||0
8414334|NCT00939484|20738626|P3|STARTED|Overall Study||3
8414335|NCT00939484|20738627|P2|STARTED|Overall Study||20
8414336|NCT00939484|20738628|P1|STARTED|Overall Study||8
8414337|NCT00939471|20738641|P1|NOT COMPLETED|Overall Study||11
8414338|NCT00939471|20738641|P1|COMPLETED|Overall Study||33
8414339|NCT00939471|20738641|P1|STARTED|Overall Study||44
8414340|NCT00939393|20738654|P2|NOT COMPLETED|Overall Study||0
8414341|NCT00939393|20738655|P1|NOT COMPLETED|Overall Study||4
8414342|NCT00939393|20738654|P2|COMPLETED|Overall Study||35
8414343|NCT00939393|20738655|P1|COMPLETED|Overall Study||33
8414344|NCT00939393|20738654|P2|STARTED|Overall Study||35
8414345|NCT00939393|20738655|P1|STARTED|Overall Study||37
8414346|NCT00939367|20738675|P2|NOT COMPLETED|Second Intervention||0
8414347|NCT00939367|20738676|P1|NOT COMPLETED|Second Intervention||0
8414348|NCT00939367|20738675|P2|COMPLETED|Second Intervention||15
8414349|NCT00939367|20738676|P1|COMPLETED|Second Intervention||15
8414350|NCT00939367|20738675|P2|STARTED|Second Intervention||15
8414351|NCT00939367|20738676|P1|STARTED|Second Intervention||15
8414352|NCT00939367|20738675|P2|NOT COMPLETED|First Intervention||0
8414353|NCT00939367|20738676|P1|NOT COMPLETED|First Intervention||0
8414354|NCT00939367|20738675|P2|COMPLETED|First Intervention||15
8414355|NCT00939367|20738676|P1|COMPLETED|First Intervention||15
8414356|NCT00939367|20738675|P2|STARTED|First Intervention||15
8414357|NCT00939367|20738676|P1|STARTED|First Intervention||15
8414358|NCT00939341|20738686|P1|NOT COMPLETED|Overall Study||66
8414359|NCT00939341|20738686|P1|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
8414360|NCT00939341|20738686|P1|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
8414361|NCT00939211|20738706|P1|NOT COMPLETED|Placebo||0
8414362|NCT00939211|20738706|P1|COMPLETED|Placebo||28
8414363|NCT00939211|20738706|P1|STARTED|Placebo||28
8414364|NCT00939211|20738706|P1|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
8414365|NCT00939211|20738706|P1|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
8414366|NCT00939211|20738706|P1|STARTED|Spiriva 18 Mcg First, Then Placebo||28
8414367|NCT00939211|20738706|P1|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
8414368|NCT00939211|20738706|P1|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
8414369|NCT00939211|20738706|P1|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
8414370|NCT00939211|20738706|P1|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
8414371|NCT00939211|20738706|P1|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
8414372|NCT00939211|20738706|P1|STARTED|AZD9164 400 Mcg First, Then Placebo||28
8414373|NCT00939211|20738706|P1|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
8414374|NCT00939211|20738706|P1|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
8414375|NCT00939211|20738706|P1|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
8414376|NCT00939198|20738768|P1|NOT COMPLETED|Overall Study||0
8414377|NCT00939198|20738768|P1|COMPLETED|Overall Study||87
8414378|NCT00939198|20738768|P1|STARTED|Overall Study||87
8414379|NCT00939185|20738773|P1|NOT COMPLETED|Overall Study||25
8414380|NCT00939185|20738773|P1|COMPLETED|Overall Study||375
8414381|NCT00939185|20738773|P1|Received Treatment|Overall Study||390
8414382|NCT00939185|20738773|P1|STARTED|Overall Study||400
8414383|NCT00939159|20738780|P1|NOT COMPLETED|Overall Study||0
8414384|NCT00939159|20738780|P1|COMPLETED|Overall Study||13
8414385|NCT00939159|20738780|P1|STARTED|Overall Study||13
8414386|NCT00939120|20738786|P2|NOT COMPLETED|Overall Study||5
8414387|NCT00939120|20738787|P1|NOT COMPLETED|Overall Study||8
8414388|NCT00939120|20738786|P2|COMPLETED|Overall Study||18
8414389|NCT00939120|20738787|P1|COMPLETED|Overall Study||15
8414390|NCT00939120|20738786|P2|STARTED|Overall Study||23
8414391|NCT00939120|20738787|P1|STARTED|Overall Study||23
8414392|NCT00939107|20738811|P2|NOT COMPLETED|Overall Study||12
8414393|NCT00939107|20738812|P1|NOT COMPLETED|Overall Study||14
8414394|NCT00939107|20738811|P2|COMPLETED|Overall Study||163
8414395|NCT00939107|20738812|P1|COMPLETED|Overall Study||161
8414396|NCT00939107|20738811|P2|12 Months Follow-up|Overall Study||163
8414397|NCT00939107|20738812|P1|12 Months Follow-up|Overall Study||161
8414398|NCT00939107|20738811|P2|STARTED|Overall Study||175
8414399|NCT00939107|20738812|P1|STARTED|Overall Study||175
8414400|NCT00939094|20738826|P2|NOT COMPLETED|Overall Study||10
8414401|NCT00939094|20738827|P1|NOT COMPLETED|Overall Study||14
8414402|NCT00939094|20738826|P2|COMPLETED|Overall Study||35
8414403|NCT00939094|20738827|P1|COMPLETED|Overall Study||28
8414404|NCT00939094|20738826|P2|STARTED|Overall Study||45
8414405|NCT00939094|20738827|P1|STARTED|Overall Study||42
8414406|NCT00939055|20738849|P2|NOT COMPLETED|Overall Study||0
8414407|NCT00939055|20738850|P1|NOT COMPLETED|Overall Study||4
8414408|NCT00939055|20738849|P2|COMPLETED|Overall Study||39
8414409|NCT00939055|20738850|P1|COMPLETED|Overall Study||69
8414410|NCT00939055|20738849|P2|STARTED|Overall Study||39
8414411|NCT00939055|20738850|P1|STARTED|Overall Study||73
8414412|NCT00939029|20738860|P2|NOT COMPLETED|Overall Study||12
8414413|NCT00939029|20738861|P1|NOT COMPLETED|Overall Study||6
8414414|NCT00939029|20738860|P2|COMPLETED|Overall Study||15
8414415|NCT00939029|20738861|P1|COMPLETED|Overall Study||19
8414416|NCT00939029|20738860|P2|STARTED|Overall Study||27
8414417|NCT00939029|20738861|P1|STARTED|Overall Study||25
8414418|NCT00939003|20738873|P2|NOT COMPLETED|Open-label Treatment Period||29
8414419|NCT00939003|20738874|P1|NOT COMPLETED|Open-label Treatment Period||29
8414420|NCT00939003|20738873|P2|COMPLETED|Open-label Treatment Period||62
8414421|NCT00939003|20738874|P1|COMPLETED|Open-label Treatment Period||66
8414422|NCT00939003|20738873|P2|STARTED|Open-label Treatment Period||91
8414423|NCT00939003|20738874|P1|STARTED|Open-label Treatment Period||95
8414424|NCT00939003|20738873|P2|NOT COMPLETED|Double-blind Treatment Period||4
8414425|NCT00939003|20738874|P1|NOT COMPLETED|Double-blind Treatment Period||2
8414426|NCT00939003|20738873|P2|COMPLETED|Double-blind Treatment Period||91
8414427|NCT00939003|20738874|P1|COMPLETED|Double-blind Treatment Period||95
8414428|NCT00939003|20738873|P2|STARTED|Double-blind Treatment Period||95
8414429|NCT00939003|20738874|P1|STARTED|Double-blind Treatment Period||97
8414430|NCT00938964|20738911|P2|NOT COMPLETED|Overall Study||28
8414431|NCT00938964|20738912|P1|NOT COMPLETED|Overall Study||30
8414432|NCT00938964|20738911|P2|COMPLETED|Overall Study||209
8414433|NCT00938964|20738912|P1|COMPLETED|Overall Study||211
8414434|NCT00938964|20738911|P2|STARTED|Overall Study||237
8414435|NCT00938964|20738912|P1|STARTED|Overall Study||241
8414436|NCT00938886|20738976|P2|NOT COMPLETED|Overall Study||10
8414437|NCT00938886|20738977|P1|NOT COMPLETED|Overall Study||7
8414438|NCT00938886|20738976|P2|COMPLETED|Overall Study||65
8414439|NCT00938886|20738977|P1|COMPLETED|Overall Study||68
8414440|NCT00938886|20738976|P2|Attended 1 Counseling Session|Overall Study||70
8414441|NCT00938886|20738977|P1|Attended 1 Counseling Session|Overall Study||70
8414442|NCT00938886|20738976|P2|STARTED|Overall Study||75
8414443|NCT00938886|20738977|P1|STARTED|Overall Study||75
8414444|NCT00938860|20738987|P2|NOT COMPLETED|Overall Study||17
8414445|NCT00938860|20738988|P1|NOT COMPLETED|Overall Study||25
8414446|NCT00938860|20738987|P2|COMPLETED|Overall Study||25
8414447|NCT00938860|20738988|P1|COMPLETED|Overall Study||25
8414448|NCT00938860|20738987|P2|Efficacy Population|Overall Study||41
8414449|NCT00938860|20738988|P1|Efficacy Population|Overall Study||40
8414450|NCT00938860|20738987|P2|STARTED|Overall Study||42
8414451|NCT00938860|20738988|P1|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
8414452|NCT00938782|20739012|P2|NOT COMPLETED|Overall Study||0
8414453|NCT00938782|20739013|P1|NOT COMPLETED|Overall Study||0
8414454|NCT00938782|20739012|P2|COMPLETED|Overall Study|Upon discharge from PACU|35
8414455|NCT00938782|20739013|P1|COMPLETED|Overall Study|Upon discharge from PACU|32
8414456|NCT00938782|20739012|P2|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
8414457|NCT00938782|20739013|P1|STARTED|Overall Study|Pre-induction of anesthesia|32
8414458|NCT00938717|20739021|P2|NOT COMPLETED|Overall Study||108
8414459|NCT00938717|20739022|P1|NOT COMPLETED|Overall Study||98
8414460|NCT00938717|20739021|P2|COMPLETED|Overall Study||294
8414461|NCT00938717|20739022|P1|COMPLETED|Overall Study||305
8414462|NCT00938717|20739021|P2|STARTED|Overall Study||402
8414463|NCT00938717|20739022|P1|STARTED|Overall Study||403
8414464|NCT00938704|20739056|P2|NOT COMPLETED|Overall Study||0
8414465|NCT00938704|20739057|P1|NOT COMPLETED|Overall Study||0
8414466|NCT00938704|20739056|P2|COMPLETED|Overall Study||37
8414467|NCT00938704|20739057|P1|COMPLETED|Overall Study||33
8414468|NCT00938704|20739056|P2|STARTED|Overall Study||37
8414469|NCT00938704|20739057|P1|STARTED|Overall Study||33
8414470|NCT00938639|20739073|P2|NOT COMPLETED|Overall Study||4
8414471|NCT00938639|20739074|P1|NOT COMPLETED|Overall Study||3
8414472|NCT00938639|20739073|P2|COMPLETED|Overall Study||116
8414473|NCT00938639|20739074|P1|COMPLETED|Overall Study||117
8414474|NCT00938639|20739073|P2|STARTED|Overall Study||120
8414475|NCT00938639|20739074|P1|STARTED|Overall Study||120
8414476|NCT00938548|20739144|P2|NOT COMPLETED|Overall Study||0
8414477|NCT00938548|20739145|P1|NOT COMPLETED|Overall Study||0
8414478|NCT00938548|20739144|P2|COMPLETED|Overall Study||35
8414479|NCT00938548|20739145|P1|COMPLETED|Overall Study||35
8414480|NCT00938548|20739144|P2|STARTED|Overall Study||35
8414481|NCT00938548|20739145|P1|STARTED|Overall Study||35
8414482|NCT00938470|20739157|P2|NOT COMPLETED|Overall Study||3
8414483|NCT00938470|20739158|P1|NOT COMPLETED|Overall Study||7
8414484|NCT00938470|20739157|P2|COMPLETED|Overall Study||25
8414485|NCT00938470|20739158|P1|COMPLETED|Overall Study||27
8414486|NCT00938470|20739157|P2|STARTED|Overall Study||28
8414487|NCT00938470|20739158|P1|STARTED|Overall Study||34
8414488|NCT00938457|20739172|P1|NOT COMPLETED|Overall Study||0
8414489|NCT00938457|20739172|P1|COMPLETED|Overall Study||3
8414490|NCT00938457|20739172|P1|STARTED|Overall Study||3
8414491|NCT00938431|20739188|P3|NOT COMPLETED|Overall Study||8
8414492|NCT00938431|20739189|P2|NOT COMPLETED|Overall Study||9
8414493|NCT00938431|20739190|P1|NOT COMPLETED|Overall Study||6
8414494|NCT00938431|20739188|P3|COMPLETED|Overall Study||1
8414495|NCT00938431|20739189|P2|COMPLETED|Overall Study||14
8414496|NCT00938431|20739190|P1|COMPLETED|Overall Study||9
8414497|NCT00938431|20739188|P3|STARTED|Overall Study||9
8414498|NCT00938431|20739189|P2|STARTED|Overall Study||23
8414499|NCT00938431|20739190|P1|STARTED|Overall Study||15
8414500|NCT00938392|20739217|P2|NOT COMPLETED|Overall Study||4
8414501|NCT00938392|20739218|P1|NOT COMPLETED|Overall Study||2
8414502|NCT00938392|20739217|P2|COMPLETED|Overall Study||358
8414503|NCT00938392|20739218|P1|COMPLETED|Overall Study||360
8414504|NCT00938392|20739217|P2|STARTED|Overall Study||362
8414505|NCT00938392|20739218|P1|STARTED|Overall Study||362
8414506|NCT00938366|20739244|P2|NOT COMPLETED|Overall Study||0
8414507|NCT00938366|20739245|P1|NOT COMPLETED|Overall Study||1
8414508|NCT00938366|20739244|P2|COMPLETED|Overall Study||9
8414509|NCT00938366|20739245|P1|COMPLETED|Overall Study||8
8414510|NCT00938366|20739244|P2|STARTED|Overall Study||9
8414511|NCT00938366|20739245|P1|STARTED|Overall Study||9
8414512|NCT00938340|20739265|P1|NOT COMPLETED|Overall Study||5
8414513|NCT00938340|20739265|P1|COMPLETED|Overall Study||15
8414514|NCT00938340|20739265|P1|Received Walnut Oil Intervention|Overall Study||15
8414515|NCT00938340|20739265|P1|Received Walnut Skins Intervention|Overall Study||15
8414516|NCT00938340|20739265|P1|Received Walnut Nutmeat Intervention|Overall Study||19
8414517|NCT00938340|20739265|P1|Received Whole Walnut Intervention|Overall Study||16
8414518|NCT00938340|20739265|P1|STARTED|Overall Study||20
8414519|NCT00938327|20739395|P1|NOT COMPLETED|Overall Study||60
8414520|NCT00938327|20739395|P1|COMPLETED|Overall Study||272
8414521|NCT00938327|20739395|P1|STARTED|Overall Study||332
8414522|NCT00938314|20739406|P4|NOT COMPLETED|Cohort 3||1
8414523|NCT00938314|20739407|P3|NOT COMPLETED|Cohort 3||4
8414524|NCT00938314|20739408|P2|NOT COMPLETED|Cohort 3||0
8414525|NCT00938314|20739409|P1|NOT COMPLETED|Cohort 3||0
8414526|NCT00938314|20739406|P4|COMPLETED|Cohort 3||7
8414527|NCT00938314|20739407|P3|COMPLETED|Cohort 3||20
8414528|NCT00938314|20739408|P2|COMPLETED|Cohort 3||0
8414529|NCT00938314|20739409|P1|COMPLETED|Cohort 3||0
8414530|NCT00938314|20739406|P4|STARTED|Cohort 3||8
8414531|NCT00938314|20739407|P3|STARTED|Cohort 3||24
8414532|NCT00938314|20739408|P2|STARTED|Cohort 3||0
8414533|NCT00938314|20739409|P1|STARTED|Cohort 3||0
8414534|NCT00938314|20739406|P4|NOT COMPLETED|Cohort 2||2
8414535|NCT00938314|20739407|P3|NOT COMPLETED|Cohort 2||0
8414536|NCT00938314|20739408|P2|NOT COMPLETED|Cohort 2||6
8414537|NCT00938314|20739409|P1|NOT COMPLETED|Cohort 2||0
8414538|NCT00938314|20739406|P4|COMPLETED|Cohort 2||6
8414539|NCT00938314|20739407|P3|COMPLETED|Cohort 2||0
8414540|NCT00938314|20739408|P2|COMPLETED|Cohort 2||18
8414541|NCT00938314|20739409|P1|COMPLETED|Cohort 2||0
8414542|NCT00938314|20739406|P4|STARTED|Cohort 2||8
8414543|NCT00938314|20739407|P3|STARTED|Cohort 2||0
8414544|NCT00938314|20739408|P2|STARTED|Cohort 2||24
8414545|NCT00938314|20739409|P1|STARTED|Cohort 2||0
8414546|NCT00938314|20739406|P4|NOT COMPLETED|Cohort 1||2
8414547|NCT00938314|20739407|P3|NOT COMPLETED|Cohort 1||0
8414548|NCT00938314|20739408|P2|NOT COMPLETED|Cohort 1||0
8414549|NCT00938314|20739409|P1|NOT COMPLETED|Cohort 1||2
8414550|NCT00938314|20739406|P4|COMPLETED|Cohort 1||6
8414551|NCT00938314|20739407|P3|COMPLETED|Cohort 1||0
8414552|NCT00938314|20739408|P2|COMPLETED|Cohort 1||0
8414553|NCT00938314|20739409|P1|COMPLETED|Cohort 1||22
8414554|NCT00938314|20739406|P4|STARTED|Cohort 1||8
8414555|NCT00938314|20739407|P3|STARTED|Cohort 1||0
8414556|NCT00938314|20739408|P2|STARTED|Cohort 1||0
8414557|NCT00938314|20739409|P1|STARTED|Cohort 1||24
8414558|NCT00938041|20739463|P1|NOT COMPLETED|Overall Study||27
8414559|NCT00938041|20739463|P1|COMPLETED|Overall Study||5
8414560|NCT00938041|20739463|P1|STARTED|Overall Study||32
8414561|NCT00938015|20739472|P1|NOT COMPLETED|Overall Study||147
8414562|NCT00938015|20739472|P1|COMPLETED|Overall Study||156
8414563|NCT00938015|20739472|P1|STARTED|Overall Study||303
8414564|NCT00937950|20739488|P1|NOT COMPLETED|Overall Study||216
8414565|NCT00937950|20739488|P1|COMPLETED|Overall Study||1787
8414566|NCT00937950|20739488|P1|STARTED|Overall Study||2003
8414570|NCT00937859|20739513|P2|NOT COMPLETED|Overall Study||19
8414571|NCT00937859|20739514|P1|NOT COMPLETED|Overall Study||19
8414572|NCT00937859|20739513|P2|COMPLETED|Overall Study||134
8414573|NCT00937859|20739514|P1|COMPLETED|Overall Study||129
8414574|NCT00937859|20739513|P2|STARTED|Overall Study||153
8414575|NCT00937859|20739514|P1|STARTED|Overall Study||148
8414576|NCT00937833|20739524|P2|NOT COMPLETED|Overall Study||17
8414577|NCT00937833|20739525|P1|NOT COMPLETED|Overall Study||15
8414578|NCT00937833|20739524|P2|COMPLETED|Overall Study||60
8414579|NCT00937833|20739525|P1|COMPLETED|Overall Study||58
8414580|NCT00937833|20739524|P2|STARTED|Overall Study||77
8414581|NCT00937833|20739525|P1|STARTED|Overall Study||73
8414585|NCT00937768|20739538|P2|NOT COMPLETED|Overall Study||8
8414586|NCT00937768|20739539|P1|NOT COMPLETED|Overall Study||8
8414587|NCT00937768|20739538|P2|COMPLETED|Overall Study||0
8414588|NCT00937768|20739539|P1|COMPLETED|Overall Study||0
8414589|NCT00937768|20739538|P2|STARTED|Overall Study||8
8414590|NCT00937768|20739539|P1|STARTED|Overall Study||8
8414591|NCT00937560|20739559|P1|NOT COMPLETED|Maintenance Treatment||18
8414592|NCT00937560|20739559|P1|COMPLETED|Maintenance Treatment||150
8414593|NCT00937560|20739559|P1|STARTED|Maintenance Treatment||168
8414594|NCT00937560|20739559|P1|NOT COMPLETED|Initial Treatment||21
8414595|NCT00937560|20739559|P1|COMPLETED|Initial Treatment||168
8414596|NCT00937560|20739559|P1|Received Treatment|Initial Treatment||189
8414597|NCT00937560|20739559|P1|STARTED|Initial Treatment||189
8414598|NCT00937547|20739570|P3|NOT COMPLETED|Overall Study||7
8414599|NCT00937547|20739571|P2|NOT COMPLETED|Overall Study||6
8414600|NCT00937547|20739572|P1|NOT COMPLETED|Overall Study||1
8414601|NCT00937547|20739570|P3|COMPLETED|Overall Study||142
8414602|NCT00937547|20739571|P2|COMPLETED|Overall Study||78
8414603|NCT00937547|20739572|P1|COMPLETED|Overall Study||95
8414604|NCT00937547|20739570|P3|Histological Samples|Overall Study||142
8414605|NCT00937547|20739571|P2|Histological Samples|Overall Study||78
8414606|NCT00937547|20739572|P1|Histological Samples|Overall Study||95
8414607|NCT00937547|20739570|P3|STARTED|Overall Study||149
8414608|NCT00937547|20739571|P2|STARTED|Overall Study||84
8414609|NCT00937547|20739572|P1|STARTED|Overall Study||96
8414610|NCT00937521|20739609|P8|NOT COMPLETED|Booster Phase||2
8414611|NCT00937521|20739610|P7|NOT COMPLETED|Booster Phase||5
8414612|NCT00937521|20739611|P6|NOT COMPLETED|Booster Phase||5
8414613|NCT00937521|20739612|P5|NOT COMPLETED|Booster Phase||5
8414614|NCT00937521|20739613|P4|NOT COMPLETED|Booster Phase||3
8414615|NCT00937521|20739614|P3|NOT COMPLETED|Booster Phase||5
8414616|NCT00937521|20739615|P2|NOT COMPLETED|Booster Phase||2
8414617|NCT00937521|20739616|P1|NOT COMPLETED|Booster Phase||3
8414618|NCT00937521|20739609|P8|COMPLETED|Booster Phase||159
8414619|NCT00937521|20739610|P7|COMPLETED|Booster Phase||160
8414620|NCT00937521|20739611|P6|COMPLETED|Booster Phase||160
8414621|NCT00937521|20739612|P5|COMPLETED|Booster Phase||163
8414622|NCT00937521|20739613|P4|COMPLETED|Booster Phase||167
8414623|NCT00937521|20739614|P3|COMPLETED|Booster Phase||164
8414624|NCT00937521|20739615|P2|COMPLETED|Booster Phase||161
8414625|NCT00937521|20739616|P1|COMPLETED|Booster Phase||152
8414626|NCT00937521|20739609|P8|Premature Withdrawal|Booster Phase||2
8414627|NCT00937521|20739610|P7|Premature Withdrawal|Booster Phase||5
8414628|NCT00937521|20739611|P6|Premature Withdrawal|Booster Phase||5
8414629|NCT00937521|20739612|P5|Premature Withdrawal|Booster Phase||5
8414630|NCT00937521|20739613|P4|Premature Withdrawal|Booster Phase||3
8414631|NCT00937521|20739614|P3|Premature Withdrawal|Booster Phase||5
8414632|NCT00937521|20739615|P2|Premature Withdrawal|Booster Phase||2
8414633|NCT00937521|20739616|P1|Premature Withdrawal|Booster Phase||3
8414634|NCT00937521|20739609|P8|STARTED|Booster Phase||161
8414635|NCT00937521|20739610|P7|STARTED|Booster Phase||165
8414636|NCT00937521|20739611|P6|STARTED|Booster Phase||165
8414637|NCT00937521|20739612|P5|STARTED|Booster Phase||168
8414638|NCT00937521|20739613|P4|STARTED|Booster Phase||170
8414639|NCT00937521|20739614|P3|STARTED|Booster Phase||169
8414640|NCT00937521|20739615|P2|STARTED|Booster Phase||163
8414641|NCT00937521|20739616|P1|STARTED|Booster Phase||155
8414642|NCT00937521|20739609|P8|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
8414643|NCT00937521|20739610|P7|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
8414644|NCT00937521|20739611|P6|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
8414645|NCT00937521|20739612|P5|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
8414646|NCT00937521|20739613|P4|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
8414647|NCT00937521|20739614|P3|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
8414648|NCT00937521|20739615|P2|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
8414649|NCT00937521|20739616|P1|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
8414650|NCT00937521|20739609|P8|COMPLETED|Overall Study - Prior to Booster Dose||183
8414651|NCT00937521|20739610|P7|COMPLETED|Overall Study - Prior to Booster Dose||181
8414652|NCT00937521|20739611|P6|COMPLETED|Overall Study - Prior to Booster Dose||187
8414653|NCT00937521|20739612|P5|COMPLETED|Overall Study - Prior to Booster Dose||188
8414654|NCT00937521|20739613|P4|COMPLETED|Overall Study - Prior to Booster Dose||187
8414655|NCT00937521|20739614|P3|COMPLETED|Overall Study - Prior to Booster Dose||186
8414656|NCT00937521|20739615|P2|COMPLETED|Overall Study - Prior to Booster Dose||185
8414657|NCT00937521|20739616|P1|COMPLETED|Overall Study - Prior to Booster Dose||185
8414658|NCT00937521|20739609|P8|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
8414659|NCT00937521|20739610|P7|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
8414660|NCT00937521|20739611|P6|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
8414661|NCT00937521|20739612|P5|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
8414662|NCT00937521|20739613|P4|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
8414663|NCT00937521|20739614|P3|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
8414664|NCT00937521|20739615|P2|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
8414665|NCT00937521|20739616|P1|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
8414666|NCT00937521|20739609|P8|STARTED|Overall Study - Prior to Booster Dose||184
8414667|NCT00937521|20739610|P7|STARTED|Overall Study - Prior to Booster Dose||186
8414668|NCT00937521|20739611|P6|STARTED|Overall Study - Prior to Booster Dose||188
8414669|NCT00937521|20739612|P5|STARTED|Overall Study - Prior to Booster Dose||191
8414670|NCT00937521|20739613|P4|STARTED|Overall Study - Prior to Booster Dose||188
8414671|NCT00937521|20739614|P3|STARTED|Overall Study - Prior to Booster Dose||192
8414672|NCT00937521|20739615|P2|STARTED|Overall Study - Prior to Booster Dose||190
8414673|NCT00937521|20739616|P1|STARTED|Overall Study - Prior to Booster Dose||188
8414674|NCT00937495|20739722|P1|NOT COMPLETED|Overall Study||2
8414675|NCT00937495|20739722|P1|COMPLETED|Overall Study||14
8414676|NCT00937495|20739722|P1|STARTED|Overall Study||16
8414677|NCT00937404|20739728|P1|NOT COMPLETED|Overall Study||2
8414678|NCT00937404|20739728|P1|COMPLETED|Overall Study||23
8414679|NCT00937404|20739728|P1|STARTED|Overall Study||25
8414680|NCT00937391|20739737|P1|NOT COMPLETED|Stage 2||1
8414681|NCT00937391|20739737|P1|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
8414682|NCT00937391|20739737|P1|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
8414683|NCT00937391|20739737|P1|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
8414684|NCT00937391|20739737|P1|NOT COMPLETED|Stage 1||0
8414685|NCT00937391|20739737|P1|COMPLETED|Stage 1||20
8414686|NCT00937391|20739737|P1|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
8414687|NCT00937391|20739737|P1|STARTED|Stage 1||20
8414688|NCT00937378|20739790|P2|NOT COMPLETED|Overall Study||18
8414689|NCT00937378|20739791|P1|NOT COMPLETED|Overall Study||18
8414690|NCT00937378|20739790|P2|COMPLETED|Overall Study||141
8414691|NCT00937378|20739791|P1|COMPLETED|Overall Study||149
8414692|NCT00937378|20739790|P2|STARTED|Overall Study||159
8414693|NCT00937378|20739791|P1|STARTED|Overall Study||167
8414694|NCT00937326|20739804|P5|NOT COMPLETED|Overall Study||5
8414695|NCT00937326|20739805|P4|NOT COMPLETED|Overall Study||5
8414696|NCT00937326|20739806|P3|NOT COMPLETED|Overall Study||4
8414697|NCT00937326|20739807|P2|NOT COMPLETED|Overall Study||7
8414698|NCT00937326|20739808|P1|NOT COMPLETED|Overall Study||3
8414699|NCT00937326|20739804|P5|COMPLETED|Overall Study||40
8414700|NCT00937326|20739805|P4|COMPLETED|Overall Study||40
8414701|NCT00937326|20739806|P3|COMPLETED|Overall Study||42
8414702|NCT00937326|20739807|P2|COMPLETED|Overall Study||38
8414703|NCT00937326|20739808|P1|COMPLETED|Overall Study||43
8414704|NCT00937326|20739804|P5|STARTED|Overall Study||45
8414705|NCT00937326|20739805|P4|STARTED|Overall Study||45
8414706|NCT00937326|20739806|P3|STARTED|Overall Study||46
8414707|NCT00937326|20739807|P2|STARTED|Overall Study||45
8414708|NCT00937326|20739808|P1|STARTED|Overall Study||46
8414709|NCT00937235|20740036|P2|NOT COMPLETED|Overall Study||0
8414710|NCT00937235|20740037|P1|NOT COMPLETED|Overall Study||0
8414711|NCT00937235|20740036|P2|COMPLETED|Overall Study||70
8414712|NCT00937235|20740037|P1|COMPLETED|Overall Study||72
8414713|NCT00937235|20740036|P2|STARTED|Overall Study||70
8414714|NCT00937235|20740037|P1|STARTED|Overall Study||72
8414718|NCT00937118|20740061|P1|NOT COMPLETED|Overall Study||0
8414719|NCT00937118|20740061|P1|COMPLETED|Overall Study||41
8414720|NCT00937118|20740061|P1|STARTED|Overall Study||41
8414721|NCT00937105|20740070|P2|NOT COMPLETED|Overall Study||39
8414722|NCT00937105|20740071|P1|NOT COMPLETED|Overall Study||40
8414723|NCT00937105|20740070|P2|COMPLETED|Overall Study||70
8414724|NCT00937105|20740071|P1|COMPLETED|Overall Study||69
8414725|NCT00937105|20740070|P2|STARTED|Overall Study||109
8414726|NCT00937105|20740071|P1|STARTED|Overall Study||109
8414727|NCT00937040|20740088|P2|NOT COMPLETED|Overall Study||37
8414728|NCT00937040|20740089|P1|NOT COMPLETED|Overall Study||41
8414729|NCT00937040|20740088|P2|COMPLETED|Overall Study||141
8414730|NCT00937040|20740089|P1|COMPLETED|Overall Study||138
8414731|NCT00937040|20740088|P2|STARTED|Overall Study||178
8414732|NCT00937040|20740089|P1|STARTED|Overall Study||179
8414733|NCT00936975|20740131|P1|NOT COMPLETED|Overall Study||6
8414734|NCT00936975|20740131|P1|COMPLETED|Overall Study||12
8414735|NCT00936975|20740131|P1|STARTED|Overall Study||18
8414736|NCT00936910|20740140|P1|NOT COMPLETED|Overall Study||3
8414737|NCT00936910|20740140|P1|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
8414738|NCT00936910|20740140|P1|STARTED|Overall Study||13
8414739|NCT00936897|20740149|P2|NOT COMPLETED|Overall Study||60
8414740|NCT00936897|20740150|P1|NOT COMPLETED|Overall Study||19
8414741|NCT00936897|20740149|P2|COMPLETED|Overall Study||356
8414742|NCT00936897|20740150|P1|COMPLETED|Overall Study||398
8414743|NCT00936897|20740149|P2|STARTED|Overall Study|Randomized|416
8414744|NCT00936897|20740150|P1|STARTED|Overall Study|Randomized|417
8414745|NCT00936884|20740164|P3|NOT COMPLETED|Open-label||19
8414746|NCT00936884|20740165|P2|NOT COMPLETED|Open-label||0
8414747|NCT00936884|20740166|P1|NOT COMPLETED|Open-label||0
8414748|NCT00936884|20740164|P3|COMPLETED|Open-label||12
8414749|NCT00936884|20740165|P2|COMPLETED|Open-label||0
8414750|NCT00936884|20740166|P1|COMPLETED|Open-label||0
8414751|NCT00936884|20740164|P3|STARTED|Open-label||31
8414752|NCT00936884|20740165|P2|STARTED|Open-label||0
8414753|NCT00936884|20740166|P1|STARTED|Open-label||0
8414754|NCT00936884|20740164|P3|NOT COMPLETED|Double-blind||0
8414755|NCT00936884|20740165|P2|NOT COMPLETED|Double-blind||7
8414756|NCT00936884|20740166|P1|NOT COMPLETED|Double-blind||12
8414757|NCT00936884|20740164|P3|COMPLETED|Double-blind||0
8414758|NCT00936884|20740165|P2|COMPLETED|Double-blind||18
8414759|NCT00936884|20740166|P1|COMPLETED|Double-blind||13
8414760|NCT00936884|20740164|P3|STARTED|Double-blind|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|0
8414761|NCT00936884|20740165|P2|STARTED|Double-blind|Twenty-four subjects received placebo, and 23 had ≥ 1 post baseline diary assessment.|25
8414762|NCT00936884|20740166|P1|STARTED|Double-blind|Twenty-five subjects received MNTX, and 24 had ≥ 1 post baseline diary assessment.|25
8414763|NCT00936741|20740177|P1|NOT COMPLETED|Overall Study||9
8414764|NCT00936741|20740177|P1|COMPLETED|Overall Study||21
8414765|NCT00936741|20740177|P1|STARTED|Overall Study||30
8414766|NCT00936715|20740182|P1|NOT COMPLETED|Overall Study||6
8414767|NCT00936715|20740182|P1|COMPLETED|Overall Study||18
8414768|NCT00936715|20740182|P1|STARTED|Overall Study||24
8414769|NCT00936702|20740186|P1|NOT COMPLETED|Overall Study||46
8414770|NCT00936702|20740186|P1|COMPLETED|Overall Study||0
8414771|NCT00936702|20740186|P1|STARTED|Overall Study||46
8414772|NCT00936663|20740196|P2|NOT COMPLETED|Overall Study||0
8414773|NCT00936663|20740197|P1|NOT COMPLETED|Overall Study||0
8414774|NCT00936663|20740196|P2|COMPLETED|Overall Study||2
8414775|NCT00936663|20740197|P1|COMPLETED|Overall Study||1
8414776|NCT00936663|20740196|P2|STARTED|Overall Study||2
8414777|NCT00936663|20740197|P1|STARTED|Overall Study||1
8414778|NCT00936598|20740219|P2|NOT COMPLETED|Overall Study||0
8414779|NCT00936598|20740220|P1|NOT COMPLETED|Overall Study||2
8414780|NCT00936598|20740219|P2|COMPLETED|Overall Study||1
8414781|NCT00936598|20740220|P1|COMPLETED|Overall Study||2
8414782|NCT00936598|20740219|P2|STARTED|Overall Study||1
8414783|NCT00936598|20740220|P1|STARTED|Overall Study||4
8414784|NCT00936585|20740230|P1|NOT COMPLETED|Overall Study||0
8414785|NCT00936585|20740230|P1|COMPLETED|Overall Study||2
8414786|NCT00936585|20740230|P1|STARTED|Overall Study||2
8414787|NCT00936481|20740236|P2|NOT COMPLETED|Overall Study||0
8414788|NCT00936481|20740237|P1|NOT COMPLETED|Overall Study||0
8414789|NCT00936481|20740236|P2|COMPLETED|Overall Study||17
8414790|NCT00936481|20740237|P1|COMPLETED|Overall Study||17
8414791|NCT00936481|20740236|P2|STARTED|Overall Study||17
8414792|NCT00936481|20740237|P1|STARTED|Overall Study||17
8414793|NCT00936455|20740247|P2|NOT COMPLETED|Overall Study||0
8414794|NCT00936455|20740248|P1|NOT COMPLETED|Overall Study||0
8414795|NCT00936455|20740247|P2|COMPLETED|Overall Study||38
8414796|NCT00936455|20740248|P1|COMPLETED|Overall Study||37
8414797|NCT00936455|20740247|P2|STARTED|Overall Study||38
8414798|NCT00936455|20740248|P1|STARTED|Overall Study||37
8414799|NCT00936377|20740263|P3|NOT COMPLETED|Overall Study||0
8414800|NCT00936377|20740264|P2|NOT COMPLETED|Overall Study||0
8414801|NCT00936377|20740265|P1|NOT COMPLETED|Overall Study||0
8414802|NCT00936377|20740263|P3|COMPLETED|Overall Study||8
8414803|NCT00936377|20740264|P2|COMPLETED|Overall Study||8
8414804|NCT00936377|20740265|P1|COMPLETED|Overall Study||8
8414805|NCT00936377|20740263|P3|STARTED|Overall Study||8
8414806|NCT00936377|20740264|P2|STARTED|Overall Study||8
8414807|NCT00936377|20740265|P1|STARTED|Overall Study||8
8414808|NCT00936351|20740296|P2|NOT COMPLETED|Overall Study||2
8414809|NCT00936351|20740297|P1|NOT COMPLETED|Overall Study||3
8414810|NCT00936351|20740296|P2|COMPLETED|Overall Study||14
8414811|NCT00936351|20740297|P1|COMPLETED|Overall Study||15
8414812|NCT00936351|20740296|P2|STARTED|Overall Study||16
8414813|NCT00936351|20740297|P1|STARTED|Overall Study||18
8414814|NCT00936299|20740309|P2|NOT COMPLETED|Overall Study||12
8414815|NCT00936299|20740310|P1|NOT COMPLETED|Overall Study||13
8414816|NCT00936299|20740309|P2|COMPLETED|Overall Study||40
8414817|NCT00936299|20740310|P1|COMPLETED|Overall Study||40
8414818|NCT00936299|20740309|P2|STARTED|Overall Study||52
8414819|NCT00936299|20740310|P1|STARTED|Overall Study||53
8414820|NCT00936221|20740322|P2|NOT COMPLETED|Overall Study||1
8414821|NCT00936221|20740323|P1|NOT COMPLETED|Overall Study||1
8414822|NCT00936221|20740322|P2|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
8414823|NCT00936221|20740323|P1|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
8414824|NCT00936221|20740322|P2|Received Treatment|Overall Study||45
8414825|NCT00936221|20740323|P1|Received Treatment|Overall Study||44
8414826|NCT00936221|20740322|P2|STARTED|Overall Study||46
8414827|NCT00936221|20740323|P1|STARTED|Overall Study||45
8414828|NCT00936208|20740337|P2|NOT COMPLETED|Overall Study||22
8414829|NCT00936208|20740338|P1|NOT COMPLETED|Overall Study||37
8414830|NCT00936208|20740337|P2|COMPLETED|Overall Study||1574
8414831|NCT00936208|20740338|P1|COMPLETED|Overall Study||1462
8414832|NCT00936208|20740337|P2|STARTED|Overall Study||1596
8414833|NCT00936208|20740338|P1|STARTED|Overall Study||1499
8414834|NCT00936117|20740356|P1|NOT COMPLETED|Overall Study||10
8414835|NCT00936117|20740356|P1|COMPLETED|Overall Study|Completed 42 days on study drug|10
8414836|NCT00936117|20740356|P1|STARTED|Overall Study||20
8414837|NCT00936065|20740364|P3|NOT COMPLETED|Overall Study||7
8414838|NCT00936065|20740365|P2|NOT COMPLETED|Overall Study||4
8414839|NCT00936065|20740366|P1|NOT COMPLETED|Overall Study||4
8414840|NCT00936065|20740364|P3|COMPLETED|Overall Study||12
8414841|NCT00936065|20740365|P2|COMPLETED|Overall Study||16
8414842|NCT00936065|20740366|P1|COMPLETED|Overall Study||17
8414843|NCT00936065|20740364|P3|Study Assessments Performed|Overall Study||18
8414844|NCT00936065|20740365|P2|Study Assessments Performed|Overall Study||19
8414845|NCT00936065|20740366|P1|Study Assessments Performed|Overall Study||21
8414846|NCT00936065|20740364|P3|Received Treatment|Overall Study||18
8414847|NCT00936065|20740365|P2|Received Treatment|Overall Study||20
8414848|NCT00936065|20740366|P1|Received Treatment|Overall Study||21
8414849|NCT00936065|20740364|P3|STARTED|Overall Study||19
8414850|NCT00936065|20740365|P2|STARTED|Overall Study||20
8414851|NCT00936065|20740366|P1|STARTED|Overall Study||21
8414852|NCT00935883|20740472|P2|NOT COMPLETED|Follow-Up Period||0
8414853|NCT00935883|20740473|P1|NOT COMPLETED|Follow-Up Period||0
8414854|NCT00935883|20740472|P2|COMPLETED|Follow-Up Period||38
8414855|NCT00935883|20740473|P1|COMPLETED|Follow-Up Period||19
8414856|NCT00935883|20740472|P2|STARTED|Follow-Up Period||38
8414857|NCT00935883|20740473|P1|STARTED|Follow-Up Period||19
8414858|NCT00935883|20740472|P2|NOT COMPLETED|Treatment Period||2
8414859|NCT00935883|20740473|P1|NOT COMPLETED|Treatment Period||1
8414860|NCT00935883|20740472|P2|COMPLETED|Treatment Period||38
8414861|NCT00935883|20740473|P1|COMPLETED|Treatment Period||19
8414862|NCT00935883|20740472|P2|STARTED|Treatment Period||40
8414863|NCT00935883|20740473|P1|STARTED|Treatment Period||20
8414864|NCT00935857|20740487|P2|NOT COMPLETED|Overall Study||0
8414865|NCT00935857|20740488|P1|NOT COMPLETED|Overall Study||0
8414866|NCT00935857|20740487|P2|COMPLETED|Overall Study||16
8414867|NCT00935857|20740488|P1|COMPLETED|Overall Study||14
8414868|NCT00935857|20740487|P2|STARTED|Overall Study||16
8414869|NCT00935857|20740488|P1|STARTED|Overall Study||14
8414870|NCT00935818|20740500|P2|NOT COMPLETED|Overall Study||100
8414871|NCT00935818|20740501|P1|NOT COMPLETED|Overall Study||91
8414872|NCT00935818|20740500|P2|COMPLETED|Overall Study||157
8414873|NCT00935818|20740501|P1|COMPLETED|Overall Study||158
8414874|NCT00935818|20740500|P2|End of Medication Phase|Overall Study||184
8414875|NCT00935818|20740501|P1|End of Medication Phase|Overall Study||182
8414876|NCT00935818|20740500|P2|STARTED|Overall Study||257
8414877|NCT00935818|20740501|P1|STARTED|Overall Study||249
8414878|NCT00935792|20740522|P3|NOT COMPLETED|Overall Study||0
8414879|NCT00935792|20740523|P2|NOT COMPLETED|Overall Study||3
8414880|NCT00935792|20740524|P1|NOT COMPLETED|Overall Study||1
8414881|NCT00935792|20740522|P3|COMPLETED|Overall Study||12
8414882|NCT00935792|20740523|P2|COMPLETED|Overall Study||6
8414883|NCT00935792|20740524|P1|COMPLETED|Overall Study||6
8414884|NCT00935792|20740522|P3|STARTED|Overall Study||12
8414885|NCT00935792|20740523|P2|STARTED|Overall Study||9
8414886|NCT00935792|20740524|P1|STARTED|Overall Study||7
8414887|NCT00935766|20740541|P2|NOT COMPLETED|Overall Study||7
8414888|NCT00935766|20740542|P1|NOT COMPLETED|Overall Study||7
8414889|NCT00935766|20740541|P2|COMPLETED|Overall Study||27
8414890|NCT00935766|20740542|P1|COMPLETED|Overall Study||35
8414891|NCT00935766|20740541|P2|STARTED|Overall Study||34
8414892|NCT00935766|20740542|P1|STARTED|Overall Study||42
8414893|NCT00935701|20740552|P1|NOT COMPLETED|Overall Study||1
8414894|NCT00935701|20740552|P1|COMPLETED|Overall Study||9
8414895|NCT00935701|20740552|P1|Transition Acupressure to Acupuncture|Overall Study||9
8414896|NCT00935701|20740552|P1|STARTED|Overall Study||10
8414897|NCT00935649|20740559|P1|NOT COMPLETED|Overall Study||5
8414898|NCT00935649|20740559|P1|COMPLETED|Overall Study||134
8414899|NCT00935649|20740559|P1|STARTED|Overall Study||139
8414900|NCT00935584|20740569|P2|NOT COMPLETED|Overall Study||4
8414901|NCT00935584|20740570|P1|NOT COMPLETED|Overall Study||49
8414902|NCT00935584|20740569|P2|COMPLETED|Overall Study||19
8414903|NCT00935584|20740570|P1|COMPLETED|Overall Study||77
8414904|NCT00935584|20740569|P2|STARTED|Overall Study||23
8414905|NCT00935584|20740570|P1|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
8414906|NCT00935532|20740582|P2|NOT COMPLETED|Overall Study||11
8414907|NCT00935532|20740583|P1|NOT COMPLETED|Overall Study||22
8414908|NCT00935532|20740582|P2|COMPLETED|Overall Study||201
8414909|NCT00935532|20740583|P1|COMPLETED|Overall Study||193
8414910|NCT00935532|20740582|P2|STARTED|Overall Study||212
8414911|NCT00935532|20740583|P1|STARTED|Overall Study||215
8414912|NCT00935493|20740612|P3|NOT COMPLETED|Overall Study||1
8414913|NCT00935493|20740613|P2|NOT COMPLETED|Overall Study||2
8414914|NCT00935493|20740614|P1|NOT COMPLETED|Overall Study||1
8414915|NCT00935493|20740612|P3|COMPLETED|Overall Study||40
8414916|NCT00935493|20740613|P2|COMPLETED|Overall Study||39
8414917|NCT00935493|20740614|P1|COMPLETED|Overall Study||40
8414918|NCT00935493|20740612|P3|STARTED|Overall Study||41
8414919|NCT00935493|20740613|P2|STARTED|Overall Study||41
8414920|NCT00935493|20740614|P1|STARTED|Overall Study||41
8414921|NCT00935428|20740628|P1|NOT COMPLETED|Overall Study||0
8414922|NCT00935428|20740628|P1|COMPLETED|Overall Study||231
8414923|NCT00935428|20740628|P1|STARTED|Overall Study||231
8414924|NCT00935311|20740642|P3|NOT COMPLETED|Overall Study||0
8414925|NCT00935311|20740643|P2|NOT COMPLETED|Overall Study||0
8414926|NCT00935311|20740644|P1|NOT COMPLETED|Overall Study||0
8414927|NCT00935311|20740642|P3|COMPLETED|Overall Study||40
8414928|NCT00935311|20740643|P2|COMPLETED|Overall Study||39
8414929|NCT00935311|20740644|P1|COMPLETED|Overall Study||43
8414930|NCT00935311|20740642|P3|STARTED|Overall Study||40
8414931|NCT00935311|20740643|P2|STARTED|Overall Study||39
8414932|NCT00935311|20740644|P1|STARTED|Overall Study||43
8414933|NCT00935272|20740663|P2|NOT COMPLETED|Overall Study||6
8414934|NCT00935272|20740664|P1|NOT COMPLETED|Overall Study||19
8414935|NCT00935272|20740663|P2|COMPLETED|Overall Study||39
8414936|NCT00935272|20740664|P1|COMPLETED|Overall Study||116
8414937|NCT00935272|20740663|P2|STARTED|Overall Study||45
8414938|NCT00935272|20740664|P1|STARTED|Overall Study||135
8414939|NCT00935259|20740673|P2|NOT COMPLETED|Period 2||0
8414940|NCT00935259|20740674|P1|NOT COMPLETED|Period 2||0
8414941|NCT00935259|20740673|P2|COMPLETED|Period 2||14
8414942|NCT00935259|20740674|P1|COMPLETED|Period 2||15
8414943|NCT00935259|20740673|P2|STARTED|Period 2||14
8414944|NCT00935259|20740674|P1|STARTED|Period 2||15
8414945|NCT00935259|20740673|P2|NOT COMPLETED|Period 1||1
8414946|NCT00935259|20740674|P1|NOT COMPLETED|Period 1||1
8414947|NCT00935259|20740673|P2|COMPLETED|Period 1||14
8414948|NCT00935259|20740674|P1|COMPLETED|Period 1||15
8414949|NCT00935259|20740673|P2|STARTED|Period 1||15
8414950|NCT00935259|20740674|P1|STARTED|Period 1||16
8414951|NCT00935220|20740688|P1|NOT COMPLETED|Overall Study||2
8414952|NCT00935220|20740688|P1|COMPLETED|Overall Study||39
8414953|NCT00935220|20740688|P1|STARTED|Overall Study||41
8414954|NCT00935064|20740702|P2|NOT COMPLETED|Overall Study||0
8414955|NCT00935064|20740703|P1|NOT COMPLETED|Overall Study||0
8414956|NCT00935064|20740702|P2|COMPLETED|Overall Study||30
8414957|NCT00935064|20740703|P1|COMPLETED|Overall Study||30
8414958|NCT00935064|20740702|P2|STARTED|Overall Study||30
8414959|NCT00935064|20740703|P1|STARTED|Overall Study||30
8414960|NCT00935012|20740717|P1|NOT COMPLETED|Overall Study||29
8414961|NCT00935012|20740717|P1|COMPLETED|Overall Study||2
8414962|NCT00935012|20740717|P1|STARTED|Overall Study||31
8414963|NCT00934947|20740759|P2|NOT COMPLETED|Overall Study||2
8414964|NCT00934947|20740760|P1|NOT COMPLETED|Overall Study||0
8414965|NCT00934947|20740759|P2|COMPLETED|Overall Study||20
8414966|NCT00934947|20740760|P1|COMPLETED|Overall Study||23
8414967|NCT00934947|20740759|P2|STARTED|Overall Study||22
8414968|NCT00934947|20740760|P1|STARTED|Overall Study||23
8414969|NCT00934921|20740774|P2|NOT COMPLETED|Second Intervention||0
8414970|NCT00934921|20740775|P1|NOT COMPLETED|Second Intervention||0
8414971|NCT00934921|20740774|P2|COMPLETED|Second Intervention||12
8414972|NCT00934921|20740775|P1|COMPLETED|Second Intervention||12
8414973|NCT00934921|20740774|P2|STARTED|Second Intervention||12
8414974|NCT00934921|20740775|P1|STARTED|Second Intervention||12
8414975|NCT00934921|20740774|P2|NOT COMPLETED|First Intervention||0
8414976|NCT00934921|20740775|P1|NOT COMPLETED|First Intervention||0
8414977|NCT00934921|20740774|P2|COMPLETED|First Intervention||12
8414978|NCT00934921|20740775|P1|COMPLETED|First Intervention||12
8414979|NCT00934921|20740774|P2|STARTED|First Intervention||12
8414980|NCT00934921|20740775|P1|STARTED|First Intervention||12
8414981|NCT00934856|20740789|P6|NOT COMPLETED|Extension Part||5
8414982|NCT00934856|20740790|P5|NOT COMPLETED|Extension Part||4
8414983|NCT00934856|20740791|P4|NOT COMPLETED|Extension Part||2
8414984|NCT00934856|20740792|P3|NOT COMPLETED|Extension Part||0
8414985|NCT00934856|20740793|P2|NOT COMPLETED|Extension Part||0
8414986|NCT00934856|20740794|P1|NOT COMPLETED|Extension Part||0
8414987|NCT00934856|20740789|P6|COMPLETED|Extension Part||19
8414988|NCT00934856|20740790|P5|COMPLETED|Extension Part||24
8414989|NCT00934856|20740791|P4|COMPLETED|Extension Part||2
8414990|NCT00934856|20740792|P3|COMPLETED|Extension Part||0
8414991|NCT00934856|20740793|P2|COMPLETED|Extension Part||0
8414992|NCT00934856|20740794|P1|COMPLETED|Extension Part||0
8414993|NCT00934856|20740789|P6|STARTED|Extension Part|New participants were enrolled in the extension part.|24
8414994|NCT00934856|20740790|P5|STARTED|Extension Part|New participants were enrolled in the extension part.|28
8414995|NCT00934856|20740791|P4|STARTED|Extension Part|New participants were enrolled in the extension part.|4
8414996|NCT00934856|20740792|P3|STARTED|Extension Part||0
8414997|NCT00934856|20740793|P2|STARTED|Extension Part||0
8414998|NCT00934856|20740794|P1|STARTED|Extension Part||0
8414999|NCT00934856|20740789|P6|NOT COMPLETED|Feasibility Part||3
8415000|NCT00934856|20740790|P5|NOT COMPLETED|Feasibility Part||0
8415001|NCT00934856|20740791|P4|NOT COMPLETED|Feasibility Part||5
8415002|NCT00934856|20740792|P3|NOT COMPLETED|Feasibility Part||3
8415003|NCT00934856|20740793|P2|NOT COMPLETED|Feasibility Part||5
8415004|NCT00934856|20740794|P1|NOT COMPLETED|Feasibility Part||5
8415005|NCT00934856|20740789|P6|COMPLETED|Feasibility Part||6
8415006|NCT00934856|20740790|P5|COMPLETED|Feasibility Part||12
8415007|NCT00934856|20740791|P4|COMPLETED|Feasibility Part||1
8415008|NCT00934856|20740792|P3|COMPLETED|Feasibility Part||0
8415009|NCT00934856|20740793|P2|COMPLETED|Feasibility Part||1
8415010|NCT00934856|20740794|P1|COMPLETED|Feasibility Part||1
8415011|NCT00934856|20740789|P6|STARTED|Feasibility Part||9
8415012|NCT00934856|20740790|P5|STARTED|Feasibility Part||12
8415013|NCT00934856|20740791|P4|STARTED|Feasibility Part||6
8415014|NCT00934856|20740792|P3|STARTED|Feasibility Part||3
8415015|NCT00934856|20740793|P2|STARTED|Feasibility Part||6
8415016|NCT00934856|20740794|P1|STARTED|Feasibility Part||6
8415017|NCT00934843|20740892|P2|NOT COMPLETED|Overall Study||1
8415018|NCT00934843|20740893|P1|NOT COMPLETED|Overall Study||0
8415019|NCT00934843|20740892|P2|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
8415020|NCT00934843|20740893|P1|COMPLETED|Overall Study||37
8415021|NCT00934843|20740892|P2|STARTED|Overall Study||40
8415022|NCT00934843|20740893|P1|STARTED|Overall Study||37
8415023|NCT00934791|20740909|P2|NOT COMPLETED|Overall Study||0
8415024|NCT00934791|20740910|P1|NOT COMPLETED|Overall Study||1
8415025|NCT00934791|20740909|P2|COMPLETED|Overall Study||0
8415026|NCT00934791|20740910|P1|COMPLETED|Overall Study||0
8415027|NCT00934791|20740909|P2|STARTED|Overall Study||0
8415028|NCT00934791|20740910|P1|STARTED|Overall Study||1
8415029|NCT00934661|20740918|P2|NOT COMPLETED|Overall Study||0
8415030|NCT00934661|20740919|P1|NOT COMPLETED|Overall Study||1
8415031|NCT00934661|20740918|P2|COMPLETED|Overall Study||20
8415032|NCT00934661|20740919|P1|COMPLETED|Overall Study||19
8415033|NCT00934661|20740918|P2|STARTED|Overall Study||20
8415034|NCT00934661|20740919|P1|STARTED|Overall Study||20
8415035|NCT00934648|20740939|P1|NOT COMPLETED|Overall Study||9
8415036|NCT00934648|20740939|P1|COMPLETED|Overall Study||6
8415037|NCT00934648|20740939|P1|STARTED|Overall Study||15
8415038|NCT00934635|20740955|P9|NOT COMPLETED|Overall Study||0
8415039|NCT00934635|20740956|P8|NOT COMPLETED|Overall Study||0
8415040|NCT00934635|20740957|P7|NOT COMPLETED|Overall Study||0
8415041|NCT00934635|20740958|P6|NOT COMPLETED|Overall Study||0
8415042|NCT00934635|20740959|P5|NOT COMPLETED|Overall Study||0
8415043|NCT00934635|20740960|P4|NOT COMPLETED|Overall Study||0
8415044|NCT00934635|20740961|P3|NOT COMPLETED|Overall Study||0
8415045|NCT00934635|20740962|P2|NOT COMPLETED|Overall Study||0
8415046|NCT00934635|20740963|P1|NOT COMPLETED|Overall Study||0
8415047|NCT00934635|20740955|P9|COMPLETED|Overall Study||1
8415048|NCT00934635|20740956|P8|COMPLETED|Overall Study||0
8415049|NCT00934635|20740957|P7|COMPLETED|Overall Study||0
8415050|NCT00934635|20740958|P6|COMPLETED|Overall Study||0
8415051|NCT00934635|20740959|P5|COMPLETED|Overall Study||0
8415052|NCT00934635|20740960|P4|COMPLETED|Overall Study||0
8415053|NCT00934635|20740961|P3|COMPLETED|Overall Study||0
8415054|NCT00934635|20740962|P2|COMPLETED|Overall Study||1
8415055|NCT00934635|20740963|P1|COMPLETED|Overall Study||0
8415056|NCT00934635|20740955|P9|STARTED|Overall Study||1
8415057|NCT00934635|20740956|P8|STARTED|Overall Study||0
8415058|NCT00934635|20740957|P7|STARTED|Overall Study||0
8415059|NCT00934635|20740958|P6|STARTED|Overall Study||0
8415060|NCT00934635|20740959|P5|STARTED|Overall Study||0
8415061|NCT00934635|20740960|P4|STARTED|Overall Study||0
8415062|NCT00934635|20740961|P3|STARTED|Overall Study||0
8415063|NCT00934635|20740962|P2|STARTED|Overall Study||1
8415064|NCT00934635|20740963|P1|STARTED|Overall Study||0
8415065|NCT00934622|20740983|P1|NOT COMPLETED|Overall Study||8
8415066|NCT00934622|20740983|P1|COMPLETED|Overall Study||68
8415067|NCT00934622|20740983|P1|STARTED|Overall Study||76
8415068|NCT00934596|20740990|P2|NOT COMPLETED|Overall Study||0
8415069|NCT00934596|20740991|P1|NOT COMPLETED|Overall Study||0
8415070|NCT00934596|20740990|P2|COMPLETED|Overall Study||10
8415071|NCT00934596|20740991|P1|COMPLETED|Overall Study||10
8415072|NCT00934596|20740990|P2|STARTED|Overall Study||10
8415073|NCT00934596|20740991|P1|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
8415074|NCT00934544|20741021|P3|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34
8415075|NCT00934544|20741022|P2|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28
8415076|NCT00934544|20741023|P1|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107
8415077|NCT00934544|20741021|P3|COMPLETED|Overall Disposition at 5 Year Follow-up||11
8415078|NCT00934544|20741022|P2|COMPLETED|Overall Disposition at 5 Year Follow-up||0
8415079|NCT00934544|20741023|P1|COMPLETED|Overall Disposition at 5 Year Follow-up||39
8415080|NCT00934544|20741021|P3|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6
8415081|NCT00934544|20741022|P2|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
8415082|NCT00934544|20741023|P1|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
8415083|NCT00934544|20741021|P3|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12
8415084|NCT00934544|20741022|P2|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
8415085|NCT00934544|20741023|P1|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
8415086|NCT00934544|20741021|P3|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27
8415087|NCT00934544|20741022|P2|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
8415088|NCT00934544|20741023|P1|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
8415089|NCT00934544|20741021|P3|STARTED|Overall Disposition at 5 Year Follow-up||45
8415090|NCT00934544|20741022|P2|STARTED|Overall Disposition at 5 Year Follow-up||28
8415091|NCT00934544|20741023|P1|STARTED|Overall Disposition at 5 Year Follow-up||146
8415092|NCT00934544|20741021|P3|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0
8415093|NCT00934544|20741022|P2|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42
8415094|NCT00934544|20741023|P1|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55
8415095|NCT00934544|20741021|P3|COMPLETED|Primary Endpoint Analysis (Interim)||0
8415096|NCT00934544|20741022|P2|COMPLETED|Primary Endpoint Analysis (Interim)||31
8415097|NCT00934544|20741023|P1|COMPLETED|Primary Endpoint Analysis (Interim)||91
8415098|NCT00934544|20741021|P3|STARTED|Primary Endpoint Analysis (Interim)||0
8415099|NCT00934544|20741022|P2|STARTED|Primary Endpoint Analysis (Interim)||73
8415100|NCT00934544|20741023|P1|STARTED|Primary Endpoint Analysis (Interim)||146
8415101|NCT00934440|20741059|P1|NOT COMPLETED|Overall Study||1
8415102|NCT00934440|20741059|P1|COMPLETED|Overall Study||10
8415103|NCT00934440|20741059|P1|STARTED|Overall Study||11
8415104|NCT00934375|20741066|P2|NOT COMPLETED|Overall Study||22
8415105|NCT00934375|20741067|P1|NOT COMPLETED|Overall Study||13
8415106|NCT00934375|20741066|P2|COMPLETED|Overall Study||55
8415107|NCT00934375|20741067|P1|COMPLETED|Overall Study||55
8415108|NCT00934375|20741066|P2|STARTED|Overall Study||77
8415109|NCT00934375|20741067|P1|STARTED|Overall Study||68
8415110|NCT00934362|20741075|P2|NOT COMPLETED|Overall Study||0
8415111|NCT00934362|20741076|P1|NOT COMPLETED|Overall Study||1
8415112|NCT00934362|20741075|P2|COMPLETED|Overall Study||8
8415113|NCT00934362|20741076|P1|COMPLETED|Overall Study||7
8415114|NCT00934362|20741075|P2|STARTED|Overall Study||8
8415115|NCT00934362|20741076|P1|STARTED|Overall Study||8
8415116|NCT00934180|20741086|P2|NOT COMPLETED|Second Intervention||0
8415117|NCT00934180|20741087|P1|NOT COMPLETED|Second Intervention||0
8415118|NCT00934180|20741086|P2|COMPLETED|Second Intervention||12
8415119|NCT00934180|20741087|P1|COMPLETED|Second Intervention||12
8415120|NCT00934180|20741086|P2|STARTED|Second Intervention||12
8415121|NCT00934180|20741087|P1|STARTED|Second Intervention||12
8415122|NCT00934180|20741086|P2|NOT COMPLETED|First Intervention||0
8415123|NCT00934180|20741087|P1|NOT COMPLETED|First Intervention||0
8415124|NCT00934180|20741086|P2|COMPLETED|First Intervention||12
8415125|NCT00934180|20741087|P1|COMPLETED|First Intervention||12
8415126|NCT00934180|20741086|P2|STARTED|First Intervention||12
8415127|NCT00934180|20741087|P1|STARTED|First Intervention||12
8415128|NCT00934141|20741099|P4|NOT COMPLETED|Overall Study||3
8415129|NCT00934141|20741100|P3|NOT COMPLETED|Overall Study||0
8415130|NCT00934141|20741101|P2|NOT COMPLETED|Overall Study||3
8415131|NCT00934141|20741102|P1|NOT COMPLETED|Overall Study||4
8415132|NCT00934141|20741099|P4|COMPLETED|Overall Study||51
8415133|NCT00934141|20741100|P3|COMPLETED|Overall Study||48
8415134|NCT00934141|20741101|P2|COMPLETED|Overall Study||47
8415135|NCT00934141|20741102|P1|COMPLETED|Overall Study||45
8415136|NCT00934141|20741099|P4|STARTED|Overall Study||54
8415137|NCT00934141|20741100|P3|STARTED|Overall Study||48
8415138|NCT00934141|20741101|P2|STARTED|Overall Study||50
8415139|NCT00934141|20741102|P1|STARTED|Overall Study||49
8415140|NCT00934128|20741126|P2|NOT COMPLETED|Second Intervention (2 Hours)||3
8415141|NCT00934128|20741127|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
8415142|NCT00934128|20741126|P2|COMPLETED|Second Intervention (2 Hours)||5
8415143|NCT00934128|20741127|P1|COMPLETED|Second Intervention (2 Hours)||3
8415144|NCT00934128|20741126|P2|STARTED|Second Intervention (2 Hours)||8
8415145|NCT00934128|20741127|P1|STARTED|Second Intervention (2 Hours)||3
8415146|NCT00934128|20741126|P2|NOT COMPLETED|Washout Period (1 Hour)||5
8415147|NCT00934128|20741127|P1|NOT COMPLETED|Washout Period (1 Hour)||7
8415148|NCT00934128|20741126|P2|COMPLETED|Washout Period (1 Hour)||8
8415149|NCT00934128|20741127|P1|COMPLETED|Washout Period (1 Hour)||3
8415150|NCT00934128|20741126|P2|STARTED|Washout Period (1 Hour)||13
8415151|NCT00934128|20741127|P1|STARTED|Washout Period (1 Hour)||10
8415152|NCT00934128|20741126|P2|NOT COMPLETED|First Intervention (2 Hours)||2
8415153|NCT00934128|20741127|P1|NOT COMPLETED|First Intervention (2 Hours)||5
8415154|NCT00934128|20741126|P2|COMPLETED|First Intervention (2 Hours)||13
8415155|NCT00934128|20741127|P1|COMPLETED|First Intervention (2 Hours)||10
8415156|NCT00934128|20741126|P2|STARTED|First Intervention (2 Hours)||15
8415157|NCT00934128|20741127|P1|STARTED|First Intervention (2 Hours)||15
8415158|NCT00934102|20741135|P3|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
8415159|NCT00934102|20741136|P2|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
8415160|NCT00934102|20741137|P1|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
8415161|NCT00934102|20741135|P3|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
8415162|NCT00934102|20741136|P2|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
8415163|NCT00934102|20741137|P1|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
8415164|NCT00934102|20741135|P3|STARTED|Period 2, 7 Days/6 Nights of Wear||15
8415165|NCT00934102|20741136|P2|STARTED|Period 2, 7 Days/6 Nights of Wear||15
8415166|NCT00934102|20741137|P1|STARTED|Period 2, 7 Days/6 Nights of Wear||15
8415167|NCT00934102|20741135|P3|NOT COMPLETED|Period 1, One Night of Wear||0
8415168|NCT00934102|20741136|P2|NOT COMPLETED|Period 1, One Night of Wear||0
8415169|NCT00934102|20741137|P1|NOT COMPLETED|Period 1, One Night of Wear||1
8415170|NCT00934102|20741135|P3|COMPLETED|Period 1, One Night of Wear||15
8415171|NCT00934102|20741136|P2|COMPLETED|Period 1, One Night of Wear||15
8415172|NCT00934102|20741137|P1|COMPLETED|Period 1, One Night of Wear||15
8415173|NCT00934102|20741135|P3|STARTED|Period 1, One Night of Wear||15
8415174|NCT00934102|20741136|P2|STARTED|Period 1, One Night of Wear||15
8415175|NCT00934102|20741137|P1|STARTED|Period 1, One Night of Wear||16
8415176|NCT00934050|20741151|P6|NOT COMPLETED|Enrolled After 15 Dec 2009||4
8415177|NCT00934050|20741152|P5|NOT COMPLETED|Enrolled After 15 Dec 2009||7
8415178|NCT00934050|20741153|P4|NOT COMPLETED|Enrolled After 15 Dec 2009||0
8415179|NCT00934050|20741154|P3|NOT COMPLETED|Enrolled After 15 Dec 2009||0
8415180|NCT00934050|20741155|P2|NOT COMPLETED|Enrolled After 15 Dec 2009||0
8415181|NCT00934050|20741156|P1|NOT COMPLETED|Enrolled After 15 Dec 2009||0
8415182|NCT00934050|20741151|P6|COMPLETED|Enrolled After 15 Dec 2009||23
8415183|NCT00934050|20741152|P5|COMPLETED|Enrolled After 15 Dec 2009||19
8415184|NCT00934050|20741153|P4|COMPLETED|Enrolled After 15 Dec 2009||0
8415185|NCT00934050|20741154|P3|COMPLETED|Enrolled After 15 Dec 2009||0
8415186|NCT00934050|20741155|P2|COMPLETED|Enrolled After 15 Dec 2009||0
8415187|NCT00934050|20741156|P1|COMPLETED|Enrolled After 15 Dec 2009||0
8415188|NCT00934050|20741151|P6|STARTED|Enrolled After 15 Dec 2009||27
8415189|NCT00934050|20741152|P5|STARTED|Enrolled After 15 Dec 2009||26
8415190|NCT00934050|20741153|P4|STARTED|Enrolled After 15 Dec 2009||0
8415191|NCT00934050|20741154|P3|STARTED|Enrolled After 15 Dec 2009||0
8415192|NCT00934050|20741155|P2|STARTED|Enrolled After 15 Dec 2009||0
8415193|NCT00934050|20741156|P1|STARTED|Enrolled After 15 Dec 2009||0
8415194|NCT00934050|20741151|P6|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415195|NCT00934050|20741152|P5|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415196|NCT00934050|20741153|P4|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
8415197|NCT00934050|20741154|P3|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
8415198|NCT00934050|20741155|P2|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
8415199|NCT00934050|20741156|P1|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
8415200|NCT00934050|20741151|P6|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415201|NCT00934050|20741152|P5|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415202|NCT00934050|20741153|P4|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415203|NCT00934050|20741154|P3|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415204|NCT00934050|20741155|P2|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415205|NCT00934050|20741156|P1|COMPLETED|Enrolled Prior to 15 Dec 2009||0
8415206|NCT00934050|20741151|P6|STARTED|Enrolled Prior to 15 Dec 2009||0
8415207|NCT00934050|20741152|P5|STARTED|Enrolled Prior to 15 Dec 2009||0
8415208|NCT00934050|20741153|P4|STARTED|Enrolled Prior to 15 Dec 2009||14
8415209|NCT00934050|20741154|P3|STARTED|Enrolled Prior to 15 Dec 2009||12
8415210|NCT00934050|20741155|P2|STARTED|Enrolled Prior to 15 Dec 2009||12
8415211|NCT00934050|20741156|P1|STARTED|Enrolled Prior to 15 Dec 2009||12
8415212|NCT00934024|20741168|P2|NOT COMPLETED|Overall Study||5
8415213|NCT00934024|20741169|P1|NOT COMPLETED|Overall Study||0
8415214|NCT00934024|20741168|P2|COMPLETED|Overall Study||6
8415215|NCT00934024|20741169|P1|COMPLETED|Overall Study||10
8415216|NCT00934024|20741168|P2|STARTED|Overall Study||11
8415217|NCT00934024|20741169|P1|STARTED|Overall Study||10
8415218|NCT00933933|20741179|P3|NOT COMPLETED|Pediatric From 2 to 21 Years||0
8415219|NCT00933933|20741180|P2|NOT COMPLETED|Pediatric From 2 to 21 Years||0
8415220|NCT00933933|20741181|P1|NOT COMPLETED|Pediatric From 2 to 21 Years||0
8415221|NCT00933933|20741179|P3|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
8415222|NCT00933933|20741180|P2|COMPLETED|Pediatric From 2 to 21 Years||64
8415223|NCT00933933|20741181|P1|COMPLETED|Pediatric From 2 to 21 Years||588
8415224|NCT00933933|20741179|P3|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
8415225|NCT00933933|20741180|P2|STARTED|Pediatric From 2 to 21 Years||64
8415226|NCT00933933|20741181|P1|STARTED|Pediatric From 2 to 21 Years||588
8415227|NCT00933933|20741179|P3|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
8415228|NCT00933933|20741180|P2|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
8415229|NCT00933933|20741181|P1|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
8415230|NCT00933933|20741179|P3|COMPLETED|Pregnant Females Between 16-44 Years||203
8415231|NCT00933933|20741180|P2|COMPLETED|Pregnant Females Between 16-44 Years||65
8415232|NCT00933933|20741181|P1|COMPLETED|Pregnant Females Between 16-44 Years||448
8415233|NCT00933933|20741179|P3|STARTED|Pregnant Females Between 16-44 Years||203
8415234|NCT00933933|20741180|P2|STARTED|Pregnant Females Between 16-44 Years||67
8415235|NCT00933933|20741181|P1|STARTED|Pregnant Females Between 16-44 Years||448
8415236|NCT00933933|20741179|P3|NOT COMPLETED|General Population From 16 to 89 Years||0
8415237|NCT00933933|20741180|P2|NOT COMPLETED|General Population From 16 to 89 Years||20
8415238|NCT00933933|20741181|P1|NOT COMPLETED|General Population From 16 to 89 Years||0
8415239|NCT00933933|20741179|P3|COMPLETED|General Population From 16 to 89 Years||1206
8415240|NCT00933933|20741180|P2|COMPLETED|General Population From 16 to 89 Years||1267
8415241|NCT00933933|20741181|P1|COMPLETED|General Population From 16 to 89 Years||6164
8415242|NCT00933933|20741179|P3|STARTED|General Population From 16 to 89 Years||1206
8415243|NCT00933933|20741180|P2|STARTED|General Population From 16 to 89 Years||1287
8415244|NCT00933933|20741181|P1|STARTED|General Population From 16 to 89 Years||6164
8415245|NCT00933686|20741199|P2|NOT COMPLETED|Overall Study||11
8415246|NCT00933686|20741200|P1|NOT COMPLETED|Overall Study||10
8415247|NCT00933686|20741199|P2|COMPLETED|Overall Study||47
8415248|NCT00933686|20741200|P1|COMPLETED|Overall Study||45
8415249|NCT00933686|20741199|P2|STARTED|Overall Study||58
8415250|NCT00933686|20741200|P1|STARTED|Overall Study||55
8415251|NCT00933608|20741220|P2|NOT COMPLETED|Overall Study||2
8415252|NCT00933608|20741221|P1|NOT COMPLETED|Overall Study||5
8415253|NCT00933608|20741220|P2|COMPLETED|Overall Study||8
8415254|NCT00933608|20741221|P1|COMPLETED|Overall Study||2
8415255|NCT00933608|20741220|P2|STARTED|Overall Study||10
8415256|NCT00933608|20741221|P1|STARTED|Overall Study||7
8415257|NCT00933543|20741229|P2|NOT COMPLETED|Overall Study||7
8415258|NCT00933543|20741230|P1|NOT COMPLETED|Overall Study||3
8415259|NCT00933543|20741229|P2|COMPLETED|Overall Study||46
8415260|NCT00933543|20741230|P1|COMPLETED|Overall Study||51
8415261|NCT00933543|20741229|P2|STARTED|Overall Study||53
8415262|NCT00933543|20741230|P1|STARTED|Overall Study||54
8415263|NCT00933491|20741288|P2|NOT COMPLETED|Overall Study||0
8415264|NCT00933491|20741289|P1|NOT COMPLETED|Overall Study||0
8415265|NCT00933491|20741288|P2|COMPLETED|Overall Study||18
8415266|NCT00933491|20741289|P1|COMPLETED|Overall Study||14
8415267|NCT00933491|20741288|P2|STARTED|Overall Study||18
8415268|NCT00933491|20741289|P1|STARTED|Overall Study||14
8415269|NCT00933335|20741299|P2|NOT COMPLETED|Overall Study||16
8415270|NCT00933335|20741300|P1|NOT COMPLETED|Overall Study||2
8415271|NCT00933335|20741299|P2|COMPLETED|Overall Study||20
8415272|NCT00933335|20741300|P1|COMPLETED|Overall Study||0
8415273|NCT00933335|20741299|P2|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
8415274|NCT00933335|20741300|P1|STARTED|Overall Study||2
8415275|NCT00933270|20741370|P1|NOT COMPLETED|Overall Study||87
8415276|NCT00933270|20741370|P1|COMPLETED|Overall Study||177
8415277|NCT00933270|20741370|P1|STARTED|Overall Study|ITT population|264
8415278|NCT00933244|20741464|P3|NOT COMPLETED|Overall Study||3
8415279|NCT00933244|20741465|P2|NOT COMPLETED|Overall Study||1
8415280|NCT00933244|20741466|P1|NOT COMPLETED|Overall Study||5
8415281|NCT00933244|20741464|P3|COMPLETED|Overall Study||73
8415282|NCT00933244|20741465|P2|COMPLETED|Overall Study||74
8415283|NCT00933244|20741466|P1|COMPLETED|Overall Study||74
8415284|NCT00933244|20741464|P3|STARTED|Overall Study||76
8415285|NCT00933244|20741465|P2|STARTED|Overall Study||75
8415286|NCT00933244|20741466|P1|STARTED|Overall Study||79
8415287|NCT00933166|20741483|P1|NOT COMPLETED|Overall Study||18
8415288|NCT00933166|20741483|P1|COMPLETED|Overall Study||151
8415289|NCT00933166|20741483|P1|STARTED|Overall Study||169
8415290|NCT00932893|20741489|P2|NOT COMPLETED|Overall Study||170
8415291|NCT00932893|20741490|P1|NOT COMPLETED|Overall Study||133
8415292|NCT00932893|20741489|P2|COMPLETED|Overall Study||4
8415293|NCT00932893|20741490|P1|COMPLETED|Overall Study||40
8415294|NCT00932893|20741489|P2|Treated|Overall Study||171
8415295|NCT00932893|20741490|P1|Treated|Overall Study||172
8415296|NCT00932893|20741489|P2|STARTED|Overall Study||174
8415297|NCT00932893|20741490|P1|STARTED|Overall Study||173
8415298|NCT00932828|20741521|P1|NOT COMPLETED|Overall Study||5
8415299|NCT00932828|20741521|P1|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
8415300|NCT00932828|20741521|P1|STARTED|Overall Study||37
8415301|NCT00932698|20741538|P11|NOT COMPLETED|Part 2 (Dose Expansion)||2
8415302|NCT00932698|20741539|P10|NOT COMPLETED|Part 2 (Dose Expansion)||6
8415303|NCT00932698|20741540|P9|NOT COMPLETED|Part 2 (Dose Expansion)||12
8415304|NCT00932698|20741541|P8|NOT COMPLETED|Part 2 (Dose Expansion)||20
8415305|NCT00932698|20741542|P7|NOT COMPLETED|Part 2 (Dose Expansion)||0
8415306|NCT00932698|20741543|P6|NOT COMPLETED|Part 2 (Dose Expansion)||0
8415307|NCT00932698|20741544|P5|NOT COMPLETED|Part 2 (Dose Expansion)||0
8415308|NCT00932698|20741545|P4|NOT COMPLETED|Part 2 (Dose Expansion)||0
8415309|NCT00932698|20741546|P3|NOT COMPLETED|Part 2 (Dose Expansion)||0
8415310|NCT00932698|20741547|P2|NOT COMPLETED|Part 2 (Dose Expansion)||0
8415311|NCT00932698|20741548|P1|NOT COMPLETED|Part 2 (Dose Expansion)||0
8415312|NCT00932698|20741538|P11|COMPLETED|Part 2 (Dose Expansion)||0
8415313|NCT00932698|20741539|P10|COMPLETED|Part 2 (Dose Expansion)||0
8415314|NCT00932698|20741540|P9|COMPLETED|Part 2 (Dose Expansion)||0
8415315|NCT00932698|20741541|P8|COMPLETED|Part 2 (Dose Expansion)||0
8415316|NCT00932698|20741542|P7|COMPLETED|Part 2 (Dose Expansion)||0
8415317|NCT00932698|20741543|P6|COMPLETED|Part 2 (Dose Expansion)||0
8415318|NCT00932698|20741544|P5|COMPLETED|Part 2 (Dose Expansion)||0
8415319|NCT00932698|20741545|P4|COMPLETED|Part 2 (Dose Expansion)||0
8415320|NCT00932698|20741546|P3|COMPLETED|Part 2 (Dose Expansion)||0
8415321|NCT00932698|20741547|P2|COMPLETED|Part 2 (Dose Expansion)||0
8415322|NCT00932698|20741548|P1|COMPLETED|Part 2 (Dose Expansion)||0
8415323|NCT00932698|20741538|P11|STARTED|Part 2 (Dose Expansion)||2
8415324|NCT00932698|20741539|P10|STARTED|Part 2 (Dose Expansion)||6
8415325|NCT00932698|20741540|P9|STARTED|Part 2 (Dose Expansion)||12
8415326|NCT00932698|20741541|P8|STARTED|Part 2 (Dose Expansion)||20
8415327|NCT00932698|20741542|P7|STARTED|Part 2 (Dose Expansion)||0
8415328|NCT00932698|20741543|P6|STARTED|Part 2 (Dose Expansion)||0
8415329|NCT00932698|20741544|P5|STARTED|Part 2 (Dose Expansion)||0
8415330|NCT00932698|20741545|P4|STARTED|Part 2 (Dose Expansion)||0
8415331|NCT00932698|20741546|P3|STARTED|Part 2 (Dose Expansion)||0
8415332|NCT00932698|20741547|P2|STARTED|Part 2 (Dose Expansion)||0
8415333|NCT00932698|20741548|P1|STARTED|Part 2 (Dose Expansion)||0
8415334|NCT00932698|20741538|P11|NOT COMPLETED|Part 1 (Dose Escalation)||0
8415335|NCT00932698|20741539|P10|NOT COMPLETED|Part 1 (Dose Escalation)||0
8415336|NCT00932698|20741540|P9|NOT COMPLETED|Part 1 (Dose Escalation)||0
8415337|NCT00932698|20741541|P8|NOT COMPLETED|Part 1 (Dose Escalation)||0
8415338|NCT00932698|20741542|P7|NOT COMPLETED|Part 1 (Dose Escalation)||4
8415339|NCT00932698|20741543|P6|NOT COMPLETED|Part 1 (Dose Escalation)||7
8415340|NCT00932698|20741544|P5|NOT COMPLETED|Part 1 (Dose Escalation)||3
8415341|NCT00932698|20741545|P4|NOT COMPLETED|Part 1 (Dose Escalation)||3
8415342|NCT00932698|20741546|P3|NOT COMPLETED|Part 1 (Dose Escalation)||3
8415343|NCT00932698|20741547|P2|NOT COMPLETED|Part 1 (Dose Escalation)||3
8415344|NCT00932698|20741548|P1|NOT COMPLETED|Part 1 (Dose Escalation)||3
8415345|NCT00932698|20741538|P11|COMPLETED|Part 1 (Dose Escalation)||0
8415346|NCT00932698|20741539|P10|COMPLETED|Part 1 (Dose Escalation)||0
8415347|NCT00932698|20741540|P9|COMPLETED|Part 1 (Dose Escalation)||0
8415348|NCT00932698|20741541|P8|COMPLETED|Part 1 (Dose Escalation)||0
8415349|NCT00932698|20741542|P7|COMPLETED|Part 1 (Dose Escalation)||0
8415350|NCT00932698|20741543|P6|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0
8415351|NCT00932698|20741544|P5|COMPLETED|Part 1 (Dose Escalation)||0
8415352|NCT00932698|20741545|P4|COMPLETED|Part 1 (Dose Escalation)||0
8415353|NCT00932698|20741546|P3|COMPLETED|Part 1 (Dose Escalation)||0
8415354|NCT00932698|20741547|P2|COMPLETED|Part 1 (Dose Escalation)||0
8415355|NCT00932698|20741548|P1|COMPLETED|Part 1 (Dose Escalation)||0
8415356|NCT00932698|20741538|P11|STARTED|Part 1 (Dose Escalation)||0
8415357|NCT00932698|20741539|P10|STARTED|Part 1 (Dose Escalation)||0
8415358|NCT00932698|20741540|P9|STARTED|Part 1 (Dose Escalation)||0
8415359|NCT00932698|20741541|P8|STARTED|Part 1 (Dose Escalation)||0
8415360|NCT00932698|20741542|P7|STARTED|Part 1 (Dose Escalation)||4
8415361|NCT00932698|20741543|P6|STARTED|Part 1 (Dose Escalation)||7
8415362|NCT00932698|20741544|P5|STARTED|Part 1 (Dose Escalation)||3
8415363|NCT00932698|20741545|P4|STARTED|Part 1 (Dose Escalation)||3
8415364|NCT00932698|20741546|P3|STARTED|Part 1 (Dose Escalation)||3
8415365|NCT00932698|20741547|P2|STARTED|Part 1 (Dose Escalation)||3
8415366|NCT00932698|20741548|P1|STARTED|Part 1 (Dose Escalation)||3
8415367|NCT00932659|20741717|P1|NOT COMPLETED|Overall Study||0
8415368|NCT00932659|20741717|P1|COMPLETED|Overall Study||8
8415369|NCT00932659|20741717|P1|STARTED|Overall Study||8
8415370|NCT00932646|20741722|P4|NOT COMPLETED|Overall Study||1
8415371|NCT00932646|20741723|P3|NOT COMPLETED|Overall Study||4
8415372|NCT00932646|20741724|P2|NOT COMPLETED|Overall Study||3
8415373|NCT00932646|20741725|P1|NOT COMPLETED|Overall Study||5
8415374|NCT00932646|20741722|P4|COMPLETED|Overall Study||24
8415375|NCT00932646|20741723|P3|COMPLETED|Overall Study||21
8415376|NCT00932646|20741724|P2|COMPLETED|Overall Study||22
8415377|NCT00932646|20741725|P1|COMPLETED|Overall Study||20
8415378|NCT00932646|20741722|P4|STARTED|Overall Study||25
8415379|NCT00932646|20741723|P3|STARTED|Overall Study||25
8415380|NCT00932646|20741724|P2|STARTED|Overall Study||25
8415381|NCT00932646|20741725|P1|STARTED|Overall Study||25
8415382|NCT00932620|20741781|P2|NOT COMPLETED|Overall Study||0
8415383|NCT00932620|20741782|P1|NOT COMPLETED|Overall Study||0
8415384|NCT00932620|20741781|P2|COMPLETED|Overall Study||50
8415385|NCT00932620|20741782|P1|COMPLETED|Overall Study||50
8415386|NCT00932620|20741781|P2|STARTED|Overall Study||50
8415387|NCT00932620|20741782|P1|STARTED|Overall Study||50
8415388|NCT00932477|20741790|P6|NOT COMPLETED|Treatment 3||0
8415389|NCT00932477|20741791|P5|NOT COMPLETED|Treatment 3||0
8415390|NCT00932477|20741792|P4|NOT COMPLETED|Treatment 3||0
8415391|NCT00932477|20741793|P3|NOT COMPLETED|Treatment 3||0
8415392|NCT00932477|20741794|P2|NOT COMPLETED|Treatment 3||0
8415393|NCT00932477|20741795|P1|NOT COMPLETED|Treatment 3||0
8415394|NCT00932477|20741790|P6|COMPLETED|Treatment 3||8
8415395|NCT00932477|20741791|P5|COMPLETED|Treatment 3||8
8415396|NCT00932477|20741792|P4|COMPLETED|Treatment 3||7
8415397|NCT00932477|20741793|P3|COMPLETED|Treatment 3||9
8415398|NCT00932477|20741794|P2|COMPLETED|Treatment 3||8
8415399|NCT00932477|20741795|P1|COMPLETED|Treatment 3||7
8415400|NCT00932477|20741790|P6|STARTED|Treatment 3||8
8415401|NCT00932477|20741791|P5|STARTED|Treatment 3||8
8415402|NCT00932477|20741792|P4|STARTED|Treatment 3||7
8415403|NCT00932477|20741793|P3|STARTED|Treatment 3||9
8415404|NCT00932477|20741794|P2|STARTED|Treatment 3||8
8415405|NCT00932477|20741795|P1|STARTED|Treatment 3||7
8415406|NCT00932477|20741790|P6|NOT COMPLETED|Treatment 2||0
8415407|NCT00932477|20741791|P5|NOT COMPLETED|Treatment 2||0
8415408|NCT00932477|20741792|P4|NOT COMPLETED|Treatment 2||0
8415409|NCT00932477|20741793|P3|NOT COMPLETED|Treatment 2||0
8415410|NCT00932477|20741794|P2|NOT COMPLETED|Treatment 2||0
8415411|NCT00932477|20741795|P1|NOT COMPLETED|Treatment 2||0
8415412|NCT00932477|20741790|P6|COMPLETED|Treatment 2||8
8415413|NCT00932477|20741791|P5|COMPLETED|Treatment 2||8
8415414|NCT00932477|20741792|P4|COMPLETED|Treatment 2||7
8415415|NCT00932477|20741793|P3|COMPLETED|Treatment 2||9
8415416|NCT00932477|20741794|P2|COMPLETED|Treatment 2||8
8415417|NCT00932477|20741795|P1|COMPLETED|Treatment 2||7
8415418|NCT00932477|20741790|P6|STARTED|Treatment 2||8
8415419|NCT00932477|20741791|P5|STARTED|Treatment 2||8
8415420|NCT00932477|20741792|P4|STARTED|Treatment 2||7
8415421|NCT00932477|20741793|P3|STARTED|Treatment 2||9
8415422|NCT00932477|20741794|P2|STARTED|Treatment 2||8
8415423|NCT00932477|20741795|P1|STARTED|Treatment 2||7
8415424|NCT00932477|20741790|P6|NOT COMPLETED|Treatment 1||0
8415425|NCT00932477|20741791|P5|NOT COMPLETED|Treatment 1||0
8415426|NCT00932477|20741792|P4|NOT COMPLETED|Treatment 1||0
8415427|NCT00932477|20741793|P3|NOT COMPLETED|Treatment 1||0
8415428|NCT00932477|20741794|P2|NOT COMPLETED|Treatment 1||0
8415429|NCT00932477|20741795|P1|NOT COMPLETED|Treatment 1||0
8415430|NCT00932477|20741790|P6|COMPLETED|Treatment 1||8
8415431|NCT00932477|20741791|P5|COMPLETED|Treatment 1||8
8415432|NCT00932477|20741792|P4|COMPLETED|Treatment 1||7
8415433|NCT00932477|20741793|P3|COMPLETED|Treatment 1||9
8415434|NCT00932477|20741794|P2|COMPLETED|Treatment 1||8
8415435|NCT00932477|20741795|P1|COMPLETED|Treatment 1||7
8415436|NCT00932477|20741790|P6|STARTED|Treatment 1||8
8415437|NCT00932477|20741791|P5|STARTED|Treatment 1||8
8415438|NCT00932477|20741792|P4|STARTED|Treatment 1||7
8415439|NCT00932477|20741793|P3|STARTED|Treatment 1||9
8415440|NCT00932477|20741794|P2|STARTED|Treatment 1||8
8415441|NCT00932477|20741795|P1|STARTED|Treatment 1||7
8415442|NCT00932451|20741812|P1|NOT COMPLETED|Overall Study||822
8415443|NCT00932451|20741812|P1|COMPLETED|Overall Study||244
8415444|NCT00932451|20741812|P1|STARTED|Overall Study||1066
8415445|NCT00932425|20741836|P2|NOT COMPLETED|Overall Study||2
8415446|NCT00932425|20741837|P1|NOT COMPLETED|Overall Study||0
8415447|NCT00932425|20741836|P2|COMPLETED|Overall Study||18
8415448|NCT00932425|20741837|P1|COMPLETED|Overall Study||20
8415449|NCT00932425|20741836|P2|STARTED|Overall Study||20
8415450|NCT00932425|20741837|P1|STARTED|Overall Study||20
8415451|NCT00932399|20741852|P2|NOT COMPLETED|Overall Study||0
8415452|NCT00932399|20741853|P1|NOT COMPLETED|Overall Study||0
8415453|NCT00932399|20741852|P2|COMPLETED|Overall Study||3790
8415454|NCT00932399|20741853|P1|COMPLETED|Overall Study||759
8415455|NCT00932399|20741852|P2|STARTED|Overall Study||3790
8415456|NCT00932399|20741853|P1|STARTED|Overall Study||759
8415457|NCT00932373|20741870|P11|NOT COMPLETED|Overall Study||3
8415458|NCT00932373|20741871|P10|NOT COMPLETED|Overall Study||13
8415459|NCT00932373|20741872|P9|NOT COMPLETED|Overall Study||2
8415460|NCT00932373|20741873|P8|NOT COMPLETED|Overall Study||3
8415461|NCT00932373|20741874|P7|NOT COMPLETED|Overall Study||1
8415462|NCT00932373|20741875|P6|NOT COMPLETED|Overall Study||3
8415463|NCT00932373|20741876|P5|NOT COMPLETED|Overall Study||14
8415464|NCT00932373|20741877|P4|NOT COMPLETED|Overall Study||0
8415465|NCT00932373|20741878|P3|NOT COMPLETED|Overall Study||1
8415466|NCT00932373|20741879|P2|NOT COMPLETED|Overall Study||1
8415467|NCT00932373|20741880|P1|NOT COMPLETED|Overall Study||3
8415468|NCT00932373|20741870|P11|COMPLETED|Overall Study||0
8415469|NCT00932373|20741871|P10|COMPLETED|Overall Study||3
8415470|NCT00932373|20741872|P9|COMPLETED|Overall Study||1
8415471|NCT00932373|20741873|P8|COMPLETED|Overall Study||0
8415472|NCT00932373|20741874|P7|COMPLETED|Overall Study||2
8415473|NCT00932373|20741875|P6|COMPLETED|Overall Study||0
8415474|NCT00932373|20741876|P5|COMPLETED|Overall Study||1
8415475|NCT00932373|20741877|P4|COMPLETED|Overall Study||1
8415476|NCT00932373|20741878|P3|COMPLETED|Overall Study||0
8415477|NCT00932373|20741879|P2|COMPLETED|Overall Study||0
8415478|NCT00932373|20741880|P1|COMPLETED|Overall Study||0
8415479|NCT00932373|20741870|P11|STARTED|Overall Study||3
8415480|NCT00932373|20741871|P10|STARTED|Overall Study||16
8415481|NCT00932373|20741872|P9|STARTED|Overall Study||3
8415482|NCT00932373|20741873|P8|STARTED|Overall Study||3
8415483|NCT00932373|20741874|P7|STARTED|Overall Study||3
8415484|NCT00932373|20741875|P6|STARTED|Overall Study||3
8415485|NCT00932373|20741876|P5|STARTED|Overall Study||15
8415486|NCT00932373|20741877|P4|STARTED|Overall Study||1
8415487|NCT00932373|20741878|P3|STARTED|Overall Study||1
8415488|NCT00932373|20741879|P2|STARTED|Overall Study||1
8415489|NCT00932373|20741880|P1|STARTED|Overall Study||3
8415490|NCT00932360|20741980|P6|NOT COMPLETED|Visit 3/Week 3||0
8415491|NCT00932360|20741981|P5|NOT COMPLETED|Visit 3/Week 3||0
8415492|NCT00932360|20741982|P4|NOT COMPLETED|Visit 3/Week 3||0
8415493|NCT00932360|20741983|P3|NOT COMPLETED|Visit 3/Week 3||0
8415494|NCT00932360|20741984|P2|NOT COMPLETED|Visit 3/Week 3||0
8415495|NCT00932360|20741985|P1|NOT COMPLETED|Visit 3/Week 3||0
8415496|NCT00932360|20741980|P6|COMPLETED|Visit 3/Week 3||7
8415497|NCT00932360|20741981|P5|COMPLETED|Visit 3/Week 3||2
8415498|NCT00932360|20741982|P4|COMPLETED|Visit 3/Week 3||13
8415499|NCT00932360|20741983|P3|COMPLETED|Visit 3/Week 3||3
8415500|NCT00932360|20741984|P2|COMPLETED|Visit 3/Week 3||6
8415501|NCT00932360|20741985|P1|COMPLETED|Visit 3/Week 3||10
8415502|NCT00932360|20741980|P6|STARTED|Visit 3/Week 3||7
8415503|NCT00932360|20741981|P5|STARTED|Visit 3/Week 3||2
8415504|NCT00932360|20741982|P4|STARTED|Visit 3/Week 3||13
8415505|NCT00932360|20741983|P3|STARTED|Visit 3/Week 3||3
8415506|NCT00932360|20741984|P2|STARTED|Visit 3/Week 3||6
8415507|NCT00932360|20741985|P1|STARTED|Visit 3/Week 3||10
8415508|NCT00932360|20741980|P6|NOT COMPLETED|Washout (One Week)||0
8415509|NCT00932360|20741981|P5|NOT COMPLETED|Washout (One Week)||0
8415510|NCT00932360|20741982|P4|NOT COMPLETED|Washout (One Week)||0
8415511|NCT00932360|20741983|P3|NOT COMPLETED|Washout (One Week)||0
8415512|NCT00932360|20741984|P2|NOT COMPLETED|Washout (One Week)||0
8415513|NCT00932360|20741985|P1|NOT COMPLETED|Washout (One Week)||0
8415514|NCT00932360|20741980|P6|COMPLETED|Washout (One Week)||7
8415515|NCT00932360|20741981|P5|COMPLETED|Washout (One Week)||2
8415516|NCT00932360|20741982|P4|COMPLETED|Washout (One Week)||13
8415517|NCT00932360|20741983|P3|COMPLETED|Washout (One Week)||3
8415518|NCT00932360|20741984|P2|COMPLETED|Washout (One Week)||6
8415519|NCT00932360|20741985|P1|COMPLETED|Washout (One Week)||10
8415520|NCT00932360|20741980|P6|STARTED|Washout (One Week)||7
8415521|NCT00932360|20741981|P5|STARTED|Washout (One Week)||2
8415522|NCT00932360|20741982|P4|STARTED|Washout (One Week)||13
8415523|NCT00932360|20741983|P3|STARTED|Washout (One Week)||3
8415524|NCT00932360|20741984|P2|STARTED|Washout (One Week)||6
8415525|NCT00932360|20741985|P1|STARTED|Washout (One Week)||10
8415526|NCT00932360|20741980|P6|NOT COMPLETED|Visit 2/Week 2||0
8415527|NCT00932360|20741981|P5|NOT COMPLETED|Visit 2/Week 2||0
8415528|NCT00932360|20741982|P4|NOT COMPLETED|Visit 2/Week 2||0
8415529|NCT00932360|20741983|P3|NOT COMPLETED|Visit 2/Week 2||0
8415530|NCT00932360|20741984|P2|NOT COMPLETED|Visit 2/Week 2||0
8415531|NCT00932360|20741985|P1|NOT COMPLETED|Visit 2/Week 2||0
8415532|NCT00932360|20741980|P6|COMPLETED|Visit 2/Week 2||7
8415533|NCT00932360|20741981|P5|COMPLETED|Visit 2/Week 2||2
8415534|NCT00932360|20741982|P4|COMPLETED|Visit 2/Week 2||13
8415535|NCT00932360|20741983|P3|COMPLETED|Visit 2/Week 2||3
8415536|NCT00932360|20741984|P2|COMPLETED|Visit 2/Week 2||6
8415537|NCT00932360|20741985|P1|COMPLETED|Visit 2/Week 2||10
8415538|NCT00932360|20741980|P6|STARTED|Visit 2/Week 2||7
8415539|NCT00932360|20741981|P5|STARTED|Visit 2/Week 2||2
8415540|NCT00932360|20741982|P4|STARTED|Visit 2/Week 2||13
8415541|NCT00932360|20741983|P3|STARTED|Visit 2/Week 2||3
8415542|NCT00932360|20741984|P2|STARTED|Visit 2/Week 2||6
8415543|NCT00932360|20741985|P1|STARTED|Visit 2/Week 2||10
8415544|NCT00932360|20741980|P6|NOT COMPLETED|Washout (One Week)||0
8415545|NCT00932360|20741981|P5|NOT COMPLETED|Washout (One Week)||2
8415546|NCT00932360|20741982|P4|NOT COMPLETED|Washout (One Week)||0
8415547|NCT00932360|20741983|P3|NOT COMPLETED|Washout (One Week)||0
8415548|NCT00932360|20741984|P2|NOT COMPLETED|Washout (One Week)||0
8415549|NCT00932360|20741985|P1|NOT COMPLETED|Washout (One Week)||0
8415550|NCT00932360|20741980|P6|COMPLETED|Washout (One Week)||7
8415551|NCT00932360|20741981|P5|COMPLETED|Washout (One Week)||2
8415552|NCT00932360|20741982|P4|COMPLETED|Washout (One Week)||13
8415553|NCT00932360|20741983|P3|COMPLETED|Washout (One Week)||3
8415554|NCT00932360|20741984|P2|COMPLETED|Washout (One Week)||6
8415555|NCT00932360|20741985|P1|COMPLETED|Washout (One Week)||10
8415556|NCT00932360|20741980|P6|STARTED|Washout (One Week)||7
8415557|NCT00932360|20741981|P5|STARTED|Washout (One Week)||4
8415558|NCT00932360|20741982|P4|STARTED|Washout (One Week)||13
8415559|NCT00932360|20741983|P3|STARTED|Washout (One Week)||3
8415560|NCT00932360|20741984|P2|STARTED|Washout (One Week)||6
8415561|NCT00932360|20741985|P1|STARTED|Washout (One Week)||10
8415562|NCT00932360|20741980|P6|NOT COMPLETED|1: Visit 1/Week1||0
8415563|NCT00932360|20741981|P5|NOT COMPLETED|1: Visit 1/Week1||0
8415564|NCT00932360|20741982|P4|NOT COMPLETED|1: Visit 1/Week1||0
8415565|NCT00932360|20741983|P3|NOT COMPLETED|1: Visit 1/Week1||0
8415566|NCT00932360|20741984|P2|NOT COMPLETED|1: Visit 1/Week1||0
8415567|NCT00932360|20741985|P1|NOT COMPLETED|1: Visit 1/Week1||0
8415568|NCT00932360|20741980|P6|COMPLETED|1: Visit 1/Week1||7
8415569|NCT00932360|20741981|P5|COMPLETED|1: Visit 1/Week1||4
8415570|NCT00932360|20741982|P4|COMPLETED|1: Visit 1/Week1||13
8415571|NCT00932360|20741983|P3|COMPLETED|1: Visit 1/Week1||3
8415572|NCT00932360|20741984|P2|COMPLETED|1: Visit 1/Week1||6
8415573|NCT00932360|20741985|P1|COMPLETED|1: Visit 1/Week1||10
8415574|NCT00932360|20741980|P6|STARTED|1: Visit 1/Week1||7
8415575|NCT00932360|20741981|P5|STARTED|1: Visit 1/Week1||4
8415576|NCT00932360|20741982|P4|STARTED|1: Visit 1/Week1||13
8415577|NCT00932360|20741983|P3|STARTED|1: Visit 1/Week1||3
8415578|NCT00932360|20741984|P2|STARTED|1: Visit 1/Week1||6
8415579|NCT00932360|20741985|P1|STARTED|1: Visit 1/Week1||10
8415580|NCT00932321|20742016|P2|NOT COMPLETED|Overall Study||46
8415581|NCT00932321|20742017|P1|NOT COMPLETED|Overall Study||171
8415582|NCT00932321|20742016|P2|COMPLETED|Overall Study||141
8415583|NCT00932321|20742017|P1|COMPLETED|Overall Study||580
8415584|NCT00932321|20742016|P2|MITT Population|Overall Study||181
8415585|NCT00932321|20742017|P1|MITT Population|Overall Study||705
8415586|NCT00932321|20742016|P2|STARTED|Overall Study||187
8415587|NCT00932321|20742017|P1|STARTED|Overall Study||751
8415588|NCT00932282|20742027|P2|NOT COMPLETED|OIT Maintenance Phase||2
8415589|NCT00932282|20742028|P1|NOT COMPLETED|OIT Maintenance Phase||1
8415590|NCT00932282|20742027|P2|COMPLETED|OIT Maintenance Phase||2
8415591|NCT00932282|20742028|P1|COMPLETED|OIT Maintenance Phase||4
8415592|NCT00932282|20742027|P2|STARTED|OIT Maintenance Phase||4
8415593|NCT00932282|20742028|P1|STARTED|OIT Maintenance Phase||5
8415594|NCT00932282|20742027|P2|NOT COMPLETED|Biweekly OIT Buildup Phase||1
8415595|NCT00932282|20742028|P1|NOT COMPLETED|Biweekly OIT Buildup Phase||1
8415596|NCT00932282|20742027|P2|COMPLETED|Biweekly OIT Buildup Phase||4
8415597|NCT00932282|20742028|P1|COMPLETED|Biweekly OIT Buildup Phase||5
8415598|NCT00932282|20742027|P2|STARTED|Biweekly OIT Buildup Phase||5
8415599|NCT00932282|20742028|P1|STARTED|Biweekly OIT Buildup Phase||6
8415600|NCT00932282|20742027|P2|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
8415601|NCT00932282|20742028|P1|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
8415602|NCT00932282|20742027|P2|COMPLETED|Modified OIT Rush Desensitization Phase||5
8415603|NCT00932282|20742028|P1|COMPLETED|Modified OIT Rush Desensitization Phase||6
8415604|NCT00932282|20742027|P2|STARTED|Modified OIT Rush Desensitization Phase||5
8415605|NCT00932282|20742028|P1|STARTED|Modified OIT Rush Desensitization Phase||6
8415606|NCT00932282|20742027|P2|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
8415607|NCT00932282|20742028|P1|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
8415608|NCT00932282|20742027|P2|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
8415609|NCT00932282|20742028|P1|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
8415610|NCT00932282|20742027|P2|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
8415611|NCT00932282|20742028|P1|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
8415612|NCT00932165|20742042|P1|NOT COMPLETED|Overall Study||1
8415613|NCT00932165|20742042|P1|COMPLETED|Overall Study||450
8415614|NCT00932165|20742042|P1|STARTED|Overall Study||451
8415615|NCT00932152|20742055|P2|NOT COMPLETED|Overall Study||2
8415616|NCT00932152|20742056|P1|NOT COMPLETED|Overall Study||1
8415617|NCT00932152|20742055|P2|COMPLETED|Overall Study||0
8415618|NCT00932152|20742056|P1|COMPLETED|Overall Study||0
8415619|NCT00932152|20742055|P2|STARTED|Overall Study||2
8415620|NCT00932152|20742056|P1|STARTED|Overall Study||1
8415621|NCT00932126|20742066|P8|NOT COMPLETED|Overall Study||10
8415622|NCT00932126|20742067|P7|NOT COMPLETED|Overall Study||5
8415623|NCT00932126|20742068|P6|NOT COMPLETED|Overall Study||3
8415624|NCT00932126|20742069|P5|NOT COMPLETED|Overall Study||5
8415625|NCT00932126|20742070|P4|NOT COMPLETED|Overall Study||3
8415626|NCT00932126|20742071|P3|NOT COMPLETED|Overall Study||3
8415627|NCT00932126|20742072|P2|NOT COMPLETED|Overall Study||3
8415628|NCT00932126|20742073|P1|NOT COMPLETED|Overall Study||3
8415629|NCT00932126|20742066|P8|COMPLETED|Overall Study||0
8415630|NCT00932126|20742067|P7|COMPLETED|Overall Study||0
8415631|NCT00932126|20742068|P6|COMPLETED|Overall Study||0
8415632|NCT00932126|20742069|P5|COMPLETED|Overall Study||0
8415633|NCT00932126|20742070|P4|COMPLETED|Overall Study||0
8415634|NCT00932126|20742071|P3|COMPLETED|Overall Study||0
8415635|NCT00932126|20742072|P2|COMPLETED|Overall Study||0
8415636|NCT00932126|20742073|P1|COMPLETED|Overall Study||0
8415637|NCT00932126|20742066|P8|STARTED|Overall Study||10
8415638|NCT00932126|20742067|P7|STARTED|Overall Study||5
8415639|NCT00932126|20742068|P6|STARTED|Overall Study||3
8415640|NCT00932126|20742069|P5|STARTED|Overall Study||5
8415641|NCT00932126|20742070|P4|STARTED|Overall Study||3
8415642|NCT00932126|20742071|P3|STARTED|Overall Study||3
8415643|NCT00932126|20742072|P2|STARTED|Overall Study||3
8415644|NCT00932126|20742073|P1|STARTED|Overall Study||3
8415645|NCT00932113|20742111|P2|NOT COMPLETED|Overall Study||0
8415646|NCT00932113|20742112|P1|NOT COMPLETED|Overall Study||1
8415647|NCT00932113|20742111|P2|COMPLETED|Overall Study||15
8415648|NCT00932113|20742112|P1|COMPLETED|Overall Study||14
8415649|NCT00932113|20742111|P2|STARTED|Overall Study||15
8415650|NCT00932113|20742112|P1|STARTED|Overall Study||15
8415651|NCT00932035|20742130|P2|NOT COMPLETED|Overall Study||0
8415652|NCT00932035|20742131|P1|NOT COMPLETED|Overall Study||0
8415653|NCT00932035|20742130|P2|COMPLETED|Overall Study||21
8415654|NCT00932035|20742131|P1|COMPLETED|Overall Study||18
8415655|NCT00932035|20742130|P2|STARTED|Overall Study||21
8415656|NCT00932035|20742131|P1|STARTED|Overall Study||18
8415657|NCT00932022|20742143|P2|NOT COMPLETED|Overall Study||4
8415658|NCT00932022|20742144|P1|NOT COMPLETED|Overall Study||5
8415659|NCT00932022|20742143|P2|COMPLETED|Overall Study||59
8415660|NCT00932022|20742144|P1|COMPLETED|Overall Study||59
8415661|NCT00932022|20742143|P2|STARTED|Overall Study||63
8415662|NCT00932022|20742144|P1|STARTED|Overall Study||64
8415663|NCT00931996|20742158|P1|NOT COMPLETED|Overall Study||7
8415664|NCT00931996|20742158|P1|COMPLETED|Overall Study||5
8415665|NCT00931996|20742158|P1|STARTED|Overall Study||12
8415666|NCT00931918|20742164|P2|NOT COMPLETED|Overall Study||17
8415667|NCT00931918|20742165|P1|NOT COMPLETED|Overall Study||17
8415668|NCT00931918|20742164|P2|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
8415669|NCT00931918|20742165|P1|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
8415670|NCT00931918|20742164|P2|Safety Population: Received Study Drug|Overall Study||101
8415671|NCT00931918|20742165|P1|Safety Population: Received Study Drug|Overall Study||100
8415672|NCT00931918|20742164|P2|STARTED|Overall Study||103
8415673|NCT00931918|20742165|P1|STARTED|Overall Study||103
8415674|NCT00931879|20742191|P2|NOT COMPLETED|Overall Study||3
8415675|NCT00931879|20742192|P1|NOT COMPLETED|Overall Study||3
8415676|NCT00931879|20742191|P2|COMPLETED|Overall Study||19
8415677|NCT00931879|20742192|P1|COMPLETED|Overall Study||19
8415678|NCT00931879|20742191|P2|STARTED|Overall Study||22
8415679|NCT00931879|20742192|P1|STARTED|Overall Study||22
8415680|NCT00931801|20742217|P3|NOT COMPLETED|Overall Study||4
8415681|NCT00931801|20742218|P2|NOT COMPLETED|Overall Study||1
8415682|NCT00931801|20742219|P1|NOT COMPLETED|Overall Study||1
8415683|NCT00931801|20742217|P3|COMPLETED|Overall Study||10
8415684|NCT00931801|20742218|P2|COMPLETED|Overall Study||14
8415685|NCT00931801|20742219|P1|COMPLETED|Overall Study||13
8415686|NCT00931801|20742217|P3|STARTED|Overall Study||14
8415687|NCT00931801|20742218|P2|STARTED|Overall Study||15
8415688|NCT00931801|20742219|P1|STARTED|Overall Study||14
8415689|NCT00931723|20742242|P2|NOT COMPLETED|Overall Study||39
8415690|NCT00931723|20742243|P1|NOT COMPLETED|Overall Study||26
8415691|NCT00931723|20742242|P2|COMPLETED|Overall Study||144
8415692|NCT00931723|20742243|P1|COMPLETED|Overall Study||147
8415693|NCT00931723|20742242|P2|STARTED|Overall Study||183
8415694|NCT00931723|20742243|P1|STARTED|Overall Study||173
8415695|NCT00931710|20742291|P2|NOT COMPLETED|Overall Study||38
8415696|NCT00931710|20742292|P1|NOT COMPLETED|Overall Study||34
8415697|NCT00931710|20742291|P2|COMPLETED|Overall Study||209
8415698|NCT00931710|20742292|P1|COMPLETED|Overall Study||207
8415699|NCT00931710|20742291|P2|STARTED|Overall Study||247
8415700|NCT00931710|20742292|P1|STARTED|Overall Study||241
8415701|NCT00931632|20742310|P2|NOT COMPLETED|Overall Study||18
8415702|NCT00931632|20742311|P1|NOT COMPLETED|Overall Study||21
8415703|NCT00931632|20742310|P2|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
8415704|NCT00931632|20742311|P1|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
8415705|NCT00931632|20742310|P2|STARTED|Overall Study|Randomized|222
8415706|NCT00931632|20742311|P1|STARTED|Overall Study|Randomized|229
8415707|NCT00931528|20742333|P2|NOT COMPLETED|Overall Study||60
8415708|NCT00931528|20742334|P1|NOT COMPLETED|Overall Study||41
8415709|NCT00931528|20742333|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
8415710|NCT00931528|20742334|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
8415711|NCT00931528|20742333|P2|STARTED|Overall Study||121
8415712|NCT00931528|20742334|P1|STARTED|Overall Study||121
8415713|NCT00931515|20742354|P2|NOT COMPLETED|Overall Study||5
8415714|NCT00931515|20742355|P1|NOT COMPLETED|Overall Study||2
8415715|NCT00931515|20742354|P2|COMPLETED|Overall Study||10
8415716|NCT00931515|20742355|P1|COMPLETED|Overall Study||13
8415717|NCT00931515|20742354|P2|STARTED|Overall Study||15
8415718|NCT00931515|20742355|P1|STARTED|Overall Study||15
8415719|NCT00931489|20742366|P5|NOT COMPLETED|Overall Study||0
8415720|NCT00931489|20742367|P4|NOT COMPLETED|Overall Study||0
8415721|NCT00931489|20742368|P3|NOT COMPLETED|Overall Study||0
8415722|NCT00931489|20742369|P2|NOT COMPLETED|Overall Study||0
8415723|NCT00931489|20742370|P1|NOT COMPLETED|Overall Study||0
8415724|NCT00931489|20742366|P5|COMPLETED|Overall Study||7
8415725|NCT00931489|20742367|P4|COMPLETED|Overall Study||39
8415726|NCT00931489|20742368|P3|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
8415727|NCT00931489|20742369|P2|COMPLETED|Overall Study||40
8415728|NCT00931489|20742370|P1|COMPLETED|Overall Study||40
8415729|NCT00931489|20742366|P5|STARTED|Overall Study||7
8415730|NCT00931489|20742367|P4|STARTED|Overall Study||39
8415731|NCT00931489|20742368|P3|STARTED|Overall Study||5
8415732|NCT00931489|20742369|P2|STARTED|Overall Study||40
8415733|NCT00931489|20742370|P1|STARTED|Overall Study||40
8415734|NCT00931463|20742385|P2|NOT COMPLETED|Overall Study||5
8415735|NCT00931463|20742386|P1|NOT COMPLETED|Overall Study||17
8415736|NCT00931463|20742385|P2|COMPLETED|Overall Study||265
8415737|NCT00931463|20742386|P1|COMPLETED|Overall Study||254
8415738|NCT00931463|20742385|P2|STARTED|Overall Study||270
8415739|NCT00931463|20742386|P1|STARTED|Overall Study||271
8415740|NCT00931411|20742402|P2|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
8415741|NCT00931411|20742403|P1|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
8415742|NCT00931411|20742402|P2|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
8415743|NCT00931411|20742403|P1|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
8415744|NCT00931411|20742402|P2|STARTED|After Crossover - 14 Days (up to Day 56)||35
8415745|NCT00931411|20742403|P1|STARTED|After Crossover - 14 Days (up to Day 56)||31
8415746|NCT00931411|20742402|P2|NOT COMPLETED|First Intervention - 42 Days||3
8415747|NCT00931411|20742403|P1|NOT COMPLETED|First Intervention - 42 Days||4
8415748|NCT00931411|20742402|P2|COMPLETED|First Intervention - 42 Days||35
8415749|NCT00931411|20742403|P1|COMPLETED|First Intervention - 42 Days||31
8415750|NCT00931411|20742402|P2|STARTED|First Intervention - 42 Days||38
8415751|NCT00931411|20742403|P1|STARTED|First Intervention - 42 Days||35
8415752|NCT00931385|20742424|P4|NOT COMPLETED|Overall Study||5
8415753|NCT00931385|20742425|P3|NOT COMPLETED|Overall Study||1
8415754|NCT00931385|20742426|P2|NOT COMPLETED|Overall Study||2
8415755|NCT00931385|20742427|P1|NOT COMPLETED|Overall Study||2
8415756|NCT00931385|20742424|P4|COMPLETED|Overall Study||21
8415757|NCT00931385|20742425|P3|COMPLETED|Overall Study||24
8415758|NCT00931385|20742426|P2|COMPLETED|Overall Study||21
8415759|NCT00931385|20742427|P1|COMPLETED|Overall Study||23
8415760|NCT00931385|20742424|P4|STARTED|Overall Study||26
8415761|NCT00931385|20742425|P3|STARTED|Overall Study||25
8415762|NCT00931385|20742426|P2|STARTED|Overall Study||23
8415763|NCT00931385|20742427|P1|STARTED|Overall Study||25
8415764|NCT00931359|20742483|P2|NOT COMPLETED|Overall Study||13
8415765|NCT00931359|20742484|P1|NOT COMPLETED|Overall Study||6
8415766|NCT00931359|20742483|P2|COMPLETED|Overall Study||68
8415767|NCT00931359|20742484|P1|COMPLETED|Overall Study||33
8415768|NCT00931359|20742483|P2|STARTED|Overall Study||81
8415769|NCT00931359|20742484|P1|STARTED|Overall Study||39
8415770|NCT00931307|20742496|P1|NOT COMPLETED|Overall Study||13
8415771|NCT00931307|20742496|P1|COMPLETED|Overall Study||9
8415772|NCT00931307|20742496|P1|STARTED|Overall Study||22
8415773|NCT00931268|20742500|P1|NOT COMPLETED|Overall Study||6
8415774|NCT00931268|20742500|P1|COMPLETED|Overall Study||4
8415775|NCT00931268|20742500|P1|STARTED|Overall Study||10
8415776|NCT00931255|20742512|P2|NOT COMPLETED|Overall Study||3
8415777|NCT00931255|20742513|P1|NOT COMPLETED|Overall Study||2
8415778|NCT00931255|20742512|P2|COMPLETED|Overall Study||12
8415779|NCT00931255|20742513|P1|COMPLETED|Overall Study||15
8415780|NCT00931255|20742512|P2|STARTED|Overall Study||15
8415781|NCT00931255|20742513|P1|STARTED|Overall Study||17
8415782|NCT00931242|20742537|P2|NOT COMPLETED|Overall Study||2
8415783|NCT00931242|20742538|P1|NOT COMPLETED|Overall Study||5
8415784|NCT00931242|20742537|P2|COMPLETED|Overall Study||0
8415785|NCT00931242|20742538|P1|COMPLETED|Overall Study||5
8415786|NCT00931242|20742537|P2|STARTED|Overall Study||2
8415787|NCT00931242|20742538|P1|STARTED|Overall Study||10
8415788|NCT00931164|20742544|P1|NOT COMPLETED|Overall Study||0
8415789|NCT00931164|20742544|P1|COMPLETED|Overall Study||6
8415790|NCT00931164|20742544|P1|STARTED|Overall Study||6
8415791|NCT00930982|20742550|P2|NOT COMPLETED|Overall Study||29
8415792|NCT00930982|20742551|P1|NOT COMPLETED|Overall Study||21
8415793|NCT00930982|20742550|P2|COMPLETED|Overall Study||35
8415794|NCT00930982|20742551|P1|COMPLETED|Overall Study||39
8415795|NCT00930982|20742550|P2|STARTED|Overall Study||64
8415796|NCT00930982|20742551|P1|STARTED|Overall Study||60
8415797|NCT00930969|20742585|P1|NOT COMPLETED|Overall Study||38
8415798|NCT00930969|20742585|P1|COMPLETED|Overall Study||137
8415799|NCT00930969|20742585|P1|STARTED|Overall Study||175
8415800|NCT00930930|20742595|P2|NOT COMPLETED|Overall Study||9
8415801|NCT00930930|20742596|P1|NOT COMPLETED|Overall Study||21
8415802|NCT00930930|20742595|P2|COMPLETED|Overall Study||40
8415803|NCT00930930|20742596|P1|COMPLETED|Overall Study||75
8415804|NCT00930930|20742595|P2|STARTED|Overall Study||49
8415805|NCT00930930|20742596|P1|STARTED|Overall Study||96
8415806|NCT00930813|20742610|P2|NOT COMPLETED|Overall Study||14
8415807|NCT00930813|20742611|P1|NOT COMPLETED|Overall Study||8
8415808|NCT00930813|20742610|P2|COMPLETED|Overall Study||38
8415809|NCT00930813|20742611|P1|COMPLETED|Overall Study||41
8415810|NCT00930813|20742610|P2|STARTED|Overall Study||52
8415811|NCT00930813|20742611|P1|STARTED|Overall Study||49
8415812|NCT00930787|20742621|P2|NOT COMPLETED|Overall Study||0
8415813|NCT00930787|20742622|P1|NOT COMPLETED|Overall Study||0
8415814|NCT00930787|20742621|P2|COMPLETED|Overall Study||9
8415815|NCT00930787|20742622|P1|COMPLETED|Overall Study||14
8415816|NCT00930787|20742621|P2|STARTED|Overall Study||9
8415817|NCT00930787|20742622|P1|STARTED|Overall Study||14
8415818|NCT00930774|20742632|P4|NOT COMPLETED|Overall Study||0
8415819|NCT00930774|20742633|P3|NOT COMPLETED|Overall Study||2
8415820|NCT00930774|20742634|P2|NOT COMPLETED|Overall Study||9
8415821|NCT00930774|20742635|P1|NOT COMPLETED|Overall Study||1
8415822|NCT00930774|20742632|P4|COMPLETED|Overall Study||25
8415823|NCT00930774|20742633|P3|COMPLETED|Overall Study||22
8415824|NCT00930774|20742634|P2|COMPLETED|Overall Study||16
8415825|NCT00930774|20742635|P1|COMPLETED|Overall Study||24
8415826|NCT00930774|20742632|P4|STARTED|Overall Study||25
8415827|NCT00930774|20742633|P3|STARTED|Overall Study||24
8415828|NCT00930774|20742634|P2|STARTED|Overall Study||25
8415829|NCT00930774|20742635|P1|STARTED|Overall Study||25
8415830|NCT00930761|20742675|P2|NOT COMPLETED|Overall Study||3
8415831|NCT00930761|20742676|P1|NOT COMPLETED|Overall Study||4
8415832|NCT00930761|20742675|P2|COMPLETED|Overall Study||48
8415833|NCT00930761|20742676|P1|COMPLETED|Overall Study||46
8415834|NCT00930761|20742675|P2|STARTED|Overall Study||51
8415835|NCT00930761|20742676|P1|STARTED|Overall Study||50
8415836|NCT00930722|20742688|P1|NOT COMPLETED|Overall Study||27
8415837|NCT00930722|20742688|P1|COMPLETED|Overall Study||302
8415838|NCT00930722|20742688|P1|STARTED|Overall Study||329
8415842|NCT00930553|20742716|P1|NOT COMPLETED|Overall Study||223
8415843|NCT00930553|20742716|P1|COMPLETED|Overall Study||1091
8415844|NCT00930553|20742716|P1|Participants Entered From CAMMS324|Overall Study||685
8415845|NCT00930553|20742716|P1|Participants Entered From CAMMS323|Overall Study||488
8415846|NCT00930553|20742716|P1|Participants Entered From CAMMS223|Overall Study||141
8415847|NCT00930553|20742716|P1|STARTED|Overall Study||1314
8415848|NCT00930293|20742784|P2|NOT COMPLETED|Overall Study||7
8415849|NCT00930293|20742785|P1|NOT COMPLETED|Overall Study||7
8415850|NCT00930293|20742784|P2|COMPLETED|Overall Study||19
8415851|NCT00930293|20742785|P1|COMPLETED|Overall Study||17
8415852|NCT00930293|20742784|P2|STARTED|Overall Study||26
8415853|NCT00930293|20742785|P1|STARTED|Overall Study||24
8415854|NCT00930176|20742793|P1|NOT COMPLETED|Overall Study||1
8415855|NCT00930176|20742793|P1|COMPLETED|Overall Study||15
8415856|NCT00930176|20742793|P1|STARTED|Overall Study||16
8415857|NCT00930059|20742800|P2|NOT COMPLETED|Overall Study||12
8415858|NCT00930059|20742801|P1|NOT COMPLETED|Overall Study||8
8415859|NCT00930059|20742800|P2|COMPLETED|Overall Study||79
8415860|NCT00930059|20742801|P1|COMPLETED|Overall Study||92
8415861|NCT00930059|20742800|P2|STARTED|Overall Study||91
8415862|NCT00930059|20742801|P1|STARTED|Overall Study||100
8415863|NCT00930046|20742831|P2|NOT COMPLETED|Overall Study||2
8415864|NCT00930046|20742832|P1|NOT COMPLETED|Overall Study||1
8415865|NCT00930046|20742831|P2|COMPLETED|Overall Study||5
8415866|NCT00930046|20742832|P1|COMPLETED|Overall Study||7
8415867|NCT00930046|20742831|P2|STARTED|Overall Study||7
8415868|NCT00930046|20742832|P1|STARTED|Overall Study||8
8415869|NCT00929994|20742840|P1|NOT COMPLETED|Overall Study||6
8415870|NCT00929994|20742840|P1|COMPLETED|Overall Study||14
8415871|NCT00929994|20742840|P1|STARTED|Overall Study||20
8415872|NCT00929981|20742847|P1|NOT COMPLETED|Overall Study||0
8415873|NCT00929981|20742847|P1|COMPLETED|Overall Study||80
8415874|NCT00929981|20742847|P1|STARTED|Overall Study||80
8415875|NCT00929864|20742859|P2|NOT COMPLETED|Overall Study||83
8415876|NCT00929864|20742860|P1|NOT COMPLETED|Overall Study||66
8415877|NCT00929864|20742859|P2|COMPLETED|Overall Study||245
8415878|NCT00929864|20742860|P1|COMPLETED|Overall Study||252
8415879|NCT00929864|20742859|P2|STARTED|Overall Study||328
8415880|NCT00929864|20742860|P1|STARTED|Overall Study||318
8415893|NCT00929773|20742897|P2|NOT COMPLETED|Overall Study||0
8415894|NCT00929773|20742898|P1|NOT COMPLETED|Overall Study||0
8415895|NCT00929773|20742897|P2|COMPLETED|Overall Study||50
8415896|NCT00929773|20742898|P1|COMPLETED|Overall Study||50
8415897|NCT00929773|20742897|P2|STARTED|Overall Study||50
8415898|NCT00929773|20742898|P1|STARTED|Overall Study||50
8415899|NCT00929734|20742916|P2|NOT COMPLETED|Overall Study||3
8415900|NCT00929734|20742917|P1|NOT COMPLETED|Overall Study||2
8415901|NCT00929734|20742916|P2|COMPLETED|Overall Study||47
8415902|NCT00929734|20742917|P1|COMPLETED|Overall Study||47
8415903|NCT00929734|20742916|P2|STARTED|Overall Study||50
8415904|NCT00929734|20742917|P1|STARTED|Overall Study||49
8415905|NCT00929708|20742934|P5|NOT COMPLETED|Overall Study||6
8415906|NCT00929708|20742935|P4|NOT COMPLETED|Overall Study||6
8415907|NCT00929708|20742936|P3|NOT COMPLETED|Overall Study||3
8415908|NCT00929708|20742937|P2|NOT COMPLETED|Overall Study||3
8415909|NCT00929708|20742938|P1|NOT COMPLETED|Overall Study||4
8415910|NCT00929708|20742934|P5|COMPLETED|Overall Study||57
8415911|NCT00929708|20742935|P4|COMPLETED|Overall Study||61
8415912|NCT00929708|20742936|P3|COMPLETED|Overall Study||62
8415913|NCT00929708|20742937|P2|COMPLETED|Overall Study||66
8415914|NCT00929708|20742938|P1|COMPLETED|Overall Study||61
8415915|NCT00929708|20742934|P5|STARTED|Overall Study||63
8415916|NCT00929708|20742935|P4|STARTED|Overall Study||67
8415917|NCT00929708|20742936|P3|STARTED|Overall Study||65
8415918|NCT00929708|20742937|P2|STARTED|Overall Study||69
8415919|NCT00929708|20742938|P1|STARTED|Overall Study||65
8415920|NCT00929695|20742992|P2|NOT COMPLETED|Overall Study||6
8415921|NCT00929695|20742993|P1|NOT COMPLETED|Overall Study||8
8415922|NCT00929695|20742992|P2|COMPLETED|Overall Study||77
8415923|NCT00929695|20742993|P1|COMPLETED|Overall Study||73
8415924|NCT00929695|20742992|P2|STARTED|Overall Study||83
8415925|NCT00929695|20742993|P1|STARTED|Overall Study||81
8415926|NCT00929669|20743023|P1|NOT COMPLETED|Overall Study||1
8415927|NCT00929669|20743023|P1|COMPLETED|Overall Study||1
8415928|NCT00929669|20743023|P1|STARTED|Overall Study||2
8415929|NCT00929656|20743030|P2|NOT COMPLETED|Overall Study||1
8415930|NCT00929656|20743031|P1|NOT COMPLETED|Overall Study||0
8415931|NCT00929656|20743030|P2|COMPLETED|Overall Study||8
8415932|NCT00929656|20743031|P1|COMPLETED|Overall Study||13
8415933|NCT00929656|20743030|P2|STARTED|Overall Study||9
8415934|NCT00929656|20743031|P1|STARTED|Overall Study||13
8415935|NCT00929643|20743045|P1|NOT COMPLETED|Overall Study||2
8415936|NCT00929643|20743045|P1|COMPLETED|Overall Study||201
8415937|NCT00929643|20743045|P1|STARTED|Overall Study||203
8415938|NCT00929578|20743054|P1|NOT COMPLETED|Overall Study||0
8415939|NCT00929578|20743054|P1|COMPLETED|Overall Study||15
8415940|NCT00929578|20743054|P1|STARTED|Overall Study||15
8415941|NCT00929526|20743067|P2|NOT COMPLETED|Overall Study||29
8415942|NCT00929526|20743068|P1|NOT COMPLETED|Overall Study||17
8415943|NCT00929526|20743067|P2|COMPLETED|Overall Study||348
8415944|NCT00929526|20743068|P1|COMPLETED|Overall Study||358
8415945|NCT00929526|20743067|P2|STARTED|Overall Study||377
8415946|NCT00929526|20743068|P1|STARTED|Overall Study||375
8415947|NCT00929500|20743104|P2|NOT COMPLETED|Overall Study||0
8415948|NCT00929500|20743105|P1|NOT COMPLETED|Overall Study||4
8415949|NCT00929500|20743104|P2|COMPLETED|Overall Study||4
8415950|NCT00929500|20743105|P1|COMPLETED|Overall Study||4
8415951|NCT00929500|20743104|P2|STARTED|Overall Study||4
8415952|NCT00929500|20743105|P1|STARTED|Overall Study||8
8415953|NCT00929474|20743119|P2|NOT COMPLETED|Overall Study||9
8415954|NCT00929474|20743120|P1|NOT COMPLETED|Overall Study||8
8415955|NCT00929474|20743119|P2|COMPLETED|Overall Study||0
8415956|NCT00929474|20743120|P1|COMPLETED|Overall Study||0
8415957|NCT00929474|20743119|P2|STARTED|Overall Study||9
8415958|NCT00929474|20743120|P1|STARTED|Overall Study||8
8415959|NCT00929383|20743126|P1|NOT COMPLETED|Overall Study||15
8415960|NCT00929383|20743126|P1|COMPLETED|Overall Study||67
8415961|NCT00929383|20743126|P1|STARTED|Overall Study||82
8415962|NCT00929357|20743136|P2|NOT COMPLETED|Overall Study||0
8415963|NCT00929357|20743137|P1|NOT COMPLETED|Overall Study||0
8415964|NCT00929357|20743136|P2|COMPLETED|Overall Study||64
8415965|NCT00929357|20743137|P1|COMPLETED|Overall Study||92
8415966|NCT00929357|20743136|P2|STARTED|Overall Study||64
8415967|NCT00929357|20743137|P1|STARTED|Overall Study||92
8415968|NCT00929344|20743160|P3|NOT COMPLETED|Overall Study||21
8415969|NCT00929344|20743161|P2|NOT COMPLETED|Overall Study||13
8415970|NCT00929344|20743162|P1|NOT COMPLETED|Overall Study||22
8415971|NCT00929344|20743160|P3|COMPLETED|Overall Study||29
8415972|NCT00929344|20743161|P2|COMPLETED|Overall Study||37
8415973|NCT00929344|20743162|P1|COMPLETED|Overall Study||28
8415974|NCT00929344|20743160|P3|STARTED|Overall Study||50
8415975|NCT00929344|20743161|P2|STARTED|Overall Study||50
8415976|NCT00929344|20743162|P1|STARTED|Overall Study||50
8415977|NCT00929331|20743178|P2|NOT COMPLETED|Overall Study||0
8415978|NCT00929331|20743179|P1|NOT COMPLETED|Overall Study||0
8415979|NCT00929331|20743178|P2|COMPLETED|Overall Study||55
8415980|NCT00929331|20743179|P1|COMPLETED|Overall Study||55
8415981|NCT00929331|20743178|P2|STARTED|Overall Study||55
8415982|NCT00929331|20743179|P1|STARTED|Overall Study||55
8415983|NCT00929305|20743213|P2|NOT COMPLETED|Overall Study||0
8415984|NCT00929305|20743214|P1|NOT COMPLETED|Overall Study||0
8415985|NCT00929305|20743213|P2|COMPLETED|Overall Study||43
8415986|NCT00929305|20743214|P1|COMPLETED|Overall Study||43
8415987|NCT00929305|20743213|P2|STARTED|Overall Study||43
8415988|NCT00929305|20743214|P1|STARTED|Overall Study||43
8415989|NCT00929240|20743222|P3|NOT COMPLETED|Maintenance Phase||91
8415990|NCT00929240|20743223|P2|NOT COMPLETED|Maintenance Phase||94
8415991|NCT00929240|20743224|P1|NOT COMPLETED|Maintenance Phase||0
8415992|NCT00929240|20743222|P3|COMPLETED|Maintenance Phase||0
8415993|NCT00929240|20743223|P2|COMPLETED|Maintenance Phase||0
8415994|NCT00929240|20743224|P1|COMPLETED|Maintenance Phase||0
8415995|NCT00929240|20743222|P3|STARTED|Maintenance Phase||91
8415996|NCT00929240|20743223|P2|STARTED|Maintenance Phase||94
8415997|NCT00929240|20743224|P1|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
8415998|NCT00929240|20743222|P3|NOT COMPLETED|Initial Treatment Phase||0
8415999|NCT00929240|20743223|P2|NOT COMPLETED|Initial Treatment Phase||0
8416000|NCT00929240|20743224|P1|NOT COMPLETED|Initial Treatment Phase||99
8416001|NCT00929240|20743222|P3|COMPLETED|Initial Treatment Phase||0
8416002|NCT00929240|20743223|P2|COMPLETED|Initial Treatment Phase||0
8416003|NCT00929240|20743224|P1|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
8416004|NCT00929240|20743222|P3|STARTED|Initial Treatment Phase||0
8416005|NCT00929240|20743223|P2|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
8416006|NCT00929240|20743224|P1|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
8416007|NCT00929201|20743251|P2|NOT COMPLETED|Period 2||0
8416008|NCT00929201|20743252|P1|NOT COMPLETED|Period 2||0
8416009|NCT00929201|20743251|P2|COMPLETED|Period 2||30
8416010|NCT00929201|20743252|P1|COMPLETED|Period 2||30
8416011|NCT00929201|20743251|P2|STARTED|Period 2||30
8416012|NCT00929201|20743252|P1|STARTED|Period 2||30
8416013|NCT00929201|20743251|P2|NOT COMPLETED|7-day Washout||0
8416014|NCT00929201|20743252|P1|NOT COMPLETED|7-day Washout||0
8416015|NCT00929201|20743251|P2|COMPLETED|7-day Washout||30
8416016|NCT00929201|20743252|P1|COMPLETED|7-day Washout||30
8416017|NCT00929201|20743251|P2|STARTED|7-day Washout||30
8416018|NCT00929201|20743252|P1|STARTED|7-day Washout||30
8416019|NCT00929201|20743251|P2|NOT COMPLETED|Period 1||1
8416020|NCT00929201|20743252|P1|NOT COMPLETED|Period 1||0
8416021|NCT00929201|20743251|P2|COMPLETED|Period 1||30
8416022|NCT00929201|20743252|P1|COMPLETED|Period 1||30
8416023|NCT00929201|20743251|P2|STARTED|Period 1||31
8416024|NCT00929201|20743252|P1|STARTED|Period 1||30
8416025|NCT00929162|20743262|P2|NOT COMPLETED|Overall Study||42
8416026|NCT00929162|20743263|P1|NOT COMPLETED|Overall Study||48
8416027|NCT00929162|20743262|P2|COMPLETED|Overall Study||19
8416028|NCT00929162|20743263|P1|COMPLETED|Overall Study||11
8416029|NCT00929162|20743262|P2|Patients Who Received Treatment|Overall Study||58
8416030|NCT00929162|20743263|P1|Patients Who Received Treatment|Overall Study||58
8416031|NCT00929162|20743262|P2|STARTED|Overall Study||61
8416032|NCT00929162|20743263|P1|STARTED|Overall Study||59
8416033|NCT00929110|20743276|P3|NOT COMPLETED|Overall Study||62
8416034|NCT00929110|20743277|P2|NOT COMPLETED|Overall Study||76
8416035|NCT00929110|20743278|P1|NOT COMPLETED|Overall Study||118
8416036|NCT00929110|20743276|P3|COMPLETED|Overall Study||206
8416037|NCT00929110|20743277|P2|COMPLETED|Overall Study||193
8416038|NCT00929110|20743278|P1|COMPLETED|Overall Study||411
8416039|NCT00929110|20743276|P3|STARTED|Overall Study||268
8416040|NCT00929110|20743277|P2|STARTED|Overall Study||269
8416041|NCT00929110|20743278|P1|STARTED|Overall Study||529
8416042|NCT00929071|20743343|P1|NOT COMPLETED|Overall Study||0
8416043|NCT00929071|20743343|P1|COMPLETED|Overall Study||10
8416044|NCT00929071|20743343|P1|STARTED|Overall Study||10
8416045|NCT00928954|20743350|P2|NOT COMPLETED|Overall Study||0
8416046|NCT00928954|20743351|P1|NOT COMPLETED|Overall Study||0
8416047|NCT00928954|20743350|P2|COMPLETED|Overall Study||6
8416048|NCT00928954|20743351|P1|COMPLETED|Overall Study||4
8416049|NCT00928954|20743350|P2|STARTED|Overall Study||6
8416050|NCT00928954|20743351|P1|STARTED|Overall Study||4
8416051|NCT00928889|20743361|P2|NOT COMPLETED|Overall Study||2
8416052|NCT00928889|20743362|P1|NOT COMPLETED|Overall Study||5
8416053|NCT00928889|20743361|P2|COMPLETED|Overall Study||78
8416054|NCT00928889|20743362|P1|COMPLETED|Overall Study||75
8416055|NCT00928889|20743361|P2|STARTED|Overall Study||80
8416056|NCT00928889|20743362|P1|STARTED|Overall Study||80
8416057|NCT00928772|20743389|P3|NOT COMPLETED|Overall Study||0
8416058|NCT00928772|20743390|P2|NOT COMPLETED|Overall Study||0
8416059|NCT00928772|20743391|P1|NOT COMPLETED|Overall Study||0
8416060|NCT00928772|20743389|P3|COMPLETED|Overall Study||38
8416061|NCT00928772|20743390|P2|COMPLETED|Overall Study||38
8416062|NCT00928772|20743391|P1|COMPLETED|Overall Study||39
8416063|NCT00928772|20743389|P3|STARTED|Overall Study||38
8416064|NCT00928772|20743390|P2|STARTED|Overall Study||38
8416065|NCT00928772|20743391|P1|STARTED|Overall Study||39
8416066|NCT00928746|20743408|P1|NOT COMPLETED|Overall Study||6
8416067|NCT00928746|20743408|P1|COMPLETED|Overall Study||136
8416068|NCT00928746|20743408|P1|STARTED|Overall Study||142
8416069|NCT00928720|20743431|P3|NOT COMPLETED|Overall Study||3
8416070|NCT00928720|20743432|P2|NOT COMPLETED|Overall Study||6
8416071|NCT00928720|20743433|P1|NOT COMPLETED|Overall Study||2
8416072|NCT00928720|20743431|P3|COMPLETED|Overall Study||15
8416073|NCT00928720|20743432|P2|COMPLETED|Overall Study||14
8416074|NCT00928720|20743433|P1|COMPLETED|Overall Study||17
8416075|NCT00928720|20743431|P3|STARTED|Overall Study||18
8416076|NCT00928720|20743432|P2|STARTED|Overall Study||20
8416077|NCT00928720|20743433|P1|STARTED|Overall Study||19
8416078|NCT00928707|20743458|P2|NOT COMPLETED|Overall Study||0
8416079|NCT00928707|20743459|P1|NOT COMPLETED|Overall Study||1
8416080|NCT00928707|20743458|P2|COMPLETED|Overall Study||22
8416081|NCT00928707|20743459|P1|COMPLETED|Overall Study||22
8416082|NCT00928707|20743458|P2|STARTED|Overall Study||22
8416083|NCT00928707|20743459|P1|STARTED|Overall Study||23
8416084|NCT00928694|20743471|P2|NOT COMPLETED|Second Intervention||0
8416085|NCT00928694|20743472|P1|NOT COMPLETED|Second Intervention||0
8416086|NCT00928694|20743471|P2|COMPLETED|Second Intervention||7
8416087|NCT00928694|20743472|P1|COMPLETED|Second Intervention||7
8416088|NCT00928694|20743471|P2|STARTED|Second Intervention||7
8416089|NCT00928694|20743472|P1|STARTED|Second Intervention||7
8416090|NCT00928694|20743471|P2|NOT COMPLETED|First Intervention||0
8416091|NCT00928694|20743472|P1|NOT COMPLETED|First Intervention||0
8416092|NCT00928694|20743471|P2|COMPLETED|First Intervention||7
8416093|NCT00928694|20743472|P1|COMPLETED|First Intervention||7
8416094|NCT00928694|20743471|P2|STARTED|First Intervention||7
8416095|NCT00928694|20743472|P1|STARTED|First Intervention||7
8416096|NCT00928668|20743480|P5|NOT COMPLETED|Overall Study||1
8416097|NCT00928668|20743481|P4|NOT COMPLETED|Overall Study||1
8416098|NCT00928668|20743482|P3|NOT COMPLETED|Overall Study||1
8416099|NCT00928668|20743483|P2|NOT COMPLETED|Overall Study||1
8416100|NCT00928668|20743484|P1|NOT COMPLETED|Overall Study||1
8416101|NCT00928668|20743480|P5|COMPLETED|Overall Study||5
8416102|NCT00928668|20743481|P4|COMPLETED|Overall Study||3
8416103|NCT00928668|20743482|P3|COMPLETED|Overall Study||6
8416104|NCT00928668|20743483|P2|COMPLETED|Overall Study||6
8416105|NCT00928668|20743484|P1|COMPLETED|Overall Study||6
8416106|NCT00928668|20743480|P5|STARTED|Overall Study||6
8416107|NCT00928668|20743481|P4|STARTED|Overall Study||4
8416108|NCT00928668|20743482|P3|STARTED|Overall Study||7
8416109|NCT00928668|20743483|P2|STARTED|Overall Study||7
8416110|NCT00928668|20743484|P1|STARTED|Overall Study||7
8416111|NCT00928642|20743526|P1|NOT COMPLETED|Overall Study||0
8416112|NCT00928642|20743526|P1|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
8416113|NCT00928642|20743526|P1|STARTED|Overall Study||8
8416114|NCT00928512|20743540|P5|NOT COMPLETED|Overall Study||15
8416115|NCT00928512|20743541|P4|NOT COMPLETED|Overall Study||21
8416116|NCT00928512|20743542|P3|NOT COMPLETED|Overall Study||11
8416117|NCT00928512|20743543|P2|NOT COMPLETED|Overall Study||6
8416118|NCT00928512|20743544|P1|NOT COMPLETED|Overall Study||10
8416119|NCT00928512|20743540|P5|COMPLETED|Overall Study||35
8416120|NCT00928512|20743541|P4|COMPLETED|Overall Study||33
8416121|NCT00928512|20743542|P3|COMPLETED|Overall Study||38
8416122|NCT00928512|20743543|P2|COMPLETED|Overall Study||37
8416123|NCT00928512|20743544|P1|COMPLETED|Overall Study||31
8416124|NCT00928512|20743540|P5|Entered/Continued to Week 20 (All)|Overall Study||45
8416125|NCT00928512|20743541|P4|Entered/Continued to Week 20 (All)|Overall Study||45
8416126|NCT00928512|20743542|P3|Entered/Continued to Week 20 (All)|Overall Study||46
8416127|NCT00928512|20743543|P2|Entered/Continued to Week 20 (All)|Overall Study||43
8416128|NCT00928512|20743544|P1|Entered/Continued to Week 20 (All)|Overall Study||37
8416129|NCT00928512|20743540|P5|Completed Week 16|Overall Study||45
8416130|NCT00928512|20743541|P4|Completed Week 16|Overall Study||48
8416131|NCT00928512|20743542|P3|Completed Week 16|Overall Study||47
8416132|NCT00928512|20743543|P2|Completed Week 16|Overall Study||43
8416133|NCT00928512|20743544|P1|Completed Week 16|Overall Study||38
8416134|NCT00928512|20743540|P5|New Groups After Reassignment|Overall Study||0
8416135|NCT00928512|20743541|P4|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
8416136|NCT00928512|20743542|P3|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
8416137|NCT00928512|20743543|P2|New Groups After Reassignment|Overall Study||115
8416138|NCT00928512|20743544|P1|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
8416139|NCT00928512|20743540|P5|Not Reassigned at Week 20 (Responders)|Overall Study||0
8416140|NCT00928512|20743541|P4|Not Reassigned at Week 20 (Responders)|Overall Study||18
8416141|NCT00928512|20743542|P3|Not Reassigned at Week 20 (Responders)|Overall Study||23
8416142|NCT00928512|20743543|P2|Not Reassigned at Week 20 (Responders)|Overall Study||20
8416143|NCT00928512|20743544|P1|Not Reassigned at Week 20 (Responders)|Overall Study||37
8416144|NCT00928512|20743540|P5|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
8416145|NCT00928512|20743541|P4|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
8416146|NCT00928512|20743542|P3|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
8416147|NCT00928512|20743543|P2|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
8416148|NCT00928512|20743544|P1|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
8416149|NCT00928512|20743540|P5|Discontinued Prior to Week 16|Overall Study||5
8416150|NCT00928512|20743541|P4|Discontinued Prior to Week 16|Overall Study||6
8416151|NCT00928512|20743542|P3|Discontinued Prior to Week 16|Overall Study||2
8416152|NCT00928512|20743543|P2|Discontinued Prior to Week 16|Overall Study||0
8416153|NCT00928512|20743544|P1|Discontinued Prior to Week 16|Overall Study||3
8416154|NCT00928512|20743540|P5|STARTED|Overall Study||50
8416155|NCT00928512|20743541|P4|STARTED|Overall Study||54
8416156|NCT00928512|20743542|P3|STARTED|Overall Study||49
8416157|NCT00928512|20743543|P2|STARTED|Overall Study||43
8416158|NCT00928512|20743544|P1|STARTED|Overall Study||41
8416159|NCT00928486|20743645|P1|NOT COMPLETED|Overall Study||10
8416160|NCT00928486|20743645|P1|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
8416161|NCT00928486|20743645|P1|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
8416162|NCT00928486|20743645|P1|STARTED|Overall Study||25
8416163|NCT00928434|20743654|P3|NOT COMPLETED|Overall Study||44
8416164|NCT00928434|20743655|P2|NOT COMPLETED|Overall Study||14
8416165|NCT00928434|20743656|P1|NOT COMPLETED|Overall Study||44
8416166|NCT00928434|20743654|P3|COMPLETED|Overall Study||134
8416167|NCT00928434|20743655|P2|COMPLETED|Overall Study||36
8416168|NCT00928434|20743656|P1|COMPLETED|Overall Study||131
8416169|NCT00928434|20743654|P3|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
8416170|NCT00928434|20743655|P2|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
8416171|NCT00928434|20743656|P1|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
8416172|NCT00928434|20743654|P3|STARTED|Overall Study|Full Analysis Set Patients|178
8416173|NCT00928434|20743655|P2|STARTED|Overall Study|Full Analysis Set Patients|50
8416174|NCT00928434|20743656|P1|STARTED|Overall Study|Full Analysis Set Patients|175
8416179|NCT00928408|20743732|P1|NOT COMPLETED|Overall Study||23
8416180|NCT00928408|20743732|P1|COMPLETED|Overall Study||282
8416181|NCT00928408|20743732|P1|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
8416182|NCT00928408|20743732|P1|STARTED|Overall Study|Number Enrolled|305
8416183|NCT00928395|20743761|P1|NOT COMPLETED|Overall Study||21
8416184|NCT00928395|20743761|P1|COMPLETED|Overall Study||29
8416185|NCT00928395|20743761|P1|STARTED|Overall Study||50
8416186|NCT00928304|20743765|P2|NOT COMPLETED|Overall Study||0
8416187|NCT00928304|20743766|P1|NOT COMPLETED|Overall Study||0
8416188|NCT00928304|20743765|P2|COMPLETED|Overall Study||70
8416189|NCT00928304|20743766|P1|COMPLETED|Overall Study||39
8416190|NCT00928304|20743765|P2|STARTED|Overall Study||70
8416191|NCT00928304|20743766|P1|STARTED|Overall Study||39
8416192|NCT00928252|20743778|P1|NOT COMPLETED|Overall Study||3
8416193|NCT00928252|20743778|P1|COMPLETED|Overall Study||42
8416194|NCT00928252|20743778|P1|STARTED|Overall Study||45
8416195|NCT00928226|20743788|P4|NOT COMPLETED|Overall Study||0
8416196|NCT00928226|20743789|P3|NOT COMPLETED|Overall Study||0
8416197|NCT00928226|20743790|P2|NOT COMPLETED|Overall Study||0
8416198|NCT00928226|20743791|P1|NOT COMPLETED|Overall Study||0
8416199|NCT00928226|20743788|P4|COMPLETED|Overall Study||12
8416200|NCT00928226|20743789|P3|COMPLETED|Overall Study||12
8416201|NCT00928226|20743790|P2|COMPLETED|Overall Study||12
8416202|NCT00928226|20743791|P1|COMPLETED|Overall Study||20
8416203|NCT00928226|20743788|P4|Strata D: Large Tumor, Not Resected|Overall Study||0
8416204|NCT00928226|20743789|P3|Strata D: Large Tumor, Not Resected|Overall Study||0
8416205|NCT00928226|20743790|P2|Strata D: Large Tumor, Not Resected|Overall Study||0
8416206|NCT00928226|20743791|P1|Strata D: Large Tumor, Not Resected|Overall Study||1
8416207|NCT00928226|20743788|P4|Strata C: Large Tumor, Resected|Overall Study||6
8416208|NCT00928226|20743789|P3|Strata C: Large Tumor, Resected|Overall Study||6
8416209|NCT00928226|20743790|P2|Strata C: Large Tumor, Resected|Overall Study||6
8416210|NCT00928226|20743791|P1|Strata C: Large Tumor, Resected|Overall Study||8
8416211|NCT00928226|20743788|P4|Strata B: Small Tumor, Not Resected|Overall Study||0
8416212|NCT00928226|20743789|P3|Strata B: Small Tumor, Not Resected|Overall Study||0
8416213|NCT00928226|20743790|P2|Strata B: Small Tumor, Not Resected|Overall Study||0
8416214|NCT00928226|20743791|P1|Strata B: Small Tumor, Not Resected|Overall Study||5
8416215|NCT00928226|20743788|P4|Strata A: Small Tumor, Resected|Overall Study||6
8416216|NCT00928226|20743789|P3|Strata A: Small Tumor, Resected|Overall Study||6
8416217|NCT00928226|20743790|P2|Strata A: Small Tumor, Resected|Overall Study||6
8416218|NCT00928226|20743791|P1|Strata A: Small Tumor, Resected|Overall Study||6
8416219|NCT00928226|20743788|P4|STARTED|Overall Study||12
8416220|NCT00928226|20743789|P3|STARTED|Overall Study||12
8416221|NCT00928226|20743790|P2|STARTED|Overall Study||12
8416222|NCT00928226|20743791|P1|STARTED|Overall Study||20
8416223|NCT00928200|20743829|P1|NOT COMPLETED|Overall Study||0
8416224|NCT00928200|20743829|P1|COMPLETED|Overall Study||1
8416225|NCT00928200|20743829|P1|STARTED|Overall Study||1
8416226|NCT00928187|20743838|P3|NOT COMPLETED|Overall Study||5
8416227|NCT00928187|20743839|P2|NOT COMPLETED|Overall Study||6
8416228|NCT00928187|20743840|P1|NOT COMPLETED|Overall Study||2
8416229|NCT00928187|20743838|P3|COMPLETED|Overall Study||150
8416230|NCT00928187|20743839|P2|COMPLETED|Overall Study||141
8416231|NCT00928187|20743840|P1|COMPLETED|Overall Study||150
8416232|NCT00928187|20743838|P3|Analysed|Overall Study||154
8416233|NCT00928187|20743839|P2|Analysed|Overall Study||145
8416234|NCT00928187|20743840|P1|Analysed|Overall Study||152
8416235|NCT00928187|20743838|P3|STARTED|Overall Study||155
8416236|NCT00928187|20743839|P2|STARTED|Overall Study||147
8416237|NCT00928187|20743840|P1|STARTED|Overall Study||152
8416238|NCT00928174|20743884|P1|NOT COMPLETED|Overall Study||5
8416239|NCT00928174|20743884|P1|COMPLETED|Overall Study|3 withdrawn before start of participation|22
8416240|NCT00928174|20743884|P1|STARTED|Overall Study||27
8416241|NCT00928083|20743891|P9|NOT COMPLETED|Overall Study||0
8416242|NCT00928083|20743892|P8|NOT COMPLETED|Overall Study||0
8416243|NCT00928083|20743893|P7|NOT COMPLETED|Overall Study||0
8416244|NCT00928083|20743894|P6|NOT COMPLETED|Overall Study||0
8416245|NCT00928083|20743895|P5|NOT COMPLETED|Overall Study||1
8416246|NCT00928083|20743896|P4|NOT COMPLETED|Overall Study||1
8416247|NCT00928083|20743897|P3|NOT COMPLETED|Overall Study||0
8416248|NCT00928083|20743898|P2|NOT COMPLETED|Overall Study||0
8416249|NCT00928083|20743899|P1|NOT COMPLETED|Overall Study||4
8416250|NCT00928083|20743891|P9|COMPLETED|Overall Study||6
8416251|NCT00928083|20743892|P8|COMPLETED|Overall Study||6
8416252|NCT00928083|20743893|P7|COMPLETED|Overall Study||6
8416253|NCT00928083|20743894|P6|COMPLETED|Overall Study||6
8416254|NCT00928083|20743895|P5|COMPLETED|Overall Study||6
8416255|NCT00928083|20743896|P4|COMPLETED|Overall Study||5
8416256|NCT00928083|20743897|P3|COMPLETED|Overall Study||8
8416257|NCT00928083|20743898|P2|COMPLETED|Overall Study||8
8416258|NCT00928083|20743899|P1|COMPLETED|Overall Study||6
8416259|NCT00928083|20743891|P9|STARTED|Overall Study||6
8416260|NCT00928083|20743892|P8|STARTED|Overall Study||6
8416261|NCT00928083|20743893|P7|STARTED|Overall Study||6
8416262|NCT00928083|20743894|P6|STARTED|Overall Study||6
8416263|NCT00928083|20743895|P5|STARTED|Overall Study||7
8416264|NCT00928083|20743896|P4|STARTED|Overall Study||6
8416265|NCT00928083|20743897|P3|STARTED|Overall Study||8
8416266|NCT00928083|20743898|P2|STARTED|Overall Study||8
8416267|NCT00928083|20743899|P1|STARTED|Overall Study||10
8416268|NCT00928070|20744010|P2|NOT COMPLETED|Overall Study||57
8416269|NCT00928070|20744011|P1|NOT COMPLETED|Overall Study||63
8416270|NCT00928070|20744010|P2|COMPLETED|Overall Study||226
8416271|NCT00928070|20744011|P1|COMPLETED|Overall Study||220
8416272|NCT00928070|20744010|P2|Treated|Overall Study||281
8416273|NCT00928070|20744011|P1|Treated|Overall Study||281
8416274|NCT00928070|20744010|P2|STARTED|Overall Study||283
8416275|NCT00928070|20744011|P1|STARTED|Overall Study||283
8416276|NCT00928057|20744069|P2|NOT COMPLETED|Overall Study||4
8416277|NCT00928057|20744070|P1|NOT COMPLETED|Overall Study||2
8416278|NCT00928057|20744069|P2|COMPLETED|Overall Study||85
8416279|NCT00928057|20744070|P1|COMPLETED|Overall Study||82
8416280|NCT00928057|20744069|P2|STARTED|Overall Study||89
8416281|NCT00928057|20744070|P1|STARTED|Overall Study||84
8416282|NCT00928018|20744095|P2|NOT COMPLETED|Overall Study||0
8416283|NCT00928018|20744096|P1|NOT COMPLETED|Overall Study||1
8416284|NCT00928018|20744095|P2|COMPLETED|Overall Study||73
8416285|NCT00928018|20744096|P1|COMPLETED|Overall Study||65
8416286|NCT00928018|20744095|P2|STARTED|Overall Study||73
8416287|NCT00928018|20744096|P1|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
8416288|NCT00927992|20744114|P1|NOT COMPLETED|Overall Study||0
8416289|NCT00927992|20744114|P1|COMPLETED|Overall Study||11
8416290|NCT00927992|20744114|P1|STARTED|Overall Study||11
8416291|NCT00927953|20744126|P2|NOT COMPLETED|Overall Study||1
8416292|NCT00927953|20744127|P1|NOT COMPLETED|Overall Study||2
8416293|NCT00927953|20744126|P2|COMPLETED|Overall Study||6
8416294|NCT00927953|20744127|P1|COMPLETED|Overall Study||4
8416295|NCT00927953|20744126|P2|STARTED|Overall Study||7
8416296|NCT00927953|20744127|P1|STARTED|Overall Study||6
8416297|NCT00927940|20744141|P1|NOT COMPLETED|Overall Study||1
8416298|NCT00927940|20744141|P1|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
8416299|NCT00927940|20744141|P1|STARTED|Overall Study||100
8416300|NCT00927927|20744161|P15|NOT COMPLETED|Overall Study||0
8416301|NCT00927927|20744162|P14|NOT COMPLETED|Overall Study||0
8416302|NCT00927927|20744163|P13|NOT COMPLETED|Overall Study||0
8416303|NCT00927927|20744164|P12|NOT COMPLETED|Overall Study||2
8416304|NCT00927927|20744165|P11|NOT COMPLETED|Overall Study||0
8416305|NCT00927927|20744166|P10|NOT COMPLETED|Overall Study||0
8416306|NCT00927927|20744167|P9|NOT COMPLETED|Overall Study||0
8416307|NCT00927927|20744168|P8|NOT COMPLETED|Overall Study||2
8416308|NCT00927927|20744169|P7|NOT COMPLETED|Overall Study||0
8416309|NCT00927927|20744170|P6|NOT COMPLETED|Overall Study||0
8416310|NCT00927927|20744171|P5|NOT COMPLETED|Overall Study||0
8416311|NCT00927927|20744172|P4|NOT COMPLETED|Overall Study||0
8416312|NCT00927927|20744173|P3|NOT COMPLETED|Overall Study||0
8416313|NCT00927927|20744174|P2|NOT COMPLETED|Overall Study||0
8416314|NCT00927927|20744175|P1|NOT COMPLETED|Overall Study||0
8416315|NCT00927927|20744161|P15|COMPLETED|Overall Study||9
8416316|NCT00927927|20744162|P14|COMPLETED|Overall Study||5
8416317|NCT00927927|20744163|P13|COMPLETED|Overall Study||5
8416318|NCT00927927|20744164|P12|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
8416319|NCT00927927|20744165|P11|COMPLETED|Overall Study||5
8416320|NCT00927927|20744166|P10|COMPLETED|Overall Study||3
8416321|NCT00927927|20744167|P9|COMPLETED|Overall Study||8
8416322|NCT00927927|20744168|P8|COMPLETED|Overall Study||1
8416323|NCT00927927|20744169|P7|COMPLETED|Overall Study||3
8416324|NCT00927927|20744170|P6|COMPLETED|Overall Study||3
8416325|NCT00927927|20744171|P5|COMPLETED|Overall Study||3
8416326|NCT00927927|20744172|P4|COMPLETED|Overall Study||3
8416327|NCT00927927|20744173|P3|COMPLETED|Overall Study||3
8416328|NCT00927927|20744174|P2|COMPLETED|Overall Study||3
8416329|NCT00927927|20744175|P1|COMPLETED|Overall Study||3
8416330|NCT00927927|20744161|P15|Exposed|Overall Study||9
8416331|NCT00927927|20744162|P14|Exposed|Overall Study||5
8416332|NCT00927927|20744163|P13|Exposed|Overall Study||5
8416333|NCT00927927|20744164|P12|Exposed|Overall Study||5
8416334|NCT00927927|20744165|P11|Exposed|Overall Study||5
8416335|NCT00927927|20744166|P10|Exposed|Overall Study||3
8416336|NCT00927927|20744167|P9|Exposed|Overall Study||8
8416337|NCT00927927|20744168|P8|Exposed|Overall Study||3
8416338|NCT00927927|20744169|P7|Exposed|Overall Study||3
8416339|NCT00927927|20744170|P6|Exposed|Overall Study||3
8416340|NCT00927927|20744171|P5|Exposed|Overall Study||3
8416341|NCT00927927|20744172|P4|Exposed|Overall Study||3
8416342|NCT00927927|20744173|P3|Exposed|Overall Study||3
8416343|NCT00927927|20744174|P2|Exposed|Overall Study||3
8416344|NCT00927927|20744175|P1|Exposed|Overall Study||3
8416345|NCT00927927|20744161|P15|STARTED|Overall Study||9
8416346|NCT00927927|20744162|P14|STARTED|Overall Study||5
8416347|NCT00927927|20744163|P13|STARTED|Overall Study||5
8416348|NCT00927927|20744164|P12|STARTED|Overall Study||6
8416349|NCT00927927|20744165|P11|STARTED|Overall Study||5
8416350|NCT00927927|20744166|P10|STARTED|Overall Study||3
8416351|NCT00927927|20744167|P9|STARTED|Overall Study||8
8416352|NCT00927927|20744168|P8|STARTED|Overall Study||3
8416353|NCT00927927|20744169|P7|STARTED|Overall Study||3
8416354|NCT00927927|20744170|P6|STARTED|Overall Study||3
8416355|NCT00927927|20744171|P5|STARTED|Overall Study||3
8416356|NCT00927927|20744172|P4|STARTED|Overall Study||3
8416357|NCT00927927|20744173|P3|STARTED|Overall Study||3
8416358|NCT00927927|20744174|P2|STARTED|Overall Study||3
8416359|NCT00927927|20744175|P1|STARTED|Overall Study||3
8416360|NCT00927901|20744222|P4|NOT COMPLETED|Treatment Period 4||1
8416361|NCT00927901|20744223|P3|NOT COMPLETED|Treatment Period 4||1
8416362|NCT00927901|20744224|P2|NOT COMPLETED|Treatment Period 4||0
8416363|NCT00927901|20744225|P1|NOT COMPLETED|Treatment Period 4||0
8416364|NCT00927901|20744222|P4|COMPLETED|Treatment Period 4||8
8416365|NCT00927901|20744223|P3|COMPLETED|Treatment Period 4||5
8416366|NCT00927901|20744224|P2|COMPLETED|Treatment Period 4||7
8416367|NCT00927901|20744225|P1|COMPLETED|Treatment Period 4||7
8416368|NCT00927901|20744222|P4|STARTED|Treatment Period 4||9
8416369|NCT00927901|20744223|P3|STARTED|Treatment Period 4||6
8416370|NCT00927901|20744224|P2|STARTED|Treatment Period 4||7
8416371|NCT00927901|20744225|P1|STARTED|Treatment Period 4||7
8416372|NCT00927901|20744222|P4|NOT COMPLETED|Treatment Period 3||0
8416373|NCT00927901|20744223|P3|NOT COMPLETED|Treatment Period 3||0
8416374|NCT00927901|20744224|P2|NOT COMPLETED|Treatment Period 3||0
8416375|NCT00927901|20744225|P1|NOT COMPLETED|Treatment Period 3||0
8416376|NCT00927901|20744222|P4|COMPLETED|Treatment Period 3||9
8416377|NCT00927901|20744223|P3|COMPLETED|Treatment Period 3||6
8416378|NCT00927901|20744224|P2|COMPLETED|Treatment Period 3||7
8416379|NCT00927901|20744225|P1|COMPLETED|Treatment Period 3||7
8416380|NCT00927901|20744222|P4|STARTED|Treatment Period 3||9
8416381|NCT00927901|20744223|P3|STARTED|Treatment Period 3||6
8416382|NCT00927901|20744224|P2|STARTED|Treatment Period 3||7
8416383|NCT00927901|20744225|P1|STARTED|Treatment Period 3||7
8416384|NCT00927901|20744222|P4|NOT COMPLETED|Treatment Period 2||0
8416385|NCT00927901|20744223|P3|NOT COMPLETED|Treatment Period 2||0
8416386|NCT00927901|20744224|P2|NOT COMPLETED|Treatment Period 2||0
8416387|NCT00927901|20744225|P1|NOT COMPLETED|Treatment Period 2||0
8416388|NCT00927901|20744222|P4|COMPLETED|Treatment Period 2||9
8416389|NCT00927901|20744223|P3|COMPLETED|Treatment Period 2||6
8416390|NCT00927901|20744224|P2|COMPLETED|Treatment Period 2||7
8416391|NCT00927901|20744225|P1|COMPLETED|Treatment Period 2||7
8416392|NCT00927901|20744222|P4|STARTED|Treatment Period 2||9
8416393|NCT00927901|20744223|P3|STARTED|Treatment Period 2||6
8416394|NCT00927901|20744224|P2|STARTED|Treatment Period 2||7
8416395|NCT00927901|20744225|P1|STARTED|Treatment Period 2||7
8416396|NCT00927901|20744222|P4|NOT COMPLETED|Treatment Period 1||0
8416397|NCT00927901|20744223|P3|NOT COMPLETED|Treatment Period 1||1
8416398|NCT00927901|20744224|P2|NOT COMPLETED|Treatment Period 1||0
8416399|NCT00927901|20744225|P1|NOT COMPLETED|Treatment Period 1||0
8416400|NCT00927901|20744222|P4|COMPLETED|Treatment Period 1||9
8416401|NCT00927901|20744223|P3|COMPLETED|Treatment Period 1||6
8416402|NCT00927901|20744224|P2|COMPLETED|Treatment Period 1||7
8416403|NCT00927901|20744225|P1|COMPLETED|Treatment Period 1||7
8416404|NCT00927901|20744222|P4|STARTED|Treatment Period 1||9
8416405|NCT00927901|20744223|P3|STARTED|Treatment Period 1||7
8416406|NCT00927901|20744224|P2|STARTED|Treatment Period 1||7
8416407|NCT00927901|20744225|P1|STARTED|Treatment Period 1||7
8416408|NCT00927888|20744255|P2|NOT COMPLETED|Overall Study||0
8416409|NCT00927888|20744256|P1|NOT COMPLETED|Overall Study||0
8416410|NCT00927888|20744255|P2|COMPLETED|Overall Study||27
8416411|NCT00927888|20744256|P1|COMPLETED|Overall Study||29
8416412|NCT00927888|20744255|P2|STARTED|Overall Study||27
8416413|NCT00927888|20744256|P1|STARTED|Overall Study||29
8416414|NCT00927862|20744266|P2|NOT COMPLETED|Overall Study||45
8416415|NCT00927862|20744267|P1|NOT COMPLETED|Overall Study||27
8416416|NCT00927862|20744266|P2|COMPLETED|Overall Study||1866
8416417|NCT00927862|20744267|P1|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
8416418|NCT00927862|20744266|P2|STARTED|Overall Study||1911
8416419|NCT00927862|20744267|P1|STARTED|Overall Study||504
8416420|NCT00927849|20744292|P3|NOT COMPLETED|Overall Study||0
8416421|NCT00927849|20744293|P2|NOT COMPLETED|Overall Study||0
8416422|NCT00927849|20744294|P1|NOT COMPLETED|Overall Study||0
8416423|NCT00927849|20744292|P3|COMPLETED|Overall Study||21
8416424|NCT00927849|20744293|P2|COMPLETED|Overall Study||21
8416425|NCT00927849|20744294|P1|COMPLETED|Overall Study||21
8416426|NCT00927849|20744292|P3|STARTED|Overall Study||21
8416427|NCT00927849|20744293|P2|STARTED|Overall Study||21
8416428|NCT00927849|20744294|P1|STARTED|Overall Study||21
8416429|NCT00927823|20744302|P4|NOT COMPLETED|Continuous Dosing Period||5
8416430|NCT00927823|20744303|P3|NOT COMPLETED|Continuous Dosing Period||26
8416431|NCT00927823|20744304|P2|NOT COMPLETED|Continuous Dosing Period||3
8416432|NCT00927823|20744305|P1|NOT COMPLETED|Continuous Dosing Period||3
8416433|NCT00927823|20744302|P4|COMPLETED|Continuous Dosing Period||0
8416434|NCT00927823|20744303|P3|COMPLETED|Continuous Dosing Period||0
8416435|NCT00927823|20744304|P2|COMPLETED|Continuous Dosing Period||0
8416436|NCT00927823|20744305|P1|COMPLETED|Continuous Dosing Period||0
8416437|NCT00927823|20744302|P4|Treated|Continuous Dosing Period||5
8416438|NCT00927823|20744303|P3|Treated|Continuous Dosing Period||23
8416439|NCT00927823|20744304|P2|Treated|Continuous Dosing Period||3
8416440|NCT00927823|20744305|P1|Treated|Continuous Dosing Period||3
8416441|NCT00927823|20744302|P4|STARTED|Continuous Dosing Period||5
8416442|NCT00927823|20744303|P3|STARTED|Continuous Dosing Period||26
8416443|NCT00927823|20744304|P2|STARTED|Continuous Dosing Period||3
8416444|NCT00927823|20744305|P1|STARTED|Continuous Dosing Period||3
8416445|NCT00927823|20744302|P4|NOT COMPLETED|Lead-In Period||0
8416446|NCT00927823|20744303|P3|NOT COMPLETED|Lead-In Period||0
8416447|NCT00927823|20744304|P2|NOT COMPLETED|Lead-In Period||0
8416448|NCT00927823|20744305|P1|NOT COMPLETED|Lead-In Period||0
8416449|NCT00927823|20744302|P4|COMPLETED|Lead-In Period||5
8416450|NCT00927823|20744303|P3|COMPLETED|Lead-In Period||26
8416451|NCT00927823|20744304|P2|COMPLETED|Lead-In Period||3
8416452|NCT00927823|20744305|P1|COMPLETED|Lead-In Period||3
8416453|NCT00927823|20744302|P4|STARTED|Lead-In Period||5
8416454|NCT00927823|20744303|P3|STARTED|Lead-In Period||26
8416455|NCT00927823|20744304|P2|STARTED|Lead-In Period||3
8416456|NCT00927823|20744305|P1|STARTED|Lead-In Period||3
8416457|NCT00927784|20744371|P2|NOT COMPLETED|Overall Study||0
8416458|NCT00927784|20744372|P1|NOT COMPLETED|Overall Study||2
8416459|NCT00927784|20744371|P2|COMPLETED|Overall Study||2
8416460|NCT00927784|20744372|P1|COMPLETED|Overall Study||6
8416461|NCT00927784|20744371|P2|STARTED|Overall Study||2
8416462|NCT00927784|20744372|P1|STARTED|Overall Study||8
8416463|NCT00927758|20744402|P6|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8416464|NCT00927758|20744403|P5|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8416465|NCT00927758|20744404|P4|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8416466|NCT00927758|20744405|P3|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8416467|NCT00927758|20744406|P2|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8416468|NCT00927758|20744407|P1|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
8416469|NCT00927758|20744402|P6|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
8416470|NCT00927758|20744403|P5|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
8416471|NCT00927758|20744404|P4|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
8416472|NCT00927758|20744405|P3|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
8416473|NCT00927758|20744406|P2|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
8416474|NCT00927758|20744407|P1|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
8416475|NCT00927758|20744402|P6|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
8416476|NCT00927758|20744403|P5|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
8416477|NCT00927758|20744404|P4|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
8416478|NCT00927758|20744405|P3|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
8416479|NCT00927758|20744406|P2|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
8416480|NCT00927758|20744407|P1|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
8416481|NCT00927758|20744402|P6|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
8416482|NCT00927758|20744403|P5|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
8416483|NCT00927758|20744404|P4|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
8416484|NCT00927758|20744405|P3|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
8416485|NCT00927758|20744406|P2|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
8416486|NCT00927758|20744407|P1|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
8416487|NCT00927758|20744402|P6|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
8416488|NCT00927758|20744403|P5|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
8416489|NCT00927758|20744404|P4|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
8416490|NCT00927758|20744405|P3|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
8416491|NCT00927758|20744406|P2|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
8416492|NCT00927758|20744407|P1|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
8416493|NCT00927758|20744402|P6|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
8416494|NCT00927758|20744403|P5|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
8416495|NCT00927758|20744404|P4|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
8416496|NCT00927758|20744405|P3|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
8416497|NCT00927758|20744406|P2|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
8416498|NCT00927758|20744407|P1|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
8416499|NCT00927758|20744402|P6|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
8416500|NCT00927758|20744403|P5|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
8416501|NCT00927758|20744404|P4|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
8416502|NCT00927758|20744405|P3|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
8416503|NCT00927758|20744406|P2|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
8416504|NCT00927758|20744407|P1|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
8416505|NCT00927758|20744402|P6|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
8416506|NCT00927758|20744403|P5|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
8416507|NCT00927758|20744404|P4|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
8416508|NCT00927758|20744405|P3|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
8416509|NCT00927758|20744406|P2|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
8416510|NCT00927758|20744407|P1|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
8416511|NCT00927758|20744402|P6|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
8416512|NCT00927758|20744403|P5|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
8416513|NCT00927758|20744404|P4|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
8416514|NCT00927758|20744405|P3|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
8416515|NCT00927758|20744406|P2|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
8416516|NCT00927758|20744407|P1|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
8416517|NCT00927758|20744402|P6|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
8416518|NCT00927758|20744403|P5|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
8416519|NCT00927758|20744404|P4|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
8416520|NCT00927758|20744405|P3|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
8416521|NCT00927758|20744406|P2|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
8416522|NCT00927758|20744407|P1|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
8416523|NCT00927758|20744402|P6|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
8416524|NCT00927758|20744403|P5|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
8416525|NCT00927758|20744404|P4|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
8416526|NCT00927758|20744405|P3|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
8416527|NCT00927758|20744406|P2|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
8416528|NCT00927758|20744407|P1|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
8416529|NCT00927589|20744415|P1|NOT COMPLETED|Overall Study||16
8416530|NCT00927589|20744415|P1|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
8416531|NCT00927589|20744415|P1|STARTED|Overall Study||59
8416532|NCT00927576|20744439|P2|NOT COMPLETED|Overall Study||0
8416533|NCT00927576|20744440|P1|NOT COMPLETED|Overall Study||0
8416534|NCT00927576|20744439|P2|COMPLETED|Overall Study||28
8416535|NCT00927576|20744440|P1|COMPLETED|Overall Study||237
8416536|NCT00927576|20744439|P2|Cognitive Testing|Overall Study||28
8416537|NCT00927576|20744440|P1|Cognitive Testing|Overall Study||237
8416538|NCT00927576|20744439|P2|STARTED|Overall Study||28
8416539|NCT00927576|20744440|P1|STARTED|Overall Study||237
8416540|NCT00927563|20744445|P1|NOT COMPLETED|Overall Study||2
8416541|NCT00927563|20744445|P1|COMPLETED|Overall Study||22
8416542|NCT00927563|20744445|P1|STARTED|Overall Study||24
8416543|NCT00927485|20744453|P2|NOT COMPLETED|Overall Study||4
8416544|NCT00927485|20744454|P1|NOT COMPLETED|Overall Study||6
8416545|NCT00927485|20744453|P2|COMPLETED|Overall Study||19
8416546|NCT00927485|20744454|P1|COMPLETED|Overall Study||15
8416547|NCT00927485|20744453|P2|STARTED|Overall Study||23
8416548|NCT00927485|20744454|P1|STARTED|Overall Study||21
8416549|NCT00927472|20744464|P2|NOT COMPLETED|Overall Study||22
8416550|NCT00927472|20744465|P1|NOT COMPLETED|Overall Study||11
8416551|NCT00927472|20744464|P2|COMPLETED|Overall Study||106
8416552|NCT00927472|20744465|P1|COMPLETED|Overall Study||115
8416553|NCT00927472|20744464|P2|STARTED|Overall Study||128
8416554|NCT00927472|20744465|P1|STARTED|Overall Study||126
8416555|NCT00927394|20744491|P2|NOT COMPLETED|Overall Study||85
8416556|NCT00927394|20744492|P1|NOT COMPLETED|Overall Study||77
8416557|NCT00927394|20744491|P2|COMPLETED|Overall Study||483
8416558|NCT00927394|20744492|P1|COMPLETED|Overall Study||498
8416559|NCT00927394|20744491|P2|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
8416560|NCT00927394|20744492|P1|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
8416561|NCT00927394|20744491|P2|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
8416562|NCT00927394|20744492|P1|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
8416563|NCT00927394|20744491|P2|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
8416564|NCT00927394|20744492|P1|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
8416565|NCT00927394|20744491|P2|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
8416566|NCT00927394|20744492|P1|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
8416567|NCT00927394|20744491|P2|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
8416568|NCT00927394|20744492|P1|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
8416569|NCT00927394|20744491|P2|Cohort 2 (Randomized)|Overall Study||403
8416570|NCT00927394|20744492|P1|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
8416571|NCT00927394|20744491|P2|Cohort 1 (Randomized)|Overall Study||165
8416572|NCT00927394|20744492|P1|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
8416573|NCT00927394|20744491|P2|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
8416574|NCT00927394|20744492|P1|STARTED|Overall Study||575
8416575|NCT00927368|20744523|P3|NOT COMPLETED|Overall Study||5
8416576|NCT00927368|20744524|P2|NOT COMPLETED|Overall Study||5
8416577|NCT00927368|20744525|P1|NOT COMPLETED|Overall Study||6
8416578|NCT00927368|20744523|P3|COMPLETED|Overall Study||138
8416579|NCT00927368|20744524|P2|COMPLETED|Overall Study||152
8416580|NCT00927368|20744525|P1|COMPLETED|Overall Study||147
8416581|NCT00927368|20744523|P3|STARTED|Overall Study||143
8416582|NCT00927368|20744524|P2|STARTED|Overall Study||157
8416583|NCT00927368|20744525|P1|STARTED|Overall Study||153
8416584|NCT00927355|20744544|P2|NOT COMPLETED|Overall Study||1
8416585|NCT00927355|20744545|P1|NOT COMPLETED|Overall Study||1
8416586|NCT00927355|20744544|P2|COMPLETED|Overall Study||4
8416587|NCT00927355|20744545|P1|COMPLETED|Overall Study||4
8416588|NCT00927355|20744544|P2|STARTED|Overall Study||5
8416589|NCT00927355|20744545|P1|STARTED|Overall Study||5
8416590|NCT00927264|20744565|P2|NOT COMPLETED|Overall Study||25
8416591|NCT00927264|20744566|P1|NOT COMPLETED|Overall Study||56
8416592|NCT00927264|20744565|P2|COMPLETED|Overall Study||140
8416593|NCT00927264|20744566|P1|COMPLETED|Overall Study||109
8416594|NCT00927264|20744565|P2|STARTED|Overall Study||165
8416595|NCT00927264|20744566|P1|STARTED|Overall Study||165
8416596|NCT00927251|20744580|P1|NOT COMPLETED|Overall Study||8
8416597|NCT00927251|20744580|P1|COMPLETED|Overall Study||82
8416598|NCT00927251|20744580|P1|STARTED|Overall Study||90
8416599|NCT00927186|20744586|P2|NOT COMPLETED|12 - 24 Months Extension Treatment||0
8416600|NCT00927186|20744587|P1|NOT COMPLETED|12 - 24 Months Extension Treatment||0
8416601|NCT00927186|20744586|P2|COMPLETED|12 - 24 Months Extension Treatment||11
8416602|NCT00927186|20744587|P1|COMPLETED|12 - 24 Months Extension Treatment||10
8416603|NCT00927186|20744586|P2|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
8416604|NCT00927186|20744587|P1|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
8416605|NCT00927186|20744586|P2|NOT COMPLETED|12 Months Primary Study||4
8416606|NCT00927186|20744587|P1|NOT COMPLETED|12 Months Primary Study||7
8416607|NCT00927186|20744586|P2|COMPLETED|12 Months Primary Study||31
8416608|NCT00927186|20744587|P1|COMPLETED|12 Months Primary Study||27
8416609|NCT00927186|20744586|P2|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
8416610|NCT00927186|20744587|P1|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
8416611|NCT00927186|20744586|P2|STARTED|12 Months Primary Study||35
8416612|NCT00927186|20744587|P1|STARTED|12 Months Primary Study||34
8416613|NCT00927160|20744705|P2|NOT COMPLETED|Overall Study||0
8416614|NCT00927160|20744706|P1|NOT COMPLETED|Overall Study||0
8416615|NCT00927160|20744705|P2|COMPLETED|Overall Study||173
8416616|NCT00927160|20744706|P1|COMPLETED|Overall Study||173
8416617|NCT00927160|20744705|P2|STARTED|Overall Study||173
8416618|NCT00927160|20744706|P1|STARTED|Overall Study||173
8416619|NCT00927095|20744717|P3|NOT COMPLETED|Overall Study||2
8416620|NCT00927095|20744718|P2|NOT COMPLETED|Overall Study||4
8416621|NCT00927095|20744719|P1|NOT COMPLETED|Overall Study||6
8416622|NCT00927095|20744717|P3|COMPLETED|Overall Study||22
8416623|NCT00927095|20744718|P2|COMPLETED|Overall Study||17
8416624|NCT00927095|20744719|P1|COMPLETED|Overall Study||16
8416625|NCT00927095|20744717|P3|STARTED|Overall Study||24
8416626|NCT00927095|20744718|P2|STARTED|Overall Study||21
8416627|NCT00927095|20744719|P1|STARTED|Overall Study||22
8416628|NCT00927082|20744731|P4|NOT COMPLETED|Overall Study||19
8416629|NCT00927082|20744732|P3|NOT COMPLETED|Overall Study||22
8416630|NCT00927082|20744733|P2|NOT COMPLETED|Overall Study||10
8416631|NCT00927082|20744734|P1|NOT COMPLETED|Overall Study||12
8416632|NCT00927082|20744731|P4|COMPLETED|Overall Study||78
8416633|NCT00927082|20744732|P3|COMPLETED|Overall Study||86
8416634|NCT00927082|20744733|P2|COMPLETED|Overall Study||77
8416635|NCT00927082|20744734|P1|COMPLETED|Overall Study||79
8416636|NCT00927082|20744731|P4|STARTED|Overall Study||97
8416637|NCT00927082|20744732|P3|STARTED|Overall Study||108
8416638|NCT00927082|20744733|P2|STARTED|Overall Study||87
8416639|NCT00927082|20744734|P1|STARTED|Overall Study||91
8416640|NCT00927069|20744798|P4|NOT COMPLETED|Week 12 to Week 24||3
8416641|NCT00927069|20744799|P3|NOT COMPLETED|Week 12 to Week 24||3
8416642|NCT00927069|20744800|P2|NOT COMPLETED|Week 12 to Week 24||0
8416643|NCT00927069|20744801|P1|NOT COMPLETED|Week 12 to Week 24||2
8416644|NCT00927069|20744798|P4|COMPLETED|Week 12 to Week 24||20
8416645|NCT00927069|20744799|P3|COMPLETED|Week 12 to Week 24||28
8416646|NCT00927069|20744800|P2|COMPLETED|Week 12 to Week 24||11
8416647|NCT00927069|20744801|P1|COMPLETED|Week 12 to Week 24||16
8416648|NCT00927069|20744798|P4|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
8416649|NCT00927069|20744799|P3|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
8416650|NCT00927069|20744800|P2|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
8416651|NCT00927069|20744801|P1|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
8416652|NCT00927069|20744798|P4|NOT COMPLETED|Week 0 to Week 12||0
8416653|NCT00927069|20744799|P3|NOT COMPLETED|Week 0 to Week 12||0
8416654|NCT00927069|20744800|P2|NOT COMPLETED|Week 0 to Week 12||1
8416655|NCT00927069|20744801|P1|NOT COMPLETED|Week 0 to Week 12||1
8416656|NCT00927069|20744798|P4|COMPLETED|Week 0 to Week 12||0
8416657|NCT00927069|20744799|P3|COMPLETED|Week 0 to Week 12||0
8416658|NCT00927069|20744800|P2|COMPLETED|Week 0 to Week 12||34
8416659|NCT00927069|20744801|P1|COMPLETED|Week 0 to Week 12||49
8416660|NCT00927069|20744798|P4|STARTED|Week 0 to Week 12||0
8416661|NCT00927069|20744799|P3|STARTED|Week 0 to Week 12||0
8416662|NCT00927069|20744800|P2|STARTED|Week 0 to Week 12||35
8416663|NCT00927069|20744801|P1|STARTED|Week 0 to Week 12||50
8416664|NCT00926952|20744811|P1|NOT COMPLETED|Overall Study||0
8416665|NCT00926952|20744811|P1|COMPLETED|Overall Study||20
8416666|NCT00926952|20744811|P1|STARTED|Overall Study||20
8416667|NCT00926887|20744825|P2|NOT COMPLETED|Overall Study||0
8416668|NCT00926887|20744826|P1|NOT COMPLETED|Overall Study||0
8416669|NCT00926887|20744825|P2|COMPLETED|Overall Study||50
8416670|NCT00926887|20744826|P1|COMPLETED|Overall Study||54
8416671|NCT00926887|20744825|P2|STARTED|Overall Study||50
8416672|NCT00926887|20744826|P1|STARTED|Overall Study||54
8416673|NCT00926848|20744838|P2|NOT COMPLETED|Overall Study||0
8416674|NCT00926848|20744839|P1|NOT COMPLETED|Overall Study||0
8416675|NCT00926848|20744838|P2|COMPLETED|Overall Study||34
8416676|NCT00926848|20744839|P1|COMPLETED|Overall Study||34
8416677|NCT00926848|20744838|P2|STARTED|Overall Study||34
8416678|NCT00926848|20744839|P1|STARTED|Overall Study||34
8416679|NCT00926796|20744857|P2|NOT COMPLETED|Overall Study||106
8416680|NCT00926796|20744858|P1|NOT COMPLETED|Overall Study||107
8416681|NCT00926796|20744857|P2|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
8416682|NCT00926796|20744858|P1|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
8416683|NCT00926796|20744857|P2|STARTED|Overall Study|Number randomized|305
8416684|NCT00926796|20744858|P1|STARTED|Overall Study|Number randomized|309
8416685|NCT00926783|20744879|P2|NOT COMPLETED|Overall Study||3
8416686|NCT00926783|20744880|P1|NOT COMPLETED|Overall Study||3
8416687|NCT00926783|20744879|P2|COMPLETED|Overall Study||38
8416688|NCT00926783|20744880|P1|COMPLETED|Overall Study||39
8416689|NCT00926783|20744879|P2|STARTED|Overall Study||41
8416690|NCT00926783|20744880|P1|STARTED|Overall Study||42
8416691|NCT00926588|20744898|P2|NOT COMPLETED|Overall Study||4
8416692|NCT00926588|20744899|P1|NOT COMPLETED|Overall Study||8
8416693|NCT00926588|20744898|P2|COMPLETED|Overall Study||122
8416694|NCT00926588|20744899|P1|COMPLETED|Overall Study||116
8416695|NCT00926588|20744898|P2|STARTED|Overall Study||126
8416696|NCT00926588|20744899|P1|STARTED|Overall Study||124
8416697|NCT00926575|20744907|P2|NOT COMPLETED|Overall Study||17
8416698|NCT00926575|20744908|P1|NOT COMPLETED|Overall Study||16
8416699|NCT00926575|20744907|P2|COMPLETED|Overall Study||53
8416700|NCT00926575|20744908|P1|COMPLETED|Overall Study||54
8416701|NCT00926575|20744907|P2|STARTED|Overall Study||70
8416702|NCT00926575|20744908|P1|STARTED|Overall Study||70
8416703|NCT00926536|20744920|P2|NOT COMPLETED|Overall Study||2
8416704|NCT00926536|20744921|P1|NOT COMPLETED|Overall Study||1
8416705|NCT00926536|20744920|P2|COMPLETED|Overall Study||41
8416706|NCT00926536|20744921|P1|COMPLETED|Overall Study||43
8416707|NCT00926536|20744920|P2|STARTED|Overall Study||43
8416708|NCT00926536|20744921|P1|STARTED|Overall Study||44
8416709|NCT00926497|20744931|P2|NOT COMPLETED|Overall Study||0
8416710|NCT00926497|20744932|P1|NOT COMPLETED|Overall Study||0
8416711|NCT00926497|20744931|P2|COMPLETED|Overall Study||61
8416712|NCT00926497|20744932|P1|COMPLETED|Overall Study||60
8416713|NCT00926497|20744931|P2|STARTED|Overall Study||61
8416714|NCT00926497|20744932|P1|STARTED|Overall Study||60
8416715|NCT00926393|20744942|P2|NOT COMPLETED|Overall Study||3
8416716|NCT00926393|20744943|P1|NOT COMPLETED|Overall Study||2
8416717|NCT00926393|20744942|P2|COMPLETED|Overall Study||67
8416718|NCT00926393|20744943|P1|COMPLETED|Overall Study||67
8416719|NCT00926393|20744942|P2|STARTED|Overall Study||70
8416720|NCT00926393|20744943|P1|STARTED|Overall Study||69
8416721|NCT00926380|20744976|P3|NOT COMPLETED|Year 2||5
8416722|NCT00926380|20744977|P2|NOT COMPLETED|Year 2||2
8416723|NCT00926380|20744978|P1|NOT COMPLETED|Year 2||2
8416724|NCT00926380|20744976|P3|COMPLETED|Year 2||24
8416725|NCT00926380|20744977|P2|COMPLETED|Year 2||28
8416726|NCT00926380|20744978|P1|COMPLETED|Year 2||31
8416727|NCT00926380|20744976|P3|STARTED|Year 2||29
8416728|NCT00926380|20744977|P2|STARTED|Year 2||30
8416729|NCT00926380|20744978|P1|STARTED|Year 2||33
8416730|NCT00926380|20744976|P3|NOT COMPLETED|Year 1||1
8416731|NCT00926380|20744977|P2|NOT COMPLETED|Year 1||1
8416732|NCT00926380|20744978|P1|NOT COMPLETED|Year 1||0
8416733|NCT00926380|20744976|P3|COMPLETED|Year 1||29
8416734|NCT00926380|20744977|P2|COMPLETED|Year 1||30
8416735|NCT00926380|20744978|P1|COMPLETED|Year 1||33
8416736|NCT00926380|20744976|P3|STARTED|Year 1||30
8416737|NCT00926380|20744977|P2|STARTED|Year 1||31
8416738|NCT00926380|20744978|P1|STARTED|Year 1||33
8416739|NCT00926367|20744988|P2|NOT COMPLETED|Overall Study||3
8416740|NCT00926367|20744989|P1|NOT COMPLETED|Overall Study||2
8416741|NCT00926367|20744988|P2|COMPLETED|Overall Study||24
8416742|NCT00926367|20744989|P1|COMPLETED|Overall Study||23
8416743|NCT00926367|20744988|P2|STARTED|Overall Study||27
8416744|NCT00926367|20744989|P1|STARTED|Overall Study||25
8416745|NCT00926328|20745031|P2|NOT COMPLETED|Overall Study||14
8416746|NCT00926328|20745032|P1|NOT COMPLETED|Overall Study||12
8416747|NCT00926328|20745031|P2|COMPLETED|Overall Study||46
8416748|NCT00926328|20745032|P1|COMPLETED|Overall Study||48
8416749|NCT00926328|20745031|P2|STARTED|Overall Study||60
8416750|NCT00926328|20745032|P1|STARTED|Overall Study||60
8416751|NCT00926289|20745042|P2|NOT COMPLETED|Overall Study||36
8416752|NCT00926289|20745043|P1|NOT COMPLETED|Overall Study||25
8416753|NCT00926289|20745042|P2|COMPLETED|Overall Study||558
8416754|NCT00926289|20745043|P1|COMPLETED|Overall Study||269
8416755|NCT00926289|20745042|P2|STARTED|Overall Study|Number of treated patients|594
8416756|NCT00926289|20745043|P1|STARTED|Overall Study|Number of treated patients|294
8416757|NCT00926263|20745079|P2|NOT COMPLETED|Overall Study||0
8416758|NCT00926263|20745080|P1|NOT COMPLETED|Overall Study||0
8416759|NCT00926263|20745079|P2|COMPLETED|Overall Study||12
8416760|NCT00926263|20745080|P1|COMPLETED|Overall Study||16
8416761|NCT00926263|20745079|P2|STARTED|Overall Study||12
8416762|NCT00926263|20745080|P1|STARTED|Overall Study||16
8416763|NCT00926237|20745111|P2|NOT COMPLETED|Overall Study||1
8416764|NCT00926237|20745112|P1|NOT COMPLETED|Overall Study||2
8416765|NCT00926237|20745111|P2|COMPLETED|Overall Study||19
8416766|NCT00926237|20745112|P1|COMPLETED|Overall Study||17
8416767|NCT00926237|20745111|P2|STARTED|Overall Study|One subjects withdrew after receiving sham rTMS but before receiving active rTMS.|20
8416768|NCT00926237|20745112|P1|STARTED|Overall Study|Two subjects withdrew after receiving sham rTMS but before receiving active rTMS.|19
8416769|NCT00926211|20745122|P1|NOT COMPLETED|Overall Study||1
8416770|NCT00926211|20745122|P1|COMPLETED|Overall Study||35
8416771|NCT00926211|20745122|P1|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
8416784|NCT00926029|20745153|P3|NOT COMPLETED|Overall Study||1
8416785|NCT00926029|20745154|P2|NOT COMPLETED|Overall Study||1
8416786|NCT00926029|20745155|P1|NOT COMPLETED|Overall Study||2
8416787|NCT00926029|20745153|P3|COMPLETED|Overall Study||33
8416788|NCT00926029|20745154|P2|COMPLETED|Overall Study||33
8416789|NCT00926029|20745155|P1|COMPLETED|Overall Study||32
8416790|NCT00926029|20745153|P3|STARTED|Overall Study||34
8416791|NCT00926029|20745154|P2|STARTED|Overall Study||34
8416792|NCT00926029|20745155|P1|STARTED|Overall Study||34
8416793|NCT00926003|20745169|P3|NOT COMPLETED|Post-Training 3-month Follow-up||0
8416794|NCT00926003|20745170|P2|NOT COMPLETED|Post-Training 3-month Follow-up||0
8416795|NCT00926003|20745171|P1|NOT COMPLETED|Post-Training 3-month Follow-up||1
8416796|NCT00926003|20745169|P3|COMPLETED|Post-Training 3-month Follow-up||52
8416797|NCT00926003|20745170|P2|COMPLETED|Post-Training 3-month Follow-up||54
8416798|NCT00926003|20745171|P1|COMPLETED|Post-Training 3-month Follow-up||51
8416799|NCT00926003|20745169|P3|STARTED|Post-Training 3-month Follow-up||52
8416800|NCT00926003|20745170|P2|STARTED|Post-Training 3-month Follow-up||54
8416801|NCT00926003|20745171|P1|STARTED|Post-Training 3-month Follow-up||52
8416802|NCT00926003|20745169|P3|NOT COMPLETED|Post-Training Evaluation||0
8416803|NCT00926003|20745170|P2|NOT COMPLETED|Post-Training Evaluation||0
8416804|NCT00926003|20745171|P1|NOT COMPLETED|Post-Training Evaluation||1
8416805|NCT00926003|20745169|P3|COMPLETED|Post-Training Evaluation||52
8416806|NCT00926003|20745170|P2|COMPLETED|Post-Training Evaluation||54
8416807|NCT00926003|20745171|P1|COMPLETED|Post-Training Evaluation||52
8416808|NCT00926003|20745169|P3|STARTED|Post-Training Evaluation||52
8416809|NCT00926003|20745170|P2|STARTED|Post-Training Evaluation||54
8416810|NCT00926003|20745171|P1|STARTED|Post-Training Evaluation||53
8416811|NCT00926003|20745169|P3|NOT COMPLETED|Baseline||0
8416812|NCT00926003|20745170|P2|NOT COMPLETED|Baseline||0
8416813|NCT00926003|20745171|P1|NOT COMPLETED|Baseline||0
8416814|NCT00926003|20745169|P3|COMPLETED|Baseline||52
8416815|NCT00926003|20745170|P2|COMPLETED|Baseline||54
8416816|NCT00926003|20745171|P1|COMPLETED|Baseline||53
8416817|NCT00926003|20745169|P3|STARTED|Baseline||52
8416818|NCT00926003|20745170|P2|STARTED|Baseline||54
8416819|NCT00926003|20745171|P1|STARTED|Baseline||53
8416820|NCT00925990|20745184|P2|NOT COMPLETED|Overall Study||11
8416821|NCT00925990|20745185|P1|NOT COMPLETED|Overall Study||5
8416822|NCT00925990|20745184|P2|COMPLETED|Overall Study||24
8416823|NCT00925990|20745185|P1|COMPLETED|Overall Study||30
8416824|NCT00925990|20745184|P2|STARTED|Overall Study||35
8416825|NCT00925990|20745185|P1|STARTED|Overall Study||35
8416826|NCT00925938|20745196|P3|NOT COMPLETED|Overall Study||0
8416827|NCT00925938|20745197|P2|NOT COMPLETED|Overall Study||0
8416828|NCT00925938|20745198|P1|NOT COMPLETED|Overall Study||0
8416829|NCT00925938|20745196|P3|COMPLETED|Overall Study||17
8416830|NCT00925938|20745197|P2|COMPLETED|Overall Study||25
8416831|NCT00925938|20745198|P1|COMPLETED|Overall Study||9
8416832|NCT00925938|20745196|P3|STARTED|Overall Study||17
8416833|NCT00925938|20745197|P2|STARTED|Overall Study||25
8416834|NCT00925938|20745198|P1|STARTED|Overall Study||9
8416835|NCT00925899|20745220|P2|NOT COMPLETED|Part 2||12
8416836|NCT00925899|20745221|P1|NOT COMPLETED|Part 2||6
8416837|NCT00925899|20745220|P2|COMPLETED|Part 2||9
8416838|NCT00925899|20745221|P1|COMPLETED|Part 2||9
8416839|NCT00925899|20745220|P2|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
8416840|NCT00925899|20745221|P1|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
8416841|NCT00925899|20745220|P2|NOT COMPLETED|Part 1||11
8416842|NCT00925899|20745221|P1|NOT COMPLETED|Part 1||11
8416843|NCT00925899|20745220|P2|COMPLETED|Part 1||27
8416844|NCT00925899|20745221|P1|COMPLETED|Part 1||23
8416845|NCT00925899|20745220|P2|STARTED|Part 1||38
8416846|NCT00925899|20745221|P1|STARTED|Part 1||34
8416847|NCT00925782|20745239|P2|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
8416848|NCT00925782|20745240|P1|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
8416849|NCT00925782|20745239|P2|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
8416850|NCT00925782|20745240|P1|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
8416851|NCT00925782|20745239|P2|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
8416852|NCT00925782|20745240|P1|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
8416853|NCT00925782|20745239|P2|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
8416854|NCT00925782|20745240|P1|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
8416855|NCT00925782|20745239|P2|COMPLETED|Study Period (Day -3 to Day 0)||12
8416856|NCT00925782|20745240|P1|COMPLETED|Study Period (Day -3 to Day 0)||12
8416857|NCT00925782|20745239|P2|STARTED|Study Period (Day -3 to Day 0)||12
8416858|NCT00925782|20745240|P1|STARTED|Study Period (Day -3 to Day 0)||12
8416859|NCT00925782|20745239|P2|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
8416860|NCT00925782|20745240|P1|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
8416861|NCT00925782|20745239|P2|COMPLETED|Pretreatment (Day -30 to Day -3)||12
8416862|NCT00925782|20745240|P1|COMPLETED|Pretreatment (Day -30 to Day -3)||12
8416863|NCT00925782|20745239|P2|STARTED|Pretreatment (Day -30 to Day -3)||12
8416864|NCT00925782|20745240|P1|STARTED|Pretreatment (Day -30 to Day -3)||12
8416865|NCT00925769|20745249|P6|NOT COMPLETED|Overall Study||3
8416866|NCT00925769|20745250|P5|NOT COMPLETED|Overall Study||3
8416867|NCT00925769|20745251|P4|NOT COMPLETED|Overall Study||6
8416868|NCT00925769|20745252|P3|NOT COMPLETED|Overall Study||6
8416869|NCT00925769|20745253|P2|NOT COMPLETED|Overall Study||6
8416870|NCT00925769|20745254|P1|NOT COMPLETED|Overall Study||6
8416871|NCT00925769|20745249|P6|COMPLETED|Overall Study||0
8416872|NCT00925769|20745250|P5|COMPLETED|Overall Study||0
8416873|NCT00925769|20745251|P4|COMPLETED|Overall Study||0
8416874|NCT00925769|20745252|P3|COMPLETED|Overall Study||0
8416875|NCT00925769|20745253|P2|COMPLETED|Overall Study||0
8416876|NCT00925769|20745254|P1|COMPLETED|Overall Study||0
8416877|NCT00925769|20745249|P6|STARTED|Overall Study||3
8416878|NCT00925769|20745250|P5|STARTED|Overall Study||3
8416879|NCT00925769|20745251|P4|STARTED|Overall Study||6
8416880|NCT00925769|20745252|P3|STARTED|Overall Study||6
8416881|NCT00925769|20745253|P2|STARTED|Overall Study||6
8416882|NCT00925769|20745254|P1|STARTED|Overall Study||6
8416883|NCT00925756|20745316|P1|NOT COMPLETED|Overall Study||0
8416884|NCT00925756|20745316|P1|COMPLETED|Overall Study||32
8416885|NCT00925756|20745316|P1|STARTED|Overall Study||32
8416976|NCT00925600|20745346|P2|NOT COMPLETED|Overall Study||28
8416977|NCT00925600|20745347|P1|NOT COMPLETED|Overall Study||32
8416978|NCT00925600|20745346|P2|COMPLETED|Overall Study||355
8416979|NCT00925600|20745347|P1|COMPLETED|Overall Study||354
8416980|NCT00925600|20745346|P2|Received Treatment|Overall Study||382
8416981|NCT00925600|20745347|P1|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
8416982|NCT00925600|20745346|P2|STARTED|Overall Study||383
8416983|NCT00925600|20745347|P1|STARTED|Overall Study||386
8416984|NCT00925587|20745369|P2|NOT COMPLETED|Overall Study||25
8416985|NCT00925587|20745370|P1|NOT COMPLETED|Overall Study||36
8416986|NCT00925587|20745369|P2|COMPLETED|Overall Study||155
8416987|NCT00925587|20745370|P1|COMPLETED|Overall Study||142
8416988|NCT00925587|20745369|P2|STARTED|Overall Study||180
8416989|NCT00925587|20745370|P1|STARTED|Overall Study||178
8416990|NCT00925548|20745484|P2|NOT COMPLETED|Overall Study||5
8416991|NCT00925548|20745485|P1|NOT COMPLETED|Overall Study||10
8416992|NCT00925548|20745484|P2|COMPLETED|Overall Study||0
8416993|NCT00925548|20745485|P1|COMPLETED|Overall Study||1
8416994|NCT00925548|20745484|P2|STARTED|Overall Study||5
8416995|NCT00925548|20745485|P1|STARTED|Overall Study||11
8416996|NCT00925522|20745511|P1|NOT COMPLETED|Overall Study||20
8416997|NCT00925522|20745511|P1|COMPLETED|Overall Study||0
8416998|NCT00925522|20745511|P1|STARTED|Overall Study||20
8416999|NCT00925353|20745515|P1|NOT COMPLETED|Overall Study||3
8417000|NCT00925353|20745515|P1|COMPLETED|Overall Study||10
8417001|NCT00925353|20745515|P1|STARTED|Overall Study||13
8417002|NCT00925301|20745521|P4|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
8417003|NCT00925301|20745522|P3|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
8417004|NCT00925301|20745523|P2|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
8417005|NCT00925301|20745524|P1|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
8417006|NCT00925301|20745521|P4|COMPLETED|12-Month Open-label Extension (Optional)||54
8417007|NCT00925301|20745522|P3|COMPLETED|12-Month Open-label Extension (Optional)||0
8417008|NCT00925301|20745523|P2|COMPLETED|12-Month Open-label Extension (Optional)||0
8417009|NCT00925301|20745524|P1|COMPLETED|12-Month Open-label Extension (Optional)||0
8417010|NCT00925301|20745521|P4|ITT-amenable|12-Month Open-label Extension (Optional)||42
8417011|NCT00925301|20745522|P3|ITT-amenable|12-Month Open-label Extension (Optional)||0
8417012|NCT00925301|20745523|P2|ITT-amenable|12-Month Open-label Extension (Optional)||0
8417013|NCT00925301|20745524|P1|ITT-amenable|12-Month Open-label Extension (Optional)||0
8417014|NCT00925301|20745521|P4|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
8417015|NCT00925301|20745522|P3|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
8417016|NCT00925301|20745523|P2|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
8417017|NCT00925301|20745524|P1|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
8417018|NCT00925301|20745521|P4|NOT COMPLETED|6-Month Open-label (Stage 2)||0
8417019|NCT00925301|20745522|P3|NOT COMPLETED|6-Month Open-label (Stage 2)||3
8417020|NCT00925301|20745523|P2|NOT COMPLETED|6-Month Open-label (Stage 2)||0
8417021|NCT00925301|20745524|P1|NOT COMPLETED|6-Month Open-label (Stage 2)||0
8417022|NCT00925301|20745521|P4|COMPLETED|6-Month Open-label (Stage 2)||0
8417023|NCT00925301|20745522|P3|COMPLETED|6-Month Open-label (Stage 2)||60
8417024|NCT00925301|20745523|P2|COMPLETED|6-Month Open-label (Stage 2)||0
8417025|NCT00925301|20745524|P1|COMPLETED|6-Month Open-label (Stage 2)||0
8417026|NCT00925301|20745521|P4|ITT-amenable|6-Month Open-label (Stage 2)||0
8417027|NCT00925301|20745522|P3|ITT-amenable|6-Month Open-label (Stage 2)||47
8417028|NCT00925301|20745523|P2|ITT-amenable|6-Month Open-label (Stage 2)||0
8417029|NCT00925301|20745524|P1|ITT-amenable|6-Month Open-label (Stage 2)||0
8417030|NCT00925301|20745521|P4|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
8417031|NCT00925301|20745522|P3|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
8417032|NCT00925301|20745523|P2|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
8417033|NCT00925301|20745524|P1|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
8417034|NCT00925301|20745521|P4|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
8417035|NCT00925301|20745522|P3|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
8417036|NCT00925301|20745523|P2|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
8417037|NCT00925301|20745524|P1|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
8417038|NCT00925301|20745521|P4|COMPLETED|6-Month Double-blind (Stage 1)||0
8417039|NCT00925301|20745522|P3|COMPLETED|6-Month Double-blind (Stage 1)||0
8417040|NCT00925301|20745523|P2|COMPLETED|6-Month Double-blind (Stage 1)||30
8417041|NCT00925301|20745524|P1|COMPLETED|6-Month Double-blind (Stage 1)||34
8417042|NCT00925301|20745521|P4|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
8417043|NCT00925301|20745522|P3|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
8417044|NCT00925301|20745523|P2|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
8417045|NCT00925301|20745524|P1|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
8417046|NCT00925301|20745521|P4|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
8417047|NCT00925301|20745522|P3|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
8417048|NCT00925301|20745523|P2|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
8417049|NCT00925301|20745524|P1|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
8417050|NCT00925301|20745521|P4|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
8417051|NCT00925301|20745522|P3|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
8417052|NCT00925301|20745523|P2|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
8417053|NCT00925301|20745524|P1|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
8417054|NCT00925301|20745521|P4|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
8417055|NCT00925301|20745522|P3|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
8417056|NCT00925301|20745523|P2|STARTED|6-Month Double-blind (Stage 1)||33
8417057|NCT00925301|20745524|P1|STARTED|6-Month Double-blind (Stage 1)||34
8417058|NCT00925288|20745540|P2|NOT COMPLETED|Overall Study||7
8417059|NCT00925288|20745541|P1|NOT COMPLETED|Overall Study||9
8417060|NCT00925288|20745540|P2|COMPLETED|Overall Study||93
8417061|NCT00925288|20745541|P1|COMPLETED|Overall Study||91
8417062|NCT00925288|20745540|P2|STARTED|Overall Study||100
8417063|NCT00925288|20745541|P1|STARTED|Overall Study||100
8417064|NCT00925132|20745553|P5|NOT COMPLETED|Overall Study||5
8417065|NCT00925132|20745554|P4|NOT COMPLETED|Overall Study||0
8417066|NCT00925132|20745555|P3|NOT COMPLETED|Overall Study||0
8417067|NCT00925132|20745556|P2|NOT COMPLETED|Overall Study||0
8417068|NCT00925132|20745557|P1|NOT COMPLETED|Overall Study||2
8417069|NCT00925132|20745553|P5|COMPLETED|Overall Study||17
8417070|NCT00925132|20745554|P4|COMPLETED|Overall Study||4
8417071|NCT00925132|20745555|P3|COMPLETED|Overall Study||4
8417072|NCT00925132|20745556|P2|COMPLETED|Overall Study||4
8417073|NCT00925132|20745557|P1|COMPLETED|Overall Study||3
8417074|NCT00925132|20745553|P5|STARTED|Overall Study||22
8417075|NCT00925132|20745554|P4|STARTED|Overall Study||4
8417076|NCT00925132|20745555|P3|STARTED|Overall Study||4
8417077|NCT00925132|20745556|P2|STARTED|Overall Study||4
8417078|NCT00925132|20745557|P1|STARTED|Overall Study||5
8417079|NCT00925119|20745563|P1|NOT COMPLETED|Overall Study||12
8417080|NCT00925119|20745563|P1|COMPLETED|Overall Study||19
8417081|NCT00925119|20745563|P1|STARTED|Overall Study||31
8417082|NCT00925054|20745578|P5|NOT COMPLETED|Overall Study||0
8417083|NCT00925054|20745579|P4|NOT COMPLETED|Overall Study||1
8417084|NCT00925054|20745580|P3|NOT COMPLETED|Overall Study||1
8417085|NCT00925054|20745581|P2|NOT COMPLETED|Overall Study||1
8417086|NCT00925054|20745582|P1|NOT COMPLETED|Overall Study||0
8417087|NCT00925054|20745578|P5|COMPLETED|Overall Study||10
8417088|NCT00925054|20745579|P4|COMPLETED|Overall Study||0
8417089|NCT00925054|20745580|P3|COMPLETED|Overall Study||12
8417090|NCT00925054|20745581|P2|COMPLETED|Overall Study||8
8417091|NCT00925054|20745582|P1|COMPLETED|Overall Study||7
8417092|NCT00925054|20745578|P5|STARTED|Overall Study||10
8417093|NCT00925054|20745579|P4|STARTED|Overall Study||1
8417094|NCT00925054|20745580|P3|STARTED|Overall Study||13
8417095|NCT00925054|20745581|P2|STARTED|Overall Study||9
8417096|NCT00925054|20745582|P1|STARTED|Overall Study||7
8417097|NCT00925015|20745652|P3|NOT COMPLETED|Overall Study||6
8417098|NCT00925015|20745653|P2|NOT COMPLETED|Overall Study||6
8417099|NCT00925015|20745654|P1|NOT COMPLETED|Overall Study||8
8417100|NCT00925015|20745652|P3|COMPLETED|Overall Study||0
8417101|NCT00925015|20745653|P2|COMPLETED|Overall Study||0
8417102|NCT00925015|20745654|P1|COMPLETED|Overall Study||0
8417103|NCT00925015|20745652|P3|STARTED|Overall Study||6
8417104|NCT00925015|20745653|P2|STARTED|Overall Study||6
8417105|NCT00925015|20745654|P1|STARTED|Overall Study||8
8417106|NCT00924950|20745710|P1|NOT COMPLETED|Overall Study||2
8417107|NCT00924950|20745710|P1|COMPLETED|Overall Study||28
8417108|NCT00924950|20745710|P1|STARTED|Overall Study||30
8417109|NCT00924898|20745717|P1|NOT COMPLETED|Overall Study||2
8417110|NCT00924898|20745717|P1|COMPLETED|Overall Study||90
8417111|NCT00924898|20745717|P1|STARTED|Overall Study||92
8417112|NCT00924885|20745728|P2|NOT COMPLETED|Overall Study||4
8417113|NCT00924885|20745729|P1|NOT COMPLETED|Overall Study||3
8417114|NCT00924885|20745728|P2|COMPLETED|Overall Study||124
8417115|NCT00924885|20745729|P1|COMPLETED|Overall Study||126
8417116|NCT00924885|20745728|P2|STARTED|Overall Study||128
8417117|NCT00924885|20745729|P1|STARTED|Overall Study||129
8417118|NCT00924833|20745740|P3|NOT COMPLETED|Overall Study||0
8417119|NCT00924833|20745741|P2|NOT COMPLETED|Overall Study||0
8417120|NCT00924833|20745742|P1|NOT COMPLETED|Overall Study||0
8417121|NCT00924833|20745740|P3|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
8417122|NCT00924833|20745741|P2|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
8417123|NCT00924833|20745742|P1|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
8417124|NCT00924833|20745740|P3|STARTED|Overall Study||9
8417125|NCT00924833|20745741|P2|STARTED|Overall Study||9
8417126|NCT00924833|20745742|P1|STARTED|Overall Study||9
8417127|NCT00924820|20745756|P1|NOT COMPLETED|Overall Study||7
8417128|NCT00924820|20745756|P1|COMPLETED|Overall Study||13
8417129|NCT00924820|20745756|P1|STARTED|Overall Study||20
8417130|NCT00924807|20745762|P1|NOT COMPLETED|Overall Study||0
8417131|NCT00924807|20745762|P1|COMPLETED|Overall Study||4
8417132|NCT00924807|20745762|P1|STARTED|Overall Study||4
8417133|NCT00924781|20745771|P2|NOT COMPLETED|Overall Study||10
8417134|NCT00924781|20745772|P1|NOT COMPLETED|Overall Study||12
8417135|NCT00924781|20745771|P2|COMPLETED|Overall Study||9
8417136|NCT00924781|20745772|P1|COMPLETED|Overall Study||8
8417137|NCT00924781|20745771|P2|STARTED|Overall Study||19
8417138|NCT00924781|20745772|P1|STARTED|Overall Study||20
8417139|NCT00924729|20745806|P2|NOT COMPLETED|Overall Study||0
8417140|NCT00924729|20745807|P1|NOT COMPLETED|Overall Study||2
8417141|NCT00924729|20745806|P2|COMPLETED|Overall Study||25
8417142|NCT00924729|20745807|P1|COMPLETED|Overall Study||23
8417143|NCT00924729|20745806|P2|STARTED|Overall Study||25
8417144|NCT00924729|20745807|P1|STARTED|Overall Study||25
8417145|NCT00924651|20745817|P2|NOT COMPLETED|Overall Study||25
8417146|NCT00924651|20745818|P1|NOT COMPLETED|Overall Study||25
8417147|NCT00924651|20745817|P2|COMPLETED|Overall Study||312
8417148|NCT00924651|20745818|P1|COMPLETED|Overall Study||331
8417149|NCT00924651|20745817|P2|STARTED|Overall Study||337
8417150|NCT00924651|20745818|P1|STARTED|Overall Study||356
8417151|NCT00924638|20745826|P2|NOT COMPLETED|Overall Study||13
8417152|NCT00924638|20745827|P1|NOT COMPLETED|Overall Study||12
8417153|NCT00924638|20745826|P2|COMPLETED|Overall Study|Completed 6 months of follow-up|207
8417154|NCT00924638|20745827|P1|COMPLETED|Overall Study|Completed 6 months of follow-up|209
8417155|NCT00924638|20745826|P2|STARTED|Overall Study|Randomized to Control Arm|220
8417156|NCT00924638|20745827|P1|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
8417157|NCT00924612|20745846|P4|NOT COMPLETED|Overall Study||0
8417158|NCT00924612|20745847|P3|NOT COMPLETED|Overall Study||0
8417159|NCT00924612|20745848|P2|NOT COMPLETED|Overall Study||0
8417160|NCT00924612|20745849|P1|NOT COMPLETED|Overall Study||0
8417161|NCT00924612|20745846|P4|COMPLETED|Overall Study||4
8417162|NCT00924612|20745847|P3|COMPLETED|Overall Study||4
8417163|NCT00924612|20745848|P2|COMPLETED|Overall Study||4
8417164|NCT00924612|20745849|P1|COMPLETED|Overall Study||4
8417165|NCT00924612|20745846|P4|STARTED|Overall Study||4
8417166|NCT00924612|20745847|P3|STARTED|Overall Study||4
8417167|NCT00924612|20745848|P2|STARTED|Overall Study||4
8417168|NCT00924612|20745849|P1|STARTED|Overall Study||4
8417169|NCT00924560|20745864|P3|NOT COMPLETED|Overall Study||83
8417170|NCT00924560|20745865|P2|NOT COMPLETED|Overall Study||208
8417171|NCT00924560|20745866|P1|NOT COMPLETED|Overall Study||211
8417172|NCT00924560|20745864|P3|COMPLETED|Overall Study||372
8417173|NCT00924560|20745865|P2|COMPLETED|Overall Study||240
8417174|NCT00924560|20745866|P1|COMPLETED|Overall Study||247
8417175|NCT00924560|20745864|P3|Received Treatment|Overall Study||0
8417176|NCT00924560|20745865|P2|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
8417177|NCT00924560|20745866|P1|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
8417178|NCT00924560|20745864|P3|STARTED|Overall Study||455
8417179|NCT00924560|20745865|P2|STARTED|Overall Study||448
8417180|NCT00924560|20745866|P1|STARTED|Overall Study||458
8417181|NCT00924508|20745910|P1|NOT COMPLETED|Overall Study||3
8417182|NCT00924508|20745910|P1|COMPLETED|Overall Study||20
8417183|NCT00924508|20745910|P1|STARTED|Overall Study||23
8417184|NCT00924482|20745917|P1|NOT COMPLETED|Overall Study||0
8417185|NCT00924482|20745917|P1|COMPLETED|Overall Study||261
8417186|NCT00924482|20745917|P1|STARTED|Overall Study||261
8417187|NCT00924469|20745924|P2|NOT COMPLETED|Overall Study||2
8417188|NCT00924469|20745925|P1|NOT COMPLETED|Overall Study||2
8417189|NCT00924469|20745924|P2|COMPLETED|Overall Study||26
8417190|NCT00924469|20745925|P1|COMPLETED|Overall Study||28
8417191|NCT00924469|20745924|P2|STARTED|Overall Study||28
8417192|NCT00924469|20745925|P1|STARTED|Overall Study||30
8417193|NCT00924443|20745947|P1|NOT COMPLETED|Overall Study||3
8417194|NCT00924443|20745947|P1|COMPLETED|Overall Study||66
8417195|NCT00924443|20745947|P1|Full Analysis Set (Received Study Drug)|Overall Study||66
8417196|NCT00924443|20745947|P1|STARTED|Overall Study||69
8417197|NCT00924404|20745957|P2|NOT COMPLETED|Overall Study||4
8417198|NCT00924404|20745958|P1|NOT COMPLETED|Overall Study||6
8417199|NCT00924404|20745957|P2|COMPLETED|Overall Study||22
8417200|NCT00924404|20745958|P1|COMPLETED|Overall Study||21
8417201|NCT00924404|20745957|P2|STARTED|Overall Study||26
8417202|NCT00924404|20745958|P1|STARTED|Overall Study||27
8417203|NCT00924352|20745966|P2|NOT COMPLETED|Overall Study||0
8417204|NCT00924352|20745967|P1|NOT COMPLETED|Overall Study||0
8417205|NCT00924352|20745966|P2|COMPLETED|Overall Study||44
8417206|NCT00924352|20745967|P1|COMPLETED|Overall Study||12
8417207|NCT00924352|20745966|P2|STARTED|Overall Study||44
8417208|NCT00924352|20745967|P1|STARTED|Overall Study||12
8417263|NCT00924313|20746029|P1|NOT COMPLETED|Overall Study||1
8417264|NCT00924313|20746029|P1|COMPLETED|Overall Study||39
8417265|NCT00924313|20746029|P1|STARTED|Overall Study||40
8417266|NCT00924287|20746041|P1|NOT COMPLETED|Overall Study||1
8417267|NCT00924287|20746041|P1|COMPLETED|Overall Study||0
8417268|NCT00924287|20746041|P1|STARTED|Overall Study||1
8417269|NCT00924209|20746047|P1|NOT COMPLETED|Overall Study||0
8417270|NCT00924209|20746047|P1|COMPLETED|Overall Study||7
8417271|NCT00924209|20746047|P1|STARTED|Overall Study||7
8417278|NCT00924118|20746098|P2|NOT COMPLETED|Overall Study||0
8417279|NCT00924118|20746099|P1|NOT COMPLETED|Overall Study||0
8417280|NCT00924118|20746098|P2|COMPLETED|Overall Study||15
8417281|NCT00924118|20746099|P1|COMPLETED|Overall Study||15
8417282|NCT00924118|20746098|P2|STARTED|Overall Study||15
8417283|NCT00924118|20746099|P1|STARTED|Overall Study||15
8417284|NCT00924066|20746107|P1|NOT COMPLETED|Overall Study||0
8417285|NCT00924066|20746107|P1|COMPLETED|Overall Study||41
8417286|NCT00924066|20746107|P1|STARTED|Overall Study||41
8417287|NCT00924053|20746116|P4|NOT COMPLETED|Overall Study||0
8417288|NCT00924053|20746117|P3|NOT COMPLETED|Overall Study||0
8417289|NCT00924053|20746118|P2|NOT COMPLETED|Overall Study||0
8417290|NCT00924053|20746119|P1|NOT COMPLETED|Overall Study||0
8417291|NCT00924053|20746116|P4|COMPLETED|Overall Study||6
8417292|NCT00924053|20746117|P3|COMPLETED|Overall Study||6
8417293|NCT00924053|20746118|P2|COMPLETED|Overall Study||6
8417294|NCT00924053|20746119|P1|COMPLETED|Overall Study||6
8417295|NCT00924053|20746116|P4|STARTED|Overall Study||6
8417296|NCT00924053|20746117|P3|STARTED|Overall Study||6
8417297|NCT00924053|20746118|P2|STARTED|Overall Study||6
8417298|NCT00924053|20746119|P1|STARTED|Overall Study||6
8417299|NCT00924040|20746165|P1|NOT COMPLETED|Overall Study||0
8417300|NCT00924040|20746165|P1|COMPLETED|Overall Study||1
8417301|NCT00924040|20746165|P1|STARTED|Overall Study||1
8417302|NCT00924001|20746177|P1|NOT COMPLETED|Overall Study||0
8417303|NCT00924001|20746177|P1|COMPLETED|Overall Study||1
8417304|NCT00924001|20746177|P1|STARTED|Overall Study||1
8417305|NCT00923975|20746183|P1|NOT COMPLETED|Overall Study||1
8417306|NCT00923975|20746183|P1|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
8417307|NCT00923975|20746183|P1|STARTED|Overall Study||51
8417308|NCT00923949|20746190|P1|NOT COMPLETED|Overall Study||0
8417309|NCT00923949|20746190|P1|COMPLETED|Overall Study||1
8417310|NCT00923949|20746190|P1|STARTED|Overall Study||1
8417311|NCT00923936|20746202|P2|NOT COMPLETED|Overall Study||3
8417312|NCT00923936|20746203|P1|NOT COMPLETED|Overall Study||8
8417313|NCT00923936|20746202|P2|COMPLETED|Overall Study||3
8417314|NCT00923936|20746203|P1|COMPLETED|Overall Study||2
8417315|NCT00923936|20746202|P2|STARTED|Overall Study||6
8417316|NCT00923936|20746203|P1|STARTED|Overall Study||10
8417317|NCT00923910|20746219|P2|NOT COMPLETED|Period 2||0
8417318|NCT00923910|20746220|P1|NOT COMPLETED|Period 2||0
8417319|NCT00923910|20746219|P2|COMPLETED|Period 2||5
8417320|NCT00923910|20746220|P1|COMPLETED|Period 2||5
8417321|NCT00923910|20746219|P2|STARTED|Period 2||5
8417322|NCT00923910|20746220|P1|STARTED|Period 2||5
8417323|NCT00923910|20746219|P2|NOT COMPLETED|Period 1||0
8417324|NCT00923910|20746220|P1|NOT COMPLETED|Period 1||0
8417325|NCT00923910|20746219|P2|COMPLETED|Period 1||5
8417326|NCT00923910|20746220|P1|COMPLETED|Period 1||5
8417327|NCT00923910|20746219|P2|STARTED|Period 1||5
8417328|NCT00923910|20746220|P1|STARTED|Period 1||5
8417329|NCT00923845|20746232|P2|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
8417330|NCT00923845|20746233|P1|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
8417331|NCT00923845|20746232|P2|COMPLETED|Allogeneic Stem Cell Therapy||10
8417332|NCT00923845|20746233|P1|COMPLETED|Allogeneic Stem Cell Therapy||0
8417333|NCT00923845|20746232|P2|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
8417334|NCT00923845|20746233|P1|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
8417335|NCT00923845|20746232|P2|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
8417336|NCT00923845|20746233|P1|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
8417337|NCT00923845|20746232|P2|STARTED|Allogeneic Stem Cell Therapy||10
8417338|NCT00923845|20746233|P1|STARTED|Allogeneic Stem Cell Therapy||0
8417339|NCT00923845|20746232|P2|NOT COMPLETED|Induction Therapy||2
8417340|NCT00923845|20746233|P1|NOT COMPLETED|Induction Therapy||0
8417341|NCT00923845|20746232|P2|COMPLETED|Induction Therapy||10
8417342|NCT00923845|20746233|P1|COMPLETED|Induction Therapy||0
8417343|NCT00923845|20746232|P2|STARTED|Induction Therapy||12
8417344|NCT00923845|20746233|P1|STARTED|Induction Therapy||0
8417345|NCT00923845|20746232|P2|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
8417346|NCT00923845|20746233|P1|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
8417347|NCT00923845|20746232|P2|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
8417348|NCT00923845|20746233|P1|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
8417349|NCT00923845|20746232|P2|STARTED|Donor Hematopoietic Stem Cell Harvest||0
8417350|NCT00923845|20746233|P1|STARTED|Donor Hematopoietic Stem Cell Harvest||13
8417351|NCT00923845|20746232|P2|NOT COMPLETED|Donor Lymphocyte Harvest||0
8417352|NCT00923845|20746233|P1|NOT COMPLETED|Donor Lymphocyte Harvest||0
8417353|NCT00923845|20746232|P2|COMPLETED|Donor Lymphocyte Harvest||0
8417354|NCT00923845|20746233|P1|COMPLETED|Donor Lymphocyte Harvest||13
8417355|NCT00923845|20746232|P2|STARTED|Donor Lymphocyte Harvest||0
8417356|NCT00923845|20746233|P1|STARTED|Donor Lymphocyte Harvest||13
8417357|NCT00923598|20746256|P2|NOT COMPLETED|Overall Study||5
8417358|NCT00923598|20746257|P1|NOT COMPLETED|Overall Study||4
8417359|NCT00923598|20746256|P2|COMPLETED|Overall Study||17
8417360|NCT00923598|20746257|P1|COMPLETED|Overall Study||19
8417361|NCT00923598|20746256|P2|STARTED|Overall Study||22
8417362|NCT00923598|20746257|P1|STARTED|Overall Study||23
8417363|NCT00923481|20746263|P1|NOT COMPLETED|Overall Study||0
8417364|NCT00923481|20746263|P1|COMPLETED|Overall Study||37
8417365|NCT00923481|20746263|P1|STARTED|Overall Study||37
8417366|NCT00923364|20746268|P2|NOT COMPLETED|Overall Study||0
8417367|NCT00923364|20746269|P1|NOT COMPLETED|Overall Study||4
8417368|NCT00923364|20746268|P2|COMPLETED|Overall Study||5
8417369|NCT00923364|20746269|P1|COMPLETED|Overall Study||10
8417370|NCT00923364|20746268|P2|STARTED|Overall Study||5
8417371|NCT00923364|20746269|P1|STARTED|Overall Study||14
8417372|NCT00923351|20746281|P3|NOT COMPLETED|Overall Study||12
8417373|NCT00923351|20746282|P2|NOT COMPLETED|Overall Study||0
8417374|NCT00923351|20746283|P1|NOT COMPLETED|Overall Study||0
8417375|NCT00923351|20746281|P3|COMPLETED|Overall Study||0
8417376|NCT00923351|20746282|P2|COMPLETED|Overall Study||26
8417377|NCT00923351|20746283|P1|COMPLETED|Overall Study||6
8417378|NCT00923351|20746281|P3|STARTED|Overall Study||12
8417379|NCT00923351|20746282|P2|STARTED|Overall Study||26
8417380|NCT00923351|20746283|P1|STARTED|Overall Study||6
8417381|NCT00923273|20746298|P5|NOT COMPLETED|Phase II Treatment Period||0
8417382|NCT00923273|20746299|P4|NOT COMPLETED|Phase II Treatment Period||7
8417383|NCT00923273|20746300|P3|NOT COMPLETED|Phase II Treatment Period||0
8417384|NCT00923273|20746301|P2|NOT COMPLETED|Phase II Treatment Period||0
8417385|NCT00923273|20746302|P1|NOT COMPLETED|Phase II Treatment Period||0
8417386|NCT00923273|20746298|P5|COMPLETED|Phase II Treatment Period||0
8417387|NCT00923273|20746299|P4|COMPLETED|Phase II Treatment Period||20
8417388|NCT00923273|20746300|P3|COMPLETED|Phase II Treatment Period||0
8417389|NCT00923273|20746301|P2|COMPLETED|Phase II Treatment Period||0
8417390|NCT00923273|20746302|P1|COMPLETED|Phase II Treatment Period||0
8417391|NCT00923273|20746298|P5|STARTED|Phase II Treatment Period||0
8417392|NCT00923273|20746299|P4|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
8417393|NCT00923273|20746300|P3|STARTED|Phase II Treatment Period||0
8417394|NCT00923273|20746301|P2|STARTED|Phase II Treatment Period||0
8417395|NCT00923273|20746302|P1|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
8417396|NCT00923273|20746298|P5|NOT COMPLETED|Phase I Treatment Period||0
8417397|NCT00923273|20746299|P4|NOT COMPLETED|Phase I Treatment Period||0
8417398|NCT00923273|20746300|P3|NOT COMPLETED|Phase I Treatment Period||0
8417399|NCT00923273|20746301|P2|NOT COMPLETED|Phase I Treatment Period||0
8417400|NCT00923273|20746302|P1|NOT COMPLETED|Phase I Treatment Period||0
8417401|NCT00923273|20746298|P5|COMPLETED|Phase I Treatment Period||5
8417402|NCT00923273|20746299|P4|COMPLETED|Phase I Treatment Period||7
8417403|NCT00923273|20746300|P3|COMPLETED|Phase I Treatment Period||3
8417404|NCT00923273|20746301|P2|COMPLETED|Phase I Treatment Period||3
8417405|NCT00923273|20746302|P1|COMPLETED|Phase I Treatment Period||4
8417406|NCT00923273|20746298|P5|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
8417407|NCT00923273|20746299|P4|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
8417408|NCT00923273|20746300|P3|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
8417409|NCT00923273|20746301|P2|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
8417410|NCT00923273|20746302|P1|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
8417411|NCT00923260|20746327|P2|NOT COMPLETED|Overall Study||1
8417412|NCT00923260|20746328|P1|NOT COMPLETED|Overall Study||1
8417413|NCT00923260|20746327|P2|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
8417414|NCT00923260|20746328|P1|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
8417415|NCT00923260|20746327|P2|STARTED|Overall Study||12
8417416|NCT00923260|20746328|P1|STARTED|Overall Study||12
8417417|NCT00923247|20746462|P2|NOT COMPLETED|Overall Study||0
8417418|NCT00923247|20746463|P1|NOT COMPLETED|Overall Study||0
8417419|NCT00923247|20746462|P2|COMPLETED|Overall Study||1
8417420|NCT00923247|20746463|P1|COMPLETED|Overall Study||21
8417421|NCT00923247|20746462|P2|STARTED|Overall Study||1
8417422|NCT00923247|20746463|P1|STARTED|Overall Study||21
8417423|NCT00923195|20746491|P2|NOT COMPLETED|Overall Study||1
8417424|NCT00923195|20746492|P1|NOT COMPLETED|Overall Study||0
8417425|NCT00923195|20746491|P2|COMPLETED|Overall Study||1
8417426|NCT00923195|20746492|P1|COMPLETED|Overall Study||2
8417427|NCT00923195|20746491|P2|STARTED|Overall Study||2
8417428|NCT00923195|20746492|P1|STARTED|Overall Study||2
8417429|NCT00923156|20746503|P3|NOT COMPLETED|Overall Study||3
8417430|NCT00923156|20746504|P2|NOT COMPLETED|Overall Study||4
8417431|NCT00923156|20746505|P1|NOT COMPLETED|Overall Study||0
8417432|NCT00923156|20746503|P3|COMPLETED|Overall Study||38
8417433|NCT00923156|20746504|P2|COMPLETED|Overall Study||38
8417434|NCT00923156|20746505|P1|COMPLETED|Overall Study||40
8417435|NCT00923156|20746503|P3|STARTED|Overall Study||41
8417436|NCT00923156|20746504|P2|STARTED|Overall Study||42
8417437|NCT00923156|20746505|P1|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
8417438|NCT00923130|20746531|P1|NOT COMPLETED|Overall Study||25
8417439|NCT00923130|20746531|P1|COMPLETED|Overall Study||5
8417440|NCT00923130|20746531|P1|STARTED|Overall Study||30
8417441|NCT00923117|20746549|P2|NOT COMPLETED|Overall Study||0
8417442|NCT00923117|20746550|P1|NOT COMPLETED|Overall Study||0
8417443|NCT00923117|20746549|P2|COMPLETED|Overall Study||43
8417444|NCT00923117|20746550|P1|COMPLETED|Overall Study||44
8417445|NCT00923117|20746549|P2|STARTED|Overall Study||43
8417446|NCT00923117|20746550|P1|STARTED|Overall Study||44
8417447|NCT00923091|20746566|P13|NOT COMPLETED|Period VI (Open-Label)||0
8417448|NCT00923091|20746567|P12|NOT COMPLETED|Period VI (Open-Label)||0
8417449|NCT00923091|20746568|P11|NOT COMPLETED|Period VI (Open-Label)||0
8417450|NCT00923091|20746569|P10|NOT COMPLETED|Period VI (Open-Label)||0
8417451|NCT00923091|20746570|P9|NOT COMPLETED|Period VI (Open-Label)||0
8417452|NCT00923091|20746571|P8|NOT COMPLETED|Period VI (Open-Label)||0
8417453|NCT00923091|20746572|P7|NOT COMPLETED|Period VI (Open-Label)||0
8417454|NCT00923091|20746573|P6|NOT COMPLETED|Period VI (Open-Label)||0
8417455|NCT00923091|20746574|P5|NOT COMPLETED|Period VI (Open-Label)||7
8417456|NCT00923091|20746575|P4|NOT COMPLETED|Period VI (Open-Label)||3
8417457|NCT00923091|20746576|P3|NOT COMPLETED|Period VI (Open-Label)||13
8417458|NCT00923091|20746577|P2|NOT COMPLETED|Period VI (Open-Label)||8
8417459|NCT00923091|20746578|P1|NOT COMPLETED|Period VI (Open-Label)||39
8417460|NCT00923091|20746566|P13|COMPLETED|Period VI (Open-Label)||0
8417461|NCT00923091|20746567|P12|COMPLETED|Period VI (Open-Label)||0
8417462|NCT00923091|20746568|P11|COMPLETED|Period VI (Open-Label)||0
8417463|NCT00923091|20746569|P10|COMPLETED|Period VI (Open-Label)||0
8417464|NCT00923091|20746570|P9|COMPLETED|Period VI (Open-Label)||0
8417465|NCT00923091|20746571|P8|COMPLETED|Period VI (Open-Label)||0
8417466|NCT00923091|20746572|P7|COMPLETED|Period VI (Open-Label)||0
8417467|NCT00923091|20746573|P6|COMPLETED|Period VI (Open-Label)||0
8417468|NCT00923091|20746574|P5|COMPLETED|Period VI (Open-Label)||157
8417469|NCT00923091|20746575|P4|COMPLETED|Period VI (Open-Label)||143
8417470|NCT00923091|20746576|P3|COMPLETED|Period VI (Open-Label)||467
8417471|NCT00923091|20746577|P2|COMPLETED|Period VI (Open-Label)||264
8417472|NCT00923091|20746578|P1|COMPLETED|Period VI (Open-Label)||1408
8417473|NCT00923091|20746566|P13|STARTED|Period VI (Open-Label)||0
8417474|NCT00923091|20746567|P12|STARTED|Period VI (Open-Label)||0
8417475|NCT00923091|20746568|P11|STARTED|Period VI (Open-Label)||0
8417476|NCT00923091|20746569|P10|STARTED|Period VI (Open-Label)||0
8417477|NCT00923091|20746570|P9|STARTED|Period VI (Open-Label)||0
8417478|NCT00923091|20746571|P8|STARTED|Period VI (Open-Label)||0
8417479|NCT00923091|20746572|P7|STARTED|Period VI (Open-Label)||0
8417480|NCT00923091|20746573|P6|STARTED|Period VI (Open-Label)||0
8417481|NCT00923091|20746574|P5|STARTED|Period VI (Open-Label)||164
8417482|NCT00923091|20746575|P4|STARTED|Period VI (Open-Label)||146
8417483|NCT00923091|20746576|P3|STARTED|Period VI (Open-Label)||480
8417484|NCT00923091|20746577|P2|STARTED|Period VI (Open-Label)||272
8417485|NCT00923091|20746578|P1|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
8417486|NCT00923091|20746566|P13|NOT COMPLETED|Period V (Double -Blind)||2
8417487|NCT00923091|20746567|P12|NOT COMPLETED|Period V (Double -Blind)||0
8417488|NCT00923091|20746568|P11|NOT COMPLETED|Period V (Double -Blind)||1
8417489|NCT00923091|20746569|P10|NOT COMPLETED|Period V (Double -Blind)||0
8417490|NCT00923091|20746570|P9|NOT COMPLETED|Period V (Double -Blind)||1
8417491|NCT00923091|20746571|P8|NOT COMPLETED|Period V (Double -Blind)||0
8417492|NCT00923091|20746572|P7|NOT COMPLETED|Period V (Double -Blind)||0
8417493|NCT00923091|20746573|P6|NOT COMPLETED|Period V (Double -Blind)||0
8417494|NCT00923091|20746574|P5|NOT COMPLETED|Period V (Double -Blind)||0
8417495|NCT00923091|20746575|P4|NOT COMPLETED|Period V (Double -Blind)||0
8417496|NCT00923091|20746576|P3|NOT COMPLETED|Period V (Double -Blind)||0
8417497|NCT00923091|20746577|P2|NOT COMPLETED|Period V (Double -Blind)||0
8417498|NCT00923091|20746578|P1|NOT COMPLETED|Period V (Double -Blind)||0
8417499|NCT00923091|20746566|P13|COMPLETED|Period V (Double -Blind)||73
8417500|NCT00923091|20746567|P12|COMPLETED|Period V (Double -Blind)||151
8417501|NCT00923091|20746568|P11|COMPLETED|Period V (Double -Blind)||193
8417502|NCT00923091|20746569|P10|COMPLETED|Period V (Double -Blind)||119
8417503|NCT00923091|20746570|P9|COMPLETED|Period V (Double -Blind)||134
8417504|NCT00923091|20746571|P8|COMPLETED|Period V (Double -Blind)||0
8417505|NCT00923091|20746572|P7|COMPLETED|Period V (Double -Blind)||0
8417506|NCT00923091|20746573|P6|COMPLETED|Period V (Double -Blind)||0
8417507|NCT00923091|20746574|P5|COMPLETED|Period V (Double -Blind)||0
8417508|NCT00923091|20746575|P4|COMPLETED|Period V (Double -Blind)||0
8417509|NCT00923091|20746576|P3|COMPLETED|Period V (Double -Blind)||0
8417510|NCT00923091|20746577|P2|COMPLETED|Period V (Double -Blind)||0
8417511|NCT00923091|20746578|P1|COMPLETED|Period V (Double -Blind)||0
8417512|NCT00923091|20746566|P13|STARTED|Period V (Double -Blind)||75
8417513|NCT00923091|20746567|P12|STARTED|Period V (Double -Blind)||151
8417514|NCT00923091|20746568|P11|STARTED|Period V (Double -Blind)||194
8417515|NCT00923091|20746569|P10|STARTED|Period V (Double -Blind)||119
8417516|NCT00923091|20746570|P9|STARTED|Period V (Double -Blind)||135
8417517|NCT00923091|20746571|P8|STARTED|Period V (Double -Blind)||0
8417518|NCT00923091|20746572|P7|STARTED|Period V (Double -Blind)||0
8417519|NCT00923091|20746573|P6|STARTED|Period V (Double -Blind)||0
8417520|NCT00923091|20746574|P5|STARTED|Period V (Double -Blind)||0
8417521|NCT00923091|20746575|P4|STARTED|Period V (Double -Blind)||0
8417522|NCT00923091|20746576|P3|STARTED|Period V (Double -Blind)||0
8417523|NCT00923091|20746577|P2|STARTED|Period V (Double -Blind)||0
8417524|NCT00923091|20746578|P1|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
8417525|NCT00923091|20746566|P13|NOT COMPLETED|Period IV (Double-Blind)||0
8417526|NCT00923091|20746567|P12|NOT COMPLETED|Period IV (Double-Blind)||0
8417527|NCT00923091|20746568|P11|NOT COMPLETED|Period IV (Double-Blind)||0
8417528|NCT00923091|20746569|P10|NOT COMPLETED|Period IV (Double-Blind)||0
8417529|NCT00923091|20746570|P9|NOT COMPLETED|Period IV (Double-Blind)||0
8417530|NCT00923091|20746571|P8|NOT COMPLETED|Period IV (Double-Blind)||0
8417531|NCT00923091|20746572|P7|NOT COMPLETED|Period IV (Double-Blind)||0
8417532|NCT00923091|20746573|P6|NOT COMPLETED|Period IV (Double-Blind)||0
8417533|NCT00923091|20746574|P5|NOT COMPLETED|Period IV (Double-Blind)||0
8417534|NCT00923091|20746575|P4|NOT COMPLETED|Period IV (Double-Blind)||0
8417535|NCT00923091|20746576|P3|NOT COMPLETED|Period IV (Double-Blind)||0
8417536|NCT00923091|20746577|P2|NOT COMPLETED|Period IV (Double-Blind)||2
8417537|NCT00923091|20746578|P1|NOT COMPLETED|Period IV (Double-Blind)||2
8417538|NCT00923091|20746566|P13|COMPLETED|Period IV (Double-Blind)||0
8417539|NCT00923091|20746567|P12|COMPLETED|Period IV (Double-Blind)||0
8417540|NCT00923091|20746568|P11|COMPLETED|Period IV (Double-Blind)||0
8417541|NCT00923091|20746569|P10|COMPLETED|Period IV (Double-Blind)||0
8417542|NCT00923091|20746570|P9|COMPLETED|Period IV (Double-Blind)||0
8417543|NCT00923091|20746571|P8|COMPLETED|Period IV (Double-Blind)||0
8417544|NCT00923091|20746572|P7|COMPLETED|Period IV (Double-Blind)||0
8417545|NCT00923091|20746573|P6|COMPLETED|Period IV (Double-Blind)||0
8417546|NCT00923091|20746574|P5|COMPLETED|Period IV (Double-Blind)||0
8417547|NCT00923091|20746575|P4|COMPLETED|Period IV (Double-Blind)||0
8417548|NCT00923091|20746576|P3|COMPLETED|Period IV (Double-Blind)||0
8417549|NCT00923091|20746577|P2|COMPLETED|Period IV (Double-Blind)||451
8417550|NCT00923091|20746578|P1|COMPLETED|Period IV (Double-Blind)||226
8417551|NCT00923091|20746566|P13|STARTED|Period IV (Double-Blind)||0
8417552|NCT00923091|20746567|P12|STARTED|Period IV (Double-Blind)||0
8417553|NCT00923091|20746568|P11|STARTED|Period IV (Double-Blind)||0
8417554|NCT00923091|20746569|P10|STARTED|Period IV (Double-Blind)||0
8417555|NCT00923091|20746570|P9|STARTED|Period IV (Double-Blind)||0
8417556|NCT00923091|20746571|P8|STARTED|Period IV (Double-Blind)||0
8417557|NCT00923091|20746572|P7|STARTED|Period IV (Double-Blind)||0
8417558|NCT00923091|20746573|P6|STARTED|Period IV (Double-Blind)||0
8417559|NCT00923091|20746574|P5|STARTED|Period IV (Double-Blind)||0
8417560|NCT00923091|20746575|P4|STARTED|Period IV (Double-Blind)||0
8417561|NCT00923091|20746576|P3|STARTED|Period IV (Double-Blind)||0
8417562|NCT00923091|20746577|P2|STARTED|Period IV (Double-Blind)||453
8417563|NCT00923091|20746578|P1|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
8417564|NCT00923091|20746566|P13|NOT COMPLETED|Period III (Single-Blind)||0
8417565|NCT00923091|20746567|P12|NOT COMPLETED|Period III (Single-Blind)||0
8417566|NCT00923091|20746568|P11|NOT COMPLETED|Period III (Single-Blind)||0
8417567|NCT00923091|20746569|P10|NOT COMPLETED|Period III (Single-Blind)||0
8417568|NCT00923091|20746570|P9|NOT COMPLETED|Period III (Single-Blind)||0
8417569|NCT00923091|20746571|P8|NOT COMPLETED|Period III (Single-Blind)||0
8417570|NCT00923091|20746572|P7|NOT COMPLETED|Period III (Single-Blind)||0
8417571|NCT00923091|20746573|P6|NOT COMPLETED|Period III (Single-Blind)||0
8417572|NCT00923091|20746574|P5|NOT COMPLETED|Period III (Single-Blind)||0
8417573|NCT00923091|20746575|P4|NOT COMPLETED|Period III (Single-Blind)||0
8417574|NCT00923091|20746576|P3|NOT COMPLETED|Period III (Single-Blind)||0
8417575|NCT00923091|20746577|P2|NOT COMPLETED|Period III (Single-Blind)||0
8417576|NCT00923091|20746578|P1|NOT COMPLETED|Period III (Single-Blind)||20
8417577|NCT00923091|20746566|P13|COMPLETED|Period III (Single-Blind)||0
8417578|NCT00923091|20746567|P12|COMPLETED|Period III (Single-Blind)||0
8417579|NCT00923091|20746568|P11|COMPLETED|Period III (Single-Blind)||0
8417580|NCT00923091|20746569|P10|COMPLETED|Period III (Single-Blind)||0
8417581|NCT00923091|20746570|P9|COMPLETED|Period III (Single-Blind)||0
8417582|NCT00923091|20746571|P8|COMPLETED|Period III (Single-Blind)||0
8417583|NCT00923091|20746572|P7|COMPLETED|Period III (Single-Blind)||0
8417584|NCT00923091|20746573|P6|COMPLETED|Period III (Single-Blind)||0
8417585|NCT00923091|20746574|P5|COMPLETED|Period III (Single-Blind)||0
8417586|NCT00923091|20746575|P4|COMPLETED|Period III (Single-Blind)||0
8417587|NCT00923091|20746576|P3|COMPLETED|Period III (Single-Blind)||0
8417588|NCT00923091|20746577|P2|COMPLETED|Period III (Single-Blind)||0
8417589|NCT00923091|20746578|P1|COMPLETED|Period III (Single-Blind)||2520
8417590|NCT00923091|20746566|P13|STARTED|Period III (Single-Blind)||0
8417591|NCT00923091|20746567|P12|STARTED|Period III (Single-Blind)||0
8417592|NCT00923091|20746568|P11|STARTED|Period III (Single-Blind)||0
8417593|NCT00923091|20746569|P10|STARTED|Period III (Single-Blind)||0
8417594|NCT00923091|20746570|P9|STARTED|Period III (Single-Blind)||0
8417595|NCT00923091|20746571|P8|STARTED|Period III (Single-Blind)||0
8417596|NCT00923091|20746572|P7|STARTED|Period III (Single-Blind)||0
8417597|NCT00923091|20746573|P6|STARTED|Period III (Single-Blind)||0
8417598|NCT00923091|20746574|P5|STARTED|Period III (Single-Blind)||0
8417599|NCT00923091|20746575|P4|STARTED|Period III (Single-Blind)||0
8417600|NCT00923091|20746576|P3|STARTED|Period III (Single-Blind)||0
8417601|NCT00923091|20746577|P2|STARTED|Period III (Single-Blind)||0
8417602|NCT00923091|20746578|P1|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
8417603|NCT00923091|20746566|P13|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417604|NCT00923091|20746567|P12|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417605|NCT00923091|20746568|P11|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417606|NCT00923091|20746569|P10|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417607|NCT00923091|20746570|P9|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417608|NCT00923091|20746571|P8|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
8417609|NCT00923091|20746572|P7|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
8417610|NCT00923091|20746573|P6|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
8417611|NCT00923091|20746574|P5|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
8417612|NCT00923091|20746575|P4|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
8417613|NCT00923091|20746576|P3|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
8417614|NCT00923091|20746577|P2|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
8417615|NCT00923091|20746578|P1|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
8417616|NCT00923091|20746566|P13|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417617|NCT00923091|20746567|P12|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417618|NCT00923091|20746568|P11|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417619|NCT00923091|20746569|P10|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417620|NCT00923091|20746570|P9|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
8417621|NCT00923091|20746571|P8|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
8417622|NCT00923091|20746572|P7|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
8417623|NCT00923091|20746573|P6|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
8417624|NCT00923091|20746574|P5|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
8417625|NCT00923091|20746575|P4|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
8417626|NCT00923091|20746576|P3|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
8417627|NCT00923091|20746577|P2|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
8417628|NCT00923091|20746578|P1|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
8417629|NCT00923091|20746566|P13|STARTED|PeriodI-II (Randomized, Double-Blind)||0
8417630|NCT00923091|20746567|P12|STARTED|PeriodI-II (Randomized, Double-Blind)||0
8417631|NCT00923091|20746568|P11|STARTED|PeriodI-II (Randomized, Double-Blind)||0
8417632|NCT00923091|20746569|P10|STARTED|PeriodI-II (Randomized, Double-Blind)||0
8417633|NCT00923091|20746570|P9|STARTED|PeriodI-II (Randomized, Double-Blind)||0
8417634|NCT00923091|20746571|P8|STARTED|PeriodI-II (Randomized, Double-Blind)||336
8417635|NCT00923091|20746572|P7|STARTED|PeriodI-II (Randomized, Double-Blind)||337
8417636|NCT00923091|20746573|P6|STARTED|PeriodI-II (Randomized, Double-Blind)||337
8417637|NCT00923091|20746574|P5|STARTED|PeriodI-II (Randomized, Double-Blind)||336
8417638|NCT00923091|20746575|P4|STARTED|PeriodI-II (Randomized, Double-Blind)||336
8417639|NCT00923091|20746576|P3|STARTED|PeriodI-II (Randomized, Double-Blind)||336
8417640|NCT00923091|20746577|P2|STARTED|PeriodI-II (Randomized, Double-Blind)||336
8417641|NCT00923091|20746578|P1|STARTED|PeriodI-II (Randomized, Double-Blind)||335
8417642|NCT00923078|20746628|P3|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
8417643|NCT00923078|20746629|P2|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
8417644|NCT00923078|20746630|P1|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
8417645|NCT00923078|20746628|P3|COMPLETED|Second Intervention (Weeks 5-8)||0
8417646|NCT00923078|20746629|P2|COMPLETED|Second Intervention (Weeks 5-8)||19
8417647|NCT00923078|20746630|P1|COMPLETED|Second Intervention (Weeks 5-8)||19
8417648|NCT00923078|20746628|P3|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
8417649|NCT00923078|20746629|P2|STARTED|Second Intervention (Weeks 5-8)||19
8417650|NCT00923078|20746630|P1|STARTED|Second Intervention (Weeks 5-8)||19
8417651|NCT00923078|20746628|P3|NOT COMPLETED|First Intervention (Weeks 1-4)||20
8417652|NCT00923078|20746629|P2|NOT COMPLETED|First Intervention (Weeks 1-4)||1
8417653|NCT00923078|20746630|P1|NOT COMPLETED|First Intervention (Weeks 1-4)||1
8417654|NCT00923078|20746628|P3|COMPLETED|First Intervention (Weeks 1-4)||0
8417655|NCT00923078|20746629|P2|COMPLETED|First Intervention (Weeks 1-4)||19
8417656|NCT00923078|20746630|P1|COMPLETED|First Intervention (Weeks 1-4)||19
8417657|NCT00923078|20746628|P3|STARTED|First Intervention (Weeks 1-4)||20
8417658|NCT00923078|20746629|P2|STARTED|First Intervention (Weeks 1-4)||20
8417659|NCT00923078|20746630|P1|STARTED|First Intervention (Weeks 1-4)||20
8417660|NCT00922987|20746649|P1|NOT COMPLETED|Overall Study||4
8417661|NCT00922987|20746649|P1|COMPLETED|Overall Study||277
8417662|NCT00922987|20746649|P1|STARTED|Overall Study||281
8417691|NCT00922935|20746680|P3|NOT COMPLETED|Overall Study||0
8417692|NCT00922935|20746681|P2|NOT COMPLETED|Overall Study||5
8417693|NCT00922935|20746682|P1|NOT COMPLETED|Overall Study||1
8417694|NCT00922935|20746680|P3|COMPLETED|Overall Study||10
8417695|NCT00922935|20746681|P2|COMPLETED|Overall Study||11
8417696|NCT00922935|20746682|P1|COMPLETED|Overall Study||9
8417697|NCT00922935|20746680|P3|STARTED|Overall Study||10
8417698|NCT00922935|20746681|P2|STARTED|Overall Study||16
8417699|NCT00922935|20746682|P1|STARTED|Overall Study||10
8417700|NCT00922883|20746690|P1|NOT COMPLETED|Overall Study||0
8417701|NCT00922883|20746690|P1|COMPLETED|Overall Study||43
8417702|NCT00922883|20746690|P1|STARTED|Overall Study||43
8417703|NCT00922779|20746694|P1|NOT COMPLETED|Overall Study||2327
8417704|NCT00922779|20746694|P1|COMPLETED|Overall Study||4334
8417705|NCT00922779|20746694|P1|STARTED|Overall Study||6661
8417706|NCT00922766|20746701|P1|NOT COMPLETED|Overall Study||7
8417707|NCT00922766|20746701|P1|COMPLETED|Overall Study||610
8417708|NCT00922766|20746701|P1|STARTED|Overall Study||617
8417709|NCT00922701|20746710|P1|NOT COMPLETED|Overall Study||0
8417710|NCT00922701|20746710|P1|COMPLETED|Overall Study||4
8417711|NCT00922701|20746710|P1|STARTED|Overall Study||4
8417712|NCT00922636|20746719|P5|NOT COMPLETED|Overall Study||16
8417713|NCT00922636|20746720|P4|NOT COMPLETED|Overall Study||17
8417714|NCT00922636|20746721|P3|NOT COMPLETED|Overall Study||20
8417715|NCT00922636|20746722|P2|NOT COMPLETED|Overall Study||16
8417716|NCT00922636|20746723|P1|NOT COMPLETED|Overall Study||7
8417717|NCT00922636|20746719|P5|COMPLETED|Overall Study||59
8417718|NCT00922636|20746720|P4|COMPLETED|Overall Study||58
8417719|NCT00922636|20746721|P3|COMPLETED|Overall Study||56
8417720|NCT00922636|20746722|P2|COMPLETED|Overall Study||62
8417721|NCT00922636|20746723|P1|COMPLETED|Overall Study||29
8417722|NCT00922636|20746719|P5|Entered Optional Taper Phase|Overall Study||12
8417723|NCT00922636|20746720|P4|Entered Optional Taper Phase|Overall Study||7
8417724|NCT00922636|20746721|P3|Entered Optional Taper Phase|Overall Study||15
8417725|NCT00922636|20746722|P2|Entered Optional Taper Phase|Overall Study||10
8417726|NCT00922636|20746723|P1|Entered Optional Taper Phase|Overall Study||4
8417727|NCT00922636|20746719|P5|STARTED|Overall Study||75
8417728|NCT00922636|20746720|P4|STARTED|Overall Study||75
8417729|NCT00922636|20746721|P3|STARTED|Overall Study||76
8417730|NCT00922636|20746722|P2|STARTED|Overall Study||78
8417731|NCT00922636|20746723|P1|STARTED|Overall Study||36
8417732|NCT00922623|20746870|P1|NOT COMPLETED|Overall Study||5
8417733|NCT00922623|20746870|P1|COMPLETED|Overall Study||88
8417734|NCT00922623|20746870|P1|STARTED|Overall Study||93
8417735|NCT00922480|20746878|P2|NOT COMPLETED|Extension Study||3
8417736|NCT00922480|20746879|P1|NOT COMPLETED|Extension Study||5
8417737|NCT00922480|20746878|P2|COMPLETED|Extension Study||82
8417738|NCT00922480|20746879|P1|COMPLETED|Extension Study||68
8417739|NCT00922480|20746878|P2|STARTED|Extension Study||85
8417740|NCT00922480|20746879|P1|STARTED|Extension Study||73
8417741|NCT00922480|20746878|P2|NOT COMPLETED|Main Study||29
8417742|NCT00922480|20746879|P1|NOT COMPLETED|Main Study||37
8417743|NCT00922480|20746878|P2|COMPLETED|Main Study||226
8417744|NCT00922480|20746879|P1|COMPLETED|Main Study||213
8417745|NCT00922480|20746878|P2|STARTED|Main Study||255
8417746|NCT00922480|20746879|P1|STARTED|Main Study||250
8417747|NCT00922441|20746890|P3|NOT COMPLETED|Overall Study||3
8417748|NCT00922441|20746891|P2|NOT COMPLETED|Overall Study||0
8417749|NCT00922441|20746892|P1|NOT COMPLETED|Overall Study||0
8417750|NCT00922441|20746890|P3|COMPLETED|Overall Study||29
8417751|NCT00922441|20746891|P2|COMPLETED|Overall Study||30
8417752|NCT00922441|20746892|P1|COMPLETED|Overall Study||30
8417753|NCT00922441|20746890|P3|STARTED|Overall Study||32
8417754|NCT00922441|20746891|P2|STARTED|Overall Study||30
8417755|NCT00922441|20746892|P1|STARTED|Overall Study||30
8417756|NCT00922428|20746900|P1|NOT COMPLETED|Overall Study||15
8417757|NCT00922428|20746900|P1|COMPLETED|Overall Study|for 11 participants no gender was given|1374
8417758|NCT00922428|20746900|P1|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
8417771|NCT00922233|20746986|P1|NOT COMPLETED|Overall Study||4
8417772|NCT00922233|20746986|P1|COMPLETED|Overall Study||68
8417773|NCT00922233|20746986|P1|STARTED|Overall Study||72
8417774|NCT00922207|20746995|P3|NOT COMPLETED|Overall Study||4
8417775|NCT00922207|20746996|P2|NOT COMPLETED|Overall Study||7
8417776|NCT00922207|20746997|P1|NOT COMPLETED|Overall Study||6
8417777|NCT00922207|20746995|P3|COMPLETED|Overall Study||90
8417778|NCT00922207|20746996|P2|COMPLETED|Overall Study||88
8417779|NCT00922207|20746997|P1|COMPLETED|Overall Study||85
8417780|NCT00922207|20746995|P3|STARTED|Overall Study||94
8417781|NCT00922207|20746996|P2|STARTED|Overall Study||95
8417782|NCT00922207|20746997|P1|STARTED|Overall Study||91
8417783|NCT00922194|20747023|P1|NOT COMPLETED|Metformin for 12 Months or More||0
8417784|NCT00922194|20747023|P1|COMPLETED|Metformin for 12 Months or More||102
8417785|NCT00922194|20747023|P1|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
8417786|NCT00922194|20747023|P1|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
8417787|NCT00922194|20747023|P1|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
8417788|NCT00922194|20747023|P1|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
8417789|NCT00922116|20747033|P1|NOT COMPLETED|Overall Study||15
8417790|NCT00922116|20747033|P1|COMPLETED|Overall Study||176
8417791|NCT00922116|20747033|P1|STARTED|Overall Study||191
8417792|NCT00921947|20747044|P2|NOT COMPLETED|Day 28||0
8417793|NCT00921947|20747045|P1|NOT COMPLETED|Day 28||0
8417794|NCT00921947|20747044|P2|COMPLETED|Day 28||30
8417795|NCT00921947|20747045|P1|COMPLETED|Day 28||28
8417796|NCT00921947|20747044|P2|STARTED|Day 28||30
8417797|NCT00921947|20747045|P1|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
8417798|NCT00921947|20747044|P2|NOT COMPLETED|Day 0||0
8417799|NCT00921947|20747045|P1|NOT COMPLETED|Day 0||0
8417800|NCT00921947|20747044|P2|COMPLETED|Day 0||30
8417801|NCT00921947|20747045|P1|COMPLETED|Day 0||30
8417802|NCT00921947|20747044|P2|STARTED|Day 0||30
8417803|NCT00921947|20747045|P1|STARTED|Day 0||30
8417804|NCT00921934|20747055|P1|NOT COMPLETED|Overall Study||0
8417805|NCT00921934|20747055|P1|COMPLETED|Overall Study||68
8417806|NCT00921934|20747055|P1|STARTED|Overall Study||68
8417807|NCT00921895|20747059|P1|NOT COMPLETED|Overall Study||0
8417808|NCT00921895|20747059|P1|COMPLETED|Overall Study||128
8417809|NCT00921895|20747059|P1|STARTED|Overall Study||128
8417810|NCT00921843|20747068|P4|NOT COMPLETED|Overall Study||0
8417811|NCT00921843|20747069|P3|NOT COMPLETED|Overall Study||0
8417812|NCT00921843|20747070|P2|NOT COMPLETED|Overall Study||0
8417813|NCT00921843|20747071|P1|NOT COMPLETED|Overall Study||0
8417814|NCT00921843|20747068|P4|COMPLETED|Overall Study||30
8417815|NCT00921843|20747069|P3|COMPLETED|Overall Study||11
8417816|NCT00921843|20747070|P2|COMPLETED|Overall Study||10
8417817|NCT00921843|20747071|P1|COMPLETED|Overall Study||10
8417818|NCT00921843|20747068|P4|STARTED|Overall Study||30
8417819|NCT00921843|20747069|P3|STARTED|Overall Study||11
8417820|NCT00921843|20747070|P2|STARTED|Overall Study||10
8417821|NCT00921843|20747071|P1|STARTED|Overall Study||10
8417822|NCT00921687|20747083|P2|NOT COMPLETED|Overall Study||0
8417823|NCT00921687|20747084|P1|NOT COMPLETED|Overall Study||0
8417824|NCT00921687|20747083|P2|COMPLETED|Overall Study||363
8417825|NCT00921687|20747084|P1|COMPLETED|Overall Study||418
8417826|NCT00921687|20747083|P2|STARTED|Overall Study||363
8417827|NCT00921687|20747084|P1|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
8417828|NCT00921557|20747095|P3|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
8417829|NCT00921557|20747096|P2|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
8417830|NCT00921557|20747097|P1|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
8417831|NCT00921557|20747095|P3|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
8417832|NCT00921557|20747096|P2|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
8417833|NCT00921557|20747097|P1|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
8417834|NCT00921557|20747095|P3|STARTED|Weeks 96-144 (Off Study Treatment)||17
8417835|NCT00921557|20747096|P2|STARTED|Weeks 96-144 (Off Study Treatment)||16
8417836|NCT00921557|20747097|P1|STARTED|Weeks 96-144 (Off Study Treatment)||15
8417837|NCT00921557|20747095|P3|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
8417838|NCT00921557|20747096|P2|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
8417839|NCT00921557|20747097|P1|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
8417840|NCT00921557|20747095|P3|COMPLETED|Weeks 48-96 (on Study Treatment)||17
8417841|NCT00921557|20747096|P2|COMPLETED|Weeks 48-96 (on Study Treatment)||16
8417842|NCT00921557|20747097|P1|COMPLETED|Weeks 48-96 (on Study Treatment)||15
8417843|NCT00921557|20747095|P3|STARTED|Weeks 48-96 (on Study Treatment)||18
8417844|NCT00921557|20747096|P2|STARTED|Weeks 48-96 (on Study Treatment)||17
8417845|NCT00921557|20747097|P1|STARTED|Weeks 48-96 (on Study Treatment)||15
8417846|NCT00921557|20747095|P3|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
8417847|NCT00921557|20747096|P2|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
8417848|NCT00921557|20747097|P1|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
8417849|NCT00921557|20747095|P3|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
8417850|NCT00921557|20747096|P2|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
8417851|NCT00921557|20747097|P1|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
8417852|NCT00921557|20747095|P3|STARTED|Weeks 0-48 (on Study Treatment)||18
8417853|NCT00921557|20747096|P2|STARTED|Weeks 0-48 (on Study Treatment)||17
8417854|NCT00921557|20747097|P1|STARTED|Weeks 0-48 (on Study Treatment)||17
8417855|NCT00921518|20747157|P2|NOT COMPLETED|Overall Study||0
8417856|NCT00921518|20747158|P1|NOT COMPLETED|Overall Study||0
8417857|NCT00921518|20747157|P2|COMPLETED|Overall Study||44
8417858|NCT00921518|20747158|P1|COMPLETED|Overall Study||48
8417859|NCT00921518|20747157|P2|STARTED|Overall Study||44
8417860|NCT00921518|20747158|P1|STARTED|Overall Study||48
8417861|NCT00921310|20747166|P3|NOT COMPLETED|Overall Study||0
8417862|NCT00921310|20747167|P2|NOT COMPLETED|Overall Study||0
8417863|NCT00921310|20747168|P1|NOT COMPLETED|Overall Study||0
8417864|NCT00921310|20747166|P3|COMPLETED|Overall Study||4
8417865|NCT00921310|20747167|P2|COMPLETED|Overall Study||6
8417866|NCT00921310|20747168|P1|COMPLETED|Overall Study||2
8417867|NCT00921310|20747166|P3|STARTED|Overall Study||4
8417868|NCT00921310|20747167|P2|STARTED|Overall Study||6
8417869|NCT00921310|20747168|P1|STARTED|Overall Study||2
8417873|NCT00921024|20747199|P2|NOT COMPLETED|Overall Study||3
8417874|NCT00921024|20747200|P1|NOT COMPLETED|Overall Study||4
8417875|NCT00921024|20747199|P2|COMPLETED|Overall Study||39
8417876|NCT00921024|20747200|P1|COMPLETED|Overall Study||81
8417877|NCT00921024|20747199|P2|STARTED|Overall Study||42
8417878|NCT00921024|20747200|P1|STARTED|Overall Study||85
8417879|NCT00920907|20747210|P2|NOT COMPLETED|Maintenance Period||13
8417880|NCT00920907|20747211|P1|NOT COMPLETED|Maintenance Period||12
8417881|NCT00920907|20747210|P2|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
8417882|NCT00920907|20747211|P1|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
8417883|NCT00920907|20747210|P2|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
8417884|NCT00920907|20747211|P1|STARTED|Maintenance Period||15
8417885|NCT00920907|20747210|P2|NOT COMPLETED|Induction Period||22
8417886|NCT00920907|20747211|P1|NOT COMPLETED|Induction Period||22
8417887|NCT00920907|20747210|P2|COMPLETED|Induction Period||16
8417888|NCT00920907|20747211|P1|COMPLETED|Induction Period||15
8417889|NCT00920907|20747210|P2|STARTED|Induction Period||38
8417890|NCT00920907|20747211|P1|STARTED|Induction Period||37
8417891|NCT00920855|20747252|P3|NOT COMPLETED|Overall Study||22
8417892|NCT00920855|20747253|P2|NOT COMPLETED|Overall Study||3
8417893|NCT00920855|20747254|P1|NOT COMPLETED|Overall Study||5
8417894|NCT00920855|20747252|P3|COMPLETED|Overall Study|completed eight cycles of treatment|9
8417895|NCT00920855|20747253|P2|COMPLETED|Overall Study|completed eight cycles of treatment|1
8417896|NCT00920855|20747254|P1|COMPLETED|Overall Study|completed eight cycles of treatment|0
8417897|NCT00920855|20747252|P3|Safety and Efficacy Populations|Overall Study||31
8417898|NCT00920855|20747253|P2|Safety and Efficacy Populations|Overall Study||4
8417899|NCT00920855|20747254|P1|Safety and Efficacy Populations|Overall Study||5
8417900|NCT00920855|20747252|P3|STARTED|Overall Study||31
8417901|NCT00920855|20747253|P2|STARTED|Overall Study||4
8417902|NCT00920855|20747254|P1|STARTED|Overall Study||5
8417903|NCT00920829|20747280|P4|NOT COMPLETED|Available for Analysis||11
8417904|NCT00920829|20747281|P3|NOT COMPLETED|Available for Analysis||10
8417905|NCT00920829|20747282|P2|NOT COMPLETED|Available for Analysis||11
8417906|NCT00920829|20747283|P1|NOT COMPLETED|Available for Analysis||8
8417907|NCT00920829|20747280|P4|COMPLETED|Available for Analysis||24
8417908|NCT00920829|20747281|P3|COMPLETED|Available for Analysis||28
8417909|NCT00920829|20747282|P2|COMPLETED|Available for Analysis||27
8417910|NCT00920829|20747283|P1|COMPLETED|Available for Analysis||27
8417911|NCT00920829|20747280|P4|STARTED|Available for Analysis||35
8417912|NCT00920829|20747281|P3|STARTED|Available for Analysis||38
8417913|NCT00920829|20747282|P2|STARTED|Available for Analysis||38
8417914|NCT00920829|20747283|P1|STARTED|Available for Analysis||35
8417915|NCT00920829|20747280|P4|NOT COMPLETED|Allocation||2
8417916|NCT00920829|20747281|P3|NOT COMPLETED|Allocation||0
8417917|NCT00920829|20747282|P2|NOT COMPLETED|Allocation||1
8417918|NCT00920829|20747283|P1|NOT COMPLETED|Allocation||3
8417919|NCT00920829|20747280|P4|COMPLETED|Allocation||35
8417920|NCT00920829|20747281|P3|COMPLETED|Allocation||38
8417921|NCT00920829|20747282|P2|COMPLETED|Allocation||38
8417922|NCT00920829|20747283|P1|COMPLETED|Allocation||35
8417923|NCT00920829|20747280|P4|STARTED|Allocation||37
8417924|NCT00920829|20747281|P3|STARTED|Allocation||38
8417925|NCT00920829|20747282|P2|STARTED|Allocation||39
8417926|NCT00920829|20747283|P1|STARTED|Allocation||38
8417943|NCT00920790|20747338|P1|NOT COMPLETED|Overall Study||14
8417944|NCT00920790|20747338|P1|COMPLETED|Overall Study||13
8417945|NCT00920790|20747338|P1|STARTED|Overall Study||27
8417946|NCT00920699|20747350|P3|NOT COMPLETED|Overall Study||4
8417947|NCT00920699|20747351|P2|NOT COMPLETED|Overall Study||1
8417948|NCT00920699|20747352|P1|NOT COMPLETED|Overall Study||2
8417949|NCT00920699|20747350|P3|COMPLETED|Overall Study||28
8417950|NCT00920699|20747351|P2|COMPLETED|Overall Study||29
8417951|NCT00920699|20747352|P1|COMPLETED|Overall Study||27
8417952|NCT00920699|20747350|P3|STARTED|Overall Study||32
8417953|NCT00920699|20747351|P2|STARTED|Overall Study||30
8417954|NCT00920699|20747352|P1|STARTED|Overall Study||29
8417955|NCT00920686|20747369|P3|NOT COMPLETED|Overall Study||13
8417956|NCT00920686|20747370|P2|NOT COMPLETED|Overall Study||22
8417957|NCT00920686|20747371|P1|NOT COMPLETED|Overall Study||19
8417958|NCT00920686|20747369|P3|COMPLETED|Overall Study||62
8417959|NCT00920686|20747370|P2|COMPLETED|Overall Study||60
8417960|NCT00920686|20747371|P1|COMPLETED|Overall Study||63
8417961|NCT00920686|20747369|P3|STARTED|Overall Study||75
8417962|NCT00920686|20747370|P2|STARTED|Overall Study||82
8417963|NCT00920686|20747371|P1|STARTED|Overall Study||82
8417976|NCT00920556|20747446|P1|NOT COMPLETED|Overall Study||24
8417977|NCT00920556|20747446|P1|COMPLETED|Overall Study||0
8417978|NCT00920556|20747446|P1|STARTED|Overall Study||24
8417979|NCT00920439|20747485|P1|NOT COMPLETED|Overall Study||0
8417980|NCT00920439|20747485|P1|COMPLETED|Overall Study||25
8417981|NCT00920439|20747485|P1|STARTED|Overall Study||25
8417982|NCT00920426|20747495|P4|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8417983|NCT00920426|20747496|P3|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8417984|NCT00920426|20747497|P2|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8417985|NCT00920426|20747498|P1|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8417986|NCT00920426|20747495|P4|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
8417987|NCT00920426|20747496|P3|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8417988|NCT00920426|20747497|P2|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8417989|NCT00920426|20747498|P1|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
8417990|NCT00920426|20747495|P4|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
8417991|NCT00920426|20747496|P3|STARTED|ITZ112929: Optimized Therapy (OT)||0
8417992|NCT00920426|20747497|P2|STARTED|ITZ112929: Optimized Therapy (OT)||0
8417993|NCT00920426|20747498|P1|STARTED|ITZ112929: Optimized Therapy (OT)||0
8417994|NCT00920426|20747495|P4|NOT COMPLETED|ITZ112929: Randomized Regimen||0
8417995|NCT00920426|20747496|P3|NOT COMPLETED|ITZ112929: Randomized Regimen||0
8417996|NCT00920426|20747497|P2|NOT COMPLETED|ITZ112929: Randomized Regimen||0
8417997|NCT00920426|20747498|P1|NOT COMPLETED|ITZ112929: Randomized Regimen||0
8417998|NCT00920426|20747495|P4|COMPLETED|ITZ112929: Randomized Regimen||0
8417999|NCT00920426|20747496|P3|COMPLETED|ITZ112929: Randomized Regimen||2
8418000|NCT00920426|20747497|P2|COMPLETED|ITZ112929: Randomized Regimen||7
8418001|NCT00920426|20747498|P1|COMPLETED|ITZ112929: Randomized Regimen||0
8418002|NCT00920426|20747495|P4|STARTED|ITZ112929: Randomized Regimen||0
8418003|NCT00920426|20747496|P3|STARTED|ITZ112929: Randomized Regimen||2
8418004|NCT00920426|20747497|P2|STARTED|ITZ112929: Randomized Regimen||7
8418005|NCT00920426|20747498|P1|STARTED|ITZ112929: Randomized Regimen||0
8418006|NCT00920426|20747495|P4|NOT COMPLETED|ITZ111451||0
8418007|NCT00920426|20747496|P3|NOT COMPLETED|ITZ111451||0
8418008|NCT00920426|20747497|P2|NOT COMPLETED|ITZ111451||0
8418009|NCT00920426|20747498|P1|NOT COMPLETED|ITZ111451||1
8418010|NCT00920426|20747495|P4|COMPLETED|ITZ111451||0
8418011|NCT00920426|20747496|P3|COMPLETED|ITZ111451||0
8418012|NCT00920426|20747497|P2|COMPLETED|ITZ111451||0
8418013|NCT00920426|20747498|P1|COMPLETED|ITZ111451||7
8418014|NCT00920426|20747495|P4|STARTED|ITZ111451||0
8418015|NCT00920426|20747496|P3|STARTED|ITZ111451||0
8418016|NCT00920426|20747497|P2|STARTED|ITZ111451||0
8418017|NCT00920426|20747498|P1|STARTED|ITZ111451||8
8418018|NCT00920374|20747567|P2|NOT COMPLETED|Overall Study||0
8418019|NCT00920374|20747568|P1|NOT COMPLETED|Overall Study||0
8418020|NCT00920374|20747567|P2|COMPLETED|Overall Study||57
8418021|NCT00920374|20747568|P1|COMPLETED|Overall Study||61
8418022|NCT00920374|20747567|P2|STARTED|Overall Study||57
8418023|NCT00920374|20747568|P1|STARTED|Overall Study||61
8418024|NCT00920309|20747594|P2|NOT COMPLETED|Overall Study||0
8418025|NCT00920309|20747595|P1|NOT COMPLETED|Overall Study||0
8418026|NCT00920309|20747594|P2|COMPLETED|Overall Study||7
8418027|NCT00920309|20747595|P1|COMPLETED|Overall Study||14
8418028|NCT00920309|20747594|P2|STARTED|Overall Study||7
8418029|NCT00920309|20747595|P1|STARTED|Overall Study||14
8418030|NCT00920231|20747605|P2|NOT COMPLETED|Overall Study||0
8418031|NCT00920231|20747606|P1|NOT COMPLETED|Overall Study||0
8418032|NCT00920231|20747605|P2|COMPLETED|Overall Study||8
8418033|NCT00920231|20747606|P1|COMPLETED|Overall Study||8
8418034|NCT00920231|20747605|P2|STARTED|Overall Study||8
8418035|NCT00920231|20747606|P1|STARTED|Overall Study||8
8418036|NCT00920218|20747618|P4|NOT COMPLETED|Overall Study||7
8418037|NCT00920218|20747619|P3|NOT COMPLETED|Overall Study||8
8418038|NCT00920218|20747620|P2|NOT COMPLETED|Overall Study||5
8418039|NCT00920218|20747621|P1|NOT COMPLETED|Overall Study||2
8418040|NCT00920218|20747618|P4|COMPLETED|Overall Study||23
8418041|NCT00920218|20747619|P3|COMPLETED|Overall Study||23
8418042|NCT00920218|20747620|P2|COMPLETED|Overall Study||24
8418043|NCT00920218|20747621|P1|COMPLETED|Overall Study||28
8418044|NCT00920218|20747618|P4|STARTED|Overall Study||30
8418045|NCT00920218|20747619|P3|STARTED|Overall Study||31
8418046|NCT00920218|20747620|P2|STARTED|Overall Study||29
8418047|NCT00920218|20747621|P1|STARTED|Overall Study||30
8418048|NCT00920140|20747724|P5|NOT COMPLETED|Phase 2||11
8418049|NCT00920140|20747725|P4|NOT COMPLETED|Phase 2||22
8418050|NCT00920140|20747726|P3|NOT COMPLETED|Phase 2||50
8418051|NCT00920140|20747727|P2|NOT COMPLETED|Phase 2||0
8418052|NCT00920140|20747728|P1|NOT COMPLETED|Phase 2||0
8418053|NCT00920140|20747724|P5|COMPLETED|Phase 2||0
8418054|NCT00920140|20747725|P4|COMPLETED|Phase 2||0
8418055|NCT00920140|20747726|P3|COMPLETED|Phase 2||0
8418056|NCT00920140|20747727|P2|COMPLETED|Phase 2||0
8418057|NCT00920140|20747728|P1|COMPLETED|Phase 2||0
8418058|NCT00920140|20747724|P5|STARTED|Phase 2||11
8418059|NCT00920140|20747725|P4|STARTED|Phase 2||22
8418060|NCT00920140|20747726|P3|STARTED|Phase 2||50
8418061|NCT00920140|20747727|P2|STARTED|Phase 2||0
8418062|NCT00920140|20747728|P1|STARTED|Phase 2||0
8418063|NCT00920140|20747724|P5|NOT COMPLETED|Phase 1 (Dose Escalation)||0
8418064|NCT00920140|20747725|P4|NOT COMPLETED|Phase 1 (Dose Escalation)||0
8418065|NCT00920140|20747726|P3|NOT COMPLETED|Phase 1 (Dose Escalation)||0
8418066|NCT00920140|20747727|P2|NOT COMPLETED|Phase 1 (Dose Escalation)||9
8418067|NCT00920140|20747728|P1|NOT COMPLETED|Phase 1 (Dose Escalation)||5
8418068|NCT00920140|20747724|P5|COMPLETED|Phase 1 (Dose Escalation)||0
8418069|NCT00920140|20747725|P4|COMPLETED|Phase 1 (Dose Escalation)||0
8418070|NCT00920140|20747726|P3|COMPLETED|Phase 1 (Dose Escalation)||0
8418071|NCT00920140|20747727|P2|COMPLETED|Phase 1 (Dose Escalation)||0
8418072|NCT00920140|20747728|P1|COMPLETED|Phase 1 (Dose Escalation)||0
8418073|NCT00920140|20747724|P5|STARTED|Phase 1 (Dose Escalation)||0
8418074|NCT00920140|20747725|P4|STARTED|Phase 1 (Dose Escalation)||0
8418075|NCT00920140|20747726|P3|STARTED|Phase 1 (Dose Escalation)||0
8418076|NCT00920140|20747727|P2|STARTED|Phase 1 (Dose Escalation)||9
8418077|NCT00920140|20747728|P1|STARTED|Phase 1 (Dose Escalation)||5
8418078|NCT00920075|20747766|P1|NOT COMPLETED|Post Study, 11 Pts Responded||0
8418079|NCT00920075|20747766|P1|COMPLETED|Post Study, 11 Pts Responded||11
8418080|NCT00920075|20747766|P1|STARTED|Post Study, 11 Pts Responded||11
8418081|NCT00920075|20747766|P1|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
8418082|NCT00920075|20747766|P1|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
8418083|NCT00920075|20747766|P1|STARTED|Last Study, 25 Pts Invited,11 Responded||11
8418084|NCT00920023|20747772|P1|NOT COMPLETED|Overall Study||0
8418085|NCT00920023|20747772|P1|COMPLETED|Overall Study||15
8418086|NCT00920023|20747772|P1|STARTED|Overall Study||15
8418087|NCT00919932|20747779|P2|NOT COMPLETED|Overall Study||0
8418088|NCT00919932|20747780|P1|NOT COMPLETED|Overall Study||0
8418089|NCT00919932|20747779|P2|COMPLETED|Overall Study||5
8418090|NCT00919932|20747780|P1|COMPLETED|Overall Study||4
8418091|NCT00919932|20747779|P2|STARTED|Overall Study||5
8418092|NCT00919932|20747780|P1|STARTED|Overall Study||4
8418093|NCT00919893|20747790|P2|NOT COMPLETED|Overall Study||9
8418094|NCT00919893|20747791|P1|NOT COMPLETED|Overall Study||19
8418095|NCT00919893|20747790|P2|COMPLETED|Overall Study||60
8418096|NCT00919893|20747791|P1|COMPLETED|Overall Study||51
8418097|NCT00919893|20747790|P2|STARTED|Overall Study||69
8418098|NCT00919893|20747791|P1|STARTED|Overall Study||70
8418189|NCT00919854|20747829|P1|NOT COMPLETED|Overall Study||1
8418190|NCT00919854|20747829|P1|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
8418191|NCT00919854|20747829|P1|STARTED|Overall Study||21
8418192|NCT00919802|20747838|P2|NOT COMPLETED|Second Intervention - (24 Hours)||0
8418193|NCT00919802|20747839|P1|NOT COMPLETED|Second Intervention - (24 Hours)||0
8418194|NCT00919802|20747838|P2|COMPLETED|Second Intervention - (24 Hours)||13
8418195|NCT00919802|20747839|P1|COMPLETED|Second Intervention - (24 Hours)||12
8418196|NCT00919802|20747838|P2|STARTED|Second Intervention - (24 Hours)||13
8418197|NCT00919802|20747839|P1|STARTED|Second Intervention - (24 Hours)||12
8418198|NCT00919802|20747838|P2|NOT COMPLETED|First Intervention - (24 Hours)||0
8418199|NCT00919802|20747839|P1|NOT COMPLETED|First Intervention - (24 Hours)||0
8418200|NCT00919802|20747838|P2|COMPLETED|First Intervention - (24 Hours)||13
8418201|NCT00919802|20747839|P1|COMPLETED|First Intervention - (24 Hours)||12
8418202|NCT00919802|20747838|P2|STARTED|First Intervention - (24 Hours)||13
8418203|NCT00919802|20747839|P1|STARTED|First Intervention - (24 Hours)||12
8418210|NCT00919724|20747858|P2|NOT COMPLETED|Overall Study||0
8418211|NCT00919724|20747859|P1|NOT COMPLETED|Overall Study||0
8418212|NCT00919724|20747858|P2|COMPLETED|Overall Study||44
8418213|NCT00919724|20747859|P1|COMPLETED|Overall Study||45
8418214|NCT00919724|20747858|P2|STARTED|Overall Study||44
8418215|NCT00919724|20747859|P1|STARTED|Overall Study||45
8418216|NCT00919711|20747867|P2|NOT COMPLETED|Overall Study||13
8418217|NCT00919711|20747868|P1|NOT COMPLETED|Overall Study||33
8418218|NCT00919711|20747867|P2|COMPLETED|Overall Study||422
8418219|NCT00919711|20747868|P1|COMPLETED|Overall Study||402
8418220|NCT00919711|20747867|P2|STARTED|Overall Study||435
8418221|NCT00919711|20747868|P1|STARTED|Overall Study||435
8418222|NCT00919633|20747884|P4|NOT COMPLETED|Overall Study||21
8418223|NCT00919633|20747885|P3|NOT COMPLETED|Overall Study||23
8418224|NCT00919633|20747886|P2|NOT COMPLETED|Overall Study||15
8418225|NCT00919633|20747887|P1|NOT COMPLETED|Overall Study||22
8418226|NCT00919633|20747884|P4|COMPLETED|Overall Study||5
8418227|NCT00919633|20747885|P3|COMPLETED|Overall Study||4
8418228|NCT00919633|20747886|P2|COMPLETED|Overall Study||10
8418229|NCT00919633|20747887|P1|COMPLETED|Overall Study||6
8418230|NCT00919633|20747884|P4|STARTED|Overall Study||26
8418231|NCT00919633|20747885|P3|STARTED|Overall Study||27
8418232|NCT00919633|20747886|P2|STARTED|Overall Study||25
8418233|NCT00919633|20747887|P1|STARTED|Overall Study||28
8418234|NCT00919191|20747905|P1|NOT COMPLETED|Overall Study||0
8418235|NCT00919191|20747905|P1|COMPLETED|Overall Study||26
8418236|NCT00919191|20747905|P1|STARTED|Overall Study||26
8418237|NCT00919126|20747915|P3|NOT COMPLETED|Overall Study||1
8418238|NCT00919126|20747916|P2|NOT COMPLETED|Overall Study||5
8418239|NCT00919126|20747917|P1|NOT COMPLETED|Overall Study||1
8418240|NCT00919126|20747915|P3|COMPLETED|Overall Study||32
8418241|NCT00919126|20747916|P2|COMPLETED|Overall Study||32
8418242|NCT00919126|20747917|P1|COMPLETED|Overall Study||31
8418243|NCT00919126|20747915|P3|STARTED|Overall Study||33
8418244|NCT00919126|20747916|P2|STARTED|Overall Study||37
8418245|NCT00919126|20747917|P1|STARTED|Overall Study||32
8418246|NCT00919113|20747963|P2|NOT COMPLETED|Overall Study||8
8418247|NCT00919113|20747964|P1|NOT COMPLETED|Overall Study||9
8418248|NCT00919113|20747963|P2|COMPLETED|Overall Study||40
8418249|NCT00919113|20747964|P1|COMPLETED|Overall Study||41
8418250|NCT00919113|20747963|P2|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
8418251|NCT00919113|20747964|P1|Received Placebo|Overall Study||0
8418252|NCT00919113|20747963|P2|Received Uracyst|Overall Study||0
8418253|NCT00919113|20747964|P1|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
8418254|NCT00919113|20747963|P2|STARTED|Overall Study||48
8418255|NCT00919113|20747964|P1|STARTED|Overall Study||50
8418256|NCT00919100|20747974|P2|NOT COMPLETED|Overall Study||0
8418257|NCT00919100|20747975|P1|NOT COMPLETED|Overall Study||0
8418258|NCT00919100|20747974|P2|COMPLETED|Overall Study||41
8418259|NCT00919100|20747975|P1|COMPLETED|Overall Study||40
8418260|NCT00919100|20747974|P2|STARTED|Overall Study||41
8418261|NCT00919100|20747975|P1|STARTED|Overall Study||40
8418262|NCT00919061|20747985|P1|NOT COMPLETED|Overall Study||2
8418263|NCT00919061|20747985|P1|COMPLETED|Overall Study||37
8418264|NCT00919061|20747985|P1|STARTED|Overall Study||39
8418265|NCT00919035|20747990|P1|NOT COMPLETED|Overall Study||0
8418266|NCT00919035|20747990|P1|COMPLETED|Overall Study||21
8418267|NCT00919035|20747990|P1|STARTED|Overall Study||21
8418268|NCT00918957|20747998|P2|NOT COMPLETED|Overall Study||0
8418269|NCT00918957|20747999|P1|NOT COMPLETED|Overall Study||3
8418270|NCT00918957|20747998|P2|COMPLETED|Overall Study||30
8418271|NCT00918957|20747999|P1|COMPLETED|Overall Study||29
8418272|NCT00918957|20747998|P2|STARTED|Overall Study||30
8418273|NCT00918957|20747999|P1|STARTED|Overall Study||32
8418274|NCT00918931|20748026|P1|NOT COMPLETED|Overall Study||0
8418275|NCT00918931|20748026|P1|COMPLETED|Overall Study||3
8418276|NCT00918931|20748026|P1|STARTED|Overall Study||3
8418277|NCT00918879|20748032|P2|NOT COMPLETED|Overall Study||6
8418278|NCT00918879|20748033|P1|NOT COMPLETED|Overall Study||6
8418279|NCT00918879|20748032|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
8418280|NCT00918879|20748033|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
8418281|NCT00918879|20748032|P2|STARTED|Overall Study|Randomized and treated|106
8418282|NCT00918879|20748033|P1|STARTED|Overall Study|Randomized and treated|107
8418283|NCT00918866|20748047|P2|NOT COMPLETED|Overall Study||0
8418284|NCT00918866|20748048|P1|NOT COMPLETED|Overall Study||0
8418285|NCT00918866|20748047|P2|COMPLETED|Overall Study||16
8418286|NCT00918866|20748048|P1|COMPLETED|Overall Study||16
8418287|NCT00918866|20748047|P2|STARTED|Overall Study||16
8418288|NCT00918866|20748048|P1|STARTED|Overall Study||16
8418289|NCT00918749|20748065|P3|NOT COMPLETED|Overall Study||7
8418290|NCT00918749|20748066|P2|NOT COMPLETED|Overall Study||3
8418291|NCT00918749|20748067|P1|NOT COMPLETED|Overall Study||7
8418292|NCT00918749|20748065|P3|COMPLETED|Overall Study||62
8418293|NCT00918749|20748066|P2|COMPLETED|Overall Study||63
8418294|NCT00918749|20748067|P1|COMPLETED|Overall Study||63
8418295|NCT00918749|20748065|P3|ITT (Intent to Treat) Population|Overall Study||69
8418296|NCT00918749|20748066|P2|ITT (Intent to Treat) Population|Overall Study||66
8418297|NCT00918749|20748067|P1|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
8418298|NCT00918749|20748065|P3|STARTED|Overall Study||69
8418299|NCT00918749|20748066|P2|STARTED|Overall Study||66
8418300|NCT00918749|20748067|P1|STARTED|Overall Study||70
8418301|NCT00918736|20748099|P1|NOT COMPLETED|Overall Study||4
8418302|NCT00918736|20748099|P1|COMPLETED|Overall Study|October, 2008|46
8418303|NCT00918736|20748099|P1|STARTED|Overall Study|October, 2007|50
8418304|NCT00918723|20748103|P1|NOT COMPLETED|Overall Study||0
8418305|NCT00918723|20748103|P1|COMPLETED|Overall Study||40
8418306|NCT00918723|20748103|P1|STARTED|Overall Study||40
8418307|NCT00918684|20748112|P1|NOT COMPLETED|Treatment Phase||25
8418308|NCT00918684|20748112|P1|COMPLETED|Treatment Phase||65
8418309|NCT00918684|20748112|P1|STARTED|Treatment Phase||90
8418310|NCT00918684|20748112|P1|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
8418311|NCT00918684|20748112|P1|COMPLETED|Two Week Drug Washout and Placebo Phase||90
8418312|NCT00918684|20748112|P1|STARTED|Two Week Drug Washout and Placebo Phase||106
8418313|NCT00918671|20748118|P1|NOT COMPLETED|Overall Study||0
8418314|NCT00918671|20748118|P1|COMPLETED|Overall Study||60
8418315|NCT00918671|20748118|P1|STARTED|Overall Study||60
8418316|NCT00918645|20748123|P1|NOT COMPLETED|Overall Study||1
8418317|NCT00918645|20748123|P1|COMPLETED|Overall Study||12
8418318|NCT00918645|20748123|P1|STARTED|Overall Study||13
8418319|NCT00918580|20748129|P1|NOT COMPLETED|After 6-month FU to 1-year FU||60
8418320|NCT00918580|20748129|P1|COMPLETED|After 6-month FU to 1-year FU||87
8418321|NCT00918580|20748129|P1|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
8418322|NCT00918580|20748129|P1|STARTED|After 6-month FU to 1-year FU||147
8418323|NCT00918580|20748129|P1|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
8418324|NCT00918580|20748129|P1|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
8418325|NCT00918580|20748129|P1|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
8418326|NCT00918580|20748129|P1|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
8418327|NCT00918580|20748129|P1|STARTED|Up to 6-month Follow-up(FU)||158
8418328|NCT00918567|20748149|P2|NOT COMPLETED|Overall Study||2
8418329|NCT00918567|20748150|P1|NOT COMPLETED|Overall Study||5
8418330|NCT00918567|20748149|P2|COMPLETED|Overall Study||25
8418331|NCT00918567|20748150|P1|COMPLETED|Overall Study||24
8418332|NCT00918567|20748149|P2|STARTED|Overall Study||27
8418333|NCT00918567|20748150|P1|STARTED|Overall Study||29
8418334|NCT00918463|20748176|P1|NOT COMPLETED|Overall Study||2
8418335|NCT00918463|20748176|P1|COMPLETED|Overall Study||0
8418336|NCT00918463|20748176|P1|STARTED|Overall Study||2
8418337|NCT00918385|20748184|P2|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
8418338|NCT00918385|20748185|P1|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
8418339|NCT00918385|20748184|P2|COMPLETED|Combination Nilutamide and Dasatinib||3
8418340|NCT00918385|20748185|P1|COMPLETED|Combination Nilutamide and Dasatinib||6
8418341|NCT00918385|20748184|P2|STARTED|Combination Nilutamide and Dasatinib||11
8418342|NCT00918385|20748185|P1|STARTED|Combination Nilutamide and Dasatinib||12
8418343|NCT00918385|20748184|P2|NOT COMPLETED|Monotherapy||6
8418344|NCT00918385|20748185|P1|NOT COMPLETED|Monotherapy||2
8418345|NCT00918385|20748184|P2|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
8418346|NCT00918385|20748185|P1|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
8418347|NCT00918385|20748184|P2|STARTED|Monotherapy||17
8418348|NCT00918385|20748185|P1|STARTED|Monotherapy||14
8418349|NCT00918346|20748194|P2|NOT COMPLETED|Post Study Period||0
8418350|NCT00918346|20748195|P1|NOT COMPLETED|Post Study Period||0
8418351|NCT00918346|20748194|P2|COMPLETED|Post Study Period||21
8418352|NCT00918346|20748195|P1|COMPLETED|Post Study Period||21
8418353|NCT00918346|20748194|P2|STARTED|Post Study Period||21
8418354|NCT00918346|20748195|P1|STARTED|Post Study Period||21
8418355|NCT00918346|20748194|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
8418356|NCT00918346|20748195|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
8418357|NCT00918346|20748194|P2|COMPLETED|Second Treatment Period (4 Weeks)||21
8418358|NCT00918346|20748195|P1|COMPLETED|Second Treatment Period (4 Weeks)||21
8418359|NCT00918346|20748194|P2|STARTED|Second Treatment Period (4 Weeks)||21
8418360|NCT00918346|20748195|P1|STARTED|Second Treatment Period (4 Weeks)||21
8418361|NCT00918346|20748194|P2|NOT COMPLETED|Washout (at Least 4 Weeks)||0
8418362|NCT00918346|20748195|P1|NOT COMPLETED|Washout (at Least 4 Weeks)||0
8418363|NCT00918346|20748194|P2|COMPLETED|Washout (at Least 4 Weeks)||21
8418364|NCT00918346|20748195|P1|COMPLETED|Washout (at Least 4 Weeks)||21
8418365|NCT00918346|20748194|P2|STARTED|Washout (at Least 4 Weeks)||21
8418366|NCT00918346|20748195|P1|STARTED|Washout (at Least 4 Weeks)||21
8418367|NCT00918346|20748194|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||1
8418368|NCT00918346|20748195|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||0
8418369|NCT00918346|20748194|P2|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
8418370|NCT00918346|20748195|P1|COMPLETED|First Treatment Period (4 Weeks)||21
8418371|NCT00918346|20748194|P2|STARTED|First Treatment Period (4 Weeks)||22
8418372|NCT00918346|20748195|P1|STARTED|First Treatment Period (4 Weeks)||21
8418373|NCT00918333|20748211|P2|NOT COMPLETED|Overall Study||5
8418374|NCT00918333|20748212|P1|NOT COMPLETED|Overall Study||3
8418375|NCT00918333|20748211|P2|COMPLETED|Overall Study||93
8418376|NCT00918333|20748212|P1|COMPLETED|Overall Study||23
8418377|NCT00918333|20748211|P2|STARTED|Overall Study||98
8418378|NCT00918333|20748212|P1|STARTED|Overall Study||26
8418379|NCT00918281|20748232|P1|NOT COMPLETED|Overall Study||29
8418380|NCT00918281|20748232|P1|COMPLETED|Overall Study||41
8418381|NCT00918281|20748232|P1|STARTED|Overall Study||70
8418382|NCT00918255|20748242|P3|NOT COMPLETED|Overall Study||5
8418383|NCT00918255|20748243|P2|NOT COMPLETED|Overall Study||0
8418384|NCT00918255|20748244|P1|NOT COMPLETED|Overall Study||6
8418385|NCT00918255|20748242|P3|COMPLETED|Overall Study||46
8418386|NCT00918255|20748243|P2|COMPLETED|Overall Study||52
8418387|NCT00918255|20748244|P1|COMPLETED|Overall Study||45
8418388|NCT00918255|20748242|P3|STARTED|Overall Study||51
8418389|NCT00918255|20748243|P2|STARTED|Overall Study||52
8418390|NCT00918255|20748244|P1|STARTED|Overall Study||51
8418391|NCT00918229|20748270|P1|NOT COMPLETED|Overall Study||0
8418392|NCT00918229|20748270|P1|COMPLETED|Overall Study||24
8418393|NCT00918229|20748270|P1|STARTED|Overall Study||24
8418394|NCT00918203|20748277|P3|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
8418395|NCT00918203|20748278|P2|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
8418396|NCT00918203|20748279|P1|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
8418397|NCT00918203|20748277|P3|COMPLETED|Crossover to Olaratumab Monotherapy||18
8418398|NCT00918203|20748278|P2|COMPLETED|Crossover to Olaratumab Monotherapy||0
8418399|NCT00918203|20748279|P1|COMPLETED|Crossover to Olaratumab Monotherapy||0
8418400|NCT00918203|20748277|P3|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
8418401|NCT00918203|20748278|P2|STARTED|Crossover to Olaratumab Monotherapy||0
8418402|NCT00918203|20748279|P1|STARTED|Crossover to Olaratumab Monotherapy||0
8418403|NCT00918203|20748277|P3|NOT COMPLETED|Treatment With or Without Olaratumab||0
8418404|NCT00918203|20748278|P2|NOT COMPLETED|Treatment With or Without Olaratumab||10
8418405|NCT00918203|20748279|P1|NOT COMPLETED|Treatment With or Without Olaratumab||6
8418406|NCT00918203|20748277|P3|COMPLETED|Treatment With or Without Olaratumab||0
8418407|NCT00918203|20748278|P2|COMPLETED|Treatment With or Without Olaratumab||57
8418408|NCT00918203|20748279|P1|COMPLETED|Treatment With or Without Olaratumab||64
8418409|NCT00918203|20748277|P3|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
8418410|NCT00918203|20748278|P2|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
8418411|NCT00918203|20748279|P1|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
8418412|NCT00918203|20748277|P3|Death Due to Any Cause|Treatment With or Without Olaratumab||0
8418413|NCT00918203|20748278|P2|Death Due to Any Cause|Treatment With or Without Olaratumab||47
8418414|NCT00918203|20748279|P1|Death Due to Any Cause|Treatment With or Without Olaratumab||53
8418415|NCT00918203|20748277|P3|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
8418416|NCT00918203|20748278|P2|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
8418417|NCT00918203|20748279|P1|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
8418418|NCT00918203|20748277|P3|STARTED|Treatment With or Without Olaratumab||0
8418419|NCT00918203|20748278|P2|STARTED|Treatment With or Without Olaratumab||67
8418420|NCT00918203|20748279|P1|STARTED|Treatment With or Without Olaratumab||70
8418421|NCT00918138|20748310|P2|NOT COMPLETED|Overall Study||1
8418422|NCT00918138|20748311|P1|NOT COMPLETED|Overall Study||2
8418423|NCT00918138|20748310|P2|COMPLETED|Overall Study||46
8418424|NCT00918138|20748311|P1|COMPLETED|Overall Study||44
8418425|NCT00918138|20748310|P2|STARTED|Overall Study||47
8418426|NCT00918138|20748311|P1|STARTED|Overall Study||46
8418427|NCT00918125|20748327|P2|NOT COMPLETED|Overall Study||0
8418428|NCT00918125|20748328|P1|NOT COMPLETED|Overall Study||0
8418429|NCT00918125|20748327|P2|COMPLETED|Overall Study||39
8418430|NCT00918125|20748328|P1|COMPLETED|Overall Study||20
8418431|NCT00918125|20748327|P2|STARTED|Overall Study||39
8418432|NCT00918125|20748328|P1|STARTED|Overall Study||20
8418433|NCT00917865|20748339|P1|NOT COMPLETED|Overall Study||0
8418434|NCT00917865|20748339|P1|COMPLETED|Overall Study||11
8418435|NCT00917865|20748339|P1|STARTED|Overall Study||11
8418436|NCT00917852|20748350|P1|NOT COMPLETED|Overall Study||6
8418437|NCT00917852|20748350|P1|COMPLETED|Overall Study||45
8418438|NCT00917852|20748350|P1|STARTED|Overall Study||51
8418439|NCT00917735|20748357|P2|NOT COMPLETED|Overall Study||63
8418440|NCT00917735|20748358|P1|NOT COMPLETED|Overall Study||75
8418441|NCT00917735|20748357|P2|COMPLETED|Overall Study||474
8418442|NCT00917735|20748358|P1|COMPLETED|Overall Study||463
8418443|NCT00917735|20748357|P2|STARTED|Overall Study||537
8418444|NCT00917735|20748358|P1|STARTED|Overall Study||538
8418481|NCT00917553|20748400|P2|NOT COMPLETED|Overall Study||1
8418482|NCT00917553|20748401|P1|NOT COMPLETED|Overall Study||2
8418483|NCT00917553|20748400|P2|COMPLETED|Overall Study||15
8418484|NCT00917553|20748401|P1|COMPLETED|Overall Study||15
8418485|NCT00917553|20748400|P2|STARTED|Overall Study||16
8418486|NCT00917553|20748401|P1|STARTED|Overall Study||17
8418487|NCT00917501|20748417|P2|NOT COMPLETED|Overall Study||5
8418488|NCT00917501|20748418|P1|NOT COMPLETED|Overall Study||8
8418489|NCT00917501|20748417|P2|COMPLETED|Overall Study||21
8418490|NCT00917501|20748418|P1|COMPLETED|Overall Study||21
8418491|NCT00917501|20748417|P2|STARTED|Overall Study||26
8418492|NCT00917501|20748418|P1|STARTED|Overall Study||29
8418493|NCT00917462|20748424|P1|NOT COMPLETED|Overall Study||1
8418494|NCT00917462|20748424|P1|COMPLETED|Overall Study||34
8418495|NCT00917462|20748424|P1|STARTED|Overall Study||35
8418496|NCT00917384|20748434|P2|NOT COMPLETED|Overall Study||4
8418497|NCT00917384|20748435|P1|NOT COMPLETED|Overall Study||14
8418498|NCT00917384|20748434|P2|COMPLETED|Overall Study||113
8418499|NCT00917384|20748435|P1|COMPLETED|Overall Study||224
8418500|NCT00917384|20748434|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
8418501|NCT00917384|20748435|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
8418502|NCT00917384|20748434|P2|STARTED|Overall Study||117
8418503|NCT00917384|20748435|P1|STARTED|Overall Study||238
8418504|NCT00917267|20748459|P2|NOT COMPLETED|Overall Study||79
8418505|NCT00917267|20748460|P1|NOT COMPLETED|Overall Study||39
8418506|NCT00917267|20748459|P2|COMPLETED|Overall Study||266
8418507|NCT00917267|20748460|P1|COMPLETED|Overall Study||307
8418508|NCT00917267|20748459|P2|Intent to Treat (ITT)|Overall Study||338
8418509|NCT00917267|20748460|P1|Intent to Treat (ITT)|Overall Study||340
8418510|NCT00917267|20748459|P2|STARTED|Overall Study||345
8418511|NCT00917267|20748460|P1|STARTED|Overall Study||346
8418512|NCT00917124|20748488|P2|NOT COMPLETED|Overall Study||6
8418513|NCT00917124|20748489|P1|NOT COMPLETED|Overall Study||4
8418514|NCT00917124|20748488|P2|COMPLETED|Overall Study||94
8418515|NCT00917124|20748489|P1|COMPLETED|Overall Study||96
8418516|NCT00917124|20748488|P2|STARTED|Overall Study||100
8418517|NCT00917124|20748489|P1|STARTED|Overall Study||100
8418518|NCT00916929|20748499|P2|NOT COMPLETED|Overall Study||29
8418519|NCT00916929|20748500|P1|NOT COMPLETED|Overall Study||10
8418520|NCT00916929|20748499|P2|COMPLETED|Overall Study||53
8418521|NCT00916929|20748500|P1|COMPLETED|Overall Study||70
8418522|NCT00916929|20748499|P2|STARTED|Overall Study||82
8418523|NCT00916929|20748500|P1|STARTED|Overall Study||80
8418524|NCT00916721|20748510|P2|NOT COMPLETED|Overall Study||10
8418525|NCT00916721|20748511|P1|NOT COMPLETED|Overall Study||10
8418526|NCT00916721|20748510|P2|COMPLETED|Overall Study||29
8418527|NCT00916721|20748511|P1|COMPLETED|Overall Study||25
8418528|NCT00916721|20748510|P2|STARTED|Overall Study||39
8418529|NCT00916721|20748511|P1|STARTED|Overall Study||35
8418530|NCT00916643|20748523|P1|NOT COMPLETED|Overall Study||0
8418531|NCT00916643|20748523|P1|COMPLETED|Overall Study||113
8418532|NCT00916643|20748523|P1|STARTED|Overall Study||113
8418533|NCT00916617|20748534|P4|NOT COMPLETED|Overall Study||7
8418534|NCT00916617|20748535|P3|NOT COMPLETED|Overall Study||10
8418535|NCT00916617|20748536|P2|NOT COMPLETED|Overall Study||21
8418536|NCT00916617|20748537|P1|NOT COMPLETED|Overall Study||23
8418537|NCT00916617|20748534|P4|COMPLETED|Overall Study||0
8418538|NCT00916617|20748535|P3|COMPLETED|Overall Study||0
8418539|NCT00916617|20748536|P2|COMPLETED|Overall Study||0
8418540|NCT00916617|20748537|P1|COMPLETED|Overall Study||1
8418541|NCT00916617|20748534|P4|STARTED|Overall Study||7
8418542|NCT00916617|20748535|P3|STARTED|Overall Study||10
8418543|NCT00916617|20748536|P2|STARTED|Overall Study||21
8418544|NCT00916617|20748537|P1|STARTED|Overall Study||24
8418545|NCT00916578|20748551|P1|NOT COMPLETED|Overall Study||7
8418546|NCT00916578|20748551|P1|COMPLETED|Overall Study||26
8418547|NCT00916578|20748551|P1|STARTED|Overall Study||33
8418548|NCT00916539|20748557|P2|NOT COMPLETED|Overall Study||0
8418549|NCT00916539|20748558|P1|NOT COMPLETED|Overall Study||0
8418550|NCT00916539|20748557|P2|COMPLETED|Overall Study||31
8418551|NCT00916539|20748558|P1|COMPLETED|Overall Study||31
8418552|NCT00916539|20748557|P2|STARTED|Overall Study||31
8418553|NCT00916539|20748558|P1|STARTED|Overall Study||31
8418554|NCT00916383|20748580|P1|NOT COMPLETED|Overall Study||3
8418555|NCT00916383|20748580|P1|COMPLETED|Overall Study||46
8418556|NCT00916383|20748580|P1|STARTED|Overall Study||49
8418557|NCT00916370|20748608|P2|NOT COMPLETED|Overall Study||2
8418558|NCT00916370|20748609|P1|NOT COMPLETED|Overall Study||5
8418559|NCT00916370|20748608|P2|COMPLETED|Overall Study||102
8418560|NCT00916370|20748609|P1|COMPLETED|Overall Study||396
8418561|NCT00916370|20748608|P2|STARTED|Overall Study||104
8418562|NCT00916370|20748609|P1|STARTED|Overall Study||401
8418563|NCT00916357|20748783|P6|NOT COMPLETED|Period 3||0
8418564|NCT00916357|20748784|P5|NOT COMPLETED|Period 3||0
8418565|NCT00916357|20748785|P4|NOT COMPLETED|Period 3||0
8418566|NCT00916357|20748786|P3|NOT COMPLETED|Period 3||0
8418567|NCT00916357|20748787|P2|NOT COMPLETED|Period 3||0
8418568|NCT00916357|20748788|P1|NOT COMPLETED|Period 3||0
8418569|NCT00916357|20748783|P6|COMPLETED|Period 3||4
8418570|NCT00916357|20748784|P5|COMPLETED|Period 3||3
8418571|NCT00916357|20748785|P4|COMPLETED|Period 3||3
8418572|NCT00916357|20748786|P3|COMPLETED|Period 3||4
8418573|NCT00916357|20748787|P2|COMPLETED|Period 3||4
8418574|NCT00916357|20748788|P1|COMPLETED|Period 3||3
8418575|NCT00916357|20748783|P6|STARTED|Period 3||4
8418576|NCT00916357|20748784|P5|STARTED|Period 3||3
8418577|NCT00916357|20748785|P4|STARTED|Period 3||3
8418578|NCT00916357|20748786|P3|STARTED|Period 3||4
8418579|NCT00916357|20748787|P2|STARTED|Period 3||4
8418580|NCT00916357|20748788|P1|STARTED|Period 3||3
8418581|NCT00916357|20748783|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
8418582|NCT00916357|20748784|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
8418583|NCT00916357|20748785|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
8418584|NCT00916357|20748786|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
8418585|NCT00916357|20748787|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
8418586|NCT00916357|20748788|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
8418587|NCT00916357|20748783|P6|COMPLETED|Washout (3 to 14 Days)||4
8418588|NCT00916357|20748784|P5|COMPLETED|Washout (3 to 14 Days)||3
8418589|NCT00916357|20748785|P4|COMPLETED|Washout (3 to 14 Days)||3
8418590|NCT00916357|20748786|P3|COMPLETED|Washout (3 to 14 Days)||4
8418591|NCT00916357|20748787|P2|COMPLETED|Washout (3 to 14 Days)||4
8418592|NCT00916357|20748788|P1|COMPLETED|Washout (3 to 14 Days)||3
8418593|NCT00916357|20748783|P6|STARTED|Washout (3 to 14 Days)||4
8418594|NCT00916357|20748784|P5|STARTED|Washout (3 to 14 Days)||3
8418595|NCT00916357|20748785|P4|STARTED|Washout (3 to 14 Days)||3
8418596|NCT00916357|20748786|P3|STARTED|Washout (3 to 14 Days)||4
8418597|NCT00916357|20748787|P2|STARTED|Washout (3 to 14 Days)||4
8418598|NCT00916357|20748788|P1|STARTED|Washout (3 to 14 Days)||3
8418599|NCT00916357|20748783|P6|NOT COMPLETED|Period 2||0
8418600|NCT00916357|20748784|P5|NOT COMPLETED|Period 2||0
8418601|NCT00916357|20748785|P4|NOT COMPLETED|Period 2||1
8418602|NCT00916357|20748786|P3|NOT COMPLETED|Period 2||0
8418603|NCT00916357|20748787|P2|NOT COMPLETED|Period 2||0
8418604|NCT00916357|20748788|P1|NOT COMPLETED|Period 2||0
8418605|NCT00916357|20748783|P6|COMPLETED|Period 2||4
8418606|NCT00916357|20748784|P5|COMPLETED|Period 2||3
8418607|NCT00916357|20748785|P4|COMPLETED|Period 2||3
8418608|NCT00916357|20748786|P3|COMPLETED|Period 2||4
8418609|NCT00916357|20748787|P2|COMPLETED|Period 2||4
8418610|NCT00916357|20748788|P1|COMPLETED|Period 2||3
8418611|NCT00916357|20748783|P6|STARTED|Period 2||4
8418612|NCT00916357|20748784|P5|STARTED|Period 2||3
8418613|NCT00916357|20748785|P4|STARTED|Period 2||4
8418614|NCT00916357|20748786|P3|STARTED|Period 2||4
8418615|NCT00916357|20748787|P2|STARTED|Period 2||4
8418616|NCT00916357|20748788|P1|STARTED|Period 2||3
8418617|NCT00916357|20748783|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
8418618|NCT00916357|20748784|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
8418619|NCT00916357|20748785|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
8418620|NCT00916357|20748786|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
8418621|NCT00916357|20748787|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
8418622|NCT00916357|20748788|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
8418623|NCT00916357|20748783|P6|COMPLETED|Washout (3 to 14 Days)||4
8418624|NCT00916357|20748784|P5|COMPLETED|Washout (3 to 14 Days)||3
8418625|NCT00916357|20748785|P4|COMPLETED|Washout (3 to 14 Days)||4
8418626|NCT00916357|20748786|P3|COMPLETED|Washout (3 to 14 Days)||4
8418627|NCT00916357|20748787|P2|COMPLETED|Washout (3 to 14 Days)||4
8418628|NCT00916357|20748788|P1|COMPLETED|Washout (3 to 14 Days)||3
8418629|NCT00916357|20748783|P6|STARTED|Washout (3 to 14 Days)||4
8418630|NCT00916357|20748784|P5|STARTED|Washout (3 to 14 Days)||3
8418631|NCT00916357|20748785|P4|STARTED|Washout (3 to 14 Days)||4
8418632|NCT00916357|20748786|P3|STARTED|Washout (3 to 14 Days)||4
8418633|NCT00916357|20748787|P2|STARTED|Washout (3 to 14 Days)||4
8418634|NCT00916357|20748788|P1|STARTED|Washout (3 to 14 Days)||3
8418635|NCT00916357|20748783|P6|NOT COMPLETED|Period 1||0
8418636|NCT00916357|20748784|P5|NOT COMPLETED|Period 1||0
8418637|NCT00916357|20748785|P4|NOT COMPLETED|Period 1||0
8418638|NCT00916357|20748786|P3|NOT COMPLETED|Period 1||0
8418639|NCT00916357|20748787|P2|NOT COMPLETED|Period 1||0
8418640|NCT00916357|20748788|P1|NOT COMPLETED|Period 1||1
8418641|NCT00916357|20748783|P6|COMPLETED|Period 1||4
8418642|NCT00916357|20748784|P5|COMPLETED|Period 1||3
8418643|NCT00916357|20748785|P4|COMPLETED|Period 1||4
8418644|NCT00916357|20748786|P3|COMPLETED|Period 1||4
8418645|NCT00916357|20748787|P2|COMPLETED|Period 1||4
8418646|NCT00916357|20748788|P1|COMPLETED|Period 1||3
8418647|NCT00916357|20748783|P6|Received at Least 1 Dose of Study Drug|Period 1||4
8418648|NCT00916357|20748784|P5|Received at Least 1 Dose of Study Drug|Period 1||3
8418649|NCT00916357|20748785|P4|Received at Least 1 Dose of Study Drug|Period 1||4
8418650|NCT00916357|20748786|P3|Received at Least 1 Dose of Study Drug|Period 1||4
8418651|NCT00916357|20748787|P2|Received at Least 1 Dose of Study Drug|Period 1||4
8418652|NCT00916357|20748788|P1|Received at Least 1 Dose of Study Drug|Period 1||4
8418653|NCT00916357|20748783|P6|STARTED|Period 1||4
8418654|NCT00916357|20748784|P5|STARTED|Period 1||3
8418655|NCT00916357|20748785|P4|STARTED|Period 1||4
8418656|NCT00916357|20748786|P3|STARTED|Period 1||4
8418657|NCT00916357|20748787|P2|STARTED|Period 1||4
8418658|NCT00916357|20748788|P1|STARTED|Period 1||4
8418659|NCT00916344|20748826|P1|NOT COMPLETED|Overall Study||8
8418660|NCT00916344|20748826|P1|COMPLETED|Overall Study||167
8418661|NCT00916344|20748826|P1|STARTED|Overall Study||175
8418662|NCT00916305|20748833|P2|NOT COMPLETED|Overall Study||28
8418663|NCT00916305|20748834|P1|NOT COMPLETED|Overall Study||21
8418664|NCT00916305|20748833|P2|COMPLETED|Overall Study||9
8418665|NCT00916305|20748834|P1|COMPLETED|Overall Study||7
8418666|NCT00916305|20748833|P2|STARTED|Overall Study||37
8418667|NCT00916305|20748834|P1|STARTED|Overall Study||28
8418668|NCT00916279|20748842|P1|NOT COMPLETED|Overall Study||4
8418669|NCT00916279|20748842|P1|COMPLETED|Overall Study||37
8418670|NCT00916279|20748842|P1|24 Months|Overall Study||37
8418671|NCT00916279|20748842|P1|6 Months|Overall Study||41
8418672|NCT00916279|20748842|P1|30 Days|Overall Study||41
8418673|NCT00916279|20748842|P1|STARTED|Overall Study||41
8418674|NCT00916149|20748853|P3|NOT COMPLETED|Overall Study||0
8418675|NCT00916149|20748854|P2|NOT COMPLETED|Overall Study||2
8418676|NCT00916149|20748855|P1|NOT COMPLETED|Overall Study||4
8418677|NCT00916149|20748853|P3|COMPLETED|Overall Study||5
8418678|NCT00916149|20748854|P2|COMPLETED|Overall Study||8
8418679|NCT00916149|20748855|P1|COMPLETED|Overall Study||12
8418680|NCT00916149|20748853|P3|STARTED|Overall Study||5
8418681|NCT00916149|20748854|P2|STARTED|Overall Study||10
8418682|NCT00916149|20748855|P1|STARTED|Overall Study||16
8418683|NCT00916136|20748926|P2|NOT COMPLETED|Overall Study||0
8418684|NCT00916136|20748927|P1|NOT COMPLETED|Overall Study||0
8418685|NCT00916136|20748926|P2|COMPLETED|Overall Study||29
8418686|NCT00916136|20748927|P1|COMPLETED|Overall Study||37
8418687|NCT00916136|20748926|P2|STARTED|Overall Study||29
8418688|NCT00916136|20748927|P1|STARTED|Overall Study||37
8418689|NCT00916058|20748942|P7|NOT COMPLETED|Phase 2||3
8418690|NCT00916058|20748943|P6|NOT COMPLETED|Phase 2||0
8418691|NCT00916058|20748944|P5|NOT COMPLETED|Phase 2||0
8418692|NCT00916058|20748945|P4|NOT COMPLETED|Phase 2||0
8418693|NCT00916058|20748946|P3|NOT COMPLETED|Phase 2||0
8418694|NCT00916058|20748947|P2|NOT COMPLETED|Phase 2||0
8418695|NCT00916058|20748948|P1|NOT COMPLETED|Phase 2||0
8418696|NCT00916058|20748942|P7|COMPLETED|Phase 2||28
8418697|NCT00916058|20748943|P6|COMPLETED|Phase 2||0
8418698|NCT00916058|20748944|P5|COMPLETED|Phase 2||0
8418699|NCT00916058|20748945|P4|COMPLETED|Phase 2||0
8418700|NCT00916058|20748946|P3|COMPLETED|Phase 2||0
8418701|NCT00916058|20748947|P2|COMPLETED|Phase 2||0
8418702|NCT00916058|20748948|P1|COMPLETED|Phase 2||0
8418703|NCT00916058|20748942|P7|STARTED|Phase 2||31
8418704|NCT00916058|20748943|P6|STARTED|Phase 2||0
8418705|NCT00916058|20748944|P5|STARTED|Phase 2||0
8418706|NCT00916058|20748945|P4|STARTED|Phase 2||0
8418707|NCT00916058|20748946|P3|STARTED|Phase 2||0
8418708|NCT00916058|20748947|P2|STARTED|Phase 2||0
8418709|NCT00916058|20748948|P1|STARTED|Phase 2||0
8418710|NCT00916058|20748942|P7|NOT COMPLETED|Phase 1||0
8418711|NCT00916058|20748943|P6|NOT COMPLETED|Phase 1||1
8418712|NCT00916058|20748944|P5|NOT COMPLETED|Phase 1||0
8418713|NCT00916058|20748945|P4|NOT COMPLETED|Phase 1||0
8418714|NCT00916058|20748946|P3|NOT COMPLETED|Phase 1||0
8418715|NCT00916058|20748947|P2|NOT COMPLETED|Phase 1||0
8418716|NCT00916058|20748948|P1|NOT COMPLETED|Phase 1||0
8418717|NCT00916058|20748942|P7|COMPLETED|Phase 1||0
8418718|NCT00916058|20748943|P6|COMPLETED|Phase 1||7
8418719|NCT00916058|20748944|P5|COMPLETED|Phase 1||3
8418720|NCT00916058|20748945|P4|COMPLETED|Phase 1||3
8418721|NCT00916058|20748946|P3|COMPLETED|Phase 1||3
8418722|NCT00916058|20748947|P2|COMPLETED|Phase 1||6
8418723|NCT00916058|20748948|P1|COMPLETED|Phase 1||3
8418724|NCT00916058|20748942|P7|STARTED|Phase 1||0
8418725|NCT00916058|20748943|P6|STARTED|Phase 1||8
8418726|NCT00916058|20748944|P5|STARTED|Phase 1||3
8418727|NCT00916058|20748945|P4|STARTED|Phase 1||3
8418728|NCT00916058|20748946|P3|STARTED|Phase 1||3
8418729|NCT00916058|20748947|P2|STARTED|Phase 1||6
8418730|NCT00916058|20748948|P1|STARTED|Phase 1||3
8418737|NCT00916006|20749011|P2|NOT COMPLETED|Overall Study||7
8418738|NCT00916006|20749012|P1|NOT COMPLETED|Overall Study||3
8418739|NCT00916006|20749011|P2|COMPLETED|Overall Study||127
8418740|NCT00916006|20749012|P1|COMPLETED|Overall Study||132
8418741|NCT00916006|20749011|P2|STARTED|Overall Study||134
8418742|NCT00916006|20749012|P1|STARTED|Overall Study||135
8418743|NCT00915967|20749022|P2|NOT COMPLETED|Overall Study||2
8418744|NCT00915967|20749023|P1|NOT COMPLETED|Overall Study||1
8418745|NCT00915967|20749022|P2|COMPLETED|Overall Study||98
8418746|NCT00915967|20749023|P1|COMPLETED|Overall Study||97
8418747|NCT00915967|20749022|P2|STARTED|Overall Study||100
8418748|NCT00915967|20749023|P1|STARTED|Overall Study||98
8418749|NCT00915954|20749032|P3|NOT COMPLETED|Overall Study||0
8418750|NCT00915954|20749033|P2|NOT COMPLETED|Overall Study||0
8418751|NCT00915954|20749034|P1|NOT COMPLETED|Overall Study||0
8418752|NCT00915954|20749032|P3|COMPLETED|Overall Study||10
8418753|NCT00915954|20749033|P2|COMPLETED|Overall Study||8
8418754|NCT00915954|20749034|P1|COMPLETED|Overall Study||10
8418755|NCT00915954|20749032|P3|STARTED|Overall Study||10
8418756|NCT00915954|20749033|P2|STARTED|Overall Study||8
8418757|NCT00915954|20749034|P1|STARTED|Overall Study||10
8418758|NCT00915928|20749053|P2|NOT COMPLETED|Overall Study||0
8418759|NCT00915928|20749054|P1|NOT COMPLETED|Overall Study||0
8418760|NCT00915928|20749053|P2|COMPLETED|Overall Study||22
8418761|NCT00915928|20749054|P1|COMPLETED|Overall Study||25
8418762|NCT00915928|20749053|P2|STARTED|Overall Study||22
8418763|NCT00915928|20749054|P1|STARTED|Overall Study||25
8418764|NCT00915902|20749063|P2|NOT COMPLETED|2nd Treatment Period||1
8418765|NCT00915902|20749064|P1|NOT COMPLETED|2nd Treatment Period||0
8418766|NCT00915902|20749063|P2|COMPLETED|2nd Treatment Period||20
8418767|NCT00915902|20749064|P1|COMPLETED|2nd Treatment Period||19
8418768|NCT00915902|20749063|P2|STARTED|2nd Treatment Period||21
8418769|NCT00915902|20749064|P1|STARTED|2nd Treatment Period||19
8418770|NCT00915902|20749063|P2|NOT COMPLETED|Washout (4 Weeks)||1
8418771|NCT00915902|20749064|P1|NOT COMPLETED|Washout (4 Weeks)||0
8418772|NCT00915902|20749063|P2|COMPLETED|Washout (4 Weeks)||21
8418773|NCT00915902|20749064|P1|COMPLETED|Washout (4 Weeks)||19
8418774|NCT00915902|20749063|P2|STARTED|Washout (4 Weeks)||22
8418775|NCT00915902|20749064|P1|STARTED|Washout (4 Weeks)||19
8418776|NCT00915902|20749063|P2|NOT COMPLETED|1st Treatment Period||0
8418777|NCT00915902|20749064|P1|NOT COMPLETED|1st Treatment Period||1
8418778|NCT00915902|20749063|P2|COMPLETED|1st Treatment Period||22
8418779|NCT00915902|20749064|P1|COMPLETED|1st Treatment Period||19
8418780|NCT00915902|20749063|P2|STARTED|1st Treatment Period||22
8418781|NCT00915902|20749064|P1|STARTED|1st Treatment Period||20
8418782|NCT00915876|20749074|P2|NOT COMPLETED|Overall Study||1
8418783|NCT00915876|20749075|P1|NOT COMPLETED|Overall Study||0
8418784|NCT00915876|20749074|P2|COMPLETED|Overall Study||20
8418785|NCT00915876|20749075|P1|COMPLETED|Overall Study||20
8418786|NCT00915876|20749074|P2|Moving Beyond First Dose|Overall Study||20
8418787|NCT00915876|20749075|P1|Moving Beyond First Dose|Overall Study||20
8418788|NCT00915876|20749074|P2|STARTED|Overall Study||21
8418789|NCT00915876|20749075|P1|STARTED|Overall Study||20
8418790|NCT00915798|20749085|P4|NOT COMPLETED|Overall Study||0
8418791|NCT00915798|20749086|P3|NOT COMPLETED|Overall Study||0
8418792|NCT00915798|20749087|P2|NOT COMPLETED|Overall Study||0
8418793|NCT00915798|20749088|P1|NOT COMPLETED|Overall Study||0
8418794|NCT00915798|20749085|P4|COMPLETED|Overall Study||26
8418795|NCT00915798|20749086|P3|COMPLETED|Overall Study||23
8418796|NCT00915798|20749087|P2|COMPLETED|Overall Study||21
8418797|NCT00915798|20749088|P1|COMPLETED|Overall Study||19
8418798|NCT00915798|20749085|P4|STARTED|Overall Study||26
8418799|NCT00915798|20749086|P3|STARTED|Overall Study||23
8418800|NCT00915798|20749087|P2|STARTED|Overall Study||21
8418801|NCT00915798|20749088|P1|STARTED|Overall Study||19
8418802|NCT00915772|20749111|P3|NOT COMPLETED|Overall Study||29
8418803|NCT00915772|20749112|P2|NOT COMPLETED|Overall Study||46
8418804|NCT00915772|20749113|P1|NOT COMPLETED|Overall Study||36
8418805|NCT00915772|20749111|P3|COMPLETED|Overall Study||142
8418806|NCT00915772|20749112|P2|COMPLETED|Overall Study||179
8418807|NCT00915772|20749113|P1|COMPLETED|Overall Study||134
8418808|NCT00915772|20749111|P3|STARTED|Overall Study||171
8418809|NCT00915772|20749112|P2|STARTED|Overall Study||225
8418810|NCT00915772|20749113|P1|STARTED|Overall Study||170
8418811|NCT00915759|20749158|P1|NOT COMPLETED|Overall Study||0
8418812|NCT00915759|20749158|P1|COMPLETED|Overall Study|number of participants|40
8418813|NCT00915759|20749158|P1|STARTED|Overall Study|number of participants|40
8418814|NCT00915655|20749168|P1|NOT COMPLETED|Overall Study||0
8418815|NCT00915655|20749168|P1|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
8418816|NCT00915655|20749168|P1|STARTED|Overall Study||12
8418817|NCT00915603|20749175|P2|NOT COMPLETED|Overall Study||55
8418818|NCT00915603|20749176|P1|NOT COMPLETED|Overall Study||56
8418819|NCT00915603|20749175|P2|COMPLETED|Overall Study||0
8418820|NCT00915603|20749176|P1|COMPLETED|Overall Study||0
8418821|NCT00915603|20749175|P2|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
8418822|NCT00915603|20749176|P1|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
8418823|NCT00915590|20749192|P2|NOT COMPLETED|Overall Study||1
8418824|NCT00915590|20749193|P1|NOT COMPLETED|Overall Study||2
8418825|NCT00915590|20749192|P2|COMPLETED|Overall Study||4
8418826|NCT00915590|20749193|P1|COMPLETED|Overall Study||3
8418827|NCT00915590|20749192|P2|STARTED|Overall Study||5
8418828|NCT00915590|20749193|P1|STARTED|Overall Study||5
8418829|NCT00915551|20749212|P2|NOT COMPLETED|Overall Study||1
8418830|NCT00915551|20749213|P1|NOT COMPLETED|Overall Study||0
8418831|NCT00915551|20749212|P2|COMPLETED|Overall Study||135
8418832|NCT00915551|20749213|P1|COMPLETED|Overall Study||142
8418833|NCT00915551|20749212|P2|STARTED|Overall Study||136
8418834|NCT00915551|20749213|P1|STARTED|Overall Study||142
8418835|NCT00915538|20749223|P2|NOT COMPLETED|Overall Study||0
8418836|NCT00915538|20749224|P1|NOT COMPLETED|Overall Study||0
8418837|NCT00915538|20749223|P2|COMPLETED|Overall Study||8
8418838|NCT00915538|20749224|P1|COMPLETED|Overall Study||8
8418839|NCT00915538|20749223|P2|STARTED|Overall Study||8
8418840|NCT00915538|20749224|P1|STARTED|Overall Study||8
8418841|NCT00915525|20749234|P2|NOT COMPLETED|Overall Study||135
8418842|NCT00915525|20749235|P1|NOT COMPLETED|Overall Study||265
8418843|NCT00915525|20749234|P2|COMPLETED|Overall Study||151
8418844|NCT00915525|20749235|P1|COMPLETED|Overall Study||278
8418845|NCT00915525|20749234|P2|STARTED|Overall Study||286
8418846|NCT00915525|20749235|P1|STARTED|Overall Study||543
8418847|NCT00915499|20749338|P2|NOT COMPLETED|Overall Study||2
8418848|NCT00915499|20749339|P1|NOT COMPLETED|Overall Study||4
8418849|NCT00915499|20749338|P2|COMPLETED|Overall Study||31
8418850|NCT00915499|20749339|P1|COMPLETED|Overall Study||29
8418851|NCT00915499|20749338|P2|STARTED|Overall Study||33
8418852|NCT00915499|20749339|P1|STARTED|Overall Study||33
8418853|NCT00915473|20749349|P2|NOT COMPLETED|4-week Follow Up||5
8418854|NCT00915473|20749350|P1|NOT COMPLETED|4-week Follow Up||1
8418855|NCT00915473|20749349|P2|COMPLETED|4-week Follow Up||30
8418856|NCT00915473|20749350|P1|COMPLETED|4-week Follow Up||33
8418857|NCT00915473|20749349|P2|STARTED|4-week Follow Up||35
8418858|NCT00915473|20749350|P1|STARTED|4-week Follow Up||34
8418859|NCT00915473|20749349|P2|NOT COMPLETED|Injection||0
8418860|NCT00915473|20749350|P1|NOT COMPLETED|Injection||0
8418861|NCT00915473|20749349|P2|COMPLETED|Injection||35
8418862|NCT00915473|20749350|P1|COMPLETED|Injection||34
8418863|NCT00915473|20749349|P2|STARTED|Injection||35
8418864|NCT00915473|20749350|P1|STARTED|Injection||34
8418865|NCT00915473|20749349|P2|NOT COMPLETED|Screening||0
8418866|NCT00915473|20749350|P1|NOT COMPLETED|Screening||1
8418867|NCT00915473|20749349|P2|COMPLETED|Screening||35
8418868|NCT00915473|20749350|P1|COMPLETED|Screening||34
8418869|NCT00915473|20749349|P2|STARTED|Screening||35
8418870|NCT00915473|20749350|P1|STARTED|Screening||35
8418871|NCT00915356|20749367|P5|NOT COMPLETED|Overall Study||0
8418872|NCT00915356|20749368|P4|NOT COMPLETED|Overall Study||0
8418873|NCT00915356|20749369|P3|NOT COMPLETED|Overall Study||0
8418874|NCT00915356|20749370|P2|NOT COMPLETED|Overall Study||0
8418875|NCT00915356|20749371|P1|NOT COMPLETED|Overall Study||1
8418876|NCT00915356|20749367|P5|COMPLETED|Overall Study||43
8418877|NCT00915356|20749368|P4|COMPLETED|Overall Study||12
8418878|NCT00915356|20749369|P3|COMPLETED|Overall Study||45
8418879|NCT00915356|20749370|P2|COMPLETED|Overall Study||45
8418880|NCT00915356|20749371|P1|COMPLETED|Overall Study||25
8418881|NCT00915356|20749367|P5|STARTED|Overall Study||43
8418882|NCT00915356|20749368|P4|STARTED|Overall Study||12
8418883|NCT00915356|20749369|P3|STARTED|Overall Study||45
8418884|NCT00915356|20749370|P2|STARTED|Overall Study||45
8418885|NCT00915356|20749371|P1|STARTED|Overall Study||26
8418886|NCT00915343|20749433|P3|NOT COMPLETED|Part B - Open Label Period||2
8418887|NCT00915343|20749434|P2|NOT COMPLETED|Part B - Open Label Period||0
8418888|NCT00915343|20749435|P1|NOT COMPLETED|Part B - Open Label Period||0
8418889|NCT00915343|20749433|P3|COMPLETED|Part B - Open Label Period||57
8418890|NCT00915343|20749434|P2|COMPLETED|Part B - Open Label Period||0
8418891|NCT00915343|20749435|P1|COMPLETED|Part B - Open Label Period||0
8418892|NCT00915343|20749433|P3|STARTED|Part B - Open Label Period||59
8418893|NCT00915343|20749434|P2|STARTED|Part B - Open Label Period||0
8418894|NCT00915343|20749435|P1|STARTED|Part B - Open Label Period||0
8418895|NCT00915343|20749433|P3|NOT COMPLETED|Part A - Second Intervention Period||0
8418896|NCT00915343|20749434|P2|NOT COMPLETED|Part A - Second Intervention Period||0
8418897|NCT00915343|20749435|P1|NOT COMPLETED|Part A - Second Intervention Period||0
8418898|NCT00915343|20749433|P3|COMPLETED|Part A - Second Intervention Period||0
8418899|NCT00915343|20749434|P2|COMPLETED|Part A - Second Intervention Period||32
8418900|NCT00915343|20749435|P1|COMPLETED|Part A - Second Intervention Period||32
8418901|NCT00915343|20749433|P3|STARTED|Part A - Second Intervention Period||0
8418902|NCT00915343|20749434|P2|STARTED|Part A - Second Intervention Period||32
8418903|NCT00915343|20749435|P1|STARTED|Part A - Second Intervention Period||32
8418904|NCT00915343|20749433|P3|NOT COMPLETED|Part A - First Intervention Period||0
8418905|NCT00915343|20749434|P2|NOT COMPLETED|Part A - First Intervention Period||0
8418906|NCT00915343|20749435|P1|NOT COMPLETED|Part A - First Intervention Period||0
8418907|NCT00915343|20749433|P3|COMPLETED|Part A - First Intervention Period||0
8418908|NCT00915343|20749434|P2|COMPLETED|Part A - First Intervention Period||32
8418909|NCT00915343|20749435|P1|COMPLETED|Part A - First Intervention Period||32
8418910|NCT00915343|20749433|P3|STARTED|Part A - First Intervention Period||0
8418911|NCT00915343|20749434|P2|STARTED|Part A - First Intervention Period||32
8418912|NCT00915343|20749435|P1|STARTED|Part A - First Intervention Period||32
8418913|NCT00915278|20749520|P6|NOT COMPLETED|Overall Study||8
8418914|NCT00915278|20749521|P5|NOT COMPLETED|Overall Study||2
8418915|NCT00915278|20749522|P4|NOT COMPLETED|Overall Study||3
8418916|NCT00915278|20749523|P3|NOT COMPLETED|Overall Study||1
8418917|NCT00915278|20749524|P2|NOT COMPLETED|Overall Study||3
8418918|NCT00915278|20749525|P1|NOT COMPLETED|Overall Study||5
8418919|NCT00915278|20749520|P6|COMPLETED|Overall Study||1
8418920|NCT00915278|20749521|P5|COMPLETED|Overall Study||1
8418921|NCT00915278|20749522|P4|COMPLETED|Overall Study||2
8418922|NCT00915278|20749523|P3|COMPLETED|Overall Study||2
8418923|NCT00915278|20749524|P2|COMPLETED|Overall Study||2
8418924|NCT00915278|20749525|P1|COMPLETED|Overall Study||3
8418925|NCT00915278|20749520|P6|STARTED|Overall Study||9
8418926|NCT00915278|20749521|P5|STARTED|Overall Study||3
8418927|NCT00915278|20749522|P4|STARTED|Overall Study||5
8418928|NCT00915278|20749523|P3|STARTED|Overall Study||3
8418929|NCT00915278|20749524|P2|STARTED|Overall Study||5
8418930|NCT00915278|20749525|P1|STARTED|Overall Study||8
8418931|NCT00915148|20749671|P1|NOT COMPLETED|Overall Study||0
8418932|NCT00915148|20749671|P1|COMPLETED|Overall Study|August 2010|110
8418933|NCT00915148|20749671|P1|STARTED|Overall Study|October 2009|110
8418934|NCT00915031|20749678|P2|NOT COMPLETED|Overall Study||0
8418935|NCT00915031|20749679|P1|NOT COMPLETED|Overall Study||0
8418936|NCT00915031|20749678|P2|COMPLETED|Overall Study||24
8418937|NCT00915031|20749679|P1|COMPLETED|Overall Study||714
8418938|NCT00915031|20749678|P2|STARTED|Overall Study||24
8418939|NCT00915031|20749679|P1|STARTED|Overall Study||714
8418940|NCT00915018|20749686|P2|NOT COMPLETED|Overall Study||207
8418941|NCT00915018|20749687|P1|NOT COMPLETED|Overall Study||215
8418942|NCT00915018|20749686|P2|COMPLETED|Overall Study||30
8418943|NCT00915018|20749687|P1|COMPLETED|Overall Study||27
8418944|NCT00915018|20749686|P2|Received Treatment|Overall Study||234
8418945|NCT00915018|20749687|P1|Received Treatment|Overall Study||240
8418946|NCT00915018|20749686|P2|STARTED|Overall Study||237
8418947|NCT00915018|20749687|P1|STARTED|Overall Study||242
8418948|NCT00915005|20749703|P2|NOT COMPLETED|Overall Study||19
8418949|NCT00915005|20749704|P1|NOT COMPLETED|Overall Study||13
8418950|NCT00915005|20749703|P2|COMPLETED|Overall Study||57
8418951|NCT00915005|20749704|P1|COMPLETED|Overall Study||92
8418952|NCT00915005|20749703|P2|STARTED|Overall Study||76
8418953|NCT00915005|20749704|P1|STARTED|Overall Study||105
8418963|NCT00914940|20749724|P1|NOT COMPLETED|2 Years to 5 Years Post-transplant||3
8418964|NCT00914940|20749724|P1|COMPLETED|2 Years to 5 Years Post-transplant||28
8418965|NCT00914940|20749724|P1|STARTED|2 Years to 5 Years Post-transplant||31
8418966|NCT00914940|20749724|P1|NOT COMPLETED|D101 to 2 Years Post-transplant||8
8418967|NCT00914940|20749724|P1|COMPLETED|D101 to 2 Years Post-transplant||31
8418968|NCT00914940|20749724|P1|STARTED|D101 to 2 Years Post-transplant||39
8418969|NCT00914940|20749724|P1|NOT COMPLETED|D0 to D100 Post-transplant||2
8418970|NCT00914940|20749724|P1|COMPLETED|D0 to D100 Post-transplant||39
8418971|NCT00914940|20749724|P1|STARTED|D0 to D100 Post-transplant||41
8418972|NCT00914927|20749739|P7|NOT COMPLETED|Overall Study||0
8418973|NCT00914927|20749740|P6|NOT COMPLETED|Overall Study||0
8418974|NCT00914927|20749741|P5|NOT COMPLETED|Overall Study||2
8418975|NCT00914927|20749742|P4|NOT COMPLETED|Overall Study||2
8418976|NCT00914927|20749743|P3|NOT COMPLETED|Overall Study||0
8418977|NCT00914927|20749744|P2|NOT COMPLETED|Overall Study||2
8418978|NCT00914927|20749745|P1|NOT COMPLETED|Overall Study||2
8418979|NCT00914927|20749739|P7|COMPLETED|Overall Study||21
8418980|NCT00914927|20749740|P6|COMPLETED|Overall Study||21
8418981|NCT00914927|20749741|P5|COMPLETED|Overall Study||19
8418982|NCT00914927|20749742|P4|COMPLETED|Overall Study||14
8418983|NCT00914927|20749743|P3|COMPLETED|Overall Study||17
8418984|NCT00914927|20749744|P2|COMPLETED|Overall Study||14
8418985|NCT00914927|20749745|P1|COMPLETED|Overall Study||16
8418986|NCT00914927|20749739|P7|STARTED|Overall Study||21
8418987|NCT00914927|20749740|P6|STARTED|Overall Study||21
8418988|NCT00914927|20749741|P5|STARTED|Overall Study||21
8418989|NCT00914927|20749742|P4|STARTED|Overall Study||16
8418990|NCT00914927|20749743|P3|STARTED|Overall Study||17
8418991|NCT00914927|20749744|P2|STARTED|Overall Study||16
8418992|NCT00914927|20749745|P1|STARTED|Overall Study||18
8418993|NCT00914862|20749794|P5|NOT COMPLETED|Overall Study||0
8418994|NCT00914862|20749795|P4|NOT COMPLETED|Overall Study||0
8418995|NCT00914862|20749796|P3|NOT COMPLETED|Overall Study||0
8418996|NCT00914862|20749797|P2|NOT COMPLETED|Overall Study||0
8418997|NCT00914862|20749798|P1|NOT COMPLETED|Overall Study||0
8418998|NCT00914862|20749794|P5|COMPLETED|Overall Study||28
8418999|NCT00914862|20749795|P4|COMPLETED|Overall Study||8
8419000|NCT00914862|20749796|P3|COMPLETED|Overall Study||8
8419001|NCT00914862|20749797|P2|COMPLETED|Overall Study||6
8419002|NCT00914862|20749798|P1|COMPLETED|Overall Study||6
8419003|NCT00914862|20749794|P5|STARTED|Overall Study||28
8419004|NCT00914862|20749795|P4|STARTED|Overall Study||8
8419005|NCT00914862|20749796|P3|STARTED|Overall Study||8
8419006|NCT00914862|20749797|P2|STARTED|Overall Study||6
8419007|NCT00914862|20749798|P1|STARTED|Overall Study||6
8419008|NCT00914849|20749872|P2|NOT COMPLETED|Overall Study||1
8419009|NCT00914849|20749873|P1|NOT COMPLETED|Overall Study||1
8419010|NCT00914849|20749872|P2|COMPLETED|Overall Study||33
8419011|NCT00914849|20749873|P1|COMPLETED|Overall Study||33
8419012|NCT00914849|20749872|P2|STARTED|Overall Study||34
8419013|NCT00914849|20749873|P1|STARTED|Overall Study||34
8419014|NCT00914810|20749907|P2|NOT COMPLETED|Overall Study||1
8419015|NCT00914810|20749908|P1|NOT COMPLETED|Overall Study||2
8419016|NCT00914810|20749907|P2|COMPLETED|Overall Study||18
8419017|NCT00914810|20749908|P1|COMPLETED|Overall Study||18
8419018|NCT00914810|20749907|P2|STARTED|Overall Study||19
8419019|NCT00914810|20749908|P1|STARTED|Overall Study||20
8419032|NCT00914589|20749951|P3|NOT COMPLETED|Overall Study||12
8419033|NCT00914589|20749952|P2|NOT COMPLETED|Overall Study||16
8419034|NCT00914589|20749953|P1|NOT COMPLETED|Overall Study||25
8419035|NCT00914589|20749951|P3|COMPLETED|Overall Study||126
8419036|NCT00914589|20749952|P2|COMPLETED|Overall Study||127
8419037|NCT00914589|20749953|P1|COMPLETED|Overall Study||103
8419038|NCT00914589|20749951|P3|STARTED|Overall Study||138
8419039|NCT00914589|20749952|P2|STARTED|Overall Study||143
8419040|NCT00914589|20749953|P1|STARTED|Overall Study||128
8419041|NCT00914485|20749973|P1|NOT COMPLETED|Overall Study||0
8419042|NCT00914485|20749973|P1|COMPLETED|Overall Study||369
8419043|NCT00914485|20749973|P1|STARTED|Overall Study||369
8419044|NCT00914459|20749979|P2|NOT COMPLETED|Overall Study||1
8419045|NCT00914459|20749980|P1|NOT COMPLETED|Overall Study||1
8419046|NCT00914459|20749979|P2|COMPLETED|Overall Study||18
8419047|NCT00914459|20749980|P1|COMPLETED|Overall Study||17
8419048|NCT00914459|20749979|P2|STARTED|Overall Study||19
8419049|NCT00914459|20749980|P1|STARTED|Overall Study||18
8419050|NCT00914316|20750010|P4|NOT COMPLETED|Phase 2||0
8419051|NCT00914316|20750011|P3|NOT COMPLETED|Phase 2||1
8419052|NCT00914316|20750012|P2|NOT COMPLETED|Phase 2||0
8419053|NCT00914316|20750013|P1|NOT COMPLETED|Phase 2||1
8419054|NCT00914316|20750010|P4|COMPLETED|Phase 2||6
8419055|NCT00914316|20750011|P3|COMPLETED|Phase 2||2
8419056|NCT00914316|20750012|P2|COMPLETED|Phase 2||4
8419057|NCT00914316|20750013|P1|COMPLETED|Phase 2||1
8419058|NCT00914316|20750010|P4|STARTED|Phase 2||6
8419059|NCT00914316|20750011|P3|STARTED|Phase 2||3
8419060|NCT00914316|20750012|P2|STARTED|Phase 2||4
8419061|NCT00914316|20750013|P1|STARTED|Phase 2||2
8419062|NCT00914316|20750010|P4|NOT COMPLETED|Phase 1||2
8419063|NCT00914316|20750011|P3|NOT COMPLETED|Phase 1||5
8419064|NCT00914316|20750012|P2|NOT COMPLETED|Phase 1||2
8419065|NCT00914316|20750013|P1|NOT COMPLETED|Phase 1||5
8419066|NCT00914316|20750010|P4|COMPLETED|Phase 1||6
8419067|NCT00914316|20750011|P3|COMPLETED|Phase 1||3
8419068|NCT00914316|20750012|P2|COMPLETED|Phase 1||4
8419069|NCT00914316|20750013|P1|COMPLETED|Phase 1||2
8419070|NCT00914316|20750010|P4|STARTED|Phase 1||8
8419071|NCT00914316|20750011|P3|STARTED|Phase 1||8
8419072|NCT00914316|20750012|P2|STARTED|Phase 1||6
8419073|NCT00914316|20750013|P1|STARTED|Phase 1||7
8419074|NCT00914186|20750031|P4|NOT COMPLETED|Overall Study||10
8419075|NCT00914186|20750032|P3|NOT COMPLETED|Overall Study||2
8419076|NCT00914186|20750033|P2|NOT COMPLETED|Overall Study||2
8419077|NCT00914186|20750034|P1|NOT COMPLETED|Overall Study||3
8419078|NCT00914186|20750031|P4|COMPLETED|Overall Study||20
8419079|NCT00914186|20750032|P3|COMPLETED|Overall Study||29
8419080|NCT00914186|20750033|P2|COMPLETED|Overall Study||28
8419081|NCT00914186|20750034|P1|COMPLETED|Overall Study||28
8419082|NCT00914186|20750031|P4|STARTED|Overall Study||30
8419083|NCT00914186|20750032|P3|STARTED|Overall Study||31
8419084|NCT00914186|20750033|P2|STARTED|Overall Study||30
8419085|NCT00914186|20750034|P1|STARTED|Overall Study||31
8419086|NCT00914069|20750068|P2|NOT COMPLETED|Overall Study||0
8419087|NCT00914069|20750069|P1|NOT COMPLETED|Overall Study||0
8419088|NCT00914069|20750068|P2|COMPLETED|Overall Study||88
8419089|NCT00914069|20750069|P1|COMPLETED|Overall Study||84
8419090|NCT00914069|20750068|P2|STARTED|Overall Study||88
8419091|NCT00914069|20750069|P1|STARTED|Overall Study||84
8419092|NCT00913978|20750085|P2|NOT COMPLETED|Overall Study||3
8419093|NCT00913978|20750086|P1|NOT COMPLETED|Overall Study||1
8419094|NCT00913978|20750085|P2|COMPLETED|Overall Study||21
8419095|NCT00913978|20750086|P1|COMPLETED|Overall Study||25
8419096|NCT00913978|20750085|P2|STARTED|Overall Study||24
8419097|NCT00913978|20750086|P1|STARTED|Overall Study||26
8419098|NCT00913913|20750094|P1|NOT COMPLETED|Overall Study||8
8419099|NCT00913913|20750094|P1|COMPLETED|Overall Study||0
8419100|NCT00913913|20750094|P1|STARTED|Overall Study||8
8419101|NCT00913835|20750103|P2|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
8419102|NCT00913835|20750104|P1|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
8419103|NCT00913835|20750103|P2|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
8419104|NCT00913835|20750104|P1|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
8419105|NCT00913835|20750103|P2|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
8419106|NCT00913835|20750104|P1|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
8419107|NCT00913835|20750103|P2|STARTED|Lip Dox: Olaratumab Monotherapy||28
8419108|NCT00913835|20750104|P1|STARTED|Lip Dox: Olaratumab Monotherapy||0
8419109|NCT00913835|20750103|P2|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
8419110|NCT00913835|20750104|P1|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
8419111|NCT00913835|20750103|P2|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
8419112|NCT00913835|20750104|P1|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
8419113|NCT00913835|20750103|P2|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
8419114|NCT00913835|20750104|P1|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
8419115|NCT00913835|20750103|P2|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
8419116|NCT00913835|20750104|P1|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
8419117|NCT00913770|20750143|P3|NOT COMPLETED|Overall Study||21
8419118|NCT00913770|20750144|P2|NOT COMPLETED|Overall Study||29
8419119|NCT00913770|20750145|P1|NOT COMPLETED|Overall Study||35
8419120|NCT00913770|20750143|P3|COMPLETED|Overall Study||93
8419121|NCT00913770|20750144|P2|COMPLETED|Overall Study||82
8419122|NCT00913770|20750145|P1|COMPLETED|Overall Study||69
8419123|NCT00913770|20750143|P3|STARTED|Overall Study||114
8419124|NCT00913770|20750144|P2|STARTED|Overall Study||111
8419125|NCT00913770|20750145|P1|STARTED|Overall Study||104
8419126|NCT00913744|20750158|P2|NOT COMPLETED|Overall Study||1
8419127|NCT00913744|20750159|P1|NOT COMPLETED|Overall Study||5
8419128|NCT00913744|20750158|P2|COMPLETED|Overall Study||24
8419129|NCT00913744|20750159|P1|COMPLETED|Overall Study||70
8419130|NCT00913744|20750158|P2|STARTED|Overall Study||25
8419131|NCT00913744|20750159|P1|STARTED|Overall Study||75
8419132|NCT00913692|20750165|P1|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
8419133|NCT00913692|20750165|P1|COMPLETED|Treatment Phase 2 (5 Months)||1
8419134|NCT00913692|20750165|P1|STARTED|Treatment Phase 2 (5 Months)||1
8419135|NCT00913692|20750165|P1|NOT COMPLETED|Washout (2 Weeks)||0
8419136|NCT00913692|20750165|P1|COMPLETED|Washout (2 Weeks)||1
8419137|NCT00913692|20750165|P1|STARTED|Washout (2 Weeks)||1
8419138|NCT00913692|20750165|P1|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
8419139|NCT00913692|20750165|P1|COMPLETED|Treatment Phase 1 (5 Months)||1
8419140|NCT00913692|20750165|P1|STARTED|Treatment Phase 1 (5 Months)||2
8419141|NCT00913692|20750165|P1|NOT COMPLETED|Screening (4 Months)||9
8419142|NCT00913692|20750165|P1|COMPLETED|Screening (4 Months)||2
8419143|NCT00913692|20750165|P1|STARTED|Screening (4 Months)||11
8419144|NCT00913627|20750179|P4|NOT COMPLETED|Overall Study||0
8419145|NCT00913627|20750180|P3|NOT COMPLETED|Overall Study||0
8419146|NCT00913627|20750181|P2|NOT COMPLETED|Overall Study||0
8419147|NCT00913627|20750182|P1|NOT COMPLETED|Overall Study||0
8419148|NCT00913627|20750179|P4|COMPLETED|Overall Study||58
8419149|NCT00913627|20750180|P3|COMPLETED|Overall Study||56
8419150|NCT00913627|20750181|P2|COMPLETED|Overall Study||53
8419151|NCT00913627|20750182|P1|COMPLETED|Overall Study||29
8419152|NCT00913627|20750179|P4|STARTED|Overall Study||58
8419153|NCT00913627|20750180|P3|STARTED|Overall Study||56
8419154|NCT00913627|20750181|P2|STARTED|Overall Study||53
8419155|NCT00913627|20750182|P1|STARTED|Overall Study||29
8419156|NCT00913523|20750259|P3|NOT COMPLETED|Overall Study||14
8419157|NCT00913523|20750260|P2|NOT COMPLETED|Overall Study||16
8419158|NCT00913523|20750261|P1|NOT COMPLETED|Overall Study||18
8419159|NCT00913523|20750259|P3|COMPLETED|Overall Study||147
8419160|NCT00913523|20750260|P2|COMPLETED|Overall Study||143
8419161|NCT00913523|20750261|P1|COMPLETED|Overall Study||144
8419162|NCT00913523|20750259|P3|STARTED|Overall Study||161
8419163|NCT00913523|20750260|P2|STARTED|Overall Study||159
8419164|NCT00913523|20750261|P1|STARTED|Overall Study||162
8419165|NCT00913510|20750286|P2|NOT COMPLETED|Overall Study||4
8419166|NCT00913510|20750287|P1|NOT COMPLETED|Overall Study||8
8419167|NCT00913510|20750286|P2|COMPLETED|Overall Study||3
8419168|NCT00913510|20750287|P1|COMPLETED|Overall Study||5
8419169|NCT00913510|20750286|P2|STARTED|Overall Study||7
8419170|NCT00913510|20750287|P1|STARTED|Overall Study||13
8419171|NCT00913458|20750293|P7|NOT COMPLETED|Phase 3||8
8419172|NCT00913458|20750294|P6|NOT COMPLETED|Phase 3||18
8419173|NCT00913458|20750295|P5|NOT COMPLETED|Phase 3||22
8419174|NCT00913458|20750296|P4|NOT COMPLETED|Phase 3||0
8419175|NCT00913458|20750297|P3|NOT COMPLETED|Phase 3||0
8419176|NCT00913458|20750298|P2|NOT COMPLETED|Phase 3||0
8419177|NCT00913458|20750299|P1|NOT COMPLETED|Phase 3||0
8419178|NCT00913458|20750293|P7|COMPLETED|Phase 3||24
8419179|NCT00913458|20750294|P6|COMPLETED|Phase 3||28
8419180|NCT00913458|20750295|P5|COMPLETED|Phase 3||31
8419181|NCT00913458|20750296|P4|COMPLETED|Phase 3||0
8419182|NCT00913458|20750297|P3|COMPLETED|Phase 3||0
8419183|NCT00913458|20750298|P2|COMPLETED|Phase 3||0
8419184|NCT00913458|20750299|P1|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
8419185|NCT00913458|20750293|P7|STARTED|Phase 3|Participants who completed Phase 2 study|32
8419186|NCT00913458|20750294|P6|STARTED|Phase 3|Participants who completed Phase 2 study|46
8419187|NCT00913458|20750295|P5|STARTED|Phase 3|Participants who completed Phase 2 study|53
8419188|NCT00913458|20750296|P4|STARTED|Phase 3||0
8419189|NCT00913458|20750297|P3|STARTED|Phase 3||0
8419190|NCT00913458|20750298|P2|STARTED|Phase 3||0
8419191|NCT00913458|20750299|P1|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
8419192|NCT00913458|20750293|P7|NOT COMPLETED|Phase 2||0
8419193|NCT00913458|20750294|P6|NOT COMPLETED|Phase 2||0
8419194|NCT00913458|20750295|P5|NOT COMPLETED|Phase 2||0
8419195|NCT00913458|20750296|P4|NOT COMPLETED|Phase 2||33
8419196|NCT00913458|20750297|P3|NOT COMPLETED|Phase 2||19
8419197|NCT00913458|20750298|P2|NOT COMPLETED|Phase 2||10
8419198|NCT00913458|20750299|P1|NOT COMPLETED|Phase 2||0
8419199|NCT00913458|20750293|P7|COMPLETED|Phase 2||0
8419200|NCT00913458|20750294|P6|COMPLETED|Phase 2||0
8419201|NCT00913458|20750295|P5|COMPLETED|Phase 2||0
8419202|NCT00913458|20750296|P4|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
8419203|NCT00913458|20750297|P3|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
8419204|NCT00913458|20750298|P2|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
8419205|NCT00913458|20750299|P1|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
8419206|NCT00913458|20750293|P7|STARTED|Phase 2||0
8419207|NCT00913458|20750294|P6|STARTED|Phase 2||0
8419208|NCT00913458|20750295|P5|STARTED|Phase 2||0
8419209|NCT00913458|20750296|P4|STARTED|Phase 2||65
8419210|NCT00913458|20750297|P3|STARTED|Phase 2||65
8419211|NCT00913458|20750298|P2|STARTED|Phase 2||63
8419212|NCT00913458|20750299|P1|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
8419213|NCT00913458|20750293|P7|NOT COMPLETED|Phase 1||0
8419214|NCT00913458|20750294|P6|NOT COMPLETED|Phase 1||0
8419215|NCT00913458|20750295|P5|NOT COMPLETED|Phase 1||0
8419216|NCT00913458|20750296|P4|NOT COMPLETED|Phase 1||0
8419217|NCT00913458|20750297|P3|NOT COMPLETED|Phase 1||0
8419218|NCT00913458|20750298|P2|NOT COMPLETED|Phase 1||0
8419219|NCT00913458|20750299|P1|NOT COMPLETED|Phase 1||112
8419220|NCT00913458|20750293|P7|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
8419221|NCT00913458|20750294|P6|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
8419222|NCT00913458|20750295|P5|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
8419223|NCT00913458|20750296|P4|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
8419224|NCT00913458|20750297|P3|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
8419225|NCT00913458|20750298|P2|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
8419226|NCT00913458|20750299|P1|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
8419227|NCT00913458|20750293|P7|STARTED|Phase 1|This arm is part of Phase 3 study|0
8419228|NCT00913458|20750294|P6|STARTED|Phase 1|This arm is part of Phase 3 study|0
8419229|NCT00913458|20750295|P5|STARTED|Phase 1|This arm is part of Phase 3 study|0
8419230|NCT00913458|20750296|P4|STARTED|Phase 1|This arm is part of Phase 2 study|0
8419231|NCT00913458|20750297|P3|STARTED|Phase 1|This arm is part of Phase 2 study|0
8419232|NCT00913458|20750298|P2|STARTED|Phase 1|This arm is part of Phase 2 study|0
8419233|NCT00913458|20750299|P1|STARTED|Phase 1||306
8419234|NCT00913380|20750392|P2|NOT COMPLETED|Clinical Outcomes||6
8419235|NCT00913380|20750393|P1|NOT COMPLETED|Clinical Outcomes||6
8419236|NCT00913380|20750392|P2|COMPLETED|Clinical Outcomes||441
8419237|NCT00913380|20750393|P1|COMPLETED|Clinical Outcomes||438
8419238|NCT00913380|20750392|P2|STARTED|Clinical Outcomes||447
8419239|NCT00913380|20750393|P1|STARTED|Clinical Outcomes||444
8419240|NCT00913380|20750392|P2|NOT COMPLETED|CT Examination||0
8419241|NCT00913380|20750393|P1|NOT COMPLETED|CT Examination||0
8419242|NCT00913380|20750392|P2|COMPLETED|CT Examination||447
8419243|NCT00913380|20750393|P1|COMPLETED|CT Examination||444
8419244|NCT00913380|20750392|P2|STARTED|CT Examination||447
8419245|NCT00913380|20750393|P1|STARTED|CT Examination||444
8419246|NCT00913263|20750419|P1|NOT COMPLETED|Overall Study||0
8419247|NCT00913263|20750419|P1|COMPLETED|Overall Study||24
8419248|NCT00913263|20750419|P1|STARTED|Overall Study||24
8419249|NCT00913133|20750428|P1|NOT COMPLETED|Overall Study||0
8419250|NCT00913133|20750428|P1|COMPLETED|Overall Study||516
8419251|NCT00913133|20750428|P1|STARTED|Overall Study||516
8419252|NCT00913081|20750433|P1|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
8419253|NCT00913081|20750433|P1|COMPLETED|Placebo + Niacin 500 mg (1day)||17
8419254|NCT00913081|20750433|P1|STARTED|Placebo + Niacin 500 mg (1day)||17
8419255|NCT00913081|20750433|P1|NOT COMPLETED|Washout #3 (7days)||0
8419256|NCT00913081|20750433|P1|COMPLETED|Washout #3 (7days)||17
8419257|NCT00913081|20750433|P1|STARTED|Washout #3 (7days)||17
8419258|NCT00913081|20750433|P1|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
8419259|NCT00913081|20750433|P1|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
8419260|NCT00913081|20750433|P1|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
8419261|NCT00913081|20750433|P1|NOT COMPLETED|Washout #2 (7 Days)||0
8419262|NCT00913081|20750433|P1|COMPLETED|Washout #2 (7 Days)||17
8419263|NCT00913081|20750433|P1|STARTED|Washout #2 (7 Days)||17
8419264|NCT00913081|20750433|P1|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
8419265|NCT00913081|20750433|P1|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
8419266|NCT00913081|20750433|P1|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
8419267|NCT00913081|20750433|P1|NOT COMPLETED|Washout #1 (7 Days)||0
8419268|NCT00913081|20750433|P1|COMPLETED|Washout #1 (7 Days)||17
8419269|NCT00913081|20750433|P1|STARTED|Washout #1 (7 Days)||17
8419270|NCT00913081|20750433|P1|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
8419271|NCT00913081|20750433|P1|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
8419272|NCT00913081|20750433|P1|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
8419273|NCT00913003|20750445|P2|NOT COMPLETED|Overall Study||0
8419274|NCT00913003|20750446|P1|NOT COMPLETED|Overall Study||0
8419275|NCT00913003|20750445|P2|COMPLETED|Overall Study||11
8419276|NCT00913003|20750446|P1|COMPLETED|Overall Study||11
8419277|NCT00913003|20750445|P2|STARTED|Overall Study||11
8419278|NCT00913003|20750446|P1|STARTED|Overall Study||11
8419279|NCT00912990|20750458|P2|NOT COMPLETED|Overall Study||0
8419280|NCT00912990|20750459|P1|NOT COMPLETED|Overall Study||0
8419281|NCT00912990|20750458|P2|COMPLETED|Overall Study||18
8419282|NCT00912990|20750459|P1|COMPLETED|Overall Study||16
8419283|NCT00912990|20750458|P2|STARTED|Overall Study||18
8419284|NCT00912990|20750459|P1|STARTED|Overall Study||16
8419285|NCT00912964|20750472|P3|NOT COMPLETED|Overall Study||54
8419286|NCT00912964|20750473|P2|NOT COMPLETED|Overall Study||46
8419287|NCT00912964|20750474|P1|NOT COMPLETED|Overall Study||66
8419288|NCT00912964|20750472|P3|COMPLETED|Overall Study||386
8419289|NCT00912964|20750473|P2|COMPLETED|Overall Study||387
8419290|NCT00912964|20750474|P1|COMPLETED|Overall Study||367
8419291|NCT00912964|20750472|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
8419292|NCT00912964|20750473|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
8419293|NCT00912964|20750474|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
8419294|NCT00912964|20750472|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
8419295|NCT00912964|20750473|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
8419296|NCT00912964|20750474|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
8419297|NCT00912964|20750472|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
8419298|NCT00912964|20750473|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
8419299|NCT00912964|20750474|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
8419300|NCT00912964|20750472|P3|STARTED|Overall Study||440
8419301|NCT00912964|20750473|P2|STARTED|Overall Study||433
8419302|NCT00912964|20750474|P1|STARTED|Overall Study||433
8419303|NCT00912925|20750598|P2|NOT COMPLETED|Overall Study||0
8419304|NCT00912925|20750599|P1|NOT COMPLETED|Overall Study||0
8419305|NCT00912925|20750598|P2|COMPLETED|Overall Study||22
8419306|NCT00912925|20750599|P1|COMPLETED|Overall Study||23
8419307|NCT00912925|20750598|P2|STARTED|Overall Study||22
8419308|NCT00912925|20750599|P1|STARTED|Overall Study||23
8419309|NCT00912912|20750617|P1|NOT COMPLETED|Overall Study||4
8419310|NCT00912912|20750617|P1|COMPLETED|Overall Study||1
8419311|NCT00912912|20750617|P1|STARTED|Overall Study||5
8419312|NCT00912808|20750623|P2|NOT COMPLETED|Second Intervention (6 Weeks)||1
8419313|NCT00912808|20750624|P1|NOT COMPLETED|Second Intervention (6 Weeks)||1
8419314|NCT00912808|20750623|P2|COMPLETED|Second Intervention (6 Weeks)||9
8419315|NCT00912808|20750624|P1|COMPLETED|Second Intervention (6 Weeks)||8
8419316|NCT00912808|20750623|P2|Received Intervention|Second Intervention (6 Weeks)||10
8419317|NCT00912808|20750624|P1|Received Intervention|Second Intervention (6 Weeks)||9
8419318|NCT00912808|20750623|P2|STARTED|Second Intervention (6 Weeks)||10
8419319|NCT00912808|20750624|P1|STARTED|Second Intervention (6 Weeks)||9
8419320|NCT00912808|20750623|P2|NOT COMPLETED|Washout||1
8419321|NCT00912808|20750624|P1|NOT COMPLETED|Washout||0
8419322|NCT00912808|20750623|P2|COMPLETED|Washout||10
8419323|NCT00912808|20750624|P1|COMPLETED|Washout||9
8419324|NCT00912808|20750623|P2|STARTED|Washout||11
8419325|NCT00912808|20750624|P1|STARTED|Washout||9
8419326|NCT00912808|20750623|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
8419327|NCT00912808|20750624|P1|NOT COMPLETED|First Intervention (6 Weeks)||2
8419328|NCT00912808|20750623|P2|COMPLETED|First Intervention (6 Weeks)||11
8419329|NCT00912808|20750624|P1|COMPLETED|First Intervention (6 Weeks)||9
8419330|NCT00912808|20750623|P2|Received Intervention|First Intervention (6 Weeks)||12
8419331|NCT00912808|20750624|P1|Received Intervention|First Intervention (6 Weeks)||11
8419332|NCT00912808|20750623|P2|STARTED|First Intervention (6 Weeks)||12
8419333|NCT00912808|20750624|P1|STARTED|First Intervention (6 Weeks)||11
8419334|NCT00912795|20750634|P2|NOT COMPLETED|Overall Study||58
8419335|NCT00912795|20750635|P1|NOT COMPLETED|Overall Study||47
8419336|NCT00912795|20750634|P2|COMPLETED|Overall Study||17
8419337|NCT00912795|20750635|P1|COMPLETED|Overall Study||29
8419338|NCT00912795|20750634|P2|STARTED|Overall Study||75
8419339|NCT00912795|20750635|P1|STARTED|Overall Study||76
8419340|NCT00912782|20750649|P2|NOT COMPLETED|Overall Study||5
8419341|NCT00912782|20750650|P1|NOT COMPLETED|Overall Study||3
8419342|NCT00912782|20750649|P2|COMPLETED|Overall Study||20
8419343|NCT00912782|20750650|P1|COMPLETED|Overall Study||24
8419344|NCT00912782|20750649|P2|STARTED|Overall Study||25
8419345|NCT00912782|20750650|P1|STARTED|Overall Study||27
8419346|NCT00912743|20750660|P2|NOT COMPLETED|Overall Study||20
8419347|NCT00912743|20750661|P1|NOT COMPLETED|Overall Study||13
8419348|NCT00912743|20750660|P2|COMPLETED|Overall Study||0
8419349|NCT00912743|20750661|P1|COMPLETED|Overall Study||0
8419350|NCT00912743|20750660|P2|STARTED|Overall Study||20
8419351|NCT00912743|20750661|P1|STARTED|Overall Study||13
8419352|NCT00912509|20750673|P2|NOT COMPLETED|Overall Study||3
8419353|NCT00912509|20750674|P1|NOT COMPLETED|Overall Study||5
8419354|NCT00912509|20750673|P2|COMPLETED|Overall Study||7
8419355|NCT00912509|20750674|P1|COMPLETED|Overall Study||15
8419356|NCT00912509|20750673|P2|STARTED|Overall Study||10
8419357|NCT00912509|20750674|P1|STARTED|Overall Study||20
8419358|NCT00912405|20750682|P1|NOT COMPLETED|Overall Study||5
8419359|NCT00912405|20750682|P1|COMPLETED|Overall Study||45
8419360|NCT00912405|20750682|P1|STARTED|Overall Study||50
8419361|NCT00912340|20750692|P3|NOT COMPLETED|Overall Study||4
8419362|NCT00912340|20750693|P2|NOT COMPLETED|Overall Study||4
8419363|NCT00912340|20750694|P1|NOT COMPLETED|Overall Study||2
8419364|NCT00912340|20750692|P3|COMPLETED|Overall Study||0
8419365|NCT00912340|20750693|P2|COMPLETED|Overall Study||26
8419366|NCT00912340|20750694|P1|COMPLETED|Overall Study||22
8419367|NCT00912340|20750692|P3|STARTED|Overall Study||4
8419368|NCT00912340|20750693|P2|STARTED|Overall Study||30
8419369|NCT00912340|20750694|P1|STARTED|Overall Study||24
8419370|NCT00912301|20750708|P3|NOT COMPLETED|Overall Study||0
8419371|NCT00912301|20750709|P2|NOT COMPLETED|Overall Study||0
8419372|NCT00912301|20750710|P1|NOT COMPLETED|Overall Study||0
8419373|NCT00912301|20750708|P3|COMPLETED|Overall Study||13
8419374|NCT00912301|20750709|P2|COMPLETED|Overall Study||12
8419375|NCT00912301|20750710|P1|COMPLETED|Overall Study||11
8419376|NCT00912301|20750708|P3|STARTED|Overall Study||13
8419377|NCT00912301|20750709|P2|STARTED|Overall Study||12
8419378|NCT00912301|20750710|P1|STARTED|Overall Study||11
8419379|NCT00912288|20750732|P2|NOT COMPLETED|Overall Study||40
8419380|NCT00912288|20750733|P1|NOT COMPLETED|Overall Study||41
8419381|NCT00912288|20750732|P2|COMPLETED|Overall Study||2
8419382|NCT00912288|20750733|P1|COMPLETED|Overall Study||3
8419383|NCT00912288|20750732|P2|STARTED|Overall Study||42
8419384|NCT00912288|20750733|P1|STARTED|Overall Study||44
8419385|NCT00912223|20750755|P1|NOT COMPLETED|Overall Study||3
8419386|NCT00912223|20750755|P1|COMPLETED|Overall Study||62
8419387|NCT00912223|20750755|P1|STARTED|Overall Study||65
8419388|NCT00912197|20750773|P2|NOT COMPLETED|Overall Study||3
8419389|NCT00912197|20750774|P1|NOT COMPLETED|Overall Study||3
8419390|NCT00912197|20750773|P2|COMPLETED|Overall Study||10
8419391|NCT00912197|20750774|P1|COMPLETED|Overall Study||12
8419392|NCT00912197|20750773|P2|STARTED|Overall Study||13
8419393|NCT00912197|20750774|P1|STARTED|Overall Study||15
8419394|NCT00912158|20750805|P3|NOT COMPLETED|Overall Study||0
8419395|NCT00912158|20750806|P2|NOT COMPLETED|Overall Study||0
8419396|NCT00912158|20750807|P1|NOT COMPLETED|Overall Study||0
8419397|NCT00912158|20750805|P3|COMPLETED|Overall Study||41
8419398|NCT00912158|20750806|P2|COMPLETED|Overall Study||44
8419399|NCT00912158|20750807|P1|COMPLETED|Overall Study||44
8419400|NCT00912158|20750805|P3|STARTED|Overall Study||41
8419401|NCT00912158|20750806|P2|STARTED|Overall Study||44
8419402|NCT00912158|20750807|P1|STARTED|Overall Study||44
8419433|NCT00912028|20750840|P5|NOT COMPLETED|Overall Study||3
8419434|NCT00912028|20750841|P4|NOT COMPLETED|Overall Study||1
8419435|NCT00912028|20750842|P3|NOT COMPLETED|Overall Study||0
8419436|NCT00912028|20750843|P2|NOT COMPLETED|Overall Study||3
8419437|NCT00912028|20750844|P1|NOT COMPLETED|Overall Study||5
8419438|NCT00912028|20750840|P5|COMPLETED|Overall Study||0
8419439|NCT00912028|20750841|P4|COMPLETED|Overall Study||16
8419440|NCT00912028|20750842|P3|COMPLETED|Overall Study||13
8419441|NCT00912028|20750843|P2|COMPLETED|Overall Study||0
8419442|NCT00912028|20750844|P1|COMPLETED|Overall Study||30
8419443|NCT00912028|20750840|P5|STARTED|Overall Study||3
8419444|NCT00912028|20750841|P4|STARTED|Overall Study||17
8419445|NCT00912028|20750842|P3|STARTED|Overall Study||13
8419446|NCT00912028|20750843|P2|STARTED|Overall Study||3
8419447|NCT00912028|20750844|P1|STARTED|Overall Study||35
8419448|NCT00912015|20750873|P4|NOT COMPLETED|Overall Study||2
8419449|NCT00912015|20750874|P3|NOT COMPLETED|Overall Study||3
8419450|NCT00912015|20750875|P2|NOT COMPLETED|Overall Study||8
8419451|NCT00912015|20750876|P1|NOT COMPLETED|Overall Study||16
8419452|NCT00912015|20750873|P4|COMPLETED|Overall Study||0
8419453|NCT00912015|20750874|P3|COMPLETED|Overall Study||22
8419454|NCT00912015|20750875|P2|COMPLETED|Overall Study||62
8419455|NCT00912015|20750876|P1|COMPLETED|Overall Study||125
8419456|NCT00912015|20750873|P4|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
8419457|NCT00912015|20750874|P3|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
8419458|NCT00912015|20750875|P2|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
8419459|NCT00912015|20750876|P1|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
8419460|NCT00912002|20750886|P1|NOT COMPLETED|Overall Study||0
8419461|NCT00912002|20750886|P1|COMPLETED|Overall Study||6
8419462|NCT00912002|20750886|P1|STARTED|Overall Study||6
8419463|NCT00911989|20750892|P1|NOT COMPLETED|Overall Study||1
8419464|NCT00911989|20750892|P1|COMPLETED|Overall Study||3
8419465|NCT00911989|20750892|P1|STARTED|Overall Study||4
8419466|NCT00911937|20750898|P2|NOT COMPLETED|Overall Study||95
8419467|NCT00911937|20750899|P1|NOT COMPLETED|Overall Study||87
8419468|NCT00911937|20750898|P2|COMPLETED|Overall Study||381
8419469|NCT00911937|20750899|P1|COMPLETED|Overall Study||400
8419470|NCT00911937|20750898|P2|Treated|Overall Study||463
8419471|NCT00911937|20750899|P1|Treated|Overall Study||474
8419472|NCT00911937|20750898|P2|STARTED|Overall Study||476
8419473|NCT00911937|20750899|P1|STARTED|Overall Study||487
8419474|NCT00911898|20750959|P1|NOT COMPLETED|Overall Study||0
8419475|NCT00911898|20750959|P1|COMPLETED|Overall Study||20
8419476|NCT00911898|20750959|P1|STARTED|Overall Study||20
8419477|NCT00911859|20750966|P3|NOT COMPLETED|Follow-up Period||41
8419478|NCT00911859|20750967|P2|NOT COMPLETED|Follow-up Period||46
8419479|NCT00911859|20750968|P1|NOT COMPLETED|Follow-up Period||11
8419480|NCT00911859|20750966|P3|COMPLETED|Follow-up Period||11
8419481|NCT00911859|20750967|P2|COMPLETED|Follow-up Period||7
8419482|NCT00911859|20750968|P1|COMPLETED|Follow-up Period||1
8419483|NCT00911859|20750966|P3|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
8419484|NCT00911859|20750967|P2|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
8419485|NCT00911859|20750968|P1|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
8419486|NCT00911859|20750966|P3|NOT COMPLETED|Maintainance Period||21
8419487|NCT00911859|20750967|P2|NOT COMPLETED|Maintainance Period||0
8419488|NCT00911859|20750968|P1|NOT COMPLETED|Maintainance Period||0
8419489|NCT00911859|20750966|P3|COMPLETED|Maintainance Period||0
8419490|NCT00911859|20750967|P2|COMPLETED|Maintainance Period||0
8419491|NCT00911859|20750968|P1|COMPLETED|Maintainance Period||0
8419492|NCT00911859|20750966|P3|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
8419493|NCT00911859|20750967|P2|STARTED|Maintainance Period||0
8419494|NCT00911859|20750968|P1|STARTED|Maintainance Period||0
8419495|NCT00911859|20750966|P3|NOT COMPLETED|Treatment Period||25
8419496|NCT00911859|20750967|P2|NOT COMPLETED|Treatment Period||21
8419497|NCT00911859|20750968|P1|NOT COMPLETED|Treatment Period||8
8419498|NCT00911859|20750966|P3|COMPLETED|Treatment Period||27
8419499|NCT00911859|20750967|P2|COMPLETED|Treatment Period||33
8419500|NCT00911859|20750968|P1|COMPLETED|Treatment Period||4
8419501|NCT00911859|20750966|P3|Received Treatment|Treatment Period||52
8419502|NCT00911859|20750967|P2|Received Treatment|Treatment Period||53
8419503|NCT00911859|20750968|P1|Received Treatment|Treatment Period||12
8419504|NCT00911859|20750966|P3|STARTED|Treatment Period||52
8419505|NCT00911859|20750967|P2|STARTED|Treatment Period||54
8419506|NCT00911859|20750968|P1|STARTED|Treatment Period||12
8419515|NCT00911807|20751012|P3|NOT COMPLETED|Overall Study||23
8419516|NCT00911807|20751013|P2|NOT COMPLETED|Overall Study||18
8419517|NCT00911807|20751014|P1|NOT COMPLETED|Overall Study||17
8419518|NCT00911807|20751012|P3|COMPLETED|Overall Study||52
8419519|NCT00911807|20751013|P2|COMPLETED|Overall Study||52
8419520|NCT00911807|20751014|P1|COMPLETED|Overall Study||55
8419521|NCT00911807|20751012|P3|STARTED|Overall Study||75
8419522|NCT00911807|20751013|P2|STARTED|Overall Study||70
8419523|NCT00911807|20751014|P1|STARTED|Overall Study||72
8419524|NCT00911768|20751024|P2|NOT COMPLETED|Overall Study||4
8419525|NCT00911768|20751025|P1|NOT COMPLETED|Overall Study||6
8419526|NCT00911768|20751024|P2|COMPLETED|Overall Study||46
8419527|NCT00911768|20751025|P1|COMPLETED|Overall Study||44
8419528|NCT00911768|20751024|P2|STARTED|Overall Study||50
8419529|NCT00911768|20751025|P1|STARTED|Overall Study||50
8419530|NCT00911742|20751037|P2|NOT COMPLETED|Treatment Phase II||0
8419531|NCT00911742|20751038|P1|NOT COMPLETED|Treatment Phase II||0
8419532|NCT00911742|20751037|P2|COMPLETED|Treatment Phase II||13
8419533|NCT00911742|20751038|P1|COMPLETED|Treatment Phase II||13
8419534|NCT00911742|20751037|P2|STARTED|Treatment Phase II||13
8419535|NCT00911742|20751038|P1|STARTED|Treatment Phase II||13
8419536|NCT00911742|20751037|P2|NOT COMPLETED|Treatment Phase I||0
8419537|NCT00911742|20751038|P1|NOT COMPLETED|Treatment Phase I||0
8419538|NCT00911742|20751037|P2|COMPLETED|Treatment Phase I||13
8419539|NCT00911742|20751038|P1|COMPLETED|Treatment Phase I||13
8419540|NCT00911742|20751037|P2|STARTED|Treatment Phase I||13
8419541|NCT00911742|20751038|P1|STARTED|Treatment Phase I||13
8419542|NCT00911625|20751054|P2|NOT COMPLETED|Overall Study||0
8419543|NCT00911625|20751055|P1|NOT COMPLETED|Overall Study||7
8419544|NCT00911625|20751054|P2|COMPLETED|Overall Study||57
8419545|NCT00911625|20751055|P1|COMPLETED|Overall Study||50
8419546|NCT00911625|20751054|P2|STARTED|Overall Study||57
8419547|NCT00911625|20751055|P1|STARTED|Overall Study||57
8419548|NCT00911612|20751065|P2|NOT COMPLETED|Overall Study||0
8419549|NCT00911612|20751066|P1|NOT COMPLETED|Overall Study||0
8419550|NCT00911612|20751065|P2|COMPLETED|Overall Study||12
8419551|NCT00911612|20751066|P1|COMPLETED|Overall Study||12
8419552|NCT00911612|20751065|P2|STARTED|Overall Study||12
8419553|NCT00911612|20751066|P1|STARTED|Overall Study||12
8419554|NCT00911586|20751080|P1|NOT COMPLETED|Overall Study||0
8419555|NCT00911586|20751080|P1|COMPLETED|Overall Study||15
8419556|NCT00911586|20751080|P1|STARTED|Overall Study||15
8419557|NCT00911547|20751089|P4|NOT COMPLETED|Overall Study||16
8419558|NCT00911547|20751090|P3|NOT COMPLETED|Overall Study||22
8419559|NCT00911547|20751091|P2|NOT COMPLETED|Overall Study||42
8419560|NCT00911547|20751092|P1|NOT COMPLETED|Overall Study||11
8419561|NCT00911547|20751089|P4|COMPLETED|Overall Study||177
8419562|NCT00911547|20751090|P3|COMPLETED|Overall Study||178
8419563|NCT00911547|20751091|P2|COMPLETED|Overall Study||159
8419564|NCT00911547|20751092|P1|COMPLETED|Overall Study||37
8419565|NCT00911547|20751089|P4|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
8419566|NCT00911547|20751090|P3|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
8419567|NCT00911547|20751091|P2|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
8419568|NCT00911547|20751092|P1|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
8419569|NCT00911534|20751120|P2|NOT COMPLETED|Overall Study||16
8419570|NCT00911534|20751121|P1|NOT COMPLETED|Overall Study||15
8419571|NCT00911534|20751120|P2|COMPLETED|Overall Study||137
8419572|NCT00911534|20751121|P1|COMPLETED|Overall Study||132
8419573|NCT00911534|20751120|P2|STARTED|Overall Study|Randomized (treated)|153
8419574|NCT00911534|20751121|P1|STARTED|Overall Study|Randomized (treated)|147
8419581|NCT00911495|20751168|P1|NOT COMPLETED|Overall Study||1
8419582|NCT00911495|20751168|P1|COMPLETED|Overall Study||14
8419583|NCT00911495|20751168|P1|STARTED|Overall Study||15
8419584|NCT00911443|20751181|P5|NOT COMPLETED|Overall Study||0
8419585|NCT00911443|20751182|P4|NOT COMPLETED|Overall Study||0
8419586|NCT00911443|20751183|P3|NOT COMPLETED|Overall Study||0
8419587|NCT00911443|20751184|P2|NOT COMPLETED|Overall Study||0
8419588|NCT00911443|20751185|P1|NOT COMPLETED|Overall Study||0
8419589|NCT00911443|20751181|P5|COMPLETED|Overall Study||97
8419590|NCT00911443|20751182|P4|COMPLETED|Overall Study||99
8419591|NCT00911443|20751183|P3|COMPLETED|Overall Study||98
8419592|NCT00911443|20751184|P2|COMPLETED|Overall Study||97
8419593|NCT00911443|20751185|P1|COMPLETED|Overall Study||97
8419594|NCT00911443|20751181|P5|STARTED|Overall Study||97
8419595|NCT00911443|20751182|P4|STARTED|Overall Study||99
8419596|NCT00911443|20751183|P3|STARTED|Overall Study||98
8419597|NCT00911443|20751184|P2|STARTED|Overall Study||97
8419598|NCT00911443|20751185|P1|STARTED|Overall Study||97
8419599|NCT00911326|20751202|P1|NOT COMPLETED|Overall Study||16
8419600|NCT00911326|20751202|P1|COMPLETED|Overall Study||85
8419601|NCT00911326|20751202|P1|STARTED|Overall Study||101
8419602|NCT00911300|20751211|P2|NOT COMPLETED|Overall Study||43
8419603|NCT00911300|20751212|P1|NOT COMPLETED|Overall Study||35
8419604|NCT00911300|20751211|P2|COMPLETED|Overall Study||131
8419605|NCT00911300|20751212|P1|COMPLETED|Overall Study||140
8419606|NCT00911300|20751211|P2|STARTED|Overall Study||174
8419607|NCT00911300|20751212|P1|STARTED|Overall Study||175
8419608|NCT00911274|20751238|P2|NOT COMPLETED|Period 2||0
8419609|NCT00911274|20751239|P1|NOT COMPLETED|Period 2||0
8419610|NCT00911274|20751238|P2|COMPLETED|Period 2||26
8419611|NCT00911274|20751239|P1|COMPLETED|Period 2||27
8419612|NCT00911274|20751238|P2|STARTED|Period 2||26
8419613|NCT00911274|20751239|P1|STARTED|Period 2||27
8419614|NCT00911274|20751238|P2|NOT COMPLETED|Period 1||0
8419615|NCT00911274|20751239|P1|NOT COMPLETED|Period 1||0
8419616|NCT00911274|20751238|P2|COMPLETED|Period 1||26
8419617|NCT00911274|20751239|P1|COMPLETED|Period 1||27
8419618|NCT00911274|20751238|P2|STARTED|Period 1||26
8419619|NCT00911274|20751239|P1|STARTED|Period 1||27
8419620|NCT00911170|20751249|P2|NOT COMPLETED|Long Term Follow-Up||422
8419621|NCT00911170|20751250|P1|NOT COMPLETED|Long Term Follow-Up||423
8419622|NCT00911170|20751249|P2|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
8419623|NCT00911170|20751250|P1|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
8419624|NCT00911170|20751249|P2|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
8419625|NCT00911170|20751250|P1|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
8419626|NCT00911170|20751249|P2|NOT COMPLETED|Treatment Period||37
8419627|NCT00911170|20751250|P1|NOT COMPLETED|Treatment Period||27
8419628|NCT00911170|20751249|P2|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
8419629|NCT00911170|20751250|P1|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
8419630|NCT00911170|20751249|P2|Received Investigational Product|Treatment Period||419
8419631|NCT00911170|20751250|P1|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
8419632|NCT00911170|20751249|P2|Received Bevacizumab|Treatment Period||420
8419633|NCT00911170|20751250|P1|Received Bevacizumab|Treatment Period||423
8419634|NCT00911170|20751249|P2|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
8419635|NCT00911170|20751250|P1|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
8419636|NCT00911170|20751249|P2|STARTED|Treatment Period||423
8419637|NCT00911170|20751250|P1|STARTED|Treatment Period||424
8419638|NCT00911157|20751274|P2|NOT COMPLETED|Overall Study||2
8419639|NCT00911157|20751275|P1|NOT COMPLETED|Overall Study||7
8419640|NCT00911157|20751274|P2|COMPLETED|Overall Study||8
8419641|NCT00911157|20751275|P1|COMPLETED|Overall Study||22
8419642|NCT00911157|20751274|P2|STARTED|Overall Study||10
8419643|NCT00911157|20751275|P1|STARTED|Overall Study||29
8419644|NCT00911144|20751291|P2|NOT COMPLETED|Overall Study||5
8419645|NCT00911144|20751292|P1|NOT COMPLETED|Overall Study||16
8419646|NCT00911144|20751291|P2|COMPLETED|Overall Study||108
8419647|NCT00911144|20751292|P1|COMPLETED|Overall Study||319
8419648|NCT00911144|20751291|P2|STARTED|Overall Study||113
8419649|NCT00911144|20751292|P1|STARTED|Overall Study||335
8419650|NCT00911053|20751321|P5|NOT COMPLETED|Overall Study||0
8419651|NCT00911053|20751322|P4|NOT COMPLETED|Overall Study||0
8419652|NCT00911053|20751323|P3|NOT COMPLETED|Overall Study||0
8419653|NCT00911053|20751324|P2|NOT COMPLETED|Overall Study||0
8419654|NCT00911053|20751325|P1|NOT COMPLETED|Overall Study||0
8419655|NCT00911053|20751321|P5|COMPLETED|Overall Study||0
8419656|NCT00911053|20751322|P4|COMPLETED|Overall Study||0
8419657|NCT00911053|20751323|P3|COMPLETED|Overall Study||0
8419658|NCT00911053|20751324|P2|COMPLETED|Overall Study||0
8419659|NCT00911053|20751325|P1|COMPLETED|Overall Study||0
8419660|NCT00911053|20751321|P5|STARTED|Overall Study||0
8419661|NCT00911053|20751322|P4|STARTED|Overall Study||0
8419662|NCT00911053|20751323|P3|STARTED|Overall Study||0
8419663|NCT00911053|20751324|P2|STARTED|Overall Study||0
8419664|NCT00911053|20751325|P1|STARTED|Overall Study||0
8419665|NCT00910988|20751346|P4|NOT COMPLETED|Overall Study||0
8419666|NCT00910988|20751347|P3|NOT COMPLETED|Overall Study||3
8419667|NCT00910988|20751348|P2|NOT COMPLETED|Overall Study||4
8419668|NCT00910988|20751349|P1|NOT COMPLETED|Overall Study||2
8419669|NCT00910988|20751346|P4|COMPLETED|Overall Study||6
8419670|NCT00910988|20751347|P3|COMPLETED|Overall Study||5
8419671|NCT00910988|20751348|P2|COMPLETED|Overall Study||12
8419672|NCT00910988|20751349|P1|COMPLETED|Overall Study||14
8419673|NCT00910988|20751346|P4|STARTED|Overall Study||6
8419674|NCT00910988|20751347|P3|STARTED|Overall Study||8
8419675|NCT00910988|20751348|P2|STARTED|Overall Study||16
8419676|NCT00910988|20751349|P1|STARTED|Overall Study||16
8419677|NCT00910962|20751394|P3|NOT COMPLETED|Overall Study||76
8419678|NCT00910962|20751395|P2|NOT COMPLETED|Overall Study||78
8419679|NCT00910962|20751396|P1|NOT COMPLETED|Overall Study||43
8419680|NCT00910962|20751394|P3|COMPLETED|Overall Study||116
8419681|NCT00910962|20751395|P2|COMPLETED|Overall Study||121
8419682|NCT00910962|20751396|P1|COMPLETED|Overall Study||92
8419683|NCT00910962|20751394|P3|STARTED|Overall Study||192
8419684|NCT00910962|20751395|P2|STARTED|Overall Study||199
8419685|NCT00910962|20751396|P1|STARTED|Overall Study||135
8419686|NCT00910910|20751488|P2|NOT COMPLETED|Overall Study||224
8419687|NCT00910910|20751489|P1|NOT COMPLETED|Overall Study||225
8419688|NCT00910910|20751488|P2|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1
8419689|NCT00910910|20751489|P1|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0
8419690|NCT00910910|20751488|P2|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
8419691|NCT00910910|20751489|P1|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
8419692|NCT00910910|20751488|P2|STARTED|Overall Study||225
8419693|NCT00910910|20751489|P1|STARTED|Overall Study||225
8419694|NCT00910871|20751525|P1|NOT COMPLETED|Overall Study||54
8419695|NCT00910871|20751525|P1|COMPLETED|Overall Study||179
8419696|NCT00910871|20751525|P1|STARTED|Overall Study||233
8419697|NCT00910858|20751533|P3|NOT COMPLETED|Combined Treatment Phase||4
8419698|NCT00910858|20751534|P2|NOT COMPLETED|Combined Treatment Phase||10
8419699|NCT00910858|20751535|P1|NOT COMPLETED|Combined Treatment Phase||9
8419700|NCT00910858|20751533|P3|COMPLETED|Combined Treatment Phase||0
8419701|NCT00910858|20751534|P2|COMPLETED|Combined Treatment Phase||0
8419702|NCT00910858|20751535|P1|COMPLETED|Combined Treatment Phase||0
8419703|NCT00910858|20751533|P3|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
8419704|NCT00910858|20751534|P2|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
8419705|NCT00910858|20751535|P1|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
8419706|NCT00910858|20751533|P3|NOT COMPLETED|Monotherapy Phase||7
8419707|NCT00910858|20751534|P2|NOT COMPLETED|Monotherapy Phase||15
8419708|NCT00910858|20751535|P1|NOT COMPLETED|Monotherapy Phase||17
8419709|NCT00910858|20751533|P3|COMPLETED|Monotherapy Phase||0
8419710|NCT00910858|20751534|P2|COMPLETED|Monotherapy Phase||0
8419711|NCT00910858|20751535|P1|COMPLETED|Monotherapy Phase||0
8419712|NCT00910858|20751533|P3|Pharmacokinetic Population|Monotherapy Phase||7
8419713|NCT00910858|20751534|P2|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
8419714|NCT00910858|20751535|P1|Pharmacokinetic Population|Monotherapy Phase||17
8419715|NCT00910858|20751533|P3|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
8419716|NCT00910858|20751534|P2|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
8419717|NCT00910858|20751535|P1|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
8419718|NCT00910858|20751533|P3|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
8419719|NCT00910858|20751534|P2|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
8419720|NCT00910858|20751535|P1|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
8419721|NCT00910858|20751533|P3|NOT COMPLETED|Pharmacokinetic Phase||0
8419722|NCT00910858|20751534|P2|NOT COMPLETED|Pharmacokinetic Phase||0
8419723|NCT00910858|20751535|P1|NOT COMPLETED|Pharmacokinetic Phase||1
8419724|NCT00910858|20751533|P3|COMPLETED|Pharmacokinetic Phase||3
8419725|NCT00910858|20751534|P2|COMPLETED|Pharmacokinetic Phase||0
8419726|NCT00910858|20751535|P1|COMPLETED|Pharmacokinetic Phase||8
8419727|NCT00910858|20751533|P3|STARTED|Pharmacokinetic Phase||3
8419728|NCT00910858|20751534|P2|STARTED|Pharmacokinetic Phase||0
8419729|NCT00910858|20751535|P1|STARTED|Pharmacokinetic Phase||9
8419730|NCT00910845|20751560|P2|NOT COMPLETED|Treatment Cycle 2||9
8419731|NCT00910845|20751561|P1|NOT COMPLETED|Treatment Cycle 2||5
8419732|NCT00910845|20751560|P2|COMPLETED|Treatment Cycle 2||203
8419733|NCT00910845|20751561|P1|COMPLETED|Treatment Cycle 2||136
8419734|NCT00910845|20751560|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
8419735|NCT00910845|20751561|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
8419736|NCT00910845|20751560|P2|NOT COMPLETED|Treatment Cycle 1||34
8419737|NCT00910845|20751561|P1|NOT COMPLETED|Treatment Cycle 1||31
8419738|NCT00910845|20751560|P2|COMPLETED|Treatment Cycle 1||243
8419739|NCT00910845|20751561|P1|COMPLETED|Treatment Cycle 1||249
8419740|NCT00910845|20751560|P2|STARTED|Treatment Cycle 1||277
8419741|NCT00910845|20751561|P1|STARTED|Treatment Cycle 1||280
8419742|NCT00910728|20751580|P9|NOT COMPLETED|Overall Study||3
8419743|NCT00910728|20751581|P8|NOT COMPLETED|Overall Study||3
8419744|NCT00910728|20751582|P7|NOT COMPLETED|Overall Study||6
8419745|NCT00910728|20751583|P6|NOT COMPLETED|Overall Study||1
8419746|NCT00910728|20751584|P5|NOT COMPLETED|Overall Study||5
8419747|NCT00910728|20751585|P4|NOT COMPLETED|Overall Study||3
8419748|NCT00910728|20751586|P3|NOT COMPLETED|Overall Study||3
8419749|NCT00910728|20751587|P2|NOT COMPLETED|Overall Study||3
8419750|NCT00910728|20751588|P1|NOT COMPLETED|Overall Study||6
8419751|NCT00910728|20751580|P9|COMPLETED|Overall Study||0
8419752|NCT00910728|20751581|P8|COMPLETED|Overall Study||1
8419753|NCT00910728|20751582|P7|COMPLETED|Overall Study||0
8419754|NCT00910728|20751583|P6|COMPLETED|Overall Study||0
8419755|NCT00910728|20751584|P5|COMPLETED|Overall Study||1
8419756|NCT00910728|20751585|P4|COMPLETED|Overall Study||0
8419757|NCT00910728|20751586|P3|COMPLETED|Overall Study||0
8419758|NCT00910728|20751587|P2|COMPLETED|Overall Study||0
8419759|NCT00910728|20751588|P1|COMPLETED|Overall Study||0
8419760|NCT00910728|20751580|P9|STARTED|Overall Study||3
8419761|NCT00910728|20751581|P8|STARTED|Overall Study||4
8419762|NCT00910728|20751582|P7|STARTED|Overall Study||6
8419763|NCT00910728|20751583|P6|STARTED|Overall Study||1
8419764|NCT00910728|20751584|P5|STARTED|Overall Study||6
8419765|NCT00910728|20751585|P4|STARTED|Overall Study||3
8419766|NCT00910728|20751586|P3|STARTED|Overall Study||3
8419767|NCT00910728|20751587|P2|STARTED|Overall Study||3
8419768|NCT00910728|20751588|P1|STARTED|Overall Study||6
8419769|NCT00910715|20751710|P3|NOT COMPLETED|Overall Study||0
8419770|NCT00910715|20751711|P2|NOT COMPLETED|Overall Study||26
8419771|NCT00910715|20751712|P1|NOT COMPLETED|Overall Study||22
8419772|NCT00910715|20751710|P3|COMPLETED|Overall Study||81
8419773|NCT00910715|20751711|P2|COMPLETED|Overall Study||91
8419774|NCT00910715|20751712|P1|COMPLETED|Overall Study||86
8419775|NCT00910715|20751710|P3|STARTED|Overall Study||81
8419776|NCT00910715|20751711|P2|STARTED|Overall Study||117
8419777|NCT00910715|20751712|P1|STARTED|Overall Study||108
8419778|NCT00910689|20751726|P4|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
8419779|NCT00910689|20751727|P3|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
8419780|NCT00910689|20751728|P2|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
8419781|NCT00910689|20751729|P1|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
8419782|NCT00910689|20751726|P4|COMPLETED|Months 11- 16: Evaluation Period II||35
8419783|NCT00910689|20751727|P3|COMPLETED|Months 11- 16: Evaluation Period II||28
8419784|NCT00910689|20751728|P2|COMPLETED|Months 11- 16: Evaluation Period II||25
8419785|NCT00910689|20751729|P1|COMPLETED|Months 11- 16: Evaluation Period II||30
8419786|NCT00910689|20751726|P4|STARTED|Months 11- 16: Evaluation Period II||41
8419787|NCT00910689|20751727|P3|STARTED|Months 11- 16: Evaluation Period II||35
8419788|NCT00910689|20751728|P2|STARTED|Months 11- 16: Evaluation Period II||35
8419789|NCT00910689|20751729|P1|STARTED|Months 11- 16: Evaluation Period II||40
8419790|NCT00910689|20751726|P4|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
8419791|NCT00910689|20751727|P3|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
8419792|NCT00910689|20751728|P2|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
8419793|NCT00910689|20751729|P1|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
8419794|NCT00910689|20751726|P4|COMPLETED|Months 5 - 10: Evaluation Period I||41
8419795|NCT00910689|20751727|P3|COMPLETED|Months 5 - 10: Evaluation Period I||35
8419796|NCT00910689|20751728|P2|COMPLETED|Months 5 - 10: Evaluation Period I||35
8419797|NCT00910689|20751729|P1|COMPLETED|Months 5 - 10: Evaluation Period I||40
8419798|NCT00910689|20751726|P4|STARTED|Months 5 - 10: Evaluation Period I||48
8419799|NCT00910689|20751727|P3|STARTED|Months 5 - 10: Evaluation Period I||42
8419800|NCT00910689|20751728|P2|STARTED|Months 5 - 10: Evaluation Period I||42
8419801|NCT00910689|20751729|P1|STARTED|Months 5 - 10: Evaluation Period I||44
8419802|NCT00910689|20751726|P4|NOT COMPLETED|Month 2- 4: Treatment Period||11
8419803|NCT00910689|20751727|P3|NOT COMPLETED|Month 2- 4: Treatment Period||8
8419804|NCT00910689|20751728|P2|NOT COMPLETED|Month 2- 4: Treatment Period||10
8419805|NCT00910689|20751729|P1|NOT COMPLETED|Month 2- 4: Treatment Period||9
8419806|NCT00910689|20751726|P4|COMPLETED|Month 2- 4: Treatment Period||48
8419807|NCT00910689|20751727|P3|COMPLETED|Month 2- 4: Treatment Period||42
8419808|NCT00910689|20751728|P2|COMPLETED|Month 2- 4: Treatment Period||42
8419809|NCT00910689|20751729|P1|COMPLETED|Month 2- 4: Treatment Period||44
8419810|NCT00910689|20751726|P4|STARTED|Month 2- 4: Treatment Period||59
8419811|NCT00910689|20751727|P3|STARTED|Month 2- 4: Treatment Period||50
8419812|NCT00910689|20751728|P2|STARTED|Month 2- 4: Treatment Period||52
8419813|NCT00910689|20751729|P1|STARTED|Month 2- 4: Treatment Period||53
8419814|NCT00910689|20751726|P4|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
8419815|NCT00910689|20751727|P3|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
8419816|NCT00910689|20751728|P2|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
8419817|NCT00910689|20751729|P1|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
8419818|NCT00910689|20751726|P4|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
8419819|NCT00910689|20751727|P3|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
8419820|NCT00910689|20751728|P2|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
8419821|NCT00910689|20751729|P1|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
8419822|NCT00910689|20751726|P4|STARTED|Month 1: Optimal Acute Therapy Run in||69
8419823|NCT00910689|20751727|P3|STARTED|Month 1: Optimal Acute Therapy Run in||55
8419824|NCT00910689|20751728|P2|STARTED|Month 1: Optimal Acute Therapy Run in||53
8419825|NCT00910689|20751729|P1|STARTED|Month 1: Optimal Acute Therapy Run in||55
8419826|NCT00910663|20751761|P2|NOT COMPLETED|Period 2||0
8419827|NCT00910663|20751762|P1|NOT COMPLETED|Period 2||0
8419828|NCT00910663|20751761|P2|COMPLETED|Period 2||29
8419829|NCT00910663|20751762|P1|COMPLETED|Period 2||30
8419830|NCT00910663|20751761|P2|STARTED|Period 2||29
8419831|NCT00910663|20751762|P1|STARTED|Period 2||30
8419832|NCT00910663|20751761|P2|NOT COMPLETED|Period 1||1
8419833|NCT00910663|20751762|P1|NOT COMPLETED|Period 1||0
8419834|NCT00910663|20751761|P2|COMPLETED|Period 1||29
8419835|NCT00910663|20751762|P1|COMPLETED|Period 1||30
8419836|NCT00910663|20751761|P2|STARTED|Period 1||30
8419837|NCT00910663|20751762|P1|STARTED|Period 1||30
8419862|NCT00910520|20751793|P2|NOT COMPLETED|Treatment Cycle 2||8
8419863|NCT00910520|20751794|P1|NOT COMPLETED|Treatment Cycle 2||7
8419864|NCT00910520|20751793|P2|COMPLETED|Treatment Cycle 2||215
8419865|NCT00910520|20751794|P1|COMPLETED|Treatment Cycle 2||156
8419866|NCT00910520|20751793|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
8419867|NCT00910520|20751794|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
8419868|NCT00910520|20751793|P2|NOT COMPLETED|Treatment Cycle 1||24
8419869|NCT00910520|20751794|P1|NOT COMPLETED|Treatment Cycle 1||20
8419870|NCT00910520|20751793|P2|COMPLETED|Treatment Cycle 1||247
8419871|NCT00910520|20751794|P1|COMPLETED|Treatment Cycle 1||257
8419872|NCT00910520|20751793|P2|STARTED|Treatment Cycle 1||271
8419873|NCT00910520|20751794|P1|STARTED|Treatment Cycle 1||277
8419874|NCT00910429|20751806|P2|NOT COMPLETED|Overall Study||21
8419875|NCT00910429|20751807|P1|NOT COMPLETED|Overall Study||39
8419876|NCT00910429|20751806|P2|COMPLETED|Overall Study|Completed treatment|61
8419877|NCT00910429|20751807|P1|COMPLETED|Overall Study|Completed treatment|116
8419878|NCT00910429|20751806|P2|STARTED|Overall Study||82
8419879|NCT00910429|20751807|P1|STARTED|Overall Study||155
8419880|NCT00910299|20751869|P2|NOT COMPLETED|Overall Study||74
8419881|NCT00910299|20751870|P1|NOT COMPLETED|Overall Study||76
8419882|NCT00910299|20751869|P2|COMPLETED|Overall Study|"1 participant died of sepsis while on study drug and was considered a protocol completer."|137
8419883|NCT00910299|20751870|P1|COMPLETED|Overall Study||136
8419884|NCT00910299|20751869|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
8419885|NCT00910299|20751870|P1|Received at Least 1 Dose of Study Drug|Overall Study||210
8419886|NCT00910299|20751869|P2|STARTED|Overall Study||211
8419887|NCT00910299|20751870|P1|STARTED|Overall Study||212
8419888|NCT00910273|20751882|P2|NOT COMPLETED|Overall Study||13
8419889|NCT00910273|20751883|P1|NOT COMPLETED|Overall Study||18
8419890|NCT00910273|20751882|P2|COMPLETED|Overall Study||3
8419891|NCT00910273|20751883|P1|COMPLETED|Overall Study||0
8419892|NCT00910273|20751882|P2|STARTED|Overall Study||16
8419893|NCT00910273|20751883|P1|STARTED|Overall Study||18
8419894|NCT00910247|20751933|P1|NOT COMPLETED|Overall Study||69
8419895|NCT00910247|20751933|P1|COMPLETED|Overall Study||205
8419896|NCT00910247|20751933|P1|STARTED|Overall Study||274
8419897|NCT00910208|20751956|P3|NOT COMPLETED|Overall Study||1
8419898|NCT00910208|20751957|P2|NOT COMPLETED|Overall Study||2
8419899|NCT00910208|20751958|P1|NOT COMPLETED|Overall Study||2
8419900|NCT00910208|20751956|P3|COMPLETED|Overall Study||69
8419901|NCT00910208|20751957|P2|COMPLETED|Overall Study||70
8419902|NCT00910208|20751958|P1|COMPLETED|Overall Study||67
8419903|NCT00910208|20751956|P3|STARTED|Overall Study||70
8419904|NCT00910208|20751957|P2|STARTED|Overall Study||72
8419905|NCT00910208|20751958|P1|STARTED|Overall Study||69
8419906|NCT00910091|20751983|P2|NOT COMPLETED|Treatment and Survival||4
8419907|NCT00910091|20751984|P1|NOT COMPLETED|Treatment and Survival||4
8419908|NCT00910091|20751983|P2|COMPLETED|Treatment and Survival||31
8419909|NCT00910091|20751984|P1|COMPLETED|Treatment and Survival||32
8419910|NCT00910091|20751983|P2|STARTED|Treatment and Survival||35
8419911|NCT00910091|20751984|P1|STARTED|Treatment and Survival||36
8419912|NCT00910091|20751983|P2|NOT COMPLETED|Pre-assignment||2
8419913|NCT00910091|20751984|P1|NOT COMPLETED|Pre-assignment||0
8419914|NCT00910091|20751983|P2|COMPLETED|Pre-assignment||35
8419915|NCT00910091|20751984|P1|COMPLETED|Pre-assignment||36
8419916|NCT00910091|20751983|P2|STARTED|Pre-assignment||37
8419917|NCT00910091|20751984|P1|STARTED|Pre-assignment||36
8419918|NCT00910039|20752012|P1|NOT COMPLETED|Overall Study||1
8419919|NCT00910039|20752012|P1|COMPLETED|Overall Study||13
8419920|NCT00910039|20752012|P1|STARTED|Overall Study||14
8419921|NCT00910000|20752029|P6|NOT COMPLETED|Overall Study||1
8419922|NCT00910000|20752030|P5|NOT COMPLETED|Overall Study||1
8419923|NCT00910000|20752031|P4|NOT COMPLETED|Overall Study||2
8419924|NCT00910000|20752032|P3|NOT COMPLETED|Overall Study||3
8419925|NCT00910000|20752033|P2|NOT COMPLETED|Overall Study||3
8419926|NCT00910000|20752034|P1|NOT COMPLETED|Overall Study||0
8419927|NCT00910000|20752029|P6|COMPLETED|Overall Study||0
8419928|NCT00910000|20752030|P5|COMPLETED|Overall Study||2
8419929|NCT00910000|20752031|P4|COMPLETED|Overall Study||0
8419930|NCT00910000|20752032|P3|COMPLETED|Overall Study||0
8419931|NCT00910000|20752033|P2|COMPLETED|Overall Study||0
8419932|NCT00910000|20752034|P1|COMPLETED|Overall Study||3
8419933|NCT00910000|20752029|P6|STARTED|Overall Study||1
8419934|NCT00910000|20752030|P5|STARTED|Overall Study||3
8419935|NCT00910000|20752031|P4|STARTED|Overall Study||2
8419936|NCT00910000|20752032|P3|STARTED|Overall Study||3
8419937|NCT00910000|20752033|P2|STARTED|Overall Study||3
8419938|NCT00910000|20752034|P1|STARTED|Overall Study||3
8419939|NCT00909870|20752052|P2|NOT COMPLETED|Overall Study||27
8419940|NCT00909870|20752053|P1|NOT COMPLETED|Overall Study||23
8419941|NCT00909870|20752052|P2|COMPLETED|Overall Study||236
8419942|NCT00909870|20752053|P1|COMPLETED|Overall Study||251
8419943|NCT00909870|20752052|P2|STARTED|Overall Study||263
8419944|NCT00909870|20752053|P1|STARTED|Overall Study||274
8419945|NCT00909857|20752065|P2|NOT COMPLETED|Overall Study||45
8419946|NCT00909857|20752066|P1|NOT COMPLETED|Overall Study||36
8419947|NCT00909857|20752065|P2|COMPLETED|Overall Study||209
8419948|NCT00909857|20752066|P1|COMPLETED|Overall Study||217
8419949|NCT00909857|20752065|P2|Treated|Overall Study||230
8419950|NCT00909857|20752066|P1|Treated|Overall Study||234
8419951|NCT00909857|20752065|P2|STARTED|Overall Study||254
8419952|NCT00909857|20752066|P1|STARTED|Overall Study||253
8419953|NCT00909844|20752206|P1|NOT COMPLETED|Overall Study||4
8419954|NCT00909844|20752206|P1|COMPLETED|Overall Study||31
8419955|NCT00909844|20752206|P1|STARTED|Overall Study||35
8419956|NCT00909792|20752224|P2|NOT COMPLETED|Period 2||1
8419957|NCT00909792|20752225|P1|NOT COMPLETED|Period 2||1
8419958|NCT00909792|20752224|P2|COMPLETED|Period 2||124
8419959|NCT00909792|20752225|P1|COMPLETED|Period 2||128
8419960|NCT00909792|20752224|P2|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
8419961|NCT00909792|20752225|P1|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
8419962|NCT00909792|20752224|P2|NOT COMPLETED|Period 1||1
8419963|NCT00909792|20752225|P1|NOT COMPLETED|Period 1||0
8419964|NCT00909792|20752224|P2|COMPLETED|Period 1||127
8419965|NCT00909792|20752225|P1|COMPLETED|Period 1||130
8419966|NCT00909792|20752224|P2|STARTED|Period 1||128
8419967|NCT00909792|20752225|P1|STARTED|Period 1||130
8419968|NCT00909779|20752233|P2|NOT COMPLETED|Overall Study||165
8419969|NCT00909779|20752234|P1|NOT COMPLETED|Overall Study||210
8419970|NCT00909779|20752233|P2|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
8419971|NCT00909779|20752234|P1|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
8419972|NCT00909779|20752233|P2|STARTED|Overall Study||420
8419973|NCT00909779|20752234|P1|STARTED|Overall Study||421
8419974|NCT00909753|20752258|P2|NOT COMPLETED|Period: Second Intervention||0
8419975|NCT00909753|20752259|P1|NOT COMPLETED|Period: Second Intervention||1
8419976|NCT00909753|20752258|P2|COMPLETED|Period: Second Intervention||43
8419977|NCT00909753|20752259|P1|COMPLETED|Period: Second Intervention||43
8419978|NCT00909753|20752258|P2|STARTED|Period: Second Intervention||43
8419979|NCT00909753|20752259|P1|STARTED|Period: Second Intervention||44
8419980|NCT00909753|20752258|P2|NOT COMPLETED|Period: Washout of 28 Days||3
8419981|NCT00909753|20752259|P1|NOT COMPLETED|Period: Washout of 28 Days||2
8419982|NCT00909753|20752258|P2|COMPLETED|Period: Washout of 28 Days||43
8419983|NCT00909753|20752259|P1|COMPLETED|Period: Washout of 28 Days||44
8419984|NCT00909753|20752258|P2|STARTED|Period: Washout of 28 Days||46
8419985|NCT00909753|20752259|P1|STARTED|Period: Washout of 28 Days||46
8419986|NCT00909753|20752258|P2|NOT COMPLETED|Period: First Intervention||0
8419987|NCT00909753|20752259|P1|NOT COMPLETED|Period: First Intervention||0
8419988|NCT00909753|20752258|P2|COMPLETED|Period: First Intervention||46
8419989|NCT00909753|20752259|P1|COMPLETED|Period: First Intervention||46
8419990|NCT00909753|20752258|P2|STARTED|Period: First Intervention||46
8419991|NCT00909753|20752259|P1|STARTED|Period: First Intervention||46
8419992|NCT00909727|20752279|P2|NOT COMPLETED|Overall Study||0
8419993|NCT00909727|20752280|P1|NOT COMPLETED|Overall Study||4
8419994|NCT00909727|20752279|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
8419995|NCT00909727|20752280|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
8419996|NCT00909727|20752279|P2|Completed Treatment Period, Week 24|Overall Study||26
8419997|NCT00909727|20752280|P1|Completed Treatment Period, Week 24|Overall Study||23
8419998|NCT00909727|20752279|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
8419999|NCT00909727|20752280|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
8420000|NCT00909649|20752296|P2|NOT COMPLETED|Overall Study||0
8420001|NCT00909649|20752297|P1|NOT COMPLETED|Overall Study||0
8420002|NCT00909649|20752296|P2|COMPLETED|Overall Study||25
8420003|NCT00909649|20752297|P1|COMPLETED|Overall Study||25
8420004|NCT00909649|20752296|P2|STARTED|Overall Study||25
8420005|NCT00909649|20752297|P1|STARTED|Overall Study||25
8420006|NCT00909610|20752303|P2|NOT COMPLETED|Period: Second Intervention||0
8420007|NCT00909610|20752304|P1|NOT COMPLETED|Period: Second Intervention||1
8420008|NCT00909610|20752303|P2|COMPLETED|Period: Second Intervention||33
8420009|NCT00909610|20752304|P1|COMPLETED|Period: Second Intervention||36
8420010|NCT00909610|20752303|P2|STARTED|Period: Second Intervention||33
8420011|NCT00909610|20752304|P1|STARTED|Period: Second Intervention||37
8420012|NCT00909610|20752303|P2|NOT COMPLETED|Period: Washout of 28 Days||6
8420013|NCT00909610|20752304|P1|NOT COMPLETED|Period: Washout of 28 Days||3
8420014|NCT00909610|20752303|P2|COMPLETED|Period: Washout of 28 Days||33
8420015|NCT00909610|20752304|P1|COMPLETED|Period: Washout of 28 Days||37
8420016|NCT00909610|20752303|P2|STARTED|Period: Washout of 28 Days||39
8420017|NCT00909610|20752304|P1|STARTED|Period: Washout of 28 Days||40
8420018|NCT00909610|20752303|P2|NOT COMPLETED|Period: First Intervention||1
8420019|NCT00909610|20752304|P1|NOT COMPLETED|Period: First Intervention||0
8420020|NCT00909610|20752303|P2|COMPLETED|Period: First Intervention||39
8420021|NCT00909610|20752304|P1|COMPLETED|Period: First Intervention||40
8420022|NCT00909610|20752303|P2|STARTED|Period: First Intervention||40
8420023|NCT00909610|20752304|P1|STARTED|Period: First Intervention||40
8420024|NCT00909545|20752326|P4|NOT COMPLETED|Overall Study||5
8420025|NCT00909545|20752327|P3|NOT COMPLETED|Overall Study||1
8420026|NCT00909545|20752328|P2|NOT COMPLETED|Overall Study||1
8420027|NCT00909545|20752329|P1|NOT COMPLETED|Overall Study||1
8420028|NCT00909545|20752326|P4|COMPLETED|Overall Study||19
8420029|NCT00909545|20752327|P3|COMPLETED|Overall Study||25
8420030|NCT00909545|20752328|P2|COMPLETED|Overall Study||22
8420031|NCT00909545|20752329|P1|COMPLETED|Overall Study||25
8420032|NCT00909545|20752326|P4|STARTED|Overall Study||24
8420033|NCT00909545|20752327|P3|STARTED|Overall Study||26
8420034|NCT00909545|20752328|P2|STARTED|Overall Study||23
8420035|NCT00909545|20752329|P1|STARTED|Overall Study||26
8420036|NCT00909532|20752465|P2|NOT COMPLETED|Overall Study||6
8420037|NCT00909532|20752466|P1|NOT COMPLETED|Overall Study||10
8420038|NCT00909532|20752465|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
8420039|NCT00909532|20752466|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
8420040|NCT00909532|20752465|P2|Completed Treatment Period, Week 24|Overall Study||80
8420041|NCT00909532|20752466|P1|Completed Treatment Period, Week 24|Overall Study||71
8420042|NCT00909532|20752465|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
8420043|NCT00909532|20752466|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
8420044|NCT00909480|20752484|P2|NOT COMPLETED|Overall Study||41
8420045|NCT00909480|20752485|P1|NOT COMPLETED|Overall Study||38
8420046|NCT00909480|20752484|P2|COMPLETED|Overall Study||188
8420047|NCT00909480|20752485|P1|COMPLETED|Overall Study||190
8420048|NCT00909480|20752484|P2|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
8420049|NCT00909480|20752485|P1|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
8420050|NCT00909480|20752484|P2|STARTED|Overall Study||229
8420051|NCT00909480|20752485|P1|STARTED|Overall Study||228
8420052|NCT00909428|20752520|P3|NOT COMPLETED|Overall Study||9
8420053|NCT00909428|20752521|P2|NOT COMPLETED|Overall Study||10
8420054|NCT00909428|20752522|P1|NOT COMPLETED|Overall Study||13
8420055|NCT00909428|20752520|P3|COMPLETED|Overall Study||0
8420056|NCT00909428|20752521|P2|COMPLETED|Overall Study||5
8420057|NCT00909428|20752522|P1|COMPLETED|Overall Study||5
8420058|NCT00909428|20752520|P3|STARTED|Overall Study||9
8420059|NCT00909428|20752521|P2|STARTED|Overall Study||15
8420060|NCT00909428|20752522|P1|STARTED|Overall Study||18
8420061|NCT00909389|20752529|P1|NOT COMPLETED|Overall Study||133
8420062|NCT00909389|20752529|P1|COMPLETED|Overall Study||4615
8420063|NCT00909389|20752529|P1|STARTED|Overall Study||4748
8420064|NCT00909363|20752536|P3|NOT COMPLETED|Overall Study||0
8420065|NCT00909363|20752537|P2|NOT COMPLETED|Overall Study||0
8420066|NCT00909363|20752538|P1|NOT COMPLETED|Overall Study||2
8420067|NCT00909363|20752536|P3|COMPLETED|Overall Study||5
8420068|NCT00909363|20752537|P2|COMPLETED|Overall Study||8
8420069|NCT00909363|20752538|P1|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9
8420070|NCT00909363|20752536|P3|STARTED|Overall Study||5
8420071|NCT00909363|20752537|P2|STARTED|Overall Study||8
8420072|NCT00909363|20752538|P1|STARTED|Overall Study||11
8420073|NCT00909324|20752557|P2|NOT COMPLETED|Overall Study||0
8420074|NCT00909324|20752558|P1|NOT COMPLETED|Overall Study||0
8420075|NCT00909324|20752557|P2|COMPLETED|Overall Study||90
8420076|NCT00909324|20752558|P1|COMPLETED|Overall Study||72
8420077|NCT00909324|20752557|P2|STARTED|Overall Study||90
8420078|NCT00909324|20752558|P1|STARTED|Overall Study||72
8420079|NCT00909220|20752570|P2|NOT COMPLETED|Overall Study||0
8420080|NCT00909220|20752571|P1|NOT COMPLETED|Overall Study||0
8420081|NCT00909220|20752570|P2|COMPLETED|Overall Study||36
8420082|NCT00909220|20752571|P1|COMPLETED|Overall Study||41
8420083|NCT00909220|20752570|P2|Submission for Publication|Overall Study||36
8420084|NCT00909220|20752571|P1|Submission for Publication|Overall Study||41
8420085|NCT00909220|20752570|P2|Data Analyses|Overall Study||36
8420086|NCT00909220|20752571|P1|Data Analyses|Overall Study||41
8420087|NCT00909220|20752570|P2|Data Entry|Overall Study||36
8420088|NCT00909220|20752571|P1|Data Entry|Overall Study||41
8420089|NCT00909220|20752570|P2|STARTED|Overall Study|Started enrolling participants May 2009|36
8420090|NCT00909220|20752571|P1|STARTED|Overall Study|Started enrolling participants May 2009|41
8420091|NCT00909181|20752585|P3|NOT COMPLETED|Overall Study||33
8420092|NCT00909181|20752586|P2|NOT COMPLETED|Overall Study||18
8420093|NCT00909181|20752587|P1|NOT COMPLETED|Overall Study||39
8420094|NCT00909181|20752585|P3|COMPLETED|Overall Study||169
8420095|NCT00909181|20752586|P2|COMPLETED|Overall Study||196
8420096|NCT00909181|20752587|P1|COMPLETED|Overall Study||171
8420097|NCT00909181|20752585|P3|STARTED|Overall Study||202
8420098|NCT00909181|20752586|P2|STARTED|Overall Study||214
8420099|NCT00909181|20752587|P1|STARTED|Overall Study||210
8420100|NCT00909155|20752598|P3|NOT COMPLETED|Overall Study||7
8420101|NCT00909155|20752599|P2|NOT COMPLETED|Overall Study||5
8420102|NCT00909155|20752600|P1|NOT COMPLETED|Overall Study||3
8420103|NCT00909155|20752598|P3|COMPLETED|Overall Study||14
8420104|NCT00909155|20752599|P2|COMPLETED|Overall Study||9
8420105|NCT00909155|20752600|P1|COMPLETED|Overall Study||12
8420106|NCT00909155|20752598|P3|STARTED|Overall Study||21
8420107|NCT00909155|20752599|P2|STARTED|Overall Study||14
8420108|NCT00909155|20752600|P1|STARTED|Overall Study||15
8420109|NCT00909090|20752613|P2|NOT COMPLETED|Overall Study||17
8420110|NCT00909090|20752614|P1|NOT COMPLETED|Overall Study||17
8420111|NCT00909090|20752613|P2|COMPLETED|Overall Study||39
8420112|NCT00909090|20752614|P1|COMPLETED|Overall Study||36
8420113|NCT00909090|20752613|P2|STARTED|Overall Study||56
8420114|NCT00909090|20752614|P1|STARTED|Overall Study||53
8420115|NCT00909064|20752626|P1|NOT COMPLETED|Overall Study||0
8420116|NCT00909064|20752626|P1|COMPLETED|Overall Study||114
8420117|NCT00909064|20752626|P1|STARTED|Overall Study||114
8420118|NCT00909038|20752632|P1|NOT COMPLETED|Overall Study||417
8420119|NCT00909038|20752632|P1|COMPLETED|Overall Study||1994
8420120|NCT00909038|20752632|P1|STARTED|Overall Study||2411
8420121|NCT00908960|20752644|P3|NOT COMPLETED|Overall Study||2
8420122|NCT00908960|20752645|P2|NOT COMPLETED|Overall Study||1
8420123|NCT00908960|20752646|P1|NOT COMPLETED|Overall Study||1
8420124|NCT00908960|20752644|P3|COMPLETED|Overall Study||32
8420125|NCT00908960|20752645|P2|COMPLETED|Overall Study||11
8420126|NCT00908960|20752646|P1|COMPLETED|Overall Study||23
8420127|NCT00908960|20752644|P3|Evaluable|Overall Study||32
8420128|NCT00908960|20752645|P2|Evaluable|Overall Study||11
8420129|NCT00908960|20752646|P1|Evaluable|Overall Study||23
8420130|NCT00908960|20752644|P3|STARTED|Overall Study||34
8420131|NCT00908960|20752645|P2|STARTED|Overall Study||12
8420132|NCT00908960|20752646|P1|STARTED|Overall Study||24
8420133|NCT00908947|20752660|P1|NOT COMPLETED|Overall Study||90
8420134|NCT00908947|20752660|P1|COMPLETED|Overall Study||83
8420135|NCT00908947|20752660|P1|STARTED|Overall Study||173
8420136|NCT00908908|20752682|P1|NOT COMPLETED|Overall Study||0
8420137|NCT00908908|20752682|P1|COMPLETED|Overall Study||6
8420138|NCT00908908|20752682|P1|Physician Decision|Overall Study||0
8420139|NCT00908908|20752682|P1|Administrative/Other|Overall Study||0
8420140|NCT00908908|20752682|P1|Withdrawl by Subject|Overall Study||0
8420141|NCT00908908|20752682|P1|Adverse Event|Overall Study||0
8420142|NCT00908908|20752682|P1|STARTED|Overall Study||6
8420143|NCT00908895|20752690|P2|NOT COMPLETED|Overall Study||6
8420144|NCT00908895|20752691|P1|NOT COMPLETED|Overall Study||4
8420145|NCT00908895|20752690|P2|COMPLETED|Overall Study||57
8420146|NCT00908895|20752691|P1|COMPLETED|Overall Study||53
8420147|NCT00908895|20752690|P2|STARTED|Overall Study||63
8420148|NCT00908895|20752691|P1|STARTED|Overall Study||57
8420149|NCT00908882|20752701|P2|NOT COMPLETED|Overall Study||30
8420150|NCT00908882|20752702|P1|NOT COMPLETED|Overall Study||28
8420151|NCT00908882|20752701|P2|COMPLETED|Overall Study||59
8420152|NCT00908882|20752702|P1|COMPLETED|Overall Study||61
8420153|NCT00908882|20752701|P2|STARTED|Overall Study||89
8420154|NCT00908882|20752702|P1|STARTED|Overall Study||89
8420155|NCT00908830|20752728|P2|NOT COMPLETED|Overall Study||0
8420156|NCT00908830|20752729|P1|NOT COMPLETED|Overall Study||0
8420157|NCT00908830|20752728|P2|COMPLETED|Overall Study||5
8420158|NCT00908830|20752729|P1|COMPLETED|Overall Study||5
8420159|NCT00908830|20752728|P2|STARTED|Overall Study||5
8420160|NCT00908830|20752729|P1|STARTED|Overall Study||5
8420161|NCT00908791|20752737|P1|NOT COMPLETED|Overall Study||0
8420162|NCT00908791|20752737|P1|COMPLETED|Overall Study||24
8420163|NCT00908791|20752737|P1|STARTED|Overall Study||24
8420164|NCT00908687|20752760|P6|NOT COMPLETED|Overall Study||6
8420165|NCT00908687|20752761|P5|NOT COMPLETED|Overall Study||4
8420166|NCT00908687|20752762|P4|NOT COMPLETED|Overall Study||3
8420167|NCT00908687|20752763|P3|NOT COMPLETED|Overall Study||3
8420168|NCT00908687|20752764|P2|NOT COMPLETED|Overall Study||1
8420169|NCT00908687|20752765|P1|NOT COMPLETED|Overall Study||1
8420170|NCT00908687|20752760|P6|COMPLETED|Overall Study||94
8420171|NCT00908687|20752761|P5|COMPLETED|Overall Study||94
8420172|NCT00908687|20752762|P4|COMPLETED|Overall Study||47
8420173|NCT00908687|20752763|P3|COMPLETED|Overall Study||99
8420174|NCT00908687|20752764|P2|COMPLETED|Overall Study||99
8420175|NCT00908687|20752765|P1|COMPLETED|Overall Study||49
8420176|NCT00908687|20752760|P6|STARTED|Overall Study||100
8420177|NCT00908687|20752761|P5|STARTED|Overall Study||98
8420178|NCT00908687|20752762|P4|STARTED|Overall Study||50
8420179|NCT00908687|20752763|P3|STARTED|Overall Study||102
8420180|NCT00908687|20752764|P2|STARTED|Overall Study||100
8420181|NCT00908687|20752765|P1|STARTED|Overall Study||50
8420188|NCT00908596|20752792|P4|NOT COMPLETED|Overall Study||37
8420189|NCT00908596|20752793|P3|NOT COMPLETED|Overall Study||74
8420190|NCT00908596|20752794|P2|NOT COMPLETED|Overall Study||13
8420191|NCT00908596|20752795|P1|NOT COMPLETED|Overall Study||47
8420192|NCT00908596|20752792|P4|COMPLETED|Overall Study||48
8420193|NCT00908596|20752793|P3|COMPLETED|Overall Study||119
8420194|NCT00908596|20752794|P2|COMPLETED|Overall Study||19
8420195|NCT00908596|20752795|P1|COMPLETED|Overall Study||0
8420196|NCT00908596|20752792|P4|STARTED|Overall Study||85
8420197|NCT00908596|20752793|P3|STARTED|Overall Study||193
8420198|NCT00908596|20752794|P2|STARTED|Overall Study||32
8420199|NCT00908596|20752795|P1|STARTED|Overall Study||47
8420200|NCT00908583|20752825|P1|NOT COMPLETED|Phase 5||3
8420201|NCT00908583|20752825|P1|COMPLETED|Phase 5||2
8420202|NCT00908583|20752825|P1|STARTED|Phase 5||5
8420203|NCT00908583|20752825|P1|NOT COMPLETED|Phase 4||2
8420204|NCT00908583|20752825|P1|COMPLETED|Phase 4||3
8420205|NCT00908583|20752825|P1|STARTED|Phase 4||5
8420206|NCT00908583|20752825|P1|NOT COMPLETED|Phase 3||2
8420207|NCT00908583|20752825|P1|COMPLETED|Phase 3||8
8420208|NCT00908583|20752825|P1|STARTED|Phase 3||10
8420209|NCT00908583|20752825|P1|NOT COMPLETED|Phase 2||2
8420210|NCT00908583|20752825|P1|COMPLETED|Phase 2||10
8420211|NCT00908583|20752825|P1|STARTED|Phase 2||12
8420212|NCT00908583|20752825|P1|NOT COMPLETED|Phase 1||5
8420213|NCT00908583|20752825|P1|COMPLETED|Phase 1||15
8420214|NCT00908583|20752825|P1|STARTED|Phase 1||20
8420215|NCT00908544|20752845|P2|NOT COMPLETED|Overall Study||6
8420216|NCT00908544|20752846|P1|NOT COMPLETED|Overall Study||5
8420217|NCT00908544|20752845|P2|COMPLETED|Overall Study||16
8420218|NCT00908544|20752846|P1|COMPLETED|Overall Study||15
8420219|NCT00908544|20752845|P2|STARTED|Overall Study||22
8420220|NCT00908544|20752846|P1|STARTED|Overall Study||20
8420221|NCT00908466|20752888|P2|NOT COMPLETED|Overall Study||1
8420222|NCT00908466|20752889|P1|NOT COMPLETED|Overall Study||1
8420223|NCT00908466|20752888|P2|COMPLETED|Overall Study||14
8420224|NCT00908466|20752889|P1|COMPLETED|Overall Study||14
8420225|NCT00908466|20752888|P2|STARTED|Overall Study||15
8420226|NCT00908466|20752889|P1|STARTED|Overall Study||15
8420227|NCT00908388|20752895|P1|NOT COMPLETED|Overall Study||10
8420228|NCT00908388|20752895|P1|COMPLETED|Overall Study||40
8420229|NCT00908388|20752895|P1|STARTED|Overall Study||50
8420230|NCT00908375|20752905|P2|NOT COMPLETED|Overall Study||10
8420231|NCT00908375|20752906|P1|NOT COMPLETED|Overall Study||10
8420232|NCT00908375|20752905|P2|COMPLETED|Overall Study||9
8420233|NCT00908375|20752906|P1|COMPLETED|Overall Study||10
8420234|NCT00908375|20752905|P2|STARTED|Overall Study||19
8420235|NCT00908375|20752906|P1|STARTED|Overall Study||20
8420236|NCT00908349|20752916|P1|NOT COMPLETED|Overall Study||35
8420237|NCT00908349|20752916|P1|COMPLETED|Overall Study||179
8420238|NCT00908349|20752916|P1|STARTED|Overall Study||214
8420239|NCT00908310|20752920|P1|NOT COMPLETED|Overall Study||60
8420240|NCT00908310|20752920|P1|COMPLETED|Overall Study||153
8420241|NCT00908310|20752920|P1|STARTED|Overall Study||213
8420242|NCT00908232|20752924|P4|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
8420243|NCT00908232|20752925|P3|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
8420244|NCT00908232|20752926|P2|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
8420245|NCT00908232|20752927|P1|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
8420246|NCT00908232|20752924|P4|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
8420247|NCT00908232|20752925|P3|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
8420248|NCT00908232|20752926|P2|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
8420249|NCT00908232|20752927|P1|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
8420250|NCT00908232|20752924|P4|STARTED|Randomization (Cycle 5) to Cycle 8||4
8420251|NCT00908232|20752925|P3|STARTED|Randomization (Cycle 5) to Cycle 8||8
8420252|NCT00908232|20752926|P2|STARTED|Randomization (Cycle 5) to Cycle 8||7
8420253|NCT00908232|20752927|P1|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
8420254|NCT00908232|20752924|P4|NOT COMPLETED|Cycle 1 to 4||0
8420255|NCT00908232|20752925|P3|NOT COMPLETED|Cycle 1 to 4||0
8420256|NCT00908232|20752926|P2|NOT COMPLETED|Cycle 1 to 4||0
8420257|NCT00908232|20752927|P1|NOT COMPLETED|Cycle 1 to 4||28
8420258|NCT00908232|20752924|P4|COMPLETED|Cycle 1 to 4||0
8420259|NCT00908232|20752925|P3|COMPLETED|Cycle 1 to 4||0
8420260|NCT00908232|20752926|P2|COMPLETED|Cycle 1 to 4||0
8420261|NCT00908232|20752927|P1|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
8420262|NCT00908232|20752924|P4|STARTED|Cycle 1 to 4||0
8420263|NCT00908232|20752925|P3|STARTED|Cycle 1 to 4||0
8420264|NCT00908232|20752926|P2|STARTED|Cycle 1 to 4||0
8420265|NCT00908232|20752927|P1|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
8420266|NCT00908141|20752945|P2|NOT COMPLETED|Overall Study||1
8420267|NCT00908141|20752946|P1|NOT COMPLETED|Overall Study||0
8420268|NCT00908141|20752945|P2|COMPLETED|Overall Study||8
8420269|NCT00908141|20752946|P1|COMPLETED|Overall Study||8
8420270|NCT00908141|20752945|P2|STARTED|Overall Study||9
8420271|NCT00908141|20752946|P1|STARTED|Overall Study||8
8420272|NCT00908128|20752954|P2|NOT COMPLETED|Period 4||0
8420273|NCT00908128|20752955|P1|NOT COMPLETED|Period 4||0
8420274|NCT00908128|20752954|P2|COMPLETED|Period 4||19
8420275|NCT00908128|20752955|P1|COMPLETED|Period 4||20
8420276|NCT00908128|20752954|P2|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
8420277|NCT00908128|20752955|P1|STARTED|Period 4||20
8420278|NCT00908128|20752954|P2|NOT COMPLETED|Period 3||0
8420279|NCT00908128|20752955|P1|NOT COMPLETED|Period 3||0
8420280|NCT00908128|20752954|P2|COMPLETED|Period 3||20
8420281|NCT00908128|20752955|P1|COMPLETED|Period 3||20
8420282|NCT00908128|20752954|P2|STARTED|Period 3||20
8420283|NCT00908128|20752955|P1|STARTED|Period 3||20
8420284|NCT00908128|20752954|P2|NOT COMPLETED|Period 2||0
8420285|NCT00908128|20752955|P1|NOT COMPLETED|Period 2||0
8420286|NCT00908128|20752954|P2|COMPLETED|Period 2||20
8420287|NCT00908128|20752955|P1|COMPLETED|Period 2||20
8420288|NCT00908128|20752954|P2|STARTED|Period 2||20
8420289|NCT00908128|20752955|P1|STARTED|Period 2||20
8420290|NCT00908128|20752954|P2|NOT COMPLETED|Period 1||0
8420291|NCT00908128|20752955|P1|NOT COMPLETED|Period 1||0
8420292|NCT00908128|20752954|P2|COMPLETED|Period 1||20
8420293|NCT00908128|20752955|P1|COMPLETED|Period 1||20
8420294|NCT00908128|20752954|P2|STARTED|Period 1||20
8420295|NCT00908128|20752955|P1|STARTED|Period 1||20
8420296|NCT00908115|20752963|P1|NOT COMPLETED|Overall Study||14
8420297|NCT00908115|20752963|P1|COMPLETED|Overall Study||1244
8420298|NCT00908115|20752963|P1|STARTED|Overall Study||1258
8420299|NCT00908076|20752971|P2|NOT COMPLETED|Overall Study||1
8420300|NCT00908076|20752972|P1|NOT COMPLETED|Overall Study||1
8420301|NCT00908076|20752971|P2|COMPLETED|Overall Study||26
8420302|NCT00908076|20752972|P1|COMPLETED|Overall Study||26
8420303|NCT00908076|20752971|P2|STARTED|Overall Study||27
8420304|NCT00908076|20752972|P1|STARTED|Overall Study||27
8420305|NCT00908037|20752985|P12|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
8420306|NCT00908037|20752986|P11|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
8420307|NCT00908037|20752987|P10|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
8420308|NCT00908037|20752988|P9|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420309|NCT00908037|20752989|P8|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420310|NCT00908037|20752990|P7|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420311|NCT00908037|20752991|P6|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420312|NCT00908037|20752992|P5|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420313|NCT00908037|20752993|P4|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420314|NCT00908037|20752994|P3|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420315|NCT00908037|20752995|P2|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420316|NCT00908037|20752996|P1|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420317|NCT00908037|20752985|P12|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
8420318|NCT00908037|20752986|P11|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
8420319|NCT00908037|20752987|P10|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
8420320|NCT00908037|20752988|P9|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420321|NCT00908037|20752989|P8|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420322|NCT00908037|20752990|P7|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420323|NCT00908037|20752991|P6|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420324|NCT00908037|20752992|P5|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420325|NCT00908037|20752993|P4|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420326|NCT00908037|20752994|P3|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420327|NCT00908037|20752995|P2|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420328|NCT00908037|20752996|P1|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
8420329|NCT00908037|20752985|P12|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
8420330|NCT00908037|20752986|P11|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
8420331|NCT00908037|20752987|P10|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
8420332|NCT00908037|20752988|P9|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420333|NCT00908037|20752989|P8|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420334|NCT00908037|20752990|P7|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420335|NCT00908037|20752991|P6|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420336|NCT00908037|20752992|P5|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420337|NCT00908037|20752993|P4|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420338|NCT00908037|20752994|P3|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420339|NCT00908037|20752995|P2|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420340|NCT00908037|20752996|P1|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
8420341|NCT00908037|20752985|P12|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420342|NCT00908037|20752986|P11|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420343|NCT00908037|20752987|P10|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420344|NCT00908037|20752988|P9|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
8420345|NCT00908037|20752989|P8|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420346|NCT00908037|20752990|P7|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
8420347|NCT00908037|20752991|P6|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420348|NCT00908037|20752992|P5|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
8420349|NCT00908037|20752993|P4|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
8420350|NCT00908037|20752994|P3|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420351|NCT00908037|20752995|P2|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420352|NCT00908037|20752996|P1|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
8420353|NCT00908037|20752985|P12|COMPLETED|Part 2 (7 Week Randomized Period)||0
8420354|NCT00908037|20752986|P11|COMPLETED|Part 2 (7 Week Randomized Period)||0
8420355|NCT00908037|20752987|P10|COMPLETED|Part 2 (7 Week Randomized Period)||0
8420356|NCT00908037|20752988|P9|COMPLETED|Part 2 (7 Week Randomized Period)||5
8420357|NCT00908037|20752989|P8|COMPLETED|Part 2 (7 Week Randomized Period)||5
8420358|NCT00908037|20752990|P7|COMPLETED|Part 2 (7 Week Randomized Period)||15
8420359|NCT00908037|20752991|P6|COMPLETED|Part 2 (7 Week Randomized Period)||9
8420360|NCT00908037|20752992|P5|COMPLETED|Part 2 (7 Week Randomized Period)||13
8420361|NCT00908037|20752993|P4|COMPLETED|Part 2 (7 Week Randomized Period)||7
8420362|NCT00908037|20752994|P3|COMPLETED|Part 2 (7 Week Randomized Period)||0
8420363|NCT00908037|20752995|P2|COMPLETED|Part 2 (7 Week Randomized Period)||0
8420364|NCT00908037|20752996|P1|COMPLETED|Part 2 (7 Week Randomized Period)||0
8420365|NCT00908037|20752985|P12|STARTED|Part 2 (7 Week Randomized Period)||0
8420366|NCT00908037|20752986|P11|STARTED|Part 2 (7 Week Randomized Period)||0
8420367|NCT00908037|20752987|P10|STARTED|Part 2 (7 Week Randomized Period)||0
8420368|NCT00908037|20752988|P9|STARTED|Part 2 (7 Week Randomized Period)||10
8420369|NCT00908037|20752989|P8|STARTED|Part 2 (7 Week Randomized Period)||5
8420370|NCT00908037|20752990|P7|STARTED|Part 2 (7 Week Randomized Period)||19
8420371|NCT00908037|20752991|P6|STARTED|Part 2 (7 Week Randomized Period)||9
8420372|NCT00908037|20752992|P5|STARTED|Part 2 (7 Week Randomized Period)||16
8420373|NCT00908037|20752993|P4|STARTED|Part 2 (7 Week Randomized Period)||8
8420374|NCT00908037|20752994|P3|STARTED|Part 2 (7 Week Randomized Period)||0
8420375|NCT00908037|20752995|P2|STARTED|Part 2 (7 Week Randomized Period)||0
8420376|NCT00908037|20752996|P1|STARTED|Part 2 (7 Week Randomized Period)||0
8420377|NCT00908037|20752985|P12|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420378|NCT00908037|20752986|P11|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420379|NCT00908037|20752987|P10|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420380|NCT00908037|20752988|P9|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420381|NCT00908037|20752989|P8|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420382|NCT00908037|20752990|P7|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420383|NCT00908037|20752991|P6|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420384|NCT00908037|20752992|P5|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420385|NCT00908037|20752993|P4|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420386|NCT00908037|20752994|P3|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420387|NCT00908037|20752995|P2|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420388|NCT00908037|20752996|P1|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420389|NCT00908037|20752985|P12|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420390|NCT00908037|20752986|P11|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420391|NCT00908037|20752987|P10|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420392|NCT00908037|20752988|P9|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420393|NCT00908037|20752989|P8|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420394|NCT00908037|20752990|P7|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420395|NCT00908037|20752991|P6|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420396|NCT00908037|20752992|P5|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420397|NCT00908037|20752993|P4|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
8420398|NCT00908037|20752994|P3|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
8420399|NCT00908037|20752995|P2|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
8420400|NCT00908037|20752996|P1|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
8420401|NCT00908037|20752985|P12|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420402|NCT00908037|20752986|P11|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420403|NCT00908037|20752987|P10|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420404|NCT00908037|20752988|P9|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420405|NCT00908037|20752989|P8|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420406|NCT00908037|20752990|P7|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420407|NCT00908037|20752991|P6|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420408|NCT00908037|20752992|P5|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420409|NCT00908037|20752993|P4|STARTED|Part1 (24 Week Dose-Finding Period)||0
8420410|NCT00908037|20752994|P3|STARTED|Part1 (24 Week Dose-Finding Period)||5
8420411|NCT00908037|20752995|P2|STARTED|Part1 (24 Week Dose-Finding Period)||5
8420412|NCT00908037|20752996|P1|STARTED|Part1 (24 Week Dose-Finding Period)||5
8420413|NCT00908011|20753145|P2|NOT COMPLETED|Overall Study||2
8420414|NCT00908011|20753146|P1|NOT COMPLETED|Overall Study||2
8420415|NCT00908011|20753145|P2|COMPLETED|Overall Study||18
8420416|NCT00908011|20753146|P1|COMPLETED|Overall Study||21
8420417|NCT00908011|20753145|P2|STARTED|Overall Study||20
8420418|NCT00908011|20753146|P1|STARTED|Overall Study||23
8420419|NCT00907907|20753154|P2|NOT COMPLETED|Period 4||0
8420420|NCT00907907|20753155|P1|NOT COMPLETED|Period 4||0
8420421|NCT00907907|20753154|P2|COMPLETED|Period 4||18
8420422|NCT00907907|20753155|P1|COMPLETED|Period 4||19
8420423|NCT00907907|20753154|P2|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
8420424|NCT00907907|20753155|P1|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
8420425|NCT00907907|20753154|P2|NOT COMPLETED|Period 3||0
8420426|NCT00907907|20753155|P1|NOT COMPLETED|Period 3||0
8420427|NCT00907907|20753154|P2|COMPLETED|Period 3||20
8420428|NCT00907907|20753155|P1|COMPLETED|Period 3||20
8420429|NCT00907907|20753154|P2|STARTED|Period 3||20
8420430|NCT00907907|20753155|P1|STARTED|Period 3||20
8420431|NCT00907907|20753154|P2|NOT COMPLETED|Period 2||0
8420432|NCT00907907|20753155|P1|NOT COMPLETED|Period 2||0
8420433|NCT00907907|20753154|P2|COMPLETED|Period 2||20
8420434|NCT00907907|20753155|P1|COMPLETED|Period 2||20
8420435|NCT00907907|20753154|P2|STARTED|Period 2||20
8420436|NCT00907907|20753155|P1|STARTED|Period 2||20
8420437|NCT00907907|20753154|P2|NOT COMPLETED|Period 1||0
8420438|NCT00907907|20753155|P1|NOT COMPLETED|Period 1||0
8420439|NCT00907907|20753154|P2|COMPLETED|Period 1||20
8420440|NCT00907907|20753155|P1|COMPLETED|Period 1||20
8420441|NCT00907907|20753154|P2|STARTED|Period 1||20
8420442|NCT00907907|20753155|P1|STARTED|Period 1||20
8420443|NCT00907881|20753163|P1|NOT COMPLETED|Overall Study||85
8420444|NCT00907881|20753163|P1|COMPLETED|Overall Study||984
8420445|NCT00907881|20753163|P1|STARTED|Overall Study||1069
8420446|NCT00907803|20753173|P3|NOT COMPLETED|Overall Study||0
8420447|NCT00907803|20753174|P2|NOT COMPLETED|Overall Study||3
8420448|NCT00907803|20753175|P1|NOT COMPLETED|Overall Study||3
8420449|NCT00907803|20753173|P3|COMPLETED|Overall Study||16
8420450|NCT00907803|20753174|P2|COMPLETED|Overall Study||43
8420451|NCT00907803|20753175|P1|COMPLETED|Overall Study||42
8420452|NCT00907803|20753173|P3|STARTED|Overall Study||16
8420453|NCT00907803|20753174|P2|STARTED|Overall Study||46
8420454|NCT00907803|20753175|P1|STARTED|Overall Study||45
8420455|NCT00907777|20753206|P2|NOT COMPLETED|Overall Study||1
8420456|NCT00907777|20753207|P1|NOT COMPLETED|Overall Study||0
8420457|NCT00907777|20753206|P2|COMPLETED|Overall Study||26
8420458|NCT00907777|20753207|P1|COMPLETED|Overall Study||25
8420459|NCT00907777|20753206|P2|STARTED|Overall Study||27
8420460|NCT00907777|20753207|P1|STARTED|Overall Study||25
8420461|NCT00907738|20753234|P5|NOT COMPLETED|Overall Study||2
8420462|NCT00907738|20753235|P4|NOT COMPLETED|Overall Study||4
8420463|NCT00907738|20753236|P3|NOT COMPLETED|Overall Study||7
8420464|NCT00907738|20753237|P2|NOT COMPLETED|Overall Study||1
8420465|NCT00907738|20753238|P1|NOT COMPLETED|Overall Study||13
8420466|NCT00907738|20753234|P5|COMPLETED|Overall Study||0
8420467|NCT00907738|20753235|P4|COMPLETED|Overall Study||0
8420468|NCT00907738|20753236|P3|COMPLETED|Overall Study||0
8420469|NCT00907738|20753237|P2|COMPLETED|Overall Study||0
8420470|NCT00907738|20753238|P1|COMPLETED|Overall Study||0
8420471|NCT00907738|20753234|P5|STARTED|Overall Study||2
8420472|NCT00907738|20753235|P4|STARTED|Overall Study||4
8420473|NCT00907738|20753236|P3|STARTED|Overall Study||7
8420474|NCT00907738|20753237|P2|STARTED|Overall Study||1
8420475|NCT00907738|20753238|P1|STARTED|Overall Study||13
8420476|NCT00907621|20753256|P2|NOT COMPLETED|Overall Study||4
8420477|NCT00907621|20753257|P1|NOT COMPLETED|Overall Study||7
8420478|NCT00907621|20753256|P2|COMPLETED|Overall Study||41
8420479|NCT00907621|20753257|P1|COMPLETED|Overall Study||38
8420480|NCT00907621|20753256|P2|STARTED|Overall Study||45
8420481|NCT00907621|20753257|P1|STARTED|Overall Study||45
8420482|NCT00907517|20753270|P5|NOT COMPLETED|Overall Study||5
8420483|NCT00907517|20753271|P4|NOT COMPLETED|Overall Study||4
8420484|NCT00907517|20753272|P3|NOT COMPLETED|Overall Study||4
8420485|NCT00907517|20753273|P2|NOT COMPLETED|Overall Study||3
8420486|NCT00907517|20753274|P1|NOT COMPLETED|Overall Study||3
8420487|NCT00907517|20753270|P5|COMPLETED|Overall Study||1
8420488|NCT00907517|20753271|P4|COMPLETED|Overall Study||2
8420489|NCT00907517|20753272|P3|COMPLETED|Overall Study||2
8420490|NCT00907517|20753273|P2|COMPLETED|Overall Study||0
8420491|NCT00907517|20753274|P1|COMPLETED|Overall Study||0
8420492|NCT00907517|20753270|P5|STARTED|Overall Study||6
8420493|NCT00907517|20753271|P4|STARTED|Overall Study||6
8420494|NCT00907517|20753272|P3|STARTED|Overall Study||6
8420495|NCT00907517|20753273|P2|STARTED|Overall Study||3
8420496|NCT00907517|20753274|P1|STARTED|Overall Study||3
8420497|NCT00907478|20753299|P3|NOT COMPLETED|Overall Study||22
8420498|NCT00907478|20753300|P2|NOT COMPLETED|Overall Study||17
8420499|NCT00907478|20753301|P1|NOT COMPLETED|Overall Study||27
8420500|NCT00907478|20753299|P3|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
8420501|NCT00907478|20753300|P2|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
8420502|NCT00907478|20753301|P1|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
8420503|NCT00907478|20753299|P3|STARTED|Overall Study||69
8420504|NCT00907478|20753300|P2|STARTED|Overall Study||50
8420505|NCT00907478|20753301|P1|STARTED|Overall Study||50
8420506|NCT00907426|20753332|P3|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
8420507|NCT00907426|20753333|P2|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
8420508|NCT00907426|20753334|P1|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
8420509|NCT00907426|20753332|P3|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
8420510|NCT00907426|20753333|P2|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
8420511|NCT00907426|20753334|P1|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
8420512|NCT00907426|20753332|P3|STARTED|Treatment Period 2 (6 to 12 Months)||84
8420513|NCT00907426|20753333|P2|STARTED|Treatment Period 2 (6 to 12 Months)||55
8420514|NCT00907426|20753334|P1|STARTED|Treatment Period 2 (6 to 12 Months)||195
8420515|NCT00907426|20753332|P3|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
8420516|NCT00907426|20753333|P2|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
8420517|NCT00907426|20753334|P1|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
8420518|NCT00907426|20753332|P3|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
8420519|NCT00907426|20753333|P2|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
8420520|NCT00907426|20753334|P1|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
8420521|NCT00907426|20753332|P3|STARTED|Treatment Period 1 (0 to 6 Months)||93
8420522|NCT00907426|20753333|P2|STARTED|Treatment Period 1 (0 to 6 Months)||60
8420523|NCT00907426|20753334|P1|STARTED|Treatment Period 1 (0 to 6 Months)||215
8420524|NCT00907374|20753351|P2|NOT COMPLETED|Overall Study||2
8420525|NCT00907374|20753352|P1|NOT COMPLETED|Overall Study||2
8420526|NCT00907374|20753351|P2|COMPLETED|Overall Study||11
8420527|NCT00907374|20753352|P1|COMPLETED|Overall Study||12
8420528|NCT00907374|20753351|P2|STARTED|Overall Study||13
8420529|NCT00907374|20753352|P1|STARTED|Overall Study||14
8420530|NCT00907335|20753366|P2|NOT COMPLETED|Overall Study||1
8420531|NCT00907335|20753367|P1|NOT COMPLETED|Overall Study||8
8420532|NCT00907335|20753366|P2|COMPLETED|Overall Study||54
8420533|NCT00907335|20753367|P1|COMPLETED|Overall Study||47
8420534|NCT00907335|20753366|P2|STARTED|Overall Study||55
8420535|NCT00907335|20753367|P1|STARTED|Overall Study||55
8420536|NCT00907296|20753393|P10|NOT COMPLETED|Overall Study||7
8420537|NCT00907296|20753394|P9|NOT COMPLETED|Overall Study||4
8420538|NCT00907296|20753395|P8|NOT COMPLETED|Overall Study||7
8420539|NCT00907296|20753396|P7|NOT COMPLETED|Overall Study||6
8420540|NCT00907296|20753397|P6|NOT COMPLETED|Overall Study||9
8420541|NCT00907296|20753398|P5|NOT COMPLETED|Overall Study||1
8420542|NCT00907296|20753399|P4|NOT COMPLETED|Overall Study||4
8420543|NCT00907296|20753400|P3|NOT COMPLETED|Overall Study||2
8420544|NCT00907296|20753401|P2|NOT COMPLETED|Overall Study||5
8420545|NCT00907296|20753402|P1|NOT COMPLETED|Overall Study||20
8420546|NCT00907296|20753393|P10|COMPLETED|Overall Study||28
8420547|NCT00907296|20753394|P9|COMPLETED|Overall Study||27
8420548|NCT00907296|20753395|P8|COMPLETED|Overall Study||26
8420549|NCT00907296|20753396|P7|COMPLETED|Overall Study||27
8420550|NCT00907296|20753397|P6|COMPLETED|Overall Study||24
8420551|NCT00907296|20753398|P5|COMPLETED|Overall Study||32
8420552|NCT00907296|20753399|P4|COMPLETED|Overall Study||29
8420553|NCT00907296|20753400|P3|COMPLETED|Overall Study||32
8420554|NCT00907296|20753401|P2|COMPLETED|Overall Study||29
8420555|NCT00907296|20753402|P1|COMPLETED|Overall Study||83
8420556|NCT00907296|20753393|P10|Received Treatment|Overall Study||35
8420557|NCT00907296|20753394|P9|Received Treatment|Overall Study||30
8420558|NCT00907296|20753395|P8|Received Treatment|Overall Study||32
8420559|NCT00907296|20753396|P7|Received Treatment|Overall Study||31
8420560|NCT00907296|20753397|P6|Received Treatment|Overall Study||32
8420561|NCT00907296|20753398|P5|Received Treatment|Overall Study||33
8420562|NCT00907296|20753399|P4|Received Treatment|Overall Study||32
8420563|NCT00907296|20753400|P3|Received Treatment|Overall Study||34
8420564|NCT00907296|20753401|P2|Received Treatment|Overall Study||34
8420565|NCT00907296|20753402|P1|Received Treatment|Overall Study||100
8420566|NCT00907296|20753393|P10|STARTED|Overall Study||35
8420567|NCT00907296|20753394|P9|STARTED|Overall Study||31
8420568|NCT00907296|20753395|P8|STARTED|Overall Study||33
8420569|NCT00907296|20753396|P7|STARTED|Overall Study||33
8420570|NCT00907296|20753397|P6|STARTED|Overall Study||33
8420571|NCT00907296|20753398|P5|STARTED|Overall Study||33
8420572|NCT00907296|20753399|P4|STARTED|Overall Study||33
8420573|NCT00907296|20753400|P3|STARTED|Overall Study||34
8420574|NCT00907296|20753401|P2|STARTED|Overall Study||34
8420575|NCT00907296|20753402|P1|STARTED|Overall Study||103
8420576|NCT00907257|20753456|P2|NOT COMPLETED|Overall Study||12
8420577|NCT00907257|20753457|P1|NOT COMPLETED|Overall Study||13
8420578|NCT00907257|20753456|P2|COMPLETED|Overall Study||112
8420579|NCT00907257|20753457|P1|COMPLETED|Overall Study||110
8420580|NCT00907257|20753456|P2|STARTED|Overall Study||124
8420581|NCT00907257|20753457|P1|STARTED|Overall Study||123
8420582|NCT00907218|20753467|P1|NOT COMPLETED|Overall Study||0
8420583|NCT00907218|20753467|P1|COMPLETED|Overall Study||2
8420584|NCT00907218|20753467|P1|STARTED|Overall Study||2
8420585|NCT00907153|20753479|P2|NOT COMPLETED|Overall Study||4
8420586|NCT00907153|20753480|P1|NOT COMPLETED|Overall Study||2
8420587|NCT00907153|20753479|P2|COMPLETED|Overall Study||11
8420588|NCT00907153|20753480|P1|COMPLETED|Overall Study||11
8420589|NCT00907153|20753479|P2|STARTED|Overall Study||15
8420590|NCT00907153|20753480|P1|STARTED|Overall Study||13
8420591|NCT00907101|20753522|P1|NOT COMPLETED|Overall Study||0
8420592|NCT00907101|20753522|P1|COMPLETED|Overall Study||30
8420593|NCT00907101|20753522|P1|STARTED|Overall Study||30
8420594|NCT00907088|20753532|P2|NOT COMPLETED|Overall Study||30
8420595|NCT00907088|20753533|P1|NOT COMPLETED|Overall Study||20
8420596|NCT00907088|20753532|P2|COMPLETED|Overall Study||99
8420597|NCT00907088|20753533|P1|COMPLETED|Overall Study||102
8420598|NCT00907088|20753532|P2|STARTED|Overall Study||129
8420599|NCT00907088|20753533|P1|STARTED|Overall Study||122
8420600|NCT00906971|20753541|P2|NOT COMPLETED|Overall Study||3
8420601|NCT00906971|20753542|P1|NOT COMPLETED|Overall Study||8
8420602|NCT00906971|20753541|P2|COMPLETED|Overall Study||33
8420603|NCT00906971|20753542|P1|COMPLETED|Overall Study||28
8420604|NCT00906971|20753541|P2|STARTED|Overall Study||36
8420605|NCT00906971|20753542|P1|STARTED|Overall Study||36
8420606|NCT00906945|20753555|P6|NOT COMPLETED|Overall Study||2
8420607|NCT00906945|20753556|P5|NOT COMPLETED|Overall Study||1
8420608|NCT00906945|20753557|P4|NOT COMPLETED|Overall Study||1
8420609|NCT00906945|20753558|P3|NOT COMPLETED|Overall Study||0
8420610|NCT00906945|20753559|P2|NOT COMPLETED|Overall Study||0
8420611|NCT00906945|20753560|P1|NOT COMPLETED|Overall Study||0
8420612|NCT00906945|20753555|P6|COMPLETED|Overall Study||14
8420613|NCT00906945|20753556|P5|COMPLETED|Overall Study||6
8420614|NCT00906945|20753557|P4|COMPLETED|Overall Study||6
8420615|NCT00906945|20753558|P3|COMPLETED|Overall Study||3
8420616|NCT00906945|20753559|P2|COMPLETED|Overall Study||3
8420617|NCT00906945|20753560|P1|COMPLETED|Overall Study||3
8420618|NCT00906945|20753555|P6|STARTED|Overall Study||16
8420619|NCT00906945|20753556|P5|STARTED|Overall Study||7
8420620|NCT00906945|20753557|P4|STARTED|Overall Study||7
8420621|NCT00906945|20753558|P3|STARTED|Overall Study||3
8420622|NCT00906945|20753559|P2|STARTED|Overall Study||3
8420623|NCT00906945|20753560|P1|STARTED|Overall Study||3
8420624|NCT00906789|20753587|P1|NOT COMPLETED|Overall Study||0
8420625|NCT00906789|20753587|P1|COMPLETED|Overall Study||15
8420626|NCT00906789|20753587|P1|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
8420627|NCT00906776|20753597|P2|NOT COMPLETED|Overall Study||0
8420628|NCT00906776|20753598|P1|NOT COMPLETED|Overall Study||0
8420629|NCT00906776|20753597|P2|COMPLETED|Overall Study||8
8420630|NCT00906776|20753598|P1|COMPLETED|Overall Study||11
8420631|NCT00906776|20753597|P2|STARTED|Overall Study||8
8420632|NCT00906776|20753598|P1|STARTED|Overall Study||11
8420633|NCT00906698|20753620|P6|NOT COMPLETED|Overall Study||5
8420634|NCT00906698|20753621|P5|NOT COMPLETED|Overall Study||18
8420635|NCT00906698|20753622|P4|NOT COMPLETED|Overall Study||4
8420636|NCT00906698|20753623|P3|NOT COMPLETED|Overall Study||6
8420637|NCT00906698|20753624|P2|NOT COMPLETED|Overall Study||19
8420638|NCT00906698|20753625|P1|NOT COMPLETED|Overall Study||3
8420639|NCT00906698|20753620|P6|COMPLETED|Overall Study||0
8420640|NCT00906698|20753621|P5|COMPLETED|Overall Study||0
8420641|NCT00906698|20753622|P4|COMPLETED|Overall Study||0
8420642|NCT00906698|20753623|P3|COMPLETED|Overall Study||0
8420643|NCT00906698|20753624|P2|COMPLETED|Overall Study||0
8420644|NCT00906698|20753625|P1|COMPLETED|Overall Study||0
8420645|NCT00906698|20753620|P6|STARTED|Overall Study||5
8420646|NCT00906698|20753621|P5|STARTED|Overall Study||18
8420647|NCT00906698|20753622|P4|STARTED|Overall Study||4
8420648|NCT00906698|20753623|P3|STARTED|Overall Study||6
8420649|NCT00906698|20753624|P2|STARTED|Overall Study||19
8420650|NCT00906698|20753625|P1|STARTED|Overall Study||3
8420651|NCT00906503|20753707|P1|NOT COMPLETED|Overall Study||0
8420652|NCT00906503|20753707|P1|COMPLETED|Overall Study||9
8420653|NCT00906503|20753707|P1|STARTED|Overall Study||9
8420654|NCT00906425|20753713|P2|NOT COMPLETED|Overall Study||72
8420655|NCT00906425|20753714|P1|NOT COMPLETED|Overall Study||73
8420656|NCT00906425|20753713|P2|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
8420657|NCT00906425|20753714|P1|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
8420658|NCT00906425|20753713|P2|2 Year|Overall Study|ITT population|58
8420659|NCT00906425|20753714|P1|2 Year|Overall Study|ITT population|62
8420660|NCT00906425|20753713|P2|1 Year|Overall Study|ITT population|60
8420661|NCT00906425|20753714|P1|1 Year|Overall Study|ITT population|67
8420662|NCT00906425|20753713|P2|6 Months|Overall Study|ITT population|64
8420663|NCT00906425|20753714|P1|6 Months|Overall Study|ITT population|69
8420664|NCT00906425|20753713|P2|STARTED|Overall Study||72
8420665|NCT00906425|20753714|P1|STARTED|Overall Study||73
8420666|NCT00906399|20753727|P7|NOT COMPLETED|Year 2||29
8420667|NCT00906399|20753728|P6|NOT COMPLETED|Year 2||47
8420668|NCT00906399|20753729|P5|NOT COMPLETED|Year 2||35
8420669|NCT00906399|20753730|P4|NOT COMPLETED|Year 2||30
8420670|NCT00906399|20753731|P3|NOT COMPLETED|Year 2||0
8420671|NCT00906399|20753732|P2|NOT COMPLETED|Year 2||0
8420672|NCT00906399|20753733|P1|NOT COMPLETED|Year 2||0
8420673|NCT00906399|20753727|P7|COMPLETED|Year 2||409
8420674|NCT00906399|20753728|P6|COMPLETED|Year 2||391
8420675|NCT00906399|20753729|P5|COMPLETED|Year 2||193
8420676|NCT00906399|20753730|P4|COMPLETED|Year 2||198
8420677|NCT00906399|20753731|P3|COMPLETED|Year 2||0
8420678|NCT00906399|20753732|P2|COMPLETED|Year 2||0
8420679|NCT00906399|20753733|P1|COMPLETED|Year 2||0
8420680|NCT00906399|20753727|P7|Completed Year 2 Study Treatment|Year 2||411
8420681|NCT00906399|20753728|P6|Completed Year 2 Study Treatment|Year 2||391
8420682|NCT00906399|20753729|P5|Completed Year 2 Study Treatment|Year 2||196
8420683|NCT00906399|20753730|P4|Completed Year 2 Study Treatment|Year 2||200
8420684|NCT00906399|20753731|P3|Completed Year 2 Study Treatment|Year 2||0
8420685|NCT00906399|20753732|P2|Completed Year 2 Study Treatment|Year 2||0
8420686|NCT00906399|20753733|P1|Completed Year 2 Study Treatment|Year 2||0
8420687|NCT00906399|20753727|P7|STARTED|Year 2||438
8420688|NCT00906399|20753728|P6|STARTED|Year 2||438
8420689|NCT00906399|20753729|P5|STARTED|Year 2||228
8420690|NCT00906399|20753730|P4|STARTED|Year 2||228
8420691|NCT00906399|20753731|P3|STARTED|Year 2||0
8420692|NCT00906399|20753732|P2|STARTED|Year 2||0
8420693|NCT00906399|20753733|P1|STARTED|Year 2||0
8420694|NCT00906399|20753727|P7|NOT COMPLETED|Year 1||0
8420695|NCT00906399|20753728|P6|NOT COMPLETED|Year 1||0
8420696|NCT00906399|20753729|P5|NOT COMPLETED|Year 1||0
8420697|NCT00906399|20753730|P4|NOT COMPLETED|Year 1||0
8420698|NCT00906399|20753731|P3|NOT COMPLETED|Year 1||76
8420699|NCT00906399|20753732|P2|NOT COMPLETED|Year 1||63
8420700|NCT00906399|20753733|P1|NOT COMPLETED|Year 1||44
8420701|NCT00906399|20753727|P7|COMPLETED|Year 1||0
8420702|NCT00906399|20753728|P6|COMPLETED|Year 1||0
8420703|NCT00906399|20753729|P5|COMPLETED|Year 1||0
8420704|NCT00906399|20753730|P4|COMPLETED|Year 1||0
8420705|NCT00906399|20753731|P3|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
8420706|NCT00906399|20753732|P2|COMPLETED|Year 1||438
8420707|NCT00906399|20753733|P1|COMPLETED|Year 1||456
8420708|NCT00906399|20753727|P7|Completed Year 1 Study Treatment|Year 1||0
8420709|NCT00906399|20753728|P6|Completed Year 1 Study Treatment|Year 1||0
8420710|NCT00906399|20753729|P5|Completed Year 1 Study Treatment|Year 1||0
8420711|NCT00906399|20753730|P4|Completed Year 1 Study Treatment|Year 1||0
8420712|NCT00906399|20753731|P3|Completed Year 1 Study Treatment|Year 1||438
8420713|NCT00906399|20753732|P2|Completed Year 1 Study Treatment|Year 1||438
8420714|NCT00906399|20753733|P1|Completed Year 1 Study Treatment|Year 1||456
8420715|NCT00906399|20753727|P7|STARTED|Year 1||0
8420716|NCT00906399|20753728|P6|STARTED|Year 1||0
8420717|NCT00906399|20753729|P5|STARTED|Year 1||0
8420718|NCT00906399|20753730|P4|STARTED|Year 1||0
8420719|NCT00906399|20753731|P3|STARTED|Year 1||515
8420720|NCT00906399|20753732|P2|STARTED|Year 1||501
8420721|NCT00906399|20753733|P1|STARTED|Year 1||500
8420722|NCT00906373|20753756|P2|NOT COMPLETED|Overall Study||8
8420723|NCT00906373|20753757|P1|NOT COMPLETED|Overall Study||0
8420724|NCT00906373|20753756|P2|COMPLETED|Overall Study||33
8420725|NCT00906373|20753757|P1|COMPLETED|Overall Study||6
8420726|NCT00906373|20753756|P2|Received Any Amount of Study Drug|Overall Study||41
8420727|NCT00906373|20753757|P1|Received Any Amount of Study Drug|Overall Study||6
8420728|NCT00906373|20753756|P2|STARTED|Overall Study||41
8420729|NCT00906373|20753757|P1|STARTED|Overall Study||6
8420730|NCT00906347|20753796|P2|NOT COMPLETED|Received Study Drug||31
8420731|NCT00906347|20753797|P1|NOT COMPLETED|Received Study Drug||40
8420732|NCT00906347|20753796|P2|COMPLETED|Received Study Drug||143
8420733|NCT00906347|20753797|P1|COMPLETED|Received Study Drug||136
8420734|NCT00906347|20753796|P2|STARTED|Received Study Drug||174
8420735|NCT00906347|20753797|P1|STARTED|Received Study Drug||176
8420736|NCT00906347|20753796|P2|NOT COMPLETED|Randomized||0
8420737|NCT00906347|20753797|P1|NOT COMPLETED|Randomized||0
8420738|NCT00906347|20753796|P2|COMPLETED|Randomized||174
8420739|NCT00906347|20753797|P1|COMPLETED|Randomized||176
8420740|NCT00906347|20753796|P2|STARTED|Randomized||174
8420741|NCT00906347|20753797|P1|STARTED|Randomized||176
8420742|NCT00906282|20753817|P1|NOT COMPLETED|Surgical Resection||0
8420743|NCT00906282|20753817|P1|COMPLETED|Surgical Resection||27
8420744|NCT00906282|20753817|P1|STARTED|Surgical Resection||27
8420745|NCT00906282|20753817|P1|NOT COMPLETED|Preoperative Chemotherapy||19
8420746|NCT00906282|20753817|P1|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
8420747|NCT00906282|20753817|P1|STARTED|Preoperative Chemotherapy||46
8420748|NCT00906243|20753825|P1|NOT COMPLETED|Overall Study||0
8420749|NCT00906243|20753825|P1|COMPLETED|Overall Study||6
8420750|NCT00906243|20753825|P1|STARTED|Overall Study||6
8420751|NCT00906204|20753831|P2|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
8420752|NCT00906204|20753832|P1|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
8420753|NCT00906204|20753831|P2|COMPLETED|Secondary Endpoints (Long-term Safety)||48
8420754|NCT00906204|20753832|P1|COMPLETED|Secondary Endpoints (Long-term Safety)||41
8420755|NCT00906204|20753831|P2|STARTED|Secondary Endpoints (Long-term Safety)||51
8420756|NCT00906204|20753832|P1|STARTED|Secondary Endpoints (Long-term Safety)||43
8420757|NCT00906204|20753831|P2|NOT COMPLETED|Primary Endpoint (Early Safety)||1
8420758|NCT00906204|20753832|P1|NOT COMPLETED|Primary Endpoint (Early Safety)||2
8420759|NCT00906204|20753831|P2|COMPLETED|Primary Endpoint (Early Safety)||51
8420760|NCT00906204|20753832|P1|COMPLETED|Primary Endpoint (Early Safety)||43
8420761|NCT00906204|20753831|P2|STARTED|Primary Endpoint (Early Safety)||52
8420762|NCT00906204|20753832|P1|STARTED|Primary Endpoint (Early Safety)||45
8420763|NCT00906178|20753850|P2|NOT COMPLETED|Overall Study||16
8420764|NCT00906178|20753851|P1|NOT COMPLETED|Overall Study||15
8420765|NCT00906178|20753850|P2|COMPLETED|Overall Study||167
8420766|NCT00906178|20753851|P1|COMPLETED|Overall Study||168
8420767|NCT00906178|20753850|P2|STARTED|Overall Study||183
8420768|NCT00906178|20753851|P1|STARTED|Overall Study||183
8420769|NCT00906165|20753865|P2|NOT COMPLETED|Overall Study||0
8420770|NCT00906165|20753866|P1|NOT COMPLETED|Overall Study||4
8420771|NCT00906165|20753865|P2|COMPLETED|Overall Study||14
8420772|NCT00906165|20753866|P1|COMPLETED|Overall Study||10
8420773|NCT00906165|20753865|P2|STARTED|Overall Study||14
8420774|NCT00906165|20753866|P1|STARTED|Overall Study||14
8420775|NCT00906087|20753886|P1|NOT COMPLETED|Final Washout Period 4 Weeks||0
8420776|NCT00906087|20753886|P1|COMPLETED|Final Washout Period 4 Weeks||12
8420777|NCT00906087|20753886|P1|STARTED|Final Washout Period 4 Weeks||12
8420778|NCT00906087|20753886|P1|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
8420779|NCT00906087|20753886|P1|COMPLETED|Cosopt Treatment 6 Weeks||12
8420780|NCT00906087|20753886|P1|STARTED|Cosopt Treatment 6 Weeks||12
8420781|NCT00906087|20753886|P1|NOT COMPLETED|Initial Washout||2
8420782|NCT00906087|20753886|P1|COMPLETED|Initial Washout||12
8420783|NCT00906087|20753886|P1|Completed Washout and Continue Protocol|Initial Washout||12
8420784|NCT00906087|20753886|P1|Begin Washout|Initial Washout||13
8420785|NCT00906087|20753886|P1|Completed Screening|Initial Washout||14
8420786|NCT00906087|20753886|P1|STARTED|Initial Washout||14
8420787|NCT00906074|20753895|P2|NOT COMPLETED|Overall Study||0
8420788|NCT00906074|20753896|P1|NOT COMPLETED|Overall Study||0
8420789|NCT00906074|20753895|P2|COMPLETED|Overall Study||90
8420790|NCT00906074|20753896|P1|COMPLETED|Overall Study||90
8420791|NCT00906074|20753895|P2|STARTED|Overall Study||90
8420792|NCT00906074|20753896|P1|STARTED|Overall Study||90
8420793|NCT00906035|20753923|P3|NOT COMPLETED|Overall Study||0
8420794|NCT00906035|20753924|P2|NOT COMPLETED|Overall Study||3
8420795|NCT00906035|20753925|P1|NOT COMPLETED|Overall Study||2
8420796|NCT00906035|20753923|P3|COMPLETED|Overall Study||8
8420797|NCT00906035|20753924|P2|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
8420798|NCT00906035|20753925|P1|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
8420799|NCT00906035|20753923|P3|STARTED|Overall Study||8
8420800|NCT00906035|20753924|P2|STARTED|Overall Study||9
8420801|NCT00906035|20753925|P1|STARTED|Overall Study||8
8420802|NCT00905840|20753939|P1|NOT COMPLETED|Overall Study||16
8420803|NCT00905840|20753939|P1|COMPLETED|Overall Study||75
8420804|NCT00905840|20753939|P1|STARTED|Overall Study||91
8420805|NCT00905827|20753951|P3|NOT COMPLETED|Overall Study||0
8420806|NCT00905827|20753952|P2|NOT COMPLETED|Overall Study||0
8420807|NCT00905827|20753953|P1|NOT COMPLETED|Overall Study||0
8420808|NCT00905827|20753951|P3|COMPLETED|Overall Study||73
8420809|NCT00905827|20753952|P2|COMPLETED|Overall Study||69
8420810|NCT00905827|20753953|P1|COMPLETED|Overall Study||70
8420811|NCT00905827|20753951|P3|STARTED|Overall Study||73
8420812|NCT00905827|20753952|P2|STARTED|Overall Study||69
8420813|NCT00905827|20753953|P1|STARTED|Overall Study||70
8420814|NCT00905632|20753970|P7|NOT COMPLETED|Overall Study||4
8420815|NCT00905632|20753971|P6|NOT COMPLETED|Overall Study||1
8420816|NCT00905632|20753972|P5|NOT COMPLETED|Overall Study||0
8420817|NCT00905632|20753973|P4|NOT COMPLETED|Overall Study||0
8420818|NCT00905632|20753974|P3|NOT COMPLETED|Overall Study||0
8420819|NCT00905632|20753975|P2|NOT COMPLETED|Overall Study||0
8420820|NCT00905632|20753976|P1|NOT COMPLETED|Overall Study||0
8420821|NCT00905632|20753970|P7|COMPLETED|Overall Study||7
8420822|NCT00905632|20753971|P6|COMPLETED|Overall Study||8
8420823|NCT00905632|20753972|P5|COMPLETED|Overall Study||10
8420824|NCT00905632|20753973|P4|COMPLETED|Overall Study||6
8420825|NCT00905632|20753974|P3|COMPLETED|Overall Study||7
8420826|NCT00905632|20753975|P2|COMPLETED|Overall Study||6
8420827|NCT00905632|20753976|P1|COMPLETED|Overall Study||8
8420828|NCT00905632|20753970|P7|STARTED|Overall Study||11
8420829|NCT00905632|20753971|P6|STARTED|Overall Study||9
8420830|NCT00905632|20753972|P5|STARTED|Overall Study||10
8420831|NCT00905632|20753973|P4|STARTED|Overall Study||6
8420832|NCT00905632|20753974|P3|STARTED|Overall Study||7
8420833|NCT00905632|20753975|P2|STARTED|Overall Study||6
8420834|NCT00905632|20753976|P1|STARTED|Overall Study||8
8420835|NCT00905606|20754114|P2|NOT COMPLETED|Period 2||0
8420836|NCT00905606|20754115|P1|NOT COMPLETED|Period 2||0
8420837|NCT00905606|20754114|P2|COMPLETED|Period 2||14
8420838|NCT00905606|20754115|P1|COMPLETED|Period 2||14
8420839|NCT00905606|20754114|P2|STARTED|Period 2||14
8420840|NCT00905606|20754115|P1|STARTED|Period 2||14
8420841|NCT00905606|20754114|P2|NOT COMPLETED|Washout||0
8420842|NCT00905606|20754115|P1|NOT COMPLETED|Washout||1
8420843|NCT00905606|20754114|P2|COMPLETED|Washout||14
8420844|NCT00905606|20754115|P1|COMPLETED|Washout||14
8420845|NCT00905606|20754114|P2|STARTED|Washout||14
8420846|NCT00905606|20754115|P1|STARTED|Washout||15
8420847|NCT00905606|20754114|P2|NOT COMPLETED|Period 1||1
8420848|NCT00905606|20754115|P1|NOT COMPLETED|Period 1||0
8420849|NCT00905606|20754114|P2|COMPLETED|Period 1||14
8420850|NCT00905606|20754115|P1|COMPLETED|Period 1||15
8420851|NCT00905606|20754114|P2|STARTED|Period 1||15
8420852|NCT00905606|20754115|P1|STARTED|Period 1||15
8420853|NCT00905580|20754125|P2|NOT COMPLETED|Overall Study||3
8420854|NCT00905580|20754126|P1|NOT COMPLETED|Overall Study||2
8420855|NCT00905580|20754125|P2|COMPLETED|Overall Study||47
8420856|NCT00905580|20754126|P1|COMPLETED|Overall Study||47
8420857|NCT00905580|20754125|P2|STARTED|Overall Study||50
8420858|NCT00905580|20754126|P1|STARTED|Overall Study||49
8420859|NCT00905567|20754140|P2|NOT COMPLETED|Period 2||0
8420860|NCT00905567|20754141|P1|NOT COMPLETED|Period 2||0
8420861|NCT00905567|20754140|P2|COMPLETED|Period 2||11
8420862|NCT00905567|20754141|P1|COMPLETED|Period 2||12
8420863|NCT00905567|20754140|P2|STARTED|Period 2||11
8420864|NCT00905567|20754141|P1|STARTED|Period 2||12
8420865|NCT00905567|20754140|P2|NOT COMPLETED|Washout||1
8420866|NCT00905567|20754141|P1|NOT COMPLETED|Washout||0
8420867|NCT00905567|20754140|P2|COMPLETED|Washout||11
8420868|NCT00905567|20754141|P1|COMPLETED|Washout||12
8420869|NCT00905567|20754140|P2|STARTED|Washout||12
8420870|NCT00905567|20754141|P1|STARTED|Washout||12
8420871|NCT00905567|20754140|P2|NOT COMPLETED|Period 1||0
8420872|NCT00905567|20754141|P1|NOT COMPLETED|Period 1||0
8420873|NCT00905567|20754140|P2|COMPLETED|Period 1||12
8420874|NCT00905567|20754141|P1|COMPLETED|Period 1||12
8420875|NCT00905567|20754140|P2|STARTED|Period 1||12
8420876|NCT00905567|20754141|P1|STARTED|Period 1||12
8420877|NCT00905554|20754151|P2|NOT COMPLETED|Overall Study||0
8420878|NCT00905554|20754152|P1|NOT COMPLETED|Overall Study||0
8420879|NCT00905554|20754151|P2|COMPLETED|Overall Study||114
8420880|NCT00905554|20754152|P1|COMPLETED|Overall Study||116
8420881|NCT00905554|20754151|P2|STARTED|Overall Study||114
8420882|NCT00905554|20754152|P1|STARTED|Overall Study||116
8420892|NCT00905489|20754173|P1|NOT COMPLETED|Optional Extension Phase (OEP)||1
8420893|NCT00905489|20754173|P1|COMPLETED|Optional Extension Phase (OEP)||39
8420894|NCT00905489|20754173|P1|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
8420895|NCT00905489|20754173|P1|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
8420896|NCT00905489|20754173|P1|COMPLETED|Pharmaco-kinetic (PK) Phase||80
8420897|NCT00905489|20754173|P1|STARTED|Pharmaco-kinetic (PK) Phase||85
8420898|NCT00905450|20754228|P8|NOT COMPLETED|Overall Study||1
8420899|NCT00905450|20754229|P7|NOT COMPLETED|Overall Study||2
8420900|NCT00905450|20754230|P6|NOT COMPLETED|Overall Study||2
8420901|NCT00905450|20754231|P5|NOT COMPLETED|Overall Study||0
8420902|NCT00905450|20754232|P4|NOT COMPLETED|Overall Study||0
8420903|NCT00905450|20754233|P3|NOT COMPLETED|Overall Study||0
8420904|NCT00905450|20754234|P2|NOT COMPLETED|Overall Study||1
8420905|NCT00905450|20754235|P1|NOT COMPLETED|Overall Study||1
8420906|NCT00905450|20754228|P8|COMPLETED|Overall Study||59
8420907|NCT00905450|20754229|P7|COMPLETED|Overall Study||58
8420908|NCT00905450|20754230|P6|COMPLETED|Overall Study||58
8420909|NCT00905450|20754231|P5|COMPLETED|Overall Study||59
8420910|NCT00905450|20754232|P4|COMPLETED|Overall Study||60
8420911|NCT00905450|20754233|P3|COMPLETED|Overall Study||28
8420912|NCT00905450|20754234|P2|COMPLETED|Overall Study||27
8420913|NCT00905450|20754235|P1|COMPLETED|Overall Study||59
8420914|NCT00905450|20754228|P8|STARTED|Overall Study||60
8420915|NCT00905450|20754229|P7|STARTED|Overall Study||60
8420916|NCT00905450|20754230|P6|STARTED|Overall Study||60
8420917|NCT00905450|20754231|P5|STARTED|Overall Study||59
8420918|NCT00905450|20754232|P4|STARTED|Overall Study||60
8420919|NCT00905450|20754233|P3|STARTED|Overall Study||28
8420920|NCT00905450|20754234|P2|STARTED|Overall Study||28
8420921|NCT00905450|20754235|P1|STARTED|Overall Study||60
8420928|NCT00905359|20754306|P2|NOT COMPLETED|Overall Study||16
8420929|NCT00905359|20754307|P1|NOT COMPLETED|Overall Study||24
8420930|NCT00905359|20754306|P2|COMPLETED|Overall Study||65
8420931|NCT00905359|20754307|P1|COMPLETED|Overall Study||58
8420932|NCT00905359|20754306|P2|24 Months Follow up|Overall Study||65
8420933|NCT00905359|20754307|P1|24 Months Follow up|Overall Study||58
8420934|NCT00905359|20754306|P2|12 Months Follow up|Overall Study||72
8420935|NCT00905359|20754307|P1|12 Months Follow up|Overall Study||68
8420936|NCT00905359|20754306|P2|STARTED|Overall Study||81
8420937|NCT00905359|20754307|P1|STARTED|Overall Study||82
8420938|NCT00905346|20754343|P2|NOT COMPLETED|Period 2||0
8420939|NCT00905346|20754344|P1|NOT COMPLETED|Period 2||0
8420940|NCT00905346|20754343|P2|COMPLETED|Period 2||11
8420941|NCT00905346|20754344|P1|COMPLETED|Period 2||10
8420942|NCT00905346|20754343|P2|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
8420943|NCT00905346|20754344|P1|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
8420944|NCT00905346|20754343|P2|NOT COMPLETED|Period 1||0
8420945|NCT00905346|20754344|P1|NOT COMPLETED|Period 1||1
8420946|NCT00905346|20754343|P2|COMPLETED|Period 1||12
8420947|NCT00905346|20754344|P1|COMPLETED|Period 1||11
8420948|NCT00905346|20754343|P2|STARTED|Period 1||12
8420949|NCT00905346|20754344|P1|STARTED|Period 1||12
8420950|NCT00905307|20754358|P6|NOT COMPLETED|Overall Study||42
8420951|NCT00905307|20754359|P5|NOT COMPLETED|Overall Study||16
8420952|NCT00905307|20754360|P4|NOT COMPLETED|Overall Study||37
8420953|NCT00905307|20754361|P3|NOT COMPLETED|Overall Study||37
8420954|NCT00905307|20754362|P2|NOT COMPLETED|Overall Study||37
8420955|NCT00905307|20754363|P1|NOT COMPLETED|Overall Study||22
8420956|NCT00905307|20754358|P6|COMPLETED|Overall Study||53
8420957|NCT00905307|20754359|P5|COMPLETED|Overall Study||34
8420958|NCT00905307|20754360|P4|COMPLETED|Overall Study||56
8420959|NCT00905307|20754361|P3|COMPLETED|Overall Study||53
8420960|NCT00905307|20754362|P2|COMPLETED|Overall Study||52
8420961|NCT00905307|20754363|P1|COMPLETED|Overall Study||20
8420962|NCT00905307|20754358|P6|STARTED|Overall Study||95
8420963|NCT00905307|20754359|P5|STARTED|Overall Study||50
8420964|NCT00905307|20754360|P4|STARTED|Overall Study||93
8420965|NCT00905307|20754361|P3|STARTED|Overall Study||90
8420966|NCT00905307|20754362|P2|STARTED|Overall Study||89
8420967|NCT00905307|20754363|P1|STARTED|Overall Study||42
8420968|NCT00905268|20754423|P4|NOT COMPLETED|Overall Study||2
8420969|NCT00905268|20754424|P3|NOT COMPLETED|Overall Study||0
8420970|NCT00905268|20754425|P2|NOT COMPLETED|Overall Study||1
8420971|NCT00905268|20754426|P1|NOT COMPLETED|Overall Study||4
8420972|NCT00905268|20754423|P4|COMPLETED|Overall Study||57
8420973|NCT00905268|20754424|P3|COMPLETED|Overall Study||59
8420974|NCT00905268|20754425|P2|COMPLETED|Overall Study||56
8420975|NCT00905268|20754426|P1|COMPLETED|Overall Study||53
8420976|NCT00905268|20754423|P4|STARTED|Overall Study||59
8420977|NCT00905268|20754424|P3|STARTED|Overall Study||59
8420978|NCT00905268|20754425|P2|STARTED|Overall Study||57
8420979|NCT00905268|20754426|P1|STARTED|Overall Study||57
8420980|NCT00905255|20754458|P2|NOT COMPLETED|Overall Study||9
8420981|NCT00905255|20754459|P1|NOT COMPLETED|Overall Study||13
8420982|NCT00905255|20754458|P2|COMPLETED|Overall Study||27
8420983|NCT00905255|20754459|P1|COMPLETED|Overall Study||20
8420984|NCT00905255|20754458|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||36
8420985|NCT00905255|20754459|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
8420986|NCT00905255|20754458|P2|Safety Population|Overall Study||36
8420987|NCT00905255|20754459|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
8420988|NCT00905255|20754458|P2|STARTED|Overall Study||36
8420989|NCT00905255|20754459|P1|STARTED|Overall Study|Randomized.|33
8420990|NCT00905164|20754477|P2|NOT COMPLETED|Period 2||0
8420991|NCT00905164|20754478|P1|NOT COMPLETED|Period 2||0
8420992|NCT00905164|20754477|P2|COMPLETED|Period 2||11
8420993|NCT00905164|20754478|P1|COMPLETED|Period 2||12
8420994|NCT00905164|20754477|P2|STARTED|Period 2||11
8420995|NCT00905164|20754478|P1|STARTED|Period 2||12
8420996|NCT00905164|20754477|P2|NOT COMPLETED|Period 1||1
8420997|NCT00905164|20754478|P1|NOT COMPLETED|Period 1||0
8420998|NCT00905164|20754477|P2|COMPLETED|Period 1||11
8420999|NCT00905164|20754478|P1|COMPLETED|Period 1||12
8421000|NCT00905164|20754477|P2|STARTED|Period 1||12
8421001|NCT00905164|20754478|P1|STARTED|Period 1||12
8421002|NCT00905151|20754486|P1|NOT COMPLETED|Overall Study||6
8421003|NCT00905151|20754486|P1|COMPLETED|Overall Study||200
8421004|NCT00905151|20754486|P1|STARTED|Overall Study||206
8421005|NCT00905125|20754492|P2|NOT COMPLETED|Overall Study||3
8421006|NCT00905125|20754493|P1|NOT COMPLETED|Overall Study||4
8421007|NCT00905125|20754492|P2|COMPLETED|Overall Study||53
8421008|NCT00905125|20754493|P1|COMPLETED|Overall Study||42
8421009|NCT00905125|20754492|P2|STARTED|Overall Study||56
8421010|NCT00905125|20754493|P1|STARTED|Overall Study||46
8421011|NCT00905034|20754525|P1|NOT COMPLETED|Overall Study||1
8421012|NCT00905034|20754525|P1|COMPLETED|Overall Study||36
8421013|NCT00905034|20754525|P1|STARTED|Overall Study||37
8421014|NCT00905021|20754529|P1|NOT COMPLETED|Overall Study||2
8421015|NCT00905021|20754529|P1|COMPLETED|Overall Study|2 patients were off study due to AE.|2
8421016|NCT00905021|20754529|P1|STARTED|Overall Study||4
8421017|NCT00904995|20754538|P2|NOT COMPLETED|Overall Study||0
8421018|NCT00904995|20754539|P1|NOT COMPLETED|Overall Study||0
8421019|NCT00904995|20754538|P2|COMPLETED|Overall Study||11
8421020|NCT00904995|20754539|P1|COMPLETED|Overall Study||10
8421021|NCT00904995|20754538|P2|STARTED|Overall Study||11
8421022|NCT00904995|20754539|P1|STARTED|Overall Study||10
8421023|NCT00904982|20754549|P4|NOT COMPLETED|Overall Study||0
8421024|NCT00904982|20754550|P3|NOT COMPLETED|Overall Study||0
8421025|NCT00904982|20754551|P2|NOT COMPLETED|Overall Study||0
8421026|NCT00904982|20754552|P1|NOT COMPLETED|Overall Study||2
8421027|NCT00904982|20754549|P4|COMPLETED|Overall Study||68
8421028|NCT00904982|20754550|P3|COMPLETED|Overall Study||67
8421029|NCT00904982|20754551|P2|COMPLETED|Overall Study||67
8421030|NCT00904982|20754552|P1|COMPLETED|Overall Study||66
8421031|NCT00904982|20754549|P4|STARTED|Overall Study||68
8421032|NCT00904982|20754550|P3|STARTED|Overall Study||67
8421033|NCT00904982|20754551|P2|STARTED|Overall Study||67
8421034|NCT00904982|20754552|P1|STARTED|Overall Study||68
8421035|NCT00904969|20754562|P1|NOT COMPLETED|Overall Study||19
8421036|NCT00904969|20754562|P1|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
8421037|NCT00904969|20754562|P1|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
8421038|NCT00904943|20754614|P2|NOT COMPLETED|Period 2||0
8421039|NCT00904943|20754615|P1|NOT COMPLETED|Period 2||0
8421040|NCT00904943|20754614|P2|COMPLETED|Period 2||8
8421041|NCT00904943|20754615|P1|COMPLETED|Period 2||9
8421042|NCT00904943|20754614|P2|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
8421043|NCT00904943|20754615|P1|STARTED|Period 2||9
8421044|NCT00904943|20754614|P2|NOT COMPLETED|Period 1||0
8421045|NCT00904943|20754615|P1|NOT COMPLETED|Period 1||0
8421046|NCT00904943|20754614|P2|COMPLETED|Period 1||9
8421047|NCT00904943|20754615|P1|COMPLETED|Period 1||9
8421048|NCT00904943|20754614|P2|STARTED|Period 1||9
8421049|NCT00904943|20754615|P1|STARTED|Period 1||9
8421050|NCT00904917|20754627|P4|NOT COMPLETED|Overall Study||2
8421051|NCT00904917|20754628|P3|NOT COMPLETED|Overall Study||2
8421052|NCT00904917|20754629|P2|NOT COMPLETED|Overall Study||2
8421053|NCT00904917|20754630|P1|NOT COMPLETED|Overall Study||2
8421054|NCT00904917|20754627|P4|COMPLETED|Overall Study||6
8421055|NCT00904917|20754628|P3|COMPLETED|Overall Study||6
8421056|NCT00904917|20754629|P2|COMPLETED|Overall Study||9
8421057|NCT00904917|20754630|P1|COMPLETED|Overall Study||5
8421058|NCT00904917|20754627|P4|STARTED|Overall Study||8
8421059|NCT00904917|20754628|P3|STARTED|Overall Study||8
8421060|NCT00904917|20754629|P2|STARTED|Overall Study||11
8421061|NCT00904917|20754630|P1|STARTED|Overall Study||7
8421062|NCT00904839|20754648|P3|NOT COMPLETED|Overall Study||15
8421063|NCT00904839|20754649|P2|NOT COMPLETED|Overall Study||18
8421064|NCT00904839|20754650|P1|NOT COMPLETED|Overall Study||1
8421065|NCT00904839|20754648|P3|COMPLETED|Overall Study||27
8421066|NCT00904839|20754649|P2|COMPLETED|Overall Study||64
8421067|NCT00904839|20754650|P1|COMPLETED|Overall Study||3
8421068|NCT00904839|20754648|P3|STARTED|Overall Study|Randomised|42
8421069|NCT00904839|20754649|P2|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
8421070|NCT00904839|20754650|P1|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
8421071|NCT00904826|20754684|P1|NOT COMPLETED|Overall Study||0
8421072|NCT00904826|20754684|P1|COMPLETED|Overall Study||14
8421073|NCT00904826|20754684|P1|STARTED|Overall Study||14
8421098|NCT00904722|20754725|P1|NOT COMPLETED|Overall Study||1
8421099|NCT00904722|20754725|P1|COMPLETED|Overall Study||29
8421100|NCT00904722|20754725|P1|STARTED|Overall Study||30
8421101|NCT00904670|20754730|P2|NOT COMPLETED|Second Intervention Period||0
8421102|NCT00904670|20754731|P1|NOT COMPLETED|Second Intervention Period||0
8421103|NCT00904670|20754730|P2|COMPLETED|Second Intervention Period||22
8421104|NCT00904670|20754731|P1|COMPLETED|Second Intervention Period||17
8421105|NCT00904670|20754730|P2|STARTED|Second Intervention Period||22
8421106|NCT00904670|20754731|P1|STARTED|Second Intervention Period||17
8421107|NCT00904670|20754730|P2|NOT COMPLETED|First Intervention Period||0
8421108|NCT00904670|20754731|P1|NOT COMPLETED|First Intervention Period||0
8421109|NCT00904670|20754730|P2|COMPLETED|First Intervention Period||22
8421110|NCT00904670|20754731|P1|COMPLETED|First Intervention Period||17
8421111|NCT00904670|20754730|P2|STARTED|First Intervention Period||22
8421112|NCT00904670|20754731|P1|STARTED|First Intervention Period||17
8421113|NCT00904670|20754730|P2|NOT COMPLETED|Open Label Phase||0
8421114|NCT00904670|20754731|P1|NOT COMPLETED|Open Label Phase||6
8421115|NCT00904670|20754730|P2|COMPLETED|Open Label Phase||22
8421116|NCT00904670|20754731|P1|COMPLETED|Open Label Phase||17
8421117|NCT00904670|20754730|P2|STARTED|Open Label Phase||22
8421118|NCT00904670|20754731|P1|STARTED|Open Label Phase||23
8421119|NCT00904618|20754752|P1|NOT COMPLETED|Overall Study||0
8421120|NCT00904618|20754752|P1|COMPLETED|Overall Study||48
8421121|NCT00904618|20754752|P1|STARTED|Overall Study||48
8421122|NCT00904488|20754762|P2|NOT COMPLETED|Overall Study||0
8421123|NCT00904488|20754763|P1|NOT COMPLETED|Overall Study||0
8421124|NCT00904488|20754762|P2|COMPLETED|Overall Study||6
8421125|NCT00904488|20754763|P1|COMPLETED|Overall Study||5
8421126|NCT00904488|20754762|P2|STARTED|Overall Study||6
8421127|NCT00904488|20754763|P1|STARTED|Overall Study||5
8421128|NCT00904423|20754793|P1|NOT COMPLETED|Overall Study||0
8421129|NCT00904423|20754793|P1|COMPLETED|Overall Study||8
8421130|NCT00904423|20754793|P1|STARTED|Overall Study||8
8421131|NCT00904371|20754801|P1|NOT COMPLETED|Overall Study||9
8421132|NCT00904371|20754801|P1|COMPLETED|Overall Study||202
8421133|NCT00904371|20754801|P1|STARTED|Overall Study||211
8421138|NCT00904215|20754826|P1|NOT COMPLETED|Overall Study||135
8421139|NCT00904215|20754826|P1|COMPLETED|Overall Study||960
8421140|NCT00904215|20754826|P1|STARTED|Overall Study||1095
8421141|NCT00904189|20754833|P1|NOT COMPLETED|Overall Study||0
8421142|NCT00904189|20754833|P1|COMPLETED|Overall Study||2
8421143|NCT00904189|20754833|P1|STARTED|Overall Study||2
8421144|NCT00904150|20754840|P2|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
8421145|NCT00904150|20754841|P1|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
8421146|NCT00904150|20754840|P2|COMPLETED|Blood Samples (RNA): Luteal Phase||30
8421147|NCT00904150|20754841|P1|COMPLETED|Blood Samples (RNA): Luteal Phase||34
8421148|NCT00904150|20754840|P2|STARTED|Blood Samples (RNA): Luteal Phase||30
8421149|NCT00904150|20754841|P1|STARTED|Blood Samples (RNA): Luteal Phase||34
8421150|NCT00904150|20754840|P2|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
8421151|NCT00904150|20754841|P1|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
8421152|NCT00904150|20754840|P2|COMPLETED|Blood Samples (RNA): Follicular Phase||32
8421153|NCT00904150|20754841|P1|COMPLETED|Blood Samples (RNA): Follicular Phase||37
8421154|NCT00904150|20754840|P2|STARTED|Blood Samples (RNA): Follicular Phase||32
8421155|NCT00904150|20754841|P1|STARTED|Blood Samples (RNA): Follicular Phase||37
8421156|NCT00904150|20754840|P2|NOT COMPLETED|Saliva Samples (DNA)||145
8421157|NCT00904150|20754841|P1|NOT COMPLETED|Saliva Samples (DNA)||3
8421158|NCT00904150|20754840|P2|COMPLETED|Saliva Samples (DNA)||155
8421159|NCT00904150|20754841|P1|COMPLETED|Saliva Samples (DNA)||282
8421160|NCT00904150|20754840|P2|STARTED|Saliva Samples (DNA)||300
8421161|NCT00904150|20754841|P1|STARTED|Saliva Samples (DNA)||285
8421162|NCT00904033|20754863|P4|NOT COMPLETED|Overall Study||2
8421163|NCT00904033|20754864|P3|NOT COMPLETED|Overall Study||1
8421164|NCT00904033|20754865|P2|NOT COMPLETED|Overall Study||1
8421165|NCT00904033|20754866|P1|NOT COMPLETED|Overall Study||1
8421166|NCT00904033|20754863|P4|COMPLETED|Overall Study||9
8421167|NCT00904033|20754864|P3|COMPLETED|Overall Study||9
8421168|NCT00904033|20754865|P2|COMPLETED|Overall Study||9
8421169|NCT00904033|20754866|P1|COMPLETED|Overall Study||9
8421170|NCT00904033|20754863|P4|STARTED|Overall Study||11
8421171|NCT00904033|20754864|P3|STARTED|Overall Study||10
8421172|NCT00904033|20754865|P2|STARTED|Overall Study||10
8421173|NCT00904033|20754866|P1|STARTED|Overall Study||10
8421174|NCT00904007|20754890|P2|NOT COMPLETED|Overall Study||0
8421175|NCT00904007|20754891|P1|NOT COMPLETED|Overall Study||0
8421176|NCT00904007|20754890|P2|COMPLETED|Overall Study||56
8421177|NCT00904007|20754891|P1|COMPLETED|Overall Study||55
8421178|NCT00904007|20754890|P2|STARTED|Overall Study||56
8421179|NCT00904007|20754891|P1|STARTED|Overall Study||55
8421180|NCT00903968|20754931|P8|NOT COMPLETED|Overall Study||33
8421181|NCT00903968|20754932|P7|NOT COMPLETED|Overall Study||3
8421182|NCT00903968|20754933|P6|NOT COMPLETED|Overall Study||6
8421183|NCT00903968|20754934|P5|NOT COMPLETED|Overall Study||4
8421184|NCT00903968|20754935|P4|NOT COMPLETED|Overall Study||3
8421185|NCT00903968|20754936|P3|NOT COMPLETED|Overall Study||3
8421186|NCT00903968|20754937|P2|NOT COMPLETED|Overall Study||3
8421187|NCT00903968|20754938|P1|NOT COMPLETED|Overall Study||3
8421188|NCT00903968|20754931|P8|COMPLETED|Overall Study||0
8421189|NCT00903968|20754932|P7|COMPLETED|Overall Study||0
8421190|NCT00903968|20754933|P6|COMPLETED|Overall Study||0
8421191|NCT00903968|20754934|P5|COMPLETED|Overall Study||0
8421192|NCT00903968|20754935|P4|COMPLETED|Overall Study||0
8421193|NCT00903968|20754936|P3|COMPLETED|Overall Study||0
8421194|NCT00903968|20754937|P2|COMPLETED|Overall Study||0
8421195|NCT00903968|20754938|P1|COMPLETED|Overall Study||0
8421196|NCT00903968|20754931|P8|STARTED|Overall Study||33
8421197|NCT00903968|20754932|P7|STARTED|Overall Study||3
8421198|NCT00903968|20754933|P6|STARTED|Overall Study||6
8421199|NCT00903968|20754934|P5|STARTED|Overall Study||4
8421200|NCT00903968|20754935|P4|STARTED|Overall Study||3
8421201|NCT00903968|20754936|P3|STARTED|Overall Study||3
8421202|NCT00903968|20754937|P2|STARTED|Overall Study||3
8421203|NCT00903968|20754938|P1|STARTED|Overall Study||3
8421204|NCT00903929|20754968|P4|NOT COMPLETED|Overall Study||3
8421205|NCT00903929|20754969|P3|NOT COMPLETED|Overall Study||1
8421206|NCT00903929|20754970|P2|NOT COMPLETED|Overall Study||0
8421207|NCT00903929|20754971|P1|NOT COMPLETED|Overall Study||0
8421208|NCT00903929|20754968|P4|COMPLETED|Overall Study||6
8421209|NCT00903929|20754969|P3|COMPLETED|Overall Study||3
8421210|NCT00903929|20754970|P2|COMPLETED|Overall Study||3
8421211|NCT00903929|20754971|P1|COMPLETED|Overall Study||3
8421212|NCT00903929|20754968|P4|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
8421213|NCT00903929|20754969|P3|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
8421214|NCT00903929|20754970|P2|STARTED|Overall Study||3
8421215|NCT00903929|20754971|P1|STARTED|Overall Study||3
8421216|NCT00903877|20754977|P1|NOT COMPLETED|Overall Study||43
8421217|NCT00903877|20754977|P1|COMPLETED|Overall Study||8
8421218|NCT00903877|20754977|P1|STARTED|Overall Study||51
8421219|NCT00903786|20754981|P1|NOT COMPLETED|Overall Study||15
8421220|NCT00903786|20754981|P1|COMPLETED|Overall Study||6
8421221|NCT00903786|20754981|P1|STARTED|Overall Study||21
8421222|NCT00903760|20754991|P2|NOT COMPLETED|Overall Study||16
8421223|NCT00903760|20754992|P1|NOT COMPLETED|Overall Study||19
8421224|NCT00903760|20754991|P2|COMPLETED|Overall Study|Completed all 24 courses|2
8421225|NCT00903760|20754992|P1|COMPLETED|Overall Study|Completed all 24 courses|0
8421226|NCT00903760|20754991|P2|STARTED|Overall Study||18
8421227|NCT00903760|20754992|P1|STARTED|Overall Study||19
8421228|NCT00903695|20755002|P2|NOT COMPLETED|Overall Study||0
8421229|NCT00903695|20755003|P1|NOT COMPLETED|Overall Study||2
8421230|NCT00903695|20755002|P2|COMPLETED|Overall Study||2
8421231|NCT00903695|20755003|P1|COMPLETED|Overall Study||6
8421232|NCT00903695|20755002|P2|STARTED|Overall Study||2
8421233|NCT00903695|20755003|P1|STARTED|Overall Study||8
8421234|NCT00903682|20755025|P2|NOT COMPLETED|Overall Study||15
8421235|NCT00903682|20755026|P1|NOT COMPLETED|Overall Study||16
8421236|NCT00903682|20755025|P2|COMPLETED|Overall Study||63
8421237|NCT00903682|20755026|P1|COMPLETED|Overall Study||63
8421238|NCT00903682|20755025|P2|STARTED|Overall Study||78
8421239|NCT00903682|20755026|P1|STARTED|Overall Study||79
8421240|NCT00903630|20755047|P3|NOT COMPLETED|Phase 2||1
8421241|NCT00903630|20755048|P2|NOT COMPLETED|Phase 2||0
8421242|NCT00903630|20755049|P1|NOT COMPLETED|Phase 2||0
8421243|NCT00903630|20755047|P3|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
8421244|NCT00903630|20755048|P2|COMPLETED|Phase 2||0
8421245|NCT00903630|20755049|P1|COMPLETED|Phase 2||6
8421246|NCT00903630|20755047|P3|STARTED|Phase 2||4
8421247|NCT00903630|20755048|P2|STARTED|Phase 2||0
8421248|NCT00903630|20755049|P1|STARTED|Phase 2||6
8421249|NCT00903630|20755047|P3|NOT COMPLETED|Phase l||0
8421250|NCT00903630|20755048|P2|NOT COMPLETED|Phase l||0
8421251|NCT00903630|20755049|P1|NOT COMPLETED|Phase l||0
8421252|NCT00903630|20755047|P3|COMPLETED|Phase l||0
8421253|NCT00903630|20755048|P2|COMPLETED|Phase l||5
8421254|NCT00903630|20755049|P1|COMPLETED|Phase l||6
8421255|NCT00903630|20755047|P3|STARTED|Phase l||0
8421256|NCT00903630|20755048|P2|STARTED|Phase l||5
8421257|NCT00903630|20755049|P1|STARTED|Phase l||6
8421258|NCT00903617|20755067|P4|NOT COMPLETED|Overall Study||1
8421259|NCT00903617|20755068|P3|NOT COMPLETED|Overall Study||5
8421260|NCT00903617|20755069|P2|NOT COMPLETED|Overall Study||5
8421261|NCT00903617|20755070|P1|NOT COMPLETED|Overall Study||3
8421262|NCT00903617|20755067|P4|COMPLETED|Overall Study||20
8421263|NCT00903617|20755068|P3|COMPLETED|Overall Study||15
8421264|NCT00903617|20755069|P2|COMPLETED|Overall Study||15
8421265|NCT00903617|20755070|P1|COMPLETED|Overall Study||16
8421266|NCT00903617|20755067|P4|STARTED|Overall Study||21
8421267|NCT00903617|20755068|P3|STARTED|Overall Study||20
8421268|NCT00903617|20755069|P2|STARTED|Overall Study||20
8421269|NCT00903617|20755070|P1|STARTED|Overall Study||19
8421270|NCT00903448|20755164|P2|NOT COMPLETED|Period 3: 5 Days||0
8421271|NCT00903448|20755165|P1|NOT COMPLETED|Period 3: 5 Days||0
8421272|NCT00903448|20755164|P2|COMPLETED|Period 3: 5 Days||20
8421273|NCT00903448|20755165|P1|COMPLETED|Period 3: 5 Days||20
8421274|NCT00903448|20755164|P2|STARTED|Period 3: 5 Days||20
8421275|NCT00903448|20755165|P1|STARTED|Period 3: 5 Days||20
8421276|NCT00903448|20755164|P2|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
8421277|NCT00903448|20755165|P1|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
8421278|NCT00903448|20755164|P2|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
8421279|NCT00903448|20755165|P1|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
8421280|NCT00903448|20755164|P2|STARTED|Period 2: 5 Days Then 10 Day Washout||20
8421281|NCT00903448|20755165|P1|STARTED|Period 2: 5 Days Then 10 Day Washout||20
8421282|NCT00903448|20755164|P2|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
8421283|NCT00903448|20755165|P1|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
8421284|NCT00903448|20755164|P2|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
8421285|NCT00903448|20755165|P1|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
8421286|NCT00903448|20755164|P2|STARTED|Period 1: 5 Days Then 10 Day Washout||20
8421287|NCT00903448|20755165|P1|STARTED|Period 1: 5 Days Then 10 Day Washout||20
8421288|NCT00903409|20755173|P2|NOT COMPLETED|Overall Study||27
8421289|NCT00903409|20755174|P1|NOT COMPLETED|Overall Study||26
8421290|NCT00903409|20755173|P2|COMPLETED|Overall Study||73
8421291|NCT00903409|20755174|P1|COMPLETED|Overall Study||62
8421292|NCT00903409|20755173|P2|STARTED|Overall Study||100
8421293|NCT00903409|20755174|P1|STARTED|Overall Study||88
8421294|NCT00903396|20755192|P4|NOT COMPLETED|Overall Study||0
8421295|NCT00903396|20755193|P3|NOT COMPLETED|Overall Study||0
8421296|NCT00903396|20755194|P2|NOT COMPLETED|Overall Study||0
8421297|NCT00903396|20755195|P1|NOT COMPLETED|Overall Study||0
8421298|NCT00903396|20755192|P4|COMPLETED|Overall Study||1
8421299|NCT00903396|20755193|P3|COMPLETED|Overall Study||3
8421300|NCT00903396|20755194|P2|COMPLETED|Overall Study||1
8421301|NCT00903396|20755195|P1|COMPLETED|Overall Study||2
8421302|NCT00903396|20755192|P4|STARTED|Overall Study||1
8421303|NCT00903396|20755193|P3|STARTED|Overall Study||3
8421304|NCT00903396|20755194|P2|STARTED|Overall Study||1
8421305|NCT00903396|20755195|P1|STARTED|Overall Study||2
8421306|NCT00903383|20755225|P4|NOT COMPLETED|Overall Study||5
8421307|NCT00903383|20755226|P3|NOT COMPLETED|Overall Study||3
8421308|NCT00903383|20755227|P2|NOT COMPLETED|Overall Study||6
8421309|NCT00903383|20755228|P1|NOT COMPLETED|Overall Study||7
8421310|NCT00903383|20755225|P4|COMPLETED|Overall Study||44
8421311|NCT00903383|20755226|P3|COMPLETED|Overall Study||47
8421312|NCT00903383|20755227|P2|COMPLETED|Overall Study||48
8421313|NCT00903383|20755228|P1|COMPLETED|Overall Study||48
8421314|NCT00903383|20755225|P4|STARTED|Overall Study||49
8421315|NCT00903383|20755226|P3|STARTED|Overall Study||50
8421316|NCT00903383|20755227|P2|STARTED|Overall Study||54
8421317|NCT00903383|20755228|P1|STARTED|Overall Study||55
8421318|NCT00903370|20755260|P2|NOT COMPLETED|Overall Study||24
8421319|NCT00903370|20755261|P1|NOT COMPLETED|Overall Study||28
8421320|NCT00903370|20755260|P2|COMPLETED|Overall Study||109
8421321|NCT00903370|20755261|P1|COMPLETED|Overall Study||99
8421322|NCT00903370|20755260|P2|STARTED|Overall Study||133
8421323|NCT00903370|20755261|P1|STARTED|Overall Study||127
8421324|NCT00903357|20755269|P2|NOT COMPLETED|Second Intervention||0
8421325|NCT00903357|20755270|P1|NOT COMPLETED|Second Intervention||1
8421326|NCT00903357|20755269|P2|COMPLETED|Second Intervention||22
8421327|NCT00903357|20755270|P1|COMPLETED|Second Intervention||21
8421328|NCT00903357|20755269|P2|STARTED|Second Intervention||22
8421329|NCT00903357|20755270|P1|STARTED|Second Intervention||22
8421330|NCT00903357|20755269|P2|NOT COMPLETED|Wash Out Period of 2 Weeks||1
8421331|NCT00903357|20755270|P1|NOT COMPLETED|Wash Out Period of 2 Weeks||0
8421332|NCT00903357|20755269|P2|COMPLETED|Wash Out Period of 2 Weeks||22
8421333|NCT00903357|20755270|P1|COMPLETED|Wash Out Period of 2 Weeks||22
8421334|NCT00903357|20755269|P2|STARTED|Wash Out Period of 2 Weeks||23
8421335|NCT00903357|20755270|P1|STARTED|Wash Out Period of 2 Weeks||22
8421336|NCT00903357|20755269|P2|NOT COMPLETED|First Intervention||4
8421337|NCT00903357|20755270|P1|NOT COMPLETED|First Intervention||5
8421338|NCT00903357|20755269|P2|COMPLETED|First Intervention||23
8421339|NCT00903357|20755270|P1|COMPLETED|First Intervention||22
8421340|NCT00903357|20755269|P2|STARTED|First Intervention||27
8421341|NCT00903357|20755270|P1|STARTED|First Intervention||27
8421342|NCT00903344|20755282|P2|NOT COMPLETED|Overall Study||3
8421343|NCT00903344|20755283|P1|NOT COMPLETED|Overall Study||5
8421344|NCT00903344|20755282|P2|COMPLETED|Overall Study||7
8421345|NCT00903344|20755283|P1|COMPLETED|Overall Study||7
8421346|NCT00903344|20755282|P2|6 Month Visit|Overall Study||10
8421347|NCT00903344|20755283|P1|6 Month Visit|Overall Study||9
8421348|NCT00903344|20755282|P2|3 Month Visit|Overall Study||10
8421349|NCT00903344|20755283|P1|3 Month Visit|Overall Study||10
8421350|NCT00903344|20755282|P2|STARTED|Overall Study||10
8421351|NCT00903344|20755283|P1|STARTED|Overall Study||12
8421352|NCT00903331|20755301|P2|NOT COMPLETED|Overall Study||18
8421353|NCT00903331|20755302|P1|NOT COMPLETED|Overall Study||5
8421354|NCT00903331|20755301|P2|COMPLETED|Overall Study||101
8421355|NCT00903331|20755302|P1|COMPLETED|Overall Study||54
8421356|NCT00903331|20755301|P2|STARTED|Overall Study||119
8421357|NCT00903331|20755302|P1|STARTED|Overall Study||59
8421358|NCT00903201|20755313|P3|NOT COMPLETED|Overall Study||2
8421359|NCT00903201|20755314|P2|NOT COMPLETED|Overall Study||6
8421360|NCT00903201|20755315|P1|NOT COMPLETED|Overall Study||5
8421361|NCT00903201|20755313|P3|COMPLETED|Overall Study||39
8421362|NCT00903201|20755314|P2|COMPLETED|Overall Study||38
8421363|NCT00903201|20755315|P1|COMPLETED|Overall Study||56
8421364|NCT00903201|20755313|P3|STARTED|Overall Study||41
8421365|NCT00903201|20755314|P2|STARTED|Overall Study||44
8421366|NCT00903201|20755315|P1|STARTED|Overall Study||61
8421367|NCT00903175|20755373|P2|NOT COMPLETED|Period 2 - Second Line||36
8421368|NCT00903175|20755374|P1|NOT COMPLETED|Period 2 - Second Line||49
8421369|NCT00903175|20755373|P2|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
8421370|NCT00903175|20755374|P1|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
8421371|NCT00903175|20755373|P2|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
8421372|NCT00903175|20755374|P1|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
8421373|NCT00903175|20755373|P2|NOT COMPLETED|Period 1 - First Line||89
8421374|NCT00903175|20755374|P1|NOT COMPLETED|Period 1 - First Line||77
8421375|NCT00903175|20755373|P2|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
8421376|NCT00903175|20755374|P1|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
8421377|NCT00903175|20755373|P2|STARTED|Period 1 - First Line||231
8421378|NCT00903175|20755374|P1|STARTED|Period 1 - First Line||238
8421379|NCT00903162|20755404|P1|NOT COMPLETED|Overall Study||4
8421380|NCT00903162|20755404|P1|COMPLETED|Overall Study||12
8421381|NCT00903162|20755404|P1|STARTED|Overall Study||16
8421382|NCT00903032|20755412|P2|NOT COMPLETED|Overall Study||5
8421383|NCT00903032|20755413|P1|NOT COMPLETED|Overall Study||7
8421384|NCT00903032|20755412|P2|COMPLETED|Overall Study||119
8421385|NCT00903032|20755413|P1|COMPLETED|Overall Study||122
8421386|NCT00903032|20755412|P2|STARTED|Overall Study||124
8421387|NCT00903032|20755413|P1|STARTED|Overall Study||129
8421388|NCT00903006|20755423|P4|NOT COMPLETED|Overall Study||0
8421389|NCT00903006|20755424|P3|NOT COMPLETED|Overall Study||1
8421390|NCT00903006|20755425|P2|NOT COMPLETED|Overall Study||3
8421391|NCT00903006|20755426|P1|NOT COMPLETED|Overall Study||2
8421392|NCT00903006|20755423|P4|COMPLETED|Overall Study||0
8421393|NCT00903006|20755424|P3|COMPLETED|Overall Study||0
8421394|NCT00903006|20755425|P2|COMPLETED|Overall Study||0
8421395|NCT00903006|20755426|P1|COMPLETED|Overall Study||0
8421396|NCT00903006|20755423|P4|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
8421397|NCT00903006|20755424|P3|STARTED|Overall Study||1
8421398|NCT00903006|20755425|P2|STARTED|Overall Study||3
8421399|NCT00903006|20755426|P1|STARTED|Overall Study||2
8421400|NCT00902850|20755438|P2|NOT COMPLETED|Overall Study||2
8421401|NCT00902850|20755439|P1|NOT COMPLETED|Overall Study||2
8421402|NCT00902850|20755438|P2|COMPLETED|Overall Study||12
8421403|NCT00902850|20755439|P1|COMPLETED|Overall Study||12
8421404|NCT00902850|20755438|P2|STARTED|Overall Study||14
8421405|NCT00902850|20755439|P1|STARTED|Overall Study||14
8421406|NCT00902746|20755445|P1|NOT COMPLETED|Overall Study||36
8421407|NCT00902746|20755445|P1|COMPLETED|Overall Study||113
8421408|NCT00902746|20755445|P1|Transfer to Step 2|Overall Study||133
8421409|NCT00902746|20755445|P1|Initiation of Study Drug Administration|Overall Study||148
8421410|NCT00902746|20755445|P1|STARTED|Overall Study||149
8421411|NCT00902668|20755450|P1|NOT COMPLETED|Overall Study||3
8421412|NCT00902668|20755450|P1|COMPLETED|Overall Study||0
8421413|NCT00902668|20755450|P1|STARTED|Overall Study||3
8421414|NCT00902577|20755454|P1|NOT COMPLETED|Overall Study||8
8421415|NCT00902577|20755454|P1|COMPLETED|Overall Study||42
8421416|NCT00902577|20755454|P1|DWI MRI|Overall Study||39
8421417|NCT00902577|20755454|P1|DSE MRI|Overall Study||37
8421418|NCT00902577|20755454|P1|DCE MRI|Overall Study||31
8421419|NCT00902577|20755454|P1|FMISO/PET|Overall Study||38
8421420|NCT00902577|20755454|P1|STARTED|Overall Study||50
8421421|NCT00902564|20755483|P1|NOT COMPLETED|Overall Study||2
8421422|NCT00902564|20755483|P1|COMPLETED|Overall Study||28
8421423|NCT00902564|20755483|P1|STARTED|Overall Study||30
8421424|NCT00902538|20755498|P6|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
8421425|NCT00902538|20755499|P5|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
8421426|NCT00902538|20755500|P4|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
8421427|NCT00902538|20755501|P3|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
8421428|NCT00902538|20755502|P2|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
8421429|NCT00902538|20755503|P1|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
8421430|NCT00902538|20755498|P6|COMPLETED|4-Randomized Double-blind 2 Treatments||196
8421431|NCT00902538|20755499|P5|COMPLETED|4-Randomized Double-blind 2 Treatments||95
8421432|NCT00902538|20755500|P4|COMPLETED|4-Randomized Double-blind 2 Treatments||458
8421433|NCT00902538|20755501|P3|COMPLETED|4-Randomized Double-blind 2 Treatments||0
8421434|NCT00902538|20755502|P2|COMPLETED|4-Randomized Double-blind 2 Treatments||0
8421435|NCT00902538|20755503|P1|COMPLETED|4-Randomized Double-blind 2 Treatments||0
8421436|NCT00902538|20755498|P6|STARTED|4-Randomized Double-blind 2 Treatments||197
8421437|NCT00902538|20755499|P5|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
8421438|NCT00902538|20755500|P4|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
8421439|NCT00902538|20755501|P3|STARTED|4-Randomized Double-blind 2 Treatments||0
8421440|NCT00902538|20755502|P2|STARTED|4-Randomized Double-blind 2 Treatments||0
8421441|NCT00902538|20755503|P1|STARTED|4-Randomized Double-blind 2 Treatments||0
8421442|NCT00902538|20755498|P6|NOT COMPLETED|3-Single-blind, Single Treatment||0
8421443|NCT00902538|20755499|P5|NOT COMPLETED|3-Single-blind, Single Treatment||0
8421444|NCT00902538|20755500|P4|NOT COMPLETED|3-Single-blind, Single Treatment||0
8421445|NCT00902538|20755501|P3|NOT COMPLETED|3-Single-blind, Single Treatment||0
8421446|NCT00902538|20755502|P2|NOT COMPLETED|3-Single-blind, Single Treatment||15
8421447|NCT00902538|20755503|P1|NOT COMPLETED|3-Single-blind, Single Treatment||0
8421448|NCT00902538|20755498|P6|COMPLETED|3-Single-blind, Single Treatment||0
8421449|NCT00902538|20755499|P5|COMPLETED|3-Single-blind, Single Treatment||0
8421450|NCT00902538|20755500|P4|COMPLETED|3-Single-blind, Single Treatment||0
8421451|NCT00902538|20755501|P3|COMPLETED|3-Single-blind, Single Treatment||0
8421452|NCT00902538|20755502|P2|COMPLETED|3-Single-blind, Single Treatment||767
8421453|NCT00902538|20755503|P1|COMPLETED|3-Single-blind, Single Treatment||0
8421454|NCT00902538|20755498|P6|STARTED|3-Single-blind, Single Treatment||0
8421455|NCT00902538|20755499|P5|STARTED|3-Single-blind, Single Treatment||0
8421456|NCT00902538|20755500|P4|STARTED|3-Single-blind, Single Treatment||0
8421457|NCT00902538|20755501|P3|STARTED|3-Single-blind, Single Treatment||0
8421458|NCT00902538|20755502|P2|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
8421459|NCT00902538|20755503|P1|STARTED|3-Single-blind, Single Treatment||0
8421460|NCT00902538|20755498|P6|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
8421461|NCT00902538|20755499|P5|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
8421462|NCT00902538|20755500|P4|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
8421463|NCT00902538|20755501|P3|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
8421464|NCT00902538|20755502|P2|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
8421465|NCT00902538|20755503|P1|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
8421466|NCT00902538|20755498|P6|COMPLETED|2-Randomized Double-blind 3 Treatments||0
8421467|NCT00902538|20755499|P5|COMPLETED|2-Randomized Double-blind 3 Treatments||0
8421468|NCT00902538|20755500|P4|COMPLETED|2-Randomized Double-blind 3 Treatments||0
8421469|NCT00902538|20755501|P3|COMPLETED|2-Randomized Double-blind 3 Treatments||262
8421470|NCT00902538|20755502|P2|COMPLETED|2-Randomized Double-blind 3 Treatments||263
8421471|NCT00902538|20755503|P1|COMPLETED|2-Randomized Double-blind 3 Treatments||260
8421472|NCT00902538|20755498|P6|STARTED|2-Randomized Double-blind 3 Treatments||0
8421473|NCT00902538|20755499|P5|STARTED|2-Randomized Double-blind 3 Treatments||0
8421474|NCT00902538|20755500|P4|STARTED|2-Randomized Double-blind 3 Treatments||0
8421475|NCT00902538|20755501|P3|STARTED|2-Randomized Double-blind 3 Treatments||270
8421476|NCT00902538|20755502|P2|STARTED|2-Randomized Double-blind 3 Treatments||269
8421477|NCT00902538|20755503|P1|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
8421478|NCT00902538|20755498|P6|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421479|NCT00902538|20755499|P5|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421480|NCT00902538|20755500|P4|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421481|NCT00902538|20755501|P3|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421482|NCT00902538|20755502|P2|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421483|NCT00902538|20755503|P1|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
8421484|NCT00902538|20755498|P6|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421485|NCT00902538|20755499|P5|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421486|NCT00902538|20755500|P4|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421487|NCT00902538|20755501|P3|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421488|NCT00902538|20755502|P2|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
8421489|NCT00902538|20755503|P1|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
8421490|NCT00902538|20755498|P6|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8421491|NCT00902538|20755499|P5|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8421492|NCT00902538|20755500|P4|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8421493|NCT00902538|20755501|P3|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8421494|NCT00902538|20755502|P2|STARTED|1-Single-blind, Run-in, Single-Treatment||0
8421495|NCT00902538|20755503|P1|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
8421496|NCT00902486|20755537|P6|NOT COMPLETED|Follow-up (After Week 24)||0
8421497|NCT00902486|20755538|P5|NOT COMPLETED|Follow-up (After Week 24)||0
8421498|NCT00902486|20755539|P4|NOT COMPLETED|Follow-up (After Week 24)||1
8421499|NCT00902486|20755540|P3|NOT COMPLETED|Follow-up (After Week 24)||0
8421500|NCT00902486|20755541|P2|NOT COMPLETED|Follow-up (After Week 24)||0
8421501|NCT00902486|20755542|P1|NOT COMPLETED|Follow-up (After Week 24)||0
8421502|NCT00902486|20755537|P6|COMPLETED|Follow-up (After Week 24)||24
8421503|NCT00902486|20755538|P5|COMPLETED|Follow-up (After Week 24)||29
8421504|NCT00902486|20755539|P4|COMPLETED|Follow-up (After Week 24)||26
8421505|NCT00902486|20755540|P3|COMPLETED|Follow-up (After Week 24)||13
8421506|NCT00902486|20755541|P2|COMPLETED|Follow-up (After Week 24)||14
8421507|NCT00902486|20755542|P1|COMPLETED|Follow-up (After Week 24)||0
8421508|NCT00902486|20755537|P6|Safety Evaluable Participants|Follow-up (After Week 24)||27
8421509|NCT00902486|20755538|P5|Safety Evaluable Participants|Follow-up (After Week 24)||30
8421510|NCT00902486|20755539|P4|Safety Evaluable Participants|Follow-up (After Week 24)||29
8421511|NCT00902486|20755540|P3|Safety Evaluable Participants|Follow-up (After Week 24)||15
8421512|NCT00902486|20755541|P2|Safety Evaluable Participants|Follow-up (After Week 24)||14
8421513|NCT00902486|20755542|P1|Safety Evaluable Participants|Follow-up (After Week 24)||0
8421514|NCT00902486|20755537|P6|STARTED|Follow-up (After Week 24)||24
8421515|NCT00902486|20755538|P5|STARTED|Follow-up (After Week 24)||29
8421516|NCT00902486|20755539|P4|STARTED|Follow-up (After Week 24)||27
8421517|NCT00902486|20755540|P3|STARTED|Follow-up (After Week 24)||13
8421518|NCT00902486|20755541|P2|STARTED|Follow-up (After Week 24)||14
8421519|NCT00902486|20755542|P1|STARTED|Follow-up (After Week 24)||0
8421520|NCT00902486|20755537|P6|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
8421521|NCT00902486|20755538|P5|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
8421522|NCT00902486|20755539|P4|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
8421523|NCT00902486|20755540|P3|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
8421524|NCT00902486|20755541|P2|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
8421525|NCT00902486|20755542|P1|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
8421526|NCT00902486|20755537|P6|COMPLETED|Extension Period (Weeks 12 Through 24)||24
8421527|NCT00902486|20755538|P5|COMPLETED|Extension Period (Weeks 12 Through 24)||29
8421528|NCT00902486|20755539|P4|COMPLETED|Extension Period (Weeks 12 Through 24)||27
8421529|NCT00902486|20755540|P3|COMPLETED|Extension Period (Weeks 12 Through 24)||13
8421530|NCT00902486|20755541|P2|COMPLETED|Extension Period (Weeks 12 Through 24)||14
8421531|NCT00902486|20755542|P1|COMPLETED|Extension Period (Weeks 12 Through 24)||0
8421532|NCT00902486|20755537|P6|STARTED|Extension Period (Weeks 12 Through 24)||27
8421533|NCT00902486|20755538|P5|STARTED|Extension Period (Weeks 12 Through 24)||30
8421534|NCT00902486|20755539|P4|STARTED|Extension Period (Weeks 12 Through 24)||29
8421535|NCT00902486|20755540|P3|STARTED|Extension Period (Weeks 12 Through 24)||15
8421536|NCT00902486|20755541|P2|STARTED|Extension Period (Weeks 12 Through 24)||14
8421537|NCT00902486|20755542|P1|STARTED|Extension Period (Weeks 12 Through 24)||0
8421538|NCT00902486|20755537|P6|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
8421539|NCT00902486|20755538|P5|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
8421540|NCT00902486|20755539|P4|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
8421541|NCT00902486|20755540|P3|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
8421542|NCT00902486|20755541|P2|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
8421543|NCT00902486|20755542|P1|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
8421544|NCT00902486|20755537|P6|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
8421545|NCT00902486|20755538|P5|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
8421546|NCT00902486|20755539|P4|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
8421547|NCT00902486|20755540|P3|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
8421548|NCT00902486|20755541|P2|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
8421549|NCT00902486|20755542|P1|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
8421550|NCT00902486|20755537|P6|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
8421551|NCT00902486|20755538|P5|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
8421552|NCT00902486|20755539|P4|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
8421553|NCT00902486|20755540|P3|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
8421554|NCT00902486|20755541|P2|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
8421555|NCT00902486|20755542|P1|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
8421556|NCT00902486|20755537|P6|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
8421557|NCT00902486|20755538|P5|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
8421558|NCT00902486|20755539|P4|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
8421559|NCT00902486|20755540|P3|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
8421560|NCT00902486|20755541|P2|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
8421561|NCT00902486|20755542|P1|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
8421562|NCT00902486|20755537|P6|STARTED|Treatment Period (Weeks 0 Through 12)||32
8421563|NCT00902486|20755538|P5|STARTED|Treatment Period (Weeks 0 Through 12)||32
8421564|NCT00902486|20755539|P4|STARTED|Treatment Period (Weeks 0 Through 12)||32
8421565|NCT00902486|20755540|P3|STARTED|Treatment Period (Weeks 0 Through 12)||0
8421566|NCT00902486|20755541|P2|STARTED|Treatment Period (Weeks 0 Through 12)||0
8421567|NCT00902486|20755542|P1|STARTED|Treatment Period (Weeks 0 Through 12)||31
8421568|NCT00902330|20755680|P2|NOT COMPLETED|Overall Study||5
8421569|NCT00902330|20755681|P1|NOT COMPLETED|Overall Study||4
8421570|NCT00902330|20755680|P2|COMPLETED|Overall Study||75
8421571|NCT00902330|20755681|P1|COMPLETED|Overall Study||77
8421572|NCT00902330|20755680|P2|STARTED|Overall Study||80
8421573|NCT00902330|20755681|P1|STARTED|Overall Study||81
8421574|NCT00902304|20755718|P3|NOT COMPLETED|Overall Study||110
8421575|NCT00902304|20755719|P2|NOT COMPLETED|Overall Study||71
8421576|NCT00902304|20755720|P1|NOT COMPLETED|Overall Study||58
8421577|NCT00902304|20755718|P3|COMPLETED|Overall Study||568
8421578|NCT00902304|20755719|P2|COMPLETED|Overall Study||289
8421579|NCT00902304|20755720|P1|COMPLETED|Overall Study||466
8421580|NCT00902304|20755718|P3|STARTED|Overall Study||678
8421581|NCT00902304|20755719|P2|STARTED|Overall Study||360
8421582|NCT00902304|20755720|P1|STARTED|Overall Study||524
8421583|NCT00902278|20755770|P5|NOT COMPLETED|Overall Study||2
8421584|NCT00902278|20755771|P4|NOT COMPLETED|Overall Study||0
8421585|NCT00902278|20755772|P3|NOT COMPLETED|Overall Study||5
8421586|NCT00902278|20755773|P2|NOT COMPLETED|Overall Study||2
8421587|NCT00902278|20755774|P1|NOT COMPLETED|Overall Study||4
8421588|NCT00902278|20755770|P5|COMPLETED|Overall Study||35
8421589|NCT00902278|20755771|P4|COMPLETED|Overall Study||12
8421590|NCT00902278|20755772|P3|COMPLETED|Overall Study||49
8421591|NCT00902278|20755773|P2|COMPLETED|Overall Study||34
8421592|NCT00902278|20755774|P1|COMPLETED|Overall Study||50
8421593|NCT00902278|20755770|P5|STARTED|Overall Study||37
8421594|NCT00902278|20755771|P4|STARTED|Overall Study||12
8421595|NCT00902278|20755772|P3|STARTED|Overall Study||54
8421596|NCT00902278|20755773|P2|STARTED|Overall Study||36
8421597|NCT00902278|20755774|P1|STARTED|Overall Study||54
8421598|NCT00902265|20755791|P1|NOT COMPLETED|Overall Study||6
8421599|NCT00902265|20755791|P1|COMPLETED|Overall Study||132
8421600|NCT00902265|20755791|P1|Participants Who Received Treatment|Overall Study||137
8421601|NCT00902265|20755791|P1|STARTED|Overall Study||138
8421602|NCT00902226|20755803|P1|NOT COMPLETED|Overall Study||0
8421603|NCT00902226|20755803|P1|COMPLETED|Overall Study||30
8421604|NCT00902226|20755803|P1|STARTED|Overall Study||30
8421605|NCT00902174|20755815|P2|NOT COMPLETED|Overall Study||18
8421606|NCT00902174|20755816|P1|NOT COMPLETED|Overall Study||34
8421607|NCT00902174|20755815|P2|COMPLETED|Overall Study||81
8421608|NCT00902174|20755816|P1|COMPLETED|Overall Study||69
8421609|NCT00902174|20755815|P2|STARTED|Overall Study||99
8421610|NCT00902174|20755816|P1|STARTED|Overall Study||103
8421611|NCT00902161|20755854|P3|NOT COMPLETED|Period 2||0
8421612|NCT00902161|20755855|P2|NOT COMPLETED|Period 2||0
8421613|NCT00902161|20755856|P1|NOT COMPLETED|Period 2||0
8421614|NCT00902161|20755854|P3|COMPLETED|Period 2||0
8421615|NCT00902161|20755855|P2|COMPLETED|Period 2||9
8421616|NCT00902161|20755856|P1|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
8421617|NCT00902161|20755854|P3|STARTED|Period 2||0
8421618|NCT00902161|20755855|P2|STARTED|Period 2||9
8421619|NCT00902161|20755856|P1|STARTED|Period 2||8
8421620|NCT00902161|20755854|P3|NOT COMPLETED|Post-clamp Washout||0
8421621|NCT00902161|20755855|P2|NOT COMPLETED|Post-clamp Washout||0
8421622|NCT00902161|20755856|P1|NOT COMPLETED|Post-clamp Washout||0
8421623|NCT00902161|20755854|P3|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
8421624|NCT00902161|20755855|P2|COMPLETED|Post-clamp Washout||0
8421625|NCT00902161|20755856|P1|COMPLETED|Post-clamp Washout||0
8421626|NCT00902161|20755854|P3|STARTED|Post-clamp Washout||22
8421627|NCT00902161|20755855|P2|STARTED|Post-clamp Washout||0
8421628|NCT00902161|20755856|P1|STARTED|Post-clamp Washout||0
8421629|NCT00902161|20755854|P3|NOT COMPLETED|Period 1||0
8421630|NCT00902161|20755855|P2|NOT COMPLETED|Period 1||0
8421631|NCT00902161|20755856|P1|NOT COMPLETED|Period 1||0
8421632|NCT00902161|20755854|P3|COMPLETED|Period 1||0
8421633|NCT00902161|20755855|P2|COMPLETED|Period 1||10
8421634|NCT00902161|20755856|P1|COMPLETED|Period 1||12
8421635|NCT00902161|20755854|P3|STARTED|Period 1||0
8421636|NCT00902161|20755855|P2|STARTED|Period 1||10
8421637|NCT00902161|20755856|P1|STARTED|Period 1||12
8421638|NCT00902161|20755854|P3|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
8421639|NCT00902161|20755855|P2|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
8421640|NCT00902161|20755856|P1|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
8421641|NCT00902161|20755854|P3|COMPLETED|Pre-study Washout/Propanolol Run-in||22
8421642|NCT00902161|20755855|P2|COMPLETED|Pre-study Washout/Propanolol Run-in||0
8421643|NCT00902161|20755856|P1|COMPLETED|Pre-study Washout/Propanolol Run-in||0
8421644|NCT00902161|20755854|P3|STARTED|Pre-study Washout/Propanolol Run-in||22
8421645|NCT00902161|20755855|P2|STARTED|Pre-study Washout/Propanolol Run-in||0
8421646|NCT00902161|20755856|P1|STARTED|Pre-study Washout/Propanolol Run-in||0
8421647|NCT00902018|20755874|P3|NOT COMPLETED|Overall Study||0
8421648|NCT00902018|20755875|P2|NOT COMPLETED|Overall Study||0
8421649|NCT00902018|20755876|P1|NOT COMPLETED|Overall Study||0
8421650|NCT00902018|20755874|P3|COMPLETED|Overall Study||10
8421651|NCT00902018|20755875|P2|COMPLETED|Overall Study||3
8421652|NCT00902018|20755876|P1|COMPLETED|Overall Study||7
8421653|NCT00902018|20755874|P3|STARTED|Overall Study||10
8421654|NCT00902018|20755875|P2|STARTED|Overall Study||3
8421655|NCT00902018|20755876|P1|STARTED|Overall Study||7
8421656|NCT00901927|20755891|P1|NOT COMPLETED|Overall Study||6
8421657|NCT00901927|20755891|P1|COMPLETED|Overall Study||8
8421658|NCT00901927|20755891|P1|STARTED|Overall Study||14
8421659|NCT00901901|20755899|P2|NOT COMPLETED|Follow-up Period||341
8421660|NCT00901901|20755900|P1|NOT COMPLETED|Follow-up Period||340
8421661|NCT00901901|20755899|P2|COMPLETED|Follow-up Period||0
8421662|NCT00901901|20755900|P1|COMPLETED|Follow-up Period||0
8421663|NCT00901901|20755899|P2|STARTED|Follow-up Period||341
8421664|NCT00901901|20755900|P1|STARTED|Follow-up Period||340
8421665|NCT00901901|20755899|P2|NOT COMPLETED|Treatment Period||177
8421666|NCT00901901|20755900|P1|NOT COMPLETED|Treatment Period||169
8421667|NCT00901901|20755899|P2|COMPLETED|Treatment Period||181
8421668|NCT00901901|20755900|P1|COMPLETED|Treatment Period||193
8421669|NCT00901901|20755899|P2|Participants Received Treatment|Treatment Period||355
8421670|NCT00901901|20755900|P1|Participants Received Treatment|Treatment Period||362
8421671|NCT00901901|20755899|P2|STARTED|Treatment Period||358
8421672|NCT00901901|20755900|P1|STARTED|Treatment Period||362
8421673|NCT00901628|20755922|P2|NOT COMPLETED|Overall Study||10
8421674|NCT00901628|20755923|P1|NOT COMPLETED|Overall Study||4
8421675|NCT00901628|20755922|P2|COMPLETED|Overall Study||42
8421676|NCT00901628|20755923|P1|COMPLETED|Overall Study||45
8421677|NCT00901628|20755922|P2|STARTED|Overall Study||52
8421678|NCT00901628|20755923|P1|STARTED|Overall Study||49
8421769|NCT00901459|20755971|P1|NOT COMPLETED|Overall Study||6
8421770|NCT00901459|20755971|P1|COMPLETED|Overall Study||15
8421771|NCT00901459|20755971|P1|STARTED|Overall Study||21
8421772|NCT00901394|20755985|P3|NOT COMPLETED|Overall Study||2
8421773|NCT00901394|20755986|P2|NOT COMPLETED|Overall Study||1
8421774|NCT00901394|20755987|P1|NOT COMPLETED|Overall Study||1
8421775|NCT00901394|20755985|P3|COMPLETED|Overall Study||20
8421776|NCT00901394|20755986|P2|COMPLETED|Overall Study||19
8421777|NCT00901394|20755987|P1|COMPLETED|Overall Study||20
8421778|NCT00901394|20755985|P3|STARTED|Overall Study||22
8421779|NCT00901394|20755986|P2|STARTED|Overall Study||20
8421780|NCT00901394|20755987|P1|STARTED|Overall Study||21
8421781|NCT00901342|20755995|P1|NOT COMPLETED|Overall Study||15
8421782|NCT00901342|20755995|P1|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
8421783|NCT00901342|20755995|P1|Received at Least 1 Infusion|Overall Study||98
8421784|NCT00901342|20755995|P1|STARTED|Overall Study||104
8421785|NCT00901316|20756001|P2|NOT COMPLETED|Overall Study||0
8421786|NCT00901316|20756002|P1|NOT COMPLETED|Overall Study||0
8421787|NCT00901316|20756001|P2|COMPLETED|Overall Study||495
8421788|NCT00901316|20756002|P1|COMPLETED|Overall Study||492
8421789|NCT00901316|20756001|P2|STARTED|Overall Study||495
8421790|NCT00901316|20756002|P1|STARTED|Overall Study||492
8421791|NCT00901303|20756010|P2|NOT COMPLETED|Overall Study||0
8421792|NCT00901303|20756011|P1|NOT COMPLETED|Overall Study||0
8421793|NCT00901303|20756010|P2|COMPLETED|Overall Study||1
8421794|NCT00901303|20756011|P1|COMPLETED|Overall Study||5
8421795|NCT00901303|20756010|P2|STARTED|Overall Study||1
8421796|NCT00901303|20756011|P1|STARTED|Overall Study||5
8421797|NCT00901225|20756017|P1|NOT COMPLETED|Overall Study||1
8421798|NCT00901225|20756017|P1|COMPLETED|Overall Study||20
8421799|NCT00901225|20756017|P1|STARTED|Overall Study||21
8421800|NCT00901186|20756028|P2|NOT COMPLETED|Overall Study||11
8421801|NCT00901186|20756029|P1|NOT COMPLETED|Overall Study||9
8421802|NCT00901186|20756028|P2|COMPLETED|Overall Study||32
8421803|NCT00901186|20756029|P1|COMPLETED|Overall Study||31
8421804|NCT00901186|20756028|P2|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
8421805|NCT00901186|20756029|P1|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
8421806|NCT00901186|20756028|P2|Safety Set|Overall Study||43
8421807|NCT00901186|20756029|P1|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
8421808|NCT00901186|20756028|P2|STARTED|Overall Study||43
8421809|NCT00901186|20756029|P1|STARTED|Overall Study||40
8421810|NCT00901017|20756045|P1|NOT COMPLETED|Overall Study||0
8421811|NCT00901017|20756045|P1|COMPLETED|Overall Study||14
8421812|NCT00901017|20756045|P1|STARTED|Overall Study||14
8421813|NCT00900822|20756059|P1|NOT COMPLETED|12 Months Clinical Evaluation||0
8421814|NCT00900822|20756059|P1|COMPLETED|12 Months Clinical Evaluation||11
8421815|NCT00900822|20756059|P1|STARTED|12 Months Clinical Evaluation||11
8421816|NCT00900822|20756059|P1|NOT COMPLETED|9 Months Histological Evaluation||0
8421817|NCT00900822|20756059|P1|COMPLETED|9 Months Histological Evaluation||11
8421818|NCT00900822|20756059|P1|STARTED|9 Months Histological Evaluation||11
8421819|NCT00900796|20756069|P1|NOT COMPLETED|Phase 2||5
8421820|NCT00900796|20756069|P1|COMPLETED|Phase 2||6
8421821|NCT00900796|20756069|P1|STARTED|Phase 2||11
8421822|NCT00900796|20756069|P1|NOT COMPLETED|Between Phase 1 and Phase 2||110
8421823|NCT00900796|20756069|P1|COMPLETED|Between Phase 1 and Phase 2||11
8421824|NCT00900796|20756069|P1|STARTED|Between Phase 1 and Phase 2||121
8421825|NCT00900796|20756069|P1|NOT COMPLETED|Phase 1||11
8421826|NCT00900796|20756069|P1|COMPLETED|Phase 1||121
8421827|NCT00900796|20756069|P1|STARTED|Phase 1||132
8421828|NCT00900757|20756079|P1|NOT COMPLETED|Overall Study||19
8421829|NCT00900757|20756079|P1|COMPLETED|Overall Study||38
8421830|NCT00900757|20756079|P1|STARTED|Overall Study||57
8421831|NCT00900731|20756089|P2|NOT COMPLETED|Overall Study||61
8421832|NCT00900731|20756090|P1|NOT COMPLETED|Overall Study||60
8421833|NCT00900731|20756089|P2|COMPLETED|Overall Study||740
8421834|NCT00900731|20756090|P1|COMPLETED|Overall Study||737
8421835|NCT00900731|20756089|P2|Safety Set: Received Study Drug|Overall Study||799
8421836|NCT00900731|20756090|P1|Safety Set: Received Study Drug|Overall Study||794
8421837|NCT00900731|20756089|P2|STARTED|Overall Study||801
8421838|NCT00900731|20756090|P1|STARTED|Overall Study|Randomized participants|797
8421839|NCT00900666|20756112|P2|NOT COMPLETED|Overall Study||0
8421840|NCT00900666|20756113|P1|NOT COMPLETED|Overall Study||0
8421841|NCT00900666|20756112|P2|COMPLETED|Overall Study||9
8421842|NCT00900666|20756113|P1|COMPLETED|Overall Study||10
8421843|NCT00900666|20756112|P2|STARTED|Overall Study||9
8421844|NCT00900666|20756113|P1|STARTED|Overall Study||10
8421845|NCT00900627|20756127|P6|NOT COMPLETED|Overall Study||26
8421846|NCT00900627|20756128|P5|NOT COMPLETED|Overall Study||29
8421847|NCT00900627|20756129|P4|NOT COMPLETED|Overall Study||6
8421848|NCT00900627|20756130|P3|NOT COMPLETED|Overall Study||6
8421849|NCT00900627|20756131|P2|NOT COMPLETED|Overall Study||2
8421850|NCT00900627|20756132|P1|NOT COMPLETED|Overall Study||6
8421851|NCT00900627|20756127|P6|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
8421852|NCT00900627|20756128|P5|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
8421853|NCT00900627|20756129|P4|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
8421854|NCT00900627|20756130|P3|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
8421855|NCT00900627|20756131|P2|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
8421856|NCT00900627|20756132|P1|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
8421857|NCT00900627|20756127|P6|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
8421858|NCT00900627|20756128|P5|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
8421859|NCT00900627|20756129|P4|STARTED|Overall Study||6
8421860|NCT00900627|20756130|P3|STARTED|Overall Study||6
8421861|NCT00900627|20756131|P2|STARTED|Overall Study||2
8421862|NCT00900627|20756132|P1|STARTED|Overall Study||6
8421863|NCT00900601|20756150|P1|NOT COMPLETED|Overall Study||1
8421864|NCT00900601|20756150|P1|COMPLETED|Overall Study||8
8421865|NCT00900601|20756150|P1|STARTED|Overall Study||9
8421866|NCT00900237|20756158|P2|NOT COMPLETED|Overall Study||0
8421867|NCT00900237|20756159|P1|NOT COMPLETED|Overall Study||0
8421868|NCT00900237|20756158|P2|COMPLETED|Overall Study||7
8421869|NCT00900237|20756159|P1|COMPLETED|Overall Study||7
8421870|NCT00900237|20756158|P2|STARTED|Overall Study||7
8421871|NCT00900237|20756159|P1|STARTED|Overall Study||7
8421872|NCT00900159|20756169|P2|NOT COMPLETED|Second Intervention||0
8421873|NCT00900159|20756170|P1|NOT COMPLETED|Second Intervention||1
8421874|NCT00900159|20756169|P2|COMPLETED|Second Intervention||13
8421875|NCT00900159|20756170|P1|COMPLETED|Second Intervention||10
8421876|NCT00900159|20756169|P2|STARTED|Second Intervention||13
8421877|NCT00900159|20756170|P1|STARTED|Second Intervention||11
8421878|NCT00900159|20756169|P2|NOT COMPLETED|Washout||0
8421879|NCT00900159|20756170|P1|NOT COMPLETED|Washout||0
8421880|NCT00900159|20756169|P2|COMPLETED|Washout||13
8421881|NCT00900159|20756170|P1|COMPLETED|Washout||11
8421882|NCT00900159|20756169|P2|STARTED|Washout||13
8421883|NCT00900159|20756170|P1|STARTED|Washout||11
8421884|NCT00900159|20756169|P2|NOT COMPLETED|First Intervention||0
8421885|NCT00900159|20756170|P1|NOT COMPLETED|First Intervention||0
8421886|NCT00900159|20756169|P2|COMPLETED|First Intervention||13
8421887|NCT00900159|20756170|P1|COMPLETED|First Intervention||11
8421888|NCT00900159|20756169|P2|STARTED|First Intervention||13
8421889|NCT00900159|20756170|P1|STARTED|First Intervention||11
8421890|NCT00900146|20756189|P5|NOT COMPLETED|Intermediate: Period III||167
8421891|NCT00900146|20756190|P4|NOT COMPLETED|Intermediate: Period III||90
8421892|NCT00900146|20756191|P3|NOT COMPLETED|Intermediate: Period III||84
8421893|NCT00900146|20756192|P2|NOT COMPLETED|Intermediate: Period III||93
8421894|NCT00900146|20756193|P1|NOT COMPLETED|Intermediate: Period III||87
8421895|NCT00900146|20756189|P5|COMPLETED|Intermediate: Period III||0
8421896|NCT00900146|20756190|P4|COMPLETED|Intermediate: Period III||0
8421897|NCT00900146|20756191|P3|COMPLETED|Intermediate: Period III||0
8421898|NCT00900146|20756192|P2|COMPLETED|Intermediate: Period III||0
8421899|NCT00900146|20756193|P1|COMPLETED|Intermediate: Period III||0
8421900|NCT00900146|20756189|P5|Safety Set|Intermediate: Period III||166
8421901|NCT00900146|20756190|P4|Safety Set|Intermediate: Period III||90
8421902|NCT00900146|20756191|P3|Safety Set|Intermediate: Period III||84
8421903|NCT00900146|20756192|P2|Safety Set|Intermediate: Period III||92
8421904|NCT00900146|20756193|P1|Safety Set|Intermediate: Period III||86
8421905|NCT00900146|20756189|P5|STARTED|Intermediate: Period III||167
8421906|NCT00900146|20756190|P4|STARTED|Intermediate: Period III||90
8421907|NCT00900146|20756191|P3|STARTED|Intermediate: Period III||84
8421908|NCT00900146|20756192|P2|STARTED|Intermediate: Period III||93
8421909|NCT00900146|20756193|P1|STARTED|Intermediate: Period III||87
8421910|NCT00900146|20756189|P5|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
8421911|NCT00900146|20756190|P4|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
8421912|NCT00900146|20756191|P3|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
8421913|NCT00900146|20756192|P2|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
8421914|NCT00900146|20756193|P1|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
8421915|NCT00900146|20756189|P5|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
8421916|NCT00900146|20756190|P4|COMPLETED|Dose Finding: Period II (4 Months)||90
8421917|NCT00900146|20756191|P3|COMPLETED|Dose Finding: Period II (4 Months)||87
8421918|NCT00900146|20756192|P2|COMPLETED|Dose Finding: Period II (4 Months)||93
8421919|NCT00900146|20756193|P1|COMPLETED|Dose Finding: Period II (4 Months)||88
8421920|NCT00900146|20756189|P5|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
8421921|NCT00900146|20756190|P4|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
8421922|NCT00900146|20756191|P3|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
8421923|NCT00900146|20756192|P2|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
8421924|NCT00900146|20756193|P1|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
8421925|NCT00900146|20756189|P5|STARTED|Dose Finding: Period II (4 Months)||179
8421926|NCT00900146|20756190|P4|STARTED|Dose Finding: Period II (4 Months)||92
8421927|NCT00900146|20756191|P3|STARTED|Dose Finding: Period II (4 Months)||92
8421928|NCT00900146|20756192|P2|STARTED|Dose Finding: Period II (4 Months)||95
8421929|NCT00900146|20756193|P1|STARTED|Dose Finding: Period II (4 Months)||93
8421930|NCT00900029|20756310|P5|NOT COMPLETED|Overall Study||6
8421931|NCT00900029|20756311|P4|NOT COMPLETED|Overall Study||7
8421932|NCT00900029|20756312|P3|NOT COMPLETED|Overall Study||3
8421933|NCT00900029|20756313|P2|NOT COMPLETED|Overall Study||4
8421934|NCT00900029|20756314|P1|NOT COMPLETED|Overall Study||3
8421935|NCT00900029|20756310|P5|COMPLETED|Overall Study||38
8421936|NCT00900029|20756311|P4|COMPLETED|Overall Study||35
8421937|NCT00900029|20756312|P3|COMPLETED|Overall Study||38
8421938|NCT00900029|20756313|P2|COMPLETED|Overall Study||37
8421939|NCT00900029|20756314|P1|COMPLETED|Overall Study||35
8421940|NCT00900029|20756310|P5|STARTED|Overall Study||44
8421941|NCT00900029|20756311|P4|STARTED|Overall Study||42
8421942|NCT00900029|20756312|P3|STARTED|Overall Study||41
8421943|NCT00900029|20756313|P2|STARTED|Overall Study||41
8421944|NCT00900029|20756314|P1|STARTED|Overall Study||38
8421945|NCT00899847|20756331|P1|NOT COMPLETED|Overall Study||2
8421946|NCT00899847|20756331|P1|COMPLETED|Overall Study||7
8421947|NCT00899847|20756331|P1|STARTED|Overall Study||9
8421948|NCT00899717|20756344|P2|NOT COMPLETED|Overall Study||0
8421949|NCT00899717|20756345|P1|NOT COMPLETED|Overall Study||0
8421950|NCT00899717|20756344|P2|COMPLETED|Overall Study||11
8421951|NCT00899717|20756345|P1|COMPLETED|Overall Study||10
8421952|NCT00899717|20756344|P2|STARTED|Overall Study||11
8421953|NCT00899717|20756345|P1|STARTED|Overall Study||10
8421954|NCT00899678|20756362|P3|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
8421955|NCT00899678|20756363|P2|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
8421956|NCT00899678|20756364|P1|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
8421957|NCT00899678|20756362|P3|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
8421958|NCT00899678|20756363|P2|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
8421959|NCT00899678|20756364|P1|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
8421960|NCT00899678|20756362|P3|STARTED|Maintenance Period (Weeks 8 to 62)||35
8421961|NCT00899678|20756363|P2|STARTED|Maintenance Period (Weeks 8 to 62)||37
8421962|NCT00899678|20756364|P1|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
8421963|NCT00899678|20756362|P3|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
8421964|NCT00899678|20756363|P2|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
8421965|NCT00899678|20756364|P1|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
8421966|NCT00899678|20756362|P3|COMPLETED|Induction Period (Weeks 0 to 6)||35
8421967|NCT00899678|20756363|P2|COMPLETED|Induction Period (Weeks 0 to 6)||37
8421968|NCT00899678|20756364|P1|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
8421969|NCT00899678|20756362|P3|STARTED|Induction Period (Weeks 0 to 6)||35
8421970|NCT00899678|20756363|P2|STARTED|Induction Period (Weeks 0 to 6)||37
8421971|NCT00899678|20756364|P1|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
8421972|NCT00899600|20756394|P2|NOT COMPLETED|Overall Study||0
8421973|NCT00899600|20756395|P1|NOT COMPLETED|Overall Study||0
8421974|NCT00899600|20756394|P2|COMPLETED|Overall Study||52
8421975|NCT00899600|20756395|P1|COMPLETED|Overall Study||50
8421976|NCT00899600|20756394|P2|STARTED|Overall Study||52
8421977|NCT00899600|20756395|P1|STARTED|Overall Study||50
8421978|NCT00899574|20756409|P1|NOT COMPLETED|Overall Study||0
8421979|NCT00899574|20756409|P1|COMPLETED|Overall Study||10
8421980|NCT00899574|20756409|P1|STARTED|Overall Study||10
8421981|NCT00899548|20756414|P1|NOT COMPLETED|Overall Study||3
8421982|NCT00899548|20756414|P1|COMPLETED|Overall Study||179
8421983|NCT00899548|20756414|P1|STARTED|Overall Study||182
8421984|NCT00899470|20756426|P4|NOT COMPLETED|Fourth Therapy||0
8421985|NCT00899470|20756427|P3|NOT COMPLETED|Fourth Therapy||0
8421986|NCT00899470|20756428|P2|NOT COMPLETED|Fourth Therapy||0
8421987|NCT00899470|20756429|P1|NOT COMPLETED|Fourth Therapy||0
8421988|NCT00899470|20756426|P4|COMPLETED|Fourth Therapy||6
8421989|NCT00899470|20756427|P3|COMPLETED|Fourth Therapy||6
8421990|NCT00899470|20756428|P2|COMPLETED|Fourth Therapy||6
8421991|NCT00899470|20756429|P1|COMPLETED|Fourth Therapy||6
8421992|NCT00899470|20756426|P4|STARTED|Fourth Therapy||6
8421993|NCT00899470|20756427|P3|STARTED|Fourth Therapy||6
8421994|NCT00899470|20756428|P2|STARTED|Fourth Therapy||6
8421995|NCT00899470|20756429|P1|STARTED|Fourth Therapy||6
8421996|NCT00899470|20756426|P4|NOT COMPLETED|Third Washout||0
8421997|NCT00899470|20756427|P3|NOT COMPLETED|Third Washout||0
8421998|NCT00899470|20756428|P2|NOT COMPLETED|Third Washout||0
8421999|NCT00899470|20756429|P1|NOT COMPLETED|Third Washout||0
8422000|NCT00899470|20756426|P4|COMPLETED|Third Washout||6
8422001|NCT00899470|20756427|P3|COMPLETED|Third Washout||6
8422002|NCT00899470|20756428|P2|COMPLETED|Third Washout||6
8422003|NCT00899470|20756429|P1|COMPLETED|Third Washout||6
8422004|NCT00899470|20756426|P4|STARTED|Third Washout||6
8422005|NCT00899470|20756427|P3|STARTED|Third Washout||6
8422006|NCT00899470|20756428|P2|STARTED|Third Washout||6
8422007|NCT00899470|20756429|P1|STARTED|Third Washout||6
8422008|NCT00899470|20756426|P4|NOT COMPLETED|Third Therapy||0
8422009|NCT00899470|20756427|P3|NOT COMPLETED|Third Therapy||0
8422010|NCT00899470|20756428|P2|NOT COMPLETED|Third Therapy||0
8422011|NCT00899470|20756429|P1|NOT COMPLETED|Third Therapy||0
8422012|NCT00899470|20756426|P4|COMPLETED|Third Therapy||6
8422013|NCT00899470|20756427|P3|COMPLETED|Third Therapy||6
8422014|NCT00899470|20756428|P2|COMPLETED|Third Therapy||6
8422015|NCT00899470|20756429|P1|COMPLETED|Third Therapy||6
8422016|NCT00899470|20756426|P4|STARTED|Third Therapy||6
8422017|NCT00899470|20756427|P3|STARTED|Third Therapy||6
8422018|NCT00899470|20756428|P2|STARTED|Third Therapy||6
8422019|NCT00899470|20756429|P1|STARTED|Third Therapy||6
8422020|NCT00899470|20756426|P4|NOT COMPLETED|Second Washout||0
8422021|NCT00899470|20756427|P3|NOT COMPLETED|Second Washout||0
8422022|NCT00899470|20756428|P2|NOT COMPLETED|Second Washout||0
8422023|NCT00899470|20756429|P1|NOT COMPLETED|Second Washout||0
8422024|NCT00899470|20756426|P4|COMPLETED|Second Washout||6
8422025|NCT00899470|20756427|P3|COMPLETED|Second Washout||6
8422026|NCT00899470|20756428|P2|COMPLETED|Second Washout||6
8422027|NCT00899470|20756429|P1|COMPLETED|Second Washout||6
8422028|NCT00899470|20756426|P4|STARTED|Second Washout||6
8422029|NCT00899470|20756427|P3|STARTED|Second Washout||6
8422030|NCT00899470|20756428|P2|STARTED|Second Washout||6
8422031|NCT00899470|20756429|P1|STARTED|Second Washout||6
8422032|NCT00899470|20756426|P4|NOT COMPLETED|Second Therapy||0
8422033|NCT00899470|20756427|P3|NOT COMPLETED|Second Therapy||0
8422034|NCT00899470|20756428|P2|NOT COMPLETED|Second Therapy||0
8422035|NCT00899470|20756429|P1|NOT COMPLETED|Second Therapy||0
8422036|NCT00899470|20756426|P4|COMPLETED|Second Therapy||6
8422037|NCT00899470|20756427|P3|COMPLETED|Second Therapy||6
8422038|NCT00899470|20756428|P2|COMPLETED|Second Therapy||6
8422039|NCT00899470|20756429|P1|COMPLETED|Second Therapy||6
8422040|NCT00899470|20756426|P4|STARTED|Second Therapy||6
8422041|NCT00899470|20756427|P3|STARTED|Second Therapy||6
8422042|NCT00899470|20756428|P2|STARTED|Second Therapy||6
8422043|NCT00899470|20756429|P1|STARTED|Second Therapy||6
8422044|NCT00899470|20756426|P4|NOT COMPLETED|First Washout Period||0
8422045|NCT00899470|20756427|P3|NOT COMPLETED|First Washout Period||0
8422046|NCT00899470|20756428|P2|NOT COMPLETED|First Washout Period||0
8422047|NCT00899470|20756429|P1|NOT COMPLETED|First Washout Period||0
8422048|NCT00899470|20756426|P4|COMPLETED|First Washout Period||6
8422049|NCT00899470|20756427|P3|COMPLETED|First Washout Period||6
8422050|NCT00899470|20756428|P2|COMPLETED|First Washout Period||6
8422051|NCT00899470|20756429|P1|COMPLETED|First Washout Period||6
8422052|NCT00899470|20756426|P4|STARTED|First Washout Period||6
8422053|NCT00899470|20756427|P3|STARTED|First Washout Period||6
8422054|NCT00899470|20756428|P2|STARTED|First Washout Period||6
8422055|NCT00899470|20756429|P1|STARTED|First Washout Period||6
8422056|NCT00899470|20756426|P4|NOT COMPLETED|First Therapy||0
8422057|NCT00899470|20756427|P3|NOT COMPLETED|First Therapy||0
8422058|NCT00899470|20756428|P2|NOT COMPLETED|First Therapy||0
8422059|NCT00899470|20756429|P1|NOT COMPLETED|First Therapy||0
8422060|NCT00899470|20756426|P4|COMPLETED|First Therapy||6
8422061|NCT00899470|20756427|P3|COMPLETED|First Therapy||6
8422062|NCT00899470|20756428|P2|COMPLETED|First Therapy||6
8422063|NCT00899470|20756429|P1|COMPLETED|First Therapy||6
8422064|NCT00899470|20756426|P4|STARTED|First Therapy||6
8422065|NCT00899470|20756427|P3|STARTED|First Therapy||6
8422066|NCT00899470|20756428|P2|STARTED|First Therapy||6
8422067|NCT00899470|20756429|P1|STARTED|First Therapy||6
8422068|NCT00899431|20756508|P3|NOT COMPLETED|Overall Study||0
8422069|NCT00899431|20756509|P2|NOT COMPLETED|Overall Study||0
8422070|NCT00899431|20756510|P1|NOT COMPLETED|Overall Study||1
8422071|NCT00899431|20756508|P3|COMPLETED|Overall Study||9
8422072|NCT00899431|20756509|P2|COMPLETED|Overall Study||8
8422073|NCT00899431|20756510|P1|COMPLETED|Overall Study||21
8422074|NCT00899431|20756508|P3|STARTED|Overall Study||9
8422075|NCT00899431|20756509|P2|STARTED|Overall Study||8
8422076|NCT00899431|20756510|P1|STARTED|Overall Study||22
8422077|NCT00899392|20756523|P2|NOT COMPLETED|Overall Study||24
8422078|NCT00899392|20756524|P1|NOT COMPLETED|Overall Study||21
8422079|NCT00899392|20756523|P2|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
8422080|NCT00899392|20756524|P1|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
8422081|NCT00899392|20756523|P2|STARTED|Overall Study||74
8422082|NCT00899392|20756524|P1|STARTED|Overall Study||68
8422083|NCT00899379|20756541|P5|NOT COMPLETED|Overall Study||31
8422084|NCT00899379|20756542|P4|NOT COMPLETED|Overall Study||37
8422085|NCT00899379|20756543|P3|NOT COMPLETED|Overall Study||29
8422086|NCT00899379|20756544|P2|NOT COMPLETED|Overall Study||29
8422087|NCT00899379|20756545|P1|NOT COMPLETED|Overall Study||34
8422088|NCT00899379|20756541|P5|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
8422089|NCT00899379|20756542|P4|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
8422090|NCT00899379|20756543|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
8422091|NCT00899379|20756544|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
8422092|NCT00899379|20756545|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
8422093|NCT00899379|20756541|P5|Patients Not Treated|Overall Study|Patients who did not take study drug|13
8422094|NCT00899379|20756542|P4|Patients Not Treated|Overall Study|Patients who did not take study drug|17
8422095|NCT00899379|20756543|P3|Patients Not Treated|Overall Study|Patients who did not take study drug|11
8422096|NCT00899379|20756544|P2|Patients Not Treated|Overall Study|Patients who did not take study drug|13
8422097|NCT00899379|20756545|P1|Patients Not Treated|Overall Study|Patients who did not take study drug|12
8422098|NCT00899379|20756541|P5|Patients Treated|Overall Study|Patients who took study drug|81
8422099|NCT00899379|20756542|P4|Patients Treated|Overall Study|Patients who took study drug|77
8422100|NCT00899379|20756543|P3|Patients Treated|Overall Study|Patients who took study drug|84
8422101|NCT00899379|20756544|P2|Patients Treated|Overall Study|Patients who took study drug|82
8422102|NCT00899379|20756545|P1|Patients Treated|Overall Study|Patients who took study drug|83
8422103|NCT00899379|20756541|P5|STARTED|Overall Study|Patients who were allocated study drug|94
8422104|NCT00899379|20756542|P4|STARTED|Overall Study|Patients who were allocated study drug|94
8422105|NCT00899379|20756543|P3|STARTED|Overall Study|Patients who were allocated study drug|95
8422106|NCT00899379|20756544|P2|STARTED|Overall Study|Patients who were allocated study drug|95
8422107|NCT00899379|20756545|P1|STARTED|Overall Study|Patients who were allocated study drug|95
8422108|NCT00899353|20756557|P1|NOT COMPLETED|Overall Study||5
8422109|NCT00899353|20756557|P1|COMPLETED|Overall Study||11
8422110|NCT00899353|20756557|P1|STARTED|Overall Study||16
8422111|NCT00898937|20756581|P3|NOT COMPLETED|Overall Study||0
8422112|NCT00898937|20756582|P2|NOT COMPLETED|Overall Study||0
8422113|NCT00898937|20756583|P1|NOT COMPLETED|Overall Study||0
8422114|NCT00898937|20756581|P3|COMPLETED|Overall Study||9
8422115|NCT00898937|20756582|P2|COMPLETED|Overall Study||21
8422116|NCT00898937|20756583|P1|COMPLETED|Overall Study||25
8422117|NCT00898937|20756581|P3|STARTED|Overall Study||9
8422118|NCT00898937|20756582|P2|STARTED|Overall Study||21
8422119|NCT00898937|20756583|P1|STARTED|Overall Study||25
8422120|NCT00898807|20756593|P2|NOT COMPLETED|Overall Study||9
8422121|NCT00898807|20756594|P1|NOT COMPLETED|Overall Study||8
8422122|NCT00898807|20756593|P2|COMPLETED|Overall Study||83
8422123|NCT00898807|20756594|P1|COMPLETED|Overall Study||86
8422124|NCT00898807|20756593|P2|STARTED|Overall Study||92
8422125|NCT00898807|20756594|P1|STARTED|Overall Study||94
8422126|NCT00898677|20756610|P4|NOT COMPLETED|Overall Study||19
8422127|NCT00898677|20756611|P3|NOT COMPLETED|Overall Study||72
8422128|NCT00898677|20756612|P2|NOT COMPLETED|Overall Study||69
8422129|NCT00898677|20756613|P1|NOT COMPLETED|Overall Study||17
8422130|NCT00898677|20756610|P4|COMPLETED|Overall Study||159
8422131|NCT00898677|20756611|P3|COMPLETED|Overall Study||383
8422132|NCT00898677|20756612|P2|COMPLETED|Overall Study||386
8422133|NCT00898677|20756613|P1|COMPLETED|Overall Study||163
8422134|NCT00898677|20756610|P4|Patients Treated|Overall Study|Patients Not Treated: 18|160
8422135|NCT00898677|20756611|P3|Patients Treated|Overall Study|Patients Not Treated: 67|388
8422136|NCT00898677|20756612|P2|Patients Treated|Overall Study|Patients Not Treated: 68|387
8422137|NCT00898677|20756613|P1|Patients Treated|Overall Study|Patients Not Treated: 16|164
8422138|NCT00898677|20756610|P4|STARTED|Overall Study||178
8422139|NCT00898677|20756611|P3|STARTED|Overall Study||455
8422140|NCT00898677|20756612|P2|STARTED|Overall Study||455
8422141|NCT00898677|20756613|P1|STARTED|Overall Study||180
8422142|NCT00898560|20756639|P1|NOT COMPLETED|Overall Study||1
8422143|NCT00898560|20756639|P1|COMPLETED|Overall Study||19
8422144|NCT00898560|20756639|P1|STARTED|Overall Study||20
8422145|NCT00898443|20756651|P2|NOT COMPLETED|Overall Study||0
8422146|NCT00898443|20756652|P1|NOT COMPLETED|Overall Study||1
8422147|NCT00898443|20756651|P2|COMPLETED|Overall Study||8
8422148|NCT00898443|20756652|P1|COMPLETED|Overall Study||9
8422149|NCT00898443|20756651|P2|STARTED|Overall Study||8
8422150|NCT00898443|20756652|P1|STARTED|Overall Study||10
8422151|NCT00898222|20756660|P1|NOT COMPLETED|Overall Study||0
8422152|NCT00898222|20756660|P1|COMPLETED|Overall Study||4
8422153|NCT00898222|20756660|P1|STARTED|Overall Study||4
8422154|NCT00897949|20756667|P3|NOT COMPLETED|Overall Study||69
8422155|NCT00897949|20756668|P2|NOT COMPLETED|Overall Study||103
8422156|NCT00897949|20756669|P1|NOT COMPLETED|Overall Study||104
8422157|NCT00897949|20756667|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
8422158|NCT00897949|20756668|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
8422159|NCT00897949|20756669|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
8422160|NCT00897949|20756667|P3|Patients Treated|Overall Study|Patients who took study drug|304
8422161|NCT00897949|20756668|P2|Patients Treated|Overall Study|Patients who took study drug|456
8422162|NCT00897949|20756669|P1|Patients Treated|Overall Study|Patients who took study drug|458
8422163|NCT00897949|20756667|P3|STARTED|Overall Study|Patients who were allocated study drug|370
8422164|NCT00897949|20756668|P2|STARTED|Overall Study|Patients who were allocated study drug|549
8422165|NCT00897949|20756669|P1|STARTED|Overall Study|Patients who were allocated study drug|554
8422166|NCT00897910|20756692|P1|NOT COMPLETED|Overall Study||0
8422167|NCT00897910|20756692|P1|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
8422168|NCT00897910|20756692|P1|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
8422169|NCT00897897|20756696|P1|NOT COMPLETED|Overall Study||0
8422170|NCT00897897|20756696|P1|COMPLETED|Overall Study||33
8422171|NCT00897897|20756696|P1|STARTED|Overall Study||33
8422172|NCT00897715|20756703|P2|NOT COMPLETED|Overall Study||1
8422173|NCT00897715|20756704|P1|NOT COMPLETED|Overall Study||2
8422174|NCT00897715|20756703|P2|COMPLETED|Overall Study||6
8422175|NCT00897715|20756704|P1|COMPLETED|Overall Study||6
8422176|NCT00897715|20756703|P2|STARTED|Overall Study||7
8422177|NCT00897715|20756704|P1|STARTED|Overall Study||8
8422178|NCT00897676|20756712|P2|NOT COMPLETED|Intervention 2(6 Hours)||0
8422179|NCT00897676|20756713|P1|NOT COMPLETED|Intervention 2(6 Hours)||0
8422180|NCT00897676|20756712|P2|COMPLETED|Intervention 2(6 Hours)||7
8422181|NCT00897676|20756713|P1|COMPLETED|Intervention 2(6 Hours)||9
8422182|NCT00897676|20756712|P2|STARTED|Intervention 2(6 Hours)||7
8422183|NCT00897676|20756713|P1|STARTED|Intervention 2(6 Hours)||9
8422184|NCT00897676|20756712|P2|NOT COMPLETED|Intervention 1(6 Hours)||0
8422185|NCT00897676|20756713|P1|NOT COMPLETED|Intervention 1(6 Hours)||0
8422186|NCT00897676|20756712|P2|COMPLETED|Intervention 1(6 Hours)||7
8422187|NCT00897676|20756713|P1|COMPLETED|Intervention 1(6 Hours)||9
8422188|NCT00897676|20756712|P2|STARTED|Intervention 1(6 Hours)||7
8422189|NCT00897676|20756713|P1|STARTED|Intervention 1(6 Hours)||9
8422190|NCT00897390|20756729|P1|NOT COMPLETED|Overall Study||6
8422191|NCT00897390|20756729|P1|COMPLETED|Overall Study||18
8422192|NCT00897390|20756729|P1|STARTED|Overall Study||24
8422193|NCT00897104|20756819|P3|NOT COMPLETED|Overall Study||8
8422194|NCT00897104|20756820|P2|NOT COMPLETED|Overall Study||71
8422195|NCT00897104|20756821|P1|NOT COMPLETED|Overall Study||64
8422196|NCT00897104|20756819|P3|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
8422197|NCT00897104|20756820|P2|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
8422198|NCT00897104|20756821|P1|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
8422199|NCT00897104|20756819|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|7
8422200|NCT00897104|20756820|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|71
8422201|NCT00897104|20756821|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|63
8422202|NCT00897104|20756819|P3|Participants Treated|Overall Study|Participants who took study drug|80
8422203|NCT00897104|20756820|P2|Participants Treated|Overall Study|Participants who took study drug|357
8422204|NCT00897104|20756821|P1|Participants Treated|Overall Study|Participants who took study drug|355
8422205|NCT00897104|20756819|P3|STARTED|Overall Study|Participants who were allocated study drug|87
8422206|NCT00897104|20756820|P2|STARTED|Overall Study|Participants who were allocated study drug|428
8422207|NCT00897104|20756821|P1|STARTED|Overall Study|Participants who were allocated study drug|418
8422208|NCT00896779|20756849|P2|NOT COMPLETED|Overall Study||1
8422209|NCT00896779|20756850|P1|NOT COMPLETED|Overall Study||0
8422210|NCT00896779|20756849|P2|COMPLETED|Overall Study||11
8422211|NCT00896779|20756850|P1|COMPLETED|Overall Study||8
8422212|NCT00896779|20756849|P2|STARTED|Overall Study||12
8422213|NCT00896779|20756850|P1|STARTED|Overall Study||8
8422214|NCT00896649|20756856|P1|NOT COMPLETED|Overall Study||5
8422215|NCT00896649|20756856|P1|COMPLETED|Overall Study||188
8422216|NCT00896649|20756856|P1|STARTED|Overall Study||193
8422217|NCT00896532|20756869|P23|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422218|NCT00896532|20756870|P22|NOT COMPLETED|Months 48-72: Follow-on Phase||2
8422219|NCT00896532|20756871|P21|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422220|NCT00896532|20756872|P20|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422221|NCT00896532|20756873|P19|NOT COMPLETED|Months 48-72: Follow-on Phase||1
8422222|NCT00896532|20756874|P18|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422223|NCT00896532|20756875|P17|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422224|NCT00896532|20756876|P16|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422225|NCT00896532|20756877|P15|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422226|NCT00896532|20756878|P14|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422227|NCT00896532|20756879|P13|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422228|NCT00896532|20756880|P12|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422229|NCT00896532|20756881|P11|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422230|NCT00896532|20756882|P10|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422231|NCT00896532|20756883|P9|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422232|NCT00896532|20756884|P8|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422233|NCT00896532|20756885|P7|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422234|NCT00896532|20756886|P6|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422235|NCT00896532|20756887|P5|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422236|NCT00896532|20756888|P4|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422237|NCT00896532|20756889|P3|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422238|NCT00896532|20756890|P2|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422239|NCT00896532|20756891|P1|NOT COMPLETED|Months 48-72: Follow-on Phase||0
8422240|NCT00896532|20756869|P23|COMPLETED|Months 48-72: Follow-on Phase||8
8422241|NCT00896532|20756870|P22|COMPLETED|Months 48-72: Follow-on Phase||57
8422242|NCT00896532|20756871|P21|COMPLETED|Months 48-72: Follow-on Phase||12
8422243|NCT00896532|20756872|P20|COMPLETED|Months 48-72: Follow-on Phase||11
8422244|NCT00896532|20756873|P19|COMPLETED|Months 48-72: Follow-on Phase||50
8422245|NCT00896532|20756874|P18|COMPLETED|Months 48-72: Follow-on Phase||0
8422246|NCT00896532|20756875|P17|COMPLETED|Months 48-72: Follow-on Phase||0
8422247|NCT00896532|20756876|P16|COMPLETED|Months 48-72: Follow-on Phase||0
8422248|NCT00896532|20756877|P15|COMPLETED|Months 48-72: Follow-on Phase||0
8422249|NCT00896532|20756878|P14|COMPLETED|Months 48-72: Follow-on Phase||0
8422250|NCT00896532|20756879|P13|COMPLETED|Months 48-72: Follow-on Phase||0
8422251|NCT00896532|20756880|P12|COMPLETED|Months 48-72: Follow-on Phase||0
8422252|NCT00896532|20756881|P11|COMPLETED|Months 48-72: Follow-on Phase||0
8422253|NCT00896532|20756882|P10|COMPLETED|Months 48-72: Follow-on Phase||0
8422254|NCT00896532|20756883|P9|COMPLETED|Months 48-72: Follow-on Phase||0
8422255|NCT00896532|20756884|P8|COMPLETED|Months 48-72: Follow-on Phase||0
8422256|NCT00896532|20756885|P7|COMPLETED|Months 48-72: Follow-on Phase||0
8422257|NCT00896532|20756886|P6|COMPLETED|Months 48-72: Follow-on Phase||0
8422258|NCT00896532|20756887|P5|COMPLETED|Months 48-72: Follow-on Phase||0
8422259|NCT00896532|20756888|P4|COMPLETED|Months 48-72: Follow-on Phase||0
8422260|NCT00896532|20756889|P3|COMPLETED|Months 48-72: Follow-on Phase||0
8422261|NCT00896532|20756890|P2|COMPLETED|Months 48-72: Follow-on Phase||0
8422262|NCT00896532|20756891|P1|COMPLETED|Months 48-72: Follow-on Phase||0
8422263|NCT00896532|20756869|P23|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
8422264|NCT00896532|20756870|P22|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
8422265|NCT00896532|20756871|P21|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
8422266|NCT00896532|20756872|P20|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
8422267|NCT00896532|20756873|P19|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422268|NCT00896532|20756874|P18|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422269|NCT00896532|20756875|P17|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422270|NCT00896532|20756876|P16|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422271|NCT00896532|20756877|P15|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422272|NCT00896532|20756878|P14|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422273|NCT00896532|20756879|P13|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422274|NCT00896532|20756880|P12|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422275|NCT00896532|20756881|P11|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422276|NCT00896532|20756882|P10|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422277|NCT00896532|20756883|P9|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422278|NCT00896532|20756884|P8|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422279|NCT00896532|20756885|P7|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422280|NCT00896532|20756886|P6|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422281|NCT00896532|20756887|P5|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422282|NCT00896532|20756888|P4|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422283|NCT00896532|20756889|P3|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422284|NCT00896532|20756890|P2|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422285|NCT00896532|20756891|P1|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
8422286|NCT00896532|20756869|P23|STARTED|Months 48-72: Follow-on Phase||8
8422287|NCT00896532|20756870|P22|STARTED|Months 48-72: Follow-on Phase||59
8422288|NCT00896532|20756871|P21|STARTED|Months 48-72: Follow-on Phase||12
8422289|NCT00896532|20756872|P20|STARTED|Months 48-72: Follow-on Phase||11
8422290|NCT00896532|20756873|P19|STARTED|Months 48-72: Follow-on Phase||51
8422291|NCT00896532|20756874|P18|STARTED|Months 48-72: Follow-on Phase||0
8422292|NCT00896532|20756875|P17|STARTED|Months 48-72: Follow-on Phase||0
8422293|NCT00896532|20756876|P16|STARTED|Months 48-72: Follow-on Phase||0
8422294|NCT00896532|20756877|P15|STARTED|Months 48-72: Follow-on Phase||0
8422295|NCT00896532|20756878|P14|STARTED|Months 48-72: Follow-on Phase||0
8422296|NCT00896532|20756879|P13|STARTED|Months 48-72: Follow-on Phase||0
8422297|NCT00896532|20756880|P12|STARTED|Months 48-72: Follow-on Phase||0
8422298|NCT00896532|20756881|P11|STARTED|Months 48-72: Follow-on Phase||0
8422299|NCT00896532|20756882|P10|STARTED|Months 48-72: Follow-on Phase||0
8422300|NCT00896532|20756883|P9|STARTED|Months 48-72: Follow-on Phase||0
8422301|NCT00896532|20756884|P8|STARTED|Months 48-72: Follow-on Phase||0
8422302|NCT00896532|20756885|P7|STARTED|Months 48-72: Follow-on Phase||0
8422303|NCT00896532|20756886|P6|STARTED|Months 48-72: Follow-on Phase||0
8422304|NCT00896532|20756887|P5|STARTED|Months 48-72: Follow-on Phase||0
8422305|NCT00896532|20756888|P4|STARTED|Months 48-72: Follow-on Phase||0
8422306|NCT00896532|20756889|P3|STARTED|Months 48-72: Follow-on Phase||0
8422307|NCT00896532|20756890|P2|STARTED|Months 48-72: Follow-on Phase||0
8422308|NCT00896532|20756891|P1|STARTED|Months 48-72: Follow-on Phase||0
8422309|NCT00896532|20756869|P23|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422310|NCT00896532|20756870|P22|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422311|NCT00896532|20756871|P21|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422312|NCT00896532|20756872|P20|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422313|NCT00896532|20756873|P19|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422314|NCT00896532|20756874|P18|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
8422315|NCT00896532|20756875|P17|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
8422316|NCT00896532|20756876|P16|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
8422317|NCT00896532|20756877|P15|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422318|NCT00896532|20756878|P14|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422319|NCT00896532|20756879|P13|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422320|NCT00896532|20756880|P12|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422321|NCT00896532|20756881|P11|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422322|NCT00896532|20756882|P10|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422323|NCT00896532|20756883|P9|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422324|NCT00896532|20756884|P8|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422325|NCT00896532|20756885|P7|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422326|NCT00896532|20756886|P6|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422327|NCT00896532|20756887|P5|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422328|NCT00896532|20756888|P4|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422329|NCT00896532|20756889|P3|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422330|NCT00896532|20756890|P2|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422331|NCT00896532|20756891|P1|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422332|NCT00896532|20756869|P23|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422333|NCT00896532|20756870|P22|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422334|NCT00896532|20756871|P21|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422335|NCT00896532|20756872|P20|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422336|NCT00896532|20756873|P19|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422337|NCT00896532|20756874|P18|COMPLETED|Months 36-48: Romosozumab Retreatment||64
8422338|NCT00896532|20756875|P17|COMPLETED|Months 36-48: Romosozumab Retreatment||65
8422339|NCT00896532|20756876|P16|COMPLETED|Months 36-48: Romosozumab Retreatment||14
8422340|NCT00896532|20756877|P15|COMPLETED|Months 36-48: Romosozumab Retreatment||12
8422341|NCT00896532|20756878|P14|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422342|NCT00896532|20756879|P13|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422343|NCT00896532|20756880|P12|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422344|NCT00896532|20756881|P11|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422345|NCT00896532|20756882|P10|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422346|NCT00896532|20756883|P9|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422347|NCT00896532|20756884|P8|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422348|NCT00896532|20756885|P7|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422349|NCT00896532|20756886|P6|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422350|NCT00896532|20756887|P5|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422351|NCT00896532|20756888|P4|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422352|NCT00896532|20756889|P3|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422353|NCT00896532|20756890|P2|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422354|NCT00896532|20756891|P1|COMPLETED|Months 36-48: Romosozumab Retreatment||0
8422355|NCT00896532|20756869|P23|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422356|NCT00896532|20756870|P22|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422357|NCT00896532|20756871|P21|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422358|NCT00896532|20756872|P20|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422359|NCT00896532|20756873|P19|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422360|NCT00896532|20756874|P18|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
8422361|NCT00896532|20756875|P17|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
8422362|NCT00896532|20756876|P16|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
8422363|NCT00896532|20756877|P15|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
8422364|NCT00896532|20756878|P14|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422365|NCT00896532|20756879|P13|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422366|NCT00896532|20756880|P12|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422367|NCT00896532|20756881|P11|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422368|NCT00896532|20756882|P10|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422369|NCT00896532|20756883|P9|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422370|NCT00896532|20756884|P8|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422371|NCT00896532|20756885|P7|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422372|NCT00896532|20756886|P6|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422373|NCT00896532|20756887|P5|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422374|NCT00896532|20756888|P4|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422375|NCT00896532|20756889|P3|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422376|NCT00896532|20756890|P2|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422377|NCT00896532|20756891|P1|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
8422378|NCT00896532|20756869|P23|STARTED|Months 36-48: Romosozumab Retreatment||0
8422379|NCT00896532|20756870|P22|STARTED|Months 36-48: Romosozumab Retreatment||0
8422380|NCT00896532|20756871|P21|STARTED|Months 36-48: Romosozumab Retreatment||0
8422381|NCT00896532|20756872|P20|STARTED|Months 36-48: Romosozumab Retreatment||0
8422382|NCT00896532|20756873|P19|STARTED|Months 36-48: Romosozumab Retreatment||0
8422383|NCT00896532|20756874|P18|STARTED|Months 36-48: Romosozumab Retreatment||67
8422384|NCT00896532|20756875|P17|STARTED|Months 36-48: Romosozumab Retreatment||72
8422385|NCT00896532|20756876|P16|STARTED|Months 36-48: Romosozumab Retreatment||16
8422386|NCT00896532|20756877|P15|STARTED|Months 36-48: Romosozumab Retreatment||12
8422387|NCT00896532|20756878|P14|STARTED|Months 36-48: Romosozumab Retreatment||0
8422388|NCT00896532|20756879|P13|STARTED|Months 36-48: Romosozumab Retreatment||0
8422389|NCT00896532|20756880|P12|STARTED|Months 36-48: Romosozumab Retreatment||0
8422390|NCT00896532|20756881|P11|STARTED|Months 36-48: Romosozumab Retreatment||0
8422391|NCT00896532|20756882|P10|STARTED|Months 36-48: Romosozumab Retreatment||0
8422392|NCT00896532|20756883|P9|STARTED|Months 36-48: Romosozumab Retreatment||0
8422393|NCT00896532|20756884|P8|STARTED|Months 36-48: Romosozumab Retreatment||0
8422394|NCT00896532|20756885|P7|STARTED|Months 36-48: Romosozumab Retreatment||0
8422395|NCT00896532|20756886|P6|STARTED|Months 36-48: Romosozumab Retreatment||0
8422396|NCT00896532|20756887|P5|STARTED|Months 36-48: Romosozumab Retreatment||0
8422397|NCT00896532|20756888|P4|STARTED|Months 36-48: Romosozumab Retreatment||0
8422398|NCT00896532|20756889|P3|STARTED|Months 36-48: Romosozumab Retreatment||0
8422399|NCT00896532|20756890|P2|STARTED|Months 36-48: Romosozumab Retreatment||0
8422400|NCT00896532|20756891|P1|STARTED|Months 36-48: Romosozumab Retreatment||0
8422401|NCT00896532|20756869|P23|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422402|NCT00896532|20756870|P22|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422403|NCT00896532|20756871|P21|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422404|NCT00896532|20756872|P20|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422405|NCT00896532|20756873|P19|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422406|NCT00896532|20756874|P18|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422407|NCT00896532|20756875|P17|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422408|NCT00896532|20756876|P16|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422409|NCT00896532|20756877|P15|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422410|NCT00896532|20756878|P14|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
8422411|NCT00896532|20756879|P13|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
8422412|NCT00896532|20756880|P12|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
8422413|NCT00896532|20756881|P11|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
8422414|NCT00896532|20756882|P10|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422415|NCT00896532|20756883|P9|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
8422416|NCT00896532|20756884|P8|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422417|NCT00896532|20756885|P7|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422418|NCT00896532|20756886|P6|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422419|NCT00896532|20756887|P5|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422420|NCT00896532|20756888|P4|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422421|NCT00896532|20756889|P3|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422422|NCT00896532|20756890|P2|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422423|NCT00896532|20756891|P1|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422424|NCT00896532|20756869|P23|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422425|NCT00896532|20756870|P22|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422426|NCT00896532|20756871|P21|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422427|NCT00896532|20756872|P20|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422428|NCT00896532|20756873|P19|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422429|NCT00896532|20756874|P18|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422430|NCT00896532|20756875|P17|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422431|NCT00896532|20756876|P16|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422432|NCT00896532|20756877|P15|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422433|NCT00896532|20756878|P14|COMPLETED|Months 24-36: Denosumab Extension Phase||88
8422434|NCT00896532|20756879|P13|COMPLETED|Months 24-36: Denosumab Extension Phase||88
8422435|NCT00896532|20756880|P12|COMPLETED|Months 24-36: Denosumab Extension Phase||19
8422436|NCT00896532|20756881|P11|COMPLETED|Months 24-36: Denosumab Extension Phase||18
8422437|NCT00896532|20756882|P10|COMPLETED|Months 24-36: Denosumab Extension Phase||18
8422438|NCT00896532|20756883|P9|COMPLETED|Months 24-36: Denosumab Extension Phase||17
8422439|NCT00896532|20756884|P8|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422440|NCT00896532|20756885|P7|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422441|NCT00896532|20756886|P6|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422442|NCT00896532|20756887|P5|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422443|NCT00896532|20756888|P4|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422444|NCT00896532|20756889|P3|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422445|NCT00896532|20756890|P2|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422446|NCT00896532|20756891|P1|COMPLETED|Months 24-36: Denosumab Extension Phase||0
8422447|NCT00896532|20756869|P23|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422448|NCT00896532|20756870|P22|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422449|NCT00896532|20756871|P21|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422450|NCT00896532|20756872|P20|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422451|NCT00896532|20756873|P19|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422452|NCT00896532|20756874|P18|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422453|NCT00896532|20756875|P17|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422454|NCT00896532|20756876|P16|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422455|NCT00896532|20756877|P15|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422456|NCT00896532|20756878|P14|Received Treatment|Months 24-36: Denosumab Extension Phase||88
8422457|NCT00896532|20756879|P13|Received Treatment|Months 24-36: Denosumab Extension Phase||90
8422458|NCT00896532|20756880|P12|Received Treatment|Months 24-36: Denosumab Extension Phase||19
8422459|NCT00896532|20756881|P11|Received Treatment|Months 24-36: Denosumab Extension Phase||19
8422460|NCT00896532|20756882|P10|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
8422461|NCT00896532|20756883|P9|Received Treatment|Months 24-36: Denosumab Extension Phase||18
8422462|NCT00896532|20756884|P8|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422463|NCT00896532|20756885|P7|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422464|NCT00896532|20756886|P6|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422465|NCT00896532|20756887|P5|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422466|NCT00896532|20756888|P4|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422467|NCT00896532|20756889|P3|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422468|NCT00896532|20756890|P2|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422469|NCT00896532|20756891|P1|Received Treatment|Months 24-36: Denosumab Extension Phase||0
8422470|NCT00896532|20756869|P23|STARTED|Months 24-36: Denosumab Extension Phase||0
8422471|NCT00896532|20756870|P22|STARTED|Months 24-36: Denosumab Extension Phase||0
8422472|NCT00896532|20756871|P21|STARTED|Months 24-36: Denosumab Extension Phase||0
8422473|NCT00896532|20756872|P20|STARTED|Months 24-36: Denosumab Extension Phase||0
8422474|NCT00896532|20756873|P19|STARTED|Months 24-36: Denosumab Extension Phase||0
8422475|NCT00896532|20756874|P18|STARTED|Months 24-36: Denosumab Extension Phase||0
8422476|NCT00896532|20756875|P17|STARTED|Months 24-36: Denosumab Extension Phase||0
8422477|NCT00896532|20756876|P16|STARTED|Months 24-36: Denosumab Extension Phase||0
8422478|NCT00896532|20756877|P15|STARTED|Months 24-36: Denosumab Extension Phase||0
8422479|NCT00896532|20756878|P14|STARTED|Months 24-36: Denosumab Extension Phase||90
8422480|NCT00896532|20756879|P13|STARTED|Months 24-36: Denosumab Extension Phase||93
8422481|NCT00896532|20756880|P12|STARTED|Months 24-36: Denosumab Extension Phase||21
8422482|NCT00896532|20756881|P11|STARTED|Months 24-36: Denosumab Extension Phase||20
8422483|NCT00896532|20756882|P10|STARTED|Months 24-36: Denosumab Extension Phase||18
8422484|NCT00896532|20756883|P9|STARTED|Months 24-36: Denosumab Extension Phase||18
8422485|NCT00896532|20756884|P8|STARTED|Months 24-36: Denosumab Extension Phase||0
8422486|NCT00896532|20756885|P7|STARTED|Months 24-36: Denosumab Extension Phase||0
8422487|NCT00896532|20756886|P6|STARTED|Months 24-36: Denosumab Extension Phase||0
8422488|NCT00896532|20756887|P5|STARTED|Months 24-36: Denosumab Extension Phase||0
8422489|NCT00896532|20756888|P4|STARTED|Months 24-36: Denosumab Extension Phase||0
8422490|NCT00896532|20756889|P3|STARTED|Months 24-36: Denosumab Extension Phase||0
8422491|NCT00896532|20756890|P2|STARTED|Months 24-36: Denosumab Extension Phase||0
8422492|NCT00896532|20756891|P1|STARTED|Months 24-36: Denosumab Extension Phase||0
8422493|NCT00896532|20756869|P23|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422494|NCT00896532|20756870|P22|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422495|NCT00896532|20756871|P21|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422496|NCT00896532|20756872|P20|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422497|NCT00896532|20756873|P19|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422498|NCT00896532|20756874|P18|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422499|NCT00896532|20756875|P17|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422500|NCT00896532|20756876|P16|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422501|NCT00896532|20756877|P15|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422502|NCT00896532|20756878|P14|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422503|NCT00896532|20756879|P13|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422504|NCT00896532|20756880|P12|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422505|NCT00896532|20756881|P11|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422506|NCT00896532|20756882|P10|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422507|NCT00896532|20756883|P9|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422508|NCT00896532|20756884|P8|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
8422509|NCT00896532|20756885|P7|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
8422510|NCT00896532|20756886|P6|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
8422511|NCT00896532|20756887|P5|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
8422512|NCT00896532|20756888|P4|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
8422513|NCT00896532|20756889|P3|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
8422514|NCT00896532|20756890|P2|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
8422515|NCT00896532|20756891|P1|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
8422516|NCT00896532|20756869|P23|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422517|NCT00896532|20756870|P22|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422518|NCT00896532|20756871|P21|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422519|NCT00896532|20756872|P20|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422520|NCT00896532|20756873|P19|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422521|NCT00896532|20756874|P18|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422522|NCT00896532|20756875|P17|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422523|NCT00896532|20756876|P16|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422524|NCT00896532|20756877|P15|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422525|NCT00896532|20756878|P14|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422526|NCT00896532|20756879|P13|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422527|NCT00896532|20756880|P12|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422528|NCT00896532|20756881|P11|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422529|NCT00896532|20756882|P10|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422530|NCT00896532|20756883|P9|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
8422531|NCT00896532|20756884|P8|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
8422532|NCT00896532|20756885|P7|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
8422533|NCT00896532|20756886|P6|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
8422534|NCT00896532|20756887|P5|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
8422535|NCT00896532|20756888|P4|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
8422536|NCT00896532|20756889|P3|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
8422537|NCT00896532|20756890|P2|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
8422538|NCT00896532|20756891|P1|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
8422539|NCT00896532|20756869|P23|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422540|NCT00896532|20756870|P22|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422541|NCT00896532|20756871|P21|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422542|NCT00896532|20756872|P20|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422543|NCT00896532|20756873|P19|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422544|NCT00896532|20756874|P18|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422545|NCT00896532|20756875|P17|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422546|NCT00896532|20756876|P16|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422547|NCT00896532|20756877|P15|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422548|NCT00896532|20756878|P14|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422549|NCT00896532|20756879|P13|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422550|NCT00896532|20756880|P12|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422551|NCT00896532|20756881|P11|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422552|NCT00896532|20756882|P10|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422553|NCT00896532|20756883|P9|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
8422554|NCT00896532|20756884|P8|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
8422555|NCT00896532|20756885|P7|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
8422556|NCT00896532|20756886|P6|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
8422557|NCT00896532|20756887|P5|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
8422558|NCT00896532|20756888|P4|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
8422559|NCT00896532|20756889|P3|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
8422560|NCT00896532|20756890|P2|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
8422561|NCT00896532|20756891|P1|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
8422562|NCT00896532|20756869|P23|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422563|NCT00896532|20756870|P22|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422564|NCT00896532|20756871|P21|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422565|NCT00896532|20756872|P20|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422566|NCT00896532|20756873|P19|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422567|NCT00896532|20756874|P18|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422568|NCT00896532|20756875|P17|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422569|NCT00896532|20756876|P16|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422570|NCT00896532|20756877|P15|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422571|NCT00896532|20756878|P14|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422572|NCT00896532|20756879|P13|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422573|NCT00896532|20756880|P12|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422574|NCT00896532|20756881|P11|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422575|NCT00896532|20756882|P10|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422576|NCT00896532|20756883|P9|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
8422577|NCT00896532|20756884|P8|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
8422578|NCT00896532|20756885|P7|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
8422579|NCT00896532|20756886|P6|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
8422580|NCT00896532|20756887|P5|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
8422581|NCT00896532|20756888|P4|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
8422582|NCT00896532|20756889|P3|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
8422583|NCT00896532|20756890|P2|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
8422584|NCT00896532|20756891|P1|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
8422585|NCT00896532|20756869|P23|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422586|NCT00896532|20756870|P22|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422587|NCT00896532|20756871|P21|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422588|NCT00896532|20756872|P20|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422589|NCT00896532|20756873|P19|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422590|NCT00896532|20756874|P18|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422591|NCT00896532|20756875|P17|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422592|NCT00896532|20756876|P16|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422593|NCT00896532|20756877|P15|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422594|NCT00896532|20756878|P14|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422595|NCT00896532|20756879|P13|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422596|NCT00896532|20756880|P12|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422597|NCT00896532|20756881|P11|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422598|NCT00896532|20756882|P10|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422599|NCT00896532|20756883|P9|STARTED|Months 1-24: Romosozumab Treatment Phase||0
8422600|NCT00896532|20756884|P8|STARTED|Months 1-24: Romosozumab Treatment Phase||52
8422601|NCT00896532|20756885|P7|STARTED|Months 1-24: Romosozumab Treatment Phase||53
8422602|NCT00896532|20756886|P6|STARTED|Months 1-24: Romosozumab Treatment Phase||51
8422603|NCT00896532|20756887|P5|STARTED|Months 1-24: Romosozumab Treatment Phase||54
8422604|NCT00896532|20756888|P4|STARTED|Months 1-24: Romosozumab Treatment Phase||51
8422605|NCT00896532|20756889|P3|STARTED|Months 1-24: Romosozumab Treatment Phase||55
8422606|NCT00896532|20756890|P2|STARTED|Months 1-24: Romosozumab Treatment Phase||51
8422607|NCT00896532|20756891|P1|STARTED|Months 1-24: Romosozumab Treatment Phase||52
8422611|NCT00896454|20757066|P1|NOT COMPLETED|Overall Study||33
8422612|NCT00896454|20757066|P1|COMPLETED|Overall Study||0
8422613|NCT00896454|20757066|P1|STARTED|Overall Study||33
8422614|NCT00896441|20757080|P2|NOT COMPLETED|Overall Study||0
8422615|NCT00896441|20757081|P1|NOT COMPLETED|Overall Study||2
8422616|NCT00896441|20757080|P2|COMPLETED|Overall Study||9
8422617|NCT00896441|20757081|P1|COMPLETED|Overall Study||15
8422618|NCT00896441|20757080|P2|STARTED|Overall Study||9
8422619|NCT00896441|20757081|P1|STARTED|Overall Study||17
8422620|NCT00896389|20757088|P1|NOT COMPLETED|HCTZ High Dose||0
8422621|NCT00896389|20757088|P1|COMPLETED|HCTZ High Dose||25
8422622|NCT00896389|20757088|P1|STARTED|HCTZ High Dose||25
8422623|NCT00896389|20757088|P1|NOT COMPLETED|HCTZ Low Dose||0
8422624|NCT00896389|20757088|P1|COMPLETED|HCTZ Low Dose||28
8422625|NCT00896389|20757088|P1|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
8422626|NCT00896389|20757088|P1|NOT COMPLETED|Salt Loading||0
8422627|NCT00896389|20757088|P1|COMPLETED|Salt Loading||124
8422628|NCT00896389|20757088|P1|STARTED|Salt Loading||124
8422629|NCT00896363|20757105|P3|NOT COMPLETED|Overall Study||8
8422630|NCT00896363|20757106|P2|NOT COMPLETED|Overall Study||11
8422631|NCT00896363|20757107|P1|NOT COMPLETED|Overall Study||6
8422632|NCT00896363|20757105|P3|COMPLETED|Overall Study||24
8422633|NCT00896363|20757106|P2|COMPLETED|Overall Study||25
8422634|NCT00896363|20757107|P1|COMPLETED|Overall Study||25
8422635|NCT00896363|20757105|P3|STARTED|Overall Study||32
8422636|NCT00896363|20757106|P2|STARTED|Overall Study||36
8422637|NCT00896363|20757107|P1|STARTED|Overall Study||31
8422638|NCT00896337|20757159|P1|NOT COMPLETED|Overall Study||25
8422639|NCT00896337|20757159|P1|COMPLETED|Overall Study||100
8422640|NCT00896337|20757159|P1|STARTED|Overall Study||125
8422641|NCT00896298|20757228|P2|NOT COMPLETED|Overall Study||3
8422642|NCT00896298|20757229|P1|NOT COMPLETED|Overall Study||3
8422643|NCT00896298|20757228|P2|COMPLETED|Overall Study||9
8422644|NCT00896298|20757229|P1|COMPLETED|Overall Study||10
8422645|NCT00896298|20757228|P2|STARTED|Overall Study||12
8422646|NCT00896298|20757229|P1|STARTED|Overall Study||13
8422647|NCT00896233|20757241|P1|NOT COMPLETED|Overall Study||1
8422648|NCT00896233|20757241|P1|COMPLETED|Overall Study||9
8422649|NCT00896233|20757241|P1|STARTED|Overall Study||10
8422650|NCT00896168|20757254|P2|NOT COMPLETED|Overall Study||19
8422651|NCT00896168|20757255|P1|NOT COMPLETED|Overall Study||14
8422652|NCT00896168|20757254|P2|COMPLETED|Overall Study||111
8422653|NCT00896168|20757255|P1|COMPLETED|Overall Study||90
8422654|NCT00896168|20757254|P2|STARTED|Overall Study||130
8422655|NCT00896168|20757255|P1|STARTED|Overall Study||104
8422656|NCT00896064|20757285|P2|NOT COMPLETED|Overall Study||0
8422657|NCT00896064|20757286|P1|NOT COMPLETED|Overall Study||0
8422658|NCT00896064|20757285|P2|COMPLETED|Overall Study||21
8422659|NCT00896064|20757286|P1|COMPLETED|Overall Study||22
8422660|NCT00896064|20757285|P2|STARTED|Overall Study||21
8422661|NCT00896064|20757286|P1|STARTED|Overall Study||22
8422662|NCT00896051|20757316|P2|NOT COMPLETED|Overall Study||9
8422663|NCT00896051|20757317|P1|NOT COMPLETED|Overall Study||10
8422664|NCT00896051|20757316|P2|COMPLETED|Overall Study||16
8422665|NCT00896051|20757317|P1|COMPLETED|Overall Study||15
8422666|NCT00896051|20757316|P2|STARTED|Overall Study||25
8422667|NCT00896051|20757317|P1|STARTED|Overall Study||25
8422668|NCT00896038|20757359|P2|NOT COMPLETED|Overall Study||1
8422669|NCT00896038|20757360|P1|NOT COMPLETED|Overall Study||4
8422670|NCT00896038|20757359|P2|COMPLETED|Overall Study||27
8422671|NCT00896038|20757360|P1|COMPLETED|Overall Study||26
8422672|NCT00896038|20757359|P2|STARTED|Overall Study||28
8422673|NCT00896038|20757360|P1|STARTED|Overall Study||30
8422674|NCT00896025|20757398|P1|NOT COMPLETED|Overall Study||0
8422675|NCT00896025|20757398|P1|COMPLETED|Overall Study||8
8422676|NCT00896025|20757398|P1|STARTED|Overall Study||8
8422677|NCT00896012|20757412|P2|NOT COMPLETED|Overall Study||11
8422678|NCT00896012|20757413|P1|NOT COMPLETED|Overall Study||11
8422679|NCT00896012|20757412|P2|COMPLETED|Overall Study||12
8422680|NCT00896012|20757413|P1|COMPLETED|Overall Study||18
8422681|NCT00896012|20757412|P2|STARTED|Overall Study||23
8422682|NCT00896012|20757413|P1|STARTED|Overall Study||29
8422683|NCT00895947|20757425|P2|NOT COMPLETED|Overall Study||10
8422684|NCT00895947|20757426|P1|NOT COMPLETED|Overall Study||12
8422685|NCT00895947|20757425|P2|COMPLETED|Overall Study||90
8422686|NCT00895947|20757426|P1|COMPLETED|Overall Study||88
8422687|NCT00895947|20757425|P2|STARTED|Overall Study||100
8422688|NCT00895947|20757426|P1|STARTED|Overall Study||100
8422689|NCT00895934|20757444|P4|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
8422690|NCT00895934|20757445|P3|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
8422691|NCT00895934|20757446|P2|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
8422692|NCT00895934|20757447|P1|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
8422693|NCT00895934|20757444|P4|COMPLETED|Efficacy of Most Tolerated Dose||37
8422694|NCT00895934|20757445|P3|COMPLETED|Efficacy of Most Tolerated Dose||0
8422695|NCT00895934|20757446|P2|COMPLETED|Efficacy of Most Tolerated Dose||0
8422696|NCT00895934|20757447|P1|COMPLETED|Efficacy of Most Tolerated Dose||0
8422697|NCT00895934|20757444|P4|STARTED|Efficacy of Most Tolerated Dose||37
8422698|NCT00895934|20757445|P3|STARTED|Efficacy of Most Tolerated Dose||0
8422699|NCT00895934|20757446|P2|STARTED|Efficacy of Most Tolerated Dose||0
8422700|NCT00895934|20757447|P1|STARTED|Efficacy of Most Tolerated Dose||0
8422701|NCT00895934|20757444|P4|NOT COMPLETED|Dose Escalation||0
8422702|NCT00895934|20757445|P3|NOT COMPLETED|Dose Escalation||0
8422703|NCT00895934|20757446|P2|NOT COMPLETED|Dose Escalation||0
8422704|NCT00895934|20757447|P1|NOT COMPLETED|Dose Escalation||0
8422705|NCT00895934|20757444|P4|COMPLETED|Dose Escalation||6
8422706|NCT00895934|20757445|P3|COMPLETED|Dose Escalation||3
8422707|NCT00895934|20757446|P2|COMPLETED|Dose Escalation||3
8422708|NCT00895934|20757447|P1|COMPLETED|Dose Escalation||3
8422709|NCT00895934|20757444|P4|STARTED|Dose Escalation||6
8422710|NCT00895934|20757445|P3|STARTED|Dose Escalation||3
8422711|NCT00895934|20757446|P2|STARTED|Dose Escalation||3
8422712|NCT00895934|20757447|P1|STARTED|Dose Escalation||3
8422713|NCT00895921|20757461|P2|NOT COMPLETED|Overall Study||0
8422714|NCT00895921|20757462|P1|NOT COMPLETED|Overall Study||0
8422715|NCT00895921|20757461|P2|COMPLETED|Overall Study||15
8422716|NCT00895921|20757462|P1|COMPLETED|Overall Study||15
8422717|NCT00895921|20757461|P2|STARTED|Overall Study||15
8422718|NCT00895921|20757462|P1|STARTED|Overall Study||15
8422719|NCT00895895|20757477|P5|NOT COMPLETED|Period 2||49
8422720|NCT00895895|20757478|P4|NOT COMPLETED|Period 2||54
8422721|NCT00895895|20757479|P3|NOT COMPLETED|Period 2||49
8422722|NCT00895895|20757480|P2|NOT COMPLETED|Period 2||53
8422723|NCT00895895|20757481|P1|NOT COMPLETED|Period 2||56
8422724|NCT00895895|20757477|P5|COMPLETED|Period 2||35
8422725|NCT00895895|20757478|P4|COMPLETED|Period 2||37
8422726|NCT00895895|20757479|P3|COMPLETED|Period 2||33
8422727|NCT00895895|20757480|P2|COMPLETED|Period 2||31
8422728|NCT00895895|20757481|P1|COMPLETED|Period 2||30
8422729|NCT00895895|20757477|P5|STARTED|Period 2||84
8422730|NCT00895895|20757478|P4|STARTED|Period 2||91
8422731|NCT00895895|20757479|P3|STARTED|Period 2||82
8422732|NCT00895895|20757480|P2|STARTED|Period 2||84
8422733|NCT00895895|20757481|P1|STARTED|Period 2||86
8422734|NCT00895895|20757477|P5|NOT COMPLETED|After Period 1, Prior to Period 2||2
8422735|NCT00895895|20757478|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
8422736|NCT00895895|20757479|P3|NOT COMPLETED|After Period 1, Prior to Period 2||2
8422737|NCT00895895|20757480|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
8422738|NCT00895895|20757481|P1|NOT COMPLETED|After Period 1, Prior to Period 2||0
8422739|NCT00895895|20757477|P5|COMPLETED|After Period 1, Prior to Period 2||84
8422740|NCT00895895|20757478|P4|COMPLETED|After Period 1, Prior to Period 2||91
8422741|NCT00895895|20757479|P3|COMPLETED|After Period 1, Prior to Period 2||82
8422742|NCT00895895|20757480|P2|COMPLETED|After Period 1, Prior to Period 2||84
8422743|NCT00895895|20757481|P1|COMPLETED|After Period 1, Prior to Period 2||86
8422744|NCT00895895|20757477|P5|STARTED|After Period 1, Prior to Period 2||86
8422745|NCT00895895|20757478|P4|STARTED|After Period 1, Prior to Period 2||91
8422746|NCT00895895|20757479|P3|STARTED|After Period 1, Prior to Period 2||84
8422747|NCT00895895|20757480|P2|STARTED|After Period 1, Prior to Period 2||84
8422748|NCT00895895|20757481|P1|STARTED|After Period 1, Prior to Period 2||86
8422749|NCT00895895|20757477|P5|NOT COMPLETED|Period 1||20
8422750|NCT00895895|20757478|P4|NOT COMPLETED|Period 1||13
8422751|NCT00895895|20757479|P3|NOT COMPLETED|Period 1||20
8422752|NCT00895895|20757480|P2|NOT COMPLETED|Period 1||21
8422753|NCT00895895|20757481|P1|NOT COMPLETED|Period 1||21
8422754|NCT00895895|20757477|P5|COMPLETED|Period 1||86
8422755|NCT00895895|20757478|P4|COMPLETED|Period 1||91
8422756|NCT00895895|20757479|P3|COMPLETED|Period 1||84
8422757|NCT00895895|20757480|P2|COMPLETED|Period 1||84
8422758|NCT00895895|20757481|P1|COMPLETED|Period 1||86
8422759|NCT00895895|20757477|P5|Randomized But Not Treated|Period 1||2
8422760|NCT00895895|20757478|P4|Randomized But Not Treated|Period 1||1
8422761|NCT00895895|20757479|P3|Randomized But Not Treated|Period 1||1
8422762|NCT00895895|20757480|P2|Randomized But Not Treated|Period 1||3
8422763|NCT00895895|20757481|P1|Randomized But Not Treated|Period 1||1
8422764|NCT00895895|20757477|P5|STARTED|Period 1||106
8422765|NCT00895895|20757478|P4|STARTED|Period 1||104
8422766|NCT00895895|20757479|P3|STARTED|Period 1||104
8422767|NCT00895895|20757480|P2|STARTED|Period 1||105
8422768|NCT00895895|20757481|P1|STARTED|Period 1||107
8422769|NCT00895843|20757595|P2|NOT COMPLETED|Overall Study||12
8422770|NCT00895843|20757596|P1|NOT COMPLETED|Overall Study||12
8422771|NCT00895843|20757595|P2|COMPLETED|Overall Study||50
8422772|NCT00895843|20757596|P1|COMPLETED|Overall Study||48
8422773|NCT00895843|20757595|P2|STARTED|Overall Study||62
8422774|NCT00895843|20757596|P1|STARTED|Overall Study||60
8422775|NCT00895830|20757607|P5|NOT COMPLETED|Overall Study||0
8422776|NCT00895830|20757608|P4|NOT COMPLETED|Overall Study||0
8422777|NCT00895830|20757609|P3|NOT COMPLETED|Overall Study||0
8422778|NCT00895830|20757610|P2|NOT COMPLETED|Overall Study||0
8422779|NCT00895830|20757611|P1|NOT COMPLETED|Overall Study||0
8422780|NCT00895830|20757607|P5|COMPLETED|Overall Study||55
8422781|NCT00895830|20757608|P4|COMPLETED|Overall Study||52
8422782|NCT00895830|20757609|P3|COMPLETED|Overall Study||49
8422783|NCT00895830|20757610|P2|COMPLETED|Overall Study||50
8422784|NCT00895830|20757611|P1|COMPLETED|Overall Study||51
8422785|NCT00895830|20757607|P5|STARTED|Overall Study||55
8422786|NCT00895830|20757608|P4|STARTED|Overall Study||52
8422787|NCT00895830|20757609|P3|STARTED|Overall Study||49
8422788|NCT00895830|20757610|P2|STARTED|Overall Study||50
8422789|NCT00895830|20757611|P1|STARTED|Overall Study||51
8422790|NCT00895817|20757625|P2|NOT COMPLETED|Overall Study||0
8422791|NCT00895817|20757626|P1|NOT COMPLETED|Overall Study||0
8422792|NCT00895817|20757625|P2|COMPLETED|Overall Study||21
8422793|NCT00895817|20757626|P1|COMPLETED|Overall Study||21
8422794|NCT00895817|20757625|P2|STARTED|Overall Study||21
8422795|NCT00895817|20757626|P1|STARTED|Overall Study||21
8422796|NCT00895752|20757632|P1|NOT COMPLETED|Overall Study||0
8422797|NCT00895752|20757632|P1|COMPLETED|Overall Study||6
8422798|NCT00895752|20757632|P1|STARTED|Overall Study||6
8422799|NCT00895661|20757643|P1|NOT COMPLETED|Overall Study||3
8422800|NCT00895661|20757643|P1|COMPLETED|Overall Study||37
8422801|NCT00895661|20757643|P1|STARTED|Overall Study||40
8422811|NCT00895583|20757682|P2|NOT COMPLETED|Overall Study||12
8422812|NCT00895583|20757683|P1|NOT COMPLETED|Overall Study||44
8422813|NCT00895583|20757682|P2|COMPLETED|Overall Study||111
8422814|NCT00895583|20757683|P1|COMPLETED|Overall Study||87
8422815|NCT00895583|20757682|P2|STARTED|Overall Study||123
8422816|NCT00895583|20757683|P1|STARTED|Overall Study||131
8422817|NCT00895531|20757763|P2|NOT COMPLETED|Overall Study||0
8422818|NCT00895531|20757764|P1|NOT COMPLETED|Overall Study||0
8422819|NCT00895531|20757763|P2|COMPLETED|Overall Study||37
8422820|NCT00895531|20757764|P1|COMPLETED|Overall Study||38
8422821|NCT00895531|20757763|P2|STARTED|Overall Study||37
8422822|NCT00895531|20757764|P1|STARTED|Overall Study||38
8422823|NCT00895453|20757773|P3|NOT COMPLETED|Overall Study||23
8422824|NCT00895453|20757774|P2|NOT COMPLETED|Overall Study||25
8422825|NCT00895453|20757775|P1|NOT COMPLETED|Overall Study||25
8422826|NCT00895453|20757773|P3|COMPLETED|Overall Study||23
8422827|NCT00895453|20757774|P2|COMPLETED|Overall Study||25
8422828|NCT00895453|20757775|P1|COMPLETED|Overall Study||23
8422829|NCT00895453|20757773|P3|STARTED|Overall Study||46
8422830|NCT00895453|20757774|P2|STARTED|Overall Study||50
8422831|NCT00895453|20757775|P1|STARTED|Overall Study||48
8422832|NCT00895414|20757783|P2|NOT COMPLETED|Second Intervention (14 Days)||0
8422833|NCT00895414|20757784|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8422834|NCT00895414|20757783|P2|COMPLETED|Second Intervention (14 Days)||9
8422835|NCT00895414|20757784|P1|COMPLETED|Second Intervention (14 Days)||8
8422836|NCT00895414|20757783|P2|STARTED|Second Intervention (14 Days)||9
8422837|NCT00895414|20757784|P1|STARTED|Second Intervention (14 Days)||8
8422838|NCT00895414|20757783|P2|NOT COMPLETED|First Intervention (14 Days)||1
8422839|NCT00895414|20757784|P1|NOT COMPLETED|First Intervention (14 Days)||1
8422840|NCT00895414|20757783|P2|COMPLETED|First Intervention (14 Days)||9
8422841|NCT00895414|20757784|P1|COMPLETED|First Intervention (14 Days)||8
8422842|NCT00895414|20757783|P2|STARTED|First Intervention (14 Days)||10
8422843|NCT00895414|20757784|P1|STARTED|First Intervention (14 Days)||9
8422844|NCT00895310|20757794|P1|NOT COMPLETED|Overall Study||1
8422845|NCT00895310|20757794|P1|COMPLETED|Overall Study||29
8422846|NCT00895310|20757794|P1|STARTED|Overall Study||30
8422847|NCT00895284|20757803|P2|NOT COMPLETED|Overall Study||0
8422848|NCT00895284|20757804|P1|NOT COMPLETED|Overall Study||0
8422849|NCT00895284|20757803|P2|COMPLETED|Overall Study||0
8422850|NCT00895284|20757804|P1|COMPLETED|Overall Study||3
8422851|NCT00895284|20757803|P2|STARTED|Overall Study||0
8422852|NCT00895284|20757804|P1|STARTED|Overall Study||3
8422853|NCT00895245|20757810|P1|NOT COMPLETED|Overall Study||6
8422854|NCT00895245|20757810|P1|COMPLETED|Overall Study||0
8422855|NCT00895245|20757810|P1|STARTED|Overall Study||6
8422856|NCT00895232|20757820|P3|NOT COMPLETED|Overall Study||5
8422857|NCT00895232|20757821|P2|NOT COMPLETED|Overall Study||4
8422858|NCT00895232|20757822|P1|NOT COMPLETED|Overall Study||3
8422859|NCT00895232|20757820|P3|COMPLETED|Overall Study||3
8422860|NCT00895232|20757821|P2|COMPLETED|Overall Study||2
8422861|NCT00895232|20757822|P1|COMPLETED|Overall Study||4
8422862|NCT00895232|20757820|P3|STARTED|Overall Study||8
8422863|NCT00895232|20757821|P2|STARTED|Overall Study||6
8422864|NCT00895232|20757822|P1|STARTED|Overall Study||7
8422865|NCT00895193|20757840|P4|NOT COMPLETED|Overall Study||0
8422866|NCT00895193|20757841|P3|NOT COMPLETED|Overall Study||0
8422867|NCT00895193|20757842|P2|NOT COMPLETED|Overall Study||0
8422868|NCT00895193|20757843|P1|NOT COMPLETED|Overall Study||0
8422869|NCT00895193|20757840|P4|COMPLETED|Overall Study||25
8422870|NCT00895193|20757841|P3|COMPLETED|Overall Study||25
8422871|NCT00895193|20757842|P2|COMPLETED|Overall Study||25
8422872|NCT00895193|20757843|P1|COMPLETED|Overall Study||25
8422873|NCT00895193|20757840|P4|STARTED|Overall Study||25
8422874|NCT00895193|20757841|P3|STARTED|Overall Study||25
8422875|NCT00895193|20757842|P2|STARTED|Overall Study||25
8422876|NCT00895193|20757843|P1|STARTED|Overall Study||25
8422877|NCT00895180|20757867|P2|NOT COMPLETED|Overall Study||0
8422878|NCT00895180|20757868|P1|NOT COMPLETED|Overall Study||0
8422879|NCT00895180|20757867|P2|COMPLETED|Overall Study||40
8422880|NCT00895180|20757868|P1|COMPLETED|Overall Study||40
8422881|NCT00895180|20757867|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
8422882|NCT00895180|20757868|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
8422883|NCT00895180|20757867|P2|STARTED|Overall Study||40
8422884|NCT00895180|20757868|P1|STARTED|Overall Study||40
8422885|NCT00895154|20757888|P2|NOT COMPLETED|Overall Study||2
8422886|NCT00895154|20757889|P1|NOT COMPLETED|Overall Study||1
8422887|NCT00895154|20757888|P2|COMPLETED|Overall Study||8
8422888|NCT00895154|20757889|P1|COMPLETED|Overall Study||7
8422889|NCT00895154|20757888|P2|Follow Up|Overall Study||8
8422890|NCT00895154|20757889|P1|Follow Up|Overall Study||7
8422891|NCT00895154|20757888|P2|STARTED|Overall Study||10
8422892|NCT00895154|20757889|P1|STARTED|Overall Study||8
8422893|NCT00895037|20757924|P3|NOT COMPLETED|Overall Study||1
8422894|NCT00895037|20757925|P2|NOT COMPLETED|Overall Study||2
8422895|NCT00895037|20757926|P1|NOT COMPLETED|Overall Study||0
8422896|NCT00895037|20757924|P3|COMPLETED|Overall Study||1
8422897|NCT00895037|20757925|P2|COMPLETED|Overall Study||75
8422898|NCT00895037|20757926|P1|COMPLETED|Overall Study||22
8422899|NCT00895037|20757924|P3|STARTED|Overall Study||2
8422900|NCT00895037|20757925|P2|STARTED|Overall Study||77
8422901|NCT00895037|20757926|P1|STARTED|Overall Study||22
8422902|NCT00895011|20757957|P3|NOT COMPLETED|Overall Study||8
8422903|NCT00895011|20757958|P2|NOT COMPLETED|Overall Study||14
8422904|NCT00895011|20757959|P1|NOT COMPLETED|Overall Study||24
8422905|NCT00895011|20757957|P3|COMPLETED|Overall Study||91
8422906|NCT00895011|20757958|P2|COMPLETED|Overall Study||85
8422907|NCT00895011|20757959|P1|COMPLETED|Overall Study||76
8422908|NCT00895011|20757957|P3|STARTED|Overall Study||99
8422909|NCT00895011|20757958|P2|STARTED|Overall Study||99
8422910|NCT00895011|20757959|P1|STARTED|Overall Study||100
8422911|NCT00894933|20757973|P1|NOT COMPLETED|Overall Study||4
8422912|NCT00894933|20757973|P1|COMPLETED|Overall Study||29
8422913|NCT00894933|20757973|P1|STARTED|Overall Study||33
8422914|NCT00894803|20757991|P2|NOT COMPLETED|Overall Study||5
8422915|NCT00894803|20757992|P1|NOT COMPLETED|Overall Study||20
8422916|NCT00894803|20757991|P2|COMPLETED|Overall Study||20
8422917|NCT00894803|20757992|P1|COMPLETED|Overall Study||81
8422918|NCT00894803|20757991|P2|STARTED|Overall Study||25
8422919|NCT00894803|20757992|P1|STARTED|Overall Study||101
8422926|NCT00894738|20758053|P2|NOT COMPLETED|Overall Study||0
8422927|NCT00894738|20758054|P1|NOT COMPLETED|Overall Study||0
8422928|NCT00894738|20758053|P2|COMPLETED|Overall Study||19
8422929|NCT00894738|20758054|P1|COMPLETED|Overall Study||25
8422930|NCT00894738|20758053|P2|STARTED|Overall Study||19
8422931|NCT00894738|20758054|P1|STARTED|Overall Study||25
8422932|NCT00894699|20758064|P2|NOT COMPLETED|Overall Study||0
8422933|NCT00894699|20758065|P1|NOT COMPLETED|Overall Study||0
8422934|NCT00894699|20758064|P2|COMPLETED|Overall Study||19
8422935|NCT00894699|20758065|P1|COMPLETED|Overall Study||21
8422936|NCT00894699|20758064|P2|STARTED|Overall Study||19
8422937|NCT00894699|20758065|P1|STARTED|Overall Study||21
8422938|NCT00894686|20758071|P1|NOT COMPLETED|Overall Study||56
8422939|NCT00894686|20758071|P1|COMPLETED|Overall Study||123
8422940|NCT00894686|20758071|P1|STARTED|Overall Study||179
8422941|NCT00894647|20758095|P2|NOT COMPLETED|Overall Study||14
8422942|NCT00894647|20758096|P1|NOT COMPLETED|Overall Study||10
8422943|NCT00894647|20758095|P2|COMPLETED|Overall Study||112
8422944|NCT00894647|20758096|P1|COMPLETED|Overall Study||111
8422945|NCT00894647|20758095|P2|STARTED|Overall Study||126
8422946|NCT00894647|20758096|P1|STARTED|Overall Study||121
8422947|NCT00894556|20758109|P4|NOT COMPLETED|Treatment Phase||0
8422948|NCT00894556|20758110|P3|NOT COMPLETED|Treatment Phase||1
8422949|NCT00894556|20758111|P2|NOT COMPLETED|Treatment Phase||4
8422950|NCT00894556|20758112|P1|NOT COMPLETED|Treatment Phase||4
8422951|NCT00894556|20758109|P4|COMPLETED|Treatment Phase||0
8422952|NCT00894556|20758110|P3|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
8422953|NCT00894556|20758111|P2|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
8422954|NCT00894556|20758112|P1|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
8422955|NCT00894556|20758109|P4|STARTED|Treatment Phase||0
8422956|NCT00894556|20758110|P3|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
8422957|NCT00894556|20758111|P2|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
8422958|NCT00894556|20758112|P1|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
8422959|NCT00894556|20758109|P4|NOT COMPLETED|Baseline Phase||85
8422960|NCT00894556|20758110|P3|NOT COMPLETED|Baseline Phase||0
8422961|NCT00894556|20758111|P2|NOT COMPLETED|Baseline Phase||0
8422962|NCT00894556|20758112|P1|NOT COMPLETED|Baseline Phase||0
8422963|NCT00894556|20758109|P4|COMPLETED|Baseline Phase||109
8422964|NCT00894556|20758110|P3|COMPLETED|Baseline Phase||0
8422965|NCT00894556|20758111|P2|COMPLETED|Baseline Phase||0
8422966|NCT00894556|20758112|P1|COMPLETED|Baseline Phase||0
8422967|NCT00894556|20758109|P4|STARTED|Baseline Phase||194
8422968|NCT00894556|20758110|P3|STARTED|Baseline Phase||0
8422969|NCT00894556|20758111|P2|STARTED|Baseline Phase||0
8422970|NCT00894556|20758112|P1|STARTED|Baseline Phase||0
8422971|NCT00894543|20758123|P2|NOT COMPLETED|Week 4 to Week 8||2
8422972|NCT00894543|20758124|P1|NOT COMPLETED|Week 4 to Week 8||4
8422973|NCT00894543|20758123|P2|COMPLETED|Week 4 to Week 8||97
8422974|NCT00894543|20758124|P1|COMPLETED|Week 4 to Week 8||97
8422975|NCT00894543|20758123|P2|STARTED|Week 4 to Week 8||99
8422976|NCT00894543|20758124|P1|STARTED|Week 4 to Week 8||101
8422977|NCT00894543|20758123|P2|NOT COMPLETED|Baseline to Week 4||2
8422978|NCT00894543|20758124|P1|NOT COMPLETED|Baseline to Week 4||3
8422979|NCT00894543|20758123|P2|COMPLETED|Baseline to Week 4||99
8422980|NCT00894543|20758124|P1|COMPLETED|Baseline to Week 4||101
8422981|NCT00894543|20758123|P2|STARTED|Baseline to Week 4||101
8422982|NCT00894543|20758124|P1|STARTED|Baseline to Week 4||104
8422983|NCT00894543|20758123|P2|NOT COMPLETED|Baseline||0
8422984|NCT00894543|20758124|P1|NOT COMPLETED|Baseline||0
8422985|NCT00894543|20758123|P2|COMPLETED|Baseline||101
8422986|NCT00894543|20758124|P1|COMPLETED|Baseline||104
8422987|NCT00894543|20758123|P2|STARTED|Baseline||101
8422988|NCT00894543|20758124|P1|STARTED|Baseline||104
8422989|NCT00894517|20758148|P2|NOT COMPLETED|Overall Study||5
8422990|NCT00894517|20758149|P1|NOT COMPLETED|Overall Study||2
8422991|NCT00894517|20758148|P2|COMPLETED|Overall Study||26
8422992|NCT00894517|20758149|P1|COMPLETED|Overall Study||28
8422993|NCT00894517|20758148|P2|STARTED|Overall Study||31
8422994|NCT00894517|20758149|P1|STARTED|Overall Study||30
8422995|NCT00894504|20758163|P1|NOT COMPLETED|Overall Study||71
8422996|NCT00894504|20758163|P1|COMPLETED|Overall Study||0
8422997|NCT00894504|20758163|P1|STARTED|Overall Study||71
8422998|NCT00894465|20758179|P2|NOT COMPLETED|Overall Study||0
8422999|NCT00894465|20758180|P1|NOT COMPLETED|Overall Study||0
8423000|NCT00894465|20758179|P2|COMPLETED|Overall Study||22
8423001|NCT00894465|20758180|P1|COMPLETED|Overall Study||22
8423002|NCT00894465|20758179|P2|STARTED|Overall Study||22
8423003|NCT00894465|20758180|P1|STARTED|Overall Study||22
8423004|NCT00894413|20758190|P2|NOT COMPLETED|Overall Study||8
8423005|NCT00894413|20758191|P1|NOT COMPLETED|Overall Study||0
8423006|NCT00894413|20758190|P2|COMPLETED|Overall Study||17
8423007|NCT00894413|20758191|P1|COMPLETED|Overall Study||15
8423008|NCT00894413|20758190|P2|STARTED|Overall Study||25
8423009|NCT00894413|20758191|P1|STARTED|Overall Study||15
8423010|NCT00894387|20758199|P2|NOT COMPLETED|Overall Study||175
8423011|NCT00894387|20758200|P1|NOT COMPLETED|Overall Study||175
8423012|NCT00894387|20758199|P2|COMPLETED|Overall Study||643
8423013|NCT00894387|20758200|P1|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
8423014|NCT00894387|20758199|P2|Completed Secondary Efficacy Phase (12m)|Overall Study||640
8423015|NCT00894387|20758200|P1|Completed Secondary Efficacy Phase (12m)|Overall Study||654
8423016|NCT00894387|20758199|P2|Completed Primary Efficacy Phase (6 m)|Overall Study||707
8423017|NCT00894387|20758200|P1|Completed Primary Efficacy Phase (6 m)|Overall Study||717
8423018|NCT00894387|20758199|P2|Full Analysis Set|Overall Study||807
8423019|NCT00894387|20758200|P1|Full Analysis Set|Overall Study||808
8423020|NCT00894387|20758199|P2|Safety Set|Overall Study||810
8423021|NCT00894387|20758200|P1|Safety Set|Overall Study||808
8423022|NCT00894387|20758199|P2|STARTED|Overall Study||818
8423023|NCT00894387|20758200|P1|STARTED|Overall Study|"Started indicates all randomized patients"|821
8423024|NCT00894361|20758220|P2|NOT COMPLETED|Overall Study||64
8423025|NCT00894361|20758221|P1|NOT COMPLETED|Overall Study||24
8423026|NCT00894361|20758220|P2|COMPLETED|Overall Study||136
8423027|NCT00894361|20758221|P1|COMPLETED|Overall Study||176
8423028|NCT00894361|20758220|P2|STARTED|Overall Study||200
8423029|NCT00894361|20758221|P1|STARTED|Overall Study||200
8423030|NCT00894322|20758232|P3|NOT COMPLETED|Overall Study||0
8423031|NCT00894322|20758233|P2|NOT COMPLETED|Overall Study||0
8423032|NCT00894322|20758234|P1|NOT COMPLETED|Overall Study||1
8423033|NCT00894322|20758232|P3|COMPLETED|Overall Study||12
8423034|NCT00894322|20758233|P2|COMPLETED|Overall Study||23
8423035|NCT00894322|20758234|P1|COMPLETED|Overall Study||29
8423036|NCT00894322|20758232|P3|STARTED|Overall Study||12
8423037|NCT00894322|20758233|P2|STARTED|Overall Study||23
8423038|NCT00894322|20758234|P1|STARTED|Overall Study||30
8423039|NCT00894244|20758273|P1|NOT COMPLETED|Overall Study||1
8423040|NCT00894244|20758273|P1|COMPLETED|Overall Study||24
8423041|NCT00894244|20758273|P1|STARTED|Overall Study||25
8423042|NCT00894166|20758285|P8|NOT COMPLETED|Overall Study||34
8423043|NCT00894166|20758286|P7|NOT COMPLETED|Overall Study||16
8423044|NCT00894166|20758287|P6|NOT COMPLETED|Overall Study||16
8423045|NCT00894166|20758288|P5|NOT COMPLETED|Overall Study||24
8423046|NCT00894166|20758289|P4|NOT COMPLETED|Overall Study||69
8423047|NCT00894166|20758290|P3|NOT COMPLETED|Overall Study||62
8423048|NCT00894166|20758291|P2|NOT COMPLETED|Overall Study||63
8423049|NCT00894166|20758292|P1|NOT COMPLETED|Overall Study||61
8423050|NCT00894166|20758285|P8|COMPLETED|Overall Study||0
8423051|NCT00894166|20758286|P7|COMPLETED|Overall Study||19
8423052|NCT00894166|20758287|P6|COMPLETED|Overall Study||20
8423053|NCT00894166|20758288|P5|COMPLETED|Overall Study||10
8423054|NCT00894166|20758289|P4|COMPLETED|Overall Study||45
8423055|NCT00894166|20758290|P3|COMPLETED|Overall Study||50
8423056|NCT00894166|20758291|P2|COMPLETED|Overall Study||46
8423057|NCT00894166|20758292|P1|COMPLETED|Overall Study||71
8423058|NCT00894166|20758285|P8|STARTED|Overall Study||34
8423059|NCT00894166|20758286|P7|STARTED|Overall Study||35
8423060|NCT00894166|20758287|P6|STARTED|Overall Study||36
8423061|NCT00894166|20758288|P5|STARTED|Overall Study||34
8423062|NCT00894166|20758289|P4|STARTED|Overall Study||114
8423063|NCT00894166|20758290|P3|STARTED|Overall Study||112
8423064|NCT00894166|20758291|P2|STARTED|Overall Study||109
8423065|NCT00894166|20758292|P1|STARTED|Overall Study||132
8423066|NCT00894127|20758322|P1|NOT COMPLETED|Overall Study||0
8423067|NCT00894127|20758322|P1|COMPLETED|Overall Study||128
8423068|NCT00894127|20758322|P1|STARTED|Overall Study||128
8423069|NCT00893997|20758326|P1|NOT COMPLETED|Overall Study||0
8423070|NCT00893997|20758326|P1|COMPLETED|Overall Study||10
8423071|NCT00893997|20758326|P1|STARTED|Overall Study||10
8423072|NCT00893984|20758331|P1|NOT COMPLETED|Overall Study||6
8423073|NCT00893984|20758331|P1|COMPLETED|Overall Study||0
8423074|NCT00893984|20758331|P1|STARTED|Overall Study||6
8423075|NCT00893971|20758338|P1|NOT COMPLETED|Overall Study||3
8423076|NCT00893971|20758338|P1|COMPLETED|Overall Study||13
8423077|NCT00893971|20758338|P1|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
8423078|NCT00893971|20758338|P1|Placebo + FF MDI (PT005)|Overall Study||13
8423079|NCT00893971|20758338|P1|Placebo + GFF MDI (PT003)|Overall Study||15
8423080|NCT00893971|20758338|P1|Placebo + GP MDI (PT001)|Overall Study||15
8423081|NCT00893971|20758338|P1|STARTED|Overall Study||16
8423082|NCT00893789|20758456|P4|NOT COMPLETED|Overall Study||13
8423083|NCT00893789|20758457|P3|NOT COMPLETED|Overall Study||7
8423084|NCT00893789|20758458|P2|NOT COMPLETED|Overall Study||4
8423085|NCT00893789|20758459|P1|NOT COMPLETED|Overall Study||6
8423086|NCT00893789|20758456|P4|COMPLETED|Overall Study||16
8423087|NCT00893789|20758457|P3|COMPLETED|Overall Study||22
8423088|NCT00893789|20758458|P2|COMPLETED|Overall Study||26
8423089|NCT00893789|20758459|P1|COMPLETED|Overall Study||23
8423090|NCT00893789|20758456|P4|Full Analysis Set (FAS)|Overall Study||27
8423091|NCT00893789|20758457|P3|Full Analysis Set (FAS)|Overall Study||28
8423092|NCT00893789|20758458|P2|Full Analysis Set (FAS)|Overall Study||29
8423093|NCT00893789|20758459|P1|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
8423094|NCT00893789|20758456|P4|Safety Analysis Set (SAS)|Overall Study||29
8423095|NCT00893789|20758457|P3|Safety Analysis Set (SAS)|Overall Study||29
8423096|NCT00893789|20758458|P2|Safety Analysis Set (SAS)|Overall Study||30
8423097|NCT00893789|20758459|P1|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
8423098|NCT00893789|20758456|P4|STARTED|Overall Study||29
8423099|NCT00893789|20758457|P3|STARTED|Overall Study||29
8423100|NCT00893789|20758458|P2|STARTED|Overall Study||30
8423101|NCT00893789|20758459|P1|STARTED|Overall Study||29
8423102|NCT00893763|20758543|P2|NOT COMPLETED|Overall Study||110
8423103|NCT00893763|20758544|P1|NOT COMPLETED|Overall Study||110
8423104|NCT00893763|20758543|P2|COMPLETED|Overall Study||47
8423105|NCT00893763|20758544|P1|COMPLETED|Overall Study||47
8423106|NCT00893763|20758543|P2|STARTED|Overall Study||157
8423107|NCT00893763|20758544|P1|STARTED|Overall Study||157
8423108|NCT00893737|20758552|P1|NOT COMPLETED|Overall Study||12
8423109|NCT00893737|20758552|P1|COMPLETED|Overall Study||135
8423110|NCT00893737|20758552|P1|STARTED|Overall Study||147
8423111|NCT00893464|20758566|P8|NOT COMPLETED|Overall Study||2
8423112|NCT00893464|20758567|P7|NOT COMPLETED|Overall Study||2
8423113|NCT00893464|20758568|P6|NOT COMPLETED|Overall Study||0
8423114|NCT00893464|20758569|P5|NOT COMPLETED|Overall Study||0
8423115|NCT00893464|20758570|P4|NOT COMPLETED|Overall Study||0
8423116|NCT00893464|20758571|P3|NOT COMPLETED|Overall Study||0
8423117|NCT00893464|20758572|P2|NOT COMPLETED|Overall Study||0
8423118|NCT00893464|20758573|P1|NOT COMPLETED|Overall Study||0
8423119|NCT00893464|20758566|P8|COMPLETED|Overall Study||3
8423120|NCT00893464|20758567|P7|COMPLETED|Overall Study||8
8423121|NCT00893464|20758568|P6|COMPLETED|Overall Study||7
8423122|NCT00893464|20758569|P5|COMPLETED|Overall Study||4
8423123|NCT00893464|20758570|P4|COMPLETED|Overall Study||1
8423124|NCT00893464|20758571|P3|COMPLETED|Overall Study||1
8423125|NCT00893464|20758572|P2|COMPLETED|Overall Study||1
8423126|NCT00893464|20758573|P1|COMPLETED|Overall Study||1
8423127|NCT00893464|20758566|P8|STARTED|Overall Study||5
8423128|NCT00893464|20758567|P7|STARTED|Overall Study||10
8423129|NCT00893464|20758568|P6|STARTED|Overall Study||7
8423130|NCT00893464|20758569|P5|STARTED|Overall Study||4
8423131|NCT00893464|20758570|P4|STARTED|Overall Study||1
8423132|NCT00893464|20758571|P3|STARTED|Overall Study||1
8423133|NCT00893464|20758572|P2|STARTED|Overall Study||1
8423134|NCT00893464|20758573|P1|STARTED|Overall Study||1
8423135|NCT00893152|20758691|P2|NOT COMPLETED|Overall Study||0
8423136|NCT00893152|20758692|P1|NOT COMPLETED|Overall Study||0
8423137|NCT00893152|20758691|P2|COMPLETED|Overall Study||36
8423138|NCT00893152|20758692|P1|COMPLETED|Overall Study||47
8423139|NCT00893152|20758691|P2|STARTED|Overall Study||36
8423140|NCT00893152|20758692|P1|STARTED|Overall Study||47
8423141|NCT00893113|20758700|P2|NOT COMPLETED|Overall Study||16
8423142|NCT00893113|20758701|P1|NOT COMPLETED|Overall Study||13
8423143|NCT00893113|20758700|P2|COMPLETED|Overall Study||22
8423144|NCT00893113|20758701|P1|COMPLETED|Overall Study||23
8423145|NCT00893113|20758700|P2|STARTED|Overall Study||38
8423146|NCT00893113|20758701|P1|STARTED|Overall Study||36
8423147|NCT00893074|20758711|P1|NOT COMPLETED|Overall Study||11
8423148|NCT00893074|20758711|P1|COMPLETED|Overall Study||13
8423149|NCT00893074|20758711|P1|STARTED|Overall Study||24
8423150|NCT00892957|20758731|P2|NOT COMPLETED|Postoperative Day 30 Assessment||0
8423151|NCT00892957|20758732|P1|NOT COMPLETED|Postoperative Day 30 Assessment||0
8423152|NCT00892957|20758731|P2|COMPLETED|Postoperative Day 30 Assessment||66
8423153|NCT00892957|20758732|P1|COMPLETED|Postoperative Day 30 Assessment||70
8423154|NCT00892957|20758731|P2|STARTED|Postoperative Day 30 Assessment||66
8423155|NCT00892957|20758732|P1|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
8423156|NCT00892957|20758731|P2|NOT COMPLETED|Postoperative Day 14 Assessment||0
8423157|NCT00892957|20758732|P1|NOT COMPLETED|Postoperative Day 14 Assessment||0
8423158|NCT00892957|20758731|P2|COMPLETED|Postoperative Day 14 Assessment||66
8423159|NCT00892957|20758732|P1|COMPLETED|Postoperative Day 14 Assessment||68
8423160|NCT00892957|20758731|P2|STARTED|Postoperative Day 14 Assessment||66
8423161|NCT00892957|20758732|P1|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
8423162|NCT00892957|20758731|P2|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
8423163|NCT00892957|20758732|P1|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
8423164|NCT00892957|20758731|P2|COMPLETED|Between Postoperative Day 1 and Day 14||66
8423165|NCT00892957|20758732|P1|COMPLETED|Between Postoperative Day 1 and Day 14||70
8423166|NCT00892957|20758731|P2|STARTED|Between Postoperative Day 1 and Day 14||70
8423167|NCT00892957|20758732|P1|STARTED|Between Postoperative Day 1 and Day 14||70
8423168|NCT00892957|20758731|P2|NOT COMPLETED|Postoperative Day 1 Assessment||0
8423169|NCT00892957|20758732|P1|NOT COMPLETED|Postoperative Day 1 Assessment||0
8423170|NCT00892957|20758731|P2|COMPLETED|Postoperative Day 1 Assessment||70
8423171|NCT00892957|20758732|P1|COMPLETED|Postoperative Day 1 Assessment||70
8423172|NCT00892957|20758731|P2|STARTED|Postoperative Day 1 Assessment||70
8423173|NCT00892957|20758732|P1|STARTED|Postoperative Day 1 Assessment||70
8423174|NCT00892957|20758731|P2|NOT COMPLETED|Intraoperative Day 0||0
8423175|NCT00892957|20758732|P1|NOT COMPLETED|Intraoperative Day 0||0
8423176|NCT00892957|20758731|P2|COMPLETED|Intraoperative Day 0||70
8423177|NCT00892957|20758732|P1|COMPLETED|Intraoperative Day 0||70
8423178|NCT00892957|20758731|P2|STARTED|Intraoperative Day 0||70
8423179|NCT00892957|20758732|P1|STARTED|Intraoperative Day 0||70
8423180|NCT00892775|20758820|P2|NOT COMPLETED|Overall Study||1
8423181|NCT00892775|20758821|P1|NOT COMPLETED|Overall Study||5
8423182|NCT00892775|20758820|P2|COMPLETED|Overall Study||165
8423183|NCT00892775|20758821|P1|COMPLETED|Overall Study||327
8423184|NCT00892775|20758820|P2|STARTED|Overall Study||166
8423185|NCT00892775|20758821|P1|STARTED|Overall Study||332
8423186|NCT00892723|20758848|P3|NOT COMPLETED|Overall Study||2
8423187|NCT00892723|20758849|P2|NOT COMPLETED|Overall Study||4
8423188|NCT00892723|20758850|P1|NOT COMPLETED|Overall Study||2
8423189|NCT00892723|20758848|P3|COMPLETED|Overall Study||17
8423190|NCT00892723|20758849|P2|COMPLETED|Overall Study||15
8423191|NCT00892723|20758850|P1|COMPLETED|Overall Study||19
8423192|NCT00892723|20758848|P3|STARTED|Overall Study||19
8423193|NCT00892723|20758849|P2|STARTED|Overall Study||19
8423194|NCT00892723|20758850|P1|STARTED|Overall Study||21
8423195|NCT00892710|20758894|P3|NOT COMPLETED|Overall Study||55
8423196|NCT00892710|20758895|P2|NOT COMPLETED|Overall Study||59
8423197|NCT00892710|20758896|P1|NOT COMPLETED|Overall Study||48
8423198|NCT00892710|20758894|P3|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
8423199|NCT00892710|20758895|P2|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
8423200|NCT00892710|20758896|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
8423201|NCT00892710|20758894|P3|STARTED|Overall Study||55
8423202|NCT00892710|20758895|P2|STARTED|Overall Study||59
8423203|NCT00892710|20758896|P1|STARTED|Overall Study||48
8423204|NCT00892697|20758919|P1|NOT COMPLETED|Overall Study||0
8423205|NCT00892697|20758919|P1|COMPLETED|Overall Study||15
8423206|NCT00892697|20758919|P1|STARTED|Overall Study||15
8423207|NCT00892606|20758926|P2|NOT COMPLETED|Overall Study||4
8423208|NCT00892606|20758927|P1|NOT COMPLETED|Overall Study||5
8423209|NCT00892606|20758926|P2|COMPLETED|Overall Study||33
8423210|NCT00892606|20758927|P1|COMPLETED|Overall Study||33
8423211|NCT00892606|20758926|P2|STARTED|Overall Study||37
8423212|NCT00892606|20758927|P1|STARTED|Overall Study||38
8423213|NCT00892437|20758939|P2|NOT COMPLETED|Open-Label Extension Phase||4
8423214|NCT00892437|20758940|P1|NOT COMPLETED|Open-Label Extension Phase||12
8423215|NCT00892437|20758939|P2|COMPLETED|Open-Label Extension Phase||15
8423216|NCT00892437|20758940|P1|COMPLETED|Open-Label Extension Phase||32
8423217|NCT00892437|20758939|P2|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
8423218|NCT00892437|20758940|P1|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
8423219|NCT00892437|20758939|P2|NOT COMPLETED|Randomized Phase||5
8423220|NCT00892437|20758940|P1|NOT COMPLETED|Randomized Phase||11
8423221|NCT00892437|20758939|P2|COMPLETED|Randomized Phase||24
8423222|NCT00892437|20758940|P1|COMPLETED|Randomized Phase||45
8423223|NCT00892437|20758939|P2|Randomized and Treated|Randomized Phase||29
8423224|NCT00892437|20758940|P1|Randomized and Treated|Randomized Phase||50
8423225|NCT00892437|20758939|P2|STARTED|Randomized Phase||29
8423226|NCT00892437|20758940|P1|STARTED|Randomized Phase||56
8423227|NCT00892281|20758959|P2|NOT COMPLETED|Overall Study||37
8423228|NCT00892281|20758960|P1|NOT COMPLETED|Overall Study||267
8423229|NCT00892281|20758959|P2|COMPLETED|Overall Study||187
8423230|NCT00892281|20758960|P1|COMPLETED|Overall Study||930
8423231|NCT00892281|20758959|P2|STARTED|Overall Study||224
8423232|NCT00892281|20758960|P1|STARTED|Overall Study||1197
8423233|NCT00892177|20758973|P6|NOT COMPLETED|Phase II||2
8423234|NCT00892177|20758974|P5|NOT COMPLETED|Phase II||5
8423235|NCT00892177|20758975|P4|NOT COMPLETED|Phase II||0
8423236|NCT00892177|20758976|P3|NOT COMPLETED|Phase II||0
8423237|NCT00892177|20758977|P2|NOT COMPLETED|Phase II||0
8423238|NCT00892177|20758978|P1|NOT COMPLETED|Phase II||0
8423239|NCT00892177|20758973|P6|COMPLETED|Phase II||38
8423240|NCT00892177|20758974|P5|COMPLETED|Phase II||83
8423241|NCT00892177|20758975|P4|COMPLETED|Phase II||0
8423242|NCT00892177|20758976|P3|COMPLETED|Phase II||0
8423243|NCT00892177|20758977|P2|COMPLETED|Phase II||0
8423244|NCT00892177|20758978|P1|COMPLETED|Phase II||0
8423245|NCT00892177|20758973|P6|STARTED|Phase II||40
8423246|NCT00892177|20758974|P5|STARTED|Phase II||88
8423247|NCT00892177|20758975|P4|STARTED|Phase II||0
8423248|NCT00892177|20758976|P3|STARTED|Phase II||0
8423249|NCT00892177|20758977|P2|STARTED|Phase II||0
8423250|NCT00892177|20758978|P1|STARTED|Phase II||0
8423251|NCT00892177|20758973|P6|NOT COMPLETED|Phase I: Dose Level 3||0
8423252|NCT00892177|20758974|P5|NOT COMPLETED|Phase I: Dose Level 3||0
8423253|NCT00892177|20758975|P4|NOT COMPLETED|Phase I: Dose Level 3||0
8423254|NCT00892177|20758976|P3|NOT COMPLETED|Phase I: Dose Level 3||0
8423255|NCT00892177|20758977|P2|NOT COMPLETED|Phase I: Dose Level 3||0
8423256|NCT00892177|20758978|P1|NOT COMPLETED|Phase I: Dose Level 3||0
8423257|NCT00892177|20758973|P6|COMPLETED|Phase I: Dose Level 3||0
8423258|NCT00892177|20758974|P5|COMPLETED|Phase I: Dose Level 3||0
8423259|NCT00892177|20758975|P4|COMPLETED|Phase I: Dose Level 3||6
8423260|NCT00892177|20758976|P3|COMPLETED|Phase I: Dose Level 3||0
8423261|NCT00892177|20758977|P2|COMPLETED|Phase I: Dose Level 3||0
8423262|NCT00892177|20758978|P1|COMPLETED|Phase I: Dose Level 3||0
8423263|NCT00892177|20758973|P6|STARTED|Phase I: Dose Level 3||0
8423264|NCT00892177|20758974|P5|STARTED|Phase I: Dose Level 3||0
8423265|NCT00892177|20758975|P4|STARTED|Phase I: Dose Level 3||6
8423266|NCT00892177|20758976|P3|STARTED|Phase I: Dose Level 3||0
8423267|NCT00892177|20758977|P2|STARTED|Phase I: Dose Level 3||0
8423268|NCT00892177|20758978|P1|STARTED|Phase I: Dose Level 3||0
8423269|NCT00892177|20758973|P6|NOT COMPLETED|Phase I: Dose Level 2||0
8423270|NCT00892177|20758974|P5|NOT COMPLETED|Phase I: Dose Level 2||0
8423271|NCT00892177|20758975|P4|NOT COMPLETED|Phase I: Dose Level 2||0
8423272|NCT00892177|20758976|P3|NOT COMPLETED|Phase I: Dose Level 2||0
8423273|NCT00892177|20758977|P2|NOT COMPLETED|Phase I: Dose Level 2||0
8423274|NCT00892177|20758978|P1|NOT COMPLETED|Phase I: Dose Level 2||0
8423275|NCT00892177|20758973|P6|COMPLETED|Phase I: Dose Level 2||0
8423276|NCT00892177|20758974|P5|COMPLETED|Phase I: Dose Level 2||0
8423277|NCT00892177|20758975|P4|COMPLETED|Phase I: Dose Level 2||0
8423278|NCT00892177|20758976|P3|COMPLETED|Phase I: Dose Level 2||3
8423279|NCT00892177|20758977|P2|COMPLETED|Phase I: Dose Level 2||0
8423280|NCT00892177|20758978|P1|COMPLETED|Phase I: Dose Level 2||0
8423281|NCT00892177|20758973|P6|STARTED|Phase I: Dose Level 2||0
8423282|NCT00892177|20758974|P5|STARTED|Phase I: Dose Level 2||0
8423283|NCT00892177|20758975|P4|STARTED|Phase I: Dose Level 2||0
8423284|NCT00892177|20758976|P3|STARTED|Phase I: Dose Level 2||3
8423285|NCT00892177|20758977|P2|STARTED|Phase I: Dose Level 2||0
8423286|NCT00892177|20758978|P1|STARTED|Phase I: Dose Level 2||0
8423287|NCT00892177|20758973|P6|NOT COMPLETED|Phase I: Dose Level 1||0
8423288|NCT00892177|20758974|P5|NOT COMPLETED|Phase I: Dose Level 1||0
8423289|NCT00892177|20758975|P4|NOT COMPLETED|Phase I: Dose Level 1||0
8423290|NCT00892177|20758976|P3|NOT COMPLETED|Phase I: Dose Level 1||0
8423291|NCT00892177|20758977|P2|NOT COMPLETED|Phase I: Dose Level 1||0
8423292|NCT00892177|20758978|P1|NOT COMPLETED|Phase I: Dose Level 1||0
8423293|NCT00892177|20758973|P6|COMPLETED|Phase I: Dose Level 1||0
8423294|NCT00892177|20758974|P5|COMPLETED|Phase I: Dose Level 1||0
8423295|NCT00892177|20758975|P4|COMPLETED|Phase I: Dose Level 1||0
8423296|NCT00892177|20758976|P3|COMPLETED|Phase I: Dose Level 1||0
8423297|NCT00892177|20758977|P2|COMPLETED|Phase I: Dose Level 1||4
8423298|NCT00892177|20758978|P1|COMPLETED|Phase I: Dose Level 1||0
8423299|NCT00892177|20758973|P6|STARTED|Phase I: Dose Level 1||0
8423300|NCT00892177|20758974|P5|STARTED|Phase I: Dose Level 1||0
8423301|NCT00892177|20758975|P4|STARTED|Phase I: Dose Level 1||0
8423302|NCT00892177|20758976|P3|STARTED|Phase I: Dose Level 1||0
8423303|NCT00892177|20758977|P2|STARTED|Phase I: Dose Level 1||4
8423304|NCT00892177|20758978|P1|STARTED|Phase I: Dose Level 1||0
8423305|NCT00892177|20758973|P6|NOT COMPLETED|Phase I: Dose Level 0||0
8423306|NCT00892177|20758974|P5|NOT COMPLETED|Phase I: Dose Level 0||0
8423307|NCT00892177|20758975|P4|NOT COMPLETED|Phase I: Dose Level 0||0
8423308|NCT00892177|20758976|P3|NOT COMPLETED|Phase I: Dose Level 0||0
8423309|NCT00892177|20758977|P2|NOT COMPLETED|Phase I: Dose Level 0||0
8423310|NCT00892177|20758978|P1|NOT COMPLETED|Phase I: Dose Level 0||0
8423311|NCT00892177|20758973|P6|COMPLETED|Phase I: Dose Level 0||0
8423312|NCT00892177|20758974|P5|COMPLETED|Phase I: Dose Level 0||0
8423313|NCT00892177|20758975|P4|COMPLETED|Phase I: Dose Level 0||0
8423314|NCT00892177|20758976|P3|COMPLETED|Phase I: Dose Level 0||0
8423315|NCT00892177|20758977|P2|COMPLETED|Phase I: Dose Level 0||0
8423316|NCT00892177|20758978|P1|COMPLETED|Phase I: Dose Level 0||3
8423317|NCT00892177|20758973|P6|STARTED|Phase I: Dose Level 0||0
8423318|NCT00892177|20758974|P5|STARTED|Phase I: Dose Level 0||0
8423319|NCT00892177|20758975|P4|STARTED|Phase I: Dose Level 0||0
8423320|NCT00892177|20758976|P3|STARTED|Phase I: Dose Level 0||0
8423321|NCT00892177|20758977|P2|STARTED|Phase I: Dose Level 0||0
8423322|NCT00892177|20758978|P1|STARTED|Phase I: Dose Level 0||3
8423323|NCT00892151|20759003|P1|NOT COMPLETED|Overall Study||1
8423324|NCT00892151|20759003|P1|COMPLETED|Overall Study||50
8423325|NCT00892151|20759003|P1|STARTED|Overall Study||51
8423326|NCT00892099|20759012|P3|NOT COMPLETED|Overall Study||7
8423327|NCT00892099|20759013|P2|NOT COMPLETED|Overall Study||1
8423328|NCT00892099|20759014|P1|NOT COMPLETED|Overall Study||5
8423329|NCT00892099|20759012|P3|COMPLETED|Overall Study||29
8423330|NCT00892099|20759013|P2|COMPLETED|Overall Study||32
8423331|NCT00892099|20759014|P1|COMPLETED|Overall Study||31
8423332|NCT00892099|20759012|P3|STARTED|Overall Study||36
8423333|NCT00892099|20759013|P2|STARTED|Overall Study||33
8423334|NCT00892099|20759014|P1|STARTED|Overall Study||36
8423335|NCT00892047|20759039|P2|NOT COMPLETED|Overall Study||7
8423336|NCT00892047|20759040|P1|NOT COMPLETED|Overall Study||4
8423337|NCT00892047|20759039|P2|COMPLETED|Overall Study||83
8423338|NCT00892047|20759040|P1|COMPLETED|Overall Study||87
8423339|NCT00892047|20759039|P2|STARTED|Overall Study||90
8423340|NCT00892047|20759040|P1|STARTED|Overall Study||91
8423341|NCT00892008|20759056|P1|NOT COMPLETED|Overall Study||565
8423342|NCT00892008|20759056|P1|COMPLETED|Overall Study||1713
8423343|NCT00892008|20759056|P1|STARTED|Overall Study||2278
8423344|NCT00891995|20759072|P2|NOT COMPLETED|Overall Study||0
8423345|NCT00891995|20759073|P1|NOT COMPLETED|Overall Study||0
8423346|NCT00891995|20759072|P2|COMPLETED|Overall Study||21
8423347|NCT00891995|20759073|P1|COMPLETED|Overall Study||50
8423348|NCT00891995|20759072|P2|STARTED|Overall Study||21
8423349|NCT00891995|20759073|P1|STARTED|Overall Study||50
8423350|NCT00891982|20759097|P2|NOT COMPLETED|Overall Study||1
8423351|NCT00891982|20759098|P1|NOT COMPLETED|Overall Study||2
8423352|NCT00891982|20759097|P2|COMPLETED|Overall Study||30
8423353|NCT00891982|20759098|P1|COMPLETED|Overall Study||28
8423354|NCT00891982|20759097|P2|STARTED|Overall Study||31
8423355|NCT00891982|20759098|P1|STARTED|Overall Study||30
8423356|NCT00891930|20759142|P1|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
8423357|NCT00891930|20759142|P1|COMPLETED|Part 2: Panitumumab + Ganitumab||5
8423358|NCT00891930|20759142|P1|STARTED|Part 2: Panitumumab + Ganitumab||36
8423359|NCT00891930|20759142|P1|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
8423360|NCT00891930|20759142|P1|COMPLETED|Part 1: Panitumumab +Irinotecan||36
8423361|NCT00891930|20759142|P1|Received Treatment|Part 1: Panitumumab +Irinotecan||74
8423362|NCT00891930|20759142|P1|STARTED|Part 1: Panitumumab +Irinotecan||76
8423363|NCT00891904|20759163|P1|NOT COMPLETED|Overall Study||2
8423364|NCT00891904|20759163|P1|COMPLETED|Overall Study||0
8423365|NCT00891904|20759163|P1|STARTED|Overall Study||2
8423366|NCT00891878|20759172|P2|NOT COMPLETED|Overall Study||0
8423367|NCT00891878|20759173|P1|NOT COMPLETED|Overall Study||0
8423368|NCT00891878|20759172|P2|COMPLETED|Overall Study||6
8423369|NCT00891878|20759173|P1|COMPLETED|Overall Study||6
8423370|NCT00891878|20759172|P2|STARTED|Overall Study||6
8423371|NCT00891878|20759173|P1|STARTED|Overall Study||6
8423372|NCT00891839|20759189|P1|NOT COMPLETED|Overall Study||7
8423373|NCT00891839|20759189|P1|COMPLETED|Overall Study|completed treatment|38
8423374|NCT00891839|20759189|P1|STARTED|Overall Study||45
8423375|NCT00891813|20759198|P1|NOT COMPLETED|Overall Study||12
8423376|NCT00891813|20759198|P1|COMPLETED|Overall Study||88
8423377|NCT00891813|20759198|P1|STARTED|Overall Study||100
8423378|NCT00891774|20759204|P1|NOT COMPLETED|Overall Study||14
8423379|NCT00891774|20759204|P1|COMPLETED|Overall Study||158
8423380|NCT00891774|20759204|P1|STARTED|Overall Study||172
8423381|NCT00891735|20759215|P4|NOT COMPLETED|Overall Study||15
8423382|NCT00891735|20759216|P3|NOT COMPLETED|Overall Study||12
8423383|NCT00891735|20759217|P2|NOT COMPLETED|Overall Study||16
8423384|NCT00891735|20759218|P1|NOT COMPLETED|Overall Study||17
8423385|NCT00891735|20759215|P4|COMPLETED|Overall Study||258
8423386|NCT00891735|20759216|P3|COMPLETED|Overall Study||263
8423387|NCT00891735|20759217|P2|COMPLETED|Overall Study||258
8423388|NCT00891735|20759218|P1|COMPLETED|Overall Study||258
8423389|NCT00891735|20759215|P4|STARTED|Overall Study||273
8423390|NCT00891735|20759216|P3|STARTED|Overall Study||275
8423391|NCT00891735|20759217|P2|STARTED|Overall Study||274
8423392|NCT00891735|20759218|P1|STARTED|Overall Study||275
8423393|NCT00891657|20759258|P2|NOT COMPLETED|Overall Study||1
8423394|NCT00891657|20759259|P1|NOT COMPLETED|Overall Study||1
8423395|NCT00891657|20759258|P2|COMPLETED|Overall Study||5
8423396|NCT00891657|20759259|P1|COMPLETED|Overall Study||8
8423397|NCT00891657|20759258|P2|STARTED|Overall Study||6
8423398|NCT00891657|20759259|P1|STARTED|Overall Study||9
8423399|NCT00891618|20759271|P1|NOT COMPLETED|Overall Study||1
8423400|NCT00891618|20759271|P1|COMPLETED|Overall Study||20
8423401|NCT00891618|20759271|P1|STARTED|Overall Study||21
8423402|NCT00891527|20759275|P1|NOT COMPLETED|Overall Study||2
8423403|NCT00891527|20759275|P1|COMPLETED|Overall Study||48
8423404|NCT00891527|20759275|P1|STARTED|Overall Study||50
8423405|NCT00891462|20759284|P3|NOT COMPLETED|Overall Study||24
8423406|NCT00891462|20759285|P2|NOT COMPLETED|Overall Study||33
8423407|NCT00891462|20759286|P1|NOT COMPLETED|Overall Study||37
8423408|NCT00891462|20759284|P3|COMPLETED|Overall Study||166
8423409|NCT00891462|20759285|P2|COMPLETED|Overall Study||152
8423410|NCT00891462|20759286|P1|COMPLETED|Overall Study||149
8423411|NCT00891462|20759284|P3|STARTED|Overall Study||190
8423412|NCT00891462|20759285|P2|STARTED|Overall Study||185
8423413|NCT00891462|20759286|P1|STARTED|Overall Study||186
8423414|NCT00891436|20759299|P2|NOT COMPLETED|Overall Study||0
8423415|NCT00891436|20759300|P1|NOT COMPLETED|Overall Study||0
8423416|NCT00891436|20759299|P2|COMPLETED|Overall Study||10
8423417|NCT00891436|20759300|P1|COMPLETED|Overall Study||10
8423418|NCT00891436|20759299|P2|STARTED|Overall Study||10
8423419|NCT00891436|20759300|P1|STARTED|Overall Study||10
8423420|NCT00891371|20759308|P1|NOT COMPLETED|Treatment||9
8423421|NCT00891371|20759308|P1|COMPLETED|Treatment||27
8423422|NCT00891371|20759308|P1|STARTED|Treatment||36
8423423|NCT00891371|20759308|P1|NOT COMPLETED|Pre-assignment||6
8423424|NCT00891371|20759308|P1|COMPLETED|Pre-assignment||36
8423425|NCT00891371|20759308|P1|STARTED|Pre-assignment||42
8423426|NCT00891319|20759319|P2|NOT COMPLETED|Overall Study||0
8423427|NCT00891319|20759320|P1|NOT COMPLETED|Overall Study||8
8423428|NCT00891319|20759319|P2|COMPLETED|Overall Study||40
8423429|NCT00891319|20759320|P1|COMPLETED|Overall Study||32
8423430|NCT00891319|20759319|P2|STARTED|Overall Study||40
8423431|NCT00891319|20759320|P1|STARTED|Overall Study||40
8423432|NCT00891293|20759330|P1|NOT COMPLETED|Overall Study||84
8423433|NCT00891293|20759330|P1|COMPLETED|Overall Study||9
8423434|NCT00891293|20759330|P1|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
8423435|NCT00891228|20759345|P3|NOT COMPLETED|Overall Study||15
8423436|NCT00891228|20759346|P2|NOT COMPLETED|Overall Study||13
8423437|NCT00891228|20759347|P1|NOT COMPLETED|Overall Study||11
8423438|NCT00891228|20759345|P3|COMPLETED|Overall Study||19
8423439|NCT00891228|20759346|P2|COMPLETED|Overall Study||20
8423440|NCT00891228|20759347|P1|COMPLETED|Overall Study||21
8423441|NCT00891228|20759345|P3|STARTED|Overall Study||34
8423442|NCT00891228|20759346|P2|STARTED|Overall Study||33
8423443|NCT00891228|20759347|P1|STARTED|Overall Study||32
8423444|NCT00891202|20759369|P4|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
8423445|NCT00891202|20759370|P3|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
8423446|NCT00891202|20759371|P2|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
8423447|NCT00891202|20759372|P1|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
8423448|NCT00891202|20759369|P4|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
8423449|NCT00891202|20759370|P3|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
8423450|NCT00891202|20759371|P2|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
8423451|NCT00891202|20759372|P1|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
8423452|NCT00891202|20759369|P4|STARTED|LTTP (Post-Week 39 up to Week 312)||20
8423453|NCT00891202|20759370|P3|STARTED|LTTP (Post-Week 39 up to Week 312)||19
8423454|NCT00891202|20759371|P2|STARTED|LTTP (Post-Week 39 up to Week 312)||0
8423455|NCT00891202|20759372|P1|STARTED|LTTP (Post-Week 39 up to Week 312)||0
8423456|NCT00891202|20759369|P4|NOT COMPLETED|PAP (Up To Week 39)||0
8423457|NCT00891202|20759370|P3|NOT COMPLETED|PAP (Up To Week 39)||0
8423458|NCT00891202|20759371|P2|NOT COMPLETED|PAP (Up To Week 39)||0
8423459|NCT00891202|20759372|P1|NOT COMPLETED|PAP (Up To Week 39)||1
8423460|NCT00891202|20759369|P4|COMPLETED|PAP (Up To Week 39)||0
8423461|NCT00891202|20759370|P3|COMPLETED|PAP (Up To Week 39)||0
8423462|NCT00891202|20759371|P2|COMPLETED|PAP (Up To Week 39)||20
8423463|NCT00891202|20759372|P1|COMPLETED|PAP (Up To Week 39)||19
8423464|NCT00891202|20759369|P4|STARTED|PAP (Up To Week 39)||0
8423465|NCT00891202|20759370|P3|STARTED|PAP (Up To Week 39)||0
8423466|NCT00891202|20759371|P2|STARTED|PAP (Up To Week 39)||20
8423467|NCT00891202|20759372|P1|STARTED|PAP (Up To Week 39)||20
8423468|NCT00891176|20759398|P4|NOT COMPLETED|At 6 Years of Age||0
8423469|NCT00891176|20759399|P3|NOT COMPLETED|At 6 Years of Age||0
8423470|NCT00891176|20759400|P2|NOT COMPLETED|At 6 Years of Age||0
8423471|NCT00891176|20759401|P1|NOT COMPLETED|At 6 Years of Age||0
8423472|NCT00891176|20759398|P4|COMPLETED|At 6 Years of Age||135
8423473|NCT00891176|20759399|P3|COMPLETED|At 6 Years of Age||135
8423474|NCT00891176|20759400|P2|COMPLETED|At 6 Years of Age||138
8423475|NCT00891176|20759401|P1|COMPLETED|At 6 Years of Age||131
8423476|NCT00891176|20759398|P4|STARTED|At 6 Years of Age||135
8423477|NCT00891176|20759399|P3|STARTED|At 6 Years of Age||135
8423478|NCT00891176|20759400|P2|STARTED|At 6 Years of Age||138
8423479|NCT00891176|20759401|P1|STARTED|At 6 Years of Age||131
8423480|NCT00891176|20759398|P4|NOT COMPLETED|At 4 Years of Age||0
8423481|NCT00891176|20759399|P3|NOT COMPLETED|At 4 Years of Age||0
8423482|NCT00891176|20759400|P2|NOT COMPLETED|At 4 Years of Age||0
8423483|NCT00891176|20759401|P1|NOT COMPLETED|At 4 Years of Age||0
8423484|NCT00891176|20759398|P4|COMPLETED|At 4 Years of Age||137
8423485|NCT00891176|20759399|P3|COMPLETED|At 4 Years of Age||142
8423486|NCT00891176|20759400|P2|COMPLETED|At 4 Years of Age||142
8423487|NCT00891176|20759401|P1|COMPLETED|At 4 Years of Age||140
8423488|NCT00891176|20759398|P4|STARTED|At 4 Years of Age||137
8423489|NCT00891176|20759399|P3|STARTED|At 4 Years of Age||142
8423490|NCT00891176|20759400|P2|STARTED|At 4 Years of Age||142
8423491|NCT00891176|20759401|P1|STARTED|At 4 Years of Age||140
8423492|NCT00891176|20759398|P4|NOT COMPLETED|At 3 Years of Age||0
8423493|NCT00891176|20759399|P3|NOT COMPLETED|At 3 Years of Age||0
8423494|NCT00891176|20759400|P2|NOT COMPLETED|At 3 Years of Age||0
8423495|NCT00891176|20759401|P1|NOT COMPLETED|At 3 Years of Age||0
8423496|NCT00891176|20759398|P4|COMPLETED|At 3 Years of Age||141
8423497|NCT00891176|20759399|P3|COMPLETED|At 3 Years of Age||149
8423498|NCT00891176|20759400|P2|COMPLETED|At 3 Years of Age||147
8423499|NCT00891176|20759401|P1|COMPLETED|At 3 Years of Age||144
8423500|NCT00891176|20759398|P4|STARTED|At 3 Years of Age||141
8423501|NCT00891176|20759399|P3|STARTED|At 3 Years of Age||149
8423502|NCT00891176|20759400|P2|STARTED|At 3 Years of Age||147
8423503|NCT00891176|20759401|P1|STARTED|At 3 Years of Age||144
8423504|NCT00891046|20759548|P5|NOT COMPLETED|Overall Study||39
8423505|NCT00891046|20759549|P4|NOT COMPLETED|Overall Study||3
8423506|NCT00891046|20759550|P3|NOT COMPLETED|Overall Study||23
8423507|NCT00891046|20759551|P2|NOT COMPLETED|Overall Study||9
8423508|NCT00891046|20759552|P1|NOT COMPLETED|Overall Study||12
8423509|NCT00891046|20759548|P5|COMPLETED|Overall Study||84
8423510|NCT00891046|20759549|P4|COMPLETED|Overall Study||8
8423511|NCT00891046|20759550|P3|COMPLETED|Overall Study||17
8423512|NCT00891046|20759551|P2|COMPLETED|Overall Study||54
8423513|NCT00891046|20759552|P1|COMPLETED|Overall Study||21
8423514|NCT00891046|20759548|P5|STARTED|Overall Study||123
8423515|NCT00891046|20759549|P4|STARTED|Overall Study||11
8423516|NCT00891046|20759550|P3|STARTED|Overall Study||40
8423517|NCT00891046|20759551|P2|STARTED|Overall Study||63
8423518|NCT00891046|20759552|P1|STARTED|Overall Study||33
8423519|NCT00891020|20759628|P3|NOT COMPLETED|Long-term Extension Period||23
8423520|NCT00891020|20759629|P2|NOT COMPLETED|Long-term Extension Period||24
8423521|NCT00891020|20759630|P1|NOT COMPLETED|Long-term Extension Period||6
8423522|NCT00891020|20759628|P3|COMPLETED|Long-term Extension Period||170
8423523|NCT00891020|20759629|P2|COMPLETED|Long-term Extension Period||172
8423524|NCT00891020|20759630|P1|COMPLETED|Long-term Extension Period||49
8423525|NCT00891020|20759628|P3|STARTED|Long-term Extension Period||193
8423526|NCT00891020|20759629|P2|STARTED|Long-term Extension Period||196
8423527|NCT00891020|20759630|P1|STARTED|Long-term Extension Period||55
8423528|NCT00891020|20759628|P3|NOT COMPLETED|24 Week Treatment Period||58
8423529|NCT00891020|20759629|P2|NOT COMPLETED|24 Week Treatment Period||60
8423530|NCT00891020|20759630|P1|NOT COMPLETED|24 Week Treatment Period||37
8423531|NCT00891020|20759628|P3|COMPLETED|24 Week Treatment Period||302
8423532|NCT00891020|20759629|P2|COMPLETED|24 Week Treatment Period||303
8423533|NCT00891020|20759630|P1|COMPLETED|24 Week Treatment Period||126
8423534|NCT00891020|20759628|P3|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
8423535|NCT00891020|20759629|P2|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
8423536|NCT00891020|20759630|P1|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
8423537|NCT00891020|20759628|P3|Intent-to-Treat (ITT)|24 Week Treatment Period||358
8423538|NCT00891020|20759629|P2|Intent-to-Treat (ITT)|24 Week Treatment Period||362
8423539|NCT00891020|20759630|P1|Intent-to-Treat (ITT)|24 Week Treatment Period||163
8423540|NCT00891020|20759628|P3|STARTED|24 Week Treatment Period||360
8423541|NCT00891020|20759629|P2|STARTED|24 Week Treatment Period||363
8423542|NCT00891020|20759630|P1|STARTED|24 Week Treatment Period||163
8423543|NCT00890981|20759663|P2|NOT COMPLETED|Overall Study||0
8423544|NCT00890981|20759664|P1|NOT COMPLETED|Overall Study||0
8423545|NCT00890981|20759663|P2|COMPLETED|Overall Study||40
8423546|NCT00890981|20759664|P1|COMPLETED|Overall Study||39
8423547|NCT00890981|20759663|P2|STARTED|Overall Study||40
8423548|NCT00890981|20759664|P1|STARTED|Overall Study||39
8423549|NCT00890929|20759694|P1|NOT COMPLETED|Overall Study||6
8423550|NCT00890929|20759694|P1|COMPLETED|Overall Study||39
8423551|NCT00890929|20759694|P1|Initiated Treatment|Overall Study||43
8423552|NCT00890929|20759694|P1|Consented & Enrolled|Overall Study||45
8423553|NCT00890929|20759694|P1|STARTED|Overall Study||45
8423562|NCT00890825|20759712|P2|NOT COMPLETED|Overall Study||14
8423563|NCT00890825|20759713|P1|NOT COMPLETED|Overall Study||14
8423564|NCT00890825|20759712|P2|COMPLETED|Overall Study||29
8423565|NCT00890825|20759713|P1|COMPLETED|Overall Study||30
8423566|NCT00890825|20759712|P2|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
8423567|NCT00890825|20759713|P1|STARTED|Overall Study||44
8423568|NCT00890721|20759733|P2|NOT COMPLETED|Overall Study||1
8423569|NCT00890721|20759734|P1|NOT COMPLETED|Overall Study||1
8423570|NCT00890721|20759733|P2|COMPLETED|Overall Study||93
8423571|NCT00890721|20759734|P1|COMPLETED|Overall Study||94
8423572|NCT00890721|20759733|P2|STARTED|Overall Study||94
8423573|NCT00890721|20759734|P1|STARTED|Overall Study||95
8423574|NCT00890695|20759742|P2|NOT COMPLETED|Overall Study||0
8423575|NCT00890695|20759743|P1|NOT COMPLETED|Overall Study||1
8423576|NCT00890695|20759742|P2|COMPLETED|Overall Study||33
8423577|NCT00890695|20759743|P1|COMPLETED|Overall Study||31
8423578|NCT00890695|20759742|P2|STARTED|Overall Study||33
8423579|NCT00890695|20759743|P1|STARTED|Overall Study||32
8423580|NCT00890682|20759761|P2|NOT COMPLETED|Overall Study||2
8423581|NCT00890682|20759762|P1|NOT COMPLETED|Overall Study||4
8423582|NCT00890682|20759761|P2|COMPLETED|Overall Study||94
8423583|NCT00890682|20759762|P1|COMPLETED|Overall Study||93
8423584|NCT00890682|20759761|P2|STARTED|Overall Study||96
8423585|NCT00890682|20759762|P1|STARTED|Overall Study||97
8423586|NCT00890656|20759768|P1|NOT COMPLETED|Overall Study||0
8423587|NCT00890656|20759768|P1|COMPLETED|Overall Study||90
8423588|NCT00890656|20759768|P1|STARTED|Overall Study||90
8423589|NCT00890617|20759772|P1|NOT COMPLETED|Overall Study||0
8423590|NCT00890617|20759772|P1|COMPLETED|Overall Study||9
8423591|NCT00890617|20759772|P1|STARTED|Overall Study||9
8423592|NCT00890591|20759777|P1|NOT COMPLETED|Overall Study||20
8423593|NCT00890591|20759777|P1|COMPLETED|Overall Study||124
8423594|NCT00890591|20759777|P1|STARTED|Overall Study||144
8423595|NCT00890552|20759783|P1|NOT COMPLETED|On-treatment||10
8423596|NCT00890552|20759783|P1|COMPLETED|On-treatment||14
8423597|NCT00890552|20759783|P1|STARTED|On-treatment||24
8423598|NCT00890552|20759783|P1|NOT COMPLETED|Enrollment and Pre-treatment||1
8423599|NCT00890552|20759783|P1|COMPLETED|Enrollment and Pre-treatment||24
8423600|NCT00890552|20759783|P1|STARTED|Enrollment and Pre-treatment||25
8423601|NCT00890409|20759792|P2|NOT COMPLETED|Overall Study||21
8423602|NCT00890409|20759793|P1|NOT COMPLETED|Overall Study||20
8423603|NCT00890409|20759792|P2|COMPLETED|Overall Study||119
8423604|NCT00890409|20759793|P1|COMPLETED|Overall Study||96
8423605|NCT00890409|20759792|P2|STARTED|Overall Study||140
8423606|NCT00890409|20759793|P1|STARTED|Overall Study||116
8423607|NCT00890396|20759803|P2|NOT COMPLETED|Overall Study||2
8423608|NCT00890396|20759804|P1|NOT COMPLETED|Overall Study||5
8423609|NCT00890396|20759803|P2|COMPLETED|Overall Study||34
8423610|NCT00890396|20759804|P1|COMPLETED|Overall Study||122
8423611|NCT00890396|20759803|P2|STARTED|Overall Study||36
8423612|NCT00890396|20759804|P1|STARTED|Overall Study||127
8423613|NCT00890201|20759830|P2|NOT COMPLETED|Overall Study||56
8423614|NCT00890201|20759831|P1|NOT COMPLETED|Overall Study||5
8423615|NCT00890201|20759830|P2|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
8423616|NCT00890201|20759831|P1|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
8423617|NCT00890201|20759830|P2|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
8423618|NCT00890201|20759831|P1|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
8423619|NCT00890162|20759839|P2|NOT COMPLETED|Overall Study||1
8423620|NCT00890162|20759840|P1|NOT COMPLETED|Overall Study||2
8423621|NCT00890162|20759839|P2|COMPLETED|Overall Study||7
8423622|NCT00890162|20759840|P1|COMPLETED|Overall Study||6
8423623|NCT00890162|20759839|P2|STARTED|Overall Study||8
8423624|NCT00890162|20759840|P1|STARTED|Overall Study||8
8423625|NCT00890097|20759849|P3|NOT COMPLETED|Overall Study||77
8423626|NCT00890097|20759850|P2|NOT COMPLETED|Overall Study||86
8423627|NCT00890097|20759851|P1|NOT COMPLETED|Overall Study||68
8423628|NCT00890097|20759849|P3|COMPLETED|Overall Study||184
8423629|NCT00890097|20759850|P2|COMPLETED|Overall Study||173
8423630|NCT00890097|20759851|P1|COMPLETED|Overall Study||184
8423631|NCT00890097|20759849|P3|STARTED|Overall Study||261
8423632|NCT00890097|20759850|P2|STARTED|Overall Study||259
8423633|NCT00890097|20759851|P1|STARTED|Overall Study||252
8423634|NCT00890084|20759859|P1|NOT COMPLETED|Overall Study||142
8423635|NCT00890084|20759859|P1|COMPLETED|Overall Study||2771
8423636|NCT00890084|20759859|P1|STARTED|Overall Study||2913
8423637|NCT00889928|20759870|P1|NOT COMPLETED|Overall Study||0
8423638|NCT00889928|20759870|P1|COMPLETED|Overall Study||7
8423639|NCT00889928|20759870|P1|STARTED|Overall Study||7
8423640|NCT00889915|20759878|P4|NOT COMPLETED|Overall Study||8
8423641|NCT00889915|20759879|P3|NOT COMPLETED|Overall Study||13
8423642|NCT00889915|20759880|P2|NOT COMPLETED|Overall Study||5
8423643|NCT00889915|20759881|P1|NOT COMPLETED|Overall Study||2
8423644|NCT00889915|20759878|P4|COMPLETED|Overall Study||40
8423645|NCT00889915|20759879|P3|COMPLETED|Overall Study||54
8423646|NCT00889915|20759880|P2|COMPLETED|Overall Study||71
8423647|NCT00889915|20759881|P1|COMPLETED|Overall Study||35
8423648|NCT00889915|20759878|P4|STARTED|Overall Study||48
8423649|NCT00889915|20759879|P3|STARTED|Overall Study||67
8423650|NCT00889915|20759880|P2|STARTED|Overall Study||76
8423651|NCT00889915|20759881|P1|STARTED|Overall Study||37
8423652|NCT00889863|20759899|P2|NOT COMPLETED|Part II: Randomized Double Blind||26
8423653|NCT00889863|20759900|P1|NOT COMPLETED|Part II: Randomized Double Blind||11
8423654|NCT00889863|20759899|P2|COMPLETED|Part II: Randomized Double Blind||24
8423655|NCT00889863|20759900|P1|COMPLETED|Part II: Randomized Double Blind||39
8423656|NCT00889863|20759899|P2|STARTED|Part II: Randomized Double Blind||50
8423657|NCT00889863|20759900|P1|STARTED|Part II: Randomized Double Blind||50
8423658|NCT00889863|20759899|P2|NOT COMPLETED|Part I: Open Label||0
8423659|NCT00889863|20759900|P1|NOT COMPLETED|Part I: Open Label||77
8423660|NCT00889863|20759899|P2|COMPLETED|Part I: Open Label||0
8423661|NCT00889863|20759900|P1|COMPLETED|Part I: Open Label||100
8423662|NCT00889863|20759899|P2|Entered Part 1d|Part I: Open Label||0
8423663|NCT00889863|20759900|P1|Entered Part 1d|Part I: Open Label||103
8423664|NCT00889863|20759899|P2|Entered Part Ic|Part I: Open Label||0
8423665|NCT00889863|20759900|P1|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
8423666|NCT00889863|20759899|P2|Entered Part Ib|Part I: Open Label||0
8423667|NCT00889863|20759900|P1|Entered Part Ib|Part I: Open Label||142
8423668|NCT00889863|20759899|P2|Entered Part Ia|Part I: Open Label||0
8423669|NCT00889863|20759900|P1|Entered Part Ia|Part I: Open Label||145
8423670|NCT00889863|20759899|P2|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
8423671|NCT00889863|20759900|P1|STARTED|Part I: Open Label||177
8423672|NCT00889824|20759922|P1|NOT COMPLETED|Overall Study||0
8423673|NCT00889824|20759922|P1|COMPLETED|Overall Study||5
8423674|NCT00889824|20759922|P1|STARTED|Overall Study||5
8423675|NCT00889720|20759926|P1|NOT COMPLETED|Overall Study||8
8423676|NCT00889720|20759926|P1|COMPLETED|Overall Study||8
8423677|NCT00889720|20759926|P1|Surgical Population|Overall Study||12
8423678|NCT00889720|20759926|P1|STARTED|Overall Study||16
8423679|NCT00889707|20759953|P2|NOT COMPLETED|Overall Study||10
8423680|NCT00889707|20759954|P1|NOT COMPLETED|Overall Study||7
8423681|NCT00889707|20759953|P2|COMPLETED|Overall Study||21
8423682|NCT00889707|20759954|P1|COMPLETED|Overall Study||54
8423683|NCT00889707|20759953|P2|STARTED|Overall Study||31
8423684|NCT00889707|20759954|P1|STARTED|Overall Study||61
8423685|NCT00889681|20759962|P1|NOT COMPLETED|Overall Study||3
8423686|NCT00889681|20759962|P1|COMPLETED|Overall Study||78
8423687|NCT00889681|20759962|P1|Received Treatment|Overall Study||78
8423688|NCT00889681|20759962|P1|STARTED|Overall Study||81
8423689|NCT00889603|20759969|P1|NOT COMPLETED|Overall Study||37
8423690|NCT00889603|20759969|P1|COMPLETED|Overall Study||333
8423691|NCT00889603|20759969|P1|STARTED|Overall Study||370
8423692|NCT00889512|20759984|P2|NOT COMPLETED|Overall Study||0
8423693|NCT00889512|20759985|P1|NOT COMPLETED|Overall Study||0
8423694|NCT00889512|20759984|P2|COMPLETED|Overall Study||9
8423695|NCT00889512|20759985|P1|COMPLETED|Overall Study||5
8423696|NCT00889512|20759984|P2|STARTED|Overall Study||9
8423697|NCT00889512|20759985|P1|STARTED|Overall Study||5
8423698|NCT00889421|20759991|P1|NOT COMPLETED|Overall Study||3
8423699|NCT00889421|20759991|P1|COMPLETED|Overall Study||0
8423700|NCT00889421|20759991|P1|STARTED|Overall Study||3
8423701|NCT00889330|20760001|P2|NOT COMPLETED|Overall Study||0
8423702|NCT00889330|20760002|P1|NOT COMPLETED|Overall Study||0
8423703|NCT00889330|20760001|P2|COMPLETED|Overall Study||30
8423704|NCT00889330|20760002|P1|COMPLETED|Overall Study||30
8423705|NCT00889330|20760001|P2|STARTED|Overall Study||30
8423706|NCT00889330|20760002|P1|STARTED|Overall Study||30
8423707|NCT00889265|20760032|P1|NOT COMPLETED|Overall Study||7
8423708|NCT00889265|20760032|P1|COMPLETED|Overall Study||44
8423709|NCT00889265|20760032|P1|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
8423710|NCT00889252|20760039|P2|NOT COMPLETED|Overall Study||4
8423711|NCT00889252|20760040|P1|NOT COMPLETED|Overall Study||7
8423712|NCT00889252|20760039|P2|COMPLETED|Overall Study||78
8423713|NCT00889252|20760040|P1|COMPLETED|Overall Study||161
8423714|NCT00889252|20760039|P2|STARTED|Overall Study||82
8423715|NCT00889252|20760040|P1|STARTED|Overall Study||168
8423716|NCT00889226|20760084|P2|NOT COMPLETED|Overall Study||35
8423717|NCT00889226|20760085|P1|NOT COMPLETED|Overall Study||25
8423718|NCT00889226|20760084|P2|COMPLETED|Overall Study||43
8423719|NCT00889226|20760085|P1|COMPLETED|Overall Study||58
8423720|NCT00889226|20760084|P2|STARTED|Overall Study||78
8423721|NCT00889226|20760085|P1|STARTED|Overall Study||83
8423722|NCT00889200|20760093|P1|NOT COMPLETED|Overall Study||0
8423723|NCT00889200|20760093|P1|COMPLETED|Overall Study||12
8423724|NCT00889200|20760093|P1|STARTED|Overall Study||12
8423725|NCT00889187|20760097|P4|NOT COMPLETED|Overall Study||0
8423726|NCT00889187|20760098|P3|NOT COMPLETED|Overall Study||0
8423727|NCT00889187|20760099|P2|NOT COMPLETED|Overall Study||0
8423728|NCT00889187|20760100|P1|NOT COMPLETED|Overall Study||0
8423729|NCT00889187|20760097|P4|COMPLETED|Overall Study||0
8423730|NCT00889187|20760098|P3|COMPLETED|Overall Study||4
8423731|NCT00889187|20760099|P2|COMPLETED|Overall Study||3
8423732|NCT00889187|20760100|P1|COMPLETED|Overall Study||3
8423733|NCT00889187|20760097|P4|STARTED|Overall Study||0
8423734|NCT00889187|20760098|P3|STARTED|Overall Study||4
8423735|NCT00889187|20760099|P2|STARTED|Overall Study||3
8423736|NCT00889187|20760100|P1|STARTED|Overall Study||3
8423737|NCT00889005|20760117|P2|NOT COMPLETED|Overall Study||2
8423738|NCT00889005|20760118|P1|NOT COMPLETED|Overall Study||8
8423739|NCT00889005|20760117|P2|COMPLETED|Overall Study||72
8423740|NCT00889005|20760118|P1|COMPLETED|Overall Study||57
8423741|NCT00889005|20760117|P2|STARTED|Overall Study||74
8423742|NCT00889005|20760118|P1|STARTED|Overall Study||65
8423743|NCT00888979|20760124|P1|NOT COMPLETED|Overall Study||4
8423744|NCT00888979|20760124|P1|COMPLETED|Overall Study||6
8423745|NCT00888979|20760124|P1|Received the Inhaler/Counseling|Overall Study||8
8423746|NCT00888979|20760124|P1|STARTED|Overall Study||10
8423747|NCT00888940|20760132|P2|NOT COMPLETED|Overall Study||21
8423748|NCT00888940|20760133|P1|NOT COMPLETED|Overall Study||28
8423749|NCT00888940|20760132|P2|COMPLETED|Overall Study||101
8423750|NCT00888940|20760133|P1|COMPLETED|Overall Study||92
8423751|NCT00888940|20760132|P2|Completed Therapy|Overall Study||106
8423752|NCT00888940|20760133|P1|Completed Therapy|Overall Study||107
8423753|NCT00888940|20760132|P2|STARTED|Overall Study||122
8423754|NCT00888940|20760133|P1|STARTED|Overall Study||120
8423755|NCT00888927|20760145|P4|NOT COMPLETED|Overall Study||2
8423756|NCT00888927|20760146|P3|NOT COMPLETED|Overall Study||0
8423757|NCT00888927|20760147|P2|NOT COMPLETED|Overall Study||0
8423758|NCT00888927|20760148|P1|NOT COMPLETED|Overall Study||0
8423759|NCT00888927|20760145|P4|COMPLETED|Overall Study||31
8423760|NCT00888927|20760146|P3|COMPLETED|Overall Study||3
8423761|NCT00888927|20760147|P2|COMPLETED|Overall Study||3
8423762|NCT00888927|20760148|P1|COMPLETED|Overall Study||3
8423763|NCT00888927|20760145|P4|STARTED|Overall Study||33
8423764|NCT00888927|20760146|P3|STARTED|Overall Study||3
8423765|NCT00888927|20760147|P2|STARTED|Overall Study||3
8423766|NCT00888927|20760148|P1|STARTED|Overall Study||3
8423767|NCT00888849|20760164|P2|NOT COMPLETED|Overall Study||9
8423768|NCT00888849|20760165|P1|NOT COMPLETED|Overall Study||5
8423769|NCT00888849|20760164|P2|COMPLETED|Overall Study||129
8423770|NCT00888849|20760165|P1|COMPLETED|Overall Study||137
8423771|NCT00888849|20760164|P2|STARTED|Overall Study||138
8423772|NCT00888849|20760165|P1|STARTED|Overall Study||142
8423773|NCT00888654|20760175|P1|NOT COMPLETED|Overall Study||10
8423774|NCT00888654|20760175|P1|COMPLETED|Overall Study||31
8423775|NCT00888654|20760175|P1|STARTED|Overall Study||41
8423776|NCT00888628|20760181|P1|NOT COMPLETED|Overall Study||3
8423777|NCT00888628|20760181|P1|COMPLETED|Overall Study||4
8423778|NCT00888628|20760181|P1|Transplanted|Overall Study||4
8423779|NCT00888628|20760181|P1|Withdrawn|Overall Study||1
8423780|NCT00888628|20760181|P1|Screen Failure|Overall Study||2
8423781|NCT00888628|20760181|P1|Enrolled|Overall Study||7
8423782|NCT00888628|20760181|P1|STARTED|Overall Study||7
8423783|NCT00888615|20760193|P1|NOT COMPLETED|Overall Study||2
8423784|NCT00888615|20760193|P1|COMPLETED|Overall Study||56
8423785|NCT00888615|20760193|P1|STARTED|Overall Study||58
8423786|NCT00888511|20760202|P1|NOT COMPLETED|Overall Study||0
8423787|NCT00888511|20760202|P1|COMPLETED|Overall Study||15
8423788|NCT00888511|20760202|P1|STARTED|Overall Study||15
8423789|NCT00888459|20760208|P2|NOT COMPLETED|Overall Study||0
8423790|NCT00888459|20760209|P1|NOT COMPLETED|Overall Study||0
8423791|NCT00888459|20760208|P2|COMPLETED|Overall Study||30
8423792|NCT00888459|20760209|P1|COMPLETED|Overall Study||30
8423793|NCT00888459|20760208|P2|STARTED|Overall Study||30
8423794|NCT00888459|20760209|P1|STARTED|Overall Study||30
8423795|NCT00888433|20760217|P2|NOT COMPLETED|Overall Study||3
8423796|NCT00888433|20760218|P1|NOT COMPLETED|Overall Study||3
8423797|NCT00888433|20760217|P2|COMPLETED|Overall Study||51
8423798|NCT00888433|20760218|P1|COMPLETED|Overall Study||49
8423799|NCT00888433|20760217|P2|STARTED|Overall Study||54
8423800|NCT00888433|20760218|P1|STARTED|Overall Study||52
8423801|NCT00888381|20760226|P2|NOT COMPLETED|Overall Study||1
8423802|NCT00888381|20760227|P1|NOT COMPLETED|Overall Study||0
8423803|NCT00888381|20760226|P2|COMPLETED|Overall Study||59
8423804|NCT00888381|20760227|P1|COMPLETED|Overall Study||60
8423805|NCT00888381|20760226|P2|STARTED|Overall Study||60
8423806|NCT00888381|20760227|P1|STARTED|Overall Study||60
8423807|NCT00888355|20760247|P4|NOT COMPLETED|Overall Study||10
8423808|NCT00888355|20760248|P3|NOT COMPLETED|Overall Study||12
8423809|NCT00888355|20760249|P2|NOT COMPLETED|Overall Study||9
8423810|NCT00888355|20760250|P1|NOT COMPLETED|Overall Study||22
8423811|NCT00888355|20760247|P4|COMPLETED|Overall Study||96
8423812|NCT00888355|20760248|P3|COMPLETED|Overall Study||94
8423813|NCT00888355|20760249|P2|COMPLETED|Overall Study||99
8423814|NCT00888355|20760250|P1|COMPLETED|Overall Study||86
8423815|NCT00888355|20760247|P4|STARTED|Overall Study||106
8423816|NCT00888355|20760248|P3|STARTED|Overall Study||106
8423817|NCT00888355|20760249|P2|STARTED|Overall Study||108
8423818|NCT00888355|20760250|P1|STARTED|Overall Study||108
8423819|NCT00888329|20760306|P2|NOT COMPLETED|Overall Study||9
8423820|NCT00888329|20760307|P1|NOT COMPLETED|Overall Study||6
8423821|NCT00888329|20760306|P2|COMPLETED|Overall Study||122
8423822|NCT00888329|20760307|P1|COMPLETED|Overall Study||119
8423823|NCT00888329|20760306|P2|STARTED|Overall Study||131
8423824|NCT00888329|20760307|P1|STARTED|Overall Study||125
8423825|NCT00888238|20760313|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
8423826|NCT00888238|20760314|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
8423827|NCT00888238|20760315|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
8423828|NCT00888238|20760313|P3|COMPLETED|Third Period of Treatment Intervention||3
8423829|NCT00888238|20760314|P2|COMPLETED|Third Period of Treatment Intervention||4
8423830|NCT00888238|20760315|P1|COMPLETED|Third Period of Treatment Intervention||4
8423831|NCT00888238|20760313|P3|STARTED|Third Period of Treatment Intervention||3
8423832|NCT00888238|20760314|P2|STARTED|Third Period of Treatment Intervention||4
8423833|NCT00888238|20760315|P1|STARTED|Third Period of Treatment Intervention||4
8423834|NCT00888238|20760313|P3|NOT COMPLETED|Washout Period After Period 2||1
8423835|NCT00888238|20760314|P2|NOT COMPLETED|Washout Period After Period 2||0
8423836|NCT00888238|20760315|P1|NOT COMPLETED|Washout Period After Period 2||0
8423837|NCT00888238|20760313|P3|COMPLETED|Washout Period After Period 2||3
8423838|NCT00888238|20760314|P2|COMPLETED|Washout Period After Period 2||4
8423839|NCT00888238|20760315|P1|COMPLETED|Washout Period After Period 2||4
8423840|NCT00888238|20760313|P3|STARTED|Washout Period After Period 2||4
8423841|NCT00888238|20760314|P2|STARTED|Washout Period After Period 2||4
8423842|NCT00888238|20760315|P1|STARTED|Washout Period After Period 2||4
8423843|NCT00888238|20760313|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
8423844|NCT00888238|20760314|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
8423845|NCT00888238|20760315|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
8423846|NCT00888238|20760313|P3|COMPLETED|Second Period of Treatment Intervention||4
8423847|NCT00888238|20760314|P2|COMPLETED|Second Period of Treatment Intervention||4
8423848|NCT00888238|20760315|P1|COMPLETED|Second Period of Treatment Intervention||4
8423849|NCT00888238|20760313|P3|STARTED|Second Period of Treatment Intervention||4
8423850|NCT00888238|20760314|P2|STARTED|Second Period of Treatment Intervention||4
8423851|NCT00888238|20760315|P1|STARTED|Second Period of Treatment Intervention||4
8423852|NCT00888238|20760313|P3|NOT COMPLETED|Washout Period After Period 1||0
8423853|NCT00888238|20760314|P2|NOT COMPLETED|Washout Period After Period 1||0
8423854|NCT00888238|20760315|P1|NOT COMPLETED|Washout Period After Period 1||0
8423855|NCT00888238|20760313|P3|COMPLETED|Washout Period After Period 1||4
8423856|NCT00888238|20760314|P2|COMPLETED|Washout Period After Period 1||4
8423857|NCT00888238|20760315|P1|COMPLETED|Washout Period After Period 1||4
8423858|NCT00888238|20760313|P3|STARTED|Washout Period After Period 1||4
8423859|NCT00888238|20760314|P2|STARTED|Washout Period After Period 1||4
8423860|NCT00888238|20760315|P1|STARTED|Washout Period After Period 1||4
8423861|NCT00888238|20760313|P3|NOT COMPLETED|First Period of Treatment Intervention||0
8423862|NCT00888238|20760314|P2|NOT COMPLETED|First Period of Treatment Intervention||0
8423952|NCT00887588|20760553|P1|Arterial Stiffness Set|Core Period||86
8423863|NCT00888238|20760315|P1|NOT COMPLETED|First Period of Treatment Intervention||0
8423864|NCT00888238|20760313|P3|COMPLETED|First Period of Treatment Intervention||4
8423865|NCT00888238|20760314|P2|COMPLETED|First Period of Treatment Intervention||4
8423866|NCT00888238|20760315|P1|COMPLETED|First Period of Treatment Intervention||4
8423867|NCT00888238|20760313|P3|STARTED|First Period of Treatment Intervention||4
8423868|NCT00888238|20760314|P2|STARTED|First Period of Treatment Intervention||4
8423869|NCT00888238|20760315|P1|STARTED|First Period of Treatment Intervention||4
8423870|NCT00888173|20760323|P1|NOT COMPLETED|Overall Study||2
8423871|NCT00888173|20760323|P1|COMPLETED|Overall Study||43
8423872|NCT00888173|20760323|P1|STARTED|Overall Study||45
8423873|NCT00888134|20760331|P1|NOT COMPLETED|Follow-up||1
8423874|NCT00888134|20760331|P1|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
8423875|NCT00888134|20760331|P1|STARTED|Follow-up||27
8423876|NCT00888134|20760331|P1|NOT COMPLETED|Treatment With Study Drug||1
8423877|NCT00888134|20760331|P1|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
8423878|NCT00888134|20760331|P1|STARTED|Treatment With Study Drug||28
8423879|NCT00887978|20760341|P2|NOT COMPLETED|Overall Study||15
8423880|NCT00887978|20760342|P1|NOT COMPLETED|Overall Study||25
8423881|NCT00887978|20760341|P2|COMPLETED|Overall Study||138
8423882|NCT00887978|20760342|P1|COMPLETED|Overall Study||132
8423883|NCT00887978|20760341|P2|STARTED|Overall Study||153
8423884|NCT00887978|20760342|P1|STARTED|Overall Study||157
8423885|NCT00887965|20760378|P1|NOT COMPLETED|Overall Study||0
8423886|NCT00887965|20760378|P1|COMPLETED|Overall Study||15
8423887|NCT00887965|20760378|P1|STARTED|Overall Study||15
8423888|NCT00887926|20760412|P4|NOT COMPLETED|Overall Study||0
8423889|NCT00887926|20760413|P3|NOT COMPLETED|Overall Study||0
8423890|NCT00887926|20760414|P2|NOT COMPLETED|Overall Study||1
8423891|NCT00887926|20760415|P1|NOT COMPLETED|Overall Study||0
8423892|NCT00887926|20760412|P4|COMPLETED|Overall Study||5
8423893|NCT00887926|20760413|P3|COMPLETED|Overall Study||3
8423894|NCT00887926|20760414|P2|COMPLETED|Overall Study||13
8423895|NCT00887926|20760415|P1|COMPLETED|Overall Study||3
8423896|NCT00887926|20760412|P4|Received at Least 1 Dose of Study Drug|Overall Study||5
8423897|NCT00887926|20760413|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8423898|NCT00887926|20760414|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
8423899|NCT00887926|20760415|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8423900|NCT00887926|20760412|P4|STARTED|Overall Study||5
8423901|NCT00887926|20760413|P3|STARTED|Overall Study||3
8423902|NCT00887926|20760414|P2|STARTED|Overall Study||14
8423903|NCT00887926|20760415|P1|STARTED|Overall Study||3
8423904|NCT00887913|20760450|P1|NOT COMPLETED|Overall Study||6
8423905|NCT00887913|20760450|P1|COMPLETED|Overall Study||63
8423906|NCT00887913|20760450|P1|STARTED|Overall Study||69
8423907|NCT00887822|20760458|P2|NOT COMPLETED|Overall Study||102
8423908|NCT00887822|20760459|P1|NOT COMPLETED|Overall Study||97
8423909|NCT00887822|20760458|P2|COMPLETED|Overall Study||0
8423910|NCT00887822|20760459|P1|COMPLETED|Overall Study||3
8423911|NCT00887822|20760458|P2|Treated (Safety Population)|Overall Study||101
8423912|NCT00887822|20760459|P1|Treated (Safety Population)|Overall Study||100
8423913|NCT00887822|20760458|P2|STARTED|Overall Study||102
8423914|NCT00887822|20760459|P1|STARTED|Overall Study||100
8423915|NCT00887809|20760491|P2|NOT COMPLETED|Overall Study||0
8423916|NCT00887809|20760492|P1|NOT COMPLETED|Overall Study||4
8423917|NCT00887809|20760491|P2|COMPLETED|Overall Study||10
8423918|NCT00887809|20760492|P1|COMPLETED|Overall Study||33
8423919|NCT00887809|20760491|P2|STARTED|Overall Study||10
8423920|NCT00887809|20760492|P1|STARTED|Overall Study||37
8423921|NCT00887783|20760500|P2|NOT COMPLETED|Overall Study||0
8423922|NCT00887783|20760501|P1|NOT COMPLETED|Overall Study||0
8423923|NCT00887783|20760500|P2|COMPLETED|Overall Study||59
8423924|NCT00887783|20760501|P1|COMPLETED|Overall Study||58
8423925|NCT00887783|20760500|P2|STARTED|Overall Study||59
8423926|NCT00887783|20760501|P1|STARTED|Overall Study||58
8423927|NCT00887744|20760513|P1|NOT COMPLETED|Overall Study||34
8423928|NCT00887744|20760513|P1|COMPLETED|Overall Study||128
8423929|NCT00887744|20760513|P1|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
8423930|NCT00887679|20760522|P1|NOT COMPLETED|Overall Study||10
8423931|NCT00887679|20760522|P1|COMPLETED|Overall Study|20 subjects completed the study.|20
8423932|NCT00887679|20760522|P1|STARTED|Overall Study||30
8423933|NCT00887653|20760531|P1|NOT COMPLETED|Overall Study||0
8423934|NCT00887653|20760531|P1|COMPLETED|Overall Study||20
8423935|NCT00887653|20760531|P1|STARTED|Overall Study||20
8423936|NCT00887640|20760537|P1|NOT COMPLETED|Overall Study||0
8423937|NCT00887640|20760537|P1|COMPLETED|Overall Study||11
8423938|NCT00887640|20760537|P1|STARTED|Overall Study||11
8423939|NCT00887588|20760552|P2|NOT COMPLETED|Extension Period||5
8423940|NCT00887588|20760553|P1|NOT COMPLETED|Extension Period||6
8423941|NCT00887588|20760552|P2|COMPLETED|Extension Period||120
8423942|NCT00887588|20760553|P1|COMPLETED|Extension Period||121
8423943|NCT00887588|20760552|P2|Arterial Stiffness Set|Extension Period||94
8423944|NCT00887588|20760553|P1|Arterial Stiffness Set|Extension Period||86
8423945|NCT00887588|20760552|P2|STARTED|Extension Period||125
8423946|NCT00887588|20760553|P1|STARTED|Extension Period||127
8423947|NCT00887588|20760552|P2|NOT COMPLETED|Core Period||21
8423948|NCT00887588|20760553|P1|NOT COMPLETED|Core Period||19
8423949|NCT00887588|20760552|P2|COMPLETED|Core Period||131
8423950|NCT00887588|20760553|P1|COMPLETED|Core Period||130
8423951|NCT00887588|20760552|P2|Arterial Stiffness Set|Core Period||94
8423953|NCT00887588|20760552|P2|Full Analysis Set|Core Period||146
8423954|NCT00887588|20760553|P1|Full Analysis Set|Core Period||148
8423955|NCT00887588|20760552|P2|Extension Efficacy Set|Core Period||125
8423956|NCT00887588|20760553|P1|Extension Efficacy Set|Core Period||127
8423957|NCT00887588|20760552|P2|STARTED|Core Period||152
8423958|NCT00887588|20760553|P1|STARTED|Core Period||149
8423959|NCT00887575|20760605|P3|NOT COMPLETED|Phase II - Maintenance Therapy||0
8423960|NCT00887575|20760606|P2|NOT COMPLETED|Phase II - Maintenance Therapy||0
8423961|NCT00887575|20760607|P1|NOT COMPLETED|Phase II - Maintenance Therapy||2
8423962|NCT00887575|20760605|P3|COMPLETED|Phase II - Maintenance Therapy||0
8423963|NCT00887575|20760606|P2|COMPLETED|Phase II - Maintenance Therapy||0
8423964|NCT00887575|20760607|P1|COMPLETED|Phase II - Maintenance Therapy||6
8423965|NCT00887575|20760605|P3|STARTED|Phase II - Maintenance Therapy||0
8423966|NCT00887575|20760606|P2|STARTED|Phase II - Maintenance Therapy||0
8423967|NCT00887575|20760607|P1|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
8423968|NCT00887575|20760605|P3|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
8423969|NCT00887575|20760606|P2|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
8423970|NCT00887575|20760607|P1|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
8423971|NCT00887575|20760605|P3|COMPLETED|Phase II - Neoadjuvant Therapy||0
8423972|NCT00887575|20760606|P2|COMPLETED|Phase II - Neoadjuvant Therapy||0
8423973|NCT00887575|20760607|P1|COMPLETED|Phase II - Neoadjuvant Therapy||16
8423974|NCT00887575|20760605|P3|STARTED|Phase II - Neoadjuvant Therapy||0
8423975|NCT00887575|20760606|P2|STARTED|Phase II - Neoadjuvant Therapy||0
8423976|NCT00887575|20760607|P1|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
8423977|NCT00887575|20760605|P3|NOT COMPLETED|Phase I||3
8423978|NCT00887575|20760606|P2|NOT COMPLETED|Phase I||6
8423979|NCT00887575|20760607|P1|NOT COMPLETED|Phase I||0
8423980|NCT00887575|20760605|P3|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8423981|NCT00887575|20760606|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8423982|NCT00887575|20760607|P1|COMPLETED|Phase I||6
8423983|NCT00887575|20760605|P3|STARTED|Phase I||3
8423984|NCT00887575|20760606|P2|STARTED|Phase I||6
8423985|NCT00887575|20760607|P1|STARTED|Phase I||6
8423986|NCT00887562|20760618|P3|NOT COMPLETED|Overall Study||1
8423987|NCT00887562|20760619|P2|NOT COMPLETED|Overall Study||2
8423988|NCT00887562|20760620|P1|NOT COMPLETED|Overall Study||3
8423989|NCT00887562|20760618|P3|COMPLETED|Overall Study||7
8423990|NCT00887562|20760619|P2|COMPLETED|Overall Study||7
8423991|NCT00887562|20760620|P1|COMPLETED|Overall Study||7
8423992|NCT00887562|20760618|P3|STARTED|Overall Study||8
8423993|NCT00887562|20760619|P2|STARTED|Overall Study||9
8423994|NCT00887562|20760620|P1|STARTED|Overall Study||10
8423995|NCT00887549|20760634|P1|NOT COMPLETED|Maintenance Therapy||43
8423996|NCT00887549|20760634|P1|COMPLETED|Maintenance Therapy||0
8423997|NCT00887549|20760634|P1|STARTED|Maintenance Therapy||43
8423998|NCT00887549|20760634|P1|NOT COMPLETED|Induction Therapy||27
8423999|NCT00887549|20760634|P1|COMPLETED|Induction Therapy||43
8424000|NCT00887549|20760634|P1|STARTED|Induction Therapy||70
8424001|NCT00887510|20760643|P2|NOT COMPLETED|Overall Study||0
8424002|NCT00887510|20760644|P1|NOT COMPLETED|Overall Study||0
8424003|NCT00887510|20760643|P2|COMPLETED|Overall Study||12
8424004|NCT00887510|20760644|P1|COMPLETED|Overall Study||12
8424005|NCT00887510|20760643|P2|STARTED|Overall Study||12
8424006|NCT00887510|20760644|P1|STARTED|Overall Study||12
8424007|NCT00887484|20760652|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
8424008|NCT00887484|20760652|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
8424009|NCT00887484|20760652|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||48
8424010|NCT00887484|20760652|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
8424011|NCT00887484|20760652|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
8424012|NCT00887484|20760652|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||48
8424013|NCT00887471|20760718|P2|NOT COMPLETED|Overall Study||0
8424014|NCT00887471|20760719|P1|NOT COMPLETED|Overall Study||0
8424015|NCT00887471|20760718|P2|COMPLETED|Overall Study||15
8424016|NCT00887471|20760719|P1|COMPLETED|Overall Study||15
8424017|NCT00887471|20760718|P2|STARTED|Overall Study||15
8424018|NCT00887471|20760719|P1|STARTED|Overall Study||15
8424019|NCT00887458|20760729|P2|NOT COMPLETED|Overall Study||4
8424020|NCT00887458|20760730|P1|NOT COMPLETED|Overall Study||0
8424021|NCT00887458|20760729|P2|COMPLETED|Overall Study||25
8424022|NCT00887458|20760730|P1|COMPLETED|Overall Study||17
8424023|NCT00887458|20760729|P2|STARTED|Overall Study||29
8424024|NCT00887458|20760730|P1|STARTED|Overall Study||17
8424025|NCT00887354|20760740|P2|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
8424026|NCT00887354|20760741|P1|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
8424027|NCT00887354|20760740|P2|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
8424028|NCT00887354|20760741|P1|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
8424029|NCT00887354|20760740|P2|STARTED|Open Label Phase (Week 26 to Week 78)||65
8424030|NCT00887354|20760741|P1|STARTED|Open Label Phase (Week 26 to Week 78)||60
8424031|NCT00887354|20760740|P2|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
8424032|NCT00887354|20760741|P1|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
8424033|NCT00887354|20760740|P2|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
8424034|NCT00887354|20760741|P1|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
8424035|NCT00887354|20760740|P2|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
8424114|NCT00887224|20760845|P2|COMPLETED|Open-label Stability (OLS) Phase||0
8424036|NCT00887354|20760741|P1|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
8424037|NCT00887354|20760740|P2|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
8424038|NCT00887354|20760741|P1|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
8424039|NCT00887354|20760740|P2|STARTED|Treatment Phase (Week 0 to Week 26)||113
8424040|NCT00887354|20760741|P1|STARTED|Treatment Phase (Week 0 to Week 26)||111
8424041|NCT00887341|20760761|P2|NOT COMPLETED|Overall Study||3
8424042|NCT00887341|20760762|P1|NOT COMPLETED|Overall Study||2
8424043|NCT00887341|20760761|P2|COMPLETED|Overall Study||36
8424044|NCT00887341|20760762|P1|COMPLETED|Overall Study||35
8424045|NCT00887341|20760761|P2|STARTED|Overall Study||39
8424046|NCT00887341|20760762|P1|STARTED|Overall Study||37
8424047|NCT00887315|20760798|P2|NOT COMPLETED|Overall Study||4
8424048|NCT00887315|20760799|P1|NOT COMPLETED|Overall Study||7
8424049|NCT00887315|20760798|P2|COMPLETED|Overall Study||0
8424050|NCT00887315|20760799|P1|COMPLETED|Overall Study||0
8424051|NCT00887315|20760798|P2|STARTED|Overall Study||4
8424052|NCT00887315|20760799|P1|STARTED|Overall Study||7
8424053|NCT00887289|20760807|P1|NOT COMPLETED|Overall Study||95
8424054|NCT00887289|20760807|P1|COMPLETED|Overall Study||1409
8424055|NCT00887289|20760807|P1|STARTED|Overall Study||1504
8424056|NCT00887250|20760819|P3|NOT COMPLETED|Overall Study||13
8424057|NCT00887250|20760820|P2|NOT COMPLETED|Overall Study||12
8424058|NCT00887250|20760821|P1|NOT COMPLETED|Overall Study||18
8424059|NCT00887250|20760819|P3|COMPLETED|Overall Study||110
8424060|NCT00887250|20760820|P2|COMPLETED|Overall Study||115
8424061|NCT00887250|20760821|P1|COMPLETED|Overall Study||98
8424062|NCT00887250|20760819|P3|STARTED|Overall Study||123
8424063|NCT00887250|20760820|P2|STARTED|Overall Study||127
8424064|NCT00887250|20760821|P1|STARTED|Overall Study||116
8424065|NCT00887224|20760844|P3|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
8424066|NCT00887224|20760845|P2|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
8424067|NCT00887224|20760846|P1|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
8424068|NCT00887224|20760844|P3|COMPLETED|DB Taper Phase / Post Study Follow Up||235
8424069|NCT00887224|20760845|P2|COMPLETED|DB Taper Phase / Post Study Follow Up||226
8424070|NCT00887224|20760846|P1|COMPLETED|DB Taper Phase / Post Study Follow Up||0
8424071|NCT00887224|20760844|P3|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
8424072|NCT00887224|20760845|P2|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
8424073|NCT00887224|20760846|P1|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
8424074|NCT00887224|20760844|P3|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
8424075|NCT00887224|20760845|P2|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
8424076|NCT00887224|20760846|P1|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
8424077|NCT00887224|20760844|P3|STARTED|DB Taper Phase / Post Study Follow Up||265
8424078|NCT00887224|20760845|P2|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
8424079|NCT00887224|20760846|P1|STARTED|DB Taper Phase / Post Study Follow Up||0
8424080|NCT00887224|20760844|P3|NOT COMPLETED|Double-blind (DB) Phase||62
8424081|NCT00887224|20760845|P2|NOT COMPLETED|Double-blind (DB) Phase||100
8424082|NCT00887224|20760846|P1|NOT COMPLETED|Double-blind (DB) Phase||0
8424083|NCT00887224|20760844|P3|COMPLETED|Double-blind (DB) Phase||210
8424084|NCT00887224|20760845|P2|COMPLETED|Double-blind (DB) Phase||176
8424085|NCT00887224|20760846|P1|COMPLETED|Double-blind (DB) Phase||0
8424086|NCT00887224|20760844|P3|STARTED|Double-blind (DB) Phase||272
8424087|NCT00887224|20760845|P2|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
8424088|NCT00887224|20760846|P1|STARTED|Double-blind (DB) Phase||0
8424089|NCT00887224|20760844|P3|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
8424090|NCT00887224|20760845|P2|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
8424091|NCT00887224|20760846|P1|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
8424092|NCT00887224|20760844|P3|COMPLETED|OL Taper Phase / OL Follow Up||0
8424093|NCT00887224|20760845|P2|COMPLETED|OL Taper Phase / OL Follow Up||0
8424094|NCT00887224|20760846|P1|COMPLETED|OL Taper Phase / OL Follow Up||163
8424095|NCT00887224|20760844|P3|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
8424096|NCT00887224|20760845|P2|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
8424097|NCT00887224|20760846|P1|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
8424098|NCT00887224|20760844|P3|STARTED|OL Taper Phase / OL Follow Up||0
8424099|NCT00887224|20760845|P2|STARTED|OL Taper Phase / OL Follow Up||0
8424100|NCT00887224|20760846|P1|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
8424101|NCT00887224|20760844|P3|NOT COMPLETED|Between OLS and DB Phases||0
8424102|NCT00887224|20760845|P2|NOT COMPLETED|Between OLS and DB Phases||0
8424103|NCT00887224|20760846|P1|NOT COMPLETED|Between OLS and DB Phases||28
8424104|NCT00887224|20760844|P3|COMPLETED|Between OLS and DB Phases||0
8424105|NCT00887224|20760845|P2|COMPLETED|Between OLS and DB Phases||0
8424106|NCT00887224|20760846|P1|COMPLETED|Between OLS and DB Phases||548
8424107|NCT00887224|20760844|P3|STARTED|Between OLS and DB Phases||0
8424108|NCT00887224|20760845|P2|STARTED|Between OLS and DB Phases||0
8424109|NCT00887224|20760846|P1|STARTED|Between OLS and DB Phases||576
8424110|NCT00887224|20760844|P3|NOT COMPLETED|Open-label Stability (OLS) Phase||0
8424111|NCT00887224|20760845|P2|NOT COMPLETED|Open-label Stability (OLS) Phase||0
8424112|NCT00887224|20760846|P1|NOT COMPLETED|Open-label Stability (OLS) Phase||83
8424113|NCT00887224|20760844|P3|COMPLETED|Open-label Stability (OLS) Phase||0
8424115|NCT00887224|20760846|P1|COMPLETED|Open-label Stability (OLS) Phase||576
8424116|NCT00887224|20760844|P3|STARTED|Open-label Stability (OLS) Phase||0
8424117|NCT00887224|20760845|P2|STARTED|Open-label Stability (OLS) Phase||0
8424118|NCT00887224|20760846|P1|STARTED|Open-label Stability (OLS) Phase||659
8424119|NCT00887224|20760844|P3|NOT COMPLETED|Between OLR and OLS Phases||0
8424120|NCT00887224|20760845|P2|NOT COMPLETED|Between OLR and OLS Phases||0
8424121|NCT00887224|20760846|P1|NOT COMPLETED|Between OLR and OLS Phases||93
8424122|NCT00887224|20760844|P3|COMPLETED|Between OLR and OLS Phases||0
8424123|NCT00887224|20760845|P2|COMPLETED|Between OLR and OLS Phases||0
8424124|NCT00887224|20760846|P1|COMPLETED|Between OLR and OLS Phases||659
8424125|NCT00887224|20760844|P3|STARTED|Between OLR and OLS Phases||0
8424126|NCT00887224|20760845|P2|STARTED|Between OLR and OLS Phases||0
8424127|NCT00887224|20760846|P1|STARTED|Between OLR and OLS Phases||752
8424128|NCT00887224|20760844|P3|NOT COMPLETED|Open-label Response (OLR) Phase||0
8424129|NCT00887224|20760845|P2|NOT COMPLETED|Open-label Response (OLR) Phase||0
8424130|NCT00887224|20760846|P1|NOT COMPLETED|Open-label Response (OLR) Phase||122
8424131|NCT00887224|20760844|P3|COMPLETED|Open-label Response (OLR) Phase||0
8424132|NCT00887224|20760845|P2|COMPLETED|Open-label Response (OLR) Phase||0
8424133|NCT00887224|20760846|P1|COMPLETED|Open-label Response (OLR) Phase||752
8424134|NCT00887224|20760844|P3|STARTED|Open-label Response (OLR) Phase||0
8424135|NCT00887224|20760845|P2|STARTED|Open-label Response (OLR) Phase||0
8424136|NCT00887224|20760846|P1|STARTED|Open-label Response (OLR) Phase||874
8424137|NCT00887198|20760873|P3|NOT COMPLETED|Cross Over (Placebo to AA)||93
8424138|NCT00887198|20760874|P2|NOT COMPLETED|Cross Over (Placebo to AA)||0
8424139|NCT00887198|20760875|P1|NOT COMPLETED|Cross Over (Placebo to AA)||0
8424140|NCT00887198|20760873|P3|COMPLETED|Cross Over (Placebo to AA)||0
8424141|NCT00887198|20760874|P2|COMPLETED|Cross Over (Placebo to AA)||0
8424142|NCT00887198|20760875|P1|COMPLETED|Cross Over (Placebo to AA)||0
8424143|NCT00887198|20760873|P3|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
8424144|NCT00887198|20760874|P2|STARTED|Cross Over (Placebo to AA)||0
8424145|NCT00887198|20760875|P1|STARTED|Cross Over (Placebo to AA)||0
8424146|NCT00887198|20760873|P3|NOT COMPLETED|Randomized Period||0
8424147|NCT00887198|20760874|P2|NOT COMPLETED|Randomized Period||542
8424148|NCT00887198|20760875|P1|NOT COMPLETED|Randomized Period||546
8424149|NCT00887198|20760873|P3|COMPLETED|Randomized Period||0
8424150|NCT00887198|20760874|P2|COMPLETED|Randomized Period||0
8424151|NCT00887198|20760875|P1|COMPLETED|Randomized Period||0
8424152|NCT00887198|20760873|P3|Treated|Randomized Period||0
8424153|NCT00887198|20760874|P2|Treated|Randomized Period||540
8424154|NCT00887198|20760875|P1|Treated|Randomized Period||542
8424155|NCT00887198|20760873|P3|STARTED|Randomized Period||0
8424156|NCT00887198|20760874|P2|STARTED|Randomized Period||542
8424157|NCT00887198|20760875|P1|STARTED|Randomized Period||546
8424158|NCT00887159|20760906|P3|NOT COMPLETED|Overall Study||56
8424159|NCT00887159|20760907|P2|NOT COMPLETED|Overall Study||56
8424160|NCT00887159|20760908|P1|NOT COMPLETED|Overall Study||29
8424161|NCT00887159|20760906|P3|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
8424162|NCT00887159|20760907|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
8424163|NCT00887159|20760908|P1|COMPLETED|Overall Study||27
8424164|NCT00887159|20760906|P3|Eligible/Treated Pts With CTCs Results|Overall Study||38
8424165|NCT00887159|20760907|P2|Eligible/Treated Pts With CTCs Results|Overall Study||42
8424166|NCT00887159|20760908|P1|Eligible/Treated Pts With CTCs Results|Overall Study||40
8424167|NCT00887159|20760906|P3|Eligible and Treated Patients|Overall Study||52
8424168|NCT00887159|20760907|P2|Eligible and Treated Patients|Overall Study||52
8424169|NCT00887159|20760908|P1|Eligible and Treated Patients|Overall Study||48
8424170|NCT00887159|20760906|P3|Patients Who Started Assigned Treatment|Overall Study||52
8424171|NCT00887159|20760907|P2|Patients Who Started Assigned Treatment|Overall Study||53
8424172|NCT00887159|20760908|P1|Patients Who Started Assigned Treatment|Overall Study||53
8424173|NCT00887159|20760906|P3|STARTED|Overall Study||56
8424174|NCT00887159|20760907|P2|STARTED|Overall Study||56
8424175|NCT00887159|20760908|P1|STARTED|Overall Study||56
8424176|NCT00887068|20760926|P2|NOT COMPLETED|Overall Study||0
8424177|NCT00887068|20760927|P1|NOT COMPLETED|Overall Study||6
8424178|NCT00887068|20760926|P2|COMPLETED|Overall Study||94
8424179|NCT00887068|20760927|P1|COMPLETED|Overall Study||87
8424180|NCT00887068|20760926|P2|STARTED|Overall Study||94
8424181|NCT00887068|20760927|P1|STARTED|Overall Study||93
8424182|NCT00886938|20760935|P1|NOT COMPLETED|Overall Study||2
8424183|NCT00886938|20760935|P1|COMPLETED|Overall Study||10
8424184|NCT00886938|20760935|P1|STARTED|Overall Study||12
8424185|NCT00886899|20760939|P1|NOT COMPLETED|Overall Study||0
8424186|NCT00886899|20760939|P1|COMPLETED|Overall Study||147
8424187|NCT00886899|20760939|P1|STARTED|Overall Study||147
8424188|NCT00886834|20760948|P2|NOT COMPLETED|Overall Study||3
8424189|NCT00886834|20760949|P1|NOT COMPLETED|Overall Study||0
8424190|NCT00886834|20760948|P2|COMPLETED|Overall Study||51
8424191|NCT00886834|20760949|P1|COMPLETED|Overall Study||54
8424192|NCT00886834|20760948|P2|STARTED|Overall Study||54
8424193|NCT00886834|20760949|P1|STARTED|Overall Study||54
8424194|NCT00886821|20760971|P14|NOT COMPLETED|Stage 2||1
8424195|NCT00886821|20760972|P13|NOT COMPLETED|Stage 2||5
8424196|NCT00886821|20760973|P12|NOT COMPLETED|Stage 2||1
8424197|NCT00886821|20760974|P11|NOT COMPLETED|Stage 2||0
8424198|NCT00886821|20760975|P10|NOT COMPLETED|Stage 2||0
8424199|NCT00886821|20760976|P9|NOT COMPLETED|Stage 2||0
8424200|NCT00886821|20760977|P8|NOT COMPLETED|Stage 2||0
8424201|NCT00886821|20760978|P7|NOT COMPLETED|Stage 2||0
8424202|NCT00886821|20760979|P6|NOT COMPLETED|Stage 2||0
8424203|NCT00886821|20760980|P5|NOT COMPLETED|Stage 2||0
8424204|NCT00886821|20760981|P4|NOT COMPLETED|Stage 2||0
8424205|NCT00886821|20760982|P3|NOT COMPLETED|Stage 2||0
8424206|NCT00886821|20760983|P2|NOT COMPLETED|Stage 2||0
8424207|NCT00886821|20760984|P1|NOT COMPLETED|Stage 2||0
8424208|NCT00886821|20760971|P14|COMPLETED|Stage 2||8
8424209|NCT00886821|20760972|P13|COMPLETED|Stage 2||8
8424210|NCT00886821|20760973|P12|COMPLETED|Stage 2||8
8424211|NCT00886821|20760974|P11|COMPLETED|Stage 2||9
8424212|NCT00886821|20760975|P10|COMPLETED|Stage 2||0
8424213|NCT00886821|20760976|P9|COMPLETED|Stage 2||0
8424214|NCT00886821|20760977|P8|COMPLETED|Stage 2||0
8424215|NCT00886821|20760978|P7|COMPLETED|Stage 2||0
8424216|NCT00886821|20760979|P6|COMPLETED|Stage 2||0
8424217|NCT00886821|20760980|P5|COMPLETED|Stage 2||0
8424218|NCT00886821|20760981|P4|COMPLETED|Stage 2||0
8424219|NCT00886821|20760982|P3|COMPLETED|Stage 2||0
8424220|NCT00886821|20760983|P2|COMPLETED|Stage 2||0
8424221|NCT00886821|20760984|P1|COMPLETED|Stage 2||0
8424222|NCT00886821|20760971|P14|STARTED|Stage 2||9
8424223|NCT00886821|20760972|P13|STARTED|Stage 2||13
8424224|NCT00886821|20760973|P12|STARTED|Stage 2||9
8424225|NCT00886821|20760974|P11|STARTED|Stage 2||9
8424226|NCT00886821|20760975|P10|STARTED|Stage 2||0
8424227|NCT00886821|20760976|P9|STARTED|Stage 2||0
8424228|NCT00886821|20760977|P8|STARTED|Stage 2||0
8424229|NCT00886821|20760978|P7|STARTED|Stage 2||0
8424230|NCT00886821|20760979|P6|STARTED|Stage 2||0
8424231|NCT00886821|20760980|P5|STARTED|Stage 2||0
8424232|NCT00886821|20760981|P4|STARTED|Stage 2||0
8424233|NCT00886821|20760982|P3|STARTED|Stage 2||0
8424234|NCT00886821|20760983|P2|STARTED|Stage 2||0
8424235|NCT00886821|20760984|P1|STARTED|Stage 2||0
8424236|NCT00886821|20760971|P14|NOT COMPLETED|Stage 1||0
8424237|NCT00886821|20760972|P13|NOT COMPLETED|Stage 1||0
8424238|NCT00886821|20760973|P12|NOT COMPLETED|Stage 1||0
8424239|NCT00886821|20760974|P11|NOT COMPLETED|Stage 1||0
8424240|NCT00886821|20760975|P10|NOT COMPLETED|Stage 1||0
8424241|NCT00886821|20760976|P9|NOT COMPLETED|Stage 1||0
8424242|NCT00886821|20760977|P8|NOT COMPLETED|Stage 1||0
8424243|NCT00886821|20760978|P7|NOT COMPLETED|Stage 1||0
8424244|NCT00886821|20760979|P6|NOT COMPLETED|Stage 1||0
8424245|NCT00886821|20760980|P5|NOT COMPLETED|Stage 1||0
8424246|NCT00886821|20760981|P4|NOT COMPLETED|Stage 1||0
8424247|NCT00886821|20760982|P3|NOT COMPLETED|Stage 1||0
8424248|NCT00886821|20760983|P2|NOT COMPLETED|Stage 1||0
8424249|NCT00886821|20760984|P1|NOT COMPLETED|Stage 1||0
8424250|NCT00886821|20760971|P14|COMPLETED|Stage 1||0
8424251|NCT00886821|20760972|P13|COMPLETED|Stage 1||0
8424252|NCT00886821|20760973|P12|COMPLETED|Stage 1||0
8424253|NCT00886821|20760974|P11|COMPLETED|Stage 1||0
8424254|NCT00886821|20760975|P10|COMPLETED|Stage 1||18
8424255|NCT00886821|20760976|P9|COMPLETED|Stage 1||6
8424256|NCT00886821|20760977|P8|COMPLETED|Stage 1||6
8424257|NCT00886821|20760978|P7|COMPLETED|Stage 1||6
8424258|NCT00886821|20760979|P6|COMPLETED|Stage 1||6
8424259|NCT00886821|20760980|P5|COMPLETED|Stage 1||6
8424260|NCT00886821|20760981|P4|COMPLETED|Stage 1||7
8424261|NCT00886821|20760982|P3|COMPLETED|Stage 1||6
8424262|NCT00886821|20760983|P2|COMPLETED|Stage 1||6
8424263|NCT00886821|20760984|P1|COMPLETED|Stage 1||7
8424264|NCT00886821|20760971|P14|STARTED|Stage 1||0
8424265|NCT00886821|20760972|P13|STARTED|Stage 1||0
8424266|NCT00886821|20760973|P12|STARTED|Stage 1||0
8424267|NCT00886821|20760974|P11|STARTED|Stage 1||0
8424268|NCT00886821|20760975|P10|STARTED|Stage 1||18
8424269|NCT00886821|20760976|P9|STARTED|Stage 1||6
8424270|NCT00886821|20760977|P8|STARTED|Stage 1||6
8424271|NCT00886821|20760978|P7|STARTED|Stage 1||6
8424272|NCT00886821|20760979|P6|STARTED|Stage 1||6
8424273|NCT00886821|20760980|P5|STARTED|Stage 1||6
8424274|NCT00886821|20760981|P4|STARTED|Stage 1||7
8424275|NCT00886821|20760982|P3|STARTED|Stage 1||6
8424276|NCT00886821|20760983|P2|STARTED|Stage 1||6
8424277|NCT00886821|20760984|P1|STARTED|Stage 1||7
8424278|NCT00886795|20761209|P1|NOT COMPLETED|Overall Study||1
8424279|NCT00886795|20761209|P1|COMPLETED|Overall Study||3
8424280|NCT00886795|20761209|P1|STARTED|Overall Study||4
8424281|NCT00886769|20761216|P2|NOT COMPLETED|Overall Study||37
8424282|NCT00886769|20761217|P1|NOT COMPLETED|Overall Study||6
8424283|NCT00886769|20761216|P2|COMPLETED|Overall Study||4
8424284|NCT00886769|20761217|P1|COMPLETED|Overall Study||37
8424285|NCT00886769|20761216|P2|STARTED|Overall Study||41
8424286|NCT00886769|20761217|P1|STARTED|Overall Study||43
8424287|NCT00886743|20761241|P1|NOT COMPLETED|Overall Study||4
8424288|NCT00886743|20761241|P1|COMPLETED|Overall Study||15
8424289|NCT00886743|20761241|P1|STARTED|Overall Study|Received treatment|19
8424290|NCT00886704|20761251|P2|NOT COMPLETED|Overall Study||0
8424291|NCT00886704|20761252|P1|NOT COMPLETED|Overall Study||0
8424292|NCT00886704|20761251|P2|COMPLETED|Overall Study||10
8424293|NCT00886704|20761252|P1|COMPLETED|Overall Study||40
8424294|NCT00886704|20761251|P2|STARTED|Overall Study||10
8424295|NCT00886704|20761252|P1|STARTED|Overall Study||40
8424296|NCT00886691|20761262|P2|NOT COMPLETED|Overall Study||0
8424297|NCT00886691|20761263|P1|NOT COMPLETED|Overall Study||0
8424298|NCT00886691|20761262|P2|COMPLETED|Overall Study||75
8424299|NCT00886691|20761263|P1|COMPLETED|Overall Study||75
8424300|NCT00886691|20761262|P2|STARTED|Overall Study||75
8424301|NCT00886691|20761263|P1|STARTED|Overall Study||75
8424302|NCT00886639|20761279|P1|NOT COMPLETED|Overall Study||16
8424303|NCT00886639|20761279|P1|COMPLETED|Overall Study||111
8424304|NCT00886639|20761279|P1|STARTED|Overall Study||127
8424305|NCT00886626|20761283|P2|NOT COMPLETED|Period 2 (90 Days)||0
8424306|NCT00886626|20761284|P1|NOT COMPLETED|Period 2 (90 Days)||0
8424307|NCT00886626|20761283|P2|COMPLETED|Period 2 (90 Days)||6
8424308|NCT00886626|20761284|P1|COMPLETED|Period 2 (90 Days)||5
8424309|NCT00886626|20761283|P2|STARTED|Period 2 (90 Days)||6
8424310|NCT00886626|20761284|P1|STARTED|Period 2 (90 Days)||5
8424311|NCT00886626|20761283|P2|NOT COMPLETED|Period 1 (90 Days)||0
8424312|NCT00886626|20761284|P1|NOT COMPLETED|Period 1 (90 Days)||1
8424313|NCT00886626|20761283|P2|COMPLETED|Period 1 (90 Days)||6
8424314|NCT00886626|20761284|P1|COMPLETED|Period 1 (90 Days)||5
8424315|NCT00886626|20761283|P2|STARTED|Period 1 (90 Days)||6
8424316|NCT00886626|20761284|P1|STARTED|Period 1 (90 Days)||6
8424317|NCT00886613|20761293|P3|NOT COMPLETED|Overall Study||3
8424318|NCT00886613|20761294|P2|NOT COMPLETED|Overall Study||0
8424319|NCT00886613|20761295|P1|NOT COMPLETED|Overall Study||2
8424320|NCT00886613|20761293|P3|COMPLETED|Overall Study||37
8424321|NCT00886613|20761294|P2|COMPLETED|Overall Study||39
8424322|NCT00886613|20761295|P1|COMPLETED|Overall Study||39
8424323|NCT00886613|20761293|P3|STARTED|Overall Study||40
8424324|NCT00886613|20761294|P2|STARTED|Overall Study||39
8424325|NCT00886613|20761295|P1|STARTED|Overall Study||41
8424326|NCT00886600|20761317|P4|NOT COMPLETED|Combination Therapy Period||0
8424327|NCT00886600|20761318|P3|NOT COMPLETED|Combination Therapy Period||2
8424328|NCT00886600|20761319|P2|NOT COMPLETED|Combination Therapy Period||0
8424329|NCT00886600|20761320|P1|NOT COMPLETED|Combination Therapy Period||0
8424330|NCT00886600|20761317|P4|COMPLETED|Combination Therapy Period||23
8424331|NCT00886600|20761318|P3|COMPLETED|Combination Therapy Period||19
8424332|NCT00886600|20761319|P2|COMPLETED|Combination Therapy Period||21
8424333|NCT00886600|20761320|P1|COMPLETED|Combination Therapy Period||28
8424334|NCT00886600|20761317|P4|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
8424335|NCT00886600|20761318|P3|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
8424336|NCT00886600|20761319|P2|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
8424337|NCT00886600|20761320|P1|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
8424338|NCT00886600|20761317|P4|NOT COMPLETED|Double-blind Monotherapy||2
8424339|NCT00886600|20761318|P3|NOT COMPLETED|Double-blind Monotherapy||1
8424340|NCT00886600|20761319|P2|NOT COMPLETED|Double-blind Monotherapy||1
8424341|NCT00886600|20761320|P1|NOT COMPLETED|Double-blind Monotherapy||2
8424342|NCT00886600|20761317|P4|COMPLETED|Double-blind Monotherapy||29
8424343|NCT00886600|20761318|P3|COMPLETED|Double-blind Monotherapy||29
8424344|NCT00886600|20761319|P2|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
8424345|NCT00886600|20761320|P1|COMPLETED|Double-blind Monotherapy||30
8424346|NCT00886600|20761317|P4|STARTED|Double-blind Monotherapy||31
8424347|NCT00886600|20761318|P3|STARTED|Double-blind Monotherapy||30
8424348|NCT00886600|20761319|P2|STARTED|Double-blind Monotherapy||29
8424349|NCT00886600|20761320|P1|STARTED|Double-blind Monotherapy||32
8424350|NCT00886587|20761344|P2|NOT COMPLETED|Overall Study||2
8424351|NCT00886587|20761345|P1|NOT COMPLETED|Overall Study||4
8424352|NCT00886587|20761344|P2|COMPLETED|Overall Study||39
8424353|NCT00886587|20761345|P1|COMPLETED|Overall Study||37
8424354|NCT00886587|20761344|P2|STARTED|Overall Study||41
8424355|NCT00886587|20761345|P1|STARTED|Overall Study||41
8424356|NCT00886483|20761359|P2|NOT COMPLETED|Overall Study||3
8424357|NCT00886483|20761360|P1|NOT COMPLETED|Overall Study||2
8424358|NCT00886483|20761359|P2|COMPLETED|Overall Study||10
8424359|NCT00886483|20761360|P1|COMPLETED|Overall Study||24
8424360|NCT00886483|20761359|P2|Completed 20 Treatments|Overall Study||11
8424361|NCT00886483|20761360|P1|Completed 20 Treatments|Overall Study||25
8424362|NCT00886483|20761359|P2|STARTED|Overall Study||13
8424363|NCT00886483|20761360|P1|STARTED|Overall Study||26
8424364|NCT00886340|20761378|P2|NOT COMPLETED|Overall Study||7
8424365|NCT00886340|20761379|P1|NOT COMPLETED|Overall Study||0
8424366|NCT00886340|20761378|P2|COMPLETED|Overall Study||24
8424367|NCT00886340|20761379|P1|COMPLETED|Overall Study||27
8424368|NCT00886340|20761378|P2|STARTED|Overall Study||31
8424369|NCT00886340|20761379|P1|STARTED|Overall Study||27
8424370|NCT00886288|20761387|P2|NOT COMPLETED|Overall Study||227
8424371|NCT00886288|20761388|P1|NOT COMPLETED|Overall Study||743
8424372|NCT00886288|20761387|P2|COMPLETED|Overall Study||457
8424373|NCT00886288|20761388|P1|COMPLETED|Overall Study||1284
8424374|NCT00886288|20761387|P2|STARTED|Overall Study|Baseline Population|684
8424375|NCT00886288|20761388|P1|STARTED|Overall Study|Baseline Population|2027
8424376|NCT00886262|20761406|P2|NOT COMPLETED|Overall Study||3
8424377|NCT00886262|20761407|P1|NOT COMPLETED|Overall Study||0
8424378|NCT00886262|20761406|P2|COMPLETED|Overall Study||7
8424379|NCT00886262|20761407|P1|COMPLETED|Overall Study||8
8424380|NCT00886262|20761406|P2|STARTED|Overall Study||10
8424381|NCT00886262|20761407|P1|STARTED|Overall Study||8
8424382|NCT00886236|20761422|P3|NOT COMPLETED|Overall Study||4
8424383|NCT00886236|20761423|P2|NOT COMPLETED|Overall Study||4
8424384|NCT00886236|20761424|P1|NOT COMPLETED|Overall Study||2
8424385|NCT00886236|20761422|P3|COMPLETED|Overall Study||17
8424386|NCT00886236|20761423|P2|COMPLETED|Overall Study||17
8424387|NCT00886236|20761424|P1|COMPLETED|Overall Study||18
8424388|NCT00886236|20761422|P3|STARTED|Overall Study||21
8424389|NCT00886236|20761423|P2|STARTED|Overall Study||21
8424390|NCT00886236|20761424|P1|STARTED|Overall Study||20
8424391|NCT00886145|20761438|P1|NOT COMPLETED|Overall Study||0
8424392|NCT00886145|20761438|P1|COMPLETED|Overall Study||1
8424393|NCT00886145|20761438|P1|STARTED|Overall Study||1
8424394|NCT00886119|20761444|P2|NOT COMPLETED|Period 2||0
8424395|NCT00886119|20761445|P1|NOT COMPLETED|Period 2||0
8424396|NCT00886119|20761444|P2|COMPLETED|Period 2||22
8424397|NCT00886119|20761445|P1|COMPLETED|Period 2||23
8424398|NCT00886119|20761444|P2|STARTED|Period 2||22
8424399|NCT00886119|20761445|P1|STARTED|Period 2||23
8424400|NCT00886119|20761444|P2|NOT COMPLETED|Period 1||0
8424401|NCT00886119|20761445|P1|NOT COMPLETED|Period 1||1
8424402|NCT00886119|20761444|P2|COMPLETED|Period 1||22
8424403|NCT00886119|20761445|P1|COMPLETED|Period 1||23
8424404|NCT00886119|20761444|P2|STARTED|Period 1||22
8424405|NCT00886119|20761445|P1|STARTED|Period 1||24
8424406|NCT00886015|20761453|P2|NOT COMPLETED|Overall Study||2
8424407|NCT00886015|20761454|P1|NOT COMPLETED|Overall Study||0
8424408|NCT00886015|20761453|P2|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
8424409|NCT00886015|20761454|P1|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
8424410|NCT00886015|20761453|P2|STARTED|Overall Study|1671 eyes; 957 participants|1671
8424411|NCT00886015|20761454|P1|STARTED|Overall Study|1674 eyes; 960 participants|1674
8424412|NCT00885846|20761473|P3|NOT COMPLETED|Overall Study||2
8424413|NCT00885846|20761474|P2|NOT COMPLETED|Overall Study||5
8424414|NCT00885846|20761475|P1|NOT COMPLETED|Overall Study||2
8424415|NCT00885846|20761473|P3|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
8424416|NCT00885846|20761474|P2|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
8424417|NCT00885846|20761475|P1|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
8424418|NCT00885846|20761473|P3|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
8424419|NCT00885846|20761474|P2|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
8424420|NCT00885846|20761475|P1|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
8424421|NCT00885768|20761483|P1|NOT COMPLETED|Overall Study||0
8424422|NCT00885768|20761483|P1|COMPLETED|Overall Study|all patients with including criteria completed the study|146
8424423|NCT00885768|20761483|P1|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
8424424|NCT00885755|20761490|P3|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
8424425|NCT00885755|20761491|P2|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
8424426|NCT00885755|20761492|P1|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
8424427|NCT00885755|20761490|P3|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
8424428|NCT00885755|20761491|P2|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
8424429|NCT00885755|20761492|P1|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
8424430|NCT00885755|20761490|P3|STARTED|Part II: Trastuzumab + Capecitabine.||0
8424431|NCT00885755|20761491|P2|STARTED|Part II: Trastuzumab + Capecitabine.||1
8424432|NCT00885755|20761492|P1|STARTED|Part II: Trastuzumab + Capecitabine.||13
8424433|NCT00885755|20761490|P3|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
8424434|NCT00885755|20761491|P2|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
8424435|NCT00885755|20761492|P1|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
8424436|NCT00885755|20761490|P3|COMPLETED|Part I: Trastuzumab+Taxane||0
8424437|NCT00885755|20761491|P2|COMPLETED|Part I: Trastuzumab+Taxane||1
8424438|NCT00885755|20761492|P1|COMPLETED|Part I: Trastuzumab+Taxane||13
8424439|NCT00885755|20761490|P3|STARTED|Part I: Trastuzumab+Taxane||1
8424440|NCT00885755|20761491|P2|STARTED|Part I: Trastuzumab+Taxane||1
8424441|NCT00885755|20761492|P1|STARTED|Part I: Trastuzumab+Taxane||31
8424442|NCT00885742|20761517|P1|NOT COMPLETED|Overall Study||0
8424443|NCT00885742|20761517|P1|COMPLETED|Overall Study||41
8424444|NCT00885742|20761517|P1|STARTED|Overall Study||41
8424445|NCT00885703|20761535|P7|NOT COMPLETED|Overall Study||6
8424446|NCT00885703|20761536|P6|NOT COMPLETED|Overall Study||13
8424447|NCT00885703|20761537|P5|NOT COMPLETED|Overall Study||12
8424448|NCT00885703|20761538|P4|NOT COMPLETED|Overall Study||9
8424449|NCT00885703|20761539|P3|NOT COMPLETED|Overall Study||11
8424450|NCT00885703|20761540|P2|NOT COMPLETED|Overall Study||10
8424451|NCT00885703|20761541|P1|NOT COMPLETED|Overall Study||10
8424452|NCT00885703|20761535|P7|COMPLETED|Overall Study||18
8424453|NCT00885703|20761536|P6|COMPLETED|Overall Study||11
8424454|NCT00885703|20761537|P5|COMPLETED|Overall Study||12
8424455|NCT00885703|20761538|P4|COMPLETED|Overall Study||15
8424456|NCT00885703|20761539|P3|COMPLETED|Overall Study||13
8424457|NCT00885703|20761540|P2|COMPLETED|Overall Study||16
8424458|NCT00885703|20761541|P1|COMPLETED|Overall Study||12
8424459|NCT00885703|20761535|P7|STARTED|Overall Study||24
8424460|NCT00885703|20761536|P6|STARTED|Overall Study||24
8424461|NCT00885703|20761537|P5|STARTED|Overall Study||24
8424462|NCT00885703|20761538|P4|STARTED|Overall Study||24
8424463|NCT00885703|20761539|P3|STARTED|Overall Study||24
8424464|NCT00885703|20761540|P2|STARTED|Overall Study||26
8424465|NCT00885703|20761541|P1|STARTED|Overall Study||22
8424466|NCT00885677|20761599|P2|NOT COMPLETED|Overall Study||178
8424467|NCT00885677|20761600|P1|NOT COMPLETED|Overall Study||183
8424468|NCT00885677|20761599|P2|COMPLETED|Overall Study||277
8424469|NCT00885677|20761600|P1|COMPLETED|Overall Study||279
8424470|NCT00885677|20761599|P2|Intention To Treat|Overall Study||428
8424471|NCT00885677|20761600|P1|Intention To Treat|Overall Study||437
8424472|NCT00885677|20761599|P2|STARTED|Overall Study||455
8424473|NCT00885677|20761600|P1|STARTED|Overall Study||462
8424474|NCT00885638|20761608|P2|NOT COMPLETED|Overall Study||0
8424475|NCT00885638|20761609|P1|NOT COMPLETED|Overall Study||0
8424476|NCT00885638|20761608|P2|COMPLETED|Overall Study||6
8424477|NCT00885638|20761609|P1|COMPLETED|Overall Study||6
8424478|NCT00885638|20761608|P2|STARTED|Overall Study||6
8424479|NCT00885638|20761609|P1|STARTED|Overall Study||6
8424480|NCT00885534|20761616|P1|NOT COMPLETED|Overall Study||1
8424481|NCT00885534|20761616|P1|COMPLETED|Overall Study||6
8424482|NCT00885534|20761616|P1|STARTED|Overall Study||7
8424483|NCT00885482|20761620|P1|NOT COMPLETED|Overall Study||4
8424484|NCT00885482|20761620|P1|COMPLETED|Overall Study||36
8424485|NCT00885482|20761620|P1|STARTED|Overall Study||40
8424486|NCT00885378|20761626|P2|NOT COMPLETED|Overall Study||8
8424487|NCT00885378|20761627|P1|NOT COMPLETED|Overall Study||8
8424488|NCT00885378|20761626|P2|COMPLETED|Overall Study||78
8424489|NCT00885378|20761627|P1|COMPLETED|Overall Study||66
8424490|NCT00885378|20761626|P2|STARTED|Overall Study|Number randomized.|86
8424491|NCT00885378|20761627|P1|STARTED|Overall Study|Number randomized.|74
8424492|NCT00885365|20761657|P2|NOT COMPLETED|4 Weeks OFF Treatment||0
8424493|NCT00885365|20761658|P1|NOT COMPLETED|4 Weeks OFF Treatment||0
8424494|NCT00885365|20761657|P2|COMPLETED|4 Weeks OFF Treatment||159
8424495|NCT00885365|20761658|P1|COMPLETED|4 Weeks OFF Treatment||155
8424496|NCT00885365|20761657|P2|STARTED|4 Weeks OFF Treatment||159
8424497|NCT00885365|20761658|P1|STARTED|4 Weeks OFF Treatment||155
8424498|NCT00885365|20761657|P2|NOT COMPLETED|4 Weeks ON Treatment||6
8424499|NCT00885365|20761658|P1|NOT COMPLETED|4 Weeks ON Treatment||4
8424500|NCT00885365|20761657|P2|COMPLETED|4 Weeks ON Treatment||159
8424501|NCT00885365|20761658|P1|COMPLETED|4 Weeks ON Treatment||155
8424502|NCT00885365|20761657|P2|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
8424503|NCT00885365|20761658|P1|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
8424504|NCT00885365|20761657|P2|Intent-to-Treat Population|4 Weeks ON Treatment||163
8424505|NCT00885365|20761658|P1|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
8424506|NCT00885365|20761657|P2|STARTED|4 Weeks ON Treatment||165
8424507|NCT00885365|20761658|P1|STARTED|4 Weeks ON Treatment||159
8424508|NCT00885352|20761694|P2|NOT COMPLETED|Overall Study||20
8424509|NCT00885352|20761695|P1|NOT COMPLETED|Overall Study||8
8424510|NCT00885352|20761694|P2|COMPLETED|Overall Study||136
8424511|NCT00885352|20761695|P1|COMPLETED|Overall Study||149
8424512|NCT00885352|20761694|P2|STARTED|Overall Study||156
8424513|NCT00885352|20761695|P1|STARTED|Overall Study||157
8424514|NCT00885170|20761707|P2|NOT COMPLETED|Overall Study||23
8424515|NCT00885170|20761708|P1|NOT COMPLETED|Overall Study||38
8424516|NCT00885170|20761707|P2|COMPLETED|Overall Study||99
8424517|NCT00885170|20761708|P1|COMPLETED|Overall Study||86
8424518|NCT00885170|20761707|P2|Treated|Overall Study||121
8424519|NCT00885170|20761708|P1|Treated|Overall Study||122
8424520|NCT00885170|20761707|P2|STARTED|Overall Study||122
8424521|NCT00885170|20761708|P1|STARTED|Overall Study||124
8424522|NCT00885118|20761767|P5|NOT COMPLETED|Overall Study||1
8424523|NCT00885118|20761768|P4|NOT COMPLETED|Overall Study||0
8424524|NCT00885118|20761769|P3|NOT COMPLETED|Overall Study||1
8424525|NCT00885118|20761770|P2|NOT COMPLETED|Overall Study||0
8424526|NCT00885118|20761771|P1|NOT COMPLETED|Overall Study||1
8424527|NCT00885118|20761767|P5|COMPLETED|Overall Study||18
8424528|NCT00885118|20761768|P4|COMPLETED|Overall Study||20
8424529|NCT00885118|20761769|P3|COMPLETED|Overall Study||20
8424530|NCT00885118|20761770|P2|COMPLETED|Overall Study||19
8424531|NCT00885118|20761771|P1|COMPLETED|Overall Study||20
8424532|NCT00885118|20761767|P5|STARTED|Overall Study||19
8424533|NCT00885118|20761768|P4|STARTED|Overall Study||20
8424534|NCT00885118|20761769|P3|STARTED|Overall Study||21
8424535|NCT00885118|20761770|P2|STARTED|Overall Study||19
8424536|NCT00885118|20761771|P1|STARTED|Overall Study||21
8424537|NCT00885105|20761910|P2|NOT COMPLETED|Overall Study||10
8424538|NCT00885105|20761911|P1|NOT COMPLETED|Overall Study||1
8424539|NCT00885105|20761910|P2|COMPLETED|Overall Study||120
8424540|NCT00885105|20761911|P1|COMPLETED|Overall Study||111
8424541|NCT00885105|20761910|P2|STARTED|Overall Study||130
8424542|NCT00885105|20761911|P1|STARTED|Overall Study||112
8424543|NCT00885092|20761929|P2|NOT COMPLETED|Period 2, 7 Days||0
8424544|NCT00885092|20761930|P1|NOT COMPLETED|Period 2, 7 Days||0
8424545|NCT00885092|20761929|P2|COMPLETED|Period 2, 7 Days||20
8424546|NCT00885092|20761930|P1|COMPLETED|Period 2, 7 Days||20
8424547|NCT00885092|20761929|P2|STARTED|Period 2, 7 Days||20
8424548|NCT00885092|20761930|P1|STARTED|Period 2, 7 Days||20
8424549|NCT00885092|20761929|P2|NOT COMPLETED|Period 1, 7 Days||0
8424550|NCT00885092|20761930|P1|NOT COMPLETED|Period 1, 7 Days||0
8424551|NCT00885092|20761929|P2|COMPLETED|Period 1, 7 Days||20
8424552|NCT00885092|20761930|P1|COMPLETED|Period 1, 7 Days||20
8424553|NCT00885092|20761929|P2|STARTED|Period 1, 7 Days||20
8424554|NCT00885092|20761930|P1|STARTED|Period 1, 7 Days||20
8424555|NCT00885079|20761942|P2|NOT COMPLETED|Overall Study||4
8424556|NCT00885079|20761943|P1|NOT COMPLETED|Overall Study||2
8424557|NCT00885079|20761942|P2|COMPLETED|Overall Study||91
8424558|NCT00885079|20761943|P1|COMPLETED|Overall Study||91
8424559|NCT00885079|20761942|P2|STARTED|Overall Study||95
8424560|NCT00885079|20761943|P1|STARTED|Overall Study||93
8424561|NCT00884949|20761951|P1|NOT COMPLETED|Continuation Period||0
8424562|NCT00884949|20761951|P1|COMPLETED|Continuation Period||18
8424563|NCT00884949|20761951|P1|STARTED|Continuation Period||18
8424564|NCT00884949|20761951|P1|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
8424565|NCT00884949|20761951|P1|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
8424566|NCT00884949|20761951|P1|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
8424567|NCT00884949|20761951|P1|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
8424568|NCT00884949|20761951|P1|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
8424569|NCT00884949|20761951|P1|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
8424570|NCT00884949|20761951|P1|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
8424571|NCT00884949|20761951|P1|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
8424572|NCT00884949|20761951|P1|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
8424573|NCT00884910|20761968|P1|NOT COMPLETED|Overall Study||1
8424574|NCT00884910|20761968|P1|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
8424575|NCT00884910|20761968|P1|STARTED|Overall Study||33
8424576|NCT00884897|20761975|P2|NOT COMPLETED|Overall Study||0
8424577|NCT00884897|20761976|P1|NOT COMPLETED|Overall Study||0
8424578|NCT00884897|20761975|P2|COMPLETED|Overall Study||15
8424579|NCT00884897|20761976|P1|COMPLETED|Overall Study||13
8424580|NCT00884897|20761975|P2|STARTED|Overall Study||15
8424581|NCT00884897|20761976|P1|STARTED|Overall Study||13
8424582|NCT00884832|20761986|P2|NOT COMPLETED|Overall Study||1
8424583|NCT00884832|20761987|P1|NOT COMPLETED|Overall Study||0
8424584|NCT00884832|20761986|P2|COMPLETED|Overall Study||21
8424585|NCT00884832|20761987|P1|COMPLETED|Overall Study||22
8424586|NCT00884832|20761986|P2|STARTED|Overall Study||22
8424587|NCT00884832|20761987|P1|STARTED|Overall Study||22
8424588|NCT00884806|20762017|P1|NOT COMPLETED|Overall Study||0
8424589|NCT00884806|20762017|P1|COMPLETED|Overall Study||110
8424590|NCT00884806|20762017|P1|STARTED|Overall Study||110
8424591|NCT00884793|20762022|P1|NOT COMPLETED|Overall Study||1
8424592|NCT00884793|20762022|P1|COMPLETED|Overall Study||7
8424593|NCT00884793|20762022|P1|STARTED|Overall Study||8
8424594|NCT00884754|20762031|P2|NOT COMPLETED|Overall Study||0
8424595|NCT00884754|20762032|P1|NOT COMPLETED|Overall Study||0
8424596|NCT00884754|20762031|P2|COMPLETED|Overall Study||30
8424597|NCT00884754|20762032|P1|COMPLETED|Overall Study||30
8424598|NCT00884754|20762031|P2|STARTED|Overall Study||30
8424599|NCT00884754|20762032|P1|STARTED|Overall Study||30
8424600|NCT00884741|20762041|P4|NOT COMPLETED|Randomization||8
8424601|NCT00884741|20762042|P3|NOT COMPLETED|Randomization||8
8424602|NCT00884741|20762043|P2|NOT COMPLETED|Randomization||0
8424603|NCT00884741|20762044|P1|NOT COMPLETED|Randomization||0
8424604|NCT00884741|20762041|P4|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
8424605|NCT00884741|20762042|P3|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
8424606|NCT00884741|20762043|P2|COMPLETED|Randomization||0
8424607|NCT00884741|20762044|P1|COMPLETED|Randomization||0
8424608|NCT00884741|20762041|P4|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
8424609|NCT00884741|20762042|P3|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
8424610|NCT00884741|20762043|P2|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
8424611|NCT00884741|20762044|P1|STARTED|Randomization||0
8424612|NCT00884741|20762041|P4|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
8424613|NCT00884741|20762042|P3|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
8424614|NCT00884741|20762043|P2|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
8424615|NCT00884741|20762044|P1|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
8424616|NCT00884741|20762041|P4|COMPLETED|Step 2 Registration: Tissue Analysis||0
8424617|NCT00884741|20762042|P3|COMPLETED|Step 2 Registration: Tissue Analysis||0
8424618|NCT00884741|20762043|P2|COMPLETED|Step 2 Registration: Tissue Analysis||637
8424619|NCT00884741|20762044|P1|COMPLETED|Step 2 Registration: Tissue Analysis||0
8424620|NCT00884741|20762041|P4|STARTED|Step 2 Registration: Tissue Analysis||0
8424621|NCT00884741|20762042|P3|STARTED|Step 2 Registration: Tissue Analysis||0
8424622|NCT00884741|20762043|P2|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
8424623|NCT00884741|20762044|P1|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
8424624|NCT00884741|20762041|P4|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
8424625|NCT00884741|20762042|P3|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
8424626|NCT00884741|20762043|P2|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
8424627|NCT00884741|20762044|P1|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
8424628|NCT00884741|20762041|P4|COMPLETED|Step 1 Registration: Tissue Screening||0
8424629|NCT00884741|20762042|P3|COMPLETED|Step 1 Registration: Tissue Screening||0
8424630|NCT00884741|20762043|P2|COMPLETED|Step 1 Registration: Tissue Screening||0
8424631|NCT00884741|20762044|P1|COMPLETED|Step 1 Registration: Tissue Screening||666
8424632|NCT00884741|20762041|P4|STARTED|Step 1 Registration: Tissue Screening||0
8424633|NCT00884741|20762042|P3|STARTED|Step 1 Registration: Tissue Screening||0
8424634|NCT00884741|20762043|P2|STARTED|Step 1 Registration: Tissue Screening||0
8424635|NCT00884741|20762044|P1|STARTED|Step 1 Registration: Tissue Screening||978
8424636|NCT00884611|20762055|P1|NOT COMPLETED|Overall Study||1
8424637|NCT00884611|20762055|P1|COMPLETED|Overall Study||19
8424638|NCT00884611|20762055|P1|Enrolled, Not Treated|Overall Study||1
8424639|NCT00884611|20762055|P1|STARTED|Overall Study||20
8424640|NCT00884585|20762079|P2|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
8424641|NCT00884585|20762080|P1|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
8424642|NCT00884585|20762079|P2|COMPLETED|Open-Label Maintenance (Months 9-12)||0
8424643|NCT00884585|20762080|P1|COMPLETED|Open-Label Maintenance (Months 9-12)||144
8424644|NCT00884585|20762079|P2|STARTED|Open-Label Maintenance (Months 9-12)||0
8424645|NCT00884585|20762080|P1|STARTED|Open-Label Maintenance (Months 9-12)||147
8424646|NCT00884585|20762079|P2|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
8424647|NCT00884585|20762080|P1|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
8424648|NCT00884585|20762079|P2|COMPLETED|Open-Label Phase (Months 3-9)||0
8424649|NCT00884585|20762080|P1|COMPLETED|Open-Label Phase (Months 3-9)||147
8424650|NCT00884585|20762079|P2|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
8424651|NCT00884585|20762080|P1|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
8424652|NCT00884585|20762079|P2|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
8424653|NCT00884585|20762080|P1|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
8424654|NCT00884585|20762079|P2|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
8424655|NCT00884585|20762080|P1|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
8424656|NCT00884585|20762079|P2|STARTED|Double-Masked Phase (Day 1-Month 3)||87
8424657|NCT00884585|20762080|P1|STARTED|Double-Masked Phase (Day 1-Month 3)||89
8424658|NCT00884390|20762094|P2|NOT COMPLETED|Overall Study||8
8424659|NCT00884390|20762095|P1|NOT COMPLETED|Overall Study||23
8424660|NCT00884390|20762094|P2|COMPLETED|Overall Study||54
8424661|NCT00884390|20762095|P1|COMPLETED|Overall Study||123
8424662|NCT00884390|20762094|P2|STARTED|Overall Study||62
8424663|NCT00884390|20762095|P1|STARTED|Overall Study||146
8424664|NCT00884377|20762113|P2|NOT COMPLETED|Overall Study||1
8424665|NCT00884377|20762114|P1|NOT COMPLETED|Overall Study||2
8424666|NCT00884377|20762113|P2|COMPLETED|Overall Study||27
8424667|NCT00884377|20762114|P1|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
8424668|NCT00884377|20762113|P2|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
8424669|NCT00884377|20762114|P1|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
8424670|NCT00884325|20762136|P2|NOT COMPLETED|Overall Study||4
8424671|NCT00884325|20762137|P1|NOT COMPLETED|Overall Study||3
8424672|NCT00884325|20762136|P2|COMPLETED|Overall Study||16
8424673|NCT00884325|20762137|P1|COMPLETED|Overall Study||17
8424674|NCT00884325|20762136|P2|STARTED|Overall Study||20
8424675|NCT00884325|20762137|P1|STARTED|Overall Study||20
8424676|NCT00884312|20762147|P2|NOT COMPLETED|Overall Study||25
8424677|NCT00884312|20762148|P1|NOT COMPLETED|Overall Study||2
8424678|NCT00884312|20762147|P2|COMPLETED|Overall Study||67
8424679|NCT00884312|20762148|P1|COMPLETED|Overall Study||7
8424680|NCT00884312|20762147|P2|Received Treatment|Overall Study||91
8424681|NCT00884312|20762148|P1|Received Treatment|Overall Study||9
8424682|NCT00884312|20762147|P2|STARTED|Overall Study||92
8424683|NCT00884312|20762148|P1|STARTED|Overall Study||9
8424684|NCT00884286|20762164|P2|NOT COMPLETED|Overall Study||33
8424685|NCT00884286|20762165|P1|NOT COMPLETED|Overall Study||32
8424686|NCT00884286|20762164|P2|COMPLETED|Overall Study||0
8424687|NCT00884286|20762165|P1|COMPLETED|Overall Study||2
8424688|NCT00884286|20762164|P2|STARTED|Overall Study||33
8424689|NCT00884286|20762165|P1|STARTED|Overall Study||34
8424690|NCT00884273|20762179|P2|NOT COMPLETED|Overall Study||5
8424691|NCT00884273|20762180|P1|NOT COMPLETED|Overall Study||2
8424692|NCT00884273|20762179|P2|COMPLETED|Overall Study||93
8424693|NCT00884273|20762180|P1|COMPLETED|Overall Study||82
8424694|NCT00884273|20762179|P2|Safety Analysis Set|Overall Study||98
8424695|NCT00884273|20762180|P1|Safety Analysis Set|Overall Study||84
8424696|NCT00884273|20762179|P2|Per Protocol (PP) Analysis Set|Overall Study||92
8424697|NCT00884273|20762180|P1|Per Protocol (PP) Analysis Set|Overall Study||81
8424698|NCT00884273|20762179|P2|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
8424699|NCT00884273|20762180|P1|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
8424700|NCT00884273|20762179|P2|STARTED|Overall Study|ITT population.|98
8424701|NCT00884273|20762180|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
8424702|NCT00884221|20762206|P2|NOT COMPLETED|Overall Study||32
8424703|NCT00884221|20762207|P1|NOT COMPLETED|Overall Study||34
8424704|NCT00884221|20762206|P2|COMPLETED|Overall Study||343
8424705|NCT00884221|20762207|P1|COMPLETED|Overall Study||340
8424706|NCT00884221|20762206|P2|STARTED|Overall Study||375
8424707|NCT00884221|20762207|P1|STARTED|Overall Study||374
8424708|NCT00884117|20762243|P1|NOT COMPLETED|Overall Study||249
8424709|NCT00884117|20762243|P1|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
8424710|NCT00884117|20762243|P1|STARTED|Overall Study||4561
8424711|NCT00884065|20762287|P2|NOT COMPLETED|Overall Study||0
8424712|NCT00884065|20762288|P1|NOT COMPLETED|Overall Study||0
8424713|NCT00884065|20762287|P2|COMPLETED|Overall Study||25
8424714|NCT00884065|20762288|P1|COMPLETED|Overall Study||25
8424715|NCT00884065|20762287|P2|STARTED|Overall Study||25
8424716|NCT00884065|20762288|P1|STARTED|Overall Study||25
8424717|NCT00884052|20762304|P2|NOT COMPLETED|Overall Study||0
8424718|NCT00884052|20762305|P1|NOT COMPLETED|Overall Study||0
8424719|NCT00884052|20762304|P2|COMPLETED|Overall Study||12
8424720|NCT00884052|20762305|P1|COMPLETED|Overall Study||6
8424721|NCT00884052|20762304|P2|STARTED|Overall Study||12
8424722|NCT00884052|20762305|P1|STARTED|Overall Study||6
8424723|NCT00884039|20762314|P2|NOT COMPLETED|Overall Study||1
8424724|NCT00884039|20762315|P1|NOT COMPLETED|Overall Study||2
8424725|NCT00884039|20762314|P2|COMPLETED|Overall Study||1
8424726|NCT00884039|20762315|P1|COMPLETED|Overall Study||3
8424727|NCT00884039|20762314|P2|STARTED|Overall Study||2
8424728|NCT00884039|20762315|P1|STARTED|Overall Study||5
8424729|NCT00883779|20762323|P2|NOT COMPLETED|Off-study Phase||202
8424730|NCT00883779|20762324|P1|NOT COMPLETED|Off-study Phase||209
8424731|NCT00883779|20762323|P2|COMPLETED|Off-study Phase||0
8424732|NCT00883779|20762324|P1|COMPLETED|Off-study Phase||0
8424733|NCT00883779|20762323|P2|STARTED|Off-study Phase||202
8424734|NCT00883779|20762324|P1|STARTED|Off-study Phase||209
8424735|NCT00883779|20762323|P2|NOT COMPLETED|Post-Study Treatment Phase||135
8424736|NCT00883779|20762324|P1|NOT COMPLETED|Post-Study Treatment Phase||112
8424737|NCT00883779|20762323|P2|COMPLETED|Post-Study Treatment Phase||0
8424738|NCT00883779|20762324|P1|COMPLETED|Post-Study Treatment Phase||0
8424739|NCT00883779|20762323|P2|STARTED|Post-Study Treatment Phase||135
8424740|NCT00883779|20762324|P1|STARTED|Post-Study Treatment Phase||112
8424741|NCT00883779|20762323|P2|NOT COMPLETED|Primary Study Treatment Phase||86
8424742|NCT00883779|20762324|P1|NOT COMPLETED|Primary Study Treatment Phase||105
8424743|NCT00883779|20762323|P2|COMPLETED|Primary Study Treatment Phase||140
8424744|NCT00883779|20762324|P1|COMPLETED|Primary Study Treatment Phase||120
8424745|NCT00883779|20762323|P2|STARTED|Primary Study Treatment Phase||226
8424746|NCT00883779|20762324|P1|STARTED|Primary Study Treatment Phase||225
8424747|NCT00883753|20762360|P1|NOT COMPLETED|Overall Study||107
8424748|NCT00883753|20762360|P1|COMPLETED|Overall Study||827
8424749|NCT00883753|20762360|P1|STARTED|Overall Study||934
8424750|NCT00883740|20762400|P2|NOT COMPLETED|Second Intervention||1
8424751|NCT00883740|20762401|P1|NOT COMPLETED|Second Intervention||1
8424752|NCT00883740|20762400|P2|COMPLETED|Second Intervention||50
8424753|NCT00883740|20762401|P1|COMPLETED|Second Intervention||52
8424754|NCT00883740|20762400|P2|STARTED|Second Intervention||51
8424755|NCT00883740|20762401|P1|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
8424756|NCT00883740|20762400|P2|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
8424757|NCT00883740|20762401|P1|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
8424758|NCT00883740|20762400|P2|COMPLETED|Taper and Washout Period (2 Weeks)||51
8424759|NCT00883740|20762401|P1|COMPLETED|Taper and Washout Period (2 Weeks)||54
8424760|NCT00883740|20762400|P2|STARTED|Taper and Washout Period (2 Weeks)||51
8424761|NCT00883740|20762401|P1|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
8424762|NCT00883740|20762400|P2|NOT COMPLETED|First Intervention||8
8424763|NCT00883740|20762401|P1|NOT COMPLETED|First Intervention||7
8424764|NCT00883740|20762400|P2|COMPLETED|First Intervention||51
8424765|NCT00883740|20762401|P1|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
8424766|NCT00883740|20762400|P2|STARTED|First Intervention||59
8424767|NCT00883740|20762401|P1|STARTED|First Intervention||60
8424768|NCT00883688|20762441|P1|NOT COMPLETED|Overall Study||2
8424769|NCT00883688|20762441|P1|COMPLETED|Overall Study||22
8424770|NCT00883688|20762441|P1|STARTED|Overall Study||24
8424771|NCT00883675|20762445|P1|NOT COMPLETED|Overall Study||0
8424772|NCT00883675|20762445|P1|COMPLETED|Overall Study||133
8424773|NCT00883675|20762445|P1|STARTED|Overall Study||133
8424774|NCT00883558|20762449|P3|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
8424775|NCT00883558|20762450|P2|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
8424776|NCT00883558|20762451|P1|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
8424777|NCT00883558|20762449|P3|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
8424778|NCT00883558|20762450|P2|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
8424779|NCT00883558|20762451|P1|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
8424780|NCT00883558|20762449|P3|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
8424781|NCT00883558|20762450|P2|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
8424782|NCT00883558|20762451|P1|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
8424783|NCT00883558|20762449|P3|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
8424784|NCT00883558|20762450|P2|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
8424785|NCT00883558|20762451|P1|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
8424786|NCT00883558|20762449|P3|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
8424787|NCT00883558|20762450|P2|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
8424788|NCT00883558|20762451|P1|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
8424789|NCT00883558|20762449|P3|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
8424790|NCT00883558|20762450|P2|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
8424791|NCT00883558|20762451|P1|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
8424792|NCT00883558|20762449|P3|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
8424793|NCT00883558|20762450|P2|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
8424794|NCT00883558|20762451|P1|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
8424795|NCT00883558|20762449|P3|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
8424796|NCT00883558|20762450|P2|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
8424797|NCT00883558|20762451|P1|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
8424798|NCT00883558|20762449|P3|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
8424799|NCT00883558|20762450|P2|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
8424800|NCT00883558|20762451|P1|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
8424801|NCT00883558|20762449|P3|COMPLETED|Titration Period (Weeks 0 to 4)||0
8424802|NCT00883558|20762450|P2|COMPLETED|Titration Period (Weeks 0 to 4)||0
8424803|NCT00883558|20762451|P1|COMPLETED|Titration Period (Weeks 0 to 4)||46
8424804|NCT00883558|20762449|P3|STARTED|Titration Period (Weeks 0 to 4)||0
8424805|NCT00883558|20762450|P2|STARTED|Titration Period (Weeks 0 to 4)||0
8424806|NCT00883558|20762451|P1|STARTED|Titration Period (Weeks 0 to 4)||48
8424807|NCT00883493|20762463|P2|NOT COMPLETED|Overall Study||50
8424808|NCT00883493|20762464|P1|NOT COMPLETED|Overall Study||46
8424809|NCT00883493|20762463|P2|COMPLETED|Overall Study||159
8424810|NCT00883493|20762464|P1|COMPLETED|Overall Study||166
8424811|NCT00883493|20762463|P2|Per Protocol Analysis Population|Overall Study||155
8424812|NCT00883493|20762464|P1|Per Protocol Analysis Population|Overall Study||162
8424813|NCT00883493|20762463|P2|Intention To Treat Analysis Population|Overall Study||195
8424814|NCT00883493|20762464|P1|Intention To Treat Analysis Population|Overall Study||204
8424815|NCT00883493|20762463|P2|STARTED|Overall Study||209
8424816|NCT00883493|20762464|P1|STARTED|Overall Study||212
8424817|NCT00883415|20762488|P1|NOT COMPLETED|Overall Study||2
8424818|NCT00883415|20762488|P1|COMPLETED|Overall Study||18
8424819|NCT00883415|20762488|P1|STARTED|Overall Study||20
8424820|NCT00883389|20762492|P1|NOT COMPLETED|Overall Study||0
8424821|NCT00883389|20762492|P1|COMPLETED|Overall Study||26
8424822|NCT00883389|20762492|P1|STARTED|Overall Study||26
8424823|NCT00883337|20762499|P3|NOT COMPLETED|Extension Treatment Period||19
8424824|NCT00883337|20762500|P2|NOT COMPLETED|Extension Treatment Period||23
8424825|NCT00883337|20762501|P1|NOT COMPLETED|Extension Treatment Period||28
8424826|NCT00883337|20762499|P3|COMPLETED|Extension Treatment Period||40
8424827|NCT00883337|20762500|P2|COMPLETED|Extension Treatment Period||66
8424828|NCT00883337|20762501|P1|COMPLETED|Extension Treatment Period||61
8424829|NCT00883337|20762499|P3|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
8424830|NCT00883337|20762500|P2|STARTED|Extension Treatment Period||89
8424831|NCT00883337|20762501|P1|STARTED|Extension Treatment Period||89
8424832|NCT00883337|20762499|P3|NOT COMPLETED|Core Treatment Period||33
8424833|NCT00883337|20762500|P2|NOT COMPLETED|Core Treatment Period||22
8424834|NCT00883337|20762501|P1|NOT COMPLETED|Core Treatment Period||20
8424835|NCT00883337|20762499|P3|COMPLETED|Core Treatment Period||71
8424836|NCT00883337|20762500|P2|COMPLETED|Core Treatment Period||89
8424837|NCT00883337|20762501|P1|COMPLETED|Core Treatment Period||89
8424838|NCT00883337|20762499|P3|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
8424839|NCT00883337|20762500|P2|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
8424840|NCT00883337|20762501|P1|Treated|Core Treatment Period||109
8424841|NCT00883337|20762499|P3|STARTED|Core Treatment Period||104
8424842|NCT00883337|20762500|P2|STARTED|Core Treatment Period||111
8424843|NCT00883337|20762501|P1|STARTED|Core Treatment Period||109
8424844|NCT00883246|20762533|P1|NOT COMPLETED|Overall Study||173
8424845|NCT00883246|20762533|P1|COMPLETED|Overall Study||626
8424846|NCT00883246|20762533|P1|STARTED|Overall Study||799
8424859|NCT00883181|20762568|P1|NOT COMPLETED|Overall Study||278
8424860|NCT00883181|20762568|P1|COMPLETED|Overall Study|Completed planned chemotherapy|1069
8424861|NCT00883181|20762568|P1|STARTED|Overall Study|Full analysis set|1347
8424862|NCT00883168|20762781|P4|NOT COMPLETED|Overall Study||15
8424863|NCT00883168|20762782|P3|NOT COMPLETED|Overall Study||19
8424864|NCT00883168|20762783|P2|NOT COMPLETED|Overall Study||15
8424865|NCT00883168|20762784|P1|NOT COMPLETED|Overall Study||14
8424866|NCT00883168|20762781|P4|COMPLETED|Overall Study||433
8424867|NCT00883168|20762782|P3|COMPLETED|Overall Study||431
8424868|NCT00883168|20762783|P2|COMPLETED|Overall Study||430
8424869|NCT00883168|20762784|P1|COMPLETED|Overall Study||434
8424870|NCT00883168|20762781|P4|STARTED|Overall Study||448
8424871|NCT00883168|20762782|P3|STARTED|Overall Study||450
8424872|NCT00883168|20762783|P2|STARTED|Overall Study||445
8424873|NCT00883168|20762784|P1|STARTED|Overall Study||448
8424874|NCT00883129|20762804|P2|NOT COMPLETED|Overall Study||36
8424875|NCT00883129|20762805|P1|NOT COMPLETED|Overall Study||20
8424876|NCT00883129|20762804|P2|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
8424877|NCT00883129|20762805|P1|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
8424878|NCT00883129|20762804|P2|STARTED|Overall Study||73
8424879|NCT00883129|20762805|P1|STARTED|Overall Study||69
8424880|NCT00883116|20762829|P2|NOT COMPLETED|Overall Study||219
8424881|NCT00883116|20762830|P1|NOT COMPLETED|Overall Study||209
8424882|NCT00883116|20762829|P2|COMPLETED|Overall Study||29
8424883|NCT00883116|20762830|P1|COMPLETED|Overall Study||39
8424884|NCT00883116|20762829|P2|Received Treatment|Overall Study||239
8424885|NCT00883116|20762830|P1|Received Treatment|Overall Study||248
8424886|NCT00883116|20762829|P2|STARTED|Overall Study||248
8424887|NCT00883116|20762830|P1|STARTED|Overall Study||248
8424888|NCT00883103|20762845|P2|NOT COMPLETED|Overall Study||0
8424889|NCT00883103|20762846|P1|NOT COMPLETED|Overall Study||0
8424890|NCT00883103|20762845|P2|COMPLETED|Overall Study||68
8424891|NCT00883103|20762846|P1|COMPLETED|Overall Study||69
8424892|NCT00883103|20762845|P2|STARTED|Overall Study||68
8424893|NCT00883103|20762846|P1|STARTED|Overall Study||69
8424894|NCT00883090|20762852|P1|NOT COMPLETED|Overall Study||2
8424895|NCT00883090|20762852|P1|COMPLETED|Overall Study||13
8424896|NCT00883090|20762852|P1|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
8424897|NCT00883051|20762872|P5|NOT COMPLETED|Overall Study||18
8424898|NCT00883051|20762873|P4|NOT COMPLETED|Overall Study||29
8424899|NCT00883051|20762874|P3|NOT COMPLETED|Overall Study||29
8424900|NCT00883051|20762875|P2|NOT COMPLETED|Overall Study||22
8424901|NCT00883051|20762876|P1|NOT COMPLETED|Overall Study||24
8424902|NCT00883051|20762872|P5|COMPLETED|Overall Study|One participant was lost to follow up and did not provide adverse event data.|85
8424903|NCT00883051|20762873|P4|COMPLETED|Overall Study||70
8424904|NCT00883051|20762874|P3|COMPLETED|Overall Study||71
8424905|NCT00883051|20762875|P2|COMPLETED|Overall Study||82
8424906|NCT00883051|20762876|P1|COMPLETED|Overall Study||82
8424907|NCT00883051|20762872|P5|Received at Least 1 Dose of Study Drug|Overall Study||86
8424908|NCT00883051|20762873|P4|Received at Least 1 Dose of Study Drug|Overall Study||70
8424909|NCT00883051|20762874|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
8424910|NCT00883051|20762875|P2|Received at Least 1 Dose of Study Drug|Overall Study||82
8424911|NCT00883051|20762876|P1|Received at Least 1 Dose of Study Drug|Overall Study||82
8424912|NCT00883051|20762872|P5|No Study Medication Used|Overall Study||17
8424913|NCT00883051|20762873|P4|No Study Medication Used|Overall Study||29
8424914|NCT00883051|20762874|P3|No Study Medication Used|Overall Study||29
8424915|NCT00883051|20762875|P2|No Study Medication Used|Overall Study||22
8424916|NCT00883051|20762876|P1|No Study Medication Used|Overall Study||24
8424917|NCT00883051|20762872|P5|STARTED|Overall Study||103
8424918|NCT00883051|20762873|P4|STARTED|Overall Study||99
8424919|NCT00883051|20762874|P3|STARTED|Overall Study||100
8424920|NCT00883051|20762875|P2|STARTED|Overall Study||104
8424921|NCT00883051|20762876|P1|STARTED|Overall Study||106
8424922|NCT00882999|20762980|P7|NOT COMPLETED|Overall Study||8
8424923|NCT00882999|20762981|P6|NOT COMPLETED|Overall Study||7
8424924|NCT00882999|20762982|P5|NOT COMPLETED|Overall Study||8
8424925|NCT00882999|20762983|P4|NOT COMPLETED|Overall Study||5
8424926|NCT00882999|20762984|P3|NOT COMPLETED|Overall Study||4
8424927|NCT00882999|20762985|P2|NOT COMPLETED|Overall Study||8
8424928|NCT00882999|20762986|P1|NOT COMPLETED|Overall Study||8
8424929|NCT00882999|20762980|P7|COMPLETED|Overall Study||27
8424930|NCT00882999|20762981|P6|COMPLETED|Overall Study||28
8424931|NCT00882999|20762982|P5|COMPLETED|Overall Study||28
8424932|NCT00882999|20762983|P4|COMPLETED|Overall Study||31
8424933|NCT00882999|20762984|P3|COMPLETED|Overall Study||30
8424934|NCT00882999|20762985|P2|COMPLETED|Overall Study||26
8424935|NCT00882999|20762986|P1|COMPLETED|Overall Study||27
8424936|NCT00882999|20762980|P7|Completed Study Treatment|Overall Study||31
8424937|NCT00882999|20762981|P6|Completed Study Treatment|Overall Study||30
8424938|NCT00882999|20762982|P5|Completed Study Treatment|Overall Study||29
8424939|NCT00882999|20762983|P4|Completed Study Treatment|Overall Study||33
8424940|NCT00882999|20762984|P3|Completed Study Treatment|Overall Study||31
8424941|NCT00882999|20762985|P2|Completed Study Treatment|Overall Study||29
8424942|NCT00882999|20762986|P1|Completed Study Treatment|Overall Study||29
8424943|NCT00882999|20762980|P7|Received Any Amount of Study Drug|Overall Study||35
8424944|NCT00882999|20762981|P6|Received Any Amount of Study Drug|Overall Study||35
8424945|NCT00882999|20762982|P5|Received Any Amount of Study Drug|Overall Study||36
8424946|NCT00882999|20762983|P4|Received Any Amount of Study Drug|Overall Study||36
8424947|NCT00882999|20762984|P3|Received Any Amount of Study Drug|Overall Study||34
8424948|NCT00882999|20762985|P2|Received Any Amount of Study Drug|Overall Study||34
8424949|NCT00882999|20762986|P1|Received Any Amount of Study Drug|Overall Study||35
8424950|NCT00882999|20762980|P7|STARTED|Overall Study||35
8424951|NCT00882999|20762981|P6|STARTED|Overall Study||35
8424952|NCT00882999|20762982|P5|STARTED|Overall Study||36
8424953|NCT00882999|20762983|P4|STARTED|Overall Study||36
8424954|NCT00882999|20762984|P3|STARTED|Overall Study||34
8424955|NCT00882999|20762985|P2|STARTED|Overall Study||34
8424956|NCT00882999|20762986|P1|STARTED|Overall Study||35
8424960|NCT00882908|20763123|P5|NOT COMPLETED|Overall Study||6
8424961|NCT00882908|20763124|P4|NOT COMPLETED|Overall Study||7
8424962|NCT00882908|20763125|P3|NOT COMPLETED|Overall Study||7
8424963|NCT00882908|20763126|P2|NOT COMPLETED|Overall Study||6
8424964|NCT00882908|20763127|P1|NOT COMPLETED|Overall Study||3
8424965|NCT00882908|20763123|P5|COMPLETED|Overall Study||71
8424966|NCT00882908|20763124|P4|COMPLETED|Overall Study||72
8424967|NCT00882908|20763125|P3|COMPLETED|Overall Study||70
8424968|NCT00882908|20763126|P2|COMPLETED|Overall Study||69
8424969|NCT00882908|20763127|P1|COMPLETED|Overall Study||75
8424970|NCT00882908|20763123|P5|STARTED|Overall Study||77
8424971|NCT00882908|20763124|P4|STARTED|Overall Study||79
8424972|NCT00882908|20763125|P3|STARTED|Overall Study||77
8424973|NCT00882908|20763126|P2|STARTED|Overall Study||75
8424974|NCT00882908|20763127|P1|STARTED|Overall Study||78
8424975|NCT00882778|20763202|P1|NOT COMPLETED|Overall Study||0
8424976|NCT00882778|20763202|P1|COMPLETED|Overall Study||86
8424977|NCT00882778|20763202|P1|STARTED|Overall Study||86
8424978|NCT00882713|20763233|P1|NOT COMPLETED|Overall Study||22
8424979|NCT00882713|20763233|P1|COMPLETED|Overall Study||172
8424980|NCT00882713|20763233|P1|STARTED|Overall Study||194
8424993|NCT00882661|20763295|P2|NOT COMPLETED|Treatment||26
8424994|NCT00882661|20763296|P1|NOT COMPLETED|Treatment||10
8424995|NCT00882661|20763295|P2|COMPLETED|Treatment||114
8424996|NCT00882661|20763296|P1|COMPLETED|Treatment||141
8424997|NCT00882661|20763295|P2|STARTED|Treatment||140
8424998|NCT00882661|20763296|P1|STARTED|Treatment||151
8424999|NCT00882661|20763295|P2|NOT COMPLETED|Investigational Training||0
8425000|NCT00882661|20763296|P1|NOT COMPLETED|Investigational Training||10
8425001|NCT00882661|20763295|P2|COMPLETED|Investigational Training||0
8425002|NCT00882661|20763296|P1|COMPLETED|Investigational Training||79
8425003|NCT00882661|20763295|P2|STARTED|Investigational Training||0
8425004|NCT00882661|20763296|P1|STARTED|Investigational Training||89
8425005|NCT00882583|20763326|P2|NOT COMPLETED|Overall Study||1
8425006|NCT00882583|20763327|P1|NOT COMPLETED|Overall Study||1
8425007|NCT00882583|20763326|P2|COMPLETED|Overall Study||11
8425008|NCT00882583|20763327|P1|COMPLETED|Overall Study||6
8425009|NCT00882583|20763326|P2|STARTED|Overall Study||12
8425010|NCT00882583|20763327|P1|STARTED|Overall Study||7
8425011|NCT00882557|20763335|P2|NOT COMPLETED|Overall Study||1
8425012|NCT00882557|20763336|P1|NOT COMPLETED|Overall Study||2
8425013|NCT00882557|20763335|P2|COMPLETED|Overall Study||7
8425014|NCT00882557|20763336|P1|COMPLETED|Overall Study||6
8425015|NCT00882557|20763335|P2|Completed Dose 2|Overall Study||7
8425016|NCT00882557|20763336|P1|Completed Dose 2|Overall Study||6
8425017|NCT00882557|20763335|P2|Completed Dose 1|Overall Study||7
8425018|NCT00882557|20763336|P1|Completed Dose 1|Overall Study||8
8425019|NCT00882557|20763335|P2|STARTED|Overall Study||8
8425020|NCT00882557|20763336|P1|STARTED|Overall Study||8
8425021|NCT00882518|20763356|P2|NOT COMPLETED|Overall Study||44
8425022|NCT00882518|20763357|P1|NOT COMPLETED|Overall Study||38
8425023|NCT00882518|20763356|P2|COMPLETED|Overall Study||148
8425024|NCT00882518|20763357|P1|COMPLETED|Overall Study||158
8425025|NCT00882518|20763356|P2|STARTED|Overall Study||192
8425026|NCT00882518|20763357|P1|STARTED|Overall Study||196
8425027|NCT00882440|20763386|P7|NOT COMPLETED|Overall Study||4
8425028|NCT00882440|20763387|P6|NOT COMPLETED|Overall Study||7
8425029|NCT00882440|20763388|P5|NOT COMPLETED|Overall Study||10
8425030|NCT00882440|20763389|P4|NOT COMPLETED|Overall Study||3
8425031|NCT00882440|20763390|P3|NOT COMPLETED|Overall Study||7
8425032|NCT00882440|20763391|P2|NOT COMPLETED|Overall Study||8
8425033|NCT00882440|20763392|P1|NOT COMPLETED|Overall Study||11
8425034|NCT00882440|20763386|P7|COMPLETED|Overall Study||79
8425035|NCT00882440|20763387|P6|COMPLETED|Overall Study||77
8425036|NCT00882440|20763388|P5|COMPLETED|Overall Study||80
8425037|NCT00882440|20763389|P4|COMPLETED|Overall Study||76
8425038|NCT00882440|20763390|P3|COMPLETED|Overall Study||75
8425039|NCT00882440|20763391|P2|COMPLETED|Overall Study||72
8425040|NCT00882440|20763392|P1|COMPLETED|Overall Study||67
8425041|NCT00882440|20763386|P7|STARTED|Overall Study||83
8425042|NCT00882440|20763387|P6|STARTED|Overall Study||84
8425043|NCT00882440|20763388|P5|STARTED|Overall Study||90
8425044|NCT00882440|20763389|P4|STARTED|Overall Study||79
8425045|NCT00882440|20763390|P3|STARTED|Overall Study||82
8425046|NCT00882440|20763391|P2|STARTED|Overall Study||80
8425047|NCT00882440|20763392|P1|STARTED|Overall Study||78
8425048|NCT00882362|20763417|P2|NOT COMPLETED|Overall Study||23
8425049|NCT00882362|20763418|P1|NOT COMPLETED|Overall Study||49
8425050|NCT00882362|20763417|P2|COMPLETED|Overall Study||10
8425051|NCT00882362|20763418|P1|COMPLETED|Overall Study||73
8425052|NCT00882362|20763417|P2|STARTED|Overall Study||33
8425053|NCT00882362|20763418|P1|STARTED|Overall Study||122
8425054|NCT00882310|20763424|P1|NOT COMPLETED|Overall Study||22
8425055|NCT00882310|20763424|P1|COMPLETED|Overall Study||15
8425056|NCT00882310|20763424|P1|STARTED|Overall Study||37
8425057|NCT00882206|20763430|P1|NOT COMPLETED|Overall Study||0
8425058|NCT00882206|20763430|P1|COMPLETED|Overall Study||13
8425059|NCT00882206|20763430|P1|STARTED|Overall Study||13
8425060|NCT00882115|20763437|P1|NOT COMPLETED|Overall Study||9
8425061|NCT00882115|20763437|P1|COMPLETED|Overall Study||29
8425062|NCT00882115|20763437|P1|STARTED|Overall Study||38
8425063|NCT00882102|20763441|P1|NOT COMPLETED|Overall Study||0
8425064|NCT00882102|20763441|P1|COMPLETED|Overall Study||40
8425065|NCT00882102|20763441|P1|STARTED|Overall Study||40
8425066|NCT00881959|20763447|P2|NOT COMPLETED|Overall Study||4
8425067|NCT00881959|20763448|P1|NOT COMPLETED|Overall Study||2
8425068|NCT00881959|20763447|P2|COMPLETED|Overall Study||38
8425069|NCT00881959|20763448|P1|COMPLETED|Overall Study||36
8425070|NCT00881959|20763447|P2|STARTED|Overall Study||42
8425071|NCT00881959|20763448|P1|STARTED|Overall Study||38
8425072|NCT00881894|20763456|P2|NOT COMPLETED|Overall Study||3
8425073|NCT00881894|20763457|P1|NOT COMPLETED|Overall Study||1
8425074|NCT00881894|20763456|P2|COMPLETED|Overall Study||23
8425075|NCT00881894|20763457|P1|COMPLETED|Overall Study||25
8425076|NCT00881894|20763456|P2|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
8425077|NCT00881894|20763457|P1|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
8425078|NCT00881894|20763456|P2|STARTED|Overall Study||26
8425079|NCT00881894|20763457|P1|STARTED|Overall Study||26
8425080|NCT00881868|20763489|P2|NOT COMPLETED|Overall Study||2
8425081|NCT00881868|20763490|P1|NOT COMPLETED|Overall Study||8
8425082|NCT00881868|20763489|P2|COMPLETED|Overall Study||38
8425083|NCT00881868|20763490|P1|COMPLETED|Overall Study||33
8425084|NCT00881868|20763489|P2|STARTED|Overall Study||40
8425085|NCT00881868|20763490|P1|STARTED|Overall Study||41
8425086|NCT00881751|20763504|P2|NOT COMPLETED|Overall Study||5
8425087|NCT00881751|20763505|P1|NOT COMPLETED|Overall Study||0
8425088|NCT00881751|20763504|P2|COMPLETED|Overall Study||43
8425089|NCT00881751|20763505|P1|COMPLETED|Overall Study||47
8425090|NCT00881751|20763504|P2|STARTED|Overall Study||48
8425091|NCT00881751|20763505|P1|STARTED|Overall Study||47
8425092|NCT00881712|20763520|P3|NOT COMPLETED|Overall Study||0
8425093|NCT00881712|20763521|P2|NOT COMPLETED|Overall Study||0
8425094|NCT00881712|20763522|P1|NOT COMPLETED|Overall Study||2
8425095|NCT00881712|20763520|P3|COMPLETED|Overall Study||0
8425096|NCT00881712|20763521|P2|COMPLETED|Overall Study||0
8425097|NCT00881712|20763522|P1|COMPLETED|Overall Study||13
8425098|NCT00881712|20763520|P3|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
8425099|NCT00881712|20763521|P2|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
8425100|NCT00881712|20763522|P1|STARTED|Overall Study||15
8425101|NCT00881647|20763544|P2|NOT COMPLETED|Overall Study||1
8425102|NCT00881647|20763545|P1|NOT COMPLETED|Overall Study||2
8425103|NCT00881647|20763544|P2|COMPLETED|Overall Study||15
8425104|NCT00881647|20763545|P1|COMPLETED|Overall Study||27
8425105|NCT00881647|20763544|P2|STARTED|Overall Study||16
8425106|NCT00881647|20763545|P1|STARTED|Overall Study||29
8425107|NCT00881621|20763555|P1|NOT COMPLETED|Overall Study||34
8425108|NCT00881621|20763555|P1|COMPLETED|Overall Study||17
8425109|NCT00881621|20763555|P1|STARTED|Overall Study||51
8425110|NCT00881608|20763567|P1|NOT COMPLETED|Overall Study||11
8425111|NCT00881608|20763567|P1|COMPLETED|Overall Study||0
8425112|NCT00881608|20763567|P1|STARTED|Overall Study||11
8425113|NCT00881569|20763586|P2|NOT COMPLETED|Overall Study||1
8425114|NCT00881569|20763587|P1|NOT COMPLETED|Overall Study||1
8425115|NCT00881569|20763586|P2|COMPLETED|Overall Study||0
8425116|NCT00881569|20763587|P1|COMPLETED|Overall Study||0
8425117|NCT00881569|20763586|P2|STARTED|Overall Study||1
8425118|NCT00881569|20763587|P1|STARTED|Overall Study||1
8425119|NCT00881530|20763603|P6|NOT COMPLETED|Overall Study||5
8425120|NCT00881530|20763604|P5|NOT COMPLETED|Overall Study||14
8425121|NCT00881530|20763605|P4|NOT COMPLETED|Overall Study||9
8425122|NCT00881530|20763606|P3|NOT COMPLETED|Overall Study||5
8425123|NCT00881530|20763607|P2|NOT COMPLETED|Overall Study||5
8425124|NCT00881530|20763608|P1|NOT COMPLETED|Overall Study||14
8425125|NCT00881530|20763603|P6|COMPLETED|Overall Study||51
8425126|NCT00881530|20763604|P5|COMPLETED|Overall Study||152
8425127|NCT00881530|20763605|P4|COMPLETED|Overall Study||157
8425128|NCT00881530|20763606|P3|COMPLETED|Overall Study||51
8425129|NCT00881530|20763607|P2|COMPLETED|Overall Study||104
8425130|NCT00881530|20763608|P1|COMPLETED|Overall Study||92
8425131|NCT00881530|20763603|P6|STARTED|Overall Study||56
8425132|NCT00881530|20763604|P5|STARTED|Overall Study||166
8425133|NCT00881530|20763605|P4|STARTED|Overall Study||166
8425134|NCT00881530|20763606|P3|STARTED|Overall Study||56
8425135|NCT00881530|20763607|P2|STARTED|Overall Study||109
8425136|NCT00881530|20763608|P1|STARTED|Overall Study||106
8425137|NCT00881504|20763664|P1|NOT COMPLETED|Overall Study||1
8425138|NCT00881504|20763664|P1|COMPLETED|Overall Study||8
8425139|NCT00881504|20763664|P1|STARTED|Overall Study||9
8425140|NCT00881465|20763671|P2|NOT COMPLETED|Overall Study||0
8425141|NCT00881465|20763672|P1|NOT COMPLETED|Overall Study||2
8425142|NCT00881465|20763671|P2|COMPLETED|Overall Study||15
8425143|NCT00881465|20763672|P1|COMPLETED|Overall Study||14
8425144|NCT00881465|20763671|P2|STARTED|Overall Study||15
8425145|NCT00881465|20763672|P1|STARTED|Overall Study||16
8425155|NCT00881335|20763701|P2|NOT COMPLETED|Overall Study||2
8425156|NCT00881335|20763702|P1|NOT COMPLETED|Overall Study||3
8425157|NCT00881335|20763701|P2|COMPLETED|Overall Study|2 participants did not complete the period|28
8425158|NCT00881335|20763702|P1|COMPLETED|Overall Study|3 participants did not complete the period|27
8425159|NCT00881335|20763701|P2|STARTED|Overall Study||30
8425160|NCT00881335|20763702|P1|STARTED|Overall Study||30
8425161|NCT00881205|20763722|P2|NOT COMPLETED|Overall Study||7
8425162|NCT00881205|20763723|P1|NOT COMPLETED|Overall Study||11
8425163|NCT00881205|20763722|P2|COMPLETED|Overall Study||34
8425164|NCT00881205|20763723|P1|COMPLETED|Overall Study||34
8425165|NCT00881205|20763722|P2|STARTED|Overall Study||41
8425166|NCT00881205|20763723|P1|STARTED|Overall Study||45
8425167|NCT00880997|20763733|P3|NOT COMPLETED|Overall Study||8
8425168|NCT00880997|20763734|P2|NOT COMPLETED|Overall Study||2
8425169|NCT00880997|20763735|P1|NOT COMPLETED|Overall Study||3
8425170|NCT00880997|20763733|P3|COMPLETED|Overall Study||5
8425171|NCT00880997|20763734|P2|COMPLETED|Overall Study||6
8425172|NCT00880997|20763735|P1|COMPLETED|Overall Study||6
8425173|NCT00880997|20763733|P3|STARTED|Overall Study||13
8425174|NCT00880997|20763734|P2|STARTED|Overall Study||8
8425175|NCT00880997|20763735|P1|STARTED|Overall Study||9
8425176|NCT00880919|20763755|P3|NOT COMPLETED|Overall Study||6
8425177|NCT00880919|20763756|P2|NOT COMPLETED|Overall Study||14
8425178|NCT00880919|20763757|P1|NOT COMPLETED|Overall Study||15
8425179|NCT00880919|20763755|P3|COMPLETED|Overall Study||23
8425180|NCT00880919|20763756|P2|COMPLETED|Overall Study||19
8425181|NCT00880919|20763757|P1|COMPLETED|Overall Study||18
8425182|NCT00880919|20763755|P3|STARTED|Overall Study||29
8425183|NCT00880919|20763756|P2|STARTED|Overall Study||33
8425184|NCT00880919|20763757|P1|STARTED|Overall Study||33
8425185|NCT00880906|20763791|P2|NOT COMPLETED|Overall Study||7
8425186|NCT00880906|20763792|P1|NOT COMPLETED|Overall Study||12
8425187|NCT00880906|20763791|P2|COMPLETED|Overall Study||14
8425188|NCT00880906|20763792|P1|COMPLETED|Overall Study||17
8425189|NCT00880906|20763791|P2|STARTED|Overall Study||21
8425190|NCT00880906|20763792|P1|STARTED|Overall Study||29
8425191|NCT00880893|20763802|P2|NOT COMPLETED|Overall Study||45
8425192|NCT00880893|20763803|P1|NOT COMPLETED|Overall Study||107
8425193|NCT00880893|20763802|P2|COMPLETED|Overall Study||255
8425194|NCT00880893|20763803|P1|COMPLETED|Overall Study||791
8425195|NCT00880893|20763802|P2|STARTED|Overall Study||300
8425196|NCT00880893|20763803|P1|STARTED|Overall Study||898
8425197|NCT00880763|20763855|P4|NOT COMPLETED|Extension Period (Part 2)||3
8425198|NCT00880763|20763856|P3|NOT COMPLETED|Extension Period (Part 2)||3
8425199|NCT00880763|20763857|P2|NOT COMPLETED|Extension Period (Part 2)||3
8425200|NCT00880763|20763858|P1|NOT COMPLETED|Extension Period (Part 2)||0
8425201|NCT00880763|20763855|P4|COMPLETED|Extension Period (Part 2)||19
8425202|NCT00880763|20763856|P3|COMPLETED|Extension Period (Part 2)||20
8425203|NCT00880763|20763857|P2|COMPLETED|Extension Period (Part 2)||19
8425204|NCT00880763|20763858|P1|COMPLETED|Extension Period (Part 2)||23
8425205|NCT00880763|20763855|P4|STARTED|Extension Period (Part 2)||22
8425206|NCT00880763|20763856|P3|STARTED|Extension Period (Part 2)||23
8425207|NCT00880763|20763857|P2|STARTED|Extension Period (Part 2)||22
8425208|NCT00880763|20763858|P1|STARTED|Extension Period (Part 2)||23
8425209|NCT00880763|20763855|P4|NOT COMPLETED|Initial Treatment Period (Part 1)||0
8425210|NCT00880763|20763856|P3|NOT COMPLETED|Initial Treatment Period (Part 1)||0
8425211|NCT00880763|20763857|P2|NOT COMPLETED|Initial Treatment Period (Part 1)||0
8425212|NCT00880763|20763858|P1|NOT COMPLETED|Initial Treatment Period (Part 1)||0
8425213|NCT00880763|20763855|P4|COMPLETED|Initial Treatment Period (Part 1)||22
8425214|NCT00880763|20763856|P3|COMPLETED|Initial Treatment Period (Part 1)||23
8425215|NCT00880763|20763857|P2|COMPLETED|Initial Treatment Period (Part 1)||22
8425216|NCT00880763|20763858|P1|COMPLETED|Initial Treatment Period (Part 1)||23
8425217|NCT00880763|20763855|P4|STARTED|Initial Treatment Period (Part 1)||22
8425218|NCT00880763|20763856|P3|STARTED|Initial Treatment Period (Part 1)||23
8425219|NCT00880763|20763857|P2|STARTED|Initial Treatment Period (Part 1)||22
8425220|NCT00880763|20763858|P1|STARTED|Initial Treatment Period (Part 1)||23
8425239|NCT00880698|20763909|P4|NOT COMPLETED|Overall Study||3
8425240|NCT00880698|20763910|P3|NOT COMPLETED|Overall Study||1
8425241|NCT00880698|20763911|P2|NOT COMPLETED|Overall Study||3
8425242|NCT00880698|20763912|P1|NOT COMPLETED|Overall Study||1
8425243|NCT00880698|20763909|P4|COMPLETED|Overall Study||36
8425244|NCT00880698|20763910|P3|COMPLETED|Overall Study||36
8425245|NCT00880698|20763911|P2|COMPLETED|Overall Study||61
8425246|NCT00880698|20763912|P1|COMPLETED|Overall Study||61
8425247|NCT00880698|20763909|P4|STARTED|Overall Study||39
8425248|NCT00880698|20763910|P3|STARTED|Overall Study||37
8425249|NCT00880698|20763911|P2|STARTED|Overall Study||64
8425250|NCT00880698|20763912|P1|STARTED|Overall Study||62
8425260|NCT00880620|20763950|P4|NOT COMPLETED|Overall Study||24
8425261|NCT00880620|20763951|P3|NOT COMPLETED|Overall Study||21
8425262|NCT00880620|20763952|P2|NOT COMPLETED|Overall Study||15
8425263|NCT00880620|20763953|P1|NOT COMPLETED|Overall Study||21
8425264|NCT00880620|20763950|P4|COMPLETED|Overall Study||74
8425265|NCT00880620|20763951|P3|COMPLETED|Overall Study||83
8425266|NCT00880620|20763952|P2|COMPLETED|Overall Study||72
8425267|NCT00880620|20763953|P1|COMPLETED|Overall Study||71
8425268|NCT00880620|20763950|P4|Week 23|Overall Study||74
8425269|NCT00880620|20763951|P3|Week 23|Overall Study||85
8425270|NCT00880620|20763952|P2|Week 23|Overall Study||72
8425271|NCT00880620|20763953|P1|Week 23|Overall Study||71
8425272|NCT00880620|20763950|P4|Week 16|Overall Study||74
8425273|NCT00880620|20763951|P3|Week 16|Overall Study||87
8425274|NCT00880620|20763952|P2|Week 16|Overall Study||73
8425275|NCT00880620|20763953|P1|Week 16|Overall Study||74
8425276|NCT00880620|20763950|P4|Week 9|Overall Study||78
8425277|NCT00880620|20763951|P3|Week 9|Overall Study||88
8425278|NCT00880620|20763952|P2|Week 9|Overall Study||73
8425279|NCT00880620|20763953|P1|Week 9|Overall Study||80
8425280|NCT00880620|20763950|P4|Week 4|Overall Study||86
8425281|NCT00880620|20763951|P3|Week 4|Overall Study||94
8425282|NCT00880620|20763952|P2|Week 4|Overall Study||79
8425283|NCT00880620|20763953|P1|Week 4|Overall Study||88
8425284|NCT00880620|20763950|P4|STARTED|Overall Study||98
8425285|NCT00880620|20763951|P3|STARTED|Overall Study||104
8425286|NCT00880620|20763952|P2|STARTED|Overall Study||87
8425287|NCT00880620|20763953|P1|STARTED|Overall Study||92
8425288|NCT00880607|20763969|P2|NOT COMPLETED|Overall Study||3
8425289|NCT00880607|20763970|P1|NOT COMPLETED|Overall Study||7
8425290|NCT00880607|20763969|P2|COMPLETED|Overall Study||34
8425291|NCT00880607|20763970|P1|COMPLETED|Overall Study||37
8425292|NCT00880607|20763969|P2|Observation After Receiving Medication|Overall Study||35
8425293|NCT00880607|20763970|P1|Observation After Receiving Medication|Overall Study||42
8425294|NCT00880607|20763969|P2|STARTED|Overall Study||37
8425295|NCT00880607|20763970|P1|STARTED|Overall Study||44
8425296|NCT00880581|20763988|P1|NOT COMPLETED|Cycle 2 Re-treatment||0
8425297|NCT00880581|20763988|P1|COMPLETED|Cycle 2 Re-treatment||24
8425298|NCT00880581|20763988|P1|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
8425299|NCT00880581|20763988|P1|NOT COMPLETED|Cycle 1||0
8425300|NCT00880581|20763988|P1|COMPLETED|Cycle 1||30
8425301|NCT00880581|20763988|P1|STARTED|Cycle 1||30
8425302|NCT00880568|20764002|P9|NOT COMPLETED|Overall Study||3
8425303|NCT00880568|20764003|P8|NOT COMPLETED|Overall Study||2
8425304|NCT00880568|20764004|P7|NOT COMPLETED|Overall Study||6
8425305|NCT00880568|20764005|P6|NOT COMPLETED|Overall Study||3
8425306|NCT00880568|20764006|P5|NOT COMPLETED|Overall Study||3
8425307|NCT00880568|20764007|P4|NOT COMPLETED|Overall Study||1
8425308|NCT00880568|20764008|P3|NOT COMPLETED|Overall Study||3
8425309|NCT00880568|20764009|P2|NOT COMPLETED|Overall Study||3
8425310|NCT00880568|20764010|P1|NOT COMPLETED|Overall Study||3
8425311|NCT00880568|20764002|P9|COMPLETED|Overall Study||0
8425312|NCT00880568|20764003|P8|COMPLETED|Overall Study||0
8425313|NCT00880568|20764004|P7|COMPLETED|Overall Study||0
8425314|NCT00880568|20764005|P6|COMPLETED|Overall Study||0
8425315|NCT00880568|20764006|P5|COMPLETED|Overall Study||0
8425316|NCT00880568|20764007|P4|COMPLETED|Overall Study||0
8425317|NCT00880568|20764008|P3|COMPLETED|Overall Study||0
8425318|NCT00880568|20764009|P2|COMPLETED|Overall Study||0
8425319|NCT00880568|20764010|P1|COMPLETED|Overall Study||0
8425320|NCT00880568|20764002|P9|STARTED|Overall Study||3
8425321|NCT00880568|20764003|P8|STARTED|Overall Study||2
8425322|NCT00880568|20764004|P7|STARTED|Overall Study||6
8425323|NCT00880568|20764005|P6|STARTED|Overall Study||3
8425324|NCT00880568|20764006|P5|STARTED|Overall Study||3
8425325|NCT00880568|20764007|P4|STARTED|Overall Study||1
8425326|NCT00880568|20764008|P3|STARTED|Overall Study||3
8425327|NCT00880568|20764009|P2|STARTED|Overall Study||3
8425328|NCT00880568|20764010|P1|STARTED|Overall Study||3
8425329|NCT00880555|20764056|P6|NOT COMPLETED|Overall Study||1
8425330|NCT00880555|20764057|P5|NOT COMPLETED|Overall Study||1
8425331|NCT00880555|20764058|P4|NOT COMPLETED|Overall Study||2
8425332|NCT00880555|20764059|P3|NOT COMPLETED|Overall Study||5
8425333|NCT00880555|20764060|P2|NOT COMPLETED|Overall Study||17
8425334|NCT00880555|20764061|P1|NOT COMPLETED|Overall Study||10
8425335|NCT00880555|20764056|P6|COMPLETED|Overall Study||0
8425336|NCT00880555|20764057|P5|COMPLETED|Overall Study||0
8425337|NCT00880555|20764058|P4|COMPLETED|Overall Study||0
8425338|NCT00880555|20764059|P3|COMPLETED|Overall Study||6
8425339|NCT00880555|20764060|P2|COMPLETED|Overall Study||23
8425340|NCT00880555|20764061|P1|COMPLETED|Overall Study||13
8425341|NCT00880555|20764056|P6|STARTED|Overall Study||1
8425342|NCT00880555|20764057|P5|STARTED|Overall Study||1
8425343|NCT00880555|20764058|P4|STARTED|Overall Study||2
8425344|NCT00880555|20764059|P3|STARTED|Overall Study||11
8425345|NCT00880555|20764060|P2|STARTED|Overall Study||40
8425346|NCT00880555|20764061|P1|STARTED|Overall Study||23
8425347|NCT00880542|20764072|P1|NOT COMPLETED|Follow-up Period||0
8425348|NCT00880542|20764072|P1|COMPLETED|Follow-up Period||7
8425349|NCT00880542|20764072|P1|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
8425350|NCT00880542|20764072|P1|NOT COMPLETED|Continued Treatment Period||0
8425351|NCT00880542|20764072|P1|COMPLETED|Continued Treatment Period||0
8425525|NCT00879710|20764609|P3|NOT COMPLETED|Wash Out Period of 4 Weeks||0
8425352|NCT00880542|20764072|P1|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
8425353|NCT00880542|20764072|P1|NOT COMPLETED|Post Surgical Evaluation||0
8425354|NCT00880542|20764072|P1|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
8425355|NCT00880542|20764072|P1|STARTED|Post Surgical Evaluation||3
8425356|NCT00880542|20764072|P1|NOT COMPLETED|REP: Surgical Resection||1
8425357|NCT00880542|20764072|P1|COMPLETED|REP: Surgical Resection||3
8425358|NCT00880542|20764072|P1|STARTED|REP: Surgical Resection||4
8425359|NCT00880542|20764072|P1|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
8425360|NCT00880542|20764072|P1|COMPLETED|Response Evaluation Period(REP): PET/CT||4
8425361|NCT00880542|20764072|P1|STARTED|Response Evaluation Period(REP): PET/CT||4
8425362|NCT00880542|20764072|P1|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
8425363|NCT00880542|20764072|P1|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
8425364|NCT00880542|20764072|P1|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
8425365|NCT00880425|20764077|P2|NOT COMPLETED|Overall Study||0
8425366|NCT00880425|20764078|P1|NOT COMPLETED|Overall Study||0
8425367|NCT00880425|20764077|P2|COMPLETED|Overall Study||27
8425368|NCT00880425|20764078|P1|COMPLETED|Overall Study||18
8425369|NCT00880425|20764077|P2|STARTED|Overall Study||27
8425370|NCT00880425|20764078|P1|STARTED|Overall Study||18
8425371|NCT00880399|20764089|P3|NOT COMPLETED|Overall Study||26
8425372|NCT00880399|20764090|P2|NOT COMPLETED|Overall Study||29
8425373|NCT00880399|20764091|P1|NOT COMPLETED|Overall Study||31
8425374|NCT00880399|20764089|P3|COMPLETED|Overall Study||81
8425375|NCT00880399|20764090|P2|COMPLETED|Overall Study||84
8425376|NCT00880399|20764091|P1|COMPLETED|Overall Study||77
8425377|NCT00880399|20764089|P3|STARTED|Overall Study||107
8425378|NCT00880399|20764090|P2|STARTED|Overall Study||113
8425379|NCT00880399|20764091|P1|STARTED|Overall Study||108
8425380|NCT00880360|20764147|P1|NOT COMPLETED|Overall Study||0
8425381|NCT00880360|20764147|P1|COMPLETED|Overall Study||19
8425382|NCT00880360|20764147|P1|STARTED|Overall Study||19
8425383|NCT00880334|20764154|P2|NOT COMPLETED|Crossover Phase||0
8425384|NCT00880334|20764155|P1|NOT COMPLETED|Crossover Phase||0
8425385|NCT00880334|20764154|P2|COMPLETED|Crossover Phase||37
8425386|NCT00880334|20764155|P1|COMPLETED|Crossover Phase||0
8425387|NCT00880334|20764154|P2|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
8425388|NCT00880334|20764155|P1|STARTED|Crossover Phase||0
8425389|NCT00880334|20764154|P2|NOT COMPLETED|Randomized Phase||40
8425390|NCT00880334|20764155|P1|NOT COMPLETED|Randomized Phase||4
8425391|NCT00880334|20764154|P2|COMPLETED|Randomized Phase||35
8425392|NCT00880334|20764155|P1|COMPLETED|Randomized Phase||70
8425393|NCT00880334|20764154|P2|Eligible & Treated|Randomized Phase||72
8425394|NCT00880334|20764155|P1|Eligible & Treated|Randomized Phase||70
8425395|NCT00880334|20764154|P2|STARTED|Randomized Phase||75
8425396|NCT00880334|20764155|P1|STARTED|Randomized Phase||74
8425397|NCT00880269|20764172|P2|NOT COMPLETED|Overall Study||27
8425398|NCT00880269|20764173|P1|NOT COMPLETED|Overall Study||32
8425399|NCT00880269|20764172|P2|COMPLETED|Overall Study||0
8425400|NCT00880269|20764173|P1|COMPLETED|Overall Study||0
8425401|NCT00880269|20764172|P2|Discontinued Treatment|Overall Study||27
8425402|NCT00880269|20764173|P1|Discontinued Treatment|Overall Study||32
8425403|NCT00880269|20764172|P2|STARTED|Overall Study||27
8425404|NCT00880269|20764173|P1|STARTED|Overall Study||32
8425405|NCT00880256|20764189|P1|NOT COMPLETED|Overall Study||28
8425406|NCT00880256|20764189|P1|COMPLETED|Overall Study||65
8425407|NCT00880256|20764189|P1|STARTED|Overall Study||93
8425408|NCT00880230|20764194|P1|NOT COMPLETED|Overall Study||7
8425409|NCT00880230|20764194|P1|COMPLETED|Overall Study||134
8425410|NCT00880230|20764194|P1|STARTED|Overall Study||141
8425411|NCT00880191|20764216|P2|NOT COMPLETED|Overall Study||8
8425412|NCT00880191|20764217|P1|NOT COMPLETED|Overall Study||13
8425413|NCT00880191|20764216|P2|COMPLETED|Overall Study||198
8425414|NCT00880191|20764217|P1|COMPLETED|Overall Study||194
8425415|NCT00880191|20764216|P2|Available for Primary Endpoint Analysis|Overall Study||206
8425416|NCT00880191|20764217|P1|Available for Primary Endpoint Analysis|Overall Study||207
8425417|NCT00880191|20764216|P2|STARTED|Overall Study||206
8425418|NCT00880191|20764217|P1|STARTED|Overall Study||207
8425419|NCT00880165|20764237|P2|NOT COMPLETED|Overall Study||50
8425420|NCT00880165|20764238|P1|NOT COMPLETED|Overall Study||62
8425421|NCT00880165|20764237|P2|COMPLETED|Overall Study||98
8425422|NCT00880165|20764238|P1|COMPLETED|Overall Study||86
8425423|NCT00880165|20764237|P2|STARTED|Overall Study||148
8425424|NCT00880165|20764238|P1|STARTED|Overall Study||148
8425425|NCT00880100|20764248|P1|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
8425426|NCT00880100|20764248|P1|COMPLETED|Treatment Phase With Ultrase® MT12||45
8425427|NCT00880100|20764248|P1|STARTED|Treatment Phase With Ultrase® MT12||48
8425428|NCT00880100|20764248|P1|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
8425429|NCT00880100|20764248|P1|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
8425430|NCT00880100|20764248|P1|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
8425431|NCT00880087|20764261|P2|NOT COMPLETED|Overall Study||2
8425432|NCT00880087|20764262|P1|NOT COMPLETED|Overall Study||0
8425433|NCT00880087|20764261|P2|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
8425434|NCT00880087|20764262|P1|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
8425435|NCT00880087|20764261|P2|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
8425436|NCT00880087|20764262|P1|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
8425437|NCT00880048|20764277|P3|NOT COMPLETED|Overall Study||35
8425438|NCT00880048|20764278|P2|NOT COMPLETED|Overall Study||33
8425439|NCT00880048|20764279|P1|NOT COMPLETED|Overall Study||28
8425440|NCT00880048|20764277|P3|COMPLETED|Overall Study||77
8425441|NCT00880048|20764278|P2|COMPLETED|Overall Study||82
8425442|NCT00880048|20764279|P1|COMPLETED|Overall Study||88
8425443|NCT00880048|20764277|P3|STARTED|Overall Study||112
8425444|NCT00880048|20764278|P2|STARTED|Overall Study||115
8425445|NCT00880048|20764279|P1|STARTED|Overall Study||116
8425446|NCT00880022|20764337|P2|NOT COMPLETED|Overall Study||3
8425447|NCT00880022|20764338|P1|NOT COMPLETED|Overall Study||2
8425448|NCT00880022|20764337|P2|COMPLETED|Overall Study||21
8425449|NCT00880022|20764338|P1|COMPLETED|Overall Study||21
8425450|NCT00880022|20764337|P2|STARTED|Overall Study||24
8425451|NCT00880022|20764338|P1|STARTED|Overall Study||23
8425452|NCT00880009|20764346|P1|NOT COMPLETED|Overall Study||16
8425453|NCT00880009|20764346|P1|COMPLETED|Overall Study||0
8425454|NCT00880009|20764346|P1|STARTED|Overall Study||16
8425455|NCT00879996|20764370|P2|NOT COMPLETED|Overall Study||13
8425456|NCT00879996|20764371|P1|NOT COMPLETED|Overall Study||15
8425457|NCT00879996|20764370|P2|COMPLETED|Overall Study||13
8425458|NCT00879996|20764371|P1|COMPLETED|Overall Study||13
8425459|NCT00879996|20764370|P2|STARTED|Overall Study||26
8425460|NCT00879996|20764371|P1|STARTED|Overall Study||28
8425461|NCT00879970|20764386|P5|NOT COMPLETED|Period 2 Vitamin D Randomization||7
8425462|NCT00879970|20764387|P4|NOT COMPLETED|Period 2 Vitamin D Randomization||4
8425463|NCT00879970|20764388|P3|NOT COMPLETED|Period 2 Vitamin D Randomization||0
8425464|NCT00879970|20764389|P2|NOT COMPLETED|Period 2 Vitamin D Randomization||0
8425465|NCT00879970|20764390|P1|NOT COMPLETED|Period 2 Vitamin D Randomization||0
8425466|NCT00879970|20764386|P5|COMPLETED|Period 2 Vitamin D Randomization||600
8425467|NCT00879970|20764387|P4|COMPLETED|Period 2 Vitamin D Randomization||610
8425468|NCT00879970|20764388|P3|COMPLETED|Period 2 Vitamin D Randomization||0
8425469|NCT00879970|20764389|P2|COMPLETED|Period 2 Vitamin D Randomization||0
8425470|NCT00879970|20764390|P1|COMPLETED|Period 2 Vitamin D Randomization||0
8425471|NCT00879970|20764386|P5|STARTED|Period 2 Vitamin D Randomization||607
8425472|NCT00879970|20764387|P4|STARTED|Period 2 Vitamin D Randomization||614
8425473|NCT00879970|20764388|P3|STARTED|Period 2 Vitamin D Randomization||0
8425474|NCT00879970|20764389|P2|STARTED|Period 2 Vitamin D Randomization||0
8425475|NCT00879970|20764390|P1|STARTED|Period 2 Vitamin D Randomization||0
8425476|NCT00879970|20764386|P5|NOT COMPLETED|Period 1 TZD Randomization||0
8425477|NCT00879970|20764387|P4|NOT COMPLETED|Period 1 TZD Randomization||0
8425478|NCT00879970|20764388|P3|NOT COMPLETED|Period 1 TZD Randomization||6
8425479|NCT00879970|20764389|P2|NOT COMPLETED|Period 1 TZD Randomization||4
8425480|NCT00879970|20764390|P1|NOT COMPLETED|Period 1 TZD Randomization||8
8425481|NCT00879970|20764386|P5|COMPLETED|Period 1 TZD Randomization||0
8425482|NCT00879970|20764387|P4|COMPLETED|Period 1 TZD Randomization||0
8425483|NCT00879970|20764388|P3|COMPLETED|Period 1 TZD Randomization||393
8425484|NCT00879970|20764389|P2|COMPLETED|Period 1 TZD Randomization||388
8425485|NCT00879970|20764390|P1|COMPLETED|Period 1 TZD Randomization||533
8425486|NCT00879970|20764386|P5|STARTED|Period 1 TZD Randomization||0
8425487|NCT00879970|20764387|P4|STARTED|Period 1 TZD Randomization||0
8425488|NCT00879970|20764388|P3|STARTED|Period 1 TZD Randomization||399
8425489|NCT00879970|20764389|P2|STARTED|Period 1 TZD Randomization||392
8425490|NCT00879970|20764390|P1|STARTED|Period 1 TZD Randomization||541
8425494|NCT00879814|20764480|P4|NOT COMPLETED|Overall Study||5
8425495|NCT00879814|20764481|P3|NOT COMPLETED|Overall Study||3
8425496|NCT00879814|20764482|P2|NOT COMPLETED|Overall Study||2
8425497|NCT00879814|20764483|P1|NOT COMPLETED|Overall Study||4
8425498|NCT00879814|20764480|P4|COMPLETED|Overall Study||7
8425499|NCT00879814|20764481|P3|COMPLETED|Overall Study||9
8425500|NCT00879814|20764482|P2|COMPLETED|Overall Study||10
8425501|NCT00879814|20764483|P1|COMPLETED|Overall Study||8
8425502|NCT00879814|20764480|P4|STARTED|Overall Study||12
8425503|NCT00879814|20764481|P3|STARTED|Overall Study||12
8425504|NCT00879814|20764482|P2|STARTED|Overall Study||12
8425505|NCT00879814|20764483|P1|STARTED|Overall Study||12
8425506|NCT00879775|20764591|P2|NOT COMPLETED|Overall Study||1
8425507|NCT00879775|20764592|P1|NOT COMPLETED|Overall Study||2
8425508|NCT00879775|20764591|P2|COMPLETED|Overall Study||20
8425509|NCT00879775|20764592|P1|COMPLETED|Overall Study||18
8425510|NCT00879775|20764591|P2|STARTED|Overall Study||21
8425511|NCT00879775|20764592|P1|STARTED|Overall Study||20
8425512|NCT00879710|20764608|P4|NOT COMPLETED|Phase 2 6 Weeks||0
8425513|NCT00879710|20764609|P3|NOT COMPLETED|Phase 2 6 Weeks||0
8425514|NCT00879710|20764610|P2|NOT COMPLETED|Phase 2 6 Weeks||0
8425515|NCT00879710|20764611|P1|NOT COMPLETED|Phase 2 6 Weeks||0
8425516|NCT00879710|20764608|P4|COMPLETED|Phase 2 6 Weeks||13
8425517|NCT00879710|20764609|P3|COMPLETED|Phase 2 6 Weeks||10
8425518|NCT00879710|20764610|P2|COMPLETED|Phase 2 6 Weeks||14
8425519|NCT00879710|20764611|P1|COMPLETED|Phase 2 6 Weeks||10
8425520|NCT00879710|20764608|P4|STARTED|Phase 2 6 Weeks||13
8425521|NCT00879710|20764609|P3|STARTED|Phase 2 6 Weeks||10
8425522|NCT00879710|20764610|P2|STARTED|Phase 2 6 Weeks||14
8425523|NCT00879710|20764611|P1|STARTED|Phase 2 6 Weeks||10
8425524|NCT00879710|20764608|P4|NOT COMPLETED|Wash Out Period of 4 Weeks||0
8425526|NCT00879710|20764610|P2|NOT COMPLETED|Wash Out Period of 4 Weeks||0
8425527|NCT00879710|20764611|P1|NOT COMPLETED|Wash Out Period of 4 Weeks||0
8425528|NCT00879710|20764608|P4|COMPLETED|Wash Out Period of 4 Weeks||13
8425529|NCT00879710|20764609|P3|COMPLETED|Wash Out Period of 4 Weeks||10
8425530|NCT00879710|20764610|P2|COMPLETED|Wash Out Period of 4 Weeks||14
8425531|NCT00879710|20764611|P1|COMPLETED|Wash Out Period of 4 Weeks||10
8425532|NCT00879710|20764608|P4|STARTED|Wash Out Period of 4 Weeks||13
8425533|NCT00879710|20764609|P3|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
8425534|NCT00879710|20764610|P2|STARTED|Wash Out Period of 4 Weeks||14
8425535|NCT00879710|20764611|P1|STARTED|Wash Out Period of 4 Weeks||10
8425536|NCT00879710|20764608|P4|NOT COMPLETED|Phase 1 - 6 Weeks||4
8425537|NCT00879710|20764609|P3|NOT COMPLETED|Phase 1 - 6 Weeks||2
8425538|NCT00879710|20764610|P2|NOT COMPLETED|Phase 1 - 6 Weeks||3
8425539|NCT00879710|20764611|P1|NOT COMPLETED|Phase 1 - 6 Weeks||2
8425540|NCT00879710|20764608|P4|COMPLETED|Phase 1 - 6 Weeks||13
8425541|NCT00879710|20764609|P3|COMPLETED|Phase 1 - 6 Weeks||9
8425542|NCT00879710|20764610|P2|COMPLETED|Phase 1 - 6 Weeks||14
8425543|NCT00879710|20764611|P1|COMPLETED|Phase 1 - 6 Weeks||10
8425544|NCT00879710|20764608|P4|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
8425545|NCT00879710|20764609|P3|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
8425546|NCT00879710|20764610|P2|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
8425547|NCT00879710|20764611|P1|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
8425548|NCT00879697|20764621|P2|NOT COMPLETED|Overall Study||2
8425549|NCT00879697|20764622|P1|NOT COMPLETED|Overall Study||2
8425550|NCT00879697|20764621|P2|COMPLETED|Overall Study|Two patients did not finish the trial|15
8425551|NCT00879697|20764622|P1|COMPLETED|Overall Study|Two patients did not finish the trial|15
8425552|NCT00879697|20764621|P2|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
8425553|NCT00879697|20764622|P1|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
8425554|NCT00879684|20764628|P7|NOT COMPLETED|Stage 2: Expanded Cohort||13
8425555|NCT00879684|20764629|P6|NOT COMPLETED|Stage 2: Expanded Cohort||0
8425556|NCT00879684|20764630|P5|NOT COMPLETED|Stage 2: Expanded Cohort||0
8425557|NCT00879684|20764631|P4|NOT COMPLETED|Stage 2: Expanded Cohort||0
8425558|NCT00879684|20764632|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
8425559|NCT00879684|20764633|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
8425560|NCT00879684|20764634|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
8425561|NCT00879684|20764628|P7|COMPLETED|Stage 2: Expanded Cohort||0
8425562|NCT00879684|20764629|P6|COMPLETED|Stage 2: Expanded Cohort||0
8425563|NCT00879684|20764630|P5|COMPLETED|Stage 2: Expanded Cohort||0
8425564|NCT00879684|20764631|P4|COMPLETED|Stage 2: Expanded Cohort||0
8425565|NCT00879684|20764632|P3|COMPLETED|Stage 2: Expanded Cohort||0
8425566|NCT00879684|20764633|P2|COMPLETED|Stage 2: Expanded Cohort||0
8425567|NCT00879684|20764634|P1|COMPLETED|Stage 2: Expanded Cohort||0
8425568|NCT00879684|20764628|P7|STARTED|Stage 2: Expanded Cohort||13
8425569|NCT00879684|20764629|P6|STARTED|Stage 2: Expanded Cohort||0
8425570|NCT00879684|20764630|P5|STARTED|Stage 2: Expanded Cohort||0
8425571|NCT00879684|20764631|P4|STARTED|Stage 2: Expanded Cohort||0
8425572|NCT00879684|20764632|P3|STARTED|Stage 2: Expanded Cohort||0
8425573|NCT00879684|20764633|P2|STARTED|Stage 2: Expanded Cohort||0
8425574|NCT00879684|20764634|P1|STARTED|Stage 2: Expanded Cohort||0
8425575|NCT00879684|20764628|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
8425576|NCT00879684|20764629|P6|NOT COMPLETED|Stage 1: Dose Escalation||3
8425577|NCT00879684|20764630|P5|NOT COMPLETED|Stage 1: Dose Escalation||3
8425578|NCT00879684|20764631|P4|NOT COMPLETED|Stage 1: Dose Escalation||6
8425579|NCT00879684|20764632|P3|NOT COMPLETED|Stage 1: Dose Escalation||3
8425580|NCT00879684|20764633|P2|NOT COMPLETED|Stage 1: Dose Escalation||3
8425581|NCT00879684|20764634|P1|NOT COMPLETED|Stage 1: Dose Escalation||3
8425582|NCT00879684|20764628|P7|COMPLETED|Stage 1: Dose Escalation||0
8425583|NCT00879684|20764629|P6|COMPLETED|Stage 1: Dose Escalation||0
8425584|NCT00879684|20764630|P5|COMPLETED|Stage 1: Dose Escalation||0
8425585|NCT00879684|20764631|P4|COMPLETED|Stage 1: Dose Escalation||0
8425586|NCT00879684|20764632|P3|COMPLETED|Stage 1: Dose Escalation||0
8425587|NCT00879684|20764633|P2|COMPLETED|Stage 1: Dose Escalation||0
8425588|NCT00879684|20764634|P1|COMPLETED|Stage 1: Dose Escalation||0
8425589|NCT00879684|20764628|P7|STARTED|Stage 1: Dose Escalation||0
8425590|NCT00879684|20764629|P6|STARTED|Stage 1: Dose Escalation||3
8425591|NCT00879684|20764630|P5|STARTED|Stage 1: Dose Escalation||3
8425592|NCT00879684|20764631|P4|STARTED|Stage 1: Dose Escalation||6
8425593|NCT00879684|20764632|P3|STARTED|Stage 1: Dose Escalation||3
8425594|NCT00879684|20764633|P2|STARTED|Stage 1: Dose Escalation||3
8425595|NCT00879684|20764634|P1|STARTED|Stage 1: Dose Escalation||3
8425596|NCT00879658|20764703|P7|NOT COMPLETED|Overall Study||0
8425597|NCT00879658|20764704|P6|NOT COMPLETED|Overall Study||1
8425598|NCT00879658|20764705|P5|NOT COMPLETED|Overall Study||2
8425599|NCT00879658|20764706|P4|NOT COMPLETED|Overall Study||4
8425600|NCT00879658|20764707|P3|NOT COMPLETED|Overall Study||7
8425601|NCT00879658|20764708|P2|NOT COMPLETED|Overall Study||5
8425602|NCT00879658|20764709|P1|NOT COMPLETED|Overall Study||15
8425603|NCT00879658|20764703|P7|COMPLETED|Overall Study||16
8425604|NCT00879658|20764704|P6|COMPLETED|Overall Study||50
8425605|NCT00879658|20764705|P5|COMPLETED|Overall Study||40
8425606|NCT00879658|20764706|P4|COMPLETED|Overall Study||42
8425607|NCT00879658|20764707|P3|COMPLETED|Overall Study||36
8425608|NCT00879658|20764708|P2|COMPLETED|Overall Study||44
8425609|NCT00879658|20764709|P1|COMPLETED|Overall Study||35
8425610|NCT00879658|20764703|P7|STARTED|Overall Study||16
8425611|NCT00879658|20764704|P6|STARTED|Overall Study||51
8425612|NCT00879658|20764705|P5|STARTED|Overall Study||42
8425613|NCT00879658|20764706|P4|STARTED|Overall Study||46
8425614|NCT00879658|20764707|P3|STARTED|Overall Study||43
8425615|NCT00879658|20764708|P2|STARTED|Overall Study||49
8425616|NCT00879658|20764709|P1|STARTED|Overall Study||50
8425617|NCT00879645|20764795|P4|NOT COMPLETED|Overall Study||0
8425618|NCT00879645|20764796|P3|NOT COMPLETED|Overall Study||0
8425619|NCT00879645|20764797|P2|NOT COMPLETED|Overall Study||0
8425620|NCT00879645|20764798|P1|NOT COMPLETED|Overall Study||1
8425621|NCT00879645|20764795|P4|COMPLETED|Overall Study||7
8425622|NCT00879645|20764796|P3|COMPLETED|Overall Study||6
8425623|NCT00879645|20764797|P2|COMPLETED|Overall Study||6
8425624|NCT00879645|20764798|P1|COMPLETED|Overall Study||8
8425625|NCT00879645|20764795|P4|STARTED|Overall Study||7
8425626|NCT00879645|20764796|P3|STARTED|Overall Study||6
8425627|NCT00879645|20764797|P2|STARTED|Overall Study||6
8425628|NCT00879645|20764798|P1|STARTED|Overall Study||9
8425629|NCT00879619|20764816|P1|NOT COMPLETED|Overall Study||0
8425630|NCT00879619|20764816|P1|COMPLETED|Overall Study||4
8425631|NCT00879619|20764816|P1|STARTED|Overall Study||4
8425632|NCT00879411|20764825|P1|NOT COMPLETED|Overall Study||162
8425633|NCT00879411|20764825|P1|COMPLETED|Overall Study||539
8425634|NCT00879411|20764825|P1|STARTED|Overall Study||701
8425635|NCT00879398|20764831|P1|NOT COMPLETED|Overall Study||675
8425636|NCT00879398|20764831|P1|COMPLETED|Overall Study||2434
8425637|NCT00879398|20764831|P1|STARTED|Overall Study||3109
8425638|NCT00879359|20764841|P1|NOT COMPLETED|Overall Study||0
8425639|NCT00879359|20764841|P1|COMPLETED|Overall Study||15
8425640|NCT00879359|20764841|P1|STARTED|Overall Study||15
8425641|NCT00879333|20764849|P2|NOT COMPLETED|Overall Study||217
8425642|NCT00879333|20764850|P1|NOT COMPLETED|Overall Study||428
8425643|NCT00879333|20764849|P2|COMPLETED|Overall Study||0
8425644|NCT00879333|20764850|P1|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
8425645|NCT00879333|20764849|P2|Discontinued Study Treatment|Overall Study||217
8425646|NCT00879333|20764850|P1|Discontinued Study Treatment|Overall Study||428
8425647|NCT00879333|20764849|P2|STARTED|Overall Study||217
8425648|NCT00879333|20764850|P1|STARTED|Overall Study||439
8425649|NCT00879255|20764870|P2|NOT COMPLETED|Overall Study||19
8425650|NCT00879255|20764871|P1|NOT COMPLETED|Overall Study||16
8425651|NCT00879255|20764870|P2|COMPLETED|Overall Study|Completed 6-mo follow-up|45
8425652|NCT00879255|20764871|P1|COMPLETED|Overall Study|Completed 6-mo follow-up|45
8425653|NCT00879255|20764870|P2|Completed 3-mo Follow-up|Overall Study||49
8425654|NCT00879255|20764871|P1|Completed 3-mo Follow-up|Overall Study||48
8425655|NCT00879255|20764870|P2|Completed Posttreatment Follow-up|Overall Study||55
8425656|NCT00879255|20764871|P1|Completed Posttreatment Follow-up|Overall Study||50
8425657|NCT00879255|20764870|P2|Received Allocated Intervention:|Overall Study||56
8425658|NCT00879255|20764871|P1|Received Allocated Intervention:|Overall Study||51
8425659|NCT00879255|20764870|P2|STARTED|Overall Study||64
8425660|NCT00879255|20764871|P1|STARTED|Overall Study||61
8425661|NCT00879229|20764883|P2|NOT COMPLETED|Overall Study||14
8425662|NCT00879229|20764884|P1|NOT COMPLETED|Overall Study||22
8425663|NCT00879229|20764883|P2|COMPLETED|Overall Study||1
8425664|NCT00879229|20764884|P1|COMPLETED|Overall Study||3
8425665|NCT00879229|20764883|P2|STARTED|Overall Study||15
8425666|NCT00879229|20764884|P1|STARTED|Overall Study||25
8425667|NCT00879190|20764910|P2|NOT COMPLETED|Overall Study||0
8425668|NCT00879190|20764911|P1|NOT COMPLETED|Overall Study||0
8425669|NCT00879190|20764910|P2|COMPLETED|Overall Study||49
8425670|NCT00879190|20764911|P1|COMPLETED|Overall Study||43
8425671|NCT00879190|20764910|P2|STARTED|Overall Study||49
8425672|NCT00879190|20764911|P1|STARTED|Overall Study||43
8425673|NCT00879034|20764921|P1|NOT COMPLETED|Overall Study||0
8425674|NCT00879034|20764921|P1|COMPLETED|Overall Study||5
8425675|NCT00879034|20764921|P1|Received Treatment|Overall Study||4
8425676|NCT00879034|20764921|P1|STARTED|Overall Study||5
8425677|NCT00878995|20764932|P2|NOT COMPLETED|Midpoint Study - Post Study||0
8425678|NCT00878995|20764933|P1|NOT COMPLETED|Midpoint Study - Post Study||0
8425679|NCT00878995|20764932|P2|COMPLETED|Midpoint Study - Post Study||10
8425680|NCT00878995|20764933|P1|COMPLETED|Midpoint Study - Post Study||12
8425681|NCT00878995|20764932|P2|STARTED|Midpoint Study - Post Study||10
8425682|NCT00878995|20764933|P1|STARTED|Midpoint Study - Post Study||12
8425683|NCT00878995|20764932|P2|NOT COMPLETED|Baseline Study - Midpoint Study||2
8425684|NCT00878995|20764933|P1|NOT COMPLETED|Baseline Study - Midpoint Study||0
8425685|NCT00878995|20764932|P2|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
8425686|NCT00878995|20764933|P1|COMPLETED|Baseline Study - Midpoint Study||12
8425687|NCT00878995|20764932|P2|Baseline Study|Baseline Study - Midpoint Study||12
8425688|NCT00878995|20764933|P1|Baseline Study|Baseline Study - Midpoint Study||12
8425689|NCT00878995|20764932|P2|STARTED|Baseline Study - Midpoint Study||12
8425690|NCT00878995|20764933|P1|STARTED|Baseline Study - Midpoint Study||12
8425691|NCT00878969|20765034|P3|NOT COMPLETED|Overall Study||11
8425692|NCT00878969|20765035|P2|NOT COMPLETED|Overall Study||15
8425693|NCT00878969|20765036|P1|NOT COMPLETED|Overall Study||15
8425694|NCT00878969|20765034|P3|COMPLETED|Overall Study||15
8425695|NCT00878969|20765035|P2|COMPLETED|Overall Study||12
8425696|NCT00878969|20765036|P1|COMPLETED|Overall Study||10
8425697|NCT00878969|20765034|P3|STARTED|Overall Study||26
8425698|NCT00878969|20765035|P2|STARTED|Overall Study||27
8425699|NCT00878969|20765036|P1|STARTED|Overall Study||25
8425700|NCT00878878|20765046|P2|NOT COMPLETED|Overall Study||0
8425701|NCT00878878|20765047|P1|NOT COMPLETED|Overall Study||0
8425702|NCT00878878|20765046|P2|COMPLETED|Overall Study||15
8425703|NCT00878878|20765047|P1|COMPLETED|Overall Study||15
8425704|NCT00878878|20765046|P2|STARTED|Overall Study||15
8425705|NCT00878878|20765047|P1|STARTED|Overall Study||15
8425706|NCT00878826|20765060|P3|NOT COMPLETED|Overall Study||0
8425707|NCT00878826|20765061|P2|NOT COMPLETED|Overall Study||0
8425708|NCT00878826|20765062|P1|NOT COMPLETED|Overall Study||0
8425709|NCT00878826|20765060|P3|COMPLETED|Overall Study||2
8425710|NCT00878826|20765061|P2|COMPLETED|Overall Study||6
8425711|NCT00878826|20765062|P1|COMPLETED|Overall Study||3
8425712|NCT00878826|20765060|P3|STARTED|Overall Study||2
8425713|NCT00878826|20765061|P2|STARTED|Overall Study||6
8425714|NCT00878826|20765062|P1|STARTED|Overall Study||3
8425715|NCT00878800|20765084|P5|NOT COMPLETED|Overall Study||16
8425716|NCT00878800|20765085|P4|NOT COMPLETED|Overall Study||6
8425717|NCT00878800|20765086|P3|NOT COMPLETED|Overall Study||9
8425718|NCT00878800|20765087|P2|NOT COMPLETED|Overall Study||7
8425719|NCT00878800|20765088|P1|NOT COMPLETED|Overall Study||3
8425720|NCT00878800|20765084|P5|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
8425721|NCT00878800|20765085|P4|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
8425722|NCT00878800|20765086|P3|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
8425723|NCT00878800|20765087|P2|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
8425724|NCT00878800|20765088|P1|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
8425725|NCT00878800|20765084|P5|STARTED|Overall Study||16
8425726|NCT00878800|20765085|P4|STARTED|Overall Study||6
8425727|NCT00878800|20765086|P3|STARTED|Overall Study||9
8425728|NCT00878800|20765087|P2|STARTED|Overall Study||7
8425729|NCT00878800|20765088|P1|STARTED|Overall Study||3
8425730|NCT00878722|20765123|P8|NOT COMPLETED|Overall Study||7
8425731|NCT00878722|20765124|P7|NOT COMPLETED|Overall Study||6
8425732|NCT00878722|20765125|P6|NOT COMPLETED|Overall Study||2
8425733|NCT00878722|20765126|P5|NOT COMPLETED|Overall Study||7
8425734|NCT00878722|20765127|P4|NOT COMPLETED|Overall Study||9
8425735|NCT00878722|20765128|P3|NOT COMPLETED|Overall Study||3
8425736|NCT00878722|20765129|P2|NOT COMPLETED|Overall Study||3
8425737|NCT00878722|20765130|P1|NOT COMPLETED|Overall Study||3
8425738|NCT00878722|20765123|P8|COMPLETED|Overall Study||0
8425739|NCT00878722|20765124|P7|COMPLETED|Overall Study||0
8425740|NCT00878722|20765125|P6|COMPLETED|Overall Study||1
8425741|NCT00878722|20765126|P5|COMPLETED|Overall Study||0
8425742|NCT00878722|20765127|P4|COMPLETED|Overall Study||0
8425743|NCT00878722|20765128|P3|COMPLETED|Overall Study||0
8425744|NCT00878722|20765129|P2|COMPLETED|Overall Study||0
8425745|NCT00878722|20765130|P1|COMPLETED|Overall Study||0
8425746|NCT00878722|20765123|P8|STARTED|Overall Study||7
8425747|NCT00878722|20765124|P7|STARTED|Overall Study||6
8425748|NCT00878722|20765125|P6|STARTED|Overall Study||3
8425749|NCT00878722|20765126|P5|STARTED|Overall Study||7
8425750|NCT00878722|20765127|P4|STARTED|Overall Study||9
8425751|NCT00878722|20765128|P3|STARTED|Overall Study||3
8425752|NCT00878722|20765129|P2|STARTED|Overall Study||3
8425753|NCT00878722|20765130|P1|STARTED|Overall Study||3
8425760|NCT00878644|20765256|P2|NOT COMPLETED|Overall Study||4
8425761|NCT00878644|20765257|P1|NOT COMPLETED|Overall Study||4
8425762|NCT00878644|20765256|P2|COMPLETED|Overall Study||136
8425763|NCT00878644|20765257|P1|COMPLETED|Overall Study||151
8425764|NCT00878644|20765256|P2|STARTED|Overall Study||140
8425765|NCT00878644|20765257|P1|STARTED|Overall Study||155
8425766|NCT00878605|20765273|P4|NOT COMPLETED|Overall Study||3
8425767|NCT00878605|20765274|P3|NOT COMPLETED|Overall Study||1
8425768|NCT00878605|20765275|P2|NOT COMPLETED|Overall Study||3
8425769|NCT00878605|20765276|P1|NOT COMPLETED|Overall Study||3
8425770|NCT00878605|20765273|P4|COMPLETED|Overall Study||6
8425771|NCT00878605|20765274|P3|COMPLETED|Overall Study||8
8425772|NCT00878605|20765275|P2|COMPLETED|Overall Study||7
8425773|NCT00878605|20765276|P1|COMPLETED|Overall Study||7
8425774|NCT00878605|20765273|P4|STARTED|Overall Study||9
8425775|NCT00878605|20765274|P3|STARTED|Overall Study||9
8425776|NCT00878605|20765275|P2|STARTED|Overall Study||10
8425777|NCT00878605|20765276|P1|STARTED|Overall Study||10
8425778|NCT00878553|20765290|P5|NOT COMPLETED|PK Study||0
8425779|NCT00878553|20765291|P4|NOT COMPLETED|PK Study||1
8425780|NCT00878553|20765292|P3|NOT COMPLETED|PK Study||0
8425781|NCT00878553|20765293|P2|NOT COMPLETED|PK Study||0
8425782|NCT00878553|20765294|P1|NOT COMPLETED|PK Study||0
8425783|NCT00878553|20765290|P5|COMPLETED|PK Study||15
8425784|NCT00878553|20765291|P4|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
8425785|NCT00878553|20765292|P3|COMPLETED|PK Study||17
8425786|NCT00878553|20765293|P2|COMPLETED|PK Study||16
8425787|NCT00878553|20765294|P1|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
8425788|NCT00878553|20765290|P5|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
8425871|NCT00878189|20765422|P6|NOT COMPLETED|Overall Study||23
8425872|NCT00878189|20765423|P5|NOT COMPLETED|Overall Study||4
8425789|NCT00878553|20765291|P4|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
8425790|NCT00878553|20765292|P3|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
8425791|NCT00878553|20765293|P2|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
8425792|NCT00878553|20765294|P1|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
8425793|NCT00878553|20765290|P5|NOT COMPLETED|Sleep Study||0
8425794|NCT00878553|20765291|P4|NOT COMPLETED|Sleep Study||0
8425795|NCT00878553|20765292|P3|NOT COMPLETED|Sleep Study||0
8425796|NCT00878553|20765293|P2|NOT COMPLETED|Sleep Study||0
8425797|NCT00878553|20765294|P1|NOT COMPLETED|Sleep Study||5
8425798|NCT00878553|20765290|P5|COMPLETED|Sleep Study||0
8425799|NCT00878553|20765291|P4|COMPLETED|Sleep Study||0
8425800|NCT00878553|20765292|P3|COMPLETED|Sleep Study||0
8425801|NCT00878553|20765293|P2|COMPLETED|Sleep Study||0
8425802|NCT00878553|20765294|P1|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
8425803|NCT00878553|20765290|P5|Number of Patients Receiving 20mg|Sleep Study||0
8425804|NCT00878553|20765291|P4|Number of Patients Receiving 20mg|Sleep Study||0
8425805|NCT00878553|20765292|P3|Number of Patients Receiving 20mg|Sleep Study||0
8425806|NCT00878553|20765293|P2|Number of Patients Receiving 20mg|Sleep Study||0
8425807|NCT00878553|20765294|P1|Number of Patients Receiving 20mg|Sleep Study||65
8425808|NCT00878553|20765290|P5|Number of Patients Receiving 15mg|Sleep Study||0
8425809|NCT00878553|20765291|P4|Number of Patients Receiving 15mg|Sleep Study||0
8425810|NCT00878553|20765292|P3|Number of Patients Receiving 15mg|Sleep Study||0
8425811|NCT00878553|20765293|P2|Number of Patients Receiving 15mg|Sleep Study||0
8425812|NCT00878553|20765294|P1|Number of Patients Receiving 15mg|Sleep Study||65
8425813|NCT00878553|20765290|P5|Number of Patients Receiving 10mg|Sleep Study||0
8425814|NCT00878553|20765291|P4|Number of Patients Receiving 10mg|Sleep Study||0
8425815|NCT00878553|20765292|P3|Number of Patients Receiving 10mg|Sleep Study||0
8425816|NCT00878553|20765293|P2|Number of Patients Receiving 10mg|Sleep Study||0
8425817|NCT00878553|20765294|P1|Number of Patients Receiving 10mg|Sleep Study||65
8425818|NCT00878553|20765290|P5|Number of Patients Receiving Placebo|Sleep Study||0
8425819|NCT00878553|20765291|P4|Number of Patients Receiving Placebo|Sleep Study||0
8425820|NCT00878553|20765292|P3|Number of Patients Receiving Placebo|Sleep Study||0
8425821|NCT00878553|20765293|P2|Number of Patients Receiving Placebo|Sleep Study||0
8425822|NCT00878553|20765294|P1|Number of Patients Receiving Placebo|Sleep Study||66
8425823|NCT00878553|20765290|P5|STARTED|Sleep Study||0
8425824|NCT00878553|20765291|P4|STARTED|Sleep Study||0
8425825|NCT00878553|20765292|P3|STARTED|Sleep Study||0
8425826|NCT00878553|20765293|P2|STARTED|Sleep Study||0
8425827|NCT00878553|20765294|P1|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
8425828|NCT00878501|20765353|P3|NOT COMPLETED|Overall Study||8
8425829|NCT00878501|20765354|P2|NOT COMPLETED|Overall Study||7
8425830|NCT00878501|20765355|P1|NOT COMPLETED|Overall Study||17
8425831|NCT00878501|20765353|P3|COMPLETED|Overall Study||85
8425832|NCT00878501|20765354|P2|COMPLETED|Overall Study||37
8425833|NCT00878501|20765355|P1|COMPLETED|Overall Study||87
8425834|NCT00878501|20765353|P3|Interim Analysis|Overall Study||81
8425835|NCT00878501|20765354|P2|Interim Analysis|Overall Study||37
8425836|NCT00878501|20765355|P1|Interim Analysis|Overall Study||83
8425837|NCT00878501|20765353|P3|STARTED|Overall Study||93
8425838|NCT00878501|20765354|P2|STARTED|Overall Study||44
8425839|NCT00878501|20765355|P1|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
8425840|NCT00878436|20765374|P2|NOT COMPLETED|Overall Study||24
8425841|NCT00878436|20765375|P1|NOT COMPLETED|Overall Study||23
8425842|NCT00878436|20765374|P2|COMPLETED|Overall Study||0
8425843|NCT00878436|20765375|P1|COMPLETED|Overall Study||5
8425844|NCT00878436|20765374|P2|6 Months|Overall Study||0
8425845|NCT00878436|20765375|P1|6 Months|Overall Study||8
8425846|NCT00878436|20765374|P2|Completed 2 Cycles|Overall Study||20
8425847|NCT00878436|20765375|P1|Completed 2 Cycles|Overall Study||21
8425848|NCT00878436|20765374|P2|STARTED|Overall Study||24
8425849|NCT00878436|20765375|P1|STARTED|Overall Study||28
8425850|NCT00878228|20765389|P2|NOT COMPLETED|Overall Study||12
8425851|NCT00878228|20765390|P1|NOT COMPLETED|Overall Study||10
8425852|NCT00878228|20765389|P2|COMPLETED|Overall Study||37
8425853|NCT00878228|20765390|P1|COMPLETED|Overall Study||39
8425854|NCT00878228|20765389|P2|STARTED|Overall Study||49
8425855|NCT00878228|20765390|P1|STARTED|Overall Study||49
8425856|NCT00878215|20765404|P4|NOT COMPLETED|Overall Study||0
8425857|NCT00878215|20765405|P3|NOT COMPLETED|Overall Study||0
8425858|NCT00878215|20765406|P2|NOT COMPLETED|Overall Study||10
8425859|NCT00878215|20765407|P1|NOT COMPLETED|Overall Study||0
8425860|NCT00878215|20765404|P4|COMPLETED|Overall Study||0
8425861|NCT00878215|20765405|P3|COMPLETED|Overall Study||0
8425862|NCT00878215|20765406|P2|COMPLETED|Overall Study||9
8425863|NCT00878215|20765407|P1|COMPLETED|Overall Study||21
8425864|NCT00878215|20765404|P4|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
8425865|NCT00878215|20765405|P3|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
8425866|NCT00878215|20765406|P2|STARTED|Overall Study||19
8425867|NCT00878215|20765407|P1|STARTED|Overall Study||21
8425868|NCT00878189|20765419|P9|NOT COMPLETED|Overall Study||8
8425869|NCT00878189|20765420|P8|NOT COMPLETED|Overall Study||3
8425870|NCT00878189|20765421|P7|NOT COMPLETED|Overall Study||16
8425873|NCT00878189|20765424|P4|NOT COMPLETED|Overall Study||8
8425874|NCT00878189|20765425|P3|NOT COMPLETED|Overall Study||4
8425875|NCT00878189|20765426|P2|NOT COMPLETED|Overall Study||3
8425876|NCT00878189|20765427|P1|NOT COMPLETED|Overall Study||3
8425877|NCT00878189|20765419|P9|COMPLETED|Overall Study||0
8425878|NCT00878189|20765420|P8|COMPLETED|Overall Study||0
8425879|NCT00878189|20765421|P7|COMPLETED|Overall Study||0
8425880|NCT00878189|20765422|P6|COMPLETED|Overall Study||0
8425881|NCT00878189|20765423|P5|COMPLETED|Overall Study||0
8425882|NCT00878189|20765424|P4|COMPLETED|Overall Study||0
8425883|NCT00878189|20765425|P3|COMPLETED|Overall Study||0
8425884|NCT00878189|20765426|P2|COMPLETED|Overall Study||0
8425885|NCT00878189|20765427|P1|COMPLETED|Overall Study||0
8425886|NCT00878189|20765419|P9|STARTED|Overall Study||8
8425887|NCT00878189|20765420|P8|STARTED|Overall Study||3
8425888|NCT00878189|20765421|P7|STARTED|Overall Study||16
8425889|NCT00878189|20765422|P6|STARTED|Overall Study||23
8425890|NCT00878189|20765423|P5|STARTED|Overall Study||4
8425891|NCT00878189|20765424|P4|STARTED|Overall Study||8
8425892|NCT00878189|20765425|P3|STARTED|Overall Study||4
8425893|NCT00878189|20765426|P2|STARTED|Overall Study||3
8425894|NCT00878189|20765427|P1|STARTED|Overall Study||3
8425895|NCT00877929|20765695|P2|NOT COMPLETED|Overall Study||35
8425896|NCT00877929|20765696|P1|NOT COMPLETED|Overall Study||20
8425897|NCT00877929|20765695|P2|COMPLETED|Overall Study||319
8425898|NCT00877929|20765696|P1|COMPLETED|Overall Study||332
8425899|NCT00877929|20765695|P2|STARTED|Overall Study||354
8425900|NCT00877929|20765696|P1|STARTED|Overall Study||352
8425901|NCT00877890|20765784|P2|NOT COMPLETED|Overall Study||30
8425902|NCT00877890|20765785|P1|NOT COMPLETED|Overall Study||20
8425903|NCT00877890|20765784|P2|COMPLETED|Overall Study||95
8425904|NCT00877890|20765785|P1|COMPLETED|Overall Study||109
8425905|NCT00877890|20765784|P2|Intent to Treat (ITT)|Overall Study||123
8425906|NCT00877890|20765785|P1|Intent to Treat (ITT)|Overall Study||129
8425907|NCT00877890|20765784|P2|STARTED|Overall Study||125
8425908|NCT00877890|20765785|P1|STARTED|Overall Study||129
8425909|NCT00877877|20765819|P1|NOT COMPLETED|Year 10||0
8425910|NCT00877877|20765819|P1|COMPLETED|Year 10||495
8425911|NCT00877877|20765819|P1|STARTED|Year 10||495
8425912|NCT00877877|20765819|P1|NOT COMPLETED|Year 9||0
8425913|NCT00877877|20765819|P1|COMPLETED|Year 9||507
8425914|NCT00877877|20765819|P1|STARTED|Year 9||507
8425915|NCT00877877|20765819|P1|NOT COMPLETED|Year 8||0
8425916|NCT00877877|20765819|P1|COMPLETED|Year 8||522
8425917|NCT00877877|20765819|P1|STARTED|Year 8||522
8425918|NCT00877877|20765819|P1|NOT COMPLETED|Year 7||0
8425919|NCT00877877|20765819|P1|COMPLETED|Year 7||523
8425920|NCT00877877|20765819|P1|STARTED|Year 7||523
8425921|NCT00877877|20765819|P1|NOT COMPLETED|Year 6||0
8425922|NCT00877877|20765819|P1|COMPLETED|Year 6||529
8425923|NCT00877877|20765819|P1|STARTED|Year 6||529
8425924|NCT00877877|20765819|P1|NOT COMPLETED|Year 5||0
8425925|NCT00877877|20765819|P1|COMPLETED|Year 5||397
8425926|NCT00877877|20765819|P1|STARTED|Year 5||397
8425927|NCT00877799|20765850|P5|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
8425928|NCT00877799|20765851|P4|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
8425929|NCT00877799|20765852|P3|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8425930|NCT00877799|20765853|P2|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8425931|NCT00877799|20765854|P1|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8425932|NCT00877799|20765850|P5|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
8425933|NCT00877799|20765851|P4|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
8425934|NCT00877799|20765852|P3|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8425935|NCT00877799|20765853|P2|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8425936|NCT00877799|20765854|P1|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
8425937|NCT00877799|20765850|P5|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
8425938|NCT00877799|20765851|P4|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
8425939|NCT00877799|20765852|P3|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
8425940|NCT00877799|20765853|P2|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
8425941|NCT00877799|20765854|P1|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
8425942|NCT00877799|20765850|P5|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8425943|NCT00877799|20765851|P4|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8425944|NCT00877799|20765852|P3|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
8425945|NCT00877799|20765853|P2|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
8425946|NCT00877799|20765854|P1|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
8425947|NCT00877799|20765850|P5|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8425948|NCT00877799|20765851|P4|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8425949|NCT00877799|20765852|P3|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
8425950|NCT00877799|20765853|P2|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
8425951|NCT00877799|20765854|P1|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
8425952|NCT00877799|20765850|P5|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8425953|NCT00877799|20765851|P4|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
8425954|NCT00877799|20765852|P3|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
8425955|NCT00877799|20765853|P2|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
8425956|NCT00877799|20765854|P1|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
8425957|NCT00877773|20765869|P1|NOT COMPLETED|Overall Study||44
8425958|NCT00877773|20765869|P1|COMPLETED|Overall Study|No participant reached to first restaging.|0
8425959|NCT00877773|20765869|P1|STARTED|Overall Study||44
8425960|NCT00877604|20765875|P2|NOT COMPLETED|Overall Study||3
8425961|NCT00877604|20765876|P1|NOT COMPLETED|Overall Study||2
8425962|NCT00877604|20765875|P2|COMPLETED|Overall Study||14
8425963|NCT00877604|20765876|P1|COMPLETED|Overall Study||15
8425964|NCT00877604|20765875|P2|STARTED|Overall Study||17
8425965|NCT00877604|20765876|P1|STARTED|Overall Study||17
8425978|NCT00877448|20765900|P7|NOT COMPLETED|Overall Study||0
8425979|NCT00877448|20765901|P6|NOT COMPLETED|Overall Study||1
8425980|NCT00877448|20765902|P5|NOT COMPLETED|Overall Study||0
8425981|NCT00877448|20765903|P4|NOT COMPLETED|Overall Study||1
8425982|NCT00877448|20765904|P3|NOT COMPLETED|Overall Study||0
8425983|NCT00877448|20765905|P2|NOT COMPLETED|Overall Study||1
8425984|NCT00877448|20765906|P1|NOT COMPLETED|Overall Study||0
8425985|NCT00877448|20765900|P7|COMPLETED|Overall Study||3
8425986|NCT00877448|20765901|P6|COMPLETED|Overall Study||9
8425987|NCT00877448|20765902|P5|COMPLETED|Overall Study||10
8425988|NCT00877448|20765903|P4|COMPLETED|Overall Study||9
8425989|NCT00877448|20765904|P3|COMPLETED|Overall Study||10
8425990|NCT00877448|20765905|P2|COMPLETED|Overall Study||9
8425991|NCT00877448|20765906|P1|COMPLETED|Overall Study||10
8425992|NCT00877448|20765900|P7|STARTED|Overall Study||3
8425993|NCT00877448|20765901|P6|STARTED|Overall Study||10
8425994|NCT00877448|20765902|P5|STARTED|Overall Study||10
8425995|NCT00877448|20765903|P4|STARTED|Overall Study||10
8425996|NCT00877448|20765904|P3|STARTED|Overall Study||10
8425997|NCT00877448|20765905|P2|STARTED|Overall Study||10
8425998|NCT00877448|20765906|P1|STARTED|Overall Study||10
8425999|NCT00877383|20765931|P2|NOT COMPLETED|Overall Study||37
8426000|NCT00877383|20765932|P1|NOT COMPLETED|Overall Study||29
8426001|NCT00877383|20765931|P2|COMPLETED|Overall Study||533
8426002|NCT00877383|20765932|P1|COMPLETED|Overall Study||543
8426003|NCT00877383|20765931|P2|STARTED|Overall Study||570
8426004|NCT00877383|20765932|P1|STARTED|Overall Study||572
8426005|NCT00877370|20765948|P1|NOT COMPLETED|Overall Study||0
8426006|NCT00877370|20765948|P1|COMPLETED|Overall Study||8
8426007|NCT00877370|20765948|P1|STARTED|Overall Study||8
8426008|NCT00877071|20765952|P1|NOT COMPLETED|Overall Study||2
8426009|NCT00877071|20765952|P1|COMPLETED|Overall Study||0
8426010|NCT00877071|20765952|P1|STARTED|Overall Study||2
8426011|NCT00877058|20765962|P3|NOT COMPLETED|Overall Study||39
8426012|NCT00877058|20765963|P2|NOT COMPLETED|Overall Study||40
8426013|NCT00877058|20765964|P1|NOT COMPLETED|Overall Study||37
8426014|NCT00877058|20765962|P3|COMPLETED|Overall Study||75
8426015|NCT00877058|20765963|P2|COMPLETED|Overall Study||131
8426016|NCT00877058|20765964|P1|COMPLETED|Overall Study||137
8426017|NCT00877058|20765962|P3|STARTED|Overall Study||114
8426018|NCT00877058|20765963|P2|STARTED|Overall Study||171
8426019|NCT00877058|20765964|P1|STARTED|Overall Study||174
8426020|NCT00877032|20765985|P7|NOT COMPLETED|Overall Study||2
8426021|NCT00877032|20765986|P6|NOT COMPLETED|Overall Study||0
8426022|NCT00877032|20765987|P5|NOT COMPLETED|Overall Study||0
8426023|NCT00877032|20765988|P4|NOT COMPLETED|Overall Study||1
8426024|NCT00877032|20765989|P3|NOT COMPLETED|Overall Study||0
8426025|NCT00877032|20765990|P2|NOT COMPLETED|Overall Study||0
8426026|NCT00877032|20765991|P1|NOT COMPLETED|Overall Study||0
8426027|NCT00877032|20765985|P7|COMPLETED|Overall Study||18
8426028|NCT00877032|20765986|P6|COMPLETED|Overall Study||6
8426029|NCT00877032|20765987|P5|COMPLETED|Overall Study||6
8426030|NCT00877032|20765988|P4|COMPLETED|Overall Study||6
8426031|NCT00877032|20765989|P3|COMPLETED|Overall Study||6
8426032|NCT00877032|20765990|P2|COMPLETED|Overall Study||6
8426033|NCT00877032|20765991|P1|COMPLETED|Overall Study||6
8426034|NCT00877032|20765985|P7|Treated|Overall Study||18
8426035|NCT00877032|20765986|P6|Treated|Overall Study||6
8426036|NCT00877032|20765987|P5|Treated|Overall Study||6
8426037|NCT00877032|20765988|P4|Treated|Overall Study||6
8426038|NCT00877032|20765989|P3|Treated|Overall Study||6
8426039|NCT00877032|20765990|P2|Treated|Overall Study||6
8426040|NCT00877032|20765991|P1|Treated|Overall Study||6
8426041|NCT00877032|20765985|P7|STARTED|Overall Study||20
8426042|NCT00877032|20765986|P6|STARTED|Overall Study||6
8426043|NCT00877032|20765987|P5|STARTED|Overall Study||6
8426044|NCT00877032|20765988|P4|STARTED|Overall Study||7
8426045|NCT00877032|20765989|P3|STARTED|Overall Study||6
8426046|NCT00877032|20765990|P2|STARTED|Overall Study||6
8426047|NCT00877032|20765991|P1|STARTED|Overall Study||6
8426048|NCT00877006|20766092|P2|NOT COMPLETED|Long-Term Follow-up Period||55
8426049|NCT00877006|20766093|P1|NOT COMPLETED|Long-Term Follow-up Period||53
8426050|NCT00877006|20766092|P2|COMPLETED|Long-Term Follow-up Period||154
8426051|NCT00877006|20766093|P1|COMPLETED|Long-Term Follow-up Period||157
8426052|NCT00877006|20766092|P2|STARTED|Long-Term Follow-up Period||209
8426053|NCT00877006|20766093|P1|STARTED|Long-Term Follow-up Period||210
8426054|NCT00877006|20766092|P2|NOT COMPLETED|Treatment Period||27
8426055|NCT00877006|20766093|P1|NOT COMPLETED|Treatment Period||25
8426056|NCT00877006|20766092|P2|COMPLETED|Treatment Period||196
8426057|NCT00877006|20766093|P1|COMPLETED|Treatment Period||199
8426058|NCT00877006|20766092|P2|STARTED|Treatment Period||223
8426059|NCT00877006|20766093|P1|STARTED|Treatment Period||224
8426060|NCT00876993|20766136|P5|NOT COMPLETED|Overall Study||2
8426061|NCT00876993|20766137|P4|NOT COMPLETED|Overall Study||0
8426062|NCT00876993|20766138|P3|NOT COMPLETED|Overall Study||2
8426063|NCT00876993|20766139|P2|NOT COMPLETED|Overall Study||0
8426064|NCT00876993|20766140|P1|NOT COMPLETED|Overall Study||1
8426065|NCT00876993|20766136|P5|COMPLETED|Overall Study||3
8426066|NCT00876993|20766137|P4|COMPLETED|Overall Study||5
8426067|NCT00876993|20766138|P3|COMPLETED|Overall Study||3
8426068|NCT00876993|20766139|P2|COMPLETED|Overall Study||6
8426069|NCT00876993|20766140|P1|COMPLETED|Overall Study||4
8426070|NCT00876993|20766136|P5|STARTED|Overall Study||5
8426071|NCT00876993|20766137|P4|STARTED|Overall Study||5
8426072|NCT00876993|20766138|P3|STARTED|Overall Study||5
8426073|NCT00876993|20766139|P2|STARTED|Overall Study||6
8426074|NCT00876993|20766140|P1|STARTED|Overall Study||5
8426075|NCT00876928|20766169|P2|NOT COMPLETED|Overall Study||5
8426076|NCT00876928|20766170|P1|NOT COMPLETED|Overall Study||3
8426077|NCT00876928|20766169|P2|COMPLETED|Overall Study||56
8426078|NCT00876928|20766170|P1|COMPLETED|Overall Study||53
8426079|NCT00876928|20766169|P2|STARTED|Overall Study||61
8426080|NCT00876928|20766170|P1|STARTED|Overall Study||56
8426081|NCT00876915|20766181|P3|NOT COMPLETED|Overall Study||0
8426082|NCT00876915|20766182|P2|NOT COMPLETED|Overall Study||14
8426083|NCT00876915|20766183|P1|NOT COMPLETED|Overall Study||19
8426084|NCT00876915|20766181|P3|COMPLETED|Overall Study||101
8426085|NCT00876915|20766182|P2|COMPLETED|Overall Study||34
8426086|NCT00876915|20766183|P1|COMPLETED|Overall Study||31
8426087|NCT00876915|20766181|P3|Week 8|Overall Study||0
8426088|NCT00876915|20766182|P2|Week 8|Overall Study||36
8426089|NCT00876915|20766183|P1|Week 8|Overall Study||33
8426090|NCT00876915|20766181|P3|Week 4|Overall Study||0
8426091|NCT00876915|20766182|P2|Week 4|Overall Study||45
8426092|NCT00876915|20766183|P1|Week 4|Overall Study||38
8426093|NCT00876915|20766181|P3|STARTED|Overall Study||101
8426094|NCT00876915|20766182|P2|STARTED|Overall Study||48
8426095|NCT00876915|20766183|P1|STARTED|Overall Study||50
8426096|NCT00876733|20766207|P4|NOT COMPLETED|Overall Study||7
8426097|NCT00876733|20766208|P3|NOT COMPLETED|Overall Study||30
8426098|NCT00876733|20766209|P2|NOT COMPLETED|Overall Study||42
8426099|NCT00876733|20766210|P1|NOT COMPLETED|Overall Study||91
8426100|NCT00876733|20766207|P4|COMPLETED|Overall Study||14
8426101|NCT00876733|20766208|P3|COMPLETED|Overall Study||63
8426102|NCT00876733|20766209|P2|COMPLETED|Overall Study||161
8426103|NCT00876733|20766210|P1|COMPLETED|Overall Study||197
8426104|NCT00876733|20766207|P4|STARTED|Overall Study||21
8426105|NCT00876733|20766208|P3|STARTED|Overall Study||93
8426106|NCT00876733|20766209|P2|STARTED|Overall Study||203
8426107|NCT00876733|20766210|P1|STARTED|Overall Study||288
8426108|NCT00876694|20766318|P2|NOT COMPLETED|Overall Study||12
8426109|NCT00876694|20766319|P1|NOT COMPLETED|Overall Study||21
8426110|NCT00876694|20766318|P2|COMPLETED|Overall Study||49
8426111|NCT00876694|20766319|P1|COMPLETED|Overall Study||104
8426112|NCT00876694|20766318|P2|STARTED|Overall Study||61
8426113|NCT00876694|20766319|P1|STARTED|Overall Study||125
8426114|NCT00876460|20766345|P8|NOT COMPLETED|Mono Therapy Phase||3
8426115|NCT00876460|20766346|P7|NOT COMPLETED|Mono Therapy Phase||1
8426116|NCT00876460|20766347|P6|NOT COMPLETED|Mono Therapy Phase||0
8426117|NCT00876460|20766348|P5|NOT COMPLETED|Mono Therapy Phase||2
8426118|NCT00876460|20766349|P4|NOT COMPLETED|Mono Therapy Phase||1
8426119|NCT00876460|20766350|P3|NOT COMPLETED|Mono Therapy Phase||0
8426120|NCT00876460|20766351|P2|NOT COMPLETED|Mono Therapy Phase||1
8426121|NCT00876460|20766352|P1|NOT COMPLETED|Mono Therapy Phase||0
8426122|NCT00876460|20766345|P8|COMPLETED|Mono Therapy Phase||0
8426123|NCT00876460|20766346|P7|COMPLETED|Mono Therapy Phase||0
8426124|NCT00876460|20766347|P6|COMPLETED|Mono Therapy Phase||0
8426125|NCT00876460|20766348|P5|COMPLETED|Mono Therapy Phase||0
8426126|NCT00876460|20766349|P4|COMPLETED|Mono Therapy Phase||0
8426127|NCT00876460|20766350|P3|COMPLETED|Mono Therapy Phase||0
8426128|NCT00876460|20766351|P2|COMPLETED|Mono Therapy Phase||0
8426129|NCT00876460|20766352|P1|COMPLETED|Mono Therapy Phase||0
8426130|NCT00876460|20766345|P8|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
8426131|NCT00876460|20766346|P7|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
8426132|NCT00876460|20766347|P6|STARTED|Mono Therapy Phase||0
8426133|NCT00876460|20766348|P5|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
8426134|NCT00876460|20766349|P4|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
8426135|NCT00876460|20766350|P3|STARTED|Mono Therapy Phase||0
8426136|NCT00876460|20766351|P2|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
8426137|NCT00876460|20766352|P1|STARTED|Mono Therapy Phase||0
8426138|NCT00876460|20766345|P8|NOT COMPLETED|Combination Therapy Phase||6
8426139|NCT00876460|20766346|P7|NOT COMPLETED|Combination Therapy Phase||8
8426140|NCT00876460|20766347|P6|NOT COMPLETED|Combination Therapy Phase||3
8426141|NCT00876460|20766348|P5|NOT COMPLETED|Combination Therapy Phase||7
8426142|NCT00876460|20766349|P4|NOT COMPLETED|Combination Therapy Phase||6
8426143|NCT00876460|20766350|P3|NOT COMPLETED|Combination Therapy Phase||3
8426144|NCT00876460|20766351|P2|NOT COMPLETED|Combination Therapy Phase||7
8426145|NCT00876460|20766352|P1|NOT COMPLETED|Combination Therapy Phase||3
8426146|NCT00876460|20766345|P8|COMPLETED|Combination Therapy Phase||0
8426147|NCT00876460|20766346|P7|COMPLETED|Combination Therapy Phase||0
8426148|NCT00876460|20766347|P6|COMPLETED|Combination Therapy Phase||0
8426149|NCT00876460|20766348|P5|COMPLETED|Combination Therapy Phase||0
8426150|NCT00876460|20766349|P4|COMPLETED|Combination Therapy Phase||0
8426151|NCT00876460|20766350|P3|COMPLETED|Combination Therapy Phase||0
8426152|NCT00876460|20766351|P2|COMPLETED|Combination Therapy Phase||0
8426153|NCT00876460|20766352|P1|COMPLETED|Combination Therapy Phase||0
8426154|NCT00876460|20766345|P8|STARTED|Combination Therapy Phase||6
8426155|NCT00876460|20766346|P7|STARTED|Combination Therapy Phase||8
8426156|NCT00876460|20766347|P6|STARTED|Combination Therapy Phase||3
8426157|NCT00876460|20766348|P5|STARTED|Combination Therapy Phase||7
8426158|NCT00876460|20766349|P4|STARTED|Combination Therapy Phase||6
8426159|NCT00876460|20766350|P3|STARTED|Combination Therapy Phase||3
8426160|NCT00876460|20766351|P2|STARTED|Combination Therapy Phase||7
8426161|NCT00876460|20766352|P1|STARTED|Combination Therapy Phase||3
8426162|NCT00876447|20766424|P2|NOT COMPLETED|Overall Study||81
8426163|NCT00876447|20766425|P1|NOT COMPLETED|Overall Study||80
8426164|NCT00876447|20766424|P2|COMPLETED|Overall Study||122
8426165|NCT00876447|20766425|P1|COMPLETED|Overall Study||105
8426166|NCT00876447|20766424|P2|STARTED|Overall Study||203
8426167|NCT00876447|20766425|P1|STARTED|Overall Study||185
8426168|NCT00876395|20766485|P2|NOT COMPLETED|Overall Study||239
8426169|NCT00876395|20766486|P1|NOT COMPLETED|Overall Study||480
8426170|NCT00876395|20766485|P2|COMPLETED|Overall Study||0
8426171|NCT00876395|20766486|P1|COMPLETED|Overall Study||0
8426172|NCT00876395|20766485|P2|Untreated|Overall Study||1
8426173|NCT00876395|20766486|P1|Untreated|Overall Study||8
8426174|NCT00876395|20766485|P2|STARTED|Overall Study||239
8426175|NCT00876395|20766486|P1|STARTED|Overall Study||480
8426176|NCT00876343|20766527|P3|NOT COMPLETED|Overall Study||12
8426177|NCT00876343|20766528|P2|NOT COMPLETED|Overall Study||17
8426178|NCT00876343|20766529|P1|NOT COMPLETED|Overall Study||17
8426179|NCT00876343|20766527|P3|COMPLETED|Overall Study||183
8426180|NCT00876343|20766528|P2|COMPLETED|Overall Study||180
8426181|NCT00876343|20766529|P1|COMPLETED|Overall Study||177
8426182|NCT00876343|20766527|P3|STARTED|Overall Study||195
8426183|NCT00876343|20766528|P2|STARTED|Overall Study||197
8426184|NCT00876343|20766529|P1|STARTED|Overall Study||194
8426185|NCT00876265|20766543|P1|NOT COMPLETED|Overall Study||12
8426186|NCT00876265|20766543|P1|COMPLETED|Overall Study||106
8426187|NCT00876265|20766543|P1|STARTED|Overall Study||118
8426188|NCT00876200|20766551|P2|NOT COMPLETED|Overall Study||3
8426189|NCT00876200|20766552|P1|NOT COMPLETED|Overall Study||1
8426190|NCT00876200|20766551|P2|COMPLETED|Overall Study||9
8426191|NCT00876200|20766552|P1|COMPLETED|Overall Study||8
8426192|NCT00876200|20766551|P2|STARTED|Overall Study||12
8426193|NCT00876200|20766552|P1|STARTED|Overall Study||9
8426194|NCT00876018|20766561|P3|NOT COMPLETED|Overall Study||3
8426195|NCT00876018|20766562|P2|NOT COMPLETED|Overall Study||5
8426196|NCT00876018|20766563|P1|NOT COMPLETED|Overall Study||5
8426197|NCT00876018|20766561|P3|COMPLETED|Overall Study||97
8426198|NCT00876018|20766562|P2|COMPLETED|Overall Study||95
8426199|NCT00876018|20766563|P1|COMPLETED|Overall Study||95
8426200|NCT00876018|20766561|P3|STARTED|Overall Study||100
8426201|NCT00876018|20766562|P2|STARTED|Overall Study||100
8426202|NCT00876018|20766563|P1|STARTED|Overall Study||100
8426203|NCT00875979|20766618|P2|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
8426204|NCT00875979|20766619|P1|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
8426205|NCT00875979|20766618|P2|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
8426206|NCT00875979|20766619|P1|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
8426207|NCT00875979|20766618|P2|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
8426208|NCT00875979|20766619|P1|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
8426209|NCT00875979|20766618|P2|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
8426210|NCT00875979|20766619|P1|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
8426211|NCT00875979|20766618|P2|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
8426212|NCT00875979|20766619|P1|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
8426213|NCT00875979|20766618|P2|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
8426214|NCT00875979|20766619|P1|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
8426215|NCT00875979|20766618|P2|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
8426216|NCT00875979|20766619|P1|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
8426217|NCT00875979|20766618|P2|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
8426218|NCT00875979|20766619|P1|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
8426219|NCT00875979|20766618|P2|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
8426220|NCT00875979|20766619|P1|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
8426221|NCT00875836|20766631|P2|NOT COMPLETED|Overall Study||40
8426222|NCT00875836|20766632|P1|NOT COMPLETED|Overall Study||43
8426223|NCT00875836|20766631|P2|COMPLETED|Overall Study||47
8426224|NCT00875836|20766632|P1|COMPLETED|Overall Study||45
8426225|NCT00875836|20766631|P2|STARTED|Overall Study||87
8426226|NCT00875836|20766632|P1|STARTED|Overall Study||88
8426227|NCT00875810|20766642|P1|NOT COMPLETED|Overall Study||46
8426228|NCT00875810|20766642|P1|COMPLETED|Overall Study||148
8426229|NCT00875810|20766642|P1|24 Months Follow up|Overall Study||148
8426230|NCT00875810|20766642|P1|12 Months Follow up|Overall Study||112
8426231|NCT00875810|20766642|P1|6 Months Follow up|Overall Study||80
8426232|NCT00875810|20766642|P1|3 Months Follow up|Overall Study||175
8426233|NCT00875810|20766642|P1|Discharged|Overall Study||177
8426234|NCT00875810|20766642|P1|Implanted|Overall Study||190
8426235|NCT00875810|20766642|P1|STARTED|Overall Study||194
8426236|NCT00875797|20766651|P2|NOT COMPLETED|Overall Study||3
8426237|NCT00875797|20766652|P1|NOT COMPLETED|Overall Study||6
8426238|NCT00875797|20766651|P2|COMPLETED|Overall Study||42
8426239|NCT00875797|20766652|P1|COMPLETED|Overall Study||39
8426240|NCT00875797|20766651|P2|STARTED|Overall Study||45
8426241|NCT00875797|20766652|P1|STARTED|Overall Study||45
8426242|NCT00875706|20766665|P3|NOT COMPLETED|Overall Study||0
8426243|NCT00875706|20766666|P2|NOT COMPLETED|Overall Study||0
8426244|NCT00875706|20766667|P1|NOT COMPLETED|Overall Study||1
8426245|NCT00875706|20766665|P3|COMPLETED|Overall Study||13
8426246|NCT00875706|20766666|P2|COMPLETED|Overall Study||24
8426247|NCT00875706|20766667|P1|COMPLETED|Overall Study||7
8426248|NCT00875706|20766665|P3|STARTED|Overall Study||13
8426249|NCT00875706|20766666|P2|STARTED|Overall Study||24
8426250|NCT00875706|20766667|P1|STARTED|Overall Study||8
8426251|NCT00875667|20766686|P2|NOT COMPLETED|Overall Study||73
8426252|NCT00875667|20766687|P1|NOT COMPLETED|Overall Study||170
8426253|NCT00875667|20766686|P2|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11
8426254|NCT00875667|20766687|P1|COMPLETED|Overall Study||0
8426255|NCT00875667|20766686|P2|Participants Treated|Overall Study||83
8426256|NCT00875667|20766687|P1|Participants Treated|Overall Study||167
8426257|NCT00875667|20766686|P2|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40
8426258|NCT00875667|20766687|P1|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0
8426259|NCT00875667|20766686|P2|STARTED|Overall Study||84
8426260|NCT00875667|20766687|P1|STARTED|Overall Study||170
8426261|NCT00875641|20766788|P3|NOT COMPLETED|Overall Study||0
8426262|NCT00875641|20766789|P2|NOT COMPLETED|Overall Study||0
8426263|NCT00875641|20766790|P1|NOT COMPLETED|Overall Study||0
8426264|NCT00875641|20766788|P3|COMPLETED|Overall Study||159344
8426265|NCT00875641|20766789|P2|COMPLETED|Overall Study||173384
8426266|NCT00875641|20766790|P1|COMPLETED|Overall Study||57931
8426267|NCT00875641|20766788|P3|STARTED|Overall Study||159344
8426268|NCT00875641|20766789|P2|STARTED|Overall Study||173384
8426269|NCT00875641|20766790|P1|STARTED|Overall Study||57931
8426270|NCT00875615|20766822|P1|NOT COMPLETED|Overall Study||1
8426271|NCT00875615|20766822|P1|COMPLETED|Overall Study||10
8426272|NCT00875615|20766822|P1|STARTED|Overall Study||11
8426273|NCT00875589|20766829|P2|NOT COMPLETED|Overall Study||0
8426274|NCT00875589|20766830|P1|NOT COMPLETED|Overall Study||0
8426275|NCT00875589|20766829|P2|COMPLETED|Overall Study||11
8426276|NCT00875589|20766830|P1|COMPLETED|Overall Study||15
8426277|NCT00875589|20766829|P2|STARTED|Overall Study||11
8426278|NCT00875589|20766830|P1|STARTED|Overall Study||15
8426279|NCT00875563|20766836|P1|NOT COMPLETED|Overall Study||24
8426280|NCT00875563|20766836|P1|COMPLETED|Overall Study||18
8426281|NCT00875563|20766836|P1|STARTED|Overall Study||42
8426282|NCT00875550|20766842|P2|NOT COMPLETED|Overall Study||10
8426283|NCT00875550|20766843|P1|NOT COMPLETED|Overall Study||12
8426284|NCT00875550|20766842|P2|COMPLETED|Overall Study||76
8426285|NCT00875550|20766843|P1|COMPLETED|Overall Study||77
8426286|NCT00875550|20766842|P2|STARTED|Overall Study||86
8426287|NCT00875550|20766843|P1|STARTED|Overall Study||89
8426288|NCT00875524|20766861|P2|NOT COMPLETED|Overall Study||6
8426289|NCT00875524|20766862|P1|NOT COMPLETED|Overall Study||8
8426290|NCT00875524|20766861|P2|COMPLETED|Overall Study||54
8426291|NCT00875524|20766862|P1|COMPLETED|Overall Study||112
8426292|NCT00875524|20766861|P2|Received Vaccination 3|Overall Study||58
8426293|NCT00875524|20766862|P1|Received Vaccination 3|Overall Study||114
8426294|NCT00875524|20766861|P2|Received Vaccination 2|Overall Study||58
8426295|NCT00875524|20766862|P1|Received Vaccination 2|Overall Study||116
8426296|NCT00875524|20766861|P2|Received Vaccination 1|Overall Study||60
8426297|NCT00875524|20766862|P1|Received Vaccination 1|Overall Study||120
8426298|NCT00875524|20766861|P2|STARTED|Overall Study||60
8426299|NCT00875524|20766862|P1|STARTED|Overall Study||120
8426300|NCT00875485|20766880|P2|NOT COMPLETED|Challenge Dose Epoch||0
8426301|NCT00875485|20766881|P1|NOT COMPLETED|Challenge Dose Epoch||1
8426302|NCT00875485|20766880|P2|COMPLETED|Challenge Dose Epoch||11
8426303|NCT00875485|20766881|P1|COMPLETED|Challenge Dose Epoch||7
8426304|NCT00875485|20766880|P2|STARTED|Challenge Dose Epoch||11
8426305|NCT00875485|20766881|P1|STARTED|Challenge Dose Epoch||8
8426306|NCT00875485|20766880|P2|NOT COMPLETED|Year 15||0
8426307|NCT00875485|20766881|P1|NOT COMPLETED|Year 15||0
8426308|NCT00875485|20766880|P2|COMPLETED|Year 15||111
8426309|NCT00875485|20766881|P1|COMPLETED|Year 15||98
8426310|NCT00875485|20766880|P2|STARTED|Year 15||111
8426311|NCT00875485|20766881|P1|STARTED|Year 15||98
8426312|NCT00875485|20766880|P2|NOT COMPLETED|Year 14||0
8426313|NCT00875485|20766881|P1|NOT COMPLETED|Year 14||0
8426314|NCT00875485|20766880|P2|COMPLETED|Year 14||113
8426315|NCT00875485|20766881|P1|COMPLETED|Year 14||100
8426316|NCT00875485|20766880|P2|STARTED|Year 14||113
8426317|NCT00875485|20766881|P1|STARTED|Year 14||100
8426318|NCT00875485|20766880|P2|NOT COMPLETED|Year 13||0
8426319|NCT00875485|20766881|P1|NOT COMPLETED|Year 13||0
8426320|NCT00875485|20766880|P2|COMPLETED|Year 13||113
8426321|NCT00875485|20766881|P1|COMPLETED|Year 13||102
8426322|NCT00875485|20766880|P2|STARTED|Year 13||113
8426323|NCT00875485|20766881|P1|STARTED|Year 13||102
8426324|NCT00875485|20766880|P2|NOT COMPLETED|Year 12||0
8426325|NCT00875485|20766881|P1|NOT COMPLETED|Year 12||0
8426326|NCT00875485|20766880|P2|COMPLETED|Year 12||109
8426327|NCT00875485|20766881|P1|COMPLETED|Year 12||101
8426328|NCT00875485|20766880|P2|STARTED|Year 12||109
8426329|NCT00875485|20766881|P1|STARTED|Year 12||101
8426330|NCT00875485|20766880|P2|NOT COMPLETED|Year 11||0
8426331|NCT00875485|20766881|P1|NOT COMPLETED|Year 11||0
8426332|NCT00875485|20766880|P2|COMPLETED|Year 11||111
8426333|NCT00875485|20766881|P1|COMPLETED|Year 11||99
8426334|NCT00875485|20766880|P2|STARTED|Year 11||111
8426335|NCT00875485|20766881|P1|STARTED|Year 11||99
8426336|NCT00875433|20766921|P1|NOT COMPLETED|Overall Study||60
8426337|NCT00875433|20766921|P1|COMPLETED|Overall Study||0
8426338|NCT00875433|20766921|P1|STARTED|Overall Study|Treated|60
8426339|NCT00875420|20766951|P5|NOT COMPLETED|Overall Study||2
8426340|NCT00875420|20766952|P4|NOT COMPLETED|Overall Study||2
8426341|NCT00875420|20766953|P3|NOT COMPLETED|Overall Study||3
8426342|NCT00875420|20766954|P2|NOT COMPLETED|Overall Study||2
8426343|NCT00875420|20766955|P1|NOT COMPLETED|Overall Study||2
8426344|NCT00875420|20766951|P5|COMPLETED|Overall Study||17
8426345|NCT00875420|20766952|P4|COMPLETED|Overall Study||16
8426346|NCT00875420|20766953|P3|COMPLETED|Overall Study||18
8426347|NCT00875420|20766954|P2|COMPLETED|Overall Study||18
8426348|NCT00875420|20766955|P1|COMPLETED|Overall Study||20
8426349|NCT00875420|20766951|P5|STARTED|Overall Study||19
8426350|NCT00875420|20766952|P4|STARTED|Overall Study||18
8426351|NCT00875420|20766953|P3|STARTED|Overall Study||21
8426352|NCT00875420|20766954|P2|STARTED|Overall Study||20
8426353|NCT00875420|20766955|P1|STARTED|Overall Study||22
8426354|NCT00875394|20766985|P3|NOT COMPLETED|Overall Study||0
8426355|NCT00875394|20766986|P2|NOT COMPLETED|Overall Study||0
8426356|NCT00875394|20766987|P1|NOT COMPLETED|Overall Study||0
8426357|NCT00875394|20766985|P3|COMPLETED|Overall Study||9
8426358|NCT00875394|20766986|P2|COMPLETED|Overall Study||23
8426359|NCT00875394|20766987|P1|COMPLETED|Overall Study||36
8426360|NCT00875394|20766985|P3|STARTED|Overall Study||9
8426361|NCT00875394|20766986|P2|STARTED|Overall Study||23
8426362|NCT00875394|20766987|P1|STARTED|Overall Study||36
8426363|NCT00875329|20766995|P1|NOT COMPLETED|Overall Study||0
8426364|NCT00875329|20766995|P1|COMPLETED|Overall Study||97
8426365|NCT00875329|20766995|P1|STARTED|Overall Study||97
8426366|NCT00875277|20766999|P1|NOT COMPLETED|Overall Study||0
8426367|NCT00875277|20766999|P1|COMPLETED|Overall Study||24
8426368|NCT00875277|20766999|P1|STARTED|Overall Study||24
8426369|NCT00875212|20767080|P1|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
8426370|NCT00875212|20767080|P1|COMPLETED|CaGP and Fluoride Dentifrice||12
8426371|NCT00875212|20767080|P1|STARTED|CaGP and Fluoride Dentifrice||12
8426372|NCT00875212|20767080|P1|NOT COMPLETED|Fluoride Only Dentifrice||0
8426373|NCT00875212|20767080|P1|COMPLETED|Fluoride Only Dentifrice||12
8426374|NCT00875212|20767080|P1|STARTED|Fluoride Only Dentifrice||12
8426375|NCT00875212|20767080|P1|NOT COMPLETED|CaGP Only Dentifrice||0
8426376|NCT00875212|20767080|P1|COMPLETED|CaGP Only Dentifrice||12
8426377|NCT00875212|20767080|P1|STARTED|CaGP Only Dentifrice||12
8426378|NCT00875212|20767080|P1|NOT COMPLETED|Placebo Dentifrice||0
8426379|NCT00875212|20767080|P1|COMPLETED|Placebo Dentifrice|all participants completed this group|12
8426380|NCT00875212|20767080|P1|STARTED|Placebo Dentifrice||12
8426381|NCT00875056|20767094|P3|NOT COMPLETED|Overall Study||6
8426382|NCT00875056|20767095|P2|NOT COMPLETED|Overall Study||9
8426383|NCT00875056|20767096|P1|NOT COMPLETED|Overall Study||23
8426384|NCT00875056|20767094|P3|COMPLETED|Overall Study||0
8426385|NCT00875056|20767095|P2|COMPLETED|Overall Study||2
8426386|NCT00875056|20767096|P1|COMPLETED|Overall Study||16
8426387|NCT00875056|20767094|P3|STARTED|Overall Study||6
8426388|NCT00875056|20767095|P2|STARTED|Overall Study||11
8426389|NCT00875056|20767096|P1|STARTED|Overall Study||39
8426516|NCT00874939|20767141|P1|NOT COMPLETED|Overall Study||4
8426517|NCT00874939|20767141|P1|COMPLETED|Overall Study||0
8426518|NCT00874939|20767141|P1|Treated|Overall Study||0
8426519|NCT00874939|20767141|P1|STARTED|Overall Study||4
8426520|NCT00874887|20767157|P2|NOT COMPLETED|Overall Study||0
8426521|NCT00874887|20767158|P1|NOT COMPLETED|Overall Study||0
8426522|NCT00874887|20767157|P2|COMPLETED|Overall Study||34
8426523|NCT00874887|20767158|P1|COMPLETED|Overall Study||32
8426524|NCT00874887|20767157|P2|STARTED|Overall Study||34
8426525|NCT00874887|20767158|P1|STARTED|Overall Study||32
8426526|NCT00874848|20767174|P2|NOT COMPLETED|Overall Study||28
8426527|NCT00874848|20767175|P1|NOT COMPLETED|Overall Study||59
8426528|NCT00874848|20767174|P2|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
8426529|NCT00874848|20767175|P1|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
8426530|NCT00874848|20767174|P2|Discontinued|Overall Study||28
8426531|NCT00874848|20767175|P1|Discontinued|Overall Study||59
8426532|NCT00874848|20767174|P2|STARTED|Overall Study||29
8426533|NCT00874848|20767175|P1|STARTED|Overall Study||59
8426534|NCT00874822|20767191|P1|NOT COMPLETED|Overall Study||8
8426535|NCT00874822|20767191|P1|COMPLETED|Overall Study||208
8426536|NCT00874822|20767191|P1|STARTED|Overall Study||216
8426537|NCT00874770|20767199|P4|NOT COMPLETED|Overall Study||5
8426538|NCT00874770|20767200|P3|NOT COMPLETED|Overall Study||4
8426539|NCT00874770|20767201|P2|NOT COMPLETED|Overall Study||1
8426540|NCT00874770|20767202|P1|NOT COMPLETED|Overall Study||5
8426541|NCT00874770|20767199|P4|COMPLETED|Overall Study||7
8426542|NCT00874770|20767200|P3|COMPLETED|Overall Study||8
8426543|NCT00874770|20767201|P2|COMPLETED|Overall Study||11
8426544|NCT00874770|20767202|P1|COMPLETED|Overall Study||7
8426545|NCT00874770|20767199|P4|STARTED|Overall Study||12
8426546|NCT00874770|20767200|P3|STARTED|Overall Study||12
8426547|NCT00874770|20767201|P2|STARTED|Overall Study||12
8426548|NCT00874770|20767202|P1|STARTED|Overall Study||12
8426549|NCT00874731|20767236|P3|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22
8426550|NCT00874731|20767237|P2|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
8426551|NCT00874731|20767238|P1|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
8426552|NCT00874731|20767236|P3|COMPLETED|Part 2: Ridaforolimus 40 mg||0
8426553|NCT00874731|20767237|P2|COMPLETED|Part 2: Ridaforolimus 40 mg||0
8426554|NCT00874731|20767238|P1|COMPLETED|Part 2: Ridaforolimus 40 mg||0
8426555|NCT00874731|20767236|P3|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, started this period in Pt 2. Ridaforolimus 40 mg arm."|22
8426556|NCT00874731|20767237|P2|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, enter into the Pt 2. Ridaforolimus 40 mg arm."|0
8426557|NCT00874731|20767238|P1|STARTED|Part 2: Ridaforolimus 40 mg||0
8426558|NCT00874731|20767236|P3|NOT COMPLETED|Washout Period||0
8426559|NCT00874731|20767237|P2|NOT COMPLETED|Washout Period||0
8426560|NCT00874731|20767238|P1|NOT COMPLETED|Washout Period||0
8426561|NCT00874731|20767236|P3|COMPLETED|Washout Period||0
8426562|NCT00874731|20767237|P2|COMPLETED|Washout Period||22
8426563|NCT00874731|20767238|P1|COMPLETED|Washout Period||0
8426564|NCT00874731|20767236|P3|STARTED|Washout Period||0
8426565|NCT00874731|20767237|P2|STARTED|Washout Period||22
8426566|NCT00874731|20767238|P1|STARTED|Washout Period||0
8426567|NCT00874731|20767236|P3|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8426568|NCT00874731|20767237|P2|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8426569|NCT00874731|20767238|P1|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8426570|NCT00874731|20767236|P3|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8426571|NCT00874731|20767237|P2|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22
8426572|NCT00874731|20767238|P1|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
8426573|NCT00874731|20767236|P3|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0
8426574|NCT00874731|20767237|P2|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, started this period in Pt 1, Day 2. Ridaforolimus 100 mg arm."|22
8426575|NCT00874731|20767238|P1|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, enter into the Pt 1, Day 2. Ridaforolimus 100 mg arm."|0
8426576|NCT00874731|20767236|P3|NOT COMPLETED|Part 1, Day 1: Placebo||0
8426577|NCT00874731|20767237|P2|NOT COMPLETED|Part 1, Day 1: Placebo||0
8426578|NCT00874731|20767238|P1|NOT COMPLETED|Part 1, Day 1: Placebo||1
8426579|NCT00874731|20767236|P3|COMPLETED|Part 1, Day 1: Placebo||0
8426580|NCT00874731|20767237|P2|COMPLETED|Part 1, Day 1: Placebo||0
8426581|NCT00874731|20767238|P1|COMPLETED|Part 1, Day 1: Placebo||22
8426582|NCT00874731|20767236|P3|STARTED|Part 1, Day 1: Placebo||0
8426583|NCT00874731|20767237|P2|STARTED|Part 1, Day 1: Placebo||0
8426584|NCT00874731|20767238|P1|STARTED|Part 1, Day 1: Placebo||23
8426585|NCT00874614|20767267|P1|NOT COMPLETED|Overall Study||58
8426586|NCT00874614|20767267|P1|COMPLETED|Overall Study|As of December 2017|16
8426587|NCT00874614|20767267|P1|Received Two Therapeutic Doses|Overall Study||50
8426588|NCT00874614|20767267|P1|Received at Least One Therapeutic Dose|Overall Study||68
8426589|NCT00874614|20767267|P1|STARTED|Overall Study||74
8426590|NCT00874549|20767279|P4|NOT COMPLETED|Overall Study||2
8426591|NCT00874549|20767280|P3|NOT COMPLETED|Overall Study||4
8426592|NCT00874549|20767281|P2|NOT COMPLETED|Overall Study||1
8426593|NCT00874549|20767282|P1|NOT COMPLETED|Overall Study||1
8426594|NCT00874549|20767279|P4|COMPLETED|Overall Study||56
8426595|NCT00874549|20767280|P3|COMPLETED|Overall Study||47
8426596|NCT00874549|20767281|P2|COMPLETED|Overall Study||55
8426597|NCT00874549|20767282|P1|COMPLETED|Overall Study||50
8426598|NCT00874549|20767279|P4|STARTED|Overall Study||58
8426599|NCT00874549|20767280|P3|STARTED|Overall Study||51
8426600|NCT00874549|20767281|P2|STARTED|Overall Study||56
8426601|NCT00874549|20767282|P1|STARTED|Overall Study||51
8426602|NCT00874510|20767350|P2|NOT COMPLETED|Year 2||0
8426603|NCT00874510|20767351|P1|NOT COMPLETED|Year 2||0
8426604|NCT00874510|20767350|P2|COMPLETED|Year 2||87
8426605|NCT00874510|20767351|P1|COMPLETED|Year 2||92
8426606|NCT00874510|20767350|P2|STARTED|Year 2||87
8426607|NCT00874510|20767351|P1|STARTED|Year 2||92
8426608|NCT00874510|20767350|P2|NOT COMPLETED|Year 1||0
8426609|NCT00874510|20767351|P1|NOT COMPLETED|Year 1||0
8426610|NCT00874510|20767350|P2|COMPLETED|Year 1||85
8426611|NCT00874510|20767351|P1|COMPLETED|Year 1||88
8426612|NCT00874510|20767350|P2|STARTED|Year 1||85
8426613|NCT00874510|20767351|P1|STARTED|Year 1||88
8426614|NCT00874497|20767359|P2|NOT COMPLETED|Overall Study||18
8426615|NCT00874497|20767360|P1|NOT COMPLETED|Overall Study||28
8426616|NCT00874497|20767359|P2|COMPLETED|Overall Study||15
8426617|NCT00874497|20767360|P1|COMPLETED|Overall Study||23
8426618|NCT00874497|20767359|P2|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
8426619|NCT00874497|20767360|P1|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
8426620|NCT00874432|20767402|P4|NOT COMPLETED|Overall Study||3
8426621|NCT00874432|20767403|P3|NOT COMPLETED|Overall Study||8
8426622|NCT00874432|20767404|P2|NOT COMPLETED|Overall Study||2
8426623|NCT00874432|20767405|P1|NOT COMPLETED|Overall Study||3
8426624|NCT00874432|20767402|P4|COMPLETED|Overall Study||11
8426625|NCT00874432|20767403|P3|COMPLETED|Overall Study||9
8426626|NCT00874432|20767404|P2|COMPLETED|Overall Study||2
8426627|NCT00874432|20767405|P1|COMPLETED|Overall Study||5
8426628|NCT00874432|20767402|P4|STARTED|Overall Study||14
8426629|NCT00874432|20767403|P3|STARTED|Overall Study||17
8426630|NCT00874432|20767404|P2|STARTED|Overall Study||4
8426631|NCT00874432|20767405|P1|STARTED|Overall Study||8
8426632|NCT00874276|20767423|P2|NOT COMPLETED|Overall Study||1
8426633|NCT00874276|20767424|P1|NOT COMPLETED|Overall Study||1
8426634|NCT00874276|20767423|P2|COMPLETED|Overall Study||7
8426635|NCT00874276|20767424|P1|COMPLETED|Overall Study||5
8426636|NCT00874276|20767423|P2|STARTED|Overall Study||8
8426637|NCT00874276|20767424|P1|STARTED|Overall Study||6
8426638|NCT00874250|20767432|P1|NOT COMPLETED|Overall Study||51
8426639|NCT00874250|20767432|P1|COMPLETED|Overall Study||0
8426640|NCT00874250|20767432|P1|STARTED|Overall Study||51
8426641|NCT00874237|20767444|P6|NOT COMPLETED|Overall Study||0
8426642|NCT00874237|20767445|P5|NOT COMPLETED|Overall Study||0
8426643|NCT00874237|20767446|P4|NOT COMPLETED|Overall Study||0
8426644|NCT00874237|20767447|P3|NOT COMPLETED|Overall Study||1
8426645|NCT00874237|20767448|P2|NOT COMPLETED|Overall Study||1
8426646|NCT00874237|20767449|P1|NOT COMPLETED|Overall Study||0
8426647|NCT00874237|20767444|P6|COMPLETED|Overall Study||8
8426648|NCT00874237|20767445|P5|COMPLETED|Overall Study||8
8426649|NCT00874237|20767446|P4|COMPLETED|Overall Study||8
8426650|NCT00874237|20767447|P3|COMPLETED|Overall Study||7
8426651|NCT00874237|20767448|P2|COMPLETED|Overall Study||7
8426652|NCT00874237|20767449|P1|COMPLETED|Overall Study||8
8426653|NCT00874237|20767444|P6|STARTED|Overall Study||8
8426654|NCT00874237|20767445|P5|STARTED|Overall Study||8
8426655|NCT00874237|20767446|P4|STARTED|Overall Study||8
8426656|NCT00874237|20767447|P3|STARTED|Overall Study||8
8426657|NCT00874237|20767448|P2|STARTED|Overall Study||8
8426658|NCT00874237|20767449|P1|STARTED|Overall Study||8
8426659|NCT00874120|20767467|P2|NOT COMPLETED|Second Intervention||0
8426660|NCT00874120|20767468|P1|NOT COMPLETED|Second Intervention||2
8426661|NCT00874120|20767467|P2|COMPLETED|Second Intervention||56
8426662|NCT00874120|20767468|P1|COMPLETED|Second Intervention||50
8426663|NCT00874120|20767467|P2|STARTED|Second Intervention||56
8426664|NCT00874120|20767468|P1|STARTED|Second Intervention||52
8426665|NCT00874120|20767467|P2|NOT COMPLETED|Wash-out Period||0
8426666|NCT00874120|20767468|P1|NOT COMPLETED|Wash-out Period||0
8426667|NCT00874120|20767467|P2|COMPLETED|Wash-out Period||56
8426668|NCT00874120|20767468|P1|COMPLETED|Wash-out Period||52
8426669|NCT00874120|20767467|P2|STARTED|Wash-out Period||56
8426670|NCT00874120|20767468|P1|STARTED|Wash-out Period||52
8426671|NCT00874120|20767467|P2|NOT COMPLETED|First Intervention||2
8426672|NCT00874120|20767468|P1|NOT COMPLETED|First Intervention||6
8426673|NCT00874120|20767467|P2|COMPLETED|First Intervention||56
8426674|NCT00874120|20767468|P1|COMPLETED|First Intervention||52
8426675|NCT00874120|20767467|P2|STARTED|First Intervention||58
8426676|NCT00874120|20767468|P1|STARTED|First Intervention||58
8426677|NCT00874094|20767474|P1|NOT COMPLETED|Overall Study||0
8426678|NCT00874094|20767474|P1|COMPLETED|Overall Study||15
8426679|NCT00874094|20767474|P1|STARTED|Overall Study||15
8426680|NCT00874029|20767481|P1|NOT COMPLETED|Overall Study||21
8426681|NCT00874029|20767481|P1|COMPLETED|Overall Study||116
8426682|NCT00874029|20767481|P1|STARTED|Overall Study||137
8426683|NCT00873912|20767497|P2|NOT COMPLETED|Overall Study||0
8426684|NCT00873912|20767498|P1|NOT COMPLETED|Overall Study||3
8426685|NCT00873912|20767497|P2|COMPLETED|Overall Study||60
8426686|NCT00873912|20767498|P1|COMPLETED|Overall Study||237
8426687|NCT00873912|20767497|P2|STARTED|Overall Study||60
8426688|NCT00873912|20767498|P1|STARTED|Overall Study||240
8426689|NCT00873873|20767516|P4|NOT COMPLETED|Overall Study||0
8426690|NCT00873873|20767517|P3|NOT COMPLETED|Overall Study||0
8426691|NCT00873873|20767518|P2|NOT COMPLETED|Overall Study||0
8426692|NCT00873873|20767519|P1|NOT COMPLETED|Overall Study||0
8426693|NCT00873873|20767516|P4|COMPLETED|Overall Study||18
8426694|NCT00873873|20767517|P3|COMPLETED|Overall Study||9
8426695|NCT00873873|20767518|P2|COMPLETED|Overall Study||8
8426696|NCT00873873|20767519|P1|COMPLETED|Overall Study||20
8426697|NCT00873873|20767516|P4|STARTED|Overall Study||18
8426698|NCT00873873|20767517|P3|STARTED|Overall Study||9
8426699|NCT00873873|20767518|P2|STARTED|Overall Study||8
8426700|NCT00873873|20767519|P1|STARTED|Overall Study||20
8426701|NCT00873860|20767537|P4|NOT COMPLETED|Overall Study||1
8426702|NCT00873860|20767538|P3|NOT COMPLETED|Overall Study||3
8426703|NCT00873860|20767539|P2|NOT COMPLETED|Overall Study||0
8426704|NCT00873860|20767540|P1|NOT COMPLETED|Overall Study||4
8426705|NCT00873860|20767537|P4|COMPLETED|Overall Study||47
8426706|NCT00873860|20767538|P3|COMPLETED|Overall Study||48
8426707|NCT00873860|20767539|P2|COMPLETED|Overall Study||47
8426708|NCT00873860|20767540|P1|COMPLETED|Overall Study||44
8426709|NCT00873860|20767537|P4|Treated|Overall Study||48
8426710|NCT00873860|20767538|P3|Treated|Overall Study||51
8426711|NCT00873860|20767539|P2|Treated|Overall Study||47
8426712|NCT00873860|20767540|P1|Treated|Overall Study||47
8426713|NCT00873860|20767537|P4|STARTED|Overall Study||48
8426714|NCT00873860|20767538|P3|STARTED|Overall Study||51
8426715|NCT00873860|20767539|P2|STARTED|Overall Study||47
8426716|NCT00873860|20767540|P1|STARTED|Overall Study||48
8426717|NCT00873821|20767611|P2|NOT COMPLETED|Overall Study||0
8426718|NCT00873821|20767612|P1|NOT COMPLETED|Overall Study||0
8426719|NCT00873821|20767611|P2|COMPLETED|Overall Study||22
8426720|NCT00873821|20767612|P1|COMPLETED|Overall Study||22
8426721|NCT00873821|20767611|P2|STARTED|Overall Study||22
8426722|NCT00873821|20767612|P1|STARTED|Overall Study||22
8426723|NCT00873782|20767622|P1|NOT COMPLETED|Overall Study||0
8426724|NCT00873782|20767622|P1|COMPLETED|Overall Study||16
8426725|NCT00873782|20767622|P1|STARTED|Overall Study||16
8426726|NCT00873730|20767628|P2|NOT COMPLETED|Overall Study||5
8426727|NCT00873730|20767629|P1|NOT COMPLETED|Overall Study||6
8426728|NCT00873730|20767628|P2|COMPLETED|Overall Study||49
8426729|NCT00873730|20767629|P1|COMPLETED|Overall Study||48
8426730|NCT00873730|20767628|P2|STARTED|Overall Study||54
8426731|NCT00873730|20767629|P1|STARTED|Overall Study||54
8426732|NCT00873457|20767665|P1|NOT COMPLETED|Overall Study||0
8426733|NCT00873457|20767665|P1|COMPLETED|Overall Study||16
8426734|NCT00873457|20767665|P1|STARTED|Overall Study||16
8426735|NCT00873366|20767672|P1|NOT COMPLETED|Overall Study||6
8426736|NCT00873366|20767672|P1|COMPLETED|Overall Study||71
8426737|NCT00873366|20767672|P1|STARTED|Overall Study||77
8426738|NCT00873327|20767691|P1|NOT COMPLETED|Overall Study||0
8426739|NCT00873327|20767691|P1|COMPLETED|Overall Study||32
8426740|NCT00873327|20767691|P1|STARTED|Overall Study||32
8426741|NCT00873119|20767697|P2|NOT COMPLETED|Overall Study||26
8426742|NCT00873119|20767698|P1|NOT COMPLETED|Overall Study||44
8426743|NCT00873119|20767697|P2|COMPLETED|Overall Study||19
8426744|NCT00873119|20767698|P1|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
8426745|NCT00873119|20767697|P2|STARTED|Overall Study||45
8426746|NCT00873119|20767698|P1|STARTED|Overall Study||44
8426747|NCT00873093|20767719|P5|NOT COMPLETED|Overall Study||2
8426748|NCT00873093|20767720|P4|NOT COMPLETED|Overall Study||11
8426749|NCT00873093|20767721|P3|NOT COMPLETED|Overall Study||16
8426750|NCT00873093|20767722|P2|NOT COMPLETED|Overall Study||27
8426751|NCT00873093|20767723|P1|NOT COMPLETED|Overall Study||1
8426752|NCT00873093|20767719|P5|COMPLETED|Overall Study||8
8426753|NCT00873093|20767720|P4|COMPLETED|Overall Study||12
8426754|NCT00873093|20767721|P3|COMPLETED|Overall Study||33
8426755|NCT00873093|20767722|P2|COMPLETED|Overall Study||35
8426756|NCT00873093|20767723|P1|COMPLETED|Overall Study||3
8426757|NCT00873093|20767719|P5|STARTED|Overall Study||10
8426758|NCT00873093|20767720|P4|STARTED|Overall Study||23
8426759|NCT00873093|20767721|P3|STARTED|Overall Study||49
8426760|NCT00873093|20767722|P2|STARTED|Overall Study||62
8426761|NCT00873093|20767723|P1|STARTED|Overall Study||4
8426762|NCT00873041|20767780|P3|NOT COMPLETED|Extension Study||2
8426763|NCT00873041|20767781|P2|NOT COMPLETED|Extension Study||0
8426764|NCT00873041|20767782|P1|NOT COMPLETED|Extension Study||1
8426765|NCT00873041|20767780|P3|COMPLETED|Extension Study||46
8426766|NCT00873041|20767781|P2|COMPLETED|Extension Study||44
8426767|NCT00873041|20767782|P1|COMPLETED|Extension Study||40
8426768|NCT00873041|20767780|P3|STARTED|Extension Study||48
8426769|NCT00873041|20767781|P2|STARTED|Extension Study||44
8426770|NCT00873041|20767782|P1|STARTED|Extension Study||41
8426771|NCT00873041|20767780|P3|NOT COMPLETED|Core Study||5
8426772|NCT00873041|20767781|P2|NOT COMPLETED|Core Study||6
8426773|NCT00873041|20767782|P1|NOT COMPLETED|Core Study||7
8426774|NCT00873041|20767780|P3|COMPLETED|Core Study||51
8426775|NCT00873041|20767781|P2|COMPLETED|Core Study||49
8426776|NCT00873041|20767782|P1|COMPLETED|Core Study||48
8426777|NCT00873041|20767780|P3|STARTED|Core Study||56
8426778|NCT00873041|20767781|P2|STARTED|Core Study||55
8426779|NCT00873041|20767782|P1|STARTED|Core Study||55
8426780|NCT00873015|20767840|P4|NOT COMPLETED|Overall Study||0
8426781|NCT00873015|20767841|P3|NOT COMPLETED|Overall Study||0
8426782|NCT00873015|20767842|P2|NOT COMPLETED|Overall Study||1
8426783|NCT00873015|20767843|P1|NOT COMPLETED|Overall Study||0
8426784|NCT00873015|20767840|P4|COMPLETED|Overall Study||3
8426785|NCT00873015|20767841|P3|COMPLETED|Overall Study||3
8426786|NCT00873015|20767842|P2|COMPLETED|Overall Study||3
8426787|NCT00873015|20767843|P1|COMPLETED|Overall Study||9
8426788|NCT00873015|20767840|P4|STARTED|Overall Study||3
8426789|NCT00873015|20767841|P3|STARTED|Overall Study||3
8426790|NCT00873015|20767842|P2|STARTED|Overall Study||4
8426791|NCT00873015|20767843|P1|STARTED|Overall Study||9
8426792|NCT00872989|20767860|P2|NOT COMPLETED|Overall Study||63
8426793|NCT00872989|20767861|P1|NOT COMPLETED|Overall Study||65
8426794|NCT00872989|20767860|P2|COMPLETED|Overall Study||0
8426795|NCT00872989|20767861|P1|COMPLETED|Overall Study||1
8426796|NCT00872989|20767860|P2|STARTED|Overall Study||63
8426797|NCT00872989|20767861|P1|STARTED|Overall Study||66
8426798|NCT00872898|20767880|P2|NOT COMPLETED|Part Two - Double Blind||6
8426799|NCT00872898|20767881|P1|NOT COMPLETED|Part Two - Double Blind||11
8426800|NCT00872898|20767880|P2|COMPLETED|Part Two - Double Blind||54
8426801|NCT00872898|20767881|P1|COMPLETED|Part Two - Double Blind||50
8426802|NCT00872898|20767880|P2|STARTED|Part Two - Double Blind||60
8426803|NCT00872898|20767881|P1|STARTED|Part Two - Double Blind||61
8426804|NCT00872898|20767880|P2|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
8426805|NCT00872898|20767881|P1|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
8426806|NCT00872898|20767880|P2|COMPLETED|Part One - Open Label, Pharmacokinetics||4
8426807|NCT00872898|20767881|P1|COMPLETED|Part One - Open Label, Pharmacokinetics||0
8426808|NCT00872898|20767880|P2|STARTED|Part One - Open Label, Pharmacokinetics||4
8426809|NCT00872898|20767881|P1|STARTED|Part One - Open Label, Pharmacokinetics||0
8426810|NCT00872833|20767915|P2|NOT COMPLETED|Overall Study||0
8426811|NCT00872833|20767916|P1|NOT COMPLETED|Overall Study||0
8426812|NCT00872833|20767915|P2|COMPLETED|Overall Study||17
8426813|NCT00872833|20767916|P1|COMPLETED|Overall Study||15
8426814|NCT00872833|20767915|P2|STARTED|Overall Study||17
8426815|NCT00872833|20767916|P1|STARTED|Overall Study||15
8426816|NCT00872729|20767925|P1|NOT COMPLETED|Overall Study||0
8426817|NCT00872729|20767925|P1|COMPLETED|Overall Study||9
8426818|NCT00872729|20767925|P1|STARTED|Overall Study||9
8426819|NCT00872599|20767955|P2|NOT COMPLETED|Second Drug During High Salt Intake||0
8426820|NCT00872599|20767956|P1|NOT COMPLETED|Second Drug During High Salt Intake||0
8426821|NCT00872599|20767955|P2|COMPLETED|Second Drug During High Salt Intake||16
8426822|NCT00872599|20767956|P1|COMPLETED|Second Drug During High Salt Intake||15
8426823|NCT00872599|20767955|P2|STARTED|Second Drug During High Salt Intake||16
8426824|NCT00872599|20767956|P1|STARTED|Second Drug During High Salt Intake||15
8426825|NCT00872599|20767955|P2|NOT COMPLETED|Second Washout Period||1
8426826|NCT00872599|20767956|P1|NOT COMPLETED|Second Washout Period||1
8426827|NCT00872599|20767955|P2|COMPLETED|Second Washout Period||16
8426828|NCT00872599|20767956|P1|COMPLETED|Second Washout Period||15
8426829|NCT00872599|20767955|P2|STARTED|Second Washout Period||17
8426830|NCT00872599|20767956|P1|STARTED|Second Washout Period||16
8426831|NCT00872599|20767955|P2|NOT COMPLETED|First Drug During High Salt Intake||0
8426832|NCT00872599|20767956|P1|NOT COMPLETED|First Drug During High Salt Intake||0
8426833|NCT00872599|20767955|P2|COMPLETED|First Drug During High Salt Intake||17
8426834|NCT00872599|20767956|P1|COMPLETED|First Drug During High Salt Intake||16
8426835|NCT00872599|20767955|P2|STARTED|First Drug During High Salt Intake||17
8426836|NCT00872599|20767956|P1|STARTED|First Drug During High Salt Intake||16
8426837|NCT00872599|20767955|P2|NOT COMPLETED|First Washout Period After Low Salt||0
8426838|NCT00872599|20767956|P1|NOT COMPLETED|First Washout Period After Low Salt||0
8426839|NCT00872599|20767955|P2|COMPLETED|First Washout Period After Low Salt||17
8426840|NCT00872599|20767956|P1|COMPLETED|First Washout Period After Low Salt||16
8426841|NCT00872599|20767955|P2|STARTED|First Washout Period After Low Salt||17
8426842|NCT00872599|20767956|P1|STARTED|First Washout Period After Low Salt||16
8426843|NCT00872534|20767966|P2|NOT COMPLETED|Overall Study||3
8426844|NCT00872534|20767967|P1|NOT COMPLETED|Overall Study||3
8426845|NCT00872534|20767966|P2|COMPLETED|Overall Study||101
8426846|NCT00872534|20767967|P1|COMPLETED|Overall Study||97
8426847|NCT00872534|20767966|P2|STARTED|Overall Study||104
8426848|NCT00872534|20767967|P1|STARTED|Overall Study||100
8426849|NCT00872521|20767976|P3|NOT COMPLETED|Secondary Endpoint Analysis||1
8426850|NCT00872521|20767977|P2|NOT COMPLETED|Secondary Endpoint Analysis||2
8426851|NCT00872521|20767978|P1|NOT COMPLETED|Secondary Endpoint Analysis||0
8426852|NCT00872521|20767976|P3|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
8426853|NCT00872521|20767977|P2|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
8426854|NCT00872521|20767978|P1|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
8426855|NCT00872521|20767976|P3|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
8426856|NCT00872521|20767977|P2|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
8426857|NCT00872521|20767978|P1|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
8426858|NCT00872521|20767976|P3|NOT COMPLETED|Completed 3-month Follow up||0
8426859|NCT00872521|20767977|P2|NOT COMPLETED|Completed 3-month Follow up||3
8426860|NCT00872521|20767978|P1|NOT COMPLETED|Completed 3-month Follow up||0
8426861|NCT00872521|20767976|P3|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
8426862|NCT00872521|20767977|P2|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
8426863|NCT00872521|20767978|P1|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
8426864|NCT00872521|20767976|P3|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
8426865|NCT00872521|20767977|P2|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
8426866|NCT00872521|20767978|P1|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
8426867|NCT00872521|20767976|P3|NOT COMPLETED|Primary Endpoint Analysis||1
8426868|NCT00872521|20767977|P2|NOT COMPLETED|Primary Endpoint Analysis||5
8426869|NCT00872521|20767978|P1|NOT COMPLETED|Primary Endpoint Analysis||1
8426870|NCT00872521|20767976|P3|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
8426871|NCT00872521|20767977|P2|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
8426872|NCT00872521|20767978|P1|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
8426873|NCT00872521|20767976|P3|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
8426874|NCT00872521|20767977|P2|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
8426875|NCT00872521|20767978|P1|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
8426876|NCT00872521|20767976|P3|NOT COMPLETED|Completed PAD Induction||0
8426877|NCT00872521|20767977|P2|NOT COMPLETED|Completed PAD Induction||4
8426878|NCT00872521|20767978|P1|NOT COMPLETED|Completed PAD Induction||5
8426879|NCT00872521|20767976|P3|COMPLETED|Completed PAD Induction|Completed PAD induction|9
8426880|NCT00872521|20767977|P2|COMPLETED|Completed PAD Induction|Completed PAD induction|68
8426881|NCT00872521|20767978|P1|COMPLETED|Completed PAD Induction|Completed PAD induction|21
8426882|NCT00872521|20767976|P3|STARTED|Completed PAD Induction|Received allocated treatment|9
8426883|NCT00872521|20767977|P2|STARTED|Completed PAD Induction|Received allocated treatment|72
8426884|NCT00872521|20767978|P1|STARTED|Completed PAD Induction|Received allocated treatment|26
8426885|NCT00872430|20768026|P2|NOT COMPLETED|Second Intervention||0
8426886|NCT00872430|20768027|P1|NOT COMPLETED|Second Intervention||0
8426887|NCT00872430|20768026|P2|COMPLETED|Second Intervention||10
8426888|NCT00872430|20768027|P1|COMPLETED|Second Intervention||10
8426889|NCT00872430|20768026|P2|STARTED|Second Intervention||10
8426890|NCT00872430|20768027|P1|STARTED|Second Intervention||10
8426891|NCT00872430|20768026|P2|NOT COMPLETED|Washout Period||0
8426892|NCT00872430|20768027|P1|NOT COMPLETED|Washout Period||0
8426893|NCT00872430|20768026|P2|COMPLETED|Washout Period||10
8426894|NCT00872430|20768027|P1|COMPLETED|Washout Period||10
8426895|NCT00872430|20768026|P2|STARTED|Washout Period||10
8426896|NCT00872430|20768027|P1|STARTED|Washout Period||10
8426897|NCT00872430|20768026|P2|NOT COMPLETED|First Intervention||0
8426898|NCT00872430|20768027|P1|NOT COMPLETED|First Intervention||0
8426899|NCT00872430|20768026|P2|COMPLETED|First Intervention||10
8426900|NCT00872430|20768027|P1|COMPLETED|First Intervention||10
8426901|NCT00872430|20768026|P2|STARTED|First Intervention||10
8426902|NCT00872430|20768027|P1|STARTED|First Intervention||10
8426903|NCT00872339|20768036|P3|NOT COMPLETED|Overall Study||0
8426904|NCT00872339|20768037|P2|NOT COMPLETED|Overall Study||0
8426905|NCT00872339|20768038|P1|NOT COMPLETED|Overall Study||0
8426906|NCT00872339|20768036|P3|COMPLETED|Overall Study||37
8426907|NCT00872339|20768037|P2|COMPLETED|Overall Study||14
8426908|NCT00872339|20768038|P1|COMPLETED|Overall Study||201
8426909|NCT00872339|20768036|P3|STARTED|Overall Study||37
8426910|NCT00872339|20768037|P2|STARTED|Overall Study||14
8426911|NCT00872339|20768038|P1|STARTED|Overall Study||201
8426912|NCT00872170|20768049|P2|NOT COMPLETED|Overall Study||0
8426913|NCT00872170|20768050|P1|NOT COMPLETED|Overall Study||1
8426914|NCT00872170|20768049|P2|COMPLETED|Overall Study||13
8426915|NCT00872170|20768050|P1|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
8426916|NCT00872170|20768049|P2|STARTED|Overall Study||13
8426917|NCT00872170|20768050|P1|STARTED|Overall Study||14
8426918|NCT00872079|20768065|P1|NOT COMPLETED|Overall Study||0
8426919|NCT00872079|20768065|P1|COMPLETED|Overall Study||175
8426920|NCT00872079|20768065|P1|STARTED|Overall Study||175
8426921|NCT00872027|20768071|P2|NOT COMPLETED|Overall Study||0
8426922|NCT00872027|20768072|P1|NOT COMPLETED|Overall Study||0
8426923|NCT00872027|20768071|P2|COMPLETED|Overall Study||8
8426924|NCT00872027|20768072|P1|COMPLETED|Overall Study||7
8426925|NCT00872027|20768071|P2|STARTED|Overall Study||8
8426926|NCT00872027|20768072|P1|STARTED|Overall Study||7
8426927|NCT00872001|20768080|P2|NOT COMPLETED|Overall Study||131
8426928|NCT00872001|20768081|P1|NOT COMPLETED|Overall Study||136
8426929|NCT00872001|20768080|P2|COMPLETED|Overall Study||1413
8426930|NCT00872001|20768081|P1|COMPLETED|Overall Study||1400
8426931|NCT00872001|20768080|P2|STARTED|Overall Study||1544
8426932|NCT00872001|20768081|P1|STARTED|Overall Study||1536
8426933|NCT00871975|20768089|P1|NOT COMPLETED|Overall Study||22
8426934|NCT00871975|20768089|P1|COMPLETED|Overall Study||133
8426935|NCT00871975|20768089|P1|STARTED|Overall Study||155
8426936|NCT00871871|20768095|P4|NOT COMPLETED|Part II||4
8426937|NCT00871871|20768096|P3|NOT COMPLETED|Part II||4
8426938|NCT00871871|20768097|P2|NOT COMPLETED|Part II||0
8426939|NCT00871871|20768098|P1|NOT COMPLETED|Part II||0
8426940|NCT00871871|20768095|P4|COMPLETED|Part II||11
8426941|NCT00871871|20768096|P3|COMPLETED|Part II||9
8426942|NCT00871871|20768097|P2|COMPLETED|Part II||0
8426943|NCT00871871|20768098|P1|COMPLETED|Part II||0
8426944|NCT00871871|20768095|P4|STARTED|Part II||15
8426945|NCT00871871|20768096|P3|STARTED|Part II||13
8426946|NCT00871871|20768097|P2|STARTED|Part II||0
8426947|NCT00871871|20768098|P1|STARTED|Part II||0
8426948|NCT00871871|20768095|P4|NOT COMPLETED|Part I||0
8426949|NCT00871871|20768096|P3|NOT COMPLETED|Part I||0
8426950|NCT00871871|20768097|P2|NOT COMPLETED|Part I||3
8426951|NCT00871871|20768098|P1|NOT COMPLETED|Part I||3
8426952|NCT00871871|20768095|P4|COMPLETED|Part I||0
8426953|NCT00871871|20768096|P3|COMPLETED|Part I||0
8426954|NCT00871871|20768097|P2|COMPLETED|Part I||15
8426955|NCT00871871|20768098|P1|COMPLETED|Part I||15
8426956|NCT00871871|20768095|P4|STARTED|Part I||0
8426957|NCT00871871|20768096|P3|STARTED|Part I||0
8426958|NCT00871871|20768097|P2|STARTED|Part I||18
8426959|NCT00871871|20768098|P1|STARTED|Part I||18
8426960|NCT00871845|20768120|P2|NOT COMPLETED|Overall Study||0
8426961|NCT00871845|20768121|P1|NOT COMPLETED|Overall Study||0
8426962|NCT00871845|20768120|P2|COMPLETED|Overall Study||25
8426963|NCT00871845|20768121|P1|COMPLETED|Overall Study||11
8426964|NCT00871845|20768120|P2|STARTED|Overall Study||25
8426965|NCT00871845|20768121|P1|STARTED|Overall Study||11
8426966|NCT00871819|20768131|P1|NOT COMPLETED|Overall Study||0
8426967|NCT00871819|20768131|P1|COMPLETED|Overall Study||20
8426968|NCT00871819|20768131|P1|STARTED|Overall Study||20
8426969|NCT00871780|20768135|P1|NOT COMPLETED|Overall Study||27
8426970|NCT00871780|20768135|P1|COMPLETED|Overall Study||197
8426971|NCT00871780|20768135|P1|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
8426972|NCT00871780|20768135|P1|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
8426973|NCT00871780|20768135|P1|STARTED|Overall Study|number enrolled|224
8426974|NCT00871741|20768155|P2|NOT COMPLETED|Overall Study||7
8426975|NCT00871741|20768156|P1|NOT COMPLETED|Overall Study||9
8426976|NCT00871741|20768155|P2|COMPLETED|Overall Study||0
8426977|NCT00871741|20768156|P1|COMPLETED|Overall Study||0
8426978|NCT00871741|20768155|P2|STARTED|Overall Study||7
8426979|NCT00871741|20768156|P1|STARTED|Overall Study||9
8426980|NCT00871728|20768170|P1|NOT COMPLETED|Overall Study||20
8426981|NCT00871728|20768170|P1|COMPLETED|Overall Study||112
8426982|NCT00871728|20768170|P1|Treated|Overall Study||130
8426983|NCT00871728|20768170|P1|STARTED|Overall Study||132
8426984|NCT00871715|20768183|P3|NOT COMPLETED|Overall Study||26
8426985|NCT00871715|20768184|P2|NOT COMPLETED|Overall Study||16
8426986|NCT00871715|20768185|P1|NOT COMPLETED|Overall Study||15
8426987|NCT00871715|20768183|P3|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
8426988|NCT00871715|20768184|P2|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
8426989|NCT00871715|20768185|P1|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
8426990|NCT00871715|20768183|P3|6-mo Follow-up|Overall Study||112
8426991|NCT00871715|20768184|P2|6-mo Follow-up|Overall Study||113
8426992|NCT00871715|20768185|P1|6-mo Follow-up|Overall Study||110
8426993|NCT00871715|20768183|P3|Post-Intervention|Overall Study||115
8426994|NCT00871715|20768184|P2|Post-Intervention|Overall Study||115
8426995|NCT00871715|20768185|P1|Post-Intervention|Overall Study||112
8426996|NCT00871715|20768183|P3|STARTED|Overall Study||122
8426997|NCT00871715|20768184|P2|STARTED|Overall Study||120
8426998|NCT00871715|20768185|P1|STARTED|Overall Study||119
8426999|NCT00871689|20768236|P1|NOT COMPLETED|Overall Study||0
8427000|NCT00871689|20768236|P1|COMPLETED|Overall Study||2
8427001|NCT00871689|20768236|P1|STARTED|Overall Study||2
8427002|NCT00871624|20768249|P2|NOT COMPLETED|Overall Study||1
8427003|NCT00871624|20768250|P1|NOT COMPLETED|Overall Study||2
8427004|NCT00871624|20768249|P2|COMPLETED|Overall Study||17
8427005|NCT00871624|20768250|P1|COMPLETED|Overall Study||16
8427006|NCT00871624|20768249|P2|STARTED|Overall Study||18
8427007|NCT00871624|20768250|P1|STARTED|Overall Study||18
8427008|NCT00871572|20768262|P4|NOT COMPLETED|Overall Study||7
8427009|NCT00871572|20768263|P3|NOT COMPLETED|Overall Study||4
8427010|NCT00871572|20768264|P2|NOT COMPLETED|Overall Study||6
8427011|NCT00871572|20768265|P1|NOT COMPLETED|Overall Study||2
8427012|NCT00871572|20768262|P4|COMPLETED|Overall Study||19
8427013|NCT00871572|20768263|P3|COMPLETED|Overall Study||30
8427014|NCT00871572|20768264|P2|COMPLETED|Overall Study||11
8427015|NCT00871572|20768265|P1|COMPLETED|Overall Study||8
8427016|NCT00871572|20768262|P4|Received at Least 1 Dose of Study Drug|Overall Study||25
8427017|NCT00871572|20768263|P3|Received at Least 1 Dose of Study Drug|Overall Study||34
8427018|NCT00871572|20768264|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
8427019|NCT00871572|20768265|P1|Received at Least 1 Dose of Study Drug|Overall Study||9
8427020|NCT00871572|20768262|P4|≥1 Post Baseline Value by Assigned Group|Overall Study||25
8427021|NCT00871572|20768263|P3|≥1 Post Baseline Value by Assigned Group|Overall Study||34
8427022|NCT00871572|20768264|P2|≥1 Post Baseline Value by Assigned Group|Overall Study||17
8427023|NCT00871572|20768265|P1|≥1 Post Baseline Value by Assigned Group|Overall Study||9
8427024|NCT00871572|20768262|P4|STARTED|Overall Study||26
8427025|NCT00871572|20768263|P3|STARTED|Overall Study||34
8427026|NCT00871572|20768264|P2|STARTED|Overall Study||17
8427027|NCT00871572|20768265|P1|STARTED|Overall Study||10
8427028|NCT00871494|20768335|P1|NOT COMPLETED|Overall Study||14
8427029|NCT00871494|20768335|P1|COMPLETED|Overall Study||62
8427030|NCT00871494|20768335|P1|STARTED|Overall Study||76
8427031|NCT00871429|20768342|P1|NOT COMPLETED|Overall Study||24
8427032|NCT00871429|20768342|P1|COMPLETED|Overall Study||75
8427033|NCT00871429|20768342|P1|STARTED|Overall Study||99
8427034|NCT00871403|20768353|P3|NOT COMPLETED|Monotherapy Treatment Phase||1
8427035|NCT00871403|20768354|P2|NOT COMPLETED|Monotherapy Treatment Phase||13
8427036|NCT00871403|20768355|P1|NOT COMPLETED|Monotherapy Treatment Phase||0
8427037|NCT00871403|20768353|P3|COMPLETED|Monotherapy Treatment Phase||0
8427038|NCT00871403|20768354|P2|COMPLETED|Monotherapy Treatment Phase||0
8427039|NCT00871403|20768355|P1|COMPLETED|Monotherapy Treatment Phase||0
8427040|NCT00871403|20768353|P3|STARTED|Monotherapy Treatment Phase||1
8427041|NCT00871403|20768354|P2|STARTED|Monotherapy Treatment Phase||13
8427042|NCT00871403|20768355|P1|STARTED|Monotherapy Treatment Phase||0
8427043|NCT00871403|20768353|P3|NOT COMPLETED|Combination Treatment Phase||12
8427044|NCT00871403|20768354|P2|NOT COMPLETED|Combination Treatment Phase||49
8427045|NCT00871403|20768355|P1|NOT COMPLETED|Combination Treatment Phase||9
8427046|NCT00871403|20768353|P3|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
8427047|NCT00871403|20768354|P2|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
8427048|NCT00871403|20768355|P1|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
8427049|NCT00871403|20768353|P3|STARTED|Combination Treatment Phase||35
8427050|NCT00871403|20768354|P2|STARTED|Combination Treatment Phase||62
8427051|NCT00871403|20768355|P1|STARTED|Combination Treatment Phase||9
8427052|NCT00871377|20768368|P6|NOT COMPLETED|Third Intervention (10 Weeks)||0
8427053|NCT00871377|20768369|P5|NOT COMPLETED|Third Intervention (10 Weeks)||0
8427054|NCT00871377|20768370|P4|NOT COMPLETED|Third Intervention (10 Weeks)||1
8427055|NCT00871377|20768371|P3|NOT COMPLETED|Third Intervention (10 Weeks)||0
8427056|NCT00871377|20768372|P2|NOT COMPLETED|Third Intervention (10 Weeks)||0
8427057|NCT00871377|20768373|P1|NOT COMPLETED|Third Intervention (10 Weeks)||0
8427058|NCT00871377|20768368|P6|COMPLETED|Third Intervention (10 Weeks)||3
8427059|NCT00871377|20768369|P5|COMPLETED|Third Intervention (10 Weeks)||4
8427060|NCT00871377|20768370|P4|COMPLETED|Third Intervention (10 Weeks)||3
8427061|NCT00871377|20768371|P3|COMPLETED|Third Intervention (10 Weeks)||3
8427062|NCT00871377|20768372|P2|COMPLETED|Third Intervention (10 Weeks)||4
8427063|NCT00871377|20768373|P1|COMPLETED|Third Intervention (10 Weeks)||2
8427064|NCT00871377|20768368|P6|STARTED|Third Intervention (10 Weeks)||3
8427065|NCT00871377|20768369|P5|STARTED|Third Intervention (10 Weeks)||4
8427066|NCT00871377|20768370|P4|STARTED|Third Intervention (10 Weeks)||4
8427067|NCT00871377|20768371|P3|STARTED|Third Intervention (10 Weeks)||3
8427068|NCT00871377|20768372|P2|STARTED|Third Intervention (10 Weeks)||4
8427069|NCT00871377|20768373|P1|STARTED|Third Intervention (10 Weeks)||2
8427070|NCT00871377|20768368|P6|NOT COMPLETED|Washout (6 Weeks)||1
8427071|NCT00871377|20768369|P5|NOT COMPLETED|Washout (6 Weeks)||0
8427072|NCT00871377|20768370|P4|NOT COMPLETED|Washout (6 Weeks)||0
8427073|NCT00871377|20768371|P3|NOT COMPLETED|Washout (6 Weeks)||0
8427074|NCT00871377|20768372|P2|NOT COMPLETED|Washout (6 Weeks)||0
8427075|NCT00871377|20768373|P1|NOT COMPLETED|Washout (6 Weeks)||0
8427076|NCT00871377|20768368|P6|COMPLETED|Washout (6 Weeks)||3
8427077|NCT00871377|20768369|P5|COMPLETED|Washout (6 Weeks)||4
8427078|NCT00871377|20768370|P4|COMPLETED|Washout (6 Weeks)||4
8427079|NCT00871377|20768371|P3|COMPLETED|Washout (6 Weeks)||3
8427080|NCT00871377|20768372|P2|COMPLETED|Washout (6 Weeks)||4
8427081|NCT00871377|20768373|P1|COMPLETED|Washout (6 Weeks)||2
8427082|NCT00871377|20768368|P6|STARTED|Washout (6 Weeks)||4
8427083|NCT00871377|20768369|P5|STARTED|Washout (6 Weeks)||4
8427084|NCT00871377|20768370|P4|STARTED|Washout (6 Weeks)||4
8427085|NCT00871377|20768371|P3|STARTED|Washout (6 Weeks)||3
8427086|NCT00871377|20768372|P2|STARTED|Washout (6 Weeks)||4
8427087|NCT00871377|20768373|P1|STARTED|Washout (6 Weeks)||2
8427088|NCT00871377|20768368|P6|NOT COMPLETED|Second Intervention (10 Weeks)||0
8427089|NCT00871377|20768369|P5|NOT COMPLETED|Second Intervention (10 Weeks)||0
8427090|NCT00871377|20768370|P4|NOT COMPLETED|Second Intervention (10 Weeks)||0
8427091|NCT00871377|20768371|P3|NOT COMPLETED|Second Intervention (10 Weeks)||0
8427092|NCT00871377|20768372|P2|NOT COMPLETED|Second Intervention (10 Weeks)||0
8427093|NCT00871377|20768373|P1|NOT COMPLETED|Second Intervention (10 Weeks)||0
8427094|NCT00871377|20768368|P6|COMPLETED|Second Intervention (10 Weeks)||4
8427095|NCT00871377|20768369|P5|COMPLETED|Second Intervention (10 Weeks)||4
8427096|NCT00871377|20768370|P4|COMPLETED|Second Intervention (10 Weeks)||4
8427097|NCT00871377|20768371|P3|COMPLETED|Second Intervention (10 Weeks)||3
8427098|NCT00871377|20768372|P2|COMPLETED|Second Intervention (10 Weeks)||4
8427099|NCT00871377|20768373|P1|COMPLETED|Second Intervention (10 Weeks)||2
8427100|NCT00871377|20768368|P6|STARTED|Second Intervention (10 Weeks)||4
8427101|NCT00871377|20768369|P5|STARTED|Second Intervention (10 Weeks)||4
8427102|NCT00871377|20768370|P4|STARTED|Second Intervention (10 Weeks)||4
8427103|NCT00871377|20768371|P3|STARTED|Second Intervention (10 Weeks)||3
8427104|NCT00871377|20768372|P2|STARTED|Second Intervention (10 Weeks)||4
8427105|NCT00871377|20768373|P1|STARTED|Second Intervention (10 Weeks)||2
8427106|NCT00871377|20768368|P6|NOT COMPLETED|Washout (6 Weeks)||0
8427107|NCT00871377|20768369|P5|NOT COMPLETED|Washout (6 Weeks)||0
8427108|NCT00871377|20768370|P4|NOT COMPLETED|Washout (6 Weeks)||0
8427109|NCT00871377|20768371|P3|NOT COMPLETED|Washout (6 Weeks)||0
8427110|NCT00871377|20768372|P2|NOT COMPLETED|Washout (6 Weeks)||0
8427111|NCT00871377|20768373|P1|NOT COMPLETED|Washout (6 Weeks)||1
8427112|NCT00871377|20768368|P6|COMPLETED|Washout (6 Weeks)||4
8427113|NCT00871377|20768369|P5|COMPLETED|Washout (6 Weeks)||4
8427114|NCT00871377|20768370|P4|COMPLETED|Washout (6 Weeks)||4
8427115|NCT00871377|20768371|P3|COMPLETED|Washout (6 Weeks)||3
8427116|NCT00871377|20768372|P2|COMPLETED|Washout (6 Weeks)||4
8427117|NCT00871377|20768373|P1|COMPLETED|Washout (6 Weeks)||2
8427118|NCT00871377|20768368|P6|STARTED|Washout (6 Weeks)||4
8427119|NCT00871377|20768369|P5|STARTED|Washout (6 Weeks)||4
8427120|NCT00871377|20768370|P4|STARTED|Washout (6 Weeks)||4
8427121|NCT00871377|20768371|P3|STARTED|Washout (6 Weeks)||3
8427122|NCT00871377|20768372|P2|STARTED|Washout (6 Weeks)||4
8427123|NCT00871377|20768373|P1|STARTED|Washout (6 Weeks)||3
8427124|NCT00871377|20768368|P6|NOT COMPLETED|First Intervention (10 Weeks)||1
8427125|NCT00871377|20768369|P5|NOT COMPLETED|First Intervention (10 Weeks)||0
8427126|NCT00871377|20768370|P4|NOT COMPLETED|First Intervention (10 Weeks)||0
8427127|NCT00871377|20768371|P3|NOT COMPLETED|First Intervention (10 Weeks)||1
8427128|NCT00871377|20768372|P2|NOT COMPLETED|First Intervention (10 Weeks)||0
8427129|NCT00871377|20768373|P1|NOT COMPLETED|First Intervention (10 Weeks)||0
8427130|NCT00871377|20768368|P6|COMPLETED|First Intervention (10 Weeks)||4
8427131|NCT00871377|20768369|P5|COMPLETED|First Intervention (10 Weeks)||4
8427132|NCT00871377|20768370|P4|COMPLETED|First Intervention (10 Weeks)||4
8427133|NCT00871377|20768371|P3|COMPLETED|First Intervention (10 Weeks)||3
8427134|NCT00871377|20768372|P2|COMPLETED|First Intervention (10 Weeks)||4
8427135|NCT00871377|20768373|P1|COMPLETED|First Intervention (10 Weeks)||3
8427136|NCT00871377|20768368|P6|STARTED|First Intervention (10 Weeks)||5
8427137|NCT00871377|20768369|P5|STARTED|First Intervention (10 Weeks)||4
8427138|NCT00871377|20768370|P4|STARTED|First Intervention (10 Weeks)||4
8427139|NCT00871377|20768371|P3|STARTED|First Intervention (10 Weeks)||4
8427140|NCT00871377|20768372|P2|STARTED|First Intervention (10 Weeks)||4
8427141|NCT00871377|20768373|P1|STARTED|First Intervention (10 Weeks)||3
8427142|NCT00871351|20768384|P3|NOT COMPLETED|Overall Study||0
8427143|NCT00871351|20768385|P2|NOT COMPLETED|Overall Study||1
8427144|NCT00871351|20768386|P1|NOT COMPLETED|Overall Study||4
8427145|NCT00871351|20768384|P3|COMPLETED|Overall Study||32
8427146|NCT00871351|20768385|P2|COMPLETED|Overall Study||45
8427147|NCT00871351|20768386|P1|COMPLETED|Overall Study||43
8427148|NCT00871351|20768384|P3|STARTED|Overall Study||32
8427149|NCT00871351|20768385|P2|STARTED|Overall Study||46
8427150|NCT00871351|20768386|P1|STARTED|Overall Study||47
8427151|NCT00871338|20768408|P2|NOT COMPLETED|After Booster||0
8427152|NCT00871338|20768409|P1|NOT COMPLETED|After Booster||0
8427153|NCT00871338|20768408|P2|COMPLETED|After Booster||135
8427154|NCT00871338|20768409|P1|COMPLETED|After Booster||139
8427155|NCT00871338|20768408|P2|STARTED|After Booster||135
8427156|NCT00871338|20768409|P1|STARTED|After Booster||139
8427157|NCT00871338|20768408|P2|NOT COMPLETED|Prior to Booster||3
8427158|NCT00871338|20768409|P1|NOT COMPLETED|Prior to Booster||2
8427159|NCT00871338|20768408|P2|COMPLETED|Prior to Booster||139
8427160|NCT00871338|20768409|P1|COMPLETED|Prior to Booster||140
8427161|NCT00871338|20768408|P2|STARTED|Prior to Booster||142
8427162|NCT00871338|20768409|P1|STARTED|Prior to Booster||142
8427163|NCT00871286|20768489|P2|NOT COMPLETED|Overall Study||6
8427164|NCT00871286|20768490|P1|NOT COMPLETED|Overall Study||0
8427165|NCT00871286|20768489|P2|COMPLETED|Overall Study||14
8427166|NCT00871286|20768490|P1|COMPLETED|Overall Study||20
8427167|NCT00871286|20768489|P2|STARTED|Overall Study||20
8427168|NCT00871286|20768490|P1|STARTED|Overall Study||20
8427169|NCT00871234|20768498|P1|NOT COMPLETED|Overall Study||5
8427170|NCT00871234|20768498|P1|COMPLETED|Overall Study||23
8427171|NCT00871234|20768498|P1|STARTED|Overall Study||28
8427172|NCT00871169|20768502|P1|NOT COMPLETED|Overall Study||3
8427173|NCT00871169|20768502|P1|COMPLETED|Overall Study||58
8427174|NCT00871169|20768502|P1|STARTED|Overall Study||61
8427175|NCT00871143|20768509|P2|NOT COMPLETED|Overall Study||0
8427176|NCT00871143|20768510|P1|NOT COMPLETED|Overall Study||0
8427177|NCT00871143|20768509|P2|COMPLETED|Overall Study||25
8427178|NCT00871143|20768510|P1|COMPLETED|Overall Study||21
8427179|NCT00871143|20768509|P2|STARTED|Overall Study||25
8427180|NCT00871143|20768510|P1|STARTED|Overall Study||21
8427181|NCT00871117|20768530|P2|NOT COMPLETED|Overall Study||10
8427182|NCT00871117|20768531|P1|NOT COMPLETED|Overall Study||5
8427183|NCT00871117|20768530|P2|COMPLETED|Overall Study||227
8427184|NCT00871117|20768531|P1|COMPLETED|Overall Study||234
8427185|NCT00871117|20768530|P2|STARTED|Overall Study||237
8427186|NCT00871117|20768531|P1|STARTED|Overall Study||239
8427187|NCT00871000|20768565|P2|NOT COMPLETED|Overall Study||0
8427188|NCT00871000|20768566|P1|NOT COMPLETED|Overall Study||1
8427189|NCT00871000|20768565|P2|COMPLETED|Overall Study||152
8427190|NCT00871000|20768566|P1|COMPLETED|Overall Study||150
8427191|NCT00871000|20768565|P2|STARTED|Overall Study||152
8427192|NCT00871000|20768566|P1|STARTED|Overall Study||151
8427193|NCT00870896|20768608|P1|NOT COMPLETED|Overall Study||0
8427194|NCT00870896|20768608|P1|COMPLETED|Overall Study||5
8427195|NCT00870896|20768608|P1|STARTED|Overall Study||5
8427196|NCT00870870|20768618|P4|NOT COMPLETED|Overall Study||5
8427197|NCT00870870|20768619|P3|NOT COMPLETED|Overall Study||3
8427198|NCT00870870|20768620|P2|NOT COMPLETED|Overall Study||1
8427199|NCT00870870|20768621|P1|NOT COMPLETED|Overall Study||0
8427200|NCT00870870|20768618|P4|COMPLETED|Overall Study||20
8427201|NCT00870870|20768619|P3|COMPLETED|Overall Study||26
8427202|NCT00870870|20768620|P2|COMPLETED|Overall Study||5
8427203|NCT00870870|20768621|P1|COMPLETED|Overall Study||4
8427204|NCT00870870|20768618|P4|STARTED|Overall Study||25
8427205|NCT00870870|20768619|P3|STARTED|Overall Study||29
8427206|NCT00870870|20768620|P2|STARTED|Overall Study||6
8427207|NCT00870870|20768621|P1|STARTED|Overall Study||4
8427208|NCT00870740|20768665|P6|NOT COMPLETED|Overall Study||17
8427209|NCT00870740|20768666|P5|NOT COMPLETED|Overall Study||11
8427210|NCT00870740|20768667|P4|NOT COMPLETED|Overall Study||12
8427211|NCT00870740|20768668|P3|NOT COMPLETED|Overall Study||10
8427212|NCT00870740|20768669|P2|NOT COMPLETED|Overall Study||9
8427213|NCT00870740|20768670|P1|NOT COMPLETED|Overall Study||12
8427214|NCT00870740|20768665|P6|COMPLETED|Overall Study||70
8427215|NCT00870740|20768666|P5|COMPLETED|Overall Study||77
8427216|NCT00870740|20768667|P4|COMPLETED|Overall Study||74
8427217|NCT00870740|20768668|P3|COMPLETED|Overall Study||76
8427218|NCT00870740|20768669|P2|COMPLETED|Overall Study||75
8427219|NCT00870740|20768670|P1|COMPLETED|Overall Study||74
8427220|NCT00870740|20768665|P6|STARTED|Overall Study|number randomized and dosed|87
8427221|NCT00870740|20768666|P5|STARTED|Overall Study|number randomized and dosed|88
8427222|NCT00870740|20768667|P4|STARTED|Overall Study|number randomized and dosed|86
8427223|NCT00870740|20768668|P3|STARTED|Overall Study|number randomized and dosed|86
8427224|NCT00870740|20768669|P2|STARTED|Overall Study|number randomized and dosed|84
8427225|NCT00870740|20768670|P1|STARTED|Overall Study|number randomized and dosed|86
8427226|NCT00870727|20768746|P2|NOT COMPLETED|Overall Study||5
8427227|NCT00870727|20768747|P1|NOT COMPLETED|Overall Study||1
8427228|NCT00870727|20768746|P2|COMPLETED|Overall Study||11
8427229|NCT00870727|20768747|P1|COMPLETED|Overall Study||16
8427230|NCT00870727|20768746|P2|STARTED|Overall Study||16
8427231|NCT00870727|20768747|P1|STARTED|Overall Study||17
8427232|NCT00870688|20768763|P1|NOT COMPLETED|Overall Study||4
8427233|NCT00870688|20768763|P1|COMPLETED|Overall Study||78
8427234|NCT00870688|20768763|P1|STARTED|Overall Study||82
8427235|NCT00870584|20768768|P2|NOT COMPLETED|Overall Study||13
8427236|NCT00870584|20768769|P1|NOT COMPLETED|Overall Study||16
8427237|NCT00870584|20768768|P2|COMPLETED|Overall Study||122
8427238|NCT00870584|20768769|P1|COMPLETED|Overall Study||120
8427239|NCT00870584|20768768|P2|STARTED|Overall Study||135
8427240|NCT00870584|20768769|P1|STARTED|Overall Study||136
8427241|NCT00870545|20768777|P1|NOT COMPLETED|Overall Study||17
8427242|NCT00870545|20768777|P1|COMPLETED|Overall Study||69
8427243|NCT00870545|20768777|P1|STARTED|Overall Study||86
8427244|NCT00870467|20768788|P6|NOT COMPLETED|Open-label||3
8427245|NCT00870467|20768789|P5|NOT COMPLETED|Open-label||5
8427246|NCT00870467|20768790|P4|NOT COMPLETED|Open-label||7
8427247|NCT00870467|20768791|P3|NOT COMPLETED|Open-label||13
8427248|NCT00870467|20768792|P2|NOT COMPLETED|Open-label||0
8427249|NCT00870467|20768793|P1|NOT COMPLETED|Open-label||0
8427250|NCT00870467|20768788|P6|COMPLETED|Open-label||21
8427251|NCT00870467|20768789|P5|COMPLETED|Open-label||5
8427252|NCT00870467|20768790|P4|COMPLETED|Open-label||120
8427253|NCT00870467|20768791|P3|COMPLETED|Open-label||132
8427254|NCT00870467|20768792|P2|COMPLETED|Open-label||0
8427255|NCT00870467|20768793|P1|COMPLETED|Open-label||0
8427256|NCT00870467|20768788|P6|STARTED|Open-label||24
8427257|NCT00870467|20768789|P5|STARTED|Open-label||10
8427258|NCT00870467|20768790|P4|STARTED|Open-label||127
8427259|NCT00870467|20768791|P3|STARTED|Open-label||145
8427260|NCT00870467|20768792|P2|STARTED|Open-label||0
8427261|NCT00870467|20768793|P1|STARTED|Open-label||0
8427262|NCT00870467|20768788|P6|NOT COMPLETED|Double-blind||0
8427263|NCT00870467|20768789|P5|NOT COMPLETED|Double-blind||0
8427264|NCT00870467|20768790|P4|NOT COMPLETED|Double-blind||0
8427265|NCT00870467|20768791|P3|NOT COMPLETED|Double-blind||0
8427266|NCT00870467|20768792|P2|NOT COMPLETED|Double-blind||12
8427267|NCT00870467|20768793|P1|NOT COMPLETED|Double-blind||16
8427268|NCT00870467|20768788|P6|COMPLETED|Double-blind||0
8427269|NCT00870467|20768789|P5|COMPLETED|Double-blind||0
8427270|NCT00870467|20768790|P4|COMPLETED|Double-blind||0
8427271|NCT00870467|20768791|P3|COMPLETED|Double-blind||0
8427272|NCT00870467|20768792|P2|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
8427273|NCT00870467|20768793|P1|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
8427274|NCT00870467|20768788|P6|STARTED|Double-blind||0
8427275|NCT00870467|20768789|P5|STARTED|Double-blind||0
8427276|NCT00870467|20768790|P4|STARTED|Double-blind||0
8427277|NCT00870467|20768791|P3|STARTED|Double-blind||0
8427278|NCT00870467|20768792|P2|STARTED|Double-blind||163
8427279|NCT00870467|20768793|P1|STARTED|Double-blind||171
8427280|NCT00870363|20768841|P4|NOT COMPLETED|Overall Study||0
8427281|NCT00870363|20768842|P3|NOT COMPLETED|Overall Study||3
8427282|NCT00870363|20768843|P2|NOT COMPLETED|Overall Study||3
8427283|NCT00870363|20768844|P1|NOT COMPLETED|Overall Study||0
8427284|NCT00870363|20768841|P4|COMPLETED|Overall Study||12
8427285|NCT00870363|20768842|P3|COMPLETED|Overall Study||8
8427286|NCT00870363|20768843|P2|COMPLETED|Overall Study||8
8427287|NCT00870363|20768844|P1|COMPLETED|Overall Study||10
8427288|NCT00870363|20768841|P4|STARTED|Overall Study||12
8427289|NCT00870363|20768842|P3|STARTED|Overall Study||11
8427290|NCT00870363|20768843|P2|STARTED|Overall Study||11
8427291|NCT00870363|20768844|P1|STARTED|Overall Study||10
8427292|NCT00870233|20768878|P1|NOT COMPLETED|Overall Study||24
8427293|NCT00870233|20768878|P1|COMPLETED|Overall Study||96
8427294|NCT00870233|20768878|P1|STARTED|Overall Study||120
8427295|NCT00870194|20768887|P2|NOT COMPLETED|Overall Study||14
8427296|NCT00870194|20768888|P1|NOT COMPLETED|Overall Study||26
8427297|NCT00870194|20768887|P2|COMPLETED|Overall Study||114
8427298|NCT00870194|20768888|P1|COMPLETED|Overall Study||101
8427299|NCT00870194|20768887|P2|Per Protocol Set|Overall Study||111
8427300|NCT00870194|20768888|P1|Per Protocol Set|Overall Study||97
8427301|NCT00870194|20768887|P2|STARTED|Overall Study||128
8427302|NCT00870194|20768888|P1|STARTED|Overall Study||127
8427303|NCT00870103|20768926|P1|NOT COMPLETED|Overall Study||4
8427304|NCT00870103|20768926|P1|COMPLETED|Overall Study||60
8427305|NCT00870103|20768926|P1|STARTED|Overall Study||64
8427306|NCT00869999|20768931|P1|NOT COMPLETED|Overall Study||2
8427307|NCT00869999|20768931|P1|COMPLETED|Overall Study||24
8427308|NCT00869999|20768931|P1|STARTED|Overall Study||26
8427309|NCT00869960|20768937|P1|NOT COMPLETED|Overall Study||2
8427310|NCT00869960|20768937|P1|COMPLETED|Overall Study||22
8427311|NCT00869960|20768937|P1|STARTED|Overall Study||24
8427312|NCT00869947|20768950|P2|NOT COMPLETED|Overall Study||0
8427313|NCT00869947|20768951|P1|NOT COMPLETED|Overall Study||0
8427314|NCT00869947|20768950|P2|COMPLETED|Overall Study||8
8427315|NCT00869947|20768951|P1|COMPLETED|Overall Study||8
8427316|NCT00869947|20768950|P2|STARTED|Overall Study||8
8427317|NCT00869947|20768951|P1|STARTED|Overall Study||8
8427318|NCT00869791|20768964|P2|NOT COMPLETED|Period 2 Treatment for 7 Days||0
8427319|NCT00869791|20768965|P1|NOT COMPLETED|Period 2 Treatment for 7 Days||0
8427320|NCT00869791|20768964|P2|COMPLETED|Period 2 Treatment for 7 Days||13
8427321|NCT00869791|20768965|P1|COMPLETED|Period 2 Treatment for 7 Days||14
8427322|NCT00869791|20768964|P2|STARTED|Period 2 Treatment for 7 Days||13
8427323|NCT00869791|20768965|P1|STARTED|Period 2 Treatment for 7 Days||14
8427324|NCT00869791|20768964|P2|NOT COMPLETED|Period 1 Treatment for 7 Days||0
8427325|NCT00869791|20768965|P1|NOT COMPLETED|Period 1 Treatment for 7 Days||0
8427326|NCT00869791|20768964|P2|COMPLETED|Period 1 Treatment for 7 Days||13
8427327|NCT00869791|20768965|P1|COMPLETED|Period 1 Treatment for 7 Days||14
8427328|NCT00869791|20768964|P2|STARTED|Period 1 Treatment for 7 Days||13
8427329|NCT00869791|20768965|P1|STARTED|Period 1 Treatment for 7 Days||14
8427330|NCT00869778|20768986|P3|NOT COMPLETED|Overall Study||10
8427331|NCT00869778|20768987|P2|NOT COMPLETED|Overall Study||7
8427332|NCT00869778|20768988|P1|NOT COMPLETED|Overall Study||12
8427333|NCT00869778|20768986|P3|COMPLETED|Overall Study||110
8427334|NCT00869778|20768987|P2|COMPLETED|Overall Study||113
8427335|NCT00869778|20768988|P1|COMPLETED|Overall Study||108
8427336|NCT00869778|20768986|P3|STARTED|Overall Study||120
8427337|NCT00869778|20768987|P2|STARTED|Overall Study||120
8427338|NCT00869778|20768988|P1|STARTED|Overall Study||120
8427339|NCT00869622|20769025|P2|NOT COMPLETED|Overall Study||14
8427340|NCT00869622|20769026|P1|NOT COMPLETED|Overall Study||13
8427341|NCT00869622|20769025|P2|COMPLETED|Overall Study||26
8427342|NCT00869622|20769026|P1|COMPLETED|Overall Study||27
8427343|NCT00869622|20769025|P2|STARTED|Overall Study||40
8427344|NCT00869622|20769026|P1|STARTED|Overall Study||40
8427345|NCT00869609|20769036|P2|NOT COMPLETED|Overall Study||3
8427346|NCT00869609|20769037|P1|NOT COMPLETED|Overall Study||6
8427347|NCT00869609|20769036|P2|COMPLETED|Overall Study||26
8427348|NCT00869609|20769037|P1|COMPLETED|Overall Study||25
8427349|NCT00869609|20769036|P2|STARTED|Overall Study||29
8427350|NCT00869609|20769037|P1|STARTED|Overall Study||31
8427351|NCT00869557|20769063|P2|NOT COMPLETED|Extension Phase||3
8427352|NCT00869557|20769064|P1|NOT COMPLETED|Extension Phase||10
8427353|NCT00869557|20769063|P2|COMPLETED|Extension Phase||11
8427354|NCT00869557|20769064|P1|COMPLETED|Extension Phase||35
8427355|NCT00869557|20769063|P2|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
8427356|NCT00869557|20769064|P1|STARTED|Extension Phase||45
8427357|NCT00869557|20769063|P2|NOT COMPLETED|Randomized Phase||2
8427358|NCT00869557|20769064|P1|NOT COMPLETED|Randomized Phase||3
8427359|NCT00869557|20769063|P2|COMPLETED|Randomized Phase||21
8427360|NCT00869557|20769064|P1|COMPLETED|Randomized Phase||45
8427361|NCT00869557|20769063|P2|STARTED|Randomized Phase||23
8427362|NCT00869557|20769064|P1|STARTED|Randomized Phase||48
8427363|NCT00869518|20769083|P2|NOT COMPLETED|Overall Study||1
8427364|NCT00869518|20769084|P1|NOT COMPLETED|Overall Study||1
8427365|NCT00869518|20769083|P2|COMPLETED|Overall Study||5
8427366|NCT00869518|20769084|P1|COMPLETED|Overall Study||5
8427367|NCT00869518|20769083|P2|STARTED|Overall Study||6
8427368|NCT00869518|20769084|P1|STARTED|Overall Study||6
8427369|NCT00869440|20769100|P4|NOT COMPLETED|Overall Study||0
8427370|NCT00869440|20769101|P3|NOT COMPLETED|Overall Study||0
8427371|NCT00869440|20769102|P2|NOT COMPLETED|Overall Study||1
8427372|NCT00869440|20769103|P1|NOT COMPLETED|Overall Study||2
8427373|NCT00869440|20769100|P4|COMPLETED|Overall Study||25
8427374|NCT00869440|20769101|P3|COMPLETED|Overall Study||25
8427375|NCT00869440|20769102|P2|COMPLETED|Overall Study||24
8427376|NCT00869440|20769103|P1|COMPLETED|Overall Study||23
8427377|NCT00869440|20769100|P4|STARTED|Overall Study||25
8427378|NCT00869440|20769101|P3|STARTED|Overall Study||25
8427379|NCT00869440|20769102|P2|STARTED|Overall Study||25
8427380|NCT00869440|20769103|P1|STARTED|Overall Study||25
8427381|NCT00869414|20769121|P3|NOT COMPLETED|Overall Study||0
8427382|NCT00869414|20769122|P2|NOT COMPLETED|Overall Study||0
8427383|NCT00869414|20769123|P1|NOT COMPLETED|Overall Study||0
8427384|NCT00869414|20769121|P3|COMPLETED|Overall Study||0
8427385|NCT00869414|20769122|P2|COMPLETED|Overall Study||0
8427386|NCT00869414|20769123|P1|COMPLETED|Overall Study||0
8427387|NCT00869414|20769121|P3|STARTED|Overall Study||0
8427388|NCT00869414|20769122|P2|STARTED|Overall Study||0
8427389|NCT00869414|20769123|P1|STARTED|Overall Study||0
8427390|NCT00869401|20769137|P5|NOT COMPLETED|Overall Study||3
8427391|NCT00869401|20769138|P4|NOT COMPLETED|Overall Study||5
8427392|NCT00869401|20769139|P3|NOT COMPLETED|Overall Study||0
8427393|NCT00869401|20769140|P2|NOT COMPLETED|Overall Study||0
8427394|NCT00869401|20769141|P1|NOT COMPLETED|Overall Study||0
8427395|NCT00869401|20769137|P5|COMPLETED|Overall Study||63
8427396|NCT00869401|20769138|P4|COMPLETED|Overall Study||133
8427397|NCT00869401|20769139|P3|COMPLETED|Overall Study||7
8427398|NCT00869401|20769140|P2|COMPLETED|Overall Study||3
8427399|NCT00869401|20769141|P1|COMPLETED|Overall Study||3
8427400|NCT00869401|20769137|P5|STARTED|Overall Study||66
8427401|NCT00869401|20769138|P4|STARTED|Overall Study||138
8427402|NCT00869401|20769139|P3|STARTED|Overall Study||7
8427403|NCT00869401|20769140|P2|STARTED|Overall Study||3
8427404|NCT00869401|20769141|P1|STARTED|Overall Study||3
8427405|NCT00869375|20769159|P2|NOT COMPLETED|Overall Study||0
8427406|NCT00869375|20769160|P1|NOT COMPLETED|Overall Study||0
8427407|NCT00869375|20769159|P2|COMPLETED|Overall Study||3
8427408|NCT00869375|20769160|P1|COMPLETED|Overall Study||3
8427409|NCT00869375|20769159|P2|STARTED|Overall Study||3
8427410|NCT00869375|20769160|P1|STARTED|Overall Study||3
8427411|NCT00869362|20769170|P2|NOT COMPLETED|Overall Study||5
8427412|NCT00869362|20769171|P1|NOT COMPLETED|Overall Study||1
8427413|NCT00869362|20769170|P2|COMPLETED|Overall Study||11
8427414|NCT00869362|20769171|P1|COMPLETED|Overall Study||14
8427415|NCT00869362|20769170|P2|STARTED|Overall Study||16
8427416|NCT00869362|20769171|P1|STARTED|Overall Study||15
8427417|NCT00869349|20769181|P2|NOT COMPLETED|Overall Study||4
8427418|NCT00869349|20769182|P1|NOT COMPLETED|Overall Study||7
8427419|NCT00869349|20769181|P2|COMPLETED|Overall Study||36
8427420|NCT00869349|20769182|P1|COMPLETED|Overall Study||32
8427421|NCT00869349|20769181|P2|STARTED|Overall Study||40
8427422|NCT00869349|20769182|P1|STARTED|Overall Study||39
8427423|NCT00869323|20769192|P1|NOT COMPLETED|Maintenance Therapy||1
8427424|NCT00869323|20769192|P1|COMPLETED|Maintenance Therapy||1
8427425|NCT00869323|20769192|P1|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
8427426|NCT00869323|20769192|P1|NOT COMPLETED|Induction Therapy||0
8427427|NCT00869323|20769192|P1|COMPLETED|Induction Therapy||3
8427428|NCT00869323|20769192|P1|STARTED|Induction Therapy||3
8427429|NCT00869258|20769200|P1|NOT COMPLETED|Overall Study||1
8427430|NCT00869258|20769200|P1|COMPLETED|Overall Study||31
8427431|NCT00869258|20769200|P1|STARTED|Overall Study||32
8427432|NCT00869206|20769206|P2|NOT COMPLETED|Overall Study||27
8427433|NCT00869206|20769207|P1|NOT COMPLETED|Overall Study||29
8427434|NCT00869206|20769206|P2|COMPLETED|Overall Study||884
8427435|NCT00869206|20769207|P1|COMPLETED|Overall Study||882
8427436|NCT00869206|20769206|P2|STARTED|Overall Study||911
8427437|NCT00869206|20769207|P1|STARTED|Overall Study||911
8427438|NCT00869167|20769237|P2|NOT COMPLETED|Overall Study||1
8427439|NCT00869167|20769238|P1|NOT COMPLETED|Overall Study||0
8427440|NCT00869167|20769237|P2|COMPLETED|Overall Study||0
8427441|NCT00869167|20769238|P1|COMPLETED|Overall Study||2
8427442|NCT00869167|20769237|P2|STARTED|Overall Study||1
8427443|NCT00869167|20769238|P1|STARTED|Overall Study||2
8427444|NCT00869141|20769254|P2|NOT COMPLETED|Overall Study||0
8427445|NCT00869141|20769255|P1|NOT COMPLETED|Overall Study||0
8427446|NCT00869141|20769254|P2|COMPLETED|Overall Study||26
8427447|NCT00869141|20769255|P1|COMPLETED|Overall Study||26
8427448|NCT00869141|20769254|P2|STARTED|Overall Study||26
8427449|NCT00869141|20769255|P1|STARTED|Overall Study||26
8427450|NCT00869128|20769265|P2|NOT COMPLETED|Overall Study||6
8427451|NCT00869128|20769266|P1|NOT COMPLETED|Overall Study||6
8427452|NCT00869128|20769265|P2|COMPLETED|Overall Study||12
8427453|NCT00869128|20769266|P1|COMPLETED|Overall Study||12
8427454|NCT00869128|20769265|P2|STARTED|Overall Study||18
8427455|NCT00869128|20769266|P1|STARTED|Overall Study||18
8427456|NCT00869089|20769270|P1|NOT COMPLETED|Overall Study||3
8427457|NCT00869089|20769270|P1|COMPLETED|Overall Study||2
8427458|NCT00869089|20769270|P1|STARTED|Overall Study||5
8427459|NCT00869050|20769274|P1|NOT COMPLETED|Overall Study||3
8427460|NCT00869050|20769274|P1|COMPLETED|Overall Study||38
8427461|NCT00869050|20769274|P1|STARTED|Overall Study||41
8427462|NCT00869024|20769281|P2|NOT COMPLETED|Overall Study||5
8427463|NCT00869024|20769282|P1|NOT COMPLETED|Overall Study||2
8427464|NCT00869024|20769281|P2|COMPLETED|Overall Study||4
8427465|NCT00869024|20769282|P1|COMPLETED|Overall Study||14
8427466|NCT00869024|20769281|P2|STARTED|Overall Study|One patient intent to treat, did not receive study product|9
8427467|NCT00869024|20769282|P1|STARTED|Overall Study||16
8427468|NCT00868998|20769298|P1|NOT COMPLETED|Overall Study||5
8427469|NCT00868998|20769298|P1|COMPLETED|Overall Study||0
8427470|NCT00868998|20769298|P1|STARTED|Overall Study||5
8427471|NCT00868959|20769303|P1|NOT COMPLETED|Overall Study||258
8427472|NCT00868959|20769303|P1|COMPLETED|Overall Study||559
8427473|NCT00868959|20769303|P1|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
8427474|NCT00868790|20769309|P14|NOT COMPLETED|Post-study||0
8427475|NCT00868790|20769310|P13|NOT COMPLETED|Post-study||0
8427476|NCT00868790|20769311|P12|NOT COMPLETED|Post-study||0
8427477|NCT00868790|20769312|P11|NOT COMPLETED|Post-study||0
8427478|NCT00868790|20769313|P10|NOT COMPLETED|Post-study||1
8427479|NCT00868790|20769314|P9|NOT COMPLETED|Post-study||0
8427480|NCT00868790|20769315|P8|NOT COMPLETED|Post-study||2
8427481|NCT00868790|20769316|P7|NOT COMPLETED|Post-study||0
8427482|NCT00868790|20769317|P6|NOT COMPLETED|Post-study||0
8427483|NCT00868790|20769318|P5|NOT COMPLETED|Post-study||1
8427484|NCT00868790|20769319|P4|NOT COMPLETED|Post-study||0
8427485|NCT00868790|20769320|P3|NOT COMPLETED|Post-study||0
8427486|NCT00868790|20769321|P2|NOT COMPLETED|Post-study||0
8427487|NCT00868790|20769322|P1|NOT COMPLETED|Post-study||0
8427488|NCT00868790|20769309|P14|COMPLETED|Post-study||7
8427489|NCT00868790|20769310|P13|COMPLETED|Post-study||6
8427490|NCT00868790|20769311|P12|COMPLETED|Post-study||3
8427491|NCT00868790|20769312|P11|COMPLETED|Post-study||5
8427492|NCT00868790|20769313|P10|COMPLETED|Post-study||1
8427493|NCT00868790|20769314|P9|COMPLETED|Post-study||6
8427494|NCT00868790|20769315|P8|COMPLETED|Post-study||12
8427495|NCT00868790|20769316|P7|COMPLETED|Post-study||4
8427496|NCT00868790|20769317|P6|COMPLETED|Post-study||1
8427497|NCT00868790|20769318|P5|COMPLETED|Post-study||17
8427498|NCT00868790|20769319|P4|COMPLETED|Post-study||3
8427499|NCT00868790|20769320|P3|COMPLETED|Post-study||3
8427500|NCT00868790|20769321|P2|COMPLETED|Post-study||6
8427501|NCT00868790|20769322|P1|COMPLETED|Post-study||7
8427502|NCT00868790|20769309|P14|STARTED|Post-study||7
8427503|NCT00868790|20769310|P13|STARTED|Post-study||6
8427504|NCT00868790|20769311|P12|STARTED|Post-study||3
8427505|NCT00868790|20769312|P11|STARTED|Post-study||5
8427506|NCT00868790|20769313|P10|STARTED|Post-study||2
8427507|NCT00868790|20769314|P9|STARTED|Post-study||6
8427508|NCT00868790|20769315|P8|STARTED|Post-study||14
8427509|NCT00868790|20769316|P7|STARTED|Post-study||4
8427510|NCT00868790|20769317|P6|STARTED|Post-study||1
8427511|NCT00868790|20769318|P5|STARTED|Post-study||18
8427512|NCT00868790|20769319|P4|STARTED|Post-study||3
8427513|NCT00868790|20769320|P3|STARTED|Post-study||3
8427514|NCT00868790|20769321|P2|STARTED|Post-study||6
8427515|NCT00868790|20769322|P1|STARTED|Post-study||7
8427516|NCT00868790|20769309|P14|NOT COMPLETED|Period 4||1
8427517|NCT00868790|20769310|P13|NOT COMPLETED|Period 4||1
8427518|NCT00868790|20769311|P12|NOT COMPLETED|Period 4||1
8427519|NCT00868790|20769312|P11|NOT COMPLETED|Period 4||3
8427520|NCT00868790|20769313|P10|NOT COMPLETED|Period 4||0
8427521|NCT00868790|20769314|P9|NOT COMPLETED|Period 4||2
8427522|NCT00868790|20769315|P8|NOT COMPLETED|Period 4||3
8427523|NCT00868790|20769316|P7|NOT COMPLETED|Period 4||0
8427524|NCT00868790|20769317|P6|NOT COMPLETED|Period 4||0
8427525|NCT00868790|20769318|P5|NOT COMPLETED|Period 4||0
8427526|NCT00868790|20769319|P4|NOT COMPLETED|Period 4||0
8427527|NCT00868790|20769320|P3|NOT COMPLETED|Period 4||1
8427528|NCT00868790|20769321|P2|NOT COMPLETED|Period 4||0
8427529|NCT00868790|20769322|P1|NOT COMPLETED|Period 4||2
8427530|NCT00868790|20769309|P14|COMPLETED|Period 4||7
8427531|NCT00868790|20769310|P13|COMPLETED|Period 4||6
8427532|NCT00868790|20769311|P12|COMPLETED|Period 4||3
8427533|NCT00868790|20769312|P11|COMPLETED|Period 4||5
8427534|NCT00868790|20769313|P10|COMPLETED|Period 4||2
8427535|NCT00868790|20769314|P9|COMPLETED|Period 4||6
8427536|NCT00868790|20769315|P8|COMPLETED|Period 4||14
8427537|NCT00868790|20769316|P7|COMPLETED|Period 4||4
8427538|NCT00868790|20769317|P6|COMPLETED|Period 4||1
8427539|NCT00868790|20769318|P5|COMPLETED|Period 4||18
8427540|NCT00868790|20769319|P4|COMPLETED|Period 4||3
8427541|NCT00868790|20769320|P3|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
8427542|NCT00868790|20769321|P2|COMPLETED|Period 4||6
8427543|NCT00868790|20769322|P1|COMPLETED|Period 4||7
8427544|NCT00868790|20769309|P14|STARTED|Period 4||8
8427545|NCT00868790|20769310|P13|STARTED|Period 4||7
8427546|NCT00868790|20769311|P12|STARTED|Period 4||4
8427547|NCT00868790|20769312|P11|STARTED|Period 4||8
8427548|NCT00868790|20769313|P10|STARTED|Period 4||2
8427549|NCT00868790|20769314|P9|STARTED|Period 4||8
8427550|NCT00868790|20769315|P8|STARTED|Period 4||17
8427551|NCT00868790|20769316|P7|STARTED|Period 4||4
8427552|NCT00868790|20769317|P6|STARTED|Period 4||1
8427553|NCT00868790|20769318|P5|STARTED|Period 4||18
8427554|NCT00868790|20769319|P4|STARTED|Period 4||3
8427555|NCT00868790|20769320|P3|STARTED|Period 4||4
8427556|NCT00868790|20769321|P2|STARTED|Period 4||6
8427557|NCT00868790|20769322|P1|STARTED|Period 4||9
8427558|NCT00868790|20769309|P14|NOT COMPLETED|Period 3||0
8427559|NCT00868790|20769310|P13|NOT COMPLETED|Period 3||0
8427560|NCT00868790|20769311|P12|NOT COMPLETED|Period 3||0
8427561|NCT00868790|20769312|P11|NOT COMPLETED|Period 3||1
8427562|NCT00868790|20769313|P10|NOT COMPLETED|Period 3||1
8427563|NCT00868790|20769314|P9|NOT COMPLETED|Period 3||0
8427564|NCT00868790|20769315|P8|NOT COMPLETED|Period 3||0
8427565|NCT00868790|20769316|P7|NOT COMPLETED|Period 3||0
8427566|NCT00868790|20769317|P6|NOT COMPLETED|Period 3||0
8427567|NCT00868790|20769318|P5|NOT COMPLETED|Period 3||0
8427568|NCT00868790|20769319|P4|NOT COMPLETED|Period 3||1
8427569|NCT00868790|20769320|P3|NOT COMPLETED|Period 3||0
8427570|NCT00868790|20769321|P2|NOT COMPLETED|Period 3||0
8427571|NCT00868790|20769322|P1|NOT COMPLETED|Period 3||0
8427572|NCT00868790|20769309|P14|COMPLETED|Period 3||8
8427573|NCT00868790|20769310|P13|COMPLETED|Period 3||7
8427574|NCT00868790|20769311|P12|COMPLETED|Period 3||4
8427575|NCT00868790|20769312|P11|COMPLETED|Period 3||8
8427576|NCT00868790|20769313|P10|COMPLETED|Period 3||2
8427577|NCT00868790|20769314|P9|COMPLETED|Period 3||8
8427578|NCT00868790|20769315|P8|COMPLETED|Period 3||17
8427579|NCT00868790|20769316|P7|COMPLETED|Period 3||4
8427580|NCT00868790|20769317|P6|COMPLETED|Period 3||1
8427581|NCT00868790|20769318|P5|COMPLETED|Period 3||18
8427582|NCT00868790|20769319|P4|COMPLETED|Period 3||3
8427583|NCT00868790|20769320|P3|COMPLETED|Period 3||4
8427584|NCT00868790|20769321|P2|COMPLETED|Period 3||6
8427585|NCT00868790|20769322|P1|COMPLETED|Period 3||9
8427586|NCT00868790|20769309|P14|STARTED|Period 3||8
8427587|NCT00868790|20769310|P13|STARTED|Period 3||7
8427588|NCT00868790|20769311|P12|STARTED|Period 3||4
8427589|NCT00868790|20769312|P11|STARTED|Period 3||9
8427590|NCT00868790|20769313|P10|STARTED|Period 3||3
8427591|NCT00868790|20769314|P9|STARTED|Period 3||8
8427592|NCT00868790|20769315|P8|STARTED|Period 3||17
8427593|NCT00868790|20769316|P7|STARTED|Period 3||4
8427594|NCT00868790|20769317|P6|STARTED|Period 3||1
8427595|NCT00868790|20769318|P5|STARTED|Period 3||18
8427596|NCT00868790|20769319|P4|STARTED|Period 3||4
8427597|NCT00868790|20769320|P3|STARTED|Period 3||4
8427598|NCT00868790|20769321|P2|STARTED|Period 3||6
8427599|NCT00868790|20769322|P1|STARTED|Period 3||9
8427600|NCT00868790|20769309|P14|NOT COMPLETED|Period 2||1
8427601|NCT00868790|20769310|P13|NOT COMPLETED|Period 2||0
8427602|NCT00868790|20769311|P12|NOT COMPLETED|Period 2||0
8427603|NCT00868790|20769312|P11|NOT COMPLETED|Period 2||0
8427604|NCT00868790|20769313|P10|NOT COMPLETED|Period 2||0
8427605|NCT00868790|20769314|P9|NOT COMPLETED|Period 2||2
8427606|NCT00868790|20769315|P8|NOT COMPLETED|Period 2||0
8427607|NCT00868790|20769316|P7|NOT COMPLETED|Period 2||0
8427608|NCT00868790|20769317|P6|NOT COMPLETED|Period 2||1
8427609|NCT00868790|20769318|P5|NOT COMPLETED|Period 2||0
8427610|NCT00868790|20769319|P4|NOT COMPLETED|Period 2||0
8427611|NCT00868790|20769320|P3|NOT COMPLETED|Period 2||0
8427612|NCT00868790|20769321|P2|NOT COMPLETED|Period 2||1
8427613|NCT00868790|20769322|P1|NOT COMPLETED|Period 2||0
8427614|NCT00868790|20769309|P14|COMPLETED|Period 2||8
8427615|NCT00868790|20769310|P13|COMPLETED|Period 2||7
8427616|NCT00868790|20769311|P12|COMPLETED|Period 2||4
8427617|NCT00868790|20769312|P11|COMPLETED|Period 2||9
8427618|NCT00868790|20769313|P10|COMPLETED|Period 2||3
8427619|NCT00868790|20769314|P9|COMPLETED|Period 2||8
8427620|NCT00868790|20769315|P8|COMPLETED|Period 2||17
8427621|NCT00868790|20769316|P7|COMPLETED|Period 2||4
8427622|NCT00868790|20769317|P6|COMPLETED|Period 2||1
8427623|NCT00868790|20769318|P5|COMPLETED|Period 2||18
8427624|NCT00868790|20769319|P4|COMPLETED|Period 2||4
8427625|NCT00868790|20769320|P3|COMPLETED|Period 2||4
8427626|NCT00868790|20769321|P2|COMPLETED|Period 2||6
8427627|NCT00868790|20769322|P1|COMPLETED|Period 2||9
8427628|NCT00868790|20769309|P14|STARTED|Period 2||9
8427629|NCT00868790|20769310|P13|STARTED|Period 2||7
8427630|NCT00868790|20769311|P12|STARTED|Period 2||4
8427631|NCT00868790|20769312|P11|STARTED|Period 2||9
8427632|NCT00868790|20769313|P10|STARTED|Period 2||3
8427633|NCT00868790|20769314|P9|STARTED|Period 2||10
8427634|NCT00868790|20769315|P8|STARTED|Period 2||17
8427635|NCT00868790|20769316|P7|STARTED|Period 2||4
8427636|NCT00868790|20769317|P6|STARTED|Period 2||2
8427637|NCT00868790|20769318|P5|STARTED|Period 2||18
8427638|NCT00868790|20769319|P4|STARTED|Period 2||4
8427639|NCT00868790|20769320|P3|STARTED|Period 2||4
8427640|NCT00868790|20769321|P2|STARTED|Period 2||7
8427641|NCT00868790|20769322|P1|STARTED|Period 2||9
8427642|NCT00868790|20769309|P14|NOT COMPLETED|Period 1||2
8427643|NCT00868790|20769310|P13|NOT COMPLETED|Period 1||0
8427644|NCT00868790|20769311|P12|NOT COMPLETED|Period 1||0
8427645|NCT00868790|20769312|P11|NOT COMPLETED|Period 1||0
8427646|NCT00868790|20769313|P10|NOT COMPLETED|Period 1||0
8427647|NCT00868790|20769314|P9|NOT COMPLETED|Period 1||1
8427648|NCT00868790|20769315|P8|NOT COMPLETED|Period 1||3
8427649|NCT00868790|20769316|P7|NOT COMPLETED|Period 1||0
8427650|NCT00868790|20769317|P6|NOT COMPLETED|Period 1||1
8427651|NCT00868790|20769318|P5|NOT COMPLETED|Period 1||1
8427652|NCT00868790|20769319|P4|NOT COMPLETED|Period 1||0
8427653|NCT00868790|20769320|P3|NOT COMPLETED|Period 1||0
8427654|NCT00868790|20769321|P2|NOT COMPLETED|Period 1||1
8427655|NCT00868790|20769322|P1|NOT COMPLETED|Period 1||2
8427656|NCT00868790|20769309|P14|COMPLETED|Period 1||9
8427657|NCT00868790|20769310|P13|COMPLETED|Period 1||7
8427658|NCT00868790|20769311|P12|COMPLETED|Period 1||4
8427659|NCT00868790|20769312|P11|COMPLETED|Period 1||9
8427660|NCT00868790|20769313|P10|COMPLETED|Period 1||3
8427661|NCT00868790|20769314|P9|COMPLETED|Period 1||10
8427662|NCT00868790|20769315|P8|COMPLETED|Period 1||17
8427663|NCT00868790|20769316|P7|COMPLETED|Period 1||4
8427664|NCT00868790|20769317|P6|COMPLETED|Period 1||2
8427665|NCT00868790|20769318|P5|COMPLETED|Period 1||18
8427666|NCT00868790|20769319|P4|COMPLETED|Period 1||4
8427667|NCT00868790|20769320|P3|COMPLETED|Period 1||4
8427668|NCT00868790|20769321|P2|COMPLETED|Period 1||7
8427669|NCT00868790|20769322|P1|COMPLETED|Period 1||9
8427670|NCT00868790|20769309|P14|STARTED|Period 1||11
8427671|NCT00868790|20769310|P13|STARTED|Period 1||7
8427672|NCT00868790|20769311|P12|STARTED|Period 1||4
8427673|NCT00868790|20769312|P11|STARTED|Period 1||9
8427674|NCT00868790|20769313|P10|STARTED|Period 1||3
8427675|NCT00868790|20769314|P9|STARTED|Period 1||11
8427676|NCT00868790|20769315|P8|STARTED|Period 1||20
8427677|NCT00868790|20769316|P7|STARTED|Period 1||4
8427678|NCT00868790|20769317|P6|STARTED|Period 1||3
8427679|NCT00868790|20769318|P5|STARTED|Period 1||19
8427680|NCT00868790|20769319|P4|STARTED|Period 1||4
8427681|NCT00868790|20769320|P3|STARTED|Period 1||4
8427682|NCT00868790|20769321|P2|STARTED|Period 1||8
8427683|NCT00868790|20769322|P1|STARTED|Period 1||11
8427684|NCT00868751|20769359|P1|NOT COMPLETED|Overall Study||1
8427685|NCT00868751|20769359|P1|COMPLETED|Overall Study||0
8427686|NCT00868751|20769359|P1|STARTED|Overall Study||1
8427687|NCT00868712|20769370|P3|NOT COMPLETED|Overall Study||0
8427688|NCT00868712|20769371|P2|NOT COMPLETED|Overall Study||0
8427689|NCT00868712|20769372|P1|NOT COMPLETED|Overall Study||0
8427690|NCT00868712|20769370|P3|COMPLETED|Overall Study||28
8427691|NCT00868712|20769371|P2|COMPLETED|Overall Study||11
8427692|NCT00868712|20769372|P1|COMPLETED|Overall Study||31
8427693|NCT00868712|20769370|P3|STARTED|Overall Study||28
8427694|NCT00868712|20769371|P2|STARTED|Overall Study||11
8427695|NCT00868712|20769372|P1|STARTED|Overall Study||31
8427696|NCT00868699|20769386|P3|NOT COMPLETED|Overall Study||43
8427697|NCT00868699|20769387|P2|NOT COMPLETED|Overall Study||45
8427698|NCT00868699|20769388|P1|NOT COMPLETED|Overall Study||43
8427699|NCT00868699|20769386|P3|COMPLETED|Overall Study||123
8427700|NCT00868699|20769387|P2|COMPLETED|Overall Study||124
8427701|NCT00868699|20769388|P1|COMPLETED|Overall Study||127
8427702|NCT00868699|20769386|P3|Safety Population|Overall Study||164
8427703|NCT00868699|20769387|P2|Safety Population|Overall Study||167
8427704|NCT00868699|20769388|P1|Safety Population|Overall Study||168
8427705|NCT00868699|20769386|P3|Intent-to-Treat Population|Overall Study||161
8427706|NCT00868699|20769387|P2|Intent-to-Treat Population|Overall Study||162
8427707|NCT00868699|20769388|P1|Intent-to-Treat Population|Overall Study||162
8427708|NCT00868699|20769386|P3|STARTED|Overall Study||166
8427709|NCT00868699|20769387|P2|STARTED|Overall Study||169
8427710|NCT00868699|20769388|P1|STARTED|Overall Study||170
8427711|NCT00868608|20769405|P3|NOT COMPLETED|Overall Study||5
8427712|NCT00868608|20769406|P2|NOT COMPLETED|Overall Study||3
8427713|NCT00868608|20769407|P1|NOT COMPLETED|Overall Study||23
8427714|NCT00868608|20769405|P3|COMPLETED|Overall Study||0
8427715|NCT00868608|20769406|P2|COMPLETED|Overall Study||1
8427716|NCT00868608|20769407|P1|COMPLETED|Overall Study||49
8427717|NCT00868608|20769405|P3|STARTED|Overall Study||5
8427718|NCT00868608|20769406|P2|STARTED|Overall Study||4
8427719|NCT00868608|20769407|P1|STARTED|Overall Study||72
8427720|NCT00868530|20769431|P1|NOT COMPLETED|Overall Study||4
8427721|NCT00868530|20769431|P1|COMPLETED|Overall Study||49
8427722|NCT00868530|20769431|P1|STARTED|Overall Study||53
8427723|NCT00868517|20769446|P3|NOT COMPLETED|Overall Study||2
8427724|NCT00868517|20769447|P2|NOT COMPLETED|Overall Study||4
8427725|NCT00868517|20769448|P1|NOT COMPLETED|Overall Study||4
8427726|NCT00868517|20769446|P3|COMPLETED|Overall Study||9
8427727|NCT00868517|20769447|P2|COMPLETED|Overall Study||8
8427728|NCT00868517|20769448|P1|COMPLETED|Overall Study||8
8427729|NCT00868517|20769446|P3|STARTED|Overall Study||11
8427730|NCT00868517|20769447|P2|STARTED|Overall Study||12
8427731|NCT00868517|20769448|P1|STARTED|Overall Study||12
8427732|NCT00868452|20769473|P2|NOT COMPLETED|Overall Study||29
8427733|NCT00868452|20769474|P1|NOT COMPLETED|Overall Study||40
8427734|NCT00868452|20769473|P2|COMPLETED|Overall Study||136
8427735|NCT00868452|20769474|P1|COMPLETED|Overall Study||143
8427736|NCT00868452|20769473|P2|STARTED|Overall Study||165
8427737|NCT00868452|20769474|P1|STARTED|Overall Study||183
8427744|NCT00868374|20769505|P2|NOT COMPLETED|Overall Study||7
8427745|NCT00868374|20769506|P1|NOT COMPLETED|Overall Study||7
8427746|NCT00868374|20769505|P2|COMPLETED|Overall Study||4
8427747|NCT00868374|20769506|P1|COMPLETED|Overall Study||5
8427748|NCT00868374|20769505|P2|STARTED|Overall Study||11
8427749|NCT00868374|20769506|P1|STARTED|Overall Study||12
8427750|NCT00868348|20769514|P2|NOT COMPLETED|Overall Study||0
8427751|NCT00868348|20769515|P1|NOT COMPLETED|Overall Study||0
8427752|NCT00868348|20769514|P2|COMPLETED|Overall Study||30
8427753|NCT00868348|20769515|P1|COMPLETED|Overall Study||30
8427754|NCT00868348|20769514|P2|STARTED|Overall Study||30
8427755|NCT00868348|20769515|P1|STARTED|Overall Study||30
8427756|NCT00868309|20769533|P2|NOT COMPLETED|Overall Study||0
8427757|NCT00868309|20769534|P1|NOT COMPLETED|Overall Study||0
8427758|NCT00868309|20769533|P2|COMPLETED|Overall Study||6
8427759|NCT00868309|20769534|P1|COMPLETED|Overall Study||6
8427760|NCT00868309|20769533|P2|STARTED|Overall Study||6
8427761|NCT00868309|20769534|P1|STARTED|Overall Study||6
8427762|NCT00868296|20769544|P2|NOT COMPLETED|Overall Study||3
8427763|NCT00868296|20769545|P1|NOT COMPLETED|Overall Study||0
8427764|NCT00868296|20769544|P2|COMPLETED|Overall Study||43
8427765|NCT00868296|20769545|P1|COMPLETED|Overall Study||12
8427766|NCT00868296|20769544|P2|STARTED|Overall Study||46
8427767|NCT00868296|20769545|P1|STARTED|Overall Study||12
8427768|NCT00868231|20769553|P6|NOT COMPLETED|Treatment Period 3||0
8427769|NCT00868231|20769554|P5|NOT COMPLETED|Treatment Period 3||0
8427770|NCT00868231|20769555|P4|NOT COMPLETED|Treatment Period 3||0
8427771|NCT00868231|20769556|P3|NOT COMPLETED|Treatment Period 3||1
8427772|NCT00868231|20769557|P2|NOT COMPLETED|Treatment Period 3||0
8427773|NCT00868231|20769558|P1|NOT COMPLETED|Treatment Period 3||0
8427774|NCT00868231|20769553|P6|COMPLETED|Treatment Period 3||5
8427775|NCT00868231|20769554|P5|COMPLETED|Treatment Period 3||4
8427776|NCT00868231|20769555|P4|COMPLETED|Treatment Period 3||5
8427777|NCT00868231|20769556|P3|COMPLETED|Treatment Period 3||4
8427778|NCT00868231|20769557|P2|COMPLETED|Treatment Period 3||5
8427779|NCT00868231|20769558|P1|COMPLETED|Treatment Period 3||4
8427780|NCT00868231|20769553|P6|STARTED|Treatment Period 3||5
8427781|NCT00868231|20769554|P5|STARTED|Treatment Period 3||4
8427782|NCT00868231|20769555|P4|STARTED|Treatment Period 3||5
8427783|NCT00868231|20769556|P3|STARTED|Treatment Period 3||5
8427784|NCT00868231|20769557|P2|STARTED|Treatment Period 3||5
8427785|NCT00868231|20769558|P1|STARTED|Treatment Period 3||4
8427786|NCT00868231|20769553|P6|NOT COMPLETED|Treatment Period 2||0
8427787|NCT00868231|20769554|P5|NOT COMPLETED|Treatment Period 2||0
8427788|NCT00868231|20769555|P4|NOT COMPLETED|Treatment Period 2||0
8427789|NCT00868231|20769556|P3|NOT COMPLETED|Treatment Period 2||0
8427790|NCT00868231|20769557|P2|NOT COMPLETED|Treatment Period 2||0
8427791|NCT00868231|20769558|P1|NOT COMPLETED|Treatment Period 2||1
8427792|NCT00868231|20769553|P6|COMPLETED|Treatment Period 2||5
8427793|NCT00868231|20769554|P5|COMPLETED|Treatment Period 2||4
8427794|NCT00868231|20769555|P4|COMPLETED|Treatment Period 2||5
8427795|NCT00868231|20769556|P3|COMPLETED|Treatment Period 2||5
8427796|NCT00868231|20769557|P2|COMPLETED|Treatment Period 2||5
8427797|NCT00868231|20769558|P1|COMPLETED|Treatment Period 2||4
8427798|NCT00868231|20769553|P6|STARTED|Treatment Period 2||5
8427799|NCT00868231|20769554|P5|STARTED|Treatment Period 2||4
8427800|NCT00868231|20769555|P4|STARTED|Treatment Period 2||5
8427801|NCT00868231|20769556|P3|STARTED|Treatment Period 2||5
8427802|NCT00868231|20769557|P2|STARTED|Treatment Period 2||5
8427803|NCT00868231|20769558|P1|STARTED|Treatment Period 2||5
8427804|NCT00868231|20769553|P6|NOT COMPLETED|Treatment Period 1||0
8427805|NCT00868231|20769554|P5|NOT COMPLETED|Treatment Period 1||1
8427806|NCT00868231|20769555|P4|NOT COMPLETED|Treatment Period 1||0
8427807|NCT00868231|20769556|P3|NOT COMPLETED|Treatment Period 1||0
8427808|NCT00868231|20769557|P2|NOT COMPLETED|Treatment Period 1||0
8427809|NCT00868231|20769558|P1|NOT COMPLETED|Treatment Period 1||0
8427810|NCT00868231|20769553|P6|COMPLETED|Treatment Period 1||5
8427811|NCT00868231|20769554|P5|COMPLETED|Treatment Period 1||4
8427812|NCT00868231|20769555|P4|COMPLETED|Treatment Period 1||5
8427813|NCT00868231|20769556|P3|COMPLETED|Treatment Period 1||5
8427814|NCT00868231|20769557|P2|COMPLETED|Treatment Period 1||5
8427815|NCT00868231|20769558|P1|COMPLETED|Treatment Period 1||5
8427816|NCT00868231|20769553|P6|STARTED|Treatment Period 1||5
8427817|NCT00868231|20769554|P5|STARTED|Treatment Period 1||5
8427818|NCT00868231|20769555|P4|STARTED|Treatment Period 1||5
8427819|NCT00868231|20769556|P3|STARTED|Treatment Period 1||5
8427820|NCT00868231|20769557|P2|STARTED|Treatment Period 1||5
8427821|NCT00868231|20769558|P1|STARTED|Treatment Period 1||5
8427822|NCT00868218|20769603|P4|NOT COMPLETED|Overall Study||0
8427823|NCT00868218|20769604|P3|NOT COMPLETED|Overall Study||0
8427824|NCT00868218|20769605|P2|NOT COMPLETED|Overall Study||0
8427825|NCT00868218|20769606|P1|NOT COMPLETED|Overall Study||0
8427826|NCT00868218|20769603|P4|COMPLETED|Overall Study||15
8427827|NCT00868218|20769604|P3|COMPLETED|Overall Study||15
8427828|NCT00868218|20769605|P2|COMPLETED|Overall Study||15
8427829|NCT00868218|20769606|P1|COMPLETED|Overall Study||15
8427830|NCT00868218|20769603|P4|STARTED|Overall Study||15
8427831|NCT00868218|20769604|P3|STARTED|Overall Study||15
8427832|NCT00868218|20769605|P2|STARTED|Overall Study||15
8427833|NCT00868218|20769606|P1|STARTED|Overall Study||15
8427834|NCT00868192|20769624|P1|NOT COMPLETED|Overall Study||4
8427835|NCT00868192|20769624|P1|COMPLETED|Overall Study||34
8427836|NCT00868192|20769624|P1|STARTED|Overall Study||38
8427837|NCT00868166|20769641|P2|NOT COMPLETED|Overall Study||114
8427838|NCT00868166|20769642|P1|NOT COMPLETED|Overall Study||112
8427839|NCT00868166|20769641|P2|COMPLETED|Overall Study||139
8427840|NCT00868166|20769642|P1|COMPLETED|Overall Study||147
8427841|NCT00868166|20769641|P2|STARTED|Overall Study||253
8427842|NCT00868166|20769642|P1|STARTED|Overall Study||259
8427843|NCT00868140|20769664|P2|NOT COMPLETED|Overall Study||0
8427844|NCT00868140|20769665|P1|NOT COMPLETED|Overall Study||0
8427845|NCT00868140|20769664|P2|COMPLETED|Overall Study||25
8427846|NCT00868140|20769665|P1|COMPLETED|Overall Study||26
8427847|NCT00868140|20769664|P2|STARTED|Overall Study||25
8427848|NCT00868140|20769665|P1|STARTED|Overall Study||26
8427849|NCT00868101|20769683|P2|NOT COMPLETED|Overall Study||0
8427850|NCT00868101|20769684|P1|NOT COMPLETED|Overall Study||0
8427851|NCT00868101|20769683|P2|COMPLETED|Overall Study||10
8427852|NCT00868101|20769684|P1|COMPLETED|Overall Study||12
8427853|NCT00868101|20769683|P2|STARTED|Overall Study||10
8427854|NCT00868101|20769684|P1|STARTED|Overall Study||12
8427855|NCT00867932|20769696|P1|NOT COMPLETED|Overall Study||0
8427856|NCT00867932|20769696|P1|COMPLETED|Overall Study||7
8427857|NCT00867932|20769696|P1|Intent-to-Treat (ITT) Population|Overall Study||7
8427858|NCT00867932|20769696|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
8427859|NCT00867932|20769696|P1|Maintenance Phase|Overall Study||7
8427860|NCT00867932|20769696|P1|Induction Phase|Overall Study||7
8427861|NCT00867932|20769696|P1|STARTED|Overall Study||7
8427862|NCT00867815|20769704|P1|NOT COMPLETED|Overall Study||1
8427863|NCT00867815|20769704|P1|COMPLETED|Overall Study||9
8427864|NCT00867815|20769704|P1|STARTED|Overall Study||10
8427865|NCT00867789|20769712|P2|NOT COMPLETED|Overall Study||0
8427866|NCT00867789|20769713|P1|NOT COMPLETED|Overall Study||2
8427867|NCT00867789|20769712|P2|COMPLETED|Overall Study||70
8427868|NCT00867789|20769713|P1|COMPLETED|Overall Study||68
8427869|NCT00867789|20769712|P2|STARTED|Overall Study||70
8427870|NCT00867789|20769713|P1|STARTED|Overall Study||70
8427871|NCT00867659|20769719|P1|NOT COMPLETED|Overall Study||0
8427872|NCT00867659|20769719|P1|COMPLETED|Overall Study|January 2010|20
8427873|NCT00867659|20769719|P1|STARTED|Overall Study|October 2009|20
8427874|NCT00867568|20769724|P1|NOT COMPLETED|Overall Study||15
8427875|NCT00867568|20769724|P1|COMPLETED|Overall Study||3
8427876|NCT00867568|20769724|P1|STARTED|Overall Study||18
8427877|NCT00867529|20769733|P1|NOT COMPLETED|Overall Study||0
8427878|NCT00867529|20769733|P1|COMPLETED|Overall Study||63
8427879|NCT00867529|20769733|P1|STARTED|Overall Study||63
8427880|NCT00867503|20769741|P1|NOT COMPLETED|Overall Study||1
8427881|NCT00867503|20769741|P1|COMPLETED|Overall Study||9
8427882|NCT00867503|20769741|P1|STARTED|Overall Study||10
8427883|NCT00867490|20769747|P1|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
8427884|NCT00867490|20769747|P1|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
8427885|NCT00867490|20769747|P1|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
8427886|NCT00867490|20769747|P1|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
8427887|NCT00867490|20769747|P1|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
8427888|NCT00867490|20769747|P1|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
8427889|NCT00867490|20769747|P1|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
8427890|NCT00867490|20769747|P1|COMPLETED|Phase 1 - Candesartan+HCTZ||176
8427891|NCT00867490|20769747|P1|STARTED|Phase 1 - Candesartan+HCTZ||186
8427892|NCT00867451|20769766|P2|NOT COMPLETED|Overall Study||0
8427893|NCT00867451|20769767|P1|NOT COMPLETED|Overall Study||0
8427894|NCT00867451|20769766|P2|COMPLETED|Overall Study||4
8427895|NCT00867451|20769767|P1|COMPLETED|Overall Study||4
8427896|NCT00867451|20769766|P2|STARTED|Overall Study||4
8427897|NCT00867451|20769767|P1|STARTED|Overall Study||4
8427898|NCT00867360|20769789|P2|NOT COMPLETED|Overall Study||1
8427899|NCT00867360|20769790|P1|NOT COMPLETED|Overall Study||1
8427900|NCT00867360|20769789|P2|COMPLETED|Overall Study||5
8427901|NCT00867360|20769790|P1|COMPLETED|Overall Study||3
8427902|NCT00867360|20769789|P2|STARTED|Overall Study||6
8427903|NCT00867360|20769790|P1|STARTED|Overall Study||4
8427904|NCT00867334|20769802|P2|NOT COMPLETED|Overall Study||1
8427905|NCT00867334|20769803|P1|NOT COMPLETED|Overall Study||2
8427906|NCT00867334|20769802|P2|COMPLETED|Overall Study||0
8427907|NCT00867334|20769803|P1|COMPLETED|Overall Study||4
8427908|NCT00867334|20769802|P2|STARTED|Overall Study||1
8427909|NCT00867334|20769803|P1|STARTED|Overall Study||6
8427910|NCT00867321|20769814|P6|NOT COMPLETED|Overall Study||0
8427911|NCT00867321|20769815|P5|NOT COMPLETED|Overall Study||0
8427912|NCT00867321|20769816|P4|NOT COMPLETED|Overall Study||0
8427913|NCT00867321|20769817|P3|NOT COMPLETED|Overall Study||0
8427914|NCT00867321|20769818|P2|NOT COMPLETED|Overall Study||1
8427915|NCT00867321|20769819|P1|NOT COMPLETED|Overall Study||0
8427916|NCT00867321|20769814|P6|COMPLETED|Overall Study||3
8427917|NCT00867321|20769815|P5|COMPLETED|Overall Study||5
8427918|NCT00867321|20769816|P4|COMPLETED|Overall Study||6
8427919|NCT00867321|20769817|P3|COMPLETED|Overall Study||3
8427920|NCT00867321|20769818|P2|COMPLETED|Overall Study||2
8427921|NCT00867321|20769819|P1|COMPLETED|Overall Study||4
8427922|NCT00867321|20769814|P6|STARTED|Overall Study||3
8427923|NCT00867321|20769815|P5|STARTED|Overall Study||5
8427924|NCT00867321|20769816|P4|STARTED|Overall Study||6
8427925|NCT00867321|20769817|P3|STARTED|Overall Study||3
8427926|NCT00867321|20769818|P2|STARTED|Overall Study||3
8427927|NCT00867321|20769819|P1|STARTED|Overall Study||4
8427928|NCT00867308|20769839|P2|NOT COMPLETED|Overall Study||18
8427929|NCT00867308|20769840|P1|NOT COMPLETED|Overall Study||9
8427930|NCT00867308|20769839|P2|COMPLETED|Overall Study||0
8427931|NCT00867308|20769840|P1|COMPLETED|Overall Study||0
8427932|NCT00867308|20769839|P2|STARTED|Overall Study||18
8427933|NCT00867308|20769840|P1|STARTED|Overall Study||9
8427934|NCT00867217|20769850|P2|NOT COMPLETED|Overall Study||10
8427935|NCT00867217|20769851|P1|NOT COMPLETED|Overall Study||3
8427936|NCT00867217|20769850|P2|COMPLETED|Overall Study||70
8427937|NCT00867217|20769851|P1|COMPLETED|Overall Study||77
8427938|NCT00867217|20769850|P2|STARTED|Overall Study||80
8427939|NCT00867217|20769851|P1|STARTED|Overall Study||80
8427940|NCT00867165|20769859|P2|NOT COMPLETED|Overall Study||0
8427941|NCT00867165|20769860|P1|NOT COMPLETED|Overall Study||4
8427942|NCT00867165|20769859|P2|COMPLETED|Overall Study||45
8427943|NCT00867165|20769860|P1|COMPLETED|Overall Study||89
8427944|NCT00867165|20769859|P2|STARTED|Overall Study||45
8427945|NCT00867165|20769860|P1|STARTED|Overall Study||93
8427946|NCT00867139|20769965|P3|NOT COMPLETED|Overall Study||1
8427947|NCT00867139|20769966|P2|NOT COMPLETED|Overall Study||0
8427948|NCT00867139|20769967|P1|NOT COMPLETED|Overall Study||0
8427949|NCT00867139|20769965|P3|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
8427950|NCT00867139|20769966|P2|COMPLETED|Overall Study||1
8427951|NCT00867139|20769967|P1|COMPLETED|Overall Study||2
8427952|NCT00867139|20769965|P3|STARTED|Overall Study||4
8427953|NCT00867139|20769966|P2|STARTED|Overall Study||1
8427954|NCT00867139|20769967|P1|STARTED|Overall Study||2
8427955|NCT00867113|20770008|P1|NOT COMPLETED|Post Treatment After Survival Follow-up||11
8427956|NCT00867113|20770008|P1|COMPLETED|Post Treatment After Survival Follow-up||57
8427957|NCT00867113|20770008|P1|STARTED|Post Treatment After Survival Follow-up||68
8427958|NCT00867113|20770008|P1|NOT COMPLETED|Treatment Period||45
8427959|NCT00867113|20770008|P1|COMPLETED|Treatment Period||46
8427960|NCT00867113|20770008|P1|Full Analysis Set (FAS)|Treatment Period||91
8427961|NCT00867113|20770008|P1|Safety Set|Treatment Period||91
8427962|NCT00867113|20770008|P1|STARTED|Treatment Period||91
8427963|NCT00867100|20770028|P13|NOT COMPLETED|Overall Study||0
8427964|NCT00867100|20770029|P12|NOT COMPLETED|Overall Study||0
8427965|NCT00867100|20770030|P11|NOT COMPLETED|Overall Study||1
8427966|NCT00867100|20770031|P10|NOT COMPLETED|Overall Study||0
8427967|NCT00867100|20770032|P9|NOT COMPLETED|Overall Study||0
8427968|NCT00867100|20770033|P8|NOT COMPLETED|Overall Study||0
8427969|NCT00867100|20770034|P7|NOT COMPLETED|Overall Study||1
8427970|NCT00867100|20770035|P6|NOT COMPLETED|Overall Study||0
8427971|NCT00867100|20770036|P5|NOT COMPLETED|Overall Study||0
8427972|NCT00867100|20770037|P4|NOT COMPLETED|Overall Study||0
8427973|NCT00867100|20770038|P3|NOT COMPLETED|Overall Study||0
8427974|NCT00867100|20770039|P2|NOT COMPLETED|Overall Study||1
8427975|NCT00867100|20770040|P1|NOT COMPLETED|Overall Study||0
8427976|NCT00867100|20770028|P13|COMPLETED|Overall Study||6
8427977|NCT00867100|20770029|P12|COMPLETED|Overall Study||6
8427978|NCT00867100|20770030|P11|COMPLETED|Overall Study||3
8427979|NCT00867100|20770031|P10|COMPLETED|Overall Study||6
8427980|NCT00867100|20770032|P9|COMPLETED|Overall Study||6
8427981|NCT00867100|20770033|P8|COMPLETED|Overall Study||3
8427982|NCT00867100|20770034|P7|COMPLETED|Overall Study||6
8427983|NCT00867100|20770035|P6|COMPLETED|Overall Study||6
8427984|NCT00867100|20770036|P5|COMPLETED|Overall Study||14
8427985|NCT00867100|20770037|P4|COMPLETED|Overall Study||8
8427986|NCT00867100|20770038|P3|COMPLETED|Overall Study||8
8427987|NCT00867100|20770039|P2|COMPLETED|Overall Study||4
8427988|NCT00867100|20770040|P1|COMPLETED|Overall Study||5
8427989|NCT00867100|20770028|P13|STARTED|Overall Study||6
8427990|NCT00867100|20770029|P12|STARTED|Overall Study||6
8427991|NCT00867100|20770030|P11|STARTED|Overall Study||4
8427992|NCT00867100|20770031|P10|STARTED|Overall Study||6
8427993|NCT00867100|20770032|P9|STARTED|Overall Study||6
8427994|NCT00867100|20770033|P8|STARTED|Overall Study||3
8427995|NCT00867100|20770034|P7|STARTED|Overall Study||7
8427996|NCT00867100|20770035|P6|STARTED|Overall Study||6
8427997|NCT00867100|20770036|P5|STARTED|Overall Study||14
8427998|NCT00867100|20770037|P4|STARTED|Overall Study||8
8427999|NCT00867100|20770038|P3|STARTED|Overall Study||8
8428000|NCT00867100|20770039|P2|STARTED|Overall Study||5
8428001|NCT00867100|20770040|P1|STARTED|Overall Study||5
8428002|NCT00867087|20770072|P1|NOT COMPLETED|Overall Study||42
8428003|NCT00867087|20770072|P1|COMPLETED|Overall Study||21
8428004|NCT00867087|20770072|P1|STARTED|Overall Study||63
8428005|NCT00867035|20770088|P2|NOT COMPLETED|Baseline to 1 Week||0
8428006|NCT00867035|20770089|P1|NOT COMPLETED|Baseline to 1 Week||1
8428007|NCT00867035|20770088|P2|COMPLETED|Baseline to 1 Week||8
8428008|NCT00867035|20770089|P1|COMPLETED|Baseline to 1 Week||11
8428009|NCT00867035|20770088|P2|STARTED|Baseline to 1 Week||8
8428010|NCT00867035|20770089|P1|STARTED|Baseline to 1 Week||12
8428011|NCT00867035|20770088|P2|NOT COMPLETED|Baseline to 4 Hours||0
8428012|NCT00867035|20770089|P1|NOT COMPLETED|Baseline to 4 Hours||0
8428013|NCT00867035|20770088|P2|COMPLETED|Baseline to 4 Hours||8
8428014|NCT00867035|20770089|P1|COMPLETED|Baseline to 4 Hours||12
8428015|NCT00867035|20770088|P2|STARTED|Baseline to 4 Hours||8
8428016|NCT00867035|20770089|P1|STARTED|Baseline to 4 Hours||12
8428017|NCT00867035|20770088|P2|NOT COMPLETED|Baseline to 2 Hours||0
8428018|NCT00867035|20770089|P1|NOT COMPLETED|Baseline to 2 Hours||0
8428019|NCT00867035|20770088|P2|COMPLETED|Baseline to 2 Hours||8
8428020|NCT00867035|20770089|P1|COMPLETED|Baseline to 2 Hours||12
8428021|NCT00867035|20770088|P2|STARTED|Baseline to 2 Hours||8
8428022|NCT00867035|20770089|P1|STARTED|Baseline to 2 Hours||12
8428023|NCT00867035|20770088|P2|NOT COMPLETED|Baseline to 1 Hour||1
8428024|NCT00867035|20770089|P1|NOT COMPLETED|Baseline to 1 Hour||1
8428025|NCT00867035|20770088|P2|COMPLETED|Baseline to 1 Hour||8
8428026|NCT00867035|20770089|P1|COMPLETED|Baseline to 1 Hour||12
8428027|NCT00867035|20770088|P2|STARTED|Baseline to 1 Hour||9
8428028|NCT00867035|20770089|P1|STARTED|Baseline to 1 Hour||13
8428029|NCT00867009|20770115|P1|NOT COMPLETED|Maintenance Period||4
8428030|NCT00867009|20770115|P1|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
8428031|NCT00867009|20770115|P1|STARTED|Maintenance Period||51
8428032|NCT00867009|20770115|P1|NOT COMPLETED|Induction Period||62
8428033|NCT00867009|20770115|P1|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
8428034|NCT00867009|20770115|P1|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
8428035|NCT00867009|20770115|P1|Received at Least 1 Dose of Study Drug|Induction Period||113
8428036|NCT00867009|20770115|P1|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
8428043|NCT00866905|20770137|P1|NOT COMPLETED|Overall Study||33
8428044|NCT00866905|20770137|P1|COMPLETED|Overall Study||135
8428045|NCT00866905|20770137|P1|STARTED|Overall Study||168
8428046|NCT00866879|20770144|P2|NOT COMPLETED|Overall Study||0
8428047|NCT00866879|20770145|P1|NOT COMPLETED|Overall Study||0
8428048|NCT00866879|20770144|P2|COMPLETED|Overall Study||185
8428049|NCT00866879|20770145|P1|COMPLETED|Overall Study||90
8428050|NCT00866879|20770144|P2|STARTED|Overall Study||185
8428051|NCT00866879|20770145|P1|STARTED|Overall Study||90
8428052|NCT00866814|20770159|P1|NOT COMPLETED|Overall Study||20
8428053|NCT00866814|20770159|P1|COMPLETED|Overall Study||99
8428054|NCT00866814|20770159|P1|STARTED|Overall Study||119
8428055|NCT00866788|20770172|P4|NOT COMPLETED|Overall Study||5
8428056|NCT00866788|20770173|P3|NOT COMPLETED|Overall Study||2
8428057|NCT00866788|20770174|P2|NOT COMPLETED|Overall Study||6
8428058|NCT00866788|20770175|P1|NOT COMPLETED|Overall Study||6
8428059|NCT00866788|20770172|P4|COMPLETED|Overall Study||16
8428060|NCT00866788|20770173|P3|COMPLETED|Overall Study||23
8428061|NCT00866788|20770174|P2|COMPLETED|Overall Study||17
8428062|NCT00866788|20770175|P1|COMPLETED|Overall Study||15
8428063|NCT00866788|20770172|P4|STARTED|Overall Study||21
8428064|NCT00866788|20770173|P3|STARTED|Overall Study||25
8428065|NCT00866788|20770174|P2|STARTED|Overall Study||23
8428066|NCT00866788|20770175|P1|STARTED|Overall Study||21
8428067|NCT00866775|20770223|P2|NOT COMPLETED|Overall Study||52
8428068|NCT00866775|20770224|P1|NOT COMPLETED|Overall Study||36
8428069|NCT00866775|20770223|P2|COMPLETED|Overall Study||76
8428070|NCT00866775|20770224|P1|COMPLETED|Overall Study||29
8428071|NCT00866775|20770223|P2|STARTED|Overall Study||128
8428072|NCT00866775|20770224|P1|STARTED|Overall Study||65
8428073|NCT00866749|20770260|P1|NOT COMPLETED|Overall Study||0
8428074|NCT00866749|20770260|P1|COMPLETED|Overall Study||120
8428075|NCT00866749|20770260|P1|STARTED|Overall Study||120
8428076|NCT00866723|20770267|P1|NOT COMPLETED|Overall Study||5
8428077|NCT00866723|20770267|P1|COMPLETED|Overall Study||0
8428078|NCT00866723|20770267|P1|STARTED|Overall Study||5
8428085|NCT00866658|20770317|P2|NOT COMPLETED|Overall Study||21
8428086|NCT00866658|20770318|P1|NOT COMPLETED|Overall Study||13
8428087|NCT00866658|20770317|P2|COMPLETED|Overall Study||133
8428088|NCT00866658|20770318|P1|COMPLETED|Overall Study||144
8428089|NCT00866658|20770317|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||154
8428090|NCT00866658|20770318|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
8428091|NCT00866658|20770317|P2|Safety Population|Overall Study||154
8428092|NCT00866658|20770318|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
8428093|NCT00866658|20770317|P2|STARTED|Overall Study||154
8428094|NCT00866658|20770318|P1|STARTED|Overall Study|Randomized.|157
8428095|NCT00866619|20770350|P4|NOT COMPLETED|Overall Study||630
8428096|NCT00866619|20770351|P3|NOT COMPLETED|Overall Study||889
8428097|NCT00866619|20770352|P2|NOT COMPLETED|Overall Study||1270
8428098|NCT00866619|20770353|P1|NOT COMPLETED|Overall Study||1846
8428099|NCT00866619|20770350|P4|COMPLETED|Overall Study||1549
8428100|NCT00866619|20770351|P3|COMPLETED|Overall Study||2085
8428101|NCT00866619|20770352|P2|COMPLETED|Overall Study||3088
8428102|NCT00866619|20770353|P1|COMPLETED|Overall Study||4102
8428103|NCT00866619|20770350|P4|STARTED|Overall Study||2179
8428104|NCT00866619|20770351|P3|STARTED|Overall Study||2974
8428105|NCT00866619|20770352|P2|STARTED|Overall Study||4358
8428106|NCT00866619|20770353|P1|STARTED|Overall Study||5948
8428107|NCT00866606|20770673|P1|NOT COMPLETED|Overall Study||4
8428108|NCT00866606|20770673|P1|COMPLETED|Overall Study||31
8428109|NCT00866606|20770673|P1|STARTED|Overall Study||35
8428110|NCT00866359|20770687|P4|NOT COMPLETED|Observational Follow-Up Phase||0
8428111|NCT00866359|20770688|P3|NOT COMPLETED|Observational Follow-Up Phase||0
8428112|NCT00866359|20770689|P2|NOT COMPLETED|Observational Follow-Up Phase||0
8428113|NCT00866359|20770690|P1|NOT COMPLETED|Observational Follow-Up Phase||0
8428114|NCT00866359|20770687|P4|COMPLETED|Observational Follow-Up Phase||54
8428115|NCT00866359|20770688|P3|COMPLETED|Observational Follow-Up Phase||54
8428116|NCT00866359|20770689|P2|COMPLETED|Observational Follow-Up Phase||0
8428117|NCT00866359|20770690|P1|COMPLETED|Observational Follow-Up Phase||0
8428118|NCT00866359|20770687|P4|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
8428119|NCT00866359|20770688|P3|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
8428120|NCT00866359|20770689|P2|STARTED|Observational Follow-Up Phase||0
8428121|NCT00866359|20770690|P1|STARTED|Observational Follow-Up Phase||0
8428122|NCT00866359|20770687|P4|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
8428123|NCT00866359|20770688|P3|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
8428124|NCT00866359|20770689|P2|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
8428125|NCT00866359|20770690|P1|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
8428126|NCT00866359|20770687|P4|COMPLETED|Extension Phase (Day 86 to 169)||47
8428127|NCT00866359|20770688|P3|COMPLETED|Extension Phase (Day 86 to 169)||44
8428128|NCT00866359|20770689|P2|COMPLETED|Extension Phase (Day 86 to 169)||0
8428129|NCT00866359|20770690|P1|COMPLETED|Extension Phase (Day 86 to 169)||0
8428130|NCT00866359|20770687|P4|STARTED|Extension Phase (Day 86 to 169)||50
8428131|NCT00866359|20770688|P3|STARTED|Extension Phase (Day 86 to 169)||45
8428132|NCT00866359|20770689|P2|STARTED|Extension Phase (Day 86 to 169)||0
8428133|NCT00866359|20770690|P1|STARTED|Extension Phase (Day 86 to 169)||0
8428134|NCT00866359|20770687|P4|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
8428135|NCT00866359|20770688|P3|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
8428136|NCT00866359|20770689|P2|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
8428137|NCT00866359|20770690|P1|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
8428138|NCT00866359|20770687|P4|COMPLETED|Treatment Phase (Days 1 to 85)||0
8428139|NCT00866359|20770688|P3|COMPLETED|Treatment Phase (Days 1 to 85)||0
8428140|NCT00866359|20770689|P2|COMPLETED|Treatment Phase (Days 1 to 85)||50
8428141|NCT00866359|20770690|P1|COMPLETED|Treatment Phase (Days 1 to 85)||45
8428142|NCT00866359|20770687|P4|STARTED|Treatment Phase (Days 1 to 85)||0
8428143|NCT00866359|20770688|P3|STARTED|Treatment Phase (Days 1 to 85)||0
8428144|NCT00866359|20770689|P2|STARTED|Treatment Phase (Days 1 to 85)||55
8428145|NCT00866359|20770690|P1|STARTED|Treatment Phase (Days 1 to 85)||56
8428146|NCT00866333|20770746|P3|NOT COMPLETED|Overall Study||12
8428147|NCT00866333|20770747|P2|NOT COMPLETED|Overall Study||7
8428148|NCT00866333|20770748|P1|NOT COMPLETED|Overall Study||5
8428149|NCT00866333|20770746|P3|COMPLETED|Overall Study||4
8428150|NCT00866333|20770747|P2|COMPLETED|Overall Study||10
8428151|NCT00866333|20770748|P1|COMPLETED|Overall Study||11
8428152|NCT00866333|20770746|P3|STARTED|Overall Study||16
8428153|NCT00866333|20770747|P2|STARTED|Overall Study||17
8428154|NCT00866333|20770748|P1|STARTED|Overall Study||16
8428155|NCT00866320|20770765|P1|NOT COMPLETED|Overall Study||6
8428156|NCT00866320|20770765|P1|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
8428157|NCT00866320|20770765|P1|STARTED|Overall Study||49
8428176|NCT00866294|20770784|P3|NOT COMPLETED|Overall Study||11
8428177|NCT00866294|20770785|P2|NOT COMPLETED|Overall Study||20
8428178|NCT00866294|20770786|P1|NOT COMPLETED|Overall Study||33
8428179|NCT00866294|20770784|P3|COMPLETED|Overall Study||72
8428180|NCT00866294|20770785|P2|COMPLETED|Overall Study||141
8428181|NCT00866294|20770786|P1|COMPLETED|Overall Study||139
8428182|NCT00866294|20770784|P3|STARTED|Overall Study||83
8428183|NCT00866294|20770785|P2|STARTED|Overall Study||161
8428184|NCT00866294|20770786|P1|STARTED|Overall Study||172
8428185|NCT00866281|20770815|P2|NOT COMPLETED|Overall Study||15
8428186|NCT00866281|20770816|P1|NOT COMPLETED|Overall Study||7
8428187|NCT00866281|20770815|P2|COMPLETED|Overall Study||0
8428188|NCT00866281|20770816|P1|COMPLETED|Overall Study||0
8428189|NCT00866281|20770815|P2|STARTED|Overall Study||15
8428190|NCT00866281|20770816|P1|STARTED|Overall Study||7
8428191|NCT00866177|20770832|P1|NOT COMPLETED|Overall Study||152
8428192|NCT00866177|20770832|P1|COMPLETED|Overall Study||15
8428193|NCT00866177|20770832|P1|STARTED|Overall Study||167
8428194|NCT00866047|20770836|P1|NOT COMPLETED|Follow-up Period||5
8428195|NCT00866047|20770836|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
8428196|NCT00866047|20770836|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|58
8428197|NCT00866047|20770836|P1|NOT COMPLETED|Treatment Period||48
8428198|NCT00866047|20770836|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
8428199|NCT00866047|20770836|P1|STARTED|Treatment Period||58
8428200|NCT00866034|20770854|P2|NOT COMPLETED|Overall Study||8
8428201|NCT00866034|20770855|P1|NOT COMPLETED|Overall Study||16
8428202|NCT00866034|20770854|P2|COMPLETED|Overall Study||301
8428203|NCT00866034|20770855|P1|COMPLETED|Overall Study||292
8428204|NCT00866034|20770854|P2|STARTED|Overall Study||309
8428205|NCT00866034|20770855|P1|STARTED|Overall Study||308
8428206|NCT00865904|20770868|P5|NOT COMPLETED|Overall Study||1
8428207|NCT00865904|20770869|P4|NOT COMPLETED|Overall Study||1
8428208|NCT00865904|20770870|P3|NOT COMPLETED|Overall Study||0
8428209|NCT00865904|20770871|P2|NOT COMPLETED|Overall Study||0
8428210|NCT00865904|20770872|P1|NOT COMPLETED|Overall Study||2
8428211|NCT00865904|20770868|P5|COMPLETED|Overall Study|Completed 14-day follow-up.|19
8428212|NCT00865904|20770869|P4|COMPLETED|Overall Study|Completed 14-day follow-up.|17
8428213|NCT00865904|20770870|P3|COMPLETED|Overall Study|Completed 14-day follow-up.|18
8428214|NCT00865904|20770871|P2|COMPLETED|Overall Study|Completed 14-day follow-up.|18
8428215|NCT00865904|20770872|P1|COMPLETED|Overall Study|Completed 14-day follow-up.|17
8428216|NCT00865904|20770868|P5|STARTED|Overall Study|Randomized.|20
8428217|NCT00865904|20770869|P4|STARTED|Overall Study|Randomized.|18
8428218|NCT00865904|20770870|P3|STARTED|Overall Study|Randomized.|18
8428219|NCT00865904|20770871|P2|STARTED|Overall Study|Randomized.|18
8428220|NCT00865904|20770872|P1|STARTED|Overall Study|Randomized.|19
8428221|NCT00865709|20770929|P2|NOT COMPLETED|Long Term Follow-up||49
8428222|NCT00865709|20770930|P1|NOT COMPLETED|Long Term Follow-up||46
8428223|NCT00865709|20770929|P2|COMPLETED|Long Term Follow-up||33
8428224|NCT00865709|20770930|P1|COMPLETED|Long Term Follow-up||24
8428225|NCT00865709|20770929|P2|STARTED|Long Term Follow-up||82
8428226|NCT00865709|20770930|P1|STARTED|Long Term Follow-up||70
8428227|NCT00865709|20770929|P2|NOT COMPLETED|Active Follow-up||1
8428228|NCT00865709|20770930|P1|NOT COMPLETED|Active Follow-up||8
8428229|NCT00865709|20770929|P2|COMPLETED|Active Follow-up||15
8428230|NCT00865709|20770930|P1|COMPLETED|Active Follow-up||17
8428231|NCT00865709|20770929|P2|STARTED|Active Follow-up||16
8428232|NCT00865709|20770930|P1|STARTED|Active Follow-up||25
8428233|NCT00865709|20770929|P2|NOT COMPLETED|Treatment||18
8428234|NCT00865709|20770930|P1|NOT COMPLETED|Treatment||30
8428235|NCT00865709|20770929|P2|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
8428236|NCT00865709|20770930|P1|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
8428237|NCT00865709|20770929|P2|Received Treatment|Treatment|Safety population|101
8428238|NCT00865709|20770930|P1|Received Treatment|Treatment|Safety population|97
8428239|NCT00865709|20770929|P2|STARTED|Treatment||101
8428240|NCT00865709|20770930|P1|STARTED|Treatment||97
8428241|NCT00865566|20770948|P2|NOT COMPLETED|Overall Study||687
8428242|NCT00865566|20770949|P1|NOT COMPLETED|Overall Study||624
8428243|NCT00865566|20770948|P2|COMPLETED|Overall Study||564
8428244|NCT00865566|20770949|P1|COMPLETED|Overall Study||629
8428245|NCT00865566|20770948|P2|Modified Intent-to-Treat Population|Overall Study||1245
8428246|NCT00865566|20770949|P1|Modified Intent-to-Treat Population|Overall Study||1251
8428247|NCT00865566|20770948|P2|STARTED|Overall Study||1251
8428248|NCT00865566|20770949|P1|STARTED|Overall Study||1253
8428249|NCT00865514|20770969|P1|NOT COMPLETED|Overall Study||2
8428250|NCT00865514|20770969|P1|COMPLETED|Overall Study||0
8428251|NCT00865514|20770969|P1|STARTED|Overall Study||2
8428252|NCT00865345|20770974|P1|NOT COMPLETED|Overall Study||2
8428253|NCT00865345|20770974|P1|COMPLETED|Overall Study||61
8428254|NCT00865345|20770974|P1|STARTED|Overall Study||63
8428255|NCT00865306|20770981|P2|NOT COMPLETED|One-Year Follow-Up||0
8428256|NCT00865306|20770982|P1|NOT COMPLETED|One-Year Follow-Up||0
8428257|NCT00865306|20770981|P2|COMPLETED|One-Year Follow-Up||15
8428258|NCT00865306|20770982|P1|COMPLETED|One-Year Follow-Up||29
8428259|NCT00865306|20770981|P2|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
8428260|NCT00865306|20770982|P1|STARTED|One-Year Follow-Up||29
8428261|NCT00865306|20770981|P2|NOT COMPLETED|Controlled Trial||2
8428262|NCT00865306|20770982|P1|NOT COMPLETED|Controlled Trial||5
8428263|NCT00865306|20770981|P2|COMPLETED|Controlled Trial||28
8428264|NCT00865306|20770982|P1|COMPLETED|Controlled Trial||29
8428265|NCT00865306|20770981|P2|STARTED|Controlled Trial||30
8428266|NCT00865306|20770982|P1|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
8428267|NCT00865202|20770994|P2|NOT COMPLETED|Overall Study||0
8428268|NCT00865202|20770995|P1|NOT COMPLETED|Overall Study||0
8428269|NCT00865202|20770994|P2|COMPLETED|Overall Study||149
8428270|NCT00865202|20770995|P1|COMPLETED|Overall Study||152
8428271|NCT00865202|20770994|P2|STARTED|Overall Study||149
8428272|NCT00865202|20770995|P1|STARTED|Overall Study||152
8428273|NCT00865189|20771011|P2|NOT COMPLETED|Overall Study||19
8428274|NCT00865189|20771012|P1|NOT COMPLETED|Overall Study||12
8428275|NCT00865189|20771011|P2|COMPLETED|Overall Study||26
8428276|NCT00865189|20771012|P1|COMPLETED|Overall Study||34
8428277|NCT00865189|20771011|P2|STARTED|Overall Study||45
8428278|NCT00865189|20771012|P1|STARTED|Overall Study||46
8428279|NCT00865124|20771040|P3|NOT COMPLETED|Overall Study||0
8428280|NCT00865124|20771041|P2|NOT COMPLETED|Overall Study||1
8428281|NCT00865124|20771042|P1|NOT COMPLETED|Overall Study||4
8428282|NCT00865124|20771040|P3|COMPLETED|Overall Study||17
8428283|NCT00865124|20771041|P2|COMPLETED|Overall Study||24
8428284|NCT00865124|20771042|P1|COMPLETED|Overall Study||23
8428285|NCT00865124|20771040|P3|STARTED|Overall Study||17
8428286|NCT00865124|20771041|P2|STARTED|Overall Study||25
8428287|NCT00865124|20771042|P1|STARTED|Overall Study||27
8428288|NCT00865098|20771059|P1|NOT COMPLETED|Overall Study||1
8428289|NCT00865098|20771059|P1|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
8428290|NCT00865098|20771059|P1|STARTED|Overall Study||22
8428291|NCT00865046|20771071|P3|NOT COMPLETED|Overall Study||1
8428292|NCT00865046|20771072|P2|NOT COMPLETED|Overall Study||5
8428293|NCT00865046|20771073|P1|NOT COMPLETED|Overall Study||6
8428294|NCT00865046|20771071|P3|COMPLETED|Overall Study||62
8428295|NCT00865046|20771072|P2|COMPLETED|Overall Study||59
8428296|NCT00865046|20771073|P1|COMPLETED|Overall Study||57
8428297|NCT00865046|20771071|P3|STARTED|Overall Study||63
8428298|NCT00865046|20771072|P2|STARTED|Overall Study||64
8428299|NCT00865046|20771073|P1|STARTED|Overall Study||63
8428300|NCT00865020|20771083|P2|NOT COMPLETED|Overall Study||51
8428301|NCT00865020|20771084|P1|NOT COMPLETED|Overall Study||49
8428302|NCT00865020|20771083|P2|COMPLETED|Overall Study||357
8428303|NCT00865020|20771084|P1|COMPLETED|Overall Study||365
8428304|NCT00865020|20771083|P2|STARTED|Overall Study||408
8428305|NCT00865020|20771084|P1|STARTED|Overall Study||414
8428306|NCT00864916|20771100|P2|NOT COMPLETED|Overall Study||4
8428307|NCT00864916|20771101|P1|NOT COMPLETED|Overall Study||6
8428308|NCT00864916|20771100|P2|COMPLETED|Overall Study||5
8428309|NCT00864916|20771101|P1|COMPLETED|Overall Study||4
8428310|NCT00864916|20771100|P2|STARTED|Overall Study||9
8428311|NCT00864916|20771101|P1|STARTED|Overall Study||10
8428321|NCT00864721|20771146|P1|NOT COMPLETED|Overall Study||34
8428322|NCT00864721|20771146|P1|COMPLETED|Overall Study||29
8428323|NCT00864721|20771146|P1|STARTED|Overall Study||63
8428324|NCT00864708|20771154|P1|NOT COMPLETED|Overall Study||0
8428325|NCT00864708|20771154|P1|COMPLETED|Overall Study||1
8428326|NCT00864708|20771154|P1|STARTED|Overall Study||1
8428327|NCT00864682|20771166|P3|NOT COMPLETED|Overall Study||2
8428328|NCT00864682|20771167|P2|NOT COMPLETED|Overall Study||1
8428329|NCT00864682|20771168|P1|NOT COMPLETED|Overall Study||2
8428330|NCT00864682|20771166|P3|COMPLETED|Overall Study||51
8428331|NCT00864682|20771167|P2|COMPLETED|Overall Study||50
8428332|NCT00864682|20771168|P1|COMPLETED|Overall Study||50
8428333|NCT00864682|20771166|P3|STARTED|Overall Study||53
8428334|NCT00864682|20771167|P2|STARTED|Overall Study||51
8428335|NCT00864682|20771168|P1|STARTED|Overall Study||52
8428336|NCT00864539|20771188|P6|NOT COMPLETED|Overall Study||14
8428337|NCT00864539|20771189|P5|NOT COMPLETED|Overall Study||22
8428338|NCT00864539|20771190|P4|NOT COMPLETED|Overall Study||7
8428339|NCT00864539|20771191|P3|NOT COMPLETED|Overall Study||10
8428340|NCT00864539|20771192|P2|NOT COMPLETED|Overall Study||23
8428341|NCT00864539|20771193|P1|NOT COMPLETED|Overall Study||9
8428342|NCT00864539|20771188|P6|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
8428343|NCT00864539|20771189|P5|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
8428344|NCT00864539|20771190|P4|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
8428345|NCT00864539|20771191|P3|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
8428346|NCT00864539|20771192|P2|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
8428347|NCT00864539|20771193|P1|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
8428348|NCT00864539|20771188|P6|STARTED|Overall Study||85
8428349|NCT00864539|20771189|P5|STARTED|Overall Study||103
8428350|NCT00864539|20771190|P4|STARTED|Overall Study||96
8428351|NCT00864539|20771191|P3|STARTED|Overall Study||102
8428352|NCT00864539|20771192|P2|STARTED|Overall Study||95
8428353|NCT00864539|20771193|P1|STARTED|Overall Study||104
8428354|NCT00864513|20771207|P1|NOT COMPLETED|Overall Study||3
8428355|NCT00864513|20771207|P1|COMPLETED|Overall Study||12
8428356|NCT00864513|20771207|P1|STARTED|Overall Study||15
8428357|NCT00864474|20771214|P1|NOT COMPLETED|Overall Study||0
8428358|NCT00864474|20771214|P1|COMPLETED|Overall Study||68
8428359|NCT00864474|20771214|P1|STARTED|Overall Study||68
8428360|NCT00864383|20771255|P3|NOT COMPLETED|Modified Intent to Treat||85
8428361|NCT00864383|20771256|P2|NOT COMPLETED|Modified Intent to Treat||87
8428362|NCT00864383|20771257|P1|NOT COMPLETED|Modified Intent to Treat||85
8428363|NCT00864383|20771255|P3|COMPLETED|Modified Intent to Treat||551
8428364|NCT00864383|20771256|P2|COMPLETED|Modified Intent to Treat||568
8428365|NCT00864383|20771257|P1|COMPLETED|Modified Intent to Treat||555
8428366|NCT00864383|20771255|P3|STARTED|Modified Intent to Treat||636
8428367|NCT00864383|20771256|P2|STARTED|Modified Intent to Treat||655
8428368|NCT00864383|20771257|P1|STARTED|Modified Intent to Treat||640
8428369|NCT00864383|20771255|P3|NOT COMPLETED|Per- Protocol||112
8428370|NCT00864383|20771256|P2|NOT COMPLETED|Per- Protocol||141
8428371|NCT00864383|20771257|P1|NOT COMPLETED|Per- Protocol||130
8428372|NCT00864383|20771255|P3|COMPLETED|Per- Protocol||524
8428373|NCT00864383|20771256|P2|COMPLETED|Per- Protocol||514
8428374|NCT00864383|20771257|P1|COMPLETED|Per- Protocol||510
8428375|NCT00864383|20771255|P3|STARTED|Per- Protocol||636
8428376|NCT00864383|20771256|P2|STARTED|Per- Protocol||655
8428377|NCT00864383|20771257|P1|STARTED|Per- Protocol||640
8428378|NCT00864253|20771291|P2|NOT COMPLETED|Overall Study||58
8428379|NCT00864253|20771292|P1|NOT COMPLETED|Overall Study||99
8428380|NCT00864253|20771291|P2|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
8428381|NCT00864253|20771292|P1|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
8428382|NCT00864253|20771291|P2|Treated|Overall Study||258
8428383|NCT00864253|20771292|P1|Treated|Overall Study||257
8428384|NCT00864253|20771291|P2|STARTED|Overall Study||265
8428385|NCT00864253|20771292|P1|STARTED|Overall Study||264
8428386|NCT00864227|20771322|P1|NOT COMPLETED|Overall Study||4
8428387|NCT00864227|20771322|P1|COMPLETED|Overall Study||50
8428388|NCT00864227|20771322|P1|STARTED|Overall Study||54
8428389|NCT00864123|20771339|P2|NOT COMPLETED|Overall Study||0
8428390|NCT00864123|20771340|P1|NOT COMPLETED|Overall Study||0
8428391|NCT00864123|20771339|P2|COMPLETED|Overall Study||15
8428392|NCT00864123|20771340|P1|COMPLETED|Overall Study||15
8428393|NCT00864123|20771339|P2|STARTED|Overall Study||15
8428394|NCT00864123|20771340|P1|STARTED|Overall Study||15
8428395|NCT00864084|20771350|P1|NOT COMPLETED|Overall Study||3
8428396|NCT00864084|20771350|P1|COMPLETED|Overall Study||11
8428397|NCT00864084|20771350|P1|STARTED|Overall Study||14
8428398|NCT00864032|20771373|P3|NOT COMPLETED|Overall Study||0
8428399|NCT00864032|20771374|P2|NOT COMPLETED|Overall Study||0
8428400|NCT00864032|20771375|P1|NOT COMPLETED|Overall Study||0
8428401|NCT00864032|20771373|P3|COMPLETED|Overall Study||0
8428402|NCT00864032|20771374|P2|COMPLETED|Overall Study||5
8428403|NCT00864032|20771375|P1|COMPLETED|Overall Study||3
8428404|NCT00864032|20771373|P3|STARTED|Overall Study||0
8428405|NCT00864032|20771374|P2|STARTED|Overall Study||5
8428406|NCT00864032|20771375|P1|STARTED|Overall Study||3
8428407|NCT00863928|20771383|P2|NOT COMPLETED|Overall Study||0
8428408|NCT00863928|20771384|P1|NOT COMPLETED|Overall Study||36
8428409|NCT00863928|20771383|P2|COMPLETED|Overall Study||41
8428410|NCT00863928|20771384|P1|COMPLETED|Overall Study||58
8428411|NCT00863928|20771383|P2|STARTED|Overall Study||41
8428412|NCT00863928|20771384|P1|STARTED|Overall Study||94
8428413|NCT00863798|20771393|P3|NOT COMPLETED|Overall Study||25
8428414|NCT00863798|20771394|P2|NOT COMPLETED|Overall Study||30
8428415|NCT00863798|20771395|P1|NOT COMPLETED|Overall Study||32
8428416|NCT00863798|20771393|P3|COMPLETED|Overall Study||202
8428417|NCT00863798|20771394|P2|COMPLETED|Overall Study||198
8428418|NCT00863798|20771395|P1|COMPLETED|Overall Study||195
8428419|NCT00863798|20771393|P3|Treated|Overall Study||224
8428420|NCT00863798|20771394|P2|Treated|Overall Study||226
8428421|NCT00863798|20771395|P1|Treated|Overall Study||223
8428422|NCT00863798|20771393|P3|STARTED|Overall Study||227
8428423|NCT00863798|20771394|P2|STARTED|Overall Study||228
8428424|NCT00863798|20771395|P1|STARTED|Overall Study||227
8428425|NCT00863746|20771447|P2|NOT COMPLETED|Survival Follow up||280
8428426|NCT00863746|20771448|P1|NOT COMPLETED|Survival Follow up||253
8428427|NCT00863746|20771447|P2|COMPLETED|Survival Follow up||51
8428428|NCT00863746|20771448|P1|COMPLETED|Survival Follow up||45
8428429|NCT00863746|20771447|P2|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
8428430|NCT00863746|20771448|P1|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
8428431|NCT00863746|20771447|P2|NOT COMPLETED|Treatment||35
8428432|NCT00863746|20771448|P1|NOT COMPLETED|Treatment||71
8428433|NCT00863746|20771447|P2|COMPLETED|Treatment||318
8428434|NCT00863746|20771448|P1|COMPLETED|Treatment||279
8428435|NCT00863746|20771447|P2|Participants Received Treatment|Treatment|Safety population|351
8428436|NCT00863746|20771448|P1|Participants Received Treatment|Treatment|Safety population|346
8428437|NCT00863746|20771447|P2|STARTED|Treatment||353
8428438|NCT00863746|20771448|P1|STARTED|Treatment||350
8428439|NCT00863707|20771474|P2|NOT COMPLETED|Overall Study||3
8428440|NCT00863707|20771475|P1|NOT COMPLETED|Overall Study||4
8428441|NCT00863707|20771474|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
8428442|NCT00863707|20771475|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
8428443|NCT00863707|20771474|P2|STARTED|Overall Study||337
8428444|NCT00863707|20771475|P1|STARTED|Overall Study||174
8428445|NCT00863681|20771484|P3|NOT COMPLETED|Overall Study||18
8428446|NCT00863681|20771485|P2|NOT COMPLETED|Overall Study||43
8428447|NCT00863681|20771486|P1|NOT COMPLETED|Overall Study||91
8428448|NCT00863681|20771484|P3|COMPLETED|Overall Study|Completed treatment|38
8428449|NCT00863681|20771485|P2|COMPLETED|Overall Study|Completed treatment|66
8428450|NCT00863681|20771486|P1|COMPLETED|Overall Study|Completed treatment|140
8428451|NCT00863681|20771484|P3|STARTED|Overall Study||56
8428452|NCT00863681|20771485|P2|STARTED|Overall Study||109
8428453|NCT00863681|20771486|P1|STARTED|Overall Study||231
8428454|NCT00863655|20771571|P2|NOT COMPLETED|Overall Study||239
8428455|NCT00863655|20771572|P1|NOT COMPLETED|Overall Study||485
8428456|NCT00863655|20771571|P2|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
8428457|NCT00863655|20771572|P1|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
8428458|NCT00863655|20771571|P2|STARTED|Overall Study||239
8428459|NCT00863655|20771572|P1|STARTED|Overall Study||485
8428460|NCT00863551|20771599|P1|NOT COMPLETED|Overall Study||0
8428461|NCT00863551|20771599|P1|COMPLETED|Overall Study||12
8428462|NCT00863551|20771599|P1|STARTED|Overall Study||12
8428463|NCT00863512|20771609|P2|NOT COMPLETED|Overall Study||0
8428464|NCT00863512|20771610|P1|NOT COMPLETED|Overall Study||14
8428465|NCT00863512|20771609|P2|COMPLETED|Overall Study||17
8428466|NCT00863512|20771610|P1|COMPLETED|Overall Study||3
8428467|NCT00863512|20771609|P2|STARTED|Overall Study||17
8428468|NCT00863512|20771610|P1|STARTED|Overall Study||17
8428469|NCT00863434|20771616|P1|NOT COMPLETED|Overall Study||0
8428470|NCT00863434|20771616|P1|COMPLETED|Overall Study||2
8428471|NCT00863434|20771616|P1|STARTED|Overall Study||2
8428472|NCT00863356|20771622|P1|NOT COMPLETED|Overall Study||0
8428473|NCT00863356|20771622|P1|COMPLETED|Overall Study||20
8428474|NCT00863356|20771622|P1|STARTED|Overall Study||20
8428475|NCT00863343|20771628|P2|NOT COMPLETED|Overall Study||0
8428476|NCT00863343|20771629|P1|NOT COMPLETED|Overall Study||0
8428477|NCT00863343|20771628|P2|COMPLETED|Overall Study||374
8428478|NCT00863343|20771629|P1|COMPLETED|Overall Study||17
8428479|NCT00863343|20771628|P2|STARTED|Overall Study||374
8428480|NCT00863343|20771629|P1|STARTED|Overall Study||17
8428481|NCT00863330|20771641|P1|NOT COMPLETED|Overall Study||6
8428482|NCT00863330|20771641|P1|COMPLETED|Overall Study||0
8428483|NCT00863330|20771641|P1|STARTED|Overall Study||6
8428484|NCT00863317|20771647|P2|NOT COMPLETED|Overall Study||9
8428485|NCT00863317|20771648|P1|NOT COMPLETED|Overall Study||8
8428486|NCT00863317|20771647|P2|COMPLETED|Overall Study||64
8428487|NCT00863317|20771648|P1|COMPLETED|Overall Study||60
8428488|NCT00863317|20771647|P2|STARTED|Overall Study||73
8428489|NCT00863317|20771648|P1|STARTED|Overall Study||68
8428490|NCT00863265|20771654|P6|NOT COMPLETED|Overall Study||0
8428491|NCT00863265|20771655|P5|NOT COMPLETED|Overall Study||1
8428492|NCT00863265|20771656|P4|NOT COMPLETED|Overall Study||0
8428493|NCT00863265|20771657|P3|NOT COMPLETED|Overall Study||0
8428494|NCT00863265|20771658|P2|NOT COMPLETED|Overall Study||0
8428495|NCT00863265|20771659|P1|NOT COMPLETED|Overall Study||0
8428496|NCT00863265|20771654|P6|COMPLETED|Overall Study||3
8428497|NCT00863265|20771655|P5|COMPLETED|Overall Study||3
8428498|NCT00863265|20771656|P4|COMPLETED|Overall Study||4
8428499|NCT00863265|20771657|P3|COMPLETED|Overall Study||4
8428500|NCT00863265|20771658|P2|COMPLETED|Overall Study||3
8428501|NCT00863265|20771659|P1|COMPLETED|Overall Study||4
8428502|NCT00863265|20771654|P6|STARTED|Overall Study||3
8428503|NCT00863265|20771655|P5|STARTED|Overall Study||4
8428504|NCT00863265|20771656|P4|STARTED|Overall Study||4
8428505|NCT00863265|20771657|P3|STARTED|Overall Study||4
8428506|NCT00863265|20771658|P2|STARTED|Overall Study||3
8428507|NCT00863265|20771659|P1|STARTED|Overall Study||4
8428508|NCT00863122|20771675|P2|NOT COMPLETED|Overall Study||0
8428509|NCT00863122|20771676|P1|NOT COMPLETED|Overall Study||0
8428510|NCT00863122|20771675|P2|COMPLETED|Overall Study||7
8428511|NCT00863122|20771676|P1|COMPLETED|Overall Study||19
8428512|NCT00863122|20771675|P2|STARTED|Overall Study||7
8428513|NCT00863122|20771676|P1|STARTED|Overall Study||19
8428514|NCT00863109|20771688|P1|NOT COMPLETED|Follow-up Period||11
8428515|NCT00863109|20771688|P1|COMPLETED|Follow-up Period||48
8428516|NCT00863109|20771688|P1|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
8428517|NCT00863109|20771688|P1|NOT COMPLETED|Treatment Period||77
8428518|NCT00863109|20771688|P1|COMPLETED|Treatment Period||53
8428519|NCT00863109|20771688|P1|STARTED|Treatment Period||130
8428520|NCT00863057|20771705|P4|NOT COMPLETED|Period 4 (Weeks 16-20)||0
8428521|NCT00863057|20771706|P3|NOT COMPLETED|Period 4 (Weeks 16-20)||0
8428522|NCT00863057|20771707|P2|NOT COMPLETED|Period 4 (Weeks 16-20)||0
8428523|NCT00863057|20771708|P1|NOT COMPLETED|Period 4 (Weeks 16-20)||0
8428524|NCT00863057|20771705|P4|COMPLETED|Period 4 (Weeks 16-20)||2
8428525|NCT00863057|20771706|P3|COMPLETED|Period 4 (Weeks 16-20)||2
8428526|NCT00863057|20771707|P2|COMPLETED|Period 4 (Weeks 16-20)||1
8428527|NCT00863057|20771708|P1|COMPLETED|Period 4 (Weeks 16-20)||3
8428528|NCT00863057|20771705|P4|STARTED|Period 4 (Weeks 16-20)||2
8428529|NCT00863057|20771706|P3|STARTED|Period 4 (Weeks 16-20)||2
8428530|NCT00863057|20771707|P2|STARTED|Period 4 (Weeks 16-20)||1
8428531|NCT00863057|20771708|P1|STARTED|Period 4 (Weeks 16-20)||3
8428532|NCT00863057|20771705|P4|NOT COMPLETED|Period 3 (Weeks 11-15)||0
8428533|NCT00863057|20771706|P3|NOT COMPLETED|Period 3 (Weeks 11-15)||0
8428534|NCT00863057|20771707|P2|NOT COMPLETED|Period 3 (Weeks 11-15)||0
8428535|NCT00863057|20771708|P1|NOT COMPLETED|Period 3 (Weeks 11-15)||0
8428536|NCT00863057|20771705|P4|COMPLETED|Period 3 (Weeks 11-15)||2
8428537|NCT00863057|20771706|P3|COMPLETED|Period 3 (Weeks 11-15)||2
8428538|NCT00863057|20771707|P2|COMPLETED|Period 3 (Weeks 11-15)||1
8428539|NCT00863057|20771708|P1|COMPLETED|Period 3 (Weeks 11-15)||3
8428540|NCT00863057|20771705|P4|STARTED|Period 3 (Weeks 11-15)||2
8428541|NCT00863057|20771706|P3|STARTED|Period 3 (Weeks 11-15)||2
8428542|NCT00863057|20771707|P2|STARTED|Period 3 (Weeks 11-15)||1
8428543|NCT00863057|20771708|P1|STARTED|Period 3 (Weeks 11-15)||3
8428544|NCT00863057|20771705|P4|NOT COMPLETED|Period 2 (Weeks 6-10)||1
8428545|NCT00863057|20771706|P3|NOT COMPLETED|Period 2 (Weeks 6-10)||1
8428546|NCT00863057|20771707|P2|NOT COMPLETED|Period 2 (Weeks 6-10)||1
8428547|NCT00863057|20771708|P1|NOT COMPLETED|Period 2 (Weeks 6-10)||0
8428548|NCT00863057|20771705|P4|COMPLETED|Period 2 (Weeks 6-10)||2
8428549|NCT00863057|20771706|P3|COMPLETED|Period 2 (Weeks 6-10)||2
8428550|NCT00863057|20771707|P2|COMPLETED|Period 2 (Weeks 6-10)||1
8428551|NCT00863057|20771708|P1|COMPLETED|Period 2 (Weeks 6-10)||3
8428552|NCT00863057|20771705|P4|STARTED|Period 2 (Weeks 6-10)||3
8428553|NCT00863057|20771706|P3|STARTED|Period 2 (Weeks 6-10)||3
8428554|NCT00863057|20771707|P2|STARTED|Period 2 (Weeks 6-10)||2
8428555|NCT00863057|20771708|P1|STARTED|Period 2 (Weeks 6-10)||3
8428556|NCT00863057|20771705|P4|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
8428557|NCT00863057|20771706|P3|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
8428558|NCT00863057|20771707|P2|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
8428559|NCT00863057|20771708|P1|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
8428560|NCT00863057|20771705|P4|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
8428561|NCT00863057|20771706|P3|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
8428562|NCT00863057|20771707|P2|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
8428563|NCT00863057|20771708|P1|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
8428564|NCT00863057|20771705|P4|STARTED|Milestones Period 1 (Weeks 0-5)||4
8428565|NCT00863057|20771706|P3|STARTED|Milestones Period 1 (Weeks 0-5)||3
8428566|NCT00863057|20771707|P2|STARTED|Milestones Period 1 (Weeks 0-5)||4
8428567|NCT00863057|20771708|P1|STARTED|Milestones Period 1 (Weeks 0-5)||4
8428568|NCT00862979|20771766|P2|NOT COMPLETED|Overall Study||7
8428569|NCT00862979|20771767|P1|NOT COMPLETED|Overall Study||8
8428570|NCT00862979|20771766|P2|COMPLETED|Overall Study||71
8428571|NCT00862979|20771767|P1|COMPLETED|Overall Study||76
8428572|NCT00862979|20771766|P2|Full Analysis Set (FAS)|Overall Study||71
8428573|NCT00862979|20771767|P1|Full Analysis Set (FAS)|Overall Study||74
8428574|NCT00862979|20771766|P2|STARTED|Overall Study||78
8428575|NCT00862979|20771767|P1|STARTED|Overall Study||84
8428576|NCT00862940|20771785|P2|NOT COMPLETED|Overall Study||30
8428577|NCT00862940|20771786|P1|NOT COMPLETED|Overall Study||30
8428578|NCT00862940|20771785|P2|COMPLETED|Overall Study||114
8428579|NCT00862940|20771786|P1|COMPLETED|Overall Study||103
8428580|NCT00862940|20771785|P2|STARTED|Overall Study||144
8428581|NCT00862940|20771786|P1|STARTED|Overall Study||133
8428582|NCT00862849|20771798|P6|NOT COMPLETED|Intervention 6||0
8428583|NCT00862849|20771799|P5|NOT COMPLETED|Intervention 6||0
8428584|NCT00862849|20771800|P4|NOT COMPLETED|Intervention 6||0
8428585|NCT00862849|20771801|P3|NOT COMPLETED|Intervention 6||0
8428586|NCT00862849|20771802|P2|NOT COMPLETED|Intervention 6||0
8428587|NCT00862849|20771803|P1|NOT COMPLETED|Intervention 6||0
8428588|NCT00862849|20771798|P6|COMPLETED|Intervention 6||3
8428589|NCT00862849|20771799|P5|COMPLETED|Intervention 6||4
8428590|NCT00862849|20771800|P4|COMPLETED|Intervention 6||4
8428591|NCT00862849|20771801|P3|COMPLETED|Intervention 6||3
8428592|NCT00862849|20771802|P2|COMPLETED|Intervention 6||3
8428593|NCT00862849|20771803|P1|COMPLETED|Intervention 6||3
8428594|NCT00862849|20771798|P6|STARTED|Intervention 6||3
8428595|NCT00862849|20771799|P5|STARTED|Intervention 6||4
8428596|NCT00862849|20771800|P4|STARTED|Intervention 6||4
8428597|NCT00862849|20771801|P3|STARTED|Intervention 6||3
8428598|NCT00862849|20771802|P2|STARTED|Intervention 6||3
8428599|NCT00862849|20771803|P1|STARTED|Intervention 6||3
8428600|NCT00862849|20771798|P6|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8428601|NCT00862849|20771799|P5|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8428602|NCT00862849|20771800|P4|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8428603|NCT00862849|20771801|P3|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8428604|NCT00862849|20771802|P2|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8428605|NCT00862849|20771803|P1|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
8428606|NCT00862849|20771798|P6|COMPLETED|Washout 5 (3 to 14 Days)||3
8428607|NCT00862849|20771799|P5|COMPLETED|Washout 5 (3 to 14 Days)||4
8428608|NCT00862849|20771800|P4|COMPLETED|Washout 5 (3 to 14 Days)||4
8428609|NCT00862849|20771801|P3|COMPLETED|Washout 5 (3 to 14 Days)||3
8428610|NCT00862849|20771802|P2|COMPLETED|Washout 5 (3 to 14 Days)||3
8428611|NCT00862849|20771803|P1|COMPLETED|Washout 5 (3 to 14 Days)||3
8428612|NCT00862849|20771798|P6|STARTED|Washout 5 (3 to 14 Days)||3
8428613|NCT00862849|20771799|P5|STARTED|Washout 5 (3 to 14 Days)||4
8428614|NCT00862849|20771800|P4|STARTED|Washout 5 (3 to 14 Days)||4
8428615|NCT00862849|20771801|P3|STARTED|Washout 5 (3 to 14 Days)||3
8428616|NCT00862849|20771802|P2|STARTED|Washout 5 (3 to 14 Days)||3
8428617|NCT00862849|20771803|P1|STARTED|Washout 5 (3 to 14 Days)||3
8428618|NCT00862849|20771798|P6|NOT COMPLETED|Intervention 5||0
8428619|NCT00862849|20771799|P5|NOT COMPLETED|Intervention 5||0
8428620|NCT00862849|20771800|P4|NOT COMPLETED|Intervention 5||0
8428621|NCT00862849|20771801|P3|NOT COMPLETED|Intervention 5||0
8428622|NCT00862849|20771802|P2|NOT COMPLETED|Intervention 5||0
8428623|NCT00862849|20771803|P1|NOT COMPLETED|Intervention 5||0
8428624|NCT00862849|20771798|P6|COMPLETED|Intervention 5||3
8428625|NCT00862849|20771799|P5|COMPLETED|Intervention 5||4
8428626|NCT00862849|20771800|P4|COMPLETED|Intervention 5||4
8428627|NCT00862849|20771801|P3|COMPLETED|Intervention 5||3
8428628|NCT00862849|20771802|P2|COMPLETED|Intervention 5||3
8428629|NCT00862849|20771803|P1|COMPLETED|Intervention 5||3
8428630|NCT00862849|20771798|P6|STARTED|Intervention 5||3
8428631|NCT00862849|20771799|P5|STARTED|Intervention 5||4
8428632|NCT00862849|20771800|P4|STARTED|Intervention 5||4
8428633|NCT00862849|20771801|P3|STARTED|Intervention 5||3
8428634|NCT00862849|20771802|P2|STARTED|Intervention 5||3
8428635|NCT00862849|20771803|P1|STARTED|Intervention 5||3
8428636|NCT00862849|20771798|P6|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8428637|NCT00862849|20771799|P5|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8428638|NCT00862849|20771800|P4|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8428639|NCT00862849|20771801|P3|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8428640|NCT00862849|20771802|P2|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8428641|NCT00862849|20771803|P1|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
8428642|NCT00862849|20771798|P6|COMPLETED|Washout 4 (3 to 14 Days)||3
8428643|NCT00862849|20771799|P5|COMPLETED|Washout 4 (3 to 14 Days)||4
8428644|NCT00862849|20771800|P4|COMPLETED|Washout 4 (3 to 14 Days)||4
8428645|NCT00862849|20771801|P3|COMPLETED|Washout 4 (3 to 14 Days)||3
8428646|NCT00862849|20771802|P2|COMPLETED|Washout 4 (3 to 14 Days)||3
8428647|NCT00862849|20771803|P1|COMPLETED|Washout 4 (3 to 14 Days)||3
8428648|NCT00862849|20771798|P6|STARTED|Washout 4 (3 to 14 Days)||3
8428649|NCT00862849|20771799|P5|STARTED|Washout 4 (3 to 14 Days)||4
8428650|NCT00862849|20771800|P4|STARTED|Washout 4 (3 to 14 Days)||4
8428651|NCT00862849|20771801|P3|STARTED|Washout 4 (3 to 14 Days)||3
8428652|NCT00862849|20771802|P2|STARTED|Washout 4 (3 to 14 Days)||3
8428653|NCT00862849|20771803|P1|STARTED|Washout 4 (3 to 14 Days)||3
8428654|NCT00862849|20771798|P6|NOT COMPLETED|Intervention 4||0
8428655|NCT00862849|20771799|P5|NOT COMPLETED|Intervention 4||0
8428656|NCT00862849|20771800|P4|NOT COMPLETED|Intervention 4||0
8428657|NCT00862849|20771801|P3|NOT COMPLETED|Intervention 4||0
8428658|NCT00862849|20771802|P2|NOT COMPLETED|Intervention 4||0
8428659|NCT00862849|20771803|P1|NOT COMPLETED|Intervention 4||0
8428660|NCT00862849|20771798|P6|COMPLETED|Intervention 4||3
8428661|NCT00862849|20771799|P5|COMPLETED|Intervention 4||4
8428662|NCT00862849|20771800|P4|COMPLETED|Intervention 4||4
8428663|NCT00862849|20771801|P3|COMPLETED|Intervention 4||3
8428664|NCT00862849|20771802|P2|COMPLETED|Intervention 4||3
8428665|NCT00862849|20771803|P1|COMPLETED|Intervention 4||3
8428666|NCT00862849|20771798|P6|STARTED|Intervention 4||3
8428667|NCT00862849|20771799|P5|STARTED|Intervention 4||4
8428668|NCT00862849|20771800|P4|STARTED|Intervention 4||4
8428669|NCT00862849|20771801|P3|STARTED|Intervention 4||3
8428670|NCT00862849|20771802|P2|STARTED|Intervention 4||3
8428671|NCT00862849|20771803|P1|STARTED|Intervention 4||3
8428672|NCT00862849|20771798|P6|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8428673|NCT00862849|20771799|P5|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8428674|NCT00862849|20771800|P4|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8428675|NCT00862849|20771801|P3|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8428676|NCT00862849|20771802|P2|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8428677|NCT00862849|20771803|P1|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
8428678|NCT00862849|20771798|P6|COMPLETED|Washout 3 (3 to 14 Days)||3
8428679|NCT00862849|20771799|P5|COMPLETED|Washout 3 (3 to 14 Days)||4
8428680|NCT00862849|20771800|P4|COMPLETED|Washout 3 (3 to 14 Days)||4
8428681|NCT00862849|20771801|P3|COMPLETED|Washout 3 (3 to 14 Days)||3
8428682|NCT00862849|20771802|P2|COMPLETED|Washout 3 (3 to 14 Days)||3
8428683|NCT00862849|20771803|P1|COMPLETED|Washout 3 (3 to 14 Days)||3
8428684|NCT00862849|20771798|P6|STARTED|Washout 3 (3 to 14 Days)||3
8428685|NCT00862849|20771799|P5|STARTED|Washout 3 (3 to 14 Days)||4
8428686|NCT00862849|20771800|P4|STARTED|Washout 3 (3 to 14 Days)||4
8428687|NCT00862849|20771801|P3|STARTED|Washout 3 (3 to 14 Days)||3
8428688|NCT00862849|20771802|P2|STARTED|Washout 3 (3 to 14 Days)||3
8428689|NCT00862849|20771803|P1|STARTED|Washout 3 (3 to 14 Days)||3
8428690|NCT00862849|20771798|P6|NOT COMPLETED|Intervention 3||0
8428691|NCT00862849|20771799|P5|NOT COMPLETED|Intervention 3||0
8428692|NCT00862849|20771800|P4|NOT COMPLETED|Intervention 3||0
8428693|NCT00862849|20771801|P3|NOT COMPLETED|Intervention 3||0
8428694|NCT00862849|20771802|P2|NOT COMPLETED|Intervention 3||0
8428695|NCT00862849|20771803|P1|NOT COMPLETED|Intervention 3||0
8428696|NCT00862849|20771798|P6|COMPLETED|Intervention 3||3
8428697|NCT00862849|20771799|P5|COMPLETED|Intervention 3||4
8428698|NCT00862849|20771800|P4|COMPLETED|Intervention 3||4
8428699|NCT00862849|20771801|P3|COMPLETED|Intervention 3||3
8428700|NCT00862849|20771802|P2|COMPLETED|Intervention 3||3
8428701|NCT00862849|20771803|P1|COMPLETED|Intervention 3||3
8428702|NCT00862849|20771798|P6|STARTED|Intervention 3||3
8428703|NCT00862849|20771799|P5|STARTED|Intervention 3||4
8428704|NCT00862849|20771800|P4|STARTED|Intervention 3||4
8428705|NCT00862849|20771801|P3|STARTED|Intervention 3||3
8428706|NCT00862849|20771802|P2|STARTED|Intervention 3||3
8428707|NCT00862849|20771803|P1|STARTED|Intervention 3||3
8428708|NCT00862849|20771798|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8428709|NCT00862849|20771799|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8428710|NCT00862849|20771800|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8428711|NCT00862849|20771801|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8428712|NCT00862849|20771802|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
8428713|NCT00862849|20771803|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
8428714|NCT00862849|20771798|P6|COMPLETED|Washout 2 (3 to 14 Days)||3
8428715|NCT00862849|20771799|P5|COMPLETED|Washout 2 (3 to 14 Days)||4
8428716|NCT00862849|20771800|P4|COMPLETED|Washout 2 (3 to 14 Days)||4
8428717|NCT00862849|20771801|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
8428718|NCT00862849|20771802|P2|COMPLETED|Washout 2 (3 to 14 Days)||3
8428719|NCT00862849|20771803|P1|COMPLETED|Washout 2 (3 to 14 Days)||3
8428720|NCT00862849|20771798|P6|STARTED|Washout 2 (3 to 14 Days)||3
8428721|NCT00862849|20771799|P5|STARTED|Washout 2 (3 to 14 Days)||4
8428722|NCT00862849|20771800|P4|STARTED|Washout 2 (3 to 14 Days)||4
8428723|NCT00862849|20771801|P3|STARTED|Washout 2 (3 to 14 Days)||3
8428724|NCT00862849|20771802|P2|STARTED|Washout 2 (3 to 14 Days)||4
8428725|NCT00862849|20771803|P1|STARTED|Washout 2 (3 to 14 Days)||3
8428726|NCT00862849|20771798|P6|NOT COMPLETED|Intervention 2||0
8428727|NCT00862849|20771799|P5|NOT COMPLETED|Intervention 2||0
8428728|NCT00862849|20771800|P4|NOT COMPLETED|Intervention 2||0
8428729|NCT00862849|20771801|P3|NOT COMPLETED|Intervention 2||0
8428730|NCT00862849|20771802|P2|NOT COMPLETED|Intervention 2||0
8428731|NCT00862849|20771803|P1|NOT COMPLETED|Intervention 2||0
8428732|NCT00862849|20771798|P6|COMPLETED|Intervention 2||3
8428733|NCT00862849|20771799|P5|COMPLETED|Intervention 2||4
8428734|NCT00862849|20771800|P4|COMPLETED|Intervention 2||4
8428735|NCT00862849|20771801|P3|COMPLETED|Intervention 2||3
8428736|NCT00862849|20771802|P2|COMPLETED|Intervention 2||4
8428737|NCT00862849|20771803|P1|COMPLETED|Intervention 2||3
8428738|NCT00862849|20771798|P6|STARTED|Intervention 2||3
8428739|NCT00862849|20771799|P5|STARTED|Intervention 2||4
8428740|NCT00862849|20771800|P4|STARTED|Intervention 2||4
8428741|NCT00862849|20771801|P3|STARTED|Intervention 2||3
8428742|NCT00862849|20771802|P2|STARTED|Intervention 2||4
8428743|NCT00862849|20771803|P1|STARTED|Intervention 2||3
8428744|NCT00862849|20771798|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8428745|NCT00862849|20771799|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8428746|NCT00862849|20771800|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8428747|NCT00862849|20771801|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8428748|NCT00862849|20771802|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
8428749|NCT00862849|20771803|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
8428750|NCT00862849|20771798|P6|COMPLETED|Washout 1 (3 to 14 Days)||3
8428751|NCT00862849|20771799|P5|COMPLETED|Washout 1 (3 to 14 Days)||4
8428752|NCT00862849|20771800|P4|COMPLETED|Washout 1 (3 to 14 Days)||4
8428753|NCT00862849|20771801|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
8428754|NCT00862849|20771802|P2|COMPLETED|Washout 1 (3 to 14 Days)||4
8428755|NCT00862849|20771803|P1|COMPLETED|Washout 1 (3 to 14 Days)||3
8428756|NCT00862849|20771798|P6|STARTED|Washout 1 (3 to 14 Days)||3
8428757|NCT00862849|20771799|P5|STARTED|Washout 1 (3 to 14 Days)||4
8428758|NCT00862849|20771800|P4|STARTED|Washout 1 (3 to 14 Days)||4
8428759|NCT00862849|20771801|P3|STARTED|Washout 1 (3 to 14 Days)||3
8428760|NCT00862849|20771802|P2|STARTED|Washout 1 (3 to 14 Days)||5
8428761|NCT00862849|20771803|P1|STARTED|Washout 1 (3 to 14 Days)||3
8428762|NCT00862849|20771798|P6|NOT COMPLETED|Intervention 1||0
8428763|NCT00862849|20771799|P5|NOT COMPLETED|Intervention 1||0
8428764|NCT00862849|20771800|P4|NOT COMPLETED|Intervention 1||0
8428765|NCT00862849|20771801|P3|NOT COMPLETED|Intervention 1||0
8428766|NCT00862849|20771802|P2|NOT COMPLETED|Intervention 1||0
8428767|NCT00862849|20771803|P1|NOT COMPLETED|Intervention 1||0
8428768|NCT00862849|20771798|P6|COMPLETED|Intervention 1||3
8428769|NCT00862849|20771799|P5|COMPLETED|Intervention 1||4
8428770|NCT00862849|20771800|P4|COMPLETED|Intervention 1||4
8428771|NCT00862849|20771801|P3|COMPLETED|Intervention 1||3
8428772|NCT00862849|20771802|P2|COMPLETED|Intervention 1||5
8428773|NCT00862849|20771803|P1|COMPLETED|Intervention 1||3
8428774|NCT00862849|20771798|P6|Received at Least One Dose of Study Drug|Intervention 1||3
8428775|NCT00862849|20771799|P5|Received at Least One Dose of Study Drug|Intervention 1||4
8428776|NCT00862849|20771800|P4|Received at Least One Dose of Study Drug|Intervention 1||4
8428777|NCT00862849|20771801|P3|Received at Least One Dose of Study Drug|Intervention 1||3
8428778|NCT00862849|20771802|P2|Received at Least One Dose of Study Drug|Intervention 1||5
8428779|NCT00862849|20771803|P1|Received at Least One Dose of Study Drug|Intervention 1||3
8428780|NCT00862849|20771798|P6|STARTED|Intervention 1||3
8428781|NCT00862849|20771799|P5|STARTED|Intervention 1||4
8428782|NCT00862849|20771800|P4|STARTED|Intervention 1||4
8428783|NCT00862849|20771801|P3|STARTED|Intervention 1||3
8428784|NCT00862849|20771802|P2|STARTED|Intervention 1||5
8428785|NCT00862849|20771803|P1|STARTED|Intervention 1||3
8428786|NCT00862836|20771826|P1|NOT COMPLETED|Overall Study||1
8428787|NCT00862836|20771826|P1|COMPLETED|Overall Study||14
8428788|NCT00862836|20771826|P1|Evaluable for Activity (Tumour Response)|Overall Study||10
8428789|NCT00862836|20771826|P1|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
8428790|NCT00862836|20771826|P1|STARTED|Overall Study||15
8428791|NCT00862823|20771837|P2|NOT COMPLETED|Second Intervention||0
8428792|NCT00862823|20771838|P1|NOT COMPLETED|Second Intervention||0
8428793|NCT00862823|20771837|P2|COMPLETED|Second Intervention||9
8428794|NCT00862823|20771838|P1|COMPLETED|Second Intervention||5
8428795|NCT00862823|20771837|P2|STARTED|Second Intervention||9
8428796|NCT00862823|20771838|P1|STARTED|Second Intervention||5
8428797|NCT00862823|20771837|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8428798|NCT00862823|20771838|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8428799|NCT00862823|20771837|P2|COMPLETED|Washout Period of 2 Weeks||9
8428800|NCT00862823|20771838|P1|COMPLETED|Washout Period of 2 Weeks||5
8428801|NCT00862823|20771837|P2|STARTED|Washout Period of 2 Weeks||9
8428802|NCT00862823|20771838|P1|STARTED|Washout Period of 2 Weeks||5
8428803|NCT00862823|20771837|P2|NOT COMPLETED|First Intervention||1
8428804|NCT00862823|20771838|P1|NOT COMPLETED|First Intervention||1
8428805|NCT00862823|20771837|P2|COMPLETED|First Intervention||9
8428806|NCT00862823|20771838|P1|COMPLETED|First Intervention||5
8428807|NCT00862823|20771837|P2|STARTED|First Intervention||10
8428808|NCT00862823|20771838|P1|STARTED|First Intervention||6
8428809|NCT00862810|20771847|P2|NOT COMPLETED|Overall Study||4
8428810|NCT00862810|20771848|P1|NOT COMPLETED|Overall Study||4
8428811|NCT00862810|20771847|P2|COMPLETED|Overall Study||35
8428812|NCT00862810|20771848|P1|COMPLETED|Overall Study||29
8428813|NCT00862810|20771847|P2|STARTED|Overall Study||39
8428814|NCT00862810|20771848|P1|STARTED|Overall Study||33
8428815|NCT00862784|20771854|P1|NOT COMPLETED|Overall Study||0
8428816|NCT00862784|20771854|P1|COMPLETED|Overall Study||48
8428817|NCT00862784|20771854|P1|Received Any Amount of Study Drug|Overall Study||48
8428818|NCT00862784|20771854|P1|STARTED|Overall Study||48
8428819|NCT00862745|20771876|P2|NOT COMPLETED|Open-label Follow-up||49
8428820|NCT00862745|20771877|P1|NOT COMPLETED|Open-label Follow-up||39
8428821|NCT00862745|20771876|P2|COMPLETED|Open-label Follow-up||225
8428822|NCT00862745|20771877|P1|COMPLETED|Open-label Follow-up||229
8428823|NCT00862745|20771876|P2|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
8428824|NCT00862745|20771877|P1|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
8428825|NCT00862745|20771876|P2|NOT COMPLETED|Randomized Control Trial||39
8428826|NCT00862745|20771877|P1|NOT COMPLETED|Randomized Control Trial||38
8428827|NCT00862745|20771876|P2|COMPLETED|Randomized Control Trial||284
8428828|NCT00862745|20771877|P1|COMPLETED|Randomized Control Trial||284
8428829|NCT00862745|20771876|P2|STARTED|Randomized Control Trial||323
8428830|NCT00862745|20771877|P1|STARTED|Randomized Control Trial||322
8428831|NCT00862719|20771887|P4|NOT COMPLETED|Overall Study||1
8428832|NCT00862719|20771888|P3|NOT COMPLETED|Overall Study||4
8428833|NCT00862719|20771889|P2|NOT COMPLETED|Overall Study||6
8428834|NCT00862719|20771890|P1|NOT COMPLETED|Overall Study||10
8428835|NCT00862719|20771887|P4|COMPLETED|Overall Study||0
8428836|NCT00862719|20771888|P3|COMPLETED|Overall Study||0
8428837|NCT00862719|20771889|P2|COMPLETED|Overall Study||1
8428838|NCT00862719|20771890|P1|COMPLETED|Overall Study||7
8428839|NCT00862719|20771887|P4|STARTED|Overall Study||1
8428840|NCT00862719|20771888|P3|STARTED|Overall Study||4
8428841|NCT00862719|20771889|P2|STARTED|Overall Study||7
8428842|NCT00862719|20771890|P1|STARTED|Overall Study||17
8428855|NCT00862641|20771930|P4|NOT COMPLETED|Overall Study||4
8428856|NCT00862641|20771931|P3|NOT COMPLETED|Overall Study||1
8428857|NCT00862641|20771932|P2|NOT COMPLETED|Overall Study||4
8428858|NCT00862641|20771933|P1|NOT COMPLETED|Overall Study||1
8428859|NCT00862641|20771930|P4|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
8428860|NCT00862641|20771931|P3|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
8428861|NCT00862641|20771932|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
8428862|NCT00862641|20771933|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
8428863|NCT00862641|20771930|P4|STARTED|Overall Study||320
8428864|NCT00862641|20771931|P3|STARTED|Overall Study||152
8428865|NCT00862641|20771932|P2|STARTED|Overall Study||360
8428866|NCT00862641|20771933|P1|STARTED|Overall Study||177
8428867|NCT00862563|20771979|P4|NOT COMPLETED|Overall Study||5
8428868|NCT00862563|20771980|P3|NOT COMPLETED|Overall Study||6
8428869|NCT00862563|20771981|P2|NOT COMPLETED|Overall Study||4
8428870|NCT00862563|20771982|P1|NOT COMPLETED|Overall Study||4
8428871|NCT00862563|20771979|P4|COMPLETED|Overall Study||19
8428872|NCT00862563|20771980|P3|COMPLETED|Overall Study||15
8428873|NCT00862563|20771981|P2|COMPLETED|Overall Study||17
8428874|NCT00862563|20771982|P1|COMPLETED|Overall Study||15
8428875|NCT00862563|20771979|P4|STARTED|Overall Study||24
8428876|NCT00862563|20771980|P3|STARTED|Overall Study||21
8428877|NCT00862563|20771981|P2|STARTED|Overall Study||21
8428878|NCT00862563|20771982|P1|STARTED|Overall Study||19
8428879|NCT00862537|20772020|P1|NOT COMPLETED|Overall Study||7
8428880|NCT00862537|20772020|P1|COMPLETED|Overall Study||11
8428881|NCT00862537|20772020|P1|STARTED|Overall Study||18
8428882|NCT00862459|20772027|P3|NOT COMPLETED|Overall Study||6
8428883|NCT00862459|20772028|P2|NOT COMPLETED|Overall Study||8
8428884|NCT00862459|20772029|P1|NOT COMPLETED|Overall Study||6
8428885|NCT00862459|20772027|P3|COMPLETED|Overall Study||66
8428886|NCT00862459|20772028|P2|COMPLETED|Overall Study||85
8428887|NCT00862459|20772029|P1|COMPLETED|Overall Study||66
8428888|NCT00862459|20772027|P3|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
8428889|NCT00862459|20772028|P2|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
8428890|NCT00862459|20772029|P1|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
8428891|NCT00862459|20772027|P3|STARTED|Overall Study||72
8428892|NCT00862459|20772028|P2|STARTED|Overall Study||93
8428893|NCT00862459|20772029|P1|STARTED|Overall Study||72
8428894|NCT00862446|20772173|P1|NOT COMPLETED|Overall Study||0
8428895|NCT00862446|20772173|P1|COMPLETED|Overall Study||48
8428896|NCT00862446|20772173|P1|STARTED|Overall Study||48
8428897|NCT00862277|20772180|P3|NOT COMPLETED|Overall Study||5
8428898|NCT00862277|20772181|P2|NOT COMPLETED|Overall Study||2
8428899|NCT00862277|20772182|P1|NOT COMPLETED|Overall Study||1
8428900|NCT00862277|20772180|P3|COMPLETED|Overall Study||100
8428901|NCT00862277|20772181|P2|COMPLETED|Overall Study||94
8428902|NCT00862277|20772182|P1|COMPLETED|Overall Study||560
8428903|NCT00862277|20772180|P3|STARTED|Overall Study||105
8428904|NCT00862277|20772181|P2|STARTED|Overall Study||96
8428905|NCT00862277|20772182|P1|STARTED|Overall Study||561
8428906|NCT00862251|20772196|P3|NOT COMPLETED|Overall Study||9
8428907|NCT00862251|20772197|P2|NOT COMPLETED|Overall Study||5
8428908|NCT00862251|20772198|P1|NOT COMPLETED|Overall Study||19
8428909|NCT00862251|20772196|P3|COMPLETED|Overall Study||315
8428910|NCT00862251|20772197|P2|COMPLETED|Overall Study||157
8428911|NCT00862251|20772198|P1|COMPLETED|Overall Study||303
8428912|NCT00862251|20772196|P3|STARTED|Overall Study||324
8428913|NCT00862251|20772197|P2|STARTED|Overall Study||162
8428914|NCT00862251|20772198|P1|STARTED|Overall Study||322
8428915|NCT00862186|20772251|P1|NOT COMPLETED|Overall Study||0
8428916|NCT00862186|20772251|P1|COMPLETED|Overall Study||15
8428917|NCT00862186|20772251|P1|STARTED|Overall Study||15
8428918|NCT00862134|20772258|P2|NOT COMPLETED|Overall Study||12
8428919|NCT00862134|20772259|P1|NOT COMPLETED|Overall Study||11
8428920|NCT00862134|20772258|P2|COMPLETED|Overall Study||11
8428921|NCT00862134|20772259|P1|COMPLETED|Overall Study||8
8428922|NCT00862134|20772258|P2|STARTED|Overall Study||23
8428923|NCT00862134|20772259|P1|STARTED|Overall Study||19
8428924|NCT00862121|20772271|P2|NOT COMPLETED|Overall Study||8
8428925|NCT00862121|20772272|P1|NOT COMPLETED|Overall Study||1
8428926|NCT00862121|20772271|P2|COMPLETED|Overall Study||4
8428927|NCT00862121|20772272|P1|COMPLETED|Overall Study||7
8428928|NCT00862121|20772271|P2|Safety Analysis Set|Overall Study||11
8428929|NCT00862121|20772272|P1|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
8428930|NCT00862121|20772271|P2|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
8428931|NCT00862121|20772272|P1|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
8428932|NCT00862121|20772271|P2|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
8428933|NCT00862121|20772272|P1|STARTED|Overall Study||8
8428934|NCT00862082|20772290|P2|NOT COMPLETED|Overall Study||1
8428935|NCT00862082|20772291|P1|NOT COMPLETED|Overall Study||5
8428936|NCT00862082|20772290|P2|COMPLETED|Overall Study||5
8428937|NCT00862082|20772291|P1|COMPLETED|Overall Study||3
8428938|NCT00862082|20772290|P2|STARTED|Overall Study||6
8428939|NCT00862082|20772291|P1|STARTED|Overall Study||8
8428940|NCT00861913|20772334|P1|NOT COMPLETED|Overall Study||0
8428941|NCT00861913|20772334|P1|COMPLETED|Overall Study||13
8428942|NCT00861913|20772334|P1|STARTED|Overall Study||13
8428943|NCT00861757|20772346|P4|NOT COMPLETED|Overall Study||9
8428944|NCT00861757|20772347|P3|NOT COMPLETED|Overall Study||18
8428945|NCT00861757|20772348|P2|NOT COMPLETED|Overall Study||15
8428946|NCT00861757|20772349|P1|NOT COMPLETED|Overall Study||9
8428947|NCT00861757|20772346|P4|COMPLETED|Overall Study||143
8428948|NCT00861757|20772347|P3|COMPLETED|Overall Study||137
8428949|NCT00861757|20772348|P2|COMPLETED|Overall Study||136
8428950|NCT00861757|20772349|P1|COMPLETED|Overall Study||145
8428951|NCT00861757|20772346|P4|STARTED|Overall Study||152
8428952|NCT00861757|20772347|P3|STARTED|Overall Study||155
8428953|NCT00861757|20772348|P2|STARTED|Overall Study||151
8428954|NCT00861757|20772349|P1|STARTED|Overall Study||154
8428955|NCT00861744|20772407|P4|NOT COMPLETED|Overall Study||33
8428956|NCT00861744|20772408|P3|NOT COMPLETED|Overall Study||24
8428957|NCT00861744|20772409|P2|NOT COMPLETED|Overall Study||29
8428958|NCT00861744|20772410|P1|NOT COMPLETED|Overall Study||17
8428959|NCT00861744|20772407|P4|COMPLETED|Overall Study||275
8428960|NCT00861744|20772408|P3|COMPLETED|Overall Study||280
8428961|NCT00861744|20772409|P2|COMPLETED|Overall Study||275
8428962|NCT00861744|20772410|P1|COMPLETED|Overall Study||287
8428963|NCT00861744|20772407|P4|STARTED|Overall Study||308
8428964|NCT00861744|20772408|P3|STARTED|Overall Study||304
8428965|NCT00861744|20772409|P2|STARTED|Overall Study||304
8428966|NCT00861744|20772410|P1|STARTED|Overall Study||304
8428979|NCT00861692|20772635|P1|NOT COMPLETED|Overall Study||6
8428980|NCT00861692|20772635|P1|COMPLETED|Overall Study||14
8428981|NCT00861692|20772635|P1|STARTED|Overall Study||20
8428982|NCT00861614|20772647|P2|NOT COMPLETED|Overall Study||368
8428983|NCT00861614|20772648|P1|NOT COMPLETED|Overall Study||371
8428984|NCT00861614|20772647|P2|COMPLETED|Overall Study||28
8428985|NCT00861614|20772648|P1|COMPLETED|Overall Study||22
8428986|NCT00861614|20772647|P2|STARTED|Overall Study||396
8428987|NCT00861614|20772648|P1|STARTED|Overall Study||393
8428988|NCT00861601|20772681|P3|NOT COMPLETED|Overall Study||0
8428989|NCT00861601|20772682|P2|NOT COMPLETED|Overall Study||0
8428990|NCT00861601|20772683|P1|NOT COMPLETED|Overall Study||0
8428991|NCT00861601|20772681|P3|COMPLETED|Overall Study||12
8428992|NCT00861601|20772682|P2|COMPLETED|Overall Study||14
8428993|NCT00861601|20772683|P1|COMPLETED|Overall Study||12
8428994|NCT00861601|20772681|P3|STARTED|Overall Study||12
8428995|NCT00861601|20772682|P2|STARTED|Overall Study||14
8428996|NCT00861601|20772683|P1|STARTED|Overall Study||12
8428997|NCT00861471|20772733|P1|NOT COMPLETED|Overall Study||9
8428998|NCT00861471|20772733|P1|COMPLETED|Overall Study||3
8428999|NCT00861471|20772733|P1|STARTED|Overall Study||12
8429000|NCT00861380|20772748|P7|NOT COMPLETED|Overall Study||3020
8429001|NCT00861380|20772749|P6|NOT COMPLETED|Overall Study||6249
8429002|NCT00861380|20772750|P5|NOT COMPLETED|Overall Study||1812
8429003|NCT00861380|20772751|P4|NOT COMPLETED|Overall Study||3689
8429004|NCT00861380|20772752|P3|NOT COMPLETED|Overall Study||8872
8429005|NCT00861380|20772753|P2|NOT COMPLETED|Overall Study||9112
8429006|NCT00861380|20772754|P1|NOT COMPLETED|Overall Study||8427
8429007|NCT00861380|20772748|P7|COMPLETED|Overall Study||0
8429008|NCT00861380|20772749|P6|COMPLETED|Overall Study||0
8429009|NCT00861380|20772750|P5|COMPLETED|Overall Study||0
8429010|NCT00861380|20772751|P4|COMPLETED|Overall Study||0
8429011|NCT00861380|20772752|P3|COMPLETED|Overall Study||0
8429012|NCT00861380|20772753|P2|COMPLETED|Overall Study||0
8429013|NCT00861380|20772754|P1|COMPLETED|Overall Study||0
8429014|NCT00861380|20772748|P7|STARTED|Overall Study||3020
8429015|NCT00861380|20772749|P6|STARTED|Overall Study||6249
8429016|NCT00861380|20772750|P5|STARTED|Overall Study||1812
8429017|NCT00861380|20772751|P4|STARTED|Overall Study||3689
8429018|NCT00861380|20772752|P3|STARTED|Overall Study||8872
8429019|NCT00861380|20772753|P2|STARTED|Overall Study||9112
8429020|NCT00861380|20772754|P1|STARTED|Overall Study||8427
8429021|NCT00861341|20772850|P1|NOT COMPLETED|Overall Study||2
8429022|NCT00861341|20772850|P1|COMPLETED|Overall Study||38
8429023|NCT00861341|20772850|P1|STARTED|Overall Study||40
8429024|NCT00861263|20772855|P1|NOT COMPLETED|Overall Study||0
8429025|NCT00861263|20772855|P1|COMPLETED|Overall Study||193
8429026|NCT00861263|20772855|P1|STARTED|Overall Study||193
8429027|NCT00861198|20772859|P1|NOT COMPLETED|Overall Study||5
8429028|NCT00861198|20772859|P1|COMPLETED|Overall Study||70
8429029|NCT00861198|20772859|P1|STARTED|Overall Study||75
8429030|NCT00861146|20772865|P2|NOT COMPLETED|Overall Study||8
8429031|NCT00861146|20772866|P1|NOT COMPLETED|Overall Study||20
8429032|NCT00861146|20772865|P2|COMPLETED|Overall Study||38
8429033|NCT00861146|20772866|P1|COMPLETED|Overall Study||85
8429034|NCT00861146|20772865|P2|Week 13 Assessment|Overall Study||38
8429035|NCT00861146|20772866|P1|Week 13 Assessment|Overall Study||85
8429036|NCT00861146|20772865|P2|Week 2 Assessment|Overall Study||45
8429037|NCT00861146|20772866|P1|Week 2 Assessment|Overall Study||97
8429038|NCT00861146|20772865|P2|STARTED|Overall Study||46
8429039|NCT00861146|20772866|P1|STARTED|Overall Study||105
8429040|NCT00860951|20772876|P1|NOT COMPLETED|Overall Study||7
8429041|NCT00860951|20772876|P1|COMPLETED|Overall Study||22
8429042|NCT00860951|20772876|P1|STARTED|Overall Study||29
8429043|NCT00860938|20772884|P2|NOT COMPLETED|Overall Study||8
8429044|NCT00860938|20772885|P1|NOT COMPLETED|Overall Study||14
8429045|NCT00860938|20772884|P2|COMPLETED|Overall Study||37
8429046|NCT00860938|20772885|P1|COMPLETED|Overall Study||31
8429047|NCT00860938|20772884|P2|STARTED|Overall Study||45
8429048|NCT00860938|20772885|P1|STARTED|Overall Study||45
8429049|NCT00860847|20772899|P2|NOT COMPLETED|Overall Study||5
8429050|NCT00860847|20772900|P1|NOT COMPLETED|Overall Study||4
8429051|NCT00860847|20772899|P2|COMPLETED|Overall Study||28
8429052|NCT00860847|20772900|P1|COMPLETED|Overall Study||28
8429053|NCT00860847|20772899|P2|STARTED|Overall Study||33
8429054|NCT00860847|20772900|P1|STARTED|Overall Study||32
8429055|NCT00860795|20772908|P2|NOT COMPLETED|Overall Study||0
8429056|NCT00860795|20772909|P1|NOT COMPLETED|Overall Study||0
8429057|NCT00860795|20772908|P2|COMPLETED|Overall Study||10
8429058|NCT00860795|20772909|P1|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
8429059|NCT00860795|20772908|P2|Number to Complete Study Medication|Overall Study||10
8429060|NCT00860795|20772909|P1|Number to Complete Study Medication|Overall Study||9
8429061|NCT00860795|20772908|P2|STARTED|Overall Study||10
8429062|NCT00860795|20772909|P1|STARTED|Overall Study||10
8429063|NCT00860743|20772933|P2|NOT COMPLETED|Overall Study||0
8429064|NCT00860743|20772934|P1|NOT COMPLETED|Overall Study||3
8429065|NCT00860743|20772933|P2|COMPLETED|Overall Study||23
8429066|NCT00860743|20772934|P1|COMPLETED|Overall Study||37
8429067|NCT00860743|20772933|P2|STARTED|Overall Study||23
8429068|NCT00860743|20772934|P1|STARTED|Overall Study||40
8429069|NCT00860535|20772940|P1|NOT COMPLETED|Overall Study||1
8429070|NCT00860535|20772940|P1|COMPLETED|Overall Study||8
8429071|NCT00860535|20772940|P1|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
8429072|NCT00860535|20772940|P1|STARTED|Overall Study||9
8429073|NCT00860470|20772947|P2|NOT COMPLETED|Overall Study||59
8429074|NCT00860470|20772948|P1|NOT COMPLETED|Overall Study||48
8429075|NCT00860470|20772947|P2|COMPLETED|Overall Study||22346
8429076|NCT00860470|20772948|P1|COMPLETED|Overall Study||22114
8429077|NCT00860470|20772947|P2|STARTED|Overall Study||22405
8429078|NCT00860470|20772948|P1|STARTED|Overall Study||22162
8429079|NCT00860457|20772972|P1|NOT COMPLETED|Overall Study||11
8429080|NCT00860457|20772972|P1|COMPLETED|Overall Study||11
8429081|NCT00860457|20772972|P1|STARTED|Overall Study||22
8429082|NCT00860405|20772978|P2|NOT COMPLETED|Overall Study||4
8429083|NCT00860405|20772979|P1|NOT COMPLETED|Overall Study||5
8429084|NCT00860405|20772978|P2|COMPLETED|Overall Study||26
8429085|NCT00860405|20772979|P1|COMPLETED|Overall Study|completed overall study|26
8429086|NCT00860405|20772978|P2|Day 28 Follow-up Performed|Overall Study||29
8429087|NCT00860405|20772979|P1|Day 28 Follow-up Performed|Overall Study||31
8429088|NCT00860405|20772978|P2|Completed Treatment|Overall Study||29
8429089|NCT00860405|20772979|P1|Completed Treatment|Overall Study||31
8429090|NCT00860405|20772978|P2|STARTED|Overall Study||30
8429091|NCT00860405|20772979|P1|STARTED|Overall Study||31
8429092|NCT00860314|20773003|P2|NOT COMPLETED|Overall Study||0
8429093|NCT00860314|20773004|P1|NOT COMPLETED|Overall Study||0
8429094|NCT00860314|20773003|P2|COMPLETED|Overall Study||48
8429095|NCT00860314|20773004|P1|COMPLETED|Overall Study||48
8429096|NCT00860314|20773003|P2|STARTED|Overall Study||48
8429097|NCT00860314|20773004|P1|STARTED|Overall Study||48
8429098|NCT00860262|20773019|P3|NOT COMPLETED|Overall Study||18
8429099|NCT00860262|20773020|P2|NOT COMPLETED|Overall Study||22
8429100|NCT00860262|20773021|P1|NOT COMPLETED|Overall Study||20
8429101|NCT00860262|20773019|P3|COMPLETED|Overall Study||202
8429102|NCT00860262|20773020|P2|COMPLETED|Overall Study||195
8429103|NCT00860262|20773021|P1|COMPLETED|Overall Study||401
8429104|NCT00860262|20773019|P3|STARTED|Overall Study||220
8429105|NCT00860262|20773020|P2|STARTED|Overall Study||217
8429106|NCT00860262|20773021|P1|STARTED|Overall Study||421
8429107|NCT00860249|20773134|P3|NOT COMPLETED|Overall Study||21
8429108|NCT00860249|20773135|P2|NOT COMPLETED|Overall Study||18
8429109|NCT00860249|20773136|P1|NOT COMPLETED|Overall Study||21
8429110|NCT00860249|20773134|P3|COMPLETED|Overall Study||0
8429111|NCT00860249|20773135|P2|COMPLETED|Overall Study||0
8429112|NCT00860249|20773136|P1|COMPLETED|Overall Study||0
8429113|NCT00860249|20773134|P3|STARTED|Overall Study||21
8429114|NCT00860249|20773135|P2|STARTED|Overall Study||18
8429115|NCT00860249|20773136|P1|STARTED|Overall Study||21
8429116|NCT00860171|20773147|P1|NOT COMPLETED|Overall Study||0
8429117|NCT00860171|20773147|P1|COMPLETED|Overall Study||16
8429118|NCT00860171|20773147|P1|STARTED|Overall Study||16
8429119|NCT00860158|20773156|P1|NOT COMPLETED|Overall Study||1
8429120|NCT00860158|20773156|P1|COMPLETED|Overall Study||0
8429121|NCT00860158|20773156|P1|STARTED|Overall Study||1
8429122|NCT00860067|20773168|P3|NOT COMPLETED|Overall Study||9
8429123|NCT00860067|20773169|P2|NOT COMPLETED|Overall Study||9
8429124|NCT00860067|20773170|P1|NOT COMPLETED|Overall Study||51
8429125|NCT00860067|20773168|P3|COMPLETED|Overall Study||292
8429126|NCT00860067|20773169|P2|COMPLETED|Overall Study||290
8429127|NCT00860067|20773170|P1|COMPLETED|Overall Study||1149
8429128|NCT00860067|20773168|P3|STARTED|Overall Study||301
8429129|NCT00860067|20773169|P2|STARTED|Overall Study||299
8429130|NCT00860067|20773170|P1|STARTED|Overall Study||1200
8429143|NCT00860015|20773241|P1|NOT COMPLETED|Overall Study||0
8429144|NCT00860015|20773241|P1|COMPLETED|Overall Study||12
8429145|NCT00860015|20773241|P1|STARTED|Overall Study||12
8429146|NCT00859976|20773247|P2|NOT COMPLETED|Overall Study||18
8429147|NCT00859976|20773248|P1|NOT COMPLETED|Overall Study||16
8429148|NCT00859976|20773247|P2|COMPLETED|Overall Study||67
8429149|NCT00859976|20773248|P1|COMPLETED|Overall Study||66
8429150|NCT00859976|20773247|P2|STARTED|Overall Study||85
8429151|NCT00859976|20773248|P1|STARTED|Overall Study||82
8429152|NCT00859950|20773264|P2|NOT COMPLETED|Overall Study||0
8429153|NCT00859950|20773265|P1|NOT COMPLETED|Overall Study||0
8429154|NCT00859950|20773264|P2|COMPLETED|Overall Study||21
8429155|NCT00859950|20773265|P1|COMPLETED|Overall Study||49
8429156|NCT00859950|20773264|P2|STARTED|Overall Study||21
8429157|NCT00859950|20773265|P1|STARTED|Overall Study||49
8429158|NCT00859937|20773273|P2|NOT COMPLETED|Overall Study||0
8429159|NCT00859937|20773274|P1|NOT COMPLETED|Overall Study||1
8429160|NCT00859937|20773273|P2|COMPLETED|Overall Study||14
8429161|NCT00859937|20773274|P1|COMPLETED|Overall Study||40
8429162|NCT00859937|20773273|P2|STARTED|Overall Study||14
8429163|NCT00859937|20773274|P1|STARTED|Overall Study||41
8429164|NCT00859898|20773289|P3|NOT COMPLETED|Overall Study||27
8429165|NCT00859898|20773290|P2|NOT COMPLETED|Overall Study||31
8429166|NCT00859898|20773291|P1|NOT COMPLETED|Overall Study||28
8429167|NCT00859898|20773289|P3|COMPLETED|Overall Study||181
8429168|NCT00859898|20773290|P2|COMPLETED|Overall Study||188
8429169|NCT00859898|20773291|P1|COMPLETED|Overall Study||183
8429170|NCT00859898|20773289|P3|STARTED|Overall Study||208
8429171|NCT00859898|20773290|P2|STARTED|Overall Study||219
8429172|NCT00859898|20773291|P1|STARTED|Overall Study||211
8429173|NCT00859833|20773332|P1|NOT COMPLETED|Overall Study||0
8429174|NCT00859833|20773332|P1|COMPLETED|Overall Study||30
8429175|NCT00859833|20773332|P1|STARTED|Overall Study||30
8429176|NCT00859651|20773339|P2|NOT COMPLETED|Overall Study||0
8429177|NCT00859651|20773340|P1|NOT COMPLETED|Overall Study||0
8429178|NCT00859651|20773339|P2|COMPLETED|Overall Study||22
8429179|NCT00859651|20773340|P1|COMPLETED|Overall Study||18
8429180|NCT00859651|20773339|P2|STARTED|Overall Study||22
8429181|NCT00859651|20773340|P1|STARTED|Overall Study||18
8429182|NCT00859638|20773350|P2|NOT COMPLETED|Overall Study||4
8429183|NCT00859638|20773351|P1|NOT COMPLETED|Overall Study||10
8429184|NCT00859638|20773350|P2|COMPLETED|Overall Study||55
8429185|NCT00859638|20773351|P1|COMPLETED|Overall Study||55
8429186|NCT00859638|20773350|P2|STARTED|Overall Study||59
8429187|NCT00859638|20773351|P1|STARTED|Overall Study||65
8429188|NCT00859586|20773357|P1|NOT COMPLETED|Overall Study||4
8429189|NCT00859586|20773357|P1|COMPLETED|Overall Study||4
8429190|NCT00859586|20773357|P1|STARTED|Overall Study||8
8429191|NCT00859573|20773373|P2|NOT COMPLETED|Overall Study||2
8429192|NCT00859573|20773374|P1|NOT COMPLETED|Overall Study||5
8429193|NCT00859573|20773373|P2|COMPLETED|Overall Study||1
8429194|NCT00859573|20773374|P1|COMPLETED|Overall Study||1
8429195|NCT00859573|20773373|P2|STARTED|Overall Study||3
8429196|NCT00859573|20773374|P1|STARTED|Overall Study||6
8429197|NCT00859547|20773380|P1|NOT COMPLETED|Overall Study||2
8429198|NCT00859547|20773380|P1|COMPLETED|Overall Study||28
8429199|NCT00859547|20773380|P1|STARTED|Overall Study||30
8429200|NCT00859521|20773393|P2|NOT COMPLETED|Second Intervention||0
8429201|NCT00859521|20773394|P1|NOT COMPLETED|Second Intervention||0
8429202|NCT00859521|20773393|P2|COMPLETED|Second Intervention||14
8429203|NCT00859521|20773394|P1|COMPLETED|Second Intervention||15
8429204|NCT00859521|20773393|P2|STARTED|Second Intervention||14
8429205|NCT00859521|20773394|P1|STARTED|Second Intervention||15
8429206|NCT00859521|20773393|P2|NOT COMPLETED|Washout||1
8429207|NCT00859521|20773394|P1|NOT COMPLETED|Washout||0
8429208|NCT00859521|20773393|P2|COMPLETED|Washout||14
8429209|NCT00859521|20773394|P1|COMPLETED|Washout||15
8429210|NCT00859521|20773393|P2|STARTED|Washout||15
8429211|NCT00859521|20773394|P1|STARTED|Washout||15
8429212|NCT00859521|20773393|P2|NOT COMPLETED|First Intervention||0
8429213|NCT00859521|20773394|P1|NOT COMPLETED|First Intervention||0
8429214|NCT00859521|20773393|P2|COMPLETED|First Intervention||15
8429215|NCT00859521|20773394|P1|COMPLETED|First Intervention||15
8429216|NCT00859521|20773393|P2|STARTED|First Intervention||15
8429217|NCT00859521|20773394|P1|STARTED|First Intervention||15
8429218|NCT00859508|20773404|P2|NOT COMPLETED|Overall Study||0
8429219|NCT00859508|20773405|P1|NOT COMPLETED|Overall Study||6
8429220|NCT00859508|20773404|P2|COMPLETED|Overall Study||37
8429221|NCT00859508|20773405|P1|COMPLETED|Overall Study||62
8429222|NCT00859508|20773404|P2|STARTED|Overall Study||37
8429223|NCT00859508|20773405|P1|STARTED|Overall Study||68
8429224|NCT00859495|20773411|P1|NOT COMPLETED|Overall Study||0
8429225|NCT00859495|20773411|P1|COMPLETED|Overall Study||9
8429226|NCT00859495|20773411|P1|STARTED|Overall Study||9
8429227|NCT00859469|20773415|P1|NOT COMPLETED|Overall Study||28
8429228|NCT00859469|20773415|P1|COMPLETED|Overall Study||1
8429229|NCT00859469|20773415|P1|6 Cycles|Overall Study||16
8429230|NCT00859469|20773415|P1|STARTED|Overall Study||29
8429231|NCT00859456|20773421|P1|NOT COMPLETED|Overall Study||8
8429232|NCT00859456|20773421|P1|COMPLETED|Overall Study||1
8429233|NCT00859456|20773421|P1|STARTED|Overall Study||9
8429234|NCT00859430|20773427|P2|NOT COMPLETED|Second Intervention||0
8429235|NCT00859430|20773428|P1|NOT COMPLETED|Second Intervention||0
8429236|NCT00859430|20773427|P2|COMPLETED|Second Intervention||10
8429237|NCT00859430|20773428|P1|COMPLETED|Second Intervention||11
8429238|NCT00859430|20773427|P2|STARTED|Second Intervention||10
8429239|NCT00859430|20773428|P1|STARTED|Second Intervention||11
8429240|NCT00859430|20773427|P2|NOT COMPLETED|First Intervention||1
8429241|NCT00859430|20773428|P1|NOT COMPLETED|First Intervention||0
8429242|NCT00859430|20773427|P2|COMPLETED|First Intervention||10
8429243|NCT00859430|20773428|P1|COMPLETED|First Intervention||11
8429244|NCT00859430|20773427|P2|STARTED|First Intervention||11
8429245|NCT00859430|20773428|P1|STARTED|First Intervention||11
8429246|NCT00859339|20773436|P1|NOT COMPLETED|Overall Study||0
8429247|NCT00859339|20773436|P1|COMPLETED|Overall Study||9
8429248|NCT00859339|20773436|P1|STARTED|Overall Study||9
8429249|NCT00859313|20773444|P1|NOT COMPLETED|Overall Study||4
8429250|NCT00859313|20773444|P1|COMPLETED|Overall Study||26
8429251|NCT00859313|20773444|P1|STARTED|Overall Study||30
8429252|NCT00859222|20773451|P5|NOT COMPLETED|Overall Study||15
8429253|NCT00859222|20773452|P4|NOT COMPLETED|Overall Study||24
8429254|NCT00859222|20773453|P3|NOT COMPLETED|Overall Study||6
8429255|NCT00859222|20773454|P2|NOT COMPLETED|Overall Study||3
8429256|NCT00859222|20773455|P1|NOT COMPLETED|Overall Study||3
8429257|NCT00859222|20773451|P5|COMPLETED|Overall Study||0
8429258|NCT00859222|20773452|P4|COMPLETED|Overall Study||0
8429259|NCT00859222|20773453|P3|COMPLETED|Overall Study||0
8429260|NCT00859222|20773454|P2|COMPLETED|Overall Study||0
8429261|NCT00859222|20773455|P1|COMPLETED|Overall Study||0
8429262|NCT00859222|20773451|P5|STARTED|Overall Study||15
8429263|NCT00859222|20773452|P4|STARTED|Overall Study||24
8429264|NCT00859222|20773453|P3|STARTED|Overall Study||6
8429265|NCT00859222|20773454|P2|STARTED|Overall Study||3
8429266|NCT00859222|20773455|P1|STARTED|Overall Study||3
8429267|NCT00859131|20773482|P2|NOT COMPLETED|Overall Study||0
8429268|NCT00859131|20773483|P1|NOT COMPLETED|Overall Study||0
8429269|NCT00859131|20773482|P2|COMPLETED|Overall Study||98
8429270|NCT00859131|20773483|P1|COMPLETED|Overall Study||102
8429271|NCT00859131|20773482|P2|STARTED|Overall Study||98
8429272|NCT00859131|20773483|P1|STARTED|Overall Study||102
8429273|NCT00859053|20773505|P4|NOT COMPLETED|Overall Study||0
8429274|NCT00859053|20773506|P3|NOT COMPLETED|Overall Study||0
8429275|NCT00859053|20773507|P2|NOT COMPLETED|Overall Study||0
8429276|NCT00859053|20773508|P1|NOT COMPLETED|Overall Study||0
8429277|NCT00859053|20773505|P4|COMPLETED|Overall Study||12
8429278|NCT00859053|20773506|P3|COMPLETED|Overall Study||6
8429279|NCT00859053|20773507|P2|COMPLETED|Overall Study||6
8429280|NCT00859053|20773508|P1|COMPLETED|Overall Study||6
8429281|NCT00859053|20773505|P4|STARTED|Overall Study||12
8429282|NCT00859053|20773506|P3|STARTED|Overall Study||6
8429283|NCT00859053|20773507|P2|STARTED|Overall Study||6
8429284|NCT00859053|20773508|P1|STARTED|Overall Study||6
8429285|NCT00859040|20773552|P2|NOT COMPLETED|Overall Study||0
8429286|NCT00859040|20773553|P1|NOT COMPLETED|Overall Study||0
8429287|NCT00859040|20773552|P2|COMPLETED|Overall Study||16
8429288|NCT00859040|20773553|P1|COMPLETED|Overall Study||18
8429289|NCT00859040|20773552|P2|STARTED|Overall Study||16
8429290|NCT00859040|20773553|P1|STARTED|Overall Study||18
8429291|NCT00859027|20773568|P2|NOT COMPLETED|Overall Study||5
8429292|NCT00859027|20773569|P1|NOT COMPLETED|Overall Study||5
8429293|NCT00859027|20773568|P2|COMPLETED|Overall Study||20
8429294|NCT00859027|20773569|P1|COMPLETED|Overall Study||20
8429295|NCT00859027|20773568|P2|STARTED|Overall Study||25
8429296|NCT00859027|20773569|P1|STARTED|Overall Study||25
8429297|NCT00859014|20773577|P1|NOT COMPLETED|Overall Study||5
8429298|NCT00859014|20773577|P1|COMPLETED|Overall Study||20
8429299|NCT00859014|20773577|P1|STARTED|Overall Study||25
8429300|NCT00858988|20773584|P2|NOT COMPLETED|Analysis||1
8429301|NCT00858988|20773585|P1|NOT COMPLETED|Analysis||2
8429302|NCT00858988|20773584|P2|COMPLETED|Analysis||72
8429303|NCT00858988|20773585|P1|COMPLETED|Analysis||72
8429304|NCT00858988|20773584|P2|STARTED|Analysis||73
8429305|NCT00858988|20773585|P1|STARTED|Analysis||74
8429306|NCT00858988|20773584|P2|NOT COMPLETED|Randomized and Allocation||0
8429307|NCT00858988|20773585|P1|NOT COMPLETED|Randomized and Allocation||0
8429308|NCT00858988|20773584|P2|COMPLETED|Randomized and Allocation||73
8429309|NCT00858988|20773585|P1|COMPLETED|Randomized and Allocation||74
8429310|NCT00858988|20773584|P2|STARTED|Randomized and Allocation||73
8429311|NCT00858988|20773585|P1|STARTED|Randomized and Allocation||74
8429312|NCT00858962|20773591|P1|NOT COMPLETED|Overall Study||0
8429313|NCT00858962|20773591|P1|COMPLETED|Overall Study||12
8429314|NCT00858962|20773591|P1|STARTED|Overall Study||12
8429315|NCT00858858|20773595|P1|NOT COMPLETED|Overall Study||18
8429316|NCT00858858|20773595|P1|COMPLETED|Overall Study||42
8429317|NCT00858858|20773595|P1|STARTED|Overall Study||60
8429318|NCT00858845|20773601|P2|NOT COMPLETED|Overall Study||1
8429319|NCT00858845|20773602|P1|NOT COMPLETED|Overall Study||0
8429320|NCT00858845|20773601|P2|COMPLETED|Overall Study||5
8429321|NCT00858845|20773602|P1|COMPLETED|Overall Study||5
8429322|NCT00858845|20773601|P2|STARTED|Overall Study||6
8429323|NCT00858845|20773602|P1|STARTED|Overall Study||5
8429324|NCT00858832|20773614|P2|NOT COMPLETED|Overall Study||1
8429325|NCT00858832|20773615|P1|NOT COMPLETED|Overall Study||1
8429326|NCT00858832|20773614|P2|COMPLETED|Overall Study||22
8429327|NCT00858832|20773615|P1|COMPLETED|Overall Study||20
8429328|NCT00858832|20773614|P2|STARTED|Overall Study||23
8429329|NCT00858832|20773615|P1|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
8429330|NCT00858780|20773621|P5|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
8429331|NCT00858780|20773622|P4|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429332|NCT00858780|20773623|P3|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429333|NCT00858780|20773624|P2|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429334|NCT00858780|20773625|P1|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429335|NCT00858780|20773621|P5|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
8429336|NCT00858780|20773622|P4|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429337|NCT00858780|20773623|P3|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429338|NCT00858780|20773624|P2|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429339|NCT00858780|20773625|P1|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
8429418|NCT00858637|20773720|P2|STARTED|Active Comparison Phase||0
8429340|NCT00858780|20773621|P5|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
8429341|NCT00858780|20773622|P4|STARTED|OL Re-Treatment (Failure to Week 48)||0
8429342|NCT00858780|20773623|P3|STARTED|OL Re-Treatment (Failure to Week 48)||0
8429343|NCT00858780|20773624|P2|STARTED|OL Re-Treatment (Failure to Week 48)||0
8429344|NCT00858780|20773625|P1|STARTED|OL Re-Treatment (Failure to Week 48)||0
8429345|NCT00858780|20773621|P5|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
8429346|NCT00858780|20773622|P4|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
8429347|NCT00858780|20773623|P3|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
8429348|NCT00858780|20773624|P2|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
8429349|NCT00858780|20773625|P1|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
8429350|NCT00858780|20773621|P5|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
8429351|NCT00858780|20773622|P4|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
8429352|NCT00858780|20773623|P3|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
8429353|NCT00858780|20773624|P2|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
8429354|NCT00858780|20773625|P1|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
8429355|NCT00858780|20773621|P5|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
8429356|NCT00858780|20773622|P4|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
8429357|NCT00858780|20773623|P3|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
8429358|NCT00858780|20773624|P2|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
8429359|NCT00858780|20773625|P1|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
8429360|NCT00858780|20773621|P5|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429361|NCT00858780|20773622|P4|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429362|NCT00858780|20773623|P3|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429363|NCT00858780|20773624|P2|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429364|NCT00858780|20773625|P1|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
8429365|NCT00858780|20773621|P5|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429366|NCT00858780|20773622|P4|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429367|NCT00858780|20773623|P3|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429368|NCT00858780|20773624|P2|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429369|NCT00858780|20773625|P1|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
8429370|NCT00858780|20773621|P5|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429371|NCT00858780|20773622|P4|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429372|NCT00858780|20773623|P3|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429373|NCT00858780|20773624|P2|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
8429374|NCT00858780|20773625|P1|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
8429375|NCT00858702|20773700|P2|NOT COMPLETED|Overall Study||2
8429376|NCT00858702|20773701|P1|NOT COMPLETED|Overall Study||5
8429377|NCT00858702|20773700|P2|COMPLETED|Overall Study||50
8429378|NCT00858702|20773701|P1|COMPLETED|Overall Study||48
8429379|NCT00858702|20773700|P2|STARTED|Overall Study||52
8429380|NCT00858702|20773701|P1|STARTED|Overall Study||53
8429381|NCT00858689|20773709|P1|NOT COMPLETED|Overall Study||1
8429382|NCT00858689|20773709|P1|COMPLETED|Overall Study||19
8429383|NCT00858689|20773709|P1|STARTED|Overall Study||20
8429384|NCT00858637|20773716|P6|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
8429385|NCT00858637|20773717|P5|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
8429386|NCT00858637|20773718|P4|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
8429387|NCT00858637|20773719|P3|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
8429388|NCT00858637|20773720|P2|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
8429389|NCT00858637|20773721|P1|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
8429390|NCT00858637|20773716|P6|COMPLETED|Placebo-controlled Withdrawal Phase||58
8429391|NCT00858637|20773717|P5|COMPLETED|Placebo-controlled Withdrawal Phase||55
8429392|NCT00858637|20773718|P4|COMPLETED|Placebo-controlled Withdrawal Phase||0
8429393|NCT00858637|20773719|P3|COMPLETED|Placebo-controlled Withdrawal Phase||53
8429394|NCT00858637|20773720|P2|COMPLETED|Placebo-controlled Withdrawal Phase||49
8429395|NCT00858637|20773721|P1|COMPLETED|Placebo-controlled Withdrawal Phase||0
8429396|NCT00858637|20773716|P6|STARTED|Placebo-controlled Withdrawal Phase||59
8429397|NCT00858637|20773717|P5|STARTED|Placebo-controlled Withdrawal Phase||56
8429398|NCT00858637|20773718|P4|STARTED|Placebo-controlled Withdrawal Phase||0
8429399|NCT00858637|20773719|P3|STARTED|Placebo-controlled Withdrawal Phase||54
8429400|NCT00858637|20773720|P2|STARTED|Placebo-controlled Withdrawal Phase||49
8429401|NCT00858637|20773721|P1|STARTED|Placebo-controlled Withdrawal Phase||0
8429402|NCT00858637|20773716|P6|NOT COMPLETED|Active Comparison Phase||0
8429403|NCT00858637|20773717|P5|NOT COMPLETED|Active Comparison Phase||0
8429404|NCT00858637|20773718|P4|NOT COMPLETED|Active Comparison Phase||18
8429405|NCT00858637|20773719|P3|NOT COMPLETED|Active Comparison Phase||0
8429406|NCT00858637|20773720|P2|NOT COMPLETED|Active Comparison Phase||0
8429407|NCT00858637|20773721|P1|NOT COMPLETED|Active Comparison Phase||24
8429408|NCT00858637|20773716|P6|COMPLETED|Active Comparison Phase||0
8429409|NCT00858637|20773717|P5|COMPLETED|Active Comparison Phase||0
8429410|NCT00858637|20773718|P4|COMPLETED|Active Comparison Phase||115
8429411|NCT00858637|20773719|P3|COMPLETED|Active Comparison Phase||0
8429412|NCT00858637|20773720|P2|COMPLETED|Active Comparison Phase||0
8429413|NCT00858637|20773721|P1|COMPLETED|Active Comparison Phase||103
8429414|NCT00858637|20773716|P6|STARTED|Active Comparison Phase||0
8429415|NCT00858637|20773717|P5|STARTED|Active Comparison Phase||0
8429416|NCT00858637|20773718|P4|STARTED|Active Comparison Phase||133
8429417|NCT00858637|20773719|P3|STARTED|Active Comparison Phase||0
8429419|NCT00858637|20773721|P1|STARTED|Active Comparison Phase||127
8429420|NCT00858507|20773733|P2|NOT COMPLETED|Overall Study||15
8429421|NCT00858507|20773734|P1|NOT COMPLETED|Overall Study||22
8429422|NCT00858507|20773733|P2|COMPLETED|Overall Study||101
8429423|NCT00858507|20773734|P1|COMPLETED|Overall Study||83
8429424|NCT00858507|20773733|P2|STARTED|Overall Study||116
8429425|NCT00858507|20773734|P1|STARTED|Overall Study||105
8429426|NCT00858494|20773740|P1|NOT COMPLETED|Overall Study||4
8429427|NCT00858494|20773740|P1|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
8429428|NCT00858494|20773740|P1|STARTED|Overall Study||49
8429429|NCT00858468|20773747|P2|NOT COMPLETED|Overall Study||0
8429430|NCT00858468|20773748|P1|NOT COMPLETED|Overall Study||0
8429431|NCT00858468|20773747|P2|COMPLETED|Overall Study||192
8429432|NCT00858468|20773748|P1|COMPLETED|Overall Study||201
8429433|NCT00858468|20773747|P2|STARTED|Overall Study||192
8429434|NCT00858468|20773748|P1|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
8429435|NCT00858442|20773762|P2|NOT COMPLETED|Compression:Start to Finish||3
8429436|NCT00858442|20773763|P1|NOT COMPLETED|Compression:Start to Finish||1
8429437|NCT00858442|20773762|P2|COMPLETED|Compression:Start to Finish||20
8429438|NCT00858442|20773763|P1|COMPLETED|Compression:Start to Finish||20
8429439|NCT00858442|20773762|P2|STARTED|Compression:Start to Finish||23
8429440|NCT00858442|20773763|P1|STARTED|Compression:Start to Finish||21
8429441|NCT00858442|20773762|P2|NOT COMPLETED|From Surgery to Start Compression;||0
8429442|NCT00858442|20773763|P1|NOT COMPLETED|From Surgery to Start Compression;||0
8429443|NCT00858442|20773762|P2|COMPLETED|From Surgery to Start Compression;||23
8429444|NCT00858442|20773763|P1|COMPLETED|From Surgery to Start Compression;||21
8429445|NCT00858442|20773762|P2|STARTED|From Surgery to Start Compression;||23
8429446|NCT00858442|20773763|P1|STARTED|From Surgery to Start Compression;||21
8429447|NCT00858403|20773773|P1|NOT COMPLETED|Overall Study||5
8429448|NCT00858403|20773773|P1|COMPLETED|Overall Study||2
8429449|NCT00858403|20773773|P1|STARTED|Overall Study||7
8429450|NCT00858390|20773785|P2|NOT COMPLETED|Overall Study||0
8429451|NCT00858390|20773786|P1|NOT COMPLETED|Overall Study||0
8429452|NCT00858390|20773785|P2|COMPLETED|Overall Study||18
8429453|NCT00858390|20773786|P1|COMPLETED|Overall Study||18
8429454|NCT00858390|20773785|P2|STARTED|Overall Study||18
8429455|NCT00858390|20773786|P1|STARTED|Overall Study||18
8429456|NCT00858364|20773794|P2|NOT COMPLETED|Overall Study||457
8429457|NCT00858364|20773795|P1|NOT COMPLETED|Overall Study||204
8429458|NCT00858364|20773794|P2|COMPLETED|Overall Study||1246
8429459|NCT00858364|20773795|P1|COMPLETED|Overall Study||642
8429460|NCT00858364|20773794|P2|Received Study Drug|Overall Study||1681
8429461|NCT00858364|20773795|P1|Received Study Drug|Overall Study||837
8429462|NCT00858364|20773794|P2|STARTED|Overall Study||1703
8429463|NCT00858364|20773795|P1|STARTED|Overall Study||846
8429464|NCT00858247|20773817|P2|NOT COMPLETED|Week 12 Follow-up||1
8429465|NCT00858247|20773818|P1|NOT COMPLETED|Week 12 Follow-up||0
8429466|NCT00858247|20773817|P2|COMPLETED|Week 12 Follow-up||23
8429467|NCT00858247|20773818|P1|COMPLETED|Week 12 Follow-up||23
8429468|NCT00858247|20773817|P2|STARTED|Week 12 Follow-up||24
8429469|NCT00858247|20773818|P1|STARTED|Week 12 Follow-up||23
8429470|NCT00858247|20773817|P2|NOT COMPLETED|Baseline Assessment||2
8429471|NCT00858247|20773818|P1|NOT COMPLETED|Baseline Assessment||2
8429472|NCT00858247|20773817|P2|COMPLETED|Baseline Assessment||24
8429473|NCT00858247|20773818|P1|COMPLETED|Baseline Assessment||23
8429474|NCT00858247|20773817|P2|STARTED|Baseline Assessment||26
8429475|NCT00858247|20773818|P1|STARTED|Baseline Assessment||25
8429476|NCT00858208|20773834|P1|NOT COMPLETED|Overall Study||79
8429477|NCT00858208|20773834|P1|COMPLETED|Overall Study||6
8429478|NCT00858208|20773834|P1|STARTED|Overall Study||85
8429479|NCT00858143|20773851|P1|NOT COMPLETED|Overall Study||50
8429480|NCT00858143|20773851|P1|COMPLETED|Overall Study||261
8429481|NCT00858143|20773851|P1|STARTED|Overall Study|Baseline|311
8429482|NCT00858130|20773900|P1|NOT COMPLETED|Overall Study||0
8429483|NCT00858130|20773900|P1|COMPLETED|Overall Study||12
8429484|NCT00858130|20773900|P1|STARTED|Overall Study||12
8429485|NCT00858117|20773908|P1|NOT COMPLETED|Follow up for 5 Years||13
8429486|NCT00858117|20773908|P1|COMPLETED|Follow up for 5 Years||17
8429487|NCT00858117|20773908|P1|STARTED|Follow up for 5 Years|All patients who receive at least one dose of drug under the protocol go into follow up for survival|30
8429488|NCT00858117|20773908|P1|NOT COMPLETED|Treatment on Study||2
8429489|NCT00858117|20773908|P1|COMPLETED|Treatment on Study||28
8429490|NCT00858117|20773908|P1|Completed 18 Weeks of Treatment|Treatment on Study||28
8429491|NCT00858117|20773908|P1|STARTED|Treatment on Study||30
8429492|NCT00858013|20773918|P2|NOT COMPLETED|Overall Study||19
8429493|NCT00858013|20773919|P1|NOT COMPLETED|Overall Study||22
8429494|NCT00858013|20773918|P2|COMPLETED|Overall Study||23
8429495|NCT00858013|20773919|P1|COMPLETED|Overall Study||24
8429496|NCT00858013|20773918|P2|STARTED|Overall Study||42
8429497|NCT00858013|20773919|P1|STARTED|Overall Study||46
8429498|NCT00857961|20773933|P1|NOT COMPLETED|Overall Study||0
8429499|NCT00857961|20773933|P1|COMPLETED|Overall Study||21
8429500|NCT00857961|20773933|P1|STARTED|Overall Study||21
8429501|NCT00857948|20773971|P4|NOT COMPLETED|Overall Study||0
8429502|NCT00857948|20773972|P3|NOT COMPLETED|Overall Study||1
8429503|NCT00857948|20773973|P2|NOT COMPLETED|Overall Study||0
8429504|NCT00857948|20773974|P1|NOT COMPLETED|Overall Study||3
8429505|NCT00857948|20773971|P4|COMPLETED|Overall Study||23
8429506|NCT00857948|20773972|P3|COMPLETED|Overall Study||18
8429507|NCT00857948|20773973|P2|COMPLETED|Overall Study||18
8429508|NCT00857948|20773974|P1|COMPLETED|Overall Study||15
8429509|NCT00857948|20773971|P4|STARTED|Overall Study||23
8429510|NCT00857948|20773972|P3|STARTED|Overall Study||19
8429511|NCT00857948|20773973|P2|STARTED|Overall Study||18
8429512|NCT00857948|20773974|P1|STARTED|Overall Study||18
8429513|NCT00857896|20773996|P1|NOT COMPLETED|Week 5 to Week 8||0
8429514|NCT00857896|20773996|P1|COMPLETED|Week 5 to Week 8||20
8429515|NCT00857896|20773996|P1|STARTED|Week 5 to Week 8||20
8429516|NCT00857896|20773996|P1|NOT COMPLETED|Baseline to Week 4||1
8429517|NCT00857896|20773996|P1|COMPLETED|Baseline to Week 4||20
8429518|NCT00857896|20773996|P1|STARTED|Baseline to Week 4||21
8429519|NCT00857857|20774008|P1|NOT COMPLETED|Overall Study||0
8429520|NCT00857857|20774008|P1|COMPLETED|Overall Study||24
8429521|NCT00857857|20774008|P1|STARTED|Overall Study||24
8429522|NCT00857818|20774152|P2|NOT COMPLETED|Overall Study||8
8429523|NCT00857818|20774153|P1|NOT COMPLETED|Overall Study||11
8429524|NCT00857818|20774152|P2|COMPLETED|Overall Study||6
8429525|NCT00857818|20774153|P1|COMPLETED|Overall Study||3
8429526|NCT00857818|20774152|P2|Received Treatment|Overall Study||12
8429527|NCT00857818|20774153|P1|Received Treatment|Overall Study||14
8429528|NCT00857818|20774152|P2|STARTED|Overall Study||14
8429529|NCT00857818|20774153|P1|STARTED|Overall Study||14
8429530|NCT00857792|20774181|P1|NOT COMPLETED|Overall Study||12
8429531|NCT00857792|20774181|P1|COMPLETED|Overall Study||108
8429532|NCT00857792|20774181|P1|STARTED|Overall Study||120
8429533|NCT00857766|20774187|P2|NOT COMPLETED|Overall Study||30
8429534|NCT00857766|20774188|P1|NOT COMPLETED|Overall Study||31
8429535|NCT00857766|20774187|P2|COMPLETED|Overall Study||96
8429536|NCT00857766|20774188|P1|COMPLETED|Overall Study||92
8429537|NCT00857766|20774187|P2|STARTED|Overall Study||126
8429538|NCT00857766|20774188|P1|STARTED|Overall Study||123
8429539|NCT00857727|20774200|P2|NOT COMPLETED|Overall Study||0
8429540|NCT00857727|20774201|P1|NOT COMPLETED|Overall Study||0
8429541|NCT00857727|20774200|P2|COMPLETED|Overall Study||14
8429542|NCT00857727|20774201|P1|COMPLETED|Overall Study||14
8429543|NCT00857727|20774200|P2|STARTED|Overall Study||14
8429544|NCT00857727|20774201|P1|STARTED|Overall Study||14
8429545|NCT00857714|20774223|P1|NOT COMPLETED|Overall Study||0
8429546|NCT00857714|20774223|P1|COMPLETED|Overall Study||1
8429547|NCT00857714|20774223|P1|STARTED|Overall Study||1
8429548|NCT00857649|20774230|P2|NOT COMPLETED|Overall Study||32
8429549|NCT00857649|20774231|P1|NOT COMPLETED|Overall Study||31
8429550|NCT00857649|20774230|P2|COMPLETED|Overall Study||155
8429551|NCT00857649|20774231|P1|COMPLETED|Overall Study||151
8429552|NCT00857649|20774230|P2|STARTED|Overall Study||187
8429553|NCT00857649|20774231|P1|STARTED|Overall Study||182
8429554|NCT00857623|20774247|P2|NOT COMPLETED|Overall Study||10
8429555|NCT00857623|20774248|P1|NOT COMPLETED|Overall Study||14
8429556|NCT00857623|20774247|P2|COMPLETED|Overall Study||55
8429557|NCT00857623|20774248|P1|COMPLETED|Overall Study||48
8429558|NCT00857623|20774247|P2|STARTED|Overall Study||65
8429559|NCT00857623|20774248|P1|STARTED|Overall Study||62
8429560|NCT00857584|20774272|P2|NOT COMPLETED|Overall Study||5
8429561|NCT00857584|20774273|P1|NOT COMPLETED|Overall Study||4
8429562|NCT00857584|20774272|P2|COMPLETED|Overall Study||8
8429563|NCT00857584|20774273|P1|COMPLETED|Overall Study||10
8429564|NCT00857584|20774272|P2|Week 8|Overall Study||8
8429565|NCT00857584|20774273|P1|Week 8|Overall Study||10
8429566|NCT00857584|20774272|P2|Week 4|Overall Study||9
8429567|NCT00857584|20774273|P1|Week 4|Overall Study||11
8429568|NCT00857584|20774272|P2|Week 2|Overall Study||11
8429569|NCT00857584|20774273|P1|Week 2|Overall Study||14
8429570|NCT00857584|20774272|P2|Week 1|Overall Study||13
8429571|NCT00857584|20774273|P1|Week 1|Overall Study||14
8429572|NCT00857584|20774272|P2|STARTED|Overall Study||13
8429573|NCT00857584|20774273|P1|STARTED|Overall Study||14
8429574|NCT00857545|20774315|P2|NOT COMPLETED|Overall Study||0
8429575|NCT00857545|20774316|P1|NOT COMPLETED|Overall Study||0
8429576|NCT00857545|20774315|P2|COMPLETED|Overall Study||85
8429577|NCT00857545|20774316|P1|COMPLETED|Overall Study|Enrolled and randomized participants.|86
8429578|NCT00857545|20774315|P2|STARTED|Overall Study||85
8429579|NCT00857545|20774316|P1|STARTED|Overall Study||86
8429580|NCT00857532|20774326|P1|NOT COMPLETED|Overall Study||0
8429581|NCT00857532|20774326|P1|COMPLETED|Overall Study||31
8429582|NCT00857532|20774326|P1|STARTED|Overall Study||31
8429583|NCT00857506|20774337|P3|NOT COMPLETED|Overall Study||18
8429584|NCT00857506|20774338|P2|NOT COMPLETED|Overall Study||15
8429585|NCT00857506|20774339|P1|NOT COMPLETED|Overall Study||15
8429586|NCT00857506|20774337|P3|COMPLETED|Overall Study||51
8429587|NCT00857506|20774338|P2|COMPLETED|Overall Study||37
8429588|NCT00857506|20774339|P1|COMPLETED|Overall Study||16
8429589|NCT00857506|20774337|P3|STARTED|Overall Study||69
8429590|NCT00857506|20774338|P2|STARTED|Overall Study||52
8429591|NCT00857506|20774339|P1|STARTED|Overall Study||31
8429592|NCT00857493|20774367|P2|NOT COMPLETED|Overall Study||0
8429593|NCT00857493|20774368|P1|NOT COMPLETED|Overall Study||3
8429594|NCT00857493|20774367|P2|COMPLETED|Overall Study||58
8429595|NCT00857493|20774368|P1|COMPLETED|Overall Study||59
8429596|NCT00857493|20774367|P2|STARTED|Overall Study||58
8429597|NCT00857493|20774368|P1|STARTED|Overall Study||62
8429598|NCT00857454|20774400|P1|NOT COMPLETED|Overall Study||20
8429599|NCT00857454|20774400|P1|COMPLETED|Overall Study||51
8429600|NCT00857454|20774400|P1|STARTED|Overall Study||71
8429601|NCT00857415|20774413|P2|NOT COMPLETED|Overall Study||0
8429602|NCT00857415|20774414|P1|NOT COMPLETED|Overall Study||117
8429603|NCT00857415|20774413|P2|COMPLETED|Overall Study||74
8429604|NCT00857415|20774414|P1|COMPLETED|Overall Study||35
8429605|NCT00857415|20774413|P2|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
8429606|NCT00857415|20774414|P1|Deceased Within One Year of AV-45 Scan|Overall Study||37
8429607|NCT00857415|20774413|P2|STARTED|Overall Study||74
8429608|NCT00857415|20774414|P1|STARTED|Overall Study||152
8429609|NCT00857389|20774421|P1|NOT COMPLETED|Overall Study||2
8429610|NCT00857389|20774421|P1|COMPLETED|Overall Study||58
8429611|NCT00857389|20774421|P1|STARTED|Overall Study||60
8429612|NCT00857311|20774435|P4|NOT COMPLETED|Overall Study||0
8429613|NCT00857311|20774436|P3|NOT COMPLETED|Overall Study||0
8429614|NCT00857311|20774437|P2|NOT COMPLETED|Overall Study||0
8429615|NCT00857311|20774438|P1|NOT COMPLETED|Overall Study||1
8429616|NCT00857311|20774435|P4|COMPLETED|Overall Study||0
8429617|NCT00857311|20774436|P3|COMPLETED|Overall Study||8
8429618|NCT00857311|20774437|P2|COMPLETED|Overall Study||0
8429619|NCT00857311|20774438|P1|COMPLETED|Overall Study||8
8429620|NCT00857311|20774435|P4|STARTED|Overall Study||0
8429621|NCT00857311|20774436|P3|STARTED|Overall Study||8
8429622|NCT00857311|20774437|P2|STARTED|Overall Study||0
8429623|NCT00857311|20774438|P1|STARTED|Overall Study||9
8429624|NCT00857285|20774450|P2|NOT COMPLETED|Overall Study||6
8429625|NCT00857285|20774451|P1|NOT COMPLETED|Overall Study||12
8429626|NCT00857285|20774450|P2|COMPLETED|Overall Study||59
8429627|NCT00857285|20774451|P1|COMPLETED|Overall Study||53
8429628|NCT00857285|20774450|P2|STARTED|Overall Study||65
8429629|NCT00857285|20774451|P1|STARTED|Overall Study||65
8429630|NCT00857272|20774457|P2|NOT COMPLETED|Overall Study||9
8429631|NCT00857272|20774458|P1|NOT COMPLETED|Overall Study||9
8429632|NCT00857272|20774457|P2|COMPLETED|Overall Study||145
8429633|NCT00857272|20774458|P1|COMPLETED|Overall Study||145
8429634|NCT00857272|20774457|P2|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
8429635|NCT00857272|20774458|P1|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
8429636|NCT00857259|20774467|P3|NOT COMPLETED|Overall Study||1
8429637|NCT00857259|20774468|P2|NOT COMPLETED|Overall Study||0
8429638|NCT00857259|20774469|P1|NOT COMPLETED|Overall Study||1
8429639|NCT00857259|20774467|P3|COMPLETED|Overall Study||6
8429640|NCT00857259|20774468|P2|COMPLETED|Overall Study||1
8429641|NCT00857259|20774469|P1|COMPLETED|Overall Study||7
8429642|NCT00857259|20774467|P3|STARTED|Overall Study||7
8429643|NCT00857259|20774468|P2|STARTED|Overall Study||1
8429644|NCT00857259|20774469|P1|STARTED|Overall Study||8
8429645|NCT00857246|20774479|P1|NOT COMPLETED|ChemoRT||3
8429646|NCT00857246|20774479|P1|COMPLETED|ChemoRT||12
8429647|NCT00857246|20774479|P1|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
8429648|NCT00857246|20774479|P1|NOT COMPLETED|Surgery (Curative)||6
8429649|NCT00857246|20774479|P1|COMPLETED|Surgery (Curative)||21
8429650|NCT00857246|20774479|P1|STARTED|Surgery (Curative)||27
8429651|NCT00857246|20774479|P1|NOT COMPLETED|Induction Regimen||3
8429652|NCT00857246|20774479|P1|COMPLETED|Induction Regimen||27
8429653|NCT00857246|20774479|P1|STARTED|Induction Regimen||30
8429654|NCT00857233|20774489|P1|NOT COMPLETED|Overall Study||55
8429655|NCT00857233|20774489|P1|COMPLETED|Overall Study||242
8429656|NCT00857233|20774489|P1|STARTED|Overall Study||297
8429657|NCT00857220|20774498|P1|NOT COMPLETED|Overall Study||183
8429658|NCT00857220|20774498|P1|COMPLETED|Overall Study||121
8429659|NCT00857220|20774498|P1|STARTED|Overall Study||304
8429660|NCT00856999|20774515|P1|NOT COMPLETED|Overall Study||5
8429661|NCT00856999|20774515|P1|COMPLETED|Overall Study||45
8429662|NCT00856999|20774515|P1|STARTED|Overall Study||50
8429663|NCT00856986|20774525|P5|NOT COMPLETED|Extension Period, Weeks 26-52||0
8429664|NCT00856986|20774526|P4|NOT COMPLETED|Extension Period, Weeks 26-52||0
8429665|NCT00856986|20774527|P3|NOT COMPLETED|Extension Period, Weeks 26-52||38
8429666|NCT00856986|20774528|P2|NOT COMPLETED|Extension Period, Weeks 26-52||14
8429667|NCT00856986|20774529|P1|NOT COMPLETED|Extension Period, Weeks 26-52||19
8429668|NCT00856986|20774525|P5|COMPLETED|Extension Period, Weeks 26-52||0
8429669|NCT00856986|20774526|P4|COMPLETED|Extension Period, Weeks 26-52||0
8429670|NCT00856986|20774527|P3|COMPLETED|Extension Period, Weeks 26-52||432
8429671|NCT00856986|20774528|P2|COMPLETED|Extension Period, Weeks 26-52||130
8429672|NCT00856986|20774529|P1|COMPLETED|Extension Period, Weeks 26-52||108
8429673|NCT00856986|20774525|P5|Enrolled in Extension|Extension Period, Weeks 26-52||0
8429674|NCT00856986|20774526|P4|Enrolled in Extension|Extension Period, Weeks 26-52||0
8429675|NCT00856986|20774527|P3|Enrolled in Extension|Extension Period, Weeks 26-52||461
8429676|NCT00856986|20774528|P2|Enrolled in Extension|Extension Period, Weeks 26-52||140
8429677|NCT00856986|20774529|P1|Enrolled in Extension|Extension Period, Weeks 26-52||122
8429678|NCT00856986|20774525|P5|STARTED|Extension Period, Weeks 26-52||0
8429679|NCT00856986|20774526|P4|STARTED|Extension Period, Weeks 26-52||0
8429680|NCT00856986|20774527|P3|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
8429681|NCT00856986|20774528|P2|STARTED|Extension Period, Weeks 26-52||144
8429682|NCT00856986|20774529|P1|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
8429683|NCT00856986|20774525|P5|NOT COMPLETED|Main Period, Weeks 0-26||0
8429684|NCT00856986|20774526|P4|NOT COMPLETED|Main Period, Weeks 0-26||0
8429685|NCT00856986|20774527|P3|NOT COMPLETED|Main Period, Weeks 0-26||28
8429686|NCT00856986|20774528|P2|NOT COMPLETED|Main Period, Weeks 0-26||18
8429687|NCT00856986|20774529|P1|NOT COMPLETED|Main Period, Weeks 0-26||34
8429688|NCT00856986|20774525|P5|COMPLETED|Main Period, Weeks 0-26||0
8429689|NCT00856986|20774526|P4|COMPLETED|Main Period, Weeks 0-26||0
8429690|NCT00856986|20774527|P3|COMPLETED|Main Period, Weeks 0-26||470
8429691|NCT00856986|20774528|P2|COMPLETED|Main Period, Weeks 0-26||144
8429692|NCT00856986|20774529|P1|COMPLETED|Main Period, Weeks 0-26||127
8429693|NCT00856986|20774525|P5|STARTED|Main Period, Weeks 0-26||0
8429694|NCT00856986|20774526|P4|STARTED|Main Period, Weeks 0-26||0
8429695|NCT00856986|20774527|P3|STARTED|Main Period, Weeks 0-26||498
8429696|NCT00856986|20774528|P2|STARTED|Main Period, Weeks 0-26||162
8429697|NCT00856986|20774529|P1|STARTED|Main Period, Weeks 0-26||161
8429698|NCT00856986|20774525|P5|NOT COMPLETED|Run-in Period, Weeks -12-0||0
8429699|NCT00856986|20774526|P4|NOT COMPLETED|Run-in Period, Weeks -12-0||167
8429700|NCT00856986|20774527|P3|NOT COMPLETED|Run-in Period, Weeks -12-0||0
8429701|NCT00856986|20774528|P2|NOT COMPLETED|Run-in Period, Weeks -12-0||0
8429702|NCT00856986|20774529|P1|NOT COMPLETED|Run-in Period, Weeks -12-0||0
8429703|NCT00856986|20774525|P5|COMPLETED|Run-in Period, Weeks -12-0||0
8429704|NCT00856986|20774526|P4|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
8429705|NCT00856986|20774527|P3|COMPLETED|Run-in Period, Weeks -12-0||498
8429706|NCT00856986|20774528|P2|COMPLETED|Run-in Period, Weeks -12-0||162
8429707|NCT00856986|20774529|P1|COMPLETED|Run-in Period, Weeks -12-0||161
8429708|NCT00856986|20774525|P5|STARTED|Run-in Period, Weeks -12-0||0
8429709|NCT00856986|20774526|P4|STARTED|Run-in Period, Weeks -12-0||167
8429710|NCT00856986|20774527|P3|STARTED|Run-in Period, Weeks -12-0||498
8429711|NCT00856986|20774528|P2|STARTED|Run-in Period, Weeks -12-0||162
8429712|NCT00856986|20774529|P1|STARTED|Run-in Period, Weeks -12-0||161
8429713|NCT00856973|20774699|P3|NOT COMPLETED|Overall Study||38
8429714|NCT00856973|20774700|P2|NOT COMPLETED|Overall Study||41
8429715|NCT00856973|20774701|P1|NOT COMPLETED|Overall Study||36
8429716|NCT00856973|20774699|P3|COMPLETED|Overall Study||123
8429717|NCT00856973|20774700|P2|COMPLETED|Overall Study||122
8429718|NCT00856973|20774701|P1|COMPLETED|Overall Study||126
8429719|NCT00856973|20774699|P3|STARTED|Overall Study||161
8429720|NCT00856973|20774700|P2|STARTED|Overall Study||163
8429721|NCT00856973|20774701|P1|STARTED|Overall Study||162
8429722|NCT00856934|20774769|P3|NOT COMPLETED|Overall Study||0
8429723|NCT00856934|20774770|P2|NOT COMPLETED|Overall Study||0
8429724|NCT00856934|20774771|P1|NOT COMPLETED|Overall Study||0
8429725|NCT00856934|20774769|P3|COMPLETED|Overall Study||15
8429726|NCT00856934|20774770|P2|COMPLETED|Overall Study||15
8429727|NCT00856934|20774771|P1|COMPLETED|Overall Study||15
8429728|NCT00856934|20774769|P3|STARTED|Overall Study||15
8429729|NCT00856934|20774770|P2|STARTED|Overall Study||15
8429730|NCT00856934|20774771|P1|STARTED|Overall Study||15
8429731|NCT00856908|20774781|P2|NOT COMPLETED|Overall Study||0
8429732|NCT00856908|20774782|P1|NOT COMPLETED|Overall Study||1
8429733|NCT00856908|20774781|P2|COMPLETED|Overall Study||5
8429734|NCT00856908|20774782|P1|COMPLETED|Overall Study||14
8429735|NCT00856908|20774781|P2|STARTED|Overall Study||5
8429736|NCT00856908|20774782|P1|STARTED|Overall Study||15
8429737|NCT00856856|20774807|P1|NOT COMPLETED|5-year Clinical Follow-up||0
8429738|NCT00856856|20774807|P1|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100
8429739|NCT00856856|20774807|P1|STARTED|5-year Clinical Follow-up||100
8429740|NCT00856856|20774807|P1|NOT COMPLETED|4-year Clinical Follow-up||1
8429741|NCT00856856|20774807|P1|COMPLETED|4-year Clinical Follow-up||99
8429742|NCT00856856|20774807|P1|STARTED|4-year Clinical Follow-up||100
8429743|NCT00856856|20774807|P1|NOT COMPLETED|3-year Clinical Follow-up||0
8429744|NCT00856856|20774807|P1|COMPLETED|3-year Clinical Follow-up||100
8429745|NCT00856856|20774807|P1|STARTED|3-year Clinical Follow-up||100
8429746|NCT00856856|20774807|P1|NOT COMPLETED|2-year Clinical Follow-up||1
8429747|NCT00856856|20774807|P1|COMPLETED|2-year Clinical Follow-up||100
8429748|NCT00856856|20774807|P1|STARTED|2-year Clinical Follow-up||101
8429749|NCT00856856|20774807|P1|NOT COMPLETED|1-year Clinical Follow-up||0
8429750|NCT00856856|20774807|P1|COMPLETED|1-year Clinical Follow-up||101
8429751|NCT00856856|20774807|P1|STARTED|1-year Clinical Follow-up||101
8429752|NCT00856856|20774807|P1|NOT COMPLETED|270-day Clinical Follow-up||0
8429753|NCT00856856|20774807|P1|COMPLETED|270-day Clinical Follow-up||101
8429754|NCT00856856|20774807|P1|STARTED|270-day Clinical Follow-up||101
8429755|NCT00856856|20774807|P1|NOT COMPLETED|180-day Clinical Follow-up||0
8429756|NCT00856856|20774807|P1|COMPLETED|180-day Clinical Follow-up||101
8429757|NCT00856856|20774807|P1|STARTED|180-day Clinical Follow-up||101
8429758|NCT00856856|20774807|P1|NOT COMPLETED|30-day Clinical Follow-up||0
8429759|NCT00856856|20774807|P1|COMPLETED|30-day Clinical Follow-up||101
8429760|NCT00856856|20774807|P1|STARTED|30-day Clinical Follow-up||101
8429761|NCT00856856|20774807|P1|NOT COMPLETED|Baseline||0
8429762|NCT00856856|20774807|P1|COMPLETED|Baseline||101
8429763|NCT00856856|20774807|P1|STARTED|Baseline||101
8429764|NCT00856843|20775006|P2|NOT COMPLETED|Overall Study||5
8429765|NCT00856843|20775007|P1|NOT COMPLETED|Overall Study||2
8429766|NCT00856843|20775006|P2|COMPLETED|Overall Study||63
8429767|NCT00856843|20775007|P1|COMPLETED|Overall Study||66
8429768|NCT00856843|20775006|P2|STARTED|Overall Study||68
8429769|NCT00856843|20775007|P1|STARTED|Overall Study||68
8429770|NCT00856830|20775043|P4|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
8429771|NCT00856830|20775044|P3|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
8429772|NCT00856830|20775045|P2|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
8429773|NCT00856830|20775046|P1|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
8429774|NCT00856830|20775043|P4|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
8429775|NCT00856830|20775044|P3|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
8429776|NCT00856830|20775045|P2|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
8429777|NCT00856830|20775046|P1|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
8429778|NCT00856830|20775043|P4|STARTED|Regimen - B (Carboplatin & Etoposide)||12
8429779|NCT00856830|20775044|P3|STARTED|Regimen - B (Carboplatin & Etoposide)||6
8429780|NCT00856830|20775045|P2|STARTED|Regimen - B (Carboplatin & Etoposide)||6
8429781|NCT00856830|20775046|P1|STARTED|Regimen - B (Carboplatin & Etoposide)||3
8429782|NCT00856830|20775043|P4|NOT COMPLETED|Irinotecan & Bendamustine||3
8429783|NCT00856830|20775044|P3|NOT COMPLETED|Irinotecan & Bendamustine||0
8429784|NCT00856830|20775045|P2|NOT COMPLETED|Irinotecan & Bendamustine||0
8429785|NCT00856830|20775046|P1|NOT COMPLETED|Irinotecan & Bendamustine||0
8429786|NCT00856830|20775043|P4|COMPLETED|Irinotecan & Bendamustine||12
8429787|NCT00856830|20775044|P3|COMPLETED|Irinotecan & Bendamustine||6
8429788|NCT00856830|20775045|P2|COMPLETED|Irinotecan & Bendamustine||6
8429789|NCT00856830|20775046|P1|COMPLETED|Irinotecan & Bendamustine||3
8429790|NCT00856830|20775043|P4|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
8429791|NCT00856830|20775044|P3|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
8429792|NCT00856830|20775045|P2|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
8429793|NCT00856830|20775046|P1|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
8429794|NCT00856830|20775043|P4|STARTED|Irinotecan & Bendamustine||15
8429795|NCT00856830|20775044|P3|STARTED|Irinotecan & Bendamustine||6
8429796|NCT00856830|20775045|P2|STARTED|Irinotecan & Bendamustine||6
8429797|NCT00856830|20775046|P1|STARTED|Irinotecan & Bendamustine||3
8429798|NCT00856791|20775052|P1|NOT COMPLETED|Overall Study||0
8429799|NCT00856791|20775052|P1|COMPLETED|Overall Study||1
8429800|NCT00856791|20775052|P1|STARTED|Overall Study||1
8429801|NCT00856778|20775057|P1|NOT COMPLETED|Overall Study||24
8429802|NCT00856778|20775057|P1|COMPLETED|Overall Study||74
8429803|NCT00856778|20775057|P1|STARTED|Overall Study||98
8429804|NCT00856739|20775076|P3|NOT COMPLETED|Overall Study||0
8429805|NCT00856739|20775077|P2|NOT COMPLETED|Overall Study||0
8429806|NCT00856739|20775078|P1|NOT COMPLETED|Overall Study||0
8429807|NCT00856739|20775076|P3|COMPLETED|Overall Study||55
8429808|NCT00856739|20775077|P2|COMPLETED|Overall Study||52
8429809|NCT00856739|20775078|P1|COMPLETED|Overall Study||70
8429810|NCT00856739|20775076|P3|STARTED|Overall Study||55
8429811|NCT00856739|20775077|P2|STARTED|Overall Study||52
8429812|NCT00856739|20775078|P1|STARTED|Overall Study||70
8429813|NCT00856726|20775089|P1|NOT COMPLETED|Overall Study||0
8429814|NCT00856726|20775089|P1|COMPLETED|Overall Study||26
8429815|NCT00856726|20775089|P1|STARTED|Overall Study||26
8429816|NCT00856661|20775100|P2|NOT COMPLETED|Overall Study||29
8429817|NCT00856661|20775101|P1|NOT COMPLETED|Overall Study||27
8429818|NCT00856661|20775100|P2|COMPLETED|Overall Study||106
8429819|NCT00856661|20775101|P1|COMPLETED|Overall Study||108
8429820|NCT00856661|20775100|P2|Randomized Not Treated|Overall Study||4
8429821|NCT00856661|20775101|P1|Randomized Not Treated|Overall Study||9
8429822|NCT00856661|20775100|P2|Treated|Overall Study||131
8429823|NCT00856661|20775101|P1|Treated|Overall Study||126
8429824|NCT00856661|20775100|P2|STARTED|Overall Study|Randomised|135
8429825|NCT00856661|20775101|P1|STARTED|Overall Study|Randomised|135
8429826|NCT00856635|20775115|P2|NOT COMPLETED|Overall Study||8
8429827|NCT00856635|20775116|P1|NOT COMPLETED|Overall Study||10
8429828|NCT00856635|20775115|P2|COMPLETED|Overall Study||14
8429829|NCT00856635|20775116|P1|COMPLETED|Overall Study||12
8429830|NCT00856635|20775115|P2|Received Study Drug|Overall Study||20
8429831|NCT00856635|20775116|P1|Received Study Drug|Overall Study||20
8429832|NCT00856635|20775115|P2|STARTED|Overall Study||22
8429833|NCT00856635|20775116|P1|STARTED|Overall Study||22
8429834|NCT00856609|20775126|P2|NOT COMPLETED|Overall Study||0
8429835|NCT00856609|20775127|P1|NOT COMPLETED|Overall Study||1
8429836|NCT00856609|20775126|P2|COMPLETED|Overall Study||39
8429837|NCT00856609|20775127|P1|COMPLETED|Overall Study||40
8429838|NCT00856609|20775126|P2|STARTED|Overall Study||39
8429839|NCT00856609|20775127|P1|STARTED|Overall Study||41
8429840|NCT00856583|20775139|P2|NOT COMPLETED|Overall Study||2597
8429841|NCT00856583|20775140|P1|NOT COMPLETED|Overall Study||3137
8429842|NCT00856583|20775139|P2|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
8429843|NCT00856583|20775140|P1|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
8429844|NCT00856583|20775139|P2|STARTED|Overall Study|Patients treated|4904
8429845|NCT00856583|20775140|P1|STARTED|Overall Study|Patients treated|4905
8429846|NCT00856557|20775170|P2|NOT COMPLETED|Overall Study||16
8429847|NCT00856557|20775171|P1|NOT COMPLETED|Overall Study||12
8429848|NCT00856557|20775170|P2|COMPLETED|Overall Study||60
8429849|NCT00856557|20775171|P1|COMPLETED|Overall Study||50
8429850|NCT00856557|20775170|P2|With Patients With Contextual Flags|Overall Study||60
8429851|NCT00856557|20775171|P1|With Patients With Contextual Flags|Overall Study||50
8429852|NCT00856557|20775170|P2|Tested With Standardized Patients|Overall Study||76
8429853|NCT00856557|20775171|P1|Tested With Standardized Patients|Overall Study||62
8429854|NCT00856557|20775170|P2|Received Intervention/Control|Overall Study||76
8429855|NCT00856557|20775171|P1|Received Intervention/Control|Overall Study||62
8429856|NCT00856557|20775170|P2|STARTED|Overall Study||76
8429857|NCT00856557|20775171|P1|STARTED|Overall Study||62
8429858|NCT00856544|20775185|P4|NOT COMPLETED|Overall Study||13
8429859|NCT00856544|20775186|P3|NOT COMPLETED|Overall Study||8
8429860|NCT00856544|20775187|P2|NOT COMPLETED|Overall Study||66
8429861|NCT00856544|20775188|P1|NOT COMPLETED|Overall Study||57
8429862|NCT00856544|20775185|P4|COMPLETED|Overall Study||67
8429863|NCT00856544|20775186|P3|COMPLETED|Overall Study||71
8429864|NCT00856544|20775187|P2|COMPLETED|Overall Study||252
8429865|NCT00856544|20775188|P1|COMPLETED|Overall Study||261
8429866|NCT00856544|20775185|P4|Treated|Overall Study||80
8429867|NCT00856544|20775186|P3|Treated|Overall Study||79
8429868|NCT00856544|20775187|P2|Treated|Overall Study||318
8429869|NCT00856544|20775188|P1|Treated|Overall Study||315
8429870|NCT00856544|20775185|P4|STARTED|Overall Study||80
8429871|NCT00856544|20775186|P3|STARTED|Overall Study||79
8429872|NCT00856544|20775187|P2|STARTED|Overall Study||318
8429873|NCT00856544|20775188|P1|STARTED|Overall Study||318
8429874|NCT00856518|20775367|P2|NOT COMPLETED|Overall Study||2
8429875|NCT00856518|20775368|P1|NOT COMPLETED|Overall Study||4
8429876|NCT00856518|20775367|P2|COMPLETED|Overall Study||16
8429877|NCT00856518|20775368|P1|COMPLETED|Overall Study||20
8429878|NCT00856518|20775367|P2|STARTED|Overall Study||18
8429879|NCT00856518|20775368|P1|STARTED|Overall Study||24
8429880|NCT00856492|20775381|P3|NOT COMPLETED|Overall Study||2
8429881|NCT00856492|20775382|P2|NOT COMPLETED|Overall Study||1
8429882|NCT00856492|20775383|P1|NOT COMPLETED|Overall Study||1
8429883|NCT00856492|20775381|P3|COMPLETED|Overall Study||51
8429884|NCT00856492|20775382|P2|COMPLETED|Overall Study||62
8429885|NCT00856492|20775383|P1|COMPLETED|Overall Study||98
8429886|NCT00856492|20775381|P3|Toxicity Eval|Overall Study||51
8429887|NCT00856492|20775382|P2|Toxicity Eval|Overall Study||60
8429888|NCT00856492|20775383|P1|Toxicity Eval|Overall Study||96
8429889|NCT00856492|20775381|P3|STARTED|Overall Study||53
8429890|NCT00856492|20775382|P2|STARTED|Overall Study||63
8429891|NCT00856492|20775383|P1|STARTED|Overall Study||99
8429892|NCT00856414|20775397|P1|NOT COMPLETED|Overall Study||0
8429893|NCT00856414|20775397|P1|COMPLETED|Overall Study||45
8429894|NCT00856414|20775397|P1|STARTED|Overall Study||45
8429895|NCT00856388|20775405|P1|NOT COMPLETED|Overall Study||1
8429896|NCT00856388|20775405|P1|COMPLETED|Overall Study||61
8429897|NCT00856388|20775405|P1|STARTED|Overall Study||62
8429898|NCT00856349|20775416|P1|NOT COMPLETED|Overall Study||1021
8429899|NCT00856349|20775416|P1|COMPLETED|Overall Study||3111
8429900|NCT00856349|20775416|P1|24 Month Follow-up|Overall Study||1698
8429901|NCT00856349|20775416|P1|18 Month Follow-up|Overall Study||2467
8429902|NCT00856349|20775416|P1|12 Month Follow-up|Overall Study||3228
8429903|NCT00856349|20775416|P1|STARTED|Overall Study||4132
8429904|NCT00856323|20775425|P1|NOT COMPLETED|Overall Study||2
8429905|NCT00856323|20775425|P1|COMPLETED|Overall Study||51
8429906|NCT00856323|20775425|P1|STARTED|Overall Study||53
8429907|NCT00856297|20775437|P5|NOT COMPLETED|Overall Study||0
8429908|NCT00856297|20775438|P4|NOT COMPLETED|Overall Study||0
8429909|NCT00856297|20775439|P3|NOT COMPLETED|Overall Study||0
8429910|NCT00856297|20775440|P2|NOT COMPLETED|Overall Study||0
8429911|NCT00856297|20775441|P1|NOT COMPLETED|Overall Study||2
8429912|NCT00856297|20775437|P5|COMPLETED|Overall Study||31
8429913|NCT00856297|20775438|P4|COMPLETED|Overall Study||44
8429914|NCT00856297|20775439|P3|COMPLETED|Overall Study||107
8429915|NCT00856297|20775440|P2|COMPLETED|Overall Study||76
8429916|NCT00856297|20775441|P1|COMPLETED|Overall Study||129
8429917|NCT00856297|20775437|P5|STARTED|Overall Study||31
8429918|NCT00856297|20775438|P4|STARTED|Overall Study||44
8429919|NCT00856297|20775439|P3|STARTED|Overall Study||107
8429920|NCT00856297|20775440|P2|STARTED|Overall Study||76
8429921|NCT00856297|20775441|P1|STARTED|Overall Study||131
8429922|NCT00856284|20775474|P3|NOT COMPLETED|Overall Study||447
8429923|NCT00856284|20775475|P2|NOT COMPLETED|Overall Study||392
8429924|NCT00856284|20775476|P1|NOT COMPLETED|Overall Study||408
8429925|NCT00856284|20775474|P3|COMPLETED|Overall Study||427
8429926|NCT00856284|20775475|P2|COMPLETED|Overall Study||493
8429927|NCT00856284|20775476|P1|COMPLETED|Overall Study||472
8429928|NCT00856284|20775474|P3|Received Study Drug|Overall Study||869
8429929|NCT00856284|20775475|P2|Received Study Drug|Overall Study||878
8429930|NCT00856284|20775476|P1|Received Study Drug|Overall Study||873
8429931|NCT00856284|20775474|P3|STARTED|Overall Study||874
8429932|NCT00856284|20775475|P2|STARTED|Overall Study||885
8429933|NCT00856284|20775476|P1|STARTED|Overall Study||880
8429934|NCT00856245|20775502|P1|NOT COMPLETED|Overall Study||5
8429935|NCT00856245|20775502|P1|COMPLETED|Overall Study||14
8429936|NCT00856245|20775502|P1|STARTED|Overall Study||19
8429937|NCT00856232|20775510|P3|NOT COMPLETED|Overall Study||0
8429938|NCT00856232|20775511|P2|NOT COMPLETED|Overall Study||0
8429939|NCT00856232|20775512|P1|NOT COMPLETED|Overall Study||0
8429940|NCT00856232|20775510|P3|COMPLETED|Overall Study||36
8429941|NCT00856232|20775511|P2|COMPLETED|Overall Study||29
8429942|NCT00856232|20775512|P1|COMPLETED|Overall Study||26
8429943|NCT00856232|20775510|P3|STARTED|Overall Study||36
8429944|NCT00856232|20775511|P2|STARTED|Overall Study||29
8429945|NCT00856232|20775512|P1|STARTED|Overall Study||26
8429946|NCT00856206|20775525|P2|NOT COMPLETED|Overall Study||161
8429947|NCT00856206|20775526|P1|NOT COMPLETED|Overall Study||54
8429948|NCT00856206|20775525|P2|COMPLETED|Overall Study||824
8429949|NCT00856206|20775526|P1|COMPLETED|Overall Study||276
8429950|NCT00856206|20775525|P2|STARTED|Overall Study||985
8429951|NCT00856206|20775526|P1|STARTED|Overall Study||330
8429952|NCT00856193|20775540|P2|NOT COMPLETED|Period 2||2
8429953|NCT00856193|20775541|P1|NOT COMPLETED|Period 2||0
8429954|NCT00856193|20775540|P2|COMPLETED|Period 2||15
8429955|NCT00856193|20775541|P1|COMPLETED|Period 2||16
8429956|NCT00856193|20775540|P2|STARTED|Period 2||17
8429957|NCT00856193|20775541|P1|STARTED|Period 2||16
8429958|NCT00856193|20775540|P2|NOT COMPLETED|Period 1||0
8429959|NCT00856193|20775541|P1|NOT COMPLETED|Period 1||0
8429960|NCT00856193|20775540|P2|COMPLETED|Period 1||17
8429961|NCT00856193|20775541|P1|COMPLETED|Period 1||16
8429962|NCT00856193|20775540|P2|STARTED|Period 1||17
8429963|NCT00856193|20775541|P1|STARTED|Period 1||16
8429964|NCT00856180|20775553|P1|NOT COMPLETED|Overall Study||20
8429965|NCT00856180|20775553|P1|COMPLETED|Overall Study||0
8429966|NCT00856180|20775553|P1|STARTED|Overall Study||20
8429967|NCT00856050|20775562|P1|NOT COMPLETED|Overall Study||0
8429968|NCT00856050|20775562|P1|COMPLETED|Overall Study||26
8429969|NCT00856050|20775562|P1|STARTED|Overall Study||26
8429970|NCT00856024|20775566|P1|NOT COMPLETED|Overall Study||0
8429971|NCT00856024|20775566|P1|COMPLETED|Overall Study||902
8429972|NCT00856024|20775566|P1|STARTED|Overall Study||902
8429973|NCT00855959|20775578|P1|NOT COMPLETED|Overall Study||9
8429974|NCT00855959|20775578|P1|COMPLETED|Overall Study||99
8429975|NCT00855959|20775578|P1|Patients Who Received Pulmicort Respules|Overall Study||105
8429976|NCT00855959|20775578|P1|STARTED|Overall Study||108
8429977|NCT00855933|20775595|P2|NOT COMPLETED|Overall Study||1
8429978|NCT00855933|20775596|P1|NOT COMPLETED|Overall Study||0
8429979|NCT00855933|20775595|P2|COMPLETED|Overall Study||29
8429980|NCT00855933|20775596|P1|COMPLETED|Overall Study||30
8429981|NCT00855933|20775595|P2|STARTED|Overall Study||30
8429982|NCT00855933|20775596|P1|STARTED|Overall Study||30
8429983|NCT00855920|20775605|P3|NOT COMPLETED|Overall Study||11
8429984|NCT00855920|20775606|P2|NOT COMPLETED|Overall Study||9
8429985|NCT00855920|20775607|P1|NOT COMPLETED|Overall Study||8
8429986|NCT00855920|20775605|P3|COMPLETED|Overall Study||64
8429987|NCT00855920|20775606|P2|COMPLETED|Overall Study||65
8429988|NCT00855920|20775607|P1|COMPLETED|Overall Study||68
8429989|NCT00855920|20775605|P3|Safety Population|Overall Study||75
8429990|NCT00855920|20775606|P2|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
8429991|NCT00855920|20775607|P1|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
8429992|NCT00855920|20775605|P3|STARTED|Overall Study||75
8429993|NCT00855920|20775606|P2|STARTED|Overall Study||74
8429994|NCT00855920|20775607|P1|STARTED|Overall Study||76
8429995|NCT00855894|20775624|P1|NOT COMPLETED|Overall Study||33
8429996|NCT00855894|20775624|P1|COMPLETED|Overall Study||8
8429997|NCT00855894|20775624|P1|STARTED|Overall Study||41
8429998|NCT00855868|20775634|P2|NOT COMPLETED|Overall Study||1
8429999|NCT00855868|20775635|P1|NOT COMPLETED|Overall Study||1
8430000|NCT00855868|20775634|P2|COMPLETED|Overall Study||14
8430001|NCT00855868|20775635|P1|COMPLETED|Overall Study||12
8430002|NCT00855868|20775634|P2|STARTED|Overall Study||15
8430003|NCT00855868|20775635|P1|STARTED|Overall Study||13
8430004|NCT00855842|20775641|P1|NOT COMPLETED|Overall Study||0
8430005|NCT00855842|20775641|P1|COMPLETED|Overall Study||4
8430006|NCT00855842|20775641|P1|STARTED|Overall Study||4
8430007|NCT00855816|20775647|P2|NOT COMPLETED|Overall Study||21
8430008|NCT00855816|20775648|P1|NOT COMPLETED|Overall Study||26
8430009|NCT00855816|20775647|P2|COMPLETED|Overall Study||12
8430010|NCT00855816|20775648|P1|COMPLETED|Overall Study||21
8430011|NCT00855816|20775647|P2|STARTED|Overall Study||33
8430012|NCT00855816|20775648|P1|STARTED|Overall Study||47
8430013|NCT00855738|20775654|P1|NOT COMPLETED|Overall Study||5
8430014|NCT00855738|20775654|P1|COMPLETED|Overall Study||106
8430015|NCT00855738|20775654|P1|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
8430016|NCT00855738|20775654|P1|STARTED|Overall Study||111
8430017|NCT00855595|20775682|P2|NOT COMPLETED|Overall Study||7
8430018|NCT00855595|20775683|P1|NOT COMPLETED|Overall Study||6
8430019|NCT00855595|20775682|P2|COMPLETED|Overall Study||94
8430020|NCT00855595|20775683|P1|COMPLETED|Overall Study||100
8430021|NCT00855595|20775682|P2|STARTED|Overall Study||101
8430022|NCT00855595|20775683|P1|STARTED|Overall Study||106
8430023|NCT00855582|20775722|P3|NOT COMPLETED|Overall Study||30
8430024|NCT00855582|20775723|P2|NOT COMPLETED|Overall Study||24
8430025|NCT00855582|20775724|P1|NOT COMPLETED|Overall Study||26
8430026|NCT00855582|20775722|P3|COMPLETED|Overall Study||170
8430027|NCT00855582|20775723|P2|COMPLETED|Overall Study||184
8430028|NCT00855582|20775724|P1|COMPLETED|Overall Study||172
8430029|NCT00855582|20775722|P3|STARTED|Overall Study||200
8430030|NCT00855582|20775723|P2|STARTED|Overall Study||208
8430031|NCT00855582|20775724|P1|STARTED|Overall Study||198
8430032|NCT00855465|20775813|P2|NOT COMPLETED|Follow-up Period (FUP)||2
8430033|NCT00855465|20775814|P1|NOT COMPLETED|Follow-up Period (FUP)||8
8430034|NCT00855465|20775813|P2|COMPLETED|Follow-up Period (FUP)||2
8430035|NCT00855465|20775814|P1|COMPLETED|Follow-up Period (FUP)||9
8430036|NCT00855465|20775813|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
8430037|NCT00855465|20775814|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
8430038|NCT00855465|20775813|P2|NOT COMPLETED|Treatment Period||5
8430039|NCT00855465|20775814|P1|NOT COMPLETED|Treatment Period||14
8430040|NCT00855465|20775813|P2|COMPLETED|Treatment Period||83
8430041|NCT00855465|20775814|P1|COMPLETED|Treatment Period||160
8430042|NCT00855465|20775813|P2|Participants Received Treatment|Treatment Period||88
8430043|NCT00855465|20775814|P1|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
8430044|NCT00855465|20775813|P2|STARTED|Treatment Period||88
8430045|NCT00855465|20775814|P1|STARTED|Treatment Period||174
8430046|NCT00855439|20775904|P2|NOT COMPLETED|Overall Study||0
8430047|NCT00855439|20775905|P1|NOT COMPLETED|Overall Study||3
8430048|NCT00855439|20775904|P2|COMPLETED|Overall Study||24
8430049|NCT00855439|20775905|P1|COMPLETED|Overall Study||19
8430050|NCT00855439|20775904|P2|STARTED|Overall Study||24
8430051|NCT00855439|20775905|P1|STARTED|Overall Study||22
8430052|NCT00855413|20775917|P1|NOT COMPLETED|Overall Study||0
8430053|NCT00855413|20775917|P1|COMPLETED|Overall Study||15
8430054|NCT00855413|20775917|P1|STARTED|Overall Study||15
8430055|NCT00855335|20775963|P5|NOT COMPLETED|Overall Study||1
8430056|NCT00855335|20775964|P4|NOT COMPLETED|Overall Study||7
8430057|NCT00855335|20775965|P3|NOT COMPLETED|Overall Study||5
8430058|NCT00855335|20775966|P2|NOT COMPLETED|Overall Study||2
8430059|NCT00855335|20775967|P1|NOT COMPLETED|Overall Study||5
8430060|NCT00855335|20775963|P5|COMPLETED|Overall Study||6
8430061|NCT00855335|20775964|P4|COMPLETED|Overall Study||12
8430062|NCT00855335|20775965|P3|COMPLETED|Overall Study||10
8430063|NCT00855335|20775966|P2|COMPLETED|Overall Study||16
8430064|NCT00855335|20775967|P1|COMPLETED|Overall Study||13
8430065|NCT00855335|20775963|P5|STARTED|Overall Study||7
8430066|NCT00855335|20775964|P4|STARTED|Overall Study||19
8430067|NCT00855335|20775965|P3|STARTED|Overall Study||15
8430068|NCT00855335|20775966|P2|STARTED|Overall Study||18
8430069|NCT00855335|20775967|P1|STARTED|Overall Study||18
8430070|NCT00855309|20776054|P2|NOT COMPLETED|Overall Study||0
8430071|NCT00855309|20776055|P1|NOT COMPLETED|Overall Study||1
8430072|NCT00855309|20776054|P2|COMPLETED|Overall Study||55
8430073|NCT00855309|20776055|P1|COMPLETED|Overall Study||56
8430074|NCT00855309|20776054|P2|STARTED|Overall Study||55
8430075|NCT00855309|20776055|P1|STARTED|Overall Study||57
8430076|NCT00855218|20776063|P2|NOT COMPLETED|Overall Study||153
8430077|NCT00855218|20776064|P1|NOT COMPLETED|Overall Study||154
8430078|NCT00855218|20776063|P2|COMPLETED|Overall Study||0
8430079|NCT00855218|20776064|P1|COMPLETED|Overall Study||0
8430080|NCT00855218|20776063|P2|Participants Received Treatment|Overall Study||151
8430081|NCT00855218|20776064|P1|Participants Received Treatment|Overall Study||153
8430082|NCT00855218|20776063|P2|STARTED|Overall Study||153
8430083|NCT00855218|20776064|P1|STARTED|Overall Study||154
8430084|NCT00855166|20776082|P2|NOT COMPLETED|Overall Study||8
8430085|NCT00855166|20776083|P1|NOT COMPLETED|Overall Study||5
8430086|NCT00855166|20776082|P2|COMPLETED|Overall Study||83
8430087|NCT00855166|20776083|P1|COMPLETED|Overall Study||86
8430088|NCT00855166|20776082|P2|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
8430089|NCT00855166|20776083|P1|STARTED|Overall Study||91
8430090|NCT00855062|20776103|P2|NOT COMPLETED|Step2||6
8430091|NCT00855062|20776104|P1|NOT COMPLETED|Step2||6
8430092|NCT00855062|20776103|P2|COMPLETED|Step2||15
8430093|NCT00855062|20776104|P1|COMPLETED|Step2||13
8430094|NCT00855062|20776103|P2|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
8430095|NCT00855062|20776104|P1|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
8430096|NCT00855062|20776103|P2|NOT COMPLETED|Step1||11
8430097|NCT00855062|20776104|P1|NOT COMPLETED|Step1||10
8430098|NCT00855062|20776103|P2|COMPLETED|Step1||26
8430099|NCT00855062|20776104|P1|COMPLETED|Step1||26
8430100|NCT00855062|20776103|P2|STARTED|Step1||37
8430101|NCT00855062|20776104|P1|STARTED|Step1||36
8430102|NCT00855010|20776130|P2|NOT COMPLETED|Overall Study||1
8430103|NCT00855010|20776131|P1|NOT COMPLETED|Overall Study||4
8430104|NCT00855010|20776130|P2|COMPLETED|Overall Study||18
8430105|NCT00855010|20776131|P1|COMPLETED|Overall Study||19
8430106|NCT00855010|20776130|P2|STARTED|Overall Study||19
8430107|NCT00855010|20776131|P1|STARTED|Overall Study||23
8430108|NCT00854906|20776153|P1|NOT COMPLETED|Overall Study||1
8430109|NCT00854906|20776153|P1|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
8430110|NCT00854906|20776153|P1|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
8430111|NCT00854724|20776162|P2|NOT COMPLETED|Second Intervention||1
8430112|NCT00854724|20776163|P1|NOT COMPLETED|Second Intervention||1
8430113|NCT00854724|20776162|P2|COMPLETED|Second Intervention||5
8430114|NCT00854724|20776163|P1|COMPLETED|Second Intervention||5
8430115|NCT00854724|20776162|P2|STARTED|Second Intervention||6
8430116|NCT00854724|20776163|P1|STARTED|Second Intervention||6
8430117|NCT00854724|20776162|P2|NOT COMPLETED|Washout||1
8430118|NCT00854724|20776163|P1|NOT COMPLETED|Washout||1
8430119|NCT00854724|20776162|P2|COMPLETED|Washout||6
8430120|NCT00854724|20776163|P1|COMPLETED|Washout||6
8430121|NCT00854724|20776162|P2|STARTED|Washout||7
8430122|NCT00854724|20776163|P1|STARTED|Washout||7
8430123|NCT00854724|20776162|P2|NOT COMPLETED|First Intervention||1
8430124|NCT00854724|20776163|P1|NOT COMPLETED|First Intervention||1
8430125|NCT00854724|20776162|P2|COMPLETED|First Intervention||7
8430126|NCT00854724|20776163|P1|COMPLETED|First Intervention||7
8430127|NCT00854724|20776162|P2|STARTED|First Intervention||8
8430128|NCT00854724|20776163|P1|STARTED|First Intervention||8
8430129|NCT00854620|20776169|P1|NOT COMPLETED|Overall Study||1
8430130|NCT00854620|20776169|P1|COMPLETED|Overall Study||8
8430131|NCT00854620|20776169|P1|STARTED|Overall Study||9
8430132|NCT00854607|20776173|P1|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
8430133|NCT00854607|20776173|P1|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
8430134|NCT00854607|20776173|P1|STARTED|2 Weeks After Start Anti-fungal Therapy||116
8430135|NCT00854607|20776173|P1|NOT COMPLETED|Enrollment||0
8430136|NCT00854607|20776173|P1|COMPLETED|Enrollment||116
8430137|NCT00854607|20776173|P1|STARTED|Enrollment||116
8430138|NCT00854594|20776208|P2|NOT COMPLETED|Overall Study||0
8430139|NCT00854594|20776209|P1|NOT COMPLETED|Overall Study||0
8430140|NCT00854594|20776208|P2|COMPLETED|Overall Study||69
8430141|NCT00854594|20776209|P1|COMPLETED|Overall Study||48
8430142|NCT00854594|20776208|P2|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
8430143|NCT00854594|20776209|P1|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
8430144|NCT00854581|20776221|P1|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
8430145|NCT00854581|20776221|P1|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
8430146|NCT00854581|20776221|P1|STARTED|Part 2 Maintenance (Up to 12 Months)||5
8430147|NCT00854581|20776221|P1|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
8430148|NCT00854581|20776221|P1|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
8430149|NCT00854581|20776221|P1|STARTED|Part 1 Maintenance (Up to Day 60)||7
8430150|NCT00854581|20776221|P1|NOT COMPLETED|Induction (Up to Day 21)||6
8430151|NCT00854581|20776221|P1|COMPLETED|Induction (Up to Day 21)||7
8430152|NCT00854581|20776221|P1|STARTED|Induction (Up to Day 21)||13
8430153|NCT00854373|20776236|P2|NOT COMPLETED|Overall Study||4
8430154|NCT00854373|20776237|P1|NOT COMPLETED|Overall Study||2
8430155|NCT00854373|20776236|P2|COMPLETED|Overall Study||89
8430156|NCT00854373|20776237|P1|COMPLETED|Overall Study||93
8430157|NCT00854373|20776236|P2|STARTED|Overall Study||93
8430158|NCT00854373|20776237|P1|STARTED|Overall Study||95
8430159|NCT00854360|20776251|P4|NOT COMPLETED|Overall Study||10
8430160|NCT00854360|20776252|P3|NOT COMPLETED|Overall Study||2
8430161|NCT00854360|20776253|P2|NOT COMPLETED|Overall Study||3
8430162|NCT00854360|20776254|P1|NOT COMPLETED|Overall Study||2
8430163|NCT00854360|20776251|P4|COMPLETED|Overall Study||114
8430164|NCT00854360|20776252|P3|COMPLETED|Overall Study||120
8430165|NCT00854360|20776253|P2|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
8430166|NCT00854360|20776254|P1|COMPLETED|Overall Study||116
8430167|NCT00854360|20776251|P4|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
8430168|NCT00854360|20776252|P3|Intent to Treat / Safety Population|Overall Study||122
8430169|NCT00854360|20776253|P2|Intent to Treat / Safety Population|Overall Study||123
8430170|NCT00854360|20776254|P1|Intent to Treat / Safety Population|Overall Study||118
8430171|NCT00854360|20776251|P4|STARTED|Overall Study||124
8430172|NCT00854360|20776252|P3|STARTED|Overall Study||122
8430173|NCT00854360|20776253|P2|STARTED|Overall Study||123
8430174|NCT00854360|20776254|P1|STARTED|Overall Study||118
8430175|NCT00854308|20776286|P2|NOT COMPLETED|Overall Study||67
8430176|NCT00854308|20776287|P1|NOT COMPLETED|Overall Study||62
8430177|NCT00854308|20776286|P2|COMPLETED|Overall Study||1
8430178|NCT00854308|20776287|P1|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
8430179|NCT00854308|20776286|P2|Received Study Drug|Overall Study||67
8430180|NCT00854308|20776287|P1|Received Study Drug|Overall Study||69
8430181|NCT00854308|20776286|P2|STARTED|Overall Study||68
8430182|NCT00854308|20776287|P1|STARTED|Overall Study||69
8430183|NCT00854113|20776312|P11|NOT COMPLETED|Overall Study||0
8430184|NCT00854113|20776313|P10|NOT COMPLETED|Overall Study||0
8430185|NCT00854113|20776314|P9|NOT COMPLETED|Overall Study||1
8430186|NCT00854113|20776315|P8|NOT COMPLETED|Overall Study||3
8430187|NCT00854113|20776316|P7|NOT COMPLETED|Overall Study||0
8430188|NCT00854113|20776317|P6|NOT COMPLETED|Overall Study||0
8430189|NCT00854113|20776318|P5|NOT COMPLETED|Overall Study||0
8430190|NCT00854113|20776319|P4|NOT COMPLETED|Overall Study||0
8430191|NCT00854113|20776320|P3|NOT COMPLETED|Overall Study||0
8430192|NCT00854113|20776321|P2|NOT COMPLETED|Overall Study||0
8430193|NCT00854113|20776322|P1|NOT COMPLETED|Overall Study||0
8430194|NCT00854113|20776312|P11|COMPLETED|Overall Study||6
8430195|NCT00854113|20776313|P10|COMPLETED|Overall Study||8
8430196|NCT00854113|20776314|P9|COMPLETED|Overall Study||7
8430197|NCT00854113|20776315|P8|COMPLETED|Overall Study||5
8430198|NCT00854113|20776316|P7|COMPLETED|Overall Study||12
8430199|NCT00854113|20776317|P6|COMPLETED|Overall Study||6
8430200|NCT00854113|20776318|P5|COMPLETED|Overall Study||6
8430201|NCT00854113|20776319|P4|COMPLETED|Overall Study||6
8430202|NCT00854113|20776320|P3|COMPLETED|Overall Study||6
8430203|NCT00854113|20776321|P2|COMPLETED|Overall Study||6
8430204|NCT00854113|20776322|P1|COMPLETED|Overall Study||6
8430205|NCT00854113|20776312|P11|STARTED|Overall Study||6
8430206|NCT00854113|20776313|P10|STARTED|Overall Study||8
8430207|NCT00854113|20776314|P9|STARTED|Overall Study||8
8430208|NCT00854113|20776315|P8|STARTED|Overall Study||8
8430209|NCT00854113|20776316|P7|STARTED|Overall Study||12
8430210|NCT00854113|20776317|P6|STARTED|Overall Study||6
8430211|NCT00854113|20776318|P5|STARTED|Overall Study||6
8430212|NCT00854113|20776319|P4|STARTED|Overall Study||6
8430213|NCT00854113|20776320|P3|STARTED|Overall Study||6
8430214|NCT00854113|20776321|P2|STARTED|Overall Study||6
8430215|NCT00854113|20776322|P1|STARTED|Overall Study||6
8430216|NCT00854100|20776426|P3|NOT COMPLETED|Overall Study||11
8430217|NCT00854100|20776427|P2|NOT COMPLETED|Overall Study||6
8430218|NCT00854100|20776428|P1|NOT COMPLETED|Overall Study||9
8430219|NCT00854100|20776426|P3|COMPLETED|Overall Study||63
8430220|NCT00854100|20776427|P2|COMPLETED|Overall Study||70
8430221|NCT00854100|20776428|P1|COMPLETED|Overall Study||72
8430222|NCT00854100|20776426|P3|STARTED|Overall Study||74
8430223|NCT00854100|20776427|P2|STARTED|Overall Study||76
8430224|NCT00854100|20776428|P1|STARTED|Overall Study||81
8430231|NCT00854061|20776449|P1|NOT COMPLETED|Overall Study||23
8430232|NCT00854061|20776449|P1|COMPLETED|Overall Study||149
8430233|NCT00854061|20776449|P1|Completed 2nd Surgery (T-PRED and Pred Forte in Opposite Eyes Compared to 1st Surgery)|Overall Study||149
8430234|NCT00854061|20776449|P1|Completed 1st Surgery (T-PRED in One Eye and Pred Forte in the Other Eye)|Overall Study||162
8430235|NCT00854061|20776449|P1|STARTED|Overall Study||172
8430236|NCT00853996|20776455|P1|NOT COMPLETED|Overall Study||0
8430237|NCT00853996|20776455|P1|COMPLETED|Overall Study||25
8430238|NCT00853996|20776455|P1|STARTED|Overall Study||25
8430239|NCT00853970|20776467|P2|NOT COMPLETED|Overall Study||3
8430240|NCT00853970|20776468|P1|NOT COMPLETED|Overall Study||6
8430241|NCT00853970|20776467|P2|COMPLETED|Overall Study||144
8430242|NCT00853970|20776468|P1|COMPLETED|Overall Study||146
8430243|NCT00853970|20776467|P2|STARTED|Overall Study||147
8430244|NCT00853970|20776468|P1|STARTED|Overall Study||152
8430245|NCT00853957|20776478|P2|NOT COMPLETED|Overall Study||19
8430246|NCT00853957|20776479|P1|NOT COMPLETED|Overall Study||14
8430247|NCT00853957|20776478|P2|COMPLETED|Overall Study||204
8430248|NCT00853957|20776479|P1|COMPLETED|Overall Study||206
8430249|NCT00853957|20776478|P2|STARTED|Overall Study||223
8430250|NCT00853957|20776479|P1|STARTED|Overall Study||220
8430251|NCT00853905|20776497|P2|NOT COMPLETED|Overall Study||4
8430252|NCT00853905|20776498|P1|NOT COMPLETED|Overall Study||2
8430253|NCT00853905|20776497|P2|COMPLETED|Overall Study||36
8430254|NCT00853905|20776498|P1|COMPLETED|Overall Study||35
8430255|NCT00853905|20776497|P2|STARTED|Overall Study||40
8430256|NCT00853905|20776498|P1|STARTED|Overall Study||37
8430257|NCT00853840|20776512|P2|NOT COMPLETED|Period 2||0
8430258|NCT00853840|20776513|P1|NOT COMPLETED|Period 2||0
8430259|NCT00853840|20776512|P2|COMPLETED|Period 2||9
8430260|NCT00853840|20776513|P1|COMPLETED|Period 2||9
8430261|NCT00853840|20776512|P2|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
8430262|NCT00853840|20776513|P1|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
8430263|NCT00853840|20776512|P2|Maraviroc (Days 1 - 3)|Period 2||9
8430264|NCT00853840|20776513|P1|Maraviroc (Days 1 - 3)|Period 2||9
8430265|NCT00853840|20776512|P2|STARTED|Period 2||9
8430266|NCT00853840|20776513|P1|STARTED|Period 2||9
8430267|NCT00853840|20776512|P2|NOT COMPLETED|Period 1||0
8430268|NCT00853840|20776513|P1|NOT COMPLETED|Period 1||0
8430269|NCT00853840|20776512|P2|COMPLETED|Period 1||9
8430270|NCT00853840|20776513|P1|COMPLETED|Period 1||9
8430271|NCT00853840|20776512|P2|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
8430272|NCT00853840|20776513|P1|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
8430273|NCT00853840|20776512|P2|Maraviroc (Days 1 - 4)|Period 1||9
8430274|NCT00853840|20776513|P1|Maraviroc (Days 1 - 4)|Period 1||9
8430275|NCT00853840|20776512|P2|STARTED|Period 1||9
8430276|NCT00853840|20776513|P1|STARTED|Period 1||9
8430277|NCT00853827|20776530|P2|NOT COMPLETED|Double Blind Period (103 Weeks)||109
8430278|NCT00853827|20776531|P1|NOT COMPLETED|Double Blind Period (103 Weeks)||104
8430279|NCT00853827|20776530|P2|COMPLETED|Double Blind Period (103 Weeks)||199
8430280|NCT00853827|20776531|P1|COMPLETED|Double Blind Period (103 Weeks)||201
8430281|NCT00853827|20776530|P2|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
8430282|NCT00853827|20776531|P1|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
8430283|NCT00853827|20776530|P2|STARTED|Double Blind Period (103 Weeks)||308
8430284|NCT00853827|20776531|P1|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
8430285|NCT00853827|20776530|P2|NOT COMPLETED|Single Blind Period (1 Week)||0
8430286|NCT00853827|20776531|P1|NOT COMPLETED|Single Blind Period (1 Week)||39
8430287|NCT00853827|20776530|P2|COMPLETED|Single Blind Period (1 Week)||0
8430288|NCT00853827|20776531|P1|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
8430289|NCT00853827|20776530|P2|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
8430290|NCT00853827|20776531|P1|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
8430291|NCT00853762|20776547|P4|NOT COMPLETED|Overall Study||22
8430292|NCT00853762|20776548|P3|NOT COMPLETED|Overall Study||17
8430293|NCT00853762|20776549|P2|NOT COMPLETED|Overall Study||19
8430294|NCT00853762|20776550|P1|NOT COMPLETED|Overall Study||16
8430295|NCT00853762|20776547|P4|COMPLETED|Overall Study||0
8430296|NCT00853762|20776548|P3|COMPLETED|Overall Study||0
8430297|NCT00853762|20776549|P2|COMPLETED|Overall Study||0
8430298|NCT00853762|20776550|P1|COMPLETED|Overall Study||0
8430299|NCT00853762|20776547|P4|STARTED|Overall Study||22
8430300|NCT00853762|20776548|P3|STARTED|Overall Study||17
8430301|NCT00853762|20776549|P2|STARTED|Overall Study||19
8430302|NCT00853762|20776550|P1|STARTED|Overall Study||16
8430303|NCT00853749|20776618|P2|NOT COMPLETED|Overall Study||1
8430304|NCT00853749|20776619|P1|NOT COMPLETED|Overall Study||0
8430305|NCT00853749|20776618|P2|COMPLETED|Overall Study||38
8430306|NCT00853749|20776619|P1|COMPLETED|Overall Study||50
8430307|NCT00853749|20776618|P2|Vaccinated|Overall Study||39
8430308|NCT00853749|20776619|P1|Vaccinated|Overall Study||50
8430309|NCT00853749|20776618|P2|STARTED|Overall Study||39
8430310|NCT00853749|20776619|P1|STARTED|Overall Study||50
8430311|NCT00853723|20776640|P3|NOT COMPLETED|Overall Study||2
8430312|NCT00853723|20776641|P2|NOT COMPLETED|Overall Study||7
8430313|NCT00853723|20776642|P1|NOT COMPLETED|Overall Study||6
8430314|NCT00853723|20776640|P3|COMPLETED|Overall Study||33
8430315|NCT00853723|20776641|P2|COMPLETED|Overall Study||28
8430316|NCT00853723|20776642|P1|COMPLETED|Overall Study||29
8430317|NCT00853723|20776640|P3|STARTED|Overall Study||35
8430318|NCT00853723|20776641|P2|STARTED|Overall Study||35
8430319|NCT00853723|20776642|P1|STARTED|Overall Study||35
8430320|NCT00853671|20776686|P1|NOT COMPLETED|Overall Study||0
8430321|NCT00853671|20776686|P1|COMPLETED|Overall Study||50
8430322|NCT00853671|20776686|P1|STARTED|Overall Study||50
8430323|NCT00853658|20776696|P3|NOT COMPLETED|Overall Study||815
8430324|NCT00853658|20776697|P2|NOT COMPLETED|Overall Study||832
8430325|NCT00853658|20776698|P1|NOT COMPLETED|Overall Study||787
8430326|NCT00853658|20776696|P3|COMPLETED|Overall Study||1539
8430327|NCT00853658|20776697|P2|COMPLETED|Overall Study||1524
8430328|NCT00853658|20776698|P1|COMPLETED|Overall Study||1567
8430329|NCT00853658|20776696|P3|Safety Set|Overall Study||2345
8430330|NCT00853658|20776697|P2|Safety Set|Overall Study||2348
8430331|NCT00853658|20776698|P1|Safety Set|Overall Study||2347
8430332|NCT00853658|20776696|P3|Full Analysis Set (FAS)|Overall Study||2336
8430333|NCT00853658|20776697|P2|Full Analysis Set (FAS)|Overall Study||2340
8430334|NCT00853658|20776698|P1|Full Analysis Set (FAS)|Overall Study||2340
8430335|NCT00853658|20776696|P3|STARTED|Overall Study||2354
8430336|NCT00853658|20776697|P2|STARTED|Overall Study||2356
8430337|NCT00853658|20776698|P1|STARTED|Overall Study||2354
8430338|NCT00853606|20776712|P1|NOT COMPLETED|Overall Study||220
8430339|NCT00853606|20776712|P1|COMPLETED|Overall Study||492
8430340|NCT00853606|20776712|P1|STARTED|Overall Study||712
8430341|NCT00853593|20776718|P1|NOT COMPLETED|Overall Study||45
8430342|NCT00853593|20776718|P1|COMPLETED|Overall Study||152
8430343|NCT00853593|20776718|P1|Model 4396 Lead Attempted|Overall Study||164
8430344|NCT00853593|20776718|P1|Implant Attempted|Overall Study||193
8430345|NCT00853593|20776718|P1|STARTED|Overall Study||197
8430346|NCT00853580|20776745|P2|NOT COMPLETED|Overall Study||16
8430347|NCT00853580|20776746|P1|NOT COMPLETED|Overall Study||7
8430348|NCT00853580|20776745|P2|COMPLETED|Overall Study||56
8430349|NCT00853580|20776746|P1|COMPLETED|Overall Study||67
8430350|NCT00853580|20776745|P2|STARTED|Overall Study||72
8430351|NCT00853580|20776746|P1|STARTED|Overall Study||74
8430352|NCT00853567|20776793|P1|NOT COMPLETED|Overall Study||71
8430353|NCT00853567|20776793|P1|COMPLETED|Overall Study||0
8430354|NCT00853567|20776793|P1|STARTED|Overall Study||71
8430355|NCT00853489|20776803|P2|NOT COMPLETED|Overall Study||2
8430356|NCT00853489|20776804|P1|NOT COMPLETED|Overall Study||5
8430357|NCT00853489|20776803|P2|COMPLETED|Overall Study||12
8430358|NCT00853489|20776804|P1|COMPLETED|Overall Study||11
8430359|NCT00853489|20776803|P2|STARTED|Overall Study||14
8430360|NCT00853489|20776804|P1|STARTED|Overall Study||16
8430361|NCT00853385|20776819|P5|NOT COMPLETED|Overall Study||42
8430362|NCT00853385|20776820|P4|NOT COMPLETED|Overall Study||13
8430363|NCT00853385|20776821|P3|NOT COMPLETED|Overall Study||9
8430364|NCT00853385|20776822|P2|NOT COMPLETED|Overall Study||43
8430365|NCT00853385|20776823|P1|NOT COMPLETED|Overall Study||54
8430366|NCT00853385|20776819|P5|COMPLETED|Overall Study||162
8430367|NCT00853385|20776820|P4|COMPLETED|Overall Study||39
8430368|NCT00853385|20776821|P3|COMPLETED|Overall Study||47
8430369|NCT00853385|20776822|P2|COMPLETED|Overall Study||158
8430370|NCT00853385|20776823|P1|COMPLETED|Overall Study||150
8430371|NCT00853385|20776819|P5|STARTED|Overall Study||204
8430372|NCT00853385|20776820|P4|STARTED|Overall Study||52
8430373|NCT00853385|20776821|P3|STARTED|Overall Study||56
8430374|NCT00853385|20776822|P2|STARTED|Overall Study||201
8430375|NCT00853385|20776823|P1|STARTED|Overall Study||204
8430376|NCT00853372|20777038|P2|NOT COMPLETED|Overall Study||29
8430377|NCT00853372|20777039|P1|NOT COMPLETED|Overall Study||32
8430378|NCT00853372|20777038|P2|COMPLETED|Overall Study||13
8430379|NCT00853372|20777039|P1|COMPLETED|Overall Study||11
8430380|NCT00853372|20777038|P2|STARTED|Overall Study||42
8430381|NCT00853372|20777039|P1|STARTED|Overall Study||43
8430382|NCT00853333|20777076|P3|NOT COMPLETED|Overall Study||0
8430383|NCT00853333|20777077|P2|NOT COMPLETED|Overall Study||0
8430384|NCT00853333|20777078|P1|NOT COMPLETED|Overall Study||0
8430385|NCT00853333|20777076|P3|COMPLETED|Overall Study||31
8430386|NCT00853333|20777077|P2|COMPLETED|Overall Study||27
8430387|NCT00853333|20777078|P1|COMPLETED|Overall Study||28
8430388|NCT00853333|20777076|P3|STARTED|Overall Study||31
8430389|NCT00853333|20777077|P2|STARTED|Overall Study||27
8430390|NCT00853333|20777078|P1|STARTED|Overall Study||28
8430391|NCT00853307|20777088|P2|NOT COMPLETED|Overall Study||5
8430392|NCT00853307|20777089|P1|NOT COMPLETED|Overall Study||2
8430393|NCT00853307|20777088|P2|COMPLETED|Overall Study||20
8430394|NCT00853307|20777089|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
8430395|NCT00853307|20777088|P2|STARTED|Overall Study||25
8430396|NCT00853307|20777089|P1|STARTED|Overall Study||6
8430397|NCT00853242|20777116|P7|NOT COMPLETED|Overall Study||5
8430398|NCT00853242|20777117|P6|NOT COMPLETED|Overall Study||2
8430399|NCT00853242|20777118|P5|NOT COMPLETED|Overall Study||4
8430400|NCT00853242|20777119|P4|NOT COMPLETED|Overall Study||4
8430401|NCT00853242|20777120|P3|NOT COMPLETED|Overall Study||3
8430402|NCT00853242|20777121|P2|NOT COMPLETED|Overall Study||3
8430403|NCT00853242|20777122|P1|NOT COMPLETED|Overall Study||3
8430404|NCT00853242|20777116|P7|COMPLETED|Overall Study||44
8430405|NCT00853242|20777117|P6|COMPLETED|Overall Study||49
8430406|NCT00853242|20777118|P5|COMPLETED|Overall Study||46
8430407|NCT00853242|20777119|P4|COMPLETED|Overall Study||46
8430408|NCT00853242|20777120|P3|COMPLETED|Overall Study||46
8430409|NCT00853242|20777121|P2|COMPLETED|Overall Study||47
8430410|NCT00853242|20777122|P1|COMPLETED|Overall Study||47
8430411|NCT00853242|20777116|P7|Treated|Overall Study||48
8430412|NCT00853242|20777117|P6|Treated|Overall Study||51
8430413|NCT00853242|20777118|P5|Treated|Overall Study||50
8430414|NCT00853242|20777119|P4|Treated|Overall Study||50
8430415|NCT00853242|20777120|P3|Treated|Overall Study||48
8430416|NCT00853242|20777121|P2|Treated|Overall Study||49
8430417|NCT00853242|20777122|P1|Treated|Overall Study||50
8430418|NCT00853242|20777116|P7|STARTED|Overall Study||49
8430419|NCT00853242|20777117|P6|STARTED|Overall Study||51
8430420|NCT00853242|20777118|P5|STARTED|Overall Study||50
8430421|NCT00853242|20777119|P4|STARTED|Overall Study||50
8430422|NCT00853242|20777120|P3|STARTED|Overall Study||49
8430423|NCT00853242|20777121|P2|STARTED|Overall Study||50
8430424|NCT00853242|20777122|P1|STARTED|Overall Study||50
8430437|NCT00853151|20777175|P4|NOT COMPLETED|Overall Study||3
8430438|NCT00853151|20777176|P3|NOT COMPLETED|Overall Study||8
8430439|NCT00853151|20777177|P2|NOT COMPLETED|Overall Study||13
8430440|NCT00853151|20777178|P1|NOT COMPLETED|Overall Study||10
8430441|NCT00853151|20777175|P4|COMPLETED|Overall Study||15
8430442|NCT00853151|20777176|P3|COMPLETED|Overall Study||30
8430443|NCT00853151|20777177|P2|COMPLETED|Overall Study||24
8430444|NCT00853151|20777178|P1|COMPLETED|Overall Study||28
8430445|NCT00853151|20777175|P4|STARTED|Overall Study||18
8430446|NCT00853151|20777176|P3|STARTED|Overall Study||38
8430447|NCT00853151|20777177|P2|STARTED|Overall Study||37
8430448|NCT00853151|20777178|P1|STARTED|Overall Study||38
8430452|NCT00853112|20777332|P7|NOT COMPLETED|Overall Study||1
8430453|NCT00853112|20777333|P6|NOT COMPLETED|Overall Study||0
8430454|NCT00853112|20777334|P5|NOT COMPLETED|Overall Study||0
8430455|NCT00853112|20777335|P4|NOT COMPLETED|Overall Study||2
8430456|NCT00853112|20777336|P3|NOT COMPLETED|Overall Study||0
8430457|NCT00853112|20777337|P2|NOT COMPLETED|Overall Study||1
8430458|NCT00853112|20777338|P1|NOT COMPLETED|Overall Study||0
8430459|NCT00853112|20777332|P7|COMPLETED|Overall Study||6
8430460|NCT00853112|20777333|P6|COMPLETED|Overall Study||7
8430461|NCT00853112|20777334|P5|COMPLETED|Overall Study||6
8430462|NCT00853112|20777335|P4|COMPLETED|Overall Study||6
8430463|NCT00853112|20777336|P3|COMPLETED|Overall Study||7
8430464|NCT00853112|20777337|P2|COMPLETED|Overall Study||6
8430465|NCT00853112|20777338|P1|COMPLETED|Overall Study||6
8430466|NCT00853112|20777332|P7|Treated|Overall Study||6
8430467|NCT00853112|20777333|P6|Treated|Overall Study||7
8430468|NCT00853112|20777334|P5|Treated|Overall Study||6
8430469|NCT00853112|20777335|P4|Treated|Overall Study||6
8430470|NCT00853112|20777336|P3|Treated|Overall Study||7
8430471|NCT00853112|20777337|P2|Treated|Overall Study||6
8430472|NCT00853112|20777338|P1|Treated|Overall Study||6
8430473|NCT00853112|20777332|P7|STARTED|Overall Study||7
8430474|NCT00853112|20777333|P6|STARTED|Overall Study||7
8430475|NCT00853112|20777334|P5|STARTED|Overall Study||6
8430476|NCT00853112|20777335|P4|STARTED|Overall Study||8
8430477|NCT00853112|20777336|P3|STARTED|Overall Study||7
8430478|NCT00853112|20777337|P2|STARTED|Overall Study||7
8430479|NCT00853112|20777338|P1|STARTED|Overall Study||6
8430480|NCT00853099|20777448|P4|NOT COMPLETED|Double-blind + Open-label Periods||147
8430481|NCT00853099|20777449|P3|NOT COMPLETED|Double-blind + Open-label Periods||0
8430482|NCT00853099|20777450|P2|NOT COMPLETED|Double-blind + Open-label Periods||0
8430483|NCT00853099|20777451|P1|NOT COMPLETED|Double-blind + Open-label Periods||0
8430484|NCT00853099|20777448|P4|COMPLETED|Double-blind + Open-label Periods||119
8430485|NCT00853099|20777449|P3|COMPLETED|Double-blind + Open-label Periods||0
8430486|NCT00853099|20777450|P2|COMPLETED|Double-blind + Open-label Periods||0
8430487|NCT00853099|20777451|P1|COMPLETED|Double-blind + Open-label Periods||0
8430488|NCT00853099|20777448|P4|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
8430489|NCT00853099|20777449|P3|STARTED|Double-blind + Open-label Periods||0
8430490|NCT00853099|20777450|P2|STARTED|Double-blind + Open-label Periods||0
8430491|NCT00853099|20777451|P1|STARTED|Double-blind + Open-label Periods||0
8430492|NCT00853099|20777448|P4|NOT COMPLETED|Double-blind Period||0
8430493|NCT00853099|20777449|P3|NOT COMPLETED|Double-blind Period||31
8430494|NCT00853099|20777450|P2|NOT COMPLETED|Double-blind Period||29
8430495|NCT00853099|20777451|P1|NOT COMPLETED|Double-blind Period||23
8430496|NCT00853099|20777448|P4|COMPLETED|Double-blind Period||0
8430497|NCT00853099|20777449|P3|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
8430498|NCT00853099|20777450|P2|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
8430499|NCT00853099|20777451|P1|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
8430500|NCT00853099|20777448|P4|Completed Week 8|Double-blind Period||0
8430501|NCT00853099|20777449|P3|Completed Week 8|Double-blind Period||86
8430502|NCT00853099|20777450|P2|Completed Week 8|Double-blind Period||85
8430503|NCT00853099|20777451|P1|Completed Week 8|Double-blind Period||92
8430504|NCT00853099|20777448|P4|Treated|Double-blind Period||0
8430505|NCT00853099|20777449|P3|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
8430506|NCT00853099|20777450|P2|Treated|Double-blind Period||87
8430507|NCT00853099|20777451|P1|Treated|Double-blind Period||96
8430508|NCT00853099|20777448|P4|STARTED|Double-blind Period||0
8430509|NCT00853099|20777449|P3|STARTED|Double-blind Period||91
8430510|NCT00853099|20777450|P2|STARTED|Double-blind Period||87
8430511|NCT00853099|20777451|P1|STARTED|Double-blind Period||96
8430512|NCT00853073|20777493|P2|NOT COMPLETED|Overall Study||2
8430513|NCT00853073|20777494|P1|NOT COMPLETED|Overall Study||3
8430514|NCT00853073|20777493|P2|COMPLETED|Overall Study||29
8430515|NCT00853073|20777494|P1|COMPLETED|Overall Study||29
8430516|NCT00853073|20777493|P2|STARTED|Overall Study||31
8430517|NCT00853073|20777494|P1|STARTED|Overall Study||32
8430518|NCT00853047|20777507|P6|NOT COMPLETED|Open-Label Extension Phase||17
8430519|NCT00853047|20777508|P5|NOT COMPLETED|Open-Label Extension Phase||0
8430520|NCT00853047|20777509|P4|NOT COMPLETED|Open-Label Extension Phase||0
8430521|NCT00853047|20777510|P3|NOT COMPLETED|Open-Label Extension Phase||0
8430522|NCT00853047|20777511|P2|NOT COMPLETED|Open-Label Extension Phase||0
8430523|NCT00853047|20777512|P1|NOT COMPLETED|Open-Label Extension Phase||0
8430524|NCT00853047|20777507|P6|COMPLETED|Open-Label Extension Phase||2
8430525|NCT00853047|20777508|P5|COMPLETED|Open-Label Extension Phase||0
8430526|NCT00853047|20777509|P4|COMPLETED|Open-Label Extension Phase||0
8430527|NCT00853047|20777510|P3|COMPLETED|Open-Label Extension Phase||0
8430528|NCT00853047|20777511|P2|COMPLETED|Open-Label Extension Phase||0
8430529|NCT00853047|20777512|P1|COMPLETED|Open-Label Extension Phase||0
8430530|NCT00853047|20777507|P6|Completed 8-week Extension Period|Open-Label Extension Phase||16
8430531|NCT00853047|20777508|P5|Completed 8-week Extension Period|Open-Label Extension Phase||0
8430532|NCT00853047|20777509|P4|Completed 8-week Extension Period|Open-Label Extension Phase||0
8430533|NCT00853047|20777510|P3|Completed 8-week Extension Period|Open-Label Extension Phase||0
8430534|NCT00853047|20777511|P2|Completed 8-week Extension Period|Open-Label Extension Phase||0
8430535|NCT00853047|20777512|P1|Completed 8-week Extension Period|Open-Label Extension Phase||0
8430536|NCT00853047|20777507|P6|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
8430537|NCT00853047|20777508|P5|STARTED|Open-Label Extension Phase||0
8430538|NCT00853047|20777509|P4|STARTED|Open-Label Extension Phase||0
8430539|NCT00853047|20777510|P3|STARTED|Open-Label Extension Phase||0
8430540|NCT00853047|20777511|P2|STARTED|Open-Label Extension Phase||0
8430541|NCT00853047|20777512|P1|STARTED|Open-Label Extension Phase||0
8430542|NCT00853047|20777507|P6|NOT COMPLETED|Core Phase||0
8430543|NCT00853047|20777508|P5|NOT COMPLETED|Core Phase||0
8430544|NCT00853047|20777509|P4|NOT COMPLETED|Core Phase||1
8430545|NCT00853047|20777510|P3|NOT COMPLETED|Core Phase||0
8430546|NCT00853047|20777511|P2|NOT COMPLETED|Core Phase||0
8430547|NCT00853047|20777512|P1|NOT COMPLETED|Core Phase||0
8430548|NCT00853047|20777507|P6|COMPLETED|Core Phase||0
8430549|NCT00853047|20777508|P5|COMPLETED|Core Phase||9
8430550|NCT00853047|20777509|P4|COMPLETED|Core Phase||2
8430551|NCT00853047|20777510|P3|COMPLETED|Core Phase||3
8430552|NCT00853047|20777511|P2|COMPLETED|Core Phase||3
8430553|NCT00853047|20777512|P1|COMPLETED|Core Phase||5
8430554|NCT00853047|20777507|P6|STARTED|Core Phase||0
8430555|NCT00853047|20777508|P5|STARTED|Core Phase||9
8430556|NCT00853047|20777509|P4|STARTED|Core Phase||3
8430557|NCT00853047|20777510|P3|STARTED|Core Phase||3
8430558|NCT00853047|20777511|P2|STARTED|Core Phase||3
8430559|NCT00853047|20777512|P1|STARTED|Core Phase||5
8430560|NCT00853021|20777578|P1|NOT COMPLETED|Overall Study||5
8430561|NCT00853021|20777578|P1|COMPLETED|Overall Study||21
8430562|NCT00853021|20777578|P1|STARTED|Overall Study||26
8430563|NCT00852995|20777590|P5|NOT COMPLETED|Overall Study||4
8430564|NCT00852995|20777591|P4|NOT COMPLETED|Overall Study||5
8430565|NCT00852995|20777592|P3|NOT COMPLETED|Overall Study||5
8430566|NCT00852995|20777593|P2|NOT COMPLETED|Overall Study||1
8430567|NCT00852995|20777594|P1|NOT COMPLETED|Overall Study||8
8430568|NCT00852995|20777590|P5|COMPLETED|Overall Study||46
8430569|NCT00852995|20777591|P4|COMPLETED|Overall Study||40
8430570|NCT00852995|20777592|P3|COMPLETED|Overall Study||39
8430571|NCT00852995|20777593|P2|COMPLETED|Overall Study||42
8430572|NCT00852995|20777594|P1|COMPLETED|Overall Study||38
8430573|NCT00852995|20777590|P5|STARTED|Overall Study||50
8430574|NCT00852995|20777591|P4|STARTED|Overall Study||45
8430575|NCT00852995|20777592|P3|STARTED|Overall Study||44
8430576|NCT00852995|20777593|P2|STARTED|Overall Study||43
8430577|NCT00852995|20777594|P1|STARTED|Overall Study||46
8430578|NCT00852969|20777638|P2|NOT COMPLETED|Overall Study||2
8430579|NCT00852969|20777639|P1|NOT COMPLETED|Overall Study||0
8430580|NCT00852969|20777638|P2|COMPLETED|Overall Study||13
8430581|NCT00852969|20777639|P1|COMPLETED|Overall Study||15
8430582|NCT00852969|20777638|P2|STARTED|Overall Study||15
8430583|NCT00852969|20777639|P1|STARTED|Overall Study||15
8430584|NCT00852930|20777650|P3|NOT COMPLETED|Overall Study||2
8430585|NCT00852930|20777651|P2|NOT COMPLETED|Overall Study||1
8430586|NCT00852930|20777652|P1|NOT COMPLETED|Overall Study||1
8430587|NCT00852930|20777650|P3|COMPLETED|Overall Study||15
8430588|NCT00852930|20777651|P2|COMPLETED|Overall Study||16
8430589|NCT00852930|20777652|P1|COMPLETED|Overall Study||15
8430590|NCT00852930|20777650|P3|STARTED|Overall Study||17
8430591|NCT00852930|20777651|P2|STARTED|Overall Study||17
8430592|NCT00852930|20777652|P1|STARTED|Overall Study||16
8430593|NCT00852917|20777673|P4|NOT COMPLETED|Overall Study||93
8430594|NCT00852917|20777674|P3|NOT COMPLETED|Overall Study||58
8430595|NCT00852917|20777675|P2|NOT COMPLETED|Overall Study||46
8430596|NCT00852917|20777676|P1|NOT COMPLETED|Overall Study||44
8430597|NCT00852917|20777673|P4|COMPLETED|Overall Study||134
8430598|NCT00852917|20777674|P3|COMPLETED|Overall Study||50
8430599|NCT00852917|20777675|P2|COMPLETED|Overall Study||65
8430600|NCT00852917|20777676|P1|COMPLETED|Overall Study||62
8430601|NCT00852917|20777673|P4|STARTED|Overall Study||227
8430602|NCT00852917|20777674|P3|STARTED|Overall Study||108
8430603|NCT00852917|20777675|P2|STARTED|Overall Study||111
8430604|NCT00852917|20777676|P1|STARTED|Overall Study||106
8430605|NCT00852761|20777716|P2|NOT COMPLETED|Overall Study||0
8430606|NCT00852761|20777717|P1|NOT COMPLETED|Overall Study||0
8430607|NCT00852761|20777716|P2|COMPLETED|Overall Study||17
8430608|NCT00852761|20777717|P1|COMPLETED|Overall Study||17
8430609|NCT00852761|20777716|P2|STARTED|Overall Study||17
8430610|NCT00852761|20777717|P1|STARTED|Overall Study||17
8430611|NCT00852644|20777759|P6|NOT COMPLETED|Overall Study||0
8430612|NCT00852644|20777760|P5|NOT COMPLETED|Overall Study||0
8430613|NCT00852644|20777761|P4|NOT COMPLETED|Overall Study||0
8430614|NCT00852644|20777762|P3|NOT COMPLETED|Overall Study||0
8430615|NCT00852644|20777763|P2|NOT COMPLETED|Overall Study||0
8430616|NCT00852644|20777764|P1|NOT COMPLETED|Overall Study||0
8430617|NCT00852644|20777759|P6|COMPLETED|Overall Study||0
8430618|NCT00852644|20777760|P5|COMPLETED|Overall Study||0
8430619|NCT00852644|20777761|P4|COMPLETED|Overall Study||3
8430620|NCT00852644|20777762|P3|COMPLETED|Overall Study||0
8430621|NCT00852644|20777763|P2|COMPLETED|Overall Study||3
8430622|NCT00852644|20777764|P1|COMPLETED|Overall Study||3
8430623|NCT00852644|20777759|P6|STARTED|Overall Study||0
8430624|NCT00852644|20777760|P5|STARTED|Overall Study||0
8430625|NCT00852644|20777761|P4|STARTED|Overall Study||3
8430626|NCT00852644|20777762|P3|STARTED|Overall Study||0
8430627|NCT00852644|20777763|P2|STARTED|Overall Study||3
8430628|NCT00852644|20777764|P1|STARTED|Overall Study||3
8430629|NCT00852631|20777785|P1|NOT COMPLETED|Overall Study||11
8430630|NCT00852631|20777785|P1|COMPLETED|Overall Study||17
8430631|NCT00852631|20777785|P1|STARTED|Overall Study||28
8430632|NCT00852592|20777793|P2|NOT COMPLETED|Overall Study||4
8430633|NCT00852592|20777794|P1|NOT COMPLETED|Overall Study||3
8430634|NCT00852592|20777793|P2|COMPLETED|Overall Study||19
8430635|NCT00852592|20777794|P1|COMPLETED|Overall Study||20
8430636|NCT00852592|20777793|P2|STARTED|Overall Study||23
8430637|NCT00852592|20777794|P1|STARTED|Overall Study||23
8430638|NCT00852540|20777804|P2|NOT COMPLETED|Overall Study||18
8430639|NCT00852540|20777805|P1|NOT COMPLETED|Overall Study||36
8430640|NCT00852540|20777804|P2|COMPLETED|Overall Study||122
8430641|NCT00852540|20777805|P1|COMPLETED|Overall Study||234
8430642|NCT00852540|20777804|P2|STARTED|Overall Study||140
8430643|NCT00852540|20777805|P1|STARTED|Overall Study||270
8430644|NCT00852527|20777831|P2|NOT COMPLETED|Overall Study||0
8430645|NCT00852527|20777832|P1|NOT COMPLETED|Overall Study||0
8430646|NCT00852527|20777831|P2|COMPLETED|Overall Study||242
8430647|NCT00852527|20777832|P1|COMPLETED|Overall Study||196
8430648|NCT00852527|20777831|P2|STARTED|Overall Study||242
8430649|NCT00852527|20777832|P1|STARTED|Overall Study||196
8430650|NCT00852475|20777839|P2|NOT COMPLETED|Overall Study||4
8430651|NCT00852475|20777840|P1|NOT COMPLETED|Overall Study||3
8430652|NCT00852475|20777839|P2|COMPLETED|Overall Study||16
8430653|NCT00852475|20777840|P1|COMPLETED|Overall Study||23
8430654|NCT00852475|20777839|P2|STARTED|Overall Study||20
8430655|NCT00852475|20777840|P1|STARTED|Overall Study||26
8430656|NCT00852397|20777851|P3|NOT COMPLETED|Overall Study||14
8430657|NCT00852397|20777852|P2|NOT COMPLETED|Overall Study||8
8430658|NCT00852397|20777853|P1|NOT COMPLETED|Overall Study||11
8430659|NCT00852397|20777851|P3|COMPLETED|Overall Study||36
8430660|NCT00852397|20777852|P2|COMPLETED|Overall Study||41
8430661|NCT00852397|20777853|P1|COMPLETED|Overall Study||41
8430662|NCT00852397|20777851|P3|Treated Participants|Overall Study||49
8430663|NCT00852397|20777852|P2|Treated Participants|Overall Study||49
8430664|NCT00852397|20777853|P1|Treated Participants|Overall Study||51
8430665|NCT00852397|20777851|P3|STARTED|Overall Study||50
8430666|NCT00852397|20777852|P2|STARTED|Overall Study||49
8430667|NCT00852397|20777853|P1|STARTED|Overall Study||52
8430668|NCT00852241|20777882|P1|NOT COMPLETED|Overall Study||18
8430669|NCT00852241|20777882|P1|COMPLETED|Overall Study||0
8430670|NCT00852241|20777882|P1|STARTED|Overall Study||18
8430671|NCT00852202|20777889|P3|NOT COMPLETED|Overall Study||26
8430672|NCT00852202|20777890|P2|NOT COMPLETED|Overall Study||12
8430673|NCT00852202|20777891|P1|NOT COMPLETED|Overall Study||17
8430674|NCT00852202|20777889|P3|COMPLETED|Overall Study||49
8430675|NCT00852202|20777890|P2|COMPLETED|Overall Study||63
8430676|NCT00852202|20777891|P1|COMPLETED|Overall Study||60
8430677|NCT00852202|20777889|P3|STARTED|Overall Study||75
8430678|NCT00852202|20777890|P2|STARTED|Overall Study||75
8430679|NCT00852202|20777891|P1|STARTED|Overall Study||77
8430680|NCT00852137|20777904|P2|NOT COMPLETED|Overall Study||0
8430681|NCT00852137|20777905|P1|NOT COMPLETED|Overall Study||0
8430682|NCT00852137|20777904|P2|COMPLETED|Overall Study||3
8430683|NCT00852137|20777905|P1|COMPLETED|Overall Study||13
8430684|NCT00852137|20777904|P2|STARTED|Overall Study||3
8430685|NCT00852137|20777905|P1|STARTED|Overall Study||13
8430692|NCT00851903|20777933|P1|NOT COMPLETED|Overall Study||2
8430693|NCT00851903|20777933|P1|COMPLETED|Overall Study||110
8430694|NCT00851903|20777933|P1|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
8430695|NCT00851903|20777933|P1|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
8430696|NCT00851903|20777933|P1|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
8430697|NCT00851903|20777933|P1|STARTED|Overall Study||112
8430698|NCT00851890|20777947|P4|NOT COMPLETED|Overall Study||1
8430699|NCT00851890|20777948|P3|NOT COMPLETED|Overall Study||0
8430700|NCT00851890|20777949|P2|NOT COMPLETED|Overall Study||1
8430701|NCT00851890|20777950|P1|NOT COMPLETED|Overall Study||0
8430702|NCT00851890|20777947|P4|COMPLETED|Overall Study||5
8430703|NCT00851890|20777948|P3|COMPLETED|Overall Study||8
8430704|NCT00851890|20777949|P2|COMPLETED|Overall Study||7
8430705|NCT00851890|20777950|P1|COMPLETED|Overall Study||8
8430706|NCT00851890|20777947|P4|STARTED|Overall Study||6
8430707|NCT00851890|20777948|P3|STARTED|Overall Study||8
8430708|NCT00851890|20777949|P2|STARTED|Overall Study||8
8430709|NCT00851890|20777950|P1|STARTED|Overall Study||8
8430710|NCT00851877|20778007|P3|NOT COMPLETED|Phase II||3
8430711|NCT00851877|20778008|P2|NOT COMPLETED|Phase II||0
8430712|NCT00851877|20778009|P1|NOT COMPLETED|Phase II||0
8430713|NCT00851877|20778007|P3|COMPLETED|Phase II||22
8430714|NCT00851877|20778008|P2|COMPLETED|Phase II||0
8430715|NCT00851877|20778009|P1|COMPLETED|Phase II||0
8430716|NCT00851877|20778007|P3|STARTED|Phase II||25
8430717|NCT00851877|20778008|P2|STARTED|Phase II||0
8430718|NCT00851877|20778009|P1|STARTED|Phase II||0
8430719|NCT00851877|20778007|P3|NOT COMPLETED|Phase I-2||0
8430720|NCT00851877|20778008|P2|NOT COMPLETED|Phase I-2||0
8430721|NCT00851877|20778009|P1|NOT COMPLETED|Phase I-2||0
8430722|NCT00851877|20778007|P3|COMPLETED|Phase I-2||0
8430723|NCT00851877|20778008|P2|COMPLETED|Phase I-2||5
8430724|NCT00851877|20778009|P1|COMPLETED|Phase I-2||0
8430725|NCT00851877|20778007|P3|STARTED|Phase I-2||0
8430726|NCT00851877|20778008|P2|STARTED|Phase I-2||5
8430727|NCT00851877|20778009|P1|STARTED|Phase I-2||0
8430728|NCT00851877|20778007|P3|NOT COMPLETED|Phase I-1||0
8430729|NCT00851877|20778008|P2|NOT COMPLETED|Phase I-1||0
8430730|NCT00851877|20778009|P1|NOT COMPLETED|Phase I-1||1
8430731|NCT00851877|20778007|P3|COMPLETED|Phase I-1||0
8430732|NCT00851877|20778008|P2|COMPLETED|Phase I-1||0
8430733|NCT00851877|20778009|P1|COMPLETED|Phase I-1||6
8430734|NCT00851877|20778007|P3|STARTED|Phase I-1||0
8430735|NCT00851877|20778008|P2|STARTED|Phase I-1||0
8430736|NCT00851877|20778009|P1|STARTED|Phase I-1||7
8430737|NCT00851799|20778019|P3|NOT COMPLETED|Overall Study||24
8430738|NCT00851799|20778020|P2|NOT COMPLETED|Overall Study||13
8430739|NCT00851799|20778021|P1|NOT COMPLETED|Overall Study||16
8430740|NCT00851799|20778019|P3|COMPLETED|Overall Study||89
8430741|NCT00851799|20778020|P2|COMPLETED|Overall Study||93
8430742|NCT00851799|20778021|P1|COMPLETED|Overall Study||93
8430743|NCT00851799|20778019|P3|STARTED|Overall Study||113
8430744|NCT00851799|20778020|P2|STARTED|Overall Study||106
8430745|NCT00851799|20778021|P1|STARTED|Overall Study||109
8430746|NCT00851786|20778109|P2|NOT COMPLETED|Overall Study||2
8430747|NCT00851786|20778110|P1|NOT COMPLETED|Overall Study||5
8430748|NCT00851786|20778109|P2|COMPLETED|Overall Study||97
8430749|NCT00851786|20778110|P1|COMPLETED|Overall Study||291
8430750|NCT00851786|20778109|P2|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
8430751|NCT00851786|20778110|P1|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
8430752|NCT00851747|20778123|P3|NOT COMPLETED|Overall Study||6
8430753|NCT00851747|20778124|P2|NOT COMPLETED|Overall Study||6
8430754|NCT00851747|20778125|P1|NOT COMPLETED|Overall Study||6
8430755|NCT00851747|20778123|P3|COMPLETED|Overall Study||0
8430756|NCT00851747|20778124|P2|COMPLETED|Overall Study||0
8430757|NCT00851747|20778125|P1|COMPLETED|Overall Study||0
8430758|NCT00851747|20778123|P3|STARTED|Overall Study||6
8430759|NCT00851747|20778124|P2|STARTED|Overall Study||6
8430760|NCT00851747|20778125|P1|STARTED|Overall Study||6
8430767|NCT00851682|20778225|P2|NOT COMPLETED|Overall Study||0
8430768|NCT00851682|20778226|P1|NOT COMPLETED|Overall Study||5
8430769|NCT00851682|20778225|P2|COMPLETED|Overall Study||5
8430770|NCT00851682|20778226|P1|COMPLETED|Overall Study||55
8430771|NCT00851682|20778225|P2|STARTED|Overall Study||5
8430772|NCT00851682|20778226|P1|STARTED|Overall Study||60
8430773|NCT00851643|20778240|P6|NOT COMPLETED|Extension Study (Up to 36 Months)||1
8430774|NCT00851643|20778241|P5|NOT COMPLETED|Extension Study (Up to 36 Months)||2
8430775|NCT00851643|20778242|P4|NOT COMPLETED|Extension Study (Up to 36 Months)||2
8430776|NCT00851643|20778243|P3|NOT COMPLETED|Extension Study (Up to 36 Months)||5
8430777|NCT00851643|20778244|P2|NOT COMPLETED|Extension Study (Up to 36 Months)||4
8430778|NCT00851643|20778245|P1|NOT COMPLETED|Extension Study (Up to 36 Months)||4
8430779|NCT00851643|20778240|P6|COMPLETED|Extension Study (Up to 36 Months)||14
8430780|NCT00851643|20778241|P5|COMPLETED|Extension Study (Up to 36 Months)||19
8430781|NCT00851643|20778242|P4|COMPLETED|Extension Study (Up to 36 Months)||5
8430782|NCT00851643|20778243|P3|COMPLETED|Extension Study (Up to 36 Months)||14
8430783|NCT00851643|20778244|P2|COMPLETED|Extension Study (Up to 36 Months)||15
8430784|NCT00851643|20778245|P1|COMPLETED|Extension Study (Up to 36 Months)||6
8430785|NCT00851643|20778240|P6|STARTED|Extension Study (Up to 36 Months)||15
8430786|NCT00851643|20778241|P5|STARTED|Extension Study (Up to 36 Months)||21
8430787|NCT00851643|20778242|P4|STARTED|Extension Study (Up to 36 Months)||7
8430788|NCT00851643|20778243|P3|STARTED|Extension Study (Up to 36 Months)||19
8430789|NCT00851643|20778244|P2|STARTED|Extension Study (Up to 36 Months)||19
8430790|NCT00851643|20778245|P1|STARTED|Extension Study (Up to 36 Months)||10
8430791|NCT00851643|20778240|P6|NOT COMPLETED|Base Study (Up to 12 Months)||1
8430792|NCT00851643|20778241|P5|NOT COMPLETED|Base Study (Up to 12 Months)||0
8430793|NCT00851643|20778242|P4|NOT COMPLETED|Base Study (Up to 12 Months)||0
8430794|NCT00851643|20778243|P3|NOT COMPLETED|Base Study (Up to 12 Months)||0
8430795|NCT00851643|20778244|P2|NOT COMPLETED|Base Study (Up to 12 Months)||0
8430796|NCT00851643|20778245|P1|NOT COMPLETED|Base Study (Up to 12 Months)||1
8430797|NCT00851643|20778240|P6|COMPLETED|Base Study (Up to 12 Months)||29
8430798|NCT00851643|20778241|P5|COMPLETED|Base Study (Up to 12 Months)||30
8430799|NCT00851643|20778242|P4|COMPLETED|Base Study (Up to 12 Months)||15
8430800|NCT00851643|20778243|P3|COMPLETED|Base Study (Up to 12 Months)||30
8430801|NCT00851643|20778244|P2|COMPLETED|Base Study (Up to 12 Months)||30
8430802|NCT00851643|20778245|P1|COMPLETED|Base Study (Up to 12 Months)||14
8430803|NCT00851643|20778240|P6|STARTED|Base Study (Up to 12 Months)||30
8430804|NCT00851643|20778241|P5|STARTED|Base Study (Up to 12 Months)||30
8430805|NCT00851643|20778242|P4|STARTED|Base Study (Up to 12 Months)||15
8430806|NCT00851643|20778243|P3|STARTED|Base Study (Up to 12 Months)||30
8430807|NCT00851643|20778244|P2|STARTED|Base Study (Up to 12 Months)||30
8430808|NCT00851643|20778245|P1|STARTED|Base Study (Up to 12 Months)||15
8430809|NCT00851630|20778266|P2|NOT COMPLETED|Overall Study||2
8430810|NCT00851630|20778267|P1|NOT COMPLETED|Overall Study||2
8430811|NCT00851630|20778266|P2|COMPLETED|Overall Study||33
8430812|NCT00851630|20778267|P1|COMPLETED|Overall Study||33
8430813|NCT00851630|20778266|P2|STARTED|Overall Study||35
8430814|NCT00851630|20778267|P1|STARTED|Overall Study||35
8430815|NCT00851591|20778281|P2|NOT COMPLETED|Overall Study||0
8430816|NCT00851591|20778282|P1|NOT COMPLETED|Overall Study||2
8430817|NCT00851591|20778281|P2|COMPLETED|Overall Study||1
8430818|NCT00851591|20778282|P1|COMPLETED|Overall Study||0
8430819|NCT00851591|20778281|P2|STARTED|Overall Study|One received treatment.|1
8430820|NCT00851591|20778282|P1|STARTED|Overall Study|These 2 participants did not receive treatment.|2
8430821|NCT00851552|20778288|P1|NOT COMPLETED|Overall Study||7
8430822|NCT00851552|20778288|P1|COMPLETED|Overall Study||2
8430823|NCT00851552|20778288|P1|STARTED|Overall Study||9
8430824|NCT00851409|20778293|P1|NOT COMPLETED|Overall Study||0
8430825|NCT00851409|20778293|P1|COMPLETED|Overall Study||25
8430826|NCT00851409|20778293|P1|STARTED|Overall Study||25
8430827|NCT00851357|20778301|P3|NOT COMPLETED|Overall Study||0
8430828|NCT00851357|20778302|P2|NOT COMPLETED|Overall Study||0
8430829|NCT00851357|20778303|P1|NOT COMPLETED|Overall Study||0
8430830|NCT00851357|20778301|P3|COMPLETED|Overall Study||1799
8430831|NCT00851357|20778302|P2|COMPLETED|Overall Study||1201
8430832|NCT00851357|20778303|P1|COMPLETED|Overall Study||1200
8430833|NCT00851357|20778301|P3|STARTED|Overall Study||1799
8430834|NCT00851357|20778302|P2|STARTED|Overall Study||1201
8430835|NCT00851357|20778303|P1|STARTED|Overall Study||1200
8430836|NCT00851318|20778318|P4|NOT COMPLETED|Overall Study||19
8430837|NCT00851318|20778319|P3|NOT COMPLETED|Overall Study||21
8430838|NCT00851318|20778320|P2|NOT COMPLETED|Overall Study||5
8430839|NCT00851318|20778321|P1|NOT COMPLETED|Overall Study||30
8430840|NCT00851318|20778318|P4|COMPLETED|Overall Study||73
8430841|NCT00851318|20778319|P3|COMPLETED|Overall Study||72
8430842|NCT00851318|20778320|P2|COMPLETED|Overall Study||14
8430843|NCT00851318|20778321|P1|COMPLETED|Overall Study||51
8430844|NCT00851318|20778318|P4|Completed Week 52|Overall Study||85
8430845|NCT00851318|20778319|P3|Completed Week 52|Overall Study||87
8430846|NCT00851318|20778320|P2|Completed Week 52|Overall Study||16
8430847|NCT00851318|20778321|P1|Completed Week 52|Overall Study||64
8430848|NCT00851318|20778318|P4|Completed Week 24|Overall Study||87
8430849|NCT00851318|20778319|P3|Completed Week 24|Overall Study||90
8430850|NCT00851318|20778320|P2|Completed Week 24|Overall Study||17
8430851|NCT00851318|20778321|P1|Completed Week 24|Overall Study||69
8430852|NCT00851318|20778318|P4|STARTED|Overall Study||92
8430853|NCT00851318|20778319|P3|STARTED|Overall Study||93
8430854|NCT00851318|20778320|P2|STARTED|Overall Study||19
8430855|NCT00851318|20778321|P1|STARTED|Overall Study||81
8430856|NCT00851279|20778351|P1|NOT COMPLETED|Overall Study||0
8430857|NCT00851279|20778351|P1|COMPLETED|Overall Study||53
8430858|NCT00851279|20778351|P1|STARTED|Overall Study||53
8430859|NCT00851253|20778357|P2|NOT COMPLETED|Overall Study||0
8430860|NCT00851253|20778358|P1|NOT COMPLETED|Overall Study||1
8430861|NCT00851253|20778357|P2|COMPLETED|Overall Study||10
8430862|NCT00851253|20778358|P1|COMPLETED|Overall Study||1
8430863|NCT00851253|20778357|P2|STARTED|Overall Study||10
8430864|NCT00851253|20778358|P1|STARTED|Overall Study||2
8430865|NCT00851084|20778368|P2|NOT COMPLETED|Overall Study||119
8430866|NCT00851084|20778369|P1|NOT COMPLETED|Overall Study||117
8430867|NCT00851084|20778368|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
8430868|NCT00851084|20778369|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
8430869|NCT00851084|20778368|P2|STARTED|Overall Study||119
8430870|NCT00851084|20778369|P1|STARTED|Overall Study||117
8430871|NCT00851006|20778385|P2|NOT COMPLETED|Overall Study||0
8430872|NCT00851006|20778386|P1|NOT COMPLETED|Overall Study||0
8430873|NCT00851006|20778385|P2|COMPLETED|Overall Study||6
8430874|NCT00851006|20778386|P1|COMPLETED|Overall Study||7
8430875|NCT00851006|20778385|P2|STARTED|Overall Study||6
8430876|NCT00851006|20778386|P1|STARTED|Overall Study||7
8430877|NCT00850993|20778397|P4|NOT COMPLETED|Overall Study||1
8430878|NCT00850993|20778398|P3|NOT COMPLETED|Overall Study||0
8430879|NCT00850993|20778399|P2|NOT COMPLETED|Overall Study||0
8430880|NCT00850993|20778400|P1|NOT COMPLETED|Overall Study||1
8430881|NCT00850993|20778397|P4|COMPLETED|Overall Study||14
8430882|NCT00850993|20778398|P3|COMPLETED|Overall Study||8
8430883|NCT00850993|20778399|P2|COMPLETED|Overall Study||18
8430884|NCT00850993|20778400|P1|COMPLETED|Overall Study||16
8430885|NCT00850993|20778397|P4|Per Protocol|Overall Study||13
8430886|NCT00850993|20778398|P3|Per Protocol|Overall Study||5
8430887|NCT00850993|20778399|P2|Per Protocol|Overall Study||13
8430888|NCT00850993|20778400|P1|Per Protocol|Overall Study||10
8430889|NCT00850993|20778397|P4|Received Phototherapy|Overall Study||8
8430890|NCT00850993|20778398|P3|Received Phototherapy|Overall Study||2
8430891|NCT00850993|20778399|P2|Received Phototherapy|Overall Study||6
8430892|NCT00850993|20778400|P1|Received Phototherapy|Overall Study||3
8430893|NCT00850993|20778397|P4|Intent-to-treat|Overall Study||15
8430894|NCT00850993|20778398|P3|Intent-to-treat|Overall Study||8
8430895|NCT00850993|20778399|P2|Intent-to-treat|Overall Study||18
8430896|NCT00850993|20778400|P1|Intent-to-treat|Overall Study||17
8430897|NCT00850993|20778397|P4|Safety|Overall Study||15
8430898|NCT00850993|20778398|P3|Safety|Overall Study||8
8430899|NCT00850993|20778399|P2|Safety|Overall Study||18
8430900|NCT00850993|20778400|P1|Safety|Overall Study||17
8430901|NCT00850993|20778397|P4|STARTED|Overall Study||15
8430902|NCT00850993|20778398|P3|STARTED|Overall Study||8
8430903|NCT00850993|20778399|P2|STARTED|Overall Study||18
8430904|NCT00850993|20778400|P1|STARTED|Overall Study||17
8430905|NCT00850889|20778414|P1|NOT COMPLETED|Overall Study||0
8430906|NCT00850889|20778414|P1|COMPLETED|Overall Study||32
8430907|NCT00850889|20778414|P1|STARTED|Overall Study||32
8430908|NCT00850759|20778429|P4|NOT COMPLETED|Overall Study||3
8430909|NCT00850759|20778430|P3|NOT COMPLETED|Overall Study||5
8430910|NCT00850759|20778431|P2|NOT COMPLETED|Overall Study||5
8430911|NCT00850759|20778432|P1|NOT COMPLETED|Overall Study||7
8430912|NCT00850759|20778429|P4|COMPLETED|Overall Study||55
8430913|NCT00850759|20778430|P3|COMPLETED|Overall Study||52
8430914|NCT00850759|20778431|P2|COMPLETED|Overall Study||52
8430915|NCT00850759|20778432|P1|COMPLETED|Overall Study||52
8430916|NCT00850759|20778429|P4|STARTED|Overall Study||58
8430917|NCT00850759|20778430|P3|STARTED|Overall Study||57
8430918|NCT00850759|20778431|P2|STARTED|Overall Study||57
8430919|NCT00850759|20778432|P1|STARTED|Overall Study||59
8430920|NCT00850720|20778442|P1|NOT COMPLETED|Overall Study||0
8430921|NCT00850720|20778442|P1|COMPLETED|Overall Study||0
8430922|NCT00850720|20778442|P1|STARTED|Overall Study||0
8430923|NCT00850642|20778448|P2|NOT COMPLETED|Overall Study||0
8430924|NCT00850642|20778449|P1|NOT COMPLETED|Overall Study||0
8430925|NCT00850642|20778448|P2|COMPLETED|Overall Study||4
8430926|NCT00850642|20778449|P1|COMPLETED|Overall Study||3
8430927|NCT00850642|20778448|P2|STARTED|Overall Study||4
8430928|NCT00850642|20778449|P1|STARTED|Overall Study||3
8430929|NCT00850603|20778487|P5|NOT COMPLETED|Overall Study||0
8430930|NCT00850603|20778488|P4|NOT COMPLETED|Overall Study||0
8430931|NCT00850603|20778489|P3|NOT COMPLETED|Overall Study||0
8430932|NCT00850603|20778490|P2|NOT COMPLETED|Overall Study||0
8430933|NCT00850603|20778491|P1|NOT COMPLETED|Overall Study||0
8430934|NCT00850603|20778487|P5|COMPLETED|Overall Study||34
8430935|NCT00850603|20778488|P4|COMPLETED|Overall Study||34
8430936|NCT00850603|20778489|P3|COMPLETED|Overall Study||34
8430937|NCT00850603|20778490|P2|COMPLETED|Overall Study||34
8430938|NCT00850603|20778491|P1|COMPLETED|Overall Study||34
8430939|NCT00850603|20778487|P5|STARTED|Overall Study||34
8430940|NCT00850603|20778488|P4|STARTED|Overall Study||34
8430941|NCT00850603|20778489|P3|STARTED|Overall Study||34
8430942|NCT00850603|20778490|P2|STARTED|Overall Study||34
8430943|NCT00850603|20778491|P1|STARTED|Overall Study||34
8430944|NCT00850564|20778513|P1|NOT COMPLETED|Overall Study||2
8430945|NCT00850564|20778513|P1|COMPLETED|Overall Study||13
8430946|NCT00850564|20778513|P1|STARTED|Overall Study||15
8430947|NCT00850538|20778518|P1|NOT COMPLETED|Overall Study||41
8430948|NCT00850538|20778518|P1|COMPLETED|Overall Study||60
8430949|NCT00850538|20778518|P1|STARTED|Overall Study||101
8430950|NCT00850499|20778524|P2|NOT COMPLETED|Overall Study||2
8430951|NCT00850499|20778525|P1|NOT COMPLETED|Overall Study||3
8430952|NCT00850499|20778524|P2|COMPLETED|Overall Study||6
8430953|NCT00850499|20778525|P1|COMPLETED|Overall Study||1
8430954|NCT00850499|20778524|P2|STARTED|Overall Study||8
8430955|NCT00850499|20778525|P1|STARTED|Overall Study||4
8430956|NCT00850473|20778533|P1|NOT COMPLETED|Overall Study||0
8430957|NCT00850473|20778533|P1|COMPLETED|Overall Study||3
8430958|NCT00850473|20778533|P1|STARTED|Overall Study||3
8430959|NCT00850460|20778539|P2|NOT COMPLETED|Overall Study||4
8430960|NCT00850460|20778540|P1|NOT COMPLETED|Overall Study||4
8430961|NCT00850460|20778539|P2|COMPLETED|Overall Study||3
8430962|NCT00850460|20778540|P1|COMPLETED|Overall Study||3
8430963|NCT00850460|20778539|P2|Completion - Week 8|Overall Study||3
8430964|NCT00850460|20778540|P1|Completion - Week 8|Overall Study||3
8430965|NCT00850460|20778539|P2|Started - Week 0|Overall Study||7
8430966|NCT00850460|20778540|P1|Started - Week 0|Overall Study||7
8430967|NCT00850460|20778539|P2|STARTED|Overall Study||7
8430968|NCT00850460|20778540|P1|STARTED|Overall Study||7
8430969|NCT00850421|20778548|P1|NOT COMPLETED|Overall Study||17
8430970|NCT00850421|20778548|P1|COMPLETED|Overall Study||18
8430971|NCT00850421|20778548|P1|STARTED|Overall Study||35
8430972|NCT00850395|20778554|P1|NOT COMPLETED|Overall Study||10
8430973|NCT00850395|20778554|P1|COMPLETED|Overall Study||69
8430974|NCT00850395|20778554|P1|STARTED|Overall Study||79
8430975|NCT00850343|20778574|P4|NOT COMPLETED|Overall Study||13
8430976|NCT00850343|20778575|P3|NOT COMPLETED|Overall Study||14
8430977|NCT00850343|20778576|P2|NOT COMPLETED|Overall Study||3
8430978|NCT00850343|20778577|P1|NOT COMPLETED|Overall Study||46
8430979|NCT00850343|20778574|P4|COMPLETED|Overall Study||30
8430980|NCT00850343|20778575|P3|COMPLETED|Overall Study||29
8430981|NCT00850343|20778576|P2|COMPLETED|Overall Study||9
8430982|NCT00850343|20778577|P1|COMPLETED|Overall Study||64
8430983|NCT00850343|20778574|P4|Completed Week 52|Overall Study||37
8430984|NCT00850343|20778575|P3|Completed Week 52|Overall Study||37
8430985|NCT00850343|20778576|P2|Completed Week 52|Overall Study||11
8430986|NCT00850343|20778577|P1|Completed Week 52|Overall Study||88
8430987|NCT00850343|20778574|P4|Completed Week 24|Overall Study||39
8430988|NCT00850343|20778575|P3|Completed Week 24|Overall Study||39
8430989|NCT00850343|20778576|P2|Completed Week 24|Overall Study||12
8430990|NCT00850343|20778577|P1|Completed Week 24|Overall Study||94
8430991|NCT00850343|20778574|P4|STARTED|Overall Study||43
8430992|NCT00850343|20778575|P3|STARTED|Overall Study||43
8430993|NCT00850343|20778576|P2|STARTED|Overall Study||12
8430994|NCT00850343|20778577|P1|STARTED|Overall Study||110
8430995|NCT00850200|20778607|P1|NOT COMPLETED|Overall Study||5
8430996|NCT00850200|20778607|P1|COMPLETED|Overall Study||15
8430997|NCT00850200|20778607|P1|STARTED|Overall Study||20
8430998|NCT00850174|20778617|P2|NOT COMPLETED|Second Intervention||0
8430999|NCT00850174|20778618|P1|NOT COMPLETED|Second Intervention||1
8431000|NCT00850174|20778617|P2|COMPLETED|Second Intervention||28
8431001|NCT00850174|20778618|P1|COMPLETED|Second Intervention||29
8431002|NCT00850174|20778617|P2|STARTED|Second Intervention||28
8431003|NCT00850174|20778618|P1|STARTED|Second Intervention||30
8431004|NCT00850174|20778617|P2|NOT COMPLETED|Washout: One Week||2
8431005|NCT00850174|20778618|P1|NOT COMPLETED|Washout: One Week||0
8431006|NCT00850174|20778617|P2|COMPLETED|Washout: One Week||28
8431007|NCT00850174|20778618|P1|COMPLETED|Washout: One Week||30
8431008|NCT00850174|20778617|P2|STARTED|Washout: One Week||30
8431009|NCT00850174|20778618|P1|STARTED|Washout: One Week||30
8431010|NCT00850174|20778617|P2|NOT COMPLETED|First Intervention||0
8431011|NCT00850174|20778618|P1|NOT COMPLETED|First Intervention||0
8431012|NCT00850174|20778617|P2|COMPLETED|First Intervention||30
8431013|NCT00850174|20778618|P1|COMPLETED|First Intervention||30
8431014|NCT00850174|20778617|P2|STARTED|First Intervention||30
8431015|NCT00850174|20778618|P1|STARTED|First Intervention||30
8431016|NCT00850135|20778632|P1|NOT COMPLETED|Overall Study||1
8431017|NCT00850135|20778632|P1|COMPLETED|Overall Study||56
8431018|NCT00850135|20778632|P1|STARTED|Overall Study||57
8431019|NCT00850096|20778640|P2|NOT COMPLETED|Overall Study||2
8431020|NCT00850096|20778641|P1|NOT COMPLETED|Overall Study||3
8431021|NCT00850096|20778640|P2|COMPLETED|Overall Study||45
8431022|NCT00850096|20778641|P1|COMPLETED|Overall Study||44
8431023|NCT00850096|20778640|P2|STARTED|Overall Study||47
8431024|NCT00850096|20778641|P1|STARTED|Overall Study||47
8431025|NCT00850070|20778651|P2|NOT COMPLETED|Overall Study||1
8431026|NCT00850070|20778652|P1|NOT COMPLETED|Overall Study||3
8431027|NCT00850070|20778651|P2|COMPLETED|Overall Study||22
8431028|NCT00850070|20778652|P1|COMPLETED|Overall Study||20
8431029|NCT00850070|20778651|P2|STARTED|Overall Study||23
8431030|NCT00850070|20778652|P1|STARTED|Overall Study||23
8431031|NCT00850031|20778676|P1|NOT COMPLETED|Overall Study||17
8431032|NCT00850031|20778676|P1|COMPLETED|Overall Study||101
8431033|NCT00850031|20778676|P1|STARTED|Overall Study||118
8431034|NCT00849940|20778681|P1|NOT COMPLETED|Overall Study||4
8431035|NCT00849940|20778681|P1|COMPLETED|Overall Study||68
8431036|NCT00849940|20778681|P1|STARTED|Overall Study||72
8431037|NCT00849901|20778692|P3|NOT COMPLETED|Extension Phase||17
8431038|NCT00849901|20778693|P2|NOT COMPLETED|Extension Phase||26
8431039|NCT00849901|20778694|P1|NOT COMPLETED|Extension Phase||27
8431040|NCT00849901|20778692|P3|COMPLETED|Extension Phase||69
8431041|NCT00849901|20778693|P2|COMPLETED|Extension Phase||65
8431042|NCT00849901|20778694|P1|COMPLETED|Extension Phase||56
8431043|NCT00849901|20778692|P3|STARTED|Extension Phase||86
8431044|NCT00849901|20778693|P2|STARTED|Extension Phase||91
8431045|NCT00849901|20778694|P1|STARTED|Extension Phase||83
8431046|NCT00849901|20778692|P3|NOT COMPLETED|Acute Treatment Phase||16
8431047|NCT00849901|20778693|P2|NOT COMPLETED|Acute Treatment Phase||26
8431048|NCT00849901|20778694|P1|NOT COMPLETED|Acute Treatment Phase||30
8431049|NCT00849901|20778692|P3|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
8431050|NCT00849901|20778693|P2|COMPLETED|Acute Treatment Phase||91
8431051|NCT00849901|20778694|P1|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
8431052|NCT00849901|20778692|P3|STARTED|Acute Treatment Phase||103
8431053|NCT00849901|20778693|P2|STARTED|Acute Treatment Phase||117
8431054|NCT00849901|20778694|P1|STARTED|Acute Treatment Phase||117
8431055|NCT00849875|20778741|P1|NOT COMPLETED|Overall Study||47
8431056|NCT00849875|20778741|P1|COMPLETED|Overall Study||1
8431057|NCT00849875|20778741|P1|STARTED|Overall Study||48
8431058|NCT00849862|20778823|P2|NOT COMPLETED|Second Intervention||0
8431059|NCT00849862|20778824|P1|NOT COMPLETED|Second Intervention||0
8431060|NCT00849862|20778823|P2|COMPLETED|Second Intervention||11
8431061|NCT00849862|20778824|P1|COMPLETED|Second Intervention||11
8431062|NCT00849862|20778823|P2|STARTED|Second Intervention||11
8431063|NCT00849862|20778824|P1|STARTED|Second Intervention||11
8431064|NCT00849862|20778823|P2|NOT COMPLETED|Washout: 7 Days||0
8431065|NCT00849862|20778824|P1|NOT COMPLETED|Washout: 7 Days||0
8431066|NCT00849862|20778823|P2|COMPLETED|Washout: 7 Days||11
8431067|NCT00849862|20778824|P1|COMPLETED|Washout: 7 Days||11
8431068|NCT00849862|20778823|P2|STARTED|Washout: 7 Days||11
8431069|NCT00849862|20778824|P1|STARTED|Washout: 7 Days||11
8431070|NCT00849862|20778823|P2|NOT COMPLETED|First Intervention||0
8431071|NCT00849862|20778824|P1|NOT COMPLETED|First Intervention||0
8431072|NCT00849862|20778823|P2|COMPLETED|First Intervention||11
8431073|NCT00849862|20778824|P1|COMPLETED|First Intervention||11
8431074|NCT00849862|20778823|P2|STARTED|First Intervention||11
8431075|NCT00849862|20778824|P1|STARTED|First Intervention||11
8431076|NCT00849810|20778832|P1|NOT COMPLETED|Overall Study||0
8431077|NCT00849810|20778832|P1|COMPLETED|Overall Study||1
8431078|NCT00849810|20778832|P1|STARTED|Overall Study||1
8431079|NCT00849797|20778838|P2|NOT COMPLETED|Second Intervention||0
8431080|NCT00849797|20778839|P1|NOT COMPLETED|Second Intervention||0
8431081|NCT00849797|20778838|P2|COMPLETED|Second Intervention||57
8431082|NCT00849797|20778839|P1|COMPLETED|Second Intervention||59
8431083|NCT00849797|20778838|P2|STARTED|Second Intervention||57
8431084|NCT00849797|20778839|P1|STARTED|Second Intervention||59
8431085|NCT00849797|20778838|P2|NOT COMPLETED|Washout: One Week||2
8431086|NCT00849797|20778839|P1|NOT COMPLETED|Washout: One Week||0
8431087|NCT00849797|20778838|P2|COMPLETED|Washout: One Week||57
8431088|NCT00849797|20778839|P1|COMPLETED|Washout: One Week||59
8431089|NCT00849797|20778838|P2|STARTED|Washout: One Week||59
8431090|NCT00849797|20778839|P1|STARTED|Washout: One Week||59
8431091|NCT00849797|20778838|P2|NOT COMPLETED|First Intervention||1
8431092|NCT00849797|20778839|P1|NOT COMPLETED|First Intervention||1
8431093|NCT00849797|20778838|P2|COMPLETED|First Intervention||59
8431094|NCT00849797|20778839|P1|COMPLETED|First Intervention||59
8431095|NCT00849797|20778838|P2|STARTED|First Intervention||60
8431096|NCT00849797|20778839|P1|STARTED|First Intervention||60
8431097|NCT00849693|20778857|P4|NOT COMPLETED|Extension Phase||38
8431098|NCT00849693|20778858|P3|NOT COMPLETED|Extension Phase||35
8431099|NCT00849693|20778859|P2|NOT COMPLETED|Extension Phase||30
8431100|NCT00849693|20778860|P1|NOT COMPLETED|Extension Phase||30
8431101|NCT00849693|20778857|P4|COMPLETED|Extension Phase||44
8431102|NCT00849693|20778858|P3|COMPLETED|Extension Phase||49
8431103|NCT00849693|20778859|P2|COMPLETED|Extension Phase||50
8431104|NCT00849693|20778860|P1|COMPLETED|Extension Phase||43
8431105|NCT00849693|20778857|P4|STARTED|Extension Phase||82
8431106|NCT00849693|20778858|P3|STARTED|Extension Phase||84
8431107|NCT00849693|20778859|P2|STARTED|Extension Phase||80
8431108|NCT00849693|20778860|P1|STARTED|Extension Phase||73
8431109|NCT00849693|20778857|P4|NOT COMPLETED|Acute Treatment Phase||37
8431110|NCT00849693|20778858|P3|NOT COMPLETED|Acute Treatment Phase||33
8431111|NCT00849693|20778859|P2|NOT COMPLETED|Acute Treatment Phase||35
8431112|NCT00849693|20778860|P1|NOT COMPLETED|Acute Treatment Phase||33
8431113|NCT00849693|20778857|P4|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
8431114|NCT00849693|20778858|P3|COMPLETED|Acute Treatment Phase||84
8431115|NCT00849693|20778859|P2|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
8431116|NCT00849693|20778860|P1|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
8431117|NCT00849693|20778857|P4|STARTED|Acute Treatment Phase||122
8431118|NCT00849693|20778858|P3|STARTED|Acute Treatment Phase||117
8431119|NCT00849693|20778859|P2|STARTED|Acute Treatment Phase||116
8431120|NCT00849693|20778860|P1|STARTED|Acute Treatment Phase||108
8431121|NCT00849680|20778927|P8|NOT COMPLETED|Overall Study||8
8431122|NCT00849680|20778928|P7|NOT COMPLETED|Overall Study||17
8431123|NCT00849680|20778929|P6|NOT COMPLETED|Overall Study||15
8431124|NCT00849680|20778930|P5|NOT COMPLETED|Overall Study||10
8431125|NCT00849680|20778931|P4|NOT COMPLETED|Overall Study||14
8431126|NCT00849680|20778932|P3|NOT COMPLETED|Overall Study||15
8431127|NCT00849680|20778933|P2|NOT COMPLETED|Overall Study||3
8431128|NCT00849680|20778934|P1|NOT COMPLETED|Overall Study||11
8431129|NCT00849680|20778927|P8|COMPLETED|Overall Study||23
8431130|NCT00849680|20778928|P7|COMPLETED|Overall Study||61
8431131|NCT00849680|20778929|P6|COMPLETED|Overall Study||27
8431132|NCT00849680|20778930|P5|COMPLETED|Overall Study||32
8431133|NCT00849680|20778931|P4|COMPLETED|Overall Study||28
8431134|NCT00849680|20778932|P3|COMPLETED|Overall Study||27
8431135|NCT00849680|20778933|P2|COMPLETED|Overall Study||10
8431136|NCT00849680|20778934|P1|COMPLETED|Overall Study||16
8431137|NCT00849680|20778927|P8|STARTED|Overall Study||31
8431138|NCT00849680|20778928|P7|STARTED|Overall Study||78
8431139|NCT00849680|20778929|P6|STARTED|Overall Study||42
8431140|NCT00849680|20778930|P5|STARTED|Overall Study||42
8431141|NCT00849680|20778931|P4|STARTED|Overall Study||42
8431142|NCT00849680|20778932|P3|STARTED|Overall Study||42
8431143|NCT00849680|20778933|P2|STARTED|Overall Study||13
8431144|NCT00849680|20778934|P1|STARTED|Overall Study||27
8431145|NCT00849524|20778976|P1|NOT COMPLETED|Overall Study||3
8431146|NCT00849524|20778976|P1|COMPLETED|Overall Study||3
8431147|NCT00849524|20778976|P1|STARTED|Overall Study||6
8431148|NCT00849485|20778984|P2|NOT COMPLETED|Second Intervention||0
8431149|NCT00849485|20778985|P1|NOT COMPLETED|Second Intervention||0
8431150|NCT00849485|20778984|P2|COMPLETED|Second Intervention||11
8431151|NCT00849485|20778985|P1|COMPLETED|Second Intervention||11
8431152|NCT00849485|20778984|P2|STARTED|Second Intervention||11
8431153|NCT00849485|20778985|P1|STARTED|Second Intervention||11
8431154|NCT00849485|20778984|P2|NOT COMPLETED|Washout: 7 Days||0
8431155|NCT00849485|20778985|P1|NOT COMPLETED|Washout: 7 Days||0
8431156|NCT00849485|20778984|P2|COMPLETED|Washout: 7 Days||11
8431157|NCT00849485|20778985|P1|COMPLETED|Washout: 7 Days||11
8431158|NCT00849485|20778984|P2|STARTED|Washout: 7 Days||11
8431159|NCT00849485|20778985|P1|STARTED|Washout: 7 Days||11
8431160|NCT00849485|20778984|P2|NOT COMPLETED|First Intervention||0
8431161|NCT00849485|20778985|P1|NOT COMPLETED|First Intervention||0
8431162|NCT00849485|20778984|P2|COMPLETED|First Intervention||11
8431163|NCT00849485|20778985|P1|COMPLETED|First Intervention||11
8431164|NCT00849485|20778984|P2|STARTED|First Intervention||11
8431165|NCT00849485|20778985|P1|STARTED|First Intervention||11
8431166|NCT00849472|20778993|P1|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
8431167|NCT00849472|20778993|P1|COMPLETED|Pazopanib Postsurgery Treatment||16
8431168|NCT00849472|20778993|P1|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
8431169|NCT00849472|20778993|P1|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
8431170|NCT00849472|20778993|P1|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
8431171|NCT00849472|20778993|P1|STARTED|Pazopanib Presurgery Treatment (PPT)||94
8431172|NCT00849472|20778993|P1|NOT COMPLETED|Weekly Paclitaxel||16
8431173|NCT00849472|20778993|P1|COMPLETED|Weekly Paclitaxel||78
8431174|NCT00849472|20778993|P1|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
8431175|NCT00849472|20778993|P1|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
8431176|NCT00849472|20778993|P1|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
8431177|NCT00849472|20778993|P1|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
8431178|NCT00849381|20779007|P1|NOT COMPLETED|Overall Study||145
8431179|NCT00849381|20779007|P1|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
8431180|NCT00849381|20779007|P1|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
8431181|NCT00849290|20779013|P1|NOT COMPLETED|Overall Study||55
8431182|NCT00849290|20779013|P1|COMPLETED|Overall Study||58
8431183|NCT00849290|20779013|P1|STARTED|Overall Study||113
8431184|NCT00849251|20779017|P2|NOT COMPLETED|Overall Study||1
8431185|NCT00849251|20779018|P1|NOT COMPLETED|Overall Study||1
8431186|NCT00849251|20779017|P2|COMPLETED|Overall Study||24
8431187|NCT00849251|20779018|P1|COMPLETED|Overall Study||5
8431188|NCT00849251|20779017|P2|STARTED|Overall Study||25
8431189|NCT00849251|20779018|P1|STARTED|Overall Study||6
8431190|NCT00849212|20779024|P1|NOT COMPLETED|Overall Study||7
8431191|NCT00849212|20779024|P1|COMPLETED|Overall Study||23
8431192|NCT00849212|20779024|P1|STARTED|Overall Study||30
8431193|NCT00849186|20779029|P1|NOT COMPLETED|Overall Study||10
8431194|NCT00849186|20779029|P1|COMPLETED|Overall Study||16
8431195|NCT00849186|20779029|P1|STARTED|Overall Study||26
8431196|NCT00849147|20779035|P1|NOT COMPLETED|Overall Study||5
8431197|NCT00849147|20779035|P1|COMPLETED|Overall Study||50
8431198|NCT00849147|20779035|P1|STARTED|Overall Study||55
8431199|NCT00849121|20779052|P2|NOT COMPLETED|Overall Study||0
8431200|NCT00849121|20779053|P1|NOT COMPLETED|Overall Study||0
8431201|NCT00849121|20779052|P2|COMPLETED|Overall Study||9
8431202|NCT00849121|20779053|P1|COMPLETED|Overall Study||8
8431203|NCT00849121|20779052|P2|STARTED|Overall Study||9
8431204|NCT00849121|20779053|P1|STARTED|Overall Study||8
8431205|NCT00849108|20779068|P2|NOT COMPLETED|Cohort 2 Efficacy||10
8431206|NCT00849108|20779069|P1|NOT COMPLETED|Cohort 2 Efficacy||0
8431207|NCT00849108|20779068|P2|COMPLETED|Cohort 2 Efficacy||133
8431208|NCT00849108|20779069|P1|COMPLETED|Cohort 2 Efficacy||0
8431209|NCT00849108|20779068|P2|STARTED|Cohort 2 Efficacy||143
8431210|NCT00849108|20779069|P1|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
8431211|NCT00849108|20779068|P2|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
8431212|NCT00849108|20779069|P1|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
8431213|NCT00849108|20779068|P2|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
8431214|NCT00849108|20779069|P1|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
8431215|NCT00849108|20779068|P2|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
8431216|NCT00849108|20779069|P1|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
8431217|NCT00849056|20779079|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
8431218|NCT00849056|20779080|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
8431219|NCT00849056|20779079|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
8431220|NCT00849056|20779080|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
8431221|NCT00849056|20779079|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
8431222|NCT00849056|20779080|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
8431223|NCT00849056|20779079|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
8431224|NCT00849056|20779080|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
8431225|NCT00849056|20779079|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||100
8431226|NCT00849056|20779080|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||88
8431227|NCT00849056|20779079|P2|STARTED|Treatment Period (TP) (156 Weeks)||150
8431228|NCT00849056|20779080|P1|STARTED|Treatment Period (TP) (156 Weeks)||151
8431229|NCT00849017|20779105|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||25
8431230|NCT00849017|20779106|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||18
8431231|NCT00849017|20779107|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||25
8431232|NCT00849017|20779105|P3|COMPLETED|Follow-up Period (8 Weeks)||74
8431233|NCT00849017|20779106|P2|COMPLETED|Follow-up Period (8 Weeks)||83
8431234|NCT00849017|20779107|P1|COMPLETED|Follow-up Period (8 Weeks)||76
8431235|NCT00849017|20779105|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
8431236|NCT00849017|20779106|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
8431237|NCT00849017|20779107|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
8431238|NCT00849017|20779105|P3|NOT COMPLETED|Treatment Period (156 Weeks)||42
8431239|NCT00849017|20779106|P2|NOT COMPLETED|Treatment Period (156 Weeks)||33
8431240|NCT00849017|20779107|P1|NOT COMPLETED|Treatment Period (156 Weeks)||43
8431241|NCT00849017|20779105|P3|COMPLETED|Treatment Period (156 Weeks)||57
8431242|NCT00849017|20779106|P2|COMPLETED|Treatment Period (156 Weeks)||68
8431243|NCT00849017|20779107|P1|COMPLETED|Treatment Period (156 Weeks)||58
8431244|NCT00849017|20779105|P3|STARTED|Treatment Period (156 Weeks)||99
8431245|NCT00849017|20779106|P2|STARTED|Treatment Period (156 Weeks)||101
8431246|NCT00849017|20779107|P1|STARTED|Treatment Period (156 Weeks)||101
8431247|NCT00848965|20779150|P1|NOT COMPLETED|Overall Study||2
8431248|NCT00848965|20779150|P1|COMPLETED|Overall Study||57
8431249|NCT00848965|20779150|P1|STARTED|Overall Study||59
8431250|NCT00848926|20779192|P1|NOT COMPLETED|Follow-up Period||12
8431251|NCT00848926|20779192|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
8431252|NCT00848926|20779192|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|102
8431253|NCT00848926|20779192|P1|NOT COMPLETED|Treatment Period||84
8431254|NCT00848926|20779192|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
8431255|NCT00848926|20779192|P1|STARTED|Treatment Period||102
8431256|NCT00848783|20779211|P3|NOT COMPLETED|Overall Study||0
8431257|NCT00848783|20779212|P2|NOT COMPLETED|Overall Study||2
8431258|NCT00848783|20779213|P1|NOT COMPLETED|Overall Study||3
8431259|NCT00848783|20779211|P3|COMPLETED|Overall Study||1
8431260|NCT00848783|20779212|P2|COMPLETED|Overall Study||1
8431261|NCT00848783|20779213|P1|COMPLETED|Overall Study||1
8431262|NCT00848783|20779211|P3|STARTED|Overall Study||1
8431263|NCT00848783|20779212|P2|STARTED|Overall Study||3
8431264|NCT00848783|20779213|P1|STARTED|Overall Study||4
8431265|NCT00848744|20779222|P1|NOT COMPLETED|Overall Study||0
8431266|NCT00848744|20779222|P1|COMPLETED|Overall Study||10
8431267|NCT00848744|20779222|P1|STARTED|Overall Study||10
8431268|NCT00848718|20779242|P13|NOT COMPLETED|Overall Study||8
8431269|NCT00848718|20779243|P12|NOT COMPLETED|Overall Study||6
8431270|NCT00848718|20779244|P11|NOT COMPLETED|Overall Study||4
8431271|NCT00848718|20779245|P10|NOT COMPLETED|Overall Study||9
8431272|NCT00848718|20779246|P9|NOT COMPLETED|Overall Study||4
8431273|NCT00848718|20779247|P8|NOT COMPLETED|Overall Study||5
8431274|NCT00848718|20779248|P7|NOT COMPLETED|Overall Study||3
8431275|NCT00848718|20779249|P6|NOT COMPLETED|Overall Study||5
8431276|NCT00848718|20779250|P5|NOT COMPLETED|Overall Study||6
8431277|NCT00848718|20779251|P4|NOT COMPLETED|Overall Study||5
8431278|NCT00848718|20779252|P3|NOT COMPLETED|Overall Study||6
8431279|NCT00848718|20779253|P2|NOT COMPLETED|Overall Study||9
8431280|NCT00848718|20779254|P1|NOT COMPLETED|Overall Study||7
8431281|NCT00848718|20779242|P13|COMPLETED|Overall Study||0
8431282|NCT00848718|20779243|P12|COMPLETED|Overall Study||0
8431283|NCT00848718|20779244|P11|COMPLETED|Overall Study||0
8431284|NCT00848718|20779245|P10|COMPLETED|Overall Study||0
8431285|NCT00848718|20779246|P9|COMPLETED|Overall Study||0
8431286|NCT00848718|20779247|P8|COMPLETED|Overall Study||0
8431287|NCT00848718|20779248|P7|COMPLETED|Overall Study||0
8431288|NCT00848718|20779249|P6|COMPLETED|Overall Study||0
8431289|NCT00848718|20779250|P5|COMPLETED|Overall Study||0
8431290|NCT00848718|20779251|P4|COMPLETED|Overall Study||0
8431291|NCT00848718|20779252|P3|COMPLETED|Overall Study||0
8431292|NCT00848718|20779253|P2|COMPLETED|Overall Study||0
8431293|NCT00848718|20779254|P1|COMPLETED|Overall Study||0
8431294|NCT00848718|20779242|P13|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6
8431295|NCT00848718|20779243|P12|Treated|Overall Study||6
8431296|NCT00848718|20779244|P11|Treated|Overall Study||4
8431297|NCT00848718|20779245|P10|Treated|Overall Study||9
8431298|NCT00848718|20779246|P9|Treated|Overall Study||4
8431299|NCT00848718|20779247|P8|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4
8431300|NCT00848718|20779248|P7|Treated|Overall Study||3
8431301|NCT00848718|20779249|P6|Treated|Overall Study||5
8431302|NCT00848718|20779250|P5|Treated|Overall Study||6
8431303|NCT00848718|20779251|P4|Treated|Overall Study||5
8431304|NCT00848718|20779252|P3|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5
8431305|NCT00848718|20779253|P2|Treated|Overall Study||9
8431306|NCT00848718|20779254|P1|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6
8431307|NCT00848718|20779242|P13|STARTED|Overall Study||8
8431308|NCT00848718|20779243|P12|STARTED|Overall Study||6
8431309|NCT00848718|20779244|P11|STARTED|Overall Study||4
8431310|NCT00848718|20779245|P10|STARTED|Overall Study||9
8431311|NCT00848718|20779246|P9|STARTED|Overall Study||4
8431312|NCT00848718|20779247|P8|STARTED|Overall Study||5
8431313|NCT00848718|20779248|P7|STARTED|Overall Study||3
8431314|NCT00848718|20779249|P6|STARTED|Overall Study||5
8431315|NCT00848718|20779250|P5|STARTED|Overall Study||6
8431316|NCT00848718|20779251|P4|STARTED|Overall Study||5
8431317|NCT00848718|20779252|P3|STARTED|Overall Study||6
8431318|NCT00848718|20779253|P2|STARTED|Overall Study||9
8431319|NCT00848718|20779254|P1|STARTED|Overall Study||7
8431320|NCT00848549|20779355|P2|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
8431321|NCT00848549|20779356|P1|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
8431322|NCT00848549|20779355|P2|COMPLETED|E2090-E044-314 (Extension Study)||134
8431323|NCT00848549|20779356|P1|COMPLETED|E2090-E044-314 (Extension Study)||120
8431324|NCT00848549|20779355|P2|STARTED|E2090-E044-314 (Extension Study)||158
8431325|NCT00848549|20779356|P1|STARTED|E2090-E044-314 (Extension Study)||137
8431326|NCT00848549|20779355|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
8431327|NCT00848549|20779356|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
8431328|NCT00848549|20779355|P2|COMPLETED|E2090-E044-310 (Base Study) Transition||158
8431329|NCT00848549|20779356|P1|COMPLETED|E2090-E044-310 (Base Study) Transition||137
8431330|NCT00848549|20779355|P2|STARTED|E2090-E044-310 (Base Study) Transition||192
8431331|NCT00848549|20779356|P1|STARTED|E2090-E044-310 (Base Study) Transition||161
8431332|NCT00848549|20779355|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
8431333|NCT00848549|20779356|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
8431334|NCT00848549|20779355|P2|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
8431335|NCT00848549|20779356|P1|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
8431336|NCT00848549|20779355|P2|STARTED|E2090-E044-310 (Base Study) Disposition||301
8431337|NCT00848549|20779356|P1|STARTED|E2090-E044-310 (Base Study) Disposition||282
8431338|NCT00848536|20779374|P2|NOT COMPLETED|Overall Study||7
8431339|NCT00848536|20779375|P1|NOT COMPLETED|Overall Study||4
8431340|NCT00848536|20779374|P2|COMPLETED|Overall Study||179
8431341|NCT00848536|20779375|P1|COMPLETED|Overall Study||181
8431342|NCT00848536|20779374|P2|STARTED|Overall Study||186
8431343|NCT00848536|20779375|P1|STARTED|Overall Study||185
8431344|NCT00848510|20779389|P4|NOT COMPLETED|Overall Study||0
8431345|NCT00848510|20779390|P3|NOT COMPLETED|Overall Study||0
8431346|NCT00848510|20779391|P2|NOT COMPLETED|Overall Study||0
8431347|NCT00848510|20779392|P1|NOT COMPLETED|Overall Study||0
8431348|NCT00848510|20779389|P4|COMPLETED|Overall Study||10
8431349|NCT00848510|20779390|P3|COMPLETED|Overall Study||8
8431350|NCT00848510|20779391|P2|COMPLETED|Overall Study||13
8431351|NCT00848510|20779392|P1|COMPLETED|Overall Study||10
8431352|NCT00848510|20779389|P4|STARTED|Overall Study||10
8431353|NCT00848510|20779390|P3|STARTED|Overall Study||8
8431354|NCT00848510|20779391|P2|STARTED|Overall Study||13
8431355|NCT00848510|20779392|P1|STARTED|Overall Study||10
8431356|NCT00848497|20779440|P2|NOT COMPLETED|Overall Study||1
8431357|NCT00848497|20779441|P1|NOT COMPLETED|Overall Study||2
8431358|NCT00848497|20779440|P2|COMPLETED|Overall Study||0
8431359|NCT00848497|20779441|P1|COMPLETED|Overall Study||0
8431360|NCT00848497|20779440|P2|STARTED|Overall Study|Completed Visit 4|1
8431361|NCT00848497|20779441|P1|STARTED|Overall Study||2
8431362|NCT00848484|20779455|P2|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
8431363|NCT00848484|20779456|P1|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
8431364|NCT00848484|20779455|P2|COMPLETED|Second Intervention (Treatment Period 2)||20
8431365|NCT00848484|20779456|P1|COMPLETED|Second Intervention (Treatment Period 2)||25
8431366|NCT00848484|20779455|P2|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
8431367|NCT00848484|20779456|P1|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
8431368|NCT00848484|20779455|P2|STARTED|Second Intervention (Treatment Period 2)||21
8431369|NCT00848484|20779456|P1|STARTED|Second Intervention (Treatment Period 2)||25
8431370|NCT00848484|20779455|P2|NOT COMPLETED|Washout Period of Two Weeks||3
8431371|NCT00848484|20779456|P1|NOT COMPLETED|Washout Period of Two Weeks||0
8431372|NCT00848484|20779455|P2|COMPLETED|Washout Period of Two Weeks||21
8431373|NCT00848484|20779456|P1|COMPLETED|Washout Period of Two Weeks||25
8431374|NCT00848484|20779455|P2|STARTED|Washout Period of Two Weeks||24
8431375|NCT00848484|20779456|P1|STARTED|Washout Period of Two Weeks||25
8431376|NCT00848484|20779455|P2|NOT COMPLETED|First Intervention (Treatment Period 1)||3
8431377|NCT00848484|20779456|P1|NOT COMPLETED|First Intervention (Treatment Period 1)||2
8431378|NCT00848484|20779455|P2|COMPLETED|First Intervention (Treatment Period 1)||24
8431379|NCT00848484|20779456|P1|COMPLETED|First Intervention (Treatment Period 1)||25
8431380|NCT00848484|20779455|P2|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
8431381|NCT00848484|20779456|P1|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
8431382|NCT00848484|20779455|P2|STARTED|First Intervention (Treatment Period 1)||27
8431383|NCT00848484|20779456|P1|STARTED|First Intervention (Treatment Period 1)||27
8431384|NCT00848393|20779475|P3|NOT COMPLETED|Overall Study||3
8431385|NCT00848393|20779476|P2|NOT COMPLETED|Overall Study||0
8431386|NCT00848393|20779477|P1|NOT COMPLETED|Overall Study||0
8431387|NCT00848393|20779475|P3|COMPLETED|Overall Study||15
8431388|NCT00848393|20779476|P2|COMPLETED|Overall Study||16
8431389|NCT00848393|20779477|P1|COMPLETED|Overall Study||17
8431390|NCT00848393|20779475|P3|STARTED|Overall Study||18
8431391|NCT00848393|20779476|P2|STARTED|Overall Study||16
8431392|NCT00848393|20779477|P1|STARTED|Overall Study||17
8431393|NCT00848367|20779505|P2|NOT COMPLETED|Overall Study||9
8431394|NCT00848367|20779506|P1|NOT COMPLETED|Overall Study||9
8431395|NCT00848367|20779505|P2|COMPLETED|Overall Study||41
8431396|NCT00848367|20779506|P1|COMPLETED|Overall Study||43
8431397|NCT00848367|20779505|P2|STARTED|Overall Study||50
8431398|NCT00848367|20779506|P1|STARTED|Overall Study||52
8431399|NCT00848354|20779516|P2|NOT COMPLETED|Phase 2 Year 2||7
8431400|NCT00848354|20779517|P1|NOT COMPLETED|Phase 2 Year 2||23
8431401|NCT00848354|20779516|P2|COMPLETED|Phase 2 Year 2||113
8431402|NCT00848354|20779517|P1|COMPLETED|Phase 2 Year 2||218
8431403|NCT00848354|20779516|P2|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
8431404|NCT00848354|20779517|P1|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.
~1 participant discontinued between Year 1 and Year 2."|241
8431405|NCT00848354|20779516|P2|NOT COMPLETED|Phase 2 Year 1||6
8431406|NCT00848354|20779517|P1|NOT COMPLETED|Phase 2 Year 1||18
8431407|NCT00848354|20779516|P2|COMPLETED|Phase 2 Year 1||120
8431408|NCT00848354|20779517|P1|COMPLETED|Phase 2 Year 1||242
8431409|NCT00848354|20779516|P2|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
8431410|NCT00848354|20779517|P1|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
8431411|NCT00848354|20779516|P2|NOT COMPLETED|Phase 1||14
8431412|NCT00848354|20779517|P1|NOT COMPLETED|Phase 1||12
8431413|NCT00848354|20779516|P2|COMPLETED|Phase 1||129
8431414|NCT00848354|20779517|P1|COMPLETED|Phase 1||269
8431415|NCT00848354|20779516|P2|STARTED|Phase 1||143
8431416|NCT00848354|20779517|P1|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
8431417|NCT00848250|20779669|P2|NOT COMPLETED|Overall Study||1
8431418|NCT00848250|20779670|P1|NOT COMPLETED|Overall Study||0
8431419|NCT00848250|20779669|P2|COMPLETED|Overall Study||9
8431420|NCT00848250|20779670|P1|COMPLETED|Overall Study||11
8431421|NCT00848250|20779669|P2|STARTED|Overall Study||10
8431422|NCT00848250|20779670|P1|STARTED|Overall Study||11
8431423|NCT00848237|20779688|P1|NOT COMPLETED|Overall Study||539
8431424|NCT00848237|20779688|P1|COMPLETED|Overall Study||4982
8431425|NCT00848237|20779688|P1|STARTED|Overall Study||5521
8431426|NCT00848211|20779701|P4|NOT COMPLETED|Overall Study||0
8431427|NCT00848211|20779702|P3|NOT COMPLETED|Overall Study||1
8431428|NCT00848211|20779703|P2|NOT COMPLETED|Overall Study||1
8431429|NCT00848211|20779704|P1|NOT COMPLETED|Overall Study||0
8431430|NCT00848211|20779701|P4|COMPLETED|Overall Study||5
8431431|NCT00848211|20779702|P3|COMPLETED|Overall Study||5
8431432|NCT00848211|20779703|P2|COMPLETED|Overall Study||6
8431433|NCT00848211|20779704|P1|COMPLETED|Overall Study||6
8431434|NCT00848211|20779701|P4|STARTED|Overall Study||5
8431435|NCT00848211|20779702|P3|STARTED|Overall Study||6
8431436|NCT00848211|20779703|P2|STARTED|Overall Study||7
8431437|NCT00848211|20779704|P1|STARTED|Overall Study||6
8431438|NCT00848198|20779722|P1|NOT COMPLETED|Overall Study||15
8431439|NCT00848198|20779722|P1|COMPLETED|Overall Study||299
8431440|NCT00848198|20779722|P1|STARTED|Overall Study||314
8431441|NCT00848185|20779763|P3|NOT COMPLETED|Overall Study||0
8431442|NCT00848185|20779764|P2|NOT COMPLETED|Overall Study||0
8431443|NCT00848185|20779765|P1|NOT COMPLETED|Overall Study||0
8431444|NCT00848185|20779763|P3|COMPLETED|Overall Study||32
8431445|NCT00848185|20779764|P2|COMPLETED|Overall Study||32
8431446|NCT00848185|20779765|P1|COMPLETED|Overall Study||32
8431447|NCT00848185|20779763|P3|STARTED|Overall Study||32
8431448|NCT00848185|20779764|P2|STARTED|Overall Study||32
8431449|NCT00848185|20779765|P1|STARTED|Overall Study||32
8431450|NCT00848172|20779775|P2|NOT COMPLETED|Visit 3 - Follow Up||0
8431451|NCT00848172|20779776|P1|NOT COMPLETED|Visit 3 - Follow Up||0
8431452|NCT00848172|20779775|P2|COMPLETED|Visit 3 - Follow Up||8
8431453|NCT00848172|20779776|P1|COMPLETED|Visit 3 - Follow Up||10
8431454|NCT00848172|20779775|P2|STARTED|Visit 3 - Follow Up||8
8431455|NCT00848172|20779776|P1|STARTED|Visit 3 - Follow Up||10
8431456|NCT00848172|20779775|P2|NOT COMPLETED|Visit 2 - Drug Administration||1
8431457|NCT00848172|20779776|P1|NOT COMPLETED|Visit 2 - Drug Administration||0
8431458|NCT00848172|20779775|P2|COMPLETED|Visit 2 - Drug Administration||8
8431459|NCT00848172|20779776|P1|COMPLETED|Visit 2 - Drug Administration||10
8431460|NCT00848172|20779775|P2|STARTED|Visit 2 - Drug Administration||9
8431461|NCT00848172|20779776|P1|STARTED|Visit 2 - Drug Administration||10
8431462|NCT00848120|20779787|P1|NOT COMPLETED|Overall Study||1
8431463|NCT00848120|20779787|P1|COMPLETED|Overall Study||28
8431464|NCT00848120|20779787|P1|STARTED|Overall Study||29
8431465|NCT00848107|20779799|P1|NOT COMPLETED|Overall Study||21
8431466|NCT00848107|20779799|P1|COMPLETED|Overall Study||94
8431467|NCT00848107|20779799|P1|STARTED|Overall Study||115
8431468|NCT00848081|20779809|P2|NOT COMPLETED|Overall Study||18
8431469|NCT00848081|20779810|P1|NOT COMPLETED|Overall Study||20
8431470|NCT00848081|20779809|P2|COMPLETED|Overall Study||140
8431471|NCT00848081|20779810|P1|COMPLETED|Overall Study||140
8431472|NCT00848081|20779809|P2|STARTED|Overall Study||158
8431473|NCT00848081|20779810|P1|STARTED|Overall Study||160
8431474|NCT00848042|20779827|P3|NOT COMPLETED|Overall Study||0
8431475|NCT00848042|20779828|P2|NOT COMPLETED|Overall Study||2
8431476|NCT00848042|20779829|P1|NOT COMPLETED|Overall Study||4
8431477|NCT00848042|20779827|P3|COMPLETED|Overall Study||1
8431478|NCT00848042|20779828|P2|COMPLETED|Overall Study||3
8431479|NCT00848042|20779829|P1|COMPLETED|Overall Study||1
8431480|NCT00848042|20779827|P3|Month 6|Overall Study||1
8431481|NCT00848042|20779828|P2|Month 6|Overall Study||3
8431482|NCT00848042|20779829|P1|Month 6|Overall Study||1
8431483|NCT00848042|20779827|P3|Month 5|Overall Study||1
8431484|NCT00848042|20779828|P2|Month 5|Overall Study||3
8431485|NCT00848042|20779829|P1|Month 5|Overall Study||1
8431486|NCT00848042|20779827|P3|Month 4|Overall Study||1
8431487|NCT00848042|20779828|P2|Month 4|Overall Study||4
8431488|NCT00848042|20779829|P1|Month 4|Overall Study||1
8431489|NCT00848042|20779827|P3|Month 3|Overall Study||1
8431490|NCT00848042|20779828|P2|Month 3|Overall Study||4
8431491|NCT00848042|20779829|P1|Month 3|Overall Study||1
8431492|NCT00848042|20779827|P3|Month 2|Overall Study||1
8431493|NCT00848042|20779828|P2|Month 2|Overall Study||5
8431494|NCT00848042|20779829|P1|Month 2|Overall Study||1
8431495|NCT00848042|20779827|P3|Month 1|Overall Study||1
8431496|NCT00848042|20779828|P2|Month 1|Overall Study||5
8431497|NCT00848042|20779829|P1|Month 1|Overall Study||4
8431498|NCT00848042|20779827|P3|Day 15|Overall Study||1
8431499|NCT00848042|20779828|P2|Day 15|Overall Study||5
8431500|NCT00848042|20779829|P1|Day 15|Overall Study||4
8431501|NCT00848042|20779827|P3|Day 8|Overall Study||1
8431502|NCT00848042|20779828|P2|Day 8|Overall Study||5
8431503|NCT00848042|20779829|P1|Day 8|Overall Study||5
8431504|NCT00848042|20779827|P3|Day 3|Overall Study||1
8431505|NCT00848042|20779828|P2|Day 3|Overall Study||5
8431506|NCT00848042|20779829|P1|Day 3|Overall Study||5
8431507|NCT00848042|20779827|P3|Day 2|Overall Study||1
8431508|NCT00848042|20779828|P2|Day 2|Overall Study||5
8431509|NCT00848042|20779829|P1|Day 2|Overall Study||5
8431510|NCT00848042|20779827|P3|Day 1|Overall Study||1
8431511|NCT00848042|20779828|P2|Day 1|Overall Study||5
8431512|NCT00848042|20779829|P1|Day 1|Overall Study||5
8431513|NCT00848042|20779827|P3|STARTED|Overall Study||1
8431514|NCT00848042|20779828|P2|STARTED|Overall Study||5
8431515|NCT00848042|20779829|P1|STARTED|Overall Study||5
8431516|NCT00848016|20779840|P1|NOT COMPLETED|Overall Study||0
8431517|NCT00848016|20779840|P1|COMPLETED|Overall Study||29
8431518|NCT00848016|20779840|P1|STARTED|Overall Study||29
8431519|NCT00847938|20779850|P4|NOT COMPLETED|Overall Study||0
8431520|NCT00847938|20779851|P3|NOT COMPLETED|Overall Study||1
8431521|NCT00847938|20779852|P2|NOT COMPLETED|Overall Study||1
8431522|NCT00847938|20779853|P1|NOT COMPLETED|Overall Study||0
8431523|NCT00847938|20779850|P4|COMPLETED|Overall Study||15
8431524|NCT00847938|20779851|P3|COMPLETED|Overall Study||15
8431525|NCT00847938|20779852|P2|COMPLETED|Overall Study||14
8431526|NCT00847938|20779853|P1|COMPLETED|Overall Study||16
8431527|NCT00847938|20779850|P4|STARTED|Overall Study||15
8431528|NCT00847938|20779851|P3|STARTED|Overall Study||16
8431529|NCT00847938|20779852|P2|STARTED|Overall Study||15
8431530|NCT00847938|20779853|P1|STARTED|Overall Study||16
8431537|NCT00847886|20779876|P2|NOT COMPLETED|Overall Study||1
8431538|NCT00847886|20779877|P1|NOT COMPLETED|Overall Study||0
8431539|NCT00847886|20779876|P2|COMPLETED|Overall Study||3
8431540|NCT00847886|20779877|P1|COMPLETED|Overall Study||12
8431541|NCT00847886|20779876|P2|STARTED|Overall Study||4
8431542|NCT00847886|20779877|P1|STARTED|Overall Study||12
8431543|NCT00847808|20779903|P1|NOT COMPLETED|Overall Study||15
8431544|NCT00847808|20779903|P1|COMPLETED|Overall Study||163
8431545|NCT00847808|20779903|P1|STARTED|Overall Study||178
8431546|NCT00847730|20779920|P1|NOT COMPLETED|Overall Study||8
8431547|NCT00847730|20779920|P1|COMPLETED|Overall Study||25
8431548|NCT00847730|20779920|P1|STARTED|Overall Study||33
8431549|NCT00847704|20779924|P1|NOT COMPLETED|Overall Study||1
8431550|NCT00847704|20779924|P1|COMPLETED|Overall Study||2
8431551|NCT00847704|20779924|P1|STARTED|Overall Study||3
8431552|NCT00847665|20779935|P2|NOT COMPLETED|Overall Study||0
8431553|NCT00847665|20779936|P1|NOT COMPLETED|Overall Study||1
8431554|NCT00847665|20779935|P2|COMPLETED|Overall Study||165
8431555|NCT00847665|20779936|P1|COMPLETED|Overall Study||164
8431556|NCT00847665|20779935|P2|STARTED|Overall Study||165
8431557|NCT00847665|20779936|P1|STARTED|Overall Study||165
8431558|NCT00847626|20779959|P11|NOT COMPLETED|Overall Study||20
8431559|NCT00847626|20779960|P10|NOT COMPLETED|Overall Study||14
8431560|NCT00847626|20779961|P9|NOT COMPLETED|Overall Study||14
8431561|NCT00847626|20779962|P8|NOT COMPLETED|Overall Study||19
8431562|NCT00847626|20779963|P7|NOT COMPLETED|Overall Study||22
8431563|NCT00847626|20779964|P6|NOT COMPLETED|Overall Study||37
8431564|NCT00847626|20779965|P5|NOT COMPLETED|Overall Study||28
8431565|NCT00847626|20779966|P4|NOT COMPLETED|Overall Study||31
8431566|NCT00847626|20779967|P3|NOT COMPLETED|Overall Study||16
8431567|NCT00847626|20779968|P2|NOT COMPLETED|Overall Study||23
8431568|NCT00847626|20779969|P1|NOT COMPLETED|Overall Study||21
8431569|NCT00847626|20779959|P11|COMPLETED|Overall Study||142
8431570|NCT00847626|20779960|P10|COMPLETED|Overall Study||139
8431571|NCT00847626|20779961|P9|COMPLETED|Overall Study||141
8431572|NCT00847626|20779962|P8|COMPLETED|Overall Study||141
8431573|NCT00847626|20779963|P7|COMPLETED|Overall Study||135
8431574|NCT00847626|20779964|P6|COMPLETED|Overall Study||125
8431575|NCT00847626|20779965|P5|COMPLETED|Overall Study||125
8431576|NCT00847626|20779966|P4|COMPLETED|Overall Study||125
8431577|NCT00847626|20779967|P3|COMPLETED|Overall Study||131
8431578|NCT00847626|20779968|P2|COMPLETED|Overall Study||131
8431579|NCT00847626|20779969|P1|COMPLETED|Overall Study||135
8431580|NCT00847626|20779959|P11|STARTED|Overall Study||162
8431581|NCT00847626|20779960|P10|STARTED|Overall Study||153
8431582|NCT00847626|20779961|P9|STARTED|Overall Study||155
8431583|NCT00847626|20779962|P8|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
8431584|NCT00847626|20779963|P7|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
8431585|NCT00847626|20779964|P6|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
8431586|NCT00847626|20779965|P5|STARTED|Overall Study||153
8431587|NCT00847626|20779966|P4|STARTED|Overall Study||156
8431588|NCT00847626|20779967|P3|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
8431589|NCT00847626|20779968|P2|STARTED|Overall Study||154
8431590|NCT00847626|20779969|P1|STARTED|Overall Study||156
8431591|NCT00847613|20780168|P4|NOT COMPLETED|Overall Study||79
8431592|NCT00847613|20780169|P3|NOT COMPLETED|Overall Study||81
8431593|NCT00847613|20780170|P2|NOT COMPLETED|Overall Study||319
8431594|NCT00847613|20780171|P1|NOT COMPLETED|Overall Study||321
8431595|NCT00847613|20780168|P4|COMPLETED|Overall Study||0
8431596|NCT00847613|20780169|P3|COMPLETED|Overall Study||0
8431597|NCT00847613|20780170|P2|COMPLETED|Overall Study||0
8431598|NCT00847613|20780171|P1|COMPLETED|Overall Study||0
8431599|NCT00847613|20780168|P4|Treated|Overall Study||79
8431600|NCT00847613|20780169|P3|Treated|Overall Study||81
8431601|NCT00847613|20780170|P2|Treated|Overall Study||316
8431602|NCT00847613|20780171|P1|Treated|Overall Study||321
8431603|NCT00847613|20780168|P4|STARTED|Overall Study||79
8431604|NCT00847613|20780169|P3|STARTED|Overall Study||81
8431605|NCT00847613|20780170|P2|STARTED|Overall Study||319
8431606|NCT00847613|20780171|P1|STARTED|Overall Study||321
8431607|NCT00847587|20780411|P2|NOT COMPLETED|Overall Study||0
8431608|NCT00847587|20780412|P1|NOT COMPLETED|Overall Study||1
8431609|NCT00847587|20780411|P2|COMPLETED|Overall Study||34
8431610|NCT00847587|20780412|P1|COMPLETED|Overall Study|Patient declined study after randomization.|34
8431611|NCT00847587|20780411|P2|STARTED|Overall Study||34
8431612|NCT00847587|20780412|P1|STARTED|Overall Study||35
8431613|NCT00847561|20780422|P2|NOT COMPLETED|Overall Study||4
8431614|NCT00847561|20780423|P1|NOT COMPLETED|Overall Study||13
8431615|NCT00847561|20780422|P2|COMPLETED|Overall Study||62
8431616|NCT00847561|20780423|P1|COMPLETED|Overall Study||57
8431617|NCT00847561|20780422|P2|STARTED|Overall Study||66
8431618|NCT00847561|20780423|P1|STARTED|Overall Study||70
8431640|NCT00847522|20780439|P1|NOT COMPLETED|Overall Study||0
8431641|NCT00847522|20780439|P1|COMPLETED|Overall Study||90
8431642|NCT00847522|20780439|P1|Phase II|Overall Study||80
8431643|NCT00847522|20780439|P1|Phase I|Overall Study||10
8431644|NCT00847522|20780439|P1|STARTED|Overall Study||90
8431645|NCT00847509|20780444|P1|NOT COMPLETED|Overall Study||11
8431646|NCT00847509|20780444|P1|COMPLETED|Overall Study||38
8431647|NCT00847509|20780444|P1|STARTED|Overall Study||49
8431648|NCT00847405|20780450|P2|NOT COMPLETED|Second Intervention||0
8431649|NCT00847405|20780451|P1|NOT COMPLETED|Second Intervention||0
8431650|NCT00847405|20780450|P2|COMPLETED|Second Intervention||13
8431651|NCT00847405|20780451|P1|COMPLETED|Second Intervention||13
8431652|NCT00847405|20780450|P2|STARTED|Second Intervention||13
8431653|NCT00847405|20780451|P1|STARTED|Second Intervention||13
8431654|NCT00847405|20780450|P2|NOT COMPLETED|Washout of 7 Days||0
8431655|NCT00847405|20780451|P1|NOT COMPLETED|Washout of 7 Days||1
8431656|NCT00847405|20780450|P2|COMPLETED|Washout of 7 Days||13
8431657|NCT00847405|20780451|P1|COMPLETED|Washout of 7 Days||13
8431658|NCT00847405|20780450|P2|STARTED|Washout of 7 Days||13
8431659|NCT00847405|20780451|P1|STARTED|Washout of 7 Days||14
8431660|NCT00847405|20780450|P2|NOT COMPLETED|First Intervention||1
8431661|NCT00847405|20780451|P1|NOT COMPLETED|First Intervention||0
8431662|NCT00847405|20780450|P2|COMPLETED|First Intervention||13
8431663|NCT00847405|20780451|P1|COMPLETED|First Intervention||14
8431664|NCT00847405|20780450|P2|STARTED|First Intervention||14
8431665|NCT00847405|20780451|P1|STARTED|First Intervention||14
8431666|NCT00847379|20780462|P3|NOT COMPLETED|Overall Study||57
8431667|NCT00847379|20780463|P2|NOT COMPLETED|Overall Study||57
8431668|NCT00847379|20780464|P1|NOT COMPLETED|Overall Study||59
8431669|NCT00847379|20780462|P3|COMPLETED|Overall Study||0
8431670|NCT00847379|20780463|P2|COMPLETED|Overall Study||0
8431671|NCT00847379|20780464|P1|COMPLETED|Overall Study||0
8431672|NCT00847379|20780462|P3|As-treated Population|Overall Study||57
8431673|NCT00847379|20780463|P2|As-treated Population|Overall Study||57
8431674|NCT00847379|20780464|P1|As-treated Population|Overall Study||59
8431675|NCT00847379|20780462|P3|STARTED|Overall Study||57
8431676|NCT00847379|20780463|P2|STARTED|Overall Study||57
8431677|NCT00847379|20780464|P1|STARTED|Overall Study||59
8431678|NCT00847301|20780562|P1|NOT COMPLETED|Overall Study||54
8431679|NCT00847301|20780562|P1|COMPLETED|Overall Study||374
8431680|NCT00847301|20780562|P1|STARTED|Overall Study||428
8431681|NCT00847288|20780572|P2|NOT COMPLETED|Overall Study||47
8431682|NCT00847288|20780573|P1|NOT COMPLETED|Overall Study||30
8431683|NCT00847288|20780572|P2|COMPLETED|Overall Study||780
8431684|NCT00847288|20780573|P1|COMPLETED|Overall Study||811
8431685|NCT00847288|20780572|P2|STARTED|Overall Study||827
8431686|NCT00847288|20780573|P1|STARTED|Overall Study||841
8431687|NCT00847210|20780587|P2|NOT COMPLETED|Overall Study||0
8431688|NCT00847210|20780588|P1|NOT COMPLETED|Overall Study||0
8431689|NCT00847210|20780587|P2|COMPLETED|Overall Study||18
8431690|NCT00847210|20780588|P1|COMPLETED|Overall Study||18
8431691|NCT00847210|20780587|P2|STARTED|Overall Study||18
8431692|NCT00847210|20780588|P1|STARTED|Overall Study||18
8431693|NCT00847197|20780610|P2|NOT COMPLETED|Overall Study||5
8431694|NCT00847197|20780611|P1|NOT COMPLETED|Overall Study||24
8431695|NCT00847197|20780610|P2|COMPLETED|Overall Study||70
8431696|NCT00847197|20780611|P1|COMPLETED|Overall Study||92
8431697|NCT00847197|20780610|P2|STARTED|Overall Study||75
8431698|NCT00847197|20780611|P1|STARTED|Overall Study||116
8431699|NCT00847171|20780621|P1|NOT COMPLETED|Overall Study||0
8431700|NCT00847171|20780621|P1|COMPLETED|Overall Study||20
8431701|NCT00847171|20780621|P1|STARTED|Overall Study||20
8431702|NCT00847145|20780635|P8|NOT COMPLETED|Overall Study||4
8431703|NCT00847145|20780636|P7|NOT COMPLETED|Overall Study||9
8431704|NCT00847145|20780637|P6|NOT COMPLETED|Overall Study||4
8431705|NCT00847145|20780638|P5|NOT COMPLETED|Overall Study||6
8431706|NCT00847145|20780639|P4|NOT COMPLETED|Overall Study||1
8431707|NCT00847145|20780640|P3|NOT COMPLETED|Overall Study||11
8431708|NCT00847145|20780641|P2|NOT COMPLETED|Overall Study||6
8431709|NCT00847145|20780642|P1|NOT COMPLETED|Overall Study||6
8431710|NCT00847145|20780635|P8|COMPLETED|Overall Study||136
8431711|NCT00847145|20780636|P7|COMPLETED|Overall Study||143
8431712|NCT00847145|20780637|P6|COMPLETED|Overall Study||152
8431713|NCT00847145|20780638|P5|COMPLETED|Overall Study||131
8431714|NCT00847145|20780639|P4|COMPLETED|Overall Study||116
8431715|NCT00847145|20780640|P3|COMPLETED|Overall Study||274
8431716|NCT00847145|20780641|P2|COMPLETED|Overall Study||627
8431717|NCT00847145|20780642|P1|COMPLETED|Overall Study||623
8431718|NCT00847145|20780635|P8|STARTED|Overall Study||140
8431719|NCT00847145|20780636|P7|STARTED|Overall Study||152
8431720|NCT00847145|20780637|P6|STARTED|Overall Study||156
8431721|NCT00847145|20780638|P5|STARTED|Overall Study||137
8431722|NCT00847145|20780639|P4|STARTED|Overall Study||117
8431723|NCT00847145|20780640|P3|STARTED|Overall Study||285
8431724|NCT00847145|20780641|P2|STARTED|Overall Study||633
8431725|NCT00847145|20780642|P1|STARTED|Overall Study||629
8431726|NCT00847132|20780692|P2|NOT COMPLETED|Overall Study||1
8431727|NCT00847132|20780693|P1|NOT COMPLETED|Overall Study||1
8431728|NCT00847132|20780692|P2|COMPLETED|Overall Study||84
8431729|NCT00847132|20780693|P1|COMPLETED|Overall Study||89
8431730|NCT00847132|20780692|P2|STARTED|Overall Study||85
8431731|NCT00847132|20780693|P1|STARTED|Overall Study||90
8431732|NCT00847015|20780701|P1|NOT COMPLETED|Overall Study||3
8431733|NCT00847015|20780701|P1|COMPLETED|Overall Study||15
8431734|NCT00847015|20780701|P1|STARTED|Overall Study||18
8431735|NCT00847002|20780709|P2|NOT COMPLETED|Overall Study||0
8431736|NCT00847002|20780710|P1|NOT COMPLETED|Overall Study||0
8431737|NCT00847002|20780709|P2|COMPLETED|Overall Study||4
8431738|NCT00847002|20780710|P1|COMPLETED|Overall Study||4
8431739|NCT00847002|20780709|P2|STARTED|Overall Study||4
8431740|NCT00847002|20780710|P1|STARTED|Overall Study||4
8431741|NCT00846885|20780720|P2|NOT COMPLETED|Second Intervention||0
8431742|NCT00846885|20780721|P1|NOT COMPLETED|Second Intervention||0
8431743|NCT00846885|20780720|P2|COMPLETED|Second Intervention||14
8431744|NCT00846885|20780721|P1|COMPLETED|Second Intervention||14
8431745|NCT00846885|20780720|P2|STARTED|Second Intervention||14
8431746|NCT00846885|20780721|P1|STARTED|Second Intervention||14
8431747|NCT00846885|20780720|P2|NOT COMPLETED|Washout of 7 Days||0
8431748|NCT00846885|20780721|P1|NOT COMPLETED|Washout of 7 Days||0
8431749|NCT00846885|20780720|P2|COMPLETED|Washout of 7 Days||14
8431750|NCT00846885|20780721|P1|COMPLETED|Washout of 7 Days||14
8431751|NCT00846885|20780720|P2|STARTED|Washout of 7 Days||14
8431752|NCT00846885|20780721|P1|STARTED|Washout of 7 Days||14
8431753|NCT00846885|20780720|P2|NOT COMPLETED|First Intervention||0
8431754|NCT00846885|20780721|P1|NOT COMPLETED|First Intervention||0
8431755|NCT00846885|20780720|P2|COMPLETED|First Intervention||14
8431756|NCT00846885|20780721|P1|COMPLETED|First Intervention||14
8431757|NCT00846885|20780720|P2|STARTED|First Intervention||14
8431758|NCT00846885|20780721|P1|STARTED|First Intervention||14
8431759|NCT00846846|20780729|P1|NOT COMPLETED|Overall Study||75
8431760|NCT00846846|20780729|P1|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
8431761|NCT00846846|20780729|P1|STARTED|Overall Study||1018
8431762|NCT00846807|20780734|P1|NOT COMPLETED|Overall Study||632
8431763|NCT00846807|20780734|P1|COMPLETED|Overall Study|Completed treatment.|4660
8431764|NCT00846807|20780734|P1|STARTED|Overall Study|Entered and treated.|5292
8431765|NCT00846768|20780742|P4|NOT COMPLETED|Overall Study||0
8431766|NCT00846768|20780743|P3|NOT COMPLETED|Overall Study||0
8431767|NCT00846768|20780744|P2|NOT COMPLETED|Overall Study||1
8431768|NCT00846768|20780745|P1|NOT COMPLETED|Overall Study||0
8431769|NCT00846768|20780742|P4|COMPLETED|Overall Study||12
8431770|NCT00846768|20780743|P3|COMPLETED|Overall Study||12
8431771|NCT00846768|20780744|P2|COMPLETED|Overall Study||11
8431772|NCT00846768|20780745|P1|COMPLETED|Overall Study||11
8431773|NCT00846768|20780742|P4|STARTED|Overall Study||12
8431774|NCT00846768|20780743|P3|STARTED|Overall Study||12
8431775|NCT00846768|20780744|P2|STARTED|Overall Study||12
8431776|NCT00846768|20780745|P1|STARTED|Overall Study||11
8431782|NCT00846651|20780823|P2|NOT COMPLETED|Overall Study||4
8431783|NCT00846651|20780824|P1|NOT COMPLETED|Overall Study||4
8431784|NCT00846651|20780823|P2|COMPLETED|Overall Study||37
8431785|NCT00846651|20780824|P1|COMPLETED|Overall Study||37
8431786|NCT00846651|20780823|P2|STARTED|Overall Study||41
8431787|NCT00846651|20780824|P1|STARTED|Overall Study||41
8431788|NCT00846586|20780842|P2|NOT COMPLETED|Overall Study||35
8431789|NCT00846586|20780843|P1|NOT COMPLETED|Overall Study||39
8431790|NCT00846586|20780842|P2|COMPLETED|Overall Study||529
8431791|NCT00846586|20780843|P1|COMPLETED|Overall Study||531
8431792|NCT00846586|20780842|P2|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
8431793|NCT00846586|20780843|P1|Received Study Drug|Overall Study||570
8431794|NCT00846586|20780842|P2|STARTED|Overall Study||564
8431795|NCT00846586|20780843|P1|STARTED|Overall Study||570
8431796|NCT00846573|20780862|P4|NOT COMPLETED|Overall Study||0
8431797|NCT00846573|20780863|P3|NOT COMPLETED|Overall Study||0
8431798|NCT00846573|20780864|P2|NOT COMPLETED|Overall Study||0
8431799|NCT00846573|20780865|P1|NOT COMPLETED|Overall Study||0
8431800|NCT00846573|20780862|P4|COMPLETED|Overall Study||0
8431801|NCT00846573|20780863|P3|COMPLETED|Overall Study||7
8431802|NCT00846573|20780864|P2|COMPLETED|Overall Study||2
8431803|NCT00846573|20780865|P1|COMPLETED|Overall Study||5
8431804|NCT00846573|20780862|P4|STARTED|Overall Study||0
8431805|NCT00846573|20780863|P3|STARTED|Overall Study||7
8431806|NCT00846573|20780864|P2|STARTED|Overall Study||2
8431807|NCT00846573|20780865|P1|STARTED|Overall Study||5
8431808|NCT00846547|20780873|P1|NOT COMPLETED|Overall Study||7
8431809|NCT00846547|20780873|P1|COMPLETED|Overall Study||25
8431810|NCT00846547|20780873|P1|STARTED|Overall Study||32
8431811|NCT00846521|20780877|P1|NOT COMPLETED|Overall Study||11
8431812|NCT00846521|20780877|P1|COMPLETED|Overall Study||12
8431813|NCT00846521|20780877|P1|STARTED|Overall Study||23
8431814|NCT00846495|20780884|P2|NOT COMPLETED|Overall Study||3
8431815|NCT00846495|20780885|P1|NOT COMPLETED|Overall Study||8
8431816|NCT00846495|20780884|P2|COMPLETED|Overall Study||24
8431817|NCT00846495|20780885|P1|COMPLETED|Overall Study||20
8431818|NCT00846495|20780884|P2|STARTED|Overall Study||27
8431819|NCT00846495|20780885|P1|STARTED|Overall Study||28
8431820|NCT00846482|20780905|P1|NOT COMPLETED|Overall Study||10
8431821|NCT00846482|20780905|P1|COMPLETED|Overall Study||54
8431822|NCT00846482|20780905|P1|STARTED|Overall Study||64
8431823|NCT00846391|20780913|P3|NOT COMPLETED|Overall Study||3
8431824|NCT00846391|20780914|P2|NOT COMPLETED|Overall Study||2
8431825|NCT00846391|20780915|P1|NOT COMPLETED|Overall Study||1
8431826|NCT00846391|20780913|P3|COMPLETED|Overall Study||3
8431827|NCT00846391|20780914|P2|COMPLETED|Overall Study||2
8431828|NCT00846391|20780915|P1|COMPLETED|Overall Study||3
8431829|NCT00846391|20780913|P3|STARTED|Overall Study||6
8431830|NCT00846391|20780914|P2|STARTED|Overall Study||4
8431831|NCT00846391|20780915|P1|STARTED|Overall Study||4
8431832|NCT00846365|20780926|P3|NOT COMPLETED|Overall Study||33
8431833|NCT00846365|20780927|P2|NOT COMPLETED|Overall Study||49
8431834|NCT00846365|20780928|P1|NOT COMPLETED|Overall Study||55
8431835|NCT00846365|20780926|P3|COMPLETED|Overall Study||323
8431836|NCT00846365|20780927|P2|COMPLETED|Overall Study||308
8431837|NCT00846365|20780928|P1|COMPLETED|Overall Study||317
8431838|NCT00846365|20780926|P3|STARTED|Overall Study||356
8431839|NCT00846365|20780927|P2|STARTED|Overall Study||357
8431840|NCT00846365|20780928|P1|STARTED|Overall Study||372
8431841|NCT00846287|20780983|P2|NOT COMPLETED|Overall Study||5
8431842|NCT00846287|20780984|P1|NOT COMPLETED|Overall Study||10
8431843|NCT00846287|20780983|P2|COMPLETED|Overall Study||10
8431844|NCT00846287|20780984|P1|COMPLETED|Overall Study||6
8431845|NCT00846287|20780983|P2|STARTED|Overall Study||15
8431846|NCT00846287|20780984|P1|STARTED|Overall Study||16
8431847|NCT00846066|20780994|P2|NOT COMPLETED|Overall Study||0
8431848|NCT00846066|20780995|P1|NOT COMPLETED|Overall Study||0
8431849|NCT00846066|20780994|P2|COMPLETED|Overall Study||29
8431850|NCT00846066|20780995|P1|COMPLETED|Overall Study||27
8431851|NCT00846066|20780994|P2|STARTED|Overall Study||29
8431852|NCT00846066|20780995|P1|STARTED|Overall Study||27
8431853|NCT00846053|20781009|P2|NOT COMPLETED|Overall Study||0
8431854|NCT00846053|20781010|P1|NOT COMPLETED|Overall Study||3
8431855|NCT00846053|20781009|P2|COMPLETED|Overall Study||8
8431856|NCT00846053|20781010|P1|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
8431857|NCT00846053|20781009|P2|STARTED|Overall Study||8
8431858|NCT00846053|20781010|P1|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
8431859|NCT00846027|20781018|P1|NOT COMPLETED|Overall Study||90
8431860|NCT00846027|20781018|P1|COMPLETED|Overall Study||0
8431861|NCT00846027|20781018|P1|Received Treatment|Overall Study||83
8431862|NCT00846027|20781018|P1|STARTED|Overall Study||90
8431863|NCT00845975|20781027|P2|NOT COMPLETED|Overall Study||0
8431864|NCT00845975|20781028|P1|NOT COMPLETED|Overall Study||0
8431865|NCT00845975|20781027|P2|COMPLETED|Overall Study||9
8431866|NCT00845975|20781028|P1|COMPLETED|Overall Study||9
8431867|NCT00845975|20781027|P2|STARTED|Overall Study||9
8431868|NCT00845975|20781028|P1|STARTED|Overall Study||9
8431869|NCT00845897|20781041|P3|NOT COMPLETED|Overall Study||3
8431870|NCT00845897|20781042|P2|NOT COMPLETED|Overall Study||5
8431871|NCT00845897|20781043|P1|NOT COMPLETED|Overall Study||2
8431872|NCT00845897|20781041|P3|COMPLETED|Overall Study||2
8431873|NCT00845897|20781042|P2|COMPLETED|Overall Study||2
8431874|NCT00845897|20781043|P1|COMPLETED|Overall Study||3
8431875|NCT00845897|20781041|P3|STARTED|Overall Study||5
8431876|NCT00845897|20781042|P2|STARTED|Overall Study||7
8431877|NCT00845897|20781043|P1|STARTED|Overall Study||5
8431878|NCT00845858|20781057|P3|NOT COMPLETED|Overall Study||8
8431879|NCT00845858|20781058|P2|NOT COMPLETED|Overall Study||12
8431880|NCT00845858|20781059|P1|NOT COMPLETED|Overall Study||8
8431881|NCT00845858|20781057|P3|COMPLETED|Overall Study||87
8431882|NCT00845858|20781058|P2|COMPLETED|Overall Study||84
8431883|NCT00845858|20781059|P1|COMPLETED|Overall Study||88
8431884|NCT00845858|20781057|P3|STARTED|Overall Study||95
8431885|NCT00845858|20781058|P2|STARTED|Overall Study|"95 subjects received allocated intervention.
~1 subject was not eligible and was not dosed."|96
8431886|NCT00845858|20781059|P1|STARTED|Overall Study|"95 subjects received allocated intervention.
~1 subject withdrew consent and was not dosed."|96
8431887|NCT00845845|20781072|P2|NOT COMPLETED|Overall Study||4
8431888|NCT00845845|20781073|P1|NOT COMPLETED|Overall Study||0
8431889|NCT00845845|20781072|P2|COMPLETED|Overall Study||2
8431890|NCT00845845|20781073|P1|COMPLETED|Overall Study||3
8431891|NCT00845845|20781072|P2|STARTED|Overall Study||6
8431892|NCT00845845|20781073|P1|STARTED|Overall Study||3
8431893|NCT00845832|20781084|P3|NOT COMPLETED|Extended Safety Follow-Up||7
8431894|NCT00845832|20781085|P2|NOT COMPLETED|Extended Safety Follow-Up||0
8431895|NCT00845832|20781086|P1|NOT COMPLETED|Extended Safety Follow-Up||0
8431896|NCT00845832|20781084|P3|COMPLETED|Extended Safety Follow-Up||0
8431897|NCT00845832|20781085|P2|COMPLETED|Extended Safety Follow-Up||5
8431898|NCT00845832|20781086|P1|COMPLETED|Extended Safety Follow-Up||2
8431899|NCT00845832|20781084|P3|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
8431900|NCT00845832|20781085|P2|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
8431901|NCT00845832|20781086|P1|STARTED|Extended Safety Follow-Up||2
8431902|NCT00845832|20781084|P3|NOT COMPLETED|Safety Follow-Up||0
8431903|NCT00845832|20781085|P2|NOT COMPLETED|Safety Follow-Up||0
8431904|NCT00845832|20781086|P1|NOT COMPLETED|Safety Follow-Up||1
8431905|NCT00845832|20781084|P3|COMPLETED|Safety Follow-Up||12
8431906|NCT00845832|20781085|P2|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
8431907|NCT00845832|20781086|P1|COMPLETED|Safety Follow-Up||2
8431908|NCT00845832|20781084|P3|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
8431909|NCT00845832|20781085|P2|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
8431910|NCT00845832|20781086|P1|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
8431911|NCT00845832|20781084|P3|NOT COMPLETED|Treatment Period||0
8431912|NCT00845832|20781085|P2|NOT COMPLETED|Treatment Period||3
8431913|NCT00845832|20781086|P1|NOT COMPLETED|Treatment Period||1
8431914|NCT00845832|20781084|P3|COMPLETED|Treatment Period||10
8431915|NCT00845832|20781085|P2|COMPLETED|Treatment Period||7
8431916|NCT00845832|20781086|P1|COMPLETED|Treatment Period||3
8431917|NCT00845832|20781084|P3|STARTED|Treatment Period||10
8431918|NCT00845832|20781085|P2|STARTED|Treatment Period||10
8431919|NCT00845832|20781086|P1|STARTED|Treatment Period||4
8431920|NCT00845728|20781132|P2|NOT COMPLETED|Overall Study||342
8431921|NCT00845728|20781133|P1|NOT COMPLETED|Overall Study||386
8431922|NCT00845728|20781132|P2|COMPLETED|Overall Study||1379
8431923|NCT00845728|20781133|P1|COMPLETED|Overall Study||1337
8431924|NCT00845728|20781132|P2|Exposed|Overall Study||1718
8431925|NCT00845728|20781133|P1|Exposed|Overall Study||1721
8431926|NCT00845728|20781132|P2|STARTED|Overall Study||1721
8431927|NCT00845728|20781133|P1|STARTED|Overall Study||1723
8431928|NCT00845702|20781141|P1|NOT COMPLETED|Dotarem MRA||0
8431929|NCT00845702|20781141|P1|COMPLETED|Dotarem MRA||32
8431930|NCT00845702|20781141|P1|STARTED|Dotarem MRA||32
8431931|NCT00845702|20781141|P1|NOT COMPLETED|TOF MRA||1
8431932|NCT00845702|20781141|P1|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
8431933|NCT00845702|20781141|P1|STARTED|TOF MRA||33
8431934|NCT00845676|20781147|P1|NOT COMPLETED|Overall Study||2
8431935|NCT00845676|20781147|P1|COMPLETED|Overall Study||19
8431936|NCT00845676|20781147|P1|STARTED|Overall Study||21
8431937|NCT00845663|20781155|P2|NOT COMPLETED|Overall Study||0
8431938|NCT00845663|20781156|P1|NOT COMPLETED|Overall Study||0
8431939|NCT00845663|20781155|P2|COMPLETED|Overall Study||49
8431940|NCT00845663|20781156|P1|COMPLETED|Overall Study||49
8431941|NCT00845663|20781155|P2|STARTED|Overall Study||49
8431942|NCT00845663|20781156|P1|STARTED|Overall Study||49
8431943|NCT00845650|20781210|P6|NOT COMPLETED|Overall Study||2
8431944|NCT00845650|20781211|P5|NOT COMPLETED|Overall Study||3
8431945|NCT00845650|20781212|P4|NOT COMPLETED|Overall Study||1
8431946|NCT00845650|20781213|P3|NOT COMPLETED|Overall Study||3
8431947|NCT00845650|20781214|P2|NOT COMPLETED|Overall Study||0
8431948|NCT00845650|20781215|P1|NOT COMPLETED|Overall Study||1
8431949|NCT00845650|20781210|P6|COMPLETED|Overall Study||15
8431950|NCT00845650|20781211|P5|COMPLETED|Overall Study||28
8431951|NCT00845650|20781212|P4|COMPLETED|Overall Study||13
8431952|NCT00845650|20781213|P3|COMPLETED|Overall Study||28
8431953|NCT00845650|20781214|P2|COMPLETED|Overall Study||5
8431954|NCT00845650|20781215|P1|COMPLETED|Overall Study||30
8431955|NCT00845650|20781210|P6|STARTED|Overall Study|1 subject not dosed|17
8431956|NCT00845650|20781211|P5|STARTED|Overall Study|2 subjects not dosed|31
8431957|NCT00845650|20781212|P4|STARTED|Overall Study||14
8431958|NCT00845650|20781213|P3|STARTED|Overall Study||31
8431959|NCT00845650|20781214|P2|STARTED|Overall Study||5
8431960|NCT00845650|20781215|P1|STARTED|Overall Study|1 subject not dosed|31
8431961|NCT00845520|20781253|P3|NOT COMPLETED|Overall Study||1
8431962|NCT00845520|20781254|P2|NOT COMPLETED|Overall Study||2
8431963|NCT00845520|20781255|P1|NOT COMPLETED|Overall Study||2
8431964|NCT00845520|20781253|P3|COMPLETED|Overall Study||23
8431965|NCT00845520|20781254|P2|COMPLETED|Overall Study||23
8431966|NCT00845520|20781255|P1|COMPLETED|Overall Study||23
8431967|NCT00845520|20781253|P3|STARTED|Overall Study||24
8431968|NCT00845520|20781254|P2|STARTED|Overall Study||25
8431969|NCT00845520|20781255|P1|STARTED|Overall Study||25
8431970|NCT00845507|20781271|P2|NOT COMPLETED|Overall Study||1
8431971|NCT00845507|20781272|P1|NOT COMPLETED|Overall Study||2
8431972|NCT00845507|20781271|P2|COMPLETED|Overall Study||29
8431973|NCT00845507|20781272|P1|COMPLETED|Overall Study||22
8431974|NCT00845507|20781271|P2|STARTED|Overall Study||30
8431975|NCT00845507|20781272|P1|STARTED|Overall Study||24
8431976|NCT00845481|20781280|P1|NOT COMPLETED|Overall Study||0
8431977|NCT00845481|20781280|P1|COMPLETED|Overall Study||24
8431978|NCT00845481|20781280|P1|STARTED|Overall Study||24
8431979|NCT00845429|20781292|P3|NOT COMPLETED|Overall Study||20
8431980|NCT00845429|20781293|P2|NOT COMPLETED|Overall Study||15
8431981|NCT00845429|20781294|P1|NOT COMPLETED|Overall Study||14
8431982|NCT00845429|20781292|P3|COMPLETED|Overall Study||224
8431983|NCT00845429|20781293|P2|COMPLETED|Overall Study||226
8431984|NCT00845429|20781294|P1|COMPLETED|Overall Study||230
8431985|NCT00845429|20781292|P3|STARTED|Overall Study||244
8431986|NCT00845429|20781293|P2|STARTED|Overall Study||241
8431987|NCT00845429|20781294|P1|STARTED|Overall Study||244
8431988|NCT00845195|20781313|P2|NOT COMPLETED|Overall Study||0
8431989|NCT00845195|20781314|P1|NOT COMPLETED|Overall Study||0
8431990|NCT00845195|20781313|P2|COMPLETED|Overall Study||75
8431991|NCT00845195|20781314|P1|COMPLETED|Overall Study||75
8431992|NCT00845195|20781313|P2|STARTED|Overall Study||75
8431993|NCT00845195|20781314|P1|STARTED|Overall Study||75
8431994|NCT00845182|20781329|P3|NOT COMPLETED|Overall Study||6
8431995|NCT00845182|20781330|P2|NOT COMPLETED|Overall Study||4
8431996|NCT00845182|20781331|P1|NOT COMPLETED|Overall Study||3
8431997|NCT00845182|20781329|P3|COMPLETED|Overall Study||9
8431998|NCT00845182|20781330|P2|COMPLETED|Overall Study||11
8431999|NCT00845182|20781331|P1|COMPLETED|Overall Study||10
8432000|NCT00845182|20781329|P3|STARTED|Overall Study||15
8432001|NCT00845182|20781330|P2|STARTED|Overall Study||15
8432002|NCT00845182|20781331|P1|STARTED|Overall Study||13
8432003|NCT00845130|20781345|P2|NOT COMPLETED|Overall Study||3
8432004|NCT00845130|20781346|P1|NOT COMPLETED|Overall Study||4
8432005|NCT00845130|20781345|P2|COMPLETED|Overall Study||19
8432006|NCT00845130|20781346|P1|COMPLETED|Overall Study||16
8432007|NCT00845130|20781345|P2|STARTED|Overall Study||22
8432008|NCT00845130|20781346|P1|STARTED|Overall Study||20
8432009|NCT00845065|20781356|P2|NOT COMPLETED|Overall Study||55
8432010|NCT00845065|20781357|P1|NOT COMPLETED|Overall Study||47
8432011|NCT00845065|20781356|P2|COMPLETED|Overall Study||79
8432012|NCT00845065|20781357|P1|COMPLETED|Overall Study||20
8432013|NCT00845065|20781356|P2|STARTED|Overall Study||134
8432014|NCT00845065|20781357|P1|STARTED|Overall Study||67
8432015|NCT00845039|20781373|P2|NOT COMPLETED|Overall Study||0
8432016|NCT00845039|20781374|P1|NOT COMPLETED|Overall Study||0
8432017|NCT00845039|20781373|P2|COMPLETED|Overall Study||2
8432018|NCT00845039|20781374|P1|COMPLETED|Overall Study||2
8432019|NCT00845039|20781373|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
8432020|NCT00845039|20781374|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
8432021|NCT00845039|20781373|P2|STARTED|Overall Study||2
8432022|NCT00845039|20781374|P1|STARTED|Overall Study||2
8432023|NCT00845000|20781401|P6|NOT COMPLETED|Period 3||0
8432024|NCT00845000|20781402|P5|NOT COMPLETED|Period 3||0
8432025|NCT00845000|20781403|P4|NOT COMPLETED|Period 3||0
8432026|NCT00845000|20781404|P3|NOT COMPLETED|Period 3||0
8432027|NCT00845000|20781405|P2|NOT COMPLETED|Period 3||0
8432028|NCT00845000|20781406|P1|NOT COMPLETED|Period 3||0
8432029|NCT00845000|20781401|P6|COMPLETED|Period 3||2
8432030|NCT00845000|20781402|P5|COMPLETED|Period 3||2
8432031|NCT00845000|20781403|P4|COMPLETED|Period 3||2
8432032|NCT00845000|20781404|P3|COMPLETED|Period 3||2
8432033|NCT00845000|20781405|P2|COMPLETED|Period 3||2
8432034|NCT00845000|20781406|P1|COMPLETED|Period 3||2
8432035|NCT00845000|20781401|P6|STARTED|Period 3||2
8432036|NCT00845000|20781402|P5|STARTED|Period 3||2
8432037|NCT00845000|20781403|P4|STARTED|Period 3||2
8432038|NCT00845000|20781404|P3|STARTED|Period 3||2
8432039|NCT00845000|20781405|P2|STARTED|Period 3||2
8432040|NCT00845000|20781406|P1|STARTED|Period 3||2
8432041|NCT00845000|20781401|P6|NOT COMPLETED|Period 2||0
8432042|NCT00845000|20781402|P5|NOT COMPLETED|Period 2||0
8432043|NCT00845000|20781403|P4|NOT COMPLETED|Period 2||0
8432044|NCT00845000|20781404|P3|NOT COMPLETED|Period 2||0
8432045|NCT00845000|20781405|P2|NOT COMPLETED|Period 2||0
8432046|NCT00845000|20781406|P1|NOT COMPLETED|Period 2||0
8432047|NCT00845000|20781401|P6|COMPLETED|Period 2||2
8432048|NCT00845000|20781402|P5|COMPLETED|Period 2||2
8432049|NCT00845000|20781403|P4|COMPLETED|Period 2||2
8432050|NCT00845000|20781404|P3|COMPLETED|Period 2||2
8432051|NCT00845000|20781405|P2|COMPLETED|Period 2||2
8432052|NCT00845000|20781406|P1|COMPLETED|Period 2||2
8432053|NCT00845000|20781401|P6|STARTED|Period 2||2
8432054|NCT00845000|20781402|P5|STARTED|Period 2||2
8432055|NCT00845000|20781403|P4|STARTED|Period 2||2
8432056|NCT00845000|20781404|P3|STARTED|Period 2||2
8432057|NCT00845000|20781405|P2|STARTED|Period 2||2
8432058|NCT00845000|20781406|P1|STARTED|Period 2||2
8432059|NCT00845000|20781401|P6|NOT COMPLETED|Period 1||0
8432060|NCT00845000|20781402|P5|NOT COMPLETED|Period 1||0
8432061|NCT00845000|20781403|P4|NOT COMPLETED|Period 1||0
8432062|NCT00845000|20781404|P3|NOT COMPLETED|Period 1||0
8432063|NCT00845000|20781405|P2|NOT COMPLETED|Period 1||0
8432064|NCT00845000|20781406|P1|NOT COMPLETED|Period 1||0
8432065|NCT00845000|20781401|P6|COMPLETED|Period 1||2
8432066|NCT00845000|20781402|P5|COMPLETED|Period 1||2
8432067|NCT00845000|20781403|P4|COMPLETED|Period 1||2
8432068|NCT00845000|20781404|P3|COMPLETED|Period 1||2
8432069|NCT00845000|20781405|P2|COMPLETED|Period 1||2
8432070|NCT00845000|20781406|P1|COMPLETED|Period 1||2
8432071|NCT00845000|20781401|P6|STARTED|Period 1||2
8432072|NCT00845000|20781402|P5|STARTED|Period 1||2
8432073|NCT00845000|20781403|P4|STARTED|Period 1||2
8432074|NCT00845000|20781404|P3|STARTED|Period 1||2
8432075|NCT00845000|20781405|P2|STARTED|Period 1||2
8432076|NCT00845000|20781406|P1|STARTED|Period 1||2
8432077|NCT00844896|20781425|P2|NOT COMPLETED|Overall Study||17
8432078|NCT00844896|20781426|P1|NOT COMPLETED|Overall Study||12
8432079|NCT00844896|20781425|P2|COMPLETED|Overall Study||11
8432080|NCT00844896|20781426|P1|COMPLETED|Overall Study||17
8432081|NCT00844896|20781425|P2|STARTED|Overall Study||28
8432082|NCT00844896|20781426|P1|STARTED|Overall Study||29
8432083|NCT00844883|20781448|P1|NOT COMPLETED|Overall Study||4
8432084|NCT00844883|20781448|P1|COMPLETED|Overall Study||46
8432085|NCT00844883|20781448|P1|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
8432086|NCT00844883|20781448|P1|STARTED|Overall Study||50
8432087|NCT00844857|20781460|P2|NOT COMPLETED|Overall Study||37
8432088|NCT00844857|20781461|P1|NOT COMPLETED|Overall Study||78
8432089|NCT00844857|20781460|P2|COMPLETED|Overall Study||60
8432090|NCT00844857|20781461|P1|COMPLETED|Overall Study||116
8432091|NCT00844857|20781460|P2|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
8432092|NCT00844857|20781461|P1|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
8432093|NCT00844857|20781460|P2|STARTED|Overall Study||97
8432094|NCT00844857|20781461|P1|STARTED|Overall Study||194
8432095|NCT00844844|20781505|P1|NOT COMPLETED|Post Treatment Period||1
8432096|NCT00844844|20781505|P1|COMPLETED|Post Treatment Period||5
8432097|NCT00844844|20781505|P1|STARTED|Post Treatment Period||6
8432098|NCT00844844|20781505|P1|NOT COMPLETED|Extension Treatment Period||2
8432099|NCT00844844|20781505|P1|COMPLETED|Extension Treatment Period||11
8432100|NCT00844844|20781505|P1|STARTED|Extension Treatment Period||13
8432101|NCT00844844|20781505|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
8432102|NCT00844844|20781505|P1|COMPLETED|Treatment Period (26 Weeks)||15
8432103|NCT00844844|20781505|P1|STARTED|Treatment Period (26 Weeks)||17
8432104|NCT00844844|20781505|P1|NOT COMPLETED|Screening Period||0
8432105|NCT00844844|20781505|P1|COMPLETED|Screening Period||17
8432106|NCT00844844|20781505|P1|STARTED|Screening Period||17
8432107|NCT00844831|20781519|P1|NOT COMPLETED|Overall Study||6
8432108|NCT00844831|20781519|P1|COMPLETED|Overall Study||19
8432109|NCT00844831|20781519|P1|STARTED|Overall Study||25
8432110|NCT00844805|20781529|P4|NOT COMPLETED|Follow-Up Phase||9
8432111|NCT00844805|20781530|P3|NOT COMPLETED|Follow-Up Phase||9
8432112|NCT00844805|20781531|P2|NOT COMPLETED|Follow-Up Phase||0
8432113|NCT00844805|20781532|P1|NOT COMPLETED|Follow-Up Phase||0
8432114|NCT00844805|20781529|P4|COMPLETED|Follow-Up Phase||32
8432115|NCT00844805|20781530|P3|COMPLETED|Follow-Up Phase||32
8432116|NCT00844805|20781531|P2|COMPLETED|Follow-Up Phase||0
8432117|NCT00844805|20781532|P1|COMPLETED|Follow-Up Phase||0
8432118|NCT00844805|20781529|P4|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
8432119|NCT00844805|20781530|P3|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
8432120|NCT00844805|20781531|P2|STARTED|Follow-Up Phase||0
8432121|NCT00844805|20781532|P1|STARTED|Follow-Up Phase||0
8432122|NCT00844805|20781529|P4|NOT COMPLETED|Treatment Phase||0
8432123|NCT00844805|20781530|P3|NOT COMPLETED|Treatment Phase||0
8432124|NCT00844805|20781531|P2|NOT COMPLETED|Treatment Phase||7
8432125|NCT00844805|20781532|P1|NOT COMPLETED|Treatment Phase||10
8432126|NCT00844805|20781529|P4|COMPLETED|Treatment Phase||0
8432127|NCT00844805|20781530|P3|COMPLETED|Treatment Phase||0
8432128|NCT00844805|20781531|P2|COMPLETED|Treatment Phase||45
8432129|NCT00844805|20781532|P1|COMPLETED|Treatment Phase||96
8432130|NCT00844805|20781529|P4|STARTED|Treatment Phase||0
8432131|NCT00844805|20781530|P3|STARTED|Treatment Phase||0
8432132|NCT00844805|20781531|P2|STARTED|Treatment Phase||52
8432133|NCT00844805|20781532|P1|STARTED|Treatment Phase||106
8432134|NCT00844753|20781576|P4|NOT COMPLETED|Overall Study||11
8432135|NCT00844753|20781577|P3|NOT COMPLETED|Overall Study||7
8432136|NCT00844753|20781578|P2|NOT COMPLETED|Overall Study||3
8432137|NCT00844753|20781579|P1|NOT COMPLETED|Overall Study||8
8432138|NCT00844753|20781576|P4|COMPLETED|Overall Study||21
8432139|NCT00844753|20781577|P3|COMPLETED|Overall Study||25
8432140|NCT00844753|20781578|P2|COMPLETED|Overall Study||29
8432141|NCT00844753|20781579|P1|COMPLETED|Overall Study||24
8432142|NCT00844753|20781576|P4|STARTED|Overall Study||32
8432143|NCT00844753|20781577|P3|STARTED|Overall Study||32
8432144|NCT00844753|20781578|P2|STARTED|Overall Study||32
8432145|NCT00844753|20781579|P1|STARTED|Overall Study||32
8432146|NCT00844714|20781591|P1|NOT COMPLETED|Overall Study||0
8432147|NCT00844714|20781591|P1|COMPLETED|Overall Study||20
8432148|NCT00844714|20781591|P1|STARTED|Overall Study||20
8432149|NCT00844649|20781597|P2|NOT COMPLETED|Overall Study||418
8432150|NCT00844649|20781598|P1|NOT COMPLETED|Overall Study||405
8432151|NCT00844649|20781597|P2|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
8432152|NCT00844649|20781598|P1|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
8432153|NCT00844649|20781597|P2|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
8432154|NCT00844649|20781598|P1|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
8432155|NCT00844649|20781597|P2|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
8432156|NCT00844649|20781598|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
8432157|NCT00844597|20781622|P6|NOT COMPLETED|Overall Study||0
8432158|NCT00844597|20781623|P5|NOT COMPLETED|Overall Study||0
8432159|NCT00844597|20781624|P4|NOT COMPLETED|Overall Study||1
8432160|NCT00844597|20781625|P3|NOT COMPLETED|Overall Study||0
8432161|NCT00844597|20781626|P2|NOT COMPLETED|Overall Study||0
8432162|NCT00844597|20781627|P1|NOT COMPLETED|Overall Study||0
8432163|NCT00844597|20781622|P6|COMPLETED|Overall Study||4
8432164|NCT00844597|20781623|P5|COMPLETED|Overall Study||4
8432165|NCT00844597|20781624|P4|COMPLETED|Overall Study||2
8432166|NCT00844597|20781625|P3|COMPLETED|Overall Study||2
8432167|NCT00844597|20781626|P2|COMPLETED|Overall Study||2
8432168|NCT00844597|20781627|P1|COMPLETED|Overall Study||4
8432169|NCT00844597|20781622|P6|STARTED|Overall Study||4
8432170|NCT00844597|20781623|P5|STARTED|Overall Study||4
8432171|NCT00844597|20781624|P4|STARTED|Overall Study||3
8432172|NCT00844597|20781625|P3|STARTED|Overall Study||2
8432173|NCT00844597|20781626|P2|STARTED|Overall Study||2
8432174|NCT00844597|20781627|P1|STARTED|Overall Study||4
8432175|NCT00844558|20781647|P2|NOT COMPLETED|Overall Study||4
8432176|NCT00844558|20781648|P1|NOT COMPLETED|Overall Study||12
8432177|NCT00844558|20781647|P2|COMPLETED|Overall Study||18
8432178|NCT00844558|20781648|P1|COMPLETED|Overall Study||24
8432179|NCT00844558|20781647|P2|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
8432180|NCT00844558|20781648|P1|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
8432181|NCT00844558|20781647|P2|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
8432182|NCT00844558|20781648|P1|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
8432183|NCT00844558|20781647|P2|3 Month Visit|Overall Study|"Lost to follow-up (n=1)
~Discontinued Intervention (n=1)"|19
8432184|NCT00844558|20781648|P1|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
8432185|NCT00844558|20781647|P2|Received Allocated Intervention|Overall Study||21
8432186|NCT00844558|20781648|P1|Received Allocated Intervention|Overall Study||33
8432187|NCT00844558|20781647|P2|STARTED|Overall Study|"Received allocated intervention (n=21)
~Did not receive allocated intervention (n=1)"|22
8432188|NCT00844558|20781648|P1|STARTED|Overall Study|"Received allocated intervention (n=33)
~Did not receive allocated intervention (n=3)"|36
8432189|NCT00844545|20781664|P1|NOT COMPLETED|Post Treatment Period||1
8432190|NCT00844545|20781664|P1|COMPLETED|Post Treatment Period||5
8432191|NCT00844545|20781664|P1|STARTED|Post Treatment Period||6
8432192|NCT00844545|20781664|P1|NOT COMPLETED|Extension Treatment Period||2
8432193|NCT00844545|20781664|P1|COMPLETED|Extension Treatment Period||11
8432194|NCT00844545|20781664|P1|STARTED|Extension Treatment Period||13
8432195|NCT00844545|20781664|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
8432196|NCT00844545|20781664|P1|COMPLETED|Treatment Period (26 Weeks)||15
8432197|NCT00844545|20781664|P1|STARTED|Treatment Period (26 Weeks)||17
8432198|NCT00844545|20781664|P1|NOT COMPLETED|Screening Period||0
8432199|NCT00844545|20781664|P1|COMPLETED|Screening Period||17
8432200|NCT00844545|20781664|P1|STARTED|Screening Period||17
8432201|NCT00844532|20781678|P1|NOT COMPLETED|Overall Study||39
8432202|NCT00844532|20781678|P1|COMPLETED|Overall Study||112
8432203|NCT00844532|20781678|P1|STARTED|Overall Study||151
8432204|NCT00844519|20781764|P2|NOT COMPLETED|Overall Study||1
8432205|NCT00844519|20781765|P1|NOT COMPLETED|Overall Study||2
8432206|NCT00844519|20781764|P2|COMPLETED|Overall Study||25
8432207|NCT00844519|20781765|P1|COMPLETED|Overall Study||24
8432208|NCT00844519|20781764|P2|STARTED|Overall Study||26
8432209|NCT00844519|20781765|P1|STARTED|Overall Study||26
8432210|NCT00844480|20781773|P2|NOT COMPLETED|Overall Study||3
8432211|NCT00844480|20781774|P1|NOT COMPLETED|Overall Study||2
8432212|NCT00844480|20781773|P2|COMPLETED|Overall Study||6
8432213|NCT00844480|20781774|P1|COMPLETED|Overall Study||6
8432214|NCT00844480|20781773|P2|STARTED|Overall Study||9
8432215|NCT00844480|20781774|P1|STARTED|Overall Study||8
8432216|NCT00844428|20781782|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
8432217|NCT00844428|20781782|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
8432218|NCT00844428|20781782|P1|STARTED|Post Treatment Period (Patients Who Disc||5
8432219|NCT00844428|20781782|P1|NOT COMPLETED|Extension Treatment Period||1
8432220|NCT00844428|20781782|P1|COMPLETED|Extension Treatment Period||18
8432221|NCT00844428|20781782|P1|STARTED|Extension Treatment Period||19
8432222|NCT00844428|20781782|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
8432223|NCT00844428|20781782|P1|COMPLETED|Treatment Period (26 Weeks)||20
8432224|NCT00844428|20781782|P1|STARTED|Treatment Period (26 Weeks)||20
8432225|NCT00844428|20781782|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
8432226|NCT00844428|20781782|P1|COMPLETED|Observation Period (8 Weeks)||20
8432227|NCT00844428|20781782|P1|STARTED|Observation Period (8 Weeks)||20
8432228|NCT00844428|20781782|P1|NOT COMPLETED|Screening Period||3
8432229|NCT00844428|20781782|P1|COMPLETED|Screening Period||20
8432230|NCT00844428|20781782|P1|STARTED|Screening Period||23
8432231|NCT00844415|20781798|P1|NOT COMPLETED|Overall Study||1
8432232|NCT00844415|20781798|P1|COMPLETED|Overall Study|Completed.|8
8432233|NCT00844415|20781798|P1|Pat. Received Single Dose 75mg|Overall Study||1
8432234|NCT00844415|20781798|P1|Pat. Received 125mg Followed by 150mg|Overall Study||2
8432235|NCT00844415|20781798|P1|Pat. Received 100mg Followed by 125mg|Overall Study||3
8432236|NCT00844415|20781798|P1|Pat. Received 75mg Followed by 100mg|Overall Study||3
8432237|NCT00844415|20781798|P1|STARTED|Overall Study|Entered and treated.|9
8432250|NCT00844298|20781831|P1|NOT COMPLETED|Overall Study||0
8432251|NCT00844298|20781831|P1|COMPLETED|Overall Study||91
8432252|NCT00844298|20781831|P1|STARTED|Overall Study||91
8432253|NCT00844194|20781837|P2|NOT COMPLETED|Overall Study||8
8432254|NCT00844194|20781838|P1|NOT COMPLETED|Overall Study||25
8432255|NCT00844194|20781837|P2|COMPLETED|Overall Study||22
8432256|NCT00844194|20781838|P1|COMPLETED|Overall Study||53
8432257|NCT00844194|20781837|P2|STARTED|Overall Study||30
8432258|NCT00844194|20781838|P1|STARTED|Overall Study||78
8432259|NCT00844090|20782044|P2|NOT COMPLETED|Overall Study||8
8432260|NCT00844090|20782045|P1|NOT COMPLETED|Overall Study||6
8432261|NCT00844090|20782044|P2|COMPLETED|Overall Study||46
8432262|NCT00844090|20782045|P1|COMPLETED|Overall Study||46
8432263|NCT00844090|20782044|P2|STARTED|Overall Study||54
8432264|NCT00844090|20782045|P1|STARTED|Overall Study||52
8432265|NCT00844051|20782053|P2|NOT COMPLETED|Overall Study||0
8432266|NCT00844051|20782054|P1|NOT COMPLETED|Overall Study||0
8432267|NCT00844051|20782053|P2|COMPLETED|Overall Study||2368
8432268|NCT00844051|20782054|P1|COMPLETED|Overall Study||2087
8432269|NCT00844051|20782053|P2|STARTED|Overall Study||2368
8432270|NCT00844051|20782054|P1|STARTED|Overall Study||2087
8432271|NCT00843986|20782064|P2|NOT COMPLETED|Overall Study||1
8432272|NCT00843986|20782065|P1|NOT COMPLETED|Overall Study||1
8432273|NCT00843986|20782064|P2|COMPLETED|Overall Study||5
8432274|NCT00843986|20782065|P1|COMPLETED|Overall Study||2
8432275|NCT00843986|20782064|P2|Completed Treatment (Infusion)|Overall Study||6
8432276|NCT00843986|20782065|P1|Completed Treatment (Infusion)|Overall Study||2
8432277|NCT00843986|20782064|P2|STARTED|Overall Study||6
8432278|NCT00843986|20782065|P1|STARTED|Overall Study||3
8432279|NCT00843856|20782093|P2|NOT COMPLETED|Overall Study||2
8432280|NCT00843856|20782094|P1|NOT COMPLETED|Overall Study||1
8432281|NCT00843856|20782093|P2|COMPLETED|Overall Study||18
8432282|NCT00843856|20782094|P1|COMPLETED|Overall Study||19
8432283|NCT00843856|20782093|P2|STARTED|Overall Study||20
8432284|NCT00843856|20782094|P1|STARTED|Overall Study||20
8432285|NCT00843843|20782104|P2|NOT COMPLETED|Overall Study||2
8432286|NCT00843843|20782105|P1|NOT COMPLETED|Overall Study||2
8432287|NCT00843843|20782104|P2|COMPLETED|Overall Study||6
8432288|NCT00843843|20782105|P1|COMPLETED|Overall Study||6
8432289|NCT00843843|20782104|P2|STARTED|Overall Study||8
8432290|NCT00843843|20782105|P1|STARTED|Overall Study||8
8432291|NCT00843830|20782113|P1|NOT COMPLETED|Overall Study||0
8432292|NCT00843830|20782113|P1|COMPLETED|Overall Study||4
8432293|NCT00843830|20782113|P1|STARTED|Overall Study||4
8432294|NCT00843778|20782118|P1|NOT COMPLETED|Overall Study||35
8432295|NCT00843778|20782118|P1|COMPLETED|Overall Study||96
8432296|NCT00843778|20782118|P1|STARTED|Overall Study||131
8432297|NCT00843713|20782153|P2|NOT COMPLETED|Overall Study||0
8432298|NCT00843713|20782154|P1|NOT COMPLETED|Overall Study||0
8432299|NCT00843713|20782153|P2|COMPLETED|Overall Study||26
8432300|NCT00843713|20782154|P1|COMPLETED|Overall Study||30
8432301|NCT00843713|20782153|P2|STARTED|Overall Study||26
8432302|NCT00843713|20782154|P1|STARTED|Overall Study||30
8432303|NCT00843635|20782163|P3|NOT COMPLETED|Overall Study||0
8432304|NCT00843635|20782164|P2|NOT COMPLETED|Overall Study||2
8432305|NCT00843635|20782165|P1|NOT COMPLETED|Overall Study||2
8432306|NCT00843635|20782163|P3|COMPLETED|Overall Study||5
8432307|NCT00843635|20782164|P2|COMPLETED|Overall Study||13
8432308|NCT00843635|20782165|P1|COMPLETED|Overall Study||13
8432309|NCT00843635|20782163|P3|STARTED|Overall Study||5
8432310|NCT00843635|20782164|P2|STARTED|Overall Study||15
8432311|NCT00843635|20782165|P1|STARTED|Overall Study||15
8432312|NCT00843622|20782185|P2|NOT COMPLETED|Overall Study||55
8432313|NCT00843622|20782186|P1|NOT COMPLETED|Overall Study||43
8432314|NCT00843622|20782185|P2|COMPLETED|Overall Study||70
8432315|NCT00843622|20782186|P1|COMPLETED|Overall Study||82
8432316|NCT00843622|20782185|P2|STARTED|Overall Study||125
8432317|NCT00843622|20782186|P1|STARTED|Overall Study||125
8432318|NCT00843531|20782192|P1|NOT COMPLETED|Overall Study||0
8432319|NCT00843531|20782192|P1|COMPLETED|Overall Study||17
8432320|NCT00843531|20782192|P1|STARTED|Overall Study||17
8432321|NCT00843518|20782204|P2|NOT COMPLETED|Period 3 (Single-blind Washout)||0
8432322|NCT00843518|20782205|P1|NOT COMPLETED|Period 3 (Single-blind Washout)||0
8432323|NCT00843518|20782204|P2|COMPLETED|Period 3 (Single-blind Washout)||49
8432324|NCT00843518|20782205|P1|COMPLETED|Period 3 (Single-blind Washout)||42
8432325|NCT00843518|20782204|P2|STARTED|Period 3 (Single-blind Washout)||49
8432326|NCT00843518|20782205|P1|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
8432327|NCT00843518|20782204|P2|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
8432328|NCT00843518|20782205|P1|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
8432329|NCT00843518|20782204|P2|COMPLETED|Period 2 (Double-blind Treatment)||49
8432330|NCT00843518|20782205|P1|COMPLETED|Period 2 (Double-blind Treatment)||43
8432331|NCT00843518|20782204|P2|STARTED|Period 2 (Double-blind Treatment)||69
8432332|NCT00843518|20782205|P1|STARTED|Period 2 (Double-blind Treatment)||63
8432333|NCT00843492|20782235|P2|NOT COMPLETED|Overall Study||14
8432334|NCT00843492|20782236|P1|NOT COMPLETED|Overall Study||8
8432335|NCT00843492|20782235|P2|COMPLETED|Overall Study||607
8432336|NCT00843492|20782236|P1|COMPLETED|Overall Study||614
8432337|NCT00843492|20782235|P2|STARTED|Overall Study||621
8432338|NCT00843492|20782236|P1|STARTED|Overall Study||622
8432339|NCT00843479|20782256|P2|NOT COMPLETED|Overall Study||0
8432340|NCT00843479|20782257|P1|NOT COMPLETED|Overall Study||0
8432341|NCT00843479|20782256|P2|COMPLETED|Overall Study||12
8432342|NCT00843479|20782257|P1|COMPLETED|Overall Study||12
8432343|NCT00843479|20782256|P2|STARTED|Overall Study||12
8432344|NCT00843479|20782257|P1|STARTED|Overall Study||12
8432345|NCT00843466|20782275|P2|NOT COMPLETED|Overall Study||0
8432346|NCT00843466|20782276|P1|NOT COMPLETED|Overall Study||0
8432347|NCT00843466|20782275|P2|COMPLETED|Overall Study||18
8432348|NCT00843466|20782276|P1|COMPLETED|Overall Study||24
8432349|NCT00843466|20782275|P2|STARTED|Overall Study||18
8432350|NCT00843466|20782276|P1|STARTED|Overall Study||24
8432351|NCT00843349|20782286|P4|NOT COMPLETED|Overall Study||1
8432352|NCT00843349|20782287|P3|NOT COMPLETED|Overall Study||0
8432353|NCT00843349|20782288|P2|NOT COMPLETED|Overall Study||0
8432354|NCT00843349|20782289|P1|NOT COMPLETED|Overall Study||3
8432355|NCT00843349|20782286|P4|COMPLETED|Overall Study||10
8432356|NCT00843349|20782287|P3|COMPLETED|Overall Study||10
8432357|NCT00843349|20782288|P2|COMPLETED|Overall Study||11
8432358|NCT00843349|20782289|P1|COMPLETED|Overall Study||8
8432359|NCT00843349|20782286|P4|STARTED|Overall Study||11
8432360|NCT00843349|20782287|P3|STARTED|Overall Study||10
8432361|NCT00843349|20782288|P2|STARTED|Overall Study||11
8432362|NCT00843349|20782289|P1|STARTED|Overall Study||11
8432363|NCT00843310|20782303|P1|NOT COMPLETED|Overall Study||7
8432364|NCT00843310|20782303|P1|COMPLETED|Overall Study||1
8432365|NCT00843310|20782303|P1|STARTED|Overall Study||8
8432369|NCT00843193|20782317|P2|NOT COMPLETED|Overall Study||11
8432370|NCT00843193|20782318|P1|NOT COMPLETED|Overall Study||8
8432371|NCT00843193|20782317|P2|COMPLETED|Overall Study||88
8432372|NCT00843193|20782318|P1|COMPLETED|Overall Study||91
8432373|NCT00843193|20782317|P2|STARTED|Overall Study||99
8432374|NCT00843193|20782318|P1|STARTED|Overall Study||99
8432375|NCT00843180|20782354|P2|NOT COMPLETED|Overall Study||0
8432376|NCT00843180|20782355|P1|NOT COMPLETED|Overall Study||0
8432377|NCT00843180|20782354|P2|COMPLETED|Overall Study||7
8432378|NCT00843180|20782355|P1|COMPLETED|Overall Study||16
8432379|NCT00843180|20782354|P2|STARTED|Overall Study||7
8432380|NCT00843180|20782355|P1|STARTED|Overall Study||16
8432381|NCT00843167|20782369|P2|NOT COMPLETED|Follow-up||0
8432382|NCT00843167|20782370|P1|NOT COMPLETED|Follow-up||0
8432383|NCT00843167|20782369|P2|COMPLETED|Follow-up||24
8432384|NCT00843167|20782370|P1|COMPLETED|Follow-up||24
8432385|NCT00843167|20782369|P2|Completed Final Visit|Follow-up||24
8432386|NCT00843167|20782370|P1|Completed Final Visit|Follow-up||24
8432387|NCT00843167|20782369|P2|STARTED|Follow-up||24
8432388|NCT00843167|20782370|P1|STARTED|Follow-up||24
8432389|NCT00843167|20782369|P2|NOT COMPLETED|Treatment Period||8
8432390|NCT00843167|20782370|P1|NOT COMPLETED|Treatment Period||3
8432391|NCT00843167|20782369|P2|COMPLETED|Treatment Period||19
8432392|NCT00843167|20782370|P1|COMPLETED|Treatment Period||24
8432393|NCT00843167|20782369|P2|STARTED|Treatment Period||27
8432394|NCT00843167|20782370|P1|STARTED|Treatment Period||27
8432395|NCT00843115|20782383|P1|NOT COMPLETED|Overall Study||66
8432396|NCT00843115|20782383|P1|COMPLETED|Overall Study||304
8432397|NCT00843115|20782383|P1|STARTED|Overall Study||370
8432398|NCT00843050|20782429|P1|NOT COMPLETED|Overall Study||13
8432399|NCT00843050|20782429|P1|COMPLETED|Overall Study||0
8432400|NCT00843050|20782429|P1|STARTED|Overall Study||13
8432401|NCT00843024|20782439|P6|NOT COMPLETED|Double-blind Treatment Phase||25
8432402|NCT00843024|20782440|P5|NOT COMPLETED|Double-blind Treatment Phase||20
8432403|NCT00843024|20782441|P4|NOT COMPLETED|Double-blind Treatment Phase||23
8432404|NCT00843024|20782442|P3|NOT COMPLETED|Double-blind Treatment Phase||31
8432405|NCT00843024|20782443|P2|NOT COMPLETED|Double-blind Treatment Phase||0
8432406|NCT00843024|20782444|P1|NOT COMPLETED|Double-blind Treatment Phase||0
8432407|NCT00843024|20782439|P6|COMPLETED|Double-blind Treatment Phase||152
8432408|NCT00843024|20782440|P5|COMPLETED|Double-blind Treatment Phase||97
8432409|NCT00843024|20782441|P4|COMPLETED|Double-blind Treatment Phase||96
8432410|NCT00843024|20782442|P3|COMPLETED|Double-blind Treatment Phase||145
8432411|NCT00843024|20782443|P2|COMPLETED|Double-blind Treatment Phase||0
8432412|NCT00843024|20782444|P1|COMPLETED|Double-blind Treatment Phase||0
8432413|NCT00843024|20782439|P6|STARTED|Double-blind Treatment Phase||177
8432414|NCT00843024|20782440|P5|STARTED|Double-blind Treatment Phase||117
8432415|NCT00843024|20782441|P4|STARTED|Double-blind Treatment Phase||119
8432416|NCT00843024|20782442|P3|STARTED|Double-blind Treatment Phase||176
8432417|NCT00843024|20782443|P2|STARTED|Double-blind Treatment Phase||0
8432418|NCT00843024|20782444|P1|STARTED|Double-blind Treatment Phase||0
8432419|NCT00843024|20782439|P6|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
8432420|NCT00843024|20782440|P5|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
8432421|NCT00843024|20782441|P4|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
8432422|NCT00843024|20782442|P3|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
8432423|NCT00843024|20782443|P2|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
8432424|NCT00843024|20782444|P1|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
8432425|NCT00843024|20782439|P6|COMPLETED|Single-blind Placebo Run-In Phase||0
8432426|NCT00843024|20782440|P5|COMPLETED|Single-blind Placebo Run-In Phase||0
8432427|NCT00843024|20782441|P4|COMPLETED|Single-blind Placebo Run-In Phase||0
8432428|NCT00843024|20782442|P3|COMPLETED|Single-blind Placebo Run-In Phase||0
8432429|NCT00843024|20782443|P2|COMPLETED|Single-blind Placebo Run-In Phase||321
8432430|NCT00843024|20782444|P1|COMPLETED|Single-blind Placebo Run-In Phase||268
8432431|NCT00843024|20782439|P6|STARTED|Single-blind Placebo Run-In Phase||0
8432432|NCT00843024|20782440|P5|STARTED|Single-blind Placebo Run-In Phase||0
8432433|NCT00843024|20782441|P4|STARTED|Single-blind Placebo Run-In Phase||0
8432434|NCT00843024|20782442|P3|STARTED|Single-blind Placebo Run-In Phase||0
8432435|NCT00843024|20782443|P2|STARTED|Single-blind Placebo Run-In Phase||457
8432436|NCT00843024|20782444|P1|STARTED|Single-blind Placebo Run-In Phase||408
8432437|NCT00842985|20782509|P1|NOT COMPLETED|Fourth Intervention||0
8432438|NCT00842985|20782509|P1|COMPLETED|Fourth Intervention||15
8432439|NCT00842985|20782509|P1|STARTED|Fourth Intervention||15
8432440|NCT00842985|20782509|P1|NOT COMPLETED|Washout Period of GE 4 Days||0
8432441|NCT00842985|20782509|P1|COMPLETED|Washout Period of GE 4 Days||15
8432442|NCT00842985|20782509|P1|STARTED|Washout Period of GE 4 Days||15
8432443|NCT00842985|20782509|P1|NOT COMPLETED|Third Intervention||0
8432444|NCT00842985|20782509|P1|COMPLETED|Third Intervention||15
8432445|NCT00842985|20782509|P1|STARTED|Third Intervention||15
8432446|NCT00842985|20782509|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
8432447|NCT00842985|20782509|P1|COMPLETED|Washout Period of GE 4 Days||15
8432448|NCT00842985|20782509|P1|STARTED|Washout Period of GE 4 Days||17
8432449|NCT00842985|20782509|P1|NOT COMPLETED|Second Intervention||1
8432450|NCT00842985|20782509|P1|COMPLETED|Second Intervention||17
8432451|NCT00842985|20782509|P1|STARTED|Second Intervention||18
8432452|NCT00842985|20782509|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
8432453|NCT00842985|20782509|P1|COMPLETED|Washout Period of GE 4 Days||18
8432454|NCT00842985|20782509|P1|STARTED|Washout Period of GE 4 Days||20
8432455|NCT00842985|20782509|P1|NOT COMPLETED|First Intervention||6
8432456|NCT00842985|20782509|P1|COMPLETED|First Intervention|Completed 1st Intervention|20
8432457|NCT00842985|20782509|P1|STARTED|First Intervention|Signed Consent|26
8432458|NCT00842985|20782509|P1|NOT COMPLETED|Screening||27
8432459|NCT00842985|20782509|P1|COMPLETED|Screening||26
8432460|NCT00842985|20782509|P1|STARTED|Screening||53
8432461|NCT00842946|20782518|P2|NOT COMPLETED|Overall Study||5
8432462|NCT00842946|20782519|P1|NOT COMPLETED|Overall Study||5
8432463|NCT00842946|20782518|P2|COMPLETED|Overall Study||19
8432464|NCT00842946|20782519|P1|COMPLETED|Overall Study||16
8432465|NCT00842946|20782518|P2|STARTED|Overall Study||24
8432466|NCT00842946|20782519|P1|STARTED|Overall Study||21
8432467|NCT00842829|20782527|P3|NOT COMPLETED|Continuation Period||61
8432468|NCT00842829|20782528|P2|NOT COMPLETED|Continuation Period||0
8432469|NCT00842829|20782529|P1|NOT COMPLETED|Continuation Period||0
8432470|NCT00842829|20782527|P3|COMPLETED|Continuation Period||27
8432471|NCT00842829|20782528|P2|COMPLETED|Continuation Period||0
8432472|NCT00842829|20782529|P1|COMPLETED|Continuation Period||0
8432473|NCT00842829|20782527|P3|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
8432474|NCT00842829|20782528|P2|Continuation Safety Analysis Set|Continuation Period||0
8432475|NCT00842829|20782529|P1|Continuation Safety Analysis Set|Continuation Period||0
8432476|NCT00842829|20782527|P3|STARTED|Continuation Period|Eligible for Continuation Period|88
8432477|NCT00842829|20782528|P2|STARTED|Continuation Period||0
8432478|NCT00842829|20782529|P1|STARTED|Continuation Period||0
8432479|NCT00842829|20782527|P3|NOT COMPLETED|Treatment Period||63
8432480|NCT00842829|20782528|P2|NOT COMPLETED|Treatment Period||0
8432481|NCT00842829|20782529|P1|NOT COMPLETED|Treatment Period||0
8432482|NCT00842829|20782527|P3|COMPLETED|Treatment Period||218
8432483|NCT00842829|20782528|P2|COMPLETED|Treatment Period||0
8432484|NCT00842829|20782529|P1|COMPLETED|Treatment Period||0
8432485|NCT00842829|20782527|P3|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
8432486|NCT00842829|20782528|P2|Safety Analysis Set|Treatment Period||0
8432487|NCT00842829|20782529|P1|Safety Analysis Set|Treatment Period||0
8432488|NCT00842829|20782527|P3|STARTED|Treatment Period||281
8432489|NCT00842829|20782528|P2|STARTED|Treatment Period||0
8432490|NCT00842829|20782529|P1|STARTED|Treatment Period||0
8432491|NCT00842829|20782527|P3|NOT COMPLETED|Dose Titration Period||0
8432492|NCT00842829|20782528|P2|NOT COMPLETED|Dose Titration Period||23
8432493|NCT00842829|20782529|P1|NOT COMPLETED|Dose Titration Period||26
8432494|NCT00842829|20782527|P3|COMPLETED|Dose Titration Period||0
8432495|NCT00842829|20782528|P2|COMPLETED|Dose Titration Period||151
8432496|NCT00842829|20782529|P1|COMPLETED|Dose Titration Period||130
8432497|NCT00842829|20782527|P3|Titration Safety Analysis Set|Dose Titration Period||0
8432498|NCT00842829|20782528|P2|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
8432499|NCT00842829|20782529|P1|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
8432500|NCT00842829|20782527|P3|STARTED|Dose Titration Period||0
8432501|NCT00842829|20782528|P2|STARTED|Dose Titration Period||174
8432502|NCT00842829|20782529|P1|STARTED|Dose Titration Period||156
8432506|NCT00842751|20782567|P1|NOT COMPLETED|Overall Study||0
8432507|NCT00842751|20782567|P1|COMPLETED|Overall Study||11
8432508|NCT00842751|20782567|P1|STARTED|Overall Study||11
8432509|NCT00842712|20782588|P7|NOT COMPLETED|Randomized Part||6
8432510|NCT00842712|20782589|P6|NOT COMPLETED|Randomized Part||1
8432511|NCT00842712|20782590|P5|NOT COMPLETED|Randomized Part||0
8432512|NCT00842712|20782591|P4|NOT COMPLETED|Randomized Part||0
8432513|NCT00842712|20782592|P3|NOT COMPLETED|Randomized Part||0
8432514|NCT00842712|20782593|P2|NOT COMPLETED|Randomized Part||0
8432515|NCT00842712|20782594|P1|NOT COMPLETED|Randomized Part||0
8432516|NCT00842712|20782588|P7|COMPLETED|Randomized Part||78
8432517|NCT00842712|20782589|P6|COMPLETED|Randomized Part||50
8432518|NCT00842712|20782590|P5|COMPLETED|Randomized Part||85
8432519|NCT00842712|20782591|P4|COMPLETED|Randomized Part||0
8432520|NCT00842712|20782592|P3|COMPLETED|Randomized Part||0
8432521|NCT00842712|20782593|P2|COMPLETED|Randomized Part||0
8432522|NCT00842712|20782594|P1|COMPLETED|Randomized Part||0
8432523|NCT00842712|20782588|P7|Treated|Randomized Part||80
8432524|NCT00842712|20782589|P6|Treated|Randomized Part||50
8432525|NCT00842712|20782590|P5|Treated|Randomized Part||85
8432526|NCT00842712|20782591|P4|Treated|Randomized Part||0
8432527|NCT00842712|20782592|P3|Treated|Randomized Part||0
8432528|NCT00842712|20782593|P2|Treated|Randomized Part||0
8432529|NCT00842712|20782594|P1|Treated|Randomized Part||0
8432530|NCT00842712|20782588|P7|STARTED|Randomized Part||84
8432531|NCT00842712|20782589|P6|STARTED|Randomized Part||51
8432532|NCT00842712|20782590|P5|STARTED|Randomized Part||85
8432533|NCT00842712|20782591|P4|STARTED|Randomized Part||0
8432534|NCT00842712|20782592|P3|STARTED|Randomized Part||0
8432535|NCT00842712|20782593|P2|STARTED|Randomized Part||0
8432536|NCT00842712|20782594|P1|STARTED|Randomized Part||0
8432537|NCT00842712|20782588|P7|NOT COMPLETED|Safety Run-in Part||0
8432538|NCT00842712|20782589|P6|NOT COMPLETED|Safety Run-in Part||0
8432539|NCT00842712|20782590|P5|NOT COMPLETED|Safety Run-in Part||0
8432540|NCT00842712|20782591|P4|NOT COMPLETED|Safety Run-in Part||1
8432541|NCT00842712|20782592|P3|NOT COMPLETED|Safety Run-in Part||0
8432542|NCT00842712|20782593|P2|NOT COMPLETED|Safety Run-in Part||2
8432543|NCT00842712|20782594|P1|NOT COMPLETED|Safety Run-in Part||3
8432544|NCT00842712|20782588|P7|COMPLETED|Safety Run-in Part||0
8432545|NCT00842712|20782589|P6|COMPLETED|Safety Run-in Part||0
8432546|NCT00842712|20782590|P5|COMPLETED|Safety Run-in Part||0
8432547|NCT00842712|20782591|P4|COMPLETED|Safety Run-in Part||2
8432548|NCT00842712|20782592|P3|COMPLETED|Safety Run-in Part||3
8432549|NCT00842712|20782593|P2|COMPLETED|Safety Run-in Part||1
8432550|NCT00842712|20782594|P1|COMPLETED|Safety Run-in Part||0
8432551|NCT00842712|20782588|P7|STARTED|Safety Run-in Part||0
8432552|NCT00842712|20782589|P6|STARTED|Safety Run-in Part||0
8432553|NCT00842712|20782590|P5|STARTED|Safety Run-in Part||0
8432554|NCT00842712|20782591|P4|STARTED|Safety Run-in Part||3
8432555|NCT00842712|20782592|P3|STARTED|Safety Run-in Part||3
8432556|NCT00842712|20782593|P2|STARTED|Safety Run-in Part||3
8432557|NCT00842712|20782594|P1|STARTED|Safety Run-in Part||3
8432558|NCT00842608|20782626|P4|NOT COMPLETED|Overall Study||1
8432559|NCT00842608|20782627|P3|NOT COMPLETED|Overall Study||0
8432560|NCT00842608|20782628|P2|NOT COMPLETED|Overall Study||1
8432561|NCT00842608|20782629|P1|NOT COMPLETED|Overall Study||4
8432562|NCT00842608|20782626|P4|COMPLETED|Overall Study||100
8432563|NCT00842608|20782627|P3|COMPLETED|Overall Study||99
8432564|NCT00842608|20782628|P2|COMPLETED|Overall Study||176
8432565|NCT00842608|20782629|P1|COMPLETED|Overall Study||170
8432566|NCT00842608|20782626|P4|STARTED|Overall Study||101
8432567|NCT00842608|20782627|P3|STARTED|Overall Study||99
8432568|NCT00842608|20782628|P2|STARTED|Overall Study||177
8432569|NCT00842608|20782629|P1|STARTED|Overall Study||174
8432570|NCT00842543|20782651|P4|NOT COMPLETED|Overall Study||4
8432571|NCT00842543|20782652|P3|NOT COMPLETED|Overall Study||3
8432572|NCT00842543|20782653|P2|NOT COMPLETED|Overall Study||0
8432573|NCT00842543|20782654|P1|NOT COMPLETED|Overall Study||2
8432574|NCT00842543|20782651|P4|COMPLETED|Overall Study||4
8432575|NCT00842543|20782652|P3|COMPLETED|Overall Study||10
8432576|NCT00842543|20782653|P2|COMPLETED|Overall Study||5
8432577|NCT00842543|20782654|P1|COMPLETED|Overall Study||11
8432578|NCT00842543|20782651|P4|STARTED|Overall Study||8
8432579|NCT00842543|20782652|P3|STARTED|Overall Study||13
8432580|NCT00842543|20782653|P2|STARTED|Overall Study||5
8432581|NCT00842543|20782654|P1|STARTED|Overall Study||13
8432582|NCT00842530|20782668|P2|NOT COMPLETED|Overall Study||57
8432583|NCT00842530|20782669|P1|NOT COMPLETED|Overall Study||117
8432584|NCT00842530|20782668|P2|COMPLETED|Overall Study||1276
8432585|NCT00842530|20782669|P1|COMPLETED|Overall Study||2552
8432586|NCT00842530|20782668|P2|Received Vaccination 3|Overall Study||1282
8432587|NCT00842530|20782669|P1|Received Vaccination 3|Overall Study||2557
8432588|NCT00842530|20782668|P2|Received Vaccination 2|Overall Study||1300
8432589|NCT00842530|20782669|P1|Received Vaccination 2|Overall Study||2584
8432590|NCT00842530|20782668|P2|Received Vaccination 1|Overall Study||1331
8432591|NCT00842530|20782669|P1|Received Vaccination 1|Overall Study||2666
8432592|NCT00842530|20782668|P2|STARTED|Overall Study||1333
8432593|NCT00842530|20782669|P1|STARTED|Overall Study||2669
8432594|NCT00842361|20782699|P2|NOT COMPLETED|Overall Study||2
8432595|NCT00842361|20782700|P1|NOT COMPLETED|Overall Study||1
8432596|NCT00842361|20782699|P2|COMPLETED|Overall Study||31
8432597|NCT00842361|20782700|P1|COMPLETED|Overall Study||32
8432598|NCT00842361|20782699|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
8432599|NCT00842361|20782700|P1|Exposed|Overall Study||33
8432600|NCT00842361|20782699|P2|STARTED|Overall Study||33
8432601|NCT00842361|20782700|P1|STARTED|Overall Study||33
8432602|NCT00842348|20782720|P2|NOT COMPLETED|Study 729||38
8432603|NCT00842348|20782721|P1|NOT COMPLETED|Study 729||26
8432604|NCT00842348|20782720|P2|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
8432605|NCT00842348|20782721|P1|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
8432606|NCT00842348|20782720|P2|STARTED|Study 729||47
8432607|NCT00842348|20782721|P1|STARTED|Study 729||42
8432608|NCT00842348|20782720|P2|NOT COMPLETED|Patients Randomised in Study 726||56
8432609|NCT00842348|20782721|P1|NOT COMPLETED|Patients Randomised in Study 726||59
8432610|NCT00842348|20782720|P2|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
8432611|NCT00842348|20782721|P1|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
8432612|NCT00842348|20782720|P2|STARTED|Patients Randomised in Study 726||103
8432613|NCT00842348|20782721|P1|STARTED|Patients Randomised in Study 726||101
8432614|NCT00842335|20782731|P1|NOT COMPLETED|Overall Study||0
8432615|NCT00842335|20782731|P1|COMPLETED|Overall Study||18
8432616|NCT00842335|20782731|P1|STARTED|Overall Study||18
8432617|NCT00842309|20782740|P2|NOT COMPLETED|Overall Study||1
8432618|NCT00842309|20782741|P1|NOT COMPLETED|Overall Study||3
8432619|NCT00842309|20782740|P2|COMPLETED|Overall Study||13
8432620|NCT00842309|20782741|P1|COMPLETED|Overall Study||11
8432621|NCT00842309|20782740|P2|STARTED|Overall Study||14
8432622|NCT00842309|20782741|P1|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14
8432623|NCT00842296|20782749|P1|NOT COMPLETED|Overall Study||0
8432624|NCT00842296|20782749|P1|COMPLETED|Overall Study||326
8432625|NCT00842296|20782749|P1|STARTED|Overall Study||326
8432626|NCT00842257|20782775|P1|NOT COMPLETED|Overall Study||1
8432627|NCT00842257|20782775|P1|COMPLETED|Overall Study||19
8432628|NCT00842257|20782775|P1|STARTED|Overall Study||20
8432629|NCT00842244|20782782|P1|NOT COMPLETED|Overall Study||21
8432630|NCT00842244|20782782|P1|COMPLETED|Overall Study||1
8432631|NCT00842244|20782782|P1|STARTED|Overall Study||22
8432632|NCT00842231|20782801|P1|NOT COMPLETED|Overall Study||0
8432633|NCT00842231|20782801|P1|COMPLETED|Overall Study||40
8432634|NCT00842231|20782801|P1|STARTED|Overall Study||40
8432635|NCT00842153|20782809|P2|NOT COMPLETED|Overall Study||3
8432636|NCT00842153|20782810|P1|NOT COMPLETED|Overall Study||1
8432637|NCT00842153|20782809|P2|COMPLETED|Overall Study||27
8432638|NCT00842153|20782810|P1|COMPLETED|Overall Study||27
8432639|NCT00842153|20782809|P2|STARTED|Overall Study||30
8432640|NCT00842153|20782810|P1|STARTED|Overall Study||28
8432641|NCT00842075|20782850|P2|NOT COMPLETED|Overall Study||0
8432642|NCT00842075|20782851|P1|NOT COMPLETED|Overall Study||0
8432643|NCT00842075|20782850|P2|COMPLETED|Overall Study||5
8432644|NCT00842075|20782851|P1|COMPLETED|Overall Study||5
8432645|NCT00842075|20782850|P2|STARTED|Overall Study||5
8432646|NCT00842075|20782851|P1|STARTED|Overall Study||5
8432647|NCT00842023|20782861|P2|NOT COMPLETED|Overall Study||0
8432648|NCT00842023|20782862|P1|NOT COMPLETED|Overall Study||0
8432649|NCT00842023|20782861|P2|COMPLETED|Overall Study||44
8432650|NCT00842023|20782862|P1|COMPLETED|Overall Study||45
8432651|NCT00842023|20782861|P2|STARTED|Overall Study||44
8432652|NCT00842023|20782862|P1|STARTED|Overall Study||45
8432653|NCT00841971|20782874|P2|NOT COMPLETED|Overall Study||1
8432654|NCT00841971|20782875|P1|NOT COMPLETED|Overall Study||2
8432655|NCT00841971|20782874|P2|COMPLETED|Overall Study||99
8432656|NCT00841971|20782875|P1|COMPLETED|Overall Study||98
8432657|NCT00841971|20782874|P2|STARTED|Overall Study||100
8432658|NCT00841971|20782875|P1|STARTED|Overall Study||100
8432659|NCT00841906|20782885|P2|NOT COMPLETED|Overall Study||0
8432660|NCT00841906|20782886|P1|NOT COMPLETED|Overall Study||2
8432661|NCT00841906|20782885|P2|COMPLETED|Overall Study||14
8432662|NCT00841906|20782886|P1|COMPLETED|Overall Study||16
8432663|NCT00841906|20782885|P2|STARTED|Overall Study||14
8432664|NCT00841906|20782886|P1|STARTED|Overall Study||18
8432665|NCT00841828|20782900|P2|NOT COMPLETED|Overall Study||2
8432666|NCT00841828|20782901|P1|NOT COMPLETED|Overall Study||10
8432667|NCT00841828|20782900|P2|COMPLETED|Overall Study||48
8432668|NCT00841828|20782901|P1|COMPLETED|Overall Study||42
8432669|NCT00841828|20782900|P2|STARTED|Overall Study||50
8432670|NCT00841828|20782901|P1|STARTED|Overall Study||52
8432671|NCT00841815|20782911|P2|NOT COMPLETED|Period 2||0
8432672|NCT00841815|20782912|P1|NOT COMPLETED|Period 2||0
8432673|NCT00841815|20782911|P2|COMPLETED|Period 2||13
8432674|NCT00841815|20782912|P1|COMPLETED|Period 2||14
8432675|NCT00841815|20782911|P2|STARTED|Period 2||13
8432676|NCT00841815|20782912|P1|STARTED|Period 2||14
8432677|NCT00841815|20782911|P2|NOT COMPLETED|Washout||1
8432678|NCT00841815|20782912|P1|NOT COMPLETED|Washout||0
8432679|NCT00841815|20782911|P2|COMPLETED|Washout||13
8432680|NCT00841815|20782912|P1|COMPLETED|Washout||14
8432681|NCT00841815|20782911|P2|STARTED|Washout||14
8432682|NCT00841815|20782912|P1|STARTED|Washout||14
8432683|NCT00841815|20782911|P2|NOT COMPLETED|Period 1||0
8432684|NCT00841815|20782912|P1|NOT COMPLETED|Period 1||0
8432685|NCT00841815|20782911|P2|COMPLETED|Period 1||14
8432686|NCT00841815|20782912|P1|COMPLETED|Period 1||14
8432687|NCT00841815|20782911|P2|STARTED|Period 1||14
8432688|NCT00841815|20782912|P1|STARTED|Period 1||14
8432689|NCT00841776|20782922|P2|NOT COMPLETED|Overall Study||3
8432690|NCT00841776|20782923|P1|NOT COMPLETED|Overall Study||2
8432691|NCT00841776|20782922|P2|COMPLETED|Overall Study||24
8432692|NCT00841776|20782923|P1|COMPLETED|Overall Study||25
8432693|NCT00841776|20782922|P2|STARTED|Overall Study||27
8432694|NCT00841776|20782923|P1|STARTED|Overall Study||27
8432707|NCT00841698|20783006|P2|NOT COMPLETED|Second Intervention||0
8432708|NCT00841698|20783007|P1|NOT COMPLETED|Second Intervention||0
8432709|NCT00841698|20783006|P2|COMPLETED|Second Intervention||25
8432710|NCT00841698|20783007|P1|COMPLETED|Second Intervention||24
8432711|NCT00841698|20783006|P2|STARTED|Second Intervention||25
8432712|NCT00841698|20783007|P1|STARTED|Second Intervention||24
8432713|NCT00841698|20783006|P2|NOT COMPLETED|Washout: 2 Weeks||0
8432714|NCT00841698|20783007|P1|NOT COMPLETED|Washout: 2 Weeks||0
8432715|NCT00841698|20783006|P2|COMPLETED|Washout: 2 Weeks||25
8432716|NCT00841698|20783007|P1|COMPLETED|Washout: 2 Weeks||24
8432717|NCT00841698|20783006|P2|STARTED|Washout: 2 Weeks||25
8432718|NCT00841698|20783007|P1|STARTED|Washout: 2 Weeks||24
8432719|NCT00841698|20783006|P2|NOT COMPLETED|First Intervention||0
8432720|NCT00841698|20783007|P1|NOT COMPLETED|First Intervention||1
8432721|NCT00841698|20783006|P2|COMPLETED|First Intervention||25
8432722|NCT00841698|20783007|P1|COMPLETED|First Intervention||24
8432723|NCT00841698|20783006|P2|STARTED|First Intervention||25
8432724|NCT00841698|20783007|P1|STARTED|First Intervention||25
8432725|NCT00841672|20783017|P2|NOT COMPLETED|Overall Study||32
8432726|NCT00841672|20783018|P1|NOT COMPLETED|Overall Study||20
8432727|NCT00841672|20783017|P2|COMPLETED|Overall Study||209
8432728|NCT00841672|20783018|P1|COMPLETED|Overall Study||224
8432729|NCT00841672|20783017|P2|STARTED|Overall Study||241
8432730|NCT00841672|20783018|P1|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
8432731|NCT00841659|20783034|P2|NOT COMPLETED|Second Intervention||0
8432732|NCT00841659|20783035|P1|NOT COMPLETED|Second Intervention||0
8432733|NCT00841659|20783034|P2|COMPLETED|Second Intervention||12
8432734|NCT00841659|20783035|P1|COMPLETED|Second Intervention||11
8432735|NCT00841659|20783034|P2|STARTED|Second Intervention||12
8432736|NCT00841659|20783035|P1|STARTED|Second Intervention||11
8432737|NCT00841659|20783034|P2|NOT COMPLETED|Washout: 2 Weeks||0
8432738|NCT00841659|20783035|P1|NOT COMPLETED|Washout: 2 Weeks||1
8432739|NCT00841659|20783034|P2|COMPLETED|Washout: 2 Weeks||12
8432740|NCT00841659|20783035|P1|COMPLETED|Washout: 2 Weeks||11
8432741|NCT00841659|20783034|P2|STARTED|Washout: 2 Weeks||12
8432742|NCT00841659|20783035|P1|STARTED|Washout: 2 Weeks||12
8432743|NCT00841659|20783034|P2|NOT COMPLETED|First Intervention||0
8432744|NCT00841659|20783035|P1|NOT COMPLETED|First Intervention||0
8432745|NCT00841659|20783034|P2|COMPLETED|First Intervention||12
8432746|NCT00841659|20783035|P1|COMPLETED|First Intervention||12
8432747|NCT00841659|20783034|P2|STARTED|First Intervention||12
8432748|NCT00841659|20783035|P1|STARTED|First Intervention||12
8432749|NCT00841568|20783043|P1|NOT COMPLETED|Overall Study||5
8432750|NCT00841568|20783043|P1|COMPLETED|Overall Study||12
8432751|NCT00841568|20783043|P1|STARTED|Overall Study||17
8432752|NCT00841555|20783059|P3|NOT COMPLETED|Overall Study||0
8432753|NCT00841555|20783060|P2|NOT COMPLETED|Overall Study||0
8432754|NCT00841555|20783061|P1|NOT COMPLETED|Overall Study||0
8432755|NCT00841555|20783059|P3|COMPLETED|Overall Study||3
8432756|NCT00841555|20783060|P2|COMPLETED|Overall Study||3
8432757|NCT00841555|20783061|P1|COMPLETED|Overall Study||3
8432758|NCT00841555|20783059|P3|STARTED|Overall Study||3
8432759|NCT00841555|20783060|P2|STARTED|Overall Study||3
8432760|NCT00841555|20783061|P1|STARTED|Overall Study||3
8432761|NCT00841542|20783071|P2|NOT COMPLETED|Period 2||0
8432762|NCT00841542|20783072|P1|NOT COMPLETED|Period 2||0
8432763|NCT00841542|20783071|P2|COMPLETED|Period 2||14
8432764|NCT00841542|20783072|P1|COMPLETED|Period 2||13
8432765|NCT00841542|20783071|P2|STARTED|Period 2||14
8432766|NCT00841542|20783072|P1|STARTED|Period 2||13
8432767|NCT00841542|20783071|P2|NOT COMPLETED|Period 1||0
8432768|NCT00841542|20783072|P1|NOT COMPLETED|Period 1||1
8432769|NCT00841542|20783071|P2|COMPLETED|Period 1||14
8432770|NCT00841542|20783072|P1|COMPLETED|Period 1||13
8432771|NCT00841542|20783071|P2|STARTED|Period 1||14
8432772|NCT00841542|20783072|P1|STARTED|Period 1||14
8432773|NCT00841412|20783080|P2|NOT COMPLETED|Overall Study||30
8432774|NCT00841412|20783081|P1|NOT COMPLETED|Overall Study||40
8432775|NCT00841412|20783080|P2|COMPLETED|Overall Study||50
8432776|NCT00841412|20783081|P1|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
8432777|NCT00841412|20783080|P2|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
8432778|NCT00841412|20783081|P1|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
8432779|NCT00841321|20783087|P2|NOT COMPLETED|Overall Study||3
8432780|NCT00841321|20783088|P1|NOT COMPLETED|Overall Study||1
8432781|NCT00841321|20783087|P2|COMPLETED|Overall Study||58
8432782|NCT00841321|20783088|P1|COMPLETED|Overall Study||58
8432783|NCT00841321|20783087|P2|STARTED|Overall Study||61
8432784|NCT00841321|20783088|P1|STARTED|Overall Study||59
8432785|NCT00841269|20783102|P2|NOT COMPLETED|Overall Study||9
8432786|NCT00841269|20783103|P1|NOT COMPLETED|Overall Study||8
8432787|NCT00841269|20783102|P2|COMPLETED|Overall Study||13
8432788|NCT00841269|20783103|P1|COMPLETED|Overall Study||12
8432789|NCT00841269|20783102|P2|STARTED|Overall Study||22
8432790|NCT00841269|20783103|P1|STARTED|Overall Study||20
8432791|NCT00841204|20783114|P2|NOT COMPLETED|Overall Study||0
8432792|NCT00841204|20783115|P1|NOT COMPLETED|Overall Study||0
8432793|NCT00841204|20783114|P2|COMPLETED|Overall Study||25
8432794|NCT00841204|20783115|P1|COMPLETED|Overall Study||25
8432795|NCT00841204|20783114|P2|STARTED|Overall Study||25
8432796|NCT00841204|20783115|P1|STARTED|Overall Study||25
8432797|NCT00841100|20783135|P1|NOT COMPLETED|Phase 3 (28 Days)||0
8432798|NCT00841100|20783135|P1|COMPLETED|Phase 3 (28 Days)||4
8432799|NCT00841100|20783135|P1|STARTED|Phase 3 (28 Days)|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4
8432800|NCT00841100|20783135|P1|NOT COMPLETED|Phase 2 (2 Weeks)||0
8432801|NCT00841100|20783135|P1|COMPLETED|Phase 2 (2 Weeks)||5
8432802|NCT00841100|20783135|P1|STARTED|Phase 2 (2 Weeks)|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5
8432803|NCT00841100|20783135|P1|NOT COMPLETED|Phase 1 (28 Days)||3
8432804|NCT00841100|20783135|P1|COMPLETED|Phase 1 (28 Days)||15
8432805|NCT00841100|20783135|P1|STARTED|Phase 1 (28 Days)|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18
8432806|NCT00841100|20783135|P1|NOT COMPLETED|Acute Component (24 Hours)||0
8432807|NCT00841100|20783135|P1|COMPLETED|Acute Component (24 Hours)||21
8432808|NCT00841100|20783135|P1|STARTED|Acute Component (24 Hours)||21
8432809|NCT00841087|20783141|P2|NOT COMPLETED|Overall Study||0
8432810|NCT00841087|20783142|P1|NOT COMPLETED|Overall Study||0
8432811|NCT00841087|20783141|P2|COMPLETED|Overall Study||32
8432812|NCT00841087|20783142|P1|COMPLETED|Overall Study||33
8432813|NCT00841087|20783141|P2|STARTED|Overall Study||32
8432814|NCT00841087|20783142|P1|STARTED|Overall Study||33
8432815|NCT00841035|20783160|P1|NOT COMPLETED|Phase 2 of Overall Study||0
8432816|NCT00841035|20783160|P1|COMPLETED|Phase 2 of Overall Study||6
8432817|NCT00841035|20783160|P1|STARTED|Phase 2 of Overall Study||6
8432818|NCT00841035|20783160|P1|NOT COMPLETED|Phase 1 Overall Study||13
8432819|NCT00841035|20783160|P1|COMPLETED|Phase 1 Overall Study||6
8432820|NCT00841035|20783160|P1|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
8432821|NCT00840996|20783167|P2|NOT COMPLETED|Overall Study||0
8432822|NCT00840996|20783168|P1|NOT COMPLETED|Overall Study||1
8432823|NCT00840996|20783167|P2|COMPLETED|Overall Study||58
8432824|NCT00840996|20783168|P1|COMPLETED|Overall Study||57
8432825|NCT00840996|20783167|P2|STARTED|Overall Study||58
8432826|NCT00840996|20783168|P1|STARTED|Overall Study||58
8432827|NCT00840970|20783186|P3|NOT COMPLETED|Overall Study||1
8432828|NCT00840970|20783187|P2|NOT COMPLETED|Overall Study||0
8432829|NCT00840970|20783188|P1|NOT COMPLETED|Overall Study||0
8432830|NCT00840970|20783186|P3|COMPLETED|Overall Study||4
8432831|NCT00840970|20783187|P2|COMPLETED|Overall Study||38
8432832|NCT00840970|20783188|P1|COMPLETED|Overall Study||7
8432833|NCT00840970|20783186|P3|STARTED|Overall Study||5
8432834|NCT00840970|20783187|P2|STARTED|Overall Study||38
8432835|NCT00840970|20783188|P1|STARTED|Overall Study||7
8432836|NCT00840879|20783208|P2|NOT COMPLETED|Second Intervention||0
8432837|NCT00840879|20783209|P1|NOT COMPLETED|Second Intervention||1
8432838|NCT00840879|20783208|P2|COMPLETED|Second Intervention||14
8432839|NCT00840879|20783209|P1|COMPLETED|Second Intervention||13
8432840|NCT00840879|20783208|P2|STARTED|Second Intervention||14
8432841|NCT00840879|20783209|P1|STARTED|Second Intervention||14
8432842|NCT00840879|20783208|P2|NOT COMPLETED|Washout: 14 Days||0
8432843|NCT00840879|20783209|P1|NOT COMPLETED|Washout: 14 Days||0
8432844|NCT00840879|20783208|P2|COMPLETED|Washout: 14 Days||14
8432845|NCT00840879|20783209|P1|COMPLETED|Washout: 14 Days||14
8432846|NCT00840879|20783208|P2|STARTED|Washout: 14 Days||14
8432847|NCT00840879|20783209|P1|STARTED|Washout: 14 Days||14
8432848|NCT00840879|20783208|P2|NOT COMPLETED|First Intervention||0
8432849|NCT00840879|20783209|P1|NOT COMPLETED|First Intervention||0
8432850|NCT00840879|20783208|P2|COMPLETED|First Intervention||14
8432851|NCT00840879|20783209|P1|COMPLETED|First Intervention||14
8432852|NCT00840879|20783208|P2|STARTED|First Intervention||14
8432853|NCT00840879|20783209|P1|STARTED|First Intervention||14
8432854|NCT00840866|20783219|P2|NOT COMPLETED|Second Intervention||0
8432855|NCT00840866|20783220|P1|NOT COMPLETED|Second Intervention||0
8432856|NCT00840866|20783219|P2|COMPLETED|Second Intervention||19
8432857|NCT00840866|20783220|P1|COMPLETED|Second Intervention||20
8432858|NCT00840866|20783219|P2|STARTED|Second Intervention||19
8432859|NCT00840866|20783220|P1|STARTED|Second Intervention||20
8432860|NCT00840866|20783219|P2|NOT COMPLETED|Washout of 7 Days||0
8432861|NCT00840866|20783220|P1|NOT COMPLETED|Washout of 7 Days||0
8432862|NCT00840866|20783219|P2|COMPLETED|Washout of 7 Days||19
8432863|NCT00840866|20783220|P1|COMPLETED|Washout of 7 Days||20
8432864|NCT00840866|20783219|P2|STARTED|Washout of 7 Days||19
8432865|NCT00840866|20783220|P1|STARTED|Washout of 7 Days||20
8432866|NCT00840866|20783219|P2|NOT COMPLETED|First Intervention||0
8432867|NCT00840866|20783220|P1|NOT COMPLETED|First Intervention||0
8432868|NCT00840866|20783219|P2|COMPLETED|First Intervention||19
8432869|NCT00840866|20783220|P1|COMPLETED|First Intervention||20
8432870|NCT00840866|20783219|P2|STARTED|First Intervention||19
8432871|NCT00840866|20783220|P1|STARTED|First Intervention||20
8432872|NCT00840840|20783230|P2|NOT COMPLETED|Period 2||0
8432873|NCT00840840|20783231|P1|NOT COMPLETED|Period 2||0
8432874|NCT00840840|20783230|P2|COMPLETED|Period 2||24
8432875|NCT00840840|20783231|P1|COMPLETED|Period 2||23
8432876|NCT00840840|20783230|P2|STARTED|Period 2||24
8432877|NCT00840840|20783231|P1|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
8432878|NCT00840840|20783230|P2|NOT COMPLETED|Period 1||0
8432879|NCT00840840|20783231|P1|NOT COMPLETED|Period 1||0
8432880|NCT00840840|20783230|P2|COMPLETED|Period 1||24
8432881|NCT00840840|20783231|P1|COMPLETED|Period 1||24
8432882|NCT00840840|20783230|P2|STARTED|Period 1||24
8432883|NCT00840840|20783231|P1|STARTED|Period 1||24
8432884|NCT00840827|20783245|P1|NOT COMPLETED|Overall Study||6
8432885|NCT00840827|20783245|P1|COMPLETED|Overall Study||0
8432886|NCT00840827|20783245|P1|STARTED|Overall Study||6
8432887|NCT00840749|20783260|P2|NOT COMPLETED|Overall Study||27
8432888|NCT00840749|20783261|P1|NOT COMPLETED|Overall Study||31
8432889|NCT00840749|20783260|P2|COMPLETED|Overall Study||0
8432890|NCT00840749|20783261|P1|COMPLETED|Overall Study||0
8432891|NCT00840749|20783260|P2|36 Months Post tx|Overall Study||0
8432892|NCT00840749|20783261|P1|36 Months Post tx|Overall Study||1
8432893|NCT00840749|20783260|P2|24 Months Post tx|Overall Study||3
8432894|NCT00840749|20783261|P1|24 Months Post tx|Overall Study||9
8432895|NCT00840749|20783260|P2|18 Months Post tx|Overall Study||6
8432896|NCT00840749|20783261|P1|18 Months Post tx|Overall Study||12
8432897|NCT00840749|20783260|P2|12 Months Post tx|Overall Study||7
8432898|NCT00840749|20783261|P1|12 Months Post tx|Overall Study||14
8432899|NCT00840749|20783260|P2|6 Months Post tx|Overall Study||10
8432900|NCT00840749|20783261|P1|6 Months Post tx|Overall Study||16
8432901|NCT00840749|20783260|P2|1 Month Post tx|Overall Study||15
8432902|NCT00840749|20783261|P1|1 Month Post tx|Overall Study||19
8432903|NCT00840749|20783260|P2|Treatment|Overall Study||16
8432904|NCT00840749|20783261|P1|Treatment|Overall Study||20
8432905|NCT00840749|20783260|P2|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|27
8432906|NCT00840749|20783261|P1|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|31
8432907|NCT00840658|20783273|P4|NOT COMPLETED|Overall Study||4
8432908|NCT00840658|20783274|P3|NOT COMPLETED|Overall Study||5
8432909|NCT00840658|20783275|P2|NOT COMPLETED|Overall Study||3
8432910|NCT00840658|20783276|P1|NOT COMPLETED|Overall Study||5
8432911|NCT00840658|20783273|P4|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
8432912|NCT00840658|20783274|P3|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
8432913|NCT00840658|20783275|P2|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
8432914|NCT00840658|20783276|P1|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
8432915|NCT00840658|20783273|P4|STARTED|Overall Study||146
8432916|NCT00840658|20783274|P3|STARTED|Overall Study||148
8432917|NCT00840658|20783275|P2|STARTED|Overall Study||146
8432918|NCT00840658|20783276|P1|STARTED|Overall Study||144
8432919|NCT00840632|20783294|P2|NOT COMPLETED|Second Intervention||0
8432920|NCT00840632|20783295|P1|NOT COMPLETED|Second Intervention||0
8432921|NCT00840632|20783294|P2|COMPLETED|Second Intervention||18
8432922|NCT00840632|20783295|P1|COMPLETED|Second Intervention||19
8432923|NCT00840632|20783294|P2|STARTED|Second Intervention||18
8432924|NCT00840632|20783295|P1|STARTED|Second Intervention||19
8432925|NCT00840632|20783294|P2|NOT COMPLETED|Washout||1
8432926|NCT00840632|20783295|P1|NOT COMPLETED|Washout||1
8432927|NCT00840632|20783294|P2|COMPLETED|Washout||18
8432928|NCT00840632|20783295|P1|COMPLETED|Washout||19
8432929|NCT00840632|20783294|P2|STARTED|Washout||19
8432930|NCT00840632|20783295|P1|STARTED|Washout||20
8432931|NCT00840632|20783294|P2|NOT COMPLETED|First Intervention||1
8432932|NCT00840632|20783295|P1|NOT COMPLETED|First Intervention||0
8432933|NCT00840632|20783294|P2|COMPLETED|First Intervention||19
8432934|NCT00840632|20783295|P1|COMPLETED|First Intervention||20
8432935|NCT00840632|20783294|P2|STARTED|First Intervention||20
8432936|NCT00840632|20783295|P1|STARTED|First Intervention||20
8432937|NCT00840476|20783311|P2|NOT COMPLETED|Second Intervention||0
8432938|NCT00840476|20783312|P1|NOT COMPLETED|Second Intervention||0
8432939|NCT00840476|20783311|P2|COMPLETED|Second Intervention||14
8432940|NCT00840476|20783312|P1|COMPLETED|Second Intervention||14
8432941|NCT00840476|20783311|P2|STARTED|Second Intervention||14
8432942|NCT00840476|20783312|P1|STARTED|Second Intervention||14
8432943|NCT00840476|20783311|P2|NOT COMPLETED|Washout: 14 Days||0
8432944|NCT00840476|20783312|P1|NOT COMPLETED|Washout: 14 Days||0
8432945|NCT00840476|20783311|P2|COMPLETED|Washout: 14 Days||14
8432946|NCT00840476|20783312|P1|COMPLETED|Washout: 14 Days||14
8432947|NCT00840476|20783311|P2|STARTED|Washout: 14 Days||14
8432948|NCT00840476|20783312|P1|STARTED|Washout: 14 Days||14
8432949|NCT00840476|20783311|P2|NOT COMPLETED|First Intervention||0
8432950|NCT00840476|20783312|P1|NOT COMPLETED|First Intervention||0
8432951|NCT00840476|20783311|P2|COMPLETED|First Intervention||14
8432952|NCT00840476|20783312|P1|COMPLETED|First Intervention||14
8432953|NCT00840476|20783311|P2|STARTED|First Intervention||14
8432954|NCT00840476|20783312|P1|STARTED|First Intervention||14
8432955|NCT00840463|20783322|P2|NOT COMPLETED|Overall Study||0
8432956|NCT00840463|20783323|P1|NOT COMPLETED|Overall Study||1
8432957|NCT00840463|20783322|P2|COMPLETED|Overall Study||1
8432958|NCT00840463|20783323|P1|COMPLETED|Overall Study||2
8432959|NCT00840463|20783322|P2|STARTED|Overall Study||1
8432960|NCT00840463|20783323|P1|STARTED|Overall Study||3
8432961|NCT00840450|20783337|P1|NOT COMPLETED|Overall Study||3
8432962|NCT00840450|20783337|P1|COMPLETED|Overall Study||9
8432963|NCT00840450|20783337|P1|STARTED|Overall Study||12
8432964|NCT00840411|20783345|P2|NOT COMPLETED|Second Intervention||0
8432965|NCT00840411|20783346|P1|NOT COMPLETED|Second Intervention||0
8432966|NCT00840411|20783345|P2|COMPLETED|Second Intervention||33
8432967|NCT00840411|20783346|P1|COMPLETED|Second Intervention||31
8432968|NCT00840411|20783345|P2|STARTED|Second Intervention||33
8432969|NCT00840411|20783346|P1|STARTED|Second Intervention||31
8432970|NCT00840411|20783345|P2|NOT COMPLETED|Washout||0
8432971|NCT00840411|20783346|P1|NOT COMPLETED|Washout||1
8432972|NCT00840411|20783345|P2|COMPLETED|Washout||33
8432973|NCT00840411|20783346|P1|COMPLETED|Washout||31
8432974|NCT00840411|20783345|P2|STARTED|Washout||33
8432975|NCT00840411|20783346|P1|STARTED|Washout||32
8432976|NCT00840411|20783345|P2|NOT COMPLETED|First Intervention||0
8432977|NCT00840411|20783346|P1|NOT COMPLETED|First Intervention||1
8432978|NCT00840411|20783345|P2|COMPLETED|First Intervention||33
8432979|NCT00840411|20783346|P1|COMPLETED|First Intervention||32
8432980|NCT00840411|20783345|P2|STARTED|First Intervention||33
8432981|NCT00840411|20783346|P1|STARTED|First Intervention||33
8432982|NCT00840307|20783354|P1|NOT COMPLETED|Overall Study||4
8432983|NCT00840307|20783354|P1|COMPLETED|Overall Study||16
8432984|NCT00840307|20783354|P1|STARTED|Overall Study||20
8432985|NCT00840294|20783360|P2|NOT COMPLETED|Overall Study||5
8432986|NCT00840294|20783361|P1|NOT COMPLETED|Overall Study||3
8432987|NCT00840294|20783360|P2|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
8432988|NCT00840294|20783361|P1|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
8432989|NCT00840294|20783360|P2|STARTED|Overall Study||43
8432990|NCT00840294|20783361|P1|STARTED|Overall Study||42
8432991|NCT00840281|20783371|P2|NOT COMPLETED|Second Intervention||0
8432992|NCT00840281|20783372|P1|NOT COMPLETED|Second Intervention||0
8432993|NCT00840281|20783371|P2|COMPLETED|Second Intervention||19
8432994|NCT00840281|20783372|P1|COMPLETED|Second Intervention||19
8432995|NCT00840281|20783371|P2|STARTED|Second Intervention||19
8432996|NCT00840281|20783372|P1|STARTED|Second Intervention||19
8432997|NCT00840281|20783371|P2|NOT COMPLETED|Washout of 7 Days||0
8432998|NCT00840281|20783372|P1|NOT COMPLETED|Washout of 7 Days||0
8432999|NCT00840281|20783371|P2|COMPLETED|Washout of 7 Days||19
8433000|NCT00840281|20783372|P1|COMPLETED|Washout of 7 Days||19
8433001|NCT00840281|20783371|P2|STARTED|Washout of 7 Days||19
8433002|NCT00840281|20783372|P1|STARTED|Washout of 7 Days||19
8433003|NCT00840281|20783371|P2|NOT COMPLETED|First Intervention||0
8433004|NCT00840281|20783372|P1|NOT COMPLETED|First Intervention||0
8433005|NCT00840281|20783371|P2|COMPLETED|First Intervention||19
8433006|NCT00840281|20783372|P1|COMPLETED|First Intervention||19
8433007|NCT00840281|20783371|P2|STARTED|First Intervention||19
8433008|NCT00840281|20783372|P1|STARTED|First Intervention||19
8433009|NCT00840216|20783382|P2|NOT COMPLETED|Second Intervention||0
8433010|NCT00840216|20783383|P1|NOT COMPLETED|Second Intervention||0
8433011|NCT00840216|20783382|P2|COMPLETED|Second Intervention||11
8433012|NCT00840216|20783383|P1|COMPLETED|Second Intervention||10
8433013|NCT00840216|20783382|P2|STARTED|Second Intervention||11
8433014|NCT00840216|20783383|P1|STARTED|Second Intervention||10
8433015|NCT00840216|20783382|P2|NOT COMPLETED|Washout: 7 Days||0
8433016|NCT00840216|20783383|P1|NOT COMPLETED|Washout: 7 Days||1
8433017|NCT00840216|20783382|P2|COMPLETED|Washout: 7 Days||11
8433018|NCT00840216|20783383|P1|COMPLETED|Washout: 7 Days||10
8433019|NCT00840216|20783382|P2|STARTED|Washout: 7 Days||11
8433020|NCT00840216|20783383|P1|STARTED|Washout: 7 Days||11
8433021|NCT00840216|20783382|P2|NOT COMPLETED|First Intervention||0
8433022|NCT00840216|20783383|P1|NOT COMPLETED|First Intervention||0
8433023|NCT00840216|20783382|P2|COMPLETED|First Intervention||11
8433024|NCT00840216|20783383|P1|COMPLETED|First Intervention||11
8433025|NCT00840216|20783382|P2|STARTED|First Intervention||11
8433026|NCT00840216|20783383|P1|STARTED|First Intervention||11
8433027|NCT00840203|20783393|P2|NOT COMPLETED|Second Intervention||0
8433028|NCT00840203|20783394|P1|NOT COMPLETED|Second Intervention||0
8433029|NCT00840203|20783393|P2|COMPLETED|Second Intervention||34
8433030|NCT00840203|20783394|P1|COMPLETED|Second Intervention||35
8433031|NCT00840203|20783393|P2|STARTED|Second Intervention||34
8433032|NCT00840203|20783394|P1|STARTED|Second Intervention||35
8433033|NCT00840203|20783393|P2|NOT COMPLETED|Washout||0
8433034|NCT00840203|20783394|P1|NOT COMPLETED|Washout||1
8433035|NCT00840203|20783393|P2|COMPLETED|Washout||34
8433036|NCT00840203|20783394|P1|COMPLETED|Washout||35
8433037|NCT00840203|20783393|P2|STARTED|Washout||34
8433038|NCT00840203|20783394|P1|STARTED|Washout||36
8433039|NCT00840203|20783393|P2|NOT COMPLETED|First Intervention||1
8433040|NCT00840203|20783394|P1|NOT COMPLETED|First Intervention||1
8433041|NCT00840203|20783393|P2|COMPLETED|First Intervention||34
8433042|NCT00840203|20783394|P1|COMPLETED|First Intervention||36
8433043|NCT00840203|20783393|P2|STARTED|First Intervention||35
8433044|NCT00840203|20783394|P1|STARTED|First Intervention||37
8433060|NCT00840099|20783432|P2|NOT COMPLETED|Period 2||0
8433061|NCT00840099|20783433|P1|NOT COMPLETED|Period 2||0
8433062|NCT00840099|20783432|P2|COMPLETED|Period 2||24
8433063|NCT00840099|20783433|P1|COMPLETED|Period 2||21
8433064|NCT00840099|20783432|P2|STARTED|Period 2||24
8433065|NCT00840099|20783433|P1|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
8433066|NCT00840099|20783432|P2|NOT COMPLETED|Period 1||0
8433067|NCT00840099|20783433|P1|NOT COMPLETED|Period 1||0
8433068|NCT00840099|20783432|P2|COMPLETED|Period 1||24
8433069|NCT00840099|20783433|P1|COMPLETED|Period 1||24
8433070|NCT00840099|20783432|P2|STARTED|Period 1||24
8433071|NCT00840099|20783433|P1|STARTED|Period 1||24
8433072|NCT00840086|20783447|P1|NOT COMPLETED|Overall Study||4
8433073|NCT00840086|20783447|P1|COMPLETED|Overall Study||146
8433074|NCT00840086|20783447|P1|STARTED|Overall Study||150
8433075|NCT00840073|20783456|P2|NOT COMPLETED|Second Intervention||1
8433076|NCT00840073|20783457|P1|NOT COMPLETED|Second Intervention||1
8433077|NCT00840073|20783456|P2|COMPLETED|Second Intervention||24
8433078|NCT00840073|20783457|P1|COMPLETED|Second Intervention||24
8433079|NCT00840073|20783456|P2|STARTED|Second Intervention||25
8433080|NCT00840073|20783457|P1|STARTED|Second Intervention||25
8433081|NCT00840073|20783456|P2|NOT COMPLETED|First Intervention||0
8433082|NCT00840073|20783457|P1|NOT COMPLETED|First Intervention||0
8433083|NCT00840073|20783456|P2|COMPLETED|First Intervention||25
8433084|NCT00840073|20783457|P1|COMPLETED|First Intervention||25
8433085|NCT00840073|20783456|P2|STARTED|First Intervention||25
8433086|NCT00840073|20783457|P1|STARTED|First Intervention||25
8433087|NCT00840060|20783471|P2|NOT COMPLETED|Overall Study||1
8433088|NCT00840060|20783472|P1|NOT COMPLETED|Overall Study||1
8433089|NCT00840060|20783471|P2|COMPLETED|Overall Study||19
8433090|NCT00840060|20783472|P1|COMPLETED|Overall Study||19
8433091|NCT00840060|20783471|P2|STARTED|Overall Study||20
8433092|NCT00840060|20783472|P1|STARTED|Overall Study||20
8433093|NCT00840034|20783482|P2|NOT COMPLETED|Taper Phase||2
8433094|NCT00840034|20783483|P1|NOT COMPLETED|Taper Phase||3
8433095|NCT00840034|20783482|P2|COMPLETED|Taper Phase||80
8433096|NCT00840034|20783483|P1|COMPLETED|Taper Phase||87
8433097|NCT00840034|20783482|P2|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
8433098|NCT00840034|20783483|P1|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
8433099|NCT00840034|20783482|P2|NOT COMPLETED|Acute Treatment Phase||36
8433100|NCT00840034|20783483|P1|NOT COMPLETED|Acute Treatment Phase||21
8433101|NCT00840034|20783482|P2|COMPLETED|Acute Treatment Phase||80
8433102|NCT00840034|20783483|P1|COMPLETED|Acute Treatment Phase||90
8433103|NCT00840034|20783482|P2|STARTED|Acute Treatment Phase||116
8433104|NCT00840034|20783483|P1|STARTED|Acute Treatment Phase||111
8433105|NCT00839982|20783519|P4|NOT COMPLETED|Overall Study||0
8433106|NCT00839982|20783520|P3|NOT COMPLETED|Overall Study||0
8433107|NCT00839982|20783521|P2|NOT COMPLETED|Overall Study||0
8433108|NCT00839982|20783522|P1|NOT COMPLETED|Overall Study||0
8433109|NCT00839982|20783519|P4|COMPLETED|Overall Study||3
8433110|NCT00839982|20783520|P3|COMPLETED|Overall Study||2
8433111|NCT00839982|20783521|P2|COMPLETED|Overall Study||26
8433112|NCT00839982|20783522|P1|COMPLETED|Overall Study||4
8433113|NCT00839982|20783519|P4|STARTED|Overall Study||3
8433114|NCT00839982|20783520|P3|STARTED|Overall Study||2
8433115|NCT00839982|20783521|P2|STARTED|Overall Study||26
8433116|NCT00839982|20783522|P1|STARTED|Overall Study||4
8433117|NCT00839956|20783536|P1|NOT COMPLETED|Overall Study||12
8433118|NCT00839956|20783536|P1|COMPLETED|Overall Study||19
8433119|NCT00839956|20783536|P1|STARTED|Overall Study||31
8433120|NCT00839930|20783545|P2|NOT COMPLETED|Second Intervention||0
8433121|NCT00839930|20783546|P1|NOT COMPLETED|Second Intervention||0
8433122|NCT00839930|20783545|P2|COMPLETED|Second Intervention||15
8433123|NCT00839930|20783546|P1|COMPLETED|Second Intervention||15
8433124|NCT00839930|20783545|P2|STARTED|Second Intervention||15
8433125|NCT00839930|20783546|P1|STARTED|Second Intervention||15
8433126|NCT00839930|20783545|P2|NOT COMPLETED|Washout: 7 Days||0
8433127|NCT00839930|20783546|P1|NOT COMPLETED|Washout: 7 Days||0
8433128|NCT00839930|20783545|P2|COMPLETED|Washout: 7 Days||15
8433129|NCT00839930|20783546|P1|COMPLETED|Washout: 7 Days||15
8433130|NCT00839930|20783545|P2|STARTED|Washout: 7 Days||15
8433131|NCT00839930|20783546|P1|STARTED|Washout: 7 Days||15
8433132|NCT00839930|20783545|P2|NOT COMPLETED|First Intervention||0
8433133|NCT00839930|20783546|P1|NOT COMPLETED|First Intervention||0
8433134|NCT00839930|20783545|P2|COMPLETED|First Intervention||15
8433135|NCT00839930|20783546|P1|COMPLETED|First Intervention||15
8433136|NCT00839930|20783545|P2|STARTED|First Intervention||15
8433137|NCT00839930|20783546|P1|STARTED|First Intervention||15
8433138|NCT00839917|20783556|P2|NOT COMPLETED|Overall Study||1
8433139|NCT00839917|20783557|P1|NOT COMPLETED|Overall Study||1
8433140|NCT00839917|20783556|P2|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
8433141|NCT00839917|20783557|P1|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
8433142|NCT00839917|20783556|P2|STARTED|Overall Study||17
8433143|NCT00839917|20783557|P1|STARTED|Overall Study||13
8433144|NCT00839852|20783593|P1|NOT COMPLETED|Overall Study||47
8433145|NCT00839852|20783593|P1|COMPLETED|Overall Study||46
8433146|NCT00839852|20783593|P1|STARTED|Overall Study||93
8433147|NCT00839800|20783600|P2|NOT COMPLETED|Overall Study||110
8433148|NCT00839800|20783601|P1|NOT COMPLETED|Overall Study||93
8433149|NCT00839800|20783600|P2|COMPLETED|Overall Study||932
8433150|NCT00839800|20783601|P1|COMPLETED|Overall Study||956
8433151|NCT00839800|20783600|P2|STARTED|Overall Study||1042
8433152|NCT00839800|20783601|P1|STARTED|Overall Study||1049
8433153|NCT00839540|20783634|P3|NOT COMPLETED|Overall Study||0
8433154|NCT00839540|20783635|P2|NOT COMPLETED|Overall Study||0
8433155|NCT00839540|20783636|P1|NOT COMPLETED|Overall Study||0
8433156|NCT00839540|20783634|P3|COMPLETED|Overall Study||5
8433157|NCT00839540|20783635|P2|COMPLETED|Overall Study||8
8433158|NCT00839540|20783636|P1|COMPLETED|Overall Study||8
8433159|NCT00839540|20783634|P3|STARTED|Overall Study||5
8433160|NCT00839540|20783635|P2|STARTED|Overall Study||8
8433161|NCT00839540|20783636|P1|STARTED|Overall Study||8
8433162|NCT00839527|20783647|P3|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
8433163|NCT00839527|20783648|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
8433164|NCT00839527|20783649|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
8433165|NCT00839527|20783647|P3|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
8433166|NCT00839527|20783648|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
8433167|NCT00839527|20783649|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
8433168|NCT00839527|20783647|P3|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
8433169|NCT00839527|20783648|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
8433170|NCT00839527|20783649|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
8433171|NCT00839527|20783647|P3|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
8433172|NCT00839527|20783648|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
8433173|NCT00839527|20783649|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
8433174|NCT00839527|20783647|P3|COMPLETED|Treatment Period (TP) (156 Weeks)||152
8433175|NCT00839527|20783648|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||159
8433176|NCT00839527|20783649|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||55
8433177|NCT00839527|20783647|P3|STARTED|Treatment Period (TP) (156 Weeks)||271
8433178|NCT00839527|20783648|P2|STARTED|Treatment Period (TP) (156 Weeks)||277
8433179|NCT00839527|20783649|P1|STARTED|Treatment Period (TP) (156 Weeks)||115
8433180|NCT00839436|20783684|P3|NOT COMPLETED|Overall Study||1
8433181|NCT00839436|20783685|P2|NOT COMPLETED|Overall Study||1
8433182|NCT00839436|20783686|P1|NOT COMPLETED|Overall Study||1
8433183|NCT00839436|20783684|P3|COMPLETED|Overall Study||0
8433184|NCT00839436|20783685|P2|COMPLETED|Overall Study||4
8433185|NCT00839436|20783686|P1|COMPLETED|Overall Study||2
8433186|NCT00839436|20783684|P3|STARTED|Overall Study||1
8433187|NCT00839436|20783685|P2|STARTED|Overall Study||5
8433188|NCT00839436|20783686|P1|STARTED|Overall Study||3
8433189|NCT00839423|20783698|P4|NOT COMPLETED|Overall Study||20
8433190|NCT00839423|20783699|P3|NOT COMPLETED|Overall Study||18
8433191|NCT00839423|20783700|P2|NOT COMPLETED|Overall Study||10
8433192|NCT00839423|20783701|P1|NOT COMPLETED|Overall Study||18
8433193|NCT00839423|20783698|P4|COMPLETED|Overall Study||93
8433194|NCT00839423|20783699|P3|COMPLETED|Overall Study||82
8433195|NCT00839423|20783700|P2|COMPLETED|Overall Study||98
8433196|NCT00839423|20783701|P1|COMPLETED|Overall Study||87
8433197|NCT00839423|20783698|P4|STARTED|Overall Study||113
8433198|NCT00839423|20783699|P3|STARTED|Overall Study||100
8433199|NCT00839423|20783700|P2|STARTED|Overall Study||108
8433200|NCT00839423|20783701|P1|STARTED|Overall Study||105
8433201|NCT00839332|20783742|P3|NOT COMPLETED|Phase 2||39
8433202|NCT00839332|20783743|P2|NOT COMPLETED|Phase 2||68
8433203|NCT00839332|20783744|P1|NOT COMPLETED|Phase 2||0
8433204|NCT00839332|20783742|P3|COMPLETED|Phase 2||0
8433205|NCT00839332|20783743|P2|COMPLETED|Phase 2||0
8433206|NCT00839332|20783744|P1|COMPLETED|Phase 2||0
8433207|NCT00839332|20783742|P3|Received at Least 1 Dose of Study Drug|Phase 2||34
8433208|NCT00839332|20783743|P2|Received at Least 1 Dose of Study Drug|Phase 2||65
8433209|NCT00839332|20783744|P1|Received at Least 1 Dose of Study Drug|Phase 2||0
8433210|NCT00839332|20783742|P3|STARTED|Phase 2||39
8433211|NCT00839332|20783743|P2|STARTED|Phase 2||68
8433212|NCT00839332|20783744|P1|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
8433213|NCT00839332|20783742|P3|NOT COMPLETED|Phase 1||0
8433214|NCT00839332|20783743|P2|NOT COMPLETED|Phase 1||0
8433215|NCT00839332|20783744|P1|NOT COMPLETED|Phase 1||50
8433216|NCT00839332|20783742|P3|COMPLETED|Phase 1||0
8433217|NCT00839332|20783743|P2|COMPLETED|Phase 1||0
8433218|NCT00839332|20783744|P1|COMPLETED|Phase 1||0
8433219|NCT00839332|20783742|P3|Received at Least 1 Dose of Study Drug|Phase 1||0
8433220|NCT00839332|20783743|P2|Received at Least 1 Dose of Study Drug|Phase 1||0
8433221|NCT00839332|20783744|P1|Received at Least 1 Dose of Study Drug|Phase 1||50
8433222|NCT00839332|20783742|P3|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
8433223|NCT00839332|20783743|P2|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
8433224|NCT00839332|20783744|P1|STARTED|Phase 1||50
8433225|NCT00839319|20783772|P5|NOT COMPLETED|Overall Study||0
8433226|NCT00839319|20783773|P4|NOT COMPLETED|Overall Study||3
8433227|NCT00839319|20783774|P3|NOT COMPLETED|Overall Study||3
8433228|NCT00839319|20783775|P2|NOT COMPLETED|Overall Study||1
8433229|NCT00839319|20783776|P1|NOT COMPLETED|Overall Study||2
8433230|NCT00839319|20783772|P5|COMPLETED|Overall Study||8
8433231|NCT00839319|20783773|P4|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
8433232|NCT00839319|20783774|P3|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
8433233|NCT00839319|20783775|P2|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
8433234|NCT00839319|20783776|P1|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
8433235|NCT00839319|20783772|P5|STARTED|Overall Study||8
8433236|NCT00839319|20783773|P4|STARTED|Overall Study||8
8433237|NCT00839319|20783774|P3|STARTED|Overall Study||8
8433238|NCT00839319|20783775|P2|STARTED|Overall Study||8
8433239|NCT00839319|20783776|P1|STARTED|Overall Study||8
8433240|NCT00839306|20783805|P2|NOT COMPLETED|Overall Study||43
8433241|NCT00839306|20783806|P1|NOT COMPLETED|Overall Study||25
8433242|NCT00839306|20783805|P2|COMPLETED|Overall Study||134
8433243|NCT00839306|20783806|P1|COMPLETED|Overall Study||35
8433244|NCT00839306|20783805|P2|STARTED|Overall Study|Treated|177
8433245|NCT00839306|20783806|P1|STARTED|Overall Study|Treated|60
8433246|NCT00839254|20783822|P8|NOT COMPLETED|Overall Study||15
8433247|NCT00839254|20783823|P7|NOT COMPLETED|Overall Study||28
8433248|NCT00839254|20783824|P6|NOT COMPLETED|Overall Study||26
8433249|NCT00839254|20783825|P5|NOT COMPLETED|Overall Study||37
8433250|NCT00839254|20783826|P4|NOT COMPLETED|Overall Study||62
8433251|NCT00839254|20783827|P3|NOT COMPLETED|Overall Study||90
8433252|NCT00839254|20783828|P2|NOT COMPLETED|Overall Study||92
8433253|NCT00839254|20783829|P1|NOT COMPLETED|Overall Study||153
8433254|NCT00839254|20783822|P8|COMPLETED|Overall Study||256
8433255|NCT00839254|20783823|P7|COMPLETED|Overall Study||340
8433256|NCT00839254|20783824|P6|COMPLETED|Overall Study||178
8433257|NCT00839254|20783825|P5|COMPLETED|Overall Study||204
8433258|NCT00839254|20783826|P4|COMPLETED|Overall Study||797
8433259|NCT00839254|20783827|P3|COMPLETED|Overall Study||979
8433260|NCT00839254|20783828|P2|COMPLETED|Overall Study||1224
8433261|NCT00839254|20783829|P1|COMPLETED|Overall Study||1696
8433262|NCT00839254|20783822|P8|STARTED|Overall Study||271
8433263|NCT00839254|20783823|P7|STARTED|Overall Study||368
8433264|NCT00839254|20783824|P6|STARTED|Overall Study||204
8433265|NCT00839254|20783825|P5|STARTED|Overall Study||241
8433266|NCT00839254|20783826|P4|STARTED|Overall Study||859
8433267|NCT00839254|20783827|P3|STARTED|Overall Study||1069
8433268|NCT00839254|20783828|P2|STARTED|Overall Study||1316
8433269|NCT00839254|20783829|P1|STARTED|Overall Study||1849
8433270|NCT00839241|20784065|P2|NOT COMPLETED|Overall Study||17
8433271|NCT00839241|20784066|P1|NOT COMPLETED|Overall Study||5
8433272|NCT00839241|20784065|P2|COMPLETED|Overall Study||8
8433273|NCT00839241|20784066|P1|COMPLETED|Overall Study||15
8433274|NCT00839241|20784065|P2|STARTED|Overall Study||25
8433275|NCT00839241|20784066|P1|STARTED|Overall Study||20
8433276|NCT00839098|20784153|P3|NOT COMPLETED|Overall Study||7
8433277|NCT00839098|20784154|P2|NOT COMPLETED|Overall Study||1
8433278|NCT00839098|20784155|P1|NOT COMPLETED|Overall Study||2
8433279|NCT00839098|20784153|P3|COMPLETED|Overall Study||6
8433280|NCT00839098|20784154|P2|COMPLETED|Overall Study||11
8433281|NCT00839098|20784155|P1|COMPLETED|Overall Study||1
8433282|NCT00839098|20784153|P3|STARTED|Overall Study||13
8433283|NCT00839098|20784154|P2|STARTED|Overall Study||12
8433284|NCT00839098|20784155|P1|STARTED|Overall Study||3
8433285|NCT00839072|20784181|P2|NOT COMPLETED|Second Intervention Period||0
8433286|NCT00839072|20784182|P1|NOT COMPLETED|Second Intervention Period||1
8433287|NCT00839072|20784181|P2|COMPLETED|Second Intervention Period||11
8433288|NCT00839072|20784182|P1|COMPLETED|Second Intervention Period||9
8433289|NCT00839072|20784181|P2|STARTED|Second Intervention Period||11
8433290|NCT00839072|20784182|P1|STARTED|Second Intervention Period||10
8433291|NCT00839072|20784181|P2|NOT COMPLETED|Washout Period of 7 Days||0
8433292|NCT00839072|20784182|P1|NOT COMPLETED|Washout Period of 7 Days||0
8433293|NCT00839072|20784181|P2|COMPLETED|Washout Period of 7 Days||11
8433294|NCT00839072|20784182|P1|COMPLETED|Washout Period of 7 Days||10
8433295|NCT00839072|20784181|P2|STARTED|Washout Period of 7 Days||11
8433296|NCT00839072|20784182|P1|STARTED|Washout Period of 7 Days||10
8433297|NCT00839072|20784181|P2|NOT COMPLETED|First Intervention Period||1
8433298|NCT00839072|20784182|P1|NOT COMPLETED|First Intervention Period||2
8433299|NCT00839072|20784181|P2|COMPLETED|First Intervention Period||11
8433300|NCT00839072|20784182|P1|COMPLETED|First Intervention Period||10
8433301|NCT00839072|20784181|P2|STARTED|First Intervention Period||12
8433302|NCT00839072|20784182|P1|STARTED|First Intervention Period||12
8433303|NCT00838981|20784202|P4|NOT COMPLETED|Day 4 to Week 11||7
8433304|NCT00838981|20784203|P3|NOT COMPLETED|Day 4 to Week 11||11
8433305|NCT00838981|20784204|P2|NOT COMPLETED|Day 4 to Week 11||8
8433306|NCT00838981|20784205|P1|NOT COMPLETED|Day 4 to Week 11||7
8433307|NCT00838981|20784202|P4|COMPLETED|Day 4 to Week 11||12
8433308|NCT00838981|20784203|P3|COMPLETED|Day 4 to Week 11||16
8433309|NCT00838981|20784204|P2|COMPLETED|Day 4 to Week 11||11
8433310|NCT00838981|20784205|P1|COMPLETED|Day 4 to Week 11||19
8433311|NCT00838981|20784202|P4|Completed Main Treatment on 400mg|Day 4 to Week 11||14
8433312|NCT00838981|20784203|P3|Completed Main Treatment on 400mg|Day 4 to Week 11||17
8433313|NCT00838981|20784204|P2|Completed Main Treatment on 400mg|Day 4 to Week 11||13
8433314|NCT00838981|20784205|P1|Completed Main Treatment on 400mg|Day 4 to Week 11||22
8433315|NCT00838981|20784202|P4|STARTED|Day 4 to Week 11||19
8433316|NCT00838981|20784203|P3|STARTED|Day 4 to Week 11||27
8433317|NCT00838981|20784204|P2|STARTED|Day 4 to Week 11||19
8433318|NCT00838981|20784205|P1|STARTED|Day 4 to Week 11||26
8433319|NCT00838981|20784202|P4|NOT COMPLETED|Week 1 Days 1-3||0
8433320|NCT00838981|20784203|P3|NOT COMPLETED|Week 1 Days 1-3||0
8433321|NCT00838981|20784204|P2|NOT COMPLETED|Week 1 Days 1-3||0
8433322|NCT00838981|20784205|P1|NOT COMPLETED|Week 1 Days 1-3||0
8433323|NCT00838981|20784202|P4|COMPLETED|Week 1 Days 1-3||19
8433324|NCT00838981|20784203|P3|COMPLETED|Week 1 Days 1-3||27
8433325|NCT00838981|20784204|P2|COMPLETED|Week 1 Days 1-3||19
8433326|NCT00838981|20784205|P1|COMPLETED|Week 1 Days 1-3||26
8433327|NCT00838981|20784202|P4|STARTED|Week 1 Days 1-3||19
8433328|NCT00838981|20784203|P3|STARTED|Week 1 Days 1-3||27
8433329|NCT00838981|20784204|P2|STARTED|Week 1 Days 1-3||19
8433330|NCT00838981|20784205|P1|STARTED|Week 1 Days 1-3||26
8433331|NCT00838929|20784226|P3|NOT COMPLETED|Overall Study||1
8433332|NCT00838929|20784227|P2|NOT COMPLETED|Overall Study||3
8433333|NCT00838929|20784228|P1|NOT COMPLETED|Overall Study||0
8433334|NCT00838929|20784226|P3|COMPLETED|Overall Study||5
8433335|NCT00838929|20784227|P2|COMPLETED|Overall Study||5
8433336|NCT00838929|20784228|P1|COMPLETED|Overall Study||3
8433337|NCT00838929|20784226|P3|STARTED|Overall Study||6
8433338|NCT00838929|20784227|P2|STARTED|Overall Study||8
8433339|NCT00838929|20784228|P1|STARTED|Overall Study||3
8433340|NCT00838916|20784236|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||51
8433341|NCT00838916|20784237|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||96
8433342|NCT00838916|20784236|P2|COMPLETED|Follow-up Period (8 Weeks)||190
8433343|NCT00838916|20784237|P1|COMPLETED|Follow-up Period (8 Weeks)||408
8433344|NCT00838916|20784236|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
8433345|NCT00838916|20784237|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
8433346|NCT00838916|20784236|P2|NOT COMPLETED|Treatment Period (156 Weeks)||77
8433347|NCT00838916|20784237|P1|NOT COMPLETED|Treatment Period (156 Weeks)||196
8433348|NCT00838916|20784236|P2|COMPLETED|Treatment Period (156 Weeks)||164
8433349|NCT00838916|20784237|P1|COMPLETED|Treatment Period (156 Weeks)||308
8433350|NCT00838916|20784236|P2|STARTED|Treatment Period (156 Weeks)||241
8433351|NCT00838916|20784237|P1|STARTED|Treatment Period (156 Weeks)||504
8433352|NCT00838903|20784266|P4|NOT COMPLETED|Follow-up Period (8 Weeks)||58
8433353|NCT00838903|20784267|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||64
8433354|NCT00838903|20784268|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||65
8433355|NCT00838903|20784269|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||26
8433356|NCT00838903|20784266|P4|COMPLETED|Follow-up Period (8 Weeks)||244
8433357|NCT00838903|20784267|P3|COMPLETED|Follow-up Period (8 Weeks)||243
8433358|NCT00838903|20784268|P2|COMPLETED|Follow-up Period (8 Weeks)||237
8433359|NCT00838903|20784269|P1|COMPLETED|Follow-up Period (8 Weeks)||75
8433360|NCT00838903|20784266|P4|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
8433361|NCT00838903|20784267|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
8433362|NCT00838903|20784268|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
8433363|NCT00838903|20784269|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
8433364|NCT00838903|20784266|P4|NOT COMPLETED|Treatment Period (156 Weeks)||110
8433365|NCT00838903|20784267|P3|NOT COMPLETED|Treatment Period (156 Weeks)||116
8433366|NCT00838903|20784268|P2|NOT COMPLETED|Treatment Period (156 Weeks)||112
8433367|NCT00838903|20784269|P1|NOT COMPLETED|Treatment Period (156 Weeks)||46
8433368|NCT00838903|20784266|P4|COMPLETED|Treatment Period (156 Weeks)||192
8433369|NCT00838903|20784267|P3|COMPLETED|Treatment Period (156 Weeks)||191
8433370|NCT00838903|20784268|P2|COMPLETED|Treatment Period (156 Weeks)||190
8433371|NCT00838903|20784269|P1|COMPLETED|Treatment Period (156 Weeks)||55
8433372|NCT00838903|20784266|P4|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
8433373|NCT00838903|20784267|P3|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
8433374|NCT00838903|20784268|P2|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
8433375|NCT00838903|20784269|P1|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
8433376|NCT00838903|20784266|P4|STARTED|Treatment Period (156 Weeks)||302
8433377|NCT00838903|20784267|P3|STARTED|Treatment Period (156 Weeks)||307
8433378|NCT00838903|20784268|P2|STARTED|Treatment Period (156 Weeks)||302
8433379|NCT00838903|20784269|P1|STARTED|Treatment Period (156 Weeks)||101
8433380|NCT00838695|20784313|P2|NOT COMPLETED|Overall Study||0
8433381|NCT00838695|20784314|P1|NOT COMPLETED|Overall Study||0
8433382|NCT00838695|20784313|P2|COMPLETED|Overall Study||64
8433383|NCT00838695|20784314|P1|COMPLETED|Overall Study||42
8433384|NCT00838695|20784313|P2|STARTED|Overall Study||64
8433385|NCT00838695|20784314|P1|STARTED|Overall Study||42
8433386|NCT00838682|20784324|P2|NOT COMPLETED|Overall Study||19
8433387|NCT00838682|20784325|P1|NOT COMPLETED|Overall Study||25
8433388|NCT00838682|20784324|P2|COMPLETED|Overall Study||33
8433389|NCT00838682|20784325|P1|COMPLETED|Overall Study||29
8433390|NCT00838682|20784324|P2|STARTED|Overall Study||52
8433391|NCT00838682|20784325|P1|STARTED|Overall Study||54
8433392|NCT00838630|20784343|P2|NOT COMPLETED|Second Intervention||0
8433393|NCT00838630|20784344|P1|NOT COMPLETED|Second Intervention||0
8433394|NCT00838630|20784343|P2|COMPLETED|Second Intervention||18
8433395|NCT00838630|20784344|P1|COMPLETED|Second Intervention||16
8433396|NCT00838630|20784343|P2|STARTED|Second Intervention||18
8433397|NCT00838630|20784344|P1|STARTED|Second Intervention||16
8433398|NCT00838630|20784343|P2|NOT COMPLETED|Washout: 7 Days||0
8433399|NCT00838630|20784344|P1|NOT COMPLETED|Washout: 7 Days||1
8433400|NCT00838630|20784343|P2|COMPLETED|Washout: 7 Days||18
8433401|NCT00838630|20784344|P1|COMPLETED|Washout: 7 Days||16
8433402|NCT00838630|20784343|P2|STARTED|Washout: 7 Days||18
8433403|NCT00838630|20784344|P1|STARTED|Washout: 7 Days||17
8433404|NCT00838630|20784343|P2|NOT COMPLETED|First Intervention||0
8433405|NCT00838630|20784344|P1|NOT COMPLETED|First Intervention||1
8433406|NCT00838630|20784343|P2|COMPLETED|First Intervention||18
8433407|NCT00838630|20784344|P1|COMPLETED|First Intervention||17
8433408|NCT00838630|20784343|P2|STARTED|First Intervention||18
8433409|NCT00838630|20784344|P1|STARTED|First Intervention||18
8433410|NCT00838578|20784352|P1|NOT COMPLETED|Overall Study||2
8433411|NCT00838578|20784352|P1|COMPLETED|Overall Study||63
8433412|NCT00838578|20784352|P1|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
8433413|NCT00838565|20784366|P6|NOT COMPLETED|Overall Study||2
8433414|NCT00838565|20784367|P5|NOT COMPLETED|Overall Study||0
8433415|NCT00838565|20784368|P4|NOT COMPLETED|Overall Study||0
8433416|NCT00838565|20784369|P3|NOT COMPLETED|Overall Study||1
8433417|NCT00838565|20784370|P2|NOT COMPLETED|Overall Study||3
8433418|NCT00838565|20784371|P1|NOT COMPLETED|Overall Study||0
8433419|NCT00838565|20784366|P6|COMPLETED|Overall Study||5
8433420|NCT00838565|20784367|P5|COMPLETED|Overall Study||6
8433421|NCT00838565|20784368|P4|COMPLETED|Overall Study||6
8433422|NCT00838565|20784369|P3|COMPLETED|Overall Study||5
8433423|NCT00838565|20784370|P2|COMPLETED|Overall Study||4
8433424|NCT00838565|20784371|P1|COMPLETED|Overall Study||9
8433425|NCT00838565|20784366|P6|Treated|Overall Study||7
8433426|NCT00838565|20784367|P5|Treated|Overall Study||6
8433427|NCT00838565|20784368|P4|Treated|Overall Study||6
8433428|NCT00838565|20784369|P3|Treated|Overall Study||6
8433429|NCT00838565|20784370|P2|Treated|Overall Study||6
8433430|NCT00838565|20784371|P1|Treated|Overall Study||9
8433431|NCT00838565|20784366|P6|STARTED|Overall Study||7
8433432|NCT00838565|20784367|P5|STARTED|Overall Study||6
8433433|NCT00838565|20784368|P4|STARTED|Overall Study||6
8433434|NCT00838565|20784369|P3|STARTED|Overall Study||6
8433435|NCT00838565|20784370|P2|STARTED|Overall Study||7
8433436|NCT00838565|20784371|P1|STARTED|Overall Study||9
8433437|NCT00838539|20784476|P12|NOT COMPLETED|Overall Study||4
8433438|NCT00838539|20784477|P11|NOT COMPLETED|Overall Study||5
8433439|NCT00838539|20784478|P10|NOT COMPLETED|Overall Study||8
8433440|NCT00838539|20784479|P9|NOT COMPLETED|Overall Study||5
8433441|NCT00838539|20784480|P8|NOT COMPLETED|Overall Study||6
8433442|NCT00838539|20784481|P7|NOT COMPLETED|Overall Study||5
8433443|NCT00838539|20784482|P6|NOT COMPLETED|Overall Study||4
8433444|NCT00838539|20784483|P5|NOT COMPLETED|Overall Study||6
8433445|NCT00838539|20784484|P4|NOT COMPLETED|Overall Study||4
8433446|NCT00838539|20784485|P3|NOT COMPLETED|Overall Study||5
8433447|NCT00838539|20784486|P2|NOT COMPLETED|Overall Study||6
8433448|NCT00838539|20784487|P1|NOT COMPLETED|Overall Study||3
8433449|NCT00838539|20784476|P12|COMPLETED|Overall Study||0
8433450|NCT00838539|20784477|P11|COMPLETED|Overall Study||0
8433451|NCT00838539|20784478|P10|COMPLETED|Overall Study||0
8433452|NCT00838539|20784479|P9|COMPLETED|Overall Study||0
8433453|NCT00838539|20784480|P8|COMPLETED|Overall Study||0
8433454|NCT00838539|20784481|P7|COMPLETED|Overall Study||2
8433455|NCT00838539|20784482|P6|COMPLETED|Overall Study||0
8433456|NCT00838539|20784483|P5|COMPLETED|Overall Study||0
8433457|NCT00838539|20784484|P4|COMPLETED|Overall Study||0
8433458|NCT00838539|20784485|P3|COMPLETED|Overall Study||0
8433459|NCT00838539|20784486|P2|COMPLETED|Overall Study||0
8433460|NCT00838539|20784487|P1|COMPLETED|Overall Study||0
8433461|NCT00838539|20784476|P12|Received Treatment|Overall Study||4
8433462|NCT00838539|20784477|P11|Received Treatment|Overall Study||5
8433463|NCT00838539|20784478|P10|Received Treatment|Overall Study||8
8433464|NCT00838539|20784479|P9|Received Treatment|Overall Study||5
8433465|NCT00838539|20784480|P8|Received Treatment|Overall Study||6
8433466|NCT00838539|20784481|P7|Received Treatment|Overall Study||7
8433467|NCT00838539|20784482|P6|Received Treatment|Overall Study||4
8433468|NCT00838539|20784483|P5|Received Treatment|Overall Study||4
8433469|NCT00838539|20784484|P4|Received Treatment|Overall Study||4
8433470|NCT00838539|20784485|P3|Received Treatment|Overall Study||5
8433471|NCT00838539|20784486|P2|Received Treatment|Overall Study||5
8433472|NCT00838539|20784487|P1|Received Treatment|Overall Study||3
8433473|NCT00838539|20784476|P12|STARTED|Overall Study||4
8433474|NCT00838539|20784477|P11|STARTED|Overall Study||5
8433475|NCT00838539|20784478|P10|STARTED|Overall Study||8
8433476|NCT00838539|20784479|P9|STARTED|Overall Study||5
8433477|NCT00838539|20784480|P8|STARTED|Overall Study||6
8433478|NCT00838539|20784481|P7|STARTED|Overall Study||7
8433479|NCT00838539|20784482|P6|STARTED|Overall Study||4
8433480|NCT00838539|20784483|P5|STARTED|Overall Study||6
8433481|NCT00838539|20784484|P4|STARTED|Overall Study||4
8433482|NCT00838539|20784485|P3|STARTED|Overall Study||5
8433483|NCT00838539|20784486|P2|STARTED|Overall Study||6
8433484|NCT00838539|20784487|P1|STARTED|Overall Study||3
8433485|NCT00838526|20784537|P2|NOT COMPLETED|Overall Study||39
8433486|NCT00838526|20784538|P1|NOT COMPLETED|Overall Study||24
8433487|NCT00838526|20784537|P2|COMPLETED|Overall Study||137
8433488|NCT00838526|20784538|P1|COMPLETED|Overall Study||35
8433489|NCT00838526|20784537|P2|STARTED|Overall Study|Treated|176
8433490|NCT00838526|20784538|P1|STARTED|Overall Study|Treated|59
8433491|NCT00838513|20784546|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
8433492|NCT00838513|20784546|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
8433493|NCT00838513|20784546|P1|STARTED|Post Treatment Period (Patients Who Disc||5
8433494|NCT00838513|20784546|P1|NOT COMPLETED|Extension Treatment Period||1
8433495|NCT00838513|20784546|P1|COMPLETED|Extension Treatment Period||18
8433496|NCT00838513|20784546|P1|STARTED|Extension Treatment Period||19
8433497|NCT00838513|20784546|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
8433498|NCT00838513|20784546|P1|COMPLETED|Treatment Period (26 Weeks)||20
8433499|NCT00838513|20784546|P1|STARTED|Treatment Period (26 Weeks)||20
8433500|NCT00838513|20784546|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
8433501|NCT00838513|20784546|P1|COMPLETED|Observation Period (8 Weeks)||20
8433502|NCT00838513|20784546|P1|STARTED|Observation Period (8 Weeks)||20
8433503|NCT00838513|20784546|P1|NOT COMPLETED|Screening Period||3
8433504|NCT00838513|20784546|P1|COMPLETED|Screening Period||20
8433505|NCT00838513|20784546|P1|STARTED|Screening Period||23
8433506|NCT00838435|20784562|P1|NOT COMPLETED|Part 2 (7 Years)||16
8433507|NCT00838435|20784562|P1|COMPLETED|Part 2 (7 Years)||49
8433508|NCT00838435|20784562|P1|STARTED|Part 2 (7 Years)|65 of 95 subjects in Part 1 were determined responders & eligible for the Part 2 of the study.|65
8433509|NCT00838435|20784562|P1|NOT COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||2
8433510|NCT00838435|20784562|P1|COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||63
8433511|NCT00838435|20784562|P1|STARTED|Safety/Efficacy Sub-Study 1 (6 Months)|65 of 95 subjects in Part 1 were determined responders & eligible for the Safety/Efficacy Sub-study.|65
8433512|NCT00838435|20784562|P1|NOT COMPLETED|PK Sub-Study 2 (4 Weeks)||1
8433513|NCT00838435|20784562|P1|COMPLETED|PK Sub-Study 2 (4 Weeks)||93
8433514|NCT00838435|20784562|P1|STARTED|PK Sub-Study 2 (4 Weeks)|1 subject declined participation in the PK Sub-Study.|94
8433515|NCT00838435|20784562|P1|NOT COMPLETED|Part 1 (4 Weeks)||0
8433516|NCT00838435|20784562|P1|COMPLETED|Part 1 (4 Weeks)||95
8433517|NCT00838435|20784562|P1|STARTED|Part 1 (4 Weeks)||95
8433518|NCT00838331|20784575|P1|NOT COMPLETED|Aged Blood Transfusion||9
8433519|NCT00838331|20784575|P1|COMPLETED|Aged Blood Transfusion||8
8433520|NCT00838331|20784575|P1|STARTED|Aged Blood Transfusion||17
8433521|NCT00838331|20784575|P1|NOT COMPLETED|Fresh Blood Transfusion||0
8433522|NCT00838331|20784575|P1|COMPLETED|Fresh Blood Transfusion||17
8433523|NCT00838331|20784575|P1|STARTED|Fresh Blood Transfusion||17
8433524|NCT00838279|20784581|P2|NOT COMPLETED|Second Intervention||0
8433525|NCT00838279|20784582|P1|NOT COMPLETED|Second Intervention||0
8433526|NCT00838279|20784581|P2|COMPLETED|Second Intervention||15
8433527|NCT00838279|20784582|P1|COMPLETED|Second Intervention||15
8433528|NCT00838279|20784581|P2|STARTED|Second Intervention||15
8433529|NCT00838279|20784582|P1|STARTED|Second Intervention||15
8433530|NCT00838279|20784581|P2|NOT COMPLETED|Washout||1
8433531|NCT00838279|20784582|P1|NOT COMPLETED|Washout||1
8433532|NCT00838279|20784581|P2|COMPLETED|Washout||15
8433533|NCT00838279|20784582|P1|COMPLETED|Washout||15
8433534|NCT00838279|20784581|P2|STARTED|Washout||16
8433535|NCT00838279|20784582|P1|STARTED|Washout||16
8433536|NCT00838279|20784581|P2|NOT COMPLETED|First Intervention||0
8433537|NCT00838279|20784582|P1|NOT COMPLETED|First Intervention||0
8433538|NCT00838279|20784581|P2|COMPLETED|First Intervention||16
8433539|NCT00838279|20784582|P1|COMPLETED|First Intervention||16
8433540|NCT00838279|20784581|P2|STARTED|First Intervention||16
8433541|NCT00838279|20784582|P1|STARTED|First Intervention||16
8433542|NCT00838201|20784592|P2|NOT COMPLETED|Overall Study||53
8433543|NCT00838201|20784593|P1|NOT COMPLETED|Overall Study||42
8433544|NCT00838201|20784592|P2|COMPLETED|Overall Study||145
8433545|NCT00838201|20784593|P1|COMPLETED|Overall Study||144
8433546|NCT00838201|20784592|P2|STARTED|Overall Study||198
8433547|NCT00838201|20784593|P1|STARTED|Overall Study||186
8433548|NCT00838162|20784603|P4|NOT COMPLETED|Overall Study||0
8433549|NCT00838162|20784604|P3|NOT COMPLETED|Overall Study||0
8433550|NCT00838162|20784605|P2|NOT COMPLETED|Overall Study||0
8433551|NCT00838162|20784606|P1|NOT COMPLETED|Overall Study||0
8433552|NCT00838162|20784603|P4|COMPLETED|Overall Study||8
8433553|NCT00838162|20784604|P3|COMPLETED|Overall Study||8
8433554|NCT00838162|20784605|P2|COMPLETED|Overall Study||8
8433555|NCT00838162|20784606|P1|COMPLETED|Overall Study||9
8433556|NCT00838162|20784603|P4|STARTED|Overall Study||8
8433557|NCT00838162|20784604|P3|STARTED|Overall Study||8
8433558|NCT00838162|20784605|P2|STARTED|Overall Study||8
8433559|NCT00838162|20784606|P1|STARTED|Overall Study||9
8433560|NCT00838136|20784650|P2|NOT COMPLETED|Second Intervention||1
8433561|NCT00838136|20784651|P1|NOT COMPLETED|Second Intervention||0
8433562|NCT00838136|20784650|P2|COMPLETED|Second Intervention||15
8433563|NCT00838136|20784651|P1|COMPLETED|Second Intervention||16
8433564|NCT00838136|20784650|P2|STARTED|Second Intervention||16
8433565|NCT00838136|20784651|P1|STARTED|Second Intervention||16
8433566|NCT00838136|20784650|P2|NOT COMPLETED|First Intervention||0
8433567|NCT00838136|20784651|P1|NOT COMPLETED|First Intervention||0
8433568|NCT00838136|20784650|P2|COMPLETED|First Intervention||16
8433569|NCT00838136|20784651|P1|COMPLETED|First Intervention||16
8433570|NCT00838136|20784650|P2|STARTED|First Intervention||16
8433571|NCT00838136|20784651|P1|STARTED|First Intervention||16
8433572|NCT00838110|20784661|P4|NOT COMPLETED|Overall Study||18
8433573|NCT00838110|20784662|P3|NOT COMPLETED|Overall Study||17
8433574|NCT00838110|20784663|P2|NOT COMPLETED|Overall Study||22
8433575|NCT00838110|20784664|P1|NOT COMPLETED|Overall Study||22
8433576|NCT00838110|20784661|P4|COMPLETED|Overall Study||226
8433577|NCT00838110|20784662|P3|COMPLETED|Overall Study||226
8433578|NCT00838110|20784663|P2|COMPLETED|Overall Study||106
8433579|NCT00838110|20784664|P1|COMPLETED|Overall Study||105
8433580|NCT00838110|20784661|P4|Treated|Overall Study||244
8433581|NCT00838110|20784662|P3|Treated|Overall Study||243
8433582|NCT00838110|20784663|P2|Treated|Overall Study||127
8433583|NCT00838110|20784664|P1|Treated|Overall Study||127
8433584|NCT00838110|20784661|P4|STARTED|Overall Study||244
8433585|NCT00838110|20784662|P3|STARTED|Overall Study||243
8433586|NCT00838110|20784663|P2|STARTED|Overall Study||128
8433587|NCT00838110|20784664|P1|STARTED|Overall Study||127
8433588|NCT00838097|20784684|P1|NOT COMPLETED|Overall Study||176
8433589|NCT00838097|20784684|P1|COMPLETED|Overall Study||145
8433590|NCT00838097|20784684|P1|Received Darbepoetin Alfa|Overall Study||319
8433591|NCT00838097|20784684|P1|STARTED|Overall Study||321
8433592|NCT00838006|20784695|P3|NOT COMPLETED|Overall Study||48
8433593|NCT00838006|20784696|P2|NOT COMPLETED|Overall Study||26
8433594|NCT00838006|20784697|P1|NOT COMPLETED|Overall Study||34
8433595|NCT00838006|20784695|P3|COMPLETED|Overall Study||94
8433596|NCT00838006|20784696|P2|COMPLETED|Overall Study||72
8433597|NCT00838006|20784697|P1|COMPLETED|Overall Study||68
8433598|NCT00838006|20784695|P3|3-month Post-deployment Follow-up|Overall Study||135
8433599|NCT00838006|20784696|P2|3-month Post-deployment Follow-up|Overall Study||80
8433600|NCT00838006|20784697|P1|3-month Post-deployment Follow-up|Overall Study||92
8433601|NCT00838006|20784695|P3|STARTED|Overall Study||142
8433602|NCT00838006|20784696|P2|STARTED|Overall Study||98
8433603|NCT00838006|20784697|P1|STARTED|Overall Study||102
8433604|NCT00837967|20784708|P2|NOT COMPLETED|Second Intervention||0
8433605|NCT00837967|20784709|P1|NOT COMPLETED|Second Intervention||0
8433606|NCT00837967|20784708|P2|COMPLETED|Second Intervention||12
8433607|NCT00837967|20784709|P1|COMPLETED|Second Intervention||11
8433608|NCT00837967|20784708|P2|STARTED|Second Intervention||12
8433609|NCT00837967|20784709|P1|STARTED|Second Intervention||11
8433610|NCT00837967|20784708|P2|NOT COMPLETED|Washout Period of 7 - 14 Days||0
8433611|NCT00837967|20784709|P1|NOT COMPLETED|Washout Period of 7 - 14 Days||2
8433612|NCT00837967|20784708|P2|COMPLETED|Washout Period of 7 - 14 Days||12
8433613|NCT00837967|20784709|P1|COMPLETED|Washout Period of 7 - 14 Days||11
8433614|NCT00837967|20784708|P2|STARTED|Washout Period of 7 - 14 Days||12
8433615|NCT00837967|20784709|P1|STARTED|Washout Period of 7 - 14 Days||13
8433616|NCT00837967|20784708|P2|NOT COMPLETED|First Intervention||0
8433617|NCT00837967|20784709|P1|NOT COMPLETED|First Intervention||0
8433618|NCT00837967|20784708|P2|COMPLETED|First Intervention||12
8433619|NCT00837967|20784709|P1|COMPLETED|First Intervention||13
8433620|NCT00837967|20784708|P2|STARTED|First Intervention||12
8433621|NCT00837967|20784709|P1|STARTED|First Intervention||13
8433622|NCT00837902|20784727|P2|NOT COMPLETED|Overall Study||0
8433623|NCT00837902|20784728|P1|NOT COMPLETED|Overall Study||0
8433624|NCT00837902|20784727|P2|COMPLETED|Overall Study||69
8433625|NCT00837902|20784728|P1|COMPLETED|Overall Study||85
8433626|NCT00837902|20784727|P2|STARTED|Overall Study||69
8433627|NCT00837902|20784728|P1|STARTED|Overall Study||85
8433628|NCT00837876|20784735|P1|NOT COMPLETED|Overall Study||37
8433629|NCT00837876|20784735|P1|COMPLETED|Overall Study||0
8433630|NCT00837876|20784735|P1|STARTED|Overall Study||37
8433631|NCT00837824|20784744|P2|NOT COMPLETED|Overall Study||0
8433632|NCT00837824|20784745|P1|NOT COMPLETED|Overall Study||0
8433633|NCT00837824|20784744|P2|COMPLETED|Overall Study||9
8433634|NCT00837824|20784745|P1|COMPLETED|Overall Study||11
8433635|NCT00837824|20784744|P2|STARTED|Overall Study||9
8433636|NCT00837824|20784745|P1|STARTED|Overall Study||11
8433637|NCT00837811|20784757|P3|NOT COMPLETED|Overall Study||1
8433638|NCT00837811|20784758|P2|NOT COMPLETED|Overall Study||34
8433639|NCT00837811|20784759|P1|NOT COMPLETED|Overall Study||7
8433640|NCT00837811|20784757|P3|COMPLETED|Overall Study||0
8433641|NCT00837811|20784758|P2|COMPLETED|Overall Study||87
8433642|NCT00837811|20784759|P1|COMPLETED|Overall Study||53
8433643|NCT00837811|20784757|P3|Included in Efficacy Analyses|Overall Study||1
8433644|NCT00837811|20784758|P2|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
8433645|NCT00837811|20784759|P1|Included in Efficacy Analyses|Overall Study||59
8433646|NCT00837811|20784757|P3|Had at Least 1 Efficacy Assessment|Overall Study||1
8433647|NCT00837811|20784758|P2|Had at Least 1 Efficacy Assessment|Overall Study||121
8433648|NCT00837811|20784759|P1|Had at Least 1 Efficacy Assessment|Overall Study||59
8433649|NCT00837811|20784757|P3|Received Any Amount of Study Drug|Overall Study||1
8433650|NCT00837811|20784758|P2|Received Any Amount of Study Drug|Overall Study||121
8433651|NCT00837811|20784759|P1|Received Any Amount of Study Drug|Overall Study||60
8433652|NCT00837811|20784757|P3|STARTED|Overall Study||1
8433653|NCT00837811|20784758|P2|STARTED|Overall Study||121
8433654|NCT00837811|20784759|P1|STARTED|Overall Study||60
8433655|NCT00837759|20784844|P1|NOT COMPLETED|Overall Study||4
8433656|NCT00837759|20784844|P1|COMPLETED|Overall Study||3
8433657|NCT00837759|20784844|P1|STARTED|Overall Study||7
8433658|NCT00837694|20784859|P6|NOT COMPLETED|Overall Study||1
8433659|NCT00837694|20784860|P5|NOT COMPLETED|Overall Study||1
8433660|NCT00837694|20784861|P4|NOT COMPLETED|Overall Study||1
8433661|NCT00837694|20784862|P3|NOT COMPLETED|Overall Study||2
8433662|NCT00837694|20784863|P2|NOT COMPLETED|Overall Study||0
8433663|NCT00837694|20784864|P1|NOT COMPLETED|Overall Study||2
8433664|NCT00837694|20784859|P6|COMPLETED|Overall Study||10
8433665|NCT00837694|20784860|P5|COMPLETED|Overall Study||11
8433666|NCT00837694|20784861|P4|COMPLETED|Overall Study||10
8433667|NCT00837694|20784862|P3|COMPLETED|Overall Study||8
8433668|NCT00837694|20784863|P2|COMPLETED|Overall Study||11
8433669|NCT00837694|20784864|P1|COMPLETED|Overall Study||8
8433670|NCT00837694|20784859|P6|STARTED|Overall Study||11
8433671|NCT00837694|20784860|P5|STARTED|Overall Study||12
8433672|NCT00837694|20784861|P4|STARTED|Overall Study||11
8433673|NCT00837694|20784862|P3|STARTED|Overall Study||10
8433674|NCT00837694|20784863|P2|STARTED|Overall Study||11
8433675|NCT00837694|20784864|P1|STARTED|Overall Study||10
8433676|NCT00837616|20784880|P2|NOT COMPLETED|Overall Study||1
8433677|NCT00837616|20784881|P1|NOT COMPLETED|Overall Study||0
8433678|NCT00837616|20784880|P2|COMPLETED|Overall Study||20
8433679|NCT00837616|20784881|P1|COMPLETED|Overall Study||20
8433680|NCT00837616|20784880|P2|STARTED|Overall Study||21
8433681|NCT00837616|20784881|P1|STARTED|Overall Study||20
8433682|NCT00837590|20784908|P3|NOT COMPLETED|Overall Study||1
8433683|NCT00837590|20784909|P2|NOT COMPLETED|Overall Study||1
8433684|NCT00837590|20784910|P1|NOT COMPLETED|Overall Study||0
8433685|NCT00837590|20784908|P3|COMPLETED|Overall Study||4
8433686|NCT00837590|20784909|P2|COMPLETED|Overall Study||4
8433687|NCT00837590|20784910|P1|COMPLETED|Overall Study||6
8433688|NCT00837590|20784908|P3|STARTED|Overall Study||5
8433689|NCT00837590|20784909|P2|STARTED|Overall Study||5
8433690|NCT00837590|20784910|P1|STARTED|Overall Study||6
8433691|NCT00837577|20784920|P2|NOT COMPLETED|Open-label Period||9
8433692|NCT00837577|20784921|P1|NOT COMPLETED|Open-label Period||8
8433693|NCT00837577|20784920|P2|COMPLETED|Open-label Period||54
8433694|NCT00837577|20784921|P1|COMPLETED|Open-label Period||60
8433695|NCT00837577|20784920|P2|STARTED|Open-label Period||63
8433696|NCT00837577|20784921|P1|STARTED|Open-label Period||68
8433697|NCT00837577|20784920|P2|NOT COMPLETED|Double-blind Period||0
8433698|NCT00837577|20784921|P1|NOT COMPLETED|Double-blind Period||2
8433699|NCT00837577|20784920|P2|COMPLETED|Double-blind Period||63
8433700|NCT00837577|20784921|P1|COMPLETED|Double-blind Period||68
8433701|NCT00837577|20784920|P2|STARTED|Double-blind Period||63
8433702|NCT00837577|20784921|P1|STARTED|Double-blind Period||70
8433703|NCT00837512|20784932|P2|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
8433704|NCT00837512|20784933|P1|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
8433705|NCT00837512|20784932|P2|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
8433706|NCT00837512|20784933|P1|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
8433707|NCT00837512|20784932|P2|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
8433708|NCT00837512|20784933|P1|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
8433709|NCT00837512|20784932|P2|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
8433710|NCT00837512|20784933|P1|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
8433711|NCT00837512|20784932|P2|COMPLETED|Both Arms: Washout (7-28 Days)||8
8433712|NCT00837512|20784933|P1|COMPLETED|Both Arms: Washout (7-28 Days)||8
8433713|NCT00837512|20784932|P2|STARTED|Both Arms: Washout (7-28 Days)||8
8433714|NCT00837512|20784933|P1|STARTED|Both Arms: Washout (7-28 Days)||8
8433715|NCT00837512|20784932|P2|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
8433716|NCT00837512|20784933|P1|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
8433717|NCT00837512|20784932|P2|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
8433718|NCT00837512|20784933|P1|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
8433719|NCT00837512|20784932|P2|STARTED|First Intervention (6hrs) - RANDOMIZED||8
8433720|NCT00837512|20784933|P1|STARTED|First Intervention (6hrs) - RANDOMIZED||8
8433721|NCT00837486|20784941|P2|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
8433722|NCT00837486|20784942|P1|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
8433723|NCT00837486|20784941|P2|COMPLETED|Long-term Follow-up Phase - Open Label||0
8433724|NCT00837486|20784942|P1|COMPLETED|Long-term Follow-up Phase - Open Label||24
8433725|NCT00837486|20784941|P2|STARTED|Long-term Follow-up Phase - Open Label||0
8433726|NCT00837486|20784942|P1|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
8433727|NCT00837486|20784941|P2|NOT COMPLETED|Blinded-treatment Phase||0
8433728|NCT00837486|20784942|P1|NOT COMPLETED|Blinded-treatment Phase||1
8433729|NCT00837486|20784941|P2|COMPLETED|Blinded-treatment Phase||14
8433730|NCT00837486|20784942|P1|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
8433731|NCT00837486|20784941|P2|STARTED|Blinded-treatment Phase||14
8433732|NCT00837486|20784942|P1|STARTED|Blinded-treatment Phase||16
8433733|NCT00837473|20784954|P1|NOT COMPLETED|Overall Study||3
8433734|NCT00837473|20784954|P1|COMPLETED|Overall Study||12
8433735|NCT00837473|20784954|P1|STARTED|Overall Study||15
8433736|NCT00837447|20784967|P1|NOT COMPLETED|Overall Study||0
8433737|NCT00837447|20784967|P1|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
8433738|NCT00837447|20784967|P1|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
8433739|NCT00837434|20784974|P2|NOT COMPLETED|Overall Study||1
8433740|NCT00837434|20784975|P1|NOT COMPLETED|Overall Study||9
8433741|NCT00837434|20784974|P2|COMPLETED|Overall Study||19
8433742|NCT00837434|20784975|P1|COMPLETED|Overall Study||34
8433743|NCT00837434|20784974|P2|STARTED|Overall Study||20
8433744|NCT00837434|20784975|P1|STARTED|Overall Study||43
8433745|NCT00837330|20784995|P2|NOT COMPLETED|Overall Study||3
8433746|NCT00837330|20784996|P1|NOT COMPLETED|Overall Study||1
8433747|NCT00837330|20784995|P2|COMPLETED|Overall Study||7
8433748|NCT00837330|20784996|P1|COMPLETED|Overall Study||9
8433749|NCT00837330|20784995|P2|STARTED|Overall Study||10
8433750|NCT00837330|20784996|P1|STARTED|Overall Study||10
8433751|NCT00837252|20785002|P1|NOT COMPLETED|Overall Study||0
8433752|NCT00837252|20785002|P1|COMPLETED|Overall Study||5
8433753|NCT00837252|20785002|P1|STARTED|Overall Study||5
8433754|NCT00837213|20785019|P2|NOT COMPLETED|Overall Study||5
8433755|NCT00837213|20785020|P1|NOT COMPLETED|Overall Study||6
8433756|NCT00837213|20785019|P2|COMPLETED|Overall Study||12
8433757|NCT00837213|20785020|P1|COMPLETED|Overall Study||10
8433758|NCT00837213|20785019|P2|STARTED|Overall Study||17
8433759|NCT00837213|20785020|P1|STARTED|Overall Study||16
8433760|NCT00837200|20785040|P1|NOT COMPLETED|Overall Study||0
8433761|NCT00837200|20785040|P1|COMPLETED|Overall Study||13
8433762|NCT00837200|20785040|P1|STARTED|Overall Study||13
8433763|NCT00837161|20785046|P1|NOT COMPLETED|Overall Study||2
8433764|NCT00837161|20785046|P1|COMPLETED|Overall Study||9
8433765|NCT00837161|20785046|P1|STARTED|Overall Study||11
8433766|NCT00837148|20785054|P1|NOT COMPLETED|Overall Study||2
8433767|NCT00837148|20785054|P1|COMPLETED|Overall Study||35
8433768|NCT00837148|20785054|P1|STARTED|Overall Study||37
8433769|NCT00837096|20785060|P2|NOT COMPLETED|Overall Study||9
8433770|NCT00837096|20785061|P1|NOT COMPLETED|Overall Study||10
8433771|NCT00837096|20785060|P2|COMPLETED|Overall Study||0
8433772|NCT00837096|20785061|P1|COMPLETED|Overall Study||0
8433773|NCT00837096|20785060|P2|STARTED|Overall Study||9
8433774|NCT00837096|20785061|P1|STARTED|Overall Study||10
8433775|NCT00837031|20785067|P1|NOT COMPLETED|Overall Study||0
8433776|NCT00837031|20785067|P1|COMPLETED|Overall Study||72
8433777|NCT00837031|20785067|P1|STARTED|Overall Study||72
8433778|NCT00836953|20785073|P1|NOT COMPLETED|Overall Study||2
8433779|NCT00836953|20785073|P1|COMPLETED|Overall Study||31
8433780|NCT00836953|20785073|P1|STARTED|Overall Study||33
8433781|NCT00836927|20785084|P5|NOT COMPLETED|Overall Study||1
8433782|NCT00836927|20785085|P4|NOT COMPLETED|Overall Study||1
8433783|NCT00836927|20785086|P3|NOT COMPLETED|Overall Study||0
8433784|NCT00836927|20785087|P2|NOT COMPLETED|Overall Study||0
8433785|NCT00836927|20785088|P1|NOT COMPLETED|Overall Study||3
8433786|NCT00836927|20785084|P5|COMPLETED|Overall Study||0
8433787|NCT00836927|20785085|P4|COMPLETED|Overall Study||0
8433788|NCT00836927|20785086|P3|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
8433789|NCT00836927|20785087|P2|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
8433790|NCT00836927|20785088|P1|COMPLETED|Overall Study||0
8433791|NCT00836927|20785084|P5|Completed Dosing Through 03 Apr 2017|Overall Study||0
8433792|NCT00836927|20785085|P4|Completed Dosing Through 03 Apr 2017|Overall Study||0
8433793|NCT00836927|20785086|P3|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
8433794|NCT00836927|20785087|P2|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
8433795|NCT00836927|20785088|P1|Completed Dosing Through 03 Apr 2017|Overall Study||0
8433796|NCT00836927|20785084|P5|STARTED|Overall Study||1
8433797|NCT00836927|20785085|P4|STARTED|Overall Study||1
8433798|NCT00836927|20785086|P3|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
8433799|NCT00836927|20785087|P2|STARTED|Overall Study||1
8433800|NCT00836927|20785088|P1|STARTED|Overall Study||3
8433801|NCT00836901|20785124|P2|NOT COMPLETED|Second Intervention||0
8433802|NCT00836901|20785125|P1|NOT COMPLETED|Second Intervention||0
8433803|NCT00836901|20785124|P2|COMPLETED|Second Intervention||28
8433804|NCT00836901|20785125|P1|COMPLETED|Second Intervention||23
8433805|NCT00836901|20785124|P2|STARTED|Second Intervention||28
8433806|NCT00836901|20785125|P1|STARTED|Second Intervention||23
8433807|NCT00836901|20785124|P2|NOT COMPLETED|First Intervention||0
8433808|NCT00836901|20785125|P1|NOT COMPLETED|First Intervention||1
8433809|NCT00836901|20785124|P2|COMPLETED|First Intervention||28
8433810|NCT00836901|20785125|P1|COMPLETED|First Intervention||23
8433811|NCT00836901|20785124|P2|STARTED|First Intervention||28
8433812|NCT00836901|20785125|P1|STARTED|First Intervention||24
8433813|NCT00836888|20785143|P4|NOT COMPLETED|Overall Study||3
8433814|NCT00836888|20785144|P3|NOT COMPLETED|Overall Study||6
8433815|NCT00836888|20785145|P2|NOT COMPLETED|Overall Study||3
8433816|NCT00836888|20785146|P1|NOT COMPLETED|Overall Study||3
8433817|NCT00836888|20785143|P4|COMPLETED|Overall Study||0
8433818|NCT00836888|20785144|P3|COMPLETED|Overall Study||0
8433819|NCT00836888|20785145|P2|COMPLETED|Overall Study||2
8433820|NCT00836888|20785146|P1|COMPLETED|Overall Study||0
8433821|NCT00836888|20785143|P4|STARTED|Overall Study||3
8433822|NCT00836888|20785144|P3|STARTED|Overall Study||6
8433823|NCT00836888|20785145|P2|STARTED|Overall Study||5
8433824|NCT00836888|20785146|P1|STARTED|Overall Study||3
8433825|NCT00836875|20785174|P2|NOT COMPLETED|Overall Study||3
8433826|NCT00836875|20785175|P1|NOT COMPLETED|Overall Study||3
8433827|NCT00836875|20785174|P2|COMPLETED|Overall Study||17
8433828|NCT00836875|20785175|P1|COMPLETED|Overall Study||8
8433829|NCT00836875|20785174|P2|STARTED|Overall Study||20
8433830|NCT00836875|20785175|P1|STARTED|Overall Study||11
8433831|NCT00836810|20785191|P2|NOT COMPLETED|Overall Study||0
8433832|NCT00836810|20785192|P1|NOT COMPLETED|Overall Study||1
8433833|NCT00836810|20785191|P2|COMPLETED|Overall Study||6
8433834|NCT00836810|20785192|P1|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
8433835|NCT00836810|20785191|P2|STARTED|Overall Study||6
8433836|NCT00836810|20785192|P1|STARTED|Overall Study||5
8433837|NCT00836758|20785208|P1|NOT COMPLETED|Overall Study||0
8433838|NCT00836758|20785208|P1|COMPLETED|Overall Study||115
8433839|NCT00836758|20785208|P1|STARTED|Overall Study||115
8433840|NCT00836745|20785214|P1|NOT COMPLETED|Overall Study||21
8433841|NCT00836745|20785214|P1|COMPLETED|Overall Study||15
8433842|NCT00836745|20785214|P1|STARTED|Overall Study||36
8433843|NCT00836719|20785221|P1|NOT COMPLETED|Overall Study||0
8433844|NCT00836719|20785221|P1|COMPLETED|Overall Study||10
8433845|NCT00836719|20785221|P1|STARTED|Overall Study||10
8433846|NCT00836706|20785228|P2|NOT COMPLETED|Second Intervention||0
8433847|NCT00836706|20785229|P1|NOT COMPLETED|Second Intervention||0
8433848|NCT00836706|20785228|P2|COMPLETED|Second Intervention||11
8433849|NCT00836706|20785229|P1|COMPLETED|Second Intervention||11
8433850|NCT00836706|20785228|P2|STARTED|Second Intervention||11
8433851|NCT00836706|20785229|P1|STARTED|Second Intervention||11
8433852|NCT00836706|20785228|P2|NOT COMPLETED|Washout: 7 Days||1
8433853|NCT00836706|20785229|P1|NOT COMPLETED|Washout: 7 Days||0
8433854|NCT00836706|20785228|P2|COMPLETED|Washout: 7 Days||11
8433855|NCT00836706|20785229|P1|COMPLETED|Washout: 7 Days||11
8433856|NCT00836706|20785228|P2|STARTED|Washout: 7 Days||12
8433857|NCT00836706|20785229|P1|STARTED|Washout: 7 Days||11
8433858|NCT00836706|20785228|P2|NOT COMPLETED|First Intervention||0
8433859|NCT00836706|20785229|P1|NOT COMPLETED|First Intervention||0
8433860|NCT00836706|20785228|P2|COMPLETED|First Intervention||12
8433861|NCT00836706|20785229|P1|COMPLETED|First Intervention||11
8433862|NCT00836706|20785228|P2|STARTED|First Intervention||12
8433863|NCT00836706|20785229|P1|STARTED|First Intervention||11
8433864|NCT00836693|20785239|P2|NOT COMPLETED|Overall Study||6
8433865|NCT00836693|20785240|P1|NOT COMPLETED|Overall Study||17
8433866|NCT00836693|20785239|P2|COMPLETED|Overall Study||64
8433867|NCT00836693|20785240|P1|COMPLETED|Overall Study||130
8433868|NCT00836693|20785239|P2|STARTED|Overall Study||70
8433869|NCT00836693|20785240|P1|STARTED|Overall Study||147
8433870|NCT00836641|20785282|P2|NOT COMPLETED|Overall Study||0
8433871|NCT00836641|20785283|P1|NOT COMPLETED|Overall Study||0
8433872|NCT00836641|20785282|P2|COMPLETED|Overall Study||34
8433873|NCT00836641|20785283|P1|COMPLETED|Overall Study||36
8433874|NCT00836641|20785282|P2|STARTED|Overall Study||34
8433875|NCT00836641|20785283|P1|STARTED|Overall Study||36
8433876|NCT00836589|20785290|P1|NOT COMPLETED|Overall Study||1266
8433877|NCT00836589|20785290|P1|COMPLETED|Overall Study||731
8433878|NCT00836589|20785290|P1|STARTED|Overall Study||1997
8433879|NCT00836498|20785323|P2|NOT COMPLETED|Overall Study||1
8433880|NCT00836498|20785324|P1|NOT COMPLETED|Overall Study||4
8433881|NCT00836498|20785323|P2|COMPLETED|Overall Study||21
8433882|NCT00836498|20785324|P1|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
8433883|NCT00836498|20785323|P2|STARTED|Overall Study||22
8433884|NCT00836498|20785324|P1|STARTED|Overall Study||44
8433885|NCT00836472|20785356|P2|NOT COMPLETED|Second Intervention||0
8433886|NCT00836472|20785357|P1|NOT COMPLETED|Second Intervention||0
8433887|NCT00836472|20785356|P2|COMPLETED|Second Intervention||27
8433888|NCT00836472|20785357|P1|COMPLETED|Second Intervention||28
8433889|NCT00836472|20785356|P2|STARTED|Second Intervention||27
8433890|NCT00836472|20785357|P1|STARTED|Second Intervention||28
8433891|NCT00836472|20785356|P2|NOT COMPLETED|Washout||3
8433892|NCT00836472|20785357|P1|NOT COMPLETED|Washout||2
8433893|NCT00836472|20785356|P2|COMPLETED|Washout||27
8433894|NCT00836472|20785357|P1|COMPLETED|Washout||28
8433895|NCT00836472|20785356|P2|STARTED|Washout||30
8433896|NCT00836472|20785357|P1|STARTED|Washout||30
8433897|NCT00836472|20785356|P2|NOT COMPLETED|First Intervention||0
8433898|NCT00836472|20785357|P1|NOT COMPLETED|First Intervention||0
8433899|NCT00836472|20785356|P2|COMPLETED|First Intervention||30
8433900|NCT00836472|20785357|P1|COMPLETED|First Intervention||30
8433901|NCT00836472|20785356|P2|STARTED|First Intervention||30
8433902|NCT00836472|20785357|P1|STARTED|First Intervention||30
8433903|NCT00836433|20785373|P2|NOT COMPLETED|Overall Study||7
8433904|NCT00836433|20785374|P1|NOT COMPLETED|Overall Study||12
8433905|NCT00836433|20785373|P2|COMPLETED|Overall Study||321
8433906|NCT00836433|20785374|P1|COMPLETED|Overall Study||349
8433907|NCT00836433|20785373|P2|STARTED|Overall Study||328
8433908|NCT00836433|20785374|P1|STARTED|Overall Study||361
8433909|NCT00836407|20785384|P2|NOT COMPLETED|Overall Study||8
8433910|NCT00836407|20785385|P1|NOT COMPLETED|Overall Study||11
8433911|NCT00836407|20785384|P2|COMPLETED|Overall Study||7
8433912|NCT00836407|20785385|P1|COMPLETED|Overall Study||4
8433913|NCT00836407|20785384|P2|STARTED|Overall Study||15
8433914|NCT00836407|20785385|P1|STARTED|Overall Study||15
8433915|NCT00836355|20785397|P4|NOT COMPLETED|Overall Study||0
8433916|NCT00836355|20785398|P3|NOT COMPLETED|Overall Study||0
8433917|NCT00836355|20785399|P2|NOT COMPLETED|Overall Study||0
8433918|NCT00836355|20785400|P1|NOT COMPLETED|Overall Study||0
8433919|NCT00836355|20785397|P4|COMPLETED|Overall Study||2
8433920|NCT00836355|20785398|P3|COMPLETED|Overall Study||0
8433921|NCT00836355|20785399|P2|COMPLETED|Overall Study||4
8433922|NCT00836355|20785400|P1|COMPLETED|Overall Study||0
8433923|NCT00836355|20785397|P4|STARTED|Overall Study||2
8433924|NCT00836355|20785398|P3|STARTED|Overall Study||0
8433925|NCT00836355|20785399|P2|STARTED|Overall Study||4
8433926|NCT00836355|20785400|P1|STARTED|Overall Study||0
8433927|NCT00836342|20785421|P3|NOT COMPLETED|Overall Study||0
8433928|NCT00836342|20785422|P2|NOT COMPLETED|Overall Study||0
8433929|NCT00836342|20785423|P1|NOT COMPLETED|Overall Study||0
8433930|NCT00836342|20785421|P3|COMPLETED|Overall Study||36
8433931|NCT00836342|20785422|P2|COMPLETED|Overall Study||23
8433932|NCT00836342|20785423|P1|COMPLETED|Overall Study||22
8433933|NCT00836342|20785421|P3|STARTED|Overall Study||36
8433934|NCT00836342|20785422|P2|STARTED|Overall Study||23
8433935|NCT00836342|20785423|P1|STARTED|Overall Study||22
8433936|NCT00836277|20785434|P1|NOT COMPLETED|Overall Study||6
8433937|NCT00836277|20785434|P1|COMPLETED|Overall Study||18
8433938|NCT00836277|20785434|P1|STARTED|Overall Study||24
8433939|NCT00836186|20785442|P1|NOT COMPLETED|Overall Study||1
8433940|NCT00836186|20785442|P1|COMPLETED|Overall Study||81
8433941|NCT00836186|20785442|P1|STARTED|Overall Study||82
8433942|NCT00836095|20785450|P2|NOT COMPLETED|Overall Study||3
8433943|NCT00836095|20785451|P1|NOT COMPLETED|Overall Study||0
8433944|NCT00836095|20785450|P2|COMPLETED|Overall Study||27
8433945|NCT00836095|20785451|P1|COMPLETED|Overall Study||22
8433946|NCT00836095|20785450|P2|STARTED|Overall Study||30
8433947|NCT00836095|20785451|P1|STARTED|Overall Study||22
8433948|NCT00836056|20785461|P2|NOT COMPLETED|Second Intervention||0
8433949|NCT00836056|20785462|P1|NOT COMPLETED|Second Intervention||0
8433950|NCT00836056|20785461|P2|COMPLETED|Second Intervention||12
8433951|NCT00836056|20785462|P1|COMPLETED|Second Intervention||11
8433952|NCT00836056|20785461|P2|STARTED|Second Intervention||12
8433953|NCT00836056|20785462|P1|STARTED|Second Intervention||11
8433954|NCT00836056|20785461|P2|NOT COMPLETED|Washout: 7 Days||0
8433955|NCT00836056|20785462|P1|NOT COMPLETED|Washout: 7 Days||0
8433956|NCT00836056|20785461|P2|COMPLETED|Washout: 7 Days||12
8433957|NCT00836056|20785462|P1|COMPLETED|Washout: 7 Days||11
8433958|NCT00836056|20785461|P2|STARTED|Washout: 7 Days||12
8433959|NCT00836056|20785462|P1|STARTED|Washout: 7 Days||11
8433960|NCT00836056|20785461|P2|NOT COMPLETED|First Intervention||0
8433961|NCT00836056|20785462|P1|NOT COMPLETED|First Intervention||1
8433962|NCT00836056|20785461|P2|COMPLETED|First Intervention||12
8433963|NCT00836056|20785462|P1|COMPLETED|First Intervention||11
8433964|NCT00836056|20785461|P2|STARTED|First Intervention||12
8433965|NCT00836056|20785462|P1|STARTED|First Intervention||12
8433966|NCT00836017|20785470|P1|NOT COMPLETED|Overall Study||544
8433967|NCT00836017|20785470|P1|COMPLETED|Overall Study||502
8433968|NCT00836017|20785470|P1|STARTED|Overall Study||1046
8433969|NCT00836004|20785480|P2|NOT COMPLETED|Second Intervention||0
8433970|NCT00836004|20785481|P1|NOT COMPLETED|Second Intervention||0
8433971|NCT00836004|20785480|P2|COMPLETED|Second Intervention||12
8433972|NCT00836004|20785481|P1|COMPLETED|Second Intervention||12
8433973|NCT00836004|20785480|P2|STARTED|Second Intervention||12
8433974|NCT00836004|20785481|P1|STARTED|Second Intervention||12
8433975|NCT00836004|20785480|P2|NOT COMPLETED|Washout: 7 Days||0
8433976|NCT00836004|20785481|P1|NOT COMPLETED|Washout: 7 Days||0
8433977|NCT00836004|20785480|P2|COMPLETED|Washout: 7 Days||12
8433978|NCT00836004|20785481|P1|COMPLETED|Washout: 7 Days||12
8433979|NCT00836004|20785480|P2|STARTED|Washout: 7 Days||12
8433980|NCT00836004|20785481|P1|STARTED|Washout: 7 Days||12
8433981|NCT00836004|20785480|P2|NOT COMPLETED|First Intervention||0
8433982|NCT00836004|20785481|P1|NOT COMPLETED|First Intervention||0
8433983|NCT00836004|20785480|P2|COMPLETED|First Intervention||12
8433984|NCT00836004|20785481|P1|COMPLETED|First Intervention||12
8433985|NCT00836004|20785480|P2|STARTED|First Intervention||12
8433986|NCT00836004|20785481|P1|STARTED|First Intervention||12
8433987|NCT00835991|20785491|P2|NOT COMPLETED|Second Intervention||0
8433988|NCT00835991|20785492|P1|NOT COMPLETED|Second Intervention||0
8433989|NCT00835991|20785491|P2|COMPLETED|Second Intervention||26
8433990|NCT00835991|20785492|P1|COMPLETED|Second Intervention||27
8433991|NCT00835991|20785491|P2|STARTED|Second Intervention||26
8433992|NCT00835991|20785492|P1|STARTED|Second Intervention||27
8433993|NCT00835991|20785491|P2|NOT COMPLETED|Washout||3
8433994|NCT00835991|20785492|P1|NOT COMPLETED|Washout||3
8433995|NCT00835991|20785491|P2|COMPLETED|Washout||26
8433996|NCT00835991|20785492|P1|COMPLETED|Washout||27
8433997|NCT00835991|20785491|P2|STARTED|Washout||29
8433998|NCT00835991|20785492|P1|STARTED|Washout||30
8433999|NCT00835991|20785491|P2|NOT COMPLETED|First Intervention||1
8434000|NCT00835991|20785492|P1|NOT COMPLETED|First Intervention||0
8434001|NCT00835991|20785491|P2|COMPLETED|First Intervention||29
8434002|NCT00835991|20785492|P1|COMPLETED|First Intervention||30
8434003|NCT00835991|20785491|P2|STARTED|First Intervention||30
8434004|NCT00835991|20785492|P1|STARTED|First Intervention||30
8434005|NCT00835978|20785510|P4|NOT COMPLETED|Overall Study||10
8434006|NCT00835978|20785511|P3|NOT COMPLETED|Overall Study||91
8434007|NCT00835978|20785512|P2|NOT COMPLETED|Overall Study||56
8434008|NCT00835978|20785513|P1|NOT COMPLETED|Overall Study||56
8434100|NCT00835679|20785786|P3|NOT COMPLETED|Overall Study||0
8434009|NCT00835978|20785510|P4|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
8434010|NCT00835978|20785511|P3|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
8434011|NCT00835978|20785512|P2|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
8434012|NCT00835978|20785513|P1|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
8434013|NCT00835978|20785510|P4|Treated|Overall Study||10
8434014|NCT00835978|20785511|P3|Treated|Overall Study||91
8434015|NCT00835978|20785512|P2|Treated|Overall Study||56
8434016|NCT00835978|20785513|P1|Treated|Overall Study||56
8434017|NCT00835978|20785510|P4|STARTED|Overall Study||10
8434018|NCT00835978|20785511|P3|STARTED|Overall Study||91
8434019|NCT00835978|20785512|P2|STARTED|Overall Study||56
8434020|NCT00835978|20785513|P1|STARTED|Overall Study||56
8434021|NCT00835926|20785573|P2|NOT COMPLETED|Overall Study||0
8434022|NCT00835926|20785574|P1|NOT COMPLETED|Overall Study||0
8434023|NCT00835926|20785573|P2|COMPLETED|Overall Study||60
8434024|NCT00835926|20785574|P1|COMPLETED|Overall Study||61
8434025|NCT00835926|20785573|P2|STARTED|Overall Study||60
8434026|NCT00835926|20785574|P1|STARTED|Overall Study||61
8434027|NCT00835900|20785588|P2|NOT COMPLETED|Overall Study||6
8434028|NCT00835900|20785589|P1|NOT COMPLETED|Overall Study||5
8434029|NCT00835900|20785588|P2|COMPLETED|Overall Study||22
8434030|NCT00835900|20785589|P1|COMPLETED|Overall Study||27
8434031|NCT00835900|20785588|P2|STARTED|Overall Study||28
8434032|NCT00835900|20785589|P1|STARTED|Overall Study||32
8434033|NCT00835861|20785599|P2|NOT COMPLETED|Overall Study||2
8434034|NCT00835861|20785600|P1|NOT COMPLETED|Overall Study||1
8434035|NCT00835861|20785599|P2|COMPLETED|Overall Study||14
8434036|NCT00835861|20785600|P1|COMPLETED|Overall Study||14
8434037|NCT00835861|20785599|P2|STARTED|Overall Study||16
8434038|NCT00835861|20785600|P1|STARTED|Overall Study||15
8434039|NCT00835796|20785624|P2|NOT COMPLETED|Second Intervention||0
8434040|NCT00835796|20785625|P1|NOT COMPLETED|Second Intervention||0
8434041|NCT00835796|20785624|P2|COMPLETED|Second Intervention||9
8434042|NCT00835796|20785625|P1|COMPLETED|Second Intervention||10
8434043|NCT00835796|20785624|P2|STARTED|Second Intervention||9
8434044|NCT00835796|20785625|P1|STARTED|Second Intervention||10
8434045|NCT00835796|20785624|P2|NOT COMPLETED|Washout||0
8434046|NCT00835796|20785625|P1|NOT COMPLETED|Washout||0
8434047|NCT00835796|20785624|P2|COMPLETED|Washout||9
8434048|NCT00835796|20785625|P1|COMPLETED|Washout||10
8434049|NCT00835796|20785624|P2|STARTED|Washout||9
8434050|NCT00835796|20785625|P1|STARTED|Washout||10
8434051|NCT00835796|20785624|P2|NOT COMPLETED|First Intervention||1
8434052|NCT00835796|20785625|P1|NOT COMPLETED|First Intervention||0
8434053|NCT00835796|20785624|P2|COMPLETED|First Intervention||9
8434054|NCT00835796|20785625|P1|COMPLETED|First Intervention||10
8434055|NCT00835796|20785624|P2|STARTED|First Intervention||10
8434056|NCT00835796|20785625|P1|STARTED|First Intervention||10
8434057|NCT00835770|20785635|P2|NOT COMPLETED|Overall Study||493
8434058|NCT00835770|20785636|P1|NOT COMPLETED|Overall Study||484
8434059|NCT00835770|20785635|P2|COMPLETED|Overall Study||375
8434060|NCT00835770|20785636|P1|COMPLETED|Overall Study||384
8434061|NCT00835770|20785635|P2|STARTED|Overall Study||868
8434062|NCT00835770|20785636|P1|STARTED|Overall Study||868
8434063|NCT00835731|20785734|P2|NOT COMPLETED|Overall Study||1
8434064|NCT00835731|20785735|P1|NOT COMPLETED|Overall Study||2
8434065|NCT00835731|20785734|P2|COMPLETED|Overall Study||60
8434066|NCT00835731|20785735|P1|COMPLETED|Overall Study||62
8434067|NCT00835731|20785734|P2|STARTED|Overall Study||61
8434068|NCT00835731|20785735|P1|STARTED|Overall Study||64
8434069|NCT00835705|20785755|P2|NOT COMPLETED|Second Intervention||0
8434070|NCT00835705|20785756|P1|NOT COMPLETED|Second Intervention||1
8434071|NCT00835705|20785755|P2|COMPLETED|Second Intervention||28
8434072|NCT00835705|20785756|P1|COMPLETED|Second Intervention||22
8434073|NCT00835705|20785755|P2|STARTED|Second Intervention||28
8434074|NCT00835705|20785756|P1|STARTED|Second Intervention||23
8434075|NCT00835705|20785755|P2|NOT COMPLETED|First Intervention||0
8434076|NCT00835705|20785756|P1|NOT COMPLETED|First Intervention||1
8434077|NCT00835705|20785755|P2|COMPLETED|First Intervention||28
8434078|NCT00835705|20785756|P1|COMPLETED|First Intervention||23
8434079|NCT00835705|20785755|P2|STARTED|First Intervention||28
8434080|NCT00835705|20785756|P1|STARTED|First Intervention||24
8434081|NCT00835692|20785772|P2|NOT COMPLETED|Second Intervention||0
8434082|NCT00835692|20785773|P1|NOT COMPLETED|Second Intervention||0
8434083|NCT00835692|20785772|P2|COMPLETED|Second Intervention||28
8434084|NCT00835692|20785773|P1|COMPLETED|Second Intervention||27
8434085|NCT00835692|20785772|P2|STARTED|Second Intervention||28
8434086|NCT00835692|20785773|P1|STARTED|Second Intervention||27
8434087|NCT00835692|20785772|P2|NOT COMPLETED|Washout||0
8434088|NCT00835692|20785773|P1|NOT COMPLETED|Washout||0
8434089|NCT00835692|20785772|P2|COMPLETED|Washout||28
8434090|NCT00835692|20785773|P1|COMPLETED|Washout||27
8434091|NCT00835692|20785772|P2|STARTED|Washout||28
8434092|NCT00835692|20785773|P1|STARTED|Washout||27
8434093|NCT00835692|20785772|P2|NOT COMPLETED|First Intervention||0
8434094|NCT00835692|20785773|P1|NOT COMPLETED|First Intervention||1
8434095|NCT00835692|20785772|P2|COMPLETED|First Intervention||28
8434096|NCT00835692|20785773|P1|COMPLETED|First Intervention||27
8434097|NCT00835692|20785772|P2|STARTED|First Intervention||28
8434098|NCT00835692|20785773|P1|STARTED|First Intervention||28
8434099|NCT00835679|20785785|P4|NOT COMPLETED|Overall Study||0
8434101|NCT00835679|20785787|P2|NOT COMPLETED|Overall Study||0
8434102|NCT00835679|20785788|P1|NOT COMPLETED|Overall Study||1
8434103|NCT00835679|20785785|P4|COMPLETED|Overall Study||0
8434104|NCT00835679|20785786|P3|COMPLETED|Overall Study||0
8434105|NCT00835679|20785787|P2|COMPLETED|Overall Study||0
8434106|NCT00835679|20785788|P1|COMPLETED|Overall Study||8
8434107|NCT00835679|20785785|P4|STARTED|Overall Study||0
8434108|NCT00835679|20785786|P3|STARTED|Overall Study||0
8434109|NCT00835679|20785787|P2|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
8434110|NCT00835679|20785788|P1|STARTED|Overall Study||9
8434111|NCT00835666|20785812|P2|NOT COMPLETED|Second Intervention||0
8434112|NCT00835666|20785813|P1|NOT COMPLETED|Second Intervention||0
8434113|NCT00835666|20785812|P2|COMPLETED|Second Intervention||16
8434114|NCT00835666|20785813|P1|COMPLETED|Second Intervention||14
8434115|NCT00835666|20785812|P2|STARTED|Second Intervention||16
8434116|NCT00835666|20785813|P1|STARTED|Second Intervention||14
8434117|NCT00835666|20785812|P2|NOT COMPLETED|Washout||0
8434118|NCT00835666|20785813|P1|NOT COMPLETED|Washout||2
8434119|NCT00835666|20785812|P2|COMPLETED|Washout||16
8434120|NCT00835666|20785813|P1|COMPLETED|Washout||14
8434121|NCT00835666|20785812|P2|STARTED|Washout||16
8434122|NCT00835666|20785813|P1|STARTED|Washout||16
8434123|NCT00835666|20785812|P2|NOT COMPLETED|First Intervention||0
8434124|NCT00835666|20785813|P1|NOT COMPLETED|First Intervention||0
8434125|NCT00835666|20785812|P2|COMPLETED|First Intervention||16
8434126|NCT00835666|20785813|P1|COMPLETED|First Intervention||16
8434127|NCT00835666|20785812|P2|STARTED|First Intervention||16
8434128|NCT00835666|20785813|P1|STARTED|First Intervention||16
8434129|NCT00835640|20785823|P2|NOT COMPLETED|Second Intervention||0
8434130|NCT00835640|20785824|P1|NOT COMPLETED|Second Intervention||1
8434131|NCT00835640|20785823|P2|COMPLETED|Second Intervention||12
8434132|NCT00835640|20785824|P1|COMPLETED|Second Intervention||11
8434133|NCT00835640|20785823|P2|STARTED|Second Intervention||12
8434134|NCT00835640|20785824|P1|STARTED|Second Intervention||12
8434135|NCT00835640|20785823|P2|NOT COMPLETED|Washout of 7 Days||0
8434136|NCT00835640|20785824|P1|NOT COMPLETED|Washout of 7 Days||0
8434137|NCT00835640|20785823|P2|COMPLETED|Washout of 7 Days||12
8434138|NCT00835640|20785824|P1|COMPLETED|Washout of 7 Days||12
8434139|NCT00835640|20785823|P2|STARTED|Washout of 7 Days||12
8434140|NCT00835640|20785824|P1|STARTED|Washout of 7 Days||12
8434141|NCT00835640|20785823|P2|NOT COMPLETED|First Intervention||0
8434142|NCT00835640|20785824|P1|NOT COMPLETED|First Intervention||0
8434143|NCT00835640|20785823|P2|COMPLETED|First Intervention||12
8434144|NCT00835640|20785824|P1|COMPLETED|First Intervention||12
8434145|NCT00835640|20785823|P2|STARTED|First Intervention||12
8434146|NCT00835640|20785824|P1|STARTED|First Intervention||12
8434147|NCT00835614|20785834|P2|NOT COMPLETED|Second Intervention||0
8434148|NCT00835614|20785835|P1|NOT COMPLETED|Second Intervention||0
8434149|NCT00835614|20785834|P2|COMPLETED|Second Intervention||13
8434150|NCT00835614|20785835|P1|COMPLETED|Second Intervention||13
8434151|NCT00835614|20785834|P2|STARTED|Second Intervention||13
8434152|NCT00835614|20785835|P1|STARTED|Second Intervention||13
8434153|NCT00835614|20785834|P2|NOT COMPLETED|Washout of 7 Days||0
8434154|NCT00835614|20785835|P1|NOT COMPLETED|Washout of 7 Days||0
8434155|NCT00835614|20785834|P2|COMPLETED|Washout of 7 Days||13
8434156|NCT00835614|20785835|P1|COMPLETED|Washout of 7 Days||13
8434157|NCT00835614|20785834|P2|STARTED|Washout of 7 Days||13
8434158|NCT00835614|20785835|P1|STARTED|Washout of 7 Days||13
8434159|NCT00835614|20785834|P2|NOT COMPLETED|First Intervention||0
8434160|NCT00835614|20785835|P1|NOT COMPLETED|First Intervention||0
8434161|NCT00835614|20785834|P2|COMPLETED|First Intervention||13
8434162|NCT00835614|20785835|P1|COMPLETED|First Intervention||13
8434163|NCT00835614|20785834|P2|STARTED|First Intervention||13
8434164|NCT00835614|20785835|P1|STARTED|First Intervention||13
8434165|NCT00835588|20785845|P2|NOT COMPLETED|Second Intervention||0
8434166|NCT00835588|20785846|P1|NOT COMPLETED|Second Intervention||0
8434167|NCT00835588|20785845|P2|COMPLETED|Second Intervention||50
8434168|NCT00835588|20785846|P1|COMPLETED|Second Intervention||50
8434169|NCT00835588|20785845|P2|STARTED|Second Intervention||50
8434170|NCT00835588|20785846|P1|STARTED|Second Intervention||50
8434171|NCT00835588|20785845|P2|NOT COMPLETED|Washout: 5 Days||0
8434172|NCT00835588|20785846|P1|NOT COMPLETED|Washout: 5 Days||0
8434173|NCT00835588|20785845|P2|COMPLETED|Washout: 5 Days||50
8434174|NCT00835588|20785846|P1|COMPLETED|Washout: 5 Days||50
8434175|NCT00835588|20785845|P2|STARTED|Washout: 5 Days||50
8434176|NCT00835588|20785846|P1|STARTED|Washout: 5 Days||50
8434177|NCT00835588|20785845|P2|NOT COMPLETED|First Intervention||0
8434178|NCT00835588|20785846|P1|NOT COMPLETED|First Intervention||0
8434179|NCT00835588|20785845|P2|COMPLETED|First Intervention||50
8434180|NCT00835588|20785846|P1|COMPLETED|First Intervention||50
8434181|NCT00835588|20785845|P2|STARTED|First Intervention||50
8434182|NCT00835588|20785846|P1|STARTED|First Intervention||50
8434183|NCT00835575|20785856|P2|NOT COMPLETED|Second Intervention||0
8434184|NCT00835575|20785857|P1|NOT COMPLETED|Second Intervention||0
8434185|NCT00835575|20785856|P2|COMPLETED|Second Intervention||16
8434186|NCT00835575|20785857|P1|COMPLETED|Second Intervention||15
8434187|NCT00835575|20785856|P2|STARTED|Second Intervention||16
8434188|NCT00835575|20785857|P1|STARTED|Second Intervention||15
8434189|NCT00835575|20785856|P2|NOT COMPLETED|Washout of 14 Days||0
8434190|NCT00835575|20785857|P1|NOT COMPLETED|Washout of 14 Days||1
8434191|NCT00835575|20785856|P2|COMPLETED|Washout of 14 Days||16
8434192|NCT00835575|20785857|P1|COMPLETED|Washout of 14 Days||15
8434193|NCT00835575|20785856|P2|STARTED|Washout of 14 Days||16
8434194|NCT00835575|20785857|P1|STARTED|Washout of 14 Days||16
8434195|NCT00835575|20785856|P2|NOT COMPLETED|First Intervention||0
8434196|NCT00835575|20785857|P1|NOT COMPLETED|First Intervention||0
8434197|NCT00835575|20785856|P2|COMPLETED|First Intervention||16
8434198|NCT00835575|20785857|P1|COMPLETED|First Intervention||16
8434199|NCT00835575|20785856|P2|STARTED|First Intervention||16
8434200|NCT00835575|20785857|P1|STARTED|First Intervention||16
8434201|NCT00835549|20785867|P2|NOT COMPLETED|Second Intervention||0
8434202|NCT00835549|20785868|P1|NOT COMPLETED|Second Intervention||0
8434203|NCT00835549|20785867|P2|COMPLETED|Second Intervention||16
8434204|NCT00835549|20785868|P1|COMPLETED|Second Intervention||14
8434205|NCT00835549|20785867|P2|STARTED|Second Intervention||16
8434206|NCT00835549|20785868|P1|STARTED|Second Intervention||14
8434207|NCT00835549|20785867|P2|NOT COMPLETED|Washout of 7 Days||0
8434208|NCT00835549|20785868|P1|NOT COMPLETED|Washout of 7 Days||2
8434209|NCT00835549|20785867|P2|COMPLETED|Washout of 7 Days||16
8434210|NCT00835549|20785868|P1|COMPLETED|Washout of 7 Days||14
8434211|NCT00835549|20785867|P2|STARTED|Washout of 7 Days||16
8434212|NCT00835549|20785868|P1|STARTED|Washout of 7 Days||16
8434213|NCT00835549|20785867|P2|NOT COMPLETED|First Intervention||0
8434214|NCT00835549|20785868|P1|NOT COMPLETED|First Intervention||0
8434215|NCT00835549|20785867|P2|COMPLETED|First Intervention||16
8434216|NCT00835549|20785868|P1|COMPLETED|First Intervention||16
8434217|NCT00835549|20785867|P2|STARTED|First Intervention||16
8434218|NCT00835549|20785868|P1|STARTED|First Intervention||16
8434219|NCT00835536|20785878|P2|NOT COMPLETED|Second Intervention||0
8434220|NCT00835536|20785879|P1|NOT COMPLETED|Second Intervention||0
8434221|NCT00835536|20785878|P2|COMPLETED|Second Intervention||14
8434222|NCT00835536|20785879|P1|COMPLETED|Second Intervention||12
8434223|NCT00835536|20785878|P2|STARTED|Second Intervention||14
8434224|NCT00835536|20785879|P1|STARTED|Second Intervention||12
8434225|NCT00835536|20785878|P2|NOT COMPLETED|Washout of 5 Weeks||0
8434226|NCT00835536|20785879|P1|NOT COMPLETED|Washout of 5 Weeks||1
8434227|NCT00835536|20785878|P2|COMPLETED|Washout of 5 Weeks||14
8434228|NCT00835536|20785879|P1|COMPLETED|Washout of 5 Weeks||12
8434229|NCT00835536|20785878|P2|STARTED|Washout of 5 Weeks||14
8434230|NCT00835536|20785879|P1|STARTED|Washout of 5 Weeks||13
8434231|NCT00835536|20785878|P2|NOT COMPLETED|First Intervention||0
8434232|NCT00835536|20785879|P1|NOT COMPLETED|First Intervention||0
8434233|NCT00835536|20785878|P2|COMPLETED|First Intervention||14
8434234|NCT00835536|20785879|P1|COMPLETED|First Intervention||13
8434235|NCT00835536|20785878|P2|STARTED|First Intervention||14
8434236|NCT00835536|20785879|P1|STARTED|First Intervention||13
8434237|NCT00835510|20785888|P3|NOT COMPLETED|Overall Study||38
8434238|NCT00835510|20785889|P2|NOT COMPLETED|Overall Study||69
8434239|NCT00835510|20785890|P1|NOT COMPLETED|Overall Study||76
8434240|NCT00835510|20785888|P3|COMPLETED|Overall Study||70
8434241|NCT00835510|20785889|P2|COMPLETED|Overall Study||152
8434242|NCT00835510|20785890|P1|COMPLETED|Overall Study||143
8434243|NCT00835510|20785888|P3|Positive Fungal Culture|Overall Study||71
8434244|NCT00835510|20785889|P2|Positive Fungal Culture|Overall Study||155
8434245|NCT00835510|20785890|P1|Positive Fungal Culture|Overall Study||149
8434246|NCT00835510|20785888|P3|STARTED|Overall Study||108
8434247|NCT00835510|20785889|P2|STARTED|Overall Study||221
8434248|NCT00835510|20785890|P1|STARTED|Overall Study||219
8434249|NCT00835497|20785912|P2|NOT COMPLETED|Second Intervention||0
8434250|NCT00835497|20785913|P1|NOT COMPLETED|Second Intervention||0
8434251|NCT00835497|20785912|P2|COMPLETED|Second Intervention||20
8434252|NCT00835497|20785913|P1|COMPLETED|Second Intervention||20
8434253|NCT00835497|20785912|P2|STARTED|Second Intervention||20
8434254|NCT00835497|20785913|P1|STARTED|Second Intervention||20
8434255|NCT00835497|20785912|P2|NOT COMPLETED|Washout: 7 Days||0
8434256|NCT00835497|20785913|P1|NOT COMPLETED|Washout: 7 Days||0
8434257|NCT00835497|20785912|P2|COMPLETED|Washout: 7 Days||20
8434258|NCT00835497|20785913|P1|COMPLETED|Washout: 7 Days||20
8434259|NCT00835497|20785912|P2|STARTED|Washout: 7 Days||20
8434260|NCT00835497|20785913|P1|STARTED|Washout: 7 Days||20
8434261|NCT00835497|20785912|P2|NOT COMPLETED|First Intervention||0
8434262|NCT00835497|20785913|P1|NOT COMPLETED|First Intervention||0
8434263|NCT00835497|20785912|P2|COMPLETED|First Intervention||20
8434264|NCT00835497|20785913|P1|COMPLETED|First Intervention||20
8434265|NCT00835497|20785912|P2|STARTED|First Intervention||20
8434266|NCT00835497|20785913|P1|STARTED|First Intervention||20
8434267|NCT00835484|20785929|P2|NOT COMPLETED|Second Intervention||0
8434268|NCT00835484|20785930|P1|NOT COMPLETED|Second Intervention||0
8434269|NCT00835484|20785929|P2|COMPLETED|Second Intervention||16
8434270|NCT00835484|20785930|P1|COMPLETED|Second Intervention||16
8434271|NCT00835484|20785929|P2|STARTED|Second Intervention||16
8434272|NCT00835484|20785930|P1|STARTED|Second Intervention||16
8434273|NCT00835484|20785929|P2|NOT COMPLETED|Washout of 7 Days||0
8434274|NCT00835484|20785930|P1|NOT COMPLETED|Washout of 7 Days||0
8434275|NCT00835484|20785929|P2|COMPLETED|Washout of 7 Days||16
8434276|NCT00835484|20785930|P1|COMPLETED|Washout of 7 Days||16
8434277|NCT00835484|20785929|P2|STARTED|Washout of 7 Days||16
8434278|NCT00835484|20785930|P1|STARTED|Washout of 7 Days||16
8434279|NCT00835484|20785929|P2|NOT COMPLETED|First Intervention||0
8434280|NCT00835484|20785930|P1|NOT COMPLETED|First Intervention||0
8434281|NCT00835484|20785929|P2|COMPLETED|First Intervention||16
8434282|NCT00835484|20785930|P1|COMPLETED|First Intervention||16
8434283|NCT00835484|20785929|P2|STARTED|First Intervention||16
8434284|NCT00835484|20785930|P1|STARTED|First Intervention||16
8434285|NCT00835406|20785940|P2|NOT COMPLETED|Period: Second Intervention||0
8434286|NCT00835406|20785941|P1|NOT COMPLETED|Period: Second Intervention||0
8434287|NCT00835406|20785940|P2|COMPLETED|Period: Second Intervention||67
8434288|NCT00835406|20785941|P1|COMPLETED|Period: Second Intervention||68
8434289|NCT00835406|20785940|P2|STARTED|Period: Second Intervention||67
8434290|NCT00835406|20785941|P1|STARTED|Period: Second Intervention||68
8434291|NCT00835406|20785940|P2|NOT COMPLETED|Period: Washout of 7 Days||2
8434292|NCT00835406|20785941|P1|NOT COMPLETED|Period: Washout of 7 Days||0
8434293|NCT00835406|20785940|P2|COMPLETED|Period: Washout of 7 Days||67
8434294|NCT00835406|20785941|P1|COMPLETED|Period: Washout of 7 Days||68
8434295|NCT00835406|20785940|P2|STARTED|Period: Washout of 7 Days||69
8434296|NCT00835406|20785941|P1|STARTED|Period: Washout of 7 Days||68
8434297|NCT00835406|20785940|P2|NOT COMPLETED|Period: First Intervention||1
8434298|NCT00835406|20785941|P1|NOT COMPLETED|Period: First Intervention||2
8434299|NCT00835406|20785940|P2|COMPLETED|Period: First Intervention||69
8434300|NCT00835406|20785941|P1|COMPLETED|Period: First Intervention||68
8434301|NCT00835406|20785940|P2|STARTED|Period: First Intervention||70
8434302|NCT00835406|20785941|P1|STARTED|Period: First Intervention||70
8434303|NCT00835380|20785947|P1|NOT COMPLETED|Overall Study||2
8434304|NCT00835380|20785947|P1|COMPLETED|Overall Study||78
8434305|NCT00835380|20785947|P1|STARTED|Overall Study||80
8434306|NCT00835367|20785954|P2|NOT COMPLETED|Second Intervention||1
8434307|NCT00835367|20785955|P1|NOT COMPLETED|Second Intervention||1
8434308|NCT00835367|20785954|P2|COMPLETED|Second Intervention||33
8434309|NCT00835367|20785955|P1|COMPLETED|Second Intervention||30
8434310|NCT00835367|20785954|P2|STARTED|Second Intervention||34
8434311|NCT00835367|20785955|P1|STARTED|Second Intervention||31
8434312|NCT00835367|20785954|P2|NOT COMPLETED|Washout||0
8434313|NCT00835367|20785955|P1|NOT COMPLETED|Washout||3
8434314|NCT00835367|20785954|P2|COMPLETED|Washout||34
8434315|NCT00835367|20785955|P1|COMPLETED|Washout||31
8434316|NCT00835367|20785954|P2|STARTED|Washout||34
8434317|NCT00835367|20785955|P1|STARTED|Washout||34
8434318|NCT00835367|20785954|P2|NOT COMPLETED|First Intervention||0
8434319|NCT00835367|20785955|P1|NOT COMPLETED|First Intervention||0
8434320|NCT00835367|20785954|P2|COMPLETED|First Intervention||34
8434321|NCT00835367|20785955|P1|COMPLETED|First Intervention||34
8434322|NCT00835367|20785954|P2|STARTED|First Intervention||34
8434323|NCT00835367|20785955|P1|STARTED|First Intervention||34
8434324|NCT00835354|20785977|P2|NOT COMPLETED|Second Intervention||0
8434325|NCT00835354|20785978|P1|NOT COMPLETED|Second Intervention||0
8434326|NCT00835354|20785977|P2|COMPLETED|Second Intervention||12
8434327|NCT00835354|20785978|P1|COMPLETED|Second Intervention||13
8434328|NCT00835354|20785977|P2|STARTED|Second Intervention||12
8434329|NCT00835354|20785978|P1|STARTED|Second Intervention||13
8434330|NCT00835354|20785977|P2|NOT COMPLETED|Washout of 7 Days||0
8434331|NCT00835354|20785978|P1|NOT COMPLETED|Washout of 7 Days||0
8434332|NCT00835354|20785977|P2|COMPLETED|Washout of 7 Days||12
8434333|NCT00835354|20785978|P1|COMPLETED|Washout of 7 Days||13
8434334|NCT00835354|20785977|P2|STARTED|Washout of 7 Days||12
8434335|NCT00835354|20785978|P1|STARTED|Washout of 7 Days||13
8434336|NCT00835354|20785977|P2|NOT COMPLETED|First Intervention||1
8434337|NCT00835354|20785978|P1|NOT COMPLETED|First Intervention||0
8434338|NCT00835354|20785977|P2|COMPLETED|First Intervention||12
8434339|NCT00835354|20785978|P1|COMPLETED|First Intervention||13
8434340|NCT00835354|20785977|P2|STARTED|First Intervention||13
8434341|NCT00835354|20785978|P1|STARTED|First Intervention||13
8434342|NCT00835341|20785988|P2|NOT COMPLETED|Overall Study||12
8434343|NCT00835341|20785989|P1|NOT COMPLETED|Overall Study||3
8434344|NCT00835341|20785988|P2|COMPLETED|Overall Study||46
8434345|NCT00835341|20785989|P1|COMPLETED|Overall Study||32
8434346|NCT00835341|20785988|P2|STARTED|Overall Study||58
8434347|NCT00835341|20785989|P1|STARTED|Overall Study||35
8434348|NCT00835328|20785999|P4|NOT COMPLETED|Cohort 4: Dose Level 4||0
8434349|NCT00835328|20786000|P3|NOT COMPLETED|Cohort 4: Dose Level 4||0
8434350|NCT00835328|20786001|P2|NOT COMPLETED|Cohort 4: Dose Level 4||0
8434351|NCT00835328|20786002|P1|NOT COMPLETED|Cohort 4: Dose Level 4||0
8434352|NCT00835328|20785999|P4|COMPLETED|Cohort 4: Dose Level 4||4
8434353|NCT00835328|20786000|P3|COMPLETED|Cohort 4: Dose Level 4||0
8434354|NCT00835328|20786001|P2|COMPLETED|Cohort 4: Dose Level 4||0
8434355|NCT00835328|20786002|P1|COMPLETED|Cohort 4: Dose Level 4||0
8434356|NCT00835328|20785999|P4|STARTED|Cohort 4: Dose Level 4||4
8434357|NCT00835328|20786000|P3|STARTED|Cohort 4: Dose Level 4||0
8434358|NCT00835328|20786001|P2|STARTED|Cohort 4: Dose Level 4||0
8434359|NCT00835328|20786002|P1|STARTED|Cohort 4: Dose Level 4|Cohort#4 enrolled 4 subsequent subjects|0
8434360|NCT00835328|20785999|P4|NOT COMPLETED|Cohort 3: Dose Level 3||0
8434361|NCT00835328|20786000|P3|NOT COMPLETED|Cohort 3: Dose Level 3||0
8434362|NCT00835328|20786001|P2|NOT COMPLETED|Cohort 3: Dose Level 3||0
8434363|NCT00835328|20786002|P1|NOT COMPLETED|Cohort 3: Dose Level 3||0
8434364|NCT00835328|20785999|P4|COMPLETED|Cohort 3: Dose Level 3||0
8434365|NCT00835328|20786000|P3|COMPLETED|Cohort 3: Dose Level 3||2
8434366|NCT00835328|20786001|P2|COMPLETED|Cohort 3: Dose Level 3||0
8434367|NCT00835328|20786002|P1|COMPLETED|Cohort 3: Dose Level 3||0
8434368|NCT00835328|20785999|P4|STARTED|Cohort 3: Dose Level 3||0
8434369|NCT00835328|20786000|P3|STARTED|Cohort 3: Dose Level 3||2
8434370|NCT00835328|20786001|P2|STARTED|Cohort 3: Dose Level 3||0
8434371|NCT00835328|20786002|P1|STARTED|Cohort 3: Dose Level 3||0
8434372|NCT00835328|20785999|P4|NOT COMPLETED|Cohort 2: Dose Level 2||0
8434373|NCT00835328|20786000|P3|NOT COMPLETED|Cohort 2: Dose Level 2||0
8434374|NCT00835328|20786001|P2|NOT COMPLETED|Cohort 2: Dose Level 2||0
8434375|NCT00835328|20786002|P1|NOT COMPLETED|Cohort 2: Dose Level 2||0
8434376|NCT00835328|20785999|P4|COMPLETED|Cohort 2: Dose Level 2||0
8434377|NCT00835328|20786000|P3|COMPLETED|Cohort 2: Dose Level 2||0
8434378|NCT00835328|20786001|P2|COMPLETED|Cohort 2: Dose Level 2||2
8434379|NCT00835328|20786002|P1|COMPLETED|Cohort 2: Dose Level 2||0
8434380|NCT00835328|20785999|P4|STARTED|Cohort 2: Dose Level 2||0
8434381|NCT00835328|20786000|P3|STARTED|Cohort 2: Dose Level 2||0
8434382|NCT00835328|20786001|P2|STARTED|Cohort 2: Dose Level 2||2
8434383|NCT00835328|20786002|P1|STARTED|Cohort 2: Dose Level 2||0
8434384|NCT00835328|20785999|P4|NOT COMPLETED|Cohort 1: Dose Level 1||0
8434385|NCT00835328|20786000|P3|NOT COMPLETED|Cohort 1: Dose Level 1||0
8434386|NCT00835328|20786001|P2|NOT COMPLETED|Cohort 1: Dose Level 1||0
8434387|NCT00835328|20786002|P1|NOT COMPLETED|Cohort 1: Dose Level 1||0
8434388|NCT00835328|20785999|P4|COMPLETED|Cohort 1: Dose Level 1||0
8434389|NCT00835328|20786000|P3|COMPLETED|Cohort 1: Dose Level 1||0
8434390|NCT00835328|20786001|P2|COMPLETED|Cohort 1: Dose Level 1||0
8434391|NCT00835328|20786002|P1|COMPLETED|Cohort 1: Dose Level 1||5
8434392|NCT00835328|20785999|P4|STARTED|Cohort 1: Dose Level 1||0
8434393|NCT00835328|20786000|P3|STARTED|Cohort 1: Dose Level 1||0
8434394|NCT00835328|20786001|P2|STARTED|Cohort 1: Dose Level 1||0
8434395|NCT00835328|20786002|P1|STARTED|Cohort 1: Dose Level 1||5
8434396|NCT00835276|20786041|P2|NOT COMPLETED|Second Intervention||0
8434397|NCT00835276|20786042|P1|NOT COMPLETED|Second Intervention||0
8434398|NCT00835276|20786041|P2|COMPLETED|Second Intervention||24
8434399|NCT00835276|20786042|P1|COMPLETED|Second Intervention||24
8434400|NCT00835276|20786041|P2|STARTED|Second Intervention||24
8434401|NCT00835276|20786042|P1|STARTED|Second Intervention||24
8434402|NCT00835276|20786041|P2|NOT COMPLETED|Washout of 7 Days||0
8434403|NCT00835276|20786042|P1|NOT COMPLETED|Washout of 7 Days||0
8434404|NCT00835276|20786041|P2|COMPLETED|Washout of 7 Days||24
8434405|NCT00835276|20786042|P1|COMPLETED|Washout of 7 Days||24
8434406|NCT00835276|20786041|P2|STARTED|Washout of 7 Days||24
8434407|NCT00835276|20786042|P1|STARTED|Washout of 7 Days||24
8434408|NCT00835276|20786041|P2|NOT COMPLETED|First Intervention||0
8434409|NCT00835276|20786042|P1|NOT COMPLETED|First Intervention||0
8434410|NCT00835276|20786041|P2|COMPLETED|First Intervention||24
8434411|NCT00835276|20786042|P1|COMPLETED|First Intervention||24
8434412|NCT00835276|20786041|P2|STARTED|First Intervention||24
8434413|NCT00835276|20786042|P1|STARTED|First Intervention||24
8434414|NCT00835263|20786052|P2|NOT COMPLETED|Second Intervention||0
8434415|NCT00835263|20786053|P1|NOT COMPLETED|Second Intervention||1
8434416|NCT00835263|20786052|P2|COMPLETED|Second Intervention||16
8434417|NCT00835263|20786053|P1|COMPLETED|Second Intervention||15
8434418|NCT00835263|20786052|P2|STARTED|Second Intervention||16
8434419|NCT00835263|20786053|P1|STARTED|Second Intervention||16
8434420|NCT00835263|20786052|P2|NOT COMPLETED|First Intervention||0
8434421|NCT00835263|20786053|P1|NOT COMPLETED|First Intervention||0
8434422|NCT00835263|20786052|P2|COMPLETED|First Intervention||16
8434423|NCT00835263|20786053|P1|COMPLETED|First Intervention||16
8434424|NCT00835263|20786052|P2|STARTED|First Intervention||16
8434425|NCT00835263|20786053|P1|STARTED|First Intervention||16
8434426|NCT00835237|20786063|P2|NOT COMPLETED|Overall Study||0
8434427|NCT00835237|20786064|P1|NOT COMPLETED|Overall Study||6
8434428|NCT00835237|20786063|P2|COMPLETED|Overall Study||445
8434429|NCT00835237|20786064|P1|COMPLETED|Overall Study||881
8434430|NCT00835237|20786063|P2|STARTED|Overall Study||445
8434431|NCT00835237|20786064|P1|STARTED|Overall Study||887
8434432|NCT00835224|20786088|P1|NOT COMPLETED|Overall Study||10
8434433|NCT00835224|20786088|P1|COMPLETED|Overall Study||24
8434434|NCT00835224|20786088|P1|STARTED|Overall Study||34
8434435|NCT00835211|20786104|P2|NOT COMPLETED|Second Intervention||0
8434436|NCT00835211|20786105|P1|NOT COMPLETED|Second Intervention||0
8434437|NCT00835211|20786104|P2|COMPLETED|Second Intervention||22
8434438|NCT00835211|20786105|P1|COMPLETED|Second Intervention||21
8434439|NCT00835211|20786104|P2|STARTED|Second Intervention||22
8434440|NCT00835211|20786105|P1|STARTED|Second Intervention||21
8434441|NCT00835211|20786104|P2|NOT COMPLETED|Washout: 7 Days||1
8434442|NCT00835211|20786105|P1|NOT COMPLETED|Washout: 7 Days||3
8434443|NCT00835211|20786104|P2|COMPLETED|Washout: 7 Days||22
8434444|NCT00835211|20786105|P1|COMPLETED|Washout: 7 Days||21
8434445|NCT00835211|20786104|P2|STARTED|Washout: 7 Days||23
8434446|NCT00835211|20786105|P1|STARTED|Washout: 7 Days||24
8434447|NCT00835211|20786104|P2|NOT COMPLETED|First Intervention||1
8434448|NCT00835211|20786105|P1|NOT COMPLETED|First Intervention||0
8434449|NCT00835211|20786104|P2|COMPLETED|First Intervention||23
8434450|NCT00835211|20786105|P1|COMPLETED|First Intervention||24
8434451|NCT00835211|20786104|P2|STARTED|First Intervention||24
8434452|NCT00835211|20786105|P1|STARTED|First Intervention||24
8434453|NCT00835198|20786115|P2|NOT COMPLETED|Overall Study||7
8434454|NCT00835198|20786116|P1|NOT COMPLETED|Overall Study||8
8434455|NCT00835198|20786115|P2|COMPLETED|Overall Study||74
8434456|NCT00835198|20786116|P1|COMPLETED|Overall Study||74
8434457|NCT00835198|20786115|P2|STARTED|Overall Study||81
8434458|NCT00835198|20786116|P1|STARTED|Overall Study||82
8434459|NCT00835185|20786128|P1|NOT COMPLETED|Overall Study||0
8434460|NCT00835185|20786128|P1|COMPLETED|Overall Study||44
8434461|NCT00835185|20786128|P1|Received at Least 1 Dose of Study Drug|Overall Study||44
8434462|NCT00835185|20786128|P1|STARTED|Overall Study||44
8434463|NCT00835172|20786151|P2|NOT COMPLETED|Second Intervention||0
8434464|NCT00835172|20786152|P1|NOT COMPLETED|Second Intervention||0
8434465|NCT00835172|20786151|P2|COMPLETED|Second Intervention||15
8434466|NCT00835172|20786152|P1|COMPLETED|Second Intervention||16
8434467|NCT00835172|20786151|P2|STARTED|Second Intervention||15
8434468|NCT00835172|20786152|P1|STARTED|Second Intervention||16
8434469|NCT00835172|20786151|P2|NOT COMPLETED|Washout||1
8434470|NCT00835172|20786152|P1|NOT COMPLETED|Washout||0
8434471|NCT00835172|20786151|P2|COMPLETED|Washout||15
8434472|NCT00835172|20786152|P1|COMPLETED|Washout||16
8434473|NCT00835172|20786151|P2|STARTED|Washout||16
8434474|NCT00835172|20786152|P1|STARTED|Washout||16
8434475|NCT00835172|20786151|P2|NOT COMPLETED|First Intervention||0
8434476|NCT00835172|20786152|P1|NOT COMPLETED|First Intervention||0
8434477|NCT00835172|20786151|P2|COMPLETED|First Intervention||16
8434478|NCT00835172|20786152|P1|COMPLETED|First Intervention||16
8434479|NCT00835172|20786151|P2|STARTED|First Intervention||16
8434480|NCT00835172|20786152|P1|STARTED|First Intervention||16
8434481|NCT00835159|20786162|P2|NOT COMPLETED|Overall Study||0
8434482|NCT00835159|20786163|P1|NOT COMPLETED|Overall Study||0
8434483|NCT00835159|20786162|P2|COMPLETED|Overall Study||17
8434484|NCT00835159|20786163|P1|COMPLETED|Overall Study||11
8434485|NCT00835159|20786162|P2|STARTED|Overall Study||17
8434486|NCT00835159|20786163|P1|STARTED|Overall Study||11
8434487|NCT00835146|20786171|P2|NOT COMPLETED|Second Intervention||0
8434488|NCT00835146|20786172|P1|NOT COMPLETED|Second Intervention||0
8434489|NCT00835146|20786171|P2|COMPLETED|Second Intervention||14
8434490|NCT00835146|20786172|P1|COMPLETED|Second Intervention||14
8434491|NCT00835146|20786171|P2|STARTED|Second Intervention||14
8434492|NCT00835146|20786172|P1|STARTED|Second Intervention||14
8434493|NCT00835146|20786171|P2|NOT COMPLETED|Washout of 5 Weeks||0
8434494|NCT00835146|20786172|P1|NOT COMPLETED|Washout of 5 Weeks||0
8434495|NCT00835146|20786171|P2|COMPLETED|Washout of 5 Weeks||14
8434496|NCT00835146|20786172|P1|COMPLETED|Washout of 5 Weeks||14
8434497|NCT00835146|20786171|P2|STARTED|Washout of 5 Weeks||14
8434498|NCT00835146|20786172|P1|STARTED|Washout of 5 Weeks||14
8434499|NCT00835146|20786171|P2|NOT COMPLETED|First Intervention||0
8434500|NCT00835146|20786172|P1|NOT COMPLETED|First Intervention||0
8434501|NCT00835146|20786171|P2|COMPLETED|First Intervention||14
8434502|NCT00835146|20786172|P1|COMPLETED|First Intervention||14
8434503|NCT00835146|20786171|P2|STARTED|First Intervention||14
8434504|NCT00835146|20786172|P1|STARTED|First Intervention||14
8434505|NCT00835120|20786178|P1|NOT COMPLETED|Overall Study||8
8434506|NCT00835120|20786178|P1|COMPLETED|Overall Study||26
8434507|NCT00835120|20786178|P1|STARTED|Overall Study||34
8434508|NCT00835081|20786188|P2|NOT COMPLETED|Second Intervention||0
8434509|NCT00835081|20786189|P1|NOT COMPLETED|Second Intervention||0
8434510|NCT00835081|20786188|P2|COMPLETED|Second Intervention||13
8434511|NCT00835081|20786189|P1|COMPLETED|Second Intervention||12
8434512|NCT00835081|20786188|P2|STARTED|Second Intervention||13
8434513|NCT00835081|20786189|P1|STARTED|Second Intervention||12
8434514|NCT00835081|20786188|P2|NOT COMPLETED|Washout of 7 Days||0
8434515|NCT00835081|20786189|P1|NOT COMPLETED|Washout of 7 Days||1
8434516|NCT00835081|20786188|P2|COMPLETED|Washout of 7 Days||13
8434517|NCT00835081|20786189|P1|COMPLETED|Washout of 7 Days||12
8434518|NCT00835081|20786188|P2|STARTED|Washout of 7 Days||13
8434519|NCT00835081|20786189|P1|STARTED|Washout of 7 Days||13
8434520|NCT00835081|20786188|P2|NOT COMPLETED|First Intervention||0
8434521|NCT00835081|20786189|P1|NOT COMPLETED|First Intervention||0
8434522|NCT00835081|20786188|P2|COMPLETED|First Intervention||13
8434523|NCT00835081|20786189|P1|COMPLETED|First Intervention||13
8434524|NCT00835081|20786188|P2|STARTED|First Intervention||13
8434525|NCT00835081|20786189|P1|STARTED|First Intervention||13
8434526|NCT00835068|20786199|P2|NOT COMPLETED|Overall Study||1
8434527|NCT00835068|20786200|P1|NOT COMPLETED|Overall Study||10
8434528|NCT00835068|20786199|P2|COMPLETED|Overall Study||0
8434529|NCT00835068|20786200|P1|COMPLETED|Overall Study||47
8434530|NCT00835068|20786199|P2|STARTED|Overall Study||1
8434531|NCT00835068|20786200|P1|STARTED|Overall Study||57
8434532|NCT00835042|20786220|P2|NOT COMPLETED|Second Intervention||0
8434533|NCT00835042|20786221|P1|NOT COMPLETED|Second Intervention||0
8434534|NCT00835042|20786220|P2|COMPLETED|Second Intervention||24
8434535|NCT00835042|20786221|P1|COMPLETED|Second Intervention||26
8434536|NCT00835042|20786220|P2|STARTED|Second Intervention||24
8434537|NCT00835042|20786221|P1|STARTED|Second Intervention||26
8434538|NCT00835042|20786220|P2|NOT COMPLETED|Washout of 21 Days||2
8434539|NCT00835042|20786221|P1|NOT COMPLETED|Washout of 21 Days||0
8434540|NCT00835042|20786220|P2|COMPLETED|Washout of 21 Days||24
8434541|NCT00835042|20786221|P1|COMPLETED|Washout of 21 Days||26
8434542|NCT00835042|20786220|P2|STARTED|Washout of 21 Days||26
8434543|NCT00835042|20786221|P1|STARTED|Washout of 21 Days||26
8434544|NCT00835042|20786220|P2|NOT COMPLETED|First Intervention||2
8434545|NCT00835042|20786221|P1|NOT COMPLETED|First Intervention||4
8434546|NCT00835042|20786220|P2|COMPLETED|First Intervention||26
8434547|NCT00835042|20786221|P1|COMPLETED|First Intervention||26
8434548|NCT00835042|20786220|P2|STARTED|First Intervention||28
8434549|NCT00835042|20786221|P1|STARTED|First Intervention||30
8434550|NCT00835003|20786243|P2|NOT COMPLETED|Overall Study||0
8434551|NCT00835003|20786244|P1|NOT COMPLETED|Overall Study||0
8434552|NCT00835003|20786243|P2|COMPLETED|Overall Study||638
8434553|NCT00835003|20786244|P1|COMPLETED|Overall Study||636
8434554|NCT00835003|20786243|P2|STARTED|Overall Study||638
8434555|NCT00835003|20786244|P1|STARTED|Overall Study||636
8434556|NCT00834990|20786252|P2|NOT COMPLETED|Second Intervention||0
8434557|NCT00834990|20786253|P1|NOT COMPLETED|Second Intervention||0
8434558|NCT00834990|20786252|P2|COMPLETED|Second Intervention||11
8434559|NCT00834990|20786253|P1|COMPLETED|Second Intervention||12
8434560|NCT00834990|20786252|P2|STARTED|Second Intervention||11
8434561|NCT00834990|20786253|P1|STARTED|Second Intervention||12
8434562|NCT00834990|20786252|P2|NOT COMPLETED|Washout of 7 Days||0
8434563|NCT00834990|20786253|P1|NOT COMPLETED|Washout of 7 Days||0
8434564|NCT00834990|20786252|P2|COMPLETED|Washout of 7 Days||11
8434565|NCT00834990|20786253|P1|COMPLETED|Washout of 7 Days||12
8434566|NCT00834990|20786252|P2|STARTED|Washout of 7 Days||11
8434567|NCT00834990|20786253|P1|STARTED|Washout of 7 Days||12
8434568|NCT00834990|20786252|P2|NOT COMPLETED|First Intervention||0
8434569|NCT00834990|20786253|P1|NOT COMPLETED|First Intervention||0
8434570|NCT00834990|20786252|P2|COMPLETED|First Intervention||11
8434571|NCT00834990|20786253|P1|COMPLETED|First Intervention||12
8434572|NCT00834990|20786252|P2|STARTED|First Intervention||11
8434573|NCT00834990|20786253|P1|STARTED|First Intervention||12
8434574|NCT00834977|20786263|P2|NOT COMPLETED|Second Intervention||0
8434575|NCT00834977|20786264|P1|NOT COMPLETED|Second Intervention||0
8434576|NCT00834977|20786263|P2|COMPLETED|Second Intervention||24
8434577|NCT00834977|20786264|P1|COMPLETED|Second Intervention||24
8434578|NCT00834977|20786263|P2|STARTED|Second Intervention||24
8434579|NCT00834977|20786264|P1|STARTED|Second Intervention||24
8434580|NCT00834977|20786263|P2|NOT COMPLETED|First Intervention||0
8434581|NCT00834977|20786264|P1|NOT COMPLETED|First Intervention||0
8434582|NCT00834977|20786263|P2|COMPLETED|First Intervention||24
8434583|NCT00834977|20786264|P1|COMPLETED|First Intervention||24
8434584|NCT00834977|20786263|P2|STARTED|First Intervention||24
8434585|NCT00834977|20786264|P1|STARTED|First Intervention||24
8434586|NCT00834964|20786286|P2|NOT COMPLETED|Second Intervention||0
8434587|NCT00834964|20786287|P1|NOT COMPLETED|Second Intervention||0
8434588|NCT00834964|20786286|P2|COMPLETED|Second Intervention||15
8434589|NCT00834964|20786287|P1|COMPLETED|Second Intervention||15
8434590|NCT00834964|20786286|P2|STARTED|Second Intervention||15
8434591|NCT00834964|20786287|P1|STARTED|Second Intervention||15
8434592|NCT00834964|20786286|P2|NOT COMPLETED|Washout: 7 Days||0
8434593|NCT00834964|20786287|P1|NOT COMPLETED|Washout: 7 Days||0
8434594|NCT00834964|20786286|P2|COMPLETED|Washout: 7 Days||15
8434595|NCT00834964|20786287|P1|COMPLETED|Washout: 7 Days||15
8434596|NCT00834964|20786286|P2|STARTED|Washout: 7 Days||15
8434597|NCT00834964|20786287|P1|STARTED|Washout: 7 Days||15
8434598|NCT00834964|20786286|P2|NOT COMPLETED|First Intervention||0
8434599|NCT00834964|20786287|P1|NOT COMPLETED|First Intervention||0
8434600|NCT00834964|20786286|P2|COMPLETED|First Intervention||15
8434601|NCT00834964|20786287|P1|COMPLETED|First Intervention||15
8434602|NCT00834964|20786286|P2|STARTED|First Intervention||15
8434603|NCT00834964|20786287|P1|STARTED|First Intervention||15
8434604|NCT00834912|20786307|P6|NOT COMPLETED|Treatment Period 3||0
8434605|NCT00834912|20786308|P5|NOT COMPLETED|Treatment Period 3||0
8434606|NCT00834912|20786309|P4|NOT COMPLETED|Treatment Period 3||0
8434607|NCT00834912|20786310|P3|NOT COMPLETED|Treatment Period 3||0
8434608|NCT00834912|20786311|P2|NOT COMPLETED|Treatment Period 3||0
8434609|NCT00834912|20786312|P1|NOT COMPLETED|Treatment Period 3||0
8434610|NCT00834912|20786307|P6|COMPLETED|Treatment Period 3||6
8434611|NCT00834912|20786308|P5|COMPLETED|Treatment Period 3||5
8434612|NCT00834912|20786309|P4|COMPLETED|Treatment Period 3||5
8434613|NCT00834912|20786310|P3|COMPLETED|Treatment Period 3||5
8434614|NCT00834912|20786311|P2|COMPLETED|Treatment Period 3||5
8434615|NCT00834912|20786312|P1|COMPLETED|Treatment Period 3||6
8434616|NCT00834912|20786307|P6|STARTED|Treatment Period 3||6
8434617|NCT00834912|20786308|P5|STARTED|Treatment Period 3||5
8434618|NCT00834912|20786309|P4|STARTED|Treatment Period 3||5
8434619|NCT00834912|20786310|P3|STARTED|Treatment Period 3||5
8434620|NCT00834912|20786311|P2|STARTED|Treatment Period 3||5
8434621|NCT00834912|20786312|P1|STARTED|Treatment Period 3||6
8434622|NCT00834912|20786307|P6|NOT COMPLETED|Treatment Period 2||0
8434623|NCT00834912|20786308|P5|NOT COMPLETED|Treatment Period 2||1
8434624|NCT00834912|20786309|P4|NOT COMPLETED|Treatment Period 2||0
8434625|NCT00834912|20786310|P3|NOT COMPLETED|Treatment Period 2||1
8434626|NCT00834912|20786311|P2|NOT COMPLETED|Treatment Period 2||0
8434627|NCT00834912|20786312|P1|NOT COMPLETED|Treatment Period 2||0
8434628|NCT00834912|20786307|P6|COMPLETED|Treatment Period 2||6
8434629|NCT00834912|20786308|P5|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
8434630|NCT00834912|20786309|P4|COMPLETED|Treatment Period 2||5
8434631|NCT00834912|20786310|P3|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
8434632|NCT00834912|20786311|P2|COMPLETED|Treatment Period 2||5
8434633|NCT00834912|20786312|P1|COMPLETED|Treatment Period 2||6
8434634|NCT00834912|20786307|P6|STARTED|Treatment Period 2||6
8434635|NCT00834912|20786308|P5|STARTED|Treatment Period 2||6
8434636|NCT00834912|20786309|P4|STARTED|Treatment Period 2||5
8434637|NCT00834912|20786310|P3|STARTED|Treatment Period 2||6
8434638|NCT00834912|20786311|P2|STARTED|Treatment Period 2||5
8434639|NCT00834912|20786312|P1|STARTED|Treatment Period 2||6
8434640|NCT00834912|20786307|P6|NOT COMPLETED|Treatment Period 1||0
8434641|NCT00834912|20786308|P5|NOT COMPLETED|Treatment Period 1||0
8434642|NCT00834912|20786309|P4|NOT COMPLETED|Treatment Period 1||1
8434643|NCT00834912|20786310|P3|NOT COMPLETED|Treatment Period 1||0
8434644|NCT00834912|20786311|P2|NOT COMPLETED|Treatment Period 1||1
8434645|NCT00834912|20786312|P1|NOT COMPLETED|Treatment Period 1||0
8434646|NCT00834912|20786307|P6|COMPLETED|Treatment Period 1||6
8434647|NCT00834912|20786308|P5|COMPLETED|Treatment Period 1||6
8434648|NCT00834912|20786309|P4|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
8434649|NCT00834912|20786310|P3|COMPLETED|Treatment Period 1||6
8434650|NCT00834912|20786311|P2|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
8434651|NCT00834912|20786312|P1|COMPLETED|Treatment Period 1||6
8434652|NCT00834912|20786307|P6|STARTED|Treatment Period 1||6
8434653|NCT00834912|20786308|P5|STARTED|Treatment Period 1||6
8434654|NCT00834912|20786309|P4|STARTED|Treatment Period 1||6
8434655|NCT00834912|20786310|P3|STARTED|Treatment Period 1||6
8434656|NCT00834912|20786311|P2|STARTED|Treatment Period 1||6
8434657|NCT00834912|20786312|P1|STARTED|Treatment Period 1||6
8434658|NCT00834899|20786334|P2|NOT COMPLETED|Overall Study||1
8434659|NCT00834899|20786335|P1|NOT COMPLETED|Overall Study||1
8434660|NCT00834899|20786334|P2|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
8434661|NCT00834899|20786335|P1|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
8434662|NCT00834899|20786334|P2|STARTED|Overall Study||4
8434663|NCT00834899|20786335|P1|STARTED|Overall Study||9
8434664|NCT00834886|20786351|P4|NOT COMPLETED|Overall Study||0
8434665|NCT00834886|20786352|P3|NOT COMPLETED|Overall Study||1
8434666|NCT00834886|20786353|P2|NOT COMPLETED|Overall Study||1
8434667|NCT00834886|20786354|P1|NOT COMPLETED|Overall Study||0
8434668|NCT00834886|20786351|P4|COMPLETED|Overall Study||10
8434669|NCT00834886|20786352|P3|COMPLETED|Overall Study||9
8434670|NCT00834886|20786353|P2|COMPLETED|Overall Study||9
8434671|NCT00834886|20786354|P1|COMPLETED|Overall Study||10
8434672|NCT00834886|20786351|P4|STARTED|Overall Study||10
8434673|NCT00834886|20786352|P3|STARTED|Overall Study||10
8434674|NCT00834886|20786353|P2|STARTED|Overall Study||10
8434675|NCT00834886|20786354|P1|STARTED|Overall Study||10
8434676|NCT00834873|20786374|P2|NOT COMPLETED|Second Intervention||0
8434677|NCT00834873|20786375|P1|NOT COMPLETED|Second Intervention||0
8434678|NCT00834873|20786374|P2|COMPLETED|Second Intervention||11
8434679|NCT00834873|20786375|P1|COMPLETED|Second Intervention||12
8434680|NCT00834873|20786374|P2|STARTED|Second Intervention||11
8434681|NCT00834873|20786375|P1|STARTED|Second Intervention||12
8434682|NCT00834873|20786374|P2|NOT COMPLETED|Washout: 7 Days||0
8434683|NCT00834873|20786375|P1|NOT COMPLETED|Washout: 7 Days||0
8434684|NCT00834873|20786374|P2|COMPLETED|Washout: 7 Days||11
8434685|NCT00834873|20786375|P1|COMPLETED|Washout: 7 Days||12
8434686|NCT00834873|20786374|P2|STARTED|Washout: 7 Days||11
8434687|NCT00834873|20786375|P1|STARTED|Washout: 7 Days||12
8434688|NCT00834873|20786374|P2|NOT COMPLETED|First Intervention||1
8434689|NCT00834873|20786375|P1|NOT COMPLETED|First Intervention||0
8434690|NCT00834873|20786374|P2|COMPLETED|First Intervention||11
8434691|NCT00834873|20786375|P1|COMPLETED|First Intervention||12
8434692|NCT00834873|20786374|P2|STARTED|First Intervention||12
8434693|NCT00834873|20786375|P1|STARTED|First Intervention||12
8434694|NCT00834834|20786385|P2|NOT COMPLETED|Overall Study||3
8434695|NCT00834834|20786386|P1|NOT COMPLETED|Overall Study||4
8434696|NCT00834834|20786385|P2|COMPLETED|Overall Study||39
8434697|NCT00834834|20786386|P1|COMPLETED|Overall Study||38
8434698|NCT00834834|20786385|P2|STARTED|Overall Study||42
8434699|NCT00834834|20786386|P1|STARTED|Overall Study||42
8434700|NCT00834808|20786397|P3|NOT COMPLETED|Treatment Period 3 (Day 15)||0
8434701|NCT00834808|20786398|P2|NOT COMPLETED|Treatment Period 3 (Day 15)||0
8434702|NCT00834808|20786399|P1|NOT COMPLETED|Treatment Period 3 (Day 15)||0
8434703|NCT00834808|20786397|P3|COMPLETED|Treatment Period 3 (Day 15)||9
8434704|NCT00834808|20786398|P2|COMPLETED|Treatment Period 3 (Day 15)||9
8434705|NCT00834808|20786399|P1|COMPLETED|Treatment Period 3 (Day 15)||9
8434706|NCT00834808|20786397|P3|STARTED|Treatment Period 3 (Day 15)||9
8434707|NCT00834808|20786398|P2|STARTED|Treatment Period 3 (Day 15)||9
8434708|NCT00834808|20786399|P1|STARTED|Treatment Period 3 (Day 15)||9
8434709|NCT00834808|20786397|P3|NOT COMPLETED|Treatment Period 2 (Day 8)||0
8434710|NCT00834808|20786398|P2|NOT COMPLETED|Treatment Period 2 (Day 8)||0
8434711|NCT00834808|20786399|P1|NOT COMPLETED|Treatment Period 2 (Day 8)||0
8434712|NCT00834808|20786397|P3|COMPLETED|Treatment Period 2 (Day 8)||9
8434713|NCT00834808|20786398|P2|COMPLETED|Treatment Period 2 (Day 8)||9
8434714|NCT00834808|20786399|P1|COMPLETED|Treatment Period 2 (Day 8)||9
8434715|NCT00834808|20786397|P3|STARTED|Treatment Period 2 (Day 8)||9
8434716|NCT00834808|20786398|P2|STARTED|Treatment Period 2 (Day 8)||9
8434717|NCT00834808|20786399|P1|STARTED|Treatment Period 2 (Day 8)||9
8434718|NCT00834808|20786397|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8434719|NCT00834808|20786398|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8434720|NCT00834808|20786399|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8434721|NCT00834808|20786397|P3|COMPLETED|Treatment Period 1 (Day 1)||9
8434722|NCT00834808|20786398|P2|COMPLETED|Treatment Period 1 (Day 1)||9
8434723|NCT00834808|20786399|P1|COMPLETED|Treatment Period 1 (Day 1)||9
8434724|NCT00834808|20786397|P3|STARTED|Treatment Period 1 (Day 1)||9
8434725|NCT00834808|20786398|P2|STARTED|Treatment Period 1 (Day 1)||9
8434726|NCT00834808|20786399|P1|STARTED|Treatment Period 1 (Day 1)||9
8434727|NCT00834795|20786421|P2|NOT COMPLETED|Second Intervention||0
8434728|NCT00834795|20786422|P1|NOT COMPLETED|Second Intervention||1
8434729|NCT00834795|20786421|P2|COMPLETED|Second Intervention||17
8434730|NCT00834795|20786422|P1|COMPLETED|Second Intervention||17
8434731|NCT00834795|20786421|P2|STARTED|Second Intervention||17
8434732|NCT00834795|20786422|P1|STARTED|Second Intervention||18
8434733|NCT00834795|20786421|P2|NOT COMPLETED|Washout: 7 Days||1
8434734|NCT00834795|20786422|P1|NOT COMPLETED|Washout: 7 Days||0
8434735|NCT00834795|20786421|P2|COMPLETED|Washout: 7 Days||17
8434736|NCT00834795|20786422|P1|COMPLETED|Washout: 7 Days||18
8434737|NCT00834795|20786421|P2|STARTED|Washout: 7 Days||18
8434738|NCT00834795|20786422|P1|STARTED|Washout: 7 Days||18
8434739|NCT00834795|20786421|P2|NOT COMPLETED|First Intervention||0
8434740|NCT00834795|20786422|P1|NOT COMPLETED|First Intervention||0
8434741|NCT00834795|20786421|P2|COMPLETED|First Intervention||18
8434742|NCT00834795|20786422|P1|COMPLETED|First Intervention||18
8434743|NCT00834795|20786421|P2|STARTED|First Intervention||18
8434744|NCT00834795|20786422|P1|STARTED|First Intervention||18
8434745|NCT00834756|20786432|P2|NOT COMPLETED|Second Intervention||0
8434746|NCT00834756|20786433|P1|NOT COMPLETED|Second Intervention||0
8434747|NCT00834756|20786432|P2|COMPLETED|Second Intervention||18
8434748|NCT00834756|20786433|P1|COMPLETED|Second Intervention||16
8434749|NCT00834756|20786432|P2|STARTED|Second Intervention||18
8434750|NCT00834756|20786433|P1|STARTED|Second Intervention||16
8434751|NCT00834756|20786432|P2|NOT COMPLETED|Washout: 21 Days||0
8434752|NCT00834756|20786433|P1|NOT COMPLETED|Washout: 21 Days||1
8434753|NCT00834756|20786432|P2|COMPLETED|Washout: 21 Days||18
8434754|NCT00834756|20786433|P1|COMPLETED|Washout: 21 Days||16
8434755|NCT00834756|20786432|P2|STARTED|Washout: 21 Days||18
8434756|NCT00834756|20786433|P1|STARTED|Washout: 21 Days||17
8434757|NCT00834756|20786432|P2|NOT COMPLETED|First Intervention||0
8434758|NCT00834756|20786433|P1|NOT COMPLETED|First Intervention||1
8434759|NCT00834756|20786432|P2|COMPLETED|First Intervention||18
8434760|NCT00834756|20786433|P1|COMPLETED|First Intervention||17
8434761|NCT00834756|20786432|P2|STARTED|First Intervention||18
8434762|NCT00834756|20786433|P1|STARTED|First Intervention||18
8434763|NCT00834743|20786443|P2|NOT COMPLETED|Second Intervention||0
8434764|NCT00834743|20786444|P1|NOT COMPLETED|Second Intervention||1
8434765|NCT00834743|20786443|P2|COMPLETED|Second Intervention||16
8434766|NCT00834743|20786444|P1|COMPLETED|Second Intervention||15
8434767|NCT00834743|20786443|P2|STARTED|Second Intervention||16
8434768|NCT00834743|20786444|P1|STARTED|Second Intervention||16
8434769|NCT00834743|20786443|P2|NOT COMPLETED|Washout of 7 Days||0
8434770|NCT00834743|20786444|P1|NOT COMPLETED|Washout of 7 Days||0
8434771|NCT00834743|20786443|P2|COMPLETED|Washout of 7 Days||16
8434772|NCT00834743|20786444|P1|COMPLETED|Washout of 7 Days||16
8434773|NCT00834743|20786443|P2|STARTED|Washout of 7 Days||16
8434774|NCT00834743|20786444|P1|STARTED|Washout of 7 Days||16
8434775|NCT00834743|20786443|P2|NOT COMPLETED|First Intervention||0
8434776|NCT00834743|20786444|P1|NOT COMPLETED|First Intervention||0
8434777|NCT00834743|20786443|P2|COMPLETED|First Intervention||16
8434778|NCT00834743|20786444|P1|COMPLETED|First Intervention||16
8434779|NCT00834743|20786443|P2|STARTED|First Intervention||16
8434780|NCT00834743|20786444|P1|STARTED|First Intervention||16
8434781|NCT00834717|20786454|P2|NOT COMPLETED|Second Intervention||0
8434782|NCT00834717|20786455|P1|NOT COMPLETED|Second Intervention||0
8434783|NCT00834717|20786454|P2|COMPLETED|Second Intervention||19
8434784|NCT00834717|20786455|P1|COMPLETED|Second Intervention||19
8434785|NCT00834717|20786454|P2|STARTED|Second Intervention||19
8434786|NCT00834717|20786455|P1|STARTED|Second Intervention||19
8434787|NCT00834717|20786454|P2|NOT COMPLETED|First Intervention||1
8434788|NCT00834717|20786455|P1|NOT COMPLETED|First Intervention||1
8434789|NCT00834717|20786454|P2|COMPLETED|First Intervention||19
8434790|NCT00834717|20786455|P1|COMPLETED|First Intervention||19
8434791|NCT00834717|20786454|P2|STARTED|First Intervention||20
8434792|NCT00834717|20786455|P1|STARTED|First Intervention||20
8434793|NCT00834678|20786463|P1|NOT COMPLETED|Overall Study||0
8434794|NCT00834678|20786463|P1|COMPLETED|Overall Study||11
8434795|NCT00834678|20786463|P1|STARTED|Overall Study||11
8434796|NCT00834652|20786477|P2|NOT COMPLETED|Overall Study||40
8434797|NCT00834652|20786478|P1|NOT COMPLETED|Overall Study||38
8434798|NCT00834652|20786477|P2|COMPLETED|Overall Study||62
8434799|NCT00834652|20786478|P1|COMPLETED|Overall Study||66
8434800|NCT00834652|20786477|P2|STARTED|Overall Study||102
8434801|NCT00834652|20786478|P1|STARTED|Overall Study||104
8434802|NCT00834639|20786486|P2|NOT COMPLETED|Second Intervention||2
8434803|NCT00834639|20786487|P1|NOT COMPLETED|Second Intervention||0
8434804|NCT00834639|20786486|P2|COMPLETED|Second Intervention||10
8434805|NCT00834639|20786487|P1|COMPLETED|Second Intervention||12
8434806|NCT00834639|20786486|P2|STARTED|Second Intervention||12
8434807|NCT00834639|20786487|P1|STARTED|Second Intervention||12
8434808|NCT00834639|20786486|P2|NOT COMPLETED|Washout of 7 Days||0
8434809|NCT00834639|20786487|P1|NOT COMPLETED|Washout of 7 Days||0
8434810|NCT00834639|20786486|P2|COMPLETED|Washout of 7 Days||12
8434811|NCT00834639|20786487|P1|COMPLETED|Washout of 7 Days||12
8434812|NCT00834639|20786486|P2|STARTED|Washout of 7 Days||12
8434813|NCT00834639|20786487|P1|STARTED|Washout of 7 Days||12
8434814|NCT00834639|20786486|P2|NOT COMPLETED|First Intervention||0
8434815|NCT00834639|20786487|P1|NOT COMPLETED|First Intervention||0
8434816|NCT00834639|20786486|P2|COMPLETED|First Intervention||12
8434817|NCT00834639|20786487|P1|COMPLETED|First Intervention||12
8434818|NCT00834639|20786486|P2|STARTED|First Intervention||12
8434819|NCT00834639|20786487|P1|STARTED|First Intervention||12
8434820|NCT00834626|20786495|P1|NOT COMPLETED|Overall Study||0
8434821|NCT00834626|20786495|P1|COMPLETED|Overall Study||30
8434822|NCT00834626|20786495|P1|1 Year Follow-up|Overall Study||30
8434823|NCT00834626|20786495|P1|STARTED|Overall Study||30
8434824|NCT00834613|20786504|P2|NOT COMPLETED|Second Intervention||0
8434825|NCT00834613|20786505|P1|NOT COMPLETED|Second Intervention||0
8434826|NCT00834613|20786504|P2|COMPLETED|Second Intervention||16
8434827|NCT00834613|20786505|P1|COMPLETED|Second Intervention||15
8434828|NCT00834613|20786504|P2|STARTED|Second Intervention||16
8434829|NCT00834613|20786505|P1|STARTED|Second Intervention||15
8434830|NCT00834613|20786504|P2|NOT COMPLETED|Washout of 7 Days||0
8434831|NCT00834613|20786505|P1|NOT COMPLETED|Washout of 7 Days||0
8434832|NCT00834613|20786504|P2|COMPLETED|Washout of 7 Days||16
8434833|NCT00834613|20786505|P1|COMPLETED|Washout of 7 Days||15
8434834|NCT00834613|20786504|P2|STARTED|Washout of 7 Days||16
8434835|NCT00834613|20786505|P1|STARTED|Washout of 7 Days||15
8434836|NCT00834613|20786504|P2|NOT COMPLETED|First Intervention||0
8434837|NCT00834613|20786505|P1|NOT COMPLETED|First Intervention||1
8434838|NCT00834613|20786504|P2|COMPLETED|First Intervention||16
8434839|NCT00834613|20786505|P1|COMPLETED|First Intervention||15
8434840|NCT00834613|20786504|P2|STARTED|First Intervention||16
8434841|NCT00834613|20786505|P1|STARTED|First Intervention||16
8434842|NCT00834587|20786515|P2|NOT COMPLETED|Second Intervention||0
8434843|NCT00834587|20786516|P1|NOT COMPLETED|Second Intervention||0
8434844|NCT00834587|20786515|P2|COMPLETED|Second Intervention||20
8434845|NCT00834587|20786516|P1|COMPLETED|Second Intervention||19
8434846|NCT00834587|20786515|P2|STARTED|Second Intervention||20
8434847|NCT00834587|20786516|P1|STARTED|Second Intervention||19
8434848|NCT00834587|20786515|P2|NOT COMPLETED|Washout: 7 Days||0
8434849|NCT00834587|20786516|P1|NOT COMPLETED|Washout: 7 Days||1
8434850|NCT00834587|20786515|P2|COMPLETED|Washout: 7 Days||20
8434851|NCT00834587|20786516|P1|COMPLETED|Washout: 7 Days||19
8434852|NCT00834587|20786515|P2|STARTED|Washout: 7 Days||20
8434853|NCT00834587|20786516|P1|STARTED|Washout: 7 Days||20
8434854|NCT00834587|20786515|P2|NOT COMPLETED|First Intervention||0
8434855|NCT00834587|20786516|P1|NOT COMPLETED|First Intervention||0
8434856|NCT00834587|20786515|P2|COMPLETED|First Intervention||20
8434857|NCT00834587|20786516|P1|COMPLETED|First Intervention||20
8434858|NCT00834587|20786515|P2|STARTED|First Intervention||20
8434859|NCT00834587|20786516|P1|STARTED|First Intervention||20
8434860|NCT00834574|20786532|P2|NOT COMPLETED|Second Intervention||0
8434861|NCT00834574|20786533|P1|NOT COMPLETED|Second Intervention||0
8434862|NCT00834574|20786532|P2|COMPLETED|Second Intervention||16
8434863|NCT00834574|20786533|P1|COMPLETED|Second Intervention||16
8434864|NCT00834574|20786532|P2|STARTED|Second Intervention||16
8434865|NCT00834574|20786533|P1|STARTED|Second Intervention||16
8434866|NCT00834574|20786532|P2|NOT COMPLETED|Washout of 7 Days||0
8434867|NCT00834574|20786533|P1|NOT COMPLETED|Washout of 7 Days||0
8434868|NCT00834574|20786532|P2|COMPLETED|Washout of 7 Days||16
8434869|NCT00834574|20786533|P1|COMPLETED|Washout of 7 Days||16
8434870|NCT00834574|20786532|P2|STARTED|Washout of 7 Days||16
8434871|NCT00834574|20786533|P1|STARTED|Washout of 7 Days||16
8434872|NCT00834574|20786532|P2|NOT COMPLETED|First Intervention||0
8434873|NCT00834574|20786533|P1|NOT COMPLETED|First Intervention||0
8434874|NCT00834574|20786532|P2|COMPLETED|First Intervention||16
8434875|NCT00834574|20786533|P1|COMPLETED|First Intervention||16
8434876|NCT00834574|20786532|P2|STARTED|First Intervention||16
8434877|NCT00834574|20786533|P1|STARTED|First Intervention||16
8434878|NCT00834561|20786543|P2|NOT COMPLETED|Second Intervention||0
8434879|NCT00834561|20786544|P1|NOT COMPLETED|Second Intervention||0
8434880|NCT00834561|20786543|P2|COMPLETED|Second Intervention||16
8434881|NCT00834561|20786544|P1|COMPLETED|Second Intervention||16
8434882|NCT00834561|20786543|P2|STARTED|Second Intervention||16
8434883|NCT00834561|20786544|P1|STARTED|Second Intervention||16
8434884|NCT00834561|20786543|P2|NOT COMPLETED|First Intervention||0
8434885|NCT00834561|20786544|P1|NOT COMPLETED|First Intervention||0
8434886|NCT00834561|20786543|P2|COMPLETED|First Intervention||16
8434887|NCT00834561|20786544|P1|COMPLETED|First Intervention||16
8434888|NCT00834561|20786543|P2|STARTED|First Intervention||16
8434889|NCT00834561|20786544|P1|STARTED|First Intervention||16
8434890|NCT00834535|20786554|P2|NOT COMPLETED|Second Intervention||0
8434891|NCT00834535|20786555|P1|NOT COMPLETED|Second Intervention||0
8434892|NCT00834535|20786554|P2|COMPLETED|Second Intervention||16
8434893|NCT00834535|20786555|P1|COMPLETED|Second Intervention||16
8434894|NCT00834535|20786554|P2|STARTED|Second Intervention||16
8434895|NCT00834535|20786555|P1|STARTED|Second Intervention||16
8434896|NCT00834535|20786554|P2|NOT COMPLETED|Washout of 7 Days||0
8434897|NCT00834535|20786555|P1|NOT COMPLETED|Washout of 7 Days||0
8434898|NCT00834535|20786554|P2|COMPLETED|Washout of 7 Days||16
8434899|NCT00834535|20786555|P1|COMPLETED|Washout of 7 Days||16
8434900|NCT00834535|20786554|P2|STARTED|Washout of 7 Days||16
8434901|NCT00834535|20786555|P1|STARTED|Washout of 7 Days||16
8434902|NCT00834535|20786554|P2|NOT COMPLETED|First Intervention||0
8434903|NCT00834535|20786555|P1|NOT COMPLETED|First Intervention||0
8434904|NCT00834535|20786554|P2|COMPLETED|First Intervention||16
8434905|NCT00834535|20786555|P1|COMPLETED|First Intervention||16
8434906|NCT00834535|20786554|P2|STARTED|First Intervention||16
8434907|NCT00834535|20786555|P1|STARTED|First Intervention||16
8434908|NCT00834522|20786565|P2|NOT COMPLETED|Second Intervention||0
8434909|NCT00834522|20786566|P1|NOT COMPLETED|Second Intervention||0
8434910|NCT00834522|20786565|P2|COMPLETED|Second Intervention||39
8434911|NCT00834522|20786566|P1|COMPLETED|Second Intervention||37
8434912|NCT00834522|20786565|P2|STARTED|Second Intervention||39
8434913|NCT00834522|20786566|P1|STARTED|Second Intervention||37
8434914|NCT00834522|20786565|P2|NOT COMPLETED|Washout||1
8434915|NCT00834522|20786566|P1|NOT COMPLETED|Washout||3
8434916|NCT00834522|20786565|P2|COMPLETED|Washout||39
8434917|NCT00834522|20786566|P1|COMPLETED|Washout||37
8434918|NCT00834522|20786565|P2|STARTED|Washout||40
8434919|NCT00834522|20786566|P1|STARTED|Washout||40
8434920|NCT00834522|20786565|P2|NOT COMPLETED|First Intervention||0
8434921|NCT00834522|20786566|P1|NOT COMPLETED|First Intervention||0
8434922|NCT00834522|20786565|P2|COMPLETED|First Intervention||40
8434923|NCT00834522|20786566|P1|COMPLETED|First Intervention||40
8434924|NCT00834522|20786565|P2|STARTED|First Intervention||40
8434925|NCT00834522|20786566|P1|STARTED|First Intervention||40
8434926|NCT00834483|20786576|P2|NOT COMPLETED|Overall Study||0
8434927|NCT00834483|20786577|P1|NOT COMPLETED|Overall Study||0
8434928|NCT00834483|20786576|P2|COMPLETED|Overall Study||29
8434929|NCT00834483|20786577|P1|COMPLETED|Overall Study||31
8434930|NCT00834483|20786576|P2|STARTED|Overall Study||29
8434931|NCT00834483|20786577|P1|STARTED|Overall Study||31
8434932|NCT00834444|20786589|P2|NOT COMPLETED|Second Intervention||0
8434933|NCT00834444|20786590|P1|NOT COMPLETED|Second Intervention||1
8434934|NCT00834444|20786589|P2|COMPLETED|Second Intervention||16
8434935|NCT00834444|20786590|P1|COMPLETED|Second Intervention||16
8434936|NCT00834444|20786589|P2|STARTED|Second Intervention||16
8434937|NCT00834444|20786590|P1|STARTED|Second Intervention||17
8434938|NCT00834444|20786589|P2|NOT COMPLETED|Washout of 7 Days||1
8434939|NCT00834444|20786590|P1|NOT COMPLETED|Washout of 7 Days||0
8434940|NCT00834444|20786589|P2|COMPLETED|Washout of 7 Days||16
8434941|NCT00834444|20786590|P1|COMPLETED|Washout of 7 Days||17
8434942|NCT00834444|20786589|P2|STARTED|Washout of 7 Days||17
8434943|NCT00834444|20786590|P1|STARTED|Washout of 7 Days||17
8434944|NCT00834444|20786589|P2|NOT COMPLETED|First Intervention||1
8434945|NCT00834444|20786590|P1|NOT COMPLETED|First Intervention||1
8434946|NCT00834444|20786589|P2|COMPLETED|First Intervention||17
8434947|NCT00834444|20786590|P1|COMPLETED|First Intervention||17
8434948|NCT00834444|20786589|P2|STARTED|First Intervention||18
8434949|NCT00834444|20786590|P1|STARTED|First Intervention||18
8434950|NCT00834431|20786600|P2|NOT COMPLETED|Second Intervention||0
8434951|NCT00834431|20786601|P1|NOT COMPLETED|Second Intervention||0
8434952|NCT00834431|20786600|P2|COMPLETED|Second Intervention||16
8434953|NCT00834431|20786601|P1|COMPLETED|Second Intervention||18
8434954|NCT00834431|20786600|P2|STARTED|Second Intervention||16
8434955|NCT00834431|20786601|P1|STARTED|Second Intervention||18
8434956|NCT00834431|20786600|P2|NOT COMPLETED|Washout of 7 Days||1
8434957|NCT00834431|20786601|P1|NOT COMPLETED|Washout of 7 Days||0
8434958|NCT00834431|20786600|P2|COMPLETED|Washout of 7 Days||16
8434959|NCT00834431|20786601|P1|COMPLETED|Washout of 7 Days||18
8434960|NCT00834431|20786600|P2|STARTED|Washout of 7 Days||17
8434961|NCT00834431|20786601|P1|STARTED|Washout of 7 Days||18
8434962|NCT00834431|20786600|P2|NOT COMPLETED|First Intervention||1
8434963|NCT00834431|20786601|P1|NOT COMPLETED|First Intervention||0
8434964|NCT00834431|20786600|P2|COMPLETED|First Intervention||17
8434965|NCT00834431|20786601|P1|COMPLETED|First Intervention||18
8434966|NCT00834431|20786600|P2|STARTED|First Intervention||18
8434967|NCT00834431|20786601|P1|STARTED|First Intervention||18
8434968|NCT00834418|20786611|P2|NOT COMPLETED|Overall Study||2
8434969|NCT00834418|20786612|P1|NOT COMPLETED|Overall Study||0
8434970|NCT00834418|20786611|P2|COMPLETED|Overall Study||40
8434971|NCT00834418|20786612|P1|COMPLETED|Overall Study||42
8434972|NCT00834418|20786611|P2|STARTED|Overall Study||42
8434973|NCT00834418|20786612|P1|STARTED|Overall Study||42
8434974|NCT00834405|20786620|P2|NOT COMPLETED|Overall Study||0
8434975|NCT00834405|20786621|P1|NOT COMPLETED|Overall Study||0
8434976|NCT00834405|20786620|P2|COMPLETED|Overall Study||17
8434977|NCT00834405|20786621|P1|COMPLETED|Overall Study||20
8434978|NCT00834405|20786620|P2|STARTED|Overall Study||17
8434979|NCT00834405|20786621|P1|STARTED|Overall Study||20
8434980|NCT00834366|20786629|P2|NOT COMPLETED|Treatment Period 2||0
8434981|NCT00834366|20786630|P1|NOT COMPLETED|Treatment Period 2||0
8434982|NCT00834366|20786629|P2|COMPLETED|Treatment Period 2||12
8434983|NCT00834366|20786630|P1|COMPLETED|Treatment Period 2||12
8434984|NCT00834366|20786629|P2|STARTED|Treatment Period 2||12
8434985|NCT00834366|20786630|P1|STARTED|Treatment Period 2||12
8434986|NCT00834366|20786629|P2|NOT COMPLETED|Treatment Period 1||1
8434987|NCT00834366|20786630|P1|NOT COMPLETED|Treatment Period 1||1
8434988|NCT00834366|20786629|P2|COMPLETED|Treatment Period 1||12
8434989|NCT00834366|20786630|P1|COMPLETED|Treatment Period 1||12
8434990|NCT00834366|20786629|P2|STARTED|Treatment Period 1||13
8434991|NCT00834366|20786630|P1|STARTED|Treatment Period 1||13
8434992|NCT00834340|20786646|P2|NOT COMPLETED|Second Intervention||0
8434993|NCT00834340|20786647|P1|NOT COMPLETED|Second Intervention||0
8434994|NCT00834340|20786646|P2|COMPLETED|Second Intervention||16
8434995|NCT00834340|20786647|P1|COMPLETED|Second Intervention||14
8434996|NCT00834340|20786646|P2|STARTED|Second Intervention||16
8434997|NCT00834340|20786647|P1|STARTED|Second Intervention||14
8434998|NCT00834340|20786646|P2|NOT COMPLETED|Washout||0
8434999|NCT00834340|20786647|P1|NOT COMPLETED|Washout||2
8435000|NCT00834340|20786646|P2|COMPLETED|Washout||16
8435001|NCT00834340|20786647|P1|COMPLETED|Washout||14
8435002|NCT00834340|20786646|P2|STARTED|Washout||16
8435003|NCT00834340|20786647|P1|STARTED|Washout||16
8435004|NCT00834340|20786646|P2|NOT COMPLETED|First Intervention||0
8435005|NCT00834340|20786647|P1|NOT COMPLETED|First Intervention||0
8435006|NCT00834340|20786646|P2|COMPLETED|First Intervention||16
8435007|NCT00834340|20786647|P1|COMPLETED|First Intervention||16
8435008|NCT00834340|20786646|P2|STARTED|First Intervention||16
8435009|NCT00834340|20786647|P1|STARTED|First Intervention||16
8435010|NCT00834288|20786657|P2|NOT COMPLETED|Treatment Phase II||0
8435011|NCT00834288|20786658|P1|NOT COMPLETED|Treatment Phase II||0
8435012|NCT00834288|20786657|P2|COMPLETED|Treatment Phase II||13
8435013|NCT00834288|20786658|P1|COMPLETED|Treatment Phase II||13
8435014|NCT00834288|20786657|P2|STARTED|Treatment Phase II||13
8435015|NCT00834288|20786658|P1|STARTED|Treatment Phase II||13
8435016|NCT00834288|20786657|P2|NOT COMPLETED|Treatment Phase I||0
8435017|NCT00834288|20786658|P1|NOT COMPLETED|Treatment Phase I||0
8435018|NCT00834288|20786657|P2|COMPLETED|Treatment Phase I||13
8435019|NCT00834288|20786658|P1|COMPLETED|Treatment Phase I||13
8435020|NCT00834288|20786657|P2|STARTED|Treatment Phase I||13
8435021|NCT00834288|20786658|P1|STARTED|Treatment Phase I||13
8435022|NCT00834275|20786680|P2|NOT COMPLETED|Second Intervention||0
8435023|NCT00834275|20786681|P1|NOT COMPLETED|Second Intervention||0
8435024|NCT00834275|20786680|P2|COMPLETED|Second Intervention||13
8435025|NCT00834275|20786681|P1|COMPLETED|Second Intervention||13
8435026|NCT00834275|20786680|P2|STARTED|Second Intervention||13
8435027|NCT00834275|20786681|P1|STARTED|Second Intervention||13
8435028|NCT00834275|20786680|P2|NOT COMPLETED|Washout of 7 Days||0
8435029|NCT00834275|20786681|P1|NOT COMPLETED|Washout of 7 Days||0
8435030|NCT00834275|20786680|P2|COMPLETED|Washout of 7 Days||13
8435031|NCT00834275|20786681|P1|COMPLETED|Washout of 7 Days||13
8435032|NCT00834275|20786680|P2|STARTED|Washout of 7 Days||13
8435033|NCT00834275|20786681|P1|STARTED|Washout of 7 Days||13
8435034|NCT00834275|20786680|P2|NOT COMPLETED|First Intervention||0
8435035|NCT00834275|20786681|P1|NOT COMPLETED|First Intervention||0
8435036|NCT00834275|20786680|P2|COMPLETED|First Intervention||13
8435037|NCT00834275|20786681|P1|COMPLETED|First Intervention||13
8435038|NCT00834275|20786680|P2|STARTED|First Intervention||13
8435039|NCT00834275|20786681|P1|STARTED|First Intervention||13
8435040|NCT00834249|20786691|P2|NOT COMPLETED|Second Intervention||0
8435041|NCT00834249|20786692|P1|NOT COMPLETED|Second Intervention||1
8435042|NCT00834249|20786691|P2|COMPLETED|Second Intervention||8
8435043|NCT00834249|20786692|P1|COMPLETED|Second Intervention||7
8435044|NCT00834249|20786691|P2|STARTED|Second Intervention||8
8435045|NCT00834249|20786692|P1|STARTED|Second Intervention||8
8435046|NCT00834249|20786691|P2|NOT COMPLETED|Washout: 7 Days||1
8435047|NCT00834249|20786692|P1|NOT COMPLETED|Washout: 7 Days||1
8435048|NCT00834249|20786691|P2|COMPLETED|Washout: 7 Days||8
8435049|NCT00834249|20786692|P1|COMPLETED|Washout: 7 Days||8
8435050|NCT00834249|20786691|P2|STARTED|Washout: 7 Days||9
8435051|NCT00834249|20786692|P1|STARTED|Washout: 7 Days||9
8435052|NCT00834249|20786691|P2|NOT COMPLETED|First Intervention||0
8435053|NCT00834249|20786692|P1|NOT COMPLETED|First Intervention||0
8435054|NCT00834249|20786691|P2|COMPLETED|First Intervention||9
8435055|NCT00834249|20786692|P1|COMPLETED|First Intervention||9
8435056|NCT00834249|20786691|P2|STARTED|First Intervention||9
8435057|NCT00834249|20786692|P1|STARTED|First Intervention||9
8435058|NCT00834236|20786708|P2|NOT COMPLETED|Overall Study||0
8435059|NCT00834236|20786709|P1|NOT COMPLETED|Overall Study||0
8435060|NCT00834236|20786708|P2|COMPLETED|Overall Study||47
8435061|NCT00834236|20786709|P1|COMPLETED|Overall Study||29
8435062|NCT00834236|20786708|P2|STARTED|Overall Study||47
8435063|NCT00834236|20786709|P1|STARTED|Overall Study||29
8435064|NCT00834210|20786717|P2|NOT COMPLETED|Overall Study||8
8435065|NCT00834210|20786718|P1|NOT COMPLETED|Overall Study||3
8435066|NCT00834210|20786717|P2|COMPLETED|Overall Study||77
8435067|NCT00834210|20786718|P1|COMPLETED|Overall Study||83
8435068|NCT00834210|20786717|P2|STARTED|Overall Study||85
8435069|NCT00834210|20786718|P1|STARTED|Overall Study||86
8435070|NCT00834197|20786732|P2|NOT COMPLETED|Second Intervention||0
8435071|NCT00834197|20786733|P1|NOT COMPLETED|Second Intervention||0
8435072|NCT00834197|20786732|P2|COMPLETED|Second Intervention||16
8435073|NCT00834197|20786733|P1|COMPLETED|Second Intervention||16
8435074|NCT00834197|20786732|P2|STARTED|Second Intervention||16
8435075|NCT00834197|20786733|P1|STARTED|Second Intervention||16
8435076|NCT00834197|20786732|P2|NOT COMPLETED|Washout of 14 Days||0
8435077|NCT00834197|20786733|P1|NOT COMPLETED|Washout of 14 Days||0
8435078|NCT00834197|20786732|P2|COMPLETED|Washout of 14 Days||16
8435079|NCT00834197|20786733|P1|COMPLETED|Washout of 14 Days||16
8435080|NCT00834197|20786732|P2|STARTED|Washout of 14 Days||16
8435081|NCT00834197|20786733|P1|STARTED|Washout of 14 Days||16
8435082|NCT00834197|20786732|P2|NOT COMPLETED|First Intervention||0
8435083|NCT00834197|20786733|P1|NOT COMPLETED|First Intervention||0
8435084|NCT00834197|20786732|P2|COMPLETED|First Intervention||16
8435085|NCT00834197|20786733|P1|COMPLETED|First Intervention||16
8435086|NCT00834197|20786732|P2|STARTED|First Intervention||16
8435087|NCT00834197|20786733|P1|STARTED|First Intervention||16
8435088|NCT00834171|20786743|P2|NOT COMPLETED|Overall Study||0
8435089|NCT00834171|20786744|P1|NOT COMPLETED|Overall Study||0
8435090|NCT00834171|20786743|P2|COMPLETED|Overall Study||7
8435091|NCT00834171|20786744|P1|COMPLETED|Overall Study||43
8435092|NCT00834171|20786743|P2|STARTED|Overall Study||7
8435093|NCT00834171|20786744|P1|STARTED|Overall Study||43
8435094|NCT00834132|20786752|P2|NOT COMPLETED|Second Intervention||0
8435095|NCT00834132|20786753|P1|NOT COMPLETED|Second Intervention||0
8435096|NCT00834132|20786752|P2|COMPLETED|Second Intervention||12
8435097|NCT00834132|20786753|P1|COMPLETED|Second Intervention||12
8435098|NCT00834132|20786752|P2|STARTED|Second Intervention||12
8435099|NCT00834132|20786753|P1|STARTED|Second Intervention||12
8435100|NCT00834132|20786752|P2|NOT COMPLETED|Washout: 21 Days||0
8435101|NCT00834132|20786753|P1|NOT COMPLETED|Washout: 21 Days||0
8435102|NCT00834132|20786752|P2|COMPLETED|Washout: 21 Days||12
8435103|NCT00834132|20786753|P1|COMPLETED|Washout: 21 Days||12
8435104|NCT00834132|20786752|P2|STARTED|Washout: 21 Days||12
8435105|NCT00834132|20786753|P1|STARTED|Washout: 21 Days||12
8435106|NCT00834132|20786752|P2|NOT COMPLETED|First Intervention||0
8435107|NCT00834132|20786753|P1|NOT COMPLETED|First Intervention||0
8435108|NCT00834132|20786752|P2|COMPLETED|First Intervention||12
8435109|NCT00834132|20786753|P1|COMPLETED|First Intervention||12
8435110|NCT00834132|20786752|P2|STARTED|First Intervention||12
8435111|NCT00834132|20786753|P1|STARTED|First Intervention||12
8435112|NCT00834106|20786763|P2|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
8435113|NCT00834106|20786764|P1|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
8435114|NCT00834106|20786763|P2|COMPLETED|Extension Study (Month 42 to Month 90)||1294
8435115|NCT00834106|20786764|P1|COMPLETED|Extension Study (Month 42 to Month 90)||1308
8435116|NCT00834106|20786763|P2|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
8435117|NCT00834106|20786764|P1|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
8435118|NCT00834106|20786763|P2|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
8435119|NCT00834106|20786764|P1|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
8435120|NCT00834106|20786763|P2|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
8435121|NCT00834106|20786764|P1|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
8435122|NCT00834106|20786763|P2|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
8435123|NCT00834106|20786764|P1|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
8435124|NCT00834106|20786763|P2|Vaccinated|Base Study (Day 1 to Month 30)||1503
8435125|NCT00834106|20786764|P1|Vaccinated|Base Study (Day 1 to Month 30)||1503
8435126|NCT00834106|20786763|P2|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
8435127|NCT00834106|20786764|P1|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
8435128|NCT00834080|20786788|P1|NOT COMPLETED|Overall Study||23
8435129|NCT00834080|20786788|P1|COMPLETED|Overall Study||15
8435130|NCT00834080|20786788|P1|STARTED|Overall Study||38
8435131|NCT00834067|20786794|P2|NOT COMPLETED|Second Intervention||0
8435132|NCT00834067|20786795|P1|NOT COMPLETED|Second Intervention||0
8435133|NCT00834067|20786794|P2|COMPLETED|Second Intervention||29
8435134|NCT00834067|20786795|P1|COMPLETED|Second Intervention||30
8435135|NCT00834067|20786794|P2|STARTED|Second Intervention||29
8435136|NCT00834067|20786795|P1|STARTED|Second Intervention||30
8435137|NCT00834067|20786794|P2|NOT COMPLETED|Washout of 21 Days||1
8435138|NCT00834067|20786795|P1|NOT COMPLETED|Washout of 21 Days||0
8435139|NCT00834067|20786794|P2|COMPLETED|Washout of 21 Days||29
8435140|NCT00834067|20786795|P1|COMPLETED|Washout of 21 Days||30
8435141|NCT00834067|20786794|P2|STARTED|Washout of 21 Days||30
8435142|NCT00834067|20786795|P1|STARTED|Washout of 21 Days||30
8435143|NCT00834067|20786794|P2|NOT COMPLETED|First Intervention||0
8435144|NCT00834067|20786795|P1|NOT COMPLETED|First Intervention||0
8435145|NCT00834067|20786794|P2|COMPLETED|First Intervention||30
8435146|NCT00834067|20786795|P1|COMPLETED|First Intervention||30
8435147|NCT00834067|20786794|P2|STARTED|First Intervention||30
8435148|NCT00834067|20786795|P1|STARTED|First Intervention||30
8435149|NCT00834041|20786817|P2|NOT COMPLETED|Overall Study||1
8435150|NCT00834041|20786818|P1|NOT COMPLETED|Overall Study||1
8435151|NCT00834041|20786817|P2|COMPLETED|Overall Study||19
8435152|NCT00834041|20786818|P1|COMPLETED|Overall Study||18
8435153|NCT00834041|20786817|P2|STARTED|Overall Study||20
8435154|NCT00834041|20786818|P1|STARTED|Overall Study||19
8435155|NCT00833989|20786836|P4|NOT COMPLETED|Overall Study||2
8435156|NCT00833989|20786837|P3|NOT COMPLETED|Overall Study||1
8435157|NCT00833989|20786838|P2|NOT COMPLETED|Overall Study||0
8435158|NCT00833989|20786839|P1|NOT COMPLETED|Overall Study||3
8435159|NCT00833989|20786836|P4|COMPLETED|Overall Study||6
8435160|NCT00833989|20786837|P3|COMPLETED|Overall Study||8
8435161|NCT00833989|20786838|P2|COMPLETED|Overall Study||8
8435162|NCT00833989|20786839|P1|COMPLETED|Overall Study||14
8435163|NCT00833989|20786836|P4|STARTED|Overall Study||8
8435164|NCT00833989|20786837|P3|STARTED|Overall Study||9
8435165|NCT00833989|20786838|P2|STARTED|Overall Study||8
8435166|NCT00833989|20786839|P1|STARTED|Overall Study||17
8435167|NCT00833976|20786943|P1|NOT COMPLETED|Overall Study||51
8435168|NCT00833976|20786943|P1|COMPLETED|Overall Study||14
8435169|NCT00833976|20786943|P1|STARTED|Overall Study||65
8435170|NCT00833937|20786951|P2|NOT COMPLETED|Second Intervention||0
8435171|NCT00833937|20786952|P1|NOT COMPLETED|Second Intervention||0
8435172|NCT00833937|20786951|P2|COMPLETED|Second Intervention||12
8435173|NCT00833937|20786952|P1|COMPLETED|Second Intervention||11
8435174|NCT00833937|20786951|P2|STARTED|Second Intervention||12
8435175|NCT00833937|20786952|P1|STARTED|Second Intervention||11
8435176|NCT00833937|20786951|P2|NOT COMPLETED|Washout||0
8435177|NCT00833937|20786952|P1|NOT COMPLETED|Washout||1
8435178|NCT00833937|20786951|P2|COMPLETED|Washout||12
8435179|NCT00833937|20786952|P1|COMPLETED|Washout||11
8435180|NCT00833937|20786951|P2|STARTED|Washout||12
8435181|NCT00833937|20786952|P1|STARTED|Washout||12
8435182|NCT00833937|20786951|P2|NOT COMPLETED|First Intervention||0
8435183|NCT00833937|20786952|P1|NOT COMPLETED|First Intervention||0
8435184|NCT00833937|20786951|P2|COMPLETED|First Intervention||12
8435185|NCT00833937|20786952|P1|COMPLETED|First Intervention||12
8435186|NCT00833937|20786951|P2|STARTED|First Intervention||12
8435187|NCT00833937|20786952|P1|STARTED|First Intervention||12
8435188|NCT00833924|20786960|P1|NOT COMPLETED|Overall Study||109
8435189|NCT00833924|20786960|P1|COMPLETED|Overall Study||11
8435190|NCT00833924|20786960|P1|12-month|Overall Study||113
8435191|NCT00833924|20786960|P1|30-day|Overall Study||120
8435192|NCT00833924|20786960|P1|STARTED|Overall Study||120
8435193|NCT00833911|20786965|P1|NOT COMPLETED|Maintenance Phase II||10
8435194|NCT00833911|20786965|P1|COMPLETED|Maintenance Phase II||166
8435195|NCT00833911|20786965|P1|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
8435196|NCT00833911|20786965|P1|NOT COMPLETED|Maintenance Phase I||98
8435197|NCT00833911|20786965|P1|COMPLETED|Maintenance Phase I||273
8435198|NCT00833911|20786965|P1|STARTED|Maintenance Phase I||371
8435199|NCT00833911|20786965|P1|NOT COMPLETED|Titration||21
8435200|NCT00833911|20786965|P1|COMPLETED|Titration||371
8435201|NCT00833911|20786965|P1|STARTED|Titration||392
8435202|NCT00833898|20786975|P2|NOT COMPLETED|Overall Study||36
8435203|NCT00833898|20786976|P1|NOT COMPLETED|Overall Study||40
8435204|NCT00833898|20786975|P2|COMPLETED|Overall Study||38
8435205|NCT00833898|20786976|P1|COMPLETED|Overall Study||34
8435206|NCT00833898|20786975|P2|Month 12 (Post Transplantation)|Overall Study||50
8435207|NCT00833898|20786976|P1|Month 12 (Post Transplantation)|Overall Study||50
8435208|NCT00833898|20786975|P2|Month 6 (Post Transplantation)|Overall Study||54
8435209|NCT00833898|20786976|P1|Month 6 (Post Transplantation)|Overall Study||59
8435210|NCT00833898|20786975|P2|Month 3 (Post Transplantation)|Overall Study||64
8435211|NCT00833898|20786976|P1|Month 3 (Post Transplantation)|Overall Study||66
8435212|NCT00833898|20786975|P2|Month 1 (Post Transplantation)|Overall Study||74
8435213|NCT00833898|20786976|P1|Month 1 (Post Transplantation)|Overall Study||72
8435214|NCT00833898|20786975|P2|STARTED|Overall Study||74
8435215|NCT00833898|20786976|P1|STARTED|Overall Study||74
8435216|NCT00833859|20787022|P1|NOT COMPLETED|Overall Study||0
8435217|NCT00833859|20787022|P1|COMPLETED|Overall Study||2
8435218|NCT00833859|20787022|P1|STARTED|Overall Study||2
8435219|NCT00833833|20787035|P6|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
8435220|NCT00833833|20787036|P5|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
8435221|NCT00833833|20787037|P4|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
8435222|NCT00833833|20787038|P3|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
8435223|NCT00833833|20787039|P2|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
8435224|NCT00833833|20787040|P1|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
8435225|NCT00833833|20787035|P6|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
8435226|NCT00833833|20787036|P5|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
8435227|NCT00833833|20787037|P4|COMPLETED|Phase 2 (as of 01 April 2011)||0
8435228|NCT00833833|20787038|P3|COMPLETED|Phase 2 (as of 01 April 2011)||0
8435229|NCT00833833|20787039|P2|COMPLETED|Phase 2 (as of 01 April 2011)||0
8435230|NCT00833833|20787040|P1|COMPLETED|Phase 2 (as of 01 April 2011)||0
8435231|NCT00833833|20787035|P6|Safety Population|Phase 2 (as of 01 April 2011)||107
8435232|NCT00833833|20787036|P5|Safety Population|Phase 2 (as of 01 April 2011)||112
8435233|NCT00833833|20787037|P4|Safety Population|Phase 2 (as of 01 April 2011)||0
8435234|NCT00833833|20787038|P3|Safety Population|Phase 2 (as of 01 April 2011)||0
8435235|NCT00833833|20787039|P2|Safety Population|Phase 2 (as of 01 April 2011)||0
8435236|NCT00833833|20787040|P1|Safety Population|Phase 2 (as of 01 April 2011)||0
8435237|NCT00833833|20787035|P6|STARTED|Phase 2 (as of 01 April 2011)||108
8435238|NCT00833833|20787036|P5|STARTED|Phase 2 (as of 01 April 2011)||113
8435239|NCT00833833|20787037|P4|STARTED|Phase 2 (as of 01 April 2011)||0
8435240|NCT00833833|20787038|P3|STARTED|Phase 2 (as of 01 April 2011)||0
8435241|NCT00833833|20787039|P2|STARTED|Phase 2 (as of 01 April 2011)||0
8435242|NCT00833833|20787040|P1|STARTED|Phase 2 (as of 01 April 2011)||0
8435243|NCT00833833|20787035|P6|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
8435244|NCT00833833|20787036|P5|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
8435245|NCT00833833|20787037|P4|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
8435246|NCT00833833|20787038|P3|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
8435247|NCT00833833|20787039|P2|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
8435248|NCT00833833|20787040|P1|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
8435249|NCT00833833|20787035|P6|COMPLETED|Phase 1 (as of 01 April 2011)||0
8435250|NCT00833833|20787036|P5|COMPLETED|Phase 1 (as of 01 April 2011)||0
8435251|NCT00833833|20787037|P4|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
8435252|NCT00833833|20787038|P3|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
8435253|NCT00833833|20787039|P2|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
8435254|NCT00833833|20787040|P1|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
8435255|NCT00833833|20787035|P6|STARTED|Phase 1 (as of 01 April 2011)||0
8435256|NCT00833833|20787036|P5|STARTED|Phase 1 (as of 01 April 2011)||0
8435257|NCT00833833|20787037|P4|STARTED|Phase 1 (as of 01 April 2011)||10
8435258|NCT00833833|20787038|P3|STARTED|Phase 1 (as of 01 April 2011)||14
8435259|NCT00833833|20787039|P2|STARTED|Phase 1 (as of 01 April 2011)||8
8435260|NCT00833833|20787040|P1|STARTED|Phase 1 (as of 01 April 2011)||6
8435261|NCT00833794|20787080|P2|NOT COMPLETED|Double-blind Phase||49
8435262|NCT00833794|20787081|P1|NOT COMPLETED|Double-blind Phase||106
8435263|NCT00833794|20787080|P2|COMPLETED|Double-blind Phase||165
8435264|NCT00833794|20787081|P1|COMPLETED|Double-blind Phase||326
8435265|NCT00833794|20787080|P2|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
8435266|NCT00833794|20787081|P1|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
8435267|NCT00833794|20787080|P2|NOT COMPLETED|Open-label Phase||0
8435268|NCT00833794|20787081|P1|NOT COMPLETED|Open-label Phase||382
8435269|NCT00833794|20787080|P2|COMPLETED|Open-label Phase||0
8435357|NCT00833586|20787345|P1|NOT COMPLETED|Washout: 14 Days||0
8435270|NCT00833794|20787081|P1|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
8435271|NCT00833794|20787080|P2|Received Open-Label Treatment|Open-label Phase||0
8435272|NCT00833794|20787081|P1|Received Open-Label Treatment|Open-label Phase||1023
8435273|NCT00833794|20787080|P2|Entered run-in Period|Open-label Phase||0
8435274|NCT00833794|20787081|P1|Entered run-in Period|Open-label Phase||1027
8435275|NCT00833794|20787080|P2|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
8435276|NCT00833794|20787081|P1|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
8435277|NCT00833781|20787109|P2|NOT COMPLETED|Overall Study||0
8435278|NCT00833781|20787110|P1|NOT COMPLETED|Overall Study||0
8435279|NCT00833781|20787109|P2|COMPLETED|Overall Study||5
8435280|NCT00833781|20787110|P1|COMPLETED|Overall Study||10
8435281|NCT00833781|20787109|P2|STARTED|Overall Study||5
8435282|NCT00833781|20787110|P1|STARTED|Overall Study||10
8435283|NCT00833755|20787125|P4|NOT COMPLETED|Overall Study||6
8435284|NCT00833755|20787126|P3|NOT COMPLETED|Overall Study||2
8435285|NCT00833755|20787127|P2|NOT COMPLETED|Overall Study||5
8435286|NCT00833755|20787128|P1|NOT COMPLETED|Overall Study||4
8435287|NCT00833755|20787125|P4|COMPLETED|Overall Study||17
8435288|NCT00833755|20787126|P3|COMPLETED|Overall Study||20
8435289|NCT00833755|20787127|P2|COMPLETED|Overall Study||13
8435290|NCT00833755|20787128|P1|COMPLETED|Overall Study||12
8435291|NCT00833755|20787125|P4|STARTED|Overall Study||23
8435292|NCT00833755|20787126|P3|STARTED|Overall Study||22
8435293|NCT00833755|20787127|P2|STARTED|Overall Study||18
8435294|NCT00833755|20787128|P1|STARTED|Overall Study||16
8435295|NCT00833703|20787148|P2|NOT COMPLETED|Overall Study||1
8435296|NCT00833703|20787149|P1|NOT COMPLETED|Overall Study||0
8435297|NCT00833703|20787148|P2|COMPLETED|Overall Study|Completed follow-up|25
8435298|NCT00833703|20787149|P1|COMPLETED|Overall Study|Completed follow-up|23
8435299|NCT00833703|20787148|P2|Completed Treatment|Overall Study||24
8435300|NCT00833703|20787149|P1|Completed Treatment|Overall Study||22
8435301|NCT00833703|20787148|P2|Treated|Overall Study||26
8435302|NCT00833703|20787149|P1|Treated|Overall Study||23
8435303|NCT00833703|20787148|P2|STARTED|Overall Study|Included|26
8435304|NCT00833703|20787149|P1|STARTED|Overall Study|Included|23
8435305|NCT00833690|20787162|P3|NOT COMPLETED|Overall Study||0
8435306|NCT00833690|20787163|P2|NOT COMPLETED|Overall Study||2
8435307|NCT00833690|20787164|P1|NOT COMPLETED|Overall Study||4
8435308|NCT00833690|20787162|P3|COMPLETED|Overall Study||26
8435309|NCT00833690|20787163|P2|COMPLETED|Overall Study||22
8435310|NCT00833690|20787164|P1|COMPLETED|Overall Study||21
8435311|NCT00833690|20787162|P3|STARTED|Overall Study||26
8435312|NCT00833690|20787163|P2|STARTED|Overall Study||24
8435313|NCT00833690|20787164|P1|STARTED|Overall Study||25
8435314|NCT00833664|20787288|P2|NOT COMPLETED|Second Intervention||0
8435315|NCT00833664|20787289|P1|NOT COMPLETED|Second Intervention||0
8435316|NCT00833664|20787288|P2|COMPLETED|Second Intervention||11
8435317|NCT00833664|20787289|P1|COMPLETED|Second Intervention||10
8435318|NCT00833664|20787288|P2|STARTED|Second Intervention||11
8435319|NCT00833664|20787289|P1|STARTED|Second Intervention||10
8435320|NCT00833664|20787288|P2|NOT COMPLETED|Washout: 14 Days||0
8435321|NCT00833664|20787289|P1|NOT COMPLETED|Washout: 14 Days||1
8435322|NCT00833664|20787288|P2|COMPLETED|Washout: 14 Days||11
8435323|NCT00833664|20787289|P1|COMPLETED|Washout: 14 Days||10
8435324|NCT00833664|20787288|P2|STARTED|Washout: 14 Days||11
8435325|NCT00833664|20787289|P1|STARTED|Washout: 14 Days||11
8435326|NCT00833664|20787288|P2|NOT COMPLETED|First Intervention||0
8435327|NCT00833664|20787289|P1|NOT COMPLETED|First Intervention||0
8435328|NCT00833664|20787288|P2|COMPLETED|First Intervention||11
8435329|NCT00833664|20787289|P1|COMPLETED|First Intervention||11
8435330|NCT00833664|20787288|P2|STARTED|First Intervention||11
8435331|NCT00833664|20787289|P1|STARTED|First Intervention||11
8435332|NCT00833638|20787300|P3|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
8435333|NCT00833638|20787301|P2|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
8435334|NCT00833638|20787302|P1|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
8435335|NCT00833638|20787300|P3|COMPLETED|Phase 3: Open-label Extension Phase||122
8435336|NCT00833638|20787301|P2|COMPLETED|Phase 3: Open-label Extension Phase||105
8435337|NCT00833638|20787302|P1|COMPLETED|Phase 3: Open-label Extension Phase||110
8435338|NCT00833638|20787300|P3|STARTED|Phase 3: Open-label Extension Phase||124
8435339|NCT00833638|20787301|P2|STARTED|Phase 3: Open-label Extension Phase||108
8435340|NCT00833638|20787302|P1|STARTED|Phase 3: Open-label Extension Phase||111
8435341|NCT00833638|20787300|P3|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
8435342|NCT00833638|20787301|P2|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
8435343|NCT00833638|20787302|P1|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
8435344|NCT00833638|20787300|P3|COMPLETED|Phase 2: Double-blind Treatment Phase||124
8435345|NCT00833638|20787301|P2|COMPLETED|Phase 2: Double-blind Treatment Phase||108
8435346|NCT00833638|20787302|P1|COMPLETED|Phase 2: Double-blind Treatment Phase||111
8435347|NCT00833638|20787300|P3|STARTED|Phase 2: Double-blind Treatment Phase||133
8435348|NCT00833638|20787301|P2|STARTED|Phase 2: Double-blind Treatment Phase||118
8435349|NCT00833638|20787302|P1|STARTED|Phase 2: Double-blind Treatment Phase||121
8435350|NCT00833586|20787344|P2|NOT COMPLETED|Second Intervention||0
8435351|NCT00833586|20787345|P1|NOT COMPLETED|Second Intervention||0
8435352|NCT00833586|20787344|P2|COMPLETED|Second Intervention||14
8435353|NCT00833586|20787345|P1|COMPLETED|Second Intervention||14
8435354|NCT00833586|20787344|P2|STARTED|Second Intervention||14
8435355|NCT00833586|20787345|P1|STARTED|Second Intervention||14
8435356|NCT00833586|20787344|P2|NOT COMPLETED|Washout: 14 Days||0
8435358|NCT00833586|20787344|P2|COMPLETED|Washout: 14 Days||14
8435359|NCT00833586|20787345|P1|COMPLETED|Washout: 14 Days||14
8435360|NCT00833586|20787344|P2|STARTED|Washout: 14 Days||14
8435361|NCT00833586|20787345|P1|STARTED|Washout: 14 Days||14
8435362|NCT00833586|20787344|P2|NOT COMPLETED|First Intervention||0
8435363|NCT00833586|20787345|P1|NOT COMPLETED|First Intervention||0
8435364|NCT00833586|20787344|P2|COMPLETED|First Intervention||14
8435365|NCT00833586|20787345|P1|COMPLETED|First Intervention||14
8435366|NCT00833586|20787344|P2|STARTED|First Intervention||14
8435367|NCT00833586|20787345|P1|STARTED|First Intervention||14
8435368|NCT00833560|20787353|P1|NOT COMPLETED|Overall Study||42
8435369|NCT00833560|20787353|P1|COMPLETED|Overall Study||353
8435370|NCT00833560|20787353|P1|STARTED|Overall Study||395
8435371|NCT00833547|20787362|P2|NOT COMPLETED|Overall Study||2
8435372|NCT00833547|20787363|P1|NOT COMPLETED|Overall Study||2
8435373|NCT00833547|20787362|P2|COMPLETED|Overall Study||10
8435374|NCT00833547|20787363|P1|COMPLETED|Overall Study||11
8435375|NCT00833547|20787362|P2|STARTED|Overall Study||12
8435376|NCT00833547|20787363|P1|STARTED|Overall Study||13
8435377|NCT00833521|20787373|P2|NOT COMPLETED|Second Intervention||0
8435378|NCT00833521|20787374|P1|NOT COMPLETED|Second Intervention||0
8435379|NCT00833521|20787373|P2|COMPLETED|Second Intervention||19
8435380|NCT00833521|20787374|P1|COMPLETED|Second Intervention||19
8435381|NCT00833521|20787373|P2|STARTED|Second Intervention||19
8435382|NCT00833521|20787374|P1|STARTED|Second Intervention||19
8435383|NCT00833521|20787373|P2|NOT COMPLETED|First Intervention||0
8435384|NCT00833521|20787374|P1|NOT COMPLETED|First Intervention||0
8435385|NCT00833521|20787373|P2|COMPLETED|First Intervention||19
8435386|NCT00833521|20787374|P1|COMPLETED|First Intervention||19
8435387|NCT00833521|20787373|P2|STARTED|First Intervention||19
8435388|NCT00833521|20787374|P1|STARTED|First Intervention||19
8435389|NCT00833482|20787384|P6|NOT COMPLETED|Days 21-30||0
8435390|NCT00833482|20787385|P5|NOT COMPLETED|Days 21-30||1
8435391|NCT00833482|20787386|P4|NOT COMPLETED|Days 21-30||0
8435392|NCT00833482|20787387|P3|NOT COMPLETED|Days 21-30||1
8435393|NCT00833482|20787388|P2|NOT COMPLETED|Days 21-30||0
8435394|NCT00833482|20787389|P1|NOT COMPLETED|Days 21-30||0
8435395|NCT00833482|20787384|P6|COMPLETED|Days 21-30||0
8435396|NCT00833482|20787385|P5|COMPLETED|Days 21-30||7
8435397|NCT00833482|20787386|P4|COMPLETED|Days 21-30||0
8435398|NCT00833482|20787387|P3|COMPLETED|Days 21-30||20
8435399|NCT00833482|20787388|P2|COMPLETED|Days 21-30||0
8435400|NCT00833482|20787389|P1|COMPLETED|Days 21-30||0
8435401|NCT00833482|20787384|P6|STARTED|Days 21-30||0
8435402|NCT00833482|20787385|P5|STARTED|Days 21-30||8
8435403|NCT00833482|20787386|P4|STARTED|Days 21-30||0
8435404|NCT00833482|20787387|P3|STARTED|Days 21-30||21
8435405|NCT00833482|20787388|P2|STARTED|Days 21-30||0
8435406|NCT00833482|20787389|P1|STARTED|Days 21-30||0
8435407|NCT00833482|20787384|P6|NOT COMPLETED|Days 11-20||0
8435408|NCT00833482|20787385|P5|NOT COMPLETED|Days 11-20||0
8435409|NCT00833482|20787386|P4|NOT COMPLETED|Days 11-20||0
8435410|NCT00833482|20787387|P3|NOT COMPLETED|Days 11-20||0
8435411|NCT00833482|20787388|P2|NOT COMPLETED|Days 11-20||3
8435412|NCT00833482|20787389|P1|NOT COMPLETED|Days 11-20||0
8435413|NCT00833482|20787384|P6|COMPLETED|Days 11-20||8
8435414|NCT00833482|20787385|P5|COMPLETED|Days 11-20||0
8435415|NCT00833482|20787386|P4|COMPLETED|Days 11-20||0
8435416|NCT00833482|20787387|P3|COMPLETED|Days 11-20||0
8435417|NCT00833482|20787388|P2|COMPLETED|Days 11-20||21
8435418|NCT00833482|20787389|P1|COMPLETED|Days 11-20||0
8435419|NCT00833482|20787384|P6|STARTED|Days 11-20|Participants who received treatment.|8
8435420|NCT00833482|20787385|P5|STARTED|Days 11-20||0
8435421|NCT00833482|20787386|P4|STARTED|Days 11-20||0
8435422|NCT00833482|20787387|P3|STARTED|Days 11-20||0
8435423|NCT00833482|20787388|P2|STARTED|Days 11-20|Participants who received treatment.|24
8435424|NCT00833482|20787389|P1|STARTED|Days 11-20||0
8435425|NCT00833482|20787384|P6|NOT COMPLETED|Days 1-3||0
8435426|NCT00833482|20787385|P5|NOT COMPLETED|Days 1-3||0
8435427|NCT00833482|20787386|P4|NOT COMPLETED|Days 1-3||0
8435428|NCT00833482|20787387|P3|NOT COMPLETED|Days 1-3||0
8435429|NCT00833482|20787388|P2|NOT COMPLETED|Days 1-3||0
8435430|NCT00833482|20787389|P1|NOT COMPLETED|Days 1-3||0
8435431|NCT00833482|20787384|P6|COMPLETED|Days 1-3||0
8435432|NCT00833482|20787385|P5|COMPLETED|Days 1-3||0
8435433|NCT00833482|20787386|P4|COMPLETED|Days 1-3||8
8435434|NCT00833482|20787387|P3|COMPLETED|Days 1-3||0
8435435|NCT00833482|20787388|P2|COMPLETED|Days 1-3||0
8435436|NCT00833482|20787389|P1|COMPLETED|Days 1-3||24
8435437|NCT00833482|20787384|P6|STARTED|Days 1-3||0
8435438|NCT00833482|20787385|P5|STARTED|Days 1-3||0
8435439|NCT00833482|20787386|P4|STARTED|Days 1-3||8
8435440|NCT00833482|20787387|P3|STARTED|Days 1-3||0
8435441|NCT00833482|20787388|P2|STARTED|Days 1-3|Participants who received treatment|0
8435442|NCT00833482|20787389|P1|STARTED|Days 1-3|Participants who received treatment|24
8435443|NCT00833469|20787445|P1|NOT COMPLETED|Overall Study||2
8435444|NCT00833469|20787445|P1|COMPLETED|Overall Study||3
8435445|NCT00833469|20787445|P1|STARTED|Overall Study||5
8435446|NCT00833443|20787453|P2|NOT COMPLETED|Overall Study||28
8435447|NCT00833443|20787454|P1|NOT COMPLETED|Overall Study||20
8435448|NCT00833443|20787453|P2|COMPLETED|Overall Study||15
8435449|NCT00833443|20787454|P1|COMPLETED|Overall Study||21
8435450|NCT00833443|20787453|P2|STARTED|Overall Study||43
8435451|NCT00833443|20787454|P1|STARTED|Overall Study||41
8435452|NCT00833417|20787468|P2|NOT COMPLETED|Overall Study||71
8435453|NCT00833417|20787469|P1|NOT COMPLETED|Overall Study||33
8435454|NCT00833417|20787468|P2|COMPLETED|Overall Study||0
8435455|NCT00833417|20787469|P1|COMPLETED|Overall Study||0
8435456|NCT00833417|20787468|P2|STARTED|Overall Study||71
8435457|NCT00833417|20787469|P1|STARTED|Overall Study||33
8435458|NCT00833365|20787484|P2|NOT COMPLETED|Overall Study||0
8435459|NCT00833365|20787485|P1|NOT COMPLETED|Overall Study||0
8435460|NCT00833365|20787484|P2|COMPLETED|Overall Study||6
8435461|NCT00833365|20787485|P1|COMPLETED|Overall Study||9
8435462|NCT00833365|20787484|P2|STARTED|Overall Study||6
8435463|NCT00833365|20787485|P1|STARTED|Overall Study||9
8435464|NCT00833261|20787493|P1|NOT COMPLETED|Overall Study||4
8435465|NCT00833261|20787493|P1|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33
8435466|NCT00833261|20787493|P1|STARTED|Overall Study||37
8435467|NCT00833248|20787500|P2|NOT COMPLETED|Overall Study||3
8435468|NCT00833248|20787501|P1|NOT COMPLETED|Overall Study||4
8435469|NCT00833248|20787500|P2|COMPLETED|Overall Study||62
8435470|NCT00833248|20787501|P1|COMPLETED|Overall Study||177
8435471|NCT00833248|20787500|P2|Safety Analysis Set|Overall Study||64
8435472|NCT00833248|20787501|P1|Safety Analysis Set|Overall Study||181
8435473|NCT00833248|20787500|P2|Per Protocol (PP) Analysis Set|Overall Study||57
8435474|NCT00833248|20787501|P1|Per Protocol (PP) Analysis Set|Overall Study||164
8435475|NCT00833248|20787500|P2|Full Analysis Set (FAS)|Overall Study||64
8435476|NCT00833248|20787501|P1|Full Analysis Set (FAS)|Overall Study||180
8435477|NCT00833248|20787500|P2|STARTED|Overall Study||65
8435478|NCT00833248|20787501|P1|STARTED|Overall Study||181
8435479|NCT00833105|20787523|P1|NOT COMPLETED|Overall Study||3
8435480|NCT00833105|20787523|P1|COMPLETED|Overall Study||10
8435481|NCT00833105|20787523|P1|STARTED|Overall Study||13
8435482|NCT00833092|20787541|P2|NOT COMPLETED|Overall Study||7
8435483|NCT00833092|20787542|P1|NOT COMPLETED|Overall Study||4
8435484|NCT00833092|20787541|P2|COMPLETED|Overall Study||50
8435485|NCT00833092|20787542|P1|COMPLETED|Overall Study||50
8435486|NCT00833092|20787541|P2|STARTED|Overall Study||57
8435487|NCT00833092|20787542|P1|STARTED|Overall Study||54
8435488|NCT00833053|20787550|P2|NOT COMPLETED|Overall Study||3
8435489|NCT00833053|20787551|P1|NOT COMPLETED|Overall Study||9
8435490|NCT00833053|20787550|P2|COMPLETED|Overall Study||17
8435491|NCT00833053|20787551|P1|COMPLETED|Overall Study||10
8435492|NCT00833053|20787550|P2|STARTED|Overall Study||20
8435493|NCT00833053|20787551|P1|STARTED|Overall Study||19
8435494|NCT00833040|20787569|P6|NOT COMPLETED|Overall Study||1
8435495|NCT00833040|20787570|P5|NOT COMPLETED|Overall Study||0
8435496|NCT00833040|20787571|P4|NOT COMPLETED|Overall Study||0
8435497|NCT00833040|20787572|P3|NOT COMPLETED|Overall Study||0
8435498|NCT00833040|20787573|P2|NOT COMPLETED|Overall Study||0
8435499|NCT00833040|20787574|P1|NOT COMPLETED|Overall Study||0
8435500|NCT00833040|20787569|P6|COMPLETED|Overall Study||4
8435501|NCT00833040|20787570|P5|COMPLETED|Overall Study||5
8435502|NCT00833040|20787571|P4|COMPLETED|Overall Study||6
8435503|NCT00833040|20787572|P3|COMPLETED|Overall Study||6
8435504|NCT00833040|20787573|P2|COMPLETED|Overall Study||6
8435505|NCT00833040|20787574|P1|COMPLETED|Overall Study||6
8435506|NCT00833040|20787569|P6|STARTED|Overall Study||5
8435507|NCT00833040|20787570|P5|STARTED|Overall Study||5
8435508|NCT00833040|20787571|P4|STARTED|Overall Study||6
8435509|NCT00833040|20787572|P3|STARTED|Overall Study||6
8435510|NCT00833040|20787573|P2|STARTED|Overall Study||6
8435511|NCT00833040|20787574|P1|STARTED|Overall Study||6
8435512|NCT00833027|20787579|P1|NOT COMPLETED|Overall Study||211
8435513|NCT00833027|20787579|P1|COMPLETED|Overall Study||397
8435514|NCT00833027|20787579|P1|STARTED|Overall Study||608
8435515|NCT00832975|20787584|P1|NOT COMPLETED|Overall Study||39
8435516|NCT00832975|20787584|P1|COMPLETED|Overall Study||118
8435517|NCT00832975|20787584|P1|STARTED|Overall Study||157
8435518|NCT00832871|20787589|P1|NOT COMPLETED|Overall Study||0
8435519|NCT00832871|20787589|P1|COMPLETED|Overall Study||4
8435520|NCT00832871|20787589|P1|STARTED|Overall Study||4
8435521|NCT00832819|20787598|P3|NOT COMPLETED|Overall Study||1
8435522|NCT00832819|20787599|P2|NOT COMPLETED|Overall Study||1
8435523|NCT00832819|20787600|P1|NOT COMPLETED|Overall Study||0
8435524|NCT00832819|20787598|P3|COMPLETED|Overall Study||15
8435525|NCT00832819|20787599|P2|COMPLETED|Overall Study||5
8435526|NCT00832819|20787600|P1|COMPLETED|Overall Study||6
8435527|NCT00832819|20787598|P3|STARTED|Overall Study||16
8435528|NCT00832819|20787599|P2|STARTED|Overall Study||6
8435529|NCT00832819|20787600|P1|STARTED|Overall Study||6
8435533|NCT00832767|20787616|P2|NOT COMPLETED|Overall Study||18
8435534|NCT00832767|20787617|P1|NOT COMPLETED|Overall Study||22
8435535|NCT00832767|20787616|P2|COMPLETED|Overall Study||63
8435536|NCT00832767|20787617|P1|COMPLETED|Overall Study||99
8435537|NCT00832767|20787616|P2|STARTED|Overall Study||81
8435538|NCT00832767|20787617|P1|STARTED|Overall Study||121
8435539|NCT00832650|20787648|P3|NOT COMPLETED|Overall Study||1
8435540|NCT00832650|20787649|P2|NOT COMPLETED|Overall Study||0
8435541|NCT00832650|20787650|P1|NOT COMPLETED|Overall Study||0
8435542|NCT00832650|20787648|P3|COMPLETED|Overall Study||22
8435543|NCT00832650|20787649|P2|COMPLETED|Overall Study||12
8435544|NCT00832650|20787650|P1|COMPLETED|Overall Study||25
8435545|NCT00832650|20787648|P3|Treated|Overall Study||22
8435546|NCT00832650|20787649|P2|Treated|Overall Study||12
8435547|NCT00832650|20787650|P1|Treated|Overall Study||25
8435548|NCT00832650|20787648|P3|STARTED|Overall Study||23
8435549|NCT00832650|20787649|P2|STARTED|Overall Study||12
8435550|NCT00832650|20787650|P1|STARTED|Overall Study||25
8435551|NCT00832637|20787682|P1|NOT COMPLETED|Overall Study||0
8435552|NCT00832637|20787682|P1|COMPLETED|Overall Study||33
8435553|NCT00832637|20787682|P1|STARTED|Overall Study||33
8435554|NCT00832624|20787690|P1|NOT COMPLETED|Overall Study||10
8435555|NCT00832624|20787690|P1|COMPLETED|Overall Study||0
8435556|NCT00832624|20787690|P1|STARTED|Overall Study||10
8435557|NCT00832598|20787694|P1|NOT COMPLETED|Overall Study||0
8435558|NCT00832598|20787694|P1|COMPLETED|Overall Study||13
8435559|NCT00832598|20787694|P1|STARTED|Overall Study||13
8435560|NCT00832585|20787700|P1|NOT COMPLETED|Overall Study||2
8435561|NCT00832585|20787700|P1|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
8435562|NCT00832585|20787700|P1|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
8435563|NCT00832572|20787707|P2|NOT COMPLETED|Period 2||0
8435564|NCT00832572|20787708|P1|NOT COMPLETED|Period 2||0
8435565|NCT00832572|20787707|P2|COMPLETED|Period 2||2
8435566|NCT00832572|20787708|P1|COMPLETED|Period 2||3
8435567|NCT00832572|20787707|P2|STARTED|Period 2||2
8435568|NCT00832572|20787708|P1|STARTED|Period 2||3
8435569|NCT00832572|20787707|P2|NOT COMPLETED|Period 1||0
8435570|NCT00832572|20787708|P1|NOT COMPLETED|Period 1||0
8435571|NCT00832572|20787707|P2|COMPLETED|Period 1||2
8435572|NCT00832572|20787708|P1|COMPLETED|Period 1||3
8435573|NCT00832572|20787707|P2|STARTED|Period 1||2
8435574|NCT00832572|20787708|P1|STARTED|Period 1||3
8435575|NCT00832520|20787720|P1|NOT COMPLETED|Overall Study||0
8435576|NCT00832520|20787720|P1|COMPLETED|Overall Study||13
8435577|NCT00832520|20787720|P1|STARTED|Overall Study||13
8435578|NCT00832455|20787725|P1|NOT COMPLETED|Overall Study||72
8435579|NCT00832455|20787725|P1|COMPLETED|Overall Study||373
8435580|NCT00832455|20787725|P1|Week 12|Overall Study||373
8435581|NCT00832455|20787725|P1|Week 8 (Optional)|Overall Study||247
8435582|NCT00832455|20787725|P1|Week 4|Overall Study||411
8435583|NCT00832455|20787725|P1|Baseline|Overall Study|420 -patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
8435584|NCT00832455|20787725|P1|STARTED|Overall Study|445 - number of patients that signed the informed consent form (Safety population)|445
8435585|NCT00832416|20787749|P4|NOT COMPLETED|Overall Study||83
8435586|NCT00832416|20787750|P3|NOT COMPLETED|Overall Study||61
8435587|NCT00832416|20787751|P2|NOT COMPLETED|Overall Study||53
8435588|NCT00832416|20787752|P1|NOT COMPLETED|Overall Study||46
8435589|NCT00832416|20787749|P4|COMPLETED|Overall Study||144
8435590|NCT00832416|20787750|P3|COMPLETED|Overall Study||54
8435591|NCT00832416|20787751|P2|COMPLETED|Overall Study||60
8435592|NCT00832416|20787752|P1|COMPLETED|Overall Study||64
8435593|NCT00832416|20787749|P4|STARTED|Overall Study||227
8435594|NCT00832416|20787750|P3|STARTED|Overall Study||115
8435595|NCT00832416|20787751|P2|STARTED|Overall Study||113
8435596|NCT00832416|20787752|P1|STARTED|Overall Study||110
8435597|NCT00832390|20787793|P3|NOT COMPLETED|Overall Study||0
8435598|NCT00832390|20787794|P2|NOT COMPLETED|Overall Study||0
8435599|NCT00832390|20787795|P1|NOT COMPLETED|Overall Study||0
8435600|NCT00832390|20787793|P3|COMPLETED|Overall Study||1
8435601|NCT00832390|20787794|P2|COMPLETED|Overall Study||16
8435602|NCT00832390|20787795|P1|COMPLETED|Overall Study||12
8435603|NCT00832390|20787793|P3|STARTED|Overall Study||1
8435604|NCT00832390|20787794|P2|STARTED|Overall Study||16
8435605|NCT00832390|20787795|P1|STARTED|Overall Study||12
8435606|NCT00832377|20787803|P1|NOT COMPLETED|Overall Study||1
8435607|NCT00832377|20787803|P1|COMPLETED|Overall Study||36
8435608|NCT00832377|20787803|P1|STARTED|Overall Study||37
8435609|NCT00832338|20787810|P1|NOT COMPLETED|Overall Study||0
8435610|NCT00832338|20787810|P1|COMPLETED|Overall Study||23
8435611|NCT00832338|20787810|P1|STARTED|Overall Study||23
8435612|NCT00832299|20787814|P1|NOT COMPLETED|Overall Study||0
8435613|NCT00832299|20787814|P1|COMPLETED|Overall Study||2
8435614|NCT00832299|20787814|P1|STARTED|Overall Study||2
8435615|NCT00832260|20787819|P1|NOT COMPLETED|Overall Study||0
8435616|NCT00832260|20787819|P1|COMPLETED|Overall Study||70
8435617|NCT00832260|20787819|P1|STARTED|Overall Study||70
8435618|NCT00832130|20787826|P2|NOT COMPLETED|Overall Study||0
8435619|NCT00832130|20787827|P1|NOT COMPLETED|Overall Study||0
8435620|NCT00832130|20787826|P2|COMPLETED|Overall Study||70
8435621|NCT00832130|20787827|P1|COMPLETED|Overall Study||69
8435622|NCT00832130|20787826|P2|STARTED|Overall Study||70
8435623|NCT00832130|20787827|P1|STARTED|Overall Study||69
8435624|NCT00832117|20787849|P1|NOT COMPLETED|Overall Study||12
8435625|NCT00832117|20787849|P1|COMPLETED|Overall Study||17
8435626|NCT00832117|20787849|P1|STARTED|Overall Study||29
8435627|NCT00832091|20787868|P2|NOT COMPLETED|Overall Study||2
8435628|NCT00832091|20787869|P1|NOT COMPLETED|Overall Study||5
8435629|NCT00832091|20787868|P2|COMPLETED|Overall Study||53
8435630|NCT00832091|20787869|P1|COMPLETED|Overall Study||12
8435631|NCT00832091|20787868|P2|STARTED|Overall Study||55
8435632|NCT00832091|20787869|P1|STARTED|Overall Study||17
8435633|NCT00832078|20787877|P2|NOT COMPLETED|Test Day 2 - 2 Period||0
8435634|NCT00832078|20787878|P1|NOT COMPLETED|Test Day 2 - 2 Period||1
8435635|NCT00832078|20787877|P2|COMPLETED|Test Day 2 - 2 Period||10
8435636|NCT00832078|20787878|P1|COMPLETED|Test Day 2 - 2 Period||12
8435637|NCT00832078|20787877|P2|STARTED|Test Day 2 - 2 Period||10
8435638|NCT00832078|20787878|P1|STARTED|Test Day 2 - 2 Period||13
8435639|NCT00832078|20787877|P2|NOT COMPLETED|Test Day 2 - 1 Period||0
8435640|NCT00832078|20787878|P1|NOT COMPLETED|Test Day 2 - 1 Period||0
8435641|NCT00832078|20787877|P2|COMPLETED|Test Day 2 - 1 Period||10
8435642|NCT00832078|20787878|P1|COMPLETED|Test Day 2 - 1 Period||13
8435643|NCT00832078|20787877|P2|STARTED|Test Day 2 - 1 Period||10
8435644|NCT00832078|20787878|P1|STARTED|Test Day 2 - 1 Period||13
8435645|NCT00832078|20787877|P2|NOT COMPLETED|Test Day 1-2 Period||2
8435646|NCT00832078|20787878|P1|NOT COMPLETED|Test Day 1-2 Period||0
8435647|NCT00832078|20787877|P2|COMPLETED|Test Day 1-2 Period||10
8435648|NCT00832078|20787878|P1|COMPLETED|Test Day 1-2 Period||13
8435649|NCT00832078|20787877|P2|STARTED|Test Day 1-2 Period||12
8435650|NCT00832078|20787878|P1|STARTED|Test Day 1-2 Period||13
8435651|NCT00832078|20787877|P2|NOT COMPLETED|Test Day 1- 1 Period||0
8435652|NCT00832078|20787878|P1|NOT COMPLETED|Test Day 1- 1 Period||0
8435653|NCT00832078|20787877|P2|COMPLETED|Test Day 1- 1 Period||12
8435654|NCT00832078|20787878|P1|COMPLETED|Test Day 1- 1 Period||13
8435655|NCT00832078|20787877|P2|STARTED|Test Day 1- 1 Period||12
8435656|NCT00832078|20787878|P1|STARTED|Test Day 1- 1 Period||13
8435657|NCT00832000|20787884|P2|NOT COMPLETED|Overall Study||1
8435658|NCT00832000|20787885|P1|NOT COMPLETED|Overall Study||6
8435659|NCT00832000|20787884|P2|COMPLETED|Overall Study||29
8435660|NCT00832000|20787885|P1|COMPLETED|Overall Study||23
8435661|NCT00832000|20787884|P2|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
8435662|NCT00832000|20787885|P1|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
8435663|NCT00832000|20787884|P2|STARTED|Overall Study|Placebo|30
8435664|NCT00832000|20787885|P1|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
8435665|NCT00831987|20787923|P2|NOT COMPLETED|Overall Study||0
8435666|NCT00831987|20787924|P1|NOT COMPLETED|Overall Study||0
8435667|NCT00831987|20787923|P2|COMPLETED|Overall Study||60
8435668|NCT00831987|20787924|P1|COMPLETED|Overall Study||60
8435669|NCT00831987|20787923|P2|STARTED|Overall Study||60
8435670|NCT00831987|20787924|P1|STARTED|Overall Study||60
8435671|NCT00831844|20787946|P10|NOT COMPLETED|Overall Study||0
8435672|NCT00831844|20787947|P9|NOT COMPLETED|Overall Study||9
8435673|NCT00831844|20787948|P8|NOT COMPLETED|Overall Study||10
8435674|NCT00831844|20787949|P7|NOT COMPLETED|Overall Study||10
8435675|NCT00831844|20787950|P6|NOT COMPLETED|Overall Study||19
8435676|NCT00831844|20787951|P5|NOT COMPLETED|Overall Study||14
8435677|NCT00831844|20787952|P4|NOT COMPLETED|Overall Study||10
8435678|NCT00831844|20787953|P3|NOT COMPLETED|Overall Study||20
8435679|NCT00831844|20787954|P2|NOT COMPLETED|Overall Study||12
8435680|NCT00831844|20787955|P1|NOT COMPLETED|Overall Study||10
8435681|NCT00831844|20787946|P10|COMPLETED|Overall Study||0
8435682|NCT00831844|20787947|P9|COMPLETED|Overall Study||0
8435683|NCT00831844|20787948|P8|COMPLETED|Overall Study||0
8435684|NCT00831844|20787949|P7|COMPLETED|Overall Study||0
8435685|NCT00831844|20787950|P6|COMPLETED|Overall Study||1
8435686|NCT00831844|20787951|P5|COMPLETED|Overall Study||0
8435687|NCT00831844|20787952|P4|COMPLETED|Overall Study||0
8435688|NCT00831844|20787953|P3|COMPLETED|Overall Study||1
8435689|NCT00831844|20787954|P2|COMPLETED|Overall Study||0
8435690|NCT00831844|20787955|P1|COMPLETED|Overall Study||0
8435691|NCT00831844|20787946|P10|STARTED|Overall Study||0
8435692|NCT00831844|20787947|P9|STARTED|Overall Study||9
8435693|NCT00831844|20787948|P8|STARTED|Overall Study||10
8435694|NCT00831844|20787949|P7|STARTED|Overall Study||10
8435695|NCT00831844|20787950|P6|STARTED|Overall Study||20
8435696|NCT00831844|20787951|P5|STARTED|Overall Study||14
8435697|NCT00831844|20787952|P4|STARTED|Overall Study||10
8435698|NCT00831844|20787953|P3|STARTED|Overall Study||21
8435699|NCT00831844|20787954|P2|STARTED|Overall Study||12
8435700|NCT00831844|20787955|P1|STARTED|Overall Study||10
8435701|NCT00831792|20787977|P1|NOT COMPLETED|Overall Study||6
8435702|NCT00831792|20787977|P1|COMPLETED|Overall Study||40
8435703|NCT00831792|20787977|P1|STARTED|Overall Study||46
8435704|NCT00831779|20787983|P2|NOT COMPLETED|Overall Study||1
8435705|NCT00831779|20787984|P1|NOT COMPLETED|Overall Study||1
8435706|NCT00831779|20787983|P2|COMPLETED|Overall Study||22
8435707|NCT00831779|20787984|P1|COMPLETED|Overall Study||20
8435708|NCT00831779|20787983|P2|STARTED|Overall Study||23
8435709|NCT00831779|20787984|P1|STARTED|Overall Study||21
8435710|NCT00831766|20787994|P2|NOT COMPLETED|Overall Study||0
8435711|NCT00831766|20787995|P1|NOT COMPLETED|Overall Study||0
8435712|NCT00831766|20787994|P2|COMPLETED|Overall Study||28
8435713|NCT00831766|20787995|P1|COMPLETED|Overall Study||23
8435714|NCT00831766|20787994|P2|STARTED|Overall Study||28
8435715|NCT00831766|20787995|P1|STARTED|Overall Study||23
8435716|NCT00831753|20788006|P2|NOT COMPLETED|Overall Study||0
8435717|NCT00831753|20788007|P1|NOT COMPLETED|Overall Study||0
8435718|NCT00831753|20788006|P2|COMPLETED|Overall Study||131
8435719|NCT00831753|20788007|P1|COMPLETED|Overall Study||132
8435720|NCT00831753|20788006|P2|STARTED|Overall Study||131
8435721|NCT00831753|20788007|P1|STARTED|Overall Study||132
8435722|NCT00831701|20788021|P2|NOT COMPLETED|Overall Study||5
8435723|NCT00831701|20788022|P1|NOT COMPLETED|Overall Study||5
8435724|NCT00831701|20788021|P2|COMPLETED|Overall Study||45
8435725|NCT00831701|20788022|P1|COMPLETED|Overall Study||45
8435726|NCT00831701|20788021|P2|STARTED|Overall Study||50
8435727|NCT00831701|20788022|P1|STARTED|Overall Study||50
8435728|NCT00831675|20788038|P2|NOT COMPLETED|Overall Study||0
8435729|NCT00831675|20788039|P1|NOT COMPLETED|Overall Study||0
8435730|NCT00831675|20788038|P2|COMPLETED|Overall Study||18
8435731|NCT00831675|20788039|P1|COMPLETED|Overall Study||12
8435732|NCT00831675|20788038|P2|STARTED|Overall Study||18
8435733|NCT00831675|20788039|P1|STARTED|Overall Study||12
8435734|NCT00831493|20788051|P1|NOT COMPLETED|Overall Study||1
8435735|NCT00831493|20788051|P1|COMPLETED|Overall Study||2
8435736|NCT00831493|20788051|P1|STARTED|Overall Study||3
8435737|NCT00831480|20788055|P1|NOT COMPLETED|Overall Study||2
8435738|NCT00831480|20788055|P1|COMPLETED|Overall Study||7
8435739|NCT00831480|20788055|P1|STARTED|Overall Study||9
8435740|NCT00831441|20788061|P2|NOT COMPLETED|Follow Up (30 Days)||174
8435741|NCT00831441|20788062|P1|NOT COMPLETED|Follow Up (30 Days)||133
8435742|NCT00831441|20788061|P2|COMPLETED|Follow Up (30 Days)||3355
8435743|NCT00831441|20788062|P1|COMPLETED|Follow Up (30 Days)||3375
8435744|NCT00831441|20788061|P2|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
8435745|NCT00831441|20788062|P1|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
8435746|NCT00831441|20788061|P2|NOT COMPLETED|Randomized||3705
8435747|NCT00831441|20788062|P1|NOT COMPLETED|Randomized||3687
8435748|NCT00831441|20788061|P2|COMPLETED|Randomized||0
8435749|NCT00831441|20788062|P1|COMPLETED|Randomized||0
8435750|NCT00831441|20788061|P2|Treated|Randomized||3672
8435751|NCT00831441|20788062|P1|Treated|Randomized||3643
8435752|NCT00831441|20788061|P2|STARTED|Randomized||3705
8435753|NCT00831441|20788062|P1|STARTED|Randomized||3687
8435754|NCT00831428|20788090|P1|NOT COMPLETED|Overall Study||0
8435755|NCT00831428|20788090|P1|COMPLETED|Overall Study||97
8435756|NCT00831428|20788090|P1|STARTED|Overall Study||97
8435757|NCT00831415|20788094|P1|NOT COMPLETED|Overall Study||75
8435758|NCT00831415|20788094|P1|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
8435759|NCT00831415|20788094|P1|"Study Completers"|Overall Study|"Defined as participants whose conclusion of study participation status was study completed."|227
8435760|NCT00831415|20788094|P1|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
8435761|NCT00831415|20788094|P1|STARTED|Overall Study||304
8435762|NCT00831389|20788103|P2|NOT COMPLETED|Overall Study||1
8435763|NCT00831389|20788104|P1|NOT COMPLETED|Overall Study||0
8435764|NCT00831389|20788103|P2|COMPLETED|Overall Study||6
8435765|NCT00831389|20788104|P1|COMPLETED|Overall Study||6
8435766|NCT00831389|20788103|P2|STARTED|Overall Study||7
8435767|NCT00831389|20788104|P1|STARTED|Overall Study||6
8435768|NCT00831311|20788130|P2|NOT COMPLETED|Overall Study||8
8435769|NCT00831311|20788131|P1|NOT COMPLETED|Overall Study||12
8435770|NCT00831311|20788130|P2|COMPLETED|Overall Study||304
8435771|NCT00831311|20788131|P1|COMPLETED|Overall Study||300
8435772|NCT00831311|20788130|P2|STARTED|Overall Study||312
8435773|NCT00831311|20788131|P1|STARTED|Overall Study||312
8435774|NCT00831272|20788153|P4|NOT COMPLETED|Overall Study||10
8435775|NCT00831272|20788154|P3|NOT COMPLETED|Overall Study||10
8435776|NCT00831272|20788155|P2|NOT COMPLETED|Overall Study||7
8435777|NCT00831272|20788156|P1|NOT COMPLETED|Overall Study||8
8435778|NCT00831272|20788153|P4|COMPLETED|Overall Study||56
8435779|NCT00831272|20788154|P3|COMPLETED|Overall Study||63
8435780|NCT00831272|20788155|P2|COMPLETED|Overall Study||37
8435781|NCT00831272|20788156|P1|COMPLETED|Overall Study||30
8435782|NCT00831272|20788153|P4|STARTED|Overall Study||66
8435783|NCT00831272|20788154|P3|STARTED|Overall Study||73
8435784|NCT00831272|20788155|P2|STARTED|Overall Study||44
8435785|NCT00831272|20788156|P1|STARTED|Overall Study||38
8435786|NCT00831233|20788168|P2|NOT COMPLETED|Overall Study||1
8435787|NCT00831233|20788169|P1|NOT COMPLETED|Overall Study||3
8435788|NCT00831233|20788168|P2|COMPLETED|Overall Study||12
8435789|NCT00831233|20788169|P1|COMPLETED|Overall Study||26
8435790|NCT00831233|20788168|P2|Per Protocol (PP) Analysis Set|Overall Study||11
8435791|NCT00831233|20788169|P1|Per Protocol (PP) Analysis Set|Overall Study||26
8435792|NCT00831233|20788168|P2|Full Analysis Set (FAS)|Overall Study||13
8435793|NCT00831233|20788169|P1|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
8435794|NCT00831233|20788168|P2|STARTED|Overall Study|ITT population.|13
8435795|NCT00831233|20788169|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
8435796|NCT00831181|20788193|P1|NOT COMPLETED|Overall Study||12
8435797|NCT00831181|20788193|P1|COMPLETED|Overall Study||15
8435798|NCT00831181|20788193|P1|STARTED|Overall Study||27
8435799|NCT00831129|20788206|P2|NOT COMPLETED|Overall Study||10
8435800|NCT00831129|20788207|P1|NOT COMPLETED|Overall Study||0
8435801|NCT00831129|20788206|P2|COMPLETED|Overall Study||23
8435802|NCT00831129|20788207|P1|COMPLETED|Overall Study||20
8435803|NCT00831129|20788206|P2|STARTED|Overall Study||33
8435804|NCT00831129|20788207|P1|STARTED|Overall Study||20
8435805|NCT00830960|20788249|P6|NOT COMPLETED|Overall Study||37
8435806|NCT00830960|20788250|P5|NOT COMPLETED|Overall Study||32
8435807|NCT00830960|20788251|P4|NOT COMPLETED|Overall Study||32
8435808|NCT00830960|20788252|P3|NOT COMPLETED|Overall Study||29
8435809|NCT00830960|20788253|P2|NOT COMPLETED|Overall Study||28
8435810|NCT00830960|20788254|P1|NOT COMPLETED|Overall Study||33
8435811|NCT00830960|20788249|P6|COMPLETED|Overall Study||63
8435812|NCT00830960|20788250|P5|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
8435813|NCT00830960|20788251|P4|COMPLETED|Overall Study||106
8435814|NCT00830960|20788252|P3|COMPLETED|Overall Study||108
8435815|NCT00830960|20788253|P2|COMPLETED|Overall Study||96
8435816|NCT00830960|20788254|P1|COMPLETED|Overall Study||91
8435817|NCT00830960|20788249|P6|Received at Least 1 Dose of Study Drug|Overall Study||93
8435818|NCT00830960|20788250|P5|Received at Least 1 Dose of Study Drug|Overall Study||91
8435819|NCT00830960|20788251|P4|Received at Least 1 Dose of Study Drug|Overall Study||135
8435820|NCT00830960|20788252|P3|Received at Least 1 Dose of Study Drug|Overall Study||133
8435821|NCT00830960|20788253|P2|Received at Least 1 Dose of Study Drug|Overall Study||122
8435822|NCT00830960|20788254|P1|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
8435823|NCT00830960|20788249|P6|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
8435824|NCT00830960|20788250|P5|STARTED|Overall Study||96
8435825|NCT00830960|20788251|P4|STARTED|Overall Study||138
8435826|NCT00830960|20788252|P3|STARTED|Overall Study||137
8435827|NCT00830960|20788253|P2|STARTED|Overall Study||124
8435828|NCT00830960|20788254|P1|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
8435829|NCT00830947|20788370|P2|NOT COMPLETED|Overall Study||4
8435830|NCT00830947|20788371|P1|NOT COMPLETED|Overall Study||4
8435831|NCT00830947|20788370|P2|COMPLETED|Overall Study||18
8435832|NCT00830947|20788371|P1|COMPLETED|Overall Study||19
8435833|NCT00830947|20788370|P2|STARTED|Overall Study||22
8435834|NCT00830947|20788371|P1|STARTED|Overall Study||23
8435835|NCT00830869|20788389|P12|NOT COMPLETED|Period 2: Part 2||20
8435836|NCT00830869|20788390|P11|NOT COMPLETED|Period 2: Part 2||11
8435837|NCT00830869|20788391|P10|NOT COMPLETED|Period 2: Part 2||20
8435838|NCT00830869|20788392|P9|NOT COMPLETED|Period 2: Part 2||22
8435839|NCT00830869|20788393|P8|NOT COMPLETED|Period 2: Part 2||20
8435840|NCT00830869|20788394|P7|NOT COMPLETED|Period 2: Part 2||0
8435841|NCT00830869|20788395|P6|NOT COMPLETED|Period 2: Part 2||0
8435842|NCT00830869|20788396|P5|NOT COMPLETED|Period 2: Part 2||0
8435843|NCT00830869|20788397|P4|NOT COMPLETED|Period 2: Part 2||0
8435844|NCT00830869|20788398|P3|NOT COMPLETED|Period 2: Part 2||0
8435845|NCT00830869|20788399|P2|NOT COMPLETED|Period 2: Part 2||0
8435846|NCT00830869|20788400|P1|NOT COMPLETED|Period 2: Part 2||0
8435847|NCT00830869|20788389|P12|COMPLETED|Period 2: Part 2||0
8435848|NCT00830869|20788390|P11|COMPLETED|Period 2: Part 2||0
8435849|NCT00830869|20788391|P10|COMPLETED|Period 2: Part 2||0
8435850|NCT00830869|20788392|P9|COMPLETED|Period 2: Part 2||0
8435851|NCT00830869|20788393|P8|COMPLETED|Period 2: Part 2||0
8435852|NCT00830869|20788394|P7|COMPLETED|Period 2: Part 2||0
8435853|NCT00830869|20788395|P6|COMPLETED|Period 2: Part 2||0
8435854|NCT00830869|20788396|P5|COMPLETED|Period 2: Part 2||0
8435855|NCT00830869|20788397|P4|COMPLETED|Period 2: Part 2||0
8435856|NCT00830869|20788398|P3|COMPLETED|Period 2: Part 2||0
8435857|NCT00830869|20788399|P2|COMPLETED|Period 2: Part 2||0
8435858|NCT00830869|20788400|P1|COMPLETED|Period 2: Part 2||0
8435859|NCT00830869|20788389|P12|STARTED|Period 2: Part 2||20
8435860|NCT00830869|20788390|P11|STARTED|Period 2: Part 2||11
8435861|NCT00830869|20788391|P10|STARTED|Period 2: Part 2||20
8435862|NCT00830869|20788392|P9|STARTED|Period 2: Part 2||22
8435863|NCT00830869|20788393|P8|STARTED|Period 2: Part 2||20
8435864|NCT00830869|20788394|P7|STARTED|Period 2: Part 2||0
8435865|NCT00830869|20788395|P6|STARTED|Period 2: Part 2||0
8435866|NCT00830869|20788396|P5|STARTED|Period 2: Part 2||0
8435867|NCT00830869|20788397|P4|STARTED|Period 2: Part 2||0
8435868|NCT00830869|20788398|P3|STARTED|Period 2: Part 2||0
8435869|NCT00830869|20788399|P2|STARTED|Period 2: Part 2||0
8435870|NCT00830869|20788400|P1|STARTED|Period 2: Part 2||0
8435871|NCT00830869|20788389|P12|NOT COMPLETED|Period 1: Part 1||0
8435872|NCT00830869|20788390|P11|NOT COMPLETED|Period 1: Part 1||0
8435873|NCT00830869|20788391|P10|NOT COMPLETED|Period 1: Part 1||0
8435874|NCT00830869|20788392|P9|NOT COMPLETED|Period 1: Part 1||0
8435875|NCT00830869|20788393|P8|NOT COMPLETED|Period 1: Part 1||0
8435876|NCT00830869|20788394|P7|NOT COMPLETED|Period 1: Part 1||3
8435877|NCT00830869|20788395|P6|NOT COMPLETED|Period 1: Part 1||6
8435878|NCT00830869|20788396|P5|NOT COMPLETED|Period 1: Part 1||4
8435879|NCT00830869|20788397|P4|NOT COMPLETED|Period 1: Part 1||7
8435880|NCT00830869|20788398|P3|NOT COMPLETED|Period 1: Part 1||1
8435881|NCT00830869|20788399|P2|NOT COMPLETED|Period 1: Part 1||1
8435882|NCT00830869|20788400|P1|NOT COMPLETED|Period 1: Part 1||1
8435883|NCT00830869|20788389|P12|COMPLETED|Period 1: Part 1||0
8435884|NCT00830869|20788390|P11|COMPLETED|Period 1: Part 1||0
8435885|NCT00830869|20788391|P10|COMPLETED|Period 1: Part 1||0
8435886|NCT00830869|20788392|P9|COMPLETED|Period 1: Part 1||0
8435887|NCT00830869|20788393|P8|COMPLETED|Period 1: Part 1||0
8435888|NCT00830869|20788394|P7|COMPLETED|Period 1: Part 1||0
8435889|NCT00830869|20788395|P6|COMPLETED|Period 1: Part 1||0
8435890|NCT00830869|20788396|P5|COMPLETED|Period 1: Part 1||0
8435891|NCT00830869|20788397|P4|COMPLETED|Period 1: Part 1||0
8435892|NCT00830869|20788398|P3|COMPLETED|Period 1: Part 1||0
8435893|NCT00830869|20788399|P2|COMPLETED|Period 1: Part 1||0
8435894|NCT00830869|20788400|P1|COMPLETED|Period 1: Part 1||0
8435895|NCT00830869|20788389|P12|STARTED|Period 1: Part 1||0
8435896|NCT00830869|20788390|P11|STARTED|Period 1: Part 1||0
8435897|NCT00830869|20788391|P10|STARTED|Period 1: Part 1||0
8435898|NCT00830869|20788392|P9|STARTED|Period 1: Part 1||0
8435899|NCT00830869|20788393|P8|STARTED|Period 1: Part 1||0
8435900|NCT00830869|20788394|P7|STARTED|Period 1: Part 1||3
8435901|NCT00830869|20788395|P6|STARTED|Period 1: Part 1||6
8435902|NCT00830869|20788396|P5|STARTED|Period 1: Part 1||4
8435903|NCT00830869|20788397|P4|STARTED|Period 1: Part 1||7
8435904|NCT00830869|20788398|P3|STARTED|Period 1: Part 1||1
8435905|NCT00830869|20788399|P2|STARTED|Period 1: Part 1||1
8435906|NCT00830869|20788400|P1|STARTED|Period 1: Part 1||1
8435907|NCT00830804|20788536|P1|NOT COMPLETED|Overall Study||15
8435908|NCT00830804|20788536|P1|COMPLETED|Overall Study||97
8435909|NCT00830804|20788536|P1|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
8435910|NCT00830791|20788562|P6|NOT COMPLETED|Overall Study||0
8435911|NCT00830791|20788563|P5|NOT COMPLETED|Overall Study||0
8435912|NCT00830791|20788564|P4|NOT COMPLETED|Overall Study||0
8435913|NCT00830791|20788565|P3|NOT COMPLETED|Overall Study||0
8435914|NCT00830791|20788566|P2|NOT COMPLETED|Overall Study||0
8435915|NCT00830791|20788567|P1|NOT COMPLETED|Overall Study||0
8435916|NCT00830791|20788562|P6|COMPLETED|Overall Study||0
8435917|NCT00830791|20788563|P5|COMPLETED|Overall Study||0
8435918|NCT00830791|20788564|P4|COMPLETED|Overall Study||8
8435919|NCT00830791|20788565|P3|COMPLETED|Overall Study||8
8435920|NCT00830791|20788566|P2|COMPLETED|Overall Study||8
8435921|NCT00830791|20788567|P1|COMPLETED|Overall Study||8
8435922|NCT00830791|20788562|P6|STARTED|Overall Study||0
8435923|NCT00830791|20788563|P5|STARTED|Overall Study||0
8435924|NCT00830791|20788564|P4|STARTED|Overall Study||8
8435925|NCT00830791|20788565|P3|STARTED|Overall Study||8
8435926|NCT00830791|20788566|P2|STARTED|Overall Study||8
8435927|NCT00830791|20788567|P1|STARTED|Overall Study||8
8435928|NCT00830765|20788616|P2|NOT COMPLETED|Overall Study||2
8435929|NCT00830765|20788617|P1|NOT COMPLETED|Overall Study||3
8435930|NCT00830765|20788616|P2|COMPLETED|Overall Study||69
8435931|NCT00830765|20788617|P1|COMPLETED|Overall Study||70
8435932|NCT00830765|20788616|P2|STARTED|Overall Study||71
8435933|NCT00830765|20788617|P1|STARTED|Overall Study||73
8435934|NCT00830596|20788626|P3|NOT COMPLETED|Overall Study||6
8435935|NCT00830596|20788627|P2|NOT COMPLETED|Overall Study||2
8435936|NCT00830596|20788628|P1|NOT COMPLETED|Overall Study||2
8435937|NCT00830596|20788626|P3|COMPLETED|Overall Study||67
8435938|NCT00830596|20788627|P2|COMPLETED|Overall Study||72
8435939|NCT00830596|20788628|P1|COMPLETED|Overall Study||72
8435940|NCT00830596|20788626|P3|STARTED|Overall Study||73
8435941|NCT00830596|20788627|P2|STARTED|Overall Study||74
8435942|NCT00830596|20788628|P1|STARTED|Overall Study||74
8435943|NCT00830518|20788650|P2|NOT COMPLETED|Overall Study||11
8435944|NCT00830518|20788651|P1|NOT COMPLETED|Overall Study||46
8435945|NCT00830518|20788650|P2|COMPLETED|Overall Study||0
8435946|NCT00830518|20788651|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
8435947|NCT00830518|20788650|P2|STARTED|Overall Study||11
8435948|NCT00830518|20788651|P1|STARTED|Overall Study||46
8435949|NCT00830440|20788670|P2|NOT COMPLETED|Overall Study||0
8435950|NCT00830440|20788671|P1|NOT COMPLETED|Overall Study||8
8435951|NCT00830440|20788670|P2|COMPLETED|Overall Study||11
8435952|NCT00830440|20788671|P1|COMPLETED|Overall Study||24
8435953|NCT00830440|20788670|P2|Completed 24 Week Follow up|Overall Study||0
8435954|NCT00830440|20788671|P1|Completed 24 Week Follow up|Overall Study||3
8435955|NCT00830440|20788670|P2|Completed 16 Week Follow up|Overall Study||0
8435956|NCT00830440|20788671|P1|Completed 16 Week Follow up|Overall Study||4
8435957|NCT00830440|20788670|P2|Completed 12 Week Follow up|Overall Study||11
8435958|NCT00830440|20788671|P1|Completed 12 Week Follow up|Overall Study||24
8435959|NCT00830440|20788670|P2|Received Device|Overall Study||0
8435960|NCT00830440|20788671|P1|Received Device|Overall Study||26
8435961|NCT00830440|20788670|P2|STARTED|Overall Study||11
8435962|NCT00830440|20788671|P1|STARTED|Overall Study||32
8435963|NCT00830388|20788681|P1|NOT COMPLETED|Overall Study||0
8435964|NCT00830388|20788681|P1|COMPLETED|Overall Study||11
8435965|NCT00830388|20788681|P1|STARTED|Overall Study||11
8435966|NCT00830375|20788686|P1|NOT COMPLETED|Overall Study||1
8435967|NCT00830375|20788686|P1|COMPLETED|Overall Study||9
8435968|NCT00830375|20788686|P1|STARTED|Overall Study||10
8435969|NCT00830362|20788692|P2|NOT COMPLETED|Overall Study||4
8435970|NCT00830362|20788693|P1|NOT COMPLETED|Overall Study||4
8435971|NCT00830362|20788692|P2|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
8435972|NCT00830362|20788693|P1|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
8435973|NCT00830362|20788692|P2|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
8435974|NCT00830362|20788693|P1|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
8435975|NCT00830362|20788692|P2|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
8435976|NCT00830362|20788693|P1|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
8435977|NCT00830336|20788701|P2|NOT COMPLETED|Second Intervention||0
8435978|NCT00830336|20788702|P1|NOT COMPLETED|Second Intervention||0
8435979|NCT00830336|20788701|P2|COMPLETED|Second Intervention||40
8435980|NCT00830336|20788702|P1|COMPLETED|Second Intervention||39
8435981|NCT00830336|20788701|P2|STARTED|Second Intervention||40
8435982|NCT00830336|20788702|P1|STARTED|Second Intervention||39
8435983|NCT00830336|20788701|P2|NOT COMPLETED|Washout: 21 Days||0
8435984|NCT00830336|20788702|P1|NOT COMPLETED|Washout: 21 Days||1
8435985|NCT00830336|20788701|P2|COMPLETED|Washout: 21 Days||40
8435986|NCT00830336|20788702|P1|COMPLETED|Washout: 21 Days||39
8435987|NCT00830336|20788701|P2|STARTED|Washout: 21 Days||40
8435988|NCT00830336|20788702|P1|STARTED|Washout: 21 Days||40
8435989|NCT00830336|20788701|P2|NOT COMPLETED|First Intervention||0
8435990|NCT00830336|20788702|P1|NOT COMPLETED|First Intervention||0
8435991|NCT00830336|20788701|P2|COMPLETED|First Intervention||40
8435992|NCT00830336|20788702|P1|COMPLETED|First Intervention||40
8435993|NCT00830336|20788701|P2|STARTED|First Intervention||40
8435994|NCT00830336|20788702|P1|STARTED|First Intervention||40
8435995|NCT00830310|20788710|P1|NOT COMPLETED|Overall Study||13
8435996|NCT00830310|20788710|P1|COMPLETED|Overall Study||30
8435997|NCT00830310|20788710|P1|STARTED|Overall Study||43
8435998|NCT00830284|20788722|P1|NOT COMPLETED|Overall Study||2
8435999|NCT00830284|20788722|P1|COMPLETED|Overall Study||10
8436000|NCT00830284|20788722|P1|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
8436001|NCT00830258|20788729|P2|NOT COMPLETED|Second Intervention||0
8436002|NCT00830258|20788730|P1|NOT COMPLETED|Second Intervention||0
8436003|NCT00830258|20788729|P2|COMPLETED|Second Intervention||30
8436004|NCT00830258|20788730|P1|COMPLETED|Second Intervention||28
8436005|NCT00830258|20788729|P2|STARTED|Second Intervention||30
8436006|NCT00830258|20788730|P1|STARTED|Second Intervention||28
8436007|NCT00830258|20788729|P2|NOT COMPLETED|Washout: 7 Days||0
8436008|NCT00830258|20788730|P1|NOT COMPLETED|Washout: 7 Days||1
8436009|NCT00830258|20788729|P2|COMPLETED|Washout: 7 Days||30
8436010|NCT00830258|20788730|P1|COMPLETED|Washout: 7 Days||28
8436011|NCT00830258|20788729|P2|STARTED|Washout: 7 Days||30
8436012|NCT00830258|20788730|P1|STARTED|Washout: 7 Days||29
8436013|NCT00830258|20788729|P2|NOT COMPLETED|First Intervention||0
8436014|NCT00830258|20788730|P1|NOT COMPLETED|First Intervention||1
8436015|NCT00830258|20788729|P2|COMPLETED|First Intervention||30
8436016|NCT00830258|20788730|P1|COMPLETED|First Intervention||29
8436017|NCT00830258|20788729|P2|STARTED|First Intervention||30
8436018|NCT00830258|20788730|P1|STARTED|First Intervention||30
8436019|NCT00830232|20788740|P2|NOT COMPLETED|Overall Study||0
8436020|NCT00830232|20788741|P1|NOT COMPLETED|Overall Study||0
8436021|NCT00830232|20788740|P2|COMPLETED|Overall Study||20
8436022|NCT00830232|20788741|P1|COMPLETED|Overall Study||20
8436023|NCT00830232|20788740|P2|STARTED|Overall Study||20
8436024|NCT00830232|20788741|P1|STARTED|Overall Study||20
8436025|NCT00830219|20788749|P2|NOT COMPLETED|Second Intervention||0
8436026|NCT00830219|20788750|P1|NOT COMPLETED|Second Intervention||0
8436027|NCT00830219|20788749|P2|COMPLETED|Second Intervention||22
8436028|NCT00830219|20788750|P1|COMPLETED|Second Intervention||22
8436029|NCT00830219|20788749|P2|STARTED|Second Intervention||22
8436030|NCT00830219|20788750|P1|STARTED|Second Intervention||22
8436031|NCT00830219|20788749|P2|NOT COMPLETED|Washout of 7 Days||1
8436032|NCT00830219|20788750|P1|NOT COMPLETED|Washout of 7 Days||1
8436033|NCT00830219|20788749|P2|COMPLETED|Washout of 7 Days||22
8436034|NCT00830219|20788750|P1|COMPLETED|Washout of 7 Days||22
8436035|NCT00830219|20788749|P2|STARTED|Washout of 7 Days||23
8436036|NCT00830219|20788750|P1|STARTED|Washout of 7 Days||23
8436037|NCT00830219|20788749|P2|NOT COMPLETED|First Intervention||0
8436038|NCT00830219|20788750|P1|NOT COMPLETED|First Intervention||0
8436039|NCT00830219|20788749|P2|COMPLETED|First Intervention||23
8436040|NCT00830219|20788750|P1|COMPLETED|First Intervention||23
8436041|NCT00830219|20788749|P2|STARTED|First Intervention||23
8436042|NCT00830219|20788750|P1|STARTED|First Intervention||23
8436043|NCT00830206|20788760|P2|NOT COMPLETED|Second Intervention||0
8436044|NCT00830206|20788761|P1|NOT COMPLETED|Second Intervention||0
8436045|NCT00830206|20788760|P2|COMPLETED|Second Intervention||39
8436046|NCT00830206|20788761|P1|COMPLETED|Second Intervention||39
8436047|NCT00830206|20788760|P2|STARTED|Second Intervention||39
8436048|NCT00830206|20788761|P1|STARTED|Second Intervention||39
8436049|NCT00830206|20788760|P2|NOT COMPLETED|Washout: 21 Days||1
8436050|NCT00830206|20788761|P1|NOT COMPLETED|Washout: 21 Days||1
8436051|NCT00830206|20788760|P2|COMPLETED|Washout: 21 Days||39
8436052|NCT00830206|20788761|P1|COMPLETED|Washout: 21 Days||39
8436053|NCT00830206|20788760|P2|STARTED|Washout: 21 Days||40
8436054|NCT00830206|20788761|P1|STARTED|Washout: 21 Days||40
8436055|NCT00830206|20788760|P2|NOT COMPLETED|First Intervention||0
8436056|NCT00830206|20788761|P1|NOT COMPLETED|First Intervention||0
8436057|NCT00830206|20788760|P2|COMPLETED|First Intervention||40
8436058|NCT00830206|20788761|P1|COMPLETED|First Intervention||40
8436059|NCT00830206|20788760|P2|STARTED|First Intervention||40
8436060|NCT00830206|20788761|P1|STARTED|First Intervention||40
8436061|NCT00830167|20788771|P2|NOT COMPLETED|Overall Study||43
8436062|NCT00830167|20788772|P1|NOT COMPLETED|Overall Study||40
8436063|NCT00830167|20788771|P2|COMPLETED|Overall Study||207
8436064|NCT00830167|20788772|P1|COMPLETED|Overall Study||208
8436065|NCT00830167|20788771|P2|STARTED|Overall Study|Treated|250
8436066|NCT00830167|20788772|P1|STARTED|Overall Study|Treated|248
8436067|NCT00830128|20788842|P1|NOT COMPLETED|Overall Study||19
8436068|NCT00830128|20788842|P1|COMPLETED|Overall Study||87
8436069|NCT00830128|20788842|P1|STARTED|Overall Study||106
8436070|NCT00830115|20788857|P1|NOT COMPLETED|Overall Study||3
8436071|NCT00830115|20788857|P1|COMPLETED|Overall Study||1042
8436072|NCT00830115|20788857|P1|STARTED|Overall Study||1045
8436073|NCT00830076|20788873|P1|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
8436074|NCT00830076|20788873|P1|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
8436075|NCT00830076|20788873|P1|STARTED|Placebo Sitagliptin + Placebo Metformin||18
8436076|NCT00830076|20788873|P1|NOT COMPLETED|7-day Washout||0
8436077|NCT00830076|20788873|P1|COMPLETED|7-day Washout||18
8436078|NCT00830076|20788873|P1|STARTED|7-day Washout||18
8436079|NCT00830076|20788873|P1|NOT COMPLETED|Sitagliptin + Metformin||0
8436080|NCT00830076|20788873|P1|COMPLETED|Sitagliptin + Metformin||18
8436081|NCT00830076|20788873|P1|STARTED|Sitagliptin + Metformin||18
8436082|NCT00830076|20788873|P1|NOT COMPLETED|7-day Washout||0
8436083|NCT00830076|20788873|P1|COMPLETED|7-day Washout||18
8436084|NCT00830076|20788873|P1|STARTED|7-day Washout||18
8436085|NCT00830076|20788873|P1|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
8436086|NCT00830076|20788873|P1|COMPLETED|Metformin + Placebo Sitagliptin||18
8436087|NCT00830076|20788873|P1|STARTED|Metformin + Placebo Sitagliptin||18
8436088|NCT00830076|20788873|P1|NOT COMPLETED|7-day Washout||0
8436089|NCT00830076|20788873|P1|COMPLETED|7-day Washout||18
8436090|NCT00830076|20788873|P1|STARTED|7-day Washout||18
8436091|NCT00830076|20788873|P1|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
8436092|NCT00830076|20788873|P1|COMPLETED|Sitagliptin + Placebo Metformin||18
8436093|NCT00830076|20788873|P1|STARTED|Sitagliptin + Placebo Metformin||18
8436094|NCT00830037|20788884|P2|NOT COMPLETED|Overall Study||19
8436095|NCT00830037|20788885|P1|NOT COMPLETED|Overall Study||18
8436096|NCT00830037|20788884|P2|COMPLETED|Overall Study||50
8436097|NCT00830037|20788885|P1|COMPLETED|Overall Study||49
8436098|NCT00830037|20788884|P2|STARTED|Overall Study||69
8436099|NCT00830037|20788885|P1|STARTED|Overall Study||67
8436100|NCT00830024|20788895|P2|NOT COMPLETED|Second Intervention||0
8436101|NCT00830024|20788896|P1|NOT COMPLETED|Second Intervention||0
8436102|NCT00830024|20788895|P2|COMPLETED|Second Intervention||18
8436103|NCT00830024|20788896|P1|COMPLETED|Second Intervention||17
8436104|NCT00830024|20788895|P2|STARTED|Second Intervention||18
8436105|NCT00830024|20788896|P1|STARTED|Second Intervention||17
8436106|NCT00830024|20788895|P2|NOT COMPLETED|Washout: 7 Days||0
8436107|NCT00830024|20788896|P1|NOT COMPLETED|Washout: 7 Days||1
8436108|NCT00830024|20788895|P2|COMPLETED|Washout: 7 Days||18
8436109|NCT00830024|20788896|P1|COMPLETED|Washout: 7 Days||17
8436110|NCT00830024|20788895|P2|STARTED|Washout: 7 Days||18
8436111|NCT00830024|20788896|P1|STARTED|Washout: 7 Days||18
8436112|NCT00830024|20788895|P2|NOT COMPLETED|First Intervention||0
8436113|NCT00830024|20788896|P1|NOT COMPLETED|First Intervention||0
8436114|NCT00830024|20788895|P2|COMPLETED|First Intervention||18
8436115|NCT00830024|20788896|P1|COMPLETED|First Intervention||18
8436116|NCT00830024|20788895|P2|STARTED|First Intervention||18
8436117|NCT00830024|20788896|P1|STARTED|First Intervention||18
8436118|NCT00829998|20788906|P2|NOT COMPLETED|Second Intervention||0
8436119|NCT00829998|20788907|P1|NOT COMPLETED|Second Intervention||0
8436120|NCT00829998|20788906|P2|COMPLETED|Second Intervention||19
8436121|NCT00829998|20788907|P1|COMPLETED|Second Intervention||21
8436122|NCT00829998|20788906|P2|STARTED|Second Intervention||19
8436123|NCT00829998|20788907|P1|STARTED|Second Intervention||21
8436124|NCT00829998|20788906|P2|NOT COMPLETED|Washout||1
8436125|NCT00829998|20788907|P1|NOT COMPLETED|Washout||0
8436126|NCT00829998|20788906|P2|COMPLETED|Washout||19
8436127|NCT00829998|20788907|P1|COMPLETED|Washout||21
8436128|NCT00829998|20788906|P2|STARTED|Washout||20
8436129|NCT00829998|20788907|P1|STARTED|Washout||21
8436130|NCT00829998|20788906|P2|NOT COMPLETED|First Intervention||0
8436131|NCT00829998|20788907|P1|NOT COMPLETED|First Intervention||0
8436132|NCT00829998|20788906|P2|COMPLETED|First Intervention||20
8436133|NCT00829998|20788907|P1|COMPLETED|First Intervention||21
8436134|NCT00829998|20788906|P2|STARTED|First Intervention||20
8436135|NCT00829998|20788907|P1|STARTED|First Intervention||21
8436136|NCT00829985|20788917|P2|NOT COMPLETED|Overall Study||4
8436137|NCT00829985|20788918|P1|NOT COMPLETED|Overall Study||9
8436138|NCT00829985|20788917|P2|COMPLETED|Overall Study||22
8436139|NCT00829985|20788918|P1|COMPLETED|Overall Study||19
8436140|NCT00829985|20788917|P2|STARTED|Overall Study||26
8436141|NCT00829985|20788918|P1|STARTED|Overall Study||28
8436142|NCT00829933|20788936|P4|NOT COMPLETED|Overall Study||14
8436143|NCT00829933|20788937|P3|NOT COMPLETED|Overall Study||13
8436144|NCT00829933|20788938|P2|NOT COMPLETED|Overall Study||13
8436145|NCT00829933|20788939|P1|NOT COMPLETED|Overall Study||14
8436146|NCT00829933|20788936|P4|COMPLETED|Overall Study||120
8436147|NCT00829933|20788937|P3|COMPLETED|Overall Study||119
8436148|NCT00829933|20788938|P2|COMPLETED|Overall Study||122
8436149|NCT00829933|20788939|P1|COMPLETED|Overall Study||121
8436150|NCT00829933|20788936|P4|Baseline Analysis Population|Overall Study||129
8436151|NCT00829933|20788937|P3|Baseline Analysis Population|Overall Study||131
8436152|NCT00829933|20788938|P2|Baseline Analysis Population|Overall Study||134
8436153|NCT00829933|20788939|P1|Baseline Analysis Population|Overall Study||131
8436154|NCT00829933|20788936|P4|STARTED|Overall Study||134
8436155|NCT00829933|20788937|P3|STARTED|Overall Study||132
8436156|NCT00829933|20788938|P2|STARTED|Overall Study||135
8436157|NCT00829933|20788939|P1|STARTED|Overall Study||135
8436158|NCT00829868|20788951|P2|NOT COMPLETED|Second Intervention||0
8436159|NCT00829868|20788952|P1|NOT COMPLETED|Second Intervention||0
8436160|NCT00829868|20788951|P2|COMPLETED|Second Intervention||21
8436161|NCT00829868|20788952|P1|COMPLETED|Second Intervention||20
8436162|NCT00829868|20788951|P2|STARTED|Second Intervention||21
8436163|NCT00829868|20788952|P1|STARTED|Second Intervention||20
8436164|NCT00829868|20788951|P2|NOT COMPLETED|Washout||0
8436165|NCT00829868|20788952|P1|NOT COMPLETED|Washout||1
8436166|NCT00829868|20788951|P2|COMPLETED|Washout||21
8436167|NCT00829868|20788952|P1|COMPLETED|Washout||20
8436168|NCT00829868|20788951|P2|STARTED|Washout||21
8436169|NCT00829868|20788952|P1|STARTED|Washout||21
8436170|NCT00829868|20788951|P2|NOT COMPLETED|First Intervention||0
8436171|NCT00829868|20788952|P1|NOT COMPLETED|First Intervention||0
8436172|NCT00829868|20788951|P2|COMPLETED|First Intervention||21
8436173|NCT00829868|20788952|P1|COMPLETED|First Intervention||21
8436174|NCT00829868|20788951|P2|STARTED|First Intervention||21
8436175|NCT00829868|20788952|P1|STARTED|First Intervention||21
8436176|NCT00829829|20788963|P3|NOT COMPLETED|Overall Study||11
8436177|NCT00829829|20788964|P2|NOT COMPLETED|Overall Study||16
8436178|NCT00829829|20788965|P1|NOT COMPLETED|Overall Study||22
8436179|NCT00829829|20788963|P3|COMPLETED|Overall Study||70
8436180|NCT00829829|20788964|P2|COMPLETED|Overall Study||64
8436181|NCT00829829|20788965|P1|COMPLETED|Overall Study||58
8436182|NCT00829829|20788963|P3|Treated|Overall Study||81
8436183|NCT00829829|20788964|P2|Treated|Overall Study||80
8436184|NCT00829829|20788965|P1|Treated|Overall Study||79
8436185|NCT00829829|20788963|P3|STARTED|Overall Study||81
8436186|NCT00829829|20788964|P2|STARTED|Overall Study||80
8436187|NCT00829829|20788965|P1|STARTED|Overall Study||80
8436188|NCT00829790|20788990|P2|NOT COMPLETED|Second Intervention||0
8436189|NCT00829790|20788991|P1|NOT COMPLETED|Second Intervention||0
8436190|NCT00829790|20788990|P2|COMPLETED|Second Intervention||14
8436191|NCT00829790|20788991|P1|COMPLETED|Second Intervention||15
8436192|NCT00829790|20788990|P2|STARTED|Second Intervention||14
8436193|NCT00829790|20788991|P1|STARTED|Second Intervention||15
8436194|NCT00829790|20788990|P2|NOT COMPLETED|Washout of 14 Days||1
8436195|NCT00829790|20788991|P1|NOT COMPLETED|Washout of 14 Days||0
8436196|NCT00829790|20788990|P2|COMPLETED|Washout of 14 Days||14
8436197|NCT00829790|20788991|P1|COMPLETED|Washout of 14 Days||15
8436198|NCT00829790|20788990|P2|STARTED|Washout of 14 Days||15
8436199|NCT00829790|20788991|P1|STARTED|Washout of 14 Days||15
8436200|NCT00829790|20788990|P2|NOT COMPLETED|First Intervention||0
8436201|NCT00829790|20788991|P1|NOT COMPLETED|First Intervention||0
8436202|NCT00829790|20788990|P2|COMPLETED|First Intervention||15
8436203|NCT00829790|20788991|P1|COMPLETED|First Intervention||15
8436204|NCT00829790|20788990|P2|STARTED|First Intervention||15
8436205|NCT00829790|20788991|P1|STARTED|First Intervention||15
8436206|NCT00829764|20789001|P2|NOT COMPLETED|Second Intervention||0
8436207|NCT00829764|20789002|P1|NOT COMPLETED|Second Intervention||0
8436208|NCT00829764|20789001|P2|COMPLETED|Second Intervention||14
8436209|NCT00829764|20789002|P1|COMPLETED|Second Intervention||13
8436210|NCT00829764|20789001|P2|STARTED|Second Intervention||14
8436211|NCT00829764|20789002|P1|STARTED|Second Intervention||13
8436212|NCT00829764|20789001|P2|NOT COMPLETED|Washout of 14 Days||0
8436213|NCT00829764|20789002|P1|NOT COMPLETED|Washout of 14 Days||0
8436214|NCT00829764|20789001|P2|COMPLETED|Washout of 14 Days||14
8436215|NCT00829764|20789002|P1|COMPLETED|Washout of 14 Days||13
8436216|NCT00829764|20789001|P2|STARTED|Washout of 14 Days||14
8436217|NCT00829764|20789002|P1|STARTED|Washout of 14 Days||13
8436218|NCT00829764|20789001|P2|NOT COMPLETED|First Intervention||1
8436219|NCT00829764|20789002|P1|NOT COMPLETED|First Intervention||2
8436220|NCT00829764|20789001|P2|COMPLETED|First Intervention||14
8436221|NCT00829764|20789002|P1|COMPLETED|First Intervention||13
8436222|NCT00829764|20789001|P2|STARTED|First Intervention||15
8436223|NCT00829764|20789002|P1|STARTED|First Intervention||15
8436224|NCT00829738|20789010|P1|NOT COMPLETED|Overall Study||8
8436225|NCT00829738|20789010|P1|COMPLETED|Overall Study||4180
8436226|NCT00829738|20789010|P1|STARTED|Overall Study||4188
8436227|NCT00829712|20789028|P2|NOT COMPLETED|Second Intervention||0
8436228|NCT00829712|20789029|P1|NOT COMPLETED|Second Intervention||0
8436229|NCT00829712|20789028|P2|COMPLETED|Second Intervention||11
8436230|NCT00829712|20789029|P1|COMPLETED|Second Intervention||12
8436231|NCT00829712|20789028|P2|STARTED|Second Intervention||11
8436232|NCT00829712|20789029|P1|STARTED|Second Intervention||12
8436233|NCT00829712|20789028|P2|NOT COMPLETED|Washout of 7 Days||1
8436234|NCT00829712|20789029|P1|NOT COMPLETED|Washout of 7 Days||0
8436235|NCT00829712|20789028|P2|COMPLETED|Washout of 7 Days||11
8436236|NCT00829712|20789029|P1|COMPLETED|Washout of 7 Days||12
8436237|NCT00829712|20789028|P2|STARTED|Washout of 7 Days||12
8436238|NCT00829712|20789029|P1|STARTED|Washout of 7 Days||12
8436239|NCT00829712|20789028|P2|NOT COMPLETED|First Intervention||0
8436240|NCT00829712|20789029|P1|NOT COMPLETED|First Intervention||0
8436241|NCT00829712|20789028|P2|COMPLETED|First Intervention||12
8436242|NCT00829712|20789029|P1|COMPLETED|First Intervention||12
8436243|NCT00829712|20789028|P2|STARTED|First Intervention||12
8436244|NCT00829712|20789029|P1|STARTED|First Intervention||12
8436245|NCT00829686|20789039|P2|NOT COMPLETED|Overall Study||0
8436246|NCT00829686|20789040|P1|NOT COMPLETED|Overall Study||0
8436247|NCT00829686|20789039|P2|COMPLETED|Overall Study||18
8436248|NCT00829686|20789040|P1|COMPLETED|Overall Study||13
8436249|NCT00829686|20789039|P2|STARTED|Overall Study||18
8436250|NCT00829686|20789040|P1|STARTED|Overall Study||13
8436251|NCT00829673|20789048|P2|NOT COMPLETED|Second Intervention||0
8436252|NCT00829673|20789049|P1|NOT COMPLETED|Second Intervention||0
8436253|NCT00829673|20789048|P2|COMPLETED|Second Intervention||12
8436254|NCT00829673|20789049|P1|COMPLETED|Second Intervention||11
8436255|NCT00829673|20789048|P2|STARTED|Second Intervention||12
8436256|NCT00829673|20789049|P1|STARTED|Second Intervention||11
8436257|NCT00829673|20789048|P2|NOT COMPLETED|Washout of 7 Days||0
8436258|NCT00829673|20789049|P1|NOT COMPLETED|Washout of 7 Days||1
8436259|NCT00829673|20789048|P2|COMPLETED|Washout of 7 Days||12
8436260|NCT00829673|20789049|P1|COMPLETED|Washout of 7 Days||11
8436261|NCT00829673|20789048|P2|STARTED|Washout of 7 Days||12
8436262|NCT00829673|20789049|P1|STARTED|Washout of 7 Days||12
8436263|NCT00829673|20789048|P2|NOT COMPLETED|First Intervention||0
8436264|NCT00829673|20789049|P1|NOT COMPLETED|First Intervention||0
8436265|NCT00829673|20789048|P2|COMPLETED|First Intervention||12
8436266|NCT00829673|20789049|P1|COMPLETED|First Intervention||12
8436267|NCT00829673|20789048|P2|STARTED|First Intervention||12
8436268|NCT00829673|20789049|P1|STARTED|First Intervention||12
8436269|NCT00829621|20789059|P2|NOT COMPLETED|Overall Study||4
8436270|NCT00829621|20789060|P1|NOT COMPLETED|Overall Study||4
8436271|NCT00829621|20789059|P2|COMPLETED|Overall Study||8
8436272|NCT00829621|20789060|P1|COMPLETED|Overall Study||4
8436273|NCT00829621|20789059|P2|STARTED|Overall Study||12
8436274|NCT00829621|20789060|P1|STARTED|Overall Study||8
8436275|NCT00829530|20789068|P2|NOT COMPLETED|Second Intervention||0
8436276|NCT00829530|20789069|P1|NOT COMPLETED|Second Intervention||1
8436277|NCT00829530|20789068|P2|COMPLETED|Second Intervention||18
8436278|NCT00829530|20789069|P1|COMPLETED|Second Intervention||19
8436279|NCT00829530|20789068|P2|STARTED|Second Intervention||18
8436280|NCT00829530|20789069|P1|STARTED|Second Intervention||20
8436281|NCT00829530|20789068|P2|NOT COMPLETED|Washout of 42 Days||0
8436282|NCT00829530|20789069|P1|NOT COMPLETED|Washout of 42 Days||0
8436283|NCT00829530|20789068|P2|COMPLETED|Washout of 42 Days||18
8436284|NCT00829530|20789069|P1|COMPLETED|Washout of 42 Days||20
8436285|NCT00829530|20789068|P2|STARTED|Washout of 42 Days||18
8436286|NCT00829530|20789069|P1|STARTED|Washout of 42 Days||20
8436287|NCT00829530|20789068|P2|NOT COMPLETED|First Intervention||2
8436288|NCT00829530|20789069|P1|NOT COMPLETED|First Intervention||0
8436289|NCT00829530|20789068|P2|COMPLETED|First Intervention||18
8436290|NCT00829530|20789069|P1|COMPLETED|First Intervention||20
8436291|NCT00829530|20789068|P2|STARTED|First Intervention||20
8436292|NCT00829530|20789069|P1|STARTED|First Intervention||20
8436293|NCT00829504|20789083|P2|NOT COMPLETED|Second Intervention||0
8436294|NCT00829504|20789084|P1|NOT COMPLETED|Second Intervention||1
8436295|NCT00829504|20789083|P2|COMPLETED|Second Intervention||22
8436296|NCT00829504|20789084|P1|COMPLETED|Second Intervention||19
8436297|NCT00829504|20789083|P2|STARTED|Second Intervention||22
8436298|NCT00829504|20789084|P1|STARTED|Second Intervention||20
8436299|NCT00829504|20789083|P2|NOT COMPLETED|Washout of 7 Days||0
8436300|NCT00829504|20789084|P1|NOT COMPLETED|Washout of 7 Days||1
8436301|NCT00829504|20789083|P2|COMPLETED|Washout of 7 Days||22
8436302|NCT00829504|20789084|P1|COMPLETED|Washout of 7 Days||20
8436303|NCT00829504|20789083|P2|STARTED|Washout of 7 Days||22
8436304|NCT00829504|20789084|P1|STARTED|Washout of 7 Days||21
8436305|NCT00829504|20789083|P2|NOT COMPLETED|First Intervention||0
8436306|NCT00829504|20789084|P1|NOT COMPLETED|First Intervention||1
8436307|NCT00829504|20789083|P2|COMPLETED|First Intervention||22
8436308|NCT00829504|20789084|P1|COMPLETED|First Intervention||21
8436309|NCT00829504|20789083|P2|STARTED|First Intervention||22
8436310|NCT00829504|20789084|P1|STARTED|First Intervention||22
8436311|NCT00829452|20789094|P2|NOT COMPLETED|Second Intervention||1
8436312|NCT00829452|20789095|P1|NOT COMPLETED|Second Intervention||0
8436313|NCT00829452|20789094|P2|COMPLETED|Second Intervention||17
8436314|NCT00829452|20789095|P1|COMPLETED|Second Intervention||20
8436315|NCT00829452|20789094|P2|STARTED|Second Intervention||18
8436316|NCT00829452|20789095|P1|STARTED|Second Intervention||20
8436317|NCT00829452|20789094|P2|NOT COMPLETED|Washout of 42 Days||1
8436318|NCT00829452|20789095|P1|NOT COMPLETED|Washout of 42 Days||0
8436319|NCT00829452|20789094|P2|COMPLETED|Washout of 42 Days||18
8436320|NCT00829452|20789095|P1|COMPLETED|Washout of 42 Days||20
8436321|NCT00829452|20789094|P2|STARTED|Washout of 42 Days||19
8436322|NCT00829452|20789095|P1|STARTED|Washout of 42 Days||20
8436323|NCT00829452|20789094|P2|NOT COMPLETED|First Intervention||1
8436324|NCT00829452|20789095|P1|NOT COMPLETED|First Intervention||0
8436325|NCT00829452|20789094|P2|COMPLETED|First Intervention||19
8436326|NCT00829452|20789095|P1|COMPLETED|First Intervention||20
8436327|NCT00829452|20789094|P2|STARTED|First Intervention||20
8436328|NCT00829452|20789095|P1|STARTED|First Intervention||20
8436329|NCT00829439|20789107|P4|NOT COMPLETED|Overall Study||0
8436330|NCT00829439|20789108|P3|NOT COMPLETED|Overall Study||1
8436331|NCT00829439|20789109|P2|NOT COMPLETED|Overall Study||0
8436332|NCT00829439|20789110|P1|NOT COMPLETED|Overall Study||0
8436333|NCT00829439|20789107|P4|COMPLETED|Overall Study||4
8436334|NCT00829439|20789108|P3|COMPLETED|Overall Study||5
8436335|NCT00829439|20789109|P2|COMPLETED|Overall Study||3
8436336|NCT00829439|20789110|P1|COMPLETED|Overall Study||3
8436337|NCT00829439|20789107|P4|STARTED|Overall Study||4
8436338|NCT00829439|20789108|P3|STARTED|Overall Study||6
8436339|NCT00829439|20789109|P2|STARTED|Overall Study||3
8436340|NCT00829439|20789110|P1|STARTED|Overall Study||3
8436341|NCT00829426|20789116|P2|NOT COMPLETED|Second Intervention||0
8436342|NCT00829426|20789117|P1|NOT COMPLETED|Second Intervention||0
8436343|NCT00829426|20789116|P2|COMPLETED|Second Intervention||16
8436344|NCT00829426|20789117|P1|COMPLETED|Second Intervention||15
8436345|NCT00829426|20789116|P2|STARTED|Second Intervention||16
8436346|NCT00829426|20789117|P1|STARTED|Second Intervention||15
8436347|NCT00829426|20789116|P2|NOT COMPLETED|Washout: 7 Days||0
8436348|NCT00829426|20789117|P1|NOT COMPLETED|Washout: 7 Days||1
8436349|NCT00829426|20789116|P2|COMPLETED|Washout: 7 Days||16
8436350|NCT00829426|20789117|P1|COMPLETED|Washout: 7 Days||15
8436351|NCT00829426|20789116|P2|STARTED|Washout: 7 Days||16
8436352|NCT00829426|20789117|P1|STARTED|Washout: 7 Days||16
8436353|NCT00829426|20789116|P2|NOT COMPLETED|First Intervention||0
8436354|NCT00829426|20789117|P1|NOT COMPLETED|First Intervention||0
8436355|NCT00829426|20789116|P2|COMPLETED|First Intervention||16
8436356|NCT00829426|20789117|P1|COMPLETED|First Intervention||16
8436357|NCT00829426|20789116|P2|STARTED|First Intervention||16
8436358|NCT00829426|20789117|P1|STARTED|First Intervention||16
8436359|NCT00829413|20789125|P1|NOT COMPLETED|Overall Study||94
8436360|NCT00829413|20789125|P1|COMPLETED|Overall Study||259
8436361|NCT00829413|20789125|P1|STARTED|Overall Study||353
8436362|NCT00829387|20789174|P2|NOT COMPLETED|Overall Study||3
8436363|NCT00829387|20789175|P1|NOT COMPLETED|Overall Study||3
8436364|NCT00829387|20789174|P2|COMPLETED|Overall Study||21
8436365|NCT00829387|20789175|P1|COMPLETED|Overall Study||20
8436366|NCT00829387|20789174|P2|STARTED|Overall Study||24
8436367|NCT00829387|20789175|P1|STARTED|Overall Study||23
8436368|NCT00829309|20789193|P2|NOT COMPLETED|Second Intervention||0
8436369|NCT00829309|20789194|P1|NOT COMPLETED|Second Intervention||0
8436370|NCT00829309|20789193|P2|COMPLETED|Second Intervention||8
8436371|NCT00829309|20789194|P1|COMPLETED|Second Intervention||7
8436372|NCT00829309|20789193|P2|STARTED|Second Intervention||8
8436373|NCT00829309|20789194|P1|STARTED|Second Intervention||7
8436374|NCT00829309|20789193|P2|NOT COMPLETED|Washout: 7 Days||0
8436375|NCT00829309|20789194|P1|NOT COMPLETED|Washout: 7 Days||1
8436376|NCT00829309|20789193|P2|COMPLETED|Washout: 7 Days||8
8436377|NCT00829309|20789194|P1|COMPLETED|Washout: 7 Days||7
8436378|NCT00829309|20789193|P2|STARTED|Washout: 7 Days||8
8436379|NCT00829309|20789194|P1|STARTED|Washout: 7 Days||8
8436380|NCT00829309|20789193|P2|NOT COMPLETED|First Intervention||0
8436381|NCT00829309|20789194|P1|NOT COMPLETED|First Intervention||0
8436382|NCT00829309|20789193|P2|COMPLETED|First Intervention||8
8436383|NCT00829309|20789194|P1|COMPLETED|First Intervention||8
8436384|NCT00829309|20789193|P2|STARTED|First Intervention||8
8436385|NCT00829309|20789194|P1|STARTED|First Intervention||8
8436386|NCT00829296|20789204|P2|NOT COMPLETED|Overall Study||4
8436387|NCT00829296|20789205|P1|NOT COMPLETED|Overall Study||5
8436388|NCT00829296|20789204|P2|COMPLETED|Overall Study||32
8436389|NCT00829296|20789205|P1|COMPLETED|Overall Study||29
8436390|NCT00829296|20789204|P2|STARTED|Overall Study||36
8436391|NCT00829296|20789205|P1|STARTED|Overall Study||34
8436392|NCT00829283|20789219|P2|NOT COMPLETED|Overall Study||25
8436393|NCT00829283|20789220|P1|NOT COMPLETED|Overall Study||7
8436394|NCT00829283|20789219|P2|COMPLETED|Overall Study||127
8436395|NCT00829283|20789220|P1|COMPLETED|Overall Study||32
8436396|NCT00829283|20789219|P2|STARTED|Overall Study||152
8436397|NCT00829283|20789220|P1|STARTED|Overall Study||39
8436398|NCT00829244|20789230|P2|NOT COMPLETED|Overall Study||21
8436399|NCT00829244|20789231|P1|NOT COMPLETED|Overall Study||14
8436400|NCT00829244|20789230|P2|COMPLETED|Overall Study||83
8436401|NCT00829244|20789231|P1|COMPLETED|Overall Study||82
8436402|NCT00829244|20789230|P2|STARTED|Overall Study||104
8436403|NCT00829244|20789231|P1|STARTED|Overall Study||96
8436404|NCT00829179|20789261|P1|NOT COMPLETED|Overall Study||1
8436405|NCT00829179|20789261|P1|COMPLETED|Overall Study||19
8436406|NCT00829179|20789261|P1|STARTED|Overall Study||20
8436407|NCT00829166|20789267|P2|NOT COMPLETED|Overall Study||496
8436408|NCT00829166|20789268|P1|NOT COMPLETED|Overall Study||495
8436409|NCT00829166|20789267|P2|COMPLETED|Overall Study||0
8436410|NCT00829166|20789268|P1|COMPLETED|Overall Study||0
8436411|NCT00829166|20789267|P2|Treated|Overall Study||488
8436412|NCT00829166|20789268|P1|Treated|Overall Study||490
8436413|NCT00829166|20789267|P2|STARTED|Overall Study||496
8436414|NCT00829166|20789268|P1|STARTED|Overall Study||495
8436415|NCT00829049|20789309|P2|NOT COMPLETED|Overall Study||20
8436416|NCT00829049|20789310|P1|NOT COMPLETED|Overall Study||17
8436417|NCT00829049|20789309|P2|COMPLETED|Overall Study||68
8436418|NCT00829049|20789310|P1|COMPLETED|Overall Study||60
8436419|NCT00829049|20789309|P2|STARTED|Overall Study||88
8436420|NCT00829049|20789310|P1|STARTED|Overall Study||77
8436421|NCT00829036|20789322|P1|NOT COMPLETED|Overall Study||0
8436422|NCT00829036|20789322|P1|COMPLETED|Overall Study||24
8436423|NCT00829036|20789322|P1|STARTED|Overall Study||24
8436424|NCT00829010|20789331|P5|NOT COMPLETED|Overall Study||2
8436425|NCT00829010|20789332|P4|NOT COMPLETED|Overall Study||8
8436426|NCT00829010|20789333|P3|NOT COMPLETED|Overall Study||3
8436427|NCT00829010|20789334|P2|NOT COMPLETED|Overall Study||9
8436428|NCT00829010|20789335|P1|NOT COMPLETED|Overall Study||10
8436429|NCT00829010|20789331|P5|COMPLETED|Overall Study||98
8436430|NCT00829010|20789332|P4|COMPLETED|Overall Study||92
8436431|NCT00829010|20789333|P3|COMPLETED|Overall Study||97
8436432|NCT00829010|20789334|P2|COMPLETED|Overall Study||92
8436433|NCT00829010|20789335|P1|COMPLETED|Overall Study||73
8436434|NCT00829010|20789331|P5|STARTED|Overall Study||100
8436435|NCT00829010|20789332|P4|STARTED|Overall Study||100
8436436|NCT00829010|20789333|P3|STARTED|Overall Study||100
8436437|NCT00829010|20789334|P2|STARTED|Overall Study||101
8436438|NCT00829010|20789335|P1|STARTED|Overall Study||83
8436439|NCT00828984|20789500|P3|NOT COMPLETED|Overall Study||9
8436440|NCT00828984|20789501|P2|NOT COMPLETED|Overall Study||16
8436441|NCT00828984|20789502|P1|NOT COMPLETED|Overall Study||14
8436442|NCT00828984|20789500|P3|COMPLETED|Overall Study||19
8436443|NCT00828984|20789501|P2|COMPLETED|Overall Study||15
8436444|NCT00828984|20789502|P1|COMPLETED|Overall Study||14
8436445|NCT00828984|20789500|P3|Post Intervention Follow-Up|Overall Study||19
8436446|NCT00828984|20789501|P2|Post Intervention Follow-Up|Overall Study||16
8436447|NCT00828984|20789502|P1|Post Intervention Follow-Up|Overall Study||15
8436448|NCT00828984|20789500|P3|Flexible Sigmoidoscopy|Overall Study||19
8436449|NCT00828984|20789501|P2|Flexible Sigmoidoscopy|Overall Study||19
8436450|NCT00828984|20789502|P1|Flexible Sigmoidoscopy|Overall Study||20
8436451|NCT00828984|20789500|P3|Treatment|Overall Study||24
8436452|NCT00828984|20789501|P2|Treatment|Overall Study||26
8436453|NCT00828984|20789502|P1|Treatment|Overall Study||24
8436454|NCT00828984|20789500|P3|Randomization|Overall Study||28
8436455|NCT00828984|20789501|P2|Randomization|Overall Study||31
8436456|NCT00828984|20789502|P1|Randomization|Overall Study||28
8436457|NCT00828984|20789500|P3|STARTED|Overall Study||28
8436458|NCT00828984|20789501|P2|STARTED|Overall Study||31
8436459|NCT00828984|20789502|P1|STARTED|Overall Study||28
8436463|NCT00828841|20789542|P3|NOT COMPLETED|Overall Study||4
8436464|NCT00828841|20789543|P2|NOT COMPLETED|Overall Study||4
8436465|NCT00828841|20789544|P1|NOT COMPLETED|Overall Study||4
8436466|NCT00828841|20789542|P3|COMPLETED|Overall Study||126
8436467|NCT00828841|20789543|P2|COMPLETED|Overall Study||232
8436468|NCT00828841|20789544|P1|COMPLETED|Overall Study||231
8436469|NCT00828841|20789542|P3|STARTED|Overall Study||130
8436470|NCT00828841|20789543|P2|STARTED|Overall Study||236
8436471|NCT00828841|20789544|P1|STARTED|Overall Study||235
8436472|NCT00828750|20789557|P1|NOT COMPLETED|Overall Study||4
8436473|NCT00828750|20789557|P1|COMPLETED|Overall Study||15
8436474|NCT00828750|20789557|P1|STARTED|Overall Study||19
8436475|NCT00828711|20789571|P3|NOT COMPLETED|Overall Study||0
8436476|NCT00828711|20789572|P2|NOT COMPLETED|Overall Study||0
8436477|NCT00828711|20789573|P1|NOT COMPLETED|Overall Study||1
8436478|NCT00828711|20789571|P3|COMPLETED|Overall Study||131
8436479|NCT00828711|20789572|P2|COMPLETED|Overall Study||125
8436480|NCT00828711|20789573|P1|COMPLETED|Overall Study||117
8436481|NCT00828711|20789571|P3|STARTED|Overall Study||131
8436482|NCT00828711|20789572|P2|STARTED|Overall Study||125
8436483|NCT00828711|20789573|P1|STARTED|Overall Study||118
8436484|NCT00828672|20789604|P2|NOT COMPLETED|Follow-up||0
8436485|NCT00828672|20789605|P1|NOT COMPLETED|Follow-up||0
8436486|NCT00828672|20789604|P2|COMPLETED|Follow-up||41
8436487|NCT00828672|20789605|P1|COMPLETED|Follow-up||42
8436488|NCT00828672|20789604|P2|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41
8436489|NCT00828672|20789605|P1|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42
8436490|NCT00828672|20789604|P2|NOT COMPLETED|Post-surgery (<30 Days)||1
8436491|NCT00828672|20789605|P1|NOT COMPLETED|Post-surgery (<30 Days)||0
8436492|NCT00828672|20789604|P2|COMPLETED|Post-surgery (<30 Days)||38
8436493|NCT00828672|20789605|P1|COMPLETED|Post-surgery (<30 Days)||41
8436494|NCT00828672|20789604|P2|STARTED|Post-surgery (<30 Days)||39
8436495|NCT00828672|20789605|P1|STARTED|Post-surgery (<30 Days)||41
8436496|NCT00828672|20789604|P2|NOT COMPLETED|Study Treatment||2
8436497|NCT00828672|20789605|P1|NOT COMPLETED|Study Treatment||2
8436498|NCT00828672|20789604|P2|COMPLETED|Study Treatment||39
8436499|NCT00828672|20789605|P1|COMPLETED|Study Treatment||41
8436500|NCT00828672|20789604|P2|STARTED|Study Treatment||41
8436501|NCT00828672|20789605|P1|STARTED|Study Treatment||43
8436502|NCT00828672|20789604|P2|NOT COMPLETED|Pre-treatment (Baseline)||0
8436503|NCT00828672|20789605|P1|NOT COMPLETED|Pre-treatment (Baseline)||0
8436504|NCT00828672|20789604|P2|COMPLETED|Pre-treatment (Baseline)||41
8436505|NCT00828672|20789605|P1|COMPLETED|Pre-treatment (Baseline)||43
8436506|NCT00828672|20789604|P2|STARTED|Pre-treatment (Baseline)||41
8436507|NCT00828672|20789605|P1|STARTED|Pre-treatment (Baseline)||43
8436508|NCT00828568|20789626|P3|NOT COMPLETED|Treated - Received at Least One Dose||5
8436509|NCT00828568|20789627|P2|NOT COMPLETED|Treated - Received at Least One Dose||29
8436510|NCT00828568|20789628|P1|NOT COMPLETED|Treated - Received at Least One Dose||30
8436511|NCT00828568|20789626|P3|COMPLETED|Treated - Received at Least One Dose||55
8436512|NCT00828568|20789627|P2|COMPLETED|Treated - Received at Least One Dose||150
8436513|NCT00828568|20789628|P1|COMPLETED|Treated - Received at Least One Dose||153
8436514|NCT00828568|20789626|P3|STARTED|Treated - Received at Least One Dose||60
8436515|NCT00828568|20789627|P2|STARTED|Treated - Received at Least One Dose||179
8436516|NCT00828568|20789628|P1|STARTED|Treated - Received at Least One Dose||183
8436517|NCT00828568|20789626|P3|NOT COMPLETED|Randomized||2
8436518|NCT00828568|20789627|P2|NOT COMPLETED|Randomized||0
8436519|NCT00828568|20789628|P1|NOT COMPLETED|Randomized||1
8436520|NCT00828568|20789626|P3|COMPLETED|Randomized||60
8436521|NCT00828568|20789627|P2|COMPLETED|Randomized||179
8436522|NCT00828568|20789628|P1|COMPLETED|Randomized||183
8436523|NCT00828568|20789626|P3|STARTED|Randomized||62
8436524|NCT00828568|20789627|P2|STARTED|Randomized||179
8436525|NCT00828568|20789628|P1|STARTED|Randomized||184
8436526|NCT00828542|20789643|P2|NOT COMPLETED|Overall Study||3
8436527|NCT00828542|20789644|P1|NOT COMPLETED|Overall Study||3
8436528|NCT00828542|20789643|P2|COMPLETED|Overall Study||20
8436529|NCT00828542|20789644|P1|COMPLETED|Overall Study||20
8436530|NCT00828542|20789643|P2|STARTED|Overall Study||23
8436531|NCT00828542|20789644|P1|STARTED|Overall Study||23
8436532|NCT00828516|20789650|P1|NOT COMPLETED|Clinical Phase: Series 2||0
8436533|NCT00828516|20789650|P1|COMPLETED|Clinical Phase: Series 2||30
8436534|NCT00828516|20789650|P1|STARTED|Clinical Phase: Series 2||30
8436535|NCT00828516|20789650|P1|NOT COMPLETED|Clinical Phase: Series 1||2
8436536|NCT00828516|20789650|P1|COMPLETED|Clinical Phase: Series 1||33
8436537|NCT00828516|20789650|P1|STARTED|Clinical Phase: Series 1||35
8436538|NCT00828464|20789655|P1|NOT COMPLETED|Overall Study||1
8436539|NCT00828464|20789655|P1|COMPLETED|Overall Study||29
8436540|NCT00828464|20789655|P1|STARTED|Overall Study||30
8436541|NCT00828451|20789672|P1|NOT COMPLETED|Overall Study||11
8436542|NCT00828451|20789672|P1|COMPLETED|Overall Study||18
8436543|NCT00828451|20789672|P1|STARTED|Overall Study||29
8436544|NCT00828412|20789680|P2|NOT COMPLETED|Overall Study||2
8436545|NCT00828412|20789681|P1|NOT COMPLETED|Overall Study||9
8436546|NCT00828412|20789680|P2|COMPLETED|Overall Study||48
8436547|NCT00828412|20789681|P1|COMPLETED|Overall Study||41
8436548|NCT00828412|20789680|P2|STARTED|Overall Study||50
8436549|NCT00828412|20789681|P1|STARTED|Overall Study||50
8436550|NCT00828347|20789689|P2|NOT COMPLETED|Overall Study||0
8436551|NCT00828347|20789690|P1|NOT COMPLETED|Overall Study||0
8436552|NCT00828347|20789689|P2|COMPLETED|Overall Study||11
8436553|NCT00828347|20789690|P1|COMPLETED|Overall Study||12
8436554|NCT00828347|20789689|P2|STARTED|Overall Study||11
8436555|NCT00828347|20789690|P1|STARTED|Overall Study||12
8436556|NCT00828321|20789698|P2|NOT COMPLETED|Second Intervention||1
8436557|NCT00828321|20789699|P1|NOT COMPLETED|Second Intervention||0
8436558|NCT00828321|20789698|P2|COMPLETED|Second Intervention||19
8436559|NCT00828321|20789699|P1|COMPLETED|Second Intervention||18
8436560|NCT00828321|20789698|P2|STARTED|Second Intervention||20
8436561|NCT00828321|20789699|P1|STARTED|Second Intervention||18
8436562|NCT00828321|20789698|P2|NOT COMPLETED|Washout of 42 Days||0
8436563|NCT00828321|20789699|P1|NOT COMPLETED|Washout of 42 Days||2
8436564|NCT00828321|20789698|P2|COMPLETED|Washout of 42 Days||20
8436565|NCT00828321|20789699|P1|COMPLETED|Washout of 42 Days||18
8436566|NCT00828321|20789698|P2|STARTED|Washout of 42 Days||20
8436567|NCT00828321|20789699|P1|STARTED|Washout of 42 Days||20
8436568|NCT00828321|20789698|P2|NOT COMPLETED|First Intervention||0
8436569|NCT00828321|20789699|P1|NOT COMPLETED|First Intervention||0
8436570|NCT00828321|20789698|P2|COMPLETED|First Intervention||20
8436571|NCT00828321|20789699|P1|COMPLETED|First Intervention||20
8436572|NCT00828321|20789698|P2|STARTED|First Intervention||20
8436573|NCT00828321|20789699|P1|STARTED|First Intervention||20
8436574|NCT00828308|20789711|P1|NOT COMPLETED|Overall Study||0
8436575|NCT00828308|20789711|P1|COMPLETED|Overall Study||16
8436576|NCT00828308|20789711|P1|STARTED|Overall Study||16
8436577|NCT00828295|20789717|P2|NOT COMPLETED|Overall Study||0
8436578|NCT00828295|20789718|P1|NOT COMPLETED|Overall Study||0
8436579|NCT00828295|20789717|P2|COMPLETED|Overall Study||75
8436580|NCT00828295|20789718|P1|COMPLETED|Overall Study||75
8436581|NCT00828295|20789717|P2|STARTED|Overall Study||75
8436582|NCT00828295|20789718|P1|STARTED|Overall Study||75
8436583|NCT00828204|20789728|P2|NOT COMPLETED|Extension Study||3
8436584|NCT00828204|20789729|P1|NOT COMPLETED|Extension Study||0
8436585|NCT00828204|20789728|P2|COMPLETED|Extension Study||61
8436586|NCT00828204|20789729|P1|COMPLETED|Extension Study||0
8436587|NCT00828204|20789728|P2|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
8436588|NCT00828204|20789729|P1|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
8436589|NCT00828204|20789728|P2|NOT COMPLETED|Main Study: After Study Restart||3
8436590|NCT00828204|20789729|P1|NOT COMPLETED|Main Study: After Study Restart||0
8436591|NCT00828204|20789728|P2|COMPLETED|Main Study: After Study Restart||71
8436592|NCT00828204|20789729|P1|COMPLETED|Main Study: After Study Restart||0
8436593|NCT00828204|20789728|P2|Continued With Autoinjector Injections|Main Study: After Study Restart||72
8436594|NCT00828204|20789729|P1|Continued With Autoinjector Injections|Main Study: After Study Restart||0
8436595|NCT00828204|20789728|P2|Completed Manual Injection|Main Study: After Study Restart||74
8436596|NCT00828204|20789729|P1|Completed Manual Injection|Main Study: After Study Restart||0
8436597|NCT00828204|20789728|P2|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
8436598|NCT00828204|20789729|P1|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
8436599|NCT00828204|20789728|P2|NOT COMPLETED|Main Study: Prior to Study Suspension||0
8436600|NCT00828204|20789729|P1|NOT COMPLETED|Main Study: Prior to Study Suspension||14
8436601|NCT00828204|20789728|P2|COMPLETED|Main Study: Prior to Study Suspension||0
8436602|NCT00828204|20789729|P1|COMPLETED|Main Study: Prior to Study Suspension||7
8436603|NCT00828204|20789728|P2|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
8436604|NCT00828204|20789729|P1|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
8436605|NCT00828204|20789728|P2|Completed Manual Injection|Main Study: Prior to Study Suspension||0
8436606|NCT00828204|20789729|P1|Completed Manual Injection|Main Study: Prior to Study Suspension||21
8436607|NCT00828204|20789728|P2|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
8436608|NCT00828204|20789729|P1|STARTED|Main Study: Prior to Study Suspension||21
8436609|NCT00828191|20789748|P2|NOT COMPLETED|Overall Study||10
8436610|NCT00828191|20789749|P1|NOT COMPLETED|Overall Study||8
8436611|NCT00828191|20789748|P2|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
8436612|NCT00828191|20789749|P1|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
8436613|NCT00828191|20789748|P2|STARTED|Overall Study|Randomized patients|400
8436614|NCT00828191|20789749|P1|STARTED|Overall Study|Randomized patients|400
8436615|NCT00828178|20789761|P2|NOT COMPLETED|Overall Study||2
8436616|NCT00828178|20789762|P1|NOT COMPLETED|Overall Study||0
8436617|NCT00828178|20789761|P2|COMPLETED|Overall Study|Two patients did not complete the study.|43
8436618|NCT00828178|20789762|P1|COMPLETED|Overall Study||42
8436619|NCT00828178|20789761|P2|STARTED|Overall Study|Eighty seven participants were randomized.|45
8436620|NCT00828178|20789762|P1|STARTED|Overall Study||42
8436621|NCT00828139|20789776|P4|NOT COMPLETED|Overall Study||51
8436622|NCT00828139|20789777|P3|NOT COMPLETED|Overall Study||55
8436623|NCT00828139|20789778|P2|NOT COMPLETED|Overall Study||41
8436624|NCT00828139|20789779|P1|NOT COMPLETED|Overall Study||41
8436625|NCT00828139|20789776|P4|COMPLETED|Overall Study||0
8436626|NCT00828139|20789777|P3|COMPLETED|Overall Study||0
8436627|NCT00828139|20789778|P2|COMPLETED|Overall Study||0
8436628|NCT00828139|20789779|P1|COMPLETED|Overall Study||1
8436629|NCT00828139|20789776|P4|STARTED|Overall Study||51
8436630|NCT00828139|20789777|P3|STARTED|Overall Study||55
8436631|NCT00828139|20789778|P2|STARTED|Overall Study||41
8436632|NCT00828139|20789779|P1|STARTED|Overall Study||42
8436633|NCT00828113|20789799|P2|NOT COMPLETED|Overall Study||31
8436634|NCT00828113|20789800|P1|NOT COMPLETED|Overall Study||30
8436635|NCT00828113|20789799|P2|COMPLETED|Overall Study||20
8436636|NCT00828113|20789800|P1|COMPLETED|Overall Study||20
8436637|NCT00828113|20789799|P2|STARTED|Overall Study||51
8436638|NCT00828113|20789800|P1|STARTED|Overall Study||50
8436639|NCT00828074|20789808|P3|NOT COMPLETED|Overall Study||0
8436640|NCT00828074|20789809|P2|NOT COMPLETED|Overall Study||0
8436641|NCT00828074|20789810|P1|NOT COMPLETED|Overall Study||0
8436642|NCT00828074|20789808|P3|COMPLETED|Overall Study||35
8436643|NCT00828074|20789809|P2|COMPLETED|Overall Study||5
8436644|NCT00828074|20789810|P1|COMPLETED|Overall Study||6
8436645|NCT00828074|20789808|P3|STARTED|Overall Study||35
8436646|NCT00828074|20789809|P2|STARTED|Overall Study||5
8436647|NCT00828074|20789810|P1|STARTED|Overall Study||6
8436648|NCT00828061|20789822|P6|NOT COMPLETED|Period 3||0
8436649|NCT00828061|20789823|P5|NOT COMPLETED|Period 3||0
8436650|NCT00828061|20789824|P4|NOT COMPLETED|Period 3||0
8436651|NCT00828061|20789825|P3|NOT COMPLETED|Period 3||0
8436652|NCT00828061|20789826|P2|NOT COMPLETED|Period 3||0
8436653|NCT00828061|20789827|P1|NOT COMPLETED|Period 3||0
8436654|NCT00828061|20789822|P6|COMPLETED|Period 3||3
8436655|NCT00828061|20789823|P5|COMPLETED|Period 3||3
8436656|NCT00828061|20789824|P4|COMPLETED|Period 3||3
8436657|NCT00828061|20789825|P3|COMPLETED|Period 3||3
8436658|NCT00828061|20789826|P2|COMPLETED|Period 3||3
8436659|NCT00828061|20789827|P1|COMPLETED|Period 3||4
8436660|NCT00828061|20789822|P6|STARTED|Period 3||3
8436661|NCT00828061|20789823|P5|STARTED|Period 3||3
8436662|NCT00828061|20789824|P4|STARTED|Period 3||3
8436663|NCT00828061|20789825|P3|STARTED|Period 3||3
8436664|NCT00828061|20789826|P2|STARTED|Period 3||3
8436665|NCT00828061|20789827|P1|STARTED|Period 3||4
8436666|NCT00828061|20789822|P6|NOT COMPLETED|Period 2||0
8436667|NCT00828061|20789823|P5|NOT COMPLETED|Period 2||0
8436668|NCT00828061|20789824|P4|NOT COMPLETED|Period 2||0
8436669|NCT00828061|20789825|P3|NOT COMPLETED|Period 2||0
8436670|NCT00828061|20789826|P2|NOT COMPLETED|Period 2||0
8436671|NCT00828061|20789827|P1|NOT COMPLETED|Period 2||0
8436672|NCT00828061|20789822|P6|COMPLETED|Period 2||3
8436673|NCT00828061|20789823|P5|COMPLETED|Period 2||3
8436674|NCT00828061|20789824|P4|COMPLETED|Period 2||3
8436675|NCT00828061|20789825|P3|COMPLETED|Period 2||3
8436676|NCT00828061|20789826|P2|COMPLETED|Period 2||3
8436677|NCT00828061|20789827|P1|COMPLETED|Period 2||4
8436678|NCT00828061|20789822|P6|STARTED|Period 2||3
8436679|NCT00828061|20789823|P5|STARTED|Period 2||3
8436680|NCT00828061|20789824|P4|STARTED|Period 2||3
8436681|NCT00828061|20789825|P3|STARTED|Period 2||3
8436682|NCT00828061|20789826|P2|STARTED|Period 2||3
8436683|NCT00828061|20789827|P1|STARTED|Period 2||4
8436684|NCT00828061|20789822|P6|NOT COMPLETED|Period 1||0
8436685|NCT00828061|20789823|P5|NOT COMPLETED|Period 1||0
8436686|NCT00828061|20789824|P4|NOT COMPLETED|Period 1||0
8436687|NCT00828061|20789825|P3|NOT COMPLETED|Period 1||0
8436688|NCT00828061|20789826|P2|NOT COMPLETED|Period 1||0
8436689|NCT00828061|20789827|P1|NOT COMPLETED|Period 1||0
8436690|NCT00828061|20789822|P6|COMPLETED|Period 1||3
8436691|NCT00828061|20789823|P5|COMPLETED|Period 1||3
8436692|NCT00828061|20789824|P4|COMPLETED|Period 1||3
8436693|NCT00828061|20789825|P3|COMPLETED|Period 1||3
8436694|NCT00828061|20789826|P2|COMPLETED|Period 1||3
8436695|NCT00828061|20789827|P1|COMPLETED|Period 1||4
8436696|NCT00828061|20789822|P6|STARTED|Period 1||3
8436697|NCT00828061|20789823|P5|STARTED|Period 1||3
8436698|NCT00828061|20789824|P4|STARTED|Period 1||3
8436699|NCT00828061|20789825|P3|STARTED|Period 1||3
8436700|NCT00828061|20789826|P2|STARTED|Period 1||3
8436701|NCT00828061|20789827|P1|STARTED|Period 1||4
8436702|NCT00828009|20789838|P1|NOT COMPLETED|Step 2 - Maintenance Therapy||33
8436703|NCT00828009|20789838|P1|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0
8436704|NCT00828009|20789838|P1|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33
8436705|NCT00828009|20789838|P1|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31
8436706|NCT00828009|20789838|P1|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39
8436707|NCT00828009|20789838|P1|Started Treatment|Step 1 - Chemo RT/Consolidation Chemo||68
8436708|NCT00828009|20789838|P1|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70
8436709|NCT00827983|20789847|P2|NOT COMPLETED|Overall Study||16
8436710|NCT00827983|20789848|P1|NOT COMPLETED|Overall Study||18
8436711|NCT00827983|20789847|P2|COMPLETED|Overall Study|patients who performed the pregnancy test|328
8436712|NCT00827983|20789848|P1|COMPLETED|Overall Study|patients who performed the pregnancy test|321
8436713|NCT00827983|20789847|P2|STARTED|Overall Study|all randomised patients|344
8436714|NCT00827983|20789848|P1|STARTED|Overall Study|All randomised patients|339
8436715|NCT00827944|20789860|P2|NOT COMPLETED|Overall Study||59
8436716|NCT00827944|20789861|P1|NOT COMPLETED|Overall Study||63
8436717|NCT00827944|20789860|P2|COMPLETED|Overall Study||240
8436718|NCT00827944|20789861|P1|COMPLETED|Overall Study||241
8436719|NCT00827944|20789860|P2|STARTED|Overall Study||299
8436720|NCT00827944|20789861|P1|STARTED|Overall Study||304
8436721|NCT00827931|20789881|P2|NOT COMPLETED|Overall Study||6
8436722|NCT00827931|20789882|P1|NOT COMPLETED|Overall Study||6
8436723|NCT00827931|20789881|P2|COMPLETED|Overall Study||39
8436724|NCT00827931|20789882|P1|COMPLETED|Overall Study||43
8436725|NCT00827931|20789881|P2|STARTED|Overall Study||45
8436726|NCT00827931|20789882|P1|STARTED|Overall Study||49
8436727|NCT00827918|20789903|P3|NOT COMPLETED|Overall Study||21
8436728|NCT00827918|20789904|P2|NOT COMPLETED|Overall Study||9
8436729|NCT00827918|20789905|P1|NOT COMPLETED|Overall Study||28
8436730|NCT00827918|20789903|P3|COMPLETED|Overall Study||62
8436731|NCT00827918|20789904|P2|COMPLETED|Overall Study||38
8436732|NCT00827918|20789905|P1|COMPLETED|Overall Study||58
8436733|NCT00827918|20789903|P3|STARTED|Overall Study||83
8436734|NCT00827918|20789904|P2|STARTED|Overall Study||47
8436735|NCT00827918|20789905|P1|STARTED|Overall Study||86
8436736|NCT00827827|20789933|P2|NOT COMPLETED|Overall Study||0
8436737|NCT00827827|20789934|P1|NOT COMPLETED|Overall Study||8
8436738|NCT00827827|20789933|P2|COMPLETED|Overall Study||16
8436739|NCT00827827|20789934|P1|COMPLETED|Overall Study||14
8436740|NCT00827827|20789933|P2|STARTED|Overall Study||16
8436741|NCT00827827|20789934|P1|STARTED|Overall Study||22
8436742|NCT00827775|20789978|P2|NOT COMPLETED|Overall Study||5
8436743|NCT00827775|20789979|P1|NOT COMPLETED|Overall Study||0
8436744|NCT00827775|20789978|P2|COMPLETED|Overall Study||25
8436745|NCT00827775|20789979|P1|COMPLETED|Overall Study||25
8436746|NCT00827775|20789978|P2|STARTED|Overall Study||30
8436747|NCT00827775|20789979|P1|STARTED|Overall Study||25
8436748|NCT00827632|20789989|P2|NOT COMPLETED|Overall Study||23
8436749|NCT00827632|20789990|P1|NOT COMPLETED|Overall Study||22
8436750|NCT00827632|20789989|P2|COMPLETED|Overall Study||75
8436751|NCT00827632|20789990|P1|COMPLETED|Overall Study||106
8436752|NCT00827632|20789989|P2|STARTED|Overall Study||98
8436753|NCT00827632|20789990|P1|STARTED|Overall Study||128
8436760|NCT00827567|20790064|P1|NOT COMPLETED|Overall Study||4
8436761|NCT00827567|20790064|P1|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
8436762|NCT00827567|20790064|P1|STARTED|Overall Study||4
8436763|NCT00827541|20790070|P2|NOT COMPLETED|Overall Study||11
8436764|NCT00827541|20790071|P1|NOT COMPLETED|Overall Study||4
8436765|NCT00827541|20790070|P2|COMPLETED|Overall Study||85
8436766|NCT00827541|20790071|P1|COMPLETED|Overall Study||15
8436767|NCT00827541|20790070|P2|STARTED|Overall Study||96
8436768|NCT00827541|20790071|P1|STARTED|Overall Study||19
8436769|NCT00827502|20790083|P1|NOT COMPLETED|Overall Study||21
8436770|NCT00827502|20790083|P1|COMPLETED|Overall Study||400
8436771|NCT00827502|20790083|P1|Received Treatment (Number Treated)|Overall Study||410
8436772|NCT00827502|20790083|P1|STARTED|Overall Study||421
8436773|NCT00827372|20790089|P1|NOT COMPLETED|Overall Study||8
8436774|NCT00827372|20790089|P1|COMPLETED|Overall Study||2
8436775|NCT00827372|20790089|P1|STARTED|Overall Study||10
8436776|NCT00827255|20790097|P1|NOT COMPLETED|Overall Study||0
8436777|NCT00827255|20790097|P1|COMPLETED|Overall Study||35
8436778|NCT00827255|20790097|P1|STARTED|Overall Study||35
8436779|NCT00827242|20790104|P2|NOT COMPLETED|Overall Study||12
8436780|NCT00827242|20790105|P1|NOT COMPLETED|Overall Study||13
8436781|NCT00827242|20790104|P2|COMPLETED|Overall Study||152
8436782|NCT00827242|20790105|P1|COMPLETED|Overall Study||148
8436783|NCT00827242|20790104|P2|STARTED|Overall Study||164
8436784|NCT00827242|20790105|P1|STARTED|Overall Study||161
8436785|NCT00827112|20790143|P2|NOT COMPLETED|Overall Study||12
8436786|NCT00827112|20790144|P1|NOT COMPLETED|Overall Study||15
8436787|NCT00827112|20790143|P2|COMPLETED|Overall Study||52
8436788|NCT00827112|20790144|P1|COMPLETED|Overall Study||50
8436789|NCT00827112|20790143|P2|Treated|Overall Study||61
8436790|NCT00827112|20790144|P1|Treated|Overall Study||60
8436791|NCT00827112|20790143|P2|STARTED|Overall Study||64
8436792|NCT00827112|20790144|P1|STARTED|Overall Study||65
8436793|NCT00827099|20790177|P1|NOT COMPLETED|Overall Study||0
8436794|NCT00827099|20790177|P1|COMPLETED|Overall Study||5
8436795|NCT00827099|20790177|P1|STARTED|Overall Study||5
8436796|NCT00827073|20790188|P2|NOT COMPLETED|Overall Study||0
8436797|NCT00827073|20790189|P1|NOT COMPLETED|Overall Study||0
8436798|NCT00827073|20790188|P2|COMPLETED|Overall Study||20
8436799|NCT00827073|20790189|P1|COMPLETED|Overall Study||20
8436800|NCT00827073|20790188|P2|STARTED|Overall Study||20
8436801|NCT00827073|20790189|P1|STARTED|Overall Study||20
8436802|NCT00826943|20790197|P6|NOT COMPLETED|Overall Study||0
8436803|NCT00826943|20790198|P5|NOT COMPLETED|Overall Study||1
8436804|NCT00826943|20790199|P4|NOT COMPLETED|Overall Study||0
8436805|NCT00826943|20790200|P3|NOT COMPLETED|Overall Study||0
8436806|NCT00826943|20790201|P2|NOT COMPLETED|Overall Study||0
8436807|NCT00826943|20790202|P1|NOT COMPLETED|Overall Study||0
8436808|NCT00826943|20790197|P6|COMPLETED|Overall Study||2
8436809|NCT00826943|20790198|P5|COMPLETED|Overall Study||6
8436810|NCT00826943|20790199|P4|COMPLETED|Overall Study||5
8436811|NCT00826943|20790200|P3|COMPLETED|Overall Study||4
8436812|NCT00826943|20790201|P2|COMPLETED|Overall Study||6
8436813|NCT00826943|20790202|P1|COMPLETED|Overall Study||6
8436814|NCT00826943|20790197|P6|STARTED|Overall Study||2
8436815|NCT00826943|20790198|P5|STARTED|Overall Study||7
8436816|NCT00826943|20790199|P4|STARTED|Overall Study||5
8436817|NCT00826943|20790200|P3|STARTED|Overall Study||4
8436818|NCT00826943|20790201|P2|STARTED|Overall Study||6
8436819|NCT00826943|20790202|P1|STARTED|Overall Study||6
8436820|NCT00826800|20790216|P1|NOT COMPLETED|Overall Study||0
8436821|NCT00826800|20790216|P1|COMPLETED|Overall Study||2
8436822|NCT00826800|20790216|P1|STARTED|Overall Study||2
8436823|NCT00826748|20790223|P3|NOT COMPLETED|Overall Study||4
8436824|NCT00826748|20790224|P2|NOT COMPLETED|Overall Study||0
8436825|NCT00826748|20790225|P1|NOT COMPLETED|Overall Study||0
8436826|NCT00826748|20790223|P3|COMPLETED|Overall Study||8
8436827|NCT00826748|20790224|P2|COMPLETED|Overall Study||4
8436828|NCT00826748|20790225|P1|COMPLETED|Overall Study||6
8436829|NCT00826748|20790223|P3|STARTED|Overall Study||12
8436830|NCT00826748|20790224|P2|STARTED|Overall Study||4
8436831|NCT00826748|20790225|P1|STARTED|Overall Study||6
8436832|NCT00826618|20790233|P1|NOT COMPLETED|Overall Study||1
8436833|NCT00826618|20790233|P1|COMPLETED|Overall Study||5
8436834|NCT00826618|20790233|P1|STARTED|Overall Study||6
8436835|NCT00826540|20790237|P1|NOT COMPLETED|Overall Study||4
8436836|NCT00826540|20790237|P1|COMPLETED|Overall Study||79
8436837|NCT00826540|20790237|P1|STARTED|Overall Study||83
8436838|NCT00826449|20790243|P1|NOT COMPLETED|Overall Study||5
8436839|NCT00826449|20790243|P1|COMPLETED|Overall Study||42
8436840|NCT00826449|20790243|P1|Phase II|Overall Study||35
8436841|NCT00826449|20790243|P1|Phase I|Overall Study||12
8436842|NCT00826449|20790243|P1|STARTED|Overall Study||47
8436843|NCT00826280|20790252|P3|NOT COMPLETED|Overall Study||46
8436844|NCT00826280|20790253|P2|NOT COMPLETED|Overall Study||46
8436845|NCT00826280|20790254|P1|NOT COMPLETED|Overall Study||48
8436846|NCT00826280|20790252|P3|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
8436847|NCT00826280|20790253|P2|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
8436848|NCT00826280|20790254|P1|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
8436849|NCT00826280|20790252|P3|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
8436850|NCT00826280|20790253|P2|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
8436851|NCT00826280|20790254|P1|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
8436852|NCT00826280|20790252|P3|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
8436853|NCT00826280|20790253|P2|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
8436854|NCT00826280|20790254|P1|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
8436855|NCT00826280|20790252|P3|STARTED|Overall Study||117
8436856|NCT00826280|20790253|P2|STARTED|Overall Study||116
8436857|NCT00826280|20790254|P1|STARTED|Overall Study||114
8436858|NCT00826267|20790283|P3|NOT COMPLETED|Overall Study||0
8436859|NCT00826267|20790284|P2|NOT COMPLETED|Overall Study||0
8436860|NCT00826267|20790285|P1|NOT COMPLETED|Overall Study||1
8436861|NCT00826267|20790283|P3|COMPLETED|Overall Study||11
8436862|NCT00826267|20790284|P2|COMPLETED|Overall Study||8
8436863|NCT00826267|20790285|P1|COMPLETED|Overall Study||9
8436864|NCT00826267|20790283|P3|STARTED|Overall Study||11
8436865|NCT00826267|20790284|P2|STARTED|Overall Study||8
8436866|NCT00826267|20790285|P1|STARTED|Overall Study||10
8436867|NCT00826241|20790303|P1|NOT COMPLETED|Overall Study||27
8436868|NCT00826241|20790303|P1|COMPLETED|Overall Study||31
8436869|NCT00826241|20790303|P1|STARTED|Overall Study||58
8436870|NCT00826228|20790309|P1|NOT COMPLETED|Overall Study||1
8436871|NCT00826228|20790309|P1|COMPLETED|Overall Study||11
8436872|NCT00826228|20790309|P1|STARTED|Overall Study||12
8436873|NCT00826202|20790316|P2|NOT COMPLETED|Overall Study||13
8436874|NCT00826202|20790317|P1|NOT COMPLETED|Overall Study||10
8436875|NCT00826202|20790316|P2|COMPLETED|Overall Study||11
8436876|NCT00826202|20790317|P1|COMPLETED|Overall Study||10
8436877|NCT00826202|20790316|P2|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
8436878|NCT00826202|20790317|P1|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
8436879|NCT00826202|20790316|P2|STARTED|Overall Study||24
8436880|NCT00826202|20790317|P1|STARTED|Overall Study||20
8436881|NCT00826176|20790331|P2|NOT COMPLETED|Overall Study||0
8436882|NCT00826176|20790332|P1|NOT COMPLETED|Overall Study||13
8436883|NCT00826176|20790331|P2|COMPLETED|Overall Study|treated and completed|36
8436884|NCT00826176|20790332|P1|COMPLETED|Overall Study|treated and completed|115
8436885|NCT00826176|20790331|P2|STARTED|Overall Study|enrolled|36
8436886|NCT00826176|20790332|P1|STARTED|Overall Study|enrolled|128
8436887|NCT00826150|20790345|P3|NOT COMPLETED|Overall Study||3
8436888|NCT00826150|20790346|P2|NOT COMPLETED|Overall Study||2
8436889|NCT00826150|20790347|P1|NOT COMPLETED|Overall Study||6
8436890|NCT00826150|20790345|P3|COMPLETED|Overall Study||0
8436891|NCT00826150|20790346|P2|COMPLETED|Overall Study||1
8436892|NCT00826150|20790347|P1|COMPLETED|Overall Study||2
8436893|NCT00826150|20790345|P3|STARTED|Overall Study||3
8436894|NCT00826150|20790346|P2|STARTED|Overall Study||3
8436895|NCT00826150|20790347|P1|STARTED|Overall Study||8
8436896|NCT00826111|20790381|P2|NOT COMPLETED|Overall Study||2
8436897|NCT00826111|20790382|P1|NOT COMPLETED|Overall Study||7
8436898|NCT00826111|20790381|P2|COMPLETED|Overall Study||3
8436899|NCT00826111|20790382|P1|COMPLETED|Overall Study||7
8436900|NCT00826111|20790381|P2|STARTED|Overall Study||5
8436901|NCT00826111|20790382|P1|STARTED|Overall Study||14
8436902|NCT00826020|20790404|P1|NOT COMPLETED|Overall Study||0
8436903|NCT00826020|20790404|P1|COMPLETED|Overall Study||72
8436904|NCT00826020|20790404|P1|STARTED|Overall Study||72
8436905|NCT00826007|20790411|P2|NOT COMPLETED|Overall Study||0
8436906|NCT00826007|20790412|P1|NOT COMPLETED|Overall Study||0
8436907|NCT00826007|20790411|P2|COMPLETED|Overall Study||279
8436908|NCT00826007|20790412|P1|COMPLETED|Overall Study|Retrospective review|308
8436909|NCT00826007|20790411|P2|STARTED|Overall Study||279
8436910|NCT00826007|20790412|P1|STARTED|Overall Study|Retrospective review|308
8436911|NCT00825994|20790417|P1|NOT COMPLETED|Overall Study||5
8436912|NCT00825994|20790417|P1|COMPLETED|Overall Study||19
8436913|NCT00825994|20790417|P1|STARTED|Overall Study||24
8436914|NCT00825916|20790425|P3|NOT COMPLETED|Overall Study||1
8436915|NCT00825916|20790426|P2|NOT COMPLETED|Overall Study||2
8436916|NCT00825916|20790427|P1|NOT COMPLETED|Overall Study||4
8436917|NCT00825916|20790425|P3|COMPLETED|Overall Study||19
8436918|NCT00825916|20790426|P2|COMPLETED|Overall Study||18
8436919|NCT00825916|20790427|P1|COMPLETED|Overall Study||15
8436920|NCT00825916|20790425|P3|STARTED|Overall Study||20
8436921|NCT00825916|20790426|P2|STARTED|Overall Study||20
8436922|NCT00825916|20790427|P1|STARTED|Overall Study||19
8436923|NCT00825825|20790468|P6|NOT COMPLETED|Third Medication Period (14 Days)||2
8436924|NCT00825825|20790469|P5|NOT COMPLETED|Third Medication Period (14 Days)||0
8436925|NCT00825825|20790470|P4|NOT COMPLETED|Third Medication Period (14 Days)||0
8436926|NCT00825825|20790471|P3|NOT COMPLETED|Third Medication Period (14 Days)||0
8436927|NCT00825825|20790472|P2|NOT COMPLETED|Third Medication Period (14 Days)||2
8436928|NCT00825825|20790473|P1|NOT COMPLETED|Third Medication Period (14 Days)||0
8436929|NCT00825825|20790468|P6|COMPLETED|Third Medication Period (14 Days)||1
8436930|NCT00825825|20790469|P5|COMPLETED|Third Medication Period (14 Days)||3
8436931|NCT00825825|20790470|P4|COMPLETED|Third Medication Period (14 Days)||3
8436932|NCT00825825|20790471|P3|COMPLETED|Third Medication Period (14 Days)||2
8436933|NCT00825825|20790472|P2|COMPLETED|Third Medication Period (14 Days)||2
8436934|NCT00825825|20790473|P1|COMPLETED|Third Medication Period (14 Days)||1
8436935|NCT00825825|20790468|P6|STARTED|Third Medication Period (14 Days)||3
8436936|NCT00825825|20790469|P5|STARTED|Third Medication Period (14 Days)||3
8436937|NCT00825825|20790470|P4|STARTED|Third Medication Period (14 Days)||3
8436938|NCT00825825|20790471|P3|STARTED|Third Medication Period (14 Days)||2
8436939|NCT00825825|20790472|P2|STARTED|Third Medication Period (14 Days)||4
8436940|NCT00825825|20790473|P1|STARTED|Third Medication Period (14 Days)||1
8436941|NCT00825825|20790468|P6|NOT COMPLETED|Second Washout Period (14 Days)||0
8436942|NCT00825825|20790469|P5|NOT COMPLETED|Second Washout Period (14 Days)||0
8436943|NCT00825825|20790470|P4|NOT COMPLETED|Second Washout Period (14 Days)||0
8436944|NCT00825825|20790471|P3|NOT COMPLETED|Second Washout Period (14 Days)||0
8436945|NCT00825825|20790472|P2|NOT COMPLETED|Second Washout Period (14 Days)||0
8436946|NCT00825825|20790473|P1|NOT COMPLETED|Second Washout Period (14 Days)||0
8436947|NCT00825825|20790468|P6|COMPLETED|Second Washout Period (14 Days)||3
8436948|NCT00825825|20790469|P5|COMPLETED|Second Washout Period (14 Days)||3
8436949|NCT00825825|20790470|P4|COMPLETED|Second Washout Period (14 Days)||3
8436950|NCT00825825|20790471|P3|COMPLETED|Second Washout Period (14 Days)||2
8436951|NCT00825825|20790472|P2|COMPLETED|Second Washout Period (14 Days)||4
8436952|NCT00825825|20790473|P1|COMPLETED|Second Washout Period (14 Days)||1
8436953|NCT00825825|20790468|P6|STARTED|Second Washout Period (14 Days)||3
8436954|NCT00825825|20790469|P5|STARTED|Second Washout Period (14 Days)||3
8436955|NCT00825825|20790470|P4|STARTED|Second Washout Period (14 Days)||3
8436956|NCT00825825|20790471|P3|STARTED|Second Washout Period (14 Days)||2
8436957|NCT00825825|20790472|P2|STARTED|Second Washout Period (14 Days)||4
8436958|NCT00825825|20790473|P1|STARTED|Second Washout Period (14 Days)||1
8436959|NCT00825825|20790468|P6|NOT COMPLETED|Second Medication Period (14 Days)||0
8436960|NCT00825825|20790469|P5|NOT COMPLETED|Second Medication Period (14 Days)||1
8436961|NCT00825825|20790470|P4|NOT COMPLETED|Second Medication Period (14 Days)||2
8436962|NCT00825825|20790471|P3|NOT COMPLETED|Second Medication Period (14 Days)||0
8436963|NCT00825825|20790472|P2|NOT COMPLETED|Second Medication Period (14 Days)||0
8436964|NCT00825825|20790473|P1|NOT COMPLETED|Second Medication Period (14 Days)||2
8436965|NCT00825825|20790468|P6|COMPLETED|Second Medication Period (14 Days)||3
8436966|NCT00825825|20790469|P5|COMPLETED|Second Medication Period (14 Days)||3
8436967|NCT00825825|20790470|P4|COMPLETED|Second Medication Period (14 Days)||3
8436968|NCT00825825|20790471|P3|COMPLETED|Second Medication Period (14 Days)||2
8436969|NCT00825825|20790472|P2|COMPLETED|Second Medication Period (14 Days)||4
8436970|NCT00825825|20790473|P1|COMPLETED|Second Medication Period (14 Days)||1
8436971|NCT00825825|20790468|P6|STARTED|Second Medication Period (14 Days)||3
8436972|NCT00825825|20790469|P5|STARTED|Second Medication Period (14 Days)||4
8436973|NCT00825825|20790470|P4|STARTED|Second Medication Period (14 Days)||5
8436974|NCT00825825|20790471|P3|STARTED|Second Medication Period (14 Days)||2
8436975|NCT00825825|20790472|P2|STARTED|Second Medication Period (14 Days)||4
8436976|NCT00825825|20790473|P1|STARTED|Second Medication Period (14 Days)||3
8436977|NCT00825825|20790468|P6|NOT COMPLETED|First Washout Period (14 Days)||0
8436978|NCT00825825|20790469|P5|NOT COMPLETED|First Washout Period (14 Days)||0
8436979|NCT00825825|20790470|P4|NOT COMPLETED|First Washout Period (14 Days)||0
8436980|NCT00825825|20790471|P3|NOT COMPLETED|First Washout Period (14 Days)||0
8436981|NCT00825825|20790472|P2|NOT COMPLETED|First Washout Period (14 Days)||0
8436982|NCT00825825|20790473|P1|NOT COMPLETED|First Washout Period (14 Days)||0
8436983|NCT00825825|20790468|P6|COMPLETED|First Washout Period (14 Days)||3
8436984|NCT00825825|20790469|P5|COMPLETED|First Washout Period (14 Days)||4
8436985|NCT00825825|20790470|P4|COMPLETED|First Washout Period (14 Days)||5
8436986|NCT00825825|20790471|P3|COMPLETED|First Washout Period (14 Days)||2
8436987|NCT00825825|20790472|P2|COMPLETED|First Washout Period (14 Days)||4
8436988|NCT00825825|20790473|P1|COMPLETED|First Washout Period (14 Days)||3
8436989|NCT00825825|20790468|P6|STARTED|First Washout Period (14 Days)||3
8436990|NCT00825825|20790469|P5|STARTED|First Washout Period (14 Days)||4
8436991|NCT00825825|20790470|P4|STARTED|First Washout Period (14 Days)||5
8436992|NCT00825825|20790471|P3|STARTED|First Washout Period (14 Days)||2
8436993|NCT00825825|20790472|P2|STARTED|First Washout Period (14 Days)||4
8436994|NCT00825825|20790473|P1|STARTED|First Washout Period (14 Days)||3
8436995|NCT00825825|20790468|P6|NOT COMPLETED|First Medication Period (14 Days)||2
8436996|NCT00825825|20790469|P5|NOT COMPLETED|First Medication Period (14 Days)||0
8436997|NCT00825825|20790470|P4|NOT COMPLETED|First Medication Period (14 Days)||0
8436998|NCT00825825|20790471|P3|NOT COMPLETED|First Medication Period (14 Days)||1
8436999|NCT00825825|20790472|P2|NOT COMPLETED|First Medication Period (14 Days)||0
8437000|NCT00825825|20790473|P1|NOT COMPLETED|First Medication Period (14 Days)||3
8437001|NCT00825825|20790468|P6|COMPLETED|First Medication Period (14 Days)||3
8437002|NCT00825825|20790469|P5|COMPLETED|First Medication Period (14 Days)||4
8437003|NCT00825825|20790470|P4|COMPLETED|First Medication Period (14 Days)||5
8437004|NCT00825825|20790471|P3|COMPLETED|First Medication Period (14 Days)||2
8437005|NCT00825825|20790472|P2|COMPLETED|First Medication Period (14 Days)||4
8437006|NCT00825825|20790473|P1|COMPLETED|First Medication Period (14 Days)||3
8437007|NCT00825825|20790468|P6|STARTED|First Medication Period (14 Days)||5
8437008|NCT00825825|20790469|P5|STARTED|First Medication Period (14 Days)||4
8437009|NCT00825825|20790470|P4|STARTED|First Medication Period (14 Days)||5
8437010|NCT00825825|20790471|P3|STARTED|First Medication Period (14 Days)||3
8437011|NCT00825825|20790472|P2|STARTED|First Medication Period (14 Days)||4
8437012|NCT00825825|20790473|P1|STARTED|First Medication Period (14 Days)||6
8437013|NCT00825812|20790489|P4|NOT COMPLETED|Overall Study||10
8437014|NCT00825812|20790490|P3|NOT COMPLETED|Overall Study||6
8437015|NCT00825812|20790491|P2|NOT COMPLETED|Overall Study||1
8437016|NCT00825812|20790492|P1|NOT COMPLETED|Overall Study||0
8437017|NCT00825812|20790489|P4|COMPLETED|Overall Study||111
8437018|NCT00825812|20790490|P3|COMPLETED|Overall Study||120
8437019|NCT00825812|20790491|P2|COMPLETED|Overall Study||31
8437020|NCT00825812|20790492|P1|COMPLETED|Overall Study||29
8437021|NCT00825812|20790489|P4|TREATED|Overall Study||111
8437022|NCT00825812|20790490|P3|TREATED|Overall Study||120
8437023|NCT00825812|20790491|P2|TREATED|Overall Study||31
8437024|NCT00825812|20790492|P1|TREATED|Overall Study||29
8437025|NCT00825812|20790489|P4|STARTED|Overall Study||121
8437026|NCT00825812|20790490|P3|STARTED|Overall Study||126
8437027|NCT00825812|20790491|P2|STARTED|Overall Study||32
8437028|NCT00825812|20790492|P1|STARTED|Overall Study||29
8437029|NCT00825786|20790508|P2|NOT COMPLETED|Overall Study||0
8437030|NCT00825786|20790509|P1|NOT COMPLETED|Overall Study||0
8437031|NCT00825786|20790508|P2|COMPLETED|Overall Study||51
8437032|NCT00825786|20790509|P1|COMPLETED|Overall Study||52
8437033|NCT00825786|20790508|P2|STARTED|Overall Study||51
8437034|NCT00825786|20790509|P1|STARTED|Overall Study||52
8437035|NCT00825734|20790527|P3|NOT COMPLETED|Phase II||76
8437036|NCT00825734|20790528|P2|NOT COMPLETED|Phase II||0
8437037|NCT00825734|20790529|P1|NOT COMPLETED|Phase II||0
8437038|NCT00825734|20790527|P3|COMPLETED|Phase II||0
8437039|NCT00825734|20790528|P2|COMPLETED|Phase II||0
8437040|NCT00825734|20790529|P1|COMPLETED|Phase II||0
8437041|NCT00825734|20790527|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
8437042|NCT00825734|20790528|P2|STARTED|Phase II||0
8437043|NCT00825734|20790529|P1|STARTED|Phase II||0
8437044|NCT00825734|20790527|P3|NOT COMPLETED|Phase I||0
8437045|NCT00825734|20790528|P2|NOT COMPLETED|Phase I||3
8437046|NCT00825734|20790529|P1|NOT COMPLETED|Phase I||4
8437047|NCT00825734|20790527|P3|COMPLETED|Phase I||3
8437048|NCT00825734|20790528|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8437049|NCT00825734|20790529|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
8437050|NCT00825734|20790527|P3|STARTED|Phase I||3
8437051|NCT00825734|20790528|P2|STARTED|Phase I||3
8437052|NCT00825734|20790529|P1|STARTED|Phase I||4
8437053|NCT00825682|20790539|P2|NOT COMPLETED|Overall Study||5
8437054|NCT00825682|20790540|P1|NOT COMPLETED|Overall Study||13
8437055|NCT00825682|20790539|P2|COMPLETED|Overall Study||20
8437056|NCT00825682|20790540|P1|COMPLETED|Overall Study||34
8437057|NCT00825682|20790539|P2|STARTED|Overall Study||25
8437058|NCT00825682|20790540|P1|STARTED|Overall Study||47
8437059|NCT00825630|20790554|P4|NOT COMPLETED|Overall Study||0
8437060|NCT00825630|20790555|P3|NOT COMPLETED|Overall Study||0
8437061|NCT00825630|20790556|P2|NOT COMPLETED|Overall Study||0
8437062|NCT00825630|20790557|P1|NOT COMPLETED|Overall Study||0
8437063|NCT00825630|20790554|P4|COMPLETED|Overall Study||13
8437064|NCT00825630|20790555|P3|COMPLETED|Overall Study||19
8437065|NCT00825630|20790556|P2|COMPLETED|Overall Study||62
8437066|NCT00825630|20790557|P1|COMPLETED|Overall Study||29
8437067|NCT00825630|20790554|P4|STARTED|Overall Study||13
8437068|NCT00825630|20790555|P3|STARTED|Overall Study||19
8437069|NCT00825630|20790556|P2|STARTED|Overall Study||62
8437070|NCT00825630|20790557|P1|STARTED|Overall Study||29
8437071|NCT00825565|20790567|P1|NOT COMPLETED|Overall Study||0
8437072|NCT00825565|20790567|P1|COMPLETED|Overall Study||8
8437073|NCT00825565|20790567|P1|STARTED|Overall Study||8
8437074|NCT00825500|20790580|P3|NOT COMPLETED|Overall Study||0
8437075|NCT00825500|20790581|P2|NOT COMPLETED|Overall Study||0
8437076|NCT00825500|20790582|P1|NOT COMPLETED|Overall Study||0
8437077|NCT00825500|20790580|P3|COMPLETED|Overall Study||120
8437078|NCT00825500|20790581|P2|COMPLETED|Overall Study||121
8437079|NCT00825500|20790582|P1|COMPLETED|Overall Study||125
8437080|NCT00825500|20790580|P3|STARTED|Overall Study||120
8437081|NCT00825500|20790581|P2|STARTED|Overall Study||121
8437082|NCT00825500|20790582|P1|STARTED|Overall Study||125
8437083|NCT00825370|20790595|P2|NOT COMPLETED|Overall Study||0
8437084|NCT00825370|20790596|P1|NOT COMPLETED|Overall Study||0
8437085|NCT00825370|20790595|P2|COMPLETED|Overall Study||175
8437086|NCT00825370|20790596|P1|COMPLETED|Overall Study||175
8437087|NCT00825370|20790595|P2|STARTED|Overall Study||175
8437088|NCT00825370|20790596|P1|STARTED|Overall Study||175
8437089|NCT00825344|20790610|P2|NOT COMPLETED|Overall Study||1
8437090|NCT00825344|20790611|P1|NOT COMPLETED|Overall Study||1
8437091|NCT00825344|20790610|P2|COMPLETED|Overall Study||42
8437092|NCT00825344|20790611|P1|COMPLETED|Overall Study||33
8437093|NCT00825344|20790610|P2|STARTED|Overall Study||43
8437094|NCT00825344|20790611|P1|STARTED|Overall Study||34
8437095|NCT00825318|20790621|P1|NOT COMPLETED|Overall Study||1
8437096|NCT00825318|20790621|P1|COMPLETED|Overall Study||12
8437097|NCT00825318|20790621|P1|STARTED|Overall Study||13
8437098|NCT00825305|20790631|P2|NOT COMPLETED|Overall Study||23
8437099|NCT00825305|20790632|P1|NOT COMPLETED|Overall Study||17
8437100|NCT00825305|20790631|P2|COMPLETED|Overall Study||252
8437101|NCT00825305|20790632|P1|COMPLETED|Overall Study||533
8437102|NCT00825305|20790631|P2|STARTED|Overall Study||275
8437103|NCT00825305|20790632|P1|STARTED|Overall Study||550
8437104|NCT00825266|20790646|P2|NOT COMPLETED|Overall Study||0
8437105|NCT00825266|20790647|P1|NOT COMPLETED|Overall Study||0
8437106|NCT00825266|20790646|P2|COMPLETED|Overall Study||1
8437107|NCT00825266|20790647|P1|COMPLETED|Overall Study||1
8437108|NCT00825266|20790646|P2|STARTED|Overall Study||1
8437109|NCT00825266|20790647|P1|STARTED|Overall Study||1
8437110|NCT00825227|20790659|P2|NOT COMPLETED|Overall Study||0
8437111|NCT00825227|20790660|P1|NOT COMPLETED|Overall Study||0
8437112|NCT00825227|20790659|P2|COMPLETED|Overall Study||4
8437113|NCT00825227|20790660|P1|COMPLETED|Overall Study||6
8437114|NCT00825227|20790659|P2|STARTED|Overall Study||4
8437115|NCT00825227|20790660|P1|STARTED|Overall Study||6
8437116|NCT00825175|20790672|P2|NOT COMPLETED|Overall Study||5
8437117|NCT00825175|20790673|P1|NOT COMPLETED|Overall Study||0
8437118|NCT00825175|20790672|P2|COMPLETED|Overall Study||7
8437119|NCT00825175|20790673|P1|COMPLETED|Overall Study||10
8437120|NCT00825175|20790672|P2|STARTED|Overall Study||12
8437121|NCT00825175|20790673|P1|STARTED|Overall Study||10
8437122|NCT00825162|20790682|P3|NOT COMPLETED|Overall Study||6
8437123|NCT00825162|20790683|P2|NOT COMPLETED|Overall Study||21
8437124|NCT00825162|20790684|P1|NOT COMPLETED|Overall Study||28
8437125|NCT00825162|20790682|P3|COMPLETED|Overall Study||396
8437126|NCT00825162|20790683|P2|COMPLETED|Overall Study||859
8437127|NCT00825162|20790684|P1|COMPLETED|Overall Study||682
8437128|NCT00825162|20790682|P3|STARTED|Overall Study||402
8437129|NCT00825162|20790683|P2|STARTED|Overall Study||880
8437130|NCT00825162|20790684|P1|STARTED|Overall Study||710
8437131|NCT00824993|20790710|P2|NOT COMPLETED|Overall Study||17
8437132|NCT00824993|20790711|P1|NOT COMPLETED|Overall Study||14
8437133|NCT00824993|20790710|P2|COMPLETED|Overall Study||22
8437134|NCT00824993|20790711|P1|COMPLETED|Overall Study||25
8437135|NCT00824993|20790710|P2|6 Month Follow up|Overall Study||27
8437136|NCT00824993|20790711|P1|6 Month Follow up|Overall Study||33
8437137|NCT00824993|20790710|P2|STARTED|Overall Study||39
8437138|NCT00824993|20790711|P1|STARTED|Overall Study||39
8437139|NCT00824850|20790719|P2|NOT COMPLETED|Overall Study||1
8437140|NCT00824850|20790720|P1|NOT COMPLETED|Overall Study||0
8437141|NCT00824850|20790719|P2|COMPLETED|Overall Study||36
8437142|NCT00824850|20790720|P1|COMPLETED|Overall Study||38
8437143|NCT00824850|20790719|P2|Received Vaccination 13vPnC|Overall Study||36
8437144|NCT00824850|20790720|P1|Received Vaccination 13vPnC|Overall Study||38
8437145|NCT00824850|20790719|P2|STARTED|Overall Study||37
8437146|NCT00824850|20790720|P1|STARTED|Overall Study||38
8437147|NCT00824824|20790766|P2|NOT COMPLETED|Overall Study||0
8437148|NCT00824824|20790767|P1|NOT COMPLETED|Overall Study||0
8437149|NCT00824824|20790766|P2|COMPLETED|Overall Study||3
8437150|NCT00824824|20790767|P1|COMPLETED|Overall Study||4
8437151|NCT00824824|20790766|P2|STARTED|Overall Study||3
8437152|NCT00824824|20790767|P1|STARTED|Overall Study||4
8437153|NCT00824772|20790773|P1|NOT COMPLETED|Overall Study||8
8437154|NCT00824772|20790773|P1|COMPLETED|Overall Study||196
8437155|NCT00824772|20790773|P1|STARTED|Overall Study||204
8437156|NCT00824746|20790778|P1|NOT COMPLETED|Overall Study||0
8437157|NCT00824746|20790778|P1|COMPLETED|Overall Study||23
8437158|NCT00824746|20790778|P1|STARTED|Overall Study||23
8437159|NCT00824733|20790784|P1|NOT COMPLETED|Overall Study||0
8437160|NCT00824733|20790784|P1|COMPLETED|Overall Study||6
8437161|NCT00824733|20790784|P1|STARTED|Overall Study||6
8437162|NCT00824720|20790793|P3|NOT COMPLETED|Overall Study||1
8437163|NCT00824720|20790794|P2|NOT COMPLETED|Overall Study||1
8437164|NCT00824720|20790795|P1|NOT COMPLETED|Overall Study||3
8437165|NCT00824720|20790793|P3|COMPLETED|Overall Study||19
8437166|NCT00824720|20790794|P2|COMPLETED|Overall Study||15
8437167|NCT00824720|20790795|P1|COMPLETED|Overall Study||16
8437168|NCT00824720|20790793|P3|STARTED|Overall Study||20
8437169|NCT00824720|20790794|P2|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
8437170|NCT00824720|20790795|P1|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
8437171|NCT00824655|20790811|P2|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
8437172|NCT00824655|20790812|P1|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
8437173|NCT00824655|20790811|P2|COMPLETED|Toddler Dose (12 Months of Age)||116
8437174|NCT00824655|20790812|P1|COMPLETED|Toddler Dose (12 Months of Age)||116
8437175|NCT00824655|20790811|P2|STARTED|Toddler Dose (12 Months of Age)||116
8437176|NCT00824655|20790812|P1|STARTED|Toddler Dose (12 Months of Age)||118
8437177|NCT00824655|20790811|P2|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
8437178|NCT00824655|20790812|P1|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
8437179|NCT00824655|20790811|P2|COMPLETED|After Infant Dose (6 Months of Age)||0
8437180|NCT00824655|20790812|P1|COMPLETED|After Infant Dose (6 Months of Age)||118
8437181|NCT00824655|20790811|P2|STARTED|After Infant Dose (6 Months of Age)||0
8437182|NCT00824655|20790812|P1|STARTED|After Infant Dose (6 Months of Age)||118
8437183|NCT00824655|20790811|P2|NOT COMPLETED|Infant Series (5 Months of Age)||0
8437184|NCT00824655|20790812|P1|NOT COMPLETED|Infant Series (5 Months of Age)||0
8437185|NCT00824655|20790811|P2|COMPLETED|Infant Series (5 Months of Age)||0
8437186|NCT00824655|20790812|P1|COMPLETED|Infant Series (5 Months of Age)||118
8437187|NCT00824655|20790811|P2|STARTED|Infant Series (5 Months of Age)||0
8437188|NCT00824655|20790812|P1|STARTED|Infant Series (5 Months of Age)||118
8437189|NCT00824616|20790832|P2|NOT COMPLETED|Overall Study||7
8437190|NCT00824616|20790833|P1|NOT COMPLETED|Overall Study||6
8437191|NCT00824616|20790832|P2|COMPLETED|Overall Study||27
8437192|NCT00824616|20790833|P1|COMPLETED|Overall Study||28
8437193|NCT00824616|20790832|P2|STARTED|Overall Study||34
8437194|NCT00824616|20790833|P1|STARTED|Overall Study||34
8437195|NCT00824564|20790843|P2|NOT COMPLETED|Overall Study||10
8437196|NCT00824564|20790844|P1|NOT COMPLETED|Overall Study||8
8437197|NCT00824564|20790843|P2|COMPLETED|Overall Study||30
8437198|NCT00824564|20790844|P1|COMPLETED|Overall Study||34
8437199|NCT00824564|20790843|P2|Treated|Overall Study||40
8437200|NCT00824564|20790844|P1|Treated|Overall Study||41
8437201|NCT00824564|20790843|P2|STARTED|Overall Study||40
8437202|NCT00824564|20790844|P1|STARTED|Overall Study||42
8437203|NCT00824538|20790862|P1|NOT COMPLETED|Overall Study||2
8437204|NCT00824538|20790862|P1|COMPLETED|Overall Study||11
8437205|NCT00824538|20790862|P1|STARTED|Overall Study|13 patients entered the study|13
8437206|NCT00824512|20790872|P2|NOT COMPLETED|Overall Study||0
8437207|NCT00824512|20790873|P1|NOT COMPLETED|Overall Study||0
8437208|NCT00824512|20790872|P2|COMPLETED|Overall Study||11
8437209|NCT00824512|20790873|P1|COMPLETED|Overall Study||11
8437210|NCT00824512|20790872|P2|STARTED|Overall Study||11
8437211|NCT00824512|20790873|P1|STARTED|Overall Study||11
8437212|NCT00824473|20790923|P2|NOT COMPLETED|Overall Study||13
8437213|NCT00824473|20790924|P1|NOT COMPLETED|Overall Study||15
8437214|NCT00824473|20790923|P2|COMPLETED|Overall Study||238
8437215|NCT00824473|20790924|P1|COMPLETED|Overall Study||240
8437216|NCT00824473|20790923|P2|STARTED|Overall Study||251
8437217|NCT00824473|20790924|P1|STARTED|Overall Study|1 subject was randomized in error|255
8437218|NCT00824460|20790946|P6|NOT COMPLETED|Overall Study||8
8437219|NCT00824460|20790947|P5|NOT COMPLETED|Overall Study||9
8437220|NCT00824460|20790948|P4|NOT COMPLETED|Overall Study||12
8437221|NCT00824460|20790949|P3|NOT COMPLETED|Overall Study||5
8437222|NCT00824460|20790950|P2|NOT COMPLETED|Overall Study||9
8437223|NCT00824460|20790951|P1|NOT COMPLETED|Overall Study||8
8437224|NCT00824460|20790946|P6|COMPLETED|Overall Study||18
8437225|NCT00824460|20790947|P5|COMPLETED|Overall Study||15
8437226|NCT00824460|20790948|P4|COMPLETED|Overall Study||15
8437227|NCT00824460|20790949|P3|COMPLETED|Overall Study||20
8437228|NCT00824460|20790950|P2|COMPLETED|Overall Study||17
8437229|NCT00824460|20790951|P1|COMPLETED|Overall Study||18
8437230|NCT00824460|20790946|P6|STARTED|Overall Study||26
8437231|NCT00824460|20790947|P5|STARTED|Overall Study||24
8437232|NCT00824460|20790948|P4|STARTED|Overall Study||27
8437233|NCT00824460|20790949|P3|STARTED|Overall Study||25
8437234|NCT00824460|20790950|P2|STARTED|Overall Study||26
8437235|NCT00824460|20790951|P1|STARTED|Overall Study||26
8437236|NCT00824434|20790983|P1|NOT COMPLETED|Overall Study||0
8437237|NCT00824434|20790983|P1|COMPLETED|Overall Study||100
8437238|NCT00824434|20790983|P1|STARTED|Overall Study||100
8437239|NCT00824421|20791005|P3|NOT COMPLETED|Overall Study||14
8437240|NCT00824421|20791006|P2|NOT COMPLETED|Overall Study||22
8437241|NCT00824421|20791007|P1|NOT COMPLETED|Overall Study||17
8437242|NCT00824421|20791005|P3|COMPLETED|Overall Study||49
8437243|NCT00824421|20791006|P2|COMPLETED|Overall Study||44
8437244|NCT00824421|20791007|P1|COMPLETED|Overall Study||49
8437245|NCT00824421|20791005|P3|Treated|Overall Study||63
8437246|NCT00824421|20791006|P2|Treated|Overall Study||65
8437247|NCT00824421|20791007|P1|Treated|Overall Study||65
8437248|NCT00824421|20791005|P3|STARTED|Overall Study||63
8437249|NCT00824421|20791006|P2|STARTED|Overall Study||66
8437250|NCT00824421|20791007|P1|STARTED|Overall Study||66
8437251|NCT00824408|20791058|P5|NOT COMPLETED|Randomized Phase||46
8437252|NCT00824408|20791059|P4|NOT COMPLETED|Randomized Phase||46
8437253|NCT00824408|20791060|P3|NOT COMPLETED|Randomized Phase||36
8437254|NCT00824408|20791061|P2|NOT COMPLETED|Randomized Phase||0
8437255|NCT00824408|20791062|P1|NOT COMPLETED|Randomized Phase||0
8437256|NCT00824408|20791058|P5|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
8437257|NCT00824408|20791059|P4|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
8437258|NCT00824408|20791060|P3|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
8437259|NCT00824408|20791061|P2|COMPLETED|Randomized Phase||0
8437260|NCT00824408|20791062|P1|COMPLETED|Randomized Phase||0
8437261|NCT00824408|20791058|P5|STARTED|Randomized Phase||47
8437262|NCT00824408|20791059|P4|STARTED|Randomized Phase||47
8437263|NCT00824408|20791060|P3|STARTED|Randomized Phase||37
8437264|NCT00824408|20791061|P2|STARTED|Randomized Phase||0
8437265|NCT00824408|20791062|P1|STARTED|Randomized Phase||0
8437266|NCT00824408|20791058|P5|NOT COMPLETED|Run-in Phase||0
8437267|NCT00824408|20791059|P4|NOT COMPLETED|Run-in Phase||0
8437268|NCT00824408|20791060|P3|NOT COMPLETED|Run-in Phase||0
8437269|NCT00824408|20791061|P2|NOT COMPLETED|Run-in Phase||6
8437270|NCT00824408|20791062|P1|NOT COMPLETED|Run-in Phase||6
8437271|NCT00824408|20791058|P5|COMPLETED|Run-in Phase||0
8437272|NCT00824408|20791059|P4|COMPLETED|Run-in Phase||0
8437273|NCT00824408|20791060|P3|COMPLETED|Run-in Phase||0
8437274|NCT00824408|20791061|P2|COMPLETED|Run-in Phase||0
8437275|NCT00824408|20791062|P1|COMPLETED|Run-in Phase||0
8437276|NCT00824408|20791058|P5|STARTED|Run-in Phase||0
8437277|NCT00824408|20791059|P4|STARTED|Run-in Phase||0
8437278|NCT00824408|20791060|P3|STARTED|Run-in Phase||0
8437279|NCT00824408|20791061|P2|STARTED|Run-in Phase||6
8437280|NCT00824408|20791062|P1|STARTED|Run-in Phase||6
8437281|NCT00824382|20791114|P4|NOT COMPLETED|Overall Study||5
8437282|NCT00824382|20791115|P3|NOT COMPLETED|Overall Study||3
8437283|NCT00824382|20791116|P2|NOT COMPLETED|Overall Study||2
8437284|NCT00824382|20791117|P1|NOT COMPLETED|Overall Study||5
8437285|NCT00824382|20791114|P4|COMPLETED|Overall Study||81
8437286|NCT00824382|20791115|P3|COMPLETED|Overall Study||76
8437287|NCT00824382|20791116|P2|COMPLETED|Overall Study||82
8437288|NCT00824382|20791117|P1|COMPLETED|Overall Study||74
8437289|NCT00824382|20791114|P4|STARTED|Overall Study||86
8437290|NCT00824382|20791115|P3|STARTED|Overall Study||79
8437291|NCT00824382|20791116|P2|STARTED|Overall Study||84
8437292|NCT00824382|20791117|P1|STARTED|Overall Study||79
8437293|NCT00824369|20791193|P6|NOT COMPLETED|Overall Study||1
8437294|NCT00824369|20791194|P5|NOT COMPLETED|Overall Study||1
8437295|NCT00824369|20791195|P4|NOT COMPLETED|Overall Study||2
8437296|NCT00824369|20791196|P3|NOT COMPLETED|Overall Study||1
8437297|NCT00824369|20791197|P2|NOT COMPLETED|Overall Study||0
8437298|NCT00824369|20791198|P1|NOT COMPLETED|Overall Study||1
8437299|NCT00824369|20791193|P6|COMPLETED|Overall Study||16
8437300|NCT00824369|20791194|P5|COMPLETED|Overall Study||11
8437301|NCT00824369|20791195|P4|COMPLETED|Overall Study||9
8437302|NCT00824369|20791196|P3|COMPLETED|Overall Study||2
8437303|NCT00824369|20791197|P2|COMPLETED|Overall Study||4
8437304|NCT00824369|20791198|P1|COMPLETED|Overall Study||4
8437305|NCT00824369|20791193|P6|STARTED|Overall Study||17
8437306|NCT00824369|20791194|P5|STARTED|Overall Study||12
8437307|NCT00824369|20791195|P4|STARTED|Overall Study||11
8437308|NCT00824369|20791196|P3|STARTED|Overall Study||3
8437309|NCT00824369|20791197|P2|STARTED|Overall Study||4
8437310|NCT00824369|20791198|P1|STARTED|Overall Study||5
8437311|NCT00824291|20791238|P2|NOT COMPLETED|Overall Study||35
8437312|NCT00824291|20791239|P1|NOT COMPLETED|Overall Study||54
8437313|NCT00824291|20791238|P2|COMPLETED|Overall Study||107
8437314|NCT00824291|20791239|P1|COMPLETED|Overall Study||231
8437315|NCT00824291|20791238|P2|STARTED|Overall Study||142
8437316|NCT00824291|20791239|P1|STARTED|Overall Study||285
8437317|NCT00824265|20791261|P2|NOT COMPLETED|Survival Follow-up Phase||16
8437318|NCT00824265|20791262|P1|NOT COMPLETED|Survival Follow-up Phase||9
8437319|NCT00824265|20791261|P2|COMPLETED|Survival Follow-up Phase||73
8437320|NCT00824265|20791262|P1|COMPLETED|Survival Follow-up Phase||87
8437321|NCT00824265|20791261|P2|STARTED|Survival Follow-up Phase||89
8437322|NCT00824265|20791262|P1|STARTED|Survival Follow-up Phase||96
8437323|NCT00824265|20791261|P2|NOT COMPLETED|Follow-up Phase||31
8437324|NCT00824265|20791262|P1|NOT COMPLETED|Follow-up Phase||18
8437325|NCT00824265|20791261|P2|COMPLETED|Follow-up Phase||129
8437326|NCT00824265|20791262|P1|COMPLETED|Follow-up Phase||154
8437327|NCT00824265|20791261|P2|STARTED|Follow-up Phase||160
8437328|NCT00824265|20791262|P1|STARTED|Follow-up Phase||172
8437329|NCT00824265|20791261|P2|NOT COMPLETED|Treatment Phase||80
8437330|NCT00824265|20791262|P1|NOT COMPLETED|Treatment Phase||64
8437331|NCT00824265|20791261|P2|COMPLETED|Treatment Phase||102
8437332|NCT00824265|20791262|P1|COMPLETED|Treatment Phase||119
8437333|NCT00824265|20791261|P2|STARTED|Treatment Phase||182
8437334|NCT00824265|20791262|P1|STARTED|Treatment Phase||183
8437335|NCT00824161|20791323|P1|NOT COMPLETED|Overall Study||2
8437336|NCT00824161|20791323|P1|COMPLETED|Overall Study||26
8437337|NCT00824161|20791323|P1|STARTED|Overall Study||28
8437338|NCT00824070|20791332|P3|NOT COMPLETED|Overall Study||0
8437339|NCT00824070|20791333|P2|NOT COMPLETED|Overall Study||0
8437340|NCT00824070|20791334|P1|NOT COMPLETED|Overall Study||0
8437341|NCT00824070|20791332|P3|COMPLETED|Overall Study||36
8437342|NCT00824070|20791333|P2|COMPLETED|Overall Study||35
8437343|NCT00824070|20791334|P1|COMPLETED|Overall Study||34
8437344|NCT00824070|20791332|P3|STARTED|Overall Study||36
8437345|NCT00824070|20791333|P2|STARTED|Overall Study||35
8437346|NCT00824070|20791334|P1|STARTED|Overall Study||34
8437347|NCT00824044|20791344|P2|NOT COMPLETED|Overall Study||6
8437348|NCT00824044|20791345|P1|NOT COMPLETED|Overall Study||9
8437349|NCT00824044|20791344|P2|COMPLETED|Overall Study||10
8437350|NCT00824044|20791345|P1|COMPLETED|Overall Study||14
8437351|NCT00824044|20791344|P2|STARTED|Overall Study||16
8437352|NCT00824044|20791345|P1|STARTED|Overall Study||23
8437353|NCT00824005|20791389|P2|NOT COMPLETED|Overall Study||2
8437354|NCT00824005|20791390|P1|NOT COMPLETED|Overall Study||0
8437355|NCT00824005|20791389|P2|COMPLETED|Overall Study||59
8437356|NCT00824005|20791390|P1|COMPLETED|Overall Study||31
8437357|NCT00824005|20791389|P2|STARTED|Overall Study||61
8437358|NCT00824005|20791390|P1|STARTED|Overall Study||31
8437359|NCT00823979|20791425|P3|NOT COMPLETED|Overall Study||24
8437360|NCT00823979|20791426|P2|NOT COMPLETED|Overall Study||32
8437361|NCT00823979|20791427|P1|NOT COMPLETED|Overall Study||29
8437362|NCT00823979|20791425|P3|COMPLETED|Overall Study||11
8437363|NCT00823979|20791426|P2|COMPLETED|Overall Study||3
8437364|NCT00823979|20791427|P1|COMPLETED|Overall Study||6
8437365|NCT00823979|20791425|P3|Treated|Overall Study||34
8437366|NCT00823979|20791426|P2|Treated|Overall Study||32
8437367|NCT00823979|20791427|P1|Treated|Overall Study||31
8437368|NCT00823979|20791425|P3|STARTED|Overall Study||35
8437369|NCT00823979|20791426|P2|STARTED|Overall Study||35
8437370|NCT00823979|20791427|P1|STARTED|Overall Study||35
8437371|NCT00823966|20791465|P1|NOT COMPLETED|Overall Study||0
8437372|NCT00823966|20791465|P1|COMPLETED|Overall Study||3
8437373|NCT00823966|20791465|P1|STARTED|Overall Study||3
8437374|NCT00823901|20791472|P2|NOT COMPLETED|Overall Study||2
8437375|NCT00823901|20791473|P1|NOT COMPLETED|Overall Study||4
8437376|NCT00823901|20791472|P2|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
8437377|NCT00823901|20791473|P1|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
8437378|NCT00823901|20791472|P2|STARTED|Overall Study|Randomized to placebo gel|40
8437379|NCT00823901|20791473|P1|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
8437380|NCT00823836|20791481|P2|NOT COMPLETED|Long-term Phase||5
8437381|NCT00823836|20791482|P1|NOT COMPLETED|Long-term Phase||5
8437382|NCT00823836|20791481|P2|COMPLETED|Long-term Phase||79
8437383|NCT00823836|20791482|P1|COMPLETED|Long-term Phase||68
8437384|NCT00823836|20791481|P2|STARTED|Long-term Phase||84
8437385|NCT00823836|20791482|P1|STARTED|Long-term Phase||73
8437386|NCT00823836|20791481|P2|NOT COMPLETED|NV and PR/XR Switching Phases||29
8437387|NCT00823836|20791482|P1|NOT COMPLETED|NV and PR/XR Switching Phases||32
8437388|NCT00823836|20791481|P2|COMPLETED|NV and PR/XR Switching Phases||117
8437389|NCT00823836|20791482|P1|COMPLETED|NV and PR/XR Switching Phases||124
8437390|NCT00823836|20791481|P2|STARTED|NV and PR/XR Switching Phases||146
8437391|NCT00823836|20791482|P1|STARTED|NV and PR/XR Switching Phases||156
8437392|NCT00823823|20791588|P2|NOT COMPLETED|Overall Study||6
8437393|NCT00823823|20791589|P1|NOT COMPLETED|Overall Study||8
8437394|NCT00823823|20791588|P2|COMPLETED|Overall Study||101
8437395|NCT00823823|20791589|P1|COMPLETED|Overall Study||101
8437396|NCT00823823|20791588|P2|STARTED|Overall Study||107
8437397|NCT00823823|20791589|P1|STARTED|Overall Study||109
8437398|NCT00823797|20791599|P2|NOT COMPLETED|Overall Study||0
8437399|NCT00823797|20791600|P1|NOT COMPLETED|Overall Study||0
8437400|NCT00823797|20791599|P2|COMPLETED|Overall Study||16
8437401|NCT00823797|20791600|P1|COMPLETED|Overall Study||29
8437402|NCT00823797|20791599|P2|STARTED|Overall Study||16
8437403|NCT00823797|20791600|P1|STARTED|Overall Study||29
8437404|NCT00823719|20791613|P2|NOT COMPLETED|Overall Study||11
8437405|NCT00823719|20791614|P1|NOT COMPLETED|Overall Study||6
8437406|NCT00823719|20791613|P2|COMPLETED|Overall Study||24
8437407|NCT00823719|20791614|P1|COMPLETED|Overall Study||20
8437408|NCT00823719|20791613|P2|STARTED|Overall Study||35
8437409|NCT00823719|20791614|P1|STARTED|Overall Study||26
8437410|NCT00823615|20791667|P2|NOT COMPLETED|Period 2||2
8437411|NCT00823615|20791668|P1|NOT COMPLETED|Period 2||3
8437412|NCT00823615|20791667|P2|COMPLETED|Period 2||17
8437413|NCT00823615|20791668|P1|COMPLETED|Period 2||16
8437414|NCT00823615|20791667|P2|STARTED|Period 2||19
8437415|NCT00823615|20791668|P1|STARTED|Period 2||19
8437416|NCT00823615|20791667|P2|NOT COMPLETED|Period 1||0
8437417|NCT00823615|20791668|P1|NOT COMPLETED|Period 1||0
8437418|NCT00823615|20791667|P2|COMPLETED|Period 1||19
8437419|NCT00823615|20791668|P1|COMPLETED|Period 1||19
8437420|NCT00823615|20791667|P2|STARTED|Period 1||19
8437421|NCT00823615|20791668|P1|STARTED|Period 1||19
8437422|NCT00823472|20791678|P2|NOT COMPLETED|Overall Study||28
8437423|NCT00823472|20791679|P1|NOT COMPLETED|Overall Study||24
8437424|NCT00823472|20791678|P2|COMPLETED|Overall Study||39
8437425|NCT00823472|20791679|P1|COMPLETED|Overall Study||56
8437426|NCT00823472|20791678|P2|STARTED|Overall Study||67
8437427|NCT00823472|20791679|P1|STARTED|Overall Study||80
8437428|NCT00823459|20791687|P1|NOT COMPLETED|Overall Study||0
8437429|NCT00823459|20791687|P1|COMPLETED|Overall Study||58
8437430|NCT00823459|20791687|P1|STARTED|Overall Study||58
8437431|NCT00823303|20791697|P2|NOT COMPLETED|Overall Study||11
8437432|NCT00823303|20791698|P1|NOT COMPLETED|Overall Study||9
8437433|NCT00823303|20791697|P2|COMPLETED|Overall Study||45
8437434|NCT00823303|20791698|P1|COMPLETED|Overall Study||45
8437435|NCT00823303|20791697|P2|STARTED|Overall Study||56
8437436|NCT00823303|20791698|P1|STARTED|Overall Study||54
8437437|NCT00823264|20791706|P2|NOT COMPLETED|Overall Study||0
8437438|NCT00823264|20791707|P1|NOT COMPLETED|Overall Study||2
8437439|NCT00823264|20791706|P2|COMPLETED|Overall Study||7
8437440|NCT00823264|20791707|P1|COMPLETED|Overall Study||8
8437441|NCT00823264|20791706|P2|STARTED|Overall Study||7
8437442|NCT00823264|20791707|P1|STARTED|Overall Study||10
8437443|NCT00823212|20791715|P2|NOT COMPLETED|Overall Study||33
8437444|NCT00823212|20791716|P1|NOT COMPLETED|Overall Study||35
8437445|NCT00823212|20791715|P2|COMPLETED|Overall Study|12-month follow-up|735
8437446|NCT00823212|20791716|P1|COMPLETED|Overall Study|12-month follow-up|727
8437447|NCT00823212|20791715|P2|STARTED|Overall Study||768
8437448|NCT00823212|20791716|P1|STARTED|Overall Study||762
8437449|NCT00823199|20791798|P1|NOT COMPLETED|Overall Study||2
8437450|NCT00823199|20791798|P1|COMPLETED|Overall Study||8
8437451|NCT00823199|20791798|P1|STARTED|Overall Study||10
8437452|NCT00823134|20791804|P1|NOT COMPLETED|Overall Study||1
8437453|NCT00823134|20791804|P1|COMPLETED|Overall Study||22
8437454|NCT00823134|20791804|P1|STARTED|Overall Study||23
8437455|NCT00823095|20791814|P1|NOT COMPLETED|Overall Study||0
8437456|NCT00823095|20791814|P1|COMPLETED|Overall Study||7
8437457|NCT00823095|20791814|P1|STARTED|Overall Study||7
8437458|NCT00823082|20791821|P2|NOT COMPLETED|Overall Study||1
8437459|NCT00823082|20791822|P1|NOT COMPLETED|Overall Study||0
8437460|NCT00823082|20791821|P2|COMPLETED|Overall Study||99
8437461|NCT00823082|20791822|P1|COMPLETED|Overall Study||100
8437462|NCT00823082|20791821|P2|Intent-to-Treat/Per Protocol Populations|Overall Study||94
8437463|NCT00823082|20791822|P1|Intent-to-Treat/Per Protocol Populations|Overall Study||100
8437464|NCT00823082|20791821|P2|Safety Population|Overall Study||99
8437465|NCT00823082|20791822|P1|Safety Population|Overall Study||100
8437466|NCT00823082|20791821|P2|STARTED|Overall Study||100
8437467|NCT00823082|20791822|P1|STARTED|Overall Study||100
8437468|NCT00823069|20791856|P1|NOT COMPLETED|Overall Study||0
8437469|NCT00823069|20791856|P1|COMPLETED|Overall Study||60
8437470|NCT00823069|20791856|P1|STARTED|Overall Study||60
8437471|NCT00823043|20791863|P2|NOT COMPLETED|Overall Study||0
8437472|NCT00823043|20791864|P1|NOT COMPLETED|Overall Study||0
8437473|NCT00823043|20791863|P2|COMPLETED|Overall Study||39
8437474|NCT00823043|20791864|P1|COMPLETED|Overall Study||64
8437475|NCT00823043|20791863|P2|STARTED|Overall Study||39
8437476|NCT00823043|20791864|P1|STARTED|Overall Study||64
8437477|NCT00822926|20791877|P2|NOT COMPLETED|Second Injection Visit||1
8437478|NCT00822926|20791878|P1|NOT COMPLETED|Second Injection Visit||1
8437479|NCT00822926|20791877|P2|COMPLETED|Second Injection Visit||2
8437480|NCT00822926|20791878|P1|COMPLETED|Second Injection Visit||1
8437481|NCT00822926|20791877|P2|STARTED|Second Injection Visit||3
8437482|NCT00822926|20791878|P1|STARTED|Second Injection Visit||2
8437483|NCT00822926|20791877|P2|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
8437484|NCT00822926|20791878|P1|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
8437485|NCT00822926|20791877|P2|COMPLETED|Washout (Varies Based on Scheduling)||3
8437486|NCT00822926|20791878|P1|COMPLETED|Washout (Varies Based on Scheduling)||2
8437487|NCT00822926|20791877|P2|STARTED|Washout (Varies Based on Scheduling)||3
8437488|NCT00822926|20791878|P1|STARTED|Washout (Varies Based on Scheduling)||2
8437489|NCT00822926|20791877|P2|NOT COMPLETED|First Injection Visit||0
8437490|NCT00822926|20791878|P1|NOT COMPLETED|First Injection Visit||0
8437491|NCT00822926|20791877|P2|COMPLETED|First Injection Visit||3
8437492|NCT00822926|20791878|P1|COMPLETED|First Injection Visit||2
8437493|NCT00822926|20791877|P2|STARTED|First Injection Visit||3
8437494|NCT00822926|20791878|P1|STARTED|First Injection Visit||2
8437495|NCT00822900|20791892|P2|NOT COMPLETED|Overall Study||93
8437496|NCT00822900|20791893|P1|NOT COMPLETED|Overall Study||108
8437497|NCT00822900|20791892|P2|COMPLETED|Overall Study||347
8437498|NCT00822900|20791893|P1|COMPLETED|Overall Study||334
8437499|NCT00822900|20791892|P2|STARTED|Overall Study||440
8437500|NCT00822900|20791893|P1|STARTED|Overall Study||442
8437501|NCT00822770|20791923|P2|NOT COMPLETED|Overall Study||1
8437502|NCT00822770|20791924|P1|NOT COMPLETED|Overall Study||3
8437503|NCT00822770|20791923|P2|COMPLETED|Overall Study||28
8437504|NCT00822770|20791924|P1|COMPLETED|Overall Study||15
8437505|NCT00822770|20791923|P2|STARTED|Overall Study||29
8437506|NCT00822770|20791924|P1|STARTED|Overall Study||18
8437507|NCT00822757|20791933|P2|NOT COMPLETED|Overall Study||0
8437508|NCT00822757|20791934|P1|NOT COMPLETED|Overall Study||0
8437509|NCT00822757|20791933|P2|COMPLETED|Overall Study||10
8437510|NCT00822757|20791934|P1|COMPLETED|Overall Study||41
8437511|NCT00822757|20791933|P2|STARTED|Overall Study||10
8437512|NCT00822757|20791934|P1|STARTED|Overall Study||41
8437513|NCT00822692|20791946|P2|NOT COMPLETED|Overall Study||25
8437514|NCT00822692|20791947|P1|NOT COMPLETED|Overall Study||17
8437515|NCT00822692|20791946|P2|COMPLETED|Overall Study|June 1 , 2009|51
8437516|NCT00822692|20791947|P1|COMPLETED|Overall Study|June 1, 2009|46
8437517|NCT00822692|20791946|P2|STARTED|Overall Study|July 1, 2008|76
8437518|NCT00822692|20791947|P1|STARTED|Overall Study|July 1, 2008|63
8437519|NCT00822679|20791955|P2|NOT COMPLETED|Overall Study||0
8437520|NCT00822679|20791956|P1|NOT COMPLETED|Overall Study||0
8437521|NCT00822679|20791955|P2|COMPLETED|Overall Study||0
8437522|NCT00822679|20791956|P1|COMPLETED|Overall Study||0
8437523|NCT00822679|20791955|P2|STARTED|Overall Study||0
8437524|NCT00822679|20791956|P1|STARTED|Overall Study||0
8437525|NCT00822588|20791964|P2|NOT COMPLETED|Overall Study||4
8437526|NCT00822588|20791965|P1|NOT COMPLETED|Overall Study||7
8437527|NCT00822588|20791964|P2|COMPLETED|Overall Study|APT/ITT analysis set|110
8437528|NCT00822588|20791965|P1|COMPLETED|Overall Study|APT/ITT analysis set|106
8437529|NCT00822588|20791964|P2|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
8437530|NCT00822588|20791965|P1|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
8437531|NCT00822523|20791974|P3|NOT COMPLETED|Overall Study||0
8437532|NCT00822523|20791975|P2|NOT COMPLETED|Overall Study||0
8437533|NCT00822523|20791976|P1|NOT COMPLETED|Overall Study||0
8437534|NCT00822523|20791974|P3|COMPLETED|Overall Study||4
8437535|NCT00822523|20791975|P2|COMPLETED|Overall Study||4
8437536|NCT00822523|20791976|P1|COMPLETED|Overall Study||5
8437537|NCT00822523|20791974|P3|STARTED|Overall Study||4
8437538|NCT00822523|20791975|P2|STARTED|Overall Study||4
8437539|NCT00822523|20791976|P1|STARTED|Overall Study||5
8437540|NCT00822510|20792022|P2|NOT COMPLETED|Overall Study||5
8437541|NCT00822510|20792023|P1|NOT COMPLETED|Overall Study||3
8437542|NCT00822510|20792022|P2|COMPLETED|Overall Study||36
8437543|NCT00822510|20792023|P1|COMPLETED|Overall Study||35
8437544|NCT00822510|20792022|P2|STARTED|Overall Study||41
8437545|NCT00822510|20792023|P1|STARTED|Overall Study||38
8437546|NCT00822354|20792043|P2|NOT COMPLETED|Second Intervention (28 Days)||0
8437547|NCT00822354|20792044|P1|NOT COMPLETED|Second Intervention (28 Days)||1
8437548|NCT00822354|20792043|P2|COMPLETED|Second Intervention (28 Days)||5
8437549|NCT00822354|20792044|P1|COMPLETED|Second Intervention (28 Days)||3
8437550|NCT00822354|20792043|P2|STARTED|Second Intervention (28 Days)||5
8437551|NCT00822354|20792044|P1|STARTED|Second Intervention (28 Days)||4
8437552|NCT00822354|20792043|P2|NOT COMPLETED|Washout (7 Days)||0
8437553|NCT00822354|20792044|P1|NOT COMPLETED|Washout (7 Days)||0
8437554|NCT00822354|20792043|P2|COMPLETED|Washout (7 Days)||5
8437555|NCT00822354|20792044|P1|COMPLETED|Washout (7 Days)||4
8437556|NCT00822354|20792043|P2|STARTED|Washout (7 Days)||5
8437557|NCT00822354|20792044|P1|STARTED|Washout (7 Days)||4
8437558|NCT00822354|20792043|P2|NOT COMPLETED|First Intervention (28 Days)||0
8437559|NCT00822354|20792044|P1|NOT COMPLETED|First Intervention (28 Days)||1
8437560|NCT00822354|20792043|P2|COMPLETED|First Intervention (28 Days)||5
8437561|NCT00822354|20792044|P1|COMPLETED|First Intervention (28 Days)||4
8437562|NCT00822354|20792043|P2|STARTED|First Intervention (28 Days)||5
8437563|NCT00822354|20792044|P1|STARTED|First Intervention (28 Days)||5
8437564|NCT00822328|20792074|P2|NOT COMPLETED|Overall Study||0
8437565|NCT00822328|20792075|P1|NOT COMPLETED|Overall Study||0
8437566|NCT00822328|20792074|P2|COMPLETED|Overall Study||12
8437567|NCT00822328|20792075|P1|COMPLETED|Overall Study||12
8437568|NCT00822328|20792074|P2|STARTED|Overall Study||12
8437569|NCT00822328|20792075|P1|STARTED|Overall Study||12
8437570|NCT00822237|20792085|P2|NOT COMPLETED|Dose 2 Vaccination||11
8437571|NCT00822237|20792086|P1|NOT COMPLETED|Dose 2 Vaccination||4
8437572|NCT00822237|20792085|P2|COMPLETED|Dose 2 Vaccination||262
8437573|NCT00822237|20792086|P1|COMPLETED|Dose 2 Vaccination||270
8437574|NCT00822237|20792085|P2|STARTED|Dose 2 Vaccination|Number who received second dose|273
8437575|NCT00822237|20792086|P1|STARTED|Dose 2 Vaccination|Number who received second dose|274
8437576|NCT00822237|20792085|P2|NOT COMPLETED|Dose 1 Vaccination||26
8437577|NCT00822237|20792086|P1|NOT COMPLETED|Dose 1 Vaccination||25
8437578|NCT00822237|20792085|P2|COMPLETED|Dose 1 Vaccination||273
8437579|NCT00822237|20792086|P1|COMPLETED|Dose 1 Vaccination||274
8437580|NCT00822237|20792085|P2|STARTED|Dose 1 Vaccination|Number randomized|299
8437581|NCT00822237|20792086|P1|STARTED|Dose 1 Vaccination|Number randomized|299
8437582|NCT00822185|20792096|P5|NOT COMPLETED|Overall Study||0
8437583|NCT00822185|20792097|P4|NOT COMPLETED|Overall Study||0
8437584|NCT00822185|20792098|P3|NOT COMPLETED|Overall Study||0
8437585|NCT00822185|20792099|P2|NOT COMPLETED|Overall Study||0
8437586|NCT00822185|20792100|P1|NOT COMPLETED|Overall Study||0
8437587|NCT00822185|20792096|P5|COMPLETED|Overall Study||8
8437588|NCT00822185|20792097|P4|COMPLETED|Overall Study||6
8437589|NCT00822185|20792098|P3|COMPLETED|Overall Study||6
8437590|NCT00822185|20792099|P2|COMPLETED|Overall Study||6
8437591|NCT00822185|20792100|P1|COMPLETED|Overall Study||6
8437592|NCT00822185|20792096|P5|STARTED|Overall Study||8
8437593|NCT00822185|20792097|P4|STARTED|Overall Study||6
8437594|NCT00822185|20792098|P3|STARTED|Overall Study||6
8437595|NCT00822185|20792099|P2|STARTED|Overall Study||6
8437596|NCT00822185|20792100|P1|STARTED|Overall Study||6
8437597|NCT00822172|20792167|P2|NOT COMPLETED|Overall Study||19
8437598|NCT00822172|20792168|P1|NOT COMPLETED|Overall Study||15
8437599|NCT00822172|20792167|P2|COMPLETED|Overall Study||64
8437600|NCT00822172|20792168|P1|COMPLETED|Overall Study||65
8437601|NCT00822172|20792167|P2|STARTED|Overall Study||83
8437602|NCT00822172|20792168|P1|STARTED|Overall Study||80
8437651|NCT00822107|20792216|P1|NOT COMPLETED|Overall Study||0
8437652|NCT00822107|20792216|P1|COMPLETED|Overall Study||5
8437653|NCT00822107|20792216|P1|STARTED|Overall Study||5
8437654|NCT00822094|20792222|P2|NOT COMPLETED|Overall Study||25
8437655|NCT00822094|20792223|P1|NOT COMPLETED|Overall Study||44
8437656|NCT00822094|20792222|P2|COMPLETED|Overall Study||20
8437657|NCT00822094|20792223|P1|COMPLETED|Overall Study||37
8437658|NCT00822094|20792222|P2|STARTED|Overall Study||45
8437659|NCT00822094|20792223|P1|STARTED|Overall Study||81
8437660|NCT00821964|20792239|P1|NOT COMPLETED|Overall Study||6
8437661|NCT00821964|20792239|P1|COMPLETED|Overall Study||9
8437662|NCT00821964|20792239|P1|Evaluable for Pathologic Response|Overall Study||7
8437663|NCT00821964|20792239|P1|Evaluable for Clinical Response|Overall Study||14
8437664|NCT00821964|20792239|P1|STARTED|Overall Study||15
8437665|NCT00821951|20792248|P1|NOT COMPLETED|Overall Study||5
8437666|NCT00821951|20792248|P1|COMPLETED|Overall Study||12
8437667|NCT00821951|20792248|P1|STARTED|Overall Study||17
8437668|NCT00821886|20792252|P1|NOT COMPLETED|Overall Study||9
8437669|NCT00821886|20792252|P1|COMPLETED|Overall Study||49
8437670|NCT00821886|20792252|P1|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
8437671|NCT00821873|20792259|P1|NOT COMPLETED|Overall Study||4
8437672|NCT00821873|20792259|P1|COMPLETED|Overall Study||5
8437673|NCT00821873|20792259|P1|STARTED|Overall Study||9
8437674|NCT00821821|20792266|P3|NOT COMPLETED|Overall Study||0
8437675|NCT00821821|20792267|P2|NOT COMPLETED|Overall Study||0
8437676|NCT00821821|20792268|P1|NOT COMPLETED|Overall Study||0
8437677|NCT00821821|20792266|P3|COMPLETED|Overall Study||11
8437678|NCT00821821|20792267|P2|COMPLETED|Overall Study||13
8437679|NCT00821821|20792268|P1|COMPLETED|Overall Study||12
8437680|NCT00821821|20792266|P3|STARTED|Overall Study||11
8437681|NCT00821821|20792267|P2|STARTED|Overall Study||13
8437682|NCT00821821|20792268|P1|STARTED|Overall Study||12
8437683|NCT00821795|20792280|P2|NOT COMPLETED|Overall Study||4
8437684|NCT00821795|20792281|P1|NOT COMPLETED|Overall Study||6
8437685|NCT00821795|20792280|P2|COMPLETED|Overall Study||60
8437686|NCT00821795|20792281|P1|COMPLETED|Overall Study||44
8437687|NCT00821795|20792280|P2|STARTED|Overall Study||64
8437688|NCT00821795|20792281|P1|STARTED|Overall Study||50
8437689|NCT00821678|20792289|P2|NOT COMPLETED|Overall Study||14
8437690|NCT00821678|20792290|P1|NOT COMPLETED|Overall Study||21
8437691|NCT00821678|20792289|P2|COMPLETED|Overall Study||118
8437692|NCT00821678|20792290|P1|COMPLETED|Overall Study||112
8437693|NCT00821678|20792289|P2|STARTED|Overall Study||132
8437694|NCT00821678|20792290|P1|STARTED|Overall Study||133
8437695|NCT00821626|20792312|P2|NOT COMPLETED|Overall Study||0
8437696|NCT00821626|20792313|P1|NOT COMPLETED|Overall Study||0
8437697|NCT00821626|20792312|P2|COMPLETED|Overall Study||33
8437698|NCT00821626|20792313|P1|COMPLETED|Overall Study||60
8437699|NCT00821626|20792312|P2|STARTED|Overall Study||33
8437700|NCT00821626|20792313|P1|STARTED|Overall Study||60
8437701|NCT00821587|20792325|P2|NOT COMPLETED|Overall Study||1
8437702|NCT00821587|20792326|P1|NOT COMPLETED|Overall Study||0
8437703|NCT00821587|20792325|P2|COMPLETED|Overall Study||18
8437704|NCT00821587|20792326|P1|COMPLETED|Overall Study||20
8437705|NCT00821587|20792325|P2|STARTED|Overall Study||19
8437706|NCT00821587|20792326|P1|STARTED|Overall Study||20
8437707|NCT00821509|20792335|P3|NOT COMPLETED|Overall Study||34
8437708|NCT00821509|20792336|P2|NOT COMPLETED|Overall Study||11
8437709|NCT00821509|20792337|P1|NOT COMPLETED|Overall Study||12
8437710|NCT00821509|20792335|P3|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
8437711|NCT00821509|20792336|P2|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
8437712|NCT00821509|20792337|P1|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
8437713|NCT00821509|20792335|P3|STARTED|Overall Study||224
8437714|NCT00821509|20792336|P2|STARTED|Overall Study||202
8437715|NCT00821509|20792337|P1|STARTED|Overall Study||257
8437716|NCT00821431|20792350|P2|NOT COMPLETED|Overall Study||5
8437717|NCT00821431|20792351|P1|NOT COMPLETED|Overall Study||15
8437718|NCT00821431|20792350|P2|COMPLETED|Overall Study||47
8437719|NCT00821431|20792351|P1|COMPLETED|Overall Study||23
8437720|NCT00821431|20792350|P2|STARTED|Overall Study||52
8437721|NCT00821431|20792351|P1|STARTED|Overall Study||38
8437722|NCT00821327|20792359|P1|NOT COMPLETED|Overall Study||35
8437723|NCT00821327|20792359|P1|COMPLETED|Overall Study||1
8437724|NCT00821327|20792359|P1|STARTED|Overall Study||36
8437725|NCT00821236|20792368|P1|NOT COMPLETED|Overall Study||3
8437726|NCT00821236|20792368|P1|COMPLETED|Overall Study||37
8437727|NCT00821236|20792368|P1|STARTED|Overall Study||40
8437728|NCT00821184|20792384|P2|NOT COMPLETED|Overall Study||0
8437729|NCT00821184|20792385|P1|NOT COMPLETED|Overall Study||0
8437730|NCT00821184|20792384|P2|COMPLETED|Overall Study||6
8437731|NCT00821184|20792385|P1|COMPLETED|Overall Study||6
8437732|NCT00821184|20792384|P2|STARTED|Overall Study||6
8437733|NCT00821184|20792385|P1|STARTED|Overall Study||6
8437734|NCT00821119|20792395|P2|NOT COMPLETED|Overall Study||0
8437735|NCT00821119|20792396|P1|NOT COMPLETED|Overall Study||0
8437736|NCT00821119|20792395|P2|COMPLETED|Overall Study||100
8437737|NCT00821119|20792396|P1|COMPLETED|Overall Study||100
8437738|NCT00821119|20792395|P2|STARTED|Overall Study||100
8437739|NCT00821119|20792396|P1|STARTED|Overall Study||100
8437740|NCT00821093|20792408|P2|NOT COMPLETED|Overall Study||40
8437741|NCT00821093|20792409|P1|NOT COMPLETED|Overall Study||49
8437742|NCT00821093|20792408|P2|COMPLETED|Overall Study||523
8437743|NCT00821093|20792409|P1|COMPLETED|Overall Study||511
8437744|NCT00821093|20792408|P2|Exposed to Drug|Overall Study||562
8437745|NCT00821093|20792409|P1|Exposed to Drug|Overall Study||559
8437746|NCT00821093|20792408|P2|STARTED|Overall Study||563
8437747|NCT00821093|20792409|P1|STARTED|Overall Study||560
8437748|NCT00821041|20792419|P2|NOT COMPLETED|Overall Study||0
8437749|NCT00821041|20792420|P1|NOT COMPLETED|Overall Study||0
8437750|NCT00821041|20792419|P2|COMPLETED|Overall Study||59
8437751|NCT00821041|20792420|P1|COMPLETED|Overall Study||59
8437752|NCT00821041|20792419|P2|STARTED|Overall Study||59
8437753|NCT00821041|20792420|P1|STARTED|Overall Study||59
8437754|NCT00821015|20792428|P1|NOT COMPLETED|Overall Study||12
8437755|NCT00821015|20792428|P1|COMPLETED|Overall Study||15
8437756|NCT00821015|20792428|P1|STARTED|Overall Study||27
8437757|NCT00820898|20792439|P1|NOT COMPLETED|Overall Study||1
8437758|NCT00820898|20792439|P1|COMPLETED|Overall Study||23
8437759|NCT00820898|20792439|P1|STARTED|Overall Study||24
8437760|NCT00820872|20792449|P1|NOT COMPLETED|Overall Study||0
8437761|NCT00820872|20792449|P1|COMPLETED|Overall Study||30
8437762|NCT00820872|20792449|P1|STARTED|Overall Study||30
8437763|NCT00820755|20792453|P3|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
8437764|NCT00820755|20792454|P2|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
8437765|NCT00820755|20792455|P1|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
8437766|NCT00820755|20792453|P3|COMPLETED|Period 2: Maintenance Therapy Phase||109
8437767|NCT00820755|20792454|P2|COMPLETED|Period 2: Maintenance Therapy Phase||112
8437768|NCT00820755|20792455|P1|COMPLETED|Period 2: Maintenance Therapy Phase||0
8437769|NCT00820755|20792453|P3|STARTED|Period 2: Maintenance Therapy Phase||154
8437770|NCT00820755|20792454|P2|STARTED|Period 2: Maintenance Therapy Phase||157
8437771|NCT00820755|20792455|P1|STARTED|Period 2: Maintenance Therapy Phase||0
8437772|NCT00820755|20792453|P3|NOT COMPLETED|Period 1: Combination Therapy Phase||0
8437773|NCT00820755|20792454|P2|NOT COMPLETED|Period 1: Combination Therapy Phase||0
8437774|NCT00820755|20792455|P1|NOT COMPLETED|Period 1: Combination Therapy Phase||270
8437775|NCT00820755|20792453|P3|COMPLETED|Period 1: Combination Therapy Phase||0
8437776|NCT00820755|20792454|P2|COMPLETED|Period 1: Combination Therapy Phase||0
8437777|NCT00820755|20792455|P1|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
8437778|NCT00820755|20792453|P3|STARTED|Period 1: Combination Therapy Phase||0
8437779|NCT00820755|20792454|P2|STARTED|Period 1: Combination Therapy Phase||0
8437780|NCT00820755|20792455|P1|STARTED|Period 1: Combination Therapy Phase||583
8437781|NCT00820664|20792479|P3|NOT COMPLETED|Overall Study||0
8437782|NCT00820664|20792480|P2|NOT COMPLETED|Overall Study||0
8437783|NCT00820664|20792481|P1|NOT COMPLETED|Overall Study||0
8437784|NCT00820664|20792479|P3|COMPLETED|Overall Study||9
8437785|NCT00820664|20792480|P2|COMPLETED|Overall Study||11
8437786|NCT00820664|20792481|P1|COMPLETED|Overall Study||9
8437787|NCT00820664|20792479|P3|STARTED|Overall Study||9
8437788|NCT00820664|20792480|P2|STARTED|Overall Study||11
8437789|NCT00820664|20792481|P1|STARTED|Overall Study||9
8437790|NCT00820612|20792491|P2|NOT COMPLETED|Overall Study||0
8437791|NCT00820612|20792492|P1|NOT COMPLETED|Overall Study||0
8437792|NCT00820612|20792491|P2|COMPLETED|Overall Study||295
8437793|NCT00820612|20792492|P1|COMPLETED|Overall Study||307
8437794|NCT00820612|20792491|P2|STARTED|Overall Study||295
8437795|NCT00820612|20792492|P1|STARTED|Overall Study||307
8437796|NCT00820599|20792498|P1|NOT COMPLETED|Overall Study||131
8437797|NCT00820599|20792498|P1|COMPLETED|Overall Study||80
8437798|NCT00820599|20792498|P1|STARTED|Overall Study||211
8437799|NCT00820573|20792507|P4|NOT COMPLETED|Overall Study||0
8437800|NCT00820573|20792508|P3|NOT COMPLETED|Overall Study||0
8437801|NCT00820573|20792509|P2|NOT COMPLETED|Overall Study||0
8437802|NCT00820573|20792510|P1|NOT COMPLETED|Overall Study||0
8437803|NCT00820573|20792507|P4|COMPLETED|Overall Study||4
8437804|NCT00820573|20792508|P3|COMPLETED|Overall Study||4
8437805|NCT00820573|20792509|P2|COMPLETED|Overall Study||4
8437806|NCT00820573|20792510|P1|COMPLETED|Overall Study||4
8437807|NCT00820573|20792507|P4|STARTED|Overall Study||4
8437808|NCT00820573|20792508|P3|STARTED|Overall Study||4
8437809|NCT00820573|20792509|P2|STARTED|Overall Study||4
8437810|NCT00820573|20792510|P1|STARTED|Overall Study||4
8437811|NCT00820534|20792534|P2|NOT COMPLETED|Overall Study||0
8437812|NCT00820534|20792535|P1|NOT COMPLETED|Overall Study||0
8437813|NCT00820534|20792534|P2|COMPLETED|Overall Study||62
8437814|NCT00820534|20792535|P1|COMPLETED|Overall Study||64
8437815|NCT00820534|20792534|P2|STARTED|Overall Study||62
8437816|NCT00820534|20792535|P1|STARTED|Overall Study||64
8437817|NCT00820443|20792543|P1|NOT COMPLETED|24 Month||43
8437818|NCT00820443|20792543|P1|COMPLETED|24 Month||202
8437819|NCT00820443|20792543|P1|STARTED|24 Month||245
8437820|NCT00820443|20792543|P1|NOT COMPLETED|12 Month||24
8437821|NCT00820443|20792543|P1|COMPLETED|12 Month||226
8437822|NCT00820443|20792543|P1|STARTED|12 Month||250
8437823|NCT00820443|20792543|P1|NOT COMPLETED|6 Month||20
8437824|NCT00820443|20792543|P1|COMPLETED|6 Month||233
8437825|NCT00820443|20792543|P1|STARTED|6 Month||253
8437826|NCT00820443|20792543|P1|NOT COMPLETED|3 Month||9
8437827|NCT00820443|20792543|P1|COMPLETED|3 Month||244
8437828|NCT00820443|20792543|P1|STARTED|3 Month||253
8437829|NCT00820443|20792543|P1|NOT COMPLETED|Immediately||5
8437830|NCT00820443|20792543|P1|COMPLETED|Immediately||248
8437831|NCT00820443|20792543|P1|STARTED|Immediately||253
8437832|NCT00820443|20792543|P1|NOT COMPLETED|Op||0
8437833|NCT00820443|20792543|P1|COMPLETED|Op||253
8437834|NCT00820443|20792543|P1|STARTED|Op||253
8437835|NCT00820443|20792543|P1|NOT COMPLETED|Pre-Op||0
8437836|NCT00820443|20792543|P1|COMPLETED|Pre-Op||253
8437837|NCT00820443|20792543|P1|STARTED|Pre-Op||253
8437838|NCT00820248|20792553|P2|NOT COMPLETED|Overall Study||1
8437839|NCT00820248|20792554|P1|NOT COMPLETED|Overall Study||4
8437840|NCT00820248|20792553|P2|COMPLETED|Overall Study||159
8437841|NCT00820248|20792554|P1|COMPLETED|Overall Study||156
8437842|NCT00820248|20792553|P2|Received Protocol Treatment|Overall Study||159
8437843|NCT00820248|20792554|P1|Received Protocol Treatment|Overall Study||156
8437844|NCT00820248|20792553|P2|STARTED|Overall Study||160
8437845|NCT00820248|20792554|P1|STARTED|Overall Study||160
8437846|NCT00820235|20792565|P3|NOT COMPLETED|Overall Study||17
8437847|NCT00820235|20792566|P2|NOT COMPLETED|Overall Study||21
8437848|NCT00820235|20792567|P1|NOT COMPLETED|Overall Study||15
8437849|NCT00820235|20792565|P3|COMPLETED|Overall Study||27
8437850|NCT00820235|20792566|P2|COMPLETED|Overall Study||28
8437851|NCT00820235|20792567|P1|COMPLETED|Overall Study||33
8437852|NCT00820235|20792565|P3|STARTED|Overall Study||44
8437853|NCT00820235|20792566|P2|STARTED|Overall Study||49
8437854|NCT00820235|20792567|P1|STARTED|Overall Study||48
8437855|NCT00820222|20792586|P2|NOT COMPLETED|Overall Study||190
8437856|NCT00820222|20792587|P1|NOT COMPLETED|Overall Study||176
8437857|NCT00820222|20792586|P2|COMPLETED|Overall Study||79
8437858|NCT00820222|20792587|P1|COMPLETED|Overall Study||95
8437859|NCT00820222|20792586|P2|STARTED|Overall Study||269
8437860|NCT00820222|20792587|P1|STARTED|Overall Study||271
8437861|NCT00820170|20792618|P5|NOT COMPLETED|Overall Study||4
8437862|NCT00820170|20792619|P4|NOT COMPLETED|Overall Study||0
8437863|NCT00820170|20792620|P3|NOT COMPLETED|Overall Study||0
8437864|NCT00820170|20792621|P2|NOT COMPLETED|Overall Study||0
8437865|NCT00820170|20792622|P1|NOT COMPLETED|Overall Study||0
8437866|NCT00820170|20792618|P5|COMPLETED|Overall Study||0
8437867|NCT00820170|20792619|P4|COMPLETED|Overall Study||40
8437868|NCT00820170|20792620|P3|COMPLETED|Overall Study||3
8437869|NCT00820170|20792621|P2|COMPLETED|Overall Study||5
8437870|NCT00820170|20792622|P1|COMPLETED|Overall Study||3
8437871|NCT00820170|20792618|P5|STARTED|Overall Study||4
8437872|NCT00820170|20792619|P4|STARTED|Overall Study||40
8437873|NCT00820170|20792620|P3|STARTED|Overall Study||3
8437874|NCT00820170|20792621|P2|STARTED|Overall Study||5
8437875|NCT00820170|20792622|P1|STARTED|Overall Study||3
8437876|NCT00820040|20792670|P1|NOT COMPLETED|Overall Study||3
8437877|NCT00820040|20792670|P1|COMPLETED|Overall Study||7
8437878|NCT00820040|20792670|P1|Full Analysis Set|Overall Study||8
8437879|NCT00820040|20792670|P1|Safety Evaluable Population|Overall Study||8
8437880|NCT00820040|20792670|P1|STARTED|Overall Study||10
8437881|NCT00820027|20792682|P4|NOT COMPLETED|Overall Study||13
8437882|NCT00820027|20792683|P3|NOT COMPLETED|Overall Study||21
8437883|NCT00820027|20792684|P2|NOT COMPLETED|Overall Study||14
8437884|NCT00820027|20792685|P1|NOT COMPLETED|Overall Study||26
8437885|NCT00820027|20792682|P4|COMPLETED|Overall Study||85
8437886|NCT00820027|20792683|P3|COMPLETED|Overall Study||203
8437887|NCT00820027|20792684|P2|COMPLETED|Overall Study||216
8437888|NCT00820027|20792685|P1|COMPLETED|Overall Study||198
8437889|NCT00820027|20792682|P4|STARTED|Overall Study||98
8437890|NCT00820027|20792683|P3|STARTED|Overall Study||224
8437891|NCT00820027|20792684|P2|STARTED|Overall Study||230
8437892|NCT00820027|20792685|P1|STARTED|Overall Study||224
8437893|NCT00819910|20792727|P4|NOT COMPLETED|Overall Study||1
8437894|NCT00819910|20792728|P3|NOT COMPLETED|Overall Study||3
8437895|NCT00819910|20792729|P2|NOT COMPLETED|Overall Study||1
8437896|NCT00819910|20792730|P1|NOT COMPLETED|Overall Study||2
8437897|NCT00819910|20792727|P4|COMPLETED|Overall Study||10
8437898|NCT00819910|20792728|P3|COMPLETED|Overall Study||7
8437899|NCT00819910|20792729|P2|COMPLETED|Overall Study||9
8437900|NCT00819910|20792730|P1|COMPLETED|Overall Study||8
8437901|NCT00819910|20792727|P4|STARTED|Overall Study||11
8437902|NCT00819910|20792728|P3|STARTED|Overall Study||10
8437903|NCT00819910|20792729|P2|STARTED|Overall Study||10
8437904|NCT00819910|20792730|P1|STARTED|Overall Study||10
8437905|NCT00819832|20792762|P6|NOT COMPLETED|Overall Study||0
8437906|NCT00819832|20792763|P5|NOT COMPLETED|Overall Study||0
8437907|NCT00819832|20792764|P4|NOT COMPLETED|Overall Study||0
8437908|NCT00819832|20792765|P3|NOT COMPLETED|Overall Study||0
8437909|NCT00819832|20792766|P2|NOT COMPLETED|Overall Study||0
8437910|NCT00819832|20792767|P1|NOT COMPLETED|Overall Study||3
8437911|NCT00819832|20792762|P6|COMPLETED|Overall Study||0
8437912|NCT00819832|20792763|P5|COMPLETED|Overall Study||0
8437913|NCT00819832|20792764|P4|COMPLETED|Overall Study||0
8437914|NCT00819832|20792765|P3|COMPLETED|Overall Study||0
8437915|NCT00819832|20792766|P2|COMPLETED|Overall Study||0
8437916|NCT00819832|20792767|P1|COMPLETED|Overall Study||0
8437917|NCT00819832|20792762|P6|STARTED|Overall Study||0
8437918|NCT00819832|20792763|P5|STARTED|Overall Study||0
8437919|NCT00819832|20792764|P4|STARTED|Overall Study||0
8437920|NCT00819832|20792765|P3|STARTED|Overall Study||0
8437921|NCT00819832|20792766|P2|STARTED|Overall Study||0
8437922|NCT00819832|20792767|P1|STARTED|Overall Study|No patient data analysis.|3
8437923|NCT00819793|20792781|P1|NOT COMPLETED|Overall Study||0
8437924|NCT00819793|20792781|P1|COMPLETED|Overall Study||32
8437925|NCT00819793|20792781|P1|STARTED|Overall Study||32
8437926|NCT00819780|20792788|P2|NOT COMPLETED|Overall Study||21
8437927|NCT00819780|20792789|P1|NOT COMPLETED|Overall Study||28
8437928|NCT00819780|20792788|P2|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
8437929|NCT00819780|20792789|P1|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
8437930|NCT00819780|20792788|P2|Received Study Treatment|Overall Study||139
8437931|NCT00819780|20792789|P1|Received Study Treatment|Overall Study||139
8437932|NCT00819780|20792788|P2|STARTED|Overall Study||143
8437933|NCT00819780|20792789|P1|STARTED|Overall Study||142
8437934|NCT00819767|20792823|P2|NOT COMPLETED|Overall Study||2
8437935|NCT00819767|20792824|P1|NOT COMPLETED|Overall Study||1
8437936|NCT00819767|20792823|P2|COMPLETED|Overall Study||33
8437937|NCT00819767|20792824|P1|COMPLETED|Overall Study||32
8437938|NCT00819767|20792823|P2|STARTED|Overall Study||35
8437939|NCT00819767|20792824|P1|STARTED|Overall Study||33
8437940|NCT00819741|20792836|P2|NOT COMPLETED|Overall Study||14
8437941|NCT00819741|20792837|P1|NOT COMPLETED|Overall Study||22
8437942|NCT00819741|20792836|P2|COMPLETED|Overall Study||201
8437943|NCT00819741|20792837|P1|COMPLETED|Overall Study||196
8437944|NCT00819741|20792836|P2|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
8437945|NCT00819741|20792837|P1|Exposed to Drug|Overall Study||218
8437946|NCT00819741|20792836|P2|STARTED|Overall Study||215
8437947|NCT00819741|20792837|P1|STARTED|Overall Study||218
8437948|NCT00819637|20792874|P3|NOT COMPLETED|Overall Study||0
8437949|NCT00819637|20792875|P2|NOT COMPLETED|Overall Study||0
8437950|NCT00819637|20792876|P1|NOT COMPLETED|Overall Study||0
8437951|NCT00819637|20792874|P3|COMPLETED|Overall Study||0
8437952|NCT00819637|20792875|P2|COMPLETED|Overall Study||0
8437953|NCT00819637|20792876|P1|COMPLETED|Overall Study||2
8437954|NCT00819637|20792874|P3|STARTED|Overall Study||0
8437955|NCT00819637|20792875|P2|STARTED|Overall Study||0
8437956|NCT00819637|20792876|P1|STARTED|Overall Study||2
8437957|NCT00819585|20792891|P11|NOT COMPLETED|Extension Study||2
8437958|NCT00819585|20792892|P10|NOT COMPLETED|Extension Study||1
8437959|NCT00819585|20792893|P9|NOT COMPLETED|Extension Study||8
8437960|NCT00819585|20792894|P8|NOT COMPLETED|Extension Study||0
8437961|NCT00819585|20792895|P7|NOT COMPLETED|Extension Study||0
8437962|NCT00819585|20792896|P6|NOT COMPLETED|Extension Study||0
8437963|NCT00819585|20792897|P5|NOT COMPLETED|Extension Study||0
8437964|NCT00819585|20792898|P4|NOT COMPLETED|Extension Study||0
8437965|NCT00819585|20792899|P3|NOT COMPLETED|Extension Study||0
8437966|NCT00819585|20792900|P2|NOT COMPLETED|Extension Study||0
8437967|NCT00819585|20792901|P1|NOT COMPLETED|Extension Study||0
8437968|NCT00819585|20792891|P11|COMPLETED|Extension Study||58
8437969|NCT00819585|20792892|P10|COMPLETED|Extension Study||24
8437970|NCT00819585|20792893|P9|COMPLETED|Extension Study||173
8437971|NCT00819585|20792894|P8|COMPLETED|Extension Study||75
8437972|NCT00819585|20792895|P7|COMPLETED|Extension Study||0
8437973|NCT00819585|20792896|P6|COMPLETED|Extension Study||0
8437974|NCT00819585|20792897|P5|COMPLETED|Extension Study||0
8437975|NCT00819585|20792898|P4|COMPLETED|Extension Study||0
8437976|NCT00819585|20792899|P3|COMPLETED|Extension Study||0
8437977|NCT00819585|20792900|P2|COMPLETED|Extension Study||0
8437978|NCT00819585|20792901|P1|COMPLETED|Extension Study||0
8437979|NCT00819585|20792891|P11|STARTED|Extension Study||60
8437980|NCT00819585|20792892|P10|STARTED|Extension Study||25
8437981|NCT00819585|20792893|P9|STARTED|Extension Study||181
8437982|NCT00819585|20792894|P8|STARTED|Extension Study||75
8437983|NCT00819585|20792895|P7|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8437984|NCT00819585|20792896|P6|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8437985|NCT00819585|20792897|P5|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8437986|NCT00819585|20792898|P4|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8437987|NCT00819585|20792899|P3|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8437988|NCT00819585|20792900|P2|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8437989|NCT00819585|20792901|P1|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
8437990|NCT00819585|20792891|P11|NOT COMPLETED|Core Study||0
8437991|NCT00819585|20792892|P10|NOT COMPLETED|Core Study||0
8437992|NCT00819585|20792893|P9|NOT COMPLETED|Core Study||0
8437993|NCT00819585|20792894|P8|NOT COMPLETED|Core Study||0
8437994|NCT00819585|20792895|P7|NOT COMPLETED|Core Study||13
8437995|NCT00819585|20792896|P6|NOT COMPLETED|Core Study||2
8437996|NCT00819585|20792897|P5|NOT COMPLETED|Core Study||3
8437997|NCT00819585|20792898|P4|NOT COMPLETED|Core Study||5
8437998|NCT00819585|20792899|P3|NOT COMPLETED|Core Study||6
8437999|NCT00819585|20792900|P2|NOT COMPLETED|Core Study||6
8438000|NCT00819585|20792901|P1|NOT COMPLETED|Core Study||6
8438001|NCT00819585|20792891|P11|COMPLETED|Core Study||0
8438002|NCT00819585|20792892|P10|COMPLETED|Core Study||0
8438003|NCT00819585|20792893|P9|COMPLETED|Core Study||0
8438004|NCT00819585|20792894|P8|COMPLETED|Core Study||0
8438005|NCT00819585|20792895|P7|COMPLETED|Core Study||95
8438006|NCT00819585|20792896|P6|COMPLETED|Core Study||52
8438007|NCT00819585|20792897|P5|COMPLETED|Core Study||50
8438008|NCT00819585|20792898|P4|COMPLETED|Core Study||49
8438009|NCT00819585|20792899|P3|COMPLETED|Core Study||48
8438010|NCT00819585|20792900|P2|COMPLETED|Core Study||48
8438011|NCT00819585|20792901|P1|COMPLETED|Core Study||49
8438012|NCT00819585|20792891|P11|Received Study Medication|Core Study||0
8438013|NCT00819585|20792892|P10|Received Study Medication|Core Study||0
8438014|NCT00819585|20792893|P9|Received Study Medication|Core Study||0
8438015|NCT00819585|20792894|P8|Received Study Medication|Core Study||0
8438016|NCT00819585|20792895|P7|Received Study Medication|Core Study||108
8438017|NCT00819585|20792896|P6|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
8438018|NCT00819585|20792897|P5|Received Study Medication|Core Study||53
8438019|NCT00819585|20792898|P4|Received Study Medication|Core Study||54
8438020|NCT00819585|20792899|P3|Received Study Medication|Core Study||54
8438021|NCT00819585|20792900|P2|Received Study Medication|Core Study||54
8438022|NCT00819585|20792901|P1|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
8438023|NCT00819585|20792891|P11|STARTED|Core Study|There were no participants in this arm during the core study.|0
8438024|NCT00819585|20792892|P10|STARTED|Core Study|There were no participants in this arm during the core study.|0
8438025|NCT00819585|20792893|P9|STARTED|Core Study|There were no participants in this arm during the core study.|0
8438026|NCT00819585|20792894|P8|STARTED|Core Study|There were no participants in this arm during the core study.|0
8438027|NCT00819585|20792895|P7|STARTED|Core Study||108
8438028|NCT00819585|20792896|P6|STARTED|Core Study||54
8438029|NCT00819585|20792897|P5|STARTED|Core Study||53
8438030|NCT00819585|20792898|P4|STARTED|Core Study||54
8438031|NCT00819585|20792899|P3|STARTED|Core Study||54
8438032|NCT00819585|20792900|P2|STARTED|Core Study||54
8438033|NCT00819585|20792901|P1|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
8438034|NCT00819507|20792972|P1|NOT COMPLETED|Overall Study||0
8438035|NCT00819507|20792972|P1|COMPLETED|Overall Study||25
8438036|NCT00819507|20792972|P1|STARTED|Overall Study||25
8438037|NCT00819403|20792979|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8438038|NCT00819403|20792980|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8438039|NCT00819403|20792979|P2|COMPLETED|Second Intervention (6 Weeks)||8
8438040|NCT00819403|20792980|P1|COMPLETED|Second Intervention (6 Weeks)||7
8438041|NCT00819403|20792979|P2|STARTED|Second Intervention (6 Weeks)||8
8438042|NCT00819403|20792980|P1|STARTED|Second Intervention (6 Weeks)||7
8438043|NCT00819403|20792979|P2|NOT COMPLETED|Washout (14 Days)||0
8438044|NCT00819403|20792980|P1|NOT COMPLETED|Washout (14 Days)||0
8438045|NCT00819403|20792979|P2|COMPLETED|Washout (14 Days)||8
8438046|NCT00819403|20792980|P1|COMPLETED|Washout (14 Days)||7
8438047|NCT00819403|20792979|P2|STARTED|Washout (14 Days)||8
8438048|NCT00819403|20792980|P1|STARTED|Washout (14 Days)||7
8438049|NCT00819403|20792979|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
8438050|NCT00819403|20792980|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
8438051|NCT00819403|20792979|P2|COMPLETED|First Intervention (6 Weeks)||8
8438052|NCT00819403|20792980|P1|COMPLETED|First Intervention (6 Weeks)||7
8438053|NCT00819403|20792979|P2|STARTED|First Intervention (6 Weeks)||8
8438054|NCT00819403|20792980|P1|STARTED|First Intervention (6 Weeks)||7
8438055|NCT00819390|20792992|P4|NOT COMPLETED|Overall Study||0
8438056|NCT00819390|20792993|P3|NOT COMPLETED|Overall Study||1
8438057|NCT00819390|20792994|P2|NOT COMPLETED|Overall Study||1
8438058|NCT00819390|20792995|P1|NOT COMPLETED|Overall Study||3
8438059|NCT00819390|20792992|P4|COMPLETED|Overall Study||19
8438060|NCT00819390|20792993|P3|COMPLETED|Overall Study||17
8438061|NCT00819390|20792994|P2|COMPLETED|Overall Study||16
8438062|NCT00819390|20792995|P1|COMPLETED|Overall Study||13
8438063|NCT00819390|20792992|P4|STARTED|Overall Study||19
8438064|NCT00819390|20792993|P3|STARTED|Overall Study||18
8438065|NCT00819390|20792994|P2|STARTED|Overall Study||17
8438066|NCT00819390|20792995|P1|STARTED|Overall Study||16
8438067|NCT00819286|20793107|P2|NOT COMPLETED|Overall Study||25
8438068|NCT00819286|20793108|P1|NOT COMPLETED|Overall Study||14
8438069|NCT00819286|20793107|P2|COMPLETED|Overall Study||45
8438070|NCT00819286|20793108|P1|COMPLETED|Overall Study||56
8438071|NCT00819286|20793107|P2|STARTED|Overall Study||70
8438072|NCT00819286|20793108|P1|STARTED|Overall Study||70
8438073|NCT00819260|20793116|P1|NOT COMPLETED|Overall Study||0
8438074|NCT00819260|20793116|P1|COMPLETED|Overall Study||31
8438075|NCT00819260|20793116|P1|STARTED|Overall Study||31
8438076|NCT00819247|20793131|P3|NOT COMPLETED|Overall Study||14
8438077|NCT00819247|20793132|P2|NOT COMPLETED|Overall Study||16
8438078|NCT00819247|20793133|P1|NOT COMPLETED|Overall Study||11
8438079|NCT00819247|20793131|P3|COMPLETED|Overall Study||26
8438080|NCT00819247|20793132|P2|COMPLETED|Overall Study||30
8438081|NCT00819247|20793133|P1|COMPLETED|Overall Study||32
8438082|NCT00819247|20793131|P3|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
8438083|NCT00819247|20793132|P2|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
8438174|NCT00819039|20793607|P1|NOT COMPLETED|Overall Study||2
8438175|NCT00819039|20793605|P3|COMPLETED|Overall Study||24
8438084|NCT00819247|20793133|P1|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
8438085|NCT00819247|20793131|P3|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
8438086|NCT00819247|20793132|P2|Intent-to-treat Population|Overall Study||46
8438087|NCT00819247|20793133|P1|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
8438088|NCT00819247|20793131|P3|Randomized|Overall Study||40
8438089|NCT00819247|20793132|P2|Randomized|Overall Study||46
8438090|NCT00819247|20793133|P1|Randomized|Overall Study||43
8438091|NCT00819247|20793131|P3|STARTED|Overall Study||40
8438092|NCT00819247|20793132|P2|STARTED|Overall Study||46
8438093|NCT00819247|20793133|P1|STARTED|Overall Study||43
8438094|NCT00819234|20793159|P10|NOT COMPLETED|Overall Study||7
8438095|NCT00819234|20793160|P9|NOT COMPLETED|Overall Study||6
8438096|NCT00819234|20793161|P8|NOT COMPLETED|Overall Study||9
8438097|NCT00819234|20793162|P7|NOT COMPLETED|Overall Study||5
8438098|NCT00819234|20793163|P6|NOT COMPLETED|Overall Study||7
8438099|NCT00819234|20793164|P5|NOT COMPLETED|Overall Study||1
8438100|NCT00819234|20793165|P4|NOT COMPLETED|Overall Study||6
8438101|NCT00819234|20793166|P3|NOT COMPLETED|Overall Study||8
8438102|NCT00819234|20793167|P2|NOT COMPLETED|Overall Study||15
8438103|NCT00819234|20793168|P1|NOT COMPLETED|Overall Study||10
8438104|NCT00819234|20793159|P10|COMPLETED|Overall Study||30
8438105|NCT00819234|20793160|P9|COMPLETED|Overall Study||31
8438106|NCT00819234|20793161|P8|COMPLETED|Overall Study||20
8438107|NCT00819234|20793162|P7|COMPLETED|Overall Study||8
8438108|NCT00819234|20793163|P6|COMPLETED|Overall Study||7
8438109|NCT00819234|20793164|P5|COMPLETED|Overall Study||12
8438110|NCT00819234|20793165|P4|COMPLETED|Overall Study||22
8438111|NCT00819234|20793166|P3|COMPLETED|Overall Study||28
8438112|NCT00819234|20793167|P2|COMPLETED|Overall Study||20
8438113|NCT00819234|20793168|P1|COMPLETED|Overall Study||21
8438114|NCT00819234|20793159|P10|STARTED|Overall Study||37
8438115|NCT00819234|20793160|P9|STARTED|Overall Study||37
8438116|NCT00819234|20793161|P8|STARTED|Overall Study||29
8438117|NCT00819234|20793162|P7|STARTED|Overall Study||13
8438118|NCT00819234|20793163|P6|STARTED|Overall Study||14
8438119|NCT00819234|20793164|P5|STARTED|Overall Study||13
8438120|NCT00819234|20793165|P4|STARTED|Overall Study||28
8438121|NCT00819234|20793166|P3|STARTED|Overall Study||36
8438122|NCT00819234|20793167|P2|STARTED|Overall Study||35
8438123|NCT00819234|20793168|P1|STARTED|Overall Study||31
8438124|NCT00819182|20793329|P3|NOT COMPLETED|Overall Study||1
8438125|NCT00819182|20793330|P2|NOT COMPLETED|Overall Study||8
8438126|NCT00819182|20793331|P1|NOT COMPLETED|Overall Study||13
8438127|NCT00819182|20793329|P3|COMPLETED|Overall Study||43
8438128|NCT00819182|20793330|P2|COMPLETED|Overall Study||78
8438129|NCT00819182|20793331|P1|COMPLETED|Overall Study||75
8438130|NCT00819182|20793329|P3|Week 16 Visit|Overall Study||43
8438131|NCT00819182|20793330|P2|Week 16 Visit|Overall Study||78
8438132|NCT00819182|20793331|P1|Week 16 Visit|Overall Study||75
8438133|NCT00819182|20793329|P3|STARTED|Overall Study|Consented participants allocated to this arm.|44
8438134|NCT00819182|20793330|P2|STARTED|Overall Study|Consented participants allocated to this arm.|86
8438135|NCT00819182|20793331|P1|STARTED|Overall Study|Consented participants allocated to this arm.|88
8438136|NCT00819156|20793367|P6|NOT COMPLETED|Overall Study||8
8438137|NCT00819156|20793368|P5|NOT COMPLETED|Overall Study||6
8438138|NCT00819156|20793369|P4|NOT COMPLETED|Overall Study||2
8438139|NCT00819156|20793370|P3|NOT COMPLETED|Overall Study||6
8438140|NCT00819156|20793371|P2|NOT COMPLETED|Overall Study||10
8438141|NCT00819156|20793372|P1|NOT COMPLETED|Overall Study||10
8438142|NCT00819156|20793367|P6|COMPLETED|Overall Study||23
8438143|NCT00819156|20793368|P5|COMPLETED|Overall Study||27
8438144|NCT00819156|20793369|P4|COMPLETED|Overall Study||28
8438145|NCT00819156|20793370|P3|COMPLETED|Overall Study||26
8438146|NCT00819156|20793371|P2|COMPLETED|Overall Study||23
8438147|NCT00819156|20793372|P1|COMPLETED|Overall Study||20
8438148|NCT00819156|20793367|P6|Randomised and Treated (ITT Population)|Overall Study||30
8438149|NCT00819156|20793368|P5|Randomised and Treated (ITT Population)|Overall Study||33
8438150|NCT00819156|20793369|P4|Randomised and Treated (ITT Population)|Overall Study||30
8438151|NCT00819156|20793370|P3|Randomised and Treated (ITT Population)|Overall Study||32
8438152|NCT00819156|20793371|P2|Randomised and Treated (ITT Population)|Overall Study||32
8438153|NCT00819156|20793372|P1|Randomised and Treated (ITT Population)|Overall Study||30
8438154|NCT00819156|20793367|P6|STARTED|Overall Study||31
8438155|NCT00819156|20793368|P5|STARTED|Overall Study||33
8438156|NCT00819156|20793369|P4|STARTED|Overall Study||30
8438157|NCT00819156|20793370|P3|STARTED|Overall Study||32
8438158|NCT00819156|20793371|P2|STARTED|Overall Study||33
8438159|NCT00819156|20793372|P1|STARTED|Overall Study||30
8438160|NCT00819091|20793462|P2|NOT COMPLETED|Overall Study||10
8438161|NCT00819091|20793463|P1|NOT COMPLETED|Overall Study||7
8438162|NCT00819091|20793462|P2|COMPLETED|Overall Study||151
8438163|NCT00819091|20793463|P1|COMPLETED|Overall Study||77
8438164|NCT00819091|20793462|P2|STARTED|Overall Study||161
8438165|NCT00819091|20793463|P1|STARTED|Overall Study||84
8438166|NCT00819052|20793489|P2|NOT COMPLETED|Overall Study||14
8438167|NCT00819052|20793490|P1|NOT COMPLETED|Overall Study||6
8438168|NCT00819052|20793489|P2|COMPLETED|Overall Study||281
8438169|NCT00819052|20793490|P1|COMPLETED|Overall Study||142
8438170|NCT00819052|20793489|P2|STARTED|Overall Study||295
8438171|NCT00819052|20793490|P1|STARTED|Overall Study||148
8438172|NCT00819039|20793605|P3|NOT COMPLETED|Overall Study||1
8438173|NCT00819039|20793606|P2|NOT COMPLETED|Overall Study||0
8438176|NCT00819039|20793606|P2|COMPLETED|Overall Study||27
8438177|NCT00819039|20793607|P1|COMPLETED|Overall Study||44
8438178|NCT00819039|20793605|P3|STARTED|Overall Study||25
8438179|NCT00819039|20793606|P2|STARTED|Overall Study||27
8438180|NCT00819039|20793607|P1|STARTED|Overall Study||46
8438181|NCT00819013|20793637|P4|NOT COMPLETED|Overall Study||4
8438182|NCT00819013|20793638|P3|NOT COMPLETED|Overall Study||5
8438183|NCT00819013|20793639|P2|NOT COMPLETED|Overall Study||1
8438184|NCT00819013|20793640|P1|NOT COMPLETED|Overall Study||3
8438185|NCT00819013|20793637|P4|COMPLETED|Overall Study||17
8438186|NCT00819013|20793638|P3|COMPLETED|Overall Study||16
8438187|NCT00819013|20793639|P2|COMPLETED|Overall Study||22
8438188|NCT00819013|20793640|P1|COMPLETED|Overall Study||19
8438189|NCT00819013|20793637|P4|STARTED|Overall Study||21
8438190|NCT00819013|20793638|P3|STARTED|Overall Study||21
8438191|NCT00819013|20793639|P2|STARTED|Overall Study||23
8438192|NCT00819013|20793640|P1|STARTED|Overall Study||22
8438193|NCT00818961|20793690|P1|NOT COMPLETED|Overall Study||0
8438194|NCT00818961|20793690|P1|COMPLETED|Overall Study||36
8438195|NCT00818961|20793690|P1|STARTED|Overall Study||36
8438196|NCT00818883|20793706|P2|NOT COMPLETED|Overall Study||46
8438197|NCT00818883|20793707|P1|NOT COMPLETED|Overall Study||51
8438198|NCT00818883|20793706|P2|COMPLETED|Overall Study||260
8438199|NCT00818883|20793707|P1|COMPLETED|Overall Study||252
8438200|NCT00818883|20793706|P2|STARTED|Overall Study||306
8438201|NCT00818883|20793707|P1|STARTED|Overall Study||303
8438202|NCT00818805|20793741|P2|NOT COMPLETED|Second Intervention||0
8438203|NCT00818805|20793742|P1|NOT COMPLETED|Second Intervention||0
8438204|NCT00818805|20793741|P2|COMPLETED|Second Intervention||25
8438205|NCT00818805|20793742|P1|COMPLETED|Second Intervention||25
8438206|NCT00818805|20793741|P2|STARTED|Second Intervention||25
8438207|NCT00818805|20793742|P1|STARTED|Second Intervention||25
8438208|NCT00818805|20793741|P2|NOT COMPLETED|First Intervention||0
8438209|NCT00818805|20793742|P1|NOT COMPLETED|First Intervention||0
8438210|NCT00818805|20793741|P2|COMPLETED|First Intervention||25
8438211|NCT00818805|20793742|P1|COMPLETED|First Intervention||25
8438212|NCT00818805|20793741|P2|STARTED|First Intervention||25
8438213|NCT00818805|20793742|P1|STARTED|First Intervention||25
8438214|NCT00818779|20793754|P2|NOT COMPLETED|Overall Study||1
8438215|NCT00818779|20793755|P1|NOT COMPLETED|Overall Study||6
8438216|NCT00818779|20793754|P2|COMPLETED|Overall Study||15
8438217|NCT00818779|20793755|P1|COMPLETED|Overall Study||16
8438218|NCT00818779|20793754|P2|STARTED|Overall Study||16
8438219|NCT00818779|20793755|P1|STARTED|Overall Study||22
8438220|NCT00818766|20793771|P2|NOT COMPLETED|Overall Study||10
8438221|NCT00818766|20793772|P1|NOT COMPLETED|Overall Study||15
8438222|NCT00818766|20793771|P2|COMPLETED|Overall Study||116
8438223|NCT00818766|20793772|P1|COMPLETED|Overall Study||110
8438224|NCT00818766|20793771|P2|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
8438225|NCT00818766|20793772|P1|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
8438226|NCT00818766|20793771|P2|Received Allocated Intervention|Overall Study||126
8438227|NCT00818766|20793772|P1|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
8438228|NCT00818766|20793771|P2|STARTED|Overall Study||126
8438229|NCT00818766|20793772|P1|STARTED|Overall Study||125
8438230|NCT00818753|20793801|P3|NOT COMPLETED|Overall Study||1
8438231|NCT00818753|20793802|P2|NOT COMPLETED|Overall Study||0
8438232|NCT00818753|20793803|P1|NOT COMPLETED|Overall Study||3
8438233|NCT00818753|20793801|P3|COMPLETED|Overall Study||9
8438234|NCT00818753|20793802|P2|COMPLETED|Overall Study||21
8438235|NCT00818753|20793803|P1|COMPLETED|Overall Study||19
8438236|NCT00818753|20793801|P3|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
8438237|NCT00818753|20793802|P2|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
8438238|NCT00818753|20793803|P1|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
8438251|NCT00818649|20793916|P1|NOT COMPLETED|Overall Study||4
8438252|NCT00818649|20793916|P1|COMPLETED|Overall Study||12
8438253|NCT00818649|20793916|P1|STARTED|Overall Study||16
8438254|NCT00818623|20793930|P8|NOT COMPLETED|Overall Study||1
8438255|NCT00818623|20793931|P7|NOT COMPLETED|Overall Study||4
8438256|NCT00818623|20793932|P6|NOT COMPLETED|Overall Study||3
8438257|NCT00818623|20793933|P5|NOT COMPLETED|Overall Study||4
8438258|NCT00818623|20793934|P4|NOT COMPLETED|Overall Study||5
8438259|NCT00818623|20793935|P3|NOT COMPLETED|Overall Study||4
8438260|NCT00818623|20793936|P2|NOT COMPLETED|Overall Study||4
8438261|NCT00818623|20793937|P1|NOT COMPLETED|Overall Study||2
8438262|NCT00818623|20793930|P8|COMPLETED|Overall Study||26
8438263|NCT00818623|20793931|P7|COMPLETED|Overall Study||23
8438264|NCT00818623|20793932|P6|COMPLETED|Overall Study||21
8438265|NCT00818623|20793933|P5|COMPLETED|Overall Study||23
8438266|NCT00818623|20793934|P4|COMPLETED|Overall Study||19
8438267|NCT00818623|20793935|P3|COMPLETED|Overall Study||9
8438268|NCT00818623|20793936|P2|COMPLETED|Overall Study||8
8438269|NCT00818623|20793937|P1|COMPLETED|Overall Study||24
8438270|NCT00818623|20793930|P8|Intent-to-treat (ITT) Population|Overall Study||27
8438271|NCT00818623|20793931|P7|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
8438272|NCT00818623|20793932|P6|Intent-to-treat (ITT) Population|Overall Study||24
8438273|NCT00818623|20793933|P5|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
8438274|NCT00818623|20793934|P4|Intent-to-treat (ITT) Population|Overall Study||24
8438275|NCT00818623|20793935|P3|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
8438276|NCT00818623|20793936|P2|Intent-to-treat (ITT) Population|Overall Study||12
8438277|NCT00818623|20793937|P1|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
8438278|NCT00818623|20793930|P8|STARTED|Overall Study||27
8438279|NCT00818623|20793931|P7|STARTED|Overall Study||27
8438280|NCT00818623|20793932|P6|STARTED|Overall Study||24
8438281|NCT00818623|20793933|P5|STARTED|Overall Study||27
8438282|NCT00818623|20793934|P4|STARTED|Overall Study||24
8438283|NCT00818623|20793935|P3|STARTED|Overall Study||13
8438284|NCT00818623|20793936|P2|STARTED|Overall Study||12
8438285|NCT00818623|20793937|P1|STARTED|Overall Study||26
8438286|NCT00818519|20794013|P2|NOT COMPLETED|Overall Study||19
8438287|NCT00818519|20794014|P1|NOT COMPLETED|Overall Study||14
8438288|NCT00818519|20794013|P2|COMPLETED|Overall Study||71
8438289|NCT00818519|20794014|P1|COMPLETED|Overall Study||75
8438290|NCT00818519|20794013|P2|Participants Received Treatment|Overall Study|= Baseline|86
8438291|NCT00818519|20794014|P1|Participants Received Treatment|Overall Study|= Baseline|87
8438292|NCT00818519|20794013|P2|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
8438293|NCT00818519|20794014|P1|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
8438294|NCT00818454|20794044|P4|NOT COMPLETED|Treatment Period 3||1
8438295|NCT00818454|20794045|P3|NOT COMPLETED|Treatment Period 3||0
8438296|NCT00818454|20794046|P2|NOT COMPLETED|Treatment Period 3||0
8438297|NCT00818454|20794047|P1|NOT COMPLETED|Treatment Period 3||0
8438298|NCT00818454|20794044|P4|COMPLETED|Treatment Period 3||138
8438299|NCT00818454|20794045|P3|COMPLETED|Treatment Period 3||26
8438300|NCT00818454|20794046|P2|COMPLETED|Treatment Period 3||0
8438301|NCT00818454|20794047|P1|COMPLETED|Treatment Period 3||0
8438302|NCT00818454|20794044|P4|STARTED|Treatment Period 3||139
8438303|NCT00818454|20794045|P3|STARTED|Treatment Period 3||26
8438304|NCT00818454|20794046|P2|STARTED|Treatment Period 3||0
8438305|NCT00818454|20794047|P1|STARTED|Treatment Period 3||0
8438306|NCT00818454|20794044|P4|NOT COMPLETED|Treatment Period 2||0
8438307|NCT00818454|20794045|P3|NOT COMPLETED|Treatment Period 2||0
8438308|NCT00818454|20794046|P2|NOT COMPLETED|Treatment Period 2||1
8438309|NCT00818454|20794047|P1|NOT COMPLETED|Treatment Period 2||2
8438310|NCT00818454|20794044|P4|COMPLETED|Treatment Period 2||0
8438311|NCT00818454|20794045|P3|COMPLETED|Treatment Period 2||0
8438312|NCT00818454|20794046|P2|COMPLETED|Treatment Period 2||106
8438313|NCT00818454|20794047|P1|COMPLETED|Treatment Period 2||106
8438314|NCT00818454|20794044|P4|STARTED|Treatment Period 2||0
8438315|NCT00818454|20794045|P3|STARTED|Treatment Period 2||0
8438316|NCT00818454|20794046|P2|STARTED|Treatment Period 2||107
8438317|NCT00818454|20794047|P1|STARTED|Treatment Period 2||108
8438318|NCT00818454|20794044|P4|NOT COMPLETED|Washout Period of 1 Week||0
8438319|NCT00818454|20794045|P3|NOT COMPLETED|Washout Period of 1 Week||0
8438320|NCT00818454|20794046|P2|NOT COMPLETED|Washout Period of 1 Week||3
8438321|NCT00818454|20794047|P1|NOT COMPLETED|Washout Period of 1 Week||4
8438322|NCT00818454|20794044|P4|COMPLETED|Washout Period of 1 Week||0
8438323|NCT00818454|20794045|P3|COMPLETED|Washout Period of 1 Week||0
8438324|NCT00818454|20794046|P2|COMPLETED|Washout Period of 1 Week||107
8438325|NCT00818454|20794047|P1|COMPLETED|Washout Period of 1 Week||108
8438326|NCT00818454|20794044|P4|STARTED|Washout Period of 1 Week||0
8438327|NCT00818454|20794045|P3|STARTED|Washout Period of 1 Week||0
8438328|NCT00818454|20794046|P2|STARTED|Washout Period of 1 Week||110
8438329|NCT00818454|20794047|P1|STARTED|Washout Period of 1 Week||112
8438330|NCT00818454|20794044|P4|NOT COMPLETED|Treatment Period 1||0
8438331|NCT00818454|20794045|P3|NOT COMPLETED|Treatment Period 1||0
8438332|NCT00818454|20794046|P2|NOT COMPLETED|Treatment Period 1||1
8438333|NCT00818454|20794047|P1|NOT COMPLETED|Treatment Period 1||3
8438334|NCT00818454|20794044|P4|COMPLETED|Treatment Period 1||0
8438335|NCT00818454|20794045|P3|COMPLETED|Treatment Period 1||0
8438336|NCT00818454|20794046|P2|COMPLETED|Treatment Period 1||110
8438337|NCT00818454|20794047|P1|COMPLETED|Treatment Period 1||112
8438338|NCT00818454|20794044|P4|STARTED|Treatment Period 1||0
8438339|NCT00818454|20794045|P3|STARTED|Treatment Period 1||0
8438340|NCT00818454|20794046|P2|STARTED|Treatment Period 1||111
8438341|NCT00818454|20794047|P1|STARTED|Treatment Period 1||115
8438342|NCT00818441|20794075|P2|NOT COMPLETED|Overall Study||30
8438343|NCT00818441|20794076|P1|NOT COMPLETED|Overall Study||89
8438344|NCT00818441|20794075|P2|COMPLETED|Overall Study||0
8438345|NCT00818441|20794076|P1|COMPLETED|Overall Study||0
8438346|NCT00818441|20794075|P2|STARTED|Overall Study||30
8438347|NCT00818441|20794076|P1|STARTED|Overall Study||89
8438348|NCT00818389|20794098|P2|NOT COMPLETED|Overall Study||6
8438349|NCT00818389|20794099|P1|NOT COMPLETED|Overall Study||4
8438350|NCT00818389|20794098|P2|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
8438351|NCT00818389|20794099|P1|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
8438352|NCT00818389|20794098|P2|STARTED|Overall Study||44
8438353|NCT00818389|20794099|P1|STARTED|Overall Study||40
8438354|NCT00818337|20794109|P1|NOT COMPLETED|Overall Study||0
8438355|NCT00818337|20794109|P1|COMPLETED|Overall Study||36
8438356|NCT00818337|20794109|P1|STARTED|Overall Study||36
8438357|NCT00818324|20794114|P1|NOT COMPLETED|Overall Study||27
8438358|NCT00818324|20794114|P1|COMPLETED|Overall Study||127
8438359|NCT00818324|20794114|P1|STARTED|Overall Study||154
8438360|NCT00818272|20794119|P1|NOT COMPLETED|Overall Study||74
8438361|NCT00818272|20794119|P1|COMPLETED|Overall Study||74
8438362|NCT00818272|20794119|P1|STARTED|Overall Study||148
8438363|NCT00818259|20794134|P9|NOT COMPLETED|Part V||0
8438364|NCT00818259|20794135|P8|NOT COMPLETED|Part V||1
8438365|NCT00818259|20794136|P7|NOT COMPLETED|Part V||0
8438366|NCT00818259|20794137|P6|NOT COMPLETED|Part V||0
8438367|NCT00818259|20794138|P5|NOT COMPLETED|Part V||0
8438368|NCT00818259|20794139|P4|NOT COMPLETED|Part V||0
8438369|NCT00818259|20794140|P3|NOT COMPLETED|Part V||0
8438370|NCT00818259|20794141|P2|NOT COMPLETED|Part V||0
8438371|NCT00818259|20794142|P1|NOT COMPLETED|Part V||0
8438372|NCT00818259|20794134|P9|COMPLETED|Part V||6
8438373|NCT00818259|20794135|P8|COMPLETED|Part V||16
8438374|NCT00818259|20794136|P7|COMPLETED|Part V||0
8438375|NCT00818259|20794137|P6|COMPLETED|Part V||0
8438376|NCT00818259|20794138|P5|COMPLETED|Part V||0
8438377|NCT00818259|20794139|P4|COMPLETED|Part V||0
8438378|NCT00818259|20794140|P3|COMPLETED|Part V||0
8438379|NCT00818259|20794141|P2|COMPLETED|Part V||0
8438380|NCT00818259|20794142|P1|COMPLETED|Part V||0
8438381|NCT00818259|20794134|P9|STARTED|Part V|Newly enrolled participants|6
8438382|NCT00818259|20794135|P8|STARTED|Part V|Participants continuing from Part IV|17
8438383|NCT00818259|20794136|P7|STARTED|Part V||0
8438384|NCT00818259|20794137|P6|STARTED|Part V||0
8438385|NCT00818259|20794138|P5|STARTED|Part V||0
8438386|NCT00818259|20794139|P4|STARTED|Part V||0
8438387|NCT00818259|20794140|P3|STARTED|Part V||0
8438388|NCT00818259|20794141|P2|STARTED|Part V||0
8438389|NCT00818259|20794142|P1|STARTED|Part V||0
8438390|NCT00818259|20794134|P9|NOT COMPLETED|Part IV||0
8438391|NCT00818259|20794135|P8|NOT COMPLETED|Part IV||0
8438392|NCT00818259|20794136|P7|NOT COMPLETED|Part IV||0
8438393|NCT00818259|20794137|P6|NOT COMPLETED|Part IV||1
8438394|NCT00818259|20794138|P5|NOT COMPLETED|Part IV||0
8438395|NCT00818259|20794139|P4|NOT COMPLETED|Part IV||0
8438396|NCT00818259|20794140|P3|NOT COMPLETED|Part IV||0
8438397|NCT00818259|20794141|P2|NOT COMPLETED|Part IV||0
8438398|NCT00818259|20794142|P1|NOT COMPLETED|Part IV||0
8438399|NCT00818259|20794134|P9|COMPLETED|Part IV||0
8438400|NCT00818259|20794135|P8|COMPLETED|Part IV||0
8438401|NCT00818259|20794136|P7|COMPLETED|Part IV||5
8438402|NCT00818259|20794137|P6|COMPLETED|Part IV||14
8438403|NCT00818259|20794138|P5|COMPLETED|Part IV||0
8438404|NCT00818259|20794139|P4|COMPLETED|Part IV||0
8438405|NCT00818259|20794140|P3|COMPLETED|Part IV||0
8438406|NCT00818259|20794141|P2|COMPLETED|Part IV||0
8438407|NCT00818259|20794142|P1|COMPLETED|Part IV||0
8438408|NCT00818259|20794134|P9|STARTED|Part IV||0
8438409|NCT00818259|20794135|P8|STARTED|Part IV||0
8438410|NCT00818259|20794136|P7|STARTED|Part IV|Newly enrolled participants|5
8438411|NCT00818259|20794137|P6|STARTED|Part IV|Participants continuing from Part III|15
8438412|NCT00818259|20794138|P5|STARTED|Part IV||0
8438413|NCT00818259|20794139|P4|STARTED|Part IV||0
8438414|NCT00818259|20794140|P3|STARTED|Part IV||0
8438415|NCT00818259|20794141|P2|STARTED|Part IV||0
8438416|NCT00818259|20794142|P1|STARTED|Part IV||0
8438417|NCT00818259|20794134|P9|NOT COMPLETED|Part III||0
8438418|NCT00818259|20794135|P8|NOT COMPLETED|Part III||0
8438419|NCT00818259|20794136|P7|NOT COMPLETED|Part III||0
8438420|NCT00818259|20794137|P6|NOT COMPLETED|Part III||0
8438421|NCT00818259|20794138|P5|NOT COMPLETED|Part III||0
8438422|NCT00818259|20794139|P4|NOT COMPLETED|Part III||0
8438423|NCT00818259|20794140|P3|NOT COMPLETED|Part III||0
8438424|NCT00818259|20794141|P2|NOT COMPLETED|Part III||0
8438425|NCT00818259|20794142|P1|NOT COMPLETED|Part III||0
8438426|NCT00818259|20794134|P9|COMPLETED|Part III||0
8438427|NCT00818259|20794135|P8|COMPLETED|Part III||0
8438428|NCT00818259|20794136|P7|COMPLETED|Part III||0
8438429|NCT00818259|20794137|P6|COMPLETED|Part III||0
8438430|NCT00818259|20794138|P5|COMPLETED|Part III||19
8438431|NCT00818259|20794139|P4|COMPLETED|Part III||0
8438432|NCT00818259|20794140|P3|COMPLETED|Part III||0
8438433|NCT00818259|20794141|P2|COMPLETED|Part III||0
8438434|NCT00818259|20794142|P1|COMPLETED|Part III||0
8438435|NCT00818259|20794134|P9|STARTED|Part III||0
8438436|NCT00818259|20794135|P8|STARTED|Part III||0
8438437|NCT00818259|20794136|P7|STARTED|Part III||0
8438438|NCT00818259|20794137|P6|STARTED|Part III||0
8438439|NCT00818259|20794138|P5|STARTED|Part III|Newly enrolled participants|19
8438440|NCT00818259|20794139|P4|STARTED|Part III||0
8438441|NCT00818259|20794140|P3|STARTED|Part III||0
8438442|NCT00818259|20794141|P2|STARTED|Part III||0
8438443|NCT00818259|20794142|P1|STARTED|Part III||0
8438444|NCT00818259|20794134|P9|NOT COMPLETED|Part II||0
8438445|NCT00818259|20794135|P8|NOT COMPLETED|Part II||0
8438446|NCT00818259|20794136|P7|NOT COMPLETED|Part II||0
8438447|NCT00818259|20794137|P6|NOT COMPLETED|Part II||0
8438448|NCT00818259|20794138|P5|NOT COMPLETED|Part II||0
8438449|NCT00818259|20794139|P4|NOT COMPLETED|Part II||2
8438450|NCT00818259|20794140|P3|NOT COMPLETED|Part II||1
8438451|NCT00818259|20794141|P2|NOT COMPLETED|Part II||0
8438452|NCT00818259|20794142|P1|NOT COMPLETED|Part II||0
8438453|NCT00818259|20794134|P9|COMPLETED|Part II||0
8438454|NCT00818259|20794135|P8|COMPLETED|Part II||0
8438455|NCT00818259|20794136|P7|COMPLETED|Part II||0
8438456|NCT00818259|20794137|P6|COMPLETED|Part II||0
8438457|NCT00818259|20794138|P5|COMPLETED|Part II||0
8438458|NCT00818259|20794139|P4|COMPLETED|Part II||18
8438459|NCT00818259|20794140|P3|COMPLETED|Part II||18
8438460|NCT00818259|20794141|P2|COMPLETED|Part II||0
8438461|NCT00818259|20794142|P1|COMPLETED|Part II||0
8438462|NCT00818259|20794134|P9|Treated|Part II||0
8438463|NCT00818259|20794135|P8|Treated|Part II||0
8438464|NCT00818259|20794136|P7|Treated|Part II||0
8438465|NCT00818259|20794137|P6|Treated|Part II||0
8438466|NCT00818259|20794138|P5|Treated|Part II||0
8438467|NCT00818259|20794139|P4|Treated|Part II||19
8438468|NCT00818259|20794140|P3|Treated|Part II||19
8438469|NCT00818259|20794141|P2|Treated|Part II||0
8438470|NCT00818259|20794142|P1|Treated|Part II||0
8438471|NCT00818259|20794134|P9|STARTED|Part II||0
8438472|NCT00818259|20794135|P8|STARTED|Part II||0
8438473|NCT00818259|20794136|P7|STARTED|Part II||0
8438474|NCT00818259|20794137|P6|STARTED|Part II||0
8438475|NCT00818259|20794138|P5|STARTED|Part II||0
8438476|NCT00818259|20794139|P4|STARTED|Part II|Newly enrolled participants|20
8438477|NCT00818259|20794140|P3|STARTED|Part II|Newly enrolled participants|19
8438478|NCT00818259|20794141|P2|STARTED|Part II||0
8438479|NCT00818259|20794142|P1|STARTED|Part II||0
8438480|NCT00818259|20794134|P9|NOT COMPLETED|Part I||0
8438481|NCT00818259|20794135|P8|NOT COMPLETED|Part I||0
8438482|NCT00818259|20794136|P7|NOT COMPLETED|Part I||0
8438483|NCT00818259|20794137|P6|NOT COMPLETED|Part I||0
8438484|NCT00818259|20794138|P5|NOT COMPLETED|Part I||0
8438485|NCT00818259|20794139|P4|NOT COMPLETED|Part I||0
8438486|NCT00818259|20794140|P3|NOT COMPLETED|Part I||0
8438487|NCT00818259|20794141|P2|NOT COMPLETED|Part I||0
8438488|NCT00818259|20794142|P1|NOT COMPLETED|Part I||1
8438489|NCT00818259|20794134|P9|COMPLETED|Part I||0
8438490|NCT00818259|20794135|P8|COMPLETED|Part I||0
8438491|NCT00818259|20794136|P7|COMPLETED|Part I||0
8438492|NCT00818259|20794137|P6|COMPLETED|Part I||0
8438493|NCT00818259|20794138|P5|COMPLETED|Part I||0
8438494|NCT00818259|20794139|P4|COMPLETED|Part I||0
8438495|NCT00818259|20794140|P3|COMPLETED|Part I||0
8438496|NCT00818259|20794141|P2|COMPLETED|Part I||11
8438497|NCT00818259|20794142|P1|COMPLETED|Part I||11
8438498|NCT00818259|20794134|P9|STARTED|Part I||0
8438499|NCT00818259|20794135|P8|STARTED|Part I||0
8438500|NCT00818259|20794136|P7|STARTED|Part I||0
8438501|NCT00818259|20794137|P6|STARTED|Part I||0
8438502|NCT00818259|20794138|P5|STARTED|Part I||0
8438503|NCT00818259|20794139|P4|STARTED|Part I||0
8438504|NCT00818259|20794140|P3|STARTED|Part I||0
8438505|NCT00818259|20794141|P2|STARTED|Part I|Newly enrolled participants|11
8438506|NCT00818259|20794142|P1|STARTED|Part I|Newly enrolled participants|12
8438507|NCT00818259|20794134|P9|NOT COMPLETED|Randomization||0
8438508|NCT00818259|20794135|P8|NOT COMPLETED|Randomization||0
8438509|NCT00818259|20794136|P7|NOT COMPLETED|Randomization||0
8438510|NCT00818259|20794137|P6|NOT COMPLETED|Randomization||0
8438511|NCT00818259|20794138|P5|NOT COMPLETED|Randomization||0
8438512|NCT00818259|20794139|P4|NOT COMPLETED|Randomization||0
8438513|NCT00818259|20794140|P3|NOT COMPLETED|Randomization||0
8438514|NCT00818259|20794141|P2|NOT COMPLETED|Randomization||0
8438515|NCT00818259|20794142|P1|NOT COMPLETED|Randomization||0
8438516|NCT00818259|20794134|P9|COMPLETED|Randomization||6
8438517|NCT00818259|20794135|P8|COMPLETED|Randomization||0
8438518|NCT00818259|20794136|P7|COMPLETED|Randomization||5
8438519|NCT00818259|20794137|P6|COMPLETED|Randomization||0
8438520|NCT00818259|20794138|P5|COMPLETED|Randomization||19
8438521|NCT00818259|20794139|P4|COMPLETED|Randomization||20
8438522|NCT00818259|20794140|P3|COMPLETED|Randomization||19
8438523|NCT00818259|20794141|P2|COMPLETED|Randomization||11
8438524|NCT00818259|20794142|P1|COMPLETED|Randomization||12
8438525|NCT00818259|20794134|P9|STARTED|Randomization||6
8438526|NCT00818259|20794135|P8|STARTED|Randomization||0
8438527|NCT00818259|20794136|P7|STARTED|Randomization||5
8438528|NCT00818259|20794137|P6|STARTED|Randomization||0
8438529|NCT00818259|20794138|P5|STARTED|Randomization||19
8438530|NCT00818259|20794139|P4|STARTED|Randomization||20
8438531|NCT00818259|20794140|P3|STARTED|Randomization||19
8438532|NCT00818259|20794141|P2|STARTED|Randomization||11
8438533|NCT00818259|20794142|P1|STARTED|Randomization||12
8438534|NCT00818246|20794214|P1|NOT COMPLETED|Overall Study||5
8438535|NCT00818246|20794214|P1|COMPLETED|Overall Study|split-face study|35
8438536|NCT00818246|20794214|P1|STARTED|Overall Study||40
8438537|NCT00818207|20794223|P2|NOT COMPLETED|Overall Study||267
8438538|NCT00818207|20794224|P1|NOT COMPLETED|Overall Study||222
8438539|NCT00818207|20794223|P2|COMPLETED|Overall Study||417
8438540|NCT00818207|20794224|P1|COMPLETED|Overall Study||474
8438541|NCT00818207|20794223|P2|STARTED|Overall Study||684
8438542|NCT00818207|20794224|P1|STARTED|Overall Study||696
8438543|NCT00818168|20794238|P1|NOT COMPLETED|Overall Study||70
8438544|NCT00818168|20794238|P1|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
8438545|NCT00818168|20794238|P1|STARTED|Overall Study||320
8438546|NCT00818116|20794246|P1|NOT COMPLETED|Overall Study||0
8438547|NCT00818116|20794246|P1|COMPLETED|Overall Study||34
8438548|NCT00818116|20794246|P1|STARTED|Overall Study||34
8438549|NCT00817999|20794252|P2|NOT COMPLETED|No Grapefruit Juice||0
8438550|NCT00817999|20794253|P1|NOT COMPLETED|No Grapefruit Juice||0
8438551|NCT00817999|20794252|P2|COMPLETED|No Grapefruit Juice||17
8438552|NCT00817999|20794253|P1|COMPLETED|No Grapefruit Juice||15
8438553|NCT00817999|20794252|P2|STARTED|No Grapefruit Juice||17
8438554|NCT00817999|20794253|P1|STARTED|No Grapefruit Juice||15
8438555|NCT00817999|20794252|P2|NOT COMPLETED|Grapefruit Juice||0
8438556|NCT00817999|20794253|P1|NOT COMPLETED|Grapefruit Juice||0
8438557|NCT00817999|20794252|P2|COMPLETED|Grapefruit Juice||17
8438558|NCT00817999|20794253|P1|COMPLETED|Grapefruit Juice||15
8438559|NCT00817999|20794252|P2|STARTED|Grapefruit Juice||17
8438560|NCT00817999|20794253|P1|STARTED|Grapefruit Juice||15
8438561|NCT00817843|20794261|P2|NOT COMPLETED|Second Period (6 Weeks)||1
8438562|NCT00817843|20794262|P1|NOT COMPLETED|Second Period (6 Weeks)||0
8438563|NCT00817843|20794261|P2|COMPLETED|Second Period (6 Weeks)||44
8438564|NCT00817843|20794262|P1|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
8438565|NCT00817843|20794261|P2|STARTED|Second Period (6 Weeks)||45
8438566|NCT00817843|20794262|P1|STARTED|Second Period (6 Weeks)||41
8438567|NCT00817843|20794261|P2|NOT COMPLETED|Washout Period (6 Weeks)||1
8438568|NCT00817843|20794262|P1|NOT COMPLETED|Washout Period (6 Weeks)||1
8438569|NCT00817843|20794261|P2|COMPLETED|Washout Period (6 Weeks)||45
8438570|NCT00817843|20794262|P1|COMPLETED|Washout Period (6 Weeks)||41
8438571|NCT00817843|20794261|P2|STARTED|Washout Period (6 Weeks)||46
8438572|NCT00817843|20794262|P1|STARTED|Washout Period (6 Weeks)||42
8438573|NCT00817843|20794261|P2|NOT COMPLETED|First Period (6 Weeks)||4
8438574|NCT00817843|20794262|P1|NOT COMPLETED|First Period (6 Weeks)||8
8438575|NCT00817843|20794261|P2|COMPLETED|First Period (6 Weeks)||46
8438576|NCT00817843|20794262|P1|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
8438577|NCT00817843|20794261|P2|STARTED|First Period (6 Weeks)||50
8438578|NCT00817843|20794262|P1|STARTED|First Period (6 Weeks)||50
8438579|NCT00817804|20794269|P2|NOT COMPLETED|Overall Study||0
8438580|NCT00817804|20794270|P1|NOT COMPLETED|Overall Study||0
8438581|NCT00817804|20794269|P2|COMPLETED|Overall Study||2
8438582|NCT00817804|20794270|P1|COMPLETED|Overall Study||1
8438583|NCT00817804|20794269|P2|STARTED|Overall Study||2
8438584|NCT00817804|20794270|P1|STARTED|Overall Study||1
8438585|NCT00817778|20794278|P2|NOT COMPLETED|Overall Study||3
8438586|NCT00817778|20794279|P1|NOT COMPLETED|Overall Study||3
8438587|NCT00817778|20794278|P2|COMPLETED|Overall Study||5
8438588|NCT00817778|20794279|P1|COMPLETED|Overall Study||16
8438589|NCT00817778|20794278|P2|STARTED|Overall Study||8
8438590|NCT00817778|20794279|P1|STARTED|Overall Study||19
8438591|NCT00817596|20794304|P1|NOT COMPLETED|Overall Study||48
8438592|NCT00817596|20794304|P1|COMPLETED|Overall Study||62
8438593|NCT00817596|20794304|P1|STARTED|Overall Study||110
8438594|NCT00817531|20794308|P1|NOT COMPLETED|Overall Study||2
8438595|NCT00817531|20794308|P1|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
8438596|NCT00817531|20794308|P1|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
8438597|NCT00817479|20794314|P2|NOT COMPLETED|Overall Study||1
8438598|NCT00817479|20794315|P1|NOT COMPLETED|Overall Study||1
8438599|NCT00817479|20794314|P2|COMPLETED|Overall Study||13
8438600|NCT00817479|20794315|P1|COMPLETED|Overall Study||5
8438601|NCT00817479|20794314|P2|STARTED|Overall Study||14
8438602|NCT00817479|20794315|P1|STARTED|Overall Study||6
8438603|NCT00817336|20794325|P2|NOT COMPLETED|Overall Study||1
8438604|NCT00817336|20794326|P1|NOT COMPLETED|Overall Study||1
8438605|NCT00817336|20794325|P2|COMPLETED|Overall Study||7
8438606|NCT00817336|20794326|P1|COMPLETED|Overall Study||7
8438607|NCT00817336|20794325|P2|STARTED|Overall Study||8
8438608|NCT00817336|20794326|P1|STARTED|Overall Study||8
8438609|NCT00817219|20794337|P1|NOT COMPLETED|Overall Study||0
8438610|NCT00817219|20794337|P1|COMPLETED|Overall Study||33
8438611|NCT00817219|20794337|P1|STARTED|Overall Study||33
8438612|NCT00817206|20794352|P2|NOT COMPLETED|Overall Study||9
8438613|NCT00817206|20794353|P1|NOT COMPLETED|Overall Study||21
8438614|NCT00817206|20794352|P2|COMPLETED|Overall Study||154
8438615|NCT00817206|20794353|P1|COMPLETED|Overall Study||142
8438616|NCT00817206|20794352|P2|STARTED|Overall Study||163
8438617|NCT00817206|20794353|P1|STARTED|Overall Study||163
8438618|NCT00817089|20794363|P4|NOT COMPLETED|Second Alcohol Challenge||0
8438619|NCT00817089|20794364|P3|NOT COMPLETED|Second Alcohol Challenge||0
8438620|NCT00817089|20794365|P2|NOT COMPLETED|Second Alcohol Challenge||1
8438621|NCT00817089|20794366|P1|NOT COMPLETED|Second Alcohol Challenge||0
8438622|NCT00817089|20794363|P4|COMPLETED|Second Alcohol Challenge||5
8438623|NCT00817089|20794364|P3|COMPLETED|Second Alcohol Challenge||4
8438624|NCT00817089|20794365|P2|COMPLETED|Second Alcohol Challenge||7
8438625|NCT00817089|20794366|P1|COMPLETED|Second Alcohol Challenge||6
8438626|NCT00817089|20794363|P4|STARTED|Second Alcohol Challenge||5
8438627|NCT00817089|20794364|P3|STARTED|Second Alcohol Challenge||4
8438628|NCT00817089|20794365|P2|STARTED|Second Alcohol Challenge||8
8438629|NCT00817089|20794366|P1|STARTED|Second Alcohol Challenge||6
8438630|NCT00817089|20794363|P4|NOT COMPLETED|First Alcohol Challenge||1
8438631|NCT00817089|20794364|P3|NOT COMPLETED|First Alcohol Challenge||0
8438632|NCT00817089|20794365|P2|NOT COMPLETED|First Alcohol Challenge||0
8438633|NCT00817089|20794366|P1|NOT COMPLETED|First Alcohol Challenge||0
8438634|NCT00817089|20794363|P4|COMPLETED|First Alcohol Challenge||5
8438635|NCT00817089|20794364|P3|COMPLETED|First Alcohol Challenge||4
8438636|NCT00817089|20794365|P2|COMPLETED|First Alcohol Challenge||8
8438637|NCT00817089|20794366|P1|COMPLETED|First Alcohol Challenge||6
8438638|NCT00817089|20794363|P4|STARTED|First Alcohol Challenge||6
8438639|NCT00817089|20794364|P3|STARTED|First Alcohol Challenge||4
8438640|NCT00817089|20794365|P2|STARTED|First Alcohol Challenge||8
8438641|NCT00817089|20794366|P1|STARTED|First Alcohol Challenge||6
8438642|NCT00817063|20794382|P2|NOT COMPLETED|Overall Study||170
8438643|NCT00817063|20794383|P1|NOT COMPLETED|Overall Study||137
8438644|NCT00817063|20794382|P2|COMPLETED|Overall Study||128
8438645|NCT00817063|20794383|P1|COMPLETED|Overall Study||161
8438646|NCT00817063|20794382|P2|STARTED|Overall Study||298
8438647|NCT00817063|20794383|P1|STARTED|Overall Study||298
8438648|NCT00816907|20794427|P2|NOT COMPLETED|Overall Study||17
8438649|NCT00816907|20794428|P1|NOT COMPLETED|Overall Study||13
8438650|NCT00816907|20794427|P2|COMPLETED|Overall Study||58
8438651|NCT00816907|20794428|P1|COMPLETED|Overall Study||58
8438652|NCT00816907|20794427|P2|STARTED|Overall Study||75
8438653|NCT00816907|20794428|P1|STARTED|Overall Study||71
8438654|NCT00816829|20794450|P2|NOT COMPLETED|Overall Study||0
8438655|NCT00816829|20794451|P1|NOT COMPLETED|Overall Study||0
8438656|NCT00816829|20794450|P2|COMPLETED|Overall Study||18
8438657|NCT00816829|20794451|P1|COMPLETED|Overall Study||16
8438658|NCT00816829|20794450|P2|STARTED|Overall Study||18
8438659|NCT00816829|20794451|P1|STARTED|Overall Study||16
8438660|NCT00816777|20794477|P2|NOT COMPLETED|Overall Study||0
8438661|NCT00816777|20794478|P1|NOT COMPLETED|Overall Study||0
8438662|NCT00816777|20794477|P2|COMPLETED|Overall Study||2
8438663|NCT00816777|20794478|P1|COMPLETED|Overall Study||2
8438664|NCT00816777|20794477|P2|STARTED|Overall Study||2
8438665|NCT00816777|20794478|P1|STARTED|Overall Study||2
8438666|NCT00816751|20794500|P2|NOT COMPLETED|Overall Study||0
8438667|NCT00816751|20794501|P1|NOT COMPLETED|Overall Study||0
8438668|NCT00816751|20794500|P2|COMPLETED|Overall Study||44
8438669|NCT00816751|20794501|P1|COMPLETED|Overall Study||45
8438670|NCT00816751|20794500|P2|STARTED|Overall Study||44
8438671|NCT00816751|20794501|P1|STARTED|Overall Study||45
8438672|NCT00816595|20794511|P2|NOT COMPLETED|Overall Study||0
8438673|NCT00816595|20794512|P1|NOT COMPLETED|Overall Study||2
8438674|NCT00816595|20794511|P2|COMPLETED|Overall Study||33
8438675|NCT00816595|20794512|P1|COMPLETED|Overall Study||33
8438676|NCT00816595|20794511|P2|STARTED|Overall Study||33
8438677|NCT00816595|20794512|P1|STARTED|Overall Study||35
8438678|NCT00816556|20794525|P3|NOT COMPLETED|Overall Study||3
8438679|NCT00816556|20794526|P2|NOT COMPLETED|Overall Study||2
8438680|NCT00816556|20794527|P1|NOT COMPLETED|Overall Study||2
8438681|NCT00816556|20794525|P3|COMPLETED|Overall Study||19
8438682|NCT00816556|20794526|P2|COMPLETED|Overall Study||19
8438683|NCT00816556|20794527|P1|COMPLETED|Overall Study||18
8438684|NCT00816556|20794525|P3|STARTED|Overall Study||22
8438685|NCT00816556|20794526|P2|STARTED|Overall Study||21
8438686|NCT00816556|20794527|P1|STARTED|Overall Study||20
8438687|NCT00816400|20794550|P9|NOT COMPLETED|Overall Study||6
8438688|NCT00816400|20794551|P8|NOT COMPLETED|Overall Study||5
8438689|NCT00816400|20794552|P7|NOT COMPLETED|Overall Study||2
8438690|NCT00816400|20794553|P6|NOT COMPLETED|Overall Study||3
8438691|NCT00816400|20794554|P5|NOT COMPLETED|Overall Study||2
8438692|NCT00816400|20794555|P4|NOT COMPLETED|Overall Study||3
8438693|NCT00816400|20794556|P3|NOT COMPLETED|Overall Study||5
8438694|NCT00816400|20794557|P2|NOT COMPLETED|Overall Study||3
8438695|NCT00816400|20794558|P1|NOT COMPLETED|Overall Study||2
8438696|NCT00816400|20794550|P9|COMPLETED|Overall Study||0
8438697|NCT00816400|20794551|P8|COMPLETED|Overall Study||1
8438698|NCT00816400|20794552|P7|COMPLETED|Overall Study||1
8438699|NCT00816400|20794553|P6|COMPLETED|Overall Study||0
8438700|NCT00816400|20794554|P5|COMPLETED|Overall Study||1
8438701|NCT00816400|20794555|P4|COMPLETED|Overall Study||0
8438702|NCT00816400|20794556|P3|COMPLETED|Overall Study||0
8438703|NCT00816400|20794557|P2|COMPLETED|Overall Study||0
8438704|NCT00816400|20794558|P1|COMPLETED|Overall Study||1
8438705|NCT00816400|20794550|P9|STARTED|Overall Study||6
8438706|NCT00816400|20794551|P8|STARTED|Overall Study||6
8438707|NCT00816400|20794552|P7|STARTED|Overall Study||3
8438708|NCT00816400|20794553|P6|STARTED|Overall Study||3
8438709|NCT00816400|20794554|P5|STARTED|Overall Study||3
8438710|NCT00816400|20794555|P4|STARTED|Overall Study||3
8438711|NCT00816400|20794556|P3|STARTED|Overall Study||5
8438712|NCT00816400|20794557|P2|STARTED|Overall Study||3
8438713|NCT00816400|20794558|P1|STARTED|Overall Study||3
8438714|NCT00816361|20794749|P9|NOT COMPLETED|Overall Study||10
8438715|NCT00816361|20794750|P8|NOT COMPLETED|Overall Study||9
8438716|NCT00816361|20794751|P7|NOT COMPLETED|Overall Study||3
8438717|NCT00816361|20794752|P6|NOT COMPLETED|Overall Study||3
8438718|NCT00816361|20794753|P5|NOT COMPLETED|Overall Study||2
8438719|NCT00816361|20794754|P4|NOT COMPLETED|Overall Study||3
8438720|NCT00816361|20794755|P3|NOT COMPLETED|Overall Study||3
8438721|NCT00816361|20794756|P2|NOT COMPLETED|Overall Study||3
8438722|NCT00816361|20794757|P1|NOT COMPLETED|Overall Study||4
8438723|NCT00816361|20794749|P9|COMPLETED|Overall Study||0
8438724|NCT00816361|20794750|P8|COMPLETED|Overall Study||1
8438725|NCT00816361|20794751|P7|COMPLETED|Overall Study||0
8438726|NCT00816361|20794752|P6|COMPLETED|Overall Study||0
8438727|NCT00816361|20794753|P5|COMPLETED|Overall Study||1
8438728|NCT00816361|20794754|P4|COMPLETED|Overall Study||0
8438729|NCT00816361|20794755|P3|COMPLETED|Overall Study||1
8438730|NCT00816361|20794756|P2|COMPLETED|Overall Study||0
8438731|NCT00816361|20794757|P1|COMPLETED|Overall Study||0
8438732|NCT00816361|20794749|P9|STARTED|Overall Study||10
8438733|NCT00816361|20794750|P8|STARTED|Overall Study||10
8438734|NCT00816361|20794751|P7|STARTED|Overall Study||3
8438735|NCT00816361|20794752|P6|STARTED|Overall Study||3
8438736|NCT00816361|20794753|P5|STARTED|Overall Study||3
8438737|NCT00816361|20794754|P4|STARTED|Overall Study||3
8438738|NCT00816361|20794755|P3|STARTED|Overall Study||4
8438739|NCT00816361|20794756|P2|STARTED|Overall Study||3
8438740|NCT00816361|20794757|P1|STARTED|Overall Study||4
8438741|NCT00816348|20794910|P1|NOT COMPLETED|Overall Study||0
8438742|NCT00816348|20794910|P1|COMPLETED|Overall Study||15
8438743|NCT00816348|20794910|P1|STARTED|Overall Study||15
8438744|NCT00816166|20794916|P2|NOT COMPLETED|Overall Study||12
8438745|NCT00816166|20794917|P1|NOT COMPLETED|Overall Study||10
8438746|NCT00816166|20794916|P2|COMPLETED|Overall Study||41
8438747|NCT00816166|20794917|P1|COMPLETED|Overall Study||49
8438748|NCT00816166|20794916|P2|ITT Population (Met Eligibility)|Overall Study||53
8438749|NCT00816166|20794917|P1|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
8438750|NCT00816166|20794916|P2|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
8438751|NCT00816166|20794917|P1|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
8438752|NCT00816101|20794926|P3|NOT COMPLETED|Overall Study||0
8438753|NCT00816101|20794927|P2|NOT COMPLETED|Overall Study||0
8438754|NCT00816101|20794928|P1|NOT COMPLETED|Overall Study||0
8438755|NCT00816101|20794926|P3|COMPLETED|Overall Study||5
8438756|NCT00816101|20794927|P2|COMPLETED|Overall Study||8
8438757|NCT00816101|20794928|P1|COMPLETED|Overall Study||13
8438758|NCT00816101|20794926|P3|STARTED|Overall Study||5
8438759|NCT00816101|20794927|P2|STARTED|Overall Study||8
8438760|NCT00816101|20794928|P1|STARTED|Overall Study||13
8438761|NCT00816062|20794942|P1|NOT COMPLETED|Overall Study||127
8438762|NCT00816062|20794942|P1|COMPLETED|Overall Study||133
8438763|NCT00816062|20794942|P1|STARTED|Overall Study||260
8438764|NCT00816036|20794949|P2|NOT COMPLETED|Overall Study||108
8438765|NCT00816036|20794950|P1|NOT COMPLETED|Overall Study||176
8438766|NCT00816036|20794949|P2|COMPLETED|Overall Study||287
8438767|NCT00816036|20794950|P1|COMPLETED|Overall Study||327
8438768|NCT00816036|20794949|P2|STARTED|Overall Study||395
8438769|NCT00816036|20794950|P1|STARTED|Overall Study||503
8438770|NCT00816023|20794964|P4|NOT COMPLETED|Overall Study||12
8438771|NCT00816023|20794965|P3|NOT COMPLETED|Overall Study||9
8438772|NCT00816023|20794966|P2|NOT COMPLETED|Overall Study||6
8438773|NCT00816023|20794967|P1|NOT COMPLETED|Overall Study||9
8438774|NCT00816023|20794964|P4|COMPLETED|Overall Study||62
8438775|NCT00816023|20794965|P3|COMPLETED|Overall Study||60
8438776|NCT00816023|20794966|P2|COMPLETED|Overall Study||56
8438777|NCT00816023|20794967|P1|COMPLETED|Overall Study||62
8438778|NCT00816023|20794964|P4|Completed Therapy|Overall Study||63
8438779|NCT00816023|20794965|P3|Completed Therapy|Overall Study||61
8438780|NCT00816023|20794966|P2|Completed Therapy|Overall Study||59
8438781|NCT00816023|20794967|P1|Completed Therapy|Overall Study||65
8438782|NCT00816023|20794964|P4|STARTED|Overall Study||74
8438783|NCT00816023|20794965|P3|STARTED|Overall Study||69
8438784|NCT00816023|20794966|P2|STARTED|Overall Study||62
8438785|NCT00816023|20794967|P1|STARTED|Overall Study||71
8438786|NCT00815997|20794983|P2|NOT COMPLETED|Overall Study||0
8438787|NCT00815997|20794984|P1|NOT COMPLETED|Overall Study||0
8438788|NCT00815997|20794983|P2|COMPLETED|Overall Study||80
8438789|NCT00815997|20794984|P1|COMPLETED|Overall Study||80
8438790|NCT00815997|20794983|P2|STARTED|Overall Study||80
8438791|NCT00815997|20794984|P1|STARTED|Overall Study||80
8438792|NCT00815919|20795004|P1|NOT COMPLETED|Overall Study||4
8438793|NCT00815919|20795004|P1|COMPLETED|Overall Study||18
8438794|NCT00815919|20795004|P1|STARTED|Overall Study||22
8438795|NCT00815776|20795015|P3|NOT COMPLETED|Overall Study||6
8438796|NCT00815776|20795016|P2|NOT COMPLETED|Overall Study||8
8438797|NCT00815776|20795017|P1|NOT COMPLETED|Overall Study||8
8438798|NCT00815776|20795015|P3|COMPLETED|Overall Study||22
8438799|NCT00815776|20795016|P2|COMPLETED|Overall Study||56
8438800|NCT00815776|20795017|P1|COMPLETED|Overall Study||52
8438801|NCT00815776|20795015|P3|STARTED|Overall Study||28
8438802|NCT00815776|20795016|P2|STARTED|Overall Study||64
8438803|NCT00815776|20795017|P1|STARTED|Overall Study||60
8438804|NCT00815698|20795033|P2|NOT COMPLETED|Overall Study||0
8438805|NCT00815698|20795034|P1|NOT COMPLETED|Overall Study||0
8438806|NCT00815698|20795033|P2|COMPLETED|Overall Study||171
8438807|NCT00815698|20795034|P1|COMPLETED|Overall Study||163
8438808|NCT00815698|20795033|P2|STARTED|Overall Study||171
8438809|NCT00815698|20795034|P1|STARTED|Overall Study||163
8438810|NCT00815685|20795042|P1|NOT COMPLETED|Overall Study||22
8438811|NCT00815685|20795042|P1|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
8438812|NCT00815685|20795042|P1|STARTED|Overall Study||36
8438813|NCT00815659|20795047|P1|NOT COMPLETED|Overall Study||23
8438814|NCT00815659|20795047|P1|COMPLETED|Overall Study||74
8438815|NCT00815659|20795047|P1|STARTED|Overall Study||97
8438816|NCT00815633|20795090|P1|NOT COMPLETED|Overall Study||1
8438817|NCT00815633|20795090|P1|COMPLETED|Overall Study||0
8438818|NCT00815633|20795090|P1|STARTED|Overall Study||1
8438819|NCT00815516|20795097|P2|NOT COMPLETED|Overall Study||1
8438820|NCT00815516|20795098|P1|NOT COMPLETED|Overall Study||4
8438821|NCT00815516|20795097|P2|COMPLETED|Overall Study||9
8438822|NCT00815516|20795098|P1|COMPLETED|Overall Study||16
8438823|NCT00815516|20795097|P2|STARTED|Overall Study||10
8438824|NCT00815516|20795098|P1|STARTED|Overall Study||20
8438825|NCT00815490|20795129|P2|NOT COMPLETED|Overall Study||0
8438826|NCT00815490|20795130|P1|NOT COMPLETED|Overall Study||0
8438827|NCT00815490|20795129|P2|COMPLETED|Overall Study||9
8438828|NCT00815490|20795130|P1|COMPLETED|Overall Study||9
8438829|NCT00815490|20795129|P2|STARTED|Overall Study||9
8438830|NCT00815490|20795130|P1|STARTED|Overall Study||9
8438831|NCT00815360|20795138|P2|NOT COMPLETED|Overall Study||0
8438832|NCT00815360|20795139|P1|NOT COMPLETED|Overall Study||0
8438833|NCT00815360|20795138|P2|COMPLETED|Overall Study||11
8438834|NCT00815360|20795139|P1|COMPLETED|Overall Study||11
8438835|NCT00815360|20795138|P2|STARTED|Overall Study||11
8438836|NCT00815360|20795139|P1|STARTED|Overall Study||11
8438837|NCT00815347|20795147|P1|NOT COMPLETED|Overall Study||4
8438838|NCT00815347|20795147|P1|COMPLETED|Overall Study||7
8438839|NCT00815347|20795147|P1|STARTED|Overall Study||11
8438840|NCT00815308|20795163|P1|NOT COMPLETED|Overall Study||10
8438841|NCT00815308|20795163|P1|COMPLETED|Overall Study||45
8438842|NCT00815308|20795163|P1|STARTED|Overall Study||55
8438843|NCT00815295|20795172|P3|NOT COMPLETED|Overall Study||3
8438844|NCT00815295|20795173|P2|NOT COMPLETED|Overall Study||1
8438845|NCT00815295|20795174|P1|NOT COMPLETED|Overall Study||0
8438846|NCT00815295|20795172|P3|COMPLETED|Overall Study||9
8438847|NCT00815295|20795173|P2|COMPLETED|Overall Study||7
8438848|NCT00815295|20795174|P1|COMPLETED|Overall Study||8
8438849|NCT00815295|20795172|P3|STARTED|Overall Study||12
8438850|NCT00815295|20795173|P2|STARTED|Overall Study||8
8438851|NCT00815295|20795174|P1|STARTED|Overall Study||8
8438852|NCT00815191|20795186|P2|NOT COMPLETED|Overall Study||1
8438853|NCT00815191|20795187|P1|NOT COMPLETED|Overall Study||1
8438854|NCT00815191|20795186|P2|COMPLETED|Overall Study||34
8438855|NCT00815191|20795187|P1|COMPLETED|Overall Study||37
8438856|NCT00815191|20795186|P2|STARTED|Overall Study||35
8438857|NCT00815191|20795187|P1|STARTED|Overall Study||38
8438858|NCT00815087|20795195|P2|NOT COMPLETED|Overall Study||0
8438859|NCT00815087|20795196|P1|NOT COMPLETED|Overall Study||0
8438860|NCT00815087|20795195|P2|COMPLETED|Overall Study||10
8438861|NCT00815087|20795196|P1|COMPLETED|Overall Study||10
8438862|NCT00815087|20795195|P2|STARTED|Overall Study||10
8438863|NCT00815087|20795196|P1|STARTED|Overall Study||10
8438864|NCT00815035|20795204|P3|NOT COMPLETED|Open Label Extension Phase||6
8438865|NCT00815035|20795205|P2|NOT COMPLETED|Open Label Extension Phase||0
8438866|NCT00815035|20795206|P1|NOT COMPLETED|Open Label Extension Phase||0
8438867|NCT00815035|20795204|P3|COMPLETED|Open Label Extension Phase||9
8438868|NCT00815035|20795205|P2|COMPLETED|Open Label Extension Phase||0
8438869|NCT00815035|20795206|P1|COMPLETED|Open Label Extension Phase||0
8438870|NCT00815035|20795204|P3|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
8438871|NCT00815035|20795205|P2|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
8438872|NCT00815035|20795206|P1|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
8438873|NCT00815035|20795204|P3|NOT COMPLETED|Blinded Phase||0
8438874|NCT00815035|20795205|P2|NOT COMPLETED|Blinded Phase||0
8438875|NCT00815035|20795206|P1|NOT COMPLETED|Blinded Phase||1
8438876|NCT00815035|20795204|P3|COMPLETED|Blinded Phase||0
8438877|NCT00815035|20795205|P2|COMPLETED|Blinded Phase||6
8438878|NCT00815035|20795206|P1|COMPLETED|Blinded Phase||9
8438879|NCT00815035|20795204|P3|STARTED|Blinded Phase||0
8438880|NCT00815035|20795205|P2|STARTED|Blinded Phase||6
8438881|NCT00815035|20795206|P1|STARTED|Blinded Phase||10
8438882|NCT00814983|20795224|P2|NOT COMPLETED|Overall Study||0
8438883|NCT00814983|20795225|P1|NOT COMPLETED|Overall Study||3
8438884|NCT00814983|20795224|P2|COMPLETED|Overall Study||0
8438885|NCT00814983|20795225|P1|COMPLETED|Overall Study||12
8438886|NCT00814983|20795224|P2|STARTED|Overall Study||0
8438887|NCT00814983|20795225|P1|STARTED|Overall Study||15
8438888|NCT00814970|20795235|P1|NOT COMPLETED|Overall Study||50
8438889|NCT00814970|20795235|P1|COMPLETED|Overall Study||146
8438890|NCT00814970|20795235|P1|STARTED|Overall Study||196
8438891|NCT00814892|20795256|P1|NOT COMPLETED|Overall Study||2
8438892|NCT00814892|20795256|P1|COMPLETED|Overall Study||0
8438893|NCT00814892|20795256|P1|STARTED|Overall Study||2
8438894|NCT00814879|20795268|P2|NOT COMPLETED|By Week 48||3
8438895|NCT00814879|20795269|P1|NOT COMPLETED|By Week 48||2
8438896|NCT00814879|20795268|P2|COMPLETED|By Week 48||26
8438897|NCT00814879|20795269|P1|COMPLETED|By Week 48||25
8438898|NCT00814879|20795268|P2|STARTED|By Week 48||29
8438899|NCT00814879|20795269|P1|STARTED|By Week 48||27
8438900|NCT00814879|20795268|P2|NOT COMPLETED|By Week 24||1
8438901|NCT00814879|20795269|P1|NOT COMPLETED|By Week 24||1
8438902|NCT00814879|20795268|P2|COMPLETED|By Week 24||29
8438903|NCT00814879|20795269|P1|COMPLETED|By Week 24||27
8438904|NCT00814879|20795268|P2|STARTED|By Week 24||30
8438905|NCT00814879|20795269|P1|STARTED|By Week 24||28
8438906|NCT00814801|20795288|P3|NOT COMPLETED|Overall Study||43
8438907|NCT00814801|20795289|P2|NOT COMPLETED|Overall Study||38
8438908|NCT00814801|20795290|P1|NOT COMPLETED|Overall Study||34
8438909|NCT00814801|20795288|P3|COMPLETED|Overall Study||151
8438910|NCT00814801|20795289|P2|COMPLETED|Overall Study||154
8438911|NCT00814801|20795290|P1|COMPLETED|Overall Study||160
8438912|NCT00814801|20795288|P3|STARTED|Overall Study||194
8438913|NCT00814801|20795289|P2|STARTED|Overall Study||192
8438914|NCT00814801|20795290|P1|STARTED|Overall Study||194
8438915|NCT00814788|20795310|P1|NOT COMPLETED|Overall Study||0
8438916|NCT00814788|20795310|P1|COMPLETED|Overall Study||24
8438917|NCT00814788|20795310|P1|STARTED|Overall Study||24
8438918|NCT00814775|20795318|P2|NOT COMPLETED|Overall Study||0
8438919|NCT00814775|20795319|P1|NOT COMPLETED|Overall Study||0
8438920|NCT00814775|20795318|P2|COMPLETED|Overall Study||20
8438921|NCT00814775|20795319|P1|COMPLETED|Overall Study||23
8438922|NCT00814775|20795318|P2|STARTED|Overall Study||20
8438923|NCT00814775|20795319|P1|STARTED|Overall Study||23
8438924|NCT00814710|20795329|P2|NOT COMPLETED|Overall Study||3
8438925|NCT00814710|20795330|P1|NOT COMPLETED|Overall Study||8
8438926|NCT00814710|20795329|P2|COMPLETED|Overall Study||117
8438927|NCT00814710|20795330|P1|COMPLETED|Overall Study||232
8438928|NCT00814710|20795329|P2|STARTED|Overall Study||120
8438929|NCT00814710|20795330|P1|STARTED|Overall Study||240
8438930|NCT00814697|20795368|P1|NOT COMPLETED|Overall Study||0
8438931|NCT00814697|20795368|P1|COMPLETED|Overall Study||12
8438932|NCT00814697|20795368|P1|STARTED|Overall Study||12
8438933|NCT00814671|20795375|P3|NOT COMPLETED|Overall Study||2
8438934|NCT00814671|20795376|P2|NOT COMPLETED|Overall Study||4
8438935|NCT00814671|20795377|P1|NOT COMPLETED|Overall Study||7
8438936|NCT00814671|20795375|P3|COMPLETED|Overall Study||49
8438937|NCT00814671|20795376|P2|COMPLETED|Overall Study||44
8438938|NCT00814671|20795377|P1|COMPLETED|Overall Study||47
8438939|NCT00814671|20795375|P3|STARTED|Overall Study||51
8438940|NCT00814671|20795376|P2|STARTED|Overall Study||48
8438941|NCT00814671|20795377|P1|STARTED|Overall Study||54
8438942|NCT00814658|20795398|P2|NOT COMPLETED|Overall Study||4
8438943|NCT00814658|20795399|P1|NOT COMPLETED|Overall Study||4
8438944|NCT00814658|20795398|P2|COMPLETED|Overall Study||8
8438945|NCT00814658|20795399|P1|COMPLETED|Overall Study||5
8438946|NCT00814658|20795398|P2|STARTED|Overall Study||12
8438947|NCT00814658|20795399|P1|STARTED|Overall Study||9
8438948|NCT00814632|20795465|P1|NOT COMPLETED|Overall Study||2
8438949|NCT00814632|20795465|P1|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
8438950|NCT00814632|20795465|P1|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
8438951|NCT00814580|20795471|P2|NOT COMPLETED|Overall Study||47
8438952|NCT00814580|20795472|P1|NOT COMPLETED|Overall Study||31
8438953|NCT00814580|20795471|P2|COMPLETED|Overall Study||141
8438954|NCT00814580|20795472|P1|COMPLETED|Overall Study||163
8438955|NCT00814580|20795471|P2|STARTED|Overall Study||188
8438956|NCT00814580|20795472|P1|STARTED|Overall Study||194
8438957|NCT00814502|20795602|P2|NOT COMPLETED|Overall Study||2
8438958|NCT00814502|20795603|P1|NOT COMPLETED|Overall Study||1
8438959|NCT00814502|20795602|P2|COMPLETED|Overall Study||7
8438960|NCT00814502|20795603|P1|COMPLETED|Overall Study||7
8438961|NCT00814502|20795602|P2|STARTED|Overall Study||9
8438962|NCT00814502|20795603|P1|STARTED|Overall Study||8
8438963|NCT00814489|20795616|P3|NOT COMPLETED|Overall Study||1
8438964|NCT00814489|20795617|P2|NOT COMPLETED|Overall Study||0
8438965|NCT00814489|20795618|P1|NOT COMPLETED|Overall Study||2
8438966|NCT00814489|20795616|P3|COMPLETED|Overall Study||7
8438967|NCT00814489|20795617|P2|COMPLETED|Overall Study||17
8438968|NCT00814489|20795618|P1|COMPLETED|Overall Study||13
8438969|NCT00814489|20795616|P3|STARTED|Overall Study||8
8438970|NCT00814489|20795617|P2|STARTED|Overall Study||17
8438971|NCT00814489|20795618|P1|STARTED|Overall Study||15
8438972|NCT00814463|20795650|P1|NOT COMPLETED|Overall Study||1
8438973|NCT00814463|20795650|P1|COMPLETED|Overall Study||0
8438974|NCT00814463|20795650|P1|STARTED|Overall Study||1
8438975|NCT00814346|20795663|P2|NOT COMPLETED|Open Phase (17 Months)||0
8438976|NCT00814346|20795664|P1|NOT COMPLETED|Open Phase (17 Months)||10
8438977|NCT00814346|20795663|P2|COMPLETED|Open Phase (17 Months)||0
8438978|NCT00814346|20795664|P1|COMPLETED|Open Phase (17 Months)||31
8438979|NCT00814346|20795663|P2|AD|Open Phase (17 Months)||0
8438980|NCT00814346|20795664|P1|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
8438981|NCT00814346|20795663|P2|MC|Open Phase (17 Months)||0
8438982|NCT00814346|20795664|P1|MC|Open Phase (17 Months)||20
8438983|NCT00814346|20795663|P2|CNE|Open Phase (17 Months)||0
8438984|NCT00814346|20795664|P1|CNE|Open Phase (17 Months)||21
8438985|NCT00814346|20795663|P2|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
8438986|NCT00814346|20795664|P1|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
8438987|NCT00814346|20795663|P2|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
8438988|NCT00814346|20795664|P1|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
8438989|NCT00814346|20795663|P2|COMPLETED|Double-blind Phase (4 Weeks)||23
8438990|NCT00814346|20795664|P1|COMPLETED|Double-blind Phase (4 Weeks)||23
8438991|NCT00814346|20795663|P2|AD|Double-blind Phase (4 Weeks)||2
8438992|NCT00814346|20795664|P1|AD|Double-blind Phase (4 Weeks)||3
8438993|NCT00814346|20795663|P2|MC|Double-blind Phase (4 Weeks)||11
8438994|NCT00814346|20795664|P1|MC|Double-blind Phase (4 Weeks)||10
8438995|NCT00814346|20795663|P2|CNE|Double-blind Phase (4 Weeks)||13
8438996|NCT00814346|20795664|P1|CNE|Double-blind Phase (4 Weeks)||10
8438997|NCT00814346|20795663|P2|STARTED|Double-blind Phase (4 Weeks)||26
8438998|NCT00814346|20795664|P1|STARTED|Double-blind Phase (4 Weeks)||23
8438999|NCT00814333|20795730|P2|NOT COMPLETED|Treatment Period||0
8439000|NCT00814333|20795731|P1|NOT COMPLETED|Treatment Period||0
8439001|NCT00814333|20795730|P2|COMPLETED|Treatment Period||0
8439002|NCT00814333|20795731|P1|COMPLETED|Treatment Period||0
8439003|NCT00814333|20795730|P2|STARTED|Treatment Period||0
8439004|NCT00814333|20795731|P1|STARTED|Treatment Period||0
8439005|NCT00814333|20795730|P2|NOT COMPLETED|Enrollment||0
8439006|NCT00814333|20795731|P1|NOT COMPLETED|Enrollment||1
8439007|NCT00814333|20795730|P2|COMPLETED|Enrollment||0
8439008|NCT00814333|20795731|P1|COMPLETED|Enrollment||0
8439009|NCT00814333|20795730|P2|STARTED|Enrollment||0
8439010|NCT00814333|20795731|P1|STARTED|Enrollment||1
8439035|NCT00814307|20795872|P4|NOT COMPLETED|Overall Study||10
8439036|NCT00814307|20795873|P3|NOT COMPLETED|Overall Study||7
8439037|NCT00814307|20795874|P2|NOT COMPLETED|Overall Study||27
8439038|NCT00814307|20795875|P1|NOT COMPLETED|Overall Study||12
8439039|NCT00814307|20795872|P4|COMPLETED|Overall Study||51
8439040|NCT00814307|20795873|P3|COMPLETED|Overall Study||54
8439041|NCT00814307|20795874|P2|COMPLETED|Overall Study||218
8439042|NCT00814307|20795875|P1|COMPLETED|Overall Study||232
8439043|NCT00814307|20795872|P4|Treated|Overall Study||61
8439044|NCT00814307|20795873|P3|Treated|Overall Study||61
8439045|NCT00814307|20795874|P2|Treated|Overall Study||245
8439046|NCT00814307|20795875|P1|Treated|Overall Study||243
8439047|NCT00814307|20795872|P4|STARTED|Overall Study||61
8439048|NCT00814307|20795873|P3|STARTED|Overall Study||61
8439049|NCT00814307|20795874|P2|STARTED|Overall Study||245
8439050|NCT00814307|20795875|P1|STARTED|Overall Study||244
8439051|NCT00814255|20796040|P3|NOT COMPLETED|Overall Study||1
8439052|NCT00814255|20796041|P2|NOT COMPLETED|Overall Study||0
8439053|NCT00814255|20796042|P1|NOT COMPLETED|Overall Study||1
8439054|NCT00814255|20796040|P3|COMPLETED|Overall Study||7
8439055|NCT00814255|20796041|P2|COMPLETED|Overall Study||7
8439056|NCT00814255|20796042|P1|COMPLETED|Overall Study||7
8439057|NCT00814255|20796040|P3|STARTED|Overall Study||8
8439058|NCT00814255|20796041|P2|STARTED|Overall Study||7
8439059|NCT00814255|20796042|P1|STARTED|Overall Study||8
8439060|NCT00814177|20796064|P2|NOT COMPLETED|Overall Study||0
8439061|NCT00814177|20796065|P1|NOT COMPLETED|Overall Study||0
8439062|NCT00814177|20796064|P2|COMPLETED|Overall Study||80
8439063|NCT00814177|20796065|P1|COMPLETED|Overall Study||80
8439064|NCT00814177|20796064|P2|STARTED|Overall Study||80
8439065|NCT00814177|20796065|P1|STARTED|Overall Study||80
8439066|NCT00814164|20796071|P1|NOT COMPLETED|Overall Study||19
8439067|NCT00814164|20796071|P1|COMPLETED|Overall Study||2
8439068|NCT00814164|20796071|P1|STARTED|Overall Study||21
8439069|NCT00814138|20796084|P2|NOT COMPLETED|Overall Study||7
8439070|NCT00814138|20796085|P1|NOT COMPLETED|Overall Study||1
8439071|NCT00814138|20796084|P2|COMPLETED|Overall Study||18
8439072|NCT00814138|20796085|P1|COMPLETED|Overall Study||24
8439073|NCT00814138|20796084|P2|STARTED|Overall Study||25
8439074|NCT00814138|20796085|P1|STARTED|Overall Study||25
8439075|NCT00813995|20796105|P2|NOT COMPLETED|Overall Study||16
8439076|NCT00813995|20796106|P1|NOT COMPLETED|Overall Study||23
8439077|NCT00813995|20796105|P2|COMPLETED|Overall Study||182
8439078|NCT00813995|20796106|P1|COMPLETED|Overall Study||174
8439079|NCT00813995|20796105|P2|STARTED|Overall Study||198
8439080|NCT00813995|20796106|P1|STARTED|Overall Study||197
8439081|NCT00813982|20796120|P1|NOT COMPLETED|Overall Study||0
8439082|NCT00813982|20796120|P1|COMPLETED|Overall Study||59
8439083|NCT00813982|20796120|P1|STARTED|Overall Study||59
8439084|NCT00813943|20796129|P3|NOT COMPLETED|Overall Study||3
8439085|NCT00813943|20796130|P2|NOT COMPLETED|Overall Study||5
8439086|NCT00813943|20796131|P1|NOT COMPLETED|Overall Study||5
8439087|NCT00813943|20796129|P3|COMPLETED|Overall Study||86
8439088|NCT00813943|20796130|P2|COMPLETED|Overall Study||83
8439089|NCT00813943|20796131|P1|COMPLETED|Overall Study||83
8439090|NCT00813943|20796129|P3|STARTED|Overall Study||89
8439091|NCT00813943|20796130|P2|STARTED|Overall Study||88
8439092|NCT00813943|20796131|P1|STARTED|Overall Study||88
8439093|NCT00813917|20796161|P2|NOT COMPLETED|Overall Study||6
8439094|NCT00813917|20796162|P1|NOT COMPLETED|Overall Study||6
8439095|NCT00813917|20796161|P2|COMPLETED|Overall Study||32
8439096|NCT00813917|20796162|P1|COMPLETED|Overall Study||32
8439097|NCT00813917|20796161|P2|STARTED|Overall Study||38
8439098|NCT00813917|20796162|P1|STARTED|Overall Study||38
8439099|NCT00813904|20796168|P1|NOT COMPLETED|Overall Study||1
8439100|NCT00813904|20796168|P1|COMPLETED|Overall Study||30
8439101|NCT00813904|20796168|P1|STARTED|Overall Study||31
8439102|NCT00813865|20796174|P1|NOT COMPLETED|Overall Study||7
8439103|NCT00813865|20796174|P1|COMPLETED|Overall Study||1
8439104|NCT00813865|20796174|P1|Pharmacodynamic (PD) Population|Overall Study||8
8439105|NCT00813865|20796174|P1|Safety Population|Overall Study||8
8439106|NCT00813865|20796174|P1|STARTED|Overall Study||8
8439107|NCT00813813|20796182|P2|NOT COMPLETED|Overall Study||9
8439108|NCT00813813|20796183|P1|NOT COMPLETED|Overall Study||3
8439109|NCT00813813|20796182|P2|COMPLETED|Overall Study||16
8439110|NCT00813813|20796183|P1|COMPLETED|Overall Study||4
8439111|NCT00813813|20796182|P2|STARTED|Overall Study||25
8439112|NCT00813813|20796183|P1|STARTED|Overall Study||7
8439113|NCT00813800|20796199|P1|NOT COMPLETED|Overall Study||6
8439114|NCT00813800|20796199|P1|COMPLETED|Overall Study||5
8439115|NCT00813800|20796199|P1|STARTED|Overall Study||11
8439116|NCT00813761|20796207|P4|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
8439117|NCT00813761|20796208|P3|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
8439118|NCT00813761|20796209|P2|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
8439119|NCT00813761|20796210|P1|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
8439120|NCT00813761|20796207|P4|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
8439121|NCT00813761|20796208|P3|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
8439122|NCT00813761|20796209|P2|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
8439123|NCT00813761|20796210|P1|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
8439124|NCT00813761|20796207|P4|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
8439125|NCT00813761|20796208|P3|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
8439126|NCT00813761|20796209|P2|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
8439127|NCT00813761|20796210|P1|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
8439128|NCT00813761|20796207|P4|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
8439129|NCT00813761|20796208|P3|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
8439130|NCT00813761|20796209|P2|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
8439131|NCT00813761|20796210|P1|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
8439132|NCT00813761|20796207|P4|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
8439133|NCT00813761|20796208|P3|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
8439134|NCT00813761|20796209|P2|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
8439135|NCT00813761|20796210|P1|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
8439136|NCT00813761|20796207|P4|STARTED|Phase 1 (Baseline to 4 Weeks)||107
8439137|NCT00813761|20796208|P3|STARTED|Phase 1 (Baseline to 4 Weeks)||115
8439138|NCT00813761|20796209|P2|STARTED|Phase 1 (Baseline to 4 Weeks)||103
8439139|NCT00813761|20796210|P1|STARTED|Phase 1 (Baseline to 4 Weeks)||121
8439140|NCT00813748|20796260|P2|NOT COMPLETED|Skin Test Substudy||1
8439141|NCT00813748|20796261|P1|NOT COMPLETED|Skin Test Substudy||0
8439142|NCT00813748|20796260|P2|COMPLETED|Skin Test Substudy||7
8439143|NCT00813748|20796261|P1|COMPLETED|Skin Test Substudy||3
8439144|NCT00813748|20796260|P2|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
8439145|NCT00813748|20796261|P1|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
8439146|NCT00813748|20796260|P2|NOT COMPLETED|Main Observational Study||0
8439147|NCT00813748|20796261|P1|NOT COMPLETED|Main Observational Study||0
8439148|NCT00813748|20796260|P2|COMPLETED|Main Observational Study||88
8439149|NCT00813748|20796261|P1|COMPLETED|Main Observational Study||30
8439150|NCT00813748|20796260|P2|STARTED|Main Observational Study||88
8439151|NCT00813748|20796261|P1|STARTED|Main Observational Study||30
8439152|NCT00813709|20796290|P6|NOT COMPLETED|Open Label Period||11
8439153|NCT00813709|20796291|P5|NOT COMPLETED|Open Label Period||10
8439154|NCT00813709|20796292|P4|NOT COMPLETED|Open Label Period||20
8439155|NCT00813709|20796293|P3|NOT COMPLETED|Open Label Period||0
8439156|NCT00813709|20796294|P2|NOT COMPLETED|Open Label Period||0
8439157|NCT00813709|20796295|P1|NOT COMPLETED|Open Label Period||0
8439158|NCT00813709|20796290|P6|COMPLETED|Open Label Period||35
8439159|NCT00813709|20796291|P5|COMPLETED|Open Label Period||41
8439160|NCT00813709|20796292|P4|COMPLETED|Open Label Period||38
8439161|NCT00813709|20796293|P3|COMPLETED|Open Label Period||0
8439162|NCT00813709|20796294|P2|COMPLETED|Open Label Period||0
8439163|NCT00813709|20796295|P1|COMPLETED|Open Label Period||0
8439164|NCT00813709|20796290|P6|Treated|Open Label Period||45
8439165|NCT00813709|20796291|P5|Treated|Open Label Period||51
8439166|NCT00813709|20796292|P4|Treated|Open Label Period||57
8439167|NCT00813709|20796293|P3|Treated|Open Label Period||0
8439168|NCT00813709|20796294|P2|Treated|Open Label Period||0
8439169|NCT00813709|20796295|P1|Treated|Open Label Period||0
8439170|NCT00813709|20796290|P6|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
8439171|NCT00813709|20796291|P5|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
8439172|NCT00813709|20796292|P4|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
8439173|NCT00813709|20796293|P3|STARTED|Open Label Period||0
8439174|NCT00813709|20796294|P2|STARTED|Open Label Period||0
8439175|NCT00813709|20796295|P1|STARTED|Open Label Period||0
8439176|NCT00813709|20796290|P6|NOT COMPLETED|Double Blind Period||0
8439177|NCT00813709|20796291|P5|NOT COMPLETED|Double Blind Period||0
8439178|NCT00813709|20796292|P4|NOT COMPLETED|Double Blind Period||0
8439179|NCT00813709|20796293|P3|NOT COMPLETED|Double Blind Period||31
8439180|NCT00813709|20796294|P2|NOT COMPLETED|Double Blind Period||41
8439181|NCT00813709|20796295|P1|NOT COMPLETED|Double Blind Period||31
8439182|NCT00813709|20796290|P6|COMPLETED|Double Blind Period||0
8439183|NCT00813709|20796291|P5|COMPLETED|Double Blind Period||0
8439184|NCT00813709|20796292|P4|COMPLETED|Double Blind Period||0
8439185|NCT00813709|20796293|P3|COMPLETED|Double Blind Period||68
8439186|NCT00813709|20796294|P2|COMPLETED|Double Blind Period||76
8439187|NCT00813709|20796295|P1|COMPLETED|Double Blind Period||53
8439188|NCT00813709|20796290|P6|Treated|Double Blind Period||0
8439189|NCT00813709|20796291|P5|Treated|Double Blind Period||0
8439190|NCT00813709|20796292|P4|Treated|Double Blind Period||0
8439191|NCT00813709|20796293|P3|Treated|Double Blind Period||98
8439192|NCT00813709|20796294|P2|Treated|Double Blind Period||114
8439193|NCT00813709|20796295|P1|Treated|Double Blind Period||83
8439194|NCT00813709|20796290|P6|STARTED|Double Blind Period||0
8439195|NCT00813709|20796291|P5|STARTED|Double Blind Period||0
8439196|NCT00813709|20796292|P4|STARTED|Double Blind Period||0
8439197|NCT00813709|20796293|P3|STARTED|Double Blind Period||99
8439198|NCT00813709|20796294|P2|STARTED|Double Blind Period||117
8439199|NCT00813709|20796295|P1|STARTED|Double Blind Period||84
8439200|NCT00813592|20796375|P1|NOT COMPLETED|Overall Study||2
8439201|NCT00813592|20796375|P1|COMPLETED|Overall Study||0
8439202|NCT00813592|20796375|P1|Response Assessment|Overall Study|One patient met the response assessment.|1
8439203|NCT00813592|20796375|P1|Treated|Overall Study|Two patients were treated.|2
8439204|NCT00813592|20796375|P1|STARTED|Overall Study||2
8439205|NCT00813488|20796384|P2|NOT COMPLETED|Open-label Extension||7
8439206|NCT00813488|20796385|P1|NOT COMPLETED|Open-label Extension||12
8439207|NCT00813488|20796384|P2|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
8439208|NCT00813488|20796385|P1|COMPLETED|Open-label Extension|This group received FBT open--label|53
8439209|NCT00813488|20796384|P2|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
8439210|NCT00813488|20796385|P1|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
8439211|NCT00813488|20796384|P2|NOT COMPLETED|Double-blind Treatment Period 2||1
8439212|NCT00813488|20796385|P1|NOT COMPLETED|Double-blind Treatment Period 2||5
8439213|NCT00813488|20796384|P2|COMPLETED|Double-blind Treatment Period 2||65
8439214|NCT00813488|20796385|P1|COMPLETED|Double-blind Treatment Period 2||66
8439215|NCT00813488|20796384|P2|STARTED|Double-blind Treatment Period 2||66
8439216|NCT00813488|20796385|P1|STARTED|Double-blind Treatment Period 2||71
8439217|NCT00813488|20796384|P2|NOT COMPLETED|Double-blind Treatment Period 1||5
8439218|NCT00813488|20796385|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
8439219|NCT00813488|20796384|P2|COMPLETED|Double-blind Treatment Period 1||66
8439220|NCT00813488|20796385|P1|COMPLETED|Double-blind Treatment Period 1||71
8439221|NCT00813488|20796384|P2|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
8439222|NCT00813488|20796385|P1|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
8439223|NCT00813488|20796384|P2|NOT COMPLETED|Titration Period 2||10
8439224|NCT00813488|20796385|P1|NOT COMPLETED|Titration Period 2||16
8439225|NCT00813488|20796384|P2|COMPLETED|Titration Period 2||79
8439226|NCT00813488|20796385|P1|COMPLETED|Titration Period 2||64
8439227|NCT00813488|20796384|P2|STARTED|Titration Period 2||89
8439228|NCT00813488|20796385|P1|STARTED|Titration Period 2||80
8439229|NCT00813488|20796384|P2|NOT COMPLETED|Titration Period 1||17
8439230|NCT00813488|20796385|P1|NOT COMPLETED|Titration Period 1||27
8439231|NCT00813488|20796384|P2|COMPLETED|Titration Period 1||89
8439232|NCT00813488|20796385|P1|COMPLETED|Titration Period 1||80
8439233|NCT00813488|20796384|P2|STARTED|Titration Period 1||106
8439234|NCT00813488|20796385|P1|STARTED|Titration Period 1||107
8439235|NCT00813319|20796483|P2|NOT COMPLETED|Overall Study||0
8439236|NCT00813319|20796484|P1|NOT COMPLETED|Overall Study||0
8439237|NCT00813319|20796483|P2|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
8439238|NCT00813319|20796484|P1|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
8439239|NCT00813319|20796483|P2|STARTED|Overall Study||108
8439240|NCT00813319|20796484|P1|STARTED|Overall Study||108
8439241|NCT00813293|20796496|P2|NOT COMPLETED|Overall Study||1
8439242|NCT00813293|20796497|P1|NOT COMPLETED|Overall Study||1
8439243|NCT00813293|20796496|P2|COMPLETED|Overall Study||9
8439244|NCT00813293|20796497|P1|COMPLETED|Overall Study||9
8439245|NCT00813293|20796496|P2|Evaluable RFA|Overall Study||8
8439246|NCT00813293|20796497|P1|Evaluable RFA|Overall Study||7
8439247|NCT00813293|20796496|P2|Started Treatment|Overall Study||10
8439248|NCT00813293|20796497|P1|Started Treatment|Overall Study||9
8439249|NCT00813293|20796496|P2|STARTED|Overall Study||10
8439250|NCT00813293|20796497|P1|STARTED|Overall Study||10
8439251|NCT00813176|20796517|P2|NOT COMPLETED|Overall Study||0
8439252|NCT00813176|20796518|P1|NOT COMPLETED|Overall Study||0
8439253|NCT00813176|20796517|P2|COMPLETED|Overall Study||25
8439254|NCT00813176|20796518|P1|COMPLETED|Overall Study||25
8439255|NCT00813176|20796517|P2|STARTED|Overall Study||25
8439256|NCT00813176|20796518|P1|STARTED|Overall Study||25
8439257|NCT00813150|20796536|P2|NOT COMPLETED|Long Term Follow-up||31
8439258|NCT00813150|20796537|P1|NOT COMPLETED|Long Term Follow-up||24
8439259|NCT00813150|20796536|P2|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
8439260|NCT00813150|20796537|P1|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
8439350|NCT00812929|20796689|P10|COMPLETED|Washout Period 4 (7 Days)||4
8439261|NCT00813150|20796536|P2|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
8439262|NCT00813150|20796537|P1|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
8439263|NCT00813150|20796536|P2|NOT COMPLETED|Treatment Period||32
8439264|NCT00813150|20796537|P1|NOT COMPLETED|Treatment Period||32
8439265|NCT00813150|20796536|P2|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
8439266|NCT00813150|20796537|P1|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
8439267|NCT00813150|20796536|P2|Intent-to-treat Participants|Treatment Period||47
8439268|NCT00813150|20796537|P1|Intent-to-treat Participants|Treatment Period||43
8439269|NCT00813150|20796536|P2|STARTED|Treatment Period|Number of randomized and treated participants|47
8439270|NCT00813150|20796537|P1|STARTED|Treatment Period|Number of randomized and treated participants|46
8439274|NCT00813111|20796555|P2|NOT COMPLETED|Overall Study||0
8439275|NCT00813111|20796556|P1|NOT COMPLETED|Overall Study||2
8439276|NCT00813111|20796555|P2|COMPLETED|Overall Study||70
8439277|NCT00813111|20796556|P1|COMPLETED|Overall Study||64
8439278|NCT00813111|20796555|P2|STARTED|Overall Study||70
8439279|NCT00813111|20796556|P1|STARTED|Overall Study||66
8439280|NCT00813098|20796565|P3|NOT COMPLETED|Overall Study||2
8439281|NCT00813098|20796566|P2|NOT COMPLETED|Overall Study||8
8439282|NCT00813098|20796567|P1|NOT COMPLETED|Overall Study||3
8439283|NCT00813098|20796565|P3|COMPLETED|Overall Study||50
8439284|NCT00813098|20796566|P2|COMPLETED|Overall Study||46
8439285|NCT00813098|20796567|P1|COMPLETED|Overall Study||46
8439286|NCT00813098|20796565|P3|STARTED|Overall Study||52
8439287|NCT00813098|20796566|P2|STARTED|Overall Study||54
8439288|NCT00813098|20796567|P1|STARTED|Overall Study||49
8439289|NCT00812981|20796592|P2|NOT COMPLETED|Overall Study||1
8439290|NCT00812981|20796593|P1|NOT COMPLETED|Overall Study||0
8439291|NCT00812981|20796592|P2|COMPLETED|Overall Study||159
8439292|NCT00812981|20796593|P1|COMPLETED|Overall Study||160
8439293|NCT00812981|20796592|P2|STARTED|Overall Study||160
8439294|NCT00812981|20796593|P1|STARTED|Overall Study||160
8439295|NCT00812968|20796631|P1|NOT COMPLETED|Overall Study||11
8439296|NCT00812968|20796631|P1|COMPLETED|Overall Study||0
8439297|NCT00812968|20796631|P1|STARTED|Overall Study||11
8439298|NCT00812955|20796666|P4|NOT COMPLETED|Overall Study||8
8439299|NCT00812955|20796667|P3|NOT COMPLETED|Overall Study||6
8439300|NCT00812955|20796668|P2|NOT COMPLETED|Overall Study||7
8439301|NCT00812955|20796669|P1|NOT COMPLETED|Overall Study||10
8439302|NCT00812955|20796666|P4|COMPLETED|Overall Study||110
8439303|NCT00812955|20796667|P3|COMPLETED|Overall Study||113
8439304|NCT00812955|20796668|P2|COMPLETED|Overall Study||111
8439305|NCT00812955|20796669|P1|COMPLETED|Overall Study||109
8439306|NCT00812955|20796666|P4|STARTED|Overall Study||118
8439307|NCT00812955|20796667|P3|STARTED|Overall Study||119
8439308|NCT00812955|20796668|P2|STARTED|Overall Study||118
8439309|NCT00812955|20796669|P1|STARTED|Overall Study||119
8439310|NCT00812929|20796689|P10|NOT COMPLETED|Treatment Period 5||0
8439311|NCT00812929|20796690|P9|NOT COMPLETED|Treatment Period 5||0
8439312|NCT00812929|20796691|P8|NOT COMPLETED|Treatment Period 5||0
8439313|NCT00812929|20796692|P7|NOT COMPLETED|Treatment Period 5||0
8439314|NCT00812929|20796693|P6|NOT COMPLETED|Treatment Period 5||0
8439315|NCT00812929|20796694|P5|NOT COMPLETED|Treatment Period 5||0
8439316|NCT00812929|20796695|P4|NOT COMPLETED|Treatment Period 5||0
8439317|NCT00812929|20796696|P3|NOT COMPLETED|Treatment Period 5||0
8439318|NCT00812929|20796697|P2|NOT COMPLETED|Treatment Period 5||0
8439319|NCT00812929|20796698|P1|NOT COMPLETED|Treatment Period 5||0
8439320|NCT00812929|20796689|P10|COMPLETED|Treatment Period 5||4
8439321|NCT00812929|20796690|P9|COMPLETED|Treatment Period 5||4
8439322|NCT00812929|20796691|P8|COMPLETED|Treatment Period 5||5
8439323|NCT00812929|20796692|P7|COMPLETED|Treatment Period 5||5
8439324|NCT00812929|20796693|P6|COMPLETED|Treatment Period 5||4
8439325|NCT00812929|20796694|P5|COMPLETED|Treatment Period 5||5
8439326|NCT00812929|20796695|P4|COMPLETED|Treatment Period 5||4
8439327|NCT00812929|20796696|P3|COMPLETED|Treatment Period 5||4
8439328|NCT00812929|20796697|P2|COMPLETED|Treatment Period 5||4
8439329|NCT00812929|20796698|P1|COMPLETED|Treatment Period 5||5
8439330|NCT00812929|20796689|P10|STARTED|Treatment Period 5||4
8439331|NCT00812929|20796690|P9|STARTED|Treatment Period 5||4
8439332|NCT00812929|20796691|P8|STARTED|Treatment Period 5||5
8439333|NCT00812929|20796692|P7|STARTED|Treatment Period 5||5
8439334|NCT00812929|20796693|P6|STARTED|Treatment Period 5||4
8439335|NCT00812929|20796694|P5|STARTED|Treatment Period 5||5
8439336|NCT00812929|20796695|P4|STARTED|Treatment Period 5||4
8439337|NCT00812929|20796696|P3|STARTED|Treatment Period 5||4
8439338|NCT00812929|20796697|P2|STARTED|Treatment Period 5||4
8439339|NCT00812929|20796698|P1|STARTED|Treatment Period 5||5
8439340|NCT00812929|20796689|P10|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439341|NCT00812929|20796690|P9|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439342|NCT00812929|20796691|P8|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439343|NCT00812929|20796692|P7|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439344|NCT00812929|20796693|P6|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439345|NCT00812929|20796694|P5|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439346|NCT00812929|20796695|P4|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439347|NCT00812929|20796696|P3|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439348|NCT00812929|20796697|P2|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439349|NCT00812929|20796698|P1|NOT COMPLETED|Washout Period 4 (7 Days)||0
8439351|NCT00812929|20796690|P9|COMPLETED|Washout Period 4 (7 Days)||4
8439352|NCT00812929|20796691|P8|COMPLETED|Washout Period 4 (7 Days)||5
8439353|NCT00812929|20796692|P7|COMPLETED|Washout Period 4 (7 Days)||5
8439354|NCT00812929|20796693|P6|COMPLETED|Washout Period 4 (7 Days)||4
8439355|NCT00812929|20796694|P5|COMPLETED|Washout Period 4 (7 Days)||5
8439356|NCT00812929|20796695|P4|COMPLETED|Washout Period 4 (7 Days)||4
8439357|NCT00812929|20796696|P3|COMPLETED|Washout Period 4 (7 Days)||4
8439358|NCT00812929|20796697|P2|COMPLETED|Washout Period 4 (7 Days)||4
8439359|NCT00812929|20796698|P1|COMPLETED|Washout Period 4 (7 Days)||5
8439360|NCT00812929|20796689|P10|STARTED|Washout Period 4 (7 Days)||4
8439361|NCT00812929|20796690|P9|STARTED|Washout Period 4 (7 Days)||4
8439362|NCT00812929|20796691|P8|STARTED|Washout Period 4 (7 Days)||5
8439363|NCT00812929|20796692|P7|STARTED|Washout Period 4 (7 Days)||5
8439364|NCT00812929|20796693|P6|STARTED|Washout Period 4 (7 Days)||4
8439365|NCT00812929|20796694|P5|STARTED|Washout Period 4 (7 Days)||5
8439366|NCT00812929|20796695|P4|STARTED|Washout Period 4 (7 Days)||4
8439367|NCT00812929|20796696|P3|STARTED|Washout Period 4 (7 Days)||4
8439368|NCT00812929|20796697|P2|STARTED|Washout Period 4 (7 Days)||4
8439369|NCT00812929|20796698|P1|STARTED|Washout Period 4 (7 Days)||5
8439370|NCT00812929|20796689|P10|NOT COMPLETED|Treatment Period 4||0
8439371|NCT00812929|20796690|P9|NOT COMPLETED|Treatment Period 4||0
8439372|NCT00812929|20796691|P8|NOT COMPLETED|Treatment Period 4||0
8439373|NCT00812929|20796692|P7|NOT COMPLETED|Treatment Period 4||0
8439374|NCT00812929|20796693|P6|NOT COMPLETED|Treatment Period 4||0
8439375|NCT00812929|20796694|P5|NOT COMPLETED|Treatment Period 4||0
8439376|NCT00812929|20796695|P4|NOT COMPLETED|Treatment Period 4||0
8439377|NCT00812929|20796696|P3|NOT COMPLETED|Treatment Period 4||0
8439378|NCT00812929|20796697|P2|NOT COMPLETED|Treatment Period 4||0
8439379|NCT00812929|20796698|P1|NOT COMPLETED|Treatment Period 4||0
8439380|NCT00812929|20796689|P10|COMPLETED|Treatment Period 4||4
8439381|NCT00812929|20796690|P9|COMPLETED|Treatment Period 4||4
8439382|NCT00812929|20796691|P8|COMPLETED|Treatment Period 4||5
8439383|NCT00812929|20796692|P7|COMPLETED|Treatment Period 4||5
8439384|NCT00812929|20796693|P6|COMPLETED|Treatment Period 4||4
8439385|NCT00812929|20796694|P5|COMPLETED|Treatment Period 4||5
8439386|NCT00812929|20796695|P4|COMPLETED|Treatment Period 4||4
8439387|NCT00812929|20796696|P3|COMPLETED|Treatment Period 4||4
8439388|NCT00812929|20796697|P2|COMPLETED|Treatment Period 4||4
8439389|NCT00812929|20796698|P1|COMPLETED|Treatment Period 4||5
8439390|NCT00812929|20796689|P10|STARTED|Treatment Period 4||4
8439391|NCT00812929|20796690|P9|STARTED|Treatment Period 4||4
8439392|NCT00812929|20796691|P8|STARTED|Treatment Period 4||5
8439393|NCT00812929|20796692|P7|STARTED|Treatment Period 4||5
8439394|NCT00812929|20796693|P6|STARTED|Treatment Period 4||4
8439395|NCT00812929|20796694|P5|STARTED|Treatment Period 4||5
8439396|NCT00812929|20796695|P4|STARTED|Treatment Period 4||4
8439397|NCT00812929|20796696|P3|STARTED|Treatment Period 4||4
8439398|NCT00812929|20796697|P2|STARTED|Treatment Period 4||4
8439399|NCT00812929|20796698|P1|STARTED|Treatment Period 4||5
8439400|NCT00812929|20796689|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439401|NCT00812929|20796690|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439402|NCT00812929|20796691|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439403|NCT00812929|20796692|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439404|NCT00812929|20796693|P6|NOT COMPLETED|Washout Period 3 (7 Days)||1
8439405|NCT00812929|20796694|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439406|NCT00812929|20796695|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439407|NCT00812929|20796696|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439408|NCT00812929|20796697|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439409|NCT00812929|20796698|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8439410|NCT00812929|20796689|P10|COMPLETED|Washout Period 3 (7 Days)||4
8439411|NCT00812929|20796690|P9|COMPLETED|Washout Period 3 (7 Days)||4
8439412|NCT00812929|20796691|P8|COMPLETED|Washout Period 3 (7 Days)||5
8439413|NCT00812929|20796692|P7|COMPLETED|Washout Period 3 (7 Days)||5
8439414|NCT00812929|20796693|P6|COMPLETED|Washout Period 3 (7 Days)||4
8439415|NCT00812929|20796694|P5|COMPLETED|Washout Period 3 (7 Days)||5
8439416|NCT00812929|20796695|P4|COMPLETED|Washout Period 3 (7 Days)||4
8439417|NCT00812929|20796696|P3|COMPLETED|Washout Period 3 (7 Days)||4
8439418|NCT00812929|20796697|P2|COMPLETED|Washout Period 3 (7 Days)||4
8439419|NCT00812929|20796698|P1|COMPLETED|Washout Period 3 (7 Days)||5
8439420|NCT00812929|20796689|P10|STARTED|Washout Period 3 (7 Days)||4
8439421|NCT00812929|20796690|P9|STARTED|Washout Period 3 (7 Days)||4
8439422|NCT00812929|20796691|P8|STARTED|Washout Period 3 (7 Days)||5
8439423|NCT00812929|20796692|P7|STARTED|Washout Period 3 (7 Days)||5
8439424|NCT00812929|20796693|P6|STARTED|Washout Period 3 (7 Days)||5
8439425|NCT00812929|20796694|P5|STARTED|Washout Period 3 (7 Days)||5
8439426|NCT00812929|20796695|P4|STARTED|Washout Period 3 (7 Days)||4
8439427|NCT00812929|20796696|P3|STARTED|Washout Period 3 (7 Days)||4
8439428|NCT00812929|20796697|P2|STARTED|Washout Period 3 (7 Days)||4
8439429|NCT00812929|20796698|P1|STARTED|Washout Period 3 (7 Days)||5
8439430|NCT00812929|20796689|P10|NOT COMPLETED|Treatment Period 3||0
8439431|NCT00812929|20796690|P9|NOT COMPLETED|Treatment Period 3||0
8439432|NCT00812929|20796691|P8|NOT COMPLETED|Treatment Period 3||0
8439433|NCT00812929|20796692|P7|NOT COMPLETED|Treatment Period 3||0
8439434|NCT00812929|20796693|P6|NOT COMPLETED|Treatment Period 3||0
8439435|NCT00812929|20796694|P5|NOT COMPLETED|Treatment Period 3||0
8439436|NCT00812929|20796695|P4|NOT COMPLETED|Treatment Period 3||0
8439437|NCT00812929|20796696|P3|NOT COMPLETED|Treatment Period 3||0
8439438|NCT00812929|20796697|P2|NOT COMPLETED|Treatment Period 3||0
8439439|NCT00812929|20796698|P1|NOT COMPLETED|Treatment Period 3||0
8439440|NCT00812929|20796689|P10|COMPLETED|Treatment Period 3||4
8439441|NCT00812929|20796690|P9|COMPLETED|Treatment Period 3||4
8439442|NCT00812929|20796691|P8|COMPLETED|Treatment Period 3||5
8439443|NCT00812929|20796692|P7|COMPLETED|Treatment Period 3||5
8439444|NCT00812929|20796693|P6|COMPLETED|Treatment Period 3||5
8439445|NCT00812929|20796694|P5|COMPLETED|Treatment Period 3||5
8439446|NCT00812929|20796695|P4|COMPLETED|Treatment Period 3||4
8439447|NCT00812929|20796696|P3|COMPLETED|Treatment Period 3||4
8439448|NCT00812929|20796697|P2|COMPLETED|Treatment Period 3||4
8439449|NCT00812929|20796698|P1|COMPLETED|Treatment Period 3||5
8439450|NCT00812929|20796689|P10|STARTED|Treatment Period 3||4
8439451|NCT00812929|20796690|P9|STARTED|Treatment Period 3||4
8439452|NCT00812929|20796691|P8|STARTED|Treatment Period 3||5
8439453|NCT00812929|20796692|P7|STARTED|Treatment Period 3||5
8439454|NCT00812929|20796693|P6|STARTED|Treatment Period 3||5
8439455|NCT00812929|20796694|P5|STARTED|Treatment Period 3||5
8439456|NCT00812929|20796695|P4|STARTED|Treatment Period 3||4
8439457|NCT00812929|20796696|P3|STARTED|Treatment Period 3||4
8439458|NCT00812929|20796697|P2|STARTED|Treatment Period 3||4
8439459|NCT00812929|20796698|P1|STARTED|Treatment Period 3||5
8439460|NCT00812929|20796689|P10|NOT COMPLETED|Washout Period 2 (7 Days)||1
8439461|NCT00812929|20796690|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439462|NCT00812929|20796691|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439463|NCT00812929|20796692|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439464|NCT00812929|20796693|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439465|NCT00812929|20796694|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439466|NCT00812929|20796695|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439467|NCT00812929|20796696|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439468|NCT00812929|20796697|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439469|NCT00812929|20796698|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8439470|NCT00812929|20796689|P10|COMPLETED|Washout Period 2 (7 Days)||4
8439471|NCT00812929|20796690|P9|COMPLETED|Washout Period 2 (7 Days)||4
8439472|NCT00812929|20796691|P8|COMPLETED|Washout Period 2 (7 Days)||5
8439473|NCT00812929|20796692|P7|COMPLETED|Washout Period 2 (7 Days)||5
8439474|NCT00812929|20796693|P6|COMPLETED|Washout Period 2 (7 Days)||5
8439475|NCT00812929|20796694|P5|COMPLETED|Washout Period 2 (7 Days)||5
8439476|NCT00812929|20796695|P4|COMPLETED|Washout Period 2 (7 Days)||4
8439477|NCT00812929|20796696|P3|COMPLETED|Washout Period 2 (7 Days)||4
8439478|NCT00812929|20796697|P2|COMPLETED|Washout Period 2 (7 Days)||4
8439479|NCT00812929|20796698|P1|COMPLETED|Washout Period 2 (7 Days)||5
8439480|NCT00812929|20796689|P10|STARTED|Washout Period 2 (7 Days)||5
8439481|NCT00812929|20796690|P9|STARTED|Washout Period 2 (7 Days)||4
8439482|NCT00812929|20796691|P8|STARTED|Washout Period 2 (7 Days)||5
8439483|NCT00812929|20796692|P7|STARTED|Washout Period 2 (7 Days)||5
8439484|NCT00812929|20796693|P6|STARTED|Washout Period 2 (7 Days)||5
8439485|NCT00812929|20796694|P5|STARTED|Washout Period 2 (7 Days)||5
8439486|NCT00812929|20796695|P4|STARTED|Washout Period 2 (7 Days)||4
8439487|NCT00812929|20796696|P3|STARTED|Washout Period 2 (7 Days)||4
8439488|NCT00812929|20796697|P2|STARTED|Washout Period 2 (7 Days)||4
8439489|NCT00812929|20796698|P1|STARTED|Washout Period 2 (7 Days)||5
8439490|NCT00812929|20796689|P10|NOT COMPLETED|Treatment Period 2||0
8439491|NCT00812929|20796690|P9|NOT COMPLETED|Treatment Period 2||0
8439492|NCT00812929|20796691|P8|NOT COMPLETED|Treatment Period 2||0
8439493|NCT00812929|20796692|P7|NOT COMPLETED|Treatment Period 2||0
8439494|NCT00812929|20796693|P6|NOT COMPLETED|Treatment Period 2||0
8439495|NCT00812929|20796694|P5|NOT COMPLETED|Treatment Period 2||0
8439496|NCT00812929|20796695|P4|NOT COMPLETED|Treatment Period 2||0
8439497|NCT00812929|20796696|P3|NOT COMPLETED|Treatment Period 2||0
8439498|NCT00812929|20796697|P2|NOT COMPLETED|Treatment Period 2||0
8439499|NCT00812929|20796698|P1|NOT COMPLETED|Treatment Period 2||0
8439500|NCT00812929|20796689|P10|COMPLETED|Treatment Period 2||5
8439501|NCT00812929|20796690|P9|COMPLETED|Treatment Period 2||4
8439502|NCT00812929|20796691|P8|COMPLETED|Treatment Period 2||5
8439503|NCT00812929|20796692|P7|COMPLETED|Treatment Period 2||5
8439504|NCT00812929|20796693|P6|COMPLETED|Treatment Period 2||5
8439505|NCT00812929|20796694|P5|COMPLETED|Treatment Period 2||5
8439506|NCT00812929|20796695|P4|COMPLETED|Treatment Period 2||4
8439507|NCT00812929|20796696|P3|COMPLETED|Treatment Period 2||4
8439508|NCT00812929|20796697|P2|COMPLETED|Treatment Period 2||4
8439509|NCT00812929|20796698|P1|COMPLETED|Treatment Period 2||5
8439510|NCT00812929|20796689|P10|STARTED|Treatment Period 2||5
8439511|NCT00812929|20796690|P9|STARTED|Treatment Period 2||4
8439512|NCT00812929|20796691|P8|STARTED|Treatment Period 2||5
8439513|NCT00812929|20796692|P7|STARTED|Treatment Period 2||5
8439514|NCT00812929|20796693|P6|STARTED|Treatment Period 2||5
8439515|NCT00812929|20796694|P5|STARTED|Treatment Period 2||5
8439516|NCT00812929|20796695|P4|STARTED|Treatment Period 2||4
8439517|NCT00812929|20796696|P3|STARTED|Treatment Period 2||4
8439518|NCT00812929|20796697|P2|STARTED|Treatment Period 2||4
8439519|NCT00812929|20796698|P1|STARTED|Treatment Period 2||5
8439520|NCT00812929|20796689|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439521|NCT00812929|20796690|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439522|NCT00812929|20796691|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439523|NCT00812929|20796692|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439524|NCT00812929|20796693|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439525|NCT00812929|20796694|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439526|NCT00812929|20796695|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439527|NCT00812929|20796696|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
8439528|NCT00812929|20796697|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439529|NCT00812929|20796698|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8439530|NCT00812929|20796689|P10|COMPLETED|Washout Period 1 (7 Days)||5
8439531|NCT00812929|20796690|P9|COMPLETED|Washout Period 1 (7 Days)||4
8439532|NCT00812929|20796691|P8|COMPLETED|Washout Period 1 (7 Days)||5
8439533|NCT00812929|20796692|P7|COMPLETED|Washout Period 1 (7 Days)||5
8439534|NCT00812929|20796693|P6|COMPLETED|Washout Period 1 (7 Days)||5
8439535|NCT00812929|20796694|P5|COMPLETED|Washout Period 1 (7 Days)||5
8439536|NCT00812929|20796695|P4|COMPLETED|Washout Period 1 (7 Days)||4
8439537|NCT00812929|20796696|P3|COMPLETED|Washout Period 1 (7 Days)||4
8439538|NCT00812929|20796697|P2|COMPLETED|Washout Period 1 (7 Days)||4
8439539|NCT00812929|20796698|P1|COMPLETED|Washout Period 1 (7 Days)||5
8439540|NCT00812929|20796689|P10|STARTED|Washout Period 1 (7 Days)||5
8439541|NCT00812929|20796690|P9|STARTED|Washout Period 1 (7 Days)||4
8439542|NCT00812929|20796691|P8|STARTED|Washout Period 1 (7 Days)||5
8439543|NCT00812929|20796692|P7|STARTED|Washout Period 1 (7 Days)||5
8439544|NCT00812929|20796693|P6|STARTED|Washout Period 1 (7 Days)||5
8439545|NCT00812929|20796694|P5|STARTED|Washout Period 1 (7 Days)||5
8439546|NCT00812929|20796695|P4|STARTED|Washout Period 1 (7 Days)||4
8439547|NCT00812929|20796696|P3|STARTED|Washout Period 1 (7 Days)||5
8439548|NCT00812929|20796697|P2|STARTED|Washout Period 1 (7 Days)||4
8439549|NCT00812929|20796698|P1|STARTED|Washout Period 1 (7 Days)||5
8439550|NCT00812929|20796689|P10|NOT COMPLETED|Treatment Period 1||0
8439551|NCT00812929|20796690|P9|NOT COMPLETED|Treatment Period 1||0
8439552|NCT00812929|20796691|P8|NOT COMPLETED|Treatment Period 1||0
8439553|NCT00812929|20796692|P7|NOT COMPLETED|Treatment Period 1||0
8439554|NCT00812929|20796693|P6|NOT COMPLETED|Treatment Period 1||0
8439555|NCT00812929|20796694|P5|NOT COMPLETED|Treatment Period 1||0
8439556|NCT00812929|20796695|P4|NOT COMPLETED|Treatment Period 1||0
8439557|NCT00812929|20796696|P3|NOT COMPLETED|Treatment Period 1||0
8439558|NCT00812929|20796697|P2|NOT COMPLETED|Treatment Period 1||0
8439559|NCT00812929|20796698|P1|NOT COMPLETED|Treatment Period 1||0
8439560|NCT00812929|20796689|P10|COMPLETED|Treatment Period 1||5
8439561|NCT00812929|20796690|P9|COMPLETED|Treatment Period 1||4
8439562|NCT00812929|20796691|P8|COMPLETED|Treatment Period 1||5
8439563|NCT00812929|20796692|P7|COMPLETED|Treatment Period 1||5
8439564|NCT00812929|20796693|P6|COMPLETED|Treatment Period 1||5
8439565|NCT00812929|20796694|P5|COMPLETED|Treatment Period 1||5
8439566|NCT00812929|20796695|P4|COMPLETED|Treatment Period 1||4
8439567|NCT00812929|20796696|P3|COMPLETED|Treatment Period 1||5
8439568|NCT00812929|20796697|P2|COMPLETED|Treatment Period 1||4
8439569|NCT00812929|20796698|P1|COMPLETED|Treatment Period 1||5
8439570|NCT00812929|20796689|P10|STARTED|Treatment Period 1||5
8439571|NCT00812929|20796690|P9|STARTED|Treatment Period 1||4
8439572|NCT00812929|20796691|P8|STARTED|Treatment Period 1||5
8439573|NCT00812929|20796692|P7|STARTED|Treatment Period 1||5
8439574|NCT00812929|20796693|P6|STARTED|Treatment Period 1||5
8439575|NCT00812929|20796694|P5|STARTED|Treatment Period 1||5
8439576|NCT00812929|20796695|P4|STARTED|Treatment Period 1||4
8439577|NCT00812929|20796696|P3|STARTED|Treatment Period 1||5
8439578|NCT00812929|20796697|P2|STARTED|Treatment Period 1||4
8439579|NCT00812929|20796698|P1|STARTED|Treatment Period 1||5
8439580|NCT00812916|20796814|P1|NOT COMPLETED|Overall Study||3
8439581|NCT00812916|20796814|P1|COMPLETED|Overall Study||203
8439582|NCT00812916|20796814|P1|CFAE - Guided Ablation|Overall Study||203
8439583|NCT00812916|20796814|P1|Data Available|Overall Study||205
8439584|NCT00812916|20796814|P1|STARTED|Overall Study|206 enrolled (consented)|206
8439585|NCT00812877|20796825|P2|NOT COMPLETED|Overall Study||51
8439586|NCT00812877|20796826|P1|NOT COMPLETED|Overall Study||37
8439587|NCT00812877|20796825|P2|COMPLETED|Overall Study||130
8439588|NCT00812877|20796826|P1|COMPLETED|Overall Study||158
8439589|NCT00812877|20796825|P2|STARTED|Overall Study||181
8439590|NCT00812877|20796826|P1|STARTED|Overall Study||195
8439591|NCT00812838|20796836|P2|NOT COMPLETED|Optional Crossover of 16 Weeks||0
8439592|NCT00812838|20796837|P1|NOT COMPLETED|Optional Crossover of 16 Weeks||0
8439593|NCT00812838|20796836|P2|COMPLETED|Optional Crossover of 16 Weeks||4
8439594|NCT00812838|20796837|P1|COMPLETED|Optional Crossover of 16 Weeks||0
8439595|NCT00812838|20796836|P2|STARTED|Optional Crossover of 16 Weeks||4
8439596|NCT00812838|20796837|P1|STARTED|Optional Crossover of 16 Weeks||0
8439597|NCT00812838|20796836|P2|NOT COMPLETED|Treatment Period of 16 Weeks||0
8439598|NCT00812838|20796837|P1|NOT COMPLETED|Treatment Period of 16 Weeks||0
8439599|NCT00812838|20796836|P2|COMPLETED|Treatment Period of 16 Weeks||6
8439600|NCT00812838|20796837|P1|COMPLETED|Treatment Period of 16 Weeks||6
8439601|NCT00812838|20796836|P2|STARTED|Treatment Period of 16 Weeks||6
8439602|NCT00812838|20796837|P1|STARTED|Treatment Period of 16 Weeks||6
8439603|NCT00812812|20796853|P2|NOT COMPLETED|Overall Study||4
8439604|NCT00812812|20796854|P1|NOT COMPLETED|Overall Study||3
8439605|NCT00812812|20796853|P2|COMPLETED|Overall Study||25
8439606|NCT00812812|20796854|P1|COMPLETED|Overall Study||24
8439607|NCT00812812|20796853|P2|STARTED|Overall Study||29
8439608|NCT00812812|20796854|P1|STARTED|Overall Study||27
8439609|NCT00812708|20796867|P1|NOT COMPLETED|Overall Study||8
8439610|NCT00812708|20796867|P1|COMPLETED|Overall Study||64
8439611|NCT00812708|20796867|P1|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
8439612|NCT00812708|20796867|P1|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
8439613|NCT00812604|20796878|P2|NOT COMPLETED|Overall Study||5
8439614|NCT00812604|20796879|P1|NOT COMPLETED|Overall Study||5
8439615|NCT00812604|20796878|P2|COMPLETED|Overall Study||22
8439616|NCT00812604|20796879|P1|COMPLETED|Overall Study||23
8439617|NCT00812604|20796878|P2|STARTED|Overall Study||27
8439618|NCT00812604|20796879|P1|STARTED|Overall Study||28
8439619|NCT00812565|20796895|P8|NOT COMPLETED|Overall Study||1
8439620|NCT00812565|20796896|P7|NOT COMPLETED|Overall Study||0
8439621|NCT00812565|20796897|P6|NOT COMPLETED|Overall Study||1
8439622|NCT00812565|20796898|P5|NOT COMPLETED|Overall Study||1
8439623|NCT00812565|20796899|P4|NOT COMPLETED|Overall Study||2
8439624|NCT00812565|20796900|P3|NOT COMPLETED|Overall Study||0
8439625|NCT00812565|20796901|P2|NOT COMPLETED|Overall Study||1
8439626|NCT00812565|20796902|P1|NOT COMPLETED|Overall Study||3
8439627|NCT00812565|20796895|P8|COMPLETED|Overall Study||6
8439628|NCT00812565|20796896|P7|COMPLETED|Overall Study||8
8439629|NCT00812565|20796897|P6|COMPLETED|Overall Study||6
8439630|NCT00812565|20796898|P5|COMPLETED|Overall Study||6
8439631|NCT00812565|20796899|P4|COMPLETED|Overall Study||5
8439632|NCT00812565|20796900|P3|COMPLETED|Overall Study||7
8439633|NCT00812565|20796901|P2|COMPLETED|Overall Study||6
8439634|NCT00812565|20796902|P1|COMPLETED|Overall Study||5
8439635|NCT00812565|20796895|P8|STARTED|Overall Study||7
8439636|NCT00812565|20796896|P7|STARTED|Overall Study||8
8439637|NCT00812565|20796897|P6|STARTED|Overall Study||7
8439638|NCT00812565|20796898|P5|STARTED|Overall Study||7
8439639|NCT00812565|20796899|P4|STARTED|Overall Study||7
8439640|NCT00812565|20796900|P3|STARTED|Overall Study||7
8439641|NCT00812565|20796901|P2|STARTED|Overall Study||7
8439642|NCT00812565|20796902|P1|STARTED|Overall Study||8
8439643|NCT00812487|20797026|P2|NOT COMPLETED|Overall Study||3
8439644|NCT00812487|20797027|P1|NOT COMPLETED|Overall Study||6
8439645|NCT00812487|20797026|P2|COMPLETED|Overall Study||39
8439646|NCT00812487|20797027|P1|COMPLETED|Overall Study||26
8439647|NCT00812487|20797026|P2|STARTED|Overall Study||42
8439648|NCT00812487|20797027|P1|STARTED|Overall Study||32
8439649|NCT00812461|20797053|P2|NOT COMPLETED|All Treated Patients||147
8439650|NCT00812461|20797054|P1|NOT COMPLETED|All Treated Patients||132
8439651|NCT00812461|20797053|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
8439652|NCT00812461|20797054|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
8439653|NCT00812461|20797053|P2|STARTED|All Treated Patients||341
8439654|NCT00812461|20797054|P1|STARTED|All Treated Patients||337
8439655|NCT00812461|20797053|P2|NOT COMPLETED|All Randomised Patients||17
8439656|NCT00812461|20797054|P1|NOT COMPLETED|All Randomised Patients||23
8439657|NCT00812461|20797053|P2|COMPLETED|All Randomised Patients||341
8439658|NCT00812461|20797054|P1|COMPLETED|All Randomised Patients||337
8439659|NCT00812461|20797053|P2|STARTED|All Randomised Patients||358
8439660|NCT00812461|20797054|P1|STARTED|All Randomised Patients||360
8439661|NCT00812331|20797077|P5|NOT COMPLETED|Overall Study||0
8439662|NCT00812331|20797078|P4|NOT COMPLETED|Overall Study||0
8439663|NCT00812331|20797079|P3|NOT COMPLETED|Overall Study||0
8439664|NCT00812331|20797080|P2|NOT COMPLETED|Overall Study||0
8439665|NCT00812331|20797081|P1|NOT COMPLETED|Overall Study||1
8439666|NCT00812331|20797077|P5|COMPLETED|Overall Study||8
8439667|NCT00812331|20797078|P4|COMPLETED|Overall Study||7
8439668|NCT00812331|20797079|P3|COMPLETED|Overall Study||8
8439669|NCT00812331|20797080|P2|COMPLETED|Overall Study||8
8439670|NCT00812331|20797081|P1|COMPLETED|Overall Study||5
8439671|NCT00812331|20797077|P5|STARTED|Overall Study||8
8439672|NCT00812331|20797078|P4|STARTED|Overall Study||7
8439673|NCT00812331|20797079|P3|STARTED|Overall Study||8
8439674|NCT00812331|20797080|P2|STARTED|Overall Study||8
8439675|NCT00812331|20797081|P1|STARTED|Overall Study||6
8439676|NCT00812253|20797156|P2|NOT COMPLETED|Overall Study||3
8439677|NCT00812253|20797157|P1|NOT COMPLETED|Overall Study||6
8439678|NCT00812253|20797156|P2|COMPLETED|Overall Study||39
8439679|NCT00812253|20797157|P1|COMPLETED|Overall Study||26
8439680|NCT00812253|20797156|P2|STARTED|Overall Study||42
8439681|NCT00812253|20797157|P1|STARTED|Overall Study||32
8439682|NCT00812110|20797173|P1|NOT COMPLETED|Overall Study||0
8439683|NCT00812110|20797173|P1|COMPLETED|Overall Study||292
8439684|NCT00812110|20797173|P1|STARTED|Overall Study||292
8439685|NCT00812097|20797182|P4|NOT COMPLETED|Overall Study||35
8439686|NCT00812097|20797183|P3|NOT COMPLETED|Overall Study||57
8439687|NCT00812097|20797184|P2|NOT COMPLETED|Overall Study||89
8439688|NCT00812097|20797185|P1|NOT COMPLETED|Overall Study||245
8439689|NCT00812097|20797182|P4|COMPLETED|Overall Study||34
8439690|NCT00812097|20797183|P3|COMPLETED|Overall Study||67
8439691|NCT00812097|20797184|P2|COMPLETED|Overall Study||101
8439692|NCT00812097|20797185|P1|COMPLETED|Overall Study||327
8439693|NCT00812097|20797182|P4|STARTED|Overall Study||69
8439694|NCT00812097|20797183|P3|STARTED|Overall Study||124
8439695|NCT00812097|20797184|P2|STARTED|Overall Study||190
8439696|NCT00812097|20797185|P1|STARTED|Overall Study||572
8439697|NCT00812006|20797214|P3|NOT COMPLETED|Overall Study||6
8439698|NCT00812006|20797215|P2|NOT COMPLETED|Overall Study||3
8439699|NCT00812006|20797216|P1|NOT COMPLETED|Overall Study||6
8439700|NCT00812006|20797214|P3|COMPLETED|Overall Study||30
8439701|NCT00812006|20797215|P2|COMPLETED|Overall Study||33
8439702|NCT00812006|20797216|P1|COMPLETED|Overall Study||30
8439703|NCT00812006|20797214|P3|STARTED|Overall Study||36
8439704|NCT00812006|20797215|P2|STARTED|Overall Study||36
8439705|NCT00812006|20797216|P1|STARTED|Overall Study||36
8439706|NCT00811954|20797233|P3|NOT COMPLETED|Overall Study||101
8439707|NCT00811954|20797234|P2|NOT COMPLETED|Overall Study||72
8439708|NCT00811954|20797235|P1|NOT COMPLETED|Overall Study||89
8439709|NCT00811954|20797233|P3|COMPLETED|Overall Study||500
8439710|NCT00811954|20797234|P2|COMPLETED|Overall Study||531
8439711|NCT00811954|20797235|P1|COMPLETED|Overall Study||516
8439712|NCT00811954|20797233|P3|STARTED|Overall Study||601
8439713|NCT00811954|20797234|P2|STARTED|Overall Study||603
8439714|NCT00811954|20797235|P1|STARTED|Overall Study||605
8439715|NCT00811941|20797299|P2|NOT COMPLETED|All Treated Patients||191
8439716|NCT00811941|20797300|P1|NOT COMPLETED|All Treated Patients||52
8439717|NCT00811941|20797299|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
8439718|NCT00811941|20797300|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
8439719|NCT00811941|20797299|P2|STARTED|All Treated Patients||501
8439720|NCT00811941|20797300|P1|STARTED|All Treated Patients||164
8439721|NCT00811941|20797299|P2|NOT COMPLETED|All Randomised Patients||8
8439722|NCT00811941|20797300|P1|NOT COMPLETED|All Randomised Patients||2
8439723|NCT00811941|20797299|P2|COMPLETED|All Randomised Patients||501
8439724|NCT00811941|20797300|P1|COMPLETED|All Randomised Patients||164
8439725|NCT00811941|20797299|P2|STARTED|All Randomised Patients||509
8439726|NCT00811941|20797300|P1|STARTED|All Randomised Patients||166
8439727|NCT00811928|20797338|P2|NOT COMPLETED|Overall Study||33
8439728|NCT00811928|20797339|P1|NOT COMPLETED|Overall Study||39
8439729|NCT00811928|20797338|P2|COMPLETED|Overall Study||90
8439730|NCT00811928|20797339|P1|COMPLETED|Overall Study||90
8439731|NCT00811928|20797338|P2|STARTED|Overall Study||123
8439732|NCT00811928|20797339|P1|STARTED|Overall Study||129
8439733|NCT00811850|20797357|P1|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
8439734|NCT00811850|20797357|P1|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
8439735|NCT00811850|20797357|P1|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
8439736|NCT00811850|20797357|P1|NOT COMPLETED|Treatment Period 2: Wash Out||0
8439737|NCT00811850|20797357|P1|COMPLETED|Treatment Period 2: Wash Out||15
8439738|NCT00811850|20797357|P1|STARTED|Treatment Period 2: Wash Out||15
8439739|NCT00811850|20797357|P1|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
8439740|NCT00811850|20797357|P1|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
8439741|NCT00811850|20797357|P1|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
8439742|NCT00811798|20797377|P1|NOT COMPLETED|Overall Study||0
8439743|NCT00811798|20797377|P1|COMPLETED|Overall Study||92
8439744|NCT00811798|20797377|P1|STARTED|Overall Study||92
8439745|NCT00811733|20797383|P2|NOT COMPLETED|Overall Study||10
8439746|NCT00811733|20797384|P1|NOT COMPLETED|Overall Study||11
8439747|NCT00811733|20797383|P2|COMPLETED|Overall Study||12
8439748|NCT00811733|20797384|P1|COMPLETED|Overall Study||4
8439749|NCT00811733|20797383|P2|STARTED|Overall Study||22
8439750|NCT00811733|20797384|P1|STARTED|Overall Study||15
8439751|NCT00811720|20797432|P2|NOT COMPLETED|All Treated Patients||164
8439752|NCT00811720|20797433|P1|NOT COMPLETED|All Treated Patients||96
8439753|NCT00811720|20797432|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
8439754|NCT00811720|20797433|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
8439755|NCT00811720|20797432|P2|STARTED|All Treated Patients||302
8439756|NCT00811720|20797433|P1|STARTED|All Treated Patients||296
8439757|NCT00811720|20797432|P2|NOT COMPLETED|All Randomised Patients||4
8439758|NCT00811720|20797433|P1|NOT COMPLETED|All Randomised Patients||2
8439759|NCT00811720|20797432|P2|COMPLETED|All Randomised Patients||302
8439760|NCT00811720|20797433|P1|COMPLETED|All Randomised Patients||296
8439761|NCT00811720|20797432|P2|STARTED|All Randomised Patients||306
8439762|NCT00811720|20797433|P1|STARTED|All Randomised Patients||298
8439763|NCT00811655|20797451|P1|NOT COMPLETED|Overall Study||1
8439764|NCT00811655|20797451|P1|COMPLETED|Overall Study||5
8439765|NCT00811655|20797451|P1|STARTED|Overall Study||6
8439766|NCT00811642|20797463|P1|NOT COMPLETED|Overall Study||15
8439767|NCT00811642|20797463|P1|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
8439768|NCT00811642|20797463|P1|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
8439769|NCT00811590|20797473|P1|NOT COMPLETED|Overall Study||0
8439770|NCT00811590|20797473|P1|COMPLETED|Overall Study||3
8439771|NCT00811590|20797473|P1|STARTED|Overall Study||3
8439772|NCT00811577|20797479|P2|NOT COMPLETED|Overall Study||1
8439773|NCT00811577|20797480|P1|NOT COMPLETED|Overall Study||10
8439774|NCT00811577|20797479|P2|COMPLETED|Overall Study||23
8439775|NCT00811577|20797480|P1|COMPLETED|Overall Study||116
8439776|NCT00811577|20797479|P2|STARTED|Overall Study||24
8439777|NCT00811577|20797480|P1|STARTED|Overall Study||126
8439778|NCT00811564|20797531|P2|NOT COMPLETED|Overall Study||2
8439779|NCT00811564|20797532|P1|NOT COMPLETED|Overall Study||9
8439780|NCT00811564|20797531|P2|COMPLETED|Overall Study||73
8439781|NCT00811564|20797532|P1|COMPLETED|Overall Study||64
8439782|NCT00811564|20797531|P2|STARTED|Overall Study||75
8439783|NCT00811564|20797532|P1|STARTED|Overall Study||73
8439784|NCT00811473|20797540|P2|NOT COMPLETED|Overall Study||26
8439785|NCT00811473|20797541|P1|NOT COMPLETED|Overall Study||23
8439786|NCT00811473|20797540|P2|COMPLETED|Overall Study||74
8439787|NCT00811473|20797541|P1|COMPLETED|Overall Study||70
8439788|NCT00811473|20797540|P2|STARTED|Overall Study||100
8439789|NCT00811473|20797541|P1|STARTED|Overall Study||93
8439790|NCT00811434|20797557|P2|NOT COMPLETED|Second Intervention||0
8439791|NCT00811434|20797558|P1|NOT COMPLETED|Second Intervention||0
8439792|NCT00811434|20797557|P2|COMPLETED|Second Intervention||5
8439793|NCT00811434|20797558|P1|COMPLETED|Second Intervention||4
8439794|NCT00811434|20797557|P2|STARTED|Second Intervention||5
8439795|NCT00811434|20797558|P1|STARTED|Second Intervention||4
8439796|NCT00811434|20797557|P2|NOT COMPLETED|Washout (1 Month)||0
8439797|NCT00811434|20797558|P1|NOT COMPLETED|Washout (1 Month)||0
8439798|NCT00811434|20797557|P2|COMPLETED|Washout (1 Month)||5
8439799|NCT00811434|20797558|P1|COMPLETED|Washout (1 Month)||4
8439800|NCT00811434|20797557|P2|STARTED|Washout (1 Month)||5
8439801|NCT00811434|20797558|P1|STARTED|Washout (1 Month)||4
8439802|NCT00811434|20797557|P2|NOT COMPLETED|First Intervention||0
8439803|NCT00811434|20797558|P1|NOT COMPLETED|First Intervention||3
8439804|NCT00811434|20797557|P2|COMPLETED|First Intervention||5
8439805|NCT00811434|20797558|P1|COMPLETED|First Intervention||4
8439806|NCT00811434|20797557|P2|STARTED|First Intervention||5
8439807|NCT00811434|20797558|P1|STARTED|First Intervention||7
8439808|NCT00811395|20797572|P6|NOT COMPLETED|Extension Treatment||2
8439809|NCT00811395|20797573|P5|NOT COMPLETED|Extension Treatment||0
8439810|NCT00811395|20797574|P4|NOT COMPLETED|Extension Treatment||3
8439811|NCT00811395|20797575|P3|NOT COMPLETED|Extension Treatment||3
8439812|NCT00811395|20797576|P2|NOT COMPLETED|Extension Treatment||6
8439813|NCT00811395|20797577|P1|NOT COMPLETED|Extension Treatment||2
8439814|NCT00811395|20797572|P6|COMPLETED|Extension Treatment|completed 48-week treatment|27
8439815|NCT00811395|20797573|P5|COMPLETED|Extension Treatment|completed 48-week treatment|30
8439816|NCT00811395|20797574|P4|COMPLETED|Extension Treatment|completed 48-week treatment|34
8439817|NCT00811395|20797575|P3|COMPLETED|Extension Treatment|completed 48-week treatment|24
8439818|NCT00811395|20797576|P2|COMPLETED|Extension Treatment|completed 48-week treatment|22
8439819|NCT00811395|20797577|P1|COMPLETED|Extension Treatment|completed 48-week treatment|29
8439820|NCT00811395|20797572|P6|STARTED|Extension Treatment|continued initial treatment|29
8439821|NCT00811395|20797573|P5|STARTED|Extension Treatment|continued initial treatment|30
8439822|NCT00811395|20797574|P4|STARTED|Extension Treatment|continued initial treatment|37
8439823|NCT00811395|20797575|P3|STARTED|Extension Treatment|continued initial treatment|27
8439824|NCT00811395|20797576|P2|STARTED|Extension Treatment|continued initial treatment|28
8439825|NCT00811395|20797577|P1|STARTED|Extension Treatment|continued initial treatment|31
8439826|NCT00811395|20797572|P6|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
8439827|NCT00811395|20797573|P5|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
8439828|NCT00811395|20797574|P4|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
8439829|NCT00811395|20797575|P3|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
8439830|NCT00811395|20797576|P2|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
8439831|NCT00811395|20797577|P1|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
8439832|NCT00811395|20797572|P6|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
8439833|NCT00811395|20797573|P5|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
8439834|NCT00811395|20797574|P4|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
8439835|NCT00811395|20797575|P3|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
8439836|NCT00811395|20797576|P2|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
8439837|NCT00811395|20797577|P1|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
8439838|NCT00811395|20797572|P6|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
8439839|NCT00811395|20797573|P5|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
8439840|NCT00811395|20797574|P4|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
8439841|NCT00811395|20797575|P3|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
8439842|NCT00811395|20797576|P2|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
8439843|NCT00811395|20797577|P1|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
8439844|NCT00811382|20797641|P2|NOT COMPLETED|Overall Study||0
8439845|NCT00811382|20797642|P1|NOT COMPLETED|Overall Study||0
8439846|NCT00811382|20797641|P2|COMPLETED|Overall Study||75
8439847|NCT00811382|20797642|P1|COMPLETED|Overall Study||88
8439848|NCT00811382|20797641|P2|STARTED|Overall Study||75
8439849|NCT00811382|20797642|P1|STARTED|Overall Study||88
8439850|NCT00811317|20797654|P1|NOT COMPLETED|Overall Study||0
8439851|NCT00811317|20797654|P1|COMPLETED|Overall Study||11
8439852|NCT00811317|20797654|P1|STARTED|Overall Study||11
8439853|NCT00811252|20797683|P3|NOT COMPLETED|Overall Study||23
8439854|NCT00811252|20797684|P2|NOT COMPLETED|Overall Study||20
8439855|NCT00811252|20797685|P1|NOT COMPLETED|Overall Study||17
8439856|NCT00811252|20797683|P3|COMPLETED|Overall Study||128
8439857|NCT00811252|20797684|P2|COMPLETED|Overall Study||136
8439858|NCT00811252|20797685|P1|COMPLETED|Overall Study||128
8439859|NCT00811252|20797683|P3|STARTED|Overall Study||151
8439860|NCT00811252|20797684|P2|STARTED|Overall Study||156
8439861|NCT00811252|20797685|P1|STARTED|Overall Study||145
8439862|NCT00811187|20797731|P2|NOT COMPLETED|Overall Study||3
8439863|NCT00811187|20797732|P1|NOT COMPLETED|Overall Study||3
8439864|NCT00811187|20797731|P2|COMPLETED|Overall Study||37
8439865|NCT00811187|20797732|P1|COMPLETED|Overall Study||37
8439866|NCT00811187|20797731|P2|STARTED|Overall Study||40
8439867|NCT00811187|20797732|P1|STARTED|Overall Study||40
8439868|NCT00811174|20797738|P1|NOT COMPLETED|Overall Study||3
8439869|NCT00811174|20797738|P1|COMPLETED|Overall Study||2
8439870|NCT00811174|20797738|P1|STARTED|Overall Study||5
8439871|NCT00811135|20797749|P1|NOT COMPLETED|Overall Study||88
8439872|NCT00811135|20797749|P1|COMPLETED|Overall Study||0
8439873|NCT00811135|20797749|P1|STARTED|Overall Study||88
8439874|NCT00811070|20797767|P6|NOT COMPLETED|Overall Study||1
8439875|NCT00811070|20797768|P5|NOT COMPLETED|Overall Study||5
8439876|NCT00811070|20797769|P4|NOT COMPLETED|Overall Study||2
8439877|NCT00811070|20797770|P3|NOT COMPLETED|Overall Study||0
8439878|NCT00811070|20797771|P2|NOT COMPLETED|Overall Study||1
8439879|NCT00811070|20797772|P1|NOT COMPLETED|Overall Study||1
8439880|NCT00811070|20797767|P6|COMPLETED|Overall Study||10
8439881|NCT00811070|20797768|P5|COMPLETED|Overall Study||2
8439882|NCT00811070|20797769|P4|COMPLETED|Overall Study||26
8439883|NCT00811070|20797770|P3|COMPLETED|Overall Study||3
8439884|NCT00811070|20797771|P2|COMPLETED|Overall Study||6
8439885|NCT00811070|20797772|P1|COMPLETED|Overall Study||6
8439886|NCT00811070|20797767|P6|STARTED|Overall Study||11
8439887|NCT00811070|20797768|P5|STARTED|Overall Study||7
8439888|NCT00811070|20797769|P4|STARTED|Overall Study||28
8439889|NCT00811070|20797770|P3|STARTED|Overall Study||3
8439890|NCT00811070|20797771|P2|STARTED|Overall Study||7
8439891|NCT00811070|20797772|P1|STARTED|Overall Study||7
8439892|NCT00811057|20797832|P3|NOT COMPLETED|Overall Study||10
8439893|NCT00811057|20797833|P2|NOT COMPLETED|Overall Study||10
8439894|NCT00811057|20797834|P1|NOT COMPLETED|Overall Study||5
8439895|NCT00811057|20797832|P3|COMPLETED|Overall Study||87
8439896|NCT00811057|20797833|P2|COMPLETED|Overall Study||104
8439897|NCT00811057|20797834|P1|COMPLETED|Overall Study||85
8439898|NCT00811057|20797832|P3|STARTED|Overall Study||97
8439899|NCT00811057|20797833|P2|STARTED|Overall Study||114
8439900|NCT00811057|20797834|P1|STARTED|Overall Study||90
8439901|NCT00811018|20797845|P1|NOT COMPLETED|Overall Study||968
8439902|NCT00811018|20797845|P1|COMPLETED|Overall Study||224
8439903|NCT00811018|20797845|P1|STARTED|Overall Study||1192
8439904|NCT00810901|20797863|P2|NOT COMPLETED|Overall Study||58
8439905|NCT00810901|20797864|P1|NOT COMPLETED|Overall Study||88
8439906|NCT00810901|20797863|P2|COMPLETED|Overall Study||118
8439907|NCT00810901|20797864|P1|COMPLETED|Overall Study||165
8439908|NCT00810901|20797863|P2|6-month Follow-up|Overall Study||122
8439909|NCT00810901|20797864|P1|6-month Follow-up|Overall Study||181
8439910|NCT00810901|20797863|P2|1-month Follow up|Overall Study||146
8439911|NCT00810901|20797864|P1|1-month Follow up|Overall Study||242
8439912|NCT00810901|20797863|P2|STARTED|Overall Study||176
8439913|NCT00810901|20797864|P1|STARTED|Overall Study||253
8439914|NCT00810888|20797875|P3|NOT COMPLETED|Overall Study||0
8439915|NCT00810888|20797876|P2|NOT COMPLETED|Overall Study||0
8439916|NCT00810888|20797877|P1|NOT COMPLETED|Overall Study||0
8439917|NCT00810888|20797875|P3|COMPLETED|Overall Study||73
8439918|NCT00810888|20797876|P2|COMPLETED|Overall Study||9
8439919|NCT00810888|20797877|P1|COMPLETED|Overall Study||10
8439920|NCT00810888|20797875|P3|STARTED|Overall Study||73
8439921|NCT00810888|20797876|P2|STARTED|Overall Study||9
8439922|NCT00810888|20797877|P1|STARTED|Overall Study||10
8439923|NCT00810810|20797910|P4|NOT COMPLETED|Overall Study||13
8439924|NCT00810810|20797911|P3|NOT COMPLETED|Overall Study||11
8439925|NCT00810810|20797912|P2|NOT COMPLETED|Overall Study||11
8439926|NCT00810810|20797913|P1|NOT COMPLETED|Overall Study||0
8439927|NCT00810810|20797910|P4|COMPLETED|Overall Study||38
8439928|NCT00810810|20797911|P3|COMPLETED|Overall Study||45
8439929|NCT00810810|20797912|P2|COMPLETED|Overall Study||38
8439930|NCT00810810|20797913|P1|COMPLETED|Overall Study||124
8439931|NCT00810810|20797910|P4|STARTED|Overall Study||51
8439932|NCT00810810|20797911|P3|STARTED|Overall Study||56
8439933|NCT00810810|20797912|P2|STARTED|Overall Study||49
8439934|NCT00810810|20797913|P1|STARTED|Overall Study||124
8439935|NCT00810797|20797927|P1|NOT COMPLETED|Overall Study||0
8439936|NCT00810797|20797927|P1|COMPLETED|Overall Study||36
8439937|NCT00810797|20797927|P1|STARTED|Overall Study||36
8439938|NCT00810771|20797935|P3|NOT COMPLETED|Overall Study||0
8439939|NCT00810771|20797936|P2|NOT COMPLETED|Overall Study||0
8439940|NCT00810771|20797937|P1|NOT COMPLETED|Overall Study||0
8439941|NCT00810771|20797935|P3|COMPLETED|Overall Study||84
8439942|NCT00810771|20797936|P2|COMPLETED|Overall Study||234
8439943|NCT00810771|20797937|P1|COMPLETED|Overall Study||232
8439944|NCT00810771|20797935|P3|STARTED|Overall Study||84
8439945|NCT00810771|20797936|P2|STARTED|Overall Study||234
8439946|NCT00810771|20797937|P1|STARTED|Overall Study||232
8439947|NCT00810719|20797957|P1|NOT COMPLETED|Overall Study||0
8439948|NCT00810719|20797957|P1|COMPLETED|Overall Study||30
8439949|NCT00810719|20797957|P1|STARTED|Overall Study||30
8439950|NCT00810693|20797966|P3|NOT COMPLETED|Follow-up Period (FUP)||4
8439951|NCT00810693|20797967|P2|NOT COMPLETED|Follow-up Period (FUP)||3
8439952|NCT00810693|20797968|P1|NOT COMPLETED|Follow-up Period (FUP)||8
8439953|NCT00810693|20797966|P3|COMPLETED|Follow-up Period (FUP)||12
8439954|NCT00810693|20797967|P2|COMPLETED|Follow-up Period (FUP)||4
8439955|NCT00810693|20797968|P1|COMPLETED|Follow-up Period (FUP)||15
8439956|NCT00810693|20797966|P3|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
8439957|NCT00810693|20797967|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
8439958|NCT00810693|20797968|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
8439959|NCT00810693|20797966|P3|NOT COMPLETED|Treatment Period||16
8439960|NCT00810693|20797967|P2|NOT COMPLETED|Treatment Period||7
8439961|NCT00810693|20797968|P1|NOT COMPLETED|Treatment Period||17
8439962|NCT00810693|20797966|P3|COMPLETED|Treatment Period||111
8439963|NCT00810693|20797967|P2|COMPLETED|Treatment Period||57
8439964|NCT00810693|20797968|P1|COMPLETED|Treatment Period||237
8439965|NCT00810693|20797966|P3|Participants Received Treatment|Treatment Period||126
8439966|NCT00810693|20797967|P2|Participants Received Treatment|Treatment Period||63
8439967|NCT00810693|20797968|P1|Participants Received Treatment|Treatment Period||254
8439968|NCT00810693|20797966|P3|STARTED|Treatment Period|1 randomized but not treated|127
8439969|NCT00810693|20797967|P2|STARTED|Treatment Period|1 randomized but not treated|64
8439970|NCT00810693|20797968|P1|STARTED|Treatment Period||254
8439971|NCT00810641|20798000|P3|NOT COMPLETED|Overall Study||2
8439972|NCT00810641|20798001|P2|NOT COMPLETED|Overall Study||1
8439973|NCT00810641|20798002|P1|NOT COMPLETED|Overall Study||0
8439974|NCT00810641|20798000|P3|COMPLETED|Overall Study||49
8439975|NCT00810641|20798001|P2|COMPLETED|Overall Study||53
8439976|NCT00810641|20798002|P1|COMPLETED|Overall Study||52
8439977|NCT00810641|20798000|P3|STARTED|Overall Study||51
8439978|NCT00810641|20798001|P2|STARTED|Overall Study||54
8439979|NCT00810641|20798002|P1|STARTED|Overall Study||52
8439980|NCT00810615|20798012|P2|NOT COMPLETED|Overall Study||1
8439981|NCT00810615|20798013|P1|NOT COMPLETED|Overall Study||1
8439982|NCT00810615|20798012|P2|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
8439983|NCT00810615|20798013|P1|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
8439984|NCT00810615|20798012|P2|STARTED|Overall Study||25
8439985|NCT00810615|20798013|P1|STARTED|Overall Study||25
8439986|NCT00810602|20798063|P2|NOT COMPLETED|Overall Study||3
8439987|NCT00810602|20798064|P1|NOT COMPLETED|Overall Study||8
8439988|NCT00810602|20798063|P2|COMPLETED|Overall Study||31
8439989|NCT00810602|20798064|P1|COMPLETED|Overall Study||19
8439990|NCT00810602|20798063|P2|STARTED|Overall Study||34
8439991|NCT00810602|20798064|P1|STARTED|Overall Study||27
8439992|NCT00810576|20798071|P1|NOT COMPLETED|Overall Study||0
8439993|NCT00810576|20798071|P1|COMPLETED|Overall Study||1
8439994|NCT00810576|20798071|P1|STARTED|Overall Study||1
8439995|NCT00810511|20798077|P2|NOT COMPLETED|Overall Study||4
8439996|NCT00810511|20798078|P1|NOT COMPLETED|Overall Study||10
8439997|NCT00810511|20798077|P2|COMPLETED|Overall Study||102
8439998|NCT00810511|20798078|P1|COMPLETED|Overall Study||97
8439999|NCT00810511|20798077|P2|STARTED|Overall Study||106
8440000|NCT00810511|20798078|P1|STARTED|Overall Study||107
8440001|NCT00810446|20798084|P1|NOT COMPLETED|Overall Study||0
8440002|NCT00810446|20798084|P1|COMPLETED|Overall Study||72
8440003|NCT00810446|20798084|P1|STARTED|Overall Study||72
8440004|NCT00810407|20798096|P1|NOT COMPLETED|Overall Study||6
8440005|NCT00810407|20798096|P1|COMPLETED|Overall Study||588
8440006|NCT00810407|20798096|P1|STARTED|Overall Study||594
8440007|NCT00810394|20798108|P1|NOT COMPLETED|Overall Study||3
8440008|NCT00810394|20798108|P1|COMPLETED|Overall Study||47
8440009|NCT00810394|20798108|P1|Cycle 3 400mg Twice Daily|Overall Study||5
8440010|NCT00810394|20798108|P1|Cycle 3 800 mg Twice Daily|Overall Study||4
8440011|NCT00810394|20798108|P1|Cycle 2 400mg Once Daily|Overall Study||22
8440012|NCT00810394|20798108|P1|Cycle 2 600mg Twice Daily|Overall Study||13
8440013|NCT00810394|20798108|P1|STARTED|Overall Study||50
8440014|NCT00810368|20798116|P2|NOT COMPLETED|Overall Study||2
8440015|NCT00810368|20798117|P1|NOT COMPLETED|Overall Study||6
8440016|NCT00810368|20798116|P2|COMPLETED|Overall Study||13
8440017|NCT00810368|20798117|P1|COMPLETED|Overall Study||12
8440018|NCT00810368|20798116|P2|STARTED|Overall Study||15
8440019|NCT00810368|20798117|P1|STARTED|Overall Study||18
8440020|NCT00810355|20798138|P3|NOT COMPLETED|Overall Study||11
8440021|NCT00810355|20798139|P2|NOT COMPLETED|Overall Study||17
8440022|NCT00810355|20798140|P1|NOT COMPLETED|Overall Study||14
8440023|NCT00810355|20798138|P3|COMPLETED|Overall Study||14
8440024|NCT00810355|20798139|P2|COMPLETED|Overall Study||8
8440025|NCT00810355|20798140|P1|COMPLETED|Overall Study||11
8440026|NCT00810355|20798138|P3|STARTED|Overall Study||25
8440027|NCT00810355|20798139|P2|STARTED|Overall Study||25
8440028|NCT00810355|20798140|P1|STARTED|Overall Study||25
8440029|NCT00810342|20798156|P2|NOT COMPLETED|12-month Followup||11
8440030|NCT00810342|20798157|P1|NOT COMPLETED|12-month Followup||12
8440031|NCT00810342|20798156|P2|COMPLETED|12-month Followup||136
8440032|NCT00810342|20798157|P1|COMPLETED|12-month Followup||113
8440033|NCT00810342|20798156|P2|STARTED|12-month Followup||147
8440034|NCT00810342|20798157|P1|STARTED|12-month Followup||125
8440035|NCT00810342|20798156|P2|NOT COMPLETED|6-month Follow-up||8
8440036|NCT00810342|20798157|P1|NOT COMPLETED|6-month Follow-up||24
8440037|NCT00810342|20798156|P2|COMPLETED|6-month Follow-up||147
8440038|NCT00810342|20798157|P1|COMPLETED|6-month Follow-up||125
8440039|NCT00810342|20798156|P2|STARTED|6-month Follow-up||155
8440040|NCT00810342|20798157|P1|STARTED|6-month Follow-up||149
8440041|NCT00810342|20798156|P2|NOT COMPLETED|Month 1 Follow-up||2
8440042|NCT00810342|20798157|P1|NOT COMPLETED|Month 1 Follow-up||5
8440043|NCT00810342|20798156|P2|COMPLETED|Month 1 Follow-up||155
8440044|NCT00810342|20798157|P1|COMPLETED|Month 1 Follow-up||149
8440045|NCT00810342|20798156|P2|STARTED|Month 1 Follow-up||157
8440046|NCT00810342|20798157|P1|STARTED|Month 1 Follow-up||154
8440047|NCT00810303|20798165|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
8440048|NCT00810303|20798165|P1|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
8440049|NCT00810303|20798165|P1|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
8440050|NCT00810303|20798165|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
8440051|NCT00810303|20798165|P1|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
8440052|NCT00810303|20798165|P1|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
8440053|NCT00810303|20798165|P1|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
8440054|NCT00810303|20798165|P1|COMPLETED|Ezetimibe Alone - Day 6-15||12
8440055|NCT00810303|20798165|P1|STARTED|Ezetimibe Alone - Day 6-15||12
8440056|NCT00810303|20798165|P1|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
8440057|NCT00810303|20798165|P1|COMPLETED|Efavirenz Alone - Day 1-5||12
8440058|NCT00810303|20798165|P1|STARTED|Efavirenz Alone - Day 1-5||12
8440059|NCT00810277|20798190|P1|NOT COMPLETED|Overall Study||1
8440060|NCT00810277|20798190|P1|COMPLETED|Overall Study||13
8440061|NCT00810277|20798190|P1|STARTED|Overall Study||14
8440062|NCT00810264|20798203|P1|NOT COMPLETED|Overall Study||1553
8440063|NCT00810264|20798203|P1|COMPLETED|Overall Study||946
8440064|NCT00810264|20798203|P1|STARTED|Overall Study||2499
8440065|NCT00810199|20798230|P2|NOT COMPLETED|Overall Study||82
8440066|NCT00810199|20798231|P1|NOT COMPLETED|Overall Study||59
8440067|NCT00810199|20798230|P2|COMPLETED|Overall Study|Completed=Completed Treatment|195
8440068|NCT00810199|20798231|P1|COMPLETED|Overall Study||220
8440069|NCT00810199|20798230|P2|Completed Week 104|Overall Study||201
8440070|NCT00810199|20798231|P1|Completed Week 104|Overall Study||222
8440071|NCT00810199|20798230|P2|Completed Week 52|Overall Study||229
8440072|NCT00810199|20798231|P1|Completed Week 52|Overall Study||243
8440073|NCT00810199|20798230|P2|Completed Week 24|Overall Study||250
8440074|NCT00810199|20798231|P1|Completed Week 24|Overall Study||259
8440075|NCT00810199|20798230|P2|Received Study Drug|Overall Study||276
8440076|NCT00810199|20798231|P1|Received Study Drug|Overall Study||277
8440077|NCT00810199|20798230|P2|STARTED|Overall Study||277
8440078|NCT00810199|20798231|P1|STARTED|Overall Study||279
8440079|NCT00810108|20798309|P2|NOT COMPLETED|Overall Study||0
8440080|NCT00810108|20798310|P1|NOT COMPLETED|Overall Study||1
8440081|NCT00810108|20798309|P2|COMPLETED|Overall Study||7
8440082|NCT00810108|20798310|P1|COMPLETED|Overall Study||5
8440083|NCT00810108|20798309|P2|STARTED|Overall Study||7
8440084|NCT00810108|20798310|P1|STARTED|Overall Study||6
8440085|NCT00810095|20798315|P1|NOT COMPLETED|Overall Study||0
8440086|NCT00810095|20798315|P1|COMPLETED|Overall Study||40
8440087|NCT00810095|20798315|P1|STARTED|Overall Study||40
8440088|NCT00810082|20798324|P2|NOT COMPLETED|Overall Study||4
8440089|NCT00810082|20798325|P1|NOT COMPLETED|Overall Study||0
8440090|NCT00810082|20798324|P2|COMPLETED|Overall Study||27
8440091|NCT00810082|20798325|P1|COMPLETED|Overall Study||34
8440092|NCT00810082|20798324|P2|STARTED|Overall Study||31
8440093|NCT00810082|20798325|P1|STARTED|Overall Study||34
8440094|NCT00810069|20798333|P3|NOT COMPLETED|Double-Blind Period II||72
8440095|NCT00810069|20798334|P2|NOT COMPLETED|Double-Blind Period II||56
8440096|NCT00810069|20798335|P1|NOT COMPLETED|Double-Blind Period II||0
8440097|NCT00810069|20798333|P3|COMPLETED|Double-Blind Period II||212
8440098|NCT00810069|20798334|P2|COMPLETED|Double-Blind Period II||226
8440099|NCT00810069|20798335|P1|COMPLETED|Double-Blind Period II||0
8440100|NCT00810069|20798333|P3|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
8440101|NCT00810069|20798334|P2|STARTED|Double-Blind Period II||282
8440102|NCT00810069|20798335|P1|STARTED|Double-Blind Period II||0
8440103|NCT00810069|20798333|P3|NOT COMPLETED|Lead-in Period I||0
8440104|NCT00810069|20798334|P2|NOT COMPLETED|Lead-in Period I||0
8440105|NCT00810069|20798335|P1|NOT COMPLETED|Lead-in Period I||274
8440106|NCT00810069|20798333|P3|COMPLETED|Lead-in Period I||0
8440107|NCT00810069|20798334|P2|COMPLETED|Lead-in Period I||0
8440108|NCT00810069|20798335|P1|COMPLETED|Lead-in Period I||566
8440109|NCT00810069|20798333|P3|STARTED|Lead-in Period I||0
8440110|NCT00810069|20798334|P2|STARTED|Lead-in Period I||0
8440111|NCT00810069|20798335|P1|STARTED|Lead-in Period I||840
8440112|NCT00810043|20798380|P3|NOT COMPLETED|Overall Study||8
8440113|NCT00810043|20798381|P2|NOT COMPLETED|Overall Study||1
8440114|NCT00810043|20798382|P1|NOT COMPLETED|Overall Study||4
8440115|NCT00810043|20798380|P3|COMPLETED|Overall Study||0
8440116|NCT00810043|20798381|P2|COMPLETED|Overall Study||54
8440117|NCT00810043|20798382|P1|COMPLETED|Overall Study||53
8440118|NCT00810043|20798380|P3|STARTED|Overall Study||8
8440119|NCT00810043|20798381|P2|STARTED|Overall Study||55
8440120|NCT00810043|20798382|P1|STARTED|Overall Study||57
8440121|NCT00809965|20798404|P3|NOT COMPLETED|Overall Study||844
8440122|NCT00809965|20798405|P2|NOT COMPLETED|Overall Study||775
8440123|NCT00809965|20798406|P1|NOT COMPLETED|Overall Study||783
8440124|NCT00809965|20798404|P3|COMPLETED|Overall Study||4332
8440125|NCT00809965|20798405|P2|COMPLETED|Overall Study||4399
8440126|NCT00809965|20798406|P1|COMPLETED|Overall Study||4393
8440127|NCT00809965|20798404|P3|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
8440128|NCT00809965|20798405|P2|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
8440129|NCT00809965|20798406|P1|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
8440130|NCT00809965|20798404|P3|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
8440131|NCT00809965|20798405|P2|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
8440132|NCT00809965|20798406|P1|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
8440133|NCT00809965|20798404|P3|STARTED|Overall Study||5176
8440134|NCT00809965|20798405|P2|STARTED|Overall Study||5174
8440135|NCT00809965|20798406|P1|STARTED|Overall Study||5176
8440136|NCT00809926|20798428|P2|NOT COMPLETED|Overall Study||23
8440137|NCT00809926|20798429|P1|NOT COMPLETED|Overall Study||31
8440138|NCT00809926|20798428|P2|COMPLETED|Overall Study||196
8440139|NCT00809926|20798429|P1|COMPLETED|Overall Study||201
8440140|NCT00809926|20798428|P2|STARTED|Overall Study||219
8440141|NCT00809926|20798429|P1|STARTED|Overall Study||232
8440142|NCT00809848|20798458|P5|NOT COMPLETED|Overall Study||3
8440143|NCT00809848|20798459|P4|NOT COMPLETED|Overall Study||1
8440144|NCT00809848|20798460|P3|NOT COMPLETED|Overall Study||0
8440145|NCT00809848|20798461|P2|NOT COMPLETED|Overall Study||0
8440146|NCT00809848|20798462|P1|NOT COMPLETED|Overall Study||0
8440147|NCT00809848|20798458|P5|COMPLETED|Overall Study||34
8440148|NCT00809848|20798459|P4|COMPLETED|Overall Study||30
8440149|NCT00809848|20798460|P3|COMPLETED|Overall Study||34
8440150|NCT00809848|20798461|P2|COMPLETED|Overall Study||34
8440151|NCT00809848|20798462|P1|COMPLETED|Overall Study||36
8440152|NCT00809848|20798458|P5|STARTED|Overall Study||37
8440153|NCT00809848|20798459|P4|STARTED|Overall Study||31
8440154|NCT00809848|20798460|P3|STARTED|Overall Study||34
8440155|NCT00809848|20798461|P2|STARTED|Overall Study||34
8440156|NCT00809848|20798462|P1|STARTED|Overall Study||36
8440157|NCT00809835|20798483|P4|NOT COMPLETED|Overall Study||2
8440158|NCT00809835|20798484|P3|NOT COMPLETED|Overall Study||11
8440159|NCT00809835|20798485|P2|NOT COMPLETED|Overall Study||7
8440160|NCT00809835|20798486|P1|NOT COMPLETED|Overall Study||8
8440161|NCT00809835|20798483|P4|COMPLETED|Overall Study||25
8440162|NCT00809835|20798484|P3|COMPLETED|Overall Study||27
8440163|NCT00809835|20798485|P2|COMPLETED|Overall Study||20
8440164|NCT00809835|20798486|P1|COMPLETED|Overall Study||20
8440165|NCT00809835|20798483|P4|STARTED|Overall Study||27
8440166|NCT00809835|20798484|P3|STARTED|Overall Study||38
8440167|NCT00809835|20798485|P2|STARTED|Overall Study||27
8440168|NCT00809835|20798486|P1|STARTED|Overall Study||28
8440169|NCT00809809|20798506|P2|NOT COMPLETED|Overall Study||2
8440170|NCT00809809|20798507|P1|NOT COMPLETED|Overall Study||3
8440171|NCT00809809|20798506|P2|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
8440172|NCT00809809|20798507|P1|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
8440173|NCT00809809|20798506|P2|STARTED|Overall Study||79
8440174|NCT00809809|20798507|P1|STARTED|Overall Study||78
8440175|NCT00809757|20798516|P3|NOT COMPLETED|Overall Study||11
8440176|NCT00809757|20798517|P2|NOT COMPLETED|Overall Study||5
8440177|NCT00809757|20798518|P1|NOT COMPLETED|Overall Study||6
8440178|NCT00809757|20798516|P3|COMPLETED|Overall Study||53
8440179|NCT00809757|20798517|P2|COMPLETED|Overall Study||60
8440180|NCT00809757|20798518|P1|COMPLETED|Overall Study||62
8440181|NCT00809757|20798516|P3|STARTED|Overall Study||64
8440182|NCT00809757|20798517|P2|STARTED|Overall Study||65
8440183|NCT00809757|20798518|P1|STARTED|Overall Study||68
8440184|NCT00809614|20798603|P2|NOT COMPLETED|Overall Study||4
8440185|NCT00809614|20798604|P1|NOT COMPLETED|Overall Study||3
8440186|NCT00809614|20798603|P2|COMPLETED|Overall Study||10
8440187|NCT00809614|20798604|P1|COMPLETED|Overall Study||25
8440188|NCT00809614|20798603|P2|Pharmacodynamic (PD) Set|Overall Study||13
8440189|NCT00809614|20798604|P1|Pharmacodynamic (PD) Set|Overall Study||24
8440190|NCT00809614|20798603|P2|Pharmacokinetic Safety Set|Overall Study||14
8440191|NCT00809614|20798604|P1|Pharmacokinetic Safety Set|Overall Study||27
8440192|NCT00809614|20798603|P2|STARTED|Overall Study||14
8440193|NCT00809614|20798604|P1|STARTED|Overall Study||28
8440194|NCT00809523|20798634|P2|NOT COMPLETED|Overall Study||4
8440195|NCT00809523|20798635|P1|NOT COMPLETED|Overall Study||7
8440196|NCT00809523|20798634|P2|COMPLETED|Overall Study||48
8440197|NCT00809523|20798635|P1|COMPLETED|Overall Study||47
8440198|NCT00809523|20798634|P2|STARTED|Overall Study||52
8440199|NCT00809523|20798635|P1|STARTED|Overall Study||54
8440200|NCT00809471|20798648|P3|NOT COMPLETED|Overall Study||17
8440201|NCT00809471|20798649|P2|NOT COMPLETED|Overall Study||20
8440202|NCT00809471|20798650|P1|NOT COMPLETED|Overall Study||20
8440203|NCT00809471|20798648|P3|COMPLETED|Overall Study||114
8440204|NCT00809471|20798649|P2|COMPLETED|Overall Study||109
8440205|NCT00809471|20798650|P1|COMPLETED|Overall Study||110
8440206|NCT00809471|20798648|P3|STARTED|Overall Study||131
8440207|NCT00809471|20798649|P2|STARTED|Overall Study||129
8440208|NCT00809471|20798650|P1|STARTED|Overall Study||130
8440209|NCT00809458|20798666|P2|NOT COMPLETED|Overall Study||1
8440210|NCT00809458|20798667|P1|NOT COMPLETED|Overall Study||1
8440211|NCT00809458|20798666|P2|COMPLETED|Overall Study||5
8440212|NCT00809458|20798667|P1|COMPLETED|Overall Study||8
8440213|NCT00809458|20798666|P2|STARTED|Overall Study||6
8440214|NCT00809458|20798667|P1|STARTED|Overall Study||9
8440215|NCT00809445|20798680|P3|NOT COMPLETED|6 Month Follow-up||24
8440216|NCT00809445|20798681|P2|NOT COMPLETED|6 Month Follow-up||23
8440217|NCT00809445|20798682|P1|NOT COMPLETED|6 Month Follow-up||24
8440218|NCT00809445|20798680|P3|COMPLETED|6 Month Follow-up||395
8440219|NCT00809445|20798681|P2|COMPLETED|6 Month Follow-up||410
8440220|NCT00809445|20798682|P1|COMPLETED|6 Month Follow-up||405
8440221|NCT00809445|20798680|P3|STARTED|6 Month Follow-up||419
8440222|NCT00809445|20798681|P2|STARTED|6 Month Follow-up||433
8440223|NCT00809445|20798682|P1|STARTED|6 Month Follow-up||429
8440224|NCT00809445|20798680|P3|NOT COMPLETED|1 Month Follow-up||4
8440225|NCT00809445|20798681|P2|NOT COMPLETED|1 Month Follow-up||4
8440226|NCT00809445|20798682|P1|NOT COMPLETED|1 Month Follow-up||2
8440227|NCT00809445|20798680|P3|COMPLETED|1 Month Follow-up||415
8440228|NCT00809445|20798681|P2|COMPLETED|1 Month Follow-up||429
8440229|NCT00809445|20798682|P1|COMPLETED|1 Month Follow-up||427
8440230|NCT00809445|20798680|P3|STARTED|1 Month Follow-up||419
8440231|NCT00809445|20798681|P2|STARTED|1 Month Follow-up||433
8440232|NCT00809445|20798682|P1|STARTED|1 Month Follow-up||429
8440233|NCT00809341|20798701|P2|NOT COMPLETED|Overall Study||1
8440234|NCT00809341|20798702|P1|NOT COMPLETED|Overall Study||0
8440235|NCT00809341|20798701|P2|COMPLETED|Overall Study||4
8440236|NCT00809341|20798702|P1|COMPLETED|Overall Study||20
8440237|NCT00809341|20798701|P2|STARTED|Overall Study||5
8440238|NCT00809341|20798702|P1|STARTED|Overall Study||20
8440239|NCT00809328|20798710|P1|NOT COMPLETED|Overall Study||29
8440240|NCT00809328|20798710|P1|COMPLETED|Overall Study||73
8440241|NCT00809328|20798710|P1|STARTED|Overall Study||102
8440242|NCT00809276|20798718|P1|NOT COMPLETED|Overall Study||0
8440243|NCT00809276|20798718|P1|COMPLETED|Overall Study||92
8440244|NCT00809276|20798718|P1|STARTED|Overall Study||92
8440245|NCT00809185|20798722|P1|NOT COMPLETED|Overall Study||0
8440246|NCT00809185|20798722|P1|COMPLETED|Overall Study||7
8440247|NCT00809185|20798722|P1|STARTED|Overall Study||7
8440248|NCT00809159|20798732|P6|NOT COMPLETED|Part 1 and 2||3
8440249|NCT00809159|20798733|P5|NOT COMPLETED|Part 1 and 2||6
8440250|NCT00809159|20798734|P4|NOT COMPLETED|Part 1 and 2||5
8440251|NCT00809159|20798735|P3|NOT COMPLETED|Part 1 and 2||10
8440252|NCT00809159|20798736|P2|NOT COMPLETED|Part 1 and 2||0
8440253|NCT00809159|20798737|P1|NOT COMPLETED|Part 1 and 2||0
8440254|NCT00809159|20798732|P6|COMPLETED|Part 1 and 2||3
8440255|NCT00809159|20798733|P5|COMPLETED|Part 1 and 2||6
8440256|NCT00809159|20798734|P4|COMPLETED|Part 1 and 2||7
8440257|NCT00809159|20798735|P3|COMPLETED|Part 1 and 2||20
8440258|NCT00809159|20798736|P2|COMPLETED|Part 1 and 2||0
8440259|NCT00809159|20798737|P1|COMPLETED|Part 1 and 2||0
8440260|NCT00809159|20798732|P6|PD Analysis Set|Part 1 and 2||6
8440261|NCT00809159|20798733|P5|PD Analysis Set|Part 1 and 2||12
8440262|NCT00809159|20798734|P4|PD Analysis Set|Part 1 and 2||12
8440263|NCT00809159|20798735|P3|PD Analysis Set|Part 1 and 2||28
8440264|NCT00809159|20798736|P2|PD Analysis Set|Part 1 and 2||0
8440265|NCT00809159|20798737|P1|PD Analysis Set|Part 1 and 2||0
8440266|NCT00809159|20798732|P6|PK Analysis Set|Part 1 and 2||6
8440267|NCT00809159|20798733|P5|PK Analysis Set|Part 1 and 2||12
8440268|NCT00809159|20798734|P4|PK Analysis Set|Part 1 and 2||12
8440269|NCT00809159|20798735|P3|PK Analysis Set|Part 1 and 2||30
8440270|NCT00809159|20798736|P2|PK Analysis Set|Part 1 and 2||0
8440271|NCT00809159|20798737|P1|PK Analysis Set|Part 1 and 2||0
8440272|NCT00809159|20798732|P6|STARTED|Part 1 and 2||6
8440273|NCT00809159|20798733|P5|STARTED|Part 1 and 2||12
8440274|NCT00809159|20798734|P4|STARTED|Part 1 and 2||12
8440275|NCT00809159|20798735|P3|STARTED|Part 1 and 2||30
8440276|NCT00809159|20798736|P2|STARTED|Part 1 and 2||0
8440277|NCT00809159|20798737|P1|STARTED|Part 1 and 2||0
8440278|NCT00809159|20798732|P6|NOT COMPLETED|Part 1||0
8440279|NCT00809159|20798733|P5|NOT COMPLETED|Part 1||0
8440280|NCT00809159|20798734|P4|NOT COMPLETED|Part 1||0
8440281|NCT00809159|20798735|P3|NOT COMPLETED|Part 1||0
8440282|NCT00809159|20798736|P2|NOT COMPLETED|Part 1||3
8440283|NCT00809159|20798737|P1|NOT COMPLETED|Part 1||8
8440284|NCT00809159|20798732|P6|COMPLETED|Part 1||0
8440285|NCT00809159|20798733|P5|COMPLETED|Part 1||0
8440286|NCT00809159|20798734|P4|COMPLETED|Part 1||0
8440287|NCT00809159|20798735|P3|COMPLETED|Part 1||0
8440288|NCT00809159|20798736|P2|COMPLETED|Part 1||3
8440289|NCT00809159|20798737|P1|COMPLETED|Part 1||16
8440290|NCT00809159|20798732|P6|PD Analysis Set|Part 1||0
8440291|NCT00809159|20798733|P5|PD Analysis Set|Part 1||0
8440292|NCT00809159|20798734|P4|PD Analysis Set|Part 1||0
8440293|NCT00809159|20798735|P3|PD Analysis Set|Part 1||0
8440294|NCT00809159|20798736|P2|PD Analysis Set|Part 1||6
8440295|NCT00809159|20798737|P1|PD Analysis Set|Part 1||23
8440296|NCT00809159|20798732|P6|PK Analysis Set|Part 1||0
8440297|NCT00809159|20798733|P5|PK Analysis Set|Part 1||0
8440298|NCT00809159|20798734|P4|PK Analysis Set|Part 1||0
8440299|NCT00809159|20798735|P3|PK Analysis Set|Part 1||0
8440300|NCT00809159|20798736|P2|PK Analysis Set|Part 1||6
8440301|NCT00809159|20798737|P1|PK Analysis Set|Part 1||24
8440302|NCT00809159|20798732|P6|STARTED|Part 1||0
8440303|NCT00809159|20798733|P5|STARTED|Part 1||0
8440304|NCT00809159|20798734|P4|STARTED|Part 1||0
8440305|NCT00809159|20798735|P3|STARTED|Part 1||0
8440306|NCT00809159|20798736|P2|STARTED|Part 1||6
8440307|NCT00809159|20798737|P1|STARTED|Part 1||24
8440308|NCT00809146|20798803|P2|NOT COMPLETED|Overall Study||0
8440309|NCT00809146|20798804|P1|NOT COMPLETED|Overall Study||0
8440310|NCT00809146|20798803|P2|COMPLETED|Overall Study||445
8440311|NCT00809146|20798804|P1|COMPLETED|Overall Study||448
8440312|NCT00809146|20798803|P2|STARTED|Overall Study||445
8440313|NCT00809146|20798804|P1|STARTED|Overall Study||448
8440314|NCT00809133|20798842|P14|NOT COMPLETED|Overall Study||7
8440315|NCT00809133|20798843|P13|NOT COMPLETED|Overall Study||5
8440316|NCT00809133|20798844|P12|NOT COMPLETED|Overall Study||8
8440317|NCT00809133|20798845|P11|NOT COMPLETED|Overall Study||6
8440318|NCT00809133|20798846|P10|NOT COMPLETED|Overall Study||9
8440319|NCT00809133|20798847|P9|NOT COMPLETED|Overall Study||3
8440320|NCT00809133|20798848|P8|NOT COMPLETED|Overall Study||8
8440321|NCT00809133|20798849|P7|NOT COMPLETED|Overall Study||6
8440322|NCT00809133|20798850|P6|NOT COMPLETED|Overall Study||7
8440323|NCT00809133|20798851|P5|NOT COMPLETED|Overall Study||5
8440324|NCT00809133|20798852|P4|NOT COMPLETED|Overall Study||3
8440325|NCT00809133|20798853|P3|NOT COMPLETED|Overall Study||6
8440326|NCT00809133|20798854|P2|NOT COMPLETED|Overall Study||7
8440327|NCT00809133|20798855|P1|NOT COMPLETED|Overall Study||3
8440328|NCT00809133|20798842|P14|COMPLETED|Overall Study||0
8440329|NCT00809133|20798843|P13|COMPLETED|Overall Study||0
8440330|NCT00809133|20798844|P12|COMPLETED|Overall Study||0
8440331|NCT00809133|20798845|P11|COMPLETED|Overall Study||0
8440332|NCT00809133|20798846|P10|COMPLETED|Overall Study||0
8440333|NCT00809133|20798847|P9|COMPLETED|Overall Study||0
8440334|NCT00809133|20798848|P8|COMPLETED|Overall Study||0
8440335|NCT00809133|20798849|P7|COMPLETED|Overall Study||0
8440336|NCT00809133|20798850|P6|COMPLETED|Overall Study||0
8440337|NCT00809133|20798851|P5|COMPLETED|Overall Study||0
8440338|NCT00809133|20798852|P4|COMPLETED|Overall Study||0
8440339|NCT00809133|20798853|P3|COMPLETED|Overall Study||0
8440340|NCT00809133|20798854|P2|COMPLETED|Overall Study||0
8440341|NCT00809133|20798855|P1|COMPLETED|Overall Study||0
8440342|NCT00809133|20798842|P14|STARTED|Overall Study||7
8440343|NCT00809133|20798843|P13|STARTED|Overall Study||5
8440344|NCT00809133|20798844|P12|STARTED|Overall Study||8
8440345|NCT00809133|20798845|P11|STARTED|Overall Study||6
8440346|NCT00809133|20798846|P10|STARTED|Overall Study||9
8440347|NCT00809133|20798847|P9|STARTED|Overall Study||3
8440348|NCT00809133|20798848|P8|STARTED|Overall Study||8
8440349|NCT00809133|20798849|P7|STARTED|Overall Study||6
8440350|NCT00809133|20798850|P6|STARTED|Overall Study||7
8440351|NCT00809133|20798851|P5|STARTED|Overall Study||5
8440352|NCT00809133|20798852|P4|STARTED|Overall Study||3
8440353|NCT00809133|20798853|P3|STARTED|Overall Study||6
8440354|NCT00809133|20798854|P2|STARTED|Overall Study||7
8440355|NCT00809133|20798855|P1|STARTED|Overall Study||3
8440356|NCT00809094|20799009|P2|NOT COMPLETED|Overall Study||1
8440357|NCT00809094|20799010|P1|NOT COMPLETED|Overall Study||0
8440358|NCT00809094|20799009|P2|COMPLETED|Overall Study||33
8440359|NCT00809094|20799010|P1|COMPLETED|Overall Study||36
8440360|NCT00809094|20799009|P2|STARTED|Overall Study||34
8440361|NCT00809094|20799010|P1|STARTED|Overall Study||36
8440362|NCT00809055|20799030|P2|NOT COMPLETED|Overall Study||7
8440363|NCT00809055|20799031|P1|NOT COMPLETED|Overall Study||9
8440364|NCT00809055|20799030|P2|COMPLETED|Overall Study||30
8440365|NCT00809055|20799031|P1|COMPLETED|Overall Study||28
8440366|NCT00809055|20799030|P2|STARTED|Overall Study||37
8440367|NCT00809055|20799031|P1|STARTED|Overall Study||37
8440368|NCT00808899|20799055|P1|NOT COMPLETED|Overall Study||4
8440369|NCT00808899|20799055|P1|COMPLETED|Overall Study||0
8440370|NCT00808899|20799055|P1|STARTED|Overall Study||4
8440371|NCT00808834|20799059|P2|NOT COMPLETED|Period 2||0
8440372|NCT00808834|20799060|P1|NOT COMPLETED|Period 2||0
8440373|NCT00808834|20799059|P2|COMPLETED|Period 2||99
8440374|NCT00808834|20799060|P1|COMPLETED|Period 2||97
8440375|NCT00808834|20799059|P2|STARTED|Period 2||99
8440376|NCT00808834|20799060|P1|STARTED|Period 2||97
8440377|NCT00808834|20799059|P2|NOT COMPLETED|Period 1||0
8440378|NCT00808834|20799060|P1|NOT COMPLETED|Period 1||0
8440379|NCT00808834|20799059|P2|COMPLETED|Period 1||99
8440380|NCT00808834|20799060|P1|COMPLETED|Period 1||97
8440381|NCT00808834|20799059|P2|STARTED|Period 1||99
8440382|NCT00808834|20799060|P1|STARTED|Period 1||97
8440383|NCT00808808|20799069|P3|NOT COMPLETED|Overall Study||2557
8440384|NCT00808808|20799070|P2|NOT COMPLETED|Overall Study||2437
8440385|NCT00808808|20799071|P1|NOT COMPLETED|Overall Study||2817
8440386|NCT00808808|20799069|P3|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
8440387|NCT00808808|20799070|P2|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
8440388|NCT00808808|20799071|P1|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
8440389|NCT00808808|20799069|P3|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
8440390|NCT00808808|20799070|P2|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
8440391|NCT00808808|20799071|P1|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
8440392|NCT00808808|20799069|P3|STARTED|Overall Study|Started includes all employees at participating sites.|4387
8440393|NCT00808808|20799070|P2|STARTED|Overall Study|Started includes all employees at participating sites|3757
8440394|NCT00808808|20799071|P1|STARTED|Overall Study|Started includes all employees at participating sites.|4078
8440395|NCT00808769|20799097|P2|NOT COMPLETED|Second Intervention||0
8440396|NCT00808769|20799098|P1|NOT COMPLETED|Second Intervention||0
8440397|NCT00808769|20799097|P2|COMPLETED|Second Intervention||15
8440398|NCT00808769|20799098|P1|COMPLETED|Second Intervention||15
8440399|NCT00808769|20799097|P2|STARTED|Second Intervention||15
8440400|NCT00808769|20799098|P1|STARTED|Second Intervention||15
8440401|NCT00808769|20799097|P2|NOT COMPLETED|First Intervention||0
8440402|NCT00808769|20799098|P1|NOT COMPLETED|First Intervention||0
8440403|NCT00808769|20799097|P2|COMPLETED|First Intervention||15
8440404|NCT00808769|20799098|P1|COMPLETED|First Intervention||15
8440405|NCT00808769|20799097|P2|STARTED|First Intervention||15
8440406|NCT00808769|20799098|P1|STARTED|First Intervention||15
8440407|NCT00808665|20799106|P2|NOT COMPLETED|Overall Study||3
8440408|NCT00808665|20799107|P1|NOT COMPLETED|Overall Study||6
8440409|NCT00808665|20799106|P2|COMPLETED|Overall Study||29
8440410|NCT00808665|20799107|P1|COMPLETED|Overall Study||25
8440411|NCT00808665|20799106|P2|Completed Post Operative Doses|Overall Study||29
8440412|NCT00808665|20799107|P1|Completed Post Operative Doses|Overall Study||25
8440413|NCT00808665|20799106|P2|Completed Intra-operative Dose|Overall Study||32
8440414|NCT00808665|20799107|P1|Completed Intra-operative Dose|Overall Study||26
8440415|NCT00808665|20799106|P2|Medication Started|Overall Study||32
8440416|NCT00808665|20799107|P1|Medication Started|Overall Study||30
8440417|NCT00808665|20799106|P2|STARTED|Overall Study||32
8440418|NCT00808665|20799107|P1|STARTED|Overall Study||31
8440419|NCT00808639|20799113|P1|NOT COMPLETED|Overall Study||1
8440420|NCT00808639|20799113|P1|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
8440421|NCT00808639|20799113|P1|STARTED|Overall Study||39
8440422|NCT00808509|20799121|P2|NOT COMPLETED|Observation Phase||0
8440423|NCT00808509|20799122|P1|NOT COMPLETED|Observation Phase||0
8440424|NCT00808509|20799121|P2|COMPLETED|Observation Phase||15
8440425|NCT00808509|20799122|P1|COMPLETED|Observation Phase||16
8440426|NCT00808509|20799121|P2|STARTED|Observation Phase|The observation phase was open to all participants|15
8440427|NCT00808509|20799122|P1|STARTED|Observation Phase|The observation phase was open to all participants|16
8440428|NCT00808509|20799121|P2|NOT COMPLETED|Randomized Phase||5
8440429|NCT00808509|20799122|P1|NOT COMPLETED|Randomized Phase||2
8440430|NCT00808509|20799121|P2|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
8440431|NCT00808509|20799122|P1|COMPLETED|Randomized Phase||15
8440432|NCT00808509|20799121|P2|Received Rescue Therapy|Randomized Phase||9
8440433|NCT00808509|20799122|P1|Received Rescue Therapy|Randomized Phase||0
8440434|NCT00808509|20799121|P2|STARTED|Randomized Phase||16
8440435|NCT00808509|20799122|P1|STARTED|Randomized Phase||17
8440436|NCT00808483|20799220|P2|NOT COMPLETED|From 5 Months to 12 Months||0
8440437|NCT00808483|20799221|P1|NOT COMPLETED|From 5 Months to 12 Months||1
8440438|NCT00808483|20799220|P2|COMPLETED|From 5 Months to 12 Months||32
8440439|NCT00808483|20799221|P1|COMPLETED|From 5 Months to 12 Months||32
8440440|NCT00808483|20799220|P2|STARTED|From 5 Months to 12 Months||32
8440441|NCT00808483|20799221|P1|STARTED|From 5 Months to 12 Months||33
8440442|NCT00808483|20799220|P2|NOT COMPLETED|From 3 to 5 Months After Surgery||1
8440443|NCT00808483|20799221|P1|NOT COMPLETED|From 3 to 5 Months After Surgery||2
8440444|NCT00808483|20799220|P2|COMPLETED|From 3 to 5 Months After Surgery||32
8440445|NCT00808483|20799221|P1|COMPLETED|From 3 to 5 Months After Surgery||33
8440446|NCT00808483|20799220|P2|STARTED|From 3 to 5 Months After Surgery||33
8440447|NCT00808483|20799221|P1|STARTED|From 3 to 5 Months After Surgery||35
8440448|NCT00808470|20799243|P2|NOT COMPLETED|Overall Study||0
8440449|NCT00808470|20799244|P1|NOT COMPLETED|Overall Study||2
8440450|NCT00808470|20799243|P2|COMPLETED|Overall Study||35
8440451|NCT00808470|20799244|P1|COMPLETED|Overall Study||35
8440452|NCT00808470|20799243|P2|STARTED|Overall Study||35
8440453|NCT00808470|20799244|P1|STARTED|Overall Study||37
8440454|NCT00808444|20799258|P2|NOT COMPLETED|Overall Study||1
8440455|NCT00808444|20799259|P1|NOT COMPLETED|Overall Study||1
8440456|NCT00808444|20799258|P2|COMPLETED|Overall Study||232
8440457|NCT00808444|20799259|P1|COMPLETED|Overall Study||232
8440458|NCT00808444|20799258|P2|STARTED|Overall Study||233
8440459|NCT00808444|20799259|P1|STARTED|Overall Study||233
8440460|NCT00808405|20799299|P2|NOT COMPLETED|Overall Study||0
8440461|NCT00808405|20799300|P1|NOT COMPLETED|Overall Study||0
8440462|NCT00808405|20799299|P2|COMPLETED|Overall Study||27
8440463|NCT00808405|20799300|P1|COMPLETED|Overall Study||61
8440464|NCT00808405|20799299|P2|STARTED|Overall Study||27
8440465|NCT00808405|20799300|P1|STARTED|Overall Study||61
8440466|NCT00808340|20799308|P6|NOT COMPLETED|Third Intervention||0
8440467|NCT00808340|20799309|P5|NOT COMPLETED|Third Intervention||0
8440468|NCT00808340|20799310|P4|NOT COMPLETED|Third Intervention||0
8440469|NCT00808340|20799311|P3|NOT COMPLETED|Third Intervention||0
8440470|NCT00808340|20799312|P2|NOT COMPLETED|Third Intervention||0
8440471|NCT00808340|20799313|P1|NOT COMPLETED|Third Intervention||0
8440472|NCT00808340|20799308|P6|COMPLETED|Third Intervention||6
8440473|NCT00808340|20799309|P5|COMPLETED|Third Intervention||5
8440474|NCT00808340|20799310|P4|COMPLETED|Third Intervention||3
8440475|NCT00808340|20799311|P3|COMPLETED|Third Intervention||7
8440476|NCT00808340|20799312|P2|COMPLETED|Third Intervention||9
8440477|NCT00808340|20799313|P1|COMPLETED|Third Intervention||4
8440478|NCT00808340|20799308|P6|STARTED|Third Intervention||6
8440479|NCT00808340|20799309|P5|STARTED|Third Intervention||5
8440480|NCT00808340|20799310|P4|STARTED|Third Intervention||3
8440481|NCT00808340|20799311|P3|STARTED|Third Intervention||7
8440482|NCT00808340|20799312|P2|STARTED|Third Intervention||9
8440483|NCT00808340|20799313|P1|STARTED|Third Intervention||4
8440484|NCT00808340|20799308|P6|NOT COMPLETED|Second Intervention||0
8440485|NCT00808340|20799309|P5|NOT COMPLETED|Second Intervention||0
8440486|NCT00808340|20799310|P4|NOT COMPLETED|Second Intervention||0
8440487|NCT00808340|20799311|P3|NOT COMPLETED|Second Intervention||0
8440488|NCT00808340|20799312|P2|NOT COMPLETED|Second Intervention||0
8440489|NCT00808340|20799313|P1|NOT COMPLETED|Second Intervention||0
8440490|NCT00808340|20799308|P6|COMPLETED|Second Intervention||6
8440491|NCT00808340|20799309|P5|COMPLETED|Second Intervention||5
8440492|NCT00808340|20799310|P4|COMPLETED|Second Intervention||3
8440493|NCT00808340|20799311|P3|COMPLETED|Second Intervention||7
8440494|NCT00808340|20799312|P2|COMPLETED|Second Intervention||9
8440495|NCT00808340|20799313|P1|COMPLETED|Second Intervention||4
8440496|NCT00808340|20799308|P6|STARTED|Second Intervention||6
8440497|NCT00808340|20799309|P5|STARTED|Second Intervention||5
8440498|NCT00808340|20799310|P4|STARTED|Second Intervention||3
8440499|NCT00808340|20799311|P3|STARTED|Second Intervention||7
8440500|NCT00808340|20799312|P2|STARTED|Second Intervention||9
8440501|NCT00808340|20799313|P1|STARTED|Second Intervention||4
8440502|NCT00808340|20799308|P6|NOT COMPLETED|First Intervention||0
8440503|NCT00808340|20799309|P5|NOT COMPLETED|First Intervention||0
8440504|NCT00808340|20799310|P4|NOT COMPLETED|First Intervention||0
8440505|NCT00808340|20799311|P3|NOT COMPLETED|First Intervention||0
8440506|NCT00808340|20799312|P2|NOT COMPLETED|First Intervention||0
8440507|NCT00808340|20799313|P1|NOT COMPLETED|First Intervention||0
8440508|NCT00808340|20799308|P6|COMPLETED|First Intervention||6
8440509|NCT00808340|20799309|P5|COMPLETED|First Intervention||5
8440510|NCT00808340|20799310|P4|COMPLETED|First Intervention||3
8440511|NCT00808340|20799311|P3|COMPLETED|First Intervention||7
8440512|NCT00808340|20799312|P2|COMPLETED|First Intervention||9
8440513|NCT00808340|20799313|P1|COMPLETED|First Intervention||4
8440514|NCT00808340|20799308|P6|STARTED|First Intervention||6
8440515|NCT00808340|20799309|P5|STARTED|First Intervention||5
8440516|NCT00808340|20799310|P4|STARTED|First Intervention||3
8440517|NCT00808340|20799311|P3|STARTED|First Intervention||7
8440518|NCT00808340|20799312|P2|STARTED|First Intervention||9
8440519|NCT00808340|20799313|P1|STARTED|First Intervention||4
8440520|NCT00808249|20799334|P4|NOT COMPLETED|Overall Study||16
8440521|NCT00808249|20799335|P3|NOT COMPLETED|Overall Study||22
8440522|NCT00808249|20799336|P2|NOT COMPLETED|Overall Study||15
8440523|NCT00808249|20799337|P1|NOT COMPLETED|Overall Study||17
8440524|NCT00808249|20799334|P4|COMPLETED|Overall Study||90
8440525|NCT00808249|20799335|P3|COMPLETED|Overall Study||83
8440526|NCT00808249|20799336|P2|COMPLETED|Overall Study||91
8440527|NCT00808249|20799337|P1|COMPLETED|Overall Study||90
8440528|NCT00808249|20799334|P4|STARTED|Overall Study||106
8440529|NCT00808249|20799335|P3|STARTED|Overall Study||105
8440530|NCT00808249|20799336|P2|STARTED|Overall Study||106
8440531|NCT00808249|20799337|P1|STARTED|Overall Study||107
8440532|NCT00808236|20799365|P2|NOT COMPLETED|Overall Study||91
8440533|NCT00808236|20799366|P1|NOT COMPLETED|Overall Study||82
8440534|NCT00808236|20799365|P2|COMPLETED|Overall Study||13
8440535|NCT00808236|20799366|P1|COMPLETED|Overall Study||14
8440536|NCT00808236|20799365|P2|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
8440537|NCT00808236|20799366|P1|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
8440538|NCT00808236|20799365|P2|Achieved ROSC|Overall Study||43
8440539|NCT00808236|20799366|P1|Achieved ROSC|Overall Study||33
8440540|NCT00808236|20799365|P2|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
8440541|NCT00808236|20799366|P1|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
8440542|NCT00808236|20799365|P2|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
8440543|NCT00808236|20799366|P1|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
8440544|NCT00808236|20799365|P2|STARTED|Overall Study||104
8440545|NCT00808236|20799366|P1|STARTED|Overall Study||96
8440546|NCT00808210|20799396|P2|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||4
8440547|NCT00808210|20799397|P1|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||9
8440548|NCT00808210|20799396|P2|COMPLETED|Open Label Ocrelizumab Treatment Period||0
8440549|NCT00808210|20799397|P1|COMPLETED|Open Label Ocrelizumab Treatment Period||0
8440550|NCT00808210|20799396|P2|STARTED|Open Label Ocrelizumab Treatment Period||4
8440551|NCT00808210|20799397|P1|STARTED|Open Label Ocrelizumab Treatment Period||9
8440552|NCT00808210|20799396|P2|NOT COMPLETED|Double-Blind TX Period||3
8440553|NCT00808210|20799397|P1|NOT COMPLETED|Double-Blind TX Period||2
8440554|NCT00808210|20799396|P2|COMPLETED|Double-Blind TX Period||10
8440555|NCT00808210|20799397|P1|COMPLETED|Double-Blind TX Period||13
8440556|NCT00808210|20799396|P2|STARTED|Double-Blind TX Period||13
8440557|NCT00808210|20799397|P1|STARTED|Double-Blind TX Period||15
8440558|NCT00808210|20799396|P2|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
8440559|NCT00808210|20799397|P1|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
8440560|NCT00808210|20799396|P2|COMPLETED|Study Period + 48 Weeks of Follow-up||4
8440561|NCT00808210|20799397|P1|COMPLETED|Study Period + 48 Weeks of Follow-up||6
8440562|NCT00808210|20799396|P2|STARTED|Study Period + 48 Weeks of Follow-up||13
8440563|NCT00808210|20799397|P1|STARTED|Study Period + 48 Weeks of Follow-up||15
8440564|NCT00808132|20799422|P5|NOT COMPLETED|Overall Study||100
8440565|NCT00808132|20799423|P4|NOT COMPLETED|Overall Study||69
8440566|NCT00808132|20799424|P3|NOT COMPLETED|Overall Study||54
8440567|NCT00808132|20799425|P2|NOT COMPLETED|Overall Study||88
8440568|NCT00808132|20799426|P1|NOT COMPLETED|Overall Study||98
8440569|NCT00808132|20799422|P5|COMPLETED|Overall Study||383
8440570|NCT00808132|20799423|P4|COMPLETED|Overall Study||159
8440571|NCT00808132|20799424|P3|COMPLETED|Overall Study||185
8440572|NCT00808132|20799425|P2|COMPLETED|Overall Study||393
8440573|NCT00808132|20799426|P1|COMPLETED|Overall Study||357
8440574|NCT00808132|20799422|P5|Treated|Overall Study||474
8440575|NCT00808132|20799423|P4|Treated|Overall Study||220
8440576|NCT00808132|20799424|P3|Treated|Overall Study||230
8440577|NCT00808132|20799425|P2|Treated|Overall Study||474
8440578|NCT00808132|20799426|P1|Treated|Overall Study||445
8440579|NCT00808132|20799422|P5|STARTED|Overall Study||483
8440580|NCT00808132|20799423|P4|STARTED|Overall Study||228
8440581|NCT00808132|20799424|P3|STARTED|Overall Study||239
8440582|NCT00808132|20799425|P2|STARTED|Overall Study||481
8440583|NCT00808132|20799426|P1|STARTED|Overall Study||455
8440584|NCT00808080|20799498|P1|NOT COMPLETED|Overall Study||6
8440585|NCT00808080|20799498|P1|COMPLETED|Overall Study||0
8440586|NCT00808080|20799498|P1|STARTED|Overall Study||6
8440587|NCT00808067|20799505|P2|NOT COMPLETED|Overall Study||518
8440588|NCT00808067|20799506|P1|NOT COMPLETED|Overall Study||481
8440589|NCT00808067|20799505|P2|COMPLETED|Overall Study||2438
8440590|NCT00808067|20799506|P1|COMPLETED|Overall Study||2446
8440591|NCT00808067|20799505|P2|STARTED|Overall Study|Number of patients which are treated.|2956
8440592|NCT00808067|20799506|P1|STARTED|Overall Study|Number of patients which are treated.|2927
8440593|NCT00808028|20799542|P4|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
8440594|NCT00808028|20799543|P3|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
8440595|NCT00808028|20799544|P2|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
8440596|NCT00808028|20799545|P1|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
8440597|NCT00808028|20799542|P4|COMPLETED|Stage 2 (Followed up to 48 Months )||128
8440598|NCT00808028|20799543|P3|COMPLETED|Stage 2 (Followed up to 48 Months )||141
8440599|NCT00808028|20799544|P2|COMPLETED|Stage 2 (Followed up to 48 Months )||0
8440600|NCT00808028|20799545|P1|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
8440601|NCT00808028|20799542|P4|STARTED|Stage 2 (Followed up to 48 Months )||151
8440602|NCT00808028|20799543|P3|STARTED|Stage 2 (Followed up to 48 Months )||170
8440603|NCT00808028|20799544|P2|STARTED|Stage 2 (Followed up to 48 Months )||0
8440604|NCT00808028|20799545|P1|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
8440605|NCT00808028|20799542|P4|NOT COMPLETED|Stage 1 (6 Months)||15
8440606|NCT00808028|20799543|P3|NOT COMPLETED|Stage 1 (6 Months)||7
8440607|NCT00808028|20799544|P2|NOT COMPLETED|Stage 1 (6 Months)||1
8440608|NCT00808028|20799545|P1|NOT COMPLETED|Stage 1 (6 Months)||5
8440609|NCT00808028|20799542|P4|COMPLETED|Stage 1 (6 Months)||183
8440610|NCT00808028|20799543|P3|COMPLETED|Stage 1 (6 Months)||191
8440611|NCT00808028|20799544|P2|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
8440612|NCT00808028|20799545|P1|COMPLETED|Stage 1 (6 Months)||116
8440613|NCT00808028|20799542|P4|STARTED|Stage 1 (6 Months)||198
8440614|NCT00808028|20799543|P3|STARTED|Stage 1 (6 Months)||198
8440615|NCT00808028|20799544|P2|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
8440616|NCT00808028|20799545|P1|STARTED|Stage 1 (6 Months)||121
8440617|NCT00808015|20799581|P1|NOT COMPLETED|Overall Study||344
8440618|NCT00808015|20799581|P1|COMPLETED|Overall Study||1033
8440619|NCT00808015|20799581|P1|Treated|Overall Study||1373
8440620|NCT00808015|20799581|P1|STARTED|Overall Study||1377
8440621|NCT00807989|20799595|P2|NOT COMPLETED|Overall Study||2
8440622|NCT00807989|20799596|P1|NOT COMPLETED|Overall Study||3
8440623|NCT00807989|20799595|P2|COMPLETED|Overall Study||98
8440624|NCT00807989|20799596|P1|COMPLETED|Overall Study||104
8440625|NCT00807989|20799595|P2|STARTED|Overall Study||100
8440626|NCT00807989|20799596|P1|STARTED|Overall Study||107
8440627|NCT00807937|20799610|P4|NOT COMPLETED|Overall Study||15
8440628|NCT00807937|20799611|P3|NOT COMPLETED|Overall Study||14
8440629|NCT00807937|20799612|P2|NOT COMPLETED|Overall Study||25
8440630|NCT00807937|20799613|P1|NOT COMPLETED|Overall Study||27
8440631|NCT00807937|20799610|P4|COMPLETED|Overall Study||77
8440632|NCT00807937|20799611|P3|COMPLETED|Overall Study||78
8440633|NCT00807937|20799612|P2|COMPLETED|Overall Study||67
8440634|NCT00807937|20799613|P1|COMPLETED|Overall Study||66
8440635|NCT00807937|20799610|P4|STARTED|Overall Study||92
8440636|NCT00807937|20799611|P3|STARTED|Overall Study||92
8440637|NCT00807937|20799612|P2|STARTED|Overall Study||92
8440638|NCT00807937|20799613|P1|STARTED|Overall Study||93
8440639|NCT00807885|20799648|P9|NOT COMPLETED|Overall Study||0
8440640|NCT00807885|20799649|P8|NOT COMPLETED|Overall Study||0
8440641|NCT00807885|20799650|P7|NOT COMPLETED|Overall Study||0
8440642|NCT00807885|20799651|P6|NOT COMPLETED|Overall Study||1
8440643|NCT00807885|20799652|P5|NOT COMPLETED|Overall Study||0
8440644|NCT00807885|20799653|P4|NOT COMPLETED|Overall Study||0
8440645|NCT00807885|20799654|P3|NOT COMPLETED|Overall Study||0
8440646|NCT00807885|20799655|P2|NOT COMPLETED|Overall Study||0
8440647|NCT00807885|20799656|P1|NOT COMPLETED|Overall Study||0
8440648|NCT00807885|20799648|P9|COMPLETED|Overall Study||11
8440649|NCT00807885|20799649|P8|COMPLETED|Overall Study||11
8440650|NCT00807885|20799650|P7|COMPLETED|Overall Study||12
8440651|NCT00807885|20799651|P6|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
8440652|NCT00807885|20799652|P5|COMPLETED|Overall Study||12
8440653|NCT00807885|20799653|P4|COMPLETED|Overall Study||10
8440654|NCT00807885|20799654|P3|COMPLETED|Overall Study||11
8440655|NCT00807885|20799655|P2|COMPLETED|Overall Study||11
8440656|NCT00807885|20799656|P1|COMPLETED|Overall Study||10
8440657|NCT00807885|20799648|P9|STARTED|Overall Study||11
8440658|NCT00807885|20799649|P8|STARTED|Overall Study||11
8440659|NCT00807885|20799650|P7|STARTED|Overall Study||12
8440660|NCT00807885|20799651|P6|STARTED|Overall Study||12
8440661|NCT00807885|20799652|P5|STARTED|Overall Study||12
8440662|NCT00807885|20799653|P4|STARTED|Overall Study||10
8440663|NCT00807885|20799654|P3|STARTED|Overall Study||11
8440664|NCT00807885|20799655|P2|STARTED|Overall Study||11
8440665|NCT00807885|20799656|P1|STARTED|Overall Study||10
8440672|NCT00807768|20799740|P2|NOT COMPLETED|Overall Study||0
8440673|NCT00807768|20799741|P1|NOT COMPLETED|Overall Study||0
8440674|NCT00807768|20799740|P2|COMPLETED|Overall Study||300
8440675|NCT00807768|20799741|P1|COMPLETED|Overall Study||301
8440676|NCT00807768|20799740|P2|STARTED|Overall Study||300
8440677|NCT00807768|20799741|P1|STARTED|Overall Study||301
8440678|NCT00807742|20799759|P2|NOT COMPLETED|Overall Study||54
8440679|NCT00807742|20799760|P1|NOT COMPLETED|Overall Study||46
8440680|NCT00807742|20799759|P2|COMPLETED|Overall Study||114
8440681|NCT00807742|20799760|P1|COMPLETED|Overall Study||126
8440682|NCT00807742|20799759|P2|STARTED|Overall Study||168
8440683|NCT00807742|20799760|P1|STARTED|Overall Study||172
8440684|NCT00807664|20799806|P2|NOT COMPLETED|Overall Study||19
8440685|NCT00807664|20799807|P1|NOT COMPLETED|Overall Study||11
8440686|NCT00807664|20799806|P2|COMPLETED|Overall Study||75
8440687|NCT00807664|20799807|P1|COMPLETED|Overall Study||77
8440688|NCT00807664|20799806|P2|STARTED|Overall Study||94
8440689|NCT00807664|20799807|P1|STARTED|Overall Study||88
8440690|NCT00807599|20799819|P3|NOT COMPLETED|Overall Study||17
8440691|NCT00807599|20799820|P2|NOT COMPLETED|Overall Study||0
8440692|NCT00807599|20799821|P1|NOT COMPLETED|Overall Study||0
8440693|NCT00807599|20799819|P3|COMPLETED|Overall Study||0
8440694|NCT00807599|20799820|P2|COMPLETED|Overall Study||24
8440695|NCT00807599|20799821|P1|COMPLETED|Overall Study||26
8440696|NCT00807599|20799819|P3|STARTED|Overall Study||17
8440697|NCT00807599|20799820|P2|STARTED|Overall Study||24
8440698|NCT00807599|20799821|P1|STARTED|Overall Study||26
8440699|NCT00807586|20799835|P2|NOT COMPLETED|Overall Study||1
8440700|NCT00807586|20799836|P1|NOT COMPLETED|Overall Study||6
8440701|NCT00807586|20799835|P2|COMPLETED|Overall Study||58
8440702|NCT00807586|20799836|P1|COMPLETED|Overall Study||54
8440703|NCT00807586|20799835|P2|STARTED|Overall Study||59
8440704|NCT00807586|20799836|P1|STARTED|Overall Study||60
8440705|NCT00807573|20799848|P1|NOT COMPLETED|Overall Study||2
8440706|NCT00807573|20799848|P1|COMPLETED|Overall Study||42
8440707|NCT00807573|20799848|P1|STARTED|Overall Study||44
8440708|NCT00807560|20799854|P2|NOT COMPLETED|Overall Study||0
8440709|NCT00807560|20799855|P1|NOT COMPLETED|Overall Study||0
8440710|NCT00807560|20799854|P2|COMPLETED|Overall Study||39
8440711|NCT00807560|20799855|P1|COMPLETED|Overall Study||38
8440712|NCT00807560|20799854|P2|STARTED|Overall Study||39
8440713|NCT00807560|20799855|P1|STARTED|Overall Study||38
8440714|NCT00807495|20799894|P5|NOT COMPLETED|Overall Study||5
8440715|NCT00807495|20799895|P4|NOT COMPLETED|Overall Study||1
8440716|NCT00807495|20799896|P3|NOT COMPLETED|Overall Study||4
8440717|NCT00807495|20799897|P2|NOT COMPLETED|Overall Study||6
8440718|NCT00807495|20799898|P1|NOT COMPLETED|Overall Study||8
8440719|NCT00807495|20799894|P5|COMPLETED|Overall Study||2
8440720|NCT00807495|20799895|P4|COMPLETED|Overall Study||0
8440721|NCT00807495|20799896|P3|COMPLETED|Overall Study||1
8440722|NCT00807495|20799897|P2|COMPLETED|Overall Study||7
8440723|NCT00807495|20799898|P1|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
8440724|NCT00807495|20799894|P5|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
8440725|NCT00807495|20799895|P4|STARTED|Overall Study||1
8440726|NCT00807495|20799896|P3|STARTED|Overall Study||5
8440727|NCT00807495|20799897|P2|STARTED|Overall Study||13
8440728|NCT00807495|20799898|P1|STARTED|Overall Study||22
8440729|NCT00807456|20799940|P1|NOT COMPLETED|Overall Study||0
8440730|NCT00807456|20799940|P1|COMPLETED|Overall Study||65
8440731|NCT00807456|20799940|P1|STARTED|Overall Study||65
8440732|NCT00807365|20799944|P1|NOT COMPLETED|Overall Study||5
8440733|NCT00807365|20799944|P1|COMPLETED|Overall Study||0
8440734|NCT00807365|20799944|P1|STARTED|Overall Study||5
8440735|NCT00807248|20799952|P4|NOT COMPLETED|Overall Study||14
8440736|NCT00807248|20799953|P3|NOT COMPLETED|Overall Study||18
8440737|NCT00807248|20799954|P2|NOT COMPLETED|Overall Study||12
8440738|NCT00807248|20799955|P1|NOT COMPLETED|Overall Study||21
8440739|NCT00807248|20799952|P4|COMPLETED|Overall Study||126
8440740|NCT00807248|20799953|P3|COMPLETED|Overall Study||121
8440741|NCT00807248|20799954|P2|COMPLETED|Overall Study||128
8440742|NCT00807248|20799955|P1|COMPLETED|Overall Study||50
8440743|NCT00807248|20799952|P4|STARTED|Overall Study||140
8440744|NCT00807248|20799953|P3|STARTED|Overall Study||139
8440745|NCT00807248|20799954|P2|STARTED|Overall Study||140
8440746|NCT00807248|20799955|P1|STARTED|Overall Study||71
8440747|NCT00807235|20799999|P2|NOT COMPLETED|Overall Study||0
8440748|NCT00807235|20800000|P1|NOT COMPLETED|Overall Study||1
8440749|NCT00807235|20799999|P2|COMPLETED|Overall Study||6
8440750|NCT00807235|20800000|P1|COMPLETED|Overall Study||10
8440751|NCT00807235|20799999|P2|STARTED|Overall Study||6
8440752|NCT00807235|20800000|P1|STARTED|Overall Study||11
8440753|NCT00807209|20800033|P3|NOT COMPLETED|Overall Study||0
8440754|NCT00807209|20800034|P2|NOT COMPLETED|Overall Study||0
8440755|NCT00807209|20800035|P1|NOT COMPLETED|Overall Study||0
8440756|NCT00807209|20800033|P3|COMPLETED|Overall Study||1
8440757|NCT00807209|20800034|P2|COMPLETED|Overall Study||1
8440758|NCT00807209|20800035|P1|COMPLETED|Overall Study||1
8440759|NCT00807209|20800033|P3|STARTED|Overall Study||1
8440760|NCT00807209|20800034|P2|STARTED|Overall Study||1
8440761|NCT00807209|20800035|P1|STARTED|Overall Study||1
8440762|NCT00807092|20800045|P2|NOT COMPLETED|Overall Study||4
8440763|NCT00807092|20800046|P1|NOT COMPLETED|Overall Study||1
8440764|NCT00807092|20800045|P2|COMPLETED|Overall Study||69
8440765|NCT00807092|20800046|P1|COMPLETED|Overall Study||71
8440766|NCT00807092|20800045|P2|Exposed to Drug|Overall Study||73
8440767|NCT00807092|20800046|P1|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
8440768|NCT00807092|20800045|P2|STARTED|Overall Study||73
8440769|NCT00807092|20800046|P1|STARTED|Overall Study||72
8440770|NCT00807040|20800076|P2|NOT COMPLETED|Overall Study||41
8440771|NCT00807040|20800077|P1|NOT COMPLETED|Overall Study||36
8440772|NCT00807040|20800076|P2|COMPLETED|Overall Study||84
8440773|NCT00807040|20800077|P1|COMPLETED|Overall Study||90
8440774|NCT00807040|20800076|P2|STARTED|Overall Study||125
8440775|NCT00807040|20800077|P1|STARTED|Overall Study||126
8440776|NCT00807014|20800087|P2|NOT COMPLETED|Overall Study||27
8440777|NCT00807014|20800088|P1|NOT COMPLETED|Overall Study||27
8440778|NCT00807014|20800087|P2|COMPLETED|Overall Study||58
8440779|NCT00807014|20800088|P1|COMPLETED|Overall Study||56
8440780|NCT00807014|20800087|P2|STARTED|Overall Study||85
8440781|NCT00807014|20800088|P1|STARTED|Overall Study||83
8440782|NCT00807001|20800119|P5|NOT COMPLETED|Overall Study||0
8440783|NCT00807001|20800120|P4|NOT COMPLETED|Overall Study||0
8440784|NCT00807001|20800121|P3|NOT COMPLETED|Overall Study||0
8440785|NCT00807001|20800122|P2|NOT COMPLETED|Overall Study||1
8440786|NCT00807001|20800123|P1|NOT COMPLETED|Overall Study||0
8440787|NCT00807001|20800119|P5|COMPLETED|Overall Study||9
8440788|NCT00807001|20800120|P4|COMPLETED|Overall Study||8
8440789|NCT00807001|20800121|P3|COMPLETED|Overall Study||8
8440790|NCT00807001|20800122|P2|COMPLETED|Overall Study||7
8440791|NCT00807001|20800123|P1|COMPLETED|Overall Study||8
8440792|NCT00807001|20800119|P5|STARTED|Overall Study||9
8440793|NCT00807001|20800120|P4|STARTED|Overall Study||8
8440794|NCT00807001|20800121|P3|STARTED|Overall Study||8
8440795|NCT00807001|20800122|P2|STARTED|Overall Study||8
8440796|NCT00807001|20800123|P1|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
8440797|NCT00806988|20800142|P2|NOT COMPLETED|Overall Study||43
8440798|NCT00806988|20800143|P1|NOT COMPLETED|Overall Study||27
8440799|NCT00806988|20800142|P2|COMPLETED|Overall Study||108
8440800|NCT00806988|20800143|P1|COMPLETED|Overall Study||123
8440801|NCT00806988|20800142|P2|STARTED|Overall Study||151
8440802|NCT00806988|20800143|P1|STARTED|Overall Study||150
8440803|NCT00806819|20800153|P2|NOT COMPLETED|Overall Study||358
8440804|NCT00806819|20800154|P1|NOT COMPLETED|Overall Study||346
8440805|NCT00806819|20800153|P2|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
8440806|NCT00806819|20800154|P1|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
8440807|NCT00806819|20800153|P2|STARTED|Overall Study|randomised patients|360
8440808|NCT00806819|20800154|P1|STARTED|Overall Study|randomised patients|353
8440809|NCT00806676|20800189|P3|NOT COMPLETED|Overall Study||6
8440810|NCT00806676|20800190|P2|NOT COMPLETED|Overall Study||0
8440811|NCT00806676|20800191|P1|NOT COMPLETED|Overall Study||4
8440812|NCT00806676|20800189|P3|COMPLETED|Overall Study||23
8440813|NCT00806676|20800190|P2|COMPLETED|Overall Study||9
8440814|NCT00806676|20800191|P1|COMPLETED|Overall Study||25
8440815|NCT00806676|20800189|P3|STARTED|Overall Study||29
8440816|NCT00806676|20800190|P2|STARTED|Overall Study||9
8440817|NCT00806676|20800191|P1|STARTED|Overall Study||29
8440818|NCT00806624|20800223|P3|NOT COMPLETED|Overall Study||6
8440819|NCT00806624|20800224|P2|NOT COMPLETED|Overall Study||12
8440820|NCT00806624|20800225|P1|NOT COMPLETED|Overall Study||9
8440821|NCT00806624|20800223|P3|COMPLETED|Overall Study||69
8440822|NCT00806624|20800224|P2|COMPLETED|Overall Study||68
8440823|NCT00806624|20800225|P1|COMPLETED|Overall Study||70
8440824|NCT00806624|20800223|P3|STARTED|Overall Study||75
8440825|NCT00806624|20800224|P2|STARTED|Overall Study||80
8440826|NCT00806624|20800225|P1|STARTED|Overall Study||79
8440827|NCT00806598|20800233|P1|NOT COMPLETED|Overall Study||0
8440828|NCT00806598|20800233|P1|COMPLETED|Overall Study||48
8440829|NCT00806598|20800233|P1|STARTED|Overall Study||48
8440830|NCT00806585|20800242|P5|NOT COMPLETED|Overall Study||31
8440831|NCT00806585|20800243|P4|NOT COMPLETED|Overall Study||15
8440832|NCT00806585|20800244|P3|NOT COMPLETED|Overall Study||32
8440833|NCT00806585|20800245|P2|NOT COMPLETED|Overall Study||31
8440834|NCT00806585|20800246|P1|NOT COMPLETED|Overall Study||32
8440835|NCT00806585|20800242|P5|COMPLETED|Overall Study||106
8440836|NCT00806585|20800243|P4|COMPLETED|Overall Study||56
8440837|NCT00806585|20800244|P3|COMPLETED|Overall Study||109
8440838|NCT00806585|20800245|P2|COMPLETED|Overall Study||103
8440839|NCT00806585|20800246|P1|COMPLETED|Overall Study||105
8440840|NCT00806585|20800242|P5|STARTED|Overall Study||137
8440841|NCT00806585|20800243|P4|STARTED|Overall Study||71
8440842|NCT00806585|20800244|P3|STARTED|Overall Study||141
8440843|NCT00806585|20800245|P2|STARTED|Overall Study||134
8440844|NCT00806585|20800246|P1|STARTED|Overall Study||137
8440845|NCT00806546|20800278|P1|NOT COMPLETED|Overall Study||307
8440846|NCT00806546|20800278|P1|COMPLETED|Overall Study||207
8440847|NCT00806546|20800278|P1|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
8440848|NCT00806494|20800282|P1|NOT COMPLETED|Overall Study||80
8440849|NCT00806494|20800282|P1|COMPLETED|Overall Study||251
8440850|NCT00806494|20800282|P1|STARTED|Overall Study||331
8440851|NCT00806442|20800306|P2|NOT COMPLETED|Overall Study||7
8440852|NCT00806442|20800307|P1|NOT COMPLETED|Overall Study||4
8440853|NCT00806442|20800306|P2|COMPLETED|Overall Study||14
8440854|NCT00806442|20800307|P1|COMPLETED|Overall Study||14
8440855|NCT00806442|20800306|P2|Second Intervention (3 Wks)|Overall Study||14
8440856|NCT00806442|20800307|P1|Second Intervention (3 Wks)|Overall Study||15
8440857|NCT00806442|20800306|P2|Washout (3 Wks)|Overall Study||14
8440858|NCT00806442|20800307|P1|Washout (3 Wks)|Overall Study||15
8440859|NCT00806442|20800306|P2|First Intervention (3 Wks)|Overall Study||21
8440860|NCT00806442|20800307|P1|First Intervention (3 Wks)|Overall Study||18
8440861|NCT00806442|20800306|P2|STARTED|Overall Study||21
8440862|NCT00806442|20800307|P1|STARTED|Overall Study||18
8440863|NCT00806416|20800329|P4|NOT COMPLETED|Period 2 - Part II||0
8440864|NCT00806416|20800330|P3|NOT COMPLETED|Period 2 - Part II||0
8440865|NCT00806416|20800331|P2|NOT COMPLETED|Period 2 - Part II||0
8440866|NCT00806416|20800332|P1|NOT COMPLETED|Period 2 - Part II||0
8440867|NCT00806416|20800329|P4|COMPLETED|Period 2 - Part II||14
8440868|NCT00806416|20800330|P3|COMPLETED|Period 2 - Part II||14
8440869|NCT00806416|20800331|P2|COMPLETED|Period 2 - Part II||0
8440870|NCT00806416|20800332|P1|COMPLETED|Period 2 - Part II||0
8440871|NCT00806416|20800329|P4|STARTED|Period 2 - Part II||14
8440872|NCT00806416|20800330|P3|STARTED|Period 2 - Part II||14
8440873|NCT00806416|20800331|P2|STARTED|Period 2 - Part II||0
8440874|NCT00806416|20800332|P1|STARTED|Period 2 - Part II||0
8440875|NCT00806416|20800329|P4|NOT COMPLETED|Period 1 - Part II||2
8440876|NCT00806416|20800330|P3|NOT COMPLETED|Period 1 - Part II||0
8440877|NCT00806416|20800331|P2|NOT COMPLETED|Period 1 - Part II||0
8440878|NCT00806416|20800332|P1|NOT COMPLETED|Period 1 - Part II||0
8440879|NCT00806416|20800329|P4|COMPLETED|Period 1 - Part II||14
8440880|NCT00806416|20800330|P3|COMPLETED|Period 1 - Part II||14
8440881|NCT00806416|20800331|P2|COMPLETED|Period 1 - Part II||0
8440882|NCT00806416|20800332|P1|COMPLETED|Period 1 - Part II||0
8440883|NCT00806416|20800329|P4|STARTED|Period 1 - Part II||16
8440884|NCT00806416|20800330|P3|STARTED|Period 1 - Part II||14
8440885|NCT00806416|20800331|P2|STARTED|Period 1 - Part II||0
8440886|NCT00806416|20800332|P1|STARTED|Period 1 - Part II||0
8440887|NCT00806416|20800329|P4|NOT COMPLETED|Period 2 - Part I||0
8440888|NCT00806416|20800330|P3|NOT COMPLETED|Period 2 - Part I||0
8440889|NCT00806416|20800331|P2|NOT COMPLETED|Period 2 - Part I||0
8440890|NCT00806416|20800332|P1|NOT COMPLETED|Period 2 - Part I||0
8440891|NCT00806416|20800329|P4|COMPLETED|Period 2 - Part I||0
8440892|NCT00806416|20800330|P3|COMPLETED|Period 2 - Part I||0
8440893|NCT00806416|20800331|P2|COMPLETED|Period 2 - Part I||103
8440894|NCT00806416|20800332|P1|COMPLETED|Period 2 - Part I||104
8440895|NCT00806416|20800329|P4|STARTED|Period 2 - Part I||0
8440896|NCT00806416|20800330|P3|STARTED|Period 2 - Part I||0
8440897|NCT00806416|20800331|P2|STARTED|Period 2 - Part I||103
8440898|NCT00806416|20800332|P1|STARTED|Period 2 - Part I||104
8440899|NCT00806416|20800329|P4|NOT COMPLETED|Period 1 - Part I||0
8440900|NCT00806416|20800330|P3|NOT COMPLETED|Period 1 - Part I||0
8440901|NCT00806416|20800331|P2|NOT COMPLETED|Period 1 - Part I||4
8440902|NCT00806416|20800332|P1|NOT COMPLETED|Period 1 - Part I||3
8440903|NCT00806416|20800329|P4|COMPLETED|Period 1 - Part I||0
8440904|NCT00806416|20800330|P3|COMPLETED|Period 1 - Part I||0
8440905|NCT00806416|20800331|P2|COMPLETED|Period 1 - Part I||103
8440906|NCT00806416|20800332|P1|COMPLETED|Period 1 - Part I||104
8440907|NCT00806416|20800329|P4|STARTED|Period 1 - Part I||0
8440908|NCT00806416|20800330|P3|STARTED|Period 1 - Part I||0
8440909|NCT00806416|20800331|P2|STARTED|Period 1 - Part I||107
8440910|NCT00806416|20800332|P1|STARTED|Period 1 - Part I||107
8440911|NCT00806403|20800345|P2|NOT COMPLETED|Overall Study||3
8440912|NCT00806403|20800346|P1|NOT COMPLETED|Overall Study||4
8440913|NCT00806403|20800345|P2|COMPLETED|Overall Study||98
8440914|NCT00806403|20800346|P1|COMPLETED|Overall Study||100
8440915|NCT00806403|20800345|P2|STARTED|Overall Study||101
8440916|NCT00806403|20800346|P1|STARTED|Overall Study||104
8440917|NCT00806390|20800360|P2|NOT COMPLETED|Overall Study||0
8440918|NCT00806390|20800361|P1|NOT COMPLETED|Overall Study||0
8440919|NCT00806390|20800360|P2|COMPLETED|Overall Study||8
8440920|NCT00806390|20800361|P1|COMPLETED|Overall Study||7
8440921|NCT00806390|20800360|P2|STARTED|Overall Study||8
8440922|NCT00806390|20800361|P1|STARTED|Overall Study||7
8440923|NCT00806351|20800369|P2|NOT COMPLETED|Overall Study||4
8440924|NCT00806351|20800370|P1|NOT COMPLETED|Overall Study||5
8440925|NCT00806351|20800369|P2|COMPLETED|Overall Study||2
8440926|NCT00806351|20800370|P1|COMPLETED|Overall Study||10
8440927|NCT00806351|20800369|P2|STARTED|Overall Study||6
8440928|NCT00806351|20800370|P1|STARTED|Overall Study||15
8440929|NCT00806286|20800404|P3|NOT COMPLETED|Overall Study||3
8440930|NCT00806286|20800405|P2|NOT COMPLETED|Overall Study||54
8440931|NCT00806286|20800406|P1|NOT COMPLETED|Overall Study||54
8440932|NCT00806286|20800404|P3|COMPLETED|Overall Study||0
8440933|NCT00806286|20800405|P2|COMPLETED|Overall Study||0
8440934|NCT00806286|20800406|P1|COMPLETED|Overall Study||0
8440935|NCT00806286|20800404|P3|STARTED|Overall Study||3
8440936|NCT00806286|20800405|P2|STARTED|Overall Study||54
8440937|NCT00806286|20800406|P1|STARTED|Overall Study||54
8440938|NCT00806260|20800428|P6|NOT COMPLETED|Period 3||0
8440939|NCT00806260|20800429|P5|NOT COMPLETED|Period 3||0
8440940|NCT00806260|20800430|P4|NOT COMPLETED|Period 3||0
8440941|NCT00806260|20800431|P3|NOT COMPLETED|Period 3||1
8440942|NCT00806260|20800432|P2|NOT COMPLETED|Period 3||1
8440943|NCT00806260|20800433|P1|NOT COMPLETED|Period 3||1
8440944|NCT00806260|20800428|P6|COMPLETED|Period 3||0
8440945|NCT00806260|20800429|P5|COMPLETED|Period 3||0
8440946|NCT00806260|20800430|P4|COMPLETED|Period 3||12
8440947|NCT00806260|20800431|P3|COMPLETED|Period 3||5
8440948|NCT00806260|20800432|P2|COMPLETED|Period 3||7
8440949|NCT00806260|20800433|P1|COMPLETED|Period 3||12
8440950|NCT00806260|20800428|P6|STARTED|Period 3||0
8440951|NCT00806260|20800429|P5|STARTED|Period 3||0
8440952|NCT00806260|20800430|P4|STARTED|Period 3||12
8440953|NCT00806260|20800431|P3|STARTED|Period 3||6
8440954|NCT00806260|20800432|P2|STARTED|Period 3||8
8440955|NCT00806260|20800433|P1|STARTED|Period 3||13
8440956|NCT00806260|20800428|P6|NOT COMPLETED|Period 2||0
8440957|NCT00806260|20800429|P5|NOT COMPLETED|Period 2||0
8440958|NCT00806260|20800430|P4|NOT COMPLETED|Period 2||2
8440959|NCT00806260|20800431|P3|NOT COMPLETED|Period 2||2
8440960|NCT00806260|20800432|P2|NOT COMPLETED|Period 2||0
8440961|NCT00806260|20800433|P1|NOT COMPLETED|Period 2||2
8440962|NCT00806260|20800428|P6|COMPLETED|Period 2||0
8440963|NCT00806260|20800429|P5|COMPLETED|Period 2||0
8440964|NCT00806260|20800430|P4|COMPLETED|Period 2||12
8440965|NCT00806260|20800431|P3|COMPLETED|Period 2||6
8440966|NCT00806260|20800432|P2|COMPLETED|Period 2||8
8440967|NCT00806260|20800433|P1|COMPLETED|Period 2||13
8440968|NCT00806260|20800428|P6|STARTED|Period 2||0
8440969|NCT00806260|20800429|P5|STARTED|Period 2||0
8440970|NCT00806260|20800430|P4|STARTED|Period 2||14
8440971|NCT00806260|20800431|P3|STARTED|Period 2||8
8440972|NCT00806260|20800432|P2|STARTED|Period 2||8
8440973|NCT00806260|20800433|P1|STARTED|Period 2||15
8440974|NCT00806260|20800428|P6|NOT COMPLETED|Period 1 (1 Day)||0
8440975|NCT00806260|20800429|P5|NOT COMPLETED|Period 1 (1 Day)||3
8440976|NCT00806260|20800430|P4|NOT COMPLETED|Period 1 (1 Day)||0
8440977|NCT00806260|20800431|P3|NOT COMPLETED|Period 1 (1 Day)||0
8440978|NCT00806260|20800432|P2|NOT COMPLETED|Period 1 (1 Day)||0
8440979|NCT00806260|20800433|P1|NOT COMPLETED|Period 1 (1 Day)||0
8440980|NCT00806260|20800428|P6|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
8440981|NCT00806260|20800429|P5|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
8440982|NCT00806260|20800430|P4|COMPLETED|Period 1 (1 Day)||14
8440983|NCT00806260|20800431|P3|COMPLETED|Period 1 (1 Day)||8
8440984|NCT00806260|20800432|P2|COMPLETED|Period 1 (1 Day)||8
8440985|NCT00806260|20800433|P1|COMPLETED|Period 1 (1 Day)||15
8440986|NCT00806260|20800428|P6|STARTED|Period 1 (1 Day)||17
8440987|NCT00806260|20800429|P5|STARTED|Period 1 (1 Day)||18
8440988|NCT00806260|20800430|P4|STARTED|Period 1 (1 Day)||14
8440989|NCT00806260|20800431|P3|STARTED|Period 1 (1 Day)||8
8440990|NCT00806260|20800432|P2|STARTED|Period 1 (1 Day)||8
8440991|NCT00806260|20800433|P1|STARTED|Period 1 (1 Day)||15
8440992|NCT00806234|20800448|P3|NOT COMPLETED|Overall Study||12
8440993|NCT00806234|20800449|P2|NOT COMPLETED|Overall Study||12
8440994|NCT00806234|20800450|P1|NOT COMPLETED|Overall Study||13
8440995|NCT00806234|20800448|P3|COMPLETED|Overall Study||37
8440996|NCT00806234|20800449|P2|COMPLETED|Overall Study||19
8440997|NCT00806234|20800450|P1|COMPLETED|Overall Study||34
8440998|NCT00806234|20800448|P3|STARTED|Overall Study||49
8440999|NCT00806234|20800449|P2|STARTED|Overall Study||31
8441000|NCT00806234|20800450|P1|STARTED|Overall Study||47
8441001|NCT00806221|20800467|P1|NOT COMPLETED|Overall Study||2
8441002|NCT00806221|20800467|P1|COMPLETED|Overall Study||20
8441003|NCT00806221|20800467|P1|STARTED|Overall Study||22
8441004|NCT00806195|20800478|P4|NOT COMPLETED|Overall Study||106
8441005|NCT00806195|20800479|P3|NOT COMPLETED|Overall Study||270
8441006|NCT00806195|20800480|P2|NOT COMPLETED|Overall Study||162
8441007|NCT00806195|20800481|P1|NOT COMPLETED|Overall Study||514
8441008|NCT00806195|20800478|P4|COMPLETED|Overall Study||383
8441009|NCT00806195|20800479|P3|COMPLETED|Overall Study||1139
8441010|NCT00806195|20800480|P2|COMPLETED|Overall Study||1321
8441011|NCT00806195|20800481|P1|COMPLETED|Overall Study||3849
8441012|NCT00806195|20800478|P4|STARTED|Overall Study||489
8441013|NCT00806195|20800479|P3|STARTED|Overall Study||1409
8441014|NCT00806195|20800480|P2|STARTED|Overall Study||1483
8441015|NCT00806195|20800481|P1|STARTED|Overall Study||4363
8441016|NCT00806078|20800495|P2|NOT COMPLETED|Second Intervention||0
8441017|NCT00806078|20800496|P1|NOT COMPLETED|Second Intervention||0
8441018|NCT00806078|20800495|P2|COMPLETED|Second Intervention||9
8441019|NCT00806078|20800496|P1|COMPLETED|Second Intervention||9
8441020|NCT00806078|20800495|P2|STARTED|Second Intervention||9
8441021|NCT00806078|20800496|P1|STARTED|Second Intervention||9
8441022|NCT00806078|20800495|P2|NOT COMPLETED|7 Day Washout Period||0
8441023|NCT00806078|20800496|P1|NOT COMPLETED|7 Day Washout Period||0
8441024|NCT00806078|20800495|P2|COMPLETED|7 Day Washout Period||9
8441025|NCT00806078|20800496|P1|COMPLETED|7 Day Washout Period||9
8441026|NCT00806078|20800495|P2|STARTED|7 Day Washout Period||9
8441027|NCT00806078|20800496|P1|STARTED|7 Day Washout Period||9
8441028|NCT00806078|20800495|P2|NOT COMPLETED|First Intervention||0
8441029|NCT00806078|20800496|P1|NOT COMPLETED|First Intervention||0
8441030|NCT00806078|20800495|P2|COMPLETED|First Intervention||9
8441031|NCT00806078|20800496|P1|COMPLETED|First Intervention||9
8441032|NCT00806078|20800495|P2|STARTED|First Intervention||9
8441033|NCT00806078|20800496|P1|STARTED|First Intervention||9
8441034|NCT00806026|20800512|P6|NOT COMPLETED|Overall Study||32
8441035|NCT00806026|20800513|P5|NOT COMPLETED|Overall Study||30
8441036|NCT00806026|20800514|P4|NOT COMPLETED|Overall Study||29
8441037|NCT00806026|20800515|P3|NOT COMPLETED|Overall Study||93
8441038|NCT00806026|20800516|P2|NOT COMPLETED|Overall Study||101
8441039|NCT00806026|20800517|P1|NOT COMPLETED|Overall Study||92
8441040|NCT00806026|20800512|P6|COMPLETED|Overall Study||29
8441041|NCT00806026|20800513|P5|COMPLETED|Overall Study||29
8441042|NCT00806026|20800514|P4|COMPLETED|Overall Study||32
8441043|NCT00806026|20800515|P3|COMPLETED|Overall Study||89
8441044|NCT00806026|20800516|P2|COMPLETED|Overall Study||82
8441045|NCT00806026|20800517|P1|COMPLETED|Overall Study||93
8441046|NCT00806026|20800512|P6|Treated|Overall Study||61
8441047|NCT00806026|20800513|P5|Treated|Overall Study||59
8441048|NCT00806026|20800514|P4|Treated|Overall Study||59
8441049|NCT00806026|20800515|P3|Treated|Overall Study||180
8441050|NCT00806026|20800516|P2|Treated|Overall Study||178
8441051|NCT00806026|20800517|P1|Treated|Overall Study||182
8441052|NCT00806026|20800512|P6|STARTED|Overall Study||61
8441053|NCT00806026|20800513|P5|STARTED|Overall Study||59
8441054|NCT00806026|20800514|P4|STARTED|Overall Study||61
8441055|NCT00806026|20800515|P3|STARTED|Overall Study||182
8441056|NCT00806026|20800516|P2|STARTED|Overall Study||183
8441057|NCT00806026|20800517|P1|STARTED|Overall Study||185
8441058|NCT00805961|20800612|P1|NOT COMPLETED|Maintenance Treatment||34
8441059|NCT00805961|20800612|P1|COMPLETED|Maintenance Treatment||23
8441060|NCT00805961|20800612|P1|STARTED|Maintenance Treatment||57
8441061|NCT00805961|20800612|P1|NOT COMPLETED|Treatment-Free Interval||7
8441062|NCT00805961|20800612|P1|COMPLETED|Treatment-Free Interval||57
8441063|NCT00805961|20800612|P1|STARTED|Treatment-Free Interval||64
8441064|NCT00805961|20800612|P1|NOT COMPLETED|Modality Therapy||4
8441065|NCT00805961|20800612|P1|COMPLETED|Modality Therapy||64
8441066|NCT00805961|20800612|P1|STARTED|Modality Therapy||68
8441067|NCT00805948|20800620|P2|NOT COMPLETED|Overall Study||96
8441068|NCT00805948|20800621|P1|NOT COMPLETED|Overall Study||68
8441069|NCT00805948|20800620|P2|COMPLETED|Overall Study||99
8441070|NCT00805948|20800621|P1|COMPLETED|Overall Study||86
8441071|NCT00805948|20800620|P2|STARTED|Overall Study||195
8441072|NCT00805948|20800621|P1|STARTED|Overall Study||154
8441073|NCT00805935|20800636|P4|NOT COMPLETED|Overall Study||11
8441074|NCT00805935|20800637|P3|NOT COMPLETED|Overall Study||15
8441075|NCT00805935|20800638|P2|NOT COMPLETED|Overall Study||19
8441076|NCT00805935|20800639|P1|NOT COMPLETED|Overall Study||13
8441077|NCT00805935|20800636|P4|COMPLETED|Overall Study||19
8441078|NCT00805935|20800637|P3|COMPLETED|Overall Study||13
8441079|NCT00805935|20800638|P2|COMPLETED|Overall Study||8
8441080|NCT00805935|20800639|P1|COMPLETED|Overall Study||12
8441081|NCT00805935|20800636|P4|STARTED|Overall Study||30
8441082|NCT00805935|20800637|P3|STARTED|Overall Study||28
8441083|NCT00805935|20800638|P2|STARTED|Overall Study||27
8441084|NCT00805935|20800639|P1|STARTED|Overall Study||25
8441085|NCT00805870|20800693|P2|NOT COMPLETED|Overall Study||0
8441086|NCT00805870|20800694|P1|NOT COMPLETED|Overall Study||0
8441087|NCT00805870|20800693|P2|COMPLETED|Overall Study||10
8441088|NCT00805870|20800694|P1|COMPLETED|Overall Study||10
8441089|NCT00805870|20800693|P2|STARTED|Overall Study||10
8441090|NCT00805870|20800694|P1|STARTED|Overall Study||10
8441094|NCT00805766|20800714|P1|NOT COMPLETED|Increased Dose Period||13
8441095|NCT00805766|20800714|P1|COMPLETED|Increased Dose Period||26
8441096|NCT00805766|20800714|P1|STARTED|Increased Dose Period||39
8441097|NCT00805766|20800714|P1|NOT COMPLETED|Screening Period||6
8441098|NCT00805766|20800714|P1|COMPLETED|Screening Period||39
8441099|NCT00805766|20800714|P1|STARTED|Screening Period||45
8441100|NCT00805740|20800728|P2|NOT COMPLETED|Overall Study||4
8441101|NCT00805740|20800729|P1|NOT COMPLETED|Overall Study||11
8441102|NCT00805740|20800728|P2|COMPLETED|Overall Study||9
8441103|NCT00805740|20800729|P1|COMPLETED|Overall Study||17
8441104|NCT00805740|20800728|P2|Treated|Overall Study||13
8441105|NCT00805740|20800729|P1|Treated|Overall Study||26
8441106|NCT00805740|20800728|P2|STARTED|Overall Study||13
8441107|NCT00805740|20800729|P1|STARTED|Overall Study||28
8441108|NCT00805675|20800754|P3|NOT COMPLETED|Overall Study||1
8441109|NCT00805675|20800755|P2|NOT COMPLETED|Overall Study||0
8441110|NCT00805675|20800756|P1|NOT COMPLETED|Overall Study||0
8441111|NCT00805675|20800754|P3|COMPLETED|Overall Study||15
8441112|NCT00805675|20800755|P2|COMPLETED|Overall Study||14
8441113|NCT00805675|20800756|P1|COMPLETED|Overall Study||16
8441114|NCT00805675|20800754|P3|STARTED|Overall Study||16
8441115|NCT00805675|20800755|P2|STARTED|Overall Study||14
8441116|NCT00805675|20800756|P1|STARTED|Overall Study||16
8441117|NCT00805545|20800790|P2|NOT COMPLETED|Overall Study||3
8441118|NCT00805545|20800791|P1|NOT COMPLETED|Overall Study||6
8441119|NCT00805545|20800790|P2|COMPLETED|Overall Study||197
8441120|NCT00805545|20800791|P1|COMPLETED|Overall Study||194
8441121|NCT00805545|20800790|P2|STARTED|Overall Study||200
8441122|NCT00805545|20800791|P1|STARTED|Overall Study||200
8441123|NCT00805532|20800799|P2|NOT COMPLETED|Overall Study||1
8441124|NCT00805532|20800800|P1|NOT COMPLETED|Overall Study||0
8441125|NCT00805532|20800799|P2|COMPLETED|Overall Study||38
8441126|NCT00805532|20800800|P1|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
8441127|NCT00805532|20800799|P2|STARTED|Overall Study||39
8441128|NCT00805532|20800800|P1|STARTED|Overall Study||42
8441129|NCT00805493|20800817|P3|NOT COMPLETED|Overall Study||1
8441130|NCT00805493|20800818|P2|NOT COMPLETED|Overall Study||0
8441131|NCT00805493|20800819|P1|NOT COMPLETED|Overall Study||2
8441132|NCT00805493|20800817|P3|COMPLETED|Overall Study||0
8441133|NCT00805493|20800818|P2|COMPLETED|Overall Study||2
8441134|NCT00805493|20800819|P1|COMPLETED|Overall Study||1
8441135|NCT00805493|20800817|P3|STARTED|Overall Study||1
8441136|NCT00805493|20800818|P2|STARTED|Overall Study||2
8441137|NCT00805493|20800819|P1|STARTED|Overall Study||3
8441138|NCT00805480|20800834|P4|NOT COMPLETED|Overall Study||5
8441139|NCT00805480|20800835|P3|NOT COMPLETED|Overall Study||12
8441140|NCT00805480|20800836|P2|NOT COMPLETED|Overall Study||7
8441141|NCT00805480|20800837|P1|NOT COMPLETED|Overall Study||14
8441142|NCT00805480|20800834|P4|COMPLETED|Overall Study||5
8441143|NCT00805480|20800835|P3|COMPLETED|Overall Study||19
8441144|NCT00805480|20800836|P2|COMPLETED|Overall Study||22
8441145|NCT00805480|20800837|P1|COMPLETED|Overall Study||16
8441146|NCT00805480|20800834|P4|Pharmacodynamic Analysis Set|Overall Study||10
8441147|NCT00805480|20800835|P3|Pharmacodynamic Analysis Set|Overall Study||29
8441148|NCT00805480|20800836|P2|Pharmacodynamic Analysis Set|Overall Study||25
8441149|NCT00805480|20800837|P1|Pharmacodynamic Analysis Set|Overall Study||30
8441150|NCT00805480|20800834|P4|STARTED|Overall Study||10
8441151|NCT00805480|20800835|P3|STARTED|Overall Study||31
8441152|NCT00805480|20800836|P2|STARTED|Overall Study||29
8441153|NCT00805480|20800837|P1|STARTED|Overall Study||30
8441154|NCT00805467|20800866|P4|NOT COMPLETED|Overall Study||237
8441155|NCT00805467|20800867|P3|NOT COMPLETED|Overall Study||103
8441156|NCT00805467|20800868|P2|NOT COMPLETED|Overall Study||34
8441157|NCT00805467|20800869|P1|NOT COMPLETED|Overall Study||0
8441158|NCT00805467|20800866|P4|COMPLETED|Overall Study|Ongoing when study terminated|144
8441159|NCT00805467|20800867|P3|COMPLETED|Overall Study|Ongoing when study terminated|80
8441160|NCT00805467|20800868|P2|COMPLETED|Overall Study|Ongoing when study terminated|25
8441161|NCT00805467|20800869|P1|COMPLETED|Overall Study|Ongoing when study terminated|1
8441162|NCT00805467|20800866|P4|Enrolled But Did Not Receive Treatment|Overall Study||0
8441163|NCT00805467|20800867|P3|Enrolled But Did Not Receive Treatment|Overall Study||0
8441164|NCT00805467|20800868|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
8441165|NCT00805467|20800869|P1|Enrolled But Did Not Receive Treatment|Overall Study||0
8441166|NCT00805467|20800866|P4|STARTED|Overall Study|Patients who received treatment|381
8441167|NCT00805467|20800867|P3|STARTED|Overall Study|Patients who received treatment|183
8441168|NCT00805467|20800868|P2|STARTED|Overall Study|Patients who received treatment|59
8441169|NCT00805467|20800869|P1|STARTED|Overall Study|Patients who received treatment|1
8441170|NCT00805441|20800889|P2|NOT COMPLETED|Overall Study||36
8441171|NCT00805441|20800890|P1|NOT COMPLETED|Overall Study||34
8441172|NCT00805441|20800889|P2|COMPLETED|Overall Study||60
8441173|NCT00805441|20800890|P1|COMPLETED|Overall Study||60
8441174|NCT00805441|20800889|P2|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
8441175|NCT00805441|20800890|P1|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
8441176|NCT00805441|20800889|P2|STARTED|Overall Study||96
8441177|NCT00805441|20800890|P1|STARTED|Overall Study||94
8441178|NCT00805389|20800925|P5|NOT COMPLETED|Overall Study||13
8441179|NCT00805389|20800926|P4|NOT COMPLETED|Overall Study||17
8441180|NCT00805389|20800927|P3|NOT COMPLETED|Overall Study||12
8441181|NCT00805389|20800928|P2|NOT COMPLETED|Overall Study||5
8441182|NCT00805389|20800929|P1|NOT COMPLETED|Overall Study||7
8441183|NCT00805389|20800925|P5|COMPLETED|Overall Study||129
8441184|NCT00805389|20800926|P4|COMPLETED|Overall Study||128
8441185|NCT00805389|20800927|P3|COMPLETED|Overall Study||129
8441186|NCT00805389|20800928|P2|COMPLETED|Overall Study||137
8441187|NCT00805389|20800929|P1|COMPLETED|Overall Study||136
8441188|NCT00805389|20800925|P5|STARTED|Overall Study||142
8441189|NCT00805389|20800926|P4|STARTED|Overall Study||145
8441190|NCT00805389|20800927|P3|STARTED|Overall Study||141
8441191|NCT00805389|20800928|P2|STARTED|Overall Study||142
8441192|NCT00805389|20800929|P1|STARTED|Overall Study||143
8441193|NCT00805285|20801176|P1|NOT COMPLETED|Overall Study||1
8441194|NCT00805285|20801176|P1|COMPLETED|Overall Study||0
8441195|NCT00805285|20801176|P1|STARTED|Overall Study||1
8441196|NCT00805207|20801193|P9|NOT COMPLETED|Overall Study||0
8441197|NCT00805207|20801194|P8|NOT COMPLETED|Overall Study||0
8441198|NCT00805207|20801195|P7|NOT COMPLETED|Overall Study||0
8441199|NCT00805207|20801196|P6|NOT COMPLETED|Overall Study||3
8441200|NCT00805207|20801197|P5|NOT COMPLETED|Overall Study||1
8441201|NCT00805207|20801198|P4|NOT COMPLETED|Overall Study||0
8441202|NCT00805207|20801199|P3|NOT COMPLETED|Overall Study||1
8441203|NCT00805207|20801200|P2|NOT COMPLETED|Overall Study||2
8441204|NCT00805207|20801201|P1|NOT COMPLETED|Overall Study||0
8441205|NCT00805207|20801193|P9|COMPLETED|Overall Study||6
8441206|NCT00805207|20801194|P8|COMPLETED|Overall Study||6
8441207|NCT00805207|20801195|P7|COMPLETED|Overall Study||6
8441208|NCT00805207|20801196|P6|COMPLETED|Overall Study||9
8441209|NCT00805207|20801197|P5|COMPLETED|Overall Study||2
8441210|NCT00805207|20801198|P4|COMPLETED|Overall Study||6
8441211|NCT00805207|20801199|P3|COMPLETED|Overall Study||11
8441212|NCT00805207|20801200|P2|COMPLETED|Overall Study||7
8441213|NCT00805207|20801201|P1|COMPLETED|Overall Study||1
8441214|NCT00805207|20801193|P9|STARTED|Overall Study||6
8441215|NCT00805207|20801194|P8|STARTED|Overall Study||6
8441216|NCT00805207|20801195|P7|STARTED|Overall Study||6
8441217|NCT00805207|20801196|P6|STARTED|Overall Study||12
8441218|NCT00805207|20801197|P5|STARTED|Overall Study||3
8441219|NCT00805207|20801198|P4|STARTED|Overall Study||6
8441220|NCT00805207|20801199|P3|STARTED|Overall Study||12
8441221|NCT00805207|20801200|P2|STARTED|Overall Study||9
8441222|NCT00805207|20801201|P1|STARTED|Overall Study||1
8441223|NCT00805194|20801259|P2|NOT COMPLETED|Overall Study||654
8441224|NCT00805194|20801260|P1|NOT COMPLETED|Overall Study||649
8441225|NCT00805194|20801259|P2|COMPLETED|Overall Study||5
8441226|NCT00805194|20801260|P1|COMPLETED|Overall Study||6
8441227|NCT00805194|20801259|P2|STARTED|Overall Study|randomised patients|659
8441228|NCT00805194|20801260|P1|STARTED|Overall Study|randomised patients|655
8441229|NCT00805142|20801294|P2|NOT COMPLETED|Maintenance Period||2
8441230|NCT00805142|20801295|P1|NOT COMPLETED|Maintenance Period||0
8441231|NCT00805142|20801294|P2|COMPLETED|Maintenance Period||30
8441232|NCT00805142|20801295|P1|COMPLETED|Maintenance Period||30
8441233|NCT00805142|20801294|P2|STARTED|Maintenance Period||32
8441234|NCT00805142|20801295|P1|STARTED|Maintenance Period||30
8441235|NCT00805142|20801294|P2|NOT COMPLETED|Titration Period||10
8441236|NCT00805142|20801295|P1|NOT COMPLETED|Titration Period||6
8441237|NCT00805142|20801294|P2|COMPLETED|Titration Period||32
8441238|NCT00805142|20801295|P1|COMPLETED|Titration Period||30
8441239|NCT00805142|20801294|P2|STARTED|Titration Period||42
8441240|NCT00805142|20801295|P1|STARTED|Titration Period||36
8441241|NCT00805038|20801321|P2|NOT COMPLETED|Overall Study||0
8441242|NCT00805038|20801322|P1|NOT COMPLETED|Overall Study||0
8441243|NCT00805038|20801321|P2|COMPLETED|Overall Study||92
8441244|NCT00805038|20801322|P1|COMPLETED|Overall Study||75
8441245|NCT00805038|20801321|P2|STARTED|Overall Study||92
8441246|NCT00805038|20801322|P1|STARTED|Overall Study||75
8441247|NCT00805025|20801328|P1|NOT COMPLETED|Overall Study||49
8441248|NCT00805025|20801328|P1|COMPLETED|Overall Study||82
8441249|NCT00805025|20801328|P1|Enrolled and Treated|Overall Study||89
8441250|NCT00805025|20801328|P1|STARTED|Overall Study||131
8441251|NCT00804999|20801338|P4|NOT COMPLETED|Overall Study||0
8441252|NCT00804999|20801339|P3|NOT COMPLETED|Overall Study||0
8441253|NCT00804999|20801340|P2|NOT COMPLETED|Overall Study||0
8441254|NCT00804999|20801341|P1|NOT COMPLETED|Overall Study||0
8441255|NCT00804999|20801338|P4|COMPLETED|Overall Study||10
8441256|NCT00804999|20801339|P3|COMPLETED|Overall Study||14
8441257|NCT00804999|20801340|P2|COMPLETED|Overall Study||12
8441258|NCT00804999|20801341|P1|COMPLETED|Overall Study||15
8441259|NCT00804999|20801338|P4|STARTED|Overall Study||10
8441260|NCT00804999|20801339|P3|STARTED|Overall Study||14
8441261|NCT00804999|20801340|P2|STARTED|Overall Study||12
8441262|NCT00804999|20801341|P1|STARTED|Overall Study||15
8441263|NCT00804986|20801357|P6|NOT COMPLETED|Overall Study||10
8441264|NCT00804986|20801358|P5|NOT COMPLETED|Overall Study||9
8441265|NCT00804986|20801359|P4|NOT COMPLETED|Overall Study||8
8441266|NCT00804986|20801360|P3|NOT COMPLETED|Overall Study||2
8441267|NCT00804986|20801361|P2|NOT COMPLETED|Overall Study||8
8441268|NCT00804986|20801362|P1|NOT COMPLETED|Overall Study||1
8441269|NCT00804986|20801357|P6|COMPLETED|Overall Study||31
8441270|NCT00804986|20801358|P5|COMPLETED|Overall Study||34
8441271|NCT00804986|20801359|P4|COMPLETED|Overall Study||34
8441272|NCT00804986|20801360|P3|COMPLETED|Overall Study||40
8441273|NCT00804986|20801361|P2|COMPLETED|Overall Study||35
8441274|NCT00804986|20801362|P1|COMPLETED|Overall Study||35
8441275|NCT00804986|20801357|P6|STARTED|Overall Study||41
8441276|NCT00804986|20801358|P5|STARTED|Overall Study||43
8441277|NCT00804986|20801359|P4|STARTED|Overall Study||42
8441278|NCT00804986|20801360|P3|STARTED|Overall Study||42
8441279|NCT00804986|20801361|P2|STARTED|Overall Study||43
8441280|NCT00804986|20801362|P1|STARTED|Overall Study||36
8441281|NCT00804973|20801457|P3|NOT COMPLETED|Overall Study||0
8441282|NCT00804973|20801458|P2|NOT COMPLETED|Overall Study||0
8441283|NCT00804973|20801459|P1|NOT COMPLETED|Overall Study||0
8441284|NCT00804973|20801457|P3|COMPLETED|Overall Study||40
8441285|NCT00804973|20801458|P2|COMPLETED|Overall Study||40
8441286|NCT00804973|20801459|P1|COMPLETED|Overall Study||40
8441287|NCT00804973|20801457|P3|Received at Least 1 Dose of Study Drug|Overall Study||40
8441288|NCT00804973|20801458|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
8441289|NCT00804973|20801459|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
8441290|NCT00804973|20801457|P3|STARTED|Overall Study||40
8441291|NCT00804973|20801458|P2|STARTED|Overall Study||40
8441292|NCT00804973|20801459|P1|STARTED|Overall Study||40
8441293|NCT00804908|20801497|P3|NOT COMPLETED|Overall Study||114
8441294|NCT00804908|20801498|P2|NOT COMPLETED|Overall Study||116
8441295|NCT00804908|20801499|P1|NOT COMPLETED|Overall Study||115
8441296|NCT00804908|20801497|P3|COMPLETED|Overall Study||1
8441297|NCT00804908|20801498|P2|COMPLETED|Overall Study||0
8441298|NCT00804908|20801499|P1|COMPLETED|Overall Study||0
8441299|NCT00804908|20801497|P3|STARTED|Overall Study||115
8441300|NCT00804908|20801498|P2|STARTED|Overall Study||116
8441301|NCT00804908|20801499|P1|STARTED|Overall Study||115
8441302|NCT00804843|20801530|P2|NOT COMPLETED|Overall Study||7
8441303|NCT00804843|20801531|P1|NOT COMPLETED|Overall Study||10
8441304|NCT00804843|20801530|P2|COMPLETED|Overall Study||43
8441305|NCT00804843|20801531|P1|COMPLETED|Overall Study||40
8441306|NCT00804843|20801530|P2|STARTED|Overall Study||50
8441307|NCT00804843|20801531|P1|STARTED|Overall Study||50
8441308|NCT00804713|20801541|P1|NOT COMPLETED|Overall Study||0
8441309|NCT00804713|20801541|P1|COMPLETED|Overall Study||1978
8441310|NCT00804713|20801541|P1|STARTED|Overall Study||1978
8441311|NCT00804687|20801549|P6|NOT COMPLETED|Period 5: Treatment Period||0
8441312|NCT00804687|20801550|P5|NOT COMPLETED|Period 5: Treatment Period||1
8441313|NCT00804687|20801551|P4|NOT COMPLETED|Period 5: Treatment Period||0
8441314|NCT00804687|20801552|P3|NOT COMPLETED|Period 5: Treatment Period||1
8441315|NCT00804687|20801553|P2|NOT COMPLETED|Period 5: Treatment Period||0
8441316|NCT00804687|20801554|P1|NOT COMPLETED|Period 5: Treatment Period||1
8441317|NCT00804687|20801549|P6|COMPLETED|Period 5: Treatment Period||8
8441318|NCT00804687|20801550|P5|COMPLETED|Period 5: Treatment Period||8
8441319|NCT00804687|20801551|P4|COMPLETED|Period 5: Treatment Period||8
8441320|NCT00804687|20801552|P3|COMPLETED|Period 5: Treatment Period||8
8441321|NCT00804687|20801553|P2|COMPLETED|Period 5: Treatment Period||9
8441322|NCT00804687|20801554|P1|COMPLETED|Period 5: Treatment Period||8
8441323|NCT00804687|20801549|P6|STARTED|Period 5: Treatment Period||8
8441324|NCT00804687|20801550|P5|STARTED|Period 5: Treatment Period||9
8441325|NCT00804687|20801551|P4|STARTED|Period 5: Treatment Period||8
8441326|NCT00804687|20801552|P3|STARTED|Period 5: Treatment Period||9
8441327|NCT00804687|20801553|P2|STARTED|Period 5: Treatment Period||9
8441328|NCT00804687|20801554|P1|STARTED|Period 5: Treatment Period||9
8441329|NCT00804687|20801549|P6|NOT COMPLETED|Period 4: Washout Period||0
8441330|NCT00804687|20801550|P5|NOT COMPLETED|Period 4: Washout Period||0
8441331|NCT00804687|20801551|P4|NOT COMPLETED|Period 4: Washout Period||0
8441332|NCT00804687|20801552|P3|NOT COMPLETED|Period 4: Washout Period||0
8441333|NCT00804687|20801553|P2|NOT COMPLETED|Period 4: Washout Period||0
8441334|NCT00804687|20801554|P1|NOT COMPLETED|Period 4: Washout Period||0
8441335|NCT00804687|20801549|P6|COMPLETED|Period 4: Washout Period||8
8441336|NCT00804687|20801550|P5|COMPLETED|Period 4: Washout Period||9
8441337|NCT00804687|20801551|P4|COMPLETED|Period 4: Washout Period||8
8441338|NCT00804687|20801552|P3|COMPLETED|Period 4: Washout Period||9
8441339|NCT00804687|20801553|P2|COMPLETED|Period 4: Washout Period||9
8441340|NCT00804687|20801554|P1|COMPLETED|Period 4: Washout Period||9
8441341|NCT00804687|20801549|P6|STARTED|Period 4: Washout Period||8
8441342|NCT00804687|20801550|P5|STARTED|Period 4: Washout Period||9
8441343|NCT00804687|20801551|P4|STARTED|Period 4: Washout Period||8
8441344|NCT00804687|20801552|P3|STARTED|Period 4: Washout Period||9
8441345|NCT00804687|20801553|P2|STARTED|Period 4: Washout Period||9
8441346|NCT00804687|20801554|P1|STARTED|Period 4: Washout Period||9
8441347|NCT00804687|20801549|P6|NOT COMPLETED|Period 3: Treatment Period||0
8441348|NCT00804687|20801550|P5|NOT COMPLETED|Period 3: Treatment Period||0
8441349|NCT00804687|20801551|P4|NOT COMPLETED|Period 3: Treatment Period||1
8441350|NCT00804687|20801552|P3|NOT COMPLETED|Period 3: Treatment Period||0
8441351|NCT00804687|20801553|P2|NOT COMPLETED|Period 3: Treatment Period||0
8441352|NCT00804687|20801554|P1|NOT COMPLETED|Period 3: Treatment Period||0
8441353|NCT00804687|20801549|P6|COMPLETED|Period 3: Treatment Period||8
8441354|NCT00804687|20801550|P5|COMPLETED|Period 3: Treatment Period||9
8441355|NCT00804687|20801551|P4|COMPLETED|Period 3: Treatment Period||8
8441356|NCT00804687|20801552|P3|COMPLETED|Period 3: Treatment Period||9
8441357|NCT00804687|20801553|P2|COMPLETED|Period 3: Treatment Period||9
8441358|NCT00804687|20801554|P1|COMPLETED|Period 3: Treatment Period||9
8441359|NCT00804687|20801549|P6|STARTED|Period 3: Treatment Period||8
8441360|NCT00804687|20801550|P5|STARTED|Period 3: Treatment Period||9
8441361|NCT00804687|20801551|P4|STARTED|Period 3: Treatment Period||9
8441362|NCT00804687|20801552|P3|STARTED|Period 3: Treatment Period||9
8441363|NCT00804687|20801553|P2|STARTED|Period 3: Treatment Period||9
8441364|NCT00804687|20801554|P1|STARTED|Period 3: Treatment Period||9
8441365|NCT00804687|20801549|P6|NOT COMPLETED|Period 2: Washout Period||0
8441366|NCT00804687|20801550|P5|NOT COMPLETED|Period 2: Washout Period||0
8441367|NCT00804687|20801551|P4|NOT COMPLETED|Period 2: Washout Period||0
8441368|NCT00804687|20801552|P3|NOT COMPLETED|Period 2: Washout Period||0
8441369|NCT00804687|20801553|P2|NOT COMPLETED|Period 2: Washout Period||0
8441370|NCT00804687|20801554|P1|NOT COMPLETED|Period 2: Washout Period||0
8441371|NCT00804687|20801549|P6|COMPLETED|Period 2: Washout Period||8
8441372|NCT00804687|20801550|P5|COMPLETED|Period 2: Washout Period||9
8441373|NCT00804687|20801551|P4|COMPLETED|Period 2: Washout Period||9
8441374|NCT00804687|20801552|P3|COMPLETED|Period 2: Washout Period||9
8441375|NCT00804687|20801553|P2|COMPLETED|Period 2: Washout Period||9
8441376|NCT00804687|20801554|P1|COMPLETED|Period 2: Washout Period||9
8441377|NCT00804687|20801549|P6|STARTED|Period 2: Washout Period||8
8441378|NCT00804687|20801550|P5|STARTED|Period 2: Washout Period||9
8441379|NCT00804687|20801551|P4|STARTED|Period 2: Washout Period||9
8441380|NCT00804687|20801552|P3|STARTED|Period 2: Washout Period||9
8441381|NCT00804687|20801553|P2|STARTED|Period 2: Washout Period||9
8441382|NCT00804687|20801554|P1|STARTED|Period 2: Washout Period||9
8441383|NCT00804687|20801549|P6|NOT COMPLETED|Period 1: Treatment Period||0
8441384|NCT00804687|20801550|P5|NOT COMPLETED|Period 1: Treatment Period||0
8441385|NCT00804687|20801551|P4|NOT COMPLETED|Period 1: Treatment Period||0
8441386|NCT00804687|20801552|P3|NOT COMPLETED|Period 1: Treatment Period||0
8441387|NCT00804687|20801553|P2|NOT COMPLETED|Period 1: Treatment Period||0
8441388|NCT00804687|20801554|P1|NOT COMPLETED|Period 1: Treatment Period||0
8441389|NCT00804687|20801549|P6|COMPLETED|Period 1: Treatment Period||8
8441390|NCT00804687|20801550|P5|COMPLETED|Period 1: Treatment Period||9
8441391|NCT00804687|20801551|P4|COMPLETED|Period 1: Treatment Period||9
8441392|NCT00804687|20801552|P3|COMPLETED|Period 1: Treatment Period||9
8441393|NCT00804687|20801553|P2|COMPLETED|Period 1: Treatment Period||9
8441394|NCT00804687|20801554|P1|COMPLETED|Period 1: Treatment Period||9
8441395|NCT00804687|20801549|P6|STARTED|Period 1: Treatment Period||8
8441396|NCT00804687|20801550|P5|STARTED|Period 1: Treatment Period||9
8441397|NCT00804687|20801551|P4|STARTED|Period 1: Treatment Period||9
8441398|NCT00804687|20801552|P3|STARTED|Period 1: Treatment Period||9
8441399|NCT00804687|20801553|P2|STARTED|Period 1: Treatment Period||9
8441400|NCT00804687|20801554|P1|STARTED|Period 1: Treatment Period||9
8441401|NCT00804648|20801571|P6|NOT COMPLETED|Third Invervention||0
8441402|NCT00804648|20801572|P5|NOT COMPLETED|Third Invervention||0
8441403|NCT00804648|20801573|P4|NOT COMPLETED|Third Invervention||0
8441404|NCT00804648|20801574|P3|NOT COMPLETED|Third Invervention||0
8441405|NCT00804648|20801575|P2|NOT COMPLETED|Third Invervention||0
8441406|NCT00804648|20801576|P1|NOT COMPLETED|Third Invervention||0
8441407|NCT00804648|20801571|P6|COMPLETED|Third Invervention||8
8441408|NCT00804648|20801572|P5|COMPLETED|Third Invervention||4
8441409|NCT00804648|20801573|P4|COMPLETED|Third Invervention||4
8441410|NCT00804648|20801574|P3|COMPLETED|Third Invervention||6
8441411|NCT00804648|20801575|P2|COMPLETED|Third Invervention||5
8441412|NCT00804648|20801576|P1|COMPLETED|Third Invervention||3
8441413|NCT00804648|20801571|P6|STARTED|Third Invervention||8
8441414|NCT00804648|20801572|P5|STARTED|Third Invervention||4
8441415|NCT00804648|20801573|P4|STARTED|Third Invervention||4
8441416|NCT00804648|20801574|P3|STARTED|Third Invervention||6
8441417|NCT00804648|20801575|P2|STARTED|Third Invervention||5
8441418|NCT00804648|20801576|P1|STARTED|Third Invervention||3
8441419|NCT00804648|20801571|P6|NOT COMPLETED|Second Intervention||0
8441420|NCT00804648|20801572|P5|NOT COMPLETED|Second Intervention||0
8441421|NCT00804648|20801573|P4|NOT COMPLETED|Second Intervention||0
8441422|NCT00804648|20801574|P3|NOT COMPLETED|Second Intervention||0
8441423|NCT00804648|20801575|P2|NOT COMPLETED|Second Intervention||0
8441424|NCT00804648|20801576|P1|NOT COMPLETED|Second Intervention||0
8441425|NCT00804648|20801571|P6|COMPLETED|Second Intervention||8
8441426|NCT00804648|20801572|P5|COMPLETED|Second Intervention||4
8441427|NCT00804648|20801573|P4|COMPLETED|Second Intervention||4
8441428|NCT00804648|20801574|P3|COMPLETED|Second Intervention||6
8441429|NCT00804648|20801575|P2|COMPLETED|Second Intervention||5
8441430|NCT00804648|20801576|P1|COMPLETED|Second Intervention||3
8441431|NCT00804648|20801571|P6|STARTED|Second Intervention||8
8441432|NCT00804648|20801572|P5|STARTED|Second Intervention||4
8441433|NCT00804648|20801573|P4|STARTED|Second Intervention||4
8441434|NCT00804648|20801574|P3|STARTED|Second Intervention||6
8441435|NCT00804648|20801575|P2|STARTED|Second Intervention||5
8441436|NCT00804648|20801576|P1|STARTED|Second Intervention||3
8441437|NCT00804648|20801571|P6|NOT COMPLETED|First Intervention||0
8441438|NCT00804648|20801572|P5|NOT COMPLETED|First Intervention||0
8441439|NCT00804648|20801573|P4|NOT COMPLETED|First Intervention||0
8441440|NCT00804648|20801574|P3|NOT COMPLETED|First Intervention||0
8441441|NCT00804648|20801575|P2|NOT COMPLETED|First Intervention||0
8441442|NCT00804648|20801576|P1|NOT COMPLETED|First Intervention||0
8441443|NCT00804648|20801571|P6|COMPLETED|First Intervention||8
8441444|NCT00804648|20801572|P5|COMPLETED|First Intervention||4
8441445|NCT00804648|20801573|P4|COMPLETED|First Intervention||4
8441446|NCT00804648|20801574|P3|COMPLETED|First Intervention||6
8441447|NCT00804648|20801575|P2|COMPLETED|First Intervention||5
8441448|NCT00804648|20801576|P1|COMPLETED|First Intervention||3
8441449|NCT00804648|20801571|P6|STARTED|First Intervention||8
8441450|NCT00804648|20801572|P5|STARTED|First Intervention||4
8441451|NCT00804648|20801573|P4|STARTED|First Intervention||4
8441452|NCT00804648|20801574|P3|STARTED|First Intervention||6
8441453|NCT00804648|20801575|P2|STARTED|First Intervention||5
8441454|NCT00804648|20801576|P1|STARTED|First Intervention||3
8441455|NCT00804609|20801619|P2|NOT COMPLETED|Overall Study||1
8441456|NCT00804609|20801620|P1|NOT COMPLETED|Overall Study||0
8441457|NCT00804609|20801619|P2|COMPLETED|Overall Study||14
8441458|NCT00804609|20801620|P1|COMPLETED|Overall Study||15
8441459|NCT00804609|20801619|P2|STARTED|Overall Study||15
8441460|NCT00804609|20801620|P1|STARTED|Overall Study||15
8441461|NCT00804596|20801626|P1|NOT COMPLETED|Overall Study||0
8441462|NCT00804596|20801626|P1|COMPLETED|Overall Study||74
8441463|NCT00804596|20801626|P1|STARTED|Overall Study||74
8441464|NCT00804570|20801633|P2|NOT COMPLETED|Overall Study||94
8441465|NCT00804570|20801634|P1|NOT COMPLETED|Overall Study||72
8441466|NCT00804570|20801633|P2|COMPLETED|Overall Study||94
8441467|NCT00804570|20801634|P1|COMPLETED|Overall Study||115
8441468|NCT00804570|20801633|P2|STARTED|Overall Study||188
8441469|NCT00804570|20801634|P1|STARTED|Overall Study||187
8441470|NCT00804349|20801692|P2|NOT COMPLETED|Overall Study||0
8441471|NCT00804349|20801693|P1|NOT COMPLETED|Overall Study||0
8441472|NCT00804349|20801692|P2|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
8441473|NCT00804349|20801693|P1|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
8441474|NCT00804349|20801692|P2|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
8441475|NCT00804349|20801693|P1|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available.|0
8441476|NCT00804193|20801708|P3|NOT COMPLETED|Overall Study||32
8441477|NCT00804193|20801709|P2|NOT COMPLETED|Overall Study||44
8441478|NCT00804193|20801710|P1|NOT COMPLETED|Overall Study||39
8441479|NCT00804193|20801708|P3|COMPLETED|Overall Study||77
8441480|NCT00804193|20801709|P2|COMPLETED|Overall Study||180
8441481|NCT00804193|20801710|P1|COMPLETED|Overall Study||181
8441482|NCT00804193|20801708|P3|STARTED|Overall Study||109
8441483|NCT00804193|20801709|P2|STARTED|Overall Study||224
8441484|NCT00804193|20801710|P1|STARTED|Overall Study||220
8441485|NCT00804141|20801724|P1|NOT COMPLETED|Overall Study||563
8441486|NCT00804141|20801724|P1|COMPLETED|Overall Study||477
8441487|NCT00804141|20801724|P1|Received at Least 1 Dose of Study Drug|Overall Study||1034
8441488|NCT00804141|20801724|P1|STARTED|Overall Study||1040
8441489|NCT00803959|20801731|P2|NOT COMPLETED|Overall Study||51
8441490|NCT00803959|20801732|P1|NOT COMPLETED|Overall Study||56
8441491|NCT00803959|20801731|P2|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
8441492|NCT00803959|20801732|P1|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
8441493|NCT00803959|20801731|P2|ITT Analysis With Primary Outcome Data|Overall Study||272
8441494|NCT00803959|20801732|P1|ITT Analysis With Primary Outcome Data|Overall Study||266
8441495|NCT00803959|20801731|P2|STARTED|Overall Study||315
8441496|NCT00803959|20801732|P1|STARTED|Overall Study||315
8441497|NCT00803790|20801764|P4|NOT COMPLETED|Period 2||1
8441498|NCT00803790|20801765|P3|NOT COMPLETED|Period 2||1
8441499|NCT00803790|20801766|P2|NOT COMPLETED|Period 2||0
8441500|NCT00803790|20801767|P1|NOT COMPLETED|Period 2||2
8441501|NCT00803790|20801764|P4|COMPLETED|Period 2||30
8441502|NCT00803790|20801765|P3|COMPLETED|Period 2||30
8441503|NCT00803790|20801766|P2|COMPLETED|Period 2||114
8441504|NCT00803790|20801767|P1|COMPLETED|Period 2||114
8441505|NCT00803790|20801764|P4|STARTED|Period 2||31
8441506|NCT00803790|20801765|P3|STARTED|Period 2||31
8441507|NCT00803790|20801766|P2|STARTED|Period 2||114
8441508|NCT00803790|20801767|P1|STARTED|Period 2||116
8441509|NCT00803790|20801764|P4|NOT COMPLETED|Period 1||4
8441510|NCT00803790|20801765|P3|NOT COMPLETED|Period 1||1
8441511|NCT00803790|20801766|P2|NOT COMPLETED|Period 1||12
8441512|NCT00803790|20801767|P1|NOT COMPLETED|Period 1||9
8441513|NCT00803790|20801764|P4|COMPLETED|Period 1||31
8441514|NCT00803790|20801765|P3|COMPLETED|Period 1||31
8441515|NCT00803790|20801766|P2|COMPLETED|Period 1||114
8441516|NCT00803790|20801767|P1|COMPLETED|Period 1||116
8441517|NCT00803790|20801764|P4|STARTED|Period 1||35
8441518|NCT00803790|20801765|P3|STARTED|Period 1||32
8441519|NCT00803790|20801766|P2|STARTED|Period 1||126
8441520|NCT00803790|20801767|P1|STARTED|Period 1||125
8441521|NCT00803777|20801778|P1|NOT COMPLETED|Overall Study||0
8441522|NCT00803777|20801778|P1|COMPLETED|Overall Study||147
8441523|NCT00803777|20801778|P1|STARTED|Overall Study||147
8441524|NCT00803751|20801788|P2|NOT COMPLETED|Overall Study||0
8441525|NCT00803751|20801789|P1|NOT COMPLETED|Overall Study||0
8441526|NCT00803751|20801788|P2|COMPLETED|Overall Study||23
8441527|NCT00803751|20801789|P1|COMPLETED|Overall Study||26
8441528|NCT00803751|20801788|P2|STARTED|Overall Study||23
8441529|NCT00803751|20801789|P1|STARTED|Overall Study||26
8441530|NCT00803738|20801807|P2|NOT COMPLETED|Overall Study||110
8441531|NCT00803738|20801808|P1|NOT COMPLETED|Overall Study||94
8441532|NCT00803738|20801807|P2|COMPLETED|Overall Study||176
8441533|NCT00803738|20801808|P1|COMPLETED|Overall Study||192
8441534|NCT00803738|20801807|P2|STARTED|Overall Study||286
8441535|NCT00803738|20801808|P1|STARTED|Overall Study||286
8441536|NCT00803712|20801820|P2|NOT COMPLETED|Overall Study||27
8441537|NCT00803712|20801821|P1|NOT COMPLETED|Overall Study||36
8441538|NCT00803712|20801820|P2|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
8441539|NCT00803712|20801821|P1|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
8441540|NCT00803712|20801820|P2|Safety Analysis Set|Overall Study|Randomized to the control group|154
8441541|NCT00803712|20801821|P1|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
8441542|NCT00803712|20801820|P2|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
8441543|NCT00803712|20801821|P1|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
8441544|NCT00803712|20801820|P2|STARTED|Overall Study|155 participants were randomized to the control group|155
8441545|NCT00803712|20801821|P1|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
8441546|NCT00803686|20801889|P4|NOT COMPLETED|Part 2, Period 3||0
8441547|NCT00803686|20801890|P3|NOT COMPLETED|Part 2, Period 3||0
8441548|NCT00803686|20801891|P2|NOT COMPLETED|Part 2, Period 3||0
8441549|NCT00803686|20801892|P1|NOT COMPLETED|Part 2, Period 3||0
8441550|NCT00803686|20801889|P4|COMPLETED|Part 2, Period 3|All who started this period completed|4
8441551|NCT00803686|20801890|P3|COMPLETED|Part 2, Period 3|All who started this period completed|5
8441552|NCT00803686|20801891|P2|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
8441553|NCT00803686|20801892|P1|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
8441554|NCT00803686|20801889|P4|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
8441555|NCT00803686|20801890|P3|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
8441556|NCT00803686|20801891|P2|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
8441557|NCT00803686|20801892|P1|STARTED|Part 2, Period 3|No subjects were treated in this period|0
8441558|NCT00803686|20801889|P4|NOT COMPLETED|Part 1, Period 2||0
8441559|NCT00803686|20801890|P3|NOT COMPLETED|Part 1, Period 2||0
8441560|NCT00803686|20801891|P2|NOT COMPLETED|Part 1, Period 2||0
8441561|NCT00803686|20801892|P1|NOT COMPLETED|Part 1, Period 2||0
8441562|NCT00803686|20801889|P4|COMPLETED|Part 1, Period 2|No subjects treated.|0
8441563|NCT00803686|20801890|P3|COMPLETED|Part 1, Period 2|No subjects treated.|0
8441564|NCT00803686|20801891|P2|COMPLETED|Part 1, Period 2||6
8441565|NCT00803686|20801892|P1|COMPLETED|Part 1, Period 2||6
8441566|NCT00803686|20801889|P4|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
8441567|NCT00803686|20801890|P3|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
8441568|NCT00803686|20801891|P2|STARTED|Part 1, Period 2||6
8441569|NCT00803686|20801892|P1|STARTED|Part 1, Period 2||6
8441570|NCT00803686|20801889|P4|NOT COMPLETED|Part 1, Period 1||0
8441571|NCT00803686|20801890|P3|NOT COMPLETED|Part 1, Period 1||0
8441572|NCT00803686|20801891|P2|NOT COMPLETED|Part 1, Period 1||0
8441573|NCT00803686|20801892|P1|NOT COMPLETED|Part 1, Period 1||0
8441574|NCT00803686|20801889|P4|COMPLETED|Part 1, Period 1||0
8441575|NCT00803686|20801890|P3|COMPLETED|Part 1, Period 1||0
8441576|NCT00803686|20801891|P2|COMPLETED|Part 1, Period 1||6
8441577|NCT00803686|20801892|P1|COMPLETED|Part 1, Period 1||6
8441578|NCT00803686|20801889|P4|STARTED|Part 1, Period 1||0
8441579|NCT00803686|20801890|P3|STARTED|Part 1, Period 1||0
8441580|NCT00803686|20801891|P2|STARTED|Part 1, Period 1||6
8441581|NCT00803686|20801892|P1|STARTED|Part 1, Period 1||6
8441582|NCT00803647|20801910|P1|NOT COMPLETED|Overall Study||0
8441583|NCT00803647|20801910|P1|COMPLETED|Overall Study||20
8441584|NCT00803647|20801910|P1|STARTED|Overall Study||20
8441585|NCT00803634|20801920|P2|NOT COMPLETED|Overall Study||5
8441586|NCT00803634|20801921|P1|NOT COMPLETED|Overall Study||6
8441587|NCT00803634|20801920|P2|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
8441588|NCT00803634|20801921|P1|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
8441589|NCT00803634|20801920|P2|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
8441590|NCT00803634|20801921|P1|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
8441591|NCT00803634|20801920|P2|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
8441592|NCT00803634|20801921|P1|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
8441593|NCT00803595|20801950|P3|NOT COMPLETED|Overall Study||16
8441594|NCT00803595|20801951|P2|NOT COMPLETED|Overall Study||8
8441595|NCT00803595|20801952|P1|NOT COMPLETED|Overall Study||15
8441596|NCT00803595|20801950|P3|COMPLETED|Overall Study||322
8441597|NCT00803595|20801951|P2|COMPLETED|Overall Study||319
8441598|NCT00803595|20801952|P1|COMPLETED|Overall Study||322
8441599|NCT00803595|20801950|P3|STARTED|Overall Study||338
8441600|NCT00803595|20801951|P2|STARTED|Overall Study||327
8441601|NCT00803595|20801952|P1|STARTED|Overall Study||337
8441602|NCT00803569|20801963|P1|NOT COMPLETED|Overall Study||4
8441603|NCT00803569|20801963|P1|COMPLETED|Overall Study||9
8441604|NCT00803569|20801963|P1|STARTED|Overall Study||13
8441605|NCT00803543|20801973|P2|NOT COMPLETED|Overall Study||12
8441606|NCT00803543|20801974|P1|NOT COMPLETED|Overall Study||24
8441607|NCT00803543|20801973|P2|COMPLETED|Overall Study||22
8441608|NCT00803543|20801974|P1|COMPLETED|Overall Study||45
8441609|NCT00803543|20801973|P2|STARTED|Overall Study||34
8441610|NCT00803543|20801974|P1|STARTED|Overall Study||69
8441611|NCT00803517|20801988|P2|NOT COMPLETED|Overall Study||0
8441612|NCT00803517|20801989|P1|NOT COMPLETED|Overall Study||0
8441613|NCT00803517|20801988|P2|COMPLETED|Overall Study||12
8441614|NCT00803517|20801989|P1|COMPLETED|Overall Study||12
8441615|NCT00803517|20801988|P2|STARTED|Overall Study||12
8441616|NCT00803517|20801989|P1|STARTED|Overall Study||12
8441617|NCT00803452|20801997|P2|NOT COMPLETED|Overall Study||5
8441618|NCT00803452|20801998|P1|NOT COMPLETED|Overall Study||0
8441619|NCT00803452|20801997|P2|COMPLETED|Overall Study||17
8441620|NCT00803452|20801998|P1|COMPLETED|Overall Study||9
8441621|NCT00803452|20801997|P2|STARTED|Overall Study||22
8441622|NCT00803452|20801998|P1|STARTED|Overall Study||9
8441623|NCT00803413|20802008|P4|NOT COMPLETED|Overall Period||0
8441624|NCT00803413|20802009|P3|NOT COMPLETED|Overall Period||0
8441625|NCT00803413|20802010|P2|NOT COMPLETED|Overall Period||0
8441626|NCT00803413|20802011|P1|NOT COMPLETED|Overall Period||0
8441627|NCT00803413|20802008|P4|COMPLETED|Overall Period||30
8441628|NCT00803413|20802009|P3|COMPLETED|Overall Period||29
8441629|NCT00803413|20802010|P2|COMPLETED|Overall Period||32
8441630|NCT00803413|20802011|P1|COMPLETED|Overall Period||28
8441631|NCT00803413|20802008|P4|STARTED|Overall Period||30
8441632|NCT00803413|20802009|P3|STARTED|Overall Period||29
8441633|NCT00803413|20802010|P2|STARTED|Overall Period||32
8441634|NCT00803413|20802011|P1|STARTED|Overall Period||28
8441641|NCT00803361|20802036|P2|NOT COMPLETED|Overall Study||28
8441642|NCT00803361|20802037|P1|NOT COMPLETED|Overall Study||26
8441643|NCT00803361|20802036|P2|COMPLETED|Overall Study||74
8441644|NCT00803361|20802037|P1|COMPLETED|Overall Study||82
8441645|NCT00803361|20802036|P2|STARTED|Overall Study||102
8441646|NCT00803361|20802037|P1|STARTED|Overall Study||108
8441647|NCT00803283|20802057|P2|NOT COMPLETED|Overall Study||0
8441648|NCT00803283|20802058|P1|NOT COMPLETED|Overall Study||0
8441649|NCT00803283|20802057|P2|COMPLETED|Overall Study||1
8441650|NCT00803283|20802058|P1|COMPLETED|Overall Study||1
8441651|NCT00803283|20802057|P2|STARTED|Overall Study||1
8441652|NCT00803283|20802058|P1|STARTED|Overall Study||1
8441653|NCT00803270|20802084|P2|NOT COMPLETED|Overall Study||2
8441654|NCT00803270|20802085|P1|NOT COMPLETED|Overall Study||1
8441655|NCT00803270|20802084|P2|COMPLETED|Overall Study||12
8441656|NCT00803270|20802085|P1|COMPLETED|Overall Study||12
8441657|NCT00803270|20802084|P2|STARTED|Overall Study||14
8441658|NCT00803270|20802085|P1|STARTED|Overall Study||13
8441659|NCT00803244|20802095|P2|NOT COMPLETED|Overall Study||15
8441660|NCT00803244|20802096|P1|NOT COMPLETED|Overall Study||7
8441661|NCT00803244|20802095|P2|COMPLETED|Overall Study||178
8441662|NCT00803244|20802096|P1|COMPLETED|Overall Study||181
8441663|NCT00803244|20802095|P2|STARTED|Overall Study||193
8441664|NCT00803244|20802096|P1|STARTED|Overall Study||188
8441665|NCT00803205|20802106|P2|NOT COMPLETED|Overall Study||14
8441666|NCT00803205|20802107|P1|NOT COMPLETED|Overall Study||20
8441667|NCT00803205|20802106|P2|COMPLETED|Overall Study||104
8441668|NCT00803205|20802107|P1|COMPLETED|Overall Study||100
8441669|NCT00803205|20802106|P2|Per Protocol Population|Overall Study||103
8441670|NCT00803205|20802107|P1|Per Protocol Population|Overall Study||100
8441671|NCT00803205|20802106|P2|ITT Population|Overall Study||116
8441672|NCT00803205|20802107|P1|ITT Population|Overall Study||116
8441673|NCT00803205|20802106|P2|As-Treated Population*|Overall Study||118
8441674|NCT00803205|20802107|P1|As-Treated Population*|Overall Study||120
8441675|NCT00803205|20802106|P2|Completed Week 24|Overall Study||110
8441676|NCT00803205|20802107|P1|Completed Week 24|Overall Study||103
8441677|NCT00803205|20802106|P2|Completed Week 16|Overall Study||113
8441678|NCT00803205|20802107|P1|Completed Week 16|Overall Study||107
8441679|NCT00803205|20802106|P2|STARTED|Overall Study||118
8441680|NCT00803205|20802107|P1|STARTED|Overall Study||120
8441681|NCT00803179|20802150|P1|NOT COMPLETED|Overall Study||3
8441682|NCT00803179|20802150|P1|COMPLETED|Overall Study||2
8441683|NCT00803179|20802150|P1|STARTED|Overall Study||5
8441684|NCT00803114|20802156|P2|NOT COMPLETED|Overall Study||0
8441685|NCT00803114|20802157|P1|NOT COMPLETED|Overall Study||0
8441686|NCT00803114|20802156|P2|COMPLETED|Overall Study||115
8441687|NCT00803114|20802157|P1|COMPLETED|Overall Study||113
8441688|NCT00803114|20802156|P2|STARTED|Overall Study||115
8441689|NCT00803114|20802157|P1|STARTED|Overall Study||113
8441690|NCT00803101|20802169|P2|NOT COMPLETED|Overall Study||22
8441691|NCT00803101|20802170|P1|NOT COMPLETED|Overall Study||18
8441692|NCT00803101|20802169|P2|COMPLETED|Overall Study||66
8441693|NCT00803101|20802170|P1|COMPLETED|Overall Study||70
8441694|NCT00803101|20802169|P2|STARTED|Overall Study||88
8441695|NCT00803101|20802170|P1|STARTED|Overall Study||88
8441696|NCT00803062|20802192|P4|NOT COMPLETED|Overall Study||0
8441697|NCT00803062|20802193|P3|NOT COMPLETED|Overall Study||0
8441698|NCT00803062|20802194|P2|NOT COMPLETED|Overall Study||0
8441699|NCT00803062|20802195|P1|NOT COMPLETED|Overall Study||0
8441700|NCT00803062|20802192|P4|COMPLETED|Overall Study||112
8441701|NCT00803062|20802193|P3|COMPLETED|Overall Study||111
8441702|NCT00803062|20802194|P2|COMPLETED|Overall Study||115
8441703|NCT00803062|20802195|P1|COMPLETED|Overall Study||114
8441704|NCT00803062|20802192|P4|STARTED|Overall Study||112
8441705|NCT00803062|20802193|P3|STARTED|Overall Study||111
8441706|NCT00803062|20802194|P2|STARTED|Overall Study||115
8441707|NCT00803062|20802195|P1|STARTED|Overall Study||114
8441708|NCT00803049|20802221|P4|NOT COMPLETED|Overall Study||102
8441709|NCT00803049|20802222|P3|NOT COMPLETED|Overall Study||44
8441710|NCT00803049|20802223|P2|NOT COMPLETED|Overall Study||118
8441711|NCT00803049|20802224|P1|NOT COMPLETED|Overall Study||61
8441712|NCT00803049|20802221|P4|COMPLETED|Overall Study||151
8441713|NCT00803049|20802222|P3|COMPLETED|Overall Study||64
8441714|NCT00803049|20802223|P2|COMPLETED|Overall Study||134
8441715|NCT00803049|20802224|P1|COMPLETED|Overall Study||68
8441716|NCT00803049|20802221|P4|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
8441717|NCT00803049|20802222|P3|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
8441718|NCT00803049|20802223|P2|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
8441719|NCT00803049|20802224|P1|Safety Population|Overall Study||129
8441720|NCT00803049|20802221|P4|Treated|Overall Study||251
8441721|NCT00803049|20802222|P3|Treated|Overall Study||108
8441722|NCT00803049|20802223|P2|Treated|Overall Study||252
8441723|NCT00803049|20802224|P1|Treated|Overall Study||129
8441724|NCT00803049|20802221|P4|STARTED|Overall Study|Randomized in extension study|253
8441725|NCT00803049|20802222|P3|STARTED|Overall Study|Randomized in extension study|108
8441726|NCT00803049|20802223|P2|STARTED|Overall Study|Randomized in extension study|252
8441727|NCT00803049|20802224|P1|STARTED|Overall Study|Randomized in extension study|129
8441728|NCT00803023|20802258|P4|NOT COMPLETED|Overall Study||8
8441729|NCT00803023|20802259|P3|NOT COMPLETED|Overall Study||11
8441730|NCT00803023|20802260|P2|NOT COMPLETED|Overall Study||8
8441731|NCT00803023|20802261|P1|NOT COMPLETED|Overall Study||5
8441732|NCT00803023|20802258|P4|COMPLETED|Overall Study||25
8441733|NCT00803023|20802259|P3|COMPLETED|Overall Study||20
8441734|NCT00803023|20802260|P2|COMPLETED|Overall Study||25
8441735|NCT00803023|20802261|P1|COMPLETED|Overall Study||27
8441736|NCT00803023|20802258|P4|STARTED|Overall Study||33
8441737|NCT00803023|20802259|P3|STARTED|Overall Study||31
8441738|NCT00803023|20802260|P2|STARTED|Overall Study||33
8441739|NCT00803023|20802261|P1|STARTED|Overall Study||32
8441740|NCT00803010|20802273|P2|NOT COMPLETED|Overall Study||0
8441741|NCT00803010|20802274|P1|NOT COMPLETED|Overall Study||0
8441742|NCT00803010|20802273|P2|COMPLETED|Overall Study||37
8441743|NCT00803010|20802274|P1|COMPLETED|Overall Study||37
8441744|NCT00803010|20802273|P2|STARTED|Overall Study||37
8441745|NCT00803010|20802274|P1|STARTED|Overall Study||37
8441746|NCT00802997|20802286|P2|NOT COMPLETED|6 Month to 9 Months||0
8441747|NCT00802997|20802287|P1|NOT COMPLETED|6 Month to 9 Months||2
8441748|NCT00802997|20802286|P2|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
8441749|NCT00802997|20802287|P1|COMPLETED|6 Month to 9 Months||25
8441750|NCT00802997|20802286|P2|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
8441751|NCT00802997|20802287|P1|STARTED|6 Month to 9 Months||27
8441752|NCT00802997|20802286|P2|NOT COMPLETED|3 Months to 6 Months||0
8441753|NCT00802997|20802287|P1|NOT COMPLETED|3 Months to 6 Months||7
8441754|NCT00802997|20802286|P2|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
8441755|NCT00802997|20802287|P1|COMPLETED|3 Months to 6 Months||27
8441756|NCT00802997|20802286|P2|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
8441757|NCT00802997|20802287|P1|STARTED|3 Months to 6 Months||34
8441758|NCT00802997|20802286|P2|NOT COMPLETED|Baseline to 3 Months||0
8441759|NCT00802997|20802287|P1|NOT COMPLETED|Baseline to 3 Months||0
8441760|NCT00802997|20802286|P2|COMPLETED|Baseline to 3 Months||17
8441761|NCT00802997|20802287|P1|COMPLETED|Baseline to 3 Months||34
8441762|NCT00802997|20802286|P2|STARTED|Baseline to 3 Months||17
8441763|NCT00802997|20802287|P1|STARTED|Baseline to 3 Months||34
8441764|NCT00802945|20802299|P2|NOT COMPLETED|Overall Study||35
8441765|NCT00802945|20802300|P1|NOT COMPLETED|Overall Study||35
8441766|NCT00802945|20802299|P2|COMPLETED|Overall Study||0
8441767|NCT00802945|20802300|P1|COMPLETED|Overall Study||0
8441768|NCT00802945|20802299|P2|STARTED|Overall Study||35
8441769|NCT00802945|20802300|P1|STARTED|Overall Study||35
8441770|NCT00802919|20802318|P2|NOT COMPLETED|Overall Study||1
8441771|NCT00802919|20802319|P1|NOT COMPLETED|Overall Study||3
8441772|NCT00802919|20802318|P2|COMPLETED|Overall Study||45
8441773|NCT00802919|20802319|P1|COMPLETED|Overall Study||42
8441774|NCT00802919|20802318|P2|STARTED|Overall Study||46
8441775|NCT00802919|20802319|P1|STARTED|Overall Study||45
8441776|NCT00802893|20802331|P1|NOT COMPLETED|Overall Study||3
8441777|NCT00802893|20802331|P1|COMPLETED|Overall Study||0
8441778|NCT00802893|20802331|P1|STARTED|Overall Study||3
8441779|NCT00802880|20802336|P1|NOT COMPLETED|Overall Study||0
8441780|NCT00802880|20802336|P1|COMPLETED|Overall Study||80
8441781|NCT00802880|20802336|P1|STARTED|Overall Study||80
8441782|NCT00802867|20802355|P1|NOT COMPLETED|Overall Study||13
8441783|NCT00802867|20802355|P1|COMPLETED|Overall Study||976
8441784|NCT00802867|20802355|P1|STARTED|Overall Study||989
8441785|NCT00802854|20802363|P1|NOT COMPLETED|Overall Study||0
8441786|NCT00802854|20802363|P1|COMPLETED|Overall Study||244
8441787|NCT00802854|20802363|P1|STARTED|Overall Study||244
8441788|NCT00802841|20802378|P2|NOT COMPLETED|Overall Study||95
8441789|NCT00802841|20802379|P1|NOT COMPLETED|Overall Study||96
8441790|NCT00802841|20802378|P2|COMPLETED|Overall Study||0
8441791|NCT00802841|20802379|P1|COMPLETED|Overall Study||0
8441792|NCT00802841|20802378|P2|Cross-over Set|Overall Study||56
8441793|NCT00802841|20802379|P1|Cross-over Set|Overall Study||13
8441794|NCT00802841|20802378|P2|Safety Set|Overall Study||93
8441795|NCT00802841|20802379|P1|Safety Set|Overall Study||96
8441796|NCT00802841|20802378|P2|Full Analysis Set|Overall Study||95
8441797|NCT00802841|20802379|P1|Full Analysis Set|Overall Study||96
8441798|NCT00802841|20802378|P2|STARTED|Overall Study||95
8441799|NCT00802841|20802379|P1|STARTED|Overall Study||96
8441800|NCT00802737|20802404|P3|NOT COMPLETED|Overall Study||1
8441801|NCT00802737|20802405|P2|NOT COMPLETED|Overall Study||11
8441802|NCT00802737|20802406|P1|NOT COMPLETED|Overall Study||17
8441803|NCT00802737|20802404|P3|COMPLETED|Overall Study||0
8441804|NCT00802737|20802405|P2|COMPLETED|Overall Study||0
8441805|NCT00802737|20802406|P1|COMPLETED|Overall Study||0
8441806|NCT00802737|20802404|P3|STARTED|Overall Study||1
8441807|NCT00802737|20802405|P2|STARTED|Overall Study||11
8441808|NCT00802737|20802406|P1|STARTED|Overall Study||17
8441809|NCT00802685|20802454|P2|NOT COMPLETED|Overall Study||0
8441810|NCT00802685|20802455|P1|NOT COMPLETED|Overall Study||0
8441811|NCT00802685|20802454|P2|COMPLETED|Overall Study||51
8441812|NCT00802685|20802455|P1|COMPLETED|Overall Study||54
8441813|NCT00802685|20802454|P2|STARTED|Overall Study||51
8441814|NCT00802685|20802455|P1|STARTED|Overall Study||54
8441815|NCT00802672|20802466|P3|NOT COMPLETED|Overall Study||34
8441816|NCT00802672|20802467|P2|NOT COMPLETED|Overall Study||52
8441817|NCT00802672|20802468|P1|NOT COMPLETED|Overall Study||68
8441818|NCT00802672|20802466|P3|COMPLETED|Overall Study||77
8441819|NCT00802672|20802467|P2|COMPLETED|Overall Study||174
8441820|NCT00802672|20802468|P1|COMPLETED|Overall Study||156
8441821|NCT00802672|20802466|P3|STARTED|Overall Study||111
8441822|NCT00802672|20802467|P2|STARTED|Overall Study||226
8441823|NCT00802672|20802468|P1|STARTED|Overall Study||224
8441824|NCT00802659|20802486|P4|NOT COMPLETED|Overall Study||0
8441825|NCT00802659|20802487|P3|NOT COMPLETED|Overall Study||0
8441826|NCT00802659|20802488|P2|NOT COMPLETED|Overall Study||1
8441827|NCT00802659|20802489|P1|NOT COMPLETED|Overall Study||0
8441828|NCT00802659|20802486|P4|COMPLETED|Overall Study||0
8441829|NCT00802659|20802487|P3|COMPLETED|Overall Study||0
8441830|NCT00802659|20802488|P2|COMPLETED|Overall Study||1
8441831|NCT00802659|20802489|P1|COMPLETED|Overall Study||0
8441832|NCT00802659|20802486|P4|STARTED|Overall Study||0
8441833|NCT00802659|20802487|P3|STARTED|Overall Study||0
8441834|NCT00802659|20802488|P2|STARTED|Overall Study||2
8441835|NCT00802659|20802489|P1|STARTED|Overall Study||0
8441836|NCT00802633|20802517|P2|NOT COMPLETED|Overall Study||0
8441837|NCT00802633|20802518|P1|NOT COMPLETED|Overall Study||0
8441838|NCT00802633|20802517|P2|COMPLETED|Overall Study||40
8441839|NCT00802633|20802518|P1|COMPLETED|Overall Study||40
8441840|NCT00802633|20802517|P2|STARTED|Overall Study||40
8441841|NCT00802633|20802518|P1|STARTED|Overall Study||40
8441842|NCT00802529|20802528|P2|NOT COMPLETED|Overall Study||1
8441843|NCT00802529|20802529|P1|NOT COMPLETED|Overall Study||0
8441844|NCT00802529|20802528|P2|COMPLETED|Overall Study||29
8441845|NCT00802529|20802529|P1|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
8441846|NCT00802529|20802528|P2|STARTED|Overall Study||30
8441847|NCT00802529|20802529|P1|STARTED|Overall Study||30
8441848|NCT00802503|20802541|P2|NOT COMPLETED|Overall Study||20
8441849|NCT00802503|20802542|P1|NOT COMPLETED|Overall Study||10
8441850|NCT00802503|20802541|P2|COMPLETED|Overall Study||133
8441851|NCT00802503|20802542|P1|COMPLETED|Overall Study||142
8441852|NCT00802503|20802541|P2|STARTED|Overall Study||153
8441853|NCT00802503|20802542|P1|STARTED|Overall Study||152
8441854|NCT00802464|20802568|P4|NOT COMPLETED|Month 8 - Month 14||0
8441855|NCT00802464|20802569|P3|NOT COMPLETED|Month 8 - Month 14||1
8441856|NCT00802464|20802570|P2|NOT COMPLETED|Month 8 - Month 14||2
8441857|NCT00802464|20802571|P1|NOT COMPLETED|Month 8 - Month 14||1
8441858|NCT00802464|20802568|P4|COMPLETED|Month 8 - Month 14||126
8441859|NCT00802464|20802569|P3|COMPLETED|Month 8 - Month 14||129
8441860|NCT00802464|20802570|P2|COMPLETED|Month 8 - Month 14||63
8441861|NCT00802464|20802571|P1|COMPLETED|Month 8 - Month 14||33
8441862|NCT00802464|20802568|P4|STARTED|Month 8 - Month 14||126
8441863|NCT00802464|20802569|P3|STARTED|Month 8 - Month 14||130
8441864|NCT00802464|20802570|P2|STARTED|Month 8 - Month 14||65
8441865|NCT00802464|20802571|P1|STARTED|Month 8 - Month 14||34
8441866|NCT00802464|20802568|P4|NOT COMPLETED|Month 0 - Month 8||9
8441867|NCT00802464|20802569|P3|NOT COMPLETED|Month 0 - Month 8||7
8441868|NCT00802464|20802570|P2|NOT COMPLETED|Month 0 - Month 8||3
8441869|NCT00802464|20802571|P1|NOT COMPLETED|Month 0 - Month 8||0
8441870|NCT00802464|20802568|P4|COMPLETED|Month 0 - Month 8||141
8441871|NCT00802464|20802569|P3|COMPLETED|Month 0 - Month 8||142
8441872|NCT00802464|20802570|P2|COMPLETED|Month 0 - Month 8||70
8441873|NCT00802464|20802571|P1|COMPLETED|Month 0 - Month 8||38
8441874|NCT00802464|20802568|P4|STARTED|Month 0 - Month 8||150
8441875|NCT00802464|20802569|P3|STARTED|Month 0 - Month 8||149
8441876|NCT00802464|20802570|P2|STARTED|Month 0 - Month 8||73
8441877|NCT00802464|20802571|P1|STARTED|Month 0 - Month 8||38
8441878|NCT00802438|20802657|P1|NOT COMPLETED|Overall Study||28
8441879|NCT00802438|20802657|P1|COMPLETED|Overall Study||10
8441880|NCT00802438|20802657|P1|STARTED|Overall Study||38
8441881|NCT00802412|20802664|P2|NOT COMPLETED|Overall Study||1
8441882|NCT00802412|20802665|P1|NOT COMPLETED|Overall Study||2
8441883|NCT00802412|20802664|P2|COMPLETED|Overall Study||66
8441884|NCT00802412|20802665|P1|COMPLETED|Overall Study||63
8441885|NCT00802412|20802664|P2|STARTED|Overall Study||67
8441886|NCT00802412|20802665|P1|STARTED|Overall Study||65
8441887|NCT00802360|20802677|P4|NOT COMPLETED|Overall Study||22
8441888|NCT00802360|20802678|P3|NOT COMPLETED|Overall Study||25
8441889|NCT00802360|20802679|P2|NOT COMPLETED|Overall Study||26
8441890|NCT00802360|20802680|P1|NOT COMPLETED|Overall Study||24
8441891|NCT00802360|20802677|P4|COMPLETED|Overall Study||17
8441892|NCT00802360|20802678|P3|COMPLETED|Overall Study||17
8441893|NCT00802360|20802679|P2|COMPLETED|Overall Study||16
8441894|NCT00802360|20802680|P1|COMPLETED|Overall Study||18
8441895|NCT00802360|20802677|P4|STARTED|Overall Study||39
8441896|NCT00802360|20802678|P3|STARTED|Overall Study||42
8441897|NCT00802360|20802679|P2|STARTED|Overall Study||42
8441898|NCT00802360|20802680|P1|STARTED|Overall Study||42
8441899|NCT00802204|20802722|P2|NOT COMPLETED|Overall Study||1
8441900|NCT00802204|20802723|P1|NOT COMPLETED|Overall Study||1
8441901|NCT00802204|20802722|P2|COMPLETED|Overall Study||18
8441902|NCT00802204|20802723|P1|COMPLETED|Overall Study||8
8441903|NCT00802204|20802722|P2|STARTED|Overall Study||19
8441904|NCT00802204|20802723|P1|STARTED|Overall Study||9
8441905|NCT00802178|20802747|P1|NOT COMPLETED|Overall Study||113
8441906|NCT00802178|20802747|P1|COMPLETED|Overall Study||2335
8441907|NCT00802178|20802747|P1|STARTED|Overall Study||2448
8441908|NCT00802113|20802756|P2|NOT COMPLETED|Overall Study||0
8441909|NCT00802113|20802757|P1|NOT COMPLETED|Overall Study||0
8441910|NCT00802113|20802756|P2|COMPLETED|Overall Study||17
8441911|NCT00802113|20802757|P1|COMPLETED|Overall Study||6
8441912|NCT00802113|20802756|P2|STARTED|Overall Study||17
8441913|NCT00802113|20802757|P1|STARTED|Overall Study||6
8441914|NCT00802100|20802778|P3|NOT COMPLETED|Overall Study||4
8441915|NCT00802100|20802779|P2|NOT COMPLETED|Overall Study||7
8441916|NCT00802100|20802780|P1|NOT COMPLETED|Overall Study||6
8441917|NCT00802100|20802778|P3|COMPLETED|Overall Study||2
8441918|NCT00802100|20802779|P2|COMPLETED|Overall Study||2
8441919|NCT00802100|20802780|P1|COMPLETED|Overall Study||0
8441920|NCT00802100|20802778|P3|STARTED|Overall Study||6
8441921|NCT00802100|20802779|P2|STARTED|Overall Study||9
8441922|NCT00802100|20802780|P1|STARTED|Overall Study||6
8441923|NCT00802074|20802795|P6|NOT COMPLETED|Overall Study||0
8441924|NCT00802074|20802796|P5|NOT COMPLETED|Overall Study||0
8441925|NCT00802074|20802797|P4|NOT COMPLETED|Overall Study||0
8441926|NCT00802074|20802798|P3|NOT COMPLETED|Overall Study||1
8441927|NCT00802074|20802799|P2|NOT COMPLETED|Overall Study||1
8441928|NCT00802074|20802800|P1|NOT COMPLETED|Overall Study||2
8441929|NCT00802074|20802795|P6|COMPLETED|Overall Study||7
8441930|NCT00802074|20802796|P5|COMPLETED|Overall Study||7
8441931|NCT00802074|20802797|P4|COMPLETED|Overall Study||7
8441932|NCT00802074|20802798|P3|COMPLETED|Overall Study||6
8441933|NCT00802074|20802799|P2|COMPLETED|Overall Study||7
8441934|NCT00802074|20802800|P1|COMPLETED|Overall Study||7
8441935|NCT00802074|20802795|P6|STARTED|Overall Study||7
8441936|NCT00802074|20802796|P5|STARTED|Overall Study||7
8441937|NCT00802074|20802797|P4|STARTED|Overall Study||7
8441938|NCT00802074|20802798|P3|STARTED|Overall Study||7
8441939|NCT00802074|20802799|P2|STARTED|Overall Study||8
8441940|NCT00802074|20802800|P1|STARTED|Overall Study||9
8441941|NCT00801983|20802834|P2|NOT COMPLETED|Period 2||1
8441942|NCT00801983|20802835|P1|NOT COMPLETED|Period 2||2
8441943|NCT00801983|20802834|P2|COMPLETED|Period 2||32
8441944|NCT00801983|20802835|P1|COMPLETED|Period 2||38
8441945|NCT00801983|20802834|P2|STARTED|Period 2||33
8441946|NCT00801983|20802835|P1|STARTED|Period 2||40
8441947|NCT00801983|20802834|P2|NOT COMPLETED|Period 1||8
8441948|NCT00801983|20802835|P1|NOT COMPLETED|Period 1||4
8441949|NCT00801983|20802834|P2|COMPLETED|Period 1||33
8441950|NCT00801983|20802835|P1|COMPLETED|Period 1||40
8441951|NCT00801983|20802834|P2|STARTED|Period 1||41
8441952|NCT00801983|20802835|P1|STARTED|Period 1||44
8441953|NCT00801931|20802841|P1|NOT COMPLETED|Overall Study||0
8441954|NCT00801931|20802841|P1|COMPLETED|Overall Study||1
8441955|NCT00801931|20802841|P1|STARTED|Overall Study||1
8441956|NCT00801892|20802850|P2|NOT COMPLETED|Sham Crossover Period||2
8441957|NCT00801892|20802851|P1|NOT COMPLETED|Sham Crossover Period||0
8441958|NCT00801892|20802850|P2|COMPLETED|Sham Crossover Period||5
8441959|NCT00801892|20802851|P1|COMPLETED|Sham Crossover Period||0
8441960|NCT00801892|20802850|P2|STARTED|Sham Crossover Period||7
8441961|NCT00801892|20802851|P1|STARTED|Sham Crossover Period||0
8441962|NCT00801892|20802850|P2|NOT COMPLETED|Main Study Period||1
8441963|NCT00801892|20802851|P1|NOT COMPLETED|Main Study Period||0
8441964|NCT00801892|20802850|P2|COMPLETED|Main Study Period||10
8441965|NCT00801892|20802851|P1|COMPLETED|Main Study Period||12
8441966|NCT00801892|20802850|P2|STARTED|Main Study Period||11
8441967|NCT00801892|20802851|P1|STARTED|Main Study Period||12
8441968|NCT00801827|20802867|P1|NOT COMPLETED|Overall Study||0
8441969|NCT00801827|20802867|P1|COMPLETED|Overall Study||5
8441970|NCT00801827|20802867|P1|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
8441971|NCT00801801|20802871|P1|NOT COMPLETED|Overall Study||0
8441972|NCT00801801|20802871|P1|COMPLETED|Overall Study||5
8441973|NCT00801801|20802871|P1|STARTED|Overall Study||5
8441974|NCT00801723|20802878|P2|NOT COMPLETED|Overall Study||35
8441975|NCT00801723|20802879|P1|NOT COMPLETED|Overall Study||36
8441976|NCT00801723|20802878|P2|COMPLETED|Overall Study||27
8441977|NCT00801723|20802879|P1|COMPLETED|Overall Study||25
8441978|NCT00801723|20802878|P2|STARTED|Overall Study||62
8441979|NCT00801723|20802879|P1|STARTED|Overall Study||61
8441980|NCT00801684|20802889|P1|NOT COMPLETED|Overall Study||0
8441981|NCT00801684|20802889|P1|COMPLETED|Overall Study||24
8441982|NCT00801684|20802889|P1|STARTED|Overall Study||24
8441983|NCT00801632|20802911|P1|NOT COMPLETED|Overall Study||1
8441984|NCT00801632|20802911|P1|COMPLETED|Overall Study||4
8441985|NCT00801632|20802911|P1|STARTED|Overall Study||5
8441986|NCT00801398|20802928|P6|NOT COMPLETED|Overall Study||3
8441987|NCT00801398|20802929|P5|NOT COMPLETED|Overall Study||7
8441988|NCT00801398|20802930|P4|NOT COMPLETED|Overall Study||6
8441989|NCT00801398|20802931|P3|NOT COMPLETED|Overall Study||7
8441990|NCT00801398|20802932|P2|NOT COMPLETED|Overall Study||9
8441991|NCT00801398|20802933|P1|NOT COMPLETED|Overall Study||6
8441992|NCT00801398|20802928|P6|COMPLETED|Overall Study||5
8441993|NCT00801398|20802929|P5|COMPLETED|Overall Study||1
8441994|NCT00801398|20802930|P4|COMPLETED|Overall Study||3
8441995|NCT00801398|20802931|P3|COMPLETED|Overall Study||4
8441996|NCT00801398|20802932|P2|COMPLETED|Overall Study||0
8441997|NCT00801398|20802933|P1|COMPLETED|Overall Study||7
8441998|NCT00801398|20802928|P6|STARTED|Overall Study||8
8441999|NCT00801398|20802929|P5|STARTED|Overall Study||8
8442000|NCT00801398|20802930|P4|STARTED|Overall Study||9
8442001|NCT00801398|20802931|P3|STARTED|Overall Study||11
8442002|NCT00801398|20802932|P2|STARTED|Overall Study||9
8442003|NCT00801398|20802933|P1|STARTED|Overall Study||13
8442004|NCT00801242|20802989|P1|NOT COMPLETED|Overall Study||52
8442005|NCT00801242|20802989|P1|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
8442006|NCT00801242|20802989|P1|Started Cycle 3|Overall Study||2
8442007|NCT00801242|20802989|P1|Started Cycle 2|Overall Study||35
8442008|NCT00801242|20802989|P1|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
8442009|NCT00801242|20802989|P1|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
8442010|NCT00801242|20802989|P1|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
8442011|NCT00801242|20802989|P1|STARTED|Overall Study|Randomized participants.|220
8442012|NCT00801229|20803002|P2|NOT COMPLETED|Received Study Drug/Placebo||4
8442013|NCT00801229|20803003|P1|NOT COMPLETED|Received Study Drug/Placebo||4
8442014|NCT00801229|20803002|P2|COMPLETED|Received Study Drug/Placebo||30
8442015|NCT00801229|20803003|P1|COMPLETED|Received Study Drug/Placebo||31
8442016|NCT00801229|20803002|P2|STARTED|Received Study Drug/Placebo||34
8442017|NCT00801229|20803003|P1|STARTED|Received Study Drug/Placebo||35
8442018|NCT00801229|20803002|P2|NOT COMPLETED|Signed Consent||3
8442019|NCT00801229|20803003|P1|NOT COMPLETED|Signed Consent||3
8442020|NCT00801229|20803002|P2|COMPLETED|Signed Consent||34
8442021|NCT00801229|20803003|P1|COMPLETED|Signed Consent||35
8442022|NCT00801229|20803002|P2|STARTED|Signed Consent||37
8442023|NCT00801229|20803003|P1|STARTED|Signed Consent||38
8442024|NCT00801138|20803013|P4|NOT COMPLETED|Overall Study||0
8442025|NCT00801138|20803014|P3|NOT COMPLETED|Overall Study||0
8442026|NCT00801138|20803015|P2|NOT COMPLETED|Overall Study||0
8442027|NCT00801138|20803016|P1|NOT COMPLETED|Overall Study||0
8442028|NCT00801138|20803013|P4|COMPLETED|Overall Study||54
8442029|NCT00801138|20803014|P3|COMPLETED|Overall Study||54
8442030|NCT00801138|20803015|P2|COMPLETED|Overall Study||56
8442031|NCT00801138|20803016|P1|COMPLETED|Overall Study||54
8442032|NCT00801138|20803013|P4|STARTED|Overall Study||54
8442033|NCT00801138|20803014|P3|STARTED|Overall Study||54
8442034|NCT00801138|20803015|P2|STARTED|Overall Study||56
8442035|NCT00801138|20803016|P1|STARTED|Overall Study||54
8442036|NCT00801099|20803038|P1|NOT COMPLETED|Overall Study||101
8442037|NCT00801099|20803038|P1|COMPLETED|Overall Study||175
8442038|NCT00801099|20803038|P1|STARTED|Overall Study||276
8442039|NCT00800982|20803044|P2|NOT COMPLETED|Overall Study||3
8442040|NCT00800982|20803045|P1|NOT COMPLETED|Overall Study||2
8442041|NCT00800982|20803044|P2|COMPLETED|Overall Study||12
8442042|NCT00800982|20803045|P1|COMPLETED|Overall Study||13
8442043|NCT00800982|20803044|P2|STARTED|Overall Study||15
8442044|NCT00800982|20803045|P1|STARTED|Overall Study||15
8442045|NCT00800865|20803053|P2|NOT COMPLETED|Overall Study||0
8442046|NCT00800865|20803054|P1|NOT COMPLETED|Overall Study||0
8442047|NCT00800865|20803053|P2|COMPLETED|Overall Study||16
8442048|NCT00800865|20803054|P1|COMPLETED|Overall Study||15
8442049|NCT00800865|20803053|P2|STARTED|Overall Study||16
8442050|NCT00800865|20803054|P1|STARTED|Overall Study||15
8442051|NCT00800839|20803062|P1|NOT COMPLETED|Overall Study||7
8442052|NCT00800839|20803062|P1|COMPLETED|Overall Study||49
8442053|NCT00800839|20803062|P1|STARTED|Overall Study||56
8442054|NCT00800735|20803071|P1|NOT COMPLETED|Overall Study||14
8442055|NCT00800735|20803071|P1|COMPLETED|Overall Study||16
8442056|NCT00800735|20803071|P1|STARTED|Overall Study||30
8442057|NCT00800683|20803077|P2|NOT COMPLETED|Overall Study||19
8442058|NCT00800683|20803078|P1|NOT COMPLETED|Overall Study||17
8442059|NCT00800683|20803077|P2|COMPLETED|Overall Study|Number who completed treatment|49
8442060|NCT00800683|20803078|P1|COMPLETED|Overall Study|Number who completed treatment|48
8442061|NCT00800683|20803077|P2|STARTED|Overall Study|Number who started treatment|68
8442062|NCT00800683|20803078|P1|STARTED|Overall Study|Number who started treatment|65
8442063|NCT00800540|20803124|P2|NOT COMPLETED|Period 2: 6 Weeks||1
8442064|NCT00800540|20803125|P1|NOT COMPLETED|Period 2: 6 Weeks||0
8442065|NCT00800540|20803124|P2|COMPLETED|Period 2: 6 Weeks||16
8442066|NCT00800540|20803125|P1|COMPLETED|Period 2: 6 Weeks||16
8442067|NCT00800540|20803124|P2|STARTED|Period 2: 6 Weeks||17
8442068|NCT00800540|20803125|P1|STARTED|Period 2: 6 Weeks||16
8442069|NCT00800540|20803124|P2|NOT COMPLETED|Washout: 4 Weeks||0
8442070|NCT00800540|20803125|P1|NOT COMPLETED|Washout: 4 Weeks||0
8442071|NCT00800540|20803124|P2|COMPLETED|Washout: 4 Weeks||17
8442072|NCT00800540|20803125|P1|COMPLETED|Washout: 4 Weeks||16
8442073|NCT00800540|20803124|P2|STARTED|Washout: 4 Weeks||17
8442074|NCT00800540|20803125|P1|STARTED|Washout: 4 Weeks||16
8442075|NCT00800540|20803124|P2|NOT COMPLETED|Period One: 6 Weeks||1
8442076|NCT00800540|20803125|P1|NOT COMPLETED|Period One: 6 Weeks||1
8442077|NCT00800540|20803124|P2|COMPLETED|Period One: 6 Weeks||17
8442078|NCT00800540|20803125|P1|COMPLETED|Period One: 6 Weeks||16
8442079|NCT00800540|20803124|P2|STARTED|Period One: 6 Weeks||18
8442080|NCT00800540|20803125|P1|STARTED|Period One: 6 Weeks||17
8442081|NCT00800436|20803160|P7|NOT COMPLETED|Overall Study||0
8442082|NCT00800436|20803161|P6|NOT COMPLETED|Overall Study||0
8442083|NCT00800436|20803162|P5|NOT COMPLETED|Overall Study||0
8442084|NCT00800436|20803163|P4|NOT COMPLETED|Overall Study||1
8442085|NCT00800436|20803164|P3|NOT COMPLETED|Overall Study||1
8442086|NCT00800436|20803165|P2|NOT COMPLETED|Overall Study||0
8442087|NCT00800436|20803166|P1|NOT COMPLETED|Overall Study||0
8442088|NCT00800436|20803160|P7|COMPLETED|Overall Study||20
8442089|NCT00800436|20803161|P6|COMPLETED|Overall Study||20
8442090|NCT00800436|20803162|P5|COMPLETED|Overall Study||6
8442091|NCT00800436|20803163|P4|COMPLETED|Overall Study||5
8442092|NCT00800436|20803164|P3|COMPLETED|Overall Study||5
8442093|NCT00800436|20803165|P2|COMPLETED|Overall Study||6
8442094|NCT00800436|20803166|P1|COMPLETED|Overall Study||6
8442095|NCT00800436|20803160|P7|STARTED|Overall Study||20
8442096|NCT00800436|20803161|P6|STARTED|Overall Study||20
8442097|NCT00800436|20803162|P5|STARTED|Overall Study||6
8442098|NCT00800436|20803163|P4|STARTED|Overall Study||6
8442099|NCT00800436|20803164|P3|STARTED|Overall Study||6
8442100|NCT00800436|20803165|P2|STARTED|Overall Study||6
8442101|NCT00800436|20803166|P1|STARTED|Overall Study||6
8442102|NCT00800384|20803212|P2|NOT COMPLETED|Overall Study||43
8442103|NCT00800384|20803213|P1|NOT COMPLETED|Overall Study||41
8442104|NCT00800384|20803212|P2|COMPLETED|Overall Study||1210
8442105|NCT00800384|20803213|P1|COMPLETED|Overall Study||1206
8442106|NCT00800384|20803212|P2|STARTED|Overall Study||1253
8442107|NCT00800384|20803213|P1|STARTED|Overall Study||1247
8442108|NCT00800345|20803221|P1|NOT COMPLETED|Overall Study||0
8442109|NCT00800345|20803221|P1|COMPLETED|Overall Study||33
8442110|NCT00800345|20803221|P1|STARTED|Overall Study||33
8442111|NCT00800254|20803228|P2|NOT COMPLETED|Overall Study||6
8442112|NCT00800254|20803229|P1|NOT COMPLETED|Overall Study||5
8442113|NCT00800254|20803228|P2|COMPLETED|Overall Study||25
8442114|NCT00800254|20803229|P1|COMPLETED|Overall Study||30
8442115|NCT00800254|20803228|P2|3.5 Weeks Post-operatively|Overall Study||31
8442116|NCT00800254|20803229|P1|3.5 Weeks Post-operatively|Overall Study||31
8442117|NCT00800254|20803228|P2|STARTED|Overall Study||31
8442118|NCT00800254|20803229|P1|STARTED|Overall Study||35
8442119|NCT00800202|20803251|P2|NOT COMPLETED|Overall Study||24
8442120|NCT00800202|20803252|P1|NOT COMPLETED|Overall Study||67
8442121|NCT00800202|20803251|P2|COMPLETED|Overall Study||0
8442122|NCT00800202|20803252|P1|COMPLETED|Overall Study||0
8442123|NCT00800202|20803251|P2|STARTED|Overall Study||24
8442124|NCT00800202|20803252|P1|STARTED|Overall Study||67
8442125|NCT00800176|20803276|P6|NOT COMPLETED|Overall Study||5
8442126|NCT00800176|20803277|P5|NOT COMPLETED|Overall Study||4
8442127|NCT00800176|20803278|P4|NOT COMPLETED|Overall Study||4
8442128|NCT00800176|20803279|P3|NOT COMPLETED|Overall Study||0
8442129|NCT00800176|20803280|P2|NOT COMPLETED|Overall Study||6
8442130|NCT00800176|20803281|P1|NOT COMPLETED|Overall Study||9
8442131|NCT00800176|20803276|P6|COMPLETED|Overall Study||62
8442132|NCT00800176|20803277|P5|COMPLETED|Overall Study||60
8442133|NCT00800176|20803278|P4|COMPLETED|Overall Study||62
8442134|NCT00800176|20803279|P3|COMPLETED|Overall Study||65
8442135|NCT00800176|20803280|P2|COMPLETED|Overall Study||60
8442136|NCT00800176|20803281|P1|COMPLETED|Overall Study||57
8442137|NCT00800176|20803276|P6|STARTED|Overall Study||67
8442138|NCT00800176|20803277|P5|STARTED|Overall Study||64
8442139|NCT00800176|20803278|P4|STARTED|Overall Study||66
8442140|NCT00800176|20803279|P3|STARTED|Overall Study||65
8442141|NCT00800176|20803280|P2|STARTED|Overall Study||66
8442142|NCT00800176|20803281|P1|STARTED|Overall Study||66
8442143|NCT00799903|20803357|P2|NOT COMPLETED|Overall Study||278
8442144|NCT00799903|20803358|P1|NOT COMPLETED|Overall Study||273
8442145|NCT00799903|20803357|P2|COMPLETED|Overall Study||7646
8442146|NCT00799903|20803358|P1|COMPLETED|Overall Study||7631
8442147|NCT00799903|20803357|P2|STARTED|Overall Study||7924
8442148|NCT00799903|20803358|P1|STARTED|Overall Study||7904
8442149|NCT00799825|20803378|P1|NOT COMPLETED|Overall Study||48
8442150|NCT00799825|20803378|P1|COMPLETED|Overall Study||296
8442151|NCT00799825|20803378|P1|STARTED|Overall Study||344
8442152|NCT00799773|20803386|P2|NOT COMPLETED|Overall Study||0
8442153|NCT00799773|20803387|P1|NOT COMPLETED|Overall Study||0
8442154|NCT00799773|20803386|P2|COMPLETED|Overall Study||1
8442155|NCT00799773|20803387|P1|COMPLETED|Overall Study||2
8442156|NCT00799773|20803386|P2|STARTED|Overall Study||1
8442157|NCT00799773|20803387|P1|STARTED|Overall Study||2
8442158|NCT00799708|20803418|P3|NOT COMPLETED|Overall Study||0
8442159|NCT00799708|20803419|P2|NOT COMPLETED|Overall Study||0
8442160|NCT00799708|20803420|P1|NOT COMPLETED|Overall Study||1
8442161|NCT00799708|20803418|P3|COMPLETED|Overall Study||11
8442162|NCT00799708|20803419|P2|COMPLETED|Overall Study||6
8442163|NCT00799708|20803420|P1|COMPLETED|Overall Study||9
8442164|NCT00799708|20803418|P3|STARTED|Overall Study||11
8442165|NCT00799708|20803419|P2|STARTED|Overall Study||6
8442166|NCT00799708|20803420|P1|STARTED|Overall Study||10
8442167|NCT00799643|20803432|P2|NOT COMPLETED|Overall Study||27
8442168|NCT00799643|20803433|P1|NOT COMPLETED|Overall Study||25
8442169|NCT00799643|20803432|P2|COMPLETED|Overall Study||119
8442170|NCT00799643|20803433|P1|COMPLETED|Overall Study||115
8442171|NCT00799643|20803432|P2|STARTED|Overall Study||146
8442172|NCT00799643|20803433|P1|STARTED|Overall Study||140
8442173|NCT00799617|20803443|P2|NOT COMPLETED|Anemia Trial||3
8442174|NCT00799617|20803444|P1|NOT COMPLETED|Anemia Trial||3
8442175|NCT00799617|20803443|P2|COMPLETED|Anemia Trial||32
8442176|NCT00799617|20803444|P1|COMPLETED|Anemia Trial||24
8442177|NCT00799617|20803443|P2|STARTED|Anemia Trial||35
8442178|NCT00799617|20803444|P1|STARTED|Anemia Trial||27
8442179|NCT00799617|20803443|P2|NOT COMPLETED|Cognitive Function Trial||1
8442180|NCT00799617|20803444|P1|NOT COMPLETED|Cognitive Function Trial||0
8442181|NCT00799617|20803443|P2|COMPLETED|Cognitive Function Trial||245
8442182|NCT00799617|20803444|P1|COMPLETED|Cognitive Function Trial||247
8442183|NCT00799617|20803443|P2|STARTED|Cognitive Function Trial||246
8442184|NCT00799617|20803444|P1|STARTED|Cognitive Function Trial||247
8442185|NCT00799617|20803443|P2|NOT COMPLETED|Bone Trial||16
8442186|NCT00799617|20803444|P1|NOT COMPLETED|Bone Trial||6
8442187|NCT00799617|20803443|P2|COMPLETED|Bone Trial||85
8442188|NCT00799617|20803444|P1|COMPLETED|Bone Trial||104
8442189|NCT00799617|20803443|P2|STARTED|Bone Trial||101
8442190|NCT00799617|20803444|P1|STARTED|Bone Trial||110
8442191|NCT00799617|20803443|P2|NOT COMPLETED|Cardiovascular Trial||17
8442192|NCT00799617|20803444|P1|NOT COMPLETED|Cardiovascular Trial||15
8442193|NCT00799617|20803443|P2|COMPLETED|Cardiovascular Trial||65
8442194|NCT00799617|20803444|P1|COMPLETED|Cardiovascular Trial||73
8442195|NCT00799617|20803443|P2|STARTED|Cardiovascular Trial||82
8442196|NCT00799617|20803444|P1|STARTED|Cardiovascular Trial||88
8442197|NCT00799617|20803443|P2|NOT COMPLETED|Vitality Trial||22
8442198|NCT00799617|20803444|P1|NOT COMPLETED|Vitality Trial||7
8442199|NCT00799617|20803443|P2|COMPLETED|Vitality Trial||216
8442200|NCT00799617|20803444|P1|COMPLETED|Vitality Trial||229
8442201|NCT00799617|20803443|P2|STARTED|Vitality Trial||238
8442202|NCT00799617|20803444|P1|STARTED|Vitality Trial||236
8442203|NCT00799617|20803443|P2|NOT COMPLETED|Physical Function Trial||11
8442204|NCT00799617|20803444|P1|NOT COMPLETED|Physical Function Trial||6
8442205|NCT00799617|20803443|P2|COMPLETED|Physical Function Trial||185
8442206|NCT00799617|20803444|P1|COMPLETED|Physical Function Trial||185
8442207|NCT00799617|20803443|P2|STARTED|Physical Function Trial||196
8442208|NCT00799617|20803444|P1|STARTED|Physical Function Trial||191
8442209|NCT00799617|20803443|P2|NOT COMPLETED|Sexual Funtion Trial||21
8442210|NCT00799617|20803444|P1|NOT COMPLETED|Sexual Funtion Trial||16
8442211|NCT00799617|20803443|P2|COMPLETED|Sexual Funtion Trial||215
8442212|NCT00799617|20803444|P1|COMPLETED|Sexual Funtion Trial||218
8442213|NCT00799617|20803443|P2|STARTED|Sexual Funtion Trial||236
8442214|NCT00799617|20803444|P1|STARTED|Sexual Funtion Trial||234
8442215|NCT00799617|20803443|P2|NOT COMPLETED|Main Testosterone Trial||21
8442216|NCT00799617|20803444|P1|NOT COMPLETED|Main Testosterone Trial||19
8442217|NCT00799617|20803443|P2|COMPLETED|Main Testosterone Trial||374
8442218|NCT00799617|20803444|P1|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
8442219|NCT00799617|20803443|P2|STARTED|Main Testosterone Trial||395
8442220|NCT00799617|20803444|P1|STARTED|Main Testosterone Trial||395
8442221|NCT00799604|20803525|P3|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
8442222|NCT00799604|20803526|P2|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
8442223|NCT00799604|20803527|P1|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
8442224|NCT00799604|20803525|P3|COMPLETED|Bolus 2 (With Anesthesia)||3
8442225|NCT00799604|20803526|P2|COMPLETED|Bolus 2 (With Anesthesia)||12
8442226|NCT00799604|20803527|P1|COMPLETED|Bolus 2 (With Anesthesia)||6
8442227|NCT00799604|20803525|P3|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
8442228|NCT00799604|20803526|P2|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
8442229|NCT00799604|20803527|P1|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
8442230|NCT00799604|20803525|P3|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
8442231|NCT00799604|20803526|P2|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
8442232|NCT00799604|20803527|P1|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
8442233|NCT00799604|20803525|P3|COMPLETED|Bolus 1 (Pre-anesthesia)||10
8442234|NCT00799604|20803526|P2|COMPLETED|Bolus 1 (Pre-anesthesia)||10
8442235|NCT00799604|20803527|P1|COMPLETED|Bolus 1 (Pre-anesthesia)||10
8442236|NCT00799604|20803525|P3|STARTED|Bolus 1 (Pre-anesthesia)||10
8442237|NCT00799604|20803526|P2|STARTED|Bolus 1 (Pre-anesthesia)||10
8442238|NCT00799604|20803527|P1|STARTED|Bolus 1 (Pre-anesthesia)||10
8442239|NCT00799591|20803551|P1|NOT COMPLETED|Overall Study||66
8442240|NCT00799591|20803551|P1|COMPLETED|Overall Study||90
8442241|NCT00799591|20803551|P1|STARTED|Overall Study||156
8442242|NCT00799578|20803562|P1|NOT COMPLETED|Overall Study||2
8442243|NCT00799578|20803562|P1|COMPLETED|Overall Study||11
8442244|NCT00799578|20803562|P1|STARTED|Overall Study||13
8442245|NCT00799487|20803569|P3|NOT COMPLETED|Double-Blind Assessment Period||2
8442246|NCT00799487|20803570|P2|NOT COMPLETED|Double-Blind Assessment Period||1
8442247|NCT00799487|20803571|P1|NOT COMPLETED|Double-Blind Assessment Period||0
8442248|NCT00799487|20803569|P3|COMPLETED|Double-Blind Assessment Period||32
8442249|NCT00799487|20803570|P2|COMPLETED|Double-Blind Assessment Period||33
8442250|NCT00799487|20803571|P1|COMPLETED|Double-Blind Assessment Period||0
8442251|NCT00799487|20803569|P3|STARTED|Double-Blind Assessment Period||34
8442252|NCT00799487|20803570|P2|STARTED|Double-Blind Assessment Period||34
8442253|NCT00799487|20803571|P1|STARTED|Double-Blind Assessment Period||0
8442254|NCT00799487|20803569|P3|NOT COMPLETED|Dose Adjustment Period||0
8442255|NCT00799487|20803570|P2|NOT COMPLETED|Dose Adjustment Period||0
8442256|NCT00799487|20803571|P1|NOT COMPLETED|Dose Adjustment Period||21
8442257|NCT00799487|20803569|P3|COMPLETED|Dose Adjustment Period||34
8442258|NCT00799487|20803570|P2|COMPLETED|Dose Adjustment Period||34
8442259|NCT00799487|20803571|P1|COMPLETED|Dose Adjustment Period||0
8442260|NCT00799487|20803569|P3|STARTED|Dose Adjustment Period||34
8442261|NCT00799487|20803570|P2|STARTED|Dose Adjustment Period||34
8442262|NCT00799487|20803571|P1|STARTED|Dose Adjustment Period||21
8442263|NCT00799474|20803651|P1|NOT COMPLETED|Overall Study||0
8442264|NCT00799474|20803651|P1|COMPLETED|Overall Study||609
8442265|NCT00799474|20803651|P1|STARTED|Overall Study||609
8442266|NCT00799435|20803659|P2|NOT COMPLETED|Overall Study||0
8442267|NCT00799435|20803660|P1|NOT COMPLETED|Overall Study||0
8442268|NCT00799435|20803659|P2|COMPLETED|Overall Study||1
8442269|NCT00799435|20803660|P1|COMPLETED|Overall Study||1
8442270|NCT00799435|20803659|P2|STARTED|Overall Study||1
8442271|NCT00799435|20803660|P1|STARTED|Overall Study||1
8442272|NCT00799422|20803668|P6|NOT COMPLETED|Third Week of Wear||0
8442273|NCT00799422|20803669|P5|NOT COMPLETED|Third Week of Wear||0
8442274|NCT00799422|20803670|P4|NOT COMPLETED|Third Week of Wear||0
8442275|NCT00799422|20803671|P3|NOT COMPLETED|Third Week of Wear||0
8442276|NCT00799422|20803672|P2|NOT COMPLETED|Third Week of Wear||0
8442277|NCT00799422|20803673|P1|NOT COMPLETED|Third Week of Wear||0
8442278|NCT00799422|20803668|P6|COMPLETED|Third Week of Wear||4
8442279|NCT00799422|20803669|P5|COMPLETED|Third Week of Wear||4
8442280|NCT00799422|20803670|P4|COMPLETED|Third Week of Wear||3
8442281|NCT00799422|20803671|P3|COMPLETED|Third Week of Wear||3
8442282|NCT00799422|20803672|P2|COMPLETED|Third Week of Wear||4
8442283|NCT00799422|20803673|P1|COMPLETED|Third Week of Wear||4
8442284|NCT00799422|20803668|P6|STARTED|Third Week of Wear||4
8442285|NCT00799422|20803669|P5|STARTED|Third Week of Wear||4
8442286|NCT00799422|20803670|P4|STARTED|Third Week of Wear||3
8442287|NCT00799422|20803671|P3|STARTED|Third Week of Wear||3
8442288|NCT00799422|20803672|P2|STARTED|Third Week of Wear||4
8442289|NCT00799422|20803673|P1|STARTED|Third Week of Wear||4
8442290|NCT00799422|20803668|P6|NOT COMPLETED|Second Week of Wear||0
8442291|NCT00799422|20803669|P5|NOT COMPLETED|Second Week of Wear||0
8442292|NCT00799422|20803670|P4|NOT COMPLETED|Second Week of Wear||0
8442293|NCT00799422|20803671|P3|NOT COMPLETED|Second Week of Wear||0
8442294|NCT00799422|20803672|P2|NOT COMPLETED|Second Week of Wear||0
8442295|NCT00799422|20803673|P1|NOT COMPLETED|Second Week of Wear||0
8442296|NCT00799422|20803668|P6|COMPLETED|Second Week of Wear||4
8442297|NCT00799422|20803669|P5|COMPLETED|Second Week of Wear||4
8442298|NCT00799422|20803670|P4|COMPLETED|Second Week of Wear||3
8442299|NCT00799422|20803671|P3|COMPLETED|Second Week of Wear||3
8442300|NCT00799422|20803672|P2|COMPLETED|Second Week of Wear||4
8442301|NCT00799422|20803673|P1|COMPLETED|Second Week of Wear||4
8442302|NCT00799422|20803668|P6|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
8442303|NCT00799422|20803669|P5|STARTED|Second Week of Wear||4
8442304|NCT00799422|20803670|P4|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
8442305|NCT00799422|20803671|P3|STARTED|Second Week of Wear||3
8442306|NCT00799422|20803672|P2|STARTED|Second Week of Wear||4
8442307|NCT00799422|20803673|P1|STARTED|Second Week of Wear||4
8442308|NCT00799422|20803668|P6|NOT COMPLETED|First Week of Wear||0
8442309|NCT00799422|20803669|P5|NOT COMPLETED|First Week of Wear||0
8442310|NCT00799422|20803670|P4|NOT COMPLETED|First Week of Wear||1
8442311|NCT00799422|20803671|P3|NOT COMPLETED|First Week of Wear||1
8442312|NCT00799422|20803672|P2|NOT COMPLETED|First Week of Wear||0
8442313|NCT00799422|20803673|P1|NOT COMPLETED|First Week of Wear||0
8442314|NCT00799422|20803668|P6|COMPLETED|First Week of Wear||5
8442315|NCT00799422|20803669|P5|COMPLETED|First Week of Wear||4
8442316|NCT00799422|20803670|P4|COMPLETED|First Week of Wear||4
8442317|NCT00799422|20803671|P3|COMPLETED|First Week of Wear||3
8442318|NCT00799422|20803672|P2|COMPLETED|First Week of Wear||4
8442319|NCT00799422|20803673|P1|COMPLETED|First Week of Wear||4
8442320|NCT00799422|20803668|P6|STARTED|First Week of Wear||5
8442321|NCT00799422|20803669|P5|STARTED|First Week of Wear||4
8442322|NCT00799422|20803670|P4|STARTED|First Week of Wear||5
8442323|NCT00799422|20803671|P3|STARTED|First Week of Wear||4
8442324|NCT00799422|20803672|P2|STARTED|First Week of Wear||4
8442325|NCT00799422|20803673|P1|STARTED|First Week of Wear||4
8442326|NCT00799409|20803690|P3|NOT COMPLETED|Overall Study||0
8442327|NCT00799409|20803691|P2|NOT COMPLETED|Overall Study||0
8442328|NCT00799409|20803692|P1|NOT COMPLETED|Overall Study||7
8442329|NCT00799409|20803690|P3|COMPLETED|Overall Study||35
8442330|NCT00799409|20803691|P2|COMPLETED|Overall Study||36
8442331|NCT00799409|20803692|P1|COMPLETED|Overall Study||0
8442332|NCT00799409|20803690|P3|STARTED|Overall Study||35
8442333|NCT00799409|20803691|P2|STARTED|Overall Study||36
8442334|NCT00799409|20803692|P1|STARTED|Overall Study||7
8442335|NCT00799396|20803772|P1|NOT COMPLETED|Clopidogrel Plus Aspirin||6
8442336|NCT00799396|20803772|P1|COMPLETED|Clopidogrel Plus Aspirin||663
8442337|NCT00799396|20803772|P1|STARTED|Clopidogrel Plus Aspirin||669
8442338|NCT00799396|20803772|P1|NOT COMPLETED|Clopidogrel Treatment||13
8442339|NCT00799396|20803772|P1|COMPLETED|Clopidogrel Treatment||669
8442340|NCT00799396|20803772|P1|STARTED|Clopidogrel Treatment||682
8442341|NCT00799383|20803779|P2|NOT COMPLETED|Overall Study||6
8442342|NCT00799383|20803780|P1|NOT COMPLETED|Overall Study||3
8442343|NCT00799383|20803779|P2|COMPLETED|Overall Study||18
8442344|NCT00799383|20803780|P1|COMPLETED|Overall Study||20
8442345|NCT00799383|20803779|P2|STARTED|Overall Study||24
8442346|NCT00799383|20803780|P1|STARTED|Overall Study||23
8442347|NCT00799292|20803802|P2|NOT COMPLETED|Overall Study||0
8442348|NCT00799292|20803803|P1|NOT COMPLETED|Overall Study||0
8442349|NCT00799292|20803802|P2|COMPLETED|Overall Study||29
8442350|NCT00799292|20803803|P1|COMPLETED|Overall Study||29
8442351|NCT00799292|20803802|P2|STARTED|Overall Study||29
8442352|NCT00799292|20803803|P1|STARTED|Overall Study||29
8442353|NCT00799266|20803809|P2|NOT COMPLETED|Overall Study||1
8442354|NCT00799266|20803810|P1|NOT COMPLETED|Overall Study||3
8442355|NCT00799266|20803809|P2|COMPLETED|Overall Study||15
8442356|NCT00799266|20803810|P1|COMPLETED|Overall Study||15
8442357|NCT00799266|20803809|P2|Safety Set|Overall Study||16
8442358|NCT00799266|20803810|P1|Safety Set|Overall Study||18
8442359|NCT00799266|20803809|P2|Modified Intention-to-treat (MITT)|Overall Study||16
8442360|NCT00799266|20803810|P1|Modified Intention-to-treat (MITT)|Overall Study||17
8442361|NCT00799266|20803809|P2|STARTED|Overall Study||16
8442362|NCT00799266|20803810|P1|STARTED|Overall Study||18
8442363|NCT00799227|20803841|P1|NOT COMPLETED|Overall Study||3
8442364|NCT00799227|20803841|P1|COMPLETED|Overall Study||53
8442365|NCT00799227|20803841|P1|STARTED|Overall Study||56
8442374|NCT00798889|20803859|P1|NOT COMPLETED|Overall Study||314
8442375|NCT00798889|20803859|P1|COMPLETED|Overall Study||0
8442376|NCT00798889|20803859|P1|Treated|Overall Study||311
8442377|NCT00798889|20803859|P1|STARTED|Overall Study||314
8442378|NCT00798759|20803865|P2|NOT COMPLETED|Overall Study||13
8442379|NCT00798759|20803866|P1|NOT COMPLETED|Overall Study||8
8442380|NCT00798759|20803865|P2|COMPLETED|Overall Study||106
8442381|NCT00798759|20803866|P1|COMPLETED|Overall Study||109
8442382|NCT00798759|20803865|P2|STARTED|Overall Study||119
8442383|NCT00798759|20803866|P1|STARTED|Overall Study||117
8442384|NCT00798720|20803874|P1|NOT COMPLETED|Overall Study||0
8442385|NCT00798720|20803874|P1|COMPLETED|Overall Study||18
8442386|NCT00798720|20803874|P1|STARTED|Overall Study||18
8442387|NCT00798707|20803884|P3|NOT COMPLETED|Overall Study||22
8442388|NCT00798707|20803885|P2|NOT COMPLETED|Overall Study||33
8442389|NCT00798707|20803886|P1|NOT COMPLETED|Overall Study||26
8442390|NCT00798707|20803884|P3|COMPLETED|Overall Study||215
8442391|NCT00798707|20803885|P2|COMPLETED|Overall Study||204
8442392|NCT00798707|20803886|P1|COMPLETED|Overall Study||209
8442393|NCT00798707|20803884|P3|Treated|Overall Study||236
8442394|NCT00798707|20803885|P2|Treated|Overall Study||232
8442395|NCT00798707|20803886|P1|Treated|Overall Study||231
8442396|NCT00798707|20803884|P3|STARTED|Overall Study||237
8442397|NCT00798707|20803885|P2|STARTED|Overall Study||237
8442398|NCT00798707|20803886|P1|STARTED|Overall Study||235
8442399|NCT00798694|20803938|P2|NOT COMPLETED|Overall Study||1
8442400|NCT00798694|20803939|P1|NOT COMPLETED|Overall Study||2
8442401|NCT00798694|20803938|P2|COMPLETED|Overall Study||27
8442402|NCT00798694|20803939|P1|COMPLETED|Overall Study||28
8442403|NCT00798694|20803938|P2|STARTED|Overall Study||28
8442404|NCT00798694|20803939|P1|STARTED|Overall Study||30
8442405|NCT00798655|20803963|P1|NOT COMPLETED|Overall Study||2
8442406|NCT00798655|20803963|P1|COMPLETED|Overall Study||44
8442407|NCT00798655|20803963|P1|STARTED|Overall Study||46
8442408|NCT00798603|20803968|P1|NOT COMPLETED|Overall Study||35
8442409|NCT00798603|20803968|P1|COMPLETED|Overall Study||27
8442410|NCT00798603|20803968|P1|STARTED|Overall Study||62
8442411|NCT00798590|20803990|P2|NOT COMPLETED|Overall Study||8
8442412|NCT00798590|20803991|P1|NOT COMPLETED|Overall Study||11
8442413|NCT00798590|20803990|P2|COMPLETED|Overall Study||0
8442414|NCT00798590|20803991|P1|COMPLETED|Overall Study||0
8442415|NCT00798590|20803990|P2|STARTED|Overall Study||8
8442416|NCT00798590|20803991|P1|STARTED|Overall Study||11
8442417|NCT00798577|20804001|P2|NOT COMPLETED|Overall Study||0
8442418|NCT00798577|20804002|P1|NOT COMPLETED|Overall Study||0
8442419|NCT00798577|20804001|P2|COMPLETED|Overall Study||7
8442420|NCT00798577|20804002|P1|COMPLETED|Overall Study||17
8442421|NCT00798577|20804001|P2|STARTED|Overall Study||7
8442422|NCT00798577|20804002|P1|STARTED|Overall Study||17
8442423|NCT00798486|20804016|P1|NOT COMPLETED|Overall Study||0
8442424|NCT00798486|20804016|P1|COMPLETED|Overall Study||110
8442425|NCT00798486|20804016|P1|STARTED|Overall Study||110
8442426|NCT00798434|20804025|P2|NOT COMPLETED|Open-Label||32
8442427|NCT00798434|20804026|P1|NOT COMPLETED|Open-Label||42
8442428|NCT00798434|20804025|P2|COMPLETED|Open-Label||282
8442429|NCT00798434|20804026|P1|COMPLETED|Open-Label||299
8442430|NCT00798434|20804025|P2|Received Treatment|Open-Label||313
8442431|NCT00798434|20804026|P1|Received Treatment|Open-Label||341
8442432|NCT00798434|20804025|P2|STARTED|Open-Label||314
8442433|NCT00798434|20804026|P1|STARTED|Open-Label||341
8442434|NCT00798434|20804025|P2|NOT COMPLETED|Double-Blind||84
8442435|NCT00798434|20804026|P1|NOT COMPLETED|Double-Blind||55
8442436|NCT00798434|20804025|P2|COMPLETED|Double-Blind||314
8442437|NCT00798434|20804026|P1|COMPLETED|Double-Blind||341
8442438|NCT00798434|20804025|P2|Received Treatment|Double-Blind||392
8442439|NCT00798434|20804026|P1|Received Treatment|Double-Blind||393
8442440|NCT00798434|20804025|P2|STARTED|Double-Blind||398
8442441|NCT00798434|20804026|P1|STARTED|Double-Blind||396
8442442|NCT00798369|20804112|P6|NOT COMPLETED|Overall Study||3
8442443|NCT00798369|20804113|P5|NOT COMPLETED|Overall Study||1
8442444|NCT00798369|20804114|P4|NOT COMPLETED|Overall Study||1
8442445|NCT00798369|20804115|P3|NOT COMPLETED|Overall Study||2
8442446|NCT00798369|20804116|P2|NOT COMPLETED|Overall Study||1
8442447|NCT00798369|20804117|P1|NOT COMPLETED|Overall Study||1
8442448|NCT00798369|20804112|P6|COMPLETED|Overall Study||54
8442449|NCT00798369|20804113|P5|COMPLETED|Overall Study||27
8442450|NCT00798369|20804114|P4|COMPLETED|Overall Study||28
8442451|NCT00798369|20804115|P3|COMPLETED|Overall Study||27
8442452|NCT00798369|20804116|P2|COMPLETED|Overall Study||28
8442453|NCT00798369|20804117|P1|COMPLETED|Overall Study||27
8442454|NCT00798369|20804112|P6|STARTED|Overall Study||57
8442455|NCT00798369|20804113|P5|STARTED|Overall Study||28
8442456|NCT00798369|20804114|P4|STARTED|Overall Study||29
8442457|NCT00798369|20804115|P3|STARTED|Overall Study||29
8442458|NCT00798369|20804116|P2|STARTED|Overall Study||29
8442459|NCT00798369|20804117|P1|STARTED|Overall Study||28
8442460|NCT00798317|20804164|P2|NOT COMPLETED|Overall Study||7
8442461|NCT00798317|20804165|P1|NOT COMPLETED|Overall Study||10
8442462|NCT00798317|20804164|P2|COMPLETED|Overall Study||74
8442463|NCT00798317|20804165|P1|COMPLETED|Overall Study||235
8442464|NCT00798317|20804164|P2|STARTED|Overall Study||81
8442465|NCT00798317|20804165|P1|STARTED|Overall Study||245
8442466|NCT00798304|20804176|P3|NOT COMPLETED|Overall Study||10
8442467|NCT00798304|20804177|P2|NOT COMPLETED|Overall Study||22
8442468|NCT00798304|20804178|P1|NOT COMPLETED|Overall Study||14
8442469|NCT00798304|20804176|P3|COMPLETED|Overall Study||0
8442470|NCT00798304|20804177|P2|COMPLETED|Overall Study||0
8442471|NCT00798304|20804178|P1|COMPLETED|Overall Study||0
8442472|NCT00798304|20804176|P3|STARTED|Overall Study||10
8442473|NCT00798304|20804177|P2|STARTED|Overall Study||22
8442474|NCT00798304|20804178|P1|STARTED|Overall Study||14
8442475|NCT00798174|20804204|P2|NOT COMPLETED|Overall Study||3
8442476|NCT00798174|20804205|P1|NOT COMPLETED|Overall Study||4
8442477|NCT00798174|20804204|P2|COMPLETED|Overall Study||13
8442478|NCT00798174|20804205|P1|COMPLETED|Overall Study||12
8442479|NCT00798174|20804204|P2|STARTED|Overall Study||16
8442480|NCT00798174|20804205|P1|STARTED|Overall Study||16
8442481|NCT00798161|20804216|P7|NOT COMPLETED|Overall Study||10
8442482|NCT00798161|20804217|P6|NOT COMPLETED|Overall Study||11
8442483|NCT00798161|20804218|P5|NOT COMPLETED|Overall Study||16
8442484|NCT00798161|20804219|P4|NOT COMPLETED|Overall Study||21
8442485|NCT00798161|20804220|P3|NOT COMPLETED|Overall Study||21
8442486|NCT00798161|20804221|P2|NOT COMPLETED|Overall Study||17
8442487|NCT00798161|20804222|P1|NOT COMPLETED|Overall Study||18
8442488|NCT00798161|20804216|P7|COMPLETED|Overall Study||56
8442489|NCT00798161|20804217|P6|COMPLETED|Overall Study||132
8442490|NCT00798161|20804218|P5|COMPLETED|Overall Study||127
8442491|NCT00798161|20804219|P4|COMPLETED|Overall Study||121
8442492|NCT00798161|20804220|P3|COMPLETED|Overall Study||126
8442493|NCT00798161|20804221|P2|COMPLETED|Overall Study||127
8442494|NCT00798161|20804222|P1|COMPLETED|Overall Study||54
8442495|NCT00798161|20804216|P7|STARTED|Overall Study||66
8442496|NCT00798161|20804217|P6|STARTED|Overall Study||143
8442497|NCT00798161|20804218|P5|STARTED|Overall Study||143
8442498|NCT00798161|20804219|P4|STARTED|Overall Study||142
8442499|NCT00798161|20804220|P3|STARTED|Overall Study||147
8442500|NCT00798161|20804221|P2|STARTED|Overall Study||144
8442501|NCT00798161|20804222|P1|STARTED|Overall Study||72
8442502|NCT00798135|20804329|P1|NOT COMPLETED|Overall Study||13
8442503|NCT00798135|20804329|P1|COMPLETED|Overall Study||0
8442504|NCT00798135|20804329|P1|STARTED|Overall Study||13
8442505|NCT00798096|20804335|P1|NOT COMPLETED|Overall Study||2
8442506|NCT00798096|20804335|P1|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
8442507|NCT00798096|20804335|P1|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
8442508|NCT00798018|20804346|P4|NOT COMPLETED|Overall Study||0
8442509|NCT00798018|20804347|P3|NOT COMPLETED|Overall Study||0
8442510|NCT00798018|20804348|P2|NOT COMPLETED|Overall Study||0
8442511|NCT00798018|20804349|P1|NOT COMPLETED|Overall Study||0
8442512|NCT00798018|20804346|P4|COMPLETED|Overall Study||25
8442513|NCT00798018|20804347|P3|COMPLETED|Overall Study||25
8442514|NCT00798018|20804348|P2|COMPLETED|Overall Study||25
8442515|NCT00798018|20804349|P1|COMPLETED|Overall Study||25
8442516|NCT00798018|20804346|P4|STARTED|Overall Study||25
8442517|NCT00798018|20804347|P3|STARTED|Overall Study||25
8442518|NCT00798018|20804348|P2|STARTED|Overall Study||25
8442519|NCT00798018|20804349|P1|STARTED|Overall Study||25
8442520|NCT00797966|20804363|P6|NOT COMPLETED|Phase A+||28
8442521|NCT00797966|20804364|P5|NOT COMPLETED|Phase A+||0
8442522|NCT00797966|20804365|P4|NOT COMPLETED|Phase A+||0
8442523|NCT00797966|20804366|P3|NOT COMPLETED|Phase A+||0
8442524|NCT00797966|20804367|P2|NOT COMPLETED|Phase A+||0
8442525|NCT00797966|20804368|P1|NOT COMPLETED|Phase A+||0
8442526|NCT00797966|20804363|P6|COMPLETED|Phase A+||207
8442527|NCT00797966|20804364|P5|COMPLETED|Phase A+||0
8442528|NCT00797966|20804365|P4|COMPLETED|Phase A+||0
8442529|NCT00797966|20804366|P3|COMPLETED|Phase A+||0
8442530|NCT00797966|20804367|P2|COMPLETED|Phase A+||0
8442531|NCT00797966|20804368|P1|COMPLETED|Phase A+||0
8442532|NCT00797966|20804363|P6|STARTED|Phase A+||235
8442533|NCT00797966|20804364|P5|STARTED|Phase A+||0
8442534|NCT00797966|20804365|P4|STARTED|Phase A+||0
8442535|NCT00797966|20804366|P3|STARTED|Phase A+||0
8442536|NCT00797966|20804367|P2|STARTED|Phase A+||0
8442537|NCT00797966|20804368|P1|STARTED|Phase A+||0
8442538|NCT00797966|20804363|P6|NOT COMPLETED|Phase B||0
8442539|NCT00797966|20804364|P5|NOT COMPLETED|Phase B||0
8442540|NCT00797966|20804365|P4|NOT COMPLETED|Phase B||16
8442541|NCT00797966|20804366|P3|NOT COMPLETED|Phase B||21
8442542|NCT00797966|20804367|P2|NOT COMPLETED|Phase B||18
8442543|NCT00797966|20804368|P1|NOT COMPLETED|Phase B||11
8442544|NCT00797966|20804363|P6|COMPLETED|Phase B||0
8442545|NCT00797966|20804364|P5|COMPLETED|Phase B||0
8442546|NCT00797966|20804365|P4|COMPLETED|Phase B||110
8442547|NCT00797966|20804366|P3|COMPLETED|Phase B||100
8442548|NCT00797966|20804367|P2|COMPLETED|Phase B||102
8442549|NCT00797966|20804368|P1|COMPLETED|Phase B||51
8442550|NCT00797966|20804363|P6|STARTED|Phase B||0
8442551|NCT00797966|20804364|P5|STARTED|Phase B||0
8442552|NCT00797966|20804365|P4|STARTED|Phase B|Randomized participants.|126
8442553|NCT00797966|20804366|P3|STARTED|Phase B|Randomized participants.|121
8442554|NCT00797966|20804367|P2|STARTED|Phase B|Randomized participants.|120
8442555|NCT00797966|20804368|P1|STARTED|Phase B|Randomized participants.|62
8442556|NCT00797966|20804363|P6|NOT COMPLETED|Phase A||0
8442557|NCT00797966|20804364|P5|NOT COMPLETED|Phase A||185
8442558|NCT00797966|20804365|P4|NOT COMPLETED|Phase A||0
8442559|NCT00797966|20804366|P3|NOT COMPLETED|Phase A||0
8442560|NCT00797966|20804367|P2|NOT COMPLETED|Phase A||0
8442561|NCT00797966|20804368|P1|NOT COMPLETED|Phase A||0
8442562|NCT00797966|20804363|P6|COMPLETED|Phase A||0
8442563|NCT00797966|20804364|P5|COMPLETED|Phase A||664
8442564|NCT00797966|20804365|P4|COMPLETED|Phase A||0
8442565|NCT00797966|20804366|P3|COMPLETED|Phase A||0
8442566|NCT00797966|20804367|P2|COMPLETED|Phase A||0
8442567|NCT00797966|20804368|P1|COMPLETED|Phase A||0
8442568|NCT00797966|20804363|P6|STARTED|Phase A||0
8442569|NCT00797966|20804364|P5|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
8442570|NCT00797966|20804365|P4|STARTED|Phase A||0
8442571|NCT00797966|20804366|P3|STARTED|Phase A||0
8442572|NCT00797966|20804367|P2|STARTED|Phase A||0
8442573|NCT00797966|20804368|P1|STARTED|Phase A||0
8442574|NCT00797862|20804433|P3|NOT COMPLETED|Overall Study||86
8442575|NCT00797862|20804434|P2|NOT COMPLETED|Overall Study||68
8442576|NCT00797862|20804435|P1|NOT COMPLETED|Overall Study||124
8442577|NCT00797862|20804433|P3|COMPLETED|Overall Study||230
8442578|NCT00797862|20804434|P2|COMPLETED|Overall Study||250
8442579|NCT00797862|20804435|P1|COMPLETED|Overall Study||496
8442580|NCT00797862|20804433|P3|Entered Double-Blind Treatment (FAS)|Overall Study||315
8442581|NCT00797862|20804434|P2|Entered Double-Blind Treatment (FAS)|Overall Study||315
8442582|NCT00797862|20804435|P1|Entered Double-Blind Treatment (FAS)|Overall Study||617
8442583|NCT00797862|20804433|P3|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
8442584|NCT00797862|20804434|P2|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
8442585|NCT00797862|20804435|P1|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
8442586|NCT00797823|20804464|P3|NOT COMPLETED|Second Period (Crossover)||0
8442587|NCT00797823|20804465|P2|NOT COMPLETED|Second Period (Crossover)||0
8442588|NCT00797823|20804466|P1|NOT COMPLETED|Second Period (Crossover)||0
8442589|NCT00797823|20804464|P3|COMPLETED|Second Period (Crossover)||0
8442590|NCT00797823|20804465|P2|COMPLETED|Second Period (Crossover)||4
8442591|NCT00797823|20804466|P1|COMPLETED|Second Period (Crossover)||3
8442592|NCT00797823|20804464|P3|STARTED|Second Period (Crossover)||0
8442593|NCT00797823|20804465|P2|STARTED|Second Period (Crossover)||4
8442594|NCT00797823|20804466|P1|STARTED|Second Period (Crossover)||3
8442595|NCT00797823|20804464|P3|NOT COMPLETED|First Period (Initial Randomization)||0
8442596|NCT00797823|20804465|P2|NOT COMPLETED|First Period (Initial Randomization)||0
8442597|NCT00797823|20804466|P1|NOT COMPLETED|First Period (Initial Randomization)||1
8442598|NCT00797823|20804464|P3|COMPLETED|First Period (Initial Randomization)||0
8442599|NCT00797823|20804465|P2|COMPLETED|First Period (Initial Randomization)||4
8442600|NCT00797823|20804466|P1|COMPLETED|First Period (Initial Randomization)||3
8442601|NCT00797823|20804464|P3|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
8442602|NCT00797823|20804465|P2|STARTED|First Period (Initial Randomization)||4
8442603|NCT00797823|20804466|P1|STARTED|First Period (Initial Randomization)||4
8442604|NCT00797823|20804464|P3|NOT COMPLETED|Pilot Studies||0
8442605|NCT00797823|20804465|P2|NOT COMPLETED|Pilot Studies||0
8442606|NCT00797823|20804466|P1|NOT COMPLETED|Pilot Studies||0
8442607|NCT00797823|20804464|P3|COMPLETED|Pilot Studies||6
8442608|NCT00797823|20804465|P2|COMPLETED|Pilot Studies||0
8442609|NCT00797823|20804466|P1|COMPLETED|Pilot Studies||0
8442610|NCT00797823|20804464|P3|STARTED|Pilot Studies||6
8442611|NCT00797823|20804465|P2|STARTED|Pilot Studies|Not involved in pilot studies|0
8442612|NCT00797823|20804466|P1|STARTED|Pilot Studies|Not involved in pilot studies|0
8442613|NCT00797797|20804477|P2|NOT COMPLETED|Overall Study||43
8442614|NCT00797797|20804478|P1|NOT COMPLETED|Overall Study||55
8442615|NCT00797797|20804477|P2|COMPLETED|Overall Study||141
8442616|NCT00797797|20804478|P1|COMPLETED|Overall Study||123
8442617|NCT00797797|20804477|P2|STARTED|Overall Study||184
8442618|NCT00797797|20804478|P1|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
8442619|NCT00797732|20804488|P3|NOT COMPLETED|Overall Study||154
8442620|NCT00797732|20804489|P2|NOT COMPLETED|Overall Study||3
8442621|NCT00797732|20804490|P1|NOT COMPLETED|Overall Study||5
8442622|NCT00797732|20804488|P3|COMPLETED|Overall Study||0
8442623|NCT00797732|20804489|P2|COMPLETED|Overall Study||18
8442624|NCT00797732|20804490|P1|COMPLETED|Overall Study||16
8442625|NCT00797732|20804488|P3|Evaluable at 12 Months|Overall Study||0
8442626|NCT00797732|20804489|P2|Evaluable at 12 Months|Overall Study||18
8442627|NCT00797732|20804490|P1|Evaluable at 12 Months|Overall Study||17
8442628|NCT00797732|20804488|P3|Evaluable at 20 Weeks|Overall Study||0
8442629|NCT00797732|20804489|P2|Evaluable at 20 Weeks|Overall Study||18
8442630|NCT00797732|20804490|P1|Evaluable at 20 Weeks|Overall Study||17
8442631|NCT00797732|20804488|P3|Evaluable at Baseline|Overall Study||0
8442632|NCT00797732|20804489|P2|Evaluable at Baseline|Overall Study||18
8442633|NCT00797732|20804490|P1|Evaluable at Baseline|Overall Study||18
8442634|NCT00797732|20804488|P3|STARTED|Overall Study||154
8442635|NCT00797732|20804489|P2|STARTED|Overall Study||21
8442636|NCT00797732|20804490|P1|STARTED|Overall Study||21
8442637|NCT00797667|20804505|P3|NOT COMPLETED|Overall Study||127
8442638|NCT00797667|20804506|P2|NOT COMPLETED|Overall Study||259
8442639|NCT00797667|20804507|P1|NOT COMPLETED|Overall Study||260
8442640|NCT00797667|20804505|P3|COMPLETED|Overall Study||4
8442641|NCT00797667|20804506|P2|COMPLETED|Overall Study||5
8442642|NCT00797667|20804507|P1|COMPLETED|Overall Study||5
8442643|NCT00797667|20804505|P3|Treated|Overall Study||130
8442644|NCT00797667|20804506|P2|Treated|Overall Study||263
8442645|NCT00797667|20804507|P1|Treated|Overall Study||263
8442646|NCT00797667|20804505|P3|STARTED|Overall Study||131
8442647|NCT00797667|20804506|P2|STARTED|Overall Study||264
8442648|NCT00797667|20804507|P1|STARTED|Overall Study||265
8442649|NCT00797563|20804533|P1|NOT COMPLETED|Overall Study||1
8442650|NCT00797563|20804533|P1|COMPLETED|Overall Study||101
8442651|NCT00797563|20804533|P1|STARTED|Overall Study|number of subjects|102
8442652|NCT00797511|20804539|P1|NOT COMPLETED|Overall Study||1
8442653|NCT00797511|20804539|P1|COMPLETED|Overall Study||131
8442654|NCT00797511|20804539|P1|STARTED|Overall Study||132
8442655|NCT00797459|20804547|P1|NOT COMPLETED|Overall Study||0
8442656|NCT00797459|20804547|P1|COMPLETED|Overall Study||60
8442657|NCT00797459|20804547|P1|STARTED|Overall Study||60
8442658|NCT00797316|20804557|P2|NOT COMPLETED|Overall Study||32
8442659|NCT00797316|20804558|P1|NOT COMPLETED|Overall Study||23
8442660|NCT00797316|20804557|P2|COMPLETED|Overall Study||233
8442661|NCT00797316|20804558|P1|COMPLETED|Overall Study||244
8442662|NCT00797316|20804557|P2|STARTED|Overall Study||265
8442663|NCT00797316|20804558|P1|STARTED|Overall Study||267
8442664|NCT00797277|20804574|P2|NOT COMPLETED|Overall Study||0
8442665|NCT00797277|20804575|P1|NOT COMPLETED|Overall Study||0
8442666|NCT00797277|20804574|P2|COMPLETED|Overall Study||30
8442667|NCT00797277|20804575|P1|COMPLETED|Overall Study||37
8442668|NCT00797277|20804574|P2|STARTED|Overall Study||30
8442669|NCT00797277|20804575|P1|STARTED|Overall Study||37
8442670|NCT00797225|20804587|P8|NOT COMPLETED|Weeks 13 to 24||0
8442671|NCT00797225|20804588|P7|NOT COMPLETED|Weeks 13 to 24||2
8442672|NCT00797225|20804589|P6|NOT COMPLETED|Weeks 13 to 24||0
8442673|NCT00797225|20804590|P5|NOT COMPLETED|Weeks 13 to 24||1
8442674|NCT00797225|20804591|P4|NOT COMPLETED|Weeks 13 to 24||0
8442675|NCT00797225|20804592|P3|NOT COMPLETED|Weeks 13 to 24||2
8442676|NCT00797225|20804593|P2|NOT COMPLETED|Weeks 13 to 24||4
8442677|NCT00797225|20804594|P1|NOT COMPLETED|Weeks 13 to 24||0
8442678|NCT00797225|20804587|P8|COMPLETED|Weeks 13 to 24||22
8442679|NCT00797225|20804588|P7|COMPLETED|Weeks 13 to 24||20
8442680|NCT00797225|20804589|P6|COMPLETED|Weeks 13 to 24||21
8442681|NCT00797225|20804590|P5|COMPLETED|Weeks 13 to 24||19
8442682|NCT00797225|20804591|P4|COMPLETED|Weeks 13 to 24||0
8442683|NCT00797225|20804592|P3|COMPLETED|Weeks 13 to 24||41
8442684|NCT00797225|20804593|P2|COMPLETED|Weeks 13 to 24||38
8442685|NCT00797225|20804594|P1|COMPLETED|Weeks 13 to 24||0
8442686|NCT00797225|20804587|P8|STARTED|Weeks 13 to 24||22
8442687|NCT00797225|20804588|P7|STARTED|Weeks 13 to 24||22
8442688|NCT00797225|20804589|P6|STARTED|Weeks 13 to 24||21
8442689|NCT00797225|20804590|P5|STARTED|Weeks 13 to 24||20
8442690|NCT00797225|20804591|P4|STARTED|Weeks 13 to 24||0
8442691|NCT00797225|20804592|P3|STARTED|Weeks 13 to 24||43
8442692|NCT00797225|20804593|P2|STARTED|Weeks 13 to 24||42
8442693|NCT00797225|20804594|P1|STARTED|Weeks 13 to 24||0
8442694|NCT00797225|20804587|P8|NOT COMPLETED|Weeks 1 to 12||0
8442695|NCT00797225|20804588|P7|NOT COMPLETED|Weeks 1 to 12||0
8442696|NCT00797225|20804589|P6|NOT COMPLETED|Weeks 1 to 12||0
8442697|NCT00797225|20804590|P5|NOT COMPLETED|Weeks 1 to 12||0
8442698|NCT00797225|20804591|P4|NOT COMPLETED|Weeks 1 to 12||0
8442699|NCT00797225|20804592|P3|NOT COMPLETED|Weeks 1 to 12||1
8442700|NCT00797225|20804593|P2|NOT COMPLETED|Weeks 1 to 12||1
8442701|NCT00797225|20804594|P1|NOT COMPLETED|Weeks 1 to 12||2
8442702|NCT00797225|20804587|P8|COMPLETED|Weeks 1 to 12||0
8442703|NCT00797225|20804588|P7|COMPLETED|Weeks 1 to 12||0
8442704|NCT00797225|20804589|P6|COMPLETED|Weeks 1 to 12||0
8442705|NCT00797225|20804590|P5|COMPLETED|Weeks 1 to 12||0
8442706|NCT00797225|20804591|P4|COMPLETED|Weeks 1 to 12||44
8442707|NCT00797225|20804592|P3|COMPLETED|Weeks 1 to 12||43
8442708|NCT00797225|20804593|P2|COMPLETED|Weeks 1 to 12||42
8442709|NCT00797225|20804594|P1|COMPLETED|Weeks 1 to 12||41
8442710|NCT00797225|20804587|P8|Received Study Drug|Weeks 1 to 12||0
8442711|NCT00797225|20804588|P7|Received Study Drug|Weeks 1 to 12||0
8442712|NCT00797225|20804589|P6|Received Study Drug|Weeks 1 to 12||0
8442713|NCT00797225|20804590|P5|Received Study Drug|Weeks 1 to 12||0
8442714|NCT00797225|20804591|P4|Received Study Drug|Weeks 1 to 12||44
8442715|NCT00797225|20804592|P3|Received Study Drug|Weeks 1 to 12||44
8442716|NCT00797225|20804593|P2|Received Study Drug|Weeks 1 to 12||43
8442717|NCT00797225|20804594|P1|Received Study Drug|Weeks 1 to 12||43
8442718|NCT00797225|20804587|P8|STARTED|Weeks 1 to 12||0
8442719|NCT00797225|20804588|P7|STARTED|Weeks 1 to 12||0
8442720|NCT00797225|20804589|P6|STARTED|Weeks 1 to 12||0
8442721|NCT00797225|20804590|P5|STARTED|Weeks 1 to 12||0
8442722|NCT00797225|20804591|P4|STARTED|Weeks 1 to 12||44
8442723|NCT00797225|20804592|P3|STARTED|Weeks 1 to 12||44
8442724|NCT00797225|20804593|P2|STARTED|Weeks 1 to 12||43
8442725|NCT00797225|20804594|P1|STARTED|Weeks 1 to 12||43
8442726|NCT00797212|20804702|P1|NOT COMPLETED|Overall Study||0
8442727|NCT00797212|20804702|P1|COMPLETED|Overall Study||50
8442728|NCT00797212|20804702|P1|STARTED|Overall Study||50
8442729|NCT00797108|20804711|P3|NOT COMPLETED|Overall Study||6
8442730|NCT00797108|20804712|P2|NOT COMPLETED|Overall Study||2
8442731|NCT00797108|20804713|P1|NOT COMPLETED|Overall Study||4
8442732|NCT00797108|20804711|P3|COMPLETED|Overall Study||6
8442733|NCT00797108|20804712|P2|COMPLETED|Overall Study||9
8442734|NCT00797108|20804713|P1|COMPLETED|Overall Study||8
8442735|NCT00797108|20804711|P3|Treated|Overall Study||12
8442736|NCT00797108|20804712|P2|Treated|Overall Study||11
8442737|NCT00797108|20804713|P1|Treated|Overall Study||10
8442738|NCT00797108|20804711|P3|STARTED|Overall Study||12
8442739|NCT00797108|20804712|P2|STARTED|Overall Study||11
8442740|NCT00797108|20804713|P1|STARTED|Overall Study||12
8442741|NCT00796991|20804748|P3|NOT COMPLETED|Overall Study||14
8442742|NCT00796991|20804749|P2|NOT COMPLETED|Overall Study||12
8442743|NCT00796991|20804750|P1|NOT COMPLETED|Overall Study||15
8442744|NCT00796991|20804748|P3|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
8442745|NCT00796991|20804749|P2|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
8442746|NCT00796991|20804750|P1|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
8442747|NCT00796991|20804748|P3|STARTED|Overall Study||20
8442748|NCT00796991|20804749|P2|STARTED|Overall Study||19
8442749|NCT00796991|20804750|P1|STARTED|Overall Study||20
8442750|NCT00796978|20804848|P1|NOT COMPLETED|Overall Study||12
8442751|NCT00796978|20804848|P1|COMPLETED|Overall Study||44
8442752|NCT00796978|20804848|P1|STARTED|Overall Study||56
8442753|NCT00796926|20804867|P2|NOT COMPLETED|Overall Study||0
8442754|NCT00796926|20804868|P1|NOT COMPLETED|Overall Study||1
8442755|NCT00796926|20804867|P2|COMPLETED|Overall Study||15
8442756|NCT00796926|20804868|P1|COMPLETED|Overall Study||14
8442757|NCT00796926|20804867|P2|STARTED|Overall Study||15
8442758|NCT00796926|20804868|P1|STARTED|Overall Study||15
8442759|NCT00796861|20804874|P1|NOT COMPLETED|Overall Study||4
8442760|NCT00796861|20804874|P1|COMPLETED|Overall Study||0
8442761|NCT00796861|20804874|P1|STARTED|Overall Study||4
8442762|NCT00796822|20804880|P2|NOT COMPLETED|Overall Study||0
8442763|NCT00796822|20804881|P1|NOT COMPLETED|Overall Study||3
8442764|NCT00796822|20804880|P2|COMPLETED|Overall Study||13
8442765|NCT00796822|20804881|P1|COMPLETED|Overall Study||10
8442766|NCT00796822|20804880|P2|STARTED|Overall Study||13
8442767|NCT00796822|20804881|P1|STARTED|Overall Study||13
8442768|NCT00796757|20804889|P1|NOT COMPLETED|Overall Study||86
8442769|NCT00796757|20804889|P1|COMPLETED|Overall Study||60
8442770|NCT00796757|20804889|P1|STARTED|Overall Study||146
8442771|NCT00796744|20804904|P3|NOT COMPLETED|Overall Study||1
8442772|NCT00796744|20804905|P2|NOT COMPLETED|Overall Study||0
8442773|NCT00796744|20804906|P1|NOT COMPLETED|Overall Study||0
8442774|NCT00796744|20804904|P3|COMPLETED|Overall Study||27
8442775|NCT00796744|20804905|P2|COMPLETED|Overall Study||26
8442776|NCT00796744|20804906|P1|COMPLETED|Overall Study||24
8442777|NCT00796744|20804904|P3|STARTED|Overall Study||28
8442778|NCT00796744|20804905|P2|STARTED|Overall Study||26
8442779|NCT00796744|20804906|P1|STARTED|Overall Study||24
8442780|NCT00796718|20804923|P1|NOT COMPLETED|Overall Study||9
8442781|NCT00796718|20804923|P1|COMPLETED|Overall Study||53
8442782|NCT00796718|20804923|P1|STARTED|Overall Study||62
8442783|NCT00796705|20804934|P4|NOT COMPLETED|Overall Study||0
8442784|NCT00796705|20804935|P3|NOT COMPLETED|Overall Study||0
8442785|NCT00796705|20804936|P2|NOT COMPLETED|Overall Study||0
8442786|NCT00796705|20804937|P1|NOT COMPLETED|Overall Study||0
8442787|NCT00796705|20804934|P4|COMPLETED|Overall Study||2
8442788|NCT00796705|20804935|P3|COMPLETED|Overall Study||4
8442789|NCT00796705|20804936|P2|COMPLETED|Overall Study||4
8442790|NCT00796705|20804937|P1|COMPLETED|Overall Study||3
8442791|NCT00796705|20804934|P4|STARTED|Overall Study||2
8442792|NCT00796705|20804935|P3|STARTED|Overall Study||4
8442793|NCT00796705|20804936|P2|STARTED|Overall Study||4
8442794|NCT00796705|20804937|P1|STARTED|Overall Study||3
8442795|NCT00796666|20804975|P2|NOT COMPLETED|Overall Study||64
8442796|NCT00796666|20804976|P1|NOT COMPLETED|Overall Study||67
8442797|NCT00796666|20804975|P2|COMPLETED|Overall Study||0
8442798|NCT00796666|20804976|P1|COMPLETED|Overall Study||0
8442799|NCT00796666|20804975|P2|Randomized and Not Treated|Overall Study||0
8442800|NCT00796666|20804976|P1|Randomized and Not Treated|Overall Study||1
8442801|NCT00796666|20804975|P2|Treated|Overall Study||64
8442802|NCT00796666|20804976|P1|Treated|Overall Study||66
8442803|NCT00796666|20804975|P2|STARTED|Overall Study||64
8442804|NCT00796666|20804976|P1|STARTED|Overall Study||67
8442805|NCT00796653|20805010|P4|NOT COMPLETED|Overall Study||40
8442806|NCT00796653|20805011|P3|NOT COMPLETED|Overall Study||36
8442807|NCT00796653|20805012|P2|NOT COMPLETED|Overall Study||37
8442808|NCT00796653|20805013|P1|NOT COMPLETED|Overall Study||51
8442809|NCT00796653|20805010|P4|COMPLETED|Overall Study||193
8442810|NCT00796653|20805011|P3|COMPLETED|Overall Study||198
8442811|NCT00796653|20805012|P2|COMPLETED|Overall Study||195
8442812|NCT00796653|20805013|P1|COMPLETED|Overall Study||184
8442813|NCT00796653|20805010|P4|STARTED|Overall Study||233
8442814|NCT00796653|20805011|P3|STARTED|Overall Study||234
8442815|NCT00796653|20805012|P2|STARTED|Overall Study||232
8442816|NCT00796653|20805013|P1|STARTED|Overall Study||235
8442817|NCT00796627|20805281|P2|NOT COMPLETED|Overall Study||0
8442818|NCT00796627|20805282|P1|NOT COMPLETED|Overall Study||0
8442819|NCT00796627|20805281|P2|COMPLETED|Overall Study||31
8442820|NCT00796627|20805282|P1|COMPLETED|Overall Study||10
8442821|NCT00796627|20805281|P2|STARTED|Overall Study||31
8442822|NCT00796627|20805282|P1|STARTED|Overall Study||10
8442823|NCT00796614|20805298|P4|NOT COMPLETED|Overall Study||1
8442824|NCT00796614|20805299|P3|NOT COMPLETED|Overall Study||3
8442825|NCT00796614|20805300|P2|NOT COMPLETED|Overall Study||4
8442826|NCT00796614|20805301|P1|NOT COMPLETED|Overall Study||5
8442827|NCT00796614|20805298|P4|COMPLETED|Overall Study||40
8442828|NCT00796614|20805299|P3|COMPLETED|Overall Study||36
8442829|NCT00796614|20805300|P2|COMPLETED|Overall Study||36
8442830|NCT00796614|20805301|P1|COMPLETED|Overall Study||36
8442831|NCT00796614|20805298|P4|Not Treated|Overall Study||0
8442832|NCT00796614|20805299|P3|Not Treated|Overall Study||1
8442833|NCT00796614|20805300|P2|Not Treated|Overall Study||0
8442834|NCT00796614|20805301|P1|Not Treated|Overall Study||0
8442835|NCT00796614|20805298|P4|STARTED|Overall Study||41
8442836|NCT00796614|20805299|P3|STARTED|Overall Study||39
8442837|NCT00796614|20805300|P2|STARTED|Overall Study||40
8442838|NCT00796614|20805301|P1|STARTED|Overall Study||41
8442839|NCT00796562|20805343|P1|NOT COMPLETED|Overall Study||49
8442840|NCT00796562|20805343|P1|COMPLETED|Overall Study||47
8442841|NCT00796562|20805343|P1|STARTED|Overall Study||96
8442842|NCT00796549|20805352|P1|NOT COMPLETED|Overall Study||218
8442843|NCT00796549|20805352|P1|COMPLETED|Overall Study||0
8442844|NCT00796549|20805352|P1|Entered|Overall Study|entered and treated|69
8442845|NCT00796549|20805352|P1|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
8442846|NCT00796523|20805369|P2|NOT COMPLETED|Overall Study||7
8442847|NCT00796523|20805370|P1|NOT COMPLETED|Overall Study||9
8442848|NCT00796523|20805369|P2|COMPLETED|Overall Study||17
8442849|NCT00796523|20805370|P1|COMPLETED|Overall Study||18
8442850|NCT00796523|20805369|P2|STARTED|Overall Study||24
8442851|NCT00796523|20805370|P1|STARTED|Overall Study||27
8442852|NCT00796510|20805380|P2|NOT COMPLETED|Overall Study||0
8442853|NCT00796510|20805381|P1|NOT COMPLETED|Overall Study||3
8442854|NCT00796510|20805380|P2|COMPLETED|Overall Study||0
8442855|NCT00796510|20805381|P1|COMPLETED|Overall Study||0
8442856|NCT00796510|20805380|P2|STARTED|Overall Study||0
8442857|NCT00796510|20805381|P1|STARTED|Overall Study||3
8442864|NCT00796419|20805446|P2|NOT COMPLETED|Overall Study||1
8442865|NCT00796419|20805447|P1|NOT COMPLETED|Overall Study||0
8442866|NCT00796419|20805446|P2|COMPLETED|Overall Study||13
8442867|NCT00796419|20805447|P1|COMPLETED|Overall Study||13
8442868|NCT00796419|20805446|P2|STARTED|Overall Study||14
8442869|NCT00796419|20805447|P1|STARTED|Overall Study||13
8442870|NCT00796367|20805460|P3|NOT COMPLETED|Overall Study||47
8442871|NCT00796367|20805461|P2|NOT COMPLETED|Overall Study||25
8442872|NCT00796367|20805462|P1|NOT COMPLETED|Overall Study||30
8442873|NCT00796367|20805460|P3|COMPLETED|Overall Study||248
8442874|NCT00796367|20805461|P2|COMPLETED|Overall Study||129
8442875|NCT00796367|20805462|P1|COMPLETED|Overall Study||197
8442876|NCT00796367|20805460|P3|STARTED|Overall Study||295
8442877|NCT00796367|20805461|P2|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
8442878|NCT00796367|20805462|P1|STARTED|Overall Study||227
8442879|NCT00796328|20805473|P1|NOT COMPLETED|Overall Study||6
8442880|NCT00796328|20805473|P1|COMPLETED|Overall Study||40
8442881|NCT00796328|20805473|P1|STARTED|Overall Study||46
8442882|NCT00796315|20805477|P3|NOT COMPLETED|Overall Study||0
8442883|NCT00796315|20805478|P2|NOT COMPLETED|Overall Study||1
8442884|NCT00796315|20805479|P1|NOT COMPLETED|Overall Study||0
8442885|NCT00796315|20805477|P3|COMPLETED|Overall Study||15
8442886|NCT00796315|20805478|P2|COMPLETED|Overall Study||16
8442887|NCT00796315|20805479|P1|COMPLETED|Overall Study||9
8442888|NCT00796315|20805477|P3|STARTED|Overall Study||15
8442889|NCT00796315|20805478|P2|STARTED|Overall Study||17
8442890|NCT00796315|20805479|P1|STARTED|Overall Study||9
8442891|NCT00796302|20805492|P2|NOT COMPLETED|Overall Study||18
8442892|NCT00796302|20805493|P1|NOT COMPLETED|Overall Study||13
8442893|NCT00796302|20805492|P2|COMPLETED|Overall Study||66
8442894|NCT00796302|20805493|P1|COMPLETED|Overall Study||71
8442895|NCT00796302|20805492|P2|STARTED|Overall Study||84
8442896|NCT00796302|20805493|P1|STARTED|Overall Study||84
8442897|NCT00796224|20805507|P2|NOT COMPLETED|Overall Study||1
8442898|NCT00796224|20805508|P1|NOT COMPLETED|Overall Study||1
8442899|NCT00796224|20805507|P2|COMPLETED|Overall Study||18
8442900|NCT00796224|20805508|P1|COMPLETED|Overall Study||18
8442901|NCT00796224|20805507|P2|STARTED|Overall Study||19
8442902|NCT00796224|20805508|P1|STARTED|Overall Study||19
8442903|NCT00796120|20805528|P2|NOT COMPLETED|Overall Study||60
8442904|NCT00796120|20805529|P1|NOT COMPLETED|Overall Study||61
8442905|NCT00796120|20805528|P2|COMPLETED|Overall Study||0
8442906|NCT00796120|20805529|P1|COMPLETED|Overall Study||0
8442907|NCT00796120|20805528|P2|Treated|Overall Study||57
8442908|NCT00796120|20805529|P1|Treated|Overall Study||61
8442909|NCT00796120|20805528|P2|STARTED|Overall Study||60
8442910|NCT00796120|20805529|P1|STARTED|Overall Study||61
8442911|NCT00796107|20805543|P1|NOT COMPLETED|Overall Study||6
8442912|NCT00796107|20805543|P1|COMPLETED|Overall Study||0
8442913|NCT00796107|20805543|P1|STARTED|Overall Study||6
8442914|NCT00796003|20805552|P2|NOT COMPLETED|Overall Study||29
8442915|NCT00796003|20805553|P1|NOT COMPLETED|Overall Study||3
8442916|NCT00796003|20805552|P2|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
8442917|NCT00796003|20805553|P1|COMPLETED|Overall Study||0
8442918|NCT00796003|20805552|P2|Treated|Overall Study|Number of participants treated|34
8442919|NCT00796003|20805553|P1|Treated|Overall Study|Number of participants treated|3
8442920|NCT00796003|20805552|P2|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
8442921|NCT00796003|20805553|P1|STARTED|Overall Study|Number of participants enrolled|3
8442922|NCT00795951|20805574|P1|NOT COMPLETED|Overall Study||2
8442923|NCT00795951|20805574|P1|COMPLETED|Overall Study||100
8442924|NCT00795951|20805574|P1|STARTED|Overall Study||102
8442925|NCT00795886|20805667|P1|NOT COMPLETED|Overall Study||10
8442926|NCT00795886|20805667|P1|COMPLETED|Overall Study||53
8442927|NCT00795886|20805667|P1|STARTED|Overall Study||63
8442928|NCT00795821|20805675|P2|NOT COMPLETED|Taper Phase||0
8442929|NCT00795821|20805676|P1|NOT COMPLETED|Taper Phase||9
8442930|NCT00795821|20805675|P2|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
8442931|NCT00795821|20805676|P1|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
8442932|NCT00795821|20805675|P2|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
8442933|NCT00795821|20805676|P1|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
8442934|NCT00795821|20805675|P2|NOT COMPLETED|Long-term Extension Phase||92
8442935|NCT00795821|20805676|P1|NOT COMPLETED|Long-term Extension Phase||90
8442936|NCT00795821|20805675|P2|COMPLETED|Long-term Extension Phase||115
8442937|NCT00795821|20805676|P1|COMPLETED|Long-term Extension Phase||100
8442938|NCT00795821|20805675|P2|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
8442939|NCT00795821|20805676|P1|STARTED|Long-term Extension Phase||190
8442940|NCT00795821|20805675|P2|NOT COMPLETED|Acute Treatment Phase||31
8442941|NCT00795821|20805676|P1|NOT COMPLETED|Acute Treatment Phase||56
8442942|NCT00795821|20805675|P2|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
8442943|NCT00795821|20805676|P1|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
8442944|NCT00795821|20805675|P2|STARTED|Acute Treatment Phase||245
8442945|NCT00795821|20805676|P1|STARTED|Acute Treatment Phase||250
8442946|NCT00795769|20805745|P1|NOT COMPLETED|Overall Study||0
8442947|NCT00795769|20805745|P1|COMPLETED|Overall Study||49
8442948|NCT00795769|20805745|P1|STARTED|Overall Study||49
8442949|NCT00795717|20805751|P2|NOT COMPLETED|Phase II||1
8442950|NCT00795717|20805752|P1|NOT COMPLETED|Phase II||0
8442951|NCT00795717|20805751|P2|COMPLETED|Phase II||18
8442952|NCT00795717|20805752|P1|COMPLETED|Phase II||18
8442953|NCT00795717|20805751|P2|STARTED|Phase II||19
8442954|NCT00795717|20805752|P1|STARTED|Phase II||18
8442955|NCT00795717|20805751|P2|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
8442956|NCT00795717|20805752|P1|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
8442957|NCT00795717|20805751|P2|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
8442958|NCT00795717|20805752|P1|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
8442959|NCT00795717|20805751|P2|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
8442960|NCT00795717|20805752|P1|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
8442961|NCT00795704|20805764|P2|NOT COMPLETED|Overall Study||3
8442962|NCT00795704|20805765|P1|NOT COMPLETED|Overall Study||4
8442963|NCT00795704|20805764|P2|COMPLETED|Overall Study||9
8442964|NCT00795704|20805765|P1|COMPLETED|Overall Study||8
8442965|NCT00795704|20805764|P2|STARTED|Overall Study||12
8442966|NCT00795704|20805765|P1|STARTED|Overall Study||12
8442967|NCT00795665|20805775|P1|NOT COMPLETED|Overall Study||0
8442968|NCT00795665|20805775|P1|COMPLETED|Overall Study||7
8442969|NCT00795665|20805775|P1|STARTED|Overall Study||7
8442970|NCT00795639|20805785|P2|NOT COMPLETED|Overall Study||26
8442971|NCT00795639|20805786|P1|NOT COMPLETED|Overall Study||21
8442972|NCT00795639|20805785|P2|COMPLETED|Overall Study||66
8442973|NCT00795639|20805786|P1|COMPLETED|Overall Study||70
8442974|NCT00795639|20805785|P2|Randomized and Not Treated|Overall Study||1
8442975|NCT00795639|20805786|P1|Randomized and Not Treated|Overall Study||0
8442976|NCT00795639|20805785|P2|STARTED|Overall Study||92
8442977|NCT00795639|20805786|P1|STARTED|Overall Study||91
8442978|NCT00795600|20805798|P2|NOT COMPLETED|Overall Study||4
8442979|NCT00795600|20805799|P1|NOT COMPLETED|Overall Study||4
8442980|NCT00795600|20805798|P2|COMPLETED|Overall Study||31
8442981|NCT00795600|20805799|P1|COMPLETED|Overall Study||21
8442982|NCT00795600|20805798|P2|Exposed to Drug|Overall Study||35
8442983|NCT00795600|20805799|P1|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
8442984|NCT00795600|20805798|P2|STARTED|Overall Study||35
8442985|NCT00795600|20805799|P1|STARTED|Overall Study||25
8442986|NCT00795535|20805919|P1|NOT COMPLETED|Overall Study||20
8442987|NCT00795535|20805919|P1|COMPLETED|Overall Study||75
8442988|NCT00795535|20805919|P1|STARTED|Overall Study||95
8442989|NCT00795509|20805926|P1|NOT COMPLETED|Overall Study||31
8442990|NCT00795509|20805926|P1|COMPLETED|Overall Study||343
8442991|NCT00795509|20805926|P1|STARTED|Overall Study||374
8442992|NCT00795366|20805933|P2|NOT COMPLETED|Overall Study||0
8442993|NCT00795366|20805934|P1|NOT COMPLETED|Overall Study||0
8442994|NCT00795366|20805933|P2|COMPLETED|Overall Study||54
8442995|NCT00795366|20805934|P1|COMPLETED|Overall Study||42
8442996|NCT00795366|20805933|P2|STARTED|Overall Study||54
8442997|NCT00795366|20805934|P1|STARTED|Overall Study||42
8442998|NCT00795340|20805942|P2|NOT COMPLETED|Overall Study||0
8442999|NCT00795340|20805943|P1|NOT COMPLETED|Overall Study||7
8443000|NCT00795340|20805942|P2|COMPLETED|Overall Study||153
8443001|NCT00795340|20805943|P1|COMPLETED|Overall Study||146
8443002|NCT00795340|20805942|P2|STARTED|Overall Study||153
8443003|NCT00795340|20805943|P1|STARTED|Overall Study||153
8443004|NCT00795288|20805955|P2|NOT COMPLETED|Overall Study||0
8443005|NCT00795288|20805956|P1|NOT COMPLETED|Overall Study||0
8443006|NCT00795288|20805955|P2|COMPLETED|Overall Study||21
8443007|NCT00795288|20805956|P1|COMPLETED|Overall Study||21
8443008|NCT00795288|20805955|P2|STARTED|Overall Study||21
8443009|NCT00795288|20805956|P1|STARTED|Overall Study||21
8443010|NCT00795236|20805968|P2|NOT COMPLETED|Overall Study||0
8443011|NCT00795236|20805969|P1|NOT COMPLETED|Overall Study||0
8443012|NCT00795236|20805968|P2|COMPLETED|Overall Study||0
8443013|NCT00795236|20805969|P1|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0
8443014|NCT00795236|20805968|P2|STARTED|Overall Study||0
8443015|NCT00795236|20805969|P1|STARTED|Overall Study||0
8443016|NCT00795210|20805982|P3|NOT COMPLETED|Overall Study||2
8443017|NCT00795210|20805983|P2|NOT COMPLETED|Overall Study||1
8443018|NCT00795210|20805984|P1|NOT COMPLETED|Overall Study||0
8443019|NCT00795210|20805982|P3|COMPLETED|Overall Study||3
8443020|NCT00795210|20805983|P2|COMPLETED|Overall Study||11
8443021|NCT00795210|20805984|P1|COMPLETED|Overall Study||8
8443022|NCT00795210|20805982|P3|STARTED|Overall Study||5
8443023|NCT00795210|20805983|P2|STARTED|Overall Study||12
8443024|NCT00795210|20805984|P1|STARTED|Overall Study||8
8443025|NCT00795184|20805995|P2|NOT COMPLETED|Overall Study||13
8443026|NCT00795184|20805996|P1|NOT COMPLETED|Overall Study||8
8443027|NCT00795184|20805995|P2|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
8443028|NCT00795184|20805996|P1|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
8443029|NCT00795184|20805995|P2|STARTED|Overall Study||57
8443030|NCT00795184|20805996|P1|STARTED|Overall Study||65
8443031|NCT00795145|20806007|P7|NOT COMPLETED|Cohort 2||0
8443032|NCT00795145|20806008|P6|NOT COMPLETED|Cohort 2||0
8443033|NCT00795145|20806009|P5|NOT COMPLETED|Cohort 2||0
8443034|NCT00795145|20806010|P4|NOT COMPLETED|Cohort 2||0
8443035|NCT00795145|20806011|P3|NOT COMPLETED|Cohort 2||0
8443036|NCT00795145|20806012|P2|NOT COMPLETED|Cohort 2||0
8443037|NCT00795145|20806013|P1|NOT COMPLETED|Cohort 2||0
8443038|NCT00795145|20806007|P7|COMPLETED|Cohort 2||10
8443039|NCT00795145|20806008|P6|COMPLETED|Cohort 2||10
8443040|NCT00795145|20806009|P5|COMPLETED|Cohort 2||10
8443041|NCT00795145|20806010|P4|COMPLETED|Cohort 2||10
8443042|NCT00795145|20806011|P3|COMPLETED|Cohort 2||0
8443043|NCT00795145|20806012|P2|COMPLETED|Cohort 2||0
8443044|NCT00795145|20806013|P1|COMPLETED|Cohort 2||0
8443045|NCT00795145|20806007|P7|STARTED|Cohort 2||10
8443046|NCT00795145|20806008|P6|STARTED|Cohort 2||10
8443047|NCT00795145|20806009|P5|STARTED|Cohort 2||10
8443048|NCT00795145|20806010|P4|STARTED|Cohort 2||10
8443049|NCT00795145|20806011|P3|STARTED|Cohort 2||0
8443050|NCT00795145|20806012|P2|STARTED|Cohort 2||0
8443051|NCT00795145|20806013|P1|STARTED|Cohort 2||0
8443052|NCT00795145|20806007|P7|NOT COMPLETED|Cohort 1||0
8443053|NCT00795145|20806008|P6|NOT COMPLETED|Cohort 1||0
8443054|NCT00795145|20806009|P5|NOT COMPLETED|Cohort 1||0
8443055|NCT00795145|20806010|P4|NOT COMPLETED|Cohort 1||0
8443056|NCT00795145|20806011|P3|NOT COMPLETED|Cohort 1||0
8443057|NCT00795145|20806012|P2|NOT COMPLETED|Cohort 1||0
8443058|NCT00795145|20806013|P1|NOT COMPLETED|Cohort 1||0
8443059|NCT00795145|20806007|P7|COMPLETED|Cohort 1||0
8443060|NCT00795145|20806008|P6|COMPLETED|Cohort 1||0
8443061|NCT00795145|20806009|P5|COMPLETED|Cohort 1||0
8443062|NCT00795145|20806010|P4|COMPLETED|Cohort 1||0
8443063|NCT00795145|20806011|P3|COMPLETED|Cohort 1||3
8443064|NCT00795145|20806012|P2|COMPLETED|Cohort 1||3
8443065|NCT00795145|20806013|P1|COMPLETED|Cohort 1||3
8443066|NCT00795145|20806007|P7|STARTED|Cohort 1||0
8443067|NCT00795145|20806008|P6|STARTED|Cohort 1||0
8443068|NCT00795145|20806009|P5|STARTED|Cohort 1||0
8443069|NCT00795145|20806010|P4|STARTED|Cohort 1||0
8443070|NCT00795145|20806011|P3|STARTED|Cohort 1||3
8443071|NCT00795145|20806012|P2|STARTED|Cohort 1||3
8443072|NCT00795145|20806013|P1|STARTED|Cohort 1||3
8443073|NCT00795132|20806057|P1|NOT COMPLETED|Overall Study||3
8443074|NCT00795132|20806057|P1|COMPLETED|Overall Study||44
8443075|NCT00795132|20806057|P1|STARTED|Overall Study||47
8443076|NCT00795002|20806071|P2|NOT COMPLETED|Overall Study||0
8443077|NCT00795002|20806072|P1|NOT COMPLETED|Overall Study||0
8443078|NCT00795002|20806071|P2|COMPLETED|Overall Study||37
8443079|NCT00795002|20806072|P1|COMPLETED|Overall Study||37
8443080|NCT00795002|20806071|P2|STARTED|Overall Study||37
8443081|NCT00795002|20806072|P1|STARTED|Overall Study||37
8443082|NCT00794963|20806084|P2|NOT COMPLETED|Overall Study||4
8443083|NCT00794963|20806085|P1|NOT COMPLETED|Overall Study||1
8443084|NCT00794963|20806084|P2|COMPLETED|Overall Study||0
8443085|NCT00794963|20806085|P1|COMPLETED|Overall Study||3
8443086|NCT00794963|20806084|P2|STARTED|Overall Study||4
8443087|NCT00794963|20806085|P1|STARTED|Overall Study||4
8443088|NCT00794950|20806091|P1|NOT COMPLETED|Beginning Sunitinib Treatment||12
8443089|NCT00794950|20806091|P1|COMPLETED|Beginning Sunitinib Treatment||24
8443090|NCT00794950|20806091|P1|STARTED|Beginning Sunitinib Treatment||36
8443091|NCT00794950|20806091|P1|NOT COMPLETED|BCG Induction||7
8443092|NCT00794950|20806091|P1|COMPLETED|BCG Induction||36
8443093|NCT00794950|20806091|P1|STARTED|BCG Induction||43
8443094|NCT00794924|20806100|P2|NOT COMPLETED|Overall Study||70
8443095|NCT00794924|20806101|P1|NOT COMPLETED|Overall Study||60
8443096|NCT00794924|20806100|P2|COMPLETED|Overall Study||101
8443097|NCT00794924|20806101|P1|COMPLETED|Overall Study||114
8443098|NCT00794924|20806100|P2|STARTED|Overall Study|14 patients refused to start the study|171
8443099|NCT00794924|20806101|P1|STARTED|Overall Study|14 patients refused to start the study|174
8443100|NCT00794820|20806105|P1|NOT COMPLETED|Overall Study||16
8443101|NCT00794820|20806105|P1|COMPLETED|Overall Study||50
8443102|NCT00794820|20806105|P1|STARTED|Overall Study||66
8443115|NCT00794664|20806136|P2|NOT COMPLETED|Follow-up Period||5
8443116|NCT00794664|20806137|P1|NOT COMPLETED|Follow-up Period||1
8443117|NCT00794664|20806136|P2|COMPLETED|Follow-up Period||28
8443118|NCT00794664|20806137|P1|COMPLETED|Follow-up Period||15
8443119|NCT00794664|20806136|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
8443120|NCT00794664|20806137|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
8443121|NCT00794664|20806136|P2|NOT COMPLETED|Treatment Period||12
8443122|NCT00794664|20806137|P1|NOT COMPLETED|Treatment Period||1
8443123|NCT00794664|20806136|P2|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
8443124|NCT00794664|20806137|P1|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
8443125|NCT00794664|20806136|P2|STARTED|Treatment Period||39
8443126|NCT00794664|20806137|P1|STARTED|Treatment Period||19
8443127|NCT00794573|20806183|P2|NOT COMPLETED|Overall Study||45
8443128|NCT00794573|20806184|P1|NOT COMPLETED|Overall Study||38
8443129|NCT00794573|20806183|P2|COMPLETED|Overall Study||106
8443130|NCT00794573|20806184|P1|COMPLETED|Overall Study||113
8443131|NCT00794573|20806183|P2|STARTED|Overall Study||151
8443132|NCT00794573|20806184|P1|STARTED|Overall Study||151
8443133|NCT00794560|20806216|P4|NOT COMPLETED|Overall Study||4
8443134|NCT00794560|20806217|P3|NOT COMPLETED|Overall Study||4
8443135|NCT00794560|20806218|P2|NOT COMPLETED|Overall Study||4
8443136|NCT00794560|20806219|P1|NOT COMPLETED|Overall Study||3
8443137|NCT00794560|20806216|P4|COMPLETED|Overall Study||34
8443138|NCT00794560|20806217|P3|COMPLETED|Overall Study||40
8443139|NCT00794560|20806218|P2|COMPLETED|Overall Study||32
8443140|NCT00794560|20806219|P1|COMPLETED|Overall Study||33
8443141|NCT00794560|20806216|P4|STARTED|Overall Study||38
8443142|NCT00794560|20806217|P3|STARTED|Overall Study||44
8443143|NCT00794560|20806218|P2|STARTED|Overall Study||36
8443144|NCT00794560|20806219|P1|STARTED|Overall Study||36
8443145|NCT00794547|20806233|P2|NOT COMPLETED|Overall Study||0
8443146|NCT00794547|20806234|P1|NOT COMPLETED|Overall Study||0
8443147|NCT00794547|20806233|P2|COMPLETED|Overall Study||16
8443148|NCT00794547|20806234|P1|COMPLETED|Overall Study||18
8443149|NCT00794547|20806233|P2|STARTED|Overall Study||16
8443150|NCT00794547|20806234|P1|STARTED|Overall Study||18
8443154|NCT00794469|20806248|P1|NOT COMPLETED|Overall Study||0
8443155|NCT00794469|20806248|P1|COMPLETED|Overall Study||21
8443156|NCT00794469|20806248|P1|STARTED|Overall Study||21
8443157|NCT00794417|20806257|P4|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||35
8443158|NCT00794417|20806258|P3|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8443159|NCT00794417|20806259|P2|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8443160|NCT00794417|20806260|P1|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8443161|NCT00794417|20806257|P4|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||7
8443162|NCT00794417|20806258|P3|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8443163|NCT00794417|20806259|P2|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8443164|NCT00794417|20806260|P1|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
8443165|NCT00794417|20806257|P4|STARTED|Phase 2: Baseline (Day 421) to Day 972||42
8443166|NCT00794417|20806258|P3|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
8443167|NCT00794417|20806259|P2|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
8443168|NCT00794417|20806260|P1|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
8443169|NCT00794417|20806257|P4|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
8443170|NCT00794417|20806258|P3|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
8443171|NCT00794417|20806259|P2|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
8443172|NCT00794417|20806260|P1|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
8443173|NCT00794417|20806257|P4|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
8443174|NCT00794417|20806258|P3|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
8443175|NCT00794417|20806259|P2|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
8443176|NCT00794417|20806260|P1|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||1
8443177|NCT00794417|20806257|P4|STARTED|Phase 1: Baseline (Day 1) up to Day 751||0
8443178|NCT00794417|20806258|P3|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
8443179|NCT00794417|20806259|P2|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
8443180|NCT00794417|20806260|P1|STARTED|Phase 1: Baseline (Day 1) up to Day 751||4
8443181|NCT00794365|20806313|P1|NOT COMPLETED|Overall Study||79
8443182|NCT00794365|20806313|P1|COMPLETED|Overall Study||251
8443183|NCT00794365|20806313|P1|STARTED|Overall Study||330
8443184|NCT00794313|20806319|P3|NOT COMPLETED|Overall Study||0
8443185|NCT00794313|20806320|P2|NOT COMPLETED|Overall Study||0
8443186|NCT00794313|20806321|P1|NOT COMPLETED|Overall Study||0
8443187|NCT00794313|20806319|P3|COMPLETED|Overall Study||1
8443188|NCT00794313|20806320|P2|COMPLETED|Overall Study||1
8443189|NCT00794313|20806321|P1|COMPLETED|Overall Study||1
8443190|NCT00794313|20806319|P3|STARTED|Overall Study||1
8443191|NCT00794313|20806320|P2|STARTED|Overall Study||1
8443192|NCT00794313|20806321|P1|STARTED|Overall Study||1
8443193|NCT00794196|20806334|P2|NOT COMPLETED|Overall Study||23
8443194|NCT00794196|20806335|P1|NOT COMPLETED|Overall Study||5
8443195|NCT00794196|20806334|P2|COMPLETED|Overall Study||64
8443196|NCT00794196|20806335|P1|COMPLETED|Overall Study||87
8443197|NCT00794196|20806334|P2|STARTED|Overall Study||87
8443198|NCT00794196|20806335|P1|STARTED|Overall Study||92
8443199|NCT00794170|20806345|P2|NOT COMPLETED|Overall Study||3
8443200|NCT00794170|20806346|P1|NOT COMPLETED|Overall Study||7
8443201|NCT00794170|20806345|P2|COMPLETED|Overall Study||152
8443202|NCT00794170|20806346|P1|COMPLETED|Overall Study||150
8443203|NCT00794170|20806345|P2|STARTED|Overall Study||155
8443204|NCT00794170|20806346|P1|STARTED|Overall Study||157
8443205|NCT00794157|20806355|P3|NOT COMPLETED|Overall Study||19
8443206|NCT00794157|20806356|P2|NOT COMPLETED|Overall Study||10
8443207|NCT00794157|20806357|P1|NOT COMPLETED|Overall Study||10
8443208|NCT00794157|20806355|P3|COMPLETED|Overall Study||98
8443209|NCT00794157|20806356|P2|COMPLETED|Overall Study||106
8443210|NCT00794157|20806357|P1|COMPLETED|Overall Study||104
8443211|NCT00794157|20806355|P3|STARTED|Overall Study||117
8443212|NCT00794157|20806356|P2|STARTED|Overall Study||116
8443213|NCT00794157|20806357|P1|STARTED|Overall Study||114
8443214|NCT00794144|20806379|P2|NOT COMPLETED|Overall Study||3
8443215|NCT00794144|20806380|P1|NOT COMPLETED|Overall Study||3
8443216|NCT00794144|20806379|P2|COMPLETED|Overall Study||63
8443217|NCT00794144|20806380|P1|COMPLETED|Overall Study||63
8443218|NCT00794144|20806379|P2|STARTED|Overall Study||66
8443219|NCT00794144|20806380|P1|STARTED|Overall Study||66
8443220|NCT00794118|20806386|P1|NOT COMPLETED|Overall Study||27
8443221|NCT00794118|20806386|P1|COMPLETED|Overall Study||272
8443222|NCT00794118|20806386|P1|STARTED|Overall Study||299
8443223|NCT00794040|20806446|P2|NOT COMPLETED|Overall Study||5
8443224|NCT00794040|20806447|P1|NOT COMPLETED|Overall Study||3
8443225|NCT00794040|20806446|P2|COMPLETED|Overall Study||23
8443226|NCT00794040|20806447|P1|COMPLETED|Overall Study||22
8443227|NCT00794040|20806446|P2|STARTED|Overall Study||28
8443228|NCT00794040|20806447|P1|STARTED|Overall Study||25
8443229|NCT00793910|20806463|P2|NOT COMPLETED|Overall Study||7
8443230|NCT00793910|20806464|P1|NOT COMPLETED|Overall Study||5
8443231|NCT00793910|20806463|P2|COMPLETED|Overall Study||46
8443232|NCT00793910|20806464|P1|COMPLETED|Overall Study||48
8443233|NCT00793910|20806463|P2|STARTED|Overall Study||53
8443234|NCT00793910|20806464|P1|STARTED|Overall Study||53
8443235|NCT00793871|20806478|P1|NOT COMPLETED|Overall Study||60
8443236|NCT00793871|20806478|P1|COMPLETED|Overall Study||0
8443237|NCT00793871|20806478|P1|Received Treatment|Overall Study||59
8443238|NCT00793871|20806478|P1|STARTED|Overall Study||60
8443239|NCT00793819|20806492|P2|NOT COMPLETED|Overall Study||9
8443240|NCT00793819|20806493|P1|NOT COMPLETED|Overall Study||14
8443241|NCT00793819|20806492|P2|COMPLETED|Overall Study||89
8443242|NCT00793819|20806493|P1|COMPLETED|Overall Study||97
8443243|NCT00793819|20806492|P2|STARTED|Overall Study||98
8443244|NCT00793819|20806493|P1|STARTED|Overall Study||111
8443245|NCT00793793|20806511|P12|NOT COMPLETED|Overall Study||6
8443246|NCT00793793|20806512|P11|NOT COMPLETED|Overall Study||3
8443247|NCT00793793|20806513|P10|NOT COMPLETED|Overall Study||9
8443248|NCT00793793|20806514|P9|NOT COMPLETED|Overall Study||9
8443249|NCT00793793|20806515|P8|NOT COMPLETED|Overall Study||0
8443250|NCT00793793|20806516|P7|NOT COMPLETED|Overall Study||4
8443251|NCT00793793|20806517|P6|NOT COMPLETED|Overall Study||2
8443252|NCT00793793|20806518|P5|NOT COMPLETED|Overall Study||2
8443253|NCT00793793|20806519|P4|NOT COMPLETED|Overall Study||3
8443254|NCT00793793|20806520|P3|NOT COMPLETED|Overall Study||2
8443255|NCT00793793|20806521|P2|NOT COMPLETED|Overall Study||1
8443256|NCT00793793|20806522|P1|NOT COMPLETED|Overall Study||0
8443257|NCT00793793|20806511|P12|COMPLETED|Overall Study||1
8443258|NCT00793793|20806512|P11|COMPLETED|Overall Study||3
8443259|NCT00793793|20806513|P10|COMPLETED|Overall Study||6
8443260|NCT00793793|20806514|P9|COMPLETED|Overall Study||6
8443261|NCT00793793|20806515|P8|COMPLETED|Overall Study||6
8443262|NCT00793793|20806516|P7|COMPLETED|Overall Study||3
8443263|NCT00793793|20806517|P6|COMPLETED|Overall Study||4
8443264|NCT00793793|20806518|P5|COMPLETED|Overall Study||4
8443265|NCT00793793|20806519|P4|COMPLETED|Overall Study||4
8443266|NCT00793793|20806520|P3|COMPLETED|Overall Study||5
8443267|NCT00793793|20806521|P2|COMPLETED|Overall Study||5
8443268|NCT00793793|20806522|P1|COMPLETED|Overall Study||8
8443269|NCT00793793|20806511|P12|STARTED|Overall Study||7
8443270|NCT00793793|20806512|P11|STARTED|Overall Study||6
8443271|NCT00793793|20806513|P10|STARTED|Overall Study||15
8443272|NCT00793793|20806514|P9|STARTED|Overall Study||15
8443273|NCT00793793|20806515|P8|STARTED|Overall Study||6
8443274|NCT00793793|20806516|P7|STARTED|Overall Study||7
8443275|NCT00793793|20806517|P6|STARTED|Overall Study||6
8443276|NCT00793793|20806518|P5|STARTED|Overall Study||6
8443277|NCT00793793|20806519|P4|STARTED|Overall Study||7
8443278|NCT00793793|20806520|P3|STARTED|Overall Study||7
8443279|NCT00793793|20806521|P2|STARTED|Overall Study||6
8443280|NCT00793793|20806522|P1|STARTED|Overall Study||8
8443281|NCT00793780|20806897|P2|NOT COMPLETED|Overall Study||1
8443282|NCT00793780|20806898|P1|NOT COMPLETED|Overall Study||2
8443283|NCT00793780|20806897|P2|COMPLETED|Overall Study||11
8443284|NCT00793780|20806898|P1|COMPLETED|Overall Study||10
8443285|NCT00793780|20806897|P2|Collected Baseline Data|Overall Study||12
8443286|NCT00793780|20806898|P1|Collected Baseline Data|Overall Study||11
8443287|NCT00793780|20806897|P2|Randomization|Overall Study||12
8443288|NCT00793780|20806898|P1|Randomization|Overall Study||12
8443289|NCT00793780|20806897|P2|STARTED|Overall Study||12
8443290|NCT00793780|20806898|P1|STARTED|Overall Study||12
8443291|NCT00793650|20806916|P2|NOT COMPLETED|Overall Study||0
8443292|NCT00793650|20806917|P1|NOT COMPLETED|Overall Study||0
8443293|NCT00793650|20806916|P2|COMPLETED|Overall Study||20
8443294|NCT00793650|20806917|P1|COMPLETED|Overall Study||19
8443295|NCT00793650|20806916|P2|STARTED|Overall Study||20
8443296|NCT00793650|20806917|P1|STARTED|Overall Study||19
8443297|NCT00793624|20806929|P4|NOT COMPLETED|Overall Study||43
8443298|NCT00793624|20806930|P3|NOT COMPLETED|Overall Study||39
8443299|NCT00793624|20806931|P2|NOT COMPLETED|Overall Study||36
8443300|NCT00793624|20806932|P1|NOT COMPLETED|Overall Study||57
8443301|NCT00793624|20806929|P4|COMPLETED|Overall Study||184
8443302|NCT00793624|20806930|P3|COMPLETED|Overall Study||186
8443303|NCT00793624|20806931|P2|COMPLETED|Overall Study||191
8443304|NCT00793624|20806932|P1|COMPLETED|Overall Study||168
8443305|NCT00793624|20806929|P4|STARTED|Overall Study||227
8443306|NCT00793624|20806930|P3|STARTED|Overall Study||225
8443307|NCT00793624|20806931|P2|STARTED|Overall Study||227
8443308|NCT00793624|20806932|P1|STARTED|Overall Study||225
8443309|NCT00793611|20807200|P2|NOT COMPLETED|Overall Study||0
8443310|NCT00793611|20807201|P1|NOT COMPLETED|Overall Study||0
8443311|NCT00793611|20807200|P2|COMPLETED|Overall Study||10
8443312|NCT00793611|20807201|P1|COMPLETED|Overall Study||10
8443313|NCT00793611|20807200|P2|STARTED|Overall Study||10
8443314|NCT00793611|20807201|P1|STARTED|Overall Study||10
8443315|NCT00793585|20807213|P2|NOT COMPLETED|Overall Study||3
8443316|NCT00793585|20807214|P1|NOT COMPLETED|Overall Study||2
8443317|NCT00793585|20807213|P2|COMPLETED|Overall Study||18
8443318|NCT00793585|20807214|P1|COMPLETED|Overall Study||17
8443319|NCT00793585|20807213|P2|STARTED|Overall Study||21
8443320|NCT00793585|20807214|P1|STARTED|Overall Study||19
8443321|NCT00793572|20807222|P1|NOT COMPLETED|Overall Study||0
8443322|NCT00793572|20807222|P1|COMPLETED|Overall Study||32
8443323|NCT00793572|20807222|P1|STARTED|Overall Study||32
8443324|NCT00793546|20807233|P2|NOT COMPLETED|Overall Study||28
8443325|NCT00793546|20807234|P1|NOT COMPLETED|Overall Study||14
8443326|NCT00793546|20807233|P2|COMPLETED|Overall Study||0
8443327|NCT00793546|20807234|P1|COMPLETED|Overall Study||0
8443328|NCT00793546|20807233|P2|STARTED|Overall Study||28
8443329|NCT00793546|20807234|P1|STARTED|Overall Study||14
8443330|NCT00793520|20807264|P2|NOT COMPLETED|Placebo Crossover to Milnacipran||1
8443331|NCT00793520|20807265|P1|NOT COMPLETED|Placebo Crossover to Milnacipran||0
8443332|NCT00793520|20807264|P2|COMPLETED|Placebo Crossover to Milnacipran||0
8443333|NCT00793520|20807265|P1|COMPLETED|Placebo Crossover to Milnacipran||0
8443334|NCT00793520|20807264|P2|STARTED|Placebo Crossover to Milnacipran||1
8443335|NCT00793520|20807265|P1|STARTED|Placebo Crossover to Milnacipran||0
8443336|NCT00793520|20807264|P2|NOT COMPLETED|Milnacipran Crossover to Placebo||0
8443337|NCT00793520|20807265|P1|NOT COMPLETED|Milnacipran Crossover to Placebo||1
8443338|NCT00793520|20807264|P2|COMPLETED|Milnacipran Crossover to Placebo||0
8443339|NCT00793520|20807265|P1|COMPLETED|Milnacipran Crossover to Placebo||0
8443340|NCT00793520|20807264|P2|STARTED|Milnacipran Crossover to Placebo||0
8443341|NCT00793520|20807265|P1|STARTED|Milnacipran Crossover to Placebo||1
8443342|NCT00793455|20807275|P2|NOT COMPLETED|Overall Study||0
8443343|NCT00793455|20807276|P1|NOT COMPLETED|Overall Study||0
8443344|NCT00793455|20807275|P2|COMPLETED|Overall Study||314
8443345|NCT00793455|20807276|P1|COMPLETED|Overall Study||314
8443346|NCT00793455|20807275|P2|STARTED|Overall Study||314
8443347|NCT00793455|20807276|P1|STARTED|Overall Study||314
8443348|NCT00793403|20807284|P1|NOT COMPLETED|Overall Study||73
8443349|NCT00793403|20807284|P1|COMPLETED|Overall Study||220
8443350|NCT00793403|20807284|P1|STARTED|Overall Study||293
8443351|NCT00793325|20807331|P1|NOT COMPLETED|Overall Study||19
8443352|NCT00793325|20807331|P1|COMPLETED|Overall Study||890
8443353|NCT00793325|20807331|P1|STARTED|Overall Study||909
8443354|NCT00793182|20807357|P2|NOT COMPLETED|Overall Study||1
8443355|NCT00793182|20807358|P1|NOT COMPLETED|Overall Study||0
8443356|NCT00793182|20807357|P2|COMPLETED|Overall Study||3
8443357|NCT00793182|20807358|P1|COMPLETED|Overall Study||2
8443358|NCT00793182|20807357|P2|STARTED|Overall Study||4
8443359|NCT00793182|20807358|P1|STARTED|Overall Study||2
8443360|NCT00793169|20807364|P1|NOT COMPLETED|Overall Study||0
8443361|NCT00793169|20807364|P1|COMPLETED|Overall Study||19
8443362|NCT00793169|20807364|P1|STARTED|Overall Study||19
8443363|NCT00793104|20807368|P1|NOT COMPLETED|Overall Study||1
8443364|NCT00793104|20807368|P1|COMPLETED|Overall Study||9
8443365|NCT00793104|20807368|P1|STARTED|Overall Study||10
8443369|NCT00792935|20807387|P2|NOT COMPLETED|Overall Study||3
8443370|NCT00792935|20807388|P1|NOT COMPLETED|Overall Study||4
8443371|NCT00792935|20807387|P2|COMPLETED|Overall Study||68
8443372|NCT00792935|20807388|P1|COMPLETED|Overall Study||68
8443373|NCT00792935|20807387|P2|STARTED|Overall Study||71
8443374|NCT00792935|20807388|P1|STARTED|Overall Study||72
8443375|NCT00792922|20807400|P4|NOT COMPLETED|At 3 Years||0
8443376|NCT00792922|20807401|P3|NOT COMPLETED|At 3 Years||0
8443377|NCT00792922|20807402|P2|NOT COMPLETED|At 3 Years||0
8443378|NCT00792922|20807403|P1|NOT COMPLETED|At 3 Years||0
8443379|NCT00792922|20807400|P4|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443380|NCT00792922|20807401|P3|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443381|NCT00792922|20807402|P2|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443382|NCT00792922|20807403|P1|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443383|NCT00792922|20807400|P4|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443384|NCT00792922|20807401|P3|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443385|NCT00792922|20807402|P2|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443386|NCT00792922|20807403|P1|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443387|NCT00792922|20807400|P4|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443388|NCT00792922|20807401|P3|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443389|NCT00792922|20807402|P2|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443390|NCT00792922|20807403|P1|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443391|NCT00792922|20807400|P4|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443392|NCT00792922|20807401|P3|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443393|NCT00792922|20807402|P2|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443394|NCT00792922|20807403|P1|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
8443395|NCT00792922|20807400|P4|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
8443396|NCT00792922|20807401|P3|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
8443397|NCT00792922|20807402|P2|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
8443472|NCT00792623|20807560|P1|NOT COMPLETED|Overall Study||7
8443398|NCT00792922|20807403|P1|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
~the trial was conducted at community level and data reported per community basis"|0
8443399|NCT00792922|20807400|P4|NOT COMPLETED|At Baseline||0
8443400|NCT00792922|20807401|P3|NOT COMPLETED|At Baseline||0
8443401|NCT00792922|20807402|P2|NOT COMPLETED|At Baseline||0
8443402|NCT00792922|20807403|P1|NOT COMPLETED|At Baseline||0
8443403|NCT00792922|20807400|P4|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443404|NCT00792922|20807401|P3|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443405|NCT00792922|20807402|P2|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443406|NCT00792922|20807403|P1|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443407|NCT00792922|20807400|P4|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443408|NCT00792922|20807401|P3|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443409|NCT00792922|20807402|P2|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443410|NCT00792922|20807403|P1|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443411|NCT00792922|20807400|P4|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443412|NCT00792922|20807401|P3|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443413|NCT00792922|20807402|P2|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443414|NCT00792922|20807403|P1|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443415|NCT00792922|20807400|P4|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443416|NCT00792922|20807401|P3|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443417|NCT00792922|20807402|P2|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443418|NCT00792922|20807403|P1|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443419|NCT00792922|20807400|P4|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443420|NCT00792922|20807401|P3|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443421|NCT00792922|20807402|P2|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443422|NCT00792922|20807403|P1|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
8443423|NCT00792909|20807420|P3|NOT COMPLETED|Overall Study||0
8443424|NCT00792909|20807421|P2|NOT COMPLETED|Overall Study||1
8443425|NCT00792909|20807422|P1|NOT COMPLETED|Overall Study||0
8443426|NCT00792909|20807420|P3|COMPLETED|Overall Study||62
8443427|NCT00792909|20807421|P2|COMPLETED|Overall Study||58
8443428|NCT00792909|20807422|P1|COMPLETED|Overall Study||51
8443429|NCT00792909|20807420|P3|STARTED|Overall Study||62
8443430|NCT00792909|20807421|P2|STARTED|Overall Study||59
8443431|NCT00792909|20807422|P1|STARTED|Overall Study||51
8443432|NCT00792805|20807478|P3|NOT COMPLETED|Overall Study||33
8443433|NCT00792805|20807479|P2|NOT COMPLETED|Overall Study||26
8443434|NCT00792805|20807480|P1|NOT COMPLETED|Overall Study||22
8443435|NCT00792805|20807478|P3|COMPLETED|Overall Study||154
8443436|NCT00792805|20807479|P2|COMPLETED|Overall Study||162
8443437|NCT00792805|20807480|P1|COMPLETED|Overall Study||166
8443438|NCT00792805|20807478|P3|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
8443439|NCT00792805|20807479|P2|Exposed to Study Medication or Placebo|Overall Study||188
8443440|NCT00792805|20807480|P1|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
8443441|NCT00792805|20807478|P3|STARTED|Overall Study||187
8443442|NCT00792805|20807479|P2|STARTED|Overall Study||188
8443443|NCT00792805|20807480|P1|STARTED|Overall Study||188
8443444|NCT00792701|20807490|P2|NOT COMPLETED|Overall Study||44
8443445|NCT00792701|20807491|P1|NOT COMPLETED|Overall Study||19
8443446|NCT00792701|20807490|P2|COMPLETED|Overall Study||22
8443447|NCT00792701|20807491|P1|COMPLETED|Overall Study||0
8443448|NCT00792701|20807490|P2|Eligible and Analyzable|Overall Study||44
8443449|NCT00792701|20807491|P1|Eligible and Analyzable|Overall Study||17
8443450|NCT00792701|20807490|P2|Eligible|Overall Study||63
8443451|NCT00792701|20807491|P1|Eligible|Overall Study||18
8443452|NCT00792701|20807490|P2|STARTED|Overall Study||66
8443453|NCT00792701|20807491|P1|STARTED|Overall Study||19
8443454|NCT00792688|20807505|P3|NOT COMPLETED|Overall Study||0
8443455|NCT00792688|20807506|P2|NOT COMPLETED|Overall Study||0
8443456|NCT00792688|20807507|P1|NOT COMPLETED|Overall Study||0
8443457|NCT00792688|20807505|P3|COMPLETED|Overall Study||9
8443458|NCT00792688|20807506|P2|COMPLETED|Overall Study||8
8443459|NCT00792688|20807507|P1|COMPLETED|Overall Study||9
8443460|NCT00792688|20807505|P3|STARTED|Overall Study||9
8443461|NCT00792688|20807506|P2|STARTED|Overall Study||8
8443462|NCT00792688|20807507|P1|STARTED|Overall Study||9
8443463|NCT00792636|20807521|P3|NOT COMPLETED|Overall Study||81
8443464|NCT00792636|20807522|P2|NOT COMPLETED|Overall Study||81
8443465|NCT00792636|20807523|P1|NOT COMPLETED|Overall Study||68
8443466|NCT00792636|20807521|P3|COMPLETED|Overall Study||55
8443467|NCT00792636|20807522|P2|COMPLETED|Overall Study||55
8443468|NCT00792636|20807523|P1|COMPLETED|Overall Study||67
8443469|NCT00792636|20807521|P3|STARTED|Overall Study||136
8443470|NCT00792636|20807522|P2|STARTED|Overall Study||136
8443471|NCT00792636|20807523|P1|STARTED|Overall Study||135
8443473|NCT00792623|20807560|P1|COMPLETED|Overall Study||22
8443474|NCT00792623|20807560|P1|STARTED|Overall Study||29
8443475|NCT00792610|20807573|P1|NOT COMPLETED|Overall Study||0
8443476|NCT00792610|20807573|P1|COMPLETED|Overall Study||127
8443477|NCT00792610|20807573|P1|Youths|Overall Study||127
8443478|NCT00792610|20807573|P1|STARTED|Overall Study||127
8443479|NCT00792571|20807577|P1|NOT COMPLETED|Overall Study||10
8443480|NCT00792571|20807577|P1|COMPLETED|Overall Study||8
8443481|NCT00792571|20807577|P1|STARTED|Overall Study||18
8443482|NCT00792428|20807588|P2|NOT COMPLETED|Overall Study||0
8443483|NCT00792428|20807589|P1|NOT COMPLETED|Overall Study||0
8443484|NCT00792428|20807588|P2|COMPLETED|Overall Study||10
8443485|NCT00792428|20807589|P1|COMPLETED|Overall Study||10
8443486|NCT00792428|20807588|P2|STARTED|Overall Study||10
8443487|NCT00792428|20807589|P1|STARTED|Overall Study||10
8443488|NCT00792298|20807597|P8|NOT COMPLETED|Treatment Period 2||2
8443489|NCT00792298|20807598|P7|NOT COMPLETED|Treatment Period 2||1
8443490|NCT00792298|20807599|P6|NOT COMPLETED|Treatment Period 2||0
8443491|NCT00792298|20807600|P5|NOT COMPLETED|Treatment Period 2||2
8443492|NCT00792298|20807601|P4|NOT COMPLETED|Treatment Period 2||2
8443493|NCT00792298|20807602|P3|NOT COMPLETED|Treatment Period 2||1
8443494|NCT00792298|20807603|P2|NOT COMPLETED|Treatment Period 2||1
8443495|NCT00792298|20807604|P1|NOT COMPLETED|Treatment Period 2||1
8443496|NCT00792298|20807597|P8|COMPLETED|Treatment Period 2||28
8443497|NCT00792298|20807598|P7|COMPLETED|Treatment Period 2||28
8443498|NCT00792298|20807599|P6|COMPLETED|Treatment Period 2||27
8443499|NCT00792298|20807600|P5|COMPLETED|Treatment Period 2||30
8443500|NCT00792298|20807601|P4|COMPLETED|Treatment Period 2||26
8443501|NCT00792298|20807602|P3|COMPLETED|Treatment Period 2||30
8443502|NCT00792298|20807603|P2|COMPLETED|Treatment Period 2||30
8443503|NCT00792298|20807604|P1|COMPLETED|Treatment Period 2||29
8443504|NCT00792298|20807597|P8|STARTED|Treatment Period 2||30
8443505|NCT00792298|20807598|P7|STARTED|Treatment Period 2||29
8443506|NCT00792298|20807599|P6|STARTED|Treatment Period 2||27
8443507|NCT00792298|20807600|P5|STARTED|Treatment Period 2||32
8443508|NCT00792298|20807601|P4|STARTED|Treatment Period 2||28
8443509|NCT00792298|20807602|P3|STARTED|Treatment Period 2||31
8443510|NCT00792298|20807603|P2|STARTED|Treatment Period 2||31
8443511|NCT00792298|20807604|P1|STARTED|Treatment Period 2||30
8443512|NCT00792298|20807597|P8|NOT COMPLETED|Washout||0
8443513|NCT00792298|20807598|P7|NOT COMPLETED|Washout||0
8443514|NCT00792298|20807599|P6|NOT COMPLETED|Washout||2
8443515|NCT00792298|20807600|P5|NOT COMPLETED|Washout||0
8443516|NCT00792298|20807601|P4|NOT COMPLETED|Washout||0
8443517|NCT00792298|20807602|P3|NOT COMPLETED|Washout||1
8443518|NCT00792298|20807603|P2|NOT COMPLETED|Washout||0
8443519|NCT00792298|20807604|P1|NOT COMPLETED|Washout||0
8443520|NCT00792298|20807597|P8|COMPLETED|Washout||30
8443521|NCT00792298|20807598|P7|COMPLETED|Washout||29
8443522|NCT00792298|20807599|P6|COMPLETED|Washout||27
8443523|NCT00792298|20807600|P5|COMPLETED|Washout||32
8443524|NCT00792298|20807601|P4|COMPLETED|Washout||28
8443525|NCT00792298|20807602|P3|COMPLETED|Washout||31
8443526|NCT00792298|20807603|P2|COMPLETED|Washout||31
8443527|NCT00792298|20807604|P1|COMPLETED|Washout||30
8443528|NCT00792298|20807597|P8|STARTED|Washout||30
8443529|NCT00792298|20807598|P7|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
8443530|NCT00792298|20807599|P6|STARTED|Washout||29
8443531|NCT00792298|20807600|P5|STARTED|Washout||32
8443532|NCT00792298|20807601|P4|STARTED|Washout||28
8443533|NCT00792298|20807602|P3|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
8443534|NCT00792298|20807603|P2|STARTED|Washout||31
8443535|NCT00792298|20807604|P1|STARTED|Washout||30
8443536|NCT00792298|20807597|P8|NOT COMPLETED|Treatment Period 1||1
8443537|NCT00792298|20807598|P7|NOT COMPLETED|Treatment Period 1||4
8443538|NCT00792298|20807599|P6|NOT COMPLETED|Treatment Period 1||3
8443539|NCT00792298|20807600|P5|NOT COMPLETED|Treatment Period 1||0
8443540|NCT00792298|20807601|P4|NOT COMPLETED|Treatment Period 1||4
8443541|NCT00792298|20807602|P3|NOT COMPLETED|Treatment Period 1||2
8443542|NCT00792298|20807603|P2|NOT COMPLETED|Treatment Period 1||1
8443543|NCT00792298|20807604|P1|NOT COMPLETED|Treatment Period 1||1
8443544|NCT00792298|20807597|P8|COMPLETED|Treatment Period 1||30
8443545|NCT00792298|20807598|P7|COMPLETED|Treatment Period 1||27
8443546|NCT00792298|20807599|P6|COMPLETED|Treatment Period 1||29
8443547|NCT00792298|20807600|P5|COMPLETED|Treatment Period 1||32
8443548|NCT00792298|20807601|P4|COMPLETED|Treatment Period 1||28
8443549|NCT00792298|20807602|P3|COMPLETED|Treatment Period 1||31
8443550|NCT00792298|20807603|P2|COMPLETED|Treatment Period 1||31
8443551|NCT00792298|20807604|P1|COMPLETED|Treatment Period 1||30
8443552|NCT00792298|20807597|P8|STARTED|Treatment Period 1||31
8443553|NCT00792298|20807598|P7|STARTED|Treatment Period 1||31
8443554|NCT00792298|20807599|P6|STARTED|Treatment Period 1||32
8443555|NCT00792298|20807600|P5|STARTED|Treatment Period 1||32
8443556|NCT00792298|20807601|P4|STARTED|Treatment Period 1||32
8443557|NCT00792298|20807602|P3|STARTED|Treatment Period 1||33
8443558|NCT00792298|20807603|P2|STARTED|Treatment Period 1||32
8443559|NCT00792298|20807604|P1|STARTED|Treatment Period 1||31
8443560|NCT00792259|20807634|P3|NOT COMPLETED|Overall Study||0
8443561|NCT00792259|20807635|P2|NOT COMPLETED|Overall Study||0
8443562|NCT00792259|20807636|P1|NOT COMPLETED|Overall Study||1
8443563|NCT00792259|20807634|P3|COMPLETED|Overall Study||13
8443564|NCT00792259|20807635|P2|COMPLETED|Overall Study||20
8443565|NCT00792259|20807636|P1|COMPLETED|Overall Study||14
8443566|NCT00792259|20807634|P3|STARTED|Overall Study||13
8443567|NCT00792259|20807635|P2|STARTED|Overall Study||20
8443568|NCT00792259|20807636|P1|STARTED|Overall Study||15
8443572|NCT00792116|20807653|P2|NOT COMPLETED|Overall Study||1
8443573|NCT00792116|20807654|P1|NOT COMPLETED|Overall Study||1
8443574|NCT00792116|20807653|P2|COMPLETED|Overall Study||54
8443575|NCT00792116|20807654|P1|COMPLETED|Overall Study||52
8443576|NCT00792116|20807653|P2|STARTED|Overall Study||55
8443577|NCT00792116|20807654|P1|STARTED|Overall Study||53
8443578|NCT00792103|20807664|P1|NOT COMPLETED|Overall Study||133
8443579|NCT00792103|20807664|P1|COMPLETED|Overall Study||65
8443580|NCT00792103|20807664|P1|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
8443581|NCT00791999|20807676|P4|NOT COMPLETED|Overall Study||52
8443582|NCT00791999|20807677|P3|NOT COMPLETED|Overall Study||20
8443583|NCT00791999|20807678|P2|NOT COMPLETED|Overall Study||16
8443584|NCT00791999|20807679|P1|NOT COMPLETED|Overall Study||21
8443585|NCT00791999|20807676|P4|COMPLETED|Overall Study||25
8443586|NCT00791999|20807677|P3|COMPLETED|Overall Study||65
8443587|NCT00791999|20807678|P2|COMPLETED|Overall Study||66
8443588|NCT00791999|20807679|P1|COMPLETED|Overall Study||51
8443589|NCT00791999|20807676|P4|STARTED|Overall Study||77
8443590|NCT00791999|20807677|P3|STARTED|Overall Study||85
8443591|NCT00791999|20807678|P2|STARTED|Overall Study||82
8443592|NCT00791999|20807679|P1|STARTED|Overall Study||72
8443593|NCT00791973|20807695|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8443594|NCT00791973|20807696|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8443595|NCT00791973|20807695|P2|COMPLETED|Second Intervention (1 Week)||7
8443596|NCT00791973|20807696|P1|COMPLETED|Second Intervention (1 Week)||8
8443597|NCT00791973|20807695|P2|STARTED|Second Intervention (1 Week)||7
8443598|NCT00791973|20807696|P1|STARTED|Second Intervention (1 Week)||8
8443599|NCT00791973|20807695|P2|NOT COMPLETED|Washout (1 Week)||0
8443600|NCT00791973|20807696|P1|NOT COMPLETED|Washout (1 Week)||0
8443601|NCT00791973|20807695|P2|COMPLETED|Washout (1 Week)||7
8443602|NCT00791973|20807696|P1|COMPLETED|Washout (1 Week)||8
8443603|NCT00791973|20807695|P2|STARTED|Washout (1 Week)||7
8443604|NCT00791973|20807696|P1|STARTED|Washout (1 Week)||8
8443605|NCT00791973|20807695|P2|NOT COMPLETED|First Intervention (1 Week)||0
8443606|NCT00791973|20807696|P1|NOT COMPLETED|First Intervention (1 Week)||0
8443607|NCT00791973|20807695|P2|COMPLETED|First Intervention (1 Week)||7
8443608|NCT00791973|20807696|P1|COMPLETED|First Intervention (1 Week)||8
8443609|NCT00791973|20807695|P2|STARTED|First Intervention (1 Week)||7
8443610|NCT00791973|20807696|P1|STARTED|First Intervention (1 Week)||8
8443611|NCT00791934|20807704|P1|NOT COMPLETED|Overall Study||15
8443612|NCT00791934|20807704|P1|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
8443613|NCT00791934|20807704|P1|STARTED|Overall Study||63
8443614|NCT00791921|20807714|P2|NOT COMPLETED|Overall Study||96
8443615|NCT00791921|20807715|P1|NOT COMPLETED|Overall Study||34
8443616|NCT00791921|20807714|P2|COMPLETED|Overall Study||18
8443617|NCT00791921|20807715|P1|COMPLETED|Overall Study||82
8443618|NCT00791921|20807714|P2|STARTED|Overall Study||114
8443619|NCT00791921|20807715|P1|STARTED|Overall Study||116
8443620|NCT00791908|20807723|P1|NOT COMPLETED|Overall Study||0
8443621|NCT00791908|20807723|P1|COMPLETED|Overall Study||15
8443622|NCT00791908|20807723|P1|STARTED|Overall Study||15
8443623|NCT00791843|20807731|P1|NOT COMPLETED|Overall Study||0
8443624|NCT00791843|20807731|P1|COMPLETED|Overall Study|Data unavailable for the study|0
8443625|NCT00791843|20807731|P1|STARTED|Overall Study|Data unavailable for the study|0
8443626|NCT00791817|20807737|P2|NOT COMPLETED|2: Single Dose||0
8443627|NCT00791817|20807738|P1|NOT COMPLETED|2: Single Dose||0
8443628|NCT00791817|20807737|P2|COMPLETED|2: Single Dose||5
8443629|NCT00791817|20807738|P1|COMPLETED|2: Single Dose||5
8443630|NCT00791817|20807737|P2|STARTED|2: Single Dose||5
8443631|NCT00791817|20807738|P1|STARTED|2: Single Dose||5
8443632|NCT00791817|20807737|P2|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
8443633|NCT00791817|20807738|P1|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
8443634|NCT00791817|20807737|P2|COMPLETED|1: Single Dose Followed by Week Washout||5
8443635|NCT00791817|20807738|P1|COMPLETED|1: Single Dose Followed by Week Washout||5
8443636|NCT00791817|20807737|P2|STARTED|1: Single Dose Followed by Week Washout||5
8443637|NCT00791817|20807738|P1|STARTED|1: Single Dose Followed by Week Washout||5
8443638|NCT00791778|20807746|P2|NOT COMPLETED|Follow-up||1
8443639|NCT00791778|20807747|P1|NOT COMPLETED|Follow-up||5
8443640|NCT00791778|20807746|P2|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
8443641|NCT00791778|20807747|P1|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
8443642|NCT00791778|20807746|P2|STARTED|Follow-up||91
8443643|NCT00791778|20807747|P1|STARTED|Follow-up||100
8443644|NCT00791778|20807746|P2|NOT COMPLETED|Double-blind Treatment||48
8443645|NCT00791778|20807747|P1|NOT COMPLETED|Double-blind Treatment||77
8443646|NCT00791778|20807746|P2|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
8443647|NCT00791778|20807747|P1|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
8443648|NCT00791778|20807746|P2|STARTED|Double-blind Treatment||123
8443649|NCT00791778|20807747|P1|STARTED|Double-blind Treatment||123
8443650|NCT00791765|20807801|P2|NOT COMPLETED|Weeks 13 to 24||8
8443651|NCT00791765|20807802|P1|NOT COMPLETED|Weeks 13 to 24||5
8443652|NCT00791765|20807801|P2|COMPLETED|Weeks 13 to 24||49
8443653|NCT00791765|20807802|P1|COMPLETED|Weeks 13 to 24||49
8443654|NCT00791765|20807801|P2|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
8443655|NCT00791765|20807802|P1|STARTED|Weeks 13 to 24||54
8443656|NCT00791765|20807801|P2|NOT COMPLETED|Weeks 1 to 12||4
8443657|NCT00791765|20807802|P1|NOT COMPLETED|Weeks 1 to 12||8
8443658|NCT00791765|20807801|P2|COMPLETED|Weeks 1 to 12||58
8443659|NCT00791765|20807802|P1|COMPLETED|Weeks 1 to 12||54
8443660|NCT00791765|20807801|P2|Treated|Weeks 1 to 12||59
8443661|NCT00791765|20807802|P1|Treated|Weeks 1 to 12||62
8443662|NCT00791765|20807801|P2|STARTED|Weeks 1 to 12||62
8443663|NCT00791765|20807802|P1|STARTED|Weeks 1 to 12||62
8443664|NCT00791700|20807817|P4|NOT COMPLETED|Overall Study||30
8443665|NCT00791700|20807818|P3|NOT COMPLETED|Overall Study||6
8443666|NCT00791700|20807819|P2|NOT COMPLETED|Overall Study||11
8443667|NCT00791700|20807820|P1|NOT COMPLETED|Overall Study||6
8443668|NCT00791700|20807817|P4|COMPLETED|Overall Study||13
8443669|NCT00791700|20807818|P3|COMPLETED|Overall Study||7
8443670|NCT00791700|20807819|P2|COMPLETED|Overall Study||20
8443671|NCT00791700|20807820|P1|COMPLETED|Overall Study||10
8443672|NCT00791700|20807817|P4|STARTED|Overall Study||43
8443673|NCT00791700|20807818|P3|STARTED|Overall Study||13
8443674|NCT00791700|20807819|P2|STARTED|Overall Study||31
8443675|NCT00791700|20807820|P1|STARTED|Overall Study||16
8443676|NCT00791661|20807908|P3|NOT COMPLETED|Period 3||0
8443677|NCT00791661|20807909|P2|NOT COMPLETED|Period 3||0
8443678|NCT00791661|20807910|P1|NOT COMPLETED|Period 3||0
8443679|NCT00791661|20807908|P3|COMPLETED|Period 3||6
8443680|NCT00791661|20807909|P2|COMPLETED|Period 3||8
8443681|NCT00791661|20807910|P1|COMPLETED|Period 3||8
8443682|NCT00791661|20807908|P3|Received Matching Placebo to MK-1006|Period 3||1
8443683|NCT00791661|20807909|P2|Received Matching Placebo to MK-1006|Period 3||2
8443684|NCT00791661|20807910|P1|Received Matching Placebo to MK-1006|Period 3||2
8443685|NCT00791661|20807908|P3|Received MK-1006|Period 3||5
8443686|NCT00791661|20807909|P2|Received MK-1006|Period 3||6
8443687|NCT00791661|20807910|P1|Received MK-1006|Period 3||6
8443688|NCT00791661|20807908|P3|STARTED|Period 3||6
8443689|NCT00791661|20807909|P2|STARTED|Period 3||8
8443690|NCT00791661|20807910|P1|STARTED|Period 3||8
8443691|NCT00791661|20807908|P3|NOT COMPLETED|7 Day Wash-out||0
8443692|NCT00791661|20807909|P2|NOT COMPLETED|7 Day Wash-out||0
8443693|NCT00791661|20807910|P1|NOT COMPLETED|7 Day Wash-out||0
8443694|NCT00791661|20807908|P3|COMPLETED|7 Day Wash-out||6
8443695|NCT00791661|20807909|P2|COMPLETED|7 Day Wash-out||8
8443696|NCT00791661|20807910|P1|COMPLETED|7 Day Wash-out||8
8443697|NCT00791661|20807908|P3|STARTED|7 Day Wash-out||6
8443698|NCT00791661|20807909|P2|STARTED|7 Day Wash-out||8
8443699|NCT00791661|20807910|P1|STARTED|7 Day Wash-out||8
8443700|NCT00791661|20807908|P3|NOT COMPLETED|Period 2||0
8443701|NCT00791661|20807909|P2|NOT COMPLETED|Period 2||0
8443702|NCT00791661|20807910|P1|NOT COMPLETED|Period 2||0
8443703|NCT00791661|20807908|P3|COMPLETED|Period 2||6
8443704|NCT00791661|20807909|P2|COMPLETED|Period 2||8
8443705|NCT00791661|20807910|P1|COMPLETED|Period 2||8
8443706|NCT00791661|20807908|P3|Received Matching Placebo to MK-1006|Period 2||2
8443707|NCT00791661|20807909|P2|Received Matching Placebo to MK-1006|Period 2||2
8443708|NCT00791661|20807910|P1|Received Matching Placebo to MK-1006|Period 2||2
8443709|NCT00791661|20807908|P3|Received MK-1006|Period 2||4
8443710|NCT00791661|20807909|P2|Received MK-1006|Period 2||6
8443711|NCT00791661|20807910|P1|Received MK-1006|Period 2||6
8443712|NCT00791661|20807908|P3|STARTED|Period 2||6
8443713|NCT00791661|20807909|P2|STARTED|Period 2||8
8443714|NCT00791661|20807910|P1|STARTED|Period 2||8
8443715|NCT00791661|20807908|P3|NOT COMPLETED|7 Day Wash-out||2
8443716|NCT00791661|20807909|P2|NOT COMPLETED|7 Day Wash-out||0
8443717|NCT00791661|20807910|P1|NOT COMPLETED|7 Day Wash-out||0
8443718|NCT00791661|20807908|P3|COMPLETED|7 Day Wash-out||6
8443719|NCT00791661|20807909|P2|COMPLETED|7 Day Wash-out||8
8443720|NCT00791661|20807910|P1|COMPLETED|7 Day Wash-out||8
8443721|NCT00791661|20807908|P3|STARTED|7 Day Wash-out||8
8443722|NCT00791661|20807909|P2|STARTED|7 Day Wash-out||8
8443723|NCT00791661|20807910|P1|STARTED|7 Day Wash-out||8
8443724|NCT00791661|20807908|P3|NOT COMPLETED|Period 1||0
8443725|NCT00791661|20807909|P2|NOT COMPLETED|Period 1||0
8443726|NCT00791661|20807910|P1|NOT COMPLETED|Period 1||0
8443727|NCT00791661|20807908|P3|COMPLETED|Period 1||8
8443728|NCT00791661|20807909|P2|COMPLETED|Period 1||8
8443729|NCT00791661|20807910|P1|COMPLETED|Period 1||8
8443730|NCT00791661|20807908|P3|Received Matching Placebo to MK-1006|Period 1||2
8443731|NCT00791661|20807909|P2|Received Matching Placebo to MK-1006|Period 1||2
8443732|NCT00791661|20807910|P1|Received Matching Placebo to MK-1006|Period 1||2
8443733|NCT00791661|20807908|P3|Received MK-1006|Period 1||6
8443734|NCT00791661|20807909|P2|Received MK-1006|Period 1||6
8443735|NCT00791661|20807910|P1|Received MK-1006|Period 1||6
8443736|NCT00791661|20807908|P3|STARTED|Period 1||8
8443737|NCT00791661|20807909|P2|STARTED|Period 1||8
8443738|NCT00791661|20807910|P1|STARTED|Period 1||8
8443739|NCT00791648|20808003|P2|NOT COMPLETED|Overall Study||2
8443740|NCT00791648|20808004|P1|NOT COMPLETED|Overall Study||0
8443741|NCT00791648|20808003|P2|COMPLETED|Overall Study||307
8443742|NCT00791648|20808004|P1|COMPLETED|Overall Study||308
8443743|NCT00791648|20808003|P2|STARTED|Overall Study||309
8443744|NCT00791648|20808004|P1|STARTED|Overall Study||308
8443745|NCT00791557|20808040|P1|NOT COMPLETED|Overall Study||1
8443746|NCT00791557|20808040|P1|COMPLETED|Overall Study||1
8443747|NCT00791557|20808040|P1|STARTED|Overall Study||2
8443748|NCT00791518|20808044|P1|NOT COMPLETED|Overall Study||93
8443749|NCT00791518|20808044|P1|COMPLETED|Overall Study||991
8443750|NCT00791518|20808044|P1|STARTED|Overall Study||1084
8443751|NCT00791492|20808072|P2|NOT COMPLETED|Overall Study||3
8443752|NCT00791492|20808073|P1|NOT COMPLETED|Overall Study||6
8443753|NCT00791492|20808072|P2|COMPLETED|Overall Study||38
8443754|NCT00791492|20808073|P1|COMPLETED|Overall Study||39
8443755|NCT00791492|20808072|P2|TREATED|Overall Study||41
8443756|NCT00791492|20808073|P1|TREATED|Overall Study||44
8443757|NCT00791492|20808072|P2|STARTED|Overall Study||41
8443758|NCT00791492|20808073|P1|STARTED|Overall Study||45
8443759|NCT00791479|20808121|P6|NOT COMPLETED|Overall Study||3
8443760|NCT00791479|20808122|P5|NOT COMPLETED|Overall Study||3
8443761|NCT00791479|20808123|P4|NOT COMPLETED|Overall Study||4
8443762|NCT00791479|20808124|P3|NOT COMPLETED|Overall Study||0
8443763|NCT00791479|20808125|P2|NOT COMPLETED|Overall Study||3
8443764|NCT00791479|20808126|P1|NOT COMPLETED|Overall Study||2
8443765|NCT00791479|20808121|P6|COMPLETED|Overall Study||29
8443766|NCT00791479|20808122|P5|COMPLETED|Overall Study||0
8443767|NCT00791479|20808123|P4|COMPLETED|Overall Study||25
8443768|NCT00791479|20808124|P3|COMPLETED|Overall Study||34
8443769|NCT00791479|20808125|P2|COMPLETED|Overall Study||31
8443770|NCT00791479|20808126|P1|COMPLETED|Overall Study||33
8443771|NCT00791479|20808121|P6|Received at Least One Dose of Study Drug|Overall Study||32
8443772|NCT00791479|20808122|P5|Received at Least One Dose of Study Drug|Overall Study||3
8443773|NCT00791479|20808123|P4|Received at Least One Dose of Study Drug|Overall Study||29
8443774|NCT00791479|20808124|P3|Received at Least One Dose of Study Drug|Overall Study||34
8443775|NCT00791479|20808125|P2|Received at Least One Dose of Study Drug|Overall Study||34
8443776|NCT00791479|20808126|P1|Received at Least One Dose of Study Drug|Overall Study||35
8443777|NCT00791479|20808121|P6|STARTED|Overall Study||32
8443778|NCT00791479|20808122|P5|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
8443779|NCT00791479|20808123|P4|STARTED|Overall Study||29
8443780|NCT00791479|20808124|P3|STARTED|Overall Study||34
8443781|NCT00791479|20808125|P2|STARTED|Overall Study||34
8443782|NCT00791479|20808126|P1|STARTED|Overall Study||35
8443783|NCT00791388|20808225|P5|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
8443784|NCT00791388|20808226|P4|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
8443785|NCT00791388|20808227|P3|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
8443786|NCT00791388|20808228|P2|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
8443787|NCT00791388|20808229|P1|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
8443788|NCT00791388|20808225|P5|COMPLETED|Period 4 - 400 mg Dose Group||4
8443789|NCT00791388|20808226|P4|COMPLETED|Period 4 - 400 mg Dose Group||0
8443790|NCT00791388|20808227|P3|COMPLETED|Period 4 - 400 mg Dose Group||0
8443791|NCT00791388|20808228|P2|COMPLETED|Period 4 - 400 mg Dose Group||0
8443792|NCT00791388|20808229|P1|COMPLETED|Period 4 - 400 mg Dose Group||4
8443793|NCT00791388|20808225|P5|STARTED|Period 4 - 400 mg Dose Group||8
8443794|NCT00791388|20808226|P4|STARTED|Period 4 - 400 mg Dose Group||0
8443795|NCT00791388|20808227|P3|STARTED|Period 4 - 400 mg Dose Group||0
8443796|NCT00791388|20808228|P2|STARTED|Period 4 - 400 mg Dose Group||0
8443797|NCT00791388|20808229|P1|STARTED|Period 4 - 400 mg Dose Group||4
8443798|NCT00791388|20808225|P5|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8443799|NCT00791388|20808226|P4|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8443800|NCT00791388|20808227|P3|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8443801|NCT00791388|20808228|P2|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8443802|NCT00791388|20808229|P1|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
8443803|NCT00791388|20808225|P5|COMPLETED|Period 3 - 200 mg Dose Group||0
8443804|NCT00791388|20808226|P4|COMPLETED|Period 3 - 200 mg Dose Group||8
8443805|NCT00791388|20808227|P3|COMPLETED|Period 3 - 200 mg Dose Group||0
8443806|NCT00791388|20808228|P2|COMPLETED|Period 3 - 200 mg Dose Group||0
8443807|NCT00791388|20808229|P1|COMPLETED|Period 3 - 200 mg Dose Group||3
8443808|NCT00791388|20808225|P5|STARTED|Period 3 - 200 mg Dose Group||0
8443809|NCT00791388|20808226|P4|STARTED|Period 3 - 200 mg Dose Group||8
8443810|NCT00791388|20808227|P3|STARTED|Period 3 - 200 mg Dose Group||0
8443811|NCT00791388|20808228|P2|STARTED|Period 3 - 200 mg Dose Group||0
8443812|NCT00791388|20808229|P1|STARTED|Period 3 - 200 mg Dose Group||3
8443813|NCT00791388|20808225|P5|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
8443814|NCT00791388|20808226|P4|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
8443815|NCT00791388|20808227|P3|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
8443816|NCT00791388|20808228|P2|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
8443817|NCT00791388|20808229|P1|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
8443818|NCT00791388|20808225|P5|COMPLETED|Period 2 - 100 mg Dose Group||0
8443819|NCT00791388|20808226|P4|COMPLETED|Period 2 - 100 mg Dose Group||0
8443820|NCT00791388|20808227|P3|COMPLETED|Period 2 - 100 mg Dose Group||8
8443821|NCT00791388|20808228|P2|COMPLETED|Period 2 - 100 mg Dose Group||0
8443822|NCT00791388|20808229|P1|COMPLETED|Period 2 - 100 mg Dose Group||2
8443823|NCT00791388|20808225|P5|STARTED|Period 2 - 100 mg Dose Group||0
8443824|NCT00791388|20808226|P4|STARTED|Period 2 - 100 mg Dose Group||0
8443825|NCT00791388|20808227|P3|STARTED|Period 2 - 100 mg Dose Group||8
8443826|NCT00791388|20808228|P2|STARTED|Period 2 - 100 mg Dose Group||0
8443827|NCT00791388|20808229|P1|STARTED|Period 2 - 100 mg Dose Group||3
8443828|NCT00791388|20808225|P5|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
8443829|NCT00791388|20808226|P4|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
8443830|NCT00791388|20808227|P3|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
8443831|NCT00791388|20808228|P2|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
8443832|NCT00791388|20808229|P1|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
8443833|NCT00791388|20808225|P5|COMPLETED|Period 1 - 50 mg Dose Group||0
8443834|NCT00791388|20808226|P4|COMPLETED|Period 1 - 50 mg Dose Group||0
8443835|NCT00791388|20808227|P3|COMPLETED|Period 1 - 50 mg Dose Group||0
8443836|NCT00791388|20808228|P2|COMPLETED|Period 1 - 50 mg Dose Group||7
8443837|NCT00791388|20808229|P1|COMPLETED|Period 1 - 50 mg Dose Group||3
8443838|NCT00791388|20808225|P5|STARTED|Period 1 - 50 mg Dose Group||0
8443839|NCT00791388|20808226|P4|STARTED|Period 1 - 50 mg Dose Group||0
8443840|NCT00791388|20808227|P3|STARTED|Period 1 - 50 mg Dose Group||0
8443841|NCT00791388|20808228|P2|STARTED|Period 1 - 50 mg Dose Group||8
8443842|NCT00791388|20808229|P1|STARTED|Period 1 - 50 mg Dose Group||3
8443843|NCT00791336|20808256|P1|NOT COMPLETED|Overall Study||0
8443844|NCT00791336|20808256|P1|COMPLETED|Overall Study||1
8443845|NCT00791336|20808256|P1|STARTED|Overall Study||1
8443846|NCT00791323|20808264|P2|NOT COMPLETED|Overall Study||0
8443847|NCT00791323|20808265|P1|NOT COMPLETED|Overall Study||0
8443848|NCT00791323|20808264|P2|COMPLETED|Overall Study||3
8443849|NCT00791323|20808265|P1|COMPLETED|Overall Study||6
8443850|NCT00791323|20808264|P2|STARTED|Overall Study||3
8443851|NCT00791323|20808265|P1|STARTED|Overall Study||6
8443852|NCT00791258|20808271|P1|NOT COMPLETED|Overall Study||263
8443853|NCT00791258|20808271|P1|COMPLETED|Overall Study||736
8443854|NCT00791258|20808271|P1|STARTED|Overall Study||999
8443855|NCT00791219|20808336|P3|NOT COMPLETED|Overall Study||14
8443856|NCT00791219|20808337|P2|NOT COMPLETED|Overall Study||16
8443857|NCT00791219|20808338|P1|NOT COMPLETED|Overall Study||5
8443858|NCT00791219|20808336|P3|COMPLETED|Overall Study||61
8443859|NCT00791219|20808337|P2|COMPLETED|Overall Study||60
8443860|NCT00791219|20808338|P1|COMPLETED|Overall Study||19
8443861|NCT00791219|20808336|P3|STARTED|Overall Study||75
8443862|NCT00791219|20808337|P2|STARTED|Overall Study||76
8443863|NCT00791219|20808338|P1|STARTED|Overall Study||24
8443864|NCT00791128|20808364|P1|NOT COMPLETED|Overall Study||9
8443865|NCT00791128|20808364|P1|COMPLETED|Overall Study||13
8443866|NCT00791128|20808364|P1|STARTED|Overall Study||22
8443867|NCT00791102|20808369|P2|NOT COMPLETED|Period 2||0
8443868|NCT00791102|20808370|P1|NOT COMPLETED|Period 2||0
8443869|NCT00791102|20808369|P2|COMPLETED|Period 2||10
8443870|NCT00791102|20808370|P1|COMPLETED|Period 2||10
8443871|NCT00791102|20808369|P2|STARTED|Period 2||10
8443872|NCT00791102|20808370|P1|STARTED|Period 2||10
8443873|NCT00791102|20808369|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8443874|NCT00791102|20808370|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8443875|NCT00791102|20808369|P2|COMPLETED|Washout Period of 2 Weeks||10
8443876|NCT00791102|20808370|P1|COMPLETED|Washout Period of 2 Weeks||10
8443877|NCT00791102|20808369|P2|STARTED|Washout Period of 2 Weeks||10
8443878|NCT00791102|20808370|P1|STARTED|Washout Period of 2 Weeks||10
8443879|NCT00791102|20808369|P2|NOT COMPLETED|Period 1||0
8443880|NCT00791102|20808370|P1|NOT COMPLETED|Period 1||0
8443881|NCT00791102|20808369|P2|COMPLETED|Period 1||10
8443882|NCT00791102|20808370|P1|COMPLETED|Period 1||10
8443883|NCT00791102|20808369|P2|STARTED|Period 1||10
8443884|NCT00791102|20808370|P1|STARTED|Period 1||10
8443885|NCT00791089|20808388|P2|NOT COMPLETED|Overall Study||6
8443886|NCT00791089|20808389|P1|NOT COMPLETED|Overall Study||6
8443887|NCT00791089|20808388|P2|COMPLETED|Overall Study||0
8443888|NCT00791089|20808389|P1|COMPLETED|Overall Study||0
8443889|NCT00791089|20808388|P2|Six-month Data Collected|Overall Study||5
8443890|NCT00791089|20808389|P1|Six-month Data Collected|Overall Study||6
8443891|NCT00791089|20808388|P2|Began Actually Taking Fish Oil or Placeb|Overall Study||5
8443892|NCT00791089|20808389|P1|Began Actually Taking Fish Oil or Placeb|Overall Study||6
8443893|NCT00791089|20808388|P2|STARTED|Overall Study||6
8443894|NCT00791089|20808389|P1|STARTED|Overall Study||6
8443895|NCT00791076|20808395|P1|NOT COMPLETED|Overall Study||8
8443896|NCT00791076|20808395|P1|COMPLETED|Overall Study||0
8443897|NCT00791076|20808395|P1|STARTED|Overall Study||8
8443898|NCT00791037|20808403|P1|NOT COMPLETED|Overall Study||0
8443899|NCT00791037|20808403|P1|COMPLETED|Overall Study||23
8443900|NCT00791037|20808403|P1|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
8443901|NCT00791037|20808403|P1|Primary Outcome|Overall Study||19
8443902|NCT00791037|20808403|P1|STARTED|Overall Study||23
8443903|NCT00790933|20808415|P5|NOT COMPLETED|Overall Study||276
8443904|NCT00790933|20808416|P4|NOT COMPLETED|Overall Study||14
8443905|NCT00790933|20808417|P3|NOT COMPLETED|Overall Study||269
8443906|NCT00790933|20808418|P2|NOT COMPLETED|Overall Study||480
8443907|NCT00790933|20808419|P1|NOT COMPLETED|Overall Study||438
8443908|NCT00790933|20808415|P5|COMPLETED|Overall Study||145
8443909|NCT00790933|20808416|P4|COMPLETED|Overall Study||23
8443910|NCT00790933|20808417|P3|COMPLETED|Overall Study||115
8443911|NCT00790933|20808418|P2|COMPLETED|Overall Study||246
8443912|NCT00790933|20808419|P1|COMPLETED|Overall Study||237
8443913|NCT00790933|20808415|P5|STARTED|Overall Study||421
8443914|NCT00790933|20808416|P4|STARTED|Overall Study||37
8443915|NCT00790933|20808417|P3|STARTED|Overall Study||384
8443916|NCT00790933|20808418|P2|STARTED|Overall Study||726
8443917|NCT00790933|20808419|P1|STARTED|Overall Study||675
8443918|NCT00790907|20808950|P3|NOT COMPLETED|Overall Study||339
8443919|NCT00790907|20808951|P2|NOT COMPLETED|Overall Study||340
8443920|NCT00790907|20808952|P1|NOT COMPLETED|Overall Study||455
8443921|NCT00790907|20808950|P3|COMPLETED|Overall Study||663
8443922|NCT00790907|20808951|P2|COMPLETED|Overall Study||684
8443923|NCT00790907|20808952|P1|COMPLETED|Overall Study||754
8443924|NCT00790907|20808950|P3|STARTED|Overall Study||1002
8443925|NCT00790907|20808951|P2|STARTED|Overall Study||1024
8443926|NCT00790907|20808952|P1|STARTED|Overall Study||1209
8443927|NCT00790868|20808975|P2|NOT COMPLETED|Overall Study||17
8443928|NCT00790868|20808976|P1|NOT COMPLETED|Overall Study||6
8443929|NCT00790868|20808975|P2|COMPLETED|Overall Study||75
8443930|NCT00790868|20808976|P1|COMPLETED|Overall Study||82
8443931|NCT00790868|20808975|P2|STARTED|Overall Study||92
8443932|NCT00790868|20808976|P1|STARTED|Overall Study||88
8443933|NCT00790855|20808990|P1|NOT COMPLETED|Overall Study||0
8443934|NCT00790855|20808990|P1|COMPLETED|Overall Study||25
8443935|NCT00790855|20808990|P1|STARTED|Overall Study||25
8443936|NCT00790842|20808998|P11|NOT COMPLETED|Expansion Cohort||0
8443937|NCT00790842|20808999|P10|NOT COMPLETED|Expansion Cohort||0
8443938|NCT00790842|20809000|P9|NOT COMPLETED|Expansion Cohort||0
8443939|NCT00790842|20809001|P8|NOT COMPLETED|Expansion Cohort||0
8443940|NCT00790842|20809002|P7|NOT COMPLETED|Expansion Cohort||1
8443941|NCT00790842|20809003|P6|NOT COMPLETED|Expansion Cohort||0
8443942|NCT00790842|20809004|P5|NOT COMPLETED|Expansion Cohort||0
8443943|NCT00790842|20809005|P4|NOT COMPLETED|Expansion Cohort||0
8443944|NCT00790842|20809006|P3|NOT COMPLETED|Expansion Cohort||7
8443945|NCT00790842|20809007|P2|NOT COMPLETED|Expansion Cohort||0
8443946|NCT00790842|20809008|P1|NOT COMPLETED|Expansion Cohort||0
8443947|NCT00790842|20808998|P11|COMPLETED|Expansion Cohort||0
8443948|NCT00790842|20808999|P10|COMPLETED|Expansion Cohort||0
8443949|NCT00790842|20809000|P9|COMPLETED|Expansion Cohort||0
8443950|NCT00790842|20809001|P8|COMPLETED|Expansion Cohort||0
8443951|NCT00790842|20809002|P7|COMPLETED|Expansion Cohort||1
8443952|NCT00790842|20809003|P6|COMPLETED|Expansion Cohort||0
8443953|NCT00790842|20809004|P5|COMPLETED|Expansion Cohort||0
8443954|NCT00790842|20809005|P4|COMPLETED|Expansion Cohort||0
8443955|NCT00790842|20809006|P3|COMPLETED|Expansion Cohort||7
8443956|NCT00790842|20809007|P2|COMPLETED|Expansion Cohort||0
8443957|NCT00790842|20809008|P1|COMPLETED|Expansion Cohort||0
8443958|NCT00790842|20808998|P11|Began Treatment|Expansion Cohort||0
8443959|NCT00790842|20808999|P10|Began Treatment|Expansion Cohort||0
8443960|NCT00790842|20809000|P9|Began Treatment|Expansion Cohort||0
8443961|NCT00790842|20809001|P8|Began Treatment|Expansion Cohort||0
8443962|NCT00790842|20809002|P7|Began Treatment|Expansion Cohort||2
8443963|NCT00790842|20809003|P6|Began Treatment|Expansion Cohort||0
8443964|NCT00790842|20809004|P5|Began Treatment|Expansion Cohort||0
8443965|NCT00790842|20809005|P4|Began Treatment|Expansion Cohort||0
8443966|NCT00790842|20809006|P3|Began Treatment|Expansion Cohort||14
8443967|NCT00790842|20809007|P2|Began Treatment|Expansion Cohort||0
8443968|NCT00790842|20809008|P1|Began Treatment|Expansion Cohort||0
8443969|NCT00790842|20808998|P11|STARTED|Expansion Cohort||0
8443970|NCT00790842|20808999|P10|STARTED|Expansion Cohort||0
8443971|NCT00790842|20809000|P9|STARTED|Expansion Cohort||0
8443972|NCT00790842|20809001|P8|STARTED|Expansion Cohort||0
8443973|NCT00790842|20809002|P7|STARTED|Expansion Cohort||2
8443974|NCT00790842|20809003|P6|STARTED|Expansion Cohort||0
8443975|NCT00790842|20809004|P5|STARTED|Expansion Cohort||0
8443976|NCT00790842|20809005|P4|STARTED|Expansion Cohort||0
8443977|NCT00790842|20809006|P3|STARTED|Expansion Cohort||14
8443978|NCT00790842|20809007|P2|STARTED|Expansion Cohort||0
8443979|NCT00790842|20809008|P1|STARTED|Expansion Cohort||0
8443980|NCT00790842|20808998|P11|NOT COMPLETED|Dose Level 4||2
8443981|NCT00790842|20808999|P10|NOT COMPLETED|Dose Level 4||0
8443982|NCT00790842|20809000|P9|NOT COMPLETED|Dose Level 4||0
8443983|NCT00790842|20809001|P8|NOT COMPLETED|Dose Level 4||0
8443984|NCT00790842|20809002|P7|NOT COMPLETED|Dose Level 4||2
8443985|NCT00790842|20809003|P6|NOT COMPLETED|Dose Level 4||0
8443986|NCT00790842|20809004|P5|NOT COMPLETED|Dose Level 4||0
8443987|NCT00790842|20809005|P4|NOT COMPLETED|Dose Level 4||0
8443988|NCT00790842|20809006|P3|NOT COMPLETED|Dose Level 4||0
8443989|NCT00790842|20809007|P2|NOT COMPLETED|Dose Level 4||0
8443990|NCT00790842|20809008|P1|NOT COMPLETED|Dose Level 4||0
8443991|NCT00790842|20808998|P11|COMPLETED|Dose Level 4||3
8443992|NCT00790842|20808999|P10|COMPLETED|Dose Level 4||0
8443993|NCT00790842|20809000|P9|COMPLETED|Dose Level 4||0
8443994|NCT00790842|20809001|P8|COMPLETED|Dose Level 4||0
8443995|NCT00790842|20809002|P7|COMPLETED|Dose Level 4||6
8443996|NCT00790842|20809003|P6|COMPLETED|Dose Level 4||0
8443997|NCT00790842|20809004|P5|COMPLETED|Dose Level 4||0
8443998|NCT00790842|20809005|P4|COMPLETED|Dose Level 4||0
8443999|NCT00790842|20809006|P3|COMPLETED|Dose Level 4||0
8444000|NCT00790842|20809007|P2|COMPLETED|Dose Level 4||0
8444001|NCT00790842|20809008|P1|COMPLETED|Dose Level 4||0
8444002|NCT00790842|20808998|P11|Began Treatment|Dose Level 4||5
8444003|NCT00790842|20808999|P10|Began Treatment|Dose Level 4||0
8444004|NCT00790842|20809000|P9|Began Treatment|Dose Level 4||0
8444005|NCT00790842|20809001|P8|Began Treatment|Dose Level 4||0
8444006|NCT00790842|20809002|P7|Began Treatment|Dose Level 4||8
8444007|NCT00790842|20809003|P6|Began Treatment|Dose Level 4||0
8444008|NCT00790842|20809004|P5|Began Treatment|Dose Level 4||0
8444009|NCT00790842|20809005|P4|Began Treatment|Dose Level 4||0
8444010|NCT00790842|20809006|P3|Began Treatment|Dose Level 4||0
8444011|NCT00790842|20809007|P2|Began Treatment|Dose Level 4||0
8444012|NCT00790842|20809008|P1|Began Treatment|Dose Level 4||0
8444013|NCT00790842|20808998|P11|STARTED|Dose Level 4||5
8444014|NCT00790842|20808999|P10|STARTED|Dose Level 4||0
8444015|NCT00790842|20809000|P9|STARTED|Dose Level 4||0
8444016|NCT00790842|20809001|P8|STARTED|Dose Level 4||0
8444017|NCT00790842|20809002|P7|STARTED|Dose Level 4||8
8444018|NCT00790842|20809003|P6|STARTED|Dose Level 4||0
8444019|NCT00790842|20809004|P5|STARTED|Dose Level 4||0
8444020|NCT00790842|20809005|P4|STARTED|Dose Level 4||0
8444021|NCT00790842|20809006|P3|STARTED|Dose Level 4||0
8444022|NCT00790842|20809007|P2|STARTED|Dose Level 4||0
8444023|NCT00790842|20809008|P1|STARTED|Dose Level 4||0
8444024|NCT00790842|20808998|P11|NOT COMPLETED|Dose Level 3||0
8444025|NCT00790842|20808999|P10|NOT COMPLETED|Dose Level 3||2
8444026|NCT00790842|20809000|P9|NOT COMPLETED|Dose Level 3||0
8444027|NCT00790842|20809001|P8|NOT COMPLETED|Dose Level 3||0
8444028|NCT00790842|20809002|P7|NOT COMPLETED|Dose Level 3||0
8444029|NCT00790842|20809003|P6|NOT COMPLETED|Dose Level 3||1
8444030|NCT00790842|20809004|P5|NOT COMPLETED|Dose Level 3||0
8444031|NCT00790842|20809005|P4|NOT COMPLETED|Dose Level 3||0
8444032|NCT00790842|20809006|P3|NOT COMPLETED|Dose Level 3||5
8444033|NCT00790842|20809007|P2|NOT COMPLETED|Dose Level 3||0
8444034|NCT00790842|20809008|P1|NOT COMPLETED|Dose Level 3||0
8444035|NCT00790842|20808998|P11|COMPLETED|Dose Level 3||0
8444036|NCT00790842|20808999|P10|COMPLETED|Dose Level 3||1
8444037|NCT00790842|20809000|P9|COMPLETED|Dose Level 3||0
8444038|NCT00790842|20809001|P8|COMPLETED|Dose Level 3||0
8444039|NCT00790842|20809002|P7|COMPLETED|Dose Level 3||0
8444040|NCT00790842|20809003|P6|COMPLETED|Dose Level 3||2
8444041|NCT00790842|20809004|P5|COMPLETED|Dose Level 3||0
8444042|NCT00790842|20809005|P4|COMPLETED|Dose Level 3||0
8444043|NCT00790842|20809006|P3|COMPLETED|Dose Level 3||2
8444044|NCT00790842|20809007|P2|COMPLETED|Dose Level 3||0
8444045|NCT00790842|20809008|P1|COMPLETED|Dose Level 3||0
8444046|NCT00790842|20808998|P11|Began Treatment|Dose Level 3||0
8444047|NCT00790842|20808999|P10|Began Treatment|Dose Level 3||3
8444048|NCT00790842|20809000|P9|Began Treatment|Dose Level 3||0
8444049|NCT00790842|20809001|P8|Began Treatment|Dose Level 3||0
8444050|NCT00790842|20809002|P7|Began Treatment|Dose Level 3||0
8444051|NCT00790842|20809003|P6|Began Treatment|Dose Level 3||3
8444052|NCT00790842|20809004|P5|Began Treatment|Dose Level 3||0
8444053|NCT00790842|20809005|P4|Began Treatment|Dose Level 3||0
8444054|NCT00790842|20809006|P3|Began Treatment|Dose Level 3||6
8444055|NCT00790842|20809007|P2|Began Treatment|Dose Level 3||0
8444056|NCT00790842|20809008|P1|Began Treatment|Dose Level 3||0
8444057|NCT00790842|20808998|P11|STARTED|Dose Level 3||0
8444058|NCT00790842|20808999|P10|STARTED|Dose Level 3||3
8444059|NCT00790842|20809000|P9|STARTED|Dose Level 3||0
8444060|NCT00790842|20809001|P8|STARTED|Dose Level 3||0
8444061|NCT00790842|20809002|P7|STARTED|Dose Level 3||0
8444062|NCT00790842|20809003|P6|STARTED|Dose Level 3||3
8444063|NCT00790842|20809004|P5|STARTED|Dose Level 3||0
8444064|NCT00790842|20809005|P4|STARTED|Dose Level 3||0
8444065|NCT00790842|20809006|P3|STARTED|Dose Level 3||7
8444066|NCT00790842|20809007|P2|STARTED|Dose Level 3||0
8444067|NCT00790842|20809008|P1|STARTED|Dose Level 3||0
8444068|NCT00790842|20808998|P11|NOT COMPLETED|Dose Level 2||0
8444069|NCT00790842|20808999|P10|NOT COMPLETED|Dose Level 2||0
8444070|NCT00790842|20809000|P9|NOT COMPLETED|Dose Level 2||2
8444071|NCT00790842|20809001|P8|NOT COMPLETED|Dose Level 2||0
8444072|NCT00790842|20809002|P7|NOT COMPLETED|Dose Level 2||0
8444073|NCT00790842|20809003|P6|NOT COMPLETED|Dose Level 2||0
8444074|NCT00790842|20809004|P5|NOT COMPLETED|Dose Level 2||1
8444075|NCT00790842|20809005|P4|NOT COMPLETED|Dose Level 2||0
8444076|NCT00790842|20809006|P3|NOT COMPLETED|Dose Level 2||0
8444077|NCT00790842|20809007|P2|NOT COMPLETED|Dose Level 2||3
8444078|NCT00790842|20809008|P1|NOT COMPLETED|Dose Level 2||0
8444079|NCT00790842|20808998|P11|COMPLETED|Dose Level 2||0
8444080|NCT00790842|20808999|P10|COMPLETED|Dose Level 2||0
8444081|NCT00790842|20809000|P9|COMPLETED|Dose Level 2||1
8444082|NCT00790842|20809001|P8|COMPLETED|Dose Level 2||0
8444083|NCT00790842|20809002|P7|COMPLETED|Dose Level 2||0
8444084|NCT00790842|20809003|P6|COMPLETED|Dose Level 2||0
8444085|NCT00790842|20809004|P5|COMPLETED|Dose Level 2||2
8444086|NCT00790842|20809005|P4|COMPLETED|Dose Level 2||0
8444087|NCT00790842|20809006|P3|COMPLETED|Dose Level 2||0
8444088|NCT00790842|20809007|P2|COMPLETED|Dose Level 2||0
8444089|NCT00790842|20809008|P1|COMPLETED|Dose Level 2||0
8444090|NCT00790842|20808998|P11|Began Treatment|Dose Level 2||0
8444091|NCT00790842|20808999|P10|Began Treatment|Dose Level 2||0
8444092|NCT00790842|20809000|P9|Began Treatment|Dose Level 2||3
8444093|NCT00790842|20809001|P8|Began Treatment|Dose Level 2||0
8444094|NCT00790842|20809002|P7|Began Treatment|Dose Level 2||0
8444095|NCT00790842|20809003|P6|Began Treatment|Dose Level 2||0
8444096|NCT00790842|20809004|P5|Began Treatment|Dose Level 2||3
8444097|NCT00790842|20809005|P4|Began Treatment|Dose Level 2||0
8444098|NCT00790842|20809006|P3|Began Treatment|Dose Level 2||0
8444099|NCT00790842|20809007|P2|Began Treatment|Dose Level 2||3
8444100|NCT00790842|20809008|P1|Began Treatment|Dose Level 2||0
8444101|NCT00790842|20808998|P11|STARTED|Dose Level 2||0
8444102|NCT00790842|20808999|P10|STARTED|Dose Level 2||0
8444103|NCT00790842|20809000|P9|STARTED|Dose Level 2||3
8444104|NCT00790842|20809001|P8|STARTED|Dose Level 2||0
8444105|NCT00790842|20809002|P7|STARTED|Dose Level 2||0
8444106|NCT00790842|20809003|P6|STARTED|Dose Level 2||0
8444107|NCT00790842|20809004|P5|STARTED|Dose Level 2||3
8444108|NCT00790842|20809005|P4|STARTED|Dose Level 2||0
8444109|NCT00790842|20809006|P3|STARTED|Dose Level 2||0
8444110|NCT00790842|20809007|P2|STARTED|Dose Level 2||3
8444111|NCT00790842|20809008|P1|STARTED|Dose Level 2||0
8444112|NCT00790842|20808998|P11|NOT COMPLETED|Dose Level 1||0
8444113|NCT00790842|20808999|P10|NOT COMPLETED|Dose Level 1||0
8444114|NCT00790842|20809000|P9|NOT COMPLETED|Dose Level 1||0
8444115|NCT00790842|20809001|P8|NOT COMPLETED|Dose Level 1||2
8444116|NCT00790842|20809002|P7|NOT COMPLETED|Dose Level 1||0
8444117|NCT00790842|20809003|P6|NOT COMPLETED|Dose Level 1||0
8444118|NCT00790842|20809004|P5|NOT COMPLETED|Dose Level 1||0
8444119|NCT00790842|20809005|P4|NOT COMPLETED|Dose Level 1||2
8444120|NCT00790842|20809006|P3|NOT COMPLETED|Dose Level 1||0
8444121|NCT00790842|20809007|P2|NOT COMPLETED|Dose Level 1||0
8444122|NCT00790842|20809008|P1|NOT COMPLETED|Dose Level 1||3
8444123|NCT00790842|20808998|P11|COMPLETED|Dose Level 1||0
8444124|NCT00790842|20808999|P10|COMPLETED|Dose Level 1||0
8444125|NCT00790842|20809000|P9|COMPLETED|Dose Level 1||0
8444126|NCT00790842|20809001|P8|COMPLETED|Dose Level 1||1
8444127|NCT00790842|20809002|P7|COMPLETED|Dose Level 1||0
8444128|NCT00790842|20809003|P6|COMPLETED|Dose Level 1||0
8444129|NCT00790842|20809004|P5|COMPLETED|Dose Level 1||0
8444130|NCT00790842|20809005|P4|COMPLETED|Dose Level 1||1
8444131|NCT00790842|20809006|P3|COMPLETED|Dose Level 1||0
8444132|NCT00790842|20809007|P2|COMPLETED|Dose Level 1||0
8444133|NCT00790842|20809008|P1|COMPLETED|Dose Level 1||3
8444134|NCT00790842|20808998|P11|Began Treatment|Dose Level 1||0
8444135|NCT00790842|20808999|P10|Began Treatment|Dose Level 1||0
8444136|NCT00790842|20809000|P9|Began Treatment|Dose Level 1||0
8444137|NCT00790842|20809001|P8|Began Treatment|Dose Level 1||3
8444138|NCT00790842|20809002|P7|Began Treatment|Dose Level 1||0
8444139|NCT00790842|20809003|P6|Began Treatment|Dose Level 1||0
8444140|NCT00790842|20809004|P5|Began Treatment|Dose Level 1||0
8444141|NCT00790842|20809005|P4|Began Treatment|Dose Level 1||3
8444142|NCT00790842|20809006|P3|Began Treatment|Dose Level 1||0
8444143|NCT00790842|20809007|P2|Began Treatment|Dose Level 1||0
8444144|NCT00790842|20809008|P1|Began Treatment|Dose Level 1||6
8444145|NCT00790842|20808998|P11|STARTED|Dose Level 1||0
8444146|NCT00790842|20808999|P10|STARTED|Dose Level 1||0
8444147|NCT00790842|20809000|P9|STARTED|Dose Level 1||0
8444148|NCT00790842|20809001|P8|STARTED|Dose Level 1||3
8444149|NCT00790842|20809002|P7|STARTED|Dose Level 1||0
8444150|NCT00790842|20809003|P6|STARTED|Dose Level 1||0
8444151|NCT00790842|20809004|P5|STARTED|Dose Level 1||0
8444152|NCT00790842|20809005|P4|STARTED|Dose Level 1||3
8444153|NCT00790842|20809006|P3|STARTED|Dose Level 1||0
8444154|NCT00790842|20809007|P2|STARTED|Dose Level 1||0
8444155|NCT00790842|20809008|P1|STARTED|Dose Level 1||6
8444156|NCT00790803|20809065|P1|NOT COMPLETED|Overall Study||0
8444157|NCT00790803|20809065|P1|COMPLETED|Overall Study||5
8444158|NCT00790803|20809065|P1|STARTED|Overall Study||5
8444159|NCT00790790|20809076|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
8444160|NCT00790790|20809077|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
8444161|NCT00790790|20809078|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
8444162|NCT00790790|20809076|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||26
8444163|NCT00790790|20809077|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||31
8444164|NCT00790790|20809078|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||37
8444165|NCT00790790|20809076|P3|STARTED|Study Period 3: 1-Week Washout Phase||27
8444166|NCT00790790|20809077|P2|STARTED|Study Period 3: 1-Week Washout Phase||32
8444167|NCT00790790|20809078|P1|STARTED|Study Period 3: 1-Week Washout Phase||37
8444168|NCT00790790|20809076|P3|NOT COMPLETED|Study Period 2: Therapy Phase||21
8444169|NCT00790790|20809077|P2|NOT COMPLETED|Study Period 2: Therapy Phase||18
8444170|NCT00790790|20809078|P1|NOT COMPLETED|Study Period 2: Therapy Phase||12
8444171|NCT00790790|20809076|P3|COMPLETED|Study Period 2: Therapy Phase||27
8444172|NCT00790790|20809077|P2|COMPLETED|Study Period 2: Therapy Phase||32
8444173|NCT00790790|20809078|P1|COMPLETED|Study Period 2: Therapy Phase||37
8444174|NCT00790790|20809076|P3|STARTED|Study Period 2: Therapy Phase||48
8444175|NCT00790790|20809077|P2|STARTED|Study Period 2: Therapy Phase||50
8444176|NCT00790790|20809078|P1|STARTED|Study Period 2: Therapy Phase||49
8444177|NCT00790751|20809155|P4|NOT COMPLETED|Overall Study||21
8444178|NCT00790751|20809156|P3|NOT COMPLETED|Overall Study||20
8444179|NCT00790751|20809157|P2|NOT COMPLETED|Overall Study||30
8444180|NCT00790751|20809158|P1|NOT COMPLETED|Overall Study||25
8444181|NCT00790751|20809155|P4|COMPLETED|Overall Study||141
8444182|NCT00790751|20809156|P3|COMPLETED|Overall Study||141
8444183|NCT00790751|20809157|P2|COMPLETED|Overall Study||131
8444184|NCT00790751|20809158|P1|COMPLETED|Overall Study||137
8444185|NCT00790751|20809155|P4|STARTED|Overall Study||162
8444186|NCT00790751|20809156|P3|STARTED|Overall Study||161
8444187|NCT00790751|20809157|P2|STARTED|Overall Study||161
8444188|NCT00790751|20809158|P1|STARTED|Overall Study||162
8444189|NCT00790738|20809178|P2|NOT COMPLETED|Overall Study||3
8444190|NCT00790738|20809179|P1|NOT COMPLETED|Overall Study||2
8444191|NCT00790738|20809178|P2|COMPLETED|Overall Study||3
8444192|NCT00790738|20809179|P1|COMPLETED|Overall Study||3
8444193|NCT00790738|20809178|P2|STARTED|Overall Study||6
8444194|NCT00790738|20809179|P1|STARTED|Overall Study||5
8444195|NCT00790699|20809191|P2|NOT COMPLETED|Overall Study||0
8444196|NCT00790699|20809192|P1|NOT COMPLETED|Overall Study||1
8444197|NCT00790699|20809191|P2|COMPLETED|Overall Study||14
8444198|NCT00790699|20809192|P1|COMPLETED|Overall Study||16
8444199|NCT00790699|20809191|P2|STARTED|Overall Study||14
8444200|NCT00790699|20809192|P1|STARTED|Overall Study||17
8444201|NCT00790673|20809204|P4|NOT COMPLETED|Overall Study||0
8444202|NCT00790673|20809205|P3|NOT COMPLETED|Overall Study||0
8444203|NCT00790673|20809206|P2|NOT COMPLETED|Overall Study||0
8444204|NCT00790673|20809207|P1|NOT COMPLETED|Overall Study||0
8444205|NCT00790673|20809204|P4|COMPLETED|Overall Study||8
8444206|NCT00790673|20809205|P3|COMPLETED|Overall Study||12
8444207|NCT00790673|20809206|P2|COMPLETED|Overall Study||6
8444208|NCT00790673|20809207|P1|COMPLETED|Overall Study||6
8444209|NCT00790673|20809204|P4|STARTED|Overall Study||8
8444210|NCT00790673|20809205|P3|STARTED|Overall Study||12
8444211|NCT00790673|20809206|P2|STARTED|Overall Study||6
8444212|NCT00790673|20809207|P1|STARTED|Overall Study||6
8444213|NCT00790647|20809217|P1|NOT COMPLETED|Overall Study||1
8444214|NCT00790647|20809217|P1|COMPLETED|Overall Study||9
8444215|NCT00790647|20809217|P1|STARTED|Overall Study||10
8444216|NCT00790582|20809226|P2|NOT COMPLETED|Overall Study||87
8444217|NCT00790582|20809227|P1|NOT COMPLETED|Overall Study||31
8444218|NCT00790582|20809226|P2|COMPLETED|Overall Study||162
8444219|NCT00790582|20809227|P1|COMPLETED|Overall Study||78
8444220|NCT00790582|20809226|P2|STARTED|Overall Study||249
8444221|NCT00790582|20809227|P1|STARTED|Overall Study||109
8444222|NCT00790569|20809238|P3|NOT COMPLETED|End of Study (12 Month Interview)||50
8444223|NCT00790569|20809239|P2|NOT COMPLETED|End of Study (12 Month Interview)||19
8444224|NCT00790569|20809240|P1|NOT COMPLETED|End of Study (12 Month Interview)||66
8444225|NCT00790569|20809238|P3|COMPLETED|End of Study (12 Month Interview)||83
8444226|NCT00790569|20809239|P2|COMPLETED|End of Study (12 Month Interview)||26
8444227|NCT00790569|20809240|P1|COMPLETED|End of Study (12 Month Interview)||71
8444228|NCT00790569|20809238|P3|STARTED|End of Study (12 Month Interview)||133
8444229|NCT00790569|20809239|P2|STARTED|End of Study (12 Month Interview)||45
8444230|NCT00790569|20809240|P1|STARTED|End of Study (12 Month Interview)||137
8444231|NCT00790569|20809238|P3|NOT COMPLETED|End of Treatment (6 Month Interview)||26
8444232|NCT00790569|20809239|P2|NOT COMPLETED|End of Treatment (6 Month Interview)||10
8444233|NCT00790569|20809240|P1|NOT COMPLETED|End of Treatment (6 Month Interview)||22
8444234|NCT00790569|20809238|P3|COMPLETED|End of Treatment (6 Month Interview)||107
8444235|NCT00790569|20809239|P2|COMPLETED|End of Treatment (6 Month Interview)||35
8444236|NCT00790569|20809240|P1|COMPLETED|End of Treatment (6 Month Interview)||115
8444237|NCT00790569|20809238|P3|STARTED|End of Treatment (6 Month Interview)||133
8444238|NCT00790569|20809239|P2|STARTED|End of Treatment (6 Month Interview)||45
8444239|NCT00790569|20809240|P1|STARTED|End of Treatment (6 Month Interview)||137
8444240|NCT00790556|20809281|P2|NOT COMPLETED|Treatment Period 2||0
8444241|NCT00790556|20809282|P1|NOT COMPLETED|Treatment Period 2||0
8444242|NCT00790556|20809281|P2|COMPLETED|Treatment Period 2||6
8444243|NCT00790556|20809282|P1|COMPLETED|Treatment Period 2||6
8444244|NCT00790556|20809281|P2|STARTED|Treatment Period 2||6
8444245|NCT00790556|20809282|P1|STARTED|Treatment Period 2||6
8444246|NCT00790556|20809281|P2|NOT COMPLETED|Washout After Period 1||0
8444247|NCT00790556|20809282|P1|NOT COMPLETED|Washout After Period 1||0
8444248|NCT00790556|20809281|P2|COMPLETED|Washout After Period 1||6
8444249|NCT00790556|20809282|P1|COMPLETED|Washout After Period 1||6
8444250|NCT00790556|20809281|P2|STARTED|Washout After Period 1||6
8444251|NCT00790556|20809282|P1|STARTED|Washout After Period 1||6
8444252|NCT00790556|20809281|P2|NOT COMPLETED|Treatment Period 1||0
8444253|NCT00790556|20809282|P1|NOT COMPLETED|Treatment Period 1||2
8444254|NCT00790556|20809281|P2|COMPLETED|Treatment Period 1||6
8444255|NCT00790556|20809282|P1|COMPLETED|Treatment Period 1||6
8444256|NCT00790556|20809281|P2|STARTED|Treatment Period 1||6
8444257|NCT00790556|20809282|P1|STARTED|Treatment Period 1||8
8444258|NCT00790452|20809294|P2|NOT COMPLETED|Overall Study||0
8444259|NCT00790452|20809295|P1|NOT COMPLETED|Overall Study||1
8444260|NCT00790452|20809294|P2|COMPLETED|Overall Study||0
8444261|NCT00790452|20809295|P1|COMPLETED|Overall Study||0
8444262|NCT00790452|20809294|P2|STARTED|Overall Study||0
8444263|NCT00790452|20809295|P1|STARTED|Overall Study||1
8444264|NCT00790400|20809303|P2|NOT COMPLETED|Everolimus Period (Core or Extension)||0
8444265|NCT00790400|20809304|P1|NOT COMPLETED|Everolimus Period (Core or Extension)||29
8444266|NCT00790400|20809303|P2|COMPLETED|Everolimus Period (Core or Extension)||0
8444267|NCT00790400|20809304|P1|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
8444268|NCT00790400|20809303|P2|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
8444269|NCT00790400|20809304|P1|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
8444270|NCT00790400|20809303|P2|NOT COMPLETED|Double-blind Period (Core Phase)||13
8444271|NCT00790400|20809304|P1|NOT COMPLETED|Double-blind Period (Core Phase)||7
8444272|NCT00790400|20809303|P2|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
8444273|NCT00790400|20809304|P1|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
8444274|NCT00790400|20809303|P2|STARTED|Double-blind Period (Core Phase)||39
8444275|NCT00790400|20809304|P1|STARTED|Double-blind Period (Core Phase)||79
8444276|NCT00790335|20809333|P2|NOT COMPLETED|Overall Study||112
8444277|NCT00790335|20809334|P1|NOT COMPLETED|Overall Study||80
8444278|NCT00790335|20809333|P2|COMPLETED|Overall Study||243
8444279|NCT00790335|20809334|P1|COMPLETED|Overall Study||257
8444280|NCT00790335|20809333|P2|STARTED|Overall Study||355
8444281|NCT00790335|20809334|P1|STARTED|Overall Study||337
8444282|NCT00790296|20809394|P2|NOT COMPLETED|Overall Study||2
8444283|NCT00790296|20809395|P1|NOT COMPLETED|Overall Study||1
8444284|NCT00790296|20809394|P2|COMPLETED|Overall Study||4
8444285|NCT00790296|20809395|P1|COMPLETED|Overall Study||4
8444286|NCT00790296|20809394|P2|STARTED|Overall Study||6
8444287|NCT00790296|20809395|P1|STARTED|Overall Study||5
8444288|NCT00790270|20809404|P3|NOT COMPLETED|Overall Study||0
8444289|NCT00790270|20809405|P2|NOT COMPLETED|Overall Study||0
8444290|NCT00790270|20809406|P1|NOT COMPLETED|Overall Study||0
8444291|NCT00790270|20809404|P3|COMPLETED|Overall Study||20
8444292|NCT00790270|20809405|P2|COMPLETED|Overall Study||20
8444293|NCT00790270|20809406|P1|COMPLETED|Overall Study||21
8444294|NCT00790270|20809404|P3|STARTED|Overall Study||20
8444295|NCT00790270|20809405|P2|STARTED|Overall Study||20
8444296|NCT00790270|20809406|P1|STARTED|Overall Study||21
8444297|NCT00790218|20809417|P3|NOT COMPLETED|Overall Study||0
8444298|NCT00790218|20809418|P2|NOT COMPLETED|Overall Study||0
8444299|NCT00790218|20809419|P1|NOT COMPLETED|Overall Study||1
8444300|NCT00790218|20809417|P3|COMPLETED|Overall Study||7
8444301|NCT00790218|20809418|P2|COMPLETED|Overall Study||6
8444302|NCT00790218|20809419|P1|COMPLETED|Overall Study||5
8444303|NCT00790218|20809417|P3|STARTED|Overall Study||7
8444304|NCT00790218|20809418|P2|STARTED|Overall Study||6
8444305|NCT00790218|20809419|P1|STARTED|Overall Study||6
8444306|NCT00790205|20809429|P2|NOT COMPLETED|Overall Study||434
8444307|NCT00790205|20809430|P1|NOT COMPLETED|Overall Study||360
8444308|NCT00790205|20809429|P2|COMPLETED|Overall Study||6905
8444309|NCT00790205|20809430|P1|COMPLETED|Overall Study||6972
8444310|NCT00790205|20809429|P2|Treated|Overall Study||7274
8444311|NCT00790205|20809430|P1|Treated|Overall Study||7266
8444312|NCT00790205|20809429|P2|STARTED|Overall Study||7339
8444313|NCT00790205|20809430|P1|STARTED|Overall Study||7332
8444314|NCT00790192|20809474|P4|NOT COMPLETED|Overall Study||48
8444315|NCT00790192|20809475|P3|NOT COMPLETED|Overall Study||23
8444316|NCT00790192|20809476|P2|NOT COMPLETED|Overall Study||28
8444317|NCT00790192|20809477|P1|NOT COMPLETED|Overall Study||36
8444318|NCT00790192|20809474|P4|COMPLETED|Overall Study||74
8444319|NCT00790192|20809475|P3|COMPLETED|Overall Study||97
8444320|NCT00790192|20809476|P2|COMPLETED|Overall Study||93
8444321|NCT00790192|20809477|P1|COMPLETED|Overall Study||89
8444322|NCT00790192|20809474|P4|STARTED|Overall Study||122
8444323|NCT00790192|20809475|P3|STARTED|Overall Study||120
8444324|NCT00790192|20809476|P2|STARTED|Overall Study||121
8444325|NCT00790192|20809477|P1|STARTED|Overall Study||125
8444326|NCT00790088|20809491|P1|NOT COMPLETED|Overall Study||39
8444327|NCT00790088|20809491|P1|COMPLETED|Overall Study||235
8444328|NCT00790088|20809491|P1|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263
8444329|NCT00790088|20809491|P1|STARTED|Overall Study||274
8444330|NCT00790062|20809504|P3|NOT COMPLETED|Overall Study||0
8444331|NCT00790062|20809505|P2|NOT COMPLETED|Overall Study||0
8444332|NCT00790062|20809506|P1|NOT COMPLETED|Overall Study||0
8444333|NCT00790062|20809504|P3|COMPLETED|Overall Study||658
8444334|NCT00790062|20809505|P2|COMPLETED|Overall Study||481
8444335|NCT00790062|20809506|P1|COMPLETED|Overall Study||659
8444336|NCT00790062|20809504|P3|STARTED|Overall Study||658
8444337|NCT00790062|20809505|P2|STARTED|Overall Study||481
8444338|NCT00790062|20809506|P1|STARTED|Overall Study||659
8444339|NCT00790036|20809537|P2|NOT COMPLETED|Overall Study||121
8444340|NCT00790036|20809538|P1|NOT COMPLETED|Overall Study||195
8444341|NCT00790036|20809537|P2|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
8444342|NCT00790036|20809538|P1|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
8444343|NCT00790036|20809537|P2|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
8444344|NCT00790036|20809538|P1|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
8444345|NCT00790036|20809537|P2|STARTED|Overall Study||370
8444346|NCT00790036|20809538|P1|STARTED|Overall Study||372
8444347|NCT00790023|20809552|P3|NOT COMPLETED|Overall Study||21
8444348|NCT00790023|20809553|P2|NOT COMPLETED|Overall Study||10
8444349|NCT00790023|20809554|P1|NOT COMPLETED|Overall Study||11
8444350|NCT00790023|20809552|P3|COMPLETED|Overall Study||214
8444351|NCT00790023|20809553|P2|COMPLETED|Overall Study||225
8444352|NCT00790023|20809554|P1|COMPLETED|Overall Study||226
8444353|NCT00790023|20809552|P3|STARTED|Overall Study||235
8444354|NCT00790023|20809553|P2|STARTED|Overall Study||235
8444355|NCT00790023|20809554|P1|STARTED|Overall Study||237
8444356|NCT00789997|20809644|P2|NOT COMPLETED|Overall Study||2
8444357|NCT00789997|20809645|P1|NOT COMPLETED|Overall Study||1
8444358|NCT00789997|20809644|P2|COMPLETED|Overall Study||38
8444359|NCT00789997|20809645|P1|COMPLETED|Overall Study||40
8444360|NCT00789997|20809644|P2|STARTED|Overall Study||40
8444361|NCT00789997|20809645|P1|STARTED|Overall Study||41
8444362|NCT00789958|20809653|P1|NOT COMPLETED|Overall Study||37
8444363|NCT00789958|20809653|P1|COMPLETED|Overall Study||68
8444364|NCT00789958|20809653|P1|Eligible and Analyzable|Overall Study||79
8444365|NCT00789958|20809653|P1|STARTED|Overall Study||105
8444366|NCT00789880|20809672|P6|NOT COMPLETED|Overall Study||0
8444367|NCT00789880|20809673|P5|NOT COMPLETED|Overall Study||3
8444368|NCT00789880|20809674|P4|NOT COMPLETED|Overall Study||1
8444369|NCT00789880|20809675|P3|NOT COMPLETED|Overall Study||0
8444370|NCT00789880|20809676|P2|NOT COMPLETED|Overall Study||1
8444371|NCT00789880|20809677|P1|NOT COMPLETED|Overall Study||1
8444372|NCT00789880|20809672|P6|COMPLETED|Overall Study||8
8444373|NCT00789880|20809673|P5|COMPLETED|Overall Study||15
8444374|NCT00789880|20809674|P4|COMPLETED|Overall Study||15
8444375|NCT00789880|20809675|P3|COMPLETED|Overall Study||8
8444376|NCT00789880|20809676|P2|COMPLETED|Overall Study||15
8444377|NCT00789880|20809677|P1|COMPLETED|Overall Study||15
8444378|NCT00789880|20809672|P6|STARTED|Overall Study||8
8444379|NCT00789880|20809673|P5|STARTED|Overall Study||18
8444380|NCT00789880|20809674|P4|STARTED|Overall Study||16
8444381|NCT00789880|20809675|P3|STARTED|Overall Study||8
8444382|NCT00789880|20809676|P2|STARTED|Overall Study||16
8444383|NCT00789880|20809677|P1|STARTED|Overall Study||16
8444384|NCT00789867|20809706|P3|NOT COMPLETED|Overall Study||0
8444385|NCT00789867|20809707|P2|NOT COMPLETED|Overall Study||0
8444386|NCT00789867|20809708|P1|NOT COMPLETED|Overall Study||0
8444387|NCT00789867|20809706|P3|COMPLETED|Overall Study||8
8444388|NCT00789867|20809707|P2|COMPLETED|Overall Study||10
8444389|NCT00789867|20809708|P1|COMPLETED|Overall Study||17
8444390|NCT00789867|20809706|P3|STARTED|Overall Study||8
8444391|NCT00789867|20809707|P2|STARTED|Overall Study||10
8444392|NCT00789867|20809708|P1|STARTED|Overall Study||17
8444393|NCT00789854|20809734|P3|NOT COMPLETED|Overall Study||47
8444394|NCT00789854|20809735|P2|NOT COMPLETED|Overall Study||35
8444395|NCT00789854|20809736|P1|NOT COMPLETED|Overall Study||49
8444396|NCT00789854|20809734|P3|COMPLETED|Overall Study||182
8444397|NCT00789854|20809735|P2|COMPLETED|Overall Study||196
8444398|NCT00789854|20809736|P1|COMPLETED|Overall Study||179
8444399|NCT00789854|20809734|P3|STARTED|Overall Study||229
8444400|NCT00789854|20809735|P2|STARTED|Overall Study||231
8444401|NCT00789854|20809736|P1|STARTED|Overall Study||228
8444402|NCT00789828|20809833|P2|NOT COMPLETED|Open-label Extension Period (4 Years)||0
8444403|NCT00789828|20809834|P1|NOT COMPLETED|Open-label Extension Period (4 Years)||29
8444404|NCT00789828|20809833|P2|COMPLETED|Open-label Extension Period (4 Years)||0
8444405|NCT00789828|20809834|P1|COMPLETED|Open-label Extension Period (4 Years)||82
8444406|NCT00789828|20809833|P2|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
8444407|NCT00789828|20809834|P1|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
8444408|NCT00789828|20809833|P2|NOT COMPLETED|Core Period (48 Weeks)||6
8444409|NCT00789828|20809834|P1|NOT COMPLETED|Core Period (48 Weeks)||0
8444410|NCT00789828|20809833|P2|COMPLETED|Core Period (48 Weeks)||33
8444411|NCT00789828|20809834|P1|COMPLETED|Core Period (48 Weeks)||78
8444412|NCT00789828|20809833|P2|STARTED|Core Period (48 Weeks)||39
8444413|NCT00789828|20809834|P1|STARTED|Core Period (48 Weeks)||78
8444414|NCT00789815|20809868|P2|NOT COMPLETED|Overall Study||1
8444415|NCT00789815|20809869|P1|NOT COMPLETED|Overall Study||7
8444416|NCT00789815|20809868|P2|COMPLETED|Overall Study||249
8444417|NCT00789815|20809869|P1|COMPLETED|Overall Study||243
8444418|NCT00789815|20809868|P2|STARTED|Overall Study||250
8444419|NCT00789815|20809869|P1|STARTED|Overall Study||250
8444420|NCT00789802|20809892|P3|NOT COMPLETED|Overall Study||6
8444421|NCT00789802|20809893|P2|NOT COMPLETED|Overall Study||7
8444422|NCT00789802|20809894|P1|NOT COMPLETED|Overall Study||10
8444423|NCT00789802|20809892|P3|COMPLETED|Overall Study||37
8444424|NCT00789802|20809893|P2|COMPLETED|Overall Study||35
8444425|NCT00789802|20809894|P1|COMPLETED|Overall Study||34
8444426|NCT00789802|20809892|P3|STARTED|Overall Study||43
8444427|NCT00789802|20809893|P2|STARTED|Overall Study||42
8444428|NCT00789802|20809894|P1|STARTED|Overall Study||44
8444429|NCT00789776|20809913|P2|NOT COMPLETED|Overall Study||1
8444430|NCT00789776|20809914|P1|NOT COMPLETED|Overall Study||0
8444431|NCT00789776|20809913|P2|COMPLETED|Overall Study||35
8444432|NCT00789776|20809914|P1|COMPLETED|Overall Study||5
8444433|NCT00789776|20809913|P2|STARTED|Overall Study||36
8444434|NCT00789776|20809914|P1|STARTED|Overall Study||5
8444435|NCT00789750|20809934|P2|NOT COMPLETED|Overall Study||60
8444436|NCT00789750|20809935|P1|NOT COMPLETED|Overall Study||59
8444437|NCT00789750|20809934|P2|COMPLETED|Overall Study||222
8444438|NCT00789750|20809935|P1|COMPLETED|Overall Study||221
8444439|NCT00789750|20809934|P2|Intent to Treat Set|Overall Study||276
8444440|NCT00789750|20809935|P1|Intent to Treat Set|Overall Study||271
8444441|NCT00789750|20809934|P2|Safety Set|Overall Study||277
8444442|NCT00789750|20809935|P1|Safety Set|Overall Study||274
8444443|NCT00789750|20809934|P2|Dropped During run-in Period|Overall Study||5
8444444|NCT00789750|20809935|P1|Dropped During run-in Period|Overall Study||6
8444445|NCT00789750|20809934|P2|STARTED|Overall Study||282
8444446|NCT00789750|20809935|P1|STARTED|Overall Study||280
8444447|NCT00789737|20809979|P2|NOT COMPLETED|Overall Study||55
8444448|NCT00789737|20809980|P1|NOT COMPLETED|Overall Study||48
8444449|NCT00789737|20809979|P2|COMPLETED|Overall Study||126
8444450|NCT00789737|20809980|P1|COMPLETED|Overall Study||128
8444451|NCT00789737|20809979|P2|STARTED|Overall Study||181
8444452|NCT00789737|20809980|P1|STARTED|Overall Study||176
8444453|NCT00789724|20810012|P2|NOT COMPLETED|Overall Study||0
8444454|NCT00789724|20810013|P1|NOT COMPLETED|Overall Study||0
8444455|NCT00789724|20810012|P2|COMPLETED|Overall Study||5
8444456|NCT00789724|20810013|P1|COMPLETED|Overall Study||5
8444457|NCT00789724|20810012|P2|STARTED|Overall Study||5
8444458|NCT00789724|20810013|P1|STARTED|Overall Study||5
8444459|NCT00789698|20810023|P4|NOT COMPLETED|Overall Study||52
8444460|NCT00789698|20810024|P3|NOT COMPLETED|Overall Study||27
8444461|NCT00789698|20810025|P2|NOT COMPLETED|Overall Study||33
8444462|NCT00789698|20810026|P1|NOT COMPLETED|Overall Study||40
8444463|NCT00789698|20810023|P4|COMPLETED|Overall Study||33
8444464|NCT00789698|20810024|P3|COMPLETED|Overall Study||29
8444465|NCT00789698|20810025|P2|COMPLETED|Overall Study||46
8444466|NCT00789698|20810026|P1|COMPLETED|Overall Study||32
8444467|NCT00789698|20810023|P4|STARTED|Overall Study||85
8444468|NCT00789698|20810024|P3|STARTED|Overall Study||56
8444469|NCT00789698|20810025|P2|STARTED|Overall Study||79
8444470|NCT00789698|20810026|P1|STARTED|Overall Study||72
8444471|NCT00789685|20810040|P1|NOT COMPLETED|Overall Study||12
8444472|NCT00789685|20810040|P1|COMPLETED|Overall Study|Completed the study to Day 28|25
8444473|NCT00789685|20810040|P1|STARTED|Overall Study||37
8444474|NCT00789672|20810048|P2|NOT COMPLETED|Overall Study||0
8444475|NCT00789672|20810049|P1|NOT COMPLETED|Overall Study||0
8444476|NCT00789672|20810048|P2|COMPLETED|Overall Study||17
8444477|NCT00789672|20810049|P1|COMPLETED|Overall Study||16
8444478|NCT00789672|20810048|P2|STARTED|Overall Study||17
8444479|NCT00789672|20810049|P1|STARTED|Overall Study||16
8444480|NCT00789581|20810081|P2|NOT COMPLETED|Adjuvant Therapy||57
8444481|NCT00789581|20810082|P1|NOT COMPLETED|Adjuvant Therapy||40
8444482|NCT00789581|20810081|P2|COMPLETED|Adjuvant Therapy||234
8444483|NCT00789581|20810082|P1|COMPLETED|Adjuvant Therapy||255
8444484|NCT00789581|20810081|P2|STARTED|Adjuvant Therapy||291
8444485|NCT00789581|20810082|P1|STARTED|Adjuvant Therapy||295
8444486|NCT00789581|20810081|P2|NOT COMPLETED|AC Therapy||17
8444487|NCT00789581|20810082|P1|NOT COMPLETED|AC Therapy||11
8444488|NCT00789581|20810081|P2|COMPLETED|AC Therapy||291
8444489|NCT00789581|20810082|P1|COMPLETED|AC Therapy||295
8444490|NCT00789581|20810081|P2|STARTED|AC Therapy||308
8444491|NCT00789581|20810082|P1|STARTED|AC Therapy||306
8444492|NCT00789555|20810093|P3|NOT COMPLETED|Overall Study||159
8444493|NCT00789555|20810094|P2|NOT COMPLETED|Overall Study||139
8444494|NCT00789555|20810095|P1|NOT COMPLETED|Overall Study||159
8444495|NCT00789555|20810093|P3|COMPLETED|Overall Study||263
8444496|NCT00789555|20810094|P2|COMPLETED|Overall Study||278
8444497|NCT00789555|20810095|P1|COMPLETED|Overall Study||262
8444498|NCT00789555|20810093|P3|STARTED|Overall Study||422
8444499|NCT00789555|20810094|P2|STARTED|Overall Study||417
8444500|NCT00789555|20810095|P1|STARTED|Overall Study||421
8444501|NCT00789529|20810120|P2|NOT COMPLETED|Overall Study||1
8444502|NCT00789529|20810121|P1|NOT COMPLETED|Overall Study||1
8444503|NCT00789529|20810120|P2|COMPLETED|Overall Study||15
8444504|NCT00789529|20810121|P1|COMPLETED|Overall Study||15
8444505|NCT00789529|20810120|P2|STARTED|Overall Study||16
8444506|NCT00789529|20810121|P1|STARTED|Overall Study||16
8444507|NCT00789477|20810134|P5|NOT COMPLETED|Overall Study||7
8444508|NCT00789477|20810135|P4|NOT COMPLETED|Overall Study||10
8444509|NCT00789477|20810136|P3|NOT COMPLETED|Overall Study||11
8444510|NCT00789477|20810137|P2|NOT COMPLETED|Overall Study||6
8444511|NCT00789477|20810138|P1|NOT COMPLETED|Overall Study||11
8444512|NCT00789477|20810134|P5|COMPLETED|Overall Study||38
8444513|NCT00789477|20810135|P4|COMPLETED|Overall Study||34
8444514|NCT00789477|20810136|P3|COMPLETED|Overall Study||33
8444515|NCT00789477|20810137|P2|COMPLETED|Overall Study||38
8444516|NCT00789477|20810138|P1|COMPLETED|Overall Study||33
8444517|NCT00789477|20810134|P5|Participants Received Treatment|Overall Study|SAF|45
8444518|NCT00789477|20810135|P4|Participants Received Treatment|Overall Study|SAF|42
8444519|NCT00789477|20810136|P3|Participants Received Treatment|Overall Study|SAF|44
8444520|NCT00789477|20810137|P2|Participants Received Treatment|Overall Study|SAF|44
8444521|NCT00789477|20810138|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
8444522|NCT00789477|20810134|P5|STARTED|Overall Study|randomized|45
8444523|NCT00789477|20810135|P4|STARTED|Overall Study|randomized|44
8444524|NCT00789477|20810136|P3|STARTED|Overall Study|randomized|44
8444525|NCT00789477|20810137|P2|STARTED|Overall Study|randomized|44
8444526|NCT00789477|20810138|P1|STARTED|Overall Study|randomized|44
8444527|NCT00789438|20810173|P3|NOT COMPLETED|Overall Study||0
8444528|NCT00789438|20810174|P2|NOT COMPLETED|Overall Study||0
8444529|NCT00789438|20810175|P1|NOT COMPLETED|Overall Study||0
8444530|NCT00789438|20810173|P3|COMPLETED|Overall Study||28
8444531|NCT00789438|20810174|P2|COMPLETED|Overall Study||20
8444532|NCT00789438|20810175|P1|COMPLETED|Overall Study||21
8444533|NCT00789438|20810173|P3|STARTED|Overall Study||28
8444534|NCT00789438|20810174|P2|STARTED|Overall Study||20
8444535|NCT00789438|20810175|P1|STARTED|Overall Study||21
8444536|NCT00789373|20810183|P3|NOT COMPLETED|Maintenance||180
8444537|NCT00789373|20810184|P2|NOT COMPLETED|Maintenance||359
8444538|NCT00789373|20810185|P1|NOT COMPLETED|Maintenance||0
8444539|NCT00789373|20810183|P3|COMPLETED|Maintenance||0
8444540|NCT00789373|20810184|P2|COMPLETED|Maintenance||0
8444541|NCT00789373|20810185|P1|COMPLETED|Maintenance||0
8444542|NCT00789373|20810183|P3|STARTED|Maintenance||180
8444543|NCT00789373|20810184|P2|STARTED|Maintenance||359
8444544|NCT00789373|20810185|P1|STARTED|Maintenance||0
8444545|NCT00789373|20810183|P3|NOT COMPLETED|Induction||0
8444546|NCT00789373|20810184|P2|NOT COMPLETED|Induction||0
8444547|NCT00789373|20810185|P1|NOT COMPLETED|Induction||399
8444548|NCT00789373|20810183|P3|COMPLETED|Induction||0
8444549|NCT00789373|20810184|P2|COMPLETED|Induction||0
8444550|NCT00789373|20810185|P1|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
8444551|NCT00789373|20810183|P3|STARTED|Induction||0
8444552|NCT00789373|20810184|P2|STARTED|Induction||0
8444553|NCT00789373|20810185|P1|STARTED|Induction||939
8444554|NCT00789360|20810212|P2|NOT COMPLETED|Overall Study||1
8444555|NCT00789360|20810213|P1|NOT COMPLETED|Overall Study||3
8444556|NCT00789360|20810212|P2|COMPLETED|Overall Study||14
8444557|NCT00789360|20810213|P1|COMPLETED|Overall Study||12
8444558|NCT00789360|20810212|P2|STARTED|Overall Study||15
8444559|NCT00789360|20810213|P1|STARTED|Overall Study||15
8444560|NCT00789321|20810223|P2|NOT COMPLETED|Overall Study||1
8444561|NCT00789321|20810224|P1|NOT COMPLETED|Overall Study||0
8444562|NCT00789321|20810223|P2|COMPLETED|Overall Study||22
8444563|NCT00789321|20810224|P1|COMPLETED|Overall Study||24
8444564|NCT00789321|20810223|P2|STARTED|Overall Study||23
8444565|NCT00789321|20810224|P1|STARTED|Overall Study||24
8444566|NCT00789256|20810234|P2|NOT COMPLETED|Overall Study||0
8444567|NCT00789256|20810235|P1|NOT COMPLETED|Overall Study||0
8444568|NCT00789256|20810234|P2|COMPLETED|Overall Study||12
8444569|NCT00789256|20810235|P1|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
8444570|NCT00789256|20810234|P2|STARTED|Overall Study||12
8444571|NCT00789256|20810235|P1|STARTED|Overall Study||14
8444572|NCT00789191|20810246|P2|NOT COMPLETED|Overall Study||19
8444573|NCT00789191|20810247|P1|NOT COMPLETED|Overall Study||14
8444574|NCT00789191|20810246|P2|COMPLETED|Overall Study||92
8444575|NCT00789191|20810247|P1|COMPLETED|Overall Study||97
8444576|NCT00789191|20810246|P2|Exposed|Overall Study|1 non-compliance|110
8444577|NCT00789191|20810247|P1|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
8444578|NCT00789191|20810246|P2|STARTED|Overall Study||111
8444579|NCT00789191|20810247|P1|STARTED|Overall Study||111
8444580|NCT00789113|20810275|P1|NOT COMPLETED|Overall Study||0
8444581|NCT00789113|20810275|P1|COMPLETED|Overall Study||12
8444582|NCT00789113|20810275|P1|STARTED|Overall Study||12
8444583|NCT00789074|20810282|P2|NOT COMPLETED|Overall Study||13
8444584|NCT00789074|20810283|P1|NOT COMPLETED|Overall Study||11
8444585|NCT00789074|20810282|P2|COMPLETED|Overall Study||35
8444586|NCT00789074|20810283|P1|COMPLETED|Overall Study||42
8444587|NCT00789074|20810282|P2|STARTED|Overall Study||48
8444588|NCT00789074|20810283|P1|STARTED|Overall Study||53
8444589|NCT00789035|20810304|P5|NOT COMPLETED|Overall Study||6
8444590|NCT00789035|20810305|P4|NOT COMPLETED|Overall Study||1
8444591|NCT00789035|20810306|P3|NOT COMPLETED|Overall Study||1
8444592|NCT00789035|20810307|P2|NOT COMPLETED|Overall Study||7
8444593|NCT00789035|20810308|P1|NOT COMPLETED|Overall Study||6
8444594|NCT00789035|20810304|P5|COMPLETED|Overall Study||74
8444595|NCT00789035|20810305|P4|COMPLETED|Overall Study||81
8444596|NCT00789035|20810306|P3|COMPLETED|Overall Study||80
8444597|NCT00789035|20810307|P2|COMPLETED|Overall Study||74
8444598|NCT00789035|20810308|P1|COMPLETED|Overall Study||76
8444599|NCT00789035|20810304|P5|STARTED|Overall Study||80
8444600|NCT00789035|20810305|P4|STARTED|Overall Study||82
8444601|NCT00789035|20810306|P3|STARTED|Overall Study||81
8444602|NCT00789035|20810307|P2|STARTED|Overall Study||81
8444603|NCT00789035|20810308|P1|STARTED|Overall Study||82
8444604|NCT00788957|20810367|P6|NOT COMPLETED|Part 3||11
8444605|NCT00788957|20810368|P5|NOT COMPLETED|Part 3||9
8444606|NCT00788957|20810369|P4|NOT COMPLETED|Part 3||0
8444607|NCT00788957|20810370|P3|NOT COMPLETED|Part 3||0
8444608|NCT00788957|20810371|P2|NOT COMPLETED|Part 3||0
8444609|NCT00788957|20810372|P1|NOT COMPLETED|Part 3||0
8444610|NCT00788957|20810367|P6|COMPLETED|Part 3|Completed the safety follow-up visit|1
8444611|NCT00788957|20810368|P5|COMPLETED|Part 3|Completed the safety follow-up visit|4
8444612|NCT00788957|20810369|P4|COMPLETED|Part 3||0
8444613|NCT00788957|20810370|P3|COMPLETED|Part 3||0
8444614|NCT00788957|20810371|P2|COMPLETED|Part 3||0
8444615|NCT00788957|20810372|P1|COMPLETED|Part 3||0
8444616|NCT00788957|20810367|P6|STARTED|Part 3||12
8444617|NCT00788957|20810368|P5|STARTED|Part 3||13
8444618|NCT00788957|20810369|P4|STARTED|Part 3||0
8444619|NCT00788957|20810370|P3|STARTED|Part 3||0
8444620|NCT00788957|20810371|P2|STARTED|Part 3||0
8444621|NCT00788957|20810372|P1|STARTED|Part 3||0
8444622|NCT00788957|20810367|P6|NOT COMPLETED|Part 2||0
8444623|NCT00788957|20810368|P5|NOT COMPLETED|Part 2||0
8444624|NCT00788957|20810369|P4|NOT COMPLETED|Part 2||41
8444625|NCT00788957|20810370|P3|NOT COMPLETED|Part 2||44
8444626|NCT00788957|20810371|P2|NOT COMPLETED|Part 2||42
8444627|NCT00788957|20810372|P1|NOT COMPLETED|Part 2||0
8444628|NCT00788957|20810367|P6|COMPLETED|Part 2||0
8444629|NCT00788957|20810368|P5|COMPLETED|Part 2||0
8444630|NCT00788957|20810369|P4|COMPLETED|Part 2|Completed the safety follow-up visit|5
8444631|NCT00788957|20810370|P3|COMPLETED|Part 2|Completed the safety follow-up visit|4
8444632|NCT00788957|20810371|P2|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
8444633|NCT00788957|20810372|P1|COMPLETED|Part 2||0
8444634|NCT00788957|20810367|P6|STARTED|Part 2||0
8444635|NCT00788957|20810368|P5|STARTED|Part 2||0
8444636|NCT00788957|20810369|P4|STARTED|Part 2||46
8444637|NCT00788957|20810370|P3|STARTED|Part 2||48
8444638|NCT00788957|20810371|P2|STARTED|Part 2||48
8444639|NCT00788957|20810372|P1|STARTED|Part 2||0
8444640|NCT00788957|20810367|P6|NOT COMPLETED|Part 1||0
8444641|NCT00788957|20810368|P5|NOT COMPLETED|Part 1||0
8444642|NCT00788957|20810369|P4|NOT COMPLETED|Part 1||0
8444643|NCT00788957|20810370|P3|NOT COMPLETED|Part 1||0
8444644|NCT00788957|20810371|P2|NOT COMPLETED|Part 1||0
8444645|NCT00788957|20810372|P1|NOT COMPLETED|Part 1||9
8444646|NCT00788957|20810367|P6|COMPLETED|Part 1||0
8444647|NCT00788957|20810368|P5|COMPLETED|Part 1||0
8444648|NCT00788957|20810369|P4|COMPLETED|Part 1||0
8444649|NCT00788957|20810370|P3|COMPLETED|Part 1||0
8444650|NCT00788957|20810371|P2|COMPLETED|Part 1||0
8444651|NCT00788957|20810372|P1|COMPLETED|Part 1|Completed the safety follow-up visit|2
8444652|NCT00788957|20810367|P6|STARTED|Part 1||0
8444653|NCT00788957|20810368|P5|STARTED|Part 1||0
8444654|NCT00788957|20810369|P4|STARTED|Part 1||0
8444655|NCT00788957|20810370|P3|STARTED|Part 1||0
8444656|NCT00788957|20810371|P2|STARTED|Part 1||0
8444657|NCT00788957|20810372|P1|STARTED|Part 1||11
8444658|NCT00788892|20810428|P2|NOT COMPLETED|Overall Study||23
8444659|NCT00788892|20810429|P1|NOT COMPLETED|Overall Study||49
8444660|NCT00788892|20810428|P2|COMPLETED|Overall Study||18
8444661|NCT00788892|20810429|P1|COMPLETED|Overall Study||36
8444662|NCT00788892|20810428|P2|STARTED|Overall Study||41
8444663|NCT00788892|20810429|P1|STARTED|Overall Study||85
8444664|NCT00788827|20810445|P1|NOT COMPLETED|Overall Study||2
8444665|NCT00788827|20810445|P1|COMPLETED|Overall Study||5
8444666|NCT00788827|20810445|P1|STARTED|Overall Study||7
8444667|NCT00788775|20810459|P2|NOT COMPLETED|Overall Study||8
8444668|NCT00788775|20810460|P1|NOT COMPLETED|Overall Study||10
8444669|NCT00788775|20810459|P2|COMPLETED|Overall Study||1
8444670|NCT00788775|20810460|P1|COMPLETED|Overall Study||1
8444671|NCT00788775|20810459|P2|Treated|Overall Study||8
8444672|NCT00788775|20810460|P1|Treated|Overall Study||11
8444673|NCT00788775|20810459|P2|STARTED|Overall Study||9
8444674|NCT00788775|20810460|P1|STARTED|Overall Study||11
8444675|NCT00788710|20810475|P3|NOT COMPLETED|Overall Study||6
8444676|NCT00788710|20810476|P2|NOT COMPLETED|Overall Study||8
8444677|NCT00788710|20810477|P1|NOT COMPLETED|Overall Study||5
8444678|NCT00788710|20810475|P3|COMPLETED|Overall Study||138
8444679|NCT00788710|20810476|P2|COMPLETED|Overall Study||134
8444680|NCT00788710|20810477|P1|COMPLETED|Overall Study||139
8444681|NCT00788710|20810475|P3|STARTED|Overall Study||144
8444682|NCT00788710|20810476|P2|STARTED|Overall Study||142
8444683|NCT00788710|20810477|P1|STARTED|Overall Study||144
8444684|NCT00788697|20810491|P1|NOT COMPLETED|Overall Study||109
8444685|NCT00788697|20810491|P1|COMPLETED|Overall Study||240
8444686|NCT00788697|20810491|P1|STARTED|Overall Study||349
8444687|NCT00788593|20810538|P3|NOT COMPLETED|Second Intervention Period||1
8444688|NCT00788593|20810539|P2|NOT COMPLETED|Second Intervention Period||1
8444689|NCT00788593|20810540|P1|NOT COMPLETED|Second Intervention Period||0
8444690|NCT00788593|20810538|P3|COMPLETED|Second Intervention Period||36
8444691|NCT00788593|20810539|P2|COMPLETED|Second Intervention Period||37
8444692|NCT00788593|20810540|P1|COMPLETED|Second Intervention Period||0
8444693|NCT00788593|20810538|P3|STARTED|Second Intervention Period||37
8444694|NCT00788593|20810539|P2|STARTED|Second Intervention Period||38
8444695|NCT00788593|20810540|P1|STARTED|Second Intervention Period||0
8444696|NCT00788593|20810538|P3|NOT COMPLETED|First Intervention Period||0
8444697|NCT00788593|20810539|P2|NOT COMPLETED|First Intervention Period||1
8444698|NCT00788593|20810540|P1|NOT COMPLETED|First Intervention Period||0
8444699|NCT00788593|20810538|P3|COMPLETED|First Intervention Period||37
8444700|NCT00788593|20810539|P2|COMPLETED|First Intervention Period||38
8444701|NCT00788593|20810540|P1|COMPLETED|First Intervention Period||0
8444702|NCT00788593|20810538|P3|STARTED|First Intervention Period||37
8444703|NCT00788593|20810539|P2|STARTED|First Intervention Period||39
8444704|NCT00788593|20810540|P1|STARTED|First Intervention Period||0
8444705|NCT00788593|20810538|P3|NOT COMPLETED|Placebo Run-in Phase||0
8444706|NCT00788593|20810539|P2|NOT COMPLETED|Placebo Run-in Phase||0
8444707|NCT00788593|20810540|P1|NOT COMPLETED|Placebo Run-in Phase||6
8444708|NCT00788593|20810538|P3|COMPLETED|Placebo Run-in Phase||0
8444709|NCT00788593|20810539|P2|COMPLETED|Placebo Run-in Phase||0
8444710|NCT00788593|20810540|P1|COMPLETED|Placebo Run-in Phase||76
8444711|NCT00788593|20810538|P3|STARTED|Placebo Run-in Phase||0
8444712|NCT00788593|20810539|P2|STARTED|Placebo Run-in Phase||0
8444713|NCT00788593|20810540|P1|STARTED|Placebo Run-in Phase||82
8444714|NCT00788372|20810557|P1|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
8444715|NCT00788372|20810557|P1|COMPLETED|Period 2 (Week 4 to Week 52)||79
8444716|NCT00788372|20810557|P1|STARTED|Period 2 (Week 4 to Week 52)||111
8444717|NCT00788372|20810557|P1|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
8444718|NCT00788372|20810557|P1|COMPLETED|Period 1 (up to 4 Weeks)||111
8444719|NCT00788372|20810557|P1|STARTED|Period 1 (up to 4 Weeks)||142
8444720|NCT00788255|20810571|P1|NOT COMPLETED|Overall Study||0
8444721|NCT00788255|20810571|P1|COMPLETED|Overall Study||25
8444722|NCT00788255|20810571|P1|Oxytocin: 0 μU/mL|Overall Study||25
8444723|NCT00788255|20810571|P1|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
8444724|NCT00788255|20810571|P1|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
8444725|NCT00788255|20810571|P1|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
8444726|NCT00788255|20810571|P1|STARTED|Overall Study||25
8444727|NCT00788151|20810586|P2|NOT COMPLETED|Overall Study||10
8444728|NCT00788151|20810587|P1|NOT COMPLETED|Overall Study||14
8444729|NCT00788151|20810586|P2|COMPLETED|Overall Study||90
8444730|NCT00788151|20810587|P1|COMPLETED|Overall Study||186
8444731|NCT00788151|20810586|P2|Received Vaccination 3|Overall Study||90
8444732|NCT00788151|20810587|P1|Received Vaccination 3|Overall Study||186
8444733|NCT00788151|20810586|P2|Received Vaccination 2|Overall Study||92
8444734|NCT00788151|20810587|P1|Received Vaccination 2|Overall Study||188
8444735|NCT00788151|20810586|P2|Received Vaccination 1|Overall Study||99
8444736|NCT00788151|20810587|P1|Received Vaccination 1|Overall Study||199
8444737|NCT00788151|20810586|P2|STARTED|Overall Study||100
8444738|NCT00788151|20810587|P1|STARTED|Overall Study||200
8444739|NCT00788073|20810631|P2|NOT COMPLETED|Placebo Then STX209||1
8444740|NCT00788073|20810632|P1|NOT COMPLETED|Placebo Then STX209||2
8444741|NCT00788073|20810631|P2|COMPLETED|Placebo Then STX209||29
8444742|NCT00788073|20810632|P1|COMPLETED|Placebo Then STX209||27
8444743|NCT00788073|20810631|P2|STARTED|Placebo Then STX209||30
8444744|NCT00788073|20810632|P1|STARTED|Placebo Then STX209||29
8444745|NCT00788073|20810631|P2|NOT COMPLETED|STX209 Then Placebo||3
8444746|NCT00788073|20810632|P1|NOT COMPLETED|STX209 Then Placebo||1
8444747|NCT00788073|20810631|P2|COMPLETED|STX209 Then Placebo||30
8444748|NCT00788073|20810632|P1|COMPLETED|STX209 Then Placebo||29
8444749|NCT00788073|20810631|P2|STARTED|STX209 Then Placebo||33
8444750|NCT00788073|20810632|P1|STARTED|STX209 Then Placebo||30
8444751|NCT00788008|20810642|P2|NOT COMPLETED|Overall Study||0
8444752|NCT00788008|20810643|P1|NOT COMPLETED|Overall Study||0
8444753|NCT00788008|20810642|P2|COMPLETED|Overall Study||101
8444754|NCT00788008|20810643|P1|COMPLETED|Overall Study||98
8444755|NCT00788008|20810642|P2|STARTED|Overall Study||101
8444756|NCT00788008|20810643|P1|STARTED|Overall Study||98
8444757|NCT00787943|20810649|P1|NOT COMPLETED|Overall Study||0
8444758|NCT00787943|20810649|P1|COMPLETED|Overall Study||10
8444759|NCT00787943|20810649|P1|STARTED|Overall Study||10
8444760|NCT00787930|20810657|P1|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
8444761|NCT00787930|20810657|P1|COMPLETED|Continuation Treatment -- up to 12 Month||16
8444762|NCT00787930|20810657|P1|STARTED|Continuation Treatment -- up to 12 Month||19
8444763|NCT00787930|20810657|P1|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
8444764|NCT00787930|20810657|P1|COMPLETED|Acute Treatment -- 3 Weeks||19
8444765|NCT00787930|20810657|P1|STARTED|Acute Treatment -- 3 Weeks||19
8444766|NCT00787917|20810672|P2|NOT COMPLETED|Open Label||0
8444767|NCT00787917|20810673|P1|NOT COMPLETED|Open Label||4
8444768|NCT00787917|20810672|P2|COMPLETED|Open Label||0
8444769|NCT00787917|20810673|P1|COMPLETED|Open Label||3
8444770|NCT00787917|20810672|P2|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
8444771|NCT00787917|20810673|P1|STARTED|Open Label||7
8444772|NCT00787917|20810672|P2|NOT COMPLETED|Blinded Treatment||2
8444773|NCT00787917|20810673|P1|NOT COMPLETED|Blinded Treatment||5
8444774|NCT00787917|20810672|P2|COMPLETED|Blinded Treatment||3
8444775|NCT00787917|20810673|P1|COMPLETED|Blinded Treatment||4
8444776|NCT00787917|20810672|P2|STARTED|Blinded Treatment||5
8444777|NCT00787917|20810673|P1|STARTED|Blinded Treatment||9
8444778|NCT00787904|20810692|P2|NOT COMPLETED|Overall Study||0
8444779|NCT00787904|20810693|P1|NOT COMPLETED|Overall Study||0
8444780|NCT00787904|20810692|P2|COMPLETED|Overall Study||13
8444781|NCT00787904|20810693|P1|COMPLETED|Overall Study||6
8444782|NCT00787904|20810692|P2|STARTED|Overall Study||13
8444783|NCT00787904|20810693|P1|STARTED|Overall Study||6
8444784|NCT00787891|20810703|P2|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
8444785|NCT00787891|20810704|P1|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
8444786|NCT00787891|20810703|P2|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
8444787|NCT00787891|20810704|P1|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
8444788|NCT00787891|20810703|P2|STARTED|Maintenance Double-blind Phase (Part 2)||31
8444789|NCT00787891|20810704|P1|STARTED|Maintenance Double-blind Phase (Part 2)||33
8444790|NCT00787891|20810703|P2|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
8444791|NCT00787891|20810704|P1|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
8444792|NCT00787891|20810703|P2|COMPLETED|Short-term Double-blind Phase (Part 1)||53
8444793|NCT00787891|20810704|P1|COMPLETED|Short-term Double-blind Phase (Part 1)||55
8444794|NCT00787891|20810703|P2|STARTED|Short-term Double-blind Phase (Part 1)||62
8444795|NCT00787891|20810704|P1|STARTED|Short-term Double-blind Phase (Part 1)||65
8444796|NCT00787852|20810724|P2|NOT COMPLETED|Overall Study||0
8444797|NCT00787852|20810725|P1|NOT COMPLETED|Overall Study||1
8444798|NCT00787852|20810724|P2|COMPLETED|Overall Study||5
8444799|NCT00787852|20810725|P1|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
8444800|NCT00787852|20810724|P2|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
8444801|NCT00787852|20810725|P1|STARTED|Overall Study||6
8444802|NCT00787839|20810731|P1|NOT COMPLETED|Overall Study||404
8444803|NCT00787839|20810731|P1|COMPLETED|Overall Study||1535
8444804|NCT00787839|20810731|P1|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
8444805|NCT00787839|20810731|P1|Completed GCT Screening|Overall Study||1876
8444806|NCT00787839|20810731|P1|Consented|Overall Study|consented|1939
8444807|NCT00787839|20810731|P1|STARTED|Overall Study||1939
8444808|NCT00787800|20810754|P2|NOT COMPLETED|Overall Study||7
8444809|NCT00787800|20810755|P1|NOT COMPLETED|Overall Study||3
8444810|NCT00787800|20810754|P2|COMPLETED|Overall Study||43
8444811|NCT00787800|20810755|P1|COMPLETED|Overall Study||47
8444812|NCT00787800|20810754|P2|STARTED|Overall Study||50
8444813|NCT00787800|20810755|P1|STARTED|Overall Study||50
8444814|NCT00787787|20810771|P1|NOT COMPLETED|Overall Study||7
8444815|NCT00787787|20810771|P1|COMPLETED|Overall Study||0
8444816|NCT00787787|20810771|P1|STARTED|Overall Study||7
8444817|NCT00787761|20810777|P1|NOT COMPLETED|Overall Study||0
8444818|NCT00787761|20810777|P1|COMPLETED|Overall Study||24
8444819|NCT00787761|20810777|P1|STARTED|Overall Study||24
8444820|NCT00787722|20810788|P1|NOT COMPLETED|Overall Study||1
8444821|NCT00787722|20810788|P1|COMPLETED|Overall Study||12
8444822|NCT00787722|20810788|P1|STARTED|Overall Study||13
8444823|NCT00787644|20810799|P2|NOT COMPLETED|Overall Study||2
8444824|NCT00787644|20810800|P1|NOT COMPLETED|Overall Study||2
8444825|NCT00787644|20810799|P2|COMPLETED|Overall Study||9
8444826|NCT00787644|20810800|P1|COMPLETED|Overall Study||10
8444827|NCT00787644|20810799|P2|STARTED|Overall Study||11
8444828|NCT00787644|20810800|P1|STARTED|Overall Study||12
8444829|NCT00787618|20810809|P3|NOT COMPLETED|Overall Study||0
8444830|NCT00787618|20810810|P2|NOT COMPLETED|Overall Study||0
8444831|NCT00787618|20810811|P1|NOT COMPLETED|Overall Study||0
8444832|NCT00787618|20810809|P3|COMPLETED|Overall Study||3
8444833|NCT00787618|20810810|P2|COMPLETED|Overall Study||0
8444834|NCT00787618|20810811|P1|COMPLETED|Overall Study||3
8444835|NCT00787618|20810809|P3|STARTED|Overall Study||3
8444836|NCT00787618|20810810|P2|STARTED|Overall Study||0
8444837|NCT00787618|20810811|P1|STARTED|Overall Study||3
8444838|NCT00787605|20810821|P2|NOT COMPLETED|Overall Study||56
8444839|NCT00787605|20810822|P1|NOT COMPLETED|Overall Study||46
8444840|NCT00787605|20810821|P2|COMPLETED|Overall Study||376
8444841|NCT00787605|20810822|P1|COMPLETED|Overall Study||382
8444842|NCT00787605|20810821|P2|STARTED|Overall Study||432
8444843|NCT00787605|20810822|P1|STARTED|Overall Study||428
8444844|NCT00787566|20810841|P3|NOT COMPLETED|Overall Study||0
8444845|NCT00787566|20810842|P2|NOT COMPLETED|Overall Study||1
8444846|NCT00787566|20810843|P1|NOT COMPLETED|Overall Study||0
8444847|NCT00787566|20810841|P3|COMPLETED|Overall Study||22
8444848|NCT00787566|20810842|P2|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
8444849|NCT00787566|20810843|P1|COMPLETED|Overall Study||21
8444850|NCT00787566|20810841|P3|STARTED|Overall Study||22
8444851|NCT00787566|20810842|P2|STARTED|Overall Study||25
8444852|NCT00787566|20810843|P1|STARTED|Overall Study||21
8444853|NCT00787527|20810851|P1|NOT COMPLETED|Overall Study||3
8444854|NCT00787527|20810851|P1|COMPLETED|Overall Study||11
8444855|NCT00787527|20810851|P1|STARTED|Overall Study||14
8444856|NCT00787332|20810861|P2|NOT COMPLETED|Overall Study||0
8444857|NCT00787332|20810862|P1|NOT COMPLETED|Overall Study||0
8444858|NCT00787332|20810861|P2|COMPLETED|Overall Study||8
8444859|NCT00787332|20810862|P1|COMPLETED|Overall Study||8
8444860|NCT00787332|20810861|P2|STARTED|Overall Study||8
8444861|NCT00787332|20810862|P1|STARTED|Overall Study||8
8444862|NCT00787319|20810868|P1|NOT COMPLETED|Overall Study||63
8444863|NCT00787319|20810868|P1|COMPLETED|Overall Study||45
8444864|NCT00787319|20810868|P1|STARTED|Overall Study||108
8444865|NCT00787267|20810880|P1|NOT COMPLETED|Overall Study||12
8444866|NCT00787267|20810880|P1|COMPLETED|Overall Study|Received at least one dose of study drug|25
8444867|NCT00787267|20810880|P1|STARTED|Overall Study|Signed a consent form|37
8444868|NCT00787254|20810890|P2|NOT COMPLETED|Overall Study||82
8444869|NCT00787254|20810891|P1|NOT COMPLETED|Overall Study||76
8444870|NCT00787254|20810890|P2|COMPLETED|Overall Study||99
8444871|NCT00787254|20810891|P1|COMPLETED|Overall Study||109
8444872|NCT00787254|20810890|P2|STARTED|Overall Study||181
8444873|NCT00787254|20810891|P1|STARTED|Overall Study||185
8444874|NCT00787241|20810994|P3|NOT COMPLETED|Overall Study||0
8444875|NCT00787241|20810995|P2|NOT COMPLETED|Overall Study||0
8444876|NCT00787241|20810996|P1|NOT COMPLETED|Overall Study||0
8444877|NCT00787241|20810994|P3|COMPLETED|Overall Study||41
8444878|NCT00787241|20810995|P2|COMPLETED|Overall Study||143
8444879|NCT00787241|20810996|P1|COMPLETED|Overall Study||261
8444880|NCT00787241|20810994|P3|STARTED|Overall Study||41
8444881|NCT00787241|20810995|P2|STARTED|Overall Study||143
8444882|NCT00787241|20810996|P1|STARTED|Overall Study||261
8444883|NCT00787202|20811015|P5|NOT COMPLETED|Overall Study||4
8444884|NCT00787202|20811016|P4|NOT COMPLETED|Overall Study||2
8444885|NCT00787202|20811017|P3|NOT COMPLETED|Overall Study||7
8444886|NCT00787202|20811018|P2|NOT COMPLETED|Overall Study||11
8444887|NCT00787202|20811019|P1|NOT COMPLETED|Overall Study||14
8444888|NCT00787202|20811015|P5|COMPLETED|Overall Study||45
8444889|NCT00787202|20811016|P4|COMPLETED|Overall Study||31
8444890|NCT00787202|20811017|P3|COMPLETED|Overall Study||26
8444891|NCT00787202|20811018|P2|COMPLETED|Overall Study||20
8444892|NCT00787202|20811019|P1|COMPLETED|Overall Study||35
8444893|NCT00787202|20811015|P5|Treated|Overall Study||49
8444894|NCT00787202|20811016|P4|Treated|Overall Study||33
8444895|NCT00787202|20811017|P3|Treated|Overall Study||33
8444896|NCT00787202|20811018|P2|Treated|Overall Study||31
8444897|NCT00787202|20811019|P1|Treated|Overall Study||48
8444898|NCT00787202|20811015|P5|STARTED|Overall Study||49
8444899|NCT00787202|20811016|P4|STARTED|Overall Study||33
8444900|NCT00787202|20811017|P3|STARTED|Overall Study||33
8444901|NCT00787202|20811018|P2|STARTED|Overall Study||31
8444902|NCT00787202|20811019|P1|STARTED|Overall Study||49
8444909|NCT00787150|20811082|P3|NOT COMPLETED|Overall Study||5
8444910|NCT00787150|20811083|P2|NOT COMPLETED|Overall Study||7
8444911|NCT00787150|20811084|P1|NOT COMPLETED|Overall Study||9
8444912|NCT00787150|20811082|P3|COMPLETED|Overall Study||66
8444913|NCT00787150|20811083|P2|COMPLETED|Overall Study||65
8444914|NCT00787150|20811084|P1|COMPLETED|Overall Study||66
8444915|NCT00787150|20811082|P3|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
8444916|NCT00787150|20811083|P2|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
8444917|NCT00787150|20811084|P1|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
8444918|NCT00787137|20811129|P3|NOT COMPLETED|Overall Study||1
8444919|NCT00787137|20811130|P2|NOT COMPLETED|Overall Study||0
8444920|NCT00787137|20811131|P1|NOT COMPLETED|Overall Study||0
8444921|NCT00787137|20811129|P3|COMPLETED|Overall Study||4
8444922|NCT00787137|20811130|P2|COMPLETED|Overall Study||6
8444923|NCT00787137|20811131|P1|COMPLETED|Overall Study||6
8444924|NCT00787137|20811129|P3|STARTED|Overall Study||5
8444925|NCT00787137|20811130|P2|STARTED|Overall Study||6
8444926|NCT00787137|20811131|P1|STARTED|Overall Study||6
8444927|NCT00787124|20811153|P2|NOT COMPLETED|Overall Study||0
8444928|NCT00787124|20811154|P1|NOT COMPLETED|Overall Study||0
8444929|NCT00787124|20811153|P2|COMPLETED|Overall Study||4
8444930|NCT00787124|20811154|P1|COMPLETED|Overall Study||4
8444931|NCT00787124|20811153|P2|STARTED|Overall Study||4
8444932|NCT00787124|20811154|P1|STARTED|Overall Study||4
8444933|NCT00787020|20811164|P2|NOT COMPLETED|Overall Study||0
8444934|NCT00787020|20811165|P1|NOT COMPLETED|Overall Study||0
8444935|NCT00787020|20811164|P2|COMPLETED|Overall Study||13
8444936|NCT00787020|20811165|P1|COMPLETED|Overall Study||24
8444937|NCT00787020|20811164|P2|STARTED|Overall Study||13
8444938|NCT00787020|20811165|P1|STARTED|Overall Study||24
8444939|NCT00786994|20811179|P4|NOT COMPLETED|Overall Study||6
8444940|NCT00786994|20811180|P3|NOT COMPLETED|Overall Study||2
8444941|NCT00786994|20811181|P2|NOT COMPLETED|Overall Study||15
8444942|NCT00786994|20811182|P1|NOT COMPLETED|Overall Study||10
8444943|NCT00786994|20811179|P4|COMPLETED|Overall Study||22
8444944|NCT00786994|20811180|P3|COMPLETED|Overall Study||24
8444945|NCT00786994|20811181|P2|COMPLETED|Overall Study||39
8444946|NCT00786994|20811182|P1|COMPLETED|Overall Study||47
8444947|NCT00786994|20811179|P4|ITT|Overall Study||28
8444948|NCT00786994|20811180|P3|ITT|Overall Study||25
8444949|NCT00786994|20811181|P2|ITT|Overall Study||51
8444950|NCT00786994|20811182|P1|ITT|Overall Study||53
8444951|NCT00786994|20811179|P4|STARTED|Overall Study||28
8444952|NCT00786994|20811180|P3|STARTED|Overall Study||26
8444953|NCT00786994|20811181|P2|STARTED|Overall Study||54
8444954|NCT00786994|20811182|P1|STARTED|Overall Study||57
8444955|NCT00786916|20811194|P3|NOT COMPLETED|Overall Study||0
8444956|NCT00786916|20811195|P2|NOT COMPLETED|Overall Study||0
8444957|NCT00786916|20811196|P1|NOT COMPLETED|Overall Study||0
8444958|NCT00786916|20811194|P3|COMPLETED|Overall Study||34
8444959|NCT00786916|20811195|P2|COMPLETED|Overall Study||36
8444960|NCT00786916|20811196|P1|COMPLETED|Overall Study||39
8444961|NCT00786916|20811194|P3|STARTED|Overall Study||34
8444962|NCT00786916|20811195|P2|STARTED|Overall Study||36
8444963|NCT00786916|20811196|P1|STARTED|Overall Study||39
8444964|NCT00786864|20811206|P2|NOT COMPLETED|Overall Study||1
8444965|NCT00786864|20811207|P1|NOT COMPLETED|Overall Study||1
8444966|NCT00786864|20811206|P2|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
8444967|NCT00786864|20811207|P1|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
8444968|NCT00786864|20811206|P2|STARTED|Overall Study||33
8444969|NCT00786864|20811207|P1|STARTED|Overall Study||39
8444970|NCT00786838|20811219|P1|NOT COMPLETED|Overall Study||49
8444971|NCT00786838|20811219|P1|COMPLETED|Overall Study||26
8444972|NCT00786838|20811219|P1|STARTED|Overall Study||75
8444973|NCT00786825|20811246|P2|NOT COMPLETED|Overall Study||0
8444974|NCT00786825|20811247|P1|NOT COMPLETED|Overall Study||0
8444975|NCT00786825|20811246|P2|COMPLETED|Overall Study||5
8444976|NCT00786825|20811247|P1|COMPLETED|Overall Study||5
8444977|NCT00786825|20811246|P2|STARTED|Overall Study||5
8444978|NCT00786825|20811247|P1|STARTED|Overall Study||5
8444979|NCT00786799|20811255|P2|NOT COMPLETED|Overall Study||1
8444980|NCT00786799|20811256|P1|NOT COMPLETED|Overall Study||1
8444981|NCT00786799|20811255|P2|COMPLETED|Overall Study||12
8444982|NCT00786799|20811256|P1|COMPLETED|Overall Study||13
8444983|NCT00786799|20811255|P2|STARTED|Overall Study||13
8444984|NCT00786799|20811256|P1|STARTED|Overall Study||14
8444985|NCT00786682|20811267|P1|NOT COMPLETED|Overall Study||0
8444986|NCT00786682|20811267|P1|COMPLETED|Overall Study||11
8444987|NCT00786682|20811267|P1|STARTED|Overall Study||11
8444988|NCT00786643|20811275|P2|NOT COMPLETED|Overall Study||0
8444989|NCT00786643|20811276|P1|NOT COMPLETED|Overall Study||0
8444990|NCT00786643|20811275|P2|COMPLETED|Overall Study||28
8444991|NCT00786643|20811276|P1|COMPLETED|Overall Study||20
8444992|NCT00786643|20811275|P2|STARTED|Overall Study||28
8444993|NCT00786643|20811276|P1|STARTED|Overall Study||20
8444994|NCT00786565|20811286|P1|NOT COMPLETED|Post Surgery||2
8444995|NCT00786565|20811286|P1|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
8444996|NCT00786565|20811286|P1|STARTED|Post Surgery||69
8444997|NCT00786565|20811286|P1|NOT COMPLETED|Enrollment Prior to Surgery||6
8444998|NCT00786565|20811286|P1|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
8444999|NCT00786565|20811286|P1|STARTED|Enrollment Prior to Surgery||75
8445000|NCT00786487|20811328|P4|NOT COMPLETED|Overall Study||0
8445001|NCT00786487|20811329|P3|NOT COMPLETED|Overall Study||0
8445002|NCT00786487|20811330|P2|NOT COMPLETED|Overall Study||0
8445003|NCT00786487|20811331|P1|NOT COMPLETED|Overall Study||0
8445004|NCT00786487|20811328|P4|COMPLETED|Overall Study||7
8445005|NCT00786487|20811329|P3|COMPLETED|Overall Study||9
8445006|NCT00786487|20811330|P2|COMPLETED|Overall Study||7
8445007|NCT00786487|20811331|P1|COMPLETED|Overall Study||10
8445008|NCT00786487|20811328|P4|STARTED|Overall Study||7
8445009|NCT00786487|20811329|P3|STARTED|Overall Study||9
8445010|NCT00786487|20811330|P2|STARTED|Overall Study||7
8445011|NCT00786487|20811331|P1|STARTED|Overall Study||10
8445012|NCT00786474|20811343|P2|NOT COMPLETED|Overall Study||43
8445013|NCT00786474|20811344|P1|NOT COMPLETED|Overall Study||37
8445014|NCT00786474|20811343|P2|COMPLETED|Overall Study||891
8445015|NCT00786474|20811344|P1|COMPLETED|Overall Study||913
8445016|NCT00786474|20811343|P2|STARTED|Overall Study||934
8445017|NCT00786474|20811344|P1|STARTED|Overall Study||950
8445018|NCT00786422|20811356|P1|NOT COMPLETED|Follow-up Period||3
8445019|NCT00786422|20811356|P1|COMPLETED|Follow-up Period||17
8445100|NCT00785785|20811608|P2|NOT COMPLETED|Optional Extension Phase||125
8445020|NCT00786422|20811356|P1|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
8445021|NCT00786422|20811356|P1|NOT COMPLETED|Rivaroxaban Treatment||11
8445022|NCT00786422|20811356|P1|COMPLETED|Rivaroxaban Treatment||14
8445023|NCT00786422|20811356|P1|STARTED|Rivaroxaban Treatment||25
8445024|NCT00786409|20811372|P1|NOT COMPLETED|Overall Study||7
8445025|NCT00786409|20811372|P1|COMPLETED|Overall Study||20
8445026|NCT00786409|20811372|P1|STARTED|Overall Study||27
8445027|NCT00786188|20811389|P2|NOT COMPLETED|Overall Study||1
8445028|NCT00786188|20811390|P1|NOT COMPLETED|Overall Study||5
8445029|NCT00786188|20811389|P2|COMPLETED|Overall Study||51
8445030|NCT00786188|20811390|P1|COMPLETED|Overall Study||45
8445031|NCT00786188|20811389|P2|STARTED|Overall Study||52
8445032|NCT00786188|20811390|P1|STARTED|Overall Study||50
8445033|NCT00786032|20811416|P1|NOT COMPLETED|Overall Study||24
8445034|NCT00786032|20811416|P1|COMPLETED|Overall Study||3
8445035|NCT00786032|20811416|P1|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
8445036|NCT00786032|20811416|P1|STARTED|Overall Study||27
8445037|NCT00786019|20811428|P2|NOT COMPLETED|Overall Study||10
8445038|NCT00786019|20811429|P1|NOT COMPLETED|Overall Study||5
8445039|NCT00786019|20811428|P2|COMPLETED|Overall Study||17
8445040|NCT00786019|20811429|P1|COMPLETED|Overall Study||15
8445041|NCT00786019|20811428|P2|STARTED|Overall Study||27
8445042|NCT00786019|20811429|P1|STARTED|Overall Study||20
8445043|NCT00785980|20811437|P1|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
8445044|NCT00785980|20811437|P1|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
8445045|NCT00785980|20811437|P1|STARTED|Quinine Sulfate With Ciprofloxacin||21
8445046|NCT00785980|20811437|P1|NOT COMPLETED|Ciprofloxacin Alone||0
8445047|NCT00785980|20811437|P1|COMPLETED|Ciprofloxacin Alone||21
8445048|NCT00785980|20811437|P1|STARTED|Ciprofloxacin Alone||21
8445049|NCT00785980|20811437|P1|NOT COMPLETED|7 Day Washout Period||3
8445050|NCT00785980|20811437|P1|COMPLETED|7 Day Washout Period||21
8445051|NCT00785980|20811437|P1|STARTED|7 Day Washout Period||24
8445052|NCT00785980|20811437|P1|NOT COMPLETED|Quinine Sulfate Alone||0
8445053|NCT00785980|20811437|P1|COMPLETED|Quinine Sulfate Alone||24
8445054|NCT00785980|20811437|P1|STARTED|Quinine Sulfate Alone||24
8445055|NCT00785928|20811455|P7|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
8445056|NCT00785928|20811456|P6|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
8445057|NCT00785928|20811457|P5|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
8445058|NCT00785928|20811458|P4|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
8445059|NCT00785928|20811459|P3|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
8445060|NCT00785928|20811460|P2|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
8445061|NCT00785928|20811461|P1|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
8445062|NCT00785928|20811455|P7|COMPLETED|Follow-up Phases (Weeks 24-72)||9
8445063|NCT00785928|20811456|P6|COMPLETED|Follow-up Phases (Weeks 24-72)||0
8445064|NCT00785928|20811457|P5|COMPLETED|Follow-up Phases (Weeks 24-72)||4
8445065|NCT00785928|20811458|P4|COMPLETED|Follow-up Phases (Weeks 24-72)||4
8445066|NCT00785928|20811459|P3|COMPLETED|Follow-up Phases (Weeks 24-72)||4
8445067|NCT00785928|20811460|P2|COMPLETED|Follow-up Phases (Weeks 24-72)||5
8445068|NCT00785928|20811461|P1|COMPLETED|Follow-up Phases (Weeks 24-72)||7
8445069|NCT00785928|20811455|P7|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
8445070|NCT00785928|20811456|P6|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
8445071|NCT00785928|20811457|P5|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
8445072|NCT00785928|20811458|P4|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
8445073|NCT00785928|20811459|P3|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
8445074|NCT00785928|20811460|P2|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
8445075|NCT00785928|20811461|P1|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
8445076|NCT00785928|20811455|P7|NOT COMPLETED|Treatment Phase||3
8445077|NCT00785928|20811456|P6|NOT COMPLETED|Treatment Phase||0
8445078|NCT00785928|20811457|P5|NOT COMPLETED|Treatment Phase||2
8445079|NCT00785928|20811458|P4|NOT COMPLETED|Treatment Phase||0
8445080|NCT00785928|20811459|P3|NOT COMPLETED|Treatment Phase||3
8445081|NCT00785928|20811460|P2|NOT COMPLETED|Treatment Phase||5
8445082|NCT00785928|20811461|P1|NOT COMPLETED|Treatment Phase||3
8445083|NCT00785928|20811455|P7|COMPLETED|Treatment Phase||23
8445084|NCT00785928|20811456|P6|COMPLETED|Treatment Phase||13
8445085|NCT00785928|20811457|P5|COMPLETED|Treatment Phase||16
8445086|NCT00785928|20811458|P4|COMPLETED|Treatment Phase||15
8445087|NCT00785928|20811459|P3|COMPLETED|Treatment Phase||17
8445088|NCT00785928|20811460|P2|COMPLETED|Treatment Phase||25
8445089|NCT00785928|20811461|P1|COMPLETED|Treatment Phase||33
8445090|NCT00785928|20811455|P7|STARTED|Treatment Phase||26
8445091|NCT00785928|20811456|P6|STARTED|Treatment Phase||13
8445092|NCT00785928|20811457|P5|STARTED|Treatment Phase||18
8445093|NCT00785928|20811458|P4|STARTED|Treatment Phase||15
8445094|NCT00785928|20811459|P3|STARTED|Treatment Phase||20
8445095|NCT00785928|20811460|P2|STARTED|Treatment Phase||30
8445096|NCT00785928|20811461|P1|STARTED|Treatment Phase||36
8445097|NCT00785798|20811601|P1|NOT COMPLETED|Overall Study||1
8445098|NCT00785798|20811601|P1|COMPLETED|Overall Study||16
8445099|NCT00785798|20811601|P1|STARTED|Overall Study||17
8445101|NCT00785785|20811609|P1|NOT COMPLETED|Optional Extension Phase||39
8445102|NCT00785785|20811608|P2|COMPLETED|Optional Extension Phase||0
8445103|NCT00785785|20811609|P1|COMPLETED|Optional Extension Phase||0
8445104|NCT00785785|20811608|P2|STARTED|Optional Extension Phase|crossover extension phase was optional|125
8445105|NCT00785785|20811609|P1|STARTED|Optional Extension Phase|crossover extension phase was optional|39
8445106|NCT00785785|20811608|P2|NOT COMPLETED|Core Phase up to 36 Months||320
8445107|NCT00785785|20811609|P1|NOT COMPLETED|Core Phase up to 36 Months||324
8445108|NCT00785785|20811608|P2|COMPLETED|Core Phase up to 36 Months||0
8445109|NCT00785785|20811609|P1|COMPLETED|Core Phase up to 36 Months||0
8445110|NCT00785785|20811608|P2|STARTED|Core Phase up to 36 Months||320
8445111|NCT00785785|20811609|P1|STARTED|Core Phase up to 36 Months||324
8445115|NCT00785707|20811623|P1|NOT COMPLETED|Overall Study||7
8445116|NCT00785707|20811623|P1|COMPLETED|Overall Study||24
8445117|NCT00785707|20811623|P1|STARTED|Overall Study||31
8445118|NCT00785629|20811632|P4|NOT COMPLETED|Overall Study||16
8445119|NCT00785629|20811633|P3|NOT COMPLETED|Overall Study||10
8445120|NCT00785629|20811634|P2|NOT COMPLETED|Overall Study||5
8445121|NCT00785629|20811635|P1|NOT COMPLETED|Overall Study||8
8445122|NCT00785629|20811632|P4|COMPLETED|Overall Study|16 not completed|41
8445123|NCT00785629|20811633|P3|COMPLETED|Overall Study|10 not completed|18
8445124|NCT00785629|20811634|P2|COMPLETED|Overall Study|5 not completed|25
8445125|NCT00785629|20811635|P1|COMPLETED|Overall Study|8 not completed|22
8445126|NCT00785629|20811632|P4|STARTED|Overall Study||57
8445127|NCT00785629|20811633|P3|STARTED|Overall Study||28
8445128|NCT00785629|20811634|P2|STARTED|Overall Study||30
8445129|NCT00785629|20811635|P1|STARTED|Overall Study||30
8445130|NCT00785577|20811648|P5|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
8445131|NCT00785577|20811649|P4|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
8445132|NCT00785577|20811650|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
8445133|NCT00785577|20811651|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
8445134|NCT00785577|20811652|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
8445135|NCT00785577|20811648|P5|COMPLETED|Study Period 3: 1-Week Washout Phase||26
8445136|NCT00785577|20811649|P4|COMPLETED|Study Period 3: 1-Week Washout Phase||35
8445137|NCT00785577|20811650|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||25
8445138|NCT00785577|20811651|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||36
8445139|NCT00785577|20811652|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||78
8445140|NCT00785577|20811648|P5|STARTED|Study Period 3: 1-Week Washout Phase||27
8445141|NCT00785577|20811649|P4|STARTED|Study Period 3: 1-Week Washout Phase||36
8445142|NCT00785577|20811650|P3|STARTED|Study Period 3: 1-Week Washout Phase||25
8445143|NCT00785577|20811651|P2|STARTED|Study Period 3: 1-Week Washout Phase||36
8445144|NCT00785577|20811652|P1|STARTED|Study Period 3: 1-Week Washout Phase||78
8445145|NCT00785577|20811648|P5|NOT COMPLETED|Study Period 2: Therapy Phase||20
8445146|NCT00785577|20811649|P4|NOT COMPLETED|Study Period 2: Therapy Phase||13
8445147|NCT00785577|20811650|P3|NOT COMPLETED|Study Period 2: Therapy Phase||18
8445148|NCT00785577|20811651|P2|NOT COMPLETED|Study Period 2: Therapy Phase||9
8445149|NCT00785577|20811652|P1|NOT COMPLETED|Study Period 2: Therapy Phase||11
8445150|NCT00785577|20811648|P5|COMPLETED|Study Period 2: Therapy Phase||27
8445151|NCT00785577|20811649|P4|COMPLETED|Study Period 2: Therapy Phase||36
8445152|NCT00785577|20811650|P3|COMPLETED|Study Period 2: Therapy Phase||25
8445153|NCT00785577|20811651|P2|COMPLETED|Study Period 2: Therapy Phase||36
8445154|NCT00785577|20811652|P1|COMPLETED|Study Period 2: Therapy Phase||78
8445155|NCT00785577|20811648|P5|STARTED|Study Period 2: Therapy Phase||47
8445156|NCT00785577|20811649|P4|STARTED|Study Period 2: Therapy Phase||49
8445157|NCT00785577|20811650|P3|STARTED|Study Period 2: Therapy Phase||43
8445158|NCT00785577|20811651|P2|STARTED|Study Period 2: Therapy Phase||45
8445159|NCT00785577|20811652|P1|STARTED|Study Period 2: Therapy Phase||89
8445160|NCT00785538|20811792|P4|NOT COMPLETED|Treatment Period||1
8445161|NCT00785538|20811793|P3|NOT COMPLETED|Treatment Period||2
8445162|NCT00785538|20811794|P2|NOT COMPLETED|Treatment Period||2
8445163|NCT00785538|20811795|P1|NOT COMPLETED|Treatment Period||1
8445164|NCT00785538|20811792|P4|COMPLETED|Treatment Period||1
8445165|NCT00785538|20811793|P3|COMPLETED|Treatment Period||4
8445166|NCT00785538|20811794|P2|COMPLETED|Treatment Period||7
8445167|NCT00785538|20811795|P1|COMPLETED|Treatment Period||6
8445168|NCT00785538|20811792|P4|Received at Least 1 Dose of Study Drug|Treatment Period||2
8445169|NCT00785538|20811793|P3|Received at Least 1 Dose of Study Drug|Treatment Period||6
8445170|NCT00785538|20811794|P2|Received at Least 1 Dose of Study Drug|Treatment Period||9
8445171|NCT00785538|20811795|P1|Received at Least 1 Dose of Study Drug|Treatment Period||7
8445172|NCT00785538|20811792|P4|STARTED|Treatment Period||2
8445173|NCT00785538|20811793|P3|STARTED|Treatment Period||6
8445174|NCT00785538|20811794|P2|STARTED|Treatment Period||9
8445175|NCT00785538|20811795|P1|STARTED|Treatment Period||7
8445176|NCT00785538|20811792|P4|NOT COMPLETED|PK Period||0
8445177|NCT00785538|20811793|P3|NOT COMPLETED|PK Period||0
8445178|NCT00785538|20811794|P2|NOT COMPLETED|PK Period||0
8445179|NCT00785538|20811795|P1|NOT COMPLETED|PK Period||0
8445180|NCT00785538|20811792|P4|COMPLETED|PK Period||0
8445181|NCT00785538|20811793|P3|COMPLETED|PK Period||1
8445182|NCT00785538|20811794|P2|COMPLETED|PK Period||1
8445183|NCT00785538|20811795|P1|COMPLETED|PK Period||7
8445184|NCT00785538|20811792|P4|STARTED|PK Period||0
8445185|NCT00785538|20811793|P3|STARTED|PK Period||1
8445186|NCT00785538|20811794|P2|STARTED|PK Period||1
8445187|NCT00785538|20811795|P1|STARTED|PK Period||7
8445188|NCT00785512|20811843|P2|NOT COMPLETED|Overall Study||4
8445189|NCT00785512|20811844|P1|NOT COMPLETED|Overall Study||3
8445190|NCT00785512|20811843|P2|COMPLETED|Overall Study||101
8445191|NCT00785512|20811844|P1|COMPLETED|Overall Study||99
8445192|NCT00785512|20811843|P2|STARTED|Overall Study||105
8445193|NCT00785512|20811844|P1|STARTED|Overall Study||102
8445194|NCT00785486|20811853|P1|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
8445195|NCT00785486|20811853|P1|COMPLETED|Midazolam With Qualaquin at Steady State||23
8445196|NCT00785486|20811853|P1|STARTED|Midazolam With Qualaquin at Steady State||23
8445197|NCT00785486|20811853|P1|NOT COMPLETED|Qualaquin Alone at Steady State||0
8445198|NCT00785486|20811853|P1|COMPLETED|Qualaquin Alone at Steady State||23
8445199|NCT00785486|20811853|P1|STARTED|Qualaquin Alone at Steady State||23
8445200|NCT00785486|20811853|P1|NOT COMPLETED|3 Day Washout||0
8445201|NCT00785486|20811853|P1|COMPLETED|3 Day Washout||23
8445202|NCT00785486|20811853|P1|STARTED|3 Day Washout||23
8445203|NCT00785486|20811853|P1|NOT COMPLETED|Midazolam Alone||1
8445204|NCT00785486|20811853|P1|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
8445205|NCT00785486|20811853|P1|STARTED|Midazolam Alone||24
8445206|NCT00785356|20811877|P1|NOT COMPLETED|Overall Study||8
8445207|NCT00785356|20811877|P1|COMPLETED|Overall Study||0
8445208|NCT00785356|20811877|P1|STARTED|Overall Study||8
8445218|NCT00785213|20811910|P1|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
8445219|NCT00785213|20811910|P1|COMPLETED|Rosiglitazone With Quinine Sulfate||18
8445220|NCT00785213|20811910|P1|STARTED|Rosiglitazone With Quinine Sulfate||19
8445221|NCT00785213|20811910|P1|NOT COMPLETED|Quinine Sulfate Alone||4
8445222|NCT00785213|20811910|P1|COMPLETED|Quinine Sulfate Alone||19
8445223|NCT00785213|20811910|P1|STARTED|Quinine Sulfate Alone||23
8445224|NCT00785213|20811910|P1|NOT COMPLETED|2 Day Washout Period||0
8445225|NCT00785213|20811910|P1|COMPLETED|2 Day Washout Period||23
8445226|NCT00785213|20811910|P1|STARTED|2 Day Washout Period||23
8445227|NCT00785213|20811910|P1|NOT COMPLETED|Rosiglitazone Alone||0
8445228|NCT00785213|20811910|P1|COMPLETED|Rosiglitazone Alone||23
8445229|NCT00785213|20811910|P1|STARTED|Rosiglitazone Alone||23
8445230|NCT00785044|20811921|P1|NOT COMPLETED|Overall Study||496
8445231|NCT00785044|20811921|P1|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
8445232|NCT00785044|20811921|P1|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
8445233|NCT00785044|20811921|P1|STARTED|Overall Study|Eligible to participate in MBG313|964
8445234|NCT00784979|20811926|P1|NOT COMPLETED|Overall Study||6
8445235|NCT00784979|20811926|P1|COMPLETED|Overall Study||20
8445236|NCT00784979|20811926|P1|STARTED|Overall Study||26
8445237|NCT00784927|20811930|P1|NOT COMPLETED|Overall Study||3
8445238|NCT00784927|20811930|P1|COMPLETED|Overall Study||33
8445239|NCT00784927|20811930|P1|STARTED|Overall Study||36
8445240|NCT00784875|20811942|P4|NOT COMPLETED|Period D||1
8445241|NCT00784875|20811943|P3|NOT COMPLETED|Period D||6
8445242|NCT00784875|20811944|P2|NOT COMPLETED|Period D||4
8445243|NCT00784875|20811945|P1|NOT COMPLETED|Period D||5
8445244|NCT00784875|20811942|P4|COMPLETED|Period D||87
8445245|NCT00784875|20811943|P3|COMPLETED|Period D||88
8445246|NCT00784875|20811944|P2|COMPLETED|Period D||85
8445247|NCT00784875|20811945|P1|COMPLETED|Period D||86
8445248|NCT00784875|20811942|P4|STARTED|Period D||88
8445249|NCT00784875|20811943|P3|STARTED|Period D||94
8445250|NCT00784875|20811944|P2|STARTED|Period D||89
8445251|NCT00784875|20811945|P1|STARTED|Period D||91
8445252|NCT00784875|20811942|P4|NOT COMPLETED|Period C||7
8445253|NCT00784875|20811943|P3|NOT COMPLETED|Period C||13
8445254|NCT00784875|20811944|P2|NOT COMPLETED|Period C||6
8445255|NCT00784875|20811945|P1|NOT COMPLETED|Period C||7
8445256|NCT00784875|20811942|P4|COMPLETED|Period C||91
8445257|NCT00784875|20811943|P3|COMPLETED|Period C||84
8445258|NCT00784875|20811944|P2|COMPLETED|Period C||91
8445259|NCT00784875|20811945|P1|COMPLETED|Period C||96
8445260|NCT00784875|20811942|P4|STARTED|Period C||98
8445261|NCT00784875|20811943|P3|STARTED|Period C||97
8445262|NCT00784875|20811944|P2|STARTED|Period C||97
8445263|NCT00784875|20811945|P1|STARTED|Period C||103
8445264|NCT00784875|20811942|P4|NOT COMPLETED|Period B - Efficacy Endpoint||19
8445265|NCT00784875|20811943|P3|NOT COMPLETED|Period B - Efficacy Endpoint||21
8445266|NCT00784875|20811944|P2|NOT COMPLETED|Period B - Efficacy Endpoint||12
8445267|NCT00784875|20811945|P1|NOT COMPLETED|Period B - Efficacy Endpoint||14
8445268|NCT00784875|20811942|P4|COMPLETED|Period B - Efficacy Endpoint||98
8445269|NCT00784875|20811943|P3|COMPLETED|Period B - Efficacy Endpoint||96
8445270|NCT00784875|20811944|P2|COMPLETED|Period B - Efficacy Endpoint||101
8445271|NCT00784875|20811945|P1|COMPLETED|Period B - Efficacy Endpoint||100
8445272|NCT00784875|20811942|P4|Cohort 2|Period B - Efficacy Endpoint||101
8445273|NCT00784875|20811943|P3|Cohort 2|Period B - Efficacy Endpoint||102
8445274|NCT00784875|20811944|P2|Cohort 2|Period B - Efficacy Endpoint||102
8445275|NCT00784875|20811945|P1|Cohort 2|Period B - Efficacy Endpoint||102
8445276|NCT00784875|20811942|P4|STARTED|Period B - Efficacy Endpoint||117
8445277|NCT00784875|20811943|P3|STARTED|Period B - Efficacy Endpoint||117
8445278|NCT00784875|20811944|P2|STARTED|Period B - Efficacy Endpoint||113
8445279|NCT00784875|20811945|P1|STARTED|Period B - Efficacy Endpoint||114
8445280|NCT00784875|20811942|P4|NOT COMPLETED|Period A - Baseline||182
8445281|NCT00784875|20811943|P3|NOT COMPLETED|Period A - Baseline||0
8445282|NCT00784875|20811944|P2|NOT COMPLETED|Period A - Baseline||0
8445283|NCT00784875|20811945|P1|NOT COMPLETED|Period A - Baseline||0
8445284|NCT00784875|20811942|P4|COMPLETED|Period A - Baseline||461
8445285|NCT00784875|20811943|P3|COMPLETED|Period A - Baseline||0
8445286|NCT00784875|20811944|P2|COMPLETED|Period A - Baseline||0
8445287|NCT00784875|20811945|P1|COMPLETED|Period A - Baseline||0
8445288|NCT00784875|20811942|P4|STARTED|Period A - Baseline||643
8445289|NCT00784875|20811943|P3|STARTED|Period A - Baseline||0
8445290|NCT00784875|20811944|P2|STARTED|Period A - Baseline||0
8445291|NCT00784875|20811945|P1|STARTED|Period A - Baseline||0
8445292|NCT00784849|20812059|P1|NOT COMPLETED|Overall Study||0
8445293|NCT00784849|20812059|P1|COMPLETED|Overall Study||62
8445294|NCT00784849|20812059|P1|STARTED|Overall Study||62
8445295|NCT00784836|20812065|P1|NOT COMPLETED|Overall Study||3
8445296|NCT00784836|20812065|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
8445297|NCT00784836|20812065|P1|STARTED|Overall Study||3
8445298|NCT00784810|20812072|P2|NOT COMPLETED|Overall Study||49
8445299|NCT00784810|20812073|P1|NOT COMPLETED|Overall Study||63
8445300|NCT00784810|20812072|P2|COMPLETED|Overall Study||74
8445301|NCT00784810|20812073|P1|COMPLETED|Overall Study||61
8445302|NCT00784810|20812072|P2|STARTED|Overall Study||123
8445303|NCT00784810|20812073|P1|STARTED|Overall Study||124
8445304|NCT00784784|20812083|P2|NOT COMPLETED|Overall Study||2
8445305|NCT00784784|20812084|P1|NOT COMPLETED|Overall Study||2
8445306|NCT00784784|20812083|P2|COMPLETED|Overall Study||40
8445307|NCT00784784|20812084|P1|COMPLETED|Overall Study||20
8445308|NCT00784784|20812083|P2|STARTED|Overall Study||42
8445309|NCT00784784|20812084|P1|STARTED|Overall Study||22
8445310|NCT00784758|20812094|P2|NOT COMPLETED|Overall Study||0
8445311|NCT00784758|20812095|P1|NOT COMPLETED|Overall Study||4
8445312|NCT00784758|20812094|P2|COMPLETED|Overall Study||39
8445313|NCT00784758|20812095|P1|COMPLETED|Overall Study||38
8445314|NCT00784758|20812094|P2|Completed Treatment|Overall Study||39
8445315|NCT00784758|20812095|P1|Completed Treatment|Overall Study||40
8445316|NCT00784758|20812094|P2|Began Treatment|Overall Study||39
8445317|NCT00784758|20812095|P1|Began Treatment|Overall Study||41
8445318|NCT00784758|20812094|P2|STARTED|Overall Study||39
8445319|NCT00784758|20812095|P1|STARTED|Overall Study||42
8445320|NCT00784719|20812144|P7|NOT COMPLETED|Overall Study||5
8445321|NCT00784719|20812145|P6|NOT COMPLETED|Overall Study||3
8445322|NCT00784719|20812146|P5|NOT COMPLETED|Overall Study||6
8445323|NCT00784719|20812147|P4|NOT COMPLETED|Overall Study||0
8445324|NCT00784719|20812148|P3|NOT COMPLETED|Overall Study||1
8445325|NCT00784719|20812149|P2|NOT COMPLETED|Overall Study||3
8445326|NCT00784719|20812150|P1|NOT COMPLETED|Overall Study||3
8445327|NCT00784719|20812144|P7|COMPLETED|Overall Study||42
8445328|NCT00784719|20812145|P6|COMPLETED|Overall Study||41
8445329|NCT00784719|20812146|P5|COMPLETED|Overall Study||42
8445330|NCT00784719|20812147|P4|COMPLETED|Overall Study||48
8445331|NCT00784719|20812148|P3|COMPLETED|Overall Study||46
8445332|NCT00784719|20812149|P2|COMPLETED|Overall Study||43
8445333|NCT00784719|20812150|P1|COMPLETED|Overall Study||44
8445334|NCT00784719|20812144|P7|STARTED|Overall Study||47
8445335|NCT00784719|20812145|P6|STARTED|Overall Study||44
8445336|NCT00784719|20812146|P5|STARTED|Overall Study||48
8445337|NCT00784719|20812147|P4|STARTED|Overall Study||48
8445338|NCT00784719|20812148|P3|STARTED|Overall Study||47
8445339|NCT00784719|20812149|P2|STARTED|Overall Study||46
8445340|NCT00784719|20812150|P1|STARTED|Overall Study||47
8445359|NCT00784641|20812357|P3|NOT COMPLETED|Overall Study||2
8445360|NCT00784641|20812358|P2|NOT COMPLETED|Overall Study||3
8445361|NCT00784641|20812359|P1|NOT COMPLETED|Overall Study||6
8445362|NCT00784641|20812357|P3|COMPLETED|Overall Study||187
8445363|NCT00784641|20812358|P2|COMPLETED|Overall Study||186
8445364|NCT00784641|20812359|P1|COMPLETED|Overall Study||183
8445365|NCT00784641|20812357|P3|STARTED|Overall Study||189
8445366|NCT00784641|20812358|P2|STARTED|Overall Study||189
8445367|NCT00784641|20812359|P1|STARTED|Overall Study||189
8445368|NCT00784563|20812370|P3|NOT COMPLETED|Year 3||3
8445369|NCT00784563|20812371|P2|NOT COMPLETED|Year 3||0
8445370|NCT00784563|20812372|P1|NOT COMPLETED|Year 3||0
8445371|NCT00784563|20812370|P3|COMPLETED|Year 3||14
8445372|NCT00784563|20812371|P2|COMPLETED|Year 3||0
8445373|NCT00784563|20812372|P1|COMPLETED|Year 3||0
8445374|NCT00784563|20812370|P3|STARTED|Year 3||17
8445375|NCT00784563|20812371|P2|STARTED|Year 3||0
8445376|NCT00784563|20812372|P1|STARTED|Year 3||0
8445377|NCT00784563|20812370|P3|NOT COMPLETED|Years 1 & 2||0
8445378|NCT00784563|20812371|P2|NOT COMPLETED|Years 1 & 2||5
8445379|NCT00784563|20812372|P1|NOT COMPLETED|Years 1 & 2||3
8445380|NCT00784563|20812370|P3|COMPLETED|Years 1 & 2||0
8445381|NCT00784563|20812371|P2|COMPLETED|Years 1 & 2||17
8445382|NCT00784563|20812372|P1|COMPLETED|Years 1 & 2||18
8445383|NCT00784563|20812370|P3|STARTED|Years 1 & 2||0
8445384|NCT00784563|20812371|P2|STARTED|Years 1 & 2||22
8445385|NCT00784563|20812372|P1|STARTED|Years 1 & 2||21
8445386|NCT00784550|20812390|P2|NOT COMPLETED|Overall Study||42
8445387|NCT00784550|20812391|P1|NOT COMPLETED|Overall Study||36
8445388|NCT00784550|20812390|P2|COMPLETED|Overall Study||127
8445389|NCT00784550|20812391|P1|COMPLETED|Overall Study||137
8445390|NCT00784550|20812390|P2|STARTED|Overall Study||169
8445391|NCT00784550|20812391|P1|STARTED|Overall Study||173
8445392|NCT00784524|20812407|P1|NOT COMPLETED|Overall Study||0
8445393|NCT00784524|20812407|P1|COMPLETED|Overall Study||14
8445394|NCT00784524|20812407|P1|STARTED|Overall Study||14
8445395|NCT00784459|20812417|P2|NOT COMPLETED|Overall Study||2
8445396|NCT00784459|20812418|P1|NOT COMPLETED|Overall Study||0
8445397|NCT00784459|20812417|P2|COMPLETED|Overall Study||11
8445398|NCT00784459|20812418|P1|COMPLETED|Overall Study||11
8445399|NCT00784459|20812417|P2|STARTED|Overall Study||13
8445400|NCT00784459|20812418|P1|STARTED|Overall Study||11
8445401|NCT00784368|20812429|P3|NOT COMPLETED|Overall Study||11
8445402|NCT00784368|20812430|P2|NOT COMPLETED|Overall Study||11
8445403|NCT00784368|20812431|P1|NOT COMPLETED|Overall Study||8
8445404|NCT00784368|20812429|P3|COMPLETED|Overall Study||12
8445405|NCT00784368|20812430|P2|COMPLETED|Overall Study||5
8445406|NCT00784368|20812431|P1|COMPLETED|Overall Study||8
8445407|NCT00784368|20812429|P3|STARTED|Overall Study||23
8445408|NCT00784368|20812430|P2|STARTED|Overall Study||16
8445409|NCT00784368|20812431|P1|STARTED|Overall Study||16
8445410|NCT00784303|20812467|P2|NOT COMPLETED|Overall Study||0
8445411|NCT00784303|20812468|P1|NOT COMPLETED|Overall Study||0
8445412|NCT00784303|20812467|P2|COMPLETED|Overall Study||59
8445413|NCT00784303|20812468|P1|COMPLETED|Overall Study||58
8445414|NCT00784303|20812467|P2|STARTED|Overall Study||59
8445415|NCT00784303|20812468|P1|STARTED|Overall Study||58
8445416|NCT00784277|20812507|P7|NOT COMPLETED|ER Treatment||15
8445417|NCT00784277|20812508|P6|NOT COMPLETED|ER Treatment||24
8445418|NCT00784277|20812509|P5|NOT COMPLETED|ER Treatment||9
8445419|NCT00784277|20812510|P4|NOT COMPLETED|ER Treatment||0
8445420|NCT00784277|20812511|P3|NOT COMPLETED|ER Treatment||0
8445421|NCT00784277|20812512|P2|NOT COMPLETED|ER Treatment||0
8445422|NCT00784277|20812513|P1|NOT COMPLETED|ER Treatment||0
8445423|NCT00784277|20812507|P7|COMPLETED|ER Treatment||76
8445424|NCT00784277|20812508|P6|COMPLETED|ER Treatment||226
8445425|NCT00784277|20812509|P5|COMPLETED|ER Treatment||113
8445426|NCT00784277|20812510|P4|COMPLETED|ER Treatment||0
8445427|NCT00784277|20812511|P3|COMPLETED|ER Treatment||0
8445428|NCT00784277|20812512|P2|COMPLETED|ER Treatment||0
8445429|NCT00784277|20812513|P1|COMPLETED|ER Treatment||0
8445430|NCT00784277|20812507|P7|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
8445431|NCT00784277|20812508|P6|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
8445432|NCT00784277|20812509|P5|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
8445433|NCT00784277|20812510|P4|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
8445434|NCT00784277|20812511|P3|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
8445435|NCT00784277|20812512|P2|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
8445436|NCT00784277|20812513|P1|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
8445437|NCT00784277|20812507|P7|NOT COMPLETED|IR Treatment||0
8445438|NCT00784277|20812508|P6|NOT COMPLETED|IR Treatment||0
8445439|NCT00784277|20812509|P5|NOT COMPLETED|IR Treatment||0
8445440|NCT00784277|20812510|P4|NOT COMPLETED|IR Treatment||43
8445441|NCT00784277|20812511|P3|NOT COMPLETED|IR Treatment||28
8445442|NCT00784277|20812512|P2|NOT COMPLETED|IR Treatment||17
8445443|NCT00784277|20812513|P1|NOT COMPLETED|IR Treatment||16
8445444|NCT00784277|20812507|P7|COMPLETED|IR Treatment||0
8445445|NCT00784277|20812508|P6|COMPLETED|IR Treatment||0
8445446|NCT00784277|20812509|P5|COMPLETED|IR Treatment||0
8445447|NCT00784277|20812510|P4|COMPLETED|IR Treatment||100
8445448|NCT00784277|20812511|P3|COMPLETED|IR Treatment||126
8445449|NCT00784277|20812512|P2|COMPLETED|IR Treatment||134
8445450|NCT00784277|20812513|P1|COMPLETED|IR Treatment||132
8445451|NCT00784277|20812507|P7|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
8445452|NCT00784277|20812508|P6|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
8445453|NCT00784277|20812509|P5|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
8445454|NCT00784277|20812510|P4|STARTED|IR Treatment||143
8445455|NCT00784277|20812511|P3|STARTED|IR Treatment||154
8445456|NCT00784277|20812512|P2|STARTED|IR Treatment||151
8445457|NCT00784277|20812513|P1|STARTED|IR Treatment||148
8445458|NCT00784238|20812530|P1|NOT COMPLETED|Overall Study||119
8445459|NCT00784238|20812530|P1|COMPLETED|Overall Study||170
8445460|NCT00784238|20812530|P1|STARTED|Overall Study||289
8445461|NCT00784225|20812575|P4|NOT COMPLETED|Overall Study||0
8445462|NCT00784225|20812576|P3|NOT COMPLETED|Overall Study||0
8445463|NCT00784225|20812577|P2|NOT COMPLETED|Overall Study||0
8445464|NCT00784225|20812578|P1|NOT COMPLETED|Overall Study||0
8445465|NCT00784225|20812575|P4|COMPLETED|Overall Study||3374
8445466|NCT00784225|20812576|P3|COMPLETED|Overall Study||3369
8445467|NCT00784225|20812577|P2|COMPLETED|Overall Study||3357
8445468|NCT00784225|20812578|P1|COMPLETED|Overall Study||3375
8445469|NCT00784225|20812575|P4|STARTED|Overall Study||3374
8445470|NCT00784225|20812576|P3|STARTED|Overall Study||3369
8445471|NCT00784225|20812577|P2|STARTED|Overall Study||3357
8445472|NCT00784225|20812578|P1|STARTED|Overall Study||3375
8445473|NCT00784147|20812602|P2|NOT COMPLETED|Overall Study||9
8445474|NCT00784147|20812603|P1|NOT COMPLETED|Overall Study||8
8445475|NCT00784147|20812602|P2|COMPLETED|Overall Study||45
8445476|NCT00784147|20812603|P1|COMPLETED|Overall Study||51
8445477|NCT00784147|20812602|P2|STARTED|Overall Study||54
8445478|NCT00784147|20812603|P1|STARTED|Overall Study||59
8445479|NCT00784134|20812623|P2|NOT COMPLETED|Overall Study||6
8445480|NCT00784134|20812624|P1|NOT COMPLETED|Overall Study||3
8445481|NCT00784134|20812623|P2|COMPLETED|Overall Study||245
8445482|NCT00784134|20812624|P1|COMPLETED|Overall Study||246
8445483|NCT00784134|20812623|P2|STARTED|Overall Study||251
8445484|NCT00784134|20812624|P1|STARTED|Overall Study||249
8445485|NCT00784095|20812723|P3|NOT COMPLETED|Overall Study||1
8445486|NCT00784095|20812724|P2|NOT COMPLETED|Overall Study||1
8445487|NCT00784095|20812725|P1|NOT COMPLETED|Overall Study||0
8445488|NCT00784095|20812723|P3|COMPLETED|Overall Study||11
8445489|NCT00784095|20812724|P2|COMPLETED|Overall Study||11
8445490|NCT00784095|20812725|P1|COMPLETED|Overall Study||12
8445491|NCT00784095|20812723|P3|STARTED|Overall Study||12
8445492|NCT00784095|20812724|P2|STARTED|Overall Study||12
8445493|NCT00784095|20812725|P1|STARTED|Overall Study||12
8445494|NCT00784043|20812747|P2|NOT COMPLETED|Overall Study||6
8445495|NCT00784043|20812748|P1|NOT COMPLETED|Overall Study||31
8445496|NCT00784043|20812747|P2|COMPLETED|Overall Study||0
8445497|NCT00784043|20812748|P1|COMPLETED|Overall Study||0
8445498|NCT00784043|20812747|P2|STARTED|Overall Study||6
8445499|NCT00784043|20812748|P1|STARTED|Overall Study||31
8445500|NCT00784030|20812760|P2|NOT COMPLETED|Overall Study||0
8445501|NCT00784030|20812761|P1|NOT COMPLETED|Overall Study||0
8445502|NCT00784030|20812760|P2|COMPLETED|Overall Study||10
8445503|NCT00784030|20812761|P1|COMPLETED|Overall Study||13
8445504|NCT00784030|20812760|P2|STARTED|Overall Study||10
8445505|NCT00784030|20812761|P1|STARTED|Overall Study||13
8445506|NCT00783965|20812769|P2|NOT COMPLETED|Second Intervention (24 Months)||9
8445507|NCT00783965|20812770|P1|NOT COMPLETED|Second Intervention (24 Months)||0
8445508|NCT00783965|20812769|P2|COMPLETED|Second Intervention (24 Months)||16
8445509|NCT00783965|20812770|P1|COMPLETED|Second Intervention (24 Months)||2
8445510|NCT00783965|20812769|P2|STARTED|Second Intervention (24 Months)||25
8445511|NCT00783965|20812770|P1|STARTED|Second Intervention (24 Months)||2
8445512|NCT00783965|20812769|P2|NOT COMPLETED|First Intervention (12 Months)||4
8445513|NCT00783965|20812770|P1|NOT COMPLETED|First Intervention (12 Months)||3
8445514|NCT00783965|20812769|P2|COMPLETED|First Intervention (12 Months)||25
8445515|NCT00783965|20812770|P1|COMPLETED|First Intervention (12 Months)||2
8445516|NCT00783965|20812769|P2|STARTED|First Intervention (12 Months)||29
8445517|NCT00783965|20812770|P1|STARTED|First Intervention (12 Months)||5
8445518|NCT00783952|20812778|P1|NOT COMPLETED|Overall Study||0
8445519|NCT00783952|20812778|P1|COMPLETED|Overall Study||8
8445520|NCT00783952|20812778|P1|STARTED|Overall Study||8
8445521|NCT00783835|20812783|P1|NOT COMPLETED|Overall Study||10
8445522|NCT00783835|20812783|P1|COMPLETED|Overall Study||50
8445523|NCT00783835|20812783|P1|STARTED|Overall Study||60
8445524|NCT00783796|20812795|P1|NOT COMPLETED|Overall Study||6
8445525|NCT00783796|20812795|P1|COMPLETED|Overall Study||144
8445526|NCT00783796|20812795|P1|STARTED|Overall Study||150
8445527|NCT00783718|20812900|P7|NOT COMPLETED|Maintenance Phase||195
8445528|NCT00783718|20812901|P6|NOT COMPLETED|Maintenance Phase||41
8445529|NCT00783718|20812902|P5|NOT COMPLETED|Maintenance Phase||45
8445530|NCT00783718|20812903|P4|NOT COMPLETED|Maintenance Phase||78
8445531|NCT00783718|20812904|P3|NOT COMPLETED|Maintenance Phase||0
8445532|NCT00783718|20812905|P2|NOT COMPLETED|Maintenance Phase||0
8445533|NCT00783718|20812906|P1|NOT COMPLETED|Maintenance Phase||105
8445534|NCT00783718|20812900|P7|COMPLETED|Maintenance Phase||135
8445535|NCT00783718|20812901|P6|COMPLETED|Maintenance Phase||84
8445536|NCT00783718|20812902|P5|COMPLETED|Maintenance Phase||77
8445537|NCT00783718|20812903|P4|COMPLETED|Maintenance Phase||48
8445538|NCT00783718|20812904|P3|COMPLETED|Maintenance Phase||0
8445539|NCT00783718|20812905|P2|COMPLETED|Maintenance Phase||0
8445540|NCT00783718|20812906|P1|COMPLETED|Maintenance Phase||30
8445541|NCT00783718|20812900|P7|STARTED|Maintenance Phase||330
8445542|NCT00783718|20812901|P6|STARTED|Maintenance Phase||125
8445543|NCT00783718|20812902|P5|STARTED|Maintenance Phase||122
8445544|NCT00783718|20812903|P4|STARTED|Maintenance Phase||126
8445545|NCT00783718|20812904|P3|STARTED|Maintenance Phase||0
8445546|NCT00783718|20812905|P2|STARTED|Maintenance Phase||0
8445547|NCT00783718|20812906|P1|STARTED|Maintenance Phase||135
8445548|NCT00783718|20812900|P7|NOT COMPLETED|Induction Phase||0
8445549|NCT00783718|20812901|P6|NOT COMPLETED|Induction Phase||0
8445550|NCT00783718|20812902|P5|NOT COMPLETED|Induction Phase||0
8445551|NCT00783718|20812903|P4|NOT COMPLETED|Induction Phase||0
8445552|NCT00783718|20812904|P3|NOT COMPLETED|Induction Phase||36
8445553|NCT00783718|20812905|P2|NOT COMPLETED|Induction Phase||7
8445554|NCT00783718|20812906|P1|NOT COMPLETED|Induction Phase||14
8445555|NCT00783718|20812900|P7|COMPLETED|Induction Phase||0
8445556|NCT00783718|20812901|P6|COMPLETED|Induction Phase||0
8445557|NCT00783718|20812902|P5|COMPLETED|Induction Phase||0
8445558|NCT00783718|20812903|P4|COMPLETED|Induction Phase||0
8445559|NCT00783718|20812904|P3|COMPLETED|Induction Phase||485
8445560|NCT00783718|20812905|P2|COMPLETED|Induction Phase||218
8445561|NCT00783718|20812906|P1|COMPLETED|Induction Phase||135
8445562|NCT00783718|20812900|P7|STARTED|Induction Phase||0
8445563|NCT00783718|20812901|P6|STARTED|Induction Phase||0
8445564|NCT00783718|20812902|P5|STARTED|Induction Phase||0
8445565|NCT00783718|20812903|P4|STARTED|Induction Phase||0
8445566|NCT00783718|20812904|P3|STARTED|Induction Phase||521
8445567|NCT00783718|20812905|P2|STARTED|Induction Phase||225
8445568|NCT00783718|20812906|P1|STARTED|Induction Phase||149
8445569|NCT00783705|20812934|P2|NOT COMPLETED|Overall Study||5
8445570|NCT00783705|20812935|P1|NOT COMPLETED|Overall Study||6
8445571|NCT00783705|20812934|P2|COMPLETED|Overall Study||36
8445572|NCT00783705|20812935|P1|COMPLETED|Overall Study||38
8445573|NCT00783705|20812934|P2|STARTED|Overall Study||41
8445574|NCT00783705|20812935|P1|STARTED|Overall Study||44
8445575|NCT00783692|20812982|P7|NOT COMPLETED|Maintenance Phase||249
8445576|NCT00783692|20812983|P6|NOT COMPLETED|Maintenance Phase||72
8445577|NCT00783692|20812984|P5|NOT COMPLETED|Maintenance Phase||81
8445578|NCT00783692|20812985|P4|NOT COMPLETED|Maintenance Phase||89
8445579|NCT00783692|20812986|P3|NOT COMPLETED|Maintenance Phase||0
8445580|NCT00783692|20812987|P2|NOT COMPLETED|Maintenance Phase||0
8445581|NCT00783692|20812988|P1|NOT COMPLETED|Maintenance Phase||95
8445582|NCT00783692|20812982|P7|COMPLETED|Maintenance Phase||163
8445583|NCT00783692|20812983|P6|COMPLETED|Maintenance Phase||82
8445584|NCT00783692|20812984|P5|COMPLETED|Maintenance Phase||73
8445585|NCT00783692|20812985|P4|COMPLETED|Maintenance Phase||64
8445586|NCT00783692|20812986|P3|COMPLETED|Maintenance Phase||0
8445587|NCT00783692|20812987|P2|COMPLETED|Maintenance Phase||0
8445588|NCT00783692|20812988|P1|COMPLETED|Maintenance Phase||42
8445589|NCT00783692|20812982|P7|STARTED|Maintenance Phase||412
8445590|NCT00783692|20812983|P6|STARTED|Maintenance Phase||154
8445591|NCT00783692|20812984|P5|STARTED|Maintenance Phase||154
8445592|NCT00783692|20812985|P4|STARTED|Maintenance Phase||153
8445593|NCT00783692|20812986|P3|STARTED|Maintenance Phase||0
8445594|NCT00783692|20812987|P2|STARTED|Maintenance Phase||0
8445595|NCT00783692|20812988|P1|STARTED|Maintenance Phase||137
8445596|NCT00783692|20812982|P7|NOT COMPLETED|Induction Phase||0
8445597|NCT00783692|20812983|P6|NOT COMPLETED|Induction Phase||0
8445598|NCT00783692|20812984|P5|NOT COMPLETED|Induction Phase||0
8445599|NCT00783692|20812985|P4|NOT COMPLETED|Induction Phase||0
8445600|NCT00783692|20812986|P3|NOT COMPLETED|Induction Phase||74
8445601|NCT00783692|20812987|P2|NOT COMPLETED|Induction Phase||21
8445602|NCT00783692|20812988|P1|NOT COMPLETED|Induction Phase||11
8445603|NCT00783692|20812982|P7|COMPLETED|Induction Phase||0
8445604|NCT00783692|20812983|P6|COMPLETED|Induction Phase||0
8445605|NCT00783692|20812984|P5|COMPLETED|Induction Phase||0
8445606|NCT00783692|20812985|P4|COMPLETED|Induction Phase||0
8445607|NCT00783692|20812986|P3|COMPLETED|Induction Phase||674
8445608|NCT00783692|20812987|P2|COMPLETED|Induction Phase||199
8445609|NCT00783692|20812988|P1|COMPLETED|Induction Phase||137
8445610|NCT00783692|20812982|P7|Treated|Induction Phase||0
8445611|NCT00783692|20812983|P6|Treated|Induction Phase||0
8445612|NCT00783692|20812984|P5|Treated|Induction Phase||0
8445613|NCT00783692|20812985|P4|Treated|Induction Phase||0
8445614|NCT00783692|20812986|P3|Treated|Induction Phase||747
8445615|NCT00783692|20812987|P2|Treated|Induction Phase||220
8445616|NCT00783692|20812988|P1|Treated|Induction Phase||148
8445617|NCT00783692|20812982|P7|STARTED|Induction Phase||0
8445618|NCT00783692|20812983|P6|STARTED|Induction Phase||0
8445619|NCT00783692|20812984|P5|STARTED|Induction Phase||0
8445620|NCT00783692|20812985|P4|STARTED|Induction Phase||0
8445621|NCT00783692|20812986|P3|STARTED|Induction Phase||748
8445622|NCT00783692|20812987|P2|STARTED|Induction Phase||220
8445623|NCT00783692|20812988|P1|STARTED|Induction Phase||148
8445624|NCT00783614|20813015|P4|NOT COMPLETED|Overall Study||0
8445625|NCT00783614|20813016|P3|NOT COMPLETED|Overall Study||0
8445626|NCT00783614|20813017|P2|NOT COMPLETED|Overall Study||0
8445627|NCT00783614|20813018|P1|NOT COMPLETED|Overall Study||0
8445628|NCT00783614|20813015|P4|COMPLETED|Overall Study||5
8445629|NCT00783614|20813016|P3|COMPLETED|Overall Study||5
8445630|NCT00783614|20813017|P2|COMPLETED|Overall Study||6
8445631|NCT00783614|20813018|P1|COMPLETED|Overall Study||6
8445632|NCT00783614|20813015|P4|STARTED|Overall Study||5
8445633|NCT00783614|20813016|P3|STARTED|Overall Study||5
8445634|NCT00783614|20813017|P2|STARTED|Overall Study||6
8445635|NCT00783614|20813018|P1|STARTED|Overall Study||6
8445636|NCT00783432|20813034|P2|NOT COMPLETED|Overall Study||78
8445637|NCT00783432|20813035|P1|NOT COMPLETED|Overall Study||85
8445638|NCT00783432|20813034|P2|COMPLETED|Overall Study||354
8445639|NCT00783432|20813035|P1|COMPLETED|Overall Study||345
8445640|NCT00783432|20813034|P2|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
8445641|NCT00783432|20813035|P1|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
8445642|NCT00783302|20813045|P1|NOT COMPLETED|Overall Study||35
8445643|NCT00783302|20813045|P1|COMPLETED|Overall Study||850
8445644|NCT00783302|20813045|P1|STARTED|Overall Study||885
8445645|NCT00783289|20813067|P4|NOT COMPLETED|Overall Study||0
8445646|NCT00783289|20813068|P3|NOT COMPLETED|Overall Study||0
8445647|NCT00783289|20813069|P2|NOT COMPLETED|Overall Study||1
8445648|NCT00783289|20813070|P1|NOT COMPLETED|Overall Study||0
8445649|NCT00783289|20813067|P4|COMPLETED|Overall Study||6
8445650|NCT00783289|20813068|P3|COMPLETED|Overall Study||6
8445651|NCT00783289|20813069|P2|COMPLETED|Overall Study||6
8445652|NCT00783289|20813070|P1|COMPLETED|Overall Study||6
8445653|NCT00783289|20813067|P4|STARTED|Overall Study||6
8445654|NCT00783289|20813068|P3|STARTED|Overall Study||6
8445655|NCT00783289|20813069|P2|STARTED|Overall Study||7
8445656|NCT00783289|20813070|P1|STARTED|Overall Study||6
8445657|NCT00783263|20813100|P4|NOT COMPLETED|Overall Study||3
8445658|NCT00783263|20813101|P3|NOT COMPLETED|Overall Study||3
8445659|NCT00783263|20813102|P2|NOT COMPLETED|Overall Study||2
8445660|NCT00783263|20813103|P1|NOT COMPLETED|Overall Study||4
8445661|NCT00783263|20813100|P4|COMPLETED|Overall Study||118
8445662|NCT00783263|20813101|P3|COMPLETED|Overall Study||119
8445663|NCT00783263|20813102|P2|COMPLETED|Overall Study||96
8445664|NCT00783263|20813103|P1|COMPLETED|Overall Study||95
8445665|NCT00783263|20813100|P4|STARTED|Overall Study||121
8445666|NCT00783263|20813101|P3|STARTED|Overall Study||122
8445667|NCT00783263|20813102|P2|STARTED|Overall Study||98
8445668|NCT00783263|20813103|P1|STARTED|Overall Study||99
8445669|NCT00783224|20813133|P4|NOT COMPLETED|Overall Study||2
8445670|NCT00783224|20813134|P3|NOT COMPLETED|Overall Study||1
8445671|NCT00783224|20813135|P2|NOT COMPLETED|Overall Study||0
8445672|NCT00783224|20813136|P1|NOT COMPLETED|Overall Study||0
8445673|NCT00783224|20813133|P4|COMPLETED|Overall Study||140
8445674|NCT00783224|20813134|P3|COMPLETED|Overall Study||142
8445675|NCT00783224|20813135|P2|COMPLETED|Overall Study||34
8445676|NCT00783224|20813136|P1|COMPLETED|Overall Study||32
8445677|NCT00783224|20813133|P4|STARTED|Overall Study||142
8445678|NCT00783224|20813134|P3|STARTED|Overall Study||143
8445679|NCT00783224|20813135|P2|STARTED|Overall Study||34
8445680|NCT00783224|20813136|P1|STARTED|Overall Study||32
8445681|NCT00783198|20813148|P3|NOT COMPLETED|Overall Study||42
8445682|NCT00783198|20813149|P2|NOT COMPLETED|Overall Study||43
8445683|NCT00783198|20813150|P1|NOT COMPLETED|Overall Study||57
8445684|NCT00783198|20813148|P3|COMPLETED|Overall Study||146
8445685|NCT00783198|20813149|P2|COMPLETED|Overall Study||144
8445686|NCT00783198|20813150|P1|COMPLETED|Overall Study||133
8445687|NCT00783198|20813148|P3|STARTED|Overall Study||188
8445688|NCT00783198|20813149|P2|STARTED|Overall Study||187
8445689|NCT00783198|20813150|P1|STARTED|Overall Study||190
8445690|NCT00783094|20813173|P3|NOT COMPLETED|Open-Label Extension Period||30
8445691|NCT00783094|20813174|P2|NOT COMPLETED|Open-Label Extension Period||19
8445692|NCT00783094|20813175|P1|NOT COMPLETED|Open-Label Extension Period||22
8445693|NCT00783094|20813173|P3|COMPLETED|Open-Label Extension Period||101
8445694|NCT00783094|20813174|P2|COMPLETED|Open-Label Extension Period||109
8445695|NCT00783094|20813175|P1|COMPLETED|Open-Label Extension Period||113
8445696|NCT00783094|20813173|P3|STARTED|Open-Label Extension Period||131
8445697|NCT00783094|20813174|P2|STARTED|Open-Label Extension Period||128
8445698|NCT00783094|20813175|P1|STARTED|Open-Label Extension Period||135
8445699|NCT00783094|20813173|P3|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
8445700|NCT00783094|20813174|P2|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
8445701|NCT00783094|20813175|P1|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
8445702|NCT00783094|20813173|P3|COMPLETED|Randomized Double-Blind Treatment Period||131
8445703|NCT00783094|20813174|P2|COMPLETED|Randomized Double-Blind Treatment Period||128
8445704|NCT00783094|20813175|P1|COMPLETED|Randomized Double-Blind Treatment Period||135
8445705|NCT00783094|20813173|P3|STARTED|Randomized Double-Blind Treatment Period||140
8445706|NCT00783094|20813174|P2|STARTED|Randomized Double-Blind Treatment Period||140
8445707|NCT00783094|20813175|P1|STARTED|Randomized Double-Blind Treatment Period||142
8445708|NCT00782834|20813251|P1|NOT COMPLETED|Treatment Phase||1
8445709|NCT00782834|20813251|P1|COMPLETED|Treatment Phase||13
8445710|NCT00782834|20813251|P1|STARTED|Treatment Phase||14
8445711|NCT00782834|20813251|P1|NOT COMPLETED|Screened Patients||1
8445712|NCT00782834|20813251|P1|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
8445713|NCT00782834|20813251|P1|STARTED|Screened Patients||15
8445714|NCT00782821|20813260|P4|NOT COMPLETED|Overall Study||2
8445715|NCT00782821|20813261|P3|NOT COMPLETED|Overall Study||1
8445716|NCT00782821|20813262|P2|NOT COMPLETED|Overall Study||0
8445717|NCT00782821|20813263|P1|NOT COMPLETED|Overall Study||0
8445718|NCT00782821|20813260|P4|COMPLETED|Overall Study||8
8445719|NCT00782821|20813261|P3|COMPLETED|Overall Study||9
8445720|NCT00782821|20813262|P2|COMPLETED|Overall Study||10
8445721|NCT00782821|20813263|P1|COMPLETED|Overall Study||10
8445722|NCT00782821|20813260|P4|STARTED|Overall Study||10
8445723|NCT00782821|20813261|P3|STARTED|Overall Study||10
8445724|NCT00782821|20813262|P2|STARTED|Overall Study||10
8445725|NCT00782821|20813263|P1|STARTED|Overall Study||10
8445726|NCT00782795|20813291|P2|NOT COMPLETED|Overall Study||2
8445727|NCT00782795|20813292|P1|NOT COMPLETED|Overall Study||1
8445728|NCT00782795|20813291|P2|COMPLETED|Overall Study||6
8445729|NCT00782795|20813292|P1|COMPLETED|Overall Study||16
8445730|NCT00782795|20813291|P2|24 Week Appointment|Overall Study||7
8445731|NCT00782795|20813292|P1|24 Week Appointment|Overall Study||16
8445732|NCT00782795|20813291|P2|6 Weeks (1st Apptment)|Overall Study||7
8445733|NCT00782795|20813292|P1|6 Weeks (1st Apptment)|Overall Study||16
8445734|NCT00782795|20813291|P2|STARTED|Overall Study||8
8445735|NCT00782795|20813292|P1|STARTED|Overall Study||17
8445736|NCT00782756|20813324|P1|NOT COMPLETED|Overall Study||0
8445737|NCT00782756|20813324|P1|COMPLETED|Overall Study||40
8445738|NCT00782756|20813324|P1|STARTED|Overall Study||40
8445739|NCT00782717|20813332|P2|NOT COMPLETED|Overall Study||28
8445740|NCT00782717|20813333|P1|NOT COMPLETED|Overall Study||15
8445741|NCT00782717|20813332|P2|COMPLETED|Overall Study||102
8445742|NCT00782717|20813333|P1|COMPLETED|Overall Study||118
8445743|NCT00782717|20813332|P2|STARTED|Overall Study||130
8445744|NCT00782717|20813333|P1|STARTED|Overall Study||133
8445745|NCT00782639|20813343|P2|NOT COMPLETED|Overall Study||0
8445746|NCT00782639|20813344|P1|NOT COMPLETED|Overall Study||0
8445747|NCT00782639|20813343|P2|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
8445748|NCT00782639|20813344|P1|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
8445749|NCT00782639|20813343|P2|STARTED|Overall Study||11
8445750|NCT00782639|20813344|P1|STARTED|Overall Study||12
8445751|NCT00782626|20813360|P1|NOT COMPLETED|Overall Study||7
8445752|NCT00782626|20813360|P1|COMPLETED|Overall Study||16
8445753|NCT00782626|20813360|P1|STARTED|Overall Study||23
8445754|NCT00782509|20813367|P3|NOT COMPLETED|Overall Study||36
8445755|NCT00782509|20813368|P2|NOT COMPLETED|Overall Study||24
8445756|NCT00782509|20813369|P1|NOT COMPLETED|Overall Study||41
8445757|NCT00782509|20813367|P3|COMPLETED|Overall Study||181
8445758|NCT00782509|20813368|P2|COMPLETED|Overall Study||185
8445759|NCT00782509|20813369|P1|COMPLETED|Overall Study||175
8445760|NCT00782509|20813367|P3|STARTED|Overall Study||217
8445761|NCT00782509|20813368|P2|STARTED|Overall Study||209
8445762|NCT00782509|20813369|P1|STARTED|Overall Study||216
8445763|NCT00782496|20813562|P2|NOT COMPLETED|Overall Study||15
8445764|NCT00782496|20813563|P1|NOT COMPLETED|Overall Study||14
8445765|NCT00782496|20813562|P2|COMPLETED|Overall Study||90
8445766|NCT00782496|20813563|P1|COMPLETED|Overall Study||92
8445767|NCT00782496|20813562|P2|STARTED|Overall Study||105
8445768|NCT00782496|20813563|P1|STARTED|Overall Study||106
8445769|NCT00782483|20813570|P1|NOT COMPLETED|Overall Study||6
8445770|NCT00782483|20813570|P1|COMPLETED|Overall Study||0
8445771|NCT00782483|20813570|P1|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
8445772|NCT00782418|20813574|P7|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8445773|NCT00782418|20813575|P6|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8445774|NCT00782418|20813576|P5|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8445775|NCT00782418|20813577|P4|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8445776|NCT00782418|20813578|P3|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8445777|NCT00782418|20813579|P2|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8445778|NCT00782418|20813580|P1|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
8445779|NCT00782418|20813574|P7|COMPLETED|Period 2 Procedure/Treatment Groups||4
8445780|NCT00782418|20813575|P6|COMPLETED|Period 2 Procedure/Treatment Groups||4
8445781|NCT00782418|20813576|P5|COMPLETED|Period 2 Procedure/Treatment Groups||3
8445782|NCT00782418|20813577|P4|COMPLETED|Period 2 Procedure/Treatment Groups||1
8445783|NCT00782418|20813578|P3|COMPLETED|Period 2 Procedure/Treatment Groups||4
8445784|NCT00782418|20813579|P2|COMPLETED|Period 2 Procedure/Treatment Groups||4
8445785|NCT00782418|20813580|P1|COMPLETED|Period 2 Procedure/Treatment Groups||3
8445786|NCT00782418|20813574|P7|STARTED|Period 2 Procedure/Treatment Groups||4
8445787|NCT00782418|20813575|P6|STARTED|Period 2 Procedure/Treatment Groups||4
8445788|NCT00782418|20813576|P5|STARTED|Period 2 Procedure/Treatment Groups||3
8445789|NCT00782418|20813577|P4|STARTED|Period 2 Procedure/Treatment Groups||1
8445790|NCT00782418|20813578|P3|STARTED|Period 2 Procedure/Treatment Groups||4
8445791|NCT00782418|20813579|P2|STARTED|Period 2 Procedure/Treatment Groups||4
8445792|NCT00782418|20813580|P1|STARTED|Period 2 Procedure/Treatment Groups||3
8445793|NCT00782418|20813574|P7|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
8445794|NCT00782418|20813575|P6|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
8445795|NCT00782418|20813576|P5|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
8445796|NCT00782418|20813577|P4|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
8445797|NCT00782418|20813578|P3|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
8445798|NCT00782418|20813579|P2|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
8445799|NCT00782418|20813580|P1|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
8445800|NCT00782418|20813574|P7|COMPLETED|Period 1 Procedure/Treatment Groups||4
8445801|NCT00782418|20813575|P6|COMPLETED|Period 1 Procedure/Treatment Groups||4
8445802|NCT00782418|20813576|P5|COMPLETED|Period 1 Procedure/Treatment Groups||4
8445803|NCT00782418|20813577|P4|COMPLETED|Period 1 Procedure/Treatment Groups||2
8445804|NCT00782418|20813578|P3|COMPLETED|Period 1 Procedure/Treatment Groups||4
8445805|NCT00782418|20813579|P2|COMPLETED|Period 1 Procedure/Treatment Groups||4
8445806|NCT00782418|20813580|P1|COMPLETED|Period 1 Procedure/Treatment Groups||1
8445807|NCT00782418|20813574|P7|STARTED|Period 1 Procedure/Treatment Groups||4
8445808|NCT00782418|20813575|P6|STARTED|Period 1 Procedure/Treatment Groups||5
8445809|NCT00782418|20813576|P5|STARTED|Period 1 Procedure/Treatment Groups||5
8445810|NCT00782418|20813577|P4|STARTED|Period 1 Procedure/Treatment Groups||2
8445811|NCT00782418|20813578|P3|STARTED|Period 1 Procedure/Treatment Groups||4
8445812|NCT00782418|20813579|P2|STARTED|Period 1 Procedure/Treatment Groups||4
8445813|NCT00782418|20813580|P1|STARTED|Period 1 Procedure/Treatment Groups||3
8445814|NCT00782379|20813600|P1|NOT COMPLETED|Overall Study||0
8445815|NCT00782379|20813600|P1|COMPLETED|Overall Study||20
8445816|NCT00782379|20813600|P1|STARTED|Overall Study||20
8445817|NCT00782340|20813617|P3|NOT COMPLETED|Randomized Double Blind||0
8445818|NCT00782340|20813618|P2|NOT COMPLETED|Randomized Double Blind||0
8445819|NCT00782340|20813619|P1|NOT COMPLETED|Randomized Double Blind||0
8445820|NCT00782340|20813617|P3|COMPLETED|Randomized Double Blind||80
8445821|NCT00782340|20813618|P2|COMPLETED|Randomized Double Blind||82
8445822|NCT00782340|20813619|P1|COMPLETED|Randomized Double Blind||0
8445823|NCT00782340|20813617|P3|STARTED|Randomized Double Blind||80
8445824|NCT00782340|20813618|P2|STARTED|Randomized Double Blind||82
8445825|NCT00782340|20813619|P1|STARTED|Randomized Double Blind||0
8445826|NCT00782340|20813617|P3|NOT COMPLETED|Open Label Titration||0
8445827|NCT00782340|20813618|P2|NOT COMPLETED|Open Label Titration||0
8445828|NCT00782340|20813619|P1|NOT COMPLETED|Open Label Titration||101
8445829|NCT00782340|20813617|P3|COMPLETED|Open Label Titration||0
8445830|NCT00782340|20813618|P2|COMPLETED|Open Label Titration||0
8445831|NCT00782340|20813619|P1|COMPLETED|Open Label Titration||162
8445832|NCT00782340|20813617|P3|STARTED|Open Label Titration||0
8445833|NCT00782340|20813618|P2|STARTED|Open Label Titration||0
8445834|NCT00782340|20813619|P1|STARTED|Open Label Titration||263
8445835|NCT00782288|20813645|P3|NOT COMPLETED|Overall Study||0
8445836|NCT00782288|20813646|P2|NOT COMPLETED|Overall Study||0
8445837|NCT00782288|20813647|P1|NOT COMPLETED|Overall Study||0
8445838|NCT00782288|20813645|P3|COMPLETED|Overall Study||8
8445839|NCT00782288|20813646|P2|COMPLETED|Overall Study||8
8445840|NCT00782288|20813647|P1|COMPLETED|Overall Study||8
8445841|NCT00782288|20813645|P3|STARTED|Overall Study||8
8445842|NCT00782288|20813646|P2|STARTED|Overall Study||8
8445843|NCT00782288|20813647|P1|STARTED|Overall Study||8
8445844|NCT00782275|20813689|P1|NOT COMPLETED|Overall Study||41
8445845|NCT00782275|20813689|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
8445846|NCT00782275|20813689|P1|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
8445847|NCT00782275|20813689|P1|Treated|Overall Study||40
8445848|NCT00782275|20813689|P1|STARTED|Overall Study||41
8445849|NCT00782210|20813698|P3|NOT COMPLETED|Overall Study||35
8445850|NCT00782210|20813699|P2|NOT COMPLETED|Overall Study||35
8445851|NCT00782210|20813700|P1|NOT COMPLETED|Overall Study||50
8445852|NCT00782210|20813698|P3|COMPLETED|Overall Study||172
8445853|NCT00782210|20813699|P2|COMPLETED|Overall Study||173
8445854|NCT00782210|20813700|P1|COMPLETED|Overall Study||159
8445855|NCT00782210|20813698|P3|STARTED|Overall Study||207
8445856|NCT00782210|20813699|P2|STARTED|Overall Study||208
8445857|NCT00782210|20813700|P1|STARTED|Overall Study||209
8445858|NCT00782184|20813893|P2|NOT COMPLETED|Overall Study||5
8445859|NCT00782184|20813894|P1|NOT COMPLETED|Overall Study||4
8445860|NCT00782184|20813893|P2|COMPLETED|Overall Study||125
8445861|NCT00782184|20813894|P1|COMPLETED|Overall Study||116
8445862|NCT00782184|20813893|P2|STARTED|Overall Study||130
8445863|NCT00782184|20813894|P1|STARTED|Overall Study||120
8445864|NCT00782171|20813931|P2|NOT COMPLETED|Overall Study||19
8445865|NCT00782171|20813932|P1|NOT COMPLETED|Overall Study||22
8445866|NCT00782171|20813931|P2|COMPLETED|Overall Study||115
8445867|NCT00782171|20813932|P1|COMPLETED|Overall Study||124
8445868|NCT00782171|20813931|P2|Surgery (Baseline)|Overall Study||128
8445869|NCT00782171|20813932|P1|Surgery (Baseline)|Overall Study||138
8445870|NCT00782171|20813931|P2|1 Year|Overall Study||120
8445871|NCT00782171|20813932|P1|1 Year|Overall Study||131
8445872|NCT00782171|20813931|P2|20-23 Weeks|Overall Study||124
8445873|NCT00782171|20813932|P1|20-23 Weeks|Overall Study||135
8445874|NCT00782171|20813931|P2|STARTED|Overall Study||134
8445875|NCT00782171|20813932|P1|STARTED|Overall Study||146
8445876|NCT00782067|20813964|P1|NOT COMPLETED|Overall Study||116
8445877|NCT00782067|20813964|P1|COMPLETED|Overall Study||0
8445878|NCT00782067|20813964|P1|Primary Efficacy Population (PEP)|Overall Study||89
8445879|NCT00782067|20813964|P1|Safety Set (SS)|Overall Study||116
8445880|NCT00782067|20813964|P1|STARTED|Overall Study||116
8445881|NCT00781963|20813976|P2|NOT COMPLETED|Overall Study||2
8445882|NCT00781963|20813977|P1|NOT COMPLETED|Overall Study||17
8445883|NCT00781963|20813976|P2|COMPLETED|Overall Study||51
8445884|NCT00781963|20813977|P1|COMPLETED|Overall Study||89
8445885|NCT00781963|20813976|P2|STARTED|Overall Study||53
8445886|NCT00781963|20813977|P1|STARTED|Overall Study||106
8445887|NCT00781950|20813995|P2|NOT COMPLETED|Overall Study||13
8445888|NCT00781950|20813996|P1|NOT COMPLETED|Overall Study||11
8445889|NCT00781950|20813995|P2|COMPLETED|Overall Study||45
8445890|NCT00781950|20813996|P1|COMPLETED|Overall Study||41
8445891|NCT00781950|20813995|P2|STARTED|Overall Study||58
8445892|NCT00781950|20813996|P1|STARTED|Overall Study||52
8445893|NCT00781937|20814006|P2|NOT COMPLETED|Follow up Period (Week 56-68)||5
8445894|NCT00781937|20814007|P1|NOT COMPLETED|Follow up Period (Week 56-68)||6
8445895|NCT00781937|20814006|P2|COMPLETED|Follow up Period (Week 56-68)||141
8445896|NCT00781937|20814007|P1|COMPLETED|Follow up Period (Week 56-68)||153
8445897|NCT00781937|20814006|P2|STARTED|Follow up Period (Week 56-68)||146
8445898|NCT00781937|20814007|P1|STARTED|Follow up Period (Week 56-68)||159
8445899|NCT00781937|20814006|P2|NOT COMPLETED|Main Trial Period Through Week 56||64
8445900|NCT00781937|20814007|P1|NOT COMPLETED|Main Trial Period Through Week 56||53
8445901|NCT00781937|20814006|P2|COMPLETED|Main Trial Period Through Week 56||146
8445902|NCT00781937|20814007|P1|COMPLETED|Main Trial Period Through Week 56||159
8445903|NCT00781937|20814006|P2|STARTED|Main Trial Period Through Week 56||210
8445904|NCT00781937|20814007|P1|STARTED|Main Trial Period Through Week 56||212
8445905|NCT00781911|20814065|P2|NOT COMPLETED|Overall Study||8
8445906|NCT00781911|20814066|P1|NOT COMPLETED|Overall Study||6
8445907|NCT00781911|20814065|P2|COMPLETED|Overall Study||4
8445908|NCT00781911|20814066|P1|COMPLETED|Overall Study||25
8445909|NCT00781911|20814065|P2|Received at Least 1 Dose of Study Drug|Overall Study||12
8445910|NCT00781911|20814066|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
8445911|NCT00781911|20814065|P2|STARTED|Overall Study||12
8445912|NCT00781911|20814066|P1|STARTED|Overall Study||31
8445913|NCT00781898|20814094|P2|NOT COMPLETED|Overall Study||29
8445914|NCT00781898|20814095|P1|NOT COMPLETED|Overall Study||34
8445915|NCT00781898|20814094|P2|COMPLETED|Overall Study||126
8445916|NCT00781898|20814095|P1|COMPLETED|Overall Study||119
8445917|NCT00781898|20814094|P2|STARTED|Overall Study||155
8445918|NCT00781898|20814095|P1|STARTED|Overall Study||153
8445919|NCT00781885|20814101|P1|NOT COMPLETED|Overall Study||1
8445920|NCT00781885|20814101|P1|COMPLETED|Overall Study||18
8445921|NCT00781885|20814101|P1|Received at Least 1 Dose of Study Drug|Overall Study||19
8445922|NCT00781885|20814101|P1|STARTED|Overall Study||19
8445923|NCT00781859|20814118|P2|NOT COMPLETED|Overall Study||9
8445924|NCT00781859|20814119|P1|NOT COMPLETED|Overall Study||19
8445925|NCT00781859|20814118|P2|COMPLETED|Overall Study||98
8445926|NCT00781859|20814119|P1|COMPLETED|Overall Study||200
8445927|NCT00781859|20814118|P2|STARTED|Overall Study||107
8445928|NCT00781859|20814119|P1|STARTED|Overall Study||219
8445929|NCT00781768|20814129|P2|NOT COMPLETED|Overall Study||2
8445930|NCT00781768|20814130|P1|NOT COMPLETED|Overall Study||0
8445931|NCT00781768|20814129|P2|COMPLETED|Overall Study||90
8445932|NCT00781768|20814130|P1|COMPLETED|Overall Study||89
8445933|NCT00781768|20814129|P2|STARTED|Overall Study||92
8445934|NCT00781768|20814130|P1|STARTED|Overall Study||89
8445935|NCT00781599|20814138|P2|NOT COMPLETED|Overall Study||4
8445936|NCT00781599|20814139|P1|NOT COMPLETED|Overall Study||7
8445937|NCT00781599|20814138|P2|COMPLETED|Overall Study||32
8445938|NCT00781599|20814139|P1|COMPLETED|Overall Study||29
8445939|NCT00781599|20814138|P2|STARTED|Overall Study||36
8445940|NCT00781599|20814139|P1|STARTED|Overall Study||36
8445941|NCT00781508|20814153|P2|NOT COMPLETED|Overall Study||0
8445942|NCT00781508|20814154|P1|NOT COMPLETED|Overall Study||0
8445943|NCT00781508|20814153|P2|COMPLETED|Overall Study||5
8445944|NCT00781508|20814154|P1|COMPLETED|Overall Study||5
8445945|NCT00781508|20814153|P2|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
8445946|NCT00781508|20814154|P1|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
8445947|NCT00781456|20814164|P2|NOT COMPLETED|Overall Study||16
8445948|NCT00781456|20814165|P1|NOT COMPLETED|Overall Study||21
8445949|NCT00781456|20814164|P2|COMPLETED|Overall Study||35
8445950|NCT00781456|20814165|P1|COMPLETED|Overall Study||37
8445951|NCT00781456|20814164|P2|Received Study Drug|Overall Study||49
8445952|NCT00781456|20814165|P1|Received Study Drug|Overall Study||57
8445953|NCT00781456|20814164|P2|STARTED|Overall Study||51
8445954|NCT00781456|20814165|P1|STARTED|Overall Study||58
8445955|NCT00781391|20814188|P3|NOT COMPLETED|Overall Study||784
8445956|NCT00781391|20814189|P2|NOT COMPLETED|Overall Study||807
8445957|NCT00781391|20814190|P1|NOT COMPLETED|Overall Study||879
8445958|NCT00781391|20814188|P3|COMPLETED|Overall Study||6250
8445959|NCT00781391|20814189|P2|COMPLETED|Overall Study||6228
8445960|NCT00781391|20814190|P1|COMPLETED|Overall Study||6157
8445961|NCT00781391|20814188|P3|Per Protocol Analysis Set|Overall Study||6982
8445962|NCT00781391|20814189|P2|Per Protocol Analysis Set|Overall Study||6995
8445963|NCT00781391|20814190|P1|Per Protocol Analysis Set|Overall Study||6993
8445964|NCT00781391|20814188|P3|mITT Analysis Set (Received Drug)|Overall Study||7002
8445965|NCT00781391|20814189|P2|mITT Analysis Set (Received Drug)|Overall Study||7012
8445966|NCT00781391|20814190|P1|mITT Analysis Set (Received Drug)|Overall Study||7012
8445967|NCT00781391|20814188|P3|Safety Analysis Set (Received Drug)|Overall Study||7002
8445968|NCT00781391|20814189|P2|Safety Analysis Set (Received Drug)|Overall Study||7012
8445969|NCT00781391|20814190|P1|Safety Analysis Set (Received Drug)|Overall Study||7012
8445970|NCT00781391|20814188|P3|STARTED|Overall Study||7034
8445971|NCT00781391|20814189|P2|STARTED|Overall Study||7035
8445972|NCT00781391|20814190|P1|STARTED|Overall Study||7036
8445973|NCT00781365|20814224|P2|NOT COMPLETED|Overall Study||36
8445974|NCT00781365|20814225|P1|NOT COMPLETED|Overall Study||34
8445975|NCT00781365|20814224|P2|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
8445976|NCT00781365|20814225|P1|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
8445977|NCT00781365|20814224|P2|STARTED|Overall Study||222
8445978|NCT00781365|20814225|P1|STARTED|Overall Study||228
8445979|NCT00781326|20814235|P1|NOT COMPLETED|Phase 2||0
8445980|NCT00781326|20814235|P1|COMPLETED|Phase 2||0
8445981|NCT00781326|20814235|P1|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
8445982|NCT00781326|20814235|P1|NOT COMPLETED|Phase I||4
8445983|NCT00781326|20814235|P1|COMPLETED|Phase I||2
8445984|NCT00781326|20814235|P1|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
8445985|NCT00781274|20814239|P1|NOT COMPLETED|Overall Study||2
8445986|NCT00781274|20814239|P1|COMPLETED|Overall Study||30
8445987|NCT00781274|20814239|P1|STARTED|Overall Study||32
8445988|NCT00781079|20814245|P2|NOT COMPLETED|Overall Study||17
8445989|NCT00781079|20814246|P1|NOT COMPLETED|Overall Study||27
8445990|NCT00781079|20814245|P2|COMPLETED|Overall Study||116
8445991|NCT00781079|20814246|P1|COMPLETED|Overall Study||122
8445992|NCT00781079|20814245|P2|STARTED|Overall Study||133
8445993|NCT00781079|20814246|P1|STARTED|Overall Study||149
8445994|NCT00780975|20814262|P1|NOT COMPLETED|Overall Study||8
8445995|NCT00780975|20814262|P1|COMPLETED|Overall Study||0
8445996|NCT00780975|20814262|P1|STARTED|Overall Study||8
8445997|NCT00780962|20814273|P2|NOT COMPLETED|Overall Study||27
8445998|NCT00780962|20814274|P1|NOT COMPLETED|Overall Study||15
8445999|NCT00780962|20814273|P2|COMPLETED|Overall Study||172
8446000|NCT00780962|20814274|P1|COMPLETED|Overall Study||185
8446001|NCT00780962|20814273|P2|Second Blood Draw (Outcome Measurement)|Overall Study||172
8446002|NCT00780962|20814274|P1|Second Blood Draw (Outcome Measurement)|Overall Study||185
8446003|NCT00780962|20814273|P2|STARTED|Overall Study||199
8446004|NCT00780962|20814274|P1|STARTED|Overall Study||200
8446005|NCT00780910|20814280|P1|NOT COMPLETED|Overall Study||2
8446006|NCT00780910|20814280|P1|COMPLETED|Overall Study||107
8446007|NCT00780910|20814280|P1|STARTED|Overall Study||109
8446008|NCT00780741|20814286|P2|NOT COMPLETED|Overall Study||10
8446009|NCT00780741|20814287|P1|NOT COMPLETED|Overall Study||7
8446010|NCT00780741|20814286|P2|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
8446011|NCT00780741|20814287|P1|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
8446012|NCT00780741|20814286|P2|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
8446013|NCT00780741|20814287|P1|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
8446014|NCT00780741|20814286|P2|STARTED|Overall Study|randomized|81
8446015|NCT00780741|20814287|P1|STARTED|Overall Study|randomized|82
8446016|NCT00780715|20814303|P4|NOT COMPLETED|Overall Study||0
8446017|NCT00780715|20814304|P3|NOT COMPLETED|Overall Study||0
8446018|NCT00780715|20814305|P2|NOT COMPLETED|Overall Study||0
8446019|NCT00780715|20814306|P1|NOT COMPLETED|Overall Study||0
8446020|NCT00780715|20814303|P4|COMPLETED|Overall Study||11
8446021|NCT00780715|20814304|P3|COMPLETED|Overall Study||6
8446022|NCT00780715|20814305|P2|COMPLETED|Overall Study||6
8446023|NCT00780715|20814306|P1|COMPLETED|Overall Study||6
8446024|NCT00780715|20814303|P4|STARTED|Overall Study||11
8446025|NCT00780715|20814304|P3|STARTED|Overall Study||6
8446026|NCT00780715|20814305|P2|STARTED|Overall Study||6
8446027|NCT00780715|20814306|P1|STARTED|Overall Study||6
8446028|NCT00780676|20814321|P5|NOT COMPLETED|Overall Study||0
8446029|NCT00780676|20814322|P4|NOT COMPLETED|Overall Study||0
8446030|NCT00780676|20814323|P3|NOT COMPLETED|Overall Study||0
8446031|NCT00780676|20814324|P2|NOT COMPLETED|Overall Study||0
8446032|NCT00780676|20814325|P1|NOT COMPLETED|Overall Study||0
8446033|NCT00780676|20814321|P5|COMPLETED|Overall Study||0
8446034|NCT00780676|20814322|P4|COMPLETED|Overall Study||0
8446035|NCT00780676|20814323|P3|COMPLETED|Overall Study||13
8446036|NCT00780676|20814324|P2|COMPLETED|Overall Study||8
8446037|NCT00780676|20814325|P1|COMPLETED|Overall Study||9
8446038|NCT00780676|20814321|P5|STARTED|Overall Study||0
8446039|NCT00780676|20814322|P4|STARTED|Overall Study||0
8446040|NCT00780676|20814323|P3|STARTED|Overall Study||13
8446041|NCT00780676|20814324|P2|STARTED|Overall Study||8
8446042|NCT00780676|20814325|P1|STARTED|Overall Study||9
8446043|NCT00780572|20814333|P2|NOT COMPLETED|Overall Study||0
8446044|NCT00780572|20814334|P1|NOT COMPLETED|Overall Study||0
8446045|NCT00780572|20814333|P2|COMPLETED|Overall Study||298
8446046|NCT00780572|20814334|P1|COMPLETED|Overall Study||297
8446047|NCT00780572|20814333|P2|STARTED|Overall Study||298
8446048|NCT00780572|20814334|P1|STARTED|Overall Study||297
8446058|NCT00780481|20814366|P1|NOT COMPLETED|Overall Study||0
8446059|NCT00780481|20814366|P1|COMPLETED|Overall Study||13
8446060|NCT00780481|20814366|P1|STARTED|Overall Study||13
8446061|NCT00780455|20814375|P2|NOT COMPLETED|Overall Study||0
8446062|NCT00780455|20814376|P1|NOT COMPLETED|Overall Study||0
8446063|NCT00780455|20814375|P2|COMPLETED|Overall Study||2
8446064|NCT00780455|20814376|P1|COMPLETED|Overall Study||2
8446065|NCT00780455|20814375|P2|STARTED|Overall Study||2
8446066|NCT00780455|20814376|P1|STARTED|Overall Study||2
8446067|NCT00780442|20814402|P2|NOT COMPLETED|Overall Study||0
8446068|NCT00780442|20814403|P1|NOT COMPLETED|Overall Study||0
8446069|NCT00780442|20814402|P2|COMPLETED|Overall Study||15
8446070|NCT00780442|20814403|P1|COMPLETED|Overall Study||12
8446071|NCT00780442|20814402|P2|STARTED|Overall Study||15
8446072|NCT00780442|20814403|P1|STARTED|Overall Study||12
8446073|NCT00780416|20814411|P2|NOT COMPLETED|Overall Study||9
8446074|NCT00780416|20814412|P1|NOT COMPLETED|Overall Study||12
8446075|NCT00780416|20814411|P2|COMPLETED|Overall Study||54
8446076|NCT00780416|20814412|P1|COMPLETED|Overall Study||114
8446077|NCT00780416|20814411|P2|STARTED|Overall Study||63
8446078|NCT00780416|20814412|P1|STARTED|Overall Study||126
8446079|NCT00780403|20814418|P2|NOT COMPLETED|Second Intervention||0
8446080|NCT00780403|20814419|P1|NOT COMPLETED|Second Intervention||0
8446081|NCT00780403|20814418|P2|COMPLETED|Second Intervention||111
8446082|NCT00780403|20814419|P1|COMPLETED|Second Intervention||109
8446083|NCT00780403|20814418|P2|STARTED|Second Intervention||111
8446084|NCT00780403|20814419|P1|STARTED|Second Intervention||109
8446085|NCT00780403|20814418|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
8446086|NCT00780403|20814419|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
8446087|NCT00780403|20814418|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||111
8446088|NCT00780403|20814419|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
8446089|NCT00780403|20814418|P2|STARTED|Interval Between Doses (8-10 Minutes)||111
8446090|NCT00780403|20814419|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
8446091|NCT00780403|20814418|P2|NOT COMPLETED|First Intervention||0
8446092|NCT00780403|20814419|P1|NOT COMPLETED|First Intervention||0
8446093|NCT00780403|20814418|P2|COMPLETED|First Intervention||111
8446094|NCT00780403|20814419|P1|COMPLETED|First Intervention||109
8446095|NCT00780403|20814418|P2|STARTED|First Intervention||111
8446096|NCT00780403|20814419|P1|STARTED|First Intervention||109
8446097|NCT00780338|20814428|P2|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
8446098|NCT00780338|20814429|P1|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
8446099|NCT00780338|20814428|P2|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
8446100|NCT00780338|20814429|P1|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
8446101|NCT00780338|20814428|P2|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
8446102|NCT00780338|20814429|P1|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
8446103|NCT00780338|20814428|P2|NOT COMPLETED|Baseline to Mid (1 Year)||38
8446104|NCT00780338|20814429|P1|NOT COMPLETED|Baseline to Mid (1 Year)||5
8446105|NCT00780338|20814428|P2|COMPLETED|Baseline to Mid (1 Year)||164
8446106|NCT00780338|20814429|P1|COMPLETED|Baseline to Mid (1 Year)||169
8446107|NCT00780338|20814428|P2|STARTED|Baseline to Mid (1 Year)||202
8446108|NCT00780338|20814429|P1|STARTED|Baseline to Mid (1 Year)||174
8446109|NCT00780273|20814457|P1|NOT COMPLETED|Overall Study||2
8446110|NCT00780273|20814457|P1|COMPLETED|Overall Study||17
8446111|NCT00780273|20814457|P1|STARTED|Overall Study||19
8446112|NCT00780234|20814468|P2|NOT COMPLETED|Overall Study||8
8446113|NCT00780234|20814469|P1|NOT COMPLETED|Overall Study||8
8446114|NCT00780234|20814468|P2|COMPLETED|Overall Study||37
8446115|NCT00780234|20814469|P1|COMPLETED|Overall Study||39
8446116|NCT00780234|20814468|P2|STARTED|Overall Study||45
8446117|NCT00780234|20814469|P1|STARTED|Overall Study||47
8446118|NCT00780208|20814475|P1|NOT COMPLETED|Overall Study||6
8446119|NCT00780208|20814475|P1|COMPLETED|Overall Study||8
8446120|NCT00780208|20814475|P1|STARTED|Overall Study||14
8446121|NCT00780143|20814480|P1|NOT COMPLETED|Overall Study||3
8446122|NCT00780143|20814480|P1|COMPLETED|Overall Study||0
8446123|NCT00780143|20814480|P1|STARTED|Overall Study||3
8446124|NCT00780026|20814488|P2|NOT COMPLETED|Overall Study||0
8446125|NCT00780026|20814489|P1|NOT COMPLETED|Overall Study||0
8446126|NCT00780026|20814488|P2|COMPLETED|Overall Study||50
8446127|NCT00780026|20814489|P1|COMPLETED|Overall Study||50
8446128|NCT00780026|20814488|P2|STARTED|Overall Study||50
8446129|NCT00780026|20814489|P1|STARTED|Overall Study||50
8446130|NCT00779909|20814511|P4|NOT COMPLETED|Overall Study||1
8446131|NCT00779909|20814512|P3|NOT COMPLETED|Overall Study||0
8446132|NCT00779909|20814513|P2|NOT COMPLETED|Overall Study||1
8446133|NCT00779909|20814514|P1|NOT COMPLETED|Overall Study||1
8446134|NCT00779909|20814511|P4|COMPLETED|Overall Study||7
8446135|NCT00779909|20814512|P3|COMPLETED|Overall Study||8
8446136|NCT00779909|20814513|P2|COMPLETED|Overall Study||8
8446137|NCT00779909|20814514|P1|COMPLETED|Overall Study||9
8446138|NCT00779909|20814511|P4|STARTED|Overall Study||8
8446139|NCT00779909|20814512|P3|STARTED|Overall Study||8
8446140|NCT00779909|20814513|P2|STARTED|Overall Study||9
8446141|NCT00779909|20814514|P1|STARTED|Overall Study||10
8446142|NCT00779870|20814559|P3|NOT COMPLETED|Overall Study||0
8446143|NCT00779870|20814560|P2|NOT COMPLETED|Overall Study||0
8446144|NCT00779870|20814561|P1|NOT COMPLETED|Overall Study||0
8446145|NCT00779870|20814559|P3|COMPLETED|Overall Study||7
8446146|NCT00779870|20814560|P2|COMPLETED|Overall Study||6
8446147|NCT00779870|20814561|P1|COMPLETED|Overall Study||5
8446148|NCT00779870|20814559|P3|STARTED|Overall Study||7
8446149|NCT00779870|20814560|P2|STARTED|Overall Study||6
8446150|NCT00779870|20814561|P1|STARTED|Overall Study||5
8446151|NCT00779857|20814578|P1|NOT COMPLETED|Overall Study||6
8446152|NCT00779857|20814578|P1|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
8446153|NCT00779857|20814578|P1|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
8446154|NCT00779857|20814578|P1|30 Day Post Procedure|Overall Study|2 missed Visit|68
8446155|NCT00779857|20814578|P1|STARTED|Overall Study|70 patients treated|70
8446156|NCT00779779|20814583|P1|NOT COMPLETED|Overall Study||24
8446157|NCT00779779|20814583|P1|COMPLETED|Overall Study||498
8446158|NCT00779779|20814583|P1|STARTED|Overall Study||522
8446159|NCT00779766|20814592|P2|NOT COMPLETED|Month 72||189
8446160|NCT00779766|20814593|P1|NOT COMPLETED|Month 72||185
8446161|NCT00779766|20814592|P2|COMPLETED|Month 72||2158
8446162|NCT00779766|20814593|P1|COMPLETED|Month 72||2134
8446163|NCT00779766|20814592|P2|STARTED|Month 72||2347
8446164|NCT00779766|20814593|P1|STARTED|Month 72||2319
8446165|NCT00779766|20814592|P2|NOT COMPLETED|Month 48||168
8446166|NCT00779766|20814593|P1|NOT COMPLETED|Month 48||174
8446167|NCT00779766|20814592|P2|COMPLETED|Month 48||2559
8446168|NCT00779766|20814593|P1|COMPLETED|Month 48||2529
8446169|NCT00779766|20814592|P2|STARTED|Month 48||2727
8446170|NCT00779766|20814593|P1|STARTED|Month 48||2703
8446171|NCT00779766|20814592|P2|NOT COMPLETED|Month 24||332
8446172|NCT00779766|20814593|P1|NOT COMPLETED|Month 24||332
8446173|NCT00779766|20814592|P2|COMPLETED|Month 24||2693
8446174|NCT00779766|20814593|P1|COMPLETED|Month 24||2694
8446175|NCT00779766|20814592|P2|STARTED|Month 24||3025
8446176|NCT00779766|20814593|P1|STARTED|Month 24||3026
8446177|NCT00779701|20814677|P1|NOT COMPLETED|Overall Study||0
8446178|NCT00779701|20814677|P1|COMPLETED|Overall Study||27
8446179|NCT00779701|20814677|P1|STARTED|Overall Study||27
8446180|NCT00779675|20814681|P1|NOT COMPLETED|Extended Treatment Period||46
8446181|NCT00779675|20814681|P1|COMPLETED|Extended Treatment Period||147
8446182|NCT00779675|20814681|P1|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
8446183|NCT00779675|20814681|P1|NOT COMPLETED|Treatment Period||332
8446184|NCT00779675|20814681|P1|COMPLETED|Treatment Period||328
8446185|NCT00779675|20814681|P1|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
8446186|NCT00779584|20814709|P9|NOT COMPLETED|Overall Study||2
8446187|NCT00779584|20814710|P8|NOT COMPLETED|Overall Study||3
8446188|NCT00779584|20814711|P7|NOT COMPLETED|Overall Study||8
8446189|NCT00779584|20814712|P6|NOT COMPLETED|Overall Study||6
8446190|NCT00779584|20814713|P5|NOT COMPLETED|Overall Study||7
8446191|NCT00779584|20814714|P4|NOT COMPLETED|Overall Study||6
8446192|NCT00779584|20814715|P3|NOT COMPLETED|Overall Study||7
8446193|NCT00779584|20814716|P2|NOT COMPLETED|Overall Study||3
8446194|NCT00779584|20814717|P1|NOT COMPLETED|Overall Study||3
8446195|NCT00779584|20814709|P9|COMPLETED|Overall Study||0
8446196|NCT00779584|20814710|P8|COMPLETED|Overall Study||0
8446197|NCT00779584|20814711|P7|COMPLETED|Overall Study||0
8446198|NCT00779584|20814712|P6|COMPLETED|Overall Study||0
8446199|NCT00779584|20814713|P5|COMPLETED|Overall Study||0
8446200|NCT00779584|20814714|P4|COMPLETED|Overall Study||0
8446201|NCT00779584|20814715|P3|COMPLETED|Overall Study||0
8446202|NCT00779584|20814716|P2|COMPLETED|Overall Study||0
8446203|NCT00779584|20814717|P1|COMPLETED|Overall Study||0
8446204|NCT00779584|20814709|P9|Treated|Overall Study||2
8446205|NCT00779584|20814710|P8|Treated|Overall Study||3
8446206|NCT00779584|20814711|P7|Treated|Overall Study||8
8446207|NCT00779584|20814712|P6|Treated|Overall Study||4
8446208|NCT00779584|20814713|P5|Treated|Overall Study||7
8446209|NCT00779584|20814714|P4|Treated|Overall Study||6
8446210|NCT00779584|20814715|P3|Treated|Overall Study||7
8446211|NCT00779584|20814716|P2|Treated|Overall Study||3
8446212|NCT00779584|20814717|P1|Treated|Overall Study||3
8446213|NCT00779584|20814709|P9|STARTED|Overall Study||2
8446214|NCT00779584|20814710|P8|STARTED|Overall Study||3
8446215|NCT00779584|20814711|P7|STARTED|Overall Study||8
8446216|NCT00779584|20814712|P6|STARTED|Overall Study||6
8446217|NCT00779584|20814713|P5|STARTED|Overall Study||7
8446218|NCT00779584|20814714|P4|STARTED|Overall Study||6
8446219|NCT00779584|20814715|P3|STARTED|Overall Study||7
8446220|NCT00779584|20814716|P2|STARTED|Overall Study||3
8446221|NCT00779584|20814717|P1|STARTED|Overall Study||3
8446222|NCT00779558|20814793|P2|NOT COMPLETED|Overall Study||7
8446223|NCT00779558|20814794|P1|NOT COMPLETED|Overall Study||4
8446224|NCT00779558|20814793|P2|COMPLETED|Overall Study||37
8446225|NCT00779558|20814794|P1|COMPLETED|Overall Study||53
8446226|NCT00779558|20814793|P2|STARTED|Overall Study||44
8446227|NCT00779558|20814794|P1|STARTED|Overall Study||57
8446228|NCT00779506|20814808|P1|NOT COMPLETED|Overall Study||29
8446229|NCT00779506|20814808|P1|COMPLETED|Overall Study||67
8446230|NCT00779506|20814808|P1|Withdrawal Treatment|Overall Study||27
8446231|NCT00779506|20814808|P1|Treatment Complete|Overall Study||67
8446232|NCT00779506|20814808|P1|MITT|Overall Study||89
8446233|NCT00779506|20814808|P1|Assigned|Overall Study||94
8446234|NCT00779506|20814808|P1|Screen Failed|Overall Study||2
8446235|NCT00779506|20814808|P1|Enrolled|Overall Study||96
8446236|NCT00779506|20814808|P1|STARTED|Overall Study||96
8446237|NCT00779467|20814822|P4|NOT COMPLETED|Overall Study||19
8446238|NCT00779467|20814823|P3|NOT COMPLETED|Overall Study||10
8446239|NCT00779467|20814824|P2|NOT COMPLETED|Overall Study||5
8446240|NCT00779467|20814825|P1|NOT COMPLETED|Overall Study||15
8446241|NCT00779467|20814822|P4|COMPLETED|Overall Study||35
8446242|NCT00779467|20814823|P3|COMPLETED|Overall Study||38
8446243|NCT00779467|20814824|P2|COMPLETED|Overall Study||40
8446244|NCT00779467|20814825|P1|COMPLETED|Overall Study||38
8446245|NCT00779467|20814822|P4|STARTED|Overall Study||54
8446246|NCT00779467|20814823|P3|STARTED|Overall Study||48
8446247|NCT00779467|20814824|P2|STARTED|Overall Study||45
8446248|NCT00779467|20814825|P1|STARTED|Overall Study||53
8446249|NCT00779402|20814865|P2|NOT COMPLETED|Long-term Follow-up||6
8446250|NCT00779402|20814866|P1|NOT COMPLETED|Long-term Follow-up||21
8446251|NCT00779402|20814865|P2|COMPLETED|Long-term Follow-up||7
8446252|NCT00779402|20814866|P1|COMPLETED|Long-term Follow-up||20
8446253|NCT00779402|20814865|P2|STARTED|Long-term Follow-up||13
8446254|NCT00779402|20814866|P1|STARTED|Long-term Follow-up||41
8446255|NCT00779402|20814865|P2|NOT COMPLETED|Surveillance Phase||31
8446256|NCT00779402|20814866|P1|NOT COMPLETED|Surveillance Phase||43
8446257|NCT00779402|20814865|P2|COMPLETED|Surveillance Phase||13
8446258|NCT00779402|20814866|P1|COMPLETED|Surveillance Phase||41
8446259|NCT00779402|20814865|P2|STARTED|Surveillance Phase||44
8446260|NCT00779402|20814866|P1|STARTED|Surveillance Phase||84
8446261|NCT00779402|20814865|P2|NOT COMPLETED|Treatment Phase 1||15
8446262|NCT00779402|20814866|P1|NOT COMPLETED|Treatment Phase 1||33
8446263|NCT00779402|20814865|P2|COMPLETED|Treatment Phase 1||44
8446264|NCT00779402|20814866|P1|COMPLETED|Treatment Phase 1||84
8446265|NCT00779402|20814865|P2|Received Booster Infusion|Treatment Phase 1||30
8446266|NCT00779402|20814866|P1|Received Booster Infusion|Treatment Phase 1||50
8446267|NCT00779402|20814865|P2|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
8446268|NCT00779402|20814866|P1|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
8446269|NCT00779402|20814865|P2|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
8446355|NCT00778999|20815002|P2|COMPLETED|Overall Study||185
8446270|NCT00779402|20814866|P1|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
8446271|NCT00779402|20814865|P2|STARTED|Treatment Phase 1||59
8446272|NCT00779402|20814866|P1|STARTED|Treatment Phase 1||117
8446273|NCT00779311|20814879|P5|NOT COMPLETED|Overall Study||0
8446274|NCT00779311|20814880|P4|NOT COMPLETED|Overall Study||0
8446275|NCT00779311|20814881|P3|NOT COMPLETED|Overall Study||0
8446276|NCT00779311|20814882|P2|NOT COMPLETED|Overall Study||0
8446277|NCT00779311|20814883|P1|NOT COMPLETED|Overall Study||0
8446278|NCT00779311|20814879|P5|COMPLETED|Overall Study||0
8446279|NCT00779311|20814880|P4|COMPLETED|Overall Study||0
8446280|NCT00779311|20814881|P3|COMPLETED|Overall Study||0
8446281|NCT00779311|20814882|P2|COMPLETED|Overall Study||0
8446282|NCT00779311|20814883|P1|COMPLETED|Overall Study||8
8446283|NCT00779311|20814879|P5|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
8446284|NCT00779311|20814880|P4|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
8446285|NCT00779311|20814881|P3|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
8446286|NCT00779311|20814882|P2|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
8446287|NCT00779311|20814883|P1|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
8446288|NCT00779311|20814879|P5|STARTED|Overall Study||0
8446289|NCT00779311|20814880|P4|STARTED|Overall Study||0
8446290|NCT00779311|20814881|P3|STARTED|Overall Study||0
8446291|NCT00779311|20814882|P2|STARTED|Overall Study||0
8446292|NCT00779311|20814883|P1|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
8446293|NCT00779285|20814905|P1|NOT COMPLETED|Overall Study||0
8446294|NCT00779285|20814905|P1|COMPLETED|Overall Study||1
8446295|NCT00779285|20814905|P1|STARTED|Overall Study||1
8446296|NCT00779259|20814909|P1|NOT COMPLETED|Theophylline With Quinine||0
8446297|NCT00779259|20814909|P1|COMPLETED|Theophylline With Quinine||22
8446298|NCT00779259|20814909|P1|STARTED|Theophylline With Quinine||22
8446299|NCT00779259|20814909|P1|NOT COMPLETED|Quinine Alone||2
8446300|NCT00779259|20814909|P1|COMPLETED|Quinine Alone||22
8446301|NCT00779259|20814909|P1|STARTED|Quinine Alone||24
8446302|NCT00779259|20814909|P1|NOT COMPLETED|4 Day Washout Period||0
8446303|NCT00779259|20814909|P1|COMPLETED|4 Day Washout Period||24
8446304|NCT00779259|20814909|P1|STARTED|4 Day Washout Period||24
8446305|NCT00779259|20814909|P1|NOT COMPLETED|Theophylline Alone||0
8446306|NCT00779259|20814909|P1|COMPLETED|Theophylline Alone||24
8446307|NCT00779259|20814909|P1|STARTED|Theophylline Alone||24
8446308|NCT00779246|20814930|P2|NOT COMPLETED|Overall Study||53
8446309|NCT00779246|20814931|P1|NOT COMPLETED|Overall Study||33
8446310|NCT00779246|20814930|P2|COMPLETED|Overall Study||715
8446311|NCT00779246|20814931|P1|COMPLETED|Overall Study||717
8446312|NCT00779246|20814930|P2|STARTED|Overall Study||768
8446313|NCT00779246|20814931|P1|STARTED|Overall Study||750
8446314|NCT00779155|20814943|P2|NOT COMPLETED|Overall Study||0
8446315|NCT00779155|20814944|P1|NOT COMPLETED|Overall Study||0
8446316|NCT00779155|20814943|P2|COMPLETED|Overall Study||6
8446317|NCT00779155|20814944|P1|COMPLETED|Overall Study||6
8446318|NCT00779155|20814943|P2|STARTED|Overall Study||6
8446319|NCT00779155|20814944|P1|STARTED|Overall Study||6
8446320|NCT00779142|20814950|P1|NOT COMPLETED|Overall Study||3
8446321|NCT00779142|20814950|P1|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
8446322|NCT00779142|20814950|P1|STARTED|Overall Study|5 patients signed consent and were screened.|5
8446323|NCT00779116|20814956|P2|NOT COMPLETED|Second Intervention||0
8446324|NCT00779116|20814957|P1|NOT COMPLETED|Second Intervention||0
8446325|NCT00779116|20814956|P2|COMPLETED|Second Intervention||108
8446326|NCT00779116|20814957|P1|COMPLETED|Second Intervention||109
8446327|NCT00779116|20814956|P2|STARTED|Second Intervention||108
8446328|NCT00779116|20814957|P1|STARTED|Second Intervention||109
8446329|NCT00779116|20814956|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
8446330|NCT00779116|20814957|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
8446331|NCT00779116|20814956|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||108
8446332|NCT00779116|20814957|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
8446333|NCT00779116|20814956|P2|STARTED|Interval Between Doses (8-10 Minutes)||108
8446334|NCT00779116|20814957|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
8446335|NCT00779116|20814956|P2|NOT COMPLETED|First Intervention||0
8446336|NCT00779116|20814957|P1|NOT COMPLETED|First Intervention||0
8446337|NCT00779116|20814956|P2|COMPLETED|First Intervention||108
8446338|NCT00779116|20814957|P1|COMPLETED|First Intervention||109
8446339|NCT00779116|20814956|P2|STARTED|First Intervention||108
8446340|NCT00779116|20814957|P1|STARTED|First Intervention||109
8446341|NCT00779103|20814964|P1|NOT COMPLETED|Overall Study||0
8446342|NCT00779103|20814964|P1|COMPLETED|Overall Study|Initial Phase (First Implant)|36
8446343|NCT00779103|20814964|P1|No Treatment|Overall Study|Optional Long Term Follow-up Phase (No Treatment)|9
8446344|NCT00779103|20814964|P1|Fourth Implant|Overall Study|Second Extension Phase (4th Implant with Yearly Implantations till no longer required): 11 Completed|13
8446345|NCT00779103|20814964|P1|Second & Third Implant|Overall Study|Initial Extension Phase/Extended Access Phase (Second and Third Implant) - 22 Completed|31
8446346|NCT00779103|20814964|P1|STARTED|Overall Study|Initial Phase (First Implant) - 36 Completed|36
8446347|NCT00779038|20814982|P1|NOT COMPLETED|Overall Study||13
8446348|NCT00779038|20814982|P1|COMPLETED|Overall Study||0
8446349|NCT00779038|20814982|P1|STARTED|Overall Study||13
8446350|NCT00779025|20814991|P1|NOT COMPLETED|Overall Study||1
8446351|NCT00779025|20814991|P1|COMPLETED|Overall Study||81
8446352|NCT00779025|20814991|P1|STARTED|Overall Study||82
8446353|NCT00778999|20815002|P2|NOT COMPLETED|Overall Study||34
8446354|NCT00778999|20815003|P1|NOT COMPLETED|Overall Study||28
8446356|NCT00778999|20815003|P1|COMPLETED|Overall Study||195
8446357|NCT00778999|20815002|P2|STARTED|Overall Study||219
8446358|NCT00778999|20815003|P1|STARTED|Overall Study||223
8446359|NCT00778921|20815012|P3|NOT COMPLETED|Overall Study||28
8446360|NCT00778921|20815013|P2|NOT COMPLETED|Overall Study||19
8446361|NCT00778921|20815014|P1|NOT COMPLETED|Overall Study||18
8446362|NCT00778921|20815012|P3|COMPLETED|Overall Study||255
8446363|NCT00778921|20815013|P2|COMPLETED|Overall Study||266
8446364|NCT00778921|20815014|P1|COMPLETED|Overall Study||261
8446365|NCT00778921|20815012|P3|STARTED|Overall Study||283
8446366|NCT00778921|20815013|P2|STARTED|Overall Study||285
8446367|NCT00778921|20815014|P1|STARTED|Overall Study||279
8446368|NCT00778895|20815031|P3|NOT COMPLETED|ESFU Phase||2
8446369|NCT00778895|20815032|P2|NOT COMPLETED|ESFU Phase||12
8446370|NCT00778895|20815033|P1|NOT COMPLETED|ESFU Phase||11
8446371|NCT00778895|20815031|P3|COMPLETED|ESFU Phase||41
8446372|NCT00778895|20815032|P2|COMPLETED|ESFU Phase||155
8446373|NCT00778895|20815033|P1|COMPLETED|ESFU Phase||153
8446374|NCT00778895|20815031|P3|STARTED|ESFU Phase||43
8446375|NCT00778895|20815032|P2|STARTED|ESFU Phase||167
8446376|NCT00778895|20815033|P1|STARTED|ESFU Phase||164
8446377|NCT00778895|20815031|P3|NOT COMPLETED|Active Phase||0
8446378|NCT00778895|20815032|P2|NOT COMPLETED|Active Phase||6
8446379|NCT00778895|20815033|P1|NOT COMPLETED|Active Phase||7
8446380|NCT00778895|20815031|P3|COMPLETED|Active Phase||43
8446381|NCT00778895|20815032|P2|COMPLETED|Active Phase||161
8446382|NCT00778895|20815033|P1|COMPLETED|Active Phase||157
8446383|NCT00778895|20815031|P3|STARTED|Active Phase||43
8446384|NCT00778895|20815032|P2|STARTED|Active Phase||167
8446385|NCT00778895|20815033|P1|STARTED|Active Phase||164
8446386|NCT00778869|20815071|P1|NOT COMPLETED|Overall Study||0
8446387|NCT00778869|20815071|P1|COMPLETED|Overall Study||10
8446388|NCT00778869|20815071|P1|STARTED|Overall Study||10
8446389|NCT00778830|20815077|P2|NOT COMPLETED|Overall Study||1
8446390|NCT00778830|20815078|P1|NOT COMPLETED|Overall Study||0
8446391|NCT00778830|20815077|P2|COMPLETED|Overall Study||187
8446392|NCT00778830|20815078|P1|COMPLETED|Overall Study||101
8446393|NCT00778830|20815077|P2|STARTED|Overall Study||188
8446394|NCT00778830|20815078|P1|STARTED|Overall Study||101
8446395|NCT00778817|20815090|P1|NOT COMPLETED|Overall Study||4
8446396|NCT00778817|20815090|P1|COMPLETED|Overall Study||16
8446397|NCT00778817|20815090|P1|STARTED|Overall Study||20
8446398|NCT00778648|20815107|P2|NOT COMPLETED|Overall Study||5
8446399|NCT00778648|20815108|P1|NOT COMPLETED|Overall Study||9
8446400|NCT00778648|20815107|P2|COMPLETED|Overall Study||266
8446401|NCT00778648|20815108|P1|COMPLETED|Overall Study||263
8446402|NCT00778648|20815107|P2|STARTED|Overall Study||271
8446403|NCT00778648|20815108|P1|STARTED|Overall Study||272
8446404|NCT00778622|20815117|P3|NOT COMPLETED|Overall Study||15
8446405|NCT00778622|20815118|P2|NOT COMPLETED|Overall Study||15
8446406|NCT00778622|20815119|P1|NOT COMPLETED|Overall Study||16
8446407|NCT00778622|20815117|P3|COMPLETED|Overall Study||109
8446408|NCT00778622|20815118|P2|COMPLETED|Overall Study||107
8446409|NCT00778622|20815119|P1|COMPLETED|Overall Study||109
8446410|NCT00778622|20815117|P3|STARTED|Overall Study||124
8446411|NCT00778622|20815118|P2|STARTED|Overall Study||122
8446412|NCT00778622|20815119|P1|STARTED|Overall Study||125
8446413|NCT00778375|20815172|P1|NOT COMPLETED|Overall Study||3
8446414|NCT00778375|20815172|P1|COMPLETED|Overall Study||119
8446415|NCT00778375|20815172|P1|STARTED|Overall Study||122
8446416|NCT00778336|20815186|P4|NOT COMPLETED|3 Month Follow Up||0
8446417|NCT00778336|20815187|P3|NOT COMPLETED|3 Month Follow Up||5
8446418|NCT00778336|20815188|P2|NOT COMPLETED|3 Month Follow Up||23
8446419|NCT00778336|20815189|P1|NOT COMPLETED|3 Month Follow Up||23
8446420|NCT00778336|20815186|P4|COMPLETED|3 Month Follow Up||12
8446421|NCT00778336|20815187|P3|COMPLETED|3 Month Follow Up||65
8446422|NCT00778336|20815188|P2|COMPLETED|3 Month Follow Up||144
8446423|NCT00778336|20815189|P1|COMPLETED|3 Month Follow Up||169
8446424|NCT00778336|20815186|P4|STARTED|3 Month Follow Up||12
8446425|NCT00778336|20815187|P3|STARTED|3 Month Follow Up||70
8446426|NCT00778336|20815188|P2|STARTED|3 Month Follow Up||167
8446427|NCT00778336|20815189|P1|STARTED|3 Month Follow Up||192
8446428|NCT00778336|20815186|P4|NOT COMPLETED|Index Procedure-Discharge||0
8446429|NCT00778336|20815187|P3|NOT COMPLETED|Index Procedure-Discharge||2
8446430|NCT00778336|20815188|P2|NOT COMPLETED|Index Procedure-Discharge||3
8446431|NCT00778336|20815189|P1|NOT COMPLETED|Index Procedure-Discharge||6
8446432|NCT00778336|20815186|P4|COMPLETED|Index Procedure-Discharge||12
8446433|NCT00778336|20815187|P3|COMPLETED|Index Procedure-Discharge||70
8446434|NCT00778336|20815188|P2|COMPLETED|Index Procedure-Discharge||167
8446435|NCT00778336|20815189|P1|COMPLETED|Index Procedure-Discharge||192
8446436|NCT00778336|20815186|P4|STARTED|Index Procedure-Discharge||12
8446437|NCT00778336|20815187|P3|STARTED|Index Procedure-Discharge||72
8446438|NCT00778336|20815188|P2|STARTED|Index Procedure-Discharge||170
8446439|NCT00778336|20815189|P1|STARTED|Index Procedure-Discharge||198
8446440|NCT00778310|20815209|P2|NOT COMPLETED|Overall Study||0
8446441|NCT00778310|20815210|P1|NOT COMPLETED|Overall Study||0
8446442|NCT00778310|20815209|P2|COMPLETED|Overall Study||26
8446443|NCT00778310|20815210|P1|COMPLETED|Overall Study||17
8446444|NCT00778310|20815209|P2|Usable Data|Overall Study||21
8446445|NCT00778310|20815210|P1|Usable Data|Overall Study||14
8446446|NCT00778310|20815209|P2|STARTED|Overall Study||26
8446447|NCT00778310|20815210|P1|STARTED|Overall Study||17
8446448|NCT00778258|20815227|P9|NOT COMPLETED|Overall Study||4
8446449|NCT00778258|20815228|P8|NOT COMPLETED|Overall Study||15
8446450|NCT00778258|20815229|P7|NOT COMPLETED|Overall Study||15
8446451|NCT00778258|20815230|P6|NOT COMPLETED|Overall Study||10
8446452|NCT00778258|20815231|P5|NOT COMPLETED|Overall Study||0
8446453|NCT00778258|20815232|P4|NOT COMPLETED|Overall Study||3
8446454|NCT00778258|20815233|P3|NOT COMPLETED|Overall Study||10
8446455|NCT00778258|20815234|P2|NOT COMPLETED|Overall Study||2
8446456|NCT00778258|20815235|P1|NOT COMPLETED|Overall Study||7
8446457|NCT00778258|20815227|P9|COMPLETED|Overall Study||6
8446458|NCT00778258|20815228|P8|COMPLETED|Overall Study||26
8446459|NCT00778258|20815229|P7|COMPLETED|Overall Study||19
8446460|NCT00778258|20815230|P6|COMPLETED|Overall Study||13
8446461|NCT00778258|20815231|P5|COMPLETED|Overall Study||6
8446462|NCT00778258|20815232|P4|COMPLETED|Overall Study||12
8446463|NCT00778258|20815233|P3|COMPLETED|Overall Study||10
8446464|NCT00778258|20815234|P2|COMPLETED|Overall Study||3
8446465|NCT00778258|20815235|P1|COMPLETED|Overall Study||9
8446466|NCT00778258|20815227|P9|STARTED|Overall Study||10
8446467|NCT00778258|20815228|P8|STARTED|Overall Study||41
8446468|NCT00778258|20815229|P7|STARTED|Overall Study||34
8446469|NCT00778258|20815230|P6|STARTED|Overall Study||23
8446470|NCT00778258|20815231|P5|STARTED|Overall Study||6
8446471|NCT00778258|20815232|P4|STARTED|Overall Study||15
8446472|NCT00778258|20815233|P3|STARTED|Overall Study||20
8446473|NCT00778258|20815234|P2|STARTED|Overall Study||5
8446474|NCT00778258|20815235|P1|STARTED|Overall Study||16
8446475|NCT00778167|20815290|P3|NOT COMPLETED|Overall Study||0
8446476|NCT00778167|20815291|P2|NOT COMPLETED|Overall Study||0
8446477|NCT00778167|20815292|P1|NOT COMPLETED|Overall Study||0
8446478|NCT00778167|20815290|P3|COMPLETED|Overall Study||4
8446479|NCT00778167|20815291|P2|COMPLETED|Overall Study||8
8446480|NCT00778167|20815292|P1|COMPLETED|Overall Study||6
8446481|NCT00778167|20815290|P3|STARTED|Overall Study||4
8446482|NCT00778167|20815291|P2|STARTED|Overall Study||8
8446483|NCT00778167|20815292|P1|STARTED|Overall Study||6
8446484|NCT00778102|20815302|P2|NOT COMPLETED|Overall Study||22
8446485|NCT00778102|20815303|P1|NOT COMPLETED|Overall Study||21
8446486|NCT00778102|20815302|P2|COMPLETED|Overall Study||19
8446487|NCT00778102|20815303|P1|COMPLETED|Overall Study||18
8446488|NCT00778102|20815302|P2|STARTED|Overall Study||41
8446489|NCT00778102|20815303|P1|STARTED|Overall Study||39
8446490|NCT00777946|20815338|P3|NOT COMPLETED|Overall Study||16
8446491|NCT00777946|20815339|P2|NOT COMPLETED|Overall Study||6
8446492|NCT00777946|20815340|P1|NOT COMPLETED|Overall Study||21
8446493|NCT00777946|20815338|P3|COMPLETED|Overall Study||244
8446494|NCT00777946|20815339|P2|COMPLETED|Overall Study||271
8446495|NCT00777946|20815340|P1|COMPLETED|Overall Study||262
8446496|NCT00777946|20815338|P3|Safety & Full Analysis Sets|Overall Study||260
8446497|NCT00777946|20815339|P2|Safety & Full Analysis Sets|Overall Study||276
8446498|NCT00777946|20815340|P1|Safety & Full Analysis Sets|Overall Study||282
8446499|NCT00777946|20815338|P3|STARTED|Overall Study||260
8446500|NCT00777946|20815339|P2|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
8446501|NCT00777946|20815340|P1|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
8446502|NCT00777920|20815363|P1|NOT COMPLETED|Overall Study||50
8446503|NCT00777920|20815363|P1|COMPLETED|Overall Study||90
8446504|NCT00777920|20815363|P1|STARTED|Overall Study||140
8446505|NCT00777855|20815367|P2|NOT COMPLETED|Second Intervention||0
8446506|NCT00777855|20815368|P1|NOT COMPLETED|Second Intervention||0
8446507|NCT00777855|20815367|P2|COMPLETED|Second Intervention||5
8446508|NCT00777855|20815368|P1|COMPLETED|Second Intervention||5
8446509|NCT00777855|20815367|P2|STARTED|Second Intervention||5
8446510|NCT00777855|20815368|P1|STARTED|Second Intervention||5
8446511|NCT00777855|20815367|P2|NOT COMPLETED|Washout Period (>= 14 Days)||0
8446512|NCT00777855|20815368|P1|NOT COMPLETED|Washout Period (>= 14 Days)||0
8446513|NCT00777855|20815367|P2|COMPLETED|Washout Period (>= 14 Days)||5
8446514|NCT00777855|20815368|P1|COMPLETED|Washout Period (>= 14 Days)||5
8446515|NCT00777855|20815367|P2|STARTED|Washout Period (>= 14 Days)||5
8446516|NCT00777855|20815368|P1|STARTED|Washout Period (>= 14 Days)||5
8446517|NCT00777855|20815367|P2|NOT COMPLETED|First Intervention||0
8446518|NCT00777855|20815368|P1|NOT COMPLETED|First Intervention||0
8446519|NCT00777855|20815367|P2|COMPLETED|First Intervention||5
8446520|NCT00777855|20815368|P1|COMPLETED|First Intervention||5
8446521|NCT00777855|20815367|P2|STARTED|First Intervention||5
8446522|NCT00777855|20815368|P1|STARTED|First Intervention||5
8446523|NCT00777803|20815379|P2|NOT COMPLETED|Overall Study||7
8446524|NCT00777803|20815380|P1|NOT COMPLETED|Overall Study||15
8446525|NCT00777803|20815379|P2|COMPLETED|Overall Study||90
8446526|NCT00777803|20815380|P1|COMPLETED|Overall Study||269
8446527|NCT00777803|20815379|P2|STARTED|Overall Study||97
8446528|NCT00777803|20815380|P1|STARTED|Overall Study||284
8446529|NCT00777790|20815415|P3|NOT COMPLETED|Overall Study||0
8446530|NCT00777790|20815416|P2|NOT COMPLETED|Overall Study||0
8446531|NCT00777790|20815417|P1|NOT COMPLETED|Overall Study||0
8446532|NCT00777790|20815415|P3|COMPLETED|Overall Study||88
8446533|NCT00777790|20815416|P2|COMPLETED|Overall Study||77
8446534|NCT00777790|20815417|P1|COMPLETED|Overall Study||76
8446535|NCT00777790|20815415|P3|STARTED|Overall Study||88
8446536|NCT00777790|20815416|P2|STARTED|Overall Study||77
8446537|NCT00777790|20815417|P1|STARTED|Overall Study||76
8446538|NCT00777764|20815427|P2|NOT COMPLETED|Overall Study||1
8446539|NCT00777764|20815428|P1|NOT COMPLETED|Overall Study||0
8446540|NCT00777764|20815427|P2|COMPLETED|Overall Study||29
8446541|NCT00777764|20815428|P1|COMPLETED|Overall Study||30
8446542|NCT00777764|20815427|P2|STARTED|Overall Study||30
8446543|NCT00777764|20815428|P1|STARTED|Overall Study||30
8446544|NCT00777634|20815440|P2|NOT COMPLETED|Overall Study||1
8446545|NCT00777634|20815441|P1|NOT COMPLETED|Overall Study||5
8446546|NCT00777634|20815440|P2|COMPLETED|Overall Study||133
8446547|NCT00777634|20815441|P1|COMPLETED|Overall Study||129
8446548|NCT00777634|20815440|P2|STARTED|Overall Study||134
8446549|NCT00777634|20815441|P1|STARTED|Overall Study||134
8446550|NCT00777608|20815459|P2|NOT COMPLETED|Overall Study||6
8446551|NCT00777608|20815460|P1|NOT COMPLETED|Overall Study||4
8446552|NCT00777608|20815459|P2|COMPLETED|Overall Study||47
8446553|NCT00777608|20815460|P1|COMPLETED|Overall Study||49
8446554|NCT00777608|20815459|P2|STARTED|Overall Study||53
8446555|NCT00777608|20815460|P1|STARTED|Overall Study||53
8446556|NCT00777556|20815470|P1|NOT COMPLETED|Overall Study||66
8446557|NCT00777556|20815470|P1|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
8446558|NCT00777556|20815470|P1|Used Product|Overall Study||297
8446559|NCT00777556|20815470|P1|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
8446560|NCT00777556|20815470|P1|Dispensed Product|Overall Study||307
8446561|NCT00777556|20815470|P1|STARTED|Overall Study|Enrolled; signed informed consent|343
8446584|NCT00777335|20815500|P2|NOT COMPLETED|Overall Study||0
8446585|NCT00777335|20815501|P1|NOT COMPLETED|Overall Study||0
8446586|NCT00777335|20815500|P2|COMPLETED|Overall Study||2
8446587|NCT00777335|20815501|P1|COMPLETED|Overall Study||2
8446588|NCT00777335|20815500|P2|STARTED|Overall Study||2
8446589|NCT00777335|20815501|P1|STARTED|Overall Study||2
8446590|NCT00777296|20815513|P4|NOT COMPLETED|Overall Study||1
8446591|NCT00777296|20815514|P3|NOT COMPLETED|Overall Study||2
8446592|NCT00777296|20815515|P2|NOT COMPLETED|Overall Study||1
8446593|NCT00777296|20815516|P1|NOT COMPLETED|Overall Study||1
8446594|NCT00777296|20815513|P4|COMPLETED|Overall Study||10
8446595|NCT00777296|20815514|P3|COMPLETED|Overall Study||21
8446596|NCT00777296|20815515|P2|COMPLETED|Overall Study||10
8446597|NCT00777296|20815516|P1|COMPLETED|Overall Study||20
8446598|NCT00777296|20815513|P4|STARTED|Overall Study||11
8446599|NCT00777296|20815514|P3|STARTED|Overall Study||23
8446600|NCT00777296|20815515|P2|STARTED|Overall Study||11
8446601|NCT00777296|20815516|P1|STARTED|Overall Study||21
8446602|NCT00777257|20815558|P3|NOT COMPLETED|Overall Study||9
8446603|NCT00777257|20815559|P2|NOT COMPLETED|Overall Study||12
8446604|NCT00777257|20815560|P1|NOT COMPLETED|Overall Study||11
8446605|NCT00777257|20815558|P3|COMPLETED|Overall Study||442
8446606|NCT00777257|20815559|P2|COMPLETED|Overall Study||438
8446607|NCT00777257|20815560|P1|COMPLETED|Overall Study||433
8446608|NCT00777257|20815558|P3|STARTED|Overall Study||451
8446609|NCT00777257|20815559|P2|STARTED|Overall Study||450
8446610|NCT00777257|20815560|P1|STARTED|Overall Study||444
8446611|NCT00777205|20815579|P2|NOT COMPLETED|Overall Study||71
8446612|NCT00777205|20815580|P1|NOT COMPLETED|Overall Study||31
8446613|NCT00777205|20815579|P2|COMPLETED|Overall Study||129
8446614|NCT00777205|20815580|P1|COMPLETED|Overall Study||212
8446615|NCT00777205|20815579|P2|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
8446616|NCT00777205|20815580|P1|Intervention Interruption|Overall Study||0
8446617|NCT00777205|20815579|P2|STARTED|Overall Study||200
8446618|NCT00777205|20815580|P1|STARTED|Overall Study||243
8446619|NCT00777179|20815596|P2|NOT COMPLETED|Overall Study||0
8446620|NCT00777179|20815597|P1|NOT COMPLETED|Overall Study||0
8446621|NCT00777179|20815596|P2|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
8446622|NCT00777179|20815597|P1|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
8446623|NCT00777179|20815596|P2|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
8446624|NCT00777179|20815597|P1|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
8446625|NCT00777153|20815614|P3|NOT COMPLETED|Overall Study||37
8446626|NCT00777153|20815615|P2|NOT COMPLETED|Overall Study||83
8446627|NCT00777153|20815616|P1|NOT COMPLETED|Overall Study||90
8446628|NCT00777153|20815614|P3|COMPLETED|Overall Study||28
8446629|NCT00777153|20815615|P2|COMPLETED|Overall Study||46
8446630|NCT00777153|20815616|P1|COMPLETED|Overall Study||41
8446631|NCT00777153|20815614|P3|STARTED|Overall Study||65
8446632|NCT00777153|20815615|P2|STARTED|Overall Study||129
8446633|NCT00777153|20815616|P1|STARTED|Overall Study||131
8446634|NCT00777101|20815641|P2|NOT COMPLETED|Overall Study||51
8446635|NCT00777101|20815642|P1|NOT COMPLETED|Overall Study||62
8446636|NCT00777101|20815641|P2|COMPLETED|Overall Study||65
8446637|NCT00777101|20815642|P1|COMPLETED|Overall Study||55
8446638|NCT00777101|20815641|P2|Treated|Overall Study||115
8446639|NCT00777101|20815642|P1|Treated|Overall Study||116
8446640|NCT00777101|20815641|P2|STARTED|Overall Study||116
8446641|NCT00777101|20815642|P1|STARTED|Overall Study||117
8446642|NCT00777088|20815660|P1|NOT COMPLETED|Overall Study||1
8446643|NCT00777088|20815660|P1|COMPLETED|Overall Study||107
8446644|NCT00777088|20815660|P1|STARTED|Overall Study||108
8446645|NCT00777062|20815674|P2|NOT COMPLETED|Overall Study||5
8446646|NCT00777062|20815675|P1|NOT COMPLETED|Overall Study||3
8446647|NCT00777062|20815674|P2|COMPLETED|Overall Study||36
8446648|NCT00777062|20815675|P1|COMPLETED|Overall Study||36
8446649|NCT00777062|20815674|P2|STARTED|Overall Study||41
8446650|NCT00777062|20815675|P1|STARTED|Overall Study||39
8446651|NCT00777049|20815685|P2|NOT COMPLETED|Overall Study||1
8446652|NCT00777049|20815686|P1|NOT COMPLETED|Overall Study||1
8446653|NCT00777049|20815685|P2|COMPLETED|Overall Study||20
8446654|NCT00777049|20815686|P1|COMPLETED|Overall Study||32
8446655|NCT00777049|20815685|P2|STARTED|Overall Study||21
8446656|NCT00777049|20815686|P1|STARTED|Overall Study||33
8446657|NCT00777036|20815695|P3|NOT COMPLETED|Follow-Up||4
8446658|NCT00777036|20815696|P2|NOT COMPLETED|Follow-Up||8
8446659|NCT00777036|20815697|P1|NOT COMPLETED|Follow-Up||5
8446660|NCT00777036|20815695|P3|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
8446661|NCT00777036|20815696|P2|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
8446662|NCT00777036|20815697|P1|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
8446663|NCT00777036|20815695|P3|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
8446664|NCT00777036|20815696|P2|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
8446665|NCT00777036|20815697|P1|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
8446666|NCT00777036|20815695|P3|NOT COMPLETED|On Treatment||23
8446667|NCT00777036|20815696|P2|NOT COMPLETED|On Treatment||16
8446668|NCT00777036|20815697|P1|NOT COMPLETED|On Treatment||15
8446669|NCT00777036|20815695|P3|COMPLETED|On Treatment|Completed = Still on treatment|61
8446670|NCT00777036|20815696|P2|COMPLETED|On Treatment|Completed = Still on treatment|1
8446671|NCT00777036|20815697|P1|COMPLETED|On Treatment|Completed = Still on treatment|14
8446672|NCT00777036|20815695|P3|STARTED|On Treatment||84
8446673|NCT00777036|20815696|P2|STARTED|On Treatment||17
8446674|NCT00777036|20815697|P1|STARTED|On Treatment||29
8446675|NCT00777023|20815793|P3|NOT COMPLETED|Overall Study||37
8446676|NCT00777023|20815794|P2|NOT COMPLETED|Overall Study||41
8446677|NCT00777023|20815795|P1|NOT COMPLETED|Overall Study||35
8446678|NCT00777023|20815793|P3|COMPLETED|Overall Study||146
8446679|NCT00777023|20815794|P2|COMPLETED|Overall Study||149
8446680|NCT00777023|20815795|P1|COMPLETED|Overall Study||151
8446681|NCT00777023|20815793|P3|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
8446682|NCT00777023|20815794|P2|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
8446683|NCT00777023|20815795|P1|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
8446684|NCT00776997|20815812|P1|NOT COMPLETED|Overall Study||2
8446685|NCT00776997|20815812|P1|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
8446686|NCT00776997|20815812|P1|STARTED|Overall Study||100
8446687|NCT00776984|20815821|P2|NOT COMPLETED|Overall Study||21
8446688|NCT00776984|20815822|P1|NOT COMPLETED|Overall Study||31
8446689|NCT00776984|20815821|P2|COMPLETED|Overall Study||198
8446690|NCT00776984|20815822|P1|COMPLETED|Overall Study||203
8446691|NCT00776984|20815821|P2|STARTED|Overall Study||219
8446692|NCT00776984|20815822|P1|STARTED|Overall Study||234
8446693|NCT00776919|20815896|P4|NOT COMPLETED|Overall Study||39
8446694|NCT00776919|20815897|P3|NOT COMPLETED|Overall Study||32
8446695|NCT00776919|20815898|P2|NOT COMPLETED|Overall Study||33
8446696|NCT00776919|20815899|P1|NOT COMPLETED|Overall Study||27
8446697|NCT00776919|20815896|P4|COMPLETED|Overall Study||293
8446698|NCT00776919|20815897|P3|COMPLETED|Overall Study||296
8446699|NCT00776919|20815898|P2|COMPLETED|Overall Study||295
8446700|NCT00776919|20815899|P1|COMPLETED|Overall Study||300
8446701|NCT00776919|20815896|P4|STARTED|Overall Study||332
8446702|NCT00776919|20815897|P3|STARTED|Overall Study||328
8446703|NCT00776919|20815898|P2|STARTED|Overall Study||328
8446704|NCT00776919|20815899|P1|STARTED|Overall Study||327
8446705|NCT00776789|20815963|P2|NOT COMPLETED|Overall Study||3
8446706|NCT00776789|20815964|P1|NOT COMPLETED|Overall Study||3
8446707|NCT00776789|20815963|P2|COMPLETED|Overall Study||18
8446708|NCT00776789|20815964|P1|COMPLETED|Overall Study||17
8446709|NCT00776789|20815963|P2|STARTED|Overall Study||21
8446710|NCT00776789|20815964|P1|STARTED|Overall Study||20
8446711|NCT00776659|20815976|P1|NOT COMPLETED|Overall Study||26
8446712|NCT00776659|20815976|P1|COMPLETED|Overall Study||13
8446713|NCT00776659|20815976|P1|STARTED|Overall Study||39
8446714|NCT00776594|20815988|P2|NOT COMPLETED|Overall Study||2
8446715|NCT00776594|20815989|P1|NOT COMPLETED|Overall Study||4
8446716|NCT00776594|20815988|P2|COMPLETED|Overall Study||34
8446717|NCT00776594|20815989|P1|COMPLETED|Overall Study||62
8446718|NCT00776594|20815988|P2|STARTED|Overall Study||36
8446719|NCT00776594|20815989|P1|STARTED|Overall Study||66
8446726|NCT00776295|20816014|P1|NOT COMPLETED|Overall Study||0
8446727|NCT00776295|20816014|P1|COMPLETED|Overall Study||2
8446728|NCT00776295|20816014|P1|STARTED|Overall Study||2
8446729|NCT00776230|20816022|P3|NOT COMPLETED|Overall Study||5
8446730|NCT00776230|20816023|P2|NOT COMPLETED|Overall Study||3
8446731|NCT00776230|20816024|P1|NOT COMPLETED|Overall Study||3
8446732|NCT00776230|20816022|P3|COMPLETED|Overall Study||97
8446733|NCT00776230|20816023|P2|COMPLETED|Overall Study||100
8446734|NCT00776230|20816024|P1|COMPLETED|Overall Study||96
8446735|NCT00776230|20816022|P3|Enrolled and Vaccinated at Day 0|Overall Study||102
8446736|NCT00776230|20816023|P2|Enrolled and Vaccinated at Day 0|Overall Study||103
8446737|NCT00776230|20816024|P1|Enrolled and Vaccinated at Day 0|Overall Study||98
8446738|NCT00776230|20816022|P3|STARTED|Overall Study||102
8446739|NCT00776230|20816023|P2|STARTED|Overall Study||103
8446740|NCT00776230|20816024|P1|STARTED|Overall Study||99
8446741|NCT00776100|20816034|P2|NOT COMPLETED|Overall Study||0
8446742|NCT00776100|20816035|P1|NOT COMPLETED|Overall Study||1
8446743|NCT00776100|20816034|P2|COMPLETED|Overall Study||1
8446744|NCT00776100|20816035|P1|COMPLETED|Overall Study||0
8446745|NCT00776100|20816034|P2|STARTED|Overall Study||1
8446746|NCT00776100|20816035|P1|STARTED|Overall Study||1
8446747|NCT00776009|20816057|P6|NOT COMPLETED|Period 3: Third Intervention||0
8446748|NCT00776009|20816058|P5|NOT COMPLETED|Period 3: Third Intervention||0
8446749|NCT00776009|20816059|P4|NOT COMPLETED|Period 3: Third Intervention||0
8446750|NCT00776009|20816060|P3|NOT COMPLETED|Period 3: Third Intervention||0
8446751|NCT00776009|20816061|P2|NOT COMPLETED|Period 3: Third Intervention||0
8446752|NCT00776009|20816062|P1|NOT COMPLETED|Period 3: Third Intervention||1
8446753|NCT00776009|20816057|P6|COMPLETED|Period 3: Third Intervention||26
8446754|NCT00776009|20816058|P5|COMPLETED|Period 3: Third Intervention||26
8446755|NCT00776009|20816059|P4|COMPLETED|Period 3: Third Intervention||27
8446756|NCT00776009|20816060|P3|COMPLETED|Period 3: Third Intervention||27
8446757|NCT00776009|20816061|P2|COMPLETED|Period 3: Third Intervention||27
8446758|NCT00776009|20816062|P1|COMPLETED|Period 3: Third Intervention||24
8446759|NCT00776009|20816057|P6|STARTED|Period 3: Third Intervention||26
8446760|NCT00776009|20816058|P5|STARTED|Period 3: Third Intervention||26
8446761|NCT00776009|20816059|P4|STARTED|Period 3: Third Intervention||27
8446762|NCT00776009|20816060|P3|STARTED|Period 3: Third Intervention||27
8446763|NCT00776009|20816061|P2|STARTED|Period 3: Third Intervention||27
8446764|NCT00776009|20816062|P1|STARTED|Period 3: Third Intervention||25
8446765|NCT00776009|20816057|P6|NOT COMPLETED|Period 2: Second Intervention||1
8446766|NCT00776009|20816058|P5|NOT COMPLETED|Period 2: Second Intervention||0
8446767|NCT00776009|20816059|P4|NOT COMPLETED|Period 2: Second Intervention||0
8446768|NCT00776009|20816060|P3|NOT COMPLETED|Period 2: Second Intervention||1
8446769|NCT00776009|20816061|P2|NOT COMPLETED|Period 2: Second Intervention||0
8446770|NCT00776009|20816062|P1|NOT COMPLETED|Period 2: Second Intervention||1
8446771|NCT00776009|20816057|P6|COMPLETED|Period 2: Second Intervention||26
8446772|NCT00776009|20816058|P5|COMPLETED|Period 2: Second Intervention||26
8446773|NCT00776009|20816059|P4|COMPLETED|Period 2: Second Intervention||27
8446774|NCT00776009|20816060|P3|COMPLETED|Period 2: Second Intervention||27
8446775|NCT00776009|20816061|P2|COMPLETED|Period 2: Second Intervention||27
8446776|NCT00776009|20816062|P1|COMPLETED|Period 2: Second Intervention||25
8446777|NCT00776009|20816057|P6|STARTED|Period 2: Second Intervention||27
8446778|NCT00776009|20816058|P5|STARTED|Period 2: Second Intervention||26
8446779|NCT00776009|20816059|P4|STARTED|Period 2: Second Intervention||27
8446780|NCT00776009|20816060|P3|STARTED|Period 2: Second Intervention||28
8446781|NCT00776009|20816061|P2|STARTED|Period 2: Second Intervention||27
8446782|NCT00776009|20816062|P1|STARTED|Period 2: Second Intervention||26
8446783|NCT00776009|20816057|P6|NOT COMPLETED|Period 1: First Intervention||0
8446784|NCT00776009|20816058|P5|NOT COMPLETED|Period 1: First Intervention||2
8446785|NCT00776009|20816059|P4|NOT COMPLETED|Period 1: First Intervention||0
8446786|NCT00776009|20816060|P3|NOT COMPLETED|Period 1: First Intervention||1
8446787|NCT00776009|20816061|P2|NOT COMPLETED|Period 1: First Intervention||1
8446788|NCT00776009|20816062|P1|NOT COMPLETED|Period 1: First Intervention||0
8446789|NCT00776009|20816057|P6|COMPLETED|Period 1: First Intervention||27
8446790|NCT00776009|20816058|P5|COMPLETED|Period 1: First Intervention||26
8446791|NCT00776009|20816059|P4|COMPLETED|Period 1: First Intervention||27
8446792|NCT00776009|20816060|P3|COMPLETED|Period 1: First Intervention||28
8446793|NCT00776009|20816061|P2|COMPLETED|Period 1: First Intervention||27
8446794|NCT00776009|20816062|P1|COMPLETED|Period 1: First Intervention||26
8446795|NCT00776009|20816057|P6|STARTED|Period 1: First Intervention||27
8446796|NCT00776009|20816058|P5|STARTED|Period 1: First Intervention||28
8446797|NCT00776009|20816059|P4|STARTED|Period 1: First Intervention||27
8446798|NCT00776009|20816060|P3|STARTED|Period 1: First Intervention||29
8446799|NCT00776009|20816061|P2|STARTED|Period 1: First Intervention||28
8446800|NCT00776009|20816062|P1|STARTED|Period 1: First Intervention||26
8446801|NCT00775983|20816084|P2|NOT COMPLETED|Overall Study||2
8446802|NCT00775983|20816085|P1|NOT COMPLETED|Overall Study||1
8446803|NCT00775983|20816084|P2|COMPLETED|Overall Study||34
8446804|NCT00775983|20816085|P1|COMPLETED|Overall Study||35
8446805|NCT00775983|20816084|P2|STARTED|Overall Study||36
8446806|NCT00775983|20816085|P1|STARTED|Overall Study||36
8446807|NCT00775944|20816097|P4|NOT COMPLETED|Overall Study||16
8446808|NCT00775944|20816098|P3|NOT COMPLETED|Overall Study||16
8446809|NCT00775944|20816099|P2|NOT COMPLETED|Overall Study||9
8446810|NCT00775944|20816100|P1|NOT COMPLETED|Overall Study||15
8446811|NCT00775944|20816097|P4|COMPLETED|Overall Study|16 participants withdrew consent|632
8446812|NCT00775944|20816098|P3|COMPLETED|Overall Study|16 participants withdrew consent|632
8446813|NCT00775944|20816099|P2|COMPLETED|Overall Study|9 participants withdrew consent|638
8446814|NCT00775944|20816100|P1|COMPLETED|Overall Study|15 participants withdrew consent|633
8446815|NCT00775944|20816097|P4|STARTED|Overall Study||648
8446816|NCT00775944|20816098|P3|STARTED|Overall Study||648
8446817|NCT00775944|20816099|P2|STARTED|Overall Study||647
8446818|NCT00775944|20816100|P1|STARTED|Overall Study||648
8446819|NCT00775931|20816128|P2|NOT COMPLETED|Overall Study||0
8446820|NCT00775931|20816129|P1|NOT COMPLETED|Overall Study||0
8446821|NCT00775931|20816128|P2|COMPLETED|Overall Study||1
8446822|NCT00775931|20816129|P1|COMPLETED|Overall Study||6
8446823|NCT00775931|20816128|P2|STARTED|Overall Study||1
8446824|NCT00775931|20816129|P1|STARTED|Overall Study||6
8446825|NCT00775684|20816144|P3|NOT COMPLETED|Overall Study||3
8446826|NCT00775684|20816145|P2|NOT COMPLETED|Overall Study||1
8446827|NCT00775684|20816146|P1|NOT COMPLETED|Overall Study||3
8446828|NCT00775684|20816144|P3|COMPLETED|Overall Study||14
8446829|NCT00775684|20816145|P2|COMPLETED|Overall Study||12
8446830|NCT00775684|20816146|P1|COMPLETED|Overall Study||14
8446831|NCT00775684|20816144|P3|STARTED|Overall Study||17
8446832|NCT00775684|20816145|P2|STARTED|Overall Study||13
8446833|NCT00775684|20816146|P1|STARTED|Overall Study||17
8446834|NCT00775671|20816168|P2|NOT COMPLETED|Overall Study||0
8446835|NCT00775671|20816169|P1|NOT COMPLETED|Overall Study||0
8446836|NCT00775671|20816168|P2|COMPLETED|Overall Study||23
8446837|NCT00775671|20816169|P1|COMPLETED|Overall Study||23
8446838|NCT00775671|20816168|P2|STARTED|Overall Study||23
8446839|NCT00775671|20816169|P1|STARTED|Overall Study||23
8446840|NCT00775658|20816177|P2|NOT COMPLETED|Second Intervention||0
8446841|NCT00775658|20816178|P1|NOT COMPLETED|Second Intervention||0
8446842|NCT00775658|20816177|P2|COMPLETED|Second Intervention||11
8446843|NCT00775658|20816178|P1|COMPLETED|Second Intervention||10
8446844|NCT00775658|20816177|P2|STARTED|Second Intervention||11
8446845|NCT00775658|20816178|P1|STARTED|Second Intervention||10
8446846|NCT00775658|20816177|P2|NOT COMPLETED|First Intervention||0
8446847|NCT00775658|20816178|P1|NOT COMPLETED|First Intervention||0
8446848|NCT00775658|20816177|P2|COMPLETED|First Intervention||11
8446849|NCT00775658|20816178|P1|COMPLETED|First Intervention||10
8446850|NCT00775658|20816177|P2|STARTED|First Intervention||11
8446851|NCT00775658|20816178|P1|STARTED|First Intervention||10
8446852|NCT00775645|20816188|P2|NOT COMPLETED|Overall Study||20
8446853|NCT00775645|20816189|P1|NOT COMPLETED|Overall Study||17
8446854|NCT00775645|20816188|P2|COMPLETED|Overall Study||181
8446855|NCT00775645|20816189|P1|COMPLETED|Overall Study||191
8446856|NCT00775645|20816188|P2|STARTED|Overall Study||201
8446857|NCT00775645|20816189|P1|STARTED|Overall Study||208
8446858|NCT00775606|20816211|P2|NOT COMPLETED|Overall Study||0
8446859|NCT00775606|20816212|P1|NOT COMPLETED|Overall Study||3
8446860|NCT00775606|20816211|P2|COMPLETED|Overall Study||5
8446861|NCT00775606|20816212|P1|COMPLETED|Overall Study||5
8446862|NCT00775606|20816211|P2|STARTED|Overall Study||5
8446863|NCT00775606|20816212|P1|STARTED|Overall Study||8
8446864|NCT00775593|20816222|P1|NOT COMPLETED|Overall Study||7
8446865|NCT00775593|20816222|P1|COMPLETED|Overall Study||53
8446866|NCT00775593|20816222|P1|STARTED|Overall Study||60
8446867|NCT00775528|20816229|P1|NOT COMPLETED|Overall Study||1
8446868|NCT00775528|20816229|P1|COMPLETED|Overall Study||18
8446869|NCT00775528|20816229|P1|STARTED|Overall Study|Started means number of patients who consented|19
8446870|NCT00775463|20816238|P2|NOT COMPLETED|Overall Study||13
8446871|NCT00775463|20816239|P1|NOT COMPLETED|Overall Study||11
8446872|NCT00775463|20816238|P2|COMPLETED|Overall Study||59
8446873|NCT00775463|20816239|P1|COMPLETED|Overall Study||65
8446874|NCT00775463|20816238|P2|STARTED|Overall Study||72
8446875|NCT00775463|20816239|P1|STARTED|Overall Study||76
8446876|NCT00775450|20816276|P5|NOT COMPLETED|Overall Study||2
8446877|NCT00775450|20816277|P4|NOT COMPLETED|Overall Study||0
8446878|NCT00775450|20816278|P3|NOT COMPLETED|Overall Study||0
8446879|NCT00775450|20816279|P2|NOT COMPLETED|Overall Study||0
8446880|NCT00775450|20816280|P1|NOT COMPLETED|Overall Study||3
8446881|NCT00775450|20816276|P5|COMPLETED|Overall Study||199
8446882|NCT00775450|20816277|P4|COMPLETED|Overall Study||108
8446883|NCT00775450|20816278|P3|COMPLETED|Overall Study||105
8446884|NCT00775450|20816279|P2|COMPLETED|Overall Study||98
8446885|NCT00775450|20816280|P1|COMPLETED|Overall Study||292
8446886|NCT00775450|20816276|P5|STARTED|Overall Study||201
8446887|NCT00775450|20816277|P4|STARTED|Overall Study||108
8446888|NCT00775450|20816278|P3|STARTED|Overall Study||105
8446889|NCT00775450|20816279|P2|STARTED|Overall Study||98
8446890|NCT00775450|20816280|P1|STARTED|Overall Study||295
8446891|NCT00775437|20816307|P1|NOT COMPLETED|Overall Study||6
8446892|NCT00775437|20816307|P1|COMPLETED|Overall Study||26
8446893|NCT00775437|20816307|P1|STARTED|Overall Study||32
8446894|NCT00775411|20816357|P1|NOT COMPLETED|Overall Study||1
8446895|NCT00775411|20816357|P1|COMPLETED|Overall Study||43
8446896|NCT00775411|20816357|P1|STARTED|Overall Study||44
8446897|NCT00775346|20816363|P1|NOT COMPLETED|Overall Study||0
8446898|NCT00775346|20816363|P1|COMPLETED|Overall Study||92
8446899|NCT00775346|20816363|P1|STARTED|Overall Study||92
8446900|NCT00775229|20816369|P2|NOT COMPLETED|Overall Study||2
8446901|NCT00775229|20816370|P1|NOT COMPLETED|Overall Study||5
8446902|NCT00775229|20816369|P2|COMPLETED|Overall Study||24
8446903|NCT00775229|20816370|P1|COMPLETED|Overall Study||20
8446904|NCT00775229|20816369|P2|STARTED|Overall Study||26
8446905|NCT00775229|20816370|P1|STARTED|Overall Study||25
8446906|NCT00775203|20816382|P2|NOT COMPLETED|Overall Study||43
8446907|NCT00775203|20816383|P1|NOT COMPLETED|Overall Study||62
8446908|NCT00775203|20816382|P2|COMPLETED|Overall Study||163
8446909|NCT00775203|20816383|P1|COMPLETED|Overall Study||144
8446910|NCT00775203|20816382|P2|Received Study Medication|Overall Study||204
8446911|NCT00775203|20816383|P1|Received Study Medication|Overall Study||202
8446912|NCT00775203|20816382|P2|STARTED|Overall Study||206
8446913|NCT00775203|20816383|P1|STARTED|Overall Study||206
8446914|NCT00775190|20816417|P2|NOT COMPLETED|Overall Study||5
8446915|NCT00775190|20816418|P1|NOT COMPLETED|Overall Study||4
8446916|NCT00775190|20816417|P2|COMPLETED|Overall Study||0
8446917|NCT00775190|20816418|P1|COMPLETED|Overall Study||3
8446918|NCT00775190|20816417|P2|STARTED|Overall Study||5
8446919|NCT00775190|20816418|P1|STARTED|Overall Study||7
8446920|NCT00775138|20816444|P4|NOT COMPLETED|Overall Study||2
8446921|NCT00775138|20816445|P3|NOT COMPLETED|Overall Study||3
8446922|NCT00775138|20816446|P2|NOT COMPLETED|Overall Study||0
8446923|NCT00775138|20816447|P1|NOT COMPLETED|Overall Study||0
8446924|NCT00775138|20816444|P4|COMPLETED|Overall Study||8
8446925|NCT00775138|20816445|P3|COMPLETED|Overall Study||17
8446926|NCT00775138|20816446|P2|COMPLETED|Overall Study||10
8446927|NCT00775138|20816447|P1|COMPLETED|Overall Study||24
8446928|NCT00775138|20816444|P4|STARTED|Overall Study||10
8446929|NCT00775138|20816445|P3|STARTED|Overall Study||20
8446930|NCT00775138|20816446|P2|STARTED|Overall Study||10
8446931|NCT00775138|20816447|P1|STARTED|Overall Study||24
8446932|NCT00775021|20816493|P2|NOT COMPLETED|Second Intervention||1
8446933|NCT00775021|20816494|P1|NOT COMPLETED|Second Intervention||0
8446934|NCT00775021|20816493|P2|COMPLETED|Second Intervention||59
8446935|NCT00775021|20816494|P1|COMPLETED|Second Intervention||62
8446936|NCT00775021|20816493|P2|STARTED|Second Intervention||60
8446937|NCT00775021|20816494|P1|STARTED|Second Intervention||62
8446938|NCT00775021|20816493|P2|NOT COMPLETED|First Intervention||0
8446939|NCT00775021|20816494|P1|NOT COMPLETED|First Intervention||1
8446940|NCT00775021|20816493|P2|COMPLETED|First Intervention||60
8446941|NCT00775021|20816494|P1|COMPLETED|First Intervention||62
8446942|NCT00775021|20816493|P2|STARTED|First Intervention||60
8446943|NCT00775021|20816494|P1|STARTED|First Intervention||63
8446944|NCT00774995|20816512|P4|NOT COMPLETED|Overall Study||0
8446945|NCT00774995|20816513|P3|NOT COMPLETED|Overall Study||1
8446946|NCT00774995|20816514|P2|NOT COMPLETED|Overall Study||0
8446947|NCT00774995|20816515|P1|NOT COMPLETED|Overall Study||0
8446948|NCT00774995|20816512|P4|COMPLETED|Overall Study||16
8446949|NCT00774995|20816513|P3|COMPLETED|Overall Study||7
8446950|NCT00774995|20816514|P2|COMPLETED|Overall Study||16
8446951|NCT00774995|20816515|P1|COMPLETED|Overall Study||9
8446952|NCT00774995|20816512|P4|STARTED|Overall Study||16
8446953|NCT00774995|20816513|P3|STARTED|Overall Study||8
8446954|NCT00774995|20816514|P2|STARTED|Overall Study||16
8446955|NCT00774995|20816515|P1|STARTED|Overall Study||9
8446956|NCT00774930|20816555|P2|NOT COMPLETED|LTOLE Phase||17
8446957|NCT00774930|20816556|P1|NOT COMPLETED|LTOLE Phase||15
8446958|NCT00774930|20816555|P2|COMPLETED|LTOLE Phase||8
8446959|NCT00774930|20816556|P1|COMPLETED|LTOLE Phase||17
8446960|NCT00774930|20816555|P2|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
8446961|NCT00774930|20816556|P1|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
8446962|NCT00774930|20816555|P2|NOT COMPLETED|IOL Phase||9
8446963|NCT00774930|20816556|P1|NOT COMPLETED|IOL Phase||13
8446964|NCT00774930|20816555|P2|COMPLETED|IOL Phase||37
8446965|NCT00774930|20816556|P1|COMPLETED|IOL Phase||43
8446966|NCT00774930|20816555|P2|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
8446967|NCT00774930|20816556|P1|STARTED|IOL Phase||56
8446968|NCT00774930|20816555|P2|NOT COMPLETED|DB Phase||22
8446969|NCT00774930|20816556|P1|NOT COMPLETED|DB Phase||14
8446970|NCT00774930|20816555|P2|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
8446971|NCT00774930|20816556|P1|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
8446972|NCT00774930|20816555|P2|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
8446973|NCT00774930|20816556|P1|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
8446974|NCT00774852|20816584|P2|NOT COMPLETED|Overall Study||41
8446975|NCT00774852|20816585|P1|NOT COMPLETED|Overall Study||45
8446976|NCT00774852|20816584|P2|COMPLETED|Overall Study||27
8446977|NCT00774852|20816585|P1|COMPLETED|Overall Study||24
8446978|NCT00774852|20816584|P2|STARTED|Overall Study||68
8446979|NCT00774852|20816585|P1|STARTED|Overall Study||69
8446980|NCT00774800|20816633|P1|NOT COMPLETED|Intervention 4||1
8446981|NCT00774800|20816633|P1|COMPLETED|Intervention 4||21
8446982|NCT00774800|20816633|P1|Received at Least One Dose of Study Drug|Intervention 4||21
8446983|NCT00774800|20816633|P1|STARTED|Intervention 4||22
8446984|NCT00774800|20816633|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
8446985|NCT00774800|20816633|P1|COMPLETED|Washout (3 to 10 Days)||22
8446986|NCT00774800|20816633|P1|STARTED|Washout (3 to 10 Days)||22
8446987|NCT00774800|20816633|P1|NOT COMPLETED|Intervention 3||0
8446988|NCT00774800|20816633|P1|COMPLETED|Intervention 3||22
8446989|NCT00774800|20816633|P1|Received at Least One Dose of Study Drug|Intervention 3||22
8446990|NCT00774800|20816633|P1|STARTED|Intervention 3||22
8446991|NCT00774800|20816633|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
8446992|NCT00774800|20816633|P1|COMPLETED|Washout (3 to 10 Days)||22
8446993|NCT00774800|20816633|P1|STARTED|Washout (3 to 10 Days)||22
8446994|NCT00774800|20816633|P1|NOT COMPLETED|Intervention 2||0
8446995|NCT00774800|20816633|P1|COMPLETED|Intervention 2||22
8446996|NCT00774800|20816633|P1|Received at Least One Dose of Study Drug|Intervention 2||22
8446997|NCT00774800|20816633|P1|STARTED|Intervention 2||22
8446998|NCT00774800|20816633|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
8446999|NCT00774800|20816633|P1|COMPLETED|Washout (3 to 10 Days)||22
8447000|NCT00774800|20816633|P1|STARTED|Washout (3 to 10 Days)||22
8447001|NCT00774800|20816633|P1|NOT COMPLETED|Intervention 1||0
8447002|NCT00774800|20816633|P1|COMPLETED|Intervention 1||22
8447003|NCT00774800|20816633|P1|Received at Least One Dose of Study Drug|Intervention 1||22
8447004|NCT00774800|20816633|P1|STARTED|Intervention 1||22
8447005|NCT00774787|20816655|P1|NOT COMPLETED|Overall Study||1
8447006|NCT00774787|20816655|P1|COMPLETED|Overall Study||26
8447007|NCT00774787|20816655|P1|STARTED|Overall Study||27
8447008|NCT00774748|20816662|P1|NOT COMPLETED|Overall Study||3
8447009|NCT00774748|20816662|P1|COMPLETED|Overall Study||18
8447010|NCT00774748|20816662|P1|STARTED|Overall Study||21
8447011|NCT00774579|20816672|P2|NOT COMPLETED|Overall Study||0
8447012|NCT00774579|20816673|P1|NOT COMPLETED|Overall Study||0
8447013|NCT00774579|20816672|P2|COMPLETED|Overall Study||9
8447014|NCT00774579|20816673|P1|COMPLETED|Overall Study||9
8447015|NCT00774579|20816672|P2|STARTED|Overall Study||9
8447016|NCT00774579|20816673|P1|STARTED|Overall Study||9
8447017|NCT00774397|20816688|P7|NOT COMPLETED|Overall Study||30
8447018|NCT00774397|20816689|P6|NOT COMPLETED|Overall Study||22
8447019|NCT00774397|20816690|P5|NOT COMPLETED|Overall Study||46
8447020|NCT00774397|20816691|P4|NOT COMPLETED|Overall Study||17
8447021|NCT00774397|20816692|P3|NOT COMPLETED|Overall Study||30
8447022|NCT00774397|20816693|P2|NOT COMPLETED|Overall Study||13
8447023|NCT00774397|20816694|P1|NOT COMPLETED|Overall Study||14
8447024|NCT00774397|20816688|P7|COMPLETED|Overall Study||41
8447025|NCT00774397|20816689|P6|COMPLETED|Overall Study||54
8447026|NCT00774397|20816690|P5|COMPLETED|Overall Study||97
8447027|NCT00774397|20816691|P4|COMPLETED|Overall Study||129
8447028|NCT00774397|20816692|P3|COMPLETED|Overall Study||113
8447029|NCT00774397|20816693|P2|COMPLETED|Overall Study||56
8447030|NCT00774397|20816694|P1|COMPLETED|Overall Study||57
8447031|NCT00774397|20816688|P7|STARTED|Overall Study||71
8447032|NCT00774397|20816689|P6|STARTED|Overall Study||76
8447033|NCT00774397|20816690|P5|STARTED|Overall Study||143
8447034|NCT00774397|20816691|P4|STARTED|Overall Study||146
8447035|NCT00774397|20816692|P3|STARTED|Overall Study||143
8447036|NCT00774397|20816693|P2|STARTED|Overall Study||69
8447037|NCT00774397|20816694|P1|STARTED|Overall Study||71
8447038|NCT00774306|20816930|P4|NOT COMPLETED|Overall Study||5
8447039|NCT00774306|20816931|P3|NOT COMPLETED|Overall Study||8
8447040|NCT00774306|20816932|P2|NOT COMPLETED|Overall Study||2
8447041|NCT00774306|20816933|P1|NOT COMPLETED|Overall Study||18
8447042|NCT00774306|20816930|P4|COMPLETED|Overall Study||2
8447043|NCT00774306|20816931|P3|COMPLETED|Overall Study||8
8447044|NCT00774306|20816932|P2|COMPLETED|Overall Study||3
8447045|NCT00774306|20816933|P1|COMPLETED|Overall Study||6
8447046|NCT00774306|20816930|P4|STARTED|Overall Study||7
8447047|NCT00774306|20816931|P3|STARTED|Overall Study||16
8447048|NCT00774306|20816932|P2|STARTED|Overall Study||5
8447049|NCT00774306|20816933|P1|STARTED|Overall Study||24
8447050|NCT00774267|20816947|P4|NOT COMPLETED|Overall Study||0
8447051|NCT00774267|20816948|P3|NOT COMPLETED|Overall Study||0
8447052|NCT00774267|20816949|P2|NOT COMPLETED|Overall Study||0
8447053|NCT00774267|20816950|P1|NOT COMPLETED|Overall Study||0
8447054|NCT00774267|20816947|P4|COMPLETED|Overall Study||135
8447055|NCT00774267|20816948|P3|COMPLETED|Overall Study||129
8447056|NCT00774267|20816949|P2|COMPLETED|Overall Study||111
8447057|NCT00774267|20816950|P1|COMPLETED|Overall Study||132
8447058|NCT00774267|20816947|P4|STARTED|Overall Study||135
8447059|NCT00774267|20816948|P3|STARTED|Overall Study||129
8447060|NCT00774267|20816949|P2|STARTED|Overall Study||111
8447061|NCT00774267|20816950|P1|STARTED|Overall Study||132
8447062|NCT00774202|20816962|P2|NOT COMPLETED|Overall Study||0
8447063|NCT00774202|20816963|P1|NOT COMPLETED|Overall Study||0
8447064|NCT00774202|20816962|P2|COMPLETED|Overall Study||8
8447065|NCT00774202|20816963|P1|COMPLETED|Overall Study||9
8447066|NCT00774202|20816962|P2|STARTED|Overall Study||8
8447067|NCT00774202|20816963|P1|STARTED|Overall Study||9
8447068|NCT00774163|20816975|P2|NOT COMPLETED|Overall Study||0
8447069|NCT00774163|20816976|P1|NOT COMPLETED|Overall Study||0
8447070|NCT00774163|20816975|P2|COMPLETED|Overall Study||15
8447071|NCT00774163|20816976|P1|COMPLETED|Overall Study||30
8447072|NCT00774163|20816975|P2|STARTED|Overall Study||15
8447073|NCT00774163|20816976|P1|STARTED|Overall Study||30
8447074|NCT00774046|20817014|P1|NOT COMPLETED|Autologous Transplant||0
8447075|NCT00774046|20817014|P1|COMPLETED|Autologous Transplant||4
8447076|NCT00774046|20817014|P1|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
8447077|NCT00774046|20817014|P1|NOT COMPLETED|Stem Cell Mobilization||3
8447078|NCT00774046|20817014|P1|COMPLETED|Stem Cell Mobilization||7
8447079|NCT00774046|20817014|P1|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
8447080|NCT00774046|20817014|P1|NOT COMPLETED|Induction Therapy||0
8447081|NCT00774046|20817014|P1|COMPLETED|Induction Therapy||32
8447082|NCT00774046|20817014|P1|STARTED|Induction Therapy||32
8447083|NCT00774046|20817014|P1|NOT COMPLETED|Enrollment||28
8447084|NCT00774046|20817014|P1|COMPLETED|Enrollment||32
8447085|NCT00774046|20817014|P1|STARTED|Enrollment||60
8447086|NCT00774046|20817014|P1|NOT COMPLETED|Screening||56
8447087|NCT00774046|20817014|P1|COMPLETED|Screening||60
8447088|NCT00774046|20817014|P1|STARTED|Screening||116
8447089|NCT00773968|20817024|P1|NOT COMPLETED|Overall Study||45
8447090|NCT00773968|20817024|P1|COMPLETED|Overall Study||95
8447091|NCT00773968|20817024|P1|Treated|Overall Study||111
8447092|NCT00773968|20817024|P1|STARTED|Overall Study||140
8447093|NCT00773955|20817033|P1|NOT COMPLETED|Overall Study||0
8447094|NCT00773955|20817033|P1|COMPLETED|Overall Study||15
8447095|NCT00773955|20817033|P1|STARTED|Overall Study||15
8447096|NCT00773786|20817040|P2|NOT COMPLETED|Second Intervention (1 Week)||0
8447097|NCT00773786|20817041|P1|NOT COMPLETED|Second Intervention (1 Week)||0
8447098|NCT00773786|20817040|P2|COMPLETED|Second Intervention (1 Week)||10
8447099|NCT00773786|20817041|P1|COMPLETED|Second Intervention (1 Week)||10
8447100|NCT00773786|20817040|P2|STARTED|Second Intervention (1 Week)||10
8447101|NCT00773786|20817041|P1|STARTED|Second Intervention (1 Week)||10
8447102|NCT00773786|20817040|P2|NOT COMPLETED|Washout (1 Week)||0
8447103|NCT00773786|20817041|P1|NOT COMPLETED|Washout (1 Week)||0
8447104|NCT00773786|20817040|P2|COMPLETED|Washout (1 Week)||10
8447105|NCT00773786|20817041|P1|COMPLETED|Washout (1 Week)||10
8447106|NCT00773786|20817040|P2|STARTED|Washout (1 Week)||10
8447107|NCT00773786|20817041|P1|STARTED|Washout (1 Week)||10
8447108|NCT00773786|20817040|P2|NOT COMPLETED|First Intervention (1 Week)||0
8447109|NCT00773786|20817041|P1|NOT COMPLETED|First Intervention (1 Week)||0
8447110|NCT00773786|20817040|P2|COMPLETED|First Intervention (1 Week)||10
8447111|NCT00773786|20817041|P1|COMPLETED|First Intervention (1 Week)||10
8447112|NCT00773786|20817040|P2|STARTED|First Intervention (1 Week)||10
8447113|NCT00773786|20817041|P1|STARTED|First Intervention (1 Week)||10
8447114|NCT00773734|20817055|P6|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
8447115|NCT00773734|20817056|P5|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
8447116|NCT00773734|20817057|P4|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
8447117|NCT00773734|20817058|P3|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
8447118|NCT00773734|20817059|P2|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
8447119|NCT00773734|20817060|P1|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
8447120|NCT00773734|20817055|P6|COMPLETED|LTE Period: Week 52 to 6 Years||0
8447121|NCT00773734|20817056|P5|COMPLETED|LTE Period: Week 52 to 6 Years||0
8447122|NCT00773734|20817057|P4|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
8447123|NCT00773734|20817058|P3|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
8447124|NCT00773734|20817059|P2|COMPLETED|LTE Period: Week 52 to 6 Years||0
8447125|NCT00773734|20817060|P1|COMPLETED|LTE Period: Week 52 to 6 Years||0
8447126|NCT00773734|20817055|P6|STARTED|LTE Period: Week 52 to 6 Years||0
8447127|NCT00773734|20817056|P5|STARTED|LTE Period: Week 52 to 6 Years||0
8447128|NCT00773734|20817057|P4|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
8447129|NCT00773734|20817058|P3|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
8447130|NCT00773734|20817059|P2|STARTED|LTE Period: Week 52 to 6 Years||0
8447131|NCT00773734|20817060|P1|STARTED|LTE Period: Week 52 to 6 Years||0
8447132|NCT00773734|20817055|P6|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
8447133|NCT00773734|20817056|P5|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
8447134|NCT00773734|20817057|P4|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
8447135|NCT00773734|20817058|P3|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
8447136|NCT00773734|20817059|P2|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
8447137|NCT00773734|20817060|P1|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
8447138|NCT00773734|20817055|P6|COMPLETED|Extension: Active Treatment Week 24-52||19
8447139|NCT00773734|20817056|P5|COMPLETED|Extension: Active Treatment Week 24-52||22
8447140|NCT00773734|20817057|P4|COMPLETED|Extension: Active Treatment Week 24-52||48
8447141|NCT00773734|20817058|P3|COMPLETED|Extension: Active Treatment Week 24-52||33
8447142|NCT00773734|20817059|P2|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
8447143|NCT00773734|20817060|P1|COMPLETED|Extension: Active Treatment Week 24-52||0
8447144|NCT00773734|20817055|P6|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
8447145|NCT00773734|20817056|P5|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
8447146|NCT00773734|20817057|P4|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
8447147|NCT00773734|20817058|P3|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
8447148|NCT00773734|20817059|P2|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
8447149|NCT00773734|20817060|P1|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
8447150|NCT00773734|20817055|P6|STARTED|Extension: Active Treatment Week 24-52||27
8447151|NCT00773734|20817056|P5|STARTED|Extension: Active Treatment Week 24-52||27
8447152|NCT00773734|20817057|P4|STARTED|Extension: Active Treatment Week 24-52||58
8447153|NCT00773734|20817058|P3|STARTED|Extension: Active Treatment Week 24-52||50
8447154|NCT00773734|20817059|P2|STARTED|Extension: Active Treatment Week 24-52||47
8447155|NCT00773734|20817060|P1|STARTED|Extension: Active Treatment Week 24-52||0
8447156|NCT00773734|20817055|P6|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
8447157|NCT00773734|20817056|P5|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
8447158|NCT00773734|20817057|P4|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
8447159|NCT00773734|20817058|P3|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
8447160|NCT00773734|20817059|P2|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
8447161|NCT00773734|20817060|P1|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
8447162|NCT00773734|20817055|P6|COMPLETED|Core: Active Treatment Phase Week 16-24||31
8447163|NCT00773734|20817056|P5|COMPLETED|Core: Active Treatment Phase Week 16-24||33
8447164|NCT00773734|20817057|P4|COMPLETED|Core: Active Treatment Phase Week 16-24||65
8447165|NCT00773734|20817058|P3|COMPLETED|Core: Active Treatment Phase Week 16-24||59
8447166|NCT00773734|20817059|P2|COMPLETED|Core: Active Treatment Phase Week 16-24||65
8447167|NCT00773734|20817060|P1|COMPLETED|Core: Active Treatment Phase Week 16-24||0
8447168|NCT00773734|20817055|P6|STARTED|Core: Active Treatment Phase Week 16-24||36
8447169|NCT00773734|20817056|P5|STARTED|Core: Active Treatment Phase Week 16-24||34
8447170|NCT00773734|20817057|P4|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
8447171|NCT00773734|20817058|P3|STARTED|Core: Active Treatment Phase Week 16-24||66
8447172|NCT00773734|20817059|P2|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
8447173|NCT00773734|20817060|P1|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
8447174|NCT00773734|20817055|P6|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
8447175|NCT00773734|20817056|P5|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
8447176|NCT00773734|20817057|P4|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
8447177|NCT00773734|20817058|P3|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
8447178|NCT00773734|20817059|P2|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
8447179|NCT00773734|20817060|P1|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
8447180|NCT00773734|20817055|P6|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
8447181|NCT00773734|20817056|P5|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
8447182|NCT00773734|20817057|P4|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
8447183|NCT00773734|20817058|P3|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
8447184|NCT00773734|20817059|P2|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
8447185|NCT00773734|20817060|P1|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
8447186|NCT00773734|20817055|P6|STARTED|Core: Placebo Controlled Phase Week 0-16||0
8447187|NCT00773734|20817056|P5|STARTED|Core: Placebo Controlled Phase Week 0-16||0
8447188|NCT00773734|20817057|P4|STARTED|Core: Placebo Controlled Phase Week 0-16||88
8447189|NCT00773734|20817058|P3|STARTED|Core: Placebo Controlled Phase Week 0-16||87
8447190|NCT00773734|20817059|P2|STARTED|Core: Placebo Controlled Phase Week 0-16||89
8447191|NCT00773734|20817060|P1|STARTED|Core: Placebo Controlled Phase Week 0-16||88
8447192|NCT00773604|20817622|P1|NOT COMPLETED|Overall Study||0
8447193|NCT00773604|20817622|P1|COMPLETED|Overall Study||9
8447194|NCT00773604|20817622|P1|STARTED|Overall Study||9
8447195|NCT00773513|20817628|P2|NOT COMPLETED|Overall Study||1109
8447196|NCT00773513|20817629|P1|NOT COMPLETED|Overall Study||1101
8447197|NCT00773513|20817628|P2|COMPLETED|Overall Study||303
8447198|NCT00773513|20817629|P1|COMPLETED|Overall Study||312
8447199|NCT00773513|20817628|P2|Received Study Treatment|Overall Study||1409
8447200|NCT00773513|20817629|P1|Received Study Treatment|Overall Study||1409
8447201|NCT00773513|20817628|P2|STARTED|Overall Study||1412
8447202|NCT00773513|20817629|P1|STARTED|Overall Study||1413
8447203|NCT00773474|20817649|P1|NOT COMPLETED|Overall Study||0
8447204|NCT00773474|20817649|P1|COMPLETED|Overall Study||29
8447205|NCT00773474|20817649|P1|STARTED|Overall Study||29
8447206|NCT00773461|20817658|P2|NOT COMPLETED|Overall Study||4
8447207|NCT00773461|20817659|P1|NOT COMPLETED|Overall Study||5
8447208|NCT00773461|20817658|P2|COMPLETED|Overall Study||135
8447209|NCT00773461|20817659|P1|COMPLETED|Overall Study||65
8447210|NCT00773461|20817658|P2|STARTED|Overall Study||139
8447211|NCT00773461|20817659|P1|STARTED|Overall Study||70
8447212|NCT00773422|20817700|P3|NOT COMPLETED|Overall Study||0
8447213|NCT00773422|20817701|P2|NOT COMPLETED|Overall Study||0
8447214|NCT00773422|20817702|P1|NOT COMPLETED|Overall Study||0
8447215|NCT00773422|20817700|P3|COMPLETED|Overall Study||10
8447216|NCT00773422|20817701|P2|COMPLETED|Overall Study||9
8447217|NCT00773422|20817702|P1|COMPLETED|Overall Study||11
8447218|NCT00773422|20817700|P3|STARTED|Overall Study||10
8447219|NCT00773422|20817701|P2|STARTED|Overall Study||9
8447220|NCT00773422|20817702|P1|STARTED|Overall Study||11
8447221|NCT00773383|20817713|P1|NOT COMPLETED|Overall Study||31
8447222|NCT00773383|20817713|P1|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
8447223|NCT00773383|20817713|P1|Received Study Drug|Overall Study||34
8447224|NCT00773383|20817713|P1|STARTED|Overall Study||35
8447225|NCT00773370|20817735|P2|NOT COMPLETED|Overall Study||10
8447226|NCT00773370|20817736|P1|NOT COMPLETED|Overall Study||18
8447227|NCT00773370|20817735|P2|COMPLETED|Overall Study||23
8447228|NCT00773370|20817736|P1|COMPLETED|Overall Study||25
8447229|NCT00773370|20817735|P2|STARTED|Overall Study||33
8447230|NCT00773370|20817736|P1|STARTED|Overall Study||43
8447231|NCT00773279|20817748|P2|NOT COMPLETED|Period 2||6
8447232|NCT00773279|20817749|P1|NOT COMPLETED|Period 2||3
8447233|NCT00773279|20817748|P2|COMPLETED|Period 2||111
8447234|NCT00773279|20817749|P1|COMPLETED|Period 2||111
8447235|NCT00773279|20817748|P2|STARTED|Period 2||117
8447236|NCT00773279|20817749|P1|STARTED|Period 2||114
8447237|NCT00773279|20817748|P2|NOT COMPLETED|Period 1||4
8447238|NCT00773279|20817749|P1|NOT COMPLETED|Period 1||7
8447239|NCT00773279|20817748|P2|COMPLETED|Period 1||117
8447240|NCT00773279|20817749|P1|COMPLETED|Period 1||114
8447241|NCT00773279|20817748|P2|STARTED|Period 1||121
8447242|NCT00773279|20817749|P1|STARTED|Period 1||121
8447243|NCT00773253|20817770|P2|NOT COMPLETED|Second Intervention (Week 24-48)||0
8447244|NCT00773253|20817771|P1|NOT COMPLETED|Second Intervention (Week 24-48)||0
8447245|NCT00773253|20817770|P2|COMPLETED|Second Intervention (Week 24-48)||4
8447246|NCT00773253|20817771|P1|COMPLETED|Second Intervention (Week 24-48)||5
8447247|NCT00773253|20817770|P2|STARTED|Second Intervention (Week 24-48)||4
8447248|NCT00773253|20817771|P1|STARTED|Second Intervention (Week 24-48)||5
8447249|NCT00773253|20817770|P2|NOT COMPLETED|First Intervention (Week 0-24)||1
8447250|NCT00773253|20817771|P1|NOT COMPLETED|First Intervention (Week 0-24)||0
8447251|NCT00773253|20817770|P2|COMPLETED|First Intervention (Week 0-24)||4
8447252|NCT00773253|20817771|P1|COMPLETED|First Intervention (Week 0-24)||5
8447253|NCT00773253|20817770|P2|STARTED|First Intervention (Week 0-24)||5
8447254|NCT00773253|20817771|P1|STARTED|First Intervention (Week 0-24)||5
8447255|NCT00773175|20817781|P2|NOT COMPLETED|Overall Study||2
8447256|NCT00773175|20817782|P1|NOT COMPLETED|Overall Study||2
8447257|NCT00773175|20817781|P2|COMPLETED|Overall Study||73
8447258|NCT00773175|20817782|P1|COMPLETED|Overall Study||71
8447259|NCT00773175|20817781|P2|No Fluids Received|Overall Study||1
8447260|NCT00773175|20817782|P1|No Fluids Received|Overall Study||0
8447261|NCT00773175|20817781|P2|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
8447262|NCT00773175|20817782|P1|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
8447263|NCT00773175|20817781|P2|Initial Fluids Via Randomized Route|Overall Study||59
8447264|NCT00773175|20817782|P1|Initial Fluids Via Randomized Route|Overall Study||73
8447265|NCT00773175|20817781|P2|STARTED|Overall Study||75
8447266|NCT00773175|20817782|P1|STARTED|Overall Study||73
8447267|NCT00773136|20817874|P1|NOT COMPLETED|Overall Study||2
8447268|NCT00773136|20817874|P1|COMPLETED|Overall Study||19
8447269|NCT00773136|20817874|P1|STARTED|Overall Study||21
8447270|NCT00773097|20817879|P1|NOT COMPLETED|Overall Study||7
8447271|NCT00773097|20817879|P1|COMPLETED|Overall Study||39
8447272|NCT00773097|20817879|P1|STARTED|Overall Study||46
8447273|NCT00772967|20817885|P6|NOT COMPLETED|Crossover Treatment 3||0
8447274|NCT00772967|20817886|P5|NOT COMPLETED|Crossover Treatment 3||1
8447275|NCT00772967|20817887|P4|NOT COMPLETED|Crossover Treatment 3||0
8447276|NCT00772967|20817888|P3|NOT COMPLETED|Crossover Treatment 3||0
8447277|NCT00772967|20817889|P2|NOT COMPLETED|Crossover Treatment 3||0
8447278|NCT00772967|20817890|P1|NOT COMPLETED|Crossover Treatment 3||0
8447279|NCT00772967|20817885|P6|COMPLETED|Crossover Treatment 3||3
8447280|NCT00772967|20817886|P5|COMPLETED|Crossover Treatment 3||3
8447281|NCT00772967|20817887|P4|COMPLETED|Crossover Treatment 3||3
8447282|NCT00772967|20817888|P3|COMPLETED|Crossover Treatment 3||3
8447283|NCT00772967|20817889|P2|COMPLETED|Crossover Treatment 3||4
8447284|NCT00772967|20817890|P1|COMPLETED|Crossover Treatment 3||3
8447285|NCT00772967|20817885|P6|STARTED|Crossover Treatment 3||3
8447286|NCT00772967|20817886|P5|STARTED|Crossover Treatment 3||4
8447287|NCT00772967|20817887|P4|STARTED|Crossover Treatment 3||3
8447288|NCT00772967|20817888|P3|STARTED|Crossover Treatment 3||3
8447289|NCT00772967|20817889|P2|STARTED|Crossover Treatment 3||4
8447290|NCT00772967|20817890|P1|STARTED|Crossover Treatment 3||3
8447291|NCT00772967|20817885|P6|NOT COMPLETED|Break 2 (4-7 Days)||0
8447292|NCT00772967|20817886|P5|NOT COMPLETED|Break 2 (4-7 Days)||0
8447293|NCT00772967|20817887|P4|NOT COMPLETED|Break 2 (4-7 Days)||0
8447294|NCT00772967|20817888|P3|NOT COMPLETED|Break 2 (4-7 Days)||0
8447295|NCT00772967|20817889|P2|NOT COMPLETED|Break 2 (4-7 Days)||0
8447296|NCT00772967|20817890|P1|NOT COMPLETED|Break 2 (4-7 Days)||0
8447297|NCT00772967|20817885|P6|COMPLETED|Break 2 (4-7 Days)||3
8447298|NCT00772967|20817886|P5|COMPLETED|Break 2 (4-7 Days)||4
8447299|NCT00772967|20817887|P4|COMPLETED|Break 2 (4-7 Days)||3
8447300|NCT00772967|20817888|P3|COMPLETED|Break 2 (4-7 Days)||3
8447301|NCT00772967|20817889|P2|COMPLETED|Break 2 (4-7 Days)||4
8447302|NCT00772967|20817890|P1|COMPLETED|Break 2 (4-7 Days)||3
8447303|NCT00772967|20817885|P6|STARTED|Break 2 (4-7 Days)||3
8447304|NCT00772967|20817886|P5|STARTED|Break 2 (4-7 Days)||4
8447305|NCT00772967|20817887|P4|STARTED|Break 2 (4-7 Days)||3
8447306|NCT00772967|20817888|P3|STARTED|Break 2 (4-7 Days)||3
8447307|NCT00772967|20817889|P2|STARTED|Break 2 (4-7 Days)||4
8447308|NCT00772967|20817890|P1|STARTED|Break 2 (4-7 Days)||3
8447309|NCT00772967|20817885|P6|NOT COMPLETED|Crossover Treatment 2||0
8447310|NCT00772967|20817886|P5|NOT COMPLETED|Crossover Treatment 2||0
8447311|NCT00772967|20817887|P4|NOT COMPLETED|Crossover Treatment 2||0
8447312|NCT00772967|20817888|P3|NOT COMPLETED|Crossover Treatment 2||0
8447313|NCT00772967|20817889|P2|NOT COMPLETED|Crossover Treatment 2||0
8447314|NCT00772967|20817890|P1|NOT COMPLETED|Crossover Treatment 2||0
8447315|NCT00772967|20817885|P6|COMPLETED|Crossover Treatment 2||3
8447316|NCT00772967|20817886|P5|COMPLETED|Crossover Treatment 2||4
8447317|NCT00772967|20817887|P4|COMPLETED|Crossover Treatment 2||3
8447318|NCT00772967|20817888|P3|COMPLETED|Crossover Treatment 2||3
8447319|NCT00772967|20817889|P2|COMPLETED|Crossover Treatment 2||4
8447320|NCT00772967|20817890|P1|COMPLETED|Crossover Treatment 2||3
8447321|NCT00772967|20817885|P6|STARTED|Crossover Treatment 2||3
8447322|NCT00772967|20817886|P5|STARTED|Crossover Treatment 2||4
8447323|NCT00772967|20817887|P4|STARTED|Crossover Treatment 2||3
8447324|NCT00772967|20817888|P3|STARTED|Crossover Treatment 2||3
8447325|NCT00772967|20817889|P2|STARTED|Crossover Treatment 2||4
8447326|NCT00772967|20817890|P1|STARTED|Crossover Treatment 2||3
8447327|NCT00772967|20817885|P6|NOT COMPLETED|Break 1 (4-7 Days)||0
8447328|NCT00772967|20817886|P5|NOT COMPLETED|Break 1 (4-7 Days)||0
8447329|NCT00772967|20817887|P4|NOT COMPLETED|Break 1 (4-7 Days)||0
8447330|NCT00772967|20817888|P3|NOT COMPLETED|Break 1 (4-7 Days)||0
8447331|NCT00772967|20817889|P2|NOT COMPLETED|Break 1 (4-7 Days)||1
8447332|NCT00772967|20817890|P1|NOT COMPLETED|Break 1 (4-7 Days)||0
8447333|NCT00772967|20817885|P6|COMPLETED|Break 1 (4-7 Days)||3
8447334|NCT00772967|20817886|P5|COMPLETED|Break 1 (4-7 Days)||4
8447335|NCT00772967|20817887|P4|COMPLETED|Break 1 (4-7 Days)||3
8447336|NCT00772967|20817888|P3|COMPLETED|Break 1 (4-7 Days)||3
8447337|NCT00772967|20817889|P2|COMPLETED|Break 1 (4-7 Days)||4
8447338|NCT00772967|20817890|P1|COMPLETED|Break 1 (4-7 Days)||3
8447339|NCT00772967|20817885|P6|STARTED|Break 1 (4-7 Days)||3
8447340|NCT00772967|20817886|P5|STARTED|Break 1 (4-7 Days)||4
8447341|NCT00772967|20817887|P4|STARTED|Break 1 (4-7 Days)||3
8447342|NCT00772967|20817888|P3|STARTED|Break 1 (4-7 Days)||3
8447343|NCT00772967|20817889|P2|STARTED|Break 1 (4-7 Days)||5
8447344|NCT00772967|20817890|P1|STARTED|Break 1 (4-7 Days)||3
8447345|NCT00772967|20817885|P6|NOT COMPLETED|Crossover Treatment 1||0
8447346|NCT00772967|20817886|P5|NOT COMPLETED|Crossover Treatment 1||0
8447347|NCT00772967|20817887|P4|NOT COMPLETED|Crossover Treatment 1||1
8447348|NCT00772967|20817888|P3|NOT COMPLETED|Crossover Treatment 1||0
8447349|NCT00772967|20817889|P2|NOT COMPLETED|Crossover Treatment 1||0
8447350|NCT00772967|20817890|P1|NOT COMPLETED|Crossover Treatment 1||0
8447351|NCT00772967|20817885|P6|COMPLETED|Crossover Treatment 1||3
8447352|NCT00772967|20817886|P5|COMPLETED|Crossover Treatment 1||4
8447353|NCT00772967|20817887|P4|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
8447354|NCT00772967|20817888|P3|COMPLETED|Crossover Treatment 1||3
8447355|NCT00772967|20817889|P2|COMPLETED|Crossover Treatment 1||5
8447356|NCT00772967|20817890|P1|COMPLETED|Crossover Treatment 1||3
8447357|NCT00772967|20817885|P6|STARTED|Crossover Treatment 1||3
8447358|NCT00772967|20817886|P5|STARTED|Crossover Treatment 1||4
8447359|NCT00772967|20817887|P4|STARTED|Crossover Treatment 1||4
8447360|NCT00772967|20817888|P3|STARTED|Crossover Treatment 1||3
8447361|NCT00772967|20817889|P2|STARTED|Crossover Treatment 1||5
8447362|NCT00772967|20817890|P1|STARTED|Crossover Treatment 1||3
8447363|NCT00772954|20817910|P3|NOT COMPLETED|Overall Study||1
8447364|NCT00772954|20817911|P2|NOT COMPLETED|Overall Study||0
8447365|NCT00772954|20817912|P1|NOT COMPLETED|Overall Study||0
8447366|NCT00772954|20817910|P3|COMPLETED|Overall Study||11
8447367|NCT00772954|20817911|P2|COMPLETED|Overall Study||12
8447368|NCT00772954|20817912|P1|COMPLETED|Overall Study||12
8447369|NCT00772954|20817910|P3|STARTED|Overall Study||12
8447370|NCT00772954|20817911|P2|STARTED|Overall Study||12
8447371|NCT00772954|20817912|P1|STARTED|Overall Study||12
8447372|NCT00772941|20817920|P1|NOT COMPLETED|Overall Study||682
8447373|NCT00772941|20817920|P1|COMPLETED|Overall Study||3257
8447374|NCT00772941|20817920|P1|STARTED|Overall Study||3939
8447375|NCT00772928|20817951|P2|NOT COMPLETED|Overall Study||41
8447376|NCT00772928|20817952|P1|NOT COMPLETED|Overall Study||44
8447377|NCT00772928|20817951|P2|COMPLETED|Overall Study||538
8447378|NCT00772928|20817952|P1|COMPLETED|Overall Study||543
8447379|NCT00772928|20817951|P2|STARTED|Overall Study||579
8447380|NCT00772928|20817952|P1|STARTED|Overall Study||587
8447381|NCT00772915|20817962|P1|NOT COMPLETED|Overall Study||15
8447382|NCT00772915|20817962|P1|COMPLETED|Overall Study||23
8447383|NCT00772915|20817962|P1|STARTED|Overall Study||38
8447384|NCT00772889|20817973|P3|NOT COMPLETED|Overall Study||16
8447385|NCT00772889|20817974|P2|NOT COMPLETED|Overall Study||18
8447386|NCT00772889|20817975|P1|NOT COMPLETED|Overall Study||22
8447387|NCT00772889|20817973|P3|COMPLETED|Overall Study||187
8447388|NCT00772889|20817974|P2|COMPLETED|Overall Study||375
8447389|NCT00772889|20817975|P1|COMPLETED|Overall Study||353
8447390|NCT00772889|20817973|P3|Completed at Day 21|Overall Study||203
8447391|NCT00772889|20817974|P2|Completed at Day 21|Overall Study||390
8447392|NCT00772889|20817975|P1|Completed at Day 21|Overall Study||374
8447393|NCT00772889|20817973|P3|STARTED|Overall Study||203
8447394|NCT00772889|20817974|P2|STARTED|Overall Study||393
8447395|NCT00772889|20817975|P1|STARTED|Overall Study||375
8447396|NCT00772772|20818028|P1|NOT COMPLETED|Overall Study||0
8447397|NCT00772772|20818028|P1|COMPLETED|Overall Study||12
8447398|NCT00772772|20818028|P1|STARTED|Overall Study||12
8447399|NCT00772707|20818033|P1|NOT COMPLETED|Overall Study||3
8447400|NCT00772707|20818033|P1|COMPLETED|Overall Study||111
8447401|NCT00772707|20818033|P1|STARTED|Overall Study||114
8447402|NCT00772668|20818038|P1|NOT COMPLETED|Overall Study||3
8447403|NCT00772668|20818038|P1|COMPLETED|Overall Study||0
8447404|NCT00772668|20818038|P1|STARTED|Overall Study||3
8447405|NCT00772629|20818047|P2|NOT COMPLETED|Overall Study||0
8447406|NCT00772629|20818048|P1|NOT COMPLETED|Overall Study||1
8447407|NCT00772629|20818047|P2|COMPLETED|Overall Study||1
8447408|NCT00772629|20818048|P1|COMPLETED|Overall Study||16
8447409|NCT00772629|20818047|P2|STARTED|Overall Study||1
8447410|NCT00772629|20818048|P1|STARTED|Overall Study||17
8447411|NCT00772603|20818057|P3|NOT COMPLETED|Overall Study||26
8447412|NCT00772603|20818058|P2|NOT COMPLETED|Overall Study||40
8447413|NCT00772603|20818059|P1|NOT COMPLETED|Overall Study||52
8447414|NCT00772603|20818057|P3|COMPLETED|Overall Study||95
8447415|NCT00772603|20818058|P2|COMPLETED|Overall Study||82
8447416|NCT00772603|20818059|P1|COMPLETED|Overall Study||71
8447417|NCT00772603|20818057|P3|STARTED|Overall Study||121
8447418|NCT00772603|20818058|P2|STARTED|Overall Study||122
8447419|NCT00772603|20818059|P1|STARTED|Overall Study||123
8447420|NCT00772590|20818083|P4|NOT COMPLETED|Overall Study||0
8447421|NCT00772590|20818084|P3|NOT COMPLETED|Overall Study||0
8447422|NCT00772590|20818085|P2|NOT COMPLETED|Overall Study||0
8447423|NCT00772590|20818086|P1|NOT COMPLETED|Overall Study||0
8447424|NCT00772590|20818083|P4|COMPLETED|Overall Study||17
8447425|NCT00772590|20818084|P3|COMPLETED|Overall Study||18
8447426|NCT00772590|20818085|P2|COMPLETED|Overall Study||19
8447427|NCT00772590|20818086|P1|COMPLETED|Overall Study||19
8447428|NCT00772590|20818083|P4|STARTED|Overall Study||17
8447429|NCT00772590|20818084|P3|STARTED|Overall Study||18
8447430|NCT00772590|20818085|P2|STARTED|Overall Study||19
8447431|NCT00772590|20818086|P1|STARTED|Overall Study||19
8447432|NCT00772577|20818098|P2|NOT COMPLETED|Overall Study||23
8447433|NCT00772577|20818099|P1|NOT COMPLETED|Overall Study||23
8447434|NCT00772577|20818098|P2|COMPLETED|Overall Study||170
8447435|NCT00772577|20818099|P1|COMPLETED|Overall Study||170
8447436|NCT00772577|20818098|P2|STARTED|Overall Study||193
8447437|NCT00772577|20818099|P1|STARTED|Overall Study||193
8447438|NCT00772538|20818115|P2|NOT COMPLETED|Overall Study||26
8447439|NCT00772538|20818116|P1|NOT COMPLETED|Overall Study||20
8447440|NCT00772538|20818115|P2|COMPLETED|Overall Study||211
8447441|NCT00772538|20818116|P1|COMPLETED|Overall Study||202
8447442|NCT00772538|20818115|P2|STARTED|Overall Study||237
8447443|NCT00772538|20818116|P1|STARTED|Overall Study||222
8447444|NCT00772447|20818188|P2|NOT COMPLETED|Overall Study||24
8447445|NCT00772447|20818189|P1|NOT COMPLETED|Overall Study||20
8447446|NCT00772447|20818188|P2|COMPLETED|Overall Study||110
8447447|NCT00772447|20818189|P1|COMPLETED|Overall Study||111
8447448|NCT00772447|20818188|P2|STARTED|Overall Study||134
8447449|NCT00772447|20818189|P1|STARTED|Overall Study||131
8447450|NCT00772382|20818217|P1|NOT COMPLETED|Overall Study||55
8447451|NCT00772382|20818217|P1|COMPLETED|Overall Study||61
8447452|NCT00772382|20818217|P1|STARTED|Overall Study||116
8447453|NCT00772369|20818222|P1|NOT COMPLETED|Overall Study||1
8447454|NCT00772369|20818222|P1|COMPLETED|Overall Study||3213
8447455|NCT00772369|20818222|P1|STARTED|Overall Study||3214
8447456|NCT00772304|20818227|P1|NOT COMPLETED|Overall Study||0
8447457|NCT00772304|20818227|P1|COMPLETED|Overall Study||102
8447458|NCT00772304|20818227|P1|STARTED|Overall Study||102
8447459|NCT00772148|20818233|P2|NOT COMPLETED|Maintenance Phase (Week 52)||5
8447460|NCT00772148|20818234|P1|NOT COMPLETED|Maintenance Phase (Week 52)||4
8447461|NCT00772148|20818233|P2|COMPLETED|Maintenance Phase (Week 52)||18
8447462|NCT00772148|20818234|P1|COMPLETED|Maintenance Phase (Week 52)||17
8447463|NCT00772148|20818233|P2|STARTED|Maintenance Phase (Week 52)||23
8447464|NCT00772148|20818234|P1|STARTED|Maintenance Phase (Week 52)||21
8447465|NCT00772148|20818233|P2|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
8447466|NCT00772148|20818234|P1|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
8447467|NCT00772148|20818233|P2|COMPLETED|Pharmacokinetic Phase (14 Days)||23
8447468|NCT00772148|20818234|P1|COMPLETED|Pharmacokinetic Phase (14 Days)||21
8447469|NCT00772148|20818233|P2|STARTED|Pharmacokinetic Phase (14 Days)||29
8447470|NCT00772148|20818234|P1|STARTED|Pharmacokinetic Phase (14 Days)||29
8447471|NCT00772109|20818254|P4|NOT COMPLETED|Overall Study||31
8447472|NCT00772109|20818255|P3|NOT COMPLETED|Overall Study||19
8447473|NCT00772109|20818256|P2|NOT COMPLETED|Overall Study||19
8447474|NCT00772109|20818257|P1|NOT COMPLETED|Overall Study||21
8447475|NCT00772109|20818254|P4|COMPLETED|Overall Study||1397
8447476|NCT00772109|20818255|P3|COMPLETED|Overall Study||936
8447477|NCT00772109|20818256|P2|COMPLETED|Overall Study||934
8447478|NCT00772109|20818257|P1|COMPLETED|Overall Study||935
8447479|NCT00772109|20818254|P4|STARTED|Overall Study||1428
8447480|NCT00772109|20818255|P3|STARTED|Overall Study||955
8447481|NCT00772109|20818256|P2|STARTED|Overall Study||953
8447482|NCT00772109|20818257|P1|STARTED|Overall Study||956
8447483|NCT00772070|20818281|P2|NOT COMPLETED|Overall Study||10
8447484|NCT00772070|20818282|P1|NOT COMPLETED|Overall Study||2
8447485|NCT00772070|20818281|P2|COMPLETED|Overall Study||61
8447486|NCT00772070|20818282|P1|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
8447487|NCT00772070|20818281|P2|STARTED|Overall Study||71
8447488|NCT00772070|20818282|P1|STARTED|Overall Study||102
8447489|NCT00772031|20818294|P2|NOT COMPLETED|Overall Study||43
8447490|NCT00772031|20818295|P1|NOT COMPLETED|Overall Study||32
8447491|NCT00772031|20818294|P2|COMPLETED|Overall Study||52
8447492|NCT00772031|20818295|P1|COMPLETED|Overall Study||64
8447493|NCT00772031|20818294|P2|STARTED|Overall Study||95
8447494|NCT00772031|20818295|P1|STARTED|Overall Study||96
8447495|NCT00772005|20818321|P4|NOT COMPLETED|Overall Study||26
8447496|NCT00772005|20818322|P3|NOT COMPLETED|Overall Study||28
8447497|NCT00772005|20818323|P2|NOT COMPLETED|Overall Study||30
8447498|NCT00772005|20818324|P1|NOT COMPLETED|Overall Study||25
8447499|NCT00772005|20818321|P4|COMPLETED|Overall Study||46
8447500|NCT00772005|20818322|P3|COMPLETED|Overall Study||44
8447501|NCT00772005|20818323|P2|COMPLETED|Overall Study||40
8447502|NCT00772005|20818324|P1|COMPLETED|Overall Study||46
8447503|NCT00772005|20818321|P4|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
8447504|NCT00772005|20818322|P3|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
8447505|NCT00772005|20818323|P2|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
8447506|NCT00772005|20818324|P1|STARTED|Overall Study||71
8447507|NCT00771953|20819012|P2|NOT COMPLETED|Overall Study||10
8447508|NCT00771953|20819013|P1|NOT COMPLETED|Overall Study||10
8447509|NCT00771953|20819012|P2|COMPLETED|Overall Study||26
8447510|NCT00771953|20819013|P1|COMPLETED|Overall Study||26
8447511|NCT00771953|20819012|P2|STARTED|Overall Study||36
8447512|NCT00771953|20819013|P1|STARTED|Overall Study||36
8447513|NCT00771927|20819023|P2|NOT COMPLETED|Overall Study||237
8447514|NCT00771927|20819024|P1|NOT COMPLETED|Overall Study||255
8447515|NCT00771927|20819023|P2|COMPLETED|Overall Study||256
8447516|NCT00771927|20819024|P1|COMPLETED|Overall Study||256
8447517|NCT00771927|20819023|P2|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
8447518|NCT00771927|20819024|P1|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
8447519|NCT00771914|20819036|P4|NOT COMPLETED|Overall Study||2
8447520|NCT00771914|20819037|P3|NOT COMPLETED|Overall Study||0
8447521|NCT00771914|20819038|P2|NOT COMPLETED|Overall Study||0
8447522|NCT00771914|20819039|P1|NOT COMPLETED|Overall Study||0
8447523|NCT00771914|20819036|P4|COMPLETED|Overall Study||6
8447524|NCT00771914|20819037|P3|COMPLETED|Overall Study||6
8447525|NCT00771914|20819038|P2|COMPLETED|Overall Study||6
8447526|NCT00771914|20819039|P1|COMPLETED|Overall Study||7
8447527|NCT00771914|20819036|P4|STARTED|Overall Study||8
8447528|NCT00771914|20819037|P3|STARTED|Overall Study||6
8447529|NCT00771914|20819038|P2|STARTED|Overall Study||6
8447530|NCT00771914|20819039|P1|STARTED|Overall Study||7
8447531|NCT00771901|20819052|P3|NOT COMPLETED|Overall Study||4
8447532|NCT00771901|20819053|P2|NOT COMPLETED|Overall Study||0
8447533|NCT00771901|20819054|P1|NOT COMPLETED|Overall Study||0
8447534|NCT00771901|20819052|P3|COMPLETED|Overall Study||6
8447535|NCT00771901|20819053|P2|COMPLETED|Overall Study||10
8447536|NCT00771901|20819054|P1|COMPLETED|Overall Study||10
8447537|NCT00771901|20819052|P3|STARTED|Overall Study||10
8447538|NCT00771901|20819053|P2|STARTED|Overall Study||10
8447539|NCT00771901|20819054|P1|STARTED|Overall Study||10
8447540|NCT00771875|20819071|P3|NOT COMPLETED|Overall Study||0
8447541|NCT00771875|20819072|P2|NOT COMPLETED|Overall Study||1
8447542|NCT00771875|20819073|P1|NOT COMPLETED|Overall Study||0
8447543|NCT00771875|20819071|P3|COMPLETED|Overall Study||10
8447544|NCT00771875|20819072|P2|COMPLETED|Overall Study||9
8447545|NCT00771875|20819073|P1|COMPLETED|Overall Study||10
8447546|NCT00771875|20819071|P3|STARTED|Overall Study||10
8447547|NCT00771875|20819072|P2|STARTED|Overall Study||10
8447548|NCT00771875|20819073|P1|STARTED|Overall Study||10
8447549|NCT00771849|20819101|P2|NOT COMPLETED|Overall Study||4
8447550|NCT00771849|20819102|P1|NOT COMPLETED|Overall Study||2
8447551|NCT00771849|20819101|P2|COMPLETED|Overall Study||47
8447552|NCT00771849|20819102|P1|COMPLETED|Overall Study||50
8447553|NCT00771849|20819101|P2|STARTED|Overall Study|One subject was not vaccinated|51
8447554|NCT00771849|20819102|P1|STARTED|Overall Study||52
8447555|NCT00771810|20819113|P3|NOT COMPLETED|Overall Study||7
8447556|NCT00771810|20819114|P2|NOT COMPLETED|Overall Study||5
8447557|NCT00771810|20819115|P1|NOT COMPLETED|Overall Study||5
8447558|NCT00771810|20819113|P3|COMPLETED|Overall Study||6
8447559|NCT00771810|20819114|P2|COMPLETED|Overall Study||6
8447560|NCT00771810|20819115|P1|COMPLETED|Overall Study||5
8447561|NCT00771810|20819113|P3|STARTED|Overall Study||13
8447562|NCT00771810|20819114|P2|STARTED|Overall Study||11
8447563|NCT00771810|20819115|P1|STARTED|Overall Study||10
8447564|NCT00771758|20819153|P3|NOT COMPLETED|Overall Study||2
8447565|NCT00771758|20819154|P2|NOT COMPLETED|Overall Study||12
8447566|NCT00771758|20819155|P1|NOT COMPLETED|Overall Study||8
8447567|NCT00771758|20819153|P3|COMPLETED|Overall Study||19
8447568|NCT00771758|20819154|P2|COMPLETED|Overall Study||31
8447569|NCT00771758|20819155|P1|COMPLETED|Overall Study||36
8447570|NCT00771758|20819153|P3|STARTED|Overall Study||21
8447571|NCT00771758|20819154|P2|STARTED|Overall Study||43
8447572|NCT00771758|20819155|P1|STARTED|Overall Study||44
8447573|NCT00771745|20819305|P2|NOT COMPLETED|Overall Study||0
8447574|NCT00771745|20819306|P1|NOT COMPLETED|Overall Study||0
8447575|NCT00771745|20819305|P2|COMPLETED|Overall Study||5
8447576|NCT00771745|20819306|P1|COMPLETED|Overall Study||6
8447577|NCT00771745|20819305|P2|STARTED|Overall Study||5
8447578|NCT00771745|20819306|P1|STARTED|Overall Study||6
8447579|NCT00771667|20819316|P10|NOT COMPLETED|Maintenance Phase||17
8447580|NCT00771667|20819317|P9|NOT COMPLETED|Maintenance Phase||22
8447581|NCT00771667|20819318|P8|NOT COMPLETED|Maintenance Phase||5
8447582|NCT00771667|20819319|P7|NOT COMPLETED|Maintenance Phase||10
8447583|NCT00771667|20819320|P6|NOT COMPLETED|Maintenance Phase||7
8447584|NCT00771667|20819321|P5|NOT COMPLETED|Maintenance Phase||2
8447585|NCT00771667|20819322|P4|NOT COMPLETED|Maintenance Phase||0
8447586|NCT00771667|20819323|P3|NOT COMPLETED|Maintenance Phase||0
8447587|NCT00771667|20819324|P2|NOT COMPLETED|Maintenance Phase||0
8447588|NCT00771667|20819325|P1|NOT COMPLETED|Maintenance Phase||0
8447589|NCT00771667|20819316|P10|COMPLETED|Maintenance Phase||92
8447590|NCT00771667|20819317|P9|COMPLETED|Maintenance Phase||88
8447591|NCT00771667|20819318|P8|COMPLETED|Maintenance Phase||67
8447592|NCT00771667|20819319|P7|COMPLETED|Maintenance Phase||63
8447593|NCT00771667|20819320|P6|COMPLETED|Maintenance Phase||78
8447594|NCT00771667|20819321|P5|COMPLETED|Maintenance Phase||26
8447595|NCT00771667|20819322|P4|COMPLETED|Maintenance Phase||0
8447596|NCT00771667|20819323|P3|COMPLETED|Maintenance Phase||0
8447597|NCT00771667|20819324|P2|COMPLETED|Maintenance Phase||0
8447598|NCT00771667|20819325|P1|COMPLETED|Maintenance Phase||0
8447599|NCT00771667|20819316|P10|STARTED|Maintenance Phase||109
8447600|NCT00771667|20819317|P9|STARTED|Maintenance Phase||110
8447601|NCT00771667|20819318|P8|STARTED|Maintenance Phase||72
8447602|NCT00771667|20819319|P7|STARTED|Maintenance Phase||73
8447603|NCT00771667|20819320|P6|STARTED|Maintenance Phase||85
8447604|NCT00771667|20819321|P5|STARTED|Maintenance Phase||28
8447605|NCT00771667|20819322|P4|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
8447606|NCT00771667|20819323|P3|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
8447607|NCT00771667|20819324|P2|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
8447608|NCT00771667|20819325|P1|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
8447609|NCT00771667|20819316|P10|NOT COMPLETED|Induction Phase||0
8447610|NCT00771667|20819317|P9|NOT COMPLETED|Induction Phase||0
8447611|NCT00771667|20819318|P8|NOT COMPLETED|Induction Phase||0
8447612|NCT00771667|20819319|P7|NOT COMPLETED|Induction Phase||0
8447613|NCT00771667|20819320|P6|NOT COMPLETED|Induction Phase||0
8447614|NCT00771667|20819321|P5|NOT COMPLETED|Induction Phase||0
8447615|NCT00771667|20819322|P4|NOT COMPLETED|Induction Phase||8
8447616|NCT00771667|20819323|P3|NOT COMPLETED|Induction Phase||12
8447617|NCT00771667|20819324|P2|NOT COMPLETED|Induction Phase||10
8447618|NCT00771667|20819325|P1|NOT COMPLETED|Induction Phase||19
8447619|NCT00771667|20819316|P10|COMPLETED|Induction Phase||0
8447620|NCT00771667|20819317|P9|COMPLETED|Induction Phase||0
8447621|NCT00771667|20819318|P8|COMPLETED|Induction Phase||0
8447622|NCT00771667|20819319|P7|COMPLETED|Induction Phase||0
8447623|NCT00771667|20819320|P6|COMPLETED|Induction Phase||0
8447624|NCT00771667|20819321|P5|COMPLETED|Induction Phase||0
8447625|NCT00771667|20819322|P4|COMPLETED|Induction Phase||123
8447626|NCT00771667|20819323|P3|COMPLETED|Induction Phase||120
8447627|NCT00771667|20819324|P2|COMPLETED|Induction Phase||121
8447628|NCT00771667|20819325|P1|COMPLETED|Induction Phase||113
8447629|NCT00771667|20819316|P10|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8447630|NCT00771667|20819317|P9|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8447631|NCT00771667|20819318|P8|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8447632|NCT00771667|20819319|P7|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8447633|NCT00771667|20819320|P6|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8447634|NCT00771667|20819321|P5|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
8447635|NCT00771667|20819322|P4|STARTED|Induction Phase||131
8447636|NCT00771667|20819323|P3|STARTED|Induction Phase||132
8447637|NCT00771667|20819324|P2|STARTED|Induction Phase||131
8447638|NCT00771667|20819325|P1|STARTED|Induction Phase||132
8447639|NCT00771615|20819370|P9|NOT COMPLETED|Overall Study||0
8447640|NCT00771615|20819371|P8|NOT COMPLETED|Overall Study||1
8447641|NCT00771615|20819372|P7|NOT COMPLETED|Overall Study||1
8447642|NCT00771615|20819373|P6|NOT COMPLETED|Overall Study||1
8447643|NCT00771615|20819374|P5|NOT COMPLETED|Overall Study||0
8447644|NCT00771615|20819375|P4|NOT COMPLETED|Overall Study||1
8447645|NCT00771615|20819376|P3|NOT COMPLETED|Overall Study||1
8447646|NCT00771615|20819377|P2|NOT COMPLETED|Overall Study||2
8447647|NCT00771615|20819378|P1|NOT COMPLETED|Overall Study||1
8447648|NCT00771615|20819370|P9|COMPLETED|Overall Study|Up to Day 364|41
8447649|NCT00771615|20819371|P8|COMPLETED|Overall Study|Up to Day 364|58
8447650|NCT00771615|20819372|P7|COMPLETED|Overall Study|Up to Day 364|45
8447651|NCT00771615|20819373|P6|COMPLETED|Overall Study|Up to Day 364|60
8447652|NCT00771615|20819374|P5|COMPLETED|Overall Study|Up to Day 364|40
8447653|NCT00771615|20819375|P4|COMPLETED|Overall Study|Up to Day 364|59
8447654|NCT00771615|20819376|P3|COMPLETED|Overall Study|Up to Day 364|40
8447655|NCT00771615|20819377|P2|COMPLETED|Overall Study|Up to Day 364|70
8447656|NCT00771615|20819378|P1|COMPLETED|Overall Study|Up to Day 364|48
8447657|NCT00771615|20819370|P9|STARTED|Overall Study||41
8447658|NCT00771615|20819371|P8|STARTED|Overall Study||59
8447659|NCT00771615|20819372|P7|STARTED|Overall Study||46
8447660|NCT00771615|20819373|P6|STARTED|Overall Study||61
8447661|NCT00771615|20819374|P5|STARTED|Overall Study||40
8447662|NCT00771615|20819375|P4|STARTED|Overall Study||60
8447663|NCT00771615|20819376|P3|STARTED|Overall Study||41
8447664|NCT00771615|20819377|P2|STARTED|Overall Study||72
8447665|NCT00771615|20819378|P1|STARTED|Overall Study||49
8447666|NCT00771602|20819572|P3|NOT COMPLETED|Overall Study||0
8447667|NCT00771602|20819573|P2|NOT COMPLETED|Overall Study||0
8447668|NCT00771602|20819574|P1|NOT COMPLETED|Overall Study||0
8447669|NCT00771602|20819572|P3|COMPLETED|Overall Study||0
8447670|NCT00771602|20819573|P2|COMPLETED|Overall Study||0
8447671|NCT00771602|20819574|P1|COMPLETED|Overall Study||1
8447672|NCT00771602|20819572|P3|STARTED|Overall Study||0
8447673|NCT00771602|20819573|P2|STARTED|Overall Study||0
8447674|NCT00771602|20819574|P1|STARTED|Overall Study||1
8447675|NCT00771537|20819598|P16|NOT COMPLETED|Overall Study||0
8447676|NCT00771537|20819599|P15|NOT COMPLETED|Overall Study||0
8447677|NCT00771537|20819600|P14|NOT COMPLETED|Overall Study||0
8447678|NCT00771537|20819601|P13|NOT COMPLETED|Overall Study||0
8447679|NCT00771537|20819602|P12|NOT COMPLETED|Overall Study||0
8447680|NCT00771537|20819603|P11|NOT COMPLETED|Overall Study||0
8447681|NCT00771537|20819604|P10|NOT COMPLETED|Overall Study||0
8447682|NCT00771537|20819605|P9|NOT COMPLETED|Overall Study||0
8447683|NCT00771537|20819606|P8|NOT COMPLETED|Overall Study||0
8447684|NCT00771537|20819607|P7|NOT COMPLETED|Overall Study||0
8447685|NCT00771537|20819608|P6|NOT COMPLETED|Overall Study||0
8447686|NCT00771537|20819609|P5|NOT COMPLETED|Overall Study||0
8447687|NCT00771537|20819610|P4|NOT COMPLETED|Overall Study||0
8447688|NCT00771537|20819611|P3|NOT COMPLETED|Overall Study||0
8447689|NCT00771537|20819612|P2|NOT COMPLETED|Overall Study||0
8447690|NCT00771537|20819613|P1|NOT COMPLETED|Overall Study||0
8447691|NCT00771537|20819598|P16|COMPLETED|Overall Study||122
8447692|NCT00771537|20819599|P15|COMPLETED|Overall Study||124
8447693|NCT00771537|20819600|P14|COMPLETED|Overall Study||124
8447694|NCT00771537|20819601|P13|COMPLETED|Overall Study||128
8447695|NCT00771537|20819602|P12|COMPLETED|Overall Study||137
8447696|NCT00771537|20819603|P11|COMPLETED|Overall Study||133
8447697|NCT00771537|20819604|P10|COMPLETED|Overall Study||119
8447698|NCT00771537|20819605|P9|COMPLETED|Overall Study||115
8447699|NCT00771537|20819606|P8|COMPLETED|Overall Study||132
8447700|NCT00771537|20819607|P7|COMPLETED|Overall Study||128
8447701|NCT00771537|20819608|P6|COMPLETED|Overall Study||118
8447702|NCT00771537|20819609|P5|COMPLETED|Overall Study||127
8447703|NCT00771537|20819610|P4|COMPLETED|Overall Study||114
8447704|NCT00771537|20819611|P3|COMPLETED|Overall Study||151
8447705|NCT00771537|20819612|P2|COMPLETED|Overall Study||124
8447706|NCT00771537|20819613|P1|COMPLETED|Overall Study||135
8447707|NCT00771537|20819598|P16|STARTED|Overall Study||122
8447708|NCT00771537|20819599|P15|STARTED|Overall Study||124
8447709|NCT00771537|20819600|P14|STARTED|Overall Study||124
8447710|NCT00771537|20819601|P13|STARTED|Overall Study||128
8447711|NCT00771537|20819602|P12|STARTED|Overall Study||137
8447712|NCT00771537|20819603|P11|STARTED|Overall Study||133
8447713|NCT00771537|20819604|P10|STARTED|Overall Study||119
8447714|NCT00771537|20819605|P9|STARTED|Overall Study||115
8447715|NCT00771537|20819606|P8|STARTED|Overall Study||132
8447716|NCT00771537|20819607|P7|STARTED|Overall Study||128
8447717|NCT00771537|20819608|P6|STARTED|Overall Study||118
8447718|NCT00771537|20819609|P5|STARTED|Overall Study||127
8447719|NCT00771537|20819610|P4|STARTED|Overall Study||114
8447720|NCT00771537|20819611|P3|STARTED|Overall Study||151
8447721|NCT00771537|20819612|P2|STARTED|Overall Study||124
8447722|NCT00771537|20819613|P1|STARTED|Overall Study||135
8447723|NCT00771472|20819639|P2|NOT COMPLETED|Overall Study||4
8447724|NCT00771472|20819640|P1|NOT COMPLETED|Overall Study||6
8447725|NCT00771472|20819639|P2|COMPLETED|Overall Study||0
8447726|NCT00771472|20819640|P1|COMPLETED|Overall Study||0
8447727|NCT00771472|20819639|P2|STARTED|Overall Study||4
8447728|NCT00771472|20819640|P1|STARTED|Overall Study||6
8447729|NCT00771407|20819651|P2|NOT COMPLETED|Overall Study||25
8447730|NCT00771407|20819652|P1|NOT COMPLETED|Overall Study||20
8447731|NCT00771407|20819651|P2|COMPLETED|Overall Study||35
8447732|NCT00771407|20819652|P1|COMPLETED|Overall Study||40
8447733|NCT00771407|20819651|P2|STARTED|Overall Study||60
8447734|NCT00771407|20819652|P1|STARTED|Overall Study||60
8447735|NCT00771316|20819660|P2|NOT COMPLETED|Overall Study||1
8447736|NCT00771316|20819661|P1|NOT COMPLETED|Overall Study||2
8447737|NCT00771316|20819660|P2|COMPLETED|Overall Study||1
8447738|NCT00771316|20819661|P1|COMPLETED|Overall Study||2
8447739|NCT00771316|20819660|P2|STARTED|Overall Study||2
8447740|NCT00771316|20819661|P1|STARTED|Overall Study||4
8447741|NCT00771277|20819671|P1|NOT COMPLETED|Overall Study||0
8447742|NCT00771277|20819671|P1|COMPLETED|Overall Study||6
8447743|NCT00771277|20819671|P1|STARTED|Overall Study||6
8447744|NCT00771264|20819679|P2|NOT COMPLETED|Overall Study||5
8447745|NCT00771264|20819680|P1|NOT COMPLETED|Overall Study||7
8447746|NCT00771264|20819679|P2|COMPLETED|Overall Study||105
8447747|NCT00771264|20819680|P1|COMPLETED|Overall Study||103
8447748|NCT00771264|20819679|P2|STARTED|Overall Study||110
8447749|NCT00771264|20819680|P1|STARTED|Overall Study||110
8447750|NCT00771238|20819688|P2|NOT COMPLETED|Overall Study||0
8447751|NCT00771238|20819689|P1|NOT COMPLETED|Overall Study||0
8447752|NCT00771238|20819688|P2|COMPLETED|Overall Study||21
8447753|NCT00771238|20819689|P1|COMPLETED|Overall Study||31
8447754|NCT00771238|20819688|P2|STARTED|Overall Study||21
8447755|NCT00771238|20819689|P1|STARTED|Overall Study||31
8447756|NCT00771173|20819699|P2|NOT COMPLETED|Overall Study||17
8447757|NCT00771173|20819700|P1|NOT COMPLETED|Overall Study||22
8447758|NCT00771173|20819699|P2|COMPLETED|Overall Study||112
8447759|NCT00771173|20819700|P1|COMPLETED|Overall Study||107
8447760|NCT00771173|20819699|P2|STARTED|Overall Study||129
8447761|NCT00771173|20819700|P1|STARTED|Overall Study||129
8447762|NCT00771056|20819706|P1|NOT COMPLETED|Overall Study||5
8447763|NCT00771056|20819706|P1|COMPLETED|Overall Study||18
8447764|NCT00771056|20819706|P1|STARTED|Overall Study||23
8447765|NCT00770991|20819713|P2|NOT COMPLETED|Overall Study||5
8447766|NCT00770991|20819714|P1|NOT COMPLETED|Overall Study||5
8447767|NCT00770991|20819713|P2|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
8447768|NCT00770991|20819714|P1|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
8447769|NCT00770991|20819713|P2|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
8447770|NCT00770991|20819714|P1|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
8447771|NCT00770965|20819730|P4|NOT COMPLETED|Excluded Set||13
8447772|NCT00770965|20819731|P3|NOT COMPLETED|Excluded Set||14
8447773|NCT00770965|20819732|P2|NOT COMPLETED|Excluded Set||13
8447774|NCT00770965|20819733|P1|NOT COMPLETED|Excluded Set||15
8447775|NCT00770965|20819730|P4|COMPLETED|Excluded Set||2
8447776|NCT00770965|20819731|P3|COMPLETED|Excluded Set||2
8447777|NCT00770965|20819732|P2|COMPLETED|Excluded Set||3
8447778|NCT00770965|20819733|P1|COMPLETED|Excluded Set||3
8447779|NCT00770965|20819730|P4|STARTED|Excluded Set||15
8447780|NCT00770965|20819731|P3|STARTED|Excluded Set||16
8447781|NCT00770965|20819732|P2|STARTED|Excluded Set||16
8447782|NCT00770965|20819733|P1|STARTED|Excluded Set||18
8447783|NCT00770965|20819730|P4|NOT COMPLETED|Safety Set||1
8447784|NCT00770965|20819731|P3|NOT COMPLETED|Safety Set||1
8447785|NCT00770965|20819732|P2|NOT COMPLETED|Safety Set||0
8447786|NCT00770965|20819733|P1|NOT COMPLETED|Safety Set||0
8447787|NCT00770965|20819730|P4|COMPLETED|Safety Set||4
8447788|NCT00770965|20819731|P3|COMPLETED|Safety Set||3
8447789|NCT00770965|20819732|P2|COMPLETED|Safety Set||4
8447790|NCT00770965|20819733|P1|COMPLETED|Safety Set||2
8447791|NCT00770965|20819730|P4|STARTED|Safety Set||5
8447792|NCT00770965|20819731|P3|STARTED|Safety Set||4
8447793|NCT00770965|20819732|P2|STARTED|Safety Set||4
8447794|NCT00770965|20819733|P1|STARTED|Safety Set||2
8447795|NCT00770913|20819754|P3|NOT COMPLETED|Overall Study||13
8447796|NCT00770913|20819755|P2|NOT COMPLETED|Overall Study||8
8447797|NCT00770913|20819756|P1|NOT COMPLETED|Overall Study||11
8447798|NCT00770913|20819754|P3|COMPLETED|Overall Study||100
8447799|NCT00770913|20819755|P2|COMPLETED|Overall Study||103
8447800|NCT00770913|20819756|P1|COMPLETED|Overall Study||102
8447801|NCT00770913|20819754|P3|STARTED|Overall Study||113
8447802|NCT00770913|20819755|P2|STARTED|Overall Study||111
8447803|NCT00770913|20819756|P1|STARTED|Overall Study||113
8447804|NCT00770874|20819766|P2|NOT COMPLETED|Overall Study||0
8447805|NCT00770874|20819767|P1|NOT COMPLETED|Overall Study||0
8447806|NCT00770874|20819766|P2|COMPLETED|Overall Study||176
8447807|NCT00770874|20819767|P1|COMPLETED|Overall Study||188
8447808|NCT00770874|20819766|P2|STARTED|Overall Study||176
8447809|NCT00770874|20819767|P1|STARTED|Overall Study||188
8447810|NCT00770861|20819777|P2|NOT COMPLETED|Overall Study||16
8447811|NCT00770861|20819778|P1|NOT COMPLETED|Overall Study||10
8447812|NCT00770861|20819777|P2|COMPLETED|Overall Study||120
8447813|NCT00770861|20819778|P1|COMPLETED|Overall Study||131
8447814|NCT00770861|20819777|P2|STARTED|Overall Study||136
8447815|NCT00770861|20819778|P1|STARTED|Overall Study||141
8447825|NCT00770770|20819801|P2|NOT COMPLETED|Overall Study||1
8447826|NCT00770770|20819802|P1|NOT COMPLETED|Overall Study||10
8447827|NCT00770770|20819801|P2|COMPLETED|Overall Study||5
8447828|NCT00770770|20819802|P1|COMPLETED|Overall Study||4
8447829|NCT00770770|20819801|P2|STARTED|Overall Study||6
8447830|NCT00770770|20819802|P1|STARTED|Overall Study||14
8447831|NCT00770757|20819808|P1|NOT COMPLETED|Overall Study||0
8447832|NCT00770757|20819808|P1|COMPLETED|Overall Study||13
8447833|NCT00770757|20819808|P1|STARTED|Overall Study||13
8447834|NCT00770692|20819820|P4|NOT COMPLETED|Overall Study||11
8447835|NCT00770692|20819821|P3|NOT COMPLETED|Overall Study||14
8447836|NCT00770692|20819822|P2|NOT COMPLETED|Overall Study||9
8447837|NCT00770692|20819823|P1|NOT COMPLETED|Overall Study||12
8447838|NCT00770692|20819820|P4|COMPLETED|Overall Study||66
8447839|NCT00770692|20819821|P3|COMPLETED|Overall Study||70
8447840|NCT00770692|20819822|P2|COMPLETED|Overall Study||74
8447841|NCT00770692|20819823|P1|COMPLETED|Overall Study||69
8447842|NCT00770692|20819820|P4|STARTED|Overall Study||77
8447843|NCT00770692|20819821|P3|STARTED|Overall Study||84
8447844|NCT00770692|20819822|P2|STARTED|Overall Study||83
8447845|NCT00770692|20819823|P1|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
8447846|NCT00770679|20819849|P1|NOT COMPLETED|Overall Study||6
8447847|NCT00770679|20819849|P1|COMPLETED|Overall Study||10
8447848|NCT00770679|20819849|P1|STARTED|Overall Study||16
8447849|NCT00770653|20819857|P2|NOT COMPLETED|Overall Study||29
8447850|NCT00770653|20819858|P1|NOT COMPLETED|Overall Study||32
8447851|NCT00770653|20819857|P2|COMPLETED|Overall Study||121
8447852|NCT00770653|20819858|P1|COMPLETED|Overall Study||123
8447853|NCT00770653|20819857|P2|STARTED|Overall Study||150
8447854|NCT00770653|20819858|P1|STARTED|Overall Study||155
8447855|NCT00770588|20819928|P2|NOT COMPLETED|Overall Study||95
8447856|NCT00770588|20819929|P1|NOT COMPLETED|Overall Study||81
8447857|NCT00770588|20819928|P2|COMPLETED|Overall Study||53
8447858|NCT00770588|20819929|P1|COMPLETED|Overall Study||67
8447859|NCT00770588|20819928|P2|STARTED|Overall Study||148
8447860|NCT00770588|20819929|P1|STARTED|Overall Study||148
8447861|NCT00770562|20819945|P2|NOT COMPLETED|Overall Study||1
8447862|NCT00770562|20819946|P1|NOT COMPLETED|Overall Study||1
8447863|NCT00770562|20819945|P2|COMPLETED|Overall Study||49
8447864|NCT00770562|20819946|P1|COMPLETED|Overall Study||52
8447865|NCT00770562|20819945|P2|STARTED|Overall Study||50
8447866|NCT00770562|20819946|P1|STARTED|Overall Study||53
8447867|NCT00770510|20819957|P1|NOT COMPLETED|Overall Study||5
8447868|NCT00770510|20819957|P1|COMPLETED|Overall Study||67
8447869|NCT00770510|20819957|P1|STARTED|Overall Study||72
8447870|NCT00770484|20819996|P2|NOT COMPLETED|Overall Study||0
8447871|NCT00770484|20819997|P1|NOT COMPLETED|Overall Study||1
8447872|NCT00770484|20819996|P2|COMPLETED|Overall Study||4
8447873|NCT00770484|20819997|P1|COMPLETED|Overall Study||7
8447874|NCT00770484|20819996|P2|STARTED|Overall Study||4
8447875|NCT00770484|20819997|P1|STARTED|Overall Study||8
8447876|NCT00770432|20820005|P2|NOT COMPLETED|Overall Study||7
8447877|NCT00770432|20820006|P1|NOT COMPLETED|Overall Study||4
8447878|NCT00770432|20820005|P2|COMPLETED|Overall Study||94
8447879|NCT00770432|20820006|P1|COMPLETED|Overall Study||98
8447880|NCT00770432|20820005|P2|STARTED|Overall Study||101
8447881|NCT00770432|20820006|P1|STARTED|Overall Study||102
8447882|NCT00770367|20820014|P2|NOT COMPLETED|Second Intervention||0
8447883|NCT00770367|20820015|P1|NOT COMPLETED|Second Intervention||2
8447884|NCT00770367|20820014|P2|COMPLETED|Second Intervention||15
8447885|NCT00770367|20820015|P1|COMPLETED|Second Intervention||16
8447886|NCT00770367|20820014|P2|STARTED|Second Intervention||15
8447887|NCT00770367|20820015|P1|STARTED|Second Intervention||18
8447888|NCT00770367|20820014|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
8447889|NCT00770367|20820015|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
8447890|NCT00770367|20820014|P2|COMPLETED|Washout Period of 4 Weeks||15
8447891|NCT00770367|20820015|P1|COMPLETED|Washout Period of 4 Weeks||18
8447892|NCT00770367|20820014|P2|STARTED|Washout Period of 4 Weeks||16
8447893|NCT00770367|20820015|P1|STARTED|Washout Period of 4 Weeks||18
8447894|NCT00770367|20820014|P2|NOT COMPLETED|First Intervention||2
8447895|NCT00770367|20820015|P1|NOT COMPLETED|First Intervention||0
8447896|NCT00770367|20820014|P2|COMPLETED|First Intervention||16
8447897|NCT00770367|20820015|P1|COMPLETED|First Intervention||18
8447898|NCT00770367|20820014|P2|STARTED|First Intervention||18
8447899|NCT00770367|20820015|P1|STARTED|First Intervention||18
8447900|NCT00770341|20820026|P3|NOT COMPLETED|Overall Study||3
8447901|NCT00770341|20820027|P2|NOT COMPLETED|Overall Study||5
8447902|NCT00770341|20820028|P1|NOT COMPLETED|Overall Study||12
8447903|NCT00770341|20820026|P3|COMPLETED|Overall Study||8
8447904|NCT00770341|20820027|P2|COMPLETED|Overall Study||17
8447905|NCT00770341|20820028|P1|COMPLETED|Overall Study||77
8447906|NCT00770341|20820026|P3|STARTED|Overall Study|Number randomized|11
8447907|NCT00770341|20820027|P2|STARTED|Overall Study|Number randomized|22
8447908|NCT00770341|20820028|P1|STARTED|Overall Study|Number randomized|89
8447909|NCT00770328|20820054|P2|NOT COMPLETED|Overall Study||4
8447910|NCT00770328|20820055|P1|NOT COMPLETED|Overall Study||13
8447911|NCT00770328|20820054|P2|COMPLETED|Overall Study||11
8447912|NCT00770328|20820055|P1|COMPLETED|Overall Study||9
8447913|NCT00770328|20820054|P2|STARTED|Overall Study||15
8447914|NCT00770328|20820055|P1|STARTED|Overall Study||22
8447915|NCT00770315|20820071|P4|NOT COMPLETED|Overall Study||38
8447916|NCT00770315|20820072|P3|NOT COMPLETED|Overall Study||57
8447917|NCT00770315|20820073|P2|NOT COMPLETED|Overall Study||43
8447918|NCT00770315|20820074|P1|NOT COMPLETED|Overall Study||40
8447919|NCT00770315|20820071|P4|COMPLETED|Overall Study||160
8447920|NCT00770315|20820072|P3|COMPLETED|Overall Study||137
8447921|NCT00770315|20820073|P2|COMPLETED|Overall Study||152
8447922|NCT00770315|20820074|P1|COMPLETED|Overall Study||157
8447923|NCT00770315|20820071|P4|STARTED|Overall Study||198
8447924|NCT00770315|20820072|P3|STARTED|Overall Study||194
8447925|NCT00770315|20820073|P2|STARTED|Overall Study||195
8447926|NCT00770315|20820074|P1|STARTED|Overall Study||197
8447927|NCT00770289|20820100|P1|NOT COMPLETED|Overall Study||6
8447928|NCT00770289|20820100|P1|COMPLETED|Overall Study||845
8447929|NCT00770289|20820100|P1|STARTED|Overall Study||851
8447930|NCT00770224|20820109|P2|NOT COMPLETED|Step 2: Maintenance||30
8447931|NCT00770224|20820110|P1|NOT COMPLETED|Step 2: Maintenance||0
8447932|NCT00770224|20820109|P2|COMPLETED|Step 2: Maintenance||41
8447933|NCT00770224|20820110|P1|COMPLETED|Step 2: Maintenance||0
8447934|NCT00770224|20820109|P2|Eligible and Evaluable|Step 2: Maintenance||69
8447935|NCT00770224|20820110|P1|Eligible and Evaluable|Step 2: Maintenance||0
8447936|NCT00770224|20820109|P2|STARTED|Step 2: Maintenance||71
8447937|NCT00770224|20820110|P1|STARTED|Step 2: Maintenance||0
8447938|NCT00770224|20820109|P2|NOT COMPLETED|Step 1: Induction||0
8447939|NCT00770224|20820110|P1|NOT COMPLETED|Step 1: Induction||14
8447940|NCT00770224|20820109|P2|COMPLETED|Step 1: Induction||0
8447941|NCT00770224|20820110|P1|COMPLETED|Step 1: Induction||73
8447942|NCT00770224|20820109|P2|Eligible and Evaluable|Step 1: Induction||0
8447943|NCT00770224|20820110|P1|Eligible and Evaluable|Step 1: Induction||84
8447944|NCT00770224|20820109|P2|STARTED|Step 1: Induction||0
8447945|NCT00770224|20820110|P1|STARTED|Step 1: Induction||87
8447946|NCT00770211|20820122|P2|NOT COMPLETED|Overall Study||2
8447947|NCT00770211|20820123|P1|NOT COMPLETED|Overall Study||1
8447948|NCT00770211|20820122|P2|COMPLETED|Overall Study||87
8447949|NCT00770211|20820123|P1|COMPLETED|Overall Study||181
8447950|NCT00770211|20820122|P2|STARTED|Overall Study||89
8447951|NCT00770211|20820123|P1|STARTED|Overall Study||182
8447952|NCT00770146|20820139|P2|NOT COMPLETED|Follow-up Period||20
8447953|NCT00770146|20820140|P1|NOT COMPLETED|Follow-up Period||11
8447954|NCT00770146|20820139|P2|COMPLETED|Follow-up Period||85
8447955|NCT00770146|20820140|P1|COMPLETED|Follow-up Period||42
8447956|NCT00770146|20820139|P2|STARTED|Follow-up Period||105
8447957|NCT00770146|20820140|P1|STARTED|Follow-up Period||53
8447958|NCT00770146|20820139|P2|NOT COMPLETED|Treatment Period||45
8447959|NCT00770146|20820140|P1|NOT COMPLETED|Treatment Period||9
8447960|NCT00770146|20820139|P2|COMPLETED|Treatment Period||60
8447961|NCT00770146|20820140|P1|COMPLETED|Treatment Period||44
8447962|NCT00770146|20820139|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
8447963|NCT00770146|20820140|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
8447964|NCT00770146|20820139|P2|Treated|Treatment Period||105
8447965|NCT00770146|20820140|P1|Treated|Treatment Period||52
8447966|NCT00770146|20820139|P2|STARTED|Treatment Period||105
8447967|NCT00770146|20820140|P1|STARTED|Treatment Period||53
8447968|NCT00770133|20820188|P4|NOT COMPLETED|Overall Study||3
8447969|NCT00770133|20820189|P3|NOT COMPLETED|Overall Study||3
8447970|NCT00770133|20820190|P2|NOT COMPLETED|Overall Study||1
8447971|NCT00770133|20820191|P1|NOT COMPLETED|Overall Study||3
8447972|NCT00770133|20820188|P4|COMPLETED|Overall Study||32
8447973|NCT00770133|20820189|P3|COMPLETED|Overall Study||32
8447974|NCT00770133|20820190|P2|COMPLETED|Overall Study||35
8447975|NCT00770133|20820191|P1|COMPLETED|Overall Study||32
8447976|NCT00770133|20820188|P4|STARTED|Overall Study||35
8447977|NCT00770133|20820189|P3|STARTED|Overall Study||35
8447978|NCT00770133|20820190|P2|STARTED|Overall Study||36
8447979|NCT00770133|20820191|P1|STARTED|Overall Study||35
8447980|NCT00770120|20820229|P1|NOT COMPLETED|Overall Study||61
8447981|NCT00770120|20820229|P1|COMPLETED|Overall Study||0
8447982|NCT00770120|20820229|P1|Not Analyzable|Overall Study||1
8447983|NCT00770120|20820229|P1|Eligible|Overall Study||60
8447984|NCT00770120|20820229|P1|STARTED|Overall Study||61
8447985|NCT00770029|20820238|P2|NOT COMPLETED|Overall Study||3
8447986|NCT00770029|20820239|P1|NOT COMPLETED|Overall Study||6
8447987|NCT00770029|20820238|P2|COMPLETED|Overall Study||89
8447988|NCT00770029|20820239|P1|COMPLETED|Overall Study||178
8447989|NCT00770029|20820238|P2|STARTED|Overall Study||92
8447990|NCT00770029|20820239|P1|STARTED|Overall Study||184
8447991|NCT00769886|20820257|P4|NOT COMPLETED|Overall Study||2
8447992|NCT00769886|20820258|P3|NOT COMPLETED|Overall Study||1
8447993|NCT00769886|20820259|P2|NOT COMPLETED|Overall Study||4
8447994|NCT00769886|20820260|P1|NOT COMPLETED|Overall Study||5
8447995|NCT00769886|20820257|P4|COMPLETED|Overall Study||35
8447996|NCT00769886|20820258|P3|COMPLETED|Overall Study||34
8447997|NCT00769886|20820259|P2|COMPLETED|Overall Study||32
8447998|NCT00769886|20820260|P1|COMPLETED|Overall Study||31
8447999|NCT00769886|20820257|P4|STARTED|Overall Study||37
8448000|NCT00769886|20820258|P3|STARTED|Overall Study||35
8448001|NCT00769886|20820259|P2|STARTED|Overall Study||36
8448002|NCT00769886|20820260|P1|STARTED|Overall Study||36
8448003|NCT00769860|20820300|P2|NOT COMPLETED|Overall Study||0
8448004|NCT00769860|20820301|P1|NOT COMPLETED|Overall Study||2
8448005|NCT00769860|20820300|P2|COMPLETED|Overall Study||8
8448006|NCT00769860|20820301|P1|COMPLETED|Overall Study||14
8448007|NCT00769860|20820300|P2|Month 8|Overall Study||8
8448008|NCT00769860|20820301|P1|Month 8|Overall Study||14
8448009|NCT00769860|20820300|P2|Month 4|Overall Study||8
8448010|NCT00769860|20820301|P1|Month 4|Overall Study||16
8448011|NCT00769860|20820300|P2|STARTED|Overall Study||8
8448012|NCT00769860|20820301|P1|STARTED|Overall Study||16
8448013|NCT00769808|20820327|P1|NOT COMPLETED|Overall Study||8
8448014|NCT00769808|20820327|P1|COMPLETED|Overall Study||64
8448015|NCT00769808|20820327|P1|STARTED|Overall Study||72
8448016|NCT00769704|20820339|P2|NOT COMPLETED|Overall Study||199
8448017|NCT00769704|20820340|P1|NOT COMPLETED|Overall Study||111
8448018|NCT00769704|20820339|P2|COMPLETED|Overall Study||97
8448019|NCT00769704|20820340|P1|COMPLETED|Overall Study||30
8448020|NCT00769704|20820339|P2|Received Treatment|Overall Study||292
8448021|NCT00769704|20820340|P1|Received Treatment|Overall Study||127
8448022|NCT00769704|20820339|P2|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
8448023|NCT00769704|20820340|P1|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
8448024|NCT00769704|20820339|P2|STARTED|Overall Study||296
8448025|NCT00769704|20820340|P1|STARTED|Overall Study||141
8448026|NCT00769652|20820360|P2|NOT COMPLETED|Overall Study||0
8448027|NCT00769652|20820361|P1|NOT COMPLETED|Overall Study||0
8448028|NCT00769652|20820360|P2|COMPLETED|Overall Study||1
8448029|NCT00769652|20820361|P1|COMPLETED|Overall Study||6
8448030|NCT00769652|20820360|P2|STARTED|Overall Study||1
8448031|NCT00769652|20820361|P1|STARTED|Overall Study||6
8448032|NCT00769600|20820373|P2|NOT COMPLETED|Overall Study||0
8448033|NCT00769600|20820374|P1|NOT COMPLETED|Overall Study||0
8448034|NCT00769600|20820373|P2|COMPLETED|Overall Study||8
8448035|NCT00769600|20820374|P1|COMPLETED|Overall Study||15
8448036|NCT00769600|20820373|P2|STARTED|Overall Study||8
8448037|NCT00769600|20820374|P1|STARTED|Overall Study||15
8448038|NCT00769561|20820390|P2|NOT COMPLETED|Overall Study||5
8448039|NCT00769561|20820391|P1|NOT COMPLETED|Overall Study||3
8448040|NCT00769561|20820390|P2|COMPLETED|Overall Study||24
8448041|NCT00769561|20820391|P1|COMPLETED|Overall Study||26
8448042|NCT00769561|20820390|P2|STARTED|Overall Study||29
8448043|NCT00769561|20820391|P1|STARTED|Overall Study||29
8448044|NCT00769483|20820417|P6|NOT COMPLETED|Overall Study||0
8448045|NCT00769483|20820418|P5|NOT COMPLETED|Overall Study||1
8448046|NCT00769483|20820419|P4|NOT COMPLETED|Overall Study||0
8448047|NCT00769483|20820420|P3|NOT COMPLETED|Overall Study||0
8448048|NCT00769483|20820421|P2|NOT COMPLETED|Overall Study||1
8448049|NCT00769483|20820422|P1|NOT COMPLETED|Overall Study||0
8448050|NCT00769483|20820417|P6|COMPLETED|Overall Study||9
8448051|NCT00769483|20820418|P5|COMPLETED|Overall Study||15
8448052|NCT00769483|20820419|P4|COMPLETED|Overall Study||15
8448053|NCT00769483|20820420|P3|COMPLETED|Overall Study||15
8448054|NCT00769483|20820421|P2|COMPLETED|Overall Study||12
8448055|NCT00769483|20820422|P1|COMPLETED|Overall Study||9
8448056|NCT00769483|20820417|P6|STARTED|Overall Study||9
8448057|NCT00769483|20820418|P5|STARTED|Overall Study||16
8448058|NCT00769483|20820419|P4|STARTED|Overall Study||15
8448059|NCT00769483|20820420|P3|STARTED|Overall Study||15
8448060|NCT00769483|20820421|P2|STARTED|Overall Study||13
8448061|NCT00769483|20820422|P1|STARTED|Overall Study||9
8448062|NCT00769392|20820460|P1|NOT COMPLETED|Overall Study||4
8448063|NCT00769392|20820460|P1|COMPLETED|Overall Study||24
8448064|NCT00769392|20820460|P1|STARTED|Overall Study||28
8448065|NCT00769314|20820467|P2|NOT COMPLETED|Overall Study||13
8448066|NCT00769314|20820468|P1|NOT COMPLETED|Overall Study||17
8448067|NCT00769314|20820467|P2|COMPLETED|Overall Study||384
8448068|NCT00769314|20820468|P1|COMPLETED|Overall Study||361
8448069|NCT00769314|20820467|P2|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
8448070|NCT00769314|20820468|P1|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
8448071|NCT00769184|20820494|P2|NOT COMPLETED|No Treatment (6 Weeks)||1
8448072|NCT00769184|20820495|P1|NOT COMPLETED|No Treatment (6 Weeks)||1
8448073|NCT00769184|20820494|P2|COMPLETED|No Treatment (6 Weeks)||6
8448074|NCT00769184|20820495|P1|COMPLETED|No Treatment (6 Weeks)||5
8448075|NCT00769184|20820494|P2|STARTED|No Treatment (6 Weeks)||7
8448076|NCT00769184|20820495|P1|STARTED|No Treatment (6 Weeks)||6
8448077|NCT00769184|20820494|P2|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
8448078|NCT00769184|20820495|P1|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
8448079|NCT00769184|20820494|P2|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
8448080|NCT00769184|20820495|P1|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
8448081|NCT00769184|20820494|P2|STARTED|+LCD / +Placebo Only (4 Weeks)||7
8448082|NCT00769184|20820495|P1|STARTED|+LCD / +Placebo Only (4 Weeks)||6
8448083|NCT00769184|20820494|P2|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
8448084|NCT00769184|20820495|P1|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
8448085|NCT00769184|20820494|P2|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
8448086|NCT00769184|20820495|P1|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
8448087|NCT00769184|20820494|P2|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
8448088|NCT00769184|20820495|P1|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
8448089|NCT00769132|20820503|P4|NOT COMPLETED|Period 4||0
8448090|NCT00769132|20820504|P3|NOT COMPLETED|Period 4||0
8448091|NCT00769132|20820505|P2|NOT COMPLETED|Period 4||1
8448092|NCT00769132|20820506|P1|NOT COMPLETED|Period 4||0
8448093|NCT00769132|20820503|P4|COMPLETED|Period 4||5
8448094|NCT00769132|20820504|P3|COMPLETED|Period 4||6
8448095|NCT00769132|20820505|P2|COMPLETED|Period 4||5
8448096|NCT00769132|20820506|P1|COMPLETED|Period 4||5
8448097|NCT00769132|20820503|P4|STARTED|Period 4||5
8448098|NCT00769132|20820504|P3|STARTED|Period 4||6
8448099|NCT00769132|20820505|P2|STARTED|Period 4||6
8448100|NCT00769132|20820506|P1|STARTED|Period 4||5
8448101|NCT00769132|20820503|P4|NOT COMPLETED|Period 3||0
8448102|NCT00769132|20820504|P3|NOT COMPLETED|Period 3||0
8448103|NCT00769132|20820505|P2|NOT COMPLETED|Period 3||0
8448104|NCT00769132|20820506|P1|NOT COMPLETED|Period 3||1
8448105|NCT00769132|20820503|P4|COMPLETED|Period 3||5
8448106|NCT00769132|20820504|P3|COMPLETED|Period 3||6
8448107|NCT00769132|20820505|P2|COMPLETED|Period 3||6
8448108|NCT00769132|20820506|P1|COMPLETED|Period 3||5
8448109|NCT00769132|20820503|P4|STARTED|Period 3||5
8448110|NCT00769132|20820504|P3|STARTED|Period 3||6
8448111|NCT00769132|20820505|P2|STARTED|Period 3||6
8448112|NCT00769132|20820506|P1|STARTED|Period 3||6
8448113|NCT00769132|20820503|P4|NOT COMPLETED|Period 2||1
8448114|NCT00769132|20820504|P3|NOT COMPLETED|Period 2||0
8448115|NCT00769132|20820505|P2|NOT COMPLETED|Period 2||0
8448116|NCT00769132|20820506|P1|NOT COMPLETED|Period 2||0
8448117|NCT00769132|20820503|P4|COMPLETED|Period 2||5
8448118|NCT00769132|20820504|P3|COMPLETED|Period 2||6
8448119|NCT00769132|20820505|P2|COMPLETED|Period 2||6
8448120|NCT00769132|20820506|P1|COMPLETED|Period 2||6
8448121|NCT00769132|20820503|P4|STARTED|Period 2||6
8448122|NCT00769132|20820504|P3|STARTED|Period 2||6
8448123|NCT00769132|20820505|P2|STARTED|Period 2||6
8448124|NCT00769132|20820506|P1|STARTED|Period 2||6
8448125|NCT00769132|20820503|P4|NOT COMPLETED|Period 1||1
8448126|NCT00769132|20820504|P3|NOT COMPLETED|Period 1||0
8448127|NCT00769132|20820505|P2|NOT COMPLETED|Period 1||0
8448128|NCT00769132|20820506|P1|NOT COMPLETED|Period 1||1
8448129|NCT00769132|20820503|P4|COMPLETED|Period 1||6
8448130|NCT00769132|20820504|P3|COMPLETED|Period 1||6
8448131|NCT00769132|20820505|P2|COMPLETED|Period 1||6
8448132|NCT00769132|20820506|P1|COMPLETED|Period 1||6
8448133|NCT00769132|20820503|P4|STARTED|Period 1||7
8448134|NCT00769132|20820504|P3|STARTED|Period 1||6
8448135|NCT00769132|20820505|P2|STARTED|Period 1||6
8448136|NCT00769132|20820506|P1|STARTED|Period 1||7
8448137|NCT00769119|20820522|P2|NOT COMPLETED|Overall Study||3
8448138|NCT00769119|20820523|P1|NOT COMPLETED|Overall Study||2
8448139|NCT00769119|20820522|P2|COMPLETED|Overall Study||13
8448140|NCT00769119|20820523|P1|COMPLETED|Overall Study||20
8448141|NCT00769119|20820522|P2|STARTED|Overall Study||16
8448142|NCT00769119|20820523|P1|STARTED|Overall Study||22
8448143|NCT00769067|20820569|P2|NOT COMPLETED|Overall Study||94
8448144|NCT00769067|20820570|P1|NOT COMPLETED|Overall Study||94
8448145|NCT00769067|20820569|P2|COMPLETED|Overall Study||0
8448146|NCT00769067|20820570|P1|COMPLETED|Overall Study||0
8448147|NCT00769067|20820569|P2|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
8448148|NCT00769067|20820570|P1|Treated|Overall Study||94
8448149|NCT00769067|20820569|P2|STARTED|Overall Study||94
8448150|NCT00769067|20820570|P1|STARTED|Overall Study||94
8448151|NCT00769015|20820597|P2|NOT COMPLETED|Overall Study||16
8448152|NCT00769015|20820598|P1|NOT COMPLETED|Overall Study||9
8448153|NCT00769015|20820597|P2|COMPLETED|Overall Study||76
8448154|NCT00769015|20820598|P1|COMPLETED|Overall Study||87
8448155|NCT00769015|20820597|P2|STARTED|Overall Study||92
8448156|NCT00769015|20820598|P1|STARTED|Overall Study||96
8448157|NCT00769002|20820620|P2|NOT COMPLETED|Overall Study||9
8448158|NCT00769002|20820621|P1|NOT COMPLETED|Overall Study||9
8448159|NCT00769002|20820620|P2|COMPLETED|Overall Study||0
8448160|NCT00769002|20820621|P1|COMPLETED|Overall Study||0
8448161|NCT00769002|20820620|P2|STARTED|Overall Study||9
8448162|NCT00769002|20820621|P1|STARTED|Overall Study||9
8448163|NCT00768989|20820628|P2|NOT COMPLETED|On or After Week 36||27
8448164|NCT00768989|20820629|P1|NOT COMPLETED|On or After Week 36||51
8448165|NCT00768989|20820628|P2|COMPLETED|On or After Week 36||0
8448166|NCT00768989|20820629|P1|COMPLETED|On or After Week 36||0
8448167|NCT00768989|20820628|P2|STARTED|On or After Week 36||27
8448168|NCT00768989|20820629|P1|STARTED|On or After Week 36||51
8448169|NCT00768989|20820628|P2|NOT COMPLETED|Week 24 to Prior to Week 36||0
8448170|NCT00768989|20820629|P1|NOT COMPLETED|Week 24 to Prior to Week 36||8
8448171|NCT00768989|20820628|P2|COMPLETED|Week 24 to Prior to Week 36||27
8448172|NCT00768989|20820629|P1|COMPLETED|Week 24 to Prior to Week 36||51
8448173|NCT00768989|20820628|P2|STARTED|Week 24 to Prior to Week 36||27
8448174|NCT00768989|20820629|P1|STARTED|Week 24 to Prior to Week 36||59
8448175|NCT00768989|20820628|P2|NOT COMPLETED|Prior to Week 24||3
8448176|NCT00768989|20820629|P1|NOT COMPLETED|Prior to Week 24||4
8448177|NCT00768989|20820628|P2|COMPLETED|Prior to Week 24||27
8448178|NCT00768989|20820629|P1|COMPLETED|Prior to Week 24||59
8448179|NCT00768989|20820628|P2|STARTED|Prior to Week 24||30
8448180|NCT00768989|20820629|P1|STARTED|Prior to Week 24||63
8448181|NCT00768898|20820677|P1|NOT COMPLETED|Overall Study||2
8448182|NCT00768898|20820677|P1|COMPLETED|Overall Study||28
8448183|NCT00768898|20820677|P1|STARTED|Overall Study||30
8448184|NCT00768755|20820701|P4|NOT COMPLETED|Phase 2||57
8448185|NCT00768755|20820702|P3|NOT COMPLETED|Phase 2||58
8448186|NCT00768755|20820703|P2|NOT COMPLETED|Phase 2||55
8448187|NCT00768755|20820704|P1|NOT COMPLETED|Phase 2||0
8448188|NCT00768755|20820701|P4|COMPLETED|Phase 2||0
8448189|NCT00768755|20820702|P3|COMPLETED|Phase 2||0
8448190|NCT00768755|20820703|P2|COMPLETED|Phase 2||0
8448191|NCT00768755|20820704|P1|COMPLETED|Phase 2||0
8448192|NCT00768755|20820701|P4|Treated|Phase 2||55
8448193|NCT00768755|20820702|P3|Treated|Phase 2||58
8448194|NCT00768755|20820703|P2|Treated|Phase 2||55
8448195|NCT00768755|20820704|P1|Treated|Phase 2||0
8448196|NCT00768755|20820701|P4|STARTED|Phase 2||57
8448197|NCT00768755|20820702|P3|STARTED|Phase 2||58
8448198|NCT00768755|20820703|P2|STARTED|Phase 2||55
8448199|NCT00768755|20820704|P1|STARTED|Phase 2||0
8448200|NCT00768755|20820701|P4|NOT COMPLETED|Phase 1||0
8448201|NCT00768755|20820702|P3|NOT COMPLETED|Phase 1||0
8448202|NCT00768755|20820703|P2|NOT COMPLETED|Phase 1||0
8448203|NCT00768755|20820704|P1|NOT COMPLETED|Phase 1||10
8448204|NCT00768755|20820701|P4|COMPLETED|Phase 1||0
8448205|NCT00768755|20820702|P3|COMPLETED|Phase 1||0
8448206|NCT00768755|20820703|P2|COMPLETED|Phase 1||0
8448207|NCT00768755|20820704|P1|COMPLETED|Phase 1||0
8448208|NCT00768755|20820701|P4|STARTED|Phase 1||0
8448209|NCT00768755|20820702|P3|STARTED|Phase 1||0
8448210|NCT00768755|20820703|P2|STARTED|Phase 1||0
8448211|NCT00768755|20820704|P1|STARTED|Phase 1||10
8448212|NCT00768716|20820730|P2|NOT COMPLETED|Overall Study||0
8448213|NCT00768716|20820731|P1|NOT COMPLETED|Overall Study||0
8448214|NCT00768716|20820730|P2|COMPLETED|Overall Study||41
8448215|NCT00768716|20820731|P1|COMPLETED|Overall Study||54
8448216|NCT00768716|20820730|P2|STARTED|Overall Study||41
8448217|NCT00768716|20820731|P1|STARTED|Overall Study||54
8448218|NCT00768651|20820752|P1|NOT COMPLETED|Overall Study||1
8448219|NCT00768651|20820752|P1|COMPLETED|Overall Study||7
8448220|NCT00768651|20820752|P1|STARTED|Overall Study||8
8448221|NCT00768599|20820760|P3|NOT COMPLETED|Overall Study||12
8448222|NCT00768599|20820761|P2|NOT COMPLETED|Overall Study||16
8448223|NCT00768599|20820762|P1|NOT COMPLETED|Overall Study||11
8448224|NCT00768599|20820760|P3|COMPLETED|Overall Study||35
8448225|NCT00768599|20820761|P2|COMPLETED|Overall Study||27
8448226|NCT00768599|20820762|P1|COMPLETED|Overall Study||34
8448227|NCT00768599|20820760|P3|STARTED|Overall Study||47
8448228|NCT00768599|20820761|P2|STARTED|Overall Study||43
8448229|NCT00768599|20820762|P1|STARTED|Overall Study||45
8448230|NCT00768560|20820791|P6|NOT COMPLETED|Intervention Set 3||0
8448231|NCT00768560|20820792|P5|NOT COMPLETED|Intervention Set 3||0
8448232|NCT00768560|20820793|P4|NOT COMPLETED|Intervention Set 3||0
8448233|NCT00768560|20820794|P3|NOT COMPLETED|Intervention Set 3||0
8448234|NCT00768560|20820795|P2|NOT COMPLETED|Intervention Set 3||0
8448235|NCT00768560|20820796|P1|NOT COMPLETED|Intervention Set 3||0
8448236|NCT00768560|20820791|P6|COMPLETED|Intervention Set 3||6
8448237|NCT00768560|20820792|P5|COMPLETED|Intervention Set 3||6
8448238|NCT00768560|20820793|P4|COMPLETED|Intervention Set 3||6
8448239|NCT00768560|20820794|P3|COMPLETED|Intervention Set 3||6
8448240|NCT00768560|20820795|P2|COMPLETED|Intervention Set 3||5
8448241|NCT00768560|20820796|P1|COMPLETED|Intervention Set 3||5
8448242|NCT00768560|20820791|P6|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
8448243|NCT00768560|20820792|P5|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
8448244|NCT00768560|20820793|P4|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
8448245|NCT00768560|20820794|P3|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
8448246|NCT00768560|20820795|P2|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
8448247|NCT00768560|20820796|P1|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
8448248|NCT00768560|20820791|P6|NOT COMPLETED|Intervention Set 2||0
8448249|NCT00768560|20820792|P5|NOT COMPLETED|Intervention Set 2||0
8448250|NCT00768560|20820793|P4|NOT COMPLETED|Intervention Set 2||0
8448251|NCT00768560|20820794|P3|NOT COMPLETED|Intervention Set 2||0
8448252|NCT00768560|20820795|P2|NOT COMPLETED|Intervention Set 2||0
8448253|NCT00768560|20820796|P1|NOT COMPLETED|Intervention Set 2||0
8448254|NCT00768560|20820791|P6|COMPLETED|Intervention Set 2||6
8448255|NCT00768560|20820792|P5|COMPLETED|Intervention Set 2||6
8448256|NCT00768560|20820793|P4|COMPLETED|Intervention Set 2||6
8448257|NCT00768560|20820794|P3|COMPLETED|Intervention Set 2||6
8448258|NCT00768560|20820795|P2|COMPLETED|Intervention Set 2||5
8448259|NCT00768560|20820796|P1|COMPLETED|Intervention Set 2||5
8448260|NCT00768560|20820791|P6|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
8448261|NCT00768560|20820792|P5|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
8448262|NCT00768560|20820793|P4|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
8448263|NCT00768560|20820794|P3|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
8448264|NCT00768560|20820795|P2|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
8448265|NCT00768560|20820796|P1|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
8448266|NCT00768560|20820791|P6|NOT COMPLETED|Intervention Set 1||0
8448267|NCT00768560|20820792|P5|NOT COMPLETED|Intervention Set 1||0
8448268|NCT00768560|20820793|P4|NOT COMPLETED|Intervention Set 1||0
8448269|NCT00768560|20820794|P3|NOT COMPLETED|Intervention Set 1||0
8448270|NCT00768560|20820795|P2|NOT COMPLETED|Intervention Set 1||1
8448271|NCT00768560|20820796|P1|NOT COMPLETED|Intervention Set 1||0
8448272|NCT00768560|20820791|P6|COMPLETED|Intervention Set 1||6
8448273|NCT00768560|20820792|P5|COMPLETED|Intervention Set 1||6
8448274|NCT00768560|20820793|P4|COMPLETED|Intervention Set 1||6
8448275|NCT00768560|20820794|P3|COMPLETED|Intervention Set 1||6
8448276|NCT00768560|20820795|P2|COMPLETED|Intervention Set 1||5
8448277|NCT00768560|20820796|P1|COMPLETED|Intervention Set 1||5
8448278|NCT00768560|20820791|P6|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
8448279|NCT00768560|20820792|P5|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
8448280|NCT00768560|20820793|P4|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
8448281|NCT00768560|20820794|P3|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
8448282|NCT00768560|20820795|P2|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
8448283|NCT00768560|20820796|P1|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
8448284|NCT00768560|20820791|P6|STARTED|Intervention Set 1|3-period/treatment crossover|6
8448285|NCT00768560|20820792|P5|STARTED|Intervention Set 1|3-period/treatment crossover|6
8448286|NCT00768560|20820793|P4|STARTED|Intervention Set 1|3-period/treatment crossover|6
8448287|NCT00768560|20820794|P3|STARTED|Intervention Set 1|3-period/treatment crossover|6
8448288|NCT00768560|20820795|P2|STARTED|Intervention Set 1|3-period/treatment crossover|6
8448289|NCT00768560|20820796|P1|STARTED|Intervention Set 1|3-period/treatment crossover|5
8448290|NCT00768521|20820822|P2|NOT COMPLETED|Period 2||0
8448291|NCT00768521|20820823|P1|NOT COMPLETED|Period 2||0
8448292|NCT00768521|20820822|P2|COMPLETED|Period 2||11
8448293|NCT00768521|20820823|P1|COMPLETED|Period 2||9
8448294|NCT00768521|20820822|P2|STARTED|Period 2||11
8448295|NCT00768521|20820823|P1|STARTED|Period 2||9
8448296|NCT00768521|20820822|P2|NOT COMPLETED|Period 1||0
8448297|NCT00768521|20820823|P1|NOT COMPLETED|Period 1||0
8448298|NCT00768521|20820822|P2|COMPLETED|Period 1||11
8448299|NCT00768521|20820823|P1|COMPLETED|Period 1||9
8448300|NCT00768521|20820822|P2|STARTED|Period 1||11
8448301|NCT00768521|20820823|P1|STARTED|Period 1||9
8448302|NCT00768469|20820833|P2|NOT COMPLETED|Overall Study||7
8448303|NCT00768469|20820834|P1|NOT COMPLETED|Overall Study||3
8448304|NCT00768469|20820833|P2|COMPLETED|Overall Study||0
8448305|NCT00768469|20820834|P1|COMPLETED|Overall Study||0
8448306|NCT00768469|20820833|P2|STARTED|Overall Study||7
8448307|NCT00768469|20820834|P1|STARTED|Overall Study||3
8448308|NCT00768430|20820849|P2|NOT COMPLETED|7 Day Endpoint||3
8448309|NCT00768430|20820850|P1|NOT COMPLETED|7 Day Endpoint||2
8448310|NCT00768430|20820849|P2|COMPLETED|7 Day Endpoint||22
8448311|NCT00768430|20820850|P1|COMPLETED|7 Day Endpoint||45
8448312|NCT00768430|20820849|P2|STARTED|7 Day Endpoint||25
8448313|NCT00768430|20820850|P1|STARTED|7 Day Endpoint||47
8448314|NCT00768430|20820849|P2|NOT COMPLETED|24 Hour Endpoint||0
8448315|NCT00768430|20820850|P1|NOT COMPLETED|24 Hour Endpoint||1
8448316|NCT00768430|20820849|P2|COMPLETED|24 Hour Endpoint||25
8448317|NCT00768430|20820850|P1|COMPLETED|24 Hour Endpoint||47
8448318|NCT00768430|20820849|P2|STARTED|24 Hour Endpoint||25
8448319|NCT00768430|20820850|P1|STARTED|24 Hour Endpoint||48
8448320|NCT00768300|20820858|P2|NOT COMPLETED|Overall Study||163
8448321|NCT00768300|20820859|P1|NOT COMPLETED|Overall Study||329
8448322|NCT00768300|20820858|P2|COMPLETED|Overall Study||1
8448323|NCT00768300|20820859|P1|COMPLETED|Overall Study||1
8448324|NCT00768300|20820858|P2|Randomized and Treated|Overall Study||163
8448325|NCT00768300|20820859|P1|Randomized and Treated|Overall Study||329
8448326|NCT00768300|20820858|P2|STARTED|Overall Study||164
8448327|NCT00768300|20820859|P1|STARTED|Overall Study||330
8448406|NCT00768261|20820925|P4|NOT COMPLETED|Overall Study||0
8448407|NCT00768261|20820926|P3|NOT COMPLETED|Overall Study||25
8448408|NCT00768261|20820927|P2|NOT COMPLETED|Overall Study||0
8448409|NCT00768261|20820928|P1|NOT COMPLETED|Overall Study||0
8448410|NCT00768261|20820925|P4|COMPLETED|Overall Study||56
8448411|NCT00768261|20820926|P3|COMPLETED|Overall Study||14
8448412|NCT00768261|20820927|P2|COMPLETED|Overall Study||18
8448413|NCT00768261|20820928|P1|COMPLETED|Overall Study||14
8448414|NCT00768261|20820925|P4|STARTED|Overall Study||56
8448415|NCT00768261|20820926|P3|STARTED|Overall Study||39
8448416|NCT00768261|20820927|P2|STARTED|Overall Study||18
8448417|NCT00768261|20820928|P1|STARTED|Overall Study||14
8448418|NCT00768248|20820943|P2|NOT COMPLETED|Overall Study||1
8448419|NCT00768248|20820944|P1|NOT COMPLETED|Overall Study||1
8448420|NCT00768248|20820943|P2|COMPLETED|Overall Study||0
8448421|NCT00768248|20820944|P1|COMPLETED|Overall Study||0
8448422|NCT00768248|20820943|P2|STARTED|Overall Study||1
8448423|NCT00768248|20820944|P1|STARTED|Overall Study||1
8448424|NCT00768222|20820960|P2|NOT COMPLETED|Overall Study||4
8448425|NCT00768222|20820961|P1|NOT COMPLETED|Overall Study||4
8448426|NCT00768222|20820960|P2|COMPLETED|Overall Study||47
8448427|NCT00768222|20820961|P1|COMPLETED|Overall Study||46
8448428|NCT00768222|20820960|P2|STARTED|Overall Study||51
8448429|NCT00768222|20820961|P1|STARTED|Overall Study||50
8448430|NCT00768144|20820983|P1|NOT COMPLETED|Overall Study||36
8448431|NCT00768144|20820983|P1|COMPLETED|Overall Study||0
8448432|NCT00768144|20820983|P1|STARTED|Overall Study||36
8448433|NCT00768118|20820989|P1|NOT COMPLETED|Overall Study||0
8448434|NCT00768118|20820989|P1|COMPLETED|Overall Study||11
8448435|NCT00768118|20820989|P1|STARTED|Overall Study||11
8448436|NCT00768079|20820996|P3|NOT COMPLETED|Overall Study||4
8448437|NCT00768079|20820997|P2|NOT COMPLETED|Overall Study||1
8448438|NCT00768079|20820998|P1|NOT COMPLETED|Overall Study||2
8448439|NCT00768079|20820996|P3|COMPLETED|Overall Study||32
8448440|NCT00768079|20820997|P2|COMPLETED|Overall Study||35
8448441|NCT00768079|20820998|P1|COMPLETED|Overall Study||36
8448442|NCT00768079|20820996|P3|STARTED|Overall Study||36
8448443|NCT00768079|20820997|P2|STARTED|Overall Study||36
8448444|NCT00768079|20820998|P1|STARTED|Overall Study||38
8448445|NCT00768066|20821055|P3|NOT COMPLETED|Overall Study||0
8448446|NCT00768066|20821056|P2|NOT COMPLETED|Overall Study||3
8448447|NCT00768066|20821057|P1|NOT COMPLETED|Overall Study||3
8448448|NCT00768066|20821055|P3|COMPLETED|Overall Study||21
8448449|NCT00768066|20821056|P2|COMPLETED|Overall Study||19
8448450|NCT00768066|20821057|P1|COMPLETED|Overall Study||19
8448451|NCT00768066|20821055|P3|STARTED|Overall Study||21
8448452|NCT00768066|20821056|P2|STARTED|Overall Study||22
8448453|NCT00768066|20821057|P1|STARTED|Overall Study||22
8448454|NCT00768053|20821089|P1|NOT COMPLETED|Overall Study||11
8448455|NCT00768053|20821089|P1|COMPLETED|Overall Study||97
8448456|NCT00768053|20821089|P1|STARTED|Overall Study||108
8448457|NCT00768040|20821120|P2|NOT COMPLETED|Overall Study||3
8448458|NCT00768040|20821121|P1|NOT COMPLETED|Overall Study||4
8448459|NCT00768040|20821120|P2|COMPLETED|Overall Study||16
8448460|NCT00768040|20821121|P1|COMPLETED|Overall Study||16
8448461|NCT00768040|20821120|P2|STARTED|Overall Study||19
8448462|NCT00768040|20821121|P1|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
8448463|NCT00767819|20821130|P3|NOT COMPLETED|Overall Study||0
8448464|NCT00767819|20821131|P2|NOT COMPLETED|Overall Study||19
8448465|NCT00767819|20821132|P1|NOT COMPLETED|Overall Study||25
8448466|NCT00767819|20821130|P3|COMPLETED|Overall Study||10
8448467|NCT00767819|20821131|P2|COMPLETED|Overall Study||5
8448468|NCT00767819|20821132|P1|COMPLETED|Overall Study||12
8448469|NCT00767819|20821130|P3|Safety Analysis Set (SAF)|Overall Study||10
8448470|NCT00767819|20821131|P2|Safety Analysis Set (SAF)|Overall Study||24
8448471|NCT00767819|20821132|P1|Safety Analysis Set (SAF)|Overall Study||37
8448472|NCT00767819|20821130|P3|Intent to Treat (ITT) Analysis Set|Overall Study||10
8448473|NCT00767819|20821131|P2|Intent to Treat (ITT) Analysis Set|Overall Study||24
8448474|NCT00767819|20821132|P1|Intent to Treat (ITT) Analysis Set|Overall Study||37
8448475|NCT00767819|20821130|P3|STARTED|Overall Study||10
8448476|NCT00767819|20821131|P2|STARTED|Overall Study||24
8448477|NCT00767819|20821132|P1|STARTED|Overall Study||37
8448478|NCT00767806|20821157|P2|NOT COMPLETED|Overall Study||47
8448479|NCT00767806|20821158|P1|NOT COMPLETED|Overall Study||51
8448480|NCT00767806|20821157|P2|COMPLETED|Overall Study||156
8448481|NCT00767806|20821158|P1|COMPLETED|Overall Study||147
8448482|NCT00767806|20821157|P2|STARTED|Overall Study||203
8448483|NCT00767806|20821158|P1|STARTED|Overall Study||198
8448484|NCT00767767|20821219|P5|NOT COMPLETED|Overall Study||0
8448485|NCT00767767|20821220|P4|NOT COMPLETED|Overall Study||0
8448486|NCT00767767|20821221|P3|NOT COMPLETED|Overall Study||0
8448487|NCT00767767|20821222|P2|NOT COMPLETED|Overall Study||0
8448488|NCT00767767|20821223|P1|NOT COMPLETED|Overall Study||0
8448489|NCT00767767|20821219|P5|COMPLETED|Overall Study||3
8448490|NCT00767767|20821220|P4|COMPLETED|Overall Study||3
8448491|NCT00767767|20821221|P3|COMPLETED|Overall Study||20
8448492|NCT00767767|20821222|P2|COMPLETED|Overall Study||20
8448493|NCT00767767|20821223|P1|COMPLETED|Overall Study||21
8448494|NCT00767767|20821219|P5|STARTED|Overall Study||3
8448495|NCT00767767|20821220|P4|STARTED|Overall Study||3
8448496|NCT00767767|20821221|P3|STARTED|Overall Study||20
8448497|NCT00767767|20821222|P2|STARTED|Overall Study||20
8448498|NCT00767767|20821223|P1|STARTED|Overall Study||21
8448499|NCT00767676|20821235|P1|NOT COMPLETED|Overall Study||54
8448500|NCT00767676|20821235|P1|COMPLETED|Overall Study||205
8448501|NCT00767676|20821235|P1|STARTED|Overall Study||259
8448502|NCT00767624|20821241|P2|NOT COMPLETED|Overall Study||17
8448503|NCT00767624|20821242|P1|NOT COMPLETED|Overall Study||24
8448504|NCT00767624|20821241|P2|COMPLETED|Overall Study||58
8448505|NCT00767624|20821242|P1|COMPLETED|Overall Study||51
8448506|NCT00767624|20821241|P2|STARTED|Overall Study||75
8448507|NCT00767624|20821242|P1|STARTED|Overall Study||75
8448508|NCT00767572|20821250|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
8448509|NCT00767572|20821250|P1|COMPLETED|Second Intervention (12 Weeks)||12
8448510|NCT00767572|20821250|P1|STARTED|Second Intervention (12 Weeks)||12
8448511|NCT00767572|20821250|P1|NOT COMPLETED|Washout (4 Weeks)||0
8448512|NCT00767572|20821250|P1|COMPLETED|Washout (4 Weeks)||12
8448513|NCT00767572|20821250|P1|STARTED|Washout (4 Weeks)||12
8448514|NCT00767572|20821250|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
8448515|NCT00767572|20821250|P1|COMPLETED|First Intervention (12 Weeks)||12
8448516|NCT00767572|20821250|P1|STARTED|First Intervention (12 Weeks)||12
8448517|NCT00767520|20821258|P2|NOT COMPLETED|Overall Study||17
8448518|NCT00767520|20821259|P1|NOT COMPLETED|Overall Study||11
8448519|NCT00767520|20821258|P2|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
8448520|NCT00767520|20821259|P1|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
8448521|NCT00767520|20821258|P2|STARTED|Overall Study||78
8448522|NCT00767520|20821259|P1|STARTED|Overall Study||79
8448523|NCT00767507|20821285|P4|NOT COMPLETED|Overall Study||3
8448524|NCT00767507|20821286|P3|NOT COMPLETED|Overall Study||0
8448525|NCT00767507|20821287|P2|NOT COMPLETED|Overall Study||0
8448526|NCT00767507|20821288|P1|NOT COMPLETED|Overall Study||0
8448527|NCT00767507|20821285|P4|COMPLETED|Overall Study||101
8448528|NCT00767507|20821286|P3|COMPLETED|Overall Study||106
8448529|NCT00767507|20821287|P2|COMPLETED|Overall Study||6
8448530|NCT00767507|20821288|P1|COMPLETED|Overall Study||5
8448531|NCT00767507|20821285|P4|STARTED|Overall Study||104
8448532|NCT00767507|20821286|P3|STARTED|Overall Study||106
8448533|NCT00767507|20821287|P2|STARTED|Overall Study||6
8448534|NCT00767507|20821288|P1|STARTED|Overall Study||5
8448535|NCT00767455|20821312|P1|NOT COMPLETED|Overall Study||19
8448536|NCT00767455|20821312|P1|COMPLETED|Overall Study||40
8448537|NCT00767455|20821312|P1|STARTED|Overall Study||59
8448538|NCT00767364|20821320|P2|NOT COMPLETED|Overall Study||0
8448539|NCT00767364|20821321|P1|NOT COMPLETED|Overall Study||0
8448540|NCT00767364|20821320|P2|COMPLETED|Overall Study||3
8448541|NCT00767364|20821321|P1|COMPLETED|Overall Study||5
8448542|NCT00767364|20821320|P2|STARTED|Overall Study||3
8448543|NCT00767364|20821321|P1|STARTED|Overall Study||5
8448544|NCT00767338|20821333|P4|NOT COMPLETED|Overall Study||0
8448545|NCT00767338|20821334|P3|NOT COMPLETED|Overall Study||0
8448546|NCT00767338|20821335|P2|NOT COMPLETED|Overall Study||2
8448547|NCT00767338|20821336|P1|NOT COMPLETED|Overall Study||1
8448548|NCT00767338|20821333|P4|COMPLETED|Overall Study||0
8448549|NCT00767338|20821334|P3|COMPLETED|Overall Study||0
8448550|NCT00767338|20821335|P2|COMPLETED|Overall Study||0
8448551|NCT00767338|20821336|P1|COMPLETED|Overall Study||0
8448552|NCT00767338|20821333|P4|STARTED|Overall Study||0
8448553|NCT00767338|20821334|P3|STARTED|Overall Study||0
8448554|NCT00767338|20821335|P2|STARTED|Overall Study||2
8448555|NCT00767338|20821336|P1|STARTED|Overall Study||1
8448556|NCT00767325|20821346|P1|NOT COMPLETED|Overall Study||15
8448557|NCT00767325|20821346|P1|COMPLETED|Overall Study||89
8448558|NCT00767325|20821346|P1|STARTED|Overall Study||104
8448559|NCT00767104|20821357|P2|NOT COMPLETED|Overall Study||2
8448560|NCT00767104|20821358|P1|NOT COMPLETED|Overall Study||1
8448561|NCT00767104|20821357|P2|COMPLETED|Overall Study||18
8448562|NCT00767104|20821358|P1|COMPLETED|Overall Study||19
8448563|NCT00767104|20821357|P2|STARTED|Overall Study||20
8448564|NCT00767104|20821358|P1|STARTED|Overall Study||20
8448565|NCT00767039|20821368|P2|NOT COMPLETED|Overall Study||2
8448566|NCT00767039|20821369|P1|NOT COMPLETED|Overall Study||5
8448567|NCT00767039|20821368|P2|COMPLETED|Overall Study||23
8448568|NCT00767039|20821369|P1|COMPLETED|Overall Study||22
8448569|NCT00767039|20821368|P2|STARTED|Overall Study||25
8448570|NCT00767039|20821369|P1|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
8448571|NCT00767000|20821400|P5|NOT COMPLETED|Optional 104-week Extension||4
8448572|NCT00767000|20821401|P4|NOT COMPLETED|Optional 104-week Extension||2
8448573|NCT00767000|20821402|P3|NOT COMPLETED|Optional 104-week Extension||7
8448574|NCT00767000|20821403|P2|NOT COMPLETED|Optional 104-week Extension||3
8448575|NCT00767000|20821404|P1|NOT COMPLETED|Optional 104-week Extension||7
8448576|NCT00767000|20821400|P5|COMPLETED|Optional 104-week Extension||0
8448577|NCT00767000|20821401|P4|COMPLETED|Optional 104-week Extension||0
8448578|NCT00767000|20821402|P3|COMPLETED|Optional 104-week Extension||0
8448579|NCT00767000|20821403|P2|COMPLETED|Optional 104-week Extension||0
8448580|NCT00767000|20821404|P1|COMPLETED|Optional 104-week Extension||0
8448581|NCT00767000|20821400|P5|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
8448582|NCT00767000|20821401|P4|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
8448583|NCT00767000|20821402|P3|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
8448584|NCT00767000|20821403|P2|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
8448585|NCT00767000|20821404|P1|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
8448586|NCT00767000|20821400|P5|NOT COMPLETED|54-week Study||224
8448587|NCT00767000|20821401|P4|NOT COMPLETED|54-week Study||225
8448588|NCT00767000|20821402|P3|NOT COMPLETED|54-week Study||109
8448589|NCT00767000|20821403|P2|NOT COMPLETED|54-week Study||113
8448590|NCT00767000|20821404|P1|NOT COMPLETED|54-week Study||108
8448591|NCT00767000|20821400|P5|COMPLETED|54-week Study||7
8448592|NCT00767000|20821401|P4|COMPLETED|54-week Study||4
8448593|NCT00767000|20821402|P3|COMPLETED|54-week Study||8
8448594|NCT00767000|20821403|P2|COMPLETED|54-week Study||4
8448595|NCT00767000|20821404|P1|COMPLETED|54-week Study||11
8448596|NCT00767000|20821400|P5|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
8448597|NCT00767000|20821401|P4|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
8448598|NCT00767000|20821402|P3|STARTED|54-week Study||117
8448599|NCT00767000|20821403|P2|STARTED|54-week Study||117
8448600|NCT00767000|20821404|P1|STARTED|54-week Study||119
8448601|NCT00766831|20821446|P1|NOT COMPLETED|Overall Study||115
8448602|NCT00766831|20821446|P1|COMPLETED|Overall Study||75
8448603|NCT00766831|20821446|P1|STARTED|Overall Study||190
8448604|NCT00766753|20821464|P2|NOT COMPLETED|Overall Study||0
8448605|NCT00766753|20821465|P1|NOT COMPLETED|Overall Study||0
8448606|NCT00766753|20821464|P2|COMPLETED|Overall Study||11
8448607|NCT00766753|20821465|P1|COMPLETED|Overall Study||11
8448608|NCT00766753|20821464|P2|Completed at Least Four Vaccines|Overall Study||9
8448609|NCT00766753|20821465|P1|Completed at Least Four Vaccines|Overall Study||10
8448610|NCT00766753|20821464|P2|Received at Least One Vaccine|Overall Study||11
8448611|NCT00766753|20821465|P1|Received at Least One Vaccine|Overall Study||11
8448612|NCT00766753|20821464|P2|STARTED|Overall Study||11
8448613|NCT00766753|20821465|P1|STARTED|Overall Study||11
8448614|NCT00766727|20821476|P1|NOT COMPLETED|Overall Study||3
8448615|NCT00766727|20821476|P1|COMPLETED|Overall Study||9
8448616|NCT00766727|20821476|P1|STARTED|Overall Study||12
8448617|NCT00766675|20821482|P1|NOT COMPLETED|Overall Study||40
8448618|NCT00766675|20821482|P1|COMPLETED|Overall Study||40
8448619|NCT00766675|20821482|P1|STARTED|Overall Study||80
8448620|NCT00766649|20821495|P1|NOT COMPLETED|Overall Study||10
8448621|NCT00766649|20821495|P1|COMPLETED|Overall Study||1
8448622|NCT00766649|20821495|P1|STARTED|Overall Study||11
8448623|NCT00766636|20821511|P2|NOT COMPLETED|Overall Study||2
8448624|NCT00766636|20821512|P1|NOT COMPLETED|Overall Study||3
8448625|NCT00766636|20821511|P2|COMPLETED|Overall Study||0
8448626|NCT00766636|20821512|P1|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
8448627|NCT00766636|20821511|P2|STARTED|Overall Study||2
8448628|NCT00766636|20821512|P1|STARTED|Overall Study||3
8448629|NCT00766597|20821518|P1|NOT COMPLETED|Overall Study||9
8448630|NCT00766597|20821518|P1|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
8448631|NCT00766597|20821518|P1|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
8448632|NCT00766597|20821518|P1|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
8448633|NCT00766597|20821518|P1|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
8448634|NCT00766597|20821518|P1|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
8448635|NCT00766597|20821518|P1|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
8448636|NCT00766532|20821530|P1|NOT COMPLETED|Overall Study||2
8448637|NCT00766532|20821530|P1|COMPLETED|Overall Study||10
8448638|NCT00766532|20821530|P1|STARTED|Overall Study||12
8448639|NCT00766506|20821536|P2|NOT COMPLETED|Overall Study||2
8448640|NCT00766506|20821537|P1|NOT COMPLETED|Overall Study||5
8448641|NCT00766506|20821536|P2|COMPLETED|Overall Study||48
8448642|NCT00766506|20821537|P1|COMPLETED|Overall Study||53
8448643|NCT00766506|20821536|P2|STARTED|Overall Study||50
8448644|NCT00766506|20821537|P1|STARTED|Overall Study||58
8448645|NCT00766493|20821561|P1|NOT COMPLETED|30 Days Post-Procedure||12
8448646|NCT00766493|20821561|P1|COMPLETED|30 Days Post-Procedure||238
8448647|NCT00766493|20821561|P1|STARTED|30 Days Post-Procedure||250
8448648|NCT00766493|20821561|P1|NOT COMPLETED|Pre-Discharge||0
8448649|NCT00766493|20821561|P1|COMPLETED|Pre-Discharge||250
8448650|NCT00766493|20821561|P1|STARTED|Pre-Discharge||250
8448651|NCT00766467|20821571|P2|NOT COMPLETED|Overall Study||8
8448652|NCT00766467|20821572|P1|NOT COMPLETED|Overall Study||11
8448653|NCT00766467|20821571|P2|COMPLETED|Overall Study||31
8448654|NCT00766467|20821572|P1|COMPLETED|Overall Study||31
8448655|NCT00766467|20821571|P2|Initiated Treatment|Overall Study||38
8448656|NCT00766467|20821572|P1|Initiated Treatment|Overall Study||39
8448657|NCT00766467|20821571|P2|STARTED|Overall Study||39
8448658|NCT00766467|20821572|P1|STARTED|Overall Study||42
8448659|NCT00766415|20821584|P2|NOT COMPLETED|Overall Study||1
8448660|NCT00766415|20821585|P1|NOT COMPLETED|Overall Study||0
8448661|NCT00766415|20821584|P2|COMPLETED|Overall Study||26
8448662|NCT00766415|20821585|P1|COMPLETED|Overall Study||25
8448663|NCT00766415|20821584|P2|STARTED|Overall Study||27
8448664|NCT00766415|20821585|P1|STARTED|Overall Study||25
8448665|NCT00766376|20821633|P1|NOT COMPLETED|Overall Study||27
8448666|NCT00766376|20821633|P1|COMPLETED|Overall Study||124
8448667|NCT00766376|20821633|P1|STARTED|Overall Study||151
8448668|NCT00766363|20821642|P4|NOT COMPLETED|Overall Study||0
8448669|NCT00766363|20821643|P3|NOT COMPLETED|Overall Study||0
8448670|NCT00766363|20821644|P2|NOT COMPLETED|Overall Study||1
8448671|NCT00766363|20821645|P1|NOT COMPLETED|Overall Study||1
8448672|NCT00766363|20821642|P4|COMPLETED|Overall Study||12
8448673|NCT00766363|20821643|P3|COMPLETED|Overall Study||12
8448674|NCT00766363|20821644|P2|COMPLETED|Overall Study||12
8448675|NCT00766363|20821645|P1|COMPLETED|Overall Study||11
8448676|NCT00766363|20821642|P4|PK POPULATION|Overall Study||13
8448677|NCT00766363|20821643|P3|PK POPULATION|Overall Study||10
8448678|NCT00766363|20821644|P2|PK POPULATION|Overall Study||13
8448679|NCT00766363|20821645|P1|PK POPULATION|Overall Study||12
8448680|NCT00766363|20821642|P4|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
8448681|NCT00766363|20821643|P3|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
8448682|NCT00766363|20821644|P2|SAFETY POPULATION|Overall Study||13
8448683|NCT00766363|20821645|P1|SAFETY POPULATION|Overall Study||12
8448684|NCT00766363|20821642|P4|STARTED|Overall Study|Number randomized.|12
8448685|NCT00766363|20821643|P3|STARTED|Overall Study|Number randomized.|12
8448686|NCT00766363|20821644|P2|STARTED|Overall Study||13
8448687|NCT00766363|20821645|P1|STARTED|Overall Study||12
8448688|NCT00766142|20821682|P1|NOT COMPLETED|Overall Study||4
8448689|NCT00766142|20821682|P1|COMPLETED|Overall Study||14
8448690|NCT00766142|20821682|P1|STARTED|Overall Study||18
8448691|NCT00766116|20821689|P1|NOT COMPLETED|Overall Study||0
8448692|NCT00766116|20821689|P1|COMPLETED|Overall Study||50
8448693|NCT00766116|20821689|P1|STARTED|Overall Study||50
8448694|NCT00766090|20821698|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8448695|NCT00766090|20821699|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8448696|NCT00766090|20821700|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8448697|NCT00766090|20821701|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8448698|NCT00766090|20821702|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8448699|NCT00766090|20821703|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8448700|NCT00766090|20821704|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8448701|NCT00766090|20821705|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8448702|NCT00766090|20821706|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8448703|NCT00766090|20821707|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8448704|NCT00766090|20821708|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||1
8448705|NCT00766090|20821709|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
8448706|NCT00766090|20821698|P12|COMPLETED|Treatment Period 3 (28 Days)||6
8448707|NCT00766090|20821699|P11|COMPLETED|Treatment Period 3 (28 Days)||7
8448708|NCT00766090|20821700|P10|COMPLETED|Treatment Period 3 (28 Days)||8
8448709|NCT00766090|20821701|P9|COMPLETED|Treatment Period 3 (28 Days)||6
8448710|NCT00766090|20821702|P8|COMPLETED|Treatment Period 3 (28 Days)||8
8448711|NCT00766090|20821703|P7|COMPLETED|Treatment Period 3 (28 Days)||6
8448712|NCT00766090|20821704|P6|COMPLETED|Treatment Period 3 (28 Days)||22
8448713|NCT00766090|20821705|P5|COMPLETED|Treatment Period 3 (28 Days)||20
8448714|NCT00766090|20821706|P4|COMPLETED|Treatment Period 3 (28 Days)||24
8448715|NCT00766090|20821707|P3|COMPLETED|Treatment Period 3 (28 Days)||20
8448716|NCT00766090|20821708|P2|COMPLETED|Treatment Period 3 (28 Days)||26
8448717|NCT00766090|20821709|P1|COMPLETED|Treatment Period 3 (28 Days)||22
8448718|NCT00766090|20821698|P12|STARTED|Treatment Period 3 (28 Days)||7
8448719|NCT00766090|20821699|P11|STARTED|Treatment Period 3 (28 Days)||7
8448720|NCT00766090|20821700|P10|STARTED|Treatment Period 3 (28 Days)||8
8448721|NCT00766090|20821701|P9|STARTED|Treatment Period 3 (28 Days)||6
8448722|NCT00766090|20821702|P8|STARTED|Treatment Period 3 (28 Days)||8
8448723|NCT00766090|20821703|P7|STARTED|Treatment Period 3 (28 Days)||6
8448724|NCT00766090|20821704|P6|STARTED|Treatment Period 3 (28 Days)||23
8448725|NCT00766090|20821705|P5|STARTED|Treatment Period 3 (28 Days)||21
8448726|NCT00766090|20821706|P4|STARTED|Treatment Period 3 (28 Days)||25
8448727|NCT00766090|20821707|P3|STARTED|Treatment Period 3 (28 Days)||20
8448728|NCT00766090|20821708|P2|STARTED|Treatment Period 3 (28 Days)||27
8448729|NCT00766090|20821709|P1|STARTED|Treatment Period 3 (28 Days)||22
8448730|NCT00766090|20821698|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448731|NCT00766090|20821699|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448732|NCT00766090|20821700|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448733|NCT00766090|20821701|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448734|NCT00766090|20821702|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448735|NCT00766090|20821703|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448736|NCT00766090|20821704|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448737|NCT00766090|20821705|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448738|NCT00766090|20821706|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448739|NCT00766090|20821707|P3|NOT COMPLETED|Washout Period 2 (14 Days)||1
8448740|NCT00766090|20821708|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448741|NCT00766090|20821709|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
8448742|NCT00766090|20821698|P12|COMPLETED|Washout Period 2 (14 Days)||7
8448743|NCT00766090|20821699|P11|COMPLETED|Washout Period 2 (14 Days)||7
8448744|NCT00766090|20821700|P10|COMPLETED|Washout Period 2 (14 Days)||8
8448745|NCT00766090|20821701|P9|COMPLETED|Washout Period 2 (14 Days)||6
8448746|NCT00766090|20821702|P8|COMPLETED|Washout Period 2 (14 Days)||8
8448747|NCT00766090|20821703|P7|COMPLETED|Washout Period 2 (14 Days)||6
8448748|NCT00766090|20821704|P6|COMPLETED|Washout Period 2 (14 Days)||23
8448749|NCT00766090|20821705|P5|COMPLETED|Washout Period 2 (14 Days)||21
8448750|NCT00766090|20821706|P4|COMPLETED|Washout Period 2 (14 Days)||25
8448751|NCT00766090|20821707|P3|COMPLETED|Washout Period 2 (14 Days)||20
8448752|NCT00766090|20821708|P2|COMPLETED|Washout Period 2 (14 Days)||27
8448753|NCT00766090|20821709|P1|COMPLETED|Washout Period 2 (14 Days)||22
8448754|NCT00766090|20821698|P12|STARTED|Washout Period 2 (14 Days)||7
8448755|NCT00766090|20821699|P11|STARTED|Washout Period 2 (14 Days)||7
8448756|NCT00766090|20821700|P10|STARTED|Washout Period 2 (14 Days)||8
8448757|NCT00766090|20821701|P9|STARTED|Washout Period 2 (14 Days)||6
8448758|NCT00766090|20821702|P8|STARTED|Washout Period 2 (14 Days)||8
8448759|NCT00766090|20821703|P7|STARTED|Washout Period 2 (14 Days)||6
8448760|NCT00766090|20821704|P6|STARTED|Washout Period 2 (14 Days)||23
8448761|NCT00766090|20821705|P5|STARTED|Washout Period 2 (14 Days)||21
8448762|NCT00766090|20821706|P4|STARTED|Washout Period 2 (14 Days)||25
8448763|NCT00766090|20821707|P3|STARTED|Washout Period 2 (14 Days)||21
8448764|NCT00766090|20821708|P2|STARTED|Washout Period 2 (14 Days)||27
8448765|NCT00766090|20821709|P1|STARTED|Washout Period 2 (14 Days)||22
8448766|NCT00766090|20821698|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448767|NCT00766090|20821699|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448768|NCT00766090|20821700|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448769|NCT00766090|20821701|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448770|NCT00766090|20821702|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448771|NCT00766090|20821703|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448772|NCT00766090|20821704|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448773|NCT00766090|20821705|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||2
8448774|NCT00766090|20821706|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448775|NCT00766090|20821707|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
8448776|NCT00766090|20821708|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448777|NCT00766090|20821709|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8448778|NCT00766090|20821698|P12|COMPLETED|Treatment Period 2 (28 Days)||7
8448779|NCT00766090|20821699|P11|COMPLETED|Treatment Period 2 (28 Days)||7
8448780|NCT00766090|20821700|P10|COMPLETED|Treatment Period 2 (28 Days)||8
8448781|NCT00766090|20821701|P9|COMPLETED|Treatment Period 2 (28 Days)||6
8448782|NCT00766090|20821702|P8|COMPLETED|Treatment Period 2 (28 Days)||8
8448783|NCT00766090|20821703|P7|COMPLETED|Treatment Period 2 (28 Days)||6
8448784|NCT00766090|20821704|P6|COMPLETED|Treatment Period 2 (28 Days)||23
8448785|NCT00766090|20821705|P5|COMPLETED|Treatment Period 2 (28 Days)||21
8448786|NCT00766090|20821706|P4|COMPLETED|Treatment Period 2 (28 Days)||25
8448787|NCT00766090|20821707|P3|COMPLETED|Treatment Period 2 (28 Days)||21
8448788|NCT00766090|20821708|P2|COMPLETED|Treatment Period 2 (28 Days)||27
8448789|NCT00766090|20821709|P1|COMPLETED|Treatment Period 2 (28 Days)||22
8448790|NCT00766090|20821698|P12|STARTED|Treatment Period 2 (28 Days)||7
8448791|NCT00766090|20821699|P11|STARTED|Treatment Period 2 (28 Days)||7
8448792|NCT00766090|20821700|P10|STARTED|Treatment Period 2 (28 Days)||8
8448793|NCT00766090|20821701|P9|STARTED|Treatment Period 2 (28 Days)||6
8448794|NCT00766090|20821702|P8|STARTED|Treatment Period 2 (28 Days)||8
8448795|NCT00766090|20821703|P7|STARTED|Treatment Period 2 (28 Days)||6
8448796|NCT00766090|20821704|P6|STARTED|Treatment Period 2 (28 Days)||23
8448797|NCT00766090|20821705|P5|STARTED|Treatment Period 2 (28 Days)||23
8448798|NCT00766090|20821706|P4|STARTED|Treatment Period 2 (28 Days)||25
8448799|NCT00766090|20821707|P3|STARTED|Treatment Period 2 (28 Days)||22
8448800|NCT00766090|20821708|P2|STARTED|Treatment Period 2 (28 Days)||27
8448801|NCT00766090|20821709|P1|STARTED|Treatment Period 2 (28 Days)||22
8448802|NCT00766090|20821698|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448803|NCT00766090|20821699|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448804|NCT00766090|20821700|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448805|NCT00766090|20821701|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448806|NCT00766090|20821702|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448807|NCT00766090|20821703|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448808|NCT00766090|20821704|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448809|NCT00766090|20821705|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448810|NCT00766090|20821706|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448811|NCT00766090|20821707|P3|NOT COMPLETED|Washout Period 1 (14 Days)||1
8448812|NCT00766090|20821708|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448813|NCT00766090|20821709|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
8448814|NCT00766090|20821698|P12|COMPLETED|Washout Period 1 (14 Days)||7
8448815|NCT00766090|20821699|P11|COMPLETED|Washout Period 1 (14 Days)||7
8448816|NCT00766090|20821700|P10|COMPLETED|Washout Period 1 (14 Days)||8
8448817|NCT00766090|20821701|P9|COMPLETED|Washout Period 1 (14 Days)||6
8448818|NCT00766090|20821702|P8|COMPLETED|Washout Period 1 (14 Days)||8
8448819|NCT00766090|20821703|P7|COMPLETED|Washout Period 1 (14 Days)||6
8448820|NCT00766090|20821704|P6|COMPLETED|Washout Period 1 (14 Days)||23
8448821|NCT00766090|20821705|P5|COMPLETED|Washout Period 1 (14 Days)||23
8448822|NCT00766090|20821706|P4|COMPLETED|Washout Period 1 (14 Days)||25
8448823|NCT00766090|20821707|P3|COMPLETED|Washout Period 1 (14 Days)||22
8448824|NCT00766090|20821708|P2|COMPLETED|Washout Period 1 (14 Days)||27
8448825|NCT00766090|20821709|P1|COMPLETED|Washout Period 1 (14 Days)||22
8448826|NCT00766090|20821698|P12|STARTED|Washout Period 1 (14 Days)||7
8448827|NCT00766090|20821699|P11|STARTED|Washout Period 1 (14 Days)||7
8448828|NCT00766090|20821700|P10|STARTED|Washout Period 1 (14 Days)||8
8448829|NCT00766090|20821701|P9|STARTED|Washout Period 1 (14 Days)||6
8448830|NCT00766090|20821702|P8|STARTED|Washout Period 1 (14 Days)||8
8448831|NCT00766090|20821703|P7|STARTED|Washout Period 1 (14 Days)||6
8448832|NCT00766090|20821704|P6|STARTED|Washout Period 1 (14 Days)||23
8448833|NCT00766090|20821705|P5|STARTED|Washout Period 1 (14 Days)||23
8448834|NCT00766090|20821706|P4|STARTED|Washout Period 1 (14 Days)||25
8448835|NCT00766090|20821707|P3|STARTED|Washout Period 1 (14 Days)||23
8448836|NCT00766090|20821708|P2|STARTED|Washout Period 1 (14 Days)||27
8448837|NCT00766090|20821709|P1|STARTED|Washout Period 1 (14 Days)||22
8448838|NCT00766090|20821698|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448839|NCT00766090|20821699|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448840|NCT00766090|20821700|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448841|NCT00766090|20821701|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8448842|NCT00766090|20821702|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448843|NCT00766090|20821703|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448844|NCT00766090|20821704|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448845|NCT00766090|20821705|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448846|NCT00766090|20821706|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8448847|NCT00766090|20821707|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448848|NCT00766090|20821708|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8448849|NCT00766090|20821709|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||3
8448850|NCT00766090|20821698|P12|COMPLETED|Treatment Period 1 (28 Days)||7
8448851|NCT00766090|20821699|P11|COMPLETED|Treatment Period 1 (28 Days)||7
8448852|NCT00766090|20821700|P10|COMPLETED|Treatment Period 1 (28 Days)||8
8448853|NCT00766090|20821701|P9|COMPLETED|Treatment Period 1 (28 Days)||6
8448854|NCT00766090|20821702|P8|COMPLETED|Treatment Period 1 (28 Days)||8
8448855|NCT00766090|20821703|P7|COMPLETED|Treatment Period 1 (28 Days)||6
8448856|NCT00766090|20821704|P6|COMPLETED|Treatment Period 1 (28 Days)||23
8448857|NCT00766090|20821705|P5|COMPLETED|Treatment Period 1 (28 Days)||23
8448858|NCT00766090|20821706|P4|COMPLETED|Treatment Period 1 (28 Days)||25
8448859|NCT00766090|20821707|P3|COMPLETED|Treatment Period 1 (28 Days)||23
8448860|NCT00766090|20821708|P2|COMPLETED|Treatment Period 1 (28 Days)||27
8448861|NCT00766090|20821709|P1|COMPLETED|Treatment Period 1 (28 Days)||22
8448862|NCT00766090|20821698|P12|STARTED|Treatment Period 1 (28 Days)||7
8448863|NCT00766090|20821699|P11|STARTED|Treatment Period 1 (28 Days)||7
8448864|NCT00766090|20821700|P10|STARTED|Treatment Period 1 (28 Days)||8
8448865|NCT00766090|20821701|P9|STARTED|Treatment Period 1 (28 Days)||7
8448866|NCT00766090|20821702|P8|STARTED|Treatment Period 1 (28 Days)||8
8448867|NCT00766090|20821703|P7|STARTED|Treatment Period 1 (28 Days)||6
8448868|NCT00766090|20821704|P6|STARTED|Treatment Period 1 (28 Days)||23
8448869|NCT00766090|20821705|P5|STARTED|Treatment Period 1 (28 Days)||23
8448870|NCT00766090|20821706|P4|STARTED|Treatment Period 1 (28 Days)||26
8448871|NCT00766090|20821707|P3|STARTED|Treatment Period 1 (28 Days)||23
8448872|NCT00766090|20821708|P2|STARTED|Treatment Period 1 (28 Days)||27
8448873|NCT00766090|20821709|P1|STARTED|Treatment Period 1 (28 Days)||25
8448874|NCT00766051|20821750|P2|NOT COMPLETED|Overall Study||0
8448875|NCT00766051|20821751|P1|NOT COMPLETED|Overall Study||2
8448876|NCT00766051|20821750|P2|COMPLETED|Overall Study||10
8448877|NCT00766051|20821751|P1|COMPLETED|Overall Study||10
8448878|NCT00766051|20821750|P2|STARTED|Overall Study||10
8448879|NCT00766051|20821751|P1|STARTED|Overall Study||12
8448880|NCT00766038|20821763|P2|NOT COMPLETED|Overall Study||14
8448881|NCT00766038|20821764|P1|NOT COMPLETED|Overall Study||15
8448882|NCT00766038|20821763|P2|COMPLETED|Overall Study||18
8448883|NCT00766038|20821764|P1|COMPLETED|Overall Study||16
8448884|NCT00766038|20821763|P2|STARTED|Overall Study||32
8448885|NCT00766038|20821764|P1|STARTED|Overall Study||31
8448886|NCT00765999|20821780|P1|NOT COMPLETED|Overall Study||784
8448887|NCT00765999|20821780|P1|COMPLETED|Overall Study||770
8448888|NCT00765999|20821780|P1|STARTED|Overall Study||1554
8448889|NCT00765947|20821786|P1|NOT COMPLETED|Overall Study||24
8448890|NCT00765947|20821786|P1|COMPLETED|Overall Study||232
8448891|NCT00765947|20821786|P1|STARTED|Overall Study||256
8448892|NCT00765895|20821797|P2|NOT COMPLETED|Overall Study||0
8448893|NCT00765895|20821798|P1|NOT COMPLETED|Overall Study||0
8448894|NCT00765895|20821797|P2|COMPLETED|Overall Study||65
8448895|NCT00765895|20821798|P1|COMPLETED|Overall Study||65
8448896|NCT00765895|20821797|P2|STARTED|Overall Study||65
8448897|NCT00765895|20821798|P1|STARTED|Overall Study||65
8448898|NCT00765882|20821807|P3|NOT COMPLETED|Overall Study||36
8448899|NCT00765882|20821808|P2|NOT COMPLETED|Overall Study||40
8448900|NCT00765882|20821809|P1|NOT COMPLETED|Overall Study||24
8448901|NCT00765882|20821807|P3|COMPLETED|Overall Study||169
8448902|NCT00765882|20821808|P2|COMPLETED|Overall Study||173
8448903|NCT00765882|20821809|P1|COMPLETED|Overall Study||191
8448904|NCT00765882|20821807|P3|STARTED|Overall Study||205
8448905|NCT00765882|20821808|P2|STARTED|Overall Study||213
8448906|NCT00765882|20821809|P1|STARTED|Overall Study||215
8448907|NCT00765856|20821838|P1|NOT COMPLETED|Maintenance Period||6
8448908|NCT00765856|20821838|P1|COMPLETED|Maintenance Period||18
8448909|NCT00765856|20821838|P1|STARTED|Maintenance Period||24
8448910|NCT00765856|20821838|P1|NOT COMPLETED|Titration Period||3
8448911|NCT00765856|20821838|P1|COMPLETED|Titration Period||24
8448912|NCT00765856|20821838|P1|STARTED|Titration Period||27
8448913|NCT00765843|20821855|P3|NOT COMPLETED|Overall Study||3
8448914|NCT00765843|20821856|P2|NOT COMPLETED|Overall Study||4
8448915|NCT00765843|20821857|P1|NOT COMPLETED|Overall Study||1
8448916|NCT00765843|20821855|P3|COMPLETED|Overall Study||23
8448917|NCT00765843|20821856|P2|COMPLETED|Overall Study||21
8448918|NCT00765843|20821857|P1|COMPLETED|Overall Study||25
8448919|NCT00765843|20821855|P3|STARTED|Overall Study||26
8448920|NCT00765843|20821856|P2|STARTED|Overall Study||25
8448921|NCT00765843|20821857|P1|STARTED|Overall Study||26
8448922|NCT00765817|20821867|P2|NOT COMPLETED|Overall Study||22
8448923|NCT00765817|20821868|P1|NOT COMPLETED|Overall Study||26
8448924|NCT00765817|20821867|P2|COMPLETED|Overall Study||101
8448925|NCT00765817|20821868|P1|COMPLETED|Overall Study||112
8448926|NCT00765817|20821867|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
8448927|NCT00765817|20821868|P1|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
8448928|NCT00765765|20821906|P1|NOT COMPLETED|Overall Study||0
8448929|NCT00765765|20821906|P1|COMPLETED|Overall Study||6
8448930|NCT00765765|20821906|P1|STARTED|Overall Study||6
8448931|NCT00765726|20821916|P1|NOT COMPLETED|Overall Study||9
8448932|NCT00765726|20821916|P1|COMPLETED|Overall Study||3
8448933|NCT00765726|20821916|P1|STARTED|Overall Study||12
8448934|NCT00765674|20821924|P4|NOT COMPLETED|Overall Study||25
8448935|NCT00765674|20821925|P3|NOT COMPLETED|Overall Study||17
8448936|NCT00765674|20821926|P2|NOT COMPLETED|Overall Study||22
8448937|NCT00765674|20821927|P1|NOT COMPLETED|Overall Study||21
8448938|NCT00765674|20821924|P4|COMPLETED|Overall Study||285
8448939|NCT00765674|20821925|P3|COMPLETED|Overall Study||279
8448940|NCT00765674|20821926|P2|COMPLETED|Overall Study||276
8448941|NCT00765674|20821927|P1|COMPLETED|Overall Study||266
8448942|NCT00765674|20821924|P4|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
8448943|NCT00765674|20821925|P3|STARTED|Overall Study||296
8448944|NCT00765674|20821926|P2|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
8448945|NCT00765674|20821927|P1|STARTED|Overall Study||287
8448946|NCT00765661|20821951|P2|NOT COMPLETED|Overall Study||0
8448947|NCT00765661|20821952|P1|NOT COMPLETED|Overall Study||0
8448948|NCT00765661|20821951|P2|COMPLETED|Overall Study||31
8448949|NCT00765661|20821952|P1|COMPLETED|Overall Study||32
8448950|NCT00765661|20821951|P2|STARTED|Overall Study||31
8448951|NCT00765661|20821952|P1|STARTED|Overall Study||32
8448952|NCT00765648|20821966|P2|NOT COMPLETED|Overall Study||2
8448953|NCT00765648|20821967|P1|NOT COMPLETED|Overall Study||1
8448954|NCT00765648|20821966|P2|COMPLETED|Overall Study||114
8448955|NCT00765648|20821967|P1|COMPLETED|Overall Study||109
8448956|NCT00765648|20821966|P2|STARTED|Overall Study||116
8448957|NCT00765648|20821967|P1|STARTED|Overall Study||110
8448958|NCT00765570|20821985|P2|NOT COMPLETED|Overall Study||0
8448959|NCT00765570|20821986|P1|NOT COMPLETED|Overall Study||2
8448960|NCT00765570|20821985|P2|COMPLETED|Overall Study||3
8448961|NCT00765570|20821986|P1|COMPLETED|Overall Study||7
8448962|NCT00765570|20821985|P2|STARTED|Overall Study||3
8448963|NCT00765570|20821986|P1|STARTED|Overall Study||9
8448964|NCT00765388|20821994|P2|NOT COMPLETED|Period 2||0
8448965|NCT00765388|20821995|P1|NOT COMPLETED|Period 2||0
8448966|NCT00765388|20821994|P2|COMPLETED|Period 2||6
8448967|NCT00765388|20821995|P1|COMPLETED|Period 2||15
8448968|NCT00765388|20821994|P2|STARTED|Period 2||6
8448969|NCT00765388|20821995|P1|STARTED|Period 2||15
8448970|NCT00765388|20821994|P2|NOT COMPLETED|Period 1||5
8448971|NCT00765388|20821995|P1|NOT COMPLETED|Period 1||1
8448972|NCT00765388|20821994|P2|COMPLETED|Period 1||6
8448973|NCT00765388|20821995|P1|COMPLETED|Period 1||15
8448974|NCT00765388|20821994|P2|STARTED|Period 1||11
8448975|NCT00765388|20821995|P1|STARTED|Period 1|A cross-over study|16
8448976|NCT00765375|20822023|P1|NOT COMPLETED|Overall Study||0
8448977|NCT00765375|20822023|P1|COMPLETED|Overall Study||5
8448978|NCT00765375|20822023|P1|STARTED|Overall Study||5
8448979|NCT00765362|20822029|P1|NOT COMPLETED|Overall Study||137
8448980|NCT00765362|20822029|P1|COMPLETED|Overall Study||282
8448981|NCT00765362|20822029|P1|STARTED|Overall Study||419
8448982|NCT00765336|20822037|P2|NOT COMPLETED|Overall Study||16
8448983|NCT00765336|20822038|P1|NOT COMPLETED|Overall Study||19
8448984|NCT00765336|20822037|P2|COMPLETED|Overall Study||73
8448985|NCT00765336|20822038|P1|COMPLETED|Overall Study||72
8448986|NCT00765336|20822037|P2|STARTED|Overall Study||89
8448987|NCT00765336|20822038|P1|STARTED|Overall Study||91
8448988|NCT00765245|20822046|P2|NOT COMPLETED|Overall Study||2
8448989|NCT00765245|20822047|P1|NOT COMPLETED|Overall Study||13
8448990|NCT00765245|20822046|P2|COMPLETED|Overall Study||20
8448991|NCT00765245|20822047|P1|COMPLETED|Overall Study||9
8448992|NCT00765245|20822046|P2|STARTED|Overall Study||22
8448993|NCT00765245|20822047|P1|STARTED|Overall Study||22
8448994|NCT00765232|20822059|P2|NOT COMPLETED|Overall Study||0
8448995|NCT00765232|20822060|P1|NOT COMPLETED|Overall Study||0
8448996|NCT00765232|20822059|P2|COMPLETED|Overall Study||54
8448997|NCT00765232|20822060|P1|COMPLETED|Overall Study||57
8448998|NCT00765232|20822059|P2|STARTED|Overall Study||54
8448999|NCT00765232|20822060|P1|STARTED|Overall Study||57
8449000|NCT00765206|20822068|P4|NOT COMPLETED|Second Intervention||0
8449001|NCT00765206|20822069|P3|NOT COMPLETED|Second Intervention||0
8449002|NCT00765206|20822070|P2|NOT COMPLETED|Second Intervention||0
8449003|NCT00765206|20822071|P1|NOT COMPLETED|Second Intervention||0
8449004|NCT00765206|20822068|P4|COMPLETED|Second Intervention||15
8449005|NCT00765206|20822069|P3|COMPLETED|Second Intervention||15
8449006|NCT00765206|20822070|P2|COMPLETED|Second Intervention||15
8449007|NCT00765206|20822071|P1|COMPLETED|Second Intervention||15
8449008|NCT00765206|20822068|P4|STARTED|Second Intervention||15
8449009|NCT00765206|20822069|P3|STARTED|Second Intervention||15
8449010|NCT00765206|20822070|P2|STARTED|Second Intervention||15
8449011|NCT00765206|20822071|P1|STARTED|Second Intervention||15
8449012|NCT00765206|20822068|P4|NOT COMPLETED|Washout Period of 14 Days||0
8449013|NCT00765206|20822069|P3|NOT COMPLETED|Washout Period of 14 Days||0
8449014|NCT00765206|20822070|P2|NOT COMPLETED|Washout Period of 14 Days||0
8449015|NCT00765206|20822071|P1|NOT COMPLETED|Washout Period of 14 Days||0
8449016|NCT00765206|20822068|P4|COMPLETED|Washout Period of 14 Days||15
8449017|NCT00765206|20822069|P3|COMPLETED|Washout Period of 14 Days||15
8449018|NCT00765206|20822070|P2|COMPLETED|Washout Period of 14 Days||15
8449019|NCT00765206|20822071|P1|COMPLETED|Washout Period of 14 Days||15
8449020|NCT00765206|20822068|P4|STARTED|Washout Period of 14 Days||15
8449021|NCT00765206|20822069|P3|STARTED|Washout Period of 14 Days||15
8449022|NCT00765206|20822070|P2|STARTED|Washout Period of 14 Days||15
8449023|NCT00765206|20822071|P1|STARTED|Washout Period of 14 Days||15
8449024|NCT00765206|20822068|P4|NOT COMPLETED|First Intervention||0
8449025|NCT00765206|20822069|P3|NOT COMPLETED|First Intervention||0
8449026|NCT00765206|20822070|P2|NOT COMPLETED|First Intervention||0
8449027|NCT00765206|20822071|P1|NOT COMPLETED|First Intervention||0
8449028|NCT00765206|20822068|P4|COMPLETED|First Intervention||15
8449029|NCT00765206|20822069|P3|COMPLETED|First Intervention||15
8449030|NCT00765206|20822070|P2|COMPLETED|First Intervention||15
8449031|NCT00765206|20822071|P1|COMPLETED|First Intervention||15
8449032|NCT00765206|20822068|P4|STARTED|First Intervention||15
8449033|NCT00765206|20822069|P3|STARTED|First Intervention||15
8449034|NCT00765206|20822070|P2|STARTED|First Intervention||15
8449035|NCT00765206|20822071|P1|STARTED|First Intervention||15
8449036|NCT00765193|20822077|P1|NOT COMPLETED|Full Body Examination||0
8449037|NCT00765193|20822077|P1|COMPLETED|Full Body Examination||14381
8449038|NCT00765193|20822077|P1|STARTED|Full Body Examination||14381
8449039|NCT00765193|20822077|P1|NOT COMPLETED|Problem Area Examination||0
8449040|NCT00765193|20822077|P1|COMPLETED|Problem Area Examination||14381
8449041|NCT00765193|20822077|P1|STARTED|Problem Area Examination||14381
8449042|NCT00765128|20822084|P2|NOT COMPLETED|Overall Study||0
8449043|NCT00765128|20822085|P1|NOT COMPLETED|Overall Study||0
8449044|NCT00765128|20822084|P2|COMPLETED|Overall Study||9
8449045|NCT00765128|20822085|P1|COMPLETED|Overall Study||8
8449046|NCT00765128|20822084|P2|STARTED|Overall Study||9
8449047|NCT00765128|20822085|P1|STARTED|Overall Study||8
8449048|NCT00765102|20822093|P1|NOT COMPLETED|Overall Study||31
8449049|NCT00765102|20822093|P1|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
8449050|NCT00765102|20822093|P1|STARTED|Overall Study||32
8449051|NCT00765076|20822118|P3|NOT COMPLETED|Overall Study||1
8449052|NCT00765076|20822119|P2|NOT COMPLETED|Overall Study||0
8449053|NCT00765076|20822120|P1|NOT COMPLETED|Overall Study||1
8449054|NCT00765076|20822118|P3|COMPLETED|Overall Study||49
8449055|NCT00765076|20822119|P2|COMPLETED|Overall Study||73
8449056|NCT00765076|20822120|P1|COMPLETED|Overall Study||68
8449057|NCT00765076|20822118|P3|STARTED|Overall Study||50
8449058|NCT00765076|20822119|P2|STARTED|Overall Study||73
8449059|NCT00765076|20822120|P1|STARTED|Overall Study||69
8449060|NCT00765063|20822173|P1|NOT COMPLETED|Overall Study||32
8449061|NCT00765063|20822173|P1|COMPLETED|Overall Study||30
8449062|NCT00765063|20822173|P1|STARTED|Overall Study||62
8449063|NCT00765037|20822189|P1|NOT COMPLETED|Overall Study||6
8449064|NCT00765037|20822189|P1|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
8449065|NCT00765037|20822189|P1|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
8449066|NCT00764946|20822196|P3|NOT COMPLETED|Overall Study||4
8449067|NCT00764946|20822197|P2|NOT COMPLETED|Overall Study||17
8449068|NCT00764946|20822198|P1|NOT COMPLETED|Overall Study||13
8449069|NCT00764946|20822196|P3|COMPLETED|Overall Study||18
8449070|NCT00764946|20822197|P2|COMPLETED|Overall Study||72
8449071|NCT00764946|20822198|P1|COMPLETED|Overall Study||85
8449072|NCT00764946|20822196|P3|TREATED|Overall Study||21
8449073|NCT00764946|20822197|P2|TREATED|Overall Study||88
8449074|NCT00764946|20822198|P1|TREATED|Overall Study||97
8449075|NCT00764946|20822196|P3|STARTED|Overall Study||22
8449076|NCT00764946|20822197|P2|STARTED|Overall Study||89
8449077|NCT00764946|20822198|P1|STARTED|Overall Study||98
8449078|NCT00764881|20822226|P2|NOT COMPLETED|Overall Study||10
8449079|NCT00764881|20822227|P1|NOT COMPLETED|Overall Study||16
8449080|NCT00764881|20822226|P2|COMPLETED|Overall Study||99
8449081|NCT00764881|20822227|P1|COMPLETED|Overall Study||92
8449082|NCT00764881|20822226|P2|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
8449083|NCT00764881|20822227|P1|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
8449084|NCT00764881|20822226|P2|STARTED|Overall Study||109
8449085|NCT00764881|20822227|P1|STARTED|Overall Study||108
8449089|NCT00764790|20822460|P3|NOT COMPLETED|Overall Study||30
8449090|NCT00764790|20822461|P2|NOT COMPLETED|Overall Study||41
8449091|NCT00764790|20822462|P1|NOT COMPLETED|Overall Study||38
8449092|NCT00764790|20822460|P3|COMPLETED|Overall Study||1074
8449093|NCT00764790|20822461|P2|COMPLETED|Overall Study||1065
8449094|NCT00764790|20822462|P1|COMPLETED|Overall Study||1069
8449095|NCT00764790|20822460|P3|STARTED|Overall Study||1104
8449096|NCT00764790|20822461|P2|STARTED|Overall Study||1106
8449097|NCT00764790|20822462|P1|STARTED|Overall Study||1107
8449098|NCT00764751|20822496|P2|NOT COMPLETED|Overall Study||1
8449099|NCT00764751|20822497|P1|NOT COMPLETED|Overall Study||2
8449100|NCT00764751|20822496|P2|COMPLETED|Overall Study||11
8449101|NCT00764751|20822497|P1|COMPLETED|Overall Study||37
8449102|NCT00764751|20822496|P2|STARTED|Overall Study||12
8449103|NCT00764751|20822497|P1|STARTED|Overall Study||39
8449104|NCT00764738|20822535|P4|NOT COMPLETED|Overall Study||6
8449105|NCT00764738|20822536|P3|NOT COMPLETED|Overall Study||3
8449106|NCT00764738|20822537|P2|NOT COMPLETED|Overall Study||3
8449107|NCT00764738|20822538|P1|NOT COMPLETED|Overall Study||2
8449108|NCT00764738|20822535|P4|COMPLETED|Overall Study||18
8449109|NCT00764738|20822536|P3|COMPLETED|Overall Study||12
8449110|NCT00764738|20822537|P2|COMPLETED|Overall Study||25
8449111|NCT00764738|20822538|P1|COMPLETED|Overall Study||22
8449112|NCT00764738|20822535|P4|STARTED|Overall Study||24
8449113|NCT00764738|20822536|P3|STARTED|Overall Study||15
8449114|NCT00764738|20822537|P2|STARTED|Overall Study||28
8449115|NCT00764738|20822538|P1|STARTED|Overall Study||24
8449116|NCT00764699|20822560|P1|NOT COMPLETED|Overall Study||3
8449117|NCT00764699|20822560|P1|COMPLETED|Overall Study||0
8449118|NCT00764699|20822560|P1|STARTED|Overall Study||3
8449119|NCT00764673|20822564|P1|NOT COMPLETED|Overall Study||12
8449120|NCT00764673|20822564|P1|COMPLETED|Overall Study||59
8449121|NCT00764673|20822564|P1|STARTED|Overall Study||71
8449122|NCT00764660|20822574|P2|NOT COMPLETED|Overall Study||11
8449123|NCT00764660|20822575|P1|NOT COMPLETED|Overall Study||22
8449124|NCT00764660|20822574|P2|COMPLETED|Overall Study||55
8449125|NCT00764660|20822575|P1|COMPLETED|Overall Study||53
8449126|NCT00764660|20822574|P2|STARTED|Overall Study||66
8449127|NCT00764660|20822575|P1|STARTED|Overall Study||75
8449128|NCT00764517|20822609|P2|NOT COMPLETED|Overall Study||14
8449129|NCT00764517|20822610|P1|NOT COMPLETED|Overall Study||15
8449130|NCT00764517|20822609|P2|COMPLETED|Overall Study||4
8449131|NCT00764517|20822610|P1|COMPLETED|Overall Study||24
8449132|NCT00764517|20822609|P2|STARTED|Overall Study||18
8449133|NCT00764517|20822610|P1|STARTED|Overall Study||39
8449134|NCT00764504|20822631|P3|NOT COMPLETED|Overall Study||103
8449135|NCT00764504|20822632|P2|NOT COMPLETED|Overall Study||70
8449136|NCT00764504|20822633|P1|NOT COMPLETED|Overall Study||66
8449137|NCT00764504|20822631|P3|COMPLETED|Overall Study||131
8449138|NCT00764504|20822632|P2|COMPLETED|Overall Study||71
8449139|NCT00764504|20822633|P1|COMPLETED|Overall Study||75
8449140|NCT00764504|20822631|P3|STARTED|Overall Study||234
8449141|NCT00764504|20822632|P2|STARTED|Overall Study||141
8449142|NCT00764504|20822633|P1|STARTED|Overall Study||141
8449143|NCT00764478|20822662|P3|NOT COMPLETED|Overall Study||8
8449144|NCT00764478|20822663|P2|NOT COMPLETED|Overall Study||22
8449145|NCT00764478|20822664|P1|NOT COMPLETED|Overall Study||15
8449146|NCT00764478|20822662|P3|COMPLETED|Overall Study||118
8449147|NCT00764478|20822663|P2|COMPLETED|Overall Study||97
8449148|NCT00764478|20822664|P1|COMPLETED|Overall Study||107
8449149|NCT00764478|20822662|P3|STARTED|Overall Study||126
8449150|NCT00764478|20822663|P2|STARTED|Overall Study||119
8449151|NCT00764478|20822664|P1|STARTED|Overall Study||122
8449152|NCT00764465|20822744|P6|NOT COMPLETED|Overall Study||1
8449153|NCT00764465|20822745|P5|NOT COMPLETED|Overall Study||1
8449154|NCT00764465|20822746|P4|NOT COMPLETED|Overall Study||1
8449155|NCT00764465|20822747|P3|NOT COMPLETED|Overall Study||1
8449156|NCT00764465|20822748|P2|NOT COMPLETED|Overall Study||1
8449157|NCT00764465|20822749|P1|NOT COMPLETED|Overall Study||2
8449158|NCT00764465|20822744|P6|COMPLETED|Overall Study||7
8449159|NCT00764465|20822745|P5|COMPLETED|Overall Study||6
8449160|NCT00764465|20822746|P4|COMPLETED|Overall Study||6
8449161|NCT00764465|20822747|P3|COMPLETED|Overall Study||6
8449162|NCT00764465|20822748|P2|COMPLETED|Overall Study||6
8449163|NCT00764465|20822749|P1|COMPLETED|Overall Study||7
8449164|NCT00764465|20822744|P6|STARTED|Overall Study||8
8449165|NCT00764465|20822745|P5|STARTED|Overall Study||7
8449166|NCT00764465|20822746|P4|STARTED|Overall Study||7
8449167|NCT00764465|20822747|P3|STARTED|Overall Study||7
8449168|NCT00764465|20822748|P2|STARTED|Overall Study||7
8449169|NCT00764465|20822749|P1|STARTED|Overall Study||9
8449170|NCT00764361|20822777|P2|NOT COMPLETED|Overall Study||4
8449171|NCT00764361|20822778|P1|NOT COMPLETED|Overall Study||2
8449172|NCT00764361|20822777|P2|COMPLETED|Overall Study||3
8449173|NCT00764361|20822778|P1|COMPLETED|Overall Study||6
8449174|NCT00764361|20822777|P2|STARTED|Overall Study||7
8449175|NCT00764361|20822778|P1|STARTED|Overall Study||8
8449176|NCT00764322|20822786|P1|NOT COMPLETED|Overall Study||20
8449177|NCT00764322|20822786|P1|COMPLETED|Overall Study||480
8449178|NCT00764322|20822786|P1|STARTED|Overall Study||500
8449179|NCT00764309|20822803|P1|NOT COMPLETED|Overall Study||0
8449180|NCT00764309|20822803|P1|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
8449181|NCT00764309|20822803|P1|STARTED|Overall Study|Number of participants treated.|31
8449191|NCT00763958|20822846|P2|NOT COMPLETED|Overall Study||11
8449192|NCT00763958|20822847|P1|NOT COMPLETED|Overall Study||14
8449193|NCT00763958|20822846|P2|COMPLETED|Overall Study||5
8449194|NCT00763958|20822847|P1|COMPLETED|Overall Study||14
8449195|NCT00763958|20822846|P2|STARTED|Overall Study||16
8449196|NCT00763958|20822847|P1|STARTED|Overall Study||28
8449197|NCT00763919|20822857|P1|NOT COMPLETED|Overall Study||13
8449198|NCT00763919|20822857|P1|COMPLETED|Overall Study||30
8449199|NCT00763919|20822857|P1|STARTED|Overall Study||43
8449200|NCT00763867|20822885|P2|NOT COMPLETED|Overall Study||12
8449201|NCT00763867|20822886|P1|NOT COMPLETED|Overall Study||5
8449202|NCT00763867|20822885|P2|COMPLETED|Overall Study||101
8449203|NCT00763867|20822886|P1|COMPLETED|Overall Study||98
8449204|NCT00763867|20822885|P2|STARTED|Overall Study||113
8449205|NCT00763867|20822886|P1|STARTED|Overall Study||103
8449206|NCT00763815|20822982|P2|NOT COMPLETED|Overall Study||84
8449207|NCT00763815|20822983|P1|NOT COMPLETED|Overall Study||52
8449208|NCT00763815|20822982|P2|COMPLETED|Overall Study||239
8449209|NCT00763815|20822983|P1|COMPLETED|Overall Study||109
8449210|NCT00763815|20822982|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||320
8449211|NCT00763815|20822983|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
8449212|NCT00763815|20822982|P2|Treated/Safety Population|Overall Study||323
8449213|NCT00763815|20822983|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
8449214|NCT00763815|20822982|P2|STARTED|Overall Study||323
8449215|NCT00763815|20822983|P1|STARTED|Overall Study|Randomized.|161
8449216|NCT00763750|20823007|P1|NOT COMPLETED|Overall Study||0
8449217|NCT00763750|20823007|P1|COMPLETED|Overall Study||25
8449218|NCT00763750|20823007|P1|STARTED|Overall Study||25
8449219|NCT00763698|20823011|P1|NOT COMPLETED|Overall Study||10
8449220|NCT00763698|20823011|P1|COMPLETED|Overall Study||76
8449221|NCT00763698|20823011|P1|STARTED|Overall Study||86
8449222|NCT00763490|20823017|P1|NOT COMPLETED|Overall Study||0
8449223|NCT00763490|20823017|P1|COMPLETED|Overall Study||20
8449224|NCT00763490|20823017|P1|STARTED|Overall Study||20
8449225|NCT00763451|20823028|P4|NOT COMPLETED|Overall Study||30
8449226|NCT00763451|20823029|P3|NOT COMPLETED|Overall Study||40
8449227|NCT00763451|20823030|P2|NOT COMPLETED|Overall Study||22
8449228|NCT00763451|20823031|P1|NOT COMPLETED|Overall Study||13
8449229|NCT00763451|20823028|P4|COMPLETED|Overall Study||131
8449230|NCT00763451|20823029|P3|COMPLETED|Overall Study||121
8449231|NCT00763451|20823030|P2|COMPLETED|Overall Study||60
8449232|NCT00763451|20823031|P1|COMPLETED|Overall Study||67
8449233|NCT00763451|20823028|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||160
8449234|NCT00763451|20823029|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||160
8449235|NCT00763451|20823030|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||80
8449236|NCT00763451|20823031|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
8449237|NCT00763451|20823028|P4|Treated/Safety Population|Overall Study||161
8449238|NCT00763451|20823029|P3|Treated/Safety Population|Overall Study||161
8449239|NCT00763451|20823030|P2|Treated/Safety Population|Overall Study||81
8449240|NCT00763451|20823031|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
8449241|NCT00763451|20823028|P4|STARTED|Overall Study||161
8449242|NCT00763451|20823029|P3|STARTED|Overall Study||161
8449243|NCT00763451|20823030|P2|STARTED|Overall Study||82
8449244|NCT00763451|20823031|P1|STARTED|Overall Study|Randomized.|80
8449245|NCT00763412|20823065|P2|NOT COMPLETED|Overall Study||4
8449246|NCT00763412|20823066|P1|NOT COMPLETED|Overall Study||4
8449247|NCT00763412|20823065|P2|COMPLETED|Overall Study||4
8449248|NCT00763412|20823066|P1|COMPLETED|Overall Study||4
8449249|NCT00763412|20823065|P2|STARTED|Overall Study||8
8449250|NCT00763412|20823066|P1|STARTED|Overall Study||8
8449251|NCT00763386|20823090|P2|NOT COMPLETED|Overall Study||40
8449252|NCT00763386|20823091|P1|NOT COMPLETED|Overall Study||48
8449253|NCT00763386|20823090|P2|COMPLETED|Overall Study||127
8449254|NCT00763386|20823091|P1|COMPLETED|Overall Study||116
8449255|NCT00763386|20823090|P2|STARTED|Overall Study||167
8449256|NCT00763386|20823091|P1|STARTED|Overall Study||164
8449257|NCT00763360|20823102|P3|NOT COMPLETED|Overall Study||0
8449258|NCT00763360|20823103|P2|NOT COMPLETED|Overall Study||2
8449259|NCT00763360|20823104|P1|NOT COMPLETED|Overall Study||0
8449260|NCT00763360|20823102|P3|COMPLETED|Overall Study||63
8449261|NCT00763360|20823103|P2|COMPLETED|Overall Study||58
8449262|NCT00763360|20823104|P1|COMPLETED|Overall Study||61
8449263|NCT00763360|20823102|P3|STARTED|Overall Study||63
8449264|NCT00763360|20823103|P2|STARTED|Overall Study||60
8449265|NCT00763360|20823104|P1|STARTED|Overall Study||61
8449266|NCT00763321|20823124|P3|NOT COMPLETED|Double-blind Period||29
8449267|NCT00763321|20823125|P2|NOT COMPLETED|Double-blind Period||21
8449268|NCT00763321|20823126|P1|NOT COMPLETED|Double-blind Period||0
8449269|NCT00763321|20823124|P3|COMPLETED|Double-blind Period||84
8449270|NCT00763321|20823125|P2|COMPLETED|Double-blind Period||88
8449271|NCT00763321|20823126|P1|COMPLETED|Double-blind Period||0
8449272|NCT00763321|20823124|P3|STARTED|Double-blind Period||113
8449273|NCT00763321|20823125|P2|STARTED|Double-blind Period||109
8449274|NCT00763321|20823126|P1|STARTED|Double-blind Period||0
8449275|NCT00763321|20823124|P3|NOT COMPLETED|Open-label Period||0
8449276|NCT00763321|20823125|P2|NOT COMPLETED|Open-label Period||0
8449277|NCT00763321|20823126|P1|NOT COMPLETED|Open-label Period||63
8449278|NCT00763321|20823124|P3|COMPLETED|Open-label Period||0
8449279|NCT00763321|20823125|P2|COMPLETED|Open-label Period||0
8449280|NCT00763321|20823126|P1|COMPLETED|Open-label Period||222
8449281|NCT00763321|20823124|P3|STARTED|Open-label Period||0
8449282|NCT00763321|20823125|P2|STARTED|Open-label Period||0
8449283|NCT00763321|20823126|P1|STARTED|Open-label Period||285
8449284|NCT00763282|20823137|P2|NOT COMPLETED|Overall Study||34
8449285|NCT00763282|20823138|P1|NOT COMPLETED|Overall Study||32
8449286|NCT00763282|20823137|P2|COMPLETED|Overall Study||38
8449287|NCT00763282|20823138|P1|COMPLETED|Overall Study||40
8449288|NCT00763282|20823137|P2|STARTED|Overall Study||72
8449289|NCT00763282|20823138|P1|STARTED|Overall Study||72
8449290|NCT00763269|20823154|P2|NOT COMPLETED|Overall Study||13
8449291|NCT00763269|20823155|P1|NOT COMPLETED|Overall Study||12
8449292|NCT00763269|20823154|P2|COMPLETED|Overall Study||299
8449293|NCT00763269|20823155|P1|COMPLETED|Overall Study||302
8449294|NCT00763269|20823154|P2|STARTED|Overall Study||312
8449295|NCT00763269|20823155|P1|STARTED|Overall Study||314
8449296|NCT00763256|20823169|P2|NOT COMPLETED|Overall Study||10
8449297|NCT00763256|20823170|P1|NOT COMPLETED|Overall Study||7
8449298|NCT00763256|20823169|P2|COMPLETED|Overall Study||8
8449299|NCT00763256|20823170|P1|COMPLETED|Overall Study||8
8449300|NCT00763256|20823169|P2|STARTED|Overall Study||18
8449301|NCT00763256|20823170|P1|STARTED|Overall Study||15
8449302|NCT00763243|20823184|P1|NOT COMPLETED|6-Month Follow-Up Period||0
8449303|NCT00763243|20823184|P1|COMPLETED|6-Month Follow-Up Period||9
8449304|NCT00763243|20823184|P1|STARTED|6-Month Follow-Up Period||9
8449305|NCT00763243|20823184|P1|NOT COMPLETED|1-Month Follow-Up Period||0
8449306|NCT00763243|20823184|P1|COMPLETED|1-Month Follow-Up Period||9
8449307|NCT00763243|20823184|P1|STARTED|1-Month Follow-Up Period||9
8449308|NCT00763243|20823184|P1|NOT COMPLETED|Training Period||0
8449309|NCT00763243|20823184|P1|COMPLETED|Training Period||9
8449310|NCT00763243|20823184|P1|STARTED|Training Period||9
8449311|NCT00763243|20823184|P1|NOT COMPLETED|Waiting Period||0
8449312|NCT00763243|20823184|P1|COMPLETED|Waiting Period||9
8449313|NCT00763243|20823184|P1|STARTED|Waiting Period||9
8449314|NCT00763139|20823206|P2|NOT COMPLETED|Overall Study||3
8449315|NCT00763139|20823207|P1|NOT COMPLETED|Overall Study||5
8449316|NCT00763139|20823206|P2|COMPLETED|Overall Study||14
8449317|NCT00763139|20823207|P1|COMPLETED|Overall Study||12
8449318|NCT00763139|20823206|P2|STARTED|Overall Study||17
8449319|NCT00763139|20823207|P1|STARTED|Overall Study||17
8449320|NCT00763061|20823229|P2|NOT COMPLETED|Overall Study||13
8449321|NCT00763061|20823230|P1|NOT COMPLETED|Overall Study||5
8449322|NCT00763061|20823229|P2|COMPLETED|Overall Study||44
8449323|NCT00763061|20823230|P1|COMPLETED|Overall Study||49
8449324|NCT00763061|20823229|P2|STARTED|Overall Study||57
8449325|NCT00763061|20823230|P1|STARTED|Overall Study||54
8449326|NCT00763048|20823244|P2|NOT COMPLETED|Overall Study||0
8449327|NCT00763048|20823245|P1|NOT COMPLETED|Overall Study||0
8449328|NCT00763048|20823244|P2|COMPLETED|Overall Study||18
8449329|NCT00763048|20823245|P1|COMPLETED|Overall Study||21
8449330|NCT00763048|20823244|P2|STARTED|Overall Study||18
8449331|NCT00763048|20823245|P1|STARTED|Overall Study||21
8449332|NCT00763035|20823269|P2|NOT COMPLETED|Second Intervention||0
8449333|NCT00763035|20823270|P1|NOT COMPLETED|Second Intervention||3
8449334|NCT00763035|20823269|P2|COMPLETED|Second Intervention||3
8449335|NCT00763035|20823270|P1|COMPLETED|Second Intervention||6
8449336|NCT00763035|20823269|P2|STARTED|Second Intervention||3
8449337|NCT00763035|20823270|P1|STARTED|Second Intervention||9
8449338|NCT00763035|20823269|P2|NOT COMPLETED|First Intervention||1
8449339|NCT00763035|20823270|P1|NOT COMPLETED|First Intervention||1
8449340|NCT00763035|20823269|P2|COMPLETED|First Intervention||3
8449341|NCT00763035|20823270|P1|COMPLETED|First Intervention||9
8449342|NCT00763035|20823269|P2|STARTED|First Intervention||4
8449343|NCT00763035|20823270|P1|STARTED|First Intervention||10
8449344|NCT00763009|20823288|P1|NOT COMPLETED|Overall Study||1
8449345|NCT00763009|20823288|P1|COMPLETED|Overall Study||7
8449346|NCT00763009|20823288|P1|STARTED|Overall Study||8
8449347|NCT00762996|20823293|P4|NOT COMPLETED|Period Two||0
8449348|NCT00762996|20823294|P3|NOT COMPLETED|Period Two||0
8449349|NCT00762996|20823295|P2|NOT COMPLETED|Period Two||0
8449350|NCT00762996|20823296|P1|NOT COMPLETED|Period Two||0
8449351|NCT00762996|20823293|P4|COMPLETED|Period Two||16
8449352|NCT00762996|20823294|P3|COMPLETED|Period Two||13
8449353|NCT00762996|20823295|P2|COMPLETED|Period Two||16
8449354|NCT00762996|20823296|P1|COMPLETED|Period Two||15
8449355|NCT00762996|20823293|P4|STARTED|Period Two||16
8449356|NCT00762996|20823294|P3|STARTED|Period Two||13
8449357|NCT00762996|20823295|P2|STARTED|Period Two||16
8449358|NCT00762996|20823296|P1|STARTED|Period Two||15
8449359|NCT00762996|20823293|P4|NOT COMPLETED|Period One||1
8449360|NCT00762996|20823294|P3|NOT COMPLETED|Period One||4
8449361|NCT00762996|20823295|P2|NOT COMPLETED|Period One||0
8449362|NCT00762996|20823296|P1|NOT COMPLETED|Period One||0
8449363|NCT00762996|20823293|P4|COMPLETED|Period One||16
8449364|NCT00762996|20823294|P3|COMPLETED|Period One||13
8449365|NCT00762996|20823295|P2|COMPLETED|Period One||16
8449366|NCT00762996|20823296|P1|COMPLETED|Period One||15
8449367|NCT00762996|20823293|P4|STARTED|Period One||17
8449368|NCT00762996|20823294|P3|STARTED|Period One||17
8449369|NCT00762996|20823295|P2|STARTED|Period One||16
8449370|NCT00762996|20823296|P1|STARTED|Period One||15
8449371|NCT00762970|20823309|P3|NOT COMPLETED|Overall Study||1
8449372|NCT00762970|20823310|P2|NOT COMPLETED|Overall Study||9
8449373|NCT00762970|20823311|P1|NOT COMPLETED|Overall Study||12
8449374|NCT00762970|20823309|P3|COMPLETED|Overall Study||46
8449375|NCT00762970|20823310|P2|COMPLETED|Overall Study||35
8449376|NCT00762970|20823311|P1|COMPLETED|Overall Study||34
8449377|NCT00762970|20823309|P3|STARTED|Overall Study||47
8449378|NCT00762970|20823310|P2|STARTED|Overall Study||44
8449379|NCT00762970|20823311|P1|STARTED|Overall Study||46
8449380|NCT00762931|20823322|P1|NOT COMPLETED|Overall Study||2
8449381|NCT00762931|20823322|P1|COMPLETED|Overall Study||23
8449382|NCT00762931|20823322|P1|STARTED|Overall Study||25
8449383|NCT00762892|20823329|P2|NOT COMPLETED|Overall Study||6
8449384|NCT00762892|20823330|P1|NOT COMPLETED|Overall Study||5
8449385|NCT00762892|20823329|P2|COMPLETED|Overall Study||8
8449386|NCT00762892|20823330|P1|COMPLETED|Overall Study||9
8449387|NCT00762892|20823329|P2|STARTED|Overall Study||14
8449388|NCT00762892|20823330|P1|STARTED|Overall Study||14
8449389|NCT00762853|20823346|P2|NOT COMPLETED|Second Treatment Period||0
8449390|NCT00762853|20823347|P1|NOT COMPLETED|Second Treatment Period||0
8449391|NCT00762853|20823346|P2|COMPLETED|Second Treatment Period||10
8449392|NCT00762853|20823347|P1|COMPLETED|Second Treatment Period||10
8449393|NCT00762853|20823346|P2|STARTED|Second Treatment Period||10
8449394|NCT00762853|20823347|P1|STARTED|Second Treatment Period||10
8449395|NCT00762853|20823346|P2|NOT COMPLETED|1 Week Washout After Treatment 1||0
8449396|NCT00762853|20823347|P1|NOT COMPLETED|1 Week Washout After Treatment 1||0
8449397|NCT00762853|20823346|P2|COMPLETED|1 Week Washout After Treatment 1||10
8449398|NCT00762853|20823347|P1|COMPLETED|1 Week Washout After Treatment 1||10
8449399|NCT00762853|20823346|P2|STARTED|1 Week Washout After Treatment 1||10
8449400|NCT00762853|20823347|P1|STARTED|1 Week Washout After Treatment 1||10
8449401|NCT00762853|20823346|P2|NOT COMPLETED|First Treatment Period||0
8449402|NCT00762853|20823347|P1|NOT COMPLETED|First Treatment Period||0
8449403|NCT00762853|20823346|P2|COMPLETED|First Treatment Period||10
8449404|NCT00762853|20823347|P1|COMPLETED|First Treatment Period||10
8449405|NCT00762853|20823346|P2|STARTED|First Treatment Period||10
8449406|NCT00762853|20823347|P1|STARTED|First Treatment Period||10
8449407|NCT00762788|20823359|P6|NOT COMPLETED|Overall Study||21
8449408|NCT00762788|20823360|P5|NOT COMPLETED|Overall Study||13
8449409|NCT00762788|20823361|P4|NOT COMPLETED|Overall Study||26
8449410|NCT00762788|20823362|P3|NOT COMPLETED|Overall Study||21
8449411|NCT00762788|20823363|P2|NOT COMPLETED|Overall Study||37
8449412|NCT00762788|20823364|P1|NOT COMPLETED|Overall Study||26
8449413|NCT00762788|20823359|P6|COMPLETED|Overall Study||31
8449414|NCT00762788|20823360|P5|COMPLETED|Overall Study||30
8449415|NCT00762788|20823361|P4|COMPLETED|Overall Study||38
8449416|NCT00762788|20823362|P3|COMPLETED|Overall Study||21
8449417|NCT00762788|20823363|P2|COMPLETED|Overall Study||21
8449418|NCT00762788|20823364|P1|COMPLETED|Overall Study||29
8449419|NCT00762788|20823359|P6|STARTED|Overall Study||52
8449420|NCT00762788|20823360|P5|STARTED|Overall Study||43
8449421|NCT00762788|20823361|P4|STARTED|Overall Study||64
8449422|NCT00762788|20823362|P3|STARTED|Overall Study||42
8449423|NCT00762788|20823363|P2|STARTED|Overall Study||58
8449424|NCT00762788|20823364|P1|STARTED|Overall Study||55
8449425|NCT00762762|20823386|P2|NOT COMPLETED|Overall Study||10
8449426|NCT00762762|20823387|P1|NOT COMPLETED|Overall Study||8
8449427|NCT00762762|20823386|P2|COMPLETED|Overall Study||20
8449428|NCT00762762|20823387|P1|COMPLETED|Overall Study||22
8449429|NCT00762762|20823386|P2|STARTED|Overall Study||30
8449430|NCT00762762|20823387|P1|STARTED|Overall Study||30
8449431|NCT00762723|20823404|P3|NOT COMPLETED|Overall Study||3
8449432|NCT00762723|20823405|P2|NOT COMPLETED|Overall Study||5
8449433|NCT00762723|20823406|P1|NOT COMPLETED|Overall Study||5
8449434|NCT00762723|20823404|P3|COMPLETED|Overall Study||0
8449435|NCT00762723|20823405|P2|COMPLETED|Overall Study||6
8449436|NCT00762723|20823406|P1|COMPLETED|Overall Study||0
8449437|NCT00762723|20823404|P3|STARTED|Overall Study||3
8449438|NCT00762723|20823405|P2|STARTED|Overall Study||11
8449439|NCT00762723|20823406|P1|STARTED|Overall Study||5
8449440|NCT00762710|20823416|P2|NOT COMPLETED|Overall Study||15
8449441|NCT00762710|20823417|P1|NOT COMPLETED|Overall Study||21
8449442|NCT00762710|20823416|P2|COMPLETED|Overall Study||29
8449443|NCT00762710|20823417|P1|COMPLETED|Overall Study||27
8449444|NCT00762710|20823416|P2|STARTED|Overall Study||44
8449445|NCT00762710|20823417|P1|STARTED|Overall Study||48
8449446|NCT00762645|20823425|P2|NOT COMPLETED|Overall Study||2
8449447|NCT00762645|20823426|P1|NOT COMPLETED|Overall Study||4
8449448|NCT00762645|20823425|P2|COMPLETED|Overall Study||12
8449449|NCT00762645|20823426|P1|COMPLETED|Overall Study||12
8449450|NCT00762645|20823425|P2|STARTED|Overall Study||14
8449451|NCT00762645|20823426|P1|STARTED|Overall Study||16
8449452|NCT00762619|20823436|P2|NOT COMPLETED|Overall Study||0
8449453|NCT00762619|20823437|P1|NOT COMPLETED|Overall Study||0
8449454|NCT00762619|20823436|P2|COMPLETED|Overall Study||50
8449455|NCT00762619|20823437|P1|COMPLETED|Overall Study||55
8449456|NCT00762619|20823436|P2|STARTED|Overall Study||50
8449457|NCT00762619|20823437|P1|STARTED|Overall Study||55
8449458|NCT00762606|20823579|P2|NOT COMPLETED|Overall Study||13
8449459|NCT00762606|20823580|P1|NOT COMPLETED|Overall Study||18
8449460|NCT00762606|20823579|P2|COMPLETED|Overall Study||38
8449461|NCT00762606|20823580|P1|COMPLETED|Overall Study||37
8449462|NCT00762606|20823579|P2|STARTED|Overall Study||51
8449463|NCT00762606|20823580|P1|STARTED|Overall Study||55
8449464|NCT00762528|20823590|P2|NOT COMPLETED|Overall Study||0
8449465|NCT00762528|20823591|P1|NOT COMPLETED|Overall Study||0
8449466|NCT00762528|20823590|P2|COMPLETED|Overall Study||25
8449467|NCT00762528|20823591|P1|COMPLETED|Overall Study||24
8449468|NCT00762528|20823590|P2|STARTED|Overall Study||25
8449469|NCT00762528|20823591|P1|STARTED|Overall Study||24
8449470|NCT00762515|20823613|P2|NOT COMPLETED|Overall Study||0
8449471|NCT00762515|20823614|P1|NOT COMPLETED|Overall Study||0
8449472|NCT00762515|20823613|P2|COMPLETED|Overall Study||22
8449473|NCT00762515|20823614|P1|COMPLETED|Overall Study||22
8449474|NCT00762515|20823613|P2|STARTED|Overall Study||22
8449475|NCT00762515|20823614|P1|STARTED|Overall Study||22
8449476|NCT00762502|20823625|P3|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
8449477|NCT00762502|20823626|P2|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
8449478|NCT00762502|20823627|P1|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
8449479|NCT00762502|20823625|P3|COMPLETED|Month 3 to Month 6 (Period 2)||23
8449480|NCT00762502|20823626|P2|COMPLETED|Month 3 to Month 6 (Period 2)||4
8449481|NCT00762502|20823627|P1|COMPLETED|Month 3 to Month 6 (Period 2)||9
8449482|NCT00762502|20823625|P3|STARTED|Month 3 to Month 6 (Period 2)||23
8449483|NCT00762502|20823626|P2|STARTED|Month 3 to Month 6 (Period 2)||5
8449484|NCT00762502|20823627|P1|STARTED|Month 3 to Month 6 (Period 2)||9
8449485|NCT00762502|20823625|P3|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
8449486|NCT00762502|20823626|P2|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
8449487|NCT00762502|20823627|P1|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
8449488|NCT00762502|20823625|P3|COMPLETED|Baseline to Month 3 (Period 1)||32
8449489|NCT00762502|20823626|P2|COMPLETED|Baseline to Month 3 (Period 1)||19
8449490|NCT00762502|20823627|P1|COMPLETED|Baseline to Month 3 (Period 1)||26
8449491|NCT00762502|20823625|P3|STARTED|Baseline to Month 3 (Period 1)||51
8449492|NCT00762502|20823626|P2|STARTED|Baseline to Month 3 (Period 1)||25
8449493|NCT00762502|20823627|P1|STARTED|Baseline to Month 3 (Period 1)||36
8449494|NCT00762476|20823641|P2|NOT COMPLETED|Overall Study||36
8449495|NCT00762476|20823642|P1|NOT COMPLETED|Overall Study||23
8449496|NCT00762476|20823641|P2|COMPLETED|Overall Study||169
8449497|NCT00762476|20823642|P1|COMPLETED|Overall Study||183
8449498|NCT00762476|20823641|P2|STARTED|Overall Study||205
8449499|NCT00762476|20823642|P1|STARTED|Overall Study||206
8449536|NCT00762450|20823742|P3|NOT COMPLETED|3rd Treatment Period||0
8449537|NCT00762450|20823743|P2|NOT COMPLETED|3rd Treatment Period||0
8449538|NCT00762450|20823744|P1|NOT COMPLETED|3rd Treatment Period||0
8449539|NCT00762450|20823742|P3|COMPLETED|3rd Treatment Period||2
8449540|NCT00762450|20823743|P2|COMPLETED|3rd Treatment Period||2
8449541|NCT00762450|20823744|P1|COMPLETED|3rd Treatment Period||2
8449542|NCT00762450|20823742|P3|STARTED|3rd Treatment Period||2
8449543|NCT00762450|20823743|P2|STARTED|3rd Treatment Period||2
8449544|NCT00762450|20823744|P1|STARTED|3rd Treatment Period||2
8449545|NCT00762450|20823742|P3|NOT COMPLETED|Washout After 2nd Treatment Period||0
8449546|NCT00762450|20823743|P2|NOT COMPLETED|Washout After 2nd Treatment Period||0
8449547|NCT00762450|20823744|P1|NOT COMPLETED|Washout After 2nd Treatment Period||0
8449548|NCT00762450|20823742|P3|COMPLETED|Washout After 2nd Treatment Period||2
8449549|NCT00762450|20823743|P2|COMPLETED|Washout After 2nd Treatment Period||2
8449550|NCT00762450|20823744|P1|COMPLETED|Washout After 2nd Treatment Period||2
8449551|NCT00762450|20823742|P3|STARTED|Washout After 2nd Treatment Period||2
8449552|NCT00762450|20823743|P2|STARTED|Washout After 2nd Treatment Period||2
8449553|NCT00762450|20823744|P1|STARTED|Washout After 2nd Treatment Period||2
8449554|NCT00762450|20823742|P3|NOT COMPLETED|2nd Treatment Period||0
8449555|NCT00762450|20823743|P2|NOT COMPLETED|2nd Treatment Period||0
8449556|NCT00762450|20823744|P1|NOT COMPLETED|2nd Treatment Period||0
8449557|NCT00762450|20823742|P3|COMPLETED|2nd Treatment Period||2
8449558|NCT00762450|20823743|P2|COMPLETED|2nd Treatment Period||2
8449559|NCT00762450|20823744|P1|COMPLETED|2nd Treatment Period||2
8449560|NCT00762450|20823742|P3|STARTED|2nd Treatment Period||2
8449561|NCT00762450|20823743|P2|STARTED|2nd Treatment Period||2
8449562|NCT00762450|20823744|P1|STARTED|2nd Treatment Period||2
8449563|NCT00762450|20823742|P3|NOT COMPLETED|Washout After 1st Treatment Period||0
8449564|NCT00762450|20823743|P2|NOT COMPLETED|Washout After 1st Treatment Period||0
8449565|NCT00762450|20823744|P1|NOT COMPLETED|Washout After 1st Treatment Period||0
8449566|NCT00762450|20823742|P3|COMPLETED|Washout After 1st Treatment Period||2
8449567|NCT00762450|20823743|P2|COMPLETED|Washout After 1st Treatment Period||2
8449568|NCT00762450|20823744|P1|COMPLETED|Washout After 1st Treatment Period||2
8449569|NCT00762450|20823742|P3|STARTED|Washout After 1st Treatment Period||2
8449570|NCT00762450|20823743|P2|STARTED|Washout After 1st Treatment Period||2
8449571|NCT00762450|20823744|P1|STARTED|Washout After 1st Treatment Period||2
8449572|NCT00762450|20823742|P3|NOT COMPLETED|1st Treatment Period||0
8449573|NCT00762450|20823743|P2|NOT COMPLETED|1st Treatment Period||0
8449574|NCT00762450|20823744|P1|NOT COMPLETED|1st Treatment Period||0
8449575|NCT00762450|20823742|P3|COMPLETED|1st Treatment Period||2
8449576|NCT00762450|20823743|P2|COMPLETED|1st Treatment Period||2
8449577|NCT00762450|20823744|P1|COMPLETED|1st Treatment Period||2
8449578|NCT00762450|20823742|P3|STARTED|1st Treatment Period||2
8449579|NCT00762450|20823743|P2|STARTED|1st Treatment Period||2
8449580|NCT00762450|20823744|P1|STARTED|1st Treatment Period||2
8449581|NCT00762424|20823754|P2|NOT COMPLETED|Overall Study||0
8449582|NCT00762424|20823755|P1|NOT COMPLETED|Overall Study||0
8449583|NCT00762424|20823754|P2|COMPLETED|Overall Study||25
8449584|NCT00762424|20823755|P1|COMPLETED|Overall Study||28
8449585|NCT00762424|20823754|P2|STARTED|Overall Study||25
8449586|NCT00762424|20823755|P1|STARTED|Overall Study||28
8449587|NCT00762411|20823763|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
8449588|NCT00762411|20823764|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
8449589|NCT00762411|20823763|P2|COMPLETED|Safety Follow Up (SFU)-Optional||312
8449590|NCT00762411|20823764|P1|COMPLETED|Safety Follow Up (SFU)-Optional||228
8449591|NCT00762411|20823763|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
8449592|NCT00762411|20823764|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
8449593|NCT00762411|20823763|P2|NOT COMPLETED|Delayed Start||26
8449594|NCT00762411|20823764|P1|NOT COMPLETED|Delayed Start||17
8449595|NCT00762411|20823763|P2|COMPLETED|Delayed Start||8
8449596|NCT00762411|20823764|P1|COMPLETED|Delayed Start||5
8449597|NCT00762411|20823763|P2|STARTED|Delayed Start||34
8449598|NCT00762411|20823764|P1|STARTED|Delayed Start||22
8449599|NCT00762411|20823763|P2|NOT COMPLETED|Initial Treatment||521
8449600|NCT00762411|20823764|P1|NOT COMPLETED|Initial Treatment||534
8449601|NCT00762411|20823763|P2|COMPLETED|Initial Treatment||34
8449602|NCT00762411|20823764|P1|COMPLETED|Initial Treatment||22
8449603|NCT00762411|20823763|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
8449604|NCT00762411|20823764|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
8449605|NCT00762411|20823763|P2|STARTED|Initial Treatment||555
8449606|NCT00762411|20823764|P1|STARTED|Initial Treatment||556
8449607|NCT00762385|20823828|P2|NOT COMPLETED|Second Intervention||3
8449608|NCT00762385|20823829|P1|NOT COMPLETED|Second Intervention||3
8449609|NCT00762385|20823828|P2|COMPLETED|Second Intervention||39
8449610|NCT00762385|20823829|P1|COMPLETED|Second Intervention||46
8449611|NCT00762385|20823828|P2|STARTED|Second Intervention||42
8449612|NCT00762385|20823829|P1|STARTED|Second Intervention||49
8449613|NCT00762385|20823828|P2|NOT COMPLETED|First Intervention||4
8449614|NCT00762385|20823829|P1|NOT COMPLETED|First Intervention||2
8449615|NCT00762385|20823828|P2|COMPLETED|First Intervention||42
8449616|NCT00762385|20823829|P1|COMPLETED|First Intervention||49
8449617|NCT00762385|20823828|P2|STARTED|First Intervention||46
8449618|NCT00762385|20823829|P1|STARTED|First Intervention||51
8449619|NCT00762372|20823842|P3|NOT COMPLETED|Overall Study||0
8449620|NCT00762372|20823843|P2|NOT COMPLETED|Overall Study||0
8449621|NCT00762372|20823844|P1|NOT COMPLETED|Overall Study||1
8449622|NCT00762372|20823842|P3|COMPLETED|Overall Study||50
8449623|NCT00762372|20823843|P2|COMPLETED|Overall Study||55
8449624|NCT00762372|20823844|P1|COMPLETED|Overall Study||110
8449625|NCT00762372|20823842|P3|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50
8449626|NCT00762372|20823843|P2|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55
8449627|NCT00762372|20823844|P1|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111
8449628|NCT00762359|20823920|P2|NOT COMPLETED|Overall Study||57
8449629|NCT00762359|20823921|P1|NOT COMPLETED|Overall Study||59
8449630|NCT00762359|20823920|P2|COMPLETED|Overall Study||178
8449631|NCT00762359|20823921|P1|COMPLETED|Overall Study||167
8449632|NCT00762359|20823920|P2|STARTED|Overall Study||235
8449633|NCT00762359|20823921|P1|STARTED|Overall Study||226
8449634|NCT00762320|20824021|P1|NOT COMPLETED|Overall Study||0
8449635|NCT00762320|20824021|P1|COMPLETED|Overall Study||8
8449636|NCT00762320|20824021|P1|STARTED|Overall Study||8
8449637|NCT00762268|20824038|P2|NOT COMPLETED|Overall Study||3
8449638|NCT00762268|20824039|P1|NOT COMPLETED|Overall Study||3
8449639|NCT00762268|20824038|P2|COMPLETED|Overall Study||8
8449640|NCT00762268|20824039|P1|COMPLETED|Overall Study||9
8449641|NCT00762268|20824038|P2|STARTED|Overall Study||11
8449642|NCT00762268|20824039|P1|STARTED|Overall Study||12
8449643|NCT00762229|20824051|P2|NOT COMPLETED|Overall Study||2
8449644|NCT00762229|20824052|P1|NOT COMPLETED|Overall Study||1
8449645|NCT00762229|20824051|P2|COMPLETED|Overall Study||22
8449646|NCT00762229|20824052|P1|COMPLETED|Overall Study||14
8449647|NCT00762229|20824051|P2|STARTED|Overall Study||24
8449648|NCT00762229|20824052|P1|STARTED|Overall Study||15
8449649|NCT00762216|20824060|P1|NOT COMPLETED|Overall Study||0
8449650|NCT00762216|20824060|P1|COMPLETED|Overall Study||71
8449651|NCT00762216|20824060|P1|STARTED|Overall Study||71
8449652|NCT00762177|20824068|P3|NOT COMPLETED|3rd Treatment Period||0
8449653|NCT00762177|20824069|P2|NOT COMPLETED|3rd Treatment Period||0
8449654|NCT00762177|20824070|P1|NOT COMPLETED|3rd Treatment Period||0
8449655|NCT00762177|20824068|P3|COMPLETED|3rd Treatment Period||8
8449656|NCT00762177|20824069|P2|COMPLETED|3rd Treatment Period||8
8449657|NCT00762177|20824070|P1|COMPLETED|3rd Treatment Period||8
8449658|NCT00762177|20824068|P3|STARTED|3rd Treatment Period||8
8449659|NCT00762177|20824069|P2|STARTED|3rd Treatment Period||8
8449660|NCT00762177|20824070|P1|STARTED|3rd Treatment Period||8
8449661|NCT00762177|20824068|P3|NOT COMPLETED|Washout After 2nd Treatment||0
8449662|NCT00762177|20824069|P2|NOT COMPLETED|Washout After 2nd Treatment||0
8449663|NCT00762177|20824070|P1|NOT COMPLETED|Washout After 2nd Treatment||0
8449664|NCT00762177|20824068|P3|COMPLETED|Washout After 2nd Treatment||8
8449665|NCT00762177|20824069|P2|COMPLETED|Washout After 2nd Treatment||8
8449666|NCT00762177|20824070|P1|COMPLETED|Washout After 2nd Treatment||8
8449667|NCT00762177|20824068|P3|STARTED|Washout After 2nd Treatment||8
8449668|NCT00762177|20824069|P2|STARTED|Washout After 2nd Treatment||8
8449669|NCT00762177|20824070|P1|STARTED|Washout After 2nd Treatment||8
8449670|NCT00762177|20824068|P3|NOT COMPLETED|2nd Treatment Period||0
8449671|NCT00762177|20824069|P2|NOT COMPLETED|2nd Treatment Period||0
8449672|NCT00762177|20824070|P1|NOT COMPLETED|2nd Treatment Period||0
8449673|NCT00762177|20824068|P3|COMPLETED|2nd Treatment Period||8
8449674|NCT00762177|20824069|P2|COMPLETED|2nd Treatment Period||8
8449675|NCT00762177|20824070|P1|COMPLETED|2nd Treatment Period||8
8449676|NCT00762177|20824068|P3|STARTED|2nd Treatment Period||8
8449677|NCT00762177|20824069|P2|STARTED|2nd Treatment Period||8
8449678|NCT00762177|20824070|P1|STARTED|2nd Treatment Period||8
8449679|NCT00762177|20824068|P3|NOT COMPLETED|Washout After 1st Treatment||0
8449680|NCT00762177|20824069|P2|NOT COMPLETED|Washout After 1st Treatment||0
8449681|NCT00762177|20824070|P1|NOT COMPLETED|Washout After 1st Treatment||0
8449682|NCT00762177|20824068|P3|COMPLETED|Washout After 1st Treatment||8
8449683|NCT00762177|20824069|P2|COMPLETED|Washout After 1st Treatment||8
8449684|NCT00762177|20824070|P1|COMPLETED|Washout After 1st Treatment||8
8449685|NCT00762177|20824068|P3|STARTED|Washout After 1st Treatment||8
8449686|NCT00762177|20824069|P2|STARTED|Washout After 1st Treatment||8
8449687|NCT00762177|20824070|P1|STARTED|Washout After 1st Treatment||8
8449688|NCT00762177|20824068|P3|NOT COMPLETED|1st Treatment Period||0
8449689|NCT00762177|20824069|P2|NOT COMPLETED|1st Treatment Period||0
8449690|NCT00762177|20824070|P1|NOT COMPLETED|1st Treatment Period||0
8449691|NCT00762177|20824068|P3|COMPLETED|1st Treatment Period||8
8449692|NCT00762177|20824069|P2|COMPLETED|1st Treatment Period||8
8449693|NCT00762177|20824070|P1|COMPLETED|1st Treatment Period||8
8449694|NCT00762177|20824068|P3|STARTED|1st Treatment Period||8
8449695|NCT00762177|20824069|P2|STARTED|1st Treatment Period||8
8449696|NCT00762177|20824070|P1|STARTED|1st Treatment Period||8
8449697|NCT00762164|20824149|P2|NOT COMPLETED|Overall Study||2
8449698|NCT00762164|20824150|P1|NOT COMPLETED|Overall Study||3
8449699|NCT00762164|20824149|P2|COMPLETED|Overall Study||15
8449700|NCT00762164|20824150|P1|COMPLETED|Overall Study||14
8449701|NCT00762164|20824149|P2|STARTED|Overall Study||17
8449702|NCT00762164|20824150|P1|STARTED|Overall Study||17
8449703|NCT00762086|20824160|P2|NOT COMPLETED|Overall Study||4
8449704|NCT00762086|20824161|P1|NOT COMPLETED|Overall Study||6
8449705|NCT00762086|20824160|P2|COMPLETED|Overall Study||24
8449706|NCT00762086|20824161|P1|COMPLETED|Overall Study||33
8449707|NCT00762086|20824160|P2|STARTED|Overall Study||28
8449708|NCT00762086|20824161|P1|STARTED|Overall Study||39
8449721|NCT00762034|20824238|P2|NOT COMPLETED|Maintenance Period||298
8449722|NCT00762034|20824239|P1|NOT COMPLETED|Maintenance Period||294
8449723|NCT00762034|20824238|P2|COMPLETED|Maintenance Period||0
8449724|NCT00762034|20824239|P1|COMPLETED|Maintenance Period||0
8449725|NCT00762034|20824238|P2|Received at Least 1 Dose of Study Drug|Maintenance Period||298
8449726|NCT00762034|20824239|P1|Received at Least 1 Dose of Study Drug|Maintenance Period||294
8449727|NCT00762034|20824238|P2|STARTED|Maintenance Period||298
8449728|NCT00762034|20824239|P1|STARTED|Maintenance Period||294
8449729|NCT00762034|20824238|P2|NOT COMPLETED|Induction Period||169
8449730|NCT00762034|20824239|P1|NOT COMPLETED|Induction Period||178
8449731|NCT00762034|20824238|P2|COMPLETED|Induction Period||298
8449732|NCT00762034|20824239|P1|COMPLETED|Induction Period||294
8449733|NCT00762034|20824238|P2|Received at Least 1 Dose of Study Drug|Induction Period||443
8449734|NCT00762034|20824239|P1|Received at Least 1 Dose of Study Drug|Induction Period||442
8449735|NCT00762034|20824238|P2|STARTED|Induction Period||467
8449736|NCT00762034|20824239|P1|STARTED|Induction Period||472
8449737|NCT00762021|20824298|P2|NOT COMPLETED|Overall Study||8
8449738|NCT00762021|20824299|P1|NOT COMPLETED|Overall Study||8
8449739|NCT00762021|20824298|P2|COMPLETED|Overall Study||44
8449740|NCT00762021|20824299|P1|COMPLETED|Overall Study||44
8449741|NCT00762021|20824298|P2|STARTED|Overall Study||52
8449742|NCT00762021|20824299|P1|STARTED|Overall Study||52
8449743|NCT00761969|20824311|P2|NOT COMPLETED|Overall Study||140
8449744|NCT00761969|20824312|P1|NOT COMPLETED|Overall Study||200
8449745|NCT00761969|20824311|P2|COMPLETED|Overall Study||573
8449746|NCT00761969|20824312|P1|COMPLETED|Overall Study||542
8449747|NCT00761969|20824311|P2|STARTED|Overall Study||713
8449748|NCT00761969|20824312|P1|STARTED|Overall Study||742
8449749|NCT00761956|20824322|P2|NOT COMPLETED|Overall Study||54
8449750|NCT00761956|20824323|P1|NOT COMPLETED|Overall Study||35
8449751|NCT00761956|20824322|P2|COMPLETED|Overall Study||48
8449752|NCT00761956|20824323|P1|COMPLETED|Overall Study||52
8449753|NCT00761956|20824322|P2|STARTED|Overall Study||102
8449754|NCT00761956|20824323|P1|STARTED|Overall Study||87
8449755|NCT00761930|20824334|P3|NOT COMPLETED|Overall Study||0
8449756|NCT00761930|20824335|P2|NOT COMPLETED|Overall Study||0
8449757|NCT00761930|20824336|P1|NOT COMPLETED|Overall Study||0
8449758|NCT00761930|20824334|P3|COMPLETED|Overall Study||35
8449759|NCT00761930|20824335|P2|COMPLETED|Overall Study||34
8449760|NCT00761930|20824336|P1|COMPLETED|Overall Study||34
8449761|NCT00761930|20824334|P3|STARTED|Overall Study||35
8449762|NCT00761930|20824335|P2|STARTED|Overall Study||34
8449763|NCT00761930|20824336|P1|STARTED|Overall Study||34
8449764|NCT00761891|20824350|P1|NOT COMPLETED|Overall Study||10
8449765|NCT00761891|20824350|P1|COMPLETED|Overall Study||54
8449766|NCT00761891|20824350|P1|STARTED|Overall Study||64
8449767|NCT00761865|20824357|P2|NOT COMPLETED|Overall Study||7
8449768|NCT00761865|20824358|P1|NOT COMPLETED|Overall Study||8
8449769|NCT00761865|20824357|P2|COMPLETED|Overall Study||11
8449770|NCT00761865|20824358|P1|COMPLETED|Overall Study||8
8449771|NCT00761865|20824357|P2|STARTED|Overall Study||18
8449772|NCT00761865|20824358|P1|STARTED|Overall Study||16
8449773|NCT00761813|20824368|P2|NOT COMPLETED|Overall Study||14
8449774|NCT00761813|20824369|P1|NOT COMPLETED|Overall Study||15
8449775|NCT00761813|20824368|P2|COMPLETED|Overall Study||537
8449776|NCT00761813|20824369|P1|COMPLETED|Overall Study||542
8449777|NCT00761813|20824368|P2|STARTED|Overall Study||551
8449778|NCT00761813|20824369|P1|STARTED|Overall Study||557
8449779|NCT00761774|20824379|P1|NOT COMPLETED|Overall Study||79
8449780|NCT00761774|20824379|P1|COMPLETED|Overall Study||29
8449781|NCT00761774|20824379|P1|STARTED|Overall Study||108
8449782|NCT00761761|20824390|P2|NOT COMPLETED|Overall Study||1
8449783|NCT00761761|20824391|P1|NOT COMPLETED|Overall Study||6
8449784|NCT00761761|20824390|P2|COMPLETED|Overall Study||29
8449785|NCT00761761|20824391|P1|COMPLETED|Overall Study||24
8449786|NCT00761761|20824390|P2|STARTED|Overall Study||30
8449787|NCT00761761|20824391|P1|STARTED|Overall Study||30
8449788|NCT00761748|20824403|P2|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
8449789|NCT00761748|20824404|P1|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
8449790|NCT00761748|20824403|P2|COMPLETED|Second Intervention (21 +/- 3 Days)||7
8449791|NCT00761748|20824404|P1|COMPLETED|Second Intervention (21 +/- 3 Days)||17
8449792|NCT00761748|20824403|P2|STARTED|Second Intervention (21 +/- 3 Days)||7
8449793|NCT00761748|20824404|P1|STARTED|Second Intervention (21 +/- 3 Days)||17
8449794|NCT00761748|20824403|P2|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
8449795|NCT00761748|20824404|P1|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
8449796|NCT00761748|20824403|P2|COMPLETED|First Intervention (21 +/- 3 Days)||7
8449797|NCT00761748|20824404|P1|COMPLETED|First Intervention (21 +/- 3 Days)||17
8449798|NCT00761748|20824403|P2|STARTED|First Intervention (21 +/- 3 Days)||10
8449799|NCT00761748|20824404|P1|STARTED|First Intervention (21 +/- 3 Days)||20
8449800|NCT00761735|20824410|P1|NOT COMPLETED|Overall Study||14
8449801|NCT00761735|20824410|P1|COMPLETED|Overall Study||80
8449802|NCT00761735|20824410|P1|STARTED|Overall Study||94
8449803|NCT00761631|20824426|P6|NOT COMPLETED|Overall Study||5
8449804|NCT00761631|20824427|P5|NOT COMPLETED|Overall Study||22
8449805|NCT00761631|20824428|P4|NOT COMPLETED|Overall Study||3
8449806|NCT00761631|20824429|P3|NOT COMPLETED|Overall Study||16
8449807|NCT00761631|20824430|P2|NOT COMPLETED|Overall Study||7
8449808|NCT00761631|20824431|P1|NOT COMPLETED|Overall Study||15
8449809|NCT00761631|20824426|P6|COMPLETED|Overall Study||294
8449810|NCT00761631|20824427|P5|COMPLETED|Overall Study||277
8449811|NCT00761631|20824428|P4|COMPLETED|Overall Study||116
8449812|NCT00761631|20824429|P3|COMPLETED|Overall Study||160
8449813|NCT00761631|20824430|P2|COMPLETED|Overall Study||174
8449814|NCT00761631|20824431|P1|COMPLETED|Overall Study||111
8449815|NCT00761631|20824426|P6|Vaccinated Dose 2|Overall Study||0
8449816|NCT00761631|20824427|P5|Vaccinated Dose 2|Overall Study||0
8449817|NCT00761631|20824428|P4|Vaccinated Dose 2|Overall Study||0
8449818|NCT00761631|20824429|P3|Vaccinated Dose 2|Overall Study||165
8449819|NCT00761631|20824430|P2|Vaccinated Dose 2|Overall Study||0
8449820|NCT00761631|20824431|P1|Vaccinated Dose 2|Overall Study||112
8449821|NCT00761631|20824426|P6|Vaccinated Dose 1|Overall Study||298
8449822|NCT00761631|20824427|P5|Vaccinated Dose 1|Overall Study||294
8449823|NCT00761631|20824428|P4|Vaccinated Dose 1|Overall Study||118
8449824|NCT00761631|20824429|P3|Vaccinated Dose 1|Overall Study||175
8449825|NCT00761631|20824430|P2|Vaccinated Dose 1|Overall Study||179
8449826|NCT00761631|20824431|P1|Vaccinated Dose 1|Overall Study||124
8449827|NCT00761631|20824426|P6|STARTED|Overall Study||299
8449828|NCT00761631|20824427|P5|STARTED|Overall Study||299
8449829|NCT00761631|20824428|P4|STARTED|Overall Study||119
8449830|NCT00761631|20824429|P3|STARTED|Overall Study||176
8449831|NCT00761631|20824430|P2|STARTED|Overall Study||181
8449832|NCT00761631|20824431|P1|STARTED|Overall Study||126
8449833|NCT00761605|20824466|P1|NOT COMPLETED|Overall Study||141
8449834|NCT00761605|20824466|P1|COMPLETED|Overall Study||246
8449835|NCT00761605|20824466|P1|STARTED|Overall Study||387
8449836|NCT00761592|20824495|P2|NOT COMPLETED|Overall Study||1
8449837|NCT00761592|20824496|P1|NOT COMPLETED|Overall Study||1
8449838|NCT00761592|20824495|P2|COMPLETED|Overall Study||32
8449839|NCT00761592|20824496|P1|COMPLETED|Overall Study||31
8449840|NCT00761592|20824495|P2|STARTED|Overall Study||33
8449841|NCT00761592|20824496|P1|STARTED|Overall Study||32
8449842|NCT00761579|20824510|P1|NOT COMPLETED|Overall Study||92
8449843|NCT00761579|20824510|P1|COMPLETED|Overall Study||98
8449844|NCT00761579|20824510|P1|STARTED|Overall Study||190
8449845|NCT00761527|20824543|P1|NOT COMPLETED|Overall Study||22
8449846|NCT00761527|20824543|P1|COMPLETED|Overall Study||2958
8449847|NCT00761527|20824543|P1|Received One Dose of Study Medication|Overall Study||2978
8449848|NCT00761527|20824543|P1|STARTED|Overall Study||2980
8449849|NCT00761514|20824550|P1|NOT COMPLETED|Overall Study||7
8449850|NCT00761514|20824550|P1|COMPLETED|Overall Study||7
8449851|NCT00761514|20824550|P1|STARTED|Overall Study||14
8449852|NCT00761462|20824557|P2|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
8449853|NCT00761462|20824558|P1|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
8449854|NCT00761462|20824557|P2|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
8449855|NCT00761462|20824558|P1|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
8449856|NCT00761462|20824557|P2|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
8449857|NCT00761462|20824558|P1|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
8449858|NCT00761462|20824557|P2|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
8449859|NCT00761462|20824558|P1|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
8449860|NCT00761462|20824557|P2|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
8449861|NCT00761462|20824558|P1|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
8449862|NCT00761462|20824557|P2|NOT COMPLETED|Treatment||12
8449863|NCT00761462|20824558|P1|NOT COMPLETED|Treatment||23
8449864|NCT00761462|20824557|P2|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
8449865|NCT00761462|20824558|P1|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
8449866|NCT00761462|20824557|P2|STARTED|Treatment|Patients enrolled in study group|519
8449867|NCT00761462|20824558|P1|STARTED|Treatment|Patients enrolled in study group|510
8449868|NCT00761345|20824566|P1|NOT COMPLETED|Overall Study||3
8449869|NCT00761345|20824566|P1|COMPLETED|Overall Study||24
8449870|NCT00761345|20824566|P1|STARTED|Overall Study||27
8449871|NCT00761319|20824572|P2|NOT COMPLETED|Overall Study||34
8449872|NCT00761319|20824573|P1|NOT COMPLETED|Overall Study||48
8449873|NCT00761319|20824572|P2|COMPLETED|Overall Study||318
8449874|NCT00761319|20824573|P1|COMPLETED|Overall Study||305
8449875|NCT00761319|20824572|P2|STARTED|Overall Study||352
8449876|NCT00761319|20824573|P1|STARTED|Overall Study||353
8449877|NCT00761306|20824581|P1|NOT COMPLETED|Overall Study||20
8449878|NCT00761306|20824581|P1|COMPLETED|Overall Study||54
8449879|NCT00761306|20824581|P1|STARTED|Overall Study||74
8449880|NCT00761280|20824592|P2|NOT COMPLETED|First Dose to End of Study||11
8449881|NCT00761280|20824593|P1|NOT COMPLETED|First Dose to End of Study||12
8449882|NCT00761280|20824592|P2|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
8449883|NCT00761280|20824593|P1|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
8449884|NCT00761280|20824592|P2|STARTED|First Dose to End of Study||11
8449885|NCT00761280|20824593|P1|STARTED|First Dose to End of Study||12
8449886|NCT00761280|20824592|P2|NOT COMPLETED|Randomization to First Dose||2
8449887|NCT00761280|20824593|P1|NOT COMPLETED|Randomization to First Dose||2
8449888|NCT00761280|20824592|P2|COMPLETED|Randomization to First Dose||11
8449889|NCT00761280|20824593|P1|COMPLETED|Randomization to First Dose||12
8449890|NCT00761280|20824592|P2|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
8449891|NCT00761280|20824593|P1|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
8449892|NCT00761280|20824592|P2|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
8449893|NCT00761280|20824593|P1|Catheter Surgery|Randomization to First Dose|Safety population|13
8449894|NCT00761280|20824592|P2|STARTED|Randomization to First Dose||13
8449895|NCT00761280|20824593|P1|STARTED|Randomization to First Dose||14
8449896|NCT00761267|20824624|P3|NOT COMPLETED|Overall Study||6
8449897|NCT00761267|20824625|P2|NOT COMPLETED|Overall Study||4
8449898|NCT00761267|20824626|P1|NOT COMPLETED|Overall Study||2
8449899|NCT00761267|20824624|P3|COMPLETED|Overall Study||24
8449900|NCT00761267|20824625|P2|COMPLETED|Overall Study||16
8449901|NCT00761267|20824626|P1|COMPLETED|Overall Study||18
8449902|NCT00761267|20824624|P3|Treated|Overall Study||30
8449903|NCT00761267|20824625|P2|Treated|Overall Study||19
8449904|NCT00761267|20824626|P1|Treated|Overall Study||19
8449905|NCT00761267|20824624|P3|STARTED|Overall Study||30
8449906|NCT00761267|20824625|P2|STARTED|Overall Study||20
8449907|NCT00761267|20824626|P1|STARTED|Overall Study||20
8449908|NCT00761215|20824677|P3|NOT COMPLETED|Overall Study||8
8449909|NCT00761215|20824678|P2|NOT COMPLETED|Overall Study||4
8449910|NCT00761215|20824679|P1|NOT COMPLETED|Overall Study||9
8449911|NCT00761215|20824677|P3|COMPLETED|Overall Study||56
8449912|NCT00761215|20824678|P2|COMPLETED|Overall Study||60
8449913|NCT00761215|20824679|P1|COMPLETED|Overall Study||55
8449914|NCT00761215|20824677|P3|STARTED|Overall Study||64
8449915|NCT00761215|20824678|P2|STARTED|Overall Study||64
8449916|NCT00761215|20824679|P1|STARTED|Overall Study||64
8449917|NCT00761202|20824704|P2|NOT COMPLETED|Overall Study||2
8449918|NCT00761202|20824705|P1|NOT COMPLETED|Overall Study||1
8449919|NCT00761202|20824704|P2|COMPLETED|Overall Study||26
8449920|NCT00761202|20824705|P1|COMPLETED|Overall Study||21
8449921|NCT00761202|20824704|P2|STARTED|Overall Study||28
8449922|NCT00761202|20824705|P1|STARTED|Overall Study||22
8449923|NCT00761189|20824721|P1|NOT COMPLETED|Overall Study||185
8449924|NCT00761189|20824721|P1|COMPLETED|Overall Study||306
8449925|NCT00761189|20824721|P1|STARTED|Overall Study||491
8449926|NCT00761176|20824738|P2|NOT COMPLETED|Overall Study||1
8449927|NCT00761176|20824739|P1|NOT COMPLETED|Overall Study||2
8449928|NCT00761176|20824738|P2|COMPLETED|Overall Study||3
8449929|NCT00761176|20824739|P1|COMPLETED|Overall Study||2
8449930|NCT00761176|20824738|P2|STARTED|Overall Study||4
8449931|NCT00761176|20824739|P1|STARTED|Overall Study||4
8449932|NCT00761150|20824748|P3|NOT COMPLETED|Double-blind Period||29
8449933|NCT00761150|20824749|P2|NOT COMPLETED|Double-blind Period||14
8449934|NCT00761150|20824750|P1|NOT COMPLETED|Double-blind Period||0
8449935|NCT00761150|20824748|P3|COMPLETED|Double-blind Period||89
8449936|NCT00761150|20824749|P2|COMPLETED|Double-blind Period||106
8449937|NCT00761150|20824750|P1|COMPLETED|Double-blind Period||0
8449938|NCT00761150|20824748|P3|STARTED|Double-blind Period||118
8449939|NCT00761150|20824749|P2|STARTED|Double-blind Period||120
8449940|NCT00761150|20824750|P1|STARTED|Double-blind Period||0
8449941|NCT00761150|20824748|P3|NOT COMPLETED|Open-label Period||0
8449942|NCT00761150|20824749|P2|NOT COMPLETED|Open-label Period||0
8449943|NCT00761150|20824750|P1|NOT COMPLETED|Open-label Period||70
8449944|NCT00761150|20824748|P3|COMPLETED|Open-label Period||0
8449945|NCT00761150|20824749|P2|COMPLETED|Open-label Period||0
8449946|NCT00761150|20824750|P1|COMPLETED|Open-label Period||238
8449947|NCT00761150|20824748|P3|STARTED|Open-label Period||0
8449948|NCT00761150|20824749|P2|STARTED|Open-label Period||0
8449949|NCT00761150|20824750|P1|STARTED|Open-label Period||308
8449950|NCT00761137|20824759|P1|NOT COMPLETED|Overall Study||0
8449951|NCT00761137|20824759|P1|COMPLETED|Overall Study||19
8449952|NCT00761137|20824759|P1|3 mg Tropicamide|Overall Study||19
8449953|NCT00761137|20824759|P1|1 mg Tropicamide|Overall Study||19
8449954|NCT00761137|20824759|P1|0.3 mg Tropicamide|Overall Study||19
8449955|NCT00761137|20824759|P1|Placebo|Overall Study||19
8449956|NCT00761137|20824759|P1|STARTED|Overall Study||19
8449957|NCT00761085|20824774|P4|NOT COMPLETED|Overall Study||4
8449958|NCT00761085|20824775|P3|NOT COMPLETED|Overall Study||0
8449959|NCT00761085|20824776|P2|NOT COMPLETED|Overall Study||6
8449960|NCT00761085|20824777|P1|NOT COMPLETED|Overall Study||0
8449961|NCT00761085|20824774|P4|COMPLETED|Overall Study||8
8449962|NCT00761085|20824775|P3|COMPLETED|Overall Study||11
8449963|NCT00761085|20824776|P2|COMPLETED|Overall Study||6
8449964|NCT00761085|20824777|P1|COMPLETED|Overall Study||12
8449965|NCT00761085|20824774|P4|STARTED|Overall Study||12
8449966|NCT00761085|20824775|P3|STARTED|Overall Study||11
8449967|NCT00761085|20824776|P2|STARTED|Overall Study||12
8449968|NCT00761085|20824777|P1|STARTED|Overall Study||12
8449969|NCT00761007|20824795|P4|NOT COMPLETED|Overall Study||7
8449970|NCT00761007|20824796|P3|NOT COMPLETED|Overall Study||18
8449971|NCT00761007|20824797|P2|NOT COMPLETED|Overall Study||11
8449972|NCT00761007|20824798|P1|NOT COMPLETED|Overall Study||13
8449973|NCT00761007|20824795|P4|COMPLETED|Overall Study||131
8449974|NCT00761007|20824796|P3|COMPLETED|Overall Study||121
8449975|NCT00761007|20824797|P2|COMPLETED|Overall Study||124
8449976|NCT00761007|20824798|P1|COMPLETED|Overall Study||129
8449977|NCT00761007|20824795|P4|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
8449978|NCT00761007|20824796|P3|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
8449979|NCT00761007|20824797|P2|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
8449980|NCT00761007|20824798|P1|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
8449981|NCT00761007|20824795|P4|Safety (>=1 Dose of Study Medication)|Overall Study||137
8449982|NCT00761007|20824796|P3|Safety (>=1 Dose of Study Medication)|Overall Study||139
8449983|NCT00761007|20824797|P2|Safety (>=1 Dose of Study Medication)|Overall Study||135
8449984|NCT00761007|20824798|P1|Safety (>=1 Dose of Study Medication)|Overall Study||140
8449985|NCT00761007|20824795|P4|STARTED|Overall Study||138
8449986|NCT00761007|20824796|P3|STARTED|Overall Study||139
8449987|NCT00761007|20824797|P2|STARTED|Overall Study||135
8449988|NCT00761007|20824798|P1|STARTED|Overall Study||142
8449989|NCT00760994|20824823|P3|NOT COMPLETED|Overall Study||3
8449990|NCT00760994|20824824|P2|NOT COMPLETED|Overall Study||4
8449991|NCT00760994|20824825|P1|NOT COMPLETED|Overall Study||4
8449992|NCT00760994|20824823|P3|COMPLETED|Overall Study||17
8449993|NCT00760994|20824824|P2|COMPLETED|Overall Study||27
8449994|NCT00760994|20824825|P1|COMPLETED|Overall Study||25
8449995|NCT00760994|20824823|P3|STARTED|Overall Study||20
8449996|NCT00760994|20824824|P2|STARTED|Overall Study||31
8449997|NCT00760994|20824825|P1|STARTED|Overall Study||29
8449998|NCT00760929|20824840|P4|NOT COMPLETED|Overall Study||55
8449999|NCT00760929|20824841|P3|NOT COMPLETED|Overall Study||58
8450000|NCT00760929|20824842|P2|NOT COMPLETED|Overall Study||28
8450001|NCT00760929|20824843|P1|NOT COMPLETED|Overall Study||26
8450002|NCT00760929|20824840|P4|COMPLETED|Overall Study||2
8450003|NCT00760929|20824841|P3|COMPLETED|Overall Study||1
8450004|NCT00760929|20824842|P2|COMPLETED|Overall Study||1
8450005|NCT00760929|20824843|P1|COMPLETED|Overall Study||0
8450006|NCT00760929|20824840|P4|STARTED|Overall Study||57
8450007|NCT00760929|20824841|P3|STARTED|Overall Study||59
8450008|NCT00760929|20824842|P2|STARTED|Overall Study||29
8450009|NCT00760929|20824843|P1|STARTED|Overall Study||26
8450010|NCT00760877|20824866|P2|NOT COMPLETED|Overall Study||26
8450011|NCT00760877|20824867|P1|NOT COMPLETED|Overall Study||45
8450012|NCT00760877|20824866|P2|COMPLETED|Overall Study||77
8450013|NCT00760877|20824867|P1|COMPLETED|Overall Study||59
8450014|NCT00760877|20824866|P2|Safety Set|Overall Study||103
8450015|NCT00760877|20824867|P1|Safety Set|Overall Study||101
8450016|NCT00760877|20824866|P2|Cross-over to Nilotinib|Overall Study||46
8450017|NCT00760877|20824867|P1|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
8450018|NCT00760877|20824866|P2|STARTED|Overall Study||103
8450019|NCT00760877|20824867|P1|STARTED|Overall Study||104
8450020|NCT00760838|20824885|P2|NOT COMPLETED|Overall Study||2
8450021|NCT00760838|20824886|P1|NOT COMPLETED|Overall Study||5
8450022|NCT00760838|20824885|P2|COMPLETED|Overall Study||53
8450023|NCT00760838|20824886|P1|COMPLETED|Overall Study||49
8450024|NCT00760838|20824885|P2|STARTED|Overall Study||55
8450025|NCT00760838|20824886|P1|STARTED|Overall Study||54
8450026|NCT00760747|20824904|P2|NOT COMPLETED|Study Period III||3
8450027|NCT00760747|20824905|P1|NOT COMPLETED|Study Period III||3
8450028|NCT00760747|20824904|P2|COMPLETED|Study Period III||38
8450029|NCT00760747|20824905|P1|COMPLETED|Study Period III||41
8450030|NCT00760747|20824904|P2|STARTED|Study Period III||41
8450031|NCT00760747|20824905|P1|STARTED|Study Period III||44
8450032|NCT00760747|20824904|P2|NOT COMPLETED|Study Period II||14
8450033|NCT00760747|20824905|P1|NOT COMPLETED|Study Period II||13
8450034|NCT00760747|20824904|P2|COMPLETED|Study Period II||41
8450035|NCT00760747|20824905|P1|COMPLETED|Study Period II||44
8450036|NCT00760747|20824904|P2|Received at Least One Dose of Study Drug|Study Period II||54
8450037|NCT00760747|20824905|P1|Received at Least One Dose of Study Drug|Study Period II||57
8450038|NCT00760747|20824904|P2|STARTED|Study Period II||55
8450039|NCT00760747|20824905|P1|STARTED|Study Period II||57
8450040|NCT00760669|20824933|P1|NOT COMPLETED|Overall Study||30
8450041|NCT00760669|20824933|P1|COMPLETED|Overall Study||1031
8450042|NCT00760669|20824933|P1|STARTED|Overall Study||1061
8450043|NCT00760617|20824950|P3|NOT COMPLETED|Overall Study||5
8450044|NCT00760617|20824951|P2|NOT COMPLETED|Overall Study||2
8450045|NCT00760617|20824952|P1|NOT COMPLETED|Overall Study||5
8450046|NCT00760617|20824950|P3|COMPLETED|Overall Study||111
8450047|NCT00760617|20824951|P2|COMPLETED|Overall Study||142
8450048|NCT00760617|20824952|P1|COMPLETED|Overall Study||261
8450049|NCT00760617|20824950|P3|STARTED|Overall Study||116
8450050|NCT00760617|20824951|P2|STARTED|Overall Study||144
8450051|NCT00760617|20824952|P1|STARTED|Overall Study||266
8450052|NCT00760578|20825027|P4|NOT COMPLETED|Overall Study||4
8450053|NCT00760578|20825028|P3|NOT COMPLETED|Overall Study||5
8450054|NCT00760578|20825029|P2|NOT COMPLETED|Overall Study||2
8450055|NCT00760578|20825030|P1|NOT COMPLETED|Overall Study||3
8450056|NCT00760578|20825027|P4|COMPLETED|Overall Study||18
8450057|NCT00760578|20825028|P3|COMPLETED|Overall Study||16
8450058|NCT00760578|20825029|P2|COMPLETED|Overall Study||19
8450059|NCT00760578|20825030|P1|COMPLETED|Overall Study||19
8450060|NCT00760578|20825027|P4|Entered Drug Treatment Period|Overall Study||22
8450061|NCT00760578|20825028|P3|Entered Drug Treatment Period|Overall Study||19
8450062|NCT00760578|20825029|P2|Entered Drug Treatment Period|Overall Study||20
8450063|NCT00760578|20825030|P1|Entered Drug Treatment Period|Overall Study||21
8450064|NCT00760578|20825027|P4|STARTED|Overall Study||22
8450065|NCT00760578|20825028|P3|STARTED|Overall Study||21
8450066|NCT00760578|20825029|P2|STARTED|Overall Study||21
8450067|NCT00760578|20825030|P1|STARTED|Overall Study||22
8450068|NCT00760552|20825066|P2|NOT COMPLETED|Overall Study||10
8450069|NCT00760552|20825067|P1|NOT COMPLETED|Overall Study||13
8450070|NCT00760552|20825066|P2|COMPLETED|Overall Study||52
8450071|NCT00760552|20825067|P1|COMPLETED|Overall Study||48
8450072|NCT00760552|20825066|P2|STARTED|Overall Study||62
8450073|NCT00760552|20825067|P1|STARTED|Overall Study||61
8450074|NCT00760526|20825075|P2|NOT COMPLETED|Overall Study||4
8450075|NCT00760526|20825076|P1|NOT COMPLETED|Overall Study||5
8450076|NCT00760526|20825075|P2|COMPLETED|Overall Study||68
8450077|NCT00760526|20825076|P1|COMPLETED|Overall Study||69
8450078|NCT00760526|20825075|P2|STARTED|Overall Study||72
8450079|NCT00760526|20825076|P1|STARTED|Overall Study||74
8450080|NCT00760513|20825103|P2|NOT COMPLETED|Overall Study||7
8450081|NCT00760513|20825104|P1|NOT COMPLETED|Overall Study||5
8450082|NCT00760513|20825103|P2|COMPLETED|Overall Study||45
8450083|NCT00760513|20825104|P1|COMPLETED|Overall Study||46
8450084|NCT00760513|20825103|P2|STARTED|Overall Study||52
8450085|NCT00760513|20825104|P1|STARTED|Overall Study||51
8450086|NCT00760487|20825114|P1|NOT COMPLETED|Overall Study||3
8450087|NCT00760487|20825114|P1|COMPLETED|Overall Study||117
8450088|NCT00760487|20825114|P1|STARTED|Overall Study||120
8450089|NCT00760474|20825120|P2|NOT COMPLETED|Period 2 (P2)||1
8450090|NCT00760474|20825121|P1|NOT COMPLETED|Period 2 (P2)||1
8450091|NCT00760474|20825120|P2|COMPLETED|Period 2 (P2)||11
8450092|NCT00760474|20825121|P1|COMPLETED|Period 2 (P2)||11
8450093|NCT00760474|20825120|P2|STARTED|Period 2 (P2)||12
8450094|NCT00760474|20825121|P1|STARTED|Period 2 (P2)||12
8450095|NCT00760474|20825120|P2|NOT COMPLETED|Placebo Washout Period||1
8450096|NCT00760474|20825121|P1|NOT COMPLETED|Placebo Washout Period||0
8450097|NCT00760474|20825120|P2|COMPLETED|Placebo Washout Period||12
8450098|NCT00760474|20825121|P1|COMPLETED|Placebo Washout Period||12
8450099|NCT00760474|20825120|P2|STARTED|Placebo Washout Period||13
8450100|NCT00760474|20825121|P1|STARTED|Placebo Washout Period||12
8450101|NCT00760474|20825120|P2|NOT COMPLETED|Period 1 (P1)||1
8450102|NCT00760474|20825121|P1|NOT COMPLETED|Period 1 (P1)||1
8450103|NCT00760474|20825120|P2|COMPLETED|Period 1 (P1)||13
8450104|NCT00760474|20825121|P1|COMPLETED|Period 1 (P1)||12
8450105|NCT00760474|20825120|P2|Overall Number of Unique Participants|Period 1 (P1)||13
8450106|NCT00760474|20825121|P1|Overall Number of Unique Participants|Period 1 (P1)||12
8450107|NCT00760474|20825120|P2|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
8450108|NCT00760474|20825121|P1|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
8450109|NCT00760474|20825120|P2|STARTED|Period 1 (P1)||14
8450110|NCT00760474|20825121|P1|STARTED|Period 1 (P1)||13
8450111|NCT00760461|20825157|P1|NOT COMPLETED|Overall Study||44
8450112|NCT00760461|20825157|P1|COMPLETED|Overall Study||0
8450113|NCT00760461|20825157|P1|STARTED|Overall Study||44
8450114|NCT00760435|20825163|P2|NOT COMPLETED|Overall Study||5
8450115|NCT00760435|20825164|P1|NOT COMPLETED|Overall Study||4
8450116|NCT00760435|20825163|P2|COMPLETED|Overall Study||93
8450117|NCT00760435|20825164|P1|COMPLETED|Overall Study||94
8450118|NCT00760435|20825163|P2|STARTED|Overall Study||98
8450119|NCT00760435|20825164|P1|STARTED|Overall Study||98
8450120|NCT00760383|20825178|P2|NOT COMPLETED|Overall Study||7
8450121|NCT00760383|20825179|P1|NOT COMPLETED|Overall Study||5
8450122|NCT00760383|20825178|P2|COMPLETED|Overall Study||12
8450123|NCT00760383|20825179|P1|COMPLETED|Overall Study||16
8450124|NCT00760383|20825178|P2|STARTED|Overall Study||19
8450125|NCT00760383|20825179|P1|STARTED|Overall Study||21
8450126|NCT00760266|20825191|P2|NOT COMPLETED|Overall Study||18
8450127|NCT00760266|20825192|P1|NOT COMPLETED|Overall Study||24
8450128|NCT00760266|20825191|P2|COMPLETED|Overall Study||205
8450129|NCT00760266|20825192|P1|COMPLETED|Overall Study||204
8450130|NCT00760266|20825191|P2|STARTED|Overall Study||223
8450131|NCT00760266|20825192|P1|STARTED|Overall Study||228
8450132|NCT00760214|20825209|P3|NOT COMPLETED|Overall Study||41
8450133|NCT00760214|20825210|P2|NOT COMPLETED|Overall Study||30
8450134|NCT00760214|20825211|P1|NOT COMPLETED|Overall Study||30
8450135|NCT00760214|20825209|P3|COMPLETED|Overall Study||255
8450136|NCT00760214|20825210|P2|COMPLETED|Overall Study||264
8450137|NCT00760214|20825211|P1|COMPLETED|Overall Study||265
8450138|NCT00760214|20825209|P3|STARTED|Overall Study||296
8450139|NCT00760214|20825210|P2|STARTED|Overall Study||294
8450140|NCT00760214|20825211|P1|STARTED|Overall Study||295
8450141|NCT00760084|20825252|P1|NOT COMPLETED|Overall Study||10
8450142|NCT00760084|20825252|P1|COMPLETED|Overall Study||0
8450143|NCT00760084|20825252|P1|STARTED|Overall Study||10
8450144|NCT00760019|20825258|P4|NOT COMPLETED|Overall Study||0
8450145|NCT00760019|20825259|P3|NOT COMPLETED|Overall Study||0
8450146|NCT00760019|20825260|P2|NOT COMPLETED|Overall Study||0
8450147|NCT00760019|20825261|P1|NOT COMPLETED|Overall Study||0
8450148|NCT00760019|20825258|P4|COMPLETED|Overall Study||14
8450149|NCT00760019|20825259|P3|COMPLETED|Overall Study||14
8450150|NCT00760019|20825260|P2|COMPLETED|Overall Study||15
8450151|NCT00760019|20825261|P1|COMPLETED|Overall Study||15
8450152|NCT00760019|20825258|P4|STARTED|Overall Study||14
8450153|NCT00760019|20825259|P3|STARTED|Overall Study||14
8450154|NCT00760019|20825260|P2|STARTED|Overall Study||15
8450155|NCT00760019|20825261|P1|STARTED|Overall Study||15
8450156|NCT00760006|20825269|P2|NOT COMPLETED|Overall Study||0
8450157|NCT00760006|20825270|P1|NOT COMPLETED|Overall Study||0
8450158|NCT00760006|20825269|P2|COMPLETED|Overall Study||138
8450159|NCT00760006|20825270|P1|COMPLETED|Overall Study||86
8450160|NCT00760006|20825269|P2|STARTED|Overall Study||138
8450161|NCT00760006|20825270|P1|STARTED|Overall Study||86
8450162|NCT00759967|20825276|P2|NOT COMPLETED|Second Intervention||0
8450163|NCT00759967|20825277|P1|NOT COMPLETED|Second Intervention||2
8450164|NCT00759967|20825276|P2|COMPLETED|Second Intervention||9
8450165|NCT00759967|20825277|P1|COMPLETED|Second Intervention||8
8450166|NCT00759967|20825276|P2|STARTED|Second Intervention||9
8450167|NCT00759967|20825277|P1|STARTED|Second Intervention||10
8450168|NCT00759967|20825276|P2|NOT COMPLETED|First Intervention||0
8450169|NCT00759967|20825277|P1|NOT COMPLETED|First Intervention||0
8450170|NCT00759967|20825276|P2|COMPLETED|First Intervention||9
8450171|NCT00759967|20825277|P1|COMPLETED|First Intervention||10
8450172|NCT00759967|20825276|P2|STARTED|First Intervention||9
8450173|NCT00759967|20825277|P1|STARTED|First Intervention||10
8450174|NCT00759954|20825295|P2|NOT COMPLETED|Overall Study||2
8450175|NCT00759954|20825296|P1|NOT COMPLETED|Overall Study||2
8450176|NCT00759954|20825295|P2|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
8450177|NCT00759954|20825296|P1|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
8450178|NCT00759954|20825295|P2|STARTED|Overall Study|All assigned participants entered trial|18
8450179|NCT00759954|20825296|P1|STARTED|Overall Study|All assigned participants entered trial|18
8450180|NCT00759941|20825310|P2|NOT COMPLETED|Overall Study||1
8450181|NCT00759941|20825311|P1|NOT COMPLETED|Overall Study||3
8450182|NCT00759941|20825310|P2|COMPLETED|Overall Study||43
8450183|NCT00759941|20825311|P1|COMPLETED|Overall Study||39
8450184|NCT00759941|20825310|P2|STARTED|Overall Study||44
8450185|NCT00759941|20825311|P1|STARTED|Overall Study||42
8450186|NCT00759915|20825325|P2|NOT COMPLETED|Overall Study||1
8450187|NCT00759915|20825326|P1|NOT COMPLETED|Overall Study||1
8450188|NCT00759915|20825325|P2|COMPLETED|Overall Study||17
8450189|NCT00759915|20825326|P1|COMPLETED|Overall Study||17
8450190|NCT00759915|20825325|P2|STARTED|Overall Study||18
8450191|NCT00759915|20825326|P1|STARTED|Overall Study||18
8450192|NCT00759902|20825340|P2|NOT COMPLETED|Overall Study||1
8450193|NCT00759902|20825341|P1|NOT COMPLETED|Overall Study||0
8450194|NCT00759902|20825340|P2|COMPLETED|Overall Study||17
8450195|NCT00759902|20825341|P1|COMPLETED|Overall Study||18
8450196|NCT00759902|20825340|P2|STARTED|Overall Study||18
8450197|NCT00759902|20825341|P1|STARTED|Overall Study||18
8450198|NCT00759876|20825353|P1|NOT COMPLETED|Overall Study||36
8450199|NCT00759876|20825353|P1|COMPLETED|Overall Study||0
8450200|NCT00759876|20825353|P1|Ambulatory Evaluable Population|Overall Study||24
8450201|NCT00759876|20825353|P1|Evaluable Population|Overall Study||35
8450202|NCT00759876|20825353|P1|As-Treated Population|Overall Study||36
8450203|NCT00759876|20825353|P1|STARTED|Overall Study||36
8450204|NCT00759863|20825377|P2|NOT COMPLETED|Overall Study||18
8450205|NCT00759863|20825378|P1|NOT COMPLETED|Overall Study||20
8450206|NCT00759863|20825377|P2|COMPLETED|Overall Study||80
8450207|NCT00759863|20825378|P1|COMPLETED|Overall Study||124
8450208|NCT00759863|20825377|P2|STARTED|Overall Study||98
8450209|NCT00759863|20825378|P1|STARTED|Overall Study||144
8450210|NCT00759811|20825390|P2|NOT COMPLETED|Overall Study||1
8450211|NCT00759811|20825391|P1|NOT COMPLETED|Overall Study||2
8450212|NCT00759811|20825390|P2|COMPLETED|Overall Study||24
8450213|NCT00759811|20825391|P1|COMPLETED|Overall Study||23
8450214|NCT00759811|20825390|P2|STARTED|Overall Study||25
8450215|NCT00759811|20825391|P1|STARTED|Overall Study||25
8450216|NCT00759785|20825399|P2|NOT COMPLETED|Overall Study||5
8450217|NCT00759785|20825400|P1|NOT COMPLETED|Overall Study||12
8450218|NCT00759785|20825399|P2|COMPLETED|Overall Study||17
8450219|NCT00759785|20825400|P1|COMPLETED|Overall Study||14
8450220|NCT00759785|20825399|P2|Treated|Overall Study||20
8450221|NCT00759785|20825400|P1|Treated|Overall Study||25
8450222|NCT00759785|20825399|P2|STARTED|Overall Study||22
8450223|NCT00759785|20825400|P1|STARTED|Overall Study||26
8450224|NCT00759772|20825414|P2|NOT COMPLETED|Overall Study||0
8450225|NCT00759772|20825415|P1|NOT COMPLETED|Overall Study||0
8450226|NCT00759772|20825414|P2|COMPLETED|Overall Study||11
8450227|NCT00759772|20825415|P1|COMPLETED|Overall Study||12
8450228|NCT00759772|20825414|P2|STARTED|Overall Study||11
8450229|NCT00759772|20825415|P1|STARTED|Overall Study||12
8450230|NCT00759759|20825423|P2|NOT COMPLETED|Overall Study||1
8450231|NCT00759759|20825424|P1|NOT COMPLETED|Overall Study||4
8450232|NCT00759759|20825423|P2|COMPLETED|Overall Study||17
8450233|NCT00759759|20825424|P1|COMPLETED|Overall Study||14
8450234|NCT00759759|20825423|P2|STARTED|Overall Study||18
8450235|NCT00759759|20825424|P1|STARTED|Overall Study||18
8450236|NCT00759707|20825436|P1|NOT COMPLETED|Overall Study||0
8450237|NCT00759707|20825436|P1|COMPLETED|Overall Study||19
8450238|NCT00759707|20825436|P1|STARTED|Overall Study||19
8450239|NCT00759681|20825442|P2|NOT COMPLETED|Overall Study||10
8450240|NCT00759681|20825443|P1|NOT COMPLETED|Overall Study||10
8450241|NCT00759681|20825442|P2|COMPLETED|Overall Study||100
8450242|NCT00759681|20825443|P1|COMPLETED|Overall Study||97
8450243|NCT00759681|20825442|P2|STARTED|Overall Study||110
8450244|NCT00759681|20825443|P1|STARTED|Overall Study||107
8450245|NCT00759668|20825453|P2|NOT COMPLETED|Overall Study||3
8450246|NCT00759668|20825454|P1|NOT COMPLETED|Overall Study||1
8450247|NCT00759668|20825453|P2|COMPLETED|Overall Study||15
8450248|NCT00759668|20825454|P1|COMPLETED|Overall Study||16
8450249|NCT00759668|20825453|P2|STARTED|Overall Study||18
8450250|NCT00759668|20825454|P1|STARTED|Overall Study||17
8450251|NCT00759655|20825470|P1|NOT COMPLETED|Overall Study||1
8450252|NCT00759655|20825470|P1|COMPLETED|Overall Study||0
8450253|NCT00759655|20825470|P1|STARTED|Overall Study||1
8450254|NCT00759642|20825481|P1|NOT COMPLETED|Overall Study||0
8450255|NCT00759642|20825481|P1|COMPLETED|Overall Study||33
8450256|NCT00759642|20825481|P1|STARTED|Overall Study||33
8450257|NCT00759603|20825485|P1|NOT COMPLETED|Overall Study||0
8450258|NCT00759603|20825485|P1|COMPLETED|Overall Study||59
8450259|NCT00759603|20825485|P1|STARTED|Overall Study||59
8450260|NCT00759577|20825489|P1|NOT COMPLETED|Overall Study||0
8450261|NCT00759577|20825489|P1|COMPLETED|Overall Study||36
8450262|NCT00759577|20825489|P1|STARTED|Overall Study||36
8450263|NCT00759564|20825498|P5|NOT COMPLETED|Second Intervention Period (4 Days)||0
8450264|NCT00759564|20825499|P4|NOT COMPLETED|Second Intervention Period (4 Days)||0
8450265|NCT00759564|20825500|P3|NOT COMPLETED|Second Intervention Period (4 Days)||0
8450266|NCT00759564|20825501|P2|NOT COMPLETED|Second Intervention Period (4 Days)||0
8450267|NCT00759564|20825502|P1|NOT COMPLETED|Second Intervention Period (4 Days)||0
8450268|NCT00759564|20825498|P5|COMPLETED|Second Intervention Period (4 Days)||3
8450269|NCT00759564|20825499|P4|COMPLETED|Second Intervention Period (4 Days)||1
8450270|NCT00759564|20825500|P3|COMPLETED|Second Intervention Period (4 Days)||8
8450271|NCT00759564|20825501|P2|COMPLETED|Second Intervention Period (4 Days)||8
8450272|NCT00759564|20825502|P1|COMPLETED|Second Intervention Period (4 Days)||8
8450273|NCT00759564|20825498|P5|STARTED|Second Intervention Period (4 Days)||3
8450274|NCT00759564|20825499|P4|STARTED|Second Intervention Period (4 Days)||1
8450275|NCT00759564|20825500|P3|STARTED|Second Intervention Period (4 Days)||8
8450276|NCT00759564|20825501|P2|STARTED|Second Intervention Period (4 Days)||8
8450277|NCT00759564|20825502|P1|STARTED|Second Intervention Period (4 Days)||8
8450278|NCT00759564|20825498|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||1
8450279|NCT00759564|20825499|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8450280|NCT00759564|20825500|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8450281|NCT00759564|20825501|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8450282|NCT00759564|20825502|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
8450283|NCT00759564|20825498|P5|COMPLETED|Washout Period (at Least 14 Days)||3
8450284|NCT00759564|20825499|P4|COMPLETED|Washout Period (at Least 14 Days)||1
8450285|NCT00759564|20825500|P3|COMPLETED|Washout Period (at Least 14 Days)||8
8450286|NCT00759564|20825501|P2|COMPLETED|Washout Period (at Least 14 Days)||8
8450287|NCT00759564|20825502|P1|COMPLETED|Washout Period (at Least 14 Days)||8
8450288|NCT00759564|20825498|P5|STARTED|Washout Period (at Least 14 Days)||4
8450289|NCT00759564|20825499|P4|STARTED|Washout Period (at Least 14 Days)||1
8450290|NCT00759564|20825500|P3|STARTED|Washout Period (at Least 14 Days)||8
8450291|NCT00759564|20825501|P2|STARTED|Washout Period (at Least 14 Days)||8
8450292|NCT00759564|20825502|P1|STARTED|Washout Period (at Least 14 Days)||8
8450293|NCT00759564|20825498|P5|NOT COMPLETED|First Intervention Period (4 Days)||0
8450294|NCT00759564|20825499|P4|NOT COMPLETED|First Intervention Period (4 Days)||0
8450295|NCT00759564|20825500|P3|NOT COMPLETED|First Intervention Period (4 Days)||0
8450296|NCT00759564|20825501|P2|NOT COMPLETED|First Intervention Period (4 Days)||0
8450297|NCT00759564|20825502|P1|NOT COMPLETED|First Intervention Period (4 Days)||0
8450298|NCT00759564|20825498|P5|COMPLETED|First Intervention Period (4 Days)||4
8450299|NCT00759564|20825499|P4|COMPLETED|First Intervention Period (4 Days)||1
8450300|NCT00759564|20825500|P3|COMPLETED|First Intervention Period (4 Days)||8
8450301|NCT00759564|20825501|P2|COMPLETED|First Intervention Period (4 Days)||8
8450302|NCT00759564|20825502|P1|COMPLETED|First Intervention Period (4 Days)||8
8450303|NCT00759564|20825498|P5|STARTED|First Intervention Period (4 Days)||4
8450304|NCT00759564|20825499|P4|STARTED|First Intervention Period (4 Days)||1
8450305|NCT00759564|20825500|P3|STARTED|First Intervention Period (4 Days)||8
8450306|NCT00759564|20825501|P2|STARTED|First Intervention Period (4 Days)||8
8450307|NCT00759564|20825502|P1|STARTED|First Intervention Period (4 Days)||8
8450308|NCT00759525|20825642|P2|NOT COMPLETED|Second Intervention (14 Days)||0
8450309|NCT00759525|20825643|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8450310|NCT00759525|20825642|P2|COMPLETED|Second Intervention (14 Days)||8
8450311|NCT00759525|20825643|P1|COMPLETED|Second Intervention (14 Days)||7
8450312|NCT00759525|20825642|P2|STARTED|Second Intervention (14 Days)||8
8450313|NCT00759525|20825643|P1|STARTED|Second Intervention (14 Days)||7
8450314|NCT00759525|20825642|P2|NOT COMPLETED|Washout (14 Days)||0
8450315|NCT00759525|20825643|P1|NOT COMPLETED|Washout (14 Days)||0
8450316|NCT00759525|20825642|P2|COMPLETED|Washout (14 Days)||8
8450317|NCT00759525|20825643|P1|COMPLETED|Washout (14 Days)||7
8450318|NCT00759525|20825642|P2|STARTED|Washout (14 Days)||8
8450319|NCT00759525|20825643|P1|STARTED|Washout (14 Days)||7
8450320|NCT00759525|20825642|P2|NOT COMPLETED|First Intervention (14 Days)||0
8450321|NCT00759525|20825643|P1|NOT COMPLETED|First Intervention (14 Days)||0
8450322|NCT00759525|20825642|P2|COMPLETED|First Intervention (14 Days)||8
8450323|NCT00759525|20825643|P1|COMPLETED|First Intervention (14 Days)||7
8450324|NCT00759525|20825642|P2|STARTED|First Intervention (14 Days)||8
8450325|NCT00759525|20825643|P1|STARTED|First Intervention (14 Days)||7
8450326|NCT00759473|20825654|P5|NOT COMPLETED|Overall Study||0
8450327|NCT00759473|20825655|P4|NOT COMPLETED|Overall Study||0
8450328|NCT00759473|20825656|P3|NOT COMPLETED|Overall Study||0
8450329|NCT00759473|20825657|P2|NOT COMPLETED|Overall Study||0
8450330|NCT00759473|20825658|P1|NOT COMPLETED|Overall Study||0
8450331|NCT00759473|20825654|P5|COMPLETED|Overall Study||24
8450332|NCT00759473|20825655|P4|COMPLETED|Overall Study||23
8450333|NCT00759473|20825656|P3|COMPLETED|Overall Study||12
8450334|NCT00759473|20825657|P2|COMPLETED|Overall Study||10
8450335|NCT00759473|20825658|P1|COMPLETED|Overall Study||10
8450336|NCT00759473|20825654|P5|STARTED|Overall Study||24
8450337|NCT00759473|20825655|P4|STARTED|Overall Study||23
8450338|NCT00759473|20825656|P3|STARTED|Overall Study||12
8450339|NCT00759473|20825657|P2|STARTED|Overall Study||10
8450340|NCT00759473|20825658|P1|STARTED|Overall Study||10
8450341|NCT00759408|20825670|P1|NOT COMPLETED|Overall Study||19
8450342|NCT00759408|20825670|P1|COMPLETED|Overall Study||19
8450343|NCT00759408|20825670|P1|STARTED|Overall Study||38
8450344|NCT00759395|20825679|P2|NOT COMPLETED|Overall Study||2
8450345|NCT00759395|20825680|P1|NOT COMPLETED|Overall Study||2
8450346|NCT00759395|20825679|P2|COMPLETED|Overall Study||7
8450347|NCT00759395|20825680|P1|COMPLETED|Overall Study||11
8450348|NCT00759395|20825679|P2|STARTED|Overall Study||9
8450349|NCT00759395|20825680|P1|STARTED|Overall Study||13
8450350|NCT00759356|20825696|P2|NOT COMPLETED|Overall Study||3
8450351|NCT00759356|20825697|P1|NOT COMPLETED|Overall Study||1
8450352|NCT00759356|20825696|P2|COMPLETED|Overall Study||15
8450353|NCT00759356|20825697|P1|COMPLETED|Overall Study||17
8450354|NCT00759356|20825696|P2|STARTED|Overall Study||18
8450355|NCT00759356|20825697|P1|STARTED|Overall Study||18
8450356|NCT00759330|20825713|P4|NOT COMPLETED|Overall Study||2
8450357|NCT00759330|20825714|P3|NOT COMPLETED|Overall Study||0
8450358|NCT00759330|20825715|P2|NOT COMPLETED|Overall Study||1
8450359|NCT00759330|20825716|P1|NOT COMPLETED|Overall Study||1
8450360|NCT00759330|20825713|P4|COMPLETED|Overall Study||41
8450361|NCT00759330|20825714|P3|COMPLETED|Overall Study||22
8450362|NCT00759330|20825715|P2|COMPLETED|Overall Study||41
8450363|NCT00759330|20825716|P1|COMPLETED|Overall Study||19
8450364|NCT00759330|20825713|P4|STARTED|Overall Study||43
8450365|NCT00759330|20825714|P3|STARTED|Overall Study||22
8450366|NCT00759330|20825715|P2|STARTED|Overall Study||42
8450367|NCT00759330|20825716|P1|STARTED|Overall Study||20
8450368|NCT00759187|20825765|P3|NOT COMPLETED|Overall Study||0
8450369|NCT00759187|20825766|P2|NOT COMPLETED|Overall Study||0
8450370|NCT00759187|20825767|P1|NOT COMPLETED|Overall Study||0
8450371|NCT00759187|20825765|P3|COMPLETED|Overall Study||9
8450372|NCT00759187|20825766|P2|COMPLETED|Overall Study||8
8450373|NCT00759187|20825767|P1|COMPLETED|Overall Study||8
8450374|NCT00759187|20825765|P3|STARTED|Overall Study||9
8450375|NCT00759187|20825766|P2|STARTED|Overall Study||8
8450376|NCT00759187|20825767|P1|STARTED|Overall Study||8
8450383|NCT00759161|20825787|P1|NOT COMPLETED|Overall Study||0
8450384|NCT00759161|20825787|P1|COMPLETED|Overall Study||35
8450385|NCT00759161|20825787|P1|STARTED|Overall Study||35
8450386|NCT00759148|20825802|P2|NOT COMPLETED|Overall Study||32
8450387|NCT00759148|20825803|P1|NOT COMPLETED|Overall Study||14
8450388|NCT00759148|20825802|P2|COMPLETED|Overall Study||554
8450389|NCT00759148|20825803|P1|COMPLETED|Overall Study||579
8450390|NCT00759148|20825802|P2|STARTED|Overall Study||586
8450391|NCT00759148|20825803|P1|STARTED|Overall Study||593
8450392|NCT00759109|20825813|P2|NOT COMPLETED|Overall Study||35
8450393|NCT00759109|20825814|P1|NOT COMPLETED|Overall Study||39
8450394|NCT00759109|20825813|P2|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
8450395|NCT00759109|20825814|P1|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
8450396|NCT00759109|20825813|P2|STARTED|Overall Study||76
8450397|NCT00759109|20825814|P1|STARTED|Overall Study||74
8450398|NCT00759096|20825830|P1|NOT COMPLETED|Overall Study||0
8450399|NCT00759096|20825830|P1|COMPLETED|Overall Study||30
8450400|NCT00759096|20825830|P1|STARTED|Overall Study||30
8450401|NCT00759031|20825836|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8450402|NCT00759031|20825837|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8450403|NCT00759031|20825836|P2|COMPLETED|Second Intervention (1 Day)||8
8450404|NCT00759031|20825837|P1|COMPLETED|Second Intervention (1 Day)||8
8450405|NCT00759031|20825836|P2|STARTED|Second Intervention (1 Day)||8
8450406|NCT00759031|20825837|P1|STARTED|Second Intervention (1 Day)||8
8450407|NCT00759031|20825836|P2|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
8450408|NCT00759031|20825837|P1|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
8450409|NCT00759031|20825836|P2|COMPLETED|Washout After 1st Intervention (1 Week)||8
8450410|NCT00759031|20825837|P1|COMPLETED|Washout After 1st Intervention (1 Week)||8
8450411|NCT00759031|20825836|P2|STARTED|Washout After 1st Intervention (1 Week)||8
8450412|NCT00759031|20825837|P1|STARTED|Washout After 1st Intervention (1 Week)||8
8450413|NCT00759031|20825836|P2|NOT COMPLETED|First Intervention (1 Day)||1
8450414|NCT00759031|20825837|P1|NOT COMPLETED|First Intervention (1 Day)||2
8450415|NCT00759031|20825836|P2|COMPLETED|First Intervention (1 Day)||8
8450416|NCT00759031|20825837|P1|COMPLETED|First Intervention (1 Day)||8
8450417|NCT00759031|20825836|P2|STARTED|First Intervention (1 Day)||9
8450418|NCT00759031|20825837|P1|STARTED|First Intervention (1 Day)||10
8450419|NCT00758862|20825843|P1|NOT COMPLETED|Overall Study||1
8450420|NCT00758862|20825843|P1|COMPLETED|Overall Study||19
8450421|NCT00758862|20825843|P1|STARTED|Overall Study||20
8450422|NCT00758836|20825863|P4|NOT COMPLETED|Overall Study||32
8450423|NCT00758836|20825864|P3|NOT COMPLETED|Overall Study||38
8450424|NCT00758836|20825865|P2|NOT COMPLETED|Overall Study||26
8450425|NCT00758836|20825866|P1|NOT COMPLETED|Overall Study||24
8450426|NCT00758836|20825863|P4|COMPLETED|Overall Study||138
8450427|NCT00758836|20825864|P3|COMPLETED|Overall Study||133
8450428|NCT00758836|20825865|P2|COMPLETED|Overall Study||145
8450429|NCT00758836|20825866|P1|COMPLETED|Overall Study||147
8450430|NCT00758836|20825863|P4|Treated|Overall Study||138
8450431|NCT00758836|20825864|P3|Treated|Overall Study||133
8450432|NCT00758836|20825865|P2|Treated|Overall Study||145
8450433|NCT00758836|20825866|P1|Treated|Overall Study||147
8450434|NCT00758836|20825863|P4|STARTED|Overall Study||170
8450435|NCT00758836|20825864|P3|STARTED|Overall Study||171
8450436|NCT00758836|20825865|P2|STARTED|Overall Study||171
8450437|NCT00758836|20825866|P1|STARTED|Overall Study||171
8450438|NCT00758784|20825888|P1|NOT COMPLETED|Overall Study||2
8450439|NCT00758784|20825888|P1|COMPLETED|Overall Study||36
8450440|NCT00758784|20825888|P1|STARTED|Overall Study||38
8450441|NCT00758771|20825896|P2|NOT COMPLETED|Overall Study||5
8450442|NCT00758771|20825897|P1|NOT COMPLETED|Overall Study||3
8450443|NCT00758771|20825896|P2|COMPLETED|Overall Study||15
8450444|NCT00758771|20825897|P1|COMPLETED|Overall Study||15
8450445|NCT00758771|20825896|P2|STARTED|Overall Study||20
8450446|NCT00758771|20825897|P1|STARTED|Overall Study||18
8450447|NCT00758758|20825911|P8|NOT COMPLETED|Overall Study||0
8450448|NCT00758758|20825912|P7|NOT COMPLETED|Overall Study||14
8450449|NCT00758758|20825913|P6|NOT COMPLETED|Overall Study||14
8450450|NCT00758758|20825914|P5|NOT COMPLETED|Overall Study||2
8450451|NCT00758758|20825915|P4|NOT COMPLETED|Overall Study||2
8450452|NCT00758758|20825916|P3|NOT COMPLETED|Overall Study||18
8450453|NCT00758758|20825917|P2|NOT COMPLETED|Overall Study||25
8450454|NCT00758758|20825918|P1|NOT COMPLETED|Overall Study||3
8450455|NCT00758758|20825911|P8|COMPLETED|Overall Study||0
8450456|NCT00758758|20825912|P7|COMPLETED|Overall Study||17
8450457|NCT00758758|20825913|P6|COMPLETED|Overall Study||36
8450458|NCT00758758|20825914|P5|COMPLETED|Overall Study||1
8450459|NCT00758758|20825915|P4|COMPLETED|Overall Study||4
8450460|NCT00758758|20825916|P3|COMPLETED|Overall Study||35
8450461|NCT00758758|20825917|P2|COMPLETED|Overall Study||49
8450462|NCT00758758|20825918|P1|COMPLETED|Overall Study||11
8450463|NCT00758758|20825911|P8|STARTED|Overall Study||0
8450464|NCT00758758|20825912|P7|STARTED|Overall Study||31
8450465|NCT00758758|20825913|P6|STARTED|Overall Study||50
8450466|NCT00758758|20825914|P5|STARTED|Overall Study||3
8450467|NCT00758758|20825915|P4|STARTED|Overall Study||6
8450468|NCT00758758|20825916|P3|STARTED|Overall Study||53
8450469|NCT00758758|20825917|P2|STARTED|Overall Study||74
8450470|NCT00758758|20825918|P1|STARTED|Overall Study||14
8450471|NCT00758745|20825946|P2|NOT COMPLETED|Overall Study||21
8450472|NCT00758745|20825947|P1|NOT COMPLETED|Overall Study||21
8450473|NCT00758745|20825946|P2|COMPLETED|Overall Study||60
8450474|NCT00758745|20825947|P1|COMPLETED|Overall Study||60
8450475|NCT00758745|20825946|P2|STARTED|Overall Study||81
8450476|NCT00758745|20825947|P1|STARTED|Overall Study||81
8450477|NCT00758706|20825955|P2|NOT COMPLETED|Overall Study||4
8450478|NCT00758706|20825956|P1|NOT COMPLETED|Overall Study||4
8450479|NCT00758706|20825955|P2|COMPLETED|Overall Study||25
8450480|NCT00758706|20825956|P1|COMPLETED|Overall Study||22
8450481|NCT00758706|20825955|P2|STARTED|Overall Study||29
8450482|NCT00758706|20825956|P1|STARTED|Overall Study||26
8450483|NCT00758680|20825992|P10|NOT COMPLETED|Overall Study||1
8450484|NCT00758680|20825993|P9|NOT COMPLETED|Overall Study||2
8450485|NCT00758680|20825994|P8|NOT COMPLETED|Overall Study||1
8450486|NCT00758680|20825995|P7|NOT COMPLETED|Overall Study||1
8450487|NCT00758680|20825996|P6|NOT COMPLETED|Overall Study||0
8450488|NCT00758680|20825997|P5|NOT COMPLETED|Overall Study||0
8450489|NCT00758680|20825998|P4|NOT COMPLETED|Overall Study||0
8450490|NCT00758680|20825999|P3|NOT COMPLETED|Overall Study||0
8450491|NCT00758680|20826000|P2|NOT COMPLETED|Overall Study||0
8450492|NCT00758680|20826001|P1|NOT COMPLETED|Overall Study||0
8450493|NCT00758680|20825992|P10|COMPLETED|Overall Study||28
8450494|NCT00758680|20825993|P9|COMPLETED|Overall Study||18
8450495|NCT00758680|20825994|P8|COMPLETED|Overall Study||19
8450496|NCT00758680|20825995|P7|COMPLETED|Overall Study||6
8450497|NCT00758680|20825996|P6|COMPLETED|Overall Study||6
8450498|NCT00758680|20825997|P5|COMPLETED|Overall Study||6
8450499|NCT00758680|20825998|P4|COMPLETED|Overall Study||6
8450500|NCT00758680|20825999|P3|COMPLETED|Overall Study||6
8450501|NCT00758680|20826000|P2|COMPLETED|Overall Study||6
8450502|NCT00758680|20826001|P1|COMPLETED|Overall Study||6
8450503|NCT00758680|20825992|P10|STARTED|Overall Study||29
8450504|NCT00758680|20825993|P9|STARTED|Overall Study||20
8450505|NCT00758680|20825994|P8|STARTED|Overall Study||20
8450506|NCT00758680|20825995|P7|STARTED|Overall Study||7
8450507|NCT00758680|20825996|P6|STARTED|Overall Study||6
8450508|NCT00758680|20825997|P5|STARTED|Overall Study||6
8450509|NCT00758680|20825998|P4|STARTED|Overall Study||6
8450510|NCT00758680|20825999|P3|STARTED|Overall Study||6
8450511|NCT00758680|20826000|P2|STARTED|Overall Study||6
8450512|NCT00758680|20826001|P1|STARTED|Overall Study||6
8450513|NCT00758667|20826043|P2|NOT COMPLETED|Overall Study||0
8450514|NCT00758667|20826044|P1|NOT COMPLETED|Overall Study||0
8450515|NCT00758667|20826043|P2|COMPLETED|Overall Study||11
8450516|NCT00758667|20826044|P1|COMPLETED|Overall Study||9
8450517|NCT00758667|20826043|P2|STARTED|Overall Study||11
8450518|NCT00758667|20826044|P1|STARTED|Overall Study||9
8450519|NCT00758602|20826054|P2|NOT COMPLETED|Overall Study||22
8450520|NCT00758602|20826055|P1|NOT COMPLETED|Overall Study||19
8450521|NCT00758602|20826054|P2|COMPLETED|Overall Study||84
8450522|NCT00758602|20826055|P1|COMPLETED|Overall Study||85
8450523|NCT00758602|20826054|P2|STARTED|Overall Study||106
8450524|NCT00758602|20826055|P1|STARTED|Overall Study||104
8450525|NCT00758589|20826081|P4|NOT COMPLETED|Overall Study||6
8450526|NCT00758589|20826082|P3|NOT COMPLETED|Overall Study||6
8450527|NCT00758589|20826083|P2|NOT COMPLETED|Overall Study||3
8450528|NCT00758589|20826084|P1|NOT COMPLETED|Overall Study||3
8450529|NCT00758589|20826081|P4|COMPLETED|Overall Study||85
8450530|NCT00758589|20826082|P3|COMPLETED|Overall Study||86
8450531|NCT00758589|20826083|P2|COMPLETED|Overall Study||87
8450532|NCT00758589|20826084|P1|COMPLETED|Overall Study||92
8450533|NCT00758589|20826081|P4|STARTED|Overall Study||91
8450534|NCT00758589|20826082|P3|STARTED|Overall Study||92
8450535|NCT00758589|20826083|P2|STARTED|Overall Study||90
8450536|NCT00758589|20826084|P1|STARTED|Overall Study||95
8450537|NCT00758576|20826150|P1|NOT COMPLETED|Overall Study||1
8450538|NCT00758576|20826150|P1|COMPLETED|Overall Study||63
8450539|NCT00758576|20826150|P1|STARTED|Overall Study||64
8450540|NCT00758563|20826158|P2|NOT COMPLETED|Overall Study||0
8450541|NCT00758563|20826159|P1|NOT COMPLETED|Overall Study||0
8450542|NCT00758563|20826158|P2|COMPLETED|Overall Study||8
8450543|NCT00758563|20826159|P1|COMPLETED|Overall Study||7
8450544|NCT00758563|20826158|P2|STARTED|Overall Study||8
8450545|NCT00758563|20826159|P1|STARTED|Overall Study||7
8450546|NCT00758550|20826165|P2|NOT COMPLETED|Overall Study||0
8450547|NCT00758550|20826166|P1|NOT COMPLETED|Overall Study||0
8450548|NCT00758550|20826165|P2|COMPLETED|Overall Study||30
8450549|NCT00758550|20826166|P1|COMPLETED|Overall Study||30
8450550|NCT00758550|20826165|P2|STARTED|Overall Study||30
8450551|NCT00758550|20826166|P1|STARTED|Overall Study||30
8450552|NCT00758498|20826177|P3|NOT COMPLETED|Overall Study||5
8450553|NCT00758498|20826178|P2|NOT COMPLETED|Overall Study||2
8450554|NCT00758498|20826179|P1|NOT COMPLETED|Overall Study||3
8450555|NCT00758498|20826177|P3|COMPLETED|Overall Study||137
8450556|NCT00758498|20826178|P2|COMPLETED|Overall Study||141
8450557|NCT00758498|20826179|P1|COMPLETED|Overall Study||139
8450558|NCT00758498|20826177|P3|STARTED|Overall Study||142
8450559|NCT00758498|20826178|P2|STARTED|Overall Study||143
8450560|NCT00758498|20826179|P1|STARTED|Overall Study||142
8450561|NCT00758485|20826264|P2|NOT COMPLETED|Overall Study||3
8450562|NCT00758485|20826265|P1|NOT COMPLETED|Overall Study||1
8450563|NCT00758485|20826264|P2|COMPLETED|Overall Study||67
8450564|NCT00758485|20826265|P1|COMPLETED|Overall Study||69
8450565|NCT00758485|20826264|P2|TREATED|Overall Study||68
8450566|NCT00758485|20826265|P1|TREATED|Overall Study||69
8450567|NCT00758485|20826264|P2|STARTED|Overall Study||70
8450568|NCT00758485|20826265|P1|STARTED|Overall Study||70
8450569|NCT00758459|20826277|P2|NOT COMPLETED|Overall Study||4
8450570|NCT00758459|20826278|P1|NOT COMPLETED|Overall Study||3
8450571|NCT00758459|20826277|P2|COMPLETED|Overall Study||35
8450572|NCT00758459|20826278|P1|COMPLETED|Overall Study||32
8450573|NCT00758459|20826277|P2|STARTED|Overall Study||39
8450574|NCT00758459|20826278|P1|STARTED|Overall Study||35
8450581|NCT00758394|20826323|P4|NOT COMPLETED|4th Intervention||0
8450582|NCT00758394|20826324|P3|NOT COMPLETED|4th Intervention||0
8450583|NCT00758394|20826325|P2|NOT COMPLETED|4th Intervention||0
8450584|NCT00758394|20826326|P1|NOT COMPLETED|4th Intervention||0
8450585|NCT00758394|20826323|P4|COMPLETED|4th Intervention||7
8450586|NCT00758394|20826324|P3|COMPLETED|4th Intervention||6
8450587|NCT00758394|20826325|P2|COMPLETED|4th Intervention||6
8450588|NCT00758394|20826326|P1|COMPLETED|4th Intervention||7
8450589|NCT00758394|20826323|P4|STARTED|4th Intervention||7
8450590|NCT00758394|20826324|P3|STARTED|4th Intervention||6
8450591|NCT00758394|20826325|P2|STARTED|4th Intervention||6
8450592|NCT00758394|20826326|P1|STARTED|4th Intervention||7
8450593|NCT00758394|20826323|P4|NOT COMPLETED|Washout After 3rd Intervention||0
8450594|NCT00758394|20826324|P3|NOT COMPLETED|Washout After 3rd Intervention||0
8450595|NCT00758394|20826325|P2|NOT COMPLETED|Washout After 3rd Intervention||0
8450596|NCT00758394|20826326|P1|NOT COMPLETED|Washout After 3rd Intervention||0
8450597|NCT00758394|20826323|P4|COMPLETED|Washout After 3rd Intervention||7
8450598|NCT00758394|20826324|P3|COMPLETED|Washout After 3rd Intervention||6
8450599|NCT00758394|20826325|P2|COMPLETED|Washout After 3rd Intervention||6
8450600|NCT00758394|20826326|P1|COMPLETED|Washout After 3rd Intervention||7
8450601|NCT00758394|20826323|P4|STARTED|Washout After 3rd Intervention||7
8450602|NCT00758394|20826324|P3|STARTED|Washout After 3rd Intervention||6
8450603|NCT00758394|20826325|P2|STARTED|Washout After 3rd Intervention||6
8450604|NCT00758394|20826326|P1|STARTED|Washout After 3rd Intervention||7
8450605|NCT00758394|20826323|P4|NOT COMPLETED|3rd Intervention||1
8450606|NCT00758394|20826324|P3|NOT COMPLETED|3rd Intervention||0
8450607|NCT00758394|20826325|P2|NOT COMPLETED|3rd Intervention||0
8450608|NCT00758394|20826326|P1|NOT COMPLETED|3rd Intervention||1
8450609|NCT00758394|20826323|P4|COMPLETED|3rd Intervention||7
8450610|NCT00758394|20826324|P3|COMPLETED|3rd Intervention||6
8450611|NCT00758394|20826325|P2|COMPLETED|3rd Intervention||6
8450612|NCT00758394|20826326|P1|COMPLETED|3rd Intervention||7
8450613|NCT00758394|20826323|P4|STARTED|3rd Intervention||8
8450614|NCT00758394|20826324|P3|STARTED|3rd Intervention||6
8450615|NCT00758394|20826325|P2|STARTED|3rd Intervention||6
8450616|NCT00758394|20826326|P1|STARTED|3rd Intervention||8
8450617|NCT00758394|20826323|P4|NOT COMPLETED|Washout After 2nd Intervention||0
8450618|NCT00758394|20826324|P3|NOT COMPLETED|Washout After 2nd Intervention||0
8450619|NCT00758394|20826325|P2|NOT COMPLETED|Washout After 2nd Intervention||0
8450620|NCT00758394|20826326|P1|NOT COMPLETED|Washout After 2nd Intervention||0
8450621|NCT00758394|20826323|P4|COMPLETED|Washout After 2nd Intervention||8
8450622|NCT00758394|20826324|P3|COMPLETED|Washout After 2nd Intervention||6
8450623|NCT00758394|20826325|P2|COMPLETED|Washout After 2nd Intervention||6
8450624|NCT00758394|20826326|P1|COMPLETED|Washout After 2nd Intervention||8
8450625|NCT00758394|20826323|P4|STARTED|Washout After 2nd Intervention||8
8450626|NCT00758394|20826324|P3|STARTED|Washout After 2nd Intervention||6
8450627|NCT00758394|20826325|P2|STARTED|Washout After 2nd Intervention||6
8450628|NCT00758394|20826326|P1|STARTED|Washout After 2nd Intervention||8
8450629|NCT00758394|20826323|P4|NOT COMPLETED|2nd Intervention Order||0
8450630|NCT00758394|20826324|P3|NOT COMPLETED|2nd Intervention Order||0
8450631|NCT00758394|20826325|P2|NOT COMPLETED|2nd Intervention Order||1
8450632|NCT00758394|20826326|P1|NOT COMPLETED|2nd Intervention Order||0
8450633|NCT00758394|20826323|P4|COMPLETED|2nd Intervention Order||8
8450634|NCT00758394|20826324|P3|COMPLETED|2nd Intervention Order||6
8450635|NCT00758394|20826325|P2|COMPLETED|2nd Intervention Order||6
8450636|NCT00758394|20826326|P1|COMPLETED|2nd Intervention Order||8
8450637|NCT00758394|20826323|P4|STARTED|2nd Intervention Order||8
8450638|NCT00758394|20826324|P3|STARTED|2nd Intervention Order||6
8450639|NCT00758394|20826325|P2|STARTED|2nd Intervention Order||7
8450640|NCT00758394|20826326|P1|STARTED|2nd Intervention Order||8
8450641|NCT00758394|20826323|P4|NOT COMPLETED|Washout After 1st Intervention||0
8450642|NCT00758394|20826324|P3|NOT COMPLETED|Washout After 1st Intervention||0
8450643|NCT00758394|20826325|P2|NOT COMPLETED|Washout After 1st Intervention||0
8450644|NCT00758394|20826326|P1|NOT COMPLETED|Washout After 1st Intervention||0
8450645|NCT00758394|20826323|P4|COMPLETED|Washout After 1st Intervention||8
8450646|NCT00758394|20826324|P3|COMPLETED|Washout After 1st Intervention||6
8450647|NCT00758394|20826325|P2|COMPLETED|Washout After 1st Intervention||7
8450648|NCT00758394|20826326|P1|COMPLETED|Washout After 1st Intervention||8
8450649|NCT00758394|20826323|P4|STARTED|Washout After 1st Intervention||8
8450650|NCT00758394|20826324|P3|STARTED|Washout After 1st Intervention||6
8450651|NCT00758394|20826325|P2|STARTED|Washout After 1st Intervention||7
8450652|NCT00758394|20826326|P1|STARTED|Washout After 1st Intervention||8
8450653|NCT00758394|20826323|P4|NOT COMPLETED|1st Intervention||0
8450654|NCT00758394|20826324|P3|NOT COMPLETED|1st Intervention||0
8450655|NCT00758394|20826325|P2|NOT COMPLETED|1st Intervention||0
8450656|NCT00758394|20826326|P1|NOT COMPLETED|1st Intervention||0
8450657|NCT00758394|20826323|P4|COMPLETED|1st Intervention||8
8450658|NCT00758394|20826324|P3|COMPLETED|1st Intervention||6
8450659|NCT00758394|20826325|P2|COMPLETED|1st Intervention||7
8450660|NCT00758394|20826326|P1|COMPLETED|1st Intervention||8
8450661|NCT00758394|20826323|P4|STARTED|1st Intervention||8
8450662|NCT00758394|20826324|P3|STARTED|1st Intervention||6
8450663|NCT00758394|20826325|P2|STARTED|1st Intervention||7
8450664|NCT00758394|20826326|P1|STARTED|1st Intervention||8
8450665|NCT00758342|20826338|P2|NOT COMPLETED|Overall Study||1
8450666|NCT00758342|20826339|P1|NOT COMPLETED|Overall Study||4
8450667|NCT00758342|20826338|P2|COMPLETED|Overall Study||17
8450668|NCT00758342|20826339|P1|COMPLETED|Overall Study||15
8450669|NCT00758342|20826338|P2|STARTED|Overall Study||18
8450670|NCT00758342|20826339|P1|STARTED|Overall Study||19
8450671|NCT00758290|20826347|P2|NOT COMPLETED|Overall Study||0
8450672|NCT00758290|20826348|P1|NOT COMPLETED|Overall Study||0
8450673|NCT00758290|20826347|P2|COMPLETED|Overall Study||12
8450674|NCT00758290|20826348|P1|COMPLETED|Overall Study||11
8450675|NCT00758290|20826347|P2|STARTED|Overall Study||12
8450676|NCT00758290|20826348|P1|STARTED|Overall Study||11
8450677|NCT00758264|20826355|P3|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
8450678|NCT00758264|20826356|P2|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
8450679|NCT00758264|20826357|P1|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
8450680|NCT00758264|20826355|P3|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
8450681|NCT00758264|20826356|P2|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
8450682|NCT00758264|20826357|P1|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
8450683|NCT00758264|20826355|P3|STARTED|Extended Safety Follow Up (ESFU) Phase||89
8450684|NCT00758264|20826356|P2|STARTED|Extended Safety Follow Up (ESFU) Phase||90
8450685|NCT00758264|20826357|P1|STARTED|Extended Safety Follow Up (ESFU) Phase||181
8450686|NCT00758264|20826355|P3|NOT COMPLETED|Active Phase||5
8450687|NCT00758264|20826356|P2|NOT COMPLETED|Active Phase||0
8450688|NCT00758264|20826357|P1|NOT COMPLETED|Active Phase||1
8450689|NCT00758264|20826355|P3|COMPLETED|Active Phase||85
8450690|NCT00758264|20826356|P2|COMPLETED|Active Phase||91
8450691|NCT00758264|20826357|P1|COMPLETED|Active Phase||181
8450692|NCT00758264|20826355|P3|STARTED|Active Phase||90
8450693|NCT00758264|20826356|P2|STARTED|Active Phase||91
8450694|NCT00758264|20826357|P1|STARTED|Active Phase||182
8450695|NCT00758160|20826416|P1|NOT COMPLETED|Overall Study||66
8450696|NCT00758160|20826416|P1|COMPLETED|Overall Study||230
8450697|NCT00758160|20826416|P1|STARTED|Overall Study||296
8450698|NCT00758069|20826437|P3|NOT COMPLETED|Overall Study||1
8450699|NCT00758069|20826438|P2|NOT COMPLETED|Overall Study||0
8450700|NCT00758069|20826439|P1|NOT COMPLETED|Overall Study||1
8450701|NCT00758069|20826437|P3|COMPLETED|Overall Study||27
8450702|NCT00758069|20826438|P2|COMPLETED|Overall Study||25
8450703|NCT00758069|20826439|P1|COMPLETED|Overall Study||26
8450704|NCT00758069|20826437|P3|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
8450705|NCT00758069|20826438|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
8450706|NCT00758069|20826439|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
8450719|NCT00757848|20826485|P2|NOT COMPLETED|Overall Study||2
8450720|NCT00757848|20826486|P1|NOT COMPLETED|Overall Study||3
8450721|NCT00757848|20826485|P2|COMPLETED|Overall Study||27
8450722|NCT00757848|20826486|P1|COMPLETED|Overall Study||24
8450723|NCT00757848|20826485|P2|STARTED|Overall Study||29
8450724|NCT00757848|20826486|P1|STARTED|Overall Study||27
8450725|NCT00757822|20826532|P2|NOT COMPLETED|Overall Study||31
8450726|NCT00757822|20826533|P1|NOT COMPLETED|Overall Study||28
8450727|NCT00757822|20826532|P2|COMPLETED|Overall Study||57
8450728|NCT00757822|20826533|P1|COMPLETED|Overall Study||64
8450729|NCT00757822|20826532|P2|Data Lock, Unblinding Analysis|Overall Study||57
8450730|NCT00757822|20826533|P1|Data Lock, Unblinding Analysis|Overall Study||64
8450731|NCT00757822|20826532|P2|Withdrawn-protocol Deviation|Overall Study||8
8450732|NCT00757822|20826533|P1|Withdrawn-protocol Deviation|Overall Study||9
8450733|NCT00757822|20826532|P2|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
8450734|NCT00757822|20826533|P1|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
8450735|NCT00757822|20826532|P2|Data Entry, QC Assessment|Overall Study||74
8450736|NCT00757822|20826533|P1|Data Entry, QC Assessment|Overall Study||85
8450737|NCT00757822|20826532|P2|2-6 wk Post-op Assessment|Overall Study||74
8450738|NCT00757822|20826533|P1|2-6 wk Post-op Assessment|Overall Study||85
8450739|NCT00757822|20826532|P2|24-48 hr Telephone Assessment|Overall Study||74
8450740|NCT00757822|20826533|P1|24-48 hr Telephone Assessment|Overall Study||85
8450741|NCT00757822|20826532|P2|DOS: Post-operative Assessments|Overall Study||74
8450742|NCT00757822|20826533|P1|DOS: Post-operative Assessments|Overall Study||85
8450743|NCT00757822|20826532|P2|Received Study Intervention|Overall Study||74
8450744|NCT00757822|20826533|P1|Received Study Intervention|Overall Study||85
8450745|NCT00757822|20826532|P2|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
8450746|NCT00757822|20826533|P1|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
8450747|NCT00757822|20826532|P2|Withdrawal by Subject-no Intervention|Overall Study||3
8450748|NCT00757822|20826533|P1|Withdrawal by Subject-no Intervention|Overall Study||1
8450749|NCT00757822|20826532|P2|Day of Surgery (DOS) Assessment|Overall Study||88
8450750|NCT00757822|20826533|P1|Day of Surgery (DOS) Assessment|Overall Study||92
8450751|NCT00757822|20826532|P2|STARTED|Overall Study||88
8450752|NCT00757822|20826533|P1|STARTED|Overall Study||92
8450753|NCT00757783|20826555|P2|NOT COMPLETED|Overall Study||6
8450754|NCT00757783|20826556|P1|NOT COMPLETED|Overall Study||5
8450755|NCT00757783|20826555|P2|COMPLETED|Overall Study||25
8450756|NCT00757783|20826556|P1|COMPLETED|Overall Study||29
8450757|NCT00757783|20826555|P2|STARTED|Overall Study||31
8450758|NCT00757783|20826556|P1|STARTED|Overall Study||34
8450759|NCT00757705|20826592|P1|NOT COMPLETED|Overall Study||121
8450760|NCT00757705|20826592|P1|COMPLETED|Overall Study||178
8450761|NCT00757705|20826592|P1|STARTED|Overall Study||299
8450762|NCT00757666|20826606|P2|NOT COMPLETED|Overall Study||23
8450763|NCT00757666|20826607|P1|NOT COMPLETED|Overall Study||22
8450764|NCT00757666|20826606|P2|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
8450765|NCT00757666|20826607|P1|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
8450766|NCT00757666|20826606|P2|STARTED|Overall Study||34
8450767|NCT00757666|20826607|P1|STARTED|Overall Study||34
8450768|NCT00757627|20826621|P1|NOT COMPLETED|Overall Study||81
8450769|NCT00757627|20826621|P1|COMPLETED|Overall Study||419
8450770|NCT00757627|20826621|P1|STARTED|Overall Study||500
8450771|NCT00757601|20826634|P12|NOT COMPLETED|Period 5||0
8450772|NCT00757601|20826635|P11|NOT COMPLETED|Period 5||0
8450773|NCT00757601|20826636|P10|NOT COMPLETED|Period 5||0
8450774|NCT00757601|20826637|P9|NOT COMPLETED|Period 5||0
8450775|NCT00757601|20826638|P8|NOT COMPLETED|Period 5||0
8450776|NCT00757601|20826639|P7|NOT COMPLETED|Period 5||0
8450777|NCT00757601|20826640|P6|NOT COMPLETED|Period 5||0
8450778|NCT00757601|20826641|P5|NOT COMPLETED|Period 5||0
8450779|NCT00757601|20826642|P4|NOT COMPLETED|Period 5||0
8450780|NCT00757601|20826643|P3|NOT COMPLETED|Period 5||0
8450781|NCT00757601|20826644|P2|NOT COMPLETED|Period 5||0
8450782|NCT00757601|20826645|P1|NOT COMPLETED|Period 5||0
8450783|NCT00757601|20826634|P12|COMPLETED|Period 5||1
8450784|NCT00757601|20826635|P11|COMPLETED|Period 5||2
8450785|NCT00757601|20826636|P10|COMPLETED|Period 5||1
8450786|NCT00757601|20826637|P9|COMPLETED|Period 5||2
8450787|NCT00757601|20826638|P8|COMPLETED|Period 5||2
8450788|NCT00757601|20826639|P7|COMPLETED|Period 5||2
8450789|NCT00757601|20826640|P6|COMPLETED|Period 5||2
8450790|NCT00757601|20826641|P5|COMPLETED|Period 5||2
8450791|NCT00757601|20826642|P4|COMPLETED|Period 5||2
8450792|NCT00757601|20826643|P3|COMPLETED|Period 5||2
8450793|NCT00757601|20826644|P2|COMPLETED|Period 5||2
8450794|NCT00757601|20826645|P1|COMPLETED|Period 5||2
8450795|NCT00757601|20826634|P12|STARTED|Period 5||1
8450796|NCT00757601|20826635|P11|STARTED|Period 5||2
8450797|NCT00757601|20826636|P10|STARTED|Period 5||1
8450798|NCT00757601|20826637|P9|STARTED|Period 5||2
8450799|NCT00757601|20826638|P8|STARTED|Period 5||2
8450800|NCT00757601|20826639|P7|STARTED|Period 5||2
8450801|NCT00757601|20826640|P6|STARTED|Period 5||2
8450802|NCT00757601|20826641|P5|STARTED|Period 5||2
8450803|NCT00757601|20826642|P4|STARTED|Period 5||2
8450804|NCT00757601|20826643|P3|STARTED|Period 5||2
8450805|NCT00757601|20826644|P2|STARTED|Period 5||2
8450806|NCT00757601|20826645|P1|STARTED|Period 5||2
8450807|NCT00757601|20826634|P12|NOT COMPLETED|Period 4||1
8450808|NCT00757601|20826635|P11|NOT COMPLETED|Period 4||0
8450809|NCT00757601|20826636|P10|NOT COMPLETED|Period 4||1
8450810|NCT00757601|20826637|P9|NOT COMPLETED|Period 4||0
8450811|NCT00757601|20826638|P8|NOT COMPLETED|Period 4||0
8450812|NCT00757601|20826639|P7|NOT COMPLETED|Period 4||0
8450813|NCT00757601|20826640|P6|NOT COMPLETED|Period 4||0
8450814|NCT00757601|20826641|P5|NOT COMPLETED|Period 4||0
8450815|NCT00757601|20826642|P4|NOT COMPLETED|Period 4||0
8450816|NCT00757601|20826643|P3|NOT COMPLETED|Period 4||0
8450817|NCT00757601|20826644|P2|NOT COMPLETED|Period 4||0
8450818|NCT00757601|20826645|P1|NOT COMPLETED|Period 4||0
8450819|NCT00757601|20826634|P12|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
8450820|NCT00757601|20826635|P11|COMPLETED|Period 4||2
8450821|NCT00757601|20826636|P10|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
8450822|NCT00757601|20826637|P9|COMPLETED|Period 4||2
8450823|NCT00757601|20826638|P8|COMPLETED|Period 4||2
8450824|NCT00757601|20826639|P7|COMPLETED|Period 4||2
8450825|NCT00757601|20826640|P6|COMPLETED|Period 4||2
8450826|NCT00757601|20826641|P5|COMPLETED|Period 4||2
8450827|NCT00757601|20826642|P4|COMPLETED|Period 4||2
8450828|NCT00757601|20826643|P3|COMPLETED|Period 4||2
8450829|NCT00757601|20826644|P2|COMPLETED|Period 4||2
8450830|NCT00757601|20826645|P1|COMPLETED|Period 4||2
8450831|NCT00757601|20826634|P12|STARTED|Period 4||2
8450832|NCT00757601|20826635|P11|STARTED|Period 4||2
8450833|NCT00757601|20826636|P10|STARTED|Period 4||2
8450834|NCT00757601|20826637|P9|STARTED|Period 4||2
8450835|NCT00757601|20826638|P8|STARTED|Period 4||2
8450836|NCT00757601|20826639|P7|STARTED|Period 4||2
8450837|NCT00757601|20826640|P6|STARTED|Period 4||2
8450838|NCT00757601|20826641|P5|STARTED|Period 4||2
8450839|NCT00757601|20826642|P4|STARTED|Period 4||2
8450840|NCT00757601|20826643|P3|STARTED|Period 4||2
8450841|NCT00757601|20826644|P2|STARTED|Period 4||2
8450842|NCT00757601|20826645|P1|STARTED|Period 4||2
8450843|NCT00757601|20826634|P12|NOT COMPLETED|Period 3||0
8450844|NCT00757601|20826635|P11|NOT COMPLETED|Period 3||0
8450845|NCT00757601|20826636|P10|NOT COMPLETED|Period 3||0
8450846|NCT00757601|20826637|P9|NOT COMPLETED|Period 3||0
8450847|NCT00757601|20826638|P8|NOT COMPLETED|Period 3||0
8450848|NCT00757601|20826639|P7|NOT COMPLETED|Period 3||0
8450849|NCT00757601|20826640|P6|NOT COMPLETED|Period 3||0
8450850|NCT00757601|20826641|P5|NOT COMPLETED|Period 3||0
8450851|NCT00757601|20826642|P4|NOT COMPLETED|Period 3||0
8450852|NCT00757601|20826643|P3|NOT COMPLETED|Period 3||0
8450853|NCT00757601|20826644|P2|NOT COMPLETED|Period 3||0
8450854|NCT00757601|20826645|P1|NOT COMPLETED|Period 3||0
8450855|NCT00757601|20826634|P12|COMPLETED|Period 3||2
8450856|NCT00757601|20826635|P11|COMPLETED|Period 3||2
8450857|NCT00757601|20826636|P10|COMPLETED|Period 3||2
8450858|NCT00757601|20826637|P9|COMPLETED|Period 3||2
8450859|NCT00757601|20826638|P8|COMPLETED|Period 3||2
8450860|NCT00757601|20826639|P7|COMPLETED|Period 3||2
8450861|NCT00757601|20826640|P6|COMPLETED|Period 3||2
8450862|NCT00757601|20826641|P5|COMPLETED|Period 3||2
8450863|NCT00757601|20826642|P4|COMPLETED|Period 3||2
8450864|NCT00757601|20826643|P3|COMPLETED|Period 3||2
8450865|NCT00757601|20826644|P2|COMPLETED|Period 3||2
8450866|NCT00757601|20826645|P1|COMPLETED|Period 3||2
8450867|NCT00757601|20826634|P12|STARTED|Period 3||2
8450868|NCT00757601|20826635|P11|STARTED|Period 3||2
8450869|NCT00757601|20826636|P10|STARTED|Period 3||2
8450870|NCT00757601|20826637|P9|STARTED|Period 3||2
8450871|NCT00757601|20826638|P8|STARTED|Period 3||2
8450872|NCT00757601|20826639|P7|STARTED|Period 3||2
8450873|NCT00757601|20826640|P6|STARTED|Period 3||2
8450874|NCT00757601|20826641|P5|STARTED|Period 3||2
8450875|NCT00757601|20826642|P4|STARTED|Period 3||2
8450876|NCT00757601|20826643|P3|STARTED|Period 3||2
8450877|NCT00757601|20826644|P2|STARTED|Period 3||2
8450878|NCT00757601|20826645|P1|STARTED|Period 3||2
8450879|NCT00757601|20826634|P12|NOT COMPLETED|Period 2||1
8450880|NCT00757601|20826635|P11|NOT COMPLETED|Period 2||0
8450881|NCT00757601|20826636|P10|NOT COMPLETED|Period 2||0
8450882|NCT00757601|20826637|P9|NOT COMPLETED|Period 2||0
8450883|NCT00757601|20826638|P8|NOT COMPLETED|Period 2||0
8450884|NCT00757601|20826639|P7|NOT COMPLETED|Period 2||0
8450885|NCT00757601|20826640|P6|NOT COMPLETED|Period 2||0
8450886|NCT00757601|20826641|P5|NOT COMPLETED|Period 2||0
8450887|NCT00757601|20826642|P4|NOT COMPLETED|Period 2||0
8450888|NCT00757601|20826643|P3|NOT COMPLETED|Period 2||0
8450889|NCT00757601|20826644|P2|NOT COMPLETED|Period 2||0
8450890|NCT00757601|20826645|P1|NOT COMPLETED|Period 2||0
8450891|NCT00757601|20826634|P12|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
8450892|NCT00757601|20826635|P11|COMPLETED|Period 2||2
8450893|NCT00757601|20826636|P10|COMPLETED|Period 2||2
8450894|NCT00757601|20826637|P9|COMPLETED|Period 2||2
8450895|NCT00757601|20826638|P8|COMPLETED|Period 2||2
8450896|NCT00757601|20826639|P7|COMPLETED|Period 2||2
8450897|NCT00757601|20826640|P6|COMPLETED|Period 2||2
8450898|NCT00757601|20826641|P5|COMPLETED|Period 2||2
8450899|NCT00757601|20826642|P4|COMPLETED|Period 2||2
8450900|NCT00757601|20826643|P3|COMPLETED|Period 2||2
8450901|NCT00757601|20826644|P2|COMPLETED|Period 2||2
8450902|NCT00757601|20826645|P1|COMPLETED|Period 2||2
8450903|NCT00757601|20826634|P12|STARTED|Period 2||3
8450904|NCT00757601|20826635|P11|STARTED|Period 2||2
8450905|NCT00757601|20826636|P10|STARTED|Period 2||2
8450906|NCT00757601|20826637|P9|STARTED|Period 2||2
8450907|NCT00757601|20826638|P8|STARTED|Period 2||2
8450908|NCT00757601|20826639|P7|STARTED|Period 2||2
8450909|NCT00757601|20826640|P6|STARTED|Period 2||2
8450910|NCT00757601|20826641|P5|STARTED|Period 2||2
8450911|NCT00757601|20826642|P4|STARTED|Period 2||2
8450912|NCT00757601|20826643|P3|STARTED|Period 2||2
8450913|NCT00757601|20826644|P2|STARTED|Period 2||2
8450914|NCT00757601|20826645|P1|STARTED|Period 2||2
8450915|NCT00757601|20826634|P12|NOT COMPLETED|Period 1||0
8450916|NCT00757601|20826635|P11|NOT COMPLETED|Period 1||0
8450917|NCT00757601|20826636|P10|NOT COMPLETED|Period 1||0
8450918|NCT00757601|20826637|P9|NOT COMPLETED|Period 1||0
8450919|NCT00757601|20826638|P8|NOT COMPLETED|Period 1||0
8450920|NCT00757601|20826639|P7|NOT COMPLETED|Period 1||0
8450921|NCT00757601|20826640|P6|NOT COMPLETED|Period 1||0
8450922|NCT00757601|20826641|P5|NOT COMPLETED|Period 1||0
8450923|NCT00757601|20826642|P4|NOT COMPLETED|Period 1||0
8450924|NCT00757601|20826643|P3|NOT COMPLETED|Period 1||0
8450925|NCT00757601|20826644|P2|NOT COMPLETED|Period 1||0
8450926|NCT00757601|20826645|P1|NOT COMPLETED|Period 1||0
8450927|NCT00757601|20826634|P12|COMPLETED|Period 1||3
8450928|NCT00757601|20826635|P11|COMPLETED|Period 1||2
8450929|NCT00757601|20826636|P10|COMPLETED|Period 1||2
8450930|NCT00757601|20826637|P9|COMPLETED|Period 1||2
8450931|NCT00757601|20826638|P8|COMPLETED|Period 1||2
8450932|NCT00757601|20826639|P7|COMPLETED|Period 1||2
8450933|NCT00757601|20826640|P6|COMPLETED|Period 1||2
8450934|NCT00757601|20826641|P5|COMPLETED|Period 1||2
8450935|NCT00757601|20826642|P4|COMPLETED|Period 1||2
8450936|NCT00757601|20826643|P3|COMPLETED|Period 1||2
8450937|NCT00757601|20826644|P2|COMPLETED|Period 1||2
8450938|NCT00757601|20826645|P1|COMPLETED|Period 1||2
8450939|NCT00757601|20826634|P12|STARTED|Period 1||3
8450940|NCT00757601|20826635|P11|STARTED|Period 1||2
8450941|NCT00757601|20826636|P10|STARTED|Period 1||2
8450942|NCT00757601|20826637|P9|STARTED|Period 1||2
8450943|NCT00757601|20826638|P8|STARTED|Period 1||2
8450944|NCT00757601|20826639|P7|STARTED|Period 1||2
8450945|NCT00757601|20826640|P6|STARTED|Period 1||2
8450946|NCT00757601|20826641|P5|STARTED|Period 1||2
8450947|NCT00757601|20826642|P4|STARTED|Period 1||2
8450948|NCT00757601|20826643|P3|STARTED|Period 1||2
8450949|NCT00757601|20826644|P2|STARTED|Period 1||2
8450950|NCT00757601|20826645|P1|STARTED|Period 1||2
8450951|NCT00757588|20826756|P2|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
8450952|NCT00757588|20826757|P1|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
8450953|NCT00757588|20826756|P2|COMPLETED|Period 2: Long-term (52-week) Phase||125
8450954|NCT00757588|20826757|P1|COMPLETED|Period 2: Long-term (52-week) Phase||246
8450955|NCT00757588|20826756|P2|STARTED|Period 2: Long-term (52-week) Phase||134
8450956|NCT00757588|20826757|P1|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
8450957|NCT00757588|20826756|P2|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
8450958|NCT00757588|20826757|P1|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
8450959|NCT00757588|20826756|P2|COMPLETED|Period 1: Short-term (24-week) Phase||134
8450960|NCT00757588|20826757|P1|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
8450961|NCT00757588|20826756|P2|STARTED|Period 1: Short-term (24-week) Phase||151
8450962|NCT00757588|20826757|P1|STARTED|Period 1: Short-term (24-week) Phase||304
8450963|NCT00757484|20826789|P1|NOT COMPLETED|Overall Study||0
8450964|NCT00757484|20826789|P1|COMPLETED|Overall Study||491
8450965|NCT00757484|20826789|P1|STARTED|Overall Study||491
8450966|NCT00757237|20826798|P2|NOT COMPLETED|Overall Study||25
8450967|NCT00757237|20826799|P1|NOT COMPLETED|Overall Study||13
8450968|NCT00757237|20826798|P2|COMPLETED|Overall Study||111
8450969|NCT00757237|20826799|P1|COMPLETED|Overall Study||124
8450970|NCT00757237|20826798|P2|Treated|Overall Study||132
8450971|NCT00757237|20826799|P1|Treated|Overall Study||136
8450972|NCT00757237|20826798|P2|STARTED|Overall Study||136
8450973|NCT00757237|20826799|P1|STARTED|Overall Study||137
8450974|NCT00757172|20826827|P1|NOT COMPLETED|Overall Study||11
8450975|NCT00757172|20826827|P1|COMPLETED|Overall Study|Participants underwent surgery.|54
8450976|NCT00757172|20826827|P1|STARTED|Overall Study||65
8450977|NCT00757003|20826835|P1|NOT COMPLETED|Overall Study||49
8450978|NCT00757003|20826835|P1|COMPLETED|Overall Study||51
8450979|NCT00757003|20826835|P1|STARTED|Overall Study||100
8450980|NCT00756977|20826843|P2|NOT COMPLETED|Overall Study||11
8450981|NCT00756977|20826844|P1|NOT COMPLETED|Overall Study||21
8450982|NCT00756977|20826843|P2|COMPLETED|Overall Study||187
8450983|NCT00756977|20826844|P1|COMPLETED|Overall Study||175
8450984|NCT00756977|20826843|P2|STARTED|Overall Study||198
8450985|NCT00756977|20826844|P1|STARTED|Overall Study||196
8450986|NCT00756964|20826872|P2|NOT COMPLETED|Overall Study||0
8450987|NCT00756964|20826873|P1|NOT COMPLETED|Overall Study||0
8450988|NCT00756964|20826872|P2|COMPLETED|Overall Study||13
8450989|NCT00756964|20826873|P1|COMPLETED|Overall Study||13
8450990|NCT00756964|20826872|P2|STARTED|Overall Study||13
8450991|NCT00756964|20826873|P1|STARTED|Overall Study||13
8450992|NCT00756938|20826882|P4|NOT COMPLETED|Optional Extension||37
8450993|NCT00756938|20826883|P3|NOT COMPLETED|Optional Extension||0
8450994|NCT00756938|20826884|P2|NOT COMPLETED|Optional Extension||0
8450995|NCT00756938|20826885|P1|NOT COMPLETED|Optional Extension||0
8450996|NCT00756938|20826882|P4|COMPLETED|Optional Extension||53
8450997|NCT00756938|20826883|P3|COMPLETED|Optional Extension||0
8450998|NCT00756938|20826884|P2|COMPLETED|Optional Extension||0
8450999|NCT00756938|20826885|P1|COMPLETED|Optional Extension||0
8451000|NCT00756938|20826882|P4|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
8451001|NCT00756938|20826883|P3|STARTED|Optional Extension||0
8451002|NCT00756938|20826884|P2|STARTED|Optional Extension||0
8451003|NCT00756938|20826885|P1|STARTED|Optional Extension||0
8451004|NCT00756938|20826882|P4|NOT COMPLETED|12-week Base Study||0
8451005|NCT00756938|20826883|P3|NOT COMPLETED|12-week Base Study||2
8451006|NCT00756938|20826884|P2|NOT COMPLETED|12-week Base Study||0
8451007|NCT00756938|20826885|P1|NOT COMPLETED|12-week Base Study||2
8451008|NCT00756938|20826882|P4|COMPLETED|12-week Base Study||0
8451009|NCT00756938|20826883|P3|COMPLETED|12-week Base Study||32
8451010|NCT00756938|20826884|P2|COMPLETED|12-week Base Study||34
8451011|NCT00756938|20826885|P1|COMPLETED|12-week Base Study||31
8451012|NCT00756938|20826882|P4|STARTED|12-week Base Study||0
8451013|NCT00756938|20826883|P3|STARTED|12-week Base Study||34
8451014|NCT00756938|20826884|P2|STARTED|12-week Base Study||34
8451015|NCT00756938|20826885|P1|STARTED|12-week Base Study||33
8451016|NCT00756886|20826913|P2|NOT COMPLETED|Overall Study||7
8451017|NCT00756886|20826914|P1|NOT COMPLETED|Overall Study||11
8451018|NCT00756886|20826913|P2|COMPLETED|Overall Study||25
8451019|NCT00756886|20826914|P1|COMPLETED|Overall Study||30
8451020|NCT00756886|20826913|P2|STARTED|Overall Study||32
8451021|NCT00756886|20826914|P1|STARTED|Overall Study||41
8451022|NCT00756730|20826922|P2|NOT COMPLETED|Overall Study||2
8451023|NCT00756730|20826923|P1|NOT COMPLETED|Overall Study||0
8451024|NCT00756730|20826922|P2|COMPLETED|Overall Study||22
8451025|NCT00756730|20826923|P1|COMPLETED|Overall Study||25
8451026|NCT00756730|20826922|P2|STARTED|Overall Study||24
8451027|NCT00756730|20826923|P1|STARTED|Overall Study||25
8451028|NCT00756717|20826943|P1|NOT COMPLETED|Overall Study||2
8451029|NCT00756717|20826943|P1|COMPLETED|Overall Study||20
8451030|NCT00756717|20826943|P1|STARTED|Overall Study||22
8451031|NCT00756678|20826947|P1|NOT COMPLETED|Overall Study||1
8451032|NCT00756678|20826947|P1|COMPLETED|Overall Study||50
8451033|NCT00756678|20826947|P1|STARTED|Overall Study||51
8451034|NCT00756652|20826960|P2|NOT COMPLETED|Re-Op Phase||0
8451035|NCT00756652|20826961|P1|NOT COMPLETED|Re-Op Phase||2876
8451036|NCT00756652|20826960|P2|COMPLETED|Re-Op Phase||0
8451037|NCT00756652|20826961|P1|COMPLETED|Re-Op Phase||8225
8451038|NCT00756652|20826960|P2|STARTED|Re-Op Phase|NA - The Re-Op Phase was limited in scope to data collection for only MemoryGel participants.|0
8451039|NCT00756652|20826961|P1|STARTED|Re-Op Phase||11101
8451040|NCT00756652|20826960|P2|NOT COMPLETED|Original Phase||921
8451041|NCT00756652|20826961|P1|NOT COMPLETED|Original Phase||35389
8451042|NCT00756652|20826960|P2|COMPLETED|Original Phase||118
8451043|NCT00756652|20826961|P1|COMPLETED|Original Phase|At Year 7|6063
8451044|NCT00756652|20826960|P2|STARTED|Original Phase||1039
8451045|NCT00756652|20826961|P1|STARTED|Original Phase||41452
8451046|NCT00756613|20826969|P2|NOT COMPLETED|Overall Study||70
8451047|NCT00756613|20826970|P1|NOT COMPLETED|Overall Study||86
8451048|NCT00756613|20826969|P2|COMPLETED|Overall Study||462
8451049|NCT00756613|20826970|P1|COMPLETED|Overall Study||426
8451050|NCT00756613|20826969|P2|STARTED|Overall Study||532
8451051|NCT00756613|20826970|P1|STARTED|Overall Study||512
8451052|NCT00756600|20826985|P2|NOT COMPLETED|Overall Study||0
8451053|NCT00756600|20826986|P1|NOT COMPLETED|Overall Study||0
8451054|NCT00756600|20826985|P2|COMPLETED|Overall Study||356
8451055|NCT00756600|20826986|P1|COMPLETED|Overall Study||287
8451056|NCT00756600|20826985|P2|STARTED|Overall Study||356
8451057|NCT00756600|20826986|P1|STARTED|Overall Study||287
8451058|NCT00756574|20827072|P2|NOT COMPLETED|Overall Study||11
8451059|NCT00756574|20827073|P1|NOT COMPLETED|Overall Study||13
8451060|NCT00756574|20827072|P2|COMPLETED|Overall Study||210
8451061|NCT00756574|20827073|P1|COMPLETED|Overall Study||212
8451062|NCT00756574|20827072|P2|STARTED|Overall Study||221
8451063|NCT00756574|20827073|P1|STARTED|Overall Study||225
8451064|NCT00756561|20827083|P1|NOT COMPLETED|Overall Study||0
8451065|NCT00756561|20827083|P1|COMPLETED|Overall Study||10
8451066|NCT00756561|20827083|P1|STARTED|Overall Study||10
8451067|NCT00756548|20827090|P2|NOT COMPLETED|Overall Study||0
8451068|NCT00756548|20827091|P1|NOT COMPLETED|Overall Study||2
8451069|NCT00756548|20827090|P2|COMPLETED|Overall Study||185
8451070|NCT00756548|20827091|P1|COMPLETED|Overall Study||184
8451071|NCT00756548|20827090|P2|STARTED|Overall Study||185
8451072|NCT00756548|20827091|P1|STARTED|Overall Study||186
8451073|NCT00756496|20827117|P1|NOT COMPLETED|Overall Study||0
8451074|NCT00756496|20827117|P1|COMPLETED|Overall Study||442
8451075|NCT00756496|20827117|P1|STARTED|Overall Study||442
8451076|NCT00756470|20827122|P1|NOT COMPLETED|Overall Study||5
8451077|NCT00756470|20827122|P1|COMPLETED|Overall Study||10
8451078|NCT00756470|20827122|P1|STARTED|Overall Study||15
8451079|NCT00756457|20827129|P2|NOT COMPLETED|Overall Study||2
8451080|NCT00756457|20827130|P1|NOT COMPLETED|Overall Study||1
8451081|NCT00756457|20827129|P2|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
8451082|NCT00756457|20827130|P1|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
8451083|NCT00756457|20827129|P2|STARTED|Overall Study||19
8451084|NCT00756457|20827130|P1|STARTED|Overall Study||20
8451085|NCT00756444|20827160|P2|NOT COMPLETED|Overall Study||21
8451086|NCT00756444|20827161|P1|NOT COMPLETED|Overall Study||15
8451087|NCT00756444|20827160|P2|COMPLETED|Overall Study||13
8451088|NCT00756444|20827161|P1|COMPLETED|Overall Study||18
8451089|NCT00756444|20827160|P2|STARTED|Overall Study||34
8451090|NCT00756444|20827161|P1|STARTED|Overall Study||33
8451091|NCT00756314|20827172|P2|NOT COMPLETED|Overall Study||59
8451092|NCT00756314|20827173|P1|NOT COMPLETED|Overall Study||2
8451093|NCT00756314|20827172|P2|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
8451094|NCT00756314|20827173|P1|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
8451095|NCT00756314|20827172|P2|STARTED|Overall Study||123
8451096|NCT00756314|20827173|P1|STARTED|Overall Study||123
8451097|NCT00756275|20827189|P2|NOT COMPLETED|Overall Study||28
8451098|NCT00756275|20827190|P1|NOT COMPLETED|Overall Study||29
8451099|NCT00756275|20827189|P2|COMPLETED|Overall Study||49
8451100|NCT00756275|20827190|P1|COMPLETED|Overall Study||31
8451101|NCT00756275|20827189|P2|STARTED|Overall Study||77
8451102|NCT00756275|20827190|P1|STARTED|Overall Study||60
8451103|NCT00756236|20827217|P3|NOT COMPLETED|Overall Study||0
8451104|NCT00756236|20827218|P2|NOT COMPLETED|Overall Study||0
8451105|NCT00756236|20827219|P1|NOT COMPLETED|Overall Study||0
8451106|NCT00756236|20827217|P3|COMPLETED|Overall Study||20
8451107|NCT00756236|20827218|P2|COMPLETED|Overall Study||20
8451108|NCT00756236|20827219|P1|COMPLETED|Overall Study||20
8451109|NCT00756236|20827217|P3|STARTED|Overall Study||20
8451110|NCT00756236|20827218|P2|STARTED|Overall Study||20
8451111|NCT00756236|20827219|P1|STARTED|Overall Study||20
8451112|NCT00756106|20827227|P1|NOT COMPLETED|Overall Study||12
8451113|NCT00756106|20827227|P1|COMPLETED|Overall Study||3
8451114|NCT00756106|20827227|P1|STARTED|Overall Study||15
8451115|NCT00756093|20827239|P4|NOT COMPLETED|Fourth Intervention||0
8451116|NCT00756093|20827240|P3|NOT COMPLETED|Fourth Intervention||0
8451117|NCT00756093|20827241|P2|NOT COMPLETED|Fourth Intervention||0
8451118|NCT00756093|20827242|P1|NOT COMPLETED|Fourth Intervention||0
8451119|NCT00756093|20827239|P4|COMPLETED|Fourth Intervention||5
8451120|NCT00756093|20827240|P3|COMPLETED|Fourth Intervention||5
8451121|NCT00756093|20827241|P2|COMPLETED|Fourth Intervention||5
8451122|NCT00756093|20827242|P1|COMPLETED|Fourth Intervention||5
8451123|NCT00756093|20827239|P4|STARTED|Fourth Intervention||5
8451124|NCT00756093|20827240|P3|STARTED|Fourth Intervention||5
8451125|NCT00756093|20827241|P2|STARTED|Fourth Intervention||5
8451126|NCT00756093|20827242|P1|STARTED|Fourth Intervention||5
8451127|NCT00756093|20827239|P4|NOT COMPLETED|Third Intervention||0
8451128|NCT00756093|20827240|P3|NOT COMPLETED|Third Intervention||0
8451129|NCT00756093|20827241|P2|NOT COMPLETED|Third Intervention||0
8451130|NCT00756093|20827242|P1|NOT COMPLETED|Third Intervention||0
8451131|NCT00756093|20827239|P4|COMPLETED|Third Intervention||5
8451132|NCT00756093|20827240|P3|COMPLETED|Third Intervention||5
8451133|NCT00756093|20827241|P2|COMPLETED|Third Intervention||5
8451134|NCT00756093|20827242|P1|COMPLETED|Third Intervention||5
8451135|NCT00756093|20827239|P4|STARTED|Third Intervention||5
8451136|NCT00756093|20827240|P3|STARTED|Third Intervention||5
8451137|NCT00756093|20827241|P2|STARTED|Third Intervention||5
8451138|NCT00756093|20827242|P1|STARTED|Third Intervention||5
8451139|NCT00756093|20827239|P4|NOT COMPLETED|Second Intervention||0
8451140|NCT00756093|20827240|P3|NOT COMPLETED|Second Intervention||0
8451141|NCT00756093|20827241|P2|NOT COMPLETED|Second Intervention||0
8451142|NCT00756093|20827242|P1|NOT COMPLETED|Second Intervention||0
8451143|NCT00756093|20827239|P4|COMPLETED|Second Intervention||5
8451144|NCT00756093|20827240|P3|COMPLETED|Second Intervention||5
8451145|NCT00756093|20827241|P2|COMPLETED|Second Intervention||5
8451146|NCT00756093|20827242|P1|COMPLETED|Second Intervention||5
8451147|NCT00756093|20827239|P4|STARTED|Second Intervention||5
8451148|NCT00756093|20827240|P3|STARTED|Second Intervention||5
8451149|NCT00756093|20827241|P2|STARTED|Second Intervention||5
8451150|NCT00756093|20827242|P1|STARTED|Second Intervention||5
8451151|NCT00756093|20827239|P4|NOT COMPLETED|First Intervention||0
8451152|NCT00756093|20827240|P3|NOT COMPLETED|First Intervention||0
8451153|NCT00756093|20827241|P2|NOT COMPLETED|First Intervention||0
8451154|NCT00756093|20827242|P1|NOT COMPLETED|First Intervention||0
8451155|NCT00756093|20827239|P4|COMPLETED|First Intervention||5
8451156|NCT00756093|20827240|P3|COMPLETED|First Intervention||5
8451157|NCT00756093|20827241|P2|COMPLETED|First Intervention||5
8451158|NCT00756093|20827242|P1|COMPLETED|First Intervention||5
8451159|NCT00756093|20827239|P4|STARTED|First Intervention||5
8451160|NCT00756093|20827240|P3|STARTED|First Intervention||5
8451161|NCT00756093|20827241|P2|STARTED|First Intervention||5
8451162|NCT00756093|20827242|P1|STARTED|First Intervention||5
8451163|NCT00756002|20827254|P2|NOT COMPLETED|Placebo Run-out||0
8451164|NCT00756002|20827255|P1|NOT COMPLETED|Placebo Run-out||0
8451165|NCT00756002|20827254|P2|COMPLETED|Placebo Run-out||0
8451166|NCT00756002|20827255|P1|COMPLETED|Placebo Run-out||114
8451167|NCT00756002|20827254|P2|STARTED|Placebo Run-out||0
8451168|NCT00756002|20827255|P1|STARTED|Placebo Run-out||114
8451169|NCT00756002|20827254|P2|NOT COMPLETED|Double-Blind Treatment Period||15
8451170|NCT00756002|20827255|P1|NOT COMPLETED|Double-Blind Treatment Period||15
8451171|NCT00756002|20827254|P2|COMPLETED|Double-Blind Treatment Period||115
8451172|NCT00756002|20827255|P1|COMPLETED|Double-Blind Treatment Period||114
8451173|NCT00756002|20827254|P2|STARTED|Double-Blind Treatment Period||130
8451174|NCT00756002|20827255|P1|STARTED|Double-Blind Treatment Period||129
8451175|NCT00756002|20827254|P2|NOT COMPLETED|Placebo Run-in||0
8451176|NCT00756002|20827255|P1|NOT COMPLETED|Placebo Run-in||229
8451177|NCT00756002|20827254|P2|COMPLETED|Placebo Run-in||0
8451178|NCT00756002|20827255|P1|COMPLETED|Placebo Run-in||259
8451179|NCT00756002|20827254|P2|STARTED|Placebo Run-in||0
8451180|NCT00756002|20827255|P1|STARTED|Placebo Run-in||488
8451181|NCT00755937|20827349|P1|NOT COMPLETED|Observational Follow-up||148
8451182|NCT00755937|20827349|P1|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
8451183|NCT00755937|20827349|P1|STARTED|Observational Follow-up||392
8451184|NCT00755937|20827349|P1|NOT COMPLETED|Recruitment||164
8451185|NCT00755937|20827349|P1|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
8451186|NCT00755937|20827349|P1|STARTED|Recruitment|Subjects registered in the program|556
8451187|NCT00755911|20827361|P2|NOT COMPLETED|Overall Study||0
8451188|NCT00755911|20827362|P1|NOT COMPLETED|Overall Study||0
8451189|NCT00755911|20827361|P2|COMPLETED|Overall Study||12
8451190|NCT00755911|20827362|P1|COMPLETED|Overall Study||12
8451191|NCT00755911|20827361|P2|STARTED|Overall Study||12
8451192|NCT00755911|20827362|P1|STARTED|Overall Study||12
8451193|NCT00755846|20827376|P6|NOT COMPLETED|Overall Study||14
8451194|NCT00755846|20827377|P5|NOT COMPLETED|Overall Study||17
8451195|NCT00755846|20827378|P4|NOT COMPLETED|Overall Study||13
8451196|NCT00755846|20827379|P3|NOT COMPLETED|Overall Study||12
8451197|NCT00755846|20827380|P2|NOT COMPLETED|Overall Study||17
8451198|NCT00755846|20827381|P1|NOT COMPLETED|Overall Study||25
8451199|NCT00755846|20827376|P6|COMPLETED|Overall Study||31
8451200|NCT00755846|20827377|P5|COMPLETED|Overall Study||27
8451201|NCT00755846|20827378|P4|COMPLETED|Overall Study||32
8451202|NCT00755846|20827379|P3|COMPLETED|Overall Study||32
8451203|NCT00755846|20827380|P2|COMPLETED|Overall Study||27
8451204|NCT00755846|20827381|P1|COMPLETED|Overall Study||18
8451205|NCT00755846|20827376|P6|STARTED|Overall Study||45
8451206|NCT00755846|20827377|P5|STARTED|Overall Study||44
8451207|NCT00755846|20827378|P4|STARTED|Overall Study||45
8451208|NCT00755846|20827379|P3|STARTED|Overall Study||44
8451209|NCT00755846|20827380|P2|STARTED|Overall Study||44
8451210|NCT00755846|20827381|P1|STARTED|Overall Study||43
8451211|NCT00755807|20827481|P2|NOT COMPLETED|Open-label Extension Phase||16
8451212|NCT00755807|20827482|P1|NOT COMPLETED|Open-label Extension Phase||18
8451213|NCT00755807|20827481|P2|COMPLETED|Open-label Extension Phase||93
8451214|NCT00755807|20827482|P1|COMPLETED|Open-label Extension Phase||82
8451215|NCT00755807|20827481|P2|STARTED|Open-label Extension Phase||109
8451216|NCT00755807|20827482|P1|STARTED|Open-label Extension Phase||100
8451217|NCT00755807|20827481|P2|NOT COMPLETED|Acute Phase||12
8451218|NCT00755807|20827482|P1|NOT COMPLETED|Acute Phase||18
8451219|NCT00755807|20827481|P2|COMPLETED|Acute Phase||109
8451220|NCT00755807|20827482|P1|COMPLETED|Acute Phase||100
8451221|NCT00755807|20827481|P2|STARTED|Acute Phase||121
8451222|NCT00755807|20827482|P1|STARTED|Acute Phase||118
8451223|NCT00755755|20827546|P3|NOT COMPLETED|Overall Study||3
8451224|NCT00755755|20827547|P2|NOT COMPLETED|Overall Study||8
8451225|NCT00755755|20827548|P1|NOT COMPLETED|Overall Study||6
8451226|NCT00755755|20827546|P3|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
8451227|NCT00755755|20827547|P2|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
8451228|NCT00755755|20827548|P1|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
8451229|NCT00755755|20827546|P3|STARTED|Overall Study|Safety population|48
8451230|NCT00755755|20827547|P2|STARTED|Overall Study|Safety population|98
8451231|NCT00755755|20827548|P1|STARTED|Overall Study|Safety population|95
8451232|NCT00755716|20827562|P3|NOT COMPLETED|Overall Study||3
8451233|NCT00755716|20827563|P2|NOT COMPLETED|Overall Study||8
8451234|NCT00755716|20827564|P1|NOT COMPLETED|Overall Study||8
8451235|NCT00755716|20827562|P3|COMPLETED|Overall Study||16
8451236|NCT00755716|20827563|P2|COMPLETED|Overall Study||11
8451237|NCT00755716|20827564|P1|COMPLETED|Overall Study||11
8451238|NCT00755716|20827562|P3|STARTED|Overall Study||19
8451239|NCT00755716|20827563|P2|STARTED|Overall Study||19
8451240|NCT00755716|20827564|P1|STARTED|Overall Study||19
8451241|NCT00755417|20827578|P3|NOT COMPLETED|Overall Study||42
8451242|NCT00755417|20827579|P2|NOT COMPLETED|Overall Study||55
8451243|NCT00755417|20827580|P1|NOT COMPLETED|Overall Study||62
8451244|NCT00755417|20827578|P3|COMPLETED|Overall Study||135
8451245|NCT00755417|20827579|P2|COMPLETED|Overall Study||126
8451246|NCT00755417|20827580|P1|COMPLETED|Overall Study||112
8451247|NCT00755417|20827578|P3|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
8451248|NCT00755417|20827579|P2|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
8451249|NCT00755417|20827580|P1|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
8451250|NCT00755326|20827599|P2|NOT COMPLETED|Overall Study||3
8451251|NCT00755326|20827600|P1|NOT COMPLETED|Overall Study||2
8451252|NCT00755326|20827599|P2|COMPLETED|Overall Study||42
8451253|NCT00755326|20827600|P1|COMPLETED|Overall Study||45
8451254|NCT00755326|20827599|P2|STARTED|Overall Study||45
8451255|NCT00755326|20827600|P1|STARTED|Overall Study||47
8451256|NCT00755274|20827612|P2|NOT COMPLETED|Overall Study||0
8451257|NCT00755274|20827613|P1|NOT COMPLETED|Overall Study||0
8451258|NCT00755274|20827612|P2|COMPLETED|Overall Study||8
8451259|NCT00755274|20827613|P1|COMPLETED|Overall Study||24
8451260|NCT00755274|20827612|P2|STARTED|Overall Study||8
8451261|NCT00755274|20827613|P1|STARTED|Overall Study||24
8451262|NCT00755261|20827633|P1|NOT COMPLETED|Overall Study||2
8451263|NCT00755261|20827633|P1|COMPLETED|Overall Study||4
8451264|NCT00755261|20827633|P1|STARTED|Overall Study||6
8451265|NCT00755235|20827639|P2|NOT COMPLETED|Overall Study||9
8451266|NCT00755235|20827640|P1|NOT COMPLETED|Overall Study||2
8451267|NCT00755235|20827639|P2|COMPLETED|Overall Study||93
8451268|NCT00755235|20827640|P1|COMPLETED|Overall Study||104
8451269|NCT00755235|20827639|P2|STARTED|Overall Study||102
8451270|NCT00755235|20827640|P1|STARTED|Overall Study||106
8451271|NCT00755222|20827650|P2|NOT COMPLETED|Overall Study||2
8451272|NCT00755222|20827651|P1|NOT COMPLETED|Overall Study||8
8451273|NCT00755222|20827650|P2|COMPLETED|Overall Study||34
8451274|NCT00755222|20827651|P1|COMPLETED|Overall Study||103
8451275|NCT00755222|20827650|P2|STARTED|Overall Study||36
8451276|NCT00755222|20827651|P1|STARTED|Overall Study||111
8451277|NCT00755196|20827665|P1|NOT COMPLETED|Overall Study||2
8451278|NCT00755196|20827665|P1|COMPLETED|Overall Study||28
8451279|NCT00755196|20827665|P1|STARTED|Overall Study||30
8451280|NCT00755183|20827672|P2|NOT COMPLETED|Overall Study||6
8451281|NCT00755183|20827673|P1|NOT COMPLETED|Overall Study||7
8451282|NCT00755183|20827672|P2|COMPLETED|Overall Study||24
8451283|NCT00755183|20827673|P1|COMPLETED|Overall Study||23
8451284|NCT00755183|20827672|P2|STARTED|Overall Study||30
8451285|NCT00755183|20827673|P1|STARTED|Overall Study||30
8451286|NCT00755131|20827683|P2|NOT COMPLETED|Overall Study||0
8451287|NCT00755131|20827684|P1|NOT COMPLETED|Overall Study||0
8451288|NCT00755131|20827683|P2|COMPLETED|Overall Study||38
8451289|NCT00755131|20827684|P1|COMPLETED|Overall Study||37
8451290|NCT00755131|20827683|P2|STARTED|Overall Study||38
8451291|NCT00755131|20827684|P1|STARTED|Overall Study||37
8451292|NCT00755105|20827697|P3|NOT COMPLETED|Overall Study||4
8451293|NCT00755105|20827698|P2|NOT COMPLETED|Overall Study||11
8451294|NCT00755105|20827699|P1|NOT COMPLETED|Overall Study||9
8451295|NCT00755105|20827697|P3|COMPLETED|Overall Study||5
8451296|NCT00755105|20827698|P2|COMPLETED|Overall Study||19
8451297|NCT00755105|20827699|P1|COMPLETED|Overall Study||29
8451298|NCT00755105|20827697|P3|STARTED|Overall Study||9
8451299|NCT00755105|20827698|P2|STARTED|Overall Study||30
8451300|NCT00755105|20827699|P1|STARTED|Overall Study||38
8451301|NCT00755079|20827709|P2|NOT COMPLETED|Overall Study||6
8451302|NCT00755079|20827710|P1|NOT COMPLETED|Overall Study||1
8451303|NCT00755079|20827709|P2|COMPLETED|Overall Study||16
8451304|NCT00755079|20827710|P1|COMPLETED|Overall Study||17
8451305|NCT00755079|20827709|P2|STARTED|Overall Study||22
8451306|NCT00755079|20827710|P1|STARTED|Overall Study||18
8451307|NCT00755040|20827720|P2|NOT COMPLETED|Overall Study||34
8451308|NCT00755040|20827721|P1|NOT COMPLETED|Overall Study||43
8451309|NCT00755040|20827720|P2|COMPLETED|Overall Study||47
8451310|NCT00755040|20827721|P1|COMPLETED|Overall Study||40
8451311|NCT00755040|20827720|P2|STARTED|Overall Study||81
8451312|NCT00755040|20827721|P1|STARTED|Overall Study||83
8451313|NCT00754936|20827729|P1|NOT COMPLETED|Overall Study||12
8451314|NCT00754936|20827729|P1|COMPLETED|Overall Study||59
8451315|NCT00754936|20827729|P1|STARTED|Overall Study||71
8451316|NCT00754923|20827734|P1|NOT COMPLETED|Overall Study||0
8451317|NCT00754923|20827734|P1|COMPLETED|Overall Study||11
8451318|NCT00754923|20827734|P1|STARTED|Overall Study||11
8451319|NCT00754845|20827743|P2|NOT COMPLETED|Overall Study||0
8451320|NCT00754845|20827744|P1|NOT COMPLETED|Overall Study||0
8451321|NCT00754845|20827743|P2|COMPLETED|Overall Study||959
8451322|NCT00754845|20827744|P1|COMPLETED|Overall Study||959
8451323|NCT00754845|20827743|P2|STARTED|Overall Study||959
8451324|NCT00754845|20827744|P1|STARTED|Overall Study||959
8451325|NCT00754832|20827756|P2|NOT COMPLETED|Second 6 Weeks Intervention||2
8451326|NCT00754832|20827757|P1|NOT COMPLETED|Second 6 Weeks Intervention||0
8451327|NCT00754832|20827756|P2|COMPLETED|Second 6 Weeks Intervention||24
8451328|NCT00754832|20827757|P1|COMPLETED|Second 6 Weeks Intervention||17
8451329|NCT00754832|20827756|P2|STARTED|Second 6 Weeks Intervention||26
8451330|NCT00754832|20827757|P1|STARTED|Second 6 Weeks Intervention||17
8451331|NCT00754832|20827756|P2|NOT COMPLETED|2 Weeks Washout||2
8451332|NCT00754832|20827757|P1|NOT COMPLETED|2 Weeks Washout||1
8451333|NCT00754832|20827756|P2|COMPLETED|2 Weeks Washout||26
8451334|NCT00754832|20827757|P1|COMPLETED|2 Weeks Washout||17
8451335|NCT00754832|20827756|P2|STARTED|2 Weeks Washout||28
8451336|NCT00754832|20827757|P1|STARTED|2 Weeks Washout||18
8451337|NCT00754832|20827756|P2|NOT COMPLETED|First 6 Weeks Intervention||2
8451338|NCT00754832|20827757|P1|NOT COMPLETED|First 6 Weeks Intervention||8
8451339|NCT00754832|20827756|P2|COMPLETED|First 6 Weeks Intervention||28
8451340|NCT00754832|20827757|P1|COMPLETED|First 6 Weeks Intervention||18
8451341|NCT00754832|20827756|P2|STARTED|First 6 Weeks Intervention||30
8451342|NCT00754832|20827757|P1|STARTED|First 6 Weeks Intervention||26
8451343|NCT00754793|20827769|P2|NOT COMPLETED|Overall Study||1
8451344|NCT00754793|20827770|P1|NOT COMPLETED|Overall Study||0
8451345|NCT00754793|20827769|P2|COMPLETED|Overall Study||1
8451346|NCT00754793|20827770|P1|COMPLETED|Overall Study||1
8451347|NCT00754793|20827769|P2|STARTED|Overall Study||2
8451348|NCT00754793|20827770|P1|STARTED|Overall Study||1
8451349|NCT00754767|20827778|P2|NOT COMPLETED|Overall Study||0
8451350|NCT00754767|20827779|P1|NOT COMPLETED|Overall Study||0
8451351|NCT00754767|20827778|P2|COMPLETED|Overall Study||0
8451352|NCT00754767|20827779|P1|COMPLETED|Overall Study||2
8451353|NCT00754767|20827778|P2|STARTED|Overall Study||0
8451354|NCT00754767|20827779|P1|STARTED|Overall Study||2
8451355|NCT00754741|20827788|P3|NOT COMPLETED|Overall Study||54
8451356|NCT00754741|20827789|P2|NOT COMPLETED|Overall Study||69
8451357|NCT00754741|20827790|P1|NOT COMPLETED|Overall Study||57
8451358|NCT00754741|20827788|P3|COMPLETED|Overall Study||502
8451359|NCT00754741|20827789|P2|COMPLETED|Overall Study||500
8451360|NCT00754741|20827790|P1|COMPLETED|Overall Study||510
8451361|NCT00754741|20827788|P3|STARTED|Overall Study||556
8451362|NCT00754741|20827789|P2|STARTED|Overall Study||569
8451363|NCT00754741|20827790|P1|STARTED|Overall Study||567
8451364|NCT00754650|20827837|P1|NOT COMPLETED|Overall Study||2
8451365|NCT00754650|20827837|P1|COMPLETED|Overall Study||0
8451366|NCT00754650|20827837|P1|STARTED|Overall Study||2
8451367|NCT00754624|20827842|P1|NOT COMPLETED|Overall Study||69
8451368|NCT00754624|20827842|P1|COMPLETED|Overall Study||160
8451369|NCT00754624|20827842|P1|STARTED|Overall Study||229
8451370|NCT00754572|20827852|P1|NOT COMPLETED|Overall Study||71
8451371|NCT00754572|20827852|P1|COMPLETED|Overall Study||347
8451372|NCT00754572|20827852|P1|STARTED|Overall Study||418
8451373|NCT00754559|20827879|P1|NOT COMPLETED|Overall Study||47
8451374|NCT00754559|20827879|P1|COMPLETED|Overall Study||239
8451375|NCT00754559|20827879|P1|STARTED|Overall Study||286
8451376|NCT00754546|20827903|P1|NOT COMPLETED|Overall Study||0
8451377|NCT00754546|20827903|P1|COMPLETED|Overall Study||20
8451378|NCT00754546|20827903|P1|STARTED|Overall Study||20
8451379|NCT00754494|20827920|P3|NOT COMPLETED|Overall Study||1
8451380|NCT00754494|20827921|P2|NOT COMPLETED|Overall Study||0
8451381|NCT00754494|20827922|P1|NOT COMPLETED|Overall Study||2
8451382|NCT00754494|20827920|P3|COMPLETED|Overall Study||14
8451383|NCT00754494|20827921|P2|COMPLETED|Overall Study||15
8451384|NCT00754494|20827922|P1|COMPLETED|Overall Study||13
8451385|NCT00754494|20827920|P3|STARTED|Overall Study||15
8451386|NCT00754494|20827921|P2|STARTED|Overall Study||15
8451387|NCT00754494|20827922|P1|STARTED|Overall Study||15
8451388|NCT00754468|20827968|P2|NOT COMPLETED|Overall Study||0
8451389|NCT00754468|20827969|P1|NOT COMPLETED|Overall Study||0
8451390|NCT00754468|20827968|P2|COMPLETED|Overall Study||3
8451391|NCT00754468|20827969|P1|COMPLETED|Overall Study||4
8451392|NCT00754468|20827968|P2|STARTED|Overall Study||3
8451393|NCT00754468|20827969|P1|STARTED|Overall Study||4
8451394|NCT00754442|20827979|P2|NOT COMPLETED|Overall Study||3
8451395|NCT00754442|20827980|P1|NOT COMPLETED|Overall Study||5
8451396|NCT00754442|20827979|P2|COMPLETED|Overall Study||6
8451397|NCT00754442|20827980|P1|COMPLETED|Overall Study||6
8451398|NCT00754442|20827979|P2|STARTED|Overall Study|patients 9|9
8451399|NCT00754442|20827980|P1|STARTED|Overall Study|controls 11|11
8451400|NCT00754390|20827987|P1|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
8451401|NCT00754390|20827987|P1|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
8451402|NCT00754390|20827987|P1|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
8451403|NCT00754390|20827987|P1|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
8451404|NCT00754390|20827987|P1|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
8451405|NCT00754390|20827987|P1|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
8451406|NCT00754390|20827987|P1|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
8451407|NCT00754390|20827987|P1|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
8451408|NCT00754390|20827987|P1|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
8451409|NCT00754390|20827987|P1|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
8451410|NCT00754390|20827987|P1|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
8451411|NCT00754390|20827987|P1|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
8451412|NCT00754377|20827996|P2|NOT COMPLETED|Overall Study||0
8451413|NCT00754377|20827997|P1|NOT COMPLETED|Overall Study||0
8451414|NCT00754377|20827996|P2|COMPLETED|Overall Study||42
8451415|NCT00754377|20827997|P1|COMPLETED|Overall Study||50
8451416|NCT00754377|20827996|P2|STARTED|Overall Study||42
8451417|NCT00754377|20827997|P1|STARTED|Overall Study||50
8451418|NCT00754338|20828009|P4|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
8451419|NCT00754338|20828010|P3|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
8451420|NCT00754338|20828011|P2|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
8451421|NCT00754338|20828012|P1|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
8451422|NCT00754338|20828009|P4|COMPLETED|Second Intervention for Phase1&Phase2||18
8451423|NCT00754338|20828010|P3|COMPLETED|Second Intervention for Phase1&Phase2||16
8451424|NCT00754338|20828011|P2|COMPLETED|Second Intervention for Phase1&Phase2||17
8451425|NCT00754338|20828012|P1|COMPLETED|Second Intervention for Phase1&Phase2||17
8451426|NCT00754338|20828009|P4|STARTED|Second Intervention for Phase1&Phase2||19
8451427|NCT00754338|20828010|P3|STARTED|Second Intervention for Phase1&Phase2||16
8451428|NCT00754338|20828011|P2|STARTED|Second Intervention for Phase1&Phase2||18
8451429|NCT00754338|20828012|P1|STARTED|Second Intervention for Phase1&Phase2||17
8451430|NCT00754338|20828009|P4|NOT COMPLETED|First Intervention for Phase1&Phase2||0
8451431|NCT00754338|20828010|P3|NOT COMPLETED|First Intervention for Phase1&Phase2||3
8451432|NCT00754338|20828011|P2|NOT COMPLETED|First Intervention for Phase1&Phase2||3
8451433|NCT00754338|20828012|P1|NOT COMPLETED|First Intervention for Phase1&Phase2||0
8451434|NCT00754338|20828009|P4|COMPLETED|First Intervention for Phase1&Phase2||19
8451435|NCT00754338|20828010|P3|COMPLETED|First Intervention for Phase1&Phase2||16
8451436|NCT00754338|20828011|P2|COMPLETED|First Intervention for Phase1&Phase2||18
8451437|NCT00754338|20828012|P1|COMPLETED|First Intervention for Phase1&Phase2||17
8451438|NCT00754338|20828009|P4|STARTED|First Intervention for Phase1&Phase2||19
8451439|NCT00754338|20828010|P3|STARTED|First Intervention for Phase1&Phase2||19
8451440|NCT00754338|20828011|P2|STARTED|First Intervention for Phase1&Phase2||21
8451441|NCT00754338|20828012|P1|STARTED|First Intervention for Phase1&Phase2||17
8451442|NCT00754325|20828044|P2|NOT COMPLETED|Progression and Cross-over||21
8451443|NCT00754325|20828045|P1|NOT COMPLETED|Progression and Cross-over||0
8451444|NCT00754325|20828044|P2|COMPLETED|Progression and Cross-over||0
8451445|NCT00754325|20828045|P1|COMPLETED|Progression and Cross-over||0
8451446|NCT00754325|20828044|P2|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
8451447|NCT00754325|20828045|P1|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
8451448|NCT00754325|20828044|P2|NOT COMPLETED|Initial Treatment||49
8451449|NCT00754325|20828045|P1|NOT COMPLETED|Initial Treatment||50
8451450|NCT00754325|20828044|P2|COMPLETED|Initial Treatment||0
8451451|NCT00754325|20828045|P1|COMPLETED|Initial Treatment||0
8451452|NCT00754325|20828044|P2|STARTED|Initial Treatment||49
8451453|NCT00754325|20828045|P1|STARTED|Initial Treatment||50
8451454|NCT00754247|20828067|P3|NOT COMPLETED|Overall Study||5
8451455|NCT00754247|20828068|P2|NOT COMPLETED|Overall Study||5
8451456|NCT00754247|20828069|P1|NOT COMPLETED|Overall Study||5
8451457|NCT00754247|20828067|P3|COMPLETED|Overall Study||5
8451458|NCT00754247|20828068|P2|COMPLETED|Overall Study||5
8451459|NCT00754247|20828069|P1|COMPLETED|Overall Study||5
8451460|NCT00754247|20828067|P3|STARTED|Overall Study||10
8451461|NCT00754247|20828068|P2|STARTED|Overall Study||10
8451462|NCT00754247|20828069|P1|STARTED|Overall Study||10
8451463|NCT00754234|20828098|P1|NOT COMPLETED|Overall Study||3
8451464|NCT00754234|20828098|P1|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
8451465|NCT00754234|20828098|P1|STARTED|Overall Study|7 Menus were consumed in randomized order|16
8451466|NCT00754208|20828102|P1|NOT COMPLETED|Overall Study||0
8451467|NCT00754208|20828102|P1|COMPLETED|Overall Study||7
8451468|NCT00754208|20828102|P1|STARTED|Overall Study||7
8451469|NCT00754156|20828111|P2|NOT COMPLETED|Overall Study||0
8451470|NCT00754156|20828112|P1|NOT COMPLETED|Overall Study||0
8451471|NCT00754156|20828111|P2|COMPLETED|Overall Study||6
8451472|NCT00754156|20828112|P1|COMPLETED|Overall Study||8
8451473|NCT00754156|20828111|P2|STARTED|Overall Study||6
8451474|NCT00754156|20828112|P1|STARTED|Overall Study||8
8451475|NCT00754130|20828136|P6|NOT COMPLETED|Period 2 (5 Days)||0
8451476|NCT00754130|20828137|P5|NOT COMPLETED|Period 2 (5 Days)||0
8451477|NCT00754130|20828138|P4|NOT COMPLETED|Period 2 (5 Days)||0
8451478|NCT00754130|20828139|P3|NOT COMPLETED|Period 2 (5 Days)||0
8451479|NCT00754130|20828140|P2|NOT COMPLETED|Period 2 (5 Days)||0
8451480|NCT00754130|20828141|P1|NOT COMPLETED|Period 2 (5 Days)||0
8451481|NCT00754130|20828136|P6|COMPLETED|Period 2 (5 Days)||4
8451482|NCT00754130|20828137|P5|COMPLETED|Period 2 (5 Days)||2
8451483|NCT00754130|20828138|P4|COMPLETED|Period 2 (5 Days)||2
8451484|NCT00754130|20828139|P3|COMPLETED|Period 2 (5 Days)||4
8451485|NCT00754130|20828140|P2|COMPLETED|Period 2 (5 Days)||2
8451486|NCT00754130|20828141|P1|COMPLETED|Period 2 (5 Days)||2
8451487|NCT00754130|20828136|P6|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
8451488|NCT00754130|20828137|P5|STARTED|Period 2 (5 Days)||2
8451489|NCT00754130|20828138|P4|STARTED|Period 2 (5 Days)||2
8451490|NCT00754130|20828139|P3|STARTED|Period 2 (5 Days)||4
8451491|NCT00754130|20828140|P2|STARTED|Period 2 (5 Days)||2
8451492|NCT00754130|20828141|P1|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
8451493|NCT00754130|20828136|P6|NOT COMPLETED|Washout Period (>=8 Days)||0
8451494|NCT00754130|20828137|P5|NOT COMPLETED|Washout Period (>=8 Days)||0
8451495|NCT00754130|20828138|P4|NOT COMPLETED|Washout Period (>=8 Days)||0
8451496|NCT00754130|20828139|P3|NOT COMPLETED|Washout Period (>=8 Days)||0
8451497|NCT00754130|20828140|P2|NOT COMPLETED|Washout Period (>=8 Days)||0
8451498|NCT00754130|20828141|P1|NOT COMPLETED|Washout Period (>=8 Days)||0
8451499|NCT00754130|20828136|P6|COMPLETED|Washout Period (>=8 Days)||4
8451500|NCT00754130|20828137|P5|COMPLETED|Washout Period (>=8 Days)||2
8451501|NCT00754130|20828138|P4|COMPLETED|Washout Period (>=8 Days)||2
8451502|NCT00754130|20828139|P3|COMPLETED|Washout Period (>=8 Days)||4
8451503|NCT00754130|20828140|P2|COMPLETED|Washout Period (>=8 Days)||2
8451504|NCT00754130|20828141|P1|COMPLETED|Washout Period (>=8 Days)||2
8451505|NCT00754130|20828136|P6|STARTED|Washout Period (>=8 Days)||4
8451506|NCT00754130|20828137|P5|STARTED|Washout Period (>=8 Days)||2
8451507|NCT00754130|20828138|P4|STARTED|Washout Period (>=8 Days)||2
8451508|NCT00754130|20828139|P3|STARTED|Washout Period (>=8 Days)||4
8451509|NCT00754130|20828140|P2|STARTED|Washout Period (>=8 Days)||2
8451510|NCT00754130|20828141|P1|STARTED|Washout Period (>=8 Days)||2
8451511|NCT00754130|20828136|P6|NOT COMPLETED|Period 1 (5 Days)||0
8451512|NCT00754130|20828137|P5|NOT COMPLETED|Period 1 (5 Days)||0
8451513|NCT00754130|20828138|P4|NOT COMPLETED|Period 1 (5 Days)||0
8451514|NCT00754130|20828139|P3|NOT COMPLETED|Period 1 (5 Days)||0
8451515|NCT00754130|20828140|P2|NOT COMPLETED|Period 1 (5 Days)||0
8451516|NCT00754130|20828141|P1|NOT COMPLETED|Period 1 (5 Days)||0
8451517|NCT00754130|20828136|P6|COMPLETED|Period 1 (5 Days)||4
8451518|NCT00754130|20828137|P5|COMPLETED|Period 1 (5 Days)||2
8451519|NCT00754130|20828138|P4|COMPLETED|Period 1 (5 Days)||2
8451520|NCT00754130|20828139|P3|COMPLETED|Period 1 (5 Days)||4
8451521|NCT00754130|20828140|P2|COMPLETED|Period 1 (5 Days)||2
8451522|NCT00754130|20828141|P1|COMPLETED|Period 1 (5 Days)||2
8451523|NCT00754130|20828136|P6|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
8451524|NCT00754130|20828137|P5|STARTED|Period 1 (5 Days)||2
8451525|NCT00754130|20828138|P4|STARTED|Period 1 (5 Days)||2
8451526|NCT00754130|20828139|P3|STARTED|Period 1 (5 Days)||4
8451527|NCT00754130|20828140|P2|STARTED|Period 1 (5 Days)||2
8451528|NCT00754130|20828141|P1|STARTED|Period 1 (5 Days)||2
8451529|NCT00754065|20828184|P2|NOT COMPLETED|Overall Study||80
8451530|NCT00754065|20828185|P1|NOT COMPLETED|Overall Study||81
8451531|NCT00754065|20828184|P2|COMPLETED|Overall Study||126
8451532|NCT00754065|20828185|P1|COMPLETED|Overall Study||122
8451533|NCT00754065|20828184|P2|Cycle 6|Overall Study||153
8451534|NCT00754065|20828185|P1|Cycle 6|Overall Study||141
8451535|NCT00754065|20828184|P2|Participants Received Treatment|Overall Study||204
8451536|NCT00754065|20828185|P1|Participants Received Treatment|Overall Study||191
8451537|NCT00754065|20828184|P2|STARTED|Overall Study||206
8451538|NCT00754065|20828185|P1|STARTED|Overall Study||203
8451539|NCT00754052|20828425|P2|NOT COMPLETED|Overall Study||3
8451540|NCT00754052|20828426|P1|NOT COMPLETED|Overall Study||5
8451541|NCT00754052|20828425|P2|COMPLETED|Overall Study||0
8451542|NCT00754052|20828426|P1|COMPLETED|Overall Study||0
8451543|NCT00754052|20828425|P2|STARTED|Overall Study||3
8451544|NCT00754052|20828426|P1|STARTED|Overall Study||5
8451545|NCT00754013|20828440|P2|NOT COMPLETED|Overall Study||5
8451546|NCT00754013|20828441|P1|NOT COMPLETED|Overall Study||4
8451547|NCT00754013|20828440|P2|COMPLETED|Overall Study||0
8451548|NCT00754013|20828441|P1|COMPLETED|Overall Study||0
8451549|NCT00754013|20828440|P2|STARTED|Overall Study||5
8451550|NCT00754013|20828441|P1|STARTED|Overall Study||4
8451551|NCT00753948|20828452|P3|NOT COMPLETED|Overall Study||0
8451552|NCT00753948|20828453|P2|NOT COMPLETED|Overall Study||0
8451553|NCT00753948|20828454|P1|NOT COMPLETED|Overall Study||0
8451554|NCT00753948|20828452|P3|COMPLETED|Overall Study||7
8451555|NCT00753948|20828453|P2|COMPLETED|Overall Study||7
8451556|NCT00753948|20828454|P1|COMPLETED|Overall Study||9
8451557|NCT00753948|20828452|P3|STARTED|Overall Study||7
8451558|NCT00753948|20828453|P2|STARTED|Overall Study||7
8451559|NCT00753948|20828454|P1|STARTED|Overall Study||9
8451560|NCT00753935|20828467|P2|NOT COMPLETED|Overall Study||0
8451561|NCT00753935|20828468|P1|NOT COMPLETED|Overall Study||0
8451562|NCT00753935|20828467|P2|COMPLETED|Overall Study||47
8451563|NCT00753935|20828468|P1|COMPLETED|Overall Study||45
8451564|NCT00753935|20828467|P2|STARTED|Overall Study||47
8451565|NCT00753935|20828468|P1|STARTED|Overall Study||45
8451566|NCT00753922|20828478|P4|NOT COMPLETED|Overall Study||23
8451567|NCT00753922|20828479|P3|NOT COMPLETED|Overall Study||63
8451568|NCT00753922|20828480|P2|NOT COMPLETED|Overall Study||94
8451569|NCT00753922|20828481|P1|NOT COMPLETED|Overall Study||246
8451570|NCT00753922|20828478|P4|COMPLETED|Overall Study||37
8451571|NCT00753922|20828479|P3|COMPLETED|Overall Study||82
8451572|NCT00753922|20828480|P2|COMPLETED|Overall Study||157
8451573|NCT00753922|20828481|P1|COMPLETED|Overall Study||306
8451574|NCT00753922|20828478|P4|STARTED|Overall Study||60
8451575|NCT00753922|20828479|P3|STARTED|Overall Study||145
8451576|NCT00753922|20828480|P2|STARTED|Overall Study||251
8451577|NCT00753922|20828481|P1|STARTED|Overall Study||552
8451578|NCT00753896|20828511|P1|NOT COMPLETED|Overall Study||16
8451579|NCT00753896|20828511|P1|COMPLETED|Overall Study||118
8451580|NCT00753896|20828511|P1|STARTED|Overall Study||134
8451581|NCT00753766|20828527|P2|NOT COMPLETED|Overall Study||0
8451582|NCT00753766|20828528|P1|NOT COMPLETED|Overall Study||1
8451583|NCT00753766|20828527|P2|COMPLETED|Overall Study||0
8451584|NCT00753766|20828528|P1|COMPLETED|Overall Study||0
8451585|NCT00753766|20828527|P2|STARTED|Overall Study||0
8451586|NCT00753766|20828528|P1|STARTED|Overall Study||1
8451587|NCT00753714|20828550|P2|NOT COMPLETED|Overall Study||62
8451588|NCT00753714|20828551|P1|NOT COMPLETED|Overall Study||60
8451589|NCT00753714|20828550|P2|COMPLETED|Overall Study||1
8451590|NCT00753714|20828551|P1|COMPLETED|Overall Study||1
8451591|NCT00753714|20828550|P2|STARTED|Overall Study||63
8451592|NCT00753714|20828551|P1|STARTED|Overall Study||61
8451593|NCT00753688|20828567|P2|NOT COMPLETED|Overall Study||246
8451594|NCT00753688|20828568|P1|NOT COMPLETED|Overall Study||123
8451595|NCT00753688|20828567|P2|COMPLETED|Overall Study||0
8451596|NCT00753688|20828568|P1|COMPLETED|Overall Study||0
8451597|NCT00753688|20828567|P2|Ongoing - in Follow-up|Overall Study||31
8451598|NCT00753688|20828568|P1|Ongoing - in Follow-up|Overall Study||15
8451599|NCT00753688|20828567|P2|STARTED|Overall Study||246
8451600|NCT00753688|20828568|P1|STARTED|Overall Study||123
8451601|NCT00753675|20828597|P3|NOT COMPLETED|Overall Study||56
8451602|NCT00753675|20828598|P2|NOT COMPLETED|Overall Study||59
8451603|NCT00753675|20828599|P1|NOT COMPLETED|Overall Study||59
8451604|NCT00753675|20828597|P3|COMPLETED|Overall Study||0
8451605|NCT00753675|20828598|P2|COMPLETED|Overall Study||0
8451606|NCT00753675|20828599|P1|COMPLETED|Overall Study||0
8451607|NCT00753675|20828597|P3|STARTED|Overall Study||56
8451608|NCT00753675|20828598|P2|STARTED|Overall Study||59
8451609|NCT00753675|20828599|P1|STARTED|Overall Study||59
8451610|NCT00753649|20828621|P2|NOT COMPLETED|Overall Study||0
8451611|NCT00753649|20828622|P1|NOT COMPLETED|Overall Study||7
8451612|NCT00753649|20828621|P2|COMPLETED|Overall Study||112
8451613|NCT00753649|20828622|P1|COMPLETED|Overall Study||105
8451614|NCT00753649|20828621|P2|STARTED|Overall Study||112
8451615|NCT00753649|20828622|P1|STARTED|Overall Study||112
8451616|NCT00753636|20828642|P1|NOT COMPLETED|Overall Study||6
8451617|NCT00753636|20828642|P1|COMPLETED|Overall Study||25
8451618|NCT00753636|20828642|P1|STARTED|Overall Study||31
8451619|NCT00753623|20828654|P2|NOT COMPLETED|Phase II (14 Days)||1
8451620|NCT00753623|20828655|P1|NOT COMPLETED|Phase II (14 Days)||0
8451621|NCT00753623|20828654|P2|COMPLETED|Phase II (14 Days)||7
8451622|NCT00753623|20828655|P1|COMPLETED|Phase II (14 Days)||8
8451623|NCT00753623|20828654|P2|STARTED|Phase II (14 Days)||8
8451624|NCT00753623|20828655|P1|STARTED|Phase II (14 Days)||8
8451625|NCT00753623|20828654|P2|NOT COMPLETED|Washout (7 Days)||0
8451626|NCT00753623|20828655|P1|NOT COMPLETED|Washout (7 Days)||1
8451627|NCT00753623|20828654|P2|COMPLETED|Washout (7 Days)||8
8451628|NCT00753623|20828655|P1|COMPLETED|Washout (7 Days)||8
8451629|NCT00753623|20828654|P2|STARTED|Washout (7 Days)||8
8451630|NCT00753623|20828655|P1|STARTED|Washout (7 Days)||9
8451631|NCT00753623|20828654|P2|NOT COMPLETED|Phase I (14 Days)||4
8451632|NCT00753623|20828655|P1|NOT COMPLETED|Phase I (14 Days)||2
8451633|NCT00753623|20828654|P2|COMPLETED|Phase I (14 Days)||8
8451634|NCT00753623|20828655|P1|COMPLETED|Phase I (14 Days)||9
8451635|NCT00753623|20828654|P2|STARTED|Phase I (14 Days)||12
8451636|NCT00753623|20828655|P1|STARTED|Phase I (14 Days)||11
8451643|NCT00753519|20828702|P2|NOT COMPLETED|Overall Study||2
8451644|NCT00753519|20828703|P1|NOT COMPLETED|Overall Study||0
8451645|NCT00753519|20828702|P2|COMPLETED|Overall Study||13
8451646|NCT00753519|20828703|P1|COMPLETED|Overall Study||13
8451647|NCT00753519|20828702|P2|STARTED|Overall Study||15
8451648|NCT00753519|20828703|P1|STARTED|Overall Study||13
8451649|NCT00753506|20828725|P2|NOT COMPLETED|Overall Study||2
8451650|NCT00753506|20828726|P1|NOT COMPLETED|Overall Study||7
8451651|NCT00753506|20828725|P2|COMPLETED|Overall Study||31
8451652|NCT00753506|20828726|P1|COMPLETED|Overall Study||26
8451653|NCT00753506|20828725|P2|STARTED|Overall Study||33
8451654|NCT00753506|20828726|P1|STARTED|Overall Study||33
8451655|NCT00753454|20828732|P1|NOT COMPLETED|Overall Study||14
8451656|NCT00753454|20828732|P1|COMPLETED|Overall Study||154
8451657|NCT00753454|20828732|P1|STARTED|Overall Study||168
8451658|NCT00753415|20828766|P10|NOT COMPLETED|Part B||1
8451659|NCT00753415|20828767|P9|NOT COMPLETED|Part B||3
8451660|NCT00753415|20828768|P8|NOT COMPLETED|Part B||1
8451661|NCT00753415|20828769|P7|NOT COMPLETED|Part B||0
8451662|NCT00753415|20828770|P6|NOT COMPLETED|Part B||0
8451663|NCT00753415|20828771|P5|NOT COMPLETED|Part B||0
8451664|NCT00753415|20828772|P4|NOT COMPLETED|Part B||0
8451665|NCT00753415|20828773|P3|NOT COMPLETED|Part B||0
8451666|NCT00753415|20828774|P2|NOT COMPLETED|Part B||0
8451667|NCT00753415|20828775|P1|NOT COMPLETED|Part B||0
8451668|NCT00753415|20828766|P10|COMPLETED|Part B||8
8451669|NCT00753415|20828767|P9|COMPLETED|Part B||6
8451670|NCT00753415|20828768|P8|COMPLETED|Part B||6
8451671|NCT00753415|20828769|P7|COMPLETED|Part B||2
8451672|NCT00753415|20828770|P6|COMPLETED|Part B||1
8451673|NCT00753415|20828771|P5|COMPLETED|Part B||0
8451674|NCT00753415|20828772|P4|COMPLETED|Part B||0
8451675|NCT00753415|20828773|P3|COMPLETED|Part B||0
8451676|NCT00753415|20828774|P2|COMPLETED|Part B||0
8451677|NCT00753415|20828775|P1|COMPLETED|Part B||0
8451678|NCT00753415|20828766|P10|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
8451679|NCT00753415|20828767|P9|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
8451680|NCT00753415|20828768|P8|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
8451681|NCT00753415|20828769|P7|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
8451682|NCT00753415|20828770|P6|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
8451683|NCT00753415|20828771|P5|STARTED|Part B||0
8451684|NCT00753415|20828772|P4|STARTED|Part B||0
8451685|NCT00753415|20828773|P3|STARTED|Part B||0
8451686|NCT00753415|20828774|P2|STARTED|Part B||0
8451687|NCT00753415|20828775|P1|STARTED|Part B||0
8451688|NCT00753415|20828766|P10|NOT COMPLETED|Part A||0
8451689|NCT00753415|20828767|P9|NOT COMPLETED|Part A||0
8451690|NCT00753415|20828768|P8|NOT COMPLETED|Part A||0
8451691|NCT00753415|20828769|P7|NOT COMPLETED|Part A||0
8451692|NCT00753415|20828770|P6|NOT COMPLETED|Part A||0
8451693|NCT00753415|20828771|P5|NOT COMPLETED|Part A||0
8451694|NCT00753415|20828772|P4|NOT COMPLETED|Part A||2
8451695|NCT00753415|20828773|P3|NOT COMPLETED|Part A||2
8451696|NCT00753415|20828774|P2|NOT COMPLETED|Part A||0
8451697|NCT00753415|20828775|P1|NOT COMPLETED|Part A||1
8451698|NCT00753415|20828766|P10|COMPLETED|Part A||0
8451699|NCT00753415|20828767|P9|COMPLETED|Part A||0
8451700|NCT00753415|20828768|P8|COMPLETED|Part A||0
8451701|NCT00753415|20828769|P7|COMPLETED|Part A||0
8451702|NCT00753415|20828770|P6|COMPLETED|Part A||0
8451703|NCT00753415|20828771|P5|COMPLETED|Part A||10
8451704|NCT00753415|20828772|P4|COMPLETED|Part A||9
8451705|NCT00753415|20828773|P3|COMPLETED|Part A||8
8451706|NCT00753415|20828774|P2|COMPLETED|Part A||3
8451707|NCT00753415|20828775|P1|COMPLETED|Part A||2
8451708|NCT00753415|20828766|P10|STARTED|Part A||0
8451709|NCT00753415|20828767|P9|STARTED|Part A||0
8451710|NCT00753415|20828768|P8|STARTED|Part A||0
8451711|NCT00753415|20828769|P7|STARTED|Part A||0
8451712|NCT00753415|20828770|P6|STARTED|Part A||0
8451713|NCT00753415|20828771|P5|STARTED|Part A||10
8451714|NCT00753415|20828772|P4|STARTED|Part A||11
8451715|NCT00753415|20828773|P3|STARTED|Part A||10
8451716|NCT00753415|20828774|P2|STARTED|Part A||3
8451717|NCT00753415|20828775|P1|STARTED|Part A||3
8451718|NCT00753363|20828819|P2|NOT COMPLETED|Overall Study||39
8451719|NCT00753363|20828820|P1|NOT COMPLETED|Overall Study||40
8451720|NCT00753363|20828819|P2|COMPLETED|Overall Study||21
8451721|NCT00753363|20828820|P1|COMPLETED|Overall Study||19
8451722|NCT00753363|20828819|P2|STARTED|Overall Study||60
8451723|NCT00753363|20828820|P1|STARTED|Overall Study||59
8451724|NCT00753337|20828830|P1|NOT COMPLETED|Overall Study||0
8451725|NCT00753337|20828830|P1|COMPLETED|Overall Study||123
8451726|NCT00753337|20828830|P1|STARTED|Overall Study||123
8451727|NCT00753298|20828846|P2|NOT COMPLETED|Overall Study||4
8451728|NCT00753298|20828847|P1|NOT COMPLETED|Overall Study||8
8451729|NCT00753298|20828846|P2|COMPLETED|Overall Study||94
8451730|NCT00753298|20828847|P1|COMPLETED|Overall Study||89
8451731|NCT00753298|20828846|P2|STARTED|Overall Study||98
8451732|NCT00753298|20828847|P1|STARTED|Overall Study||97
8451733|NCT00753272|20828865|P2|NOT COMPLETED|Overall Study||4907
8451734|NCT00753272|20828866|P1|NOT COMPLETED|Overall Study||4982
8451735|NCT00753272|20828865|P2|COMPLETED|Overall Study||16895
8451736|NCT00753272|20828866|P1|COMPLETED|Overall Study||16911
8451737|NCT00753272|20828865|P2|STARTED|Overall Study||21802
8451738|NCT00753272|20828866|P1|STARTED|Overall Study||21893
8451739|NCT00753220|20828928|P1|NOT COMPLETED|Overall Study||5
8451740|NCT00753220|20828928|P1|COMPLETED|Overall Study||2
8451741|NCT00753220|20828928|P1|STARTED|Overall Study||7
8451742|NCT00753142|20828935|P3|NOT COMPLETED|Overall Study||0
8451743|NCT00753142|20828936|P2|NOT COMPLETED|Overall Study||0
8451744|NCT00753142|20828937|P1|NOT COMPLETED|Overall Study||0
8451745|NCT00753142|20828935|P3|COMPLETED|Overall Study||13
8451746|NCT00753142|20828936|P2|COMPLETED|Overall Study||7
8451747|NCT00753142|20828937|P1|COMPLETED|Overall Study||8
8451748|NCT00753142|20828935|P3|STARTED|Overall Study||13
8451749|NCT00753142|20828936|P2|STARTED|Overall Study||7
8451750|NCT00753142|20828937|P1|STARTED|Overall Study||8
8451751|NCT00753012|20828950|P2|NOT COMPLETED|Overall Study||1
8451752|NCT00753012|20828951|P1|NOT COMPLETED|Overall Study||8
8451753|NCT00753012|20828950|P2|COMPLETED|Overall Study||8
8451754|NCT00753012|20828951|P1|COMPLETED|Overall Study||7
8451755|NCT00753012|20828950|P2|STARTED|Overall Study||9
8451756|NCT00753012|20828951|P1|STARTED|Overall Study||15
8451757|NCT00752986|20828964|P3|NOT COMPLETED|Overall Study||2
8451758|NCT00752986|20828965|P2|NOT COMPLETED|Overall Study||1
8451759|NCT00752986|20828966|P1|NOT COMPLETED|Overall Study||5
8451760|NCT00752986|20828964|P3|COMPLETED|Overall Study||9
8451761|NCT00752986|20828965|P2|COMPLETED|Overall Study||11
8451762|NCT00752986|20828966|P1|COMPLETED|Overall Study||11
8451763|NCT00752986|20828964|P3|STARTED|Overall Study||11
8451764|NCT00752986|20828965|P2|STARTED|Overall Study||12
8451765|NCT00752986|20828966|P1|STARTED|Overall Study||16
8451766|NCT00752973|20828983|P1|NOT COMPLETED|Overall Study||0
8451767|NCT00752973|20828983|P1|COMPLETED|Overall Study||12
8451768|NCT00752973|20828983|P1|STARTED|Overall Study||12
8451769|NCT00752908|20828995|P2|NOT COMPLETED|Overall Study||0
8451770|NCT00752908|20828996|P1|NOT COMPLETED|Overall Study||0
8451771|NCT00752908|20828995|P2|COMPLETED|Overall Study||13
8451772|NCT00752908|20828996|P1|COMPLETED|Overall Study||14
8451773|NCT00752908|20828995|P2|STARTED|Overall Study||13
8451774|NCT00752908|20828996|P1|STARTED|Overall Study||14
8451775|NCT00752895|20829006|P2|NOT COMPLETED|Overall Study||3
8451776|NCT00752895|20829007|P1|NOT COMPLETED|Overall Study||8
8451777|NCT00752895|20829006|P2|COMPLETED|Overall Study||143
8451778|NCT00752895|20829007|P1|COMPLETED|Overall Study||139
8451779|NCT00752895|20829006|P2|STARTED|Overall Study||146
8451780|NCT00752895|20829007|P1|STARTED|Overall Study||147
8451781|NCT00752856|20829017|P2|NOT COMPLETED|Overall Study||1
8451782|NCT00752856|20829018|P1|NOT COMPLETED|Overall Study||0
8451783|NCT00752856|20829017|P2|COMPLETED|Overall Study||24
8451784|NCT00752856|20829018|P1|COMPLETED|Overall Study||26
8451785|NCT00752856|20829017|P2|STARTED|Overall Study||25
8451786|NCT00752856|20829018|P1|STARTED|Overall Study||26
8451787|NCT00752791|20829030|P1|NOT COMPLETED|Overall Study||16
8451788|NCT00752791|20829030|P1|COMPLETED|Overall Study||43
8451789|NCT00752791|20829030|P1|STARTED|Overall Study||59
8451790|NCT00752726|20829042|P2|NOT COMPLETED|Overall Study||13
8451791|NCT00752726|20829043|P1|NOT COMPLETED|Overall Study||11
8451792|NCT00752726|20829042|P2|COMPLETED|Overall Study||53
8451793|NCT00752726|20829043|P1|COMPLETED|Overall Study||54
8451794|NCT00752726|20829042|P2|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
8451795|NCT00752726|20829043|P1|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
8451796|NCT00752726|20829042|P2|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
8451797|NCT00752726|20829043|P1|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
8451798|NCT00752726|20829042|P2|STARTED|Overall Study||66
8451799|NCT00752726|20829043|P1|STARTED|Overall Study||65
8451800|NCT00752622|20829068|P1|NOT COMPLETED|Interventional Phase||8
8451801|NCT00752622|20829068|P1|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
8451802|NCT00752622|20829068|P1|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
8451803|NCT00752622|20829068|P1|NOT COMPLETED|Observational Phase||43
8451804|NCT00752622|20829068|P1|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
8451805|NCT00752622|20829068|P1|STARTED|Observational Phase||65
8451806|NCT00752622|20829068|P1|NOT COMPLETED|Induction Phase||35
8451807|NCT00752622|20829068|P1|COMPLETED|Induction Phase||65
8451808|NCT00752622|20829068|P1|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
8451809|NCT00752609|20829081|P2|NOT COMPLETED|Overall Study||2
8451810|NCT00752609|20829082|P1|NOT COMPLETED|Overall Study||9
8451811|NCT00752609|20829081|P2|COMPLETED|Overall Study||47
8451812|NCT00752609|20829082|P1|COMPLETED|Overall Study||44
8451813|NCT00752609|20829081|P2|Full Analysis Set|Overall Study||49
8451814|NCT00752609|20829082|P1|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
8451815|NCT00752609|20829081|P2|STARTED|Overall Study||49
8451816|NCT00752609|20829082|P1|STARTED|Overall Study||53
8451817|NCT00752557|20829104|P3|NOT COMPLETED|Overall Study||6
8451818|NCT00752557|20829105|P2|NOT COMPLETED|Overall Study||5
8451819|NCT00752557|20829106|P1|NOT COMPLETED|Overall Study||5
8451820|NCT00752557|20829104|P3|COMPLETED|Overall Study||11
8451821|NCT00752557|20829105|P2|COMPLETED|Overall Study||11
8451822|NCT00752557|20829106|P1|COMPLETED|Overall Study||12
8451823|NCT00752557|20829104|P3|STARTED|Overall Study||17
8451824|NCT00752557|20829105|P2|STARTED|Overall Study||16
8451825|NCT00752557|20829106|P1|STARTED|Overall Study||17
8451826|NCT00752232|20829138|P7|NOT COMPLETED|Overall Study||0
8451827|NCT00752232|20829139|P6|NOT COMPLETED|Overall Study||1
8451828|NCT00752232|20829140|P5|NOT COMPLETED|Overall Study||3
8451829|NCT00752232|20829141|P4|NOT COMPLETED|Overall Study||1
8451830|NCT00752232|20829142|P3|NOT COMPLETED|Overall Study||1
8451831|NCT00752232|20829143|P2|NOT COMPLETED|Overall Study||0
8451832|NCT00752232|20829144|P1|NOT COMPLETED|Overall Study||2
8451833|NCT00752232|20829138|P7|COMPLETED|Overall Study||4
8451834|NCT00752232|20829139|P6|COMPLETED|Overall Study||5
8451835|NCT00752232|20829140|P5|COMPLETED|Overall Study||3
8451836|NCT00752232|20829141|P4|COMPLETED|Overall Study||5
8451837|NCT00752232|20829142|P3|COMPLETED|Overall Study||5
8451838|NCT00752232|20829143|P2|COMPLETED|Overall Study||6
8451839|NCT00752232|20829144|P1|COMPLETED|Overall Study||4
8451840|NCT00752232|20829138|P7|STARTED|Overall Study||4
8451841|NCT00752232|20829139|P6|STARTED|Overall Study||6
8451842|NCT00752232|20829140|P5|STARTED|Overall Study||6
8451843|NCT00752232|20829141|P4|STARTED|Overall Study||6
8451844|NCT00752232|20829142|P3|STARTED|Overall Study||6
8451845|NCT00752232|20829143|P2|STARTED|Overall Study||6
8451846|NCT00752232|20829144|P1|STARTED|Overall Study||6
8451847|NCT00752219|20829218|P2|NOT COMPLETED|Overall Study||6
8451848|NCT00752219|20829219|P1|NOT COMPLETED|Overall Study||11
8451849|NCT00752219|20829218|P2|COMPLETED|Overall Study||96
8451850|NCT00752219|20829219|P1|COMPLETED|Overall Study||91
8451851|NCT00752219|20829218|P2|Treated|Overall Study||102
8451852|NCT00752219|20829219|P1|Treated|Overall Study||101
8451853|NCT00752219|20829218|P2|STARTED|Overall Study||102
8451854|NCT00752219|20829219|P1|STARTED|Overall Study||102
8451855|NCT00752206|20829245|P2|NOT COMPLETED|Overall Study||11
8451856|NCT00752206|20829246|P1|NOT COMPLETED|Overall Study||9
8451857|NCT00752206|20829245|P2|COMPLETED|Overall Study||8
8451858|NCT00752206|20829246|P1|COMPLETED|Overall Study||10
8451859|NCT00752206|20829245|P2|STARTED|Overall Study||19
8451860|NCT00752206|20829246|P1|STARTED|Overall Study||19
8451861|NCT00752128|20829264|P1|NOT COMPLETED|Overall Study||4
8451862|NCT00752128|20829264|P1|COMPLETED|Overall Study||2345
8451863|NCT00752128|20829264|P1|STARTED|Overall Study||2349
8451864|NCT00752102|20829271|P2|NOT COMPLETED|Overall Study||1
8451865|NCT00752102|20829272|P1|NOT COMPLETED|Overall Study||3
8451866|NCT00752102|20829271|P2|COMPLETED|Overall Study||21
8451867|NCT00752102|20829272|P1|COMPLETED|Overall Study||19
8451868|NCT00752102|20829271|P2|STARTED|Overall Study||22
8451869|NCT00752102|20829272|P1|STARTED|Overall Study||22
8451870|NCT00752089|20829278|P1|NOT COMPLETED|Overall Study||6
8451871|NCT00752089|20829278|P1|COMPLETED|Overall Study||14
8451872|NCT00752089|20829278|P1|Received Placebo|Overall Study||18
8451873|NCT00752089|20829278|P1|Received NaF|Overall Study||18
8451874|NCT00752089|20829278|P1|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
8451875|NCT00752089|20829278|P1|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
8451876|NCT00752089|20829278|P1|STARTED|Overall Study||20
8451880|NCT00751972|20829298|P2|NOT COMPLETED|Overall Study||0
8451881|NCT00751972|20829299|P1|NOT COMPLETED|Overall Study||0
8451882|NCT00751972|20829298|P2|COMPLETED|Overall Study||499
8451883|NCT00751972|20829299|P1|COMPLETED|Overall Study||140
8451884|NCT00751972|20829298|P2|STARTED|Overall Study||499
8451885|NCT00751972|20829299|P1|STARTED|Overall Study||140
8451886|NCT00751933|20829311|P4|NOT COMPLETED|Overall Study||1
8451887|NCT00751933|20829312|P3|NOT COMPLETED|Overall Study||1
8451888|NCT00751933|20829313|P2|NOT COMPLETED|Overall Study||1
8451889|NCT00751933|20829314|P1|NOT COMPLETED|Overall Study||0
8451890|NCT00751933|20829311|P4|COMPLETED|Overall Study||0
8451891|NCT00751933|20829312|P3|COMPLETED|Overall Study||0
8451892|NCT00751933|20829313|P2|COMPLETED|Overall Study||0
8451893|NCT00751933|20829314|P1|COMPLETED|Overall Study||0
8451894|NCT00751933|20829311|P4|STARTED|Overall Study||1
8451895|NCT00751933|20829312|P3|STARTED|Overall Study||1
8451896|NCT00751933|20829313|P2|STARTED|Overall Study||1
8451897|NCT00751933|20829314|P1|STARTED|Overall Study||0
8451898|NCT00751881|20829322|P3|NOT COMPLETED|Extension Study Period||66
8451899|NCT00751881|20829323|P2|NOT COMPLETED|Extension Study Period||71
8451900|NCT00751881|20829324|P1|NOT COMPLETED|Extension Study Period||65
8451901|NCT00751881|20829322|P3|COMPLETED|Extension Study Period||167
8451902|NCT00751881|20829323|P2|COMPLETED|Extension Study Period||194
8451903|NCT00751881|20829324|P1|COMPLETED|Extension Study Period||188
8451904|NCT00751881|20829322|P3|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
8451905|NCT00751881|20829323|P2|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
8451906|NCT00751881|20829324|P1|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
8451907|NCT00751881|20829322|P3|NOT COMPLETED|Core Treatment Period||128
8451908|NCT00751881|20829323|P2|NOT COMPLETED|Core Treatment Period||135
8451909|NCT00751881|20829324|P1|NOT COMPLETED|Core Treatment Period||126
8451910|NCT00751881|20829322|P3|COMPLETED|Core Treatment Period||244
8451911|NCT00751881|20829323|P2|COMPLETED|Core Treatment Period||273
8451912|NCT00751881|20829324|P1|COMPLETED|Core Treatment Period||263
8451913|NCT00751881|20829322|P3|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
8451914|NCT00751881|20829323|P2|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
8451915|NCT00751881|20829324|P1|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
8451916|NCT00751881|20829322|P3|STARTED|Core Treatment Period|Randomized|372
8451917|NCT00751881|20829323|P2|STARTED|Core Treatment Period|Randomized|408
8451918|NCT00751881|20829324|P1|STARTED|Core Treatment Period|Randomized|389
8451919|NCT00751790|20829371|P1|NOT COMPLETED|Overall Study||5
8451920|NCT00751790|20829371|P1|COMPLETED|Overall Study||115
8451921|NCT00751790|20829371|P1|STARTED|Overall Study||120
8451922|NCT00751777|20829377|P2|NOT COMPLETED|Overall Study||3
8451923|NCT00751777|20829378|P1|NOT COMPLETED|Overall Study||11
8451924|NCT00751777|20829377|P2|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
8452014|NCT00750815|20829656|P2|COMPLETED|Overall Study||46
8451925|NCT00751777|20829378|P1|COMPLETED|Overall Study|Day 380: study completion for LT group|70
8451926|NCT00751777|20829377|P2|STARTED|Overall Study||39
8451927|NCT00751777|20829378|P1|STARTED|Overall Study||81
8451928|NCT00751634|20829394|P1|NOT COMPLETED|Overall Study||0
8451929|NCT00751634|20829394|P1|COMPLETED|Overall Study||20
8451930|NCT00751634|20829394|P1|STARTED|Overall Study||20
8451931|NCT00751621|20829402|P1|NOT COMPLETED|Overall Study||4
8451932|NCT00751621|20829402|P1|COMPLETED|Overall Study||36
8451933|NCT00751621|20829402|P1|STARTED|Overall Study||40
8451934|NCT00751530|20829421|P2|NOT COMPLETED|Overall Study||0
8451935|NCT00751530|20829422|P1|NOT COMPLETED|Overall Study||0
8451936|NCT00751530|20829421|P2|COMPLETED|Overall Study||110
8451937|NCT00751530|20829422|P1|COMPLETED|Overall Study||332
8451938|NCT00751530|20829421|P2|STARTED|Overall Study||110
8451939|NCT00751530|20829422|P1|STARTED|Overall Study||332
8451940|NCT00751400|20829436|P1|NOT COMPLETED|Overall Study||10
8451941|NCT00751400|20829436|P1|COMPLETED|Overall Study||487
8451942|NCT00751400|20829436|P1|Subjects Provided Detailed Use Data|Overall Study||467
8451943|NCT00751400|20829436|P1|Subjects Consumed Drug|Overall Study||485
8451944|NCT00751400|20829436|P1|Subjects Provided Drug|Overall Study||497
8451945|NCT00751400|20829436|P1|STARTED|Overall Study||497
8451946|NCT00751348|20829451|P2|NOT COMPLETED|Overall Study||2
8451947|NCT00751348|20829452|P1|NOT COMPLETED|Overall Study||6
8451948|NCT00751348|20829451|P2|COMPLETED|Overall Study||159
8451949|NCT00751348|20829452|P1|COMPLETED|Overall Study||307
8451950|NCT00751348|20829451|P2|STARTED|Overall Study||161
8451951|NCT00751348|20829452|P1|STARTED|Overall Study||313
8451952|NCT00751335|20829476|P2|NOT COMPLETED|Overall Study||0
8451953|NCT00751335|20829477|P1|NOT COMPLETED|Overall Study||0
8451954|NCT00751335|20829476|P2|COMPLETED|Overall Study||0
8451955|NCT00751335|20829477|P1|COMPLETED|Overall Study||0
8451956|NCT00751335|20829476|P2|STARTED|Overall Study||0
8451957|NCT00751335|20829477|P1|STARTED|Overall Study||0
8451958|NCT00751296|20829485|P1|NOT COMPLETED|Overall Study||2
8451959|NCT00751296|20829485|P1|COMPLETED|Overall Study||25
8451960|NCT00751296|20829485|P1|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
8451961|NCT00751179|20829492|P2|NOT COMPLETED|Overall Study||15
8451962|NCT00751179|20829493|P1|NOT COMPLETED|Overall Study||14
8451963|NCT00751179|20829492|P2|COMPLETED|Overall Study||70
8451964|NCT00751179|20829493|P1|COMPLETED|Overall Study||62
8451965|NCT00751179|20829492|P2|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
8451966|NCT00751179|20829493|P1|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
8451967|NCT00751140|20829513|P1|NOT COMPLETED|Overall Study||1
8451968|NCT00751140|20829513|P1|COMPLETED|Overall Study||19
8451969|NCT00751140|20829513|P1|STARTED|Overall Study||20
8451970|NCT00751114|20829523|P2|NOT COMPLETED|Overall Study||32
8451971|NCT00751114|20829524|P1|NOT COMPLETED|Overall Study||38
8451972|NCT00751114|20829523|P2|COMPLETED|Overall Study||233
8451973|NCT00751114|20829524|P1|COMPLETED|Overall Study||212
8451974|NCT00751114|20829523|P2|mITT Population|Overall Study||253
8451975|NCT00751114|20829524|P1|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
8451976|NCT00751114|20829523|P2|TREATED = Safety Population|Overall Study||264
8451977|NCT00751114|20829524|P1|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
8451978|NCT00751114|20829523|P2|STARTED|Overall Study||265
8451979|NCT00751114|20829524|P1|STARTED|Overall Study|randomized|250
8451980|NCT00751101|20829549|P2|NOT COMPLETED|Overall Study||5
8451981|NCT00751101|20829550|P1|NOT COMPLETED|Overall Study||2
8451982|NCT00751101|20829549|P2|COMPLETED|Overall Study||7
8451983|NCT00751101|20829550|P1|COMPLETED|Overall Study||10
8451984|NCT00751101|20829549|P2|Started Capecitabine|Overall Study||11
8451985|NCT00751101|20829550|P1|Started Capecitabine|Overall Study||11
8451986|NCT00751101|20829549|P2|STARTED|Overall Study||12
8451987|NCT00751101|20829550|P1|STARTED|Overall Study||12
8451988|NCT00751036|20829570|P2|NOT COMPLETED|Overall Study||46
8451989|NCT00751036|20829571|P1|NOT COMPLETED|Overall Study||48
8451990|NCT00751036|20829570|P2|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
8451991|NCT00751036|20829571|P1|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
8451992|NCT00751036|20829570|P2|STARTED|Overall Study|Started = Treated|46
8451993|NCT00751036|20829571|P1|STARTED|Overall Study|Started = Treated|48
8451994|NCT00751023|20829585|P2|NOT COMPLETED|Overall Study||7
8451995|NCT00751023|20829586|P1|NOT COMPLETED|Overall Study||11
8451996|NCT00751023|20829585|P2|COMPLETED|Overall Study||13
8451997|NCT00751023|20829586|P1|COMPLETED|Overall Study||9
8451998|NCT00751023|20829585|P2|STARTED|Overall Study||20
8451999|NCT00751023|20829586|P1|STARTED|Overall Study||20
8452003|NCT00750893|20829614|P1|NOT COMPLETED|Overall Study||542
8452004|NCT00750893|20829614|P1|COMPLETED|Overall Study||2569
8452005|NCT00750893|20829614|P1|STARTED|Overall Study||3111
8452006|NCT00750880|20829626|P1|NOT COMPLETED|Overall Study||215
8452007|NCT00750880|20829626|P1|COMPLETED|Overall Study||1466
8452008|NCT00750880|20829626|P1|STARTED|Overall Study||1681
8452009|NCT00750867|20829649|P1|NOT COMPLETED|Overall Study||2
8452010|NCT00750867|20829649|P1|COMPLETED|Overall Study||7
8452011|NCT00750867|20829649|P1|STARTED|Overall Study||9
8452012|NCT00750815|20829656|P2|NOT COMPLETED|Overall Study||0
8452013|NCT00750815|20829657|P1|NOT COMPLETED|Overall Study||0
8452015|NCT00750815|20829657|P1|COMPLETED|Overall Study||12
8452016|NCT00750815|20829656|P2|STARTED|Overall Study||46
8452017|NCT00750815|20829657|P1|STARTED|Overall Study||12
8452018|NCT00750737|20829670|P2|NOT COMPLETED|Overall Study||3
8452019|NCT00750737|20829671|P1|NOT COMPLETED|Overall Study||3
8452020|NCT00750737|20829670|P2|COMPLETED|Overall Study||19
8452021|NCT00750737|20829671|P1|COMPLETED|Overall Study||21
8452022|NCT00750737|20829670|P2|STARTED|Overall Study||22
8452023|NCT00750737|20829671|P1|STARTED|Overall Study||24
8452024|NCT00750555|20829679|P1|NOT COMPLETED|Overall Study||0
8452025|NCT00750555|20829679|P1|COMPLETED|Overall Study||0
8452026|NCT00750555|20829679|P1|STARTED|Overall Study||0
8452027|NCT00750438|20829686|P2|NOT COMPLETED|Overall Study||4
8452028|NCT00750438|20829687|P1|NOT COMPLETED|Overall Study||7
8452029|NCT00750438|20829686|P2|COMPLETED|Overall Study||25
8452030|NCT00750438|20829687|P1|COMPLETED|Overall Study||24
8452031|NCT00750438|20829686|P2|STARTED|Overall Study||29
8452032|NCT00750438|20829687|P1|STARTED|Overall Study||31
8452033|NCT00750373|20829703|P2|NOT COMPLETED|Overall Study||0
8452034|NCT00750373|20829704|P1|NOT COMPLETED|Overall Study||0
8452035|NCT00750373|20829703|P2|COMPLETED|Overall Study||37
8452036|NCT00750373|20829704|P1|COMPLETED|Overall Study||39
8452037|NCT00750373|20829703|P2|STARTED|Overall Study||37
8452038|NCT00750373|20829704|P1|STARTED|Overall Study||39
8452039|NCT00750360|20829716|P6|NOT COMPLETED|Overall Study||0
8452040|NCT00750360|20829717|P5|NOT COMPLETED|Overall Study||0
8452041|NCT00750360|20829718|P4|NOT COMPLETED|Overall Study||0
8452042|NCT00750360|20829719|P3|NOT COMPLETED|Overall Study||0
8452043|NCT00750360|20829720|P2|NOT COMPLETED|Overall Study||0
8452044|NCT00750360|20829721|P1|NOT COMPLETED|Overall Study||0
8452045|NCT00750360|20829716|P6|COMPLETED|Overall Study||71
8452046|NCT00750360|20829717|P5|COMPLETED|Overall Study||46
8452047|NCT00750360|20829718|P4|COMPLETED|Overall Study||79
8452048|NCT00750360|20829719|P3|COMPLETED|Overall Study||384
8452049|NCT00750360|20829720|P2|COMPLETED|Overall Study||1
8452050|NCT00750360|20829721|P1|COMPLETED|Overall Study||294
8452051|NCT00750360|20829716|P6|STARTED|Overall Study||71
8452052|NCT00750360|20829717|P5|STARTED|Overall Study||46
8452053|NCT00750360|20829718|P4|STARTED|Overall Study||79
8452054|NCT00750360|20829719|P3|STARTED|Overall Study||384
8452055|NCT00750360|20829720|P2|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
8452056|NCT00750360|20829721|P1|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
8452057|NCT00750308|20829753|P12|NOT COMPLETED|Fourth Treatment||0
8452058|NCT00750308|20829754|P11|NOT COMPLETED|Fourth Treatment||0
8452059|NCT00750308|20829755|P10|NOT COMPLETED|Fourth Treatment||0
8452060|NCT00750308|20829756|P9|NOT COMPLETED|Fourth Treatment||0
8452061|NCT00750308|20829757|P8|NOT COMPLETED|Fourth Treatment||0
8452062|NCT00750308|20829758|P7|NOT COMPLETED|Fourth Treatment||0
8452063|NCT00750308|20829759|P6|NOT COMPLETED|Fourth Treatment||0
8452064|NCT00750308|20829760|P5|NOT COMPLETED|Fourth Treatment||0
8452065|NCT00750308|20829761|P4|NOT COMPLETED|Fourth Treatment||0
8452066|NCT00750308|20829762|P3|NOT COMPLETED|Fourth Treatment||0
8452067|NCT00750308|20829763|P2|NOT COMPLETED|Fourth Treatment||0
8452068|NCT00750308|20829764|P1|NOT COMPLETED|Fourth Treatment||0
8452069|NCT00750308|20829753|P12|COMPLETED|Fourth Treatment||1
8452070|NCT00750308|20829754|P11|COMPLETED|Fourth Treatment||1
8452071|NCT00750308|20829755|P10|COMPLETED|Fourth Treatment||2
8452072|NCT00750308|20829756|P9|COMPLETED|Fourth Treatment||1
8452073|NCT00750308|20829757|P8|COMPLETED|Fourth Treatment||2
8452074|NCT00750308|20829758|P7|COMPLETED|Fourth Treatment||2
8452075|NCT00750308|20829759|P6|COMPLETED|Fourth Treatment||2
8452076|NCT00750308|20829760|P5|COMPLETED|Fourth Treatment||1
8452077|NCT00750308|20829761|P4|COMPLETED|Fourth Treatment||1
8452078|NCT00750308|20829762|P3|COMPLETED|Fourth Treatment||2
8452079|NCT00750308|20829763|P2|COMPLETED|Fourth Treatment||1
8452080|NCT00750308|20829764|P1|COMPLETED|Fourth Treatment||2
8452081|NCT00750308|20829753|P12|STARTED|Fourth Treatment||1
8452082|NCT00750308|20829754|P11|STARTED|Fourth Treatment||1
8452083|NCT00750308|20829755|P10|STARTED|Fourth Treatment||2
8452084|NCT00750308|20829756|P9|STARTED|Fourth Treatment||1
8452085|NCT00750308|20829757|P8|STARTED|Fourth Treatment||2
8452086|NCT00750308|20829758|P7|STARTED|Fourth Treatment||2
8452087|NCT00750308|20829759|P6|STARTED|Fourth Treatment||2
8452088|NCT00750308|20829760|P5|STARTED|Fourth Treatment||1
8452089|NCT00750308|20829761|P4|STARTED|Fourth Treatment||1
8452090|NCT00750308|20829762|P3|STARTED|Fourth Treatment||2
8452091|NCT00750308|20829763|P2|STARTED|Fourth Treatment||1
8452092|NCT00750308|20829764|P1|STARTED|Fourth Treatment||2
8452093|NCT00750308|20829753|P12|NOT COMPLETED|Washout||0
8452094|NCT00750308|20829754|P11|NOT COMPLETED|Washout||0
8452095|NCT00750308|20829755|P10|NOT COMPLETED|Washout||0
8452096|NCT00750308|20829756|P9|NOT COMPLETED|Washout||0
8452097|NCT00750308|20829757|P8|NOT COMPLETED|Washout||0
8452098|NCT00750308|20829758|P7|NOT COMPLETED|Washout||0
8452099|NCT00750308|20829759|P6|NOT COMPLETED|Washout||0
8452100|NCT00750308|20829760|P5|NOT COMPLETED|Washout||0
8452101|NCT00750308|20829761|P4|NOT COMPLETED|Washout||0
8452102|NCT00750308|20829762|P3|NOT COMPLETED|Washout||0
8452103|NCT00750308|20829763|P2|NOT COMPLETED|Washout||0
8452104|NCT00750308|20829764|P1|NOT COMPLETED|Washout||0
8452105|NCT00750308|20829753|P12|COMPLETED|Washout||1
8452106|NCT00750308|20829754|P11|COMPLETED|Washout||1
8452107|NCT00750308|20829755|P10|COMPLETED|Washout||2
8452108|NCT00750308|20829756|P9|COMPLETED|Washout||1
8452109|NCT00750308|20829757|P8|COMPLETED|Washout||2
8452110|NCT00750308|20829758|P7|COMPLETED|Washout||2
8452111|NCT00750308|20829759|P6|COMPLETED|Washout||2
8452112|NCT00750308|20829760|P5|COMPLETED|Washout||1
8452113|NCT00750308|20829761|P4|COMPLETED|Washout||1
8452114|NCT00750308|20829762|P3|COMPLETED|Washout||2
8452115|NCT00750308|20829763|P2|COMPLETED|Washout||1
8452116|NCT00750308|20829764|P1|COMPLETED|Washout||2
8452117|NCT00750308|20829753|P12|STARTED|Washout||1
8452118|NCT00750308|20829754|P11|STARTED|Washout||1
8452119|NCT00750308|20829755|P10|STARTED|Washout||2
8452120|NCT00750308|20829756|P9|STARTED|Washout||1
8452121|NCT00750308|20829757|P8|STARTED|Washout||2
8452122|NCT00750308|20829758|P7|STARTED|Washout||2
8452123|NCT00750308|20829759|P6|STARTED|Washout||2
8452124|NCT00750308|20829760|P5|STARTED|Washout||1
8452125|NCT00750308|20829761|P4|STARTED|Washout||1
8452126|NCT00750308|20829762|P3|STARTED|Washout||2
8452127|NCT00750308|20829763|P2|STARTED|Washout||1
8452128|NCT00750308|20829764|P1|STARTED|Washout||2
8452129|NCT00750308|20829753|P12|NOT COMPLETED|Third Treatment||0
8452130|NCT00750308|20829754|P11|NOT COMPLETED|Third Treatment||0
8452131|NCT00750308|20829755|P10|NOT COMPLETED|Third Treatment||0
8452132|NCT00750308|20829756|P9|NOT COMPLETED|Third Treatment||0
8452133|NCT00750308|20829757|P8|NOT COMPLETED|Third Treatment||0
8452134|NCT00750308|20829758|P7|NOT COMPLETED|Third Treatment||0
8452135|NCT00750308|20829759|P6|NOT COMPLETED|Third Treatment||0
8452136|NCT00750308|20829760|P5|NOT COMPLETED|Third Treatment||0
8452137|NCT00750308|20829761|P4|NOT COMPLETED|Third Treatment||0
8452138|NCT00750308|20829762|P3|NOT COMPLETED|Third Treatment||0
8452139|NCT00750308|20829763|P2|NOT COMPLETED|Third Treatment||1
8452140|NCT00750308|20829764|P1|NOT COMPLETED|Third Treatment||0
8452141|NCT00750308|20829753|P12|COMPLETED|Third Treatment||1
8452142|NCT00750308|20829754|P11|COMPLETED|Third Treatment||1
8452143|NCT00750308|20829755|P10|COMPLETED|Third Treatment||2
8452144|NCT00750308|20829756|P9|COMPLETED|Third Treatment||1
8452145|NCT00750308|20829757|P8|COMPLETED|Third Treatment||2
8452146|NCT00750308|20829758|P7|COMPLETED|Third Treatment||2
8452147|NCT00750308|20829759|P6|COMPLETED|Third Treatment||2
8452148|NCT00750308|20829760|P5|COMPLETED|Third Treatment||1
8452149|NCT00750308|20829761|P4|COMPLETED|Third Treatment||1
8452150|NCT00750308|20829762|P3|COMPLETED|Third Treatment||2
8452151|NCT00750308|20829763|P2|COMPLETED|Third Treatment||1
8452152|NCT00750308|20829764|P1|COMPLETED|Third Treatment||2
8452153|NCT00750308|20829753|P12|STARTED|Third Treatment||1
8452154|NCT00750308|20829754|P11|STARTED|Third Treatment||1
8452155|NCT00750308|20829755|P10|STARTED|Third Treatment||2
8452156|NCT00750308|20829756|P9|STARTED|Third Treatment||1
8452157|NCT00750308|20829757|P8|STARTED|Third Treatment||2
8452158|NCT00750308|20829758|P7|STARTED|Third Treatment||2
8452159|NCT00750308|20829759|P6|STARTED|Third Treatment||2
8452160|NCT00750308|20829760|P5|STARTED|Third Treatment||1
8452161|NCT00750308|20829761|P4|STARTED|Third Treatment||1
8452162|NCT00750308|20829762|P3|STARTED|Third Treatment||2
8452163|NCT00750308|20829763|P2|STARTED|Third Treatment||2
8452164|NCT00750308|20829764|P1|STARTED|Third Treatment||2
8452165|NCT00750308|20829753|P12|NOT COMPLETED|Washout||0
8452166|NCT00750308|20829754|P11|NOT COMPLETED|Washout||0
8452167|NCT00750308|20829755|P10|NOT COMPLETED|Washout||0
8452168|NCT00750308|20829756|P9|NOT COMPLETED|Washout||0
8452169|NCT00750308|20829757|P8|NOT COMPLETED|Washout||0
8452170|NCT00750308|20829758|P7|NOT COMPLETED|Washout||0
8452171|NCT00750308|20829759|P6|NOT COMPLETED|Washout||0
8452172|NCT00750308|20829760|P5|NOT COMPLETED|Washout||0
8452173|NCT00750308|20829761|P4|NOT COMPLETED|Washout||0
8452174|NCT00750308|20829762|P3|NOT COMPLETED|Washout||0
8452175|NCT00750308|20829763|P2|NOT COMPLETED|Washout||0
8452176|NCT00750308|20829764|P1|NOT COMPLETED|Washout||0
8452177|NCT00750308|20829753|P12|COMPLETED|Washout||1
8452178|NCT00750308|20829754|P11|COMPLETED|Washout||1
8452179|NCT00750308|20829755|P10|COMPLETED|Washout||2
8452180|NCT00750308|20829756|P9|COMPLETED|Washout||1
8452181|NCT00750308|20829757|P8|COMPLETED|Washout||2
8452182|NCT00750308|20829758|P7|COMPLETED|Washout||2
8452183|NCT00750308|20829759|P6|COMPLETED|Washout||2
8452184|NCT00750308|20829760|P5|COMPLETED|Washout||1
8452185|NCT00750308|20829761|P4|COMPLETED|Washout||1
8452186|NCT00750308|20829762|P3|COMPLETED|Washout||2
8452187|NCT00750308|20829763|P2|COMPLETED|Washout||2
8452188|NCT00750308|20829764|P1|COMPLETED|Washout||2
8452189|NCT00750308|20829753|P12|STARTED|Washout||1
8452190|NCT00750308|20829754|P11|STARTED|Washout||1
8452191|NCT00750308|20829755|P10|STARTED|Washout||2
8452192|NCT00750308|20829756|P9|STARTED|Washout||1
8452193|NCT00750308|20829757|P8|STARTED|Washout||2
8452194|NCT00750308|20829758|P7|STARTED|Washout||2
8452195|NCT00750308|20829759|P6|STARTED|Washout||2
8452196|NCT00750308|20829760|P5|STARTED|Washout||1
8452197|NCT00750308|20829761|P4|STARTED|Washout||1
8452198|NCT00750308|20829762|P3|STARTED|Washout||2
8452199|NCT00750308|20829763|P2|STARTED|Washout||2
8452200|NCT00750308|20829764|P1|STARTED|Washout||2
8452201|NCT00750308|20829753|P12|NOT COMPLETED|Second Treatment||0
8452202|NCT00750308|20829754|P11|NOT COMPLETED|Second Treatment||0
8452203|NCT00750308|20829755|P10|NOT COMPLETED|Second Treatment||0
8452204|NCT00750308|20829756|P9|NOT COMPLETED|Second Treatment||1
8452205|NCT00750308|20829757|P8|NOT COMPLETED|Second Treatment||0
8452206|NCT00750308|20829758|P7|NOT COMPLETED|Second Treatment||0
8452207|NCT00750308|20829759|P6|NOT COMPLETED|Second Treatment||1
8452208|NCT00750308|20829760|P5|NOT COMPLETED|Second Treatment||1
8452209|NCT00750308|20829761|P4|NOT COMPLETED|Second Treatment||0
8452210|NCT00750308|20829762|P3|NOT COMPLETED|Second Treatment||0
8452211|NCT00750308|20829763|P2|NOT COMPLETED|Second Treatment||0
8452212|NCT00750308|20829764|P1|NOT COMPLETED|Second Treatment||0
8452213|NCT00750308|20829753|P12|COMPLETED|Second Treatment||1
8452214|NCT00750308|20829754|P11|COMPLETED|Second Treatment||1
8452215|NCT00750308|20829755|P10|COMPLETED|Second Treatment||2
8452216|NCT00750308|20829756|P9|COMPLETED|Second Treatment||1
8452217|NCT00750308|20829757|P8|COMPLETED|Second Treatment||2
8452218|NCT00750308|20829758|P7|COMPLETED|Second Treatment||2
8452219|NCT00750308|20829759|P6|COMPLETED|Second Treatment||2
8452220|NCT00750308|20829760|P5|COMPLETED|Second Treatment||1
8452221|NCT00750308|20829761|P4|COMPLETED|Second Treatment||1
8452222|NCT00750308|20829762|P3|COMPLETED|Second Treatment||2
8452223|NCT00750308|20829763|P2|COMPLETED|Second Treatment||2
8452224|NCT00750308|20829764|P1|COMPLETED|Second Treatment||2
8452225|NCT00750308|20829753|P12|STARTED|Second Treatment||1
8452226|NCT00750308|20829754|P11|STARTED|Second Treatment||1
8452227|NCT00750308|20829755|P10|STARTED|Second Treatment||2
8452228|NCT00750308|20829756|P9|STARTED|Second Treatment||2
8452229|NCT00750308|20829757|P8|STARTED|Second Treatment||2
8452230|NCT00750308|20829758|P7|STARTED|Second Treatment||2
8452231|NCT00750308|20829759|P6|STARTED|Second Treatment||3
8452232|NCT00750308|20829760|P5|STARTED|Second Treatment||2
8452233|NCT00750308|20829761|P4|STARTED|Second Treatment||1
8452234|NCT00750308|20829762|P3|STARTED|Second Treatment||2
8452235|NCT00750308|20829763|P2|STARTED|Second Treatment||2
8452236|NCT00750308|20829764|P1|STARTED|Second Treatment||2
8452237|NCT00750308|20829753|P12|NOT COMPLETED|Washout||0
8452238|NCT00750308|20829754|P11|NOT COMPLETED|Washout||0
8452239|NCT00750308|20829755|P10|NOT COMPLETED|Washout||0
8452240|NCT00750308|20829756|P9|NOT COMPLETED|Washout||0
8452241|NCT00750308|20829757|P8|NOT COMPLETED|Washout||0
8452242|NCT00750308|20829758|P7|NOT COMPLETED|Washout||0
8452243|NCT00750308|20829759|P6|NOT COMPLETED|Washout||0
8452244|NCT00750308|20829760|P5|NOT COMPLETED|Washout||0
8452245|NCT00750308|20829761|P4|NOT COMPLETED|Washout||0
8452246|NCT00750308|20829762|P3|NOT COMPLETED|Washout||0
8452247|NCT00750308|20829763|P2|NOT COMPLETED|Washout||0
8452248|NCT00750308|20829764|P1|NOT COMPLETED|Washout||0
8452249|NCT00750308|20829753|P12|COMPLETED|Washout||1
8452250|NCT00750308|20829754|P11|COMPLETED|Washout||1
8452251|NCT00750308|20829755|P10|COMPLETED|Washout||2
8452252|NCT00750308|20829756|P9|COMPLETED|Washout||2
8452253|NCT00750308|20829757|P8|COMPLETED|Washout||2
8452254|NCT00750308|20829758|P7|COMPLETED|Washout||2
8452255|NCT00750308|20829759|P6|COMPLETED|Washout||3
8452256|NCT00750308|20829760|P5|COMPLETED|Washout||2
8452257|NCT00750308|20829761|P4|COMPLETED|Washout||1
8452258|NCT00750308|20829762|P3|COMPLETED|Washout||2
8452259|NCT00750308|20829763|P2|COMPLETED|Washout||2
8452260|NCT00750308|20829764|P1|COMPLETED|Washout||2
8452261|NCT00750308|20829753|P12|STARTED|Washout||1
8452262|NCT00750308|20829754|P11|STARTED|Washout||1
8452263|NCT00750308|20829755|P10|STARTED|Washout||2
8452264|NCT00750308|20829756|P9|STARTED|Washout||2
8452265|NCT00750308|20829757|P8|STARTED|Washout||2
8452266|NCT00750308|20829758|P7|STARTED|Washout||2
8452267|NCT00750308|20829759|P6|STARTED|Washout||3
8452268|NCT00750308|20829760|P5|STARTED|Washout||2
8452269|NCT00750308|20829761|P4|STARTED|Washout||1
8452270|NCT00750308|20829762|P3|STARTED|Washout||2
8452271|NCT00750308|20829763|P2|STARTED|Washout||2
8452272|NCT00750308|20829764|P1|STARTED|Washout||2
8452273|NCT00750308|20829753|P12|NOT COMPLETED|First Treatment||1
8452274|NCT00750308|20829754|P11|NOT COMPLETED|First Treatment||1
8452275|NCT00750308|20829755|P10|NOT COMPLETED|First Treatment||0
8452276|NCT00750308|20829756|P9|NOT COMPLETED|First Treatment||0
8452277|NCT00750308|20829757|P8|NOT COMPLETED|First Treatment||1
8452278|NCT00750308|20829758|P7|NOT COMPLETED|First Treatment||0
8452279|NCT00750308|20829759|P6|NOT COMPLETED|First Treatment||0
8452280|NCT00750308|20829760|P5|NOT COMPLETED|First Treatment||0
8452281|NCT00750308|20829761|P4|NOT COMPLETED|First Treatment||1
8452282|NCT00750308|20829762|P3|NOT COMPLETED|First Treatment||0
8452283|NCT00750308|20829763|P2|NOT COMPLETED|First Treatment||1
8452284|NCT00750308|20829764|P1|NOT COMPLETED|First Treatment||0
8452285|NCT00750308|20829753|P12|COMPLETED|First Treatment||1
8452286|NCT00750308|20829754|P11|COMPLETED|First Treatment||1
8452287|NCT00750308|20829755|P10|COMPLETED|First Treatment||2
8452288|NCT00750308|20829756|P9|COMPLETED|First Treatment||2
8452289|NCT00750308|20829757|P8|COMPLETED|First Treatment||2
8452290|NCT00750308|20829758|P7|COMPLETED|First Treatment||2
8452291|NCT00750308|20829759|P6|COMPLETED|First Treatment||3
8452292|NCT00750308|20829760|P5|COMPLETED|First Treatment||2
8452293|NCT00750308|20829761|P4|COMPLETED|First Treatment||1
8452294|NCT00750308|20829762|P3|COMPLETED|First Treatment||2
8452295|NCT00750308|20829763|P2|COMPLETED|First Treatment||2
8452296|NCT00750308|20829764|P1|COMPLETED|First Treatment||2
8452297|NCT00750308|20829753|P12|STARTED|First Treatment||2
8452298|NCT00750308|20829754|P11|STARTED|First Treatment||2
8452299|NCT00750308|20829755|P10|STARTED|First Treatment||2
8452300|NCT00750308|20829756|P9|STARTED|First Treatment||2
8452301|NCT00750308|20829757|P8|STARTED|First Treatment||3
8452302|NCT00750308|20829758|P7|STARTED|First Treatment||2
8452303|NCT00750308|20829759|P6|STARTED|First Treatment||3
8452304|NCT00750308|20829760|P5|STARTED|First Treatment||2
8452305|NCT00750308|20829761|P4|STARTED|First Treatment||2
8452306|NCT00750308|20829762|P3|STARTED|First Treatment||2
8452307|NCT00750308|20829763|P2|STARTED|First Treatment||3
8452308|NCT00750308|20829764|P1|STARTED|First Treatment|One female withdrew due to muscle pain|2
8452309|NCT00750282|20829782|P4|NOT COMPLETED|Overall Study||1
8452310|NCT00750282|20829783|P3|NOT COMPLETED|Overall Study||1
8452311|NCT00750282|20829784|P2|NOT COMPLETED|Overall Study||1
8452312|NCT00750282|20829785|P1|NOT COMPLETED|Overall Study||0
8452313|NCT00750282|20829782|P4|COMPLETED|Overall Study||147
8452314|NCT00750282|20829783|P3|COMPLETED|Overall Study||125
8452315|NCT00750282|20829784|P2|COMPLETED|Overall Study||81
8452316|NCT00750282|20829785|P1|COMPLETED|Overall Study||69
8452317|NCT00750282|20829782|P4|STARTED|Overall Study||148
8452318|NCT00750282|20829783|P3|STARTED|Overall Study||126
8452319|NCT00750282|20829784|P2|STARTED|Overall Study||82
8452320|NCT00750282|20829785|P1|STARTED|Overall Study||69
8452321|NCT00750269|20829814|P5|NOT COMPLETED|Overall Study||10
8452322|NCT00750269|20829815|P4|NOT COMPLETED|Overall Study||5
8452323|NCT00750269|20829816|P3|NOT COMPLETED|Overall Study||4
8452324|NCT00750269|20829817|P2|NOT COMPLETED|Overall Study||1
8452325|NCT00750269|20829818|P1|NOT COMPLETED|Overall Study||0
8452326|NCT00750269|20829814|P5|COMPLETED|Overall Study||33
8452327|NCT00750269|20829815|P4|COMPLETED|Overall Study||38
8452328|NCT00750269|20829816|P3|COMPLETED|Overall Study||14
8452329|NCT00750269|20829817|P2|COMPLETED|Overall Study||7
8452330|NCT00750269|20829818|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
8452331|NCT00750269|20829814|P5|STARTED|Overall Study||43
8452332|NCT00750269|20829815|P4|STARTED|Overall Study||43
8452333|NCT00750269|20829816|P3|STARTED|Overall Study||18
8452334|NCT00750269|20829817|P2|STARTED|Overall Study||8
8452335|NCT00750269|20829818|P1|STARTED|Overall Study||8
8452336|NCT00750204|20829865|P2|NOT COMPLETED|Overall Study||1
8452337|NCT00750204|20829866|P1|NOT COMPLETED|Overall Study||1
8452338|NCT00750204|20829865|P2|COMPLETED|Overall Study||0
8452339|NCT00750204|20829866|P1|COMPLETED|Overall Study||0
8452340|NCT00750204|20829865|P2|STARTED|Overall Study||1
8452341|NCT00750204|20829866|P1|STARTED|Overall Study||1
8452342|NCT00750191|20829874|P2|NOT COMPLETED|Overall Study||10
8452343|NCT00750191|20829875|P1|NOT COMPLETED|Overall Study||5
8452344|NCT00750191|20829874|P2|COMPLETED|Overall Study||20
8452345|NCT00750191|20829875|P1|COMPLETED|Overall Study||22
8452346|NCT00750191|20829874|P2|STARTED|Overall Study||30
8452347|NCT00750191|20829875|P1|STARTED|Overall Study||27
8452348|NCT00750165|20829887|P1|NOT COMPLETED|Overall Study||11
8452349|NCT00750165|20829887|P1|COMPLETED|Overall Study||21
8452350|NCT00750165|20829887|P1|STARTED|Overall Study||32
8452351|NCT00750152|20829896|P2|NOT COMPLETED|Overall Study||27
8452352|NCT00750152|20829897|P1|NOT COMPLETED|Overall Study||22
8452353|NCT00750152|20829896|P2|COMPLETED|Overall Study||141
8452354|NCT00750152|20829897|P1|COMPLETED|Overall Study||144
8452355|NCT00750152|20829896|P2|STARTED|Overall Study||168
8452356|NCT00750152|20829897|P1|STARTED|Overall Study||166
8452357|NCT00750139|20829909|P4|NOT COMPLETED|Overall Study||46
8452358|NCT00750139|20829910|P3|NOT COMPLETED|Overall Study||101
8452359|NCT00750139|20829911|P2|NOT COMPLETED|Overall Study||59
8452360|NCT00750139|20829912|P1|NOT COMPLETED|Overall Study||89
8452361|NCT00750139|20829909|P4|COMPLETED|Overall Study||73
8452362|NCT00750139|20829910|P3|COMPLETED|Overall Study||135
8452363|NCT00750139|20829911|P2|COMPLETED|Overall Study||59
8452364|NCT00750139|20829912|P1|COMPLETED|Overall Study||145
8452365|NCT00750139|20829909|P4|STARTED|Overall Study||119
8452366|NCT00750139|20829910|P3|STARTED|Overall Study||236
8452367|NCT00750139|20829911|P2|STARTED|Overall Study||118
8452368|NCT00750139|20829912|P1|STARTED|Overall Study||234
8452369|NCT00750061|20829928|P2|NOT COMPLETED|Overall Study||2
8452370|NCT00750061|20829929|P1|NOT COMPLETED|Overall Study||2
8452371|NCT00750061|20829928|P2|COMPLETED|Overall Study||18
8452372|NCT00750061|20829929|P1|COMPLETED|Overall Study||18
8452373|NCT00750061|20829928|P2|STARTED|Overall Study||20
8452374|NCT00750061|20829929|P1|STARTED|Overall Study||20
8452375|NCT00749996|20829939|P2|NOT COMPLETED|Overall Study||13
8452376|NCT00749996|20829940|P1|NOT COMPLETED|Overall Study||18
8452377|NCT00749996|20829939|P2|COMPLETED|Overall Study||58
8452378|NCT00749996|20829940|P1|COMPLETED|Overall Study||57
8452379|NCT00749996|20829939|P2|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
8452380|NCT00749996|20829940|P1|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
8452381|NCT00749996|20829939|P2|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
8452382|NCT00749996|20829940|P1|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
8452383|NCT00749996|20829939|P2|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
8452384|NCT00749996|20829940|P1|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
8452385|NCT00749996|20829939|P2|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
8452386|NCT00749996|20829940|P1|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
8452387|NCT00749996|20829939|P2|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
8452388|NCT00749996|20829940|P1|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
8452389|NCT00749996|20829939|P2|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
8452390|NCT00749996|20829940|P1|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
8452391|NCT00749957|20829950|P2|NOT COMPLETED|Overall Study||0
8452392|NCT00749957|20829951|P1|NOT COMPLETED|Overall Study||0
8452393|NCT00749957|20829950|P2|COMPLETED|Overall Study||6
8452394|NCT00749957|20829951|P1|COMPLETED|Overall Study||6
8452395|NCT00749957|20829950|P2|STARTED|Overall Study||6
8452396|NCT00749957|20829951|P1|STARTED|Overall Study||6
8452397|NCT00749944|20829963|P2|NOT COMPLETED|Overall Study||1
8452398|NCT00749944|20829964|P1|NOT COMPLETED|Overall Study||5
8452399|NCT00749944|20829963|P2|COMPLETED|Overall Study||54
8452400|NCT00749944|20829964|P1|COMPLETED|Overall Study||50
8452401|NCT00749944|20829963|P2|STARTED|Overall Study||55
8452402|NCT00749944|20829964|P1|STARTED|Overall Study||55
8452403|NCT00749931|20830032|P3|NOT COMPLETED|Overall Study||0
8452404|NCT00749931|20830033|P2|NOT COMPLETED|Overall Study||0
8452405|NCT00749931|20830034|P1|NOT COMPLETED|Overall Study||0
8452406|NCT00749931|20830032|P3|COMPLETED|Overall Study||68
8452407|NCT00749931|20830033|P2|COMPLETED|Overall Study||298
8452408|NCT00749931|20830034|P1|COMPLETED|Overall Study||298
8452409|NCT00749931|20830032|P3|STARTED|Overall Study||68
8452410|NCT00749931|20830033|P2|STARTED|Overall Study||298
8452411|NCT00749931|20830034|P1|STARTED|Overall Study||298
8452412|NCT00749892|20830043|P1|NOT COMPLETED|Overall Study||3
8452413|NCT00749892|20830043|P1|COMPLETED|Overall Study||31
8452414|NCT00749892|20830043|P1|STARTED|Overall Study||34
8452415|NCT00749879|20830047|P1|NOT COMPLETED|Overall Study||0
8452416|NCT00749879|20830047|P1|COMPLETED|Overall Study||12
8452417|NCT00749879|20830047|P1|STARTED|Overall Study||12
8452418|NCT00749775|20830079|P1|NOT COMPLETED|Overall Study||107
8452419|NCT00749775|20830079|P1|COMPLETED|Overall Study||3210
8452420|NCT00749775|20830079|P1|STARTED|Overall Study||3317
8452421|NCT00749749|20830097|P2|NOT COMPLETED|Overall Study||0
8452422|NCT00749749|20830098|P1|NOT COMPLETED|Overall Study||0
8452423|NCT00749749|20830097|P2|COMPLETED|Overall Study||13
8452424|NCT00749749|20830098|P1|COMPLETED|Overall Study||14
8452425|NCT00749749|20830097|P2|STARTED|Overall Study||13
8452426|NCT00749749|20830098|P1|STARTED|Overall Study||14
8452427|NCT00749684|20830116|P1|NOT COMPLETED|Overall Study||82
8452428|NCT00749684|20830116|P1|COMPLETED|Overall Study||56
8452429|NCT00749684|20830116|P1|STARTED|Overall Study||138
8452430|NCT00749671|20830123|P2|NOT COMPLETED|Overall Study||0
8452431|NCT00749671|20830124|P1|NOT COMPLETED|Overall Study||0
8452432|NCT00749671|20830123|P2|COMPLETED|Overall Study||9
8452433|NCT00749671|20830124|P1|COMPLETED|Overall Study||11
8452434|NCT00749671|20830123|P2|STARTED|Overall Study||9
8452435|NCT00749671|20830124|P1|STARTED|Overall Study||11
8452436|NCT00749658|20830134|P2|NOT COMPLETED|Overall Study||0
8452437|NCT00749658|20830135|P1|NOT COMPLETED|Overall Study||0
8452438|NCT00749658|20830134|P2|COMPLETED|Overall Study||61
8452439|NCT00749658|20830135|P1|COMPLETED|Overall Study||60
8452440|NCT00749658|20830134|P2|STARTED|Overall Study||61
8452441|NCT00749658|20830135|P1|STARTED|Overall Study||60
8452442|NCT00749606|20830143|P2|NOT COMPLETED|Year 3 (Observation)||3
8452443|NCT00749606|20830144|P1|NOT COMPLETED|Year 3 (Observation)||0
8452444|NCT00749606|20830143|P2|COMPLETED|Year 3 (Observation)||69
8452445|NCT00749606|20830144|P1|COMPLETED|Year 3 (Observation)||63
8452446|NCT00749606|20830143|P2|STARTED|Year 3 (Observation)||72
8452447|NCT00749606|20830144|P1|STARTED|Year 3 (Observation)||63
8452448|NCT00749606|20830143|P2|NOT COMPLETED|Year 2||8
8452449|NCT00749606|20830144|P1|NOT COMPLETED|Year 2||11
8452450|NCT00749606|20830143|P2|COMPLETED|Year 2||72
8452451|NCT00749606|20830144|P1|COMPLETED|Year 2||63
8452452|NCT00749606|20830143|P2|STARTED|Year 2||80
8452453|NCT00749606|20830144|P1|STARTED|Year 2||74
8452454|NCT00749606|20830143|P2|NOT COMPLETED|Year 1||48
8452455|NCT00749606|20830144|P1|NOT COMPLETED|Year 1||55
8452456|NCT00749606|20830143|P2|COMPLETED|Year 1||80
8452457|NCT00749606|20830144|P1|COMPLETED|Year 1||74
8452458|NCT00749606|20830143|P2|STARTED|Year 1||128
8452459|NCT00749606|20830144|P1|STARTED|Year 1||129
8452460|NCT00749580|20830164|P2|NOT COMPLETED|Overall Study||9
8452461|NCT00749580|20830165|P1|NOT COMPLETED|Overall Study||4
8452462|NCT00749580|20830164|P2|COMPLETED|Overall Study||16
8452463|NCT00749580|20830165|P1|COMPLETED|Overall Study|December 2010|17
8452464|NCT00749580|20830164|P2|STARTED|Overall Study||25
8452465|NCT00749580|20830165|P1|STARTED|Overall Study|September 2008|21
8452466|NCT00749515|20830175|P2|NOT COMPLETED|Overall Study||0
8452467|NCT00749515|20830176|P1|NOT COMPLETED|Overall Study||0
8452468|NCT00749515|20830175|P2|COMPLETED|Overall Study||5
8452469|NCT00749515|20830176|P1|COMPLETED|Overall Study||10
8452470|NCT00749515|20830175|P2|STARTED|Overall Study||5
8452471|NCT00749515|20830176|P1|STARTED|Overall Study||10
8452472|NCT00749476|20830192|P1|NOT COMPLETED|Overall Study||0
8452473|NCT00749476|20830192|P1|COMPLETED|Overall Study||1
8452474|NCT00749476|20830192|P1|STARTED|Overall Study||1
8452475|NCT00749463|20830199|P3|NOT COMPLETED|Overall Study||1
8452476|NCT00749463|20830200|P2|NOT COMPLETED|Overall Study||4
8452477|NCT00749463|20830201|P1|NOT COMPLETED|Overall Study||1
8452478|NCT00749463|20830199|P3|COMPLETED|Overall Study||149
8452479|NCT00749463|20830200|P2|COMPLETED|Overall Study||60
8452480|NCT00749463|20830201|P1|COMPLETED|Overall Study||85
8452481|NCT00749463|20830199|P3|STARTED|Overall Study||150
8452482|NCT00749463|20830200|P2|STARTED|Overall Study||64
8452483|NCT00749463|20830201|P1|STARTED|Overall Study||86
8452484|NCT00749411|20830229|P2|NOT COMPLETED|Overall Study||5
8452485|NCT00749411|20830230|P1|NOT COMPLETED|Overall Study||1
8452486|NCT00749411|20830229|P2|COMPLETED|Overall Study||35
8452487|NCT00749411|20830230|P1|COMPLETED|Overall Study||20
8452488|NCT00749411|20830229|P2|STARTED|Overall Study||40
8452489|NCT00749411|20830230|P1|STARTED|Overall Study||21
8452490|NCT00749398|20830238|P1|NOT COMPLETED|Overall Study||53
8452491|NCT00749398|20830238|P1|COMPLETED|Overall Study||71
8452492|NCT00749398|20830238|P1|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
8452493|NCT00749268|20830256|P2|NOT COMPLETED|Overall Study||36
8452494|NCT00749268|20830257|P1|NOT COMPLETED|Overall Study||34
8452495|NCT00749268|20830256|P2|COMPLETED|Overall Study||74
8452496|NCT00749268|20830257|P1|COMPLETED|Overall Study||72
8452497|NCT00749268|20830256|P2|STARTED|Overall Study||110
8452498|NCT00749268|20830257|P1|STARTED|Overall Study||106
8452499|NCT00749203|20830281|P2|NOT COMPLETED|Second Infusion at 2 Weeks||2
8452500|NCT00749203|20830282|P1|NOT COMPLETED|Second Infusion at 2 Weeks||0
8452501|NCT00749203|20830281|P2|COMPLETED|Second Infusion at 2 Weeks||13
8452502|NCT00749203|20830282|P1|COMPLETED|Second Infusion at 2 Weeks||16
8452503|NCT00749203|20830281|P2|STARTED|Second Infusion at 2 Weeks||15
8452504|NCT00749203|20830282|P1|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
8452505|NCT00749203|20830281|P2|NOT COMPLETED|no Infusion at Week 1||4
8452506|NCT00749203|20830282|P1|NOT COMPLETED|no Infusion at Week 1||0
8452507|NCT00749203|20830281|P2|COMPLETED|no Infusion at Week 1||15
8452508|NCT00749203|20830282|P1|COMPLETED|no Infusion at Week 1||22
8452509|NCT00749203|20830281|P2|STARTED|no Infusion at Week 1||19
8452510|NCT00749203|20830282|P1|STARTED|no Infusion at Week 1||22
8452511|NCT00749203|20830281|P2|NOT COMPLETED|First Infusion Day 1||0
8452512|NCT00749203|20830282|P1|NOT COMPLETED|First Infusion Day 1||0
8452513|NCT00749203|20830281|P2|COMPLETED|First Infusion Day 1||19
8452514|NCT00749203|20830282|P1|COMPLETED|First Infusion Day 1||22
8452515|NCT00749203|20830281|P2|STARTED|First Infusion Day 1||19
8452516|NCT00749203|20830282|P1|STARTED|First Infusion Day 1||22
8452517|NCT00749190|20830303|P7|NOT COMPLETED|Overall Study||1
8452518|NCT00749190|20830304|P6|NOT COMPLETED|Overall Study||5
8452519|NCT00749190|20830305|P5|NOT COMPLETED|Overall Study||0
8452520|NCT00749190|20830306|P4|NOT COMPLETED|Overall Study||5
8452521|NCT00749190|20830307|P3|NOT COMPLETED|Overall Study||1
8452522|NCT00749190|20830308|P2|NOT COMPLETED|Overall Study||5
8452523|NCT00749190|20830309|P1|NOT COMPLETED|Overall Study||5
8452524|NCT00749190|20830303|P7|COMPLETED|Overall Study||70
8452525|NCT00749190|20830304|P6|COMPLETED|Overall Study||65
8452526|NCT00749190|20830305|P5|COMPLETED|Overall Study||70
8452527|NCT00749190|20830306|P4|COMPLETED|Overall Study||66
8452528|NCT00749190|20830307|P3|COMPLETED|Overall Study||70
8452529|NCT00749190|20830308|P2|COMPLETED|Overall Study||66
8452530|NCT00749190|20830309|P1|COMPLETED|Overall Study||66
8452531|NCT00749190|20830303|P7|STARTED|Overall Study||71
8452532|NCT00749190|20830304|P6|STARTED|Overall Study||70
8452533|NCT00749190|20830305|P5|STARTED|Overall Study||70
8452534|NCT00749190|20830306|P4|STARTED|Overall Study||71
8452535|NCT00749190|20830307|P3|STARTED|Overall Study||71
8452536|NCT00749190|20830308|P2|STARTED|Overall Study||71
8452537|NCT00749190|20830309|P1|STARTED|Overall Study||71
8452538|NCT00749125|20830388|P2|NOT COMPLETED|Overall Study||18
8452539|NCT00749125|20830389|P1|NOT COMPLETED|Overall Study||11
8452540|NCT00749125|20830388|P2|COMPLETED|Overall Study||34
8452541|NCT00749125|20830389|P1|COMPLETED|Overall Study||36
8452542|NCT00749125|20830388|P2|STARTED|Overall Study||52
8452543|NCT00749125|20830389|P1|STARTED|Overall Study||47
8452544|NCT00749073|20830395|P1|NOT COMPLETED|Overall Study||0
8452545|NCT00749073|20830395|P1|COMPLETED|Overall Study||10
8452546|NCT00749073|20830395|P1|STARTED|Overall Study||10
8452547|NCT00748982|20830403|P2|NOT COMPLETED|Overall Study||0
8452548|NCT00748982|20830404|P1|NOT COMPLETED|Overall Study||0
8452549|NCT00748982|20830403|P2|COMPLETED|Overall Study||4
8452550|NCT00748982|20830404|P1|COMPLETED|Overall Study||12
8452551|NCT00748982|20830403|P2|STARTED|Overall Study||4
8452552|NCT00748982|20830404|P1|STARTED|Overall Study||12
8452553|NCT00748969|20830418|P2|NOT COMPLETED|Overall Study||1
8452554|NCT00748969|20830419|P1|NOT COMPLETED|Overall Study||1
8452555|NCT00748969|20830418|P2|COMPLETED|Overall Study||0
8452556|NCT00748969|20830419|P1|COMPLETED|Overall Study||0
8452557|NCT00748969|20830418|P2|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
8452558|NCT00748969|20830419|P1|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
8452559|NCT00748956|20830430|P3|NOT COMPLETED|Overall Study||0
8452560|NCT00748956|20830431|P2|NOT COMPLETED|Overall Study||0
8452561|NCT00748956|20830432|P1|NOT COMPLETED|Overall Study||0
8452562|NCT00748956|20830430|P3|COMPLETED|Overall Study||5
8452563|NCT00748956|20830431|P2|COMPLETED|Overall Study||5
8452564|NCT00748956|20830432|P1|COMPLETED|Overall Study||0
8452565|NCT00748956|20830430|P3|STARTED|Overall Study||5
8452566|NCT00748956|20830431|P2|STARTED|Overall Study||5
8452567|NCT00748956|20830432|P1|STARTED|Overall Study||0
8452568|NCT00748865|20830455|P2|NOT COMPLETED|Overall Study||0
8452569|NCT00748865|20830456|P1|NOT COMPLETED|Overall Study||0
8452570|NCT00748865|20830455|P2|COMPLETED|Overall Study||10
8452571|NCT00748865|20830456|P1|COMPLETED|Overall Study||10
8452572|NCT00748865|20830455|P2|STARTED|Overall Study||10
8452573|NCT00748865|20830456|P1|STARTED|Overall Study||10
8452574|NCT00748826|20830462|P1|NOT COMPLETED|Overall Study||301
8452575|NCT00748826|20830462|P1|COMPLETED|Overall Study||207
8452576|NCT00748826|20830462|P1|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
8452577|NCT00748709|20830469|P1|NOT COMPLETED|Overall Study||20
8452578|NCT00748709|20830469|P1|COMPLETED|Overall Study||0
8452579|NCT00748709|20830469|P1|STARTED|Overall Study|Treated|20
8452580|NCT00748657|20830481|P1|NOT COMPLETED|Overall Study||0
8452581|NCT00748657|20830481|P1|COMPLETED|Overall Study||36
8452582|NCT00748657|20830481|P1|STARTED|Overall Study||36
8452583|NCT00748579|20830495|P2|NOT COMPLETED|Overall Study||0
8452584|NCT00748579|20830496|P1|NOT COMPLETED|Overall Study||0
8452585|NCT00748579|20830495|P2|COMPLETED|Overall Study||0
8452586|NCT00748579|20830496|P1|COMPLETED|Overall Study||2
8452587|NCT00748579|20830495|P2|STARTED|Overall Study||0
8452588|NCT00748579|20830496|P1|STARTED|Overall Study||2
8452592|NCT00748553|20830542|P2|NOT COMPLETED|Overall Study||1
8452593|NCT00748553|20830543|P1|NOT COMPLETED|Overall Study||3
8452594|NCT00748553|20830542|P2|COMPLETED|Overall Study||13
8452595|NCT00748553|20830543|P1|COMPLETED|Overall Study||13
8452596|NCT00748553|20830542|P2|STARTED|Overall Study||14
8452597|NCT00748553|20830543|P1|STARTED|Overall Study||16
8452598|NCT00748540|20830550|P1|NOT COMPLETED|Overall Study||1
8452599|NCT00748540|20830550|P1|COMPLETED|Overall Study||49
8452600|NCT00748540|20830550|P1|STARTED|Overall Study||50
8452601|NCT00748410|20830559|P2|NOT COMPLETED|Overall Study||0
8452602|NCT00748410|20830560|P1|NOT COMPLETED|Overall Study||0
8452603|NCT00748410|20830559|P2|COMPLETED|Overall Study||2
8452604|NCT00748410|20830560|P1|COMPLETED|Overall Study||1
8452605|NCT00748410|20830559|P2|STARTED|Overall Study||2
8452606|NCT00748410|20830560|P1|STARTED|Overall Study||1
8452607|NCT00748241|20830576|P1|NOT COMPLETED|Overall Study||8
8452608|NCT00748241|20830576|P1|COMPLETED|Overall Study||11
8452609|NCT00748241|20830576|P1|STARTED|Overall Study||19
8452610|NCT00748215|20830586|P2|NOT COMPLETED|Overall Study||18
8452611|NCT00748215|20830587|P1|NOT COMPLETED|Overall Study||9
8452612|NCT00748215|20830586|P2|COMPLETED|Overall Study||32
8452613|NCT00748215|20830587|P1|COMPLETED|Overall Study||41
8452614|NCT00748215|20830586|P2|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||17
8452615|NCT00748215|20830587|P1|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||22
8452616|NCT00748215|20830586|P2|STARTED|Overall Study||50
8452617|NCT00748215|20830587|P1|STARTED|Overall Study||50
8452618|NCT00748189|20830595|P2|NOT COMPLETED|Overall Study||212
8452619|NCT00748189|20830596|P1|NOT COMPLETED|Overall Study||216
8452620|NCT00748189|20830595|P2|COMPLETED|Overall Study||9
8452621|NCT00748189|20830596|P1|COMPLETED|Overall Study||10
8452622|NCT00748189|20830595|P2|STARTED|Overall Study||221
8452623|NCT00748189|20830596|P1|STARTED|Overall Study||226
8452624|NCT00748098|20830651|P2|NOT COMPLETED|Second Taper Period||0
8452625|NCT00748098|20830652|P1|NOT COMPLETED|Second Taper Period||0
8452626|NCT00748098|20830651|P2|COMPLETED|Second Taper Period||61
8452627|NCT00748098|20830652|P1|COMPLETED|Second Taper Period||53
8452628|NCT00748098|20830651|P2|STARTED|Second Taper Period||61
8452629|NCT00748098|20830652|P1|STARTED|Second Taper Period||53
8452630|NCT00748098|20830651|P2|NOT COMPLETED|Second Treatment Intervention Period||3
8452631|NCT00748098|20830652|P1|NOT COMPLETED|Second Treatment Intervention Period||6
8452632|NCT00748098|20830651|P2|COMPLETED|Second Treatment Intervention Period||61
8452633|NCT00748098|20830652|P1|COMPLETED|Second Treatment Intervention Period||53
8452634|NCT00748098|20830651|P2|STARTED|Second Treatment Intervention Period||64
8452635|NCT00748098|20830652|P1|STARTED|Second Treatment Intervention Period||59
8452636|NCT00748098|20830651|P2|NOT COMPLETED|1-Week Washout Period||1
8452637|NCT00748098|20830652|P1|NOT COMPLETED|1-Week Washout Period||2
8452638|NCT00748098|20830651|P2|COMPLETED|1-Week Washout Period||64
8452639|NCT00748098|20830652|P1|COMPLETED|1-Week Washout Period||59
8452640|NCT00748098|20830651|P2|STARTED|1-Week Washout Period||65
8452641|NCT00748098|20830652|P1|STARTED|1-Week Washout Period||61
8452642|NCT00748098|20830651|P2|NOT COMPLETED|First Taper Period||1
8452643|NCT00748098|20830652|P1|NOT COMPLETED|First Taper Period||3
8452644|NCT00748098|20830651|P2|COMPLETED|First Taper Period||65
8452645|NCT00748098|20830652|P1|COMPLETED|First Taper Period||61
8452646|NCT00748098|20830651|P2|STARTED|First Taper Period||66
8452647|NCT00748098|20830652|P1|STARTED|First Taper Period||64
8452648|NCT00748098|20830651|P2|NOT COMPLETED|First Treatment Intervention Period||1
8452649|NCT00748098|20830652|P1|NOT COMPLETED|First Treatment Intervention Period||5
8452650|NCT00748098|20830651|P2|COMPLETED|First Treatment Intervention Period||66
8452651|NCT00748098|20830652|P1|COMPLETED|First Treatment Intervention Period||64
8452652|NCT00748098|20830651|P2|STARTED|First Treatment Intervention Period||67
8452653|NCT00748098|20830652|P1|STARTED|First Treatment Intervention Period||69
8452654|NCT00748085|20830712|P1|NOT COMPLETED|Overall Study||0
8452655|NCT00748085|20830712|P1|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
8452656|NCT00748085|20830712|P1|STARTED|Overall Study||5
8452657|NCT00748072|20830719|P2|NOT COMPLETED|Overall Study||0
8452658|NCT00748072|20830720|P1|NOT COMPLETED|Overall Study||0
8452659|NCT00748072|20830719|P2|COMPLETED|Overall Study||80
8452660|NCT00748072|20830720|P1|COMPLETED|Overall Study||82
8452661|NCT00748072|20830719|P2|STARTED|Overall Study||80
8452662|NCT00748072|20830720|P1|STARTED|Overall Study||82
8452663|NCT00747916|20830726|P1|NOT COMPLETED|Overall Study||0
8452664|NCT00747916|20830726|P1|COMPLETED|Overall Study||3
8452665|NCT00747916|20830726|P1|STARTED|Overall Study||3
8452666|NCT00747812|20830733|P2|NOT COMPLETED|Overall Study||3
8452667|NCT00747812|20830734|P1|NOT COMPLETED|Overall Study||5
8452668|NCT00747812|20830733|P2|COMPLETED|Overall Study||0
8452669|NCT00747812|20830734|P1|COMPLETED|Overall Study||0
8452670|NCT00747812|20830733|P2|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
8452671|NCT00747812|20830734|P1|STARTED|Overall Study||5
8452672|NCT00747747|20830745|P3|NOT COMPLETED|Overall Study||0
8452673|NCT00747747|20830746|P2|NOT COMPLETED|Overall Study||0
8452674|NCT00747747|20830747|P1|NOT COMPLETED|Overall Study||0
8452675|NCT00747747|20830745|P3|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
8452676|NCT00747747|20830746|P2|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
8452677|NCT00747747|20830747|P1|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
8452678|NCT00747747|20830745|P3|STARTED|Overall Study||21
8452679|NCT00747747|20830746|P2|STARTED|Overall Study||14
8452680|NCT00747747|20830747|P1|STARTED|Overall Study||14
8452681|NCT00747643|20830772|P2|NOT COMPLETED|Overall Study||27
8452682|NCT00747643|20830773|P1|NOT COMPLETED|Overall Study||36
8452683|NCT00747643|20830772|P2|COMPLETED|Overall Study||54
8452684|NCT00747643|20830773|P1|COMPLETED|Overall Study||46
8452685|NCT00747643|20830772|P2|STARTED|Overall Study||81
8452686|NCT00747643|20830773|P1|STARTED|Overall Study||82
8452687|NCT00747617|20830787|P2|NOT COMPLETED|Overall Study||1
8452688|NCT00747617|20830788|P1|NOT COMPLETED|Overall Study||3
8452689|NCT00747617|20830787|P2|COMPLETED|Overall Study||11
8452690|NCT00747617|20830788|P1|COMPLETED|Overall Study||10
8452691|NCT00747617|20830787|P2|STARTED|Overall Study||12
8452692|NCT00747617|20830788|P1|STARTED|Overall Study||13
8452693|NCT00747565|20830798|P2|NOT COMPLETED|Overall Study||7
8452694|NCT00747565|20830799|P1|NOT COMPLETED|Overall Study||14
8452695|NCT00747565|20830798|P2|COMPLETED|Overall Study||116
8452696|NCT00747565|20830799|P1|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
8452697|NCT00747565|20830798|P2|STARTED|Overall Study||123
8452698|NCT00747565|20830799|P1|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
8452699|NCT00747552|20830807|P1|NOT COMPLETED|Overall Study||0
8452700|NCT00747552|20830807|P1|COMPLETED|Overall Study||30
8452701|NCT00747552|20830807|P1|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
8452702|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452703|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452704|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452705|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452706|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452707|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452708|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452709|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452710|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452711|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452712|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452713|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452714|NCT00747474|20830812|P12|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
8452715|NCT00747474|20830813|P11|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452716|NCT00747474|20830814|P10|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452717|NCT00747474|20830815|P9|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452718|NCT00747474|20830816|P8|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452719|NCT00747474|20830817|P7|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452720|NCT00747474|20830818|P6|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452721|NCT00747474|20830819|P5|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452722|NCT00747474|20830820|P4|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452723|NCT00747474|20830821|P3|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452724|NCT00747474|20830822|P2|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452725|NCT00747474|20830823|P1|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
8452726|NCT00747474|20830812|P12|STARTED|Cohort 12 (60 mg/m^2) Period||6
8452727|NCT00747474|20830813|P11|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452728|NCT00747474|20830814|P10|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452729|NCT00747474|20830815|P9|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452730|NCT00747474|20830816|P8|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452731|NCT00747474|20830817|P7|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452732|NCT00747474|20830818|P6|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452733|NCT00747474|20830819|P5|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452734|NCT00747474|20830820|P4|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452735|NCT00747474|20830821|P3|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452736|NCT00747474|20830822|P2|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452737|NCT00747474|20830823|P1|STARTED|Cohort 12 (60 mg/m^2) Period||0
8452738|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452739|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452740|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452741|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452742|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452743|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452744|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452745|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452746|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452747|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452748|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452749|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452750|NCT00747474|20830812|P12|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452751|NCT00747474|20830813|P11|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
8452752|NCT00747474|20830814|P10|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452753|NCT00747474|20830815|P9|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452754|NCT00747474|20830816|P8|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452755|NCT00747474|20830817|P7|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452756|NCT00747474|20830818|P6|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452757|NCT00747474|20830819|P5|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452758|NCT00747474|20830820|P4|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452759|NCT00747474|20830821|P3|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452760|NCT00747474|20830822|P2|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452761|NCT00747474|20830823|P1|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
8452762|NCT00747474|20830812|P12|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452763|NCT00747474|20830813|P11|STARTED|Cohort 11 (50 mg/m^2) Period||5
8452764|NCT00747474|20830814|P10|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452765|NCT00747474|20830815|P9|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452766|NCT00747474|20830816|P8|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452767|NCT00747474|20830817|P7|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452768|NCT00747474|20830818|P6|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452769|NCT00747474|20830819|P5|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452770|NCT00747474|20830820|P4|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452771|NCT00747474|20830821|P3|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452772|NCT00747474|20830822|P2|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452773|NCT00747474|20830823|P1|STARTED|Cohort 11 (50 mg/m^2) Period||0
8452774|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452775|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452776|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452777|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452778|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452779|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452780|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452781|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452782|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452783|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452784|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452785|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452786|NCT00747474|20830812|P12|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452787|NCT00747474|20830813|P11|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452788|NCT00747474|20830814|P10|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
8452789|NCT00747474|20830815|P9|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452790|NCT00747474|20830816|P8|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452791|NCT00747474|20830817|P7|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452792|NCT00747474|20830818|P6|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452793|NCT00747474|20830819|P5|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452794|NCT00747474|20830820|P4|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452795|NCT00747474|20830821|P3|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452796|NCT00747474|20830822|P2|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452797|NCT00747474|20830823|P1|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
8452798|NCT00747474|20830812|P12|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452799|NCT00747474|20830813|P11|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452800|NCT00747474|20830814|P10|STARTED|Cohort 10 (40 mg/m^2) Period||7
8452801|NCT00747474|20830815|P9|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452802|NCT00747474|20830816|P8|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452803|NCT00747474|20830817|P7|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452804|NCT00747474|20830818|P6|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452805|NCT00747474|20830819|P5|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452806|NCT00747474|20830820|P4|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452807|NCT00747474|20830821|P3|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452808|NCT00747474|20830822|P2|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452809|NCT00747474|20830823|P1|STARTED|Cohort 10 (40 mg/m^2) Period||0
8452810|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452811|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452812|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452813|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452814|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452815|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452816|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452817|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452818|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452819|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452820|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452821|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452822|NCT00747474|20830812|P12|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452823|NCT00747474|20830813|P11|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452824|NCT00747474|20830814|P10|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452825|NCT00747474|20830815|P9|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
8452826|NCT00747474|20830816|P8|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452827|NCT00747474|20830817|P7|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452828|NCT00747474|20830818|P6|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452829|NCT00747474|20830819|P5|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452830|NCT00747474|20830820|P4|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452831|NCT00747474|20830821|P3|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452832|NCT00747474|20830822|P2|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452833|NCT00747474|20830823|P1|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
8452834|NCT00747474|20830812|P12|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452835|NCT00747474|20830813|P11|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452836|NCT00747474|20830814|P10|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452837|NCT00747474|20830815|P9|STARTED|Cohort 9 (35 mg/m^2) Period||4
8452838|NCT00747474|20830816|P8|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452839|NCT00747474|20830817|P7|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452840|NCT00747474|20830818|P6|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452841|NCT00747474|20830819|P5|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452842|NCT00747474|20830820|P4|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452843|NCT00747474|20830821|P3|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452844|NCT00747474|20830822|P2|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452845|NCT00747474|20830823|P1|STARTED|Cohort 9 (35 mg/m^2) Period||0
8452846|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452847|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452848|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452849|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452850|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
8452851|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452852|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452853|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452854|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452855|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452856|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452857|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452858|NCT00747474|20830812|P12|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452859|NCT00747474|20830813|P11|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452860|NCT00747474|20830814|P10|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452861|NCT00747474|20830815|P9|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452862|NCT00747474|20830816|P8|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
8452863|NCT00747474|20830817|P7|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452864|NCT00747474|20830818|P6|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452865|NCT00747474|20830819|P5|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452866|NCT00747474|20830820|P4|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452867|NCT00747474|20830821|P3|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452868|NCT00747474|20830822|P2|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452869|NCT00747474|20830823|P1|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
8452870|NCT00747474|20830812|P12|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452871|NCT00747474|20830813|P11|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452872|NCT00747474|20830814|P10|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452873|NCT00747474|20830815|P9|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452874|NCT00747474|20830816|P8|STARTED|Cohort 8 (40 mg/m^2) Period||6
8452875|NCT00747474|20830817|P7|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452876|NCT00747474|20830818|P6|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452877|NCT00747474|20830819|P5|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452878|NCT00747474|20830820|P4|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452879|NCT00747474|20830821|P3|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452880|NCT00747474|20830822|P2|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452881|NCT00747474|20830823|P1|STARTED|Cohort 8 (40 mg/m^2) Period||0
8452882|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452883|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452884|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452885|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452886|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452887|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452888|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452889|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452890|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452891|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452892|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452893|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452894|NCT00747474|20830812|P12|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452895|NCT00747474|20830813|P11|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452896|NCT00747474|20830814|P10|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452897|NCT00747474|20830815|P9|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452898|NCT00747474|20830816|P8|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452899|NCT00747474|20830817|P7|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
8452900|NCT00747474|20830818|P6|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452901|NCT00747474|20830819|P5|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452902|NCT00747474|20830820|P4|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452903|NCT00747474|20830821|P3|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452904|NCT00747474|20830822|P2|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452905|NCT00747474|20830823|P1|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
8452906|NCT00747474|20830812|P12|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452907|NCT00747474|20830813|P11|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452908|NCT00747474|20830814|P10|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452909|NCT00747474|20830815|P9|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452910|NCT00747474|20830816|P8|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452911|NCT00747474|20830817|P7|STARTED|Cohort 7 (30 mg/m^2) Period||4
8452912|NCT00747474|20830818|P6|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452913|NCT00747474|20830819|P5|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452914|NCT00747474|20830820|P4|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452915|NCT00747474|20830821|P3|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452916|NCT00747474|20830822|P2|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452917|NCT00747474|20830823|P1|STARTED|Cohort 7 (30 mg/m^2) Period||0
8452918|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452919|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452920|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452921|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452922|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452923|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452924|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452925|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452926|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452927|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452928|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452929|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452930|NCT00747474|20830812|P12|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452931|NCT00747474|20830813|P11|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452932|NCT00747474|20830814|P10|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452933|NCT00747474|20830815|P9|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452934|NCT00747474|20830816|P8|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452935|NCT00747474|20830817|P7|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452936|NCT00747474|20830818|P6|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
8452937|NCT00747474|20830819|P5|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452938|NCT00747474|20830820|P4|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452939|NCT00747474|20830821|P3|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452940|NCT00747474|20830822|P2|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452941|NCT00747474|20830823|P1|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
8452942|NCT00747474|20830812|P12|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452943|NCT00747474|20830813|P11|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452944|NCT00747474|20830814|P10|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452945|NCT00747474|20830815|P9|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452946|NCT00747474|20830816|P8|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452947|NCT00747474|20830817|P7|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452948|NCT00747474|20830818|P6|STARTED|Cohort 6 (20 mg/m^2) Period||4
8452949|NCT00747474|20830819|P5|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452950|NCT00747474|20830820|P4|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452951|NCT00747474|20830821|P3|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452952|NCT00747474|20830822|P2|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452953|NCT00747474|20830823|P1|STARTED|Cohort 6 (20 mg/m^2) Period||0
8452954|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452955|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452956|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452957|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452958|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452959|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452960|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452961|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452962|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452963|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452964|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452965|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452966|NCT00747474|20830812|P12|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452967|NCT00747474|20830813|P11|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452968|NCT00747474|20830814|P10|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452969|NCT00747474|20830815|P9|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452970|NCT00747474|20830816|P8|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452971|NCT00747474|20830817|P7|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452972|NCT00747474|20830818|P6|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452973|NCT00747474|20830819|P5|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
8452974|NCT00747474|20830820|P4|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452975|NCT00747474|20830821|P3|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452976|NCT00747474|20830822|P2|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452977|NCT00747474|20830823|P1|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
8452978|NCT00747474|20830812|P12|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452979|NCT00747474|20830813|P11|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452980|NCT00747474|20830814|P10|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452981|NCT00747474|20830815|P9|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452982|NCT00747474|20830816|P8|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452983|NCT00747474|20830817|P7|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452984|NCT00747474|20830818|P6|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452985|NCT00747474|20830819|P5|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
8452986|NCT00747474|20830820|P4|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452987|NCT00747474|20830821|P3|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452988|NCT00747474|20830822|P2|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452989|NCT00747474|20830823|P1|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
8452990|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452991|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452992|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452993|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452994|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452995|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452996|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452997|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452998|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8452999|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453000|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453001|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453002|NCT00747474|20830812|P12|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453003|NCT00747474|20830813|P11|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453004|NCT00747474|20830814|P10|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453005|NCT00747474|20830815|P9|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453006|NCT00747474|20830816|P8|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453007|NCT00747474|20830817|P7|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453008|NCT00747474|20830818|P6|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453009|NCT00747474|20830819|P5|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453010|NCT00747474|20830820|P4|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
8453011|NCT00747474|20830821|P3|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453012|NCT00747474|20830822|P2|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453013|NCT00747474|20830823|P1|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
8453014|NCT00747474|20830812|P12|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453015|NCT00747474|20830813|P11|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453016|NCT00747474|20830814|P10|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453017|NCT00747474|20830815|P9|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453018|NCT00747474|20830816|P8|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453019|NCT00747474|20830817|P7|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453020|NCT00747474|20830818|P6|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453021|NCT00747474|20830819|P5|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453022|NCT00747474|20830820|P4|STARTED|Cohort 4 (9 mg/m^2) Period||4
8453023|NCT00747474|20830821|P3|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453024|NCT00747474|20830822|P2|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453025|NCT00747474|20830823|P1|STARTED|Cohort 4 (9 mg/m^2) Period||0
8453026|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453027|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453028|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453029|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453030|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453031|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453032|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453033|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453034|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453035|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453036|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453037|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453038|NCT00747474|20830812|P12|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453039|NCT00747474|20830813|P11|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453040|NCT00747474|20830814|P10|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453041|NCT00747474|20830815|P9|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453042|NCT00747474|20830816|P8|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453043|NCT00747474|20830817|P7|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453044|NCT00747474|20830818|P6|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453045|NCT00747474|20830819|P5|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453046|NCT00747474|20830820|P4|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453047|NCT00747474|20830821|P3|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
8453048|NCT00747474|20830822|P2|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453049|NCT00747474|20830823|P1|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
8453050|NCT00747474|20830812|P12|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453051|NCT00747474|20830813|P11|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453052|NCT00747474|20830814|P10|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453053|NCT00747474|20830815|P9|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453054|NCT00747474|20830816|P8|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453055|NCT00747474|20830817|P7|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453056|NCT00747474|20830818|P6|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453057|NCT00747474|20830819|P5|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453058|NCT00747474|20830820|P4|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453059|NCT00747474|20830821|P3|STARTED|Cohort 3 (6 mg/m^2) Period||3
8453060|NCT00747474|20830822|P2|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453061|NCT00747474|20830823|P1|STARTED|Cohort 3 (6 mg/m^2) Period||0
8453062|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453063|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453064|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453065|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453066|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453067|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453068|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453069|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453070|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453071|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453072|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453073|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453074|NCT00747474|20830812|P12|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453075|NCT00747474|20830813|P11|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453076|NCT00747474|20830814|P10|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453077|NCT00747474|20830815|P9|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453078|NCT00747474|20830816|P8|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453079|NCT00747474|20830817|P7|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453080|NCT00747474|20830818|P6|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453081|NCT00747474|20830819|P5|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453082|NCT00747474|20830820|P4|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453083|NCT00747474|20830821|P3|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453084|NCT00747474|20830822|P2|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
8453085|NCT00747474|20830823|P1|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
8453086|NCT00747474|20830812|P12|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453087|NCT00747474|20830813|P11|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453088|NCT00747474|20830814|P10|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453089|NCT00747474|20830815|P9|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453090|NCT00747474|20830816|P8|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453091|NCT00747474|20830817|P7|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453092|NCT00747474|20830818|P6|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453093|NCT00747474|20830819|P5|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453094|NCT00747474|20830820|P4|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453095|NCT00747474|20830821|P3|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453096|NCT00747474|20830822|P2|STARTED|Cohort 2 (3 mg/m^2) Period||4
8453097|NCT00747474|20830823|P1|STARTED|Cohort 2 (3 mg/m^2) Period||0
8453098|NCT00747474|20830812|P12|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453099|NCT00747474|20830813|P11|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453100|NCT00747474|20830814|P10|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453101|NCT00747474|20830815|P9|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453102|NCT00747474|20830816|P8|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453103|NCT00747474|20830817|P7|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453104|NCT00747474|20830818|P6|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453105|NCT00747474|20830819|P5|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453106|NCT00747474|20830820|P4|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453107|NCT00747474|20830821|P3|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453108|NCT00747474|20830822|P2|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453109|NCT00747474|20830823|P1|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453110|NCT00747474|20830812|P12|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453111|NCT00747474|20830813|P11|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453112|NCT00747474|20830814|P10|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453113|NCT00747474|20830815|P9|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453114|NCT00747474|20830816|P8|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453115|NCT00747474|20830817|P7|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453116|NCT00747474|20830818|P6|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453117|NCT00747474|20830819|P5|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453118|NCT00747474|20830820|P4|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453119|NCT00747474|20830821|P3|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453120|NCT00747474|20830822|P2|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
8453121|NCT00747474|20830823|P1|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
8453122|NCT00747474|20830812|P12|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453123|NCT00747474|20830813|P11|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453124|NCT00747474|20830814|P10|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453125|NCT00747474|20830815|P9|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453126|NCT00747474|20830816|P8|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453127|NCT00747474|20830817|P7|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453128|NCT00747474|20830818|P6|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453129|NCT00747474|20830819|P5|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453130|NCT00747474|20830820|P4|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453131|NCT00747474|20830821|P3|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453132|NCT00747474|20830822|P2|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
8453133|NCT00747474|20830823|P1|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
8453134|NCT00747461|20830849|P1|NOT COMPLETED|Overall Study||5
8453135|NCT00747461|20830849|P1|COMPLETED|Overall Study||0
8453136|NCT00747461|20830849|P1|STARTED|Overall Study||5
8453137|NCT00747435|20830854|P1|NOT COMPLETED|Overall Study||6
8453138|NCT00747435|20830854|P1|COMPLETED|Overall Study||67
8453139|NCT00747435|20830854|P1|STARTED|Overall Study||73
8453140|NCT00747344|20830864|P4|NOT COMPLETED|After Controlled Period||1
8453141|NCT00747344|20830865|P3|NOT COMPLETED|After Controlled Period||0
8453142|NCT00747344|20830866|P2|NOT COMPLETED|After Controlled Period||0
8453143|NCT00747344|20830867|P1|NOT COMPLETED|After Controlled Period||0
8453144|NCT00747344|20830864|P4|COMPLETED|After Controlled Period||56
8453145|NCT00747344|20830865|P3|COMPLETED|After Controlled Period||55
8453146|NCT00747344|20830866|P2|COMPLETED|After Controlled Period||0
8453147|NCT00747344|20830867|P1|COMPLETED|After Controlled Period||0
8453148|NCT00747344|20830864|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
8453149|NCT00747344|20830865|P3|STARTED|After Controlled Period||55
8453150|NCT00747344|20830866|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8453151|NCT00747344|20830867|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8453152|NCT00747344|20830864|P4|NOT COMPLETED|Controlled Period||0
8453153|NCT00747344|20830865|P3|NOT COMPLETED|Controlled Period||0
8453154|NCT00747344|20830866|P2|NOT COMPLETED|Controlled Period||4
8453155|NCT00747344|20830867|P1|NOT COMPLETED|Controlled Period||5
8453156|NCT00747344|20830864|P4|COMPLETED|Controlled Period||0
8453157|NCT00747344|20830865|P3|COMPLETED|Controlled Period||0
8453158|NCT00747344|20830866|P2|COMPLETED|Controlled Period||57
8453159|NCT00747344|20830867|P1|COMPLETED|Controlled Period||55
8453160|NCT00747344|20830864|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8453161|NCT00747344|20830865|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8453162|NCT00747344|20830866|P2|STARTED|Controlled Period||61
8453163|NCT00747344|20830867|P1|STARTED|Controlled Period||60
8453164|NCT00747227|20830881|P2|NOT COMPLETED|Overall Study||4
8453165|NCT00747227|20830882|P1|NOT COMPLETED|Overall Study||6
8453166|NCT00747227|20830881|P2|COMPLETED|Overall Study||120
8453167|NCT00747227|20830882|P1|COMPLETED|Overall Study||120
8453168|NCT00747227|20830881|P2|STARTED|Overall Study||124
8453169|NCT00747227|20830882|P1|STARTED|Overall Study||126
8453170|NCT00747214|20830896|P2|NOT COMPLETED|Overall Study||3
8453171|NCT00747214|20830897|P1|NOT COMPLETED|Overall Study||8
8453172|NCT00747214|20830896|P2|COMPLETED|Overall Study||29
8453173|NCT00747214|20830897|P1|COMPLETED|Overall Study||19
8453174|NCT00747214|20830896|P2|STARTED|Overall Study||32
8453175|NCT00747214|20830897|P1|STARTED|Overall Study||27
8453176|NCT00747149|20830911|P2|NOT COMPLETED|Overall Study||43
8453177|NCT00747149|20830912|P1|NOT COMPLETED|Overall Study||1
8453178|NCT00747149|20830911|P2|COMPLETED|Overall Study||401
8453179|NCT00747149|20830912|P1|COMPLETED|Overall Study||153
8453180|NCT00747149|20830911|P2|STARTED|Overall Study||444
8453181|NCT00747149|20830912|P1|STARTED|Overall Study||154
8453182|NCT00747006|20830927|P3|NOT COMPLETED|Overall Study||1
8453183|NCT00747006|20830928|P2|NOT COMPLETED|Overall Study||1
8453184|NCT00747006|20830929|P1|NOT COMPLETED|Overall Study||3
8453185|NCT00747006|20830927|P3|COMPLETED|Overall Study||2
8453186|NCT00747006|20830928|P2|COMPLETED|Overall Study||7
8453187|NCT00747006|20830929|P1|COMPLETED|Overall Study||4
8453188|NCT00747006|20830927|P3|STARTED|Overall Study||3
8453189|NCT00747006|20830928|P2|STARTED|Overall Study||8
8453190|NCT00747006|20830929|P1|STARTED|Overall Study||7
8453191|NCT00746954|20830995|P3|NOT COMPLETED|Overall Study||0
8453192|NCT00746954|20830996|P2|NOT COMPLETED|Overall Study||0
8453193|NCT00746954|20830997|P1|NOT COMPLETED|Overall Study||0
8453194|NCT00746954|20830995|P3|COMPLETED|Overall Study||2
8453195|NCT00746954|20830996|P2|COMPLETED|Overall Study||3
8453196|NCT00746954|20830997|P1|COMPLETED|Overall Study||3
8453197|NCT00746954|20830995|P3|STARTED|Overall Study||2
8453198|NCT00746954|20830996|P2|STARTED|Overall Study||3
8453199|NCT00746954|20830997|P1|STARTED|Overall Study||3
8453200|NCT00746941|20831007|P4|NOT COMPLETED|Overall Study||13
8453201|NCT00746941|20831008|P3|NOT COMPLETED|Overall Study||2
8453202|NCT00746941|20831009|P2|NOT COMPLETED|Overall Study||4
8453203|NCT00746941|20831010|P1|NOT COMPLETED|Overall Study||7
8453204|NCT00746941|20831007|P4|COMPLETED|Overall Study||7
8453205|NCT00746941|20831008|P3|COMPLETED|Overall Study||3
8453206|NCT00746941|20831009|P2|COMPLETED|Overall Study||1
8453207|NCT00746941|20831010|P1|COMPLETED|Overall Study||0
8453208|NCT00746941|20831007|P4|STARTED|Overall Study||20
8453209|NCT00746941|20831008|P3|STARTED|Overall Study||5
8453210|NCT00746941|20831009|P2|STARTED|Overall Study||5
8453211|NCT00746941|20831010|P1|STARTED|Overall Study||7
8453212|NCT00746889|20831038|P2|NOT COMPLETED|Overall Study||4
8453213|NCT00746889|20831039|P1|NOT COMPLETED|Overall Study||4
8453214|NCT00746889|20831038|P2|COMPLETED|Overall Study||35
8453215|NCT00746889|20831039|P1|COMPLETED|Overall Study||36
8453216|NCT00746889|20831038|P2|STARTED|Overall Study||39
8453217|NCT00746889|20831039|P1|STARTED|Overall Study||40
8453218|NCT00746863|20831049|P2|NOT COMPLETED|Overall Study||0
8453219|NCT00746863|20831050|P1|NOT COMPLETED|Overall Study||0
8453220|NCT00746863|20831049|P2|COMPLETED|Overall Study||21
8453221|NCT00746863|20831050|P1|COMPLETED|Overall Study||21
8453222|NCT00746863|20831049|P2|STARTED|Overall Study||21
8453223|NCT00746863|20831050|P1|STARTED|Overall Study||21
8453224|NCT00746798|20831068|P4|NOT COMPLETED|Overall Study||0
8453225|NCT00746798|20831069|P3|NOT COMPLETED|Overall Study||3
8453226|NCT00746798|20831070|P2|NOT COMPLETED|Overall Study||2
8453227|NCT00746798|20831071|P1|NOT COMPLETED|Overall Study||1
8453228|NCT00746798|20831068|P4|COMPLETED|Overall Study||120
8453229|NCT00746798|20831069|P3|COMPLETED|Overall Study||110
8453230|NCT00746798|20831070|P2|COMPLETED|Overall Study||122
8453231|NCT00746798|20831071|P1|COMPLETED|Overall Study||121
8453232|NCT00746798|20831068|P4|STARTED|Overall Study||120
8453233|NCT00746798|20831069|P3|STARTED|Overall Study||113
8453234|NCT00746798|20831070|P2|STARTED|Overall Study||124
8453235|NCT00746798|20831071|P1|STARTED|Overall Study||122
8453236|NCT00746785|20831096|P3|NOT COMPLETED|Overall Study||27
8453237|NCT00746785|20831097|P2|NOT COMPLETED|Overall Study||25
8453238|NCT00746785|20831098|P1|NOT COMPLETED|Overall Study||29
8453239|NCT00746785|20831096|P3|COMPLETED|Overall Study||13
8453240|NCT00746785|20831097|P2|COMPLETED|Overall Study||21
8453241|NCT00746785|20831098|P1|COMPLETED|Overall Study||14
8453242|NCT00746785|20831096|P3|STARTED|Overall Study||40
8453243|NCT00746785|20831097|P2|STARTED|Overall Study||46
8453244|NCT00746785|20831098|P1|STARTED|Overall Study||43
8453269|NCT00746694|20831167|P1|NOT COMPLETED|Overall Study||0
8453270|NCT00746694|20831167|P1|COMPLETED|Overall Study||154
8453271|NCT00746694|20831167|P1|STARTED|Overall Study||154
8453272|NCT00746668|20831172|P7|NOT COMPLETED|Overall Study||0
8453273|NCT00746668|20831173|P6|NOT COMPLETED|Overall Study||0
8453274|NCT00746668|20831174|P5|NOT COMPLETED|Overall Study||0
8453275|NCT00746668|20831175|P4|NOT COMPLETED|Overall Study||0
8453276|NCT00746668|20831176|P3|NOT COMPLETED|Overall Study||0
8453277|NCT00746668|20831177|P2|NOT COMPLETED|Overall Study||0
8453278|NCT00746668|20831178|P1|NOT COMPLETED|Overall Study||0
8453279|NCT00746668|20831172|P7|COMPLETED|Overall Study||5
8453280|NCT00746668|20831173|P6|COMPLETED|Overall Study||5
8453281|NCT00746668|20831174|P5|COMPLETED|Overall Study||5
8453282|NCT00746668|20831175|P4|COMPLETED|Overall Study||5
8453283|NCT00746668|20831176|P3|COMPLETED|Overall Study||5
8453284|NCT00746668|20831177|P2|COMPLETED|Overall Study||5
8453285|NCT00746668|20831178|P1|COMPLETED|Overall Study||6
8453286|NCT00746668|20831172|P7|STARTED|Overall Study||5
8453287|NCT00746668|20831173|P6|STARTED|Overall Study||5
8453288|NCT00746668|20831174|P5|STARTED|Overall Study||5
8453289|NCT00746668|20831175|P4|STARTED|Overall Study||5
8453290|NCT00746668|20831176|P3|STARTED|Overall Study||5
8453291|NCT00746668|20831177|P2|STARTED|Overall Study||5
8453292|NCT00746668|20831178|P1|STARTED|Overall Study||6
8453293|NCT00746590|20831191|P1|NOT COMPLETED|Overall Study||1
8453294|NCT00746590|20831191|P1|COMPLETED|Overall Study||0
8453295|NCT00746590|20831191|P1|STARTED|Overall Study||1
8453296|NCT00746564|20831195|P1|NOT COMPLETED|Overall Study||2
8453297|NCT00746564|20831195|P1|COMPLETED|Overall Study||73
8453298|NCT00746564|20831195|P1|STARTED|Overall Study||75
8453299|NCT00746551|20831210|P2|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
8453300|NCT00746551|20831211|P1|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
8453301|NCT00746551|20831210|P2|COMPLETED|At Delivery (GA of 39 Weeks)||25
8453302|NCT00746551|20831211|P1|COMPLETED|At Delivery (GA of 39 Weeks)||25
8453303|NCT00746551|20831210|P2|STARTED|At Delivery (GA of 39 Weeks)||40
8453304|NCT00746551|20831211|P1|STARTED|At Delivery (GA of 39 Weeks)||40
8453305|NCT00746551|20831210|P2|NOT COMPLETED|At Gestational Age of 36 Weeks||4
8453306|NCT00746551|20831211|P1|NOT COMPLETED|At Gestational Age of 36 Weeks||2
8453307|NCT00746551|20831210|P2|COMPLETED|At Gestational Age of 36 Weeks||36
8453308|NCT00746551|20831211|P1|COMPLETED|At Gestational Age of 36 Weeks||38
8453309|NCT00746551|20831210|P2|STARTED|At Gestational Age of 36 Weeks||40
8453310|NCT00746551|20831211|P1|STARTED|At Gestational Age of 36 Weeks||40
8453311|NCT00746512|20831223|P4|NOT COMPLETED|Overall Study||0
8453312|NCT00746512|20831224|P3|NOT COMPLETED|Overall Study||0
8453313|NCT00746512|20831225|P2|NOT COMPLETED|Overall Study||0
8453314|NCT00746512|20831226|P1|NOT COMPLETED|Overall Study||0
8453315|NCT00746512|20831223|P4|COMPLETED|Overall Study||9
8453316|NCT00746512|20831224|P3|COMPLETED|Overall Study||18
8453317|NCT00746512|20831225|P2|COMPLETED|Overall Study||10
8453318|NCT00746512|20831226|P1|COMPLETED|Overall Study||8
8453319|NCT00746512|20831223|P4|STARTED|Overall Study||9
8453320|NCT00746512|20831224|P3|STARTED|Overall Study||18
8453321|NCT00746512|20831225|P2|STARTED|Overall Study||10
8453322|NCT00746512|20831226|P1|STARTED|Overall Study||8
8453323|NCT00746421|20831242|P2|NOT COMPLETED|Overall Study||2
8453324|NCT00746421|20831243|P1|NOT COMPLETED|Overall Study||7
8453325|NCT00746421|20831242|P2|COMPLETED|Overall Study||9
8453326|NCT00746421|20831243|P1|COMPLETED|Overall Study||5
8453327|NCT00746421|20831242|P2|STARTED|Overall Study||11
8453328|NCT00746421|20831243|P1|STARTED|Overall Study||12
8453329|NCT00746395|20831253|P2|NOT COMPLETED|Overall Study||0
8453330|NCT00746395|20831254|P1|NOT COMPLETED|Overall Study||0
8453331|NCT00746395|20831253|P2|COMPLETED|Overall Study||20
8453332|NCT00746395|20831254|P1|COMPLETED|Overall Study||20
8453333|NCT00746395|20831253|P2|STARTED|Overall Study||20
8453334|NCT00746395|20831254|P1|STARTED|Overall Study||20
8453335|NCT00746356|20831262|P2|NOT COMPLETED|Overall Study||7
8453336|NCT00746356|20831263|P1|NOT COMPLETED|Overall Study||11
8453337|NCT00746356|20831262|P2|COMPLETED|Overall Study||40
8453338|NCT00746356|20831263|P1|COMPLETED|Overall Study||70
8453339|NCT00746356|20831262|P2|STARTED|Overall Study||47
8453340|NCT00746356|20831263|P1|STARTED|Overall Study||81
8453341|NCT00746330|20831275|P4|NOT COMPLETED|Period 4||0
8453342|NCT00746330|20831276|P3|NOT COMPLETED|Period 4||0
8453343|NCT00746330|20831277|P2|NOT COMPLETED|Period 4||0
8453344|NCT00746330|20831278|P1|NOT COMPLETED|Period 4||0
8453345|NCT00746330|20831275|P4|COMPLETED|Period 4||7
8453346|NCT00746330|20831276|P3|COMPLETED|Period 4||8
8453347|NCT00746330|20831277|P2|COMPLETED|Period 4||9
8453348|NCT00746330|20831278|P1|COMPLETED|Period 4||7
8453349|NCT00746330|20831275|P4|STARTED|Period 4||7
8453350|NCT00746330|20831276|P3|STARTED|Period 4||8
8453351|NCT00746330|20831277|P2|STARTED|Period 4||9
8453352|NCT00746330|20831278|P1|STARTED|Period 4||7
8453353|NCT00746330|20831275|P4|NOT COMPLETED|Period 3||0
8453354|NCT00746330|20831276|P3|NOT COMPLETED|Period 3||0
8453355|NCT00746330|20831277|P2|NOT COMPLETED|Period 3||0
8453356|NCT00746330|20831278|P1|NOT COMPLETED|Period 3||0
8453357|NCT00746330|20831275|P4|COMPLETED|Period 3||7
8453358|NCT00746330|20831276|P3|COMPLETED|Period 3||8
8453359|NCT00746330|20831277|P2|COMPLETED|Period 3||9
8453360|NCT00746330|20831278|P1|COMPLETED|Period 3||7
8453361|NCT00746330|20831275|P4|STARTED|Period 3||7
8453362|NCT00746330|20831276|P3|STARTED|Period 3||8
8453363|NCT00746330|20831277|P2|STARTED|Period 3||9
8453364|NCT00746330|20831278|P1|STARTED|Period 3||7
8453365|NCT00746330|20831275|P4|NOT COMPLETED|Period 2||0
8453366|NCT00746330|20831276|P3|NOT COMPLETED|Period 2||0
8453367|NCT00746330|20831277|P2|NOT COMPLETED|Period 2||0
8453368|NCT00746330|20831278|P1|NOT COMPLETED|Period 2||0
8453369|NCT00746330|20831275|P4|COMPLETED|Period 2||7
8453370|NCT00746330|20831276|P3|COMPLETED|Period 2||8
8453371|NCT00746330|20831277|P2|COMPLETED|Period 2||9
8453372|NCT00746330|20831278|P1|COMPLETED|Period 2||7
8453373|NCT00746330|20831275|P4|STARTED|Period 2||7
8453374|NCT00746330|20831276|P3|STARTED|Period 2||8
8453375|NCT00746330|20831277|P2|STARTED|Period 2||9
8453376|NCT00746330|20831278|P1|STARTED|Period 2||7
8453377|NCT00746330|20831275|P4|NOT COMPLETED|Period 1||0
8453378|NCT00746330|20831276|P3|NOT COMPLETED|Period 1||1
8453379|NCT00746330|20831277|P2|NOT COMPLETED|Period 1||0
8453380|NCT00746330|20831278|P1|NOT COMPLETED|Period 1||0
8453381|NCT00746330|20831275|P4|COMPLETED|Period 1||7
8453382|NCT00746330|20831276|P3|COMPLETED|Period 1||8
8453383|NCT00746330|20831277|P2|COMPLETED|Period 1||9
8453384|NCT00746330|20831278|P1|COMPLETED|Period 1||7
8453385|NCT00746330|20831275|P4|STARTED|Period 1||7
8453386|NCT00746330|20831276|P3|STARTED|Period 1||9
8453387|NCT00746330|20831277|P2|STARTED|Period 1||9
8453388|NCT00746330|20831278|P1|STARTED|Period 1||7
8453389|NCT00746252|20831308|P2|NOT COMPLETED|Overall Study||2
8453390|NCT00746252|20831309|P1|NOT COMPLETED|Overall Study||1
8453391|NCT00746252|20831308|P2|COMPLETED|Overall Study||0
8453392|NCT00746252|20831309|P1|COMPLETED|Overall Study||0
8453393|NCT00746252|20831308|P2|STARTED|Overall Study||2
8453394|NCT00746252|20831309|P1|STARTED|Overall Study||1
8453395|NCT00746239|20831315|P1|NOT COMPLETED|Overall Study||6
8453396|NCT00746239|20831315|P1|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
8453397|NCT00746239|20831315|P1|STARTED|Overall Study||11
8453398|NCT00746187|20831322|P2|NOT COMPLETED|Overall Study||2
8453399|NCT00746187|20831323|P1|NOT COMPLETED|Overall Study||3
8453400|NCT00746187|20831322|P2|COMPLETED|Overall Study||16
8453401|NCT00746187|20831323|P1|COMPLETED|Overall Study||15
8453402|NCT00746187|20831322|P2|STARTED|Overall Study||18
8453403|NCT00746187|20831323|P1|STARTED|Overall Study||18
8453404|NCT00746122|20831331|P2|NOT COMPLETED|Overall Study||0
8453405|NCT00746122|20831332|P1|NOT COMPLETED|Overall Study||0
8453406|NCT00746122|20831331|P2|COMPLETED|Overall Study||316
8453407|NCT00746122|20831332|P1|COMPLETED|Overall Study||297
8453408|NCT00746122|20831331|P2|STARTED|Overall Study|After 600 recruitment target 13 more patients were randomised before sites could be closed down.|316
8453409|NCT00746122|20831332|P1|STARTED|Overall Study||297
8453410|NCT00746096|20831344|P2|NOT COMPLETED|Overall Study||3
8453411|NCT00746096|20831345|P1|NOT COMPLETED|Overall Study||10
8453412|NCT00746096|20831344|P2|COMPLETED|Overall Study||54
8453413|NCT00746096|20831345|P1|COMPLETED|Overall Study||48
8453414|NCT00746096|20831344|P2|STARTED|Overall Study||57
8453415|NCT00746096|20831345|P1|STARTED|Overall Study||58
8453416|NCT00746018|20831353|P1|NOT COMPLETED|Overall Study||0
8453417|NCT00746018|20831353|P1|COMPLETED|Overall Study||39
8453418|NCT00746018|20831353|P1|STARTED|Overall Study||39
8453419|NCT00745940|20831359|P2|NOT COMPLETED|Overall Study||10
8453420|NCT00745940|20831360|P1|NOT COMPLETED|Overall Study||19
8453421|NCT00745940|20831359|P2|COMPLETED|Overall Study||38
8453422|NCT00745940|20831360|P1|COMPLETED|Overall Study||38
8453423|NCT00745940|20831359|P2|STARTED|Overall Study||48
8453424|NCT00745940|20831360|P1|STARTED|Overall Study||57
8453425|NCT00745901|20831376|P2|NOT COMPLETED|Overall Study||21
8453426|NCT00745901|20831377|P1|NOT COMPLETED|Overall Study||24
8453427|NCT00745901|20831376|P2|COMPLETED|Overall Study||156
8453428|NCT00745901|20831377|P1|COMPLETED|Overall Study||154
8453429|NCT00745901|20831376|P2|STARTED|Overall Study|Number of Patients Randomized|177
8453430|NCT00745901|20831377|P1|STARTED|Overall Study|Number of Patients Randomized|178
8453431|NCT00745875|20831423|P2|NOT COMPLETED|Overall Study||4
8453432|NCT00745875|20831424|P1|NOT COMPLETED|Overall Study||4
8453433|NCT00745875|20831423|P2|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
8453434|NCT00745875|20831424|P1|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
8453435|NCT00745875|20831423|P2|STARTED|Overall Study|Started - Number of patients randomised|30
8453436|NCT00745875|20831424|P1|STARTED|Overall Study|Started - Number of patients randomised|36
8453437|NCT00745849|20831432|P2|NOT COMPLETED|Second Intervention||1
8453438|NCT00745849|20831433|P1|NOT COMPLETED|Second Intervention||2
8453439|NCT00745849|20831432|P2|COMPLETED|Second Intervention||19
8453440|NCT00745849|20831433|P1|COMPLETED|Second Intervention||18
8453441|NCT00745849|20831432|P2|STARTED|Second Intervention||20
8453442|NCT00745849|20831433|P1|STARTED|Second Intervention||20
8453443|NCT00745849|20831432|P2|NOT COMPLETED|Washout Period||0
8453444|NCT00745849|20831433|P1|NOT COMPLETED|Washout Period||0
8453445|NCT00745849|20831432|P2|COMPLETED|Washout Period||20
8453446|NCT00745849|20831433|P1|COMPLETED|Washout Period||20
8453447|NCT00745849|20831432|P2|STARTED|Washout Period||20
8453448|NCT00745849|20831433|P1|STARTED|Washout Period||20
8453449|NCT00745849|20831432|P2|NOT COMPLETED|First Intervention||2
8453450|NCT00745849|20831433|P1|NOT COMPLETED|First Intervention||1
8453451|NCT00745849|20831432|P2|COMPLETED|First Intervention||20
8453452|NCT00745849|20831433|P1|COMPLETED|First Intervention||20
8453453|NCT00745849|20831432|P2|STARTED|First Intervention||22
8453454|NCT00745849|20831433|P1|STARTED|First Intervention||21
8453455|NCT00745823|20831441|P2|NOT COMPLETED|Overall Study||386
8453456|NCT00745823|20831442|P1|NOT COMPLETED|Overall Study||385
8453457|NCT00745823|20831441|P2|COMPLETED|Overall Study||3
8453458|NCT00745823|20831442|P1|COMPLETED|Overall Study||1
8453459|NCT00745823|20831441|P2|TREATED Week 0 - 96|Overall Study||388
8453460|NCT00745823|20831442|P1|TREATED Week 0 - 96|Overall Study||382
8453461|NCT00745823|20831441|P2|STARTED|Overall Study||389
8453462|NCT00745823|20831442|P1|STARTED|Overall Study||386
8453463|NCT00745615|20831470|P6|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108
8453464|NCT00745615|20831471|P5|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91
8453465|NCT00745615|20831472|P4|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453466|NCT00745615|20831473|P3|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453467|NCT00745615|20831474|P2|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453468|NCT00745615|20831475|P1|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453469|NCT00745615|20831470|P6|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
8453470|NCT00745615|20831471|P5|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
8453471|NCT00745615|20831472|P4|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453472|NCT00745615|20831473|P3|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453473|NCT00745615|20831474|P2|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453474|NCT00745615|20831475|P1|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
8453475|NCT00745615|20831470|P6|STARTED|Open-Label (up to Approx 10.5 Years)||113
8453476|NCT00745615|20831471|P5|STARTED|Open-Label (up to Approx 10.5 Years)||96
8453477|NCT00745615|20831472|P4|STARTED|Open-Label (up to Approx 10.5 Years)||0
8453478|NCT00745615|20831473|P3|STARTED|Open-Label (up to Approx 10.5 Years)||0
8453479|NCT00745615|20831474|P2|STARTED|Open-Label (up to Approx 10.5 Years)||0
8453480|NCT00745615|20831475|P1|STARTED|Open-Label (up to Approx 10.5 Years)||0
8453481|NCT00745615|20831470|P6|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
8453482|NCT00745615|20831471|P5|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
8453483|NCT00745615|20831472|P4|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
8453484|NCT00745615|20831473|P3|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1
8453485|NCT00745615|20831474|P2|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7
8453486|NCT00745615|20831475|P1|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
8453487|NCT00745615|20831470|P6|COMPLETED|Double-Blind Extension (36 Weeks)||0
8453488|NCT00745615|20831471|P5|COMPLETED|Double-Blind Extension (36 Weeks)||0
8453489|NCT00745615|20831472|P4|COMPLETED|Double-Blind Extension (36 Weeks)||39
8453490|NCT00745615|20831473|P3|COMPLETED|Double-Blind Extension (36 Weeks)||38
8453491|NCT00745615|20831474|P2|COMPLETED|Double-Blind Extension (36 Weeks)||87
8453492|NCT00745615|20831475|P1|COMPLETED|Double-Blind Extension (36 Weeks)||75
8453493|NCT00745615|20831470|P6|STARTED|Double-Blind Extension (36 Weeks)||0
8453494|NCT00745615|20831471|P5|STARTED|Double-Blind Extension (36 Weeks)||0
8453495|NCT00745615|20831472|P4|STARTED|Double-Blind Extension (36 Weeks)||44
8453496|NCT00745615|20831473|P3|STARTED|Double-Blind Extension (36 Weeks)||39
8453497|NCT00745615|20831474|P2|STARTED|Double-Blind Extension (36 Weeks)||94
8453498|NCT00745615|20831475|P1|STARTED|Double-Blind Extension (36 Weeks)||80
8453499|NCT00745498|20831524|P3|NOT COMPLETED|Overall Study||8
8453500|NCT00745498|20831525|P2|NOT COMPLETED|Overall Study||6
8453501|NCT00745498|20831526|P1|NOT COMPLETED|Overall Study||5
8453502|NCT00745498|20831524|P3|COMPLETED|Overall Study||34
8453503|NCT00745498|20831525|P2|COMPLETED|Overall Study||37
8453504|NCT00745498|20831526|P1|COMPLETED|Overall Study||36
8453505|NCT00745498|20831524|P3|STARTED|Overall Study||42
8453506|NCT00745498|20831525|P2|STARTED|Overall Study||43
8453507|NCT00745498|20831526|P1|STARTED|Overall Study||41
8453508|NCT00745420|20831540|P1|NOT COMPLETED|Overall Study||1
8453509|NCT00745420|20831540|P1|COMPLETED|Overall Study||29
8453510|NCT00745420|20831540|P1|STARTED|Overall Study||30
8453511|NCT00745368|20831557|P1|NOT COMPLETED|Overall Study||3
8453512|NCT00745368|20831557|P1|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
8453513|NCT00745368|20831557|P1|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
8453514|NCT00745290|20831570|P2|NOT COMPLETED|Overall Study||0
8453515|NCT00745290|20831571|P1|NOT COMPLETED|Overall Study||0
8453516|NCT00745290|20831570|P2|COMPLETED|Overall Study||122
8453517|NCT00745290|20831571|P1|COMPLETED|Overall Study||123
8453518|NCT00745290|20831570|P2|STARTED|Overall Study||122
8453519|NCT00745290|20831571|P1|STARTED|Overall Study||123
8453520|NCT00745251|20831579|P2|NOT COMPLETED|Overall Study||3
8453521|NCT00745251|20831580|P1|NOT COMPLETED|Overall Study||2
8453522|NCT00745251|20831579|P2|COMPLETED|Overall Study||19
8453523|NCT00745251|20831580|P1|COMPLETED|Overall Study||21
8453524|NCT00745251|20831579|P2|STARTED|Overall Study||22
8453525|NCT00745251|20831580|P1|STARTED|Overall Study||23
8453526|NCT00745121|20831590|P2|NOT COMPLETED|Overall Study||2
8453527|NCT00745121|20831591|P1|NOT COMPLETED|Overall Study||9
8453528|NCT00745121|20831590|P2|COMPLETED|Overall Study||26
8453529|NCT00745121|20831591|P1|COMPLETED|Overall Study||11
8453530|NCT00745121|20831590|P2|STARTED|Overall Study||28
8453531|NCT00745121|20831591|P1|STARTED|Overall Study||20
8453532|NCT00745095|20831603|P6|NOT COMPLETED|Overall Study||123
8453533|NCT00745095|20831604|P5|NOT COMPLETED|Overall Study||122
8453534|NCT00745095|20831605|P4|NOT COMPLETED|Overall Study||3
8453535|NCT00745095|20831606|P3|NOT COMPLETED|Overall Study||3
8453536|NCT00745095|20831607|P2|NOT COMPLETED|Overall Study||2
8453537|NCT00745095|20831608|P1|NOT COMPLETED|Overall Study||1
8453538|NCT00745095|20831603|P6|COMPLETED|Overall Study||27
8453539|NCT00745095|20831604|P5|COMPLETED|Overall Study||28
8453540|NCT00745095|20831605|P4|COMPLETED|Overall Study||12
8453541|NCT00745095|20831606|P3|COMPLETED|Overall Study||12
8453542|NCT00745095|20831607|P2|COMPLETED|Overall Study||13
8453543|NCT00745095|20831608|P1|COMPLETED|Overall Study||14
8453544|NCT00745095|20831603|P6|STARTED|Overall Study||150
8453545|NCT00745095|20831604|P5|STARTED|Overall Study||150
8453546|NCT00745095|20831605|P4|STARTED|Overall Study||15
8453547|NCT00745095|20831606|P3|STARTED|Overall Study||15
8453548|NCT00745095|20831607|P2|STARTED|Overall Study||15
8453549|NCT00745095|20831608|P1|STARTED|Overall Study||15
8453550|NCT00745030|20831630|P2|NOT COMPLETED|Overall Study||0
8453551|NCT00745030|20831631|P1|NOT COMPLETED|Overall Study||0
8453552|NCT00745030|20831630|P2|COMPLETED|Overall Study||2
8453553|NCT00745030|20831631|P1|COMPLETED|Overall Study||1
8453554|NCT00745030|20831630|P2|STARTED|Overall Study||2
8453555|NCT00745030|20831631|P1|STARTED|Overall Study||1
8453556|NCT00744991|20831637|P1|NOT COMPLETED|Overall Study||25
8453557|NCT00744991|20831637|P1|COMPLETED|Overall Study||0
8453558|NCT00744991|20831637|P1|Received at Least 1 Dose|Overall Study||25
8453559|NCT00744991|20831637|P1|STARTED|Overall Study||25
8453560|NCT00744978|20831654|P2|NOT COMPLETED|Period 2||1
8453561|NCT00744978|20831655|P1|NOT COMPLETED|Period 2||0
8453562|NCT00744978|20831654|P2|COMPLETED|Period 2||28
8453563|NCT00744978|20831655|P1|COMPLETED|Period 2||26
8453564|NCT00744978|20831654|P2|STARTED|Period 2||29
8453565|NCT00744978|20831655|P1|STARTED|Period 2||26
8453566|NCT00744978|20831654|P2|NOT COMPLETED|Placebo Washout||0
8453567|NCT00744978|20831655|P1|NOT COMPLETED|Placebo Washout||0
8453568|NCT00744978|20831654|P2|COMPLETED|Placebo Washout||29
8453569|NCT00744978|20831655|P1|COMPLETED|Placebo Washout||26
8453570|NCT00744978|20831654|P2|STARTED|Placebo Washout||29
8453571|NCT00744978|20831655|P1|STARTED|Placebo Washout||26
8453572|NCT00744978|20831654|P2|NOT COMPLETED|Period 1||5
8453573|NCT00744978|20831655|P1|NOT COMPLETED|Period 1||6
8453574|NCT00744978|20831654|P2|COMPLETED|Period 1||29
8453575|NCT00744978|20831655|P1|COMPLETED|Period 1||26
8453576|NCT00744978|20831654|P2|Treated|Period 1||33
8453577|NCT00744978|20831655|P1|Treated|Period 1||31
8453578|NCT00744978|20831654|P2|STARTED|Period 1||34
8453579|NCT00744978|20831655|P1|STARTED|Period 1||32
8453580|NCT00744965|20831705|P2|NOT COMPLETED|Overall Study||9
8453581|NCT00744965|20831706|P1|NOT COMPLETED|Overall Study||11
8453582|NCT00744965|20831705|P2|COMPLETED|Overall Study||189
8453583|NCT00744965|20831706|P1|COMPLETED|Overall Study||186
8453584|NCT00744965|20831705|P2|STARTED|Overall Study||198
8453585|NCT00744965|20831706|P1|STARTED|Overall Study||197
8453586|NCT00744939|20831736|P1|NOT COMPLETED|Overall Study||91
8453587|NCT00744939|20831736|P1|COMPLETED|Overall Study||77
8453588|NCT00744939|20831736|P1|Treatment Received|Overall Study||141
8453589|NCT00744939|20831736|P1|STARTED|Overall Study||168
8453590|NCT00744874|20831772|P1|NOT COMPLETED|Overall Study||4
8453591|NCT00744874|20831772|P1|COMPLETED|Overall Study||51
8453592|NCT00744874|20831772|P1|STARTED|Overall Study||55
8453593|NCT00744848|20831790|P2|NOT COMPLETED|Overall Study||0
8453594|NCT00744848|20831791|P1|NOT COMPLETED|Overall Study||0
8453595|NCT00744848|20831790|P2|COMPLETED|Overall Study||101
8453596|NCT00744848|20831791|P1|COMPLETED|Overall Study||103
8453597|NCT00744848|20831790|P2|STARTED|Overall Study||101
8453598|NCT00744848|20831791|P1|STARTED|Overall Study||103
8453599|NCT00744796|20831797|P1|NOT COMPLETED|Post-Operative 6-9 Months||12
8453600|NCT00744796|20831797|P1|COMPLETED|Post-Operative 6-9 Months||9
8453601|NCT00744796|20831797|P1|STARTED|Post-Operative 6-9 Months||21
8453602|NCT00744796|20831797|P1|NOT COMPLETED|Post-Operative 3-6 Months||0
8453603|NCT00744796|20831797|P1|COMPLETED|Post-Operative 3-6 Months||21
8453604|NCT00744796|20831797|P1|STARTED|Post-Operative 3-6 Months||21
8453605|NCT00744796|20831797|P1|NOT COMPLETED|Post-Operative Day 1||0
8453606|NCT00744796|20831797|P1|COMPLETED|Post-Operative Day 1||21
8453607|NCT00744796|20831797|P1|STARTED|Post-Operative Day 1||21
8453608|NCT00744796|20831797|P1|NOT COMPLETED|Pre-operative||0
8453609|NCT00744796|20831797|P1|COMPLETED|Pre-operative||21
8453610|NCT00744796|20831797|P1|STARTED|Pre-operative||21
8453611|NCT00744757|20831803|P1|NOT COMPLETED|Overall Study||21
8453612|NCT00744757|20831803|P1|COMPLETED|Overall Study||16
8453613|NCT00744757|20831803|P1|STARTED|Overall Study||37
8453614|NCT00744692|20831816|P1|NOT COMPLETED|Overall Study||0
8453615|NCT00744692|20831816|P1|COMPLETED|Overall Study||22
8453616|NCT00744692|20831816|P1|STARTED|Overall Study||22
8453617|NCT00744653|20831828|P1|NOT COMPLETED|Overall Study||16
8453618|NCT00744653|20831828|P1|COMPLETED|Overall Study||1
8453619|NCT00744653|20831828|P1|STARTED|Overall Study||17
8453620|NCT00744627|20831836|P2|NOT COMPLETED|Overall Study||22
8453621|NCT00744627|20831837|P1|NOT COMPLETED|Overall Study||25
8453622|NCT00744627|20831836|P2|COMPLETED|Overall Study||128
8453623|NCT00744627|20831837|P1|COMPLETED|Overall Study||126
8453624|NCT00744627|20831836|P2|Treated|Overall Study||150
8453625|NCT00744627|20831837|P1|Treated|Overall Study||150
8453626|NCT00744627|20831836|P2|STARTED|Overall Study||150
8453627|NCT00744627|20831837|P1|STARTED|Overall Study||151
8453628|NCT00744523|20831893|P2|NOT COMPLETED|30 Days After the Procedure||5
8453629|NCT00744523|20831894|P1|NOT COMPLETED|30 Days After the Procedure||0
8453630|NCT00744523|20831893|P2|COMPLETED|30 Days After the Procedure||220
8453631|NCT00744523|20831894|P1|COMPLETED|30 Days After the Procedure||37
8453632|NCT00744523|20831893|P2|STARTED|30 Days After the Procedure||225
8453633|NCT00744523|20831894|P1|STARTED|30 Days After the Procedure||37
8453634|NCT00744523|20831893|P2|NOT COMPLETED|Procedure||0
8453635|NCT00744523|20831894|P1|NOT COMPLETED|Procedure||0
8453636|NCT00744523|20831893|P2|COMPLETED|Procedure||225
8453637|NCT00744523|20831894|P1|COMPLETED|Procedure||37
8453638|NCT00744523|20831893|P2|STARTED|Procedure||225
8453639|NCT00744523|20831894|P1|STARTED|Procedure||37
8453640|NCT00744497|20831914|P2|NOT COMPLETED|Overall Study||762
8453641|NCT00744497|20831915|P1|NOT COMPLETED|Overall Study||760
8453642|NCT00744497|20831914|P2|COMPLETED|Overall Study||0
8453643|NCT00744497|20831915|P1|COMPLETED|Overall Study||0
8453644|NCT00744497|20831914|P2|Received Treatment|Overall Study||761
8453645|NCT00744497|20831915|P1|Received Treatment|Overall Study||757
8453646|NCT00744497|20831914|P2|STARTED|Overall Study|Randomized|762
8453647|NCT00744497|20831915|P1|STARTED|Overall Study|Randomized|760
8453648|NCT00744380|20831951|P2|NOT COMPLETED|Overall Study||0
8453649|NCT00744380|20831952|P1|NOT COMPLETED|Overall Study||0
8453650|NCT00744380|20831951|P2|COMPLETED|Overall Study||11
8453651|NCT00744380|20831952|P1|COMPLETED|Overall Study||12
8453652|NCT00744380|20831951|P2|STARTED|Overall Study||11
8453653|NCT00744380|20831952|P1|STARTED|Overall Study||12
8453654|NCT00744328|20831975|P3|NOT COMPLETED|Overall Study||8
8453655|NCT00744328|20831976|P2|NOT COMPLETED|Overall Study||8
8453656|NCT00744328|20831977|P1|NOT COMPLETED|Overall Study||7
8453657|NCT00744328|20831975|P3|COMPLETED|Overall Study||21
8453658|NCT00744328|20831976|P2|COMPLETED|Overall Study||22
8453659|NCT00744328|20831977|P1|COMPLETED|Overall Study||19
8453660|NCT00744328|20831975|P3|STARTED|Overall Study||29
8453661|NCT00744328|20831976|P2|STARTED|Overall Study||30
8453662|NCT00744328|20831977|P1|STARTED|Overall Study||26
8453663|NCT00744263|20831990|P2|NOT COMPLETED|Overall Study||5320
8453664|NCT00744263|20831991|P1|NOT COMPLETED|Overall Study||5236
8453665|NCT00744263|20831990|P2|COMPLETED|Overall Study||36936
8453666|NCT00744263|20831991|P1|COMPLETED|Overall Study||37004
8453667|NCT00744263|20831990|P2|STARTED|Overall Study||42256
8453668|NCT00744263|20831991|P1|STARTED|Overall Study||42240
8453669|NCT00744237|20832014|P3|NOT COMPLETED|Overall Study||15
8453670|NCT00744237|20832015|P2|NOT COMPLETED|Overall Study||27
8453671|NCT00744237|20832016|P1|NOT COMPLETED|Overall Study||27
8453672|NCT00744237|20832014|P3|COMPLETED|Overall Study||59
8453673|NCT00744237|20832015|P2|COMPLETED|Overall Study||46
8453674|NCT00744237|20832016|P1|COMPLETED|Overall Study||56
8453675|NCT00744237|20832014|P3|STARTED|Overall Study||74
8453676|NCT00744237|20832015|P2|STARTED|Overall Study||73
8453677|NCT00744237|20832016|P1|STARTED|Overall Study||83
8453678|NCT00744211|20832030|P3|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
8453679|NCT00744211|20832031|P2|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
8453680|NCT00744211|20832032|P1|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
8453681|NCT00744211|20832030|P3|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
8453682|NCT00744211|20832031|P2|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
8453683|NCT00744211|20832032|P1|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
8453684|NCT00744211|20832030|P3|STARTED|24 Hours After Cardiopulmonary Bypass||10
8453685|NCT00744211|20832031|P2|STARTED|24 Hours After Cardiopulmonary Bypass||9
8453686|NCT00744211|20832032|P1|STARTED|24 Hours After Cardiopulmonary Bypass||10
8453687|NCT00744211|20832030|P3|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
8453688|NCT00744211|20832031|P2|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
8453689|NCT00744211|20832032|P1|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
8453690|NCT00744211|20832030|P3|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
8453691|NCT00744211|20832031|P2|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
8453692|NCT00744211|20832032|P1|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
8453693|NCT00744211|20832030|P3|STARTED|12 Hours After Cardiopulmonary Bypass||10
8453694|NCT00744211|20832031|P2|STARTED|12 Hours After Cardiopulmonary Bypass||9
8453695|NCT00744211|20832032|P1|STARTED|12 Hours After Cardiopulmonary Bypass||10
8453696|NCT00744211|20832030|P3|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
8453697|NCT00744211|20832031|P2|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
8453698|NCT00744211|20832032|P1|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
8453699|NCT00744211|20832030|P3|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
8453700|NCT00744211|20832031|P2|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
8453701|NCT00744211|20832032|P1|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
8453702|NCT00744211|20832030|P3|STARTED|6 Hours After Cardiopulmonary Bypass||10
8453703|NCT00744211|20832031|P2|STARTED|6 Hours After Cardiopulmonary Bypass||9
8453704|NCT00744211|20832032|P1|STARTED|6 Hours After Cardiopulmonary Bypass||10
8453705|NCT00744211|20832030|P3|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
8453706|NCT00744211|20832031|P2|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
8453707|NCT00744211|20832032|P1|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
8453708|NCT00744211|20832030|P3|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
8453709|NCT00744211|20832031|P2|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
8453710|NCT00744211|20832032|P1|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
8453711|NCT00744211|20832030|P3|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
8453712|NCT00744211|20832031|P2|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
8453713|NCT00744211|20832032|P1|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
8453714|NCT00744211|20832030|P3|NOT COMPLETED|Baseline||0
8453715|NCT00744211|20832031|P2|NOT COMPLETED|Baseline||0
8453716|NCT00744211|20832032|P1|NOT COMPLETED|Baseline||0
8453717|NCT00744211|20832030|P3|COMPLETED|Baseline||10
8453718|NCT00744211|20832031|P2|COMPLETED|Baseline||9
8453719|NCT00744211|20832032|P1|COMPLETED|Baseline||10
8453720|NCT00744211|20832030|P3|STARTED|Baseline||10
8453721|NCT00744211|20832031|P2|STARTED|Baseline||9
8453722|NCT00744211|20832032|P1|STARTED|Baseline||10
8453723|NCT00744055|20832050|P2|NOT COMPLETED|Overall Study||14
8453724|NCT00744055|20832051|P1|NOT COMPLETED|Overall Study||7
8453725|NCT00744055|20832050|P2|COMPLETED|Overall Study||32
8453726|NCT00744055|20832051|P1|COMPLETED|Overall Study||43
8453727|NCT00744055|20832050|P2|STARTED|Overall Study||46
8453728|NCT00744055|20832051|P1|STARTED|Overall Study||50
8453729|NCT00744042|20832059|P1|NOT COMPLETED|Overall Study||1
8453730|NCT00744042|20832059|P1|COMPLETED|Overall Study||10
8453731|NCT00744042|20832059|P1|STARTED|Overall Study||11
8453732|NCT00743730|20832075|P3|NOT COMPLETED|Overall Study||5
8453733|NCT00743730|20832076|P2|NOT COMPLETED|Overall Study||4
8453734|NCT00743730|20832077|P1|NOT COMPLETED|Overall Study||5
8453735|NCT00743730|20832075|P3|COMPLETED|Overall Study||28
8453736|NCT00743730|20832076|P2|COMPLETED|Overall Study||30
8453737|NCT00743730|20832077|P1|COMPLETED|Overall Study||22
8453738|NCT00743730|20832075|P3|STARTED|Overall Study||33
8453739|NCT00743730|20832076|P2|STARTED|Overall Study||34
8453740|NCT00743730|20832077|P1|STARTED|Overall Study||27
8453741|NCT00743717|20832093|P2|NOT COMPLETED|Overall Study||0
8453742|NCT00743717|20832094|P1|NOT COMPLETED|Overall Study||0
8453743|NCT00743717|20832093|P2|COMPLETED|Overall Study||2
8453744|NCT00743717|20832094|P1|COMPLETED|Overall Study||2
8453745|NCT00743717|20832093|P2|STARTED|Overall Study||2
8453746|NCT00743717|20832094|P1|STARTED|Overall Study||2
8453747|NCT00743652|20832105|P5|NOT COMPLETED|Overall Study||0
8453748|NCT00743652|20832106|P4|NOT COMPLETED|Overall Study||4
8453749|NCT00743652|20832107|P3|NOT COMPLETED|Overall Study||2
8453750|NCT00743652|20832108|P2|NOT COMPLETED|Overall Study||3
8453751|NCT00743652|20832109|P1|NOT COMPLETED|Overall Study||10
8453752|NCT00743652|20832105|P5|COMPLETED|Overall Study||79
8453753|NCT00743652|20832106|P4|COMPLETED|Overall Study||63
8453754|NCT00743652|20832107|P3|COMPLETED|Overall Study||23
8453755|NCT00743652|20832108|P2|COMPLETED|Overall Study||48
8453756|NCT00743652|20832109|P1|COMPLETED|Overall Study||141
8453757|NCT00743652|20832105|P5|Toddler Dose|Overall Study||0
8453758|NCT00743652|20832106|P4|Toddler Dose|Overall Study||0
8453759|NCT00743652|20832107|P3|Toddler Dose|Overall Study||16
8453760|NCT00743652|20832108|P2|Toddler Dose|Overall Study||23
8453761|NCT00743652|20832109|P1|Toddler Dose|Overall Study||15
8453762|NCT00743652|20832105|P5|Vaccinated Dose 3|Overall Study||0
8453763|NCT00743652|20832106|P4|Vaccinated Dose 3|Overall Study||0
8453764|NCT00743652|20832107|P3|Vaccinated Dose 3|Overall Study||0
8453765|NCT00743652|20832108|P2|Vaccinated Dose 3|Overall Study||0
8453766|NCT00743652|20832109|P1|Vaccinated Dose 3|Overall Study||74
8453767|NCT00743652|20832105|P5|Vaccinated Dose 2|Overall Study||0
8453768|NCT00743652|20832106|P4|Vaccinated Dose 2|Overall Study||49
8453769|NCT00743652|20832107|P3|Vaccinated Dose 2|Overall Study||0
8453770|NCT00743652|20832108|P2|Vaccinated Dose 2|Overall Study||41
8453771|NCT00743652|20832109|P1|Vaccinated Dose 2|Overall Study||112
8453772|NCT00743652|20832105|P5|Vaccinated Dose 1|Overall Study||79
8453773|NCT00743652|20832106|P4|Vaccinated Dose 1|Overall Study||66
8453774|NCT00743652|20832107|P3|Vaccinated Dose 1|Overall Study||25
8453775|NCT00743652|20832108|P2|Vaccinated Dose 1|Overall Study||51
8453776|NCT00743652|20832109|P1|Vaccinated Dose 1|Overall Study||151
8453777|NCT00743652|20832105|P5|STARTED|Overall Study||79
8453778|NCT00743652|20832106|P4|STARTED|Overall Study||67
8453779|NCT00743652|20832107|P3|STARTED|Overall Study||25
8453780|NCT00743652|20832108|P2|STARTED|Overall Study||51
8453781|NCT00743652|20832109|P1|STARTED|Overall Study||151
8453788|NCT00743509|20832193|P1|NOT COMPLETED|Overall Study||2
8453789|NCT00743509|20832193|P1|COMPLETED|Overall Study||47
8453790|NCT00743509|20832193|P1|STARTED|Overall Study||49
8453791|NCT00743483|20832198|P1|NOT COMPLETED|Treatment Period||1
8453792|NCT00743483|20832198|P1|COMPLETED|Treatment Period||13
8453793|NCT00743483|20832198|P1|STARTED|Treatment Period||14
8453794|NCT00743483|20832198|P1|NOT COMPLETED|Baseline Period||1
8453795|NCT00743483|20832198|P1|COMPLETED|Baseline Period||14
8453796|NCT00743483|20832198|P1|STARTED|Baseline Period||15
8453797|NCT00743444|20832202|P2|NOT COMPLETED|Second Intervention||0
8453798|NCT00743444|20832203|P1|NOT COMPLETED|Second Intervention||0
8453799|NCT00743444|20832202|P2|COMPLETED|Second Intervention||11
8453800|NCT00743444|20832203|P1|COMPLETED|Second Intervention||14
8453801|NCT00743444|20832202|P2|STARTED|Second Intervention||11
8453802|NCT00743444|20832203|P1|STARTED|Second Intervention||14
8453803|NCT00743444|20832202|P2|NOT COMPLETED|Washout Period||1
8453804|NCT00743444|20832203|P1|NOT COMPLETED|Washout Period||0
8453805|NCT00743444|20832202|P2|COMPLETED|Washout Period||11
8453806|NCT00743444|20832203|P1|COMPLETED|Washout Period||14
8453807|NCT00743444|20832202|P2|STARTED|Washout Period||12
8453808|NCT00743444|20832203|P1|STARTED|Washout Period||14
8453809|NCT00743444|20832202|P2|NOT COMPLETED|First Intervention||1
8453810|NCT00743444|20832203|P1|NOT COMPLETED|First Intervention||0
8453811|NCT00743444|20832202|P2|COMPLETED|First Intervention||12
8453812|NCT00743444|20832203|P1|COMPLETED|First Intervention||14
8453813|NCT00743444|20832202|P2|STARTED|First Intervention||13
8453814|NCT00743444|20832203|P1|STARTED|First Intervention||14
8453815|NCT00743431|20832212|P1|NOT COMPLETED|Overall Study||126
8453816|NCT00743431|20832212|P1|COMPLETED|Overall Study||98
8453817|NCT00743431|20832212|P1|STARTED|Overall Study||224
8453818|NCT00743366|20832216|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
8453819|NCT00743366|20832217|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
8453820|NCT00743366|20832216|P2|COMPLETED|Intervention 2 (8 Days)||7
8453821|NCT00743366|20832217|P1|COMPLETED|Intervention 2 (8 Days)||7
8453822|NCT00743366|20832216|P2|STARTED|Intervention 2 (8 Days)||7
8453823|NCT00743366|20832217|P1|STARTED|Intervention 2 (8 Days)||7
8453824|NCT00743366|20832216|P2|NOT COMPLETED|Intervention 1 (8 Days)||3
8453825|NCT00743366|20832217|P1|NOT COMPLETED|Intervention 1 (8 Days)||3
8453826|NCT00743366|20832216|P2|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
8453827|NCT00743366|20832217|P1|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
8453828|NCT00743366|20832216|P2|STARTED|Intervention 1 (8 Days)||10
8453829|NCT00743366|20832217|P1|STARTED|Intervention 1 (8 Days)||10
8453830|NCT00743340|20832223|P1|NOT COMPLETED|Overall Study||41
8453831|NCT00743340|20832223|P1|COMPLETED|Overall Study||9
8453832|NCT00743340|20832223|P1|STARTED|Overall Study||50
8453833|NCT00743288|20832227|P7|NOT COMPLETED|Overall Study||9
8453834|NCT00743288|20832228|P6|NOT COMPLETED|Overall Study||5
8453835|NCT00743288|20832229|P5|NOT COMPLETED|Overall Study||6
8453836|NCT00743288|20832230|P4|NOT COMPLETED|Overall Study||7
8453837|NCT00743288|20832231|P3|NOT COMPLETED|Overall Study||5
8453838|NCT00743288|20832232|P2|NOT COMPLETED|Overall Study||3
8453839|NCT00743288|20832233|P1|NOT COMPLETED|Overall Study||3
8453840|NCT00743288|20832227|P7|COMPLETED|Overall Study||0
8453841|NCT00743288|20832228|P6|COMPLETED|Overall Study||1
8453842|NCT00743288|20832229|P5|COMPLETED|Overall Study||0
8453843|NCT00743288|20832230|P4|COMPLETED|Overall Study||0
8453844|NCT00743288|20832231|P3|COMPLETED|Overall Study||1
8453845|NCT00743288|20832232|P2|COMPLETED|Overall Study||0
8453846|NCT00743288|20832233|P1|COMPLETED|Overall Study||0
8453847|NCT00743288|20832227|P7|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
8453848|NCT00743288|20832228|P6|STARTED|Overall Study||6
8453849|NCT00743288|20832229|P5|STARTED|Overall Study||6
8453850|NCT00743288|20832230|P4|STARTED|Overall Study||7
8453851|NCT00743288|20832231|P3|STARTED|Overall Study||6
8453852|NCT00743288|20832232|P2|STARTED|Overall Study||3
8453853|NCT00743288|20832233|P1|STARTED|Overall Study||3
8453854|NCT00743275|20832247|P2|NOT COMPLETED|Overall Study||1
8453855|NCT00743275|20832248|P1|NOT COMPLETED|Overall Study||0
8453856|NCT00743275|20832247|P2|COMPLETED|Overall Study||60
8453857|NCT00743275|20832248|P1|COMPLETED|Overall Study||59
8453858|NCT00743275|20832247|P2|STARTED|Overall Study||61
8453859|NCT00743275|20832248|P1|STARTED|Overall Study||59
8453860|NCT00743262|20832260|P1|NOT COMPLETED|Overall Study||0
8453861|NCT00743262|20832260|P1|COMPLETED|Overall Study||15
8453862|NCT00743262|20832260|P1|STARTED|Overall Study||15
8453863|NCT00743249|20832268|P2|NOT COMPLETED|Overall Study||6
8453864|NCT00743249|20832269|P1|NOT COMPLETED|Overall Study||2
8453865|NCT00743249|20832268|P2|COMPLETED|Overall Study||24
8453866|NCT00743249|20832269|P1|COMPLETED|Overall Study||28
8453867|NCT00743249|20832268|P2|STARTED|Overall Study||30
8453868|NCT00743249|20832269|P1|STARTED|Overall Study||30
8453869|NCT00743197|20832279|P2|NOT COMPLETED|Overall Study||2
8453870|NCT00743197|20832280|P1|NOT COMPLETED|Overall Study||1
8453871|NCT00743197|20832279|P2|COMPLETED|Overall Study||0
8453872|NCT00743197|20832280|P1|COMPLETED|Overall Study||0
8453873|NCT00743197|20832279|P2|STARTED|Overall Study||2
8453874|NCT00743197|20832280|P1|STARTED|Overall Study||1
8453875|NCT00743145|20832286|P1|NOT COMPLETED|Overall Study||4
8453876|NCT00743145|20832286|P1|COMPLETED|Overall Study||19
8453877|NCT00743145|20832286|P1|STARTED|Overall Study||23
8453878|NCT00743119|20832300|P1|NOT COMPLETED|Overall Study||4
8453879|NCT00743119|20832300|P1|COMPLETED|Overall Study||30
8453880|NCT00743119|20832300|P1|STARTED|Overall Study||34
8453881|NCT00743106|20832314|P2|NOT COMPLETED|Overall Study||5
8453882|NCT00743106|20832315|P1|NOT COMPLETED|Overall Study||8
8453883|NCT00743106|20832314|P2|COMPLETED|Overall Study||43
8453884|NCT00743106|20832315|P1|COMPLETED|Overall Study||34
8453885|NCT00743106|20832314|P2|STARTED|Overall Study||48
8453886|NCT00743106|20832315|P1|STARTED|Overall Study||42
8453887|NCT00743093|20832325|P2|NOT COMPLETED|Extended Dosing Period||0
8453888|NCT00743093|20832326|P1|NOT COMPLETED|Extended Dosing Period||3
8453889|NCT00743093|20832325|P2|COMPLETED|Extended Dosing Period||1
8453890|NCT00743093|20832326|P1|COMPLETED|Extended Dosing Period||48
8453891|NCT00743093|20832325|P2|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
8453984|NCT00742508|20832547|P1|COMPLETED|8-Week Primary Evaluation Period||11
8453892|NCT00743093|20832326|P1|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
8453893|NCT00743093|20832325|P2|NOT COMPLETED|Base Study Period||5
8453894|NCT00743093|20832326|P1|NOT COMPLETED|Base Study Period||19
8453895|NCT00743093|20832325|P2|COMPLETED|Base Study Period||47
8453896|NCT00743093|20832326|P1|COMPLETED|Base Study Period||205
8453897|NCT00743093|20832325|P2|STARTED|Base Study Period||52
8453898|NCT00743093|20832326|P1|STARTED|Base Study Period||224
8453899|NCT00742963|20832334|P1|NOT COMPLETED|Overall Study||33
8453900|NCT00742963|20832334|P1|COMPLETED|Overall Study||68
8453901|NCT00742963|20832334|P1|Completed All Treatment Cycles|Overall Study||68
8453902|NCT00742963|20832334|P1|STARTED|Overall Study||101
8453903|NCT00742924|20832342|P4|NOT COMPLETED|Overall Study||6
8453904|NCT00742924|20832343|P3|NOT COMPLETED|Overall Study||4
8453905|NCT00742924|20832344|P2|NOT COMPLETED|Overall Study||2
8453906|NCT00742924|20832345|P1|NOT COMPLETED|Overall Study||5
8453907|NCT00742924|20832342|P4|COMPLETED|Overall Study||0
8453908|NCT00742924|20832343|P3|COMPLETED|Overall Study||2
8453909|NCT00742924|20832344|P2|COMPLETED|Overall Study||4
8453910|NCT00742924|20832345|P1|COMPLETED|Overall Study||1
8453911|NCT00742924|20832342|P4|STARTED|Overall Study||6
8453912|NCT00742924|20832343|P3|STARTED|Overall Study||6
8453913|NCT00742924|20832344|P2|STARTED|Overall Study||6
8453914|NCT00742924|20832345|P1|STARTED|Overall Study||6
8453915|NCT00742885|20832357|P2|NOT COMPLETED|Overall Study||0
8453916|NCT00742885|20832358|P1|NOT COMPLETED|Overall Study||1
8453917|NCT00742885|20832357|P2|COMPLETED|Overall Study|to Day 182|50
8453918|NCT00742885|20832358|P1|COMPLETED|Overall Study|to Day 182|49
8453919|NCT00742885|20832357|P2|STARTED|Overall Study||50
8453920|NCT00742885|20832358|P1|STARTED|Overall Study||50
8453921|NCT00742872|20832406|P2|NOT COMPLETED|Overall Study||8
8453922|NCT00742872|20832407|P1|NOT COMPLETED|Overall Study||12
8453923|NCT00742872|20832406|P2|COMPLETED|Overall Study||12
8453924|NCT00742872|20832407|P1|COMPLETED|Overall Study||9
8453925|NCT00742872|20832406|P2|STARTED|Overall Study||20
8453926|NCT00742872|20832407|P1|STARTED|Overall Study||21
8453927|NCT00742859|20832417|P4|NOT COMPLETED|Overall Study||8
8453928|NCT00742859|20832418|P3|NOT COMPLETED|Overall Study||11
8453929|NCT00742859|20832419|P2|NOT COMPLETED|Overall Study||12
8453930|NCT00742859|20832420|P1|NOT COMPLETED|Overall Study||11
8453931|NCT00742859|20832417|P4|COMPLETED|Overall Study||119
8453932|NCT00742859|20832418|P3|COMPLETED|Overall Study||116
8453933|NCT00742859|20832419|P2|COMPLETED|Overall Study||115
8453934|NCT00742859|20832420|P1|COMPLETED|Overall Study||116
8453935|NCT00742859|20832417|P4|STARTED|Overall Study||127
8453936|NCT00742859|20832418|P3|STARTED|Overall Study||127
8453937|NCT00742859|20832419|P2|STARTED|Overall Study||127
8453938|NCT00742859|20832420|P1|STARTED|Overall Study||127
8453939|NCT00742781|20832434|P1|NOT COMPLETED|Overall Study||3
8453940|NCT00742781|20832434|P1|COMPLETED|Overall Study||18
8453941|NCT00742781|20832434|P1|STARTED|Overall Study||21
8453942|NCT00742625|20832443|P1|NOT COMPLETED|Consolidation||21
8453943|NCT00742625|20832443|P1|COMPLETED|Consolidation||20
8453944|NCT00742625|20832443|P1|STARTED|Consolidation||41
8453945|NCT00742625|20832443|P1|NOT COMPLETED|Remission Induction||54
8453946|NCT00742625|20832443|P1|COMPLETED|Remission Induction||41
8453947|NCT00742625|20832443|P1|STARTED|Remission Induction||95
8453948|NCT00742573|20832454|P2|NOT COMPLETED|Overall Study||62
8453949|NCT00742573|20832455|P1|NOT COMPLETED|Overall Study||57
8453950|NCT00742573|20832454|P2|COMPLETED|Overall Study||25
8453951|NCT00742573|20832455|P1|COMPLETED|Overall Study||26
8453952|NCT00742573|20832454|P2|Week 52|Overall Study||25
8453953|NCT00742573|20832455|P1|Week 52|Overall Study||26
8453954|NCT00742573|20832454|P2|Week 24|Overall Study||37
8453955|NCT00742573|20832455|P1|Week 24|Overall Study||39
8453956|NCT00742573|20832454|P2|Week 12|Overall Study||51
8453957|NCT00742573|20832455|P1|Week 12|Overall Study||46
8453958|NCT00742573|20832454|P2|STARTED|Overall Study||87
8453959|NCT00742573|20832455|P1|STARTED|Overall Study||83
8453960|NCT00742560|20832468|P5|NOT COMPLETED|Overall Study||37
8453961|NCT00742560|20832469|P4|NOT COMPLETED|Overall Study||36
8453962|NCT00742560|20832470|P3|NOT COMPLETED|Overall Study||22
8453963|NCT00742560|20832471|P2|NOT COMPLETED|Overall Study||3
8453964|NCT00742560|20832472|P1|NOT COMPLETED|Overall Study||3
8453965|NCT00742560|20832468|P5|COMPLETED|Overall Study||0
8453966|NCT00742560|20832469|P4|COMPLETED|Overall Study||0
8453967|NCT00742560|20832470|P3|COMPLETED|Overall Study||0
8453968|NCT00742560|20832471|P2|COMPLETED|Overall Study||0
8453969|NCT00742560|20832472|P1|COMPLETED|Overall Study||0
8453970|NCT00742560|20832468|P5|STARTED|Overall Study||37
8453971|NCT00742560|20832469|P4|STARTED|Overall Study||36
8453972|NCT00742560|20832470|P3|STARTED|Overall Study||22
8453973|NCT00742560|20832471|P2|STARTED|Overall Study||3
8453974|NCT00742560|20832472|P1|STARTED|Overall Study||3
8453975|NCT00742508|20832546|P2|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
8453976|NCT00742508|20832547|P1|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
8453977|NCT00742508|20832546|P2|COMPLETED|4-Week Exploratory Evaluation Period||7
8453978|NCT00742508|20832547|P1|COMPLETED|4-Week Exploratory Evaluation Period||0
8453979|NCT00742508|20832546|P2|STARTED|4-Week Exploratory Evaluation Period||8
8453980|NCT00742508|20832547|P1|STARTED|4-Week Exploratory Evaluation Period||0
8453981|NCT00742508|20832546|P2|NOT COMPLETED|8-Week Primary Evaluation Period||11
8453982|NCT00742508|20832547|P1|NOT COMPLETED|8-Week Primary Evaluation Period||11
8453983|NCT00742508|20832546|P2|COMPLETED|8-Week Primary Evaluation Period||8
8453985|NCT00742508|20832546|P2|STARTED|8-Week Primary Evaluation Period||19
8453986|NCT00742508|20832547|P1|STARTED|8-Week Primary Evaluation Period||22
8453987|NCT00742469|20832611|P2|NOT COMPLETED|Overall Study||35
8453988|NCT00742469|20832612|P1|NOT COMPLETED|Overall Study||18
8453989|NCT00742469|20832611|P2|COMPLETED|Overall Study||69
8453990|NCT00742469|20832612|P1|COMPLETED|Overall Study||88
8453991|NCT00742469|20832611|P2|STARTED|Overall Study||104
8453992|NCT00742469|20832612|P1|STARTED|Overall Study||106
8453993|NCT00742417|20832620|P2|NOT COMPLETED|Maintenance II||0
8453994|NCT00742417|20832621|P1|NOT COMPLETED|Maintenance II||0
8453995|NCT00742417|20832620|P2|COMPLETED|Maintenance II||19
8453996|NCT00742417|20832621|P1|COMPLETED|Maintenance II||16
8453997|NCT00742417|20832620|P2|STARTED|Maintenance II||19
8453998|NCT00742417|20832621|P1|STARTED|Maintenance II||16
8453999|NCT00742417|20832620|P2|NOT COMPLETED|Maintenance I||0
8454000|NCT00742417|20832621|P1|NOT COMPLETED|Maintenance I||0
8454001|NCT00742417|20832620|P2|COMPLETED|Maintenance I||19
8454002|NCT00742417|20832621|P1|COMPLETED|Maintenance I||16
8454003|NCT00742417|20832620|P2|STARTED|Maintenance I||19
8454004|NCT00742417|20832621|P1|STARTED|Maintenance I||16
8454005|NCT00742417|20832620|P2|NOT COMPLETED|Intensive Period||1
8454006|NCT00742417|20832621|P1|NOT COMPLETED|Intensive Period||3
8454007|NCT00742417|20832620|P2|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
8454008|NCT00742417|20832621|P1|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
8454009|NCT00742417|20832620|P2|STARTED|Intensive Period||20
8454010|NCT00742417|20832621|P1|STARTED|Intensive Period||19
8454011|NCT00742417|20832620|P2|NOT COMPLETED|Randomized||1
8454012|NCT00742417|20832621|P1|NOT COMPLETED|Randomized||2
8454013|NCT00742417|20832620|P2|COMPLETED|Randomized||20
8454014|NCT00742417|20832621|P1|COMPLETED|Randomized||19
8454015|NCT00742417|20832620|P2|STARTED|Randomized||21
8454016|NCT00742417|20832621|P1|STARTED|Randomized||21
8454017|NCT00742391|20832645|P2|NOT COMPLETED|Overall Study||1
8454018|NCT00742391|20832646|P1|NOT COMPLETED|Overall Study||4
8454019|NCT00742391|20832645|P2|COMPLETED|Overall Study||128
8454020|NCT00742391|20832646|P1|COMPLETED|Overall Study||122
8454021|NCT00742391|20832645|P2|STARTED|Overall Study||129
8454022|NCT00742391|20832646|P1|STARTED|Overall Study||126
8454023|NCT00742326|20832656|P2|NOT COMPLETED|Overall Study||1
8454024|NCT00742326|20832657|P1|NOT COMPLETED|Overall Study||0
8454025|NCT00742326|20832656|P2|COMPLETED|Overall Study||6
8454026|NCT00742326|20832657|P1|COMPLETED|Overall Study||6
8454027|NCT00742326|20832656|P2|STARTED|Overall Study||7
8454028|NCT00742326|20832657|P1|STARTED|Overall Study||6
8454029|NCT00742313|20832667|P2|NOT COMPLETED|Overall Study||0
8454030|NCT00742313|20832668|P1|NOT COMPLETED|Overall Study||1
8454031|NCT00742313|20832667|P2|COMPLETED|Overall Study||19
8454032|NCT00742313|20832668|P1|COMPLETED|Overall Study||24
8454033|NCT00742313|20832667|P2|STARTED|Overall Study||19
8454034|NCT00742313|20832668|P1|STARTED|Overall Study||25
8454035|NCT00742274|20832676|P2|NOT COMPLETED|Overall Study||3
8454036|NCT00742274|20832677|P1|NOT COMPLETED|Overall Study||3
8454037|NCT00742274|20832676|P2|COMPLETED|Overall Study||28
8454038|NCT00742274|20832677|P1|COMPLETED|Overall Study||27
8454039|NCT00742274|20832676|P2|STARTED|Overall Study||31
8454040|NCT00742274|20832677|P1|STARTED|Overall Study||30
8454041|NCT00742235|20832685|P2|NOT COMPLETED|Overall Study||31
8454042|NCT00742235|20832686|P1|NOT COMPLETED|Overall Study||0
8454043|NCT00742235|20832685|P2|COMPLETED|Overall Study||36
8454044|NCT00742235|20832686|P1|COMPLETED|Overall Study||32
8454045|NCT00742235|20832685|P2|STARTED|Overall Study||67
8454046|NCT00742235|20832686|P1|STARTED|Overall Study||32
8454047|NCT00742209|20832699|P5|NOT COMPLETED|Overall Study||25
8454048|NCT00742209|20832700|P4|NOT COMPLETED|Overall Study||37
8454049|NCT00742209|20832701|P3|NOT COMPLETED|Overall Study||46
8454050|NCT00742209|20832702|P2|NOT COMPLETED|Overall Study||18
8454051|NCT00742209|20832703|P1|NOT COMPLETED|Overall Study||34
8454052|NCT00742209|20832699|P5|COMPLETED|Overall Study||37
8454053|NCT00742209|20832700|P4|COMPLETED|Overall Study||97
8454054|NCT00742209|20832701|P3|COMPLETED|Overall Study||88
8454055|NCT00742209|20832702|P2|COMPLETED|Overall Study||49
8454056|NCT00742209|20832703|P1|COMPLETED|Overall Study||95
8454057|NCT00742209|20832699|P5|STARTED|Overall Study||62
8454058|NCT00742209|20832700|P4|STARTED|Overall Study||134
8454059|NCT00742209|20832701|P3|STARTED|Overall Study||134
8454060|NCT00742209|20832702|P2|STARTED|Overall Study||67
8454061|NCT00742209|20832703|P1|STARTED|Overall Study||129
8454062|NCT00742183|20832806|P2|NOT COMPLETED|Overall Study||12
8454063|NCT00742183|20832807|P1|NOT COMPLETED|Overall Study||9
8454064|NCT00742183|20832806|P2|COMPLETED|Overall Study||39
8454065|NCT00742183|20832807|P1|COMPLETED|Overall Study||40
8454066|NCT00742183|20832806|P2|STARTED|Overall Study||51
8454067|NCT00742183|20832807|P1|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
8454068|NCT00742170|20832815|P2|NOT COMPLETED|Overall Study||5
8454069|NCT00742170|20832816|P1|NOT COMPLETED|Overall Study||2
8454070|NCT00742170|20832815|P2|COMPLETED|Overall Study||24
8454071|NCT00742170|20832816|P1|COMPLETED|Overall Study||24
8454072|NCT00742170|20832815|P2|STARTED|Overall Study||29
8454073|NCT00742170|20832816|P1|STARTED|Overall Study||26
8454074|NCT00742079|20832826|P2|NOT COMPLETED|Overall Study||1
8454075|NCT00742079|20832827|P1|NOT COMPLETED|Overall Study||0
8454076|NCT00742079|20832826|P2|COMPLETED|Overall Study||9
8454077|NCT00742079|20832827|P1|COMPLETED|Overall Study||11
8454078|NCT00742079|20832826|P2|Week 2 (Received Dose 2)|Overall Study||9
8454079|NCT00742079|20832827|P1|Week 2 (Received Dose 2)|Overall Study||11
8454080|NCT00742079|20832826|P2|Baseline/Week 1 (Received Dose 1)|Overall Study||9
8454081|NCT00742079|20832827|P1|Baseline/Week 1 (Received Dose 1)|Overall Study||11
8454082|NCT00742079|20832826|P2|STARTED|Overall Study||10
8454083|NCT00742079|20832827|P1|STARTED|Overall Study||11
8454084|NCT00742053|20832841|P1|NOT COMPLETED|Overall Study||0
8454085|NCT00742053|20832841|P1|COMPLETED|Overall Study||7
8454086|NCT00742053|20832841|P1|STARTED|Overall Study||7
8454087|NCT00742001|20832848|P3|NOT COMPLETED|Overall Study||1
8454088|NCT00742001|20832849|P2|NOT COMPLETED|Overall Study||0
8454089|NCT00742001|20832850|P1|NOT COMPLETED|Overall Study||0
8454090|NCT00742001|20832848|P3|COMPLETED|Overall Study||3
8454091|NCT00742001|20832849|P2|COMPLETED|Overall Study||4
8454092|NCT00742001|20832850|P1|COMPLETED|Overall Study||4
8454093|NCT00742001|20832848|P3|STARTED|Overall Study||4
8454094|NCT00742001|20832849|P2|STARTED|Overall Study||4
8454095|NCT00742001|20832850|P1|STARTED|Overall Study||4
8454096|NCT00741988|20832866|P2|NOT COMPLETED|Overall Study||4
8454097|NCT00741988|20832867|P1|NOT COMPLETED|Overall Study||4
8454098|NCT00741988|20832866|P2|COMPLETED|Overall Study||36
8454099|NCT00741988|20832867|P1|COMPLETED|Overall Study||38
8454100|NCT00741988|20832866|P2|STARTED|Overall Study||40
8454101|NCT00741988|20832867|P1|STARTED|Overall Study||42
8454102|NCT00741936|20832879|P2|NOT COMPLETED|Overall Study||8
8454103|NCT00741936|20832880|P1|NOT COMPLETED|Overall Study||9
8454104|NCT00741936|20832879|P2|COMPLETED|Overall Study||52
8454105|NCT00741936|20832880|P1|COMPLETED|Overall Study||51
8454106|NCT00741936|20832879|P2|STARTED|Overall Study||60
8454107|NCT00741936|20832880|P1|STARTED|Overall Study||60
8454108|NCT00741858|20832908|P2|NOT COMPLETED|Overall Study||0
8454109|NCT00741858|20832909|P1|NOT COMPLETED|Overall Study||0
8454110|NCT00741858|20832908|P2|COMPLETED|Overall Study||18
8454111|NCT00741858|20832909|P1|COMPLETED|Overall Study||16
8454112|NCT00741858|20832908|P2|STARTED|Overall Study||18
8454113|NCT00741858|20832909|P1|STARTED|Overall Study||16
8454114|NCT00741819|20832915|P1|NOT COMPLETED|Overall Study||8
8454115|NCT00741819|20832915|P1|COMPLETED|Overall Study||65
8454116|NCT00741819|20832915|P1|STARTED|Overall Study||73
8454117|NCT00741611|20832929|P3|NOT COMPLETED|Overall Study||3
8454118|NCT00741611|20832930|P2|NOT COMPLETED|Overall Study||2
8454119|NCT00741611|20832931|P1|NOT COMPLETED|Overall Study||0
8454120|NCT00741611|20832929|P3|COMPLETED|Overall Study||26
8454121|NCT00741611|20832930|P2|COMPLETED|Overall Study||1
8454122|NCT00741611|20832931|P1|COMPLETED|Overall Study||4
8454123|NCT00741611|20832929|P3|STARTED|Overall Study||29
8454124|NCT00741611|20832930|P2|STARTED|Overall Study||3
8454125|NCT00741611|20832931|P1|STARTED|Overall Study||4
8454126|NCT00741598|20832950|P2|NOT COMPLETED|Overall Study||9
8454127|NCT00741598|20832951|P1|NOT COMPLETED|Overall Study||9
8454128|NCT00741598|20832950|P2|COMPLETED|Overall Study||30
8454129|NCT00741598|20832951|P1|COMPLETED|Overall Study||24
8454130|NCT00741598|20832950|P2|STARTED|Overall Study||39
8454131|NCT00741598|20832951|P1|STARTED|Overall Study||33
8454132|NCT00741468|20832965|P1|NOT COMPLETED|Overall Study||0
8454133|NCT00741468|20832965|P1|COMPLETED|Overall Study||18
8454134|NCT00741468|20832965|P1|STARTED|Overall Study||18
8454135|NCT00741455|20832973|P1|NOT COMPLETED|Overall Study||1
8454136|NCT00741455|20832973|P1|COMPLETED|Overall Study||17
8454137|NCT00741455|20832973|P1|STARTED|Overall Study||18
8454138|NCT00741390|20832982|P4|NOT COMPLETED|Visit 2||1
8454139|NCT00741390|20832983|P3|NOT COMPLETED|Visit 2||1
8454140|NCT00741390|20832984|P2|NOT COMPLETED|Visit 2||0
8454141|NCT00741390|20832985|P1|NOT COMPLETED|Visit 2||0
8454142|NCT00741390|20832982|P4|COMPLETED|Visit 2||60
8454143|NCT00741390|20832983|P3|COMPLETED|Visit 2||54
8454144|NCT00741390|20832984|P2|COMPLETED|Visit 2||61
8454145|NCT00741390|20832985|P1|COMPLETED|Visit 2||59
8454146|NCT00741390|20832982|P4|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
8454147|NCT00741390|20832983|P3|STARTED|Visit 2||55
8454148|NCT00741390|20832984|P2|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
8454149|NCT00741390|20832985|P1|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
8454150|NCT00741390|20832982|P4|NOT COMPLETED|Visit 1||1
8454151|NCT00741390|20832983|P3|NOT COMPLETED|Visit 1||7
8454152|NCT00741390|20832984|P2|NOT COMPLETED|Visit 1||0
8454153|NCT00741390|20832985|P1|NOT COMPLETED|Visit 1||2
8454154|NCT00741390|20832982|P4|COMPLETED|Visit 1||62
8454155|NCT00741390|20832983|P3|COMPLETED|Visit 1||55
8454156|NCT00741390|20832984|P2|COMPLETED|Visit 1||63
8454157|NCT00741390|20832985|P1|COMPLETED|Visit 1||60
8454158|NCT00741390|20832982|P4|STARTED|Visit 1||63
8454159|NCT00741390|20832983|P3|STARTED|Visit 1||62
8454160|NCT00741390|20832984|P2|STARTED|Visit 1||63
8454161|NCT00741390|20832985|P1|STARTED|Visit 1||62
8454162|NCT00741338|20833006|P2|NOT COMPLETED|Overall Study||1
8454163|NCT00741338|20833007|P1|NOT COMPLETED|Overall Study||0
8454164|NCT00741338|20833006|P2|COMPLETED|Overall Study||2
8454165|NCT00741338|20833007|P1|COMPLETED|Overall Study||3
8454166|NCT00741338|20833006|P2|STARTED|Overall Study||3
8454167|NCT00741338|20833007|P1|STARTED|Overall Study||3
8454168|NCT00741286|20833017|P2|NOT COMPLETED|Overall Study||19
8454169|NCT00741286|20833018|P1|NOT COMPLETED|Overall Study||20
8454170|NCT00741286|20833017|P2|COMPLETED|Overall Study||81
8454171|NCT00741286|20833018|P1|COMPLETED|Overall Study||83
8454172|NCT00741286|20833017|P2|STARTED|Overall Study||100
8454173|NCT00741286|20833018|P1|STARTED|Overall Study||103
8454174|NCT00741273|20833028|P2|NOT COMPLETED|Overall Study||0
8454175|NCT00741273|20833029|P1|NOT COMPLETED|Overall Study||0
8454176|NCT00741273|20833028|P2|COMPLETED|Overall Study||8
8454177|NCT00741273|20833029|P1|COMPLETED|Overall Study||8
8454178|NCT00741273|20833028|P2|STARTED|Overall Study||8
8454179|NCT00741273|20833029|P1|STARTED|Overall Study||8
8454180|NCT00741260|20833052|P7|NOT COMPLETED|Overall Study||7
8454181|NCT00741260|20833053|P6|NOT COMPLETED|Overall Study||45
8454182|NCT00741260|20833054|P5|NOT COMPLETED|Overall Study||9
8454183|NCT00741260|20833055|P4|NOT COMPLETED|Overall Study||6
8454184|NCT00741260|20833056|P3|NOT COMPLETED|Overall Study||4
8454185|NCT00741260|20833057|P2|NOT COMPLETED|Overall Study||8
8454186|NCT00741260|20833058|P1|NOT COMPLETED|Overall Study||6
8454187|NCT00741260|20833052|P7|COMPLETED|Overall Study||0
8454188|NCT00741260|20833053|P6|COMPLETED|Overall Study||20
8454189|NCT00741260|20833054|P5|COMPLETED|Overall Study||0
8454190|NCT00741260|20833055|P4|COMPLETED|Overall Study||0
8454191|NCT00741260|20833056|P3|COMPLETED|Overall Study||0
8454192|NCT00741260|20833057|P2|COMPLETED|Overall Study||0
8454193|NCT00741260|20833058|P1|COMPLETED|Overall Study||0
8454194|NCT00741260|20833052|P7|STARTED|Overall Study||7
8454195|NCT00741260|20833053|P6|STARTED|Overall Study||65
8454196|NCT00741260|20833054|P5|STARTED|Overall Study||9
8454197|NCT00741260|20833055|P4|STARTED|Overall Study||6
8454198|NCT00741260|20833056|P3|STARTED|Overall Study||4
8454199|NCT00741260|20833057|P2|STARTED|Overall Study||8
8454200|NCT00741260|20833058|P1|STARTED|Overall Study||6
8454201|NCT00741156|20833085|P1|NOT COMPLETED|Overall Study||0
8454202|NCT00741156|20833085|P1|COMPLETED|Overall Study||12
8454203|NCT00741156|20833085|P1|STARTED|Overall Study||12
8454204|NCT00741104|20833100|P1|NOT COMPLETED|Overall Study||0
8454205|NCT00741104|20833100|P1|COMPLETED|Overall Study||363
8454206|NCT00741104|20833100|P1|STARTED|Overall Study||363
8454207|NCT00741091|20833107|P1|NOT COMPLETED|Overall Study||57
8454208|NCT00741091|20833107|P1|COMPLETED|Overall Study||1040
8454209|NCT00741091|20833107|P1|STARTED|Overall Study||1097
8454210|NCT00741039|20833117|P2|NOT COMPLETED|Overall Study||0
8454211|NCT00741039|20833118|P1|NOT COMPLETED|Overall Study||2
8454212|NCT00741039|20833117|P2|COMPLETED|Overall Study||25
8454213|NCT00741039|20833118|P1|COMPLETED|Overall Study||100
8454214|NCT00741039|20833117|P2|STARTED|Overall Study||25
8454215|NCT00741039|20833118|P1|STARTED|Overall Study||102
8454216|NCT00741026|20833124|P1|NOT COMPLETED|Overall Study||0
8454217|NCT00741026|20833124|P1|COMPLETED|Overall Study||15
8454218|NCT00741026|20833124|P1|STARTED|Overall Study||15
8454219|NCT00741013|20833155|P3|NOT COMPLETED|Overall Study||1
8454220|NCT00741013|20833156|P2|NOT COMPLETED|Overall Study||2
8454221|NCT00741013|20833157|P1|NOT COMPLETED|Overall Study||1
8454222|NCT00741013|20833155|P3|COMPLETED|Overall Study||6
8454223|NCT00741013|20833156|P2|COMPLETED|Overall Study||6
8454224|NCT00741013|20833157|P1|COMPLETED|Overall Study||6
8454225|NCT00741013|20833155|P3|STARTED|Overall Study||7
8454226|NCT00741013|20833156|P2|STARTED|Overall Study||8
8454227|NCT00741013|20833157|P1|STARTED|Overall Study||7
8454231|NCT00740857|20833183|P3|NOT COMPLETED|Overall Study||0
8454232|NCT00740857|20833184|P2|NOT COMPLETED|Overall Study||0
8454233|NCT00740857|20833185|P1|NOT COMPLETED|Overall Study||1
8454234|NCT00740857|20833183|P3|COMPLETED|Overall Study||90
8454235|NCT00740857|20833184|P2|COMPLETED|Overall Study||88
8454236|NCT00740857|20833185|P1|COMPLETED|Overall Study||32
8454237|NCT00740857|20833183|P3|STARTED|Overall Study||90
8454238|NCT00740857|20833184|P2|STARTED|Overall Study||88
8454239|NCT00740857|20833185|P1|STARTED|Overall Study||33
8454240|NCT00740831|20833217|P3|NOT COMPLETED|Overall Study||6
8454241|NCT00740831|20833218|P2|NOT COMPLETED|Overall Study||3
8454242|NCT00740831|20833219|P1|NOT COMPLETED|Overall Study||4
8454243|NCT00740831|20833217|P3|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
8454244|NCT00740831|20833218|P2|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
8454245|NCT00740831|20833219|P1|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
8454246|NCT00740831|20833217|P3|STARTED|Overall Study|Safety population|101
8454247|NCT00740831|20833218|P2|STARTED|Overall Study|Safety population|103
8454248|NCT00740831|20833219|P1|STARTED|Overall Study|Safety population|97
8454249|NCT00740792|20833240|P4|NOT COMPLETED|Overall Study||10
8454250|NCT00740792|20833241|P3|NOT COMPLETED|Overall Study||9
8454251|NCT00740792|20833242|P2|NOT COMPLETED|Overall Study||8
8454252|NCT00740792|20833243|P1|NOT COMPLETED|Overall Study||10
8454253|NCT00740792|20833240|P4|COMPLETED|Overall Study||190
8454254|NCT00740792|20833241|P3|COMPLETED|Overall Study||180
8454255|NCT00740792|20833242|P2|COMPLETED|Overall Study||186
8454256|NCT00740792|20833243|P1|COMPLETED|Overall Study||183
8454257|NCT00740792|20833240|P4|STARTED|Overall Study||200
8454258|NCT00740792|20833241|P3|STARTED|Overall Study||189
8454259|NCT00740792|20833242|P2|STARTED|Overall Study||194
8454260|NCT00740792|20833243|P1|STARTED|Overall Study||193
8454261|NCT00740779|20833264|P3|NOT COMPLETED|Overall Study||13
8454262|NCT00740779|20833265|P2|NOT COMPLETED|Overall Study||14
8454263|NCT00740779|20833266|P1|NOT COMPLETED|Overall Study||9
8454264|NCT00740779|20833264|P3|COMPLETED|Overall Study||41
8454265|NCT00740779|20833265|P2|COMPLETED|Overall Study||31
8454266|NCT00740779|20833266|P1|COMPLETED|Overall Study||43
8454267|NCT00740779|20833264|P3|STARTED|Overall Study||54
8454268|NCT00740779|20833265|P2|STARTED|Overall Study||45
8454269|NCT00740779|20833266|P1|STARTED|Overall Study||52
8454270|NCT00740727|20833274|P1|NOT COMPLETED|Overall Study||0
8454271|NCT00740727|20833274|P1|COMPLETED|Overall Study||18
8454272|NCT00740727|20833274|P1|STARTED|Overall Study||18
8454273|NCT00740714|20833283|P3|NOT COMPLETED|Overall Study||29
8454274|NCT00740714|20833284|P2|NOT COMPLETED|Overall Study||19
8454275|NCT00740714|20833285|P1|NOT COMPLETED|Overall Study||17
8454276|NCT00740714|20833283|P3|COMPLETED|Overall Study||174
8454277|NCT00740714|20833284|P2|COMPLETED|Overall Study||182
8454278|NCT00740714|20833285|P1|COMPLETED|Overall Study||179
8454279|NCT00740714|20833283|P3|Active Patients at Study Termination|Overall Study||33
8454280|NCT00740714|20833284|P2|Active Patients at Study Termination|Overall Study||12
8454281|NCT00740714|20833285|P1|Active Patients at Study Termination|Overall Study||24
8454282|NCT00740714|20833283|P3|Reaching Endpoint Before May 6, 2011|Overall Study||94
8454283|NCT00740714|20833284|P2|Reaching Endpoint Before May 6, 2011|Overall Study||87
8454284|NCT00740714|20833285|P1|Reaching Endpoint Before May 6, 2011|Overall Study||86
8454285|NCT00740714|20833283|P3|STARTED|Overall Study|Randomized throughout the recruitment period|203
8454286|NCT00740714|20833284|P2|STARTED|Overall Study|Randomized throughout the recruitment period|201
8454287|NCT00740714|20833285|P1|STARTED|Overall Study|Randomized throughout the recruitment period|196
8454288|NCT00740636|20833361|P2|NOT COMPLETED|Overall Study||4
8454289|NCT00740636|20833362|P1|NOT COMPLETED|Overall Study||2
8454290|NCT00740636|20833361|P2|COMPLETED|Overall Study||63
8454291|NCT00740636|20833362|P1|COMPLETED|Overall Study||23
8454292|NCT00740636|20833361|P2|STARTED|Overall Study||67
8454293|NCT00740636|20833362|P1|STARTED|Overall Study||25
8454294|NCT00740597|20833368|P1|NOT COMPLETED|Overall Study||1
8454295|NCT00740597|20833368|P1|COMPLETED|Overall Study||0
8454296|NCT00740597|20833368|P1|STARTED|Overall Study||1
8454297|NCT00740584|20833372|P1|NOT COMPLETED|Overall Study||1
8454298|NCT00740584|20833372|P1|COMPLETED|Overall Study||11
8454299|NCT00740584|20833372|P1|STARTED|Overall Study||12
8454300|NCT00740480|20833377|P1|NOT COMPLETED|Overall Study||2
8454301|NCT00740480|20833377|P1|COMPLETED|Overall Study||23
8454302|NCT00740480|20833377|P1|STARTED|Overall Study||25
8454303|NCT00740376|20833383|P2|NOT COMPLETED|Overall Study||3
8454304|NCT00740376|20833384|P1|NOT COMPLETED|Overall Study||3
8454305|NCT00740376|20833383|P2|COMPLETED|Overall Study||12
8454306|NCT00740376|20833384|P1|COMPLETED|Overall Study||19
8454307|NCT00740376|20833383|P2|STARTED|Overall Study||15
8454308|NCT00740376|20833384|P1|STARTED|Overall Study||22
8454309|NCT00740220|20833402|P1|NOT COMPLETED|Overall Study||9
8454310|NCT00740220|20833402|P1|COMPLETED|Overall Study||88
8454311|NCT00740220|20833402|P1|STARTED|Overall Study||97
8454312|NCT00740207|20833408|P2|NOT COMPLETED|Overall Study||0
8454313|NCT00740207|20833409|P1|NOT COMPLETED|Overall Study||0
8454314|NCT00740207|20833408|P2|COMPLETED|Overall Study||16
8454315|NCT00740207|20833409|P1|COMPLETED|Overall Study||17
8454316|NCT00740207|20833408|P2|STARTED|Overall Study||16
8454317|NCT00740207|20833409|P1|STARTED|Overall Study||17
8454318|NCT00740181|20833421|P1|NOT COMPLETED|Overall Study||0
8454319|NCT00740181|20833421|P1|COMPLETED|Overall Study||9
8454320|NCT00740181|20833421|P1|STARTED|Overall Study||9
8454321|NCT00740051|20833427|P2|NOT COMPLETED|Overall Study||32
8454322|NCT00740051|20833428|P1|NOT COMPLETED|Overall Study||18
8454323|NCT00740051|20833427|P2|COMPLETED|Overall Study||119
8454324|NCT00740051|20833428|P1|COMPLETED|Overall Study||58
8454325|NCT00740051|20833427|P2|STARTED|Overall Study||151
8454326|NCT00740051|20833428|P1|STARTED|Overall Study||76
8454333|NCT00739973|20833531|P9|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
8454334|NCT00739973|20833532|P8|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
8454335|NCT00739973|20833533|P7|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
8454336|NCT00739973|20833534|P6|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
8454337|NCT00739973|20833535|P5|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
8454338|NCT00739973|20833536|P4|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
8454339|NCT00739973|20833537|P3|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
8454340|NCT00739973|20833538|P2|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
8454341|NCT00739973|20833539|P1|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
8454342|NCT00739973|20833531|P9|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
8454343|NCT00739973|20833532|P8|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
8454344|NCT00739973|20833533|P7|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
8454345|NCT00739973|20833534|P6|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
8454346|NCT00739973|20833535|P5|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
8454347|NCT00739973|20833536|P4|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
8454348|NCT00739973|20833537|P3|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
8454349|NCT00739973|20833538|P2|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
8454350|NCT00739973|20833539|P1|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
8454351|NCT00739973|20833531|P9|STARTED|Double-blind:Randomized Period (8 Weeks)||184
8454352|NCT00739973|20833532|P8|STARTED|Double-blind:Randomized Period (8 Weeks)||178
8454353|NCT00739973|20833533|P7|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
8454354|NCT00739973|20833534|P6|STARTED|Double-blind:Randomized Period (8 Weeks)||181
8454355|NCT00739973|20833535|P5|STARTED|Double-blind:Randomized Period (8 Weeks)||181
8454356|NCT00739973|20833536|P4|STARTED|Double-blind:Randomized Period (8 Weeks)||185
8454357|NCT00739973|20833537|P3|STARTED|Double-blind:Randomized Period (8 Weeks)||203
8454358|NCT00739973|20833538|P2|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
8454359|NCT00739973|20833539|P1|STARTED|Double-blind:Randomized Period (8 Weeks)||198
8454360|NCT00739973|20833531|P9|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454361|NCT00739973|20833532|P8|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454362|NCT00739973|20833533|P7|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454363|NCT00739973|20833534|P6|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454364|NCT00739973|20833535|P5|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454365|NCT00739973|20833536|P4|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454366|NCT00739973|20833537|P3|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454367|NCT00739973|20833538|P2|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454368|NCT00739973|20833539|P1|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
8454369|NCT00739973|20833531|P9|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454370|NCT00739973|20833532|P8|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454371|NCT00739973|20833533|P7|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454372|NCT00739973|20833534|P6|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454373|NCT00739973|20833535|P5|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454374|NCT00739973|20833536|P4|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454375|NCT00739973|20833537|P3|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454376|NCT00739973|20833538|P2|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
8454377|NCT00739973|20833539|P1|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
8454378|NCT00739973|20833531|P9|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454379|NCT00739973|20833532|P8|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454380|NCT00739973|20833533|P7|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454381|NCT00739973|20833534|P6|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454382|NCT00739973|20833535|P5|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454383|NCT00739973|20833536|P4|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454384|NCT00739973|20833537|P3|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454385|NCT00739973|20833538|P2|STARTED|Single-blind Period (2 to 4 Weeks)||0
8454386|NCT00739973|20833539|P1|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
8454387|NCT00739960|20833625|P1|NOT COMPLETED|Overall Study||0
8454388|NCT00739960|20833625|P1|COMPLETED|Overall Study||1
8454389|NCT00739960|20833625|P1|STARTED|Overall Study||1
8454390|NCT00739934|20833630|P1|NOT COMPLETED|Voriconazole Oral||3
8454391|NCT00739934|20833630|P1|COMPLETED|Voriconazole Oral||31
8454392|NCT00739934|20833630|P1|STARTED|Voriconazole Oral||34
8454393|NCT00739934|20833630|P1|NOT COMPLETED|Voriconazole IV||6
8454394|NCT00739934|20833630|P1|COMPLETED|Voriconazole IV||34
8454395|NCT00739934|20833630|P1|STARTED|Voriconazole IV||40
8454396|NCT00739908|20833652|P2|NOT COMPLETED|Overall Study||25
8454397|NCT00739908|20833653|P1|NOT COMPLETED|Overall Study||25
8454398|NCT00739908|20833652|P2|COMPLETED|Overall Study||118
8454399|NCT00739908|20833653|P1|COMPLETED|Overall Study||117
8454400|NCT00739908|20833652|P2|STARTED|Overall Study||143
8454401|NCT00739908|20833653|P1|STARTED|Overall Study||142
8454402|NCT00739882|20833673|P2|NOT COMPLETED|Open-label Period||5
8454403|NCT00739882|20833674|P1|NOT COMPLETED|Open-label Period||10
8454404|NCT00739882|20833673|P2|COMPLETED|Open-label Period||9
8454405|NCT00739882|20833674|P1|COMPLETED|Open-label Period||7
8454406|NCT00739882|20833673|P2|STARTED|Open-label Period||14
8454407|NCT00739882|20833674|P1|STARTED|Open-label Period||17
8454408|NCT00739882|20833673|P2|NOT COMPLETED|Double-blind Period||11
8454409|NCT00739882|20833674|P1|NOT COMPLETED|Double-blind Period||19
8454410|NCT00739882|20833673|P2|COMPLETED|Double-blind Period||14
8454411|NCT00739882|20833674|P1|COMPLETED|Double-blind Period||32
8454412|NCT00739882|20833673|P2|STARTED|Double-blind Period||25
8454413|NCT00739882|20833674|P1|STARTED|Double-blind Period||51
8454414|NCT00739765|20833695|P3|NOT COMPLETED|Overall Study||11
8454415|NCT00739765|20833696|P2|NOT COMPLETED|Overall Study||11
8454416|NCT00739765|20833697|P1|NOT COMPLETED|Overall Study||6
8454417|NCT00739765|20833695|P3|COMPLETED|Overall Study||21
8454418|NCT00739765|20833696|P2|COMPLETED|Overall Study||27
8454419|NCT00739765|20833697|P1|COMPLETED|Overall Study||34
8454420|NCT00739765|20833695|P3|STARTED|Overall Study||32
8454421|NCT00739765|20833696|P2|STARTED|Overall Study||38
8454422|NCT00739765|20833697|P1|STARTED|Overall Study||40
8454423|NCT00739752|20833714|P6|NOT COMPLETED|Overall Study||0
8454424|NCT00739752|20833715|P5|NOT COMPLETED|Overall Study||0
8454425|NCT00739752|20833716|P4|NOT COMPLETED|Overall Study||0
8454426|NCT00739752|20833717|P3|NOT COMPLETED|Overall Study||0
8454427|NCT00739752|20833718|P2|NOT COMPLETED|Overall Study||0
8454428|NCT00739752|20833719|P1|NOT COMPLETED|Overall Study||0
8454429|NCT00739752|20833714|P6|COMPLETED|Overall Study||293
8454430|NCT00739752|20833715|P5|COMPLETED|Overall Study||291
8454431|NCT00739752|20833716|P4|COMPLETED|Overall Study||288
8454432|NCT00739752|20833717|P3|COMPLETED|Overall Study||292
8454433|NCT00739752|20833718|P2|COMPLETED|Overall Study||284
8454434|NCT00739752|20833719|P1|COMPLETED|Overall Study||299
8454435|NCT00739752|20833714|P6|STARTED|Overall Study||293
8454436|NCT00739752|20833715|P5|STARTED|Overall Study||291
8454437|NCT00739752|20833716|P4|STARTED|Overall Study||288
8454438|NCT00739752|20833717|P3|STARTED|Overall Study||292
8454439|NCT00739752|20833718|P2|STARTED|Overall Study||284
8454440|NCT00739752|20833719|P1|STARTED|Overall Study||299
8454441|NCT00739674|20833735|P2|NOT COMPLETED|Overall Study||122
8454442|NCT00739674|20833736|P1|NOT COMPLETED|Overall Study||181
8454443|NCT00739674|20833735|P2|COMPLETED|Overall Study||335
8454444|NCT00739674|20833736|P1|COMPLETED|Overall Study||354
8454445|NCT00739674|20833735|P2|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
8454446|NCT00739674|20833736|P1|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
8454447|NCT00739674|20833735|P2|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
8454448|NCT00739674|20833736|P1|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
8454449|NCT00739674|20833735|P2|No Follow-up Data|Overall Study||18
8454450|NCT00739674|20833736|P1|No Follow-up Data|Overall Study||33
8454451|NCT00739674|20833735|P2|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
8454452|NCT00739674|20833736|P1|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
8454453|NCT00739674|20833735|P2|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
8454454|NCT00739674|20833736|P1|Screening Failures|Overall Study||19
8454455|NCT00739674|20833735|P2|STARTED|Overall Study||457
8454456|NCT00739674|20833736|P1|STARTED|Overall Study||535
8454457|NCT00739661|20833764|P2|NOT COMPLETED|Overall Study||42
8454458|NCT00739661|20833765|P1|NOT COMPLETED|Overall Study||46
8454459|NCT00739661|20833764|P2|COMPLETED|Overall Study||10
8454460|NCT00739661|20833765|P1|COMPLETED|Overall Study||6
8454461|NCT00739661|20833764|P2|STARTED|Overall Study||52
8454462|NCT00739661|20833765|P1|STARTED|Overall Study||52
8454463|NCT00739648|20833777|P2|NOT COMPLETED|Overall Study||53
8454464|NCT00739648|20833778|P1|NOT COMPLETED|Overall Study||26
8454465|NCT00739648|20833777|P2|COMPLETED|Overall Study||161
8454466|NCT00739648|20833778|P1|COMPLETED|Overall Study||82
8454467|NCT00739648|20833777|P2|STARTED|Overall Study||214
8454468|NCT00739648|20833778|P1|STARTED|Overall Study||108
8454469|NCT00739596|20833792|P2|NOT COMPLETED|Overall Study||17
8454470|NCT00739596|20833793|P1|NOT COMPLETED|Overall Study||25
8454471|NCT00739596|20833792|P2|COMPLETED|Overall Study||149
8454472|NCT00739596|20833793|P1|COMPLETED|Overall Study||141
8454473|NCT00739596|20833792|P2|STARTED|Overall Study||166
8454474|NCT00739596|20833793|P1|STARTED|Overall Study||166
8454475|NCT00739583|20833809|P2|NOT COMPLETED|Overall Study||0
8454476|NCT00739583|20833810|P1|NOT COMPLETED|Overall Study||0
8454477|NCT00739583|20833809|P2|COMPLETED|Overall Study||10
8454478|NCT00739583|20833810|P1|COMPLETED|Overall Study||10
8454479|NCT00739583|20833809|P2|STARTED|Overall Study||10
8454480|NCT00739583|20833810|P1|STARTED|Overall Study||10
8454481|NCT00739336|20833822|P2|NOT COMPLETED|Overall Study||0
8454482|NCT00739336|20833823|P1|NOT COMPLETED|Overall Study||4
8454483|NCT00739336|20833822|P2|COMPLETED|Overall Study||24
8454484|NCT00739336|20833823|P1|COMPLETED|Overall Study||17
8454485|NCT00739336|20833822|P2|STARTED|Overall Study||24
8454486|NCT00739336|20833823|P1|STARTED|Overall Study||21
8454487|NCT00739310|20833835|P1|NOT COMPLETED|Overall Study||7
8454488|NCT00739310|20833835|P1|COMPLETED|Overall Study||22
8454489|NCT00739310|20833835|P1|STARTED|Overall Study||29
8454490|NCT00739297|20833840|P7|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
8454491|NCT00739297|20833841|P6|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
8454492|NCT00739297|20833842|P5|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8454493|NCT00739297|20833843|P4|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8454494|NCT00739297|20833844|P3|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8454495|NCT00739297|20833845|P2|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8454496|NCT00739297|20833846|P1|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
8454497|NCT00739297|20833840|P7|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
8454498|NCT00739297|20833841|P6|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
8454499|NCT00739297|20833842|P5|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
8454500|NCT00739297|20833843|P4|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
8454501|NCT00739297|20833844|P3|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
8454502|NCT00739297|20833845|P2|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
8454503|NCT00739297|20833846|P1|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
8454504|NCT00739297|20833840|P7|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
8454505|NCT00739297|20833841|P6|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
8454506|NCT00739297|20833842|P5|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
8454507|NCT00739297|20833843|P4|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
8454508|NCT00739297|20833844|P3|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
8454509|NCT00739297|20833845|P2|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
8454510|NCT00739297|20833846|P1|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
8454511|NCT00739297|20833840|P7|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8454512|NCT00739297|20833841|P6|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8454513|NCT00739297|20833842|P5|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8454514|NCT00739297|20833843|P4|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8454515|NCT00739297|20833844|P3|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8454516|NCT00739297|20833845|P2|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8454517|NCT00739297|20833846|P1|NOT COMPLETED|Third Washout Period of 4-7 Days||0
8454518|NCT00739297|20833840|P7|COMPLETED|Third Washout Period of 4-7 Days||66
8454519|NCT00739297|20833841|P6|COMPLETED|Third Washout Period of 4-7 Days||8
8454520|NCT00739297|20833842|P5|COMPLETED|Third Washout Period of 4-7 Days||6
8454521|NCT00739297|20833843|P4|COMPLETED|Third Washout Period of 4-7 Days||18
8454522|NCT00739297|20833844|P3|COMPLETED|Third Washout Period of 4-7 Days||6
8454523|NCT00739297|20833845|P2|COMPLETED|Third Washout Period of 4-7 Days||12
8454524|NCT00739297|20833846|P1|COMPLETED|Third Washout Period of 4-7 Days||16
8454525|NCT00739297|20833840|P7|STARTED|Third Washout Period of 4-7 Days||66
8454526|NCT00739297|20833841|P6|STARTED|Third Washout Period of 4-7 Days||8
8454527|NCT00739297|20833842|P5|STARTED|Third Washout Period of 4-7 Days||6
8454528|NCT00739297|20833843|P4|STARTED|Third Washout Period of 4-7 Days||18
8454529|NCT00739297|20833844|P3|STARTED|Third Washout Period of 4-7 Days||6
8454530|NCT00739297|20833845|P2|STARTED|Third Washout Period of 4-7 Days||12
8454531|NCT00739297|20833846|P1|STARTED|Third Washout Period of 4-7 Days||16
8454532|NCT00739297|20833840|P7|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8454533|NCT00739297|20833841|P6|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8454534|NCT00739297|20833842|P5|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8454535|NCT00739297|20833843|P4|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8454536|NCT00739297|20833844|P3|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8454537|NCT00739297|20833845|P2|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8454538|NCT00739297|20833846|P1|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
8454539|NCT00739297|20833840|P7|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
8454540|NCT00739297|20833841|P6|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
8454541|NCT00739297|20833842|P5|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
8454542|NCT00739297|20833843|P4|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
8454543|NCT00739297|20833844|P3|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
8454544|NCT00739297|20833845|P2|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
8454545|NCT00739297|20833846|P1|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
8454546|NCT00739297|20833840|P7|STARTED|Third Intervention (Visit 7 to Visit 8)||66
8454547|NCT00739297|20833841|P6|STARTED|Third Intervention (Visit 7 to Visit 8)||8
8454548|NCT00739297|20833842|P5|STARTED|Third Intervention (Visit 7 to Visit 8)||6
8454549|NCT00739297|20833843|P4|STARTED|Third Intervention (Visit 7 to Visit 8)||18
8454550|NCT00739297|20833844|P3|STARTED|Third Intervention (Visit 7 to Visit 8)||6
8454551|NCT00739297|20833845|P2|STARTED|Third Intervention (Visit 7 to Visit 8)||12
8454552|NCT00739297|20833846|P1|STARTED|Third Intervention (Visit 7 to Visit 8)||16
8454553|NCT00739297|20833840|P7|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8454554|NCT00739297|20833841|P6|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8454555|NCT00739297|20833842|P5|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8454556|NCT00739297|20833843|P4|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8454557|NCT00739297|20833844|P3|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8454558|NCT00739297|20833845|P2|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8454559|NCT00739297|20833846|P1|NOT COMPLETED|Second Washout Period of 4-7 Days||0
8454560|NCT00739297|20833840|P7|COMPLETED|Second Washout Period of 4-7 Days||66
8454561|NCT00739297|20833841|P6|COMPLETED|Second Washout Period of 4-7 Days||10
8454562|NCT00739297|20833842|P5|COMPLETED|Second Washout Period of 4-7 Days||6
8454563|NCT00739297|20833843|P4|COMPLETED|Second Washout Period of 4-7 Days||14
8454564|NCT00739297|20833844|P3|COMPLETED|Second Washout Period of 4-7 Days||10
8454565|NCT00739297|20833845|P2|COMPLETED|Second Washout Period of 4-7 Days||8
8454566|NCT00739297|20833846|P1|COMPLETED|Second Washout Period of 4-7 Days||18
8454567|NCT00739297|20833840|P7|STARTED|Second Washout Period of 4-7 Days||66
8454568|NCT00739297|20833841|P6|STARTED|Second Washout Period of 4-7 Days||10
8454569|NCT00739297|20833842|P5|STARTED|Second Washout Period of 4-7 Days||6
8454570|NCT00739297|20833843|P4|STARTED|Second Washout Period of 4-7 Days||14
8454571|NCT00739297|20833844|P3|STARTED|Second Washout Period of 4-7 Days||10
8454572|NCT00739297|20833845|P2|STARTED|Second Washout Period of 4-7 Days||8
8454573|NCT00739297|20833846|P1|STARTED|Second Washout Period of 4-7 Days||18
8454574|NCT00739297|20833840|P7|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8454575|NCT00739297|20833841|P6|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8454576|NCT00739297|20833842|P5|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8454577|NCT00739297|20833843|P4|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8454578|NCT00739297|20833844|P3|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8454579|NCT00739297|20833845|P2|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8454580|NCT00739297|20833846|P1|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
8454581|NCT00739297|20833840|P7|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
8454582|NCT00739297|20833841|P6|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
8454583|NCT00739297|20833842|P5|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
8454584|NCT00739297|20833843|P4|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
8454585|NCT00739297|20833844|P3|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
8454586|NCT00739297|20833845|P2|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
8454587|NCT00739297|20833846|P1|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
8454588|NCT00739297|20833840|P7|STARTED|Second Intervention (Visit 5 to Visit 6)||66
8454589|NCT00739297|20833841|P6|STARTED|Second Intervention (Visit 5 to Visit 6)||10
8454590|NCT00739297|20833842|P5|STARTED|Second Intervention (Visit 5 to Visit 6)||6
8454591|NCT00739297|20833843|P4|STARTED|Second Intervention (Visit 5 to Visit 6)||14
8454592|NCT00739297|20833844|P3|STARTED|Second Intervention (Visit 5 to Visit 6)||10
8454593|NCT00739297|20833845|P2|STARTED|Second Intervention (Visit 5 to Visit 6)||8
8454594|NCT00739297|20833846|P1|STARTED|Second Intervention (Visit 5 to Visit 6)||18
8454595|NCT00739297|20833840|P7|NOT COMPLETED|First Washout Period of 4-7 Days||2
8454596|NCT00739297|20833841|P6|NOT COMPLETED|First Washout Period of 4-7 Days||0
8454597|NCT00739297|20833842|P5|NOT COMPLETED|First Washout Period of 4-7 Days||0
8454598|NCT00739297|20833843|P4|NOT COMPLETED|First Washout Period of 4-7 Days||2
8454599|NCT00739297|20833844|P3|NOT COMPLETED|First Washout Period of 4-7 Days||0
8454600|NCT00739297|20833845|P2|NOT COMPLETED|First Washout Period of 4-7 Days||0
8454601|NCT00739297|20833846|P1|NOT COMPLETED|First Washout Period of 4-7 Days||0
8454602|NCT00739297|20833840|P7|COMPLETED|First Washout Period of 4-7 Days||66
8454603|NCT00739297|20833841|P6|COMPLETED|First Washout Period of 4-7 Days||9
8454604|NCT00739297|20833842|P5|COMPLETED|First Washout Period of 4-7 Days||6
8454605|NCT00739297|20833843|P4|COMPLETED|First Washout Period of 4-7 Days||17
8454606|NCT00739297|20833844|P3|COMPLETED|First Washout Period of 4-7 Days||6
8454607|NCT00739297|20833845|P2|COMPLETED|First Washout Period of 4-7 Days||11
8454608|NCT00739297|20833846|P1|COMPLETED|First Washout Period of 4-7 Days||17
8454609|NCT00739297|20833840|P7|STARTED|First Washout Period of 4-7 Days||68
8454610|NCT00739297|20833841|P6|STARTED|First Washout Period of 4-7 Days||9
8454611|NCT00739297|20833842|P5|STARTED|First Washout Period of 4-7 Days||6
8454612|NCT00739297|20833843|P4|STARTED|First Washout Period of 4-7 Days||19
8454613|NCT00739297|20833844|P3|STARTED|First Washout Period of 4-7 Days||6
8454614|NCT00739297|20833845|P2|STARTED|First Washout Period of 4-7 Days||11
8454615|NCT00739297|20833846|P1|STARTED|First Washout Period of 4-7 Days||17
8454616|NCT00739297|20833840|P7|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8454617|NCT00739297|20833841|P6|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8454618|NCT00739297|20833842|P5|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8454619|NCT00739297|20833843|P4|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8454620|NCT00739297|20833844|P3|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8454621|NCT00739297|20833845|P2|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8454622|NCT00739297|20833846|P1|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
8454623|NCT00739297|20833840|P7|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
8454624|NCT00739297|20833841|P6|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
8454625|NCT00739297|20833842|P5|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
8454626|NCT00739297|20833843|P4|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
8454627|NCT00739297|20833844|P3|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
8454628|NCT00739297|20833845|P2|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
8454629|NCT00739297|20833846|P1|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
8454630|NCT00739297|20833840|P7|STARTED|First Intervention (Visit 3 to Visit 4)||68
8454631|NCT00739297|20833841|P6|STARTED|First Intervention (Visit 3 to Visit 4)||9
8454632|NCT00739297|20833842|P5|STARTED|First Intervention (Visit 3 to Visit 4)||6
8454633|NCT00739297|20833843|P4|STARTED|First Intervention (Visit 3 to Visit 4)||19
8454634|NCT00739297|20833844|P3|STARTED|First Intervention (Visit 3 to Visit 4)||6
8454635|NCT00739297|20833845|P2|STARTED|First Intervention (Visit 3 to Visit 4)||11
8454636|NCT00739297|20833846|P1|STARTED|First Intervention (Visit 3 to Visit 4)||17
8454637|NCT00739102|20833874|P1|NOT COMPLETED|Overall Study||15
8454638|NCT00739102|20833874|P1|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
8454639|NCT00739102|20833874|P1|STARTED|Overall Study||250
8454640|NCT00739063|20833890|P1|NOT COMPLETED|Overall Study||8
8454641|NCT00739063|20833890|P1|COMPLETED|Overall Study||3
8454642|NCT00739063|20833890|P1|STARTED|Overall Study||11
8454643|NCT00739050|20833894|P2|NOT COMPLETED|Overall Study||0
8454644|NCT00739050|20833895|P1|NOT COMPLETED|Overall Study||1
8454645|NCT00739050|20833894|P2|COMPLETED|Overall Study||0
8454646|NCT00739050|20833895|P1|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
8454647|NCT00739050|20833894|P2|STARTED|Overall Study||0
8454648|NCT00739050|20833895|P1|STARTED|Overall Study||4
8454649|NCT00739024|20833909|P2|NOT COMPLETED|Overall Study||0
8454650|NCT00739024|20833910|P1|NOT COMPLETED|Overall Study||0
8454651|NCT00739024|20833909|P2|COMPLETED|Overall Study||6
8454652|NCT00739024|20833910|P1|COMPLETED|Overall Study||7
8454653|NCT00739024|20833909|P2|STARTED|Overall Study||6
8454654|NCT00739024|20833910|P1|STARTED|Overall Study||7
8454655|NCT00738972|20833920|P4|NOT COMPLETED|Overall Study||1
8454656|NCT00738972|20833921|P3|NOT COMPLETED|Overall Study||0
8454657|NCT00738972|20833922|P2|NOT COMPLETED|Overall Study||0
8454658|NCT00738972|20833923|P1|NOT COMPLETED|Overall Study||0
8454659|NCT00738972|20833920|P4|COMPLETED|Overall Study||2
8454660|NCT00738972|20833921|P3|COMPLETED|Overall Study||3
8454661|NCT00738972|20833922|P2|COMPLETED|Overall Study||3
8454662|NCT00738972|20833923|P1|COMPLETED|Overall Study||3
8454663|NCT00738972|20833920|P4|STARTED|Overall Study||3
8454664|NCT00738972|20833921|P3|STARTED|Overall Study||3
8454665|NCT00738972|20833922|P2|STARTED|Overall Study||3
8454666|NCT00738972|20833923|P1|STARTED|Overall Study||3
8454667|NCT00738894|20833935|P2|NOT COMPLETED|Overall Study||33
8454668|NCT00738894|20833936|P1|NOT COMPLETED|Overall Study||39
8454669|NCT00738894|20833935|P2|COMPLETED|Overall Study||190
8454670|NCT00738894|20833936|P1|COMPLETED|Overall Study||402
8454671|NCT00738894|20833935|P2|STARTED|Overall Study||223
8454672|NCT00738894|20833936|P1|STARTED|Overall Study||441
8454673|NCT00738881|20833949|P2|NOT COMPLETED|Overall Study||2
8454674|NCT00738881|20833950|P1|NOT COMPLETED|Overall Study||0
8454675|NCT00738881|20833949|P2|COMPLETED|Overall Study||10
8454676|NCT00738881|20833950|P1|COMPLETED|Overall Study||11
8454677|NCT00738881|20833949|P2|STARTED|Overall Study||12
8454678|NCT00738881|20833950|P1|STARTED|Overall Study||11
8454679|NCT00738699|20833964|P2|NOT COMPLETED|Overall Study||140
8454680|NCT00738699|20833965|P1|NOT COMPLETED|Overall Study||275
8454681|NCT00738699|20833964|P2|COMPLETED|Overall Study||0
8454682|NCT00738699|20833965|P1|COMPLETED|Overall Study||0
8454683|NCT00738699|20833964|P2|Participants Treated|Overall Study||139
8454684|NCT00738699|20833965|P1|Participants Treated|Overall Study||273
8454685|NCT00738699|20833964|P2|Participants Not Treated|Overall Study||1
8454686|NCT00738699|20833965|P1|Participants Not Treated|Overall Study||2
8454687|NCT00738699|20833964|P2|STARTED|Overall Study||140
8454688|NCT00738699|20833965|P1|STARTED|Overall Study||275
8454689|NCT00738673|20833983|P2|NOT COMPLETED|Overall Study||11
8454690|NCT00738673|20833984|P1|NOT COMPLETED|Overall Study||24
8454691|NCT00738673|20833983|P2|COMPLETED|Overall Study||1
8454692|NCT00738673|20833984|P1|COMPLETED|Overall Study||1
8454693|NCT00738673|20833983|P2|Intent to Treat Population|Overall Study||12
8454694|NCT00738673|20833984|P1|Intent to Treat Population|Overall Study||24
8454695|NCT00738673|20833983|P2|STARTED|Overall Study||12
8454696|NCT00738673|20833984|P1|STARTED|Overall Study||25
8454697|NCT00738543|20834012|P1|NOT COMPLETED|Control||0
8454698|NCT00738543|20834012|P1|COMPLETED|Control||48
8454699|NCT00738543|20834012|P1|STARTED|Control||48
8454700|NCT00738543|20834012|P1|NOT COMPLETED|Sodium Hypochlorite||0
8454701|NCT00738543|20834012|P1|COMPLETED|Sodium Hypochlorite||48
8454702|NCT00738543|20834012|P1|STARTED|Sodium Hypochlorite||48
8454703|NCT00738543|20834012|P1|NOT COMPLETED|Povidone Iodine||0
8454704|NCT00738543|20834012|P1|COMPLETED|Povidone Iodine||48
8454705|NCT00738543|20834012|P1|STARTED|Povidone Iodine||48
8454706|NCT00738530|20834022|P2|NOT COMPLETED|Overall Study||238
8454707|NCT00738530|20834023|P1|NOT COMPLETED|Overall Study||234
8454708|NCT00738530|20834022|P2|COMPLETED|Overall Study||84
8454709|NCT00738530|20834023|P1|COMPLETED|Overall Study||93
8454710|NCT00738530|20834022|P2|Treated|Overall Study||316
8454711|NCT00738530|20834023|P1|Treated|Overall Study||325
8454712|NCT00738530|20834022|P2|STARTED|Overall Study||322
8454713|NCT00738530|20834023|P1|STARTED|Overall Study||327
8454714|NCT00738426|20834049|P2|NOT COMPLETED|Overall Study||3
8454715|NCT00738426|20834050|P1|NOT COMPLETED|Overall Study||2
8454716|NCT00738426|20834049|P2|COMPLETED|Overall Study||32
8454717|NCT00738426|20834050|P1|COMPLETED|Overall Study||35
8454718|NCT00738426|20834049|P2|STARTED|Overall Study||35
8454719|NCT00738426|20834050|P1|STARTED|Overall Study||37
8454720|NCT00738400|20834058|P2|NOT COMPLETED|Overall Study||7
8454721|NCT00738400|20834059|P1|NOT COMPLETED|Overall Study||4
8454722|NCT00738400|20834058|P2|COMPLETED|Overall Study||67
8454723|NCT00738400|20834059|P1|COMPLETED|Overall Study||72
8454724|NCT00738400|20834058|P2|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
8454725|NCT00738400|20834059|P1|ITT (Intent To Treatment) Population|Overall Study||75
8454726|NCT00738400|20834058|P2|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
8454727|NCT00738400|20834059|P1|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
8454728|NCT00738400|20834058|P2|STARTED|Overall Study||74
8454729|NCT00738400|20834059|P1|STARTED|Overall Study||76
8454730|NCT00738374|20834080|P4|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
8454731|NCT00738374|20834081|P3|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
8454732|NCT00738374|20834082|P2|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
8454733|NCT00738374|20834083|P1|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
8454734|NCT00738374|20834080|P4|COMPLETED|Maintenance Treatment/Observation Phase||20
8454735|NCT00738374|20834081|P3|COMPLETED|Maintenance Treatment/Observation Phase||27
8454736|NCT00738374|20834082|P2|COMPLETED|Maintenance Treatment/Observation Phase||0
8454737|NCT00738374|20834083|P1|COMPLETED|Maintenance Treatment/Observation Phase||0
8454738|NCT00738374|20834080|P4|STARTED|Maintenance Treatment/Observation Phase||32
8454739|NCT00738374|20834081|P3|STARTED|Maintenance Treatment/Observation Phase||34
8454740|NCT00738374|20834082|P2|STARTED|Maintenance Treatment/Observation Phase||7
8454741|NCT00738374|20834083|P1|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
8454742|NCT00738374|20834080|P4|NOT COMPLETED|Induction Treatment Phase||0
8454743|NCT00738374|20834081|P3|NOT COMPLETED|Induction Treatment Phase||0
8454744|NCT00738374|20834082|P2|NOT COMPLETED|Induction Treatment Phase||0
8454745|NCT00738374|20834083|P1|NOT COMPLETED|Induction Treatment Phase||24
8454746|NCT00738374|20834080|P4|COMPLETED|Induction Treatment Phase||0
8454747|NCT00738374|20834081|P3|COMPLETED|Induction Treatment Phase||0
8454748|NCT00738374|20834082|P2|COMPLETED|Induction Treatment Phase||0
8454749|NCT00738374|20834083|P1|COMPLETED|Induction Treatment Phase||73
8454750|NCT00738374|20834080|P4|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
8454751|NCT00738374|20834081|P3|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
8454752|NCT00738374|20834082|P2|STARTED|Induction Treatment Phase||0
8454753|NCT00738374|20834083|P1|STARTED|Induction Treatment Phase||97
8454754|NCT00738361|20834115|P1|NOT COMPLETED|Overall Study||0
8454755|NCT00738361|20834115|P1|COMPLETED|Overall Study||4
8454756|NCT00738361|20834115|P1|STARTED|Overall Study||4
8454757|NCT00738283|20834121|P1|NOT COMPLETED|Overall Study||4
8454758|NCT00738283|20834121|P1|COMPLETED|Overall Study||13
8454759|NCT00738283|20834121|P1|STARTED|Overall Study||17
8454763|NCT00738062|20834140|P3|NOT COMPLETED|Open-Label Extension||0
8454764|NCT00738062|20834141|P2|NOT COMPLETED|Open-Label Extension||0
8454765|NCT00738062|20834142|P1|NOT COMPLETED|Open-Label Extension||17
8454766|NCT00738062|20834140|P3|COMPLETED|Open-Label Extension||0
8454767|NCT00738062|20834141|P2|COMPLETED|Open-Label Extension||0
8454768|NCT00738062|20834142|P1|COMPLETED|Open-Label Extension||57
8454769|NCT00738062|20834140|P3|STARTED|Open-Label Extension||0
8454770|NCT00738062|20834141|P2|STARTED|Open-Label Extension||0
8454771|NCT00738062|20834142|P1|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
8454772|NCT00738062|20834140|P3|NOT COMPLETED|2 Week Randomized Withdrawal||0
8454773|NCT00738062|20834141|P2|NOT COMPLETED|2 Week Randomized Withdrawal||0
8454774|NCT00738062|20834142|P1|NOT COMPLETED|2 Week Randomized Withdrawal||0
8454775|NCT00738062|20834140|P3|COMPLETED|2 Week Randomized Withdrawal||37
8454776|NCT00738062|20834141|P2|COMPLETED|2 Week Randomized Withdrawal||38
8454777|NCT00738062|20834142|P1|COMPLETED|2 Week Randomized Withdrawal||0
8454778|NCT00738062|20834140|P3|STARTED|2 Week Randomized Withdrawal||37
8454779|NCT00738062|20834141|P2|STARTED|2 Week Randomized Withdrawal||38
8454780|NCT00738062|20834142|P1|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
8454781|NCT00738062|20834140|P3|NOT COMPLETED|Open Label Treatment||0
8454782|NCT00738062|20834141|P2|NOT COMPLETED|Open Label Treatment||0
8454783|NCT00738062|20834142|P1|NOT COMPLETED|Open Label Treatment||28
8454784|NCT00738062|20834140|P3|COMPLETED|Open Label Treatment||0
8454785|NCT00738062|20834141|P2|COMPLETED|Open Label Treatment||0
8454786|NCT00738062|20834142|P1|COMPLETED|Open Label Treatment||75
8454787|NCT00738062|20834140|P3|STARTED|Open Label Treatment||0
8454788|NCT00738062|20834141|P2|STARTED|Open Label Treatment||0
8454789|NCT00738062|20834142|P1|STARTED|Open Label Treatment||103
8454790|NCT00738049|20834169|P2|NOT COMPLETED|Washout||0
8454791|NCT00738049|20834170|P1|NOT COMPLETED|Washout||0
8454792|NCT00738049|20834169|P2|COMPLETED|Washout||7
8454793|NCT00738049|20834170|P1|COMPLETED|Washout||13
8454794|NCT00738049|20834169|P2|STARTED|Washout||7
8454795|NCT00738049|20834170|P1|STARTED|Washout||13
8454796|NCT00738049|20834169|P2|NOT COMPLETED|2nd Intervention(14 Days)||0
8454797|NCT00738049|20834170|P1|NOT COMPLETED|2nd Intervention(14 Days)||0
8454798|NCT00738049|20834169|P2|COMPLETED|2nd Intervention(14 Days)||7
8454799|NCT00738049|20834170|P1|COMPLETED|2nd Intervention(14 Days)||13
8454800|NCT00738049|20834169|P2|STARTED|2nd Intervention(14 Days)||7
8454801|NCT00738049|20834170|P1|STARTED|2nd Intervention(14 Days)||13
8454802|NCT00738049|20834169|P2|NOT COMPLETED|1st Intervention(14 Days)||0
8454803|NCT00738049|20834170|P1|NOT COMPLETED|1st Intervention(14 Days)||0
8454804|NCT00738049|20834169|P2|COMPLETED|1st Intervention(14 Days)||7
8454805|NCT00738049|20834170|P1|COMPLETED|1st Intervention(14 Days)||13
8454806|NCT00738049|20834169|P2|STARTED|1st Intervention(14 Days)||7
8454807|NCT00738049|20834170|P1|STARTED|1st Intervention(14 Days)||13
8454808|NCT00738023|20834184|P2|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
8454809|NCT00738023|20834185|P1|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
8454810|NCT00738023|20834184|P2|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
8454811|NCT00738023|20834185|P1|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
8454812|NCT00738023|20834184|P2|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
8454813|NCT00738023|20834185|P1|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
8454814|NCT00738023|20834184|P2|NOT COMPLETED|Saline Infusion||0
8454815|NCT00738023|20834185|P1|NOT COMPLETED|Saline Infusion||0
8454816|NCT00738023|20834184|P2|COMPLETED|Saline Infusion||0
8454817|NCT00738023|20834185|P1|COMPLETED|Saline Infusion||19
8454818|NCT00738023|20834184|P2|STARTED|Saline Infusion||0
8454819|NCT00738023|20834185|P1|STARTED|Saline Infusion||19
8454820|NCT00738023|20834184|P2|NOT COMPLETED|Intralipid Infusion||0
8454821|NCT00738023|20834185|P1|NOT COMPLETED|Intralipid Infusion||0
8454822|NCT00738023|20834184|P2|COMPLETED|Intralipid Infusion||13
8454823|NCT00738023|20834185|P1|COMPLETED|Intralipid Infusion||19
8454824|NCT00738023|20834184|P2|STARTED|Intralipid Infusion||13
8454825|NCT00738023|20834185|P1|STARTED|Intralipid Infusion||19
8454832|NCT00737737|20834246|P2|NOT COMPLETED|Overall Study||0
8454833|NCT00737737|20834247|P1|NOT COMPLETED|Overall Study||0
8454834|NCT00737737|20834246|P2|COMPLETED|Overall Study||2
8454835|NCT00737737|20834247|P1|COMPLETED|Overall Study||2
8454836|NCT00737737|20834246|P2|STARTED|Overall Study||2
8454837|NCT00737737|20834247|P1|STARTED|Overall Study||2
8454838|NCT00737711|20834255|P1|NOT COMPLETED|Overall Study||31
8454839|NCT00737711|20834255|P1|COMPLETED|Overall Study||158
8454840|NCT00737711|20834255|P1|STARTED|Overall Study||189
8454841|NCT00737698|20834289|P3|NOT COMPLETED|Overall Study||4
8454842|NCT00737698|20834290|P2|NOT COMPLETED|Overall Study||5
8454843|NCT00737698|20834291|P1|NOT COMPLETED|Overall Study||6
8454844|NCT00737698|20834289|P3|COMPLETED|Overall Study||17
8454845|NCT00737698|20834290|P2|COMPLETED|Overall Study||37
8454846|NCT00737698|20834291|P1|COMPLETED|Overall Study||17
8454847|NCT00737698|20834289|P3|STARTED|Overall Study||21
8454848|NCT00737698|20834290|P2|STARTED|Overall Study||42
8454849|NCT00737698|20834291|P1|STARTED|Overall Study||23
8454850|NCT00737672|20834301|P2|NOT COMPLETED|Overall Study||83
8454851|NCT00737672|20834302|P1|NOT COMPLETED|Overall Study||80
8454852|NCT00737672|20834301|P2|COMPLETED|Overall Study||65
8454853|NCT00737672|20834302|P1|COMPLETED|Overall Study||65
8454854|NCT00737672|20834301|P2|Per Protocol Population|Overall Study||138
8454855|NCT00737672|20834302|P1|Per Protocol Population|Overall Study||131
8454856|NCT00737672|20834301|P2|Exclusions Due to Protocol Deviations|Overall Study||10
8454857|NCT00737672|20834302|P1|Exclusions Due to Protocol Deviations|Overall Study||14
8454858|NCT00737672|20834301|P2|STARTED|Overall Study||148
8454859|NCT00737672|20834302|P1|STARTED|Overall Study||145
8454860|NCT00737633|20834340|P2|NOT COMPLETED|Overall Study||57
8454861|NCT00737633|20834341|P1|NOT COMPLETED|Overall Study||44
8454862|NCT00737633|20834340|P2|COMPLETED|Overall Study||0
8454863|NCT00737633|20834341|P1|COMPLETED|Overall Study||0
8454864|NCT00737633|20834340|P2|STARTED|Overall Study||57
8454865|NCT00737633|20834341|P1|STARTED|Overall Study||44
8454866|NCT00737594|20834352|P3|NOT COMPLETED|Overall Study||0
8454867|NCT00737594|20834353|P2|NOT COMPLETED|Overall Study||0
8454868|NCT00737594|20834354|P1|NOT COMPLETED|Overall Study||0
8454869|NCT00737594|20834352|P3|COMPLETED|Overall Study||0
8454870|NCT00737594|20834353|P2|COMPLETED|Overall Study||0
8454871|NCT00737594|20834354|P1|COMPLETED|Overall Study||0
8454872|NCT00737594|20834352|P3|STARTED|Overall Study||0
8454873|NCT00737594|20834353|P2|STARTED|Overall Study||0
8454874|NCT00737594|20834354|P1|STARTED|Overall Study||0
8454875|NCT00737568|20834364|P2|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
8454876|NCT00737568|20834365|P1|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
8454877|NCT00737568|20834364|P2|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
8454878|NCT00737568|20834365|P1|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
8454879|NCT00737568|20834364|P2|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
8454880|NCT00737568|20834365|P1|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
8454881|NCT00737568|20834364|P2|NOT COMPLETED|Treatment Period Through Week 240||21
8454882|NCT00737568|20834365|P1|NOT COMPLETED|Treatment Period Through Week 240||20
8454883|NCT00737568|20834364|P2|COMPLETED|Treatment Period Through Week 240||118
8454884|NCT00737568|20834365|P1|COMPLETED|Treatment Period Through Week 240||121
8454885|NCT00737568|20834364|P2|STARTED|Treatment Period Through Week 240||139
8454886|NCT00737568|20834365|P1|STARTED|Treatment Period Through Week 240||141
8454887|NCT00737529|20834395|P1|NOT COMPLETED|Overall Study||133
8454888|NCT00737529|20834395|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
8454889|NCT00737529|20834395|P1|STARTED|Overall Study||134
8454890|NCT00737477|20834409|P1|NOT COMPLETED|Overall Study||34
8454891|NCT00737477|20834409|P1|COMPLETED|Overall Study||62
8454892|NCT00737477|20834409|P1|STARTED|Overall Study||96
8454893|NCT00737464|20834425|P1|NOT COMPLETED|Overall Study||18
8454894|NCT00737464|20834425|P1|COMPLETED|Overall Study||114
8454895|NCT00737464|20834425|P1|STARTED|Overall Study||132
8454896|NCT00737438|20834446|P1|NOT COMPLETED|Overall Study||3
8454897|NCT00737438|20834446|P1|COMPLETED|Overall Study||20
8454898|NCT00737438|20834446|P1|STARTED|Overall Study||23
8454899|NCT00737360|20834450|P1|NOT COMPLETED|Overall Study||0
8454900|NCT00737360|20834450|P1|COMPLETED|Overall Study||27
8454901|NCT00737360|20834450|P1|STARTED|Overall Study||27
8454902|NCT00737282|20834459|P1|NOT COMPLETED|Overall Study||175
8454903|NCT00737282|20834459|P1|COMPLETED|Overall Study||0
8454904|NCT00737282|20834459|P1|STARTED|Overall Study||175
8454905|NCT00737243|20834465|P1|NOT COMPLETED|Overall Study||95
8454906|NCT00737243|20834465|P1|COMPLETED|Overall Study||194
8454907|NCT00737243|20834465|P1|Empiric CUP Therapy|Overall Study||29
8454908|NCT00737243|20834465|P1|Site Specific Therapy Less Responsive|Overall Study||79
8454909|NCT00737243|20834465|P1|Site Specific Therapy More Responsive|Overall Study||115
8454910|NCT00737243|20834465|P1|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
8454911|NCT00737243|20834465|P1|Treated|Overall Study||223
8454912|NCT00737243|20834465|P1|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
8454913|NCT00737243|20834465|P1|Successful Assay Performed|Overall Study||252
8454914|NCT00737243|20834465|P1|STARTED|Overall Study||289
8454915|NCT00737204|20834473|P2|NOT COMPLETED|Overall Study||6
8454916|NCT00737204|20834474|P1|NOT COMPLETED|Overall Study||0
8454917|NCT00737204|20834473|P2|COMPLETED|Overall Study||28
8454918|NCT00737204|20834474|P1|COMPLETED|Overall Study||36
8454919|NCT00737204|20834473|P2|STARTED|Overall Study||34
8454920|NCT00737204|20834474|P1|STARTED|Overall Study||36
8454921|NCT00737178|20834488|P2|NOT COMPLETED|Overall Study||9
8454922|NCT00737178|20834489|P1|NOT COMPLETED|Overall Study||5
8454923|NCT00737178|20834488|P2|COMPLETED|Overall Study||76
8454924|NCT00737178|20834489|P1|COMPLETED|Overall Study||66
8454925|NCT00737178|20834488|P2|STARTED|Overall Study||85
8454926|NCT00737178|20834489|P1|STARTED|Overall Study||71
8454927|NCT00737100|20834502|P3|NOT COMPLETED|Overall Study||7
8454928|NCT00737100|20834503|P2|NOT COMPLETED|Overall Study||7
8454929|NCT00737100|20834504|P1|NOT COMPLETED|Overall Study||7
8454930|NCT00737100|20834502|P3|COMPLETED|Overall Study||169
8454931|NCT00737100|20834503|P2|COMPLETED|Overall Study||159
8454932|NCT00737100|20834504|P1|COMPLETED|Overall Study||161
8454933|NCT00737100|20834502|P3|STARTED|Overall Study||176
8454934|NCT00737100|20834503|P2|STARTED|Overall Study||166
8454935|NCT00737100|20834504|P1|STARTED|Overall Study||168
8454936|NCT00737061|20834548|P1|NOT COMPLETED|1 Year Wearing Period||17
8454937|NCT00737061|20834548|P1|COMPLETED|1 Year Wearing Period||553
8454938|NCT00737061|20834548|P1|STARTED|1 Year Wearing Period||570
8454939|NCT00737061|20834548|P1|NOT COMPLETED|Waiting Period||75
8454940|NCT00737061|20834548|P1|COMPLETED|Waiting Period||570
8454941|NCT00737061|20834548|P1|STARTED|Waiting Period||645
8454942|NCT00737048|20834565|P3|NOT COMPLETED|Overall Study||4
8454943|NCT00737048|20834566|P2|NOT COMPLETED|Overall Study||6
8454944|NCT00737048|20834567|P1|NOT COMPLETED|Overall Study||3
8454945|NCT00737048|20834565|P3|COMPLETED|Overall Study||126
8454946|NCT00737048|20834566|P2|COMPLETED|Overall Study||60
8454947|NCT00737048|20834567|P1|COMPLETED|Overall Study||129
8454948|NCT00737048|20834565|P3|STARTED|Overall Study||130
8454949|NCT00737048|20834566|P2|STARTED|Overall Study||66
8454950|NCT00737048|20834567|P1|STARTED|Overall Study||132
8454951|NCT00736996|20834611|P3|NOT COMPLETED|Overall Study||2
8454952|NCT00736996|20834612|P2|NOT COMPLETED|Overall Study||9
8454953|NCT00736996|20834613|P1|NOT COMPLETED|Overall Study||1
8454954|NCT00736996|20834611|P3|COMPLETED|Overall Study||25
8454955|NCT00736996|20834612|P2|COMPLETED|Overall Study||17
8454956|NCT00736996|20834613|P1|COMPLETED|Overall Study||24
8454957|NCT00736996|20834611|P3|STARTED|Overall Study||27
8454958|NCT00736996|20834612|P2|STARTED|Overall Study||26
8454959|NCT00736996|20834613|P1|STARTED|Overall Study||25
8454960|NCT00736957|20834627|P1|NOT COMPLETED|Overall Study||122
8454961|NCT00736957|20834627|P1|COMPLETED|Overall Study||97
8454962|NCT00736957|20834627|P1|Treated|Overall Study||190
8454963|NCT00736957|20834627|P1|STARTED|Overall Study||219
8454964|NCT00736944|20834637|P1|NOT COMPLETED|Definitive Treatment||1
8454965|NCT00736944|20834637|P1|COMPLETED|Definitive Treatment||28
8454966|NCT00736944|20834637|P1|STARTED|Definitive Treatment||29
8454967|NCT00736944|20834637|P1|NOT COMPLETED|Induction||1
8454968|NCT00736944|20834637|P1|COMPLETED|Induction||29
8454969|NCT00736944|20834637|P1|STARTED|Induction||30
8454970|NCT00736879|20834671|P4|NOT COMPLETED|Follow up Period - No Drug Treatment||0
8454971|NCT00736879|20834672|P3|NOT COMPLETED|Follow up Period - No Drug Treatment||0
8454972|NCT00736879|20834673|P2|NOT COMPLETED|Follow up Period - No Drug Treatment||3
8454973|NCT00736879|20834674|P1|NOT COMPLETED|Follow up Period - No Drug Treatment||1
8454974|NCT00736879|20834671|P4|COMPLETED|Follow up Period - No Drug Treatment||62
8454975|NCT00736879|20834672|P3|COMPLETED|Follow up Period - No Drug Treatment||66
8454976|NCT00736879|20834673|P2|COMPLETED|Follow up Period - No Drug Treatment||67
8454977|NCT00736879|20834674|P1|COMPLETED|Follow up Period - No Drug Treatment||65
8454978|NCT00736879|20834671|P4|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
8454979|NCT00736879|20834672|P3|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
8454980|NCT00736879|20834673|P2|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
8454981|NCT00736879|20834674|P1|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
8454982|NCT00736879|20834671|P4|NOT COMPLETED|Double Blind Treatment Period||5
8454983|NCT00736879|20834672|P3|NOT COMPLETED|Double Blind Treatment Period||7
8454984|NCT00736879|20834673|P2|NOT COMPLETED|Double Blind Treatment Period||4
8454985|NCT00736879|20834674|P1|NOT COMPLETED|Double Blind Treatment Period||3
8454986|NCT00736879|20834671|P4|COMPLETED|Double Blind Treatment Period||63
8454987|NCT00736879|20834672|P3|COMPLETED|Double Blind Treatment Period||67
8454988|NCT00736879|20834673|P2|COMPLETED|Double Blind Treatment Period||68
8454989|NCT00736879|20834674|P1|COMPLETED|Double Blind Treatment Period||65
8454990|NCT00736879|20834671|P4|STARTED|Double Blind Treatment Period||68
8454991|NCT00736879|20834672|P3|STARTED|Double Blind Treatment Period||74
8454992|NCT00736879|20834673|P2|STARTED|Double Blind Treatment Period||72
8454993|NCT00736879|20834674|P1|STARTED|Double Blind Treatment Period||68
8454994|NCT00736853|20834728|P3|NOT COMPLETED|Double-Blind Period||48
8454995|NCT00736853|20834729|P2|NOT COMPLETED|Double-Blind Period||24
8454996|NCT00736853|20834730|P1|NOT COMPLETED|Double-Blind Period||0
8454997|NCT00736853|20834728|P3|COMPLETED|Double-Blind Period||45
8454998|NCT00736853|20834729|P2|COMPLETED|Double-Blind Period||70
8454999|NCT00736853|20834730|P1|COMPLETED|Double-Blind Period||0
8455000|NCT00736853|20834728|P3|STARTED|Double-Blind Period||93
8455001|NCT00736853|20834729|P2|STARTED|Double-Blind Period||94
8455002|NCT00736853|20834730|P1|STARTED|Double-Blind Period||0
8455003|NCT00736853|20834728|P3|NOT COMPLETED|Open-Label Period||0
8455004|NCT00736853|20834729|P2|NOT COMPLETED|Open-Label Period||0
8455005|NCT00736853|20834730|P1|NOT COMPLETED|Open-Label Period||132
8455006|NCT00736853|20834728|P3|COMPLETED|Open-Label Period||0
8455007|NCT00736853|20834729|P2|COMPLETED|Open-Label Period||0
8455008|NCT00736853|20834730|P1|COMPLETED|Open-Label Period||187
8455009|NCT00736853|20834728|P3|Treated|Open-Label Period||0
8455010|NCT00736853|20834729|P2|Treated|Open-Label Period||0
8455011|NCT00736853|20834730|P1|Treated|Open-Label Period||277
8455012|NCT00736853|20834728|P3|STARTED|Open-Label Period||0
8455013|NCT00736853|20834729|P2|STARTED|Open-Label Period||0
8455014|NCT00736853|20834730|P1|STARTED|Open-Label Period||319
8455015|NCT00736840|20834770|P1|NOT COMPLETED|Overall Study||13
8455016|NCT00736840|20834770|P1|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
8455017|NCT00736840|20834770|P1|STARTED|Overall Study||414
8455018|NCT00736723|20834777|P2|NOT COMPLETED|Overall Study||3
8455019|NCT00736723|20834778|P1|NOT COMPLETED|Overall Study||4
8455020|NCT00736723|20834777|P2|COMPLETED|Overall Study||18
8455021|NCT00736723|20834778|P1|COMPLETED|Overall Study||26
8455022|NCT00736723|20834777|P2|STARTED|Overall Study||21
8455023|NCT00736723|20834778|P1|STARTED|Overall Study||30
8455024|NCT00736645|20834788|P4|NOT COMPLETED|Overall Study||0
8455025|NCT00736645|20834789|P3|NOT COMPLETED|Overall Study||0
8455026|NCT00736645|20834790|P2|NOT COMPLETED|Overall Study||2
8455027|NCT00736645|20834791|P1|NOT COMPLETED|Overall Study||0
8455028|NCT00736645|20834788|P4|COMPLETED|Overall Study||13
8455029|NCT00736645|20834789|P3|COMPLETED|Overall Study||14
8455030|NCT00736645|20834790|P2|COMPLETED|Overall Study||13
8455031|NCT00736645|20834791|P1|COMPLETED|Overall Study||13
8455032|NCT00736645|20834788|P4|STARTED|Overall Study||13
8455033|NCT00736645|20834789|P3|STARTED|Overall Study||14
8455034|NCT00736645|20834790|P2|STARTED|Overall Study||15
8455035|NCT00736645|20834791|P1|STARTED|Overall Study||13
8455036|NCT00736632|20834808|P3|NOT COMPLETED|Overall Study||0
8455037|NCT00736632|20834809|P2|NOT COMPLETED|Overall Study||0
8455038|NCT00736632|20834810|P1|NOT COMPLETED|Overall Study||0
8455039|NCT00736632|20834808|P3|COMPLETED|Overall Study||31
8455040|NCT00736632|20834809|P2|COMPLETED|Overall Study||50
8455041|NCT00736632|20834810|P1|COMPLETED|Overall Study||44
8455042|NCT00736632|20834808|P3|STARTED|Overall Study||31
8455043|NCT00736632|20834809|P2|STARTED|Overall Study||50
8455044|NCT00736632|20834810|P1|STARTED|Overall Study||44
8455045|NCT00736580|20834834|P2|NOT COMPLETED|Overall Study||0
8455046|NCT00736580|20834835|P1|NOT COMPLETED|Overall Study||0
8455047|NCT00736580|20834834|P2|COMPLETED|Overall Study||123
8455048|NCT00736580|20834835|P1|COMPLETED|Overall Study||117
8455049|NCT00736580|20834834|P2|STARTED|Overall Study||123
8455050|NCT00736580|20834835|P1|STARTED|Overall Study||117
8455051|NCT00736502|20834841|P1|NOT COMPLETED|Overall Study||65
8455052|NCT00736502|20834841|P1|COMPLETED|Overall Study||213
8455053|NCT00736502|20834841|P1|STARTED|Overall Study|Entered and treated.|278
8455054|NCT00736489|20834847|P6|NOT COMPLETED|Period 6||0
8455055|NCT00736489|20834848|P5|NOT COMPLETED|Period 6||0
8455056|NCT00736489|20834849|P4|NOT COMPLETED|Period 6||0
8455057|NCT00736489|20834850|P3|NOT COMPLETED|Period 6||0
8455058|NCT00736489|20834851|P2|NOT COMPLETED|Period 6||0
8455059|NCT00736489|20834852|P1|NOT COMPLETED|Period 6||0
8455060|NCT00736489|20834847|P6|COMPLETED|Period 6||5
8455061|NCT00736489|20834848|P5|COMPLETED|Period 6||7
8455062|NCT00736489|20834849|P4|COMPLETED|Period 6||7
8455063|NCT00736489|20834850|P3|COMPLETED|Period 6||6
8455064|NCT00736489|20834851|P2|COMPLETED|Period 6||5
8455065|NCT00736489|20834852|P1|COMPLETED|Period 6||5
8455066|NCT00736489|20834847|P6|STARTED|Period 6||5
8455067|NCT00736489|20834848|P5|STARTED|Period 6||7
8455068|NCT00736489|20834849|P4|STARTED|Period 6||7
8455069|NCT00736489|20834850|P3|STARTED|Period 6||6
8455070|NCT00736489|20834851|P2|STARTED|Period 6||5
8455071|NCT00736489|20834852|P1|STARTED|Period 6||5
8455072|NCT00736489|20834847|P6|NOT COMPLETED|Period 5||0
8455073|NCT00736489|20834848|P5|NOT COMPLETED|Period 5||0
8455074|NCT00736489|20834849|P4|NOT COMPLETED|Period 5||0
8455075|NCT00736489|20834850|P3|NOT COMPLETED|Period 5||0
8455076|NCT00736489|20834851|P2|NOT COMPLETED|Period 5||0
8455077|NCT00736489|20834852|P1|NOT COMPLETED|Period 5||0
8455078|NCT00736489|20834847|P6|COMPLETED|Period 5||5
8455079|NCT00736489|20834848|P5|COMPLETED|Period 5||7
8455080|NCT00736489|20834849|P4|COMPLETED|Period 5||7
8455081|NCT00736489|20834850|P3|COMPLETED|Period 5||6
8455082|NCT00736489|20834851|P2|COMPLETED|Period 5||5
8455083|NCT00736489|20834852|P1|COMPLETED|Period 5||5
8455084|NCT00736489|20834847|P6|STARTED|Period 5||5
8455085|NCT00736489|20834848|P5|STARTED|Period 5||7
8455086|NCT00736489|20834849|P4|STARTED|Period 5||7
8455087|NCT00736489|20834850|P3|STARTED|Period 5||6
8455088|NCT00736489|20834851|P2|STARTED|Period 5||5
8455089|NCT00736489|20834852|P1|STARTED|Period 5||5
8455090|NCT00736489|20834847|P6|NOT COMPLETED|Period 4||0
8455091|NCT00736489|20834848|P5|NOT COMPLETED|Period 4||0
8455092|NCT00736489|20834849|P4|NOT COMPLETED|Period 4||0
8455093|NCT00736489|20834850|P3|NOT COMPLETED|Period 4||0
8455094|NCT00736489|20834851|P2|NOT COMPLETED|Period 4||0
8455095|NCT00736489|20834852|P1|NOT COMPLETED|Period 4||0
8455096|NCT00736489|20834847|P6|COMPLETED|Period 4||5
8455097|NCT00736489|20834848|P5|COMPLETED|Period 4||7
8455098|NCT00736489|20834849|P4|COMPLETED|Period 4||7
8455099|NCT00736489|20834850|P3|COMPLETED|Period 4||6
8455100|NCT00736489|20834851|P2|COMPLETED|Period 4||5
8455101|NCT00736489|20834852|P1|COMPLETED|Period 4||5
8455102|NCT00736489|20834847|P6|STARTED|Period 4||5
8455103|NCT00736489|20834848|P5|STARTED|Period 4||7
8455104|NCT00736489|20834849|P4|STARTED|Period 4||7
8455105|NCT00736489|20834850|P3|STARTED|Period 4||6
8455106|NCT00736489|20834851|P2|STARTED|Period 4||5
8455107|NCT00736489|20834852|P1|STARTED|Period 4||5
8455108|NCT00736489|20834847|P6|NOT COMPLETED|Period 3||0
8455109|NCT00736489|20834848|P5|NOT COMPLETED|Period 3||0
8455110|NCT00736489|20834849|P4|NOT COMPLETED|Period 3||0
8455111|NCT00736489|20834850|P3|NOT COMPLETED|Period 3||0
8455112|NCT00736489|20834851|P2|NOT COMPLETED|Period 3||0
8455113|NCT00736489|20834852|P1|NOT COMPLETED|Period 3||0
8455114|NCT00736489|20834847|P6|COMPLETED|Period 3||5
8455115|NCT00736489|20834848|P5|COMPLETED|Period 3||7
8455116|NCT00736489|20834849|P4|COMPLETED|Period 3||7
8455117|NCT00736489|20834850|P3|COMPLETED|Period 3||6
8455118|NCT00736489|20834851|P2|COMPLETED|Period 3||5
8455119|NCT00736489|20834852|P1|COMPLETED|Period 3||5
8455120|NCT00736489|20834847|P6|STARTED|Period 3||5
8455121|NCT00736489|20834848|P5|STARTED|Period 3||7
8455122|NCT00736489|20834849|P4|STARTED|Period 3||7
8455123|NCT00736489|20834850|P3|STARTED|Period 3||6
8455124|NCT00736489|20834851|P2|STARTED|Period 3||5
8455125|NCT00736489|20834852|P1|STARTED|Period 3||5
8455126|NCT00736489|20834847|P6|NOT COMPLETED|Period 2||0
8455127|NCT00736489|20834848|P5|NOT COMPLETED|Period 2||0
8455128|NCT00736489|20834849|P4|NOT COMPLETED|Period 2||0
8455129|NCT00736489|20834850|P3|NOT COMPLETED|Period 2||0
8455130|NCT00736489|20834851|P2|NOT COMPLETED|Period 2||0
8455131|NCT00736489|20834852|P1|NOT COMPLETED|Period 2||0
8455132|NCT00736489|20834847|P6|COMPLETED|Period 2||5
8455133|NCT00736489|20834848|P5|COMPLETED|Period 2||7
8455134|NCT00736489|20834849|P4|COMPLETED|Period 2||7
8455135|NCT00736489|20834850|P3|COMPLETED|Period 2||6
8455136|NCT00736489|20834851|P2|COMPLETED|Period 2||5
8455137|NCT00736489|20834852|P1|COMPLETED|Period 2||5
8455138|NCT00736489|20834847|P6|STARTED|Period 2||5
8455139|NCT00736489|20834848|P5|STARTED|Period 2||7
8455140|NCT00736489|20834849|P4|STARTED|Period 2||7
8455141|NCT00736489|20834850|P3|STARTED|Period 2||6
8455142|NCT00736489|20834851|P2|STARTED|Period 2||5
8455143|NCT00736489|20834852|P1|STARTED|Period 2||5
8455144|NCT00736489|20834847|P6|NOT COMPLETED|Period 1||1
8455145|NCT00736489|20834848|P5|NOT COMPLETED|Period 1||0
8455146|NCT00736489|20834849|P4|NOT COMPLETED|Period 1||0
8455147|NCT00736489|20834850|P3|NOT COMPLETED|Period 1||0
8455148|NCT00736489|20834851|P2|NOT COMPLETED|Period 1||0
8455149|NCT00736489|20834852|P1|NOT COMPLETED|Period 1||1
8455150|NCT00736489|20834847|P6|COMPLETED|Period 1||5
8455151|NCT00736489|20834848|P5|COMPLETED|Period 1||7
8455152|NCT00736489|20834849|P4|COMPLETED|Period 1||7
8455153|NCT00736489|20834850|P3|COMPLETED|Period 1||6
8455154|NCT00736489|20834851|P2|COMPLETED|Period 1||5
8455155|NCT00736489|20834852|P1|COMPLETED|Period 1||5
8455156|NCT00736489|20834847|P6|STARTED|Period 1||6
8455157|NCT00736489|20834848|P5|STARTED|Period 1||7
8455158|NCT00736489|20834849|P4|STARTED|Period 1||7
8455159|NCT00736489|20834850|P3|STARTED|Period 1||6
8455160|NCT00736489|20834851|P2|STARTED|Period 1||5
8455161|NCT00736489|20834852|P1|STARTED|Period 1|Cross-over study|6
8455162|NCT00736476|20835006|P2|NOT COMPLETED|Overall Study||0
8455163|NCT00736476|20835007|P1|NOT COMPLETED|Overall Study||1
8455164|NCT00736476|20835006|P2|COMPLETED|Overall Study||27
8455165|NCT00736476|20835007|P1|COMPLETED|Overall Study||35
8455166|NCT00736476|20835006|P2|STARTED|Overall Study||27
8455167|NCT00736476|20835007|P1|STARTED|Overall Study||36
8455168|NCT00736450|20835027|P1|NOT COMPLETED|Overall Study||25
8455169|NCT00736450|20835027|P1|COMPLETED|Overall Study||12
8455170|NCT00736450|20835027|P1|STARTED|Overall Study||37
8455171|NCT00736385|20835035|P2|NOT COMPLETED|Overall Study||3
8455172|NCT00736385|20835036|P1|NOT COMPLETED|Overall Study||2
8455173|NCT00736385|20835035|P2|COMPLETED|Overall Study||2
8455174|NCT00736385|20835036|P1|COMPLETED|Overall Study||2
8455175|NCT00736385|20835035|P2|STARTED|Overall Study||5
8455176|NCT00736385|20835036|P1|STARTED|Overall Study||4
8455177|NCT00736333|20835048|P1|NOT COMPLETED|Overall Study||111
8455178|NCT00736333|20835048|P1|COMPLETED|Overall Study||56
8455179|NCT00736333|20835048|P1|STARTED|Overall Study||167
8455180|NCT00736255|20835059|P2|NOT COMPLETED|Overall Study||1
8455181|NCT00736255|20835060|P1|NOT COMPLETED|Overall Study||3
8455182|NCT00736255|20835059|P2|COMPLETED|Overall Study||14
8455183|NCT00736255|20835060|P1|COMPLETED|Overall Study||14
8455184|NCT00736255|20835059|P2|STARTED|Overall Study||15
8455185|NCT00736255|20835060|P1|STARTED|Overall Study||17
8455186|NCT00736242|20835078|P1|NOT COMPLETED|Overall Study||125
8455187|NCT00736242|20835078|P1|COMPLETED|Overall Study||107
8455188|NCT00736242|20835078|P1|Participants in Safety Analysis Set|Overall Study||229
8455189|NCT00736242|20835078|P1|STARTED|Overall Study||232
8455190|NCT00736229|20835092|P3|NOT COMPLETED|Overall Study||0
8455191|NCT00736229|20835093|P2|NOT COMPLETED|Overall Study||0
8455192|NCT00736229|20835094|P1|NOT COMPLETED|Overall Study||0
8455193|NCT00736229|20835092|P3|COMPLETED|Overall Study||84
8455194|NCT00736229|20835093|P2|COMPLETED|Overall Study||71
8455195|NCT00736229|20835094|P1|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
8455196|NCT00736229|20835092|P3|STARTED|Overall Study|Historic Control|84
8455197|NCT00736229|20835093|P2|STARTED|Overall Study|Historic control|71
8455198|NCT00736229|20835094|P1|STARTED|Overall Study|Actively Enrolled|40
8455199|NCT00736190|20835107|P1|NOT COMPLETED|Overall Study||3
8455200|NCT00736190|20835107|P1|COMPLETED|Overall Study||87
8455201|NCT00736190|20835107|P1|STARTED|Overall Study||90
8455202|NCT00736125|20835122|P2|NOT COMPLETED|Overall Study||2
8455203|NCT00736125|20835123|P1|NOT COMPLETED|Overall Study||1
8455204|NCT00736125|20835122|P2|COMPLETED|Overall Study||8
8455205|NCT00736125|20835123|P1|COMPLETED|Overall Study||9
8455206|NCT00736125|20835122|P2|STARTED|Overall Study||10
8455207|NCT00736125|20835123|P1|STARTED|Overall Study||10
8455208|NCT00736099|20835137|P2|NOT COMPLETED|Overall Study||58
8455209|NCT00736099|20835138|P1|NOT COMPLETED|Overall Study||183
8455210|NCT00736099|20835137|P2|COMPLETED|Overall Study|Number who completed treatment.|531
8455211|NCT00736099|20835138|P1|COMPLETED|Overall Study|Number who completed treatment.|1349
8455212|NCT00736099|20835137|P2|STARTED|Overall Study|Number who started treatment.|589
8455213|NCT00736099|20835138|P1|STARTED|Overall Study|Number who started treatment.|1532
8455214|NCT00736073|20835236|P2|NOT COMPLETED|Overall Study||0
8455215|NCT00736073|20835237|P1|NOT COMPLETED|Overall Study||0
8455216|NCT00736073|20835236|P2|COMPLETED|Overall Study||39
8455217|NCT00736073|20835237|P1|COMPLETED|Overall Study||34
8455218|NCT00736073|20835236|P2|STARTED|Overall Study||39
8455219|NCT00736073|20835237|P1|STARTED|Overall Study||34
8455220|NCT00736034|20835247|P1|NOT COMPLETED|Overall Study||2
8455221|NCT00736034|20835247|P1|COMPLETED|Overall Study||16
8455222|NCT00736034|20835247|P1|STARTED|Overall Study||18
8455223|NCT00735969|20835251|P1|NOT COMPLETED|Overall Study||0
8455224|NCT00735969|20835251|P1|COMPLETED|Overall Study||21
8455225|NCT00735969|20835251|P1|STARTED|Overall Study||21
8455226|NCT00735943|20835255|P1|NOT COMPLETED|Overall Study||2
8455227|NCT00735943|20835255|P1|COMPLETED|Overall Study||20
8455228|NCT00735943|20835255|P1|STARTED|Overall Study||22
8455229|NCT00735917|20835272|P1|NOT COMPLETED|Overall Study||0
8455230|NCT00735917|20835272|P1|COMPLETED|Overall Study||19
8455231|NCT00735917|20835272|P1|STARTED|Overall Study||19
8455232|NCT00735904|20835280|P1|NOT COMPLETED|Overall Study||38
8455233|NCT00735904|20835280|P1|COMPLETED|Overall Study||0
8455234|NCT00735904|20835280|P1|STARTED|Overall Study||38
8455235|NCT00735878|20835290|P3|NOT COMPLETED|Phase II- Determined Dose||0
8455236|NCT00735878|20835291|P2|NOT COMPLETED|Phase II- Determined Dose||0
8455237|NCT00735878|20835292|P1|NOT COMPLETED|Phase II- Determined Dose||0
8455238|NCT00735878|20835290|P3|COMPLETED|Phase II- Determined Dose||0
8455239|NCT00735878|20835291|P2|COMPLETED|Phase II- Determined Dose||7
8455240|NCT00735878|20835292|P1|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
8455241|NCT00735878|20835290|P3|STARTED|Phase II- Determined Dose||0
8455242|NCT00735878|20835291|P2|STARTED|Phase II- Determined Dose||7
8455243|NCT00735878|20835292|P1|STARTED|Phase II- Determined Dose||0
8455244|NCT00735878|20835290|P3|NOT COMPLETED|Phase I- Dose Determination||1
8455245|NCT00735878|20835291|P2|NOT COMPLETED|Phase I- Dose Determination||0
8455246|NCT00735878|20835292|P1|NOT COMPLETED|Phase I- Dose Determination||0
8455247|NCT00735878|20835290|P3|COMPLETED|Phase I- Dose Determination||4
8455248|NCT00735878|20835291|P2|COMPLETED|Phase I- Dose Determination||7
8455249|NCT00735878|20835292|P1|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
8455250|NCT00735878|20835290|P3|STARTED|Phase I- Dose Determination||5
8455251|NCT00735878|20835291|P2|STARTED|Phase I- Dose Determination||7
8455252|NCT00735878|20835292|P1|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
8455253|NCT00735839|20835305|P2|NOT COMPLETED|Overall Study||0
8455254|NCT00735839|20835306|P1|NOT COMPLETED|Overall Study||0
8455255|NCT00735839|20835305|P2|COMPLETED|Overall Study||10
8455256|NCT00735839|20835306|P1|COMPLETED|Overall Study||30
8455257|NCT00735839|20835305|P2|STARTED|Overall Study||10
8455258|NCT00735839|20835306|P1|STARTED|Overall Study||30
8455259|NCT00735826|20835314|P1|NOT COMPLETED|Overall Study||0
8455260|NCT00735826|20835314|P1|COMPLETED|Overall Study||10
8455261|NCT00735826|20835314|P1|STARTED|Overall Study||10
8455262|NCT00735787|20835322|P2|NOT COMPLETED|Period 2||1
8455263|NCT00735787|20835323|P1|NOT COMPLETED|Period 2||5
8455264|NCT00735787|20835322|P2|COMPLETED|Period 2||40
8455265|NCT00735787|20835323|P1|COMPLETED|Period 2||13
8455266|NCT00735787|20835322|P2|STARTED|Period 2||41
8455267|NCT00735787|20835323|P1|STARTED|Period 2||18
8455268|NCT00735787|20835322|P2|NOT COMPLETED|Period 1||8
8455269|NCT00735787|20835323|P1|NOT COMPLETED|Period 1||6
8455270|NCT00735787|20835322|P2|COMPLETED|Period 1||41
8455271|NCT00735787|20835323|P1|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
8455272|NCT00735787|20835322|P2|STARTED|Period 1||49
8455273|NCT00735787|20835323|P1|STARTED|Period 1||23
8455274|NCT00735709|20835371|P4|NOT COMPLETED|Overall Study||18
8455275|NCT00735709|20835372|P3|NOT COMPLETED|Overall Study||11
8455276|NCT00735709|20835373|P2|NOT COMPLETED|Overall Study||13
8455277|NCT00735709|20835374|P1|NOT COMPLETED|Overall Study||13
8455278|NCT00735709|20835371|P4|COMPLETED|Overall Study||122
8455279|NCT00735709|20835372|P3|COMPLETED|Overall Study||129
8455280|NCT00735709|20835373|P2|COMPLETED|Overall Study||127
8455281|NCT00735709|20835374|P1|COMPLETED|Overall Study||127
8455282|NCT00735709|20835371|P4|Treated|Overall Study||139
8455283|NCT00735709|20835372|P3|Treated|Overall Study||140
8455284|NCT00735709|20835373|P2|Treated|Overall Study||140
8455285|NCT00735709|20835374|P1|Treated|Overall Study||140
8455286|NCT00735709|20835371|P4|STARTED|Overall Study||140
8455287|NCT00735709|20835372|P3|STARTED|Overall Study||140
8455288|NCT00735709|20835373|P2|STARTED|Overall Study||140
8455289|NCT00735709|20835374|P1|STARTED|Overall Study||140
8455290|NCT00735696|20835484|P1|NOT COMPLETED|Overall Study||2
8455291|NCT00735696|20835484|P1|COMPLETED|Overall Study||39
8455292|NCT00735696|20835484|P1|Received Any Quantity of Study Drug|Overall Study||40
8455293|NCT00735696|20835484|P1|STARTED|Overall Study||41
8455294|NCT00735670|20835498|P2|NOT COMPLETED|Overall Study||5
8455295|NCT00735670|20835499|P1|NOT COMPLETED|Overall Study||4
8455296|NCT00735670|20835498|P2|COMPLETED|Overall Study||6
8455297|NCT00735670|20835499|P1|COMPLETED|Overall Study||6
8455298|NCT00735670|20835498|P2|STARTED|Overall Study||11
8455299|NCT00735670|20835499|P1|STARTED|Overall Study||10
8455300|NCT00735644|20835512|P5|NOT COMPLETED|Overall Study||0
8455301|NCT00735644|20835513|P4|NOT COMPLETED|Overall Study||1
8455302|NCT00735644|20835514|P3|NOT COMPLETED|Overall Study||1
8455303|NCT00735644|20835515|P2|NOT COMPLETED|Overall Study||2
8455304|NCT00735644|20835516|P1|NOT COMPLETED|Overall Study||0
8455305|NCT00735644|20835512|P5|COMPLETED|Overall Study||102
8455306|NCT00735644|20835513|P4|COMPLETED|Overall Study||198
8455307|NCT00735644|20835514|P3|COMPLETED|Overall Study||295
8455308|NCT00735644|20835515|P2|COMPLETED|Overall Study||298
8455309|NCT00735644|20835516|P1|COMPLETED|Overall Study||303
8455310|NCT00735644|20835512|P5|STARTED|Overall Study||102
8455311|NCT00735644|20835513|P4|STARTED|Overall Study||199
8455312|NCT00735644|20835514|P3|STARTED|Overall Study||296
8455313|NCT00735644|20835515|P2|STARTED|Overall Study||300
8455314|NCT00735644|20835516|P1|STARTED|Overall Study||303
8455315|NCT00735618|20835553|P1|NOT COMPLETED|Overall Study||0
8455316|NCT00735618|20835553|P1|COMPLETED|Overall Study||19
8455317|NCT00735618|20835553|P1|STARTED|Overall Study||19
8455318|NCT00735553|20835560|P1|NOT COMPLETED|Overall Study||77
8455319|NCT00735553|20835560|P1|COMPLETED|Overall Study||0
8455320|NCT00735553|20835560|P1|STARTED|Overall Study||77
8455321|NCT00735475|20835570|P2|NOT COMPLETED|Overall Study||11
8455322|NCT00735475|20835571|P1|NOT COMPLETED|Overall Study||8
8455323|NCT00735475|20835570|P2|COMPLETED|Overall Study||626
8455324|NCT00735475|20835571|P1|COMPLETED|Overall Study||623
8455325|NCT00735475|20835570|P2|STARTED|Overall Study||637
8455326|NCT00735475|20835571|P1|STARTED|Overall Study||631
8455327|NCT00735462|20835592|P3|NOT COMPLETED|Overall Study||28
8455328|NCT00735462|20835593|P2|NOT COMPLETED|Overall Study||55
8455329|NCT00735462|20835594|P1|NOT COMPLETED|Overall Study||63
8455330|NCT00735462|20835592|P3|COMPLETED|Overall Study||77
8455331|NCT00735462|20835593|P2|COMPLETED|Overall Study||149
8455332|NCT00735462|20835594|P1|COMPLETED|Overall Study||139
8455333|NCT00735462|20835592|P3|STARTED|Overall Study||105
8455334|NCT00735462|20835593|P2|STARTED|Overall Study||204
8455335|NCT00735462|20835594|P1|STARTED|Overall Study||202
8455336|NCT00735449|20835607|P2|NOT COMPLETED|Overall Study||6
8455337|NCT00735449|20835608|P1|NOT COMPLETED|Overall Study||7
8455338|NCT00735449|20835607|P2|COMPLETED|Overall Study||96
8455339|NCT00735449|20835608|P1|COMPLETED|Overall Study||95
8455340|NCT00735449|20835607|P2|STARTED|Overall Study||102
8455341|NCT00735449|20835608|P1|STARTED|Overall Study||102
8455342|NCT00735436|20835622|P1|NOT COMPLETED|Overall Study||0
8455343|NCT00735436|20835622|P1|COMPLETED|Overall Study||18
8455344|NCT00735436|20835622|P1|STARTED|Overall Study||18
8455345|NCT00735397|20835631|P1|NOT COMPLETED|Overall Study||1183
8455346|NCT00735397|20835631|P1|COMPLETED|Overall Study||35
8455347|NCT00735397|20835631|P1|STARTED|Overall Study||1218
8455360|NCT00735306|20835666|P1|NOT COMPLETED|Overall Study||0
8455361|NCT00735306|20835666|P1|COMPLETED|Overall Study||12
8455362|NCT00735306|20835666|P1|STARTED|Overall Study||12
8455363|NCT00735254|20835676|P4|NOT COMPLETED|Overall Study||0
8455364|NCT00735254|20835677|P3|NOT COMPLETED|Overall Study||1
8455365|NCT00735254|20835678|P2|NOT COMPLETED|Overall Study||1
8455366|NCT00735254|20835679|P1|NOT COMPLETED|Overall Study||1
8455367|NCT00735254|20835676|P4|COMPLETED|Overall Study||0
8455368|NCT00735254|20835677|P3|COMPLETED|Overall Study||0
8455369|NCT00735254|20835678|P2|COMPLETED|Overall Study||0
8455370|NCT00735254|20835679|P1|COMPLETED|Overall Study||0
8455371|NCT00735254|20835676|P4|STARTED|Overall Study||0
8455372|NCT00735254|20835677|P3|STARTED|Overall Study||1
8455373|NCT00735254|20835678|P2|STARTED|Overall Study||1
8455374|NCT00735254|20835679|P1|STARTED|Overall Study||1
8455375|NCT00735072|20835691|P2|NOT COMPLETED|Overall Study||1
8455376|NCT00735072|20835692|P1|NOT COMPLETED|Overall Study||1
8455377|NCT00735072|20835691|P2|COMPLETED|Overall Study||21
8455378|NCT00735072|20835692|P1|COMPLETED|Overall Study||22
8455379|NCT00735072|20835691|P2|STARTED|Overall Study||22
8455380|NCT00735072|20835692|P1|STARTED|Overall Study||23
8455381|NCT00735007|20835706|P1|NOT COMPLETED|Overall Study||5
8455382|NCT00735007|20835706|P1|COMPLETED|Overall Study||101
8455383|NCT00735007|20835706|P1|STARTED|Overall Study||106
8455384|NCT00734994|20835731|P1|NOT COMPLETED|Overall Study||1
8455385|NCT00734994|20835731|P1|COMPLETED|Overall Study||14
8455386|NCT00734994|20835731|P1|STARTED|Overall Study||15
8455387|NCT00734968|20835738|P2|NOT COMPLETED|Overall Study||1
8455388|NCT00734968|20835739|P1|NOT COMPLETED|Overall Study||1
8455389|NCT00734968|20835738|P2|COMPLETED|Overall Study||75
8455390|NCT00734968|20835739|P1|COMPLETED|Overall Study||76
8455391|NCT00734968|20835738|P2|STARTED|Overall Study||76
8455392|NCT00734968|20835739|P1|STARTED|Overall Study||77
8455393|NCT00734929|20835751|P2|NOT COMPLETED|Overall Study||5
8455394|NCT00734929|20835752|P1|NOT COMPLETED|Overall Study||6
8455395|NCT00734929|20835751|P2|COMPLETED|Overall Study||53
8455396|NCT00734929|20835752|P1|COMPLETED|Overall Study||51
8455397|NCT00734929|20835751|P2|STARTED|Overall Study||58
8455398|NCT00734929|20835752|P1|STARTED|Overall Study||57
8455399|NCT00734903|20835782|P2|NOT COMPLETED|Overall Study||1
8455400|NCT00734903|20835783|P1|NOT COMPLETED|Overall Study||3
8455401|NCT00734903|20835782|P2|COMPLETED|Overall Study||32
8455402|NCT00734903|20835783|P1|COMPLETED|Overall Study||30
8455403|NCT00734903|20835782|P2|Completed 3-month Followup|Overall Study||15
8455404|NCT00734903|20835783|P1|Completed 3-month Followup|Overall Study||14
8455405|NCT00734903|20835782|P2|Completed End of Treatment Assessment|Overall Study||23
8455406|NCT00734903|20835783|P1|Completed End of Treatment Assessment|Overall Study||21
8455407|NCT00734903|20835782|P2|STARTED|Overall Study||33
8455408|NCT00734903|20835783|P1|STARTED|Overall Study||33
8455409|NCT00734851|20835809|P1|NOT COMPLETED|Overall Study||21
8455410|NCT00734851|20835809|P1|COMPLETED|Overall Study||13
8455411|NCT00734851|20835809|P1|STARTED|Overall Study||34
8455412|NCT00734799|20835821|P2|NOT COMPLETED|Overall Study||4
8455413|NCT00734799|20835822|P1|NOT COMPLETED|Overall Study||0
8455414|NCT00734799|20835821|P2|COMPLETED|Overall Study||9
8455415|NCT00734799|20835822|P1|COMPLETED|Overall Study||9
8455416|NCT00734799|20835821|P2|STARTED|Overall Study||13
8455417|NCT00734799|20835822|P1|STARTED|Overall Study||9
8455418|NCT00734747|20835830|P1|NOT COMPLETED|6 Month Follow-up||3
8455419|NCT00734747|20835830|P1|COMPLETED|6 Month Follow-up||66
8455420|NCT00734747|20835830|P1|STARTED|6 Month Follow-up||69
8455421|NCT00734747|20835830|P1|NOT COMPLETED|SRS Procedure||3
8455422|NCT00734747|20835830|P1|COMPLETED|SRS Procedure||69
8455423|NCT00734747|20835830|P1|STARTED|SRS Procedure||72
8455424|NCT00734734|20835837|P1|NOT COMPLETED|Overall Study||0
8455425|NCT00734734|20835837|P1|COMPLETED|Overall Study||64
8455426|NCT00734734|20835837|P1|STARTED|Overall Study||64
8455427|NCT00734656|20835844|P4|NOT COMPLETED|Lab Session 4||1
8455428|NCT00734656|20835845|P3|NOT COMPLETED|Lab Session 4||0
8455429|NCT00734656|20835846|P2|NOT COMPLETED|Lab Session 4||0
8455430|NCT00734656|20835847|P1|NOT COMPLETED|Lab Session 4||0
8455431|NCT00734656|20835844|P4|COMPLETED|Lab Session 4||19
8455432|NCT00734656|20835845|P3|COMPLETED|Lab Session 4||16
8455433|NCT00734656|20835846|P2|COMPLETED|Lab Session 4||18
8455434|NCT00734656|20835847|P1|COMPLETED|Lab Session 4||20
8455435|NCT00734656|20835844|P4|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
8455436|NCT00734656|20835845|P3|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
8455437|NCT00734656|20835846|P2|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
8455438|NCT00734656|20835847|P1|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
8455439|NCT00734656|20835844|P4|NOT COMPLETED|Washout 3||1
8455440|NCT00734656|20835845|P3|NOT COMPLETED|Washout 3||0
8455441|NCT00734656|20835846|P2|NOT COMPLETED|Washout 3||0
8455442|NCT00734656|20835847|P1|NOT COMPLETED|Washout 3||1
8455443|NCT00734656|20835844|P4|COMPLETED|Washout 3||18
8455444|NCT00734656|20835845|P3|COMPLETED|Washout 3||20
8455445|NCT00734656|20835846|P2|COMPLETED|Washout 3||19
8455446|NCT00734656|20835847|P1|COMPLETED|Washout 3||17
8455447|NCT00734656|20835844|P4|STARTED|Washout 3||19
8455448|NCT00734656|20835845|P3|STARTED|Washout 3||20
8455449|NCT00734656|20835846|P2|STARTED|Washout 3||19
8455450|NCT00734656|20835847|P1|STARTED|Washout 3||18
8455451|NCT00734656|20835844|P4|NOT COMPLETED|Lab Session 3||0
8455452|NCT00734656|20835845|P3|NOT COMPLETED|Lab Session 3||0
8455453|NCT00734656|20835846|P2|NOT COMPLETED|Lab Session 3||0
8455454|NCT00734656|20835847|P1|NOT COMPLETED|Lab Session 3||0
8455455|NCT00734656|20835844|P4|COMPLETED|Lab Session 3||19
8455456|NCT00734656|20835845|P3|COMPLETED|Lab Session 3||20
8455457|NCT00734656|20835846|P2|COMPLETED|Lab Session 3||19
8455458|NCT00734656|20835847|P1|COMPLETED|Lab Session 3||18
8455459|NCT00734656|20835844|P4|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
8455460|NCT00734656|20835845|P3|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
8455461|NCT00734656|20835846|P2|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
8455462|NCT00734656|20835847|P1|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
8455463|NCT00734656|20835844|P4|NOT COMPLETED|Washout 2||0
8455464|NCT00734656|20835845|P3|NOT COMPLETED|Washout 2||1
8455465|NCT00734656|20835846|P2|NOT COMPLETED|Washout 2||1
8455466|NCT00734656|20835847|P1|NOT COMPLETED|Washout 2||1
8455467|NCT00734656|20835844|P4|COMPLETED|Washout 2||19
8455468|NCT00734656|20835845|P3|COMPLETED|Washout 2||20
8455469|NCT00734656|20835846|P2|COMPLETED|Washout 2||20
8455470|NCT00734656|20835847|P1|COMPLETED|Washout 2||17
8455471|NCT00734656|20835844|P4|STARTED|Washout 2||19
8455472|NCT00734656|20835845|P3|STARTED|Washout 2||21
8455473|NCT00734656|20835846|P2|STARTED|Washout 2||21
8455474|NCT00734656|20835847|P1|STARTED|Washout 2||18
8455475|NCT00734656|20835844|P4|NOT COMPLETED|Lab Session 2||1
8455476|NCT00734656|20835845|P3|NOT COMPLETED|Lab Session 2||0
8455477|NCT00734656|20835846|P2|NOT COMPLETED|Lab Session 2||0
8455478|NCT00734656|20835847|P1|NOT COMPLETED|Lab Session 2||1
8455479|NCT00734656|20835844|P4|COMPLETED|Lab Session 2||19
8455480|NCT00734656|20835845|P3|COMPLETED|Lab Session 2||21
8455481|NCT00734656|20835846|P2|COMPLETED|Lab Session 2||21
8455482|NCT00734656|20835847|P1|COMPLETED|Lab Session 2||18
8455483|NCT00734656|20835844|P4|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
8455484|NCT00734656|20835845|P3|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
8455485|NCT00734656|20835846|P2|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
8455486|NCT00734656|20835847|P1|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
8455487|NCT00734656|20835844|P4|NOT COMPLETED|Washout 1||3
8455488|NCT00734656|20835845|P3|NOT COMPLETED|Washout 1||2
8455489|NCT00734656|20835846|P2|NOT COMPLETED|Washout 1||5
8455490|NCT00734656|20835847|P1|NOT COMPLETED|Washout 1||1
8455491|NCT00734656|20835844|P4|COMPLETED|Washout 1||18
8455492|NCT00734656|20835845|P3|COMPLETED|Washout 1||24
8455493|NCT00734656|20835846|P2|COMPLETED|Washout 1||18
8455494|NCT00734656|20835847|P1|COMPLETED|Washout 1||21
8455495|NCT00734656|20835844|P4|STARTED|Washout 1||21
8455496|NCT00734656|20835845|P3|STARTED|Washout 1||26
8455497|NCT00734656|20835846|P2|STARTED|Washout 1||23
8455498|NCT00734656|20835847|P1|STARTED|Washout 1||22
8455499|NCT00734656|20835844|P4|NOT COMPLETED|Lab Session 1||0
8455500|NCT00734656|20835845|P3|NOT COMPLETED|Lab Session 1||0
8455501|NCT00734656|20835846|P2|NOT COMPLETED|Lab Session 1||0
8455502|NCT00734656|20835847|P1|NOT COMPLETED|Lab Session 1||2
8455503|NCT00734656|20835844|P4|COMPLETED|Lab Session 1||21
8455504|NCT00734656|20835845|P3|COMPLETED|Lab Session 1||26
8455505|NCT00734656|20835846|P2|COMPLETED|Lab Session 1||23
8455506|NCT00734656|20835847|P1|COMPLETED|Lab Session 1||22
8455507|NCT00734656|20835844|P4|STARTED|Lab Session 1||21
8455508|NCT00734656|20835845|P3|STARTED|Lab Session 1||26
8455509|NCT00734656|20835846|P2|STARTED|Lab Session 1||23
8455510|NCT00734656|20835847|P1|STARTED|Lab Session 1||24
8455511|NCT00734630|20835871|P2|NOT COMPLETED|Overall Study||33
8455512|NCT00734630|20835872|P1|NOT COMPLETED|Overall Study||29
8455513|NCT00734630|20835871|P2|COMPLETED|Overall Study||200
8455514|NCT00734630|20835872|P1|COMPLETED|Overall Study||229
8455515|NCT00734630|20835871|P2|STARTED|Overall Study||233
8455516|NCT00734630|20835872|P1|STARTED|Overall Study||258
8455517|NCT00734617|20835882|P2|NOT COMPLETED|Overall Study||102
8455518|NCT00734617|20835883|P1|NOT COMPLETED|Overall Study||107
8455519|NCT00734617|20835882|P2|COMPLETED|Overall Study||128
8455520|NCT00734617|20835883|P1|COMPLETED|Overall Study||142
8455521|NCT00734617|20835882|P2|STARTED|Overall Study||230
8455522|NCT00734617|20835883|P1|STARTED|Overall Study||249
8455523|NCT00734604|20835895|P6|NOT COMPLETED|Overall Study||6
8455524|NCT00734604|20835896|P5|NOT COMPLETED|Overall Study||8
8455525|NCT00734604|20835897|P4|NOT COMPLETED|Overall Study||9
8455526|NCT00734604|20835898|P3|NOT COMPLETED|Overall Study||6
8455527|NCT00734604|20835899|P2|NOT COMPLETED|Overall Study||12
8455528|NCT00734604|20835900|P1|NOT COMPLETED|Overall Study||3
8455529|NCT00734604|20835895|P6|COMPLETED|Overall Study||58
8455530|NCT00734604|20835896|P5|COMPLETED|Overall Study||55
8455531|NCT00734604|20835897|P4|COMPLETED|Overall Study||54
8455532|NCT00734604|20835898|P3|COMPLETED|Overall Study||57
8455533|NCT00734604|20835899|P2|COMPLETED|Overall Study||51
8455534|NCT00734604|20835900|P1|COMPLETED|Overall Study||59
8455535|NCT00734604|20835895|P6|STARTED|Overall Study||64
8455536|NCT00734604|20835896|P5|STARTED|Overall Study||63
8455537|NCT00734604|20835897|P4|STARTED|Overall Study||63
8455538|NCT00734604|20835898|P3|STARTED|Overall Study||63
8455539|NCT00734604|20835899|P2|STARTED|Overall Study||63
8455540|NCT00734604|20835900|P1|STARTED|Overall Study||62
8455541|NCT00734591|20835950|P2|NOT COMPLETED|Prospective Period||44
8455542|NCT00734591|20835951|P1|NOT COMPLETED|Prospective Period||51
8455543|NCT00734591|20835950|P2|COMPLETED|Prospective Period||1229
8455544|NCT00734591|20835951|P1|COMPLETED|Prospective Period||1307
8455545|NCT00734591|20835950|P2|STARTED|Prospective Period||1273
8455546|NCT00734591|20835951|P1|STARTED|Prospective Period||1358
8455547|NCT00734591|20835950|P2|NOT COMPLETED|Screening for Prospective Period||2291
8455548|NCT00734591|20835951|P1|NOT COMPLETED|Screening for Prospective Period||2517
8455549|NCT00734591|20835950|P2|COMPLETED|Screening for Prospective Period||1273
8455550|NCT00734591|20835951|P1|COMPLETED|Screening for Prospective Period||1358
8455551|NCT00734591|20835950|P2|STARTED|Screening for Prospective Period||3564
8455552|NCT00734591|20835951|P1|STARTED|Screening for Prospective Period||3875
8455553|NCT00734591|20835950|P2|NOT COMPLETED|Retrospective Period||0
8455554|NCT00734591|20835951|P1|NOT COMPLETED|Retrospective Period||0
8455555|NCT00734591|20835950|P2|COMPLETED|Retrospective Period||3564
8455556|NCT00734591|20835951|P1|COMPLETED|Retrospective Period||3875
8455557|NCT00734591|20835950|P2|STARTED|Retrospective Period||3564
8455558|NCT00734591|20835951|P1|STARTED|Retrospective Period||3875
8455568|NCT00734539|20836002|P2|NOT COMPLETED|Long Term Follow up||31
8455569|NCT00734539|20836003|P1|NOT COMPLETED|Long Term Follow up||34
8455570|NCT00734539|20836002|P2|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
8455571|NCT00734539|20836003|P1|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
8455572|NCT00734539|20836002|P2|STARTED|Long Term Follow up||138
8455573|NCT00734539|20836003|P1|STARTED|Long Term Follow up||152
8455574|NCT00734539|20836002|P2|NOT COMPLETED|Main Study||35
8455575|NCT00734539|20836003|P1|NOT COMPLETED|Main Study||37
8455576|NCT00734539|20836002|P2|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
8455577|NCT00734539|20836003|P1|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
8455578|NCT00734539|20836002|P2|STARTED|Main Study||173
8455579|NCT00734539|20836003|P1|STARTED|Main Study||189
8455580|NCT00734500|20836031|P1|NOT COMPLETED|Overall Study||1
8455581|NCT00734500|20836031|P1|COMPLETED|Overall Study||14
8455582|NCT00734500|20836031|P1|STARTED|Overall Study||15
8455583|NCT00734474|20836045|P9|NOT COMPLETED|Overall Study||82
8455584|NCT00734474|20836046|P8|NOT COMPLETED|Overall Study||129
8455585|NCT00734474|20836047|P7|NOT COMPLETED|Overall Study||24
8455586|NCT00734474|20836048|P6|NOT COMPLETED|Overall Study||25
8455587|NCT00734474|20836049|P5|NOT COMPLETED|Overall Study||118
8455588|NCT00734474|20836050|P4|NOT COMPLETED|Overall Study||10
8455589|NCT00734474|20836051|P3|NOT COMPLETED|Overall Study||112
8455590|NCT00734474|20836052|P2|NOT COMPLETED|Overall Study||30
8455591|NCT00734474|20836053|P1|NOT COMPLETED|Overall Study||15
8455592|NCT00734474|20836045|P9|COMPLETED|Overall Study||95
8455593|NCT00734474|20836046|P8|COMPLETED|Overall Study||186
8455594|NCT00734474|20836047|P7|COMPLETED|Overall Study||0
8455595|NCT00734474|20836048|P6|COMPLETED|Overall Study||0
8455596|NCT00734474|20836049|P5|COMPLETED|Overall Study||184
8455597|NCT00734474|20836050|P4|COMPLETED|Overall Study||0
8455598|NCT00734474|20836051|P3|COMPLETED|Overall Study||192
8455599|NCT00734474|20836052|P2|COMPLETED|Overall Study||0
8455600|NCT00734474|20836053|P1|COMPLETED|Overall Study||0
8455601|NCT00734474|20836045|P9|Completed 52-Week Visit|Overall Study||112
8455602|NCT00734474|20836046|P8|Completed 52-Week Visit|Overall Study||238
8455603|NCT00734474|20836047|P7|Completed 52-Week Visit|Overall Study||0
8455604|NCT00734474|20836048|P6|Completed 52-Week Visit|Overall Study||0
8455605|NCT00734474|20836049|P5|Completed 52-Week Visit|Overall Study||243
8455606|NCT00734474|20836050|P4|Completed 52-Week Visit|Overall Study||0
8455607|NCT00734474|20836051|P3|Completed 52-Week Visit|Overall Study||238
8455608|NCT00734474|20836052|P2|Completed 52-Week Visit|Overall Study||0
8455609|NCT00734474|20836053|P1|Completed 52-Week Visit|Overall Study||0
8455610|NCT00734474|20836045|P9|Completed 26-Week Visit|Overall Study||124
8455611|NCT00734474|20836046|P8|Completed 26-Week Visit|Overall Study||270
8455612|NCT00734474|20836047|P7|Completed 26-Week Visit|Overall Study||2
8455613|NCT00734474|20836048|P6|Completed 26-Week Visit|Overall Study||2
8455614|NCT00734474|20836049|P5|Completed 26-Week Visit|Overall Study||268
8455615|NCT00734474|20836050|P4|Completed 26-Week Visit|Overall Study||2
8455616|NCT00734474|20836051|P3|Completed 26-Week Visit|Overall Study||258
8455617|NCT00734474|20836052|P2|Completed 26-Week Visit|Overall Study||0
8455618|NCT00734474|20836053|P1|Completed 26-Week Visit|Overall Study||0
8455619|NCT00734474|20836045|P9|Entered Study After Dose Decision Point|Overall Study||139
8455620|NCT00734474|20836046|P8|Entered Study After Dose Decision Point|Overall Study||273
8455621|NCT00734474|20836047|P7|Entered Study After Dose Decision Point|Overall Study||0
8455622|NCT00734474|20836048|P6|Entered Study After Dose Decision Point|Overall Study||0
8455623|NCT00734474|20836049|P5|Entered Study After Dose Decision Point|Overall Study||281
8455624|NCT00734474|20836050|P4|Entered Study After Dose Decision Point|Overall Study||0
8455625|NCT00734474|20836051|P3|Entered Study After Dose Decision Point|Overall Study||279
8455626|NCT00734474|20836052|P2|Entered Study After Dose Decision Point|Overall Study||0
8455627|NCT00734474|20836053|P1|Entered Study After Dose Decision Point|Overall Study||0
8455628|NCT00734474|20836045|P9|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
8455629|NCT00734474|20836046|P8|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
8455630|NCT00734474|20836047|P7|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
8455631|NCT00734474|20836048|P6|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
8455632|NCT00734474|20836049|P5|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
8455633|NCT00734474|20836050|P4|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
8455634|NCT00734474|20836051|P3|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
8455635|NCT00734474|20836052|P2|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
8455636|NCT00734474|20836053|P1|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
8455637|NCT00734474|20836045|P9|Entered Study Before Dose Decision Point|Overall Study||38
8455638|NCT00734474|20836046|P8|Entered Study Before Dose Decision Point|Overall Study||42
8455639|NCT00734474|20836047|P7|Entered Study Before Dose Decision Point|Overall Study||24
8455640|NCT00734474|20836048|P6|Entered Study Before Dose Decision Point|Overall Study||25
8455641|NCT00734474|20836049|P5|Entered Study Before Dose Decision Point|Overall Study||21
8455642|NCT00734474|20836050|P4|Entered Study Before Dose Decision Point|Overall Study||10
8455643|NCT00734474|20836051|P3|Entered Study Before Dose Decision Point|Overall Study||25
8455644|NCT00734474|20836052|P2|Entered Study Before Dose Decision Point|Overall Study||30
8455645|NCT00734474|20836053|P1|Entered Study Before Dose Decision Point|Overall Study||15
8455646|NCT00734474|20836045|P9|Received at Least 1 Dose of Study Drug|Overall Study||177
8455647|NCT00734474|20836046|P8|Received at Least 1 Dose of Study Drug|Overall Study||315
8455648|NCT00734474|20836047|P7|Received at Least 1 Dose of Study Drug|Overall Study||24
8455649|NCT00734474|20836048|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
8455650|NCT00734474|20836049|P5|Received at Least 1 Dose of Study Drug|Overall Study||302
8455651|NCT00734474|20836050|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
8455652|NCT00734474|20836051|P3|Received at Least 1 Dose of Study Drug|Overall Study||304
8455653|NCT00734474|20836052|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
8455654|NCT00734474|20836053|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
8455655|NCT00734474|20836045|P9|STARTED|Overall Study||177
8455656|NCT00734474|20836046|P8|STARTED|Overall Study||315
8455657|NCT00734474|20836047|P7|STARTED|Overall Study||24
8455658|NCT00734474|20836048|P6|STARTED|Overall Study||25
8455659|NCT00734474|20836049|P5|STARTED|Overall Study||302
8455660|NCT00734474|20836050|P4|STARTED|Overall Study||10
8455661|NCT00734474|20836051|P3|STARTED|Overall Study||304
8455662|NCT00734474|20836052|P2|STARTED|Overall Study||30
8455663|NCT00734474|20836053|P1|STARTED|Overall Study||15
8455664|NCT00734409|20836222|P2|NOT COMPLETED|Overall Study||0
8455665|NCT00734409|20836223|P1|NOT COMPLETED|Overall Study||0
8455666|NCT00734409|20836222|P2|COMPLETED|Overall Study||145
8455667|NCT00734409|20836223|P1|COMPLETED|Overall Study||155
8455668|NCT00734409|20836222|P2|STARTED|Overall Study||145
8455669|NCT00734409|20836223|P1|STARTED|Overall Study||155
8455670|NCT00734344|20836235|P2|NOT COMPLETED|Overall Study||0
8455671|NCT00734344|20836236|P1|NOT COMPLETED|Overall Study||0
8455672|NCT00734344|20836235|P2|COMPLETED|Overall Study||9
8455673|NCT00734344|20836236|P1|COMPLETED|Overall Study||9
8455674|NCT00734344|20836235|P2|STARTED|Overall Study||9
8455675|NCT00734344|20836236|P1|STARTED|Overall Study||9
8455676|NCT00734305|20836306|P7|NOT COMPLETED|Overall Study||0
8455677|NCT00734305|20836307|P6|NOT COMPLETED|Overall Study||0
8455678|NCT00734305|20836308|P5|NOT COMPLETED|Overall Study||0
8455679|NCT00734305|20836309|P4|NOT COMPLETED|Overall Study||0
8455680|NCT00734305|20836310|P3|NOT COMPLETED|Overall Study||0
8455681|NCT00734305|20836311|P2|NOT COMPLETED|Overall Study||0
8455682|NCT00734305|20836312|P1|NOT COMPLETED|Overall Study||1
8455683|NCT00734305|20836306|P7|COMPLETED|Overall Study||18
8455684|NCT00734305|20836307|P6|COMPLETED|Overall Study||4
8455685|NCT00734305|20836308|P5|COMPLETED|Overall Study||5
8455686|NCT00734305|20836309|P4|COMPLETED|Overall Study||3
8455687|NCT00734305|20836310|P3|COMPLETED|Overall Study||4
8455688|NCT00734305|20836311|P2|COMPLETED|Overall Study||3
8455689|NCT00734305|20836312|P1|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
8455690|NCT00734305|20836306|P7|STARTED|Overall Study||18
8455691|NCT00734305|20836307|P6|STARTED|Overall Study||4
8455692|NCT00734305|20836308|P5|STARTED|Overall Study||5
8455693|NCT00734305|20836309|P4|STARTED|Overall Study||3
8455694|NCT00734305|20836310|P3|STARTED|Overall Study||4
8455695|NCT00734305|20836311|P2|STARTED|Overall Study||3
8455696|NCT00734305|20836312|P1|STARTED|Overall Study||7
8455697|NCT00734214|20836343|P2|NOT COMPLETED|Overall Study||4
8455698|NCT00734214|20836344|P1|NOT COMPLETED|Overall Study||4
8455699|NCT00734214|20836343|P2|COMPLETED|Overall Study||126
8455700|NCT00734214|20836344|P1|COMPLETED|Overall Study||124
8455701|NCT00734214|20836343|P2|STARTED|Overall Study||130
8455702|NCT00734214|20836344|P1|STARTED|Overall Study||128
8455703|NCT00734162|20836354|P4|NOT COMPLETED|Open-Label Phase||3
8455704|NCT00734162|20836355|P3|NOT COMPLETED|Open-Label Phase||1
8455705|NCT00734162|20836356|P2|NOT COMPLETED|Open-Label Phase||2
8455706|NCT00734162|20836357|P1|NOT COMPLETED|Open-Label Phase||3
8455707|NCT00734162|20836354|P4|COMPLETED|Open-Label Phase||36
8455708|NCT00734162|20836355|P3|COMPLETED|Open-Label Phase||12
8455709|NCT00734162|20836356|P2|COMPLETED|Open-Label Phase||39
8455710|NCT00734162|20836357|P1|COMPLETED|Open-Label Phase||7
8455711|NCT00734162|20836354|P4|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
8455712|NCT00734162|20836355|P3|STARTED|Open-Label Phase||13
8455713|NCT00734162|20836356|P2|STARTED|Open-Label Phase||41
8455714|NCT00734162|20836357|P1|STARTED|Open-Label Phase||10
8455715|NCT00734162|20836354|P4|NOT COMPLETED|Randomized Phase (Through Week 72)||4
8455716|NCT00734162|20836355|P3|NOT COMPLETED|Randomized Phase (Through Week 72)||0
8455717|NCT00734162|20836356|P2|NOT COMPLETED|Randomized Phase (Through Week 72)||1
8455718|NCT00734162|20836357|P1|NOT COMPLETED|Randomized Phase (Through Week 72)||0
8455719|NCT00734162|20836354|P4|COMPLETED|Randomized Phase (Through Week 72)||37
8455720|NCT00734162|20836355|P3|COMPLETED|Randomized Phase (Through Week 72)||13
8455721|NCT00734162|20836356|P2|COMPLETED|Randomized Phase (Through Week 72)||41
8455722|NCT00734162|20836357|P1|COMPLETED|Randomized Phase (Through Week 72)||10
8455723|NCT00734162|20836354|P4|STARTED|Randomized Phase (Through Week 72)||41
8455724|NCT00734162|20836355|P3|STARTED|Randomized Phase (Through Week 72)||13
8455725|NCT00734162|20836356|P2|STARTED|Randomized Phase (Through Week 72)||42
8455726|NCT00734162|20836357|P1|STARTED|Randomized Phase (Through Week 72)||10
8455727|NCT00734149|20836581|P1|NOT COMPLETED|Overall Study||1
8455728|NCT00734149|20836581|P1|COMPLETED|Overall Study||44
8455729|NCT00734149|20836581|P1|STARTED|Overall Study||45
8455730|NCT00734097|20836588|P1|NOT COMPLETED|Open Label||16
8455731|NCT00734097|20836588|P1|COMPLETED|Open Label|16 patients discontinued after randomization|301
8455732|NCT00734097|20836588|P1|Per Protocol|Open Label||301
8455733|NCT00734097|20836588|P1|Full Analysis|Open Label||311
8455734|NCT00734097|20836588|P1|Safety Analysis|Open Label||317
8455735|NCT00734097|20836588|P1|STARTED|Open Label|Full analysis performed in 311|317
8455736|NCT00734097|20836588|P1|NOT COMPLETED|Screening||20
8455737|NCT00734097|20836588|P1|COMPLETED|Screening|20 participants were screening failure.|317
8455738|NCT00734097|20836588|P1|STARTED|Screening||337
8455739|NCT00734071|20836605|P2|NOT COMPLETED|Overall Study||27
8455740|NCT00734071|20836606|P1|NOT COMPLETED|Overall Study||38
8455741|NCT00734071|20836605|P2|COMPLETED|Overall Study||125
8455742|NCT00734071|20836606|P1|COMPLETED|Overall Study||114
8455743|NCT00734071|20836605|P2|Treated|Overall Study||148
8455744|NCT00734071|20836606|P1|Treated|Overall Study||151
8455745|NCT00734071|20836605|P2|STARTED|Overall Study||152
8455746|NCT00734071|20836606|P1|STARTED|Overall Study||152
8455747|NCT00734032|20836664|P4|NOT COMPLETED|Overall Study||0
8455748|NCT00734032|20836665|P3|NOT COMPLETED|Overall Study||0
8455749|NCT00734032|20836666|P2|NOT COMPLETED|Overall Study||1
8455750|NCT00734032|20836667|P1|NOT COMPLETED|Overall Study||0
8455751|NCT00734032|20836664|P4|COMPLETED|Overall Study||26
8455752|NCT00734032|20836665|P3|COMPLETED|Overall Study||28
8455753|NCT00734032|20836666|P2|COMPLETED|Overall Study||27
8455754|NCT00734032|20836667|P1|COMPLETED|Overall Study||25
8455755|NCT00734032|20836664|P4|STARTED|Overall Study||26
8455756|NCT00734032|20836665|P3|STARTED|Overall Study||28
8455757|NCT00734032|20836666|P2|STARTED|Overall Study||28
8455758|NCT00734032|20836667|P1|STARTED|Overall Study||25
8455759|NCT00733993|20836687|P2|NOT COMPLETED|Overall Study||0
8455760|NCT00733993|20836688|P1|NOT COMPLETED|Overall Study||0
8455761|NCT00733993|20836687|P2|COMPLETED|Overall Study||10
8455762|NCT00733993|20836688|P1|COMPLETED|Overall Study||13
8455763|NCT00733993|20836687|P2|STARTED|Overall Study||10
8455764|NCT00733993|20836688|P1|STARTED|Overall Study||13
8455765|NCT00733980|20836723|P2|NOT COMPLETED|Overall Study||21
8455766|NCT00733980|20836724|P1|NOT COMPLETED|Overall Study||22
8455767|NCT00733980|20836723|P2|COMPLETED|Overall Study||55
8455768|NCT00733980|20836724|P1|COMPLETED|Overall Study||52
8455769|NCT00733980|20836723|P2|STARTED|Overall Study||76
8455770|NCT00733980|20836724|P1|STARTED|Overall Study||74
8455771|NCT00733954|20836768|P2|NOT COMPLETED|Overall Study||2
8455772|NCT00733954|20836769|P1|NOT COMPLETED|Overall Study||8
8455773|NCT00733954|20836768|P2|COMPLETED|Overall Study||123
8455774|NCT00733954|20836769|P1|COMPLETED|Overall Study||116
8455775|NCT00733954|20836768|P2|STARTED|Overall Study||125
8455776|NCT00733954|20836769|P1|STARTED|Overall Study||124
8455777|NCT00733824|20836816|P5|NOT COMPLETED|Phase II||0
8455778|NCT00733824|20836817|P4|NOT COMPLETED|Phase II||0
8455779|NCT00733824|20836818|P3|NOT COMPLETED|Phase II||0
8455780|NCT00733824|20836819|P2|NOT COMPLETED|Phase II||0
8455781|NCT00733824|20836820|P1|NOT COMPLETED|Phase II||0
8455782|NCT00733824|20836816|P5|COMPLETED|Phase II||36
8455783|NCT00733824|20836817|P4|COMPLETED|Phase II||0
8455784|NCT00733824|20836818|P3|COMPLETED|Phase II||0
8455785|NCT00733824|20836819|P2|COMPLETED|Phase II||0
8455786|NCT00733824|20836820|P1|COMPLETED|Phase II||0
8455787|NCT00733824|20836816|P5|STARTED|Phase II||36
8455788|NCT00733824|20836817|P4|STARTED|Phase II||0
8455789|NCT00733824|20836818|P3|STARTED|Phase II||0
8455790|NCT00733824|20836819|P2|STARTED|Phase II||0
8455791|NCT00733824|20836820|P1|STARTED|Phase II||0
8455792|NCT00733824|20836816|P5|NOT COMPLETED|Phase I||0
8455793|NCT00733824|20836817|P4|NOT COMPLETED|Phase I||0
8455794|NCT00733824|20836818|P3|NOT COMPLETED|Phase I||0
8455795|NCT00733824|20836819|P2|NOT COMPLETED|Phase I||0
8455796|NCT00733824|20836820|P1|NOT COMPLETED|Phase I||1
8455797|NCT00733824|20836816|P5|COMPLETED|Phase I||0
8455798|NCT00733824|20836817|P4|COMPLETED|Phase I||6
8455799|NCT00733824|20836818|P3|COMPLETED|Phase I||6
8455800|NCT00733824|20836819|P2|COMPLETED|Phase I||3
8455801|NCT00733824|20836820|P1|COMPLETED|Phase I||9
8455802|NCT00733824|20836816|P5|STARTED|Phase I||0
8455803|NCT00733824|20836817|P4|STARTED|Phase I||6
8455804|NCT00733824|20836818|P3|STARTED|Phase I||6
8455805|NCT00733824|20836819|P2|STARTED|Phase I||3
8455806|NCT00733824|20836820|P1|STARTED|Phase I||10
8455807|NCT00733746|20836839|P1|NOT COMPLETED|Overall Study||5
8455808|NCT00733746|20836839|P1|COMPLETED|Overall Study||114
8455809|NCT00733746|20836839|P1|STARTED|Overall Study||119
8455810|NCT00733512|20836847|P1|NOT COMPLETED|Overall Study||0
8455811|NCT00733512|20836847|P1|COMPLETED|Overall Study||146
8455812|NCT00733512|20836847|P1|STARTED|Overall Study||146
8455813|NCT00733499|20836854|P2|NOT COMPLETED|10 Year Followup||19
8455814|NCT00733499|20836855|P1|NOT COMPLETED|10 Year Followup||20
8455815|NCT00733499|20836854|P2|COMPLETED|10 Year Followup||13
8455816|NCT00733499|20836855|P1|COMPLETED|10 Year Followup||26
8455817|NCT00733499|20836854|P2|STARTED|10 Year Followup||32
8455818|NCT00733499|20836855|P1|STARTED|10 Year Followup||46
8455819|NCT00733499|20836854|P2|NOT COMPLETED|5 Year Followup||25
8455820|NCT00733499|20836855|P1|NOT COMPLETED|5 Year Followup||21
8455821|NCT00733499|20836854|P2|COMPLETED|5 Year Followup||53
8455822|NCT00733499|20836855|P1|COMPLETED|5 Year Followup||70
8455823|NCT00733499|20836854|P2|STARTED|5 Year Followup||78
8455824|NCT00733499|20836855|P1|STARTED|5 Year Followup||91
8455825|NCT00733499|20836854|P2|NOT COMPLETED|24 Months Follow-up||1
8455826|NCT00733499|20836855|P1|NOT COMPLETED|24 Months Follow-up||0
8455827|NCT00733499|20836854|P2|COMPLETED|24 Months Follow-up||95
8455828|NCT00733499|20836855|P1|COMPLETED|24 Months Follow-up||99
8455829|NCT00733499|20836854|P2|STARTED|24 Months Follow-up||96
8455830|NCT00733499|20836855|P1|STARTED|24 Months Follow-up||99
8455831|NCT00733499|20836854|P2|NOT COMPLETED|12 Months Follow-up||1
8455832|NCT00733499|20836855|P1|NOT COMPLETED|12 Months Follow-up||2
8455833|NCT00733499|20836854|P2|COMPLETED|12 Months Follow-up||96
8455834|NCT00733499|20836855|P1|COMPLETED|12 Months Follow-up||99
8455835|NCT00733499|20836854|P2|STARTED|12 Months Follow-up||97
8455836|NCT00733499|20836855|P1|STARTED|12 Months Follow-up||101
8455837|NCT00733499|20836854|P2|NOT COMPLETED|6 Months Follow-up||3
8455838|NCT00733499|20836855|P1|NOT COMPLETED|6 Months Follow-up||0
8455839|NCT00733499|20836854|P2|COMPLETED|6 Months Follow-up||97
8455840|NCT00733499|20836855|P1|COMPLETED|6 Months Follow-up||101
8455841|NCT00733499|20836854|P2|STARTED|6 Months Follow-up||100
8455842|NCT00733499|20836855|P1|STARTED|6 Months Follow-up||101
8455843|NCT00733499|20836854|P2|NOT COMPLETED|3 Months Follow-up||2
8455844|NCT00733499|20836855|P1|NOT COMPLETED|3 Months Follow-up||1
8455845|NCT00733499|20836854|P2|COMPLETED|3 Months Follow-up||100
8455846|NCT00733499|20836855|P1|COMPLETED|3 Months Follow-up||101
8455847|NCT00733499|20836854|P2|STARTED|3 Months Follow-up||102
8455848|NCT00733499|20836855|P1|STARTED|3 Months Follow-up||102
8455849|NCT00733499|20836854|P2|NOT COMPLETED|Pre-operative||1
8455850|NCT00733499|20836855|P1|NOT COMPLETED|Pre-operative||0
8455851|NCT00733499|20836854|P2|COMPLETED|Pre-operative||102
8455852|NCT00733499|20836855|P1|COMPLETED|Pre-operative||102
8455853|NCT00733499|20836854|P2|STARTED|Pre-operative|A death occurred prior to surgery which left a total of 102 participants|103
8455854|NCT00733499|20836855|P1|STARTED|Pre-operative||102
8455855|NCT00733421|20836915|P2|NOT COMPLETED|Overall Study||1
8455856|NCT00733421|20836916|P1|NOT COMPLETED|Overall Study||1
8455857|NCT00733421|20836915|P2|COMPLETED|Overall Study|All but one randomised patient|49
8455858|NCT00733421|20836916|P1|COMPLETED|Overall Study|All but one randomsied patient|49
8455859|NCT00733421|20836915|P2|STARTED|Overall Study|November 2008|50
8455860|NCT00733421|20836916|P1|STARTED|Overall Study|November 2008|50
8455861|NCT00733408|20836938|P1|NOT COMPLETED|Overall Study||4
8455862|NCT00733408|20836938|P1|COMPLETED|Overall Study||55
8455863|NCT00733408|20836938|P1|STARTED|Overall Study||59
8455864|NCT00733369|20836950|P2|NOT COMPLETED|Overall Study||9
8455865|NCT00733369|20836951|P1|NOT COMPLETED|Overall Study||10
8455866|NCT00733369|20836950|P2|COMPLETED|Overall Study||47
8455867|NCT00733369|20836951|P1|COMPLETED|Overall Study||40
8455868|NCT00733369|20836950|P2|STARTED|Overall Study||56
8455869|NCT00733369|20836951|P1|STARTED|Overall Study||50
8455870|NCT00733356|20837067|P1|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
8455871|NCT00733356|20837067|P1|COMPLETED|Modified Lab School, Reading Evaluation||26
8455872|NCT00733356|20837067|P1|STARTED|Modified Lab School, Reading Evaluation||26
8455873|NCT00733356|20837067|P1|NOT COMPLETED|Vyvanse Dose Titration||2
8455874|NCT00733356|20837067|P1|COMPLETED|Vyvanse Dose Titration||26
8455875|NCT00733356|20837067|P1|STARTED|Vyvanse Dose Titration||28
8455876|NCT00733343|20837073|P2|NOT COMPLETED|Overall Study||81
8455877|NCT00733343|20837074|P1|NOT COMPLETED|Overall Study||83
8455878|NCT00733343|20837073|P2|COMPLETED|Overall Study||578
8455879|NCT00733343|20837074|P1|COMPLETED|Overall Study||583
8455880|NCT00733343|20837073|P2|STARTED|Overall Study||659
8455881|NCT00733343|20837074|P1|STARTED|Overall Study||666
8455882|NCT00733330|20837164|P2|NOT COMPLETED|Overall Study||4
8455883|NCT00733330|20837165|P1|NOT COMPLETED|Overall Study||2
8455884|NCT00733330|20837164|P2|COMPLETED|Overall Study||48
8455885|NCT00733330|20837165|P1|COMPLETED|Overall Study||30
8455886|NCT00733330|20837164|P2|STARTED|Overall Study||52
8455887|NCT00733330|20837165|P1|STARTED|Overall Study||32
8455888|NCT00733304|20837250|P3|NOT COMPLETED|Overall Study||5
8455889|NCT00733304|20837251|P2|NOT COMPLETED|Overall Study||3
8455890|NCT00733304|20837252|P1|NOT COMPLETED|Overall Study||7
8455891|NCT00733304|20837250|P3|COMPLETED|Overall Study||3
8455892|NCT00733304|20837251|P2|COMPLETED|Overall Study||12
8455893|NCT00733304|20837252|P1|COMPLETED|Overall Study||12
8455894|NCT00733304|20837250|P3|STARTED|Overall Study||8
8455895|NCT00733304|20837251|P2|STARTED|Overall Study||15
8455896|NCT00733304|20837252|P1|STARTED|Overall Study||19
8455897|NCT00733291|20837334|P4|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
8455898|NCT00733291|20837335|P3|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
8455899|NCT00733291|20837336|P2|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
8455900|NCT00733291|20837337|P1|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
8455901|NCT00733291|20837334|P4|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8455902|NCT00733291|20837335|P3|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8455903|NCT00733291|20837336|P2|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8455904|NCT00733291|20837337|P1|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
8455905|NCT00733291|20837334|P4|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8455906|NCT00733291|20837335|P3|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8455907|NCT00733291|20837336|P2|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
8455908|NCT00733291|20837337|P1|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
8455909|NCT00733291|20837334|P4|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
8455910|NCT00733291|20837335|P3|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
8455911|NCT00733291|20837336|P2|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
8455912|NCT00733291|20837337|P1|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
8455913|NCT00733291|20837334|P4|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
8455914|NCT00733291|20837335|P3|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
8455915|NCT00733291|20837336|P2|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
8455916|NCT00733291|20837337|P1|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
8455917|NCT00733291|20837334|P4|STARTED|Washout Period, 3 Days (+/-1 Day)||17
8455918|NCT00733291|20837335|P3|STARTED|Washout Period, 3 Days (+/-1 Day)||17
8455919|NCT00733291|20837336|P2|STARTED|Washout Period, 3 Days (+/-1 Day)||17
8455920|NCT00733291|20837337|P1|STARTED|Washout Period, 3 Days (+/-1 Day)||13
8455921|NCT00733291|20837334|P4|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
8455922|NCT00733291|20837335|P3|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
8455923|NCT00733291|20837336|P2|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
8455924|NCT00733291|20837337|P1|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
8455925|NCT00733291|20837334|P4|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
8455926|NCT00733291|20837335|P3|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
8455927|NCT00733291|20837336|P2|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
8455928|NCT00733291|20837337|P1|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
8455929|NCT00733291|20837334|P4|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
8455930|NCT00733291|20837335|P3|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
8455931|NCT00733291|20837336|P2|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
8455932|NCT00733291|20837337|P1|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
8455933|NCT00733278|20837359|P1|NOT COMPLETED|Overall Study||0
8455934|NCT00733278|20837359|P1|COMPLETED|Overall Study||7
8455935|NCT00733278|20837359|P1|STARTED|Overall Study||7
8455936|NCT00733226|20837366|P2|NOT COMPLETED|Overall Study||0
8455937|NCT00733226|20837367|P1|NOT COMPLETED|Overall Study||5
8455938|NCT00733226|20837366|P2|COMPLETED|Overall Study||40
8455939|NCT00733226|20837367|P1|COMPLETED|Overall Study||35
8455940|NCT00733226|20837366|P2|STARTED|Overall Study||40
8455941|NCT00733226|20837367|P1|STARTED|Overall Study||40
8455942|NCT00733135|20837383|P1|NOT COMPLETED|Overall Study||2
8455943|NCT00733135|20837383|P1|COMPLETED|Overall Study||131
8455944|NCT00733135|20837383|P1|STARTED|Overall Study||133
8455945|NCT00733096|20837395|P3|NOT COMPLETED|Overall Study||0
8455946|NCT00733096|20837396|P2|NOT COMPLETED|Overall Study||0
8455947|NCT00733096|20837397|P1|NOT COMPLETED|Overall Study||0
8455948|NCT00733096|20837395|P3|COMPLETED|Overall Study||30
8455949|NCT00733096|20837396|P2|COMPLETED|Overall Study||26
8455950|NCT00733096|20837397|P1|COMPLETED|Overall Study||28
8455951|NCT00733096|20837395|P3|STARTED|Overall Study||30
8455952|NCT00733096|20837396|P2|STARTED|Overall Study||26
8455953|NCT00733096|20837397|P1|STARTED|Overall Study||28
8455954|NCT00733005|20837416|P2|NOT COMPLETED|Overall Study||3
8455955|NCT00733005|20837417|P1|NOT COMPLETED|Overall Study||2
8455956|NCT00733005|20837416|P2|COMPLETED|Overall Study||159
8455957|NCT00733005|20837417|P1|COMPLETED|Overall Study||160
8455958|NCT00733005|20837416|P2|STARTED|Overall Study||162
8455959|NCT00733005|20837417|P1|STARTED|Overall Study||162
8455960|NCT00732992|20837427|P2|NOT COMPLETED|Overall Study||6
8455961|NCT00732992|20837428|P1|NOT COMPLETED|Overall Study||6
8455962|NCT00732992|20837427|P2|COMPLETED|Overall Study||0
8455963|NCT00732992|20837428|P1|COMPLETED|Overall Study||0
8455964|NCT00732992|20837427|P2|STARTED|Overall Study||6
8455965|NCT00732992|20837428|P1|STARTED|Overall Study||6
8455966|NCT00732940|20837447|P2|NOT COMPLETED|Overall Study||3
8455967|NCT00732940|20837448|P1|NOT COMPLETED|Overall Study||2
8455968|NCT00732940|20837447|P2|COMPLETED|Overall Study||25
8455969|NCT00732940|20837448|P1|COMPLETED|Overall Study||26
8455970|NCT00732940|20837447|P2|STARTED|Overall Study||28
8455971|NCT00732940|20837448|P1|STARTED|Overall Study||28
8455972|NCT00732901|20837518|P2|NOT COMPLETED|Overall Study||0
8455973|NCT00732901|20837519|P1|NOT COMPLETED|Overall Study||0
8455974|NCT00732901|20837518|P2|COMPLETED|Overall Study||12
8455975|NCT00732901|20837519|P1|COMPLETED|Overall Study||11
8455976|NCT00732901|20837518|P2|STARTED|Overall Study||12
8455977|NCT00732901|20837519|P1|STARTED|Overall Study||11
8455978|NCT00732875|20837529|P1|NOT COMPLETED|Overall Study||35
8455979|NCT00732875|20837529|P1|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
8455980|NCT00732875|20837529|P1|STARTED|Overall Study||92
8455981|NCT00732758|20837537|P2|NOT COMPLETED|Overall Study||16
8455982|NCT00732758|20837538|P1|NOT COMPLETED|Overall Study||8
8455983|NCT00732758|20837537|P2|COMPLETED|Overall Study||63
8455984|NCT00732758|20837538|P1|COMPLETED|Overall Study||70
8455985|NCT00732758|20837537|P2|STARTED|Overall Study||79
8455986|NCT00732758|20837538|P1|STARTED|Overall Study||78
8455987|NCT00732680|20837550|P1|NOT COMPLETED|Overall Study||0
8455988|NCT00732680|20837550|P1|COMPLETED|Overall Study||9
8455989|NCT00732680|20837550|P1|STARTED|Overall Study||9
8455990|NCT00732654|20837557|P3|NOT COMPLETED|Overall Study||0
8455991|NCT00732654|20837558|P2|NOT COMPLETED|Overall Study||1
8455992|NCT00732654|20837559|P1|NOT COMPLETED|Overall Study||0
8455993|NCT00732654|20837557|P3|COMPLETED|Overall Study||10
8455994|NCT00732654|20837558|P2|COMPLETED|Overall Study||9
8455995|NCT00732654|20837559|P1|COMPLETED|Overall Study||10
8455996|NCT00732654|20837557|P3|STARTED|Overall Study||10
8455997|NCT00732654|20837558|P2|STARTED|Overall Study||10
8455998|NCT00732654|20837559|P1|STARTED|Overall Study||10
8455999|NCT00732641|20837578|P2|NOT COMPLETED|Overall Study||112
8456000|NCT00732641|20837579|P1|NOT COMPLETED|Overall Study||106
8456001|NCT00732641|20837578|P2|COMPLETED|Overall Study||9
8456002|NCT00732641|20837579|P1|COMPLETED|Overall Study||17
8456003|NCT00732641|20837578|P2|STARTED|Overall Study||121
8456004|NCT00732641|20837579|P1|STARTED|Overall Study||123
8456011|NCT00732498|20837612|P1|NOT COMPLETED|Overall Study||6
8456012|NCT00732498|20837612|P1|COMPLETED|Overall Study||22
8456013|NCT00732498|20837612|P1|STARTED|Overall Study||28
8456014|NCT00732472|20837623|P4|NOT COMPLETED|Overall Study||3
8456015|NCT00732472|20837624|P3|NOT COMPLETED|Overall Study||1
8456016|NCT00732472|20837625|P2|NOT COMPLETED|Overall Study||3
8456017|NCT00732472|20837626|P1|NOT COMPLETED|Overall Study||0
8456018|NCT00732472|20837623|P4|COMPLETED|Overall Study||6
8456019|NCT00732472|20837624|P3|COMPLETED|Overall Study||9
8456020|NCT00732472|20837625|P2|COMPLETED|Overall Study||7
8456021|NCT00732472|20837626|P1|COMPLETED|Overall Study||9
8456022|NCT00732472|20837623|P4|STARTED|Overall Study||9
8456023|NCT00732472|20837624|P3|STARTED|Overall Study||10
8456024|NCT00732472|20837625|P2|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
8456025|NCT00732472|20837626|P1|STARTED|Overall Study||9
8456026|NCT00732381|20837726|P2|NOT COMPLETED|Overall Study||1
8456027|NCT00732381|20837727|P1|NOT COMPLETED|Overall Study||2
8456028|NCT00732381|20837726|P2|COMPLETED|Overall Study||174
8456029|NCT00732381|20837727|P1|COMPLETED|Overall Study||174
8456030|NCT00732381|20837726|P2|STARTED|Overall Study||175
8456031|NCT00732381|20837727|P1|STARTED|Overall Study||176
8456032|NCT00732303|20837735|P1|NOT COMPLETED|Overall Study||2
8456033|NCT00732303|20837735|P1|COMPLETED|Overall Study||6
8456034|NCT00732303|20837735|P1|STARTED|Overall Study||8
8456035|NCT00732251|20837741|P1|NOT COMPLETED|Overall Study||7
8456036|NCT00732251|20837741|P1|COMPLETED|Overall Study||1
8456037|NCT00732251|20837741|P1|STARTED|Overall Study||8
8456038|NCT00732238|20837749|P2|NOT COMPLETED|Overall Study||1
8456039|NCT00732238|20837750|P1|NOT COMPLETED|Overall Study||5
8456040|NCT00732238|20837749|P2|COMPLETED|Overall Study||27
8456041|NCT00732238|20837750|P1|COMPLETED|Overall Study||28
8456042|NCT00732238|20837749|P2|STARTED|Overall Study||28
8456043|NCT00732238|20837750|P1|STARTED|Overall Study||33
8456044|NCT00732225|20837763|P5|NOT COMPLETED|Overall Study||6
8456045|NCT00732225|20837764|P4|NOT COMPLETED|Overall Study||4
8456046|NCT00732225|20837765|P3|NOT COMPLETED|Overall Study||3
8456047|NCT00732225|20837766|P2|NOT COMPLETED|Overall Study||8
8456048|NCT00732225|20837767|P1|NOT COMPLETED|Overall Study||11
8456049|NCT00732225|20837763|P5|COMPLETED|Overall Study|48 eyes of 48 patients|48
8456050|NCT00732225|20837764|P4|COMPLETED|Overall Study|29 eyes of 29 patients|29
8456051|NCT00732225|20837765|P3|COMPLETED|Overall Study|23 eyes of 23 patients|23
8456052|NCT00732225|20837766|P2|COMPLETED|Overall Study|33 eyes of 32 patients|32
8456053|NCT00732225|20837767|P1|COMPLETED|Overall Study|64 eyes of 60 patients|60
8456054|NCT00732225|20837763|P5|STARTED|Overall Study|55 eyes of 54 patients|54
8456055|NCT00732225|20837764|P4|STARTED|Overall Study|33 eyes of 33 patients|33
8456056|NCT00732225|20837765|P3|STARTED|Overall Study|26 eyes of 26 patients|26
8456057|NCT00732225|20837766|P2|STARTED|Overall Study|41 eyes of 40 patients|40
8456058|NCT00732225|20837767|P1|STARTED|Overall Study|76 eyes of 71 patients|71
8456059|NCT00732212|20837818|P2|NOT COMPLETED|Overall Study||0
8456060|NCT00732212|20837819|P1|NOT COMPLETED|Overall Study||0
8456061|NCT00732212|20837818|P2|COMPLETED|Overall Study||123
8456062|NCT00732212|20837819|P1|COMPLETED|Overall Study||112
8456063|NCT00732212|20837818|P2|Temporarily Suspended|Overall Study||50
8456064|NCT00732212|20837819|P1|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
8456065|NCT00732212|20837818|P2|STARTED|Overall Study||123
8456066|NCT00732212|20837819|P1|STARTED|Overall Study||112
8456067|NCT00732199|20837851|P2|NOT COMPLETED|Overall Study||26
8456068|NCT00732199|20837852|P1|NOT COMPLETED|Overall Study||34
8456069|NCT00732199|20837851|P2|COMPLETED|Overall Study||16
8456070|NCT00732199|20837852|P1|COMPLETED|Overall Study||16
8456071|NCT00732199|20837851|P2|STARTED|Overall Study||42
8456072|NCT00732199|20837852|P1|STARTED|Overall Study||50
8456073|NCT00732160|20837867|P4|NOT COMPLETED|Overall Study||2
8456074|NCT00732160|20837868|P3|NOT COMPLETED|Overall Study||3
8456075|NCT00732160|20837869|P2|NOT COMPLETED|Overall Study||4
8456076|NCT00732160|20837870|P1|NOT COMPLETED|Overall Study||5
8456077|NCT00732160|20837867|P4|COMPLETED|Overall Study||3
8456078|NCT00732160|20837868|P3|COMPLETED|Overall Study||3
8456079|NCT00732160|20837869|P2|COMPLETED|Overall Study||1
8456080|NCT00732160|20837870|P1|COMPLETED|Overall Study||2
8456081|NCT00732160|20837867|P4|LS Aldosterone|Overall Study||5
8456082|NCT00732160|20837868|P3|LS Aldosterone|Overall Study||6
8456083|NCT00732160|20837869|P2|LS Aldosterone|Overall Study||1
8456084|NCT00732160|20837870|P1|LS Aldosterone|Overall Study||2
8456085|NCT00732160|20837867|P4|LS Vehicle|Overall Study||5
8456086|NCT00732160|20837868|P3|LS Vehicle|Overall Study||6
8456087|NCT00732160|20837869|P2|LS Vehicle|Overall Study||1
8456088|NCT00732160|20837870|P1|LS Vehicle|Overall Study||2
8456089|NCT00732160|20837867|P4|HS Aldosterone|Overall Study||3
8456090|NCT00732160|20837868|P3|HS Aldosterone|Overall Study||3
8456091|NCT00732160|20837869|P2|HS Aldosterone|Overall Study||5
8456092|NCT00732160|20837870|P1|HS Aldosterone|Overall Study||7
8456093|NCT00732160|20837867|P4|HS Vehicle|Overall Study||3
8456094|NCT00732160|20837868|P3|HS Vehicle|Overall Study||3
8456095|NCT00732160|20837869|P2|HS Vehicle|Overall Study||5
8456096|NCT00732160|20837870|P1|HS Vehicle|Overall Study||7
8456097|NCT00732160|20837867|P4|STARTED|Overall Study||5
8456098|NCT00732160|20837868|P3|STARTED|Overall Study||6
8456099|NCT00732160|20837869|P2|STARTED|Overall Study||5
8456100|NCT00732160|20837870|P1|STARTED|Overall Study||7
8456101|NCT00732069|20837884|P6|NOT COMPLETED|Third Study Drug||0
8456102|NCT00732069|20837885|P5|NOT COMPLETED|Third Study Drug||0
8456103|NCT00732069|20837886|P4|NOT COMPLETED|Third Study Drug||0
8456104|NCT00732069|20837887|P3|NOT COMPLETED|Third Study Drug||0
8456105|NCT00732069|20837888|P2|NOT COMPLETED|Third Study Drug||0
8456106|NCT00732069|20837889|P1|NOT COMPLETED|Third Study Drug||0
8456107|NCT00732069|20837884|P6|COMPLETED|Third Study Drug||2
8456108|NCT00732069|20837885|P5|COMPLETED|Third Study Drug||3
8456109|NCT00732069|20837886|P4|COMPLETED|Third Study Drug||2
8456110|NCT00732069|20837887|P3|COMPLETED|Third Study Drug||3
8456111|NCT00732069|20837888|P2|COMPLETED|Third Study Drug||3
8456112|NCT00732069|20837889|P1|COMPLETED|Third Study Drug||2
8456113|NCT00732069|20837884|P6|STARTED|Third Study Drug||2
8456114|NCT00732069|20837885|P5|STARTED|Third Study Drug||3
8456115|NCT00732069|20837886|P4|STARTED|Third Study Drug||2
8456116|NCT00732069|20837887|P3|STARTED|Third Study Drug||3
8456117|NCT00732069|20837888|P2|STARTED|Third Study Drug||3
8456118|NCT00732069|20837889|P1|STARTED|Third Study Drug||2
8456119|NCT00732069|20837884|P6|NOT COMPLETED|Washout After Second Study Drug||0
8456120|NCT00732069|20837885|P5|NOT COMPLETED|Washout After Second Study Drug||0
8456121|NCT00732069|20837886|P4|NOT COMPLETED|Washout After Second Study Drug||0
8456122|NCT00732069|20837887|P3|NOT COMPLETED|Washout After Second Study Drug||0
8456123|NCT00732069|20837888|P2|NOT COMPLETED|Washout After Second Study Drug||0
8456124|NCT00732069|20837889|P1|NOT COMPLETED|Washout After Second Study Drug||0
8456125|NCT00732069|20837884|P6|COMPLETED|Washout After Second Study Drug||2
8456126|NCT00732069|20837885|P5|COMPLETED|Washout After Second Study Drug||3
8456127|NCT00732069|20837886|P4|COMPLETED|Washout After Second Study Drug||2
8456128|NCT00732069|20837887|P3|COMPLETED|Washout After Second Study Drug||3
8456129|NCT00732069|20837888|P2|COMPLETED|Washout After Second Study Drug||3
8456130|NCT00732069|20837889|P1|COMPLETED|Washout After Second Study Drug||2
8456131|NCT00732069|20837884|P6|STARTED|Washout After Second Study Drug||2
8456132|NCT00732069|20837885|P5|STARTED|Washout After Second Study Drug||3
8456133|NCT00732069|20837886|P4|STARTED|Washout After Second Study Drug||2
8456134|NCT00732069|20837887|P3|STARTED|Washout After Second Study Drug||3
8456135|NCT00732069|20837888|P2|STARTED|Washout After Second Study Drug||3
8456136|NCT00732069|20837889|P1|STARTED|Washout After Second Study Drug||2
8456137|NCT00732069|20837884|P6|NOT COMPLETED|Second Study Drug||0
8456138|NCT00732069|20837885|P5|NOT COMPLETED|Second Study Drug||0
8456139|NCT00732069|20837886|P4|NOT COMPLETED|Second Study Drug||0
8456140|NCT00732069|20837887|P3|NOT COMPLETED|Second Study Drug||0
8456141|NCT00732069|20837888|P2|NOT COMPLETED|Second Study Drug||0
8456142|NCT00732069|20837889|P1|NOT COMPLETED|Second Study Drug||0
8456143|NCT00732069|20837884|P6|COMPLETED|Second Study Drug||2
8456144|NCT00732069|20837885|P5|COMPLETED|Second Study Drug||3
8456145|NCT00732069|20837886|P4|COMPLETED|Second Study Drug||2
8456146|NCT00732069|20837887|P3|COMPLETED|Second Study Drug||3
8456147|NCT00732069|20837888|P2|COMPLETED|Second Study Drug||3
8456148|NCT00732069|20837889|P1|COMPLETED|Second Study Drug||2
8456149|NCT00732069|20837884|P6|STARTED|Second Study Drug||2
8456150|NCT00732069|20837885|P5|STARTED|Second Study Drug||3
8456151|NCT00732069|20837886|P4|STARTED|Second Study Drug||2
8456152|NCT00732069|20837887|P3|STARTED|Second Study Drug||3
8456153|NCT00732069|20837888|P2|STARTED|Second Study Drug||3
8456154|NCT00732069|20837889|P1|STARTED|Second Study Drug||2
8456155|NCT00732069|20837884|P6|NOT COMPLETED|Washout After First Study Drug||0
8456156|NCT00732069|20837885|P5|NOT COMPLETED|Washout After First Study Drug||0
8456157|NCT00732069|20837886|P4|NOT COMPLETED|Washout After First Study Drug||0
8456158|NCT00732069|20837887|P3|NOT COMPLETED|Washout After First Study Drug||0
8456159|NCT00732069|20837888|P2|NOT COMPLETED|Washout After First Study Drug||0
8456160|NCT00732069|20837889|P1|NOT COMPLETED|Washout After First Study Drug||1
8456161|NCT00732069|20837884|P6|COMPLETED|Washout After First Study Drug||2
8456162|NCT00732069|20837885|P5|COMPLETED|Washout After First Study Drug||3
8456163|NCT00732069|20837886|P4|COMPLETED|Washout After First Study Drug||2
8456164|NCT00732069|20837887|P3|COMPLETED|Washout After First Study Drug||3
8456165|NCT00732069|20837888|P2|COMPLETED|Washout After First Study Drug||3
8456166|NCT00732069|20837889|P1|COMPLETED|Washout After First Study Drug||2
8456167|NCT00732069|20837884|P6|STARTED|Washout After First Study Drug||2
8456168|NCT00732069|20837885|P5|STARTED|Washout After First Study Drug||3
8456169|NCT00732069|20837886|P4|STARTED|Washout After First Study Drug||2
8456170|NCT00732069|20837887|P3|STARTED|Washout After First Study Drug||3
8456171|NCT00732069|20837888|P2|STARTED|Washout After First Study Drug||3
8456172|NCT00732069|20837889|P1|STARTED|Washout After First Study Drug||3
8456173|NCT00732069|20837884|P6|NOT COMPLETED|First Study Drug||0
8456174|NCT00732069|20837885|P5|NOT COMPLETED|First Study Drug||0
8456175|NCT00732069|20837886|P4|NOT COMPLETED|First Study Drug||0
8456176|NCT00732069|20837887|P3|NOT COMPLETED|First Study Drug||0
8456177|NCT00732069|20837888|P2|NOT COMPLETED|First Study Drug||0
8456178|NCT00732069|20837889|P1|NOT COMPLETED|First Study Drug||0
8456179|NCT00732069|20837884|P6|COMPLETED|First Study Drug||2
8456180|NCT00732069|20837885|P5|COMPLETED|First Study Drug||3
8456181|NCT00732069|20837886|P4|COMPLETED|First Study Drug||2
8456182|NCT00732069|20837887|P3|COMPLETED|First Study Drug||3
8456183|NCT00732069|20837888|P2|COMPLETED|First Study Drug||3
8456184|NCT00732069|20837889|P1|COMPLETED|First Study Drug||3
8456185|NCT00732069|20837884|P6|STARTED|First Study Drug||2
8456186|NCT00732069|20837885|P5|STARTED|First Study Drug||3
8456187|NCT00732069|20837886|P4|STARTED|First Study Drug||2
8456188|NCT00732069|20837887|P3|STARTED|First Study Drug||3
8456189|NCT00732069|20837888|P2|STARTED|First Study Drug||3
8456190|NCT00732069|20837889|P1|STARTED|First Study Drug||3
8456191|NCT00732030|20837900|P1|NOT COMPLETED|Overall Study||2
8456192|NCT00732030|20837900|P1|COMPLETED|Overall Study||24
8456193|NCT00732030|20837900|P1|STARTED|Overall Study||26
8456194|NCT00731939|20837907|P1|NOT COMPLETED|Overall Study||34
8456195|NCT00731939|20837907|P1|COMPLETED|Overall Study||90
8456196|NCT00731939|20837907|P1|STARTED|Overall Study||124
8456197|NCT00731874|20837957|P2|NOT COMPLETED|Overall Study||0
8456198|NCT00731874|20837958|P1|NOT COMPLETED|Overall Study||0
8456199|NCT00731874|20837957|P2|COMPLETED|Overall Study||13
8456200|NCT00731874|20837958|P1|COMPLETED|Overall Study||10
8456201|NCT00731874|20837957|P2|STARTED|Overall Study||13
8456202|NCT00731874|20837958|P1|STARTED|Overall Study||10
8456203|NCT00731822|20837984|P2|NOT COMPLETED|Overall Study||1
8456204|NCT00731822|20837985|P1|NOT COMPLETED|Overall Study||4
8456205|NCT00731822|20837984|P2|COMPLETED|Overall Study||39
8456206|NCT00731822|20837985|P1|COMPLETED|Overall Study||16
8456207|NCT00731822|20837984|P2|STARTED|Overall Study||40
8456208|NCT00731822|20837985|P1|STARTED|Overall Study||20
8456209|NCT00731783|20837999|P2|NOT COMPLETED|12 Month Follow-Up Visit||7
8456210|NCT00731783|20838000|P1|NOT COMPLETED|12 Month Follow-Up Visit||6
8456211|NCT00731783|20837999|P2|COMPLETED|12 Month Follow-Up Visit||58
8456212|NCT00731783|20838000|P1|COMPLETED|12 Month Follow-Up Visit||68
8456213|NCT00731783|20837999|P2|STARTED|12 Month Follow-Up Visit||65
8456214|NCT00731783|20838000|P1|STARTED|12 Month Follow-Up Visit||74
8456215|NCT00731783|20837999|P2|NOT COMPLETED|Six Month Follow-Up Visit||3
8456216|NCT00731783|20838000|P1|NOT COMPLETED|Six Month Follow-Up Visit||6
8456217|NCT00731783|20837999|P2|COMPLETED|Six Month Follow-Up Visit||64
8456218|NCT00731783|20838000|P1|COMPLETED|Six Month Follow-Up Visit||71
8456219|NCT00731783|20837999|P2|STARTED|Six Month Follow-Up Visit||67
8456220|NCT00731783|20838000|P1|STARTED|Six Month Follow-Up Visit||77
8456221|NCT00731783|20837999|P2|NOT COMPLETED|Three Month Follow-Up Visit||16
8456222|NCT00731783|20838000|P1|NOT COMPLETED|Three Month Follow-Up Visit||7
8456223|NCT00731783|20837999|P2|COMPLETED|Three Month Follow-Up Visit||57
8456224|NCT00731783|20838000|P1|COMPLETED|Three Month Follow-Up Visit||72
8456225|NCT00731783|20837999|P2|STARTED|Three Month Follow-Up Visit||73
8456226|NCT00731783|20838000|P1|STARTED|Three Month Follow-Up Visit||79
8456227|NCT00731783|20837999|P2|NOT COMPLETED|One Month Follow-Up Visit||22
8456228|NCT00731783|20838000|P1|NOT COMPLETED|One Month Follow-Up Visit||14
8456229|NCT00731783|20837999|P2|COMPLETED|One Month Follow-Up Visit||69
8456230|NCT00731783|20838000|P1|COMPLETED|One Month Follow-Up Visit||78
8456231|NCT00731783|20837999|P2|STARTED|One Month Follow-Up Visit||91
8456232|NCT00731783|20838000|P1|STARTED|One Month Follow-Up Visit||92
8456233|NCT00731770|20838022|P2|NOT COMPLETED|Overall Study||0
8456234|NCT00731770|20838023|P1|NOT COMPLETED|Overall Study||0
8456235|NCT00731770|20838022|P2|COMPLETED|Overall Study||5
8456236|NCT00731770|20838023|P1|COMPLETED|Overall Study||5
8456237|NCT00731770|20838022|P2|STARTED|Overall Study||5
8456238|NCT00731770|20838023|P1|STARTED|Overall Study||5
8456248|NCT00731692|20838054|P3|NOT COMPLETED|Extension Phase||301
8456249|NCT00731692|20838055|P2|NOT COMPLETED|Extension Phase||196
8456250|NCT00731692|20838056|P1|NOT COMPLETED|Extension Phase||74
8456251|NCT00731692|20838054|P3|COMPLETED|Extension Phase||0
8456252|NCT00731692|20838055|P2|COMPLETED|Extension Phase||0
8456253|NCT00731692|20838056|P1|COMPLETED|Extension Phase||0
8456254|NCT00731692|20838054|P3|STARTED|Extension Phase||301
8456255|NCT00731692|20838055|P2|STARTED|Extension Phase||196
8456256|NCT00731692|20838056|P1|STARTED|Extension Phase||74
8456257|NCT00731692|20838054|P3|NOT COMPLETED|Core Study (36 Months)||170
8456258|NCT00731692|20838055|P2|NOT COMPLETED|Core Study (36 Months)||116
8456259|NCT00731692|20838056|P1|NOT COMPLETED|Core Study (36 Months)||68
8456260|NCT00731692|20838054|P3|COMPLETED|Core Study (36 Months)||317
8456261|NCT00731692|20838055|P2|COMPLETED|Core Study (36 Months)||220
8456262|NCT00731692|20838056|P1|COMPLETED|Core Study (36 Months)||79
8456263|NCT00731692|20838054|P3|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
8456264|NCT00731692|20838055|P2|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
8456265|NCT00731692|20838056|P1|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
8456266|NCT00731692|20838054|P3|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
8456267|NCT00731692|20838055|P2|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
8456268|NCT00731692|20838056|P1|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
8456269|NCT00731692|20838054|P3|Full Analysis Set (FAS)|Core Study (36 Months)||487
8456270|NCT00731692|20838055|P2|Full Analysis Set (FAS)|Core Study (36 Months)||336
8456271|NCT00731692|20838056|P1|Full Analysis Set (FAS)|Core Study (36 Months)||0
8456272|NCT00731692|20838054|P3|Safety Set (SAF)|Core Study (36 Months)||487
8456273|NCT00731692|20838055|P2|Safety Set (SAF)|Core Study (36 Months)||336
8456274|NCT00731692|20838056|P1|Safety Set (SAF)|Core Study (36 Months)||0
8456275|NCT00731692|20838054|P3|STARTED|Core Study (36 Months)||487
8456276|NCT00731692|20838055|P2|STARTED|Core Study (36 Months)||336
8456277|NCT00731692|20838056|P1|STARTED|Core Study (36 Months)||147
8456278|NCT00731679|20838102|P2|NOT COMPLETED|Overall Study||26
8456279|NCT00731679|20838103|P1|NOT COMPLETED|Overall Study||22
8456280|NCT00731679|20838102|P2|COMPLETED|Overall Study||283
8456281|NCT00731679|20838103|P1|COMPLETED|Overall Study||292
8456282|NCT00731679|20838102|P2|STARTED|Overall Study||309
8456283|NCT00731679|20838103|P1|STARTED|Overall Study||314
8456284|NCT00731666|20838111|P1|NOT COMPLETED|Overall Study||12
8456285|NCT00731666|20838111|P1|COMPLETED|Overall Study||28
8456286|NCT00731666|20838111|P1|STARTED|Overall Study||40
8456287|NCT00731653|20838117|P1|NOT COMPLETED|Overall Study||9
8456288|NCT00731653|20838117|P1|COMPLETED|Overall Study||72
8456289|NCT00731653|20838117|P1|STARTED|Overall Study||81
8456290|NCT00731640|20838123|P2|NOT COMPLETED|Overall Study||0
8456291|NCT00731640|20838124|P1|NOT COMPLETED|Overall Study||0
8456292|NCT00731640|20838123|P2|COMPLETED|Overall Study||32
8456293|NCT00731640|20838124|P1|COMPLETED|Overall Study||20
8456294|NCT00731640|20838123|P2|STARTED|Overall Study||32
8456295|NCT00731640|20838124|P1|STARTED|Overall Study||20
8456296|NCT00731614|20838138|P2|NOT COMPLETED|Overall Study||13
8456297|NCT00731614|20838139|P1|NOT COMPLETED|Overall Study||7
8456298|NCT00731614|20838138|P2|COMPLETED|Overall Study||18
8456299|NCT00731614|20838139|P1|COMPLETED|Overall Study||16
8456300|NCT00731614|20838138|P2|12 Weeks Posttreatment|Overall Study||23
8456301|NCT00731614|20838139|P1|12 Weeks Posttreatment|Overall Study||18
8456302|NCT00731614|20838138|P2|End of Treatment|Overall Study||24
8456303|NCT00731614|20838139|P1|End of Treatment|Overall Study||16
8456304|NCT00731614|20838138|P2|STARTED|Overall Study||31
8456305|NCT00731614|20838139|P1|STARTED|Overall Study||23
8456306|NCT00731549|20838147|P1|NOT COMPLETED|Overall Study||223
8456307|NCT00731549|20838147|P1|COMPLETED|Overall Study||858
8456308|NCT00731549|20838147|P1|STARTED|Overall Study||1081
8456309|NCT00731484|20838160|P1|NOT COMPLETED|Overall Study||0
8456310|NCT00731484|20838160|P1|COMPLETED|Overall Study||233
8456311|NCT00731484|20838160|P1|STARTED|Overall Study||233
8456315|NCT00731211|20838173|P1|NOT COMPLETED|Overall Study||0
8456316|NCT00731211|20838173|P1|COMPLETED|Overall Study||55
8456317|NCT00731211|20838173|P1|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
8456318|NCT00731198|20838180|P2|NOT COMPLETED|Overall Study||6
8456319|NCT00731198|20838181|P1|NOT COMPLETED|Overall Study||6
8456320|NCT00731198|20838180|P2|COMPLETED|Overall Study||319
8456321|NCT00731198|20838181|P1|COMPLETED|Overall Study||319
8456322|NCT00731198|20838180|P2|STARTED|Overall Study||325
8456323|NCT00731198|20838181|P1|STARTED|Overall Study||325
8456324|NCT00731133|20838187|P1|NOT COMPLETED|Overall Study||10
8456325|NCT00731133|20838187|P1|COMPLETED|Overall Study||5
8456326|NCT00731133|20838187|P1|STARTED|Overall Study||15
8456327|NCT00731120|20838195|P3|NOT COMPLETED|Overall Study||36
8456328|NCT00731120|20838196|P2|NOT COMPLETED|Overall Study||43
8456329|NCT00731120|20838197|P1|NOT COMPLETED|Overall Study||42
8456330|NCT00731120|20838195|P3|COMPLETED|Overall Study||116
8456331|NCT00731120|20838196|P2|COMPLETED|Overall Study||109
8456332|NCT00731120|20838197|P1|COMPLETED|Overall Study||111
8456333|NCT00731120|20838195|P3|Treated|Overall Study||152
8456334|NCT00731120|20838196|P2|Treated|Overall Study||151
8456335|NCT00731120|20838197|P1|Treated|Overall Study||153
8456336|NCT00731120|20838195|P3|STARTED|Overall Study||152
8456337|NCT00731120|20838196|P2|STARTED|Overall Study||152
8456338|NCT00731120|20838197|P1|STARTED|Overall Study||153
8456339|NCT00731094|20838234|P2|NOT COMPLETED|Overall Study||11
8456340|NCT00731094|20838235|P1|NOT COMPLETED|Overall Study||18
8456341|NCT00731094|20838234|P2|COMPLETED|Overall Study||105
8456342|NCT00731094|20838235|P1|COMPLETED|Overall Study||98
8456343|NCT00731094|20838234|P2|Month 6|Overall Study||107
8456344|NCT00731094|20838235|P1|Month 6|Overall Study||101
8456345|NCT00731094|20838234|P2|STARTED|Overall Study||116
8456346|NCT00731094|20838235|P1|STARTED|Overall Study||116
8456347|NCT00731055|20838305|P1|NOT COMPLETED|Overall Study||0
8456348|NCT00731055|20838305|P1|COMPLETED|Overall Study||16
8456349|NCT00731055|20838305|P1|Received Varenicline 2.0 mg|Overall Study||16
8456350|NCT00731055|20838305|P1|Received Varenicline 1.0 mg|Overall Study||16
8456351|NCT00731055|20838305|P1|Received Varenicline 0.5 mg|Overall Study||16
8456352|NCT00731055|20838305|P1|Received Placebo|Overall Study||16
8456353|NCT00731055|20838305|P1|STARTED|Overall Study|This is a within-subjects study design.|16
8456354|NCT00731042|20838314|P2|NOT COMPLETED|Second Intervention||2
8456355|NCT00731042|20838315|P1|NOT COMPLETED|Second Intervention||0
8456356|NCT00731042|20838314|P2|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
8456357|NCT00731042|20838315|P1|COMPLETED|Second Intervention||16
8456358|NCT00731042|20838314|P2|STARTED|Second Intervention||17
8456359|NCT00731042|20838315|P1|STARTED|Second Intervention||16
8456360|NCT00731042|20838314|P2|NOT COMPLETED|Wash-out||0
8456361|NCT00731042|20838315|P1|NOT COMPLETED|Wash-out||0
8456362|NCT00731042|20838314|P2|COMPLETED|Wash-out||17
8456363|NCT00731042|20838315|P1|COMPLETED|Wash-out||16
8456364|NCT00731042|20838314|P2|STARTED|Wash-out||17
8456365|NCT00731042|20838315|P1|STARTED|Wash-out||16
8456366|NCT00731042|20838314|P2|NOT COMPLETED|First Intervention||0
8456367|NCT00731042|20838315|P1|NOT COMPLETED|First Intervention||0
8456368|NCT00731042|20838314|P2|COMPLETED|First Intervention||17
8456369|NCT00731042|20838315|P1|COMPLETED|First Intervention||16
8456370|NCT00731042|20838314|P2|STARTED|First Intervention||17
8456371|NCT00731042|20838315|P1|STARTED|First Intervention||16
8456372|NCT00730964|20838321|P1|NOT COMPLETED|Overall Study||0
8456373|NCT00730964|20838321|P1|COMPLETED|Overall Study||1039
8456374|NCT00730964|20838321|P1|STARTED|Overall Study||1039
8456375|NCT00730925|20838326|P1|NOT COMPLETED|Overall Study||41
8456376|NCT00730925|20838326|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
8456377|NCT00730925|20838326|P1|STARTED|Overall Study||41
8456378|NCT00730912|20838336|P3|NOT COMPLETED|Overall Study||1
8456379|NCT00730912|20838337|P2|NOT COMPLETED|Overall Study||0
8456380|NCT00730912|20838338|P1|NOT COMPLETED|Overall Study||0
8456381|NCT00730912|20838336|P3|COMPLETED|Overall Study||103
8456382|NCT00730912|20838337|P2|COMPLETED|Overall Study||104
8456383|NCT00730912|20838338|P1|COMPLETED|Overall Study||53
8456384|NCT00730912|20838336|P3|STARTED|Overall Study||104
8456385|NCT00730912|20838337|P2|STARTED|Overall Study||104
8456386|NCT00730912|20838338|P1|STARTED|Overall Study||53
8456387|NCT00730886|20838351|P2|NOT COMPLETED|Overall Study||0
8456388|NCT00730886|20838352|P1|NOT COMPLETED|Overall Study||2
8456389|NCT00730886|20838351|P2|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
8456390|NCT00730886|20838352|P1|COMPLETED|Overall Study||0
8456391|NCT00730886|20838351|P2|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
8456392|NCT00730886|20838352|P1|STARTED|Overall Study||2
8456393|NCT00730847|20838376|P1|NOT COMPLETED|Overall Study||131
8456394|NCT00730847|20838376|P1|COMPLETED|Overall Study||465
8456395|NCT00730847|20838376|P1|STARTED|Overall Study||596
8456396|NCT00730756|20838385|P2|NOT COMPLETED|Overall Study||5
8456397|NCT00730756|20838386|P1|NOT COMPLETED|Overall Study||4
8456398|NCT00730756|20838385|P2|COMPLETED|Overall Study||48
8456399|NCT00730756|20838386|P1|COMPLETED|Overall Study||45
8456400|NCT00730756|20838385|P2|STARTED|Overall Study||53
8456401|NCT00730756|20838386|P1|STARTED|Overall Study||49
8456402|NCT00730730|20838408|P1|NOT COMPLETED|Overall Study||0
8456403|NCT00730730|20838408|P1|COMPLETED|Overall Study||50
8456404|NCT00730730|20838408|P1|STARTED|Overall Study||50
8456405|NCT00730691|20838420|P5|NOT COMPLETED|Overall Study||50
8456406|NCT00730691|20838421|P4|NOT COMPLETED|Overall Study||45
8456407|NCT00730691|20838422|P3|NOT COMPLETED|Overall Study||39
8456408|NCT00730691|20838423|P2|NOT COMPLETED|Overall Study||36
8456409|NCT00730691|20838424|P1|NOT COMPLETED|Overall Study||36
8456410|NCT00730691|20838420|P5|COMPLETED|Overall Study||106
8456411|NCT00730691|20838421|P4|COMPLETED|Overall Study||111
8456412|NCT00730691|20838422|P3|COMPLETED|Overall Study||117
8456413|NCT00730691|20838423|P2|COMPLETED|Overall Study||120
8456414|NCT00730691|20838424|P1|COMPLETED|Overall Study||121
8456415|NCT00730691|20838420|P5|STARTED|Overall Study||156
8456416|NCT00730691|20838421|P4|STARTED|Overall Study||156
8456417|NCT00730691|20838422|P3|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
8456418|NCT00730691|20838423|P2|STARTED|Overall Study||156
8456419|NCT00730691|20838424|P1|STARTED|Overall Study||157
8456420|NCT00730639|20838516|P5|NOT COMPLETED|Overall Study||131
8456421|NCT00730639|20838517|P4|NOT COMPLETED|Overall Study||54
8456422|NCT00730639|20838518|P3|NOT COMPLETED|Overall Study||86
8456423|NCT00730639|20838519|P2|NOT COMPLETED|Overall Study||18
8456424|NCT00730639|20838520|P1|NOT COMPLETED|Overall Study||17
8456425|NCT00730639|20838516|P5|COMPLETED|Overall Study||0
8456426|NCT00730639|20838517|P4|COMPLETED|Overall Study||0
8456427|NCT00730639|20838518|P3|COMPLETED|Overall Study||0
8456428|NCT00730639|20838519|P2|COMPLETED|Overall Study||0
8456429|NCT00730639|20838520|P1|COMPLETED|Overall Study||0
8456430|NCT00730639|20838516|P5|STARTED|Overall Study||131
8456431|NCT00730639|20838517|P4|STARTED|Overall Study||54
8456432|NCT00730639|20838518|P3|STARTED|Overall Study||86
8456433|NCT00730639|20838519|P2|STARTED|Overall Study||18
8456434|NCT00730639|20838520|P1|STARTED|Overall Study||17
8456435|NCT00730522|20838586|P2|NOT COMPLETED|Overall Study||0
8456436|NCT00730522|20838587|P1|NOT COMPLETED|Overall Study||0
8456437|NCT00730522|20838586|P2|COMPLETED|Overall Study||27
8456438|NCT00730522|20838587|P1|COMPLETED|Overall Study||28
8456439|NCT00730522|20838586|P2|STARTED|Overall Study||27
8456440|NCT00730522|20838587|P1|STARTED|Overall Study||28
8456441|NCT00730483|20838595|P1|NOT COMPLETED|Overall Study||7
8456442|NCT00730483|20838595|P1|COMPLETED|Overall Study||6
8456443|NCT00730483|20838595|P1|6 Months After First DEB-TACE|Overall Study||10
8456444|NCT00730483|20838595|P1|1 Month After First DEB-TACE|Overall Study||13
8456445|NCT00730483|20838595|P1|STARTED|Overall Study||13
8456446|NCT00730405|20838608|P5|NOT COMPLETED|Overall Study-follow-up Phase||22
8456447|NCT00730405|20838609|P4|NOT COMPLETED|Overall Study-follow-up Phase||17
8456448|NCT00730405|20838610|P3|NOT COMPLETED|Overall Study-follow-up Phase||23
8456449|NCT00730405|20838611|P2|NOT COMPLETED|Overall Study-follow-up Phase||21
8456450|NCT00730405|20838612|P1|NOT COMPLETED|Overall Study-follow-up Phase||21
8456451|NCT00730405|20838608|P5|COMPLETED|Overall Study-follow-up Phase||93
8456452|NCT00730405|20838609|P4|COMPLETED|Overall Study-follow-up Phase||100
8456453|NCT00730405|20838610|P3|COMPLETED|Overall Study-follow-up Phase||94
8456454|NCT00730405|20838611|P2|COMPLETED|Overall Study-follow-up Phase||96
8456455|NCT00730405|20838612|P1|COMPLETED|Overall Study-follow-up Phase||95
8456456|NCT00730405|20838608|P5|STARTED|Overall Study-follow-up Phase||115
8456457|NCT00730405|20838609|P4|STARTED|Overall Study-follow-up Phase||117
8456458|NCT00730405|20838610|P3|STARTED|Overall Study-follow-up Phase||117
8456459|NCT00730405|20838611|P2|STARTED|Overall Study-follow-up Phase||117
8456460|NCT00730405|20838612|P1|STARTED|Overall Study-follow-up Phase||116
8456461|NCT00730405|20838608|P5|NOT COMPLETED|Overall Study-Treatment Phase||20
8456462|NCT00730405|20838609|P4|NOT COMPLETED|Overall Study-Treatment Phase||19
8456463|NCT00730405|20838610|P3|NOT COMPLETED|Overall Study-Treatment Phase||21
8456464|NCT00730405|20838611|P2|NOT COMPLETED|Overall Study-Treatment Phase||21
8456465|NCT00730405|20838612|P1|NOT COMPLETED|Overall Study-Treatment Phase||19
8456466|NCT00730405|20838608|P5|COMPLETED|Overall Study-Treatment Phase||95
8456467|NCT00730405|20838609|P4|COMPLETED|Overall Study-Treatment Phase||98
8456468|NCT00730405|20838610|P3|COMPLETED|Overall Study-Treatment Phase||96
8456469|NCT00730405|20838611|P2|COMPLETED|Overall Study-Treatment Phase||96
8456470|NCT00730405|20838612|P1|COMPLETED|Overall Study-Treatment Phase||97
8456471|NCT00730405|20838608|P5|STARTED|Overall Study-Treatment Phase||115
8456472|NCT00730405|20838609|P4|STARTED|Overall Study-Treatment Phase||117
8456473|NCT00730405|20838610|P3|STARTED|Overall Study-Treatment Phase||117
8456474|NCT00730405|20838611|P2|STARTED|Overall Study-Treatment Phase||117
8456475|NCT00730405|20838612|P1|STARTED|Overall Study-Treatment Phase||116
8456476|NCT00730353|20838649|P1|NOT COMPLETED|Overall Study||0
8456477|NCT00730353|20838649|P1|COMPLETED|Overall Study||28
8456478|NCT00730353|20838649|P1|STARTED|Overall Study||28
8456479|NCT00730327|20838659|P2|NOT COMPLETED|Overall Study||37
8456480|NCT00730327|20838660|P1|NOT COMPLETED|Overall Study||27
8456481|NCT00730327|20838659|P2|COMPLETED|Overall Study||93
8456482|NCT00730327|20838660|P1|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
8456483|NCT00730327|20838659|P2|Completed Week 26|Overall Study||99
8456484|NCT00730327|20838660|P1|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
8456485|NCT00730327|20838659|P2|STARTED|Overall Study||130
8456486|NCT00730327|20838660|P1|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
8456487|NCT00730275|20838685|P4|NOT COMPLETED|Overall Study||1
8456488|NCT00730275|20838686|P3|NOT COMPLETED|Overall Study||0
8456489|NCT00730275|20838687|P2|NOT COMPLETED|Overall Study||0
8456490|NCT00730275|20838688|P1|NOT COMPLETED|Overall Study||0
8456491|NCT00730275|20838685|P4|COMPLETED|Overall Study||8
8456492|NCT00730275|20838686|P3|COMPLETED|Overall Study||8
8456493|NCT00730275|20838687|P2|COMPLETED|Overall Study||9
8456494|NCT00730275|20838688|P1|COMPLETED|Overall Study||9
8456495|NCT00730275|20838685|P4|STARTED|Overall Study||9
8456496|NCT00730275|20838686|P3|STARTED|Overall Study||8
8456497|NCT00730275|20838687|P2|STARTED|Overall Study||9
8456498|NCT00730275|20838688|P1|STARTED|Overall Study||9
8456499|NCT00730236|20838714|P1|NOT COMPLETED|Overall Study||6
8456500|NCT00730236|20838714|P1|COMPLETED|Overall Study||23
8456501|NCT00730236|20838714|P1|STARTED|Overall Study||29
8456502|NCT00730171|20838729|P1|NOT COMPLETED|Overall Study||771
8456503|NCT00730171|20838729|P1|COMPLETED|Overall Study||954
8456504|NCT00730171|20838729|P1|IBS-C Safety Population|Overall Study||1119
8456505|NCT00730171|20838729|P1|CC Safety Population|Overall Study||607
8456506|NCT00730171|20838729|P1|STARTED|Overall Study||1725
8456507|NCT00730158|20838739|P2|NOT COMPLETED|Overall Study||1
8456508|NCT00730158|20838740|P1|NOT COMPLETED|Overall Study||1
8456509|NCT00730158|20838739|P2|COMPLETED|Overall Study||15
8456510|NCT00730158|20838740|P1|COMPLETED|Overall Study||16
8456511|NCT00730158|20838739|P2|STARTED|Overall Study||16
8456512|NCT00730158|20838740|P1|STARTED|Overall Study||17
8456513|NCT00730132|20838778|P1|NOT COMPLETED|Overall Study||155
8456514|NCT00730132|20838778|P1|COMPLETED|Overall Study||557
8456515|NCT00730132|20838778|P1|STARTED|Overall Study||712
8456516|NCT00730041|20838796|P2|NOT COMPLETED|Overall Study||2
8456517|NCT00730041|20838797|P1|NOT COMPLETED|Overall Study||0
8456518|NCT00730041|20838796|P2|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
8456519|NCT00730041|20838797|P1|COMPLETED|Overall Study||26
8456520|NCT00730041|20838796|P2|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
8456521|NCT00730041|20838797|P1|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
8456522|NCT00730028|20838820|P5|NOT COMPLETED|Overall Study||82
8456523|NCT00730028|20838821|P4|NOT COMPLETED|Overall Study||56
8456524|NCT00730028|20838822|P3|NOT COMPLETED|Overall Study||45
8456525|NCT00730028|20838823|P2|NOT COMPLETED|Overall Study||66
8456526|NCT00730028|20838824|P1|NOT COMPLETED|Overall Study||60
8456527|NCT00730028|20838820|P5|COMPLETED|Overall Study||175
8456528|NCT00730028|20838821|P4|COMPLETED|Overall Study||207
8456529|NCT00730028|20838822|P3|COMPLETED|Overall Study||221
8456530|NCT00730028|20838823|P2|COMPLETED|Overall Study||194
8456531|NCT00730028|20838824|P1|COMPLETED|Overall Study||204
8456532|NCT00730028|20838820|P5|STARTED|Overall Study||257
8456533|NCT00730028|20838821|P4|STARTED|Overall Study||263
8456534|NCT00730028|20838822|P3|STARTED|Overall Study||266
8456535|NCT00730028|20838823|P2|STARTED|Overall Study||260
8456536|NCT00730028|20838824|P1|STARTED|Overall Study||264
8456537|NCT00730015|20838874|P3|NOT COMPLETED|Overall Study||32
8456538|NCT00730015|20838875|P2|NOT COMPLETED|Overall Study||40
8456539|NCT00730015|20838876|P1|NOT COMPLETED|Overall Study||31
8456540|NCT00730015|20838874|P3|COMPLETED|Overall Study||177
8456541|NCT00730015|20838875|P2|COMPLETED|Overall Study||177
8456542|NCT00730015|20838876|P1|COMPLETED|Overall Study||186
8456543|NCT00730015|20838874|P3|STARTED|Overall Study||209
8456544|NCT00730015|20838875|P2|STARTED|Overall Study||217
8456545|NCT00730015|20838876|P1|STARTED|Overall Study||217
8456546|NCT00729937|20838916|P6|NOT COMPLETED|Overall Study||37
8456547|NCT00729937|20838917|P5|NOT COMPLETED|Overall Study||28
8456548|NCT00729937|20838918|P4|NOT COMPLETED|Overall Study||34
8456549|NCT00729937|20838919|P3|NOT COMPLETED|Overall Study||29
8456550|NCT00729937|20838920|P2|NOT COMPLETED|Overall Study||88
8456551|NCT00729937|20838921|P1|NOT COMPLETED|Overall Study||74
8456552|NCT00729937|20838916|P6|COMPLETED|Overall Study||214
8456553|NCT00729937|20838917|P5|COMPLETED|Overall Study||221
8456554|NCT00729937|20838918|P4|COMPLETED|Overall Study||215
8456555|NCT00729937|20838919|P3|COMPLETED|Overall Study||222
8456556|NCT00729937|20838920|P2|COMPLETED|Overall Study||548
8456557|NCT00729937|20838921|P1|COMPLETED|Overall Study||555
8456558|NCT00729937|20838916|P6|STARTED|Overall Study||251
8456559|NCT00729937|20838917|P5|STARTED|Overall Study||249
8456560|NCT00729937|20838918|P4|STARTED|Overall Study||249
8456561|NCT00729937|20838919|P3|STARTED|Overall Study||251
8456562|NCT00729937|20838920|P2|STARTED|Overall Study||636
8456563|NCT00729937|20838921|P1|STARTED|Overall Study||629
8456564|NCT00729924|20839115|P1|NOT COMPLETED|Overall Study||0
8456565|NCT00729924|20839115|P1|COMPLETED|Overall Study||40
8456566|NCT00729924|20839115|P1|STARTED|Overall Study||40
8456567|NCT00729859|20839125|P3|NOT COMPLETED|Overall Study||0
8456568|NCT00729859|20839126|P2|NOT COMPLETED|Overall Study||2
8456569|NCT00729859|20839127|P1|NOT COMPLETED|Overall Study||0
8456570|NCT00729859|20839125|P3|COMPLETED|Overall Study||8
8456571|NCT00729859|20839126|P2|COMPLETED|Overall Study||6
8456572|NCT00729859|20839127|P1|COMPLETED|Overall Study||8
8456573|NCT00729859|20839125|P3|STARTED|Overall Study||8
8456574|NCT00729859|20839126|P2|STARTED|Overall Study||8
8456575|NCT00729859|20839127|P1|STARTED|Overall Study||8
8456576|NCT00729846|20839164|P2|NOT COMPLETED|Overall Study||0
8456577|NCT00729846|20839165|P1|NOT COMPLETED|Overall Study||0
8456578|NCT00729846|20839164|P2|COMPLETED|Overall Study||11
8456579|NCT00729846|20839165|P1|COMPLETED|Overall Study||11
8456580|NCT00729846|20839164|P2|STARTED|Overall Study||11
8456581|NCT00729846|20839165|P1|STARTED|Overall Study||11
8456582|NCT00729833|20839171|P4|NOT COMPLETED|Overall Study||6
8456583|NCT00729833|20839172|P3|NOT COMPLETED|Overall Study||12
8456584|NCT00729833|20839173|P2|NOT COMPLETED|Overall Study||7
8456585|NCT00729833|20839174|P1|NOT COMPLETED|Overall Study||20
8456586|NCT00729833|20839171|P4|COMPLETED|Overall Study||0
8456587|NCT00729833|20839172|P3|COMPLETED|Overall Study||0
8456588|NCT00729833|20839173|P2|COMPLETED|Overall Study||0
8456589|NCT00729833|20839174|P1|COMPLETED|Overall Study||0
8456590|NCT00729833|20839171|P4|STARTED|Overall Study||6
8456591|NCT00729833|20839172|P3|STARTED|Overall Study||12
8456592|NCT00729833|20839173|P2|STARTED|Overall Study||7
8456593|NCT00729833|20839174|P1|STARTED|Overall Study||20
8456594|NCT00729807|20839213|P1|NOT COMPLETED|Overall Study||0
8456595|NCT00729807|20839213|P1|COMPLETED|Overall Study||6
8456596|NCT00729807|20839213|P1|STARTED|Overall Study||6
8456597|NCT00729781|20839223|P1|NOT COMPLETED|Long-term Follow-up Study||0
8456598|NCT00729781|20839223|P1|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
8456599|NCT00729781|20839223|P1|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
8456600|NCT00729781|20839223|P1|NOT COMPLETED|Original Study||0
8456601|NCT00729781|20839223|P1|COMPLETED|Original Study||45
8456602|NCT00729781|20839223|P1|STARTED|Original Study||45
8456603|NCT00729690|20839232|P3|NOT COMPLETED|Overall Study||2
8456604|NCT00729690|20839233|P2|NOT COMPLETED|Overall Study||2
8456605|NCT00729690|20839234|P1|NOT COMPLETED|Overall Study||0
8456606|NCT00729690|20839232|P3|COMPLETED|Overall Study||14
8456607|NCT00729690|20839233|P2|COMPLETED|Overall Study||14
8456608|NCT00729690|20839234|P1|COMPLETED|Overall Study||16
8456609|NCT00729690|20839232|P3|STARTED|Overall Study||16
8456610|NCT00729690|20839233|P2|STARTED|Overall Study||16
8456611|NCT00729690|20839234|P1|STARTED|Overall Study||16
8456612|NCT00729677|20839251|P1|NOT COMPLETED|Overall Study||0
8456613|NCT00729677|20839251|P1|COMPLETED|Overall Study||64
8456614|NCT00729677|20839251|P1|STARTED|Overall Study||64
8456615|NCT00729651|20839264|P2|NOT COMPLETED|Overall Study||18
8456616|NCT00729651|20839265|P1|NOT COMPLETED|Overall Study||19
8456617|NCT00729651|20839264|P2|COMPLETED|Overall Study||152
8456618|NCT00729651|20839265|P1|COMPLETED|Overall Study||154
8456619|NCT00729651|20839264|P2|STARTED|Overall Study||170
8456620|NCT00729651|20839265|P1|STARTED|Overall Study||173
8456621|NCT00729612|20839277|P1|NOT COMPLETED|Overall Study||10
8456622|NCT00729612|20839277|P1|COMPLETED|Overall Study||53
8456623|NCT00729612|20839277|P1|Died After Cycle 2 Before Response Eval|Overall Study||1
8456624|NCT00729612|20839277|P1|Received Cycle 2|Overall Study||54
8456625|NCT00729612|20839277|P1|Did Not Receive Cycle 2|Overall Study||7
8456626|NCT00729612|20839277|P1|Received Cycle 1|Overall Study||62
8456627|NCT00729612|20839277|P1|Died Before Cycle 1|Overall Study||1
8456628|NCT00729612|20839277|P1|STARTED|Overall Study||63
8456629|NCT00729586|20839286|P2|NOT COMPLETED|Overall Study||1
8456630|NCT00729586|20839287|P1|NOT COMPLETED|Overall Study||1
8456631|NCT00729586|20839286|P2|COMPLETED|Overall Study|Eligible and treated patients|21
8456632|NCT00729586|20839287|P1|COMPLETED|Overall Study|Eligible and treated patients|50
8456633|NCT00729586|20839286|P2|STARTED|Overall Study||22
8456634|NCT00729586|20839287|P1|STARTED|Overall Study||51
8456635|NCT00729560|20839300|P1|NOT COMPLETED|Overall Study||3
8456636|NCT00729560|20839300|P1|COMPLETED|Overall Study||5
8456637|NCT00729560|20839300|P1|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
8456638|NCT00729521|20839307|P3|NOT COMPLETED|Overall Study||0
8456639|NCT00729521|20839308|P2|NOT COMPLETED|Overall Study||0
8456640|NCT00729521|20839309|P1|NOT COMPLETED|Overall Study||0
8456641|NCT00729521|20839307|P3|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
8456904|NCT00727909|20840031|P1|NOT COMPLETED|Overall Study||5
8456642|NCT00729521|20839308|P2|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
8456643|NCT00729521|20839309|P1|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
8456644|NCT00729521|20839307|P3|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
8456645|NCT00729521|20839308|P2|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
8456646|NCT00729521|20839309|P1|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
8456647|NCT00729482|20839317|P1|NOT COMPLETED|Overall Study||0
8456648|NCT00729482|20839317|P1|COMPLETED|Overall Study||54
8456649|NCT00729482|20839317|P1|STARTED|Overall Study||54
8456650|NCT00729469|20839326|P2|NOT COMPLETED|Overall Study||47
8456651|NCT00729469|20839327|P1|NOT COMPLETED|Overall Study||53
8456652|NCT00729469|20839326|P2|COMPLETED|Overall Study||416
8456653|NCT00729469|20839327|P1|COMPLETED|Overall Study||403
8456654|NCT00729469|20839326|P2|STARTED|Overall Study||463
8456655|NCT00729469|20839327|P1|STARTED|Overall Study||456
8456656|NCT00729430|20839365|P2|NOT COMPLETED|Overall Study||50
8456657|NCT00729430|20839366|P1|NOT COMPLETED|Overall Study||47
8456658|NCT00729430|20839365|P2|COMPLETED|Overall Study||128
8456659|NCT00729430|20839366|P1|COMPLETED|Overall Study||133
8456660|NCT00729430|20839365|P2|STARTED|Overall Study||178
8456661|NCT00729430|20839366|P1|STARTED|Overall Study||180
8456686|NCT00729365|20839580|P3|NOT COMPLETED|Overall Study||7
8456687|NCT00729365|20839581|P2|NOT COMPLETED|Overall Study||6
8456688|NCT00729365|20839582|P1|NOT COMPLETED|Overall Study||33
8456689|NCT00729365|20839580|P3|COMPLETED|Overall Study|Study terminated|0
8456690|NCT00729365|20839581|P2|COMPLETED|Overall Study|Study Terminated|0
8456691|NCT00729365|20839582|P1|COMPLETED|Overall Study|Study terminated|0
8456692|NCT00729365|20839580|P3|STARTED|Overall Study||7
8456693|NCT00729365|20839581|P2|STARTED|Overall Study||6
8456694|NCT00729365|20839582|P1|STARTED|Overall Study||33
8456695|NCT00729326|20839595|P2|NOT COMPLETED|Overall Study||9
8456696|NCT00729326|20839596|P1|NOT COMPLETED|Overall Study||10
8456697|NCT00729326|20839595|P2|COMPLETED|Overall Study||33
8456698|NCT00729326|20839596|P1|COMPLETED|Overall Study||31
8456699|NCT00729326|20839595|P2|STARTED|Overall Study||42
8456700|NCT00729326|20839596|P1|STARTED|Overall Study||41
8456701|NCT00729248|20839638|P1|NOT COMPLETED|Overall Study||2
8456702|NCT00729248|20839638|P1|COMPLETED|Overall Study||10
8456703|NCT00729248|20839638|P1|STARTED|Overall Study||12
8456704|NCT00729183|20839645|P2|NOT COMPLETED|Overall Study||15
8456705|NCT00729183|20839646|P1|NOT COMPLETED|Overall Study||25
8456706|NCT00729183|20839645|P2|COMPLETED|Overall Study|Completed 24 month visit|90
8456707|NCT00729183|20839646|P1|COMPLETED|Overall Study|Completed 24 month visit|84
8456708|NCT00729183|20839645|P2|STARTED|Overall Study||105
8456709|NCT00729183|20839646|P1|STARTED|Overall Study||109
8456710|NCT00729157|20839678|P1|NOT COMPLETED|Overall Study||1
8456711|NCT00729157|20839678|P1|COMPLETED|Overall Study||40
8456712|NCT00729157|20839678|P1|STARTED|Overall Study||41
8456713|NCT00729053|20839690|P4|NOT COMPLETED|Overall Study||0
8456714|NCT00729053|20839691|P3|NOT COMPLETED|Overall Study||0
8456715|NCT00729053|20839692|P2|NOT COMPLETED|Overall Study||0
8456716|NCT00729053|20839693|P1|NOT COMPLETED|Overall Study||0
8456717|NCT00729053|20839690|P4|COMPLETED|Overall Study||23
8456718|NCT00729053|20839691|P3|COMPLETED|Overall Study||23
8456719|NCT00729053|20839692|P2|COMPLETED|Overall Study||23
8456720|NCT00729053|20839693|P1|COMPLETED|Overall Study||23
8456721|NCT00729053|20839690|P4|STARTED|Overall Study||23
8456722|NCT00729053|20839691|P3|STARTED|Overall Study||23
8456723|NCT00729053|20839692|P2|STARTED|Overall Study||23
8456724|NCT00729053|20839693|P1|STARTED|Overall Study||23
8456735|NCT00728962|20839740|P1|NOT COMPLETED|Two Year Post Placement Follow-up||3
8456736|NCT00728962|20839740|P1|COMPLETED|Two Year Post Placement Follow-up||59
8456737|NCT00728962|20839740|P1|STARTED|Two Year Post Placement Follow-up||62
8456738|NCT00728962|20839740|P1|NOT COMPLETED|One Year Post Placement Follow-up||0
8456739|NCT00728962|20839740|P1|COMPLETED|One Year Post Placement Follow-up||62
8456740|NCT00728962|20839740|P1|STARTED|One Year Post Placement Follow-up||62
8456741|NCT00728962|20839740|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
8456742|NCT00728962|20839740|P1|COMPLETED|Permanent Prosthesis Placement||62
8456743|NCT00728962|20839740|P1|STARTED|Permanent Prosthesis Placement||65
8456744|NCT00728962|20839740|P1|NOT COMPLETED|Implant Placement Surgery||10
8456745|NCT00728962|20839740|P1|COMPLETED|Implant Placement Surgery||65
8456746|NCT00728962|20839740|P1|STARTED|Implant Placement Surgery||75
8456747|NCT00728949|20839746|P2|NOT COMPLETED|Overall Study||4
8456748|NCT00728949|20839747|P1|NOT COMPLETED|Overall Study||11
8456749|NCT00728949|20839746|P2|COMPLETED|Overall Study||27
8456750|NCT00728949|20839747|P1|COMPLETED|Overall Study||51
8456751|NCT00728949|20839746|P2|STARTED|Overall Study||31
8456752|NCT00728949|20839747|P1|STARTED|Overall Study||62
8456753|NCT00728936|20839772|P7|NOT COMPLETED|Overall Study||0
8456754|NCT00728936|20839773|P6|NOT COMPLETED|Overall Study||1
8456755|NCT00728936|20839774|P5|NOT COMPLETED|Overall Study||0
8456756|NCT00728936|20839775|P4|NOT COMPLETED|Overall Study||0
8456757|NCT00728936|20839776|P3|NOT COMPLETED|Overall Study||0
8456758|NCT00728936|20839777|P2|NOT COMPLETED|Overall Study||0
8456759|NCT00728936|20839778|P1|NOT COMPLETED|Overall Study||0
8456760|NCT00728936|20839772|P7|COMPLETED|Overall Study||7
8456761|NCT00728936|20839773|P6|COMPLETED|Overall Study||7
8456762|NCT00728936|20839774|P5|COMPLETED|Overall Study||8
8456763|NCT00728936|20839775|P4|COMPLETED|Overall Study||8
8456764|NCT00728936|20839776|P3|COMPLETED|Overall Study||9
8456765|NCT00728936|20839777|P2|COMPLETED|Overall Study||8
8456766|NCT00728936|20839778|P1|COMPLETED|Overall Study||10
8456767|NCT00728936|20839772|P7|STARTED|Overall Study||7
8456768|NCT00728936|20839773|P6|STARTED|Overall Study||8
8456769|NCT00728936|20839774|P5|STARTED|Overall Study||8
8456770|NCT00728936|20839775|P4|STARTED|Overall Study||8
8456771|NCT00728936|20839776|P3|STARTED|Overall Study||9
8456772|NCT00728936|20839777|P2|STARTED|Overall Study||8
8456773|NCT00728936|20839778|P1|STARTED|Overall Study||10
8456774|NCT00728923|20839794|P1|NOT COMPLETED|Overall Study||0
8456775|NCT00728923|20839794|P1|COMPLETED|Overall Study||9
8456776|NCT00728923|20839794|P1|STARTED|Overall Study||9
8456777|NCT00728910|20839799|P1|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
8456778|NCT00728910|20839799|P1|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
8456779|NCT00728910|20839799|P1|STARTED|Atorvastatin+ABT335+ER Niacin||22
8456780|NCT00728910|20839799|P1|NOT COMPLETED|Atorvastatin+ABT335||0
8456781|NCT00728910|20839799|P1|COMPLETED|Atorvastatin+ABT335||22
8456782|NCT00728910|20839799|P1|STARTED|Atorvastatin+ABT335||22
8456783|NCT00728910|20839799|P1|NOT COMPLETED|Atorvastatin||3
8456784|NCT00728910|20839799|P1|COMPLETED|Atorvastatin||22
8456785|NCT00728910|20839799|P1|STARTED|Atorvastatin||25
8456798|NCT00728845|20839817|P2|NOT COMPLETED|Overall Study||0
8456799|NCT00728845|20839818|P1|NOT COMPLETED|Overall Study||0
8456800|NCT00728845|20839817|P2|COMPLETED|Overall Study||0
8456801|NCT00728845|20839818|P1|COMPLETED|Overall Study||8
8456802|NCT00728845|20839817|P2|STARTED|Overall Study||0
8456803|NCT00728845|20839818|P1|STARTED|Overall Study||8
8456804|NCT00728819|20839834|P2|NOT COMPLETED|Overall Study||29
8456805|NCT00728819|20839835|P1|NOT COMPLETED|Overall Study||36
8456806|NCT00728819|20839834|P2|COMPLETED|Overall Study||139
8456807|NCT00728819|20839835|P1|COMPLETED|Overall Study||135
8456808|NCT00728819|20839834|P2|STARTED|Overall Study||168
8456809|NCT00728819|20839835|P1|STARTED|Overall Study||171
8456810|NCT00728754|20839847|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
8456811|NCT00728754|20839848|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
8456812|NCT00728754|20839847|P2|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
8456813|NCT00728754|20839848|P1|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
8456814|NCT00728754|20839847|P2|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
8456815|NCT00728754|20839848|P1|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
8456816|NCT00728754|20839847|P2|NOT COMPLETED|One Year Post Placement Follow-up||0
8456817|NCT00728754|20839848|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
8456818|NCT00728754|20839847|P2|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
8456819|NCT00728754|20839848|P1|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
8456905|NCT00727909|20840028|P4|COMPLETED|Overall Study||70
8456820|NCT00728754|20839847|P2|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
8456821|NCT00728754|20839848|P1|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
8456822|NCT00728754|20839847|P2|NOT COMPLETED|Permanent Prosthesis Placement||4
8456823|NCT00728754|20839848|P1|NOT COMPLETED|Permanent Prosthesis Placement||4
8456824|NCT00728754|20839847|P2|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
8456825|NCT00728754|20839848|P1|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
8456826|NCT00728754|20839847|P2|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
8456827|NCT00728754|20839848|P1|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
8456828|NCT00728754|20839847|P2|NOT COMPLETED|Implant Placement Surgery||0
8456829|NCT00728754|20839848|P1|NOT COMPLETED|Implant Placement Surgery||0
8456830|NCT00728754|20839847|P2|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
8456831|NCT00728754|20839848|P1|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
8456832|NCT00728754|20839847|P2|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
8456833|NCT00728754|20839848|P1|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
8456834|NCT00728728|20839856|P2|NOT COMPLETED|Overall Study||12
8456835|NCT00728728|20839857|P1|NOT COMPLETED|Overall Study||4
8456836|NCT00728728|20839856|P2|COMPLETED|Overall Study||34
8456837|NCT00728728|20839857|P1|COMPLETED|Overall Study||38
8456838|NCT00728728|20839856|P2|STARTED|Overall Study||46
8456839|NCT00728728|20839857|P1|STARTED|Overall Study||42
8456840|NCT00728689|20839877|P2|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
8456841|NCT00728689|20839878|P1|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
8456842|NCT00728689|20839877|P2|COMPLETED|Second Intervention (Days 11 - 13)||6
8456843|NCT00728689|20839878|P1|COMPLETED|Second Intervention (Days 11 - 13)||5
8456844|NCT00728689|20839877|P2|STARTED|Second Intervention (Days 11 - 13)||6
8456845|NCT00728689|20839878|P1|STARTED|Second Intervention (Days 11 - 13)||5
8456846|NCT00728689|20839877|P2|NOT COMPLETED|Washout Period (Days 4 - 10)||0
8456847|NCT00728689|20839878|P1|NOT COMPLETED|Washout Period (Days 4 - 10)||1
8456848|NCT00728689|20839877|P2|COMPLETED|Washout Period (Days 4 - 10)||6
8456849|NCT00728689|20839878|P1|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
8456850|NCT00728689|20839877|P2|STARTED|Washout Period (Days 4 - 10)||6
8456851|NCT00728689|20839878|P1|STARTED|Washout Period (Days 4 - 10)||6
8456852|NCT00728689|20839877|P2|NOT COMPLETED|First Intervention (Days 1 - 3)||0
8456853|NCT00728689|20839878|P1|NOT COMPLETED|First Intervention (Days 1 - 3)||0
8456854|NCT00728689|20839877|P2|COMPLETED|First Intervention (Days 1 - 3)||6
8456855|NCT00728689|20839878|P1|COMPLETED|First Intervention (Days 1 - 3)||6
8456856|NCT00728689|20839877|P2|STARTED|First Intervention (Days 1 - 3)||6
8456857|NCT00728689|20839878|P1|STARTED|First Intervention (Days 1 - 3)||6
8456858|NCT00728507|20839896|P2|NOT COMPLETED|Overall Study||8
8456859|NCT00728507|20839897|P1|NOT COMPLETED|Overall Study||2
8456860|NCT00728507|20839896|P2|COMPLETED|Overall Study||51
8456861|NCT00728507|20839897|P1|COMPLETED|Overall Study||60
8456862|NCT00728507|20839896|P2|STARTED|Overall Study||59
8456863|NCT00728507|20839897|P1|STARTED|Overall Study||62
8456864|NCT00728494|20839907|P2|NOT COMPLETED|Overall Study||7
8456865|NCT00728494|20839908|P1|NOT COMPLETED|Overall Study||9
8456866|NCT00728494|20839907|P2|COMPLETED|Overall Study||32
8456867|NCT00728494|20839908|P1|COMPLETED|Overall Study||51
8456868|NCT00728494|20839907|P2|STARTED|Overall Study||39
8456869|NCT00728494|20839908|P1|STARTED|Overall Study||60
8456870|NCT00728481|20839926|P2|NOT COMPLETED|Overall Study||4
8456871|NCT00728481|20839927|P1|NOT COMPLETED|Overall Study||1
8456872|NCT00728481|20839926|P2|COMPLETED|Overall Study||28
8456873|NCT00728481|20839927|P1|COMPLETED|Overall Study||18
8456874|NCT00728481|20839926|P2|STARTED|Overall Study||32
8456875|NCT00728481|20839927|P1|STARTED|Overall Study||19
8456876|NCT00728468|20839943|P1|NOT COMPLETED|Overall Study||16
8456877|NCT00728468|20839943|P1|COMPLETED|Overall Study||0
8456878|NCT00728468|20839943|P1|Treated|Overall Study||15
8456879|NCT00728468|20839943|P1|STARTED|Overall Study||16
8456880|NCT00728416|20839967|P2|NOT COMPLETED|Overall Study||2
8456881|NCT00728416|20839968|P1|NOT COMPLETED|Overall Study||2
8456882|NCT00728416|20839967|P2|COMPLETED|Overall Study||163
8456883|NCT00728416|20839968|P1|COMPLETED|Overall Study||166
8456884|NCT00728416|20839967|P2|STARTED|Overall Study||165
8456885|NCT00728416|20839968|P1|STARTED|Overall Study||168
8456886|NCT00728260|20839976|P1|NOT COMPLETED|Overall Study||0
8456887|NCT00728260|20839976|P1|COMPLETED|Overall Study||1421
8456888|NCT00728260|20839976|P1|STARTED|Overall Study||1421
8456889|NCT00728182|20839984|P2|NOT COMPLETED|Overall Study||3
8456890|NCT00728182|20839985|P1|NOT COMPLETED|Overall Study||3
8456891|NCT00728182|20839984|P2|COMPLETED|Overall Study||90
8456892|NCT00728182|20839985|P1|COMPLETED|Overall Study||89
8456893|NCT00728182|20839984|P2|STARTED|Overall Study||93
8456894|NCT00728182|20839985|P1|STARTED|Overall Study||92
8456895|NCT00728130|20840013|P1|NOT COMPLETED|Overall Study||3
8456896|NCT00728130|20840013|P1|COMPLETED|Overall Study||19
8456897|NCT00728130|20840013|P1|STARTED|Overall Study||22
8456898|NCT00727961|20840018|P1|NOT COMPLETED|Overall Study||37
8456899|NCT00727961|20840018|P1|COMPLETED|Overall Study||21
8456900|NCT00727961|20840018|P1|STARTED|Overall Study||58
8456901|NCT00727909|20840028|P4|NOT COMPLETED|Overall Study||5
8456902|NCT00727909|20840029|P3|NOT COMPLETED|Overall Study||9
8456903|NCT00727909|20840030|P2|NOT COMPLETED|Overall Study||11
8456906|NCT00727909|20840029|P3|COMPLETED|Overall Study||58
8456907|NCT00727909|20840030|P2|COMPLETED|Overall Study||61
8456908|NCT00727909|20840031|P1|COMPLETED|Overall Study||60
8456909|NCT00727909|20840028|P4|STARTED|Overall Study||75
8456910|NCT00727909|20840029|P3|STARTED|Overall Study||67
8456911|NCT00727909|20840030|P2|STARTED|Overall Study||72
8456912|NCT00727909|20840031|P1|STARTED|Overall Study||65
8456913|NCT00727857|20840038|P3|NOT COMPLETED|Overall Study||68
8456914|NCT00727857|20840039|P2|NOT COMPLETED|Overall Study||64
8456915|NCT00727857|20840040|P1|NOT COMPLETED|Overall Study||44
8456916|NCT00727857|20840038|P3|COMPLETED|Overall Study||142
8456917|NCT00727857|20840039|P2|COMPLETED|Overall Study||125
8456918|NCT00727857|20840040|P1|COMPLETED|Overall Study||157
8456919|NCT00727857|20840038|P3|STARTED|Overall Study||210
8456920|NCT00727857|20840039|P2|STARTED|Overall Study||189
8456921|NCT00727857|20840040|P1|STARTED|Overall Study||201
8456922|NCT00727844|20840128|P4|NOT COMPLETED|Second Randomization||0
8456923|NCT00727844|20840129|P3|NOT COMPLETED|Second Randomization||0
8456924|NCT00727844|20840130|P2|NOT COMPLETED|Second Randomization||0
8456925|NCT00727844|20840131|P1|NOT COMPLETED|Second Randomization||0
8456926|NCT00727844|20840128|P4|COMPLETED|Second Randomization||16
8456927|NCT00727844|20840129|P3|COMPLETED|Second Randomization||17
8456928|NCT00727844|20840130|P2|COMPLETED|Second Randomization||0
8456929|NCT00727844|20840131|P1|COMPLETED|Second Randomization||0
8456930|NCT00727844|20840128|P4|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
8456931|NCT00727844|20840129|P3|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
8456932|NCT00727844|20840130|P2|STARTED|Second Randomization||0
8456933|NCT00727844|20840131|P1|STARTED|Second Randomization||0
8456934|NCT00727844|20840128|P4|NOT COMPLETED|Initial Randomization||0
8456935|NCT00727844|20840129|P3|NOT COMPLETED|Initial Randomization||0
8456936|NCT00727844|20840130|P2|NOT COMPLETED|Initial Randomization||0
8456937|NCT00727844|20840131|P1|NOT COMPLETED|Initial Randomization||2
8456938|NCT00727844|20840128|P4|COMPLETED|Initial Randomization||0
8456939|NCT00727844|20840129|P3|COMPLETED|Initial Randomization||0
8456940|NCT00727844|20840130|P2|COMPLETED|Initial Randomization||20
8456941|NCT00727844|20840131|P1|COMPLETED|Initial Randomization||19
8456942|NCT00727844|20840128|P4|Included in MITT Analysis|Initial Randomization||0
8456943|NCT00727844|20840129|P3|Included in MITT Analysis|Initial Randomization||0
8456944|NCT00727844|20840130|P2|Included in MITT Analysis|Initial Randomization||20
8456945|NCT00727844|20840131|P1|Included in MITT Analysis|Initial Randomization||19
8456946|NCT00727844|20840128|P4|STARTED|Initial Randomization||0
8456947|NCT00727844|20840129|P3|STARTED|Initial Randomization||0
8456948|NCT00727844|20840130|P2|STARTED|Initial Randomization||20
8456949|NCT00727844|20840131|P1|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
8456950|NCT00727740|20840138|P2|NOT COMPLETED|Overall Study||0
8456951|NCT00727740|20840139|P1|NOT COMPLETED|Overall Study||0
8456952|NCT00727740|20840138|P2|COMPLETED|Overall Study||61
8456953|NCT00727740|20840139|P1|COMPLETED|Overall Study||56
8456954|NCT00727740|20840138|P2|STARTED|Overall Study||61
8456955|NCT00727740|20840139|P1|STARTED|Overall Study||56
8456956|NCT00727714|20840145|P1|NOT COMPLETED|Overall Study||2
8456957|NCT00727714|20840145|P1|COMPLETED|Overall Study||93
8456958|NCT00727714|20840145|P1|STARTED|Overall Study||95
8456959|NCT00727649|20840155|P2|NOT COMPLETED|Second Intervention (4-weeks)||3
8456960|NCT00727649|20840156|P1|NOT COMPLETED|Second Intervention (4-weeks)||1
8456961|NCT00727649|20840155|P2|COMPLETED|Second Intervention (4-weeks)||34
8456962|NCT00727649|20840156|P1|COMPLETED|Second Intervention (4-weeks)||29
8456963|NCT00727649|20840155|P2|STARTED|Second Intervention (4-weeks)||37
8456964|NCT00727649|20840156|P1|STARTED|Second Intervention (4-weeks)||30
8456965|NCT00727649|20840155|P2|NOT COMPLETED|Wash-out (2-weeks)||3
8456966|NCT00727649|20840156|P1|NOT COMPLETED|Wash-out (2-weeks)||4
8456967|NCT00727649|20840155|P2|COMPLETED|Wash-out (2-weeks)||37
8456968|NCT00727649|20840156|P1|COMPLETED|Wash-out (2-weeks)||30
8456969|NCT00727649|20840155|P2|STARTED|Wash-out (2-weeks)||40
8456970|NCT00727649|20840156|P1|STARTED|Wash-out (2-weeks)||34
8456971|NCT00727649|20840155|P2|NOT COMPLETED|First Intervention (4-weeks)||3
8456972|NCT00727649|20840156|P1|NOT COMPLETED|First Intervention (4-weeks)||3
8456973|NCT00727649|20840155|P2|COMPLETED|First Intervention (4-weeks)||40
8456974|NCT00727649|20840156|P1|COMPLETED|First Intervention (4-weeks)||34
8456975|NCT00727649|20840155|P2|STARTED|First Intervention (4-weeks)||43
8456976|NCT00727649|20840156|P1|STARTED|First Intervention (4-weeks)||37
8456977|NCT00727636|20840170|P2|NOT COMPLETED|Overall Study||0
8456978|NCT00727636|20840171|P1|NOT COMPLETED|Overall Study||4
8456979|NCT00727636|20840170|P2|COMPLETED|Overall Study||15
8456980|NCT00727636|20840171|P1|COMPLETED|Overall Study||33
8456981|NCT00727636|20840170|P2|STARTED|Overall Study||15
8456982|NCT00727636|20840171|P1|STARTED|Overall Study||37
8456983|NCT00727597|20840185|P2|NOT COMPLETED|Overall Study||0
8456984|NCT00727597|20840186|P1|NOT COMPLETED|Overall Study||0
8456985|NCT00727597|20840185|P2|COMPLETED|Overall Study||50
8456986|NCT00727597|20840186|P1|COMPLETED|Overall Study||51
8456987|NCT00727597|20840185|P2|STARTED|Overall Study||50
8456988|NCT00727597|20840186|P1|STARTED|Overall Study||51
8456989|NCT00727571|20840198|P4|NOT COMPLETED|Overall Study||6
8456990|NCT00727571|20840199|P3|NOT COMPLETED|Overall Study||30
8456991|NCT00727571|20840200|P2|NOT COMPLETED|Overall Study||55
8456992|NCT00727571|20840201|P1|NOT COMPLETED|Overall Study||1
8456993|NCT00727571|20840198|P4|COMPLETED|Overall Study||163
8456994|NCT00727571|20840199|P3|COMPLETED|Overall Study||135
8456995|NCT00727571|20840200|P2|COMPLETED|Overall Study||173
8456996|NCT00727571|20840201|P1|COMPLETED|Overall Study||231
8456997|NCT00727571|20840198|P4|STARTED|Overall Study||169
8456998|NCT00727571|20840199|P3|STARTED|Overall Study||165
8456999|NCT00727571|20840200|P2|STARTED|Overall Study||228
8457000|NCT00727571|20840201|P1|STARTED|Overall Study||232
8457001|NCT00727558|20840228|P2|NOT COMPLETED|Overall Study||3
8457002|NCT00727558|20840229|P1|NOT COMPLETED|Overall Study||2
8457003|NCT00727558|20840228|P2|COMPLETED|Overall Study||118
8457004|NCT00727558|20840229|P1|COMPLETED|Overall Study||125
8457005|NCT00727558|20840228|P2|STARTED|Overall Study||121
8457006|NCT00727558|20840229|P1|STARTED|Overall Study||127
8457007|NCT00727532|20840247|P1|NOT COMPLETED|Overall Study||2
8457008|NCT00727532|20840247|P1|COMPLETED|Overall Study||7
8457009|NCT00727532|20840247|P1|STARTED|Overall Study||9
8457010|NCT00727506|20840259|P6|NOT COMPLETED|Overall Study||39
8457011|NCT00727506|20840260|P5|NOT COMPLETED|Overall Study||41
8457012|NCT00727506|20840261|P4|NOT COMPLETED|Overall Study||39
8457013|NCT00727506|20840262|P3|NOT COMPLETED|Overall Study||18
8457014|NCT00727506|20840263|P2|NOT COMPLETED|Overall Study||8
8457015|NCT00727506|20840264|P1|NOT COMPLETED|Overall Study||6
8457016|NCT00727506|20840259|P6|COMPLETED|Overall Study||0
8457017|NCT00727506|20840260|P5|COMPLETED|Overall Study||0
8457018|NCT00727506|20840261|P4|COMPLETED|Overall Study||0
8457019|NCT00727506|20840262|P3|COMPLETED|Overall Study||0
8457020|NCT00727506|20840263|P2|COMPLETED|Overall Study||0
8457021|NCT00727506|20840264|P1|COMPLETED|Overall Study||0
8457022|NCT00727506|20840259|P6|STARTED|Overall Study|Randomized|39
8457023|NCT00727506|20840260|P5|STARTED|Overall Study|Randomized|41
8457024|NCT00727506|20840261|P4|STARTED|Overall Study|Randomized|39
8457025|NCT00727506|20840262|P3|STARTED|Overall Study|Entered|18
8457026|NCT00727506|20840263|P2|STARTED|Overall Study|Entered|8
8457027|NCT00727506|20840264|P1|STARTED|Overall Study|Entered|6
8457028|NCT00727441|20840360|P3|NOT COMPLETED|Overall Study||25
8457029|NCT00727441|20840361|P2|NOT COMPLETED|Overall Study||22
8457030|NCT00727441|20840362|P1|NOT COMPLETED|Overall Study||18
8457031|NCT00727441|20840360|P3|COMPLETED|Overall Study||5
8457032|NCT00727441|20840361|P2|COMPLETED|Overall Study||6
8457033|NCT00727441|20840362|P1|COMPLETED|Overall Study||11
8457034|NCT00727441|20840360|P3|STARTED|Overall Study||30
8457035|NCT00727441|20840361|P2|STARTED|Overall Study||28
8457036|NCT00727441|20840362|P1|STARTED|Overall Study||29
8457037|NCT00727415|20840382|P1|NOT COMPLETED|Phase II||0
8457038|NCT00727415|20840382|P1|COMPLETED|Phase II||33
8457039|NCT00727415|20840382|P1|STARTED|Phase II||33
8457040|NCT00727415|20840382|P1|NOT COMPLETED|Phase I||2
8457041|NCT00727415|20840382|P1|COMPLETED|Phase I||7
8457042|NCT00727415|20840382|P1|STARTED|Phase I||9
8457043|NCT00727402|20840391|P1|NOT COMPLETED|Overall Study||116
8457044|NCT00727402|20840391|P1|COMPLETED|Overall Study||89
8457045|NCT00727402|20840391|P1|STARTED|Overall Study||205
8457046|NCT00727337|20840399|P4|NOT COMPLETED|Overall Study||9
8457047|NCT00727337|20840400|P3|NOT COMPLETED|Overall Study||10
8457048|NCT00727337|20840401|P2|NOT COMPLETED|Overall Study||10
8457049|NCT00727337|20840402|P1|NOT COMPLETED|Overall Study||7
8457050|NCT00727337|20840399|P4|COMPLETED|Overall Study||64
8457051|NCT00727337|20840400|P3|COMPLETED|Overall Study||63
8457052|NCT00727337|20840401|P2|COMPLETED|Overall Study||55
8457053|NCT00727337|20840402|P1|COMPLETED|Overall Study||61
8457054|NCT00727337|20840399|P4|STARTED|Overall Study||73
8457055|NCT00727337|20840400|P3|STARTED|Overall Study||73
8457056|NCT00727337|20840401|P2|STARTED|Overall Study||65
8457057|NCT00727337|20840402|P1|STARTED|Overall Study||68
8457058|NCT00727311|20840420|P1|NOT COMPLETED|Overall Study||1107
8457059|NCT00727311|20840420|P1|COMPLETED|Overall Study||1195
8457060|NCT00727311|20840420|P1|STARTED|Overall Study||2302
8457061|NCT00727298|20840427|P1|NOT COMPLETED|Overall Study||1257
8457062|NCT00727298|20840427|P1|COMPLETED|Overall Study||3228
8457063|NCT00727298|20840427|P1|STARTED|Overall Study||4485
8457064|NCT00727272|20840433|P3|NOT COMPLETED|Period III||0
8457065|NCT00727272|20840434|P2|NOT COMPLETED|Period III||0
8457066|NCT00727272|20840435|P1|NOT COMPLETED|Period III||0
8457067|NCT00727272|20840433|P3|COMPLETED|Period III||7
8457068|NCT00727272|20840434|P2|COMPLETED|Period III||9
8457069|NCT00727272|20840435|P1|COMPLETED|Period III||9
8457070|NCT00727272|20840433|P3|STARTED|Period III||7
8457071|NCT00727272|20840434|P2|STARTED|Period III||9
8457072|NCT00727272|20840435|P1|STARTED|Period III||9
8457073|NCT00727272|20840433|P3|NOT COMPLETED|Washout Period B||1
8457074|NCT00727272|20840434|P2|NOT COMPLETED|Washout Period B||0
8457075|NCT00727272|20840435|P1|NOT COMPLETED|Washout Period B||0
8457076|NCT00727272|20840433|P3|COMPLETED|Washout Period B|personal reasons|7
8457077|NCT00727272|20840434|P2|COMPLETED|Washout Period B||9
8457078|NCT00727272|20840435|P1|COMPLETED|Washout Period B||9
8457079|NCT00727272|20840433|P3|STARTED|Washout Period B||8
8457080|NCT00727272|20840434|P2|STARTED|Washout Period B||9
8457081|NCT00727272|20840435|P1|STARTED|Washout Period B||9
8457082|NCT00727272|20840433|P3|NOT COMPLETED|Period II||0
8457083|NCT00727272|20840434|P2|NOT COMPLETED|Period II||0
8457084|NCT00727272|20840435|P1|NOT COMPLETED|Period II||0
8457085|NCT00727272|20840433|P3|COMPLETED|Period II||8
8457086|NCT00727272|20840434|P2|COMPLETED|Period II||9
8457087|NCT00727272|20840435|P1|COMPLETED|Period II||9
8457088|NCT00727272|20840433|P3|STARTED|Period II||8
8457089|NCT00727272|20840434|P2|STARTED|Period II||9
8457090|NCT00727272|20840435|P1|STARTED|Period II||9
8457091|NCT00727272|20840433|P3|NOT COMPLETED|Washout Period A||1
8457092|NCT00727272|20840434|P2|NOT COMPLETED|Washout Period A||0
8457093|NCT00727272|20840435|P1|NOT COMPLETED|Washout Period A||0
8457094|NCT00727272|20840433|P3|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
8457095|NCT00727272|20840434|P2|COMPLETED|Washout Period A||9
8457096|NCT00727272|20840435|P1|COMPLETED|Washout Period A||9
8457097|NCT00727272|20840433|P3|STARTED|Washout Period A||9
8457098|NCT00727272|20840434|P2|STARTED|Washout Period A||9
8457099|NCT00727272|20840435|P1|STARTED|Washout Period A||9
8457100|NCT00727272|20840433|P3|NOT COMPLETED|Period I||0
8457101|NCT00727272|20840434|P2|NOT COMPLETED|Period I||0
8457102|NCT00727272|20840435|P1|NOT COMPLETED|Period I||0
8457103|NCT00727272|20840433|P3|COMPLETED|Period I||9
8457104|NCT00727272|20840434|P2|COMPLETED|Period I||9
8457105|NCT00727272|20840435|P1|COMPLETED|Period I||9
8457106|NCT00727272|20840433|P3|STARTED|Period I||9
8457107|NCT00727272|20840434|P2|STARTED|Period I||9
8457108|NCT00727272|20840435|P1|STARTED|Period I||9
8457109|NCT00727259|20840452|P1|NOT COMPLETED|Overall Study||1055
8457110|NCT00727259|20840452|P1|COMPLETED|Overall Study||940
8457111|NCT00727259|20840452|P1|STARTED|Overall Study||1995
8457112|NCT00727246|20840461|P4|NOT COMPLETED|Overall Study||2
8457113|NCT00727246|20840462|P3|NOT COMPLETED|Overall Study||1
8457114|NCT00727246|20840463|P2|NOT COMPLETED|Overall Study||1
8457115|NCT00727246|20840464|P1|NOT COMPLETED|Overall Study||0
8457116|NCT00727246|20840461|P4|COMPLETED|Overall Study||3
8457117|NCT00727246|20840462|P3|COMPLETED|Overall Study||7
8457118|NCT00727246|20840463|P2|COMPLETED|Overall Study||2
8457119|NCT00727246|20840464|P1|COMPLETED|Overall Study||3
8457120|NCT00727246|20840461|P4|STARTED|Overall Study||5
8457121|NCT00727246|20840462|P3|STARTED|Overall Study||8
8457122|NCT00727246|20840463|P2|STARTED|Overall Study||3
8457123|NCT00727246|20840464|P1|STARTED|Overall Study||3
8457124|NCT00727220|20840480|P2|NOT COMPLETED|Overall Study||4
8457125|NCT00727220|20840481|P1|NOT COMPLETED|Overall Study||1
8457126|NCT00727220|20840480|P2|COMPLETED|Overall Study||17
8457127|NCT00727220|20840481|P1|COMPLETED|Overall Study||20
8457128|NCT00727220|20840480|P2|STARTED|Overall Study||21
8457129|NCT00727220|20840481|P1|STARTED|Overall Study||21
8457130|NCT00727194|20840487|P3|NOT COMPLETED|Treatment Period 2||0
8457131|NCT00727194|20840488|P2|NOT COMPLETED|Treatment Period 2||1
8457132|NCT00727194|20840489|P1|NOT COMPLETED|Treatment Period 2||0
8457133|NCT00727194|20840487|P3|COMPLETED|Treatment Period 2||0
8457134|NCT00727194|20840488|P2|COMPLETED|Treatment Period 2||5
8457135|NCT00727194|20840489|P1|COMPLETED|Treatment Period 2||6
8457136|NCT00727194|20840487|P3|STARTED|Treatment Period 2||0
8457137|NCT00727194|20840488|P2|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
8457138|NCT00727194|20840489|P1|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
8457139|NCT00727194|20840487|P3|NOT COMPLETED|Washout Period||0
8457140|NCT00727194|20840488|P2|NOT COMPLETED|Washout Period||0
8457141|NCT00727194|20840489|P1|NOT COMPLETED|Washout Period||0
8457142|NCT00727194|20840487|P3|COMPLETED|Washout Period||0
8457143|NCT00727194|20840488|P2|COMPLETED|Washout Period||7
8457144|NCT00727194|20840489|P1|COMPLETED|Washout Period||7
8457145|NCT00727194|20840487|P3|STARTED|Washout Period||0
8457146|NCT00727194|20840488|P2|STARTED|Washout Period||7
8457147|NCT00727194|20840489|P1|STARTED|Washout Period||7
8457148|NCT00727194|20840487|P3|NOT COMPLETED|Treatment Period 1||0
8457149|NCT00727194|20840488|P2|NOT COMPLETED|Treatment Period 1||0
8457150|NCT00727194|20840489|P1|NOT COMPLETED|Treatment Period 1||0
8457151|NCT00727194|20840487|P3|COMPLETED|Treatment Period 1||0
8457152|NCT00727194|20840488|P2|COMPLETED|Treatment Period 1||7
8457153|NCT00727194|20840489|P1|COMPLETED|Treatment Period 1||7
8457154|NCT00727194|20840487|P3|STARTED|Treatment Period 1||0
8457155|NCT00727194|20840488|P2|STARTED|Treatment Period 1||7
8457156|NCT00727194|20840489|P1|STARTED|Treatment Period 1||7
8457157|NCT00727194|20840487|P3|NOT COMPLETED|Screening Period||16
8457158|NCT00727194|20840488|P2|NOT COMPLETED|Screening Period||0
8457159|NCT00727194|20840489|P1|NOT COMPLETED|Screening Period||0
8457160|NCT00727194|20840487|P3|COMPLETED|Screening Period||0
8457161|NCT00727194|20840488|P2|COMPLETED|Screening Period||7
8457162|NCT00727194|20840489|P1|COMPLETED|Screening Period||7
8457163|NCT00727194|20840487|P3|STARTED|Screening Period||16
8457164|NCT00727194|20840488|P2|STARTED|Screening Period||7
8457165|NCT00727194|20840489|P1|STARTED|Screening Period||7
8457166|NCT00727090|20840525|P2|NOT COMPLETED|Overall Study||0
8457167|NCT00727090|20840526|P1|NOT COMPLETED|Overall Study||0
8457168|NCT00727090|20840525|P2|COMPLETED|Overall Study||3
8457169|NCT00727090|20840526|P1|COMPLETED|Overall Study||3
8457170|NCT00727090|20840525|P2|STARTED|Overall Study||3
8457171|NCT00727090|20840526|P1|STARTED|Overall Study||3
8457172|NCT00727064|20840544|P2|NOT COMPLETED|Overall Study||0
8457173|NCT00727064|20840545|P1|NOT COMPLETED|Overall Study||0
8457174|NCT00727064|20840544|P2|COMPLETED|Overall Study||7
8457175|NCT00727064|20840545|P1|COMPLETED|Overall Study||7
8457176|NCT00727064|20840544|P2|STARTED|Overall Study||7
8457177|NCT00727064|20840545|P1|STARTED|Overall Study||7
8457178|NCT00727025|20840561|P1|NOT COMPLETED|Overall Study||23
8457179|NCT00727025|20840561|P1|COMPLETED|Overall Study||51
8457180|NCT00727025|20840561|P1|STARTED|Overall Study||74
8457181|NCT00726999|20840573|P2|NOT COMPLETED|Overall Study||1
8457182|NCT00726999|20840574|P1|NOT COMPLETED|Overall Study||3
8457183|NCT00726999|20840573|P2|COMPLETED|Overall Study||30
8457184|NCT00726999|20840574|P1|COMPLETED|Overall Study||29
8457185|NCT00726999|20840573|P2|STARTED|Overall Study||31
8457186|NCT00726999|20840574|P1|STARTED|Overall Study||32
8457187|NCT00726986|20840586|P1|NOT COMPLETED|Maintenance Phase||3
8457188|NCT00726986|20840586|P1|COMPLETED|Maintenance Phase||0
8457189|NCT00726986|20840586|P1|STARTED|Maintenance Phase||3
8457190|NCT00726986|20840586|P1|NOT COMPLETED|Induction Phase||15
8457191|NCT00726986|20840586|P1|COMPLETED|Induction Phase||3
8457192|NCT00726986|20840586|P1|Maintance|Induction Phase||3
8457193|NCT00726986|20840586|P1|STARTED|Induction Phase||18
8457194|NCT00726895|20840593|P2|NOT COMPLETED|Second Intervention||0
8457195|NCT00726895|20840594|P1|NOT COMPLETED|Second Intervention||0
8457196|NCT00726895|20840593|P2|COMPLETED|Second Intervention||11
8457197|NCT00726895|20840594|P1|COMPLETED|Second Intervention||12
8457198|NCT00726895|20840593|P2|STARTED|Second Intervention||11
8457199|NCT00726895|20840594|P1|STARTED|Second Intervention||12
8457200|NCT00726895|20840593|P2|NOT COMPLETED|Washout Period of 7 Days||1
8457201|NCT00726895|20840594|P1|NOT COMPLETED|Washout Period of 7 Days||0
8457202|NCT00726895|20840593|P2|COMPLETED|Washout Period of 7 Days||11
8457203|NCT00726895|20840594|P1|COMPLETED|Washout Period of 7 Days||12
8457204|NCT00726895|20840593|P2|STARTED|Washout Period of 7 Days||12
8457205|NCT00726895|20840594|P1|STARTED|Washout Period of 7 Days||12
8457206|NCT00726895|20840593|P2|NOT COMPLETED|First Intervention||0
8457207|NCT00726895|20840594|P1|NOT COMPLETED|First Intervention||0
8457208|NCT00726895|20840593|P2|COMPLETED|First Intervention||12
8457209|NCT00726895|20840594|P1|COMPLETED|First Intervention||12
8457210|NCT00726895|20840593|P2|STARTED|First Intervention||12
8457211|NCT00726895|20840594|P1|STARTED|First Intervention||12
8457212|NCT00726882|20840607|P1|NOT COMPLETED|Overall Study||22
8457213|NCT00726882|20840607|P1|COMPLETED|Overall Study||13
8457214|NCT00726882|20840607|P1|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
8457215|NCT00726882|20840607|P1|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
8457216|NCT00726882|20840607|P1|STARTED|Overall Study||35
8457217|NCT00726830|20840615|P2|NOT COMPLETED|Overall Study||0
8457218|NCT00726830|20840616|P1|NOT COMPLETED|Overall Study||0
8457219|NCT00726830|20840615|P2|COMPLETED|Overall Study||0
8457220|NCT00726830|20840616|P1|COMPLETED|Overall Study||1
8457221|NCT00726830|20840615|P2|STARTED|Overall Study||0
8457222|NCT00726830|20840616|P1|STARTED|Overall Study||1
8457223|NCT00726752|20840622|P1|NOT COMPLETED|Overall Study||6
8457224|NCT00726752|20840622|P1|COMPLETED|Overall Study||0
8457225|NCT00726752|20840622|P1|STARTED|Overall Study||6
8457226|NCT00726739|20840638|P2|NOT COMPLETED|Overall Study||0
8457227|NCT00726739|20840639|P1|NOT COMPLETED|Overall Study||1
8457228|NCT00726739|20840638|P2|COMPLETED|Overall Study||10
8457229|NCT00726739|20840639|P1|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
8457230|NCT00726739|20840638|P2|STARTED|Overall Study||10
8457231|NCT00726739|20840639|P1|STARTED|Overall Study||11
8457232|NCT00726713|20840655|P2|NOT COMPLETED|Overall Study||7
8457233|NCT00726713|20840656|P1|NOT COMPLETED|Overall Study||7
8457234|NCT00726713|20840655|P2|COMPLETED|Overall Study||101
8457235|NCT00726713|20840656|P1|COMPLETED|Overall Study||99
8457236|NCT00726713|20840655|P2|STARTED|Overall Study||108
8457237|NCT00726713|20840656|P1|STARTED|Overall Study||106
8457238|NCT00726661|20840684|P2|NOT COMPLETED|Overall Study||418
8457239|NCT00726661|20840685|P1|NOT COMPLETED|Overall Study||814
8457240|NCT00726661|20840684|P2|COMPLETED|Overall Study||17
8457241|NCT00726661|20840685|P1|COMPLETED|Overall Study||18
8457242|NCT00726661|20840684|P2|STARTED|Overall Study||435
8457243|NCT00726661|20840685|P1|STARTED|Overall Study||832
8457244|NCT00726622|20840702|P2|NOT COMPLETED|Overall Study||3
8457245|NCT00726622|20840703|P1|NOT COMPLETED|Overall Study||18
8457246|NCT00726622|20840702|P2|COMPLETED|Overall Study||240
8457247|NCT00726622|20840703|P1|COMPLETED|Overall Study||225
8457248|NCT00726622|20840702|P2|STARTED|Overall Study||243
8457249|NCT00726622|20840703|P1|STARTED|Overall Study||243
8457250|NCT00726609|20840721|P1|NOT COMPLETED|Overall Study||98
8457251|NCT00726609|20840721|P1|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
8457252|NCT00726609|20840721|P1|STARTED|Overall Study||214
8457253|NCT00726557|20840725|P1|NOT COMPLETED|Overall Study||128
8457254|NCT00726557|20840725|P1|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
8457255|NCT00726557|20840725|P1|STARTED|Overall Study||246
8457256|NCT00726453|20840732|P2|NOT COMPLETED|38 mm Length Group||3
8457257|NCT00726453|20840733|P1|NOT COMPLETED|38 mm Length Group||0
8457258|NCT00726453|20840732|P2|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
8457259|NCT00726453|20840733|P1|COMPLETED|38 mm Length Group||0
8457260|NCT00726453|20840732|P2|STARTED|38 mm Length Group||114
8457261|NCT00726453|20840733|P1|STARTED|38 mm Length Group||0
8457262|NCT00726453|20840732|P2|NOT COMPLETED|Primary Enrollment Group||0
8457263|NCT00726453|20840733|P1|NOT COMPLETED|Primary Enrollment Group||31
8457264|NCT00726453|20840732|P2|COMPLETED|Primary Enrollment Group||0
8457265|NCT00726453|20840733|P1|COMPLETED|Primary Enrollment Group||1371
8457266|NCT00726453|20840732|P2|STARTED|Primary Enrollment Group||0
8457267|NCT00726453|20840733|P1|STARTED|Primary Enrollment Group||1402
8457268|NCT00726414|20840743|P2|NOT COMPLETED|Second Intervention||0
8457269|NCT00726414|20840744|P1|NOT COMPLETED|Second Intervention||0
8457270|NCT00726414|20840743|P2|COMPLETED|Second Intervention||11
8457271|NCT00726414|20840744|P1|COMPLETED|Second Intervention||11
8457272|NCT00726414|20840743|P2|STARTED|Second Intervention||11
8457273|NCT00726414|20840744|P1|STARTED|Second Intervention||11
8457274|NCT00726414|20840743|P2|NOT COMPLETED|Washout Period of 7 Days||0
8457275|NCT00726414|20840744|P1|NOT COMPLETED|Washout Period of 7 Days||0
8457276|NCT00726414|20840743|P2|COMPLETED|Washout Period of 7 Days||11
8457277|NCT00726414|20840744|P1|COMPLETED|Washout Period of 7 Days||11
8457278|NCT00726414|20840743|P2|STARTED|Washout Period of 7 Days||11
8457279|NCT00726414|20840744|P1|STARTED|Washout Period of 7 Days||11
8457280|NCT00726414|20840743|P2|NOT COMPLETED|First Intervention||0
8457281|NCT00726414|20840744|P1|NOT COMPLETED|First Intervention||0
8457282|NCT00726414|20840743|P2|COMPLETED|First Intervention||11
8457283|NCT00726414|20840744|P1|COMPLETED|First Intervention||11
8457284|NCT00726414|20840743|P2|STARTED|First Intervention||11
8457285|NCT00726414|20840744|P1|STARTED|First Intervention||11
8457286|NCT00726375|20840754|P1|NOT COMPLETED|Overall Study||0
8457287|NCT00726375|20840754|P1|COMPLETED|Overall Study||34
8457288|NCT00726375|20840754|P1|STARTED|Overall Study||34
8457289|NCT00726323|20840761|P2|NOT COMPLETED|Overall Study||31
8457290|NCT00726323|20840762|P1|NOT COMPLETED|Overall Study||37
8457291|NCT00726323|20840761|P2|COMPLETED|Overall Study||6
8457292|NCT00726323|20840762|P1|COMPLETED|Overall Study||0
8457293|NCT00726323|20840761|P2|STARTED|Overall Study||37
8457294|NCT00726323|20840762|P1|STARTED|Overall Study||37
8457295|NCT00726232|20840792|P8|NOT COMPLETED|Expansion Phase||38
8457296|NCT00726232|20840793|P7|NOT COMPLETED|Expansion Phase||24
8457297|NCT00726232|20840794|P6|NOT COMPLETED|Expansion Phase||0
8457298|NCT00726232|20840795|P5|NOT COMPLETED|Expansion Phase||0
8457299|NCT00726232|20840796|P4|NOT COMPLETED|Expansion Phase||0
8457300|NCT00726232|20840797|P3|NOT COMPLETED|Expansion Phase||0
8457301|NCT00726232|20840798|P2|NOT COMPLETED|Expansion Phase||0
8457302|NCT00726232|20840799|P1|NOT COMPLETED|Expansion Phase||0
8457303|NCT00726232|20840792|P8|COMPLETED|Expansion Phase||1
8457304|NCT00726232|20840793|P7|COMPLETED|Expansion Phase||10
8457305|NCT00726232|20840794|P6|COMPLETED|Expansion Phase||0
8457306|NCT00726232|20840795|P5|COMPLETED|Expansion Phase||0
8457307|NCT00726232|20840796|P4|COMPLETED|Expansion Phase||0
8457308|NCT00726232|20840797|P3|COMPLETED|Expansion Phase||0
8457309|NCT00726232|20840798|P2|COMPLETED|Expansion Phase||0
8457310|NCT00726232|20840799|P1|COMPLETED|Expansion Phase||0
8457311|NCT00726232|20840792|P8|ITT Participants|Expansion Phase||39
8457312|NCT00726232|20840793|P7|ITT Participants|Expansion Phase||34
8457313|NCT00726232|20840794|P6|ITT Participants|Expansion Phase||0
8457314|NCT00726232|20840795|P5|ITT Participants|Expansion Phase||0
8457315|NCT00726232|20840796|P4|ITT Participants|Expansion Phase||0
8457316|NCT00726232|20840797|P3|ITT Participants|Expansion Phase||0
8457317|NCT00726232|20840798|P2|ITT Participants|Expansion Phase||0
8457318|NCT00726232|20840799|P1|ITT Participants|Expansion Phase||0
8457319|NCT00726232|20840792|P8|Safety Evaluable Participants|Expansion Phase||39
8457320|NCT00726232|20840793|P7|Safety Evaluable Participants|Expansion Phase||34
8457321|NCT00726232|20840794|P6|Safety Evaluable Participants|Expansion Phase||0
8457322|NCT00726232|20840795|P5|Safety Evaluable Participants|Expansion Phase||0
8457323|NCT00726232|20840796|P4|Safety Evaluable Participants|Expansion Phase||0
8457324|NCT00726232|20840797|P3|Safety Evaluable Participants|Expansion Phase||0
8457325|NCT00726232|20840798|P2|Safety Evaluable Participants|Expansion Phase||0
8457326|NCT00726232|20840799|P1|Safety Evaluable Participants|Expansion Phase||0
8457327|NCT00726232|20840792|P8|STARTED|Expansion Phase||39
8457328|NCT00726232|20840793|P7|STARTED|Expansion Phase||34
8457329|NCT00726232|20840794|P6|STARTED|Expansion Phase||0
8457330|NCT00726232|20840795|P5|STARTED|Expansion Phase||0
8457331|NCT00726232|20840796|P4|STARTED|Expansion Phase||0
8457332|NCT00726232|20840797|P3|STARTED|Expansion Phase||0
8457333|NCT00726232|20840798|P2|STARTED|Expansion Phase||0
8457334|NCT00726232|20840799|P1|STARTED|Expansion Phase||0
8457335|NCT00726232|20840792|P8|NOT COMPLETED|Initial Phase (Dose-finding)||0
8457336|NCT00726232|20840793|P7|NOT COMPLETED|Initial Phase (Dose-finding)||0
8457337|NCT00726232|20840794|P6|NOT COMPLETED|Initial Phase (Dose-finding)||9
8457338|NCT00726232|20840795|P5|NOT COMPLETED|Initial Phase (Dose-finding)||21
8457339|NCT00726232|20840796|P4|NOT COMPLETED|Initial Phase (Dose-finding)||8
8457340|NCT00726232|20840797|P3|NOT COMPLETED|Initial Phase (Dose-finding)||5
8457341|NCT00726232|20840798|P2|NOT COMPLETED|Initial Phase (Dose-finding)||6
8457342|NCT00726232|20840799|P1|NOT COMPLETED|Initial Phase (Dose-finding)||13
8457343|NCT00726232|20840792|P8|COMPLETED|Initial Phase (Dose-finding)||0
8457344|NCT00726232|20840793|P7|COMPLETED|Initial Phase (Dose-finding)||0
8457345|NCT00726232|20840794|P6|COMPLETED|Initial Phase (Dose-finding)||0
8457346|NCT00726232|20840795|P5|COMPLETED|Initial Phase (Dose-finding)||1
8457347|NCT00726232|20840796|P4|COMPLETED|Initial Phase (Dose-finding)||0
8457348|NCT00726232|20840797|P3|COMPLETED|Initial Phase (Dose-finding)||2
8457349|NCT00726232|20840798|P2|COMPLETED|Initial Phase (Dose-finding)||2
8457350|NCT00726232|20840799|P1|COMPLETED|Initial Phase (Dose-finding)||6
8457351|NCT00726232|20840792|P8|ITT Participants|Initial Phase (Dose-finding)||0
8457352|NCT00726232|20840793|P7|ITT Participants|Initial Phase (Dose-finding)||0
8457353|NCT00726232|20840794|P6|ITT Participants|Initial Phase (Dose-finding)||9
8457354|NCT00726232|20840795|P5|ITT Participants|Initial Phase (Dose-finding)||22
8457355|NCT00726232|20840796|P4|ITT Participants|Initial Phase (Dose-finding)||8
8457356|NCT00726232|20840797|P3|ITT Participants|Initial Phase (Dose-finding)||7
8457357|NCT00726232|20840798|P2|ITT Participants|Initial Phase (Dose-finding)||8
8457358|NCT00726232|20840799|P1|ITT Participants|Initial Phase (Dose-finding)||19
8457359|NCT00726232|20840792|P8|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
8457360|NCT00726232|20840793|P7|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
8457361|NCT00726232|20840794|P6|Safety Evaluable Participants|Initial Phase (Dose-finding)||9
8457362|NCT00726232|20840795|P5|Safety Evaluable Participants|Initial Phase (Dose-finding)||22
8457363|NCT00726232|20840796|P4|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
8457364|NCT00726232|20840797|P3|Safety Evaluable Participants|Initial Phase (Dose-finding)||7
8457365|NCT00726232|20840798|P2|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
8457366|NCT00726232|20840799|P1|Safety Evaluable Participants|Initial Phase (Dose-finding)||19
8457367|NCT00726232|20840792|P8|STARTED|Initial Phase (Dose-finding)||0
8457368|NCT00726232|20840793|P7|STARTED|Initial Phase (Dose-finding)||0
8457369|NCT00726232|20840794|P6|STARTED|Initial Phase (Dose-finding)||9
8457370|NCT00726232|20840795|P5|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
8457371|NCT00726232|20840796|P4|STARTED|Initial Phase (Dose-finding)||8
8457372|NCT00726232|20840797|P3|STARTED|Initial Phase (Dose-finding)||7
8457373|NCT00726232|20840798|P2|STARTED|Initial Phase (Dose-finding)||8
8457374|NCT00726232|20840799|P1|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
8457375|NCT00726180|20840845|P1|NOT COMPLETED|Overall Study||0
8457376|NCT00726180|20840845|P1|COMPLETED|Overall Study||1
8457377|NCT00726180|20840845|P1|STARTED|Overall Study||1
8457378|NCT00726063|20840851|P2|NOT COMPLETED|Overall Study||7
8457379|NCT00726063|20840852|P1|NOT COMPLETED|Overall Study||9
8457380|NCT00726063|20840851|P2|COMPLETED|Overall Study|Number of implants = 239|112
8457381|NCT00726063|20840852|P1|COMPLETED|Overall Study|Number of implants =230|113
8457382|NCT00726063|20840851|P2|STARTED|Overall Study|Number of implants= 246|119
8457383|NCT00726063|20840852|P1|STARTED|Overall Study|Number of implants= 239|122
8457384|NCT00726037|20840858|P1|NOT COMPLETED|Overall Study||0
8457385|NCT00726037|20840858|P1|COMPLETED|Overall Study||7
8457386|NCT00726037|20840858|P1|STARTED|Overall Study||7
8457543|NCT00725959|20840905|P2|NOT COMPLETED|Overall Study||197
8457544|NCT00725959|20840906|P1|NOT COMPLETED|Overall Study||289
8457545|NCT00725959|20840905|P2|COMPLETED|Overall Study||439
8457546|NCT00725959|20840906|P1|COMPLETED|Overall Study||653
8457547|NCT00725959|20840905|P2|STARTED|Overall Study||636
8457548|NCT00725959|20840906|P1|STARTED|Overall Study||942
8457549|NCT00725920|20840914|P2|NOT COMPLETED|Overall Study||6
8457550|NCT00725920|20840915|P1|NOT COMPLETED|Overall Study||3
8457551|NCT00725920|20840914|P2|COMPLETED|Overall Study||12
8457552|NCT00725920|20840915|P1|COMPLETED|Overall Study||14
8457553|NCT00725920|20840914|P2|STARTED|Overall Study||18
8457554|NCT00725920|20840915|P1|STARTED|Overall Study||17
8457555|NCT00725842|20840921|P1|NOT COMPLETED|Overall Study||40
8457556|NCT00725842|20840921|P1|COMPLETED|Overall Study||57
8457557|NCT00725842|20840921|P1|Participants Eligible for Analysis|Overall Study||90
8457558|NCT00725842|20840921|P1|STARTED|Overall Study||97
8457559|NCT00725764|20840928|P1|NOT COMPLETED|Overall Study||14
8457560|NCT00725764|20840928|P1|COMPLETED|Overall Study||0
8457561|NCT00725764|20840928|P1|STARTED|Overall Study||14
8457562|NCT00725751|20840948|P2|NOT COMPLETED|Overall Study||108
8457563|NCT00725751|20840949|P1|NOT COMPLETED|Overall Study||34
8457564|NCT00725751|20840948|P2|COMPLETED|Overall Study||150
8457565|NCT00725751|20840949|P1|COMPLETED|Overall Study||56
8457566|NCT00725751|20840948|P2|STARTED|Overall Study||258
8457567|NCT00725751|20840949|P1|STARTED|Overall Study||90
8457568|NCT00725725|20840961|P3|NOT COMPLETED|Overall Study||5
8457569|NCT00725725|20840962|P2|NOT COMPLETED|Overall Study||4
8457570|NCT00725725|20840963|P1|NOT COMPLETED|Overall Study||4
8457571|NCT00725725|20840961|P3|COMPLETED|Overall Study||12
8457572|NCT00725725|20840962|P2|COMPLETED|Overall Study||11
8457573|NCT00725725|20840963|P1|COMPLETED|Overall Study||10
8457574|NCT00725725|20840961|P3|Treated|Overall Study||14
8457575|NCT00725725|20840962|P2|Treated|Overall Study||15
8457576|NCT00725725|20840963|P1|Treated|Overall Study||11
8457577|NCT00725725|20840961|P3|STARTED|Overall Study||17
8457578|NCT00725725|20840962|P2|STARTED|Overall Study||15
8457579|NCT00725725|20840963|P1|STARTED|Overall Study||14
8457580|NCT00725712|20841006|P2|NOT COMPLETED|Overall Study||26
8457581|NCT00725712|20841007|P1|NOT COMPLETED|Overall Study||48
8457582|NCT00725712|20841006|P2|COMPLETED|Overall Study||0
8457583|NCT00725712|20841007|P1|COMPLETED|Overall Study||0
8457584|NCT00725712|20841006|P2|STARTED|Overall Study||26
8457585|NCT00725712|20841007|P1|STARTED|Overall Study||48
8457586|NCT00725621|20841043|P1|NOT COMPLETED|Overall Study||271
8457587|NCT00725621|20841043|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
8457588|NCT00725621|20841043|P1|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
8457589|NCT00725608|20841066|P1|NOT COMPLETED|Overall Study||167
8457590|NCT00725608|20841066|P1|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
8457591|NCT00725608|20841066|P1|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
8457592|NCT00725543|20841072|P1|NOT COMPLETED|Overall Study||153
8457593|NCT00725543|20841072|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
8457594|NCT00725543|20841072|P1|STARTED|Overall Study||358
8457595|NCT00725530|20841081|P2|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
8457596|NCT00725530|20841082|P1|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
8457597|NCT00725530|20841081|P2|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
8457598|NCT00725530|20841082|P1|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
8457599|NCT00725530|20841081|P2|STARTED|Second Intervention, 7 Days (+0/-1)||27
8457600|NCT00725530|20841082|P1|STARTED|Second Intervention, 7 Days (+0/-1)||27
8457601|NCT00725530|20841081|P2|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
8457602|NCT00725530|20841082|P1|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
8457603|NCT00725530|20841081|P2|COMPLETED|First Intervention, 7 Days (+0/-1)||27
8457604|NCT00725530|20841082|P1|COMPLETED|First Intervention, 7 Days (+0/-1)||27
8457605|NCT00725530|20841081|P2|STARTED|First Intervention, 7 Days (+0/-1)||27
8457606|NCT00725530|20841082|P1|STARTED|First Intervention, 7 Days (+0/-1)||27
8457607|NCT00725504|20841088|P1|NOT COMPLETED|Overall Study||0
8457608|NCT00725504|20841088|P1|COMPLETED|Overall Study||71
8457609|NCT00725504|20841088|P1|STARTED|Overall Study||71
8457610|NCT00725491|20841097|P2|NOT COMPLETED|Overall Study||18
8457611|NCT00725491|20841098|P1|NOT COMPLETED|Overall Study||9
8457612|NCT00725491|20841097|P2|COMPLETED|Overall Study||102
8457613|NCT00725491|20841098|P1|COMPLETED|Overall Study||104
8457614|NCT00725491|20841097|P2|STARTED|Overall Study|Intent-to-Treat Group|120
8457615|NCT00725491|20841098|P1|STARTED|Overall Study|Intent-to-Treat Group|113
8457616|NCT00725452|20841104|P1|NOT COMPLETED|Overall Study||11
8457617|NCT00725452|20841104|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
8457618|NCT00725452|20841104|P1|STARTED|Overall Study||26
8457619|NCT00725361|20841113|P1|NOT COMPLETED|Overall Study||4
8457620|NCT00725361|20841113|P1|COMPLETED|Overall Study||16
8457621|NCT00725361|20841113|P1|STARTED|Overall Study||20
8457622|NCT00725322|20841123|P2|NOT COMPLETED|Second Injection Visit||0
8457623|NCT00725322|20841124|P1|NOT COMPLETED|Second Injection Visit||0
8457624|NCT00725322|20841123|P2|COMPLETED|Second Injection Visit||14
8457625|NCT00725322|20841124|P1|COMPLETED|Second Injection Visit||13
8457626|NCT00725322|20841123|P2|STARTED|Second Injection Visit||14
8457627|NCT00725322|20841124|P1|STARTED|Second Injection Visit||13
8457628|NCT00725322|20841123|P2|NOT COMPLETED|Washout (28 Days)||1
8457629|NCT00725322|20841124|P1|NOT COMPLETED|Washout (28 Days)||2
8457630|NCT00725322|20841123|P2|COMPLETED|Washout (28 Days)||14
8457631|NCT00725322|20841124|P1|COMPLETED|Washout (28 Days)||13
8457632|NCT00725322|20841123|P2|STARTED|Washout (28 Days)||15
8457633|NCT00725322|20841124|P1|STARTED|Washout (28 Days)||15
8457634|NCT00725322|20841123|P2|NOT COMPLETED|First Injection Visit||0
8457635|NCT00725322|20841124|P1|NOT COMPLETED|First Injection Visit||0
8457636|NCT00725322|20841123|P2|COMPLETED|First Injection Visit||15
8457637|NCT00725322|20841124|P1|COMPLETED|First Injection Visit||15
8457638|NCT00725322|20841123|P2|STARTED|First Injection Visit||15
8457639|NCT00725322|20841124|P1|STARTED|First Injection Visit||15
8457640|NCT00725296|20841132|P1|NOT COMPLETED|Overall Study||62
8457641|NCT00725296|20841132|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
8457642|NCT00725296|20841132|P1|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
8457643|NCT00725283|20841141|P1|NOT COMPLETED|Overall Study||24
8457644|NCT00725283|20841141|P1|COMPLETED|Overall Study||10
8457645|NCT00725283|20841141|P1|STARTED|Overall Study||34
8457646|NCT00725270|20841153|P2|NOT COMPLETED|Overall Study||0
8457647|NCT00725270|20841154|P1|NOT COMPLETED|Overall Study||0
8457648|NCT00725270|20841153|P2|COMPLETED|Overall Study||7
8457649|NCT00725270|20841154|P1|COMPLETED|Overall Study||5
8457650|NCT00725270|20841153|P2|STARTED|Overall Study||7
8457651|NCT00725270|20841154|P1|STARTED|Overall Study||5
8457652|NCT00725205|20841162|P1|NOT COMPLETED|Overall Study||87
8457653|NCT00725205|20841162|P1|COMPLETED|Overall Study||207
8457654|NCT00725205|20841162|P1|STARTED|Overall Study||294
8457655|NCT00725153|20841168|P2|NOT COMPLETED|Period Two, 10 Hours of Wear||0
8457656|NCT00725153|20841169|P1|NOT COMPLETED|Period Two, 10 Hours of Wear||0
8457657|NCT00725153|20841168|P2|COMPLETED|Period Two, 10 Hours of Wear||28
8457658|NCT00725153|20841169|P1|COMPLETED|Period Two, 10 Hours of Wear||27
8457659|NCT00725153|20841168|P2|STARTED|Period Two, 10 Hours of Wear||28
8457660|NCT00725153|20841169|P1|STARTED|Period Two, 10 Hours of Wear||27
8457661|NCT00725153|20841168|P2|NOT COMPLETED|Period One, 10 Hours of Wear||0
8457662|NCT00725153|20841169|P1|NOT COMPLETED|Period One, 10 Hours of Wear||0
8457663|NCT00725153|20841168|P2|COMPLETED|Period One, 10 Hours of Wear||28
8457664|NCT00725153|20841169|P1|COMPLETED|Period One, 10 Hours of Wear||27
8457665|NCT00725153|20841168|P2|STARTED|Period One, 10 Hours of Wear||28
8457666|NCT00725153|20841169|P1|STARTED|Period One, 10 Hours of Wear||27
8457667|NCT00725101|20841175|P1|NOT COMPLETED|Overall Study||495
8457668|NCT00725101|20841175|P1|COMPLETED|Overall Study||1205
8457669|NCT00725101|20841175|P1|STARTED|Overall Study||1700
8457670|NCT00725075|20841198|P3|NOT COMPLETED|Overall Study||9
8457671|NCT00725075|20841199|P2|NOT COMPLETED|Overall Study||8
8457672|NCT00725075|20841200|P1|NOT COMPLETED|Overall Study||11
8457673|NCT00725075|20841198|P3|COMPLETED|Overall Study||61
8457674|NCT00725075|20841199|P2|COMPLETED|Overall Study||65
8457675|NCT00725075|20841200|P1|COMPLETED|Overall Study||61
8457676|NCT00725075|20841198|P3|Treated|Overall Study||70
8457677|NCT00725075|20841199|P2|Treated|Overall Study||73
8457678|NCT00725075|20841200|P1|Treated|Overall Study||71
8457679|NCT00725075|20841198|P3|STARTED|Overall Study||70
8457680|NCT00725075|20841199|P2|STARTED|Overall Study||73
8457681|NCT00725075|20841200|P1|STARTED|Overall Study||72
8457688|NCT00725010|20841253|P1|NOT COMPLETED|Overall Study||25
8457689|NCT00725010|20841253|P1|COMPLETED|Overall Study||25
8457690|NCT00725010|20841253|P1|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
8457691|NCT00724984|20841267|P6|NOT COMPLETED|Overall Study||5
8457692|NCT00724984|20841268|P5|NOT COMPLETED|Overall Study||4
8457693|NCT00724984|20841269|P4|NOT COMPLETED|Overall Study||2
8457694|NCT00724984|20841270|P3|NOT COMPLETED|Overall Study||0
8457695|NCT00724984|20841271|P2|NOT COMPLETED|Overall Study||1
8457696|NCT00724984|20841272|P1|NOT COMPLETED|Overall Study||1
8457697|NCT00724984|20841267|P6|COMPLETED|Overall Study||9
8457698|NCT00724984|20841268|P5|COMPLETED|Overall Study||12
8457699|NCT00724984|20841269|P4|COMPLETED|Overall Study||7
8457700|NCT00724984|20841270|P3|COMPLETED|Overall Study||3
8457701|NCT00724984|20841271|P2|COMPLETED|Overall Study||7
8457702|NCT00724984|20841272|P1|COMPLETED|Overall Study||4
8457703|NCT00724984|20841267|P6|STARTED|Overall Study||14
8457704|NCT00724984|20841268|P5|STARTED|Overall Study||16
8457705|NCT00724984|20841269|P4|STARTED|Overall Study||9
8457706|NCT00724984|20841270|P3|STARTED|Overall Study||3
8457707|NCT00724984|20841271|P2|STARTED|Overall Study||8
8457708|NCT00724984|20841272|P1|STARTED|Overall Study||5
8457709|NCT00724971|20841286|P1|NOT COMPLETED|Overall Study||6
8457710|NCT00724971|20841286|P1|COMPLETED|Overall Study||4
8457711|NCT00724971|20841286|P1|STARTED|Overall Study||10
8457712|NCT00724958|20841301|P1|NOT COMPLETED|Overall Study||182
8457713|NCT00724958|20841301|P1|COMPLETED|Overall Study||166
8457714|NCT00724958|20841301|P1|STARTED|Overall Study||348
8457715|NCT00724945|20841310|P2|NOT COMPLETED|Period 2||0
8457716|NCT00724945|20841311|P1|NOT COMPLETED|Period 2||4
8457717|NCT00724945|20841310|P2|COMPLETED|Period 2||54
8457718|NCT00724945|20841311|P1|COMPLETED|Period 2||51
8457719|NCT00724945|20841310|P2|STARTED|Period 2||54
8457720|NCT00724945|20841311|P1|STARTED|Period 2||55
8457721|NCT00724945|20841310|P2|NOT COMPLETED|Period 1||1
8457722|NCT00724945|20841311|P1|NOT COMPLETED|Period 1||3
8457723|NCT00724945|20841310|P2|COMPLETED|Period 1||54
8457724|NCT00724945|20841311|P1|COMPLETED|Period 1||55
8457725|NCT00724945|20841310|P2|STARTED|Period 1||55
8457726|NCT00724945|20841311|P1|STARTED|Period 1||58
8457727|NCT00724932|20841323|P2|NOT COMPLETED|Overall Study||3
8457728|NCT00724932|20841324|P1|NOT COMPLETED|Overall Study||5
8457729|NCT00724932|20841323|P2|COMPLETED|Overall Study||67
8457730|NCT00724932|20841324|P1|COMPLETED|Overall Study||65
8457731|NCT00724932|20841323|P2|STARTED|Overall Study||70
8457732|NCT00724932|20841324|P1|STARTED|Overall Study||70
8457733|NCT00724893|20841395|P2|NOT COMPLETED|Overall Study||458
8457734|NCT00724893|20841396|P1|NOT COMPLETED|Overall Study||364
8457735|NCT00724893|20841395|P2|COMPLETED|Overall Study||670
8457736|NCT00724893|20841396|P1|COMPLETED|Overall Study||938
8457737|NCT00724893|20841395|P2|STARTED|Overall Study||1128
8457738|NCT00724893|20841396|P1|STARTED|Overall Study||1302
8457739|NCT00724867|20841464|P1|NOT COMPLETED|Overall Study||128
8457740|NCT00724867|20841464|P1|COMPLETED|Overall Study||140
8457741|NCT00724867|20841464|P1|STARTED|Overall Study||268
8457742|NCT00724854|20841504|P2|NOT COMPLETED|Overall Study||31
8457743|NCT00724854|20841505|P1|NOT COMPLETED|Overall Study||403
8457744|NCT00724854|20841504|P2|COMPLETED|Overall Study||41
8457745|NCT00724854|20841505|P1|COMPLETED|Overall Study||607
8457746|NCT00724854|20841504|P2|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
8457747|NCT00724854|20841505|P1|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
8457748|NCT00724815|20841522|P2|NOT COMPLETED|Overall Study||39
8457749|NCT00724815|20841523|P1|NOT COMPLETED|Overall Study||43
8457750|NCT00724815|20841522|P2|COMPLETED|Overall Study||226
8457751|NCT00724815|20841523|P1|COMPLETED|Overall Study||222
8457752|NCT00724815|20841522|P2|STARTED|Overall Study|subjects randomized|265
8457753|NCT00724815|20841523|P1|STARTED|Overall Study|subjects randomized|265
8457754|NCT00724750|20841537|P2|NOT COMPLETED|Overall Study||0
8457755|NCT00724750|20841538|P1|NOT COMPLETED|Overall Study||0
8457756|NCT00724750|20841537|P2|COMPLETED|Overall Study||42
8457757|NCT00724750|20841538|P1|COMPLETED|Overall Study||45
8457758|NCT00724750|20841537|P2|STARTED|Overall Study||42
8457759|NCT00724750|20841538|P1|STARTED|Overall Study||45
8457760|NCT00724711|20841556|P2|NOT COMPLETED|Overall Study||17
8457761|NCT00724711|20841557|P1|NOT COMPLETED|Overall Study||17
8457762|NCT00724711|20841556|P2|COMPLETED|Overall Study||139
8457763|NCT00724711|20841557|P1|COMPLETED|Overall Study||138
8457764|NCT00724711|20841556|P2|STARTED|Overall Study||156
8457765|NCT00724711|20841557|P1|STARTED|Overall Study||155
8457766|NCT00724698|20841589|P1|NOT COMPLETED|Overall Study||90
8457767|NCT00724698|20841589|P1|COMPLETED|Overall Study||2921
8457768|NCT00724698|20841589|P1|STARTED|Overall Study||3011
8457781|NCT00724568|20841634|P2|NOT COMPLETED|Overall Study||0
8457782|NCT00724568|20841635|P1|NOT COMPLETED|Overall Study||0
8457783|NCT00724568|20841634|P2|COMPLETED|Overall Study||32
8457784|NCT00724568|20841635|P1|COMPLETED|Overall Study||42
8457785|NCT00724568|20841634|P2|STARTED|Overall Study||32
8457786|NCT00724568|20841635|P1|STARTED|Overall Study||42
8457787|NCT00724503|20841642|P2|NOT COMPLETED|Overall Study||220
8457788|NCT00724503|20841643|P1|NOT COMPLETED|Overall Study||210
8457789|NCT00724503|20841642|P2|COMPLETED|Overall Study||43
8457790|NCT00724503|20841643|P1|COMPLETED|Overall Study||57
8457791|NCT00724503|20841642|P2|STARTED|Overall Study||263
8457792|NCT00724503|20841643|P1|STARTED|Overall Study||267
8457793|NCT00724477|20841651|P1|NOT COMPLETED|Overall Study||0
8457794|NCT00724477|20841651|P1|COMPLETED|Overall Study||1663
8457795|NCT00724477|20841651|P1|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
8457796|NCT00724464|20841655|P1|NOT COMPLETED|Overall Study||23
8457797|NCT00724464|20841655|P1|COMPLETED|Overall Study||309
8457798|NCT00724464|20841655|P1|STARTED|Overall Study||332
8457799|NCT00724451|20841667|P1|NOT COMPLETED|Overall Study||802
8457800|NCT00724451|20841667|P1|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
8457801|NCT00724451|20841667|P1|Received Antiviral Treatment|Overall Study||500
8457802|NCT00724451|20841667|P1|STARTED|Overall Study||1128
8457803|NCT00724373|20841673|P1|NOT COMPLETED|Overall Study||171
8457804|NCT00724373|20841673|P1|COMPLETED|Overall Study||271
8457805|NCT00724373|20841673|P1|STARTED|Overall Study||442
8457806|NCT00724347|20841677|P1|NOT COMPLETED|Overall Study||2
8457807|NCT00724347|20841677|P1|COMPLETED|Overall Study||16
8457808|NCT00724347|20841677|P1|Baseline Testing|Overall Study||18
8457809|NCT00724347|20841677|P1|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
8457810|NCT00724308|20841683|P2|NOT COMPLETED|Overall Study||97
8457811|NCT00724308|20841684|P1|NOT COMPLETED|Overall Study||80
8457812|NCT00724308|20841683|P2|COMPLETED|Overall Study||210
8457813|NCT00724308|20841684|P1|COMPLETED|Overall Study||190
8457814|NCT00724308|20841683|P2|STARTED|Overall Study||307
8457815|NCT00724308|20841684|P1|STARTED|Overall Study||270
8457816|NCT00724282|20841698|P1|NOT COMPLETED|Overall Study||4
8457817|NCT00724282|20841698|P1|COMPLETED|Overall Study||16
8457818|NCT00724282|20841698|P1|STARTED|Overall Study||20
8457819|NCT00724243|20841702|P1|NOT COMPLETED|Overall Study||15
8457820|NCT00724243|20841702|P1|COMPLETED|Overall Study||18
8457821|NCT00724243|20841702|P1|STARTED|Overall Study||33
8457822|NCT00724152|20841712|P3|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
8457823|NCT00724152|20841713|P2|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
8457824|NCT00724152|20841714|P1|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
8457825|NCT00724152|20841712|P3|COMPLETED|Three-arm Study Period (+Standard Care)||1
8457826|NCT00724152|20841713|P2|COMPLETED|Three-arm Study Period (+Standard Care)||0
8457827|NCT00724152|20841714|P1|COMPLETED|Three-arm Study Period (+Standard Care)||3
8457828|NCT00724152|20841712|P3|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
8457829|NCT00724152|20841713|P2|STARTED|Three-arm Study Period (+Standard Care)||2
8457830|NCT00724152|20841714|P1|STARTED|Three-arm Study Period (+Standard Care)||4
8457831|NCT00724152|20841712|P3|NOT COMPLETED|Two-arm Study Period||0
8457832|NCT00724152|20841713|P2|NOT COMPLETED|Two-arm Study Period||2
8457833|NCT00724152|20841714|P1|NOT COMPLETED|Two-arm Study Period||3
8457834|NCT00724152|20841712|P3|COMPLETED|Two-arm Study Period||0
8457835|NCT00724152|20841713|P2|COMPLETED|Two-arm Study Period||9
8457836|NCT00724152|20841714|P1|COMPLETED|Two-arm Study Period||11
8457837|NCT00724152|20841712|P3|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
8457838|NCT00724152|20841713|P2|STARTED|Two-arm Study Period||11
8457839|NCT00724152|20841714|P1|STARTED|Two-arm Study Period||14
8457840|NCT00724126|20841731|P2|NOT COMPLETED|Overall Study||15
8457841|NCT00724126|20841732|P1|NOT COMPLETED|Overall Study||19
8457842|NCT00724126|20841731|P2|COMPLETED|Overall Study||301
8457843|NCT00724126|20841732|P1|COMPLETED|Overall Study||302
8457844|NCT00724126|20841731|P2|STARTED|Overall Study||316
8457845|NCT00724126|20841732|P1|STARTED|Overall Study||321
8457846|NCT00724061|20841740|P1|NOT COMPLETED|Maintenance Therapy||0
8457847|NCT00724061|20841740|P1|COMPLETED|Maintenance Therapy||2
8457848|NCT00724061|20841740|P1|STARTED|Maintenance Therapy||2
8457849|NCT00724061|20841740|P1|NOT COMPLETED|Dose Escalation Phase||5
8457850|NCT00724061|20841740|P1|COMPLETED|Dose Escalation Phase||2
8457851|NCT00724061|20841740|P1|STARTED|Dose Escalation Phase||7
8457852|NCT00724009|20841747|P1|NOT COMPLETED|Overall Study||0
8457853|NCT00724009|20841747|P1|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
8457854|NCT00724009|20841747|P1|STARTED|Overall Study||29
8457855|NCT00723957|20841760|P2|NOT COMPLETED|Overall Study||53
8457856|NCT00723957|20841761|P1|NOT COMPLETED|Overall Study||51
8457857|NCT00723957|20841760|P2|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
8457858|NCT00723957|20841761|P1|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
8457859|NCT00723957|20841760|P2|STARTED|Overall Study|Randomized|99
8457860|NCT00723957|20841761|P1|STARTED|Overall Study|Randomized|98
8457861|NCT00723944|20841785|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
8457862|NCT00723944|20841786|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
8457863|NCT00723944|20841785|P2|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
8457864|NCT00723944|20841786|P1|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
8457865|NCT00723944|20841785|P2|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
8457866|NCT00723944|20841786|P1|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
8457867|NCT00723944|20841785|P2|NOT COMPLETED|One Year Post Placement Follow-up||4
8457868|NCT00723944|20841786|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
8457869|NCT00723944|20841785|P2|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
8457870|NCT00723944|20841786|P1|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
8457871|NCT00723944|20841785|P2|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
8457872|NCT00723944|20841786|P1|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
8458038|NCT00723255|20842168|P1|STARTED|Overall Study||53
8457873|NCT00723944|20841785|P2|NOT COMPLETED|Permanent Prosthesis Placement||9
8457874|NCT00723944|20841786|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
8457875|NCT00723944|20841785|P2|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
8457876|NCT00723944|20841786|P1|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
8457877|NCT00723944|20841785|P2|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
8457878|NCT00723944|20841786|P1|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
8457879|NCT00723944|20841785|P2|NOT COMPLETED|Implant Placement Surgery||0
8457880|NCT00723944|20841786|P1|NOT COMPLETED|Implant Placement Surgery||0
8457881|NCT00723944|20841785|P2|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
8457882|NCT00723944|20841786|P1|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
8457883|NCT00723944|20841785|P2|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
8457884|NCT00723944|20841786|P1|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
8457885|NCT00723931|20841792|P1|NOT COMPLETED|Overall Study||0
8457886|NCT00723931|20841792|P1|COMPLETED|Overall Study||1267
8457887|NCT00723931|20841792|P1|STARTED|Overall Study||1267
8457888|NCT00723892|20841799|P2|NOT COMPLETED|Overall Study||87
8457889|NCT00723892|20841800|P1|NOT COMPLETED|Overall Study||107
8457890|NCT00723892|20841799|P2|COMPLETED|Overall Study||168
8457891|NCT00723892|20841800|P1|COMPLETED|Overall Study||206
8457892|NCT00723892|20841799|P2|STARTED|Overall Study||255
8457893|NCT00723892|20841800|P1|STARTED|Overall Study||313
8457894|NCT00723840|20841807|P1|NOT COMPLETED|Overall Study||82
8457895|NCT00723840|20841807|P1|COMPLETED|Overall Study||163
8457896|NCT00723840|20841807|P1|STARTED|Overall Study||245
8457897|NCT00723827|20841818|P1|NOT COMPLETED|Overall Study||0
8457898|NCT00723827|20841818|P1|COMPLETED|Overall Study||682
8457899|NCT00723827|20841818|P1|STARTED|Overall Study||682
8457900|NCT00723801|20841828|P2|NOT COMPLETED|Overall Study||3
8457901|NCT00723801|20841829|P1|NOT COMPLETED|Overall Study||3
8457902|NCT00723801|20841828|P2|COMPLETED|Overall Study||17
8457903|NCT00723801|20841829|P1|COMPLETED|Overall Study||17
8457904|NCT00723801|20841828|P2|STARTED|Overall Study||20
8457905|NCT00723801|20841829|P1|STARTED|Overall Study||20
8457906|NCT00723788|20841837|P1|NOT COMPLETED|Overall Study||0
8457907|NCT00723788|20841837|P1|COMPLETED|Overall Study||21
8457908|NCT00723788|20841837|P1|STARTED|Overall Study||21
8457909|NCT00723749|20841843|P1|NOT COMPLETED|Overall Study||163
8457910|NCT00723749|20841843|P1|COMPLETED|Overall Study||182
8457911|NCT00723749|20841843|P1|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
8457912|NCT00723736|20841850|P1|NOT COMPLETED|Overall Study||1
8457913|NCT00723736|20841850|P1|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
8457914|NCT00723736|20841850|P1|STARTED|Overall Study||100
8457915|NCT00723710|20841854|P1|NOT COMPLETED|Overall Study||174
8457916|NCT00723710|20841854|P1|COMPLETED|Overall Study||120
8457917|NCT00723710|20841854|P1|STARTED|Overall Study||294
8457918|NCT00723697|20841858|P1|NOT COMPLETED|Overall Study||18
8457919|NCT00723697|20841858|P1|COMPLETED|Overall Study||1289
8457920|NCT00723697|20841858|P1|STARTED|Overall Study||1307
8457921|NCT00723645|20841866|P1|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
8457922|NCT00723645|20841866|P1|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
8457923|NCT00723645|20841866|P1|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
8457924|NCT00723645|20841866|P1|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
8457925|NCT00723645|20841866|P1|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
8457926|NCT00723645|20841866|P1|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
8457927|NCT00723645|20841866|P1|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
8457928|NCT00723645|20841866|P1|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
8457929|NCT00723645|20841866|P1|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
8457930|NCT00723632|20841871|P1|NOT COMPLETED|Overall Study||203
8457931|NCT00723632|20841871|P1|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
8457932|NCT00723632|20841871|P1|STARTED|Overall Study||901
8457939|NCT00723580|20841896|P1|NOT COMPLETED|Overall Study||0
8457940|NCT00723580|20841896|P1|COMPLETED|Overall Study|Completion of repeated Measurements|1
8457941|NCT00723580|20841896|P1|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
8457942|NCT00723580|20841896|P1|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
8457943|NCT00723554|20841900|P1|NOT COMPLETED|Overall Study||29
8457944|NCT00723554|20841900|P1|COMPLETED|Overall Study||34
8457945|NCT00723554|20841900|P1|STARTED|Overall Study||63
8457946|NCT00723528|20841950|P7|NOT COMPLETED|Period 2: After Controlled Period||4
8457947|NCT00723528|20841951|P6|NOT COMPLETED|Period 2: After Controlled Period||6
8457948|NCT00723528|20841952|P5|NOT COMPLETED|Period 2: After Controlled Period||2
8457949|NCT00723528|20841953|P4|NOT COMPLETED|Period 2: After Controlled Period||1
8457950|NCT00723528|20841954|P3|NOT COMPLETED|Period 2: After Controlled Period||0
8457951|NCT00723528|20841955|P2|NOT COMPLETED|Period 2: After Controlled Period||0
8457952|NCT00723528|20841956|P1|NOT COMPLETED|Period 2: After Controlled Period||0
8457953|NCT00723528|20841950|P7|COMPLETED|Period 2: After Controlled Period||54
8457954|NCT00723528|20841951|P6|COMPLETED|Period 2: After Controlled Period||58
8457955|NCT00723528|20841952|P5|COMPLETED|Period 2: After Controlled Period||11
8457956|NCT00723528|20841953|P4|COMPLETED|Period 2: After Controlled Period||14
8457957|NCT00723528|20841954|P3|COMPLETED|Period 2: After Controlled Period||0
8457958|NCT00723528|20841955|P2|COMPLETED|Period 2: After Controlled Period||0
8457959|NCT00723528|20841956|P1|COMPLETED|Period 2: After Controlled Period||0
8457960|NCT00723528|20841950|P7|STARTED|Period 2: After Controlled Period||58
8457961|NCT00723528|20841951|P6|STARTED|Period 2: After Controlled Period||64
8457962|NCT00723528|20841952|P5|STARTED|Period 2: After Controlled Period||13
8457963|NCT00723528|20841953|P4|STARTED|Period 2: After Controlled Period||15
8457964|NCT00723528|20841954|P3|STARTED|Period 2: After Controlled Period||0
8457965|NCT00723528|20841955|P2|STARTED|Period 2: After Controlled Period||0
8457966|NCT00723528|20841956|P1|STARTED|Period 2: After Controlled Period||0
8457967|NCT00723528|20841950|P7|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8457968|NCT00723528|20841951|P6|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8457969|NCT00723528|20841952|P5|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8457970|NCT00723528|20841953|P4|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8457971|NCT00723528|20841954|P3|NOT COMPLETED|Period 1: Controlled Period (CP)||4
8457972|NCT00723528|20841955|P2|NOT COMPLETED|Period 1: Controlled Period (CP)||0
8457973|NCT00723528|20841956|P1|NOT COMPLETED|Period 1: Controlled Period (CP)||4
8457974|NCT00723528|20841950|P7|COMPLETED|Period 1: Controlled Period (CP)||0
8457975|NCT00723528|20841951|P6|COMPLETED|Period 1: Controlled Period (CP)||0
8457976|NCT00723528|20841952|P5|COMPLETED|Period 1: Controlled Period (CP)||0
8457977|NCT00723528|20841953|P4|COMPLETED|Period 1: Controlled Period (CP)||0
8457978|NCT00723528|20841954|P3|COMPLETED|Period 1: Controlled Period (CP)||58
8457979|NCT00723528|20841955|P2|COMPLETED|Period 1: Controlled Period (CP)||64
8457980|NCT00723528|20841956|P1|COMPLETED|Period 1: Controlled Period (CP)||28
8457981|NCT00723528|20841950|P7|STARTED|Period 1: Controlled Period (CP)||0
8457982|NCT00723528|20841951|P6|STARTED|Period 1: Controlled Period (CP)||0
8457983|NCT00723528|20841952|P5|STARTED|Period 1: Controlled Period (CP)||0
8457984|NCT00723528|20841953|P4|STARTED|Period 1: Controlled Period (CP)||0
8457985|NCT00723528|20841954|P3|STARTED|Period 1: Controlled Period (CP)||62
8457986|NCT00723528|20841955|P2|STARTED|Period 1: Controlled Period (CP)||64
8457987|NCT00723528|20841956|P1|STARTED|Period 1: Controlled Period (CP)||32
8457988|NCT00723489|20842018|P4|NOT COMPLETED|Overall Study||3
8457989|NCT00723489|20842019|P3|NOT COMPLETED|Overall Study||0
8457990|NCT00723489|20842020|P2|NOT COMPLETED|Overall Study||4
8457991|NCT00723489|20842021|P1|NOT COMPLETED|Overall Study||1
8457992|NCT00723489|20842018|P4|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
8457993|NCT00723489|20842019|P3|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
8457994|NCT00723489|20842020|P2|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
8457995|NCT00723489|20842021|P1|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
8457996|NCT00723489|20842018|P4|STARTED|Overall Study||23
8457997|NCT00723489|20842019|P3|STARTED|Overall Study||19
8457998|NCT00723489|20842020|P2|STARTED|Overall Study||19
8457999|NCT00723489|20842021|P1|STARTED|Overall Study||21
8458000|NCT00723450|20842049|P3|NOT COMPLETED|Randomized Phase||67
8458001|NCT00723450|20842050|P2|NOT COMPLETED|Randomized Phase||65
8458002|NCT00723450|20842051|P1|NOT COMPLETED|Randomized Phase||0
8458003|NCT00723450|20842049|P3|COMPLETED|Randomized Phase||20
8458004|NCT00723450|20842050|P2|COMPLETED|Randomized Phase||21
8458005|NCT00723450|20842051|P1|COMPLETED|Randomized Phase||0
8458006|NCT00723450|20842049|P3|STARTED|Randomized Phase||87
8458007|NCT00723450|20842050|P2|STARTED|Randomized Phase||86
8458008|NCT00723450|20842051|P1|STARTED|Randomized Phase||0
8458009|NCT00723450|20842049|P3|NOT COMPLETED|Open-Label Phase||0
8458010|NCT00723450|20842050|P2|NOT COMPLETED|Open-Label Phase||0
8458011|NCT00723450|20842051|P1|NOT COMPLETED|Open-Label Phase||125
8458012|NCT00723450|20842049|P3|COMPLETED|Open-Label Phase||0
8458013|NCT00723450|20842050|P2|COMPLETED|Open-Label Phase||0
8458014|NCT00723450|20842051|P1|COMPLETED|Open-Label Phase||173
8458015|NCT00723450|20842049|P3|STARTED|Open-Label Phase||0
8458016|NCT00723450|20842050|P2|STARTED|Open-Label Phase||0
8458017|NCT00723450|20842051|P1|STARTED|Open-Label Phase||298
8458018|NCT00723398|20842097|P5|NOT COMPLETED|Overall Study||9
8458019|NCT00723398|20842098|P4|NOT COMPLETED|Overall Study||5
8458020|NCT00723398|20842099|P3|NOT COMPLETED|Overall Study||17
8458021|NCT00723398|20842100|P2|NOT COMPLETED|Overall Study||15
8458022|NCT00723398|20842101|P1|NOT COMPLETED|Overall Study||6
8458023|NCT00723398|20842097|P5|COMPLETED|Overall Study||44
8458024|NCT00723398|20842098|P4|COMPLETED|Overall Study||49
8458025|NCT00723398|20842099|P3|COMPLETED|Overall Study||36
8458026|NCT00723398|20842100|P2|COMPLETED|Overall Study||38
8458027|NCT00723398|20842101|P1|COMPLETED|Overall Study||47
8458028|NCT00723398|20842097|P5|STARTED|Overall Study||53
8458029|NCT00723398|20842098|P4|STARTED|Overall Study||54
8458030|NCT00723398|20842099|P3|STARTED|Overall Study||53
8458031|NCT00723398|20842100|P2|STARTED|Overall Study||53
8458032|NCT00723398|20842101|P1|STARTED|Overall Study||53
8458033|NCT00723294|20842163|P1|NOT COMPLETED|Overall Study||13
8458034|NCT00723294|20842163|P1|COMPLETED|Overall Study||86
8458035|NCT00723294|20842163|P1|STARTED|Overall Study||99
8458036|NCT00723255|20842168|P1|NOT COMPLETED|Overall Study||4
8458037|NCT00723255|20842168|P1|COMPLETED|Overall Study|Eligible and treated patients|49
8458039|NCT00723229|20842195|P2|NOT COMPLETED|Second Intervention||0
8458040|NCT00723229|20842196|P1|NOT COMPLETED|Second Intervention||0
8458041|NCT00723229|20842195|P2|COMPLETED|Second Intervention||20
8458042|NCT00723229|20842196|P1|COMPLETED|Second Intervention||18
8458043|NCT00723229|20842195|P2|STARTED|Second Intervention||20
8458044|NCT00723229|20842196|P1|STARTED|Second Intervention||18
8458045|NCT00723229|20842195|P2|NOT COMPLETED|First Intervention||3
8458046|NCT00723229|20842196|P1|NOT COMPLETED|First Intervention||7
8458047|NCT00723229|20842195|P2|COMPLETED|First Intervention||20
8458048|NCT00723229|20842196|P1|COMPLETED|First Intervention||18
8458049|NCT00723229|20842195|P2|STARTED|First Intervention||23
8458050|NCT00723229|20842196|P1|STARTED|First Intervention||25
8458051|NCT00723203|20842208|P1|NOT COMPLETED|Overall Study||3
8458052|NCT00723203|20842208|P1|COMPLETED|Overall Study||13
8458053|NCT00723203|20842208|P1|STARTED|Overall Study||16
8458054|NCT00723190|20842212|P1|NOT COMPLETED|Overall Study||142
8458055|NCT00723190|20842212|P1|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
8458056|NCT00723190|20842212|P1|SAFETY POPULATION|Overall Study||301
8458057|NCT00723190|20842212|P1|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
8458058|NCT00723177|20842230|P3|NOT COMPLETED|Overall Study||5
8458059|NCT00723177|20842231|P2|NOT COMPLETED|Overall Study||4
8458060|NCT00723177|20842232|P1|NOT COMPLETED|Overall Study||5
8458061|NCT00723177|20842230|P3|COMPLETED|Overall Study||10
8458062|NCT00723177|20842231|P2|COMPLETED|Overall Study||10
8458063|NCT00723177|20842232|P1|COMPLETED|Overall Study||10
8458064|NCT00723177|20842230|P3|STARTED|Overall Study||15
8458065|NCT00723177|20842231|P2|STARTED|Overall Study||14
8458066|NCT00723177|20842232|P1|STARTED|Overall Study||15
8458073|NCT00723099|20842256|P1|NOT COMPLETED|Overall Study||1
8458074|NCT00723099|20842256|P1|COMPLETED|Overall Study||72
8458075|NCT00723099|20842256|P1|STARTED|Overall Study||73
8458076|NCT00723073|20842270|P2|NOT COMPLETED|Overall Study||0
8458077|NCT00723073|20842271|P1|NOT COMPLETED|Overall Study||0
8458078|NCT00723073|20842270|P2|COMPLETED|Overall Study||174
8458079|NCT00723073|20842271|P1|COMPLETED|Overall Study||149
8458080|NCT00723073|20842270|P2|STARTED|Overall Study||174
8458081|NCT00723073|20842271|P1|STARTED|Overall Study||149
8458082|NCT00723021|20842295|P5|NOT COMPLETED|Intervention Period 5||0
8458083|NCT00723021|20842296|P4|NOT COMPLETED|Intervention Period 5||0
8458084|NCT00723021|20842297|P3|NOT COMPLETED|Intervention Period 5||0
8458085|NCT00723021|20842298|P2|NOT COMPLETED|Intervention Period 5||0
8458086|NCT00723021|20842299|P1|NOT COMPLETED|Intervention Period 5||0
8458087|NCT00723021|20842295|P5|COMPLETED|Intervention Period 5||2
8458088|NCT00723021|20842296|P4|COMPLETED|Intervention Period 5||3
8458089|NCT00723021|20842297|P3|COMPLETED|Intervention Period 5||3
8458090|NCT00723021|20842298|P2|COMPLETED|Intervention Period 5||3
8458091|NCT00723021|20842299|P1|COMPLETED|Intervention Period 5||3
8458092|NCT00723021|20842295|P5|STARTED|Intervention Period 5||2
8458093|NCT00723021|20842296|P4|STARTED|Intervention Period 5||3
8458094|NCT00723021|20842297|P3|STARTED|Intervention Period 5||3
8458095|NCT00723021|20842298|P2|STARTED|Intervention Period 5||3
8458096|NCT00723021|20842299|P1|STARTED|Intervention Period 5||3
8458097|NCT00723021|20842295|P5|NOT COMPLETED|Intervention Period 4||1
8458098|NCT00723021|20842296|P4|NOT COMPLETED|Intervention Period 4||0
8458099|NCT00723021|20842297|P3|NOT COMPLETED|Intervention Period 4||0
8458100|NCT00723021|20842298|P2|NOT COMPLETED|Intervention Period 4||0
8458101|NCT00723021|20842299|P1|NOT COMPLETED|Intervention Period 4||0
8458102|NCT00723021|20842295|P5|COMPLETED|Intervention Period 4||2
8458103|NCT00723021|20842296|P4|COMPLETED|Intervention Period 4||3
8458104|NCT00723021|20842297|P3|COMPLETED|Intervention Period 4||3
8458105|NCT00723021|20842298|P2|COMPLETED|Intervention Period 4||3
8458106|NCT00723021|20842299|P1|COMPLETED|Intervention Period 4||3
8458107|NCT00723021|20842295|P5|STARTED|Intervention Period 4||3
8458108|NCT00723021|20842296|P4|STARTED|Intervention Period 4||3
8458109|NCT00723021|20842297|P3|STARTED|Intervention Period 4||3
8458110|NCT00723021|20842298|P2|STARTED|Intervention Period 4||3
8458111|NCT00723021|20842299|P1|STARTED|Intervention Period 4||3
8458112|NCT00723021|20842295|P5|NOT COMPLETED|Intervention Period 3||0
8458113|NCT00723021|20842296|P4|NOT COMPLETED|Intervention Period 3||0
8458114|NCT00723021|20842297|P3|NOT COMPLETED|Intervention Period 3||0
8458115|NCT00723021|20842298|P2|NOT COMPLETED|Intervention Period 3||0
8458116|NCT00723021|20842299|P1|NOT COMPLETED|Intervention Period 3||0
8458117|NCT00723021|20842295|P5|COMPLETED|Intervention Period 3||3
8458118|NCT00723021|20842296|P4|COMPLETED|Intervention Period 3||3
8458119|NCT00723021|20842297|P3|COMPLETED|Intervention Period 3||3
8458120|NCT00723021|20842298|P2|COMPLETED|Intervention Period 3||3
8458121|NCT00723021|20842299|P1|COMPLETED|Intervention Period 3||3
8458122|NCT00723021|20842295|P5|STARTED|Intervention Period 3||3
8458123|NCT00723021|20842296|P4|STARTED|Intervention Period 3||3
8458124|NCT00723021|20842297|P3|STARTED|Intervention Period 3||3
8458125|NCT00723021|20842298|P2|STARTED|Intervention Period 3||3
8458126|NCT00723021|20842299|P1|STARTED|Intervention Period 3||3
8458127|NCT00723021|20842295|P5|NOT COMPLETED|Intervention Period 2||0
8458128|NCT00723021|20842296|P4|NOT COMPLETED|Intervention Period 2||0
8458129|NCT00723021|20842297|P3|NOT COMPLETED|Intervention Period 2||0
8458130|NCT00723021|20842298|P2|NOT COMPLETED|Intervention Period 2||0
8458131|NCT00723021|20842299|P1|NOT COMPLETED|Intervention Period 2||0
8458132|NCT00723021|20842295|P5|COMPLETED|Intervention Period 2||3
8458133|NCT00723021|20842296|P4|COMPLETED|Intervention Period 2||3
8458134|NCT00723021|20842297|P3|COMPLETED|Intervention Period 2||3
8458135|NCT00723021|20842298|P2|COMPLETED|Intervention Period 2||3
8458136|NCT00723021|20842299|P1|COMPLETED|Intervention Period 2||3
8458137|NCT00723021|20842295|P5|STARTED|Intervention Period 2||3
8458138|NCT00723021|20842296|P4|STARTED|Intervention Period 2||3
8458139|NCT00723021|20842297|P3|STARTED|Intervention Period 2||3
8458140|NCT00723021|20842298|P2|STARTED|Intervention Period 2||3
8458141|NCT00723021|20842299|P1|STARTED|Intervention Period 2||3
8458142|NCT00723021|20842295|P5|NOT COMPLETED|Intervention Period 1||0
8458143|NCT00723021|20842296|P4|NOT COMPLETED|Intervention Period 1||0
8458144|NCT00723021|20842297|P3|NOT COMPLETED|Intervention Period 1||0
8458145|NCT00723021|20842298|P2|NOT COMPLETED|Intervention Period 1||0
8458146|NCT00723021|20842299|P1|NOT COMPLETED|Intervention Period 1||0
8458147|NCT00723021|20842295|P5|COMPLETED|Intervention Period 1||3
8458148|NCT00723021|20842296|P4|COMPLETED|Intervention Period 1||3
8458149|NCT00723021|20842297|P3|COMPLETED|Intervention Period 1||3
8458150|NCT00723021|20842298|P2|COMPLETED|Intervention Period 1||3
8458151|NCT00723021|20842299|P1|COMPLETED|Intervention Period 1||3
8458152|NCT00723021|20842295|P5|STARTED|Intervention Period 1||3
8458153|NCT00723021|20842296|P4|STARTED|Intervention Period 1||3
8458154|NCT00723021|20842297|P3|STARTED|Intervention Period 1||3
8458155|NCT00723021|20842298|P2|STARTED|Intervention Period 1||3
8458156|NCT00723021|20842299|P1|STARTED|Intervention Period 1||3
8458157|NCT00723008|20842353|P2|NOT COMPLETED|4-Week Unblinded Treatment||1
8458158|NCT00723008|20842354|P1|NOT COMPLETED|4-Week Unblinded Treatment||1
8458159|NCT00723008|20842353|P2|COMPLETED|4-Week Unblinded Treatment||3
8458160|NCT00723008|20842354|P1|COMPLETED|4-Week Unblinded Treatment||4
8458161|NCT00723008|20842353|P2|STARTED|4-Week Unblinded Treatment||4
8458162|NCT00723008|20842354|P1|STARTED|4-Week Unblinded Treatment||5
8458163|NCT00723008|20842353|P2|NOT COMPLETED|4-Week Double Blinded||5
8458164|NCT00723008|20842354|P1|NOT COMPLETED|4-Week Double Blinded||5
8458165|NCT00723008|20842353|P2|COMPLETED|4-Week Double Blinded||4
8458166|NCT00723008|20842354|P1|COMPLETED|4-Week Double Blinded||5
8458167|NCT00723008|20842353|P2|STARTED|4-Week Double Blinded||9
8458168|NCT00723008|20842354|P1|STARTED|4-Week Double Blinded||10
8458169|NCT00723008|20842353|P2|NOT COMPLETED|Enrollment||0
8458170|NCT00723008|20842354|P1|NOT COMPLETED|Enrollment||1
8458171|NCT00723008|20842353|P2|COMPLETED|Enrollment||9
8458172|NCT00723008|20842354|P1|COMPLETED|Enrollment||10
8458173|NCT00723008|20842353|P2|STARTED|Enrollment||9
8458174|NCT00723008|20842354|P1|STARTED|Enrollment||11
8458175|NCT00722865|20842376|P1|NOT COMPLETED|Overall Study||2
8458176|NCT00722865|20842376|P1|COMPLETED|Overall Study||23
8458177|NCT00722865|20842376|P1|STARTED|Overall Study||25
8458178|NCT00722800|20842386|P2|NOT COMPLETED|Overall Study||0
8458179|NCT00722800|20842387|P1|NOT COMPLETED|Overall Study||2
8458180|NCT00722800|20842386|P2|COMPLETED|Overall Study||2
8458181|NCT00722800|20842387|P1|COMPLETED|Overall Study||0
8458182|NCT00722800|20842386|P2|STARTED|Overall Study||2
8458183|NCT00722800|20842387|P1|STARTED|Overall Study||2
8458184|NCT00722761|20842399|P2|NOT COMPLETED|Overall Study||6
8458185|NCT00722761|20842400|P1|NOT COMPLETED|Overall Study||6
8458186|NCT00722761|20842399|P2|COMPLETED|Overall Study||8
8458187|NCT00722761|20842400|P1|COMPLETED|Overall Study||10
8458188|NCT00722761|20842399|P2|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
8458189|NCT00722761|20842400|P1|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
8458190|NCT00722761|20842399|P2|STARTED|Overall Study||14
8458191|NCT00722761|20842400|P1|STARTED|Overall Study||16
8458192|NCT00722722|20842411|P3|NOT COMPLETED|Overall Study||0
8458193|NCT00722722|20842412|P2|NOT COMPLETED|Overall Study||0
8458194|NCT00722722|20842413|P1|NOT COMPLETED|Overall Study||0
8458195|NCT00722722|20842411|P3|COMPLETED|Overall Study||10
8458196|NCT00722722|20842412|P2|COMPLETED|Overall Study||5
8458197|NCT00722722|20842413|P1|COMPLETED|Overall Study||3
8458198|NCT00722722|20842411|P3|STARTED|Overall Study||10
8458199|NCT00722722|20842412|P2|STARTED|Overall Study||5
8458200|NCT00722722|20842413|P1|STARTED|Overall Study||3
8458201|NCT00722566|20842423|P2|NOT COMPLETED|Overall Study||35
8458202|NCT00722566|20842424|P1|NOT COMPLETED|Overall Study||67
8458203|NCT00722566|20842423|P2|COMPLETED|Overall Study|Completed 8 cycles|39
8458204|NCT00722566|20842424|P1|COMPLETED|Overall Study|Completed 8 cycles|81
8458205|NCT00722566|20842423|P2|STARTED|Overall Study||74
8458206|NCT00722566|20842424|P1|STARTED|Overall Study|One patient randomized and not dosed|148
8458207|NCT00722553|20842432|P1|NOT COMPLETED|Overall Study||0
8458208|NCT00722553|20842432|P1|COMPLETED|Overall Study||30
8458209|NCT00722553|20842432|P1|STARTED|Overall Study||30
8458210|NCT00722436|20842442|P2|NOT COMPLETED|Overall Study||0
8458211|NCT00722436|20842443|P1|NOT COMPLETED|Overall Study||0
8458212|NCT00722436|20842442|P2|COMPLETED|Overall Study||11
8458213|NCT00722436|20842443|P1|COMPLETED|Overall Study||9
8458214|NCT00722436|20842442|P2|STARTED|Overall Study||11
8458215|NCT00722436|20842443|P1|STARTED|Overall Study||9
8458216|NCT00722423|20842457|P2|NOT COMPLETED|Overall Study||1
8458217|NCT00722423|20842458|P1|NOT COMPLETED|Overall Study||0
8458218|NCT00722423|20842457|P2|COMPLETED|Overall Study||181
8458219|NCT00722423|20842458|P1|COMPLETED|Overall Study||182
8458220|NCT00722423|20842457|P2|STARTED|Overall Study||182
8458221|NCT00722423|20842458|P1|STARTED|Overall Study||182
8458222|NCT00722371|20842473|P7|NOT COMPLETED|Overall Study||51
8458223|NCT00722371|20842474|P6|NOT COMPLETED|Overall Study||53
8458224|NCT00722371|20842475|P5|NOT COMPLETED|Overall Study||48
8458225|NCT00722371|20842476|P4|NOT COMPLETED|Overall Study||63
8458226|NCT00722371|20842477|P3|NOT COMPLETED|Overall Study||65
8458227|NCT00722371|20842478|P2|NOT COMPLETED|Overall Study||72
8458228|NCT00722371|20842479|P1|NOT COMPLETED|Overall Study||56
8458229|NCT00722371|20842473|P7|COMPLETED|Overall Study||179
8458230|NCT00722371|20842474|P6|COMPLETED|Overall Study||178
8458231|NCT00722371|20842475|P5|COMPLETED|Overall Study||182
8458232|NCT00722371|20842476|P4|COMPLETED|Overall Study||167
8458233|NCT00722371|20842477|P3|COMPLETED|Overall Study||168
8458234|NCT00722371|20842478|P2|COMPLETED|Overall Study||158
8458235|NCT00722371|20842479|P1|COMPLETED|Overall Study||175
8458236|NCT00722371|20842473|P7|STARTED|Overall Study||230
8458237|NCT00722371|20842474|P6|STARTED|Overall Study||231
8458238|NCT00722371|20842475|P5|STARTED|Overall Study||230
8458239|NCT00722371|20842476|P4|STARTED|Overall Study||230
8458240|NCT00722371|20842477|P3|STARTED|Overall Study||233
8458241|NCT00722371|20842478|P2|STARTED|Overall Study||230
8458242|NCT00722371|20842479|P1|STARTED|Overall Study||231
8458243|NCT00722137|20842532|P2|NOT COMPLETED|Overall Study||48
8458244|NCT00722137|20842533|P1|NOT COMPLETED|Overall Study||45
8458245|NCT00722137|20842532|P2|COMPLETED|Overall Study||195
8458246|NCT00722137|20842533|P1|COMPLETED|Overall Study||199
8458247|NCT00722137|20842532|P2|STARTED|Overall Study||243
8458248|NCT00722137|20842533|P1|STARTED|Overall Study||244
8458249|NCT00722124|20842562|P3|NOT COMPLETED|Overall Study||20
8458250|NCT00722124|20842563|P2|NOT COMPLETED|Overall Study||14
8458251|NCT00722124|20842564|P1|NOT COMPLETED|Overall Study||17
8458252|NCT00722124|20842562|P3|COMPLETED|Overall Study||20
8458253|NCT00722124|20842563|P2|COMPLETED|Overall Study||26
8458254|NCT00722124|20842564|P1|COMPLETED|Overall Study||23
8458255|NCT00722124|20842562|P3|STARTED|Overall Study||40
8458256|NCT00722124|20842563|P2|STARTED|Overall Study||40
8458257|NCT00722124|20842564|P1|STARTED|Overall Study||40
8458258|NCT00722111|20842574|P2|NOT COMPLETED|Overall Study||0
8458259|NCT00722111|20842575|P1|NOT COMPLETED|Overall Study||0
8458260|NCT00722111|20842574|P2|COMPLETED|Overall Study||72
8458261|NCT00722111|20842575|P1|COMPLETED|Overall Study||11
8458262|NCT00722111|20842574|P2|STARTED|Overall Study||72
8458263|NCT00722111|20842575|P1|STARTED|Overall Study||11
8458264|NCT00722072|20842582|P1|NOT COMPLETED|Overall Study||3
8458265|NCT00722072|20842582|P1|COMPLETED|Overall Study||9
8458266|NCT00722072|20842582|P1|STARTED|Overall Study||12
8458267|NCT00722020|20842592|P2|NOT COMPLETED|Overall Study||0
8458268|NCT00722020|20842593|P1|NOT COMPLETED|Overall Study||0
8458269|NCT00722020|20842592|P2|COMPLETED|Overall Study||24
8458270|NCT00722020|20842593|P1|COMPLETED|Overall Study||19
8458271|NCT00722020|20842592|P2|STARTED|Overall Study||24
8458272|NCT00722020|20842593|P1|STARTED|Overall Study||19
8458273|NCT00722007|20842601|P1|NOT COMPLETED|Overall Study||30
8458274|NCT00722007|20842601|P1|COMPLETED|Overall Study||117
8458275|NCT00722007|20842601|P1|STARTED|Overall Study||147
8458276|NCT00721968|20842611|P2|NOT COMPLETED|Overall Study||0
8458277|NCT00721968|20842612|P1|NOT COMPLETED|Overall Study||2
8458278|NCT00721968|20842611|P2|COMPLETED|Overall Study||17
8458279|NCT00721968|20842612|P1|COMPLETED|Overall Study||25
8458280|NCT00721968|20842611|P2|STARTED|Overall Study||17
8458281|NCT00721968|20842612|P1|STARTED|Overall Study||27
8458282|NCT00721955|20842623|P3|NOT COMPLETED|Overall Study||2
8458283|NCT00721955|20842624|P2|NOT COMPLETED|Overall Study||0
8458284|NCT00721955|20842625|P1|NOT COMPLETED|Overall Study||0
8458285|NCT00721955|20842623|P3|COMPLETED|Overall Study||103
8458286|NCT00721955|20842624|P2|COMPLETED|Overall Study||104
8458287|NCT00721955|20842625|P1|COMPLETED|Overall Study||105
8458288|NCT00721955|20842623|P3|STARTED|Overall Study||105
8458289|NCT00721955|20842624|P2|STARTED|Overall Study||104
8458290|NCT00721955|20842625|P1|STARTED|Overall Study||105
8458291|NCT00721799|20842639|P1|NOT COMPLETED|Overall Study||8
8458292|NCT00721799|20842639|P1|COMPLETED|Overall Study||25
8458293|NCT00721799|20842639|P1|Received FLT PET Scan #2|Overall Study||25
8458294|NCT00721799|20842639|P1|Recieved FLT PET Scan 1|Overall Study||26
8458295|NCT00721799|20842639|P1|STARTED|Overall Study||33
8458296|NCT00721734|20842679|P5|NOT COMPLETED|Overall Study||6
8458297|NCT00721734|20842680|P4|NOT COMPLETED|Overall Study||6
8458298|NCT00721734|20842681|P3|NOT COMPLETED|Overall Study||8
8458299|NCT00721734|20842682|P2|NOT COMPLETED|Overall Study||12
8458300|NCT00721734|20842683|P1|NOT COMPLETED|Overall Study||8
8458301|NCT00721734|20842679|P5|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
8458302|NCT00721734|20842680|P4|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
8458303|NCT00721734|20842681|P3|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
8458304|NCT00721734|20842682|P2|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
8458305|NCT00721734|20842683|P1|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
8458306|NCT00721734|20842679|P5|STARTED|Overall Study||8
8458307|NCT00721734|20842680|P4|STARTED|Overall Study||8
8458308|NCT00721734|20842681|P3|STARTED|Overall Study||10
8458309|NCT00721734|20842682|P2|STARTED|Overall Study||12
8458310|NCT00721734|20842683|P1|STARTED|Overall Study||12
8458311|NCT00721630|20842795|P1|NOT COMPLETED|Overall Study||1
8458312|NCT00721630|20842795|P1|COMPLETED|Overall Study||23
8458313|NCT00721630|20842795|P1|STARTED|Overall Study||24
8458314|NCT00721617|20842800|P1|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
8458315|NCT00721617|20842800|P1|COMPLETED|8 Hours Into Intralipid/Dextrose||12
8458316|NCT00721617|20842800|P1|STARTED|8 Hours Into Intralipid/Dextrose||12
8458317|NCT00721617|20842800|P1|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
8458318|NCT00721617|20842800|P1|COMPLETED|4 Hours Into Intralipid/Dextrose||12
8458319|NCT00721617|20842800|P1|STARTED|4 Hours Into Intralipid/Dextrose||12
8458320|NCT00721617|20842800|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
8458321|NCT00721617|20842800|P1|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
8458322|NCT00721617|20842800|P1|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
8458323|NCT00721617|20842800|P1|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
8458324|NCT00721617|20842800|P1|COMPLETED|8 Hours Into Dextrose Infusion||12
8458325|NCT00721617|20842800|P1|STARTED|8 Hours Into Dextrose Infusion||12
8458326|NCT00721617|20842800|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
8458327|NCT00721617|20842800|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
8458328|NCT00721617|20842800|P1|STARTED|4 Hours Into Dextrose Infusion||12
8458329|NCT00721617|20842800|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
8458330|NCT00721617|20842800|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
8458331|NCT00721617|20842800|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
8458332|NCT00721617|20842800|P1|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
8458333|NCT00721617|20842800|P1|COMPLETED|8 Hours Into Intralipid Infusion||12
8458334|NCT00721617|20842800|P1|STARTED|8 Hours Into Intralipid Infusion||12
8458335|NCT00721617|20842800|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
8458336|NCT00721617|20842800|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
8458337|NCT00721617|20842800|P1|STARTED|4 Hours Into Intralipid Infusion||12
8458338|NCT00721617|20842800|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
8458339|NCT00721617|20842800|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
8458340|NCT00721617|20842800|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
8458341|NCT00721617|20842800|P1|NOT COMPLETED|8 Hours Into Saline Infusion||0
8458342|NCT00721617|20842800|P1|COMPLETED|8 Hours Into Saline Infusion||12
8458343|NCT00721617|20842800|P1|STARTED|8 Hours Into Saline Infusion||12
8458344|NCT00721617|20842800|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
8458345|NCT00721617|20842800|P1|COMPLETED|4 Hours Into Saline Infusion||12
8458346|NCT00721617|20842800|P1|STARTED|4 Hours Into Saline Infusion||12
8458347|NCT00721617|20842800|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
8458348|NCT00721617|20842800|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
8458349|NCT00721617|20842800|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
8458350|NCT00721578|20842824|P2|NOT COMPLETED|Overall Study||2
8458351|NCT00721578|20842825|P1|NOT COMPLETED|Overall Study||2
8458352|NCT00721578|20842824|P2|COMPLETED|Overall Study||9
8458353|NCT00721578|20842825|P1|COMPLETED|Overall Study||10
8458354|NCT00721578|20842824|P2|STARTED|Overall Study||11
8458355|NCT00721578|20842825|P1|STARTED|Overall Study||12
8458356|NCT00721539|20842837|P1|NOT COMPLETED|Overall Study||0
8458357|NCT00721539|20842837|P1|COMPLETED|Overall Study||9
8458358|NCT00721539|20842837|P1|STARTED|Overall Study||9
8458359|NCT00721513|20842844|P1|NOT COMPLETED|Overall Study||0
8458360|NCT00721513|20842844|P1|COMPLETED|Overall Study||20
8458361|NCT00721513|20842844|P1|STARTED|Overall Study||20
8458362|NCT00721500|20842856|P4|NOT COMPLETED|Period Three||0
8458363|NCT00721500|20842857|P3|NOT COMPLETED|Period Three||0
8458364|NCT00721500|20842858|P2|NOT COMPLETED|Period Three||0
8458365|NCT00721500|20842859|P1|NOT COMPLETED|Period Three||0
8458366|NCT00721500|20842856|P4|COMPLETED|Period Three||6
8458367|NCT00721500|20842857|P3|COMPLETED|Period Three||6
8458368|NCT00721500|20842858|P2|COMPLETED|Period Three||7
8458369|NCT00721500|20842859|P1|COMPLETED|Period Three||6
8458370|NCT00721500|20842856|P4|STARTED|Period Three||6
8458371|NCT00721500|20842857|P3|STARTED|Period Three||6
8458372|NCT00721500|20842858|P2|STARTED|Period Three||7
8458373|NCT00721500|20842859|P1|STARTED|Period Three||6
8458374|NCT00721500|20842856|P4|NOT COMPLETED|Period Two||0
8458375|NCT00721500|20842857|P3|NOT COMPLETED|Period Two||0
8458376|NCT00721500|20842858|P2|NOT COMPLETED|Period Two||0
8458377|NCT00721500|20842859|P1|NOT COMPLETED|Period Two||0
8458378|NCT00721500|20842856|P4|COMPLETED|Period Two||6
8458379|NCT00721500|20842857|P3|COMPLETED|Period Two||6
8458380|NCT00721500|20842858|P2|COMPLETED|Period Two||7
8458381|NCT00721500|20842859|P1|COMPLETED|Period Two||6
8458382|NCT00721500|20842856|P4|STARTED|Period Two||6
8458383|NCT00721500|20842857|P3|STARTED|Period Two||6
8458384|NCT00721500|20842858|P2|STARTED|Period Two||7
8458385|NCT00721500|20842859|P1|STARTED|Period Two||6
8458386|NCT00721500|20842856|P4|NOT COMPLETED|Period One||0
8458387|NCT00721500|20842857|P3|NOT COMPLETED|Period One||0
8458388|NCT00721500|20842858|P2|NOT COMPLETED|Period One||0
8458389|NCT00721500|20842859|P1|NOT COMPLETED|Period One||0
8458390|NCT00721500|20842856|P4|COMPLETED|Period One||6
8458391|NCT00721500|20842857|P3|COMPLETED|Period One||6
8458392|NCT00721500|20842858|P2|COMPLETED|Period One||7
8458393|NCT00721500|20842859|P1|COMPLETED|Period One||6
8458394|NCT00721500|20842856|P4|STARTED|Period One||6
8458395|NCT00721500|20842857|P3|STARTED|Period One||6
8458396|NCT00721500|20842858|P2|STARTED|Period One||7
8458397|NCT00721500|20842859|P1|STARTED|Period One||6
8458398|NCT00721409|20842880|P3|NOT COMPLETED|Overall Study||79
8458399|NCT00721409|20842881|P2|NOT COMPLETED|Overall Study||82
8458400|NCT00721409|20842882|P1|NOT COMPLETED|Overall Study||12
8458401|NCT00721409|20842880|P3|COMPLETED|Overall Study||2
8458402|NCT00721409|20842881|P2|COMPLETED|Overall Study||2
8458403|NCT00721409|20842882|P1|COMPLETED|Overall Study||0
8458404|NCT00721409|20842880|P3|Treated|Overall Study||77
8458405|NCT00721409|20842881|P2|Treated|Overall Study||83
8458406|NCT00721409|20842882|P1|Treated|Overall Study||12
8458407|NCT00721409|20842880|P3|STARTED|Overall Study||81
8458408|NCT00721409|20842881|P2|STARTED|Overall Study||84
8458409|NCT00721409|20842882|P1|STARTED|Overall Study||12
8458410|NCT00721396|20843009|P4|NOT COMPLETED|Overall Study||10
8458411|NCT00721396|20843010|P3|NOT COMPLETED|Overall Study||10
8458412|NCT00721396|20843011|P2|NOT COMPLETED|Overall Study||36
8458413|NCT00721396|20843012|P1|NOT COMPLETED|Overall Study||30
8458414|NCT00721396|20843009|P4|COMPLETED|Overall Study||302
8458415|NCT00721396|20843010|P3|COMPLETED|Overall Study||308
8458416|NCT00721396|20843011|P2|COMPLETED|Overall Study||592
8458417|NCT00721396|20843012|P1|COMPLETED|Overall Study||597
8458418|NCT00721396|20843009|P4|STARTED|Overall Study||312
8458419|NCT00721396|20843010|P3|STARTED|Overall Study||318
8458420|NCT00721396|20843011|P2|STARTED|Overall Study||628
8458421|NCT00721396|20843012|P1|STARTED|Overall Study||627
8458422|NCT00721357|20843050|P2|NOT COMPLETED|Overall Study||0
8458423|NCT00721357|20843051|P1|NOT COMPLETED|Overall Study||0
8458424|NCT00721357|20843050|P2|COMPLETED|Overall Study||15
8458425|NCT00721357|20843051|P1|COMPLETED|Overall Study||15
8458426|NCT00721357|20843050|P2|STARTED|Overall Study||15
8458427|NCT00721357|20843051|P1|STARTED|Overall Study||15
8458428|NCT00721279|20843063|P2|NOT COMPLETED|Overall Study||24
8458429|NCT00721279|20843064|P1|NOT COMPLETED|Overall Study||36
8458430|NCT00721279|20843063|P2|COMPLETED|Overall Study||73
8458431|NCT00721279|20843064|P1|COMPLETED|Overall Study||416
8458432|NCT00721279|20843063|P2|STARTED|Overall Study||97
8458433|NCT00721279|20843064|P1|STARTED|Overall Study||452
8458434|NCT00721253|20843078|P3|NOT COMPLETED|Overall Study||0
8458435|NCT00721253|20843079|P2|NOT COMPLETED|Overall Study||0
8458436|NCT00721253|20843080|P1|NOT COMPLETED|Overall Study||0
8458437|NCT00721253|20843078|P3|COMPLETED|Overall Study||0
8458438|NCT00721253|20843079|P2|COMPLETED|Overall Study||22
8458439|NCT00721253|20843080|P1|COMPLETED|Overall Study||20
8458440|NCT00721253|20843078|P3|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
8458441|NCT00721253|20843079|P2|STARTED|Overall Study||22
8458442|NCT00721253|20843080|P1|STARTED|Overall Study||20
8458443|NCT00721227|20843092|P2|NOT COMPLETED|Overall Study||0
8458444|NCT00721227|20843093|P1|NOT COMPLETED|Overall Study||4
8458445|NCT00721227|20843092|P2|COMPLETED|Overall Study||6
8458446|NCT00721227|20843093|P1|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
8458447|NCT00721227|20843092|P2|STARTED|Overall Study||6
8458448|NCT00721227|20843093|P1|STARTED|Overall Study||9
8458449|NCT00721214|20843103|P1|NOT COMPLETED|Overall Study||4
8458450|NCT00721214|20843103|P1|COMPLETED|Overall Study||12
8458451|NCT00721214|20843103|P1|STARTED|Overall Study||16
8458452|NCT00721188|20843114|P1|NOT COMPLETED|Overall Study||0
8458453|NCT00721188|20843114|P1|COMPLETED|Overall Study||11
8458454|NCT00721188|20843114|P1|STARTED|Overall Study||11
8458455|NCT00721175|20843131|P2|NOT COMPLETED|Overall Study||0
8458456|NCT00721175|20843132|P1|NOT COMPLETED|Overall Study||0
8458457|NCT00721175|20843131|P2|COMPLETED|Overall Study||54
8458458|NCT00721175|20843132|P1|COMPLETED|Overall Study||54
8458459|NCT00721175|20843131|P2|STARTED|Overall Study||54
8458460|NCT00721175|20843132|P1|STARTED|Overall Study||54
8458461|NCT00721162|20843144|P1|NOT COMPLETED|Overall Study||0
8458462|NCT00721162|20843144|P1|COMPLETED|Overall Study||60
8458463|NCT00721162|20843144|P1|Received Any Amount of Study Drug|Overall Study||60
8458464|NCT00721162|20843144|P1|STARTED|Overall Study||60
8458465|NCT00721149|20843153|P1|NOT COMPLETED|Overall Study||1
8458466|NCT00721149|20843153|P1|COMPLETED|Overall Study||9
8458467|NCT00721149|20843153|P1|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
8458468|NCT00721136|20843166|P4|NOT COMPLETED|Overall Study||0
8458469|NCT00721136|20843167|P3|NOT COMPLETED|Overall Study||0
8458470|NCT00721136|20843168|P2|NOT COMPLETED|Overall Study||0
8458471|NCT00721136|20843169|P1|NOT COMPLETED|Overall Study||0
8458472|NCT00721136|20843166|P4|COMPLETED|Overall Study||8
8458473|NCT00721136|20843167|P3|COMPLETED|Overall Study||8
8458474|NCT00721136|20843168|P2|COMPLETED|Overall Study||42
8458475|NCT00721136|20843169|P1|COMPLETED|Overall Study||42
8458476|NCT00721136|20843166|P4|STARTED|Overall Study||8
8458477|NCT00721136|20843167|P3|STARTED|Overall Study||8
8458478|NCT00721136|20843168|P2|STARTED|Overall Study||42
8458479|NCT00721136|20843169|P1|STARTED|Overall Study||42
8458480|NCT00721123|20843187|P1|NOT COMPLETED|Overall Study||183
8458481|NCT00721123|20843187|P1|COMPLETED|Overall Study||355
8458482|NCT00721123|20843187|P1|STARTED|Overall Study||538
8458483|NCT00721110|20843265|P4|NOT COMPLETED|Overall Study||0
8458484|NCT00721110|20843266|P3|NOT COMPLETED|Overall Study||1
8458485|NCT00721110|20843267|P2|NOT COMPLETED|Overall Study||0
8458486|NCT00721110|20843268|P1|NOT COMPLETED|Overall Study||1
8458487|NCT00721110|20843265|P4|COMPLETED|Overall Study||16
8458488|NCT00721110|20843266|P3|COMPLETED|Overall Study||15
8458489|NCT00721110|20843267|P2|COMPLETED|Overall Study||16
8458490|NCT00721110|20843268|P1|COMPLETED|Overall Study||15
8458491|NCT00721110|20843265|P4|STARTED|Overall Study||16
8458492|NCT00721110|20843266|P3|STARTED|Overall Study||16
8458493|NCT00721110|20843267|P2|STARTED|Overall Study||16
8458494|NCT00721110|20843268|P1|STARTED|Overall Study||16
8458503|NCT00720876|20843337|P1|NOT COMPLETED|Overall Study||2
8458504|NCT00720876|20843337|P1|COMPLETED|Overall Study||28
8458505|NCT00720876|20843337|P1|STARTED|Overall Study||30
8458506|NCT00720798|20843343|P1|NOT COMPLETED|Overall Study||756
8458507|NCT00720798|20843343|P1|COMPLETED|Overall Study||1311
8458508|NCT00720798|20843343|P1|STARTED|Overall Study||2067
8458509|NCT00720759|20843366|P4|NOT COMPLETED|Overall Study||0
8458510|NCT00720759|20843367|P3|NOT COMPLETED|Overall Study||1
8458511|NCT00720759|20843368|P2|NOT COMPLETED|Overall Study||1
8458512|NCT00720759|20843369|P1|NOT COMPLETED|Overall Study||0
8458513|NCT00720759|20843366|P4|COMPLETED|Overall Study||6
8458514|NCT00720759|20843367|P3|COMPLETED|Overall Study||5
8458515|NCT00720759|20843368|P2|COMPLETED|Overall Study||5
8458516|NCT00720759|20843369|P1|COMPLETED|Overall Study||6
8458517|NCT00720759|20843366|P4|STARTED|Overall Study||6
8458518|NCT00720759|20843367|P3|STARTED|Overall Study||6
8458519|NCT00720759|20843368|P2|STARTED|Overall Study||6
8458520|NCT00720759|20843369|P1|STARTED|Overall Study||6
8458521|NCT00720629|20843379|P1|NOT COMPLETED|Overall Study||0
8458522|NCT00720629|20843379|P1|COMPLETED|Overall Study||8
8458523|NCT00720629|20843379|P1|STARTED|Overall Study||8
8458524|NCT00720499|20843389|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
8458525|NCT00720499|20843390|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
8458526|NCT00720499|20843389|P2|COMPLETED|Treatment Period 2 (4 Weeks)||67
8458527|NCT00720499|20843390|P1|COMPLETED|Treatment Period 2 (4 Weeks)||64
8458528|NCT00720499|20843389|P2|STARTED|Treatment Period 2 (4 Weeks)||70
8458529|NCT00720499|20843390|P1|STARTED|Treatment Period 2 (4 Weeks)||66
8458530|NCT00720499|20843389|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
8458531|NCT00720499|20843390|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
8458532|NCT00720499|20843389|P2|COMPLETED|Washout Period (2 Weeks)||70
8458533|NCT00720499|20843390|P1|COMPLETED|Washout Period (2 Weeks)||66
8458534|NCT00720499|20843389|P2|STARTED|Washout Period (2 Weeks)||70
8458535|NCT00720499|20843390|P1|STARTED|Washout Period (2 Weeks)||66
8458536|NCT00720499|20843389|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
8458537|NCT00720499|20843390|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
8458538|NCT00720499|20843389|P2|COMPLETED|Treatment Period 1 (4 Weeks)||70
8458539|NCT00720499|20843390|P1|COMPLETED|Treatment Period 1 (4 Weeks)||66
8458540|NCT00720499|20843389|P2|STARTED|Treatment Period 1 (4 Weeks)||72
8458541|NCT00720499|20843390|P1|STARTED|Treatment Period 1 (4 Weeks)||69
8458542|NCT00720473|20843454|P2|NOT COMPLETED|Overall Study||8
8458543|NCT00720473|20843455|P1|NOT COMPLETED|Overall Study||30
8458544|NCT00720473|20843454|P2|COMPLETED|Overall Study||16
8458545|NCT00720473|20843455|P1|COMPLETED|Overall Study||15
8458546|NCT00720473|20843454|P2|STARTED|Overall Study||24
8458547|NCT00720473|20843455|P1|STARTED|Overall Study||45
8458548|NCT00720434|20843483|P4|NOT COMPLETED|Open-Label Period (Week 5-72)||4
8458549|NCT00720434|20843484|P3|NOT COMPLETED|Open-Label Period (Week 5-72)||4
8458550|NCT00720434|20843485|P2|NOT COMPLETED|Open-Label Period (Week 5-72)||3
8458551|NCT00720434|20843486|P1|NOT COMPLETED|Open-Label Period (Week 5-72)||6
8458552|NCT00720434|20843483|P4|COMPLETED|Open-Label Period (Week 5-72)||4
8458553|NCT00720434|20843484|P3|COMPLETED|Open-Label Period (Week 5-72)||4
8458554|NCT00720434|20843485|P2|COMPLETED|Open-Label Period (Week 5-72)||5
8458555|NCT00720434|20843486|P1|COMPLETED|Open-Label Period (Week 5-72)||4
8458556|NCT00720434|20843483|P4|STARTED|Open-Label Period (Week 5-72)||8
8458557|NCT00720434|20843484|P3|STARTED|Open-Label Period (Week 5-72)||8
8458558|NCT00720434|20843485|P2|STARTED|Open-Label Period (Week 5-72)||8
8458559|NCT00720434|20843486|P1|STARTED|Open-Label Period (Week 5-72)||10
8458560|NCT00720434|20843483|P4|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
8458561|NCT00720434|20843484|P3|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
8458562|NCT00720434|20843485|P2|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
8458563|NCT00720434|20843486|P1|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
8458564|NCT00720434|20843483|P4|COMPLETED|Double-Blind Period (Week 1-4)||8
8458565|NCT00720434|20843484|P3|COMPLETED|Double-Blind Period (Week 1-4)||8
8458566|NCT00720434|20843485|P2|COMPLETED|Double-Blind Period (Week 1-4)||8
8458567|NCT00720434|20843486|P1|COMPLETED|Double-Blind Period (Week 1-4)||10
8458568|NCT00720434|20843483|P4|STARTED|Double-Blind Period (Week 1-4)||8
8458569|NCT00720434|20843484|P3|STARTED|Double-Blind Period (Week 1-4)||8
8458570|NCT00720434|20843485|P2|STARTED|Double-Blind Period (Week 1-4)||9
8458571|NCT00720434|20843486|P1|STARTED|Double-Blind Period (Week 1-4)||10
8458572|NCT00720382|20843510|P2|NOT COMPLETED|Overall Study||59
8458573|NCT00720382|20843511|P1|NOT COMPLETED|Overall Study||176
8458574|NCT00720382|20843510|P2|COMPLETED|Overall Study||178
8458575|NCT00720382|20843511|P1|COMPLETED|Overall Study||290
8458576|NCT00720382|20843510|P2|STARTED|Overall Study||237
8458577|NCT00720382|20843511|P1|STARTED|Overall Study||466
8458578|NCT00720369|20843521|P2|NOT COMPLETED|Overall Study||0
8458579|NCT00720369|20843522|P1|NOT COMPLETED|Overall Study||1
8458580|NCT00720369|20843521|P2|COMPLETED|Overall Study||8
8458581|NCT00720369|20843522|P1|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
8458582|NCT00720369|20843521|P2|STARTED|Overall Study||8
8458583|NCT00720369|20843522|P1|STARTED|Overall Study||11
8458584|NCT00720356|20843530|P1|NOT COMPLETED|Follow up Until Death||5
8458585|NCT00720356|20843530|P1|COMPLETED|Follow up Until Death||43
8458586|NCT00720356|20843530|P1|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
8458587|NCT00720356|20843530|P1|NOT COMPLETED|Went on to be Treated Cycle 3||2
8458588|NCT00720356|20843530|P1|COMPLETED|Went on to be Treated Cycle 3||44
8458589|NCT00720356|20843530|P1|STARTED|Went on to be Treated Cycle 3||46
8458590|NCT00720356|20843530|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
8458591|NCT00720356|20843530|P1|COMPLETED|Reached 1st Response/2 Cycles||46
8458592|NCT00720356|20843530|P1|STARTED|Reached 1st Response/2 Cycles||48
8458593|NCT00720356|20843530|P1|NOT COMPLETED|Registration to Study||67
8458594|NCT00720356|20843530|P1|COMPLETED|Registration to Study||48
8458595|NCT00720356|20843530|P1|Completed Registration Step 2|Registration to Study||48
8458596|NCT00720356|20843530|P1|Completed Registration Step 1|Registration to Study||115
8458597|NCT00720356|20843530|P1|STARTED|Registration to Study||115
8458598|NCT00720343|20843544|P1|NOT COMPLETED|Overall Study||6
8458599|NCT00720343|20843544|P1|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
8458600|NCT00720343|20843544|P1|STARTED|Overall Study||54
8458601|NCT00720330|20843553|P3|NOT COMPLETED|Overall Study||0
8458602|NCT00720330|20843554|P2|NOT COMPLETED|Overall Study||0
8458603|NCT00720330|20843555|P1|NOT COMPLETED|Overall Study||0
8458604|NCT00720330|20843553|P3|COMPLETED|Overall Study||3
8458605|NCT00720330|20843554|P2|COMPLETED|Overall Study||4
8458606|NCT00720330|20843555|P1|COMPLETED|Overall Study||5
8458607|NCT00720330|20843553|P3|STARTED|Overall Study||3
8458608|NCT00720330|20843554|P2|STARTED|Overall Study||4
8458609|NCT00720330|20843555|P1|STARTED|Overall Study||5
8458610|NCT00720278|20843578|P3|NOT COMPLETED|Overall Study||6
8458611|NCT00720278|20843579|P2|NOT COMPLETED|Overall Study||4
8458612|NCT00720278|20843580|P1|NOT COMPLETED|Overall Study||7
8458613|NCT00720278|20843578|P3|COMPLETED|Overall Study||172
8458614|NCT00720278|20843579|P2|COMPLETED|Overall Study||166
8458615|NCT00720278|20843580|P1|COMPLETED|Overall Study||171
8458616|NCT00720278|20843578|P3|STARTED|Overall Study|1 subject was randomized in error|178
8458617|NCT00720278|20843579|P2|STARTED|Overall Study|1 subject was randomized in error|170
8458618|NCT00720278|20843580|P1|STARTED|Overall Study|1 subject was randomized in error|178
8458619|NCT00720226|20843602|P2|NOT COMPLETED|Overall Study||4
8458620|NCT00720226|20843603|P1|NOT COMPLETED|Overall Study||7
8458621|NCT00720226|20843602|P2|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
8458622|NCT00720226|20843603|P1|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
8458623|NCT00720226|20843602|P2|STARTED|Overall Study||52
8458624|NCT00720226|20843603|P1|STARTED|Overall Study||54
8458625|NCT00720213|20843611|P3|NOT COMPLETED|Treatment Period||0
8458626|NCT00720213|20843612|P2|NOT COMPLETED|Treatment Period||0
8458627|NCT00720213|20843613|P1|NOT COMPLETED|Treatment Period||0
8458628|NCT00720213|20843611|P3|COMPLETED|Treatment Period||17
8458629|NCT00720213|20843612|P2|COMPLETED|Treatment Period||20
8458630|NCT00720213|20843613|P1|COMPLETED|Treatment Period||0
8458631|NCT00720213|20843611|P3|STARTED|Treatment Period||17
8458632|NCT00720213|20843612|P2|STARTED|Treatment Period||20
8458633|NCT00720213|20843613|P1|STARTED|Treatment Period||0
8458634|NCT00720213|20843611|P3|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
8458635|NCT00720213|20843612|P2|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
8458636|NCT00720213|20843613|P1|NOT COMPLETED|Screening Phase With Diagnostic PSG||7
8458637|NCT00720213|20843611|P3|COMPLETED|Screening Phase With Diagnostic PSG||0
8458638|NCT00720213|20843612|P2|COMPLETED|Screening Phase With Diagnostic PSG||0
8458639|NCT00720213|20843613|P1|COMPLETED|Screening Phase With Diagnostic PSG||37
8458640|NCT00720213|20843611|P3|STARTED|Screening Phase With Diagnostic PSG||0
8458641|NCT00720213|20843612|P2|STARTED|Screening Phase With Diagnostic PSG||0
8458642|NCT00720213|20843613|P1|STARTED|Screening Phase With Diagnostic PSG||44
8458643|NCT00720122|20843651|P1|NOT COMPLETED|Overall Study||9
8458644|NCT00720122|20843651|P1|COMPLETED|Overall Study||19
8458645|NCT00720122|20843651|P1|STARTED|Overall Study||28
8458646|NCT00720109|20843655|P3|NOT COMPLETED|Risk Stratification Period||8
8458647|NCT00720109|20843656|P2|NOT COMPLETED|Risk Stratification Period||15
8458648|NCT00720109|20843657|P1|NOT COMPLETED|Risk Stratification Period||0
8458649|NCT00720109|20843655|P3|COMPLETED|Risk Stratification Period||1
8458650|NCT00720109|20843656|P2|COMPLETED|Risk Stratification Period||33
8458651|NCT00720109|20843657|P1|COMPLETED|Risk Stratification Period||0
8458652|NCT00720109|20843655|P3|STARTED|Risk Stratification Period||9
8458653|NCT00720109|20843656|P2|STARTED|Risk Stratification Period||48
8458654|NCT00720109|20843657|P1|STARTED|Risk Stratification Period||0
8458655|NCT00720109|20843655|P3|NOT COMPLETED|Induction Period||0
8458656|NCT00720109|20843656|P2|NOT COMPLETED|Induction Period||0
8458657|NCT00720109|20843657|P1|NOT COMPLETED|Induction Period||6
8458658|NCT00720109|20843655|P3|COMPLETED|Induction Period||0
8458659|NCT00720109|20843656|P2|COMPLETED|Induction Period||0
8458660|NCT00720109|20843657|P1|COMPLETED|Induction Period||57
8458661|NCT00720109|20843655|P3|STARTED|Induction Period||0
8458662|NCT00720109|20843656|P2|STARTED|Induction Period||0
8458663|NCT00720109|20843657|P1|STARTED|Induction Period||63
8458664|NCT00720096|20843677|P2|NOT COMPLETED|Overall Study||2
8458665|NCT00720096|20843678|P1|NOT COMPLETED|Overall Study||0
8458666|NCT00720096|20843677|P2|COMPLETED|Overall Study||0
8458667|NCT00720096|20843678|P1|COMPLETED|Overall Study||2
8458668|NCT00720096|20843677|P2|STARTED|Overall Study||2
8458669|NCT00720096|20843678|P1|STARTED|Overall Study||2
8458670|NCT00720083|20843690|P2|NOT COMPLETED|Overall Study||2
8458671|NCT00720083|20843691|P1|NOT COMPLETED|Overall Study||1
8458672|NCT00720083|20843690|P2|COMPLETED|Overall Study||13
8458673|NCT00720083|20843691|P1|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
8458674|NCT00720083|20843690|P2|STARTED|Overall Study||15
8458675|NCT00720083|20843691|P1|STARTED|Overall Study||17
8458676|NCT00720057|20843699|P2|NOT COMPLETED|Overall Study||3
8458677|NCT00720057|20843700|P1|NOT COMPLETED|Overall Study||1
8458678|NCT00720057|20843699|P2|COMPLETED|Overall Study||156
8458679|NCT00720057|20843700|P1|COMPLETED|Overall Study||152
8458680|NCT00720057|20843699|P2|STARTED|Overall Study||159
8458681|NCT00720057|20843700|P1|STARTED|Overall Study||153
8458682|NCT00719953|20843716|P1|NOT COMPLETED|Overall Study||4
8458683|NCT00719953|20843716|P1|COMPLETED|Overall Study||26
8458684|NCT00719953|20843716|P1|STARTED|Overall Study||30
8458685|NCT00719914|20843722|P2|NOT COMPLETED|Overall Study||0
8458686|NCT00719914|20843723|P1|NOT COMPLETED|Overall Study||0
8458687|NCT00719914|20843722|P2|COMPLETED|Overall Study||7
8458688|NCT00719914|20843723|P1|COMPLETED|Overall Study||10
8458689|NCT00719914|20843722|P2|STARTED|Overall Study||7
8458690|NCT00719914|20843723|P1|STARTED|Overall Study||10
8458691|NCT00719901|20843729|P1|NOT COMPLETED|Overall Study||11
8458692|NCT00719901|20843729|P1|COMPLETED|Overall Study||0
8458693|NCT00719901|20843729|P1|STARTED|Overall Study||11
8458694|NCT00719862|20843741|P2|NOT COMPLETED|Overall Study||6
8458695|NCT00719862|20843742|P1|NOT COMPLETED|Overall Study||8
8458696|NCT00719862|20843741|P2|COMPLETED|Overall Study||233
8458697|NCT00719862|20843742|P1|COMPLETED|Overall Study||234
8458698|NCT00719862|20843741|P2|STARTED|Overall Study|1 subject was randomized in error|239
8458699|NCT00719862|20843742|P1|STARTED|Overall Study||242
8458700|NCT00719849|20843760|P2|NOT COMPLETED|Overall Study||1
8458701|NCT00719849|20843761|P1|NOT COMPLETED|Overall Study||0
8458702|NCT00719849|20843760|P2|COMPLETED|Overall Study||8
8458703|NCT00719849|20843761|P1|COMPLETED|Overall Study||4
8458704|NCT00719849|20843760|P2|STARTED|Overall Study||9
8458705|NCT00719849|20843761|P1|STARTED|Overall Study||4
8458706|NCT00719810|20843800|P3|NOT COMPLETED|Overall Study||8
8458707|NCT00719810|20843801|P2|NOT COMPLETED|Overall Study||4
8458708|NCT00719810|20843802|P1|NOT COMPLETED|Overall Study||3
8458709|NCT00719810|20843800|P3|COMPLETED|Overall Study||42
8458710|NCT00719810|20843801|P2|COMPLETED|Overall Study||47
8458711|NCT00719810|20843802|P1|COMPLETED|Overall Study||46
8458712|NCT00719810|20843800|P3|STARTED|Overall Study||50
8458713|NCT00719810|20843801|P2|STARTED|Overall Study||51
8458714|NCT00719810|20843802|P1|STARTED|Overall Study||49
8458715|NCT00719732|20843813|P1|NOT COMPLETED|Overall Study||22
8458716|NCT00719732|20843813|P1|COMPLETED|Overall Study||196
8458717|NCT00719732|20843813|P1|STARTED|Overall Study||218
8458718|NCT00719706|20843819|P2|NOT COMPLETED|Overall Study||6
8458719|NCT00719706|20843820|P1|NOT COMPLETED|Overall Study||9
8458720|NCT00719706|20843819|P2|COMPLETED|Overall Study||14
8458721|NCT00719706|20843820|P1|COMPLETED|Overall Study||11
8458722|NCT00719706|20843819|P2|STARTED|Overall Study||20
8458723|NCT00719706|20843820|P1|STARTED|Overall Study||20
8458724|NCT00719680|20843834|P1|NOT COMPLETED|Overall Study||5
8458725|NCT00719680|20843834|P1|COMPLETED|Overall Study||16
8458726|NCT00719680|20843834|P1|STARTED|Overall Study||21
8458727|NCT00719615|20843857|P3|NOT COMPLETED|Overall Study||0
8458728|NCT00719615|20843858|P2|NOT COMPLETED|Overall Study||0
8458729|NCT00719615|20843859|P1|NOT COMPLETED|Overall Study||0
8458730|NCT00719615|20843857|P3|COMPLETED|Overall Study||24
8458731|NCT00719615|20843858|P2|COMPLETED|Overall Study||45
8458732|NCT00719615|20843859|P1|COMPLETED|Overall Study||42
8458733|NCT00719615|20843857|P3|STARTED|Overall Study||24
8458734|NCT00719615|20843858|P2|STARTED|Overall Study||45
8458735|NCT00719615|20843859|P1|STARTED|Overall Study||42
8458742|NCT00719563|20843890|P2|NOT COMPLETED|Overall Study||42
8458743|NCT00719563|20843891|P1|NOT COMPLETED|Overall Study||38
8458744|NCT00719563|20843890|P2|COMPLETED|Overall Study||128
8458745|NCT00719563|20843891|P1|COMPLETED|Overall Study||133
8458746|NCT00719563|20843890|P2|STARTED|Overall Study||170
8458747|NCT00719563|20843891|P1|STARTED|Overall Study||171
8458748|NCT00719537|20843923|P2|NOT COMPLETED|Overall Study||1
8458749|NCT00719537|20843924|P1|NOT COMPLETED|Overall Study||1
8458750|NCT00719537|20843923|P2|COMPLETED|Overall Study||0
8458751|NCT00719537|20843924|P1|COMPLETED|Overall Study||1
8458752|NCT00719537|20843923|P2|STARTED|Overall Study||1
8458753|NCT00719537|20843924|P1|STARTED|Overall Study||2
8458754|NCT00719472|20843930|P1|NOT COMPLETED|Received Cycle 2 Treatment||68
8458755|NCT00719472|20843930|P1|COMPLETED|Received Cycle 2 Treatment||304
8458756|NCT00719472|20843930|P1|STARTED|Received Cycle 2 Treatment||372
8458757|NCT00719472|20843930|P1|NOT COMPLETED|Received Cycle 1 Treatment||53
8458758|NCT00719472|20843930|P1|COMPLETED|Received Cycle 1 Treatment||372
8458759|NCT00719472|20843930|P1|STARTED|Received Cycle 1 Treatment||425
8458760|NCT00719472|20843930|P1|NOT COMPLETED|Enrolled in Study||26
8458761|NCT00719472|20843930|P1|COMPLETED|Enrolled in Study||425
8458762|NCT00719472|20843930|P1|STARTED|Enrolled in Study||451
8458763|NCT00719355|20843941|P2|NOT COMPLETED|Overall Study||13
8458764|NCT00719355|20843942|P1|NOT COMPLETED|Overall Study||18
8458765|NCT00719355|20843941|P2|COMPLETED|Overall Study||39
8458766|NCT00719355|20843942|P1|COMPLETED|Overall Study||33
8458767|NCT00719355|20843941|P2|Completed 32 Weeks|Overall Study||39
8458768|NCT00719355|20843942|P1|Completed 32 Weeks|Overall Study||33
8458769|NCT00719355|20843941|P2|Completed 24 Weeks|Overall Study||43
8458770|NCT00719355|20843942|P1|Completed 24 Weeks|Overall Study||34
8458771|NCT00719355|20843941|P2|Completed 12 Weeks|Overall Study||46
8458772|NCT00719355|20843942|P1|Completed 12 Weeks|Overall Study||43
8458773|NCT00719355|20843941|P2|Completed 6 Weeks|Overall Study||48
8458774|NCT00719355|20843942|P1|Completed 6 Weeks|Overall Study||49
8458775|NCT00719355|20843941|P2|STARTED|Overall Study||52
8458776|NCT00719355|20843942|P1|STARTED|Overall Study||51
8458777|NCT00719329|20843953|P3|NOT COMPLETED|Overall Study||1
8458778|NCT00719329|20843954|P2|NOT COMPLETED|Overall Study||2
8458779|NCT00719329|20843955|P1|NOT COMPLETED|Overall Study||0
8458780|NCT00719329|20843953|P3|COMPLETED|Overall Study||646
8458781|NCT00719329|20843954|P2|COMPLETED|Overall Study||569
8458782|NCT00719329|20843955|P1|COMPLETED|Overall Study||705
8458783|NCT00719329|20843953|P3|Day 7 Swab|Overall Study||561
8458784|NCT00719329|20843954|P2|Day 7 Swab|Overall Study||467
8458785|NCT00719329|20843955|P1|Day 7 Swab|Overall Study||593
8458786|NCT00719329|20843953|P3|Day 3 Swab|Overall Study||578
8458787|NCT00719329|20843954|P2|Day 3 Swab|Overall Study||501
8458788|NCT00719329|20843955|P1|Day 3 Swab|Overall Study||614
8458789|NCT00719329|20843953|P3|Day 1 Swab|Overall Study||646
8458790|NCT00719329|20843954|P2|Day 1 Swab|Overall Study||569
8458791|NCT00719329|20843955|P1|Day 1 Swab|Overall Study||705
8458792|NCT00719329|20843953|P3|STARTED|Overall Study||647
8458793|NCT00719329|20843954|P2|STARTED|Overall Study||571
8458794|NCT00719329|20843955|P1|STARTED|Overall Study||705
8458795|NCT00719264|20843971|P2|NOT COMPLETED|Overall Study||183
8458796|NCT00719264|20843972|P1|NOT COMPLETED|Overall Study||182
8458797|NCT00719264|20843971|P2|COMPLETED|Overall Study||0
8458798|NCT00719264|20843972|P1|COMPLETED|Overall Study||0
8458799|NCT00719264|20843971|P2|Safety Set|Overall Study||181
8458800|NCT00719264|20843972|P1|Safety Set|Overall Study||180
8458801|NCT00719264|20843971|P2|Full Analysis Set|Overall Study||183
8458802|NCT00719264|20843972|P1|Full Analysis Set|Overall Study||182
8458803|NCT00719264|20843971|P2|STARTED|Overall Study||183
8458804|NCT00719264|20843972|P1|STARTED|Overall Study||182
8458805|NCT00719212|20843991|P1|NOT COMPLETED|Overall Study||44
8458806|NCT00719212|20843991|P1|COMPLETED|Overall Study||17
8458807|NCT00719212|20843991|P1|STARTED|Overall Study||61
8458808|NCT00719186|20844003|P2|NOT COMPLETED|Overall Study||0
8458809|NCT00719186|20844004|P1|NOT COMPLETED|Overall Study||0
8458810|NCT00719186|20844003|P2|COMPLETED|Overall Study||374
8458811|NCT00719186|20844004|P1|COMPLETED|Overall Study||376
8458812|NCT00719186|20844003|P2|STARTED|Overall Study||374
8458813|NCT00719186|20844004|P1|STARTED|Overall Study||376
8458814|NCT00719160|20844018|P2|NOT COMPLETED|Overall Study||0
8458815|NCT00719160|20844019|P1|NOT COMPLETED|Overall Study||0
8458816|NCT00719160|20844018|P2|COMPLETED|Overall Study||6
8458817|NCT00719160|20844019|P1|COMPLETED|Overall Study||6
8458818|NCT00719160|20844018|P2|STARTED|Overall Study||6
8458819|NCT00719160|20844019|P1|STARTED|Overall Study||6
8458820|NCT00719134|20844026|P1|NOT COMPLETED|Overall Study||10
8458821|NCT00719134|20844026|P1|COMPLETED|Overall Study||66
8458822|NCT00719134|20844026|P1|STARTED|Overall Study||76
8458823|NCT00719043|20844039|P7|NOT COMPLETED|Overall Study||28
8458824|NCT00719043|20844040|P6|NOT COMPLETED|Overall Study||34
8458825|NCT00719043|20844041|P5|NOT COMPLETED|Overall Study||27
8458826|NCT00719043|20844042|P4|NOT COMPLETED|Overall Study||23
8458827|NCT00719043|20844043|P3|NOT COMPLETED|Overall Study||20
8458828|NCT00719043|20844044|P2|NOT COMPLETED|Overall Study||25
8458829|NCT00719043|20844045|P1|NOT COMPLETED|Overall Study||32
8458830|NCT00719043|20844039|P7|COMPLETED|Overall Study|Up to Day 909|92
8458831|NCT00719043|20844040|P6|COMPLETED|Overall Study|Up to Day 909|86
8458832|NCT00719043|20844041|P5|COMPLETED|Overall Study|Up to Day 909|95
8458833|NCT00719043|20844042|P4|COMPLETED|Overall Study|Up to Day 909|96
8458834|NCT00719043|20844043|P3|COMPLETED|Overall Study|Up to Day 909|99
8458835|NCT00719043|20844044|P2|COMPLETED|Overall Study|Up to Day 909|96
8458836|NCT00719043|20844045|P1|COMPLETED|Overall Study|Up to Day 909|88
8458837|NCT00719043|20844039|P7|STARTED|Overall Study||120
8458838|NCT00719043|20844040|P6|STARTED|Overall Study||120
8458839|NCT00719043|20844041|P5|STARTED|Overall Study||122
8458840|NCT00719043|20844042|P4|STARTED|Overall Study||119
8458841|NCT00719043|20844043|P3|STARTED|Overall Study||119
8458842|NCT00719043|20844044|P2|STARTED|Overall Study||121
8458843|NCT00719043|20844045|P1|STARTED|Overall Study||120
8458844|NCT00718887|20844169|P2|NOT COMPLETED|Overall Study||9
8458845|NCT00718887|20844170|P1|NOT COMPLETED|Overall Study||5
8458846|NCT00718887|20844169|P2|COMPLETED|Overall Study||68
8458847|NCT00718887|20844170|P1|COMPLETED|Overall Study|Continued in study after 48 weeks|84
8458848|NCT00718887|20844169|P2|STARTED|Overall Study|Participants who received treatment.|77
8458849|NCT00718887|20844170|P1|STARTED|Overall Study|Participants who received treatment.|89
8458850|NCT00718861|20844194|P2|NOT COMPLETED|Overall Study||18
8458851|NCT00718861|20844195|P1|NOT COMPLETED|Overall Study||21
8458852|NCT00718861|20844194|P2|COMPLETED|Overall Study||77
8458853|NCT00718861|20844195|P1|COMPLETED|Overall Study||74
8458854|NCT00718861|20844194|P2|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
8458855|NCT00718861|20844195|P1|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
8458856|NCT00718861|20844194|P2|Safety Set|Overall Study||95
8458857|NCT00718861|20844195|P1|Safety Set|Overall Study|3 patients randomized but never received study drug|92
8458858|NCT00718861|20844194|P2|STARTED|Overall Study||95
8458859|NCT00718861|20844195|P1|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
8458860|NCT00718809|20844223|P2|NOT COMPLETED|Overall Study||9
8458861|NCT00718809|20844224|P1|NOT COMPLETED|Overall Study||12
8458862|NCT00718809|20844223|P2|COMPLETED|Overall Study||0
8458863|NCT00718809|20844224|P1|COMPLETED|Overall Study||0
8458864|NCT00718809|20844223|P2|STARTED|Overall Study||9
8458865|NCT00718809|20844224|P1|STARTED|Overall Study||12
8458866|NCT00718770|20844238|P1|NOT COMPLETED|Overall Study||8
8458867|NCT00718770|20844238|P1|COMPLETED|Overall Study||2
8458868|NCT00718770|20844238|P1|STARTED|Overall Study||10
8458869|NCT00718718|20844249|P10|NOT COMPLETED|Week 12 to End of Study||0
8458870|NCT00718718|20844250|P9|NOT COMPLETED|Week 12 to End of Study||1
8458871|NCT00718718|20844251|P8|NOT COMPLETED|Week 12 to End of Study||1
8458872|NCT00718718|20844252|P7|NOT COMPLETED|Week 12 to End of Study||2
8458873|NCT00718718|20844253|P6|NOT COMPLETED|Week 12 to End of Study||3
8458874|NCT00718718|20844254|P5|NOT COMPLETED|Week 12 to End of Study||0
8458875|NCT00718718|20844255|P4|NOT COMPLETED|Week 12 to End of Study||1
8458876|NCT00718718|20844256|P3|NOT COMPLETED|Week 12 to End of Study||0
8458877|NCT00718718|20844257|P2|NOT COMPLETED|Week 12 to End of Study||1
8458878|NCT00718718|20844258|P1|NOT COMPLETED|Week 12 to End of Study||0
8458879|NCT00718718|20844249|P10|COMPLETED|Week 12 to End of Study||31
8458880|NCT00718718|20844250|P9|COMPLETED|Week 12 to End of Study||27
8458881|NCT00718718|20844251|P8|COMPLETED|Week 12 to End of Study||27
8458882|NCT00718718|20844252|P7|COMPLETED|Week 12 to End of Study||27
8458883|NCT00718718|20844253|P6|COMPLETED|Week 12 to End of Study||24
8458884|NCT00718718|20844254|P5|COMPLETED|Week 12 to End of Study||0
8458885|NCT00718718|20844255|P4|COMPLETED|Week 12 to End of Study||15
8458886|NCT00718718|20844256|P3|COMPLETED|Week 12 to End of Study||0
8458887|NCT00718718|20844257|P2|COMPLETED|Week 12 to End of Study||17
8458888|NCT00718718|20844258|P1|COMPLETED|Week 12 to End of Study||0
8458889|NCT00718718|20844249|P10|Treated|Week 12 to End of Study||31
8458890|NCT00718718|20844250|P9|Treated|Week 12 to End of Study||28
8458891|NCT00718718|20844251|P8|Treated|Week 12 to End of Study||28
8458892|NCT00718718|20844252|P7|Treated|Week 12 to End of Study||29
8458893|NCT00718718|20844253|P6|Treated|Week 12 to End of Study||26
8458894|NCT00718718|20844254|P5|Treated|Week 12 to End of Study||0
8458895|NCT00718718|20844255|P4|Treated|Week 12 to End of Study||16
8458896|NCT00718718|20844256|P3|Treated|Week 12 to End of Study||0
8458897|NCT00718718|20844257|P2|Treated|Week 12 to End of Study||18
8458898|NCT00718718|20844258|P1|Treated|Week 12 to End of Study||0
8458899|NCT00718718|20844249|P10|STARTED|Week 12 to End of Study||31
8458900|NCT00718718|20844250|P9|STARTED|Week 12 to End of Study||28
8458901|NCT00718718|20844251|P8|STARTED|Week 12 to End of Study||28
8458902|NCT00718718|20844252|P7|STARTED|Week 12 to End of Study||29
8458903|NCT00718718|20844253|P6|STARTED|Week 12 to End of Study||27
8458904|NCT00718718|20844254|P5|STARTED|Week 12 to End of Study||0
8458905|NCT00718718|20844255|P4|STARTED|Week 12 to End of Study||16
8458906|NCT00718718|20844256|P3|STARTED|Week 12 to End of Study||0
8458907|NCT00718718|20844257|P2|STARTED|Week 12 to End of Study||18
8458908|NCT00718718|20844258|P1|STARTED|Week 12 to End of Study||0
8458909|NCT00718718|20844249|P10|NOT COMPLETED|Prior to Week 12||0
8458910|NCT00718718|20844250|P9|NOT COMPLETED|Prior to Week 12||2
8458911|NCT00718718|20844251|P8|NOT COMPLETED|Prior to Week 12||2
8458912|NCT00718718|20844252|P7|NOT COMPLETED|Prior to Week 12||1
8458913|NCT00718718|20844253|P6|NOT COMPLETED|Prior to Week 12||0
8458914|NCT00718718|20844254|P5|NOT COMPLETED|Prior to Week 12||3
8458915|NCT00718718|20844255|P4|NOT COMPLETED|Prior to Week 12||0
8458916|NCT00718718|20844256|P3|NOT COMPLETED|Prior to Week 12||1
8458917|NCT00718718|20844257|P2|NOT COMPLETED|Prior to Week 12||0
8458918|NCT00718718|20844258|P1|NOT COMPLETED|Prior to Week 12||1
8458919|NCT00718718|20844249|P10|COMPLETED|Prior to Week 12||31
8458920|NCT00718718|20844250|P9|COMPLETED|Prior to Week 12||28
8458921|NCT00718718|20844251|P8|COMPLETED|Prior to Week 12||28
8458922|NCT00718718|20844252|P7|COMPLETED|Prior to Week 12||29
8458923|NCT00718718|20844253|P6|COMPLETED|Prior to Week 12||0
8458924|NCT00718718|20844254|P5|COMPLETED|Prior to Week 12||27
8458925|NCT00718718|20844255|P4|COMPLETED|Prior to Week 12||0
8458926|NCT00718718|20844256|P3|COMPLETED|Prior to Week 12||16
8458927|NCT00718718|20844257|P2|COMPLETED|Prior to Week 12||0
8458928|NCT00718718|20844258|P1|COMPLETED|Prior to Week 12||18
8458929|NCT00718718|20844249|P10|STARTED|Prior to Week 12||31
8458930|NCT00718718|20844250|P9|STARTED|Prior to Week 12||30
8458931|NCT00718718|20844251|P8|STARTED|Prior to Week 12||30
8458932|NCT00718718|20844252|P7|STARTED|Prior to Week 12||30
8458933|NCT00718718|20844253|P6|STARTED|Prior to Week 12||0
8458934|NCT00718718|20844254|P5|STARTED|Prior to Week 12||30
8458935|NCT00718718|20844255|P4|STARTED|Prior to Week 12||0
8458936|NCT00718718|20844256|P3|STARTED|Prior to Week 12||17
8458937|NCT00718718|20844257|P2|STARTED|Prior to Week 12||0
8458938|NCT00718718|20844258|P1|STARTED|Prior to Week 12||19
8458939|NCT00718666|20844301|P3|NOT COMPLETED|Booster Phase Year 5||6
8458940|NCT00718666|20844302|P2|NOT COMPLETED|Booster Phase Year 5||0
8458941|NCT00718666|20844303|P1|NOT COMPLETED|Booster Phase Year 5||2
8458942|NCT00718666|20844301|P3|COMPLETED|Booster Phase Year 5||94
8458943|NCT00718666|20844302|P2|COMPLETED|Booster Phase Year 5||46
8458944|NCT00718666|20844303|P1|COMPLETED|Booster Phase Year 5||36
8458945|NCT00718666|20844301|P3|STARTED|Booster Phase Year 5||100
8458946|NCT00718666|20844302|P2|STARTED|Booster Phase Year 5||46
8458947|NCT00718666|20844303|P1|STARTED|Booster Phase Year 5||38
8458948|NCT00718666|20844301|P3|NOT COMPLETED|Persistence Phase Year 5||0
8458949|NCT00718666|20844302|P2|NOT COMPLETED|Persistence Phase Year 5||0
8458950|NCT00718666|20844303|P1|NOT COMPLETED|Persistence Phase Year 5||0
8458951|NCT00718666|20844301|P3|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
8458952|NCT00718666|20844302|P2|COMPLETED|Persistence Phase Year 5||82
8458953|NCT00718666|20844303|P1|COMPLETED|Persistence Phase Year 5||70
8458954|NCT00718666|20844301|P3|STARTED|Persistence Phase Year 5||0
8458955|NCT00718666|20844302|P2|STARTED|Persistence Phase Year 5||82
8458956|NCT00718666|20844303|P1|STARTED|Persistence Phase Year 5||70
8458957|NCT00718666|20844301|P3|NOT COMPLETED|Persistence Phase Year 3||0
8458958|NCT00718666|20844302|P2|NOT COMPLETED|Persistence Phase Year 3||0
8458959|NCT00718666|20844303|P1|NOT COMPLETED|Persistence Phase Year 3||0
8458960|NCT00718666|20844301|P3|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
8458961|NCT00718666|20844302|P2|COMPLETED|Persistence Phase Year 3||104
8458962|NCT00718666|20844303|P1|COMPLETED|Persistence Phase Year 3||98
8458963|NCT00718666|20844301|P3|STARTED|Persistence Phase Year 3||0
8458964|NCT00718666|20844302|P2|STARTED|Persistence Phase Year 3||104
8458965|NCT00718666|20844303|P1|STARTED|Persistence Phase Year 3||98
8458966|NCT00718666|20844301|P3|NOT COMPLETED|Persistence Phase Year 1||0
8458967|NCT00718666|20844302|P2|NOT COMPLETED|Persistence Phase Year 1||0
8458968|NCT00718666|20844303|P1|NOT COMPLETED|Persistence Phase Year 1||0
8458969|NCT00718666|20844301|P3|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
8458970|NCT00718666|20844302|P2|COMPLETED|Persistence Phase Year 1||130
8458971|NCT00718666|20844303|P1|COMPLETED|Persistence Phase Year 1||118
8458972|NCT00718666|20844301|P3|STARTED|Persistence Phase Year 1||0
8458973|NCT00718666|20844302|P2|STARTED|Persistence Phase Year 1||130
8458974|NCT00718666|20844303|P1|STARTED|Persistence Phase Year 1||118
8458975|NCT00718640|20844387|P1|NOT COMPLETED|Overall Study||7
8458976|NCT00718640|20844387|P1|COMPLETED|Overall Study||3
8458977|NCT00718640|20844387|P1|STARTED|Overall Study||10
8458978|NCT00718549|20844399|P3|NOT COMPLETED|Maintenance/ Observation Phase||30
8458979|NCT00718549|20844400|P2|NOT COMPLETED|Maintenance/ Observation Phase||28
8458980|NCT00718549|20844401|P1|NOT COMPLETED|Maintenance/ Observation Phase||0
8458981|NCT00718549|20844399|P3|COMPLETED|Maintenance/ Observation Phase||3
8458982|NCT00718549|20844400|P2|COMPLETED|Maintenance/ Observation Phase||5
8458983|NCT00718549|20844401|P1|COMPLETED|Maintenance/ Observation Phase||0
8458984|NCT00718549|20844399|P3|STARTED|Maintenance/ Observation Phase||33
8458985|NCT00718549|20844400|P2|STARTED|Maintenance/ Observation Phase||33
8458986|NCT00718549|20844401|P1|STARTED|Maintenance/ Observation Phase||0
8458987|NCT00718549|20844399|P3|NOT COMPLETED|Induction Phase||0
8458988|NCT00718549|20844400|P2|NOT COMPLETED|Induction Phase||0
8458989|NCT00718549|20844401|P1|NOT COMPLETED|Induction Phase||62
8458990|NCT00718549|20844399|P3|COMPLETED|Induction Phase||0
8458991|NCT00718549|20844400|P2|COMPLETED|Induction Phase||0
8458992|NCT00718549|20844401|P1|COMPLETED|Induction Phase||66
8458993|NCT00718549|20844399|P3|STARTED|Induction Phase||0
8458994|NCT00718549|20844400|P2|STARTED|Induction Phase||0
8458995|NCT00718549|20844401|P1|STARTED|Induction Phase||128
8458996|NCT00718523|20844426|P2|NOT COMPLETED|Overall Study||24
8458997|NCT00718523|20844427|P1|NOT COMPLETED|Overall Study||18
8458998|NCT00718523|20844426|P2|COMPLETED|Overall Study||62
8458999|NCT00718523|20844427|P1|COMPLETED|Overall Study||66
8459000|NCT00718523|20844426|P2|STARTED|Overall Study||86
8459001|NCT00718523|20844427|P1|STARTED|Overall Study||84
8459002|NCT00718510|20844439|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8459003|NCT00718510|20844440|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
8459004|NCT00718510|20844439|P2|COMPLETED|Second Intervention (3 Weeks)||7
8459005|NCT00718510|20844440|P1|COMPLETED|Second Intervention (3 Weeks)||6
8459006|NCT00718510|20844439|P2|STARTED|Second Intervention (3 Weeks)||7
8459007|NCT00718510|20844440|P1|STARTED|Second Intervention (3 Weeks)||7
8459008|NCT00718510|20844439|P2|NOT COMPLETED|Washout (5 Days)||0
8459009|NCT00718510|20844440|P1|NOT COMPLETED|Washout (5 Days)||0
8459010|NCT00718510|20844439|P2|COMPLETED|Washout (5 Days)||7
8459011|NCT00718510|20844440|P1|COMPLETED|Washout (5 Days)||7
8459012|NCT00718510|20844439|P2|STARTED|Washout (5 Days)||7
8459013|NCT00718510|20844440|P1|STARTED|Washout (5 Days)||7
8459014|NCT00718510|20844439|P2|NOT COMPLETED|First Intervention (3 Weeks)||1
8459015|NCT00718510|20844440|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
8459016|NCT00718510|20844439|P2|COMPLETED|First Intervention (3 Weeks)||7
8459017|NCT00718510|20844440|P1|COMPLETED|First Intervention (3 Weeks)||7
8459018|NCT00718510|20844439|P2|Received Intervention|First Intervention (3 Weeks)||7
8459019|NCT00718510|20844440|P1|Received Intervention|First Intervention (3 Weeks)||7
8459020|NCT00718510|20844439|P2|STARTED|First Intervention (3 Weeks)||8
8459021|NCT00718510|20844440|P1|STARTED|First Intervention (3 Weeks)||7
8459022|NCT00718419|20844452|P2|NOT COMPLETED|Overall Study||39
8459023|NCT00718419|20844453|P1|NOT COMPLETED|Overall Study||13
8459024|NCT00718419|20844452|P2|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|3
8459025|NCT00718419|20844453|P1|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|1
8459026|NCT00718419|20844452|P2|Received at Least One Dose of Study Drug|Overall Study||42
8459027|NCT00718419|20844453|P1|Received at Least One Dose of Study Drug|Overall Study||14
8459028|NCT00718419|20844452|P2|STARTED|Overall Study||42
8459029|NCT00718419|20844453|P1|STARTED|Overall Study||14
8459030|NCT00718328|20844469|P2|NOT COMPLETED|Overall Study||0
8459031|NCT00718328|20844470|P1|NOT COMPLETED|Overall Study||1
8459032|NCT00718328|20844469|P2|COMPLETED|Overall Study|Terminated due to poor enrollment|0
8459033|NCT00718328|20844470|P1|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
8459034|NCT00718328|20844469|P2|STARTED|Overall Study||0
8459035|NCT00718328|20844470|P1|STARTED|Overall Study||1
8459036|NCT00718315|20844479|P3|NOT COMPLETED|Overall Study||21
8459037|NCT00718315|20844480|P2|NOT COMPLETED|Overall Study||22
8459038|NCT00718315|20844481|P1|NOT COMPLETED|Overall Study||19
8459039|NCT00718315|20844479|P3|COMPLETED|Overall Study||46
8459040|NCT00718315|20844480|P2|COMPLETED|Overall Study||45
8459041|NCT00718315|20844481|P1|COMPLETED|Overall Study||48
8459042|NCT00718315|20844479|P3|STARTED|Overall Study||67
8459043|NCT00718315|20844480|P2|STARTED|Overall Study||67
8459044|NCT00718315|20844481|P1|STARTED|Overall Study||67
8459045|NCT00718302|20844515|P2|NOT COMPLETED|Overall Study||0
8459046|NCT00718302|20844516|P1|NOT COMPLETED|Overall Study||0
8459047|NCT00718302|20844515|P2|COMPLETED|Overall Study||114
8459048|NCT00718302|20844516|P1|COMPLETED|Overall Study||119
8459049|NCT00718302|20844515|P2|STARTED|Overall Study||114
8459050|NCT00718302|20844516|P1|STARTED|Overall Study||119
8459051|NCT00718237|20844532|P2|NOT COMPLETED|Overall Study||15
8459052|NCT00718237|20844533|P1|NOT COMPLETED|Overall Study||13
8459053|NCT00718237|20844532|P2|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
8459054|NCT00718237|20844533|P1|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
8459055|NCT00718237|20844532|P2|Vaccinated at Visit 3|Overall Study||369
8459056|NCT00718237|20844533|P1|Vaccinated at Visit 3|Overall Study||371
8459057|NCT00718237|20844532|P2|Vaccinated at Visit 2|Overall Study||374
8459058|NCT00718237|20844533|P1|Vaccinated at Visit 2|Overall Study||373
8459059|NCT00718237|20844532|P2|Vaccinated at Visit 1|Overall Study||381
8459060|NCT00718237|20844533|P1|Vaccinated at Visit 1|Overall Study||380
8459061|NCT00718237|20844532|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
8459062|NCT00718237|20844533|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
8459063|NCT00718159|20844550|P7|NOT COMPLETED|Overall Study||1
8459064|NCT00718159|20844551|P6|NOT COMPLETED|Overall Study||1
8459065|NCT00718159|20844552|P5|NOT COMPLETED|Overall Study||8
8459066|NCT00718159|20844553|P4|NOT COMPLETED|Overall Study||4
8459067|NCT00718159|20844554|P3|NOT COMPLETED|Overall Study||3
8459068|NCT00718159|20844555|P2|NOT COMPLETED|Overall Study||3
8459069|NCT00718159|20844556|P1|NOT COMPLETED|Overall Study||3
8459070|NCT00718159|20844550|P7|COMPLETED|Overall Study||0
8459071|NCT00718159|20844551|P6|COMPLETED|Overall Study||0
8459072|NCT00718159|20844552|P5|COMPLETED|Overall Study||0
8459073|NCT00718159|20844553|P4|COMPLETED|Overall Study||0
8459074|NCT00718159|20844554|P3|COMPLETED|Overall Study||0
8459075|NCT00718159|20844555|P2|COMPLETED|Overall Study||0
8459076|NCT00718159|20844556|P1|COMPLETED|Overall Study||0
8459077|NCT00718159|20844550|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
8459078|NCT00718159|20844551|P6|Received at Least 1 Dose of Study Drug|Overall Study||1
8459079|NCT00718159|20844552|P5|Received at Least 1 Dose of Study Drug|Overall Study||8
8459080|NCT00718159|20844553|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
8459081|NCT00718159|20844554|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8459082|NCT00718159|20844555|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8459083|NCT00718159|20844556|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8459084|NCT00718159|20844550|P7|STARTED|Overall Study||1
8459085|NCT00718159|20844551|P6|STARTED|Overall Study||1
8459086|NCT00718159|20844552|P5|STARTED|Overall Study||8
8459087|NCT00718159|20844553|P4|STARTED|Overall Study||4
8459088|NCT00718159|20844554|P3|STARTED|Overall Study||3
8459089|NCT00718159|20844555|P2|STARTED|Overall Study||3
8459090|NCT00718159|20844556|P1|STARTED|Overall Study||3
8459091|NCT00718120|20844582|P2|NOT COMPLETED|Overall Study||0
8459092|NCT00718120|20844583|P1|NOT COMPLETED|Overall Study||0
8459093|NCT00718120|20844582|P2|COMPLETED|Overall Study||55
8459094|NCT00718120|20844583|P1|COMPLETED|Overall Study||55
8459095|NCT00718120|20844582|P2|STARTED|Overall Study||55
8459096|NCT00718120|20844583|P1|STARTED|Overall Study||55
8459097|NCT00718094|20844603|P2|NOT COMPLETED|Overall Study||0
8459098|NCT00718094|20844604|P1|NOT COMPLETED|Overall Study||0
8459099|NCT00718094|20844603|P2|COMPLETED|Overall Study||5
8459100|NCT00718094|20844604|P1|COMPLETED|Overall Study||15
8459101|NCT00718094|20844603|P2|STARTED|Overall Study||5
8459102|NCT00718094|20844604|P1|STARTED|Overall Study||15
8459103|NCT00718081|20844613|P3|NOT COMPLETED|Overall Study||21
8459104|NCT00718081|20844614|P2|NOT COMPLETED|Overall Study||4
8459105|NCT00718081|20844615|P1|NOT COMPLETED|Overall Study||7
8459106|NCT00718081|20844613|P3|COMPLETED|Overall Study||9
8459107|NCT00718081|20844614|P2|COMPLETED|Overall Study||25
8459108|NCT00718081|20844615|P1|COMPLETED|Overall Study||22
8459109|NCT00718081|20844613|P3|STARTED|Overall Study||30
8459110|NCT00718081|20844614|P2|STARTED|Overall Study||29
8459111|NCT00718081|20844615|P1|STARTED|Overall Study||29
8459112|NCT00718042|20844632|P6|NOT COMPLETED|Donor Follow-up||0
8459113|NCT00718042|20844633|P5|NOT COMPLETED|Donor Follow-up||19
8459114|NCT00718042|20844634|P4|NOT COMPLETED|Donor Follow-up||0
8459115|NCT00718042|20844635|P3|NOT COMPLETED|Donor Follow-up||0
8459116|NCT00718042|20844636|P2|NOT COMPLETED|Donor Follow-up||0
8459117|NCT00718042|20844637|P1|NOT COMPLETED|Donor Follow-up||13
8459118|NCT00718042|20844632|P6|COMPLETED|Donor Follow-up||0
8459119|NCT00718042|20844633|P5|COMPLETED|Donor Follow-up||24
8459120|NCT00718042|20844634|P4|COMPLETED|Donor Follow-up||0
8459121|NCT00718042|20844635|P3|COMPLETED|Donor Follow-up||0
8459122|NCT00718042|20844636|P2|COMPLETED|Donor Follow-up||0
8459123|NCT00718042|20844637|P1|COMPLETED|Donor Follow-up||23
8459124|NCT00718042|20844632|P6|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
8459125|NCT00718042|20844633|P5|STARTED|Donor Follow-up||43
8459126|NCT00718042|20844634|P4|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
8459127|NCT00718042|20844635|P3|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
8459128|NCT00718042|20844636|P2|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
8459129|NCT00718042|20844637|P1|STARTED|Donor Follow-up||36
8459130|NCT00718042|20844632|P6|NOT COMPLETED|ESA Chagas Testing||0
8459131|NCT00718042|20844633|P5|NOT COMPLETED|ESA Chagas Testing||0
8459132|NCT00718042|20844634|P4|NOT COMPLETED|ESA Chagas Testing||0
8459133|NCT00718042|20844635|P3|NOT COMPLETED|ESA Chagas Testing||0
8459134|NCT00718042|20844636|P2|NOT COMPLETED|ESA Chagas Testing||0
8459135|NCT00718042|20844637|P1|NOT COMPLETED|ESA Chagas Testing||0
8459136|NCT00718042|20844632|P6|COMPLETED|ESA Chagas Testing||330
8459137|NCT00718042|20844633|P5|COMPLETED|ESA Chagas Testing||43
8459138|NCT00718042|20844634|P4|COMPLETED|ESA Chagas Testing||110
8459139|NCT00718042|20844635|P3|COMPLETED|ESA Chagas Testing||524
8459140|NCT00718042|20844636|P2|COMPLETED|ESA Chagas Testing||287
8459141|NCT00718042|20844637|P1|COMPLETED|ESA Chagas Testing||36
8459142|NCT00718042|20844632|P6|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
8459143|NCT00718042|20844633|P5|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
8459144|NCT00718042|20844634|P4|STARTED|ESA Chagas Testing||110
8459145|NCT00718042|20844635|P3|STARTED|ESA Chagas Testing||524
8459146|NCT00718042|20844636|P2|STARTED|ESA Chagas Testing||287
8459147|NCT00718042|20844637|P1|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
8459148|NCT00718042|20844632|P6|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
8459149|NCT00718042|20844633|P5|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
8459150|NCT00718042|20844634|P4|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
8459151|NCT00718042|20844635|P3|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
8459152|NCT00718042|20844636|P2|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
8459153|NCT00718042|20844637|P1|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
8459154|NCT00718042|20844632|P6|COMPLETED|ABBOTT PRISM Chagas Testing||0
8459155|NCT00718042|20844633|P5|COMPLETED|ABBOTT PRISM Chagas Testing||25511
8459156|NCT00718042|20844634|P4|COMPLETED|ABBOTT PRISM Chagas Testing||110
8459157|NCT00718042|20844635|P3|COMPLETED|ABBOTT PRISM Chagas Testing||524
8459158|NCT00718042|20844636|P2|COMPLETED|ABBOTT PRISM Chagas Testing||287
8459159|NCT00718042|20844637|P1|COMPLETED|ABBOTT PRISM Chagas Testing||16249
8459160|NCT00718042|20844632|P6|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
8459161|NCT00718042|20844633|P5|STARTED|ABBOTT PRISM Chagas Testing||25549
8459162|NCT00718042|20844634|P4|STARTED|ABBOTT PRISM Chagas Testing||110
8459163|NCT00718042|20844635|P3|STARTED|ABBOTT PRISM Chagas Testing||525
8459164|NCT00718042|20844636|P2|STARTED|ABBOTT PRISM Chagas Testing||289
8459165|NCT00718042|20844637|P1|STARTED|ABBOTT PRISM Chagas Testing||16313
8459166|NCT00717977|20844649|P1|NOT COMPLETED|Overall Study||0
8459167|NCT00717977|20844649|P1|COMPLETED|Overall Study||74
8459168|NCT00717977|20844649|P1|STARTED|Overall Study||74
8459169|NCT00717912|20844677|P6|NOT COMPLETED|Overall Study||0
8459170|NCT00717912|20844678|P5|NOT COMPLETED|Overall Study||0
8459171|NCT00717912|20844679|P4|NOT COMPLETED|Overall Study||0
8459172|NCT00717912|20844680|P3|NOT COMPLETED|Overall Study||0
8459173|NCT00717912|20844681|P2|NOT COMPLETED|Overall Study||0
8459174|NCT00717912|20844682|P1|NOT COMPLETED|Overall Study||0
8459175|NCT00717912|20844677|P6|COMPLETED|Overall Study||1
8459176|NCT00717912|20844678|P5|COMPLETED|Overall Study||1
8459177|NCT00717912|20844679|P4|COMPLETED|Overall Study||1
8459178|NCT00717912|20844680|P3|COMPLETED|Overall Study||1
8459179|NCT00717912|20844681|P2|COMPLETED|Overall Study||1
8459180|NCT00717912|20844682|P1|COMPLETED|Overall Study||1
8459181|NCT00717912|20844677|P6|STARTED|Overall Study||1
8459182|NCT00717912|20844678|P5|STARTED|Overall Study||1
8459183|NCT00717912|20844679|P4|STARTED|Overall Study||1
8459184|NCT00717912|20844680|P3|STARTED|Overall Study||1
8459185|NCT00717912|20844681|P2|STARTED|Overall Study||1
8459186|NCT00717912|20844682|P1|STARTED|Overall Study||1
8459187|NCT00717886|20844693|P1|NOT COMPLETED|Overall Study||4
8459188|NCT00717886|20844693|P1|COMPLETED|Overall Study||9
8459189|NCT00717886|20844693|P1|STARTED|Overall Study||13
8459190|NCT00717873|20844699|P2|NOT COMPLETED|Overall Study||0
8459191|NCT00717873|20844700|P1|NOT COMPLETED|Overall Study||0
8459192|NCT00717873|20844699|P2|COMPLETED|Overall Study||59
8459193|NCT00717873|20844700|P1|COMPLETED|Overall Study||46
8459194|NCT00717873|20844699|P2|STARTED|Overall Study||59
8459195|NCT00717873|20844700|P1|STARTED|Overall Study||46
8459196|NCT00717860|20844708|P2|NOT COMPLETED|Overall Study||28
8459197|NCT00717860|20844709|P1|NOT COMPLETED|Overall Study||27
8459198|NCT00717860|20844708|P2|COMPLETED|Overall Study||32
8459199|NCT00717860|20844709|P1|COMPLETED|Overall Study||34
8459200|NCT00717860|20844708|P2|STARTED|Overall Study||60
8459201|NCT00717860|20844709|P1|STARTED|Overall Study||61
8459202|NCT00717756|20844719|P1|NOT COMPLETED|Overall Study||1
8459203|NCT00717756|20844719|P1|COMPLETED|Overall Study||40
8459204|NCT00717756|20844719|P1|STARTED|Overall Study||41
8459205|NCT00717626|20844723|P1|NOT COMPLETED|Overall Study||0
8459206|NCT00717626|20844723|P1|COMPLETED|Overall Study||14
8459207|NCT00717626|20844723|P1|STARTED|Overall Study||14
8459208|NCT00717574|20844735|P2|NOT COMPLETED|Overall Study||2
8459209|NCT00717574|20844736|P1|NOT COMPLETED|Overall Study||2
8459210|NCT00717574|20844735|P2|COMPLETED|Overall Study||14
8459211|NCT00717574|20844736|P1|COMPLETED|Overall Study||14
8459212|NCT00717574|20844735|P2|STARTED|Overall Study||16
8459213|NCT00717574|20844736|P1|STARTED|Overall Study||16
8459214|NCT00717522|20844742|P1|NOT COMPLETED|Overall Study||7
8459215|NCT00717522|20844742|P1|COMPLETED|Overall Study||0
8459216|NCT00717522|20844742|P1|STARTED|Overall Study||7
8459217|NCT00717418|20844751|P4|NOT COMPLETED|1-Year Follow-Up||4
8459218|NCT00717418|20844752|P3|NOT COMPLETED|1-Year Follow-Up||434
8459219|NCT00717418|20844753|P2|NOT COMPLETED|1-Year Follow-Up||51
8459220|NCT00717418|20844754|P1|NOT COMPLETED|1-Year Follow-Up||147
8459221|NCT00717418|20844751|P4|COMPLETED|1-Year Follow-Up||0
8459222|NCT00717418|20844752|P3|COMPLETED|1-Year Follow-Up||74
8459223|NCT00717418|20844753|P2|COMPLETED|1-Year Follow-Up||23
8459224|NCT00717418|20844754|P1|COMPLETED|1-Year Follow-Up||33
8459225|NCT00717418|20844751|P4|STARTED|1-Year Follow-Up||4
8459226|NCT00717418|20844752|P3|STARTED|1-Year Follow-Up||508
8459227|NCT00717418|20844753|P2|STARTED|1-Year Follow-Up||74
8459228|NCT00717418|20844754|P1|STARTED|1-Year Follow-Up||180
8459229|NCT00717418|20844751|P4|NOT COMPLETED|Baseline||15
8459230|NCT00717418|20844752|P3|NOT COMPLETED|Baseline||0
8459231|NCT00717418|20844753|P2|NOT COMPLETED|Baseline||0
8459232|NCT00717418|20844754|P1|NOT COMPLETED|Baseline||0
8459233|NCT00717418|20844751|P4|COMPLETED|Baseline||4
8459234|NCT00717418|20844752|P3|COMPLETED|Baseline||508
8459235|NCT00717418|20844753|P2|COMPLETED|Baseline||74
8459236|NCT00717418|20844754|P1|COMPLETED|Baseline||180
8459237|NCT00717418|20844751|P4|STARTED|Baseline||19
8459238|NCT00717418|20844752|P3|STARTED|Baseline||508
8459239|NCT00717418|20844753|P2|STARTED|Baseline||74
8459240|NCT00717418|20844754|P1|STARTED|Baseline||180
8459241|NCT00717405|20844759|P1|NOT COMPLETED|Overall Study||0
8459242|NCT00717405|20844759|P1|COMPLETED|Overall Study||52
8459243|NCT00717405|20844759|P1|STARTED|Overall Study||52
8459244|NCT00717366|20844778|P2|NOT COMPLETED|Extension Period (52 Weeks)||16
8459245|NCT00717366|20844779|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
8459246|NCT00717366|20844778|P2|COMPLETED|Extension Period (52 Weeks)||12
8459247|NCT00717366|20844779|P1|COMPLETED|Extension Period (52 Weeks)||5
8459248|NCT00717366|20844778|P2|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
8459249|NCT00717366|20844779|P1|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
8459250|NCT00717366|20844778|P2|STARTED|Extension Period (52 Weeks)||28
8459251|NCT00717366|20844779|P1|STARTED|Extension Period (52 Weeks)||9
8459252|NCT00717366|20844778|P2|NOT COMPLETED|Core Study Period (20 Weeks)||13
8459253|NCT00717366|20844779|P1|NOT COMPLETED|Core Study Period (20 Weeks)||4
8459254|NCT00717366|20844778|P2|COMPLETED|Core Study Period (20 Weeks)||35
8459255|NCT00717366|20844779|P1|COMPLETED|Core Study Period (20 Weeks)||12
8459256|NCT00717366|20844778|P2|STARTED|Core Study Period (20 Weeks)||48
8459257|NCT00717366|20844779|P1|STARTED|Core Study Period (20 Weeks)||16
8459258|NCT00717314|20844803|P2|NOT COMPLETED|Overall Study||10
8459259|NCT00717314|20844804|P1|NOT COMPLETED|Overall Study||6
8459260|NCT00717314|20844803|P2|COMPLETED|Overall Study||34
8459261|NCT00717314|20844804|P1|COMPLETED|Overall Study||37
8459262|NCT00717314|20844803|P2|STARTED|Overall Study||44
8459263|NCT00717314|20844804|P1|STARTED|Overall Study||43
8459264|NCT00717288|20844825|P3|NOT COMPLETED|Overall Study||0
8459265|NCT00717288|20844826|P2|NOT COMPLETED|Overall Study||0
8459266|NCT00717288|20844827|P1|NOT COMPLETED|Overall Study||0
8459267|NCT00717288|20844825|P3|COMPLETED|Overall Study||25
8459268|NCT00717288|20844826|P2|COMPLETED|Overall Study||29
8459269|NCT00717288|20844827|P1|COMPLETED|Overall Study||28
8459270|NCT00717288|20844825|P3|STARTED|Overall Study||25
8459271|NCT00717288|20844826|P2|STARTED|Overall Study||29
8459272|NCT00717288|20844827|P1|STARTED|Overall Study||28
8459273|NCT00717275|20844841|P1|NOT COMPLETED|Overall Study||3
8459274|NCT00717275|20844841|P1|COMPLETED|Overall Study||0
8459275|NCT00717275|20844841|P1|STARTED|Overall Study||3
8459276|NCT00717249|20844847|P2|NOT COMPLETED|Overall Study||15
8459277|NCT00717249|20844848|P1|NOT COMPLETED|Overall Study||22
8459278|NCT00717249|20844847|P2|COMPLETED|Overall Study||150
8459279|NCT00717249|20844848|P1|COMPLETED|Overall Study||304
8459280|NCT00717249|20844847|P2|STARTED|Overall Study||165
8459281|NCT00717249|20844848|P1|STARTED|Overall Study||326
8459282|NCT00717236|20844862|P2|NOT COMPLETED|Open-Label Period||21
8459283|NCT00717236|20844863|P1|NOT COMPLETED|Open-Label Period||125
8459284|NCT00717236|20844862|P2|COMPLETED|Open-Label Period||163
8459285|NCT00717236|20844863|P1|COMPLETED|Open-Label Period||646
8459286|NCT00717236|20844862|P2|STARTED|Open-Label Period||184
8459287|NCT00717236|20844863|P1|STARTED|Open-Label Period||771
8459288|NCT00717236|20844862|P2|NOT COMPLETED|Double-Blind Period||28
8459289|NCT00717236|20844863|P1|NOT COMPLETED|Double-Blind Period||80
8459290|NCT00717236|20844862|P2|COMPLETED|Double-Blind Period||184
8459291|NCT00717236|20844863|P1|COMPLETED|Double-Blind Period||771
8459292|NCT00717236|20844862|P2|STARTED|Double-Blind Period||212
8459293|NCT00717236|20844863|P1|STARTED|Double-Blind Period||851
8459294|NCT00717197|20844932|P1|NOT COMPLETED|Overall Study||7
8459295|NCT00717197|20844932|P1|COMPLETED|Overall Study||23
8459296|NCT00717197|20844932|P1|STARTED|Overall Study||30
8459297|NCT00717093|20844938|P2|NOT COMPLETED|Overall Study||48
8459298|NCT00717093|20844939|P1|NOT COMPLETED|Overall Study||44
8459299|NCT00717093|20844938|P2|COMPLETED|Overall Study||170
8459300|NCT00717093|20844939|P1|COMPLETED|Overall Study||170
8459301|NCT00717093|20844938|P2|Received Treatment|Overall Study||218
8459302|NCT00717093|20844939|P1|Received Treatment|Overall Study||213
8459303|NCT00717093|20844938|P2|STARTED|Overall Study||218
8459304|NCT00717093|20844939|P1|STARTED|Overall Study||214
8459305|NCT00717067|20844956|P5|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8459306|NCT00717067|20844957|P4|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8459307|NCT00717067|20844958|P3|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8459308|NCT00717067|20844959|P2|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8459309|NCT00717067|20844960|P1|NOT COMPLETED|Part 2: End Stage Renal Disease||0
8459310|NCT00717067|20844956|P5|COMPLETED|Part 2: End Stage Renal Disease||6
8459311|NCT00717067|20844957|P4|COMPLETED|Part 2: End Stage Renal Disease||0
8459312|NCT00717067|20844958|P3|COMPLETED|Part 2: End Stage Renal Disease||0
8459313|NCT00717067|20844959|P2|COMPLETED|Part 2: End Stage Renal Disease||0
8459314|NCT00717067|20844960|P1|COMPLETED|Part 2: End Stage Renal Disease||0
8459315|NCT00717067|20844956|P5|STARTED|Part 2: End Stage Renal Disease||6
8459316|NCT00717067|20844957|P4|STARTED|Part 2: End Stage Renal Disease||0
8459317|NCT00717067|20844958|P3|STARTED|Part 2: End Stage Renal Disease||0
8459318|NCT00717067|20844959|P2|STARTED|Part 2: End Stage Renal Disease||0
8459319|NCT00717067|20844960|P1|STARTED|Part 2: End Stage Renal Disease||0
8459320|NCT00717067|20844956|P5|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8459321|NCT00717067|20844957|P4|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8459322|NCT00717067|20844958|P3|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8459323|NCT00717067|20844959|P2|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8459324|NCT00717067|20844960|P1|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
8459325|NCT00717067|20844956|P5|COMPLETED|Part 1b: Severe Renal Impairment||0
8459326|NCT00717067|20844957|P4|COMPLETED|Part 1b: Severe Renal Impairment||6
8459327|NCT00717067|20844958|P3|COMPLETED|Part 1b: Severe Renal Impairment||0
8459328|NCT00717067|20844959|P2|COMPLETED|Part 1b: Severe Renal Impairment||0
8459329|NCT00717067|20844960|P1|COMPLETED|Part 1b: Severe Renal Impairment||0
8459330|NCT00717067|20844956|P5|STARTED|Part 1b: Severe Renal Impairment||0
8459331|NCT00717067|20844957|P4|STARTED|Part 1b: Severe Renal Impairment||6
8459332|NCT00717067|20844958|P3|STARTED|Part 1b: Severe Renal Impairment||0
8459333|NCT00717067|20844959|P2|STARTED|Part 1b: Severe Renal Impairment||0
8459334|NCT00717067|20844960|P1|STARTED|Part 1b: Severe Renal Impairment||0
8459335|NCT00717067|20844956|P5|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8459336|NCT00717067|20844957|P4|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8459337|NCT00717067|20844958|P3|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
8459338|NCT00717067|20844959|P2|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8459339|NCT00717067|20844960|P1|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8459340|NCT00717067|20844956|P5|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8459341|NCT00717067|20844957|P4|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
8459342|NCT00717067|20844958|P3|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
8459343|NCT00717067|20844959|P2|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
8459344|NCT00717067|20844960|P1|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
8459345|NCT00717067|20844956|P5|STARTED|Part 1a: Normal/Mild/Moderate Group||0
8459346|NCT00717067|20844957|P4|STARTED|Part 1a: Normal/Mild/Moderate Group||0
8459347|NCT00717067|20844958|P3|STARTED|Part 1a: Normal/Mild/Moderate Group||6
8459348|NCT00717067|20844959|P2|STARTED|Part 1a: Normal/Mild/Moderate Group||6
8459349|NCT00717067|20844960|P1|STARTED|Part 1a: Normal/Mild/Moderate Group||6
8459350|NCT00717054|20845044|P2|NOT COMPLETED|Overall Study||0
8459351|NCT00717054|20845045|P1|NOT COMPLETED|Overall Study||0
8459352|NCT00717054|20845044|P2|COMPLETED|Overall Study||57
8459353|NCT00717054|20845045|P1|COMPLETED|Overall Study||58
8459354|NCT00717054|20845044|P2|STARTED|Overall Study||57
8459355|NCT00717054|20845045|P1|STARTED|Overall Study||58
8459356|NCT00717041|20845057|P1|NOT COMPLETED|Overall Study||0
8459357|NCT00717041|20845057|P1|COMPLETED|Overall Study||1206
8459358|NCT00717041|20845057|P1|STARTED|Overall Study||1206
8459365|NCT00716963|20845090|P6|NOT COMPLETED|Overall Study||0
8459366|NCT00716963|20845091|P5|NOT COMPLETED|Overall Study||0
8459367|NCT00716963|20845092|P4|NOT COMPLETED|Overall Study||0
8459368|NCT00716963|20845093|P3|NOT COMPLETED|Overall Study||0
8459369|NCT00716963|20845094|P2|NOT COMPLETED|Overall Study||0
8459370|NCT00716963|20845095|P1|NOT COMPLETED|Overall Study||1
8459371|NCT00716963|20845090|P6|COMPLETED|Overall Study||1
8459372|NCT00716963|20845091|P5|COMPLETED|Overall Study||1
8459373|NCT00716963|20845092|P4|COMPLETED|Overall Study||1
8459374|NCT00716963|20845093|P3|COMPLETED|Overall Study||1
8459375|NCT00716963|20845094|P2|COMPLETED|Overall Study||1
8459376|NCT00716963|20845095|P1|COMPLETED|Overall Study||1
8459377|NCT00716963|20845090|P6|STARTED|Overall Study||1
8459378|NCT00716963|20845091|P5|STARTED|Overall Study||1
8459379|NCT00716963|20845092|P4|STARTED|Overall Study||1
8459380|NCT00716963|20845093|P3|STARTED|Overall Study||1
8459381|NCT00716963|20845094|P2|STARTED|Overall Study||1
8459382|NCT00716963|20845095|P1|STARTED|Overall Study||2
8459391|NCT00716820|20845133|P1|NOT COMPLETED|Overall Study||0
8459392|NCT00716820|20845133|P1|COMPLETED|Overall Study||472
8459393|NCT00716820|20845133|P1|STARTED|Overall Study||472
8459394|NCT00716807|20845168|P4|NOT COMPLETED|Overall Study||0
8459395|NCT00716807|20845169|P3|NOT COMPLETED|Overall Study||0
8459396|NCT00716807|20845170|P2|NOT COMPLETED|Overall Study||0
8459397|NCT00716807|20845171|P1|NOT COMPLETED|Overall Study||0
8459398|NCT00716807|20845168|P4|COMPLETED|Overall Study||15
8459399|NCT00716807|20845169|P3|COMPLETED|Overall Study||18
8459400|NCT00716807|20845170|P2|COMPLETED|Overall Study||5
8459401|NCT00716807|20845171|P1|COMPLETED|Overall Study||8
8459402|NCT00716807|20845168|P4|STARTED|Overall Study||15
8459403|NCT00716807|20845169|P3|STARTED|Overall Study||18
8459404|NCT00716807|20845170|P2|STARTED|Overall Study||5
8459405|NCT00716807|20845171|P1|STARTED|Overall Study||8
8459406|NCT00716742|20845184|P3|NOT COMPLETED|3 Year Follow-up||21
8459407|NCT00716742|20845185|P2|NOT COMPLETED|3 Year Follow-up||32
8459408|NCT00716742|20845186|P1|NOT COMPLETED|3 Year Follow-up||30
8459409|NCT00716742|20845184|P3|COMPLETED|3 Year Follow-up||29
8459410|NCT00716742|20845185|P2|COMPLETED|3 Year Follow-up||35
8459411|NCT00716742|20845186|P1|COMPLETED|3 Year Follow-up||26
8459412|NCT00716742|20845184|P3|STARTED|3 Year Follow-up||50
8459413|NCT00716742|20845185|P2|STARTED|3 Year Follow-up||67
8459414|NCT00716742|20845186|P1|STARTED|3 Year Follow-up||56
8459415|NCT00716742|20845184|P3|NOT COMPLETED|2 Year Follow-up||102
8459416|NCT00716742|20845185|P2|NOT COMPLETED|2 Year Follow-up||96
8459417|NCT00716742|20845186|P1|NOT COMPLETED|2 Year Follow-up||104
8459418|NCT00716742|20845184|P3|COMPLETED|2 Year Follow-up||50
8459419|NCT00716742|20845185|P2|COMPLETED|2 Year Follow-up||67
8459420|NCT00716742|20845186|P1|COMPLETED|2 Year Follow-up||56
8459421|NCT00716742|20845184|P3|STARTED|2 Year Follow-up||152
8459422|NCT00716742|20845185|P2|STARTED|2 Year Follow-up||163
8459423|NCT00716742|20845186|P1|STARTED|2 Year Follow-up||160
8459424|NCT00716742|20845184|P3|NOT COMPLETED|1 Year Follow-up||200
8459425|NCT00716742|20845185|P2|NOT COMPLETED|1 Year Follow-up||193
8459426|NCT00716742|20845186|P1|NOT COMPLETED|1 Year Follow-up||187
8459427|NCT00716742|20845184|P3|COMPLETED|1 Year Follow-up||152
8459428|NCT00716742|20845185|P2|COMPLETED|1 Year Follow-up||163
8459429|NCT00716742|20845186|P1|COMPLETED|1 Year Follow-up||160
8459430|NCT00716742|20845184|P3|STARTED|1 Year Follow-up||352
8459431|NCT00716742|20845185|P2|STARTED|1 Year Follow-up||356
8459432|NCT00716742|20845186|P1|STARTED|1 Year Follow-up||347
8459433|NCT00716742|20845184|P3|NOT COMPLETED|Baseline||13
8459434|NCT00716742|20845185|P2|NOT COMPLETED|Baseline||14
8459435|NCT00716742|20845186|P1|NOT COMPLETED|Baseline||17
8459436|NCT00716742|20845184|P3|COMPLETED|Baseline||352
8459437|NCT00716742|20845185|P2|COMPLETED|Baseline||356
8459438|NCT00716742|20845186|P1|COMPLETED|Baseline||347
8459439|NCT00716742|20845184|P3|STARTED|Baseline||365
8459440|NCT00716742|20845185|P2|STARTED|Baseline||370
8459441|NCT00716742|20845186|P1|STARTED|Baseline||364
8459442|NCT00716625|20845194|P1|NOT COMPLETED|Overall Study||1
8459443|NCT00716625|20845194|P1|COMPLETED|Overall Study||1673
8459444|NCT00716625|20845194|P1|STARTED|Overall Study||1674
8459445|NCT00716482|20845219|P1|NOT COMPLETED|Overall Study||119
8459446|NCT00716482|20845219|P1|COMPLETED|Overall Study||1562
8459447|NCT00716482|20845219|P1|STARTED|Overall Study||1681
8459448|NCT00716456|20845232|P3|NOT COMPLETED|Overall Study||0
8459449|NCT00716456|20845233|P2|NOT COMPLETED|Overall Study||2
8459450|NCT00716456|20845234|P1|NOT COMPLETED|Overall Study||0
8459451|NCT00716456|20845232|P3|COMPLETED|Overall Study||13
8459452|NCT00716456|20845233|P2|COMPLETED|Overall Study||3
8459453|NCT00716456|20845234|P1|COMPLETED|Overall Study||3
8459454|NCT00716456|20845232|P3|STARTED|Overall Study||13
8459455|NCT00716456|20845233|P2|STARTED|Overall Study||5
8459456|NCT00716456|20845234|P1|STARTED|Overall Study||3
8459457|NCT00716443|20845242|P1|NOT COMPLETED|Overall Study||0
8459458|NCT00716443|20845242|P1|COMPLETED|Overall Study||51
8459459|NCT00716443|20845242|P1|STARTED|Overall Study||51
8459460|NCT00716417|20845285|P10|NOT COMPLETED|Overall Study||3
8459461|NCT00716417|20845286|P9|NOT COMPLETED|Overall Study||5
8459462|NCT00716417|20845287|P8|NOT COMPLETED|Overall Study||3
8459463|NCT00716417|20845288|P7|NOT COMPLETED|Overall Study||7
8459464|NCT00716417|20845289|P6|NOT COMPLETED|Overall Study||3
8459465|NCT00716417|20845290|P5|NOT COMPLETED|Overall Study||1
8459466|NCT00716417|20845291|P4|NOT COMPLETED|Overall Study||11
8459467|NCT00716417|20845292|P3|NOT COMPLETED|Overall Study||5
8459468|NCT00716417|20845293|P2|NOT COMPLETED|Overall Study||6
8459469|NCT00716417|20845294|P1|NOT COMPLETED|Overall Study||3
8459470|NCT00716417|20845285|P10|COMPLETED|Overall Study||0
8459471|NCT00716417|20845286|P9|COMPLETED|Overall Study||0
8459472|NCT00716417|20845287|P8|COMPLETED|Overall Study||0
8459473|NCT00716417|20845288|P7|COMPLETED|Overall Study||0
8459474|NCT00716417|20845289|P6|COMPLETED|Overall Study||0
8459475|NCT00716417|20845290|P5|COMPLETED|Overall Study||0
8459476|NCT00716417|20845291|P4|COMPLETED|Overall Study||0
8459477|NCT00716417|20845292|P3|COMPLETED|Overall Study||0
8459478|NCT00716417|20845293|P2|COMPLETED|Overall Study||0
8459479|NCT00716417|20845294|P1|COMPLETED|Overall Study||0
8459480|NCT00716417|20845285|P10|STARTED|Overall Study||3
8459481|NCT00716417|20845286|P9|STARTED|Overall Study||5
8459482|NCT00716417|20845287|P8|STARTED|Overall Study||3
8459483|NCT00716417|20845288|P7|STARTED|Overall Study||7
8459484|NCT00716417|20845289|P6|STARTED|Overall Study||3
8459485|NCT00716417|20845290|P5|STARTED|Overall Study||1
8459486|NCT00716417|20845291|P4|STARTED|Overall Study||11
8459487|NCT00716417|20845292|P3|STARTED|Overall Study||5
8459488|NCT00716417|20845293|P2|STARTED|Overall Study||6
8459489|NCT00716417|20845294|P1|STARTED|Overall Study||3
8459490|NCT00716274|20845341|P6|NOT COMPLETED|Study Period III (16-Weeks)||0
8459491|NCT00716274|20845342|P5|NOT COMPLETED|Study Period III (16-Weeks)||3
8459492|NCT00716274|20845343|P4|NOT COMPLETED|Study Period III (16-Weeks)||1
8459493|NCT00716274|20845344|P3|NOT COMPLETED|Study Period III (16-Weeks)||2
8459494|NCT00716274|20845345|P2|NOT COMPLETED|Study Period III (16-Weeks)||0
8459495|NCT00716274|20845346|P1|NOT COMPLETED|Study Period III (16-Weeks)||0
8459496|NCT00716274|20845341|P6|COMPLETED|Study Period III (16-Weeks)||19
8459497|NCT00716274|20845342|P5|COMPLETED|Study Period III (16-Weeks)||32
8459498|NCT00716274|20845343|P4|COMPLETED|Study Period III (16-Weeks)||17
8459499|NCT00716274|20845344|P3|COMPLETED|Study Period III (16-Weeks)||16
8459500|NCT00716274|20845345|P2|COMPLETED|Study Period III (16-Weeks)||0
8459501|NCT00716274|20845346|P1|COMPLETED|Study Period III (16-Weeks)||0
8459502|NCT00716274|20845341|P6|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
8459503|NCT00716274|20845342|P5|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
8459504|NCT00716274|20845343|P4|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
8459505|NCT00716274|20845344|P3|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
8459506|NCT00716274|20845345|P2|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
8459507|NCT00716274|20845346|P1|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
8459508|NCT00716274|20845341|P6|NOT COMPLETED|Study Period II (16-Weeks)||2
8459509|NCT00716274|20845342|P5|NOT COMPLETED|Study Period II (16-Weeks)||0
8459510|NCT00716274|20845343|P4|NOT COMPLETED|Study Period II (16-Weeks)||0
8459511|NCT00716274|20845344|P3|NOT COMPLETED|Study Period II (16-Weeks)||0
8459512|NCT00716274|20845345|P2|NOT COMPLETED|Study Period II (16-Weeks)||9
8459513|NCT00716274|20845346|P1|NOT COMPLETED|Study Period II (16-Weeks)||9
8459514|NCT00716274|20845341|P6|COMPLETED|Study Period II (16-Weeks)||19
8459515|NCT00716274|20845342|P5|COMPLETED|Study Period II (16-Weeks)||0
8459516|NCT00716274|20845343|P4|COMPLETED|Study Period II (16-Weeks)||0
8459517|NCT00716274|20845344|P3|COMPLETED|Study Period II (16-Weeks)||0
8459518|NCT00716274|20845345|P2|COMPLETED|Study Period II (16-Weeks)||35
8459519|NCT00716274|20845346|P1|COMPLETED|Study Period II (16-Weeks)||36
8459520|NCT00716274|20845341|P6|STARTED|Study Period II (16-Weeks)||21
8459521|NCT00716274|20845342|P5|STARTED|Study Period II (16-Weeks)||0
8459522|NCT00716274|20845343|P4|STARTED|Study Period II (16-Weeks)||0
8459523|NCT00716274|20845344|P3|STARTED|Study Period II (16-Weeks)||0
8459524|NCT00716274|20845345|P2|STARTED|Study Period II (16-Weeks)||44
8459525|NCT00716274|20845346|P1|STARTED|Study Period II (16-Weeks)||45
8459526|NCT00716144|20845480|P4|NOT COMPLETED|Overall Study||12
8459527|NCT00716144|20845481|P3|NOT COMPLETED|Overall Study||12
8459528|NCT00716144|20845482|P2|NOT COMPLETED|Overall Study||7
8459529|NCT00716144|20845483|P1|NOT COMPLETED|Overall Study||9
8459530|NCT00716144|20845480|P4|COMPLETED|Overall Study||33
8459531|NCT00716144|20845481|P3|COMPLETED|Overall Study||33
8459532|NCT00716144|20845482|P2|COMPLETED|Overall Study||38
8459533|NCT00716144|20845483|P1|COMPLETED|Overall Study||32
8459534|NCT00716144|20845480|P4|STARTED|Overall Study||45
8459535|NCT00716144|20845481|P3|STARTED|Overall Study||45
8459536|NCT00716144|20845482|P2|STARTED|Overall Study||45
8459537|NCT00716144|20845483|P1|STARTED|Overall Study||41
8459538|NCT00716092|20845508|P3|NOT COMPLETED|Overall Study||0
8459539|NCT00716092|20845509|P2|NOT COMPLETED|Overall Study||1
8459540|NCT00716092|20845510|P1|NOT COMPLETED|Overall Study||2
8459541|NCT00716092|20845508|P3|COMPLETED|Overall Study||41
8459542|NCT00716092|20845509|P2|COMPLETED|Overall Study||39
8459543|NCT00716092|20845510|P1|COMPLETED|Overall Study||38
8459544|NCT00716092|20845508|P3|STARTED|Overall Study||41
8459545|NCT00716092|20845509|P2|STARTED|Overall Study||40
8459546|NCT00716092|20845510|P1|STARTED|Overall Study||40
8459547|NCT00716079|20845541|P2|NOT COMPLETED|Overall Study||15
8459548|NCT00716079|20845542|P1|NOT COMPLETED|Overall Study||9
8459549|NCT00716079|20845541|P2|COMPLETED|Overall Study||1421
8459550|NCT00716079|20845542|P1|COMPLETED|Overall Study||1394
8459551|NCT00716079|20845541|P2|STARTED|Overall Study||1436
8459552|NCT00716079|20845542|P1|STARTED|Overall Study||1403
8459553|NCT00715962|20845552|P2|NOT COMPLETED|Overall Study||2
8459554|NCT00715962|20845553|P1|NOT COMPLETED|Overall Study||6
8459555|NCT00715962|20845552|P2|COMPLETED|Overall Study||48
8459556|NCT00715962|20845553|P1|COMPLETED|Overall Study||44
8459557|NCT00715962|20845552|P2|STARTED|Overall Study||50
8459558|NCT00715962|20845553|P1|STARTED|Overall Study||50
8459559|NCT00715949|20845563|P1|NOT COMPLETED|Overall Study||4
8459560|NCT00715949|20845563|P1|COMPLETED|Overall Study|116 patients completed first test|116
8459561|NCT00715949|20845563|P1|STARTED|Overall Study|4 dropped because could not finish first test|120
8459562|NCT00715910|20845571|P6|NOT COMPLETED|Booster and ESFU Phase||13
8459563|NCT00715910|20845572|P5|NOT COMPLETED|Booster and ESFU Phase||2
8459564|NCT00715910|20845573|P4|NOT COMPLETED|Booster and ESFU Phase||11
8459565|NCT00715910|20845574|P3|NOT COMPLETED|Booster and ESFU Phase||0
8459566|NCT00715910|20845575|P2|NOT COMPLETED|Booster and ESFU Phase||0
8459567|NCT00715910|20845576|P1|NOT COMPLETED|Booster and ESFU Phase||0
8459568|NCT00715910|20845571|P6|COMPLETED|Booster and ESFU Phase||88
8459569|NCT00715910|20845572|P5|COMPLETED|Booster and ESFU Phase||36
8459570|NCT00715910|20845573|P4|COMPLETED|Booster and ESFU Phase||172
8459571|NCT00715910|20845574|P3|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
8459572|NCT00715910|20845575|P2|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
8459573|NCT00715910|20845576|P1|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
8459574|NCT00715910|20845571|P6|STARTED|Booster and ESFU Phase||101
8459575|NCT00715910|20845572|P5|STARTED|Booster and ESFU Phase||38
8459576|NCT00715910|20845573|P4|STARTED|Booster and ESFU Phase||183
8459577|NCT00715910|20845574|P3|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
8459578|NCT00715910|20845575|P2|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
8459579|NCT00715910|20845576|P1|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
8459580|NCT00715910|20845571|P6|NOT COMPLETED|Year 5||0
8459581|NCT00715910|20845572|P5|NOT COMPLETED|Year 5||0
8459582|NCT00715910|20845573|P4|NOT COMPLETED|Year 5||0
8459583|NCT00715910|20845574|P3|NOT COMPLETED|Year 5||0
8459584|NCT00715910|20845575|P2|NOT COMPLETED|Year 5||0
8459585|NCT00715910|20845576|P1|NOT COMPLETED|Year 5||0
8459586|NCT00715910|20845571|P6|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
8459587|NCT00715910|20845572|P5|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
8459588|NCT00715910|20845573|P4|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
8459589|NCT00715910|20845574|P3|COMPLETED|Year 5||38
8459590|NCT00715910|20845575|P2|COMPLETED|Year 5||56
8459591|NCT00715910|20845576|P1|COMPLETED|Year 5||218
8459592|NCT00715910|20845571|P6|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
8459593|NCT00715910|20845572|P5|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
8459594|NCT00715910|20845573|P4|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
8459595|NCT00715910|20845574|P3|STARTED|Year 5||38
8459596|NCT00715910|20845575|P2|STARTED|Year 5||56
8459597|NCT00715910|20845576|P1|STARTED|Year 5||218
8459598|NCT00715910|20845571|P6|NOT COMPLETED|Year 3||0
8459599|NCT00715910|20845572|P5|NOT COMPLETED|Year 3||0
8459600|NCT00715910|20845573|P4|NOT COMPLETED|Year 3||0
8459601|NCT00715910|20845574|P3|NOT COMPLETED|Year 3||0
8459602|NCT00715910|20845575|P2|NOT COMPLETED|Year 3||0
8459603|NCT00715910|20845576|P1|NOT COMPLETED|Year 3||0
8459604|NCT00715910|20845571|P6|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
8459605|NCT00715910|20845572|P5|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
8459606|NCT00715910|20845573|P4|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
8459607|NCT00715910|20845574|P3|COMPLETED|Year 3||56
8459608|NCT00715910|20845575|P2|COMPLETED|Year 3||86
8459609|NCT00715910|20845576|P1|COMPLETED|Year 3||345
8459610|NCT00715910|20845571|P6|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
8459611|NCT00715910|20845572|P5|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
8459612|NCT00715910|20845573|P4|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
8459613|NCT00715910|20845574|P3|STARTED|Year 3||56
8459614|NCT00715910|20845575|P2|STARTED|Year 3||86
8459615|NCT00715910|20845576|P1|STARTED|Year 3||345
8459616|NCT00715910|20845571|P6|NOT COMPLETED|Year 1||0
8459617|NCT00715910|20845572|P5|NOT COMPLETED|Year 1||0
8459618|NCT00715910|20845573|P4|NOT COMPLETED|Year 1||0
8459619|NCT00715910|20845574|P3|NOT COMPLETED|Year 1||0
8459620|NCT00715910|20845575|P2|NOT COMPLETED|Year 1||0
8459621|NCT00715910|20845576|P1|NOT COMPLETED|Year 1||0
8459622|NCT00715910|20845571|P6|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
8459623|NCT00715910|20845572|P5|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
8459624|NCT00715910|20845573|P4|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
8459625|NCT00715910|20845574|P3|COMPLETED|Year 1||68
8459626|NCT00715910|20845575|P2|COMPLETED|Year 1||147
8459627|NCT00715910|20845576|P1|COMPLETED|Year 1||433
8459628|NCT00715910|20845571|P6|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
8459629|NCT00715910|20845572|P5|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
8459630|NCT00715910|20845573|P4|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
8459631|NCT00715910|20845574|P3|STARTED|Year 1||68
8459632|NCT00715910|20845575|P2|STARTED|Year 1||147
8459633|NCT00715910|20845576|P1|STARTED|Year 1||433
8459634|NCT00715884|20845652|P2|NOT COMPLETED|Overall Study||1
8459635|NCT00715884|20845653|P1|NOT COMPLETED|Overall Study||8
8459636|NCT00715884|20845652|P2|COMPLETED|Overall Study||225
8459637|NCT00715884|20845653|P1|COMPLETED|Overall Study||444
8459638|NCT00715884|20845652|P2|STARTED|Overall Study||226
8459639|NCT00715884|20845653|P1|STARTED|Overall Study||452
8459640|NCT00715793|20845695|P2|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
8459641|NCT00715793|20845696|P1|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
8459642|NCT00715793|20845695|P2|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
8459643|NCT00715793|20845696|P1|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
8459644|NCT00715793|20845695|P2|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
8459645|NCT00715793|20845696|P1|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
8459646|NCT00715793|20845695|P2|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
8459647|NCT00715793|20845696|P1|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
8459648|NCT00715793|20845695|P2|COMPLETED|Phase 1 RP2D DAC + TMZ||6
8459649|NCT00715793|20845696|P1|COMPLETED|Phase 1 RP2D DAC + TMZ||3
8459650|NCT00715793|20845695|P2|STARTED|Phase 1 RP2D DAC + TMZ||6
8459651|NCT00715793|20845696|P1|STARTED|Phase 1 RP2D DAC + TMZ||4
8459652|NCT00715754|20845708|P1|NOT COMPLETED|Overall Study||0
8459653|NCT00715754|20845708|P1|COMPLETED|Overall Study||47
8459654|NCT00715754|20845708|P1|STARTED|Overall Study||47
8459655|NCT00715741|20845718|P4|NOT COMPLETED|Overall Study||0
8459656|NCT00715741|20845719|P3|NOT COMPLETED|Overall Study||0
8459657|NCT00715741|20845720|P2|NOT COMPLETED|Overall Study||0
8459658|NCT00715741|20845721|P1|NOT COMPLETED|Overall Study||0
8459659|NCT00715741|20845718|P4|COMPLETED|Overall Study||25
8459660|NCT00715741|20845719|P3|COMPLETED|Overall Study||25
8459661|NCT00715741|20845720|P2|COMPLETED|Overall Study||25
8459662|NCT00715741|20845721|P1|COMPLETED|Overall Study||25
8459663|NCT00715741|20845718|P4|STARTED|Overall Study||25
8459664|NCT00715741|20845719|P3|STARTED|Overall Study||25
8459665|NCT00715741|20845720|P2|STARTED|Overall Study||25
8459666|NCT00715741|20845721|P1|STARTED|Overall Study||25
8459667|NCT00715728|20845745|P2|NOT COMPLETED|Overall Study||0
8459668|NCT00715728|20845746|P1|NOT COMPLETED|Overall Study||0
8459669|NCT00715728|20845745|P2|COMPLETED|Overall Study||14
8459670|NCT00715728|20845746|P1|COMPLETED|Overall Study||14
8459671|NCT00715728|20845745|P2|STARTED|Overall Study||14
8459672|NCT00715728|20845746|P1|STARTED|Overall Study||14
8459673|NCT00715676|20845757|P3|NOT COMPLETED|Overall Study||32
8459674|NCT00715676|20845758|P2|NOT COMPLETED|Overall Study||11
8459675|NCT00715676|20845759|P1|NOT COMPLETED|Overall Study||6
8459676|NCT00715676|20845757|P3|COMPLETED|Overall Study||21
8459677|NCT00715676|20845758|P2|COMPLETED|Overall Study||43
8459678|NCT00715676|20845759|P1|COMPLETED|Overall Study||43
8459679|NCT00715676|20845757|P3|STARTED|Overall Study||53
8459680|NCT00715676|20845758|P2|STARTED|Overall Study||54
8459681|NCT00715676|20845759|P1|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
8459682|NCT00715650|20845787|P2|NOT COMPLETED|Follow-up||5
8459683|NCT00715650|20845788|P1|NOT COMPLETED|Follow-up||13
8459684|NCT00715650|20845787|P2|COMPLETED|Follow-up||37
8459685|NCT00715650|20845788|P1|COMPLETED|Follow-up||29
8459686|NCT00715650|20845787|P2|Completed Month 6 Follow-up|Follow-up||37
8459687|NCT00715650|20845788|P1|Completed Month 6 Follow-up|Follow-up||29
8459688|NCT00715650|20845787|P2|Completed Month 3 Follow-up|Follow-up||40
8459689|NCT00715650|20845788|P1|Completed Month 3 Follow-up|Follow-up||35
8459690|NCT00715650|20845787|P2|Completed Month 1 Follow-up|Follow-up||38
8459691|NCT00715650|20845788|P1|Completed Month 1 Follow-up|Follow-up||40
8459692|NCT00715650|20845787|P2|STARTED|Follow-up||42
8459693|NCT00715650|20845788|P1|STARTED|Follow-up||42
8459694|NCT00715650|20845787|P2|NOT COMPLETED|Intervention||3
8459695|NCT00715650|20845788|P1|NOT COMPLETED|Intervention||5
8459696|NCT00715650|20845787|P2|COMPLETED|Intervention||42
8459697|NCT00715650|20845788|P1|COMPLETED|Intervention||42
8459698|NCT00715650|20845787|P2|Attended ≥ 3 Sessions|Intervention||17
8459699|NCT00715650|20845788|P1|Attended ≥ 3 Sessions|Intervention||23
8459700|NCT00715650|20845787|P2|Attended ≥ 2 Sessions|Intervention||33
8459701|NCT00715650|20845788|P1|Attended ≥ 2 Sessions|Intervention||36
8459702|NCT00715650|20845787|P2|Received Any Session|Intervention||38
8459703|NCT00715650|20845788|P1|Received Any Session|Intervention||39
8459704|NCT00715650|20845787|P2|STARTED|Intervention||45
8459705|NCT00715650|20845788|P1|STARTED|Intervention||47
8459706|NCT00715624|20845802|P2|NOT COMPLETED|Overall Study||116
8459707|NCT00715624|20845803|P1|NOT COMPLETED|Overall Study||52
8459708|NCT00715624|20845802|P2|COMPLETED|Overall Study||213
8459709|NCT00715624|20845803|P1|COMPLETED|Overall Study||115
8459710|NCT00715624|20845802|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||327
8459711|NCT00715624|20845803|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
8459712|NCT00715624|20845802|P2|Treated/Safety Population|Overall Study||328
8459713|NCT00715624|20845803|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
8459714|NCT00715624|20845802|P2|STARTED|Overall Study||329
8459715|NCT00715624|20845803|P1|STARTED|Overall Study|Randomized|167
8459716|NCT00715559|20845831|P1|NOT COMPLETED|Overall Study||1
8459717|NCT00715559|20845831|P1|COMPLETED|Overall Study||2
8459718|NCT00715559|20845831|P1|STARTED|Overall Study||3
8459719|NCT00715520|20845841|P3|NOT COMPLETED|Overall Study||2
8459720|NCT00715520|20845842|P2|NOT COMPLETED|Overall Study||1
8459721|NCT00715520|20845843|P1|NOT COMPLETED|Overall Study||10
8459722|NCT00715520|20845841|P3|COMPLETED|Overall Study||1
8459723|NCT00715520|20845842|P2|COMPLETED|Overall Study||9
8459724|NCT00715520|20845843|P1|COMPLETED|Overall Study||10
8459725|NCT00715520|20845841|P3|STARTED|Overall Study||3
8459726|NCT00715520|20845842|P2|STARTED|Overall Study||10
8459727|NCT00715520|20845843|P1|STARTED|Overall Study||20
8459728|NCT00715429|20845858|P2|NOT COMPLETED|Overall Study||1
8459729|NCT00715429|20845859|P1|NOT COMPLETED|Overall Study||0
8459730|NCT00715429|20845858|P2|COMPLETED|Overall Study||6
8459731|NCT00715429|20845859|P1|COMPLETED|Overall Study||7
8459732|NCT00715429|20845858|P2|STARTED|Overall Study||7
8459733|NCT00715429|20845859|P1|STARTED|Overall Study||7
8459734|NCT00715403|20845874|P7|NOT COMPLETED|Overall Study||1
8459735|NCT00715403|20845875|P6|NOT COMPLETED|Overall Study||19
8459736|NCT00715403|20845876|P5|NOT COMPLETED|Overall Study||6
8459737|NCT00715403|20845877|P4|NOT COMPLETED|Overall Study||9
8459738|NCT00715403|20845878|P3|NOT COMPLETED|Overall Study||4
8459739|NCT00715403|20845879|P2|NOT COMPLETED|Overall Study||1
8459740|NCT00715403|20845880|P1|NOT COMPLETED|Overall Study||1
8459741|NCT00715403|20845874|P7|COMPLETED|Overall Study||0
8459742|NCT00715403|20845875|P6|COMPLETED|Overall Study||0
8459743|NCT00715403|20845876|P5|COMPLETED|Overall Study||0
8459744|NCT00715403|20845877|P4|COMPLETED|Overall Study||0
8459745|NCT00715403|20845878|P3|COMPLETED|Overall Study||0
8459746|NCT00715403|20845879|P2|COMPLETED|Overall Study||0
8459747|NCT00715403|20845880|P1|COMPLETED|Overall Study||0
8459748|NCT00715403|20845874|P7|STARTED|Overall Study||1
8459749|NCT00715403|20845875|P6|STARTED|Overall Study||19
8459750|NCT00715403|20845876|P5|STARTED|Overall Study||6
8459751|NCT00715403|20845877|P4|STARTED|Overall Study||9
8459752|NCT00715403|20845878|P3|STARTED|Overall Study||4
8459753|NCT00715403|20845879|P2|STARTED|Overall Study||1
8459754|NCT00715403|20845880|P1|STARTED|Overall Study||1
8459755|NCT00715390|20846015|P1|NOT COMPLETED|Overall Study||0
8459756|NCT00715390|20846015|P1|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
8459757|NCT00715390|20846015|P1|Eligible|Overall Study||234
8459758|NCT00715390|20846015|P1|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
8459759|NCT00715299|20846019|P1|NOT COMPLETED|Overall Study||6
8459760|NCT00715299|20846019|P1|COMPLETED|Overall Study||30
8459761|NCT00715299|20846019|P1|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
8459762|NCT00715208|20846025|P2|NOT COMPLETED|Overall Study||9
8459763|NCT00715208|20846026|P1|NOT COMPLETED|Overall Study||1
8459764|NCT00715208|20846025|P2|COMPLETED|Overall Study||39
8459765|NCT00715208|20846026|P1|COMPLETED|Overall Study||6
8459766|NCT00715208|20846025|P2|STARTED|Overall Study||48
8459767|NCT00715208|20846026|P1|STARTED|Overall Study||7
8459768|NCT00715117|20846042|P2|NOT COMPLETED|Overall Study||1
8459769|NCT00715117|20846043|P1|NOT COMPLETED|Overall Study||0
8459770|NCT00715117|20846042|P2|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
8459771|NCT00715117|20846043|P1|COMPLETED|Overall Study||6
8459772|NCT00715117|20846042|P2|Completion fo 8 Week Study|Overall Study||6
8459773|NCT00715117|20846043|P1|Completion fo 8 Week Study|Overall Study||6
8459774|NCT00715117|20846042|P2|STARTED|Overall Study||6
8459775|NCT00715117|20846043|P1|STARTED|Overall Study||6
8459776|NCT00715104|20846057|P3|NOT COMPLETED|Overall Study||0
8459777|NCT00715104|20846058|P2|NOT COMPLETED|Overall Study||0
8459778|NCT00715104|20846059|P1|NOT COMPLETED|Overall Study||0
8459779|NCT00715104|20846057|P3|COMPLETED|Overall Study||8
8459780|NCT00715104|20846058|P2|COMPLETED|Overall Study||16
8459781|NCT00715104|20846059|P1|COMPLETED|Overall Study||18
8459782|NCT00715104|20846057|P3|STARTED|Overall Study||8
8459783|NCT00715104|20846058|P2|STARTED|Overall Study||16
8459784|NCT00715104|20846059|P1|STARTED|Overall Study||18
8459785|NCT00715078|20846111|P3|NOT COMPLETED|Overall Study||38
8459786|NCT00715078|20846112|P2|NOT COMPLETED|Overall Study||36
8459787|NCT00715078|20846113|P1|NOT COMPLETED|Overall Study||30
8459788|NCT00715078|20846111|P3|COMPLETED|Overall Study||3
8459789|NCT00715078|20846112|P2|COMPLETED|Overall Study||4
8459790|NCT00715078|20846113|P1|COMPLETED|Overall Study||11
8459791|NCT00715078|20846111|P3|Received ≥ 1 Leukapheresis|Overall Study||40
8459792|NCT00715078|20846112|P2|Received ≥ 1 Leukapheresis|Overall Study||40
8459793|NCT00715078|20846113|P1|Received ≥ 1 Leukapheresis|Overall Study||40
8459794|NCT00715078|20846111|P3|Received ≥ 1 Study Infusion|Overall Study||39
8459795|NCT00715078|20846112|P2|Received ≥ 1 Study Infusion|Overall Study||40
8459796|NCT00715078|20846113|P1|Received ≥ 1 Study Infusion|Overall Study||40
8459797|NCT00715078|20846111|P3|STARTED|Overall Study||41
8459798|NCT00715078|20846112|P2|STARTED|Overall Study||40
8459799|NCT00715078|20846113|P1|STARTED|Overall Study||41
8459800|NCT00715026|20846121|P1|NOT COMPLETED|Overall Study||10
8459801|NCT00715026|20846121|P1|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
8459802|NCT00715026|20846121|P1|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
8459803|NCT00715026|20846121|P1|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
8459804|NCT00714948|20846126|P1|NOT COMPLETED|Overall Study||2
8459805|NCT00714948|20846126|P1|COMPLETED|Overall Study||0
8459806|NCT00714948|20846126|P1|STARTED|Overall Study||2
8459807|NCT00714870|20846132|P2|NOT COMPLETED|Overall Study||5
8459808|NCT00714870|20846133|P1|NOT COMPLETED|Overall Study||27
8459809|NCT00714870|20846132|P2|COMPLETED|Overall Study||22
8459810|NCT00714870|20846133|P1|COMPLETED|Overall Study||22
8459811|NCT00714870|20846132|P2|STARTED|Overall Study||27
8459812|NCT00714870|20846133|P1|STARTED|Overall Study||49
8459813|NCT00714792|20846141|P2|NOT COMPLETED|Overall Study||0
8459814|NCT00714792|20846142|P1|NOT COMPLETED|Overall Study||0
8459815|NCT00714792|20846141|P2|COMPLETED|Overall Study||8
8459816|NCT00714792|20846142|P1|COMPLETED|Overall Study||10
8459817|NCT00714792|20846141|P2|STARTED|Overall Study||8
8459818|NCT00714792|20846142|P1|STARTED|Overall Study||10
8459819|NCT00714753|20846148|P1|NOT COMPLETED|Overall Study||0
8459820|NCT00714753|20846148|P1|COMPLETED|Overall Study||5
8459821|NCT00714753|20846148|P1|External Beam Radiotherapy (EBRT)|Overall Study||1
8459822|NCT00714753|20846148|P1|HDR Brachytherapy|Overall Study||5
8459823|NCT00714753|20846148|P1|STARTED|Overall Study||5
8459824|NCT00714714|20846157|P1|NOT COMPLETED|Overall Study||1
8459825|NCT00714714|20846157|P1|COMPLETED|Overall Study||24
8459826|NCT00714714|20846157|P1|STARTED|Overall Study||25
8459827|NCT00714688|20846166|P3|NOT COMPLETED|Overall Study||37
8459828|NCT00714688|20846167|P2|NOT COMPLETED|Overall Study||35
8459829|NCT00714688|20846168|P1|NOT COMPLETED|Overall Study||29
8459830|NCT00714688|20846166|P3|COMPLETED|Overall Study||55
8459831|NCT00714688|20846167|P2|COMPLETED|Overall Study||55
8459832|NCT00714688|20846168|P1|COMPLETED|Overall Study||68
8459833|NCT00714688|20846166|P3|STARTED|Overall Study||92
8459834|NCT00714688|20846167|P2|STARTED|Overall Study||90
8459835|NCT00714688|20846168|P1|STARTED|Overall Study||97
8459836|NCT00714571|20846191|P6|NOT COMPLETED|Stage 2||0
8459837|NCT00714571|20846192|P5|NOT COMPLETED|Stage 2||0
8459838|NCT00714571|20846193|P4|NOT COMPLETED|Stage 2||0
8459839|NCT00714571|20846194|P3|NOT COMPLETED|Stage 2||0
8459840|NCT00714571|20846195|P2|NOT COMPLETED|Stage 2||0
8459841|NCT00714571|20846196|P1|NOT COMPLETED|Stage 2||0
8459842|NCT00714571|20846191|P6|COMPLETED|Stage 2||15
8459843|NCT00714571|20846192|P5|COMPLETED|Stage 2||15
8459844|NCT00714571|20846193|P4|COMPLETED|Stage 2||0
8459845|NCT00714571|20846194|P3|COMPLETED|Stage 2||0
8459846|NCT00714571|20846195|P2|COMPLETED|Stage 2||0
8459847|NCT00714571|20846196|P1|COMPLETED|Stage 2||0
8459848|NCT00714571|20846191|P6|STARTED|Stage 2||15
8459849|NCT00714571|20846192|P5|STARTED|Stage 2||15
8459850|NCT00714571|20846193|P4|STARTED|Stage 2||0
8459851|NCT00714571|20846194|P3|STARTED|Stage 2||0
8459852|NCT00714571|20846195|P2|STARTED|Stage 2||0
8459853|NCT00714571|20846196|P1|STARTED|Stage 2||0
8459854|NCT00714571|20846191|P6|NOT COMPLETED|Stage 1||0
8459855|NCT00714571|20846192|P5|NOT COMPLETED|Stage 1||0
8459856|NCT00714571|20846193|P4|NOT COMPLETED|Stage 1||0
8459857|NCT00714571|20846194|P3|NOT COMPLETED|Stage 1||1
8459858|NCT00714571|20846195|P2|NOT COMPLETED|Stage 1||0
8459859|NCT00714571|20846196|P1|NOT COMPLETED|Stage 1||0
8459860|NCT00714571|20846191|P6|COMPLETED|Stage 1||0
8459861|NCT00714571|20846192|P5|COMPLETED|Stage 1||0
8459862|NCT00714571|20846193|P4|COMPLETED|Stage 1||14
8459863|NCT00714571|20846194|P3|COMPLETED|Stage 1||10
8459864|NCT00714571|20846195|P2|COMPLETED|Stage 1||15
8459865|NCT00714571|20846196|P1|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
8459866|NCT00714571|20846191|P6|STARTED|Stage 1||0
8459867|NCT00714571|20846192|P5|STARTED|Stage 1||0
8459868|NCT00714571|20846193|P4|STARTED|Stage 1||14
8459869|NCT00714571|20846194|P3|STARTED|Stage 1||11
8459870|NCT00714571|20846195|P2|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
8459871|NCT00714571|20846196|P1|STARTED|Stage 1||12
8459872|NCT00714493|20846210|P1|NOT COMPLETED|Overall Study||49
8459873|NCT00714493|20846210|P1|COMPLETED|Overall Study||154
8459874|NCT00714493|20846210|P1|STARTED|Overall Study||203
8459875|NCT00714415|20846222|P2|NOT COMPLETED|Overall Study||0
8459876|NCT00714415|20846223|P1|NOT COMPLETED|Overall Study||2
8459877|NCT00714415|20846222|P2|COMPLETED|Overall Study||55
8459878|NCT00714415|20846223|P1|COMPLETED|Overall Study||23
8459879|NCT00714415|20846222|P2|STARTED|Overall Study||55
8459880|NCT00714415|20846223|P1|STARTED|Overall Study||25
8459881|NCT00714389|20846255|P1|NOT COMPLETED|Overall Study||0
8459882|NCT00714389|20846255|P1|COMPLETED|Overall Study||12
8459883|NCT00714389|20846255|P1|STARTED|Overall Study||12
8459884|NCT00714311|20846262|P2|NOT COMPLETED|Overall Study||22
8459885|NCT00714311|20846263|P1|NOT COMPLETED|Overall Study||13
8459886|NCT00714311|20846262|P2|COMPLETED|Overall Study||30
8459887|NCT00714311|20846263|P1|COMPLETED|Overall Study||39
8459888|NCT00714311|20846262|P2|STARTED|Overall Study||52
8459889|NCT00714311|20846263|P1|STARTED|Overall Study||52
8459890|NCT00714285|20846273|P4|NOT COMPLETED|Overall Study||1
8459891|NCT00714285|20846274|P3|NOT COMPLETED|Overall Study||0
8459892|NCT00714285|20846275|P2|NOT COMPLETED|Overall Study||3
8459893|NCT00714285|20846276|P1|NOT COMPLETED|Overall Study||0
8459894|NCT00714285|20846273|P4|COMPLETED|Overall Study|Completed upto Day 180|104
8459895|NCT00714285|20846274|P3|COMPLETED|Overall Study|Completed upto Day 180|105
8459896|NCT00714285|20846275|P2|COMPLETED|Overall Study|Completed upto Day 180|102
8459897|NCT00714285|20846276|P1|COMPLETED|Overall Study|Completed upto Day 180|105
8459898|NCT00714285|20846273|P4|STARTED|Overall Study||105
8459899|NCT00714285|20846274|P3|STARTED|Overall Study||105
8459900|NCT00714285|20846275|P2|STARTED|Overall Study||105
8459901|NCT00714285|20846276|P1|STARTED|Overall Study||105
8459902|NCT00714272|20846328|P2|NOT COMPLETED|Overall Study||0
8459903|NCT00714272|20846329|P1|NOT COMPLETED|Overall Study||0
8459904|NCT00714272|20846328|P2|COMPLETED|Overall Study||2
8459905|NCT00714272|20846329|P1|COMPLETED|Overall Study||2
8459906|NCT00714272|20846328|P2|STARTED|Overall Study||2
8459907|NCT00714272|20846329|P1|STARTED|Overall Study||2
8459908|NCT00714259|20846337|P1|NOT COMPLETED|Overall Study||2
8459909|NCT00714259|20846337|P1|COMPLETED|Overall Study||3
8459910|NCT00714259|20846337|P1|STARTED|Overall Study||5
8459911|NCT00714233|20846351|P4|NOT COMPLETED|Overall Study||4
8459912|NCT00714233|20846352|P3|NOT COMPLETED|Overall Study||1
8459913|NCT00714233|20846353|P2|NOT COMPLETED|Overall Study||1
8459914|NCT00714233|20846354|P1|NOT COMPLETED|Overall Study||4
8459915|NCT00714233|20846351|P4|COMPLETED|Overall Study||6
8459916|NCT00714233|20846352|P3|COMPLETED|Overall Study||10
8459917|NCT00714233|20846353|P2|COMPLETED|Overall Study||10
8459918|NCT00714233|20846354|P1|COMPLETED|Overall Study||6
8459919|NCT00714233|20846351|P4|STARTED|Overall Study||10
8459920|NCT00714233|20846352|P3|STARTED|Overall Study||11
8459921|NCT00714233|20846353|P2|STARTED|Overall Study||11
8459922|NCT00714233|20846354|P1|STARTED|Overall Study||10
8459923|NCT00714168|20846383|P2|NOT COMPLETED|Overall Study||59
8459924|NCT00714168|20846384|P1|NOT COMPLETED|Overall Study||44
8459925|NCT00714168|20846383|P2|COMPLETED|Overall Study||139
8459926|NCT00714168|20846384|P1|COMPLETED|Overall Study||121
8459927|NCT00714168|20846383|P2|STARTED|Overall Study||198
8459928|NCT00714168|20846384|P1|STARTED|Overall Study||165
8459929|NCT00714051|20846400|P2|NOT COMPLETED|Overall Study||1
8459930|NCT00714051|20846401|P1|NOT COMPLETED|Overall Study||1
8459931|NCT00714051|20846400|P2|COMPLETED|Overall Study||27
8459932|NCT00714051|20846401|P1|COMPLETED|Overall Study||26
8459933|NCT00714051|20846400|P2|STARTED|Overall Study||28
8459934|NCT00714051|20846401|P1|STARTED|Overall Study||27
8459935|NCT00713830|20846409|P2|NOT COMPLETED|Overall Study||177
8459936|NCT00713830|20846410|P1|NOT COMPLETED|Overall Study||82
8459937|NCT00713830|20846409|P2|COMPLETED|Overall Study||396
8459938|NCT00713830|20846410|P1|COMPLETED|Overall Study||204
8459939|NCT00713830|20846409|P2|Subgroup for Standardized Meal Test|Overall Study||313
8459940|NCT00713830|20846410|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
8459941|NCT00713830|20846409|P2|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
8459942|NCT00713830|20846410|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
8459943|NCT00713830|20846409|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||570
8459944|NCT00713830|20846410|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
8459945|NCT00713830|20846409|P2|STARTED|Overall Study||573
8459946|NCT00713830|20846410|P1|STARTED|Overall Study|Randomized.|286
8459947|NCT00713817|20846448|P2|NOT COMPLETED|Overall Study||0
8459948|NCT00713817|20846449|P1|NOT COMPLETED|Overall Study||0
8459949|NCT00713817|20846448|P2|COMPLETED|Overall Study||9
8459950|NCT00713817|20846449|P1|COMPLETED|Overall Study||10
8459951|NCT00713817|20846448|P2|STARTED|Overall Study||9
8459952|NCT00713817|20846449|P1|STARTED|Overall Study||10
8459953|NCT00713700|20846467|P1|NOT COMPLETED|Overall Study||4
8459954|NCT00713700|20846467|P1|COMPLETED|Overall Study||188
8459955|NCT00713700|20846467|P1|STARTED|Overall Study||192
8459956|NCT00713661|20846476|P4|NOT COMPLETED|Overall Study||0
8459957|NCT00713661|20846477|P3|NOT COMPLETED|Overall Study||0
8459958|NCT00713661|20846478|P2|NOT COMPLETED|Overall Study||0
8459959|NCT00713661|20846479|P1|NOT COMPLETED|Overall Study||0
8459960|NCT00713661|20846476|P4|COMPLETED|Overall Study||5
8459961|NCT00713661|20846477|P3|COMPLETED|Overall Study||4
8459962|NCT00713661|20846478|P2|COMPLETED|Overall Study||9
8459963|NCT00713661|20846479|P1|COMPLETED|Overall Study||7
8459964|NCT00713661|20846476|P4|STARTED|Overall Study||5
8459965|NCT00713661|20846477|P3|STARTED|Overall Study||4
8459966|NCT00713661|20846478|P2|STARTED|Overall Study||9
8459967|NCT00713661|20846479|P1|STARTED|Overall Study||7
8459968|NCT00713648|20846493|P1|NOT COMPLETED|Overall Study||8
8459969|NCT00713648|20846493|P1|COMPLETED|Overall Study||33
8459970|NCT00713648|20846493|P1|STARTED|Overall Study||41
8459971|NCT00713609|20846506|P6|NOT COMPLETED|Overall Study||8
8459972|NCT00713609|20846507|P5|NOT COMPLETED|Overall Study||19
8459973|NCT00713609|20846508|P4|NOT COMPLETED|Overall Study||9
8459974|NCT00713609|20846509|P3|NOT COMPLETED|Overall Study||15
8459975|NCT00713609|20846510|P2|NOT COMPLETED|Overall Study||15
8459976|NCT00713609|20846511|P1|NOT COMPLETED|Overall Study||21
8459977|NCT00713609|20846506|P6|COMPLETED|Overall Study||47
8459978|NCT00713609|20846507|P5|COMPLETED|Overall Study||87
8459979|NCT00713609|20846508|P4|COMPLETED|Overall Study||99
8459980|NCT00713609|20846509|P3|COMPLETED|Overall Study||92
8459981|NCT00713609|20846510|P2|COMPLETED|Overall Study||90
8459982|NCT00713609|20846511|P1|COMPLETED|Overall Study||85
8459983|NCT00713609|20846506|P6|STARTED|Overall Study||55
8459984|NCT00713609|20846507|P5|STARTED|Overall Study||106
8459985|NCT00713609|20846508|P4|STARTED|Overall Study||108
8459986|NCT00713609|20846509|P3|STARTED|Overall Study||107
8459987|NCT00713609|20846510|P2|STARTED|Overall Study||105
8459988|NCT00713609|20846511|P1|STARTED|Overall Study||106
8459989|NCT00713596|20846546|P3|NOT COMPLETED|Overall Study||2
8459990|NCT00713596|20846547|P2|NOT COMPLETED|Overall Study||3
8459991|NCT00713596|20846548|P1|NOT COMPLETED|Overall Study||2
8459992|NCT00713596|20846546|P3|COMPLETED|Overall Study||6
8459993|NCT00713596|20846547|P2|COMPLETED|Overall Study||5
8459994|NCT00713596|20846548|P1|COMPLETED|Overall Study||7
8459995|NCT00713596|20846546|P3|STARTED|Overall Study||8
8459996|NCT00713596|20846547|P2|STARTED|Overall Study||8
8459997|NCT00713596|20846548|P1|STARTED|Overall Study||9
8459998|NCT00713583|20846561|P2|NOT COMPLETED|Overall Study||0
8459999|NCT00713583|20846562|P1|NOT COMPLETED|Overall Study||0
8460000|NCT00713583|20846561|P2|COMPLETED|Overall Study||40
8460001|NCT00713583|20846562|P1|COMPLETED|Overall Study||45
8460002|NCT00713583|20846561|P2|STARTED|Overall Study||40
8460003|NCT00713583|20846562|P1|STARTED|Overall Study||45
8460004|NCT00713544|20846574|P6|NOT COMPLETED|Overall Study||9
8460005|NCT00713544|20846575|P5|NOT COMPLETED|Overall Study||8
8460006|NCT00713544|20846576|P4|NOT COMPLETED|Overall Study||10
8460007|NCT00713544|20846577|P3|NOT COMPLETED|Overall Study||11
8460008|NCT00713544|20846578|P2|NOT COMPLETED|Overall Study||6
8460009|NCT00713544|20846579|P1|NOT COMPLETED|Overall Study||7
8460010|NCT00713544|20846574|P6|COMPLETED|Overall Study||67
8460011|NCT00713544|20846575|P5|COMPLETED|Overall Study||57
8460012|NCT00713544|20846576|P4|COMPLETED|Overall Study||66
8460013|NCT00713544|20846577|P3|COMPLETED|Overall Study||41
8460014|NCT00713544|20846578|P2|COMPLETED|Overall Study||46
8460015|NCT00713544|20846579|P1|COMPLETED|Overall Study||45
8460016|NCT00713544|20846574|P6|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
8460017|NCT00713544|20846575|P5|STARTED|Overall Study||65
8460018|NCT00713544|20846576|P4|STARTED|Overall Study||76
8460019|NCT00713544|20846577|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
8460020|NCT00713544|20846578|P2|STARTED|Overall Study||52
8460021|NCT00713544|20846579|P1|STARTED|Overall Study||52
8460022|NCT00713479|20846617|P2|NOT COMPLETED|Next Medication Condition||0
8460023|NCT00713479|20846618|P1|NOT COMPLETED|Next Medication Condition||0
8460024|NCT00713479|20846617|P2|COMPLETED|Next Medication Condition||6
8460025|NCT00713479|20846618|P1|COMPLETED|Next Medication Condition||2
8460026|NCT00713479|20846617|P2|STARTED|Next Medication Condition||6
8460027|NCT00713479|20846618|P1|STARTED|Next Medication Condition||2
8460028|NCT00713479|20846617|P2|NOT COMPLETED|Washout||0
8460029|NCT00713479|20846618|P1|NOT COMPLETED|Washout||0
8460030|NCT00713479|20846617|P2|COMPLETED|Washout||6
8460031|NCT00713479|20846618|P1|COMPLETED|Washout||2
8460032|NCT00713479|20846617|P2|STARTED|Washout||6
8460033|NCT00713479|20846618|P1|STARTED|Washout||2
8460034|NCT00713479|20846617|P2|NOT COMPLETED|First Medication Condition||0
8460035|NCT00713479|20846618|P1|NOT COMPLETED|First Medication Condition||4
8460036|NCT00713479|20846617|P2|COMPLETED|First Medication Condition||6
8460037|NCT00713479|20846618|P1|COMPLETED|First Medication Condition||2
8460038|NCT00713479|20846617|P2|STARTED|First Medication Condition||6
8460039|NCT00713479|20846618|P1|STARTED|First Medication Condition||6
8460040|NCT00713349|20846630|P1|NOT COMPLETED|Overall Study||1
8460041|NCT00713349|20846630|P1|COMPLETED|Overall Study||24
8460042|NCT00713349|20846630|P1|STARTED|Overall Study||25
8460043|NCT00713323|20846636|P1|NOT COMPLETED|Overall Study||146
8460044|NCT00713323|20846636|P1|COMPLETED|Overall Study||234
8460045|NCT00713323|20846636|P1|STARTED|Overall Study||380
8460046|NCT00713310|20846649|P2|NOT COMPLETED|Overall Study||6
8460047|NCT00713310|20846650|P1|NOT COMPLETED|Overall Study||5
8460048|NCT00713310|20846649|P2|COMPLETED|Overall Study||36
8460049|NCT00713310|20846650|P1|COMPLETED|Overall Study||36
8460050|NCT00713310|20846649|P2|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
8460051|NCT00713310|20846650|P1|mITT Population|Overall Study||41
8460052|NCT00713310|20846649|P2|STARTED|Overall Study||42
8460053|NCT00713310|20846650|P1|STARTED|Overall Study||41
8460054|NCT00713284|20846658|P1|NOT COMPLETED|Overall Study||16
8460055|NCT00713284|20846658|P1|COMPLETED|Overall Study||13
8460056|NCT00713284|20846658|P1|STARTED|Overall Study|29 participants were screened but only 13 eligible for conversion and continue in the study.|29
8460057|NCT00713258|20846664|P2|NOT COMPLETED|Overall Study||6
8460058|NCT00713258|20846665|P1|NOT COMPLETED|Overall Study||5
8460059|NCT00713258|20846664|P2|COMPLETED|Overall Study||28
8460060|NCT00713258|20846665|P1|COMPLETED|Overall Study||36
8460061|NCT00713258|20846664|P2|STARTED|Overall Study||34
8460062|NCT00713258|20846665|P1|STARTED|Overall Study||41
8460063|NCT00713219|20846673|P1|NOT COMPLETED|Overall Study||2
8460064|NCT00713219|20846673|P1|COMPLETED|Overall Study||12
8460065|NCT00713219|20846673|P1|STARTED|Overall Study||14
8460066|NCT00713206|20846679|P2|NOT COMPLETED|Overall Study||3
8460067|NCT00713206|20846680|P1|NOT COMPLETED|Overall Study||7
8460068|NCT00713206|20846679|P2|COMPLETED|Overall Study||27
8460069|NCT00713206|20846680|P1|COMPLETED|Overall Study||55
8460070|NCT00713206|20846679|P2|STARTED|Overall Study||30
8460071|NCT00713206|20846680|P1|STARTED|Overall Study||62
8460072|NCT00712985|20846686|P1|NOT COMPLETED|Overall Study||5
8460073|NCT00712985|20846686|P1|COMPLETED|Overall Study||13
8460074|NCT00712985|20846686|P1|STARTED|Overall Study||18
8460075|NCT00712959|20846692|P2|NOT COMPLETED|Overall Study||3
8460076|NCT00712959|20846693|P1|NOT COMPLETED|Overall Study||19
8460077|NCT00712959|20846692|P2|COMPLETED|Overall Study||404
8460078|NCT00712959|20846693|P1|COMPLETED|Overall Study||342
8460079|NCT00712959|20846692|P2|STARTED|Overall Study||407
8460080|NCT00712959|20846693|P1|STARTED|Overall Study||361
8460081|NCT00712933|20846711|P1|NOT COMPLETED|Overall Study||367
8460082|NCT00712933|20846711|P1|COMPLETED|Overall Study||368
8460083|NCT00712933|20846711|P1|STARTED|Overall Study||735
8460084|NCT00712920|20846741|P3|NOT COMPLETED|Overall Study||12
8460085|NCT00712920|20846742|P2|NOT COMPLETED|Overall Study||17
8460086|NCT00712920|20846743|P1|NOT COMPLETED|Overall Study||17
8460087|NCT00712920|20846741|P3|COMPLETED|Overall Study||180
8460088|NCT00712920|20846742|P2|COMPLETED|Overall Study||180
8460089|NCT00712920|20846743|P1|COMPLETED|Overall Study||175
8460090|NCT00712920|20846741|P3|STARTED|Overall Study||192
8460091|NCT00712920|20846742|P2|STARTED|Overall Study|3 subjects were randomized in error|197
8460092|NCT00712920|20846743|P1|STARTED|Overall Study||192
8460093|NCT00712725|20846771|P8|NOT COMPLETED|Overall Study||11
8460094|NCT00712725|20846772|P7|NOT COMPLETED|Overall Study||22
8460095|NCT00712725|20846773|P6|NOT COMPLETED|Overall Study||16
8460096|NCT00712725|20846774|P5|NOT COMPLETED|Overall Study||19
8460097|NCT00712725|20846775|P4|NOT COMPLETED|Overall Study||17
8460098|NCT00712725|20846776|P3|NOT COMPLETED|Overall Study||10
8460099|NCT00712725|20846777|P2|NOT COMPLETED|Overall Study||6
8460100|NCT00712725|20846778|P1|NOT COMPLETED|Overall Study||29
8460101|NCT00712725|20846771|P8|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
8460102|NCT00712725|20846772|P7|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
8460103|NCT00712725|20846773|P6|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
8460104|NCT00712725|20846774|P5|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
8460105|NCT00712725|20846775|P4|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
8460106|NCT00712725|20846776|P3|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
8460107|NCT00712725|20846777|P2|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
8460108|NCT00712725|20846778|P1|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
8460109|NCT00712725|20846771|P8|STARTED|Overall Study||74
8460110|NCT00712725|20846772|P7|STARTED|Overall Study||83
8460111|NCT00712725|20846773|P6|STARTED|Overall Study||84
8460112|NCT00712725|20846774|P5|STARTED|Overall Study||86
8460113|NCT00712725|20846775|P4|STARTED|Overall Study||84
8460114|NCT00712725|20846776|P3|STARTED|Overall Study||57
8460115|NCT00712725|20846777|P2|STARTED|Overall Study||39
8460116|NCT00712725|20846778|P1|STARTED|Overall Study||169
8460117|NCT00712673|20846839|P4|NOT COMPLETED|Overall Study||70
8460118|NCT00712673|20846840|P3|NOT COMPLETED|Overall Study||57
8460119|NCT00712673|20846841|P2|NOT COMPLETED|Overall Study||21
8460120|NCT00712673|20846842|P1|NOT COMPLETED|Overall Study||21
8460121|NCT00712673|20846839|P4|COMPLETED|Overall Study||185
8460122|NCT00712673|20846840|P3|COMPLETED|Overall Study||198
8460123|NCT00712673|20846841|P2|COMPLETED|Overall Study||64
8460124|NCT00712673|20846842|P1|COMPLETED|Overall Study||64
8460125|NCT00712673|20846839|P4|Subgroup for Standardized Meal Test|Overall Study||0
8460126|NCT00712673|20846840|P3|Subgroup for Standardized Meal Test|Overall Study||255
8460127|NCT00712673|20846841|P2|Subgroup for Standardized Meal Test|Overall Study||0
8460128|NCT00712673|20846842|P1|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
8460129|NCT00712673|20846839|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||255
8460130|NCT00712673|20846840|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||255
8460131|NCT00712673|20846841|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||85
8460132|NCT00712673|20846842|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
8460133|NCT00712673|20846839|P4|Safety Population|Overall Study||255
8460134|NCT00712673|20846840|P3|Safety Population|Overall Study||255
8460135|NCT00712673|20846841|P2|Safety Population|Overall Study||85
8460136|NCT00712673|20846842|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
8460137|NCT00712673|20846839|P4|STARTED|Overall Study||255
8460138|NCT00712673|20846840|P3|STARTED|Overall Study||255
8460139|NCT00712673|20846841|P2|STARTED|Overall Study||85
8460140|NCT00712673|20846842|P1|STARTED|Overall Study|Randomized.|85
8460141|NCT00712543|20846906|P2|NOT COMPLETED|Day 8-14||2
8460142|NCT00712543|20846907|P1|NOT COMPLETED|Day 8-14||0
8460143|NCT00712543|20846906|P2|COMPLETED|Day 8-14||25
8460144|NCT00712543|20846907|P1|COMPLETED|Day 8-14||23
8460145|NCT00712543|20846906|P2|STARTED|Day 8-14||27
8460146|NCT00712543|20846907|P1|STARTED|Day 8-14||23
8460147|NCT00712543|20846906|P2|NOT COMPLETED|Day 1-7||0
8460148|NCT00712543|20846907|P1|NOT COMPLETED|Day 1-7||0
8460149|NCT00712543|20846906|P2|COMPLETED|Day 1-7||27
8460150|NCT00712543|20846907|P1|COMPLETED|Day 1-7||23
8460151|NCT00712543|20846906|P2|STARTED|Day 1-7||27
8460152|NCT00712543|20846907|P1|STARTED|Day 1-7||23
8460153|NCT00712530|20846916|P3|NOT COMPLETED|Overall Study||0
8460154|NCT00712530|20846917|P2|NOT COMPLETED|Overall Study||0
8460155|NCT00712530|20846918|P1|NOT COMPLETED|Overall Study||0
8460156|NCT00712530|20846916|P3|COMPLETED|Overall Study||3
8460157|NCT00712530|20846917|P2|COMPLETED|Overall Study||3
8460158|NCT00712530|20846918|P1|COMPLETED|Overall Study||3
8460159|NCT00712530|20846916|P3|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
8460160|NCT00712530|20846917|P2|STARTED|Overall Study||3
8460161|NCT00712530|20846918|P1|STARTED|Overall Study||3
8460162|NCT00712348|20846941|P1|NOT COMPLETED|Overall Study||1
8460163|NCT00712348|20846941|P1|COMPLETED|Overall Study||30
8460164|NCT00712348|20846941|P1|STARTED|Overall Study||31
8460165|NCT00712335|20846953|P5|NOT COMPLETED|Overall Study||0
8460166|NCT00712335|20846954|P4|NOT COMPLETED|Overall Study||5
8460167|NCT00712335|20846955|P3|NOT COMPLETED|Overall Study||5
8460168|NCT00712335|20846956|P2|NOT COMPLETED|Overall Study||17
8460169|NCT00712335|20846957|P1|NOT COMPLETED|Overall Study||3
8460170|NCT00712335|20846953|P5|COMPLETED|Overall Study||30
8460171|NCT00712335|20846954|P4|COMPLETED|Overall Study||19
8460172|NCT00712335|20846955|P3|COMPLETED|Overall Study||6
8460173|NCT00712335|20846956|P2|COMPLETED|Overall Study||15
8460174|NCT00712335|20846957|P1|COMPLETED|Overall Study||5
8460175|NCT00712335|20846953|P5|STARTED|Overall Study||30
8460176|NCT00712335|20846954|P4|STARTED|Overall Study||24
8460177|NCT00712335|20846955|P3|STARTED|Overall Study||11
8460178|NCT00712335|20846956|P2|STARTED|Overall Study||32
8460179|NCT00712335|20846957|P1|STARTED|Overall Study||8
8460180|NCT00712296|20847004|P5|NOT COMPLETED|Phase II (28 Weeks)||12
8460181|NCT00712296|20847005|P4|NOT COMPLETED|Phase II (28 Weeks)||15
8460182|NCT00712296|20847006|P3|NOT COMPLETED|Phase II (28 Weeks)||13
8460183|NCT00712296|20847007|P2|NOT COMPLETED|Phase II (28 Weeks)||0
8460184|NCT00712296|20847008|P1|NOT COMPLETED|Phase II (28 Weeks)||0
8460185|NCT00712296|20847004|P5|COMPLETED|Phase II (28 Weeks)||3
8460186|NCT00712296|20847005|P4|COMPLETED|Phase II (28 Weeks)||1
8460187|NCT00712296|20847006|P3|COMPLETED|Phase II (28 Weeks)|ASHMI/Placebo was discontinued on 9/29/10.20 participants were re-randomized into the Phase II.|2
8460188|NCT00712296|20847007|P2|COMPLETED|Phase II (28 Weeks)||0
8460189|NCT00712296|20847008|P1|COMPLETED|Phase II (28 Weeks)||0
8460190|NCT00712296|20847004|P5|STARTED|Phase II (28 Weeks)||15
8460191|NCT00712296|20847005|P4|STARTED|Phase II (28 Weeks)||16
8460192|NCT00712296|20847006|P3|STARTED|Phase II (28 Weeks)||15
8460193|NCT00712296|20847007|P2|STARTED|Phase II (28 Weeks)||0
8460194|NCT00712296|20847008|P1|STARTED|Phase II (28 Weeks)||0
8460195|NCT00712296|20847004|P5|NOT COMPLETED|Phase I ( 1 Week)||0
8460196|NCT00712296|20847005|P4|NOT COMPLETED|Phase I ( 1 Week)||0
8460197|NCT00712296|20847006|P3|NOT COMPLETED|Phase I ( 1 Week)||0
8460198|NCT00712296|20847007|P2|NOT COMPLETED|Phase I ( 1 Week)||0
8460199|NCT00712296|20847008|P1|NOT COMPLETED|Phase I ( 1 Week)||0
8460200|NCT00712296|20847004|P5|COMPLETED|Phase I ( 1 Week)||0
8460201|NCT00712296|20847005|P4|COMPLETED|Phase I ( 1 Week)||0
8460202|NCT00712296|20847006|P3|COMPLETED|Phase I ( 1 Week)||0
8460203|NCT00712296|20847007|P2|COMPLETED|Phase I ( 1 Week)||8
8460204|NCT00712296|20847008|P1|COMPLETED|Phase I ( 1 Week)||12
8460205|NCT00712296|20847004|P5|STARTED|Phase I ( 1 Week)||0
8460206|NCT00712296|20847005|P4|STARTED|Phase I ( 1 Week)||0
8460207|NCT00712296|20847006|P3|STARTED|Phase I ( 1 Week)||0
8460208|NCT00712296|20847007|P2|STARTED|Phase I ( 1 Week)||8
8460209|NCT00712296|20847008|P1|STARTED|Phase I ( 1 Week)||12
8460210|NCT00712270|20847087|P1|NOT COMPLETED|Overall Study||14
8460211|NCT00712270|20847087|P1|COMPLETED|Overall Study||7
8460212|NCT00712270|20847087|P1|STARTED|Overall Study||21
8460213|NCT00712244|20847100|P4|NOT COMPLETED|Overall Study||1
8460214|NCT00712244|20847101|P3|NOT COMPLETED|Overall Study||2
8460215|NCT00712244|20847102|P2|NOT COMPLETED|Overall Study||1
8460216|NCT00712244|20847103|P1|NOT COMPLETED|Overall Study||4
8460217|NCT00712244|20847100|P4|COMPLETED|Overall Study||26
8460218|NCT00712244|20847101|P3|COMPLETED|Overall Study||25
8460219|NCT00712244|20847102|P2|COMPLETED|Overall Study||28
8460220|NCT00712244|20847103|P1|COMPLETED|Overall Study||25
8460221|NCT00712244|20847100|P4|STARTED|Overall Study||27
8460222|NCT00712244|20847101|P3|STARTED|Overall Study||27
8460223|NCT00712244|20847102|P2|STARTED|Overall Study||29
8460224|NCT00712244|20847103|P1|STARTED|Overall Study||29
8460225|NCT00712179|20847145|P1|NOT COMPLETED|Overall Study||12
8460226|NCT00712179|20847145|P1|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
8460227|NCT00712179|20847145|P1|STARTED|Overall Study||49
8460228|NCT00712166|20847151|P2|NOT COMPLETED|Overall Study||1
8460229|NCT00712166|20847152|P1|NOT COMPLETED|Overall Study||0
8460230|NCT00712166|20847151|P2|COMPLETED|Overall Study||75
8460231|NCT00712166|20847152|P1|COMPLETED|Overall Study||81
8460232|NCT00712166|20847151|P2|STARTED|Overall Study||76
8460233|NCT00712166|20847152|P1|STARTED|Overall Study||81
8460234|NCT00712075|20847179|P3|NOT COMPLETED|Overall Study||11
8460235|NCT00712075|20847180|P2|NOT COMPLETED|Overall Study||4
8460236|NCT00712075|20847181|P1|NOT COMPLETED|Overall Study||5
8460237|NCT00712075|20847179|P3|COMPLETED|Overall Study||14
8460238|NCT00712075|20847180|P2|COMPLETED|Overall Study||26
8460239|NCT00712075|20847181|P1|COMPLETED|Overall Study||17
8460240|NCT00712075|20847179|P3|STARTED|Overall Study||25
8460241|NCT00712075|20847180|P2|STARTED|Overall Study||30
8460242|NCT00712075|20847181|P1|STARTED|Overall Study||22
8460243|NCT00712010|20847195|P1|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
8460244|NCT00712010|20847195|P1|COMPLETED|7th and Last Protein Testing (1 Day)||23
8460245|NCT00712010|20847195|P1|STARTED|7th and Last Protein Testing (1 Day)||23
8460246|NCT00712010|20847195|P1|NOT COMPLETED|Washout (7 Days)||0
8460247|NCT00712010|20847195|P1|COMPLETED|Washout (7 Days)||23
8460248|NCT00712010|20847195|P1|STARTED|Washout (7 Days)||23
8460249|NCT00712010|20847195|P1|NOT COMPLETED|6th Protein Testing (1 Day)||0
8460250|NCT00712010|20847195|P1|COMPLETED|6th Protein Testing (1 Day)||23
8460251|NCT00712010|20847195|P1|STARTED|6th Protein Testing (1 Day)||23
8460252|NCT00712010|20847195|P1|NOT COMPLETED|Washout (7 Days)||0
8460253|NCT00712010|20847195|P1|COMPLETED|Washout (7 Days)||23
8460254|NCT00712010|20847195|P1|STARTED|Washout (7 Days)||23
8460255|NCT00712010|20847195|P1|NOT COMPLETED|5th Protein Testing (1 Day)||0
8460256|NCT00712010|20847195|P1|COMPLETED|5th Protein Testing (1 Day)||23
8460257|NCT00712010|20847195|P1|STARTED|5th Protein Testing (1 Day)||23
8460258|NCT00712010|20847195|P1|NOT COMPLETED|Washout (7 Days)||1
8460259|NCT00712010|20847195|P1|COMPLETED|Washout (7 Days)||23
8460260|NCT00712010|20847195|P1|STARTED|Washout (7 Days)||24
8460261|NCT00712010|20847195|P1|NOT COMPLETED|4th Protein Testing (1 Day)||0
8460262|NCT00712010|20847195|P1|COMPLETED|4th Protein Testing (1 Day)||24
8460263|NCT00712010|20847195|P1|STARTED|4th Protein Testing (1 Day)||24
8460264|NCT00712010|20847195|P1|NOT COMPLETED|Washout (7 Days)||0
8460265|NCT00712010|20847195|P1|COMPLETED|Washout (7 Days)||24
8460266|NCT00712010|20847195|P1|STARTED|Washout (7 Days)||24
8460267|NCT00712010|20847195|P1|NOT COMPLETED|3rd Protein Testing (1 Day)||0
8460268|NCT00712010|20847195|P1|COMPLETED|3rd Protein Testing (1 Day)||24
8460269|NCT00712010|20847195|P1|STARTED|3rd Protein Testing (1 Day)||24
8460270|NCT00712010|20847195|P1|NOT COMPLETED|Washout (7 Days)||0
8460271|NCT00712010|20847195|P1|COMPLETED|Washout (7 Days)||24
8460272|NCT00712010|20847195|P1|STARTED|Washout (7 Days)||24
8460273|NCT00712010|20847195|P1|NOT COMPLETED|2nd Protein Testing (1 Day)||0
8460274|NCT00712010|20847195|P1|COMPLETED|2nd Protein Testing (1 Day)||24
8460275|NCT00712010|20847195|P1|STARTED|2nd Protein Testing (1 Day)||24
8460276|NCT00712010|20847195|P1|NOT COMPLETED|Washout (7 Days)||0
8460277|NCT00712010|20847195|P1|COMPLETED|Washout (7 Days)||24
8460278|NCT00712010|20847195|P1|STARTED|Washout (7 Days)||24
8460279|NCT00712010|20847195|P1|NOT COMPLETED|1st Protein Testing (1 Day)||0
8460280|NCT00712010|20847195|P1|COMPLETED|1st Protein Testing (1 Day)||24
8460281|NCT00712010|20847195|P1|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
8460282|NCT00711997|20847220|P2|NOT COMPLETED|Overall Study||0
8460283|NCT00711997|20847221|P1|NOT COMPLETED|Overall Study||0
8460284|NCT00711997|20847220|P2|COMPLETED|Overall Study||6
8460285|NCT00711997|20847221|P1|COMPLETED|Overall Study||3
8460286|NCT00711997|20847220|P2|STARTED|Overall Study||6
8460287|NCT00711997|20847221|P1|STARTED|Overall Study||3
8460288|NCT00711971|20847234|P3|NOT COMPLETED|Overall Study||1
8460289|NCT00711971|20847235|P2|NOT COMPLETED|Overall Study||4
8460290|NCT00711971|20847236|P1|NOT COMPLETED|Overall Study||3
8460291|NCT00711971|20847234|P3|COMPLETED|Overall Study||41
8460292|NCT00711971|20847235|P2|COMPLETED|Overall Study||38
8460293|NCT00711971|20847236|P1|COMPLETED|Overall Study||39
8460294|NCT00711971|20847234|P3|STARTED|Overall Study||42
8460295|NCT00711971|20847235|P2|STARTED|Overall Study||42
8460296|NCT00711971|20847236|P1|STARTED|Overall Study||42
8460297|NCT00711958|20847270|P2|NOT COMPLETED|Overall Study||23
8460298|NCT00711958|20847271|P1|NOT COMPLETED|Overall Study||33
8460299|NCT00711958|20847270|P2|COMPLETED|Overall Study||17
8460300|NCT00711958|20847271|P1|COMPLETED|Overall Study||41
8460301|NCT00711958|20847270|P2|STARTED|Overall Study||40
8460302|NCT00711958|20847271|P1|STARTED|Overall Study||74
8460309|NCT00711867|20847318|P2|NOT COMPLETED|Overall Study||4
8460310|NCT00711867|20847319|P1|NOT COMPLETED|Overall Study||5
8460311|NCT00711867|20847318|P2|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
8460312|NCT00711867|20847319|P1|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
8460313|NCT00711867|20847318|P2|STARTED|Overall Study||25
8460314|NCT00711867|20847319|P1|STARTED|Overall Study||30
8460315|NCT00711828|20847325|P1|NOT COMPLETED|Overall Study||0
8460316|NCT00711828|20847325|P1|COMPLETED|Overall Study||21
8460317|NCT00711828|20847325|P1|STARTED|Overall Study||21
8460318|NCT00711802|20847342|P8|NOT COMPLETED|Overall Study||2
8460319|NCT00711802|20847343|P7|NOT COMPLETED|Overall Study||5
8460320|NCT00711802|20847344|P6|NOT COMPLETED|Overall Study||8
8460321|NCT00711802|20847345|P5|NOT COMPLETED|Overall Study||14
8460322|NCT00711802|20847346|P4|NOT COMPLETED|Overall Study||3
8460323|NCT00711802|20847347|P3|NOT COMPLETED|Overall Study||6
8460324|NCT00711802|20847348|P2|NOT COMPLETED|Overall Study||6
8460325|NCT00711802|20847349|P1|NOT COMPLETED|Overall Study||2
8460326|NCT00711802|20847342|P8|COMPLETED|Overall Study||13
8460327|NCT00711802|20847343|P7|COMPLETED|Overall Study||25
8460328|NCT00711802|20847344|P6|COMPLETED|Overall Study||34
8460329|NCT00711802|20847345|P5|COMPLETED|Overall Study||69
8460330|NCT00711802|20847346|P4|COMPLETED|Overall Study||35
8460331|NCT00711802|20847347|P3|COMPLETED|Overall Study||69
8460332|NCT00711802|20847348|P2|COMPLETED|Overall Study||32
8460333|NCT00711802|20847349|P1|COMPLETED|Overall Study||73
8460334|NCT00711802|20847342|P8|Received at Least 1 Dose of Study Drug|Overall Study||15
8460335|NCT00711802|20847343|P7|Received at Least 1 Dose of Study Drug|Overall Study||30
8460336|NCT00711802|20847344|P6|Received at Least 1 Dose of Study Drug|Overall Study||42
8460337|NCT00711802|20847345|P5|Received at Least 1 Dose of Study Drug|Overall Study||81
8460338|NCT00711802|20847346|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
8460339|NCT00711802|20847347|P3|Received at Least 1 Dose of Study Drug|Overall Study||73
8460340|NCT00711802|20847348|P2|Received at Least 1 Dose of Study Drug|Overall Study||37
8460341|NCT00711802|20847349|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
8460342|NCT00711802|20847342|P8|STARTED|Overall Study||15
8460343|NCT00711802|20847343|P7|STARTED|Overall Study||30
8460344|NCT00711802|20847344|P6|STARTED|Overall Study||42
8460345|NCT00711802|20847345|P5|STARTED|Overall Study||83
8460346|NCT00711802|20847346|P4|STARTED|Overall Study||38
8460347|NCT00711802|20847347|P3|STARTED|Overall Study||75
8460348|NCT00711802|20847348|P2|STARTED|Overall Study||38
8460349|NCT00711802|20847349|P1|STARTED|Overall Study||75
8460350|NCT00711711|20847381|P2|NOT COMPLETED|Overall Study||6
8460351|NCT00711711|20847382|P1|NOT COMPLETED|Overall Study||1
8460352|NCT00711711|20847381|P2|COMPLETED|Overall Study||24
8460353|NCT00711711|20847382|P1|COMPLETED|Overall Study||29
8460354|NCT00711711|20847381|P2|Seventh Postsurgical Day|Overall Study||27
8460355|NCT00711711|20847382|P1|Seventh Postsurgical Day|Overall Study||29
8460356|NCT00711711|20847381|P2|Second Postsurgical Day|Overall Study||30
8460357|NCT00711711|20847382|P1|Second Postsurgical Day|Overall Study||30
8460358|NCT00711711|20847381|P2|STARTED|Overall Study||30
8460359|NCT00711711|20847382|P1|STARTED|Overall Study||30
8460360|NCT00711646|20847392|P2|NOT COMPLETED|Overall Study||3
8460361|NCT00711646|20847393|P1|NOT COMPLETED|Overall Study||12
8460362|NCT00711646|20847392|P2|COMPLETED|Overall Study||62
8460363|NCT00711646|20847393|P1|COMPLETED|Overall Study||112
8460364|NCT00711646|20847392|P2|STARTED|Overall Study||65
8460365|NCT00711646|20847393|P1|STARTED|Overall Study||124
8460366|NCT00711594|20847415|P4|NOT COMPLETED|Overall Study||62
8460367|NCT00711594|20847416|P3|NOT COMPLETED|Overall Study||6
8460368|NCT00711594|20847417|P2|NOT COMPLETED|Overall Study||3
8460369|NCT00711594|20847418|P1|NOT COMPLETED|Overall Study||3
8460370|NCT00711594|20847415|P4|COMPLETED|Overall Study||0
8460371|NCT00711594|20847416|P3|COMPLETED|Overall Study||0
8460372|NCT00711594|20847417|P2|COMPLETED|Overall Study||0
8460373|NCT00711594|20847418|P1|COMPLETED|Overall Study||0
8460374|NCT00711594|20847415|P4|STARTED|Overall Study||62
8460375|NCT00711594|20847416|P3|STARTED|Overall Study||6
8460376|NCT00711594|20847417|P2|STARTED|Overall Study||3
8460377|NCT00711594|20847418|P1|STARTED|Overall Study||3
8460381|NCT00711529|20847464|P2|NOT COMPLETED|Overall Study||6
8460382|NCT00711529|20847465|P1|NOT COMPLETED|Overall Study||4
8460383|NCT00711529|20847464|P2|COMPLETED|Overall Study||8
8460384|NCT00711529|20847465|P1|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
8460385|NCT00711529|20847464|P2|STARTED|Overall Study||14
8460386|NCT00711529|20847465|P1|STARTED|Overall Study||13
8460387|NCT00711516|20847489|P2|NOT COMPLETED|Overall Study||3
8460388|NCT00711516|20847490|P1|NOT COMPLETED|Overall Study||1
8460389|NCT00711516|20847489|P2|COMPLETED|Overall Study||16
8460390|NCT00711516|20847490|P1|COMPLETED|Overall Study||20
8460391|NCT00711516|20847489|P2|STARTED|Overall Study||19
8460392|NCT00711516|20847490|P1|STARTED|Overall Study||21
8460393|NCT00711490|20847584|P1|NOT COMPLETED|Overall Study||0
8460394|NCT00711490|20847584|P1|COMPLETED|Overall Study||5
8460395|NCT00711490|20847584|P1|STARTED|Overall Study||5
8460396|NCT00711477|20847597|P2|NOT COMPLETED|Overall Study||3
8460397|NCT00711477|20847598|P1|NOT COMPLETED|Overall Study||3
8460398|NCT00711477|20847597|P2|COMPLETED|Overall Study||20
8460399|NCT00711477|20847598|P1|COMPLETED|Overall Study||20
8460400|NCT00711477|20847597|P2|STARTED|Overall Study||23
8460401|NCT00711477|20847598|P1|STARTED|Overall Study||23
8460402|NCT00711464|20847626|P1|NOT COMPLETED|Overall Study||0
8460403|NCT00711464|20847626|P1|COMPLETED|Overall Study||29
8460404|NCT00711464|20847626|P1|STARTED|Overall Study||29
8460405|NCT00711425|20847644|P1|NOT COMPLETED|Overall Study||4
8460406|NCT00711425|20847644|P1|COMPLETED|Overall Study||41
8460407|NCT00711425|20847644|P1|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
8460408|NCT00711412|20847650|P1|NOT COMPLETED|Survival Follow up Until Death||12
8460409|NCT00711412|20847650|P1|COMPLETED|Survival Follow up Until Death||26
8460410|NCT00711412|20847650|P1|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
8460411|NCT00711412|20847650|P1|NOT COMPLETED|Evaluation for Response and Surgery||6
8460412|NCT00711412|20847650|P1|COMPLETED|Evaluation for Response and Surgery||28
8460413|NCT00711412|20847650|P1|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
8460414|NCT00711412|20847650|P1|NOT COMPLETED|Combination Treatment||1
8460415|NCT00711412|20847650|P1|COMPLETED|Combination Treatment||33
8460416|NCT00711412|20847650|P1|STARTED|Combination Treatment||34
8460417|NCT00711412|20847650|P1|NOT COMPLETED|Evaluated for Combination Treatment||6
8460418|NCT00711412|20847650|P1|COMPLETED|Evaluated for Combination Treatment||34
8460419|NCT00711412|20847650|P1|STARTED|Evaluated for Combination Treatment||40
8460420|NCT00711412|20847650|P1|NOT COMPLETED|Induction Treatment||4
8460421|NCT00711412|20847650|P1|COMPLETED|Induction Treatment||40
8460422|NCT00711412|20847650|P1|Started Induction Treatment|Induction Treatment||43
8460423|NCT00711412|20847650|P1|Registered to Study|Induction Treatment||44
8460424|NCT00711412|20847650|P1|STARTED|Induction Treatment||44
8460425|NCT00711347|20847664|P2|NOT COMPLETED|Overall Study||0
8460426|NCT00711347|20847665|P1|NOT COMPLETED|Overall Study||0
8460427|NCT00711347|20847664|P2|COMPLETED|Overall Study||14
8460428|NCT00711347|20847665|P1|COMPLETED|Overall Study||14
8460429|NCT00711347|20847664|P2|STARTED|Overall Study||14
8460430|NCT00711347|20847665|P1|STARTED|Overall Study||14
8460431|NCT00711269|20847685|P4|NOT COMPLETED|Overall Study||14
8460432|NCT00711269|20847686|P3|NOT COMPLETED|Overall Study||50
8460433|NCT00711269|20847687|P2|NOT COMPLETED|Overall Study||48
8460434|NCT00711269|20847688|P1|NOT COMPLETED|Overall Study||44
8460435|NCT00711269|20847685|P4|COMPLETED|Overall Study||51
8460436|NCT00711269|20847686|P3|COMPLETED|Overall Study||83
8460437|NCT00711269|20847687|P2|COMPLETED|Overall Study||83
8460438|NCT00711269|20847688|P1|COMPLETED|Overall Study||87
8460439|NCT00711269|20847685|P4|STARTED|Overall Study||65
8460440|NCT00711269|20847686|P3|STARTED|Overall Study||133
8460441|NCT00711269|20847687|P2|STARTED|Overall Study||131
8460442|NCT00711269|20847688|P1|STARTED|Overall Study||131
8460443|NCT00711243|20847728|P6|NOT COMPLETED|Follow up Every 3 Months Until Death||2
8460444|NCT00711243|20847729|P5|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8460445|NCT00711243|20847730|P4|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8460446|NCT00711243|20847731|P3|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8460447|NCT00711243|20847732|P2|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8460448|NCT00711243|20847733|P1|NOT COMPLETED|Follow up Every 3 Months Until Death||0
8460449|NCT00711243|20847728|P6|COMPLETED|Follow up Every 3 Months Until Death||37
8460450|NCT00711243|20847729|P5|COMPLETED|Follow up Every 3 Months Until Death||3
8460451|NCT00711243|20847730|P4|COMPLETED|Follow up Every 3 Months Until Death||3
8460452|NCT00711243|20847731|P3|COMPLETED|Follow up Every 3 Months Until Death||3
8460453|NCT00711243|20847732|P2|COMPLETED|Follow up Every 3 Months Until Death||3
8460454|NCT00711243|20847733|P1|COMPLETED|Follow up Every 3 Months Until Death||3
8460455|NCT00711243|20847728|P6|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
8460456|NCT00711243|20847729|P5|STARTED|Follow up Every 3 Months Until Death||3
8460457|NCT00711243|20847730|P4|STARTED|Follow up Every 3 Months Until Death||3
8460458|NCT00711243|20847731|P3|STARTED|Follow up Every 3 Months Until Death||3
8460459|NCT00711243|20847732|P2|STARTED|Follow up Every 3 Months Until Death||3
8460460|NCT00711243|20847733|P1|STARTED|Follow up Every 3 Months Until Death||3
8460461|NCT00711243|20847728|P6|NOT COMPLETED|Treated Cycle 5 After First Response||4
8460462|NCT00711243|20847729|P5|NOT COMPLETED|Treated Cycle 5 After First Response||1
8460463|NCT00711243|20847730|P4|NOT COMPLETED|Treated Cycle 5 After First Response||0
8460464|NCT00711243|20847731|P3|NOT COMPLETED|Treated Cycle 5 After First Response||0
8460465|NCT00711243|20847732|P2|NOT COMPLETED|Treated Cycle 5 After First Response||2
8460466|NCT00711243|20847733|P1|NOT COMPLETED|Treated Cycle 5 After First Response||1
8460467|NCT00711243|20847728|P6|COMPLETED|Treated Cycle 5 After First Response||37
8460468|NCT00711243|20847729|P5|COMPLETED|Treated Cycle 5 After First Response||2
8460469|NCT00711243|20847730|P4|COMPLETED|Treated Cycle 5 After First Response||2
8460470|NCT00711243|20847731|P3|COMPLETED|Treated Cycle 5 After First Response||3
8460471|NCT00711243|20847732|P2|COMPLETED|Treated Cycle 5 After First Response||1
8460472|NCT00711243|20847733|P1|COMPLETED|Treated Cycle 5 After First Response||2
8460473|NCT00711243|20847728|P6|STARTED|Treated Cycle 5 After First Response||41
8460474|NCT00711243|20847729|P5|STARTED|Treated Cycle 5 After First Response||3
8460475|NCT00711243|20847730|P4|STARTED|Treated Cycle 5 After First Response||2
8460476|NCT00711243|20847731|P3|STARTED|Treated Cycle 5 After First Response||3
8460477|NCT00711243|20847732|P2|STARTED|Treated Cycle 5 After First Response||3
8460478|NCT00711243|20847733|P1|STARTED|Treated Cycle 5 After First Response||3
8460479|NCT00711243|20847728|P6|NOT COMPLETED|Reached First Response/4 Cycles||2
8460480|NCT00711243|20847729|P5|NOT COMPLETED|Reached First Response/4 Cycles||0
8460481|NCT00711243|20847730|P4|NOT COMPLETED|Reached First Response/4 Cycles||1
8460482|NCT00711243|20847731|P3|NOT COMPLETED|Reached First Response/4 Cycles||0
8460483|NCT00711243|20847732|P2|NOT COMPLETED|Reached First Response/4 Cycles||0
8460484|NCT00711243|20847733|P1|NOT COMPLETED|Reached First Response/4 Cycles||0
8460485|NCT00711243|20847728|P6|COMPLETED|Reached First Response/4 Cycles||41
8460486|NCT00711243|20847729|P5|COMPLETED|Reached First Response/4 Cycles||3
8460487|NCT00711243|20847730|P4|COMPLETED|Reached First Response/4 Cycles||2
8460488|NCT00711243|20847731|P3|COMPLETED|Reached First Response/4 Cycles||3
8460489|NCT00711243|20847732|P2|COMPLETED|Reached First Response/4 Cycles||3
8460490|NCT00711243|20847733|P1|COMPLETED|Reached First Response/4 Cycles||3
8460491|NCT00711243|20847728|P6|STARTED|Reached First Response/4 Cycles||43
8460492|NCT00711243|20847729|P5|STARTED|Reached First Response/4 Cycles||3
8460493|NCT00711243|20847730|P4|STARTED|Reached First Response/4 Cycles||3
8460494|NCT00711243|20847731|P3|STARTED|Reached First Response/4 Cycles||3
8460495|NCT00711243|20847732|P2|STARTED|Reached First Response/4 Cycles||3
8460496|NCT00711243|20847733|P1|STARTED|Reached First Response/4 Cycles||3
8460497|NCT00711243|20847728|P6|NOT COMPLETED|Registed and Started Treatment||1
8460498|NCT00711243|20847729|P5|NOT COMPLETED|Registed and Started Treatment||0
8460499|NCT00711243|20847730|P4|NOT COMPLETED|Registed and Started Treatment||0
8460500|NCT00711243|20847731|P3|NOT COMPLETED|Registed and Started Treatment||0
8460501|NCT00711243|20847732|P2|NOT COMPLETED|Registed and Started Treatment||0
8460502|NCT00711243|20847733|P1|NOT COMPLETED|Registed and Started Treatment||0
8460503|NCT00711243|20847728|P6|COMPLETED|Registed and Started Treatment||43
8460504|NCT00711243|20847729|P5|COMPLETED|Registed and Started Treatment||3
8460505|NCT00711243|20847730|P4|COMPLETED|Registed and Started Treatment||3
8460506|NCT00711243|20847731|P3|COMPLETED|Registed and Started Treatment||3
8460507|NCT00711243|20847732|P2|COMPLETED|Registed and Started Treatment||3
8460508|NCT00711243|20847733|P1|COMPLETED|Registed and Started Treatment||3
8460509|NCT00711243|20847728|P6|Started Treatment|Registed and Started Treatment||43
8460510|NCT00711243|20847729|P5|Started Treatment|Registed and Started Treatment||3
8460511|NCT00711243|20847730|P4|Started Treatment|Registed and Started Treatment||3
8460512|NCT00711243|20847731|P3|Started Treatment|Registed and Started Treatment||3
8460513|NCT00711243|20847732|P2|Started Treatment|Registed and Started Treatment||3
8460514|NCT00711243|20847733|P1|Started Treatment|Registed and Started Treatment||3
8460515|NCT00711243|20847728|P6|Registered to Study|Registed and Started Treatment||44
8460516|NCT00711243|20847729|P5|Registered to Study|Registed and Started Treatment||3
8460517|NCT00711243|20847730|P4|Registered to Study|Registed and Started Treatment||3
8460518|NCT00711243|20847731|P3|Registered to Study|Registed and Started Treatment||3
8460519|NCT00711243|20847732|P2|Registered to Study|Registed and Started Treatment||3
8460520|NCT00711243|20847733|P1|Registered to Study|Registed and Started Treatment||3
8460521|NCT00711243|20847728|P6|STARTED|Registed and Started Treatment||44
8460522|NCT00711243|20847729|P5|STARTED|Registed and Started Treatment||3
8460523|NCT00711243|20847730|P4|STARTED|Registed and Started Treatment||3
8460524|NCT00711243|20847731|P3|STARTED|Registed and Started Treatment||3
8460525|NCT00711243|20847732|P2|STARTED|Registed and Started Treatment||3
8460526|NCT00711243|20847733|P1|STARTED|Registed and Started Treatment||3
8460527|NCT00711191|20847756|P3|NOT COMPLETED|Overall Study||12
8460528|NCT00711191|20847757|P2|NOT COMPLETED|Overall Study||5
8460529|NCT00711191|20847758|P1|NOT COMPLETED|Overall Study||3
8460530|NCT00711191|20847756|P3|COMPLETED|Overall Study||1
8460531|NCT00711191|20847757|P2|COMPLETED|Overall Study||1
8460532|NCT00711191|20847758|P1|COMPLETED|Overall Study||0
8460533|NCT00711191|20847756|P3|STARTED|Overall Study||13
8460534|NCT00711191|20847757|P2|STARTED|Overall Study||6
8460535|NCT00711191|20847758|P1|STARTED|Overall Study||3
8460536|NCT00711113|20847795|P1|NOT COMPLETED|Overall Study||11
8460537|NCT00711113|20847795|P1|COMPLETED|Overall Study||36
8460538|NCT00711113|20847795|P1|STARTED|Overall Study||47
8460539|NCT00711100|20847801|P1|NOT COMPLETED|Overall Study||13
8460540|NCT00711100|20847801|P1|COMPLETED|Overall Study||91
8460541|NCT00711100|20847801|P1|STARTED|Overall Study||104
8460542|NCT00711087|20847819|P2|NOT COMPLETED|Overall Study||0
8460543|NCT00711087|20847820|P1|NOT COMPLETED|Overall Study||1
8460544|NCT00711087|20847819|P2|COMPLETED|Overall Study||0
8460545|NCT00711087|20847820|P1|COMPLETED|Overall Study||0
8460546|NCT00711087|20847819|P2|STARTED|Overall Study||0
8460547|NCT00711087|20847820|P1|STARTED|Overall Study||1
8460548|NCT00711022|20847826|P1|NOT COMPLETED|Overall Study||11
8460549|NCT00711022|20847826|P1|COMPLETED|Overall Study||40
8460550|NCT00711022|20847826|P1|STARTED|Overall Study||51
8460551|NCT00711009|20847832|P2|NOT COMPLETED|Overall Study||19
8460552|NCT00711009|20847833|P1|NOT COMPLETED|Overall Study||15
8460553|NCT00711009|20847832|P2|COMPLETED|Overall Study||82
8460554|NCT00711009|20847833|P1|COMPLETED|Overall Study||90
8460555|NCT00711009|20847832|P2|STARTED|Overall Study||101
8460556|NCT00711009|20847833|P1|STARTED|Overall Study||105
8460557|NCT00710996|20848004|P3|NOT COMPLETED|Overall Study||0
8460558|NCT00710996|20848005|P2|NOT COMPLETED|Overall Study||4
8460559|NCT00710996|20848006|P1|NOT COMPLETED|Overall Study||1
8460560|NCT00710996|20848004|P3|COMPLETED|Overall Study||21
8460561|NCT00710996|20848005|P2|COMPLETED|Overall Study||16
8460562|NCT00710996|20848006|P1|COMPLETED|Overall Study||16
8460563|NCT00710996|20848004|P3|STARTED|Overall Study||21
8460564|NCT00710996|20848005|P2|STARTED|Overall Study||20
8460565|NCT00710996|20848006|P1|STARTED|Overall Study||17
8460566|NCT00710970|20848014|P1|NOT COMPLETED|Overall Study||10
8460567|NCT00710970|20848014|P1|COMPLETED|Overall Study||18
8460568|NCT00710970|20848014|P1|STARTED|Overall Study||28
8460569|NCT00710944|20848021|P3|NOT COMPLETED|Overall Study||2
8460570|NCT00710944|20848022|P2|NOT COMPLETED|Overall Study||9
8460571|NCT00710944|20848023|P1|NOT COMPLETED|Overall Study||10
8460572|NCT00710944|20848021|P3|COMPLETED|Overall Study||17
8460573|NCT00710944|20848022|P2|COMPLETED|Overall Study||49
8460574|NCT00710944|20848023|P1|COMPLETED|Overall Study||45
8460575|NCT00710944|20848021|P3|STARTED|Overall Study||19
8460576|NCT00710944|20848022|P2|STARTED|Overall Study||58
8460577|NCT00710944|20848023|P1|STARTED|Overall Study||55
8460578|NCT00710931|20848031|P1|NOT COMPLETED|Overall Study||5
8460579|NCT00710931|20848031|P1|COMPLETED|Overall Study||29
8460580|NCT00710931|20848031|P1|STARTED|Overall Study||34
8460581|NCT00710905|20848035|P1|NOT COMPLETED|Overall Study||16
8460582|NCT00710905|20848035|P1|COMPLETED|Overall Study||34
8460583|NCT00710905|20848035|P1|STARTED|Overall Study||50
8460584|NCT00710879|20848041|P2|NOT COMPLETED|Overall Study||4
8460585|NCT00710879|20848042|P1|NOT COMPLETED|Overall Study||2
8460586|NCT00710879|20848041|P2|COMPLETED|Overall Study||113
8460587|NCT00710879|20848042|P1|COMPLETED|Overall Study||58
8460588|NCT00710879|20848041|P2|STARTED|Overall Study||117
8460589|NCT00710879|20848042|P1|STARTED|Overall Study||60
8460590|NCT00710866|20848054|P2|NOT COMPLETED|Overall Study||6
8460591|NCT00710866|20848055|P1|NOT COMPLETED|Overall Study||9
8460592|NCT00710866|20848054|P2|COMPLETED|Overall Study||128
8460593|NCT00710866|20848055|P1|COMPLETED|Overall Study||124
8460594|NCT00710866|20848054|P2|STARTED|Overall Study||134
8460595|NCT00710866|20848055|P1|STARTED|Overall Study||133
8460596|NCT00710840|20848077|P2|NOT COMPLETED|Overall Study||3
8460597|NCT00710840|20848078|P1|NOT COMPLETED|Overall Study||0
8460598|NCT00710840|20848077|P2|COMPLETED|Overall Study||19
8460599|NCT00710840|20848078|P1|COMPLETED|Overall Study||22
8460600|NCT00710840|20848077|P2|STARTED|Overall Study||22
8460601|NCT00710840|20848078|P1|STARTED|Overall Study||22
8460602|NCT00710814|20848092|P2|NOT COMPLETED|Overall Study||3
8460603|NCT00710814|20848093|P1|NOT COMPLETED|Overall Study||1
8460604|NCT00710814|20848092|P2|COMPLETED|Overall Study||13
8460605|NCT00710814|20848093|P1|COMPLETED|Overall Study||14
8460606|NCT00710814|20848092|P2|STARTED|Overall Study||16
8460607|NCT00710814|20848093|P1|STARTED|Overall Study||15
8460608|NCT00710762|20848101|P2|NOT COMPLETED|Overall Study||40
8460609|NCT00710762|20848102|P1|NOT COMPLETED|Overall Study||39
8460610|NCT00710762|20848101|P2|COMPLETED|Overall Study||0
8460611|NCT00710762|20848102|P1|COMPLETED|Overall Study||5
8460612|NCT00710762|20848101|P2|STARTED|Overall Study||40
8460613|NCT00710762|20848102|P1|STARTED|Overall Study||44
8460614|NCT00710749|20848118|P2|NOT COMPLETED|Second Intervention||0
8460615|NCT00710749|20848119|P1|NOT COMPLETED|Second Intervention||0
8460616|NCT00710749|20848118|P2|COMPLETED|Second Intervention||30
8460617|NCT00710749|20848119|P1|COMPLETED|Second Intervention||29
8460618|NCT00710749|20848118|P2|STARTED|Second Intervention||30
8460619|NCT00710749|20848119|P1|STARTED|Second Intervention||29
8460620|NCT00710749|20848118|P2|NOT COMPLETED|First Intervention||0
8460621|NCT00710749|20848119|P1|NOT COMPLETED|First Intervention||1
8460622|NCT00710749|20848118|P2|COMPLETED|First Intervention||30
8460623|NCT00710749|20848119|P1|COMPLETED|First Intervention||29
8460624|NCT00710749|20848118|P2|STARTED|First Intervention||30
8460625|NCT00710749|20848119|P1|STARTED|First Intervention||30
8460626|NCT00710749|20848118|P2|NOT COMPLETED|Clinic Baseline Recording||0
8460627|NCT00710749|20848119|P1|NOT COMPLETED|Clinic Baseline Recording||0
8460628|NCT00710749|20848118|P2|COMPLETED|Clinic Baseline Recording||30
8460629|NCT00710749|20848119|P1|COMPLETED|Clinic Baseline Recording||30
8460630|NCT00710749|20848118|P2|STARTED|Clinic Baseline Recording||30
8460631|NCT00710749|20848119|P1|STARTED|Clinic Baseline Recording||30
8460632|NCT00710684|20848130|P3|NOT COMPLETED|Overall Study||64
8460633|NCT00710684|20848131|P2|NOT COMPLETED|Overall Study||74
8460634|NCT00710684|20848132|P1|NOT COMPLETED|Overall Study||74
8460635|NCT00710684|20848130|P3|COMPLETED|Overall Study||172
8460636|NCT00710684|20848131|P2|COMPLETED|Overall Study||147
8460637|NCT00710684|20848132|P1|COMPLETED|Overall Study||151
8460638|NCT00710684|20848130|P3|STARTED|Overall Study||236
8460639|NCT00710684|20848131|P2|STARTED|Overall Study||221
8460640|NCT00710684|20848132|P1|STARTED|Overall Study||225
8460641|NCT00710606|20848189|P2|NOT COMPLETED|Overall Study||2
8460642|NCT00710606|20848190|P1|NOT COMPLETED|Overall Study||0
8460643|NCT00710606|20848189|P2|COMPLETED|Overall Study||18
8460644|NCT00710606|20848190|P1|COMPLETED|Overall Study||20
8460645|NCT00710606|20848189|P2|STARTED|Overall Study||20
8460646|NCT00710606|20848190|P1|STARTED|Overall Study||20
8460647|NCT00710593|20848202|P2|NOT COMPLETED|Overall Study||5
8460648|NCT00710593|20848203|P1|NOT COMPLETED|Overall Study||15
8460649|NCT00710593|20848202|P2|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
8460650|NCT00710593|20848203|P1|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
8460651|NCT00710593|20848202|P2|STARTED|Overall Study||30
8460652|NCT00710593|20848203|P1|STARTED|Overall Study||69
8460653|NCT00710554|20848246|P2|NOT COMPLETED|Overall Study||24
8460654|NCT00710554|20848247|P1|NOT COMPLETED|Overall Study||49
8460655|NCT00710554|20848246|P2|COMPLETED|Overall Study||94
8460656|NCT00710554|20848247|P1|COMPLETED|Overall Study||79
8460657|NCT00710554|20848246|P2|STARTED|Overall Study||118
8460658|NCT00710554|20848247|P1|STARTED|Overall Study||128
8460659|NCT00710424|20848275|P2|NOT COMPLETED|Overall Study||23
8460660|NCT00710424|20848276|P1|NOT COMPLETED|Overall Study||44
8460661|NCT00710424|20848275|P2|COMPLETED|Overall Study||125
8460662|NCT00710424|20848276|P1|COMPLETED|Overall Study||105
8460663|NCT00710424|20848275|P2|STARTED|Overall Study||148
8460664|NCT00710424|20848276|P1|STARTED|Overall Study||149
8460665|NCT00710385|20848300|P1|NOT COMPLETED|Overall Study||5
8460666|NCT00710385|20848300|P1|COMPLETED|Overall Study||12
8460667|NCT00710385|20848300|P1|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
8460668|NCT00710203|20848317|P1|NOT COMPLETED|Overall Study||0
8460669|NCT00710203|20848317|P1|COMPLETED|Overall Study||10
8460670|NCT00710203|20848317|P1|STARTED|Overall Study||10
8460671|NCT00710034|20848345|P2|NOT COMPLETED|Completed 12 Weeks of Treatment||11
8460672|NCT00710034|20848346|P1|NOT COMPLETED|Completed 12 Weeks of Treatment||13
8460673|NCT00710034|20848345|P2|COMPLETED|Completed 12 Weeks of Treatment||138
8460674|NCT00710034|20848346|P1|COMPLETED|Completed 12 Weeks of Treatment||141
8460675|NCT00710034|20848345|P2|STARTED|Completed 12 Weeks of Treatment||149
8460676|NCT00710034|20848346|P1|STARTED|Completed 12 Weeks of Treatment||154
8460677|NCT00710034|20848345|P2|NOT COMPLETED|Completed 6 Weeks of Treatment||47
8460678|NCT00710034|20848346|P1|NOT COMPLETED|Completed 6 Weeks of Treatment||41
8460679|NCT00710034|20848345|P2|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
8460680|NCT00710034|20848346|P1|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
8460681|NCT00710034|20848345|P2|STARTED|Completed 6 Weeks of Treatment||196
8460682|NCT00710034|20848346|P1|STARTED|Completed 6 Weeks of Treatment||195
8460683|NCT00710021|20848363|P3|NOT COMPLETED|Overall Study||1
8460684|NCT00710021|20848364|P2|NOT COMPLETED|Overall Study||3
8460685|NCT00710021|20848365|P1|NOT COMPLETED|Overall Study||1
8460686|NCT00710021|20848363|P3|COMPLETED|Overall Study||18
8460687|NCT00710021|20848364|P2|COMPLETED|Overall Study||16
8460688|NCT00710021|20848365|P1|COMPLETED|Overall Study||18
8460689|NCT00710021|20848363|P3|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
8460690|NCT00710021|20848364|P2|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
8460691|NCT00710021|20848365|P1|Modified Intent-to-Treat (mITT)|Overall Study||19
8460692|NCT00710021|20848363|P3|STARTED|Overall Study||19
8460693|NCT00710021|20848364|P2|STARTED|Overall Study||19
8460694|NCT00710021|20848365|P1|STARTED|Overall Study||19
8460695|NCT00709995|20848480|P2|NOT COMPLETED|Overall Study||5
8460696|NCT00709995|20848481|P1|NOT COMPLETED|Overall Study||5
8460697|NCT00709995|20848480|P2|COMPLETED|Overall Study||1
8460698|NCT00709995|20848481|P1|COMPLETED|Overall Study||6
8460699|NCT00709995|20848480|P2|Progressive Disease|Overall Study||1
8460700|NCT00709995|20848481|P1|Progressive Disease|Overall Study||6
8460701|NCT00709995|20848480|P2|STARTED|Overall Study||6
8460702|NCT00709995|20848481|P1|STARTED|Overall Study||11
8460703|NCT00709956|20848499|P2|NOT COMPLETED|Overall Study||4
8460704|NCT00709956|20848500|P1|NOT COMPLETED|Overall Study||3
8460705|NCT00709956|20848499|P2|COMPLETED|Overall Study||33
8460706|NCT00709956|20848500|P1|COMPLETED|Overall Study||30
8460707|NCT00709956|20848499|P2|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
8460708|NCT00709956|20848500|P1|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
8460709|NCT00709956|20848499|P2|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
8460710|NCT00709956|20848500|P1|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
8460711|NCT00709891|20848508|P1|NOT COMPLETED|Longitudinal Follow-up Phase||4982
8460712|NCT00709891|20848508|P1|COMPLETED|Longitudinal Follow-up Phase||5020
8460713|NCT00709891|20848508|P1|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
8460714|NCT00709891|20848508|P1|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
8460715|NCT00709891|20848508|P1|COMPLETED|Baseline, Cross-sectional Phase||45758
8460716|NCT00709891|20848508|P1|STARTED|Baseline, Cross-sectional Phase||47208
8460717|NCT00709878|20848517|P4|NOT COMPLETED|Overall Study||0
8460718|NCT00709878|20848518|P3|NOT COMPLETED|Overall Study||0
8460719|NCT00709878|20848519|P2|NOT COMPLETED|Overall Study||0
8460720|NCT00709878|20848520|P1|NOT COMPLETED|Overall Study||0
8460721|NCT00709878|20848517|P4|COMPLETED|Overall Study||8
8460722|NCT00709878|20848518|P3|COMPLETED|Overall Study||8
8460723|NCT00709878|20848519|P2|COMPLETED|Overall Study||8
8460724|NCT00709878|20848520|P1|COMPLETED|Overall Study||8
8460725|NCT00709878|20848517|P4|STARTED|Overall Study||8
8460726|NCT00709878|20848518|P3|STARTED|Overall Study||8
8460727|NCT00709878|20848519|P2|STARTED|Overall Study||8
8460728|NCT00709878|20848520|P1|STARTED|Overall Study||8
8460729|NCT00709852|20848530|P2|NOT COMPLETED|Period 2||2
8460730|NCT00709852|20848531|P1|NOT COMPLETED|Period 2||9
8460731|NCT00709852|20848530|P2|COMPLETED|Period 2||169
8460732|NCT00709852|20848531|P1|COMPLETED|Period 2||211
8460733|NCT00709852|20848530|P2|STARTED|Period 2||171
8460734|NCT00709852|20848531|P1|STARTED|Period 2||220
8460735|NCT00709852|20848530|P2|NOT COMPLETED|Period 1||3
8460736|NCT00709852|20848531|P1|NOT COMPLETED|Period 1||8
8460737|NCT00709852|20848530|P2|COMPLETED|Period 1||171
8460738|NCT00709852|20848531|P1|COMPLETED|Period 1||220
8460739|NCT00709852|20848530|P2|STARTED|Period 1||174
8460740|NCT00709852|20848531|P1|STARTED|Period 1||228
8460741|NCT00709826|20848686|P2|NOT COMPLETED|Overall Study||1
8460742|NCT00709826|20848687|P1|NOT COMPLETED|Overall Study||2
8460743|NCT00709826|20848686|P2|COMPLETED|Overall Study||38
8460744|NCT00709826|20848687|P1|COMPLETED|Overall Study||68
8460745|NCT00709826|20848686|P2|STARTED|Overall Study||39
8460746|NCT00709826|20848687|P1|STARTED|Overall Study||70
8460747|NCT00709761|20848695|P1|NOT COMPLETED|Overall Study||27
8460748|NCT00709761|20848695|P1|COMPLETED|Overall Study||33
8460749|NCT00709761|20848695|P1|STARTED|Overall Study||60
8460750|NCT00709735|20848706|P2|NOT COMPLETED|Overall Study||2
8460751|NCT00709735|20848707|P1|NOT COMPLETED|Overall Study||3
8460752|NCT00709735|20848706|P2|COMPLETED|Overall Study||10
8460753|NCT00709735|20848707|P1|COMPLETED|Overall Study||8
8460754|NCT00709735|20848706|P2|STARTED|Overall Study||12
8460755|NCT00709735|20848707|P1|STARTED|Overall Study||11
8460756|NCT00709722|20848715|P1|NOT COMPLETED|Overall Study||1
8460757|NCT00709722|20848715|P1|COMPLETED|Overall Study||20
8460758|NCT00709722|20848715|P1|STARTED|Overall Study||21
8460759|NCT00709696|20848723|P2|NOT COMPLETED|Overall Study||0
8460760|NCT00709696|20848724|P1|NOT COMPLETED|Overall Study||0
8460761|NCT00709696|20848723|P2|COMPLETED|Overall Study||3
8460762|NCT00709696|20848724|P1|COMPLETED|Overall Study||4
8460763|NCT00709696|20848723|P2|STARTED|Overall Study||3
8460764|NCT00709696|20848724|P1|STARTED|Overall Study||4
8460765|NCT00709618|20848730|P1|NOT COMPLETED|Overall Study||30
8460766|NCT00709618|20848730|P1|COMPLETED|Overall Study||14
8460767|NCT00709618|20848730|P1|STARTED|Overall Study||44
8460768|NCT00709592|20848742|P2|NOT COMPLETED|Overall Study||1
8460769|NCT00709592|20848743|P1|NOT COMPLETED|Overall Study||0
8460770|NCT00709592|20848742|P2|COMPLETED|Overall Study||22
8460771|NCT00709592|20848743|P1|COMPLETED|Overall Study||19
8460772|NCT00709592|20848742|P2|STARTED|Overall Study||23
8460773|NCT00709592|20848743|P1|STARTED|Overall Study||19
8460774|NCT00709319|20848765|P1|NOT COMPLETED|Overall Study||6
8460775|NCT00709319|20848765|P1|COMPLETED|Overall Study||81
8460776|NCT00709319|20848765|P1|STARTED|Overall Study||87
8460777|NCT00709306|20848777|P4|NOT COMPLETED|Overall Study||10
8460778|NCT00709306|20848778|P3|NOT COMPLETED|Overall Study||10
8460779|NCT00709306|20848779|P2|NOT COMPLETED|Overall Study||14
8460780|NCT00709306|20848780|P1|NOT COMPLETED|Overall Study||9
8460781|NCT00709306|20848777|P4|COMPLETED|Overall Study||37
8460782|NCT00709306|20848778|P3|COMPLETED|Overall Study||48
8460783|NCT00709306|20848779|P2|COMPLETED|Overall Study||30
8460784|NCT00709306|20848780|P1|COMPLETED|Overall Study||39
8460785|NCT00709306|20848777|P4|STARTED|Overall Study||47
8460786|NCT00709306|20848778|P3|STARTED|Overall Study||58
8460787|NCT00709306|20848779|P2|STARTED|Overall Study||44
8460788|NCT00709306|20848780|P1|STARTED|Overall Study||48
8460789|NCT00709228|20848794|P1|NOT COMPLETED|Overall Study||332
8460790|NCT00709228|20848794|P1|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
8460791|NCT00709228|20848794|P1|STARTED|Overall Study||496
8460792|NCT00709202|20848800|P2|NOT COMPLETED|Overall Study||6
8460793|NCT00709202|20848801|P1|NOT COMPLETED|Overall Study||6
8460794|NCT00709202|20848800|P2|COMPLETED|Overall Study||15
8460795|NCT00709202|20848801|P1|COMPLETED|Overall Study||13
8460796|NCT00709202|20848800|P2|STARTED|Overall Study||21
8460797|NCT00709202|20848801|P1|STARTED|Overall Study||19
8460798|NCT00709124|20848829|P2|NOT COMPLETED|Overall Study||1
8460799|NCT00709124|20848830|P1|NOT COMPLETED|Overall Study||4
8460800|NCT00709124|20848829|P2|COMPLETED|Overall Study||17
8460801|NCT00709124|20848830|P1|COMPLETED|Overall Study||12
8460802|NCT00709124|20848829|P2|STARTED|Overall Study||18
8460803|NCT00709124|20848830|P1|STARTED|Overall Study||16
8460804|NCT00709111|20848864|P1|NOT COMPLETED|Overall Study||2
8460805|NCT00709111|20848864|P1|COMPLETED|Overall Study||32
8460806|NCT00709111|20848864|P1|Week 22/24|Overall Study||33
8460807|NCT00709111|20848864|P1|STARTED|Overall Study||34
8460808|NCT00709098|20848905|P3|NOT COMPLETED|Open-label Period||14
8460809|NCT00709098|20848906|P2|NOT COMPLETED|Open-label Period||0
8460810|NCT00709098|20848907|P1|NOT COMPLETED|Open-label Period||0
8460811|NCT00709098|20848905|P3|COMPLETED|Open-label Period||18
8460812|NCT00709098|20848906|P2|COMPLETED|Open-label Period||0
8460813|NCT00709098|20848907|P1|COMPLETED|Open-label Period||0
8460814|NCT00709098|20848905|P3|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
8460815|NCT00709098|20848906|P2|STARTED|Open-label Period||0
8460816|NCT00709098|20848907|P1|STARTED|Open-label Period||0
8460817|NCT00709098|20848905|P3|NOT COMPLETED|Double-blind Period||0
8460818|NCT00709098|20848906|P2|NOT COMPLETED|Double-blind Period||8
8460819|NCT00709098|20848907|P1|NOT COMPLETED|Double-blind Period||6
8460820|NCT00709098|20848905|P3|COMPLETED|Double-blind Period||0
8460821|NCT00709098|20848906|P2|COMPLETED|Double-blind Period||16
8460822|NCT00709098|20848907|P1|COMPLETED|Double-blind Period||19
8460823|NCT00709098|20848905|P3|STARTED|Double-blind Period||0
8460824|NCT00709098|20848906|P2|STARTED|Double-blind Period||24
8460825|NCT00709098|20848907|P1|STARTED|Double-blind Period||25
8460826|NCT00709059|20848926|P1|NOT COMPLETED|Overall Study||94
8460827|NCT00709059|20848926|P1|COMPLETED|Overall Study||444
8460828|NCT00709059|20848926|P1|STARTED|Overall Study||538
8460829|NCT00708942|20848935|P5|NOT COMPLETED|Overall Study||1
8460830|NCT00708942|20848936|P4|NOT COMPLETED|Overall Study||0
8460831|NCT00708942|20848937|P3|NOT COMPLETED|Overall Study||2
8460832|NCT00708942|20848938|P2|NOT COMPLETED|Overall Study||1
8460833|NCT00708942|20848939|P1|NOT COMPLETED|Overall Study||7
8460834|NCT00708942|20848935|P5|COMPLETED|Overall Study||2
8460835|NCT00708942|20848936|P4|COMPLETED|Overall Study||10
8460836|NCT00708942|20848937|P3|COMPLETED|Overall Study||9
8460837|NCT00708942|20848938|P2|COMPLETED|Overall Study||11
8460838|NCT00708942|20848939|P1|COMPLETED|Overall Study||40
8460839|NCT00708942|20848935|P5|STARTED|Overall Study||3
8460840|NCT00708942|20848936|P4|STARTED|Overall Study||10
8460841|NCT00708942|20848937|P3|STARTED|Overall Study||11
8460842|NCT00708942|20848938|P2|STARTED|Overall Study||12
8460843|NCT00708942|20848939|P1|STARTED|Overall Study||47
8460844|NCT00708877|20848961|P1|NOT COMPLETED|Overall Study||0
8460845|NCT00708877|20848961|P1|COMPLETED|Overall Study||5
8460846|NCT00708877|20848961|P1|STARTED|Overall Study||5
8460847|NCT00708851|20848965|P1|NOT COMPLETED|Overall Study||0
8460848|NCT00708851|20848965|P1|COMPLETED|Overall Study||12
8460849|NCT00708851|20848965|P1|STARTED|Overall Study||12
8460850|NCT00708734|20848973|P1|NOT COMPLETED|Overall Study||7
8460851|NCT00708734|20848973|P1|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
8460852|NCT00708734|20848973|P1|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
8460853|NCT00708721|20848977|P4|NOT COMPLETED|Overall Study||0
8460854|NCT00708721|20848978|P3|NOT COMPLETED|Overall Study||0
8460855|NCT00708721|20848979|P2|NOT COMPLETED|Overall Study||0
8460856|NCT00708721|20848980|P1|NOT COMPLETED|Overall Study||0
8460857|NCT00708721|20848977|P4|COMPLETED|Overall Study||2
8460858|NCT00708721|20848978|P3|COMPLETED|Overall Study||3
8460859|NCT00708721|20848979|P2|COMPLETED|Overall Study||4
8460860|NCT00708721|20848980|P1|COMPLETED|Overall Study||2
8460861|NCT00708721|20848977|P4|STARTED|Overall Study||2
8460862|NCT00708721|20848978|P3|STARTED|Overall Study||3
8460863|NCT00708721|20848979|P2|STARTED|Overall Study||4
8460864|NCT00708721|20848980|P1|STARTED|Overall Study||2
8460865|NCT00708708|20848993|P1|NOT COMPLETED|Overall Study||742
8460866|NCT00708708|20848993|P1|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
8460867|NCT00708708|20848993|P1|STARTED|Overall Study||955
8460868|NCT00708682|20849041|P1|NOT COMPLETED|Toddler Dose||8
8460869|NCT00708682|20849041|P1|COMPLETED|Toddler Dose||183
8460870|NCT00708682|20849041|P1|STARTED|Toddler Dose||191
8460871|NCT00708682|20849041|P1|NOT COMPLETED|After Infant Series||1
8460872|NCT00708682|20849041|P1|COMPLETED|After Infant Series||191
8460873|NCT00708682|20849041|P1|STARTED|After Infant Series||192
8460874|NCT00708682|20849041|P1|NOT COMPLETED|Infant Series||33
8460875|NCT00708682|20849041|P1|COMPLETED|Infant Series||192
8460876|NCT00708682|20849041|P1|Vaccinated Dose 3|Infant Series||194
8460877|NCT00708682|20849041|P1|Vaccinated Dose 2|Infant Series||214
8460878|NCT00708682|20849041|P1|Vaccinated Dose 1|Infant Series||223
8460879|NCT00708682|20849041|P1|STARTED|Infant Series||225
8460880|NCT00708643|20849062|P2|NOT COMPLETED|Overall Study||1
8460881|NCT00708643|20849063|P1|NOT COMPLETED|Overall Study||0
8460882|NCT00708643|20849062|P2|COMPLETED|Overall Study||39
8460883|NCT00708643|20849063|P1|COMPLETED|Overall Study||40
8460884|NCT00708643|20849062|P2|STARTED|Overall Study||40
8460885|NCT00708643|20849063|P1|STARTED|Overall Study||40
8460886|NCT00708552|20849083|P4|NOT COMPLETED|Overall Study||21
8460887|NCT00708552|20849084|P3|NOT COMPLETED|Overall Study||15
8460888|NCT00708552|20849085|P2|NOT COMPLETED|Overall Study||18
8460889|NCT00708552|20849086|P1|NOT COMPLETED|Overall Study||27
8460890|NCT00708552|20849083|P4|COMPLETED|Overall Study||130
8460891|NCT00708552|20849084|P3|COMPLETED|Overall Study||118
8460892|NCT00708552|20849085|P2|COMPLETED|Overall Study||127
8460893|NCT00708552|20849086|P1|COMPLETED|Overall Study||118
8460894|NCT00708552|20849083|P4|STARTED|Overall Study||151
8460895|NCT00708552|20849084|P3|STARTED|Overall Study||133
8460896|NCT00708552|20849085|P2|STARTED|Overall Study||145
8460897|NCT00708552|20849086|P1|STARTED|Overall Study||145
8460898|NCT00708526|20849236|P2|NOT COMPLETED|Return of Cognitive Function||0
8460899|NCT00708526|20849237|P1|NOT COMPLETED|Return of Cognitive Function||0
8460900|NCT00708526|20849236|P2|COMPLETED|Return of Cognitive Function||11
8460901|NCT00708526|20849237|P1|COMPLETED|Return of Cognitive Function||11
8460902|NCT00708526|20849236|P2|STARTED|Return of Cognitive Function||11
8460903|NCT00708526|20849237|P1|STARTED|Return of Cognitive Function||11
8460904|NCT00708526|20849236|P2|NOT COMPLETED|Wake up After Anesthesia||0
8460905|NCT00708526|20849237|P1|NOT COMPLETED|Wake up After Anesthesia||0
8460906|NCT00708526|20849236|P2|COMPLETED|Wake up After Anesthesia||11
8460907|NCT00708526|20849237|P1|COMPLETED|Wake up After Anesthesia||11
8460908|NCT00708526|20849236|P2|STARTED|Wake up After Anesthesia||11
8460909|NCT00708526|20849237|P1|STARTED|Wake up After Anesthesia||11
8460910|NCT00708500|20849248|P3|NOT COMPLETED|FOLLOWUP||15
8460911|NCT00708500|20849249|P2|NOT COMPLETED|FOLLOWUP||15
8460912|NCT00708500|20849250|P1|NOT COMPLETED|FOLLOWUP||40
8460913|NCT00708500|20849248|P3|COMPLETED|FOLLOWUP||143
8460914|NCT00708500|20849249|P2|COMPLETED|FOLLOWUP||136
8460915|NCT00708500|20849250|P1|COMPLETED|FOLLOWUP||37
8460916|NCT00708500|20849248|P3|STARTED|FOLLOWUP||158
8460917|NCT00708500|20849249|P2|STARTED|FOLLOWUP||151
8460918|NCT00708500|20849250|P1|STARTED|FOLLOWUP||77
8460919|NCT00708500|20849248|P3|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
8460920|NCT00708500|20849249|P2|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
8460921|NCT00708500|20849250|P1|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
8460922|NCT00708500|20849248|P3|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
8460923|NCT00708500|20849249|P2|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
8460924|NCT00708500|20849250|P1|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
8460925|NCT00708500|20849248|P3|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
8460926|NCT00708500|20849249|P2|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
8460927|NCT00708500|20849250|P1|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
8460928|NCT00708500|20849248|P3|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
8460929|NCT00708500|20849249|P2|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
8460930|NCT00708500|20849250|P1|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
8460931|NCT00708500|20849248|P3|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
8460932|NCT00708500|20849249|P2|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
8460933|NCT00708500|20849250|P1|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
8460934|NCT00708500|20849248|P3|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
8460935|NCT00708500|20849249|P2|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
8460936|NCT00708500|20849250|P1|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
8460937|NCT00708500|20849248|P3|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
8460938|NCT00708500|20849249|P2|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
8460939|NCT00708500|20849250|P1|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
8460940|NCT00708461|20849269|P2|NOT COMPLETED|Overall Study||200
8460941|NCT00708461|20849270|P1|NOT COMPLETED|Overall Study||141
8460942|NCT00708461|20849269|P2|COMPLETED|Overall Study||795
8460943|NCT00708461|20849270|P1|COMPLETED|Overall Study||611
8460944|NCT00708461|20849269|P2|STARTED|Overall Study||995
8460945|NCT00708461|20849270|P1|STARTED|Overall Study||752
8460946|NCT00708435|20849278|P2|NOT COMPLETED|Overall Study||17
8460947|NCT00708435|20849279|P1|NOT COMPLETED|Overall Study||25
8460948|NCT00708435|20849278|P2|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
8460949|NCT00708435|20849279|P1|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
8460950|NCT00708435|20849278|P2|STARTED|Overall Study||109
8460951|NCT00708435|20849279|P1|STARTED|Overall Study||107
8460952|NCT00708422|20849306|P2|NOT COMPLETED|Overall Study||1
8460953|NCT00708422|20849307|P1|NOT COMPLETED|Overall Study||4
8460954|NCT00708422|20849306|P2|COMPLETED|Overall Study||114
8460955|NCT00708422|20849307|P1|COMPLETED|Overall Study||112
8460956|NCT00708422|20849306|P2|STARTED|Overall Study||115
8460957|NCT00708422|20849307|P1|STARTED|Overall Study||116
8460958|NCT00708305|20849315|P4|NOT COMPLETED|Period 4||0
8460959|NCT00708305|20849316|P3|NOT COMPLETED|Period 4||0
8460960|NCT00708305|20849317|P2|NOT COMPLETED|Period 4||0
8460961|NCT00708305|20849318|P1|NOT COMPLETED|Period 4||0
8460962|NCT00708305|20849315|P4|COMPLETED|Period 4||14
8460963|NCT00708305|20849316|P3|COMPLETED|Period 4||14
8460964|NCT00708305|20849317|P2|COMPLETED|Period 4||14
8460965|NCT00708305|20849318|P1|COMPLETED|Period 4||12
8460966|NCT00708305|20849315|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
8460967|NCT00708305|20849316|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
8460968|NCT00708305|20849317|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
8460969|NCT00708305|20849318|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
8460970|NCT00708305|20849315|P4|NOT COMPLETED|Period 3||0
8460971|NCT00708305|20849316|P3|NOT COMPLETED|Period 3||0
8460972|NCT00708305|20849317|P2|NOT COMPLETED|Period 3||2
8460973|NCT00708305|20849318|P1|NOT COMPLETED|Period 3||1
8460974|NCT00708305|20849315|P4|COMPLETED|Period 3||14
8460975|NCT00708305|20849316|P3|COMPLETED|Period 3||14
8460976|NCT00708305|20849317|P2|COMPLETED|Period 3||12
8460977|NCT00708305|20849318|P1|COMPLETED|Period 3||14
8460978|NCT00708305|20849315|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
8460979|NCT00708305|20849316|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
8460980|NCT00708305|20849317|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
8460981|NCT00708305|20849318|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
8460982|NCT00708305|20849315|P4|NOT COMPLETED|Period 2||1
8460983|NCT00708305|20849316|P3|NOT COMPLETED|Period 2||0
8460984|NCT00708305|20849317|P2|NOT COMPLETED|Period 2||2
8460985|NCT00708305|20849318|P1|NOT COMPLETED|Period 2||1
8460986|NCT00708305|20849315|P4|COMPLETED|Period 2||14
8460987|NCT00708305|20849316|P3|COMPLETED|Period 2||16
8460988|NCT00708305|20849317|P2|COMPLETED|Period 2||13
8460989|NCT00708305|20849318|P1|COMPLETED|Period 2||14
8460990|NCT00708305|20849315|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
8460991|NCT00708305|20849316|P3|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
8460992|NCT00708305|20849317|P2|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
8460993|NCT00708305|20849318|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
8460994|NCT00708305|20849315|P4|NOT COMPLETED|Period 1||2
8460995|NCT00708305|20849316|P3|NOT COMPLETED|Period 1||1
8460996|NCT00708305|20849317|P2|NOT COMPLETED|Period 1||0
8460997|NCT00708305|20849318|P1|NOT COMPLETED|Period 1||1
8460998|NCT00708305|20849315|P4|COMPLETED|Period 1||14
8460999|NCT00708305|20849316|P3|COMPLETED|Period 1||16
8461000|NCT00708305|20849317|P2|COMPLETED|Period 1||16
8461001|NCT00708305|20849318|P1|COMPLETED|Period 1||15
8461002|NCT00708305|20849315|P4|STARTED|Period 1||16
8461003|NCT00708305|20849316|P3|STARTED|Period 1||17
8461004|NCT00708305|20849317|P2|STARTED|Period 1||16
8461005|NCT00708305|20849318|P1|STARTED|Period 1||16
8461006|NCT00708227|20849354|P4|NOT COMPLETED|Overall Study||3
8461007|NCT00708227|20849355|P3|NOT COMPLETED|Overall Study||1
8461008|NCT00708227|20849356|P2|NOT COMPLETED|Overall Study||5
8461009|NCT00708227|20849357|P1|NOT COMPLETED|Overall Study||1
8461010|NCT00708227|20849354|P4|COMPLETED|Overall Study||22
8461011|NCT00708227|20849355|P3|COMPLETED|Overall Study||17
8461012|NCT00708227|20849356|P2|COMPLETED|Overall Study||21
8461013|NCT00708227|20849357|P1|COMPLETED|Overall Study||18
8461014|NCT00708227|20849354|P4|STARTED|Overall Study||25
8461015|NCT00708227|20849355|P3|STARTED|Overall Study||18
8461016|NCT00708227|20849356|P2|STARTED|Overall Study||26
8461017|NCT00708227|20849357|P1|STARTED|Overall Study||19
8461018|NCT00708214|20849390|P3|NOT COMPLETED|Overall Study||8
8461019|NCT00708214|20849391|P2|NOT COMPLETED|Overall Study||13
8461020|NCT00708214|20849392|P1|NOT COMPLETED|Overall Study||7
8461021|NCT00708214|20849390|P3|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
8461022|NCT00708214|20849391|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
8461023|NCT00708214|20849392|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
8461024|NCT00708214|20849390|P3|STARTED|Overall Study||8
8461025|NCT00708214|20849391|P2|STARTED|Overall Study||13
8461026|NCT00708214|20849392|P1|STARTED|Overall Study||7
8461027|NCT00708201|20849435|P2|NOT COMPLETED|Overall Study||6
8461028|NCT00708201|20849436|P1|NOT COMPLETED|Overall Study||7
8461029|NCT00708201|20849435|P2|COMPLETED|Overall Study||137
8461030|NCT00708201|20849436|P1|COMPLETED|Overall Study||130
8461031|NCT00708201|20849435|P2|Received at Least 1 Dose of Study Drug|Overall Study||137
8461032|NCT00708201|20849436|P1|Received at Least 1 Dose of Study Drug|Overall Study||130
8461033|NCT00708201|20849435|P2|STARTED|Overall Study||143
8461034|NCT00708201|20849436|P1|STARTED|Overall Study||137
8461035|NCT00708175|20849460|P2|NOT COMPLETED|Overall Study||21
8461036|NCT00708175|20849461|P1|NOT COMPLETED|Overall Study||18
8461037|NCT00708175|20849460|P2|COMPLETED|Overall Study||57
8461038|NCT00708175|20849461|P1|COMPLETED|Overall Study||60
8461039|NCT00708175|20849460|P2|STARTED|Overall Study||78
8461040|NCT00708175|20849461|P1|STARTED|Overall Study||78
8461041|NCT00708162|20849477|P2|NOT COMPLETED|Open-Label Phase||30
8461042|NCT00708162|20849478|P1|NOT COMPLETED|Open-Label Phase||44
8461043|NCT00708162|20849477|P2|COMPLETED|Open-Label Phase||121
8461044|NCT00708162|20849478|P1|COMPLETED|Open-Label Phase||152
8461045|NCT00708162|20849477|P2|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
8461046|NCT00708162|20849478|P1|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
8461047|NCT00708162|20849477|P2|NOT COMPLETED|Randomized Phase||154
8461048|NCT00708162|20849478|P1|NOT COMPLETED|Randomized Phase||156
8461049|NCT00708162|20849477|P2|COMPLETED|Randomized Phase||209
8461050|NCT00708162|20849478|P1|COMPLETED|Randomized Phase||205
8461051|NCT00708162|20849477|P2|Randomized and Treated|Randomized Phase||358
8461052|NCT00708162|20849478|P1|Randomized and Treated|Randomized Phase||354
8461053|NCT00708162|20849477|P2|STARTED|Randomized Phase||363
8461054|NCT00708162|20849478|P1|STARTED|Randomized Phase||361
8461055|NCT00708123|20849519|P5|NOT COMPLETED|Period 5||0
8461056|NCT00708123|20849520|P4|NOT COMPLETED|Period 5||0
8461057|NCT00708123|20849521|P3|NOT COMPLETED|Period 5||0
8461058|NCT00708123|20849522|P2|NOT COMPLETED|Period 5||0
8461059|NCT00708123|20849523|P1|NOT COMPLETED|Period 5||0
8461060|NCT00708123|20849519|P5|COMPLETED|Period 5||10
8461061|NCT00708123|20849520|P4|COMPLETED|Period 5||11
8461062|NCT00708123|20849521|P3|COMPLETED|Period 5||11
8461063|NCT00708123|20849522|P2|COMPLETED|Period 5||10
8461064|NCT00708123|20849523|P1|COMPLETED|Period 5||10
8461065|NCT00708123|20849519|P5|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
8461066|NCT00708123|20849520|P4|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
8461067|NCT00708123|20849521|P3|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
8461068|NCT00708123|20849522|P2|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
8461069|NCT00708123|20849523|P1|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
8461070|NCT00708123|20849519|P5|NOT COMPLETED|Period 4||0
8461071|NCT00708123|20849520|P4|NOT COMPLETED|Period 4||0
8461072|NCT00708123|20849521|P3|NOT COMPLETED|Period 4||0
8461073|NCT00708123|20849522|P2|NOT COMPLETED|Period 4||1
8461074|NCT00708123|20849523|P1|NOT COMPLETED|Period 4||0
8461075|NCT00708123|20849519|P5|COMPLETED|Period 4||11
8461076|NCT00708123|20849520|P4|COMPLETED|Period 4||10
8461077|NCT00708123|20849521|P3|COMPLETED|Period 4||10
8461078|NCT00708123|20849522|P2|COMPLETED|Period 4||11
8461079|NCT00708123|20849523|P1|COMPLETED|Period 4||10
8461080|NCT00708123|20849519|P5|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
8461081|NCT00708123|20849520|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
8461082|NCT00708123|20849521|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
8461083|NCT00708123|20849522|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
8461084|NCT00708123|20849523|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
8461085|NCT00708123|20849519|P5|NOT COMPLETED|Period 3||0
8461086|NCT00708123|20849520|P4|NOT COMPLETED|Period 3||1
8461087|NCT00708123|20849521|P3|NOT COMPLETED|Period 3||1
8461088|NCT00708123|20849522|P2|NOT COMPLETED|Period 3||0
8461089|NCT00708123|20849523|P1|NOT COMPLETED|Period 3||0
8461090|NCT00708123|20849519|P5|COMPLETED|Period 3||10
8461091|NCT00708123|20849520|P4|COMPLETED|Period 3||11
8461092|NCT00708123|20849521|P3|COMPLETED|Period 3||10
8461093|NCT00708123|20849522|P2|COMPLETED|Period 3||10
8461094|NCT00708123|20849523|P1|COMPLETED|Period 3||12
8461095|NCT00708123|20849519|P5|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
8461096|NCT00708123|20849520|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
8461097|NCT00708123|20849521|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
8461098|NCT00708123|20849522|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
8461099|NCT00708123|20849523|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
8461100|NCT00708123|20849519|P5|NOT COMPLETED|Period 2||0
8461101|NCT00708123|20849520|P4|NOT COMPLETED|Period 2||1
8461102|NCT00708123|20849521|P3|NOT COMPLETED|Period 2||0
8461103|NCT00708123|20849522|P2|NOT COMPLETED|Period 2||0
8461104|NCT00708123|20849523|P1|NOT COMPLETED|Period 2||1
8461105|NCT00708123|20849519|P5|COMPLETED|Period 2||11
8461106|NCT00708123|20849520|P4|COMPLETED|Period 2||10
8461107|NCT00708123|20849521|P3|COMPLETED|Period 2||12
8461108|NCT00708123|20849522|P2|COMPLETED|Period 2||12
8461109|NCT00708123|20849523|P1|COMPLETED|Period 2||10
8461110|NCT00708123|20849519|P5|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
8461111|NCT00708123|20849520|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
8461112|NCT00708123|20849521|P3|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
8461113|NCT00708123|20849522|P2|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
8461114|NCT00708123|20849523|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
8461115|NCT00708123|20849519|P5|NOT COMPLETED|Period 1||0
8461116|NCT00708123|20849520|P4|NOT COMPLETED|Period 1||1
8461117|NCT00708123|20849521|P3|NOT COMPLETED|Period 1||1
8461118|NCT00708123|20849522|P2|NOT COMPLETED|Period 1||1
8461119|NCT00708123|20849523|P1|NOT COMPLETED|Period 1||0
8461120|NCT00708123|20849519|P5|COMPLETED|Period 1||12
8461121|NCT00708123|20849520|P4|COMPLETED|Period 1||11
8461122|NCT00708123|20849521|P3|COMPLETED|Period 1||11
8461123|NCT00708123|20849522|P2|COMPLETED|Period 1||11
8461124|NCT00708123|20849523|P1|COMPLETED|Period 1||12
8461125|NCT00708123|20849519|P5|STARTED|Period 1||12
8461126|NCT00708123|20849520|P4|STARTED|Period 1||12
8461127|NCT00708123|20849521|P3|STARTED|Period 1||12
8461128|NCT00708123|20849522|P2|STARTED|Period 1||12
8461129|NCT00708123|20849523|P1|STARTED|Period 1||12
8461130|NCT00708110|20849547|P4|NOT COMPLETED|Overall Study||0
8461131|NCT00708110|20849548|P3|NOT COMPLETED|Overall Study||0
8461132|NCT00708110|20849549|P2|NOT COMPLETED|Overall Study||0
8461133|NCT00708110|20849550|P1|NOT COMPLETED|Overall Study||0
8461134|NCT00708110|20849547|P4|COMPLETED|Overall Study||10
8461135|NCT00708110|20849548|P3|COMPLETED|Overall Study||9
8461136|NCT00708110|20849549|P2|COMPLETED|Overall Study||9
8461137|NCT00708110|20849550|P1|COMPLETED|Overall Study||7
8461138|NCT00708110|20849547|P4|STARTED|Overall Study||10
8461139|NCT00708110|20849548|P3|STARTED|Overall Study||9
8461140|NCT00708110|20849549|P2|STARTED|Overall Study||9
8461141|NCT00708110|20849550|P1|STARTED|Overall Study||7
8461142|NCT00708097|20849656|P5|NOT COMPLETED|Period 5||0
8461143|NCT00708097|20849657|P4|NOT COMPLETED|Period 5||0
8461144|NCT00708097|20849658|P3|NOT COMPLETED|Period 5||0
8461145|NCT00708097|20849659|P2|NOT COMPLETED|Period 5||0
8461146|NCT00708097|20849660|P1|NOT COMPLETED|Period 5||0
8461147|NCT00708097|20849656|P5|COMPLETED|Period 5||12
8461148|NCT00708097|20849657|P4|COMPLETED|Period 5||10
8461149|NCT00708097|20849658|P3|COMPLETED|Period 5||11
8461150|NCT00708097|20849659|P2|COMPLETED|Period 5||9
8461151|NCT00708097|20849660|P1|COMPLETED|Period 5||8
8461152|NCT00708097|20849656|P5|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
8461153|NCT00708097|20849657|P4|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
8461154|NCT00708097|20849658|P3|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
8461155|NCT00708097|20849659|P2|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
8461156|NCT00708097|20849660|P1|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
8461157|NCT00708097|20849656|P5|NOT COMPLETED|Period 4||0
8461158|NCT00708097|20849657|P4|NOT COMPLETED|Period 4||0
8461159|NCT00708097|20849658|P3|NOT COMPLETED|Period 4||0
8461160|NCT00708097|20849659|P2|NOT COMPLETED|Period 4||0
8461161|NCT00708097|20849660|P1|NOT COMPLETED|Period 4||0
8461162|NCT00708097|20849656|P5|COMPLETED|Period 4||8
8461163|NCT00708097|20849657|P4|COMPLETED|Period 4||11
8461164|NCT00708097|20849658|P3|COMPLETED|Period 4||10
8461165|NCT00708097|20849659|P2|COMPLETED|Period 4||9
8461166|NCT00708097|20849660|P1|COMPLETED|Period 4||12
8461167|NCT00708097|20849656|P5|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
8461168|NCT00708097|20849657|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
8461169|NCT00708097|20849658|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
8461170|NCT00708097|20849659|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
8461171|NCT00708097|20849660|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
8461172|NCT00708097|20849656|P5|NOT COMPLETED|Period 3||0
8461173|NCT00708097|20849657|P4|NOT COMPLETED|Period 3||0
8461174|NCT00708097|20849658|P3|NOT COMPLETED|Period 3||0
8461175|NCT00708097|20849659|P2|NOT COMPLETED|Period 3||0
8461176|NCT00708097|20849660|P1|NOT COMPLETED|Period 3||0
8461177|NCT00708097|20849656|P5|COMPLETED|Period 3||10
8461178|NCT00708097|20849657|P4|COMPLETED|Period 3||10
8461179|NCT00708097|20849658|P3|COMPLETED|Period 3||10
8461180|NCT00708097|20849659|P2|COMPLETED|Period 3||11
8461181|NCT00708097|20849660|P1|COMPLETED|Period 3||9
8461182|NCT00708097|20849656|P5|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
8461183|NCT00708097|20849657|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
8461184|NCT00708097|20849658|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
8461185|NCT00708097|20849659|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
8461186|NCT00708097|20849660|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
8461187|NCT00708097|20849656|P5|NOT COMPLETED|Period 2||0
8461188|NCT00708097|20849657|P4|NOT COMPLETED|Period 2||1
8461189|NCT00708097|20849658|P3|NOT COMPLETED|Period 2||1
8461190|NCT00708097|20849659|P2|NOT COMPLETED|Period 2||1
8461191|NCT00708097|20849660|P1|NOT COMPLETED|Period 2||0
8461192|NCT00708097|20849656|P5|COMPLETED|Period 2||10
8461193|NCT00708097|20849657|P4|COMPLETED|Period 2||10
8461194|NCT00708097|20849658|P3|COMPLETED|Period 2||9
8461195|NCT00708097|20849659|P2|COMPLETED|Period 2||11
8461196|NCT00708097|20849660|P1|COMPLETED|Period 2||10
8461197|NCT00708097|20849656|P5|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
8461198|NCT00708097|20849657|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
8461199|NCT00708097|20849658|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
8461200|NCT00708097|20849659|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
8461201|NCT00708097|20849660|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
8461202|NCT00708097|20849656|P5|NOT COMPLETED|Period 1||1
8461203|NCT00708097|20849657|P4|NOT COMPLETED|Period 1||2
8461204|NCT00708097|20849658|P3|NOT COMPLETED|Period 1||0
8461205|NCT00708097|20849659|P2|NOT COMPLETED|Period 1||1
8461206|NCT00708097|20849660|P1|NOT COMPLETED|Period 1||0
8461207|NCT00708097|20849656|P5|COMPLETED|Period 1||10
8461208|NCT00708097|20849657|P4|COMPLETED|Period 1||9
8461209|NCT00708097|20849658|P3|COMPLETED|Period 1||12
8461210|NCT00708097|20849659|P2|COMPLETED|Period 1||11
8461211|NCT00708097|20849660|P1|COMPLETED|Period 1||11
8461212|NCT00708097|20849656|P5|STARTED|Period 1||11
8461213|NCT00708097|20849657|P4|STARTED|Period 1||11
8461214|NCT00708097|20849658|P3|STARTED|Period 1||12
8461215|NCT00708097|20849659|P2|STARTED|Period 1||12
8461216|NCT00708097|20849660|P1|STARTED|Period 1||11
8461217|NCT00708071|20849690|P1|NOT COMPLETED|Overall Study||0
8461218|NCT00708071|20849690|P1|COMPLETED|Overall Study||45
8461219|NCT00708071|20849690|P1|STARTED|Overall Study|Randomized and treated|45
8461220|NCT00708032|20849770|P2|NOT COMPLETED|Overall Study||16
8461221|NCT00708032|20849771|P1|NOT COMPLETED|Overall Study||10
8461222|NCT00708032|20849770|P2|COMPLETED|Overall Study||22
8461223|NCT00708032|20849771|P1|COMPLETED|Overall Study||26
8461224|NCT00708032|20849770|P2|STARTED|Overall Study||38
8461225|NCT00708032|20849771|P1|STARTED|Overall Study||36
8461226|NCT00708019|20849787|P2|NOT COMPLETED|Overall Study||15
8461227|NCT00708019|20849788|P1|NOT COMPLETED|Overall Study||15
8461228|NCT00708019|20849787|P2|COMPLETED|Overall Study||78
8461229|NCT00708019|20849788|P1|COMPLETED|Overall Study||77
8461230|NCT00708019|20849787|P2|STARTED|Overall Study||93
8461231|NCT00708019|20849788|P1|STARTED|Overall Study||92
8461232|NCT00707993|20849798|P2|NOT COMPLETED|Overall Study||94
8461233|NCT00707993|20849799|P1|NOT COMPLETED|Overall Study||89
8461234|NCT00707993|20849798|P2|COMPLETED|Overall Study||125
8461235|NCT00707993|20849799|P1|COMPLETED|Overall Study||133
8461236|NCT00707993|20849798|P2|STARTED|Overall Study||219
8461237|NCT00707993|20849799|P1|STARTED|Overall Study||222
8461238|NCT00707980|20849841|P1|NOT COMPLETED|Overall Study||310
8461239|NCT00707980|20849841|P1|COMPLETED|Overall Study||526
8461240|NCT00707980|20849841|P1|Received Treatment|Overall Study||834
8461241|NCT00707980|20849841|P1|STARTED|Overall Study||836
8461242|NCT00707967|20849859|P3|NOT COMPLETED|Overall Study||0
8461243|NCT00707967|20849860|P2|NOT COMPLETED|Overall Study||0
8461244|NCT00707967|20849861|P1|NOT COMPLETED|Overall Study||0
8461245|NCT00707967|20849859|P3|COMPLETED|Overall Study||7
8461246|NCT00707967|20849860|P2|COMPLETED|Overall Study||8
8461247|NCT00707967|20849861|P1|COMPLETED|Overall Study||22
8461248|NCT00707967|20849859|P3|STARTED|Overall Study||7
8461249|NCT00707967|20849860|P2|STARTED|Overall Study||8
8461250|NCT00707967|20849861|P1|STARTED|Overall Study||22
8461251|NCT00707954|20849925|P5|NOT COMPLETED|Overall Study||1
8461252|NCT00707954|20849926|P4|NOT COMPLETED|Overall Study||0
8461253|NCT00707954|20849927|P3|NOT COMPLETED|Overall Study||0
8461254|NCT00707954|20849928|P2|NOT COMPLETED|Overall Study||0
8461255|NCT00707954|20849929|P1|NOT COMPLETED|Overall Study||0
8461256|NCT00707954|20849925|P5|COMPLETED|Overall Study||9
8461257|NCT00707954|20849926|P4|COMPLETED|Overall Study||13
8461258|NCT00707954|20849927|P3|COMPLETED|Overall Study||14
8461259|NCT00707954|20849928|P2|COMPLETED|Overall Study||12
8461260|NCT00707954|20849929|P1|COMPLETED|Overall Study||12
8461261|NCT00707954|20849925|P5|STARTED|Overall Study||10
8461262|NCT00707954|20849926|P4|STARTED|Overall Study||13
8461263|NCT00707954|20849927|P3|STARTED|Overall Study||14
8461264|NCT00707954|20849928|P2|STARTED|Overall Study||12
8461265|NCT00707954|20849929|P1|STARTED|Overall Study||12
8461266|NCT00707915|20849941|P1|NOT COMPLETED|Overall Study||0
8461267|NCT00707915|20849941|P1|COMPLETED|Overall Study||30
8461268|NCT00707915|20849941|P1|Effects of Discontinuing Benzodiazepine|Overall Study||30
8461269|NCT00707915|20849941|P1|STARTED|Overall Study||30
8461270|NCT00707863|20849952|P2|NOT COMPLETED|Overall Study||3
8461271|NCT00707863|20849953|P1|NOT COMPLETED|Overall Study||0
8461272|NCT00707863|20849952|P2|COMPLETED|Overall Study||8
8461273|NCT00707863|20849953|P1|COMPLETED|Overall Study||6
8461274|NCT00707863|20849952|P2|STARTED|Overall Study||11
8461275|NCT00707863|20849953|P1|STARTED|Overall Study||6
8461276|NCT00707759|20849961|P2|NOT COMPLETED|Overall Study||2
8461277|NCT00707759|20849962|P1|NOT COMPLETED|Overall Study||2
8461278|NCT00707759|20849961|P2|COMPLETED|Overall Study||12
8461279|NCT00707759|20849962|P1|COMPLETED|Overall Study||12
8461280|NCT00707759|20849961|P2|STARTED|Overall Study||14
8461281|NCT00707759|20849962|P1|STARTED|Overall Study||14
8461282|NCT00707746|20849970|P2|NOT COMPLETED|Follow-up Period||0
8461283|NCT00707746|20849971|P1|NOT COMPLETED|Follow-up Period||0
8461284|NCT00707746|20849970|P2|COMPLETED|Follow-up Period||21
8461285|NCT00707746|20849971|P1|COMPLETED|Follow-up Period||12
8461286|NCT00707746|20849970|P2|STARTED|Follow-up Period||21
8461287|NCT00707746|20849971|P1|STARTED|Follow-up Period||12
8461288|NCT00707746|20849970|P2|NOT COMPLETED|Treatment Period||5
8461289|NCT00707746|20849971|P1|NOT COMPLETED|Treatment Period||2
8461290|NCT00707746|20849970|P2|COMPLETED|Treatment Period||17
8461291|NCT00707746|20849971|P1|COMPLETED|Treatment Period||10
8461292|NCT00707746|20849970|P2|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
8461293|NCT00707746|20849971|P1|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
8461294|NCT00707746|20849970|P2|STARTED|Treatment Period||22
8461295|NCT00707746|20849971|P1|STARTED|Treatment Period||12
8461296|NCT00707655|20850019|P2|NOT COMPLETED|Overall Study||2
8461297|NCT00707655|20850020|P1|NOT COMPLETED|Overall Study||0
8461298|NCT00707655|20850019|P2|COMPLETED|Overall Study||3
8461299|NCT00707655|20850020|P1|COMPLETED|Overall Study||3
8461300|NCT00707655|20850019|P2|STARTED|Overall Study||5
8461301|NCT00707655|20850020|P1|STARTED|Overall Study||3
8461302|NCT00707577|20850032|P2|NOT COMPLETED|Overall Study||38
8461303|NCT00707577|20850033|P1|NOT COMPLETED|Overall Study||54
8461304|NCT00707577|20850032|P2|COMPLETED|Overall Study||118
8461305|NCT00707577|20850033|P1|COMPLETED|Overall Study||120
8461306|NCT00707577|20850032|P2|STARTED|Overall Study||156
8461307|NCT00707577|20850033|P1|STARTED|Overall Study||174
8461308|NCT00707486|20850039|P1|NOT COMPLETED|Overall Study||1
8461309|NCT00707486|20850039|P1|COMPLETED|Overall Study||71
8461310|NCT00707486|20850039|P1|STARTED|Overall Study||72
8461311|NCT00707447|20850050|P2|NOT COMPLETED|Overall Study||8
8461312|NCT00707447|20850051|P1|NOT COMPLETED|Overall Study||8
8461313|NCT00707447|20850050|P2|COMPLETED|Overall Study||85
8461314|NCT00707447|20850051|P1|COMPLETED|Overall Study||81
8461315|NCT00707447|20850050|P2|STARTED|Overall Study||93
8461316|NCT00707447|20850051|P1|STARTED|Overall Study||89
8461317|NCT00707434|20850075|P1|NOT COMPLETED|Overall Study||1
8461318|NCT00707434|20850075|P1|COMPLETED|Overall Study||5
8461319|NCT00707434|20850075|P1|STARTED|Overall Study||6
8461320|NCT00707343|20850079|P1|NOT COMPLETED|Overall Study||0
8461321|NCT00707343|20850079|P1|COMPLETED|Overall Study||15
8461322|NCT00707343|20850079|P1|STARTED|Overall Study||15
8461323|NCT00707239|20850086|P3|NOT COMPLETED|Overall Study||14
8461324|NCT00707239|20850087|P2|NOT COMPLETED|Overall Study||11
8461325|NCT00707239|20850088|P1|NOT COMPLETED|Overall Study||19
8461326|NCT00707239|20850086|P3|COMPLETED|Overall Study||21
8461327|NCT00707239|20850087|P2|COMPLETED|Overall Study||25
8461328|NCT00707239|20850088|P1|COMPLETED|Overall Study||18
8461329|NCT00707239|20850086|P3|Treated|Overall Study||34
8461330|NCT00707239|20850087|P2|Treated|Overall Study||35
8461331|NCT00707239|20850088|P1|Treated|Overall Study||36
8461332|NCT00707239|20850086|P3|STARTED|Overall Study||35
8461333|NCT00707239|20850087|P2|STARTED|Overall Study||36
8461334|NCT00707239|20850088|P1|STARTED|Overall Study||37
8461335|NCT00707174|20850136|P2|NOT COMPLETED|Overall Study||7
8461336|NCT00707174|20850137|P1|NOT COMPLETED|Overall Study||5
8461337|NCT00707174|20850136|P2|COMPLETED|Overall Study||37
8461338|NCT00707174|20850137|P1|COMPLETED|Overall Study||41
8461339|NCT00707174|20850136|P2|STARTED|Overall Study||44
8461340|NCT00707174|20850137|P1|STARTED|Overall Study||46
8461341|NCT00707161|20850143|P1|NOT COMPLETED|Overall Study||6
8461342|NCT00707161|20850143|P1|COMPLETED|Overall Study||0
8461343|NCT00707161|20850143|P1|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
8461344|NCT00707057|20850149|P2|NOT COMPLETED|Overall Study||4
8461345|NCT00707057|20850150|P1|NOT COMPLETED|Overall Study||8
8461346|NCT00707057|20850149|P2|COMPLETED|Overall Study||83
8461347|NCT00707057|20850150|P1|COMPLETED|Overall Study||161
8461348|NCT00707057|20850149|P2|STARTED|Overall Study||87
8461349|NCT00707057|20850150|P1|STARTED|Overall Study||169
8461350|NCT00707031|20850184|P2|NOT COMPLETED|Overall Study||99
8461351|NCT00707031|20850185|P1|NOT COMPLETED|Overall Study||104
8461352|NCT00707031|20850184|P2|COMPLETED|Overall Study||220
8461353|NCT00707031|20850185|P1|COMPLETED|Overall Study||216
8461354|NCT00707031|20850184|P2|Modified Intent-to-Treat Population|Overall Study||315
8461355|NCT00707031|20850185|P1|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
8461356|NCT00707031|20850184|P2|Treated/Safety Population|Overall Study||316
8461357|NCT00707031|20850185|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
8461358|NCT00707031|20850184|P2|STARTED|Overall Study||319
8461359|NCT00707031|20850185|P1|STARTED|Overall Study|Randomized|320
8461360|NCT00706992|20850214|P7|NOT COMPLETED|Overall Study||3
8461361|NCT00706992|20850215|P6|NOT COMPLETED|Overall Study||2
8461362|NCT00706992|20850216|P5|NOT COMPLETED|Overall Study||4
8461363|NCT00706992|20850217|P4|NOT COMPLETED|Overall Study||2
8461364|NCT00706992|20850218|P3|NOT COMPLETED|Overall Study||6
8461365|NCT00706992|20850219|P2|NOT COMPLETED|Overall Study||5
8461366|NCT00706992|20850220|P1|NOT COMPLETED|Overall Study||5
8461367|NCT00706992|20850214|P7|COMPLETED|Overall Study||3
8461368|NCT00706992|20850215|P6|COMPLETED|Overall Study||3
8461369|NCT00706992|20850216|P5|COMPLETED|Overall Study||2
8461370|NCT00706992|20850217|P4|COMPLETED|Overall Study||6
8461371|NCT00706992|20850218|P3|COMPLETED|Overall Study||3
8461372|NCT00706992|20850219|P2|COMPLETED|Overall Study||3
8461373|NCT00706992|20850220|P1|COMPLETED|Overall Study||3
8461374|NCT00706992|20850214|P7|STARTED|Overall Study||6
8461375|NCT00706992|20850215|P6|STARTED|Overall Study||5
8461376|NCT00706992|20850216|P5|STARTED|Overall Study||6
8461377|NCT00706992|20850217|P4|STARTED|Overall Study||8
8461378|NCT00706992|20850218|P3|STARTED|Overall Study||9
8461379|NCT00706992|20850219|P2|STARTED|Overall Study||8
8461380|NCT00706992|20850220|P1|STARTED|Overall Study||8
8461381|NCT00706979|20850239|P2|NOT COMPLETED|Overall Study||0
8461382|NCT00706979|20850240|P1|NOT COMPLETED|Overall Study||0
8461383|NCT00706979|20850239|P2|COMPLETED|Overall Study||423
8461384|NCT00706979|20850240|P1|COMPLETED|Overall Study||426
8461385|NCT00706979|20850239|P2|STARTED|Overall Study||423
8461386|NCT00706979|20850240|P1|STARTED|Overall Study||426
8461387|NCT00706966|20850252|P1|NOT COMPLETED|Overall Study||1
8461388|NCT00706966|20850252|P1|COMPLETED|Overall Study||9
8461389|NCT00706966|20850252|P1|STARTED|Overall Study||10
8461390|NCT00706914|20850288|P3|NOT COMPLETED|Overall Study||1
8461391|NCT00706914|20850289|P2|NOT COMPLETED|Overall Study||4
8461392|NCT00706914|20850290|P1|NOT COMPLETED|Overall Study||6
8461393|NCT00706914|20850288|P3|COMPLETED|Overall Study||30
8461394|NCT00706914|20850289|P2|COMPLETED|Overall Study||58
8461395|NCT00706914|20850290|P1|COMPLETED|Overall Study||57
8461396|NCT00706914|20850288|P3|STARTED|Overall Study||31
8461397|NCT00706914|20850289|P2|STARTED|Overall Study||62
8461398|NCT00706914|20850290|P1|STARTED|Overall Study||63
8461399|NCT00706901|20850313|P3|NOT COMPLETED|Overall Study||8
8461400|NCT00706901|20850314|P2|NOT COMPLETED|Overall Study||5
8461401|NCT00706901|20850315|P1|NOT COMPLETED|Overall Study||8
8461402|NCT00706901|20850313|P3|COMPLETED|Overall Study||51
8461403|NCT00706901|20850314|P2|COMPLETED|Overall Study||57
8461404|NCT00706901|20850315|P1|COMPLETED|Overall Study||51
8461405|NCT00706901|20850313|P3|STARTED|Overall Study||59
8461406|NCT00706901|20850314|P2|STARTED|Overall Study||62
8461407|NCT00706901|20850315|P1|STARTED|Overall Study||59
8461408|NCT00706849|20850340|P2|NOT COMPLETED|Follow-up Period||3
8461409|NCT00706849|20850341|P1|NOT COMPLETED|Follow-up Period||0
8461410|NCT00706849|20850340|P2|COMPLETED|Follow-up Period||25
8461411|NCT00706849|20850341|P1|COMPLETED|Follow-up Period||3
8461412|NCT00706849|20850340|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
8461413|NCT00706849|20850341|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
8461414|NCT00706849|20850340|P2|NOT COMPLETED|Treatment Period||10
8461415|NCT00706849|20850341|P1|NOT COMPLETED|Treatment Period||0
8461416|NCT00706849|20850340|P2|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
8461417|NCT00706849|20850341|P1|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
8461418|NCT00706849|20850340|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
8461419|NCT00706849|20850341|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
8461420|NCT00706849|20850340|P2|STARTED|Treatment Period||83
8461421|NCT00706849|20850341|P1|STARTED|Treatment Period||41
8461422|NCT00706836|20850385|P1|NOT COMPLETED|Overall Study||0
8461423|NCT00706836|20850385|P1|COMPLETED|Overall Study||16
8461424|NCT00706836|20850385|P1|STARTED|Overall Study||16
8461425|NCT00706823|20850395|P2|NOT COMPLETED|Overall Study||0
8461426|NCT00706823|20850396|P1|NOT COMPLETED|Overall Study||0
8461427|NCT00706823|20850395|P2|COMPLETED|Overall Study||25
8461428|NCT00706823|20850396|P1|COMPLETED|Overall Study||25
8461429|NCT00706823|20850395|P2|STARTED|Overall Study||25
8461430|NCT00706823|20850396|P1|STARTED|Overall Study||25
8461431|NCT00706810|20850412|P1|NOT COMPLETED|Overall Study||1
8461432|NCT00706810|20850412|P1|COMPLETED|Overall Study||7
8461433|NCT00706810|20850412|P1|STARTED|Overall Study||8
8461434|NCT00706797|20850419|P2|NOT COMPLETED|Overall Study||71
8461435|NCT00706797|20850420|P1|NOT COMPLETED|Overall Study||69
8461436|NCT00706797|20850419|P2|COMPLETED|Overall Study||0
8461437|NCT00706797|20850420|P1|COMPLETED|Overall Study||1
8461438|NCT00706797|20850419|P2|Safety Population|Overall Study||71
8461439|NCT00706797|20850420|P1|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
8461440|NCT00706797|20850419|P2|STARTED|Overall Study||71
8461441|NCT00706797|20850420|P1|STARTED|Overall Study||70
8461442|NCT00706784|20850462|P2|NOT COMPLETED|Overall Study||0
8461443|NCT00706784|20850463|P1|NOT COMPLETED|Overall Study||0
8461444|NCT00706784|20850462|P2|COMPLETED|Overall Study||3
8461445|NCT00706784|20850463|P1|COMPLETED|Overall Study||3
8461446|NCT00706784|20850462|P2|STARTED|Overall Study||3
8461447|NCT00706784|20850463|P1|STARTED|Overall Study||3
8461448|NCT00706719|20850472|P3|NOT COMPLETED|Overall Study||4
8461449|NCT00706719|20850473|P2|NOT COMPLETED|Overall Study||1
8461450|NCT00706719|20850474|P1|NOT COMPLETED|Overall Study||0
8461451|NCT00706719|20850472|P3|COMPLETED|Overall Study||1
8461452|NCT00706719|20850473|P2|COMPLETED|Overall Study||6
8461453|NCT00706719|20850474|P1|COMPLETED|Overall Study||5
8461454|NCT00706719|20850472|P3|STARTED|Overall Study||5
8461455|NCT00706719|20850473|P2|STARTED|Overall Study||7
8461456|NCT00706719|20850474|P1|STARTED|Overall Study||5
8461457|NCT00706706|20850489|P1|NOT COMPLETED|Overall Study||105
8461458|NCT00706706|20850489|P1|COMPLETED|Overall Study||0
8461459|NCT00706706|20850489|P1|STARTED|Overall Study||105
8461460|NCT00706654|20850499|P4|NOT COMPLETED|Depot Maintenance Phase||70
8461461|NCT00706654|20850500|P3|NOT COMPLETED|Depot Maintenance Phase||88
8461462|NCT00706654|20850501|P2|NOT COMPLETED|Depot Maintenance Phase||69
8461463|NCT00706654|20850502|P1|NOT COMPLETED|Depot Maintenance Phase||0
8461464|NCT00706654|20850499|P4|COMPLETED|Depot Maintenance Phase||61
8461465|NCT00706654|20850500|P3|COMPLETED|Depot Maintenance Phase||178
8461466|NCT00706654|20850501|P2|COMPLETED|Depot Maintenance Phase||196
8461467|NCT00706654|20850502|P1|COMPLETED|Depot Maintenance Phase||0
8461468|NCT00706654|20850499|P4|STARTED|Depot Maintenance Phase||131
8461469|NCT00706654|20850500|P3|STARTED|Depot Maintenance Phase||266
8461470|NCT00706654|20850501|P2|STARTED|Depot Maintenance Phase||265
8461471|NCT00706654|20850502|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
8461472|NCT00706654|20850499|P4|NOT COMPLETED|Oral Stabilization Phase||0
8461473|NCT00706654|20850500|P3|NOT COMPLETED|Oral Stabilization Phase||0
8461474|NCT00706654|20850501|P2|NOT COMPLETED|Oral Stabilization Phase||0
8461475|NCT00706654|20850502|P1|NOT COMPLETED|Oral Stabilization Phase||180
8461476|NCT00706654|20850499|P4|COMPLETED|Oral Stabilization Phase||0
8461477|NCT00706654|20850500|P3|COMPLETED|Oral Stabilization Phase||0
8461478|NCT00706654|20850501|P2|COMPLETED|Oral Stabilization Phase||0
8461479|NCT00706654|20850502|P1|COMPLETED|Oral Stabilization Phase||662
8461480|NCT00706654|20850499|P4|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8461481|NCT00706654|20850500|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8461482|NCT00706654|20850501|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8461575|NCT00706433|20850738|P3|STARTED|Overall Study||67
8461483|NCT00706654|20850502|P1|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
8461484|NCT00706654|20850499|P4|NOT COMPLETED|Conversion Phase||0
8461485|NCT00706654|20850500|P3|NOT COMPLETED|Conversion Phase||0
8461486|NCT00706654|20850501|P2|NOT COMPLETED|Conversion Phase||0
8461487|NCT00706654|20850502|P1|NOT COMPLETED|Conversion Phase||95
8461488|NCT00706654|20850499|P4|COMPLETED|Conversion Phase||0
8461489|NCT00706654|20850500|P3|COMPLETED|Conversion Phase||0
8461490|NCT00706654|20850501|P2|COMPLETED|Conversion Phase||0
8461491|NCT00706654|20850502|P1|COMPLETED|Conversion Phase||614
8461492|NCT00706654|20850499|P4|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8461493|NCT00706654|20850500|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8461494|NCT00706654|20850501|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8461495|NCT00706654|20850502|P1|STARTED|Conversion Phase||709
8461496|NCT00706641|20850521|P1|NOT COMPLETED|Radical Cystectomy||1
8461497|NCT00706641|20850521|P1|COMPLETED|Radical Cystectomy||22
8461498|NCT00706641|20850521|P1|STARTED|Radical Cystectomy||23
8461499|NCT00706641|20850521|P1|NOT COMPLETED|Dasatinib Administration||2
8461500|NCT00706641|20850521|P1|COMPLETED|Dasatinib Administration||23
8461501|NCT00706641|20850521|P1|Toxicity Evaluation|Dasatinib Administration||24
8461502|NCT00706641|20850521|P1|STARTED|Dasatinib Administration||25
8461503|NCT00706628|20850535|P4|NOT COMPLETED|Overall Study||3
8461504|NCT00706628|20850536|P3|NOT COMPLETED|Overall Study||16
8461505|NCT00706628|20850537|P2|NOT COMPLETED|Overall Study||21
8461506|NCT00706628|20850538|P1|NOT COMPLETED|Overall Study||47
8461507|NCT00706628|20850535|P4|COMPLETED|Overall Study||0
8461508|NCT00706628|20850536|P3|COMPLETED|Overall Study||0
8461509|NCT00706628|20850537|P2|COMPLETED|Overall Study||0
8461510|NCT00706628|20850538|P1|COMPLETED|Overall Study||0
8461511|NCT00706628|20850535|P4|STARTED|Overall Study||3
8461512|NCT00706628|20850536|P3|STARTED|Overall Study||16
8461513|NCT00706628|20850537|P2|STARTED|Overall Study||21
8461514|NCT00706628|20850538|P1|STARTED|Overall Study||47
8461515|NCT00706589|20850588|P2|NOT COMPLETED|Overall Study||4
8461516|NCT00706589|20850589|P1|NOT COMPLETED|Overall Study||3
8461517|NCT00706589|20850588|P2|COMPLETED|Overall Study||25
8461518|NCT00706589|20850589|P1|COMPLETED|Overall Study||29
8461519|NCT00706589|20850588|P2|STARTED|Overall Study||29
8461520|NCT00706589|20850589|P1|STARTED|Overall Study||32
8461521|NCT00706563|20850597|P2|NOT COMPLETED|Overall Study||0
8461522|NCT00706563|20850598|P1|NOT COMPLETED|Overall Study||0
8461523|NCT00706563|20850597|P2|COMPLETED|Overall Study||59
8461524|NCT00706563|20850598|P1|COMPLETED|Overall Study||61
8461525|NCT00706563|20850597|P2|STARTED|Overall Study||59
8461526|NCT00706563|20850598|P1|STARTED|Overall Study||61
8461527|NCT00706550|20850622|P2|NOT COMPLETED|Overall Study||28
8461528|NCT00706550|20850623|P1|NOT COMPLETED|Overall Study||7
8461529|NCT00706550|20850622|P2|COMPLETED|Overall Study||36
8461530|NCT00706550|20850623|P1|COMPLETED|Overall Study||36
8461531|NCT00706550|20850622|P2|STARTED|Overall Study||64
8461532|NCT00706550|20850623|P1|STARTED|Overall Study||43
8461533|NCT00706511|20850643|P4|NOT COMPLETED|Overall Study||0
8461534|NCT00706511|20850644|P3|NOT COMPLETED|Overall Study||0
8461535|NCT00706511|20850645|P2|NOT COMPLETED|Overall Study||0
8461536|NCT00706511|20850646|P1|NOT COMPLETED|Overall Study||1
8461537|NCT00706511|20850643|P4|COMPLETED|Overall Study||10
8461538|NCT00706511|20850644|P3|COMPLETED|Overall Study||3
8461539|NCT00706511|20850645|P2|COMPLETED|Overall Study||4
8461540|NCT00706511|20850646|P1|COMPLETED|Overall Study||9
8461541|NCT00706511|20850643|P4|STARTED|Overall Study||10
8461542|NCT00706511|20850644|P3|STARTED|Overall Study||3
8461543|NCT00706511|20850645|P2|STARTED|Overall Study||4
8461544|NCT00706511|20850646|P1|STARTED|Overall Study||10
8461545|NCT00706485|20850678|P1|NOT COMPLETED|Overall Study||0
8461546|NCT00706485|20850678|P1|COMPLETED|Overall Study||5
8461547|NCT00706485|20850678|P1|STARTED|Overall Study||5
8461548|NCT00706446|20850690|P6|NOT COMPLETED|Overall Study||38
8461549|NCT00706446|20850691|P5|NOT COMPLETED|Overall Study||44
8461550|NCT00706446|20850692|P4|NOT COMPLETED|Overall Study||22
8461551|NCT00706446|20850693|P3|NOT COMPLETED|Overall Study||37
8461552|NCT00706446|20850694|P2|NOT COMPLETED|Overall Study||49
8461553|NCT00706446|20850695|P1|NOT COMPLETED|Overall Study||26
8461554|NCT00706446|20850690|P6|COMPLETED|Overall Study||7
8461555|NCT00706446|20850691|P5|COMPLETED|Overall Study||10
8461556|NCT00706446|20850692|P4|COMPLETED|Overall Study||4
8461557|NCT00706446|20850693|P3|COMPLETED|Overall Study||7
8461558|NCT00706446|20850694|P2|COMPLETED|Overall Study||8
8461559|NCT00706446|20850695|P1|COMPLETED|Overall Study||3
8461560|NCT00706446|20850690|P6|STARTED|Overall Study||45
8461561|NCT00706446|20850691|P5|STARTED|Overall Study||54
8461562|NCT00706446|20850692|P4|STARTED|Overall Study||26
8461563|NCT00706446|20850693|P3|STARTED|Overall Study||44
8461564|NCT00706446|20850694|P2|STARTED|Overall Study||57
8461565|NCT00706446|20850695|P1|STARTED|Overall Study||29
8461566|NCT00706433|20850737|P4|NOT COMPLETED|Overall Study||2
8461567|NCT00706433|20850738|P3|NOT COMPLETED|Overall Study||10
8461568|NCT00706433|20850739|P2|NOT COMPLETED|Overall Study||3
8461569|NCT00706433|20850740|P1|NOT COMPLETED|Overall Study||5
8461570|NCT00706433|20850737|P4|COMPLETED|Overall Study||64
8461571|NCT00706433|20850738|P3|COMPLETED|Overall Study||57
8461572|NCT00706433|20850739|P2|COMPLETED|Overall Study||62
8461573|NCT00706433|20850740|P1|COMPLETED|Overall Study||63
8461574|NCT00706433|20850737|P4|STARTED|Overall Study||66
8461576|NCT00706433|20850739|P2|STARTED|Overall Study||65
8461577|NCT00706433|20850740|P1|STARTED|Overall Study||68
8461578|NCT00706407|20851056|P1|NOT COMPLETED|Overall Study||9
8461579|NCT00706407|20851056|P1|COMPLETED|Overall Study||33
8461580|NCT00706407|20851056|P1|STARTED|Overall Study||42
8461581|NCT00706381|20851067|P4|NOT COMPLETED|Overall Study||0
8461582|NCT00706381|20851068|P3|NOT COMPLETED|Overall Study||1
8461583|NCT00706381|20851069|P2|NOT COMPLETED|Overall Study||1
8461584|NCT00706381|20851070|P1|NOT COMPLETED|Overall Study||0
8461585|NCT00706381|20851067|P4|COMPLETED|Overall Study||9
8461586|NCT00706381|20851068|P3|COMPLETED|Overall Study||5
8461587|NCT00706381|20851069|P2|COMPLETED|Overall Study||5
8461588|NCT00706381|20851070|P1|COMPLETED|Overall Study||10
8461589|NCT00706381|20851067|P4|Intervention 5 (1 Day)|Overall Study||9
8461590|NCT00706381|20851068|P3|Intervention 5 (1 Day)|Overall Study||5
8461591|NCT00706381|20851069|P2|Intervention 5 (1 Day)|Overall Study||5
8461592|NCT00706381|20851070|P1|Intervention 5 (1 Day)|Overall Study||10
8461593|NCT00706381|20851067|P4|Intervention 4 (1 Day)|Overall Study||9
8461594|NCT00706381|20851068|P3|Intervention 4 (1 Day)|Overall Study||6
8461595|NCT00706381|20851069|P2|Intervention 4 (1 Day)|Overall Study||5
8461596|NCT00706381|20851070|P1|Intervention 4 (1 Day)|Overall Study||10
8461597|NCT00706381|20851067|P4|Intervention 3 (1 Day)|Overall Study||9
8461598|NCT00706381|20851068|P3|Intervention 3 (1 Day)|Overall Study||6
8461599|NCT00706381|20851069|P2|Intervention 3 (1 Day)|Overall Study||6
8461600|NCT00706381|20851070|P1|Intervention 3 (1 Day)|Overall Study||10
8461601|NCT00706381|20851067|P4|Intervention 2 (1 Day)|Overall Study||9
8461602|NCT00706381|20851068|P3|Intervention 2 (1 Day)|Overall Study||6
8461603|NCT00706381|20851069|P2|Intervention 2 (1 Day)|Overall Study||6
8461604|NCT00706381|20851070|P1|Intervention 2 (1 Day)|Overall Study||10
8461605|NCT00706381|20851067|P4|Intervention 1 (1 Day)|Overall Study||9
8461606|NCT00706381|20851068|P3|Intervention 1 (1 Day)|Overall Study||6
8461607|NCT00706381|20851069|P2|Intervention 1 (1 Day)|Overall Study||6
8461608|NCT00706381|20851070|P1|Intervention 1 (1 Day)|Overall Study||10
8461609|NCT00706381|20851067|P4|STARTED|Overall Study||9
8461610|NCT00706381|20851068|P3|STARTED|Overall Study||6
8461611|NCT00706381|20851069|P2|STARTED|Overall Study||6
8461612|NCT00706381|20851070|P1|STARTED|Overall Study||10
8461613|NCT00706355|20851091|P4|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
8461614|NCT00706355|20851092|P3|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
8461615|NCT00706355|20851093|P2|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
8461616|NCT00706355|20851094|P1|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
8461617|NCT00706355|20851091|P4|COMPLETED|Period 4: PF-04217903 150 mg||0
8461618|NCT00706355|20851092|P3|COMPLETED|Period 4: PF-04217903 150 mg||0
8461619|NCT00706355|20851093|P2|COMPLETED|Period 4: PF-04217903 150 mg||0
8461620|NCT00706355|20851094|P1|COMPLETED|Period 4: PF-04217903 150 mg||0
8461621|NCT00706355|20851091|P4|STARTED|Period 4: PF-04217903 150 mg||4
8461622|NCT00706355|20851092|P3|STARTED|Period 4: PF-04217903 150 mg||0
8461623|NCT00706355|20851093|P2|STARTED|Period 4: PF-04217903 150 mg||0
8461624|NCT00706355|20851094|P1|STARTED|Period 4: PF-04217903 150 mg||0
8461625|NCT00706355|20851091|P4|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
8461626|NCT00706355|20851092|P3|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
8461627|NCT00706355|20851093|P2|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
8461628|NCT00706355|20851094|P1|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
8461629|NCT00706355|20851091|P4|COMPLETED|Period 3: PF-04217903 200 mg||0
8461630|NCT00706355|20851092|P3|COMPLETED|Period 3: PF-04217903 200 mg||0
8461631|NCT00706355|20851093|P2|COMPLETED|Period 3: PF-04217903 200 mg||0
8461632|NCT00706355|20851094|P1|COMPLETED|Period 3: PF-04217903 200 mg||0
8461633|NCT00706355|20851091|P4|STARTED|Period 3: PF-04217903 200 mg||0
8461634|NCT00706355|20851092|P3|STARTED|Period 3: PF-04217903 200 mg||2
8461635|NCT00706355|20851093|P2|STARTED|Period 3: PF-04217903 200 mg||0
8461636|NCT00706355|20851094|P1|STARTED|Period 3: PF-04217903 200 mg||0
8461637|NCT00706355|20851091|P4|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
8461638|NCT00706355|20851092|P3|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
8461639|NCT00706355|20851093|P2|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
8461640|NCT00706355|20851094|P1|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
8461641|NCT00706355|20851091|P4|COMPLETED|Period 2: PF-04217903 100 mg||0
8461642|NCT00706355|20851092|P3|COMPLETED|Period 2: PF-04217903 100 mg||0
8461643|NCT00706355|20851093|P2|COMPLETED|Period 2: PF-04217903 100 mg||0
8461644|NCT00706355|20851094|P1|COMPLETED|Period 2: PF-04217903 100 mg||0
8461645|NCT00706355|20851091|P4|STARTED|Period 2: PF-04217903 100 mg||0
8461646|NCT00706355|20851092|P3|STARTED|Period 2: PF-04217903 100 mg||0
8461647|NCT00706355|20851093|P2|STARTED|Period 2: PF-04217903 100 mg||7
8461648|NCT00706355|20851094|P1|STARTED|Period 2: PF-04217903 100 mg||0
8461649|NCT00706355|20851091|P4|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
8461650|NCT00706355|20851092|P3|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
8461651|NCT00706355|20851093|P2|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
8461652|NCT00706355|20851094|P1|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
8461653|NCT00706355|20851091|P4|COMPLETED|Period 1: PF-04217903 50 mg||0
8461654|NCT00706355|20851092|P3|COMPLETED|Period 1: PF-04217903 50 mg||0
8461655|NCT00706355|20851093|P2|COMPLETED|Period 1: PF-04217903 50 mg||0
8461656|NCT00706355|20851094|P1|COMPLETED|Period 1: PF-04217903 50 mg||0
8461657|NCT00706355|20851091|P4|STARTED|Period 1: PF-04217903 50 mg||0
8461658|NCT00706355|20851092|P3|STARTED|Period 1: PF-04217903 50 mg||0
8461659|NCT00706355|20851093|P2|STARTED|Period 1: PF-04217903 50 mg||0
8461660|NCT00706355|20851094|P1|STARTED|Period 1: PF-04217903 50 mg||3
8461661|NCT00706342|20851146|P1|NOT COMPLETED|Overall Study||18
8461662|NCT00706342|20851146|P1|COMPLETED|Overall Study||0
8461663|NCT00706342|20851146|P1|STARTED|Overall Study||18
8461664|NCT00706329|20851155|P1|NOT COMPLETED|Overall Study||0
8461665|NCT00706329|20851155|P1|COMPLETED|Overall Study||25
8461666|NCT00706329|20851155|P1|STARTED|Overall Study||25
8461667|NCT00706238|20851159|P1|NOT COMPLETED|Overall Study||5
8461668|NCT00706238|20851159|P1|COMPLETED|Overall Study||0
8461669|NCT00706238|20851159|P1|STARTED|Overall Study||5
8461670|NCT00706134|20851176|P4|NOT COMPLETED|Overall Study||11
8461671|NCT00706134|20851177|P3|NOT COMPLETED|Overall Study||6
8461672|NCT00706134|20851178|P2|NOT COMPLETED|Overall Study||19
8461673|NCT00706134|20851179|P1|NOT COMPLETED|Overall Study||20
8461674|NCT00706134|20851176|P4|COMPLETED|Overall Study||175
8461675|NCT00706134|20851177|P3|COMPLETED|Overall Study||183
8461676|NCT00706134|20851178|P2|COMPLETED|Overall Study||173
8461677|NCT00706134|20851179|P1|COMPLETED|Overall Study||169
8461678|NCT00706134|20851176|P4|Entered Double-blind Period|Overall Study||186
8461679|NCT00706134|20851177|P3|Entered Double-blind Period|Overall Study||189
8461680|NCT00706134|20851178|P2|Entered Double-blind Period|Overall Study||192
8461681|NCT00706134|20851179|P1|Entered Double-blind Period|Overall Study||187
8461682|NCT00706134|20851176|P4|STARTED|Overall Study||186
8461683|NCT00706134|20851177|P3|STARTED|Overall Study||189
8461684|NCT00706134|20851178|P2|STARTED|Overall Study||192
8461685|NCT00706134|20851179|P1|STARTED|Overall Study||189
8461686|NCT00706121|20851213|P4|NOT COMPLETED|Overall Study||352
8461687|NCT00706121|20851214|P3|NOT COMPLETED|Overall Study||404
8461688|NCT00706121|20851215|P2|NOT COMPLETED|Overall Study||396
8461689|NCT00706121|20851216|P1|NOT COMPLETED|Overall Study||396
8461690|NCT00706121|20851213|P4|COMPLETED|Overall Study||1577
8461691|NCT00706121|20851214|P3|COMPLETED|Overall Study||1626
8461692|NCT00706121|20851215|P2|COMPLETED|Overall Study||1700
8461693|NCT00706121|20851216|P1|COMPLETED|Overall Study||1643
8461694|NCT00706121|20851213|P4|STARTED|Overall Study||1929
8461695|NCT00706121|20851214|P3|STARTED|Overall Study||2030
8461696|NCT00706121|20851215|P2|STARTED|Overall Study||2096
8461697|NCT00706121|20851216|P1|STARTED|Overall Study||2039
8461698|NCT00706095|20851245|P3|NOT COMPLETED|Overall Study||5
8461699|NCT00706095|20851246|P2|NOT COMPLETED|Overall Study||7
8461700|NCT00706095|20851247|P1|NOT COMPLETED|Overall Study||6
8461701|NCT00706095|20851245|P3|COMPLETED|Overall Study||0
8461702|NCT00706095|20851246|P2|COMPLETED|Overall Study||0
8461703|NCT00706095|20851247|P1|COMPLETED|Overall Study||0
8461704|NCT00706095|20851245|P3|STARTED|Overall Study||5
8461705|NCT00706095|20851246|P2|STARTED|Overall Study||7
8461706|NCT00706095|20851247|P1|STARTED|Overall Study||6
8461707|NCT00706030|20851265|P4|NOT COMPLETED|Overall Study||16
8461708|NCT00706030|20851266|P3|NOT COMPLETED|Overall Study||60
8461709|NCT00706030|20851267|P2|NOT COMPLETED|Overall Study||6
8461710|NCT00706030|20851268|P1|NOT COMPLETED|Overall Study||6
8461711|NCT00706030|20851265|P4|COMPLETED|Overall Study||0
8461712|NCT00706030|20851266|P3|COMPLETED|Overall Study||4
8461713|NCT00706030|20851267|P2|COMPLETED|Overall Study||0
8461714|NCT00706030|20851268|P1|COMPLETED|Overall Study||0
8461715|NCT00706030|20851265|P4|Treated|Overall Study||15
8461716|NCT00706030|20851266|P3|Treated|Overall Study||64
8461717|NCT00706030|20851267|P2|Treated|Overall Study||6
8461718|NCT00706030|20851268|P1|Treated|Overall Study||6
8461719|NCT00706030|20851265|P4|STARTED|Overall Study||16
8461720|NCT00706030|20851266|P3|STARTED|Overall Study||64
8461721|NCT00706030|20851267|P2|STARTED|Overall Study||6
8461722|NCT00706030|20851268|P1|STARTED|Overall Study||6
8461723|NCT00706004|20851283|P1|NOT COMPLETED|Overall Study||2
8461724|NCT00706004|20851283|P1|COMPLETED|Overall Study||7
8461725|NCT00706004|20851283|P1|STARTED|Overall Study||9
8461726|NCT00705939|20851311|P3|NOT COMPLETED|Overall Study||4
8461727|NCT00705939|20851312|P2|NOT COMPLETED|Overall Study||2
8461728|NCT00705939|20851313|P1|NOT COMPLETED|Overall Study||0
8461729|NCT00705939|20851311|P3|COMPLETED|Overall Study||14
8461730|NCT00705939|20851312|P2|COMPLETED|Overall Study||12
8461731|NCT00705939|20851313|P1|COMPLETED|Overall Study||12
8461732|NCT00705939|20851311|P3|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
8461733|NCT00705939|20851312|P2|STARTED|Overall Study||14
8461734|NCT00705939|20851313|P1|STARTED|Overall Study||12
8461735|NCT00705874|20851343|P7|NOT COMPLETED|Overall Study||0
8461736|NCT00705874|20851344|P6|NOT COMPLETED|Overall Study||4
8461737|NCT00705874|20851345|P5|NOT COMPLETED|Overall Study||12
8461738|NCT00705874|20851346|P4|NOT COMPLETED|Overall Study||1
8461739|NCT00705874|20851347|P3|NOT COMPLETED|Overall Study||2
8461740|NCT00705874|20851348|P2|NOT COMPLETED|Overall Study||1
8461741|NCT00705874|20851349|P1|NOT COMPLETED|Overall Study||2
8461742|NCT00705874|20851343|P7|COMPLETED|Overall Study||3
8461743|NCT00705874|20851344|P6|COMPLETED|Overall Study||28
8461744|NCT00705874|20851345|P5|COMPLETED|Overall Study||36
8461745|NCT00705874|20851346|P4|COMPLETED|Overall Study||33
8461746|NCT00705874|20851347|P3|COMPLETED|Overall Study||32
8461747|NCT00705874|20851348|P2|COMPLETED|Overall Study||8
8461748|NCT00705874|20851349|P1|COMPLETED|Overall Study||10
8461749|NCT00705874|20851343|P7|STARTED|Overall Study||3
8461750|NCT00705874|20851344|P6|STARTED|Overall Study||32
8461751|NCT00705874|20851345|P5|STARTED|Overall Study||48
8461752|NCT00705874|20851346|P4|STARTED|Overall Study||34
8461753|NCT00705874|20851347|P3|STARTED|Overall Study||34
8461754|NCT00705874|20851348|P2|STARTED|Overall Study||9
8461755|NCT00705874|20851349|P1|STARTED|Overall Study||12
8461756|NCT00705783|20851367|P3|NOT COMPLETED|Depot Maintenance Phase||131
8461757|NCT00705783|20851368|P2|NOT COMPLETED|Depot Maintenance Phase||246
8461758|NCT00705783|20851369|P1|NOT COMPLETED|Depot Maintenance Phase||0
8461759|NCT00705783|20851367|P3|COMPLETED|Depot Maintenance Phase||3
8461760|NCT00705783|20851368|P2|COMPLETED|Depot Maintenance Phase||23
8461761|NCT00705783|20851369|P1|COMPLETED|Depot Maintenance Phase||0
8461762|NCT00705783|20851367|P3|STARTED|Depot Maintenance Phase||134
8461763|NCT00705783|20851368|P2|STARTED|Depot Maintenance Phase||269
8461764|NCT00705783|20851369|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
8461765|NCT00705783|20851367|P3|NOT COMPLETED|Depot Stabilization Phase||0
8461766|NCT00705783|20851368|P2|NOT COMPLETED|Depot Stabilization Phase||0
8461767|NCT00705783|20851369|P1|NOT COMPLETED|Depot Stabilization Phase||173
8461768|NCT00705783|20851367|P3|COMPLETED|Depot Stabilization Phase||0
8461769|NCT00705783|20851368|P2|COMPLETED|Depot Stabilization Phase||0
8461770|NCT00705783|20851369|P1|COMPLETED|Depot Stabilization Phase||403
8461771|NCT00705783|20851367|P3|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8461772|NCT00705783|20851368|P2|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8461773|NCT00705783|20851369|P1|STARTED|Depot Stabilization Phase||576
8461774|NCT00705783|20851367|P3|NOT COMPLETED|Oral Stabilization Phase||0
8461775|NCT00705783|20851368|P2|NOT COMPLETED|Oral Stabilization Phase||0
8461776|NCT00705783|20851369|P1|NOT COMPLETED|Oral Stabilization Phase||134
8461777|NCT00705783|20851367|P3|COMPLETED|Oral Stabilization Phase||0
8461778|NCT00705783|20851368|P2|COMPLETED|Oral Stabilization Phase||0
8461779|NCT00705783|20851369|P1|COMPLETED|Oral Stabilization Phase||576
8461780|NCT00705783|20851367|P3|Received Study Medication|Oral Stabilization Phase||0
8461781|NCT00705783|20851368|P2|Received Study Medication|Oral Stabilization Phase||0
8461782|NCT00705783|20851369|P1|Received Study Medication|Oral Stabilization Phase||709
8461783|NCT00705783|20851367|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8461784|NCT00705783|20851368|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
8461785|NCT00705783|20851369|P1|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
8461786|NCT00705783|20851367|P3|NOT COMPLETED|Conversion Phase||0
8461787|NCT00705783|20851368|P2|NOT COMPLETED|Conversion Phase||0
8461788|NCT00705783|20851369|P1|NOT COMPLETED|Conversion Phase||133
8461789|NCT00705783|20851367|P3|COMPLETED|Conversion Phase||0
8461790|NCT00705783|20851368|P2|COMPLETED|Conversion Phase||0
8461791|NCT00705783|20851369|P1|COMPLETED|Conversion Phase||500
8461792|NCT00705783|20851367|P3|Received Study Medication|Conversion Phase||0
8461793|NCT00705783|20851368|P2|Received Study Medication|Conversion Phase||0
8461794|NCT00705783|20851369|P1|Received Study Medication|Conversion Phase||632
8461795|NCT00705783|20851367|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8461796|NCT00705783|20851368|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
8461797|NCT00705783|20851369|P1|STARTED|Conversion Phase||633
8461798|NCT00705757|20851399|P3|NOT COMPLETED|Overall Study||11
8461799|NCT00705757|20851400|P2|NOT COMPLETED|Overall Study||8
8461800|NCT00705757|20851401|P1|NOT COMPLETED|Overall Study||13
8461801|NCT00705757|20851399|P3|COMPLETED|Overall Study||17
8461802|NCT00705757|20851400|P2|COMPLETED|Overall Study||21
8461803|NCT00705757|20851401|P1|COMPLETED|Overall Study||19
8461804|NCT00705757|20851399|P3|STARTED|Overall Study||28
8461805|NCT00705757|20851400|P2|STARTED|Overall Study||29
8461806|NCT00705757|20851401|P1|STARTED|Overall Study||32
8461807|NCT00705718|20851411|P2|NOT COMPLETED|Overall Study||22
8461808|NCT00705718|20851412|P1|NOT COMPLETED|Overall Study||7
8461809|NCT00705718|20851411|P2|COMPLETED|Overall Study||128
8461810|NCT00705718|20851412|P1|COMPLETED|Overall Study||37
8461811|NCT00705718|20851411|P2|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
8461812|NCT00705718|20851412|P1|12 Month Follow up|Overall Study|2 Deaths|37
8461813|NCT00705718|20851411|P2|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
8461814|NCT00705718|20851412|P1|6 Month Follow up|Overall Study|3 Deaths|40
8461815|NCT00705718|20851411|P2|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
8461816|NCT00705718|20851412|P1|1 Month Follow up|Overall Study|1 Death|43
8461817|NCT00705718|20851411|P2|STARTED|Overall Study||150
8461818|NCT00705718|20851412|P1|STARTED|Overall Study||44
8461819|NCT00705679|20851433|P5|NOT COMPLETED|Overall Study||69
8461820|NCT00705679|20851434|P4|NOT COMPLETED|Overall Study||80
8461821|NCT00705679|20851435|P3|NOT COMPLETED|Overall Study||115
8461822|NCT00705679|20851436|P2|NOT COMPLETED|Overall Study||139
8461823|NCT00705679|20851437|P1|NOT COMPLETED|Overall Study||65
8461824|NCT00705679|20851433|P5|COMPLETED|Overall Study||934
8461825|NCT00705679|20851434|P4|COMPLETED|Overall Study||927
8461826|NCT00705679|20851435|P3|COMPLETED|Overall Study||894
8461827|NCT00705679|20851436|P2|COMPLETED|Overall Study||864
8461828|NCT00705679|20851437|P1|COMPLETED|Overall Study||942
8461829|NCT00705679|20851433|P5|STARTED|Overall Study||1003
8461830|NCT00705679|20851434|P4|STARTED|Overall Study||1007
8461831|NCT00705679|20851435|P3|STARTED|Overall Study||1009
8461832|NCT00705679|20851436|P2|STARTED|Overall Study||1003
8461833|NCT00705679|20851437|P1|STARTED|Overall Study||1007
8461834|NCT00705666|20851472|P1|NOT COMPLETED|Overall Study||339
8461835|NCT00705666|20851472|P1|COMPLETED|Overall Study||450
8461836|NCT00705666|20851472|P1|STARTED|Overall Study||789
8461837|NCT00705653|20851476|P1|NOT COMPLETED|Overall Study||0
8461838|NCT00705653|20851476|P1|COMPLETED|Overall Study||46
8461839|NCT00705653|20851476|P1|STARTED|Overall Study||46
8461840|NCT00705614|20851483|P2|NOT COMPLETED|Switch to Remicade||49
8461841|NCT00705614|20851484|P1|NOT COMPLETED|Switch to Remicade||0
8461842|NCT00705614|20851483|P2|COMPLETED|Switch to Remicade||249
8461843|NCT00705614|20851484|P1|COMPLETED|Switch to Remicade||0
8461844|NCT00705614|20851483|P2|STARTED|Switch to Remicade||298
8461845|NCT00705614|20851484|P1|STARTED|Switch to Remicade||0
8461846|NCT00705614|20851483|P2|NOT COMPLETED|Initial Intervention||321
8461847|NCT00705614|20851484|P1|NOT COMPLETED|Initial Intervention||518
8461848|NCT00705614|20851483|P2|COMPLETED|Initial Intervention||800
8461849|NCT00705614|20851484|P1|COMPLETED|Initial Intervention||1023
8461850|NCT00705614|20851483|P2|STARTED|Initial Intervention||1121
8461851|NCT00705614|20851484|P1|STARTED|Initial Intervention||1541
8461852|NCT00705575|20851533|P2|NOT COMPLETED|Overall Study||46
8461853|NCT00705575|20851534|P1|NOT COMPLETED|Overall Study||23
8461854|NCT00705575|20851533|P2|COMPLETED|Overall Study||293
8461855|NCT00705575|20851534|P1|COMPLETED|Overall Study||326
8461856|NCT00705575|20851533|P2|STARTED|Overall Study||339
8461857|NCT00705575|20851534|P1|STARTED|Overall Study||349
8461858|NCT00705536|20851548|P4|NOT COMPLETED|Completed Study||0
8461859|NCT00705536|20851549|P3|NOT COMPLETED|Completed Study||0
8461860|NCT00705536|20851550|P2|NOT COMPLETED|Completed Study||0
8461861|NCT00705536|20851551|P1|NOT COMPLETED|Completed Study||0
8461862|NCT00705536|20851548|P4|COMPLETED|Completed Study||6
8461863|NCT00705536|20851549|P3|COMPLETED|Completed Study||7
8461864|NCT00705536|20851550|P2|COMPLETED|Completed Study||6
8461865|NCT00705536|20851551|P1|COMPLETED|Completed Study||6
8461866|NCT00705536|20851548|P4|STARTED|Completed Study||6
8461867|NCT00705536|20851549|P3|STARTED|Completed Study||7
8461868|NCT00705536|20851550|P2|STARTED|Completed Study||6
8461869|NCT00705536|20851551|P1|STARTED|Completed Study||6
8461870|NCT00705536|20851548|P4|NOT COMPLETED|Start Period 2||0
8461871|NCT00705536|20851549|P3|NOT COMPLETED|Start Period 2||0
8461872|NCT00705536|20851550|P2|NOT COMPLETED|Start Period 2||0
8461873|NCT00705536|20851551|P1|NOT COMPLETED|Start Period 2||0
8461874|NCT00705536|20851548|P4|COMPLETED|Start Period 2||6
8461875|NCT00705536|20851549|P3|COMPLETED|Start Period 2||7
8461876|NCT00705536|20851550|P2|COMPLETED|Start Period 2||6
8461877|NCT00705536|20851551|P1|COMPLETED|Start Period 2||6
8461878|NCT00705536|20851548|P4|STARTED|Start Period 2||6
8461879|NCT00705536|20851549|P3|STARTED|Start Period 2||7
8461880|NCT00705536|20851550|P2|STARTED|Start Period 2||6
8461881|NCT00705536|20851551|P1|STARTED|Start Period 2||6
8461882|NCT00705536|20851548|P4|NOT COMPLETED|Washout Period of at Least 6 Days||0
8461883|NCT00705536|20851549|P3|NOT COMPLETED|Washout Period of at Least 6 Days||0
8461884|NCT00705536|20851550|P2|NOT COMPLETED|Washout Period of at Least 6 Days||0
8461885|NCT00705536|20851551|P1|NOT COMPLETED|Washout Period of at Least 6 Days||0
8461886|NCT00705536|20851548|P4|COMPLETED|Washout Period of at Least 6 Days||6
8461887|NCT00705536|20851549|P3|COMPLETED|Washout Period of at Least 6 Days||7
8461888|NCT00705536|20851550|P2|COMPLETED|Washout Period of at Least 6 Days||6
8461889|NCT00705536|20851551|P1|COMPLETED|Washout Period of at Least 6 Days||6
8461890|NCT00705536|20851548|P4|STARTED|Washout Period of at Least 6 Days||6
8461891|NCT00705536|20851549|P3|STARTED|Washout Period of at Least 6 Days||7
8461892|NCT00705536|20851550|P2|STARTED|Washout Period of at Least 6 Days||6
8461893|NCT00705536|20851551|P1|STARTED|Washout Period of at Least 6 Days||6
8461894|NCT00705536|20851548|P4|NOT COMPLETED|Start Period 1||1
8461895|NCT00705536|20851549|P3|NOT COMPLETED|Start Period 1||0
8461896|NCT00705536|20851550|P2|NOT COMPLETED|Start Period 1||0
8461897|NCT00705536|20851551|P1|NOT COMPLETED|Start Period 1||0
8461898|NCT00705536|20851548|P4|COMPLETED|Start Period 1||6
8461899|NCT00705536|20851549|P3|COMPLETED|Start Period 1||7
8461900|NCT00705536|20851550|P2|COMPLETED|Start Period 1||6
8461901|NCT00705536|20851551|P1|COMPLETED|Start Period 1||6
8461902|NCT00705536|20851548|P4|Received at Least 1 Dose of Study Drug|Start Period 1||7
8461903|NCT00705536|20851549|P3|Received at Least 1 Dose of Study Drug|Start Period 1||7
8461904|NCT00705536|20851550|P2|Received at Least 1 Dose of Study Drug|Start Period 1||6
8461905|NCT00705536|20851551|P1|Received at Least 1 Dose of Study Drug|Start Period 1||6
8461906|NCT00705536|20851548|P4|STARTED|Start Period 1||7
8461907|NCT00705536|20851549|P3|STARTED|Start Period 1||7
8461908|NCT00705536|20851550|P2|STARTED|Start Period 1||6
8461909|NCT00705536|20851551|P1|STARTED|Start Period 1||6
8461910|NCT00705523|20851612|P2|NOT COMPLETED|Overall Study||3
8461911|NCT00705523|20851613|P1|NOT COMPLETED|Overall Study||2
8461912|NCT00705523|20851612|P2|COMPLETED|Overall Study||18
8461913|NCT00705523|20851613|P1|COMPLETED|Overall Study||17
8461914|NCT00705523|20851612|P2|STARTED|Overall Study||21
8461915|NCT00705523|20851613|P1|STARTED|Overall Study||19
8461916|NCT00705484|20851623|P2|NOT COMPLETED|Overall Study||408
8461917|NCT00705484|20851624|P1|NOT COMPLETED|Overall Study||382
8461918|NCT00705484|20851623|P2|COMPLETED|Overall Study||772
8461919|NCT00705484|20851624|P1|COMPLETED|Overall Study||677
8461920|NCT00705484|20851623|P2|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
8461921|NCT00705484|20851624|P1|Follow-up Period|Overall Study||1059
8461922|NCT00705484|20851623|P2|STARTED|Overall Study|Number Enrolled|1180
8461923|NCT00705484|20851624|P1|STARTED|Overall Study|Number Enrolled|1059
8461924|NCT00705432|20851638|P6|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
8461925|NCT00705432|20851639|P5|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
8461926|NCT00705432|20851640|P4|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
8461927|NCT00705432|20851641|P3|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
8461928|NCT00705432|20851642|P2|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
8461929|NCT00705432|20851643|P1|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
8461930|NCT00705432|20851638|P6|COMPLETED|Follow-up Period (Upto Week 72)||46
8461931|NCT00705432|20851639|P5|COMPLETED|Follow-up Period (Upto Week 72)||38
8461932|NCT00705432|20851640|P4|COMPLETED|Follow-up Period (Upto Week 72)||28
8461933|NCT00705432|20851641|P3|COMPLETED|Follow-up Period (Upto Week 72)||266
8461934|NCT00705432|20851642|P2|COMPLETED|Follow-up Period (Upto Week 72)||252
8461935|NCT00705432|20851643|P1|COMPLETED|Follow-up Period (Upto Week 72)||207
8461936|NCT00705432|20851638|P6|STARTED|Follow-up Period (Upto Week 72)||53
8461937|NCT00705432|20851639|P5|STARTED|Follow-up Period (Upto Week 72)||44
8461938|NCT00705432|20851640|P4|STARTED|Follow-up Period (Upto Week 72)||42
8461939|NCT00705432|20851641|P3|STARTED|Follow-up Period (Upto Week 72)||291
8461940|NCT00705432|20851642|P2|STARTED|Follow-up Period (Upto Week 72)||295
8461941|NCT00705432|20851643|P1|STARTED|Follow-up Period (Upto Week 72)||278
8461942|NCT00705432|20851638|P6|NOT COMPLETED|Treatment Period||30
8461943|NCT00705432|20851639|P5|NOT COMPLETED|Treatment Period||28
8461944|NCT00705432|20851640|P4|NOT COMPLETED|Treatment Period||41
8461945|NCT00705432|20851641|P3|NOT COMPLETED|Treatment Period||121
8461946|NCT00705432|20851642|P2|NOT COMPLETED|Treatment Period||111
8461947|NCT00705432|20851643|P1|NOT COMPLETED|Treatment Period||163
8461948|NCT00705432|20851638|P6|COMPLETED|Treatment Period||25
8461949|NCT00705432|20851639|P5|COMPLETED|Treatment Period||24
8461950|NCT00705432|20851640|P4|COMPLETED|Treatment Period||11
8461951|NCT00705432|20851641|P3|COMPLETED|Treatment Period||190
8461952|NCT00705432|20851642|P2|COMPLETED|Treatment Period||205
8461953|NCT00705432|20851643|P1|COMPLETED|Treatment Period||148
8461954|NCT00705432|20851638|P6|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
8461955|NCT00705432|20851639|P5|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
8461956|NCT00705432|20851640|P4|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
8461957|NCT00705432|20851641|P3|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
8461958|NCT00705432|20851642|P2|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
8461959|NCT00705432|20851643|P1|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
8461960|NCT00705432|20851638|P6|STARTED|Treatment Period||55
8461961|NCT00705432|20851639|P5|STARTED|Treatment Period||52
8461962|NCT00705432|20851640|P4|STARTED|Treatment Period||52
8461963|NCT00705432|20851641|P3|STARTED|Treatment Period||311
8461964|NCT00705432|20851642|P2|STARTED|Treatment Period||316
8461965|NCT00705432|20851643|P1|STARTED|Treatment Period||311
8461966|NCT00705406|20851680|P2|NOT COMPLETED|Overall Study||5
8461967|NCT00705406|20851681|P1|NOT COMPLETED|Overall Study||4
8461968|NCT00705406|20851680|P2|COMPLETED|Overall Study||197
8461969|NCT00705406|20851681|P1|COMPLETED|Overall Study||199
8461970|NCT00705406|20851680|P2|STARTED|Overall Study||202
8461971|NCT00705406|20851681|P1|STARTED|Overall Study||203
8461972|NCT00705367|20851705|P2|NOT COMPLETED|Long-term Extension Period||0
8461973|NCT00705367|20851706|P1|NOT COMPLETED|Long-term Extension Period||9
8461974|NCT00705367|20851705|P2|COMPLETED|Long-term Extension Period||0
8461975|NCT00705367|20851706|P1|COMPLETED|Long-term Extension Period||0
8461976|NCT00705367|20851705|P2|STARTED|Long-term Extension Period||0
8461977|NCT00705367|20851706|P1|STARTED|Long-term Extension Period||9
8461978|NCT00705367|20851705|P2|NOT COMPLETED|Short-term Period||0
8461979|NCT00705367|20851706|P1|NOT COMPLETED|Short-term Period||0
8461980|NCT00705367|20851705|P2|COMPLETED|Short-term Period||3
8461981|NCT00705367|20851706|P1|COMPLETED|Short-term Period||6
8461982|NCT00705367|20851705|P2|STARTED|Short-term Period||3
8461983|NCT00705367|20851706|P1|STARTED|Short-term Period||6
8461984|NCT00705341|20851733|P4|NOT COMPLETED|Phase 2: Trial||4
8461985|NCT00705341|20851734|P3|NOT COMPLETED|Phase 2: Trial||7
8461986|NCT00705341|20851735|P2|NOT COMPLETED|Phase 2: Trial||0
8461987|NCT00705341|20851736|P1|NOT COMPLETED|Phase 2: Trial||0
8461988|NCT00705341|20851733|P4|COMPLETED|Phase 2: Trial||28
8461989|NCT00705341|20851734|P3|COMPLETED|Phase 2: Trial||23
8461990|NCT00705341|20851735|P2|COMPLETED|Phase 2: Trial||0
8461991|NCT00705341|20851736|P1|COMPLETED|Phase 2: Trial||0
8461992|NCT00705341|20851733|P4|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
8461993|NCT00705341|20851734|P3|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
8461994|NCT00705341|20851735|P2|STARTED|Phase 2: Trial||0
8461995|NCT00705341|20851736|P1|STARTED|Phase 2: Trial||0
8461996|NCT00705341|20851733|P4|NOT COMPLETED|Phase 1:Control Challenge||0
8461997|NCT00705341|20851734|P3|NOT COMPLETED|Phase 1:Control Challenge||0
8461998|NCT00705341|20851735|P2|NOT COMPLETED|Phase 1:Control Challenge||0
8461999|NCT00705341|20851736|P1|NOT COMPLETED|Phase 1:Control Challenge||0
8462000|NCT00705341|20851733|P4|COMPLETED|Phase 1:Control Challenge||0
8462001|NCT00705341|20851734|P3|COMPLETED|Phase 1:Control Challenge||0
8462002|NCT00705341|20851735|P2|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
8462003|NCT00705341|20851736|P1|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
8462004|NCT00705341|20851733|P4|STARTED|Phase 1:Control Challenge||0
8462005|NCT00705341|20851734|P3|STARTED|Phase 1:Control Challenge||0
8462006|NCT00705341|20851735|P2|STARTED|Phase 1:Control Challenge||93
8462007|NCT00705341|20851736|P1|STARTED|Phase 1:Control Challenge||126
8462008|NCT00705289|20851744|P1|NOT COMPLETED|Overall Study||131
8462009|NCT00705289|20851744|P1|COMPLETED|Overall Study||597
8462010|NCT00705289|20851744|P1|STARTED|Overall Study||728
8462011|NCT00705263|20851768|P1|NOT COMPLETED|Overall Study||2
8462012|NCT00705263|20851768|P1|COMPLETED|Overall Study||108
8462013|NCT00705263|20851768|P1|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
8462014|NCT00705250|20851772|P1|NOT COMPLETED|Overall Study||2
8462015|NCT00705250|20851772|P1|COMPLETED|Overall Study||34
8462016|NCT00705250|20851772|P1|STARTED|Overall Study||36
8462017|NCT00705224|20851776|P1|NOT COMPLETED|Overall Study||11
8462018|NCT00705224|20851776|P1|COMPLETED|Overall Study||239
8462019|NCT00705224|20851776|P1|STARTED|Overall Study||250
8462020|NCT00705159|20851792|P4|NOT COMPLETED|Overall Study||4
8462021|NCT00705159|20851793|P3|NOT COMPLETED|Overall Study||5
8462022|NCT00705159|20851794|P2|NOT COMPLETED|Overall Study||2
8462023|NCT00705159|20851795|P1|NOT COMPLETED|Overall Study||0
8462024|NCT00705159|20851792|P4|COMPLETED|Overall Study||30
8462025|NCT00705159|20851793|P3|COMPLETED|Overall Study||29
8462026|NCT00705159|20851794|P2|COMPLETED|Overall Study||33
8462027|NCT00705159|20851795|P1|COMPLETED|Overall Study||34
8462028|NCT00705159|20851792|P4|STARTED|Overall Study||34
8462029|NCT00705159|20851793|P3|STARTED|Overall Study||34
8462030|NCT00705159|20851794|P2|STARTED|Overall Study||35
8462031|NCT00705159|20851795|P1|STARTED|Overall Study||34
8462032|NCT00705146|20851815|P2|NOT COMPLETED|Overall Study||1
8462033|NCT00705146|20851816|P1|NOT COMPLETED|Overall Study||1
8462034|NCT00705146|20851815|P2|COMPLETED|Overall Study||23
8462035|NCT00705146|20851816|P1|COMPLETED|Overall Study||31
8462036|NCT00705146|20851815|P2|STARTED|Overall Study||24
8462037|NCT00705146|20851816|P1|STARTED|Overall Study||32
8462038|NCT00705133|20851824|P1|NOT COMPLETED|Overall Study||0
8462039|NCT00705133|20851824|P1|COMPLETED|Overall Study||15
8462040|NCT00705133|20851824|P1|STARTED|Overall Study||15
8462041|NCT00705107|20851831|P1|NOT COMPLETED|Overall Study||49
8462042|NCT00705107|20851831|P1|COMPLETED|Overall Study||218
8462043|NCT00705107|20851831|P1|STARTED|Overall Study||267
8462044|NCT00705081|20851838|P2|NOT COMPLETED|Overall Study||0
8462045|NCT00705081|20851839|P1|NOT COMPLETED|Overall Study||0
8462046|NCT00705081|20851838|P2|COMPLETED|Overall Study||198
8462047|NCT00705081|20851839|P1|COMPLETED|Overall Study||255
8462048|NCT00705081|20851838|P2|STARTED|Overall Study||198
8462049|NCT00705081|20851839|P1|STARTED|Overall Study||255
8462050|NCT00705016|20851852|P3|NOT COMPLETED|Overall Study||58
8462051|NCT00705016|20851853|P2|NOT COMPLETED|Overall Study||58
8462052|NCT00705016|20851854|P1|NOT COMPLETED|Overall Study||60
8462053|NCT00705016|20851852|P3|COMPLETED|Overall Study||4
8462054|NCT00705016|20851853|P2|COMPLETED|Overall Study||2
8462055|NCT00705016|20851854|P1|COMPLETED|Overall Study||2
8462056|NCT00705016|20851852|P3|STARTED|Overall Study||62
8462057|NCT00705016|20851853|P2|STARTED|Overall Study||60
8462058|NCT00705016|20851854|P1|STARTED|Overall Study||62
8462059|NCT00705003|20851883|P3|NOT COMPLETED|Treated||3
8462060|NCT00705003|20851884|P2|NOT COMPLETED|Treated||6
8462061|NCT00705003|20851885|P1|NOT COMPLETED|Treated||13
8462062|NCT00705003|20851883|P3|COMPLETED|Treated||30
8462063|NCT00705003|20851884|P2|COMPLETED|Treated||28
8462064|NCT00705003|20851885|P1|COMPLETED|Treated||54
8462065|NCT00705003|20851883|P3|STARTED|Treated||33
8462066|NCT00705003|20851884|P2|STARTED|Treated||34
8462067|NCT00705003|20851885|P1|STARTED|Treated||67
8462068|NCT00705003|20851883|P3|NOT COMPLETED|Enrolled||1
8462069|NCT00705003|20851884|P2|NOT COMPLETED|Enrolled||3
8462070|NCT00705003|20851885|P1|NOT COMPLETED|Enrolled||4
8462071|NCT00705003|20851883|P3|COMPLETED|Enrolled||33
8462072|NCT00705003|20851884|P2|COMPLETED|Enrolled||34
8462073|NCT00705003|20851885|P1|COMPLETED|Enrolled||67
8462074|NCT00705003|20851883|P3|STARTED|Enrolled||34
8462075|NCT00705003|20851884|P2|STARTED|Enrolled||37
8462076|NCT00705003|20851885|P1|STARTED|Enrolled||71
8462077|NCT00704964|20851905|P1|NOT COMPLETED|Overall Study||328
8462078|NCT00704964|20851905|P1|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
8462079|NCT00704964|20851905|P1|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
8462080|NCT00704938|20851912|P2|NOT COMPLETED|Overall Study||0
8462081|NCT00704938|20851913|P1|NOT COMPLETED|Overall Study||0
8462082|NCT00704938|20851912|P2|COMPLETED|Overall Study||1
8462083|NCT00704938|20851913|P1|COMPLETED|Overall Study||2
8462084|NCT00704938|20851912|P2|STARTED|Overall Study||1
8462085|NCT00704938|20851913|P1|STARTED|Overall Study||2
8462086|NCT00704912|20851924|P3|NOT COMPLETED|Overall Study||7
8462087|NCT00704912|20851925|P2|NOT COMPLETED|Overall Study||4
8462088|NCT00704912|20851926|P1|NOT COMPLETED|Overall Study||6
8462089|NCT00704912|20851924|P3|COMPLETED|Overall Study||43
8462090|NCT00704912|20851925|P2|COMPLETED|Overall Study||45
8462091|NCT00704912|20851926|P1|COMPLETED|Overall Study||44
8462092|NCT00704912|20851924|P3|STARTED|Overall Study||50
8462093|NCT00704912|20851925|P2|STARTED|Overall Study||49
8462094|NCT00704912|20851926|P1|STARTED|Overall Study||50
8462095|NCT00704847|20851945|P2|NOT COMPLETED|Overall Study||170
8462096|NCT00704847|20851946|P1|NOT COMPLETED|Overall Study||221
8462097|NCT00704847|20851945|P2|COMPLETED|Overall Study||339
8462098|NCT00704847|20851946|P1|COMPLETED|Overall Study||300
8462099|NCT00704847|20851945|P2|STARTED|Overall Study||509
8462100|NCT00704847|20851946|P1|STARTED|Overall Study||521
8462101|NCT00704808|20851966|P1|NOT COMPLETED|Overall Study||131
8462102|NCT00704808|20851966|P1|COMPLETED|Overall Study||49
8462103|NCT00704808|20851966|P1|STARTED|Overall Study||180
8462104|NCT00704769|20851970|P1|NOT COMPLETED|Overall Study||0
8462105|NCT00704769|20851970|P1|COMPLETED|Overall Study||591
8462106|NCT00704769|20851970|P1|STARTED|Overall Study||591
8462113|NCT00704717|20851994|P1|NOT COMPLETED|Overall Study||0
8462114|NCT00704717|20851994|P1|COMPLETED|Overall Study||185
8462115|NCT00704717|20851994|P1|STARTED|Overall Study||185
8462116|NCT00704535|20851998|P1|NOT COMPLETED|Overall Study||146
8462117|NCT00704535|20851998|P1|COMPLETED|Overall Study||3959
8462118|NCT00704535|20851998|P1|STARTED|Overall Study||4105
8462119|NCT00704522|20852011|P2|NOT COMPLETED|Overall Study||45
8462120|NCT00704522|20852012|P1|NOT COMPLETED|Overall Study||183
8462121|NCT00704522|20852011|P2|COMPLETED|Overall Study||75
8462122|NCT00704522|20852012|P1|COMPLETED|Overall Study||298
8462123|NCT00704522|20852011|P2|STARTED|Overall Study||120
8462124|NCT00704522|20852012|P1|STARTED|Overall Study||481
8462125|NCT00704496|20852021|P2|NOT COMPLETED|Overall Study||0
8462126|NCT00704496|20852022|P1|NOT COMPLETED|Overall Study||0
8462127|NCT00704496|20852021|P2|COMPLETED|Overall Study||0
8462128|NCT00704496|20852022|P1|COMPLETED|Overall Study||0
8462129|NCT00704496|20852021|P2|STARTED|Overall Study||0
8462130|NCT00704496|20852022|P1|STARTED|Overall Study||0
8462131|NCT00704418|20852032|P2|NOT COMPLETED|Overall Study||6
8462132|NCT00704418|20852033|P1|NOT COMPLETED|Overall Study||5
8462133|NCT00704418|20852032|P2|COMPLETED|Overall Study||72
8462134|NCT00704418|20852033|P1|COMPLETED|Overall Study||73
8462135|NCT00704418|20852032|P2|STARTED|Overall Study||78
8462136|NCT00704418|20852033|P1|STARTED|Overall Study||78
8462137|NCT00704405|20852046|P5|NOT COMPLETED|Overall Study (C Population)||0
8462138|NCT00704405|20852047|P4|NOT COMPLETED|Overall Study (C Population)||1
8462139|NCT00704405|20852048|P3|NOT COMPLETED|Overall Study (C Population)||1
8462140|NCT00704405|20852049|P2|NOT COMPLETED|Overall Study (C Population)||3
8462141|NCT00704405|20852050|P1|NOT COMPLETED|Overall Study (C Population)||1
8462142|NCT00704405|20852046|P5|COMPLETED|Overall Study (C Population)||14
8462143|NCT00704405|20852047|P4|COMPLETED|Overall Study (C Population)||14
8462144|NCT00704405|20852048|P3|COMPLETED|Overall Study (C Population)||14
8462145|NCT00704405|20852049|P2|COMPLETED|Overall Study (C Population)||11
8462146|NCT00704405|20852050|P1|COMPLETED|Overall Study (C Population)||15
8462147|NCT00704405|20852046|P5|STARTED|Overall Study (C Population)||14
8462148|NCT00704405|20852047|P4|STARTED|Overall Study (C Population)||15
8462149|NCT00704405|20852048|P3|STARTED|Overall Study (C Population)||15
8462150|NCT00704405|20852049|P2|STARTED|Overall Study (C Population)||14
8462151|NCT00704405|20852050|P1|STARTED|Overall Study (C Population)||16
8462152|NCT00704405|20852046|P5|NOT COMPLETED|Overall Study (NC Population)||5
8462153|NCT00704405|20852047|P4|NOT COMPLETED|Overall Study (NC Population)||4
8462154|NCT00704405|20852048|P3|NOT COMPLETED|Overall Study (NC Population)||3
8462155|NCT00704405|20852049|P2|NOT COMPLETED|Overall Study (NC Population)||4
8462156|NCT00704405|20852050|P1|NOT COMPLETED|Overall Study (NC Population)||5
8462157|NCT00704405|20852046|P5|COMPLETED|Overall Study (NC Population)||37
8462158|NCT00704405|20852047|P4|COMPLETED|Overall Study (NC Population)||38
8462159|NCT00704405|20852048|P3|COMPLETED|Overall Study (NC Population)||38
8462160|NCT00704405|20852049|P2|COMPLETED|Overall Study (NC Population)||40
8462161|NCT00704405|20852050|P1|COMPLETED|Overall Study (NC Population)||37
8462162|NCT00704405|20852046|P5|STARTED|Overall Study (NC Population)||42
8462163|NCT00704405|20852047|P4|STARTED|Overall Study (NC Population)||42
8462164|NCT00704405|20852048|P3|STARTED|Overall Study (NC Population)||41
8462165|NCT00704405|20852049|P2|STARTED|Overall Study (NC Population)||44
8462166|NCT00704405|20852050|P1|STARTED|Overall Study (NC Population)||42
8462167|NCT00704379|20852080|P2|NOT COMPLETED|Overall Study||7
8462168|NCT00704379|20852081|P1|NOT COMPLETED|Overall Study||7
8462169|NCT00704379|20852080|P2|COMPLETED|Overall Study||41
8462170|NCT00704379|20852081|P1|COMPLETED|Overall Study||39
8462171|NCT00704379|20852080|P2|STARTED|Overall Study||48
8462172|NCT00704379|20852081|P1|STARTED|Overall Study||46
8462173|NCT00704353|20852099|P2|NOT COMPLETED|Overall Study||114
8462174|NCT00704353|20852100|P1|NOT COMPLETED|Overall Study||98
8462175|NCT00704353|20852099|P2|COMPLETED|Overall Study||255
8462176|NCT00704353|20852100|P1|COMPLETED|Overall Study||268
8462177|NCT00704353|20852099|P2|STARTED|Overall Study||369
8462178|NCT00704353|20852100|P1|STARTED|Overall Study||366
8462179|NCT00704340|20852108|P2|NOT COMPLETED|Overall Study||2
8462180|NCT00704340|20852109|P1|NOT COMPLETED|Overall Study||2
8462181|NCT00704340|20852108|P2|COMPLETED|Overall Study||115
8462182|NCT00704340|20852109|P1|COMPLETED|Overall Study||118
8462183|NCT00704340|20852108|P2|STARTED|Overall Study||117
8462184|NCT00704340|20852109|P1|STARTED|Overall Study||120
8462185|NCT00704262|20852119|P1|NOT COMPLETED|Overall Study||2
8462186|NCT00704262|20852119|P1|COMPLETED|Overall Study||31
8462187|NCT00704262|20852119|P1|STARTED|Overall Study||33
8462188|NCT00704184|20852140|P5|NOT COMPLETED|Open-Label Treatment||3
8462189|NCT00704184|20852141|P4|NOT COMPLETED|Open-Label Treatment||5
8462190|NCT00704184|20852142|P3|NOT COMPLETED|Open-Label Treatment||4
8462191|NCT00704184|20852143|P2|NOT COMPLETED|Open-Label Treatment||2
8462192|NCT00704184|20852144|P1|NOT COMPLETED|Open-Label Treatment||1
8462193|NCT00704184|20852140|P5|COMPLETED|Open-Label Treatment||16
8462194|NCT00704184|20852141|P4|COMPLETED|Open-Label Treatment||13
8462195|NCT00704184|20852142|P3|COMPLETED|Open-Label Treatment||16
8462196|NCT00704184|20852143|P2|COMPLETED|Open-Label Treatment||16
8462197|NCT00704184|20852144|P1|COMPLETED|Open-Label Treatment||18
8462198|NCT00704184|20852140|P5|STARTED|Open-Label Treatment||19
8462199|NCT00704184|20852141|P4|STARTED|Open-Label Treatment||18
8462200|NCT00704184|20852142|P3|STARTED|Open-Label Treatment||20
8462201|NCT00704184|20852143|P2|STARTED|Open-Label Treatment||18
8462202|NCT00704184|20852144|P1|STARTED|Open-Label Treatment||19
8462203|NCT00704184|20852140|P5|NOT COMPLETED|Double-Blind Treatment||0
8462204|NCT00704184|20852141|P4|NOT COMPLETED|Double-Blind Treatment||0
8462205|NCT00704184|20852142|P3|NOT COMPLETED|Double-Blind Treatment||0
8462206|NCT00704184|20852143|P2|NOT COMPLETED|Double-Blind Treatment||0
8462207|NCT00704184|20852144|P1|NOT COMPLETED|Double-Blind Treatment||1
8462208|NCT00704184|20852140|P5|COMPLETED|Double-Blind Treatment||19
8462209|NCT00704184|20852141|P4|COMPLETED|Double-Blind Treatment||18
8462210|NCT00704184|20852142|P3|COMPLETED|Double-Blind Treatment||20
8462211|NCT00704184|20852143|P2|COMPLETED|Double-Blind Treatment||18
8462212|NCT00704184|20852144|P1|COMPLETED|Double-Blind Treatment||19
8462213|NCT00704184|20852140|P5|Treated|Double-Blind Treatment||19
8462214|NCT00704184|20852141|P4|Treated|Double-Blind Treatment||18
8462215|NCT00704184|20852142|P3|Treated|Double-Blind Treatment||20
8462216|NCT00704184|20852143|P2|Treated|Double-Blind Treatment||18
8462217|NCT00704184|20852144|P1|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
8462218|NCT00704184|20852140|P5|STARTED|Double-Blind Treatment||19
8462219|NCT00704184|20852141|P4|STARTED|Double-Blind Treatment||18
8462220|NCT00704184|20852142|P3|STARTED|Double-Blind Treatment||20
8462221|NCT00704184|20852143|P2|STARTED|Double-Blind Treatment||18
8462222|NCT00704184|20852144|P1|STARTED|Double-Blind Treatment||20
8462223|NCT00704171|20852183|P2|NOT COMPLETED|Overall Study||0
8462224|NCT00704171|20852184|P1|NOT COMPLETED|Overall Study||1
8462225|NCT00704171|20852183|P2|COMPLETED|Overall Study|All control subjects completed the study.|59
8462226|NCT00704171|20852184|P1|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
8462227|NCT00704171|20852183|P2|STARTED|Overall Study||59
8462228|NCT00704171|20852184|P1|STARTED|Overall Study||62
8462229|NCT00704132|20852202|P2|NOT COMPLETED|Overall Study||2
8462230|NCT00704132|20852203|P1|NOT COMPLETED|Overall Study||1
8462231|NCT00704132|20852202|P2|COMPLETED|Overall Study||22
8462232|NCT00704132|20852203|P1|COMPLETED|Overall Study||25
8462233|NCT00704132|20852202|P2|STARTED|Overall Study||24
8462234|NCT00704132|20852203|P1|STARTED|Overall Study||26
8462235|NCT00704028|20852211|P2|NOT COMPLETED|Overall Study||21
8462236|NCT00704028|20852212|P1|NOT COMPLETED|Overall Study||12
8462237|NCT00704028|20852211|P2|COMPLETED|Overall Study||57
8462238|NCT00704028|20852212|P1|COMPLETED|Overall Study||70
8462239|NCT00704028|20852211|P2|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
8462240|NCT00704028|20852212|P1|STARTED|Overall Study||82
8462241|NCT00703976|20852220|P2|NOT COMPLETED|Overall Study||0
8462242|NCT00703976|20852221|P1|NOT COMPLETED|Overall Study||0
8462243|NCT00703976|20852220|P2|COMPLETED|Overall Study||41
8462244|NCT00703976|20852221|P1|COMPLETED|Overall Study||37
8462245|NCT00703976|20852220|P2|STARTED|Overall Study||41
8462246|NCT00703976|20852221|P1|STARTED|Overall Study||37
8462247|NCT00703963|20852231|P2|NOT COMPLETED|Overall Study||14
8462248|NCT00703963|20852232|P1|NOT COMPLETED|Overall Study||7
8462249|NCT00703963|20852231|P2|COMPLETED|Overall Study||86
8462250|NCT00703963|20852232|P1|COMPLETED|Overall Study||93
8462251|NCT00703963|20852231|P2|STARTED|Overall Study||100
8462252|NCT00703963|20852232|P1|STARTED|Overall Study||100
8462253|NCT00703937|20852244|P2|NOT COMPLETED|Overall Study||93
8462254|NCT00703937|20852245|P1|NOT COMPLETED|Overall Study||65
8462255|NCT00703937|20852244|P2|COMPLETED|Overall Study||267
8462256|NCT00703937|20852245|P1|COMPLETED|Overall Study||278
8462257|NCT00703937|20852244|P2|STARTED|Overall Study||360
8462258|NCT00703937|20852245|P1|STARTED|Overall Study||343
8462259|NCT00703924|20852253|P2|NOT COMPLETED|Overall Study||1
8462260|NCT00703924|20852254|P1|NOT COMPLETED|Overall Study||1
8462261|NCT00703924|20852253|P2|COMPLETED|Overall Study||41
8462262|NCT00703924|20852254|P1|COMPLETED|Overall Study||49
8462263|NCT00703924|20852253|P2|STARTED|Overall Study||42
8462264|NCT00703924|20852254|P1|STARTED|Overall Study||50
8462265|NCT00703911|20852270|P1|NOT COMPLETED|Overall Study||10
8462266|NCT00703911|20852270|P1|COMPLETED|Overall Study||92
8462267|NCT00703911|20852270|P1|STARTED|Overall Study||102
8462268|NCT00703885|20852298|P1|NOT COMPLETED|Overall Study||0
8462269|NCT00703885|20852298|P1|COMPLETED|Overall Study||16
8462270|NCT00703885|20852298|P1|STARTED|Overall Study||16
8462271|NCT00703846|20852303|P1|NOT COMPLETED|Overall Study||137
8462272|NCT00703846|20852303|P1|COMPLETED|Overall Study||363
8462273|NCT00703846|20852303|P1|STARTED|Overall Study||500
8462280|NCT00703781|20852329|P2|NOT COMPLETED|Overall Study||2
8462281|NCT00703781|20852330|P1|NOT COMPLETED|Overall Study||2
8462282|NCT00703781|20852329|P2|COMPLETED|Overall Study||61
8462283|NCT00703781|20852330|P1|COMPLETED|Overall Study||61
8462284|NCT00703781|20852329|P2|STARTED|Overall Study||63
8462285|NCT00703781|20852330|P1|STARTED|Overall Study||63
8462286|NCT00703729|20852340|P2|NOT COMPLETED|Overall Study||3
8462287|NCT00703729|20852341|P1|NOT COMPLETED|Overall Study||0
8462288|NCT00703729|20852340|P2|COMPLETED|Overall Study||21
8462289|NCT00703729|20852341|P1|COMPLETED|Overall Study||25
8462290|NCT00703729|20852340|P2|STARTED|Overall Study||24
8462291|NCT00703729|20852341|P1|STARTED|Overall Study||25
8462292|NCT00703677|20852375|P1|NOT COMPLETED|Overall Study||3
8462293|NCT00703677|20852375|P1|COMPLETED|Overall Study||14
8462294|NCT00703677|20852375|P1|STARTED|Overall Study||17
8462295|NCT00703664|20852391|P3|NOT COMPLETED|Overall Study||0
8462296|NCT00703664|20852392|P2|NOT COMPLETED|Overall Study||0
8462297|NCT00703664|20852393|P1|NOT COMPLETED|Overall Study||0
8462298|NCT00703664|20852391|P3|COMPLETED|Overall Study||39
8462299|NCT00703664|20852392|P2|COMPLETED|Overall Study||4
8462300|NCT00703664|20852393|P1|COMPLETED|Overall Study||22
8462301|NCT00703664|20852391|P3|STARTED|Overall Study||39
8462302|NCT00703664|20852392|P2|STARTED|Overall Study||4
8462303|NCT00703664|20852393|P1|STARTED|Overall Study||22
8462304|NCT00703534|20852415|P2|NOT COMPLETED|Overall Study||25
8462305|NCT00703534|20852416|P1|NOT COMPLETED|Overall Study||30
8462306|NCT00703534|20852415|P2|COMPLETED|Overall Study||218
8462307|NCT00703534|20852416|P1|COMPLETED|Overall Study||205
8462308|NCT00703534|20852415|P2|STARTED|Overall Study||243
8462309|NCT00703534|20852416|P1|STARTED|Overall Study||235
8462310|NCT00703508|20852422|P1|NOT COMPLETED|Overall Study||0
8462311|NCT00703508|20852422|P1|COMPLETED|Overall Study||26
8462312|NCT00703508|20852422|P1|STARTED|Overall Study||26
8462313|NCT00703391|20852436|P2|NOT COMPLETED|Overall Study||0
8462314|NCT00703391|20852437|P1|NOT COMPLETED|Overall Study||0
8462315|NCT00703391|20852436|P2|COMPLETED|Overall Study||6
8462316|NCT00703391|20852437|P1|COMPLETED|Overall Study||12
8462317|NCT00703391|20852436|P2|STARTED|Overall Study||6
8462318|NCT00703391|20852437|P1|STARTED|Overall Study||12
8462319|NCT00703339|20852481|P1|NOT COMPLETED|Overall Study||0
8462320|NCT00703339|20852481|P1|COMPLETED|Overall Study||1
8462321|NCT00703339|20852481|P1|STARTED|Overall Study||1
8462330|NCT00703261|20852511|P2|NOT COMPLETED|Overall Study||6
8462331|NCT00703261|20852512|P1|NOT COMPLETED|Overall Study||6
8462332|NCT00703261|20852511|P2|COMPLETED|Overall Study||35
8462333|NCT00703261|20852512|P1|COMPLETED|Overall Study||36
8462334|NCT00703261|20852511|P2|STARTED|Overall Study||41
8462335|NCT00703261|20852512|P1|STARTED|Overall Study||42
8462336|NCT00703157|20852521|P2|NOT COMPLETED|Overall Study||2
8462337|NCT00703157|20852522|P1|NOT COMPLETED|Overall Study||4
8462338|NCT00703157|20852521|P2|COMPLETED|Overall Study||24
8462339|NCT00703157|20852522|P1|COMPLETED|Overall Study||22
8462340|NCT00703157|20852521|P2|24 Months FU|Overall Study||24
8462341|NCT00703157|20852522|P1|24 Months FU|Overall Study||22
8462342|NCT00703157|20852521|P2|6 Months FU|Overall Study||25
8462343|NCT00703157|20852522|P1|6 Months FU|Overall Study||25
8462344|NCT00703157|20852521|P2|STARTED|Overall Study||26
8462345|NCT00703157|20852522|P1|STARTED|Overall Study||26
8462346|NCT00703118|20852556|P3|NOT COMPLETED|Overall Study||22
8462347|NCT00703118|20852557|P2|NOT COMPLETED|Overall Study||16
8462348|NCT00703118|20852558|P1|NOT COMPLETED|Overall Study||21
8462349|NCT00703118|20852556|P3|COMPLETED|Overall Study||110
8462350|NCT00703118|20852557|P2|COMPLETED|Overall Study||248
8462351|NCT00703118|20852558|P1|COMPLETED|Overall Study||245
8462352|NCT00703118|20852556|P3|STARTED|Overall Study||132
8462353|NCT00703118|20852557|P2|STARTED|Overall Study||264
8462354|NCT00703118|20852558|P1|STARTED|Overall Study||266
8462355|NCT00703092|20852589|P1|NOT COMPLETED|Overall Study||2
8462356|NCT00703092|20852589|P1|COMPLETED|Overall Study||0
8462357|NCT00703092|20852589|P1|STARTED|Overall Study||2
8462358|NCT00703053|20852603|P9|NOT COMPLETED|Overall Study||1
8462359|NCT00703053|20852604|P8|NOT COMPLETED|Overall Study||6
8462360|NCT00703053|20852605|P7|NOT COMPLETED|Overall Study||7
8462361|NCT00703053|20852606|P6|NOT COMPLETED|Overall Study||6
8462362|NCT00703053|20852607|P5|NOT COMPLETED|Overall Study||1
8462363|NCT00703053|20852608|P4|NOT COMPLETED|Overall Study||3
8462364|NCT00703053|20852609|P3|NOT COMPLETED|Overall Study||3
8462365|NCT00703053|20852610|P2|NOT COMPLETED|Overall Study||2
8462366|NCT00703053|20852611|P1|NOT COMPLETED|Overall Study||1
8462367|NCT00703053|20852603|P9|COMPLETED|Overall Study||102
8462368|NCT00703053|20852604|P8|COMPLETED|Overall Study||91
8462369|NCT00703053|20852605|P7|COMPLETED|Overall Study||45
8462370|NCT00703053|20852606|P6|COMPLETED|Overall Study||43
8462371|NCT00703053|20852607|P5|COMPLETED|Overall Study||50
8462372|NCT00703053|20852608|P4|COMPLETED|Overall Study||46
8462373|NCT00703053|20852609|P3|COMPLETED|Overall Study||48
8462374|NCT00703053|20852610|P2|COMPLETED|Overall Study||24
8462375|NCT00703053|20852611|P1|COMPLETED|Overall Study||26
8462376|NCT00703053|20852603|P9|STARTED|Overall Study||103
8462377|NCT00703053|20852604|P8|STARTED|Overall Study||97
8462378|NCT00703053|20852605|P7|STARTED|Overall Study||52
8462379|NCT00703053|20852606|P6|STARTED|Overall Study||49
8462380|NCT00703053|20852607|P5|STARTED|Overall Study||51
8462381|NCT00703053|20852608|P4|STARTED|Overall Study||49
8462382|NCT00703053|20852609|P3|STARTED|Overall Study||51
8462383|NCT00703053|20852610|P2|STARTED|Overall Study||26
8462384|NCT00703053|20852611|P1|STARTED|Overall Study||27
8462385|NCT00703014|20852797|P4|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
8462386|NCT00703014|20852798|P3|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
8462387|NCT00703014|20852799|P2|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
8462388|NCT00703014|20852800|P1|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
8462389|NCT00703014|20852797|P4|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
8462390|NCT00703014|20852798|P3|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
8462391|NCT00703014|20852799|P2|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
8462392|NCT00703014|20852800|P1|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
8462393|NCT00703014|20852797|P4|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
8462394|NCT00703014|20852798|P3|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
8462395|NCT00703014|20852799|P2|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
8462396|NCT00703014|20852800|P1|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
8462397|NCT00703014|20852797|P4|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
8462398|NCT00703014|20852798|P3|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
8462399|NCT00703014|20852799|P2|STARTED|Fetuses/Infants Follow Up Trial P05712||0
8462400|NCT00703014|20852800|P1|STARTED|Fetuses/Infants Follow Up Trial P05712||0
8462401|NCT00703014|20852797|P4|NOT COMPLETED|Mothers Follow Up Trial P05712||0
8462402|NCT00703014|20852798|P3|NOT COMPLETED|Mothers Follow Up Trial P05712||0
8462403|NCT00703014|20852799|P2|NOT COMPLETED|Mothers Follow Up Trial P05712||32
8462404|NCT00703014|20852800|P1|NOT COMPLETED|Mothers Follow Up Trial P05712||33
8462405|NCT00703014|20852797|P4|COMPLETED|Mothers Follow Up Trial P05712||0
8462406|NCT00703014|20852798|P3|COMPLETED|Mothers Follow Up Trial P05712||0
8462407|NCT00703014|20852799|P2|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
8462408|NCT00703014|20852800|P1|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
8462409|NCT00703014|20852797|P4|STARTED|Mothers Follow Up Trial P05712||0
8462410|NCT00703014|20852798|P3|STARTED|Mothers Follow Up Trial P05712||0
8462411|NCT00703014|20852799|P2|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
8462412|NCT00703014|20852800|P1|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
8462413|NCT00703014|20852797|P4|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
8462414|NCT00703014|20852798|P3|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
8462415|NCT00703014|20852799|P2|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
8462416|NCT00703014|20852800|P1|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
8462417|NCT00703014|20852797|P4|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
8462418|NCT00703014|20852798|P3|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
8462419|NCT00703014|20852799|P2|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
8462420|NCT00703014|20852800|P1|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
8462421|NCT00703014|20852797|P4|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
8462422|NCT00703014|20852798|P3|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
8462423|NCT00703014|20852799|P2|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
8462424|NCT00703014|20852800|P1|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
8462425|NCT00703014|20852797|P4|Treated|Mothers Base Trial P05787 (NCT00696800)||0
8462426|NCT00703014|20852798|P3|Treated|Mothers Base Trial P05787 (NCT00696800)||0
8462427|NCT00703014|20852799|P2|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
8462428|NCT00703014|20852800|P1|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
8462429|NCT00703014|20852797|P4|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
8462430|NCT00703014|20852798|P3|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
8462431|NCT00703014|20852799|P2|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
8462432|NCT00703014|20852800|P1|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
8462433|NCT00702962|20852820|P2|NOT COMPLETED|Overall Study||1
8462434|NCT00702962|20852821|P1|NOT COMPLETED|Overall Study||1
8462435|NCT00702962|20852820|P2|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
8462436|NCT00702962|20852821|P1|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
8462437|NCT00702962|20852820|P2|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
8462438|NCT00702962|20852821|P1|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
8462439|NCT00702949|20852832|P3|NOT COMPLETED|Overall Study||8
8462440|NCT00702949|20852833|P2|NOT COMPLETED|Overall Study||9
8462441|NCT00702949|20852834|P1|NOT COMPLETED|Overall Study||5
8462442|NCT00702949|20852832|P3|COMPLETED|Overall Study||54
8462443|NCT00702949|20852833|P2|COMPLETED|Overall Study||57
8462444|NCT00702949|20852834|P1|COMPLETED|Overall Study||58
8462445|NCT00702949|20852832|P3|Evaluable for Primary Endpoint|Overall Study||51
8462446|NCT00702949|20852833|P2|Evaluable for Primary Endpoint|Overall Study||56
8462447|NCT00702949|20852834|P1|Evaluable for Primary Endpoint|Overall Study||56
8462448|NCT00702949|20852832|P3|STARTED|Overall Study||62
8462449|NCT00702949|20852833|P2|STARTED|Overall Study||66
8462450|NCT00702949|20852834|P1|STARTED|Overall Study||63
8462451|NCT00702923|20852859|P1|NOT COMPLETED|Overall Study||1
8462452|NCT00702923|20852859|P1|COMPLETED|Overall Study||11
8462453|NCT00702923|20852859|P1|STARTED|Overall Study||12
8462454|NCT00702884|20852868|P1|NOT COMPLETED|Overall Study||0
8462455|NCT00702884|20852868|P1|COMPLETED|Overall Study||25
8462456|NCT00702884|20852868|P1|STARTED|Overall Study||25
8462457|NCT00702845|20852882|P2|NOT COMPLETED|Overall Study||8
8462458|NCT00702845|20852883|P1|NOT COMPLETED|Overall Study||22
8462459|NCT00702845|20852882|P2|COMPLETED|Overall Study||121
8462460|NCT00702845|20852883|P1|COMPLETED|Overall Study||246
8462461|NCT00702845|20852882|P2|Randomized|Overall Study||128
8462462|NCT00702845|20852883|P1|Randomized|Overall Study||268
8462463|NCT00702845|20852882|P2|STARTED|Overall Study|Includes one treated participant who was not randomized|129
8462464|NCT00702845|20852883|P1|STARTED|Overall Study||268
8462465|NCT00702780|20852923|P2|NOT COMPLETED|Overall Study||8
8462466|NCT00702780|20852924|P1|NOT COMPLETED|Overall Study||9
8462467|NCT00702780|20852923|P2|COMPLETED|Overall Study||29
8462468|NCT00702780|20852924|P1|COMPLETED|Overall Study||28
8462469|NCT00702780|20852923|P2|STARTED|Overall Study||37
8462470|NCT00702780|20852924|P1|STARTED|Overall Study||37
8462471|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
8462472|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
8462473|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
8462474|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
8462475|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
8462476|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
8462477|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
8462478|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
8462479|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
8462480|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
8462481|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
8462482|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
8462483|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
8462484|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
8462485|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
8462486|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
8462487|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
8462488|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
8462489|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
8462490|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
8462491|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
8462492|NCT00702754|20852932|P1|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
8462493|NCT00702754|20852932|P1|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
8462494|NCT00702754|20852932|P1|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
8462495|NCT00702715|20852945|P2|NOT COMPLETED|Overall Study||0
8462496|NCT00702715|20852946|P1|NOT COMPLETED|Overall Study||1
8462497|NCT00702715|20852945|P2|COMPLETED|Overall Study||33
8462498|NCT00702715|20852946|P1|COMPLETED|Overall Study||34
8462499|NCT00702715|20852945|P2|STARTED|Overall Study|One subject was enrolled but did not start study|33
8462500|NCT00702715|20852946|P1|STARTED|Overall Study||35
8462501|NCT00702702|20852959|P1|NOT COMPLETED|Overall Study||56
8462502|NCT00702702|20852959|P1|COMPLETED|Overall Study||0
8462503|NCT00702702|20852959|P1|STARTED|Overall Study||56
8462504|NCT00702689|20852967|P1|NOT COMPLETED|Overall Study||6
8462505|NCT00702689|20852967|P1|COMPLETED|Overall Study||14
8462506|NCT00702689|20852967|P1|STARTED|Overall Study||20
8462507|NCT00702650|20852978|P1|NOT COMPLETED|Overall Study||20
8462508|NCT00702650|20852978|P1|COMPLETED|Overall Study||135
8462509|NCT00702650|20852978|P1|STARTED|Overall Study||155
8462510|NCT00702624|20852998|P4|NOT COMPLETED|Fetuses/Infant Follow-up||0
8462511|NCT00702624|20852999|P3|NOT COMPLETED|Fetuses/Infant Follow-up||10
8462512|NCT00702624|20853000|P2|NOT COMPLETED|Fetuses/Infant Follow-up||0
8462513|NCT00702624|20853001|P1|NOT COMPLETED|Fetuses/Infant Follow-up||0
8462514|NCT00702624|20852998|P4|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
8462515|NCT00702624|20852999|P3|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
8462516|NCT00702624|20853000|P2|COMPLETED|Fetuses/Infant Follow-up||0
8462517|NCT00702624|20853001|P1|COMPLETED|Fetuses/Infant Follow-up||0
8462518|NCT00702624|20852998|P4|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
8462519|NCT00702624|20852999|P3|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
8462520|NCT00702624|20853000|P2|Live Born Infants|Fetuses/Infant Follow-up||0
8462521|NCT00702624|20853001|P1|Live Born Infants|Fetuses/Infant Follow-up||0
8462522|NCT00702624|20852998|P4|STARTED|Fetuses/Infant Follow-up||55
8462523|NCT00702624|20852999|P3|STARTED|Fetuses/Infant Follow-up||88
8462524|NCT00702624|20853000|P2|STARTED|Fetuses/Infant Follow-up||0
8462525|NCT00702624|20853001|P1|STARTED|Fetuses/Infant Follow-up||0
8462526|NCT00702624|20852998|P4|NOT COMPLETED|Expectant Mother Follow-up||0
8462527|NCT00702624|20852999|P3|NOT COMPLETED|Expectant Mother Follow-up||0
8462528|NCT00702624|20853000|P2|NOT COMPLETED|Expectant Mother Follow-up||0
8462529|NCT00702624|20853001|P1|NOT COMPLETED|Expectant Mother Follow-up||7
8462530|NCT00702624|20852998|P4|COMPLETED|Expectant Mother Follow-up||0
8462531|NCT00702624|20852999|P3|COMPLETED|Expectant Mother Follow-up||0
8462532|NCT00702624|20853000|P2|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
8462533|NCT00702624|20853001|P1|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
8462534|NCT00702624|20852998|P4|STARTED|Expectant Mother Follow-up||0
8462535|NCT00702624|20852999|P3|STARTED|Expectant Mother Follow-up||0
8462536|NCT00702624|20853000|P2|STARTED|Expectant Mother Follow-up||45
8462537|NCT00702624|20853001|P1|STARTED|Expectant Mother Follow-up||68
8462538|NCT00702624|20852998|P4|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
8462539|NCT00702624|20852999|P3|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
8462540|NCT00702624|20853000|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
8462541|NCT00702624|20853001|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
8462542|NCT00702624|20852998|P4|COMPLETED|Base Study P05690 (NCT00702845)||0
8462543|NCT00702624|20852999|P3|COMPLETED|Base Study P05690 (NCT00702845)||0
8462544|NCT00702624|20853000|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
8462545|NCT00702624|20853001|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
8462546|NCT00702624|20852998|P4|STARTED|Base Study P05690 (NCT00702845)||0
8462547|NCT00702624|20852999|P3|STARTED|Base Study P05690 (NCT00702845)||0
8462548|NCT00702624|20853000|P2|STARTED|Base Study P05690 (NCT00702845)||128
8462549|NCT00702624|20853001|P1|STARTED|Base Study P05690 (NCT00702845)||268
8462550|NCT00702546|20853019|P2|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
8462551|NCT00702546|20853020|P1|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
8462552|NCT00702546|20853019|P2|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
8462553|NCT00702546|20853020|P1|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
8462554|NCT00702546|20853019|P2|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
8462555|NCT00702546|20853020|P1|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
8462556|NCT00702546|20853019|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
8462557|NCT00702546|20853020|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
8462558|NCT00702546|20853019|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
8462559|NCT00702546|20853020|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
8462560|NCT00702546|20853019|P2|STARTED|Base Study P05690 (NCT00702845)||128
8462561|NCT00702546|20853020|P1|STARTED|Base Study P05690 (NCT00702845)||268
8462562|NCT00702520|20853040|P4|NOT COMPLETED|Follow-up Study P05783||0
8462563|NCT00702520|20853041|P3|NOT COMPLETED|Follow-up Study P05783||0
8462564|NCT00702520|20853042|P2|NOT COMPLETED|Follow-up Study P05783||0
8462565|NCT00702520|20853043|P1|NOT COMPLETED|Follow-up Study P05783||0
8462566|NCT00702520|20853040|P4|COMPLETED|Follow-up Study P05783||11
8462567|NCT00702520|20853041|P3|COMPLETED|Follow-up Study P05783||8
8462568|NCT00702520|20853042|P2|COMPLETED|Follow-up Study P05783||8
8462569|NCT00702520|20853043|P1|COMPLETED|Follow-up Study P05783||7
8462570|NCT00702520|20853040|P4|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
8462571|NCT00702520|20853041|P3|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
8462572|NCT00702520|20853042|P2|STARTED|Follow-up Study P05783||8
8462573|NCT00702520|20853043|P1|STARTED|Follow-up Study P05783||7
8462574|NCT00702520|20853040|P4|NOT COMPLETED|Base Study P05788 - Follow-Up||0
8462575|NCT00702520|20853041|P3|NOT COMPLETED|Base Study P05788 - Follow-Up||0
8462576|NCT00702520|20853042|P2|NOT COMPLETED|Base Study P05788 - Follow-Up||10
8462577|NCT00702520|20853043|P1|NOT COMPLETED|Base Study P05788 - Follow-Up||15
8462578|NCT00702520|20853040|P4|COMPLETED|Base Study P05788 - Follow-Up||0
8462579|NCT00702520|20853041|P3|COMPLETED|Base Study P05788 - Follow-Up||0
8462580|NCT00702520|20853042|P2|COMPLETED|Base Study P05788 - Follow-Up||8
8462581|NCT00702520|20853043|P1|COMPLETED|Base Study P05788 - Follow-Up||7
8462582|NCT00702520|20853040|P4|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
8462583|NCT00702520|20853041|P3|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
8462584|NCT00702520|20853042|P2|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
8462585|NCT00702520|20853043|P1|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
8462586|NCT00702520|20853040|P4|STARTED|Base Study P05788 - Follow-Up||0
8462587|NCT00702520|20853041|P3|STARTED|Base Study P05788 - Follow-Up||0
8462588|NCT00702520|20853042|P2|STARTED|Base Study P05788 - Follow-Up||18
8462589|NCT00702520|20853043|P1|STARTED|Base Study P05788 - Follow-Up||22
8462590|NCT00702520|20853040|P4|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
8462591|NCT00702520|20853041|P3|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
8462592|NCT00702520|20853042|P2|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
8462593|NCT00702520|20853043|P1|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
8462594|NCT00702520|20853040|P4|COMPLETED|Base Study P05788 - Embryo Transfer||0
8462595|NCT00702520|20853041|P3|COMPLETED|Base Study P05788 - Embryo Transfer||0
8462596|NCT00702520|20853042|P2|COMPLETED|Base Study P05788 - Embryo Transfer||18
8462597|NCT00702520|20853043|P1|COMPLETED|Base Study P05788 - Embryo Transfer||22
8462598|NCT00702520|20853040|P4|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
8462599|NCT00702520|20853041|P3|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
8462600|NCT00702520|20853042|P2|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
8462601|NCT00702520|20853043|P1|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
8462602|NCT00702520|20853040|P4|STARTED|Base Study P05788 - Embryo Transfer||0
8462603|NCT00702520|20853041|P3|STARTED|Base Study P05788 - Embryo Transfer||0
8462604|NCT00702520|20853042|P2|STARTED|Base Study P05788 - Embryo Transfer||24
8462605|NCT00702520|20853043|P1|STARTED|Base Study P05788 - Embryo Transfer||25
8462606|NCT00702520|20853040|P4|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
8462607|NCT00702520|20853041|P3|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
8462608|NCT00702520|20853042|P2|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
8462609|NCT00702520|20853043|P1|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
8462610|NCT00702520|20853040|P4|COMPLETED|Base Study P05788 - Assigned Treatment||0
8462611|NCT00702520|20853041|P3|COMPLETED|Base Study P05788 - Assigned Treatment||0
8462612|NCT00702520|20853042|P2|COMPLETED|Base Study P05788 - Assigned Treatment||24
8462613|NCT00702520|20853043|P1|COMPLETED|Base Study P05788 - Assigned Treatment||25
8462614|NCT00702520|20853040|P4|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
8462615|NCT00702520|20853041|P3|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
8462616|NCT00702520|20853042|P2|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
8462617|NCT00702520|20853043|P1|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
8462618|NCT00702520|20853040|P4|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
8462619|NCT00702520|20853041|P3|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
8462620|NCT00702520|20853042|P2|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
8462621|NCT00702520|20853043|P1|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
8462622|NCT00702520|20853040|P4|STARTED|Base Study P05788 - Assigned Treatment||0
8462623|NCT00702520|20853041|P3|STARTED|Base Study P05788 - Assigned Treatment||0
8462624|NCT00702520|20853042|P2|STARTED|Base Study P05788 - Assigned Treatment||25
8462625|NCT00702520|20853043|P1|STARTED|Base Study P05788 - Assigned Treatment||25
8462626|NCT00702507|20853059|P1|NOT COMPLETED|Follow-up Phase||27
8462627|NCT00702507|20853059|P1|COMPLETED|Follow-up Phase||132
8462628|NCT00702507|20853059|P1|STARTED|Follow-up Phase||159
8462629|NCT00702507|20853059|P1|NOT COMPLETED|Initial Treatment Phase||41
8462630|NCT00702507|20853059|P1|COMPLETED|Initial Treatment Phase||159
8462631|NCT00702507|20853059|P1|STARTED|Initial Treatment Phase||200
8462632|NCT00702468|20853073|P2|NOT COMPLETED|Overall Study||16
8462633|NCT00702468|20853074|P1|NOT COMPLETED|Overall Study||3
8462634|NCT00702468|20853073|P2|COMPLETED|Overall Study||2
8462635|NCT00702468|20853074|P1|COMPLETED|Overall Study||15
8462636|NCT00702468|20853073|P2|STARTED|Overall Study||18
8462637|NCT00702468|20853074|P1|STARTED|Overall Study||18
8462638|NCT00702403|20853096|P1|NOT COMPLETED|From Engraftment to Study Completion||27
8462639|NCT00702403|20853096|P1|COMPLETED|From Engraftment to Study Completion||13
8462640|NCT00702403|20853096|P1|Patient Drop-outs|From Engraftment to Study Completion||27
8462641|NCT00702403|20853096|P1|STARTED|From Engraftment to Study Completion||40
8462642|NCT00702403|20853096|P1|NOT COMPLETED|From Consent to Engraftment||17
8462643|NCT00702403|20853096|P1|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
8462644|NCT00702403|20853096|P1|Ineligible for Study Drug|From Consent to Engraftment||17
8462645|NCT00702403|20853096|P1|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
8462646|NCT00702377|20853106|P2|NOT COMPLETED|Overall Study||3
8462647|NCT00702377|20853107|P1|NOT COMPLETED|Overall Study||1
8462648|NCT00702377|20853106|P2|COMPLETED|Overall Study||53
8462649|NCT00702377|20853107|P1|COMPLETED|Overall Study||52
8462650|NCT00702377|20853106|P2|STARTED|Overall Study||56
8462651|NCT00702377|20853107|P1|STARTED|Overall Study||53
8462652|NCT00702364|20853119|P2|NOT COMPLETED|Overall Study||4
8462653|NCT00702364|20853120|P1|NOT COMPLETED|Overall Study||2
8462654|NCT00702364|20853119|P2|COMPLETED|Overall Study||25
8462655|NCT00702364|20853120|P1|COMPLETED|Overall Study||24
8462656|NCT00702364|20853119|P2|STARTED|Overall Study||29
8462657|NCT00702364|20853120|P1|STARTED|Overall Study||26
8462658|NCT00702338|20853132|P3|NOT COMPLETED|Follow-up Study: Infant FU||2
8462659|NCT00702338|20853133|P2|NOT COMPLETED|Follow-up Study: Infant FU||0
8462660|NCT00702338|20853134|P1|NOT COMPLETED|Follow-up Study: Infant FU||0
8462661|NCT00702338|20853132|P3|COMPLETED|Follow-up Study: Infant FU||0
8462662|NCT00702338|20853133|P2|COMPLETED|Follow-up Study: Infant FU||0
8462663|NCT00702338|20853134|P1|COMPLETED|Follow-up Study: Infant FU||0
8462664|NCT00702338|20853132|P3|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
8462665|NCT00702338|20853133|P2|STARTED|Follow-up Study: Infant FU||0
8462666|NCT00702338|20853134|P1|STARTED|Follow-up Study: Infant FU||0
8462667|NCT00702338|20853132|P3|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
8462668|NCT00702338|20853133|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
8462669|NCT00702338|20853134|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
8462670|NCT00702338|20853132|P3|COMPLETED|Follow-up Study: Expectant Mothers FU||0
8462737|NCT00702143|20853263|P3|NOT COMPLETED|Overall Study||1
8462738|NCT00702143|20853264|P2|NOT COMPLETED|Overall Study||0
8462671|NCT00702338|20853133|P2|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
8462672|NCT00702338|20853134|P1|COMPLETED|Follow-up Study: Expectant Mothers FU||0
8462673|NCT00702338|20853132|P3|STARTED|Follow-up Study: Expectant Mothers FU||0
8462674|NCT00702338|20853133|P2|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
8462675|NCT00702338|20853134|P1|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
8462676|NCT00702338|20853132|P3|NOT COMPLETED|Base Study (NCT00697255)||0
8462677|NCT00702338|20853133|P2|NOT COMPLETED|Base Study (NCT00697255)||2
8462678|NCT00702338|20853134|P1|NOT COMPLETED|Base Study (NCT00697255)||3
8462679|NCT00702338|20853132|P3|COMPLETED|Base Study (NCT00697255)||0
8462680|NCT00702338|20853133|P2|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
8462681|NCT00702338|20853134|P1|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
8462682|NCT00702338|20853132|P3|STARTED|Base Study (NCT00697255)||0
8462683|NCT00702338|20853133|P2|STARTED|Base Study (NCT00697255)||3
8462684|NCT00702338|20853134|P1|STARTED|Base Study (NCT00697255)||5
8462685|NCT00702325|20853150|P2|NOT COMPLETED|Overall Study||53
8462686|NCT00702325|20853151|P1|NOT COMPLETED|Overall Study||38
8462687|NCT00702325|20853150|P2|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
8462688|NCT00702325|20853151|P1|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
8462689|NCT00702325|20853150|P2|STARTED|Overall Study|Randomized|155
8462690|NCT00702325|20853151|P1|STARTED|Overall Study|Randomized|156
8462691|NCT00702299|20853203|P1|NOT COMPLETED|Overall Study||0
8462692|NCT00702299|20853203|P1|COMPLETED|Overall Study||15
8462693|NCT00702299|20853203|P1|STARTED|Overall Study||15
8462694|NCT00702273|20853216|P2|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
8462695|NCT00702273|20853217|P1|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
8462696|NCT00702273|20853216|P2|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
8462697|NCT00702273|20853217|P1|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
8462698|NCT00702273|20853216|P2|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
8462699|NCT00702273|20853217|P1|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
8462700|NCT00702273|20853216|P2|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
8462701|NCT00702273|20853217|P1|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
8462702|NCT00702273|20853216|P2|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
8462703|NCT00702273|20853217|P1|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
8462704|NCT00702273|20853216|P2|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
8462705|NCT00702273|20853217|P1|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
8462706|NCT00702273|20853216|P2|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
8462707|NCT00702273|20853217|P1|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
8462708|NCT00702234|20853235|P2|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
8462709|NCT00702234|20853236|P1|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
8462710|NCT00702234|20853235|P2|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
8462711|NCT00702234|20853236|P1|COMPLETED|Follow-up Study: Fetuses/Infants||0
8462712|NCT00702234|20853235|P2|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
8462713|NCT00702234|20853236|P1|Live Born Infants|Follow-up Study: Fetuses/Infants||0
8462714|NCT00702234|20853235|P2|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
8462715|NCT00702234|20853236|P1|STARTED|Follow-up Study: Fetuses/Infants||0
8462716|NCT00702234|20853235|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
8462717|NCT00702234|20853236|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
8462718|NCT00702234|20853235|P2|COMPLETED|Follow-up Study: Expectant Mothers||0
8462719|NCT00702234|20853236|P1|COMPLETED|Follow-up Study: Expectant Mothers||246
8462720|NCT00702234|20853235|P2|STARTED|Follow-up Study: Expectant Mothers||0
8462721|NCT00702234|20853236|P1|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
8462722|NCT00702234|20853235|P2|NOT COMPLETED|Base Study (NCT00696878)||0
8462723|NCT00702234|20853236|P1|NOT COMPLETED|Base Study (NCT00696878)||504
8462724|NCT00702234|20853235|P2|COMPLETED|Base Study (NCT00696878)||0
8462725|NCT00702234|20853236|P1|COMPLETED|Base Study (NCT00696878)||178
8462726|NCT00702234|20853235|P2|STARTED|Base Study (NCT00696878)||0
8462727|NCT00702234|20853236|P1|STARTED|Base Study (NCT00696878)||682
8462728|NCT00702221|20853247|P2|NOT COMPLETED|Overall Study||3
8462729|NCT00702221|20853248|P1|NOT COMPLETED|Overall Study||4
8462730|NCT00702221|20853247|P2|COMPLETED|Overall Study||7
8462731|NCT00702221|20853248|P1|COMPLETED|Overall Study||6
8462732|NCT00702221|20853247|P2|STARTED|Overall Study||10
8462733|NCT00702221|20853248|P1|STARTED|Overall Study||10
8462734|NCT00702208|20853254|P1|NOT COMPLETED|Overall Study||31
8462735|NCT00702208|20853254|P1|COMPLETED|Overall Study||167
8462736|NCT00702208|20853254|P1|STARTED|Overall Study||198
8462739|NCT00702143|20853265|P1|NOT COMPLETED|Overall Study||0
8462740|NCT00702143|20853263|P3|COMPLETED|Overall Study||78
8462741|NCT00702143|20853264|P2|COMPLETED|Overall Study||60
8462742|NCT00702143|20853265|P1|COMPLETED|Overall Study||45
8462743|NCT00702143|20853263|P3|STARTED|Overall Study||79
8462744|NCT00702143|20853264|P2|STARTED|Overall Study||60
8462745|NCT00702143|20853265|P1|STARTED|Overall Study||45
8462746|NCT00701935|20853279|P2|NOT COMPLETED|Overall Study||11
8462747|NCT00701935|20853280|P1|NOT COMPLETED|Overall Study||16
8462748|NCT00701935|20853279|P2|COMPLETED|Overall Study||26
8462749|NCT00701935|20853280|P1|COMPLETED|Overall Study||27
8462750|NCT00701935|20853279|P2|STARTED|Overall Study||37
8462751|NCT00701935|20853280|P1|STARTED|Overall Study||43
8462752|NCT00701896|20853312|P2|NOT COMPLETED|Overall Study||33
8462753|NCT00701896|20853313|P1|NOT COMPLETED|Overall Study||33
8462754|NCT00701896|20853312|P2|COMPLETED|Overall Study||118
8462755|NCT00701896|20853313|P1|COMPLETED|Overall Study||110
8462756|NCT00701896|20853312|P2|STARTED|Overall Study|Includes those eligible but declined to participate|151
8462757|NCT00701896|20853313|P1|STARTED|Overall Study|Includes those eligible but declined to participate|143
8462758|NCT00701805|20853325|P4|NOT COMPLETED|Overall Study||4
8462759|NCT00701805|20853326|P3|NOT COMPLETED|Overall Study||7
8462760|NCT00701805|20853327|P2|NOT COMPLETED|Overall Study||4
8462761|NCT00701805|20853328|P1|NOT COMPLETED|Overall Study||3
8462762|NCT00701805|20853325|P4|COMPLETED|Overall Study||22
8462763|NCT00701805|20853326|P3|COMPLETED|Overall Study||16
8462764|NCT00701805|20853327|P2|COMPLETED|Overall Study||25
8462765|NCT00701805|20853328|P1|COMPLETED|Overall Study||23
8462766|NCT00701805|20853325|P4|STARTED|Overall Study||26
8462767|NCT00701805|20853326|P3|STARTED|Overall Study||23
8462768|NCT00701805|20853327|P2|STARTED|Overall Study||29
8462769|NCT00701805|20853328|P1|STARTED|Overall Study||26
8462770|NCT00701779|20853378|P1|NOT COMPLETED|Overall Study||9
8462771|NCT00701779|20853378|P1|COMPLETED|Overall Study||54
8462772|NCT00701779|20853378|P1|12 Month|Overall Study||54
8462773|NCT00701779|20853378|P1|9 Month|Overall Study||56
8462774|NCT00701779|20853378|P1|6 Month|Overall Study||58
8462775|NCT00701779|20853378|P1|3 Month|Overall Study||60
8462776|NCT00701779|20853378|P1|STARTED|Overall Study||63
8462777|NCT00701727|20853390|P2|NOT COMPLETED|Second Treatment Period||0
8462778|NCT00701727|20853391|P1|NOT COMPLETED|Second Treatment Period||2
8462779|NCT00701727|20853390|P2|COMPLETED|Second Treatment Period||13
8462780|NCT00701727|20853391|P1|COMPLETED|Second Treatment Period||13
8462781|NCT00701727|20853390|P2|STARTED|Second Treatment Period||13
8462782|NCT00701727|20853391|P1|STARTED|Second Treatment Period||15
8462783|NCT00701727|20853390|P2|NOT COMPLETED|First Treatment Period||2
8462784|NCT00701727|20853391|P1|NOT COMPLETED|First Treatment Period||1
8462785|NCT00701727|20853390|P2|COMPLETED|First Treatment Period||13
8462786|NCT00701727|20853391|P1|COMPLETED|First Treatment Period||15
8462787|NCT00701727|20853390|P2|STARTED|First Treatment Period||15
8462788|NCT00701727|20853391|P1|STARTED|First Treatment Period||16
8462789|NCT00701714|20853411|P2|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
8462790|NCT00701714|20853412|P1|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
8462791|NCT00701714|20853411|P2|COMPLETED|Safety Follow-up Period (6 Months)||112
8462792|NCT00701714|20853412|P1|COMPLETED|Safety Follow-up Period (6 Months)||144
8462793|NCT00701714|20853411|P2|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
8462794|NCT00701714|20853412|P1|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
8462795|NCT00701714|20853411|P2|NOT COMPLETED|Treatment Period (up to 1 Year)||134
8462796|NCT00701714|20853412|P1|NOT COMPLETED|Treatment Period (up to 1 Year)||137
8462797|NCT00701714|20853411|P2|COMPLETED|Treatment Period (up to 1 Year)||29
8462798|NCT00701714|20853412|P1|COMPLETED|Treatment Period (up to 1 Year)||37
8462799|NCT00701714|20853411|P2|STARTED|Treatment Period (up to 1 Year)||163
8462800|NCT00701714|20853412|P1|STARTED|Treatment Period (up to 1 Year)||174
8462801|NCT00701701|20853426|P2|NOT COMPLETED|Overall Study||2
8462802|NCT00701701|20853427|P1|NOT COMPLETED|Overall Study||0
8462803|NCT00701701|20853426|P2|COMPLETED|Overall Study||1
8462804|NCT00701701|20853427|P1|COMPLETED|Overall Study||1
8462805|NCT00701701|20853426|P2|STARTED|Overall Study||3
8462806|NCT00701701|20853427|P1|STARTED|Overall Study||1
8462807|NCT00701675|20853452|P3|NOT COMPLETED|Overall Study||7
8462808|NCT00701675|20853453|P2|NOT COMPLETED|Overall Study||8
8462809|NCT00701675|20853454|P1|NOT COMPLETED|Overall Study||4
8462810|NCT00701675|20853452|P3|COMPLETED|Overall Study||7
8462811|NCT00701675|20853453|P2|COMPLETED|Overall Study||6
8462812|NCT00701675|20853454|P1|COMPLETED|Overall Study||10
8462813|NCT00701675|20853452|P3|STARTED|Overall Study||14
8462814|NCT00701675|20853453|P2|STARTED|Overall Study||14
8462815|NCT00701675|20853454|P1|STARTED|Overall Study||14
8462816|NCT00701662|20853462|P1|NOT COMPLETED|Overall Study||1
8462817|NCT00701662|20853462|P1|COMPLETED|Overall Study||7
8462818|NCT00701662|20853462|P1|STARTED|Overall Study||8
8462819|NCT00701636|20853481|P2|NOT COMPLETED|Overall Study||0
8462820|NCT00701636|20853482|P1|NOT COMPLETED|Overall Study||0
8462821|NCT00701636|20853481|P2|COMPLETED|Overall Study||15
8462822|NCT00701636|20853482|P1|COMPLETED|Overall Study||15
8462823|NCT00701636|20853481|P2|STARTED|Overall Study||15
8462824|NCT00701636|20853482|P1|STARTED|Overall Study||15
8462825|NCT00701558|20853487|P1|NOT COMPLETED|Overall Study||15
8462826|NCT00701558|20853487|P1|COMPLETED|Overall Study||4
8462827|NCT00701558|20853487|P1|STARTED|Overall Study||19
8462828|NCT00701441|20853495|P2|NOT COMPLETED|Overall Study||4
8462829|NCT00701441|20853496|P1|NOT COMPLETED|Overall Study||0
8462830|NCT00701441|20853495|P2|COMPLETED|Overall Study||12
8462831|NCT00701441|20853496|P1|COMPLETED|Overall Study||9
8462832|NCT00701441|20853495|P2|STARTED|Overall Study||16
8462833|NCT00701441|20853496|P1|STARTED|Overall Study||9
8462834|NCT00701415|20853508|P2|NOT COMPLETED|Overall Study||1
8462835|NCT00701415|20853509|P1|NOT COMPLETED|Overall Study||1
8462836|NCT00701415|20853508|P2|COMPLETED|Overall Study||14
8462837|NCT00701415|20853509|P1|COMPLETED|Overall Study||15
8462838|NCT00701415|20853508|P2|STARTED|Overall Study||15
8462839|NCT00701415|20853509|P1|STARTED|Overall Study||16
8462840|NCT00701389|20853519|P4|NOT COMPLETED|Period 4||0
8462841|NCT00701389|20853520|P3|NOT COMPLETED|Period 4||0
8462842|NCT00701389|20853521|P2|NOT COMPLETED|Period 4||0
8462843|NCT00701389|20853522|P1|NOT COMPLETED|Period 4||0
8462844|NCT00701389|20853519|P4|COMPLETED|Period 4||6
8462845|NCT00701389|20853520|P3|COMPLETED|Period 4||6
8462846|NCT00701389|20853521|P2|COMPLETED|Period 4||6
8462847|NCT00701389|20853522|P1|COMPLETED|Period 4||6
8462848|NCT00701389|20853519|P4|STARTED|Period 4||6
8462849|NCT00701389|20853520|P3|STARTED|Period 4||6
8462850|NCT00701389|20853521|P2|STARTED|Period 4||6
8462851|NCT00701389|20853522|P1|STARTED|Period 4||6
8462852|NCT00701389|20853519|P4|NOT COMPLETED|Period 3||0
8462853|NCT00701389|20853520|P3|NOT COMPLETED|Period 3||0
8462854|NCT00701389|20853521|P2|NOT COMPLETED|Period 3||0
8462855|NCT00701389|20853522|P1|NOT COMPLETED|Period 3||0
8462856|NCT00701389|20853519|P4|COMPLETED|Period 3||6
8462857|NCT00701389|20853520|P3|COMPLETED|Period 3||6
8462858|NCT00701389|20853521|P2|COMPLETED|Period 3||6
8462859|NCT00701389|20853522|P1|COMPLETED|Period 3||6
8462860|NCT00701389|20853519|P4|STARTED|Period 3||6
8462861|NCT00701389|20853520|P3|STARTED|Period 3||6
8462862|NCT00701389|20853521|P2|STARTED|Period 3||6
8462863|NCT00701389|20853522|P1|STARTED|Period 3||6
8462864|NCT00701389|20853519|P4|NOT COMPLETED|Period 2||0
8462865|NCT00701389|20853520|P3|NOT COMPLETED|Period 2||0
8462866|NCT00701389|20853521|P2|NOT COMPLETED|Period 2||0
8462867|NCT00701389|20853522|P1|NOT COMPLETED|Period 2||0
8462868|NCT00701389|20853519|P4|COMPLETED|Period 2||6
8462869|NCT00701389|20853520|P3|COMPLETED|Period 2||6
8462870|NCT00701389|20853521|P2|COMPLETED|Period 2||6
8462871|NCT00701389|20853522|P1|COMPLETED|Period 2||6
8462872|NCT00701389|20853519|P4|STARTED|Period 2||6
8462873|NCT00701389|20853520|P3|STARTED|Period 2||6
8462874|NCT00701389|20853521|P2|STARTED|Period 2||6
8462875|NCT00701389|20853522|P1|STARTED|Period 2||6
8462876|NCT00701389|20853519|P4|NOT COMPLETED|Period 1||0
8462877|NCT00701389|20853520|P3|NOT COMPLETED|Period 1||0
8462878|NCT00701389|20853521|P2|NOT COMPLETED|Period 1||0
8462879|NCT00701389|20853522|P1|NOT COMPLETED|Period 1||0
8462880|NCT00701389|20853519|P4|COMPLETED|Period 1||6
8462881|NCT00701389|20853520|P3|COMPLETED|Period 1||6
8462882|NCT00701389|20853521|P2|COMPLETED|Period 1||6
8462883|NCT00701389|20853522|P1|COMPLETED|Period 1||6
8462884|NCT00701389|20853519|P4|STARTED|Period 1||6
8462885|NCT00701389|20853520|P3|STARTED|Period 1||6
8462886|NCT00701389|20853521|P2|STARTED|Period 1||6
8462887|NCT00701389|20853522|P1|STARTED|Period 1||6
8462888|NCT00701376|20853540|P1|NOT COMPLETED|Overall Study||1
8462889|NCT00701376|20853540|P1|COMPLETED|Overall Study||105
8462890|NCT00701376|20853540|P1|STARTED|Overall Study||106
8462891|NCT00701363|20853568|P4|NOT COMPLETED|Treatment Phase 2||0
8462892|NCT00701363|20853569|P3|NOT COMPLETED|Treatment Phase 2||2
8462893|NCT00701363|20853570|P2|NOT COMPLETED|Treatment Phase 2||0
8462894|NCT00701363|20853571|P1|NOT COMPLETED|Treatment Phase 2||0
8462895|NCT00701363|20853568|P4|COMPLETED|Treatment Phase 2||26
8462896|NCT00701363|20853569|P3|COMPLETED|Treatment Phase 2||68
8462897|NCT00701363|20853570|P2|COMPLETED|Treatment Phase 2||13
8462898|NCT00701363|20853571|P1|COMPLETED|Treatment Phase 2||0
8462899|NCT00701363|20853568|P4|STARTED|Treatment Phase 2||26
8462900|NCT00701363|20853569|P3|STARTED|Treatment Phase 2||70
8462901|NCT00701363|20853570|P2|STARTED|Treatment Phase 2||13
8462902|NCT00701363|20853571|P1|STARTED|Treatment Phase 2||0
8462903|NCT00701363|20853568|P4|NOT COMPLETED|Treatment Phase 1||0
8462904|NCT00701363|20853569|P3|NOT COMPLETED|Treatment Phase 1||0
8462905|NCT00701363|20853570|P2|NOT COMPLETED|Treatment Phase 1||0
8462906|NCT00701363|20853571|P1|NOT COMPLETED|Treatment Phase 1||15
8462907|NCT00701363|20853568|P4|COMPLETED|Treatment Phase 1||0
8462908|NCT00701363|20853569|P3|COMPLETED|Treatment Phase 1||0
8462909|NCT00701363|20853570|P2|COMPLETED|Treatment Phase 1||0
8462910|NCT00701363|20853571|P1|COMPLETED|Treatment Phase 1||109
8462911|NCT00701363|20853568|P4|STARTED|Treatment Phase 1||0
8462912|NCT00701363|20853569|P3|STARTED|Treatment Phase 1||0
8462913|NCT00701363|20853570|P2|STARTED|Treatment Phase 1||0
8462914|NCT00701363|20853571|P1|STARTED|Treatment Phase 1||124
8462915|NCT00701363|20853568|P4|NOT COMPLETED|Screening (Pre-assignment) Phase||0
8462916|NCT00701363|20853569|P3|NOT COMPLETED|Screening (Pre-assignment) Phase||0
8462917|NCT00701363|20853570|P2|NOT COMPLETED|Screening (Pre-assignment) Phase||0
8462918|NCT00701363|20853571|P1|NOT COMPLETED|Screening (Pre-assignment) Phase||4
8462919|NCT00701363|20853568|P4|COMPLETED|Screening (Pre-assignment) Phase||0
8462920|NCT00701363|20853569|P3|COMPLETED|Screening (Pre-assignment) Phase||0
8462921|NCT00701363|20853570|P2|COMPLETED|Screening (Pre-assignment) Phase||0
8462922|NCT00701363|20853571|P1|COMPLETED|Screening (Pre-assignment) Phase||124
8462923|NCT00701363|20853568|P4|STARTED|Screening (Pre-assignment) Phase||0
8462924|NCT00701363|20853569|P3|STARTED|Screening (Pre-assignment) Phase||0
8462925|NCT00701363|20853570|P2|STARTED|Screening (Pre-assignment) Phase||0
8462926|NCT00701363|20853571|P1|STARTED|Screening (Pre-assignment) Phase||128
8462927|NCT00701311|20853611|P1|NOT COMPLETED|Overall Study||8
8462928|NCT00701311|20853611|P1|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
8462929|NCT00701311|20853611|P1|STARTED|Overall Study||17
8462930|NCT00701129|20853615|P1|NOT COMPLETED|Overall Study||2
8462931|NCT00701129|20853615|P1|COMPLETED|Overall Study||2
8462932|NCT00701129|20853615|P1|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
8462933|NCT00701129|20853615|P1|STARTED|Overall Study||4
8462934|NCT00701103|20853637|P11|NOT COMPLETED|Overall Study||11
8462935|NCT00701103|20853638|P10|NOT COMPLETED|Overall Study||11
8462936|NCT00701103|20853639|P9|NOT COMPLETED|Overall Study||9
8462937|NCT00701103|20853640|P8|NOT COMPLETED|Overall Study||7
8462938|NCT00701103|20853641|P7|NOT COMPLETED|Overall Study||8
8462939|NCT00701103|20853642|P6|NOT COMPLETED|Overall Study||6
8462940|NCT00701103|20853643|P5|NOT COMPLETED|Overall Study||6
8462941|NCT00701103|20853644|P4|NOT COMPLETED|Overall Study||6
8462942|NCT00701103|20853645|P3|NOT COMPLETED|Overall Study||8
8462943|NCT00701103|20853646|P2|NOT COMPLETED|Overall Study||3
8462944|NCT00701103|20853647|P1|NOT COMPLETED|Overall Study||5
8462945|NCT00701103|20853637|P11|COMPLETED|Overall Study||0
8462946|NCT00701103|20853638|P10|COMPLETED|Overall Study||0
8462947|NCT00701103|20853639|P9|COMPLETED|Overall Study||0
8462948|NCT00701103|20853640|P8|COMPLETED|Overall Study||0
8462949|NCT00701103|20853641|P7|COMPLETED|Overall Study||0
8462950|NCT00701103|20853642|P6|COMPLETED|Overall Study||0
8462951|NCT00701103|20853643|P5|COMPLETED|Overall Study||0
8462952|NCT00701103|20853644|P4|COMPLETED|Overall Study||0
8462953|NCT00701103|20853645|P3|COMPLETED|Overall Study||0
8462954|NCT00701103|20853646|P2|COMPLETED|Overall Study||0
8462955|NCT00701103|20853647|P1|COMPLETED|Overall Study||0
8462956|NCT00701103|20853637|P11|STARTED|Overall Study||11
8462957|NCT00701103|20853638|P10|STARTED|Overall Study||11
8462958|NCT00701103|20853639|P9|STARTED|Overall Study||9
8462959|NCT00701103|20853640|P8|STARTED|Overall Study||7
8462960|NCT00701103|20853641|P7|STARTED|Overall Study||8
8462961|NCT00701103|20853642|P6|STARTED|Overall Study||6
8462962|NCT00701103|20853643|P5|STARTED|Overall Study||6
8462963|NCT00701103|20853644|P4|STARTED|Overall Study||6
8462964|NCT00701103|20853645|P3|STARTED|Overall Study||8
8462965|NCT00701103|20853646|P2|STARTED|Overall Study||3
8462966|NCT00701103|20853647|P1|STARTED|Overall Study||5
8462967|NCT00701090|20853753|P2|NOT COMPLETED|Overall Study||51
8462968|NCT00701090|20853754|P1|NOT COMPLETED|Overall Study||48
8462969|NCT00701090|20853753|P2|COMPLETED|Overall Study||468
8462970|NCT00701090|20853754|P1|COMPLETED|Overall Study||468
8462971|NCT00701090|20853753|P2|STARTED|Overall Study||519
8462972|NCT00701090|20853754|P1|STARTED|Overall Study||516
8462973|NCT00701064|20853772|P2|NOT COMPLETED|Overall Study||4
8462974|NCT00701064|20853773|P1|NOT COMPLETED|Overall Study||4
8462975|NCT00701064|20853772|P2|COMPLETED|Overall Study||32
8462976|NCT00701064|20853773|P1|COMPLETED|Overall Study||31
8462977|NCT00701064|20853772|P2|STARTED|Overall Study||36
8462978|NCT00701064|20853773|P1|STARTED|Overall Study||35
8462979|NCT00701051|20853785|P3|NOT COMPLETED|Detraining Intervention (Optional)||0
8462980|NCT00701051|20853786|P2|NOT COMPLETED|Detraining Intervention (Optional)||0
8462981|NCT00701051|20853787|P1|NOT COMPLETED|Detraining Intervention (Optional)||0
8462982|NCT00701051|20853785|P3|COMPLETED|Detraining Intervention (Optional)||6
8462983|NCT00701051|20853786|P2|COMPLETED|Detraining Intervention (Optional)||6
8462984|NCT00701051|20853787|P1|COMPLETED|Detraining Intervention (Optional)||0
8462985|NCT00701051|20853785|P3|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
8462986|NCT00701051|20853786|P2|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
8462987|NCT00701051|20853787|P1|STARTED|Detraining Intervention (Optional)||0
8462988|NCT00701051|20853785|P3|NOT COMPLETED|Exercise Intervention||3
8462989|NCT00701051|20853786|P2|NOT COMPLETED|Exercise Intervention||5
8462990|NCT00701051|20853787|P1|NOT COMPLETED|Exercise Intervention||0
8462991|NCT00701051|20853785|P3|COMPLETED|Exercise Intervention||9
8462992|NCT00701051|20853786|P2|COMPLETED|Exercise Intervention||14
8462993|NCT00701051|20853787|P1|COMPLETED|Exercise Intervention||0
8462994|NCT00701051|20853785|P3|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
8462995|NCT00701051|20853786|P2|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
8462996|NCT00701051|20853787|P1|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
8462997|NCT00701051|20853785|P3|NOT COMPLETED|Screening||0
8462998|NCT00701051|20853786|P2|NOT COMPLETED|Screening||0
8462999|NCT00701051|20853787|P1|NOT COMPLETED|Screening||59
8463000|NCT00701051|20853785|P3|COMPLETED|Screening||0
8463001|NCT00701051|20853786|P2|COMPLETED|Screening||0
8463002|NCT00701051|20853787|P1|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
8463003|NCT00701051|20853785|P3|STARTED|Screening||0
8463004|NCT00701051|20853786|P2|STARTED|Screening||0
8463005|NCT00701051|20853787|P1|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
8463006|NCT00701038|20853805|P2|NOT COMPLETED|Overall Study||4
8463007|NCT00701038|20853806|P1|NOT COMPLETED|Overall Study||4
8463008|NCT00701038|20853805|P2|COMPLETED|Overall Study||23
8463009|NCT00701038|20853806|P1|COMPLETED|Overall Study||23
8463010|NCT00701038|20853805|P2|STARTED|Overall Study||27
8463011|NCT00701038|20853806|P1|STARTED|Overall Study||27
8463012|NCT00700999|20853814|P2|NOT COMPLETED|Overall Study||9
8463013|NCT00700999|20853815|P1|NOT COMPLETED|Overall Study||15
8463014|NCT00700999|20853814|P2|COMPLETED|Overall Study||20
8463015|NCT00700999|20853815|P1|COMPLETED|Overall Study||21
8463016|NCT00700999|20853814|P2|Second MRI Scan|Overall Study||18
8463017|NCT00700999|20853815|P1|Second MRI Scan|Overall Study||19
8463018|NCT00700999|20853814|P2|First MRI Scan|Overall Study||22
8463019|NCT00700999|20853815|P1|First MRI Scan|Overall Study||29
8463020|NCT00700999|20853814|P2|STARTED|Overall Study||29
8463021|NCT00700999|20853815|P1|STARTED|Overall Study||36
8463022|NCT00700973|20853823|P2|NOT COMPLETED|Overall Study||7
8463023|NCT00700973|20853824|P1|NOT COMPLETED|Overall Study||8
8463024|NCT00700973|20853823|P2|COMPLETED|Overall Study||63
8463025|NCT00700973|20853824|P1|COMPLETED|Overall Study||63
8463026|NCT00700973|20853823|P2|STARTED|Overall Study||70
8463027|NCT00700973|20853824|P1|STARTED|Overall Study||71
8463034|NCT00700817|20853839|P5|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
8463035|NCT00700817|20853840|P4|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
8463036|NCT00700817|20853841|P3|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
8463037|NCT00700817|20853842|P2|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
8463038|NCT00700817|20853843|P1|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
8463039|NCT00700817|20853839|P5|COMPLETED|Week 52-78 (Extension Period 2)||63
8463040|NCT00700817|20853840|P4|COMPLETED|Week 52-78 (Extension Period 2)||59
8463041|NCT00700817|20853841|P3|COMPLETED|Week 52-78 (Extension Period 2)||0
8463042|NCT00700817|20853842|P2|COMPLETED|Week 52-78 (Extension Period 2)||135
8463043|NCT00700817|20853843|P1|COMPLETED|Week 52-78 (Extension Period 2)||124
8463044|NCT00700817|20853839|P5|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
8463045|NCT00700817|20853840|P4|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
8463046|NCT00700817|20853841|P3|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
8463047|NCT00700817|20853842|P2|STARTED|Week 52-78 (Extension Period 2)||150
8463048|NCT00700817|20853843|P1|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
8463049|NCT00700817|20853839|P5|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
8463050|NCT00700817|20853840|P4|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
8463051|NCT00700817|20853841|P3|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
8463052|NCT00700817|20853842|P2|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
8463053|NCT00700817|20853843|P1|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
8463054|NCT00700817|20853839|P5|COMPLETED|Week 26-52 (Extension Period 1)||0
8463055|NCT00700817|20853840|P4|COMPLETED|Week 26-52 (Extension Period 1)||0
8463056|NCT00700817|20853841|P3|COMPLETED|Week 26-52 (Extension Period 1)||151
8463057|NCT00700817|20853842|P2|COMPLETED|Week 26-52 (Extension Period 1)||150
8463058|NCT00700817|20853843|P1|COMPLETED|Week 26-52 (Extension Period 1)||135
8463059|NCT00700817|20853839|P5|STARTED|Week 26-52 (Extension Period 1)||0
8463060|NCT00700817|20853840|P4|STARTED|Week 26-52 (Extension Period 1)||0
8463061|NCT00700817|20853841|P3|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
8463062|NCT00700817|20853842|P2|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
8463063|NCT00700817|20853843|P1|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
8463064|NCT00700817|20853839|P5|NOT COMPLETED|Week 0-26 (Main Period)||0
8463065|NCT00700817|20853840|P4|NOT COMPLETED|Week 0-26 (Main Period)||0
8463066|NCT00700817|20853841|P3|NOT COMPLETED|Week 0-26 (Main Period)||25
8463067|NCT00700817|20853842|P2|NOT COMPLETED|Week 0-26 (Main Period)||30
8463068|NCT00700817|20853843|P1|NOT COMPLETED|Week 0-26 (Main Period)||56
8463069|NCT00700817|20853839|P5|COMPLETED|Week 0-26 (Main Period)||0
8463070|NCT00700817|20853840|P4|COMPLETED|Week 0-26 (Main Period)||0
8463071|NCT00700817|20853841|P3|COMPLETED|Week 0-26 (Main Period)||194
8463072|NCT00700817|20853842|P2|COMPLETED|Week 0-26 (Main Period)||191
8463073|NCT00700817|20853843|P1|COMPLETED|Week 0-26 (Main Period)||169
8463074|NCT00700817|20853839|P5|Exposed|Week 0-26 (Main Period)||0
8463075|NCT00700817|20853840|P4|Exposed|Week 0-26 (Main Period)||0
8463076|NCT00700817|20853841|P3|Exposed|Week 0-26 (Main Period)||219
8463077|NCT00700817|20853842|P2|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
8463078|NCT00700817|20853843|P1|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
8463079|NCT00700817|20853839|P5|STARTED|Week 0-26 (Main Period)||0
8463080|NCT00700817|20853840|P4|STARTED|Week 0-26 (Main Period)||0
8463081|NCT00700817|20853841|P3|STARTED|Week 0-26 (Main Period)|Randomised|219
8463082|NCT00700817|20853842|P2|STARTED|Week 0-26 (Main Period)|Randomised|221
8463083|NCT00700817|20853843|P1|STARTED|Week 0-26 (Main Period)|Randomised|225
8463084|NCT00700804|20854225|P2|NOT COMPLETED|Overall Study||4
8463085|NCT00700804|20854226|P1|NOT COMPLETED|Overall Study||3
8463086|NCT00700804|20854225|P2|COMPLETED|Overall Study||13
8463087|NCT00700804|20854226|P1|COMPLETED|Overall Study||14
8463088|NCT00700804|20854225|P2|STARTED|Overall Study||17
8463089|NCT00700804|20854226|P1|STARTED|Overall Study||17
8463090|NCT00700778|20854234|P1|NOT COMPLETED|Overall Study||2
8463091|NCT00700778|20854234|P1|COMPLETED|Overall Study||0
8463092|NCT00700778|20854234|P1|STARTED|Overall Study||2
8463093|NCT00700752|20854238|P2|NOT COMPLETED|Second Intervention||0
8463094|NCT00700752|20854239|P1|NOT COMPLETED|Second Intervention||0
8463095|NCT00700752|20854238|P2|COMPLETED|Second Intervention||18
8463096|NCT00700752|20854239|P1|COMPLETED|Second Intervention||20
8463097|NCT00700752|20854238|P2|STARTED|Second Intervention||18
8463098|NCT00700752|20854239|P1|STARTED|Second Intervention||20
8463099|NCT00700752|20854238|P2|NOT COMPLETED|First Intervention||2
8463100|NCT00700752|20854239|P1|NOT COMPLETED|First Intervention||0
8463101|NCT00700752|20854238|P2|COMPLETED|First Intervention||18
8463102|NCT00700752|20854239|P1|COMPLETED|First Intervention||20
8463103|NCT00700752|20854238|P2|STARTED|First Intervention||20
8463104|NCT00700752|20854239|P1|STARTED|First Intervention||20
8463105|NCT00700739|20854247|P2|NOT COMPLETED|Overall Study||4
8463106|NCT00700739|20854248|P1|NOT COMPLETED|Overall Study||4
8463107|NCT00700739|20854247|P2|COMPLETED|Overall Study||12
8463108|NCT00700739|20854248|P1|COMPLETED|Overall Study||18
8463109|NCT00700739|20854247|P2|STARTED|Overall Study||16
8463110|NCT00700739|20854248|P1|STARTED|Overall Study||22
8463111|NCT00700713|20854287|P3|NOT COMPLETED|Overall Study||2
8463112|NCT00700713|20854288|P2|NOT COMPLETED|Overall Study||0
8463113|NCT00700713|20854289|P1|NOT COMPLETED|Overall Study||1
8463114|NCT00700713|20854287|P3|COMPLETED|Overall Study||65
8463115|NCT00700713|20854288|P2|COMPLETED|Overall Study||66
8463116|NCT00700713|20854289|P1|COMPLETED|Overall Study||47
8463117|NCT00700713|20854287|P3|STARTED|Overall Study||67
8463118|NCT00700713|20854288|P2|STARTED|Overall Study||66
8463119|NCT00700713|20854289|P1|STARTED|Overall Study||48
8463120|NCT00700635|20854306|P3|NOT COMPLETED|Overall Study||1
8463121|NCT00700635|20854307|P2|NOT COMPLETED|Overall Study||8
8463122|NCT00700635|20854308|P1|NOT COMPLETED|Overall Study||11
8463123|NCT00700635|20854306|P3|COMPLETED|Overall Study||110
8463124|NCT00700635|20854307|P2|COMPLETED|Overall Study||103
8463125|NCT00700635|20854308|P1|COMPLETED|Overall Study||100
8463126|NCT00700635|20854306|P3|STARTED|Overall Study||111
8463127|NCT00700635|20854307|P2|STARTED|Overall Study||111
8463128|NCT00700635|20854308|P1|STARTED|Overall Study||111
8463129|NCT00700622|20854330|P2|NOT COMPLETED|Overall Study||5
8463130|NCT00700622|20854331|P1|NOT COMPLETED|Overall Study||13
8463131|NCT00700622|20854330|P2|COMPLETED|Overall Study||60
8463132|NCT00700622|20854331|P1|COMPLETED|Overall Study||52
8463133|NCT00700622|20854330|P2|STARTED|Overall Study||65
8463134|NCT00700622|20854331|P1|STARTED|Overall Study||65
8463135|NCT00700570|20854339|P2|NOT COMPLETED|Overall Study||26
8463136|NCT00700570|20854340|P1|NOT COMPLETED|Overall Study||11
8463137|NCT00700570|20854339|P2|COMPLETED|Overall Study||0
8463138|NCT00700570|20854340|P1|COMPLETED|Overall Study||8
8463139|NCT00700570|20854339|P2|STARTED|Overall Study||26
8463140|NCT00700570|20854340|P1|STARTED|Overall Study||19
8463141|NCT00700440|20854352|P1|NOT COMPLETED|Overall Study||0
8463142|NCT00700440|20854352|P1|COMPLETED|Overall Study||100
8463143|NCT00700440|20854352|P1|STARTED|Overall Study||100
8463144|NCT00700427|20854356|P5|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
8463145|NCT00700427|20854357|P4|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
8463146|NCT00700427|20854358|P3|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
8463147|NCT00700427|20854359|P2|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
8463148|NCT00700427|20854360|P1|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
8463149|NCT00700427|20854356|P5|COMPLETED|Study Period 4 (Open-Label Extension)||96
8463150|NCT00700427|20854357|P4|COMPLETED|Study Period 4 (Open-Label Extension)||0
8463151|NCT00700427|20854358|P3|COMPLETED|Study Period 4 (Open-Label Extension)||0
8463152|NCT00700427|20854359|P2|COMPLETED|Study Period 4 (Open-Label Extension)||0
8463153|NCT00700427|20854360|P1|COMPLETED|Study Period 4 (Open-Label Extension)||0
8463154|NCT00700427|20854356|P5|STARTED|Study Period 4 (Open-Label Extension)||180
8463155|NCT00700427|20854357|P4|STARTED|Study Period 4 (Open-Label Extension)||0
8463156|NCT00700427|20854358|P3|STARTED|Study Period 4 (Open-Label Extension)||0
8463157|NCT00700427|20854359|P2|STARTED|Study Period 4 (Open-Label Extension)||0
8463158|NCT00700427|20854360|P1|STARTED|Study Period 4 (Open-Label Extension)||0
8463159|NCT00700427|20854356|P5|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8463160|NCT00700427|20854357|P4|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
8463161|NCT00700427|20854358|P3|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
8463162|NCT00700427|20854359|P2|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8463163|NCT00700427|20854360|P1|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8463164|NCT00700427|20854356|P5|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8463165|NCT00700427|20854357|P4|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
8463166|NCT00700427|20854358|P3|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
8463167|NCT00700427|20854359|P2|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8463168|NCT00700427|20854360|P1|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
8463169|NCT00700427|20854356|P5|STARTED|Study Period 3B (Randomized Withdrawal)||0
8463170|NCT00700427|20854357|P4|STARTED|Study Period 3B (Randomized Withdrawal)||258
8463171|NCT00700427|20854358|P3|STARTED|Study Period 3B (Randomized Withdrawal)||266
8463172|NCT00700427|20854359|P2|STARTED|Study Period 3B (Randomized Withdrawal)||0
8463173|NCT00700427|20854360|P1|STARTED|Study Period 3B (Randomized Withdrawal)||0
8463174|NCT00700427|20854356|P5|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463175|NCT00700427|20854357|P4|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463176|NCT00700427|20854358|P3|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463177|NCT00700427|20854359|P2|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
8463178|NCT00700427|20854360|P1|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463179|NCT00700427|20854356|P5|COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463180|NCT00700427|20854357|P4|COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463181|NCT00700427|20854358|P3|COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463182|NCT00700427|20854359|P2|COMPLETED|Study Period 3A (Blinded Maintenance)||524
8463183|NCT00700427|20854360|P1|COMPLETED|Study Period 3A (Blinded Maintenance)||0
8463184|NCT00700427|20854356|P5|STARTED|Study Period 3A (Blinded Maintenance)||0
8463185|NCT00700427|20854357|P4|STARTED|Study Period 3A (Blinded Maintenance)||0
8463186|NCT00700427|20854358|P3|STARTED|Study Period 3A (Blinded Maintenance)||0
8463187|NCT00700427|20854359|P2|STARTED|Study Period 3A (Blinded Maintenance)||1005
8463188|NCT00700427|20854360|P1|STARTED|Study Period 3A (Blinded Maintenance)||0
8463189|NCT00700427|20854356|P5|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463190|NCT00700427|20854357|P4|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463191|NCT00700427|20854358|P3|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463192|NCT00700427|20854359|P2|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463193|NCT00700427|20854360|P1|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
8463194|NCT00700427|20854356|P5|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463195|NCT00700427|20854357|P4|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463196|NCT00700427|20854358|P3|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463197|NCT00700427|20854359|P2|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
8463198|NCT00700427|20854360|P1|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
8463199|NCT00700427|20854356|P5|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
8463200|NCT00700427|20854357|P4|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
8463201|NCT00700427|20854358|P3|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
8463202|NCT00700427|20854359|P2|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
8463203|NCT00700427|20854360|P1|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
8463204|NCT00700427|20854356|P5|STARTED|Study Period 2 (Open-Label Acute Trx)||0
8463205|NCT00700427|20854357|P4|STARTED|Study Period 2 (Open-Label Acute Trx)||0
8463206|NCT00700427|20854358|P3|STARTED|Study Period 2 (Open-Label Acute Trx)||0
8463207|NCT00700427|20854359|P2|STARTED|Study Period 2 (Open-Label Acute Trx)||0
8463208|NCT00700427|20854360|P1|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
8463209|NCT00700401|20854382|P1|NOT COMPLETED|Overall Study||94
8463210|NCT00700401|20854382|P1|COMPLETED|Overall Study||168
8463211|NCT00700401|20854382|P1|STARTED|Overall Study||262
8463212|NCT00700375|20854395|P2|NOT COMPLETED|Overall Study||0
8463213|NCT00700375|20854396|P1|NOT COMPLETED|Overall Study||0
8463214|NCT00700375|20854395|P2|COMPLETED|Overall Study||29
8463215|NCT00700375|20854396|P1|COMPLETED|Overall Study||30
8463216|NCT00700375|20854395|P2|2 Days After Creatinine Mesurement|Overall Study||29
8463217|NCT00700375|20854396|P1|2 Days After Creatinine Mesurement|Overall Study||30
8463218|NCT00700375|20854395|P2|STARTED|Overall Study||29
8463219|NCT00700375|20854396|P1|STARTED|Overall Study||30
8463220|NCT00700310|20854406|P4|NOT COMPLETED|Overall Study||26
8463221|NCT00700310|20854407|P3|NOT COMPLETED|Overall Study||16
8463222|NCT00700310|20854408|P2|NOT COMPLETED|Overall Study||26
8463223|NCT00700310|20854409|P1|NOT COMPLETED|Overall Study||21
8463224|NCT00700310|20854406|P4|COMPLETED|Overall Study||145
8463225|NCT00700310|20854407|P3|COMPLETED|Overall Study||158
8463226|NCT00700310|20854408|P2|COMPLETED|Overall Study||154
8463227|NCT00700310|20854409|P1|COMPLETED|Overall Study||166
8463228|NCT00700310|20854406|P4|STARTED|Overall Study||171
8463229|NCT00700310|20854407|P3|STARTED|Overall Study||174
8463230|NCT00700310|20854408|P2|STARTED|Overall Study||180
8463231|NCT00700310|20854409|P1|STARTED|Overall Study||187
8463232|NCT00700271|20854429|P2|NOT COMPLETED|Overall Study||12
8463233|NCT00700271|20854430|P1|NOT COMPLETED|Overall Study||14
8463234|NCT00700271|20854429|P2|COMPLETED|Overall Study||256
8463235|NCT00700271|20854430|P1|COMPLETED|Overall Study||264
8463236|NCT00700271|20854429|P2|STARTED|Overall Study||268
8463237|NCT00700271|20854430|P1|STARTED|Overall Study||278
8463238|NCT00700180|20854458|P2|NOT COMPLETED|Overall Study||149
8463239|NCT00700180|20854459|P1|NOT COMPLETED|Overall Study||154
8463240|NCT00700180|20854458|P2|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
8463241|NCT00700180|20854459|P1|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
8463242|NCT00700180|20854458|P2|STARTED|Overall Study||149
8463243|NCT00700180|20854459|P1|STARTED|Overall Study||154
8463244|NCT00700141|20854481|P1|NOT COMPLETED|Overall Study||0
8463245|NCT00700141|20854481|P1|COMPLETED|Overall Study||482
8463246|NCT00700141|20854481|P1|STARTED|Overall Study||482
8463247|NCT00700115|20854488|P2|NOT COMPLETED|Overall Study||1
8463248|NCT00700115|20854489|P1|NOT COMPLETED|Overall Study||1
8463249|NCT00700115|20854488|P2|COMPLETED|Overall Study||19
8463250|NCT00700115|20854489|P1|COMPLETED|Overall Study||39
8463251|NCT00700115|20854488|P2|STARTED|Overall Study||20
8463252|NCT00700115|20854489|P1|STARTED|Overall Study||40
8463253|NCT00700102|20854499|P2|NOT COMPLETED|Overall Study||395
8463254|NCT00700102|20854500|P1|NOT COMPLETED|Overall Study||402
8463255|NCT00700102|20854499|P2|COMPLETED|Overall Study||14
8463256|NCT00700102|20854500|P1|COMPLETED|Overall Study||9
8463257|NCT00700102|20854499|P2|Received at Least One Dose|Overall Study||403
8463258|NCT00700102|20854500|P1|Received at Least One Dose|Overall Study||407
8463259|NCT00700102|20854499|P2|Intention to Treat|Overall Study||409
8463260|NCT00700102|20854500|P1|Intention to Treat|Overall Study||410
8463261|NCT00700102|20854499|P2|STARTED|Overall Study||409
8463262|NCT00700102|20854500|P1|STARTED|Overall Study||411
8463263|NCT00700063|20854524|P8|NOT COMPLETED|Overall Study||0
8463264|NCT00700063|20854525|P7|NOT COMPLETED|Overall Study||0
8463265|NCT00700063|20854526|P6|NOT COMPLETED|Overall Study||0
8463266|NCT00700063|20854527|P5|NOT COMPLETED|Overall Study||2
8463267|NCT00700063|20854528|P4|NOT COMPLETED|Overall Study||2
8463268|NCT00700063|20854529|P3|NOT COMPLETED|Overall Study||0
8463269|NCT00700063|20854530|P2|NOT COMPLETED|Overall Study||0
8463270|NCT00700063|20854531|P1|NOT COMPLETED|Overall Study||1
8463271|NCT00700063|20854524|P8|COMPLETED|Overall Study||33
8463272|NCT00700063|20854525|P7|COMPLETED|Overall Study||32
8463273|NCT00700063|20854526|P6|COMPLETED|Overall Study||34
8463274|NCT00700063|20854527|P5|COMPLETED|Overall Study||31
8463275|NCT00700063|20854528|P4|COMPLETED|Overall Study||31
8463276|NCT00700063|20854529|P3|COMPLETED|Overall Study||33
8463277|NCT00700063|20854530|P2|COMPLETED|Overall Study||34
8463278|NCT00700063|20854531|P1|COMPLETED|Overall Study||32
8463279|NCT00700063|20854524|P8|STARTED|Overall Study||33
8463280|NCT00700063|20854525|P7|STARTED|Overall Study||32
8463281|NCT00700063|20854526|P6|STARTED|Overall Study||34
8463282|NCT00700063|20854527|P5|STARTED|Overall Study||33
8463283|NCT00700063|20854528|P4|STARTED|Overall Study||33
8463284|NCT00700063|20854529|P3|STARTED|Overall Study||33
8463285|NCT00700063|20854530|P2|STARTED|Overall Study||34
8463286|NCT00700063|20854531|P1|STARTED|Overall Study||33
8463287|NCT00700011|20854639|P2|NOT COMPLETED|Overall Study||1
8463288|NCT00700011|20854640|P1|NOT COMPLETED|Overall Study||0
8463289|NCT00700011|20854639|P2|COMPLETED|Overall Study||1
8463290|NCT00700011|20854640|P1|COMPLETED|Overall Study||8
8463291|NCT00700011|20854639|P2|STARTED|Overall Study||2
8463292|NCT00700011|20854640|P1|STARTED|Overall Study||8
8463293|NCT00699998|20854656|P4|NOT COMPLETED|Overall Study||82
8463294|NCT00699998|20854657|P3|NOT COMPLETED|Overall Study||206
8463295|NCT00699998|20854658|P2|NOT COMPLETED|Overall Study||86
8463296|NCT00699998|20854659|P1|NOT COMPLETED|Overall Study||199
8463297|NCT00699998|20854656|P4|COMPLETED|Overall Study||958
8463298|NCT00699998|20854657|P3|COMPLETED|Overall Study||3417
8463299|NCT00699998|20854658|P2|COMPLETED|Overall Study||957
8463300|NCT00699998|20854659|P1|COMPLETED|Overall Study||3421
8463301|NCT00699998|20854656|P4|Received at Least 1 Dose of Study Drug|Overall Study||1027
8463302|NCT00699998|20854657|P3|Received at Least 1 Dose of Study Drug|Overall Study||3590
8463303|NCT00699998|20854658|P2|Received at Least 1 Dose of Study Drug|Overall Study||1033
8463304|NCT00699998|20854659|P1|Received at Least 1 Dose of Study Drug|Overall Study||3590
8463305|NCT00699998|20854656|P4|STARTED|Overall Study||1040
8463306|NCT00699998|20854657|P3|STARTED|Overall Study||3623
8463307|NCT00699998|20854658|P2|STARTED|Overall Study||1043
8463308|NCT00699998|20854659|P1|STARTED|Overall Study||3620
8463309|NCT00699972|20854704|P3|NOT COMPLETED|Overall Study||35
8463310|NCT00699972|20854705|P2|NOT COMPLETED|Overall Study||19
8463311|NCT00699972|20854706|P1|NOT COMPLETED|Overall Study||16
8463312|NCT00699972|20854704|P3|COMPLETED|Overall Study||100
8463313|NCT00699972|20854705|P2|COMPLETED|Overall Study||114
8463314|NCT00699972|20854706|P1|COMPLETED|Overall Study||106
8463315|NCT00699972|20854704|P3|STARTED|Overall Study||135
8463316|NCT00699972|20854705|P2|STARTED|Overall Study||133
8463317|NCT00699972|20854706|P1|STARTED|Overall Study||122
8463318|NCT00699907|20854723|P3|NOT COMPLETED|Overall Study||8
8463319|NCT00699907|20854724|P2|NOT COMPLETED|Overall Study||10
8463320|NCT00699907|20854725|P1|NOT COMPLETED|Overall Study||2
8463321|NCT00699907|20854723|P3|COMPLETED|Overall Study||48
8463322|NCT00699907|20854724|P2|COMPLETED|Overall Study||47
8463323|NCT00699907|20854725|P1|COMPLETED|Overall Study||12
8463324|NCT00699907|20854723|P3|STARTED|Overall Study||56
8463325|NCT00699907|20854724|P2|STARTED|Overall Study||57
8463326|NCT00699907|20854725|P1|STARTED|Overall Study||14
8463327|NCT00699842|20854760|P3|NOT COMPLETED|Overall Study||0
8463328|NCT00699842|20854761|P2|NOT COMPLETED|Overall Study||1
8463329|NCT00699842|20854762|P1|NOT COMPLETED|Overall Study||0
8463330|NCT00699842|20854760|P3|COMPLETED|Overall Study||0
8463331|NCT00699842|20854761|P2|COMPLETED|Overall Study||4
8463332|NCT00699842|20854762|P1|COMPLETED|Overall Study||3
8463333|NCT00699842|20854760|P3|STARTED|Overall Study||0
8463334|NCT00699842|20854761|P2|STARTED|Overall Study||5
8463335|NCT00699842|20854762|P1|STARTED|Overall Study||3
8463336|NCT00699816|20854775|P2|NOT COMPLETED|Overall Study||3
8463337|NCT00699816|20854776|P1|NOT COMPLETED|Overall Study||1
8463338|NCT00699816|20854775|P2|COMPLETED|Overall Study||112
8463339|NCT00699816|20854776|P1|COMPLETED|Overall Study||114
8463340|NCT00699816|20854775|P2|STARTED|Overall Study||115
8463341|NCT00699816|20854776|P1|STARTED|Overall Study||115
8463342|NCT00699803|20854794|P2|NOT COMPLETED|Overall Study||6
8463343|NCT00699803|20854795|P1|NOT COMPLETED|Overall Study||2
8463344|NCT00699803|20854794|P2|COMPLETED|Overall Study||26
8463345|NCT00699803|20854795|P1|COMPLETED|Overall Study||30
8463346|NCT00699803|20854794|P2|STARTED|Overall Study||32
8463347|NCT00699803|20854795|P1|STARTED|Overall Study||32
8463348|NCT00699751|20854803|P2|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
8463349|NCT00699751|20854804|P1|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
8463350|NCT00699751|20854803|P2|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
8463351|NCT00699751|20854804|P1|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
8463352|NCT00699751|20854803|P2|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
8463353|NCT00699751|20854804|P1|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
8463354|NCT00699751|20854803|P2|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
8463355|NCT00699751|20854804|P1|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
8463356|NCT00699751|20854803|P2|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
8463357|NCT00699751|20854804|P1|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
8463358|NCT00699751|20854803|P2|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
8463359|NCT00699751|20854804|P1|STARTED|Period 2:Switched From Placebo to Xofigo||0
8463360|NCT00699751|20854803|P2|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
8463361|NCT00699751|20854804|P1|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
8463362|NCT00699751|20854803|P2|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
8463363|NCT00699751|20854804|P1|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
8463364|NCT00699751|20854803|P2|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
8463365|NCT00699751|20854804|P1|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
8463366|NCT00699751|20854803|P2|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
8463367|NCT00699751|20854804|P1|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
8463368|NCT00699751|20854803|P2|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
8463369|NCT00699751|20854804|P1|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
8463370|NCT00699751|20854803|P2|STARTED|Period 1: Without/Before Drug Switch||307
8463371|NCT00699751|20854804|P1|STARTED|Period 1: Without/Before Drug Switch||614
8463372|NCT00699699|20854889|P1|NOT COMPLETED|Overall Study||57
8463373|NCT00699699|20854889|P1|COMPLETED|Overall Study||1223
8463374|NCT00699699|20854889|P1|STARTED|Overall Study||1280
8463375|NCT00699660|20854898|P2|NOT COMPLETED|Overall Study||8
8463376|NCT00699660|20854899|P1|NOT COMPLETED|Overall Study||14
8463377|NCT00699660|20854898|P2|COMPLETED|Overall Study||208
8463378|NCT00699660|20854899|P1|COMPLETED|Overall Study||176
8463379|NCT00699660|20854898|P2|STARTED|Overall Study||216
8463380|NCT00699660|20854899|P1|STARTED|Overall Study||190
8463381|NCT00699608|20854911|P6|NOT COMPLETED|Third Intervention||0
8463382|NCT00699608|20854912|P5|NOT COMPLETED|Third Intervention||0
8463383|NCT00699608|20854913|P4|NOT COMPLETED|Third Intervention||0
8463384|NCT00699608|20854914|P3|NOT COMPLETED|Third Intervention||0
8463385|NCT00699608|20854915|P2|NOT COMPLETED|Third Intervention||0
8463386|NCT00699608|20854916|P1|NOT COMPLETED|Third Intervention||0
8463387|NCT00699608|20854911|P6|COMPLETED|Third Intervention||15
8463388|NCT00699608|20854912|P5|COMPLETED|Third Intervention||14
8463389|NCT00699608|20854913|P4|COMPLETED|Third Intervention||14
8463390|NCT00699608|20854914|P3|COMPLETED|Third Intervention||13
8463391|NCT00699608|20854915|P2|COMPLETED|Third Intervention||15
8463392|NCT00699608|20854916|P1|COMPLETED|Third Intervention||16
8463393|NCT00699608|20854911|P6|STARTED|Third Intervention||15
8463394|NCT00699608|20854912|P5|STARTED|Third Intervention||14
8463395|NCT00699608|20854913|P4|STARTED|Third Intervention||14
8463396|NCT00699608|20854914|P3|STARTED|Third Intervention||13
8463397|NCT00699608|20854915|P2|STARTED|Third Intervention||15
8463398|NCT00699608|20854916|P1|STARTED|Third Intervention||16
8463399|NCT00699608|20854911|P6|NOT COMPLETED|Second 4-14 Day Washout Period||0
8463400|NCT00699608|20854912|P5|NOT COMPLETED|Second 4-14 Day Washout Period||0
8463401|NCT00699608|20854913|P4|NOT COMPLETED|Second 4-14 Day Washout Period||0
8463402|NCT00699608|20854914|P3|NOT COMPLETED|Second 4-14 Day Washout Period||0
8463403|NCT00699608|20854915|P2|NOT COMPLETED|Second 4-14 Day Washout Period||0
8463404|NCT00699608|20854916|P1|NOT COMPLETED|Second 4-14 Day Washout Period||0
8463405|NCT00699608|20854911|P6|COMPLETED|Second 4-14 Day Washout Period||15
8463406|NCT00699608|20854912|P5|COMPLETED|Second 4-14 Day Washout Period||14
8463407|NCT00699608|20854913|P4|COMPLETED|Second 4-14 Day Washout Period||14
8463408|NCT00699608|20854914|P3|COMPLETED|Second 4-14 Day Washout Period||13
8463409|NCT00699608|20854915|P2|COMPLETED|Second 4-14 Day Washout Period||15
8463410|NCT00699608|20854916|P1|COMPLETED|Second 4-14 Day Washout Period||16
8463411|NCT00699608|20854911|P6|STARTED|Second 4-14 Day Washout Period||15
8463412|NCT00699608|20854912|P5|STARTED|Second 4-14 Day Washout Period||14
8463413|NCT00699608|20854913|P4|STARTED|Second 4-14 Day Washout Period||14
8463414|NCT00699608|20854914|P3|STARTED|Second 4-14 Day Washout Period||13
8463415|NCT00699608|20854915|P2|STARTED|Second 4-14 Day Washout Period||15
8463416|NCT00699608|20854916|P1|STARTED|Second 4-14 Day Washout Period||16
8463417|NCT00699608|20854911|P6|NOT COMPLETED|Second Intervention||0
8463418|NCT00699608|20854912|P5|NOT COMPLETED|Second Intervention||0
8463419|NCT00699608|20854913|P4|NOT COMPLETED|Second Intervention||1
8463420|NCT00699608|20854914|P3|NOT COMPLETED|Second Intervention||1
8463421|NCT00699608|20854915|P2|NOT COMPLETED|Second Intervention||0
8463422|NCT00699608|20854916|P1|NOT COMPLETED|Second Intervention||0
8463423|NCT00699608|20854911|P6|COMPLETED|Second Intervention||15
8463424|NCT00699608|20854912|P5|COMPLETED|Second Intervention||14
8463425|NCT00699608|20854913|P4|COMPLETED|Second Intervention||14
8463426|NCT00699608|20854914|P3|COMPLETED|Second Intervention||13
8463427|NCT00699608|20854915|P2|COMPLETED|Second Intervention||15
8463428|NCT00699608|20854916|P1|COMPLETED|Second Intervention||16
8463429|NCT00699608|20854911|P6|STARTED|Second Intervention||15
8463430|NCT00699608|20854912|P5|STARTED|Second Intervention||14
8463431|NCT00699608|20854913|P4|STARTED|Second Intervention||15
8463432|NCT00699608|20854914|P3|STARTED|Second Intervention||14
8463433|NCT00699608|20854915|P2|STARTED|Second Intervention||15
8463434|NCT00699608|20854916|P1|STARTED|Second Intervention||16
8463435|NCT00699608|20854911|P6|NOT COMPLETED|First 4-14 Day Washout Period||0
8463436|NCT00699608|20854912|P5|NOT COMPLETED|First 4-14 Day Washout Period||0
8463437|NCT00699608|20854913|P4|NOT COMPLETED|First 4-14 Day Washout Period||0
8463438|NCT00699608|20854914|P3|NOT COMPLETED|First 4-14 Day Washout Period||0
8463439|NCT00699608|20854915|P2|NOT COMPLETED|First 4-14 Day Washout Period||0
8463440|NCT00699608|20854916|P1|NOT COMPLETED|First 4-14 Day Washout Period||0
8463441|NCT00699608|20854911|P6|COMPLETED|First 4-14 Day Washout Period||15
8463442|NCT00699608|20854912|P5|COMPLETED|First 4-14 Day Washout Period||14
8463443|NCT00699608|20854913|P4|COMPLETED|First 4-14 Day Washout Period||15
8463444|NCT00699608|20854914|P3|COMPLETED|First 4-14 Day Washout Period||14
8463445|NCT00699608|20854915|P2|COMPLETED|First 4-14 Day Washout Period||15
8463446|NCT00699608|20854916|P1|COMPLETED|First 4-14 Day Washout Period||16
8463447|NCT00699608|20854911|P6|STARTED|First 4-14 Day Washout Period||15
8463448|NCT00699608|20854912|P5|STARTED|First 4-14 Day Washout Period||14
8463449|NCT00699608|20854913|P4|STARTED|First 4-14 Day Washout Period||15
8463450|NCT00699608|20854914|P3|STARTED|First 4-14 Day Washout Period||14
8463451|NCT00699608|20854915|P2|STARTED|First 4-14 Day Washout Period||15
8463452|NCT00699608|20854916|P1|STARTED|First 4-14 Day Washout Period||16
8463453|NCT00699608|20854911|P6|NOT COMPLETED|First Intervention||0
8463454|NCT00699608|20854912|P5|NOT COMPLETED|First Intervention||1
8463455|NCT00699608|20854913|P4|NOT COMPLETED|First Intervention||0
8463456|NCT00699608|20854914|P3|NOT COMPLETED|First Intervention||1
8463457|NCT00699608|20854915|P2|NOT COMPLETED|First Intervention||0
8463458|NCT00699608|20854916|P1|NOT COMPLETED|First Intervention||0
8463459|NCT00699608|20854911|P6|COMPLETED|First Intervention||15
8463460|NCT00699608|20854912|P5|COMPLETED|First Intervention||14
8463461|NCT00699608|20854913|P4|COMPLETED|First Intervention||15
8463462|NCT00699608|20854914|P3|COMPLETED|First Intervention||14
8463463|NCT00699608|20854915|P2|COMPLETED|First Intervention||15
8463464|NCT00699608|20854916|P1|COMPLETED|First Intervention||16
8463465|NCT00699608|20854911|P6|STARTED|First Intervention||15
8463466|NCT00699608|20854912|P5|STARTED|First Intervention||15
8463467|NCT00699608|20854913|P4|STARTED|First Intervention||15
8463468|NCT00699608|20854914|P3|STARTED|First Intervention||15
8463469|NCT00699608|20854915|P2|STARTED|First Intervention||15
8463470|NCT00699608|20854916|P1|STARTED|First Intervention||16
8463471|NCT00699582|20854969|P3|NOT COMPLETED|Overall Study||28
8463472|NCT00699582|20854970|P2|NOT COMPLETED|Overall Study||22
8463473|NCT00699582|20854971|P1|NOT COMPLETED|Overall Study||18
8463474|NCT00699582|20854969|P3|COMPLETED|Overall Study||93
8463475|NCT00699582|20854970|P2|COMPLETED|Overall Study||108
8463476|NCT00699582|20854971|P1|COMPLETED|Overall Study||120
8463477|NCT00699582|20854969|P3|STARTED|Overall Study||121
8463478|NCT00699582|20854970|P2|STARTED|Overall Study||130
8463479|NCT00699582|20854971|P1|STARTED|Overall Study||138
8463480|NCT00699556|20854985|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8463481|NCT00699556|20854986|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8463482|NCT00699556|20854985|P2|COMPLETED|Second Intervention (1 Day)||11
8463483|NCT00699556|20854986|P1|COMPLETED|Second Intervention (1 Day)||11
8463484|NCT00699556|20854985|P2|STARTED|Second Intervention (1 Day)||11
8463485|NCT00699556|20854986|P1|STARTED|Second Intervention (1 Day)||11
8463486|NCT00699556|20854985|P2|NOT COMPLETED|First Intervention (1 Day)||0
8463487|NCT00699556|20854986|P1|NOT COMPLETED|First Intervention (1 Day)||0
8463488|NCT00699556|20854985|P2|COMPLETED|First Intervention (1 Day)||11
8463489|NCT00699556|20854986|P1|COMPLETED|First Intervention (1 Day)||11
8463490|NCT00699556|20854985|P2|STARTED|First Intervention (1 Day)||11
8463491|NCT00699556|20854986|P1|STARTED|First Intervention (1 Day)||11
8463492|NCT00699491|20855000|P6|NOT COMPLETED|Overall Study||0
8463493|NCT00699491|20855001|P5|NOT COMPLETED|Overall Study||0
8463494|NCT00699491|20855002|P4|NOT COMPLETED|Overall Study||0
8463495|NCT00699491|20855003|P3|NOT COMPLETED|Overall Study||0
8463496|NCT00699491|20855004|P2|NOT COMPLETED|Overall Study||0
8463497|NCT00699491|20855005|P1|NOT COMPLETED|Overall Study||0
8463498|NCT00699491|20855000|P6|COMPLETED|Overall Study||22
8463499|NCT00699491|20855001|P5|COMPLETED|Overall Study||8
8463500|NCT00699491|20855002|P4|COMPLETED|Overall Study||6
8463501|NCT00699491|20855003|P3|COMPLETED|Overall Study||7
8463502|NCT00699491|20855004|P2|COMPLETED|Overall Study||2
8463503|NCT00699491|20855005|P1|COMPLETED|Overall Study||3
8463504|NCT00699491|20855000|P6|STARTED|Overall Study||22
8463505|NCT00699491|20855001|P5|STARTED|Overall Study||8
8463506|NCT00699491|20855002|P4|STARTED|Overall Study||6
8463507|NCT00699491|20855003|P3|STARTED|Overall Study||7
8463508|NCT00699491|20855004|P2|STARTED|Overall Study||2
8463509|NCT00699491|20855005|P1|STARTED|Overall Study||3
8463510|NCT00699413|20855026|P2|NOT COMPLETED|Overall Study||4
8463511|NCT00699413|20855027|P1|NOT COMPLETED|Overall Study||4
8463512|NCT00699413|20855026|P2|COMPLETED|Overall Study||0
8463513|NCT00699413|20855027|P1|COMPLETED|Overall Study||0
8463514|NCT00699413|20855026|P2|STARTED|Overall Study||4
8463515|NCT00699413|20855027|P1|STARTED|Overall Study||4
8463516|NCT00699400|20855042|P6|NOT COMPLETED|Overall Study||11
8463517|NCT00699400|20855043|P5|NOT COMPLETED|Overall Study||0
8463518|NCT00699400|20855044|P4|NOT COMPLETED|Overall Study||0
8463519|NCT00699400|20855045|P3|NOT COMPLETED|Overall Study||0
8463520|NCT00699400|20855046|P2|NOT COMPLETED|Overall Study||0
8463521|NCT00699400|20855047|P1|NOT COMPLETED|Overall Study||0
8463522|NCT00699400|20855042|P6|COMPLETED|Overall Study||0
8463523|NCT00699400|20855043|P5|COMPLETED|Overall Study||4
8463524|NCT00699400|20855044|P4|COMPLETED|Overall Study||6
8463525|NCT00699400|20855045|P3|COMPLETED|Overall Study||138
8463526|NCT00699400|20855046|P2|COMPLETED|Overall Study||3
8463527|NCT00699400|20855047|P1|COMPLETED|Overall Study||42
8463528|NCT00699400|20855042|P6|STARTED|Overall Study||11
8463529|NCT00699400|20855043|P5|STARTED|Overall Study||4
8463530|NCT00699400|20855044|P4|STARTED|Overall Study||6
8463531|NCT00699400|20855045|P3|STARTED|Overall Study||138
8463532|NCT00699400|20855046|P2|STARTED|Overall Study||3
8463533|NCT00699400|20855047|P1|STARTED|Overall Study||42
8463534|NCT00699374|20855081|P2|NOT COMPLETED|Overall Study||544
8463535|NCT00699374|20855082|P1|NOT COMPLETED|Overall Study||530
8463536|NCT00699374|20855081|P2|COMPLETED|Overall Study||0
8463537|NCT00699374|20855082|P1|COMPLETED|Overall Study||0
8463538|NCT00699374|20855081|P2|Treated|Overall Study||542
8463539|NCT00699374|20855082|P1|Treated|Overall Study||526
8463540|NCT00699374|20855081|P2|STARTED|Overall Study||544
8463541|NCT00699374|20855082|P1|STARTED|Overall Study||530
8463542|NCT00699348|20855094|P1|NOT COMPLETED|Overall Study||90
8463543|NCT00699348|20855094|P1|COMPLETED|Overall Study||261
8463544|NCT00699348|20855094|P1|STARTED|Overall Study||351
8463545|NCT00699335|20855103|P1|NOT COMPLETED|Overall Study||228
8463546|NCT00699335|20855103|P1|COMPLETED|Overall Study||5080
8463547|NCT00699335|20855103|P1|STARTED|Overall Study||5308
8463548|NCT00699283|20855136|P2|NOT COMPLETED|Overall Study||8
8463549|NCT00699283|20855137|P1|NOT COMPLETED|Overall Study||33
8463550|NCT00699283|20855136|P2|COMPLETED|Overall Study||7
8463551|NCT00699283|20855137|P1|COMPLETED|Overall Study||14
8463552|NCT00699283|20855136|P2|STARTED|Overall Study||15
8463553|NCT00699283|20855137|P1|STARTED|Overall Study||47
8463554|NCT00699218|20855142|P1|NOT COMPLETED|Overall Study||0
8463555|NCT00699218|20855142|P1|COMPLETED|Overall Study||15
8463556|NCT00699218|20855142|P1|STARTED|Overall Study||15
8463557|NCT00699192|20855150|P3|NOT COMPLETED|Overall Study||11
8463558|NCT00699192|20855151|P2|NOT COMPLETED|Overall Study||12
8463559|NCT00699192|20855152|P1|NOT COMPLETED|Overall Study||16
8463560|NCT00699192|20855150|P3|COMPLETED|Overall Study||261
8463561|NCT00699192|20855151|P2|COMPLETED|Overall Study||260
8463562|NCT00699192|20855152|P1|COMPLETED|Overall Study||259
8463563|NCT00699192|20855150|P3|STARTED|Overall Study||272
8463564|NCT00699192|20855151|P2|STARTED|Overall Study||272
8463565|NCT00699192|20855152|P1|STARTED|Overall Study||275
8463566|NCT00699153|20855174|P2|NOT COMPLETED|Overall Study||2
8463567|NCT00699153|20855175|P1|NOT COMPLETED|Overall Study||3
8463568|NCT00699153|20855174|P2|COMPLETED|Overall Study||200
8463569|NCT00699153|20855175|P1|COMPLETED|Overall Study||200
8463570|NCT00699153|20855174|P2|STARTED|Overall Study|Intent to treat population|202
8463571|NCT00699153|20855175|P1|STARTED|Overall Study|Intent to treat population|203
8463572|NCT00699140|20855187|P1|NOT COMPLETED|Overall Study||0
8463573|NCT00699140|20855187|P1|COMPLETED|Overall Study||18
8463574|NCT00699140|20855187|P1|STARTED|Overall Study||18
8463575|NCT00699010|20855201|P2|NOT COMPLETED|Overall Study||0
8463576|NCT00699010|20855202|P1|NOT COMPLETED|Overall Study||0
8463577|NCT00699010|20855201|P2|COMPLETED|Overall Study||15
8463578|NCT00699010|20855202|P1|COMPLETED|Overall Study||15
8463579|NCT00699010|20855201|P2|STARTED|Overall Study||15
8463580|NCT00699010|20855202|P1|STARTED|Overall Study||15
8463581|NCT00698997|20855210|P2|NOT COMPLETED|Overall Study||27
8463582|NCT00698997|20855211|P1|NOT COMPLETED|Overall Study||10
8463583|NCT00698997|20855210|P2|COMPLETED|Overall Study|36 - final assessment completed|36
8463584|NCT00698997|20855211|P1|COMPLETED|Overall Study|45 - final participant assessment completed|45
8463585|NCT00698997|20855210|P2|STARTED|Overall Study|1 enrollment|63
8463586|NCT00698997|20855211|P1|STARTED|Overall Study|1 enrollment|55
8463587|NCT00698932|20855225|P2|NOT COMPLETED|Overall Study||36
8463588|NCT00698932|20855226|P1|NOT COMPLETED|Overall Study||22
8463589|NCT00698932|20855225|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
8463590|NCT00698932|20855226|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
8463591|NCT00698932|20855225|P2|STARTED|Overall Study|Randomized and treated|284
8463592|NCT00698932|20855226|P1|STARTED|Overall Study|Randomized and treated|284
8463593|NCT00698867|20855242|P1|NOT COMPLETED|Overall Study||91
8463594|NCT00698867|20855242|P1|COMPLETED|Overall Study||27
8463595|NCT00698867|20855242|P1|Subjects With 4 Year Data|Overall Study||34
8463596|NCT00698867|20855242|P1|Subjects With 3 Year Data|Overall Study||35
8463597|NCT00698867|20855242|P1|Subjects With 2 Year Data|Overall Study||55
8463598|NCT00698867|20855242|P1|Subjects With 1 Year Data|Overall Study||68
8463599|NCT00698867|20855242|P1|STARTED|Overall Study||118
8463600|NCT00698841|20855252|P1|NOT COMPLETED|Overall Study||18
8463601|NCT00698841|20855252|P1|COMPLETED|Overall Study||33
8463602|NCT00698841|20855252|P1|STARTED|Overall Study||51
8463603|NCT00698815|20855266|P3|NOT COMPLETED|Overall Study||10
8463604|NCT00698815|20855267|P2|NOT COMPLETED|Overall Study||14
8463605|NCT00698815|20855268|P1|NOT COMPLETED|Overall Study||10
8463606|NCT00698815|20855266|P3|COMPLETED|Overall Study||31
8463607|NCT00698815|20855267|P2|COMPLETED|Overall Study||33
8463608|NCT00698815|20855268|P1|COMPLETED|Overall Study||32
8463609|NCT00698815|20855266|P3|STARTED|Overall Study||41
8463610|NCT00698815|20855267|P2|STARTED|Overall Study||47
8463611|NCT00698815|20855268|P1|STARTED|Overall Study||42
8463612|NCT00698685|20855285|P1|NOT COMPLETED|Overall Study||2
8463613|NCT00698685|20855285|P1|COMPLETED|Overall Study||12
8463614|NCT00698685|20855285|P1|STARTED|Overall Study||14
8463615|NCT00698646|20855293|P3|NOT COMPLETED|Overall Study||29
8463616|NCT00698646|20855294|P2|NOT COMPLETED|Overall Study||31
8463617|NCT00698646|20855295|P1|NOT COMPLETED|Overall Study||36
8463618|NCT00698646|20855293|P3|COMPLETED|Overall Study||99
8463619|NCT00698646|20855294|P2|COMPLETED|Overall Study||97
8463620|NCT00698646|20855295|P1|COMPLETED|Overall Study||92
8463621|NCT00698646|20855293|P3|STARTED|Overall Study||128
8463622|NCT00698646|20855294|P2|STARTED|Overall Study||128
8463623|NCT00698646|20855295|P1|STARTED|Overall Study||128
8463624|NCT00698581|20855320|P2|NOT COMPLETED|Overall Study||12
8463625|NCT00698581|20855321|P1|NOT COMPLETED|Overall Study||45
8463626|NCT00698581|20855320|P2|COMPLETED|Overall Study||8
8463627|NCT00698581|20855321|P1|COMPLETED|Overall Study||23
8463628|NCT00698581|20855320|P2|STARTED|Overall Study||20
8463629|NCT00698581|20855321|P1|STARTED|Overall Study||68
8463630|NCT00698516|20855332|P1|NOT COMPLETED|Overall Study||5
8463631|NCT00698516|20855332|P1|COMPLETED|Overall Study||45
8463632|NCT00698516|20855332|P1|STARTED|Overall Study||50
8463633|NCT00698451|20855350|P1|NOT COMPLETED|Overall Study||39
8463634|NCT00698451|20855350|P1|COMPLETED|Overall Study||15
8463635|NCT00698451|20855350|P1|STARTED|Overall Study||54
8463636|NCT00698204|20855357|P2|NOT COMPLETED|Overall Study||0
8463637|NCT00698204|20855358|P1|NOT COMPLETED|Overall Study||1
8463638|NCT00698204|20855357|P2|COMPLETED|Overall Study||20
8463639|NCT00698204|20855358|P1|COMPLETED|Overall Study||19
8463640|NCT00698204|20855357|P2|STARTED|Overall Study||20
8463641|NCT00698204|20855358|P1|STARTED|Overall Study||20
8463642|NCT00698139|20855369|P3|NOT COMPLETED|Overall Study||0
8463643|NCT00698139|20855370|P2|NOT COMPLETED|Overall Study||0
8463644|NCT00698139|20855371|P1|NOT COMPLETED|Overall Study||0
8463645|NCT00698139|20855369|P3|COMPLETED|Overall Study||1
8463646|NCT00698139|20855370|P2|COMPLETED|Overall Study||1
8463647|NCT00698139|20855371|P1|COMPLETED|Overall Study||1
8463648|NCT00698139|20855369|P3|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
8463649|NCT00698139|20855370|P2|2nd Visit|Overall Study||1
8463650|NCT00698139|20855371|P1|2nd Visit|Overall Study||1
8463651|NCT00698139|20855369|P3|STARTED|Overall Study||1
8463652|NCT00698139|20855370|P2|STARTED|Overall Study||1
8463653|NCT00698139|20855371|P1|STARTED|Overall Study||1
8463654|NCT00698035|20855387|P2|NOT COMPLETED|Overall Study||2
8463655|NCT00698035|20855388|P1|NOT COMPLETED|Overall Study||4
8463656|NCT00698035|20855387|P2|COMPLETED|Overall Study||34
8463657|NCT00698035|20855388|P1|COMPLETED|Overall Study||35
8463658|NCT00698035|20855387|P2|STARTED|Overall Study||36
8463659|NCT00698035|20855388|P1|STARTED|Overall Study||39
8463660|NCT00698022|20855408|P3|NOT COMPLETED|Overall Study||2
8463661|NCT00698022|20855409|P2|NOT COMPLETED|Overall Study||10
8463662|NCT00698022|20855410|P1|NOT COMPLETED|Overall Study||16
8463663|NCT00698022|20855408|P3|COMPLETED|Overall Study||14
8463664|NCT00698022|20855409|P2|COMPLETED|Overall Study||20
8463665|NCT00698022|20855410|P1|COMPLETED|Overall Study||14
8463666|NCT00698022|20855408|P3|STARTED|Overall Study||16
8463667|NCT00698022|20855409|P2|STARTED|Overall Study||30
8463668|NCT00698022|20855410|P1|STARTED|Overall Study||30
8463669|NCT00698009|20855418|P1|NOT COMPLETED|Overall Study||1
8463670|NCT00698009|20855418|P1|COMPLETED|Overall Study||0
8463671|NCT00698009|20855418|P1|STARTED|Overall Study||1
8463672|NCT00697827|20855424|P2|NOT COMPLETED|Overall Study||1
8463673|NCT00697827|20855425|P1|NOT COMPLETED|Overall Study||2
8463674|NCT00697827|20855424|P2|COMPLETED|Overall Study||15
8463675|NCT00697827|20855425|P1|COMPLETED|Overall Study||26
8463676|NCT00697827|20855424|P2|STARTED|Overall Study||16
8463677|NCT00697827|20855425|P1|STARTED|Overall Study||28
8463678|NCT00697801|20855436|P3|NOT COMPLETED|Overall Study||24
8463679|NCT00697801|20855437|P2|NOT COMPLETED|Overall Study||12
8463680|NCT00697801|20855438|P1|NOT COMPLETED|Overall Study||12
8463681|NCT00697801|20855436|P3|COMPLETED|Overall Study||45
8463682|NCT00697801|20855437|P2|COMPLETED|Overall Study||58
8463683|NCT00697801|20855438|P1|COMPLETED|Overall Study||57
8463684|NCT00697801|20855436|P3|STARTED|Overall Study||69
8463685|NCT00697801|20855437|P2|STARTED|Overall Study||70
8463686|NCT00697801|20855438|P1|STARTED|Overall Study||69
8463687|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463688|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463689|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463690|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463691|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463692|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463693|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463694|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463695|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
8463696|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463697|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463698|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463699|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463700|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463701|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463702|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463703|NCT00697788|20855452|P8|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
8463704|NCT00697788|20855453|P7|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463705|NCT00697788|20855454|P6|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463706|NCT00697788|20855455|P5|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463707|NCT00697788|20855456|P4|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463708|NCT00697788|20855457|P3|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463709|NCT00697788|20855458|P2|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463710|NCT00697788|20855459|P1|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
8463711|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463712|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463713|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463714|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463715|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463716|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463717|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463718|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463719|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463720|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
8463721|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463722|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463723|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463724|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463725|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463726|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463727|NCT00697788|20855452|P8|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463728|NCT00697788|20855453|P7|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
8463729|NCT00697788|20855454|P6|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463730|NCT00697788|20855455|P5|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463731|NCT00697788|20855456|P4|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463732|NCT00697788|20855457|P3|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463733|NCT00697788|20855458|P2|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463734|NCT00697788|20855459|P1|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
8463735|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463736|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463737|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463738|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463739|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463740|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463741|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463742|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463743|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463744|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463745|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
8463746|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463747|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463748|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463749|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463750|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463751|NCT00697788|20855452|P8|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463752|NCT00697788|20855453|P7|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463753|NCT00697788|20855454|P6|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
8463754|NCT00697788|20855455|P5|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463755|NCT00697788|20855456|P4|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463756|NCT00697788|20855457|P3|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463757|NCT00697788|20855458|P2|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463758|NCT00697788|20855459|P1|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
8463759|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463760|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463761|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463762|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
8463763|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463764|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463765|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463766|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463767|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463768|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463769|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463770|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
8463771|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463772|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463773|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463774|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463775|NCT00697788|20855452|P8|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463776|NCT00697788|20855453|P7|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463777|NCT00697788|20855454|P6|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463778|NCT00697788|20855455|P5|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
8463779|NCT00697788|20855456|P4|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463780|NCT00697788|20855457|P3|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463781|NCT00697788|20855458|P2|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463782|NCT00697788|20855459|P1|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
8463783|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463784|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463785|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463786|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463787|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463788|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463789|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463790|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463791|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463792|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463793|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463794|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463795|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
8463796|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463797|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463798|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463799|NCT00697788|20855452|P8|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463800|NCT00697788|20855453|P7|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463801|NCT00697788|20855454|P6|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463802|NCT00697788|20855455|P5|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463803|NCT00697788|20855456|P4|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
8463804|NCT00697788|20855457|P3|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463805|NCT00697788|20855458|P2|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463806|NCT00697788|20855459|P1|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
8463807|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463808|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463809|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463810|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463811|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463812|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463813|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463814|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463815|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463816|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463817|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463818|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463819|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463820|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
8463821|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463822|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463823|NCT00697788|20855452|P8|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463824|NCT00697788|20855453|P7|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463825|NCT00697788|20855454|P6|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463826|NCT00697788|20855455|P5|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463827|NCT00697788|20855456|P4|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463828|NCT00697788|20855457|P3|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
8463829|NCT00697788|20855458|P2|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463830|NCT00697788|20855459|P1|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
8463831|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463832|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463833|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463834|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463835|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463836|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463837|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
8463838|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463839|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463840|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463841|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463842|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463843|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463844|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463845|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
8463846|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463847|NCT00697788|20855452|P8|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463848|NCT00697788|20855453|P7|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463849|NCT00697788|20855454|P6|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463850|NCT00697788|20855455|P5|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463851|NCT00697788|20855456|P4|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463852|NCT00697788|20855457|P3|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463853|NCT00697788|20855458|P2|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
8463854|NCT00697788|20855459|P1|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
8463855|NCT00697788|20855452|P8|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463856|NCT00697788|20855453|P7|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463857|NCT00697788|20855454|P6|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463858|NCT00697788|20855455|P5|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463859|NCT00697788|20855456|P4|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463860|NCT00697788|20855457|P3|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463861|NCT00697788|20855458|P2|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463862|NCT00697788|20855459|P1|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463863|NCT00697788|20855452|P8|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463864|NCT00697788|20855453|P7|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463865|NCT00697788|20855454|P6|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463866|NCT00697788|20855455|P5|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463867|NCT00697788|20855456|P4|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463868|NCT00697788|20855457|P3|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463869|NCT00697788|20855458|P2|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
8463870|NCT00697788|20855459|P1|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
8463871|NCT00697788|20855452|P8|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8463872|NCT00697788|20855453|P7|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8463873|NCT00697788|20855454|P6|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8463874|NCT00697788|20855455|P5|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8463875|NCT00697788|20855456|P4|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
8463876|NCT00697788|20855457|P3|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
8463877|NCT00697788|20855458|P2|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
8463878|NCT00697788|20855459|P1|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
8463879|NCT00697697|20855503|P2|NOT COMPLETED|Overall Study||54
8463880|NCT00697697|20855504|P1|NOT COMPLETED|Overall Study||49
8463881|NCT00697697|20855503|P2|COMPLETED|Overall Study||44
8463882|NCT00697697|20855504|P1|COMPLETED|Overall Study||45
8463883|NCT00697697|20855503|P2|STARTED|Overall Study||98
8463884|NCT00697697|20855504|P1|STARTED|Overall Study||94
8463885|NCT00697619|20855514|P2|NOT COMPLETED|Overall Study||8
8463886|NCT00697619|20855515|P1|NOT COMPLETED|Overall Study||6
8463887|NCT00697619|20855514|P2|COMPLETED|Overall Study||22
8463888|NCT00697619|20855515|P1|COMPLETED|Overall Study||24
8463889|NCT00697619|20855514|P2|STARTED|Overall Study||30
8463890|NCT00697619|20855515|P1|STARTED|Overall Study||30
8463891|NCT00697593|20855521|P1|NOT COMPLETED|Overall Study||19
8463892|NCT00697593|20855521|P1|COMPLETED|Overall Study||51
8463893|NCT00697593|20855521|P1|STARTED|Overall Study||70
8463918|NCT00697463|20855594|P1|NOT COMPLETED|Overall Study||1
8463919|NCT00697463|20855594|P1|COMPLETED|Overall Study||21
8463920|NCT00697463|20855594|P1|STARTED|Overall Study||22
8463921|NCT00697346|20855601|P3|NOT COMPLETED|Overall Study||1
8463922|NCT00697346|20855602|P2|NOT COMPLETED|Overall Study||26
8463923|NCT00697346|20855603|P1|NOT COMPLETED|Overall Study||28
8463924|NCT00697346|20855601|P3|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1
8463925|NCT00697346|20855602|P2|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2
8463926|NCT00697346|20855603|P1|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
8463927|NCT00697346|20855601|P3|STARTED|Overall Study||2
8463928|NCT00697346|20855602|P2|STARTED|Overall Study||28
8463929|NCT00697346|20855603|P1|STARTED|Overall Study||28
8463930|NCT00697255|20855711|P2|NOT COMPLETED|Stage 1b||2
8463931|NCT00697255|20855712|P1|NOT COMPLETED|Stage 1b||0
8463932|NCT00697255|20855711|P2|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
8463933|NCT00697255|20855712|P1|COMPLETED|Stage 1b||0
8463934|NCT00697255|20855711|P2|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
8463935|NCT00697255|20855712|P1|STARTED|Stage 1b||0
8463936|NCT00697255|20855711|P2|NOT COMPLETED|Stage 1a||0
8463937|NCT00697255|20855712|P1|NOT COMPLETED|Stage 1a||3
8463938|NCT00697255|20855711|P2|COMPLETED|Stage 1a||0
8463939|NCT00697255|20855712|P1|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
8463940|NCT00697255|20855711|P2|STARTED|Stage 1a||0
8463941|NCT00697255|20855712|P1|STARTED|Stage 1a||5
8463942|NCT00697203|20855732|P4|NOT COMPLETED|Overall Study||7
8463943|NCT00697203|20855733|P3|NOT COMPLETED|Overall Study||8
8463944|NCT00697203|20855734|P2|NOT COMPLETED|Overall Study||6
8463945|NCT00697203|20855735|P1|NOT COMPLETED|Overall Study||9
8463946|NCT00697203|20855732|P4|COMPLETED|Overall Study||67
8463947|NCT00697203|20855733|P3|COMPLETED|Overall Study||66
8463948|NCT00697203|20855734|P2|COMPLETED|Overall Study||62
8463949|NCT00697203|20855735|P1|COMPLETED|Overall Study||67
8463950|NCT00697203|20855732|P4|STARTED|Overall Study||74
8463951|NCT00697203|20855733|P3|STARTED|Overall Study||74
8463952|NCT00697203|20855734|P2|STARTED|Overall Study||68
8463953|NCT00697203|20855735|P1|STARTED|Overall Study||76
8463954|NCT00697190|20855765|P2|NOT COMPLETED|Second Intervention||0
8463955|NCT00697190|20855766|P1|NOT COMPLETED|Second Intervention||0
8463956|NCT00697190|20855765|P2|COMPLETED|Second Intervention||20
8463957|NCT00697190|20855766|P1|COMPLETED|Second Intervention||18
8463958|NCT00697190|20855765|P2|STARTED|Second Intervention||20
8463959|NCT00697190|20855766|P1|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
8463960|NCT00697190|20855765|P2|NOT COMPLETED|First Intervention||0
8463961|NCT00697190|20855766|P1|NOT COMPLETED|First Intervention||0
8463962|NCT00697190|20855765|P2|COMPLETED|First Intervention||20
8463963|NCT00697190|20855766|P1|COMPLETED|First Intervention||19
8463964|NCT00697190|20855765|P2|STARTED|First Intervention||20
8463965|NCT00697190|20855766|P1|STARTED|First Intervention||19
8463966|NCT00697112|20855800|P1|NOT COMPLETED|Overall Study||10
8463967|NCT00697112|20855800|P1|COMPLETED|Overall Study||43
8463968|NCT00697112|20855800|P1|Met the Inclusion Criteria|Overall Study||52
8463969|NCT00697112|20855800|P1|STARTED|Overall Study||53
8463970|NCT00697073|20855824|P1|NOT COMPLETED|Overall Study||9
8463971|NCT00697073|20855824|P1|COMPLETED|Overall Study||59
8463972|NCT00697073|20855824|P1|STARTED|Overall Study||68
8463973|NCT00696878|20855828|P1|NOT COMPLETED|Overall Study||504
8463974|NCT00696878|20855828|P1|COMPLETED|Overall Study||178
8463975|NCT00696878|20855828|P1|STARTED|Overall Study||682
8463976|NCT00696800|20855902|P2|NOT COMPLETED|Overall Study||48
8463977|NCT00696800|20855903|P1|NOT COMPLETED|Overall Study||85
8463978|NCT00696800|20855902|P2|COMPLETED|Overall Study|Participants who had embryos transferred|704
8463979|NCT00696800|20855903|P1|COMPLETED|Overall Study|Participants who had embryos transferred|672
8463980|NCT00696800|20855902|P2|Treated (ITT)|Overall Study|The ITT group|750
8463981|NCT00696800|20855903|P1|Treated (ITT)|Overall Study|The ITT group|756
8463982|NCT00696800|20855902|P2|STARTED|Overall Study||752
8463983|NCT00696800|20855903|P1|STARTED|Overall Study||757
8463984|NCT00696787|20855956|P3|NOT COMPLETED|Overall Study||26
8463985|NCT00696787|20855957|P2|NOT COMPLETED|Overall Study||20
8463986|NCT00696787|20855958|P1|NOT COMPLETED|Overall Study||15
8463987|NCT00696787|20855956|P3|COMPLETED|Overall Study||17
8463988|NCT00696787|20855957|P2|COMPLETED|Overall Study||22
8463989|NCT00696787|20855958|P1|COMPLETED|Overall Study||25
8463990|NCT00696787|20855956|P3|STARTED|Overall Study||43
8463991|NCT00696787|20855957|P2|STARTED|Overall Study||42
8463992|NCT00696787|20855958|P1|STARTED|Overall Study||40
8463993|NCT00696774|20855972|P3|NOT COMPLETED|Period III||0
8463994|NCT00696774|20855973|P2|NOT COMPLETED|Period III||7
8463995|NCT00696774|20855974|P1|NOT COMPLETED|Period III||7
8463996|NCT00696774|20855972|P3|COMPLETED|Period III||0
8463997|NCT00696774|20855973|P2|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
8463998|NCT00696774|20855974|P1|COMPLETED|Period III||106
8463999|NCT00696774|20855972|P3|STARTED|Period III||0
8464000|NCT00696774|20855973|P2|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
8464001|NCT00696774|20855974|P1|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
8464002|NCT00696774|20855972|P3|NOT COMPLETED|Period II||36
8464003|NCT00696774|20855973|P2|NOT COMPLETED|Period II||0
8464004|NCT00696774|20855974|P1|NOT COMPLETED|Period II||0
8464005|NCT00696774|20855972|P3|COMPLETED|Period II||0
8464006|NCT00696774|20855973|P2|COMPLETED|Period II||91
8464007|NCT00696774|20855974|P1|COMPLETED|Period II||115
8464008|NCT00696774|20855972|P3|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
8464009|NCT00696774|20855973|P2|STARTED|Period II||91
8464010|NCT00696774|20855974|P1|STARTED|Period II||115
8464023|NCT00696709|20856034|P5|NOT COMPLETED|Overall Study||3
8464024|NCT00696709|20856035|P4|NOT COMPLETED|Overall Study||5
8464025|NCT00696709|20856036|P3|NOT COMPLETED|Overall Study||1
8464026|NCT00696709|20856037|P2|NOT COMPLETED|Overall Study||3
8464027|NCT00696709|20856038|P1|NOT COMPLETED|Overall Study||3
8464028|NCT00696709|20856034|P5|COMPLETED|Overall Study||62
8464029|NCT00696709|20856035|P4|COMPLETED|Overall Study||59
8464030|NCT00696709|20856036|P3|COMPLETED|Overall Study||32
8464031|NCT00696709|20856037|P2|COMPLETED|Overall Study||60
8464032|NCT00696709|20856038|P1|COMPLETED|Overall Study||62
8464033|NCT00696709|20856034|P5|Vaccination 4 (~Day 90)|Overall Study||63
8464034|NCT00696709|20856035|P4|Vaccination 4 (~Day 90)|Overall Study||59
8464035|NCT00696709|20856036|P3|Vaccination 4 (~Day 90)|Overall Study||32
8464036|NCT00696709|20856037|P2|Vaccination 4 (~Day 90)|Overall Study||60
8464037|NCT00696709|20856038|P1|Vaccination 4 (~Day 90)|Overall Study||62
8464038|NCT00696709|20856034|P5|Vaccination 3 (~Day 60)|Overall Study||63
8464039|NCT00696709|20856035|P4|Vaccination 3 (~Day 60)|Overall Study||59
8464040|NCT00696709|20856036|P3|Vaccination 3 (~Day 60)|Overall Study||32
8464041|NCT00696709|20856037|P2|Vaccination 3 (~Day 60)|Overall Study||60
8464042|NCT00696709|20856038|P1|Vaccination 3 (~Day 60)|Overall Study||64
8464043|NCT00696709|20856034|P5|Vaccination 2 (~Day 30)|Overall Study||64
8464044|NCT00696709|20856035|P4|Vaccination 2 (~Day 30)|Overall Study||61
8464045|NCT00696709|20856036|P3|Vaccination 2 (~Day 30)|Overall Study||32
8464046|NCT00696709|20856037|P2|Vaccination 2 (~Day 30)|Overall Study||60
8464047|NCT00696709|20856038|P1|Vaccination 2 (~Day 30)|Overall Study||64
8464048|NCT00696709|20856034|P5|Vaccination 1 (Day 1)|Overall Study||65
8464049|NCT00696709|20856035|P4|Vaccination 1 (Day 1)|Overall Study||64
8464050|NCT00696709|20856036|P3|Vaccination 1 (Day 1)|Overall Study||32
8464051|NCT00696709|20856037|P2|Vaccination 1 (Day 1)|Overall Study||63
8464052|NCT00696709|20856038|P1|Vaccination 1 (Day 1)|Overall Study||65
8464053|NCT00696709|20856034|P5|STARTED|Overall Study||65
8464054|NCT00696709|20856035|P4|STARTED|Overall Study||64
8464055|NCT00696709|20856036|P3|STARTED|Overall Study||33
8464056|NCT00696709|20856037|P2|STARTED|Overall Study||63
8464057|NCT00696709|20856038|P1|STARTED|Overall Study||65
8464058|NCT00696696|20856074|P1|NOT COMPLETED|Overall Study||18
8464059|NCT00696696|20856074|P1|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
8464060|NCT00696696|20856074|P1|STARTED|Overall Study||44
8464061|NCT00696657|20856089|P9|NOT COMPLETED|Overall Study||9
8464062|NCT00696657|20856090|P8|NOT COMPLETED|Overall Study||3
8464063|NCT00696657|20856091|P7|NOT COMPLETED|Overall Study||15
8464064|NCT00696657|20856092|P6|NOT COMPLETED|Overall Study||12
8464065|NCT00696657|20856093|P5|NOT COMPLETED|Overall Study||10
8464066|NCT00696657|20856094|P4|NOT COMPLETED|Overall Study||11
8464067|NCT00696657|20856095|P3|NOT COMPLETED|Overall Study||8
8464068|NCT00696657|20856096|P2|NOT COMPLETED|Overall Study||5
8464069|NCT00696657|20856097|P1|NOT COMPLETED|Overall Study||1
8464070|NCT00696657|20856089|P9|COMPLETED|Overall Study||41
8464071|NCT00696657|20856090|P8|COMPLETED|Overall Study||42
8464072|NCT00696657|20856091|P7|COMPLETED|Overall Study||30
8464073|NCT00696657|20856092|P6|COMPLETED|Overall Study||33
8464074|NCT00696657|20856093|P5|COMPLETED|Overall Study||34
8464075|NCT00696657|20856094|P4|COMPLETED|Overall Study||38
8464076|NCT00696657|20856095|P3|COMPLETED|Overall Study||36
8464077|NCT00696657|20856096|P2|COMPLETED|Overall Study||42
8464078|NCT00696657|20856097|P1|COMPLETED|Overall Study||45
8464079|NCT00696657|20856089|P9|EXPOSED|Overall Study||50
8464080|NCT00696657|20856090|P8|EXPOSED|Overall Study||45
8464081|NCT00696657|20856091|P7|EXPOSED|Overall Study||45
8464082|NCT00696657|20856092|P6|EXPOSED|Overall Study||43
8464083|NCT00696657|20856093|P5|EXPOSED|Overall Study||44
8464084|NCT00696657|20856094|P4|EXPOSED|Overall Study||48
8464085|NCT00696657|20856095|P3|EXPOSED|Overall Study||43
8464086|NCT00696657|20856096|P2|EXPOSED|Overall Study||47
8464087|NCT00696657|20856097|P1|EXPOSED|Overall Study||46
8464088|NCT00696657|20856089|P9|STARTED|Overall Study||50
8464089|NCT00696657|20856090|P8|STARTED|Overall Study||45
8464090|NCT00696657|20856091|P7|STARTED|Overall Study||45
8464091|NCT00696657|20856092|P6|STARTED|Overall Study||45
8464092|NCT00696657|20856093|P5|STARTED|Overall Study||44
8464093|NCT00696657|20856094|P4|STARTED|Overall Study||49
8464094|NCT00696657|20856095|P3|STARTED|Overall Study||44
8464095|NCT00696657|20856096|P2|STARTED|Overall Study||47
8464096|NCT00696657|20856097|P1|STARTED|Overall Study||46
8464097|NCT00696618|20856424|P3|NOT COMPLETED|Overall Study||0
8464098|NCT00696618|20856425|P2|NOT COMPLETED|Overall Study||0
8464099|NCT00696618|20856426|P1|NOT COMPLETED|Overall Study||0
8464100|NCT00696618|20856424|P3|COMPLETED|Overall Study||3
8464101|NCT00696618|20856425|P2|COMPLETED|Overall Study||3
8464102|NCT00696618|20856426|P1|COMPLETED|Overall Study||3
8464103|NCT00696618|20856424|P3|STARTED|Overall Study||3
8464104|NCT00696618|20856425|P2|STARTED|Overall Study||3
8464105|NCT00696618|20856426|P1|STARTED|Overall Study||3
8464106|NCT00696488|20856440|P1|NOT COMPLETED|Overall Study||0
8464107|NCT00696488|20856440|P1|COMPLETED|Overall Study||20
8464108|NCT00696488|20856440|P1|STARTED|Overall Study||20
8464109|NCT00696449|20856448|P4|NOT COMPLETED|Overall Study||3
8464110|NCT00696449|20856449|P3|NOT COMPLETED|Overall Study||1
8464111|NCT00696449|20856450|P2|NOT COMPLETED|Overall Study||6
8464112|NCT00696449|20856451|P1|NOT COMPLETED|Overall Study||3
8464113|NCT00696449|20856448|P4|COMPLETED|Overall Study||13
8464114|NCT00696449|20856449|P3|COMPLETED|Overall Study||14
8464115|NCT00696449|20856450|P2|COMPLETED|Overall Study||9
8464116|NCT00696449|20856451|P1|COMPLETED|Overall Study||12
8464117|NCT00696449|20856448|P4|STARTED|Overall Study||16
8464118|NCT00696449|20856449|P3|STARTED|Overall Study||15
8464119|NCT00696449|20856450|P2|STARTED|Overall Study||15
8464120|NCT00696449|20856451|P1|STARTED|Overall Study||15
8464121|NCT00696436|20856466|P5|NOT COMPLETED|Overall Study||13
8464122|NCT00696436|20856467|P4|NOT COMPLETED|Overall Study||22
8464123|NCT00696436|20856468|P3|NOT COMPLETED|Overall Study||28
8464124|NCT00696436|20856469|P2|NOT COMPLETED|Overall Study||30
8464125|NCT00696436|20856470|P1|NOT COMPLETED|Overall Study||23
8464126|NCT00696436|20856466|P5|COMPLETED|Overall Study||141
8464127|NCT00696436|20856467|P4|COMPLETED|Overall Study||268
8464128|NCT00696436|20856468|P3|COMPLETED|Overall Study||254
8464129|NCT00696436|20856469|P2|COMPLETED|Overall Study||255
8464130|NCT00696436|20856470|P1|COMPLETED|Overall Study||257
8464131|NCT00696436|20856466|P5|STARTED|Overall Study|Randomized participants only.|154
8464132|NCT00696436|20856467|P4|STARTED|Overall Study|Randomized participants only.|290
8464133|NCT00696436|20856468|P3|STARTED|Overall Study|Randomized participants only.|282
8464134|NCT00696436|20856469|P2|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
8464135|NCT00696436|20856470|P1|STARTED|Overall Study|Randomized participants only.|280
8464136|NCT00696423|20856554|P2|NOT COMPLETED|Overall Study||5
8464137|NCT00696423|20856555|P1|NOT COMPLETED|Overall Study||0
8464138|NCT00696423|20856554|P2|COMPLETED|Overall Study||218
8464139|NCT00696423|20856555|P1|COMPLETED|Overall Study||244
8464140|NCT00696423|20856554|P2|STARTED|Overall Study||223
8464141|NCT00696423|20856555|P1|STARTED|Overall Study||244
8464142|NCT00696410|20856587|P2|NOT COMPLETED|Overall Study||0
8464143|NCT00696410|20856588|P1|NOT COMPLETED|Overall Study||13
8464144|NCT00696410|20856587|P2|COMPLETED|Overall Study||10
8464145|NCT00696410|20856588|P1|COMPLETED|Overall Study||25
8464146|NCT00696410|20856587|P2|STARTED|Overall Study||10
8464147|NCT00696410|20856588|P1|STARTED|Overall Study||38
8464148|NCT00696384|20856602|P3|NOT COMPLETED|Double Blind Phase||6
8464149|NCT00696384|20856603|P2|NOT COMPLETED|Double Blind Phase||11
8464150|NCT00696384|20856604|P1|NOT COMPLETED|Double Blind Phase||0
8464151|NCT00696384|20856602|P3|COMPLETED|Double Blind Phase||145
8464152|NCT00696384|20856603|P2|COMPLETED|Double Blind Phase||137
8464153|NCT00696384|20856604|P1|COMPLETED|Double Blind Phase||0
8464154|NCT00696384|20856602|P3|STARTED|Double Blind Phase||151
8464155|NCT00696384|20856603|P2|STARTED|Double Blind Phase||148
8464156|NCT00696384|20856604|P1|STARTED|Double Blind Phase||0
8464157|NCT00696384|20856602|P3|NOT COMPLETED|Open Label Phase||0
8464158|NCT00696384|20856603|P2|NOT COMPLETED|Open Label Phase||0
8464159|NCT00696384|20856604|P1|NOT COMPLETED|Open Label Phase||119
8464160|NCT00696384|20856602|P3|COMPLETED|Open Label Phase||0
8464161|NCT00696384|20856603|P2|COMPLETED|Open Label Phase||0
8464162|NCT00696384|20856604|P1|COMPLETED|Open Label Phase||299
8464163|NCT00696384|20856602|P3|STARTED|Open Label Phase||0
8464164|NCT00696384|20856603|P2|STARTED|Open Label Phase||0
8464165|NCT00696384|20856604|P1|STARTED|Open Label Phase||418
8464166|NCT00696293|20856618|P1|NOT COMPLETED|Overall Study||2
8464167|NCT00696293|20856618|P1|COMPLETED|Overall Study||28
8464168|NCT00696293|20856618|P1|STARTED|Overall Study||30
8464169|NCT00696241|20856628|P5|NOT COMPLETED|Overall Study||12
8464170|NCT00696241|20856629|P4|NOT COMPLETED|Overall Study||14
8464171|NCT00696241|20856630|P3|NOT COMPLETED|Overall Study||24
8464172|NCT00696241|20856631|P2|NOT COMPLETED|Overall Study||22
8464173|NCT00696241|20856632|P1|NOT COMPLETED|Overall Study||24
8464174|NCT00696241|20856628|P5|COMPLETED|Overall Study||130
8464175|NCT00696241|20856629|P4|COMPLETED|Overall Study||268
8464176|NCT00696241|20856630|P3|COMPLETED|Overall Study||261
8464177|NCT00696241|20856631|P2|COMPLETED|Overall Study||261
8464178|NCT00696241|20856632|P1|COMPLETED|Overall Study||259
8464179|NCT00696241|20856628|P5|STARTED|Overall Study||142
8464180|NCT00696241|20856629|P4|STARTED|Overall Study||282
8464181|NCT00696241|20856630|P3|STARTED|Overall Study||285
8464182|NCT00696241|20856631|P2|STARTED|Overall Study||283
8464183|NCT00696241|20856632|P1|STARTED|Overall Study||283
8464184|NCT00696137|20856714|P1|NOT COMPLETED|Overall Study||2
8464185|NCT00696137|20856714|P1|COMPLETED|Overall Study||3
8464186|NCT00696137|20856714|P1|STARTED|Overall Study||5
8464187|NCT00696072|20856720|P2|NOT COMPLETED|Overall Study||63
8464188|NCT00696072|20856721|P1|NOT COMPLETED|Overall Study||57
8464189|NCT00696072|20856720|P2|COMPLETED|Overall Study||0
8464190|NCT00696072|20856721|P1|COMPLETED|Overall Study||0
8464191|NCT00696072|20856720|P2|STARTED|Overall Study||63
8464192|NCT00696072|20856721|P1|STARTED|Overall Study||57
8464193|NCT00696020|20856742|P4|NOT COMPLETED|Overall Study||4
8464194|NCT00696020|20856743|P3|NOT COMPLETED|Overall Study||3
8464195|NCT00696020|20856744|P2|NOT COMPLETED|Overall Study||2
8464196|NCT00696020|20856745|P1|NOT COMPLETED|Overall Study||4
8464197|NCT00696020|20856742|P4|COMPLETED|Overall Study||84
8464198|NCT00696020|20856743|P3|COMPLETED|Overall Study||90
8464199|NCT00696020|20856744|P2|COMPLETED|Overall Study||87
8464200|NCT00696020|20856745|P1|COMPLETED|Overall Study||86
8464201|NCT00696020|20856742|P4|STARTED|Overall Study||88
8464202|NCT00696020|20856743|P3|STARTED|Overall Study||93
8464203|NCT00696020|20856744|P2|STARTED|Overall Study||89
8464204|NCT00696020|20856745|P1|STARTED|Overall Study||90
8464205|NCT00695955|20856853|P1|NOT COMPLETED|Cohort 2||104
8464206|NCT00695955|20856853|P1|COMPLETED|Cohort 2||203
8464207|NCT00695955|20856853|P1|STARTED|Cohort 2||307
8464208|NCT00695955|20856853|P1|NOT COMPLETED|Cohort 1||102
8464209|NCT00695955|20856853|P1|COMPLETED|Cohort 1||260
8464210|NCT00695955|20856853|P1|STARTED|Cohort 1||362
8464211|NCT00695903|20856865|P2|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
8464212|NCT00695903|20856866|P1|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
8464213|NCT00695903|20856865|P2|COMPLETED|Had Test of Cure (TOC) Assessment||3
8464214|NCT00695903|20856866|P1|COMPLETED|Had Test of Cure (TOC) Assessment||5
8464215|NCT00695903|20856865|P2|STARTED|Had Test of Cure (TOC) Assessment||4
8464216|NCT00695903|20856866|P1|STARTED|Had Test of Cure (TOC) Assessment||7
8464217|NCT00695903|20856865|P2|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
8464218|NCT00695903|20856866|P1|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
8464219|NCT00695903|20856865|P2|COMPLETED|Had End of Therapy (EOT) Assessment||4
8464220|NCT00695903|20856866|P1|COMPLETED|Had End of Therapy (EOT) Assessment||7
8464221|NCT00695903|20856865|P2|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
8464222|NCT00695903|20856866|P1|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
8464223|NCT00695903|20856865|P2|STARTED|Had End of Therapy (EOT) Assessment||19
8464224|NCT00695903|20856866|P1|STARTED|Had End of Therapy (EOT) Assessment||19
8464225|NCT00695864|20856878|P1|NOT COMPLETED|Ondansetron||5
8464226|NCT00695864|20856878|P1|COMPLETED|Ondansetron||9
8464227|NCT00695864|20856878|P1|STARTED|Ondansetron||14
8464228|NCT00695864|20856878|P1|NOT COMPLETED|Placebo||5
8464229|NCT00695864|20856878|P1|COMPLETED|Placebo||9
8464230|NCT00695864|20856878|P1|STARTED|Placebo||14
8464231|NCT00695669|20856888|P4|NOT COMPLETED|Overall Study||4
8464232|NCT00695669|20856889|P3|NOT COMPLETED|Overall Study||3
8464233|NCT00695669|20856890|P2|NOT COMPLETED|Overall Study||4
8464234|NCT00695669|20856891|P1|NOT COMPLETED|Overall Study||4
8464235|NCT00695669|20856888|P4|COMPLETED|Overall Study||74
8464236|NCT00695669|20856889|P3|COMPLETED|Overall Study||75
8464237|NCT00695669|20856890|P2|COMPLETED|Overall Study||74
8464238|NCT00695669|20856891|P1|COMPLETED|Overall Study||74
8464239|NCT00695669|20856888|P4|STARTED|Overall Study||78
8464240|NCT00695669|20856889|P3|STARTED|Overall Study||78
8464241|NCT00695669|20856890|P2|STARTED|Overall Study||78
8464242|NCT00695669|20856891|P1|STARTED|Overall Study||78
8464243|NCT00695578|20856967|P2|NOT COMPLETED|Overall Study||0
8464244|NCT00695578|20856968|P1|NOT COMPLETED|Overall Study||0
8464245|NCT00695578|20856967|P2|COMPLETED|Overall Study||10
8464246|NCT00695578|20856968|P1|COMPLETED|Overall Study||10
8464247|NCT00695578|20856967|P2|STARTED|Overall Study||10
8464248|NCT00695578|20856968|P1|STARTED|Overall Study||10
8464249|NCT00695565|20856976|P2|NOT COMPLETED|Overall Study||9
8464250|NCT00695565|20856977|P1|NOT COMPLETED|Overall Study||13
8464251|NCT00695565|20856976|P2|COMPLETED|Overall Study||81
8464252|NCT00695565|20856977|P1|COMPLETED|Overall Study||77
8464253|NCT00695565|20856976|P2|STARTED|Overall Study||90
8464254|NCT00695565|20856977|P1|STARTED|Overall Study||90
8464255|NCT00695500|20857011|P2|NOT COMPLETED|Overall Study||5
8464256|NCT00695500|20857012|P1|NOT COMPLETED|Overall Study||3
8464257|NCT00695500|20857011|P2|COMPLETED|Overall Study||17
8464258|NCT00695500|20857012|P1|COMPLETED|Overall Study||21
8464259|NCT00695500|20857011|P2|STARTED|Overall Study||22
8464260|NCT00695500|20857012|P1|STARTED|Overall Study||24
8464261|NCT00695435|20857022|P3|NOT COMPLETED|Overall Study||0
8464262|NCT00695435|20857023|P2|NOT COMPLETED|Overall Study||0
8464263|NCT00695435|20857024|P1|NOT COMPLETED|Overall Study||0
8464264|NCT00695435|20857022|P3|COMPLETED|Overall Study||7
8464265|NCT00695435|20857023|P2|COMPLETED|Overall Study||7
8464266|NCT00695435|20857024|P1|COMPLETED|Overall Study||7
8464267|NCT00695435|20857022|P3|STARTED|Overall Study||7
8464268|NCT00695435|20857023|P2|STARTED|Overall Study||7
8464269|NCT00695435|20857024|P1|STARTED|Overall Study||7
8464270|NCT00695409|20857035|P1|NOT COMPLETED|Overall Study||0
8464271|NCT00695409|20857035|P1|COMPLETED|Overall Study||122
8464272|NCT00695409|20857035|P1|STARTED|Overall Study||122
8464273|NCT00695396|20857050|P3|NOT COMPLETED|Overall Study||8
8464274|NCT00695396|20857051|P2|NOT COMPLETED|Overall Study||8
8464275|NCT00695396|20857052|P1|NOT COMPLETED|Overall Study||7
8464276|NCT00695396|20857050|P3|COMPLETED|Overall Study||1
8464277|NCT00695396|20857051|P2|COMPLETED|Overall Study||0
8464278|NCT00695396|20857052|P1|COMPLETED|Overall Study||1
8464279|NCT00695396|20857050|P3|STARTED|Overall Study||9
8464280|NCT00695396|20857051|P2|STARTED|Overall Study||8
8464281|NCT00695396|20857052|P1|STARTED|Overall Study||8
8464282|NCT00695318|20857068|P2|NOT COMPLETED|Overall Study||1
8464283|NCT00695318|20857069|P1|NOT COMPLETED|Overall Study||5
8464284|NCT00695318|20857068|P2|COMPLETED|Overall Study||6
8464285|NCT00695318|20857069|P1|COMPLETED|Overall Study||5
8464286|NCT00695318|20857068|P2|STARTED|Overall Study||7
8464287|NCT00695318|20857069|P1|STARTED|Overall Study||10
8464288|NCT00695292|20857080|P1|NOT COMPLETED|Overall Study||0
8464289|NCT00695292|20857080|P1|COMPLETED|Overall Study||37
8464290|NCT00695292|20857080|P1|STARTED|Overall Study||37
8464291|NCT00695188|20857087|P2|NOT COMPLETED|Overall Study||0
8464292|NCT00695188|20857088|P1|NOT COMPLETED|Overall Study||0
8464293|NCT00695188|20857087|P2|COMPLETED|Overall Study||9
8464294|NCT00695188|20857088|P1|COMPLETED|Overall Study||10
8464295|NCT00695188|20857087|P2|STARTED|Overall Study||9
8464296|NCT00695188|20857088|P1|STARTED|Overall Study||10
8464297|NCT00695136|20857094|P1|NOT COMPLETED|Overall Study||2
8464298|NCT00695136|20857094|P1|COMPLETED|Overall Study||5
8464299|NCT00695136|20857094|P1|STARTED|Overall Study|7|7
8464300|NCT00695097|20857100|P2|NOT COMPLETED|Overall Study||0
8464301|NCT00695097|20857101|P1|NOT COMPLETED|Overall Study||1
8464302|NCT00695097|20857100|P2|COMPLETED|Overall Study||5
8464303|NCT00695097|20857101|P1|COMPLETED|Overall Study||9
8464304|NCT00695097|20857100|P2|STARTED|Overall Study||5
8464305|NCT00695097|20857101|P1|STARTED|Overall Study||10
8464306|NCT00695019|20857110|P3|NOT COMPLETED|Overall Study||10
8464307|NCT00695019|20857111|P2|NOT COMPLETED|Overall Study||14
8464308|NCT00695019|20857112|P1|NOT COMPLETED|Overall Study||13
8464309|NCT00695019|20857110|P3|COMPLETED|Overall Study||47
8464310|NCT00695019|20857111|P2|COMPLETED|Overall Study||39
8464311|NCT00695019|20857112|P1|COMPLETED|Overall Study||46
8464312|NCT00695019|20857110|P3|STARTED|Overall Study||57
8464313|NCT00695019|20857111|P2|STARTED|Overall Study||53
8464314|NCT00695019|20857112|P1|STARTED|Overall Study||59
8464315|NCT00694707|20857146|P5|NOT COMPLETED|Overall Study||40
8464316|NCT00694707|20857147|P4|NOT COMPLETED|Overall Study||50
8464317|NCT00694707|20857148|P3|NOT COMPLETED|Overall Study||51
8464318|NCT00694707|20857149|P2|NOT COMPLETED|Overall Study||55
8464319|NCT00694707|20857150|P1|NOT COMPLETED|Overall Study||72
8464320|NCT00694707|20857146|P5|COMPLETED|Overall Study||101
8464321|NCT00694707|20857147|P4|COMPLETED|Overall Study||98
8464322|NCT00694707|20857148|P3|COMPLETED|Overall Study||96
8464323|NCT00694707|20857149|P2|COMPLETED|Overall Study||90
8464324|NCT00694707|20857150|P1|COMPLETED|Overall Study||79
8464325|NCT00694707|20857146|P5|STARTED|Overall Study||141
8464326|NCT00694707|20857147|P4|STARTED|Overall Study||148
8464327|NCT00694707|20857148|P3|STARTED|Overall Study||147
8464328|NCT00694707|20857149|P2|STARTED|Overall Study||145
8464329|NCT00694707|20857150|P1|STARTED|Overall Study||151
8464330|NCT00694603|20857167|P1|NOT COMPLETED|Overall Study||0
8464331|NCT00694603|20857167|P1|COMPLETED|Overall Study||18
8464332|NCT00694603|20857167|P1|STARTED|Overall Study||18
8464333|NCT00694564|20857172|P1|NOT COMPLETED|Overall Study||2
8464334|NCT00694564|20857172|P1|COMPLETED|Overall Study||6
8464335|NCT00694564|20857172|P1|STARTED|Overall Study||8
8464336|NCT00694551|20857179|P3|NOT COMPLETED|Overall Study||1
8464337|NCT00694551|20857180|P2|NOT COMPLETED|Overall Study||0
8464338|NCT00694551|20857181|P1|NOT COMPLETED|Overall Study||1
8464339|NCT00694551|20857179|P3|COMPLETED|Overall Study||8
8464340|NCT00694551|20857180|P2|COMPLETED|Overall Study||10
8464341|NCT00694551|20857181|P1|COMPLETED|Overall Study||9
8464342|NCT00694551|20857179|P3|STARTED|Overall Study||9
8464343|NCT00694551|20857180|P2|STARTED|Overall Study||10
8464344|NCT00694551|20857181|P1|STARTED|Overall Study||10
8464345|NCT00694473|20857195|P1|NOT COMPLETED|Overall Study||7
8464346|NCT00694473|20857195|P1|COMPLETED|Overall Study|Dec 2010|69
8464347|NCT00694473|20857195|P1|STARTED|Overall Study|Aug 2008|76
8464348|NCT00694369|20857210|P5|NOT COMPLETED|Overall Study||6
8464349|NCT00694369|20857211|P4|NOT COMPLETED|Overall Study||3
8464350|NCT00694369|20857212|P3|NOT COMPLETED|Overall Study||2
8464351|NCT00694369|20857213|P2|NOT COMPLETED|Overall Study||3
8464352|NCT00694369|20857214|P1|NOT COMPLETED|Overall Study||1
8464353|NCT00694369|20857210|P5|COMPLETED|Overall Study||56
8464354|NCT00694369|20857211|P4|COMPLETED|Overall Study||189
8464355|NCT00694369|20857212|P3|COMPLETED|Overall Study||95
8464356|NCT00694369|20857213|P2|COMPLETED|Overall Study||188
8464357|NCT00694369|20857214|P1|COMPLETED|Overall Study||45
8464358|NCT00694369|20857210|P5|STARTED|Overall Study||62
8464359|NCT00694369|20857211|P4|STARTED|Overall Study||192
8464360|NCT00694369|20857212|P3|STARTED|Overall Study||97
8464361|NCT00694369|20857213|P2|STARTED|Overall Study||191
8464362|NCT00694369|20857214|P1|STARTED|Overall Study||46
8464363|NCT00694356|20857234|P3|NOT COMPLETED|Overall Study||6
8464364|NCT00694356|20857235|P2|NOT COMPLETED|Overall Study||6
8464365|NCT00694356|20857236|P1|NOT COMPLETED|Overall Study||3
8464366|NCT00694356|20857234|P3|COMPLETED|Overall Study||0
8464367|NCT00694356|20857235|P2|COMPLETED|Overall Study||0
8464368|NCT00694356|20857236|P1|COMPLETED|Overall Study||0
8464369|NCT00694356|20857234|P3|STARTED|Overall Study||6
8464370|NCT00694356|20857235|P2|STARTED|Overall Study||6
8464371|NCT00694356|20857236|P1|STARTED|Overall Study||3
8464372|NCT00694304|20857271|P1|NOT COMPLETED|Overall Study||207
8464373|NCT00694304|20857271|P1|COMPLETED|Overall Study||328
8464374|NCT00694304|20857271|P1|STARTED|Overall Study||535
8464375|NCT00694161|20857284|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
8464376|NCT00694161|20857284|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
8464377|NCT00694161|20857284|P1|STARTED|Part 2 (After Week 6 up to Month 12)||35
8464378|NCT00694161|20857284|P1|NOT COMPLETED|Part 1 (up to Week 6)||0
8464379|NCT00694161|20857284|P1|COMPLETED|Part 1 (up to Week 6)||35
8464380|NCT00694161|20857284|P1|STARTED|Part 1 (up to Week 6)||35
8464381|NCT00694122|20857323|P2|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
8464382|NCT00694122|20857324|P1|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
8464383|NCT00694122|20857323|P2|COMPLETED|Second Intervention (3-4 Weeks)||5
8464384|NCT00694122|20857324|P1|COMPLETED|Second Intervention (3-4 Weeks)||10
8464385|NCT00694122|20857323|P2|STARTED|Second Intervention (3-4 Weeks)||5
8464386|NCT00694122|20857324|P1|STARTED|Second Intervention (3-4 Weeks)||10
8464387|NCT00694122|20857323|P2|NOT COMPLETED|Washout (1 Day)||0
8464388|NCT00694122|20857324|P1|NOT COMPLETED|Washout (1 Day)||0
8464389|NCT00694122|20857323|P2|COMPLETED|Washout (1 Day)||5
8464390|NCT00694122|20857324|P1|COMPLETED|Washout (1 Day)||10
8464391|NCT00694122|20857323|P2|STARTED|Washout (1 Day)||5
8464392|NCT00694122|20857324|P1|STARTED|Washout (1 Day)||10
8464393|NCT00694122|20857323|P2|NOT COMPLETED|First Intervention (3-4 Weeks)||2
8464394|NCT00694122|20857324|P1|NOT COMPLETED|First Intervention (3-4 Weeks)||10
8464395|NCT00694122|20857323|P2|COMPLETED|First Intervention (3-4 Weeks)||5
8464396|NCT00694122|20857324|P1|COMPLETED|First Intervention (3-4 Weeks)||10
8464397|NCT00694122|20857323|P2|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
8464398|NCT00694122|20857324|P1|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
8464399|NCT00694109|20857340|P1|NOT COMPLETED|Overall Study||117
8464400|NCT00694109|20857340|P1|COMPLETED|Overall Study||25
8464401|NCT00694109|20857340|P1|Completed Consented Length of Treatment|Overall Study||60
8464402|NCT00694109|20857340|P1|Consented 2 Years Additional Treatment|Overall Study||42
8464403|NCT00694109|20857340|P1|Treated|Overall Study||141
8464404|NCT00694109|20857340|P1|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
8464405|NCT00694096|20857364|P1|NOT COMPLETED|Overall Study||5
8464406|NCT00694096|20857364|P1|COMPLETED|Overall Study||20
8464407|NCT00694096|20857364|P1|STARTED|Overall Study||25
8464408|NCT00694070|20857370|P1|NOT COMPLETED|Overall Study||0
8464409|NCT00694070|20857370|P1|COMPLETED|Overall Study||51
8464410|NCT00694070|20857370|P1|STARTED|Overall Study||51
8464411|NCT00694018|20857378|P2|NOT COMPLETED|Overall Study||9
8464412|NCT00694018|20857379|P1|NOT COMPLETED|Overall Study||13
8464413|NCT00694018|20857378|P2|COMPLETED|Overall Study||102
8464414|NCT00694018|20857379|P1|COMPLETED|Overall Study||105
8464415|NCT00694018|20857378|P2|6 Months|Overall Study||101
8464416|NCT00694018|20857379|P1|6 Months|Overall Study||106
8464417|NCT00694018|20857378|P2|STARTED|Overall Study||111
8464418|NCT00694018|20857379|P1|STARTED|Overall Study||118
8464419|NCT00693992|20857387|P2|NOT COMPLETED|Overall Study||0
8464420|NCT00693992|20857388|P1|NOT COMPLETED|Overall Study||0
8464421|NCT00693992|20857387|P2|COMPLETED|Overall Study||104
8464422|NCT00693992|20857388|P1|COMPLETED|Overall Study||106
8464423|NCT00693992|20857387|P2|STARTED|Overall Study||104
8464424|NCT00693992|20857388|P1|STARTED|Overall Study||106
8464425|NCT00693784|20857404|P1|NOT COMPLETED|Overall Study||4
8464426|NCT00693784|20857404|P1|COMPLETED|Overall Study||11
8464427|NCT00693784|20857404|P1|104-week Extended Follow-up|Overall Study||11
8464428|NCT00693784|20857404|P1|52-week Extended Follow-up|Overall Study||13
8464429|NCT00693784|20857404|P1|26-Week Primary Endpoint|Overall Study||15
8464430|NCT00693784|20857404|P1|STARTED|Overall Study||15
8464431|NCT00693719|20857410|P1|NOT COMPLETED|Overall Study||0
8464432|NCT00693719|20857410|P1|COMPLETED|Overall Study||31
8464433|NCT00693719|20857410|P1|STARTED|Overall Study||31
8464434|NCT00693706|20857417|P2|NOT COMPLETED|Overall Study||1
8464435|NCT00693706|20857418|P1|NOT COMPLETED|Overall Study||0
8464436|NCT00693706|20857417|P2|COMPLETED|Overall Study||98
8464437|NCT00693706|20857418|P1|COMPLETED|Overall Study||101
8464438|NCT00693706|20857417|P2|STARTED|Overall Study||99
8464439|NCT00693706|20857418|P1|STARTED|Overall Study||101
8464440|NCT00693693|20857445|P3|NOT COMPLETED|Overall Study||2
8464441|NCT00693693|20857446|P2|NOT COMPLETED|Overall Study||1
8464442|NCT00693693|20857447|P1|NOT COMPLETED|Overall Study||1
8464443|NCT00693693|20857445|P3|COMPLETED|Overall Study||7
8464444|NCT00693693|20857446|P2|COMPLETED|Overall Study||8
8464445|NCT00693693|20857447|P1|COMPLETED|Overall Study||6
8464446|NCT00693693|20857445|P3|STARTED|Overall Study||9
8464447|NCT00693693|20857446|P2|STARTED|Overall Study||9
8464448|NCT00693693|20857447|P1|STARTED|Overall Study||7
8464449|NCT00693654|20857457|P2|NOT COMPLETED|Overall Study||0
8464450|NCT00693654|20857458|P1|NOT COMPLETED|Overall Study||0
8464451|NCT00693654|20857457|P2|COMPLETED|Overall Study||14
8464452|NCT00693654|20857458|P1|COMPLETED|Overall Study||14
8464453|NCT00693654|20857457|P2|STARTED|Overall Study||14
8464454|NCT00693654|20857458|P1|STARTED|Overall Study||14
8464455|NCT00693628|20857468|P2|NOT COMPLETED|Overall Study||0
8464456|NCT00693628|20857469|P1|NOT COMPLETED|Overall Study||0
8464457|NCT00693628|20857468|P2|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
8464458|NCT00693628|20857469|P1|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
8464459|NCT00693628|20857468|P2|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
8464460|NCT00693628|20857469|P1|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
8464461|NCT00693498|20857477|P2|NOT COMPLETED|Overall Study||0
8464462|NCT00693498|20857478|P1|NOT COMPLETED|Overall Study||0
8464463|NCT00693498|20857477|P2|COMPLETED|Overall Study||81
8464464|NCT00693498|20857478|P1|COMPLETED|Overall Study||81
8464465|NCT00693498|20857477|P2|STARTED|Overall Study||81
8464466|NCT00693498|20857478|P1|STARTED|Overall Study||81
8464467|NCT00693485|20857489|P3|NOT COMPLETED|Overall Study||0
8464468|NCT00693485|20857490|P2|NOT COMPLETED|Overall Study||2
8464469|NCT00693485|20857491|P1|NOT COMPLETED|Overall Study||0
8464470|NCT00693485|20857489|P3|COMPLETED|Overall Study||24
8464471|NCT00693485|20857490|P2|COMPLETED|Overall Study||19
8464472|NCT00693485|20857491|P1|COMPLETED|Overall Study||25
8464473|NCT00693485|20857489|P3|STARTED|Overall Study||24
8464474|NCT00693485|20857490|P2|STARTED|Overall Study||21
8464475|NCT00693485|20857491|P1|STARTED|Overall Study||25
8464476|NCT00693472|20857506|P4|NOT COMPLETED|Part 2||2
8464477|NCT00693472|20857507|P3|NOT COMPLETED|Part 2||2
8464478|NCT00693472|20857508|P2|NOT COMPLETED|Part 2||0
8464479|NCT00693472|20857509|P1|NOT COMPLETED|Part 2||0
8464480|NCT00693472|20857506|P4|COMPLETED|Part 2||4
8464481|NCT00693472|20857507|P3|COMPLETED|Part 2||6
8464482|NCT00693472|20857508|P2|COMPLETED|Part 2||0
8464483|NCT00693472|20857509|P1|COMPLETED|Part 2||0
8464484|NCT00693472|20857506|P4|STARTED|Part 2||6
8464485|NCT00693472|20857507|P3|STARTED|Part 2||8
8464486|NCT00693472|20857508|P2|STARTED|Part 2||0
8464487|NCT00693472|20857509|P1|STARTED|Part 2||0
8464488|NCT00693472|20857506|P4|NOT COMPLETED|Part 1||0
8464489|NCT00693472|20857507|P3|NOT COMPLETED|Part 1||0
8464490|NCT00693472|20857508|P2|NOT COMPLETED|Part 1||4
8464491|NCT00693472|20857509|P1|NOT COMPLETED|Part 1||6
8464492|NCT00693472|20857506|P4|COMPLETED|Part 1||0
8464493|NCT00693472|20857507|P3|COMPLETED|Part 1||0
8464494|NCT00693472|20857508|P2|COMPLETED|Part 1||9
8464495|NCT00693472|20857509|P1|COMPLETED|Part 1||13
8464496|NCT00693472|20857506|P4|STARTED|Part 1||0
8464497|NCT00693472|20857507|P3|STARTED|Part 1||0
8464498|NCT00693472|20857508|P2|STARTED|Part 1||13
8464499|NCT00693472|20857509|P1|STARTED|Part 1||19
8464500|NCT00693420|20857529|P2|NOT COMPLETED|Overall Study||15
8464501|NCT00693420|20857530|P1|NOT COMPLETED|Overall Study||6
8464502|NCT00693420|20857529|P2|COMPLETED|Overall Study||126
8464503|NCT00693420|20857530|P1|COMPLETED|Overall Study||131
8464504|NCT00693420|20857529|P2|STARTED|Overall Study||141
8464505|NCT00693420|20857530|P1|STARTED|Overall Study||137
8464506|NCT00693303|20857554|P1|NOT COMPLETED|Overall Study||0
8464507|NCT00693303|20857554|P1|COMPLETED|Overall Study||21
8464508|NCT00693303|20857554|P1|STARTED|Overall Study||21
8464509|NCT00693238|20857560|P2|NOT COMPLETED|Overall Study||0
8464510|NCT00693238|20857561|P1|NOT COMPLETED|Overall Study||0
8464511|NCT00693238|20857560|P2|COMPLETED|Overall Study||106
8464512|NCT00693238|20857561|P1|COMPLETED|Overall Study||122
8464513|NCT00693238|20857560|P2|STARTED|Overall Study||106
8464514|NCT00693238|20857561|P1|STARTED|Overall Study||122
8464515|NCT00693225|20857569|P2|NOT COMPLETED|Overall Study||5
8464516|NCT00693225|20857570|P1|NOT COMPLETED|Overall Study||2
8464517|NCT00693225|20857569|P2|COMPLETED|Overall Study||43
8464518|NCT00693225|20857570|P1|COMPLETED|Overall Study||41
8464519|NCT00693225|20857569|P2|STARTED|Overall Study||48
8464520|NCT00693225|20857570|P1|STARTED|Overall Study||43
8464521|NCT00693160|20857582|P2|NOT COMPLETED|Overall Study||0
8464522|NCT00693160|20857583|P1|NOT COMPLETED|Overall Study||0
8464523|NCT00693160|20857582|P2|COMPLETED|Overall Study||16
8464524|NCT00693160|20857583|P1|COMPLETED|Overall Study||14
8464525|NCT00693160|20857582|P2|STARTED|Overall Study||16
8464526|NCT00693160|20857583|P1|STARTED|Overall Study||14
8464527|NCT00693017|20857593|P2|NOT COMPLETED|Overall Study||2
8464528|NCT00693017|20857594|P1|NOT COMPLETED|Overall Study||2
8464529|NCT00693017|20857593|P2|COMPLETED|Overall Study||0
8464530|NCT00693017|20857594|P1|COMPLETED|Overall Study||0
8464531|NCT00693017|20857593|P2|STARTED|Overall Study||2
8464532|NCT00693017|20857594|P1|STARTED|Overall Study||2
8464533|NCT00692978|20857604|P2|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
8464534|NCT00692978|20857605|P1|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
8464535|NCT00692978|20857604|P2|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
8464536|NCT00692978|20857605|P1|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
8464537|NCT00692978|20857604|P2|STARTED|FP 6 Microns Size With MDI Inhaler||15
8464538|NCT00692978|20857605|P1|STARTED|FP 6 Microns Size With MDI Inhaler||15
8464539|NCT00692978|20857604|P2|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
8464540|NCT00692978|20857605|P1|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
8464541|NCT00692978|20857604|P2|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
8464542|NCT00692978|20857605|P1|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
8464543|NCT00692978|20857604|P2|STARTED|FP 3 Microns Size With MDI Inhaler||15
8464544|NCT00692978|20857605|P1|STARTED|FP 3 Microns Size With MDI Inhaler||15
8464545|NCT00692978|20857604|P2|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
8464546|NCT00692978|20857605|P1|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
8464547|NCT00692978|20857604|P2|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
8464548|NCT00692978|20857605|P1|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
8464549|NCT00692978|20857604|P2|STARTED|FP1.5 Microns Size With MDI Inhaler||15
8464550|NCT00692978|20857605|P1|STARTED|FP1.5 Microns Size With MDI Inhaler||15
8464551|NCT00692978|20857604|P2|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
8464552|NCT00692978|20857605|P1|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
8464553|NCT00692978|20857604|P2|COMPLETED|FP From Active 250 ug MDI Inhaler||15
8464554|NCT00692978|20857605|P1|COMPLETED|FP From Active 250 ug MDI Inhaler||15
8464555|NCT00692978|20857604|P2|STARTED|FP From Active 250 ug MDI Inhaler||15
8464556|NCT00692978|20857605|P1|STARTED|FP From Active 250 ug MDI Inhaler||15
8464557|NCT00692913|20857625|P2|NOT COMPLETED|Overall Study||30
8464558|NCT00692913|20857626|P1|NOT COMPLETED|Overall Study||29
8464559|NCT00692913|20857625|P2|COMPLETED|Overall Study||228
8464560|NCT00692913|20857626|P1|COMPLETED|Overall Study||228
8464561|NCT00692913|20857625|P2|STARTED|Overall Study||258
8464562|NCT00692913|20857626|P1|STARTED|Overall Study||257
8464563|NCT00692770|20857648|P2|NOT COMPLETED|Overall Study||558
8464564|NCT00692770|20857649|P1|NOT COMPLETED|Overall Study||556
8464565|NCT00692770|20857648|P2|COMPLETED|Overall Study||0
8464566|NCT00692770|20857649|P1|COMPLETED|Overall Study||0
8464567|NCT00692770|20857648|P2|Participants Received Treatment|Overall Study||554
8464568|NCT00692770|20857649|P1|Participants Received Treatment|Overall Study||553
8464569|NCT00692770|20857648|P2|STARTED|Overall Study||558
8464570|NCT00692770|20857649|P1|STARTED|Overall Study||556
8464571|NCT00692692|20857673|P2|NOT COMPLETED|Overall Study||0
8464572|NCT00692692|20857674|P1|NOT COMPLETED|Overall Study||0
8464573|NCT00692692|20857673|P2|COMPLETED|Overall Study||16
8464574|NCT00692692|20857674|P1|COMPLETED|Overall Study||20
8464575|NCT00692692|20857673|P2|STARTED|Overall Study||16
8464576|NCT00692692|20857674|P1|STARTED|Overall Study||20
8464577|NCT00692419|20857684|P2|NOT COMPLETED|Overall Study||18
8464578|NCT00692419|20857685|P1|NOT COMPLETED|Overall Study||16
8464579|NCT00692419|20857684|P2|COMPLETED|Overall Study||102
8464580|NCT00692419|20857685|P1|COMPLETED|Overall Study||84
8464581|NCT00692419|20857684|P2|STARTED|Overall Study||120
8464582|NCT00692419|20857685|P1|STARTED|Overall Study||100
8464583|NCT00692406|20857695|P1|NOT COMPLETED|Overall Study||57
8464584|NCT00692406|20857695|P1|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
8464585|NCT00692406|20857695|P1|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
8464586|NCT00692341|20857709|P3|NOT COMPLETED|Overall Study||0
8464587|NCT00692341|20857710|P2|NOT COMPLETED|Overall Study||0
8464588|NCT00692341|20857711|P1|NOT COMPLETED|Overall Study||0
8464589|NCT00692341|20857709|P3|COMPLETED|Overall Study||8
8464590|NCT00692341|20857710|P2|COMPLETED|Overall Study||8
8464591|NCT00692341|20857711|P1|COMPLETED|Overall Study||8
8464592|NCT00692341|20857709|P3|STARTED|Overall Study||8
8464593|NCT00692341|20857710|P2|STARTED|Overall Study||8
8464594|NCT00692341|20857711|P1|STARTED|Overall Study||8
8464595|NCT00692276|20857757|P2|NOT COMPLETED|Completed 24 Months||14
8464596|NCT00692276|20857758|P1|NOT COMPLETED|Completed 24 Months||7
8464597|NCT00692276|20857757|P2|COMPLETED|Completed 24 Months||187
8464598|NCT00692276|20857758|P1|COMPLETED|Completed 24 Months||183
8464599|NCT00692276|20857757|P2|STARTED|Completed 24 Months||201
8464600|NCT00692276|20857758|P1|STARTED|Completed 24 Months||190
8464601|NCT00692276|20857757|P2|NOT COMPLETED|Randomized Population||0
8464602|NCT00692276|20857758|P1|NOT COMPLETED|Randomized Population||0
8464603|NCT00692276|20857757|P2|COMPLETED|Randomized Population||201
8464604|NCT00692276|20857758|P1|COMPLETED|Randomized Population||190
8464605|NCT00692276|20857757|P2|STARTED|Randomized Population||201
8464606|NCT00692276|20857758|P1|STARTED|Randomized Population||190
8464607|NCT00692237|20857766|P2|NOT COMPLETED|Overall Study||4
8464608|NCT00692237|20857767|P1|NOT COMPLETED|Overall Study||1
8464609|NCT00692237|20857766|P2|COMPLETED|Overall Study||25
8464610|NCT00692237|20857767|P1|COMPLETED|Overall Study||29
8464611|NCT00692237|20857766|P2|STARTED|Overall Study||29
8464612|NCT00692237|20857767|P1|STARTED|Overall Study||30
8464613|NCT00692211|20857777|P2|NOT COMPLETED|Overall Study||0
8464614|NCT00692211|20857778|P1|NOT COMPLETED|Overall Study||0
8464615|NCT00692211|20857777|P2|COMPLETED|Overall Study||202
8464616|NCT00692211|20857778|P1|COMPLETED|Overall Study||202
8464617|NCT00692211|20857777|P2|STARTED|Overall Study||202
8464618|NCT00692211|20857778|P1|STARTED|Overall Study||202
8464619|NCT00692198|20857786|P2|NOT COMPLETED|Overall Study||0
8464620|NCT00692198|20857787|P1|NOT COMPLETED|Overall Study||0
8464621|NCT00692198|20857786|P2|COMPLETED|Overall Study||370
8464622|NCT00692198|20857787|P1|COMPLETED|Overall Study||368
8464623|NCT00692198|20857786|P2|STARTED|Overall Study||370
8464624|NCT00692198|20857787|P1|STARTED|Overall Study||368
8464625|NCT00692185|20857822|P2|NOT COMPLETED|Overall Study||3
8464626|NCT00692185|20857823|P1|NOT COMPLETED|Overall Study||3
8464627|NCT00692185|20857822|P2|COMPLETED|Overall Study||9
8464628|NCT00692185|20857823|P1|COMPLETED|Overall Study||8
8464629|NCT00692185|20857822|P2|STARTED|Overall Study||12
8464630|NCT00692185|20857823|P1|STARTED|Overall Study||11
8464631|NCT00692094|20857835|P4|NOT COMPLETED|Overall Study||0
8464632|NCT00692094|20857836|P3|NOT COMPLETED|Overall Study||0
8464633|NCT00692094|20857837|P2|NOT COMPLETED|Overall Study||0
8464634|NCT00692094|20857838|P1|NOT COMPLETED|Overall Study||0
8464635|NCT00692094|20857835|P4|COMPLETED|Overall Study||0
8464636|NCT00692094|20857836|P3|COMPLETED|Overall Study||0
8464637|NCT00692094|20857837|P2|COMPLETED|Overall Study||0
8464638|NCT00692094|20857838|P1|COMPLETED|Overall Study||0
8464639|NCT00692094|20857835|P4|STARTED|Overall Study||0
8464640|NCT00692094|20857836|P3|STARTED|Overall Study||0
8464641|NCT00692094|20857837|P2|STARTED|Overall Study||0
8464642|NCT00692094|20857838|P1|STARTED|Overall Study||0
8464643|NCT00692003|20857854|P2|NOT COMPLETED|Overall Study||1
8464644|NCT00692003|20857855|P1|NOT COMPLETED|Overall Study||5
8464645|NCT00692003|20857854|P2|COMPLETED|Overall Study||0
8464646|NCT00692003|20857855|P1|COMPLETED|Overall Study||0
8464647|NCT00692003|20857854|P2|STARTED|Overall Study||1
8464648|NCT00692003|20857855|P1|STARTED|Overall Study||5
8464649|NCT00691938|20857870|P7|NOT COMPLETED|Overall Study||0
8464650|NCT00691938|20857871|P6|NOT COMPLETED|Overall Study||0
8464651|NCT00691938|20857872|P5|NOT COMPLETED|Overall Study||0
8464652|NCT00691938|20857873|P4|NOT COMPLETED|Overall Study||0
8464653|NCT00691938|20857874|P3|NOT COMPLETED|Overall Study||0
8464654|NCT00691938|20857875|P2|NOT COMPLETED|Overall Study||0
8464655|NCT00691938|20857876|P1|NOT COMPLETED|Overall Study||1
8464656|NCT00691938|20857870|P7|COMPLETED|Overall Study||14
8464657|NCT00691938|20857871|P6|COMPLETED|Overall Study||6
8464658|NCT00691938|20857872|P5|COMPLETED|Overall Study||10
8464659|NCT00691938|20857873|P4|COMPLETED|Overall Study||8
8464660|NCT00691938|20857874|P3|COMPLETED|Overall Study||6
8464661|NCT00691938|20857875|P2|COMPLETED|Overall Study||3
8464662|NCT00691938|20857876|P1|COMPLETED|Overall Study||4
8464663|NCT00691938|20857870|P7|STARTED|Overall Study||14
8464664|NCT00691938|20857871|P6|STARTED|Overall Study||6
8464665|NCT00691938|20857872|P5|STARTED|Overall Study||10
8464666|NCT00691938|20857873|P4|STARTED|Overall Study||8
8464667|NCT00691938|20857874|P3|STARTED|Overall Study||6
8464668|NCT00691938|20857875|P2|STARTED|Overall Study||3
8464669|NCT00691938|20857876|P1|STARTED|Overall Study||5
8464670|NCT00691808|20857900|P3|NOT COMPLETED|Overall Study||0
8464671|NCT00691808|20857901|P2|NOT COMPLETED|Overall Study||1
8464672|NCT00691808|20857902|P1|NOT COMPLETED|Overall Study||0
8464673|NCT00691808|20857900|P3|COMPLETED|Overall Study||32
8464674|NCT00691808|20857901|P2|COMPLETED|Overall Study||35
8464675|NCT00691808|20857902|P1|COMPLETED|Overall Study||35
8464676|NCT00691808|20857900|P3|STARTED|Overall Study||32
8464677|NCT00691808|20857901|P2|STARTED|Overall Study||36
8464678|NCT00691808|20857902|P1|STARTED|Overall Study||35
8464679|NCT00691704|20857943|P1|NOT COMPLETED|Two Years of Maintenance Therapy||13
8464680|NCT00691704|20857943|P1|COMPLETED|Two Years of Maintenance Therapy||3
8464681|NCT00691704|20857943|P1|STARTED|Two Years of Maintenance Therapy||16
8464682|NCT00691704|20857943|P1|NOT COMPLETED|Induction Therapy||2
8464683|NCT00691704|20857943|P1|COMPLETED|Induction Therapy||16
8464684|NCT00691704|20857943|P1|STARTED|Induction Therapy||18
8464685|NCT00691665|20857953|P2|NOT COMPLETED|Overall Study||0
8464686|NCT00691665|20857954|P1|NOT COMPLETED|Overall Study||0
8464687|NCT00691665|20857953|P2|COMPLETED|Overall Study||65
8464688|NCT00691665|20857954|P1|COMPLETED|Overall Study||65
8464689|NCT00691665|20857953|P2|STARTED|Overall Study||65
8464690|NCT00691665|20857954|P1|STARTED|Overall Study||65
8464691|NCT00691652|20857966|P1|NOT COMPLETED|Overall Study||1
8464692|NCT00691652|20857966|P1|COMPLETED|Overall Study||1
8464693|NCT00691652|20857966|P1|STARTED|Overall Study||2
8464694|NCT00691600|20857978|P2|NOT COMPLETED|Overall Study||0
8464695|NCT00691600|20857979|P1|NOT COMPLETED|Overall Study||0
8464696|NCT00691600|20857978|P2|COMPLETED|Overall Study||11
8464697|NCT00691600|20857979|P1|COMPLETED|Overall Study||12
8464698|NCT00691600|20857978|P2|STARTED|Overall Study||11
8464699|NCT00691600|20857979|P1|STARTED|Overall Study||12
8464700|NCT00691574|20857991|P2|NOT COMPLETED|Overall Study||0
8464701|NCT00691574|20857992|P1|NOT COMPLETED|Overall Study||0
8464702|NCT00691574|20857991|P2|COMPLETED|Overall Study||0
8464703|NCT00691574|20857992|P1|COMPLETED|Overall Study||0
8464704|NCT00691574|20857991|P2|STARTED|Overall Study||0
8464705|NCT00691574|20857992|P1|STARTED|Overall Study||0
8464706|NCT00691483|20858004|P2|NOT COMPLETED|Overall Study||25
8464707|NCT00691483|20858005|P1|NOT COMPLETED|Overall Study||68
8464708|NCT00691483|20858004|P2|COMPLETED|Overall Study||141
8464709|NCT00691483|20858005|P1|COMPLETED|Overall Study|Completed refers to completion of the study.|425
8464710|NCT00691483|20858004|P2|Received Treatment|Overall Study||165
8464711|NCT00691483|20858005|P1|Received Treatment|Overall Study||486
8464712|NCT00691483|20858004|P2|STARTED|Overall Study||166
8464713|NCT00691483|20858005|P1|STARTED|Overall Study||493
8464714|NCT00691444|20858024|P3|NOT COMPLETED|Overall Study||0
8464715|NCT00691444|20858025|P2|NOT COMPLETED|Overall Study||0
8464716|NCT00691444|20858026|P1|NOT COMPLETED|Overall Study||0
8464717|NCT00691444|20858024|P3|COMPLETED|Overall Study||0
8464718|NCT00691444|20858025|P2|COMPLETED|Overall Study||0
8464719|NCT00691444|20858026|P1|COMPLETED|Overall Study||0
8464720|NCT00691444|20858024|P3|STARTED|Overall Study||0
8464721|NCT00691444|20858025|P2|STARTED|Overall Study||0
8464722|NCT00691444|20858026|P1|STARTED|Overall Study||0
8464723|NCT00691327|20858039|P2|NOT COMPLETED|Overall Study||2508
8464724|NCT00691327|20858040|P1|NOT COMPLETED|Overall Study||2841
8464725|NCT00691327|20858039|P2|COMPLETED|Overall Study||36766
8464726|NCT00691327|20858040|P1|COMPLETED|Overall Study||42214
8464727|NCT00691327|20858039|P2|STARTED|Overall Study||39274
8464728|NCT00691327|20858040|P1|STARTED|Overall Study||45055
8464729|NCT00691301|20858048|P1|NOT COMPLETED|Overall Study||54
8464730|NCT00691301|20858048|P1|COMPLETED|Overall Study||1
8464731|NCT00691301|20858048|P1|STARTED|Overall Study||55
8464732|NCT00691210|20858068|P8|NOT COMPLETED|Overall Study||0
8464733|NCT00691210|20858069|P7|NOT COMPLETED|Overall Study||0
8464734|NCT00691210|20858070|P6|NOT COMPLETED|Overall Study||1
8464735|NCT00691210|20858071|P5|NOT COMPLETED|Overall Study||0
8464736|NCT00691210|20858072|P4|NOT COMPLETED|Overall Study||3
8464737|NCT00691210|20858073|P3|NOT COMPLETED|Overall Study||0
8464738|NCT00691210|20858074|P2|NOT COMPLETED|Overall Study||0
8464739|NCT00691210|20858075|P1|NOT COMPLETED|Overall Study||0
8464740|NCT00691210|20858068|P8|COMPLETED|Overall Study||0
8464741|NCT00691210|20858069|P7|COMPLETED|Overall Study||6
8464742|NCT00691210|20858070|P6|COMPLETED|Overall Study||6
8464743|NCT00691210|20858071|P5|COMPLETED|Overall Study||5
8464744|NCT00691210|20858072|P4|COMPLETED|Overall Study||6
8464745|NCT00691210|20858073|P3|COMPLETED|Overall Study||3
8464746|NCT00691210|20858074|P2|COMPLETED|Overall Study||5
8464747|NCT00691210|20858075|P1|COMPLETED|Overall Study||3
8464748|NCT00691210|20858068|P8|STARTED|Overall Study||0
8464749|NCT00691210|20858069|P7|STARTED|Overall Study||6
8464750|NCT00691210|20858070|P6|STARTED|Overall Study||7
8464751|NCT00691210|20858071|P5|STARTED|Overall Study||5
8464752|NCT00691210|20858072|P4|STARTED|Overall Study||9
8464753|NCT00691210|20858073|P3|STARTED|Overall Study||3
8464754|NCT00691210|20858074|P2|STARTED|Overall Study||5
8464755|NCT00691210|20858075|P1|STARTED|Overall Study||3
8464756|NCT00691197|20858095|P2|NOT COMPLETED|Overall Study||5
8464757|NCT00691197|20858096|P1|NOT COMPLETED|Overall Study||11
8464758|NCT00691197|20858095|P2|COMPLETED|Overall Study||75
8464759|NCT00691197|20858096|P1|COMPLETED|Overall Study||155
8464760|NCT00691197|20858095|P2|STARTED|Overall Study||80
8464761|NCT00691197|20858096|P1|STARTED|Overall Study||166
8464762|NCT00691132|20858110|P2|NOT COMPLETED|Overall Study||13
8464763|NCT00691132|20858111|P1|NOT COMPLETED|Overall Study||12
8464764|NCT00691132|20858110|P2|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
8464765|NCT00691132|20858111|P1|COMPLETED|Overall Study||41
8464766|NCT00691132|20858110|P2|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
8464767|NCT00691132|20858111|P1|STARTED|Overall Study||53
8464768|NCT00691093|20858130|P1|NOT COMPLETED|Overall Study||7
8464769|NCT00691093|20858130|P1|COMPLETED|Overall Study||816
8464770|NCT00691093|20858130|P1|STARTED|Overall Study||823
8464771|NCT00691054|20858164|P1|NOT COMPLETED|Overall Study||1
8464772|NCT00691054|20858164|P1|COMPLETED|Overall Study||19
8464773|NCT00691054|20858164|P1|STARTED|Overall Study||20
8464774|NCT00691028|20858176|P4|NOT COMPLETED|Double-blind Period||0
8464775|NCT00691028|20858177|P3|NOT COMPLETED|Double-blind Period||9
8464776|NCT00691028|20858178|P2|NOT COMPLETED|Double-blind Period||13
8464777|NCT00691028|20858179|P1|NOT COMPLETED|Double-blind Period||13
8464778|NCT00691028|20858176|P4|COMPLETED|Double-blind Period||0
8464779|NCT00691028|20858177|P3|COMPLETED|Double-blind Period||95
8464780|NCT00691028|20858178|P2|COMPLETED|Double-blind Period||91
8464781|NCT00691028|20858179|P1|COMPLETED|Double-blind Period||86
8464782|NCT00691028|20858176|P4|STARTED|Double-blind Period||0
8464783|NCT00691028|20858177|P3|STARTED|Double-blind Period||104
8464784|NCT00691028|20858178|P2|STARTED|Double-blind Period||104
8464785|NCT00691028|20858179|P1|STARTED|Double-blind Period||99
8464786|NCT00691028|20858176|P4|NOT COMPLETED|Open-label Period||20
8464787|NCT00691028|20858177|P3|NOT COMPLETED|Open-label Period||0
8464788|NCT00691028|20858178|P2|NOT COMPLETED|Open-label Period||0
8464789|NCT00691028|20858179|P1|NOT COMPLETED|Open-label Period||0
8464790|NCT00691028|20858176|P4|COMPLETED|Open-label Period||307
8464791|NCT00691028|20858177|P3|COMPLETED|Open-label Period||0
8464792|NCT00691028|20858178|P2|COMPLETED|Open-label Period||0
8464793|NCT00691028|20858179|P1|COMPLETED|Open-label Period||0
8464794|NCT00691028|20858176|P4|STARTED|Open-label Period||327
8464795|NCT00691028|20858177|P3|STARTED|Open-label Period||0
8464796|NCT00691028|20858178|P2|STARTED|Open-label Period||0
8464797|NCT00691028|20858179|P1|STARTED|Open-label Period||0
8464798|NCT00691015|20858212|P1|NOT COMPLETED|Overall Study||1
8464799|NCT00691015|20858212|P1|COMPLETED|Overall Study||47
8464800|NCT00691015|20858212|P1|STARTED|Overall Study||48
8464801|NCT00690924|20858223|P1|NOT COMPLETED|Overall Study||0
8464802|NCT00690924|20858223|P1|COMPLETED|Overall Study||16
8464803|NCT00690924|20858223|P1|STARTED|Overall Study||16
8464804|NCT00690898|20858227|P1|NOT COMPLETED|TREATMENT||26
8464805|NCT00690898|20858227|P1|COMPLETED|TREATMENT||64
8464806|NCT00690898|20858227|P1|STARTED|TREATMENT|Total number of patients treated.|90
8464807|NCT00690898|20858227|P1|NOT COMPLETED|SCREENING||18
8464808|NCT00690898|20858227|P1|COMPLETED|SCREENING|Number of patients included in the study.|90
8464809|NCT00690898|20858227|P1|STARTED|SCREENING|Total of patients screened for the study.|108
8464810|NCT00690833|20858241|P1|NOT COMPLETED|Overall Study||2
8464811|NCT00690833|20858241|P1|COMPLETED|Overall Study||39
8464812|NCT00690833|20858241|P1|STARTED|Overall Study||41
8464813|NCT00690820|20858247|P2|NOT COMPLETED|Period 2||0
8464814|NCT00690820|20858248|P1|NOT COMPLETED|Period 2||0
8464815|NCT00690820|20858247|P2|COMPLETED|Period 2||8
8464816|NCT00690820|20858248|P1|COMPLETED|Period 2||8
8464817|NCT00690820|20858247|P2|STARTED|Period 2||8
8464818|NCT00690820|20858248|P1|STARTED|Period 2||8
8464819|NCT00690820|20858247|P2|NOT COMPLETED|Period 1||1
8464820|NCT00690820|20858248|P1|NOT COMPLETED|Period 1||0
8464821|NCT00690820|20858247|P2|COMPLETED|Period 1||8
8464822|NCT00690820|20858248|P1|COMPLETED|Period 1||8
8464823|NCT00690820|20858247|P2|STARTED|Period 1||9
8464824|NCT00690820|20858248|P1|STARTED|Period 1||8
8464825|NCT00690794|20858270|P2|NOT COMPLETED|Overall Study||35
8464826|NCT00690794|20858271|P1|NOT COMPLETED|Overall Study||21
8464827|NCT00690794|20858270|P2|COMPLETED|Overall Study||328
8464828|NCT00690794|20858271|P1|COMPLETED|Overall Study||342
8464829|NCT00690794|20858270|P2|STARTED|Overall Study||363
8464830|NCT00690794|20858271|P1|STARTED|Overall Study||363
8464831|NCT00690755|20858286|P7|NOT COMPLETED|Overall Study||0
8464832|NCT00690755|20858287|P6|NOT COMPLETED|Overall Study||4
8464833|NCT00690755|20858288|P5|NOT COMPLETED|Overall Study||0
8464834|NCT00690755|20858289|P4|NOT COMPLETED|Overall Study||5
8464835|NCT00690755|20858290|P3|NOT COMPLETED|Overall Study||46
8464836|NCT00690755|20858291|P2|NOT COMPLETED|Overall Study||0
8464837|NCT00690755|20858292|P1|NOT COMPLETED|Overall Study||2
8464838|NCT00690755|20858286|P7|COMPLETED|Overall Study||0
8464839|NCT00690755|20858287|P6|COMPLETED|Overall Study||6
8464840|NCT00690755|20858288|P5|COMPLETED|Overall Study||0
8464841|NCT00690755|20858289|P4|COMPLETED|Overall Study||15
8464842|NCT00690755|20858290|P3|COMPLETED|Overall Study||51
8464843|NCT00690755|20858291|P2|COMPLETED|Overall Study||0
8464844|NCT00690755|20858292|P1|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
8464845|NCT00690755|20858286|P7|STARTED|Overall Study||0
8464846|NCT00690755|20858287|P6|STARTED|Overall Study||10
8464847|NCT00690755|20858288|P5|STARTED|Overall Study||0
8464848|NCT00690755|20858289|P4|STARTED|Overall Study||20
8464849|NCT00690755|20858290|P3|STARTED|Overall Study||97
8464850|NCT00690755|20858291|P2|STARTED|Overall Study||0
8464851|NCT00690755|20858292|P1|STARTED|Overall Study||30
8464852|NCT00690612|20858308|P1|NOT COMPLETED|Overall Study||3
8464853|NCT00690612|20858308|P1|COMPLETED|Overall Study||32
8464854|NCT00690612|20858308|P1|STARTED|Overall Study||35
8464855|NCT00690573|20858313|P1|NOT COMPLETED|Overall Study||9
8464856|NCT00690573|20858313|P1|COMPLETED|Overall Study||16
8464857|NCT00690573|20858313|P1|STARTED|Overall Study||25
8464858|NCT00690495|20858323|P2|NOT COMPLETED|Overall Study||0
8464859|NCT00690495|20858324|P1|NOT COMPLETED|Overall Study||0
8464860|NCT00690495|20858323|P2|COMPLETED|Overall Study||50
8464861|NCT00690495|20858324|P1|COMPLETED|Overall Study||50
8464862|NCT00690495|20858323|P2|Primary Endpoint|Overall Study||50
8464863|NCT00690495|20858324|P1|Primary Endpoint|Overall Study||50
8464864|NCT00690495|20858323|P2|STARTED|Overall Study||50
8464865|NCT00690495|20858324|P1|STARTED|Overall Study||50
8464866|NCT00690482|20858332|P2|NOT COMPLETED|Overall Study||3
8464867|NCT00690482|20858333|P1|NOT COMPLETED|Overall Study||4
8464868|NCT00690482|20858332|P2|COMPLETED|Overall Study||54
8464869|NCT00690482|20858333|P1|COMPLETED|Overall Study||57
8464870|NCT00690482|20858332|P2|STARTED|Overall Study||57
8464871|NCT00690482|20858333|P1|STARTED|Overall Study||61
8464872|NCT00690443|20858367|P2|NOT COMPLETED|Overall Study||2
8464873|NCT00690443|20858368|P1|NOT COMPLETED|Overall Study||1
8464874|NCT00690443|20858367|P2|COMPLETED|Overall Study||19
8464875|NCT00690443|20858368|P1|COMPLETED|Overall Study||22
8464876|NCT00690443|20858367|P2|STARTED|Overall Study||21
8464877|NCT00690443|20858368|P1|STARTED|Overall Study||23
8464878|NCT00690430|20858378|P3|NOT COMPLETED|Extension Phase||13
8464879|NCT00690430|20858379|P2|NOT COMPLETED|Extension Phase||5
8464880|NCT00690430|20858380|P1|NOT COMPLETED|Extension Phase||18
8464881|NCT00690430|20858378|P3|COMPLETED|Extension Phase||2
8464882|NCT00690430|20858379|P2|COMPLETED|Extension Phase||1
8464883|NCT00690430|20858380|P1|COMPLETED|Extension Phase||2
8464884|NCT00690430|20858378|P3|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
8464885|NCT00690430|20858379|P2|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
8464886|NCT00690430|20858380|P1|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
8464887|NCT00690430|20858378|P3|NOT COMPLETED|Core Phase||0
8464888|NCT00690430|20858379|P2|NOT COMPLETED|Core Phase||23
8464889|NCT00690430|20858380|P1|NOT COMPLETED|Core Phase||18
8464890|NCT00690430|20858378|P3|COMPLETED|Core Phase||0
8464891|NCT00690430|20858379|P2|COMPLETED|Core Phase||34
8464892|NCT00690430|20858380|P1|COMPLETED|Core Phase||35
8464893|NCT00690430|20858378|P3|STARTED|Core Phase|This arm belongs to Extension Phase.|0
8464894|NCT00690430|20858379|P2|STARTED|Core Phase||57
8464895|NCT00690430|20858380|P1|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
8464896|NCT00690378|20858409|P2|NOT COMPLETED|Overall Study||14
8464897|NCT00690378|20858410|P1|NOT COMPLETED|Overall Study||20
8464898|NCT00690378|20858409|P2|COMPLETED|Overall Study|Up to LFU visit|54
8464899|NCT00690378|20858410|P1|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
8464900|NCT00690378|20858409|P2|Treated|Overall Study||67
8464901|NCT00690378|20858410|P1|Treated|Overall Study||68
8464902|NCT00690378|20858409|P2|STARTED|Overall Study|Randomized|68
8464903|NCT00690378|20858410|P1|STARTED|Overall Study|Randomized|69
8464904|NCT00690339|20858458|P4|NOT COMPLETED|Overall Study||25
8464905|NCT00690339|20858459|P3|NOT COMPLETED|Overall Study||57
8464906|NCT00690339|20858460|P2|NOT COMPLETED|Overall Study||81
8464907|NCT00690339|20858461|P1|NOT COMPLETED|Overall Study||117
8464908|NCT00690339|20858458|P4|COMPLETED|Overall Study||43
8464909|NCT00690339|20858459|P3|COMPLETED|Overall Study||99
8464910|NCT00690339|20858460|P2|COMPLETED|Overall Study||144
8464911|NCT00690339|20858461|P1|COMPLETED|Overall Study||375
8464912|NCT00690339|20858458|P4|STARTED|Overall Study||68
8464913|NCT00690339|20858459|P3|STARTED|Overall Study||156
8464914|NCT00690339|20858460|P2|STARTED|Overall Study||225
8464915|NCT00690339|20858461|P1|STARTED|Overall Study||492
8464916|NCT00690274|20858477|P2|NOT COMPLETED|Overall Study||8
8464917|NCT00690274|20858478|P1|NOT COMPLETED|Overall Study||6
8464918|NCT00690274|20858477|P2|COMPLETED|Overall Study||15
8464919|NCT00690274|20858478|P1|COMPLETED|Overall Study||23
8464920|NCT00690274|20858477|P2|STARTED|Overall Study||23
8464921|NCT00690274|20858478|P1|STARTED|Overall Study||29
8464922|NCT00690235|20858488|P2|NOT COMPLETED|Overall Study||4
8464923|NCT00690235|20858489|P1|NOT COMPLETED|Overall Study||5
8464924|NCT00690235|20858488|P2|COMPLETED|Overall Study||12
8464925|NCT00690235|20858489|P1|COMPLETED|Overall Study||12
8464926|NCT00690235|20858488|P2|STARTED|Overall Study||16
8464927|NCT00690235|20858489|P1|STARTED|Overall Study||17
8464928|NCT00690040|20858497|P2|NOT COMPLETED|Overall Study||0
8464929|NCT00690040|20858498|P1|NOT COMPLETED|Overall Study||0
8464930|NCT00690040|20858497|P2|COMPLETED|Overall Study||148
8464931|NCT00690040|20858498|P1|COMPLETED|Overall Study||145
8464932|NCT00690040|20858497|P2|STARTED|Overall Study||148
8464933|NCT00690040|20858498|P1|STARTED|Overall Study||145
8464934|NCT00689936|20858507|P3|NOT COMPLETED|Long-Term Follow Up Phase||144
8464935|NCT00689936|20858508|P2|NOT COMPLETED|Long-Term Follow Up Phase||188
8464936|NCT00689936|20858509|P1|NOT COMPLETED|Long-Term Follow Up Phase||127
8464937|NCT00689936|20858507|P3|COMPLETED|Long-Term Follow Up Phase||315
8464938|NCT00689936|20858508|P2|COMPLETED|Long-Term Follow Up Phase||275
8464939|NCT00689936|20858509|P1|COMPLETED|Long-Term Follow Up Phase||255
8464940|NCT00689936|20858507|P3|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
8464941|NCT00689936|20858508|P2|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
8464942|NCT00689936|20858509|P1|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
8464943|NCT00689936|20858507|P3|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
8464944|NCT00689936|20858508|P2|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
8464945|NCT00689936|20858509|P1|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
8464946|NCT00689936|20858507|P3|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
8464947|NCT00689936|20858508|P2|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
8464948|NCT00689936|20858509|P1|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
8464949|NCT00689936|20858507|P3|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
8464950|NCT00689936|20858508|P2|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
8464951|NCT00689936|20858509|P1|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
8464952|NCT00689936|20858507|P3|NOT COMPLETED|Active Treatment Phase||547
8464953|NCT00689936|20858508|P2|NOT COMPLETED|Active Treatment Phase||541
8464954|NCT00689936|20858509|P1|NOT COMPLETED|Active Treatment Phase||535
8464955|NCT00689936|20858507|P3|COMPLETED|Active Treatment Phase||0
8464956|NCT00689936|20858508|P2|COMPLETED|Active Treatment Phase||0
8464957|NCT00689936|20858509|P1|COMPLETED|Active Treatment Phase||0
8464958|NCT00689936|20858507|P3|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
8464959|NCT00689936|20858508|P2|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
8464960|NCT00689936|20858509|P1|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
8464961|NCT00689936|20858507|P3|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
8464962|NCT00689936|20858508|P2|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
8464963|NCT00689936|20858509|P1|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
8464964|NCT00689936|20858507|P3|STARTED|Active Treatment Phase||547
8464965|NCT00689936|20858508|P2|STARTED|Active Treatment Phase||541
8464966|NCT00689936|20858509|P1|STARTED|Active Treatment Phase||535
8464967|NCT00689884|20858649|P1|NOT COMPLETED|Overall Study||0
8464968|NCT00689884|20858649|P1|COMPLETED|Overall Study||7
8464969|NCT00689884|20858649|P1|STARTED|Overall Study||7
8464970|NCT00689871|20858658|P4|NOT COMPLETED|Overall Study||7
8464971|NCT00689871|20858659|P3|NOT COMPLETED|Overall Study||73
8464972|NCT00689871|20858660|P2|NOT COMPLETED|Overall Study||52
8464973|NCT00689871|20858661|P1|NOT COMPLETED|Overall Study||175
8464974|NCT00689871|20858658|P4|COMPLETED|Overall Study|4 Patients discontinued|8
8464975|NCT00689871|20858659|P3|COMPLETED|Overall Study|28 Patients discontinued|74
8464976|NCT00689871|20858660|P2|COMPLETED|Overall Study|35 Patients discontinued|46
8464977|NCT00689871|20858661|P1|COMPLETED|Overall Study|35 Patients discontinued|280
8464978|NCT00689871|20858658|P4|STARTED|Overall Study|25 Implants|15
8464979|NCT00689871|20858659|P3|STARTED|Overall Study|288 Implants|147
8464980|NCT00689871|20858660|P2|STARTED|Overall Study|127 Implants|98
8464981|NCT00689871|20858661|P1|STARTED|Overall Study|908 Implants|455
8464982|NCT00689819|20858677|P2|NOT COMPLETED|Overall Study||15
8464983|NCT00689819|20858678|P1|NOT COMPLETED|Overall Study||20
8464984|NCT00689819|20858677|P2|COMPLETED|Overall Study||43
8464985|NCT00689819|20858678|P1|COMPLETED|Overall Study||45
8464986|NCT00689819|20858677|P2|STARTED|Overall Study||58
8464987|NCT00689819|20858678|P1|STARTED|Overall Study||65
8464988|NCT00689793|20858688|P2|NOT COMPLETED|Overall Study||5
8464989|NCT00689793|20858689|P1|NOT COMPLETED|Overall Study||4
8464990|NCT00689793|20858688|P2|COMPLETED|Overall Study||71
8464991|NCT00689793|20858689|P1|COMPLETED|Overall Study||74
8464992|NCT00689793|20858688|P2|STARTED|Overall Study||76
8464993|NCT00689793|20858689|P1|STARTED|Overall Study||78
8464994|NCT00689728|20858708|P3|NOT COMPLETED|Optional Follow-Up||6
8464995|NCT00689728|20858709|P2|NOT COMPLETED|Optional Follow-Up||6
8464996|NCT00689728|20858710|P1|NOT COMPLETED|Optional Follow-Up||3
8464997|NCT00689728|20858708|P3|COMPLETED|Optional Follow-Up||4
8464998|NCT00689728|20858709|P2|COMPLETED|Optional Follow-Up||5
8464999|NCT00689728|20858710|P1|COMPLETED|Optional Follow-Up||6
8465000|NCT00689728|20858708|P3|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
8465001|NCT00689728|20858709|P2|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
8465002|NCT00689728|20858710|P1|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
8465003|NCT00689728|20858708|P3|NOT COMPLETED|Rescue||1
8465004|NCT00689728|20858709|P2|NOT COMPLETED|Rescue||2
8465005|NCT00689728|20858710|P1|NOT COMPLETED|Rescue||1
8465006|NCT00689728|20858708|P3|COMPLETED|Rescue||29
8465007|NCT00689728|20858709|P2|COMPLETED|Rescue||24
8465008|NCT00689728|20858710|P1|COMPLETED|Rescue||30
8465009|NCT00689728|20858708|P3|STARTED|Rescue||30
8465010|NCT00689728|20858709|P2|STARTED|Rescue||26
8465011|NCT00689728|20858710|P1|STARTED|Rescue||31
8465012|NCT00689728|20858708|P3|NOT COMPLETED|Double-Blind Treatment||5
8465013|NCT00689728|20858709|P2|NOT COMPLETED|Double-Blind Treatment||4
8465014|NCT00689728|20858710|P1|NOT COMPLETED|Double-Blind Treatment||4
8465015|NCT00689728|20858708|P3|COMPLETED|Double-Blind Treatment||30
8465016|NCT00689728|20858709|P2|COMPLETED|Double-Blind Treatment||26
8465017|NCT00689728|20858710|P1|COMPLETED|Double-Blind Treatment||31
8465018|NCT00689728|20858708|P3|STARTED|Double-Blind Treatment||35
8465019|NCT00689728|20858709|P2|STARTED|Double-Blind Treatment||30
8465020|NCT00689728|20858710|P1|STARTED|Double-Blind Treatment||35
8465021|NCT00689611|20858793|P2|NOT COMPLETED|Overall Study||46
8465022|NCT00689611|20858794|P1|NOT COMPLETED|Overall Study||41
8465023|NCT00689611|20858793|P2|COMPLETED|Overall Study||146
8465024|NCT00689611|20858794|P1|COMPLETED|Overall Study||159
8465025|NCT00689611|20858793|P2|STARTED|Overall Study||192
8465026|NCT00689611|20858794|P1|STARTED|Overall Study||200
8465027|NCT00689481|20858804|P2|NOT COMPLETED|Overall Study||14
8465028|NCT00689481|20858805|P1|NOT COMPLETED|Overall Study||24
8465029|NCT00689481|20858804|P2|COMPLETED|Overall Study||95
8465030|NCT00689481|20858805|P1|COMPLETED|Overall Study||190
8465031|NCT00689481|20858804|P2|STARTED|Overall Study||109
8465032|NCT00689481|20858805|P1|STARTED|Overall Study||214
8465033|NCT00689390|20858823|P2|NOT COMPLETED|Overall Study||10
8465034|NCT00689390|20858824|P1|NOT COMPLETED|Overall Study||426
8465035|NCT00689390|20858823|P2|COMPLETED|Overall Study||37
8465036|NCT00689390|20858824|P1|COMPLETED|Overall Study||1481
8465037|NCT00689390|20858823|P2|STARTED|Overall Study||47
8465038|NCT00689390|20858824|P1|STARTED|Overall Study||1907
8465039|NCT00689351|20858842|P2|NOT COMPLETED|Toddler Dose||0
8465040|NCT00689351|20858843|P1|NOT COMPLETED|Toddler Dose||0
8465041|NCT00689351|20858842|P2|COMPLETED|Toddler Dose||88
8465042|NCT00689351|20858843|P1|COMPLETED|Toddler Dose||84
8465043|NCT00689351|20858842|P2|STARTED|Toddler Dose||88
8465044|NCT00689351|20858843|P1|STARTED|Toddler Dose||84
8465045|NCT00689351|20858842|P2|NOT COMPLETED|After Infant Series||0
8465046|NCT00689351|20858843|P1|NOT COMPLETED|After Infant Series||1
8465047|NCT00689351|20858842|P2|COMPLETED|After Infant Series||88
8465048|NCT00689351|20858843|P1|COMPLETED|After Infant Series||84
8465049|NCT00689351|20858842|P2|STARTED|After Infant Series||88
8465050|NCT00689351|20858843|P1|STARTED|After Infant Series||85
8465051|NCT00689351|20858842|P2|NOT COMPLETED|Infant Series of Dosing||1
8465052|NCT00689351|20858843|P1|NOT COMPLETED|Infant Series of Dosing||6
8465053|NCT00689351|20858842|P2|COMPLETED|Infant Series of Dosing||88
8465054|NCT00689351|20858843|P1|COMPLETED|Infant Series of Dosing||85
8465055|NCT00689351|20858842|P2|Vaccinated Dose 3|Infant Series of Dosing||88
8465056|NCT00689351|20858843|P1|Vaccinated Dose 3|Infant Series of Dosing||85
8465057|NCT00689351|20858842|P2|Vaccinated Dose 2|Infant Series of Dosing||88
8465058|NCT00689351|20858843|P1|Vaccinated Dose 2|Infant Series of Dosing||86
8465059|NCT00689351|20858842|P2|Vaccinated Dose 1|Infant Series of Dosing||89
8465060|NCT00689351|20858843|P1|Vaccinated Dose 1|Infant Series of Dosing||88
8465061|NCT00689351|20858842|P2|STARTED|Infant Series of Dosing||89
8465062|NCT00689351|20858843|P1|STARTED|Infant Series of Dosing||91
8465063|NCT00689338|20858875|P1|NOT COMPLETED|Overall Study||143
8465064|NCT00689338|20858875|P1|COMPLETED|Overall Study||73
8465065|NCT00689338|20858875|P1|STARTED|Overall Study||216
8465066|NCT00689299|20858888|P3|NOT COMPLETED|Overall Study||5
8465067|NCT00689299|20858889|P2|NOT COMPLETED|Overall Study||3
8465068|NCT00689299|20858890|P1|NOT COMPLETED|Overall Study||7
8465069|NCT00689299|20858888|P3|COMPLETED|Overall Study||49
8465070|NCT00689299|20858889|P2|COMPLETED|Overall Study||54
8465071|NCT00689299|20858890|P1|COMPLETED|Overall Study||51
8465072|NCT00689299|20858888|P3|STARTED|Overall Study||54
8465073|NCT00689299|20858889|P2|STARTED|Overall Study||57
8465074|NCT00689299|20858890|P1|STARTED|Overall Study||58
8465075|NCT00689260|20858900|P2|NOT COMPLETED|Overall Study||0
8465076|NCT00689260|20858901|P1|NOT COMPLETED|Overall Study||2
8465077|NCT00689260|20858900|P2|COMPLETED|Overall Study||21
8465078|NCT00689260|20858901|P1|COMPLETED|Overall Study||19
8465079|NCT00689260|20858900|P2|STARTED|Overall Study||21
8465080|NCT00689260|20858901|P1|STARTED|Overall Study||21
8465081|NCT00689221|20858919|P2|NOT COMPLETED|Overall Study||36
8465082|NCT00689221|20858920|P1|NOT COMPLETED|Overall Study||39
8465083|NCT00689221|20858919|P2|COMPLETED|Overall Study||237
8465084|NCT00689221|20858920|P1|COMPLETED|Overall Study||233
8465085|NCT00689221|20858919|P2|STARTED|Overall Study||273
8465086|NCT00689221|20858920|P1|STARTED|Overall Study||272
8465087|NCT00689117|20858949|P4|NOT COMPLETED|Overall Study||31
8465088|NCT00689117|20858950|P3|NOT COMPLETED|Overall Study||59
8465089|NCT00689117|20858951|P2|NOT COMPLETED|Overall Study||51
8465090|NCT00689117|20858952|P1|NOT COMPLETED|Overall Study||62
8465091|NCT00689117|20858949|P4|COMPLETED|Overall Study||211
8465092|NCT00689117|20858950|P3|COMPLETED|Overall Study||405
8465093|NCT00689117|20858951|P2|COMPLETED|Overall Study||416
8465094|NCT00689117|20858952|P1|COMPLETED|Overall Study||414
8465095|NCT00689117|20858949|P4|STARTED|Overall Study||242
8465096|NCT00689117|20858950|P3|STARTED|Overall Study||464
8465097|NCT00689117|20858951|P2|STARTED|Overall Study||467
8465098|NCT00689117|20858952|P1|STARTED|Overall Study||476
8465099|NCT00689104|20858982|P4|NOT COMPLETED|Overall Study||50
8465100|NCT00689104|20858983|P3|NOT COMPLETED|Overall Study||45
8465101|NCT00689104|20858984|P2|NOT COMPLETED|Overall Study||57
8465102|NCT00689104|20858985|P1|NOT COMPLETED|Overall Study||44
8465103|NCT00689104|20858982|P4|COMPLETED|Overall Study||445
8465104|NCT00689104|20858983|P3|COMPLETED|Overall Study||453
8465105|NCT00689104|20858984|P2|COMPLETED|Overall Study||440
8465106|NCT00689104|20858985|P1|COMPLETED|Overall Study||453
8465107|NCT00689104|20858982|P4|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
8465108|NCT00689104|20858983|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
8465193|NCT00688740|20859293|P1|COMPLETED|Overall Study||679
8465109|NCT00689104|20858984|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
8465110|NCT00689104|20858985|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
8465111|NCT00689104|20858982|P4|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
8465112|NCT00689104|20858983|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
8465113|NCT00689104|20858984|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
8465114|NCT00689104|20858985|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
8465115|NCT00689104|20858982|P4|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
8465116|NCT00689104|20858983|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
8465117|NCT00689104|20858984|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
8465118|NCT00689104|20858985|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
8465119|NCT00689104|20858982|P4|STARTED|Overall Study||495
8465120|NCT00689104|20858983|P3|STARTED|Overall Study||498
8465121|NCT00689104|20858984|P2|STARTED|Overall Study||497
8465122|NCT00689104|20858985|P1|STARTED|Overall Study||497
8465123|NCT00689091|20859117|P2|NOT COMPLETED|Overall Study||1394
8465124|NCT00689091|20859118|P1|NOT COMPLETED|Overall Study||1371
8465125|NCT00689091|20859117|P2|COMPLETED|Overall Study||9376
8465126|NCT00689091|20859118|P1|COMPLETED|Overall Study||9460
8465127|NCT00689091|20859117|P2|STARTED|Overall Study||10770
8465128|NCT00689091|20859118|P1|STARTED|Overall Study||10831
8465129|NCT00689078|20859140|P4|NOT COMPLETED|Overall Study||1
8465130|NCT00689078|20859141|P3|NOT COMPLETED|Overall Study||1
8465131|NCT00689078|20859142|P2|NOT COMPLETED|Overall Study||2
8465132|NCT00689078|20859143|P1|NOT COMPLETED|Overall Study||0
8465133|NCT00689078|20859140|P4|COMPLETED|Overall Study||8
8465134|NCT00689078|20859141|P3|COMPLETED|Overall Study||8
8465135|NCT00689078|20859142|P2|COMPLETED|Overall Study||7
8465136|NCT00689078|20859143|P1|COMPLETED|Overall Study||9
8465137|NCT00689078|20859140|P4|Intent to Treat|Overall Study||8
8465138|NCT00689078|20859141|P3|Intent to Treat|Overall Study||8
8465139|NCT00689078|20859142|P2|Intent to Treat|Overall Study||7
8465140|NCT00689078|20859143|P1|Intent to Treat|Overall Study||9
8465141|NCT00689078|20859140|P4|STARTED|Overall Study||9
8465142|NCT00689078|20859141|P3|STARTED|Overall Study||9
8465143|NCT00689078|20859142|P2|STARTED|Overall Study||9
8465144|NCT00689078|20859143|P1|STARTED|Overall Study||9
8465145|NCT00689052|20859191|P2|NOT COMPLETED|Overall Study||30
8465146|NCT00689052|20859192|P1|NOT COMPLETED|Overall Study||31
8465147|NCT00689052|20859191|P2|COMPLETED|Overall Study||0
8465148|NCT00689052|20859192|P1|COMPLETED|Overall Study||0
8465149|NCT00689052|20859191|P2|STARTED|Overall Study||30
8465150|NCT00689052|20859192|P1|STARTED|Overall Study||31
8465151|NCT00689026|20859224|P2|NOT COMPLETED|Overall Study||6
8465152|NCT00689026|20859225|P1|NOT COMPLETED|Overall Study||13
8465153|NCT00689026|20859224|P2|COMPLETED|Overall Study||24
8465154|NCT00689026|20859225|P1|COMPLETED|Overall Study||17
8465155|NCT00689026|20859224|P2|STARTED|Overall Study||30
8465156|NCT00689026|20859225|P1|STARTED|Overall Study||30
8465157|NCT00688935|20859231|P1|NOT COMPLETED|Overall Study||0
8465158|NCT00688935|20859231|P1|COMPLETED|Overall Study||0
8465159|NCT00688935|20859231|P1|STARTED|Overall Study||0
8465160|NCT00688870|20859238|P2|NOT COMPLETED|Toddler Dose||0
8465161|NCT00688870|20859239|P1|NOT COMPLETED|Toddler Dose||0
8465162|NCT00688870|20859238|P2|COMPLETED|Toddler Dose||84
8465163|NCT00688870|20859239|P1|COMPLETED|Toddler Dose||80
8465164|NCT00688870|20859238|P2|STARTED|Toddler Dose||84
8465165|NCT00688870|20859239|P1|STARTED|Toddler Dose||80
8465166|NCT00688870|20859238|P2|NOT COMPLETED|After Infant Series||0
8465167|NCT00688870|20859239|P1|NOT COMPLETED|After Infant Series||0
8465168|NCT00688870|20859238|P2|COMPLETED|After Infant Series||84
8465169|NCT00688870|20859239|P1|COMPLETED|After Infant Series||80
8465170|NCT00688870|20859238|P2|STARTED|After Infant Series||84
8465171|NCT00688870|20859239|P1|STARTED|After Infant Series||80
8465172|NCT00688870|20859238|P2|NOT COMPLETED|Infant Series||0
8465173|NCT00688870|20859239|P1|NOT COMPLETED|Infant Series||4
8465174|NCT00688870|20859238|P2|COMPLETED|Infant Series||84
8465175|NCT00688870|20859239|P1|COMPLETED|Infant Series||80
8465176|NCT00688870|20859238|P2|Vaccinated Dose 3|Infant Series||84
8465177|NCT00688870|20859239|P1|Vaccinated Dose 3|Infant Series||80
8465178|NCT00688870|20859238|P2|Vaccinated Dose 2|Infant Series||84
8465179|NCT00688870|20859239|P1|Vaccinated Dose 2|Infant Series||80
8465180|NCT00688870|20859238|P2|Vaccinated Dose 1|Infant Series||84
8465181|NCT00688870|20859239|P1|Vaccinated Dose 1|Infant Series||83
8465182|NCT00688870|20859238|P2|STARTED|Infant Series||84
8465183|NCT00688870|20859239|P1|STARTED|Infant Series||84
8465184|NCT00688844|20859271|P1|NOT COMPLETED|Overall Study||10
8465185|NCT00688844|20859271|P1|COMPLETED|Overall Study||48
8465186|NCT00688844|20859271|P1|STARTED|Overall Study||58
8465187|NCT00688753|20859281|P1|NOT COMPLETED|Overall Study||92
8465188|NCT00688753|20859281|P1|COMPLETED|Overall Study||0
8465189|NCT00688753|20859281|P1|STARTED|Overall Study||92
8465190|NCT00688740|20859292|P2|NOT COMPLETED|Overall Study||35
8465191|NCT00688740|20859293|P1|NOT COMPLETED|Overall Study||66
8465192|NCT00688740|20859292|P2|COMPLETED|Overall Study||711
8465194|NCT00688740|20859292|P2|STARTED|Overall Study||746
8465195|NCT00688740|20859293|P1|STARTED|Overall Study||745
8465196|NCT00688701|20859306|P4|NOT COMPLETED|Overall Study||11
8465197|NCT00688701|20859307|P3|NOT COMPLETED|Overall Study||10
8465198|NCT00688701|20859308|P2|NOT COMPLETED|Overall Study||5
8465199|NCT00688701|20859309|P1|NOT COMPLETED|Overall Study||4
8465200|NCT00688701|20859306|P4|COMPLETED|Overall Study||108
8465201|NCT00688701|20859307|P3|COMPLETED|Overall Study||110
8465202|NCT00688701|20859308|P2|COMPLETED|Overall Study||56
8465203|NCT00688701|20859309|P1|COMPLETED|Overall Study||57
8465204|NCT00688701|20859306|P4|Subgroup for Standardized Meal Test|Overall Study||65
8465205|NCT00688701|20859307|P3|Subgroup for Standardized Meal Test|Overall Study||60
8465206|NCT00688701|20859308|P2|Subgroup for Standardized Meal Test|Overall Study||35
8465207|NCT00688701|20859309|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
8465208|NCT00688701|20859306|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||118
8465209|NCT00688701|20859307|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||120
8465210|NCT00688701|20859308|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||60
8465211|NCT00688701|20859309|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
8465212|NCT00688701|20859306|P4|Treated/Safety Population|Overall Study||119
8465213|NCT00688701|20859307|P3|Treated/Safety Population|Overall Study||120
8465214|NCT00688701|20859308|P2|Treated/Safety Population|Overall Study||61
8465215|NCT00688701|20859309|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
8465216|NCT00688701|20859306|P4|STARTED|Overall Study||119
8465217|NCT00688701|20859307|P3|STARTED|Overall Study||120
8465218|NCT00688701|20859308|P2|STARTED|Overall Study||61
8465219|NCT00688701|20859309|P1|STARTED|Overall Study|Randomized|61
8465220|NCT00688688|20859350|P3|NOT COMPLETED|Overall Study||192
8465221|NCT00688688|20859351|P2|NOT COMPLETED|Overall Study||179
8465222|NCT00688688|20859352|P1|NOT COMPLETED|Overall Study||186
8465223|NCT00688688|20859350|P3|COMPLETED|Overall Study||621
8465224|NCT00688688|20859351|P2|COMPLETED|Overall Study||645
8465225|NCT00688688|20859352|P1|COMPLETED|Overall Study||629
8465226|NCT00688688|20859350|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
8465227|NCT00688688|20859351|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
8465228|NCT00688688|20859352|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
8465229|NCT00688688|20859350|P3|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
8465230|NCT00688688|20859351|P2|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
8465231|NCT00688688|20859352|P1|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
8465232|NCT00688688|20859350|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
8465233|NCT00688688|20859351|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
8465234|NCT00688688|20859352|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
8465235|NCT00688688|20859350|P3|STARTED|Overall Study||813
8465236|NCT00688688|20859351|P2|STARTED|Overall Study||824
8465237|NCT00688688|20859352|P1|STARTED|Overall Study||815
8465238|NCT00688662|20859443|P2|NOT COMPLETED|Overall Study||18
8465239|NCT00688662|20859444|P1|NOT COMPLETED|Overall Study||23
8465240|NCT00688662|20859443|P2|COMPLETED|Overall Study||55
8465241|NCT00688662|20859444|P1|COMPLETED|Overall Study||118
8465242|NCT00688662|20859443|P2|STARTED|Overall Study||73
8465243|NCT00688662|20859444|P1|STARTED|Overall Study||141
8465244|NCT00688636|20859454|P2|NOT COMPLETED|Overall Study||1
8465245|NCT00688636|20859455|P1|NOT COMPLETED|Overall Study||2
8465246|NCT00688636|20859454|P2|COMPLETED|Overall Study||12
8465247|NCT00688636|20859455|P1|COMPLETED|Overall Study||9
8465248|NCT00688636|20859454|P2|STARTED|Overall Study||13
8465249|NCT00688636|20859455|P1|STARTED|Overall Study||11
8465250|NCT00688623|20859469|P1|NOT COMPLETED|Overall Study||55
8465251|NCT00688623|20859469|P1|COMPLETED|Overall Study||18
8465252|NCT00688623|20859469|P1|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60
8465253|NCT00688623|20859469|P1|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73
8465254|NCT00688623|20859469|P1|STARTED|Overall Study|Intent to treat (ITT)|73
8465255|NCT00688597|20859483|P3|NOT COMPLETED|Overall Study||0
8465256|NCT00688597|20859484|P2|NOT COMPLETED|Overall Study||0
8465257|NCT00688597|20859485|P1|NOT COMPLETED|Overall Study||3
8465258|NCT00688597|20859483|P3|COMPLETED|Overall Study||0
8465259|NCT00688597|20859484|P2|COMPLETED|Overall Study||0
8465260|NCT00688597|20859485|P1|COMPLETED|Overall Study||0
8465261|NCT00688597|20859483|P3|Received at Least 1 Dose of Study Drug|Overall Study||0
8465262|NCT00688597|20859484|P2|Received at Least 1 Dose of Study Drug|Overall Study||0
8465263|NCT00688597|20859485|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8465264|NCT00688597|20859483|P3|STARTED|Overall Study||0
8465265|NCT00688597|20859484|P2|STARTED|Overall Study||0
8465266|NCT00688597|20859485|P1|STARTED|Overall Study||3
8465275|NCT00688519|20859509|P2|NOT COMPLETED|Overall Study||15
8465276|NCT00688519|20859510|P1|NOT COMPLETED|Overall Study||19
8465277|NCT00688519|20859509|P2|COMPLETED|Overall Study||98
8465278|NCT00688519|20859510|P1|COMPLETED|Overall Study||204
8465279|NCT00688519|20859509|P2|STARTED|Overall Study||113
8465280|NCT00688519|20859510|P1|STARTED|Overall Study||223
8465281|NCT00688467|20859528|P2|NOT COMPLETED|Treatment Period 2||2
8465282|NCT00688467|20859529|P1|NOT COMPLETED|Treatment Period 2||0
8465283|NCT00688467|20859528|P2|COMPLETED|Treatment Period 2||6
8465284|NCT00688467|20859529|P1|COMPLETED|Treatment Period 2||7
8465285|NCT00688467|20859528|P2|STARTED|Treatment Period 2||8
8465286|NCT00688467|20859529|P1|STARTED|Treatment Period 2||7
8465287|NCT00688467|20859528|P2|NOT COMPLETED|Treatment Period 1||2
8465288|NCT00688467|20859529|P1|NOT COMPLETED|Treatment Period 1||2
8465289|NCT00688467|20859528|P2|COMPLETED|Treatment Period 1||8
8465290|NCT00688467|20859529|P1|COMPLETED|Treatment Period 1||7
8465291|NCT00688467|20859528|P2|STARTED|Treatment Period 1||10
8465292|NCT00688467|20859529|P1|STARTED|Treatment Period 1||9
8465293|NCT00688376|20859561|P2|NOT COMPLETED|Blinded Extension Phase||5
8465294|NCT00688376|20859562|P1|NOT COMPLETED|Blinded Extension Phase||5
8465295|NCT00688376|20859561|P2|COMPLETED|Blinded Extension Phase||20
8465296|NCT00688376|20859562|P1|COMPLETED|Blinded Extension Phase||29
8465297|NCT00688376|20859561|P2|STARTED|Blinded Extension Phase||25
8465298|NCT00688376|20859562|P1|STARTED|Blinded Extension Phase||34
8465299|NCT00688376|20859561|P2|NOT COMPLETED|Double-Blind Phase||7
8465300|NCT00688376|20859562|P1|NOT COMPLETED|Double-Blind Phase||6
8465301|NCT00688376|20859561|P2|COMPLETED|Double-Blind Phase||25
8465302|NCT00688376|20859562|P1|COMPLETED|Double-Blind Phase||34
8465303|NCT00688376|20859561|P2|Safety Population|Double-Blind Phase||31
8465304|NCT00688376|20859562|P1|Safety Population|Double-Blind Phase||40
8465305|NCT00688376|20859561|P2|STARTED|Double-Blind Phase||32
8465306|NCT00688376|20859562|P1|STARTED|Double-Blind Phase||40
8465307|NCT00688324|20859576|P1|NOT COMPLETED|Overall Study||8
8465308|NCT00688324|20859576|P1|COMPLETED|Overall Study||28
8465309|NCT00688324|20859576|P1|STARTED|Overall Study||36
8465310|NCT00688259|20859621|P2|NOT COMPLETED|Overall Study||8
8465311|NCT00688259|20859622|P1|NOT COMPLETED|Overall Study||7
8465312|NCT00688259|20859621|P2|COMPLETED|Overall Study||36
8465313|NCT00688259|20859622|P1|COMPLETED|Overall Study||37
8465314|NCT00688259|20859621|P2|End to Active Treatment,|Overall Study||37
8465315|NCT00688259|20859622|P1|End to Active Treatment,|Overall Study||37
8465316|NCT00688259|20859621|P2|STARTED|Overall Study||44
8465317|NCT00688259|20859622|P1|STARTED|Overall Study||44
8465318|NCT00688155|20859642|P4|NOT COMPLETED|Overall Study||1
8465319|NCT00688155|20859643|P3|NOT COMPLETED|Overall Study||1
8465320|NCT00688155|20859644|P2|NOT COMPLETED|Overall Study||2
8465321|NCT00688155|20859645|P1|NOT COMPLETED|Overall Study||2
8465322|NCT00688155|20859642|P4|COMPLETED|Overall Study||17
8465323|NCT00688155|20859643|P3|COMPLETED|Overall Study||18
8465324|NCT00688155|20859644|P2|COMPLETED|Overall Study||16
8465325|NCT00688155|20859645|P1|COMPLETED|Overall Study||16
8465326|NCT00688155|20859642|P4|STARTED|Overall Study||18
8465327|NCT00688155|20859643|P3|STARTED|Overall Study||19
8465328|NCT00688155|20859644|P2|STARTED|Overall Study||18
8465329|NCT00688155|20859645|P1|STARTED|Overall Study||18
8465330|NCT00688103|20859665|P2|NOT COMPLETED|Overall Study||13
8465331|NCT00688103|20859666|P1|NOT COMPLETED|Overall Study||30
8465332|NCT00688103|20859665|P2|COMPLETED|Overall Study||64
8465333|NCT00688103|20859666|P1|COMPLETED|Overall Study||44
8465334|NCT00688103|20859665|P2|Actually Treated|Overall Study||76
8465335|NCT00688103|20859666|P1|Actually Treated|Overall Study||71
8465336|NCT00688103|20859665|P2|STARTED|Overall Study||77
8465337|NCT00688103|20859666|P1|STARTED|Overall Study||74
8465344|NCT00687973|20859695|P2|NOT COMPLETED|Overall Study||38
8465345|NCT00687973|20859696|P1|NOT COMPLETED|Overall Study||24
8465346|NCT00687973|20859695|P2|COMPLETED|Overall Study||162
8465347|NCT00687973|20859696|P1|COMPLETED|Overall Study||169
8465348|NCT00687973|20859695|P2|STARTED|Overall Study||200
8465349|NCT00687973|20859696|P1|STARTED|Overall Study||193
8465356|NCT00687856|20859740|P1|NOT COMPLETED|Overall Study||0
8465357|NCT00687856|20859740|P1|COMPLETED|Overall Study||211
8465358|NCT00687856|20859740|P1|STARTED|Overall Study||211
8465359|NCT00687830|20859746|P2|NOT COMPLETED|Overall Study||0
8465360|NCT00687830|20859747|P1|NOT COMPLETED|Overall Study||0
8465361|NCT00687830|20859746|P2|COMPLETED|Overall Study||68
8465362|NCT00687830|20859747|P1|COMPLETED|Overall Study||68
8465363|NCT00687830|20859746|P2|STARTED|Overall Study||68
8465364|NCT00687830|20859747|P1|STARTED|Overall Study||68
8465365|NCT00687804|20859758|P3|NOT COMPLETED|Open-Label Extension Study||11
8465366|NCT00687804|20859759|P2|NOT COMPLETED|Open-Label Extension Study||11
8465367|NCT00687804|20859760|P1|NOT COMPLETED|Open-Label Extension Study||10
8465368|NCT00687804|20859758|P3|COMPLETED|Open-Label Extension Study||63
8465369|NCT00687804|20859759|P2|COMPLETED|Open-Label Extension Study||72
8465370|NCT00687804|20859760|P1|COMPLETED|Open-Label Extension Study||73
8465371|NCT00687804|20859758|P3|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
8465372|NCT00687804|20859759|P2|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
8465373|NCT00687804|20859760|P1|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
8465374|NCT00687804|20859758|P3|STARTED|Open-Label Extension Study||74
8465375|NCT00687804|20859759|P2|STARTED|Open-Label Extension Study||83
8465376|NCT00687804|20859760|P1|STARTED|Open-Label Extension Study||83
8465377|NCT00687804|20859758|P3|NOT COMPLETED|Core Study||13
8465378|NCT00687804|20859759|P2|NOT COMPLETED|Core Study||15
8465379|NCT00687804|20859760|P1|NOT COMPLETED|Core Study||14
8465380|NCT00687804|20859758|P3|COMPLETED|Core Study||98
8465381|NCT00687804|20859759|P2|COMPLETED|Core Study||103
8465382|NCT00687804|20859760|P1|COMPLETED|Core Study||102
8465383|NCT00687804|20859758|P3|STARTED|Core Study||111
8465384|NCT00687804|20859759|P2|STARTED|Core Study||118
8465385|NCT00687804|20859760|P1|STARTED|Core Study||116
8465386|NCT00687739|20859807|P4|NOT COMPLETED|Overall Study||2
8465387|NCT00687739|20859808|P3|NOT COMPLETED|Overall Study||2
8465388|NCT00687739|20859809|P2|NOT COMPLETED|Overall Study||3
8465389|NCT00687739|20859810|P1|NOT COMPLETED|Overall Study||2
8465390|NCT00687739|20859807|P4|COMPLETED|Overall Study||12
8465391|NCT00687739|20859808|P3|COMPLETED|Overall Study||23
8465392|NCT00687739|20859809|P2|COMPLETED|Overall Study||12
8465393|NCT00687739|20859810|P1|COMPLETED|Overall Study||23
8465394|NCT00687739|20859807|P4|STARTED|Overall Study||14
8465395|NCT00687739|20859808|P3|STARTED|Overall Study||25
8465396|NCT00687739|20859809|P2|STARTED|Overall Study||15
8465397|NCT00687739|20859810|P1|STARTED|Overall Study||25
8465398|NCT00687713|20859836|P2|NOT COMPLETED|Overall Study||40
8465399|NCT00687713|20859837|P1|NOT COMPLETED|Overall Study||32
8465400|NCT00687713|20859836|P2|COMPLETED|Overall Study||64
8465401|NCT00687713|20859837|P1|COMPLETED|Overall Study||68
8465402|NCT00687713|20859836|P2|STARTED|Overall Study||104
8465403|NCT00687713|20859837|P1|STARTED|Overall Study||100
8465404|NCT00687674|20859845|P1|NOT COMPLETED|Overall Study||2
8465405|NCT00687674|20859845|P1|COMPLETED|Overall Study||11
8465406|NCT00687674|20859845|P1|STARTED|Overall Study||13
8465407|NCT00687609|20859852|P1|NOT COMPLETED|Overall Study||3
8465408|NCT00687609|20859852|P1|COMPLETED|Overall Study||4
8465409|NCT00687609|20859852|P1|STARTED|Overall Study||7
8465410|NCT00687544|20859866|P1|NOT COMPLETED|Overall Study||11
8465411|NCT00687544|20859866|P1|COMPLETED|Overall Study||0
8465412|NCT00687544|20859866|P1|STARTED|Overall Study||11
8465413|NCT00687531|20859875|P1|NOT COMPLETED|Overall Study||135
8465414|NCT00687531|20859875|P1|COMPLETED|Overall Study||250
8465415|NCT00687531|20859875|P1|RECEIVED TREATMENT|Overall Study||281
8465416|NCT00687531|20859875|P1|STARTED|Overall Study|Completed screening procedures|385
8465417|NCT00687453|20859891|P2|NOT COMPLETED|Overall Study||6
8465418|NCT00687453|20859892|P1|NOT COMPLETED|Overall Study||3
8465419|NCT00687453|20859891|P2|COMPLETED|Overall Study||7
8465420|NCT00687453|20859892|P1|COMPLETED|Overall Study||8
8465421|NCT00687453|20859891|P2|STARTED|Overall Study||13
8465422|NCT00687453|20859892|P1|STARTED|Overall Study||11
8465423|NCT00687440|20859898|P1|NOT COMPLETED|Overall Study||12
8465424|NCT00687440|20859898|P1|COMPLETED|Overall Study||15
8465425|NCT00687440|20859898|P1|STARTED|Overall Study|Number of screened participants|27
8465426|NCT00687401|20859902|P1|NOT COMPLETED|Overall Study||30
8465427|NCT00687401|20859902|P1|COMPLETED|Overall Study||129
8465428|NCT00687401|20859902|P1|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
8465429|NCT00687362|20859907|P1|NOT COMPLETED|Overall Study||3
8465430|NCT00687362|20859907|P1|COMPLETED|Overall Study|Completed protocol at Week 24|19
8465431|NCT00687362|20859907|P1|STARTED|Overall Study||22
8465432|NCT00687323|20859911|P1|NOT COMPLETED|Overall Study||180
8465433|NCT00687323|20859911|P1|COMPLETED|Overall Study|Number of participants alive at one year|15
8465434|NCT00687323|20859911|P1|Received Treatment|Overall Study||47
8465435|NCT00687323|20859911|P1|STARTED|Overall Study|Number of screened participants|195
8465436|NCT00687297|20859927|P2|NOT COMPLETED|Maintenance||1
8465437|NCT00687297|20859928|P1|NOT COMPLETED|Maintenance||3
8465438|NCT00687297|20859927|P2|COMPLETED|Maintenance||25
8465439|NCT00687297|20859928|P1|COMPLETED|Maintenance||29
8465440|NCT00687297|20859927|P2|STARTED|Maintenance||26
8465441|NCT00687297|20859928|P1|STARTED|Maintenance||32
8465442|NCT00687297|20859927|P2|NOT COMPLETED|Induction||55
8465443|NCT00687297|20859928|P1|NOT COMPLETED|Induction||45
8465444|NCT00687297|20859927|P2|COMPLETED|Induction||26
8465445|NCT00687297|20859928|P1|COMPLETED|Induction||32
8465446|NCT00687297|20859927|P2|STARTED|Induction||81
8465447|NCT00687297|20859928|P1|STARTED|Induction||77
8465448|NCT00687297|20859927|P2|NOT COMPLETED|Randomization||1
8465449|NCT00687297|20859928|P1|NOT COMPLETED|Randomization||3
8465450|NCT00687297|20859927|P2|COMPLETED|Randomization||81
8465451|NCT00687297|20859928|P1|COMPLETED|Randomization||77
8465452|NCT00687297|20859927|P2|STARTED|Randomization||82
8465453|NCT00687297|20859928|P1|STARTED|Randomization||80
8465454|NCT00687271|20859942|P4|NOT COMPLETED|Overall Study||0
8465455|NCT00687271|20859943|P3|NOT COMPLETED|Overall Study||5
8465456|NCT00687271|20859944|P2|NOT COMPLETED|Overall Study||6
8465457|NCT00687271|20859945|P1|NOT COMPLETED|Overall Study||3
8465458|NCT00687271|20859942|P4|COMPLETED|Overall Study||48
8465459|NCT00687271|20859943|P3|COMPLETED|Overall Study||91
8465460|NCT00687271|20859944|P2|COMPLETED|Overall Study||90
8465461|NCT00687271|20859945|P1|COMPLETED|Overall Study||91
8465462|NCT00687271|20859942|P4|Treated|Overall Study||48
8465463|NCT00687271|20859943|P3|Treated|Overall Study||96
8465464|NCT00687271|20859944|P2|Treated|Overall Study||95
8465465|NCT00687271|20859945|P1|Treated|Overall Study||94
8465466|NCT00687271|20859942|P4|STARTED|Overall Study||48
8465467|NCT00687271|20859943|P3|STARTED|Overall Study||96
8465468|NCT00687271|20859944|P2|STARTED|Overall Study||96
8465469|NCT00687271|20859945|P1|STARTED|Overall Study||94
8465470|NCT00687219|20859983|P1|NOT COMPLETED|Overall Study||51
8465471|NCT00687219|20859983|P1|COMPLETED|Overall Study||51
8465472|NCT00687219|20859983|P1|STARTED|Overall Study||102
8465473|NCT00687193|20859995|P6|NOT COMPLETED|Overall Study||4
8465474|NCT00687193|20859996|P5|NOT COMPLETED|Overall Study||2
8465475|NCT00687193|20859997|P4|NOT COMPLETED|Overall Study||4
8465476|NCT00687193|20859998|P3|NOT COMPLETED|Overall Study||2
8465477|NCT00687193|20859999|P2|NOT COMPLETED|Overall Study||4
8465478|NCT00687193|20860000|P1|NOT COMPLETED|Overall Study||2
8465479|NCT00687193|20859995|P6|COMPLETED|Overall Study||48
8465480|NCT00687193|20859996|P5|COMPLETED|Overall Study||52
8465481|NCT00687193|20859997|P4|COMPLETED|Overall Study||49
8465482|NCT00687193|20859998|P3|COMPLETED|Overall Study||50
8465483|NCT00687193|20859999|P2|COMPLETED|Overall Study||49
8465484|NCT00687193|20860000|P1|COMPLETED|Overall Study||51
8465485|NCT00687193|20859995|P6|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
8465486|NCT00687193|20859996|P5|STARTED|Overall Study||54
8465487|NCT00687193|20859997|P4|STARTED|Overall Study||53
8465488|NCT00687193|20859998|P3|STARTED|Overall Study||52
8465489|NCT00687193|20859999|P2|STARTED|Overall Study||53
8465490|NCT00687193|20860000|P1|STARTED|Overall Study||53
8465491|NCT00687167|20860164|P2|NOT COMPLETED|Second Intervention||0
8465492|NCT00687167|20860165|P1|NOT COMPLETED|Second Intervention||0
8465493|NCT00687167|20860164|P2|COMPLETED|Second Intervention||17
8465494|NCT00687167|20860165|P1|COMPLETED|Second Intervention||17
8465495|NCT00687167|20860164|P2|STARTED|Second Intervention||17
8465496|NCT00687167|20860165|P1|STARTED|Second Intervention||17
8465497|NCT00687167|20860164|P2|NOT COMPLETED|Washout Period of 28 Days||0
8465498|NCT00687167|20860165|P1|NOT COMPLETED|Washout Period of 28 Days||0
8465499|NCT00687167|20860164|P2|COMPLETED|Washout Period of 28 Days||17
8465500|NCT00687167|20860165|P1|COMPLETED|Washout Period of 28 Days||17
8465501|NCT00687167|20860164|P2|STARTED|Washout Period of 28 Days||17
8465502|NCT00687167|20860165|P1|STARTED|Washout Period of 28 Days||17
8465503|NCT00687167|20860164|P2|NOT COMPLETED|First Intervention||0
8465504|NCT00687167|20860165|P1|NOT COMPLETED|First Intervention||0
8465505|NCT00687167|20860164|P2|COMPLETED|First Intervention||17
8465506|NCT00687167|20860165|P1|COMPLETED|First Intervention||17
8465507|NCT00687167|20860164|P2|STARTED|First Intervention||17
8465508|NCT00687167|20860165|P1|STARTED|First Intervention||17
8465509|NCT00687102|20860175|P2|NOT COMPLETED|Overall Study||0
8465510|NCT00687102|20860176|P1|NOT COMPLETED|Overall Study||0
8465511|NCT00687102|20860175|P2|COMPLETED|Overall Study||765
8465512|NCT00687102|20860176|P1|COMPLETED|Overall Study||733
8465513|NCT00687102|20860175|P2|STARTED|Overall Study||765
8465514|NCT00687102|20860176|P1|STARTED|Overall Study||733
8465515|NCT00687076|20860198|P2|NOT COMPLETED|Overall Study||30
8465516|NCT00687076|20860199|P1|NOT COMPLETED|Overall Study||32
8465517|NCT00687076|20860198|P2|COMPLETED|Overall Study||21
8465518|NCT00687076|20860199|P1|COMPLETED|Overall Study||19
8465519|NCT00687076|20860198|P2|STARTED|Overall Study||51
8465520|NCT00687076|20860199|P1|STARTED|Overall Study||51
8465521|NCT00686998|20860210|P3|NOT COMPLETED|Overall Study||4
8465522|NCT00686998|20860211|P2|NOT COMPLETED|Overall Study||8
8465523|NCT00686998|20860212|P1|NOT COMPLETED|Overall Study||13
8465524|NCT00686998|20860210|P3|COMPLETED|Overall Study||18
8465525|NCT00686998|20860211|P2|COMPLETED|Overall Study||33
8465526|NCT00686998|20860212|P1|COMPLETED|Overall Study||30
8465527|NCT00686998|20860210|P3|Completed Scheduled Treatment|Overall Study||18
8465528|NCT00686998|20860211|P2|Completed Scheduled Treatment|Overall Study||33
8465529|NCT00686998|20860212|P1|Completed Scheduled Treatment|Overall Study||30
8465530|NCT00686998|20860210|P3|Eligible for Efficacy Analysis|Overall Study||21
8465531|NCT00686998|20860211|P2|Eligible for Efficacy Analysis|Overall Study||39
8465532|NCT00686998|20860212|P1|Eligible for Efficacy Analysis|Overall Study||42
8465533|NCT00686998|20860210|P3|Received Treatment|Overall Study||22
8465534|NCT00686998|20860211|P2|Received Treatment|Overall Study||41
8465535|NCT00686998|20860212|P1|Received Treatment|Overall Study||43
8465536|NCT00686998|20860210|P3|Randomized|Overall Study||22
8465537|NCT00686998|20860211|P2|Randomized|Overall Study||41
8465538|NCT00686998|20860212|P1|Randomized|Overall Study||43
8465539|NCT00686998|20860210|P3|STARTED|Overall Study|Randomized & received study medication|22
8465540|NCT00686998|20860211|P2|STARTED|Overall Study|Randomized & received study medication|41
8465541|NCT00686998|20860212|P1|STARTED|Overall Study|Randomized & received study medication|43
8465542|NCT00686972|20860220|P1|NOT COMPLETED|Overall Study||51
8465543|NCT00686972|20860220|P1|COMPLETED|Overall Study||0
8465544|NCT00686972|20860220|P1|STARTED|Overall Study||51
8465545|NCT00686959|20860226|P2|NOT COMPLETED|Overall Study||117
8465546|NCT00686959|20860227|P1|NOT COMPLETED|Overall Study||124
8465547|NCT00686959|20860226|P2|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
8465548|NCT00686959|20860227|P1|COMPLETED|Overall Study|Study completion includes death due to any cause|177
8465549|NCT00686959|20860226|P2|Entered Consolidation Phase|Overall Study||202
8465550|NCT00686959|20860227|P1|Entered Consolidation Phase|Overall Study||229
8465551|NCT00686959|20860226|P2|Received at Least One Dose of Study Drug|Overall Study||272
8465552|NCT00686959|20860227|P1|Received at Least One Dose of Study Drug|Overall Study||283
8465553|NCT00686959|20860226|P2|STARTED|Overall Study||297
8465554|NCT00686959|20860227|P1|STARTED|Overall Study||301
8465555|NCT00686920|20860247|P2|NOT COMPLETED|Overall Study||36
8465556|NCT00686920|20860248|P1|NOT COMPLETED|Overall Study||132
8465557|NCT00686920|20860247|P2|COMPLETED|Overall Study||34
8465558|NCT00686920|20860248|P1|COMPLETED|Overall Study||120
8465559|NCT00686920|20860247|P2|Received At Least 1 Dose Of Study Drug|Overall Study||70
8465560|NCT00686920|20860248|P1|Received At Least 1 Dose Of Study Drug|Overall Study||252
8465561|NCT00686920|20860247|P2|STARTED|Overall Study||70
8465562|NCT00686920|20860248|P1|STARTED|Overall Study||252
8465563|NCT00686894|20860260|P1|NOT COMPLETED|Overall Study||6
8465564|NCT00686894|20860260|P1|COMPLETED|Overall Study||1
8465565|NCT00686894|20860260|P1|STARTED|Overall Study||7
8465566|NCT00686881|20860266|P2|NOT COMPLETED|Overall Study||81
8465567|NCT00686881|20860267|P1|NOT COMPLETED|Overall Study||82
8465568|NCT00686881|20860266|P2|COMPLETED|Overall Study||53
8465569|NCT00686881|20860267|P1|COMPLETED|Overall Study||45
8465570|NCT00686881|20860266|P2|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
8465571|NCT00686881|20860267|P1|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
8465572|NCT00686855|20860279|P2|NOT COMPLETED|Overall Study||1
8465573|NCT00686855|20860280|P1|NOT COMPLETED|Overall Study||1
8465574|NCT00686855|20860279|P2|COMPLETED|Overall Study||17
8465575|NCT00686855|20860280|P1|COMPLETED|Overall Study||27
8465576|NCT00686855|20860279|P2|STARTED|Overall Study||18
8465577|NCT00686855|20860280|P1|STARTED|Overall Study||28
8465578|NCT00686842|20860286|P1|NOT COMPLETED|Overall Study||0
8465579|NCT00686842|20860286|P1|COMPLETED|Overall Study||17
8465580|NCT00686842|20860286|P1|STARTED|Overall Study||17
8465581|NCT00686829|20860290|P1|NOT COMPLETED|Overall Study||79
8465582|NCT00686829|20860290|P1|COMPLETED|Overall Study||0
8465583|NCT00686829|20860290|P1|STARTED|Overall Study||79
8465584|NCT00686803|20860307|P3|NOT COMPLETED|Overall Study||0
8465585|NCT00686803|20860308|P2|NOT COMPLETED|Overall Study||0
8465586|NCT00686803|20860309|P1|NOT COMPLETED|Overall Study||0
8465587|NCT00686803|20860307|P3|COMPLETED|Overall Study||3
8465588|NCT00686803|20860308|P2|COMPLETED|Overall Study||12
8465589|NCT00686803|20860309|P1|COMPLETED|Overall Study||6
8465590|NCT00686803|20860307|P3|STARTED|Overall Study||3
8465591|NCT00686803|20860308|P2|STARTED|Overall Study||12
8465592|NCT00686803|20860309|P1|STARTED|Overall Study||6
8465593|NCT00686790|20860320|P1|NOT COMPLETED|Overall Study||16
8465594|NCT00686790|20860320|P1|COMPLETED|Overall Study||32
8465595|NCT00686790|20860320|P1|STARTED|Overall Study||48
8465596|NCT00686777|20860328|P1|NOT COMPLETED|Overall Study||10
8465597|NCT00686777|20860328|P1|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
8465598|NCT00686777|20860328|P1|Completed 24 Weeks of Follow-up|Overall Study||70
8465599|NCT00686777|20860328|P1|Included in Follow-up (All Treated)|Overall Study||75
8465600|NCT00686777|20860328|P1|Completed 48 Weeks of Treatment|Overall Study||65
8465601|NCT00686777|20860328|P1|Completed 24 Weeks of Treatment|Overall Study||69
8465602|NCT00686777|20860328|P1|STARTED|Overall Study||75
8465603|NCT00686725|20860336|P2|NOT COMPLETED|Overall Study||42
8465604|NCT00686725|20860337|P1|NOT COMPLETED|Overall Study||46
8465605|NCT00686725|20860336|P2|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
8465606|NCT00686725|20860337|P1|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
8465607|NCT00686725|20860336|P2|STARTED|Overall Study||52
8465608|NCT00686725|20860337|P1|STARTED|Overall Study||47
8465609|NCT00686712|20860362|P3|NOT COMPLETED|Overall Study||13
8465610|NCT00686712|20860363|P2|NOT COMPLETED|Overall Study||11
8465611|NCT00686712|20860364|P1|NOT COMPLETED|Overall Study||10
8465612|NCT00686712|20860362|P3|COMPLETED|Overall Study||17
8465613|NCT00686712|20860363|P2|COMPLETED|Overall Study||14
8465614|NCT00686712|20860364|P1|COMPLETED|Overall Study||20
8465615|NCT00686712|20860362|P3|STARTED|Overall Study||30
8465616|NCT00686712|20860363|P2|STARTED|Overall Study||25
8465617|NCT00686712|20860364|P1|STARTED|Overall Study||30
8465618|NCT00686699|20860392|P2|NOT COMPLETED|Treatment Period 2||0
8465619|NCT00686699|20860393|P1|NOT COMPLETED|Treatment Period 2||0
8465620|NCT00686699|20860392|P2|COMPLETED|Treatment Period 2||5
8465621|NCT00686699|20860393|P1|COMPLETED|Treatment Period 2||4
8465622|NCT00686699|20860392|P2|STARTED|Treatment Period 2||5
8465623|NCT00686699|20860393|P1|STARTED|Treatment Period 2||4
8465624|NCT00686699|20860392|P2|NOT COMPLETED|Treatment Period 1||2
8465625|NCT00686699|20860393|P1|NOT COMPLETED|Treatment Period 1||0
8465626|NCT00686699|20860392|P2|COMPLETED|Treatment Period 1||5
8465627|NCT00686699|20860393|P1|COMPLETED|Treatment Period 1||4
8465628|NCT00686699|20860392|P2|STARTED|Treatment Period 1||7
8465629|NCT00686699|20860393|P1|STARTED|Treatment Period 1||4
8465630|NCT00686686|20860417|P1|NOT COMPLETED|Overall Study||6
8465631|NCT00686686|20860417|P1|COMPLETED|Overall Study||17
8465632|NCT00686686|20860417|P1|STARTED|Overall Study||23
8465633|NCT00686647|20860425|P1|NOT COMPLETED|Overall Study||2
8465634|NCT00686647|20860425|P1|COMPLETED|Overall Study||91
8465635|NCT00686647|20860425|P1|STARTED|Overall Study||93
8465636|NCT00686634|20860431|P1|NOT COMPLETED|Overall Study||6
8465637|NCT00686634|20860431|P1|COMPLETED|Overall Study||102
8465638|NCT00686634|20860431|P1|STARTED|Overall Study||108
8465639|NCT00686595|20860438|P1|NOT COMPLETED|Overall Study||7
8465640|NCT00686595|20860438|P1|COMPLETED|Overall Study||31
8465641|NCT00686595|20860438|P1|STARTED|Overall Study||38
8465642|NCT00686582|20860466|P3|NOT COMPLETED|Overall Study||0
8465643|NCT00686582|20860467|P2|NOT COMPLETED|Overall Study||14
8465644|NCT00686582|20860468|P1|NOT COMPLETED|Overall Study||18
8465645|NCT00686582|20860466|P3|COMPLETED|Overall Study||121
8465646|NCT00686582|20860467|P2|COMPLETED|Overall Study||77
8465647|NCT00686582|20860468|P1|COMPLETED|Overall Study||74
8465648|NCT00686582|20860466|P3|Booster Vaccination|Overall Study||0
8465649|NCT00686582|20860467|P2|Booster Vaccination|Overall Study||77
8465650|NCT00686582|20860468|P1|Booster Vaccination|Overall Study||75
8465651|NCT00686582|20860466|P3|STARTED|Overall Study||121
8465652|NCT00686582|20860467|P2|STARTED|Overall Study||91
8465653|NCT00686582|20860468|P1|STARTED|Overall Study||92
8465654|NCT00686543|20860498|P4|NOT COMPLETED|Overall Study||3
8465655|NCT00686543|20860499|P3|NOT COMPLETED|Overall Study||5
8465656|NCT00686543|20860500|P2|NOT COMPLETED|Overall Study||1
8465657|NCT00686543|20860501|P1|NOT COMPLETED|Overall Study||14
8465658|NCT00686543|20860498|P4|COMPLETED|Overall Study||17
8465659|NCT00686543|20860499|P3|COMPLETED|Overall Study||15
8465660|NCT00686543|20860500|P2|COMPLETED|Overall Study||20
8465661|NCT00686543|20860501|P1|COMPLETED|Overall Study||0
8465662|NCT00686543|20860498|P4|STARTED|Overall Study||20
8465663|NCT00686543|20860499|P3|STARTED|Overall Study||20
8465664|NCT00686543|20860500|P2|STARTED|Overall Study||21
8465665|NCT00686543|20860501|P1|STARTED|Overall Study||14
8465666|NCT00686517|20860522|P3|NOT COMPLETED|Follow-up||10
8465667|NCT00686517|20860523|P2|NOT COMPLETED|Follow-up||10
8465668|NCT00686517|20860524|P1|NOT COMPLETED|Follow-up||8
8465669|NCT00686517|20860522|P3|COMPLETED|Follow-up||29
8465670|NCT00686517|20860523|P2|COMPLETED|Follow-up||28
8465671|NCT00686517|20860524|P1|COMPLETED|Follow-up||29
8465672|NCT00686517|20860522|P3|STARTED|Follow-up||39
8465673|NCT00686517|20860523|P2|STARTED|Follow-up||38
8465674|NCT00686517|20860524|P1|STARTED|Follow-up||37
8465675|NCT00686517|20860522|P3|NOT COMPLETED|Treatment||1
8465676|NCT00686517|20860523|P2|NOT COMPLETED|Treatment||3
8465677|NCT00686517|20860524|P1|NOT COMPLETED|Treatment||6
8465678|NCT00686517|20860522|P3|COMPLETED|Treatment||42
8465679|NCT00686517|20860523|P2|COMPLETED|Treatment||40
8465680|NCT00686517|20860524|P1|COMPLETED|Treatment||38
8465681|NCT00686517|20860522|P3|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
8465682|NCT00686517|20860523|P2|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
8465683|NCT00686517|20860524|P1|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
8465684|NCT00686517|20860522|P3|STARTED|Treatment||43
8465685|NCT00686517|20860523|P2|STARTED|Treatment||43
8465686|NCT00686517|20860524|P1|STARTED|Treatment||44
8465687|NCT00686374|20860547|P1|NOT COMPLETED|Overall Study||61
8465688|NCT00686374|20860547|P1|COMPLETED|Overall Study||39
8465689|NCT00686374|20860547|P1|STARTED|Overall Study||100
8465690|NCT00686335|20860558|P1|NOT COMPLETED|Treatment Period||0
8465691|NCT00686335|20860558|P1|COMPLETED|Treatment Period||7
8465692|NCT00686335|20860558|P1|STARTED|Treatment Period||7
8465693|NCT00686335|20860558|P1|NOT COMPLETED|Run-in Period||5
8465694|NCT00686335|20860558|P1|COMPLETED|Run-in Period||7
8465695|NCT00686335|20860558|P1|STARTED|Run-in Period||12
8465696|NCT00686257|20860566|P2|NOT COMPLETED|Overall Study||0
8465697|NCT00686257|20860567|P1|NOT COMPLETED|Overall Study||0
8465698|NCT00686257|20860566|P2|COMPLETED|Overall Study||31
8465699|NCT00686257|20860567|P1|COMPLETED|Overall Study||29
8465700|NCT00686257|20860566|P2|STARTED|Overall Study||31
8465701|NCT00686257|20860567|P1|STARTED|Overall Study||29
8465702|NCT00686231|20860587|P4|NOT COMPLETED|Combination Test - Visit 2||0
8465703|NCT00686231|20860588|P3|NOT COMPLETED|Combination Test - Visit 2||0
8465704|NCT00686231|20860589|P2|NOT COMPLETED|Combination Test - Visit 2||0
8465705|NCT00686231|20860590|P1|NOT COMPLETED|Combination Test - Visit 2||0
8465706|NCT00686231|20860587|P4|COMPLETED|Combination Test - Visit 2||9
8465707|NCT00686231|20860588|P3|COMPLETED|Combination Test - Visit 2||10
8465708|NCT00686231|20860589|P2|COMPLETED|Combination Test - Visit 2||0
8465709|NCT00686231|20860590|P1|COMPLETED|Combination Test - Visit 2||0
8465710|NCT00686231|20860587|P4|STARTED|Combination Test - Visit 2||9
8465711|NCT00686231|20860588|P3|STARTED|Combination Test - Visit 2||10
8465712|NCT00686231|20860589|P2|STARTED|Combination Test - Visit 2||0
8465713|NCT00686231|20860590|P1|STARTED|Combination Test - Visit 2||0
8465714|NCT00686231|20860587|P4|NOT COMPLETED|Dose Test - Visit 1||0
8465715|NCT00686231|20860588|P3|NOT COMPLETED|Dose Test - Visit 1||0
8465716|NCT00686231|20860589|P2|NOT COMPLETED|Dose Test - Visit 1||0
8465717|NCT00686231|20860590|P1|NOT COMPLETED|Dose Test - Visit 1||0
8465718|NCT00686231|20860587|P4|COMPLETED|Dose Test - Visit 1||0
8465719|NCT00686231|20860588|P3|COMPLETED|Dose Test - Visit 1||0
8465720|NCT00686231|20860589|P2|COMPLETED|Dose Test - Visit 1||7
8465721|NCT00686231|20860590|P1|COMPLETED|Dose Test - Visit 1||12
8465722|NCT00686231|20860587|P4|STARTED|Dose Test - Visit 1||0
8465723|NCT00686231|20860588|P3|STARTED|Dose Test - Visit 1||0
8465724|NCT00686231|20860589|P2|STARTED|Dose Test - Visit 1||7
8465725|NCT00686231|20860590|P1|STARTED|Dose Test - Visit 1||12
8465726|NCT00686205|20860602|P2|NOT COMPLETED|Overall Study||981
8465727|NCT00686205|20860603|P1|NOT COMPLETED|Overall Study||6007
8465728|NCT00686205|20860602|P2|COMPLETED|Overall Study||1524
8465729|NCT00686205|20860603|P1|COMPLETED|Overall Study||15599
8465730|NCT00686205|20860602|P2|STARTED|Overall Study||2505
8465731|NCT00686205|20860603|P1|STARTED|Overall Study||21606
8465732|NCT00686166|20860609|P1|NOT COMPLETED|Overall Study||20
8465733|NCT00686166|20860609|P1|COMPLETED|Overall Study||63
8465734|NCT00686166|20860609|P1|Eligible and Began Protocol Therapy|Overall Study||74
8465735|NCT00686166|20860609|P1|Eligible|Overall Study||78
8465736|NCT00686166|20860609|P1|STARTED|Overall Study||83
8465737|NCT00686127|20860621|P2|NOT COMPLETED|Overall Study||6
8465738|NCT00686127|20860622|P1|NOT COMPLETED|Overall Study||14
8465739|NCT00686127|20860621|P2|COMPLETED|Overall Study||1
8465740|NCT00686127|20860622|P1|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
8465741|NCT00686127|20860621|P2|STARTED|Overall Study||7
8465742|NCT00686127|20860622|P1|STARTED|Overall Study||14
8465743|NCT00686075|20860638|P10|NOT COMPLETED|Overall Study||10
8465744|NCT00686075|20860639|P9|NOT COMPLETED|Overall Study||6
8465745|NCT00686075|20860640|P8|NOT COMPLETED|Overall Study||2
8465746|NCT00686075|20860641|P7|NOT COMPLETED|Overall Study||0
8465747|NCT00686075|20860642|P6|NOT COMPLETED|Overall Study||3
8465748|NCT00686075|20860643|P5|NOT COMPLETED|Overall Study||4
8465749|NCT00686075|20860644|P4|NOT COMPLETED|Overall Study||9
8465750|NCT00686075|20860645|P3|NOT COMPLETED|Overall Study||6
8465751|NCT00686075|20860646|P2|NOT COMPLETED|Overall Study||10
8465752|NCT00686075|20860647|P1|NOT COMPLETED|Overall Study||8
8465753|NCT00686075|20860638|P10|COMPLETED|Overall Study||69
8465754|NCT00686075|20860639|P9|COMPLETED|Overall Study||75
8465755|NCT00686075|20860640|P8|COMPLETED|Overall Study||76
8465756|NCT00686075|20860641|P7|COMPLETED|Overall Study||82
8465757|NCT00686075|20860642|P6|COMPLETED|Overall Study||37
8465758|NCT00686075|20860643|P5|COMPLETED|Overall Study||36
8465759|NCT00686075|20860644|P4|COMPLETED|Overall Study||71
8465760|NCT00686075|20860645|P3|COMPLETED|Overall Study||74
8465761|NCT00686075|20860646|P2|COMPLETED|Overall Study||71
8465762|NCT00686075|20860647|P1|COMPLETED|Overall Study||71
8465763|NCT00686075|20860638|P10|Treated|Overall Study||78
8465764|NCT00686075|20860639|P9|Treated|Overall Study||80
8465765|NCT00686075|20860640|P8|Treated|Overall Study||77
8465766|NCT00686075|20860641|P7|Treated|Overall Study||82
8465767|NCT00686075|20860642|P6|Treated|Overall Study||40
8465768|NCT00686075|20860643|P5|Treated|Overall Study||40
8465769|NCT00686075|20860644|P4|Treated|Overall Study||80
8465770|NCT00686075|20860645|P3|Treated|Overall Study||80
8465771|NCT00686075|20860646|P2|Treated|Overall Study||79
8465772|NCT00686075|20860647|P1|Treated|Overall Study||78
8465773|NCT00686075|20860638|P10|STARTED|Overall Study||79
8465774|NCT00686075|20860639|P9|STARTED|Overall Study||81
8465775|NCT00686075|20860640|P8|STARTED|Overall Study||78
8465776|NCT00686075|20860641|P7|STARTED|Overall Study||82
8465777|NCT00686075|20860642|P6|STARTED|Overall Study||40
8465778|NCT00686075|20860643|P5|STARTED|Overall Study||40
8465779|NCT00686075|20860644|P4|STARTED|Overall Study||80
8465780|NCT00686075|20860645|P3|STARTED|Overall Study||80
8465781|NCT00686075|20860646|P2|STARTED|Overall Study||81
8465782|NCT00686075|20860647|P1|STARTED|Overall Study||79
8465783|NCT00686036|20860841|P2|NOT COMPLETED|Overall Study||6
8465784|NCT00686036|20860842|P1|NOT COMPLETED|Overall Study||9
8465785|NCT00686036|20860841|P2|COMPLETED|Overall Study||2
8465786|NCT00686036|20860842|P1|COMPLETED|Overall Study||0
8465787|NCT00686036|20860841|P2|STARTED|Overall Study||8
8465788|NCT00686036|20860842|P1|STARTED|Overall Study||9
8465789|NCT00685945|20860854|P1|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
8465790|NCT00685945|20860854|P1|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
8465791|NCT00685945|20860854|P1|STARTED|Sildenafil + L-NMMA + Bradykinin||12
8465792|NCT00685945|20860854|P1|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
8465793|NCT00685945|20860854|P1|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
8465794|NCT00685945|20860854|P1|STARTED|Isosorbide + L-NMMA + Bradykinin||11
8465795|NCT00685945|20860854|P1|NOT COMPLETED|L-NMMA + Bradykinin||1
8465796|NCT00685945|20860854|P1|COMPLETED|L-NMMA + Bradykinin||23
8465797|NCT00685945|20860854|P1|STARTED|L-NMMA + Bradykinin||24
8465798|NCT00685945|20860854|P1|NOT COMPLETED|Control (Bradykinin Infusion)||0
8465799|NCT00685945|20860854|P1|COMPLETED|Control (Bradykinin Infusion)||24
8465800|NCT00685945|20860854|P1|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
8465801|NCT00685932|20860871|P2|NOT COMPLETED|Overall Study||20
8465802|NCT00685932|20860872|P1|NOT COMPLETED|Overall Study||21
8465803|NCT00685932|20860871|P2|COMPLETED|Overall Study||58
8465804|NCT00685932|20860872|P1|COMPLETED|Overall Study||55
8465805|NCT00685932|20860871|P2|STARTED|Overall Study||78
8465806|NCT00685932|20860872|P1|STARTED|Overall Study||76
8465807|NCT00685880|20860882|P2|NOT COMPLETED|Overall Study||0
8465808|NCT00685880|20860883|P1|NOT COMPLETED|Overall Study||0
8465809|NCT00685880|20860882|P2|COMPLETED|Overall Study||2
8465810|NCT00685880|20860883|P1|COMPLETED|Overall Study||0
8465811|NCT00685880|20860882|P2|STARTED|Overall Study||2
8465812|NCT00685880|20860883|P1|STARTED|Overall Study||0
8465813|NCT00685802|20860889|P2|NOT COMPLETED|Second Intervention||0
8465814|NCT00685802|20860890|P1|NOT COMPLETED|Second Intervention||0
8465815|NCT00685802|20860889|P2|COMPLETED|Second Intervention||15
8465816|NCT00685802|20860890|P1|COMPLETED|Second Intervention||14
8465817|NCT00685802|20860889|P2|STARTED|Second Intervention||15
8465818|NCT00685802|20860890|P1|STARTED|Second Intervention||14
8465819|NCT00685802|20860889|P2|NOT COMPLETED|Washout Period of 7 Days||1
8465820|NCT00685802|20860890|P1|NOT COMPLETED|Washout Period of 7 Days||2
8465821|NCT00685802|20860889|P2|COMPLETED|Washout Period of 7 Days||15
8465822|NCT00685802|20860890|P1|COMPLETED|Washout Period of 7 Days||14
8465823|NCT00685802|20860889|P2|STARTED|Washout Period of 7 Days||16
8465824|NCT00685802|20860890|P1|STARTED|Washout Period of 7 Days||16
8465825|NCT00685802|20860889|P2|NOT COMPLETED|First Intervention||0
8465826|NCT00685802|20860890|P1|NOT COMPLETED|First Intervention||0
8465827|NCT00685802|20860889|P2|COMPLETED|First Intervention||16
8465828|NCT00685802|20860890|P1|COMPLETED|First Intervention||16
8465829|NCT00685802|20860889|P2|STARTED|First Intervention||16
8465830|NCT00685802|20860890|P1|STARTED|First Intervention||16
8465831|NCT00685763|20860900|P1|NOT COMPLETED|Overall Study||2
8465832|NCT00685763|20860900|P1|COMPLETED|Overall Study||11
8465833|NCT00685763|20860900|P1|STARTED|Overall Study||13
8465834|NCT00685750|20860911|P7|NOT COMPLETED|Overall Study||1
8465835|NCT00685750|20860912|P6|NOT COMPLETED|Overall Study||0
8465836|NCT00685750|20860913|P5|NOT COMPLETED|Overall Study||0
8465837|NCT00685750|20860914|P4|NOT COMPLETED|Overall Study||0
8465838|NCT00685750|20860915|P3|NOT COMPLETED|Overall Study||2
8465839|NCT00685750|20860916|P2|NOT COMPLETED|Overall Study||0
8465840|NCT00685750|20860917|P1|NOT COMPLETED|Overall Study||0
8465841|NCT00685750|20860911|P7|COMPLETED|Overall Study||9
8465842|NCT00685750|20860912|P6|COMPLETED|Overall Study||20
8465843|NCT00685750|20860913|P5|COMPLETED|Overall Study||15
8465844|NCT00685750|20860914|P4|COMPLETED|Overall Study||2
8465845|NCT00685750|20860915|P3|COMPLETED|Overall Study||19
8465846|NCT00685750|20860916|P2|COMPLETED|Overall Study||3
8465847|NCT00685750|20860917|P1|COMPLETED|Overall Study||17
8465848|NCT00685750|20860911|P7|STARTED|Overall Study||10
8465849|NCT00685750|20860912|P6|STARTED|Overall Study||20
8465850|NCT00685750|20860913|P5|STARTED|Overall Study||15
8465851|NCT00685750|20860914|P4|STARTED|Overall Study||2
8465852|NCT00685750|20860915|P3|STARTED|Overall Study||21
8465853|NCT00685750|20860916|P2|STARTED|Overall Study||3
8465854|NCT00685750|20860917|P1|STARTED|Overall Study||17
8465855|NCT00685698|20860945|P1|NOT COMPLETED|Overall Study||13
8465856|NCT00685698|20860945|P1|COMPLETED|Overall Study||25
8465857|NCT00685698|20860945|P1|STARTED|Overall Study||38
8465858|NCT00685685|20860980|P2|NOT COMPLETED|Second Intervention||0
8465859|NCT00685685|20860981|P1|NOT COMPLETED|Second Intervention||0
8465860|NCT00685685|20860980|P2|COMPLETED|Second Intervention||26
8465861|NCT00685685|20860981|P1|COMPLETED|Second Intervention||25
8465862|NCT00685685|20860980|P2|STARTED|Second Intervention||26
8465863|NCT00685685|20860981|P1|STARTED|Second Intervention||25
8465864|NCT00685685|20860980|P2|NOT COMPLETED|Washout Period of 7 Days||1
8465865|NCT00685685|20860981|P1|NOT COMPLETED|Washout Period of 7 Days||2
8465866|NCT00685685|20860980|P2|COMPLETED|Washout Period of 7 Days||26
8465867|NCT00685685|20860981|P1|COMPLETED|Washout Period of 7 Days||25
8465868|NCT00685685|20860980|P2|STARTED|Washout Period of 7 Days||27
8465869|NCT00685685|20860981|P1|STARTED|Washout Period of 7 Days||27
8465870|NCT00685685|20860980|P2|NOT COMPLETED|First Intervention||0
8465871|NCT00685685|20860981|P1|NOT COMPLETED|First Intervention||0
8465872|NCT00685685|20860980|P2|COMPLETED|First Intervention||27
8465873|NCT00685685|20860981|P1|COMPLETED|First Intervention||27
8465874|NCT00685685|20860980|P2|STARTED|First Intervention||27
8465875|NCT00685685|20860981|P1|STARTED|First Intervention||27
8465876|NCT00685659|20860994|P3|NOT COMPLETED|Overall Study||15
8465877|NCT00685659|20860995|P2|NOT COMPLETED|Overall Study||25
8465878|NCT00685659|20860996|P1|NOT COMPLETED|Overall Study||31
8465879|NCT00685659|20860994|P3|COMPLETED|Overall Study||92
8465880|NCT00685659|20860995|P2|COMPLETED|Overall Study||81
8465881|NCT00685659|20860996|P1|COMPLETED|Overall Study||77
8465882|NCT00685659|20860994|P3|STARTED|Overall Study||107
8465883|NCT00685659|20860995|P2|STARTED|Overall Study||106
8465884|NCT00685659|20860996|P1|STARTED|Overall Study||108
8465885|NCT00685516|20861094|P3|NOT COMPLETED|Overall Study||7
8465886|NCT00685516|20861095|P2|NOT COMPLETED|Overall Study||5
8465887|NCT00685516|20861096|P1|NOT COMPLETED|Overall Study||8
8465888|NCT00685516|20861094|P3|COMPLETED|Overall Study||26
8465889|NCT00685516|20861095|P2|COMPLETED|Overall Study||33
8465890|NCT00685516|20861096|P1|COMPLETED|Overall Study||34
8465891|NCT00685516|20861094|P3|STARTED|Overall Study||33
8465892|NCT00685516|20861095|P2|STARTED|Overall Study||38
8465893|NCT00685516|20861096|P1|STARTED|Overall Study||42
8465894|NCT00685477|20861113|P6|NOT COMPLETED|Overall Study||0
8465895|NCT00685477|20861114|P5|NOT COMPLETED|Overall Study||0
8465896|NCT00685477|20861115|P4|NOT COMPLETED|Overall Study||0
8465897|NCT00685477|20861116|P3|NOT COMPLETED|Overall Study||0
8465898|NCT00685477|20861117|P2|NOT COMPLETED|Overall Study||0
8465899|NCT00685477|20861118|P1|NOT COMPLETED|Overall Study||0
8465900|NCT00685477|20861113|P6|COMPLETED|Overall Study||10
8465901|NCT00685477|20861114|P5|COMPLETED|Overall Study||10
8465902|NCT00685477|20861115|P4|COMPLETED|Overall Study||10
8465903|NCT00685477|20861116|P3|COMPLETED|Overall Study||10
8465904|NCT00685477|20861117|P2|COMPLETED|Overall Study||10
8465905|NCT00685477|20861118|P1|COMPLETED|Overall Study||10
8465906|NCT00685477|20861113|P6|STARTED|Overall Study||10
8465907|NCT00685477|20861114|P5|STARTED|Overall Study||10
8465908|NCT00685477|20861115|P4|STARTED|Overall Study||10
8465909|NCT00685477|20861116|P3|STARTED|Overall Study||10
8465910|NCT00685477|20861117|P2|STARTED|Overall Study||10
8465911|NCT00685477|20861118|P1|STARTED|Overall Study||10
8465912|NCT00685399|20861134|P8|NOT COMPLETED|Extension||0
8465913|NCT00685399|20861135|P7|NOT COMPLETED|Extension||0
8465914|NCT00685399|20861136|P6|NOT COMPLETED|Extension||0
8465915|NCT00685399|20861137|P5|NOT COMPLETED|Extension||0
8465916|NCT00685399|20861138|P4|NOT COMPLETED|Extension||7
8465917|NCT00685399|20861139|P3|NOT COMPLETED|Extension||0
8465918|NCT00685399|20861140|P2|NOT COMPLETED|Extension||0
8465919|NCT00685399|20861141|P1|NOT COMPLETED|Extension||0
8465920|NCT00685399|20861134|P8|COMPLETED|Extension||0
8465921|NCT00685399|20861135|P7|COMPLETED|Extension||0
8465922|NCT00685399|20861136|P6|COMPLETED|Extension||0
8465923|NCT00685399|20861137|P5|COMPLETED|Extension||0
8465924|NCT00685399|20861138|P4|COMPLETED|Extension||21
8465925|NCT00685399|20861139|P3|COMPLETED|Extension||0
8465926|NCT00685399|20861140|P2|COMPLETED|Extension||0
8465927|NCT00685399|20861141|P1|COMPLETED|Extension||0
8465928|NCT00685399|20861134|P8|STARTED|Extension||0
8465929|NCT00685399|20861135|P7|STARTED|Extension||0
8465930|NCT00685399|20861136|P6|STARTED|Extension||0
8465931|NCT00685399|20861137|P5|STARTED|Extension||0
8465932|NCT00685399|20861138|P4|STARTED|Extension||28
8465933|NCT00685399|20861139|P3|STARTED|Extension||0
8465934|NCT00685399|20861140|P2|STARTED|Extension||0
8465935|NCT00685399|20861141|P1|STARTED|Extension||0
8465936|NCT00685399|20861134|P8|NOT COMPLETED|Treatment Period 2||2
8465937|NCT00685399|20861135|P7|NOT COMPLETED|Treatment Period 2||0
8465938|NCT00685399|20861136|P6|NOT COMPLETED|Treatment Period 2||2
8465939|NCT00685399|20861137|P5|NOT COMPLETED|Treatment Period 2||0
8465940|NCT00685399|20861138|P4|NOT COMPLETED|Treatment Period 2||0
8465941|NCT00685399|20861139|P3|NOT COMPLETED|Treatment Period 2||3
8465942|NCT00685399|20861140|P2|NOT COMPLETED|Treatment Period 2||12
8465943|NCT00685399|20861141|P1|NOT COMPLETED|Treatment Period 2||0
8465944|NCT00685399|20861134|P8|COMPLETED|Treatment Period 2||10
8465945|NCT00685399|20861135|P7|COMPLETED|Treatment Period 2||13
8465946|NCT00685399|20861136|P6|COMPLETED|Treatment Period 2||10
8465947|NCT00685399|20861137|P5|COMPLETED|Treatment Period 2||4
8465948|NCT00685399|20861138|P4|COMPLETED|Treatment Period 2|in extension period only|0
8465949|NCT00685399|20861139|P3|COMPLETED|Treatment Period 2||2
8465950|NCT00685399|20861140|P2|COMPLETED|Treatment Period 2||2
8465951|NCT00685399|20861141|P1|COMPLETED|Treatment Period 2||0
8465952|NCT00685399|20861134|P8|STARTED|Treatment Period 2||12
8465953|NCT00685399|20861135|P7|STARTED|Treatment Period 2||13
8465954|NCT00685399|20861136|P6|STARTED|Treatment Period 2||12
8465955|NCT00685399|20861137|P5|STARTED|Treatment Period 2||4
8465956|NCT00685399|20861138|P4|STARTED|Treatment Period 2|in extension period only|0
8465957|NCT00685399|20861139|P3|STARTED|Treatment Period 2||5
8465958|NCT00685399|20861140|P2|STARTED|Treatment Period 2||14
8465959|NCT00685399|20861141|P1|STARTED|Treatment Period 2||0
8465960|NCT00685399|20861134|P8|NOT COMPLETED|Treatment Period 1||0
8465961|NCT00685399|20861135|P7|NOT COMPLETED|Treatment Period 1||0
8465962|NCT00685399|20861136|P6|NOT COMPLETED|Treatment Period 1||0
8465963|NCT00685399|20861137|P5|NOT COMPLETED|Treatment Period 1||0
8465964|NCT00685399|20861138|P4|NOT COMPLETED|Treatment Period 1||0
8465965|NCT00685399|20861139|P3|NOT COMPLETED|Treatment Period 1||0
8465966|NCT00685399|20861140|P2|NOT COMPLETED|Treatment Period 1||0
8465967|NCT00685399|20861141|P1|NOT COMPLETED|Treatment Period 1||6
8465968|NCT00685399|20861134|P8|COMPLETED|Treatment Period 1||0
8465969|NCT00685399|20861135|P7|COMPLETED|Treatment Period 1||0
8465970|NCT00685399|20861136|P6|COMPLETED|Treatment Period 1||0
8465971|NCT00685399|20861137|P5|COMPLETED|Treatment Period 1||0
8465972|NCT00685399|20861138|P4|COMPLETED|Treatment Period 1||0
8465973|NCT00685399|20861139|P3|COMPLETED|Treatment Period 1||0
8465974|NCT00685399|20861140|P2|COMPLETED|Treatment Period 1||0
8465975|NCT00685399|20861141|P1|COMPLETED|Treatment Period 1||10
8465976|NCT00685399|20861134|P8|STARTED|Treatment Period 1||0
8465977|NCT00685399|20861135|P7|STARTED|Treatment Period 1||0
8465978|NCT00685399|20861136|P6|STARTED|Treatment Period 1||0
8465979|NCT00685399|20861137|P5|STARTED|Treatment Period 1||0
8465980|NCT00685399|20861138|P4|STARTED|Treatment Period 1||0
8465981|NCT00685399|20861139|P3|STARTED|Treatment Period 1||0
8465982|NCT00685399|20861140|P2|STARTED|Treatment Period 1||0
8465983|NCT00685399|20861141|P1|STARTED|Treatment Period 1||16
8465984|NCT00685373|20861174|P1|NOT COMPLETED|Overall Study||15
8465985|NCT00685373|20861174|P1|COMPLETED|Overall Study||151
8465986|NCT00685373|20861174|P1|STARTED|Overall Study||166
8465987|NCT00685334|20861183|P2|NOT COMPLETED|Overall Study||7
8465988|NCT00685334|20861184|P1|NOT COMPLETED|Overall Study||10
8465989|NCT00685334|20861183|P2|COMPLETED|Overall Study||3
8465990|NCT00685334|20861184|P1|COMPLETED|Overall Study||2
8465991|NCT00685334|20861183|P2|STARTED|Overall Study||10
8465992|NCT00685334|20861184|P1|STARTED|Overall Study||12
8465993|NCT00685295|20861194|P2|NOT COMPLETED|Overall Study||0
8465994|NCT00685295|20861195|P1|NOT COMPLETED|Overall Study||0
8465995|NCT00685295|20861194|P2|COMPLETED|Overall Study||30
8465996|NCT00685295|20861195|P1|COMPLETED|Overall Study||30
8465997|NCT00685295|20861194|P2|STARTED|Overall Study||30
8465998|NCT00685295|20861195|P1|STARTED|Overall Study||30
8465999|NCT00685178|20861209|P4|NOT COMPLETED|Overall Study||14
8466000|NCT00685178|20861210|P3|NOT COMPLETED|Overall Study||12
8466001|NCT00685178|20861211|P2|NOT COMPLETED|Overall Study||19
8466002|NCT00685178|20861212|P1|NOT COMPLETED|Overall Study||13
8466003|NCT00685178|20861209|P4|COMPLETED|Overall Study||33
8466004|NCT00685178|20861210|P3|COMPLETED|Overall Study||27
8466005|NCT00685178|20861211|P2|COMPLETED|Overall Study||26
8466006|NCT00685178|20861212|P1|COMPLETED|Overall Study||27
8466007|NCT00685178|20861209|P4|STARTED|Overall Study||47
8466008|NCT00685178|20861210|P3|STARTED|Overall Study||39
8466009|NCT00685178|20861211|P2|STARTED|Overall Study||45
8466010|NCT00685178|20861212|P1|STARTED|Overall Study||40
8466011|NCT00685165|20861226|P2|NOT COMPLETED|Second Intervention||0
8466012|NCT00685165|20861227|P1|NOT COMPLETED|Second Intervention||0
8466013|NCT00685165|20861226|P2|COMPLETED|Second Intervention||11
8466014|NCT00685165|20861227|P1|COMPLETED|Second Intervention||10
8466015|NCT00685165|20861226|P2|STARTED|Second Intervention||11
8466016|NCT00685165|20861227|P1|STARTED|Second Intervention||10
8466017|NCT00685165|20861226|P2|NOT COMPLETED|Washout Period of 14 Days||0
8466018|NCT00685165|20861227|P1|NOT COMPLETED|Washout Period of 14 Days||1
8466019|NCT00685165|20861226|P2|COMPLETED|Washout Period of 14 Days||11
8466020|NCT00685165|20861227|P1|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
8466021|NCT00685165|20861226|P2|STARTED|Washout Period of 14 Days||11
8466022|NCT00685165|20861227|P1|STARTED|Washout Period of 14 Days||11
8466023|NCT00685165|20861226|P2|NOT COMPLETED|First Intervention||0
8466024|NCT00685165|20861227|P1|NOT COMPLETED|First Intervention||0
8466025|NCT00685165|20861226|P2|COMPLETED|First Intervention||11
8466026|NCT00685165|20861227|P1|COMPLETED|First Intervention||11
8466027|NCT00685165|20861226|P2|STARTED|First Intervention||11
8466028|NCT00685165|20861227|P1|STARTED|First Intervention||11
8466029|NCT00685139|20861237|P2|NOT COMPLETED|Second Intervention||0
8466030|NCT00685139|20861238|P1|NOT COMPLETED|Second Intervention||0
8466031|NCT00685139|20861237|P2|COMPLETED|Second Intervention||17
8466032|NCT00685139|20861238|P1|COMPLETED|Second Intervention||17
8466033|NCT00685139|20861237|P2|STARTED|Second Intervention||17
8466034|NCT00685139|20861238|P1|STARTED|Second Intervention||17
8466035|NCT00685139|20861237|P2|NOT COMPLETED|Washout Period of 28 Days||0
8466036|NCT00685139|20861238|P1|NOT COMPLETED|Washout Period of 28 Days||0
8466037|NCT00685139|20861237|P2|COMPLETED|Washout Period of 28 Days||17
8466038|NCT00685139|20861238|P1|COMPLETED|Washout Period of 28 Days||17
8466039|NCT00685139|20861237|P2|STARTED|Washout Period of 28 Days||17
8466040|NCT00685139|20861238|P1|STARTED|Washout Period of 28 Days||17
8466041|NCT00685139|20861237|P2|NOT COMPLETED|First Intervention||0
8466042|NCT00685139|20861238|P1|NOT COMPLETED|First Intervention||0
8466043|NCT00685139|20861237|P2|COMPLETED|First Intervention||17
8466044|NCT00685139|20861238|P1|COMPLETED|First Intervention||17
8466045|NCT00685139|20861237|P2|STARTED|First Intervention||17
8466046|NCT00685139|20861238|P1|STARTED|First Intervention||17
8466047|NCT00685035|20861246|P2|NOT COMPLETED|Period 3: 2nd Intervention||0
8466048|NCT00685035|20861247|P1|NOT COMPLETED|Period 3: 2nd Intervention||0
8466049|NCT00685035|20861246|P2|COMPLETED|Period 3: 2nd Intervention||8
8466050|NCT00685035|20861247|P1|COMPLETED|Period 3: 2nd Intervention||8
8466051|NCT00685035|20861246|P2|STARTED|Period 3: 2nd Intervention||8
8466052|NCT00685035|20861247|P1|STARTED|Period 3: 2nd Intervention||8
8466053|NCT00685035|20861246|P2|NOT COMPLETED|Period 2: 2-day Washout||0
8466054|NCT00685035|20861247|P1|NOT COMPLETED|Period 2: 2-day Washout||0
8466055|NCT00685035|20861246|P2|COMPLETED|Period 2: 2-day Washout||8
8466056|NCT00685035|20861247|P1|COMPLETED|Period 2: 2-day Washout||8
8466057|NCT00685035|20861246|P2|STARTED|Period 2: 2-day Washout||8
8466058|NCT00685035|20861247|P1|STARTED|Period 2: 2-day Washout||8
8466059|NCT00685035|20861246|P2|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
8466060|NCT00685035|20861247|P1|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
8466061|NCT00685035|20861246|P2|COMPLETED|Period 1: First Intervention: 30 Minutes||8
8466062|NCT00685035|20861247|P1|COMPLETED|Period 1: First Intervention: 30 Minutes||8
8466063|NCT00685035|20861246|P2|STARTED|Period 1: First Intervention: 30 Minutes||8
8466064|NCT00685035|20861247|P1|STARTED|Period 1: First Intervention: 30 Minutes||9
8466065|NCT00684996|20861271|P1|NOT COMPLETED|Overall Study||5
8466066|NCT00684996|20861271|P1|COMPLETED|Overall Study||0
8466067|NCT00684996|20861271|P1|Eligible|Overall Study||5
8466068|NCT00684996|20861271|P1|STARTED|Overall Study||5
8466069|NCT00684983|20861286|P2|NOT COMPLETED|Overall Study||0
8466070|NCT00684983|20861287|P1|NOT COMPLETED|Overall Study||0
8466071|NCT00684983|20861286|P2|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
8466072|NCT00684983|20861287|P1|COMPLETED|Overall Study||19
8466073|NCT00684983|20861286|P2|STARTED|Overall Study||45
8466074|NCT00684983|20861287|P1|STARTED|Overall Study||19
8466075|NCT00684814|20861303|P2|NOT COMPLETED|Second Intervention||0
8466076|NCT00684814|20861304|P1|NOT COMPLETED|Second Intervention||1
8466077|NCT00684814|20861303|P2|COMPLETED|Second Intervention||15
8466078|NCT00684814|20861304|P1|COMPLETED|Second Intervention||16
8466079|NCT00684814|20861303|P2|STARTED|Second Intervention||15
8466080|NCT00684814|20861304|P1|STARTED|Second Intervention||17
8466081|NCT00684814|20861303|P2|NOT COMPLETED|Washout Period of 7 Days||4
8466082|NCT00684814|20861304|P1|NOT COMPLETED|Washout Period of 7 Days||2
8466083|NCT00684814|20861303|P2|COMPLETED|Washout Period of 7 Days||15
8466084|NCT00684814|20861304|P1|COMPLETED|Washout Period of 7 Days||17
8466085|NCT00684814|20861303|P2|STARTED|Washout Period of 7 Days||19
8466086|NCT00684814|20861304|P1|STARTED|Washout Period of 7 Days||19
8466087|NCT00684814|20861303|P2|NOT COMPLETED|First Intervention||0
8466088|NCT00684814|20861304|P1|NOT COMPLETED|First Intervention||0
8466089|NCT00684814|20861303|P2|COMPLETED|First Intervention||19
8466090|NCT00684814|20861304|P1|COMPLETED|First Intervention||19
8466091|NCT00684814|20861303|P2|STARTED|First Intervention||19
8466092|NCT00684814|20861304|P1|STARTED|First Intervention||19
8466093|NCT00684788|20861316|P2|NOT COMPLETED|Overall Study||0
8466094|NCT00684788|20861317|P1|NOT COMPLETED|Overall Study||0
8466095|NCT00684788|20861316|P2|COMPLETED|Overall Study||18
8466096|NCT00684788|20861317|P1|COMPLETED|Overall Study||17
8466097|NCT00684788|20861316|P2|STARTED|Overall Study||18
8466098|NCT00684788|20861317|P1|STARTED|Overall Study||17
8466099|NCT00684775|20861337|P2|NOT COMPLETED|Overall Study||0
8466100|NCT00684775|20861338|P1|NOT COMPLETED|Overall Study||0
8466101|NCT00684775|20861337|P2|COMPLETED|Overall Study||19
8466102|NCT00684775|20861338|P1|COMPLETED|Overall Study||19
8466103|NCT00684775|20861337|P2|STARTED|Overall Study||19
8466104|NCT00684775|20861338|P1|STARTED|Overall Study||19
8466105|NCT00684762|20861356|P2|NOT COMPLETED|Second Intervention||0
8466106|NCT00684762|20861357|P1|NOT COMPLETED|Second Intervention||0
8466107|NCT00684762|20861356|P2|COMPLETED|Second Intervention||14
8466108|NCT00684762|20861357|P1|COMPLETED|Second Intervention||14
8466109|NCT00684762|20861356|P2|STARTED|Second Intervention||14
8466110|NCT00684762|20861357|P1|STARTED|Second Intervention||14
8466111|NCT00684762|20861356|P2|NOT COMPLETED|Washout Period of 7 Days||2
8466112|NCT00684762|20861357|P1|NOT COMPLETED|Washout Period of 7 Days||2
8466113|NCT00684762|20861356|P2|COMPLETED|Washout Period of 7 Days||14
8466114|NCT00684762|20861357|P1|COMPLETED|Washout Period of 7 Days||14
8466115|NCT00684762|20861356|P2|STARTED|Washout Period of 7 Days||16
8466116|NCT00684762|20861357|P1|STARTED|Washout Period of 7 Days||16
8466117|NCT00684762|20861356|P2|NOT COMPLETED|First Intervention||0
8466118|NCT00684762|20861357|P1|NOT COMPLETED|First Intervention||0
8466119|NCT00684762|20861356|P2|COMPLETED|First Intervention||16
8466120|NCT00684762|20861357|P1|COMPLETED|First Intervention||16
8466121|NCT00684762|20861356|P2|STARTED|First Intervention||16
8466122|NCT00684762|20861357|P1|STARTED|First Intervention||16
8466123|NCT00684749|20861367|P1|NOT COMPLETED|Overall Study||0
8466124|NCT00684749|20861367|P1|COMPLETED|Overall Study||142
8466125|NCT00684749|20861367|P1|STARTED|Overall Study||142
8466126|NCT00684723|20861371|P2|NOT COMPLETED|Second Intervention||0
8466127|NCT00684723|20861372|P1|NOT COMPLETED|Second Intervention||0
8466128|NCT00684723|20861371|P2|COMPLETED|Second Intervention||27
8466129|NCT00684723|20861372|P1|COMPLETED|Second Intervention||27
8466130|NCT00684723|20861371|P2|STARTED|Second Intervention||27
8466131|NCT00684723|20861372|P1|STARTED|Second Intervention||27
8466132|NCT00684723|20861371|P2|NOT COMPLETED|Washout Period of 7 Days||0
8466133|NCT00684723|20861372|P1|NOT COMPLETED|Washout Period of 7 Days||0
8466134|NCT00684723|20861371|P2|COMPLETED|Washout Period of 7 Days||27
8466135|NCT00684723|20861372|P1|COMPLETED|Washout Period of 7 Days||27
8466136|NCT00684723|20861371|P2|STARTED|Washout Period of 7 Days||27
8466137|NCT00684723|20861372|P1|STARTED|Washout Period of 7 Days||27
8466138|NCT00684723|20861371|P2|NOT COMPLETED|First Intervention||0
8466139|NCT00684723|20861372|P1|NOT COMPLETED|First Intervention||0
8466140|NCT00684723|20861371|P2|COMPLETED|First Intervention||27
8466141|NCT00684723|20861372|P1|COMPLETED|First Intervention||27
8466142|NCT00684723|20861371|P2|STARTED|First Intervention||27
8466143|NCT00684723|20861372|P1|STARTED|First Intervention||27
8466144|NCT00684671|20861385|P3|NOT COMPLETED|Overall Study||0
8466145|NCT00684671|20861386|P2|NOT COMPLETED|Overall Study||0
8466146|NCT00684671|20861387|P1|NOT COMPLETED|Overall Study||3
8466147|NCT00684671|20861385|P3|COMPLETED|Overall Study||164
8466148|NCT00684671|20861386|P2|COMPLETED|Overall Study||170
8466149|NCT00684671|20861387|P1|COMPLETED|Overall Study||169
8466150|NCT00684671|20861385|P3|STARTED|Overall Study||164
8466151|NCT00684671|20861386|P2|STARTED|Overall Study||170
8466152|NCT00684671|20861387|P1|STARTED|Overall Study||172
8466153|NCT00684645|20861416|P1|NOT COMPLETED|Overall Study||114
8466154|NCT00684645|20861416|P1|COMPLETED|Overall Study||72
8466155|NCT00684645|20861416|P1|STARTED|Overall Study||186
8466156|NCT00684593|20861436|P2|NOT COMPLETED|Overall Study||2
8466157|NCT00684593|20861437|P1|NOT COMPLETED|Overall Study||0
8466158|NCT00684593|20861436|P2|COMPLETED|Overall Study||8
8466159|NCT00684593|20861437|P1|COMPLETED|Overall Study||21
8466160|NCT00684593|20861436|P2|STARTED|Overall Study||10
8466161|NCT00684593|20861437|P1|STARTED|Overall Study||21
8466162|NCT00684567|20861449|P1|NOT COMPLETED|Monotherapy Period||14
8466163|NCT00684567|20861449|P1|COMPLETED|Monotherapy Period||9
8466164|NCT00684567|20861449|P1|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
8466165|NCT00684567|20861449|P1|NOT COMPLETED|Concomitant Radiotherapy Period||2
8466166|NCT00684567|20861449|P1|COMPLETED|Concomitant Radiotherapy Period||28
8466167|NCT00684567|20861449|P1|STARTED|Concomitant Radiotherapy Period||30
8466168|NCT00684554|20861459|P2|NOT COMPLETED|Overall Study||0
8466169|NCT00684554|20861460|P1|NOT COMPLETED|Overall Study||0
8466170|NCT00684554|20861459|P2|COMPLETED|Overall Study||10
8466171|NCT00684554|20861460|P1|COMPLETED|Overall Study||10
8466172|NCT00684554|20861459|P2|STARTED|Overall Study||10
8466173|NCT00684554|20861460|P1|STARTED|Overall Study||10
8466174|NCT00684541|20861470|P2|NOT COMPLETED|Overall Study||3
8466175|NCT00684541|20861471|P1|NOT COMPLETED|Overall Study||3
8466176|NCT00684541|20861470|P2|COMPLETED|Overall Study||23
8466177|NCT00684541|20861471|P1|COMPLETED|Overall Study||20
8466178|NCT00684541|20861470|P2|STARTED|Overall Study||26
8466179|NCT00684541|20861471|P1|STARTED|Overall Study||23
8466180|NCT00684515|20861482|P3|NOT COMPLETED|Overall Study||1
8466181|NCT00684515|20861483|P2|NOT COMPLETED|Overall Study||3
8466182|NCT00684515|20861484|P1|NOT COMPLETED|Overall Study||4
8466183|NCT00684515|20861482|P3|COMPLETED|Overall Study||27
8466184|NCT00684515|20861483|P2|COMPLETED|Overall Study||26
8466185|NCT00684515|20861484|P1|COMPLETED|Overall Study||29
8466186|NCT00684515|20861482|P3|STARTED|Overall Study||28
8466187|NCT00684515|20861483|P2|STARTED|Overall Study||29
8466188|NCT00684515|20861484|P1|STARTED|Overall Study||33
8466192|NCT00684411|20861522|P1|NOT COMPLETED|Overall Study||12
8466193|NCT00684411|20861522|P1|COMPLETED|Overall Study||0
8466194|NCT00684411|20861522|P1|Disease Evaluable|Overall Study||11
8466195|NCT00684411|20861522|P1|STARTED|Overall Study||12
8466196|NCT00684320|20861530|P2|NOT COMPLETED|Overall Study||0
8466197|NCT00684320|20861531|P1|NOT COMPLETED|Overall Study||4
8466198|NCT00684320|20861530|P2|COMPLETED|Overall Study||22
8466199|NCT00684320|20861531|P1|COMPLETED|Overall Study||22
8466200|NCT00684320|20861530|P2|STARTED|Overall Study||22
8466201|NCT00684320|20861531|P1|STARTED|Overall Study||26
8466202|NCT00684307|20861544|P5|NOT COMPLETED|Overall Study||25
8466203|NCT00684307|20861545|P4|NOT COMPLETED|Overall Study||32
8466204|NCT00684307|20861546|P3|NOT COMPLETED|Overall Study||28
8466205|NCT00684307|20861547|P2|NOT COMPLETED|Overall Study||22
8466206|NCT00684307|20861548|P1|NOT COMPLETED|Overall Study||24
8466207|NCT00684307|20861544|P5|COMPLETED|Overall Study||293
8466208|NCT00684307|20861545|P4|COMPLETED|Overall Study||128
8466209|NCT00684307|20861546|P3|COMPLETED|Overall Study||128
8466210|NCT00684307|20861547|P2|COMPLETED|Overall Study||129
8466211|NCT00684307|20861548|P1|COMPLETED|Overall Study||140
8466212|NCT00684307|20861544|P5|On Treatment Period Completed|Overall Study||293
8466213|NCT00684307|20861545|P4|On Treatment Period Completed|Overall Study||128
8466214|NCT00684307|20861546|P3|On Treatment Period Completed|Overall Study||128
8466215|NCT00684307|20861547|P2|On Treatment Period Completed|Overall Study||129
8466216|NCT00684307|20861548|P1|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
8466217|NCT00684307|20861544|P5|On Treatment Period Started|Overall Study||318
8466218|NCT00684307|20861545|P4|On Treatment Period Started|Overall Study||160
8466219|NCT00684307|20861546|P3|On Treatment Period Started|Overall Study||156
8466220|NCT00684307|20861547|P2|On Treatment Period Started|Overall Study||151
8466221|NCT00684307|20861548|P1|On Treatment Period Started|Overall Study||164
8466222|NCT00684307|20861544|P5|STARTED|Overall Study||318
8466223|NCT00684307|20861545|P4|STARTED|Overall Study||160
8466224|NCT00684307|20861546|P3|STARTED|Overall Study||156
8466225|NCT00684307|20861547|P2|STARTED|Overall Study||151
8466226|NCT00684307|20861548|P1|STARTED|Overall Study|Patients who received treatment|164
8466227|NCT00684255|20861615|P1|NOT COMPLETED|Overall Study||0
8466228|NCT00684255|20861615|P1|COMPLETED|Overall Study||1
8466229|NCT00684255|20861615|P1|STARTED|Overall Study||1
8466230|NCT00684242|20861620|P1|NOT COMPLETED|Overall Study||0
8466231|NCT00684242|20861620|P1|COMPLETED|Overall Study||3
8466232|NCT00684242|20861620|P1|STARTED|Overall Study||3
8466233|NCT00684203|20861630|P6|NOT COMPLETED|Overall Study||0
8466234|NCT00684203|20861631|P5|NOT COMPLETED|Overall Study||0
8466235|NCT00684203|20861632|P4|NOT COMPLETED|Overall Study||0
8466236|NCT00684203|20861633|P3|NOT COMPLETED|Overall Study||9
8466237|NCT00684203|20861634|P2|NOT COMPLETED|Overall Study||8
8466238|NCT00684203|20861635|P1|NOT COMPLETED|Overall Study||9
8466239|NCT00684203|20861630|P6|COMPLETED|Overall Study||2
8466240|NCT00684203|20861631|P5|COMPLETED|Overall Study||17
8466241|NCT00684203|20861632|P4|COMPLETED|Overall Study||6
8466242|NCT00684203|20861633|P3|COMPLETED|Overall Study||12
8466243|NCT00684203|20861634|P2|COMPLETED|Overall Study||23
8466244|NCT00684203|20861635|P1|COMPLETED|Overall Study||31
8466245|NCT00684203|20861630|P6|STARTED|Overall Study||2
8466246|NCT00684203|20861631|P5|STARTED|Overall Study||17
8466247|NCT00684203|20861632|P4|STARTED|Overall Study||6
8466248|NCT00684203|20861633|P3|STARTED|Overall Study||21
8466249|NCT00684203|20861634|P2|STARTED|Overall Study||31
8466250|NCT00684203|20861635|P1|STARTED|Overall Study||40
8466251|NCT00684177|20861696|P2|NOT COMPLETED|Overall Study||23
8466252|NCT00684177|20861697|P1|NOT COMPLETED|Overall Study||21
8466253|NCT00684177|20861696|P2|COMPLETED|Overall Study||141
8466254|NCT00684177|20861697|P1|COMPLETED|Overall Study||322
8466255|NCT00684177|20861696|P2|STARTED|Overall Study||164
8466256|NCT00684177|20861697|P1|STARTED|Overall Study||343
8466257|NCT00684138|20861715|P2|NOT COMPLETED|Overall Study||8
8466258|NCT00684138|20861716|P1|NOT COMPLETED|Overall Study||3
8466259|NCT00684138|20861715|P2|COMPLETED|Overall Study||131
8466260|NCT00684138|20861716|P1|COMPLETED|Overall Study||138
8466261|NCT00684138|20861715|P2|STARTED|Overall Study||139
8466262|NCT00684138|20861716|P1|STARTED|Overall Study||141
8466263|NCT00684073|20861732|P1|NOT COMPLETED|Treatment (Days 1 Through 5)||1
8466264|NCT00684073|20861732|P1|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
8466265|NCT00684073|20861732|P1|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
8466266|NCT00684073|20861732|P1|NOT COMPLETED|Selection||7
8466267|NCT00684073|20861732|P1|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
8466268|NCT00684073|20861732|P1|STARTED|Selection||60
8466269|NCT00684060|20861742|P2|NOT COMPLETED|Overall Study||3
8466270|NCT00684060|20861743|P1|NOT COMPLETED|Overall Study||3
8466271|NCT00684060|20861742|P2|COMPLETED|Overall Study||26
8466272|NCT00684060|20861743|P1|COMPLETED|Overall Study||55
8466273|NCT00684060|20861742|P2|STARTED|Overall Study||29
8466274|NCT00684060|20861743|P1|STARTED|Overall Study||58
8466275|NCT00684047|20861766|P3|NOT COMPLETED|Overall Study||5
8466276|NCT00684047|20861767|P2|NOT COMPLETED|Overall Study||16
8466277|NCT00684047|20861768|P1|NOT COMPLETED|Overall Study||13
8466278|NCT00684047|20861766|P3|COMPLETED|Overall Study||52
8466279|NCT00684047|20861767|P2|COMPLETED|Overall Study||94
8466280|NCT00684047|20861768|P1|COMPLETED|Overall Study||59
8466281|NCT00684047|20861766|P3|STARTED|Overall Study||57
8466282|NCT00684047|20861767|P2|STARTED|Overall Study||110
8466283|NCT00684047|20861768|P1|STARTED|Overall Study||72
8466284|NCT00684021|20861782|P4|NOT COMPLETED|Overall Study||2
8466285|NCT00684021|20861783|P3|NOT COMPLETED|Overall Study||2
8466286|NCT00684021|20861784|P2|NOT COMPLETED|Overall Study||2
8466287|NCT00684021|20861785|P1|NOT COMPLETED|Overall Study||2
8466288|NCT00684021|20861782|P4|COMPLETED|Overall Study||15
8466289|NCT00684021|20861783|P3|COMPLETED|Overall Study||34
8466290|NCT00684021|20861784|P2|COMPLETED|Overall Study||22
8466291|NCT00684021|20861785|P1|COMPLETED|Overall Study||41
8466292|NCT00684021|20861782|P4|STARTED|Overall Study||17
8466293|NCT00684021|20861783|P3|STARTED|Overall Study||36
8466294|NCT00684021|20861784|P2|STARTED|Overall Study||24
8466295|NCT00684021|20861785|P1|STARTED|Overall Study||43
8466296|NCT00683930|20861826|P3|NOT COMPLETED|Overall Study||9
8466297|NCT00683930|20861827|P2|NOT COMPLETED|Overall Study||3
8466298|NCT00683930|20861828|P1|NOT COMPLETED|Overall Study||7
8466299|NCT00683930|20861826|P3|COMPLETED|Overall Study||28
8466300|NCT00683930|20861827|P2|COMPLETED|Overall Study||18
8466301|NCT00683930|20861828|P1|COMPLETED|Overall Study||29
8466302|NCT00683930|20861826|P3|STARTED|Overall Study||37
8466303|NCT00683930|20861827|P2|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
8466304|NCT00683930|20861828|P1|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
8466305|NCT00683917|20861846|P1|NOT COMPLETED|Overall Study||10
8466306|NCT00683917|20861846|P1|COMPLETED|Overall Study||0
8466307|NCT00683917|20861846|P1|STARTED|Overall Study||10
8466308|NCT00683904|20861856|P2|NOT COMPLETED|Dose Level 2||2
8466309|NCT00683904|20861857|P1|NOT COMPLETED|Dose Level 2||0
8466310|NCT00683904|20861856|P2|COMPLETED|Dose Level 2||4
8466311|NCT00683904|20861857|P1|COMPLETED|Dose Level 2||0
8466312|NCT00683904|20861856|P2|STARTED|Dose Level 2||6
8466313|NCT00683904|20861857|P1|STARTED|Dose Level 2||0
8466314|NCT00683904|20861856|P2|NOT COMPLETED|Dose Level 1||0
8466315|NCT00683904|20861857|P1|NOT COMPLETED|Dose Level 1||3
8466316|NCT00683904|20861856|P2|COMPLETED|Dose Level 1||0
8466317|NCT00683904|20861857|P1|COMPLETED|Dose Level 1||3
8466318|NCT00683904|20861856|P2|STARTED|Dose Level 1||0
8466319|NCT00683904|20861857|P1|STARTED|Dose Level 1||6
8466320|NCT00683878|20861893|P3|NOT COMPLETED|Overall Study||14
8466321|NCT00683878|20861894|P2|NOT COMPLETED|Overall Study||16
8466322|NCT00683878|20861895|P1|NOT COMPLETED|Overall Study||23
8466323|NCT00683878|20861893|P3|COMPLETED|Overall Study||126
8466324|NCT00683878|20861894|P2|COMPLETED|Overall Study||125
8466325|NCT00683878|20861895|P1|COMPLETED|Overall Study||116
8466326|NCT00683878|20861893|P3|STARTED|Overall Study||140
8466327|NCT00683878|20861894|P2|STARTED|Overall Study||141
8466328|NCT00683878|20861895|P1|STARTED|Overall Study||139
8466329|NCT00683852|20861923|P3|NOT COMPLETED|30-Day Phase 2 Period||9
8466330|NCT00683852|20861924|P2|NOT COMPLETED|30-Day Phase 2 Period||5
8466331|NCT00683852|20861925|P1|NOT COMPLETED|30-Day Phase 2 Period||6
8466332|NCT00683852|20861923|P3|COMPLETED|30-Day Phase 2 Period||75
8466333|NCT00683852|20861924|P2|COMPLETED|30-Day Phase 2 Period||78
8466334|NCT00683852|20861925|P1|COMPLETED|30-Day Phase 2 Period||48
8466335|NCT00683852|20861923|P3|STARTED|30-Day Phase 2 Period||84
8466336|NCT00683852|20861924|P2|STARTED|30-Day Phase 2 Period||83
8466337|NCT00683852|20861925|P1|STARTED|30-Day Phase 2 Period||54
8466338|NCT00683852|20861923|P3|NOT COMPLETED|30-Day Phase 1 Period||1
8466339|NCT00683852|20861924|P2|NOT COMPLETED|30-Day Phase 1 Period||1
8466340|NCT00683852|20861925|P1|NOT COMPLETED|30-Day Phase 1 Period||2
8466341|NCT00683852|20861923|P3|COMPLETED|30-Day Phase 1 Period||84
8466342|NCT00683852|20861924|P2|COMPLETED|30-Day Phase 1 Period||83
8466343|NCT00683852|20861925|P1|COMPLETED|30-Day Phase 1 Period||54
8466344|NCT00683852|20861923|P3|STARTED|30-Day Phase 1 Period||85
8466345|NCT00683852|20861924|P2|STARTED|30-Day Phase 1 Period||84
8466346|NCT00683852|20861925|P1|STARTED|30-Day Phase 1 Period||56
8466347|NCT00683826|20861959|P1|NOT COMPLETED|Overall Study||1
8466348|NCT00683826|20861959|P1|COMPLETED|Overall Study||7
8466349|NCT00683826|20861959|P1|4g Leucine|Overall Study||7
8466350|NCT00683826|20861959|P1|8g Leucine|Overall Study||8
8466351|NCT00683826|20861959|P1|0g Leucine|Overall Study||8
8466352|NCT00683826|20861959|P1|STARTED|Overall Study||8
8466353|NCT00683800|20861969|P2|NOT COMPLETED|Overall Study||366
8466354|NCT00683800|20861970|P1|NOT COMPLETED|Overall Study||432
8466355|NCT00683800|20861969|P2|COMPLETED|Overall Study||719
8466356|NCT00683800|20861970|P1|COMPLETED|Overall Study||669
8466357|NCT00683800|20861969|P2|Treated|Overall Study||1052
8466358|NCT00683800|20861970|P1|Treated|Overall Study||1066
8466359|NCT00683800|20861969|P2|STARTED|Overall Study||1085
8466360|NCT00683800|20861970|P1|STARTED|Overall Study||1101
8466361|NCT00683787|20862037|P3|NOT COMPLETED|Overall Study||2
8466362|NCT00683787|20862038|P2|NOT COMPLETED|Overall Study||3
8466363|NCT00683787|20862039|P1|NOT COMPLETED|Overall Study||3
8466364|NCT00683787|20862037|P3|COMPLETED|Overall Study||0
8466365|NCT00683787|20862038|P2|COMPLETED|Overall Study||0
8466366|NCT00683787|20862039|P1|COMPLETED|Overall Study||0
8466367|NCT00683787|20862037|P3|STARTED|Overall Study||2
8466368|NCT00683787|20862038|P2|STARTED|Overall Study||3
8466369|NCT00683787|20862039|P1|STARTED|Overall Study||3
8466370|NCT00683774|20862058|P2|NOT COMPLETED|Overall Study||1
8466371|NCT00683774|20862059|P1|NOT COMPLETED|Overall Study||3
8466372|NCT00683774|20862058|P2|COMPLETED|Overall Study||9
8466373|NCT00683774|20862059|P1|COMPLETED|Overall Study||8
8466374|NCT00683774|20862058|P2|STARTED|Overall Study||10
8466375|NCT00683774|20862059|P1|STARTED|Overall Study||11
8466376|NCT00683696|20862069|P2|NOT COMPLETED|Overall Study||405
8466377|NCT00683696|20862070|P1|NOT COMPLETED|Overall Study||404
8466378|NCT00683696|20862069|P2|COMPLETED|Overall Study||0
8466379|NCT00683696|20862070|P1|COMPLETED|Overall Study||0
8466380|NCT00683696|20862069|P2|STARTED|Overall Study||405
8466381|NCT00683696|20862070|P1|STARTED|Overall Study||404
8466382|NCT00683657|20862089|P2|NOT COMPLETED|Overall Study||1
8466383|NCT00683657|20862090|P1|NOT COMPLETED|Overall Study||1
8466384|NCT00683657|20862089|P2|COMPLETED|Overall Study||46
8466385|NCT00683657|20862090|P1|COMPLETED|Overall Study||45
8466386|NCT00683657|20862089|P2|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
8466387|NCT00683657|20862090|P1|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
8466388|NCT00683657|20862089|P2|STARTED|Overall Study||47
8466389|NCT00683657|20862090|P1|STARTED|Overall Study||46
8466390|NCT00683644|20862106|P2|NOT COMPLETED|Overall Study||14
8466391|NCT00683644|20862107|P1|NOT COMPLETED|Overall Study||13
8466392|NCT00683644|20862106|P2|COMPLETED|Overall Study||44
8466393|NCT00683644|20862107|P1|COMPLETED|Overall Study||45
8466394|NCT00683644|20862106|P2|STARTED|Overall Study||58
8466395|NCT00683644|20862107|P1|STARTED|Overall Study||58
8466396|NCT00683618|20862120|P3|NOT COMPLETED|Extension Treatment Period||0
8466397|NCT00683618|20862121|P2|NOT COMPLETED|Extension Treatment Period||0
8466398|NCT00683618|20862122|P1|NOT COMPLETED|Extension Treatment Period||3
8466399|NCT00683618|20862120|P3|COMPLETED|Extension Treatment Period||0
8466400|NCT00683618|20862121|P2|COMPLETED|Extension Treatment Period||23
8466401|NCT00683618|20862122|P1|COMPLETED|Extension Treatment Period||33
8466402|NCT00683618|20862120|P3|STARTED|Extension Treatment Period||0
8466403|NCT00683618|20862121|P2|STARTED|Extension Treatment Period||23
8466404|NCT00683618|20862122|P1|STARTED|Extension Treatment Period||36
8466405|NCT00683618|20862120|P3|NOT COMPLETED|Randomised Treatment Period||6
8466406|NCT00683618|20862121|P2|NOT COMPLETED|Randomised Treatment Period||2
8466407|NCT00683618|20862122|P1|NOT COMPLETED|Randomised Treatment Period||6
8466408|NCT00683618|20862120|P3|COMPLETED|Randomised Treatment Period||140
8466409|NCT00683618|20862121|P2|COMPLETED|Randomised Treatment Period||143
8466410|NCT00683618|20862122|P1|COMPLETED|Randomised Treatment Period||139
8466411|NCT00683618|20862120|P3|STARTED|Randomised Treatment Period||146
8466412|NCT00683618|20862121|P2|STARTED|Randomised Treatment Period||145
8466413|NCT00683618|20862122|P1|STARTED|Randomised Treatment Period||145
8466414|NCT00683592|20862172|P2|NOT COMPLETED|Overall Study||46
8466415|NCT00683592|20862173|P1|NOT COMPLETED|Overall Study||47
8466416|NCT00683592|20862172|P2|COMPLETED|Overall Study||195
8466417|NCT00683592|20862173|P1|COMPLETED|Overall Study||193
8466418|NCT00683592|20862172|P2|Safety Population|Overall Study||233
8466419|NCT00683592|20862173|P1|Safety Population|Overall Study||235
8466420|NCT00683592|20862172|P2|Intent to Treat Population|Overall Study||232
8466421|NCT00683592|20862173|P1|Intent to Treat Population|Overall Study||231
8466422|NCT00683592|20862172|P2|STARTED|Overall Study||241
8466423|NCT00683592|20862173|P1|STARTED|Overall Study||240
8466424|NCT00683475|20862191|P2|NOT COMPLETED|Overall Study||3
8466425|NCT00683475|20862192|P1|NOT COMPLETED|Overall Study||4
8466426|NCT00683475|20862191|P2|COMPLETED|Overall Study||66
8466427|NCT00683475|20862192|P1|COMPLETED|Overall Study||65
8466428|NCT00683475|20862191|P2|Received Any Quantity of Study Drug|Overall Study||66
8466429|NCT00683475|20862192|P1|Received Any Quantity of Study Drug|Overall Study||66
8466430|NCT00683475|20862191|P2|STARTED|Overall Study||69
8466431|NCT00683475|20862192|P1|STARTED|Overall Study||69
8466432|NCT00683449|20862227|P5|NOT COMPLETED|Overall Study||0
8466433|NCT00683449|20862228|P4|NOT COMPLETED|Overall Study||0
8466434|NCT00683449|20862229|P3|NOT COMPLETED|Overall Study||0
8466435|NCT00683449|20862230|P2|NOT COMPLETED|Overall Study||1
8466436|NCT00683449|20862231|P1|NOT COMPLETED|Overall Study||0
8466437|NCT00683449|20862227|P5|COMPLETED|Overall Study||2
8466438|NCT00683449|20862228|P4|COMPLETED|Overall Study||6
8466439|NCT00683449|20862229|P3|COMPLETED|Overall Study||3
8466440|NCT00683449|20862230|P2|COMPLETED|Overall Study||12
8466441|NCT00683449|20862231|P1|COMPLETED|Overall Study||5
8466442|NCT00683449|20862227|P5|STARTED|Overall Study||2
8466443|NCT00683449|20862228|P4|STARTED|Overall Study||6
8466444|NCT00683449|20862229|P3|STARTED|Overall Study||3
8466445|NCT00683449|20862230|P2|STARTED|Overall Study||13
8466446|NCT00683449|20862231|P1|STARTED|Overall Study||5
8466447|NCT00683410|20862253|P1|NOT COMPLETED|Overall Study||0
8466448|NCT00683410|20862253|P1|COMPLETED|Overall Study||3366
8466449|NCT00683410|20862253|P1|Vaccinated Dose 4|Overall Study||175
8466450|NCT00683410|20862253|P1|Vaccinated Dose 3|Overall Study||817
8466451|NCT00683410|20862253|P1|Vaccinated Dose 2|Overall Study||1623
8466452|NCT00683410|20862253|P1|Vaccinated Dose 1|Overall Study||3240
8466453|NCT00683410|20862253|P1|STARTED|Overall Study||3366
8466454|NCT00683384|20862257|P1|NOT COMPLETED|Overall Study||2
8466455|NCT00683384|20862257|P1|COMPLETED|Overall Study||91
8466456|NCT00683384|20862257|P1|STARTED|Overall Study||93
8466457|NCT00683332|20862261|P1|NOT COMPLETED|Overall Study||0
8466458|NCT00683332|20862261|P1|COMPLETED|Overall Study||621
8466459|NCT00683332|20862261|P1|STARTED|Overall Study||621
8466460|NCT00683293|20862267|P2|NOT COMPLETED|Overall Study||3
8466461|NCT00683293|20862268|P1|NOT COMPLETED|Overall Study||2
8466462|NCT00683293|20862267|P2|COMPLETED|Overall Study||47
8466463|NCT00683293|20862268|P1|COMPLETED|Overall Study||48
8466464|NCT00683293|20862267|P2|STARTED|Overall Study||50
8466465|NCT00683293|20862268|P1|STARTED|Overall Study||50
8466466|NCT00683163|20862278|P2|NOT COMPLETED|Overall Study||0
8466467|NCT00683163|20862279|P1|NOT COMPLETED|Overall Study||0
8466468|NCT00683163|20862278|P2|COMPLETED|Overall Study||22
8466469|NCT00683163|20862279|P1|COMPLETED|Overall Study||22
8466470|NCT00683163|20862278|P2|STARTED|Overall Study||22
8466471|NCT00683163|20862279|P1|STARTED|Overall Study||22
8466472|NCT00683085|20862287|P1|NOT COMPLETED|Overall Study||0
8466473|NCT00683085|20862287|P1|COMPLETED|Overall Study||2
8466474|NCT00683085|20862287|P1|STARTED|Overall Study||2
8466475|NCT00683046|20862292|P1|NOT COMPLETED|Overall Study||0
8466476|NCT00683046|20862292|P1|COMPLETED|Overall Study||204
8466477|NCT00683046|20862292|P1|STARTED|Overall Study||204
8466478|NCT00683020|20862299|P2|NOT COMPLETED|Overall Study||55
8466479|NCT00683020|20862300|P1|NOT COMPLETED|Overall Study||55
8466480|NCT00683020|20862299|P2|COMPLETED|Overall Study||125
8466481|NCT00683020|20862300|P1|COMPLETED|Overall Study||127
8466482|NCT00683020|20862299|P2|STARTED|Overall Study||180
8466483|NCT00683020|20862300|P1|STARTED|Overall Study||182
8466484|NCT00682929|20862331|P3|NOT COMPLETED|Overall Study||2
8466485|NCT00682929|20862332|P2|NOT COMPLETED|Overall Study||5
8466486|NCT00682929|20862333|P1|NOT COMPLETED|Overall Study||6
8466487|NCT00682929|20862331|P3|COMPLETED|Overall Study||12
8466488|NCT00682929|20862332|P2|COMPLETED|Overall Study||9
8466489|NCT00682929|20862333|P1|COMPLETED|Overall Study||7
8466490|NCT00682929|20862331|P3|STARTED|Overall Study||14
8466491|NCT00682929|20862332|P2|STARTED|Overall Study||14
8466492|NCT00682929|20862333|P1|STARTED|Overall Study||13
8466493|NCT00682890|20862502|P2|NOT COMPLETED|Overall Study||2
8466494|NCT00682890|20862503|P1|NOT COMPLETED|Overall Study||2
8466495|NCT00682890|20862502|P2|COMPLETED|Overall Study||9
8466496|NCT00682890|20862503|P1|COMPLETED|Overall Study||10
8466497|NCT00682890|20862502|P2|STARTED|Overall Study||11
8466498|NCT00682890|20862503|P1|STARTED|Overall Study||12
8466499|NCT00682851|20862513|P2|NOT COMPLETED|Overall Study||0
8466500|NCT00682851|20862514|P1|NOT COMPLETED|Overall Study||0
8466501|NCT00682851|20862513|P2|COMPLETED|Overall Study||268
8466502|NCT00682851|20862514|P1|COMPLETED|Overall Study||251
8466503|NCT00682851|20862513|P2|STARTED|Overall Study||268
8466504|NCT00682851|20862514|P1|STARTED|Overall Study||251
8466505|NCT00682838|20862530|P4|NOT COMPLETED|Overall Study||0
8466506|NCT00682838|20862531|P3|NOT COMPLETED|Overall Study||0
8466507|NCT00682838|20862532|P2|NOT COMPLETED|Overall Study||0
8466508|NCT00682838|20862533|P1|NOT COMPLETED|Overall Study||0
8466509|NCT00682838|20862530|P4|COMPLETED|Overall Study||73
8466510|NCT00682838|20862531|P3|COMPLETED|Overall Study||75
8466511|NCT00682838|20862532|P2|COMPLETED|Overall Study||67
8466512|NCT00682838|20862533|P1|COMPLETED|Overall Study||65
8466513|NCT00682838|20862530|P4|STARTED|Overall Study||73
8466514|NCT00682838|20862531|P3|STARTED|Overall Study||75
8466515|NCT00682838|20862532|P2|STARTED|Overall Study||67
8466516|NCT00682838|20862533|P1|STARTED|Overall Study||65
8466517|NCT00682786|20862545|P2|NOT COMPLETED|Overall Study||3
8466518|NCT00682786|20862546|P1|NOT COMPLETED|Overall Study||2
8466519|NCT00682786|20862545|P2|COMPLETED|Overall Study||34
8466520|NCT00682786|20862546|P1|COMPLETED|Overall Study||96
8466521|NCT00682786|20862545|P2|STARTED|Overall Study||37
8466522|NCT00682786|20862546|P1|STARTED|Overall Study||98
8466523|NCT00682734|20862583|P3|NOT COMPLETED|48 Hour Follow-up||11
8466524|NCT00682734|20862584|P2|NOT COMPLETED|48 Hour Follow-up||6
8466525|NCT00682734|20862585|P1|NOT COMPLETED|48 Hour Follow-up||6
8466526|NCT00682734|20862583|P3|COMPLETED|48 Hour Follow-up||106
8466527|NCT00682734|20862584|P2|COMPLETED|48 Hour Follow-up||111
8466528|NCT00682734|20862585|P1|COMPLETED|48 Hour Follow-up||107
8466529|NCT00682734|20862583|P3|STARTED|48 Hour Follow-up||117
8466530|NCT00682734|20862584|P2|STARTED|48 Hour Follow-up||117
8466531|NCT00682734|20862585|P1|STARTED|48 Hour Follow-up||113
8466532|NCT00682734|20862583|P3|NOT COMPLETED|Emergency Department Portion||1
8466533|NCT00682734|20862584|P2|NOT COMPLETED|Emergency Department Portion||1
8466534|NCT00682734|20862585|P1|NOT COMPLETED|Emergency Department Portion||0
8466535|NCT00682734|20862583|P3|COMPLETED|Emergency Department Portion||117
8466536|NCT00682734|20862584|P2|COMPLETED|Emergency Department Portion||117
8466537|NCT00682734|20862585|P1|COMPLETED|Emergency Department Portion||113
8466538|NCT00682734|20862583|P3|STARTED|Emergency Department Portion||118
8466539|NCT00682734|20862584|P2|STARTED|Emergency Department Portion||118
8466540|NCT00682734|20862585|P1|STARTED|Emergency Department Portion||113
8466541|NCT00682643|20862595|P2|NOT COMPLETED|Overall Study||169
8466542|NCT00682643|20862596|P1|NOT COMPLETED|Overall Study||78
8466543|NCT00682643|20862595|P2|COMPLETED|Overall Study||199
8466544|NCT00682643|20862596|P1|COMPLETED|Overall Study||104
8466545|NCT00682643|20862595|P2|STARTED|Overall Study||368
8466546|NCT00682643|20862596|P1|STARTED|Overall Study||182
8466547|NCT00682617|20862630|P2|NOT COMPLETED|Overall Study||7
8466548|NCT00682617|20862631|P1|NOT COMPLETED|Overall Study||3
8466549|NCT00682617|20862630|P2|COMPLETED|Overall Study||21
8466550|NCT00682617|20862631|P1|COMPLETED|Overall Study||10
8466551|NCT00682617|20862630|P2|STARTED|Overall Study||28
8466552|NCT00682617|20862631|P1|STARTED|Overall Study||13
8466553|NCT00682565|20862644|P3|NOT COMPLETED|Overall Study||0
8466554|NCT00682565|20862645|P2|NOT COMPLETED|Overall Study||3
8466555|NCT00682565|20862646|P1|NOT COMPLETED|Overall Study||1
8466556|NCT00682565|20862644|P3|COMPLETED|Overall Study||29
8466557|NCT00682565|20862645|P2|COMPLETED|Overall Study||32
8466558|NCT00682565|20862646|P1|COMPLETED|Overall Study||30
8466559|NCT00682565|20862644|P3|STARTED|Overall Study||29
8466560|NCT00682565|20862645|P2|STARTED|Overall Study||35
8466561|NCT00682565|20862646|P1|STARTED|Overall Study||31
8466562|NCT00682539|20862670|P3|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
8466563|NCT00682539|20862671|P2|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
8466564|NCT00682539|20862672|P1|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
8466565|NCT00682539|20862670|P3|COMPLETED|Ranibizumab vs Triamcinolone||10
8466566|NCT00682539|20862671|P2|COMPLETED|Ranibizumab vs Triamcinolone||15
8466567|NCT00682539|20862672|P1|COMPLETED|Ranibizumab vs Triamcinolone||0
8466568|NCT00682539|20862670|P3|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
8466569|NCT00682539|20862671|P2|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
8466570|NCT00682539|20862672|P1|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
8466571|NCT00682539|20862670|P3|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
8466572|NCT00682539|20862671|P2|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
8466573|NCT00682539|20862672|P1|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
8466574|NCT00682539|20862670|P3|COMPLETED|Bevacizumab vs Triamcinolone||0
8466575|NCT00682539|20862671|P2|COMPLETED|Bevacizumab vs Triamcinolone||15
8466576|NCT00682539|20862672|P1|COMPLETED|Bevacizumab vs Triamcinolone||15
8466577|NCT00682539|20862670|P3|STARTED|Bevacizumab vs Triamcinolone||0
8466578|NCT00682539|20862671|P2|STARTED|Bevacizumab vs Triamcinolone||16
8466579|NCT00682539|20862672|P1|STARTED|Bevacizumab vs Triamcinolone||18
8466580|NCT00682461|20862685|P2|NOT COMPLETED|Overall Study||31
8466581|NCT00682461|20862686|P1|NOT COMPLETED|Overall Study||25
8466582|NCT00682461|20862685|P2|COMPLETED|Overall Study||69
8466583|NCT00682461|20862686|P1|COMPLETED|Overall Study||75
8466584|NCT00682461|20862685|P2|STARTED|Overall Study||100
8466585|NCT00682461|20862686|P1|STARTED|Overall Study||100
8466586|NCT00682435|20862700|P1|NOT COMPLETED|Overall Study||7
8466587|NCT00682435|20862700|P1|COMPLETED|Overall Study||223
8466588|NCT00682435|20862700|P1|Sufficient Data to Carry Out Analysis|Overall Study||223
8466589|NCT00682435|20862700|P1|Ensured Enrolled Only Once|Overall Study||228
8466590|NCT00682435|20862700|P1|STARTED|Overall Study||230
8466591|NCT00682357|20862710|P3|NOT COMPLETED|Overall Study||0
8466592|NCT00682357|20862711|P2|NOT COMPLETED|Overall Study||0
8466593|NCT00682357|20862712|P1|NOT COMPLETED|Overall Study||0
8466594|NCT00682357|20862710|P3|COMPLETED|Overall Study||5
8466595|NCT00682357|20862711|P2|COMPLETED|Overall Study||10
8466596|NCT00682357|20862712|P1|COMPLETED|Overall Study||10
8466597|NCT00682357|20862710|P3|STARTED|Overall Study||5
8466598|NCT00682357|20862711|P2|STARTED|Overall Study||10
8466599|NCT00682357|20862712|P1|STARTED|Overall Study||10
8466600|NCT00681889|20862729|P1|NOT COMPLETED|Overall Study||0
8466601|NCT00681889|20862729|P1|COMPLETED|Overall Study||9
8466602|NCT00681889|20862729|P1|STARTED|Overall Study||9
8466603|NCT00681863|20862733|P1|NOT COMPLETED|Overall Study||23
8466604|NCT00681863|20862733|P1|COMPLETED|Overall Study||22
8466605|NCT00681863|20862733|P1|STARTED|Overall Study||45
8466606|NCT00681824|20862781|P3|NOT COMPLETED|Overall Study||1
8466607|NCT00681824|20862782|P2|NOT COMPLETED|Overall Study||1
8466608|NCT00681824|20862783|P1|NOT COMPLETED|Overall Study||1
8466609|NCT00681824|20862781|P3|COMPLETED|Overall Study||33
8466610|NCT00681824|20862782|P2|COMPLETED|Overall Study||12
8466611|NCT00681824|20862783|P1|COMPLETED|Overall Study||27
8466612|NCT00681824|20862781|P3|STARTED|Overall Study||34
8466613|NCT00681824|20862782|P2|STARTED|Overall Study||13
8466614|NCT00681824|20862783|P1|STARTED|Overall Study||28
8466621|NCT00681668|20862830|P1|NOT COMPLETED|Overall Study||2
8466622|NCT00681668|20862830|P1|COMPLETED|Overall Study||3
8466623|NCT00681668|20862830|P1|STARTED|Overall Study||5
8466624|NCT00681629|20862839|P2|NOT COMPLETED|Overall Study||2
8466625|NCT00681629|20862840|P1|NOT COMPLETED|Overall Study||5
8466626|NCT00681629|20862839|P2|COMPLETED|Overall Study||0
8466627|NCT00681629|20862840|P1|COMPLETED|Overall Study||0
8466628|NCT00681629|20862839|P2|STARTED|Overall Study|It was planned to recruit 100 patient|2
8466629|NCT00681629|20862840|P1|STARTED|Overall Study|It was planned to recruit 100 patient|5
8466630|NCT00681590|20862886|P2|NOT COMPLETED|Overall Study||12
8466631|NCT00681590|20862887|P1|NOT COMPLETED|Overall Study||2
8466632|NCT00681590|20862886|P2|COMPLETED|Overall Study||59
8466633|NCT00681590|20862887|P1|COMPLETED|Overall Study||32
8466634|NCT00681590|20862886|P2|STARTED|Overall Study||71
8466635|NCT00681590|20862887|P1|STARTED|Overall Study||34
8466636|NCT00681564|20862897|P2|NOT COMPLETED|Overall Study||8
8466637|NCT00681564|20862898|P1|NOT COMPLETED|Overall Study||6
8466638|NCT00681564|20862897|P2|COMPLETED|Overall Study||47
8466639|NCT00681564|20862898|P1|COMPLETED|Overall Study||41
8466640|NCT00681564|20862897|P2|STARTED|Overall Study||55
8466641|NCT00681564|20862898|P1|STARTED|Overall Study||47
8466642|NCT00681538|20862928|P2|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
8466643|NCT00681538|20862929|P1|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
8466644|NCT00681538|20862928|P2|COMPLETED|Phase B- Responders;12 Week Double-blind||115
8466645|NCT00681538|20862929|P1|COMPLETED|Phase B- Responders;12 Week Double-blind||109
8466646|NCT00681538|20862928|P2|STARTED|Phase B- Responders;12 Week Double-blind||117
8466647|NCT00681538|20862929|P1|STARTED|Phase B- Responders;12 Week Double-blind||124
8466648|NCT00681538|20862928|P2|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
8466649|NCT00681538|20862929|P1|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
8466650|NCT00681538|20862928|P2|COMPLETED|Phase A- 4 Weeks Single Blind||0
8466651|NCT00681538|20862929|P1|COMPLETED|Phase A- 4 Weeks Single Blind||538
8466652|NCT00681538|20862928|P2|STARTED|Phase A- 4 Weeks Single Blind||0
8466653|NCT00681538|20862929|P1|STARTED|Phase A- 4 Weeks Single Blind||572
8466654|NCT00681473|20862959|P1|NOT COMPLETED|Overall Study||0
8466655|NCT00681473|20862959|P1|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
8466656|NCT00681473|20862959|P1|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
8466657|NCT00681291|20862967|P2|NOT COMPLETED|Overall Study||27
8466658|NCT00681291|20862968|P1|NOT COMPLETED|Overall Study||13
8466659|NCT00681291|20862967|P2|COMPLETED|Overall Study||57
8466660|NCT00681291|20862968|P1|COMPLETED|Overall Study||75
8466661|NCT00681291|20862967|P2|STARTED|Overall Study||84
8466662|NCT00681291|20862968|P1|STARTED|Overall Study||88
8466663|NCT00681265|20862980|P1|NOT COMPLETED|Overall Study||0
8466664|NCT00681265|20862980|P1|COMPLETED|Overall Study||16
8466665|NCT00681265|20862980|P1|STARTED|Overall Study||16
8466666|NCT00681187|20862990|P2|NOT COMPLETED|Overall Study||2
8466667|NCT00681187|20862991|P1|NOT COMPLETED|Overall Study||1
8466668|NCT00681187|20862990|P2|COMPLETED|Overall Study||13
8466669|NCT00681187|20862991|P1|COMPLETED|Overall Study||10
8466670|NCT00681187|20862990|P2|STARTED|Overall Study||15
8466671|NCT00681187|20862991|P1|STARTED|Overall Study||11
8466672|NCT00681109|20863026|P3|NOT COMPLETED|Overall Study||0
8466673|NCT00681109|20863027|P2|NOT COMPLETED|Overall Study||6
8466674|NCT00681109|20863028|P1|NOT COMPLETED|Overall Study||2
8466675|NCT00681109|20863026|P3|COMPLETED|Overall Study||15
8466676|NCT00681109|20863027|P2|COMPLETED|Overall Study||24
8466677|NCT00681109|20863028|P1|COMPLETED|Overall Study||28
8466678|NCT00681109|20863026|P3|STARTED|Overall Study||15
8466679|NCT00681109|20863027|P2|STARTED|Overall Study||30
8466680|NCT00681109|20863028|P1|STARTED|Overall Study||30
8466681|NCT00681083|20863045|P2|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
8466682|NCT00681083|20863046|P1|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
8466683|NCT00681083|20863045|P2|COMPLETED|Night 2 (Crossover of Night 1)||10
8466684|NCT00681083|20863046|P1|COMPLETED|Night 2 (Crossover of Night 1)||10
8466685|NCT00681083|20863045|P2|STARTED|Night 2 (Crossover of Night 1)||10
8466686|NCT00681083|20863046|P1|STARTED|Night 2 (Crossover of Night 1)||10
8466687|NCT00681083|20863045|P2|NOT COMPLETED|Night 1||3
8466688|NCT00681083|20863046|P1|NOT COMPLETED|Night 1||3
8466689|NCT00681083|20863045|P2|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
8466690|NCT00681083|20863046|P1|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
8466691|NCT00681083|20863045|P2|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
8466692|NCT00681083|20863046|P1|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
8466693|NCT00681044|20863054|P1|NOT COMPLETED|Overall Study||0
8466694|NCT00681044|20863054|P1|COMPLETED|Overall Study||4
8466695|NCT00681044|20863054|P1|STARTED|Overall Study||4
8466699|NCT00680992|20863069|P3|NOT COMPLETED|Overall Study||12
8466700|NCT00680992|20863070|P2|NOT COMPLETED|Overall Study||252
8466701|NCT00680992|20863071|P1|NOT COMPLETED|Overall Study||268
8466702|NCT00680992|20863069|P3|COMPLETED|Overall Study||0
8466703|NCT00680992|20863070|P2|COMPLETED|Overall Study||0
8466704|NCT00680992|20863071|P1|COMPLETED|Overall Study||0
8466705|NCT00680992|20863069|P3|Efficacy Analysis Set|Overall Study||11
8466706|NCT00680992|20863070|P2|Efficacy Analysis Set|Overall Study||242
8466707|NCT00680992|20863071|P1|Efficacy Analysis Set|Overall Study||260
8466708|NCT00680992|20863069|P3|Safety Analysis Set|Overall Study||12
8466709|NCT00680992|20863070|P2|Safety Analysis Set|Overall Study||249
8466710|NCT00680992|20863071|P1|Safety Analysis Set|Overall Study||265
8466711|NCT00680992|20863069|P3|STARTED|Overall Study||12
8466712|NCT00680992|20863070|P2|STARTED|Overall Study||252
8466713|NCT00680992|20863071|P1|STARTED|Overall Study||268
8466714|NCT00680953|20863087|P3|NOT COMPLETED|Overall Study||47
8466715|NCT00680953|20863088|P2|NOT COMPLETED|Overall Study||95
8466716|NCT00680953|20863089|P1|NOT COMPLETED|Overall Study||86
8466717|NCT00680953|20863087|P3|COMPLETED|Overall Study||204
8466718|NCT00680953|20863088|P2|COMPLETED|Overall Study||416
8466719|NCT00680953|20863089|P1|COMPLETED|Overall Study||414
8466720|NCT00680953|20863087|P3|STARTED|Overall Study||251
8466721|NCT00680953|20863088|P2|STARTED|Overall Study||511
8466722|NCT00680953|20863089|P1|STARTED|Overall Study||500
8466723|NCT00680914|20863105|P2|NOT COMPLETED|Overall Study||4
8466724|NCT00680914|20863106|P1|NOT COMPLETED|Overall Study||10
8466725|NCT00680914|20863105|P2|COMPLETED|Overall Study||125
8466726|NCT00680914|20863106|P1|COMPLETED|Overall Study||364
8466727|NCT00680914|20863105|P2|STARTED|Overall Study||129
8466728|NCT00680914|20863106|P1|STARTED|Overall Study||374
8466739|NCT00680862|20863173|P1|NOT COMPLETED|Overall Study||0
8466740|NCT00680862|20863173|P1|COMPLETED|Overall Study||25
8466741|NCT00680862|20863173|P1|STARTED|Overall Study||25
8466742|NCT00680836|20863179|P2|NOT COMPLETED|Overall Study||2
8466743|NCT00680836|20863180|P1|NOT COMPLETED|Overall Study||8
8466744|NCT00680836|20863179|P2|COMPLETED|Overall Study||25
8466745|NCT00680836|20863180|P1|COMPLETED|Overall Study||19
8466746|NCT00680836|20863179|P2|STARTED|Overall Study||27
8466747|NCT00680836|20863180|P1|STARTED|Overall Study||27
8466748|NCT00680823|20863199|P3|NOT COMPLETED|Overall Study||0
8466749|NCT00680823|20863200|P2|NOT COMPLETED|Overall Study||0
8466750|NCT00680823|20863201|P1|NOT COMPLETED|Overall Study||0
8466751|NCT00680823|20863199|P3|COMPLETED|Overall Study||50
8466752|NCT00680823|20863200|P2|COMPLETED|Overall Study||50
8466753|NCT00680823|20863201|P1|COMPLETED|Overall Study||50
8466754|NCT00680823|20863199|P3|STARTED|Overall Study||50
8466755|NCT00680823|20863200|P2|STARTED|Overall Study||50
8466756|NCT00680823|20863201|P1|STARTED|Overall Study||50
8466757|NCT00680797|20863219|P4|NOT COMPLETED|Overall Study||0
8466758|NCT00680797|20863220|P3|NOT COMPLETED|Overall Study||0
8466759|NCT00680797|20863221|P2|NOT COMPLETED|Overall Study||0
8466760|NCT00680797|20863222|P1|NOT COMPLETED|Overall Study||0
8466761|NCT00680797|20863219|P4|COMPLETED|Overall Study||8
8466762|NCT00680797|20863220|P3|COMPLETED|Overall Study||8
8466763|NCT00680797|20863221|P2|COMPLETED|Overall Study||8
8466764|NCT00680797|20863222|P1|COMPLETED|Overall Study||9
8466765|NCT00680797|20863219|P4|STARTED|Overall Study||8
8466766|NCT00680797|20863220|P3|STARTED|Overall Study||8
8466767|NCT00680797|20863221|P2|STARTED|Overall Study||8
8466768|NCT00680797|20863222|P1|STARTED|Overall Study||9
8466769|NCT00680771|20863234|P2|NOT COMPLETED|Overall Study||2
8466770|NCT00680771|20863235|P1|NOT COMPLETED|Overall Study||6
8466771|NCT00680771|20863234|P2|COMPLETED|Overall Study||11
8466772|NCT00680771|20863235|P1|COMPLETED|Overall Study||9
8466773|NCT00680771|20863234|P2|STARTED|Overall Study||13
8466774|NCT00680771|20863235|P1|STARTED|Overall Study||15
8466775|NCT00680745|20863245|P4|NOT COMPLETED|Overall Study||13
8466776|NCT00680745|20863246|P3|NOT COMPLETED|Overall Study||10
8466777|NCT00680745|20863247|P2|NOT COMPLETED|Overall Study||13
8466778|NCT00680745|20863248|P1|NOT COMPLETED|Overall Study||14
8466779|NCT00680745|20863245|P4|COMPLETED|Overall Study||133
8466780|NCT00680745|20863246|P3|COMPLETED|Overall Study||141
8466781|NCT00680745|20863247|P2|COMPLETED|Overall Study||132
8466782|NCT00680745|20863248|P1|COMPLETED|Overall Study||140
8466783|NCT00680745|20863245|P4|STARTED|Overall Study|Safety Analysis Set|146
8466784|NCT00680745|20863246|P3|STARTED|Overall Study|Safety Analysis Set|151
8466785|NCT00680745|20863247|P2|STARTED|Overall Study|Safety Analysis Set|145
8466786|NCT00680745|20863248|P1|STARTED|Overall Study|Safety Analysis Set|154
8466787|NCT00680706|20863280|P2|NOT COMPLETED|Overall Study||5
8466788|NCT00680706|20863281|P1|NOT COMPLETED|Overall Study||7
8466789|NCT00680706|20863280|P2|COMPLETED|Overall Study||55
8466790|NCT00680706|20863281|P1|COMPLETED|Overall Study||63
8466791|NCT00680706|20863280|P2|STARTED|Overall Study||60
8466792|NCT00680706|20863281|P1|STARTED|Overall Study||70
8466793|NCT00680628|20863291|P2|NOT COMPLETED|Overall Study||0
8466794|NCT00680628|20863292|P1|NOT COMPLETED|Overall Study||0
8466795|NCT00680628|20863291|P2|COMPLETED|Overall Study||40
8466796|NCT00680628|20863292|P1|COMPLETED|Overall Study||43
8466797|NCT00680628|20863291|P2|STARTED|Overall Study||40
8466798|NCT00680628|20863292|P1|STARTED|Overall Study||43
8466799|NCT00680524|20863302|P1|NOT COMPLETED|Overall Study||3
8466800|NCT00680524|20863302|P1|COMPLETED|Overall Study||17
8466801|NCT00680524|20863302|P1|STARTED|Overall Study||20
8466802|NCT00680459|20863308|P2|NOT COMPLETED|Overall Study||0
8466803|NCT00680459|20863309|P1|NOT COMPLETED|Overall Study||0
8466804|NCT00680459|20863308|P2|COMPLETED|Overall Study||6
8466805|NCT00680459|20863309|P1|COMPLETED|Overall Study||7
8466806|NCT00680459|20863308|P2|STARTED|Overall Study||6
8466807|NCT00680459|20863309|P1|STARTED|Overall Study||7
8466808|NCT00680407|20863322|P3|NOT COMPLETED|Overall Study||3
8466809|NCT00680407|20863323|P2|NOT COMPLETED|Overall Study||5
8466810|NCT00680407|20863324|P1|NOT COMPLETED|Overall Study||8
8466811|NCT00680407|20863322|P3|COMPLETED|Overall Study||22
8466812|NCT00680407|20863323|P2|COMPLETED|Overall Study||22
8466813|NCT00680407|20863324|P1|COMPLETED|Overall Study||18
8466814|NCT00680407|20863322|P3|STARTED|Overall Study||25
8466815|NCT00680407|20863323|P2|STARTED|Overall Study||27
8466816|NCT00680407|20863324|P1|STARTED|Overall Study||26
8466817|NCT00680368|20863338|P1|NOT COMPLETED|Overall Study||15
8466818|NCT00680368|20863338|P1|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
8466819|NCT00680368|20863338|P1|STARTED|Overall Study||112
8466820|NCT00680316|20863346|P2|NOT COMPLETED|Overall Study||0
8466821|NCT00680316|20863347|P1|NOT COMPLETED|Overall Study||0
8466822|NCT00680316|20863346|P2|COMPLETED|Overall Study||2
8466823|NCT00680316|20863347|P1|COMPLETED|Overall Study||1
8466824|NCT00680316|20863346|P2|STARTED|Overall Study||2
8466825|NCT00680316|20863347|P1|STARTED|Overall Study||1
8466826|NCT00680225|20863359|P1|NOT COMPLETED|Overall Study||2
8466827|NCT00680225|20863359|P1|COMPLETED|Overall Study||8
8466828|NCT00680225|20863359|P1|STARTED|Overall Study||10
8466829|NCT00680186|20863366|P2|NOT COMPLETED|Overall Study||116
8466830|NCT00680186|20863367|P1|NOT COMPLETED|Overall Study||125
8466831|NCT00680186|20863366|P2|COMPLETED|Overall Study|Completed planned observation time.|1172
8466832|NCT00680186|20863367|P1|COMPLETED|Overall Study|Completed planned observation time.|1155
8466833|NCT00680186|20863366|P2|STARTED|Overall Study|Started treatment.|1288
8466834|NCT00680186|20863367|P1|STARTED|Overall Study|Started treatment.|1280
8466835|NCT00680121|20863393|P2|NOT COMPLETED|Overall Study||23
8466836|NCT00680121|20863394|P1|NOT COMPLETED|Overall Study||27
8466837|NCT00680121|20863393|P2|COMPLETED|Overall Study||37
8466838|NCT00680121|20863394|P1|COMPLETED|Overall Study||33
8466839|NCT00680121|20863393|P2|STARTED|Overall Study||60
8466840|NCT00680121|20863394|P1|STARTED|Overall Study||60
8466841|NCT00680056|20863408|P2|NOT COMPLETED|Second Intervention||1
8466842|NCT00680056|20863409|P1|NOT COMPLETED|Second Intervention||3
8466843|NCT00680056|20863408|P2|COMPLETED|Second Intervention||14
8466844|NCT00680056|20863409|P1|COMPLETED|Second Intervention||12
8466845|NCT00680056|20863408|P2|STARTED|Second Intervention||15
8466846|NCT00680056|20863409|P1|STARTED|Second Intervention||15
8466847|NCT00680056|20863408|P2|NOT COMPLETED|Washout Period of One Week||0
8466848|NCT00680056|20863409|P1|NOT COMPLETED|Washout Period of One Week||0
8466849|NCT00680056|20863408|P2|COMPLETED|Washout Period of One Week||15
8466850|NCT00680056|20863409|P1|COMPLETED|Washout Period of One Week||15
8466851|NCT00680056|20863408|P2|STARTED|Washout Period of One Week||15
8466852|NCT00680056|20863409|P1|STARTED|Washout Period of One Week||15
8466853|NCT00680056|20863408|P2|NOT COMPLETED|First Intervention||2
8466854|NCT00680056|20863409|P1|NOT COMPLETED|First Intervention||1
8466855|NCT00680056|20863408|P2|COMPLETED|First Intervention||15
8466856|NCT00680056|20863409|P1|COMPLETED|First Intervention||15
8466857|NCT00680056|20863408|P2|STARTED|First Intervention||17
8466858|NCT00680056|20863409|P1|STARTED|First Intervention||16
8466859|NCT00680043|20863420|P3|NOT COMPLETED|Overall Study||4
8466860|NCT00680043|20863421|P2|NOT COMPLETED|Overall Study||1
8466861|NCT00680043|20863422|P1|NOT COMPLETED|Overall Study||2
8466862|NCT00680043|20863420|P3|COMPLETED|Overall Study||34
8466863|NCT00680043|20863421|P2|COMPLETED|Overall Study||36
8466864|NCT00680043|20863422|P1|COMPLETED|Overall Study||37
8466865|NCT00680043|20863420|P3|STARTED|Overall Study||38
8466866|NCT00680043|20863421|P2|STARTED|Overall Study||37
8466867|NCT00680043|20863422|P1|STARTED|Overall Study||39
8466868|NCT00680017|20863438|P2|NOT COMPLETED|Overall Study||12
8466869|NCT00680017|20863439|P1|NOT COMPLETED|Overall Study||17
8466870|NCT00680017|20863438|P2|COMPLETED|Overall Study||128
8466871|NCT00680017|20863439|P1|COMPLETED|Overall Study||123
8466872|NCT00680017|20863438|P2|STARTED|Overall Study||140
8466873|NCT00680017|20863439|P1|STARTED|Overall Study||140
8466874|NCT00679952|20863449|P2|NOT COMPLETED|Overall Study||0
8466875|NCT00679952|20863450|P1|NOT COMPLETED|Overall Study||0
8466876|NCT00679952|20863449|P2|COMPLETED|Overall Study||82
8466877|NCT00679952|20863450|P1|COMPLETED|Overall Study||86
8466878|NCT00679952|20863449|P2|STARTED|Overall Study||82
8466879|NCT00679952|20863450|P1|STARTED|Overall Study||86
8466880|NCT00679939|20863458|P2|NOT COMPLETED|24-Week Open-Label (OL) Period||4
8466881|NCT00679939|20863459|P1|NOT COMPLETED|24-Week Open-Label (OL) Period||7
8466882|NCT00679939|20863458|P2|COMPLETED|24-Week Open-Label (OL) Period||80
8466883|NCT00679939|20863459|P1|COMPLETED|24-Week Open-Label (OL) Period||69
8466884|NCT00679939|20863458|P2|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
8466885|NCT00679939|20863459|P1|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
8466886|NCT00679939|20863458|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
8466887|NCT00679939|20863459|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
8466888|NCT00679939|20863458|P2|COMPLETED|52-Week Double-Blind (DB) Period||85
8466889|NCT00679939|20863459|P1|COMPLETED|52-Week Double-Blind (DB) Period||77
8466890|NCT00679939|20863458|P2|STARTED|52-Week Double-Blind (DB) Period||112
8466891|NCT00679939|20863459|P1|STARTED|52-Week Double-Blind (DB) Period||114
8466892|NCT00679926|20863608|P1|NOT COMPLETED|Overall Study||13
8466893|NCT00679926|20863608|P1|COMPLETED|Overall Study||2
8466894|NCT00679926|20863608|P1|STARTED|Overall Study||15
8466895|NCT00679913|20863625|P2|NOT COMPLETED|Overall Study||13
8466896|NCT00679913|20863626|P1|NOT COMPLETED|Overall Study||18
8466897|NCT00679913|20863625|P2|COMPLETED|Overall Study||86
8466898|NCT00679913|20863626|P1|COMPLETED|Overall Study||83
8466899|NCT00679913|20863625|P2|STARTED|Overall Study||99
8466900|NCT00679913|20863626|P1|STARTED|Overall Study||101
8466922|NCT00679627|20863700|P2|NOT COMPLETED|Overall Study||685
8466923|NCT00679627|20863701|P1|NOT COMPLETED|Overall Study||699
8466924|NCT00679627|20863700|P2|COMPLETED|Overall Study||339
8466925|NCT00679627|20863701|P1|COMPLETED|Overall Study||322
8466926|NCT00679627|20863700|P2|STARTED|Overall Study||1024
8466927|NCT00679627|20863701|P1|STARTED|Overall Study||1021
8466928|NCT00679549|20863725|P2|NOT COMPLETED|Overall Study||9
8466929|NCT00679549|20863726|P1|NOT COMPLETED|Overall Study||6
8466930|NCT00679549|20863725|P2|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66
8466931|NCT00679549|20863726|P1|COMPLETED|Overall Study||69
8466932|NCT00679549|20863725|P2|STARTED|Overall Study||75
8466933|NCT00679549|20863726|P1|STARTED|Overall Study||75
8466934|NCT00679432|20863736|P4|NOT COMPLETED|Overall Study||32
8466935|NCT00679432|20863737|P3|NOT COMPLETED|Overall Study||53
8466936|NCT00679432|20863738|P2|NOT COMPLETED|Overall Study||38
8466937|NCT00679432|20863739|P1|NOT COMPLETED|Overall Study||37
8466938|NCT00679432|20863736|P4|COMPLETED|Overall Study||95
8466939|NCT00679432|20863737|P3|COMPLETED|Overall Study||76
8466940|NCT00679432|20863738|P2|COMPLETED|Overall Study||89
8466941|NCT00679432|20863739|P1|COMPLETED|Overall Study||89
8466942|NCT00679432|20863736|P4|STARTED|Overall Study||127
8466943|NCT00679432|20863737|P3|STARTED|Overall Study||129
8466944|NCT00679432|20863738|P2|STARTED|Overall Study||127
8466945|NCT00679432|20863739|P1|STARTED|Overall Study||126
8466946|NCT00679380|20863761|P4|NOT COMPLETED|Overall Study||28
8466947|NCT00679380|20863762|P3|NOT COMPLETED|Overall Study||35
8466948|NCT00679380|20863763|P2|NOT COMPLETED|Overall Study||33
8466949|NCT00679380|20863764|P1|NOT COMPLETED|Overall Study||42
8466950|NCT00679380|20863761|P4|COMPLETED|Overall Study||61
8466951|NCT00679380|20863762|P3|COMPLETED|Overall Study||68
8466952|NCT00679380|20863763|P2|COMPLETED|Overall Study||76
8466953|NCT00679380|20863764|P1|COMPLETED|Overall Study||67
8466954|NCT00679380|20863761|P4|STARTED|Overall Study||89
8466955|NCT00679380|20863762|P3|STARTED|Overall Study||103
8466956|NCT00679380|20863763|P2|STARTED|Overall Study||109
8466957|NCT00679380|20863764|P1|STARTED|Overall Study||109
8466958|NCT00679367|20863782|P1|NOT COMPLETED|Overall Study||12
8466959|NCT00679367|20863782|P1|COMPLETED|Overall Study||4
8466960|NCT00679367|20863782|P1|STARTED|Overall Study||16
8466961|NCT00679354|20863788|P1|NOT COMPLETED|Overall Study||30
8466962|NCT00679354|20863788|P1|COMPLETED|Overall Study||0
8466963|NCT00679354|20863788|P1|STARTED|Overall Study||30
8466964|NCT00679341|20863806|P2|NOT COMPLETED|Overall Study||51
8466965|NCT00679341|20863807|P1|NOT COMPLETED|Overall Study||53
8466966|NCT00679341|20863806|P2|COMPLETED|Overall Study||19
8466967|NCT00679341|20863807|P1|COMPLETED|Overall Study||14
8466968|NCT00679341|20863806|P2|STARTED|Overall Study||70
8466969|NCT00679341|20863807|P1|STARTED|Overall Study||67
8466970|NCT00679302|20863827|P2|NOT COMPLETED|Overall Study||4
8466971|NCT00679302|20863828|P1|NOT COMPLETED|Overall Study||8
8466972|NCT00679302|20863827|P2|COMPLETED|Overall Study||73
8466973|NCT00679302|20863828|P1|COMPLETED|Overall Study||76
8466974|NCT00679302|20863827|P2|STARTED|Overall Study||77
8466975|NCT00679302|20863828|P1|STARTED|Overall Study||84
8466976|NCT00679289|20863839|P3|NOT COMPLETED|Overall Study||23
8466977|NCT00679289|20863840|P2|NOT COMPLETED|Overall Study||6
8466978|NCT00679289|20863841|P1|NOT COMPLETED|Overall Study||5
8466979|NCT00679289|20863839|P3|COMPLETED|Overall Study||1
8466980|NCT00679289|20863840|P2|COMPLETED|Overall Study||0
8466981|NCT00679289|20863841|P1|COMPLETED|Overall Study||1
8466982|NCT00679289|20863839|P3|STARTED|Overall Study||24
8466983|NCT00679289|20863840|P2|STARTED|Overall Study||6
8466984|NCT00679289|20863841|P1|STARTED|Overall Study||6
8466985|NCT00679263|20863863|P3|NOT COMPLETED|Visit 2/Dose 1||0
8466986|NCT00679263|20863864|P2|NOT COMPLETED|Visit 2/Dose 1||1
8466987|NCT00679263|20863865|P1|NOT COMPLETED|Visit 2/Dose 1||2
8466988|NCT00679263|20863863|P3|COMPLETED|Visit 2/Dose 1||11
8466989|NCT00679263|20863864|P2|COMPLETED|Visit 2/Dose 1||5
8466990|NCT00679263|20863865|P1|COMPLETED|Visit 2/Dose 1||9
8466991|NCT00679263|20863863|P3|STARTED|Visit 2/Dose 1||11
8466992|NCT00679263|20863864|P2|STARTED|Visit 2/Dose 1||6
8466993|NCT00679263|20863865|P1|STARTED|Visit 2/Dose 1||11
8466994|NCT00679263|20863863|P3|NOT COMPLETED|Visit 3/Dose 2||0
8466995|NCT00679263|20863864|P2|NOT COMPLETED|Visit 3/Dose 2||5
8466996|NCT00679263|20863865|P1|NOT COMPLETED|Visit 3/Dose 2||1
8466997|NCT00679263|20863863|P3|COMPLETED|Visit 3/Dose 2||11
8466998|NCT00679263|20863864|P2|COMPLETED|Visit 3/Dose 2||6
8466999|NCT00679263|20863865|P1|COMPLETED|Visit 3/Dose 2||9
8467000|NCT00679263|20863863|P3|STARTED|Visit 3/Dose 2||11
8467001|NCT00679263|20863864|P2|STARTED|Visit 3/Dose 2||11
8467002|NCT00679263|20863865|P1|STARTED|Visit 3/Dose 2||10
8467003|NCT00679211|20863876|P1|NOT COMPLETED|Overall Study||110
8467004|NCT00679211|20863876|P1|COMPLETED|Overall Study||0
8467005|NCT00679211|20863876|P1|STARTED|Overall Study||110
8467006|NCT00679172|20863893|P5|NOT COMPLETED|Overall Study||0
8467007|NCT00679172|20863894|P4|NOT COMPLETED|Overall Study||1
8467008|NCT00679172|20863895|P3|NOT COMPLETED|Overall Study||1
8467009|NCT00679172|20863896|P2|NOT COMPLETED|Overall Study||1
8467010|NCT00679172|20863897|P1|NOT COMPLETED|Overall Study||1
8467011|NCT00679172|20863893|P5|COMPLETED|Overall Study||37
8467012|NCT00679172|20863894|P4|COMPLETED|Overall Study||38
8467013|NCT00679172|20863895|P3|COMPLETED|Overall Study||35
8467014|NCT00679172|20863896|P2|COMPLETED|Overall Study||37
8467015|NCT00679172|20863897|P1|COMPLETED|Overall Study||36
8467016|NCT00679172|20863893|P5|STARTED|Overall Study||37
8467017|NCT00679172|20863894|P4|STARTED|Overall Study||39
8467018|NCT00679172|20863895|P3|STARTED|Overall Study||36
8467019|NCT00679172|20863896|P2|STARTED|Overall Study||38
8467020|NCT00679172|20863897|P1|STARTED|Overall Study||37
8467021|NCT00679081|20863960|P1|NOT COMPLETED|Overall Study||1
8467022|NCT00679081|20863960|P1|COMPLETED|Overall Study||14
8467023|NCT00679081|20863960|P1|STARTED|Overall Study|Study design was within-subject control.|15
8467024|NCT00679055|20863970|P2|NOT COMPLETED|Overall Study||5
8467025|NCT00679055|20863971|P1|NOT COMPLETED|Overall Study||2
8467026|NCT00679055|20863970|P2|COMPLETED|Overall Study||1
8467027|NCT00679055|20863971|P1|COMPLETED|Overall Study||6
8467028|NCT00679055|20863970|P2|STARTED|Overall Study||6
8467029|NCT00679055|20863971|P1|STARTED|Overall Study||8
8467030|NCT00679029|20863981|P1|NOT COMPLETED|Overall Study||5
8467031|NCT00679029|20863981|P1|COMPLETED|Overall Study||10
8467032|NCT00679029|20863981|P1|STARTED|Overall Study||15
8467033|NCT00678899|20863988|P1|NOT COMPLETED|Overall Study||1
8467034|NCT00678899|20863988|P1|COMPLETED|Overall Study||49
8467035|NCT00678899|20863988|P1|STARTED|Overall Study||50
8467036|NCT00678886|20863997|P4|NOT COMPLETED|Overall Study||9
8467037|NCT00678886|20863998|P3|NOT COMPLETED|Overall Study||9
8467038|NCT00678886|20863999|P2|NOT COMPLETED|Overall Study||0
8467039|NCT00678886|20864000|P1|NOT COMPLETED|Overall Study||0
8467040|NCT00678886|20863997|P4|COMPLETED|Overall Study||153
8467041|NCT00678886|20863998|P3|COMPLETED|Overall Study||72
8467042|NCT00678886|20863999|P2|COMPLETED|Overall Study||19
8467043|NCT00678886|20864000|P1|COMPLETED|Overall Study||10
8467044|NCT00678886|20863997|P4|STARTED|Overall Study||162
8467045|NCT00678886|20863998|P3|STARTED|Overall Study||81
8467046|NCT00678886|20863999|P2|STARTED|Overall Study||19
8467047|NCT00678886|20864000|P1|STARTED|Overall Study||10
8467048|NCT00678834|20864047|P3|NOT COMPLETED|Overall Study||9
8467049|NCT00678834|20864048|P2|NOT COMPLETED|Overall Study||0
8467050|NCT00678834|20864049|P1|NOT COMPLETED|Overall Study||16
8467051|NCT00678834|20864047|P3|COMPLETED|Overall Study||16
8467052|NCT00678834|20864048|P2|COMPLETED|Overall Study||15
8467053|NCT00678834|20864049|P1|COMPLETED|Overall Study||24
8467054|NCT00678834|20864047|P3|STARTED|Overall Study||25
8467055|NCT00678834|20864048|P2|STARTED|Overall Study||15
8467056|NCT00678834|20864049|P1|STARTED|Overall Study||40
8467057|NCT00678795|20864069|P2|NOT COMPLETED|Overall Study||6
8467058|NCT00678795|20864070|P1|NOT COMPLETED|Overall Study||11
8467059|NCT00678795|20864069|P2|COMPLETED|Overall Study||62
8467060|NCT00678795|20864070|P1|COMPLETED|Overall Study||56
8467061|NCT00678795|20864069|P2|STARTED|Overall Study||68
8467062|NCT00678795|20864070|P1|STARTED|Overall Study||67
8467063|NCT00678691|20864092|P2|NOT COMPLETED|Overall Study||4
8467064|NCT00678691|20864093|P1|NOT COMPLETED|Overall Study||6
8467065|NCT00678691|20864092|P2|COMPLETED|Overall Study||24
8467066|NCT00678691|20864093|P1|COMPLETED|Overall Study||21
8467067|NCT00678691|20864092|P2|STARTED|Overall Study||28
8467068|NCT00678691|20864093|P1|STARTED|Overall Study||27
8467069|NCT00678652|20864103|P4|NOT COMPLETED|Overall Study||0
8467070|NCT00678652|20864104|P3|NOT COMPLETED|Overall Study||1
8467071|NCT00678652|20864105|P2|NOT COMPLETED|Overall Study||0
8467072|NCT00678652|20864106|P1|NOT COMPLETED|Overall Study||3
8467073|NCT00678652|20864103|P4|COMPLETED|Overall Study||9
8467074|NCT00678652|20864104|P3|COMPLETED|Overall Study||8
8467075|NCT00678652|20864105|P2|COMPLETED|Overall Study||9
8467076|NCT00678652|20864106|P1|COMPLETED|Overall Study||6
8467077|NCT00678652|20864103|P4|STARTED|Overall Study||9
8467078|NCT00678652|20864104|P3|STARTED|Overall Study||9
8467079|NCT00678652|20864105|P2|STARTED|Overall Study||9
8467080|NCT00678652|20864106|P1|STARTED|Overall Study||9
8467081|NCT00678639|20864130|P2|NOT COMPLETED|Overall Study||0
8467082|NCT00678639|20864131|P1|NOT COMPLETED|Overall Study||2
8467083|NCT00678639|20864130|P2|COMPLETED|Overall Study||57
8467084|NCT00678639|20864131|P1|COMPLETED|Overall Study||51
8467085|NCT00678639|20864130|P2|Hospital Discharge|Overall Study||57
8467086|NCT00678639|20864131|P1|Hospital Discharge|Overall Study||53
8467087|NCT00678639|20864130|P2|STARTED|Overall Study||57
8467088|NCT00678639|20864131|P1|STARTED|Overall Study||53
8467089|NCT00678587|20864146|P2|NOT COMPLETED|Overall Study||18
8467090|NCT00678587|20864147|P1|NOT COMPLETED|Overall Study||20
8467091|NCT00678587|20864146|P2|COMPLETED|Overall Study||127
8467092|NCT00678587|20864147|P1|COMPLETED|Overall Study||127
8467093|NCT00678587|20864146|P2|STARTED|Overall Study||145
8467094|NCT00678587|20864147|P1|STARTED|Overall Study||147
8467095|NCT00678574|20864181|P2|NOT COMPLETED|Overall Study||0
8467096|NCT00678574|20864182|P1|NOT COMPLETED|Overall Study||0
8467097|NCT00678574|20864181|P2|COMPLETED|Overall Study||27
8467098|NCT00678574|20864182|P1|COMPLETED|Overall Study||18
8467099|NCT00678574|20864181|P2|STARTED|Overall Study||27
8467100|NCT00678574|20864182|P1|STARTED|Overall Study||18
8467101|NCT00678561|20864196|P8|NOT COMPLETED|Overall Study||1
8467102|NCT00678561|20864197|P7|NOT COMPLETED|Overall Study||0
8467103|NCT00678561|20864198|P6|NOT COMPLETED|Overall Study||1
8467104|NCT00678561|20864199|P5|NOT COMPLETED|Overall Study||2
8467105|NCT00678561|20864200|P4|NOT COMPLETED|Overall Study||0
8467106|NCT00678561|20864201|P3|NOT COMPLETED|Overall Study||1
8467107|NCT00678561|20864202|P2|NOT COMPLETED|Overall Study||1
8467108|NCT00678561|20864203|P1|NOT COMPLETED|Overall Study||0
8467109|NCT00678561|20864196|P8|COMPLETED|Overall Study||7
8467110|NCT00678561|20864197|P7|COMPLETED|Overall Study||15
8467111|NCT00678561|20864198|P6|COMPLETED|Overall Study||16
8467112|NCT00678561|20864199|P5|COMPLETED|Overall Study||15
8467113|NCT00678561|20864200|P4|COMPLETED|Overall Study||4
8467114|NCT00678561|20864201|P3|COMPLETED|Overall Study||7
8467115|NCT00678561|20864202|P2|COMPLETED|Overall Study||5
8467116|NCT00678561|20864203|P1|COMPLETED|Overall Study||6
8467117|NCT00678561|20864196|P8|STARTED|Overall Study||8
8467118|NCT00678561|20864197|P7|STARTED|Overall Study||15
8467119|NCT00678561|20864198|P6|STARTED|Overall Study||17
8467120|NCT00678561|20864199|P5|STARTED|Overall Study||17
8467121|NCT00678561|20864200|P4|STARTED|Overall Study||4
8467122|NCT00678561|20864201|P3|STARTED|Overall Study||8
8467123|NCT00678561|20864202|P2|STARTED|Overall Study||6
8467124|NCT00678561|20864203|P1|STARTED|Overall Study||6
8467125|NCT00678535|20864258|P2|NOT COMPLETED|Overall Study||98
8467126|NCT00678535|20864259|P1|NOT COMPLETED|Overall Study||93
8467127|NCT00678535|20864258|P2|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
8467128|NCT00678535|20864259|P1|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
8467129|NCT00678535|20864258|P2|STARTED|Overall Study|ITT population|449
8467130|NCT00678535|20864259|P1|STARTED|Overall Study|ITT population|455
8467131|NCT00678470|20864275|P1|NOT COMPLETED|Overall Study||4
8467132|NCT00678470|20864275|P1|COMPLETED|Overall Study||14
8467133|NCT00678470|20864275|P1|STARTED|Overall Study||18
8467134|NCT00678444|20864281|P2|NOT COMPLETED|Overall Study||0
8467135|NCT00678444|20864282|P1|NOT COMPLETED|Overall Study||0
8467136|NCT00678444|20864281|P2|COMPLETED|Overall Study||99
8467137|NCT00678444|20864282|P1|COMPLETED|Overall Study||100
8467138|NCT00678444|20864281|P2|STARTED|Overall Study||99
8467139|NCT00678444|20864282|P1|STARTED|Overall Study||100
8467140|NCT00678418|20864292|P2|NOT COMPLETED|Part B (Open Label)||0
8467141|NCT00678418|20864293|P1|NOT COMPLETED|Part B (Open Label)||43
8467142|NCT00678418|20864292|P2|COMPLETED|Part B (Open Label)||0
8467143|NCT00678418|20864293|P1|COMPLETED|Part B (Open Label)||71
8467144|NCT00678418|20864292|P2|STARTED|Part B (Open Label)||0
8467145|NCT00678418|20864293|P1|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
8467146|NCT00678418|20864292|P2|NOT COMPLETED|Part A (Double Blind)||77
8467147|NCT00678418|20864293|P1|NOT COMPLETED|Part A (Double Blind)||59
8467148|NCT00678418|20864292|P2|COMPLETED|Part A (Double Blind)||47
8467149|NCT00678418|20864293|P1|COMPLETED|Part A (Double Blind)||67
8467150|NCT00678418|20864292|P2|STARTED|Part A (Double Blind)||124
8467151|NCT00678418|20864293|P1|STARTED|Part A (Double Blind)||126
8467152|NCT00678392|20864309|P2|NOT COMPLETED|Overall Study||362
8467153|NCT00678392|20864310|P1|NOT COMPLETED|Overall Study||361
8467154|NCT00678392|20864309|P2|COMPLETED|Overall Study||0
8467155|NCT00678392|20864310|P1|COMPLETED|Overall Study||0
8467156|NCT00678392|20864309|P2|Treated|Overall Study||355
8467157|NCT00678392|20864310|P1|Treated|Overall Study||359
8467158|NCT00678392|20864309|P2|STARTED|Overall Study||362
8467159|NCT00678392|20864310|P1|STARTED|Overall Study||361
8467160|NCT00678379|20864345|P3|NOT COMPLETED|Overall Study||4
8467161|NCT00678379|20864346|P2|NOT COMPLETED|Overall Study||3
8467162|NCT00678379|20864347|P1|NOT COMPLETED|Overall Study||6
8467163|NCT00678379|20864345|P3|COMPLETED|Overall Study||36
8467164|NCT00678379|20864346|P2|COMPLETED|Overall Study||37
8467165|NCT00678379|20864347|P1|COMPLETED|Overall Study||34
8467166|NCT00678379|20864345|P3|STARTED|Overall Study||40
8467167|NCT00678379|20864346|P2|STARTED|Overall Study||40
8467168|NCT00678379|20864347|P1|STARTED|Overall Study||40
8467169|NCT00678301|20864375|P2|NOT COMPLETED|Overall Study||2
8467170|NCT00678301|20864376|P1|NOT COMPLETED|Overall Study||8
8467171|NCT00678301|20864375|P2|COMPLETED|Overall Study||116
8467172|NCT00678301|20864376|P1|COMPLETED|Overall Study||231
8467173|NCT00678301|20864375|P2|STARTED|Overall Study||118
8467174|NCT00678301|20864376|P1|STARTED|Overall Study||239
8467175|NCT00678288|20864434|P2|NOT COMPLETED|Overall Study||6
8467176|NCT00678288|20864435|P1|NOT COMPLETED|Overall Study||10
8467177|NCT00678288|20864434|P2|COMPLETED|Overall Study||0
8467178|NCT00678288|20864435|P1|COMPLETED|Overall Study||0
8467179|NCT00678288|20864434|P2|STARTED|Overall Study||6
8467180|NCT00678288|20864435|P1|STARTED|Overall Study||10
8467181|NCT00678249|20864452|P3|NOT COMPLETED|Overall Study||0
8467182|NCT00678249|20864453|P2|NOT COMPLETED|Overall Study||0
8467183|NCT00678249|20864454|P1|NOT COMPLETED|Overall Study||0
8467184|NCT00678249|20864452|P3|COMPLETED|Overall Study||37
8467185|NCT00678249|20864453|P2|COMPLETED|Overall Study||93
8467186|NCT00678249|20864454|P1|COMPLETED|Overall Study||97
8467187|NCT00678249|20864452|P3|STARTED|Overall Study||37
8467188|NCT00678249|20864453|P2|STARTED|Overall Study||93
8467189|NCT00678249|20864454|P1|STARTED|Overall Study||97
8467190|NCT00678210|20864490|P4|NOT COMPLETED|Overall Study||20
8467191|NCT00678210|20864491|P3|NOT COMPLETED|Overall Study||6
8467192|NCT00678210|20864492|P2|NOT COMPLETED|Overall Study||11
8467193|NCT00678210|20864493|P1|NOT COMPLETED|Overall Study||11
8467194|NCT00678210|20864490|P4|COMPLETED|Overall Study||30
8467195|NCT00678210|20864491|P3|COMPLETED|Overall Study||43
8467196|NCT00678210|20864492|P2|COMPLETED|Overall Study||38
8467197|NCT00678210|20864493|P1|COMPLETED|Overall Study||38
8467198|NCT00678210|20864490|P4|STARTED|Overall Study||50
8467199|NCT00678210|20864491|P3|STARTED|Overall Study||49
8467200|NCT00678210|20864492|P2|STARTED|Overall Study||49
8467201|NCT00678210|20864493|P1|STARTED|Overall Study||49
8467202|NCT00678080|20864529|P2|NOT COMPLETED|Overall Study||1
8467203|NCT00678080|20864530|P1|NOT COMPLETED|Overall Study||3
8467204|NCT00678080|20864529|P2|COMPLETED|Overall Study||13
8467205|NCT00678080|20864530|P1|COMPLETED|Overall Study||8
8467206|NCT00678080|20864529|P2|STARTED|Overall Study||14
8467207|NCT00678080|20864530|P1|STARTED|Overall Study||11
8467208|NCT00678041|20864556|P2|NOT COMPLETED|Overall Study||5
8467209|NCT00678041|20864557|P1|NOT COMPLETED|Overall Study||5
8467210|NCT00678041|20864556|P2|COMPLETED|Overall Study||0
8467211|NCT00678041|20864557|P1|COMPLETED|Overall Study||0
8467212|NCT00678041|20864556|P2|STARTED|Overall Study||5
8467213|NCT00678041|20864557|P1|STARTED|Overall Study||5
8467214|NCT00678015|20864569|P1|NOT COMPLETED|Overall Study||0
8467215|NCT00678015|20864569|P1|COMPLETED|Overall Study||12
8467216|NCT00678015|20864569|P1|STARTED|Overall Study||12
8467217|NCT00677924|20864578|P2|NOT COMPLETED|Overall Study||0
8467218|NCT00677924|20864579|P1|NOT COMPLETED|Overall Study||0
8467219|NCT00677924|20864578|P2|COMPLETED|Overall Study||6
8467220|NCT00677924|20864579|P1|COMPLETED|Overall Study||3
8467221|NCT00677924|20864578|P2|STARTED|Overall Study||6
8467222|NCT00677924|20864579|P1|STARTED|Overall Study||3
8467223|NCT00677898|20864589|P2|NOT COMPLETED|Overall Study||18
8467224|NCT00677898|20864590|P1|NOT COMPLETED|Overall Study||20
8467225|NCT00677898|20864589|P2|COMPLETED|Overall Study||102
8467226|NCT00677898|20864590|P1|COMPLETED|Overall Study||99
8467227|NCT00677898|20864589|P2|STARTED|Overall Study||120
8467228|NCT00677898|20864590|P1|STARTED|Overall Study||119
8467229|NCT00677833|20864610|P4|NOT COMPLETED|Overall Study||3
8467230|NCT00677833|20864611|P3|NOT COMPLETED|Overall Study||2
8467231|NCT00677833|20864612|P2|NOT COMPLETED|Overall Study||0
8467232|NCT00677833|20864613|P1|NOT COMPLETED|Overall Study||4
8467233|NCT00677833|20864610|P4|COMPLETED|Overall Study||128
8467234|NCT00677833|20864611|P3|COMPLETED|Overall Study||122
8467235|NCT00677833|20864612|P2|COMPLETED|Overall Study||51
8467236|NCT00677833|20864613|P1|COMPLETED|Overall Study||51
8467237|NCT00677833|20864610|P4|STARTED|Overall Study||131
8467238|NCT00677833|20864611|P3|STARTED|Overall Study||124
8467239|NCT00677833|20864612|P2|STARTED|Overall Study||51
8467240|NCT00677833|20864613|P1|STARTED|Overall Study||55
8467241|NCT00677820|20864663|P2|NOT COMPLETED|Overall Study||0
8467242|NCT00677820|20864664|P1|NOT COMPLETED|Overall Study||1
8467243|NCT00677820|20864663|P2|COMPLETED|Overall Study||60
8467244|NCT00677820|20864664|P1|COMPLETED|Overall Study||239
8467245|NCT00677820|20864663|P2|STARTED|Overall Study||60
8467246|NCT00677820|20864664|P1|STARTED|Overall Study||240
8467247|NCT00677807|20864685|P3|NOT COMPLETED|Overall Study||20
8467248|NCT00677807|20864686|P2|NOT COMPLETED|Overall Study||11
8467249|NCT00677807|20864687|P1|NOT COMPLETED|Overall Study||18
8467250|NCT00677807|20864685|P3|COMPLETED|Overall Study||105
8467251|NCT00677807|20864686|P2|COMPLETED|Overall Study||135
8467252|NCT00677807|20864687|P1|COMPLETED|Overall Study||126
8467253|NCT00677807|20864685|P3|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
8467254|NCT00677807|20864686|P2|Safety/ITT: Received Study Drug|Overall Study||146
8467255|NCT00677807|20864687|P1|Safety/ITT: Received Study Drug|Overall Study||144
8467256|NCT00677807|20864685|P3|STARTED|Overall Study||125
8467257|NCT00677807|20864686|P2|STARTED|Overall Study||146
8467258|NCT00677807|20864687|P1|STARTED|Overall Study||144
8467259|NCT00677690|20864718|P2|NOT COMPLETED|Overall Study||0
8467260|NCT00677690|20864719|P1|NOT COMPLETED|Overall Study||0
8467261|NCT00677690|20864718|P2|COMPLETED|Overall Study||41
8467262|NCT00677690|20864719|P1|COMPLETED|Overall Study||42
8467263|NCT00677690|20864718|P2|STARTED|Overall Study||41
8467264|NCT00677690|20864719|P1|STARTED|Overall Study||42
8467265|NCT00677534|20864733|P1|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
8467266|NCT00677534|20864733|P1|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
8467267|NCT00677534|20864733|P1|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
8467268|NCT00677534|20864733|P1|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
8467269|NCT00677534|20864733|P1|COMPLETED|Cholecalciferol (Weeks 5-12)||7
8467270|NCT00677534|20864733|P1|STARTED|Cholecalciferol (Weeks 5-12)||7
8467271|NCT00677534|20864733|P1|NOT COMPLETED|Washout (Weeks 1-4)||3
8467272|NCT00677534|20864733|P1|COMPLETED|Washout (Weeks 1-4)||7
8467273|NCT00677534|20864733|P1|STARTED|Washout (Weeks 1-4)||10
8467274|NCT00677365|20864741|P4|NOT COMPLETED|Overall Study||3
8467275|NCT00677365|20864742|P3|NOT COMPLETED|Overall Study||2
8467276|NCT00677365|20864743|P2|NOT COMPLETED|Overall Study||1
8467277|NCT00677365|20864744|P1|NOT COMPLETED|Overall Study||2
8467278|NCT00677365|20864741|P4|COMPLETED|Overall Study||36
8467279|NCT00677365|20864742|P3|COMPLETED|Overall Study||35
8467280|NCT00677365|20864743|P2|COMPLETED|Overall Study||37
8467281|NCT00677365|20864744|P1|COMPLETED|Overall Study||35
8467282|NCT00677365|20864741|P4|STARTED|Overall Study||39
8467283|NCT00677365|20864742|P3|STARTED|Overall Study||37
8467284|NCT00677365|20864743|P2|STARTED|Overall Study||38
8467285|NCT00677365|20864744|P1|STARTED|Overall Study||37
8467286|NCT00677352|20864776|P2|NOT COMPLETED|Tapering Phase||10
8467287|NCT00677352|20864777|P1|NOT COMPLETED|Tapering Phase||6
8467288|NCT00677352|20864776|P2|COMPLETED|Tapering Phase||112
8467289|NCT00677352|20864777|P1|COMPLETED|Tapering Phase||126
8467290|NCT00677352|20864776|P2|STARTED|Tapering Phase||122
8467291|NCT00677352|20864777|P1|STARTED|Tapering Phase||132
8467292|NCT00677352|20864776|P2|NOT COMPLETED|Treatment Phase||42
8467293|NCT00677352|20864777|P1|NOT COMPLETED|Treatment Phase||25
8467294|NCT00677352|20864776|P2|COMPLETED|Treatment Phase||122
8467295|NCT00677352|20864777|P1|COMPLETED|Treatment Phase||132
8467296|NCT00677352|20864776|P2|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
8467297|NCT00677352|20864777|P1|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
8467298|NCT00677235|20864797|P2|NOT COMPLETED|Overall Study||38
8467299|NCT00677235|20864798|P1|NOT COMPLETED|Overall Study||41
8467300|NCT00677235|20864797|P2|COMPLETED|Overall Study||94
8467301|NCT00677235|20864798|P1|COMPLETED|Overall Study||97
8467302|NCT00677235|20864797|P2|STARTED|Overall Study||132
8467303|NCT00677235|20864798|P1|STARTED|Overall Study||138
8467304|NCT00677092|20864838|P1|NOT COMPLETED|Overall Study||6
8467305|NCT00677092|20864838|P1|COMPLETED|Overall Study||6
8467306|NCT00677092|20864838|P1|Received Study Treatment|Overall Study||11
8467307|NCT00677092|20864838|P1|STARTED|Overall Study||12
8467308|NCT00677040|20864847|P1|NOT COMPLETED|Overall Study||0
8467309|NCT00677040|20864847|P1|COMPLETED|Overall Study||20
8467310|NCT00677040|20864847|P1|STARTED|Overall Study||20
8467311|NCT00677014|20864855|P3|NOT COMPLETED|Overall Study||49
8467312|NCT00677014|20864856|P2|NOT COMPLETED|Overall Study||41
8467313|NCT00677014|20864857|P1|NOT COMPLETED|Overall Study||44
8467314|NCT00677014|20864855|P3|COMPLETED|Overall Study||283
8467315|NCT00677014|20864856|P2|COMPLETED|Overall Study||282
8467316|NCT00677014|20864857|P1|COMPLETED|Overall Study||281
8467317|NCT00677014|20864855|P3|STARTED|Overall Study||332
8467318|NCT00677014|20864856|P2|STARTED|Overall Study||323
8467319|NCT00677014|20864857|P1|STARTED|Overall Study||325
8467320|NCT00676897|20864867|P2|NOT COMPLETED|Overall Study||0
8467321|NCT00676897|20864868|P1|NOT COMPLETED|Overall Study||0
8467322|NCT00676897|20864867|P2|COMPLETED|Overall Study||10
8467323|NCT00676897|20864868|P1|COMPLETED|Overall Study||8
8467324|NCT00676897|20864867|P2|STARTED|Overall Study||10
8467325|NCT00676897|20864868|P1|STARTED|Overall Study||8
8467326|NCT00676806|20864878|P2|NOT COMPLETED|Overall Study||0
8467327|NCT00676806|20864879|P1|NOT COMPLETED|Overall Study||0
8467328|NCT00676806|20864878|P2|COMPLETED|Overall Study||3
8467329|NCT00676806|20864879|P1|COMPLETED|Overall Study||3
8467330|NCT00676806|20864878|P2|STARTED|Overall Study||3
8467331|NCT00676806|20864879|P1|STARTED|Overall Study||3
8467332|NCT00676793|20864895|P1|NOT COMPLETED|Overall Study||13
8467333|NCT00676793|20864895|P1|COMPLETED|Overall Study||19
8467334|NCT00676793|20864895|P1|STARTED|Overall Study||32
8467335|NCT00676780|20864900|P1|NOT COMPLETED|Overall Study||7
8467336|NCT00676780|20864900|P1|COMPLETED|Overall Study||26
8467337|NCT00676780|20864900|P1|STARTED|Overall Study||33
8467338|NCT00676715|20864910|P4|NOT COMPLETED|Overall Study||40
8467339|NCT00676715|20864911|P3|NOT COMPLETED|Overall Study||41
8467340|NCT00676715|20864912|P2|NOT COMPLETED|Overall Study||47
8467341|NCT00676715|20864913|P1|NOT COMPLETED|Overall Study||40
8467342|NCT00676715|20864910|P4|COMPLETED|Overall Study||14
8467343|NCT00676715|20864911|P3|COMPLETED|Overall Study||14
8467344|NCT00676715|20864912|P2|COMPLETED|Overall Study||8
8467345|NCT00676715|20864913|P1|COMPLETED|Overall Study||14
8467346|NCT00676715|20864910|P4|STARTED|Overall Study||54
8467347|NCT00676715|20864911|P3|STARTED|Overall Study||55
8467348|NCT00676715|20864912|P2|STARTED|Overall Study||55
8467349|NCT00676715|20864913|P1|STARTED|Overall Study||54
8467350|NCT00676689|20864943|P1|NOT COMPLETED|Overall Study||61
8467351|NCT00676689|20864943|P1|COMPLETED|Overall Study||20
8467352|NCT00676689|20864943|P1|1 Year Follow-up|Overall Study||64
8467353|NCT00676689|20864943|P1|30 Day Follow-up|Overall Study||78
8467354|NCT00676689|20864943|P1|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
8467355|NCT00676689|20864943|P1|STARTED|Overall Study||81
8467356|NCT00676676|20864949|P1|NOT COMPLETED|Overall Study||0
8467357|NCT00676676|20864949|P1|COMPLETED|Overall Study||9
8467358|NCT00676676|20864949|P1|STARTED|Overall Study||9
8467359|NCT00676663|20864955|P2|NOT COMPLETED|Overall Study||38
8467360|NCT00676663|20864956|P1|NOT COMPLETED|Overall Study||45
8467361|NCT00676663|20864955|P2|COMPLETED|Overall Study||26
8467362|NCT00676663|20864956|P1|COMPLETED|Overall Study||21
8467363|NCT00676663|20864955|P2|STARTED|Overall Study||64
8467364|NCT00676663|20864956|P1|STARTED|Overall Study||66
8467365|NCT00676650|20864972|P2|NOT COMPLETED|Overall Study||289
8467366|NCT00676650|20864973|P1|NOT COMPLETED|Overall Study||584
8467367|NCT00676650|20864972|P2|COMPLETED|Overall Study||0
8467368|NCT00676650|20864973|P1|COMPLETED|Overall Study||0
8467369|NCT00676650|20864972|P2|Treated|Overall Study||285
8467370|NCT00676650|20864973|P1|Treated|Overall Study||581
8467371|NCT00676650|20864972|P2|STARTED|Overall Study||289
8467372|NCT00676650|20864973|P1|STARTED|Overall Study||584
8467373|NCT00676585|20864993|P2|NOT COMPLETED|Overall Study||0
8467374|NCT00676585|20864994|P1|NOT COMPLETED|Overall Study||0
8467375|NCT00676585|20864993|P2|COMPLETED|Overall Study||25
8467376|NCT00676585|20864994|P1|COMPLETED|Overall Study||25
8467377|NCT00676585|20864993|P2|STARTED|Overall Study||25
8467378|NCT00676585|20864994|P1|STARTED|Overall Study||25
8467379|NCT00676572|20865006|P2|NOT COMPLETED|Overall Study||0
8467380|NCT00676572|20865007|P1|NOT COMPLETED|Overall Study||0
8467381|NCT00676572|20865006|P2|COMPLETED|Overall Study||6
8467382|NCT00676572|20865007|P1|COMPLETED|Overall Study||6
8467383|NCT00676572|20865006|P2|STARTED|Overall Study||6
8467384|NCT00676572|20865007|P1|STARTED|Overall Study||6
8467385|NCT00676520|20865015|P1|NOT COMPLETED|Overall Study||731
8467386|NCT00676520|20865015|P1|COMPLETED|Overall Study||7309
8467387|NCT00676520|20865015|P1|STARTED|Overall Study||8040
8467388|NCT00676494|20865072|P1|NOT COMPLETED|Overall Study||14
8467389|NCT00676494|20865072|P1|COMPLETED|Overall Study||158
8467390|NCT00676494|20865072|P1|STARTED|Overall Study||172
8467391|NCT00676455|20865078|P1|NOT COMPLETED|Overall Study||0
8467392|NCT00676455|20865078|P1|COMPLETED|Overall Study||14
8467393|NCT00676455|20865078|P1|STARTED|Overall Study||14
8467412|NCT00676364|20865224|P2|NOT COMPLETED|Overall Study||0
8467413|NCT00676364|20865225|P1|NOT COMPLETED|Overall Study||0
8467414|NCT00676364|20865224|P2|COMPLETED|Overall Study||57
8467415|NCT00676364|20865225|P1|COMPLETED|Overall Study||57
8467416|NCT00676364|20865224|P2|STARTED|Overall Study||57
8467417|NCT00676364|20865225|P1|STARTED|Overall Study||57
8467418|NCT00676338|20865237|P4|NOT COMPLETED|Overall Study||23
8467419|NCT00676338|20865238|P3|NOT COMPLETED|Overall Study||30
8467420|NCT00676338|20865239|P2|NOT COMPLETED|Overall Study||33
8467421|NCT00676338|20865240|P1|NOT COMPLETED|Overall Study||38
8467422|NCT00676338|20865237|P4|COMPLETED|Overall Study||140
8467423|NCT00676338|20865238|P3|COMPLETED|Overall Study||133
8467424|NCT00676338|20865239|P2|COMPLETED|Overall Study||213
8467425|NCT00676338|20865240|P1|COMPLETED|Overall Study||210
8467426|NCT00676338|20865237|P4|STARTED|Overall Study||163
8467427|NCT00676338|20865238|P3|STARTED|Overall Study||163
8467428|NCT00676338|20865239|P2|STARTED|Overall Study||246
8467429|NCT00676338|20865240|P1|STARTED|Overall Study||248
8467430|NCT00676208|20865292|P2|NOT COMPLETED|Overall Study||6
8467431|NCT00676208|20865293|P1|NOT COMPLETED|Overall Study||2
8467432|NCT00676208|20865292|P2|COMPLETED|Overall Study||13
8467433|NCT00676208|20865293|P1|COMPLETED|Overall Study||12
8467434|NCT00676208|20865292|P2|STARTED|Overall Study||19
8467435|NCT00676208|20865293|P1|STARTED|Overall Study||14
8467436|NCT00676195|20865301|P1|NOT COMPLETED|Overall Study||3
8467437|NCT00676195|20865301|P1|COMPLETED|Overall Study||21
8467438|NCT00676195|20865301|P1|STARTED|Overall Study||24
8467439|NCT00676182|20865311|P1|NOT COMPLETED|Overall Study||0
8467440|NCT00676182|20865311|P1|COMPLETED|Overall Study||75
8467441|NCT00676182|20865311|P1|STARTED|Overall Study||75
8467442|NCT00676143|20865326|P2|NOT COMPLETED|Overall Study||260
8467443|NCT00676143|20865327|P1|NOT COMPLETED|Overall Study||156
8467444|NCT00676143|20865326|P2|COMPLETED|Overall Study||398
8467445|NCT00676143|20865327|P1|COMPLETED|Overall Study||285
8467446|NCT00676143|20865326|P2|Treated|Overall Study||654
8467447|NCT00676143|20865327|P1|Treated|Overall Study||439
8467448|NCT00676143|20865326|P2|STARTED|Overall Study||658
8467449|NCT00676143|20865327|P1|STARTED|Overall Study||441
8467450|NCT00676130|20865367|P2|NOT COMPLETED|Overall Study||4
8467451|NCT00676130|20865368|P1|NOT COMPLETED|Overall Study||3
8467452|NCT00676130|20865367|P2|COMPLETED|Overall Study||73
8467453|NCT00676130|20865368|P1|COMPLETED|Overall Study||73
8467454|NCT00676130|20865367|P2|STARTED|Overall Study||77
8467455|NCT00676130|20865368|P1|STARTED|Overall Study||76
8467456|NCT00676091|20865378|P2|NOT COMPLETED|Toddler Dose||0
8467457|NCT00676091|20865379|P1|NOT COMPLETED|Toddler Dose||3
8467458|NCT00676091|20865378|P2|COMPLETED|Toddler Dose||156
8467459|NCT00676091|20865379|P1|COMPLETED|Toddler Dose||153
8467460|NCT00676091|20865378|P2|STARTED|Toddler Dose||156
8467461|NCT00676091|20865379|P1|STARTED|Toddler Dose||156
8467462|NCT00676091|20865378|P2|NOT COMPLETED|After Infant Series||3
8467463|NCT00676091|20865379|P1|NOT COMPLETED|After Infant Series||1
8467464|NCT00676091|20865378|P2|COMPLETED|After Infant Series||156
8467465|NCT00676091|20865379|P1|COMPLETED|After Infant Series||156
8467466|NCT00676091|20865378|P2|STARTED|After Infant Series||159
8467467|NCT00676091|20865379|P1|STARTED|After Infant Series||157
8467468|NCT00676091|20865378|P2|NOT COMPLETED|Infant Series||18
8467469|NCT00676091|20865379|P1|NOT COMPLETED|Infant Series||20
8467470|NCT00676091|20865378|P2|COMPLETED|Infant Series||159
8467471|NCT00676091|20865379|P1|COMPLETED|Infant Series||157
8467472|NCT00676091|20865378|P2|Vaccinated Dose 3|Infant Series||161
8467473|NCT00676091|20865379|P1|Vaccinated Dose 3|Infant Series||158
8467474|NCT00676091|20865378|P2|Vaccinated Dose 2|Infant Series||162
8467475|NCT00676091|20865379|P1|Vaccinated Dose 2|Infant Series||159
8467476|NCT00676091|20865378|P2|Vaccinated Dose 1|Infant Series||162
8467477|NCT00676091|20865379|P1|Vaccinated Dose 1|Infant Series||163
8467478|NCT00676091|20865378|P2|STARTED|Infant Series||177
8467479|NCT00676091|20865379|P1|STARTED|Infant Series||177
8467480|NCT00676065|20865414|P3|NOT COMPLETED|Overall Study||0
8467481|NCT00676065|20865415|P2|NOT COMPLETED|Overall Study||0
8467482|NCT00676065|20865416|P1|NOT COMPLETED|Overall Study||0
8467483|NCT00676065|20865414|P3|COMPLETED|Overall Study||26341
8467484|NCT00676065|20865415|P2|COMPLETED|Overall Study||15428
8467485|NCT00676065|20865416|P1|COMPLETED|Overall Study||16534
8467486|NCT00676065|20865414|P3|STARTED|Overall Study||26341
8467487|NCT00676065|20865415|P2|STARTED|Overall Study||15428
8467488|NCT00676065|20865416|P1|STARTED|Overall Study||16534
8467489|NCT00676052|20865436|P6|NOT COMPLETED|Overall Study||6
8467490|NCT00676052|20865437|P5|NOT COMPLETED|Overall Study||6
8467491|NCT00676052|20865438|P4|NOT COMPLETED|Overall Study||5
8467492|NCT00676052|20865439|P3|NOT COMPLETED|Overall Study||6
8467493|NCT00676052|20865440|P2|NOT COMPLETED|Overall Study||7
8467494|NCT00676052|20865441|P1|NOT COMPLETED|Overall Study||9
8467495|NCT00676052|20865436|P6|COMPLETED|Overall Study||91
8467496|NCT00676052|20865437|P5|COMPLETED|Overall Study||89
8467497|NCT00676052|20865438|P4|COMPLETED|Overall Study||92
8467498|NCT00676052|20865439|P3|COMPLETED|Overall Study||90
8467499|NCT00676052|20865440|P2|COMPLETED|Overall Study||88
8467500|NCT00676052|20865441|P1|COMPLETED|Overall Study||87
8467501|NCT00676052|20865436|P6|STARTED|Overall Study||97
8467502|NCT00676052|20865437|P5|STARTED|Overall Study||95
8467503|NCT00676052|20865438|P4|STARTED|Overall Study||97
8467504|NCT00676052|20865439|P3|STARTED|Overall Study||96
8467505|NCT00676052|20865440|P2|STARTED|Overall Study||95
8467506|NCT00676052|20865441|P1|STARTED|Overall Study||96
8467507|NCT00676026|20865473|P1|NOT COMPLETED|Overall Study||0
8467508|NCT00676026|20865473|P1|COMPLETED|Overall Study||8
8467509|NCT00676026|20865473|P1|STARTED|Overall Study||8
8467510|NCT00676013|20865477|P1|NOT COMPLETED|Overall Study||1
8467511|NCT00676013|20865477|P1|COMPLETED|Overall Study||157
8467512|NCT00676013|20865477|P1|STARTED|Overall Study||158
8467513|NCT00675987|20865486|P2|NOT COMPLETED|Overall Study||0
8467514|NCT00675987|20865487|P1|NOT COMPLETED|Overall Study||0
8467515|NCT00675987|20865486|P2|COMPLETED|Overall Study||27
8467516|NCT00675987|20865487|P1|COMPLETED|Overall Study||26
8467517|NCT00675987|20865486|P2|STARTED|Overall Study||27
8467518|NCT00675987|20865487|P1|STARTED|Overall Study||26
8467519|NCT00675948|20865511|P2|NOT COMPLETED|Overall Study||3
8467520|NCT00675948|20865512|P1|NOT COMPLETED|Overall Study||39
8467521|NCT00675948|20865511|P2|COMPLETED|Overall Study||1
8467522|NCT00675948|20865512|P1|COMPLETED|Overall Study||0
8467523|NCT00675948|20865511|P2|STARTED|Overall Study||4
8467524|NCT00675948|20865512|P1|STARTED|Overall Study||39
8467525|NCT00675922|20865522|P1|NOT COMPLETED|Overall Study||0
8467526|NCT00675922|20865522|P1|COMPLETED|Overall Study||98
8467527|NCT00675922|20865522|P1|STARTED|Overall Study||98
8467528|NCT00675909|20865530|P3|NOT COMPLETED|Overall Study||0
8467529|NCT00675909|20865531|P2|NOT COMPLETED|Overall Study||0
8467530|NCT00675909|20865532|P1|NOT COMPLETED|Overall Study||0
8467531|NCT00675909|20865530|P3|COMPLETED|Overall Study||60
8467532|NCT00675909|20865531|P2|COMPLETED|Overall Study||60
8467533|NCT00675909|20865532|P1|COMPLETED|Overall Study||60
8467534|NCT00675909|20865530|P3|STARTED|Overall Study||60
8467535|NCT00675909|20865531|P2|STARTED|Overall Study||60
8467536|NCT00675909|20865532|P1|STARTED|Overall Study||60
8467537|NCT00675792|20865554|P2|NOT COMPLETED|Overall Study||0
8467538|NCT00675792|20865555|P1|NOT COMPLETED|Overall Study||0
8467539|NCT00675792|20865554|P2|COMPLETED|Overall Study||49
8467540|NCT00675792|20865555|P1|COMPLETED|Overall Study||51
8467541|NCT00675792|20865554|P2|STARTED|Overall Study||49
8467542|NCT00675792|20865555|P1|STARTED|Overall Study||51
8467543|NCT00675766|20865575|P4|NOT COMPLETED|Overall Study||26
8467544|NCT00675766|20865576|P3|NOT COMPLETED|Overall Study||21
8467545|NCT00675766|20865577|P2|NOT COMPLETED|Overall Study||5
8467546|NCT00675766|20865578|P1|NOT COMPLETED|Overall Study||6
8467547|NCT00675766|20865575|P4|COMPLETED|Overall Study||11
8467548|NCT00675766|20865576|P3|COMPLETED|Overall Study||29
8467549|NCT00675766|20865577|P2|COMPLETED|Overall Study||25
8467550|NCT00675766|20865578|P1|COMPLETED|Overall Study||100
8467551|NCT00675766|20865575|P4|Year 3|Overall Study||11
8467552|NCT00675766|20865576|P3|Year 3|Overall Study||29
8467553|NCT00675766|20865577|P2|Year 3|Overall Study||25
8467554|NCT00675766|20865578|P1|Year 3|Overall Study||100
8467555|NCT00675766|20865575|P4|Year 2|Overall Study||20
8467556|NCT00675766|20865576|P3|Year 2|Overall Study||34
8467557|NCT00675766|20865577|P2|Year 2|Overall Study||28
8467558|NCT00675766|20865578|P1|Year 2|Overall Study||105
8467559|NCT00675766|20865575|P4|STARTED|Overall Study||37
8467560|NCT00675766|20865576|P3|STARTED|Overall Study||50
8467561|NCT00675766|20865577|P2|STARTED|Overall Study||30
8467562|NCT00675766|20865578|P1|STARTED|Overall Study||106
8467563|NCT00675597|20865588|P1|NOT COMPLETED|Overall Study||3
8467564|NCT00675597|20865588|P1|COMPLETED|Overall Study||23
8467565|NCT00675597|20865588|P1|STARTED|Overall Study||26
8467566|NCT00675584|20865594|P2|NOT COMPLETED|Overall Study||26
8467567|NCT00675584|20865595|P1|NOT COMPLETED|Overall Study||39
8467568|NCT00675584|20865594|P2|COMPLETED|Overall Study||113
8467569|NCT00675584|20865595|P1|COMPLETED|Overall Study||100
8467570|NCT00675584|20865594|P2|STARTED|Overall Study||139
8467571|NCT00675584|20865595|P1|STARTED|Overall Study||139
8467572|NCT00675558|20865624|P3|NOT COMPLETED|Second Operation||0
8467573|NCT00675558|20865625|P2|NOT COMPLETED|Second Operation||0
8467574|NCT00675558|20865626|P1|NOT COMPLETED|Second Operation||0
8467575|NCT00675558|20865624|P3|COMPLETED|Second Operation||10
8467576|NCT00675558|20865625|P2|COMPLETED|Second Operation||0
8467577|NCT00675558|20865626|P1|COMPLETED|Second Operation||0
8467578|NCT00675558|20865624|P3|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
8467579|NCT00675558|20865625|P2|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
8467580|NCT00675558|20865626|P1|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
8467581|NCT00675558|20865624|P3|NOT COMPLETED|Surgery||0
8467582|NCT00675558|20865625|P2|NOT COMPLETED|Surgery||0
8467583|NCT00675558|20865626|P1|NOT COMPLETED|Surgery||0
8467584|NCT00675558|20865624|P3|COMPLETED|Surgery||30
8467585|NCT00675558|20865625|P2|COMPLETED|Surgery||10
8467586|NCT00675558|20865626|P1|COMPLETED|Surgery||10
8467587|NCT00675558|20865624|P3|STARTED|Surgery||30
8467588|NCT00675558|20865625|P2|STARTED|Surgery||10
8467589|NCT00675558|20865626|P1|STARTED|Surgery||10
8467590|NCT00675506|20865642|P2|NOT COMPLETED|Overall Study||12
8467591|NCT00675506|20865643|P1|NOT COMPLETED|Overall Study||12
8467592|NCT00675506|20865642|P2|COMPLETED|Overall Study||17
8467593|NCT00675506|20865643|P1|COMPLETED|Overall Study||19
8467594|NCT00675506|20865642|P2|Received Intervention|Overall Study||29
8467595|NCT00675506|20865643|P1|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
8467596|NCT00675506|20865642|P2|STARTED|Overall Study||29
8467597|NCT00675506|20865643|P1|STARTED|Overall Study||31
8467598|NCT00675441|20865659|P1|NOT COMPLETED|Overall Study||3
8467599|NCT00675441|20865659|P1|COMPLETED|Overall Study||2
8467600|NCT00675441|20865659|P1|STARTED|Overall Study||5
8467601|NCT00675428|20865665|P2|NOT COMPLETED|Overall Study||3
8467602|NCT00675428|20865666|P1|NOT COMPLETED|Overall Study||3
8467603|NCT00675428|20865665|P2|COMPLETED|Overall Study||0
8467604|NCT00675428|20865666|P1|COMPLETED|Overall Study||0
8467605|NCT00675428|20865665|P2|STARTED|Overall Study||3
8467606|NCT00675428|20865666|P1|STARTED|Overall Study||3
8467607|NCT00675415|20865686|P2|NOT COMPLETED|Overall Study||8
8467608|NCT00675415|20865687|P1|NOT COMPLETED|Overall Study||8
8467609|NCT00675415|20865686|P2|COMPLETED|Overall Study||123
8467610|NCT00675415|20865687|P1|COMPLETED|Overall Study||124
8467611|NCT00675415|20865686|P2|STARTED|Overall Study||131
8467612|NCT00675415|20865687|P1|STARTED|Overall Study||132
8467613|NCT00675259|20865699|P1|NOT COMPLETED|Overall Study||14
8467614|NCT00675259|20865699|P1|COMPLETED|Overall Study||19
8467615|NCT00675259|20865699|P1|STARTED|Overall Study||33
8467616|NCT00675103|20865708|P1|NOT COMPLETED|Overall Study||3
8467617|NCT00675103|20865708|P1|COMPLETED|Overall Study||4
8467618|NCT00675103|20865708|P1|STARTED|Overall Study||7
8467619|NCT00674986|20865715|P2|NOT COMPLETED|Overall Study||81
8467620|NCT00674986|20865716|P1|NOT COMPLETED|Overall Study||43
8467621|NCT00674986|20865715|P2|COMPLETED|Overall Study||188
8467622|NCT00674986|20865716|P1|COMPLETED|Overall Study||187
8467623|NCT00674986|20865715|P2|Intent to Treat Population|Overall Study||256
8467624|NCT00674986|20865716|P1|Intent to Treat Population|Overall Study||227
8467625|NCT00674986|20865715|P2|STARTED|Overall Study||269
8467626|NCT00674986|20865716|P1|STARTED|Overall Study||230
8467627|NCT00674973|20865737|P2|NOT COMPLETED|Overall Study||102
8467628|NCT00674973|20865738|P1|NOT COMPLETED|Overall Study||100
8467629|NCT00674973|20865737|P2|COMPLETED|Overall Study|Completed double-blind treatment.|2
8467630|NCT00674973|20865738|P1|COMPLETED|Overall Study|Completed double-blind treatment.|3
8467631|NCT00674973|20865737|P2|Switch to Open-Label Erlotinib|Overall Study||0
8467632|NCT00674973|20865738|P1|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
8467633|NCT00674973|20865737|P2|STARTED|Overall Study||104
8467634|NCT00674973|20865738|P1|STARTED|Overall Study||103
8467635|NCT00674817|20865752|P1|NOT COMPLETED|Period 6||0
8467636|NCT00674817|20865752|P1|COMPLETED|Period 6||38
8467637|NCT00674817|20865752|P1|STARTED|Period 6||38
8467638|NCT00674817|20865752|P1|NOT COMPLETED|Period 5||0
8467639|NCT00674817|20865752|P1|COMPLETED|Period 5||38
8467640|NCT00674817|20865752|P1|STARTED|Period 5||38
8467641|NCT00674817|20865752|P1|NOT COMPLETED|Period 4||1
8467642|NCT00674817|20865752|P1|COMPLETED|Period 4||38
8467643|NCT00674817|20865752|P1|STARTED|Period 4||39
8467644|NCT00674817|20865752|P1|NOT COMPLETED|Period 3||2
8467645|NCT00674817|20865752|P1|COMPLETED|Period 3||39
8467646|NCT00674817|20865752|P1|STARTED|Period 3||41
8467647|NCT00674817|20865752|P1|NOT COMPLETED|Period 2||0
8467648|NCT00674817|20865752|P1|COMPLETED|Period 2||41
8467649|NCT00674817|20865752|P1|STARTED|Period 2||41
8467650|NCT00674817|20865752|P1|NOT COMPLETED|Period 1||3
8467651|NCT00674817|20865752|P1|COMPLETED|Period 1||41
8467652|NCT00674817|20865752|P1|STARTED|Period 1||44
8467653|NCT00674765|20865900|P2|NOT COMPLETED|Overall Study||29
8467654|NCT00674765|20865901|P1|NOT COMPLETED|Overall Study||36
8467655|NCT00674765|20865900|P2|COMPLETED|Overall Study||46
8467656|NCT00674765|20865901|P1|COMPLETED|Overall Study||45
8467657|NCT00674765|20865900|P2|STARTED|Overall Study||75
8467658|NCT00674765|20865901|P1|STARTED|Overall Study||81
8467659|NCT00674739|20865910|P3|NOT COMPLETED|Overall Study||32
8467660|NCT00674739|20865911|P2|NOT COMPLETED|Overall Study||59
8467661|NCT00674739|20865912|P1|NOT COMPLETED|Overall Study||57
8467662|NCT00674739|20865910|P3|COMPLETED|Overall Study||65
8467663|NCT00674739|20865911|P2|COMPLETED|Overall Study||136
8467664|NCT00674739|20865912|P1|COMPLETED|Overall Study||121
8467665|NCT00674739|20865910|P3|STARTED|Overall Study||97
8467666|NCT00674739|20865911|P2|STARTED|Overall Study||195
8467667|NCT00674739|20865912|P1|STARTED|Overall Study||178
8467668|NCT00674700|20865929|P3|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
8467669|NCT00674700|20865930|P2|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
8467670|NCT00674700|20865931|P1|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
8467671|NCT00674700|20865929|P3|COMPLETED|Year 2 Follow-up Without Treatment||141
8467672|NCT00674700|20865930|P2|COMPLETED|Year 2 Follow-up Without Treatment||123
8467673|NCT00674700|20865931|P1|COMPLETED|Year 2 Follow-up Without Treatment||133
8467674|NCT00674700|20865929|P3|STARTED|Year 2 Follow-up Without Treatment||153
8467675|NCT00674700|20865930|P2|STARTED|Year 2 Follow-up Without Treatment||135
8467676|NCT00674700|20865931|P1|STARTED|Year 2 Follow-up Without Treatment||139
8467677|NCT00674700|20865929|P3|NOT COMPLETED|Year 1||17
8467678|NCT00674700|20865930|P2|NOT COMPLETED|Year 1||34
8467679|NCT00674700|20865931|P1|NOT COMPLETED|Year 1||31
8467680|NCT00674700|20865929|P3|COMPLETED|Year 1||153
8467681|NCT00674700|20865930|P2|COMPLETED|Year 1||135
8467682|NCT00674700|20865931|P1|COMPLETED|Year 1||139
8467683|NCT00674700|20865929|P3|STARTED|Year 1||170
8467684|NCT00674700|20865930|P2|STARTED|Year 1||169
8467685|NCT00674700|20865931|P1|STARTED|Year 1||170
8467692|NCT00674622|20865954|P3|NOT COMPLETED|Overall Study||0
8467693|NCT00674622|20865955|P2|NOT COMPLETED|Overall Study||4
8467694|NCT00674622|20865956|P1|NOT COMPLETED|Overall Study||1
8467695|NCT00674622|20865954|P3|COMPLETED|Overall Study||22
8467696|NCT00674622|20865955|P2|COMPLETED|Overall Study||18
8467697|NCT00674622|20865956|P1|COMPLETED|Overall Study||21
8467698|NCT00674622|20865954|P3|STARTED|Overall Study||22
8467699|NCT00674622|20865955|P2|STARTED|Overall Study||22
8467700|NCT00674622|20865956|P1|STARTED|Overall Study||22
8467701|NCT00674609|20865979|P3|NOT COMPLETED|Overall Study||8
8467702|NCT00674609|20865980|P2|NOT COMPLETED|Overall Study||13
8467703|NCT00674609|20865981|P1|NOT COMPLETED|Overall Study||12
8467704|NCT00674609|20865979|P3|COMPLETED|Overall Study||51
8467705|NCT00674609|20865980|P2|COMPLETED|Overall Study||45
8467706|NCT00674609|20865981|P1|COMPLETED|Overall Study||48
8467707|NCT00674609|20865979|P3|STARTED|Overall Study||59
8467708|NCT00674609|20865980|P2|STARTED|Overall Study||58
8467709|NCT00674609|20865981|P1|STARTED|Overall Study||60
8467710|NCT00674583|20866015|P2|NOT COMPLETED|Overall Study||0
8467711|NCT00674583|20866016|P1|NOT COMPLETED|Overall Study||0
8467712|NCT00674583|20866015|P2|COMPLETED|Overall Study||103
8467713|NCT00674583|20866016|P1|COMPLETED|Overall Study||311
8467714|NCT00674583|20866015|P2|STARTED|Overall Study||103
8467715|NCT00674583|20866016|P1|STARTED|Overall Study||311
8467716|NCT00674570|20866043|P3|NOT COMPLETED|Overall Study||0
8467717|NCT00674570|20866044|P2|NOT COMPLETED|Overall Study||2
8467718|NCT00674570|20866045|P1|NOT COMPLETED|Overall Study||0
8467719|NCT00674570|20866043|P3|COMPLETED|Overall Study||35
8467720|NCT00674570|20866044|P2|COMPLETED|Overall Study||32
8467721|NCT00674570|20866045|P1|COMPLETED|Overall Study||37
8467722|NCT00674570|20866043|P3|STARTED|Overall Study||35
8467723|NCT00674570|20866044|P2|STARTED|Overall Study||34
8467724|NCT00674570|20866045|P1|STARTED|Overall Study||37
8467725|NCT00674492|20866053|P1|NOT COMPLETED|Overall Study||0
8467726|NCT00674492|20866053|P1|COMPLETED|Overall Study||21
8467727|NCT00674492|20866053|P1|STARTED|Overall Study||21
8467728|NCT00674479|20866057|P1|NOT COMPLETED|Overall Study||0
8467729|NCT00674479|20866057|P1|COMPLETED|Overall Study||51
8467730|NCT00674479|20866057|P1|STARTED|Overall Study||51
8467731|NCT00674466|20866066|P3|NOT COMPLETED|Overall Study||9
8467732|NCT00674466|20866067|P2|NOT COMPLETED|Overall Study||8
8467733|NCT00674466|20866068|P1|NOT COMPLETED|Overall Study||7
8467734|NCT00674466|20866066|P3|COMPLETED|Overall Study||21
8467735|NCT00674466|20866067|P2|COMPLETED|Overall Study||22
8467736|NCT00674466|20866068|P1|COMPLETED|Overall Study||23
8467737|NCT00674466|20866066|P3|STARTED|Overall Study||30
8467738|NCT00674466|20866067|P2|STARTED|Overall Study||30
8467739|NCT00674466|20866068|P1|STARTED|Overall Study||30
8467740|NCT00674362|20866084|P2|NOT COMPLETED|Open Label||0
8467741|NCT00674362|20866085|P1|NOT COMPLETED|Open Label||2
8467742|NCT00674362|20866084|P2|COMPLETED|Open Label||7
8467743|NCT00674362|20866085|P1|COMPLETED|Open Label||18
8467744|NCT00674362|20866084|P2|STARTED|Open Label||7
8467745|NCT00674362|20866085|P1|STARTED|Open Label||20
8467746|NCT00674362|20866084|P2|NOT COMPLETED|Double Blind||18
8467747|NCT00674362|20866085|P1|NOT COMPLETED|Double Blind||12
8467748|NCT00674362|20866084|P2|COMPLETED|Double Blind||80
8467749|NCT00674362|20866085|P1|COMPLETED|Double Blind||84
8467750|NCT00674362|20866084|P2|STARTED|Double Blind||98
8467751|NCT00674362|20866085|P1|STARTED|Double Blind||96
8467752|NCT00674323|20866153|P3|NOT COMPLETED|Overall Study||0
8467753|NCT00674323|20866154|P2|NOT COMPLETED|Overall Study||1
8467754|NCT00674323|20866155|P1|NOT COMPLETED|Overall Study||1
8467755|NCT00674323|20866153|P3|COMPLETED|Overall Study||21
8467756|NCT00674323|20866154|P2|COMPLETED|Overall Study||20
8467757|NCT00674323|20866155|P1|COMPLETED|Overall Study||18
8467758|NCT00674323|20866153|P3|STARTED|Overall Study||21
8467759|NCT00674323|20866154|P2|STARTED|Overall Study||21
8467760|NCT00674323|20866155|P1|STARTED|Overall Study||19
8467761|NCT00674297|20866172|P4|NOT COMPLETED|Overall Study||3
8467762|NCT00674297|20866173|P3|NOT COMPLETED|Overall Study||4
8467763|NCT00674297|20866174|P2|NOT COMPLETED|Overall Study||0
8467764|NCT00674297|20866175|P1|NOT COMPLETED|Overall Study||10
8467765|NCT00674297|20866172|P4|COMPLETED|Overall Study||4
8467766|NCT00674297|20866173|P3|COMPLETED|Overall Study||5
8467767|NCT00674297|20866174|P2|COMPLETED|Overall Study||7
8467768|NCT00674297|20866175|P1|COMPLETED|Overall Study||8
8467769|NCT00674297|20866172|P4|STARTED|Overall Study||7
8467770|NCT00674297|20866173|P3|STARTED|Overall Study||9
8467771|NCT00674297|20866174|P2|STARTED|Overall Study||7
8467772|NCT00674297|20866175|P1|STARTED|Overall Study||18
8467773|NCT00674219|20866192|P2|NOT COMPLETED|Overall Study||0
8467774|NCT00674219|20866193|P1|NOT COMPLETED|Overall Study||0
8467775|NCT00674219|20866192|P2|COMPLETED|Overall Study||7
8467776|NCT00674219|20866193|P1|COMPLETED|Overall Study||10
8467777|NCT00674219|20866192|P2|STARTED|Overall Study||7
8467778|NCT00674219|20866193|P1|STARTED|Overall Study||10
8467779|NCT00674206|20866199|P1|NOT COMPLETED|Overall Study||0
8467780|NCT00674206|20866199|P1|COMPLETED|Overall Study||6
8467781|NCT00674206|20866199|P1|STARTED|Overall Study||6
8467782|NCT00674154|20866206|P2|NOT COMPLETED|Overall Study||3
8467783|NCT00674154|20866207|P1|NOT COMPLETED|Overall Study||3
8467784|NCT00674154|20866206|P2|COMPLETED|Overall Study||20
8467785|NCT00674154|20866207|P1|COMPLETED|Overall Study||20
8467786|NCT00674154|20866206|P2|STARTED|Overall Study||23
8467787|NCT00674154|20866207|P1|STARTED|Overall Study||23
8467788|NCT00674128|20866215|P2|NOT COMPLETED|Overall Study||23
8467789|NCT00674128|20866216|P1|NOT COMPLETED|Overall Study||25
8467790|NCT00674128|20866215|P2|COMPLETED|Overall Study||21
8467791|NCT00674128|20866216|P1|COMPLETED|Overall Study||25
8467792|NCT00674128|20866215|P2|STARTED|Overall Study||44
8467793|NCT00674128|20866216|P1|STARTED|Overall Study||50
8467794|NCT00674115|20866222|P4|NOT COMPLETED|Third Intervention||0
8467795|NCT00674115|20866223|P3|NOT COMPLETED|Third Intervention||0
8467796|NCT00674115|20866224|P2|NOT COMPLETED|Third Intervention||0
8467797|NCT00674115|20866225|P1|NOT COMPLETED|Third Intervention||0
8467798|NCT00674115|20866222|P4|COMPLETED|Third Intervention||0
8467799|NCT00674115|20866223|P3|COMPLETED|Third Intervention||0
8467800|NCT00674115|20866224|P2|COMPLETED|Third Intervention||16
8467801|NCT00674115|20866225|P1|COMPLETED|Third Intervention||14
8467802|NCT00674115|20866222|P4|STARTED|Third Intervention||0
8467803|NCT00674115|20866223|P3|STARTED|Third Intervention||0
8467804|NCT00674115|20866224|P2|STARTED|Third Intervention||16
8467805|NCT00674115|20866225|P1|STARTED|Third Intervention||14
8467806|NCT00674115|20866222|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
8467807|NCT00674115|20866223|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
8467808|NCT00674115|20866224|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8467809|NCT00674115|20866225|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8467810|NCT00674115|20866222|P4|COMPLETED|Washout Period of 2 Weeks||0
8467811|NCT00674115|20866223|P3|COMPLETED|Washout Period of 2 Weeks||0
8467812|NCT00674115|20866224|P2|COMPLETED|Washout Period of 2 Weeks||16
8467813|NCT00674115|20866225|P1|COMPLETED|Washout Period of 2 Weeks||14
8467814|NCT00674115|20866222|P4|STARTED|Washout Period of 2 Weeks||0
8467815|NCT00674115|20866223|P3|STARTED|Washout Period of 2 Weeks||0
8467816|NCT00674115|20866224|P2|STARTED|Washout Period of 2 Weeks||16
8467817|NCT00674115|20866225|P1|STARTED|Washout Period of 2 Weeks||14
8467818|NCT00674115|20866222|P4|NOT COMPLETED|Second Intervention||0
8467819|NCT00674115|20866223|P3|NOT COMPLETED|Second Intervention||0
8467820|NCT00674115|20866224|P2|NOT COMPLETED|Second Intervention||0
8467821|NCT00674115|20866225|P1|NOT COMPLETED|Second Intervention||0
8467822|NCT00674115|20866222|P4|COMPLETED|Second Intervention||16
8467823|NCT00674115|20866223|P3|COMPLETED|Second Intervention||14
8467824|NCT00674115|20866224|P2|COMPLETED|Second Intervention||16
8467825|NCT00674115|20866225|P1|COMPLETED|Second Intervention||14
8467826|NCT00674115|20866222|P4|STARTED|Second Intervention||16
8467827|NCT00674115|20866223|P3|STARTED|Second Intervention||14
8467828|NCT00674115|20866224|P2|STARTED|Second Intervention||16
8467829|NCT00674115|20866225|P1|STARTED|Second Intervention||14
8467830|NCT00674115|20866222|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
8467831|NCT00674115|20866223|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
8467832|NCT00674115|20866224|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8467833|NCT00674115|20866225|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8467834|NCT00674115|20866222|P4|COMPLETED|Washout Period of 2 Weeks||16
8467835|NCT00674115|20866223|P3|COMPLETED|Washout Period of 2 Weeks||14
8467836|NCT00674115|20866224|P2|COMPLETED|Washout Period of 2 Weeks||16
8467837|NCT00674115|20866225|P1|COMPLETED|Washout Period of 2 Weeks||14
8467838|NCT00674115|20866222|P4|STARTED|Washout Period of 2 Weeks||16
8467839|NCT00674115|20866223|P3|STARTED|Washout Period of 2 Weeks||14
8467840|NCT00674115|20866224|P2|STARTED|Washout Period of 2 Weeks||16
8467841|NCT00674115|20866225|P1|STARTED|Washout Period of 2 Weeks||14
8467842|NCT00674115|20866222|P4|NOT COMPLETED|First Intervention||0
8467843|NCT00674115|20866223|P3|NOT COMPLETED|First Intervention||0
8467844|NCT00674115|20866224|P2|NOT COMPLETED|First Intervention||0
8467845|NCT00674115|20866225|P1|NOT COMPLETED|First Intervention||0
8467846|NCT00674115|20866222|P4|COMPLETED|First Intervention||16
8467847|NCT00674115|20866223|P3|COMPLETED|First Intervention||14
8467848|NCT00674115|20866224|P2|COMPLETED|First Intervention||16
8467849|NCT00674115|20866225|P1|COMPLETED|First Intervention||14
8467850|NCT00674115|20866222|P4|STARTED|First Intervention||16
8467851|NCT00674115|20866223|P3|STARTED|First Intervention||14
8467852|NCT00674115|20866224|P2|STARTED|First Intervention||16
8467853|NCT00674115|20866225|P1|STARTED|First Intervention||14
8467854|NCT00673959|20866234|P2|NOT COMPLETED|Overall Study||0
8467855|NCT00673959|20866235|P1|NOT COMPLETED|Overall Study||0
8467856|NCT00673959|20866234|P2|COMPLETED|Overall Study||10
8467857|NCT00673959|20866235|P1|COMPLETED|Overall Study||10
8467858|NCT00673959|20866234|P2|STARTED|Overall Study||10
8467859|NCT00673959|20866235|P1|STARTED|Overall Study||10
8467860|NCT00673933|20866241|P1|NOT COMPLETED|Overall Study||3
8467861|NCT00673933|20866241|P1|COMPLETED|Overall Study||17
8467862|NCT00673933|20866241|P1|STARTED|Overall Study||20
8467863|NCT00673920|20866265|P8|NOT COMPLETED|Week 24 to Week 48||0
8467864|NCT00673920|20866266|P7|NOT COMPLETED|Week 24 to Week 48||1
8467865|NCT00673920|20866267|P6|NOT COMPLETED|Week 24 to Week 48||3
8467866|NCT00673920|20866268|P5|NOT COMPLETED|Week 24 to Week 48||0
8467867|NCT00673920|20866269|P4|NOT COMPLETED|Week 24 to Week 48||1
8467868|NCT00673920|20866270|P3|NOT COMPLETED|Week 24 to Week 48||0
8467869|NCT00673920|20866271|P2|NOT COMPLETED|Week 24 to Week 48||0
8467870|NCT00673920|20866272|P1|NOT COMPLETED|Week 24 to Week 48||0
8467871|NCT00673920|20866265|P8|COMPLETED|Week 24 to Week 48||28
8467872|NCT00673920|20866266|P7|COMPLETED|Week 24 to Week 48||28
8467873|NCT00673920|20866267|P6|COMPLETED|Week 24 to Week 48||106
8467874|NCT00673920|20866268|P5|COMPLETED|Week 24 to Week 48||61
8467875|NCT00673920|20866269|P4|COMPLETED|Week 24 to Week 48||60
8467876|NCT00673920|20866270|P3|COMPLETED|Week 24 to Week 48||0
8467877|NCT00673920|20866271|P2|COMPLETED|Week 24 to Week 48||0
8467878|NCT00673920|20866272|P1|COMPLETED|Week 24 to Week 48||0
8467879|NCT00673920|20866265|P8|STARTED|Week 24 to Week 48||28
8467880|NCT00673920|20866266|P7|STARTED|Week 24 to Week 48||29
8467881|NCT00673920|20866267|P6|STARTED|Week 24 to Week 48||109
8467882|NCT00673920|20866268|P5|STARTED|Week 24 to Week 48||61
8467883|NCT00673920|20866269|P4|STARTED|Week 24 to Week 48||61
8467884|NCT00673920|20866270|P3|STARTED|Week 24 to Week 48||0
8467885|NCT00673920|20866271|P2|STARTED|Week 24 to Week 48||0
8467886|NCT00673920|20866272|P1|STARTED|Week 24 to Week 48||0
8467887|NCT00673920|20866265|P8|NOT COMPLETED|Baseline up to Week 48||0
8467888|NCT00673920|20866266|P7|NOT COMPLETED|Baseline up to Week 48||0
8467889|NCT00673920|20866267|P6|NOT COMPLETED|Baseline up to Week 48||0
8467890|NCT00673920|20866268|P5|NOT COMPLETED|Baseline up to Week 48||0
8467891|NCT00673920|20866269|P4|NOT COMPLETED|Baseline up to Week 48||0
8467892|NCT00673920|20866270|P3|NOT COMPLETED|Baseline up to Week 48||7
8467893|NCT00673920|20866271|P2|NOT COMPLETED|Baseline up to Week 48||3
8467894|NCT00673920|20866272|P1|NOT COMPLETED|Baseline up to Week 48||4
8467895|NCT00673920|20866265|P8|COMPLETED|Baseline up to Week 48||0
8467896|NCT00673920|20866266|P7|COMPLETED|Baseline up to Week 48||0
8467897|NCT00673920|20866267|P6|COMPLETED|Baseline up to Week 48||0
8467898|NCT00673920|20866268|P5|COMPLETED|Baseline up to Week 48||0
8467899|NCT00673920|20866269|P4|COMPLETED|Baseline up to Week 48||0
8467900|NCT00673920|20866270|P3|COMPLETED|Baseline up to Week 48||126
8467901|NCT00673920|20866271|P2|COMPLETED|Baseline up to Week 48||114
8467902|NCT00673920|20866272|P1|COMPLETED|Baseline up to Week 48||60
8467903|NCT00673920|20866265|P8|STARTED|Baseline up to Week 48||0
8467904|NCT00673920|20866266|P7|STARTED|Baseline up to Week 48||0
8467905|NCT00673920|20866267|P6|STARTED|Baseline up to Week 48||0
8467906|NCT00673920|20866268|P5|STARTED|Baseline up to Week 48||0
8467907|NCT00673920|20866269|P4|STARTED|Baseline up to Week 48||0
8467908|NCT00673920|20866270|P3|STARTED|Baseline up to Week 48||133
8467909|NCT00673920|20866271|P2|STARTED|Baseline up to Week 48||117
8467910|NCT00673920|20866272|P1|STARTED|Baseline up to Week 48||64
8467911|NCT00673894|20866418|P2|NOT COMPLETED|Second Intervention 4 Weeks||0
8467912|NCT00673894|20866419|P1|NOT COMPLETED|Second Intervention 4 Weeks||0
8467913|NCT00673894|20866418|P2|COMPLETED|Second Intervention 4 Weeks||7
8467914|NCT00673894|20866419|P1|COMPLETED|Second Intervention 4 Weeks||6
8467915|NCT00673894|20866418|P2|STARTED|Second Intervention 4 Weeks||7
8467916|NCT00673894|20866419|P1|STARTED|Second Intervention 4 Weeks||6
8467917|NCT00673894|20866418|P2|NOT COMPLETED|Washout 4-6 Weeks||0
8467918|NCT00673894|20866419|P1|NOT COMPLETED|Washout 4-6 Weeks||0
8467919|NCT00673894|20866418|P2|COMPLETED|Washout 4-6 Weeks||7
8467920|NCT00673894|20866419|P1|COMPLETED|Washout 4-6 Weeks||6
8467921|NCT00673894|20866418|P2|STARTED|Washout 4-6 Weeks||7
8467922|NCT00673894|20866419|P1|STARTED|Washout 4-6 Weeks||6
8467923|NCT00673894|20866418|P2|NOT COMPLETED|First Intervention 4 Weeks||0
8467924|NCT00673894|20866419|P1|NOT COMPLETED|First Intervention 4 Weeks||2
8467925|NCT00673894|20866418|P2|COMPLETED|First Intervention 4 Weeks||7
8467926|NCT00673894|20866419|P1|COMPLETED|First Intervention 4 Weeks||6
8467927|NCT00673894|20866418|P2|STARTED|First Intervention 4 Weeks||7
8467928|NCT00673894|20866419|P1|STARTED|First Intervention 4 Weeks||8
8467929|NCT00673881|20866427|P1|NOT COMPLETED|Overall Study||1
8467930|NCT00673881|20866427|P1|COMPLETED|Overall Study||24
8467931|NCT00673881|20866427|P1|STARTED|Overall Study||25
8467932|NCT00673855|20866434|P2|NOT COMPLETED|Second Intervention||0
8467933|NCT00673855|20866435|P1|NOT COMPLETED|Second Intervention||0
8467934|NCT00673855|20866434|P2|COMPLETED|Second Intervention||10
8467935|NCT00673855|20866435|P1|COMPLETED|Second Intervention||10
8467936|NCT00673855|20866434|P2|STARTED|Second Intervention||10
8467937|NCT00673855|20866435|P1|STARTED|Second Intervention||10
8467938|NCT00673855|20866434|P2|NOT COMPLETED|First Intervention||0
8467939|NCT00673855|20866435|P1|NOT COMPLETED|First Intervention||0
8467940|NCT00673855|20866434|P2|COMPLETED|First Intervention||10
8467941|NCT00673855|20866435|P1|COMPLETED|First Intervention||10
8467942|NCT00673855|20866434|P2|STARTED|First Intervention||10
8467943|NCT00673855|20866435|P1|STARTED|First Intervention||10
8467944|NCT00673816|20866441|P1|NOT COMPLETED|Overall Study||2
8467945|NCT00673816|20866441|P1|COMPLETED|Overall Study||0
8467946|NCT00673816|20866441|P1|STARTED|Overall Study||2
8467947|NCT00673790|20866451|P3|NOT COMPLETED|Overall Study||12
8467948|NCT00673790|20866452|P2|NOT COMPLETED|Overall Study||38
8467949|NCT00673790|20866453|P1|NOT COMPLETED|Overall Study||45
8467950|NCT00673790|20866451|P3|COMPLETED|Overall Study||90
8467951|NCT00673790|20866452|P2|COMPLETED|Overall Study||174
8467952|NCT00673790|20866453|P1|COMPLETED|Overall Study||178
8467953|NCT00673790|20866451|P3|STARTED|Overall Study||102
8467954|NCT00673790|20866452|P2|STARTED|Overall Study||212
8467955|NCT00673790|20866453|P1|STARTED|Overall Study||223
8467956|NCT00673764|20866463|P2|NOT COMPLETED|Overall Study||0
8467957|NCT00673764|20866464|P1|NOT COMPLETED|Overall Study||0
8467958|NCT00673764|20866463|P2|COMPLETED|Overall Study||24
8467959|NCT00673764|20866464|P1|COMPLETED|Overall Study||24
8467960|NCT00673764|20866463|P2|STARTED|Overall Study||24
8467961|NCT00673764|20866464|P1|STARTED|Overall Study||24
8467962|NCT00673738|20866472|P1|NOT COMPLETED|Overall Study||0
8467963|NCT00673738|20866472|P1|COMPLETED|Overall Study||27
8467964|NCT00673738|20866472|P1|STARTED|Overall Study||27
8467965|NCT00673712|20866480|P2|NOT COMPLETED|Overall Study||0
8467966|NCT00673712|20866481|P1|NOT COMPLETED|Overall Study||0
8467967|NCT00673712|20866480|P2|COMPLETED|Overall Study||326
8467968|NCT00673712|20866481|P1|COMPLETED|Overall Study||321
8467969|NCT00673712|20866480|P2|STARTED|Overall Study||326
8467970|NCT00673712|20866481|P1|STARTED|Overall Study||321
8467971|NCT00673673|20866491|P1|NOT COMPLETED|Overall Study||36
8467972|NCT00673673|20866491|P1|COMPLETED|Overall Study||3
8467973|NCT00673673|20866491|P1|STARTED|Overall Study||39
8467977|NCT00673595|20866510|P2|NOT COMPLETED|Overall Study||0
8467978|NCT00673595|20866511|P1|NOT COMPLETED|Overall Study||0
8467979|NCT00673595|20866510|P2|COMPLETED|Overall Study||11
8467980|NCT00673595|20866511|P1|COMPLETED|Overall Study||8
8467981|NCT00673595|20866510|P2|STARTED|Overall Study||11
8467982|NCT00673595|20866511|P1|STARTED|Overall Study||8
8467983|NCT00673465|20866519|P12|NOT COMPLETED|Part 2 (India)||0
8467984|NCT00673465|20866520|P11|NOT COMPLETED|Part 2 (India)||0
8467985|NCT00673465|20866521|P10|NOT COMPLETED|Part 2 (India)||0
8467986|NCT00673465|20866522|P9|NOT COMPLETED|Part 2 (India)||0
8467987|NCT00673465|20866523|P8|NOT COMPLETED|Part 2 (India)||0
8467988|NCT00673465|20866524|P7|NOT COMPLETED|Part 2 (India)||0
8467989|NCT00673465|20866525|P6|NOT COMPLETED|Part 2 (India)||0
8467990|NCT00673465|20866526|P5|NOT COMPLETED|Part 2 (India)||0
8467991|NCT00673465|20866527|P4|NOT COMPLETED|Part 2 (India)||0
8467992|NCT00673465|20866528|P3|NOT COMPLETED|Part 2 (India)||0
8467993|NCT00673465|20866529|P2|NOT COMPLETED|Part 2 (India)||0
8467994|NCT00673465|20866530|P1|NOT COMPLETED|Part 2 (India)||0
8467995|NCT00673465|20866519|P12|COMPLETED|Part 2 (India)||0
8467996|NCT00673465|20866520|P11|COMPLETED|Part 2 (India)||0
8467997|NCT00673465|20866521|P10|COMPLETED|Part 2 (India)||0
8467998|NCT00673465|20866522|P9|COMPLETED|Part 2 (India)||0
8467999|NCT00673465|20866523|P8|COMPLETED|Part 2 (India)||0
8468000|NCT00673465|20866524|P7|COMPLETED|Part 2 (India)||0
8468001|NCT00673465|20866525|P6|COMPLETED|Part 2 (India)||0
8468002|NCT00673465|20866526|P5|COMPLETED|Part 2 (India)||0
8468003|NCT00673465|20866527|P4|COMPLETED|Part 2 (India)||0
8468004|NCT00673465|20866528|P3|COMPLETED|Part 2 (India)||0
8468005|NCT00673465|20866529|P2|COMPLETED|Part 2 (India)||0
8468006|NCT00673465|20866530|P1|COMPLETED|Part 2 (India)||0
8468007|NCT00673465|20866519|P12|STARTED|Part 2 (India)||0
8468008|NCT00673465|20866520|P11|STARTED|Part 2 (India)||0
8468009|NCT00673465|20866521|P10|STARTED|Part 2 (India)||0
8468010|NCT00673465|20866522|P9|STARTED|Part 2 (India)||0
8468011|NCT00673465|20866523|P8|STARTED|Part 2 (India)||0
8468012|NCT00673465|20866524|P7|STARTED|Part 2 (India)||0
8468013|NCT00673465|20866525|P6|STARTED|Part 2 (India)||0
8468014|NCT00673465|20866526|P5|STARTED|Part 2 (India)||0
8468015|NCT00673465|20866527|P4|STARTED|Part 2 (India)||0
8468016|NCT00673465|20866528|P3|STARTED|Part 2 (India)||0
8468017|NCT00673465|20866529|P2|STARTED|Part 2 (India)||0
8468018|NCT00673465|20866530|P1|STARTED|Part 2 (India)||0
8468019|NCT00673465|20866519|P12|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468020|NCT00673465|20866520|P11|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468021|NCT00673465|20866521|P10|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468022|NCT00673465|20866522|P9|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468023|NCT00673465|20866523|P8|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468024|NCT00673465|20866524|P7|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468025|NCT00673465|20866525|P6|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468026|NCT00673465|20866526|P5|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468027|NCT00673465|20866527|P4|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468028|NCT00673465|20866528|P3|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468029|NCT00673465|20866529|P2|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468030|NCT00673465|20866530|P1|NOT COMPLETED|Part 1/Period 3 (United States)||0
8468031|NCT00673465|20866519|P12|COMPLETED|Part 1/Period 3 (United States)||0
8468032|NCT00673465|20866520|P11|COMPLETED|Part 1/Period 3 (United States)||0
8468033|NCT00673465|20866521|P10|COMPLETED|Part 1/Period 3 (United States)||0
8468034|NCT00673465|20866522|P9|COMPLETED|Part 1/Period 3 (United States)||0
8468035|NCT00673465|20866523|P8|COMPLETED|Part 1/Period 3 (United States)||0
8468036|NCT00673465|20866524|P7|COMPLETED|Part 1/Period 3 (United States)||0
8468037|NCT00673465|20866525|P6|COMPLETED|Part 1/Period 3 (United States)||1
8468038|NCT00673465|20866526|P5|COMPLETED|Part 1/Period 3 (United States)||1
8468039|NCT00673465|20866527|P4|COMPLETED|Part 1/Period 3 (United States)||3
8468040|NCT00673465|20866528|P3|COMPLETED|Part 1/Period 3 (United States)||3
8468041|NCT00673465|20866529|P2|COMPLETED|Part 1/Period 3 (United States)||3
8468042|NCT00673465|20866530|P1|COMPLETED|Part 1/Period 3 (United States)||3
8468043|NCT00673465|20866519|P12|STARTED|Part 1/Period 3 (United States)||0
8468044|NCT00673465|20866520|P11|STARTED|Part 1/Period 3 (United States)||0
8468045|NCT00673465|20866521|P10|STARTED|Part 1/Period 3 (United States)||0
8468046|NCT00673465|20866522|P9|STARTED|Part 1/Period 3 (United States)||0
8468047|NCT00673465|20866523|P8|STARTED|Part 1/Period 3 (United States)||0
8468048|NCT00673465|20866524|P7|STARTED|Part 1/Period 3 (United States)||0
8468049|NCT00673465|20866525|P6|STARTED|Part 1/Period 3 (United States)||1
8468050|NCT00673465|20866526|P5|STARTED|Part 1/Period 3 (United States)||1
8468051|NCT00673465|20866527|P4|STARTED|Part 1/Period 3 (United States)||3
8468052|NCT00673465|20866528|P3|STARTED|Part 1/Period 3 (United States)||3
8468053|NCT00673465|20866529|P2|STARTED|Part 1/Period 3 (United States)||3
8468054|NCT00673465|20866530|P1|STARTED|Part 1/Period 3 (United States)||3
8468055|NCT00673465|20866519|P12|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468056|NCT00673465|20866520|P11|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468057|NCT00673465|20866521|P10|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468058|NCT00673465|20866522|P9|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468059|NCT00673465|20866523|P8|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468060|NCT00673465|20866524|P7|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468061|NCT00673465|20866525|P6|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468062|NCT00673465|20866526|P5|NOT COMPLETED|Part 1/Period 2 (United States)||1
8468063|NCT00673465|20866527|P4|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468064|NCT00673465|20866528|P3|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468065|NCT00673465|20866529|P2|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468066|NCT00673465|20866530|P1|NOT COMPLETED|Part 1/Period 2 (United States)||0
8468067|NCT00673465|20866519|P12|COMPLETED|Part 1/Period 2 (United States)||0
8468068|NCT00673465|20866520|P11|COMPLETED|Part 1/Period 2 (United States)||0
8468069|NCT00673465|20866521|P10|COMPLETED|Part 1/Period 2 (United States)||0
8468070|NCT00673465|20866522|P9|COMPLETED|Part 1/Period 2 (United States)||0
8468071|NCT00673465|20866523|P8|COMPLETED|Part 1/Period 2 (United States)||0
8468072|NCT00673465|20866524|P7|COMPLETED|Part 1/Period 2 (United States)||0
8468073|NCT00673465|20866525|P6|COMPLETED|Part 1/Period 2 (United States)||1
8468074|NCT00673465|20866526|P5|COMPLETED|Part 1/Period 2 (United States)||1
8468075|NCT00673465|20866527|P4|COMPLETED|Part 1/Period 2 (United States)||3
8468076|NCT00673465|20866528|P3|COMPLETED|Part 1/Period 2 (United States)||3
8468077|NCT00673465|20866529|P2|COMPLETED|Part 1/Period 2 (United States)||3
8468078|NCT00673465|20866530|P1|COMPLETED|Part 1/Period 2 (United States)||3
8468079|NCT00673465|20866519|P12|STARTED|Part 1/Period 2 (United States)||0
8468080|NCT00673465|20866520|P11|STARTED|Part 1/Period 2 (United States)||0
8468081|NCT00673465|20866521|P10|STARTED|Part 1/Period 2 (United States)||0
8468082|NCT00673465|20866522|P9|STARTED|Part 1/Period 2 (United States)||0
8468083|NCT00673465|20866523|P8|STARTED|Part 1/Period 2 (United States)||0
8468084|NCT00673465|20866524|P7|STARTED|Part 1/Period 2 (United States)||0
8468085|NCT00673465|20866525|P6|STARTED|Part 1/Period 2 (United States)||1
8468086|NCT00673465|20866526|P5|STARTED|Part 1/Period 2 (United States)||2
8468087|NCT00673465|20866527|P4|STARTED|Part 1/Period 2 (United States)||3
8468088|NCT00673465|20866528|P3|STARTED|Part 1/Period 2 (United States)||3
8468089|NCT00673465|20866529|P2|STARTED|Part 1/Period 2 (United States)||3
8468090|NCT00673465|20866530|P1|STARTED|Part 1/Period 2 (United States)||3
8468091|NCT00673465|20866519|P12|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468092|NCT00673465|20866520|P11|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468093|NCT00673465|20866521|P10|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468094|NCT00673465|20866522|P9|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468095|NCT00673465|20866523|P8|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468096|NCT00673465|20866524|P7|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468097|NCT00673465|20866525|P6|NOT COMPLETED|Part 1/Period 1 (United States)||1
8468098|NCT00673465|20866526|P5|NOT COMPLETED|Part 1/Period 1 (United States)||1
8468099|NCT00673465|20866527|P4|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468100|NCT00673465|20866528|P3|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468101|NCT00673465|20866529|P2|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468102|NCT00673465|20866530|P1|NOT COMPLETED|Part 1/Period 1 (United States)||0
8468103|NCT00673465|20866519|P12|COMPLETED|Part 1/Period 1 (United States)||0
8468104|NCT00673465|20866520|P11|COMPLETED|Part 1/Period 1 (United States)||0
8468105|NCT00673465|20866521|P10|COMPLETED|Part 1/Period 1 (United States)||0
8468106|NCT00673465|20866522|P9|COMPLETED|Part 1/Period 1 (United States)||0
8468107|NCT00673465|20866523|P8|COMPLETED|Part 1/Period 1 (United States)||0
8468108|NCT00673465|20866524|P7|COMPLETED|Part 1/Period 1 (United States)||0
8468109|NCT00673465|20866525|P6|COMPLETED|Part 1/Period 1 (United States)||1
8468110|NCT00673465|20866526|P5|COMPLETED|Part 1/Period 1 (United States)||2
8468111|NCT00673465|20866527|P4|COMPLETED|Part 1/Period 1 (United States)||3
8468112|NCT00673465|20866528|P3|COMPLETED|Part 1/Period 1 (United States)||3
8468113|NCT00673465|20866529|P2|COMPLETED|Part 1/Period 1 (United States)||3
8468114|NCT00673465|20866530|P1|COMPLETED|Part 1/Period 1 (United States)||3
8468115|NCT00673465|20866519|P12|STARTED|Part 1/Period 1 (United States)||0
8468116|NCT00673465|20866520|P11|STARTED|Part 1/Period 1 (United States)||0
8468117|NCT00673465|20866521|P10|STARTED|Part 1/Period 1 (United States)||0
8468118|NCT00673465|20866522|P9|STARTED|Part 1/Period 1 (United States)||0
8468119|NCT00673465|20866523|P8|STARTED|Part 1/Period 1 (United States)||0
8468120|NCT00673465|20866524|P7|STARTED|Part 1/Period 1 (United States)||0
8468121|NCT00673465|20866525|P6|STARTED|Part 1/Period 1 (United States)||2
8468122|NCT00673465|20866526|P5|STARTED|Part 1/Period 1 (United States)||3
8468123|NCT00673465|20866527|P4|STARTED|Part 1/Period 1 (United States)||3
8468124|NCT00673465|20866528|P3|STARTED|Part 1/Period 1 (United States)||3
8468125|NCT00673465|20866529|P2|STARTED|Part 1/Period 1 (United States)||3
8468126|NCT00673465|20866530|P1|STARTED|Part 1/Period 1 (United States)||3
8468127|NCT00673452|20866579|P2|NOT COMPLETED|Continuation Double-Blind Phase||34
8468128|NCT00673452|20866580|P1|NOT COMPLETED|Continuation Double-Blind Phase||25
8468129|NCT00673452|20866579|P2|COMPLETED|Continuation Double-Blind Phase||153
8468130|NCT00673452|20866580|P1|COMPLETED|Continuation Double-Blind Phase||151
8468131|NCT00673452|20866579|P2|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
8468132|NCT00673452|20866580|P1|STARTED|Continuation Double-Blind Phase||176
8468133|NCT00673452|20866579|P2|NOT COMPLETED|Acute Double-Blind Phase||80
8468134|NCT00673452|20866580|P1|NOT COMPLETED|Acute Double-Blind Phase||87
8468135|NCT00673452|20866579|P2|COMPLETED|Acute Double-Blind Phase||187
8468136|NCT00673452|20866580|P1|COMPLETED|Acute Double-Blind Phase||176
8468137|NCT00673452|20866579|P2|STARTED|Acute Double-Blind Phase||267
8468138|NCT00673452|20866580|P1|STARTED|Acute Double-Blind Phase||263
8468139|NCT00673439|20866614|P1|NOT COMPLETED|Overall Study||0
8468140|NCT00673439|20866614|P1|COMPLETED|Overall Study||3
8468141|NCT00673439|20866614|P1|STARTED|Overall Study||3
8468142|NCT00673400|20866619|P1|NOT COMPLETED|Overall Study||0
8468143|NCT00673400|20866619|P1|COMPLETED|Overall Study||52
8468144|NCT00673400|20866619|P1|STARTED|Overall Study||52
8468145|NCT00673387|20866644|P8|NOT COMPLETED|Overall Study||35
8468146|NCT00673387|20866645|P7|NOT COMPLETED|Overall Study||30
8468147|NCT00673387|20866646|P6|NOT COMPLETED|Overall Study||34
8468148|NCT00673387|20866647|P5|NOT COMPLETED|Overall Study||30
8468149|NCT00673387|20866648|P4|NOT COMPLETED|Overall Study||26
8468150|NCT00673387|20866649|P3|NOT COMPLETED|Overall Study||31
8468151|NCT00673387|20866650|P2|NOT COMPLETED|Overall Study||23
8468152|NCT00673387|20866651|P1|NOT COMPLETED|Overall Study||29
8468153|NCT00673387|20866644|P8|COMPLETED|Overall Study||40
8468154|NCT00673387|20866645|P7|COMPLETED|Overall Study||48
8468155|NCT00673387|20866646|P6|COMPLETED|Overall Study||44
8468156|NCT00673387|20866647|P5|COMPLETED|Overall Study||48
8468157|NCT00673387|20866648|P4|COMPLETED|Overall Study||49
8468158|NCT00673387|20866649|P3|COMPLETED|Overall Study||41
8468159|NCT00673387|20866650|P2|COMPLETED|Overall Study||54
8468160|NCT00673387|20866651|P1|COMPLETED|Overall Study||46
8468161|NCT00673387|20866644|P8|STARTED|Overall Study||75
8468162|NCT00673387|20866645|P7|STARTED|Overall Study||78
8468163|NCT00673387|20866646|P6|STARTED|Overall Study||78
8468164|NCT00673387|20866647|P5|STARTED|Overall Study||78
8468165|NCT00673387|20866648|P4|STARTED|Overall Study||75
8468166|NCT00673387|20866649|P3|STARTED|Overall Study||72
8468167|NCT00673387|20866650|P2|STARTED|Overall Study||77
8468168|NCT00673387|20866651|P1|STARTED|Overall Study||75
8468169|NCT00673361|20866867|P1|NOT COMPLETED|Overall Study||2
8468170|NCT00673361|20866867|P1|COMPLETED|Overall Study||7
8468171|NCT00673361|20866867|P1|STARTED|Overall Study||9
8468172|NCT00673309|20866881|P10|NOT COMPLETED|Overall Study||0
8468173|NCT00673309|20866882|P9|NOT COMPLETED|Overall Study||0
8468174|NCT00673309|20866883|P8|NOT COMPLETED|Overall Study||0
8468175|NCT00673309|20866884|P7|NOT COMPLETED|Overall Study||0
8468176|NCT00673309|20866885|P6|NOT COMPLETED|Overall Study||0
8468177|NCT00673309|20866886|P5|NOT COMPLETED|Overall Study||0
8468178|NCT00673309|20866887|P4|NOT COMPLETED|Overall Study||0
8468179|NCT00673309|20866888|P3|NOT COMPLETED|Overall Study||0
8468180|NCT00673309|20866889|P2|NOT COMPLETED|Overall Study||0
8468181|NCT00673309|20866890|P1|NOT COMPLETED|Overall Study||0
8468182|NCT00673309|20866881|P10|COMPLETED|Overall Study||30
8468183|NCT00673309|20866882|P9|COMPLETED|Overall Study||17
8468184|NCT00673309|20866883|P8|COMPLETED|Overall Study||13
8468185|NCT00673309|20866884|P7|COMPLETED|Overall Study||14
8468186|NCT00673309|20866885|P6|COMPLETED|Overall Study||35
8468187|NCT00673309|20866886|P5|COMPLETED|Overall Study||18
8468188|NCT00673309|20866887|P4|COMPLETED|Overall Study||25
8468189|NCT00673309|20866888|P3|COMPLETED|Overall Study||14
8468190|NCT00673309|20866889|P2|COMPLETED|Overall Study||14
8468191|NCT00673309|20866890|P1|COMPLETED|Overall Study||64
8468192|NCT00673309|20866881|P10|STARTED|Overall Study||30
8468193|NCT00673309|20866882|P9|STARTED|Overall Study||17
8468194|NCT00673309|20866883|P8|STARTED|Overall Study||13
8468195|NCT00673309|20866884|P7|STARTED|Overall Study||14
8468196|NCT00673309|20866885|P6|STARTED|Overall Study||35
8468197|NCT00673309|20866886|P5|STARTED|Overall Study||18
8468198|NCT00673309|20866887|P4|STARTED|Overall Study||25
8468199|NCT00673309|20866888|P3|STARTED|Overall Study||14
8468200|NCT00673309|20866889|P2|STARTED|Overall Study||14
8468201|NCT00673309|20866890|P1|STARTED|Overall Study||64
8468202|NCT00673257|20866903|P1|NOT COMPLETED|Overall Study||5
8468203|NCT00673257|20866903|P1|COMPLETED|Overall Study||102
8468204|NCT00673257|20866903|P1|STARTED|Overall Study||107
8468205|NCT00673244|20866910|P2|NOT COMPLETED|Overall Study||0
8468206|NCT00673244|20866911|P1|NOT COMPLETED|Overall Study||0
8468207|NCT00673244|20866910|P2|COMPLETED|Overall Study||25
8468208|NCT00673244|20866911|P1|COMPLETED|Overall Study||52
8468209|NCT00673244|20866910|P2|STARTED|Overall Study||25
8468210|NCT00673244|20866911|P1|STARTED|Overall Study||52
8468211|NCT00673231|20866921|P4|NOT COMPLETED|Overall Study||18
8468212|NCT00673231|20866922|P3|NOT COMPLETED|Overall Study||26
8468213|NCT00673231|20866923|P2|NOT COMPLETED|Overall Study||22
8468214|NCT00673231|20866924|P1|NOT COMPLETED|Overall Study||29
8468215|NCT00673231|20866921|P4|COMPLETED|Overall Study||178
8468216|NCT00673231|20866922|P3|COMPLETED|Overall Study||186
8468217|NCT00673231|20866923|P2|COMPLETED|Overall Study||180
8468218|NCT00673231|20866924|P1|COMPLETED|Overall Study||168
8468219|NCT00673231|20866921|P4|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
8468220|NCT00673231|20866922|P3|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
8468221|NCT00673231|20866923|P2|STARTED|Overall Study|All 202 were included in the full analysis set|202
8468222|NCT00673231|20866924|P1|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
8468223|NCT00673179|20866956|P2|NOT COMPLETED|Overall Study||0
8468224|NCT00673179|20866957|P1|NOT COMPLETED|Overall Study||3
8468225|NCT00673179|20866956|P2|COMPLETED|Overall Study||0
8468226|NCT00673179|20866957|P1|COMPLETED|Overall Study||4
8468227|NCT00673179|20866956|P2|STARTED|Overall Study||0
8468228|NCT00673179|20866957|P1|STARTED|Overall Study||7
8468229|NCT00673153|20866963|P1|NOT COMPLETED|Overall Study||1
8468230|NCT00673153|20866963|P1|COMPLETED|Overall Study||30
8468231|NCT00673153|20866963|P1|STARTED|Overall Study||31
8468232|NCT00673127|20866971|P1|NOT COMPLETED|Overall Study||0
8468233|NCT00673127|20866971|P1|COMPLETED|Overall Study||57
8468234|NCT00673127|20866971|P1|STARTED|Overall Study||57
8468235|NCT00673114|20866976|P1|NOT COMPLETED|Overall Study||0
8468236|NCT00673114|20866976|P1|COMPLETED|Overall Study||3
8468237|NCT00673114|20866976|P1|STARTED|Overall Study||3
8468238|NCT00673075|20866989|P2|NOT COMPLETED|Overall Study||7
8468239|NCT00673075|20866990|P1|NOT COMPLETED|Overall Study||9
8468240|NCT00673075|20866989|P2|COMPLETED|Overall Study||11
8468241|NCT00673075|20866990|P1|COMPLETED|Overall Study||12
8468242|NCT00673075|20866989|P2|STARTED|Overall Study||18
8468243|NCT00673075|20866990|P1|STARTED|Overall Study||21
8468244|NCT00673049|20867006|P4|NOT COMPLETED|After Progression on Erlotinib||83
8468245|NCT00673049|20867007|P3|NOT COMPLETED|After Progression on Erlotinib||0
8468246|NCT00673049|20867008|P2|NOT COMPLETED|After Progression on Erlotinib||0
8468247|NCT00673049|20867009|P1|NOT COMPLETED|After Progression on Erlotinib||0
8468248|NCT00673049|20867006|P4|COMPLETED|After Progression on Erlotinib||0
8468249|NCT00673049|20867007|P3|COMPLETED|After Progression on Erlotinib||0
8468250|NCT00673049|20867008|P2|COMPLETED|After Progression on Erlotinib||0
8468251|NCT00673049|20867009|P1|COMPLETED|After Progression on Erlotinib||0
8468252|NCT00673049|20867006|P4|STARTED|After Progression on Erlotinib||83
8468253|NCT00673049|20867007|P3|STARTED|After Progression on Erlotinib||0
8468254|NCT00673049|20867008|P2|STARTED|After Progression on Erlotinib||0
8468255|NCT00673049|20867009|P1|STARTED|After Progression on Erlotinib||0
8468256|NCT00673049|20867006|P4|NOT COMPLETED|Before Progression on Erlotinib||0
8468257|NCT00673049|20867007|P3|NOT COMPLETED|Before Progression on Erlotinib||1
8468258|NCT00673049|20867008|P2|NOT COMPLETED|Before Progression on Erlotinib||290
8468259|NCT00673049|20867009|P1|NOT COMPLETED|Before Progression on Erlotinib||292
8468260|NCT00673049|20867006|P4|COMPLETED|Before Progression on Erlotinib||0
8468261|NCT00673049|20867007|P3|COMPLETED|Before Progression on Erlotinib||0
8468262|NCT00673049|20867008|P2|COMPLETED|Before Progression on Erlotinib||0
8468263|NCT00673049|20867009|P1|COMPLETED|Before Progression on Erlotinib||0
8468264|NCT00673049|20867006|P4|Treated|Before Progression on Erlotinib||0
8468265|NCT00673049|20867007|P3|Treated|Before Progression on Erlotinib||1
8468266|NCT00673049|20867008|P2|Treated|Before Progression on Erlotinib||289
8468267|NCT00673049|20867009|P1|Treated|Before Progression on Erlotinib||289
8468268|NCT00673049|20867006|P4|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
8468269|NCT00673049|20867007|P3|STARTED|Before Progression on Erlotinib||1
8468270|NCT00673049|20867008|P2|STARTED|Before Progression on Erlotinib||290
8468271|NCT00673049|20867009|P1|STARTED|Before Progression on Erlotinib||292
8468299|NCT00672958|20867086|P2|NOT COMPLETED|Overall Study||56
8468300|NCT00672958|20867087|P1|NOT COMPLETED|Overall Study||64
8468301|NCT00672958|20867086|P2|COMPLETED|Overall Study||244
8468302|NCT00672958|20867087|P1|COMPLETED|Overall Study||236
8468303|NCT00672958|20867086|P2|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
8468304|NCT00672958|20867087|P1|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
8468305|NCT00672958|20867086|P2|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
8468306|NCT00672958|20867087|P1|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
8468307|NCT00672958|20867086|P2|STARTED|Overall Study||300
8468308|NCT00672958|20867087|P1|STARTED|Overall Study||300
8468309|NCT00672932|20867119|P2|NOT COMPLETED|Overall Study||0
8468310|NCT00672932|20867120|P1|NOT COMPLETED|Overall Study||0
8468311|NCT00672932|20867119|P2|COMPLETED|Overall Study||9
8468312|NCT00672932|20867120|P1|COMPLETED|Overall Study||9
8468313|NCT00672932|20867119|P2|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
8468314|NCT00672932|20867120|P1|Rolled Over to Raltegravir|Overall Study||0
8468315|NCT00672932|20867119|P2|Provided Analyzable Blood and CSF Sample|Overall Study||9
8468316|NCT00672932|20867120|P1|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
8468317|NCT00672932|20867119|P2|Completed Initial 12-week Assignment|Overall Study||9
8468318|NCT00672932|20867120|P1|Completed Initial 12-week Assignment|Overall Study||9
8468319|NCT00672932|20867119|P2|STARTED|Overall Study||9
8468320|NCT00672932|20867120|P1|STARTED|Overall Study||9
8468321|NCT00672854|20867130|P2|NOT COMPLETED|Overall Study||0
8468322|NCT00672854|20867131|P1|NOT COMPLETED|Overall Study||0
8468323|NCT00672854|20867130|P2|COMPLETED|Overall Study||51
8468324|NCT00672854|20867131|P1|COMPLETED|Overall Study||49
8468325|NCT00672854|20867130|P2|STARTED|Overall Study||51
8468326|NCT00672854|20867131|P1|STARTED|Overall Study||49
8468327|NCT00672841|20867153|P2|NOT COMPLETED|Overall Study||15
8468328|NCT00672841|20867154|P1|NOT COMPLETED|Overall Study||1
8468329|NCT00672841|20867153|P2|COMPLETED|Overall Study||32
8468330|NCT00672841|20867154|P1|COMPLETED|Overall Study||16
8468331|NCT00672841|20867153|P2|STARTED|Overall Study||47
8468332|NCT00672841|20867154|P1|STARTED|Overall Study||17
8468333|NCT00672737|20867166|P1|NOT COMPLETED|Overall Study||8
8468334|NCT00672737|20867166|P1|COMPLETED|Overall Study||48
8468335|NCT00672737|20867166|P1|STARTED|Overall Study||56
8468336|NCT00672646|20867176|P3|NOT COMPLETED|Overall Study||3
8468337|NCT00672646|20867177|P2|NOT COMPLETED|Overall Study||1
8468338|NCT00672646|20867178|P1|NOT COMPLETED|Overall Study||0
8468339|NCT00672646|20867176|P3|COMPLETED|Overall Study||37
8468340|NCT00672646|20867177|P2|COMPLETED|Overall Study||22
8468341|NCT00672646|20867178|P1|COMPLETED|Overall Study||40
8468342|NCT00672646|20867176|P3|STARTED|Overall Study||40
8468343|NCT00672646|20867177|P2|STARTED|Overall Study||23
8468344|NCT00672646|20867178|P1|STARTED|Overall Study||40
8468345|NCT00672633|20867203|P2|NOT COMPLETED|Overall Study||1
8468346|NCT00672633|20867204|P1|NOT COMPLETED|Overall Study||0
8468347|NCT00672633|20867203|P2|COMPLETED|Overall Study||12
8468348|NCT00672633|20867204|P1|COMPLETED|Overall Study||12
8468349|NCT00672633|20867203|P2|STARTED|Overall Study||13
8468350|NCT00672633|20867204|P1|STARTED|Overall Study||12
8468351|NCT00672620|20867218|P4|NOT COMPLETED|Overall Study||42
8468352|NCT00672620|20867219|P3|NOT COMPLETED|Overall Study||31
8468353|NCT00672620|20867220|P2|NOT COMPLETED|Overall Study||54
8468354|NCT00672620|20867221|P1|NOT COMPLETED|Overall Study||33
8468355|NCT00672620|20867218|P4|COMPLETED|Overall Study||110
8468356|NCT00672620|20867219|P3|COMPLETED|Overall Study||122
8468357|NCT00672620|20867220|P2|COMPLETED|Overall Study||99
8468358|NCT00672620|20867221|P1|COMPLETED|Overall Study||120
8468359|NCT00672620|20867218|P4|Treated|Overall Study||150
8468360|NCT00672620|20867219|P3|Treated|Overall Study||153
8468361|NCT00672620|20867220|P2|Treated|Overall Study||149
8468362|NCT00672620|20867221|P1|Treated|Overall Study||151
8468363|NCT00672620|20867218|P4|STARTED|Overall Study||152
8468364|NCT00672620|20867219|P3|STARTED|Overall Study||153
8468365|NCT00672620|20867220|P2|STARTED|Overall Study||153
8468366|NCT00672620|20867221|P1|STARTED|Overall Study||153
8468367|NCT00672594|20867275|P1|NOT COMPLETED|Overall Study||3
8468368|NCT00672594|20867275|P1|COMPLETED|Overall Study||27
8468369|NCT00672594|20867275|P1|STARTED|Overall Study||30
8468370|NCT00672555|20867286|P1|NOT COMPLETED|Overall Study||6
8468371|NCT00672555|20867286|P1|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
8468372|NCT00672555|20867286|P1|STARTED|Overall Study||70
8468373|NCT00672490|20867297|P2|NOT COMPLETED|Overall Study||32
8468374|NCT00672490|20867298|P1|NOT COMPLETED|Overall Study||24
8468375|NCT00672490|20867297|P2|COMPLETED|Overall Study||157
8468376|NCT00672490|20867298|P1|COMPLETED|Overall Study||163
8468377|NCT00672490|20867297|P2|STARTED|Overall Study||189
8468378|NCT00672490|20867298|P1|STARTED|Overall Study||187
8468379|NCT00672477|20867322|P2|NOT COMPLETED|Overall Study||26
8468380|NCT00672477|20867323|P1|NOT COMPLETED|Overall Study||27
8468381|NCT00672477|20867322|P2|COMPLETED|Overall Study||88
8468382|NCT00672477|20867323|P1|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
8468383|NCT00672477|20867322|P2|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
8468384|NCT00672477|20867323|P1|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
8468385|NCT00672451|20867333|P2|NOT COMPLETED|Overall Study||0
8468386|NCT00672451|20867334|P1|NOT COMPLETED|Overall Study||0
8468387|NCT00672451|20867333|P2|COMPLETED|Overall Study||2
8468388|NCT00672451|20867334|P1|COMPLETED|Overall Study||1
8468389|NCT00672451|20867333|P2|STARTED|Overall Study||2
8468390|NCT00672451|20867334|P1|STARTED|Overall Study||1
8468391|NCT00672438|20867344|P2|NOT COMPLETED|Infusion 2||0
8468392|NCT00672438|20867345|P1|NOT COMPLETED|Infusion 2||0
8468393|NCT00672438|20867344|P2|COMPLETED|Infusion 2||118
8468394|NCT00672438|20867345|P1|COMPLETED|Infusion 2||119
8468395|NCT00672438|20867344|P2|STARTED|Infusion 2||118
8468396|NCT00672438|20867345|P1|STARTED|Infusion 2||119
8468397|NCT00672438|20867344|P2|NOT COMPLETED|Washout||0
8468398|NCT00672438|20867345|P1|NOT COMPLETED|Washout||0
8468399|NCT00672438|20867344|P2|COMPLETED|Washout||118
8468400|NCT00672438|20867345|P1|COMPLETED|Washout||119
8468401|NCT00672438|20867344|P2|STARTED|Washout||118
8468402|NCT00672438|20867345|P1|STARTED|Washout||119
8468403|NCT00672438|20867344|P2|NOT COMPLETED|Infusion 1||0
8468404|NCT00672438|20867345|P1|NOT COMPLETED|Infusion 1||0
8468405|NCT00672438|20867344|P2|COMPLETED|Infusion 1||118
8468406|NCT00672438|20867345|P1|COMPLETED|Infusion 1||119
8468407|NCT00672438|20867344|P2|STARTED|Infusion 1||118
8468408|NCT00672438|20867345|P1|STARTED|Infusion 1||119
8468409|NCT00672256|20867376|P1|NOT COMPLETED|Overall Study||44
8468410|NCT00672256|20867376|P1|COMPLETED|Overall Study||18
8468411|NCT00672256|20867376|P1|STARTED|Overall Study|January 2007|62
8468412|NCT00672243|20867383|P1|NOT COMPLETED|Overall Study||0
8468413|NCT00672243|20867383|P1|COMPLETED|Overall Study||32
8468414|NCT00672243|20867383|P1|STARTED|Overall Study||32
8468415|NCT00672204|20867391|P1|NOT COMPLETED|Overall Study||20
8468416|NCT00672204|20867391|P1|COMPLETED|Overall Study||3
8468417|NCT00672204|20867391|P1|STARTED|Overall Study||23
8468418|NCT00672178|20867395|P1|NOT COMPLETED|Overall Study||0
8468419|NCT00672178|20867395|P1|COMPLETED|Overall Study||1
8468420|NCT00672178|20867395|P1|STARTED|Overall Study||1
8468421|NCT00672139|20867401|P2|NOT COMPLETED|Overall Study||45
8468422|NCT00672139|20867402|P1|NOT COMPLETED|Overall Study||30
8468423|NCT00672139|20867401|P2|COMPLETED|Overall Study||47
8468424|NCT00672139|20867402|P1|COMPLETED|Overall Study||27
8468425|NCT00672139|20867401|P2|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
8468426|NCT00672139|20867402|P1|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
8468427|NCT00672100|20867411|P3|NOT COMPLETED|Overall Study||0
8468428|NCT00672100|20867412|P2|NOT COMPLETED|Overall Study||0
8468429|NCT00672100|20867413|P1|NOT COMPLETED|Overall Study||0
8468430|NCT00672100|20867411|P3|COMPLETED|Overall Study||12
8468431|NCT00672100|20867412|P2|COMPLETED|Overall Study||12
8468432|NCT00672100|20867413|P1|COMPLETED|Overall Study||12
8468433|NCT00672100|20867411|P3|PACU (Within 8 Hours)|Overall Study||12
8468434|NCT00672100|20867412|P2|PACU (Within 8 Hours)|Overall Study||12
8468435|NCT00672100|20867413|P1|PACU (Within 8 Hours)|Overall Study||12
8468436|NCT00672100|20867411|P3|STARTED|Overall Study||12
8468437|NCT00672100|20867412|P2|STARTED|Overall Study||12
8468438|NCT00672100|20867413|P1|STARTED|Overall Study||12
8468439|NCT00671970|20867430|P2|NOT COMPLETED|Overall Study||0
8468440|NCT00671970|20867431|P1|NOT COMPLETED|Overall Study||0
8468441|NCT00671970|20867430|P2|COMPLETED|Overall Study||25
8468442|NCT00671970|20867431|P1|COMPLETED|Overall Study||32
8468443|NCT00671970|20867430|P2|STARTED|Overall Study||25
8468444|NCT00671970|20867431|P1|STARTED|Overall Study||32
8468445|NCT00671931|20867459|P5|NOT COMPLETED|Overall Study||1
8468446|NCT00671931|20867460|P4|NOT COMPLETED|Overall Study||2
8468447|NCT00671931|20867461|P3|NOT COMPLETED|Overall Study||0
8468448|NCT00671931|20867462|P2|NOT COMPLETED|Overall Study||0
8468449|NCT00671931|20867463|P1|NOT COMPLETED|Overall Study||1
8468450|NCT00671931|20867459|P5|COMPLETED|Overall Study|Low heart rate requiring treatment|7
8468451|NCT00671931|20867460|P4|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
8468452|NCT00671931|20867461|P3|COMPLETED|Overall Study|all completed|9
8468453|NCT00671931|20867462|P2|COMPLETED|Overall Study|All completed|8
8468454|NCT00671931|20867463|P1|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
8468455|NCT00671931|20867459|P5|STARTED|Overall Study||8
8468456|NCT00671931|20867460|P4|STARTED|Overall Study||10
8468457|NCT00671931|20867461|P3|STARTED|Overall Study||9
8468458|NCT00671931|20867462|P2|STARTED|Overall Study||8
8468459|NCT00671931|20867463|P1|STARTED|Overall Study||9
8468460|NCT00671918|20867475|P1|NOT COMPLETED|Overall Study||17
8468461|NCT00671918|20867475|P1|COMPLETED|Overall Study||169
8468462|NCT00671918|20867475|P1|STARTED|Overall Study||186
8468463|NCT00671879|20867483|P3|NOT COMPLETED|Overall Study||6
8468464|NCT00671879|20867484|P2|NOT COMPLETED|Overall Study||4
8468465|NCT00671879|20867485|P1|NOT COMPLETED|Overall Study||0
8468466|NCT00671879|20867483|P3|COMPLETED|Overall Study||274
8468467|NCT00671879|20867484|P2|COMPLETED|Overall Study||275
8468468|NCT00671879|20867485|P1|COMPLETED|Overall Study||281
8468469|NCT00671879|20867483|P3|STARTED|Overall Study||280
8468470|NCT00671879|20867484|P2|STARTED|Overall Study||279
8468471|NCT00671879|20867485|P1|STARTED|Overall Study||281
8468472|NCT00671853|20867498|P2|NOT COMPLETED|Overall Study||27
8468473|NCT00671853|20867499|P1|NOT COMPLETED|Overall Study||20
8468474|NCT00671853|20867498|P2|COMPLETED|Overall Study||18
8468475|NCT00671853|20867499|P1|COMPLETED|Overall Study||26
8468476|NCT00671853|20867498|P2|STARTED|Overall Study||45
8468477|NCT00671853|20867499|P1|STARTED|Overall Study||46
8468478|NCT00671788|20867515|P1|NOT COMPLETED|Overall Study||14
8468479|NCT00671788|20867515|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
8468480|NCT00671788|20867515|P1|STARTED|Overall Study||35
8468481|NCT00671749|20867522|P1|NOT COMPLETED|Overall Study||8
8468482|NCT00671749|20867522|P1|COMPLETED|Overall Study||92
8468483|NCT00671749|20867522|P1|STARTED|Overall Study||100
8468484|NCT00671723|20867535|P3|NOT COMPLETED|Overall Study||0
8468485|NCT00671723|20867536|P2|NOT COMPLETED|Overall Study||0
8468486|NCT00671723|20867537|P1|NOT COMPLETED|Overall Study||0
8468487|NCT00671723|20867535|P3|COMPLETED|Overall Study||11
8468488|NCT00671723|20867536|P2|COMPLETED|Overall Study||11
8468489|NCT00671723|20867537|P1|COMPLETED|Overall Study||11
8468490|NCT00671723|20867535|P3|STARTED|Overall Study||11
8468491|NCT00671723|20867536|P2|STARTED|Overall Study||11
8468492|NCT00671723|20867537|P1|STARTED|Overall Study||11
8468493|NCT00671671|20867550|P2|NOT COMPLETED|Overall Study||0
8468494|NCT00671671|20867551|P1|NOT COMPLETED|Overall Study||0
8468495|NCT00671671|20867550|P2|COMPLETED|Overall Study||10
8468496|NCT00671671|20867551|P1|COMPLETED|Overall Study||10
8468497|NCT00671671|20867550|P2|STARTED|Overall Study||10
8468498|NCT00671671|20867551|P1|STARTED|Overall Study||10
8468499|NCT00671658|20867577|P1|NOT COMPLETED|Overall Study||5
8468500|NCT00671658|20867577|P1|COMPLETED|Overall Study||215
8468501|NCT00671658|20867577|P1|STARTED|Overall Study||220
8468502|NCT00671606|20867581|P1|NOT COMPLETED|Overall Study||0
8468503|NCT00671606|20867581|P1|COMPLETED|Overall Study||5
8468504|NCT00671606|20867581|P1|STARTED|Overall Study||5
8468505|NCT00671554|20867585|P1|NOT COMPLETED|Overall Study||3
8468506|NCT00671554|20867585|P1|COMPLETED|Overall Study||0
8468507|NCT00671554|20867585|P1|STARTED|Overall Study||3
8468508|NCT00671528|20867593|P3|NOT COMPLETED|Overall Study||0
8468509|NCT00671528|20867594|P2|NOT COMPLETED|Overall Study||0
8468510|NCT00671528|20867595|P1|NOT COMPLETED|Overall Study||0
8468511|NCT00671528|20867593|P3|COMPLETED|Overall Study||1
8468512|NCT00671528|20867594|P2|COMPLETED|Overall Study||1
8468513|NCT00671528|20867595|P1|COMPLETED|Overall Study||1
8468514|NCT00671528|20867593|P3|STARTED|Overall Study||1
8468515|NCT00671528|20867594|P2|STARTED|Overall Study||1
8468516|NCT00671528|20867595|P1|STARTED|Overall Study||1
8468517|NCT00671515|20867606|P1|NOT COMPLETED|Phase 2||4
8468518|NCT00671515|20867606|P1|COMPLETED|Phase 2||9
8468519|NCT00671515|20867606|P1|STARTED|Phase 2||13
8468520|NCT00671515|20867606|P1|NOT COMPLETED|Phase 1||3
8468521|NCT00671515|20867606|P1|COMPLETED|Phase 1||20
8468522|NCT00671515|20867606|P1|STARTED|Phase 1||23
8468523|NCT00671502|20867614|P3|NOT COMPLETED|Overall Study||27
8468524|NCT00671502|20867615|P2|NOT COMPLETED|Overall Study||39
8468525|NCT00671502|20867616|P1|NOT COMPLETED|Overall Study||39
8468526|NCT00671502|20867614|P3|COMPLETED|Overall Study||252
8468527|NCT00671502|20867615|P2|COMPLETED|Overall Study||241
8468528|NCT00671502|20867616|P1|COMPLETED|Overall Study||242
8468529|NCT00671502|20867614|P3|STARTED|Overall Study||279
8468530|NCT00671502|20867615|P2|STARTED|Overall Study||280
8468531|NCT00671502|20867616|P1|STARTED|Overall Study||281
8468532|NCT00671437|20867624|P1|NOT COMPLETED|Overall Study||15
8468533|NCT00671437|20867624|P1|COMPLETED|Overall Study||27
8468534|NCT00671437|20867624|P1|STARTED|Overall Study||42
8468535|NCT00671177|20867645|P2|NOT COMPLETED|Overall Study||1
8468536|NCT00671177|20867646|P1|NOT COMPLETED|Overall Study||2
8468537|NCT00671177|20867645|P2|COMPLETED|Overall Study||114
8468538|NCT00671177|20867646|P1|COMPLETED|Overall Study||112
8468539|NCT00671177|20867645|P2|STARTED|Overall Study||115
8468540|NCT00671177|20867646|P1|STARTED|Overall Study||114
8468541|NCT00671060|20867658|P2|NOT COMPLETED|Overall Study||1
8468542|NCT00671060|20867659|P1|NOT COMPLETED|Overall Study||1
8468543|NCT00671060|20867658|P2|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
8468544|NCT00671060|20867659|P1|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
8468545|NCT00671060|20867658|P2|STARTED|Overall Study||76
8468546|NCT00671060|20867659|P1|STARTED|Overall Study||77
8468556|NCT00670982|20867707|P2|NOT COMPLETED|Overall Study||0
8468557|NCT00670982|20867708|P1|NOT COMPLETED|Overall Study||0
8468558|NCT00670982|20867707|P2|COMPLETED|Overall Study||7
8468559|NCT00670982|20867708|P1|COMPLETED|Overall Study||22
8468560|NCT00670982|20867707|P2|STARTED|Overall Study||7
8468561|NCT00670982|20867708|P1|STARTED|Overall Study||22
8468562|NCT00670956|20867717|P1|NOT COMPLETED|Overall Study||0
8468563|NCT00670956|20867717|P1|COMPLETED|Overall Study||1
8468564|NCT00670956|20867717|P1|STARTED|Overall Study||1
8468565|NCT00670930|20867725|P2|NOT COMPLETED|Overall Study||1
8468566|NCT00670930|20867726|P1|NOT COMPLETED|Overall Study||1
8468567|NCT00670930|20867725|P2|COMPLETED|Overall Study||12
8468568|NCT00670930|20867726|P1|COMPLETED|Overall Study||22
8468569|NCT00670930|20867725|P2|Intent to Treat (ITT) Population|Overall Study||12
8468570|NCT00670930|20867726|P1|Intent to Treat (ITT) Population|Overall Study||23
8468571|NCT00670930|20867725|P2|STARTED|Overall Study||13
8468572|NCT00670930|20867726|P1|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
8468573|NCT00670800|20867742|P2|NOT COMPLETED|Overall Study||2
8468574|NCT00670800|20867743|P1|NOT COMPLETED|Overall Study||0
8468575|NCT00670800|20867742|P2|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
8468576|NCT00670800|20867743|P1|COMPLETED|Overall Study||7
8468577|NCT00670800|20867742|P2|STARTED|Overall Study||7
8468578|NCT00670800|20867743|P1|STARTED|Overall Study||7
8468579|NCT00670774|20867759|P1|NOT COMPLETED|Overall Study||0
8468580|NCT00670774|20867759|P1|COMPLETED|Overall Study||26
8468581|NCT00670774|20867759|P1|STARTED|Overall Study||26
8468582|NCT00670748|20867774|P4|NOT COMPLETED|Overall Study||1
8468583|NCT00670748|20867775|P3|NOT COMPLETED|Overall Study||2
8468584|NCT00670748|20867776|P2|NOT COMPLETED|Overall Study||2
8468585|NCT00670748|20867777|P1|NOT COMPLETED|Overall Study||3
8468586|NCT00670748|20867774|P4|COMPLETED|Overall Study||4
8468587|NCT00670748|20867775|P3|COMPLETED|Overall Study||5
8468588|NCT00670748|20867776|P2|COMPLETED|Overall Study||14
8468589|NCT00670748|20867777|P1|COMPLETED|Overall Study||14
8468590|NCT00670748|20867774|P4|STARTED|Overall Study||5
8468591|NCT00670748|20867775|P3|STARTED|Overall Study||7
8468592|NCT00670748|20867776|P2|STARTED|Overall Study||16
8468593|NCT00670748|20867777|P1|STARTED|Overall Study||17
8468594|NCT00670709|20867797|P2|NOT COMPLETED|Overall Study||0
8468595|NCT00670709|20867798|P1|NOT COMPLETED|Overall Study||0
8468596|NCT00670709|20867797|P2|COMPLETED|Overall Study||15
8468597|NCT00670709|20867798|P1|COMPLETED|Overall Study||27
8468598|NCT00670709|20867797|P2|STARTED|Overall Study||15
8468599|NCT00670709|20867798|P1|STARTED|Overall Study||27
8468600|NCT00670631|20867806|P1|NOT COMPLETED|Overall Study||0
8468601|NCT00670631|20867806|P1|COMPLETED|Overall Study||0
8468602|NCT00670631|20867806|P1|STARTED|Overall Study||0
8468603|NCT00670540|20867812|P1|NOT COMPLETED|Overall Study||3325
8468604|NCT00670540|20867812|P1|COMPLETED|Overall Study|total recruited for the follow up|4931
8468605|NCT00670540|20867812|P1|STARTED|Overall Study||8256
8468606|NCT00670488|20867832|P10|NOT COMPLETED|Overall Study||2
8468607|NCT00670488|20867833|P9|NOT COMPLETED|Overall Study||3
8468608|NCT00670488|20867834|P8|NOT COMPLETED|Overall Study||3
8468609|NCT00670488|20867835|P7|NOT COMPLETED|Overall Study||17
8468610|NCT00670488|20867836|P6|NOT COMPLETED|Overall Study||5
8468611|NCT00670488|20867837|P5|NOT COMPLETED|Overall Study||3
8468612|NCT00670488|20867838|P4|NOT COMPLETED|Overall Study||7
8468613|NCT00670488|20867839|P3|NOT COMPLETED|Overall Study||3
8468614|NCT00670488|20867840|P2|NOT COMPLETED|Overall Study||58
8468615|NCT00670488|20867841|P1|NOT COMPLETED|Overall Study||3
8468616|NCT00670488|20867832|P10|COMPLETED|Overall Study||0
8468617|NCT00670488|20867833|P9|COMPLETED|Overall Study||0
8468618|NCT00670488|20867834|P8|COMPLETED|Overall Study||0
8468619|NCT00670488|20867835|P7|COMPLETED|Overall Study||0
8468620|NCT00670488|20867836|P6|COMPLETED|Overall Study||0
8468621|NCT00670488|20867837|P5|COMPLETED|Overall Study||0
8468622|NCT00670488|20867838|P4|COMPLETED|Overall Study||0
8468623|NCT00670488|20867839|P3|COMPLETED|Overall Study||0
8468624|NCT00670488|20867840|P2|COMPLETED|Overall Study||0
8468625|NCT00670488|20867841|P1|COMPLETED|Overall Study||0
8468626|NCT00670488|20867832|P10|STARTED|Overall Study||2
8468627|NCT00670488|20867833|P9|STARTED|Overall Study||3
8468628|NCT00670488|20867834|P8|STARTED|Overall Study||3
8468629|NCT00670488|20867835|P7|STARTED|Overall Study||17
8468630|NCT00670488|20867836|P6|STARTED|Overall Study||5
8468631|NCT00670488|20867837|P5|STARTED|Overall Study||3
8468632|NCT00670488|20867838|P4|STARTED|Overall Study||7
8468633|NCT00670488|20867839|P3|STARTED|Overall Study||3
8468634|NCT00670488|20867840|P2|STARTED|Overall Study||58
8468635|NCT00670488|20867841|P1|STARTED|Overall Study||3
8468636|NCT00670462|20867995|P2|NOT COMPLETED|Overall Study||31
8468637|NCT00670462|20867996|P1|NOT COMPLETED|Overall Study||30
8468638|NCT00670462|20867995|P2|COMPLETED|Overall Study||76
8468639|NCT00670462|20867996|P1|COMPLETED|Overall Study||76
8468640|NCT00670462|20867995|P2|STARTED|Overall Study||107
8468641|NCT00670462|20867996|P1|STARTED|Overall Study||106
8468642|NCT00670449|20868028|P4|NOT COMPLETED|Overall Study||8
8468643|NCT00670449|20868029|P3|NOT COMPLETED|Overall Study||9
8468644|NCT00670449|20868030|P2|NOT COMPLETED|Overall Study||10
8468645|NCT00670449|20868031|P1|NOT COMPLETED|Overall Study||9
8468646|NCT00670449|20868028|P4|COMPLETED|Overall Study||15
8468647|NCT00670449|20868029|P3|COMPLETED|Overall Study||18
8468648|NCT00670449|20868030|P2|COMPLETED|Overall Study||36
8468649|NCT00670449|20868031|P1|COMPLETED|Overall Study||38
8468650|NCT00670449|20868028|P4|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
8468651|NCT00670449|20868029|P3|Switched to 0.5mg (Open Label)|Overall Study||23
8468652|NCT00670449|20868030|P2|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
8468653|NCT00670449|20868031|P1|Switched to 0.5mg (Open Label)|Overall Study||45
8468654|NCT00670449|20868028|P4|STARTED|Overall Study||23
8468655|NCT00670449|20868029|P3|STARTED|Overall Study||27
8468656|NCT00670449|20868030|P2|STARTED|Overall Study||46
8468657|NCT00670449|20868031|P1|STARTED|Overall Study||47
8468658|NCT00670306|20868055|P1|NOT COMPLETED|Overall Study||55
8468659|NCT00670306|20868055|P1|COMPLETED|Overall Study||473
8468660|NCT00670306|20868055|P1|STARTED|Overall Study||528
8468661|NCT00670267|20868059|P1|NOT COMPLETED|Overall Study||1
8468662|NCT00670267|20868059|P1|COMPLETED|Overall Study||9
8468663|NCT00670267|20868059|P1|STARTED|Overall Study||10
8468664|NCT00670241|20868070|P3|NOT COMPLETED|Overall Study||27
8468665|NCT00670241|20868071|P2|NOT COMPLETED|Overall Study||21
8468666|NCT00670241|20868072|P1|NOT COMPLETED|Overall Study||12
8468667|NCT00670241|20868070|P3|COMPLETED|Overall Study||64
8468668|NCT00670241|20868071|P2|COMPLETED|Overall Study||163
8468669|NCT00670241|20868072|P1|COMPLETED|Overall Study||171
8468670|NCT00670241|20868070|P3|STARTED|Overall Study||91
8468671|NCT00670241|20868071|P2|STARTED|Overall Study||184
8468672|NCT00670241|20868072|P1|STARTED|Overall Study||183
8468673|NCT00670228|20868094|P2|NOT COMPLETED|Overall Study||3
8468674|NCT00670228|20868095|P1|NOT COMPLETED|Overall Study||5
8468675|NCT00670228|20868094|P2|COMPLETED|Overall Study||12
8468676|NCT00670228|20868095|P1|COMPLETED|Overall Study||13
8468677|NCT00670228|20868094|P2|STARTED|Overall Study||15
8468678|NCT00670228|20868095|P1|STARTED|Overall Study||18
8468679|NCT00670202|20868109|P2|NOT COMPLETED|Overall Study||0
8468680|NCT00670202|20868110|P1|NOT COMPLETED|Overall Study||0
8468681|NCT00670202|20868109|P2|COMPLETED|Overall Study||0
8468682|NCT00670202|20868110|P1|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
8468683|NCT00670202|20868109|P2|STARTED|Overall Study||0
8468684|NCT00670202|20868110|P1|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
8468685|NCT00670111|20868119|P3|NOT COMPLETED|Six Months to Twelve Months||0
8468686|NCT00670111|20868120|P2|NOT COMPLETED|Six Months to Twelve Months||0
8468687|NCT00670111|20868121|P1|NOT COMPLETED|Six Months to Twelve Months||0
8468688|NCT00670111|20868119|P3|COMPLETED|Six Months to Twelve Months||0
8468689|NCT00670111|20868120|P2|COMPLETED|Six Months to Twelve Months||8
8468690|NCT00670111|20868121|P1|COMPLETED|Six Months to Twelve Months||4
8468691|NCT00670111|20868119|P3|STARTED|Six Months to Twelve Months||0
8468692|NCT00670111|20868120|P2|STARTED|Six Months to Twelve Months||8
8468693|NCT00670111|20868121|P1|STARTED|Six Months to Twelve Months||4
8468694|NCT00670111|20868119|P3|NOT COMPLETED|One Month to Six Months||0
8468695|NCT00670111|20868120|P2|NOT COMPLETED|One Month to Six Months||0
8468696|NCT00670111|20868121|P1|NOT COMPLETED|One Month to Six Months||0
8468697|NCT00670111|20868119|P3|COMPLETED|One Month to Six Months||0
8468698|NCT00670111|20868120|P2|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
8468699|NCT00670111|20868121|P1|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
8468700|NCT00670111|20868119|P3|STARTED|One Month to Six Months||0
8468701|NCT00670111|20868120|P2|STARTED|One Month to Six Months||8
8468702|NCT00670111|20868121|P1|STARTED|One Month to Six Months||4
8468703|NCT00670111|20868119|P3|NOT COMPLETED|One Month Period B||0
8468704|NCT00670111|20868120|P2|NOT COMPLETED|One Month Period B||0
8468705|NCT00670111|20868121|P1|NOT COMPLETED|One Month Period B||0
8468706|NCT00670111|20868119|P3|COMPLETED|One Month Period B||0
8468707|NCT00670111|20868120|P2|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
8468708|NCT00670111|20868121|P1|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
8468709|NCT00670111|20868119|P3|STARTED|One Month Period B||0
8468710|NCT00670111|20868120|P2|STARTED|One Month Period B||8
8468711|NCT00670111|20868121|P1|STARTED|One Month Period B||4
8468712|NCT00670111|20868119|P3|NOT COMPLETED|One Month Period A||0
8468713|NCT00670111|20868120|P2|NOT COMPLETED|One Month Period A||0
8468714|NCT00670111|20868121|P1|NOT COMPLETED|One Month Period A||0
8468715|NCT00670111|20868119|P3|COMPLETED|One Month Period A||0
8468716|NCT00670111|20868120|P2|COMPLETED|One Month Period A||8
8468717|NCT00670111|20868121|P1|COMPLETED|One Month Period A||4
8468718|NCT00670111|20868119|P3|STARTED|One Month Period A||0
8468719|NCT00670111|20868120|P2|STARTED|One Month Period A||8
8468720|NCT00670111|20868121|P1|STARTED|One Month Period A||4
8468721|NCT00670111|20868119|P3|NOT COMPLETED|Enrollment to One Month||19
8468722|NCT00670111|20868120|P2|NOT COMPLETED|Enrollment to One Month||0
8468723|NCT00670111|20868121|P1|NOT COMPLETED|Enrollment to One Month||1
8468724|NCT00670111|20868119|P3|COMPLETED|Enrollment to One Month||0
8468725|NCT00670111|20868120|P2|COMPLETED|Enrollment to One Month||8
8468726|NCT00670111|20868121|P1|COMPLETED|Enrollment to One Month||4
8468727|NCT00670111|20868119|P3|STARTED|Enrollment to One Month||19
8468728|NCT00670111|20868120|P2|STARTED|Enrollment to One Month||8
8468729|NCT00670111|20868121|P1|STARTED|Enrollment to One Month||5
8468730|NCT00670046|20868131|P2|NOT COMPLETED|Overall Study||2
8468731|NCT00670046|20868132|P1|NOT COMPLETED|Overall Study||1
8468732|NCT00670046|20868131|P2|COMPLETED|Overall Study||6
8468733|NCT00670046|20868132|P1|COMPLETED|Overall Study||6
8468734|NCT00670046|20868131|P2|STARTED|Overall Study||8
8468735|NCT00670046|20868132|P1|STARTED|Overall Study||7
8468736|NCT00670007|20868146|P1|NOT COMPLETED|Overall Study||9
8468737|NCT00670007|20868146|P1|COMPLETED|Overall Study||131
8468738|NCT00670007|20868146|P1|STARTED|Overall Study||140
8468739|NCT00669955|20868173|P2|NOT COMPLETED|Overall Study||27
8468740|NCT00669955|20868174|P1|NOT COMPLETED|Overall Study||14
8468741|NCT00669955|20868173|P2|COMPLETED|Overall Study||195
8468742|NCT00669955|20868174|P1|COMPLETED|Overall Study||204
8468743|NCT00669955|20868173|P2|STARTED|Overall Study||222
8468744|NCT00669955|20868174|P1|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
8468745|NCT00669942|20868204|P12|NOT COMPLETED|Healthy Volunteers||0
8468746|NCT00669942|20868205|P11|NOT COMPLETED|Healthy Volunteers||1
8468747|NCT00669942|20868206|P10|NOT COMPLETED|Healthy Volunteers||0
8468748|NCT00669942|20868207|P9|NOT COMPLETED|Healthy Volunteers||0
8468749|NCT00669942|20868208|P8|NOT COMPLETED|Healthy Volunteers||0
8468750|NCT00669942|20868209|P7|NOT COMPLETED|Healthy Volunteers||0
8468751|NCT00669942|20868210|P6|NOT COMPLETED|Healthy Volunteers||0
8468752|NCT00669942|20868211|P5|NOT COMPLETED|Healthy Volunteers||0
8468753|NCT00669942|20868212|P4|NOT COMPLETED|Healthy Volunteers||0
8468754|NCT00669942|20868213|P3|NOT COMPLETED|Healthy Volunteers||0
8468755|NCT00669942|20868214|P2|NOT COMPLETED|Healthy Volunteers||0
8468756|NCT00669942|20868215|P1|NOT COMPLETED|Healthy Volunteers||0
8468757|NCT00669942|20868204|P12|COMPLETED|Healthy Volunteers||2
8468758|NCT00669942|20868205|P11|COMPLETED|Healthy Volunteers||2
8468759|NCT00669942|20868206|P10|COMPLETED|Healthy Volunteers||3
8468760|NCT00669942|20868207|P9|COMPLETED|Healthy Volunteers||0
8468761|NCT00669942|20868208|P8|COMPLETED|Healthy Volunteers||0
8468762|NCT00669942|20868209|P7|COMPLETED|Healthy Volunteers||0
8468763|NCT00669942|20868210|P6|COMPLETED|Healthy Volunteers||0
8468764|NCT00669942|20868211|P5|COMPLETED|Healthy Volunteers||0
8468765|NCT00669942|20868212|P4|COMPLETED|Healthy Volunteers||0
8468766|NCT00669942|20868213|P3|COMPLETED|Healthy Volunteers||0
8468767|NCT00669942|20868214|P2|COMPLETED|Healthy Volunteers||0
8468768|NCT00669942|20868215|P1|COMPLETED|Healthy Volunteers||0
8468769|NCT00669942|20868204|P12|STARTED|Healthy Volunteers||2
8468770|NCT00669942|20868205|P11|STARTED|Healthy Volunteers||3
8468771|NCT00669942|20868206|P10|STARTED|Healthy Volunteers||3
8468772|NCT00669942|20868207|P9|STARTED|Healthy Volunteers||0
8468773|NCT00669942|20868208|P8|STARTED|Healthy Volunteers||0
8468774|NCT00669942|20868209|P7|STARTED|Healthy Volunteers||0
8468775|NCT00669942|20868210|P6|STARTED|Healthy Volunteers||0
8468776|NCT00669942|20868211|P5|STARTED|Healthy Volunteers||0
8468777|NCT00669942|20868212|P4|STARTED|Healthy Volunteers||0
8468778|NCT00669942|20868213|P3|STARTED|Healthy Volunteers||0
8468779|NCT00669942|20868214|P2|STARTED|Healthy Volunteers||0
8468780|NCT00669942|20868215|P1|STARTED|Healthy Volunteers||0
8468781|NCT00669942|20868204|P12|NOT COMPLETED|Parts 2 and 3||0
8468782|NCT00669942|20868205|P11|NOT COMPLETED|Parts 2 and 3||0
8468783|NCT00669942|20868206|P10|NOT COMPLETED|Parts 2 and 3||0
8468784|NCT00669942|20868207|P9|NOT COMPLETED|Parts 2 and 3||3
8468785|NCT00669942|20868208|P8|NOT COMPLETED|Parts 2 and 3||2
8468786|NCT00669942|20868209|P7|NOT COMPLETED|Parts 2 and 3||0
8468787|NCT00669942|20868210|P6|NOT COMPLETED|Parts 2 and 3||2
8468788|NCT00669942|20868211|P5|NOT COMPLETED|Parts 2 and 3||0
8468789|NCT00669942|20868212|P4|NOT COMPLETED|Parts 2 and 3||0
8468790|NCT00669942|20868213|P3|NOT COMPLETED|Parts 2 and 3||0
8468791|NCT00669942|20868214|P2|NOT COMPLETED|Parts 2 and 3||0
8468792|NCT00669942|20868215|P1|NOT COMPLETED|Parts 2 and 3||0
8468793|NCT00669942|20868204|P12|COMPLETED|Parts 2 and 3||0
8468794|NCT00669942|20868205|P11|COMPLETED|Parts 2 and 3||0
8468795|NCT00669942|20868206|P10|COMPLETED|Parts 2 and 3||0
8468796|NCT00669942|20868207|P9|COMPLETED|Parts 2 and 3||23
8468797|NCT00669942|20868208|P8|COMPLETED|Parts 2 and 3||24
8468798|NCT00669942|20868209|P7|COMPLETED|Parts 2 and 3||6
8468799|NCT00669942|20868210|P6|COMPLETED|Parts 2 and 3||4
8468800|NCT00669942|20868211|P5|COMPLETED|Parts 2 and 3||0
8468801|NCT00669942|20868212|P4|COMPLETED|Parts 2 and 3||0
8468802|NCT00669942|20868213|P3|COMPLETED|Parts 2 and 3||0
8468803|NCT00669942|20868214|P2|COMPLETED|Parts 2 and 3||0
8468804|NCT00669942|20868215|P1|COMPLETED|Parts 2 and 3||0
8468805|NCT00669942|20868204|P12|STARTED|Parts 2 and 3||0
8468806|NCT00669942|20868205|P11|STARTED|Parts 2 and 3||0
8468807|NCT00669942|20868206|P10|STARTED|Parts 2 and 3||0
8468808|NCT00669942|20868207|P9|STARTED|Parts 2 and 3||26
8468809|NCT00669942|20868208|P8|STARTED|Parts 2 and 3||26
8468810|NCT00669942|20868209|P7|STARTED|Parts 2 and 3||6
8468811|NCT00669942|20868210|P6|STARTED|Parts 2 and 3||6
8468812|NCT00669942|20868211|P5|STARTED|Parts 2 and 3||0
8468813|NCT00669942|20868212|P4|STARTED|Parts 2 and 3||0
8468814|NCT00669942|20868213|P3|STARTED|Parts 2 and 3||0
8468815|NCT00669942|20868214|P2|STARTED|Parts 2 and 3||0
8468816|NCT00669942|20868215|P1|STARTED|Parts 2 and 3||0
8468817|NCT00669942|20868204|P12|NOT COMPLETED|Part 1||0
8468818|NCT00669942|20868205|P11|NOT COMPLETED|Part 1||0
8468819|NCT00669942|20868206|P10|NOT COMPLETED|Part 1||0
8468820|NCT00669942|20868207|P9|NOT COMPLETED|Part 1||0
8468821|NCT00669942|20868208|P8|NOT COMPLETED|Part 1||0
8468822|NCT00669942|20868209|P7|NOT COMPLETED|Part 1||0
8468823|NCT00669942|20868210|P6|NOT COMPLETED|Part 1||0
8468824|NCT00669942|20868211|P5|NOT COMPLETED|Part 1||0
8468825|NCT00669942|20868212|P4|NOT COMPLETED|Part 1||0
8468826|NCT00669942|20868213|P3|NOT COMPLETED|Part 1||0
8468827|NCT00669942|20868214|P2|NOT COMPLETED|Part 1||0
8468828|NCT00669942|20868215|P1|NOT COMPLETED|Part 1||0
8468829|NCT00669942|20868204|P12|COMPLETED|Part 1||0
8468830|NCT00669942|20868205|P11|COMPLETED|Part 1||0
8468831|NCT00669942|20868206|P10|COMPLETED|Part 1||0
8468832|NCT00669942|20868207|P9|COMPLETED|Part 1||0
8468833|NCT00669942|20868208|P8|COMPLETED|Part 1||0
8468834|NCT00669942|20868209|P7|COMPLETED|Part 1||0
8468835|NCT00669942|20868210|P6|COMPLETED|Part 1||0
8468836|NCT00669942|20868211|P5|COMPLETED|Part 1||8
8468837|NCT00669942|20868212|P4|COMPLETED|Part 1||6
8468838|NCT00669942|20868213|P3|COMPLETED|Part 1||6
8468839|NCT00669942|20868214|P2|COMPLETED|Part 1||6
8468840|NCT00669942|20868215|P1|COMPLETED|Part 1||6
8468841|NCT00669942|20868204|P12|STARTED|Part 1||0
8468842|NCT00669942|20868205|P11|STARTED|Part 1||0
8468843|NCT00669942|20868206|P10|STARTED|Part 1||0
8468844|NCT00669942|20868207|P9|STARTED|Part 1||0
8468845|NCT00669942|20868208|P8|STARTED|Part 1||0
8468846|NCT00669942|20868209|P7|STARTED|Part 1||0
8468847|NCT00669942|20868210|P6|STARTED|Part 1||0
8468848|NCT00669942|20868211|P5|STARTED|Part 1||8
8468849|NCT00669942|20868212|P4|STARTED|Part 1||6
8468850|NCT00669942|20868213|P3|STARTED|Part 1||6
8468851|NCT00669942|20868214|P2|STARTED|Part 1||6
8468852|NCT00669942|20868215|P1|STARTED|Part 1||6
8468853|NCT00669916|20868279|P2|NOT COMPLETED|Overall Study||0
8468854|NCT00669916|20868280|P1|NOT COMPLETED|Overall Study||0
8468855|NCT00669916|20868279|P2|COMPLETED|Overall Study||18
8468856|NCT00669916|20868280|P1|COMPLETED|Overall Study||18
8468857|NCT00669916|20868279|P2|STARTED|Overall Study||18
8468858|NCT00669916|20868280|P1|STARTED|Overall Study||18
8468859|NCT00669903|20868298|P4|NOT COMPLETED|Overall Study||4
8468860|NCT00669903|20868299|P3|NOT COMPLETED|Overall Study||5
8468861|NCT00669903|20868300|P2|NOT COMPLETED|Overall Study||5
8468862|NCT00669903|20868301|P1|NOT COMPLETED|Overall Study||1
8468863|NCT00669903|20868298|P4|COMPLETED|Overall Study||18
8468864|NCT00669903|20868299|P3|COMPLETED|Overall Study||13
8468865|NCT00669903|20868300|P2|COMPLETED|Overall Study||32
8468866|NCT00669903|20868301|P1|COMPLETED|Overall Study||22
8468867|NCT00669903|20868298|P4|Completed Treatment Period|Overall Study||19
8468868|NCT00669903|20868299|P3|Completed Treatment Period|Overall Study||13
8468869|NCT00669903|20868300|P2|Completed Treatment Period|Overall Study||33
8468870|NCT00669903|20868301|P1|Completed Treatment Period|Overall Study||23
8468871|NCT00669903|20868298|P4|STARTED|Overall Study||22
8468872|NCT00669903|20868299|P3|STARTED|Overall Study||18
8468873|NCT00669903|20868300|P2|STARTED|Overall Study||37
8468874|NCT00669903|20868301|P1|STARTED|Overall Study||23
8468875|NCT00669877|20868331|P1|NOT COMPLETED|Overall Study||4
8468876|NCT00669877|20868331|P1|COMPLETED|Overall Study||52
8468877|NCT00669877|20868331|P1|STARTED|Overall Study||56
8468878|NCT00669864|20868336|P1|NOT COMPLETED|Overall Study||9
8468879|NCT00669864|20868336|P1|COMPLETED|Overall Study||284
8468880|NCT00669864|20868336|P1|STARTED|Overall Study||293
8468881|NCT00669682|20868345|P1|NOT COMPLETED|Overall Study||0
8468882|NCT00669682|20868345|P1|COMPLETED|Overall Study||9
8468883|NCT00669682|20868345|P1|STARTED|Overall Study||9
8468887|NCT00669617|20868355|P5|NOT COMPLETED|Period 5||0
8468888|NCT00669617|20868356|P4|NOT COMPLETED|Period 5||0
8468889|NCT00669617|20868357|P3|NOT COMPLETED|Period 5||0
8468890|NCT00669617|20868358|P2|NOT COMPLETED|Period 5||0
8468891|NCT00669617|20868359|P1|NOT COMPLETED|Period 5||0
8468892|NCT00669617|20868355|P5|COMPLETED|Period 5||17
8468893|NCT00669617|20868356|P4|COMPLETED|Period 5||18
8468894|NCT00669617|20868357|P3|COMPLETED|Period 5||17
8468895|NCT00669617|20868358|P2|COMPLETED|Period 5||17
8468896|NCT00669617|20868359|P1|COMPLETED|Period 5||17
8468897|NCT00669617|20868355|P5|STARTED|Period 5||17
8468898|NCT00669617|20868356|P4|STARTED|Period 5||18
8468899|NCT00669617|20868357|P3|STARTED|Period 5||17
8468900|NCT00669617|20868358|P2|STARTED|Period 5||17
8468901|NCT00669617|20868359|P1|STARTED|Period 5||17
8468902|NCT00669617|20868355|P5|NOT COMPLETED|Period 4||0
8468903|NCT00669617|20868356|P4|NOT COMPLETED|Period 4||0
8468904|NCT00669617|20868357|P3|NOT COMPLETED|Period 4||0
8468905|NCT00669617|20868358|P2|NOT COMPLETED|Period 4||0
8468906|NCT00669617|20868359|P1|NOT COMPLETED|Period 4||0
8468907|NCT00669617|20868355|P5|COMPLETED|Period 4||17
8468908|NCT00669617|20868356|P4|COMPLETED|Period 4||18
8468909|NCT00669617|20868357|P3|COMPLETED|Period 4||17
8468910|NCT00669617|20868358|P2|COMPLETED|Period 4||17
8468911|NCT00669617|20868359|P1|COMPLETED|Period 4||17
8468912|NCT00669617|20868355|P5|STARTED|Period 4||17
8468913|NCT00669617|20868356|P4|STARTED|Period 4||18
8468914|NCT00669617|20868357|P3|STARTED|Period 4||17
8468915|NCT00669617|20868358|P2|STARTED|Period 4||17
8468916|NCT00669617|20868359|P1|STARTED|Period 4||17
8468917|NCT00669617|20868355|P5|NOT COMPLETED|Period 3||0
8468918|NCT00669617|20868356|P4|NOT COMPLETED|Period 3||0
8468919|NCT00669617|20868357|P3|NOT COMPLETED|Period 3||0
8468920|NCT00669617|20868358|P2|NOT COMPLETED|Period 3||0
8468921|NCT00669617|20868359|P1|NOT COMPLETED|Period 3||1
8468922|NCT00669617|20868355|P5|COMPLETED|Period 3||17
8468923|NCT00669617|20868356|P4|COMPLETED|Period 3||18
8468924|NCT00669617|20868357|P3|COMPLETED|Period 3||17
8468925|NCT00669617|20868358|P2|COMPLETED|Period 3||17
8468926|NCT00669617|20868359|P1|COMPLETED|Period 3||17
8468927|NCT00669617|20868355|P5|STARTED|Period 3||17
8468928|NCT00669617|20868356|P4|STARTED|Period 3||18
8468929|NCT00669617|20868357|P3|STARTED|Period 3||17
8468930|NCT00669617|20868358|P2|STARTED|Period 3||17
8468931|NCT00669617|20868359|P1|STARTED|Period 3||18
8468932|NCT00669617|20868355|P5|NOT COMPLETED|Period 2||0
8468933|NCT00669617|20868356|P4|NOT COMPLETED|Period 2||0
8468934|NCT00669617|20868357|P3|NOT COMPLETED|Period 2||0
8468935|NCT00669617|20868358|P2|NOT COMPLETED|Period 2||0
8468936|NCT00669617|20868359|P1|NOT COMPLETED|Period 2||0
8468937|NCT00669617|20868355|P5|COMPLETED|Period 2||17
8468938|NCT00669617|20868356|P4|COMPLETED|Period 2||18
8468939|NCT00669617|20868357|P3|COMPLETED|Period 2||17
8468940|NCT00669617|20868358|P2|COMPLETED|Period 2||17
8468941|NCT00669617|20868359|P1|COMPLETED|Period 2||18
8468942|NCT00669617|20868355|P5|STARTED|Period 2||17
8468943|NCT00669617|20868356|P4|STARTED|Period 2||18
8468944|NCT00669617|20868357|P3|STARTED|Period 2||17
8468945|NCT00669617|20868358|P2|STARTED|Period 2||17
8468946|NCT00669617|20868359|P1|STARTED|Period 2||18
8468947|NCT00669617|20868355|P5|NOT COMPLETED|Period 1||1
8468948|NCT00669617|20868356|P4|NOT COMPLETED|Period 1||0
8468949|NCT00669617|20868357|P3|NOT COMPLETED|Period 1||1
8468950|NCT00669617|20868358|P2|NOT COMPLETED|Period 1||0
8468951|NCT00669617|20868359|P1|NOT COMPLETED|Period 1||0
8468952|NCT00669617|20868355|P5|COMPLETED|Period 1||17
8468953|NCT00669617|20868356|P4|COMPLETED|Period 1||18
8468954|NCT00669617|20868357|P3|COMPLETED|Period 1||17
8468955|NCT00669617|20868358|P2|COMPLETED|Period 1||17
8468956|NCT00669617|20868359|P1|COMPLETED|Period 1||18
8468957|NCT00669617|20868355|P5|STARTED|Period 1||18
8468958|NCT00669617|20868356|P4|STARTED|Period 1||18
8468959|NCT00669617|20868357|P3|STARTED|Period 1||18
8468960|NCT00669617|20868358|P2|STARTED|Period 1||17
8468961|NCT00669617|20868359|P1|STARTED|Period 1||18
8468962|NCT00669578|20868373|P2|NOT COMPLETED|Overall Study||0
8468963|NCT00669578|20868374|P1|NOT COMPLETED|Overall Study||0
8468964|NCT00669578|20868373|P2|COMPLETED|Overall Study||65
8468965|NCT00669578|20868374|P1|COMPLETED|Overall Study||12
8468966|NCT00669578|20868373|P2|STARTED|Overall Study||65
8468967|NCT00669578|20868374|P1|STARTED|Overall Study||12
8468968|NCT00669552|20868387|P1|NOT COMPLETED|Overall Study||0
8468969|NCT00669552|20868387|P1|COMPLETED|Overall Study||11
8468970|NCT00669552|20868387|P1|STARTED|Overall Study||11
8468971|NCT00669539|20868393|P2|NOT COMPLETED|Overall Study||9
8468972|NCT00669539|20868394|P1|NOT COMPLETED|Overall Study||8
8468973|NCT00669539|20868393|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
8468974|NCT00669539|20868394|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
8468975|NCT00669539|20868393|P2|STARTED|Overall Study||52
8468976|NCT00669539|20868394|P1|STARTED|Overall Study||94
8468977|NCT00669461|20868400|P1|NOT COMPLETED|Overall Study||0
8468978|NCT00669461|20868400|P1|COMPLETED|Overall Study||1
8468979|NCT00669461|20868400|P1|STARTED|Overall Study||1
8468980|NCT00669396|20868407|P2|NOT COMPLETED|Overall Study||12
8468981|NCT00669396|20868408|P1|NOT COMPLETED|Overall Study||10
8468982|NCT00669396|20868407|P2|COMPLETED|Overall Study||22
8468983|NCT00669396|20868408|P1|COMPLETED|Overall Study||13
8468984|NCT00669396|20868407|P2|STARTED|Overall Study||34
8468985|NCT00669396|20868408|P1|STARTED|Overall Study||23
8468986|NCT00669383|20868422|P2|NOT COMPLETED|Overall Study||0
8468987|NCT00669383|20868423|P1|NOT COMPLETED|Overall Study||0
8468988|NCT00669383|20868422|P2|COMPLETED|Overall Study||41
8468989|NCT00669383|20868423|P1|COMPLETED|Overall Study||44
8468990|NCT00669383|20868422|P2|STARTED|Overall Study||41
8468991|NCT00669383|20868423|P1|STARTED|Overall Study||44
8468992|NCT00669331|20868435|P2|NOT COMPLETED|Blinded Treatment Period||39
8468993|NCT00669331|20868436|P1|NOT COMPLETED|Blinded Treatment Period||42
8468994|NCT00669331|20868435|P2|COMPLETED|Blinded Treatment Period||189
8468995|NCT00669331|20868436|P1|COMPLETED|Blinded Treatment Period||191
8468996|NCT00669331|20868435|P2|STARTED|Blinded Treatment Period||228
8468997|NCT00669331|20868436|P1|STARTED|Blinded Treatment Period||233
8468998|NCT00669331|20868435|P2|NOT COMPLETED|Randomisation to First Dose||13
8468999|NCT00669331|20868436|P1|NOT COMPLETED|Randomisation to First Dose||11
8469000|NCT00669331|20868435|P2|COMPLETED|Randomisation to First Dose||228
8469001|NCT00669331|20868436|P1|COMPLETED|Randomisation to First Dose||233
8469002|NCT00669331|20868435|P2|STARTED|Randomisation to First Dose||241
8469003|NCT00669331|20868436|P1|STARTED|Randomisation to First Dose||244
8469004|NCT00669318|20868478|P1|NOT COMPLETED|Overall Study||2
8469005|NCT00669318|20868478|P1|COMPLETED|Overall Study||39
8469006|NCT00669318|20868478|P1|STARTED|Overall Study||41
8469007|NCT00669279|20868488|P2|NOT COMPLETED|Overall Study||0
8469008|NCT00669279|20868489|P1|NOT COMPLETED|Overall Study||0
8469009|NCT00669279|20868488|P2|COMPLETED|Overall Study||19
8469010|NCT00669279|20868489|P1|COMPLETED|Overall Study||22
8469011|NCT00669279|20868488|P2|STARTED|Overall Study||19
8469012|NCT00669279|20868489|P1|STARTED|Overall Study||22
8469013|NCT00669240|20868495|P1|NOT COMPLETED|Overall Study||165
8469014|NCT00669240|20868495|P1|COMPLETED|Overall Study||402
8469015|NCT00669240|20868495|P1|Received Treatment|Overall Study||551
8469016|NCT00669240|20868495|P1|Assigned to Treatment|Overall Study||566
8469017|NCT00669240|20868495|P1|STARTED|Overall Study||567
8469018|NCT00669214|20868511|P2|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
8469019|NCT00669214|20868512|P1|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
8469020|NCT00669214|20868511|P2|COMPLETED|Open-Label Treatment Period (Week 24)||46
8469021|NCT00669214|20868512|P1|COMPLETED|Open-Label Treatment Period (Week 24)||18
8469022|NCT00669214|20868511|P2|STARTED|Open-Label Treatment Period (Week 24)||55
8469023|NCT00669214|20868512|P1|STARTED|Open-Label Treatment Period (Week 24)||22
8469024|NCT00669214|20868511|P2|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
8469025|NCT00669214|20868512|P1|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
8469026|NCT00669214|20868511|P2|COMPLETED|Double-Blind Treatment Period (Week 12)||55
8469027|NCT00669214|20868512|P1|COMPLETED|Double-Blind Treatment Period (Week 12)||22
8469028|NCT00669214|20868511|P2|STARTED|Double-Blind Treatment Period (Week 12)||62
8469029|NCT00669214|20868512|P1|STARTED|Double-Blind Treatment Period (Week 12)||27
8469030|NCT00669162|20868544|P1|NOT COMPLETED|Overall Study||1
8469031|NCT00669162|20868544|P1|COMPLETED|Overall Study||26
8469032|NCT00669162|20868544|P1|STARTED|Overall Study||27
8469039|NCT00669071|20868587|P1|NOT COMPLETED|Overall Study||4
8469040|NCT00669071|20868587|P1|COMPLETED|Overall Study||52
8469041|NCT00669071|20868587|P1|STARTED|Overall Study||56
8469042|NCT00669032|20868608|P2|NOT COMPLETED|Overall Study||59
8469043|NCT00669032|20868609|P1|NOT COMPLETED|Overall Study||44
8469044|NCT00669032|20868608|P2|COMPLETED|Overall Study||94
8469045|NCT00669032|20868609|P1|COMPLETED|Overall Study||109
8469046|NCT00669032|20868608|P2|STARTED|Overall Study||153
8469047|NCT00669032|20868609|P1|STARTED|Overall Study||153
8469048|NCT00669019|20868637|P1|NOT COMPLETED|Overall Study||0
8469049|NCT00669019|20868637|P1|COMPLETED|Overall Study||23
8469050|NCT00669019|20868637|P1|STARTED|Overall Study||23
8469051|NCT00668902|20868645|P3|NOT COMPLETED|Overall Study||0
8469052|NCT00668902|20868646|P2|NOT COMPLETED|Overall Study||0
8469053|NCT00668902|20868647|P1|NOT COMPLETED|Overall Study||0
8469054|NCT00668902|20868645|P3|COMPLETED|Overall Study||5
8469055|NCT00668902|20868646|P2|COMPLETED|Overall Study||10
8469056|NCT00668902|20868647|P1|COMPLETED|Overall Study||10
8469057|NCT00668902|20868645|P3|STARTED|Overall Study||5
8469058|NCT00668902|20868646|P2|STARTED|Overall Study||10
8469059|NCT00668902|20868647|P1|STARTED|Overall Study||10
8469060|NCT00668863|20868655|P1|NOT COMPLETED|Overall Study||71
8469061|NCT00668863|20868655|P1|COMPLETED|Overall Study||0
8469062|NCT00668863|20868655|P1|STARTED|Overall Study||71
8469063|NCT00668811|20868674|P1|NOT COMPLETED|Overall Study||0
8469064|NCT00668811|20868674|P1|COMPLETED|Overall Study||23
8469065|NCT00668811|20868674|P1|STARTED|Overall Study||23
8469066|NCT00668785|20868679|P1|NOT COMPLETED|Overall Study||0
8469067|NCT00668785|20868679|P1|COMPLETED|Overall Study||6
8469068|NCT00668785|20868679|P1|STARTED|Overall Study||6
8469069|NCT00668746|20868687|P2|NOT COMPLETED|Overall Study||1
8469070|NCT00668746|20868688|P1|NOT COMPLETED|Overall Study||2
8469071|NCT00668746|20868687|P2|COMPLETED|Overall Study||11
8469072|NCT00668746|20868688|P1|COMPLETED|Overall Study||21
8469073|NCT00668746|20868687|P2|STARTED|Overall Study||12
8469074|NCT00668746|20868688|P1|STARTED|Overall Study||23
8469075|NCT00668733|20868708|P2|NOT COMPLETED|Overall Study||7
8469076|NCT00668733|20868709|P1|NOT COMPLETED|Overall Study||2
8469077|NCT00668733|20868708|P2|COMPLETED|Overall Study||83
8469078|NCT00668733|20868709|P1|COMPLETED|Overall Study||87
8469079|NCT00668733|20868708|P2|STARTED|Overall Study||90
8469080|NCT00668733|20868709|P1|STARTED|Overall Study||89
8469081|NCT00668564|20868715|P1|NOT COMPLETED|Overall Study||0
8469082|NCT00668564|20868715|P1|COMPLETED|Overall Study||18
8469083|NCT00668564|20868715|P1|STARTED|Overall Study||18
8469084|NCT00668525|20868723|P3|NOT COMPLETED|Overall Study||53
8469085|NCT00668525|20868724|P2|NOT COMPLETED|Overall Study||93
8469086|NCT00668525|20868725|P1|NOT COMPLETED|Overall Study||77
8469087|NCT00668525|20868723|P3|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
8469088|NCT00668525|20868724|P2|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
8469089|NCT00668525|20868725|P1|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
8469090|NCT00668525|20868723|P3|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
8469091|NCT00668525|20868724|P2|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
8469092|NCT00668525|20868725|P1|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
8469093|NCT00668434|20868738|P2|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
8469094|NCT00668434|20868739|P1|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
8469095|NCT00668434|20868738|P2|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
8469096|NCT00668434|20868739|P1|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
8469097|NCT00668434|20868738|P2|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
8469098|NCT00668434|20868739|P1|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
8469099|NCT00668434|20868738|P2|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
8469100|NCT00668434|20868739|P1|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
8469101|NCT00668434|20868738|P2|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
8469102|NCT00668434|20868739|P1|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
8469103|NCT00668434|20868738|P2|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
8469104|NCT00668434|20868739|P1|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
8469105|NCT00668395|20868754|P3|NOT COMPLETED|Overall Study||1
8469106|NCT00668395|20868755|P2|NOT COMPLETED|Overall Study||6
8469107|NCT00668395|20868756|P1|NOT COMPLETED|Overall Study||6
8469108|NCT00668395|20868754|P3|COMPLETED|Overall Study||5
8469109|NCT00668395|20868755|P2|COMPLETED|Overall Study||16
8469110|NCT00668395|20868756|P1|COMPLETED|Overall Study||39
8469111|NCT00668395|20868754|P3|STARTED|Overall Study||6
8469112|NCT00668395|20868755|P2|STARTED|Overall Study||22
8469113|NCT00668395|20868756|P1|STARTED|Overall Study||45
8469114|NCT00668382|20868764|P1|NOT COMPLETED|Overall Study||0
8469115|NCT00668382|20868764|P1|COMPLETED|Overall Study||11
8469116|NCT00668382|20868764|P1|STARTED|Overall Study|beginning of trial|11
8469117|NCT00668317|20868768|P1|NOT COMPLETED|Overall Study||2
8469118|NCT00668317|20868768|P1|COMPLETED|Overall Study||3
8469119|NCT00668317|20868768|P1|STARTED|Overall Study||5
8469120|NCT00668265|20868774|P2|NOT COMPLETED|Overall Study||5
8469121|NCT00668265|20868775|P1|NOT COMPLETED|Overall Study||9
8469122|NCT00668265|20868774|P2|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
8469123|NCT00668265|20868775|P1|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
8469124|NCT00668265|20868774|P2|STARTED|Overall Study||5
8469125|NCT00668265|20868775|P1|STARTED|Overall Study||9
8469126|NCT00668200|20868783|P1|NOT COMPLETED|Overall Study||3
8469127|NCT00668200|20868783|P1|COMPLETED|Overall Study||77
8469128|NCT00668200|20868783|P1|Intent to Treat (ITT)|Overall Study||80
8469129|NCT00668200|20868783|P1|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
8469130|NCT00668200|20868783|P1|STARTED|Overall Study||80
8469131|NCT00668148|20868789|P1|NOT COMPLETED|Overall Study||10
8469132|NCT00668148|20868789|P1|COMPLETED|Overall Study||103
8469133|NCT00668148|20868789|P1|Received at Least 1 Dose of Study Drug|Overall Study||111
8469134|NCT00668148|20868789|P1|STARTED|Overall Study||113
8469135|NCT00667992|20868828|P2|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
8469136|NCT00667992|20868829|P1|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
8469137|NCT00667992|20868828|P2|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
8469138|NCT00667992|20868829|P1|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
8469139|NCT00667992|20868828|P2|STARTED|Forth Intervention 400 Mcg Twice Daily||35
8469140|NCT00667992|20868829|P1|STARTED|Forth Intervention 400 Mcg Twice Daily||33
8469141|NCT00667992|20868828|P2|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
8469142|NCT00667992|20868829|P1|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
8469143|NCT00667992|20868828|P2|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
8469144|NCT00667992|20868829|P1|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
8469145|NCT00667992|20868828|P2|STARTED|Third Intervention 100 Mcg Twice Daily||36
8469146|NCT00667992|20868829|P1|STARTED|Third Intervention 100 Mcg Twice Daily||34
8469147|NCT00667992|20868828|P2|NOT COMPLETED|Wash-out||5
8469148|NCT00667992|20868829|P1|NOT COMPLETED|Wash-out||7
8469149|NCT00667992|20868828|P2|COMPLETED|Wash-out||36
8469150|NCT00667992|20868829|P1|COMPLETED|Wash-out||34
8469151|NCT00667992|20868828|P2|STARTED|Wash-out||41
8469152|NCT00667992|20868829|P1|STARTED|Wash-out||41
8469153|NCT00667992|20868828|P2|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
8469154|NCT00667992|20868829|P1|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
8469155|NCT00667992|20868828|P2|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
8469156|NCT00667992|20868829|P1|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
8469157|NCT00667992|20868828|P2|STARTED|Second Intervention 400 Mcg Twice Daily||45
8469158|NCT00667992|20868829|P1|STARTED|Second Intervention 400 Mcg Twice Daily||44
8469159|NCT00667992|20868828|P2|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
8469160|NCT00667992|20868829|P1|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
8469161|NCT00667992|20868828|P2|COMPLETED|First Intervention 100 Mcg Twice Daily||45
8469162|NCT00667992|20868829|P1|COMPLETED|First Intervention 100 Mcg Twice Daily||44
8469163|NCT00667992|20868828|P2|STARTED|First Intervention 100 Mcg Twice Daily||50
8469164|NCT00667992|20868829|P1|STARTED|First Intervention 100 Mcg Twice Daily||49
8469165|NCT00667888|20868885|P2|NOT COMPLETED|Overall Study||9
8469166|NCT00667888|20868886|P1|NOT COMPLETED|Overall Study||10
8469167|NCT00667888|20868885|P2|COMPLETED|Overall Study||102
8469168|NCT00667888|20868886|P1|COMPLETED|Overall Study||101
8469169|NCT00667888|20868885|P2|STARTED|Overall Study||111
8469170|NCT00667888|20868886|P1|STARTED|Overall Study||111
8469171|NCT00667875|20868895|P3|NOT COMPLETED|Overall Study||13
8469172|NCT00667875|20868896|P2|NOT COMPLETED|Overall Study||11
8469173|NCT00667875|20868897|P1|NOT COMPLETED|Overall Study||10
8469174|NCT00667875|20868895|P3|COMPLETED|Overall Study||8
8469175|NCT00667875|20868896|P2|COMPLETED|Overall Study||10
8469176|NCT00667875|20868897|P1|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
8469177|NCT00667875|20868895|P3|Subjects Included in Analysisd|Overall Study||19
8469178|NCT00667875|20868896|P2|Subjects Included in Analysisd|Overall Study||21
8469179|NCT00667875|20868897|P1|Subjects Included in Analysisd|Overall Study||20
8469180|NCT00667875|20868895|P3|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
8469181|NCT00667875|20868896|P2|STARTED|Overall Study||21
8469182|NCT00667875|20868897|P1|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
8469183|NCT00667849|20868916|P2|NOT COMPLETED|Overall Study||121
8469184|NCT00667849|20868917|P1|NOT COMPLETED|Overall Study||108
8469185|NCT00667849|20868916|P2|COMPLETED|Overall Study||130
8469186|NCT00667849|20868917|P1|COMPLETED|Overall Study||142
8469187|NCT00667849|20868916|P2|STARTED|Overall Study||251
8469188|NCT00667849|20868917|P1|STARTED|Overall Study||250
8469189|NCT00667810|20868931|P4|NOT COMPLETED|Overall Study||2
8469190|NCT00667810|20868932|P3|NOT COMPLETED|Overall Study||222
8469191|NCT00667810|20868933|P2|NOT COMPLETED|Overall Study||170
8469192|NCT00667810|20868934|P1|NOT COMPLETED|Overall Study||167
8469193|NCT00667810|20868931|P4|COMPLETED|Overall Study||9
8469194|NCT00667810|20868932|P3|COMPLETED|Overall Study||124
8469195|NCT00667810|20868933|P2|COMPLETED|Overall Study||94
8469196|NCT00667810|20868934|P1|COMPLETED|Overall Study||102
8469197|NCT00667810|20868931|P4|Treated|Overall Study||11
8469198|NCT00667810|20868932|P3|Treated|Overall Study||344
8469199|NCT00667810|20868933|P2|Treated|Overall Study||263
8469200|NCT00667810|20868934|P1|Treated|Overall Study||267
8469201|NCT00667810|20868931|P4|STARTED|Overall Study||11
8469202|NCT00667810|20868932|P3|STARTED|Overall Study||346
8469203|NCT00667810|20868933|P2|STARTED|Overall Study||264
8469204|NCT00667810|20868934|P1|STARTED|Overall Study||269
8469205|NCT00667745|20868993|P2|NOT COMPLETED|Overall Study||21
8469206|NCT00667745|20868994|P1|NOT COMPLETED|Overall Study||25
8469207|NCT00667745|20868993|P2|COMPLETED|Overall Study||121
8469208|NCT00667745|20868994|P1|COMPLETED|Overall Study||116
8469209|NCT00667745|20868993|P2|STARTED|Overall Study||142
8469210|NCT00667745|20868994|P1|STARTED|Overall Study||141
8469211|NCT00667732|20869010|P3|NOT COMPLETED|Extension (26 Weeks)||0
8469212|NCT00667732|20869011|P2|NOT COMPLETED|Extension (26 Weeks)||0
8469213|NCT00667732|20869012|P1|NOT COMPLETED|Extension (26 Weeks)||0
8469214|NCT00667732|20869010|P3|COMPLETED|Extension (26 Weeks)||17
8469215|NCT00667732|20869011|P2|COMPLETED|Extension (26 Weeks)||14
8469216|NCT00667732|20869012|P1|COMPLETED|Extension (26 Weeks)||0
8469217|NCT00667732|20869010|P3|STARTED|Extension (26 Weeks)||17
8469218|NCT00667732|20869011|P2|STARTED|Extension (26 Weeks)||14
8469219|NCT00667732|20869012|P1|STARTED|Extension (26 Weeks)||0
8469220|NCT00667732|20869010|P3|NOT COMPLETED|Randomization (24 Weeks)||0
8469221|NCT00667732|20869011|P2|NOT COMPLETED|Randomization (24 Weeks)||1
8469222|NCT00667732|20869012|P1|NOT COMPLETED|Randomization (24 Weeks)||0
8469223|NCT00667732|20869010|P3|COMPLETED|Randomization (24 Weeks)||17
8469224|NCT00667732|20869011|P2|COMPLETED|Randomization (24 Weeks)||16
8469225|NCT00667732|20869012|P1|COMPLETED|Randomization (24 Weeks)||0
8469226|NCT00667732|20869010|P3|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
8469227|NCT00667732|20869011|P2|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
8469228|NCT00667732|20869012|P1|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
8469229|NCT00667732|20869010|P3|STARTED|Randomization (24 Weeks)||17
8469230|NCT00667732|20869011|P2|STARTED|Randomization (24 Weeks)||17
8469231|NCT00667732|20869012|P1|STARTED|Randomization (24 Weeks)||0
8469232|NCT00667732|20869010|P3|NOT COMPLETED|Run -In (8 Weeks)||0
8469233|NCT00667732|20869011|P2|NOT COMPLETED|Run -In (8 Weeks)||0
8469234|NCT00667732|20869012|P1|NOT COMPLETED|Run -In (8 Weeks)||7
8469235|NCT00667732|20869010|P3|COMPLETED|Run -In (8 Weeks)||0
8469236|NCT00667732|20869011|P2|COMPLETED|Run -In (8 Weeks)||0
8469237|NCT00667732|20869012|P1|COMPLETED|Run -In (8 Weeks)||34
8469238|NCT00667732|20869010|P3|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
8469239|NCT00667732|20869011|P2|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
8469240|NCT00667732|20869012|P1|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
8469241|NCT00667732|20869010|P3|STARTED|Run -In (8 Weeks)||0
8469242|NCT00667732|20869011|P2|STARTED|Run -In (8 Weeks)||0
8469243|NCT00667732|20869012|P1|STARTED|Run -In (8 Weeks)||41
8469244|NCT00667693|20869025|P2|NOT COMPLETED|Overall Study||2
8469245|NCT00667693|20869026|P1|NOT COMPLETED|Overall Study||0
8469246|NCT00667693|20869025|P2|COMPLETED|Overall Study||50
8469247|NCT00667693|20869026|P1|COMPLETED|Overall Study||49
8469248|NCT00667693|20869025|P2|STARTED|Overall Study||52
8469249|NCT00667693|20869026|P1|STARTED|Overall Study||49
8469250|NCT00667615|20869040|P1|NOT COMPLETED|Overall Study||0
8469251|NCT00667615|20869040|P1|COMPLETED|Overall Study||30
8469252|NCT00667615|20869040|P1|STARTED|Overall Study||30
8469253|NCT00667602|20869048|P3|NOT COMPLETED|Overall Study||18
8469254|NCT00667602|20869049|P2|NOT COMPLETED|Overall Study||15
8469255|NCT00667602|20869050|P1|NOT COMPLETED|Overall Study||8
8469256|NCT00667602|20869048|P3|COMPLETED|Overall Study||197
8469257|NCT00667602|20869049|P2|COMPLETED|Overall Study||213
8469258|NCT00667602|20869050|P1|COMPLETED|Overall Study||211
8469259|NCT00667602|20869048|P3|STARTED|Overall Study||215
8469260|NCT00667602|20869049|P2|STARTED|Overall Study||228
8469261|NCT00667602|20869050|P1|STARTED|Overall Study||219
8469262|NCT00667589|20869100|P4|NOT COMPLETED|Overall Study||1
8469263|NCT00667589|20869101|P3|NOT COMPLETED|Overall Study||3
8469264|NCT00667589|20869102|P2|NOT COMPLETED|Overall Study||0
8469265|NCT00667589|20869103|P1|NOT COMPLETED|Overall Study||1
8469266|NCT00667589|20869100|P4|COMPLETED|Overall Study||1
8469267|NCT00667589|20869101|P3|COMPLETED|Overall Study||0
8469268|NCT00667589|20869102|P2|COMPLETED|Overall Study||0
8469269|NCT00667589|20869103|P1|COMPLETED|Overall Study||0
8469270|NCT00667589|20869100|P4|STARTED|Overall Study||2
8469271|NCT00667589|20869101|P3|STARTED|Overall Study||3
8469272|NCT00667589|20869102|P2|STARTED|Overall Study||0
8469273|NCT00667589|20869103|P1|STARTED|Overall Study||1
8469274|NCT00667576|20869118|P5|NOT COMPLETED|Overall Study||1
8469275|NCT00667576|20869119|P4|NOT COMPLETED|Overall Study||4
8469276|NCT00667576|20869120|P3|NOT COMPLETED|Overall Study||2
8469277|NCT00667576|20869121|P2|NOT COMPLETED|Overall Study||1
8469278|NCT00667576|20869122|P1|NOT COMPLETED|Overall Study||2
8469279|NCT00667576|20869118|P5|COMPLETED|Overall Study||29
8469280|NCT00667576|20869119|P4|COMPLETED|Overall Study||27
8469281|NCT00667576|20869120|P3|COMPLETED|Overall Study||29
8469282|NCT00667576|20869121|P2|COMPLETED|Overall Study||30
8469283|NCT00667576|20869122|P1|COMPLETED|Overall Study||28
8469284|NCT00667576|20869118|P5|STARTED|Overall Study||30
8469285|NCT00667576|20869119|P4|STARTED|Overall Study||31
8469286|NCT00667576|20869120|P3|STARTED|Overall Study||31
8469287|NCT00667576|20869121|P2|STARTED|Overall Study||31
8469288|NCT00667576|20869122|P1|STARTED|Overall Study||30
8469289|NCT00667563|20869169|P1|NOT COMPLETED|Overall Study||24
8469290|NCT00667563|20869169|P1|COMPLETED|Overall Study||126
8469291|NCT00667563|20869169|P1|STARTED|Overall Study||150
8469292|NCT00667511|20869179|P1|NOT COMPLETED|Intervention 2: Home NHD||4
8469293|NCT00667511|20869179|P1|COMPLETED|Intervention 2: Home NHD||39
8469294|NCT00667511|20869179|P1|STARTED|Intervention 2: Home NHD||43
8469295|NCT00667511|20869179|P1|NOT COMPLETED|Training/Transition Period||8
8469296|NCT00667511|20869179|P1|COMPLETED|Training/Transition Period||43
8469297|NCT00667511|20869179|P1|STARTED|Training/Transition Period||51
8469298|NCT00667511|20869179|P1|NOT COMPLETED|Intervention 1: Home DHD||7
8469299|NCT00667511|20869179|P1|COMPLETED|Intervention 1: Home DHD||51
8469300|NCT00667511|20869179|P1|STARTED|Intervention 1: Home DHD||58
8469301|NCT00667459|20869189|P2|NOT COMPLETED|Overall Study||45
8469302|NCT00667459|20869190|P1|NOT COMPLETED|Overall Study||8
8469303|NCT00667459|20869189|P2|COMPLETED|Overall Study||220
8469304|NCT00667459|20869190|P1|COMPLETED|Overall Study||272
8469305|NCT00667459|20869189|P2|STARTED|Overall Study||265
8469306|NCT00667459|20869190|P1|STARTED|Overall Study||280
8469307|NCT00667446|20869232|P2|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
8469308|NCT00667446|20869233|P1|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
8469309|NCT00667446|20869232|P2|COMPLETED|Safety Follow-up Period (12 Weeks)||25
8469310|NCT00667446|20869233|P1|COMPLETED|Safety Follow-up Period (12 Weeks)||28
8469311|NCT00667446|20869232|P2|STARTED|Safety Follow-up Period (12 Weeks)||26
8469312|NCT00667446|20869233|P1|STARTED|Safety Follow-up Period (12 Weeks)||28
8469313|NCT00667446|20869232|P2|NOT COMPLETED|Treatment Period (36 Months)||25
8469314|NCT00667446|20869233|P1|NOT COMPLETED|Treatment Period (36 Months)||23
8469315|NCT00667446|20869232|P2|COMPLETED|Treatment Period (36 Months)||13
8469316|NCT00667446|20869233|P1|COMPLETED|Treatment Period (36 Months)||11
8469317|NCT00667446|20869232|P2|STARTED|Treatment Period (36 Months)||38
8469318|NCT00667446|20869233|P1|STARTED|Treatment Period (36 Months)||34
8469319|NCT00667420|20869255|P1|NOT COMPLETED|Overall Study||10
8469320|NCT00667420|20869255|P1|COMPLETED|Overall Study||7
8469321|NCT00667420|20869255|P1|Completion of Surgery/Re-staging|Overall Study||11
8469322|NCT00667420|20869255|P1|Completion of Pre-operative EOX-P|Overall Study||15
8469323|NCT00667420|20869255|P1|STARTED|Overall Study||17
8469324|NCT00667394|20869265|P2|NOT COMPLETED|Overall Study||0
8469325|NCT00667394|20869266|P1|NOT COMPLETED|Overall Study||4
8469326|NCT00667394|20869265|P2|COMPLETED|Overall Study||1
8469327|NCT00667394|20869266|P1|COMPLETED|Overall Study||37
8469328|NCT00667394|20869265|P2|STARTED|Overall Study||1
8469329|NCT00667394|20869266|P1|STARTED|Overall Study||41
8469330|NCT00667381|20869276|P2|NOT COMPLETED|Overall Study||0
8469331|NCT00667381|20869277|P1|NOT COMPLETED|Overall Study||0
8469332|NCT00667381|20869276|P2|COMPLETED|Overall Study||503
8469333|NCT00667381|20869277|P1|COMPLETED|Overall Study||501
8469334|NCT00667381|20869276|P2|STARTED|Overall Study||503
8469335|NCT00667381|20869277|P1|STARTED|Overall Study||501
8469336|NCT00667368|20869293|P2|NOT COMPLETED|Overall Study||172
8469337|NCT00667368|20869294|P1|NOT COMPLETED|Overall Study||200
8469338|NCT00667368|20869293|P2|COMPLETED|Overall Study||511
8469339|NCT00667368|20869294|P1|COMPLETED|Overall Study||482
8469340|NCT00667368|20869293|P2|STARTED|Overall Study||683
8469341|NCT00667368|20869294|P1|STARTED|Overall Study||682
8469342|NCT00667355|20869302|P1|NOT COMPLETED|Overall Study||11
8469343|NCT00667355|20869302|P1|COMPLETED|Overall Study||30
8469344|NCT00667355|20869302|P1|STARTED|Overall Study||41
8469345|NCT00667342|20869327|P3|NOT COMPLETED|Overall Study||9
8469346|NCT00667342|20869328|P2|NOT COMPLETED|Overall Study||0
8469347|NCT00667342|20869329|P1|NOT COMPLETED|Overall Study||14
8469348|NCT00667342|20869327|P3|COMPLETED|Overall Study||3
8469349|NCT00667342|20869328|P2|COMPLETED|Overall Study||0
8469350|NCT00667342|20869329|P1|COMPLETED|Overall Study||17
8469351|NCT00667342|20869327|P3|STARTED|Overall Study||12
8469352|NCT00667342|20869328|P2|STARTED|Overall Study||0
8469353|NCT00667342|20869329|P1|STARTED|Overall Study||31
8469354|NCT00667277|20869367|P1|NOT COMPLETED|Overall Study||2
8469355|NCT00667277|20869367|P1|COMPLETED|Overall Study||11
8469356|NCT00667277|20869367|P1|STARTED|Overall Study||13
8469369|NCT00667225|20869401|P2|NOT COMPLETED|Overall Study||1
8469370|NCT00667225|20869402|P1|NOT COMPLETED|Overall Study||1
8469371|NCT00667225|20869401|P2|COMPLETED|Overall Study||12
8469372|NCT00667225|20869402|P1|COMPLETED|Overall Study||15
8469373|NCT00667225|20869401|P2|STARTED|Overall Study||13
8469374|NCT00667225|20869402|P1|STARTED|Overall Study||16
8469375|NCT00667186|20869412|P2|NOT COMPLETED|Overall Study||0
8469376|NCT00667186|20869413|P1|NOT COMPLETED|Overall Study||0
8469377|NCT00667186|20869412|P2|COMPLETED|Overall Study||4880
8469378|NCT00667186|20869413|P1|COMPLETED|Overall Study||4692
8469379|NCT00667186|20869412|P2|STARTED|Overall Study||4880
8469380|NCT00667186|20869413|P1|STARTED|Overall Study||4692
8469381|NCT00667095|20869423|P2|NOT COMPLETED|Overall Study||1
8469382|NCT00667095|20869424|P1|NOT COMPLETED|Overall Study||0
8469383|NCT00667095|20869423|P2|COMPLETED|Overall Study||9
8469384|NCT00667095|20869424|P1|COMPLETED|Overall Study||11
8469385|NCT00667095|20869423|P2|STARTED|Overall Study||10
8469386|NCT00667095|20869424|P1|STARTED|Overall Study||11
8469387|NCT00667017|20869440|P1|NOT COMPLETED|Overall Study||1
8469388|NCT00667017|20869440|P1|COMPLETED|Overall Study||0
8469389|NCT00667017|20869440|P1|STARTED|Overall Study||1
8469390|NCT00667004|20869446|P2|NOT COMPLETED|Overall Study||3
8469391|NCT00667004|20869447|P1|NOT COMPLETED|Overall Study||2
8469392|NCT00667004|20869446|P2|COMPLETED|Overall Study||85
8469393|NCT00667004|20869447|P1|COMPLETED|Overall Study||93
8469394|NCT00667004|20869446|P2|STARTED|Overall Study||88
8469395|NCT00667004|20869447|P1|STARTED|Overall Study||95
8469396|NCT00666978|20869455|P2|NOT COMPLETED|Overall Study||83
8469397|NCT00666978|20869456|P1|NOT COMPLETED|Overall Study||78
8469398|NCT00666978|20869455|P2|COMPLETED|Overall Study||187
8469399|NCT00666978|20869456|P1|COMPLETED|Overall Study||192
8469400|NCT00666978|20869455|P2|STARTED|Overall Study||270
8469401|NCT00666978|20869456|P1|STARTED|Overall Study||270
8469402|NCT00666965|20869469|P4|NOT COMPLETED|Overall Study||15
8469403|NCT00666965|20869470|P3|NOT COMPLETED|Overall Study||2
8469404|NCT00666965|20869471|P2|NOT COMPLETED|Overall Study||4
8469405|NCT00666965|20869472|P1|NOT COMPLETED|Overall Study||3
8469406|NCT00666965|20869469|P4|COMPLETED|Overall Study||42
8469407|NCT00666965|20869470|P3|COMPLETED|Overall Study||56
8469408|NCT00666965|20869471|P2|COMPLETED|Overall Study||53
8469409|NCT00666965|20869472|P1|COMPLETED|Overall Study||55
8469410|NCT00666965|20869469|P4|STARTED|Overall Study||57
8469411|NCT00666965|20869470|P3|STARTED|Overall Study||58
8469412|NCT00666965|20869471|P2|STARTED|Overall Study||57
8469413|NCT00666965|20869472|P1|STARTED|Overall Study||58
8469414|NCT00666926|20869502|P16|NOT COMPLETED|Overall Study||8
8469415|NCT00666926|20869503|P15|NOT COMPLETED|Overall Study||7
8469416|NCT00666926|20869504|P14|NOT COMPLETED|Overall Study||4
8469417|NCT00666926|20869505|P13|NOT COMPLETED|Overall Study||3
8469418|NCT00666926|20869506|P12|NOT COMPLETED|Overall Study||33
8469419|NCT00666926|20869507|P11|NOT COMPLETED|Overall Study||6
8469420|NCT00666926|20869508|P10|NOT COMPLETED|Overall Study||10
8469421|NCT00666926|20869509|P9|NOT COMPLETED|Overall Study||3
8469422|NCT00666926|20869510|P8|NOT COMPLETED|Overall Study||1
8469423|NCT00666926|20869511|P7|NOT COMPLETED|Overall Study||4
8469424|NCT00666926|20869512|P6|NOT COMPLETED|Overall Study||4
8469425|NCT00666926|20869513|P5|NOT COMPLETED|Overall Study||3
8469426|NCT00666926|20869514|P4|NOT COMPLETED|Overall Study||4
8469427|NCT00666926|20869515|P3|NOT COMPLETED|Overall Study||3
8469428|NCT00666926|20869516|P2|NOT COMPLETED|Overall Study||4
8469429|NCT00666926|20869517|P1|NOT COMPLETED|Overall Study||2
8469430|NCT00666926|20869502|P16|COMPLETED|Overall Study||0
8469431|NCT00666926|20869503|P15|COMPLETED|Overall Study||0
8469432|NCT00666926|20869504|P14|COMPLETED|Overall Study||0
8469433|NCT00666926|20869505|P13|COMPLETED|Overall Study||0
8469434|NCT00666926|20869506|P12|COMPLETED|Overall Study||0
8469435|NCT00666926|20869507|P11|COMPLETED|Overall Study||0
8469436|NCT00666926|20869508|P10|COMPLETED|Overall Study||0
8469437|NCT00666926|20869509|P9|COMPLETED|Overall Study||0
8469438|NCT00666926|20869510|P8|COMPLETED|Overall Study||0
8469439|NCT00666926|20869511|P7|COMPLETED|Overall Study||0
8469440|NCT00666926|20869512|P6|COMPLETED|Overall Study||0
8469441|NCT00666926|20869513|P5|COMPLETED|Overall Study||0
8469442|NCT00666926|20869514|P4|COMPLETED|Overall Study||0
8469443|NCT00666926|20869515|P3|COMPLETED|Overall Study||0
8469444|NCT00666926|20869516|P2|COMPLETED|Overall Study||0
8469445|NCT00666926|20869517|P1|COMPLETED|Overall Study||0
8469446|NCT00666926|20869502|P16|STARTED|Overall Study||8
8469447|NCT00666926|20869503|P15|STARTED|Overall Study||7
8469448|NCT00666926|20869504|P14|STARTED|Overall Study||4
8469449|NCT00666926|20869505|P13|STARTED|Overall Study||3
8469450|NCT00666926|20869506|P12|STARTED|Overall Study||33
8469451|NCT00666926|20869507|P11|STARTED|Overall Study||6
8469452|NCT00666926|20869508|P10|STARTED|Overall Study||10
8469453|NCT00666926|20869509|P9|STARTED|Overall Study||3
8469454|NCT00666926|20869510|P8|STARTED|Overall Study||1
8469455|NCT00666926|20869511|P7|STARTED|Overall Study||4
8469456|NCT00666926|20869512|P6|STARTED|Overall Study||4
8469457|NCT00666926|20869513|P5|STARTED|Overall Study||3
8469458|NCT00666926|20869514|P4|STARTED|Overall Study||4
8469459|NCT00666926|20869515|P3|STARTED|Overall Study||3
8469460|NCT00666926|20869516|P2|STARTED|Overall Study||4
8469461|NCT00666926|20869517|P1|STARTED|Overall Study||2
8469462|NCT00666848|20869811|P3|NOT COMPLETED|Overall Study||0
8469463|NCT00666848|20869812|P2|NOT COMPLETED|Overall Study||0
8469464|NCT00666848|20869813|P1|NOT COMPLETED|Overall Study||0
8469465|NCT00666848|20869811|P3|COMPLETED|Overall Study|finished Aim 3|7
8469466|NCT00666848|20869812|P2|COMPLETED|Overall Study|finished Aim 1|9
8469467|NCT00666848|20869813|P1|COMPLETED|Overall Study|finished Aim 2|8
8469468|NCT00666848|20869811|P3|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
8469469|NCT00666848|20869812|P2|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
8469470|NCT00666848|20869813|P1|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
8469471|NCT00666835|20869826|P2|NOT COMPLETED|Overall Study||22
8469472|NCT00666835|20869827|P1|NOT COMPLETED|Overall Study||53
8469473|NCT00666835|20869826|P2|COMPLETED|Overall Study||142
8469474|NCT00666835|20869827|P1|COMPLETED|Overall Study||261
8469475|NCT00666835|20869826|P2|STARTED|Overall Study||164
8469476|NCT00666835|20869827|P1|STARTED|Overall Study||314
8469477|NCT00666757|20869837|P2|NOT COMPLETED|Overall Study||97
8469478|NCT00666757|20869838|P1|NOT COMPLETED|Overall Study||100
8469479|NCT00666757|20869837|P2|COMPLETED|Overall Study||281
8469480|NCT00666757|20869838|P1|COMPLETED|Overall Study||272
8469481|NCT00666757|20869837|P2|STARTED|Overall Study||378
8469482|NCT00666757|20869838|P1|STARTED|Overall Study||372
8469483|NCT00666718|20869897|P2|NOT COMPLETED|Overall Study||18
8469484|NCT00666718|20869898|P1|NOT COMPLETED|Overall Study||12
8469485|NCT00666718|20869897|P2|COMPLETED|Overall Study||169
8469486|NCT00666718|20869898|P1|COMPLETED|Overall Study||175
8469487|NCT00666718|20869897|P2|STARTED|Overall Study||187
8469488|NCT00666718|20869898|P1|STARTED|Overall Study||187
8469489|NCT00666705|20869924|P1|NOT COMPLETED|Overall Study||1
8469490|NCT00666705|20869924|P1|COMPLETED|Overall Study||17
8469491|NCT00666705|20869924|P1|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
8469492|NCT00666705|20869924|P1|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
8469493|NCT00666705|20869924|P1|Washout (Days 4 - 5)|Overall Study||18
8469494|NCT00666705|20869924|P1|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
8469495|NCT00666705|20869924|P1|STARTED|Overall Study||18
8469496|NCT00666679|20869943|P2|NOT COMPLETED|Second Intervention||1
8469497|NCT00666679|20869944|P1|NOT COMPLETED|Second Intervention||1
8469498|NCT00666679|20869943|P2|COMPLETED|Second Intervention||64
8469499|NCT00666679|20869944|P1|COMPLETED|Second Intervention||61
8469500|NCT00666679|20869943|P2|STARTED|Second Intervention||65
8469501|NCT00666679|20869944|P1|STARTED|Second Intervention||62
8469502|NCT00666679|20869943|P2|NOT COMPLETED|Washout Period of 1 Week||2
8469503|NCT00666679|20869944|P1|NOT COMPLETED|Washout Period of 1 Week||0
8469504|NCT00666679|20869943|P2|COMPLETED|Washout Period of 1 Week||65
8469505|NCT00666679|20869944|P1|COMPLETED|Washout Period of 1 Week||62
8469506|NCT00666679|20869943|P2|STARTED|Washout Period of 1 Week||67
8469507|NCT00666679|20869944|P1|STARTED|Washout Period of 1 Week||62
8469508|NCT00666679|20869943|P2|NOT COMPLETED|First Intervention||1
8469509|NCT00666679|20869944|P1|NOT COMPLETED|First Intervention||4
8469510|NCT00666679|20869943|P2|COMPLETED|First Intervention||67
8469511|NCT00666679|20869944|P1|COMPLETED|First Intervention||62
8469512|NCT00666679|20869943|P2|STARTED|First Intervention||68
8469513|NCT00666679|20869944|P1|STARTED|First Intervention||66
8469514|NCT00666666|20869964|P1|NOT COMPLETED|Overall Study||0
8469515|NCT00666666|20869964|P1|COMPLETED|Overall Study||55
8469516|NCT00666666|20869964|P1|STARTED|Overall Study||55
8469517|NCT00666588|20869974|P4|NOT COMPLETED|Overall Study||2
8469518|NCT00666588|20869975|P3|NOT COMPLETED|Overall Study||0
8469519|NCT00666588|20869976|P2|NOT COMPLETED|Overall Study||0
8469520|NCT00666588|20869977|P1|NOT COMPLETED|Overall Study||4
8469521|NCT00666588|20869974|P4|COMPLETED|Overall Study||20
8469522|NCT00666588|20869975|P3|COMPLETED|Overall Study||6
8469523|NCT00666588|20869976|P2|COMPLETED|Overall Study||6
8469524|NCT00666588|20869977|P1|COMPLETED|Overall Study||14
8469525|NCT00666588|20869974|P4|STARTED|Overall Study||22
8469526|NCT00666588|20869975|P3|STARTED|Overall Study||6
8469527|NCT00666588|20869976|P2|STARTED|Overall Study||6
8469528|NCT00666588|20869977|P1|STARTED|Overall Study||18
8469529|NCT00666562|20870010|P3|NOT COMPLETED|Overall Study||0
8469530|NCT00666562|20870011|P2|NOT COMPLETED|Overall Study||2
8469531|NCT00666562|20870012|P1|NOT COMPLETED|Overall Study||0
8469532|NCT00666562|20870010|P3|COMPLETED|Overall Study||10
8469533|NCT00666562|20870011|P2|COMPLETED|Overall Study||8
8469534|NCT00666562|20870012|P1|COMPLETED|Overall Study||11
8469535|NCT00666562|20870010|P3|STARTED|Overall Study||10
8469536|NCT00666562|20870011|P2|STARTED|Overall Study||10
8469537|NCT00666562|20870012|P1|STARTED|Overall Study||11
8469538|NCT00666536|20870059|P2|NOT COMPLETED|Overall Study||37
8469539|NCT00666536|20870060|P1|NOT COMPLETED|Overall Study||33
8469540|NCT00666536|20870059|P2|COMPLETED|Overall Study||322
8469541|NCT00666536|20870060|P1|COMPLETED|Overall Study||336
8469542|NCT00666536|20870059|P2|STARTED|Overall Study||359
8469543|NCT00666536|20870060|P1|STARTED|Overall Study||369
8469544|NCT00666458|20870078|P2|NOT COMPLETED|Overall Study||24
8469545|NCT00666458|20870079|P1|NOT COMPLETED|Overall Study||38
8469546|NCT00666458|20870078|P2|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
8469547|NCT00666458|20870079|P1|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
8469548|NCT00666458|20870078|P2|STARTED|Overall Study|Randomized and treated|398
8469549|NCT00666458|20870079|P1|STARTED|Overall Study|Randomized and treated|403
8469562|NCT00666328|20870167|P1|NOT COMPLETED|Overall Study||5
8469563|NCT00666328|20870167|P1|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
8469564|NCT00666328|20870167|P1|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
8469565|NCT00666328|20870167|P1|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
8469566|NCT00666276|20870180|P1|NOT COMPLETED|Overall Study||34
8469567|NCT00666276|20870180|P1|COMPLETED|Overall Study||970
8469568|NCT00666276|20870180|P1|STARTED|Overall Study||1004
8469605|NCT00666224|20870349|P2|NOT COMPLETED|Open-Label||85
8469606|NCT00666224|20870350|P1|NOT COMPLETED|Open-Label||35
8469607|NCT00666224|20870349|P2|COMPLETED|Open-Label||126
8469608|NCT00666224|20870350|P1|COMPLETED|Open-Label||163
8469609|NCT00666224|20870349|P2|STARTED|Open-Label||211
8469610|NCT00666224|20870350|P1|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
8469611|NCT00666224|20870349|P2|NOT COMPLETED|Double-Blind||27
8469612|NCT00666224|20870350|P1|NOT COMPLETED|Double-Blind||45
8469613|NCT00666224|20870349|P2|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
8469614|NCT00666224|20870350|P1|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
8469615|NCT00666224|20870349|P2|STARTED|Double-Blind||238
8469616|NCT00666224|20870350|P1|STARTED|Double-Blind||243
8469617|NCT00666211|20870369|P2|NOT COMPLETED|Overall Study||38
8469618|NCT00666211|20870370|P1|NOT COMPLETED|Overall Study||20
8469619|NCT00666211|20870369|P2|COMPLETED|Overall Study||18
8469620|NCT00666211|20870370|P1|COMPLETED|Overall Study||22
8469621|NCT00666211|20870369|P2|STARTED|Overall Study||56
8469622|NCT00666211|20870370|P1|STARTED|Overall Study||42
8469626|NCT00666029|20870403|P2|NOT COMPLETED|Overall Study||0
8469627|NCT00666029|20870404|P1|NOT COMPLETED|Overall Study||1
8469628|NCT00666029|20870403|P2|COMPLETED|Overall Study||20
8469629|NCT00666029|20870404|P1|COMPLETED|Overall Study||19
8469630|NCT00666029|20870403|P2|STARTED|Overall Study||20
8469631|NCT00666029|20870404|P1|STARTED|Overall Study||20
8469632|NCT00665925|20870416|P4|NOT COMPLETED|Overall Study||21
8469633|NCT00665925|20870417|P3|NOT COMPLETED|Overall Study||26
8469634|NCT00665925|20870418|P2|NOT COMPLETED|Overall Study||17
8469635|NCT00665925|20870419|P1|NOT COMPLETED|Overall Study||15
8469636|NCT00665925|20870416|P4|COMPLETED|Overall Study|Participants completed the study|131
8469637|NCT00665925|20870417|P3|COMPLETED|Overall Study|Participants completed the study|126
8469638|NCT00665925|20870418|P2|COMPLETED|Overall Study|Participants completed the study|59
8469639|NCT00665925|20870419|P1|COMPLETED|Overall Study|Participants completed the study|62
8469640|NCT00665925|20870416|P4|STARTED|Overall Study|Participants randomized|152
8469641|NCT00665925|20870417|P3|STARTED|Overall Study|Participants randomized|152
8469642|NCT00665925|20870418|P2|STARTED|Overall Study|Participants randomized|76
8469643|NCT00665925|20870419|P1|STARTED|Overall Study|Participants randomized|77
8469644|NCT00665847|20870830|P1|NOT COMPLETED|Overall Study||25
8469645|NCT00665847|20870830|P1|COMPLETED|Overall Study||76
8469646|NCT00665847|20870830|P1|STARTED|Overall Study||101
8469647|NCT00665704|20870842|P1|NOT COMPLETED|Overall Study||0
8469648|NCT00665704|20870842|P1|COMPLETED|Overall Study||9
8469649|NCT00665704|20870842|P1|STARTED|Overall Study||9
8469650|NCT00665652|20870847|P1|NOT COMPLETED|Overall Study||6
8469651|NCT00665652|20870847|P1|COMPLETED|Overall Study||2
8469652|NCT00665652|20870847|P1|STARTED|Overall Study||8
8469653|NCT00665626|20870853|P2|NOT COMPLETED|Overall Study||22
8469654|NCT00665626|20870854|P1|NOT COMPLETED|Overall Study||10
8469655|NCT00665626|20870853|P2|COMPLETED|Overall Study|Participants completed the study|124
8469656|NCT00665626|20870854|P1|COMPLETED|Overall Study|Participants completed the study|63
8469657|NCT00665626|20870853|P2|STARTED|Overall Study|Participants randomized|146
8469658|NCT00665626|20870854|P1|STARTED|Overall Study|Participants randomized|73
8469659|NCT00665561|20870922|P2|NOT COMPLETED|Overall Study||534
8469660|NCT00665561|20870923|P1|NOT COMPLETED|Overall Study||502
8469661|NCT00665561|20870922|P2|COMPLETED|Overall Study||596
8469662|NCT00665561|20870923|P1|COMPLETED|Overall Study||814
8469663|NCT00665561|20870922|P2|STARTED|Overall Study||1130
8469664|NCT00665561|20870923|P1|STARTED|Overall Study||1316
8469665|NCT00665470|20870959|P2|NOT COMPLETED|Overall Study||0
8469666|NCT00665470|20870960|P1|NOT COMPLETED|Overall Study||0
8469667|NCT00665470|20870959|P2|COMPLETED|Overall Study||0
8469668|NCT00665470|20870960|P1|COMPLETED|Overall Study||10
8469669|NCT00665470|20870959|P2|STARTED|Overall Study||0
8469670|NCT00665470|20870960|P1|STARTED|Overall Study||10
8469671|NCT00665457|20870968|P1|NOT COMPLETED|Overall Study||0
8469672|NCT00665457|20870968|P1|COMPLETED|Overall Study||3
8469673|NCT00665457|20870968|P1|STARTED|Overall Study||3
8469674|NCT00665444|20870973|P1|NOT COMPLETED|Overall Study||2
8469675|NCT00665444|20870973|P1|COMPLETED|Overall Study||1
8469676|NCT00665444|20870973|P1|STARTED|Overall Study||3
8469677|NCT00665431|20870985|P3|NOT COMPLETED|Overall Study||24
8469678|NCT00665431|20870986|P2|NOT COMPLETED|Overall Study||57
8469679|NCT00665431|20870987|P1|NOT COMPLETED|Overall Study||40
8469680|NCT00665431|20870985|P3|COMPLETED|Overall Study||98
8469681|NCT00665431|20870986|P2|COMPLETED|Overall Study||188
8469682|NCT00665431|20870987|P1|COMPLETED|Overall Study||203
8469683|NCT00665431|20870985|P3|STARTED|Overall Study|Safety population|122
8469684|NCT00665431|20870986|P2|STARTED|Overall Study|Safety population|245
8469685|NCT00665431|20870987|P1|STARTED|Overall Study|Safety population|243
8469686|NCT00665366|20871030|P2|NOT COMPLETED|Overall Study||59
8469687|NCT00665366|20871031|P1|NOT COMPLETED|Overall Study||58
8469688|NCT00665366|20871030|P2|COMPLETED|Overall Study||122
8469689|NCT00665366|20871031|P1|COMPLETED|Overall Study||131
8469690|NCT00665366|20871030|P2|STARTED|Overall Study|Participants randomized|181
8469691|NCT00665366|20871031|P1|STARTED|Overall Study|Participants randomized|189
8469692|NCT00665353|20871059|P1|NOT COMPLETED|Study Step 2||14
8469693|NCT00665353|20871059|P1|COMPLETED|Study Step 2||2
8469694|NCT00665353|20871059|P1|STARTED|Study Step 2||16
8469695|NCT00665353|20871059|P1|NOT COMPLETED|Study Step 1||3
8469696|NCT00665353|20871059|P1|COMPLETED|Study Step 1||16
8469697|NCT00665353|20871059|P1|STARTED|Study Step 1||19
8469698|NCT00665132|20871069|P1|NOT COMPLETED|Overall Study||0
8469699|NCT00665132|20871069|P1|COMPLETED|Overall Study||10
8469700|NCT00665132|20871069|P1|STARTED|Overall Study||10
8469701|NCT00665002|20871076|P1|NOT COMPLETED|Overall Study||12
8469702|NCT00665002|20871076|P1|COMPLETED|Overall Study||4
8469703|NCT00665002|20871076|P1|STARTED|Overall Study||16
8469704|NCT00664859|20871084|P3|NOT COMPLETED|Overall Study||21
8469705|NCT00664859|20871085|P2|NOT COMPLETED|Overall Study||10
8469706|NCT00664859|20871086|P1|NOT COMPLETED|Overall Study||17
8469707|NCT00664859|20871084|P3|COMPLETED|Overall Study||23
8469708|NCT00664859|20871085|P2|COMPLETED|Overall Study||35
8469709|NCT00664859|20871086|P1|COMPLETED|Overall Study||34
8469710|NCT00664859|20871084|P3|STARTED|Overall Study||44
8469711|NCT00664859|20871085|P2|STARTED|Overall Study||45
8469712|NCT00664859|20871086|P1|STARTED|Overall Study||51
8469713|NCT00664755|20871099|P2|NOT COMPLETED|Overall Study||0
8469714|NCT00664755|20871100|P1|NOT COMPLETED|Overall Study||0
8469715|NCT00664755|20871099|P2|COMPLETED|Overall Study||73
8469716|NCT00664755|20871100|P1|COMPLETED|Overall Study||67
8469717|NCT00664755|20871099|P2|STARTED|Overall Study||73
8469718|NCT00664755|20871100|P1|STARTED|Overall Study||67
8469719|NCT00664742|20871106|P1|NOT COMPLETED|Overall Study||126
8469720|NCT00664742|20871106|P1|COMPLETED|Overall Study||481
8469721|NCT00664742|20871106|P1|STARTED|Overall Study||607
8469722|NCT00664560|20871114|P3|NOT COMPLETED|Overall Study||19
8469723|NCT00664560|20871115|P2|NOT COMPLETED|Overall Study||35
8469724|NCT00664560|20871116|P1|NOT COMPLETED|Overall Study||39
8469725|NCT00664560|20871114|P3|COMPLETED|Overall Study||105
8469726|NCT00664560|20871115|P2|COMPLETED|Overall Study||208
8469727|NCT00664560|20871116|P1|COMPLETED|Overall Study||208
8469728|NCT00664560|20871114|P3|STARTED|Overall Study|Safety Population|124
8469729|NCT00664560|20871115|P2|STARTED|Overall Study|Safety Population|243
8469730|NCT00664560|20871116|P1|STARTED|Overall Study|Safety Population|247
8469731|NCT00664534|20871159|P2|NOT COMPLETED|Overall Study||33
8469732|NCT00664534|20871160|P1|NOT COMPLETED|Overall Study||41
8469733|NCT00664534|20871159|P2|COMPLETED|Overall Study||138
8469734|NCT00664534|20871160|P1|COMPLETED|Overall Study||132
8469735|NCT00664534|20871159|P2|STARTED|Overall Study||171
8469736|NCT00664534|20871160|P1|STARTED|Overall Study||173
8469737|NCT00664521|20871188|P2|NOT COMPLETED|Overall Study||1
8469738|NCT00664521|20871189|P1|NOT COMPLETED|Overall Study||6
8469739|NCT00664521|20871188|P2|COMPLETED|Overall Study||8
8469740|NCT00664521|20871189|P1|COMPLETED|Overall Study||12
8469741|NCT00664521|20871188|P2|STARTED|Overall Study||9
8469742|NCT00664521|20871189|P1|STARTED|Overall Study||18
8469743|NCT00664430|20871209|P1|NOT COMPLETED|Overall Study||13
8469744|NCT00664430|20871209|P1|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
8469745|NCT00664430|20871209|P1|STARTED|Overall Study||13
8469746|NCT00664209|20871215|P1|NOT COMPLETED|Study Treatment Period||6
8469747|NCT00664209|20871215|P1|COMPLETED|Study Treatment Period||0
8469748|NCT00664209|20871215|P1|STARTED|Study Treatment Period||6
8469749|NCT00664209|20871215|P1|NOT COMPLETED|Motor Fluctuations Screen||7
8469750|NCT00664209|20871215|P1|COMPLETED|Motor Fluctuations Screen||6
8469751|NCT00664209|20871215|P1|STARTED|Motor Fluctuations Screen||13
8469752|NCT00664105|20871223|P1|NOT COMPLETED|Overall Study||24
8469753|NCT00664105|20871223|P1|COMPLETED|Overall Study||39
8469754|NCT00664105|20871223|P1|STARTED|Overall Study||63
8469758|NCT00663962|20871236|P2|NOT COMPLETED|Overall Study||0
8469759|NCT00663962|20871237|P1|NOT COMPLETED|Overall Study||1
8469760|NCT00663962|20871236|P2|COMPLETED|Overall Study||8
8469761|NCT00663962|20871237|P1|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
8469762|NCT00663962|20871236|P2|STARTED|Overall Study||8
8469763|NCT00663962|20871237|P1|STARTED|Overall Study||7
8469764|NCT00663923|20871243|P1|NOT COMPLETED|Overall Study||2
8469765|NCT00663923|20871243|P1|COMPLETED|Overall Study||48
8469766|NCT00663923|20871243|P1|STARTED|Overall Study||50
8469767|NCT00663858|20871260|P3|NOT COMPLETED|Overall Study||20
8469768|NCT00663858|20871261|P2|NOT COMPLETED|Overall Study||10
8469769|NCT00663858|20871262|P1|NOT COMPLETED|Overall Study||34
8469770|NCT00663858|20871260|P3|COMPLETED|Overall Study||82
8469771|NCT00663858|20871261|P2|COMPLETED|Overall Study||96
8469772|NCT00663858|20871262|P1|COMPLETED|Overall Study||178
8469773|NCT00663858|20871260|P3|STARTED|Overall Study||102
8469774|NCT00663858|20871261|P2|STARTED|Overall Study||106
8469775|NCT00663858|20871262|P1|STARTED|Overall Study||212
8469776|NCT00663819|20871272|P2|NOT COMPLETED|Overall Study||0
8469777|NCT00663819|20871273|P1|NOT COMPLETED|Overall Study||0
8469778|NCT00663819|20871272|P2|COMPLETED|Overall Study||135
8469779|NCT00663819|20871273|P1|COMPLETED|Overall Study||123
8469780|NCT00663819|20871272|P2|STARTED|Overall Study||135
8469781|NCT00663819|20871273|P1|STARTED|Overall Study||123
8469782|NCT00663793|20871287|P2|NOT COMPLETED|Overall Study||0
8469783|NCT00663793|20871288|P1|NOT COMPLETED|Overall Study||0
8469784|NCT00663793|20871287|P2|COMPLETED|Overall Study||8
8469785|NCT00663793|20871288|P1|COMPLETED|Overall Study||8
8469786|NCT00663793|20871287|P2|STARTED|Overall Study||8
8469787|NCT00663793|20871288|P1|STARTED|Overall Study||8
8469788|NCT00663702|20871300|P2|NOT COMPLETED|Overall Study||10
8469789|NCT00663702|20871301|P1|NOT COMPLETED|Overall Study||18
8469790|NCT00663702|20871300|P2|COMPLETED|Overall Study||61
8469791|NCT00663702|20871301|P1|COMPLETED|Overall Study||34
8469792|NCT00663702|20871300|P2|STARTED|Overall Study||71
8469793|NCT00663702|20871301|P1|STARTED|Overall Study||52
8469794|NCT00663403|20871324|P1|NOT COMPLETED|Overall Study||0
8469795|NCT00663403|20871324|P1|COMPLETED|Overall Study||8
8469796|NCT00663403|20871324|P1|STARTED|Overall Study||8
8469797|NCT00663260|20871337|P3|NOT COMPLETED|Overall Study||16
8469798|NCT00663260|20871338|P2|NOT COMPLETED|Overall Study||11
8469799|NCT00663260|20871339|P1|NOT COMPLETED|Overall Study||21
8469800|NCT00663260|20871337|P3|COMPLETED|Overall Study||69
8469801|NCT00663260|20871338|P2|COMPLETED|Overall Study||72
8469802|NCT00663260|20871339|P1|COMPLETED|Overall Study||63
8469803|NCT00663260|20871337|P3|STARTED|Overall Study||85
8469804|NCT00663260|20871338|P2|STARTED|Overall Study||83
8469805|NCT00663260|20871339|P1|STARTED|Overall Study||84
8469806|NCT00663234|20871353|P1|NOT COMPLETED|Overall Study||1
8469807|NCT00663234|20871353|P1|COMPLETED|Overall Study||27
8469808|NCT00663234|20871353|P1|Dose Increased to 20 mg at Week 8|Overall Study||10
8469809|NCT00663234|20871353|P1|STARTED|Overall Study||28
8469810|NCT00663208|20871386|P7|NOT COMPLETED|Follow-up Period||1
8469811|NCT00663208|20871387|P6|NOT COMPLETED|Follow-up Period||0
8469812|NCT00663208|20871388|P5|NOT COMPLETED|Follow-up Period||0
8469813|NCT00663208|20871389|P4|NOT COMPLETED|Follow-up Period||2
8469814|NCT00663208|20871390|P3|NOT COMPLETED|Follow-up Period||3
8469815|NCT00663208|20871391|P2|NOT COMPLETED|Follow-up Period||0
8469816|NCT00663208|20871392|P1|NOT COMPLETED|Follow-up Period||3
8469817|NCT00663208|20871386|P7|COMPLETED|Follow-up Period||5
8469818|NCT00663208|20871387|P6|COMPLETED|Follow-up Period||4
8469819|NCT00663208|20871388|P5|COMPLETED|Follow-up Period||4
8469820|NCT00663208|20871389|P4|COMPLETED|Follow-up Period||2
8469821|NCT00663208|20871390|P3|COMPLETED|Follow-up Period||1
8469822|NCT00663208|20871391|P2|COMPLETED|Follow-up Period||3
8469823|NCT00663208|20871392|P1|COMPLETED|Follow-up Period||1
8469824|NCT00663208|20871386|P7|STARTED|Follow-up Period||6
8469825|NCT00663208|20871387|P6|STARTED|Follow-up Period||4
8469826|NCT00663208|20871388|P5|STARTED|Follow-up Period||4
8469827|NCT00663208|20871389|P4|STARTED|Follow-up Period||4
8469828|NCT00663208|20871390|P3|STARTED|Follow-up Period||4
8469829|NCT00663208|20871391|P2|STARTED|Follow-up Period||3
8469830|NCT00663208|20871392|P1|STARTED|Follow-up Period||4
8469831|NCT00663208|20871386|P7|NOT COMPLETED|Treatment Period||0
8469832|NCT00663208|20871387|P6|NOT COMPLETED|Treatment Period||0
8469833|NCT00663208|20871388|P5|NOT COMPLETED|Treatment Period||0
8469834|NCT00663208|20871389|P4|NOT COMPLETED|Treatment Period||0
8469835|NCT00663208|20871390|P3|NOT COMPLETED|Treatment Period||0
8469836|NCT00663208|20871391|P2|NOT COMPLETED|Treatment Period||1
8469837|NCT00663208|20871392|P1|NOT COMPLETED|Treatment Period||0
8469838|NCT00663208|20871386|P7|COMPLETED|Treatment Period||6
8469839|NCT00663208|20871387|P6|COMPLETED|Treatment Period||4
8469840|NCT00663208|20871388|P5|COMPLETED|Treatment Period||4
8469841|NCT00663208|20871389|P4|COMPLETED|Treatment Period||4
8469842|NCT00663208|20871390|P3|COMPLETED|Treatment Period||4
8469843|NCT00663208|20871391|P2|COMPLETED|Treatment Period||3
8469844|NCT00663208|20871392|P1|COMPLETED|Treatment Period||4
8469845|NCT00663208|20871386|P7|STARTED|Treatment Period||6
8469846|NCT00663208|20871387|P6|STARTED|Treatment Period||4
8469847|NCT00663208|20871388|P5|STARTED|Treatment Period||4
8469848|NCT00663208|20871389|P4|STARTED|Treatment Period||4
8469849|NCT00663208|20871390|P3|STARTED|Treatment Period||4
8469850|NCT00663208|20871391|P2|STARTED|Treatment Period||4
8469851|NCT00663208|20871392|P1|STARTED|Treatment Period||4
8469852|NCT00663169|20871544|P2|NOT COMPLETED|Overall Study||0
8469853|NCT00663169|20871545|P1|NOT COMPLETED|Overall Study||0
8469854|NCT00663169|20871544|P2|COMPLETED|Overall Study||3
8469855|NCT00663169|20871545|P1|COMPLETED|Overall Study||3
8469856|NCT00663169|20871544|P2|STARTED|Overall Study||3
8469857|NCT00663169|20871545|P1|STARTED|Overall Study||3
8469858|NCT00663117|20871570|P2|NOT COMPLETED|Overall Study||0
8469859|NCT00663117|20871571|P1|NOT COMPLETED|Overall Study||1
8469860|NCT00663117|20871570|P2|COMPLETED|Overall Study||20
8469861|NCT00663117|20871571|P1|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
8469862|NCT00663117|20871570|P2|STARTED|Overall Study||20
8469863|NCT00663117|20871571|P1|STARTED|Overall Study||20
8469864|NCT00663052|20871585|P2|NOT COMPLETED|Overall Study||10
8469865|NCT00663052|20871586|P1|NOT COMPLETED|Overall Study||12
8469866|NCT00663052|20871585|P2|COMPLETED|Overall Study||127
8469867|NCT00663052|20871586|P1|COMPLETED|Overall Study||124
8469868|NCT00663052|20871585|P2|STARTED|Overall Study||137
8469869|NCT00663052|20871586|P1|STARTED|Overall Study||136
8469870|NCT00663039|20871666|P2|NOT COMPLETED|Overall Study||4
8469871|NCT00663039|20871667|P1|NOT COMPLETED|Overall Study||4
8469872|NCT00663039|20871666|P2|COMPLETED|Overall Study||9
8469873|NCT00663039|20871667|P1|COMPLETED|Overall Study||10
8469874|NCT00663039|20871666|P2|STARTED|Overall Study||13
8469875|NCT00663039|20871667|P1|STARTED|Overall Study||14
8469876|NCT00663026|20871692|P3|NOT COMPLETED|Overall Study||4
8469877|NCT00663026|20871693|P2|NOT COMPLETED|Overall Study||6
8469878|NCT00663026|20871694|P1|NOT COMPLETED|Overall Study||2
8469879|NCT00663026|20871692|P3|COMPLETED|Overall Study||27
8469880|NCT00663026|20871693|P2|COMPLETED|Overall Study||23
8469881|NCT00663026|20871694|P1|COMPLETED|Overall Study||17
8469882|NCT00663026|20871692|P3|STARTED|Overall Study||31
8469883|NCT00663026|20871693|P2|STARTED|Overall Study||29
8469884|NCT00663026|20871694|P1|STARTED|Overall Study||19
8469885|NCT00662909|20871717|P3|NOT COMPLETED|Overall Study||53
8469886|NCT00662909|20871718|P2|NOT COMPLETED|Overall Study||59
8469887|NCT00662909|20871719|P1|NOT COMPLETED|Overall Study||69
8469888|NCT00662909|20871717|P3|COMPLETED|Overall Study||380
8469889|NCT00662909|20871718|P2|COMPLETED|Overall Study||383
8469890|NCT00662909|20871719|P1|COMPLETED|Overall Study||385
8469891|NCT00662909|20871717|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
8469892|NCT00662909|20871718|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
8469893|NCT00662909|20871719|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
8469894|NCT00662909|20871717|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
8469895|NCT00662909|20871718|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
8469896|NCT00662909|20871719|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
8469897|NCT00662909|20871717|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
8469898|NCT00662909|20871718|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
8469899|NCT00662909|20871719|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
8469900|NCT00662909|20871717|P3|STARTED|Overall Study||433
8469901|NCT00662909|20871718|P2|STARTED|Overall Study||442
8469902|NCT00662909|20871719|P1|STARTED|Overall Study||454
8469903|NCT00662857|20871817|P2|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
8469904|NCT00662857|20871818|P1|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
8469905|NCT00662857|20871817|P2|COMPLETED|Lispro Dosing Period (1 Day)||14
8469906|NCT00662857|20871818|P1|COMPLETED|Lispro Dosing Period (1 Day)||12
8469907|NCT00662857|20871817|P2|STARTED|Lispro Dosing Period (1 Day)||14
8469908|NCT00662857|20871818|P1|STARTED|Lispro Dosing Period (1 Day)||12
8469909|NCT00662857|20871817|P2|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
8469910|NCT00662857|20871818|P1|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
8469911|NCT00662857|20871817|P2|COMPLETED|Washout 2 (3 - 14 Days)||14
8469912|NCT00662857|20871818|P1|COMPLETED|Washout 2 (3 - 14 Days)||12
8469913|NCT00662857|20871817|P2|STARTED|Washout 2 (3 - 14 Days)||14
8469914|NCT00662857|20871818|P1|STARTED|Washout 2 (3 - 14 Days)||13
8469915|NCT00662857|20871817|P2|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
8469916|NCT00662857|20871818|P1|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
8469917|NCT00662857|20871817|P2|COMPLETED|TI Dosing Period 2 (1 Day)||14
8469918|NCT00662857|20871818|P1|COMPLETED|TI Dosing Period 2 (1 Day)||13
8469919|NCT00662857|20871817|P2|STARTED|TI Dosing Period 2 (1 Day)||14
8469920|NCT00662857|20871818|P1|STARTED|TI Dosing Period 2 (1 Day)||13
8469921|NCT00662857|20871817|P2|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
8469922|NCT00662857|20871818|P1|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
8469923|NCT00662857|20871817|P2|COMPLETED|Washout 1 (3 - 14 Days)||14
8469924|NCT00662857|20871818|P1|COMPLETED|Washout 1 (3 - 14 Days)||13
8469925|NCT00662857|20871817|P2|STARTED|Washout 1 (3 - 14 Days)||16
8469926|NCT00662857|20871818|P1|STARTED|Washout 1 (3 - 14 Days)||13
8469927|NCT00662857|20871817|P2|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
8469928|NCT00662857|20871818|P1|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
8469929|NCT00662857|20871817|P2|COMPLETED|TI Dosing Period 1 (1 Day)||16
8469930|NCT00662857|20871818|P1|COMPLETED|TI Dosing Period 1 (1 Day)||13
8469931|NCT00662857|20871817|P2|STARTED|TI Dosing Period 1 (1 Day)||16
8469932|NCT00662857|20871818|P1|STARTED|TI Dosing Period 1 (1 Day)||13
8469933|NCT00662831|20871833|P2|NOT COMPLETED|Overall Study||59
8469934|NCT00662831|20871834|P1|NOT COMPLETED|Overall Study||106
8469935|NCT00662831|20871833|P2|COMPLETED|Overall Study||33
8469936|NCT00662831|20871834|P1|COMPLETED|Overall Study||78
8469937|NCT00662831|20871833|P2|STARTED|Overall Study||92
8469938|NCT00662831|20871834|P1|STARTED|Overall Study||184
8469939|NCT00662818|20871874|P2|NOT COMPLETED|Period 2 (6 Weeks)||12
8469940|NCT00662818|20871875|P1|NOT COMPLETED|Period 2 (6 Weeks)||13
8469941|NCT00662818|20871874|P2|COMPLETED|Period 2 (6 Weeks)||41
8469942|NCT00662818|20871875|P1|COMPLETED|Period 2 (6 Weeks)||38
8469943|NCT00662818|20871874|P2|STARTED|Period 2 (6 Weeks)||53
8469944|NCT00662818|20871875|P1|STARTED|Period 2 (6 Weeks)||51
8469945|NCT00662818|20871874|P2|NOT COMPLETED|Wash-Out (14 Days)||5
8469946|NCT00662818|20871875|P1|NOT COMPLETED|Wash-Out (14 Days)||5
8469947|NCT00662818|20871874|P2|COMPLETED|Wash-Out (14 Days)||53
8469948|NCT00662818|20871875|P1|COMPLETED|Wash-Out (14 Days)||51
8469949|NCT00662818|20871874|P2|STARTED|Wash-Out (14 Days)||58
8469950|NCT00662818|20871875|P1|STARTED|Wash-Out (14 Days)||56
8469951|NCT00662818|20871874|P2|NOT COMPLETED|Period 1 (6 Weeks)||23
8469952|NCT00662818|20871875|P1|NOT COMPLETED|Period 1 (6 Weeks)||28
8469953|NCT00662818|20871874|P2|COMPLETED|Period 1 (6 Weeks)||58
8469954|NCT00662818|20871875|P1|COMPLETED|Period 1 (6 Weeks)||56
8469955|NCT00662818|20871874|P2|Treated|Period 1 (6 Weeks)||58
8469956|NCT00662818|20871875|P1|Treated|Period 1 (6 Weeks)||56
8469957|NCT00662818|20871874|P2|STARTED|Period 1 (6 Weeks)||81
8469958|NCT00662818|20871875|P1|STARTED|Period 1 (6 Weeks)||84
8469959|NCT00662675|20871899|P2|NOT COMPLETED|Overall Study||0
8469960|NCT00662675|20871900|P1|NOT COMPLETED|Overall Study||0
8469961|NCT00662675|20871899|P2|COMPLETED|Overall Study||20
8469962|NCT00662675|20871900|P1|COMPLETED|Overall Study||20
8469963|NCT00662675|20871899|P2|STARTED|Overall Study||20
8469964|NCT00662675|20871900|P1|STARTED|Overall Study||20
8469965|NCT00662649|20871914|P5|NOT COMPLETED|Extension Study (Month 24 to 60)||29
8469966|NCT00662649|20871915|P4|NOT COMPLETED|Extension Study (Month 24 to 60)||33
8469967|NCT00662649|20871916|P3|NOT COMPLETED|Extension Study (Month 24 to 60)||0
8469968|NCT00662649|20871917|P2|NOT COMPLETED|Extension Study (Month 24 to 60)||41
8469969|NCT00662649|20871918|P1|NOT COMPLETED|Extension Study (Month 24 to 60)||44
8469970|NCT00662649|20871914|P5|COMPLETED|Extension Study (Month 24 to 60)||126
8469971|NCT00662649|20871915|P4|COMPLETED|Extension Study (Month 24 to 60)||112
8469972|NCT00662649|20871916|P3|COMPLETED|Extension Study (Month 24 to 60)||0
8469973|NCT00662649|20871917|P2|COMPLETED|Extension Study (Month 24 to 60)||290
8469974|NCT00662649|20871918|P1|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
8469975|NCT00662649|20871914|P5|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
8469976|NCT00662649|20871915|P4|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
8469977|NCT00662649|20871916|P3|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
8469978|NCT00662649|20871917|P2|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
8469979|NCT00662649|20871918|P1|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
8469980|NCT00662649|20871914|P5|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
8469981|NCT00662649|20871915|P4|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
8469982|NCT00662649|20871916|P3|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
8469983|NCT00662649|20871917|P2|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
8469984|NCT00662649|20871918|P1|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
8469985|NCT00662649|20871914|P5|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
8469986|NCT00662649|20871915|P4|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
8469987|NCT00662649|20871916|P3|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
8469988|NCT00662649|20871917|P2|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
8469989|NCT00662649|20871918|P1|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
8469990|NCT00662649|20871914|P5|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
8469991|NCT00662649|20871915|P4|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
8469992|NCT00662649|20871916|P3|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
8469993|NCT00662649|20871917|P2|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
8469994|NCT00662649|20871918|P1|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
8469995|NCT00662649|20871914|P5|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
8469996|NCT00662649|20871915|P4|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
8469997|NCT00662649|20871916|P3|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
8469998|NCT00662649|20871917|P2|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
8469999|NCT00662649|20871918|P1|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
8470000|NCT00662649|20871914|P5|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
8470001|NCT00662649|20871915|P4|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
8470002|NCT00662649|20871916|P3|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
8470003|NCT00662649|20871917|P2|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
8470004|NCT00662649|20871918|P1|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
8470005|NCT00662649|20871914|P5|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
8470006|NCT00662649|20871915|P4|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
8470007|NCT00662649|20871916|P3|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
8470008|NCT00662649|20871917|P2|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
8470009|NCT00662649|20871918|P1|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
8470010|NCT00662649|20871914|P5|STARTED|Extension Study (Month 24 to 60)||155
8470011|NCT00662649|20871915|P4|STARTED|Extension Study (Month 24 to 60)||145
8470012|NCT00662649|20871916|P3|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
8470013|NCT00662649|20871917|P2|STARTED|Extension Study (Month 24 to 60)||331
8470014|NCT00662649|20871918|P1|STARTED|Extension Study (Month 24 to 60)||289
8470015|NCT00662649|20871914|P5|NOT COMPLETED|Core Study (24 Months)||0
8470016|NCT00662649|20871915|P4|NOT COMPLETED|Core Study (24 Months)||0
8470017|NCT00662649|20871916|P3|NOT COMPLETED|Core Study (24 Months)||86
8470018|NCT00662649|20871917|P2|NOT COMPLETED|Core Study (24 Months)||56
8470019|NCT00662649|20871918|P1|NOT COMPLETED|Core Study (24 Months)||97
8470020|NCT00662649|20871914|P5|COMPLETED|Core Study (24 Months)||0
8470021|NCT00662649|20871915|P4|COMPLETED|Core Study (24 Months)||0
8470022|NCT00662649|20871916|P3|COMPLETED|Core Study (24 Months)||332
8470023|NCT00662649|20871917|P2|COMPLETED|Core Study (24 Months)||369
8470024|NCT00662649|20871918|P1|COMPLETED|Core Study (24 Months)||332
8470025|NCT00662649|20871914|P5|Intent to Treat (ITT)|Core Study (24 Months)||0
8470026|NCT00662649|20871915|P4|Intent to Treat (ITT)|Core Study (24 Months)||0
8470027|NCT00662649|20871916|P3|Intent to Treat (ITT)|Core Study (24 Months)||418
8470028|NCT00662649|20871917|P2|Intent to Treat (ITT)|Core Study (24 Months)||425
8470029|NCT00662649|20871918|P1|Intent to Treat (ITT)|Core Study (24 Months)||429
8470030|NCT00662649|20871914|P5|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
8470031|NCT00662649|20871915|P4|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
8470032|NCT00662649|20871916|P3|STARTED|Core Study (24 Months)||418
8470033|NCT00662649|20871917|P2|STARTED|Core Study (24 Months)||425
8470034|NCT00662649|20871918|P1|STARTED|Core Study (24 Months)||429
8470043|NCT00662545|20871993|P2|NOT COMPLETED|Overall Study||0
8470044|NCT00662545|20871994|P1|NOT COMPLETED|Overall Study||0
8470045|NCT00662545|20871993|P2|COMPLETED|Overall Study||5
8470046|NCT00662545|20871994|P1|COMPLETED|Overall Study||5
8470047|NCT00662545|20871993|P2|STARTED|Overall Study||5
8470048|NCT00662545|20871994|P1|STARTED|Overall Study||5
8470049|NCT00662532|20872010|P2|NOT COMPLETED|Overall Study||2
8470050|NCT00662532|20872011|P1|NOT COMPLETED|Overall Study||0
8470051|NCT00662532|20872010|P2|COMPLETED|Overall Study||20
8470052|NCT00662532|20872011|P1|COMPLETED|Overall Study||22
8470053|NCT00662532|20872010|P2|STARTED|Overall Study||22
8470054|NCT00662532|20872011|P1|STARTED|Overall Study||22
8470055|NCT00662389|20872021|P1|NOT COMPLETED|Overall Study||0
8470056|NCT00662389|20872021|P1|COMPLETED|Overall Study||4
8470057|NCT00662389|20872021|P1|STARTED|Overall Study||4
8470058|NCT00662363|20872026|P2|NOT COMPLETED|Overall Study||10
8470059|NCT00662363|20872027|P1|NOT COMPLETED|Overall Study||11
8470060|NCT00662363|20872026|P2|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
8470061|NCT00662363|20872027|P1|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
8470062|NCT00662363|20872026|P2|STARTED|Overall Study||32
8470063|NCT00662363|20872027|P1|STARTED|Overall Study||32
8470064|NCT00662311|20872038|P3|NOT COMPLETED|Overall Study||0
8470065|NCT00662311|20872039|P2|NOT COMPLETED|Overall Study||0
8470066|NCT00662311|20872040|P1|NOT COMPLETED|Overall Study||1
8470067|NCT00662311|20872038|P3|COMPLETED|Overall Study||0
8470068|NCT00662311|20872039|P2|COMPLETED|Overall Study||0
8470069|NCT00662311|20872040|P1|COMPLETED|Overall Study||4
8470070|NCT00662311|20872038|P3|STARTED|Overall Study||0
8470071|NCT00662311|20872039|P2|STARTED|Overall Study||0
8470072|NCT00662311|20872040|P1|STARTED|Overall Study||5
8470073|NCT00662298|20872063|P1|NOT COMPLETED|Overall Study||0
8470074|NCT00662298|20872063|P1|COMPLETED|Overall Study||5
8470075|NCT00662298|20872063|P1|STARTED|Overall Study||5
8470076|NCT00662259|20872075|P2|NOT COMPLETED|Overall Study||0
8470077|NCT00662259|20872076|P1|NOT COMPLETED|Overall Study||2
8470078|NCT00662259|20872075|P2|COMPLETED|Overall Study||11
8470079|NCT00662259|20872076|P1|COMPLETED|Overall Study||19
8470080|NCT00662259|20872075|P2|STARTED|Overall Study||11
8470081|NCT00662259|20872076|P1|STARTED|Overall Study||21
8470082|NCT00662207|20872090|P1|NOT COMPLETED|Overall Study||0
8470083|NCT00662207|20872090|P1|COMPLETED|Overall Study||3
8470084|NCT00662207|20872090|P1|STARTED|Overall Study||3
8470085|NCT00662155|20872101|P4|NOT COMPLETED|Overall Study||4
8470086|NCT00662155|20872102|P3|NOT COMPLETED|Overall Study||7
8470087|NCT00662155|20872103|P2|NOT COMPLETED|Overall Study||5
8470088|NCT00662155|20872104|P1|NOT COMPLETED|Overall Study||3
8470089|NCT00662155|20872101|P4|COMPLETED|Overall Study||14
8470090|NCT00662155|20872102|P3|COMPLETED|Overall Study||13
8470091|NCT00662155|20872103|P2|COMPLETED|Overall Study||15
8470092|NCT00662155|20872104|P1|COMPLETED|Overall Study||13
8470093|NCT00662155|20872101|P4|STARTED|Overall Study||18
8470094|NCT00662155|20872102|P3|STARTED|Overall Study||20
8470095|NCT00662155|20872103|P2|STARTED|Overall Study||20
8470096|NCT00662155|20872104|P1|STARTED|Overall Study||16
8470097|NCT00662129|20872118|P1|NOT COMPLETED|Overall Study||3
8470098|NCT00662129|20872118|P1|COMPLETED|Overall Study||47
8470099|NCT00662129|20872118|P1|STARTED|Overall Study||50
8470100|NCT00662038|20872128|P1|NOT COMPLETED|Overall Study||631
8470101|NCT00662038|20872128|P1|COMPLETED|Overall Study||427
8470102|NCT00662038|20872128|P1|STARTED|Overall Study||1058
8470103|NCT00662025|20872132|P1|NOT COMPLETED|Overall Study||63
8470104|NCT00662025|20872132|P1|COMPLETED|Overall Study||0
8470105|NCT00662025|20872132|P1|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
8470109|NCT00661999|20872160|P3|NOT COMPLETED|Overall Study||57
8470110|NCT00661999|20872161|P2|NOT COMPLETED|Overall Study||50
8470111|NCT00661999|20872162|P1|NOT COMPLETED|Overall Study||59
8470112|NCT00661999|20872160|P3|COMPLETED|Overall Study||106
8470113|NCT00661999|20872161|P2|COMPLETED|Overall Study||113
8470114|NCT00661999|20872162|P1|COMPLETED|Overall Study||105
8470115|NCT00661999|20872160|P3|STARTED|Overall Study||163
8470116|NCT00661999|20872161|P2|STARTED|Overall Study||163
8470117|NCT00661999|20872162|P1|STARTED|Overall Study||164
8470118|NCT00661960|20872218|P3|NOT COMPLETED|Overall Study||1
8470119|NCT00661960|20872219|P2|NOT COMPLETED|Overall Study||3
8470120|NCT00661960|20872220|P1|NOT COMPLETED|Overall Study||0
8470121|NCT00661960|20872218|P3|COMPLETED|Overall Study||9
8470122|NCT00661960|20872219|P2|COMPLETED|Overall Study||7
8470123|NCT00661960|20872220|P1|COMPLETED|Overall Study||5
8470124|NCT00661960|20872218|P3|STARTED|Overall Study||10
8470125|NCT00661960|20872219|P2|STARTED|Overall Study||10
8470126|NCT00661960|20872220|P1|STARTED|Overall Study||5
8470127|NCT00661895|20872230|P2|NOT COMPLETED|Overall Study||0
8470128|NCT00661895|20872231|P1|NOT COMPLETED|Overall Study||0
8470129|NCT00661895|20872230|P2|COMPLETED|Overall Study||50
8470130|NCT00661895|20872231|P1|COMPLETED|Overall Study||49
8470131|NCT00661895|20872230|P2|STARTED|Overall Study||50
8470132|NCT00661895|20872231|P1|STARTED|Overall Study||49
8470133|NCT00661830|20872239|P2|NOT COMPLETED|Overall Study||42
8470134|NCT00661830|20872240|P1|NOT COMPLETED|Overall Study||40
8470135|NCT00661830|20872239|P2|COMPLETED|Overall Study||6
8470136|NCT00661830|20872240|P1|COMPLETED|Overall Study||9
8470137|NCT00661830|20872239|P2|STARTED|Overall Study||48
8470138|NCT00661830|20872240|P1|STARTED|Overall Study||49
8470139|NCT00661778|20872252|P1|NOT COMPLETED|Overall Study||50
8470140|NCT00661778|20872252|P1|COMPLETED|Overall Study||0
8470141|NCT00661778|20872252|P1|STARTED|Overall Study||50
8470142|NCT00661726|20872259|P1|NOT COMPLETED|Overall Study||1
8470143|NCT00661726|20872259|P1|COMPLETED|Overall Study||5
8470144|NCT00661726|20872259|P1|STARTED|Overall Study||6
8470145|NCT00661713|20872282|P8|NOT COMPLETED|Overall Study||11
8470146|NCT00661713|20872283|P7|NOT COMPLETED|Overall Study||64
8470147|NCT00661713|20872284|P6|NOT COMPLETED|Overall Study||37
8470148|NCT00661713|20872285|P5|NOT COMPLETED|Overall Study||20
8470149|NCT00661713|20872286|P4|NOT COMPLETED|Overall Study||28
8470150|NCT00661713|20872287|P3|NOT COMPLETED|Overall Study||17
8470151|NCT00661713|20872288|P2|NOT COMPLETED|Overall Study||39
8470152|NCT00661713|20872289|P1|NOT COMPLETED|Overall Study||16
8470153|NCT00661713|20872282|P8|COMPLETED|Overall Study||117
8470154|NCT00661713|20872283|P7|COMPLETED|Overall Study||309
8470155|NCT00661713|20872284|P6|COMPLETED|Overall Study||216
8470156|NCT00661713|20872285|P5|COMPLETED|Overall Study||107
8470157|NCT00661713|20872286|P4|COMPLETED|Overall Study||219
8470158|NCT00661713|20872287|P3|COMPLETED|Overall Study||111
8470159|NCT00661713|20872288|P2|COMPLETED|Overall Study||208
8470160|NCT00661713|20872289|P1|COMPLETED|Overall Study||112
8470161|NCT00661713|20872282|P8|STARTED|Overall Study||128
8470162|NCT00661713|20872283|P7|STARTED|Overall Study||373
8470163|NCT00661713|20872284|P6|STARTED|Overall Study||253
8470164|NCT00661713|20872285|P5|STARTED|Overall Study||127
8470165|NCT00661713|20872286|P4|STARTED|Overall Study||247
8470166|NCT00661713|20872287|P3|STARTED|Overall Study||128
8470167|NCT00661713|20872288|P2|STARTED|Overall Study||247
8470168|NCT00661713|20872289|P1|STARTED|Overall Study||128
8470169|NCT00661687|20872381|P1|NOT COMPLETED|Overall Study||15
8470170|NCT00661687|20872381|P1|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
8470171|NCT00661687|20872381|P1|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
8470172|NCT00661674|20872391|P6|NOT COMPLETED|Overall Study||0
8470173|NCT00661674|20872392|P5|NOT COMPLETED|Overall Study||0
8470174|NCT00661674|20872393|P4|NOT COMPLETED|Overall Study||0
8470175|NCT00661674|20872394|P3|NOT COMPLETED|Overall Study||0
8470176|NCT00661674|20872395|P2|NOT COMPLETED|Overall Study||0
8470177|NCT00661674|20872396|P1|NOT COMPLETED|Overall Study||0
8470178|NCT00661674|20872391|P6|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
8470179|NCT00661674|20872392|P5|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
8470180|NCT00661674|20872393|P4|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
8470181|NCT00661674|20872394|P3|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
8470182|NCT00661674|20872395|P2|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
8470183|NCT00661674|20872396|P1|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
8470184|NCT00661674|20872391|P6|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
8470185|NCT00661674|20872392|P5|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
8470186|NCT00661674|20872393|P4|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
8470187|NCT00661674|20872394|P3|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
8470188|NCT00661674|20872395|P2|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
8470189|NCT00661674|20872396|P1|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
8470190|NCT00661661|20872409|P2|NOT COMPLETED|Overall Study||39
8470191|NCT00661661|20872410|P1|NOT COMPLETED|Overall Study||140
8470192|NCT00661661|20872409|P2|COMPLETED|Overall Study||66
8470193|NCT00661661|20872410|P1|COMPLETED|Overall Study||242
8470194|NCT00661661|20872409|P2|STARTED|Overall Study||105
8470195|NCT00661661|20872410|P1|STARTED|Overall Study||382
8470196|NCT00661622|20872486|P2|NOT COMPLETED|Overall Study||0
8470197|NCT00661622|20872487|P1|NOT COMPLETED|Overall Study||1
8470198|NCT00661622|20872486|P2|COMPLETED|Overall Study||27
8470199|NCT00661622|20872487|P1|COMPLETED|Overall Study||25
8470200|NCT00661622|20872486|P2|STARTED|Overall Study||27
8470201|NCT00661622|20872487|P1|STARTED|Overall Study||26
8470202|NCT00661609|20872501|P1|NOT COMPLETED|Overall Study||41
8470203|NCT00661609|20872501|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8470204|NCT00661609|20872501|P1|STARTED|Overall Study|All dosed patients|41
8470205|NCT00661583|20872511|P3|NOT COMPLETED|Overall Study||0
8470206|NCT00661583|20872512|P2|NOT COMPLETED|Overall Study||0
8470207|NCT00661583|20872513|P1|NOT COMPLETED|Overall Study||0
8470208|NCT00661583|20872511|P3|COMPLETED|Overall Study||10
8470209|NCT00661583|20872512|P2|COMPLETED|Overall Study||10
8470210|NCT00661583|20872513|P1|COMPLETED|Overall Study||10
8470211|NCT00661583|20872511|P3|STARTED|Overall Study||10
8470212|NCT00661583|20872512|P2|STARTED|Overall Study||10
8470213|NCT00661583|20872513|P1|STARTED|Overall Study||10
8470214|NCT00661570|20872530|P1|NOT COMPLETED|Overall Study||0
8470215|NCT00661570|20872530|P1|COMPLETED|Overall Study||26
8470216|NCT00661570|20872530|P1|STARTED|Overall Study||26
8470217|NCT00661557|20872539|P2|NOT COMPLETED|Overall Study||0
8470218|NCT00661557|20872540|P1|NOT COMPLETED|Overall Study||9
8470219|NCT00661557|20872539|P2|COMPLETED|Overall Study||79
8470220|NCT00661557|20872540|P1|COMPLETED|Overall Study||183
8470221|NCT00661557|20872539|P2|STARTED|Overall Study||79
8470222|NCT00661557|20872540|P1|STARTED|Overall Study||192
8470223|NCT00661544|20872564|P1|NOT COMPLETED|Overall Study||0
8470224|NCT00661544|20872564|P1|COMPLETED|Overall Study||48
8470225|NCT00661544|20872564|P1|STARTED|Overall Study||48
8470226|NCT00661531|20872568|P1|NOT COMPLETED|Overall Study||3
8470227|NCT00661531|20872568|P1|COMPLETED|Overall Study||8
8470228|NCT00661531|20872568|P1|STARTED|Overall Study||11
8470229|NCT00661505|20872573|P1|NOT COMPLETED|Overall Study||30
8470230|NCT00661505|20872573|P1|COMPLETED|Overall Study||102
8470231|NCT00661505|20872573|P1|STARTED|Overall Study||132
8470232|NCT00661492|20872601|P2|NOT COMPLETED|Overall Study||29
8470233|NCT00661492|20872602|P1|NOT COMPLETED|Overall Study||68
8470234|NCT00661492|20872601|P2|COMPLETED|Overall Study||11
8470235|NCT00661492|20872602|P1|COMPLETED|Overall Study||7
8470236|NCT00661492|20872601|P2|STARTED|Overall Study||40
8470237|NCT00661492|20872602|P1|STARTED|Overall Study||75
8470238|NCT00661479|20872626|P4|NOT COMPLETED|Overall Study||0
8470239|NCT00661479|20872627|P3|NOT COMPLETED|Overall Study||0
8470240|NCT00661479|20872628|P2|NOT COMPLETED|Overall Study||0
8470241|NCT00661479|20872629|P1|NOT COMPLETED|Overall Study||0
8470242|NCT00661479|20872626|P4|COMPLETED|Overall Study||3
8470243|NCT00661479|20872627|P3|COMPLETED|Overall Study||3
8470244|NCT00661479|20872628|P2|COMPLETED|Overall Study||3
8470245|NCT00661479|20872629|P1|COMPLETED|Overall Study||12
8470246|NCT00661479|20872626|P4|STARTED|Overall Study||3
8470247|NCT00661479|20872627|P3|STARTED|Overall Study||3
8470248|NCT00661479|20872628|P2|STARTED|Overall Study||3
8470249|NCT00661479|20872629|P1|STARTED|Overall Study||12
8470250|NCT00661466|20872644|P2|NOT COMPLETED|Overall Study||0
8470251|NCT00661466|20872645|P1|NOT COMPLETED|Overall Study||0
8470252|NCT00661466|20872644|P2|COMPLETED|Overall Study|Participants|3
8470253|NCT00661466|20872645|P1|COMPLETED|Overall Study|Participants|4
8470254|NCT00661466|20872644|P2|STARTED|Overall Study|Participants|3
8470255|NCT00661466|20872645|P1|STARTED|Overall Study|Participants|4
8470256|NCT00661453|20872671|P1|NOT COMPLETED|Overall Study||13
8470257|NCT00661453|20872671|P1|COMPLETED|Overall Study||25
8470258|NCT00661453|20872671|P1|STARTED|Overall Study||38
8470259|NCT00661427|20872677|P2|NOT COMPLETED|Overall Study||7
8470260|NCT00661427|20872678|P1|NOT COMPLETED|Overall Study||5
8470261|NCT00661427|20872677|P2|COMPLETED|Overall Study||19
8470262|NCT00661427|20872678|P1|COMPLETED|Overall Study||30
8470263|NCT00661427|20872677|P2|STARTED|Overall Study||26
8470264|NCT00661427|20872678|P1|STARTED|Overall Study||35
8470265|NCT00661388|20872686|P1|NOT COMPLETED|Overall Study||24
8470266|NCT00661388|20872686|P1|COMPLETED|Overall Study||51
8470267|NCT00661388|20872686|P1|STARTED|Overall Study||75
8470268|NCT00661362|20872709|P2|NOT COMPLETED|Overall Study||40
8470269|NCT00661362|20872710|P1|NOT COMPLETED|Overall Study||29
8470270|NCT00661362|20872709|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
8470271|NCT00661362|20872710|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
8470272|NCT00661362|20872709|P2|STARTED|Overall Study|Randomized and treated|287
8470273|NCT00661362|20872710|P1|STARTED|Overall Study|Randomized and treated|283
8470274|NCT00661271|20872728|P2|NOT COMPLETED|Overall Study||25
8470275|NCT00661271|20872729|P1|NOT COMPLETED|Overall Study||28
8470276|NCT00661271|20872728|P2|COMPLETED|Overall Study||20
8470277|NCT00661271|20872729|P1|COMPLETED|Overall Study||20
8470278|NCT00661271|20872728|P2|STARTED|Overall Study||45
8470279|NCT00661271|20872729|P1|STARTED|Overall Study||48
8470280|NCT00661258|20872739|P2|NOT COMPLETED|Overall Study||1
8470281|NCT00661258|20872740|P1|NOT COMPLETED|Overall Study||3
8470282|NCT00661258|20872739|P2|COMPLETED|Overall Study||33
8470283|NCT00661258|20872740|P1|COMPLETED|Overall Study||31
8470284|NCT00661258|20872739|P2|STARTED|Overall Study||34
8470285|NCT00661258|20872740|P1|STARTED|Overall Study||34
8470286|NCT00661193|20872750|P2|NOT COMPLETED|Overall Study||26
8470287|NCT00661193|20872751|P1|NOT COMPLETED|Overall Study||33
8470288|NCT00661193|20872750|P2|COMPLETED|Overall Study||0
8470289|NCT00661193|20872751|P1|COMPLETED|Overall Study||0
8470290|NCT00661193|20872750|P2|STARTED|Overall Study||26
8470291|NCT00661193|20872751|P1|STARTED|Overall Study||33
8470292|NCT00661141|20872762|P6|NOT COMPLETED|Overall Study||0
8470293|NCT00661141|20872763|P5|NOT COMPLETED|Overall Study||0
8470294|NCT00661141|20872764|P4|NOT COMPLETED|Overall Study||0
8470295|NCT00661141|20872765|P3|NOT COMPLETED|Overall Study||0
8470296|NCT00661141|20872766|P2|NOT COMPLETED|Overall Study||0
8470297|NCT00661141|20872767|P1|NOT COMPLETED|Overall Study||0
8470298|NCT00661141|20872762|P6|COMPLETED|Overall Study||4
8470299|NCT00661141|20872763|P5|COMPLETED|Overall Study||4
8470300|NCT00661141|20872764|P4|COMPLETED|Overall Study||4
8470301|NCT00661141|20872765|P3|COMPLETED|Overall Study||4
8470302|NCT00661141|20872766|P2|COMPLETED|Overall Study||8
8470303|NCT00661141|20872767|P1|COMPLETED|Overall Study||8
8470304|NCT00661141|20872762|P6|Administered 30 Minutes After Ethanol|Overall Study||0
8470305|NCT00661141|20872763|P5|Administered 30 Minutes After Ethanol|Overall Study||0
8470306|NCT00661141|20872764|P4|Administered 30 Minutes After Ethanol|Overall Study||2
8470307|NCT00661141|20872765|P3|Administered 30 Minutes After Ethanol|Overall Study||2
8470308|NCT00661141|20872766|P2|Administered 30 Minutes After Ethanol|Overall Study||2
8470309|NCT00661141|20872767|P1|Administered 30 Minutes After Ethanol|Overall Study||2
8470310|NCT00661141|20872762|P6|Administered 30 Minutes Prior to Ethanol|Overall Study||4
8470311|NCT00661141|20872763|P5|Administered 30 Minutes Prior to Ethanol|Overall Study||4
8470312|NCT00661141|20872764|P4|Administered 30 Minutes Prior to Ethanol|Overall Study||2
8470313|NCT00661141|20872765|P3|Administered 30 Minutes Prior to Ethanol|Overall Study||2
8470314|NCT00661141|20872766|P2|Administered 30 Minutes Prior to Ethanol|Overall Study||6
8470315|NCT00661141|20872767|P1|Administered 30 Minutes Prior to Ethanol|Overall Study||6
8470316|NCT00661141|20872762|P6|STARTED|Overall Study||4
8470317|NCT00661141|20872763|P5|STARTED|Overall Study||4
8470318|NCT00661141|20872764|P4|STARTED|Overall Study||4
8470319|NCT00661141|20872765|P3|STARTED|Overall Study||4
8470320|NCT00661141|20872766|P2|STARTED|Overall Study||8
8470321|NCT00661141|20872767|P1|STARTED|Overall Study||8
8470322|NCT00661089|20872976|P2|NOT COMPLETED|Overall Study||2
8470323|NCT00661089|20872977|P1|NOT COMPLETED|Overall Study||0
8470324|NCT00661089|20872976|P2|COMPLETED|Overall Study||9
8470325|NCT00661089|20872977|P1|COMPLETED|Overall Study||10
8470326|NCT00661089|20872976|P2|STARTED|Overall Study||11
8470327|NCT00661089|20872977|P1|STARTED|Overall Study||10
8470328|NCT00661037|20872987|P2|NOT COMPLETED|Overall Study||257
8470329|NCT00661037|20872988|P1|NOT COMPLETED|Overall Study||154
8470330|NCT00661037|20872987|P2|COMPLETED|Overall Study||1027
8470331|NCT00661037|20872988|P1|COMPLETED|Overall Study||682
8470332|NCT00661037|20872987|P2|Deaths|Overall Study||188
8470333|NCT00661037|20872988|P1|Deaths|Overall Study||108
8470334|NCT00661037|20872987|P2|Witdrawn|Overall Study||68
8470335|NCT00661037|20872988|P1|Witdrawn|Overall Study||47
8470336|NCT00661037|20872987|P2|STARTED|Overall Study||1284
8470337|NCT00661037|20872988|P1|STARTED|Overall Study||836
8470344|NCT00660907|20873025|P2|NOT COMPLETED|Overall Study||94
8470345|NCT00660907|20873026|P1|NOT COMPLETED|Overall Study||84
8470346|NCT00660907|20873025|P2|COMPLETED|Overall Study||314
8470347|NCT00660907|20873026|P1|COMPLETED|Overall Study||322
8470348|NCT00660907|20873025|P2|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
8470349|NCT00660907|20873026|P1|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
8470350|NCT00660829|20873040|P2|NOT COMPLETED|Overall Study||19
8470351|NCT00660829|20873041|P1|NOT COMPLETED|Overall Study||18
8470352|NCT00660829|20873040|P2|COMPLETED|Overall Study||249
8470353|NCT00660829|20873041|P1|COMPLETED|Overall Study||250
8470354|NCT00660829|20873040|P2|STARTED|Overall Study|2 subjects were randomized in error|268
8470355|NCT00660829|20873041|P1|STARTED|Overall Study|2 subjects were randomized in error|268
8470356|NCT00660816|20873059|P2|NOT COMPLETED|Overall Study||19
8470357|NCT00660816|20873060|P1|NOT COMPLETED|Overall Study||20
8470358|NCT00660816|20873059|P2|COMPLETED|Overall Study||3
8470359|NCT00660816|20873060|P1|COMPLETED|Overall Study||4
8470360|NCT00660816|20873059|P2|STARTED|Overall Study||22
8470361|NCT00660816|20873060|P1|STARTED|Overall Study||24
8470368|NCT00660699|20873076|P1|NOT COMPLETED|Overall Study||2
8470369|NCT00660699|20873076|P1|COMPLETED|Overall Study||48
8470370|NCT00660699|20873076|P1|STARTED|Overall Study||50
8470371|NCT00660660|20873092|P2|NOT COMPLETED|Overall Study||9
8470372|NCT00660660|20873093|P1|NOT COMPLETED|Overall Study||5
8470373|NCT00660660|20873092|P2|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
8470374|NCT00660660|20873093|P1|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
8470375|NCT00660660|20873092|P2|Met Criteria for MITT Population|Overall Study||125
8470376|NCT00660660|20873093|P1|Met Criteria for MITT Population|Overall Study||137
8470377|NCT00660660|20873092|P2|STARTED|Overall Study|Randomized|133
8470378|NCT00660660|20873093|P1|STARTED|Overall Study|Randomized|143
8470379|NCT00660595|20873193|P2|NOT COMPLETED|Overall Study||9
8470380|NCT00660595|20873194|P1|NOT COMPLETED|Overall Study||18
8470381|NCT00660595|20873193|P2|COMPLETED|Overall Study|One of the two was lost to follow-up|1
8470382|NCT00660595|20873194|P1|COMPLETED|Overall Study||1
8470383|NCT00660595|20873193|P2|STARTED|Overall Study||10
8470384|NCT00660595|20873194|P1|STARTED|Overall Study||19
8470385|NCT00660543|20873206|P1|NOT COMPLETED|Overall Study||0
8470386|NCT00660543|20873206|P1|COMPLETED|Overall Study||14
8470387|NCT00660543|20873206|P1|STARTED|Overall Study||14
8470388|NCT00660530|20873215|P1|NOT COMPLETED|Overall Study||0
8470389|NCT00660530|20873215|P1|COMPLETED|Overall Study||11
8470390|NCT00660530|20873215|P1|STARTED|Overall Study||11
8470391|NCT00660517|20873225|P4|NOT COMPLETED|Overall Study||7
8470392|NCT00660517|20873226|P3|NOT COMPLETED|Overall Study||7
8470393|NCT00660517|20873227|P2|NOT COMPLETED|Overall Study||8
8470394|NCT00660517|20873228|P1|NOT COMPLETED|Overall Study||8
8470395|NCT00660517|20873225|P4|COMPLETED|Overall Study||144
8470396|NCT00660517|20873226|P3|COMPLETED|Overall Study||144
8470397|NCT00660517|20873227|P2|COMPLETED|Overall Study||144
8470398|NCT00660517|20873228|P1|COMPLETED|Overall Study||145
8470399|NCT00660517|20873225|P4|STARTED|Overall Study||151
8470400|NCT00660517|20873226|P3|STARTED|Overall Study||151
8470401|NCT00660517|20873227|P2|STARTED|Overall Study||152
8470402|NCT00660517|20873228|P1|STARTED|Overall Study||153
8470403|NCT00660504|20873248|P2|NOT COMPLETED|Overall Study||1
8470404|NCT00660504|20873249|P1|NOT COMPLETED|Overall Study||0
8470405|NCT00660504|20873248|P2|COMPLETED|Overall Study||150
8470406|NCT00660504|20873249|P1|COMPLETED|Overall Study||149
8470407|NCT00660504|20873248|P2|STARTED|Overall Study||151
8470408|NCT00660504|20873249|P1|STARTED|Overall Study||149
8470409|NCT00660400|20873261|P1|NOT COMPLETED|Overall Study||4
8470410|NCT00660400|20873261|P1|COMPLETED|Overall Study||21
8470411|NCT00660400|20873261|P1|STARTED|Overall Study||25
8470412|NCT00660387|20873270|P2|NOT COMPLETED|Overall Study||3
8470413|NCT00660387|20873271|P1|NOT COMPLETED|Overall Study||2
8470414|NCT00660387|20873270|P2|COMPLETED|Overall Study||31
8470415|NCT00660387|20873271|P1|COMPLETED|Overall Study||35
8470416|NCT00660387|20873270|P2|STARTED|Overall Study||34
8470417|NCT00660387|20873271|P1|STARTED|Overall Study||37
8470418|NCT00660348|20873325|P2|NOT COMPLETED|Overall Study||0
8470419|NCT00660348|20873326|P1|NOT COMPLETED|Overall Study||1
8470420|NCT00660348|20873325|P2|COMPLETED|Overall Study||0
8470421|NCT00660348|20873326|P1|COMPLETED|Overall Study||0
8470422|NCT00660348|20873325|P2|STARTED|Overall Study||0
8470423|NCT00660348|20873326|P1|STARTED|Overall Study||1
8470424|NCT00660309|20873334|P2|NOT COMPLETED|Overall Study||3
8470425|NCT00660309|20873335|P1|NOT COMPLETED|Overall Study||2
8470426|NCT00660309|20873334|P2|COMPLETED|Overall Study||19
8470427|NCT00660309|20873335|P1|COMPLETED|Overall Study||21
8470428|NCT00660309|20873334|P2|Pharmacodynamic Analysis Set|Overall Study||20
8470429|NCT00660309|20873335|P1|Pharmacodynamic Analysis Set|Overall Study||22
8470430|NCT00660309|20873334|P2|Treated With Aliskiren or Irbesartan|Overall Study||21
8470431|NCT00660309|20873335|P1|Treated With Aliskiren or Irbesartan|Overall Study||22
8470432|NCT00660309|20873334|P2|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
8470433|NCT00660309|20873335|P1|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
8470434|NCT00660192|20873376|P2|NOT COMPLETED|Overall Study||3
8470435|NCT00660192|20873377|P1|NOT COMPLETED|Overall Study||2
8470436|NCT00660192|20873376|P2|COMPLETED|Overall Study||10
8470437|NCT00660192|20873377|P1|COMPLETED|Overall Study||10
8470438|NCT00660192|20873376|P2|STARTED|Overall Study||13
8470439|NCT00660192|20873377|P1|STARTED|Overall Study||12
8470440|NCT00660179|20873388|P3|NOT COMPLETED|Overall Study||41
8470441|NCT00660179|20873389|P2|NOT COMPLETED|Overall Study||58
8470442|NCT00660179|20873390|P1|NOT COMPLETED|Overall Study||56
8470443|NCT00660179|20873388|P3|COMPLETED|Overall Study||201
8470444|NCT00660179|20873389|P2|COMPLETED|Overall Study||192
8470445|NCT00660179|20873390|P1|COMPLETED|Overall Study||194
8470446|NCT00660179|20873388|P3|STARTED|Overall Study||242
8470447|NCT00660179|20873389|P2|STARTED|Overall Study||250
8470448|NCT00660179|20873390|P1|STARTED|Overall Study||250
8470449|NCT00660075|20873424|P2|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
8470450|NCT00660075|20873425|P1|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
8470451|NCT00660075|20873424|P2|COMPLETED|Second Intervention (Week 11 to Week 16||18
8470452|NCT00660075|20873425|P1|COMPLETED|Second Intervention (Week 11 to Week 16||18
8470453|NCT00660075|20873424|P2|STARTED|Second Intervention (Week 11 to Week 16||18
8470454|NCT00660075|20873425|P1|STARTED|Second Intervention (Week 11 to Week 16||18
8470455|NCT00660075|20873424|P2|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
8470456|NCT00660075|20873425|P1|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
8470457|NCT00660075|20873424|P2|COMPLETED|Washout Period (Week 7 to Week 10)||18
8470458|NCT00660075|20873425|P1|COMPLETED|Washout Period (Week 7 to Week 10)||18
8470459|NCT00660075|20873424|P2|STARTED|Washout Period (Week 7 to Week 10)||18
8470460|NCT00660075|20873425|P1|STARTED|Washout Period (Week 7 to Week 10)||18
8470461|NCT00660075|20873424|P2|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
8470462|NCT00660075|20873425|P1|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
8470463|NCT00660075|20873424|P2|COMPLETED|First Intervention (Week 1 to Week 6)||18
8470464|NCT00660075|20873425|P1|COMPLETED|First Intervention (Week 1 to Week 6)||18
8470465|NCT00660075|20873424|P2|STARTED|First Intervention (Week 1 to Week 6)||18
8470466|NCT00660075|20873425|P1|STARTED|First Intervention (Week 1 to Week 6)||18
8470467|NCT00660049|20873431|P1|NOT COMPLETED|Overall Study||6
8470468|NCT00660049|20873431|P1|COMPLETED|Overall Study||6
8470469|NCT00660049|20873431|P1|STARTED|Overall Study||12
8470470|NCT00660023|20873435|P1|NOT COMPLETED|Overall Study||29
8470471|NCT00660023|20873435|P1|COMPLETED|Overall Study||95
8470472|NCT00660023|20873435|P1|Treated|Overall Study||114
8470473|NCT00660023|20873435|P1|STARTED|Overall Study||124
8470474|NCT00660010|20873446|P1|NOT COMPLETED|Overall Study||9
8470475|NCT00660010|20873446|P1|COMPLETED|Overall Study||46
8470476|NCT00660010|20873446|P1|STARTED|Overall Study||55
8470477|NCT00659984|20873460|P1|NOT COMPLETED|Overall Study||1
8470478|NCT00659984|20873460|P1|COMPLETED|Overall Study||14
8470479|NCT00659984|20873460|P1|STARTED|Overall Study||15
8470480|NCT00659945|20873473|P2|NOT COMPLETED|Overall Study||0
8470481|NCT00659945|20873474|P1|NOT COMPLETED|Overall Study||0
8470482|NCT00659945|20873473|P2|COMPLETED|Overall Study||75
8470483|NCT00659945|20873474|P1|COMPLETED|Overall Study||75
8470484|NCT00659945|20873473|P2|STARTED|Overall Study||75
8470485|NCT00659945|20873474|P1|STARTED|Overall Study||75
8470486|NCT00659880|20873480|P1|NOT COMPLETED|Overall Study||5
8470487|NCT00659880|20873480|P1|COMPLETED|Overall Study|60 months|4
8470488|NCT00659880|20873480|P1|24 Months|Overall Study||6
8470489|NCT00659880|20873480|P1|12 Months|Overall Study||7
8470490|NCT00659880|20873480|P1|6 Months|Overall Study||9
8470491|NCT00659880|20873480|P1|6 Weeks|Overall Study||9
8470492|NCT00659880|20873480|P1|STARTED|Overall Study||9
8470493|NCT00659828|20873485|P1|NOT COMPLETED|Overall Study||0
8470494|NCT00659828|20873485|P1|COMPLETED|Overall Study||1
8470495|NCT00659828|20873485|P1|STARTED|Overall Study||1
8470496|NCT00659815|20873493|P2|NOT COMPLETED|Overall Study||4
8470497|NCT00659815|20873494|P1|NOT COMPLETED|Overall Study||4
8470498|NCT00659815|20873493|P2|COMPLETED|Overall Study||147
8470499|NCT00659815|20873494|P1|COMPLETED|Overall Study||153
8470500|NCT00659815|20873493|P2|STARTED|Overall Study||151
8470501|NCT00659815|20873494|P1|STARTED|Overall Study||157
8470502|NCT00659802|20873507|P3|NOT COMPLETED|Overall Study||11
8470503|NCT00659802|20873508|P2|NOT COMPLETED|Overall Study||18
8470504|NCT00659802|20873509|P1|NOT COMPLETED|Overall Study||15
8470505|NCT00659802|20873507|P3|COMPLETED|Overall Study||64
8470506|NCT00659802|20873508|P2|COMPLETED|Overall Study||57
8470507|NCT00659802|20873509|P1|COMPLETED|Overall Study||59
8470508|NCT00659802|20873507|P3|STARTED|Overall Study||75
8470509|NCT00659802|20873508|P2|STARTED|Overall Study|One patient was incorrectly randomized and was excluded from the efficacy analyses.|75
8470510|NCT00659802|20873509|P1|STARTED|Overall Study||74
8470511|NCT00659789|20873525|P2|NOT COMPLETED|Overall Study||7
8470512|NCT00659789|20873526|P1|NOT COMPLETED|Overall Study||7
8470513|NCT00659789|20873525|P2|COMPLETED|Overall Study||36
8470514|NCT00659789|20873526|P1|COMPLETED|Overall Study||86
8470515|NCT00659789|20873525|P2|STARTED|Overall Study||43
8470516|NCT00659789|20873526|P1|STARTED|Overall Study||93
8470517|NCT00659737|20873544|P2|NOT COMPLETED|Overall Study||0
8470518|NCT00659737|20873545|P1|NOT COMPLETED|Overall Study||0
8470519|NCT00659737|20873544|P2|COMPLETED|Overall Study||58
8470520|NCT00659737|20873545|P1|COMPLETED|Overall Study||57
8470521|NCT00659737|20873544|P2|STARTED|Overall Study||58
8470522|NCT00659737|20873545|P1|STARTED|Overall Study||57
8470523|NCT00659724|20873551|P1|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
8470524|NCT00659724|20873551|P1|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
8470525|NCT00659724|20873551|P1|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
8470526|NCT00659724|20873551|P1|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
8470527|NCT00659724|20873551|P1|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
8470528|NCT00659724|20873551|P1|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
8470529|NCT00659633|20873569|P1|NOT COMPLETED|Overall Study||0
8470530|NCT00659633|20873569|P1|COMPLETED|Overall Study||10
8470531|NCT00659633|20873569|P1|STARTED|Overall Study||10
8470532|NCT00659607|20873573|P1|NOT COMPLETED|Overall Study||316
8470533|NCT00659607|20873573|P1|COMPLETED|Overall Study||3616
8470534|NCT00659607|20873573|P1|STARTED|Overall Study||3932
8470535|NCT00659581|20873591|P1|NOT COMPLETED|Overall Study||8582
8470536|NCT00659581|20873591|P1|COMPLETED|Overall Study||12412
8470537|NCT00659581|20873591|P1|STARTED|Overall Study||20994
8470538|NCT00659529|20873603|P1|NOT COMPLETED|Overall Study||16
8470539|NCT00659529|20873603|P1|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
8470540|NCT00659529|20873603|P1|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
8470541|NCT00659529|20873603|P1|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
8470542|NCT00659490|20873610|P3|NOT COMPLETED|Overall Study||1
8470543|NCT00659490|20873611|P2|NOT COMPLETED|Overall Study||0
8470544|NCT00659490|20873612|P1|NOT COMPLETED|Overall Study||2
8470545|NCT00659490|20873610|P3|COMPLETED|Overall Study||30
8470546|NCT00659490|20873611|P2|COMPLETED|Overall Study||59
8470547|NCT00659490|20873612|P1|COMPLETED|Overall Study||59
8470548|NCT00659490|20873610|P3|STARTED|Overall Study||31
8470549|NCT00659490|20873611|P2|STARTED|Overall Study||59
8470550|NCT00659490|20873612|P1|STARTED|Overall Study||61
8470551|NCT00659438|20873685|P2|NOT COMPLETED|Overall Study||8
8470552|NCT00659438|20873686|P1|NOT COMPLETED|Overall Study||14
8470553|NCT00659438|20873685|P2|COMPLETED|Overall Study||40
8470554|NCT00659438|20873686|P1|COMPLETED|Overall Study||33
8470555|NCT00659438|20873685|P2|Safety Analysis Set|Overall Study||47
8470556|NCT00659438|20873686|P1|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
8470557|NCT00659438|20873685|P2|Secondary Analysis Set|Overall Study||48
8470558|NCT00659438|20873686|P1|Secondary Analysis Set|Overall Study||47
8470559|NCT00659438|20873685|P2|Assessable Set : Primary Analysis|Overall Study||45
8470560|NCT00659438|20873686|P1|Assessable Set : Primary Analysis|Overall Study||44
8470561|NCT00659438|20873685|P2|STARTED|Overall Study||48
8470562|NCT00659438|20873686|P1|STARTED|Overall Study||47
8470563|NCT00659425|20873718|P10|NOT COMPLETED|Overall Study||13
8470564|NCT00659425|20873719|P9|NOT COMPLETED|Overall Study||6
8470565|NCT00659425|20873720|P8|NOT COMPLETED|Overall Study||11
8470566|NCT00659425|20873721|P7|NOT COMPLETED|Overall Study||8
8470567|NCT00659425|20873722|P6|NOT COMPLETED|Overall Study||4
8470568|NCT00659425|20873723|P5|NOT COMPLETED|Overall Study||4
8470569|NCT00659425|20873724|P4|NOT COMPLETED|Overall Study||4
8470570|NCT00659425|20873725|P3|NOT COMPLETED|Overall Study||1
8470571|NCT00659425|20873726|P2|NOT COMPLETED|Overall Study||1
8470572|NCT00659425|20873727|P1|NOT COMPLETED|Overall Study||1
8470573|NCT00659425|20873718|P10|COMPLETED|Overall Study||1
8470574|NCT00659425|20873719|P9|COMPLETED|Overall Study||0
8470575|NCT00659425|20873720|P8|COMPLETED|Overall Study||0
8470576|NCT00659425|20873721|P7|COMPLETED|Overall Study||0
8470577|NCT00659425|20873722|P6|COMPLETED|Overall Study||1
8470578|NCT00659425|20873723|P5|COMPLETED|Overall Study||0
8470579|NCT00659425|20873724|P4|COMPLETED|Overall Study||0
8470580|NCT00659425|20873725|P3|COMPLETED|Overall Study||0
8470581|NCT00659425|20873726|P2|COMPLETED|Overall Study||0
8470582|NCT00659425|20873727|P1|COMPLETED|Overall Study||0
8470583|NCT00659425|20873718|P10|STARTED|Overall Study||14
8470584|NCT00659425|20873719|P9|STARTED|Overall Study||6
8470585|NCT00659425|20873720|P8|STARTED|Overall Study||11
8470586|NCT00659425|20873721|P7|STARTED|Overall Study||8
8470587|NCT00659425|20873722|P6|STARTED|Overall Study||5
8470588|NCT00659425|20873723|P5|STARTED|Overall Study||4
8470589|NCT00659425|20873724|P4|STARTED|Overall Study||4
8470590|NCT00659425|20873725|P3|STARTED|Overall Study||1
8470591|NCT00659425|20873726|P2|STARTED|Overall Study||1
8470592|NCT00659425|20873727|P1|STARTED|Overall Study||1
8470593|NCT00659373|20873958|P2|NOT COMPLETED|Overall Study||7
8470594|NCT00659373|20873959|P1|NOT COMPLETED|Overall Study||5
8470595|NCT00659373|20873958|P2|COMPLETED|Overall Study||54
8470596|NCT00659373|20873959|P1|COMPLETED|Overall Study||20
8470597|NCT00659373|20873958|P2|STARTED|Overall Study||61
8470598|NCT00659373|20873959|P1|STARTED|Overall Study||25
8470599|NCT00659360|20873965|P1|NOT COMPLETED|Overall Study||0
8470600|NCT00659360|20873965|P1|COMPLETED|Overall Study||17
8470601|NCT00659360|20873965|P1|STARTED|Overall Study||17
8470602|NCT00659334|20873981|P7|NOT COMPLETED|Overall Study||1
8470603|NCT00659334|20873982|P6|NOT COMPLETED|Overall Study||0
8470604|NCT00659334|20873983|P5|NOT COMPLETED|Overall Study||0
8470605|NCT00659334|20873984|P4|NOT COMPLETED|Overall Study||0
8470606|NCT00659334|20873985|P3|NOT COMPLETED|Overall Study||0
8470607|NCT00659334|20873986|P2|NOT COMPLETED|Overall Study||5
8470608|NCT00659334|20873987|P1|NOT COMPLETED|Overall Study||8
8470609|NCT00659334|20873981|P7|COMPLETED|Overall Study|1 screen failure|20
8470610|NCT00659334|20873982|P6|COMPLETED|Overall Study||0
8470611|NCT00659334|20873983|P5|COMPLETED|Overall Study||1
8470612|NCT00659334|20873984|P4|COMPLETED|Overall Study||2
8470613|NCT00659334|20873985|P3|COMPLETED|Overall Study||5
8470614|NCT00659334|20873986|P2|COMPLETED|Overall Study|5 Screen failures|36
8470615|NCT00659334|20873987|P1|COMPLETED|Overall Study|8 Screen failures|38
8470616|NCT00659334|20873981|P7|STARTED|Overall Study||21
8470617|NCT00659334|20873982|P6|STARTED|Overall Study||0
8470618|NCT00659334|20873983|P5|STARTED|Overall Study||1
8470619|NCT00659334|20873984|P4|STARTED|Overall Study||2
8470620|NCT00659334|20873985|P3|STARTED|Overall Study||5
8470621|NCT00659334|20873986|P2|STARTED|Overall Study||41
8470622|NCT00659334|20873987|P1|STARTED|Overall Study||46
8470623|NCT00659295|20874005|P2|NOT COMPLETED|Overall Study||5603
8470624|NCT00659295|20874006|P1|NOT COMPLETED|Overall Study||2708
8470625|NCT00659295|20874005|P2|COMPLETED|Overall Study||32038
8470626|NCT00659295|20874006|P1|COMPLETED|Overall Study||10821
8470627|NCT00659295|20874005|P2|STARTED|Overall Study||37641
8470628|NCT00659295|20874006|P1|STARTED|Overall Study||13529
8470629|NCT00659269|20874014|P2|NOT COMPLETED|Overall Study||1
8470630|NCT00659269|20874015|P1|NOT COMPLETED|Overall Study||1
8470631|NCT00659269|20874014|P2|COMPLETED|Overall Study||161
8470632|NCT00659269|20874015|P1|COMPLETED|Overall Study||156
8470633|NCT00659269|20874014|P2|Group 3 (Taxanes)|Overall Study||97
8470634|NCT00659269|20874015|P1|Group 3 (Taxanes)|Overall Study||92
8470635|NCT00659269|20874014|P2|Group 2 (Vinca Alkaloids)|Overall Study||12
8470636|NCT00659269|20874015|P1|Group 2 (Vinca Alkaloids)|Overall Study||12
8470637|NCT00659269|20874014|P2|Group 1 (Heavy Metals)|Overall Study||52
8470638|NCT00659269|20874015|P1|Group 1 (Heavy Metals)|Overall Study||52
8470639|NCT00659269|20874014|P2|STARTED|Overall Study||162
8470640|NCT00659269|20874015|P1|STARTED|Overall Study||157
8470641|NCT00659230|20874045|P2|NOT COMPLETED|Overall Study||12
8470642|NCT00659230|20874046|P1|NOT COMPLETED|Overall Study||9
8470643|NCT00659230|20874045|P2|COMPLETED|Overall Study||37
8470644|NCT00659230|20874046|P1|COMPLETED|Overall Study||42
8470645|NCT00659230|20874045|P2|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
8470646|NCT00659230|20874046|P1|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
8470647|NCT00659165|20874060|P2|NOT COMPLETED|Overall Study||0
8470648|NCT00659165|20874061|P1|NOT COMPLETED|Overall Study||0
8470649|NCT00659165|20874060|P2|COMPLETED|Overall Study||5
8470650|NCT00659165|20874061|P1|COMPLETED|Overall Study||5
8470651|NCT00659165|20874060|P2|STARTED|Overall Study||5
8470652|NCT00659165|20874061|P1|STARTED|Overall Study||5
8470653|NCT00659061|20874069|P2|NOT COMPLETED|Overall Study||15
8470654|NCT00659061|20874070|P1|NOT COMPLETED|Overall Study||21
8470655|NCT00659061|20874069|P2|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
8470656|NCT00659061|20874070|P1|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
8470657|NCT00659061|20874069|P2|STARTED|Overall Study||302
8470658|NCT00659061|20874070|P1|STARTED|Overall Study||308
8470659|NCT00658996|20874088|P2|NOT COMPLETED|Second Intervention||1
8470660|NCT00658996|20874089|P1|NOT COMPLETED|Second Intervention||1
8470661|NCT00658996|20874088|P2|COMPLETED|Second Intervention||104
8470662|NCT00658996|20874089|P1|COMPLETED|Second Intervention||105
8470663|NCT00658996|20874088|P2|STARTED|Second Intervention||105
8470664|NCT00658996|20874089|P1|STARTED|Second Intervention||106
8470665|NCT00658996|20874088|P2|NOT COMPLETED|Crossover Period||1
8470666|NCT00658996|20874089|P1|NOT COMPLETED|Crossover Period||2
8470667|NCT00658996|20874088|P2|COMPLETED|Crossover Period||105
8470668|NCT00658996|20874089|P1|COMPLETED|Crossover Period||106
8470669|NCT00658996|20874088|P2|STARTED|Crossover Period||106
8470670|NCT00658996|20874089|P1|STARTED|Crossover Period||108
8470671|NCT00658996|20874088|P2|NOT COMPLETED|First Intervention||1
8470672|NCT00658996|20874089|P1|NOT COMPLETED|First Intervention||1
8470673|NCT00658996|20874088|P2|COMPLETED|First Intervention||106
8470674|NCT00658996|20874089|P1|COMPLETED|First Intervention||108
8470675|NCT00658996|20874088|P2|STARTED|First Intervention||107
8470676|NCT00658996|20874089|P1|STARTED|First Intervention||109
8470677|NCT00658879|20874099|P1|NOT COMPLETED|Overall Study||1
8470678|NCT00658879|20874099|P1|COMPLETED|Overall Study||250
8470679|NCT00658879|20874099|P1|STARTED|Overall Study||251
8470706|NCT00658788|20874131|P1|NOT COMPLETED|Overall Study||74
8470707|NCT00658788|20874131|P1|COMPLETED|Overall Study||231
8470708|NCT00658788|20874131|P1|STARTED|Overall Study||305
8470709|NCT00658775|20874186|P2|NOT COMPLETED|Overall Study||43
8470710|NCT00658775|20874187|P1|NOT COMPLETED|Overall Study||42
8470711|NCT00658775|20874186|P2|COMPLETED|Overall Study||485
8470712|NCT00658775|20874187|P1|COMPLETED|Overall Study||495
8470713|NCT00658775|20874186|P2|STARTED|Overall Study|Treated|528
8470714|NCT00658775|20874187|P1|STARTED|Overall Study|Treated|537
8470715|NCT00658736|20874199|P2|NOT COMPLETED|Overall Study||2
8470716|NCT00658736|20874200|P1|NOT COMPLETED|Overall Study||6
8470717|NCT00658736|20874199|P2|COMPLETED|Overall Study||19
8470718|NCT00658736|20874200|P1|COMPLETED|Overall Study||13
8470719|NCT00658736|20874199|P2|STARTED|Overall Study||21
8470720|NCT00658736|20874200|P1|STARTED|Overall Study||19
8470721|NCT00658723|20874210|P3|NOT COMPLETED|Overall Study||7
8470722|NCT00658723|20874211|P2|NOT COMPLETED|Overall Study||4
8470723|NCT00658723|20874212|P1|NOT COMPLETED|Overall Study||4
8470724|NCT00658723|20874210|P3|COMPLETED|Overall Study||44
8470725|NCT00658723|20874211|P2|COMPLETED|Overall Study||26
8470726|NCT00658723|20874212|P1|COMPLETED|Overall Study||56
8470727|NCT00658723|20874210|P3|STARTED|Overall Study||51
8470728|NCT00658723|20874211|P2|STARTED|Overall Study||30
8470729|NCT00658723|20874212|P1|STARTED|Overall Study||60
8470730|NCT00658697|20874239|P1|NOT COMPLETED|Overall Study||0
8470731|NCT00658697|20874239|P1|COMPLETED|Overall Study||41
8470732|NCT00658697|20874239|P1|STARTED|Overall Study||41
8470733|NCT00658684|20874250|P4|NOT COMPLETED|Overall Study||1
8470734|NCT00658684|20874251|P3|NOT COMPLETED|Overall Study||3
8470735|NCT00658684|20874252|P2|NOT COMPLETED|Overall Study||15
8470736|NCT00658684|20874253|P1|NOT COMPLETED|Overall Study||19
8470737|NCT00658684|20874250|P4|COMPLETED|Overall Study||27
8470738|NCT00658684|20874251|P3|COMPLETED|Overall Study||22
8470739|NCT00658684|20874252|P2|COMPLETED|Overall Study||84
8470740|NCT00658684|20874253|P1|COMPLETED|Overall Study||133
8470741|NCT00658684|20874250|P4|STARTED|Overall Study||28
8470742|NCT00658684|20874251|P3|STARTED|Overall Study||25
8470743|NCT00658684|20874252|P2|STARTED|Overall Study||99
8470744|NCT00658684|20874253|P1|STARTED|Overall Study||152
8470745|NCT00658658|20874308|P5|NOT COMPLETED|Overall Study||5
8470746|NCT00658658|20874309|P4|NOT COMPLETED|Overall Study||2
8470747|NCT00658658|20874310|P3|NOT COMPLETED|Overall Study||0
8470748|NCT00658658|20874311|P2|NOT COMPLETED|Overall Study||2
8470749|NCT00658658|20874312|P1|NOT COMPLETED|Overall Study||5
8470750|NCT00658658|20874308|P5|COMPLETED|Overall Study||3
8470751|NCT00658658|20874309|P4|COMPLETED|Overall Study||4
8470752|NCT00658658|20874310|P3|COMPLETED|Overall Study||4
8470753|NCT00658658|20874311|P2|COMPLETED|Overall Study||5
8470754|NCT00658658|20874312|P1|COMPLETED|Overall Study||1
8470755|NCT00658658|20874308|P5|STARTED|Overall Study||8
8470756|NCT00658658|20874309|P4|STARTED|Overall Study||6
8470757|NCT00658658|20874310|P3|STARTED|Overall Study||4
8470758|NCT00658658|20874311|P2|STARTED|Overall Study||7
8470759|NCT00658658|20874312|P1|STARTED|Overall Study||6
8470760|NCT00658632|20874371|P2|NOT COMPLETED|Overall Study||65
8470761|NCT00658632|20874372|P1|NOT COMPLETED|Overall Study||64
8470762|NCT00658632|20874371|P2|COMPLETED|Overall Study||633
8470763|NCT00658632|20874372|P1|COMPLETED|Overall Study||618
8470764|NCT00658632|20874371|P2|STARTED|Overall Study|Treated|698
8470765|NCT00658632|20874372|P1|STARTED|Overall Study|Treated|682
8470766|NCT00658619|20874387|P5|NOT COMPLETED|Overall Study||2
8470767|NCT00658619|20874388|P4|NOT COMPLETED|Overall Study||12
8470768|NCT00658619|20874389|P3|NOT COMPLETED|Overall Study||10
8470769|NCT00658619|20874390|P2|NOT COMPLETED|Overall Study||1
8470770|NCT00658619|20874391|P1|NOT COMPLETED|Overall Study||0
8470771|NCT00658619|20874387|P5|COMPLETED|Overall Study||21
8470772|NCT00658619|20874388|P4|COMPLETED|Overall Study||37
8470773|NCT00658619|20874389|P3|COMPLETED|Overall Study||31
8470774|NCT00658619|20874390|P2|COMPLETED|Overall Study||2
8470775|NCT00658619|20874391|P1|COMPLETED|Overall Study||3
8470776|NCT00658619|20874387|P5|STARTED|Overall Study||23
8470777|NCT00658619|20874388|P4|STARTED|Overall Study||49
8470778|NCT00658619|20874389|P3|STARTED|Overall Study||41
8470779|NCT00658619|20874390|P2|STARTED|Overall Study||3
8470780|NCT00658619|20874391|P1|STARTED|Overall Study||3
8470781|NCT00658606|20874413|P2|NOT COMPLETED|Overall Study||23
8470782|NCT00658606|20874414|P1|NOT COMPLETED|Overall Study||16
8470783|NCT00658606|20874413|P2|COMPLETED|Overall Study|Represents patients who completed follow-up|26
8470784|NCT00658606|20874414|P1|COMPLETED|Overall Study|Represents patients who completed follow-up|33
8470785|NCT00658606|20874413|P2|Completed Treatment|Overall Study||44
8470786|NCT00658606|20874414|P1|Completed Treatment|Overall Study||42
8470787|NCT00658606|20874413|P2|STARTED|Overall Study||49
8470788|NCT00658606|20874414|P1|STARTED|Overall Study||49
8470789|NCT00658567|20874443|P3|NOT COMPLETED|Overall Study||6
8470790|NCT00658567|20874444|P2|NOT COMPLETED|Overall Study||4
8470791|NCT00658567|20874445|P1|NOT COMPLETED|Overall Study||8
8470792|NCT00658567|20874443|P3|COMPLETED|Overall Study||35
8470793|NCT00658567|20874444|P2|COMPLETED|Overall Study||38
8470794|NCT00658567|20874445|P1|COMPLETED|Overall Study||32
8470795|NCT00658567|20874443|P3|STARTED|Overall Study||41
8470796|NCT00658567|20874444|P2|STARTED|Overall Study||42
8470797|NCT00658567|20874445|P1|STARTED|Overall Study||40
8470798|NCT00658541|20874456|P2|NOT COMPLETED|Second Intervention||0
8470799|NCT00658541|20874457|P1|NOT COMPLETED|Second Intervention||0
8470800|NCT00658541|20874456|P2|COMPLETED|Second Intervention||17
8470801|NCT00658541|20874457|P1|COMPLETED|Second Intervention||18
8470802|NCT00658541|20874456|P2|STARTED|Second Intervention||17
8470803|NCT00658541|20874457|P1|STARTED|Second Intervention||18
8470804|NCT00658541|20874456|P2|NOT COMPLETED|Washout Period of 7 Days||2
8470805|NCT00658541|20874457|P1|NOT COMPLETED|Washout Period of 7 Days||1
8470806|NCT00658541|20874456|P2|COMPLETED|Washout Period of 7 Days||17
8470807|NCT00658541|20874457|P1|COMPLETED|Washout Period of 7 Days||18
8470808|NCT00658541|20874456|P2|STARTED|Washout Period of 7 Days||19
8470809|NCT00658541|20874457|P1|STARTED|Washout Period of 7 Days||19
8470810|NCT00658541|20874456|P2|NOT COMPLETED|First Intervention||0
8470811|NCT00658541|20874457|P1|NOT COMPLETED|First Intervention||0
8470812|NCT00658541|20874456|P2|COMPLETED|First Intervention||19
8470813|NCT00658541|20874457|P1|COMPLETED|First Intervention||19
8470814|NCT00658541|20874456|P2|STARTED|First Intervention||19
8470815|NCT00658541|20874457|P1|STARTED|First Intervention||19
8470816|NCT00658528|20874469|P2|NOT COMPLETED|Overall Study||45
8470817|NCT00658528|20874470|P1|NOT COMPLETED|Overall Study||40
8470818|NCT00658528|20874469|P2|COMPLETED|Overall Study||479
8470819|NCT00658528|20874470|P1|COMPLETED|Overall Study||491
8470820|NCT00658528|20874469|P2|STARTED|Overall Study|Treated|524
8470821|NCT00658528|20874470|P1|STARTED|Overall Study|Treated|531
8470822|NCT00658515|20874482|P2|NOT COMPLETED|Overall Study||265
8470823|NCT00658515|20874483|P1|NOT COMPLETED|Overall Study||312
8470824|NCT00658515|20874482|P2|COMPLETED|Overall Study||7668
8470825|NCT00658515|20874483|P1|COMPLETED|Overall Study||7626
8470826|NCT00658515|20874482|P2|STARTED|Overall Study||7933
8470827|NCT00658515|20874483|P1|STARTED|Overall Study||7938
8470828|NCT00658411|20874495|P1|NOT COMPLETED|Overall Study||0
8470829|NCT00658411|20874495|P1|COMPLETED|Overall Study||5
8470830|NCT00658411|20874495|P1|STARTED|Overall Study||5
8470831|NCT00658385|20874503|P1|NOT COMPLETED|Overall Study||0
8470832|NCT00658385|20874503|P1|COMPLETED|Overall Study||5
8470833|NCT00658385|20874503|P1|STARTED|Overall Study||5
8470834|NCT00658359|20874510|P3|NOT COMPLETED|Overall Study||46
8470835|NCT00658359|20874511|P2|NOT COMPLETED|Overall Study||45
8470836|NCT00658359|20874512|P1|NOT COMPLETED|Overall Study||28
8470837|NCT00658359|20874510|P3|COMPLETED|Overall Study||8
8470838|NCT00658359|20874511|P2|COMPLETED|Overall Study||15
8470839|NCT00658359|20874512|P1|COMPLETED|Overall Study||36
8470840|NCT00658359|20874510|P3|STARTED|Overall Study||54
8470841|NCT00658359|20874511|P2|STARTED|Overall Study||60
8470842|NCT00658359|20874512|P1|STARTED|Overall Study||64
8470843|NCT00658333|20874600|P2|NOT COMPLETED|Overall Study||1
8470844|NCT00658333|20874601|P1|NOT COMPLETED|Overall Study||2
8470845|NCT00658333|20874600|P2|COMPLETED|Overall Study||14
8470846|NCT00658333|20874601|P1|COMPLETED|Overall Study||13
8470847|NCT00658333|20874600|P2|STARTED|Overall Study||15
8470848|NCT00658333|20874601|P1|STARTED|Overall Study||15
8470849|NCT00658320|20874611|P2|NOT COMPLETED|Extension Study: After Month 24||0
8470850|NCT00658320|20874612|P1|NOT COMPLETED|Extension Study: After Month 24||2
8470851|NCT00658320|20874611|P2|COMPLETED|Extension Study: After Month 24||0
8470852|NCT00658320|20874612|P1|COMPLETED|Extension Study: After Month 24||42
8470853|NCT00658320|20874611|P2|STARTED|Extension Study: After Month 24||0
8470854|NCT00658320|20874612|P1|STARTED|Extension Study: After Month 24||44
8470855|NCT00658320|20874611|P2|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
8470856|NCT00658320|20874612|P1|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
8470857|NCT00658320|20874611|P2|COMPLETED|Extension Study: Month 12 to Month 24||50
8470858|NCT00658320|20874612|P1|COMPLETED|Extension Study: Month 12 to Month 24||47
8470859|NCT00658320|20874611|P2|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
8470860|NCT00658320|20874612|P1|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
8470861|NCT00658320|20874611|P2|STARTED|Extension Study: Month 12 to Month 24||57
8470862|NCT00658320|20874612|P1|STARTED|Extension Study: Month 12 to Month 24||53
8470863|NCT00658320|20874611|P2|NOT COMPLETED|Core Study: 12 Months||3
8470864|NCT00658320|20874612|P1|NOT COMPLETED|Core Study: 12 Months||5
8470865|NCT00658320|20874611|P2|COMPLETED|Core Study: 12 Months||58
8470866|NCT00658320|20874612|P1|COMPLETED|Core Study: 12 Months||56
8470867|NCT00658320|20874611|P2|STARTED|Core Study: 12 Months||61
8470868|NCT00658320|20874612|P1|STARTED|Core Study: 12 Months||61
8470869|NCT00658138|20874635|P1|NOT COMPLETED|Overall Study||21
8470870|NCT00658138|20874635|P1|COMPLETED|Overall Study||40
8470871|NCT00658138|20874635|P1|STARTED|Overall Study||61
8470872|NCT00658112|20874640|P1|NOT COMPLETED|Overall Study||9
8470873|NCT00658112|20874640|P1|COMPLETED|Overall Study||11
8470874|NCT00658112|20874640|P1|STARTED|Overall Study||20
8470875|NCT00658021|20874647|P3|NOT COMPLETED|Long-term Safety Follow-up Period||0
8470876|NCT00658021|20874648|P2|NOT COMPLETED|Long-term Safety Follow-up Period||3
8470877|NCT00658021|20874649|P1|NOT COMPLETED|Long-term Safety Follow-up Period||0
8470878|NCT00658021|20874647|P3|COMPLETED|Long-term Safety Follow-up Period||7
8470879|NCT00658021|20874648|P2|COMPLETED|Long-term Safety Follow-up Period||2
8470880|NCT00658021|20874649|P1|COMPLETED|Long-term Safety Follow-up Period||7
8470881|NCT00658021|20874647|P3|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
8470882|NCT00658021|20874648|P2|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|5
8470883|NCT00658021|20874649|P1|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
8470884|NCT00658021|20874647|P3|NOT COMPLETED|28-Week Treatment Period||17
8470885|NCT00658021|20874648|P2|NOT COMPLETED|28-Week Treatment Period||13
8470886|NCT00658021|20874649|P1|NOT COMPLETED|28-Week Treatment Period||11
8470887|NCT00658021|20874647|P3|COMPLETED|28-Week Treatment Period||25
8470888|NCT00658021|20874648|P2|COMPLETED|28-Week Treatment Period||25
8470889|NCT00658021|20874649|P1|COMPLETED|28-Week Treatment Period||31
8470890|NCT00658021|20874647|P3|Received Treatment|28-Week Treatment Period||42
8470891|NCT00658021|20874648|P2|Received Treatment|28-Week Treatment Period||38
8470892|NCT00658021|20874649|P1|Received Treatment|28-Week Treatment Period||40
8470893|NCT00658021|20874647|P3|STARTED|28-Week Treatment Period||42
8470894|NCT00658021|20874648|P2|STARTED|28-Week Treatment Period||38
8470895|NCT00658021|20874649|P1|STARTED|28-Week Treatment Period||42
8470896|NCT00657917|20874673|P1|NOT COMPLETED|Overall Study||0
8470897|NCT00657917|20874673|P1|COMPLETED|Overall Study||1
8470898|NCT00657917|20874673|P1|STARTED|Overall Study||1
8470899|NCT00657709|20874684|P5|NOT COMPLETED|Overall Study||33
8470900|NCT00657709|20874685|P4|NOT COMPLETED|Overall Study||14
8470901|NCT00657709|20874686|P3|NOT COMPLETED|Overall Study||28
8470902|NCT00657709|20874687|P2|NOT COMPLETED|Overall Study||33
8470903|NCT00657709|20874688|P1|NOT COMPLETED|Overall Study||23
8470904|NCT00657709|20874684|P5|COMPLETED|Overall Study||457
8470905|NCT00657709|20874685|P4|COMPLETED|Overall Study||645
8470906|NCT00657709|20874686|P3|COMPLETED|Overall Study||792
8470907|NCT00657709|20874687|P2|COMPLETED|Overall Study||795
8470908|NCT00657709|20874688|P1|COMPLETED|Overall Study||810
8470909|NCT00657709|20874684|P5|STARTED|Overall Study||490
8470910|NCT00657709|20874685|P4|STARTED|Overall Study||659
8470911|NCT00657709|20874686|P3|STARTED|Overall Study||820
8470912|NCT00657709|20874687|P2|STARTED|Overall Study||828
8470913|NCT00657709|20874688|P1|STARTED|Overall Study||833
8470914|NCT00657657|20874729|P1|NOT COMPLETED|Overall Study||0
8470915|NCT00657657|20874729|P1|COMPLETED|Overall Study||29
8470916|NCT00657657|20874729|P1|STARTED|Overall Study||29
8470917|NCT00657618|20874737|P1|NOT COMPLETED|Overall Study||43
8470918|NCT00657618|20874737|P1|COMPLETED|Overall Study||34
8470919|NCT00657618|20874737|P1|STARTED|Overall Study||77
8470920|NCT00657605|20874742|P1|NOT COMPLETED|Overall Study||0
8470921|NCT00657605|20874742|P1|COMPLETED|Overall Study||3
8470922|NCT00657605|20874742|P1|STARTED|Overall Study||3
8470923|NCT00657553|20874749|P2|NOT COMPLETED|Overall Study||5
8470924|NCT00657553|20874750|P1|NOT COMPLETED|Overall Study||5
8470925|NCT00657553|20874749|P2|COMPLETED|Overall Study||0
8470926|NCT00657553|20874750|P1|COMPLETED|Overall Study||0
8470927|NCT00657553|20874749|P2|STARTED|Overall Study||5
8470928|NCT00657553|20874750|P1|STARTED|Overall Study||5
8470929|NCT00657540|20874758|P2|NOT COMPLETED|Overall Study||4
8470930|NCT00657540|20874759|P1|NOT COMPLETED|Overall Study||1
8470931|NCT00657540|20874758|P2|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
8470932|NCT00657540|20874759|P1|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
8470933|NCT00657540|20874758|P2|STARTED|Overall Study||31
8470934|NCT00657540|20874759|P1|STARTED|Overall Study||29
8470935|NCT00657371|20874773|P1|NOT COMPLETED|Overall Study||39
8470936|NCT00657371|20874773|P1|COMPLETED|Overall Study||249
8470937|NCT00657371|20874773|P1|STARTED|Overall Study||288
8470938|NCT00657358|20874778|P1|NOT COMPLETED|Overall Study||6
8470939|NCT00657358|20874778|P1|COMPLETED|Overall Study||16
8470940|NCT00657358|20874778|P1|STARTED|Overall Study||22
8470941|NCT00657280|20874786|P1|NOT COMPLETED|Overall Study||0
8470942|NCT00657280|20874786|P1|COMPLETED|Overall Study||16
8470943|NCT00657280|20874786|P1|STARTED|Overall Study||16
8470944|NCT00657267|20874790|P1|NOT COMPLETED|Overall Study||54
8470945|NCT00657267|20874790|P1|COMPLETED|Overall Study||4
8470946|NCT00657267|20874790|P1|STARTED|Overall Study||58
8470947|NCT00657150|20874800|P2|NOT COMPLETED|Treatment||97
8470948|NCT00657150|20874801|P1|NOT COMPLETED|Treatment||107
8470949|NCT00657150|20874800|P2|COMPLETED|Treatment||906
8470950|NCT00657150|20874801|P1|COMPLETED|Treatment||903
8470951|NCT00657150|20874800|P2|STARTED|Treatment||1003
8470952|NCT00657150|20874801|P1|STARTED|Treatment||1010
8470953|NCT00657150|20874800|P2|NOT COMPLETED|Overall Study||93
8470954|NCT00657150|20874801|P1|NOT COMPLETED|Overall Study||115
8470955|NCT00657150|20874800|P2|COMPLETED|Overall Study||910
8470956|NCT00657150|20874801|P1|COMPLETED|Overall Study||895
8470957|NCT00657150|20874800|P2|STARTED|Overall Study||1003
8470958|NCT00657150|20874801|P1|STARTED|Overall Study||1010
8470959|NCT00657046|20874832|P3|NOT COMPLETED|Overall Study||2
8470960|NCT00657046|20874833|P2|NOT COMPLETED|Overall Study||3
8470961|NCT00657046|20874834|P1|NOT COMPLETED|Overall Study||4
8470962|NCT00657046|20874832|P3|COMPLETED|Overall Study||21
8470963|NCT00657046|20874833|P2|COMPLETED|Overall Study||29
8470964|NCT00657046|20874834|P1|COMPLETED|Overall Study||26
8470965|NCT00657046|20874832|P3|Had Visits up to Visit 18|Overall Study||23
8470966|NCT00657046|20874833|P2|Had Visits up to Visit 18|Overall Study||30
8470967|NCT00657046|20874834|P1|Had Visits up to Visit 18|Overall Study||28
8470968|NCT00657046|20874832|P3|Had at Least 1 Post Baseline Visit|Overall Study||23
8470969|NCT00657046|20874833|P2|Had at Least 1 Post Baseline Visit|Overall Study||31
8470970|NCT00657046|20874834|P1|Had at Least 1 Post Baseline Visit|Overall Study||30
8470971|NCT00657046|20874832|P3|STARTED|Overall Study||23
8470972|NCT00657046|20874833|P2|STARTED|Overall Study||32
8470973|NCT00657046|20874834|P1|STARTED|Overall Study||30
8470974|NCT00657020|20874866|P2|NOT COMPLETED|PERIOD 2||0
8470975|NCT00657020|20874867|P1|NOT COMPLETED|PERIOD 2||0
8470976|NCT00657020|20874866|P2|COMPLETED|PERIOD 2||11
8470977|NCT00657020|20874867|P1|COMPLETED|PERIOD 2||11
8470978|NCT00657020|20874866|P2|STARTED|PERIOD 2||11
8470979|NCT00657020|20874867|P1|STARTED|PERIOD 2||11
8470980|NCT00657020|20874866|P2|NOT COMPLETED|PERIOD 1||1
8470981|NCT00657020|20874867|P1|NOT COMPLETED|PERIOD 1||0
8470982|NCT00657020|20874866|P2|COMPLETED|PERIOD 1||11
8470983|NCT00657020|20874867|P1|COMPLETED|PERIOD 1||11
8470984|NCT00657020|20874866|P2|STARTED|PERIOD 1||12
8470985|NCT00657020|20874867|P1|STARTED|PERIOD 1||11
8470986|NCT00656968|20874897|P2|NOT COMPLETED|Overall Study||0
8470987|NCT00656968|20874898|P1|NOT COMPLETED|Overall Study||0
8470988|NCT00656968|20874897|P2|COMPLETED|Overall Study||117
8470989|NCT00656968|20874898|P1|COMPLETED|Overall Study||115
8470990|NCT00656968|20874897|P2|STARTED|Overall Study||117
8470991|NCT00656968|20874898|P1|STARTED|Overall Study||115
8470992|NCT00656916|20874908|P2|NOT COMPLETED|Overall Study||0
8470993|NCT00656916|20874909|P1|NOT COMPLETED|Overall Study||0
8470994|NCT00656916|20874908|P2|COMPLETED|Overall Study||0
8470995|NCT00656916|20874909|P1|COMPLETED|Overall Study||1
8470996|NCT00656916|20874908|P2|STARTED|Overall Study||0
8470997|NCT00656916|20874909|P1|STARTED|Overall Study||1
8470998|NCT00656851|20874917|P2|NOT COMPLETED|Overall Study||4
8470999|NCT00656851|20874918|P1|NOT COMPLETED|Overall Study||0
8471000|NCT00656851|20874917|P2|COMPLETED|Overall Study||8
8471001|NCT00656851|20874918|P1|COMPLETED|Overall Study||12
8471002|NCT00656851|20874917|P2|STARTED|Overall Study||12
8471003|NCT00656851|20874918|P1|STARTED|Overall Study||12
8471004|NCT00656799|20874940|P1|NOT COMPLETED|Overall Study||2
8471005|NCT00656799|20874940|P1|COMPLETED|Overall Study||4
8471006|NCT00656799|20874940|P1|STARTED|Overall Study||6
8471007|NCT00656669|20874962|P1|NOT COMPLETED|AC (Cycles 6-9)||2
8471008|NCT00656669|20874962|P1|COMPLETED|AC (Cycles 6-9)||15
8471009|NCT00656669|20874962|P1|STARTED|AC (Cycles 6-9)||17
8471010|NCT00656669|20874962|P1|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
8471011|NCT00656669|20874962|P1|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
8471012|NCT00656669|20874962|P1|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
8471013|NCT00656669|20874962|P1|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
8471014|NCT00656669|20874962|P1|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
8471015|NCT00656669|20874962|P1|STARTED|Single Agent Sunitinib (Cycle 1)||23
8471016|NCT00656656|20874971|P1|NOT COMPLETED|Overall Study||0
8471017|NCT00656656|20874971|P1|COMPLETED|Overall Study||23
8471018|NCT00656656|20874971|P1|STARTED|Overall Study||23
8471019|NCT00656630|20874979|P3|NOT COMPLETED|Overall Study||2
8471020|NCT00656630|20874980|P2|NOT COMPLETED|Overall Study||2
8471021|NCT00656630|20874981|P1|NOT COMPLETED|Overall Study||2
8471022|NCT00656630|20874979|P3|COMPLETED|Overall Study||17
8471023|NCT00656630|20874980|P2|COMPLETED|Overall Study||25
8471024|NCT00656630|20874981|P1|COMPLETED|Overall Study||20
8471025|NCT00656630|20874979|P3|STARTED|Overall Study||19
8471026|NCT00656630|20874980|P2|STARTED|Overall Study||27
8471027|NCT00656630|20874981|P1|STARTED|Overall Study||22
8471028|NCT00656617|20875001|P1|NOT COMPLETED|Overall Study||7
8471029|NCT00656617|20875001|P1|COMPLETED|Overall Study||99
8471030|NCT00656617|20875001|P1|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
8471031|NCT00656617|20875001|P1|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
8471032|NCT00656617|20875001|P1|STARTED|Overall Study||106
8471033|NCT00656513|20875010|P3|NOT COMPLETED|Overall Study||22
8471034|NCT00656513|20875011|P2|NOT COMPLETED|Overall Study||30
8471035|NCT00656513|20875012|P1|NOT COMPLETED|Overall Study||4
8471036|NCT00656513|20875010|P3|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
8471037|NCT00656513|20875011|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
8471038|NCT00656513|20875012|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
8471039|NCT00656513|20875010|P3|STARTED|Overall Study||75
8471040|NCT00656513|20875011|P2|STARTED|Overall Study||73
8471041|NCT00656513|20875012|P1|STARTED|Overall Study||48
8471042|NCT00656487|20875034|P3|NOT COMPLETED|Overall Study||0
8471043|NCT00656487|20875035|P2|NOT COMPLETED|Overall Study||4
8471044|NCT00656487|20875036|P1|NOT COMPLETED|Overall Study||2
8471045|NCT00656487|20875034|P3|COMPLETED|Overall Study||20
8471046|NCT00656487|20875035|P2|COMPLETED|Overall Study||19
8471047|NCT00656487|20875036|P1|COMPLETED|Overall Study||21
8471048|NCT00656487|20875034|P3|STARTED|Overall Study||20
8471049|NCT00656487|20875035|P2|STARTED|Overall Study||23
8471050|NCT00656487|20875036|P1|STARTED|Overall Study||23
8471051|NCT00656474|20875059|P1|NOT COMPLETED|Overall Study||1
8471052|NCT00656474|20875059|P1|COMPLETED|Overall Study||11
8471053|NCT00656474|20875059|P1|STARTED|Overall Study||12
8471054|NCT00656448|20875068|P2|NOT COMPLETED|Overall Study||0
8471055|NCT00656448|20875069|P1|NOT COMPLETED|Overall Study||0
8471056|NCT00656448|20875068|P2|COMPLETED|Overall Study||25
8471057|NCT00656448|20875069|P1|COMPLETED|Overall Study||25
8471058|NCT00656448|20875068|P2|STARTED|Overall Study||25
8471059|NCT00656448|20875069|P1|STARTED|Overall Study||25
8471060|NCT00656370|20875077|P1|NOT COMPLETED|Overall Study||10
8471061|NCT00656370|20875077|P1|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
8471062|NCT00656370|20875077|P1|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
8471063|NCT00656305|20875093|P2|NOT COMPLETED|Overall Study||7
8471064|NCT00656305|20875094|P1|NOT COMPLETED|Overall Study||22
8471065|NCT00656305|20875093|P2|COMPLETED|Overall Study||21
8471066|NCT00656305|20875094|P1|COMPLETED|Overall Study||65
8471067|NCT00656305|20875093|P2|STARTED|Overall Study||28
8471068|NCT00656305|20875094|P1|STARTED|Overall Study||87
8471069|NCT00656292|20875106|P2|NOT COMPLETED|Overall Study||5
8471070|NCT00656292|20875107|P1|NOT COMPLETED|Overall Study||3
8471071|NCT00656292|20875106|P2|COMPLETED|Overall Study||24
8471072|NCT00656292|20875107|P1|COMPLETED|Overall Study||29
8471073|NCT00656292|20875106|P2|STARTED|Overall Study||29
8471074|NCT00656292|20875107|P1|STARTED|Overall Study||32
8471075|NCT00656201|20875125|P2|NOT COMPLETED|Overall Study||32
8471076|NCT00656201|20875126|P1|NOT COMPLETED|Overall Study||29
8471077|NCT00656201|20875125|P2|COMPLETED|Overall Study||201
8471078|NCT00656201|20875126|P1|COMPLETED|Overall Study||206
8471079|NCT00656201|20875125|P2|STARTED|Overall Study||233
8471080|NCT00656201|20875126|P1|STARTED|Overall Study||235
8471081|NCT00656175|20875134|P2|NOT COMPLETED|Overall Study||1
8471082|NCT00656175|20875135|P1|NOT COMPLETED|Overall Study||1
8471083|NCT00656175|20875134|P2|COMPLETED|Overall Study||20
8471084|NCT00656175|20875135|P1|COMPLETED|Overall Study||17
8471085|NCT00656175|20875134|P2|STARTED|Overall Study||21
8471086|NCT00656175|20875135|P1|STARTED|Overall Study||18
8471087|NCT00656136|20875143|P2|NOT COMPLETED|Overall Study||390
8471088|NCT00656136|20875144|P1|NOT COMPLETED|Overall Study||195
8471089|NCT00656136|20875143|P2|COMPLETED|Overall Study||0
8471090|NCT00656136|20875144|P1|COMPLETED|Overall Study||0
8471091|NCT00656136|20875143|P2|STARTED|Overall Study|Randomised patients.|390
8471092|NCT00656136|20875144|P1|STARTED|Overall Study|Randomised patients.|195
8471093|NCT00656084|20875154|P1|NOT COMPLETED|Overall Study||7
8471094|NCT00656084|20875154|P1|COMPLETED|Overall Study||9
8471095|NCT00656084|20875154|P1|STARTED|Overall Study||16
8471096|NCT00656058|20875161|P1|NOT COMPLETED|Overall Study||6
8471097|NCT00656058|20875161|P1|COMPLETED|Overall Study||19
8471098|NCT00656058|20875161|P1|STARTED|Overall Study||25
8471099|NCT00656019|20875174|P4|NOT COMPLETED|Overall Study||0
8471100|NCT00656019|20875175|P3|NOT COMPLETED|Overall Study||0
8471101|NCT00656019|20875176|P2|NOT COMPLETED|Overall Study||1
8471102|NCT00656019|20875177|P1|NOT COMPLETED|Overall Study||14
8471103|NCT00656019|20875174|P4|COMPLETED|Overall Study||4
8471104|NCT00656019|20875175|P3|COMPLETED|Overall Study||11
8471105|NCT00656019|20875176|P2|COMPLETED|Overall Study||18
8471106|NCT00656019|20875177|P1|COMPLETED|Overall Study||15
8471107|NCT00656019|20875174|P4|STARTED|Overall Study||4
8471108|NCT00656019|20875175|P3|STARTED|Overall Study||11
8471109|NCT00656019|20875176|P2|STARTED|Overall Study||19
8471110|NCT00656019|20875177|P1|STARTED|Overall Study||29
8471111|NCT00655980|20875190|P3|NOT COMPLETED|Overall Study||5
8471112|NCT00655980|20875191|P2|NOT COMPLETED|Overall Study||31
8471113|NCT00655980|20875192|P1|NOT COMPLETED|Overall Study||26
8471114|NCT00655980|20875190|P3|COMPLETED|Overall Study||125
8471115|NCT00655980|20875191|P2|COMPLETED|Overall Study||250
8471116|NCT00655980|20875192|P1|COMPLETED|Overall Study||250
8471117|NCT00655980|20875190|P3|STARTED|Overall Study||130
8471118|NCT00655980|20875191|P2|STARTED|Overall Study||281
8471119|NCT00655980|20875192|P1|STARTED|Overall Study||276
8471120|NCT00655928|20875205|P2|NOT COMPLETED|Overall Study||2
8471121|NCT00655928|20875206|P1|NOT COMPLETED|Overall Study||3
8471122|NCT00655928|20875205|P2|COMPLETED|Overall Study||24
8471123|NCT00655928|20875206|P1|COMPLETED|Overall Study||23
8471124|NCT00655928|20875205|P2|STARTED|Overall Study||26
8471125|NCT00655928|20875206|P1|STARTED|Overall Study||26
8471129|NCT00655876|20875219|P2|NOT COMPLETED|Overall Study||7
8471130|NCT00655876|20875220|P1|NOT COMPLETED|Overall Study||9
8471131|NCT00655876|20875219|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
8471132|NCT00655876|20875220|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
8471133|NCT00655876|20875219|P2|STARTED|Overall Study||176
8471134|NCT00655876|20875220|P1|STARTED|Overall Study||168
8471135|NCT00655863|20875239|P3|NOT COMPLETED|Overall Study||1
8471136|NCT00655863|20875240|P2|NOT COMPLETED|Overall Study||0
8471137|NCT00655863|20875241|P1|NOT COMPLETED|Overall Study||0
8471138|NCT00655863|20875239|P3|COMPLETED|Overall Study||21
8471139|NCT00655863|20875240|P2|COMPLETED|Overall Study||25
8471140|NCT00655863|20875241|P1|COMPLETED|Overall Study||24
8471141|NCT00655863|20875239|P3|STARTED|Overall Study||22
8471142|NCT00655863|20875240|P2|STARTED|Overall Study||25
8471143|NCT00655863|20875241|P1|STARTED|Overall Study||24
8471144|NCT00655850|20875300|P1|NOT COMPLETED|Overall Study||3
8471145|NCT00655850|20875300|P1|COMPLETED|Overall Study||36
8471146|NCT00655850|20875300|P1|STARTED|Overall Study||39
8471147|NCT00655824|20875307|P1|NOT COMPLETED|Overall Study||84
8471148|NCT00655824|20875307|P1|COMPLETED|Overall Study||8
8471149|NCT00655824|20875307|P1|STARTED|Overall Study||92
8471150|NCT00655811|20875341|P1|NOT COMPLETED|Overall Study||0
8471151|NCT00655811|20875341|P1|COMPLETED|Overall Study||40
8471152|NCT00655811|20875341|P1|STARTED|Overall Study||40
8471153|NCT00655746|20875355|P1|NOT COMPLETED|Overall Study||1
8471154|NCT00655746|20875355|P1|COMPLETED|Overall Study||13
8471155|NCT00655746|20875355|P1|STARTED|Overall Study||14
8471156|NCT00655733|20875374|P2|NOT COMPLETED|Overall Study||8
8471157|NCT00655733|20875375|P1|NOT COMPLETED|Overall Study||7
8471158|NCT00655733|20875374|P2|COMPLETED|Overall Study||42
8471159|NCT00655733|20875375|P1|COMPLETED|Overall Study||44
8471160|NCT00655733|20875374|P2|STARTED|Overall Study||50
8471161|NCT00655733|20875375|P1|STARTED|Overall Study||51
8471162|NCT00655707|20875403|P1|NOT COMPLETED|Overall Study||0
8471163|NCT00655707|20875403|P1|COMPLETED|Overall Study||5
8471164|NCT00655707|20875403|P1|STARTED|Overall Study||5
8471165|NCT00655668|20875408|P1|NOT COMPLETED|Overall Study||54
8471166|NCT00655668|20875408|P1|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
8471167|NCT00655668|20875408|P1|STARTED|Overall Study|Planned enrollment: 80 participants|54
8471168|NCT00655642|20875420|P4|NOT COMPLETED|Overall Study||2
8471169|NCT00655642|20875421|P3|NOT COMPLETED|Overall Study||2
8471170|NCT00655642|20875422|P2|NOT COMPLETED|Overall Study||3
8471171|NCT00655642|20875423|P1|NOT COMPLETED|Overall Study||1
8471172|NCT00655642|20875420|P4|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
8471173|NCT00655642|20875421|P3|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
8471174|NCT00655642|20875422|P2|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
8471175|NCT00655642|20875423|P1|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
8471176|NCT00655642|20875420|P4|STARTED|Overall Study||41
8471177|NCT00655642|20875421|P3|STARTED|Overall Study||45
8471178|NCT00655642|20875422|P2|STARTED|Overall Study||43
8471179|NCT00655642|20875423|P1|STARTED|Overall Study||42
8471180|NCT00655629|20875435|P2|NOT COMPLETED|Overall Study||23
8471181|NCT00655629|20875436|P1|NOT COMPLETED|Overall Study||21
8471182|NCT00655629|20875435|P2|COMPLETED|Overall Study||144
8471183|NCT00655629|20875436|P1|COMPLETED|Overall Study||151
8471184|NCT00655629|20875435|P2|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
8471185|NCT00655629|20875436|P1|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
8471186|NCT00655629|20875435|P2|STARTED|Overall Study||167
8471187|NCT00655629|20875436|P1|STARTED|Overall Study||172
8471188|NCT00655564|20875472|P1|NOT COMPLETED|Overall Study||3
8471189|NCT00655564|20875472|P1|COMPLETED|Overall Study||12
8471190|NCT00655564|20875472|P1|STARTED|Overall Study||15
8471191|NCT00655551|20875480|P3|NOT COMPLETED|Period 4 (up to 7 Days)||0
8471192|NCT00655551|20875481|P2|NOT COMPLETED|Period 4 (up to 7 Days)||2
8471193|NCT00655551|20875482|P1|NOT COMPLETED|Period 4 (up to 7 Days)||0
8471194|NCT00655551|20875480|P3|COMPLETED|Period 4 (up to 7 Days)||0
8471195|NCT00655551|20875481|P2|COMPLETED|Period 4 (up to 7 Days)||23
8471196|NCT00655551|20875482|P1|COMPLETED|Period 4 (up to 7 Days)||0
8471197|NCT00655551|20875480|P3|STARTED|Period 4 (up to 7 Days)||0
8471198|NCT00655551|20875481|P2|STARTED|Period 4 (up to 7 Days)||25
8471199|NCT00655551|20875482|P1|STARTED|Period 4 (up to 7 Days)||0
8471200|NCT00655551|20875480|P3|NOT COMPLETED|Period 3 (up to 7 Days)||4
8471201|NCT00655551|20875481|P2|NOT COMPLETED|Period 3 (up to 7 Days)||0
8471202|NCT00655551|20875482|P1|NOT COMPLETED|Period 3 (up to 7 Days)||0
8471203|NCT00655551|20875480|P3|COMPLETED|Period 3 (up to 7 Days)||21
8471204|NCT00655551|20875481|P2|COMPLETED|Period 3 (up to 7 Days)||0
8471205|NCT00655551|20875482|P1|COMPLETED|Period 3 (up to 7 Days)||0
8471206|NCT00655551|20875480|P3|STARTED|Period 3 (up to 7 Days)||25
8471207|NCT00655551|20875481|P2|STARTED|Period 3 (up to 7 Days)||0
8471208|NCT00655551|20875482|P1|STARTED|Period 3 (up to 7 Days)||0
8471209|NCT00655551|20875480|P3|NOT COMPLETED|Period 2 (up to 7 Days)||0
8471210|NCT00655551|20875481|P2|NOT COMPLETED|Period 2 (up to 7 Days)||1
8471211|NCT00655551|20875482|P1|NOT COMPLETED|Period 2 (up to 7 Days)||0
8471212|NCT00655551|20875480|P3|COMPLETED|Period 2 (up to 7 Days)||0
8471213|NCT00655551|20875481|P2|COMPLETED|Period 2 (up to 7 Days)||24
8471214|NCT00655551|20875482|P1|COMPLETED|Period 2 (up to 7 Days)||0
8471215|NCT00655551|20875480|P3|STARTED|Period 2 (up to 7 Days)||0
8471216|NCT00655551|20875481|P2|STARTED|Period 2 (up to 7 Days)||25
8471217|NCT00655551|20875482|P1|STARTED|Period 2 (up to 7 Days)||0
8471218|NCT00655551|20875480|P3|NOT COMPLETED|Period 1 (up to 7 Days)||0
8471219|NCT00655551|20875481|P2|NOT COMPLETED|Period 1 (up to 7 Days)||0
8471220|NCT00655551|20875482|P1|NOT COMPLETED|Period 1 (up to 7 Days)||0
8471221|NCT00655551|20875480|P3|COMPLETED|Period 1 (up to 7 Days)||0
8471222|NCT00655551|20875481|P2|COMPLETED|Period 1 (up to 7 Days)||0
8471223|NCT00655551|20875482|P1|COMPLETED|Period 1 (up to 7 Days)||25
8471224|NCT00655551|20875480|P3|STARTED|Period 1 (up to 7 Days)||0
8471225|NCT00655551|20875481|P2|STARTED|Period 1 (up to 7 Days)||0
8471226|NCT00655551|20875482|P1|STARTED|Period 1 (up to 7 Days)||25
8471227|NCT00655551|20875480|P3|NOT COMPLETED|All Periods Combined||4
8471228|NCT00655551|20875481|P2|NOT COMPLETED|All Periods Combined||3
8471229|NCT00655551|20875482|P1|NOT COMPLETED|All Periods Combined||0
8471230|NCT00655551|20875480|P3|COMPLETED|All Periods Combined||21
8471231|NCT00655551|20875481|P2|COMPLETED|All Periods Combined||47
8471232|NCT00655551|20875482|P1|COMPLETED|All Periods Combined||25
8471233|NCT00655551|20875480|P3|STARTED|All Periods Combined||25
8471234|NCT00655551|20875481|P2|STARTED|All Periods Combined||50
8471235|NCT00655551|20875482|P1|STARTED|All Periods Combined||25
8471236|NCT00655538|20875498|P2|NOT COMPLETED|Overall Study||27
8471237|NCT00655538|20875499|P1|NOT COMPLETED|Overall Study||24
8471238|NCT00655538|20875498|P2|COMPLETED|Overall Study||211
8471239|NCT00655538|20875499|P1|COMPLETED|Overall Study||214
8471240|NCT00655538|20875498|P2|STARTED|Overall Study||238
8471241|NCT00655538|20875499|P1|STARTED|Overall Study||238
8471242|NCT00655486|20875519|P1|NOT COMPLETED|Overall Study||28
8471243|NCT00655486|20875519|P1|COMPLETED|Overall Study||69
8471244|NCT00655486|20875519|P1|STARTED|Overall Study||97
8471245|NCT00655473|20875526|P2|NOT COMPLETED|Overall Study||15
8471246|NCT00655473|20875527|P1|NOT COMPLETED|Overall Study||11
8471247|NCT00655473|20875526|P2|COMPLETED|Overall Study||51
8471248|NCT00655473|20875527|P1|COMPLETED|Overall Study||53
8471249|NCT00655473|20875526|P2|STARTED|Overall Study||66
8471250|NCT00655473|20875527|P1|STARTED|Overall Study||64
8471251|NCT00655356|20875547|P2|NOT COMPLETED|Overall Study||10
8471252|NCT00655356|20875548|P1|NOT COMPLETED|Overall Study||17
8471253|NCT00655356|20875547|P2|COMPLETED|Overall Study||98
8471254|NCT00655356|20875548|P1|COMPLETED|Overall Study||93
8471255|NCT00655356|20875547|P2|STARTED|Overall Study||108
8471256|NCT00655356|20875548|P1|STARTED|Overall Study||110
8471257|NCT00655083|20875562|P2|NOT COMPLETED|Overall Study||0
8471258|NCT00655083|20875563|P1|NOT COMPLETED|Overall Study||0
8471259|NCT00655083|20875562|P2|COMPLETED|Overall Study||8
8471260|NCT00655083|20875563|P1|COMPLETED|Overall Study||12
8471261|NCT00655083|20875562|P2|STARTED|Overall Study||8
8471262|NCT00655083|20875563|P1|STARTED|Overall Study||12
8471263|NCT00655057|20875578|P3|NOT COMPLETED|Overall Study||0
8471264|NCT00655057|20875579|P2|NOT COMPLETED|Overall Study||0
8471265|NCT00655057|20875580|P1|NOT COMPLETED|Overall Study||0
8471266|NCT00655057|20875578|P3|COMPLETED|Overall Study||0
8471267|NCT00655057|20875579|P2|COMPLETED|Overall Study||0
8471268|NCT00655057|20875580|P1|COMPLETED|Overall Study||0
8471269|NCT00655057|20875578|P3|STARTED|Overall Study||0
8471270|NCT00655057|20875579|P2|STARTED|Overall Study||0
8471271|NCT00655057|20875580|P1|STARTED|Overall Study||0
8471272|NCT00654992|20875590|P2|NOT COMPLETED|Overall Study||0
8471273|NCT00654992|20875591|P1|NOT COMPLETED|Overall Study||0
8471274|NCT00654992|20875590|P2|COMPLETED|Overall Study||35
8471275|NCT00654992|20875591|P1|COMPLETED|Overall Study||36
8471276|NCT00654992|20875590|P2|STARTED|Overall Study||35
8471277|NCT00654992|20875591|P1|STARTED|Overall Study||36
8471278|NCT00654953|20875600|P3|NOT COMPLETED|Overall Study||22
8471279|NCT00654953|20875601|P2|NOT COMPLETED|Overall Study||28
8471280|NCT00654953|20875602|P1|NOT COMPLETED|Overall Study||30
8471281|NCT00654953|20875600|P3|COMPLETED|Overall Study||8
8471282|NCT00654953|20875601|P2|COMPLETED|Overall Study||8
8471283|NCT00654953|20875602|P1|COMPLETED|Overall Study||6
8471284|NCT00654953|20875600|P3|STARTED|Overall Study||30
8471285|NCT00654953|20875601|P2|STARTED|Overall Study||36
8471286|NCT00654953|20875602|P1|STARTED|Overall Study||36
8471307|NCT00654927|20875625|P1|NOT COMPLETED|Overall Study||107
8471308|NCT00654927|20875625|P1|COMPLETED|Overall Study||70
8471309|NCT00654927|20875625|P1|STARTED|Overall Study||177
8471310|NCT00654901|20875637|P4|NOT COMPLETED|Overall Study||0
8471311|NCT00654901|20875638|P3|NOT COMPLETED|Overall Study||2
8471312|NCT00654901|20875639|P2|NOT COMPLETED|Overall Study||0
8471313|NCT00654901|20875640|P1|NOT COMPLETED|Overall Study||4
8471314|NCT00654901|20875637|P4|COMPLETED|Overall Study||113
8471315|NCT00654901|20875638|P3|COMPLETED|Overall Study||250
8471316|NCT00654901|20875639|P2|COMPLETED|Overall Study||262
8471317|NCT00654901|20875640|P1|COMPLETED|Overall Study||250
8471318|NCT00654901|20875637|P4|STARTED|Overall Study||113
8471319|NCT00654901|20875638|P3|STARTED|Overall Study||252
8471320|NCT00654901|20875639|P2|STARTED|Overall Study||262
8471321|NCT00654901|20875640|P1|STARTED|Overall Study||254
8471322|NCT00654875|20875660|P2|NOT COMPLETED|Overall Study||17
8471323|NCT00654875|20875661|P1|NOT COMPLETED|Overall Study||17
8471324|NCT00654875|20875660|P2|COMPLETED|Overall Study||147
8471325|NCT00654875|20875661|P1|COMPLETED|Overall Study||147
8471326|NCT00654875|20875660|P2|STARTED|Overall Study||164
8471327|NCT00654875|20875661|P1|STARTED|Overall Study||164
8471328|NCT00654836|20875679|P1|NOT COMPLETED|Overall Study||0
8471329|NCT00654836|20875679|P1|COMPLETED|Overall Study||32
8471330|NCT00654836|20875679|P1|STARTED|Overall Study||32
8471331|NCT00654784|20875687|P2|NOT COMPLETED|Overall Study||0
8471332|NCT00654784|20875688|P1|NOT COMPLETED|Overall Study||0
8471333|NCT00654784|20875687|P2|COMPLETED|Overall Study||8
8471334|NCT00654784|20875688|P1|COMPLETED|Overall Study||13
8471335|NCT00654784|20875687|P2|STARTED|Overall Study||8
8471336|NCT00654784|20875688|P1|STARTED|Overall Study||13
8471337|NCT00654745|20875694|P1|NOT COMPLETED|Overall Study||43
8471338|NCT00654745|20875694|P1|COMPLETED|Overall Study||164
8471339|NCT00654745|20875694|P1|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
8471340|NCT00654732|20875734|P2|NOT COMPLETED|Overall Study||6
8471341|NCT00654732|20875735|P1|NOT COMPLETED|Overall Study||4
8471342|NCT00654732|20875734|P2|COMPLETED|Overall Study||26
8471343|NCT00654732|20875735|P1|COMPLETED|Overall Study||22
8471344|NCT00654732|20875734|P2|STARTED|Overall Study||32
8471345|NCT00654732|20875735|P1|STARTED|Overall Study||26
8471346|NCT00654654|20875741|P1|NOT COMPLETED|Overall Study||7
8471347|NCT00654654|20875741|P1|COMPLETED|Overall Study||43
8471348|NCT00654654|20875741|P1|STARTED|Overall Study||50
8471349|NCT00654641|20875748|P2|NOT COMPLETED|Overall Study||3
8471350|NCT00654641|20875749|P1|NOT COMPLETED|Overall Study||2
8471351|NCT00654641|20875748|P2|COMPLETED|Overall Study||23
8471352|NCT00654641|20875749|P1|COMPLETED|Overall Study||26
8471353|NCT00654641|20875748|P2|STARTED|Overall Study||26
8471354|NCT00654641|20875749|P1|STARTED|Overall Study||28
8471355|NCT00654628|20875755|P1|NOT COMPLETED|6 -Week Extension Period (Single Site)||5
8471356|NCT00654628|20875755|P1|COMPLETED|6 -Week Extension Period (Single Site)||55
8471357|NCT00654628|20875755|P1|STARTED|6 -Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
8471358|NCT00654628|20875755|P1|NOT COMPLETED|6-week Active Treatment Period||21
8471359|NCT00654628|20875755|P1|COMPLETED|6-week Active Treatment Period||152
8471360|NCT00654628|20875755|P1|STARTED|6-week Active Treatment Period||173
8471361|NCT00654615|20875772|P2|NOT COMPLETED|Overall Study||7
8471362|NCT00654615|20875773|P1|NOT COMPLETED|Overall Study||8
8471363|NCT00654615|20875772|P2|COMPLETED|Overall Study||23
8471364|NCT00654615|20875773|P1|COMPLETED|Overall Study||22
8471365|NCT00654615|20875772|P2|STARTED|Overall Study||30
8471366|NCT00654615|20875773|P1|STARTED|Overall Study||30
8471379|NCT00654498|20875804|P2|NOT COMPLETED|Overall Study||12
8471380|NCT00654498|20875805|P1|NOT COMPLETED|Overall Study||14
8471381|NCT00654498|20875804|P2|COMPLETED|Overall Study||91
8471382|NCT00654498|20875805|P1|COMPLETED|Overall Study||189
8471383|NCT00654498|20875804|P2|STARTED|Overall Study||103
8471384|NCT00654498|20875805|P1|STARTED|Overall Study||203
8471385|NCT00654420|20875837|P4|NOT COMPLETED|Phase II||38
8471386|NCT00654420|20875838|P3|NOT COMPLETED|Phase II||37
8471387|NCT00654420|20875839|P2|NOT COMPLETED|Phase II||0
8471388|NCT00654420|20875840|P1|NOT COMPLETED|Phase II||0
8471389|NCT00654420|20875837|P4|COMPLETED|Phase II||0
8471390|NCT00654420|20875838|P3|COMPLETED|Phase II||0
8471391|NCT00654420|20875839|P2|COMPLETED|Phase II||0
8471392|NCT00654420|20875840|P1|COMPLETED|Phase II||0
8471393|NCT00654420|20875837|P4|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
8471394|NCT00654420|20875838|P3|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
8471395|NCT00654420|20875839|P2|STARTED|Phase II||0
8471396|NCT00654420|20875840|P1|STARTED|Phase II||0
8471397|NCT00654420|20875837|P4|NOT COMPLETED|Phase I (Dose Escalation)||0
8471398|NCT00654420|20875838|P3|NOT COMPLETED|Phase I (Dose Escalation)||0
8471399|NCT00654420|20875839|P2|NOT COMPLETED|Phase I (Dose Escalation)||16
8471400|NCT00654420|20875840|P1|NOT COMPLETED|Phase I (Dose Escalation)||4
8471401|NCT00654420|20875837|P4|COMPLETED|Phase I (Dose Escalation)||0
8471402|NCT00654420|20875838|P3|COMPLETED|Phase I (Dose Escalation)||0
8471403|NCT00654420|20875839|P2|COMPLETED|Phase I (Dose Escalation)||0
8471404|NCT00654420|20875840|P1|COMPLETED|Phase I (Dose Escalation)||0
8471405|NCT00654420|20875837|P4|STARTED|Phase I (Dose Escalation)||0
8471406|NCT00654420|20875838|P3|STARTED|Phase I (Dose Escalation)||0
8471407|NCT00654420|20875839|P2|STARTED|Phase I (Dose Escalation)||16
8471408|NCT00654420|20875840|P1|STARTED|Phase I (Dose Escalation)||4
8471409|NCT00654381|20875866|P6|NOT COMPLETED|Extension Stage||3
8471410|NCT00654381|20875867|P5|NOT COMPLETED|Extension Stage||3
8471411|NCT00654381|20875868|P4|NOT COMPLETED|Extension Stage||9
8471412|NCT00654381|20875869|P3|NOT COMPLETED|Extension Stage||11
8471413|NCT00654381|20875870|P2|NOT COMPLETED|Extension Stage||2
8471414|NCT00654381|20875871|P1|NOT COMPLETED|Extension Stage||1
8471415|NCT00654381|20875866|P6|COMPLETED|Extension Stage||73
8471416|NCT00654381|20875867|P5|COMPLETED|Extension Stage||68
8471417|NCT00654381|20875868|P4|COMPLETED|Extension Stage||142
8471418|NCT00654381|20875869|P3|COMPLETED|Extension Stage||142
8471419|NCT00654381|20875870|P2|COMPLETED|Extension Stage||36
8471420|NCT00654381|20875871|P1|COMPLETED|Extension Stage||33
8471421|NCT00654381|20875866|P6|STARTED|Extension Stage||76
8471422|NCT00654381|20875867|P5|STARTED|Extension Stage||71
8471423|NCT00654381|20875868|P4|STARTED|Extension Stage||151
8471424|NCT00654381|20875869|P3|STARTED|Extension Stage||153
8471425|NCT00654381|20875870|P2|STARTED|Extension Stage||38
8471426|NCT00654381|20875871|P1|STARTED|Extension Stage||34
8471427|NCT00654381|20875866|P6|NOT COMPLETED|2nd Stage||3
8471428|NCT00654381|20875867|P5|NOT COMPLETED|2nd Stage||8
8471429|NCT00654381|20875868|P4|NOT COMPLETED|2nd Stage||4
8471430|NCT00654381|20875869|P3|NOT COMPLETED|2nd Stage||3
8471431|NCT00654381|20875870|P2|NOT COMPLETED|2nd Stage||0
8471432|NCT00654381|20875871|P1|NOT COMPLETED|2nd Stage||2
8471433|NCT00654381|20875866|P6|COMPLETED|2nd Stage||76
8471434|NCT00654381|20875867|P5|COMPLETED|2nd Stage||71
8471435|NCT00654381|20875868|P4|COMPLETED|2nd Stage||151
8471436|NCT00654381|20875869|P3|COMPLETED|2nd Stage||153
8471437|NCT00654381|20875870|P2|COMPLETED|2nd Stage||38
8471438|NCT00654381|20875871|P1|COMPLETED|2nd Stage||34
8471439|NCT00654381|20875866|P6|STARTED|2nd Stage||79
8471440|NCT00654381|20875867|P5|STARTED|2nd Stage||79
8471441|NCT00654381|20875868|P4|STARTED|2nd Stage||155
8471442|NCT00654381|20875869|P3|STARTED|2nd Stage||156
8471443|NCT00654381|20875870|P2|STARTED|2nd Stage||38
8471444|NCT00654381|20875871|P1|STARTED|2nd Stage||36
8471445|NCT00654381|20875866|P6|NOT COMPLETED|1st Stage||2
8471446|NCT00654381|20875867|P5|NOT COMPLETED|1st Stage||2
8471447|NCT00654381|20875868|P4|NOT COMPLETED|1st Stage||5
8471448|NCT00654381|20875869|P3|NOT COMPLETED|1st Stage||3
8471449|NCT00654381|20875870|P2|NOT COMPLETED|1st Stage||3
8471450|NCT00654381|20875871|P1|NOT COMPLETED|1st Stage||3
8471451|NCT00654381|20875866|P6|COMPLETED|1st Stage||79
8471452|NCT00654381|20875867|P5|COMPLETED|1st Stage||79
8471453|NCT00654381|20875868|P4|COMPLETED|1st Stage||155
8471454|NCT00654381|20875869|P3|COMPLETED|1st Stage||156
8471455|NCT00654381|20875870|P2|COMPLETED|1st Stage||38
8471456|NCT00654381|20875871|P1|COMPLETED|1st Stage||36
8471457|NCT00654381|20875866|P6|STARTED|1st Stage||81
8471458|NCT00654381|20875867|P5|STARTED|1st Stage||81
8471459|NCT00654381|20875868|P4|STARTED|1st Stage||160
8471460|NCT00654381|20875869|P3|STARTED|1st Stage||159
8471461|NCT00654381|20875870|P2|STARTED|1st Stage||41
8471462|NCT00654381|20875871|P1|STARTED|1st Stage||39
8471463|NCT00654368|20875908|P3|NOT COMPLETED|Overall Study||32
8471464|NCT00654368|20875909|P2|NOT COMPLETED|Overall Study||48
8471465|NCT00654368|20875910|P1|NOT COMPLETED|Overall Study||53
8471466|NCT00654368|20875908|P3|COMPLETED|Overall Study||75
8471467|NCT00654368|20875909|P2|COMPLETED|Overall Study||50
8471468|NCT00654368|20875910|P1|COMPLETED|Overall Study||0
8471469|NCT00654368|20875908|P3|STARTED|Overall Study||107
8471470|NCT00654368|20875909|P2|STARTED|Overall Study||98
8471471|NCT00654368|20875910|P1|STARTED|Overall Study||53
8471472|NCT00654355|20875943|P2|NOT COMPLETED|Overall Study||2
8471473|NCT00654355|20875944|P1|NOT COMPLETED|Overall Study||2
8471474|NCT00654355|20875943|P2|COMPLETED|Overall Study||13
8471475|NCT00654355|20875944|P1|COMPLETED|Overall Study||13
8471476|NCT00654355|20875943|P2|STARTED|Overall Study||15
8471477|NCT00654355|20875944|P1|STARTED|Overall Study||15
8471478|NCT00654329|20875958|P4|NOT COMPLETED|Overall Study||0
8471479|NCT00654329|20875959|P3|NOT COMPLETED|Overall Study||0
8471480|NCT00654329|20875960|P2|NOT COMPLETED|Overall Study||0
8471481|NCT00654329|20875961|P1|NOT COMPLETED|Overall Study||0
8471482|NCT00654329|20875958|P4|COMPLETED|Overall Study||27
8471483|NCT00654329|20875959|P3|COMPLETED|Overall Study||23
8471484|NCT00654329|20875960|P2|COMPLETED|Overall Study||28
8471485|NCT00654329|20875961|P1|COMPLETED|Overall Study||23
8471486|NCT00654329|20875958|P4|STARTED|Overall Study||27
8471487|NCT00654329|20875959|P3|STARTED|Overall Study||23
8471488|NCT00654329|20875960|P2|STARTED|Overall Study||28
8471489|NCT00654329|20875961|P1|STARTED|Overall Study||23
8471490|NCT00654238|20875975|P1|NOT COMPLETED|Overall Study||4
8471491|NCT00654238|20875975|P1|COMPLETED|Overall Study||55
8471492|NCT00654238|20875975|P1|STARTED|Overall Study||59
8471493|NCT00654186|20875980|P1|NOT COMPLETED|Overall Study||5
8471494|NCT00654186|20875980|P1|COMPLETED|Overall Study||27
8471495|NCT00654186|20875980|P1|STARTED|Overall Study||32
8471496|NCT00654147|20875988|P2|NOT COMPLETED|Overall Study||4
8471497|NCT00654147|20875989|P1|NOT COMPLETED|Overall Study||2
8471498|NCT00654147|20875988|P2|COMPLETED|Overall Study||19
8471499|NCT00654147|20875989|P1|COMPLETED|Overall Study||19
8471500|NCT00654147|20875988|P2|STARTED|Overall Study||23
8471501|NCT00654147|20875989|P1|STARTED|Overall Study||21
8471502|NCT00654095|20876005|P1|NOT COMPLETED|Overall Study||32
8471503|NCT00654095|20876005|P1|COMPLETED|Overall Study||114
8471504|NCT00654095|20876005|P1|STARTED|Overall Study||146
8471505|NCT00654069|20876012|P3|NOT COMPLETED|Overall Study||18
8471506|NCT00654069|20876013|P2|NOT COMPLETED|Overall Study||11
8471507|NCT00654069|20876014|P1|NOT COMPLETED|Overall Study||17
8471508|NCT00654069|20876012|P3|COMPLETED|Overall Study||116
8471509|NCT00654069|20876013|P2|COMPLETED|Overall Study||124
8471510|NCT00654069|20876014|P1|COMPLETED|Overall Study||119
8471511|NCT00654069|20876012|P3|STARTED|Overall Study||134
8471512|NCT00654069|20876013|P2|STARTED|Overall Study||135
8471513|NCT00654069|20876014|P1|STARTED|Overall Study||136
8471514|NCT00654030|20876022|P1|NOT COMPLETED|Overall Study||1
8471515|NCT00654030|20876022|P1|COMPLETED|Overall Study||11
8471516|NCT00654030|20876022|P1|STARTED|Overall Study||12
8471517|NCT00654004|20876028|P2|NOT COMPLETED|Overall Study||0
8471518|NCT00654004|20876029|P1|NOT COMPLETED|Overall Study||1
8471519|NCT00654004|20876028|P2|COMPLETED|Overall Study||12
8471520|NCT00654004|20876029|P1|COMPLETED|Overall Study||13
8471521|NCT00654004|20876028|P2|STARTED|Overall Study||12
8471522|NCT00654004|20876029|P1|STARTED|Overall Study||14
8471523|NCT00653991|20876045|P2|NOT COMPLETED|6 Month Follow-up||141
8471524|NCT00653991|20876046|P1|NOT COMPLETED|6 Month Follow-up||133
8471525|NCT00653991|20876045|P2|COMPLETED|6 Month Follow-up||350
8471526|NCT00653991|20876046|P1|COMPLETED|6 Month Follow-up||311
8471527|NCT00653991|20876045|P2|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491
8471528|NCT00653991|20876046|P1|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444
8471529|NCT00653991|20876045|P2|NOT COMPLETED|3 Month Follow-up||157
8471530|NCT00653991|20876046|P1|NOT COMPLETED|3 Month Follow-up||150
8471531|NCT00653991|20876045|P2|COMPLETED|3 Month Follow-up||334
8471532|NCT00653991|20876046|P1|COMPLETED|3 Month Follow-up||294
8471533|NCT00653991|20876045|P2|STARTED|3 Month Follow-up||491
8471534|NCT00653991|20876046|P1|STARTED|3 Month Follow-up||444
8471535|NCT00653939|20876058|P2|NOT COMPLETED|Overall Study||15
8471536|NCT00653939|20876059|P1|NOT COMPLETED|Overall Study||12
8471537|NCT00653939|20876058|P2|COMPLETED|Overall Study||17
8471538|NCT00653939|20876059|P1|COMPLETED|Overall Study||19
8471539|NCT00653939|20876058|P2|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
8471540|NCT00653939|20876059|P1|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
8471541|NCT00653861|20876075|P1|NOT COMPLETED|Overall Study||0
8471542|NCT00653861|20876075|P1|COMPLETED|Overall Study||72
8471543|NCT00653861|20876075|P1|STARTED|Overall Study||72
8471544|NCT00653523|20876084|P1|NOT COMPLETED|Overall Study||19
8471545|NCT00653523|20876084|P1|COMPLETED|Overall Study||132
8471546|NCT00653523|20876084|P1|STARTED|Overall Study||151
8471547|NCT00653432|20876090|P2|NOT COMPLETED|Overall Study||16
8471548|NCT00653432|20876091|P1|NOT COMPLETED|Overall Study||22
8471549|NCT00653432|20876090|P2|COMPLETED|Overall Study||169
8471550|NCT00653432|20876091|P1|COMPLETED|Overall Study||162
8471551|NCT00653432|20876090|P2|Intend-to-treat ITT|Overall Study|1 of 185 excluded from ITT group for not having at least 1 post-injection visit. ITT=184 subjects|184
8471552|NCT00653432|20876091|P1|Intend-to-treat ITT|Overall Study|3 of 184 excluded from ITT group for not having at least 1 post-injection visit. ITT=181 subjects|181
8471553|NCT00653432|20876090|P2|STARTED|Overall Study||185
8471554|NCT00653432|20876091|P1|STARTED|Overall Study||184
8471555|NCT00653328|20876115|P1|NOT COMPLETED|Overall Study||15
8471556|NCT00653328|20876115|P1|COMPLETED|Overall Study||0
8471557|NCT00653328|20876115|P1|STARTED|Overall Study||15
8471561|NCT00653224|20876130|P2|NOT COMPLETED|Overall Study||7
8471562|NCT00653224|20876131|P1|NOT COMPLETED|Overall Study||7
8471563|NCT00653224|20876130|P2|COMPLETED|Overall Study||280
8471564|NCT00653224|20876131|P1|COMPLETED|Overall Study||286
8471565|NCT00653224|20876130|P2|STARTED|Overall Study||287
8471566|NCT00653224|20876131|P1|STARTED|Overall Study||293
8471567|NCT00653159|20876317|P2|NOT COMPLETED|Overall Study||3
8471568|NCT00653159|20876318|P1|NOT COMPLETED|Overall Study||5
8471569|NCT00653159|20876317|P2|COMPLETED|Overall Study||9
8471570|NCT00653159|20876318|P1|COMPLETED|Overall Study||6
8471571|NCT00653159|20876317|P2|STARTED|Overall Study||12
8471572|NCT00653159|20876318|P1|STARTED|Overall Study||11
8471573|NCT00653133|20876334|P2|NOT COMPLETED|Overall Study||0
8471574|NCT00653133|20876335|P1|NOT COMPLETED|Overall Study||0
8471575|NCT00653133|20876334|P2|COMPLETED|Overall Study||497
8471576|NCT00653133|20876335|P1|COMPLETED|Overall Study||1324
8471577|NCT00653133|20876334|P2|STARTED|Overall Study||497
8471578|NCT00653133|20876335|P1|STARTED|Overall Study||1324
8471582|NCT00652951|20876359|P3|NOT COMPLETED|Booster Phase||0
8471583|NCT00652951|20876360|P2|NOT COMPLETED|Booster Phase||1
8471584|NCT00652951|20876361|P1|NOT COMPLETED|Booster Phase||1
8471585|NCT00652951|20876359|P3|COMPLETED|Booster Phase||258
8471586|NCT00652951|20876360|P2|COMPLETED|Booster Phase||258
8471587|NCT00652951|20876361|P1|COMPLETED|Booster Phase||256
8471588|NCT00652951|20876359|P3|STARTED|Booster Phase||258
8471589|NCT00652951|20876360|P2|STARTED|Booster Phase||259
8471590|NCT00652951|20876361|P1|STARTED|Booster Phase||257
8471591|NCT00652951|20876359|P3|NOT COMPLETED|Primary Phase||0
8471592|NCT00652951|20876360|P2|NOT COMPLETED|Primary Phase||0
8471593|NCT00652951|20876361|P1|NOT COMPLETED|Primary Phase||0
8471594|NCT00652951|20876359|P3|COMPLETED|Primary Phase||260
8471595|NCT00652951|20876360|P2|COMPLETED|Primary Phase||260
8471596|NCT00652951|20876361|P1|COMPLETED|Primary Phase||260
8471597|NCT00652951|20876359|P3|STARTED|Primary Phase||260
8471598|NCT00652951|20876360|P2|STARTED|Primary Phase||260
8471599|NCT00652951|20876361|P1|STARTED|Primary Phase||260
8471600|NCT00652938|20876498|P3|NOT COMPLETED|Overall Study||5
8471601|NCT00652938|20876499|P2|NOT COMPLETED|Overall Study||7
8471602|NCT00652938|20876500|P1|NOT COMPLETED|Overall Study||1
8471603|NCT00652938|20876498|P3|COMPLETED|Overall Study||242
8471604|NCT00652938|20876499|P2|COMPLETED|Overall Study||240
8471605|NCT00652938|20876500|P1|COMPLETED|Overall Study||246
8471606|NCT00652938|20876498|P3|STARTED|Overall Study||247
8471607|NCT00652938|20876499|P2|STARTED|Overall Study||247
8471608|NCT00652938|20876500|P1|STARTED|Overall Study||247
8471609|NCT00652899|20876565|P1|NOT COMPLETED|Overall Study||2
8471610|NCT00652899|20876565|P1|COMPLETED|Overall Study||12
8471611|NCT00652899|20876565|P1|STARTED|Overall Study||14
8471612|NCT00652834|20876575|P1|NOT COMPLETED|Overall Study||5
8471613|NCT00652834|20876575|P1|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
8471614|NCT00652834|20876575|P1|STARTED|Overall Study||23
8471615|NCT00652743|20876582|P3|NOT COMPLETED|Months 42-48||0
8471616|NCT00652743|20876583|P2|NOT COMPLETED|Months 42-48||0
8471617|NCT00652743|20876584|P1|NOT COMPLETED|Months 42-48||0
8471618|NCT00652743|20876582|P3|COMPLETED|Months 42-48||367
8471619|NCT00652743|20876583|P2|COMPLETED|Months 42-48||170
8471620|NCT00652743|20876584|P1|COMPLETED|Months 42-48||196
8471621|NCT00652743|20876582|P3|STARTED|Months 42-48||367
8471622|NCT00652743|20876583|P2|STARTED|Months 42-48||170
8471623|NCT00652743|20876584|P1|STARTED|Months 42-48||196
8471624|NCT00652743|20876582|P3|NOT COMPLETED|Months 36-42||9
8471625|NCT00652743|20876583|P2|NOT COMPLETED|Months 36-42||5
8471626|NCT00652743|20876584|P1|NOT COMPLETED|Months 36-42||6
8471627|NCT00652743|20876582|P3|COMPLETED|Months 36-42||381
8471628|NCT00652743|20876583|P2|COMPLETED|Months 36-42||180
8471629|NCT00652743|20876584|P1|COMPLETED|Months 36-42||210
8471630|NCT00652743|20876582|P3|STARTED|Months 36-42||390
8471631|NCT00652743|20876583|P2|STARTED|Months 36-42||185
8471632|NCT00652743|20876584|P1|STARTED|Months 36-42||216
8471633|NCT00652743|20876582|P3|NOT COMPLETED|Months 24-30||11
8471634|NCT00652743|20876583|P2|NOT COMPLETED|Months 24-30||1
8471635|NCT00652743|20876584|P1|NOT COMPLETED|Months 24-30||5
8471636|NCT00652743|20876582|P3|COMPLETED|Months 24-30||422
8471637|NCT00652743|20876583|P2|COMPLETED|Months 24-30||185
8471638|NCT00652743|20876584|P1|COMPLETED|Months 24-30||207
8471639|NCT00652743|20876582|P3|STARTED|Months 24-30||433
8471640|NCT00652743|20876583|P2|STARTED|Months 24-30||186
8471641|NCT00652743|20876584|P1|STARTED|Months 24-30||212
8471642|NCT00652743|20876582|P3|NOT COMPLETED|Months 12-18||7
8471643|NCT00652743|20876583|P2|NOT COMPLETED|Months 12-18||2
8471644|NCT00652743|20876584|P1|NOT COMPLETED|Months 12-18||1
8471645|NCT00652743|20876582|P3|COMPLETED|Months 12-18||430
8471646|NCT00652743|20876583|P2|COMPLETED|Months 12-18||186
8471647|NCT00652743|20876584|P1|COMPLETED|Months 12-18||218
8471648|NCT00652743|20876582|P3|STARTED|Months 12-18||437
8471649|NCT00652743|20876583|P2|STARTED|Months 12-18||188
8471650|NCT00652743|20876584|P1|STARTED|Months 12-18||219
8471651|NCT00652626|20876666|P7|NOT COMPLETED|Extension Phase||3
8471652|NCT00652626|20876667|P6|NOT COMPLETED|Extension Phase||12
8471653|NCT00652626|20876668|P5|NOT COMPLETED|Extension Phase||0
8471654|NCT00652626|20876669|P4|NOT COMPLETED|Extension Phase||0
8471655|NCT00652626|20876670|P3|NOT COMPLETED|Extension Phase||0
8471656|NCT00652626|20876671|P2|NOT COMPLETED|Extension Phase||0
8471657|NCT00652626|20876672|P1|NOT COMPLETED|Extension Phase||0
8471658|NCT00652626|20876666|P7|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
8471659|NCT00652626|20876667|P6|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
8471660|NCT00652626|20876668|P5|COMPLETED|Extension Phase||0
8471661|NCT00652626|20876669|P4|COMPLETED|Extension Phase||0
8471662|NCT00652626|20876670|P3|COMPLETED|Extension Phase||0
8471663|NCT00652626|20876671|P2|COMPLETED|Extension Phase||0
8471664|NCT00652626|20876672|P1|COMPLETED|Extension Phase||0
8471665|NCT00652626|20876666|P7|STARTED|Extension Phase||4
8471666|NCT00652626|20876667|P6|STARTED|Extension Phase||14
8471667|NCT00652626|20876668|P5|STARTED|Extension Phase||0
8471668|NCT00652626|20876669|P4|STARTED|Extension Phase||0
8471669|NCT00652626|20876670|P3|STARTED|Extension Phase||0
8471670|NCT00652626|20876671|P2|STARTED|Extension Phase||0
8471671|NCT00652626|20876672|P1|STARTED|Extension Phase||0
8471672|NCT00652626|20876666|P7|NOT COMPLETED|Initial Treatment Phase||0
8471673|NCT00652626|20876667|P6|NOT COMPLETED|Initial Treatment Phase||0
8471674|NCT00652626|20876668|P5|NOT COMPLETED|Initial Treatment Phase||3
8471675|NCT00652626|20876669|P4|NOT COMPLETED|Initial Treatment Phase||1
8471676|NCT00652626|20876670|P3|NOT COMPLETED|Initial Treatment Phase||1
8471677|NCT00652626|20876671|P2|NOT COMPLETED|Initial Treatment Phase||0
8471678|NCT00652626|20876672|P1|NOT COMPLETED|Initial Treatment Phase||0
8471679|NCT00652626|20876666|P7|COMPLETED|Initial Treatment Phase||0
8471680|NCT00652626|20876667|P6|COMPLETED|Initial Treatment Phase||0
8471681|NCT00652626|20876668|P5|COMPLETED|Initial Treatment Phase||5
8471682|NCT00652626|20876669|P4|COMPLETED|Initial Treatment Phase||5
8471683|NCT00652626|20876670|P3|COMPLETED|Initial Treatment Phase||6
8471684|NCT00652626|20876671|P2|COMPLETED|Initial Treatment Phase||5
8471685|NCT00652626|20876672|P1|COMPLETED|Initial Treatment Phase||5
8471686|NCT00652626|20876666|P7|Received Study Drug|Initial Treatment Phase||0
8471687|NCT00652626|20876667|P6|Received Study Drug|Initial Treatment Phase||0
8471688|NCT00652626|20876668|P5|Received Study Drug|Initial Treatment Phase||6
8471689|NCT00652626|20876669|P4|Received Study Drug|Initial Treatment Phase||5
8471690|NCT00652626|20876670|P3|Received Study Drug|Initial Treatment Phase||6
8471691|NCT00652626|20876671|P2|Received Study Drug|Initial Treatment Phase||5
8471692|NCT00652626|20876672|P1|Received Study Drug|Initial Treatment Phase||5
8471693|NCT00652626|20876666|P7|STARTED|Initial Treatment Phase||0
8471694|NCT00652626|20876667|P6|STARTED|Initial Treatment Phase||0
8471695|NCT00652626|20876668|P5|STARTED|Initial Treatment Phase||8
8471696|NCT00652626|20876669|P4|STARTED|Initial Treatment Phase||6
8471697|NCT00652626|20876670|P3|STARTED|Initial Treatment Phase||7
8471698|NCT00652626|20876671|P2|STARTED|Initial Treatment Phase||5
8471699|NCT00652626|20876672|P1|STARTED|Initial Treatment Phase||5
8471700|NCT00652457|20876736|P2|NOT COMPLETED|Overall Study||0
8471701|NCT00652457|20876737|P1|NOT COMPLETED|Overall Study||0
8471702|NCT00652457|20876736|P2|COMPLETED|Overall Study||27
8471703|NCT00652457|20876737|P1|COMPLETED|Overall Study||23
8471704|NCT00652457|20876736|P2|STARTED|Overall Study||27
8471705|NCT00652457|20876737|P1|STARTED|Overall Study||23
8471706|NCT00652366|20876750|P5|NOT COMPLETED|Overall Study||36
8471707|NCT00652366|20876751|P4|NOT COMPLETED|Overall Study||179
8471708|NCT00652366|20876752|P3|NOT COMPLETED|Overall Study||71
8471709|NCT00652366|20876753|P2|NOT COMPLETED|Overall Study||75
8471710|NCT00652366|20876754|P1|NOT COMPLETED|Overall Study||106
8471711|NCT00652366|20876750|P5|COMPLETED|Overall Study||0
8471712|NCT00652366|20876751|P4|COMPLETED|Overall Study||0
8471713|NCT00652366|20876752|P3|COMPLETED|Overall Study||0
8471714|NCT00652366|20876753|P2|COMPLETED|Overall Study||0
8471715|NCT00652366|20876754|P1|COMPLETED|Overall Study||0
8471716|NCT00652366|20876750|P5|STARTED|Overall Study||36
8471717|NCT00652366|20876751|P4|STARTED|Overall Study||179
8471718|NCT00652366|20876752|P3|STARTED|Overall Study||71
8471719|NCT00652366|20876753|P2|STARTED|Overall Study||75
8471720|NCT00652366|20876754|P1|STARTED|Overall Study||106
8471721|NCT00652340|20876789|P2|NOT COMPLETED|Overall Study||3
8471722|NCT00652340|20876790|P1|NOT COMPLETED|Overall Study||4
8471723|NCT00652340|20876789|P2|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
8471724|NCT00652340|20876790|P1|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
8471725|NCT00652340|20876789|P2|STARTED|Overall Study||42
8471726|NCT00652340|20876790|P1|STARTED|Overall Study||78
8471727|NCT00652327|20876800|P2|NOT COMPLETED|Overall Study||5
8471728|NCT00652327|20876801|P1|NOT COMPLETED|Overall Study||0
8471729|NCT00652327|20876800|P2|COMPLETED|Overall Study||36
8471730|NCT00652327|20876801|P1|COMPLETED|Overall Study||42
8471731|NCT00652327|20876800|P2|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
8471732|NCT00652327|20876801|P1|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
8471733|NCT00652314|20876809|P2|NOT COMPLETED|Overall Study||9
8471734|NCT00652314|20876810|P1|NOT COMPLETED|Overall Study||9
8471735|NCT00652314|20876809|P2|COMPLETED|Overall Study||26
8471736|NCT00652314|20876810|P1|COMPLETED|Overall Study||53
8471737|NCT00652314|20876809|P2|STARTED|Overall Study||35
8471738|NCT00652314|20876810|P1|STARTED|Overall Study||62
8471739|NCT00652145|20876826|P2|NOT COMPLETED|Overall Study||0
8471740|NCT00652145|20876827|P1|NOT COMPLETED|Overall Study||0
8471741|NCT00652145|20876826|P2|COMPLETED|Overall Study||26
8471742|NCT00652145|20876827|P1|COMPLETED|Overall Study||26
8471743|NCT00652145|20876826|P2|STARTED|Overall Study||26
8471744|NCT00652145|20876827|P1|STARTED|Overall Study||26
8471745|NCT00652093|20876843|P6|NOT COMPLETED|Overall Study||0
8471746|NCT00652093|20876844|P5|NOT COMPLETED|Overall Study||2
8471747|NCT00652093|20876845|P4|NOT COMPLETED|Overall Study||0
8471748|NCT00652093|20876846|P3|NOT COMPLETED|Overall Study||1
8471749|NCT00652093|20876847|P2|NOT COMPLETED|Overall Study||0
8471750|NCT00652093|20876848|P1|NOT COMPLETED|Overall Study||0
8471751|NCT00652093|20876843|P6|COMPLETED|Overall Study||4
8471752|NCT00652093|20876844|P5|COMPLETED|Overall Study||2
8471753|NCT00652093|20876845|P4|COMPLETED|Overall Study||4
8471754|NCT00652093|20876846|P3|COMPLETED|Overall Study||3
8471755|NCT00652093|20876847|P2|COMPLETED|Overall Study||4
8471756|NCT00652093|20876848|P1|COMPLETED|Overall Study||4
8471757|NCT00652093|20876843|P6|STARTED|Overall Study||4
8471758|NCT00652093|20876844|P5|STARTED|Overall Study||4
8471759|NCT00652093|20876845|P4|STARTED|Overall Study||4
8471760|NCT00652093|20876846|P3|STARTED|Overall Study||4
8471761|NCT00652093|20876847|P2|STARTED|Overall Study||4
8471762|NCT00652093|20876848|P1|STARTED|Overall Study||4
8471763|NCT00652080|20876928|P1|NOT COMPLETED|Overall Study||4
8471764|NCT00652080|20876928|P1|COMPLETED|Overall Study||31
8471765|NCT00652080|20876928|P1|STARTED|Overall Study||35
8471766|NCT00652028|20876938|P4|NOT COMPLETED|Overall Study||0
8471767|NCT00652028|20876939|P3|NOT COMPLETED|Overall Study||1
8471768|NCT00652028|20876940|P2|NOT COMPLETED|Overall Study||1
8471769|NCT00652028|20876941|P1|NOT COMPLETED|Overall Study||1
8471770|NCT00652028|20876938|P4|COMPLETED|Overall Study||14
8471771|NCT00652028|20876939|P3|COMPLETED|Overall Study||14
8471772|NCT00652028|20876940|P2|COMPLETED|Overall Study||13
8471773|NCT00652028|20876941|P1|COMPLETED|Overall Study||15
8471774|NCT00652028|20876938|P4|STARTED|Overall Study||14
8471775|NCT00652028|20876939|P3|STARTED|Overall Study||15
8471776|NCT00652028|20876940|P2|STARTED|Overall Study||14
8471777|NCT00652028|20876941|P1|STARTED|Overall Study||16
8471778|NCT00651937|20876985|P2|NOT COMPLETED|Overall Study||1
8471779|NCT00651937|20876986|P1|NOT COMPLETED|Overall Study||4
8471780|NCT00651937|20876985|P2|COMPLETED|Overall Study||40
8471781|NCT00651937|20876986|P1|COMPLETED|Overall Study||35
8471782|NCT00651937|20876985|P2|STARTED|Overall Study||41
8471783|NCT00651937|20876986|P1|STARTED|Overall Study||39
8471784|NCT00651924|20876996|P2|NOT COMPLETED|Overall Study||7
8471785|NCT00651924|20876997|P1|NOT COMPLETED|Overall Study||0
8471786|NCT00651924|20876996|P2|COMPLETED|Overall Study||2
8471787|NCT00651924|20876997|P1|COMPLETED|Overall Study||18
8471788|NCT00651924|20876996|P2|STARTED|Overall Study||9
8471789|NCT00651924|20876997|P1|STARTED|Overall Study||18
8471790|NCT00651820|20877003|P1|NOT COMPLETED|Overall Study||2
8471791|NCT00651820|20877003|P1|COMPLETED|Overall Study||26
8471792|NCT00651820|20877003|P1|STARTED|Overall Study||28
8471793|NCT00651794|20877013|P3|NOT COMPLETED|Overall Study||21
8471794|NCT00651794|20877014|P2|NOT COMPLETED|Overall Study||22
8471795|NCT00651794|20877015|P1|NOT COMPLETED|Overall Study||21
8471796|NCT00651794|20877013|P3|COMPLETED|Overall Study||10
8471797|NCT00651794|20877014|P2|COMPLETED|Overall Study||9
8471798|NCT00651794|20877015|P1|COMPLETED|Overall Study||15
8471799|NCT00651794|20877013|P3|STARTED|Overall Study||31
8471800|NCT00651794|20877014|P2|STARTED|Overall Study||31
8471801|NCT00651794|20877015|P1|STARTED|Overall Study||36
8471802|NCT00651755|20877035|P2|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
8471803|NCT00651755|20877036|P1|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
8471804|NCT00651755|20877035|P2|COMPLETED|Cycle 2 (Second 21 Days)||8
8471805|NCT00651755|20877036|P1|COMPLETED|Cycle 2 (Second 21 Days)||10
8471806|NCT00651755|20877035|P2|STARTED|Cycle 2 (Second 21 Days)||9
8471807|NCT00651755|20877036|P1|STARTED|Cycle 2 (Second 21 Days)||10
8471808|NCT00651755|20877035|P2|NOT COMPLETED|Cycle 1 (First 21 Days)||0
8471809|NCT00651755|20877036|P1|NOT COMPLETED|Cycle 1 (First 21 Days)||1
8471810|NCT00651755|20877035|P2|COMPLETED|Cycle 1 (First 21 Days)||9
8471811|NCT00651755|20877036|P1|COMPLETED|Cycle 1 (First 21 Days)||10
8471812|NCT00651755|20877035|P2|STARTED|Cycle 1 (First 21 Days)||9
8471813|NCT00651755|20877036|P1|STARTED|Cycle 1 (First 21 Days)||11
8471814|NCT00651664|20877062|P10|NOT COMPLETED|Overall Study||7
8471815|NCT00651664|20877063|P9|NOT COMPLETED|Overall Study||7
8471816|NCT00651664|20877064|P8|NOT COMPLETED|Overall Study||7
8471817|NCT00651664|20877065|P7|NOT COMPLETED|Overall Study||6
8471818|NCT00651664|20877066|P6|NOT COMPLETED|Overall Study||3
8471819|NCT00651664|20877067|P5|NOT COMPLETED|Overall Study||6
8471820|NCT00651664|20877068|P4|NOT COMPLETED|Overall Study||14
8471821|NCT00651664|20877069|P3|NOT COMPLETED|Overall Study||3
8471822|NCT00651664|20877070|P2|NOT COMPLETED|Overall Study||3
8471823|NCT00651664|20877071|P1|NOT COMPLETED|Overall Study||3
8471824|NCT00651664|20877062|P10|COMPLETED|Overall Study||0
8471825|NCT00651664|20877063|P9|COMPLETED|Overall Study||0
8471826|NCT00651664|20877064|P8|COMPLETED|Overall Study||0
8471827|NCT00651664|20877065|P7|COMPLETED|Overall Study||0
8471828|NCT00651664|20877066|P6|COMPLETED|Overall Study||0
8471829|NCT00651664|20877067|P5|COMPLETED|Overall Study||0
8471830|NCT00651664|20877068|P4|COMPLETED|Overall Study||0
8471831|NCT00651664|20877069|P3|COMPLETED|Overall Study||0
8471832|NCT00651664|20877070|P2|COMPLETED|Overall Study||0
8471833|NCT00651664|20877071|P1|COMPLETED|Overall Study||0
8471834|NCT00651664|20877062|P10|STARTED|Overall Study||7
8471835|NCT00651664|20877063|P9|STARTED|Overall Study||7
8471836|NCT00651664|20877064|P8|STARTED|Overall Study||7
8471837|NCT00651664|20877065|P7|STARTED|Overall Study||6
8471838|NCT00651664|20877066|P6|STARTED|Overall Study||3
8471839|NCT00651664|20877067|P5|STARTED|Overall Study||6
8471840|NCT00651664|20877068|P4|STARTED|Overall Study||14
8471841|NCT00651664|20877069|P3|STARTED|Overall Study||3
8471842|NCT00651664|20877070|P2|STARTED|Overall Study||3
8471843|NCT00651664|20877071|P1|STARTED|Overall Study||3
8471844|NCT00651625|20877197|P2|NOT COMPLETED|Overall Study||0
8471845|NCT00651625|20877198|P1|NOT COMPLETED|Overall Study||0
8471846|NCT00651625|20877197|P2|COMPLETED|Overall Study||218
8471847|NCT00651625|20877198|P1|COMPLETED|Overall Study||219
8471848|NCT00651625|20877197|P2|STARTED|Overall Study||218
8471849|NCT00651625|20877198|P1|STARTED|Overall Study||219
8471850|NCT00651573|20877212|P2|NOT COMPLETED|Overall Study||3
8471851|NCT00651573|20877213|P1|NOT COMPLETED|Overall Study||2
8471852|NCT00651573|20877212|P2|COMPLETED|Overall Study||354
8471853|NCT00651573|20877213|P1|COMPLETED|Overall Study||363
8471854|NCT00651573|20877212|P2|STARTED|Overall Study||357
8471855|NCT00651573|20877213|P1|STARTED|Overall Study||365
8471856|NCT00651482|20877229|P1|NOT COMPLETED|Overall Study||0
8471857|NCT00651482|20877229|P1|COMPLETED|Overall Study||10
8471858|NCT00651482|20877229|P1|STARTED|Overall Study||10
8471859|NCT00651313|20877243|P2|NOT COMPLETED|Overall Study||6
8471860|NCT00651313|20877244|P1|NOT COMPLETED|Overall Study||6
8471861|NCT00651313|20877243|P2|COMPLETED|Overall Study||37
8471862|NCT00651313|20877244|P1|COMPLETED|Overall Study||35
8471863|NCT00651313|20877243|P2|STARTED|Overall Study||43
8471864|NCT00651313|20877244|P1|STARTED|Overall Study||41
8471871|NCT00651183|20877269|P2|NOT COMPLETED|Overall Study||10
8471872|NCT00651183|20877270|P1|NOT COMPLETED|Overall Study||20
8471873|NCT00651183|20877269|P2|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
8471874|NCT00651183|20877270|P1|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
8471875|NCT00651183|20877269|P2|STARTED|Overall Study||97
8471876|NCT00651183|20877270|P1|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
8471877|NCT00651157|20877282|P1|NOT COMPLETED|Overall Study||2
8471878|NCT00651157|20877282|P1|COMPLETED|Overall Study||21
8471879|NCT00651157|20877282|P1|STARTED|Overall Study||23
8471880|NCT00651118|20877292|P4|NOT COMPLETED|Overall Study||7
8471881|NCT00651118|20877293|P3|NOT COMPLETED|Overall Study||11
8471882|NCT00651118|20877294|P2|NOT COMPLETED|Overall Study||7
8471883|NCT00651118|20877295|P1|NOT COMPLETED|Overall Study||9
8471884|NCT00651118|20877292|P4|COMPLETED|Overall Study||203
8471885|NCT00651118|20877293|P3|COMPLETED|Overall Study||197
8471886|NCT00651118|20877294|P2|COMPLETED|Overall Study||200
8471887|NCT00651118|20877295|P1|COMPLETED|Overall Study||198
8471888|NCT00651118|20877292|P4|STARTED|Overall Study||210
8471889|NCT00651118|20877293|P3|STARTED|Overall Study||208
8471890|NCT00651118|20877294|P2|STARTED|Overall Study||207
8471891|NCT00651118|20877295|P1|STARTED|Overall Study||207
8471892|NCT00651040|20877315|P2|NOT COMPLETED|Overall Study||1
8471893|NCT00651040|20877316|P1|NOT COMPLETED|Overall Study||3
8471894|NCT00651040|20877315|P2|COMPLETED|Overall Study||14
8471895|NCT00651040|20877316|P1|COMPLETED|Overall Study||13
8471896|NCT00651040|20877315|P2|STARTED|Overall Study||15
8471897|NCT00651040|20877316|P1|STARTED|Overall Study||16
8471898|NCT00650936|20877322|P1|NOT COMPLETED|Overall Study||70
8471899|NCT00650936|20877322|P1|COMPLETED|Overall Study||930
8471900|NCT00650936|20877322|P1|STARTED|Overall Study||1000
8471901|NCT00650858|20877331|P3|NOT COMPLETED|Overall Study||0
8471902|NCT00650858|20877332|P2|NOT COMPLETED|Overall Study||0
8471903|NCT00650858|20877333|P1|NOT COMPLETED|Overall Study||0
8471904|NCT00650858|20877331|P3|COMPLETED|Overall Study||36
8471905|NCT00650858|20877332|P2|COMPLETED|Overall Study||8
8471906|NCT00650858|20877333|P1|COMPLETED|Overall Study||8
8471907|NCT00650858|20877331|P3|STARTED|Overall Study||36
8471908|NCT00650858|20877332|P2|STARTED|Overall Study||8
8471909|NCT00650858|20877333|P1|STARTED|Overall Study||8
8471910|NCT00650845|20877364|P2|NOT COMPLETED|Overall Study||13
8471911|NCT00650845|20877365|P1|NOT COMPLETED|Overall Study||5
8471912|NCT00650845|20877364|P2|COMPLETED|Overall Study||44
8471913|NCT00650845|20877365|P1|COMPLETED|Overall Study||70
8471914|NCT00650845|20877364|P2|STARTED|Overall Study||57
8471915|NCT00650845|20877365|P1|STARTED|Overall Study||75
8471916|NCT00650806|20877385|P4|NOT COMPLETED|Overall Study||26
8471917|NCT00650806|20877386|P3|NOT COMPLETED|Overall Study||29
8471918|NCT00650806|20877387|P2|NOT COMPLETED|Overall Study||21
8471919|NCT00650806|20877388|P1|NOT COMPLETED|Overall Study||18
8471920|NCT00650806|20877385|P4|COMPLETED|Overall Study||70
8471921|NCT00650806|20877386|P3|COMPLETED|Overall Study||64
8471922|NCT00650806|20877387|P2|COMPLETED|Overall Study||77
8471923|NCT00650806|20877388|P1|COMPLETED|Overall Study||71
8471924|NCT00650806|20877385|P4|STARTED|Overall Study||96
8471925|NCT00650806|20877386|P3|STARTED|Overall Study||93
8471926|NCT00650806|20877387|P2|STARTED|Overall Study||98
8471927|NCT00650806|20877388|P1|STARTED|Overall Study||89
8471928|NCT00650767|20877430|P4|NOT COMPLETED|Overall Study||11
8471929|NCT00650767|20877431|P3|NOT COMPLETED|Overall Study||14
8471930|NCT00650767|20877432|P2|NOT COMPLETED|Overall Study||9
8471931|NCT00650767|20877433|P1|NOT COMPLETED|Overall Study||5
8471932|NCT00650767|20877430|P4|COMPLETED|Overall Study||39
8471933|NCT00650767|20877431|P3|COMPLETED|Overall Study||36
8471934|NCT00650767|20877432|P2|COMPLETED|Overall Study||41
8471935|NCT00650767|20877433|P1|COMPLETED|Overall Study||46
8471936|NCT00650767|20877430|P4|STARTED|Overall Study||50
8471937|NCT00650767|20877431|P3|STARTED|Overall Study||50
8471938|NCT00650767|20877432|P2|STARTED|Overall Study||50
8471939|NCT00650767|20877433|P1|STARTED|Overall Study||51
8471940|NCT00650585|20877937|P2|NOT COMPLETED|Overall Study||1477
8471941|NCT00650585|20877938|P1|NOT COMPLETED|Overall Study||1797
8471942|NCT00650585|20877937|P2|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
8471943|NCT00650585|20877938|P1|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
8471944|NCT00650585|20877937|P2|STARTED|Overall Study||3990
8471945|NCT00650585|20877938|P1|STARTED|Overall Study||4348
8471946|NCT00650546|20877958|P1|NOT COMPLETED|Overall Study||0
8471947|NCT00650546|20877958|P1|COMPLETED|Overall Study||8
8471948|NCT00650546|20877958|P1|STARTED|Overall Study||8
8471949|NCT00650260|20877965|P2|NOT COMPLETED|Overall Study||0
8471950|NCT00650260|20877966|P1|NOT COMPLETED|Overall Study||0
8471951|NCT00650260|20877965|P2|COMPLETED|Overall Study||21
8471952|NCT00650260|20877966|P1|COMPLETED|Overall Study||21
8471953|NCT00650260|20877965|P2|STARTED|Overall Study||21
8471954|NCT00650260|20877966|P1|STARTED|Overall Study||21
8471955|NCT00650104|20877982|P1|NOT COMPLETED|Overall Study||41
8471956|NCT00650104|20877982|P1|COMPLETED|Overall Study||42
8471957|NCT00650104|20877982|P1|STARTED|Overall Study||83
8471958|NCT00650091|20877997|P3|NOT COMPLETED|Amended Study Design||0
8471959|NCT00650091|20877998|P2|NOT COMPLETED|Amended Study Design||20
8471960|NCT00650091|20877999|P1|NOT COMPLETED|Amended Study Design||23
8471961|NCT00650091|20877997|P3|COMPLETED|Amended Study Design||0
8471962|NCT00650091|20877998|P2|COMPLETED|Amended Study Design||111
8471963|NCT00650091|20877999|P1|COMPLETED|Amended Study Design||110
8471964|NCT00650091|20877997|P3|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
8471965|NCT00650091|20877998|P2|STARTED|Amended Study Design||131
8471966|NCT00650091|20877999|P1|STARTED|Amended Study Design||133
8471967|NCT00650091|20877997|P3|NOT COMPLETED|Initial Study Design - Interim Analysis||0
8471968|NCT00650091|20877998|P2|NOT COMPLETED|Initial Study Design - Interim Analysis||0
8471969|NCT00650091|20877999|P1|NOT COMPLETED|Initial Study Design - Interim Analysis||0
8471970|NCT00650091|20877997|P3|COMPLETED|Initial Study Design - Interim Analysis||77
8471971|NCT00650091|20877998|P2|COMPLETED|Initial Study Design - Interim Analysis||78
8471972|NCT00650091|20877999|P1|COMPLETED|Initial Study Design - Interim Analysis||81
8471973|NCT00650091|20877997|P3|STARTED|Initial Study Design - Interim Analysis||77
8471974|NCT00650091|20877998|P2|STARTED|Initial Study Design - Interim Analysis||78
8471975|NCT00650091|20877999|P1|STARTED|Initial Study Design - Interim Analysis||81
8471976|NCT00650078|20878019|P2|NOT COMPLETED|Overall Study||13
8471977|NCT00650078|20878020|P1|NOT COMPLETED|Overall Study||14
8471978|NCT00650078|20878019|P2|COMPLETED|Overall Study||106
8471979|NCT00650078|20878020|P1|COMPLETED|Overall Study||217
8471980|NCT00650078|20878019|P2|STARTED|Overall Study||119
8471981|NCT00650078|20878020|P1|STARTED|Overall Study||231
8471982|NCT00649961|20878028|P1|NOT COMPLETED|Overall Study||0
8471983|NCT00649961|20878028|P1|COMPLETED|Overall Study||18
8471984|NCT00649961|20878028|P1|STARTED|Overall Study||18
8471985|NCT00649792|20878032|P1|NOT COMPLETED|Overall Study||68
8471986|NCT00649792|20878032|P1|COMPLETED|Overall Study||146
8471987|NCT00649792|20878032|P1|STARTED|Overall Study||214
8471988|NCT00649428|20878042|P2|NOT COMPLETED|Overall Study||15
8471989|NCT00649428|20878043|P1|NOT COMPLETED|Overall Study||20
8471990|NCT00649428|20878042|P2|COMPLETED|Overall Study||88
8471991|NCT00649428|20878043|P1|COMPLETED|Overall Study||80
8471992|NCT00649428|20878042|P2|STARTED|Overall Study||103
8471993|NCT00649428|20878043|P1|STARTED|Overall Study||100
8471994|NCT00649389|20878059|P4|NOT COMPLETED|Overall Study||111
8471995|NCT00649389|20878060|P3|NOT COMPLETED|Overall Study||88
8471996|NCT00649389|20878061|P2|NOT COMPLETED|Overall Study||106
8471997|NCT00649389|20878062|P1|NOT COMPLETED|Overall Study||71
8471998|NCT00649389|20878059|P4|COMPLETED|Overall Study||516
8471999|NCT00649389|20878060|P3|COMPLETED|Overall Study||512
8472000|NCT00649389|20878061|P2|COMPLETED|Overall Study||531
8472001|NCT00649389|20878062|P1|COMPLETED|Overall Study||557
8472002|NCT00649389|20878059|P4|STARTED|Overall Study||627
8472003|NCT00649389|20878060|P3|STARTED|Overall Study||600
8472004|NCT00649389|20878061|P2|STARTED|Overall Study||637
8472005|NCT00649389|20878062|P1|STARTED|Overall Study||628
8472006|NCT00649220|20878084|P1|NOT COMPLETED|Overall Study||3
8472007|NCT00649220|20878084|P1|COMPLETED|Overall Study||16
8472008|NCT00649220|20878084|P1|STARTED|Overall Study||19
8472009|NCT00648908|20878095|P1|NOT COMPLETED|Overall Study||115
8472010|NCT00648908|20878095|P1|COMPLETED|Overall Study||154
8472011|NCT00648908|20878095|P1|STARTED|Overall Study||269
8472012|NCT00648895|20878105|P2|NOT COMPLETED|Overall Study||1
8472013|NCT00648895|20878106|P1|NOT COMPLETED|Overall Study||0
8472014|NCT00648895|20878105|P2|COMPLETED|Overall Study||5
8472015|NCT00648895|20878106|P1|COMPLETED|Overall Study||6
8472016|NCT00648895|20878105|P2|STARTED|Overall Study||6
8472017|NCT00648895|20878106|P1|STARTED|Overall Study||6
8472018|NCT00648739|20878112|P7|NOT COMPLETED|Overall Study||1
8472019|NCT00648739|20878113|P6|NOT COMPLETED|Overall Study||5
8472020|NCT00648739|20878114|P5|NOT COMPLETED|Overall Study||2
8472021|NCT00648739|20878115|P4|NOT COMPLETED|Overall Study||2
8472022|NCT00648739|20878116|P3|NOT COMPLETED|Overall Study||3
8472023|NCT00648739|20878117|P2|NOT COMPLETED|Overall Study||2
8472024|NCT00648739|20878118|P1|NOT COMPLETED|Overall Study||2
8472025|NCT00648739|20878112|P7|COMPLETED|Overall Study||0
8472026|NCT00648739|20878113|P6|COMPLETED|Overall Study||2
8472027|NCT00648739|20878114|P5|COMPLETED|Overall Study||1
8472028|NCT00648739|20878115|P4|COMPLETED|Overall Study||1
8472029|NCT00648739|20878116|P3|COMPLETED|Overall Study||0
8472030|NCT00648739|20878117|P2|COMPLETED|Overall Study||3
8472031|NCT00648739|20878118|P1|COMPLETED|Overall Study||2
8472032|NCT00648739|20878112|P7|Received at Least 1 Dose of Study Drug|Overall Study||1
8472033|NCT00648739|20878113|P6|Received at Least 1 Dose of Study Drug|Overall Study||7
8472034|NCT00648739|20878114|P5|Received at Least 1 Dose of Study Drug|Overall Study||3
8472035|NCT00648739|20878115|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8472036|NCT00648739|20878116|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8472037|NCT00648739|20878117|P2|Received at Least 1 Dose of Study Drug|Overall Study||5
8472038|NCT00648739|20878118|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
8472039|NCT00648739|20878112|P7|STARTED|Overall Study||1
8472040|NCT00648739|20878113|P6|STARTED|Overall Study||7
8472041|NCT00648739|20878114|P5|STARTED|Overall Study||3
8472042|NCT00648739|20878115|P4|STARTED|Overall Study||3
8472043|NCT00648739|20878116|P3|STARTED|Overall Study||3
8472044|NCT00648739|20878117|P2|STARTED|Overall Study||5
8472045|NCT00648739|20878118|P1|STARTED|Overall Study||4
8472046|NCT00648648|20878184|P28|NOT COMPLETED|Overall Study||12
8472047|NCT00648648|20878185|P27|NOT COMPLETED|Overall Study||26
8472048|NCT00648648|20878186|P26|NOT COMPLETED|Overall Study||4
8472049|NCT00648648|20878187|P25|NOT COMPLETED|Overall Study||4
8472050|NCT00648648|20878188|P24|NOT COMPLETED|Overall Study||4
8472051|NCT00648648|20878189|P23|NOT COMPLETED|Overall Study||14
8472052|NCT00648648|20878190|P22|NOT COMPLETED|Overall Study||10
8472053|NCT00648648|20878191|P21|NOT COMPLETED|Overall Study||6
8472054|NCT00648648|20878192|P20|NOT COMPLETED|Overall Study||7
8472055|NCT00648648|20878193|P19|NOT COMPLETED|Overall Study||5
8472056|NCT00648648|20878194|P18|NOT COMPLETED|Overall Study||6
8472057|NCT00648648|20878195|P17|NOT COMPLETED|Overall Study||14
8472058|NCT00648648|20878196|P16|NOT COMPLETED|Overall Study||11
8472059|NCT00648648|20878197|P15|NOT COMPLETED|Overall Study||4
8472060|NCT00648648|20878198|P14|NOT COMPLETED|Overall Study||5
8472061|NCT00648648|20878199|P13|NOT COMPLETED|Overall Study||6
8472062|NCT00648648|20878200|P12|NOT COMPLETED|Overall Study||13
8472063|NCT00648648|20878201|P11|NOT COMPLETED|Overall Study||6
8472064|NCT00648648|20878202|P10|NOT COMPLETED|Overall Study||10
8472065|NCT00648648|20878203|P9|NOT COMPLETED|Overall Study||3
8472066|NCT00648648|20878204|P8|NOT COMPLETED|Overall Study||1
8472067|NCT00648648|20878205|P7|NOT COMPLETED|Overall Study||10
8472068|NCT00648648|20878206|P6|NOT COMPLETED|Overall Study||1
8472069|NCT00648648|20878207|P5|NOT COMPLETED|Overall Study||9
8472070|NCT00648648|20878208|P4|NOT COMPLETED|Overall Study||4
8472071|NCT00648648|20878209|P3|NOT COMPLETED|Overall Study||0
8472072|NCT00648648|20878210|P2|NOT COMPLETED|Overall Study||0
8472073|NCT00648648|20878211|P1|NOT COMPLETED|Overall Study||0
8472074|NCT00648648|20878184|P28|COMPLETED|Overall Study||0
8472075|NCT00648648|20878185|P27|COMPLETED|Overall Study||0
8472076|NCT00648648|20878186|P26|COMPLETED|Overall Study||0
8472077|NCT00648648|20878187|P25|COMPLETED|Overall Study||0
8472078|NCT00648648|20878188|P24|COMPLETED|Overall Study||0
8472079|NCT00648648|20878189|P23|COMPLETED|Overall Study||0
8472080|NCT00648648|20878190|P22|COMPLETED|Overall Study||0
8472081|NCT00648648|20878191|P21|COMPLETED|Overall Study||0
8472082|NCT00648648|20878192|P20|COMPLETED|Overall Study||0
8472083|NCT00648648|20878193|P19|COMPLETED|Overall Study||0
8472084|NCT00648648|20878194|P18|COMPLETED|Overall Study||0
8472085|NCT00648648|20878195|P17|COMPLETED|Overall Study||2
8472086|NCT00648648|20878196|P16|COMPLETED|Overall Study||0
8472087|NCT00648648|20878197|P15|COMPLETED|Overall Study||0
8472088|NCT00648648|20878198|P14|COMPLETED|Overall Study||0
8472089|NCT00648648|20878199|P13|COMPLETED|Overall Study||0
8472090|NCT00648648|20878200|P12|COMPLETED|Overall Study||0
8472091|NCT00648648|20878201|P11|COMPLETED|Overall Study||0
8472092|NCT00648648|20878202|P10|COMPLETED|Overall Study||0
8472093|NCT00648648|20878203|P9|COMPLETED|Overall Study||0
8472094|NCT00648648|20878204|P8|COMPLETED|Overall Study||0
8472095|NCT00648648|20878205|P7|COMPLETED|Overall Study||0
8472096|NCT00648648|20878206|P6|COMPLETED|Overall Study||0
8472097|NCT00648648|20878207|P5|COMPLETED|Overall Study||0
8472098|NCT00648648|20878208|P4|COMPLETED|Overall Study||0
8472099|NCT00648648|20878209|P3|COMPLETED|Overall Study||3
8472100|NCT00648648|20878210|P2|COMPLETED|Overall Study||3
8472101|NCT00648648|20878211|P1|COMPLETED|Overall Study||3
8472102|NCT00648648|20878184|P28|Treated|Overall Study||12
8472103|NCT00648648|20878185|P27|Treated|Overall Study||26
8472104|NCT00648648|20878186|P26|Treated|Overall Study||4
8472105|NCT00648648|20878187|P25|Treated|Overall Study||4
8472106|NCT00648648|20878188|P24|Treated|Overall Study||4
8472107|NCT00648648|20878189|P23|Treated|Overall Study||14
8472108|NCT00648648|20878190|P22|Treated|Overall Study||10
8472109|NCT00648648|20878191|P21|Treated|Overall Study||6
8472110|NCT00648648|20878192|P20|Treated|Overall Study||7
8472111|NCT00648648|20878193|P19|Treated|Overall Study||4
8472112|NCT00648648|20878194|P18|Treated|Overall Study||6
8472113|NCT00648648|20878195|P17|Treated|Overall Study||16
8472114|NCT00648648|20878196|P16|Treated|Overall Study||11
8472115|NCT00648648|20878197|P15|Treated|Overall Study||4
8472116|NCT00648648|20878198|P14|Treated|Overall Study||5
8472117|NCT00648648|20878199|P13|Treated|Overall Study||6
8472118|NCT00648648|20878200|P12|Treated|Overall Study||13
8472119|NCT00648648|20878201|P11|Treated|Overall Study||6
8472120|NCT00648648|20878202|P10|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
8472121|NCT00648648|20878203|P9|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3
8472122|NCT00648648|20878204|P8|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
8472123|NCT00648648|20878205|P7|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
8472124|NCT00648648|20878206|P6|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
8472125|NCT00648648|20878207|P5|Treated|Overall Study||8
8472126|NCT00648648|20878208|P4|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4
8472127|NCT00648648|20878209|P3|Treated|Overall Study||3
8472128|NCT00648648|20878210|P2|Treated|Overall Study||3
8472129|NCT00648648|20878211|P1|Treated|Overall Study||3
8472130|NCT00648648|20878184|P28|STARTED|Overall Study||12
8472131|NCT00648648|20878185|P27|STARTED|Overall Study||26
8472132|NCT00648648|20878186|P26|STARTED|Overall Study||4
8472133|NCT00648648|20878187|P25|STARTED|Overall Study||4
8472134|NCT00648648|20878188|P24|STARTED|Overall Study||4
8472135|NCT00648648|20878189|P23|STARTED|Overall Study||14
8472136|NCT00648648|20878190|P22|STARTED|Overall Study||10
8472137|NCT00648648|20878191|P21|STARTED|Overall Study||6
8472138|NCT00648648|20878192|P20|STARTED|Overall Study||7
8472139|NCT00648648|20878193|P19|STARTED|Overall Study||5
8472140|NCT00648648|20878194|P18|STARTED|Overall Study||6
8472141|NCT00648648|20878195|P17|STARTED|Overall Study||16
8472142|NCT00648648|20878196|P16|STARTED|Overall Study||11
8472143|NCT00648648|20878197|P15|STARTED|Overall Study||4
8472144|NCT00648648|20878198|P14|STARTED|Overall Study||5
8472145|NCT00648648|20878199|P13|STARTED|Overall Study||6
8472146|NCT00648648|20878200|P12|STARTED|Overall Study||13
8472147|NCT00648648|20878201|P11|STARTED|Overall Study||6
8472148|NCT00648648|20878202|P10|STARTED|Overall Study||10
8472149|NCT00648648|20878203|P9|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3
8472150|NCT00648648|20878204|P8|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
8472325|NCT00646646|20878699|P3|STARTED|Overall Study||15
8472151|NCT00648648|20878205|P7|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10
8472152|NCT00648648|20878206|P6|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
8472153|NCT00648648|20878207|P5|STARTED|Overall Study||9
8472154|NCT00648648|20878208|P4|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4
8472155|NCT00648648|20878209|P3|STARTED|Overall Study||3
8472156|NCT00648648|20878210|P2|STARTED|Overall Study||3
8472157|NCT00648648|20878211|P1|STARTED|Overall Study||3
8472158|NCT00648375|20878439|P2|NOT COMPLETED|Overall Study||0
8472159|NCT00648375|20878440|P1|NOT COMPLETED|Overall Study||0
8472160|NCT00648375|20878439|P2|COMPLETED|Overall Study||2
8472161|NCT00648375|20878440|P1|COMPLETED|Overall Study||1
8472162|NCT00648375|20878439|P2|STARTED|Overall Study||2
8472163|NCT00648375|20878440|P1|STARTED|Overall Study||1
8472164|NCT00648167|20878452|P1|NOT COMPLETED|Overall Study||7
8472165|NCT00648167|20878452|P1|COMPLETED|Overall Study||48
8472166|NCT00648167|20878452|P1|Start Dose 6 g/Day|Overall Study||21
8472167|NCT00648167|20878452|P1|Start Dose 4.5 g/Day|Overall Study||34
8472168|NCT00648167|20878452|P1|STARTED|Overall Study||55
8472169|NCT00648115|20878459|P3|NOT COMPLETED|Overall Study||0
8472170|NCT00648115|20878460|P2|NOT COMPLETED|Overall Study||0
8472171|NCT00648115|20878461|P1|NOT COMPLETED|Overall Study||0
8472172|NCT00648115|20878459|P3|COMPLETED|Overall Study||27
8472173|NCT00648115|20878460|P2|COMPLETED|Overall Study||42
8472174|NCT00648115|20878461|P1|COMPLETED|Overall Study||42
8472175|NCT00648115|20878459|P3|STARTED|Overall Study||27
8472176|NCT00648115|20878460|P2|STARTED|Overall Study||42
8472177|NCT00648115|20878461|P1|STARTED|Overall Study||42
8472178|NCT00648037|20878472|P1|NOT COMPLETED|Overall Study||16
8472179|NCT00648037|20878472|P1|COMPLETED|Overall Study||10
8472180|NCT00648037|20878472|P1|STARTED|Overall Study||26
8472181|NCT00647998|20878478|P2|NOT COMPLETED|Overall Study||0
8472182|NCT00647998|20878479|P1|NOT COMPLETED|Overall Study||0
8472183|NCT00647998|20878478|P2|COMPLETED|Overall Study||9
8472184|NCT00647998|20878479|P1|COMPLETED|Overall Study||9
8472185|NCT00647998|20878478|P2|STARTED|Overall Study||9
8472186|NCT00647998|20878479|P1|STARTED|Overall Study||9
8472193|NCT00647556|20878500|P2|NOT COMPLETED|Overall Study||2
8472194|NCT00647556|20878501|P1|NOT COMPLETED|Overall Study||3
8472195|NCT00647556|20878500|P2|COMPLETED|Overall Study||13
8472196|NCT00647556|20878501|P1|COMPLETED|Overall Study||12
8472197|NCT00647556|20878500|P2|STARTED|Overall Study||15
8472198|NCT00647556|20878501|P1|STARTED|Overall Study||15
8472199|NCT00647426|20878515|P1|NOT COMPLETED|Overall Study||2
8472200|NCT00647426|20878515|P1|COMPLETED|Overall Study||5
8472201|NCT00647426|20878515|P1|STARTED|Overall Study||7
8472202|NCT00647400|20878524|P2|NOT COMPLETED|Overall Study||13
8472203|NCT00647400|20878525|P1|NOT COMPLETED|Overall Study||22
8472204|NCT00647400|20878524|P2|COMPLETED|Overall Study||45
8472205|NCT00647400|20878525|P1|COMPLETED|Overall Study||67
8472206|NCT00647400|20878524|P2|STARTED|Overall Study||58
8472207|NCT00647400|20878525|P1|STARTED|Overall Study||89
8472208|NCT00647348|20878537|P2|NOT COMPLETED|Overall Study||6
8472209|NCT00647348|20878538|P1|NOT COMPLETED|Overall Study||3
8472210|NCT00647348|20878537|P2|COMPLETED|Overall Study||64
8472211|NCT00647348|20878538|P1|COMPLETED|Overall Study||67
8472212|NCT00647348|20878537|P2|STARTED|Overall Study||70
8472213|NCT00647348|20878538|P1|STARTED|Overall Study||70
8472214|NCT00647270|20878563|P3|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
8472215|NCT00647270|20878564|P2|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
8472216|NCT00647270|20878565|P1|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
8472217|NCT00647270|20878563|P3|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
8472218|NCT00647270|20878564|P2|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
8472219|NCT00647270|20878565|P1|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
8472220|NCT00647270|20878563|P3|STARTED|Period 2, Placebo Switched to Adalimumab||182
8472221|NCT00647270|20878564|P2|STARTED|Period 2, Placebo Switched to Adalimumab||146
8472222|NCT00647270|20878565|P1|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
8472223|NCT00647270|20878563|P3|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
8472224|NCT00647270|20878564|P2|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
8472225|NCT00647270|20878565|P1|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
8472226|NCT00647270|20878563|P3|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
8472227|NCT00647270|20878564|P2|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
8472228|NCT00647270|20878565|P1|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
8472229|NCT00647270|20878563|P3|STARTED|Period 1, Placebo-control (12 Weeks)||205
8472230|NCT00647270|20878564|P2|STARTED|Period 1, Placebo-control (12 Weeks)||159
8472231|NCT00647270|20878565|P1|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
8472232|NCT00646958|20878591|P3|NOT COMPLETED|Overall Study||9
8472233|NCT00646958|20878592|P2|NOT COMPLETED|Overall Study||9
8472234|NCT00646958|20878593|P1|NOT COMPLETED|Overall Study||11
8472235|NCT00646958|20878591|P3|COMPLETED|Overall Study||40
8472236|NCT00646958|20878592|P2|COMPLETED|Overall Study||41
8472237|NCT00646958|20878593|P1|COMPLETED|Overall Study||40
8472238|NCT00646958|20878591|P3|STARTED|Overall Study|No. Participants Randomized|49
8472239|NCT00646958|20878592|P2|STARTED|Overall Study|No. Participants Randomized|50
8472240|NCT00646958|20878593|P1|STARTED|Overall Study|Number (No.) Participants Randomized|51
8472241|NCT00646906|20878608|P7|NOT COMPLETED|Crossover Period 2||1
8472242|NCT00646906|20878609|P6|NOT COMPLETED|Crossover Period 2||0
8472243|NCT00646906|20878610|P5|NOT COMPLETED|Crossover Period 2||0
8472244|NCT00646906|20878611|P4|NOT COMPLETED|Crossover Period 2||1
8472245|NCT00646906|20878612|P3|NOT COMPLETED|Crossover Period 2||2
8472246|NCT00646906|20878613|P2|NOT COMPLETED|Crossover Period 2||1
8472247|NCT00646906|20878614|P1|NOT COMPLETED|Crossover Period 2||0
8472248|NCT00646906|20878608|P7|COMPLETED|Crossover Period 2||4
8472249|NCT00646906|20878609|P6|COMPLETED|Crossover Period 2||4
8472250|NCT00646906|20878610|P5|COMPLETED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
8472251|NCT00646906|20878611|P4|COMPLETED|Crossover Period 2||8
8472252|NCT00646906|20878612|P3|COMPLETED|Crossover Period 2||8
8472253|NCT00646906|20878613|P2|COMPLETED|Crossover Period 2||8
8472254|NCT00646906|20878614|P1|COMPLETED|Crossover Period 2||8
8472255|NCT00646906|20878608|P7|STARTED|Crossover Period 2||5
8472256|NCT00646906|20878609|P6|STARTED|Crossover Period 2||4
8472257|NCT00646906|20878610|P5|STARTED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
8472258|NCT00646906|20878611|P4|STARTED|Crossover Period 2||9
8472259|NCT00646906|20878612|P3|STARTED|Crossover Period 2||10
8472260|NCT00646906|20878613|P2|STARTED|Crossover Period 2||9
8472261|NCT00646906|20878614|P1|STARTED|Crossover Period 2||8
8472262|NCT00646906|20878608|P7|NOT COMPLETED|Washout (>/= 14 Days)||0
8472263|NCT00646906|20878609|P6|NOT COMPLETED|Washout (>/= 14 Days)||0
8472264|NCT00646906|20878610|P5|NOT COMPLETED|Washout (>/= 14 Days)||0
8472265|NCT00646906|20878611|P4|NOT COMPLETED|Washout (>/= 14 Days)||0
8472266|NCT00646906|20878612|P3|NOT COMPLETED|Washout (>/= 14 Days)||0
8472267|NCT00646906|20878613|P2|NOT COMPLETED|Washout (>/= 14 Days)||0
8472268|NCT00646906|20878614|P1|NOT COMPLETED|Washout (>/= 14 Days)||0
8472269|NCT00646906|20878608|P7|COMPLETED|Washout (>/= 14 Days)||5
8472270|NCT00646906|20878609|P6|COMPLETED|Washout (>/= 14 Days)||4
8472271|NCT00646906|20878610|P5|COMPLETED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
8472272|NCT00646906|20878611|P4|COMPLETED|Washout (>/= 14 Days)||9
8472273|NCT00646906|20878612|P3|COMPLETED|Washout (>/= 14 Days)||10
8472274|NCT00646906|20878613|P2|COMPLETED|Washout (>/= 14 Days)||9
8472275|NCT00646906|20878614|P1|COMPLETED|Washout (>/= 14 Days)||8
8472276|NCT00646906|20878608|P7|STARTED|Washout (>/= 14 Days)||5
8472277|NCT00646906|20878609|P6|STARTED|Washout (>/= 14 Days)||4
8472278|NCT00646906|20878610|P5|STARTED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
8472279|NCT00646906|20878611|P4|STARTED|Washout (>/= 14 Days)||9
8472280|NCT00646906|20878612|P3|STARTED|Washout (>/= 14 Days)||10
8472281|NCT00646906|20878613|P2|STARTED|Washout (>/= 14 Days)||9
8472282|NCT00646906|20878614|P1|STARTED|Washout (>/= 14 Days)||8
8472283|NCT00646906|20878608|P7|NOT COMPLETED|Crossover Period 1||0
8472284|NCT00646906|20878609|P6|NOT COMPLETED|Crossover Period 1||1
8472285|NCT00646906|20878610|P5|NOT COMPLETED|Crossover Period 1||0
8472286|NCT00646906|20878611|P4|NOT COMPLETED|Crossover Period 1||0
8472287|NCT00646906|20878612|P3|NOT COMPLETED|Crossover Period 1||0
8472288|NCT00646906|20878613|P2|NOT COMPLETED|Crossover Period 1||0
8472289|NCT00646906|20878614|P1|NOT COMPLETED|Crossover Period 1||1
8472290|NCT00646906|20878608|P7|COMPLETED|Crossover Period 1||5
8472291|NCT00646906|20878609|P6|COMPLETED|Crossover Period 1||4
8472292|NCT00646906|20878610|P5|COMPLETED|Crossover Period 1|Phase 1b had only one treatment period and no crossover. Phase 1b ended here.|8
8472293|NCT00646906|20878611|P4|COMPLETED|Crossover Period 1||9
8472294|NCT00646906|20878612|P3|COMPLETED|Crossover Period 1||10
8472295|NCT00646906|20878613|P2|COMPLETED|Crossover Period 1||9
8472296|NCT00646906|20878614|P1|COMPLETED|Crossover Period 1||8
8472297|NCT00646906|20878608|P7|STARTED|Crossover Period 1||5
8472298|NCT00646906|20878609|P6|STARTED|Crossover Period 1||5
8472299|NCT00646906|20878610|P5|STARTED|Crossover Period 1||8
8472300|NCT00646906|20878611|P4|STARTED|Crossover Period 1||9
8472301|NCT00646906|20878612|P3|STARTED|Crossover Period 1||10
8472302|NCT00646906|20878613|P2|STARTED|Crossover Period 1||9
8472303|NCT00646906|20878614|P1|STARTED|Crossover Period 1||9
8472304|NCT00646776|20878633|P2|NOT COMPLETED|Overall Study||13
8472305|NCT00646776|20878634|P1|NOT COMPLETED|Overall Study||1
8472306|NCT00646776|20878633|P2|COMPLETED|Overall Study||5
8472307|NCT00646776|20878634|P1|COMPLETED|Overall Study||14
8472308|NCT00646776|20878633|P2|STARTED|Overall Study|Treated on Day 1|18
8472309|NCT00646776|20878634|P1|STARTED|Overall Study|Treated on Day 1|15
8472310|NCT00646763|20878683|P2|NOT COMPLETED|Overall Study||0
8472311|NCT00646763|20878684|P1|NOT COMPLETED|Overall Study||0
8472312|NCT00646763|20878683|P2|COMPLETED|Overall Study||17
8472313|NCT00646763|20878684|P1|COMPLETED|Overall Study||18
8472314|NCT00646763|20878683|P2|STARTED|Overall Study||17
8472315|NCT00646763|20878684|P1|STARTED|Overall Study||18
8472316|NCT00646646|20878698|P4|NOT COMPLETED|Overall Study||0
8472317|NCT00646646|20878699|P3|NOT COMPLETED|Overall Study||0
8472318|NCT00646646|20878700|P2|NOT COMPLETED|Overall Study||0
8472319|NCT00646646|20878701|P1|NOT COMPLETED|Overall Study||0
8472320|NCT00646646|20878698|P4|COMPLETED|Overall Study||20
8472321|NCT00646646|20878699|P3|COMPLETED|Overall Study||15
8472322|NCT00646646|20878700|P2|COMPLETED|Overall Study||15
8472323|NCT00646646|20878701|P1|COMPLETED|Overall Study||15
8472324|NCT00646646|20878698|P4|STARTED|Overall Study||20
8472326|NCT00646646|20878700|P2|STARTED|Overall Study||15
8472327|NCT00646646|20878701|P1|STARTED|Overall Study||15
8472328|NCT00646581|20878713|P2|NOT COMPLETED|Overall Study||0
8472329|NCT00646581|20878714|P1|NOT COMPLETED|Overall Study||0
8472330|NCT00646581|20878713|P2|COMPLETED|Overall Study||15
8472331|NCT00646581|20878714|P1|COMPLETED|Overall Study||15
8472332|NCT00646581|20878713|P2|STARTED|Overall Study||15
8472333|NCT00646581|20878714|P1|STARTED|Overall Study||15
8472334|NCT00646399|20878732|P2|NOT COMPLETED|Overall Study||74
8472335|NCT00646399|20878733|P1|NOT COMPLETED|Overall Study||83
8472336|NCT00646399|20878732|P2|COMPLETED|Overall Study||713
8472337|NCT00646399|20878733|P1|COMPLETED|Overall Study||709
8472338|NCT00646399|20878732|P2|STARTED|Overall Study||787
8472339|NCT00646399|20878733|P1|STARTED|Overall Study||792
8472340|NCT00646282|20878741|P2|NOT COMPLETED|Overall Study||4
8472341|NCT00646282|20878742|P1|NOT COMPLETED|Overall Study||4
8472342|NCT00646282|20878741|P2|COMPLETED|Overall Study||0
8472343|NCT00646282|20878742|P1|COMPLETED|Overall Study||0
8472344|NCT00646282|20878741|P2|STARTED|Overall Study||4
8472345|NCT00646282|20878742|P1|STARTED|Overall Study||4
8472346|NCT00646113|20878748|P1|NOT COMPLETED|Overall Study||8
8472347|NCT00646113|20878748|P1|COMPLETED|Overall Study||61
8472348|NCT00646113|20878748|P1|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69
8472349|NCT00646048|20878752|P1|NOT COMPLETED|Overall Study||16
8472350|NCT00646048|20878752|P1|COMPLETED|Overall Study||27
8472351|NCT00646048|20878752|P1|STARTED|Overall Study||43
8472352|NCT00645970|20878760|P2|NOT COMPLETED|Overall Study||186
8472353|NCT00645970|20878761|P1|NOT COMPLETED|Overall Study||109
8472354|NCT00645970|20878760|P2|COMPLETED|Overall Study||32
8472355|NCT00645970|20878761|P1|COMPLETED|Overall Study||32
8472356|NCT00645970|20878760|P2|1 Year|Overall Study||42
8472357|NCT00645970|20878761|P1|1 Year|Overall Study||37
8472358|NCT00645970|20878760|P2|6 Months|Overall Study||97
8472359|NCT00645970|20878761|P1|6 Months|Overall Study||58
8472360|NCT00645970|20878760|P2|STARTED|Overall Study||218
8472361|NCT00645970|20878761|P1|STARTED|Overall Study||141
8472362|NCT00645944|20878769|P2|NOT COMPLETED|Received Medication||3
8472363|NCT00645944|20878770|P1|NOT COMPLETED|Received Medication||6
8472364|NCT00645944|20878769|P2|COMPLETED|Received Medication||14
8472365|NCT00645944|20878770|P1|COMPLETED|Received Medication||13
8472366|NCT00645944|20878769|P2|STARTED|Received Medication||17
8472367|NCT00645944|20878770|P1|STARTED|Received Medication||19
8472368|NCT00645944|20878769|P2|NOT COMPLETED|Randomized||2
8472369|NCT00645944|20878770|P1|NOT COMPLETED|Randomized||1
8472370|NCT00645944|20878769|P2|COMPLETED|Randomized||17
8472371|NCT00645944|20878770|P1|COMPLETED|Randomized||19
8472372|NCT00645944|20878769|P2|STARTED|Randomized||19
8472373|NCT00645944|20878770|P1|STARTED|Randomized||20
8472374|NCT00645853|20878778|P2|NOT COMPLETED|Overall Study||57
8472375|NCT00645853|20878779|P1|NOT COMPLETED|Overall Study||92
8472376|NCT00645853|20878778|P2|COMPLETED|Overall Study||178
8472377|NCT00645853|20878779|P1|COMPLETED|Overall Study||196
8472378|NCT00645853|20878778|P2|AZ Study Closure in Hungary|Overall Study||40
8472379|NCT00645853|20878779|P1|AZ Study Closure in Hungary|Overall Study||60
8472380|NCT00645853|20878778|P2|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
8472381|NCT00645853|20878779|P1|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
8472382|NCT00645853|20878778|P2|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
8472383|NCT00645853|20878779|P1|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
8472384|NCT00645853|20878778|P2|STARTED|Overall Study||235
8472385|NCT00645853|20878779|P1|STARTED|Overall Study||288
8472386|NCT00645840|20878797|P1|NOT COMPLETED|Overall Study||3
8472387|NCT00645840|20878797|P1|COMPLETED|Overall Study||12
8472388|NCT00645840|20878797|P1|STARTED|Overall Study||15
8472389|NCT00645827|20878804|P2|NOT COMPLETED|Overall Study||0
8472390|NCT00645827|20878805|P1|NOT COMPLETED|Overall Study||0
8472391|NCT00645827|20878804|P2|COMPLETED|Overall Study||17
8472392|NCT00645827|20878805|P1|COMPLETED|Overall Study||14
8472393|NCT00645827|20878804|P2|STARTED|Overall Study||17
8472394|NCT00645827|20878805|P1|STARTED|Overall Study||14
8472395|NCT00645788|20878815|P4|NOT COMPLETED|Overall Study||14
8472396|NCT00645788|20878816|P3|NOT COMPLETED|Overall Study||18
8472397|NCT00645788|20878817|P2|NOT COMPLETED|Overall Study||27
8472398|NCT00645788|20878818|P1|NOT COMPLETED|Overall Study||20
8472399|NCT00645788|20878815|P4|COMPLETED|Overall Study||21
8472400|NCT00645788|20878816|P3|COMPLETED|Overall Study||47
8472401|NCT00645788|20878817|P2|COMPLETED|Overall Study||67
8472402|NCT00645788|20878818|P1|COMPLETED|Overall Study||74
8472403|NCT00645788|20878815|P4|Participants Receive Treatment|Overall Study||35
8472404|NCT00645788|20878816|P3|Participants Receive Treatment|Overall Study||65
8472405|NCT00645788|20878817|P2|Participants Receive Treatment|Overall Study||93
8472406|NCT00645788|20878818|P1|Participants Receive Treatment|Overall Study||93
8472407|NCT00645788|20878815|P4|STARTED|Overall Study||35
8472408|NCT00645788|20878816|P3|STARTED|Overall Study||65
8472409|NCT00645788|20878817|P2|STARTED|Overall Study||94
8472410|NCT00645788|20878818|P1|STARTED|Overall Study||94
8472411|NCT00645762|20878868|P1|NOT COMPLETED|Overall Study||4
8472412|NCT00645762|20878868|P1|COMPLETED|Overall Study||67
8472413|NCT00645762|20878868|P1|STARTED|Overall Study||71
8472414|NCT00645710|20878877|P3|NOT COMPLETED|Overall Study||0
8472415|NCT00645710|20878878|P2|NOT COMPLETED|Overall Study||0
8472416|NCT00645710|20878879|P1|NOT COMPLETED|Overall Study||0
8472417|NCT00645710|20878877|P3|COMPLETED|Overall Study||10
8472418|NCT00645710|20878878|P2|COMPLETED|Overall Study||3
8472419|NCT00645710|20878879|P1|COMPLETED|Overall Study||3
8472420|NCT00645710|20878877|P3|STARTED|Overall Study||10
8472421|NCT00645710|20878878|P2|STARTED|Overall Study||3
8472422|NCT00645710|20878879|P1|STARTED|Overall Study||3
8472423|NCT00645671|20878896|P2|NOT COMPLETED|Overall Study||6
8472424|NCT00645671|20878897|P1|NOT COMPLETED|Overall Study||1
8472425|NCT00645671|20878896|P2|COMPLETED|Overall Study||193
8472426|NCT00645671|20878897|P1|COMPLETED|Overall Study||200
8472427|NCT00645671|20878896|P2|STARTED|Overall Study||199
8472428|NCT00645671|20878897|P1|STARTED|Overall Study||201
8472429|NCT00645593|20878911|P2|NOT COMPLETED|Overall Study||0
8472430|NCT00645593|20878912|P1|NOT COMPLETED|Overall Study||1
8472431|NCT00645593|20878911|P2|COMPLETED|Overall Study||60
8472432|NCT00645593|20878912|P1|COMPLETED|Overall Study||28
8472433|NCT00645593|20878911|P2|STARTED|Overall Study||60
8472434|NCT00645593|20878912|P1|STARTED|Overall Study||29
8472435|NCT00645567|20878924|P1|NOT COMPLETED|Overall Study||1
8472436|NCT00645567|20878924|P1|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
8472437|NCT00645567|20878924|P1|STARTED|Overall Study||5
8472438|NCT00645528|20878932|P1|NOT COMPLETED|Overall Study||7
8472439|NCT00645528|20878932|P1|COMPLETED|Overall Study||32
8472440|NCT00645528|20878932|P1|STARTED|Overall Study||39
8472441|NCT00645450|20878943|P2|NOT COMPLETED|Overall Study||0
8472442|NCT00645450|20878944|P1|NOT COMPLETED|Overall Study||0
8472443|NCT00645450|20878943|P2|COMPLETED|Overall Study||4
8472444|NCT00645450|20878944|P1|COMPLETED|Overall Study||5
8472445|NCT00645450|20878943|P2|STARTED|Overall Study||4
8472446|NCT00645450|20878944|P1|STARTED|Overall Study||5
8472447|NCT00645411|20878954|P4|NOT COMPLETED|Overall Study||103
8472448|NCT00645411|20878955|P3|NOT COMPLETED|Overall Study||151
8472449|NCT00645411|20878956|P2|NOT COMPLETED|Overall Study||6
8472450|NCT00645411|20878957|P1|NOT COMPLETED|Overall Study||13
8472451|NCT00645411|20878954|P4|COMPLETED|Overall Study||919
8472452|NCT00645411|20878955|P3|COMPLETED|Overall Study||1457
8472453|NCT00645411|20878956|P2|COMPLETED|Overall Study||312
8472454|NCT00645411|20878957|P1|COMPLETED|Overall Study||643
8472455|NCT00645411|20878954|P4|STARTED|Overall Study||1022
8472456|NCT00645411|20878955|P3|STARTED|Overall Study||1608
8472457|NCT00645411|20878956|P2|STARTED|Overall Study||318
8472458|NCT00645411|20878957|P1|STARTED|Overall Study||656
8472459|NCT00645359|20878989|P1|NOT COMPLETED|Overall Study||0
8472460|NCT00645359|20878989|P1|COMPLETED|Overall Study||9
8472461|NCT00645359|20878989|P1|STARTED|Overall Study||9
8472462|NCT00645333|20878994|P1|NOT COMPLETED|Overall Study||0
8472463|NCT00645333|20878994|P1|COMPLETED|Overall Study||30
8472464|NCT00645333|20878994|P1|STARTED|Overall Study||30
8472465|NCT00645164|20878999|P1|NOT COMPLETED|Overall Study||7
8472466|NCT00645164|20878999|P1|COMPLETED|Overall Study||52
8472467|NCT00645164|20878999|P1|STARTED|Overall Study||59
8472468|NCT00645099|20879005|P2|NOT COMPLETED|Overall Study||42
8472469|NCT00645099|20879006|P1|NOT COMPLETED|Overall Study||71
8472470|NCT00645099|20879005|P2|COMPLETED|Overall Study||178
8472471|NCT00645099|20879006|P1|COMPLETED|Overall Study||168
8472472|NCT00645099|20879005|P2|STARTED|Overall Study||220
8472473|NCT00645099|20879006|P1|STARTED|Overall Study||239
8472474|NCT00645047|20879050|P2|NOT COMPLETED|Overall Study||39
8472475|NCT00645047|20879051|P1|NOT COMPLETED|Overall Study||43
8472476|NCT00645047|20879050|P2|COMPLETED|Overall Study||65
8472477|NCT00645047|20879051|P1|COMPLETED|Overall Study|6 month follow up|60
8472478|NCT00645047|20879050|P2|Post|Overall Study||80
8472479|NCT00645047|20879051|P1|Post|Overall Study||74
8472480|NCT00645047|20879050|P2|STARTED|Overall Study||104
8472481|NCT00645047|20879051|P1|STARTED|Overall Study||103
8472482|NCT00644995|20879075|P2|NOT COMPLETED|Overall Study||4
8472483|NCT00644995|20879076|P1|NOT COMPLETED|Overall Study||2
8472484|NCT00644995|20879075|P2|COMPLETED|Overall Study||23
8472485|NCT00644995|20879076|P1|COMPLETED|Overall Study|Completed 6 month assessment|23
8472486|NCT00644995|20879075|P2|Completed 4 Month Assessment|Overall Study||24
8472487|NCT00644995|20879076|P1|Completed 4 Month Assessment|Overall Study||23
8472488|NCT00644995|20879075|P2|STARTED|Overall Study||27
8472489|NCT00644995|20879076|P1|STARTED|Overall Study||25
8472490|NCT00644969|20879096|P2|NOT COMPLETED|Post Treatment Phase||3
8472491|NCT00644969|20879097|P1|NOT COMPLETED|Post Treatment Phase||10
8472492|NCT00644969|20879096|P2|COMPLETED|Post Treatment Phase||37
8472493|NCT00644969|20879097|P1|COMPLETED|Post Treatment Phase||61
8472494|NCT00644969|20879096|P2|STARTED|Post Treatment Phase||40
8472495|NCT00644969|20879097|P1|STARTED|Post Treatment Phase||71
8472496|NCT00644969|20879096|P2|NOT COMPLETED|Treatment Phase||3
8472497|NCT00644969|20879097|P1|NOT COMPLETED|Treatment Phase||14
8472498|NCT00644969|20879096|P2|COMPLETED|Treatment Phase||40
8472499|NCT00644969|20879097|P1|COMPLETED|Treatment Phase||71
8472500|NCT00644969|20879096|P2|STARTED|Treatment Phase||43
8472501|NCT00644969|20879097|P1|STARTED|Treatment Phase||85
8472502|NCT00644917|20879143|P1|NOT COMPLETED|Overall Study||2
8472503|NCT00644917|20879143|P1|COMPLETED|Overall Study||36
8472504|NCT00644917|20879143|P1|STARTED|Overall Study||38
8472505|NCT00644787|20879151|P3|NOT COMPLETED|Period 2: Double Blind Phase||7
8472506|NCT00644787|20879152|P2|NOT COMPLETED|Period 2: Double Blind Phase||9
8472507|NCT00644787|20879153|P1|NOT COMPLETED|Period 2: Double Blind Phase||0
8472508|NCT00644787|20879151|P3|COMPLETED|Period 2: Double Blind Phase||55
8472509|NCT00644787|20879152|P2|COMPLETED|Period 2: Double Blind Phase||49
8472510|NCT00644787|20879153|P1|COMPLETED|Period 2: Double Blind Phase||0
8472511|NCT00644787|20879151|P3|STARTED|Period 2: Double Blind Phase||62
8472512|NCT00644787|20879152|P2|STARTED|Period 2: Double Blind Phase||58
8472513|NCT00644787|20879153|P1|STARTED|Period 2: Double Blind Phase||0
8472514|NCT00644787|20879151|P3|NOT COMPLETED|Period 1: Titration Phase||0
8472515|NCT00644787|20879152|P2|NOT COMPLETED|Period 1: Titration Phase||0
8472516|NCT00644787|20879153|P1|NOT COMPLETED|Period 1: Titration Phase||27
8472517|NCT00644787|20879151|P3|COMPLETED|Period 1: Titration Phase||0
8472518|NCT00644787|20879152|P2|COMPLETED|Period 1: Titration Phase||0
8472519|NCT00644787|20879153|P1|COMPLETED|Period 1: Titration Phase||129
8472520|NCT00644787|20879151|P3|STARTED|Period 1: Titration Phase||0
8472521|NCT00644787|20879152|P2|STARTED|Period 1: Titration Phase||0
8472522|NCT00644787|20879153|P1|STARTED|Period 1: Titration Phase||156
8472523|NCT00644657|20879181|P1|NOT COMPLETED|Overall Study||0
8472524|NCT00644657|20879181|P1|COMPLETED|Overall Study||27
8472525|NCT00644657|20879181|P1|STARTED|Overall Study||27
8472526|NCT00644592|20879188|P2|NOT COMPLETED|Overall Study||0
8472527|NCT00644592|20879189|P1|NOT COMPLETED|Overall Study||0
8472528|NCT00644592|20879188|P2|COMPLETED|Overall Study||6
8472529|NCT00644592|20879189|P1|COMPLETED|Overall Study||5
8472530|NCT00644592|20879188|P2|STARTED|Overall Study||6
8472531|NCT00644592|20879189|P1|STARTED|Overall Study||5
8472532|NCT00644423|20879197|P2|NOT COMPLETED|Overall Study||1
8472533|NCT00644423|20879198|P1|NOT COMPLETED|Overall Study||1
8472534|NCT00644423|20879197|P2|COMPLETED|Overall Study||4
8472535|NCT00644423|20879198|P1|COMPLETED|Overall Study||5
8472536|NCT00644423|20879197|P2|STARTED|Overall Study||5
8472537|NCT00644423|20879198|P1|STARTED|Overall Study||6
8472538|NCT00644358|20879216|P1|NOT COMPLETED|Overall Study||362
8472539|NCT00644358|20879216|P1|COMPLETED|Overall Study||254
8472540|NCT00644358|20879216|P1|STARTED|Overall Study||616
8472541|NCT00644332|20879223|P1|NOT COMPLETED|Overall Study||21
8472542|NCT00644332|20879223|P1|COMPLETED|Overall Study||150
8472543|NCT00644332|20879223|P1|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
8472544|NCT00644280|20879238|P2|NOT COMPLETED|Overall Study||0
8472545|NCT00644280|20879239|P1|NOT COMPLETED|Overall Study||0
8472546|NCT00644280|20879238|P2|COMPLETED|Overall Study||5
8472547|NCT00644280|20879239|P1|COMPLETED|Overall Study||6
8472548|NCT00644280|20879238|P2|STARTED|Overall Study||5
8472549|NCT00644280|20879239|P1|STARTED|Overall Study||6
8472598|NCT00644059|20879279|P3|NOT COMPLETED|Overall Study||65
8472599|NCT00644059|20879280|P2|NOT COMPLETED|Overall Study||123
8472600|NCT00644059|20879281|P1|NOT COMPLETED|Overall Study||124
8472601|NCT00644059|20879279|P3|COMPLETED|Overall Study||969
8472602|NCT00644059|20879280|P2|COMPLETED|Overall Study||1726
8472603|NCT00644059|20879281|P1|COMPLETED|Overall Study||1895
8472604|NCT00644059|20879279|P3|STARTED|Overall Study||1034
8472605|NCT00644059|20879280|P2|STARTED|Overall Study||1849
8472606|NCT00644059|20879281|P1|STARTED|Overall Study||2019
8472607|NCT00643916|20879371|P6|NOT COMPLETED|Overall Study||1
8472608|NCT00643916|20879372|P5|NOT COMPLETED|Overall Study||2
8472609|NCT00643916|20879373|P4|NOT COMPLETED|Overall Study||2
8472610|NCT00643916|20879374|P3|NOT COMPLETED|Overall Study||6
8472611|NCT00643916|20879375|P2|NOT COMPLETED|Overall Study||6
8472612|NCT00643916|20879376|P1|NOT COMPLETED|Overall Study||4
8472613|NCT00643916|20879371|P6|COMPLETED|Overall Study||66
8472614|NCT00643916|20879372|P5|COMPLETED|Overall Study||57
8472615|NCT00643916|20879373|P4|COMPLETED|Overall Study||60
8472616|NCT00643916|20879374|P3|COMPLETED|Overall Study||62
8472617|NCT00643916|20879375|P2|COMPLETED|Overall Study||61
8472618|NCT00643916|20879376|P1|COMPLETED|Overall Study||51
8472619|NCT00643916|20879371|P6|STARTED|Overall Study||67
8472620|NCT00643916|20879372|P5|STARTED|Overall Study||59
8472621|NCT00643916|20879373|P4|STARTED|Overall Study||62
8472622|NCT00643916|20879374|P3|STARTED|Overall Study||68
8472623|NCT00643916|20879375|P2|STARTED|Overall Study||67
8472624|NCT00643916|20879376|P1|STARTED|Overall Study||55
8472625|NCT00643864|20879396|P1|NOT COMPLETED|Post-test Assessment||0
8472626|NCT00643864|20879396|P1|COMPLETED|Post-test Assessment||3
8472627|NCT00643864|20879396|P1|STARTED|Post-test Assessment||3
8472628|NCT00643864|20879396|P1|NOT COMPLETED|Pre-test Assessment||0
8472629|NCT00643864|20879396|P1|COMPLETED|Pre-test Assessment||3
8472630|NCT00643864|20879396|P1|STARTED|Pre-test Assessment||3
8472631|NCT00643851|20879405|P3|NOT COMPLETED|Overall Study||30
8472632|NCT00643851|20879406|P2|NOT COMPLETED|Overall Study||33
8472633|NCT00643851|20879407|P1|NOT COMPLETED|Overall Study||17
8472634|NCT00643851|20879405|P3|COMPLETED|Overall Study||171
8472635|NCT00643851|20879406|P2|COMPLETED|Overall Study||170
8472636|NCT00643851|20879407|P1|COMPLETED|Overall Study||177
8472637|NCT00643851|20879405|P3|STARTED|Overall Study||201
8472638|NCT00643851|20879406|P2|STARTED|Overall Study||203
8472639|NCT00643851|20879407|P1|STARTED|Overall Study||194
8472640|NCT00643760|20879435|P5|NOT COMPLETED|Overall Study||19
8472641|NCT00643760|20879436|P4|NOT COMPLETED|Overall Study||38
8472642|NCT00643760|20879437|P3|NOT COMPLETED|Overall Study||19
8472643|NCT00643760|20879438|P2|NOT COMPLETED|Overall Study||15
8472644|NCT00643760|20879439|P1|NOT COMPLETED|Overall Study||30
8472645|NCT00643760|20879435|P5|COMPLETED|Overall Study||47
8472646|NCT00643760|20879436|P4|COMPLETED|Overall Study||79
8472647|NCT00643760|20879437|P3|COMPLETED|Overall Study||37
8472648|NCT00643760|20879438|P2|COMPLETED|Overall Study||47
8472649|NCT00643760|20879439|P1|COMPLETED|Overall Study||90
8472650|NCT00643760|20879435|P5|ITT Population|Overall Study||66
8472651|NCT00643760|20879436|P4|ITT Population|Overall Study||116
8472652|NCT00643760|20879437|P3|ITT Population|Overall Study||56
8472653|NCT00643760|20879438|P2|ITT Population|Overall Study||62
8472654|NCT00643760|20879439|P1|ITT Population|Overall Study||120
8472655|NCT00643760|20879435|P5|Safety Population/Treated With Drug|Overall Study||66
8472656|NCT00643760|20879436|P4|Safety Population/Treated With Drug|Overall Study||116
8472657|NCT00643760|20879437|P3|Safety Population/Treated With Drug|Overall Study||56
8472658|NCT00643760|20879438|P2|Safety Population/Treated With Drug|Overall Study||62
8472659|NCT00643760|20879439|P1|Safety Population/Treated With Drug|Overall Study||120
8472660|NCT00643760|20879435|P5|STARTED|Overall Study||66
8472661|NCT00643760|20879436|P4|STARTED|Overall Study||117
8472662|NCT00643760|20879437|P3|STARTED|Overall Study||56
8472663|NCT00643760|20879438|P2|STARTED|Overall Study||62
8472664|NCT00643760|20879439|P1|STARTED|Overall Study||120
8472665|NCT00643682|20879543|P2|NOT COMPLETED|Overall Study||509
8472666|NCT00643682|20879544|P1|NOT COMPLETED|Overall Study||522
8472667|NCT00643682|20879543|P2|COMPLETED|Overall Study||492
8472668|NCT00643682|20879544|P1|COMPLETED|Overall Study||477
8472669|NCT00643682|20879543|P2|STARTED|Overall Study||1001
8472670|NCT00643682|20879544|P1|STARTED|Overall Study||999
8472671|NCT00643604|20879556|P1|NOT COMPLETED|Overall Study||1
8472672|NCT00643604|20879556|P1|COMPLETED|Overall Study||6
8472673|NCT00643604|20879556|P1|STARTED|Overall Study||7
8472674|NCT00643578|20879573|P2|NOT COMPLETED|Overall Study||0
8472675|NCT00643578|20879574|P1|NOT COMPLETED|Overall Study||2
8472676|NCT00643578|20879573|P2|COMPLETED|Overall Study||6
8472677|NCT00643578|20879574|P1|COMPLETED|Overall Study||4
8472678|NCT00643578|20879573|P2|STARTED|Overall Study||6
8472679|NCT00643578|20879574|P1|STARTED|Overall Study||6
8472680|NCT00643565|20879584|P2|NOT COMPLETED|Overall Study||67
8472681|NCT00643565|20879585|P1|NOT COMPLETED|Overall Study||73
8472682|NCT00643565|20879584|P2|COMPLETED|Overall Study||7
8472683|NCT00643565|20879585|P1|COMPLETED|Overall Study||7
8472684|NCT00643565|20879584|P2|STARTED|Overall Study||74
8472685|NCT00643565|20879585|P1|STARTED|Overall Study||80
8472686|NCT00643487|20879607|P1|NOT COMPLETED|Overall Study||3
8472687|NCT00643487|20879607|P1|COMPLETED|Overall Study||5
8472688|NCT00643487|20879607|P1|STARTED|Overall Study||8
8472689|NCT00643448|20879614|P3|NOT COMPLETED|Overall Study||6
8472690|NCT00643448|20879615|P2|NOT COMPLETED|Overall Study||5
8472691|NCT00643448|20879616|P1|NOT COMPLETED|Overall Study||4
8472692|NCT00643448|20879614|P3|COMPLETED|Overall Study||16
8472693|NCT00643448|20879615|P2|COMPLETED|Overall Study||17
8472694|NCT00643448|20879616|P1|COMPLETED|Overall Study||17
8472695|NCT00643448|20879614|P3|STARTED|Overall Study||22
8472696|NCT00643448|20879615|P2|STARTED|Overall Study||22
8472697|NCT00643448|20879616|P1|STARTED|Overall Study||21
8472698|NCT00643279|20879633|P2|NOT COMPLETED|Overall Study||13
8472699|NCT00643279|20879634|P1|NOT COMPLETED|Overall Study||16
8472700|NCT00643279|20879633|P2|COMPLETED|Overall Study||127
8472701|NCT00643279|20879634|P1|COMPLETED|Overall Study||118
8472702|NCT00643279|20879633|P2|STARTED|Overall Study||140
8472703|NCT00643279|20879634|P1|STARTED|Overall Study||134
8472704|NCT00643201|20879656|P2|NOT COMPLETED|Completed Study Follow Up||79
8472705|NCT00643201|20879657|P1|NOT COMPLETED|Completed Study Follow Up||70
8472706|NCT00643201|20879656|P2|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
8472707|NCT00643201|20879657|P1|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
8472708|NCT00643201|20879656|P2|STARTED|Completed Study Follow Up||2639
8472709|NCT00643201|20879657|P1|STARTED|Completed Study Follow Up||2617
8472710|NCT00643201|20879656|P2|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
8472711|NCT00643201|20879657|P1|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
8472712|NCT00643201|20879656|P2|COMPLETED|Randomized, Completed 6 Months of Study||2291
8472713|NCT00643201|20879657|P1|COMPLETED|Randomized, Completed 6 Months of Study||2314
8472714|NCT00643201|20879656|P2|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
8472715|NCT00643201|20879657|P1|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
8472716|NCT00643162|20879705|P2|NOT COMPLETED|Overall Study||1
8472717|NCT00643162|20879706|P1|NOT COMPLETED|Overall Study||1
8472718|NCT00643162|20879705|P2|COMPLETED|Overall Study||4
8472719|NCT00643162|20879706|P1|COMPLETED|Overall Study||6
8472720|NCT00643162|20879705|P2|STARTED|Overall Study||5
8472721|NCT00643162|20879706|P1|STARTED|Overall Study||7
8472722|NCT00643123|20879718|P2|NOT COMPLETED|Overall Study||1
8472723|NCT00643123|20879719|P1|NOT COMPLETED|Overall Study||5
8472724|NCT00643123|20879718|P2|COMPLETED|Overall Study||11
8472725|NCT00643123|20879719|P1|COMPLETED|Overall Study||10
8472726|NCT00643123|20879718|P2|STARTED|Overall Study||12
8472727|NCT00643123|20879719|P1|STARTED|Overall Study||15
8472728|NCT00643097|20879730|P3|NOT COMPLETED|Overall Study||0
8472729|NCT00643097|20879731|P2|NOT COMPLETED|Overall Study||0
8472730|NCT00643097|20879732|P1|NOT COMPLETED|Overall Study||0
8472731|NCT00643097|20879730|P3|COMPLETED|Overall Study||10
8472732|NCT00643097|20879731|P2|COMPLETED|Overall Study||12
8472733|NCT00643097|20879732|P1|COMPLETED|Overall Study||18
8472734|NCT00643097|20879730|P3|STARTED|Overall Study||10
8472735|NCT00643097|20879731|P2|STARTED|Overall Study||12
8472736|NCT00643097|20879732|P1|STARTED|Overall Study||18
8472737|NCT00643006|20879751|P2|NOT COMPLETED|Overall Study||4
8472738|NCT00643006|20879752|P1|NOT COMPLETED|Overall Study||5
8472739|NCT00643006|20879751|P2|COMPLETED|Overall Study||29
8472740|NCT00643006|20879752|P1|COMPLETED|Overall Study||29
8472741|NCT00643006|20879751|P2|STARTED|Overall Study||33
8472742|NCT00643006|20879752|P1|STARTED|Overall Study||34
8472743|NCT00642993|20879762|P2|NOT COMPLETED|Overall Study||16
8472744|NCT00642993|20879763|P1|NOT COMPLETED|Overall Study||106
8472745|NCT00642993|20879762|P2|COMPLETED|Overall Study||118
8472746|NCT00642993|20879763|P1|COMPLETED|Overall Study||161
8472747|NCT00642993|20879762|P2|STARTED|Overall Study||134
8472748|NCT00642993|20879763|P1|STARTED|Overall Study||267
8472749|NCT00642954|20879782|P5|NOT COMPLETED|Overall Study||16
8472750|NCT00642954|20879783|P4|NOT COMPLETED|Overall Study||3
8472751|NCT00642954|20879784|P3|NOT COMPLETED|Overall Study||3
8472752|NCT00642954|20879785|P2|NOT COMPLETED|Overall Study||4
8472753|NCT00642954|20879786|P1|NOT COMPLETED|Overall Study||4
8472754|NCT00642954|20879782|P5|COMPLETED|Overall Study||1
8472755|NCT00642954|20879783|P4|COMPLETED|Overall Study||0
8472756|NCT00642954|20879784|P3|COMPLETED|Overall Study||0
8472757|NCT00642954|20879785|P2|COMPLETED|Overall Study||0
8472758|NCT00642954|20879786|P1|COMPLETED|Overall Study||0
8472759|NCT00642954|20879782|P5|STARTED|Overall Study||17
8472760|NCT00642954|20879783|P4|STARTED|Overall Study||3
8472761|NCT00642954|20879784|P3|STARTED|Overall Study||3
8472762|NCT00642954|20879785|P2|STARTED|Overall Study||4
8472763|NCT00642954|20879786|P1|STARTED|Overall Study||4
8472764|NCT00642902|20879812|P4|NOT COMPLETED|Overall Study||40
8472765|NCT00642902|20879813|P3|NOT COMPLETED|Overall Study||43
8472766|NCT00642902|20879814|P2|NOT COMPLETED|Overall Study||42
8472767|NCT00642902|20879815|P1|NOT COMPLETED|Overall Study||40
8472768|NCT00642902|20879812|P4|COMPLETED|Overall Study||25
8472769|NCT00642902|20879813|P3|COMPLETED|Overall Study||21
8472770|NCT00642902|20879814|P2|COMPLETED|Overall Study||21
8472771|NCT00642902|20879815|P1|COMPLETED|Overall Study||23
8472772|NCT00642902|20879812|P4|Treated|Overall Study||65
8472773|NCT00642902|20879813|P3|Treated|Overall Study||63
8472774|NCT00642902|20879814|P2|Treated|Overall Study||63
8472775|NCT00642902|20879815|P1|Treated|Overall Study||63
8472776|NCT00642902|20879812|P4|STARTED|Overall Study||65
8472777|NCT00642902|20879813|P3|STARTED|Overall Study||64
8472778|NCT00642902|20879814|P2|STARTED|Overall Study||63
8472779|NCT00642902|20879815|P1|STARTED|Overall Study||63
8472780|NCT00642850|20879837|P1|NOT COMPLETED|Overall Study||33
8472781|NCT00642850|20879837|P1|COMPLETED|Overall Study||155
8472782|NCT00642850|20879837|P1|STARTED|Overall Study||188
8472783|NCT00642811|20879853|P6|NOT COMPLETED|Overall Study||1
8472784|NCT00642811|20879854|P5|NOT COMPLETED|Overall Study||1
8472785|NCT00642811|20879855|P4|NOT COMPLETED|Overall Study||1
8472786|NCT00642811|20879856|P3|NOT COMPLETED|Overall Study||0
8472787|NCT00642811|20879857|P2|NOT COMPLETED|Overall Study||4
8472788|NCT00642811|20879858|P1|NOT COMPLETED|Overall Study||3
8472789|NCT00642811|20879853|P6|COMPLETED|Overall Study||13
8472790|NCT00642811|20879854|P5|COMPLETED|Overall Study||13
8472791|NCT00642811|20879855|P4|COMPLETED|Overall Study||15
8472792|NCT00642811|20879856|P3|COMPLETED|Overall Study||13
8472793|NCT00642811|20879857|P2|COMPLETED|Overall Study||17
8472794|NCT00642811|20879858|P1|COMPLETED|Overall Study||17
8472795|NCT00642811|20879853|P6|STARTED|Overall Study||14
8472796|NCT00642811|20879854|P5|STARTED|Overall Study||14
8472797|NCT00642811|20879855|P4|STARTED|Overall Study||16
8472798|NCT00642811|20879856|P3|STARTED|Overall Study||13
8472799|NCT00642811|20879857|P2|STARTED|Overall Study||21
8472800|NCT00642811|20879858|P1|STARTED|Overall Study||20
8472801|NCT00642772|20879880|P1|NOT COMPLETED|Overall Study||10
8472802|NCT00642772|20879880|P1|COMPLETED|Overall Study||14
8472803|NCT00642772|20879880|P1|STARTED|Overall Study||24
8472804|NCT00642759|20879884|P1|NOT COMPLETED|Overall Study||1
8472805|NCT00642759|20879884|P1|COMPLETED|Overall Study||35
8472806|NCT00642759|20879884|P1|STARTED|Overall Study||36
8472807|NCT00642746|20879893|P2|NOT COMPLETED|Overall Study||0
8472808|NCT00642746|20879894|P1|NOT COMPLETED|Overall Study||1
8472809|NCT00642746|20879893|P2|COMPLETED|Overall Study||1
8472810|NCT00642746|20879894|P1|COMPLETED|Overall Study||9
8472811|NCT00642746|20879893|P2|STARTED|Overall Study||1
8472812|NCT00642746|20879894|P1|STARTED|Overall Study||10
8472813|NCT00642707|20879908|P4|NOT COMPLETED|Overall Study||2
8472814|NCT00642707|20879909|P3|NOT COMPLETED|Overall Study||0
8472815|NCT00642707|20879910|P2|NOT COMPLETED|Overall Study||0
8472816|NCT00642707|20879911|P1|NOT COMPLETED|Overall Study||1
8472817|NCT00642707|20879908|P4|COMPLETED|Overall Study||8
8472818|NCT00642707|20879909|P3|COMPLETED|Overall Study||12
8472819|NCT00642707|20879910|P2|COMPLETED|Overall Study||11
8472820|NCT00642707|20879911|P1|COMPLETED|Overall Study||10
8472821|NCT00642707|20879908|P4|STARTED|Overall Study||10
8472822|NCT00642707|20879909|P3|STARTED|Overall Study||12
8472823|NCT00642707|20879910|P2|STARTED|Overall Study||11
8472824|NCT00642707|20879911|P1|STARTED|Overall Study||11
8472825|NCT00642694|20879923|P2|NOT COMPLETED|Overall Study||4
8472826|NCT00642694|20879924|P1|NOT COMPLETED|Overall Study||6
8472827|NCT00642694|20879923|P2|COMPLETED|Overall Study||11
8472828|NCT00642694|20879924|P1|COMPLETED|Overall Study||8
8472829|NCT00642694|20879923|P2|STARTED|Overall Study||15
8472830|NCT00642694|20879924|P1|STARTED|Overall Study||14
8472831|NCT00642668|20879946|P1|NOT COMPLETED|Overall Study||14
8472832|NCT00642668|20879946|P1|COMPLETED|Overall Study||21
8472833|NCT00642668|20879946|P1|STARTED|Overall Study||35
8472834|NCT00642642|20879954|P1|NOT COMPLETED|Treatment & Follow Up||17
8472835|NCT00642642|20879954|P1|COMPLETED|Treatment & Follow Up||92
8472836|NCT00642642|20879954|P1|STARTED|Treatment & Follow Up||109
8472837|NCT00642642|20879954|P1|NOT COMPLETED|Biopsy & Product Manufacture||13
8472838|NCT00642642|20879954|P1|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
8472839|NCT00642642|20879954|P1|STARTED|Biopsy & Product Manufacture||122
8472840|NCT00642616|20879971|P4|NOT COMPLETED|Overall Study||7
8472841|NCT00642616|20879972|P3|NOT COMPLETED|Overall Study||9
8472842|NCT00642616|20879973|P2|NOT COMPLETED|Overall Study||7
8472843|NCT00642616|20879974|P1|NOT COMPLETED|Overall Study||9
8472844|NCT00642616|20879971|P4|COMPLETED|Overall Study||1
8472845|NCT00642616|20879972|P3|COMPLETED|Overall Study||0
8472846|NCT00642616|20879973|P2|COMPLETED|Overall Study||1
8472847|NCT00642616|20879974|P1|COMPLETED|Overall Study||0
8472848|NCT00642616|20879971|P4|STARTED|Overall Study||8
8472849|NCT00642616|20879972|P3|STARTED|Overall Study||9
8472850|NCT00642616|20879973|P2|STARTED|Overall Study||8
8472851|NCT00642616|20879974|P1|STARTED|Overall Study||9
8472852|NCT00642603|20879998|P2|NOT COMPLETED|Overall Study||18
8472853|NCT00642603|20879999|P1|NOT COMPLETED|Overall Study||21
8472854|NCT00642603|20879998|P2|COMPLETED|Overall Study||2
8472855|NCT00642603|20879999|P1|COMPLETED|Overall Study||0
8472856|NCT00642603|20879998|P2|Safety Population|Overall Study||20
8472857|NCT00642603|20879999|P1|Safety Population|Overall Study||19
8472858|NCT00642603|20879998|P2|STARTED|Overall Study||20
8472859|NCT00642603|20879999|P1|STARTED|Overall Study||21
8472860|NCT00642473|20880007|P2|NOT COMPLETED|Overall Study||11
8472861|NCT00642473|20880008|P1|NOT COMPLETED|Overall Study||4
8472862|NCT00642473|20880007|P2|COMPLETED|Overall Study||5
8472863|NCT00642473|20880008|P1|COMPLETED|Overall Study||14
8472864|NCT00642473|20880007|P2|STARTED|Overall Study||16
8472865|NCT00642473|20880008|P1|STARTED|Overall Study||18
8472866|NCT00642460|20880022|P6|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
8472867|NCT00642460|20880023|P5|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
8472868|NCT00642460|20880024|P4|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
8472869|NCT00642460|20880025|P3|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
8472870|NCT00642460|20880026|P2|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
8472871|NCT00642460|20880027|P1|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
8472872|NCT00642460|20880022|P6|COMPLETED|Part III: Open-Label Up to Week 260||38
8472873|NCT00642460|20880023|P5|COMPLETED|Part III: Open-Label Up to Week 260||28
8472874|NCT00642460|20880024|P4|COMPLETED|Part III: Open-Label Up to Week 260||0
8472875|NCT00642460|20880025|P3|COMPLETED|Part III: Open-Label Up to Week 260||0
8472876|NCT00642460|20880026|P2|COMPLETED|Part III: Open-Label Up to Week 260||0
8472877|NCT00642460|20880027|P1|COMPLETED|Part III: Open-Label Up to Week 260||0
8472878|NCT00642460|20880022|P6|STARTED|Part III: Open-Label Up to Week 260||59
8472879|NCT00642460|20880023|P5|STARTED|Part III: Open-Label Up to Week 260||53
8472880|NCT00642460|20880024|P4|STARTED|Part III: Open-Label Up to Week 260||0
8472881|NCT00642460|20880025|P3|STARTED|Part III: Open-Label Up to Week 260||0
8472882|NCT00642460|20880026|P2|STARTED|Part III: Open-Label Up to Week 260||0
8472883|NCT00642460|20880027|P1|STARTED|Part III: Open-Label Up to Week 260||0
8472884|NCT00642460|20880022|P6|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
8472885|NCT00642460|20880023|P5|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
8472886|NCT00642460|20880024|P4|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
8472887|NCT00642460|20880025|P3|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
8472888|NCT00642460|20880026|P2|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
8472889|NCT00642460|20880027|P1|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
8472890|NCT00642460|20880022|P6|COMPLETED|Part II: Open-Label Up to Week 92||0
8472891|NCT00642460|20880023|P5|COMPLETED|Part II: Open-Label Up to Week 92||0
8472892|NCT00642460|20880024|P4|COMPLETED|Part II: Open-Label Up to Week 92||17
8472893|NCT00642460|20880025|P3|COMPLETED|Part II: Open-Label Up to Week 92||0
8472894|NCT00642460|20880026|P2|COMPLETED|Part II: Open-Label Up to Week 92||32
8472895|NCT00642460|20880027|P1|COMPLETED|Part II: Open-Label Up to Week 92||43
8472896|NCT00642460|20880022|P6|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
8472897|NCT00642460|20880023|P5|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
8472898|NCT00642460|20880024|P4|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
8472899|NCT00642460|20880025|P3|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
8472900|NCT00642460|20880026|P2|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
8472901|NCT00642460|20880027|P1|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
8472902|NCT00642460|20880022|P6|STARTED|Part II: Open-Label Up to Week 92||0
8472903|NCT00642460|20880023|P5|STARTED|Part II: Open-Label Up to Week 92||0
8472904|NCT00642460|20880024|P4|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
8472905|NCT00642460|20880025|P3|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
8472906|NCT00642460|20880026|P2|STARTED|Part II: Open-Label Up to Week 92||40
8472907|NCT00642460|20880027|P1|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
8472908|NCT00642460|20880022|P6|NOT COMPLETED|Part I: 12 Week Double-Blind||0
8472909|NCT00642460|20880023|P5|NOT COMPLETED|Part I: 12 Week Double-Blind||0
8472910|NCT00642460|20880024|P4|NOT COMPLETED|Part I: 12 Week Double-Blind||0
8472911|NCT00642460|20880025|P3|NOT COMPLETED|Part I: 12 Week Double-Blind||1
8472912|NCT00642460|20880026|P2|NOT COMPLETED|Part I: 12 Week Double-Blind||1
8472913|NCT00642460|20880027|P1|NOT COMPLETED|Part I: 12 Week Double-Blind||1
8472914|NCT00642460|20880022|P6|COMPLETED|Part I: 12 Week Double-Blind||0
8472915|NCT00642460|20880023|P5|COMPLETED|Part I: 12 Week Double-Blind||0
8472916|NCT00642460|20880024|P4|COMPLETED|Part I: 12 Week Double-Blind||0
8472917|NCT00642460|20880025|P3|COMPLETED|Part I: 12 Week Double-Blind||36
8472918|NCT00642460|20880026|P2|COMPLETED|Part I: 12 Week Double-Blind||37
8472919|NCT00642460|20880027|P1|COMPLETED|Part I: 12 Week Double-Blind||36
8472920|NCT00642460|20880022|P6|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
8472921|NCT00642460|20880023|P5|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
8472922|NCT00642460|20880024|P4|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
8472923|NCT00642460|20880025|P3|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
8472924|NCT00642460|20880026|P2|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
8472925|NCT00642460|20880027|P1|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
8472926|NCT00642460|20880022|P6|STARTED|Part I: 12 Week Double-Blind||0
8472927|NCT00642460|20880023|P5|STARTED|Part I: 12 Week Double-Blind||0
8472928|NCT00642460|20880024|P4|STARTED|Part I: 12 Week Double-Blind||0
8472929|NCT00642460|20880025|P3|STARTED|Part I: 12 Week Double-Blind||37
8472930|NCT00642460|20880026|P2|STARTED|Part I: 12 Week Double-Blind||38
8472931|NCT00642460|20880027|P1|STARTED|Part I: 12 Week Double-Blind||37
8472932|NCT00642382|20880093|P2|NOT COMPLETED|Overall Study||0
8472933|NCT00642382|20880094|P1|NOT COMPLETED|Overall Study||0
8472934|NCT00642382|20880093|P2|COMPLETED|Overall Study||0
8472935|NCT00642382|20880094|P1|COMPLETED|Overall Study||0
8472936|NCT00642382|20880093|P2|STARTED|Overall Study||0
8472937|NCT00642382|20880094|P1|STARTED|Overall Study||0
8472938|NCT00642369|20880102|P2|NOT COMPLETED|Overall Study||6
8472939|NCT00642369|20880103|P1|NOT COMPLETED|Overall Study||5
8472940|NCT00642369|20880102|P2|COMPLETED|Overall Study||24
8472941|NCT00642369|20880103|P1|COMPLETED|Overall Study||25
8472942|NCT00642369|20880102|P2|STARTED|Overall Study||30
8472943|NCT00642369|20880103|P1|STARTED|Overall Study||30
8472944|NCT00642356|20880113|P2|NOT COMPLETED|Overall Study||3
8472945|NCT00642356|20880114|P1|NOT COMPLETED|Overall Study||2
8472946|NCT00642356|20880113|P2|COMPLETED|Overall Study||4
8472947|NCT00642356|20880114|P1|COMPLETED|Overall Study||5
8472948|NCT00642356|20880113|P2|STARTED|Overall Study||7
8472949|NCT00642356|20880114|P1|STARTED|Overall Study||7
8472950|NCT00642304|20880122|P1|NOT COMPLETED|Overall Study||6
8472951|NCT00642304|20880122|P1|COMPLETED|Overall Study||14
8472952|NCT00642304|20880122|P1|STARTED|Overall Study||20
8472953|NCT00642278|20880138|P7|NOT COMPLETED|Overall Study||5
8472954|NCT00642278|20880139|P6|NOT COMPLETED|Overall Study||7
8472955|NCT00642278|20880140|P5|NOT COMPLETED|Overall Study||8
8472956|NCT00642278|20880141|P4|NOT COMPLETED|Overall Study||9
8472957|NCT00642278|20880142|P3|NOT COMPLETED|Overall Study||5
8472958|NCT00642278|20880143|P2|NOT COMPLETED|Overall Study||5
8472959|NCT00642278|20880144|P1|NOT COMPLETED|Overall Study||10
8472960|NCT00642278|20880138|P7|COMPLETED|Overall Study||60
8472961|NCT00642278|20880139|P6|COMPLETED|Overall Study||57
8472962|NCT00642278|20880140|P5|COMPLETED|Overall Study||56
8472963|NCT00642278|20880141|P4|COMPLETED|Overall Study||56
8472964|NCT00642278|20880142|P3|COMPLETED|Overall Study||59
8472965|NCT00642278|20880143|P2|COMPLETED|Overall Study||59
8472966|NCT00642278|20880144|P1|COMPLETED|Overall Study||55
8472967|NCT00642278|20880138|P7|STARTED|Overall Study||65
8472968|NCT00642278|20880139|P6|STARTED|Overall Study||64
8472969|NCT00642278|20880140|P5|STARTED|Overall Study||64
8472970|NCT00642278|20880141|P4|STARTED|Overall Study||65
8472971|NCT00642278|20880142|P3|STARTED|Overall Study||64
8472972|NCT00642278|20880143|P2|STARTED|Overall Study||64
8472973|NCT00642278|20880144|P1|STARTED|Overall Study||65
8472974|NCT00642174|20880197|P2|NOT COMPLETED|Period 2 - Crossover Drug||0
8472975|NCT00642174|20880198|P1|NOT COMPLETED|Period 2 - Crossover Drug||0
8472976|NCT00642174|20880197|P2|COMPLETED|Period 2 - Crossover Drug||16
8472977|NCT00642174|20880198|P1|COMPLETED|Period 2 - Crossover Drug||18
8472978|NCT00642174|20880197|P2|STARTED|Period 2 - Crossover Drug||16
8472979|NCT00642174|20880198|P1|STARTED|Period 2 - Crossover Drug||18
8472980|NCT00642174|20880197|P2|NOT COMPLETED|Period 1 - Initial Drug||1
8472981|NCT00642174|20880198|P1|NOT COMPLETED|Period 1 - Initial Drug||0
8472982|NCT00642174|20880197|P2|COMPLETED|Period 1 - Initial Drug||16
8472983|NCT00642174|20880198|P1|COMPLETED|Period 1 - Initial Drug||18
8472984|NCT00642174|20880197|P2|STARTED|Period 1 - Initial Drug||17
8472985|NCT00642174|20880198|P1|STARTED|Period 1 - Initial Drug||18
8472986|NCT00642018|20880214|P2|NOT COMPLETED|Overall Study||79
8472987|NCT00642018|20880215|P1|NOT COMPLETED|Overall Study||28
8472988|NCT00642018|20880214|P2|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23
8472989|NCT00642018|20880215|P1|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24
8472990|NCT00642018|20880214|P2|Received at Least One Dose of Study Drug|Overall Study||98
8472991|NCT00642018|20880215|P1|Received at Least One Dose of Study Drug|Overall Study||51
8472992|NCT00642018|20880214|P2|STARTED|Overall Study||102
8472993|NCT00642018|20880215|P1|STARTED|Overall Study||52
8472994|NCT00641862|20880245|P2|NOT COMPLETED|Overall Study||38
8472995|NCT00641862|20880246|P1|NOT COMPLETED|Overall Study||44
8472996|NCT00641862|20880245|P2|COMPLETED|Overall Study||145
8472997|NCT00641862|20880246|P1|COMPLETED|Overall Study||139
8472998|NCT00641862|20880245|P2|STARTED|Overall Study||183
8472999|NCT00641862|20880246|P1|STARTED|Overall Study||183
8473000|NCT00641797|20880264|P2|NOT COMPLETED|Overall Study||0
8473001|NCT00641797|20880265|P1|NOT COMPLETED|Overall Study||0
8473002|NCT00641797|20880264|P2|COMPLETED|Overall Study||15
8473003|NCT00641797|20880265|P1|COMPLETED|Overall Study||11
8473004|NCT00641797|20880264|P2|STARTED|Overall Study||15
8473005|NCT00641797|20880265|P1|STARTED|Overall Study||11
8473006|NCT00641745|20880273|P2|NOT COMPLETED|Overall Study||113
8473007|NCT00641745|20880274|P1|NOT COMPLETED|Overall Study||280
8473008|NCT00641745|20880273|P2|COMPLETED|Overall Study||89
8473009|NCT00641745|20880274|P1|COMPLETED|Overall Study||147
8473010|NCT00641745|20880273|P2|STARTED|Overall Study||202
8473011|NCT00641745|20880274|P1|STARTED|Overall Study||427
8473012|NCT00641719|20880282|P2|NOT COMPLETED|Overall Study||37
8473013|NCT00641719|20880283|P1|NOT COMPLETED|Overall Study||30
8473014|NCT00641719|20880282|P2|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
8473015|NCT00641719|20880283|P1|COMPLETED|Overall Study||99
8473016|NCT00641719|20880282|P2|STARTED|Overall Study||129
8473017|NCT00641719|20880283|P1|STARTED|Overall Study||129
8473018|NCT00641706|20880307|P2|NOT COMPLETED|Overall Study||3
8473019|NCT00641706|20880308|P1|NOT COMPLETED|Overall Study||9
8473020|NCT00641706|20880307|P2|COMPLETED|Overall Study||4
8473021|NCT00641706|20880308|P1|COMPLETED|Overall Study||28
8473022|NCT00641706|20880307|P2|STARTED|Overall Study||7
8473023|NCT00641706|20880308|P1|STARTED|Overall Study||37
8473024|NCT00641667|20880320|P1|NOT COMPLETED|Overall Study||6
8473025|NCT00641667|20880320|P1|COMPLETED|Overall Study||60
8473026|NCT00641667|20880320|P1|STARTED|Overall Study||66
8473027|NCT00641641|20880330|P1|NOT COMPLETED|Overall Study||0
8473028|NCT00641641|20880330|P1|COMPLETED|Overall Study||16
8473029|NCT00641641|20880330|P1|STARTED|Overall Study||16
8473030|NCT00641563|20880334|P2|NOT COMPLETED|Infusion 2||0
8473031|NCT00641563|20880335|P1|NOT COMPLETED|Infusion 2||0
8473032|NCT00641563|20880334|P2|COMPLETED|Infusion 2||5
8473033|NCT00641563|20880335|P1|COMPLETED|Infusion 2||5
8473034|NCT00641563|20880334|P2|STARTED|Infusion 2||5
8473035|NCT00641563|20880335|P1|STARTED|Infusion 2||5
8473036|NCT00641563|20880334|P2|NOT COMPLETED|Infusion 1||0
8473037|NCT00641563|20880335|P1|NOT COMPLETED|Infusion 1||0
8473038|NCT00641563|20880334|P2|COMPLETED|Infusion 1||5
8473039|NCT00641563|20880335|P1|COMPLETED|Infusion 1||5
8473040|NCT00641563|20880334|P2|STARTED|Infusion 1||5
8473041|NCT00641563|20880335|P1|STARTED|Infusion 1||5
8473042|NCT00641537|20880348|P8|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
8473043|NCT00641537|20880349|P7|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
8473044|NCT00641537|20880350|P6|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
8473045|NCT00641537|20880351|P5|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
8473046|NCT00641537|20880352|P4|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
8473047|NCT00641537|20880353|P3|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
8473048|NCT00641537|20880354|P2|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
8473049|NCT00641537|20880355|P1|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
8473050|NCT00641537|20880348|P8|COMPLETED|24-Week Supplemental Follow-up Period||10
8473051|NCT00641537|20880349|P7|COMPLETED|24-Week Supplemental Follow-up Period||8
8473052|NCT00641537|20880350|P6|COMPLETED|24-Week Supplemental Follow-up Period||14
8473053|NCT00641537|20880351|P5|COMPLETED|24-Week Supplemental Follow-up Period||193
8473054|NCT00641537|20880352|P4|COMPLETED|24-Week Supplemental Follow-up Period||147
8473055|NCT00641537|20880353|P3|COMPLETED|24-Week Supplemental Follow-up Period||140
8473056|NCT00641537|20880354|P2|COMPLETED|24-Week Supplemental Follow-up Period||66
8473057|NCT00641537|20880355|P1|COMPLETED|24-Week Supplemental Follow-up Period||75
8473058|NCT00641537|20880348|P8|STARTED|24-Week Supplemental Follow-up Period||11
8473059|NCT00641537|20880349|P7|STARTED|24-Week Supplemental Follow-up Period||9
8473060|NCT00641537|20880350|P6|STARTED|24-Week Supplemental Follow-up Period||15
8473061|NCT00641537|20880351|P5|STARTED|24-Week Supplemental Follow-up Period||198
8473062|NCT00641537|20880352|P4|STARTED|24-Week Supplemental Follow-up Period||151
8473063|NCT00641537|20880353|P3|STARTED|24-Week Supplemental Follow-up Period||143
8473064|NCT00641537|20880354|P2|STARTED|24-Week Supplemental Follow-up Period||69
8473065|NCT00641537|20880355|P1|STARTED|24-Week Supplemental Follow-up Period||75
8473066|NCT00641537|20880348|P8|NOT COMPLETED|96-week Period||6
8473067|NCT00641537|20880349|P7|NOT COMPLETED|96-week Period||5
8473068|NCT00641537|20880350|P6|NOT COMPLETED|96-week Period||7
8473069|NCT00641537|20880351|P5|NOT COMPLETED|96-week Period||17
8473070|NCT00641537|20880352|P4|NOT COMPLETED|96-week Period||12
8473071|NCT00641537|20880353|P3|NOT COMPLETED|96-week Period||20
8473072|NCT00641537|20880354|P2|NOT COMPLETED|96-week Period||10
8473073|NCT00641537|20880355|P1|NOT COMPLETED|96-week Period||9
8473074|NCT00641537|20880348|P8|COMPLETED|96-week Period||16
8473075|NCT00641537|20880349|P7|COMPLETED|96-week Period||12
8473076|NCT00641537|20880350|P6|COMPLETED|96-week Period||15
8473077|NCT00641537|20880351|P5|COMPLETED|96-week Period||227
8473078|NCT00641537|20880352|P4|COMPLETED|96-week Period||174
8473079|NCT00641537|20880353|P3|COMPLETED|96-week Period||166
8473080|NCT00641537|20880354|P2|COMPLETED|96-week Period||82
8473081|NCT00641537|20880355|P1|COMPLETED|96-week Period||89
8473082|NCT00641537|20880348|P8|STARTED|96-week Period||22
8473083|NCT00641537|20880349|P7|STARTED|96-week Period||17
8473084|NCT00641537|20880350|P6|STARTED|96-week Period||22
8473085|NCT00641537|20880351|P5|STARTED|96-week Period||244
8473086|NCT00641537|20880352|P4|STARTED|96-week Period||186
8473087|NCT00641537|20880353|P3|STARTED|96-week Period||186
8473088|NCT00641537|20880354|P2|STARTED|96-week Period||92
8473089|NCT00641537|20880355|P1|STARTED|96-week Period||98
8473090|NCT00641147|20880443|P2|NOT COMPLETED|Completed 16 Months.||0
8473091|NCT00641147|20880444|P1|NOT COMPLETED|Completed 16 Months.||2
8473092|NCT00641147|20880443|P2|COMPLETED|Completed 16 Months.||19
8473093|NCT00641147|20880444|P1|COMPLETED|Completed 16 Months.||13
8473094|NCT00641147|20880443|P2|STARTED|Completed 16 Months.||19
8473095|NCT00641147|20880444|P1|STARTED|Completed 16 Months.||15
8473096|NCT00641147|20880443|P2|NOT COMPLETED|Completed 12 Months.||2
8473097|NCT00641147|20880444|P1|NOT COMPLETED|Completed 12 Months.||1
8473098|NCT00641147|20880443|P2|COMPLETED|Completed 12 Months.||19
8473099|NCT00641147|20880444|P1|COMPLETED|Completed 12 Months.||15
8473100|NCT00641147|20880443|P2|STARTED|Completed 12 Months.||21
8473101|NCT00641147|20880444|P1|STARTED|Completed 12 Months.||16
8473102|NCT00641147|20880443|P2|NOT COMPLETED|Completed 8 Months.||2
8473103|NCT00641147|20880444|P1|NOT COMPLETED|Completed 8 Months.||3
8473104|NCT00641147|20880443|P2|COMPLETED|Completed 8 Months.||21
8473105|NCT00641147|20880444|P1|COMPLETED|Completed 8 Months.||16
8473106|NCT00641147|20880443|P2|STARTED|Completed 8 Months.||23
8473107|NCT00641147|20880444|P1|STARTED|Completed 8 Months.||19
8473108|NCT00641147|20880443|P2|NOT COMPLETED|Completed 4 Months.||0
8473109|NCT00641147|20880444|P1|NOT COMPLETED|Completed 4 Months.||2
8473110|NCT00641147|20880443|P2|COMPLETED|Completed 4 Months.||23
8473111|NCT00641147|20880444|P1|COMPLETED|Completed 4 Months.||19
8473112|NCT00641147|20880443|P2|STARTED|Completed 4 Months.||23
8473113|NCT00641147|20880444|P1|STARTED|Completed 4 Months.||21
8473114|NCT00641108|20880488|P2|NOT COMPLETED|Overall Study||0
8473115|NCT00641108|20880489|P1|NOT COMPLETED|Overall Study||0
8473116|NCT00641108|20880488|P2|COMPLETED|Overall Study||0
8473117|NCT00641108|20880489|P1|COMPLETED|Overall Study||0
8473118|NCT00641108|20880488|P2|STARTED|Overall Study||0
8473119|NCT00641108|20880489|P1|STARTED|Overall Study||0
8473120|NCT00641056|20880497|P2|NOT COMPLETED|Overall Study||25
8473121|NCT00641056|20880498|P1|NOT COMPLETED|Overall Study||29
8473122|NCT00641056|20880497|P2|COMPLETED|Overall Study||209
8473123|NCT00641056|20880498|P1|COMPLETED|Overall Study||204
8473124|NCT00641056|20880497|P2|Intent to Treat (ITT)|Overall Study||223
8473125|NCT00641056|20880498|P1|Intent to Treat (ITT)|Overall Study||233
8473126|NCT00641056|20880497|P2|STARTED|Overall Study||234
8473127|NCT00641056|20880498|P1|STARTED|Overall Study||233
8473128|NCT00641043|20880526|P2|NOT COMPLETED|Overall Study||15
8473129|NCT00641043|20880527|P1|NOT COMPLETED|Overall Study||19
8473130|NCT00641043|20880526|P2|COMPLETED|Overall Study|number who completed treatment|244
8473131|NCT00641043|20880527|P1|COMPLETED|Overall Study|number who completed treatment|111
8473132|NCT00641043|20880526|P2|STARTED|Overall Study|number who started treatment|259
8473133|NCT00641043|20880527|P1|STARTED|Overall Study|number who started treatment|130
8473134|NCT00640978|20880557|P1|NOT COMPLETED|Overall Study||0
8473135|NCT00640978|20880557|P1|COMPLETED|Overall Study||15
8473136|NCT00640978|20880557|P1|STARTED|Overall Study||15
8473137|NCT00640926|20880564|P3|NOT COMPLETED|Overall Study||8
8473138|NCT00640926|20880565|P2|NOT COMPLETED|Overall Study||6
8473139|NCT00640926|20880566|P1|NOT COMPLETED|Overall Study||8
8473140|NCT00640926|20880564|P3|COMPLETED|Overall Study||45
8473141|NCT00640926|20880565|P2|COMPLETED|Overall Study||46
8473142|NCT00640926|20880566|P1|COMPLETED|Overall Study||45
8473143|NCT00640926|20880564|P3|STARTED|Overall Study||53
8473144|NCT00640926|20880565|P2|STARTED|Overall Study||52
8473145|NCT00640926|20880566|P1|STARTED|Overall Study||53
8473146|NCT00640835|20880579|P2|NOT COMPLETED|Overall Study||57
8473147|NCT00640835|20880580|P1|NOT COMPLETED|Overall Study||76
8473148|NCT00640835|20880579|P2|COMPLETED|Overall Study||131
8473149|NCT00640835|20880580|P1|COMPLETED|Overall Study||118
8473150|NCT00640835|20880579|P2|STARTED|Overall Study||188
8473151|NCT00640835|20880580|P1|STARTED|Overall Study||194
8473152|NCT00640822|20880591|P3|NOT COMPLETED|Overall Study||25
8473153|NCT00640822|20880592|P2|NOT COMPLETED|Overall Study||59
8473154|NCT00640822|20880593|P1|NOT COMPLETED|Overall Study||43
8473155|NCT00640822|20880591|P3|COMPLETED|Overall Study||77
8473156|NCT00640822|20880592|P2|COMPLETED|Overall Study||258
8473157|NCT00640822|20880593|P1|COMPLETED|Overall Study||279
8473158|NCT00640822|20880591|P3|STARTED|Overall Study||102
8473159|NCT00640822|20880592|P2|STARTED|Overall Study||317
8473160|NCT00640822|20880593|P1|STARTED|Overall Study||322
8473161|NCT00640653|20880606|P5|NOT COMPLETED|Overall Study||5
8473162|NCT00640653|20880607|P4|NOT COMPLETED|Overall Study||2
8473163|NCT00640653|20880608|P3|NOT COMPLETED|Overall Study||0
8473164|NCT00640653|20880609|P2|NOT COMPLETED|Overall Study||3
8473165|NCT00640653|20880610|P1|NOT COMPLETED|Overall Study||3
8473166|NCT00640653|20880606|P5|COMPLETED|Overall Study||129
8473167|NCT00640653|20880607|P4|COMPLETED|Overall Study||132
8473168|NCT00640653|20880608|P3|COMPLETED|Overall Study||129
8473169|NCT00640653|20880609|P2|COMPLETED|Overall Study||131
8473170|NCT00640653|20880610|P1|COMPLETED|Overall Study||128
8473171|NCT00640653|20880606|P5|Followed-up at 24 mo|Overall Study||112
8473172|NCT00640653|20880607|P4|Followed-up at 24 mo|Overall Study||112
8473173|NCT00640653|20880608|P3|Followed-up at 24 mo|Overall Study||105
8473174|NCT00640653|20880609|P2|Followed-up at 24 mo|Overall Study||116
8473175|NCT00640653|20880610|P1|Followed-up at 24 mo|Overall Study||114
8473176|NCT00640653|20880606|P5|Followed-up at 18 mo|Overall Study||117
8473177|NCT00640653|20880607|P4|Followed-up at 18 mo|Overall Study||117
8473178|NCT00640653|20880608|P3|Followed-up at 18 mo|Overall Study||113
8473179|NCT00640653|20880609|P2|Followed-up at 18 mo|Overall Study||112
8473180|NCT00640653|20880610|P1|Followed-up at 18 mo|Overall Study||118
8473181|NCT00640653|20880606|P5|Followed-up at 12 mo|Overall Study||116
8473182|NCT00640653|20880607|P4|Followed-up at 12 mo|Overall Study||122
8473183|NCT00640653|20880608|P3|Followed-up at 12 mo|Overall Study||115
8473184|NCT00640653|20880609|P2|Followed-up at 12 mo|Overall Study||121
8473185|NCT00640653|20880610|P1|Followed-up at 12 mo|Overall Study||124
8473186|NCT00640653|20880606|P5|Followed-up at 6 mo|Overall Study||125
8473187|NCT00640653|20880607|P4|Followed-up at 6 mo|Overall Study||130
8473188|NCT00640653|20880608|P3|Followed-up at 6 mo|Overall Study||124
8473189|NCT00640653|20880609|P2|Followed-up at 6 mo|Overall Study||130
8473190|NCT00640653|20880610|P1|Followed-up at 6 mo|Overall Study||127
8473191|NCT00640653|20880606|P5|Followed-up at 3 mo|Overall Study||126
8473192|NCT00640653|20880607|P4|Followed-up at 3 mo|Overall Study||129
8473193|NCT00640653|20880608|P3|Followed-up at 3 mo|Overall Study||125
8473194|NCT00640653|20880609|P2|Followed-up at 3 mo|Overall Study||127
8473195|NCT00640653|20880610|P1|Followed-up at 3 mo|Overall Study||126
8473196|NCT00640653|20880606|P5|STARTED|Overall Study||134
8473197|NCT00640653|20880607|P4|STARTED|Overall Study||134
8473198|NCT00640653|20880608|P3|STARTED|Overall Study||129
8473199|NCT00640653|20880609|P2|STARTED|Overall Study||134
8473200|NCT00640653|20880610|P1|STARTED|Overall Study||131
8473201|NCT00640614|20880644|P2|NOT COMPLETED|Overall Study||0
8473202|NCT00640614|20880645|P1|NOT COMPLETED|Overall Study||1
8473203|NCT00640614|20880644|P2|COMPLETED|Overall Study||110
8473204|NCT00640614|20880645|P1|COMPLETED|Overall Study||124
8473205|NCT00640614|20880644|P2|STARTED|Overall Study||110
8473206|NCT00640614|20880645|P1|STARTED|Overall Study||125
8473207|NCT00640601|20880687|P1|NOT COMPLETED|Overall Study||112
8473208|NCT00640601|20880687|P1|COMPLETED|Overall Study||183
8473209|NCT00640601|20880687|P1|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
8473210|NCT00640562|20880703|P2|NOT COMPLETED|Overall Study||26
8473211|NCT00640562|20880704|P1|NOT COMPLETED|Overall Study||18
8473212|NCT00640562|20880703|P2|COMPLETED|Overall Study||81
8473213|NCT00640562|20880704|P1|COMPLETED|Overall Study||91
8473214|NCT00640562|20880703|P2|STARTED|Overall Study||107
8473215|NCT00640562|20880704|P1|STARTED|Overall Study||109
8473216|NCT00640510|20880732|P2|NOT COMPLETED|Overall Study||2
8473217|NCT00640510|20880733|P1|NOT COMPLETED|Overall Study||1
8473218|NCT00640510|20880732|P2|COMPLETED|Overall Study||15
8473219|NCT00640510|20880733|P1|COMPLETED|Overall Study||16
8473220|NCT00640510|20880732|P2|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
8473221|NCT00640510|20880733|P1|STARTED|Overall Study||17
8473222|NCT00640393|20880745|P3|NOT COMPLETED|Part 2||3
8473223|NCT00640393|20880746|P2|NOT COMPLETED|Part 2||10
8473224|NCT00640393|20880747|P1|NOT COMPLETED|Part 2||0
8473225|NCT00640393|20880745|P3|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
8473226|NCT00640393|20880746|P2|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
8473227|NCT00640393|20880747|P1|COMPLETED|Part 2||0
8473228|NCT00640393|20880745|P3|STARTED|Part 2||38
8473229|NCT00640393|20880746|P2|STARTED|Part 2||37
8473230|NCT00640393|20880747|P1|STARTED|Part 2||0
8473231|NCT00640393|20880745|P3|NOT COMPLETED|Randomization||0
8473232|NCT00640393|20880746|P2|NOT COMPLETED|Randomization||0
8473233|NCT00640393|20880747|P1|NOT COMPLETED|Randomization||19
8473234|NCT00640393|20880745|P3|COMPLETED|Randomization||0
8473235|NCT00640393|20880746|P2|COMPLETED|Randomization||0
8473236|NCT00640393|20880747|P1|COMPLETED|Randomization||75
8473237|NCT00640393|20880745|P3|STARTED|Randomization||0
8473238|NCT00640393|20880746|P2|STARTED|Randomization||0
8473239|NCT00640393|20880747|P1|STARTED|Randomization||94
8473240|NCT00640393|20880745|P3|NOT COMPLETED|Part 1||0
8473241|NCT00640393|20880746|P2|NOT COMPLETED|Part 1||0
8473242|NCT00640393|20880747|P1|NOT COMPLETED|Part 1||5
8473243|NCT00640393|20880745|P3|COMPLETED|Part 1||0
8473244|NCT00640393|20880746|P2|COMPLETED|Part 1||0
8473245|NCT00640393|20880747|P1|COMPLETED|Part 1||94
8473246|NCT00640393|20880745|P3|STARTED|Part 1||0
8473247|NCT00640393|20880746|P2|STARTED|Part 1||0
8473248|NCT00640393|20880747|P1|STARTED|Part 1||99
8473249|NCT00640341|20880812|P3|NOT COMPLETED|Overall Study||7
8473250|NCT00640341|20880813|P2|NOT COMPLETED|Overall Study||5
8473251|NCT00640341|20880814|P1|NOT COMPLETED|Overall Study||21
8473252|NCT00640341|20880812|P3|COMPLETED|Overall Study||163
8473253|NCT00640341|20880813|P2|COMPLETED|Overall Study||165
8473254|NCT00640341|20880814|P1|COMPLETED|Overall Study||149
8473255|NCT00640341|20880812|P3|Eligible Participants at Baseline|Overall Study||168
8473256|NCT00640341|20880813|P2|Eligible Participants at Baseline|Overall Study||167
8473257|NCT00640341|20880814|P1|Eligible Participants at Baseline|Overall Study||165
8473258|NCT00640341|20880812|P3|STARTED|Overall Study||170
8473259|NCT00640341|20880813|P2|STARTED|Overall Study||170
8473260|NCT00640341|20880814|P1|STARTED|Overall Study|All Starting participants were dispensed lenses|170
8473261|NCT00640328|20880834|P6|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
8473262|NCT00640328|20880835|P5|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
8473263|NCT00640328|20880836|P4|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
8473264|NCT00640328|20880837|P3|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
8473265|NCT00640328|20880838|P2|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
8473266|NCT00640328|20880839|P1|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
8473267|NCT00640328|20880834|P6|COMPLETED|IFUP (Week 48 to Individual Termination)||4
8473268|NCT00640328|20880835|P5|COMPLETED|IFUP (Week 48 to Individual Termination)||4
8473269|NCT00640328|20880836|P4|COMPLETED|IFUP (Week 48 to Individual Termination)||3
8473270|NCT00640328|20880837|P3|COMPLETED|IFUP (Week 48 to Individual Termination)||6
8473271|NCT00640328|20880838|P2|COMPLETED|IFUP (Week 48 to Individual Termination)||10
8473272|NCT00640328|20880839|P1|COMPLETED|IFUP (Week 48 to Individual Termination)||8
8473273|NCT00640328|20880834|P6|STARTED|IFUP (Week 48 to Individual Termination)||4
8473274|NCT00640328|20880835|P5|STARTED|IFUP (Week 48 to Individual Termination)||4
8473275|NCT00640328|20880836|P4|STARTED|IFUP (Week 48 to Individual Termination)||4
8473276|NCT00640328|20880837|P3|STARTED|IFUP (Week 48 to Individual Termination)||7
8473277|NCT00640328|20880838|P2|STARTED|IFUP (Week 48 to Individual Termination)||11
8473278|NCT00640328|20880839|P1|STARTED|IFUP (Week 48 to Individual Termination)||8
8473279|NCT00640328|20880834|P6|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8473280|NCT00640328|20880835|P5|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
8473281|NCT00640328|20880836|P4|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8473282|NCT00640328|20880837|P3|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8473283|NCT00640328|20880838|P2|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8473284|NCT00640328|20880839|P1|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
8473285|NCT00640328|20880834|P6|COMPLETED|Second Treatment Period (Weeks 24-48)||4
8473286|NCT00640328|20880835|P5|COMPLETED|Second Treatment Period (Weeks 24-48)||3
8473287|NCT00640328|20880836|P4|COMPLETED|Second Treatment Period (Weeks 24-48)||4
8473288|NCT00640328|20880837|P3|COMPLETED|Second Treatment Period (Weeks 24-48)||7
8473289|NCT00640328|20880838|P2|COMPLETED|Second Treatment Period (Weeks 24-48)||10
8473290|NCT00640328|20880839|P1|COMPLETED|Second Treatment Period (Weeks 24-48)||8
8473291|NCT00640328|20880834|P6|STARTED|Second Treatment Period (Weeks 24-48)||4
8473292|NCT00640328|20880835|P5|STARTED|Second Treatment Period (Weeks 24-48)||4
8473293|NCT00640328|20880836|P4|STARTED|Second Treatment Period (Weeks 24-48)||4
8473294|NCT00640328|20880837|P3|STARTED|Second Treatment Period (Weeks 24-48)||7
8473295|NCT00640328|20880838|P2|STARTED|Second Treatment Period (Weeks 24-48)||10
8473296|NCT00640328|20880839|P1|STARTED|Second Treatment Period (Weeks 24-48)||8
8473297|NCT00640328|20880834|P6|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8473298|NCT00640328|20880835|P5|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8473299|NCT00640328|20880836|P4|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8473300|NCT00640328|20880837|P3|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8473301|NCT00640328|20880838|P2|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
8473302|NCT00640328|20880839|P1|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
8473303|NCT00640328|20880834|P6|COMPLETED|First Treatment Period (Weeks 0-24)||4
8473304|NCT00640328|20880835|P5|COMPLETED|First Treatment Period (Weeks 0-24)||4
8473305|NCT00640328|20880836|P4|COMPLETED|First Treatment Period (Weeks 0-24)||4
8473306|NCT00640328|20880837|P3|COMPLETED|First Treatment Period (Weeks 0-24)||7
8473307|NCT00640328|20880838|P2|COMPLETED|First Treatment Period (Weeks 0-24)||10
8473308|NCT00640328|20880839|P1|COMPLETED|First Treatment Period (Weeks 0-24)||8
8473309|NCT00640328|20880834|P6|STARTED|First Treatment Period (Weeks 0-24)||4
8473310|NCT00640328|20880835|P5|STARTED|First Treatment Period (Weeks 0-24)||4
8473311|NCT00640328|20880836|P4|STARTED|First Treatment Period (Weeks 0-24)||4
8473312|NCT00640328|20880837|P3|STARTED|First Treatment Period (Weeks 0-24)||7
8473313|NCT00640328|20880838|P2|STARTED|First Treatment Period (Weeks 0-24)||11
8473314|NCT00640328|20880839|P1|STARTED|First Treatment Period (Weeks 0-24)||8
8473315|NCT00640315|20881005|P2|NOT COMPLETED|Overall Study||1
8473316|NCT00640315|20881006|P1|NOT COMPLETED|Overall Study||0
8473317|NCT00640315|20881005|P2|COMPLETED|Overall Study||12
8473318|NCT00640315|20881006|P1|COMPLETED|Overall Study||10
8473319|NCT00640315|20881005|P2|Participants Received Treatment|Overall Study||13
8473320|NCT00640315|20881006|P1|Participants Received Treatment|Overall Study||10
8473321|NCT00640315|20881005|P2|STARTED|Overall Study||13
8473322|NCT00640315|20881006|P1|STARTED|Overall Study||10
8473323|NCT00640289|20881132|P1|NOT COMPLETED|Overall Study||13
8473324|NCT00640289|20881132|P1|COMPLETED|Overall Study||59
8473325|NCT00640289|20881132|P1|STARTED|Overall Study||72
8473326|NCT00640250|20881137|P1|NOT COMPLETED|Overall Study||0
8473327|NCT00640250|20881137|P1|COMPLETED|Overall Study||48
8473328|NCT00640250|20881137|P1|STARTED|Overall Study||48
8473329|NCT00640224|20881244|P4|NOT COMPLETED|Overall Study||0
8473330|NCT00640224|20881245|P3|NOT COMPLETED|Overall Study||0
8473331|NCT00640224|20881246|P2|NOT COMPLETED|Overall Study||3
8473332|NCT00640224|20881247|P1|NOT COMPLETED|Overall Study||6
8473333|NCT00640224|20881244|P4|COMPLETED|Overall Study||0
8473334|NCT00640224|20881245|P3|COMPLETED|Overall Study||0
8473335|NCT00640224|20881246|P2|COMPLETED|Overall Study||20
8473336|NCT00640224|20881247|P1|COMPLETED|Overall Study||17
8473337|NCT00640224|20881244|P4|STARTED|Overall Study||0
8473338|NCT00640224|20881245|P3|STARTED|Overall Study||0
8473339|NCT00640224|20881246|P2|STARTED|Overall Study||23
8473340|NCT00640224|20881247|P1|STARTED|Overall Study||23
8473341|NCT00640146|20881347|P2|NOT COMPLETED|Overall Study||6
8473342|NCT00640146|20881348|P1|NOT COMPLETED|Overall Study||4
8473343|NCT00640146|20881347|P2|COMPLETED|Overall Study||12
8473344|NCT00640146|20881348|P1|COMPLETED|Overall Study||15
8473345|NCT00640146|20881347|P2|Received at Least 1 Dose of Study Drug|Overall Study||15
8473346|NCT00640146|20881348|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
8473347|NCT00640146|20881347|P2|STARTED|Overall Study||18
8473348|NCT00640146|20881348|P1|STARTED|Overall Study||19
8473361|NCT00640042|20881381|P1|NOT COMPLETED|Treatment||926
8473362|NCT00640042|20881381|P1|COMPLETED|Treatment||561
8473363|NCT00640042|20881381|P1|STARTED|Treatment||1487
8473364|NCT00640042|20881381|P1|NOT COMPLETED|Enrollment||83
8473365|NCT00640042|20881381|P1|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
8473366|NCT00640042|20881381|P1|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
8473367|NCT00640016|20881397|P4|NOT COMPLETED|Overall Study||3
8473368|NCT00640016|20881398|P3|NOT COMPLETED|Overall Study||3
8473369|NCT00640016|20881399|P2|NOT COMPLETED|Overall Study||2
8473370|NCT00640016|20881400|P1|NOT COMPLETED|Overall Study||2
8473371|NCT00640016|20881397|P4|COMPLETED|Overall Study||1
8473372|NCT00640016|20881398|P3|COMPLETED|Overall Study||1
8473373|NCT00640016|20881399|P2|COMPLETED|Overall Study||1
8473374|NCT00640016|20881400|P1|COMPLETED|Overall Study||1
8473375|NCT00640016|20881397|P4|Treated|Overall Study||4
8473376|NCT00640016|20881398|P3|Treated|Overall Study||4
8473377|NCT00640016|20881399|P2|Treated|Overall Study||2
8473378|NCT00640016|20881400|P1|Treated|Overall Study||3
8473379|NCT00640016|20881397|P4|STARTED|Overall Study||4
8473380|NCT00640016|20881398|P3|STARTED|Overall Study||4
8473381|NCT00640016|20881399|P2|STARTED|Overall Study||3
8473382|NCT00640016|20881400|P1|STARTED|Overall Study||3
8473383|NCT00639860|20881444|P1|NOT COMPLETED|Overall Study||0
8473384|NCT00639860|20881444|P1|COMPLETED|Overall Study||10
8473385|NCT00639860|20881444|P1|STARTED|Overall Study||10
8473386|NCT00639769|20881452|P1|NOT COMPLETED|Overall Study||40
8473387|NCT00639769|20881452|P1|COMPLETED|Overall Study||0
8473388|NCT00639769|20881452|P1|STARTED|Overall Study||40
8473389|NCT00639717|20881457|P1|NOT COMPLETED|Overall Study||0
8473390|NCT00639717|20881457|P1|COMPLETED|Overall Study||48
8473391|NCT00639717|20881457|P1|STARTED|Overall Study||48
8473392|NCT00639678|20881469|P4|NOT COMPLETED|Overall Study||0
8473393|NCT00639678|20881470|P3|NOT COMPLETED|Overall Study||11
8473394|NCT00639678|20881471|P2|NOT COMPLETED|Overall Study||1
8473395|NCT00639678|20881472|P1|NOT COMPLETED|Overall Study||4
8473396|NCT00639678|20881469|P4|COMPLETED|Overall Study||23
8473397|NCT00639678|20881470|P3|COMPLETED|Overall Study||206
8473398|NCT00639678|20881471|P2|COMPLETED|Overall Study||5
8473399|NCT00639678|20881472|P1|COMPLETED|Overall Study||70
8473400|NCT00639678|20881469|P4|STARTED|Overall Study||23
8473401|NCT00639678|20881470|P3|STARTED|Overall Study||217
8473402|NCT00639678|20881471|P2|STARTED|Overall Study||6
8473403|NCT00639678|20881472|P1|STARTED|Overall Study||74
8473404|NCT00639626|20881532|P1|NOT COMPLETED|Overall Study||0
8473405|NCT00639626|20881532|P1|COMPLETED|Overall Study||0
8473406|NCT00639626|20881532|P1|STARTED|Overall Study||0
8473407|NCT00639509|20881537|P1|NOT COMPLETED|Overall Study||1
8473408|NCT00639509|20881537|P1|COMPLETED|Overall Study||23
8473409|NCT00639509|20881537|P1|STARTED|Overall Study||24
8473410|NCT00639457|20881545|P2|NOT COMPLETED|Overall Study||3
8473411|NCT00639457|20881546|P1|NOT COMPLETED|Overall Study||2
8473412|NCT00639457|20881545|P2|COMPLETED|Overall Study||19
8473413|NCT00639457|20881546|P1|COMPLETED|Overall Study||20
8473414|NCT00639457|20881545|P2|STARTED|Overall Study||22
8473415|NCT00639457|20881546|P1|STARTED|Overall Study||22
8473416|NCT00639418|20881584|P4|NOT COMPLETED|Overall Study||0
8473417|NCT00639418|20881585|P3|NOT COMPLETED|Overall Study||0
8473418|NCT00639418|20881586|P2|NOT COMPLETED|Overall Study||0
8473419|NCT00639418|20881587|P1|NOT COMPLETED|Overall Study||0
8473420|NCT00639418|20881584|P4|COMPLETED|Overall Study||46930
8473421|NCT00639418|20881585|P3|COMPLETED|Overall Study||36496
8473422|NCT00639418|20881586|P2|COMPLETED|Overall Study||35967
8473423|NCT00639418|20881587|P1|COMPLETED|Overall Study||28101
8473424|NCT00639418|20881584|P4|STARTED|Overall Study||46930
8473425|NCT00639418|20881585|P3|STARTED|Overall Study||36496
8473426|NCT00639418|20881586|P2|STARTED|Overall Study||35967
8473427|NCT00639418|20881587|P1|STARTED|Overall Study||28101
8473428|NCT00639379|20881605|P2|NOT COMPLETED|Period 2 - 2 Weeks||0
8473429|NCT00639379|20881606|P1|NOT COMPLETED|Period 2 - 2 Weeks||0
8473430|NCT00639379|20881605|P2|COMPLETED|Period 2 - 2 Weeks||45
8473431|NCT00639379|20881606|P1|COMPLETED|Period 2 - 2 Weeks||39
8473432|NCT00639379|20881605|P2|STARTED|Period 2 - 2 Weeks||45
8473433|NCT00639379|20881606|P1|STARTED|Period 2 - 2 Weeks||39
8473434|NCT00639379|20881605|P2|NOT COMPLETED|Period 1 - 2 Weeks||0
8473435|NCT00639379|20881606|P1|NOT COMPLETED|Period 1 - 2 Weeks||5
8473436|NCT00639379|20881605|P2|COMPLETED|Period 1 - 2 Weeks||45
8473437|NCT00639379|20881606|P1|COMPLETED|Period 1 - 2 Weeks||39
8473438|NCT00639379|20881605|P2|STARTED|Period 1 - 2 Weeks||45
8473439|NCT00639379|20881606|P1|STARTED|Period 1 - 2 Weeks||44
8473440|NCT00639223|20881622|P2|NOT COMPLETED|Overall Study||2
8473441|NCT00639223|20881623|P1|NOT COMPLETED|Overall Study||0
8473442|NCT00639223|20881622|P2|COMPLETED|Overall Study||19
8473443|NCT00639223|20881623|P1|COMPLETED|Overall Study||22
8473444|NCT00639223|20881622|P2|STARTED|Overall Study||21
8473445|NCT00639223|20881623|P1|STARTED|Overall Study||22
8473446|NCT00639158|20881633|P2|NOT COMPLETED|Overall Study||30
8473447|NCT00639158|20881634|P1|NOT COMPLETED|Overall Study||26
8473448|NCT00639158|20881633|P2|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
8473449|NCT00639158|20881634|P1|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
8473450|NCT00639158|20881633|P2|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
8473451|NCT00639158|20881634|P1|STARTED|Overall Study|All randomized subjects were treated.|272
8473452|NCT00639093|20881656|P2|NOT COMPLETED|Overall Study||0
8473453|NCT00639093|20881657|P1|NOT COMPLETED|Overall Study||0
8473454|NCT00639093|20881656|P2|COMPLETED|Overall Study|46|46
8473455|NCT00639093|20881657|P1|COMPLETED|Overall Study|45|45
8473456|NCT00639093|20881656|P2|STARTED|Overall Study|46|46
8473457|NCT00639093|20881657|P1|STARTED|Overall Study|45|45
8473458|NCT00639002|20881663|P1|NOT COMPLETED|Overall Study||13
8473459|NCT00639002|20881663|P1|COMPLETED|Overall Study||0
8473460|NCT00639002|20881663|P1|Received Ruxolitinib + Dexamethasone|Overall Study||7
8473461|NCT00639002|20881663|P1|Received Ruxolitinib|Overall Study||13
8473462|NCT00639002|20881663|P1|STARTED|Overall Study||13
8473463|NCT00638989|20881672|P3|NOT COMPLETED|Overall Study||1
8473464|NCT00638989|20881673|P2|NOT COMPLETED|Overall Study||0
8473465|NCT00638989|20881674|P1|NOT COMPLETED|Overall Study||0
8473466|NCT00638989|20881672|P3|COMPLETED|Overall Study||9
8473467|NCT00638989|20881673|P2|COMPLETED|Overall Study||10
8473468|NCT00638989|20881674|P1|COMPLETED|Overall Study||10
8473469|NCT00638989|20881672|P3|STARTED|Overall Study||10
8473470|NCT00638989|20881673|P2|STARTED|Overall Study||10
8473471|NCT00638989|20881674|P1|STARTED|Overall Study||10
8473472|NCT00638963|20881714|P2|NOT COMPLETED|Overall Study||0
8473473|NCT00638963|20881715|P1|NOT COMPLETED|Overall Study||1
8473474|NCT00638963|20881714|P2|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
8473475|NCT00638963|20881715|P1|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
8473476|NCT00638963|20881714|P2|STARTED|Overall Study|Received randomized treatment assignment|3
8473477|NCT00638963|20881715|P1|STARTED|Overall Study|Received randomized treatment assignment|3
8473478|NCT00638937|20881734|P1|NOT COMPLETED|Overall Study||0
8473479|NCT00638937|20881734|P1|COMPLETED|Overall Study||37
8473480|NCT00638937|20881734|P1|STARTED|Overall Study||37
8473481|NCT00638924|20881745|P1|NOT COMPLETED|Overall Study||0
8473482|NCT00638924|20881745|P1|COMPLETED|Overall Study||40
8473483|NCT00638924|20881745|P1|2 Months|Overall Study||40
8473484|NCT00638924|20881745|P1|STARTED|Overall Study||40
8473485|NCT00638885|20881750|P1|NOT COMPLETED|Overall Study||0
8473486|NCT00638885|20881750|P1|COMPLETED|Overall Study||142
8473487|NCT00638885|20881750|P1|STARTED|Overall Study||142
8473488|NCT00638846|20881756|P2|NOT COMPLETED|Overall Study||6
8473489|NCT00638846|20881757|P1|NOT COMPLETED|Overall Study||4
8473490|NCT00638846|20881756|P2|COMPLETED|Overall Study||133
8473491|NCT00638846|20881757|P1|COMPLETED|Overall Study||133
8473492|NCT00638846|20881756|P2|STARTED|Overall Study||139
8473493|NCT00638846|20881757|P1|STARTED|Overall Study||137
8473494|NCT00638820|20881773|P1|NOT COMPLETED|Overall Study||0
8473495|NCT00638820|20881773|P1|COMPLETED|Overall Study||3
8473496|NCT00638820|20881773|P1|STARTED|Overall Study||3
8473497|NCT00638716|20881783|P3|NOT COMPLETED|Overall Study||12
8473498|NCT00638716|20881784|P2|NOT COMPLETED|Overall Study||15
8473499|NCT00638716|20881785|P1|NOT COMPLETED|Overall Study||7
8473500|NCT00638716|20881783|P3|COMPLETED|Overall Study||46
8473501|NCT00638716|20881784|P2|COMPLETED|Overall Study||37
8473502|NCT00638716|20881785|P1|COMPLETED|Overall Study||43
8473503|NCT00638716|20881783|P3|STARTED|Overall Study||58
8473504|NCT00638716|20881784|P2|STARTED|Overall Study||52
8473505|NCT00638716|20881785|P1|STARTED|Overall Study||50
8473506|NCT00638690|20881801|P2|NOT COMPLETED|Overall Study||342
8473507|NCT00638690|20881802|P1|NOT COMPLETED|Overall Study||681
8473508|NCT00638690|20881801|P2|COMPLETED|Overall Study||56
8473509|NCT00638690|20881802|P1|COMPLETED|Overall Study||116
8473510|NCT00638690|20881801|P2|STARTED|Overall Study||398
8473511|NCT00638690|20881802|P1|STARTED|Overall Study||797
8473512|NCT00638651|20881815|P1|NOT COMPLETED|Overall Study||0
8473513|NCT00638651|20881815|P1|COMPLETED|Overall Study||3
8473514|NCT00638651|20881815|P1|STARTED|Overall Study||3
8473515|NCT00638508|20881822|P2|NOT COMPLETED|Overall Study||2
8473516|NCT00638508|20881823|P1|NOT COMPLETED|Overall Study||5
8473517|NCT00638508|20881822|P2|COMPLETED|Overall Study||30
8473518|NCT00638508|20881823|P1|COMPLETED|Overall Study||30
8473519|NCT00638508|20881822|P2|STARTED|Overall Study||32
8473520|NCT00638508|20881823|P1|STARTED|Overall Study||35
8473521|NCT00638456|20881869|P2|NOT COMPLETED|Overall Study||2
8473522|NCT00638456|20881870|P1|NOT COMPLETED|Overall Study||6
8473523|NCT00638456|20881869|P2|COMPLETED|Overall Study||9
8473524|NCT00638456|20881870|P1|COMPLETED|Overall Study||15
8473525|NCT00638456|20881869|P2|STARTED|Overall Study||11
8473526|NCT00638456|20881870|P1|STARTED|Overall Study||21
8473527|NCT00638443|20881880|P2|NOT COMPLETED|Second Intervention||0
8473528|NCT00638443|20881881|P1|NOT COMPLETED|Second Intervention||0
8473529|NCT00638443|20881880|P2|COMPLETED|Second Intervention||14
8473530|NCT00638443|20881881|P1|COMPLETED|Second Intervention||12
8473531|NCT00638443|20881880|P2|STARTED|Second Intervention||14
8473532|NCT00638443|20881881|P1|STARTED|Second Intervention||12
8473533|NCT00638443|20881880|P2|NOT COMPLETED|Washout||0
8473534|NCT00638443|20881881|P1|NOT COMPLETED|Washout||0
8473535|NCT00638443|20881880|P2|COMPLETED|Washout||14
8473536|NCT00638443|20881881|P1|COMPLETED|Washout||12
8473537|NCT00638443|20881880|P2|STARTED|Washout||14
8473538|NCT00638443|20881881|P1|STARTED|Washout||12
8473539|NCT00638443|20881880|P2|NOT COMPLETED|First Intervention||1
8473540|NCT00638443|20881881|P1|NOT COMPLETED|First Intervention||2
8473541|NCT00638443|20881880|P2|COMPLETED|First Intervention||14
8473542|NCT00638443|20881881|P1|COMPLETED|First Intervention||12
8473543|NCT00638443|20881880|P2|STARTED|First Intervention||15
8473544|NCT00638443|20881881|P1|STARTED|First Intervention||14
8473545|NCT00638404|20881911|P2|NOT COMPLETED|Overall Study||0
8473546|NCT00638404|20881912|P1|NOT COMPLETED|Overall Study||8
8473547|NCT00638404|20881911|P2|COMPLETED|Overall Study||100
8473548|NCT00638404|20881912|P1|COMPLETED|Overall Study||192
8473549|NCT00638404|20881911|P2|STARTED|Overall Study||100
8473550|NCT00638404|20881912|P1|STARTED|Overall Study||200
8473551|NCT00638378|20881924|P1|NOT COMPLETED|Overall Study||22
8473552|NCT00638378|20881924|P1|COMPLETED|Overall Study||0
8473553|NCT00638378|20881924|P1|STARTED|Overall Study||22
8473554|NCT00638365|20881934|P3|NOT COMPLETED|Overall Study||0
8473555|NCT00638365|20881935|P2|NOT COMPLETED|Overall Study||0
8473556|NCT00638365|20881936|P1|NOT COMPLETED|Overall Study||0
8473557|NCT00638365|20881934|P3|COMPLETED|Overall Study||8
8473558|NCT00638365|20881935|P2|COMPLETED|Overall Study||10
8473559|NCT00638365|20881936|P1|COMPLETED|Overall Study||9
8473560|NCT00638365|20881934|P3|STARTED|Overall Study||8
8473561|NCT00638365|20881935|P2|STARTED|Overall Study||10
8473562|NCT00638365|20881936|P1|STARTED|Overall Study||9
8473563|NCT00638274|20881946|P2|NOT COMPLETED|Overall Study||5
8473564|NCT00638274|20881947|P1|NOT COMPLETED|Overall Study||6
8473565|NCT00638274|20881946|P2|COMPLETED|Overall Study||172
8473566|NCT00638274|20881947|P1|COMPLETED|Overall Study||173
8473567|NCT00638274|20881946|P2|STARTED|Overall Study||177
8473568|NCT00638274|20881947|P1|STARTED|Overall Study||179
8473569|NCT00638235|20881964|P9|NOT COMPLETED|Overall Study||18
8473570|NCT00638235|20881965|P8|NOT COMPLETED|Overall Study||1
8473571|NCT00638235|20881966|P7|NOT COMPLETED|Overall Study||0
8473572|NCT00638235|20881967|P6|NOT COMPLETED|Overall Study||26
8473573|NCT00638235|20881968|P5|NOT COMPLETED|Overall Study||13
8473574|NCT00638235|20881969|P4|NOT COMPLETED|Overall Study||10
8473575|NCT00638235|20881970|P3|NOT COMPLETED|Overall Study||18
8473576|NCT00638235|20881971|P2|NOT COMPLETED|Overall Study||3
8473577|NCT00638235|20881972|P1|NOT COMPLETED|Overall Study||31
8473578|NCT00638235|20881964|P9|COMPLETED|Overall Study||124
8473579|NCT00638235|20881965|P8|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
8473580|NCT00638235|20881966|P7|COMPLETED|Overall Study||23
8473581|NCT00638235|20881967|P6|COMPLETED|Overall Study||113
8473582|NCT00638235|20881968|P5|COMPLETED|Overall Study||42
8473583|NCT00638235|20881969|P4|COMPLETED|Overall Study||46
8473584|NCT00638235|20881970|P3|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
8473585|NCT00638235|20881971|P2|COMPLETED|Overall Study||23
8473586|NCT00638235|20881972|P1|COMPLETED|Overall Study||110
8473587|NCT00638235|20881964|P9|STARTED|Overall Study||142
8473588|NCT00638235|20881965|P8|STARTED|Overall Study||35
8473589|NCT00638235|20881966|P7|STARTED|Overall Study||23
8473590|NCT00638235|20881967|P6|STARTED|Overall Study||139
8473591|NCT00638235|20881968|P5|STARTED|Overall Study||55
8473592|NCT00638235|20881969|P4|STARTED|Overall Study||56
8473593|NCT00638235|20881970|P3|STARTED|Overall Study||81
8473594|NCT00638235|20881971|P2|STARTED|Overall Study||26
8473595|NCT00638235|20881972|P1|STARTED|Overall Study||141
8473596|NCT00638222|20882373|P3|NOT COMPLETED|Overall Study||0
8473597|NCT00638222|20882374|P2|NOT COMPLETED|Overall Study||0
8473598|NCT00638222|20882375|P1|NOT COMPLETED|Overall Study||0
8473599|NCT00638222|20882373|P3|COMPLETED|Overall Study||6
8473600|NCT00638222|20882374|P2|COMPLETED|Overall Study||0
8473601|NCT00638222|20882375|P1|COMPLETED|Overall Study||0
8473602|NCT00638222|20882373|P3|STARTED|Overall Study||6
8473603|NCT00638222|20882374|P2|STARTED|Overall Study||0
8473604|NCT00638222|20882375|P1|STARTED|Overall Study||0
8473605|NCT00638183|20882382|P1|NOT COMPLETED|Overall Study||119
8473606|NCT00638183|20882382|P1|COMPLETED|Overall Study||266
8473607|NCT00638183|20882382|P1|STARTED|Overall Study||385
8473616|NCT00638027|20882402|P2|NOT COMPLETED|Overall Study||2
8473617|NCT00638027|20882403|P1|NOT COMPLETED|Overall Study||0
8473618|NCT00638027|20882402|P2|COMPLETED|Overall Study|all 10 included in analyses|8
8473619|NCT00638027|20882403|P1|COMPLETED|Overall Study||11
8473620|NCT00638027|20882402|P2|STARTED|Overall Study||10
8473621|NCT00638027|20882403|P1|STARTED|Overall Study||11
8473622|NCT00638014|20882415|P2|NOT COMPLETED|Overall Study||0
8473623|NCT00638014|20882416|P1|NOT COMPLETED|Overall Study||0
8473624|NCT00638014|20882415|P2|COMPLETED|Overall Study||28
8473625|NCT00638014|20882416|P1|COMPLETED|Overall Study||23
8473626|NCT00638014|20882415|P2|STARTED|Overall Study||28
8473627|NCT00638014|20882416|P1|STARTED|Overall Study||23
8473628|NCT00637923|20882426|P2|NOT COMPLETED|Overall Study||19
8473629|NCT00637923|20882427|P1|NOT COMPLETED|Overall Study||30
8473630|NCT00637923|20882426|P2|COMPLETED|Overall Study||18
8473631|NCT00637923|20882427|P1|COMPLETED|Overall Study||45
8473632|NCT00637923|20882426|P2|STARTED|Overall Study||37
8473633|NCT00637923|20882427|P1|STARTED|Overall Study||75
8473634|NCT00637806|20882450|P4|NOT COMPLETED|Extension Phase||1
8473635|NCT00637806|20882451|P3|NOT COMPLETED|Extension Phase||0
8473636|NCT00637806|20882452|P2|NOT COMPLETED|Extension Phase||0
8473637|NCT00637806|20882453|P1|NOT COMPLETED|Extension Phase||0
8473638|NCT00637806|20882450|P4|COMPLETED|Extension Phase||0
8473639|NCT00637806|20882451|P3|COMPLETED|Extension Phase||0
8473640|NCT00637806|20882452|P2|COMPLETED|Extension Phase||0
8473641|NCT00637806|20882453|P1|COMPLETED|Extension Phase||0
8473642|NCT00637806|20882450|P4|STARTED|Extension Phase||1
8473643|NCT00637806|20882451|P3|STARTED|Extension Phase||0
8473644|NCT00637806|20882452|P2|STARTED|Extension Phase||0
8473645|NCT00637806|20882453|P1|STARTED|Extension Phase||0
8473646|NCT00637806|20882450|P4|NOT COMPLETED|Double-blind Phase||0
8473647|NCT00637806|20882451|P3|NOT COMPLETED|Double-blind Phase||1
8473648|NCT00637806|20882452|P2|NOT COMPLETED|Double-blind Phase||0
8473649|NCT00637806|20882453|P1|NOT COMPLETED|Double-blind Phase||2
8473650|NCT00637806|20882450|P4|COMPLETED|Double-blind Phase||0
8473651|NCT00637806|20882451|P3|COMPLETED|Double-blind Phase||1
8473652|NCT00637806|20882452|P2|COMPLETED|Double-blind Phase||0
8473653|NCT00637806|20882453|P1|COMPLETED|Double-blind Phase||0
8473654|NCT00637806|20882450|P4|STARTED|Double-blind Phase||0
8473655|NCT00637806|20882451|P3|STARTED|Double-blind Phase||2
8473656|NCT00637806|20882452|P2|STARTED|Double-blind Phase||0
8473657|NCT00637806|20882453|P1|STARTED|Double-blind Phase||2
8473658|NCT00637780|20882471|P1|NOT COMPLETED|Overall Study||0
8473659|NCT00637780|20882471|P1|COMPLETED|Overall Study||2
8473660|NCT00637780|20882471|P1|STARTED|Overall Study||2
8473661|NCT00637728|20882488|P3|NOT COMPLETED|Extension Phase||0
8473662|NCT00637728|20882489|P2|NOT COMPLETED|Extension Phase||0
8473663|NCT00637728|20882490|P1|NOT COMPLETED|Extension Phase||0
8473664|NCT00637728|20882488|P3|COMPLETED|Extension Phase||0
8473665|NCT00637728|20882489|P2|COMPLETED|Extension Phase||0
8473666|NCT00637728|20882490|P1|COMPLETED|Extension Phase||0
8473667|NCT00637728|20882488|P3|STARTED|Extension Phase||0
8473668|NCT00637728|20882489|P2|STARTED|Extension Phase||0
8473669|NCT00637728|20882490|P1|STARTED|Extension Phase||0
8473670|NCT00637728|20882488|P3|NOT COMPLETED|Double-blind Phase||0
8473671|NCT00637728|20882489|P2|NOT COMPLETED|Double-blind Phase||1
8473672|NCT00637728|20882490|P1|NOT COMPLETED|Double-blind Phase||4
8473673|NCT00637728|20882488|P3|COMPLETED|Double-blind Phase||0
8473674|NCT00637728|20882489|P2|COMPLETED|Double-blind Phase||0
8473675|NCT00637728|20882490|P1|COMPLETED|Double-blind Phase||0
8473676|NCT00637728|20882488|P3|STARTED|Double-blind Phase||0
8473677|NCT00637728|20882489|P2|STARTED|Double-blind Phase||1
8473678|NCT00637728|20882490|P1|STARTED|Double-blind Phase||4
8473679|NCT00637572|20882505|P2|NOT COMPLETED|Overall Study||7
8473680|NCT00637572|20882506|P1|NOT COMPLETED|Overall Study||3
8473681|NCT00637572|20882505|P2|COMPLETED|Overall Study||24
8473682|NCT00637572|20882506|P1|COMPLETED|Overall Study||29
8473683|NCT00637572|20882505|P2|STARTED|Overall Study||31
8473684|NCT00637572|20882506|P1|STARTED|Overall Study||32
8473685|NCT00637494|20882534|P2|NOT COMPLETED|Overall Study||43
8473686|NCT00637494|20882535|P1|NOT COMPLETED|Overall Study||32
8473687|NCT00637494|20882534|P2|COMPLETED|Overall Study||108
8473688|NCT00637494|20882535|P1|COMPLETED|Overall Study||109
8473689|NCT00637494|20882534|P2|STARTED|Overall Study||151
8473690|NCT00637494|20882535|P1|STARTED|Overall Study||141
8473691|NCT00637416|20882545|P2|NOT COMPLETED|Overall Study||2
8473692|NCT00637416|20882546|P1|NOT COMPLETED|Overall Study||1
8473693|NCT00637416|20882545|P2|COMPLETED|Overall Study||3
8473694|NCT00637416|20882546|P1|COMPLETED|Overall Study||3
8473695|NCT00637416|20882545|P2|STARTED|Overall Study||5
8473696|NCT00637416|20882546|P1|STARTED|Overall Study||4
8473697|NCT00637377|20882556|P4|NOT COMPLETED|Overall Study||29
8473698|NCT00637377|20882557|P3|NOT COMPLETED|Overall Study||37
8473699|NCT00637377|20882558|P2|NOT COMPLETED|Overall Study||32
8473700|NCT00637377|20882559|P1|NOT COMPLETED|Overall Study||27
8473701|NCT00637377|20882556|P4|COMPLETED|Overall Study||284
8473702|NCT00637377|20882557|P3|COMPLETED|Overall Study||274
8473703|NCT00637377|20882558|P2|COMPLETED|Overall Study||281
8473704|NCT00637377|20882559|P1|COMPLETED|Overall Study||276
8473705|NCT00637377|20882556|P4|Participants Treated (FAS)|Overall Study||306
8473706|NCT00637377|20882557|P3|Participants Treated (FAS)|Overall Study||296
8473707|NCT00637377|20882558|P2|Participants Treated (FAS)|Overall Study||309
8473708|NCT00637377|20882559|P1|Participants Treated (FAS)|Overall Study||291
8473709|NCT00637377|20882556|P4|Participants Received Treatment|Overall Study|safety population|307
8473710|NCT00637377|20882557|P3|Participants Received Treatment|Overall Study|safety population|297
8473711|NCT00637377|20882558|P2|Participants Received Treatment|Overall Study|safety population|309
8473712|NCT00637377|20882559|P1|Participants Received Treatment|Overall Study|safety population|291
8473713|NCT00637377|20882556|P4|STARTED|Overall Study||313
8473714|NCT00637377|20882557|P3|STARTED|Overall Study||311
8473715|NCT00637377|20882558|P2|STARTED|Overall Study||313
8473716|NCT00637377|20882559|P1|STARTED|Overall Study||303
8473717|NCT00637312|20882587|P2|NOT COMPLETED|Overall Study||17
8473718|NCT00637312|20882588|P1|NOT COMPLETED|Overall Study||42
8473719|NCT00637312|20882587|P2|COMPLETED|Overall Study||19
8473720|NCT00637312|20882588|P1|COMPLETED|Overall Study||30
8473721|NCT00637312|20882587|P2|STARTED|Overall Study||36
8473722|NCT00637312|20882588|P1|STARTED|Overall Study||72
8473723|NCT00637299|20882596|P2|NOT COMPLETED|Overall Study||0
8473724|NCT00637299|20882597|P1|NOT COMPLETED|Overall Study||0
8473725|NCT00637299|20882596|P2|COMPLETED|Overall Study||10
8473726|NCT00637299|20882597|P1|COMPLETED|Overall Study||10
8473727|NCT00637299|20882596|P2|STARTED|Overall Study||10
8473728|NCT00637299|20882597|P1|STARTED|Overall Study||10
8473729|NCT00637273|20882608|P3|NOT COMPLETED|Overall Study||41
8473730|NCT00637273|20882609|P2|NOT COMPLETED|Overall Study||28
8473731|NCT00637273|20882610|P1|NOT COMPLETED|Overall Study||43
8473732|NCT00637273|20882608|P3|COMPLETED|Overall Study||131
8473733|NCT00637273|20882609|P2|COMPLETED|Overall Study||144
8473734|NCT00637273|20882610|P1|COMPLETED|Overall Study||127
8473735|NCT00637273|20882608|P3|Intent to Treat (ITT)|Overall Study||165
8473736|NCT00637273|20882609|P2|Intent to Treat (ITT)|Overall Study||166
8473737|NCT00637273|20882610|P1|Intent to Treat (ITT)|Overall Study||160
8473738|NCT00637273|20882608|P3|STARTED|Overall Study||172
8473739|NCT00637273|20882609|P2|STARTED|Overall Study||172
8473740|NCT00637273|20882610|P1|STARTED|Overall Study||170
8473741|NCT00637247|20882653|P2|NOT COMPLETED|Overall Study||0
8473742|NCT00637247|20882654|P1|NOT COMPLETED|Overall Study||0
8473743|NCT00637247|20882653|P2|COMPLETED|Overall Study||70
8473744|NCT00637247|20882654|P1|COMPLETED|Overall Study||72
8473745|NCT00637247|20882653|P2|STARTED|Overall Study||70
8473746|NCT00637247|20882654|P1|STARTED|Overall Study||72
8473747|NCT00637195|20882668|P2|NOT COMPLETED|Overall Study||1
8473748|NCT00637195|20882669|P1|NOT COMPLETED|Overall Study||3
8473749|NCT00637195|20882668|P2|COMPLETED|Overall Study||75
8473750|NCT00637195|20882669|P1|COMPLETED|Overall Study||73
8473751|NCT00637195|20882668|P2|STARTED|Overall Study||76
8473752|NCT00637195|20882669|P1|STARTED|Overall Study||76
8473753|NCT00637156|20882705|P2|NOT COMPLETED|Overall Study||24
8473754|NCT00637156|20882706|P1|NOT COMPLETED|Overall Study||10
8473755|NCT00637156|20882705|P2|COMPLETED|Overall Study||164
8473756|NCT00637156|20882706|P1|COMPLETED|Overall Study||199
8473757|NCT00637156|20882705|P2|STARTED|Overall Study||188
8473758|NCT00637156|20882706|P1|STARTED|Overall Study||209
8473759|NCT00637000|20882748|P2|NOT COMPLETED|Overall Study||3
8473760|NCT00637000|20882749|P1|NOT COMPLETED|Overall Study||4
8473761|NCT00637000|20882748|P2|COMPLETED|Overall Study||15
8473762|NCT00637000|20882749|P1|COMPLETED|Overall Study||16
8473763|NCT00637000|20882748|P2|Evaluable|Overall Study||16
8473764|NCT00637000|20882749|P1|Evaluable|Overall Study||18
8473765|NCT00637000|20882748|P2|STARTED|Overall Study|Randomized and treated|18
8473766|NCT00637000|20882749|P1|STARTED|Overall Study|Randomized and treated|20
8473767|NCT00636987|20882789|P1|NOT COMPLETED|Overall Study||189
8473768|NCT00636987|20882789|P1|COMPLETED|Overall Study||108
8473769|NCT00636987|20882789|P1|STARTED|Overall Study||297
8473770|NCT00636961|20882799|P2|NOT COMPLETED|Period 2||0
8473771|NCT00636961|20882800|P1|NOT COMPLETED|Period 2||1
8473772|NCT00636961|20882799|P2|COMPLETED|Period 2||12
8473773|NCT00636961|20882800|P1|COMPLETED|Period 2||12
8473774|NCT00636961|20882799|P2|STARTED|Period 2||12
8473775|NCT00636961|20882800|P1|STARTED|Period 2||13
8473776|NCT00636961|20882799|P2|NOT COMPLETED|Period 1||1
8473777|NCT00636961|20882800|P1|NOT COMPLETED|Period 1||1
8473778|NCT00636961|20882799|P2|COMPLETED|Period 1||12
8473779|NCT00636961|20882800|P1|COMPLETED|Period 1||13
8473780|NCT00636961|20882799|P2|STARTED|Period 1||13
8473781|NCT00636961|20882800|P1|STARTED|Period 1||14
8473782|NCT00636818|20882814|P1|NOT COMPLETED|Overall Study||11
8473783|NCT00636818|20882814|P1|COMPLETED|Overall Study||34
8473784|NCT00636818|20882814|P1|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
8473785|NCT00636818|20882814|P1|STARTED|Overall Study||45
8473786|NCT00636805|20882829|P1|NOT COMPLETED|Overall Study||0
8473787|NCT00636805|20882829|P1|COMPLETED|Overall Study||63
8473788|NCT00636805|20882829|P1|STARTED|Overall Study||63
8473789|NCT00636792|20882839|P1|NOT COMPLETED|Overall Study||33
8473790|NCT00636792|20882839|P1|COMPLETED|Overall Study||40
8473791|NCT00636792|20882839|P1|STARTED|Overall Study||73
8473792|NCT00636701|20882846|P2|NOT COMPLETED|Overall Study||0
8473793|NCT00636701|20882847|P1|NOT COMPLETED|Overall Study||0
8473794|NCT00636701|20882846|P2|COMPLETED|Overall Study||2
8473795|NCT00636701|20882847|P1|COMPLETED|Overall Study||2
8473796|NCT00636701|20882846|P2|STARTED|Overall Study||2
8473797|NCT00636701|20882847|P1|STARTED|Overall Study||2
8473798|NCT00636675|20882855|P2|NOT COMPLETED|Overall Study||41
8473799|NCT00636675|20882856|P1|NOT COMPLETED|Overall Study||140
8473800|NCT00636675|20882855|P2|COMPLETED|Overall Study||734
8473801|NCT00636675|20882856|P1|COMPLETED|Overall Study||811
8473802|NCT00636675|20882855|P2|STARTED|Overall Study||775
8473803|NCT00636675|20882856|P1|STARTED|Overall Study||951
8473804|NCT00636649|20882868|P2|NOT COMPLETED|Overall Study||0
8473805|NCT00636649|20882869|P1|NOT COMPLETED|Overall Study||0
8473806|NCT00636649|20882868|P2|COMPLETED|Overall Study||20
8473807|NCT00636649|20882869|P1|COMPLETED|Overall Study||20
8473808|NCT00636649|20882868|P2|STARTED|Overall Study||20
8473809|NCT00636649|20882869|P1|STARTED|Overall Study||20
8473810|NCT00636636|20882899|P2|NOT COMPLETED|Overall Study||39
8473811|NCT00636636|20882900|P1|NOT COMPLETED|Overall Study||36
8473812|NCT00636636|20882899|P2|COMPLETED|Overall Study||192
8473813|NCT00636636|20882900|P1|COMPLETED|Overall Study||185
8473814|NCT00636636|20882899|P2|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
8473815|NCT00636636|20882900|P1|379|Overall Study||186
8473816|NCT00636636|20882899|P2|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
8473817|NCT00636636|20882900|P1|Safety & Efficacy of Gabapentin ER|Overall Study||186
8473818|NCT00636636|20882899|P2|STARTED|Overall Study||231
8473819|NCT00636636|20882900|P1|STARTED|Overall Study||221
8473820|NCT00636610|20882916|P2|NOT COMPLETED|Overall Study||83
8473821|NCT00636610|20882917|P1|NOT COMPLETED|Overall Study||92
8473822|NCT00636610|20882916|P2|COMPLETED|Overall Study||18
8473823|NCT00636610|20882917|P1|COMPLETED|Overall Study||6
8473824|NCT00636610|20882916|P2|STARTED|Overall Study||101
8473825|NCT00636610|20882917|P1|STARTED|Overall Study||98
8473826|NCT00636506|20882927|P1|NOT COMPLETED|Overall Study||16
8473827|NCT00636506|20882927|P1|COMPLETED|Overall Study||60
8473828|NCT00636506|20882927|P1|STARTED|Overall Study||76
8473829|NCT00636441|20882974|P7|NOT COMPLETED|Overall Study||18
8473830|NCT00636441|20882975|P6|NOT COMPLETED|Overall Study||1
8473831|NCT00636441|20882976|P5|NOT COMPLETED|Overall Study||0
8473832|NCT00636441|20882977|P4|NOT COMPLETED|Overall Study||0
8473833|NCT00636441|20882978|P3|NOT COMPLETED|Overall Study||1
8473834|NCT00636441|20882979|P2|NOT COMPLETED|Overall Study||1
8473835|NCT00636441|20882980|P1|NOT COMPLETED|Overall Study||0
8473836|NCT00636441|20882974|P7|COMPLETED|Overall Study||0
8473837|NCT00636441|20882975|P6|COMPLETED|Overall Study||6
8473838|NCT00636441|20882976|P5|COMPLETED|Overall Study||6
8473839|NCT00636441|20882977|P4|COMPLETED|Overall Study||6
8473840|NCT00636441|20882978|P3|COMPLETED|Overall Study||5
8473841|NCT00636441|20882979|P2|COMPLETED|Overall Study||6
8473842|NCT00636441|20882980|P1|COMPLETED|Overall Study||6
8473843|NCT00636441|20882974|P7|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
8473844|NCT00636441|20882975|P6|Assigned Treatment|Overall Study||7
8473845|NCT00636441|20882976|P5|Assigned Treatment|Overall Study||6
8473846|NCT00636441|20882977|P4|Assigned Treatment|Overall Study||6
8473847|NCT00636441|20882978|P3|Assigned Treatment|Overall Study||6
8473848|NCT00636441|20882979|P2|Assigned Treatment|Overall Study||7
8473849|NCT00636441|20882980|P1|Assigned Treatment|Overall Study||6
8473850|NCT00636441|20882974|P7|STARTED|Overall Study||18
8473851|NCT00636441|20882975|P6|STARTED|Overall Study||7
8473852|NCT00636441|20882976|P5|STARTED|Overall Study||6
8473853|NCT00636441|20882977|P4|STARTED|Overall Study||6
8473854|NCT00636441|20882978|P3|STARTED|Overall Study||6
8473855|NCT00636441|20882979|P2|STARTED|Overall Study||7
8473856|NCT00636441|20882980|P1|STARTED|Overall Study||6
8473857|NCT00636389|20883009|P2|NOT COMPLETED|Period 2 - 1 Week||0
8473858|NCT00636389|20883010|P1|NOT COMPLETED|Period 2 - 1 Week||0
8473859|NCT00636389|20883009|P2|COMPLETED|Period 2 - 1 Week||5
8473860|NCT00636389|20883010|P1|COMPLETED|Period 2 - 1 Week||7
8473861|NCT00636389|20883009|P2|STARTED|Period 2 - 1 Week||5
8473862|NCT00636389|20883010|P1|STARTED|Period 2 - 1 Week||7
8473863|NCT00636389|20883009|P2|NOT COMPLETED|Period 1 - 1 Week||0
8473864|NCT00636389|20883010|P1|NOT COMPLETED|Period 1 - 1 Week||0
8473865|NCT00636389|20883009|P2|COMPLETED|Period 1 - 1 Week||5
8473866|NCT00636389|20883010|P1|COMPLETED|Period 1 - 1 Week||7
8473867|NCT00636389|20883009|P2|STARTED|Period 1 - 1 Week||5
8473868|NCT00636389|20883010|P1|STARTED|Period 1 - 1 Week||7
8473869|NCT00636363|20883023|P3|NOT COMPLETED|Overall Study||18
8473870|NCT00636363|20883024|P2|NOT COMPLETED|Overall Study||20
8473871|NCT00636363|20883025|P1|NOT COMPLETED|Overall Study||13
8473872|NCT00636363|20883023|P3|COMPLETED|Overall Study||163
8473873|NCT00636363|20883024|P2|COMPLETED|Overall Study||156
8473874|NCT00636363|20883025|P1|COMPLETED|Overall Study||165
8473875|NCT00636363|20883023|P3|STARTED|Overall Study||181
8473876|NCT00636363|20883024|P2|STARTED|Overall Study||176
8473877|NCT00636363|20883025|P1|STARTED|Overall Study||178
8473878|NCT00636220|20883039|P1|NOT COMPLETED|Overall Study||0
8473879|NCT00636220|20883039|P1|COMPLETED|Overall Study||101
8473880|NCT00636220|20883039|P1|STARTED|Overall Study||101
8473881|NCT00636207|20883046|P7|NOT COMPLETED|Overall Study||0
8473882|NCT00636207|20883047|P6|NOT COMPLETED|Overall Study||0
8473883|NCT00636207|20883048|P5|NOT COMPLETED|Overall Study||1
8473884|NCT00636207|20883049|P4|NOT COMPLETED|Overall Study||0
8473885|NCT00636207|20883050|P3|NOT COMPLETED|Overall Study||0
8473886|NCT00636207|20883051|P2|NOT COMPLETED|Overall Study||1
8473887|NCT00636207|20883052|P1|NOT COMPLETED|Overall Study||1
8473888|NCT00636207|20883046|P7|COMPLETED|Overall Study||3
8473889|NCT00636207|20883047|P6|COMPLETED|Overall Study||1
8473890|NCT00636207|20883048|P5|COMPLETED|Overall Study||8
8473891|NCT00636207|20883049|P4|COMPLETED|Overall Study||6
8473892|NCT00636207|20883050|P3|COMPLETED|Overall Study||18
8473893|NCT00636207|20883051|P2|COMPLETED|Overall Study||7
8473894|NCT00636207|20883052|P1|COMPLETED|Overall Study||0
8473895|NCT00636207|20883046|P7|STARTED|Overall Study||3
8473896|NCT00636207|20883047|P6|STARTED|Overall Study||1
8473897|NCT00636207|20883048|P5|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
8473898|NCT00636207|20883049|P4|STARTED|Overall Study||6
8473899|NCT00636207|20883050|P3|STARTED|Overall Study||18
8473900|NCT00636207|20883051|P2|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
8473901|NCT00636207|20883052|P1|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
8473902|NCT00636194|20883116|P2|NOT COMPLETED|Overall Study||0
8473903|NCT00636194|20883117|P1|NOT COMPLETED|Overall Study||3
8473904|NCT00636194|20883116|P2|COMPLETED|Overall Study||175
8473905|NCT00636194|20883117|P1|COMPLETED|Overall Study||172
8473906|NCT00636194|20883116|P2|STARTED|Overall Study||175
8473907|NCT00636194|20883117|P1|STARTED|Overall Study||175
8473908|NCT00636181|20883130|P3|NOT COMPLETED|Overall Study||10
8473909|NCT00636181|20883131|P2|NOT COMPLETED|Overall Study||6
8473910|NCT00636181|20883132|P1|NOT COMPLETED|Overall Study||8
8473911|NCT00636181|20883130|P3|COMPLETED|Overall Study||47
8473912|NCT00636181|20883131|P2|COMPLETED|Overall Study||47
8473913|NCT00636181|20883132|P1|COMPLETED|Overall Study||46
8473914|NCT00636181|20883130|P3|STARTED|Overall Study||57
8473915|NCT00636181|20883131|P2|STARTED|Overall Study||53
8473916|NCT00636181|20883132|P1|STARTED|Overall Study||54
8473917|NCT00636168|20883160|P2|NOT COMPLETED|Long Term Follow-Up||14
8473918|NCT00636168|20883161|P1|NOT COMPLETED|Long Term Follow-Up||11
8473919|NCT00636168|20883160|P2|COMPLETED|Long Term Follow-Up||129
8473920|NCT00636168|20883161|P1|COMPLETED|Long Term Follow-Up||130
8473921|NCT00636168|20883160|P2|STARTED|Long Term Follow-Up||143
8473922|NCT00636168|20883161|P1|STARTED|Long Term Follow-Up||141
8473923|NCT00636168|20883160|P2|NOT COMPLETED|Treated With Study Drug||331
8473924|NCT00636168|20883161|P1|NOT COMPLETED|Treated With Study Drug||408
8473925|NCT00636168|20883160|P2|COMPLETED|Treated With Study Drug||143
8473926|NCT00636168|20883161|P1|COMPLETED|Treated With Study Drug||63
8473927|NCT00636168|20883160|P2|STARTED|Treated With Study Drug||474
8473928|NCT00636168|20883161|P1|STARTED|Treated With Study Drug||471
8473929|NCT00636168|20883160|P2|NOT COMPLETED|Randomized to Study Drug||2
8473930|NCT00636168|20883161|P1|NOT COMPLETED|Randomized to Study Drug||4
8473931|NCT00636168|20883160|P2|COMPLETED|Randomized to Study Drug||474
8473932|NCT00636168|20883161|P1|COMPLETED|Randomized to Study Drug||471
8473933|NCT00636168|20883160|P2|STARTED|Randomized to Study Drug||476
8473934|NCT00636168|20883161|P1|STARTED|Randomized to Study Drug||475
8473935|NCT00636155|20883189|P1|NOT COMPLETED|Overall Study||18
8473936|NCT00636155|20883189|P1|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
8473937|NCT00636155|20883189|P1|STARTED|Overall Study||20
8473938|NCT00636077|20883195|P4|NOT COMPLETED|Week 4||0
8473939|NCT00636077|20883196|P3|NOT COMPLETED|Week 4||0
8473940|NCT00636077|20883197|P2|NOT COMPLETED|Week 4||0
8473941|NCT00636077|20883198|P1|NOT COMPLETED|Week 4||0
8473942|NCT00636077|20883195|P4|COMPLETED|Week 4||3
8473943|NCT00636077|20883196|P3|COMPLETED|Week 4||3
8473944|NCT00636077|20883197|P2|COMPLETED|Week 4||3
8473945|NCT00636077|20883198|P1|COMPLETED|Week 4||3
8473946|NCT00636077|20883195|P4|STARTED|Week 4||3
8473947|NCT00636077|20883196|P3|STARTED|Week 4||3
8473948|NCT00636077|20883197|P2|STARTED|Week 4||3
8473949|NCT00636077|20883198|P1|STARTED|Week 4||3
8473950|NCT00636077|20883195|P4|NOT COMPLETED|Week 3||0
8473951|NCT00636077|20883196|P3|NOT COMPLETED|Week 3||0
8473952|NCT00636077|20883197|P2|NOT COMPLETED|Week 3||0
8473953|NCT00636077|20883198|P1|NOT COMPLETED|Week 3||0
8473954|NCT00636077|20883195|P4|COMPLETED|Week 3||3
8473955|NCT00636077|20883196|P3|COMPLETED|Week 3||3
8473956|NCT00636077|20883197|P2|COMPLETED|Week 3||3
8473957|NCT00636077|20883198|P1|COMPLETED|Week 3||3
8473958|NCT00636077|20883195|P4|STARTED|Week 3||3
8473959|NCT00636077|20883196|P3|STARTED|Week 3||3
8473960|NCT00636077|20883197|P2|STARTED|Week 3||3
8473961|NCT00636077|20883198|P1|STARTED|Week 3||3
8473962|NCT00636077|20883195|P4|NOT COMPLETED|Week 2||0
8473963|NCT00636077|20883196|P3|NOT COMPLETED|Week 2||0
8473964|NCT00636077|20883197|P2|NOT COMPLETED|Week 2||0
8473965|NCT00636077|20883198|P1|NOT COMPLETED|Week 2||0
8473966|NCT00636077|20883195|P4|COMPLETED|Week 2||3
8473967|NCT00636077|20883196|P3|COMPLETED|Week 2||3
8473968|NCT00636077|20883197|P2|COMPLETED|Week 2||3
8473969|NCT00636077|20883198|P1|COMPLETED|Week 2||3
8473970|NCT00636077|20883195|P4|STARTED|Week 2||3
8473971|NCT00636077|20883196|P3|STARTED|Week 2||3
8473972|NCT00636077|20883197|P2|STARTED|Week 2||3
8473973|NCT00636077|20883198|P1|STARTED|Week 2||3
8473974|NCT00636077|20883195|P4|NOT COMPLETED|Week 1||0
8473975|NCT00636077|20883196|P3|NOT COMPLETED|Week 1||0
8473976|NCT00636077|20883197|P2|NOT COMPLETED|Week 1||0
8473977|NCT00636077|20883198|P1|NOT COMPLETED|Week 1||0
8473978|NCT00636077|20883195|P4|COMPLETED|Week 1||3
8473979|NCT00636077|20883196|P3|COMPLETED|Week 1||3
8473980|NCT00636077|20883197|P2|COMPLETED|Week 1||3
8473981|NCT00636077|20883198|P1|COMPLETED|Week 1||3
8473982|NCT00636077|20883195|P4|STARTED|Week 1||3
8473983|NCT00636077|20883196|P3|STARTED|Week 1||3
8473984|NCT00636077|20883197|P2|STARTED|Week 1||3
8473985|NCT00636077|20883198|P1|STARTED|Week 1||3
8473986|NCT00635999|20883231|P3|NOT COMPLETED|Overall Study||1
8473987|NCT00635999|20883232|P2|NOT COMPLETED|Overall Study||2
8473988|NCT00635999|20883233|P1|NOT COMPLETED|Overall Study||4
8473989|NCT00635999|20883231|P3|COMPLETED|Overall Study||23
8473990|NCT00635999|20883232|P2|COMPLETED|Overall Study||23
8473991|NCT00635999|20883233|P1|COMPLETED|Overall Study||23
8473992|NCT00635999|20883231|P3|STARTED|Overall Study||24
8473993|NCT00635999|20883232|P2|STARTED|Overall Study||25
8473994|NCT00635999|20883233|P1|STARTED|Overall Study||27
8473995|NCT00635882|20883250|P6|NOT COMPLETED|Overall Study||0
8473996|NCT00635882|20883251|P5|NOT COMPLETED|Overall Study||0
8473997|NCT00635882|20883252|P4|NOT COMPLETED|Overall Study||0
8473998|NCT00635882|20883253|P3|NOT COMPLETED|Overall Study||0
8473999|NCT00635882|20883254|P2|NOT COMPLETED|Overall Study||0
8474000|NCT00635882|20883255|P1|NOT COMPLETED|Overall Study||1
8474001|NCT00635882|20883250|P6|COMPLETED|Overall Study||13
8474002|NCT00635882|20883251|P5|COMPLETED|Overall Study||16
8474003|NCT00635882|20883252|P4|COMPLETED|Overall Study||15
8474004|NCT00635882|20883253|P3|COMPLETED|Overall Study||12
8474005|NCT00635882|20883254|P2|COMPLETED|Overall Study||17
8474006|NCT00635882|20883255|P1|COMPLETED|Overall Study||19
8474007|NCT00635882|20883250|P6|STARTED|Overall Study||13
8474008|NCT00635882|20883251|P5|STARTED|Overall Study||16
8474009|NCT00635882|20883252|P4|STARTED|Overall Study||15
8474010|NCT00635882|20883253|P3|STARTED|Overall Study||12
8474011|NCT00635882|20883254|P2|STARTED|Overall Study||17
8474012|NCT00635882|20883255|P1|STARTED|Overall Study||20
8474013|NCT00635830|20883319|P2|NOT COMPLETED|Overall Study||0
8474014|NCT00635830|20883320|P1|NOT COMPLETED|Overall Study||0
8474015|NCT00635830|20883319|P2|COMPLETED|Overall Study||20
8474016|NCT00635830|20883320|P1|COMPLETED|Overall Study||20
8474017|NCT00635830|20883319|P2|STARTED|Overall Study||20
8474018|NCT00635830|20883320|P1|STARTED|Overall Study||20
8474019|NCT00635817|20883330|P4|NOT COMPLETED|Overall Study||0
8474020|NCT00635817|20883331|P3|NOT COMPLETED|Overall Study||2
8474021|NCT00635817|20883332|P2|NOT COMPLETED|Overall Study||2
8474022|NCT00635817|20883333|P1|NOT COMPLETED|Overall Study||6
8474023|NCT00635817|20883330|P4|COMPLETED|Overall Study||21
8474024|NCT00635817|20883331|P3|COMPLETED|Overall Study||19
8474025|NCT00635817|20883332|P2|COMPLETED|Overall Study||19
8474026|NCT00635817|20883333|P1|COMPLETED|Overall Study||15
8474027|NCT00635817|20883330|P4|STARTED|Overall Study||21
8474028|NCT00635817|20883331|P3|STARTED|Overall Study||21
8474029|NCT00635817|20883332|P2|STARTED|Overall Study||21
8474030|NCT00635817|20883333|P1|STARTED|Overall Study||21
8474031|NCT00635804|20883385|P8|NOT COMPLETED|Overall Study||0
8474032|NCT00635804|20883386|P7|NOT COMPLETED|Overall Study||0
8474033|NCT00635804|20883387|P6|NOT COMPLETED|Overall Study||1
8474034|NCT00635804|20883388|P5|NOT COMPLETED|Overall Study||0
8474035|NCT00635804|20883389|P4|NOT COMPLETED|Overall Study||0
8474036|NCT00635804|20883390|P3|NOT COMPLETED|Overall Study||0
8474037|NCT00635804|20883391|P2|NOT COMPLETED|Overall Study||0
8474038|NCT00635804|20883392|P1|NOT COMPLETED|Overall Study||1
8474039|NCT00635804|20883385|P8|COMPLETED|Overall Study||14
8474040|NCT00635804|20883386|P7|COMPLETED|Overall Study||3
8474041|NCT00635804|20883387|P6|COMPLETED|Overall Study||11
8474042|NCT00635804|20883388|P5|COMPLETED|Overall Study||6
8474043|NCT00635804|20883389|P4|COMPLETED|Overall Study||6
8474044|NCT00635804|20883390|P3|COMPLETED|Overall Study||6
8474045|NCT00635804|20883391|P2|COMPLETED|Overall Study||6
8474046|NCT00635804|20883392|P1|COMPLETED|Overall Study||6
8474047|NCT00635804|20883385|P8|STARTED|Overall Study||14
8474048|NCT00635804|20883386|P7|STARTED|Overall Study||3
8474049|NCT00635804|20883387|P6|STARTED|Overall Study||12
8474050|NCT00635804|20883388|P5|STARTED|Overall Study||6
8474051|NCT00635804|20883389|P4|STARTED|Overall Study||6
8474052|NCT00635804|20883390|P3|STARTED|Overall Study||6
8474053|NCT00635804|20883391|P2|STARTED|Overall Study||6
8474054|NCT00635804|20883392|P1|STARTED|Overall Study||7
8474055|NCT00635778|20883496|P7|NOT COMPLETED|Overall Study||6
8474056|NCT00635778|20883497|P6|NOT COMPLETED|Overall Study||21
8474057|NCT00635778|20883498|P5|NOT COMPLETED|Overall Study||8
8474058|NCT00635778|20883499|P4|NOT COMPLETED|Overall Study||8
8474059|NCT00635778|20883500|P3|NOT COMPLETED|Overall Study||3
8474060|NCT00635778|20883501|P2|NOT COMPLETED|Overall Study||3
8474061|NCT00635778|20883502|P1|NOT COMPLETED|Overall Study||1
8474062|NCT00635778|20883496|P7|COMPLETED|Overall Study||0
8474063|NCT00635778|20883497|P6|COMPLETED|Overall Study||0
8474064|NCT00635778|20883498|P5|COMPLETED|Overall Study||0
8474065|NCT00635778|20883499|P4|COMPLETED|Overall Study||0
8474066|NCT00635778|20883500|P3|COMPLETED|Overall Study||0
8474067|NCT00635778|20883501|P2|COMPLETED|Overall Study||0
8474068|NCT00635778|20883502|P1|COMPLETED|Overall Study||0
8474069|NCT00635778|20883496|P7|STARTED|Overall Study||6
8474070|NCT00635778|20883497|P6|STARTED|Overall Study||21
8474071|NCT00635778|20883498|P5|STARTED|Overall Study||8
8474072|NCT00635778|20883499|P4|STARTED|Overall Study||8
8474073|NCT00635778|20883500|P3|STARTED|Overall Study||3
8474074|NCT00635778|20883501|P2|STARTED|Overall Study||3
8474075|NCT00635778|20883502|P1|STARTED|Overall Study||1
8474076|NCT00635739|20883555|P2|NOT COMPLETED|Overall Study||2
8474077|NCT00635739|20883556|P1|NOT COMPLETED|Overall Study||3
8474078|NCT00635739|20883555|P2|COMPLETED|Overall Study||36
8474079|NCT00635739|20883556|P1|COMPLETED|Overall Study||39
8474080|NCT00635739|20883555|P2|STARTED|Overall Study||38
8474081|NCT00635739|20883556|P1|STARTED|Overall Study||42
8474082|NCT00635700|20883566|P2|NOT COMPLETED|Overall Study||14
8474083|NCT00635700|20883567|P1|NOT COMPLETED|Overall Study||15
8474084|NCT00635700|20883566|P2|COMPLETED|Overall Study||13
8474085|NCT00635700|20883567|P1|COMPLETED|Overall Study||9
8474086|NCT00635700|20883566|P2|STARTED|Overall Study||27
8474087|NCT00635700|20883567|P1|STARTED|Overall Study||24
8474088|NCT00635661|20883573|P1|NOT COMPLETED|Overall Study||4
8474089|NCT00635661|20883573|P1|COMPLETED|Overall Study||30
8474090|NCT00635661|20883573|P1|STARTED|Overall Study||34
8474091|NCT00635648|20883577|P1|NOT COMPLETED|Overall Study||37
8474092|NCT00635648|20883577|P1|COMPLETED|Overall Study||26
8474093|NCT00635648|20883577|P1|STARTED|Overall Study||63
8474094|NCT00635609|20883586|P2|NOT COMPLETED|Overall Study||3
8474095|NCT00635609|20883587|P1|NOT COMPLETED|Overall Study||7
8474096|NCT00635609|20883586|P2|COMPLETED|Overall Study||42
8474097|NCT00635609|20883587|P1|COMPLETED|Overall Study||41
8474098|NCT00635609|20883586|P2|STARTED|Overall Study||45
8474099|NCT00635609|20883587|P1|STARTED|Overall Study||48
8474106|NCT00635492|20883614|P2|NOT COMPLETED|Overall Study||282
8474107|NCT00635492|20883615|P1|NOT COMPLETED|Overall Study||279
8474108|NCT00635492|20883614|P2|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
8474109|NCT00635492|20883615|P1|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
8474110|NCT00635492|20883614|P2|STARTED|Overall Study|This population consists of the analysis population.|1274
8474111|NCT00635492|20883615|P1|STARTED|Overall Study|This population consists of the analysis population.|1114
8474112|NCT00635479|20883661|P2|NOT COMPLETED|Overall Study||18
8474113|NCT00635479|20883662|P1|NOT COMPLETED|Overall Study||6
8474114|NCT00635479|20883661|P2|COMPLETED|Overall Study||42
8474115|NCT00635479|20883662|P1|COMPLETED|Overall Study||49
8474116|NCT00635479|20883661|P2|STARTED|Overall Study||60
8474117|NCT00635479|20883662|P1|STARTED|Overall Study||55
8474145|NCT00635362|20883714|P2|NOT COMPLETED|Overall Study||8
8474146|NCT00635362|20883715|P1|NOT COMPLETED|Overall Study||13
8474147|NCT00635362|20883714|P2|COMPLETED|Overall Study||12
8474148|NCT00635362|20883715|P1|COMPLETED|Overall Study||9
8474149|NCT00635362|20883714|P2|STARTED|Overall Study||20
8474150|NCT00635362|20883715|P1|STARTED|Overall Study||22
8474151|NCT00635349|20883731|P2|NOT COMPLETED|Overall Study||48
8474152|NCT00635349|20883732|P1|NOT COMPLETED|Overall Study||44
8474153|NCT00635349|20883731|P2|COMPLETED|Overall Study||19
8474154|NCT00635349|20883732|P1|COMPLETED|Overall Study||29
8474155|NCT00635349|20883731|P2|STARTED|Overall Study||67
8474156|NCT00635349|20883732|P1|STARTED|Overall Study||73
8474157|NCT00635232|20883755|P5|NOT COMPLETED|Overall Study||8
8474158|NCT00635232|20883756|P4|NOT COMPLETED|Overall Study||10
8474159|NCT00635232|20883757|P3|NOT COMPLETED|Overall Study||3
8474160|NCT00635232|20883758|P2|NOT COMPLETED|Overall Study||20
8474161|NCT00635232|20883759|P1|NOT COMPLETED|Overall Study||14
8474162|NCT00635232|20883755|P5|COMPLETED|Overall Study||20
8474163|NCT00635232|20883756|P4|COMPLETED|Overall Study||48
8474164|NCT00635232|20883757|P3|COMPLETED|Overall Study||55
8474165|NCT00635232|20883758|P2|COMPLETED|Overall Study||39
8474166|NCT00635232|20883759|P1|COMPLETED|Overall Study||44
8474167|NCT00635232|20883755|P5|STARTED|Overall Study||28
8474168|NCT00635232|20883756|P4|STARTED|Overall Study||58
8474169|NCT00635232|20883757|P3|STARTED|Overall Study||58
8474170|NCT00635232|20883758|P2|STARTED|Overall Study||59
8474171|NCT00635232|20883759|P1|STARTED|Overall Study||58
8474172|NCT00635219|20883786|P5|NOT COMPLETED|Overall Study||42
8474173|NCT00635219|20883787|P4|NOT COMPLETED|Overall Study||34
8474174|NCT00635219|20883788|P3|NOT COMPLETED|Overall Study||35
8474175|NCT00635219|20883789|P2|NOT COMPLETED|Overall Study||25
8474176|NCT00635219|20883790|P1|NOT COMPLETED|Overall Study||25
8474177|NCT00635219|20883786|P5|COMPLETED|Overall Study||113
8474178|NCT00635219|20883787|P4|COMPLETED|Overall Study||117
8474179|NCT00635219|20883788|P3|COMPLETED|Overall Study||122
8474180|NCT00635219|20883789|P2|COMPLETED|Overall Study||130
8474181|NCT00635219|20883790|P1|COMPLETED|Overall Study||123
8474182|NCT00635219|20883786|P5|STARTED|Overall Study||155
8474183|NCT00635219|20883787|P4|STARTED|Overall Study||151
8474184|NCT00635219|20883788|P3|STARTED|Overall Study||157
8474185|NCT00635219|20883789|P2|STARTED|Overall Study||155
8474186|NCT00635219|20883790|P1|STARTED|Overall Study||148
8474187|NCT00635167|20883847|P1|NOT COMPLETED|Overall Study||0
8474188|NCT00635167|20883847|P1|COMPLETED|Overall Study||1
8474189|NCT00635167|20883847|P1|STARTED|Overall Study||1
8474190|NCT00635154|20883853|P1|NOT COMPLETED|Overall Study||33
8474191|NCT00635154|20883853|P1|COMPLETED|Overall Study||21
8474192|NCT00635154|20883853|P1|STARTED|Overall Study||54
8474193|NCT00635128|20883865|P2|NOT COMPLETED|Overall Study||0
8474194|NCT00635128|20883866|P1|NOT COMPLETED|Overall Study||0
8474195|NCT00635128|20883865|P2|COMPLETED|Overall Study||64
8474196|NCT00635128|20883866|P1|COMPLETED|Overall Study||351
8474197|NCT00635128|20883865|P2|STARTED|Overall Study||64
8474198|NCT00635128|20883866|P1|STARTED|Overall Study||351
8474199|NCT00635102|20883896|P2|NOT COMPLETED|Overall Study||8
8474200|NCT00635102|20883897|P1|NOT COMPLETED|Overall Study||7
8474201|NCT00635102|20883896|P2|COMPLETED|Overall Study||22
8474202|NCT00635102|20883897|P1|COMPLETED|Overall Study||20
8474203|NCT00635102|20883896|P2|STARTED|Overall Study||30
8474204|NCT00635102|20883897|P1|STARTED|Overall Study||27
8474205|NCT00635089|20883991|P1|NOT COMPLETED|Overall Study||78
8474206|NCT00635089|20883991|P1|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
8474207|NCT00635089|20883991|P1|Completed >/= 16 Weeks of Study|Overall Study||181
8474208|NCT00635089|20883991|P1|STARTED|Overall Study||190
8474209|NCT00635050|20884018|P1|NOT COMPLETED|Overall Study||1
8474210|NCT00635050|20884018|P1|COMPLETED|Overall Study|Followup through 10 years planned.|31
8474211|NCT00635050|20884018|P1|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
8474212|NCT00635024|20884025|P1|NOT COMPLETED|Overall Study||1
8474213|NCT00635024|20884025|P1|COMPLETED|Overall Study||0
8474214|NCT00635024|20884025|P1|STARTED|Overall Study||1
8474215|NCT00634972|20884035|P2|NOT COMPLETED|Overall Study||0
8474216|NCT00634972|20884036|P1|NOT COMPLETED|Overall Study||0
8474217|NCT00634972|20884035|P2|COMPLETED|Overall Study||43
8474218|NCT00634972|20884036|P1|COMPLETED|Overall Study||40
8474219|NCT00634972|20884035|P2|STARTED|Overall Study||43
8474220|NCT00634972|20884036|P1|STARTED|Overall Study||40
8474221|NCT00634933|20884045|P5|NOT COMPLETED|Part B: Week 24 to Week 52||10
8474222|NCT00634933|20884046|P4|NOT COMPLETED|Part B: Week 24 to Week 52||6
8474223|NCT00634933|20884047|P3|NOT COMPLETED|Part B: Week 24 to Week 52||22
8474224|NCT00634933|20884048|P2|NOT COMPLETED|Part B: Week 24 to Week 52||14
8474225|NCT00634933|20884049|P1|NOT COMPLETED|Part B: Week 24 to Week 52||0
8474226|NCT00634933|20884045|P5|COMPLETED|Part B: Week 24 to Week 52||22
8474227|NCT00634933|20884046|P4|COMPLETED|Part B: Week 24 to Week 52||25
8474228|NCT00634933|20884047|P3|COMPLETED|Part B: Week 24 to Week 52||33
8474229|NCT00634933|20884048|P2|COMPLETED|Part B: Week 24 to Week 52||42
8474230|NCT00634933|20884049|P1|COMPLETED|Part B: Week 24 to Week 52||0
8474231|NCT00634933|20884045|P5|STARTED|Part B: Week 24 to Week 52||32
8474232|NCT00634933|20884046|P4|STARTED|Part B: Week 24 to Week 52||31
8474233|NCT00634933|20884047|P3|STARTED|Part B: Week 24 to Week 52||55
8474234|NCT00634933|20884048|P2|STARTED|Part B: Week 24 to Week 52||56
8474235|NCT00634933|20884049|P1|STARTED|Part B: Week 24 to Week 52||0
8474236|NCT00634933|20884045|P5|NOT COMPLETED|Between Part A and Part B||0
8474237|NCT00634933|20884046|P4|NOT COMPLETED|Between Part A and Part B||0
8474238|NCT00634933|20884047|P3|NOT COMPLETED|Between Part A and Part B||0
8474239|NCT00634933|20884048|P2|NOT COMPLETED|Between Part A and Part B||1
8474240|NCT00634933|20884049|P1|NOT COMPLETED|Between Part A and Part B||0
8474241|NCT00634933|20884045|P5|COMPLETED|Between Part A and Part B||32
8474242|NCT00634933|20884046|P4|COMPLETED|Between Part A and Part B||31
8474243|NCT00634933|20884047|P3|COMPLETED|Between Part A and Part B||55
8474244|NCT00634933|20884048|P2|COMPLETED|Between Part A and Part B||56
8474245|NCT00634933|20884049|P1|COMPLETED|Between Part A and Part B||0
8474246|NCT00634933|20884045|P5|STARTED|Between Part A and Part B||32
8474247|NCT00634933|20884046|P4|STARTED|Between Part A and Part B||31
8474248|NCT00634933|20884047|P3|STARTED|Between Part A and Part B||55
8474249|NCT00634933|20884048|P2|STARTED|Between Part A and Part B||57
8474250|NCT00634933|20884049|P1|STARTED|Between Part A and Part B||0
8474251|NCT00634933|20884045|P5|NOT COMPLETED|Part A: Baseline to Week 24||0
8474252|NCT00634933|20884046|P4|NOT COMPLETED|Part A: Baseline to Week 24||0
8474253|NCT00634933|20884047|P3|NOT COMPLETED|Part A: Baseline to Week 24||18
8474254|NCT00634933|20884048|P2|NOT COMPLETED|Part A: Baseline to Week 24||18
8474255|NCT00634933|20884049|P1|NOT COMPLETED|Part A: Baseline to Week 24||11
8474256|NCT00634933|20884045|P5|COMPLETED|Part A: Baseline to Week 24||0
8474257|NCT00634933|20884046|P4|COMPLETED|Part A: Baseline to Week 24||0
8474258|NCT00634933|20884047|P3|COMPLETED|Part A: Baseline to Week 24||55
8474259|NCT00634933|20884048|P2|COMPLETED|Part A: Baseline to Week 24||57
8474260|NCT00634933|20884049|P1|COMPLETED|Part A: Baseline to Week 24||63
8474261|NCT00634933|20884045|P5|STARTED|Part A: Baseline to Week 24||0
8474262|NCT00634933|20884046|P4|STARTED|Part A: Baseline to Week 24||0
8474263|NCT00634933|20884047|P3|STARTED|Part A: Baseline to Week 24||73
8474264|NCT00634933|20884048|P2|STARTED|Part A: Baseline to Week 24||75
8474265|NCT00634933|20884049|P1|STARTED|Part A: Baseline to Week 24||74
8474266|NCT00634920|20884118|P3|NOT COMPLETED|Period 2 - Post-Randomization||0
8474267|NCT00634920|20884119|P2|NOT COMPLETED|Period 2 - Post-Randomization||32
8474268|NCT00634920|20884120|P1|NOT COMPLETED|Period 2 - Post-Randomization||61
8474269|NCT00634920|20884118|P3|COMPLETED|Period 2 - Post-Randomization||0
8474270|NCT00634920|20884119|P2|COMPLETED|Period 2 - Post-Randomization||68
8474271|NCT00634920|20884120|P1|COMPLETED|Period 2 - Post-Randomization||43
8474272|NCT00634920|20884118|P3|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
8474273|NCT00634920|20884119|P2|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
8474274|NCT00634920|20884120|P1|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
8474275|NCT00634920|20884118|P3|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
8474276|NCT00634920|20884119|P2|STARTED|Period 2 - Post-Randomization||100
8474277|NCT00634920|20884120|P1|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
8474278|NCT00634920|20884118|P3|NOT COMPLETED|Period 1 - Pre-Randomization||137
8474279|NCT00634920|20884119|P2|NOT COMPLETED|Period 1 - Pre-Randomization||0
8474280|NCT00634920|20884120|P1|NOT COMPLETED|Period 1 - Pre-Randomization||0
8474281|NCT00634920|20884118|P3|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
8474282|NCT00634920|20884119|P2|COMPLETED|Period 1 - Pre-Randomization||0
8474283|NCT00634920|20884120|P1|COMPLETED|Period 1 - Pre-Randomization||0
8474284|NCT00634920|20884118|P3|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
8474285|NCT00634920|20884119|P2|STARTED|Period 1 - Pre-Randomization||0
8474286|NCT00634920|20884120|P1|STARTED|Period 1 - Pre-Randomization||0
8474287|NCT00634907|20884164|P2|NOT COMPLETED|Overall Study||17
8474288|NCT00634907|20884165|P1|NOT COMPLETED|Overall Study||17
8474289|NCT00634907|20884164|P2|COMPLETED|Overall Study||115
8474290|NCT00634907|20884165|P1|COMPLETED|Overall Study||114
8474291|NCT00634907|20884164|P2|STARTED|Overall Study||132
8474292|NCT00634907|20884165|P1|STARTED|Overall Study||131
8474293|NCT00634842|20884189|P2|NOT COMPLETED|Overall Study||18
8474294|NCT00634842|20884190|P1|NOT COMPLETED|Overall Study||15
8474295|NCT00634842|20884189|P2|COMPLETED|Overall Study||104
8474296|NCT00634842|20884190|P1|COMPLETED|Overall Study||107
8474297|NCT00634842|20884189|P2|STARTED|Overall Study||122
8474298|NCT00634842|20884190|P1|STARTED|Overall Study||122
8474317|NCT00634751|20884225|P4|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
8474318|NCT00634751|20884226|P3|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
8474319|NCT00634751|20884227|P2|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
8474320|NCT00634751|20884228|P1|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
8474321|NCT00634751|20884225|P4|COMPLETED|Pancreatic and Bilial Tract Cancer||7
8474322|NCT00634751|20884226|P3|COMPLETED|Pancreatic and Bilial Tract Cancer||23
8474323|NCT00634751|20884227|P2|COMPLETED|Pancreatic and Bilial Tract Cancer||0
8474324|NCT00634751|20884228|P1|COMPLETED|Pancreatic and Bilial Tract Cancer||0
8474325|NCT00634751|20884225|P4|STARTED|Pancreatic and Bilial Tract Cancer||8
8474326|NCT00634751|20884226|P3|STARTED|Pancreatic and Bilial Tract Cancer||24
8474327|NCT00634751|20884227|P2|STARTED|Pancreatic and Bilial Tract Cancer||0
8474328|NCT00634751|20884228|P1|STARTED|Pancreatic and Bilial Tract Cancer||0
8474329|NCT00634751|20884225|P4|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8474330|NCT00634751|20884226|P3|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8474331|NCT00634751|20884227|P2|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
8474332|NCT00634751|20884228|P1|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8474333|NCT00634751|20884225|P4|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8474334|NCT00634751|20884226|P3|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8474335|NCT00634751|20884227|P2|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
8474336|NCT00634751|20884228|P1|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
8474337|NCT00634751|20884225|P4|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
8474338|NCT00634751|20884226|P3|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
8474339|NCT00634751|20884227|P2|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
8474340|NCT00634751|20884228|P1|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
8474341|NCT00634751|20884225|P4|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8474342|NCT00634751|20884226|P3|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8474343|NCT00634751|20884227|P2|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8474344|NCT00634751|20884228|P1|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
8474345|NCT00634751|20884225|P4|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8474346|NCT00634751|20884226|P3|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8474347|NCT00634751|20884227|P2|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
8474348|NCT00634751|20884228|P1|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
8474349|NCT00634751|20884225|P4|STARTED|Phase I: 200mg Sorafenib+2DOC||0
8474350|NCT00634751|20884226|P3|STARTED|Phase I: 200mg Sorafenib+2DOC||0
8474351|NCT00634751|20884227|P2|STARTED|Phase I: 200mg Sorafenib+2DOC||0
8474352|NCT00634751|20884228|P1|STARTED|Phase I: 200mg Sorafenib+2DOC||9
8474353|NCT00634647|20884246|P1|NOT COMPLETED|Overall Study||7
8474354|NCT00634647|20884246|P1|COMPLETED|Overall Study||17
8474355|NCT00634647|20884246|P1|STARTED|Overall Study||24
8474356|NCT00634621|20884252|P1|NOT COMPLETED|Overall Study||0
8474357|NCT00634621|20884252|P1|COMPLETED|Overall Study||283
8474358|NCT00634621|20884252|P1|STARTED|Overall Study||283
8474359|NCT00634582|20884260|P1|NOT COMPLETED|Overall Study||0
8474360|NCT00634582|20884260|P1|COMPLETED|Overall Study||2
8474361|NCT00634582|20884260|P1|STARTED|Overall Study||2
8474362|NCT00634569|20884266|P2|NOT COMPLETED|Overall Study||5
8474363|NCT00634569|20884267|P1|NOT COMPLETED|Overall Study||0
8474364|NCT00634569|20884266|P2|COMPLETED|Overall Study||5
8474365|NCT00634569|20884267|P1|COMPLETED|Overall Study||14
8474366|NCT00634569|20884266|P2|STARTED|Overall Study||10
8474367|NCT00634569|20884267|P1|STARTED|Overall Study||14
8474368|NCT00634543|20884281|P2|NOT COMPLETED|Overall Study||21
8474369|NCT00634543|20884282|P1|NOT COMPLETED|Overall Study||19
8474370|NCT00634543|20884281|P2|COMPLETED|Overall Study||63
8474371|NCT00634543|20884282|P1|COMPLETED|Overall Study||59
8474372|NCT00634543|20884281|P2|Treated|Overall Study||80
8474373|NCT00634543|20884282|P1|Treated|Overall Study||76
8474374|NCT00634543|20884281|P2|STARTED|Overall Study||84
8474375|NCT00634543|20884282|P1|STARTED|Overall Study||78
8474376|NCT00634504|20884300|P2|NOT COMPLETED|Overall Study||0
8474377|NCT00634504|20884301|P1|NOT COMPLETED|Overall Study||1
8474378|NCT00634504|20884300|P2|COMPLETED|Overall Study||9
8474379|NCT00634504|20884301|P1|COMPLETED|Overall Study||10
8474380|NCT00634504|20884300|P2|STARTED|Overall Study||9
8474381|NCT00634504|20884301|P1|STARTED|Overall Study||11
8474382|NCT00634322|20884310|P3|NOT COMPLETED|Overall Study||0
8474383|NCT00634322|20884311|P2|NOT COMPLETED|Overall Study||0
8474384|NCT00634322|20884312|P1|NOT COMPLETED|Overall Study||0
8474385|NCT00634322|20884310|P3|COMPLETED|Overall Study||5
8474386|NCT00634322|20884311|P2|COMPLETED|Overall Study||1
8474387|NCT00634322|20884312|P1|COMPLETED|Overall Study||1
8474388|NCT00634322|20884310|P3|STARTED|Overall Study||5
8474389|NCT00634322|20884311|P2|STARTED|Overall Study||1
8474390|NCT00634322|20884312|P1|STARTED|Overall Study||1
8474391|NCT00634283|20884320|P1|NOT COMPLETED|Overall Study||0
8474392|NCT00634283|20884320|P1|COMPLETED|Overall Study||6
8474393|NCT00634283|20884320|P1|STARTED|Overall Study||6
8474394|NCT00634270|20884330|P2|NOT COMPLETED|Overall Study||1
8474395|NCT00634270|20884331|P1|NOT COMPLETED|Overall Study||3
8474396|NCT00634270|20884330|P2|COMPLETED|Overall Study||12
8474397|NCT00634270|20884331|P1|COMPLETED|Overall Study||46
8474398|NCT00634270|20884330|P2|STARTED|Overall Study||13
8474399|NCT00634270|20884331|P1|STARTED|Overall Study|February 12, 2008|49
8474400|NCT00634244|20884360|P3|NOT COMPLETED|Overall Study||0
8474401|NCT00634244|20884361|P2|NOT COMPLETED|Overall Study||13
8474402|NCT00634244|20884362|P1|NOT COMPLETED|Overall Study||1
8474403|NCT00634244|20884360|P3|COMPLETED|Overall Study||20
8474404|NCT00634244|20884361|P2|COMPLETED|Overall Study||24
8474405|NCT00634244|20884362|P1|COMPLETED|Overall Study||34
8474406|NCT00634244|20884360|P3|Eligible and Treated|Overall Study||20
8474407|NCT00634244|20884361|P2|Eligible and Treated|Overall Study||36
8474408|NCT00634244|20884362|P1|Eligible and Treated|Overall Study||35
8474409|NCT00634244|20884360|P3|STARTED|Overall Study||20
8474410|NCT00634244|20884361|P2|STARTED|Overall Study||37
8474411|NCT00634244|20884362|P1|STARTED|Overall Study||35
8474412|NCT00634179|20884373|P1|NOT COMPLETED|Phase II: Maintenance||1
8474413|NCT00634179|20884373|P1|COMPLETED|Phase II: Maintenance||29
8474414|NCT00634179|20884373|P1|STARTED|Phase II: Maintenance||30
8474415|NCT00634179|20884373|P1|NOT COMPLETED|Phase I: Induction||0
8474416|NCT00634179|20884373|P1|COMPLETED|Phase I: Induction||19
8474417|NCT00634179|20884373|P1|STARTED|Phase I: Induction||19
8474418|NCT00634166|20884382|P2|NOT COMPLETED|Overall Study||60
8474419|NCT00634166|20884383|P1|NOT COMPLETED|Overall Study||60
8474420|NCT00634166|20884382|P2|COMPLETED|Overall Study||78
8474421|NCT00634166|20884383|P1|COMPLETED|Overall Study||22
8474422|NCT00634166|20884382|P2|STARTED|Overall Study||138
8474423|NCT00634166|20884383|P1|STARTED|Overall Study||82
8474424|NCT00634114|20884392|P3|NOT COMPLETED|Overall Study||39
8474425|NCT00634114|20884393|P2|NOT COMPLETED|Overall Study||35
8474426|NCT00634114|20884394|P1|NOT COMPLETED|Overall Study||28
8474427|NCT00634114|20884392|P3|COMPLETED|Overall Study|Completed|148
8474428|NCT00634114|20884393|P2|COMPLETED|Overall Study|Completed|154
8474429|NCT00634114|20884394|P1|COMPLETED|Overall Study|Completed|160
8474430|NCT00634114|20884392|P3|STARTED|Overall Study|Randomised|187
8474431|NCT00634114|20884393|P2|STARTED|Overall Study|Randomised|189
8474432|NCT00634114|20884394|P1|STARTED|Overall Study|Randomised|188
8474433|NCT00634101|20884410|P2|NOT COMPLETED|Overall Study||3
8474434|NCT00634101|20884411|P1|NOT COMPLETED|Overall Study||5
8474435|NCT00634101|20884410|P2|COMPLETED|Overall Study||56
8474436|NCT00634101|20884411|P1|COMPLETED|Overall Study||61
8474437|NCT00634101|20884410|P2|STARTED|Overall Study||59
8474438|NCT00634101|20884411|P1|STARTED|Overall Study||66
8474439|NCT00634088|20884445|P4|NOT COMPLETED|Time Period 4: Triplet Combination||0
8474440|NCT00634088|20884446|P3|NOT COMPLETED|Time Period 4: Triplet Combination||0
8474441|NCT00634088|20884447|P2|NOT COMPLETED|Time Period 4: Triplet Combination||0
8474442|NCT00634088|20884448|P1|NOT COMPLETED|Time Period 4: Triplet Combination||0
8474443|NCT00634088|20884445|P4|COMPLETED|Time Period 4: Triplet Combination||0
8474444|NCT00634088|20884446|P3|COMPLETED|Time Period 4: Triplet Combination||0
8474445|NCT00634088|20884447|P2|COMPLETED|Time Period 4: Triplet Combination||0
8474446|NCT00634088|20884448|P1|COMPLETED|Time Period 4: Triplet Combination||0
8474447|NCT00634088|20884445|P4|STARTED|Time Period 4: Triplet Combination||0
8474448|NCT00634088|20884446|P3|STARTED|Time Period 4: Triplet Combination||0
8474449|NCT00634088|20884447|P2|STARTED|Time Period 4: Triplet Combination||0
8474450|NCT00634088|20884448|P1|STARTED|Time Period 4: Triplet Combination||0
8474451|NCT00634088|20884445|P4|NOT COMPLETED|Time Period 3: Dose Level 3||0
8474452|NCT00634088|20884446|P3|NOT COMPLETED|Time Period 3: Dose Level 3||1
8474453|NCT00634088|20884447|P2|NOT COMPLETED|Time Period 3: Dose Level 3||0
8474454|NCT00634088|20884448|P1|NOT COMPLETED|Time Period 3: Dose Level 3||0
8474455|NCT00634088|20884445|P4|COMPLETED|Time Period 3: Dose Level 3||0
8474456|NCT00634088|20884446|P3|COMPLETED|Time Period 3: Dose Level 3||0
8474457|NCT00634088|20884447|P2|COMPLETED|Time Period 3: Dose Level 3||0
8474458|NCT00634088|20884448|P1|COMPLETED|Time Period 3: Dose Level 3||0
8474459|NCT00634088|20884445|P4|STARTED|Time Period 3: Dose Level 3||0
8474460|NCT00634088|20884446|P3|STARTED|Time Period 3: Dose Level 3||1
8474461|NCT00634088|20884447|P2|STARTED|Time Period 3: Dose Level 3||0
8474462|NCT00634088|20884448|P1|STARTED|Time Period 3: Dose Level 3||0
8474463|NCT00634088|20884445|P4|NOT COMPLETED|Time Period 2: Dose Level 2||0
8474464|NCT00634088|20884446|P3|NOT COMPLETED|Time Period 2: Dose Level 2||0
8474465|NCT00634088|20884447|P2|NOT COMPLETED|Time Period 2: Dose Level 2||3
8474466|NCT00634088|20884448|P1|NOT COMPLETED|Time Period 2: Dose Level 2||0
8474467|NCT00634088|20884445|P4|COMPLETED|Time Period 2: Dose Level 2||0
8474468|NCT00634088|20884446|P3|COMPLETED|Time Period 2: Dose Level 2||0
8474469|NCT00634088|20884447|P2|COMPLETED|Time Period 2: Dose Level 2||0
8474470|NCT00634088|20884448|P1|COMPLETED|Time Period 2: Dose Level 2||0
8474471|NCT00634088|20884445|P4|STARTED|Time Period 2: Dose Level 2||0
8474472|NCT00634088|20884446|P3|STARTED|Time Period 2: Dose Level 2||0
8474473|NCT00634088|20884447|P2|STARTED|Time Period 2: Dose Level 2||3
8474474|NCT00634088|20884448|P1|STARTED|Time Period 2: Dose Level 2||0
8474475|NCT00634088|20884445|P4|NOT COMPLETED|Time Period 1: Dose Level 1||0
8474476|NCT00634088|20884446|P3|NOT COMPLETED|Time Period 1: Dose Level 1||0
8474477|NCT00634088|20884447|P2|NOT COMPLETED|Time Period 1: Dose Level 1||0
8474478|NCT00634088|20884448|P1|NOT COMPLETED|Time Period 1: Dose Level 1||6
8474479|NCT00634088|20884445|P4|COMPLETED|Time Period 1: Dose Level 1||0
8474480|NCT00634088|20884446|P3|COMPLETED|Time Period 1: Dose Level 1||0
8474481|NCT00634088|20884447|P2|COMPLETED|Time Period 1: Dose Level 1||0
8474482|NCT00634088|20884448|P1|COMPLETED|Time Period 1: Dose Level 1||0
8474483|NCT00634088|20884445|P4|STARTED|Time Period 1: Dose Level 1||0
8474484|NCT00634088|20884446|P3|STARTED|Time Period 1: Dose Level 1||0
8474485|NCT00634088|20884447|P2|STARTED|Time Period 1: Dose Level 1||0
8474486|NCT00634088|20884448|P1|STARTED|Time Period 1: Dose Level 1||6
8474487|NCT00634049|20884499|P1|NOT COMPLETED|Overall Study||3
8474488|NCT00634049|20884499|P1|COMPLETED|Overall Study||146
8474489|NCT00634049|20884499|P1|STARTED|Overall Study||149
8474490|NCT00634036|20884578|P2|NOT COMPLETED|Overall Study||2
8474491|NCT00634036|20884579|P1|NOT COMPLETED|Overall Study||2
8474492|NCT00634036|20884578|P2|COMPLETED|Overall Study||9
8474493|NCT00634036|20884579|P1|COMPLETED|Overall Study||10
8474494|NCT00634036|20884578|P2|STARTED|Overall Study||11
8474495|NCT00634036|20884579|P1|STARTED|Overall Study||12
8474496|NCT00634010|20884593|P2|NOT COMPLETED|Overall Study||14
8474497|NCT00634010|20884594|P1|NOT COMPLETED|Overall Study||10
8474498|NCT00634010|20884593|P2|COMPLETED|Overall Study||4
8474499|NCT00634010|20884594|P1|COMPLETED|Overall Study||8
8474500|NCT00634010|20884593|P2|STARTED|Overall Study||18
8474501|NCT00634010|20884594|P1|STARTED|Overall Study||18
8474502|NCT00633984|20884602|P2|NOT COMPLETED|Overall Study||13
8474503|NCT00633984|20884603|P1|NOT COMPLETED|Overall Study||9
8474504|NCT00633984|20884602|P2|COMPLETED|Overall Study||69
8474505|NCT00633984|20884603|P1|COMPLETED|Overall Study||78
8474506|NCT00633984|20884602|P2|STARTED|Overall Study||82
8474507|NCT00633984|20884603|P1|STARTED|Overall Study||87
8474508|NCT00633945|20884611|P1|NOT COMPLETED|Overall Study||2
8474509|NCT00633945|20884611|P1|COMPLETED|Overall Study||3
8474510|NCT00633945|20884611|P1|STARTED|Overall Study||5
8474511|NCT00633932|20884627|P3|NOT COMPLETED|Overall Study||11
8474512|NCT00633932|20884628|P2|NOT COMPLETED|Overall Study||14
8474513|NCT00633932|20884629|P1|NOT COMPLETED|Overall Study||12
8474514|NCT00633932|20884627|P3|COMPLETED|Overall Study||180
8474515|NCT00633932|20884628|P2|COMPLETED|Overall Study||176
8474516|NCT00633932|20884629|P1|COMPLETED|Overall Study||179
8474517|NCT00633932|20884627|P3|STARTED|Overall Study|Randomised|191
8474518|NCT00633932|20884628|P2|STARTED|Overall Study|Randomised|190
8474519|NCT00633932|20884629|P1|STARTED|Overall Study|Randomised|191
8474520|NCT00633919|20884642|P2|NOT COMPLETED|Overall Study||22
8474521|NCT00633919|20884643|P1|NOT COMPLETED|Overall Study||27
8474522|NCT00633919|20884642|P2|COMPLETED|Overall Study||39
8474523|NCT00633919|20884643|P1|COMPLETED|Overall Study||36
8474524|NCT00633919|20884642|P2|STARTED|Overall Study||61
8474525|NCT00633919|20884643|P1|STARTED|Overall Study||63
8474526|NCT00633893|20884660|P3|NOT COMPLETED|Overall Study||188
8474527|NCT00633893|20884661|P2|NOT COMPLETED|Overall Study||129
8474528|NCT00633893|20884662|P1|NOT COMPLETED|Overall Study||114
8474529|NCT00633893|20884660|P3|COMPLETED|Overall Study||641
8474530|NCT00633893|20884661|P2|COMPLETED|Overall Study||684
8474531|NCT00633893|20884662|P1|COMPLETED|Overall Study||726
8474532|NCT00633893|20884660|P3|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
8474533|NCT00633893|20884661|P2|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
8474534|NCT00633893|20884662|P1|STARTED|Overall Study||840
8474535|NCT00633880|20884736|P3|NOT COMPLETED|Randomized Double Blind||0
8474536|NCT00633880|20884737|P2|NOT COMPLETED|Randomized Double Blind||0
8474537|NCT00633880|20884738|P1|NOT COMPLETED|Randomized Double Blind||0
8474538|NCT00633880|20884736|P3|COMPLETED|Randomized Double Blind||51
8474539|NCT00633880|20884737|P2|COMPLETED|Randomized Double Blind||50
8474540|NCT00633880|20884738|P1|COMPLETED|Randomized Double Blind||0
8474541|NCT00633880|20884736|P3|STARTED|Randomized Double Blind||51
8474542|NCT00633880|20884737|P2|STARTED|Randomized Double Blind||50
8474543|NCT00633880|20884738|P1|STARTED|Randomized Double Blind||0
8474544|NCT00633880|20884736|P3|NOT COMPLETED|Open Label Titration||0
8474545|NCT00633880|20884737|P2|NOT COMPLETED|Open Label Titration||0
8474546|NCT00633880|20884738|P1|NOT COMPLETED|Open Label Titration||80
8474547|NCT00633880|20884736|P3|COMPLETED|Open Label Titration||0
8474548|NCT00633880|20884737|P2|COMPLETED|Open Label Titration||0
8474549|NCT00633880|20884738|P1|COMPLETED|Open Label Titration||101
8474550|NCT00633880|20884736|P3|STARTED|Open Label Titration||0
8474551|NCT00633880|20884737|P2|STARTED|Open Label Titration||0
8474552|NCT00633880|20884738|P1|STARTED|Open Label Titration||181
8474553|NCT00633867|20884767|P2|NOT COMPLETED|Overall Study||0
8474554|NCT00633867|20884768|P1|NOT COMPLETED|Overall Study||0
8474555|NCT00633867|20884767|P2|COMPLETED|Overall Study||60
8474556|NCT00633867|20884768|P1|COMPLETED|Overall Study||60
8474557|NCT00633867|20884767|P2|STARTED|Overall Study||60
8474558|NCT00633867|20884768|P1|STARTED|Overall Study||60
8474559|NCT00633750|20884774|P1|NOT COMPLETED|Overall Study||5
8474560|NCT00633750|20884774|P1|COMPLETED|Overall Study||42
8474561|NCT00633750|20884774|P1|STARTED|Overall Study||47
8474562|NCT00633594|20884783|P3|NOT COMPLETED|Overall Study||10
8474563|NCT00633594|20884784|P2|NOT COMPLETED|Overall Study||5
8474564|NCT00633594|20884785|P1|NOT COMPLETED|Overall Study||0
8474565|NCT00633594|20884783|P3|COMPLETED|Overall Study||16
8474566|NCT00633594|20884784|P2|COMPLETED|Overall Study||3
8474567|NCT00633594|20884785|P1|COMPLETED|Overall Study||5
8474568|NCT00633594|20884783|P3|STARTED|Overall Study||26
8474569|NCT00633594|20884784|P2|STARTED|Overall Study||8
8474570|NCT00633594|20884785|P1|STARTED|Overall Study||5
8474571|NCT00633477|20884814|P2|NOT COMPLETED|Overall Study||0
8474572|NCT00633477|20884815|P1|NOT COMPLETED|Overall Study||2
8474573|NCT00633477|20884814|P2|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
8474574|NCT00633477|20884815|P1|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
8474575|NCT00633477|20884814|P2|Completed Study Through Day 28|Overall Study||8
8474576|NCT00633477|20884815|P1|Completed Study Through Day 28|Overall Study||4
8474577|NCT00633477|20884814|P2|Prematurely Discontinued Study Drug|Overall Study||0
8474578|NCT00633477|20884815|P1|Prematurely Discontinued Study Drug|Overall Study||1
8474579|NCT00633477|20884814|P2|Randomized But Not Treated|Overall Study||0
8474580|NCT00633477|20884815|P1|Randomized But Not Treated|Overall Study||1
8474581|NCT00633477|20884814|P2|STARTED|Overall Study||11
8474582|NCT00633477|20884815|P1|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
8474583|NCT00633464|20884831|P2|NOT COMPLETED|Overall Study||2
8474584|NCT00633464|20884832|P1|NOT COMPLETED|Overall Study||0
8474585|NCT00633464|20884831|P2|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
8474586|NCT00633464|20884832|P1|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
8474587|NCT00633464|20884831|P2|Treated|Overall Study||37
8474588|NCT00633464|20884832|P1|Treated|Overall Study||40
8474589|NCT00633464|20884831|P2|STARTED|Overall Study||39
8474590|NCT00633464|20884832|P1|STARTED|Overall Study||40
8474591|NCT00633399|20884854|P2|NOT COMPLETED|Overall Study||15
8474592|NCT00633399|20884855|P1|NOT COMPLETED|Overall Study||22
8474593|NCT00633399|20884854|P2|COMPLETED|Overall Study||53
8474594|NCT00633399|20884855|P1|COMPLETED|Overall Study||49
8474595|NCT00633399|20884854|P2|STARTED|Overall Study||68
8474596|NCT00633399|20884855|P1|STARTED|Overall Study||71
8474597|NCT00633360|20884867|P2|NOT COMPLETED|Overall Study||3
8474598|NCT00633360|20884868|P1|NOT COMPLETED|Overall Study||4
8474599|NCT00633360|20884867|P2|COMPLETED|Overall Study||13
8474600|NCT00633360|20884868|P1|COMPLETED|Overall Study||12
8474601|NCT00633360|20884867|P2|STARTED|Overall Study||16
8474602|NCT00633360|20884868|P1|STARTED|Overall Study||16
8474603|NCT00633256|20884878|P2|NOT COMPLETED|Overall Study||3
8474604|NCT00633256|20884879|P1|NOT COMPLETED|Overall Study||4
8474605|NCT00633256|20884878|P2|COMPLETED|Overall Study||10
8474606|NCT00633256|20884879|P1|COMPLETED|Overall Study||8
8474607|NCT00633256|20884878|P2|STARTED|Overall Study||13
8474608|NCT00633256|20884879|P1|STARTED|Overall Study||12
8474609|NCT00633243|20884891|P2|NOT COMPLETED|Overall Study||7
8474610|NCT00633243|20884892|P1|NOT COMPLETED|Overall Study||1
8474611|NCT00633243|20884891|P2|COMPLETED|Overall Study||2
8474612|NCT00633243|20884892|P1|COMPLETED|Overall Study||11
8474613|NCT00633243|20884891|P2|STARTED|Overall Study||9
8474614|NCT00633243|20884892|P1|STARTED|Overall Study||12
8474615|NCT00633217|20884900|P2|NOT COMPLETED|Overall Study||23
8474616|NCT00633217|20884901|P1|NOT COMPLETED|Overall Study||15
8474617|NCT00633217|20884900|P2|COMPLETED|Overall Study||103
8474618|NCT00633217|20884901|P1|COMPLETED|Overall Study||106
8474619|NCT00633217|20884900|P2|STARTED|Overall Study||126
8474620|NCT00633217|20884901|P1|STARTED|Overall Study||121
8474621|NCT00633152|20884913|P2|NOT COMPLETED|Overall Study||6
8474622|NCT00633152|20884914|P1|NOT COMPLETED|Overall Study||14
8474623|NCT00633152|20884913|P2|COMPLETED|Overall Study||41
8474624|NCT00633152|20884914|P1|COMPLETED|Overall Study||89
8474625|NCT00633152|20884913|P2|Clinically Evaluable Population|Overall Study||39
8474626|NCT00633152|20884914|P1|Clinically Evaluable Population|Overall Study||86
8474627|NCT00633152|20884913|P2|MITT and Safety Population|Overall Study||45
8474628|NCT00633152|20884914|P1|MITT and Safety Population|Overall Study||98
8474629|NCT00633152|20884913|P2|STARTED|Overall Study||47
8474630|NCT00633152|20884914|P1|STARTED|Overall Study||103
8474640|NCT00633126|20884941|P1|NOT COMPLETED|Overall Study||1
8474641|NCT00633126|20884941|P1|COMPLETED|Overall Study||8
8474642|NCT00633126|20884941|P1|STARTED|Overall Study||9
8474643|NCT00633087|20884946|P1|NOT COMPLETED|Overall Study||0
8474644|NCT00633087|20884946|P1|COMPLETED|Overall Study||12
8474645|NCT00633087|20884946|P1|STARTED|Overall Study||12
8474646|NCT00633074|20884955|P2|NOT COMPLETED|Overall Study||0
8474647|NCT00633074|20884956|P1|NOT COMPLETED|Overall Study||1
8474648|NCT00633074|20884955|P2|COMPLETED|Overall Study||360
8474649|NCT00633074|20884956|P1|COMPLETED|Overall Study||359
8474650|NCT00633074|20884955|P2|STARTED|Overall Study||360
8474651|NCT00633074|20884956|P1|STARTED|Overall Study||360
8474652|NCT00633061|20884986|P2|NOT COMPLETED|Overall Study||0
8474653|NCT00633061|20884987|P1|NOT COMPLETED|Overall Study||86
8474654|NCT00633061|20884986|P2|COMPLETED|Overall Study||0
8474655|NCT00633061|20884987|P1|COMPLETED|Overall Study||50
8474656|NCT00633061|20884986|P2|Had Prior Thrombosis Identified|Overall Study||0
8474657|NCT00633061|20884987|P1|Had Prior Thrombosis Identified|Overall Study||25
8474658|NCT00633061|20884986|P2|Met Criteria for Imaging|Overall Study||0
8474659|NCT00633061|20884987|P1|Met Criteria for Imaging|Overall Study||25
8474660|NCT00633061|20884986|P2|STARTED|Overall Study||0
8474661|NCT00633061|20884987|P1|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136
8474662|NCT00633022|20884998|P3|NOT COMPLETED|Overall Study||5
8474663|NCT00633022|20884999|P2|NOT COMPLETED|Overall Study||1
8474664|NCT00633022|20885000|P1|NOT COMPLETED|Overall Study||1
8474665|NCT00633022|20884998|P3|COMPLETED|Overall Study||27
8474666|NCT00633022|20884999|P2|COMPLETED|Overall Study||32
8474667|NCT00633022|20885000|P1|COMPLETED|Overall Study||33
8474668|NCT00633022|20884998|P3|STARTED|Overall Study||32
8474669|NCT00633022|20884999|P2|STARTED|Overall Study||33
8474670|NCT00633022|20885000|P1|STARTED|Overall Study||34
8474671|NCT00633009|20885038|P3|NOT COMPLETED|Overall Study||1
8474672|NCT00633009|20885039|P2|NOT COMPLETED|Overall Study||4
8474673|NCT00633009|20885040|P1|NOT COMPLETED|Overall Study||4
8474674|NCT00633009|20885038|P3|COMPLETED|Overall Study||10
8474675|NCT00633009|20885039|P2|COMPLETED|Overall Study||23
8474676|NCT00633009|20885040|P1|COMPLETED|Overall Study||8
8474677|NCT00633009|20885038|P3|STARTED|Overall Study||11
8474678|NCT00633009|20885039|P2|STARTED|Overall Study||27
8474679|NCT00633009|20885040|P1|STARTED|Overall Study||12
8474680|NCT00632970|20885053|P2|NOT COMPLETED|Overall Study||0
8474681|NCT00632970|20885054|P1|NOT COMPLETED|Overall Study||0
8474682|NCT00632970|20885053|P2|COMPLETED|Overall Study||3
8474683|NCT00632970|20885054|P1|COMPLETED|Overall Study||3
8474684|NCT00632970|20885053|P2|STARTED|Overall Study||3
8474685|NCT00632970|20885054|P1|STARTED|Overall Study||3
8474686|NCT00632931|20885062|P3|NOT COMPLETED|Part 2||24
8474687|NCT00632931|20885063|P2|NOT COMPLETED|Part 2||0
8474688|NCT00632931|20885064|P1|NOT COMPLETED|Part 2||0
8474689|NCT00632931|20885062|P3|COMPLETED|Part 2||0
8474690|NCT00632931|20885063|P2|COMPLETED|Part 2||0
8474691|NCT00632931|20885064|P1|COMPLETED|Part 2||0
8474692|NCT00632931|20885062|P3|STARTED|Part 2||24
8474693|NCT00632931|20885063|P2|STARTED|Part 2||0
8474694|NCT00632931|20885064|P1|STARTED|Part 2||0
8474695|NCT00632931|20885062|P3|NOT COMPLETED|Post-Part 1 Washout||0
8474696|NCT00632931|20885063|P2|NOT COMPLETED|Post-Part 1 Washout||0
8474697|NCT00632931|20885064|P1|NOT COMPLETED|Post-Part 1 Washout||0
8474698|NCT00632931|20885062|P3|COMPLETED|Post-Part 1 Washout||0
8474699|NCT00632931|20885063|P2|COMPLETED|Post-Part 1 Washout||12
8474700|NCT00632931|20885064|P1|COMPLETED|Post-Part 1 Washout||12
8474701|NCT00632931|20885062|P3|STARTED|Post-Part 1 Washout||0
8474702|NCT00632931|20885063|P2|STARTED|Post-Part 1 Washout||12
8474703|NCT00632931|20885064|P1|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
8474704|NCT00632931|20885062|P3|NOT COMPLETED|Part 1, Period 2||0
8474705|NCT00632931|20885063|P2|NOT COMPLETED|Part 1, Period 2||0
8474706|NCT00632931|20885064|P1|NOT COMPLETED|Part 1, Period 2||0
8474707|NCT00632931|20885062|P3|COMPLETED|Part 1, Period 2||0
8474708|NCT00632931|20885063|P2|COMPLETED|Part 1, Period 2||12
8474709|NCT00632931|20885064|P1|COMPLETED|Part 1, Period 2||11
8474710|NCT00632931|20885062|P3|STARTED|Part 1, Period 2||0
8474711|NCT00632931|20885063|P2|STARTED|Part 1, Period 2||12
8474712|NCT00632931|20885064|P1|STARTED|Part 1, Period 2||11
8474713|NCT00632931|20885062|P3|NOT COMPLETED|Part 1, Washout||0
8474714|NCT00632931|20885063|P2|NOT COMPLETED|Part 1, Washout||0
8474715|NCT00632931|20885064|P1|NOT COMPLETED|Part 1, Washout||0
8474716|NCT00632931|20885062|P3|COMPLETED|Part 1, Washout||0
8474717|NCT00632931|20885063|P2|COMPLETED|Part 1, Washout||12
8474718|NCT00632931|20885064|P1|COMPLETED|Part 1, Washout||11
8474719|NCT00632931|20885062|P3|STARTED|Part 1, Washout||0
8474720|NCT00632931|20885063|P2|STARTED|Part 1, Washout||12
8474721|NCT00632931|20885064|P1|STARTED|Part 1, Washout||11
8474722|NCT00632931|20885062|P3|NOT COMPLETED|Part 1, Period 1||0
8474723|NCT00632931|20885063|P2|NOT COMPLETED|Part 1, Period 1||0
8474724|NCT00632931|20885064|P1|NOT COMPLETED|Part 1, Period 1||2
8474725|NCT00632931|20885062|P3|COMPLETED|Part 1, Period 1||0
8474726|NCT00632931|20885063|P2|COMPLETED|Part 1, Period 1||12
8474727|NCT00632931|20885064|P1|COMPLETED|Part 1, Period 1||11
8474728|NCT00632931|20885062|P3|STARTED|Part 1, Period 1||0
8474729|NCT00632931|20885063|P2|STARTED|Part 1, Period 1||12
8474730|NCT00632931|20885064|P1|STARTED|Part 1, Period 1||13
8474731|NCT00632827|20885083|P1|NOT COMPLETED|Overall Study||10
8474732|NCT00632827|20885083|P1|COMPLETED|Overall Study||11
8474733|NCT00632827|20885083|P1|Evaluated Post Stem Cell Transplant|Overall Study||16
8474734|NCT00632827|20885083|P1|Received M-CHOP|Overall Study||18
8474735|NCT00632827|20885083|P1|Received GVD|Overall Study||21
8474736|NCT00632827|20885083|P1|STARTED|Overall Study||21
8474737|NCT00632814|20885093|P3|NOT COMPLETED|Overall Study||0
8474738|NCT00632814|20885094|P2|NOT COMPLETED|Overall Study||0
8474739|NCT00632814|20885095|P1|NOT COMPLETED|Overall Study||0
8474740|NCT00632814|20885093|P3|COMPLETED|Overall Study||8
8474741|NCT00632814|20885094|P2|COMPLETED|Overall Study||13
8474742|NCT00632814|20885095|P1|COMPLETED|Overall Study||11
8474743|NCT00632814|20885093|P3|STARTED|Overall Study||8
8474744|NCT00632814|20885094|P2|STARTED|Overall Study||13
8474745|NCT00632814|20885095|P1|STARTED|Overall Study||11
8474746|NCT00632749|20885141|P14|NOT COMPLETED|Overall Study||6
8474747|NCT00632749|20885142|P13|NOT COMPLETED|Overall Study||3
8474748|NCT00632749|20885143|P12|NOT COMPLETED|Overall Study||4
8474749|NCT00632749|20885144|P11|NOT COMPLETED|Overall Study||7
8474750|NCT00632749|20885145|P10|NOT COMPLETED|Overall Study||3
8474751|NCT00632749|20885146|P9|NOT COMPLETED|Overall Study||5
8474752|NCT00632749|20885147|P8|NOT COMPLETED|Overall Study||4
8474753|NCT00632749|20885148|P7|NOT COMPLETED|Overall Study||5
8474754|NCT00632749|20885149|P6|NOT COMPLETED|Overall Study||8
8474755|NCT00632749|20885150|P5|NOT COMPLETED|Overall Study||7
8474756|NCT00632749|20885151|P4|NOT COMPLETED|Overall Study||4
8474757|NCT00632749|20885152|P3|NOT COMPLETED|Overall Study||3
8474758|NCT00632749|20885153|P2|NOT COMPLETED|Overall Study||5
8474759|NCT00632749|20885154|P1|NOT COMPLETED|Overall Study||4
8474760|NCT00632749|20885141|P14|COMPLETED|Overall Study||0
8474761|NCT00632749|20885142|P13|COMPLETED|Overall Study||0
8474762|NCT00632749|20885143|P12|COMPLETED|Overall Study||0
8474763|NCT00632749|20885144|P11|COMPLETED|Overall Study||0
8474764|NCT00632749|20885145|P10|COMPLETED|Overall Study||0
8474765|NCT00632749|20885146|P9|COMPLETED|Overall Study||0
8474766|NCT00632749|20885147|P8|COMPLETED|Overall Study||0
8474767|NCT00632749|20885148|P7|COMPLETED|Overall Study||0
8474768|NCT00632749|20885149|P6|COMPLETED|Overall Study||0
8474769|NCT00632749|20885150|P5|COMPLETED|Overall Study||0
8474770|NCT00632749|20885151|P4|COMPLETED|Overall Study||0
8474771|NCT00632749|20885152|P3|COMPLETED|Overall Study||0
8474772|NCT00632749|20885153|P2|COMPLETED|Overall Study||0
8474773|NCT00632749|20885154|P1|COMPLETED|Overall Study||0
8474774|NCT00632749|20885141|P14|Not Treated|Overall Study||0
8474775|NCT00632749|20885142|P13|Not Treated|Overall Study||0
8474776|NCT00632749|20885143|P12|Not Treated|Overall Study||0
8474777|NCT00632749|20885144|P11|Not Treated|Overall Study||0
8474778|NCT00632749|20885145|P10|Not Treated|Overall Study||0
8474779|NCT00632749|20885146|P9|Not Treated|Overall Study||0
8474780|NCT00632749|20885147|P8|Not Treated|Overall Study||0
8474781|NCT00632749|20885148|P7|Not Treated|Overall Study||1
8474782|NCT00632749|20885149|P6|Not Treated|Overall Study||1
8474783|NCT00632749|20885150|P5|Not Treated|Overall Study||0
8474784|NCT00632749|20885151|P4|Not Treated|Overall Study||0
8474785|NCT00632749|20885152|P3|Not Treated|Overall Study||0
8474786|NCT00632749|20885153|P2|Not Treated|Overall Study||2
8474787|NCT00632749|20885154|P1|Not Treated|Overall Study||0
8474788|NCT00632749|20885141|P14|Treated|Overall Study||6
8474789|NCT00632749|20885142|P13|Treated|Overall Study||3
8474790|NCT00632749|20885143|P12|Treated|Overall Study||4
8474791|NCT00632749|20885144|P11|Treated|Overall Study||7
8474792|NCT00632749|20885145|P10|Treated|Overall Study||3
8474793|NCT00632749|20885146|P9|Treated|Overall Study||5
8474794|NCT00632749|20885147|P8|Treated|Overall Study||4
8474795|NCT00632749|20885148|P7|Treated|Overall Study||4
8474796|NCT00632749|20885149|P6|Treated|Overall Study||7
8474797|NCT00632749|20885150|P5|Treated|Overall Study||7
8474798|NCT00632749|20885151|P4|Treated|Overall Study||4
8474799|NCT00632749|20885152|P3|Treated|Overall Study||3
8474800|NCT00632749|20885153|P2|Treated|Overall Study||3
8474801|NCT00632749|20885154|P1|Treated|Overall Study||4
8474802|NCT00632749|20885141|P14|STARTED|Overall Study||6
8474803|NCT00632749|20885142|P13|STARTED|Overall Study||3
8474804|NCT00632749|20885143|P12|STARTED|Overall Study||4
8474805|NCT00632749|20885144|P11|STARTED|Overall Study||7
8474806|NCT00632749|20885145|P10|STARTED|Overall Study||3
8474807|NCT00632749|20885146|P9|STARTED|Overall Study||5
8474808|NCT00632749|20885147|P8|STARTED|Overall Study||4
8474809|NCT00632749|20885148|P7|STARTED|Overall Study||5
8474810|NCT00632749|20885149|P6|STARTED|Overall Study||8
8474811|NCT00632749|20885150|P5|STARTED|Overall Study||7
8474812|NCT00632749|20885151|P4|STARTED|Overall Study||4
8474813|NCT00632749|20885152|P3|STARTED|Overall Study||3
8474814|NCT00632749|20885153|P2|STARTED|Overall Study||5
8474815|NCT00632749|20885154|P1|STARTED|Overall Study||4
8474816|NCT00632736|20885448|P1|NOT COMPLETED|Overall Study||268
8474817|NCT00632736|20885448|P1|COMPLETED|Overall Study||151
8474818|NCT00632736|20885448|P1|STARTED|Overall Study||419
8474819|NCT00632632|20885455|P2|NOT COMPLETED|Overall Study||3
8474820|NCT00632632|20885456|P1|NOT COMPLETED|Overall Study||0
8474821|NCT00632632|20885455|P2|COMPLETED|Overall Study||9
8474822|NCT00632632|20885456|P1|COMPLETED|Overall Study||13
8474823|NCT00632632|20885455|P2|STARTED|Overall Study||12
8474824|NCT00632632|20885456|P1|STARTED|Overall Study||13
8474825|NCT00632619|20885468|P2|NOT COMPLETED|Overall Study||4
8474826|NCT00632619|20885469|P1|NOT COMPLETED|Overall Study||8
8474827|NCT00632619|20885468|P2|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10
~nd cohort completed follow up 7/18/11"|31
8474828|NCT00632619|20885469|P1|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10
~nd cohort completed follow up 7/18/11"|25
8474829|NCT00632619|20885468|P2|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
8474830|NCT00632619|20885469|P1|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
8474831|NCT00632541|20885483|P1|NOT COMPLETED|Overall Study||7
8474832|NCT00632541|20885483|P1|COMPLETED|Overall Study||11
8474833|NCT00632541|20885483|P1|STARTED|Overall Study|18 subjects were accrued to the study|18
8474834|NCT00632502|20885492|P2|NOT COMPLETED|Overall Study||1
8474835|NCT00632502|20885493|P1|NOT COMPLETED|Overall Study||3
8474836|NCT00632502|20885492|P2|COMPLETED|Overall Study||11
8474837|NCT00632502|20885493|P1|COMPLETED|Overall Study||22
8474838|NCT00632502|20885492|P2|Completed Treatment|Overall Study||9
8474839|NCT00632502|20885493|P1|Completed Treatment|Overall Study||19
8474840|NCT00632502|20885492|P2|Treated|Overall Study||12
8474841|NCT00632502|20885493|P1|Treated|Overall Study||22
8474842|NCT00632502|20885492|P2|STARTED|Overall Study||12
8474843|NCT00632502|20885493|P1|STARTED|Overall Study||25
8474844|NCT00632489|20885521|P3|NOT COMPLETED|Overall Study||0
8474845|NCT00632489|20885522|P2|NOT COMPLETED|Overall Study||5
8474846|NCT00632489|20885523|P1|NOT COMPLETED|Overall Study||15
8474847|NCT00632489|20885521|P3|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
8474848|NCT00632489|20885522|P2|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
8474849|NCT00632489|20885523|P1|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
8474850|NCT00632489|20885521|P3|STARTED|Overall Study||0
8474851|NCT00632489|20885522|P2|STARTED|Overall Study||5
8474852|NCT00632489|20885523|P1|STARTED|Overall Study||15
8474853|NCT00632463|20885537|P3|NOT COMPLETED|Overall Study||0
8474854|NCT00632463|20885538|P2|NOT COMPLETED|Overall Study||1
8474855|NCT00632463|20885539|P1|NOT COMPLETED|Overall Study||0
8474856|NCT00632463|20885537|P3|COMPLETED|Overall Study||7
8474857|NCT00632463|20885538|P2|COMPLETED|Overall Study||6
8474858|NCT00632463|20885539|P1|COMPLETED|Overall Study||7
8474859|NCT00632463|20885537|P3|STARTED|Overall Study||7
8474860|NCT00632463|20885538|P2|STARTED|Overall Study||7
8474861|NCT00632463|20885539|P1|STARTED|Overall Study||7
8474862|NCT00632424|20885556|P1|NOT COMPLETED|Overall Study||18
8474863|NCT00632424|20885556|P1|COMPLETED|Overall Study||0
8474864|NCT00632424|20885556|P1|STARTED|Overall Study||18
8474865|NCT00632411|20885580|P2|NOT COMPLETED|Overall Study||176
8474866|NCT00632411|20885581|P1|NOT COMPLETED|Overall Study||160
8474867|NCT00632411|20885580|P2|COMPLETED|Overall Study||473
8474868|NCT00632411|20885581|P1|COMPLETED|Overall Study||489
8474869|NCT00632411|20885580|P2|STARTED|Overall Study||649
8474870|NCT00632411|20885581|P1|STARTED|Overall Study||649
8474871|NCT00632359|20885587|P1|NOT COMPLETED|Overall Study||2
8474872|NCT00632359|20885587|P1|COMPLETED|Overall Study||31
8474873|NCT00632359|20885587|P1|STARTED|Overall Study||33
8474874|NCT00632281|20885593|P1|NOT COMPLETED|Overall Study||0
8474875|NCT00632281|20885593|P1|COMPLETED|Overall Study||38
8474876|NCT00632281|20885593|P1|STARTED|Overall Study||38
8474877|NCT00632229|20885600|P2|NOT COMPLETED|Overall Study||6
8474878|NCT00632229|20885601|P1|NOT COMPLETED|Overall Study||6
8474879|NCT00632229|20885600|P2|COMPLETED|Overall Study||11
8474880|NCT00632229|20885601|P1|COMPLETED|Overall Study||11
8474881|NCT00632229|20885600|P2|STARTED|Overall Study||17
8474882|NCT00632229|20885601|P1|STARTED|Overall Study||17
8474883|NCT00632203|20885611|P2|NOT COMPLETED|Overall Study||0
8474884|NCT00632203|20885612|P1|NOT COMPLETED|Overall Study||1
8474885|NCT00632203|20885611|P2|COMPLETED|Overall Study||27
8474886|NCT00632203|20885612|P1|COMPLETED|Overall Study||25
8474887|NCT00632203|20885611|P2|STARTED|Overall Study||27
8474888|NCT00632203|20885612|P1|STARTED|Overall Study||26
8474889|NCT00632125|20885630|P1|NOT COMPLETED|Overall Study||302
8474890|NCT00632125|20885630|P1|COMPLETED|Overall Study||1393
8474891|NCT00632125|20885630|P1|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
8474892|NCT00632099|20885636|P2|NOT COMPLETED|Overall Study||3
8474893|NCT00632099|20885637|P1|NOT COMPLETED|Overall Study||3
8474894|NCT00632099|20885636|P2|COMPLETED|Overall Study||8
8474895|NCT00632099|20885637|P1|COMPLETED|Overall Study||7
8474896|NCT00632099|20885636|P2|STARTED|Overall Study||11
8474897|NCT00632099|20885637|P1|STARTED|Overall Study||10
8474898|NCT00632021|20885645|P2|NOT COMPLETED|Overall Study||7
8474899|NCT00632021|20885646|P1|NOT COMPLETED|Overall Study||4
8474900|NCT00632021|20885645|P2|COMPLETED|Overall Study||423
8474901|NCT00632021|20885646|P1|COMPLETED|Overall Study||428
8474902|NCT00632021|20885645|P2|STARTED|Overall Study||430
8474903|NCT00632021|20885646|P1|STARTED|Overall Study||432
8474904|NCT00631969|20885656|P2|NOT COMPLETED|Overall Study||21
8474905|NCT00631969|20885657|P1|NOT COMPLETED|Overall Study||15
8474906|NCT00631969|20885656|P2|COMPLETED|Overall Study||155
8474907|NCT00631969|20885657|P1|COMPLETED|Overall Study||171
8474908|NCT00631969|20885656|P2|Received Treatment|Overall Study|safety population|174
8474909|NCT00631969|20885657|P1|Received Treatment|Overall Study|safety population|184
8474910|NCT00631969|20885656|P2|STARTED|Overall Study||176
8474911|NCT00631969|20885657|P1|STARTED|Overall Study||186
8474912|NCT00631917|20885703|P2|NOT COMPLETED|Overall Study||108
8474913|NCT00631917|20885704|P1|NOT COMPLETED|Overall Study||88
8474914|NCT00631917|20885703|P2|COMPLETED|Overall Study||291
8474915|NCT00631917|20885704|P1|COMPLETED|Overall Study||287
8474916|NCT00631917|20885703|P2|STARTED|Overall Study||399
8474917|NCT00631917|20885704|P1|STARTED|Overall Study||375
8474918|NCT00631748|20885720|P2|NOT COMPLETED|Overall Study||22
8474919|NCT00631748|20885721|P1|NOT COMPLETED|Overall Study||18
8474920|NCT00631748|20885720|P2|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
8474921|NCT00631748|20885721|P1|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
8474922|NCT00631748|20885720|P2|STARTED|Overall Study||31
8474923|NCT00631748|20885721|P1|STARTED|Overall Study||29
8474924|NCT00631696|20885731|P2|NOT COMPLETED|Overall Study||40
8474925|NCT00631696|20885732|P1|NOT COMPLETED|Overall Study||37
8474926|NCT00631696|20885731|P2|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
8474927|NCT00631696|20885732|P1|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
8474928|NCT00631696|20885731|P2|Ongoing at Database Release 18Oct2011|Overall Study||0
8474929|NCT00631696|20885732|P1|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
8474930|NCT00631696|20885731|P2|Received Study Treatment (Tx)|Overall Study||109
8474931|NCT00631696|20885732|P1|Received Study Treatment (Tx)|Overall Study||111
8474932|NCT00631696|20885731|P2|STARTED|Overall Study||110
8474933|NCT00631696|20885732|P1|STARTED|Overall Study||112
8474934|NCT00631670|20885758|P2|NOT COMPLETED|Overall Study||0
8474935|NCT00631670|20885759|P1|NOT COMPLETED|Overall Study||0
8474936|NCT00631670|20885758|P2|COMPLETED|Overall Study||0
8474937|NCT00631670|20885759|P1|COMPLETED|Overall Study||21
8474938|NCT00631670|20885758|P2|STARTED|Overall Study||0
8474939|NCT00631670|20885759|P1|STARTED|Overall Study||21
8474940|NCT00631657|20885775|P3|NOT COMPLETED|7-Day Discontinuation Period||1
8474941|NCT00631657|20885776|P2|NOT COMPLETED|7-Day Discontinuation Period||1
8474942|NCT00631657|20885777|P1|NOT COMPLETED|7-Day Discontinuation Period||2
8474943|NCT00631657|20885775|P3|COMPLETED|7-Day Discontinuation Period||65
8474944|NCT00631657|20885776|P2|COMPLETED|7-Day Discontinuation Period||136
8474945|NCT00631657|20885777|P1|COMPLETED|7-Day Discontinuation Period||65
8474946|NCT00631657|20885775|P3|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
8474947|NCT00631657|20885776|P2|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
8474948|NCT00631657|20885777|P1|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
8474949|NCT00631657|20885775|P3|STARTED|7-Day Discontinuation Period||66
8474950|NCT00631657|20885776|P2|STARTED|7-Day Discontinuation Period||137
8474951|NCT00631657|20885777|P1|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
8474952|NCT00631657|20885775|P3|NOT COMPLETED|6-Month Treatment Period||50
8474953|NCT00631657|20885776|P2|NOT COMPLETED|6-Month Treatment Period||0
8474954|NCT00631657|20885777|P1|NOT COMPLETED|6-Month Treatment Period||141
8474955|NCT00631657|20885775|P3|COMPLETED|6-Month Treatment Period||66
8474956|NCT00631657|20885776|P2|COMPLETED|6-Month Treatment Period||0
8474957|NCT00631657|20885777|P1|COMPLETED|6-Month Treatment Period||203
8474958|NCT00631657|20885775|P3|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
8474959|NCT00631657|20885776|P2|Treated|6-Month Treatment Period||0
8474960|NCT00631657|20885777|P1|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
8474961|NCT00631657|20885775|P3|STARTED|6-Month Treatment Period||116
8474962|NCT00631657|20885776|P2|STARTED|6-Month Treatment Period||0
8474963|NCT00631657|20885777|P1|STARTED|6-Month Treatment Period||344
8474964|NCT00631566|20885807|P3|NOT COMPLETED|Overall Study||0
8474965|NCT00631566|20885808|P2|NOT COMPLETED|Overall Study||4
8474966|NCT00631566|20885809|P1|NOT COMPLETED|Overall Study||2
8474967|NCT00631566|20885807|P3|COMPLETED|Overall Study||501
8474968|NCT00631566|20885808|P2|COMPLETED|Overall Study||24
8474969|NCT00631566|20885809|P1|COMPLETED|Overall Study||19
8474970|NCT00631566|20885807|P3|STARTED|Overall Study||501
8474971|NCT00631566|20885808|P2|STARTED|Overall Study||28
8474972|NCT00631566|20885809|P1|STARTED|Overall Study||21
8474973|NCT00631540|20885826|P1|NOT COMPLETED|Overall Study||14
8474974|NCT00631540|20885826|P1|COMPLETED|Overall Study||86
8474975|NCT00631540|20885826|P1|STARTED|Overall Study||100
8474976|NCT00631488|20885838|P3|NOT COMPLETED|Overall Study||2
8474977|NCT00631488|20885839|P2|NOT COMPLETED|Overall Study||2
8474978|NCT00631488|20885840|P1|NOT COMPLETED|Overall Study||4
8474979|NCT00631488|20885838|P3|COMPLETED|Overall Study||47
8474980|NCT00631488|20885839|P2|COMPLETED|Overall Study||47
8474981|NCT00631488|20885840|P1|COMPLETED|Overall Study||44
8474982|NCT00631488|20885838|P3|Completed Post-Treatment Period|Overall Study||47
8474983|NCT00631488|20885839|P2|Completed Post-Treatment Period|Overall Study||47
8474984|NCT00631488|20885840|P1|Completed Post-Treatment Period|Overall Study||44
8474985|NCT00631488|20885838|P3|STARTED|Overall Study||49
8474986|NCT00631488|20885839|P2|STARTED|Overall Study||49
8474987|NCT00631488|20885840|P1|STARTED|Overall Study||48
8474988|NCT00631475|20885860|P1|NOT COMPLETED|Overall Study||45
8474989|NCT00631475|20885860|P1|COMPLETED|Overall Study||83
8474990|NCT00631475|20885860|P1|STARTED|Overall Study||128
8474991|NCT00631449|20885870|P2|NOT COMPLETED|Overall Study||0
8474992|NCT00631449|20885871|P1|NOT COMPLETED|Overall Study||0
8474993|NCT00631449|20885870|P2|COMPLETED|Overall Study||15
8474994|NCT00631449|20885871|P1|COMPLETED|Overall Study||15
8474995|NCT00631449|20885870|P2|STARTED|Overall Study||15
8474996|NCT00631449|20885871|P1|STARTED|Overall Study||15
8474997|NCT00631410|20885881|P2|NOT COMPLETED|Overall Study||6
8474998|NCT00631410|20885882|P1|NOT COMPLETED|Overall Study||6
8474999|NCT00631410|20885881|P2|COMPLETED|Overall Study||0
8475000|NCT00631410|20885882|P1|COMPLETED|Overall Study||0
8475001|NCT00631410|20885881|P2|STARTED|Overall Study||6
8475002|NCT00631410|20885882|P1|STARTED|Overall Study||6
8475003|NCT00631371|20885901|P2|NOT COMPLETED|Overall Study||391
8475004|NCT00631371|20885902|P1|NOT COMPLETED|Overall Study||400
8475005|NCT00631371|20885901|P2|COMPLETED|Overall Study||0
8475006|NCT00631371|20885902|P1|COMPLETED|Overall Study||0
8475007|NCT00631371|20885901|P2|Treated|Overall Study||391
8475008|NCT00631371|20885902|P1|Treated|Overall Study||393
8475009|NCT00631371|20885901|P2|STARTED|Overall Study||391
8475010|NCT00631371|20885902|P1|STARTED|Overall Study||400
8475011|NCT00631358|20885916|P2|NOT COMPLETED|Overall Study||2
8475012|NCT00631358|20885917|P1|NOT COMPLETED|Overall Study||6
8475013|NCT00631358|20885916|P2|COMPLETED|Overall Study||45
8475014|NCT00631358|20885917|P1|COMPLETED|Overall Study||44
8475015|NCT00631358|20885916|P2|STARTED|Overall Study||47
8475016|NCT00631358|20885917|P1|STARTED|Overall Study||50
8475017|NCT00631319|20885933|P2|NOT COMPLETED|Double-blind Phase||35
8475018|NCT00631319|20885934|P1|NOT COMPLETED|Double-blind Phase||40
8475019|NCT00631319|20885933|P2|COMPLETED|Double-blind Phase||65
8475020|NCT00631319|20885934|P1|COMPLETED|Double-blind Phase||60
8475021|NCT00631319|20885933|P2|STARTED|Double-blind Phase||100
8475022|NCT00631319|20885934|P1|STARTED|Double-blind Phase||100
8475023|NCT00631319|20885933|P2|NOT COMPLETED|Conversion and Titration Phase||0
8475024|NCT00631319|20885934|P1|NOT COMPLETED|Conversion and Titration Phase||143
8475025|NCT00631319|20885933|P2|COMPLETED|Conversion and Titration Phase||0
8475026|NCT00631319|20885934|P1|COMPLETED|Conversion and Titration Phase||200
8475027|NCT00631319|20885933|P2|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
8475028|NCT00631319|20885934|P1|STARTED|Conversion and Titration Phase||343
8475029|NCT00631189|20885945|P4|NOT COMPLETED|Treatment Phase||7
8475030|NCT00631189|20885946|P3|NOT COMPLETED|Treatment Phase||11
8475031|NCT00631189|20885947|P2|NOT COMPLETED|Treatment Phase||7
8475032|NCT00631189|20885948|P1|NOT COMPLETED|Treatment Phase||0
8475033|NCT00631189|20885945|P4|COMPLETED|Treatment Phase||103
8475034|NCT00631189|20885946|P3|COMPLETED|Treatment Phase||92
8475035|NCT00631189|20885947|P2|COMPLETED|Treatment Phase||97
8475036|NCT00631189|20885948|P1|COMPLETED|Treatment Phase||0
8475037|NCT00631189|20885945|P4|STARTED|Treatment Phase||110
8475038|NCT00631189|20885946|P3|STARTED|Treatment Phase||103
8475039|NCT00631189|20885947|P2|STARTED|Treatment Phase||104
8475040|NCT00631189|20885948|P1|STARTED|Treatment Phase||0
8475041|NCT00631189|20885945|P4|NOT COMPLETED|Initial Phase||0
8475042|NCT00631189|20885946|P3|NOT COMPLETED|Initial Phase||0
8475043|NCT00631189|20885947|P2|NOT COMPLETED|Initial Phase||0
8475044|NCT00631189|20885948|P1|NOT COMPLETED|Initial Phase||351
8475045|NCT00631189|20885945|P4|COMPLETED|Initial Phase||0
8475046|NCT00631189|20885946|P3|COMPLETED|Initial Phase||0
8475047|NCT00631189|20885947|P2|COMPLETED|Initial Phase||0
8475048|NCT00631189|20885948|P1|COMPLETED|Initial Phase||317
8475049|NCT00631189|20885945|P4|STARTED|Initial Phase||0
8475050|NCT00631189|20885946|P3|STARTED|Initial Phase||0
8475051|NCT00631189|20885947|P2|STARTED|Initial Phase||0
8475052|NCT00631189|20885948|P1|STARTED|Initial Phase||668
8475053|NCT00631137|20885992|P2|NOT COMPLETED|Overall Study||0
8475054|NCT00631137|20885993|P1|NOT COMPLETED|Overall Study||1
8475055|NCT00631137|20885992|P2|COMPLETED|Overall Study||0
8475056|NCT00631137|20885993|P1|COMPLETED|Overall Study||0
8475057|NCT00631137|20885992|P2|STARTED|Overall Study||0
8475058|NCT00631137|20885993|P1|STARTED|Overall Study||1
8475059|NCT00631020|20886011|P1|NOT COMPLETED|Overall Study||8
8475060|NCT00631020|20886011|P1|COMPLETED|Overall Study||26
8475061|NCT00631020|20886011|P1|STARTED|Overall Study||34
8475062|NCT00631007|20886026|P6|NOT COMPLETED|Overall Study||15
8475063|NCT00631007|20886027|P5|NOT COMPLETED|Overall Study||12
8475064|NCT00631007|20886028|P4|NOT COMPLETED|Overall Study||9
8475065|NCT00631007|20886029|P3|NOT COMPLETED|Overall Study||10
8475066|NCT00631007|20886030|P2|NOT COMPLETED|Overall Study||11
8475067|NCT00631007|20886031|P1|NOT COMPLETED|Overall Study||11
8475068|NCT00631007|20886026|P6|COMPLETED|Overall Study||46
8475069|NCT00631007|20886027|P5|COMPLETED|Overall Study||48
8475070|NCT00631007|20886028|P4|COMPLETED|Overall Study||53
8475071|NCT00631007|20886029|P3|COMPLETED|Overall Study||53
8475072|NCT00631007|20886030|P2|COMPLETED|Overall Study||50
8475073|NCT00631007|20886031|P1|COMPLETED|Overall Study||49
8475074|NCT00631007|20886026|P6|STARTED|Overall Study||61
8475075|NCT00631007|20886027|P5|STARTED|Overall Study||60
8475076|NCT00631007|20886028|P4|STARTED|Overall Study||62
8475077|NCT00631007|20886029|P3|STARTED|Overall Study||63
8475078|NCT00631007|20886030|P2|STARTED|Overall Study||61
8475079|NCT00631007|20886031|P1|STARTED|Overall Study||60
8475080|NCT00630994|20886051|P1|NOT COMPLETED|Overall Study||4
8475081|NCT00630994|20886051|P1|COMPLETED|Overall Study||0
8475082|NCT00630994|20886051|P1|STARTED|Overall Study||4
8475083|NCT00630955|20886062|P3|NOT COMPLETED|Overall Study||12
8475084|NCT00630955|20886063|P2|NOT COMPLETED|Overall Study||6
8475085|NCT00630955|20886064|P1|NOT COMPLETED|Overall Study||3
8475086|NCT00630955|20886062|P3|COMPLETED|Overall Study||28
8475087|NCT00630955|20886063|P2|COMPLETED|Overall Study||31
8475088|NCT00630955|20886064|P1|COMPLETED|Overall Study||31
8475089|NCT00630955|20886062|P3|STARTED|Overall Study||40
8475090|NCT00630955|20886063|P2|STARTED|Overall Study||37
8475091|NCT00630955|20886064|P1|STARTED|Overall Study||34
8475092|NCT00630916|20886081|P1|NOT COMPLETED|Overall Study||210
8475093|NCT00630916|20886081|P1|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
8475094|NCT00630916|20886081|P1|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
8475095|NCT00630916|20886081|P1|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
8475096|NCT00630877|20886091|P3|NOT COMPLETED|Overall Study||10
8475097|NCT00630877|20886092|P2|NOT COMPLETED|Overall Study||15
8475098|NCT00630877|20886093|P1|NOT COMPLETED|Overall Study||19
8475099|NCT00630877|20886091|P3|COMPLETED|Overall Study||80
8475100|NCT00630877|20886092|P2|COMPLETED|Overall Study||75
8475101|NCT00630877|20886093|P1|COMPLETED|Overall Study||72
8475102|NCT00630877|20886091|P3|STARTED|Overall Study||90
8475103|NCT00630877|20886092|P2|STARTED|Overall Study||90
8475104|NCT00630877|20886093|P1|STARTED|Overall Study|For all arms, started means treated.|91
8475105|NCT00630864|20886111|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
8475106|NCT00630864|20886111|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
8475107|NCT00630864|20886111|P1|STARTED|Part 2 (After Week 6 up to Month 12)||20
8475108|NCT00630864|20886111|P1|NOT COMPLETED|Part 1 (up to Week 6)||1
8475109|NCT00630864|20886111|P1|COMPLETED|Part 1 (up to Week 6)||20
8475110|NCT00630864|20886111|P1|STARTED|Part 1 (up to Week 6)||21
8475111|NCT00630838|20886150|P2|NOT COMPLETED|Overall Study||2
8475112|NCT00630838|20886151|P1|NOT COMPLETED|Overall Study||0
8475113|NCT00630838|20886150|P2|COMPLETED|Overall Study||28
8475114|NCT00630838|20886151|P1|COMPLETED|Overall Study||32
8475115|NCT00630838|20886150|P2|STARTED|Overall Study||30
8475116|NCT00630838|20886151|P1|STARTED|Overall Study||32
8475117|NCT00630825|20886163|P4|NOT COMPLETED|Overall Study||6
8475118|NCT00630825|20886164|P3|NOT COMPLETED|Overall Study||8
8475119|NCT00630825|20886165|P2|NOT COMPLETED|Overall Study||7
8475120|NCT00630825|20886166|P1|NOT COMPLETED|Overall Study||9
8475121|NCT00630825|20886163|P4|COMPLETED|Overall Study||60
8475122|NCT00630825|20886164|P3|COMPLETED|Overall Study||58
8475123|NCT00630825|20886165|P2|COMPLETED|Overall Study||58
8475124|NCT00630825|20886166|P1|COMPLETED|Overall Study||56
8475125|NCT00630825|20886163|P4|Received at Least One Dose of Study Drug|Overall Study||66
8475126|NCT00630825|20886164|P3|Received at Least One Dose of Study Drug|Overall Study||66
8475127|NCT00630825|20886165|P2|Received at Least One Dose of Study Drug|Overall Study||65
8475128|NCT00630825|20886166|P1|Received at Least One Dose of Study Drug|Overall Study||65
8475129|NCT00630825|20886163|P4|STARTED|Overall Study||66
8475130|NCT00630825|20886164|P3|STARTED|Overall Study||66
8475131|NCT00630825|20886165|P2|STARTED|Overall Study||65
8475132|NCT00630825|20886166|P1|STARTED|Overall Study||65
8475133|NCT00630812|20886237|P2|NOT COMPLETED|Double Blind Treatment Period||14
8475134|NCT00630812|20886238|P1|NOT COMPLETED|Double Blind Treatment Period||31
8475135|NCT00630812|20886237|P2|COMPLETED|Double Blind Treatment Period||107
8475136|NCT00630812|20886238|P1|COMPLETED|Double Blind Treatment Period||153
8475137|NCT00630812|20886237|P2|STARTED|Double Blind Treatment Period||121
8475138|NCT00630812|20886238|P1|STARTED|Double Blind Treatment Period||184
8475139|NCT00630812|20886237|P2|NOT COMPLETED|Randomisation to First Dose||5
8475140|NCT00630812|20886238|P1|NOT COMPLETED|Randomisation to First Dose||8
8475141|NCT00630812|20886237|P2|COMPLETED|Randomisation to First Dose||121
8475142|NCT00630812|20886238|P1|COMPLETED|Randomisation to First Dose||184
8475143|NCT00630812|20886237|P2|STARTED|Randomisation to First Dose||126
8475144|NCT00630812|20886238|P1|STARTED|Randomisation to First Dose||192
8475145|NCT00630786|20886263|P3|NOT COMPLETED|Overall Study||2
8475146|NCT00630786|20886264|P2|NOT COMPLETED|Overall Study||2
8475147|NCT00630786|20886265|P1|NOT COMPLETED|Overall Study||1
8475148|NCT00630786|20886263|P3|COMPLETED|Overall Study|Completed study defined as participant death|7
8475149|NCT00630786|20886264|P2|COMPLETED|Overall Study|Completed study defined as participant death|23
8475150|NCT00630786|20886265|P1|COMPLETED|Overall Study|Completed study defined as participant death|18
8475151|NCT00630786|20886263|P3|Received Study Medication|Overall Study||8
8475152|NCT00630786|20886264|P2|Received Study Medication|Overall Study||25
8475153|NCT00630786|20886265|P1|Received Study Medication|Overall Study||19
8475154|NCT00630786|20886263|P3|STARTED|Overall Study|All patients were enrolled in Part 2.|9
8475155|NCT00630786|20886264|P2|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
8475156|NCT00630786|20886265|P1|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
8475161|NCT00630734|20886296|P3|NOT COMPLETED|Overall Study||1
8475162|NCT00630734|20886297|P2|NOT COMPLETED|Overall Study||1
8475163|NCT00630734|20886298|P1|NOT COMPLETED|Overall Study||2
8475164|NCT00630734|20886296|P3|COMPLETED|Overall Study||7
8475165|NCT00630734|20886297|P2|COMPLETED|Overall Study||12
8475166|NCT00630734|20886298|P1|COMPLETED|Overall Study||9
8475167|NCT00630734|20886296|P3|STARTED|Overall Study||8
8475168|NCT00630734|20886297|P2|STARTED|Overall Study||13
8475169|NCT00630734|20886298|P1|STARTED|Overall Study||11
8475170|NCT00630539|20886337|P4|NOT COMPLETED|Overall Study||3
8475171|NCT00630539|20886338|P3|NOT COMPLETED|Overall Study||1
8475172|NCT00630539|20886339|P2|NOT COMPLETED|Overall Study||4
8475173|NCT00630539|20886340|P1|NOT COMPLETED|Overall Study||1
8475174|NCT00630539|20886337|P4|COMPLETED|Overall Study||27
8475175|NCT00630539|20886338|P3|COMPLETED|Overall Study||28
8475176|NCT00630539|20886339|P2|COMPLETED|Overall Study||29
8475177|NCT00630539|20886340|P1|COMPLETED|Overall Study||33
8475178|NCT00630539|20886337|P4|STARTED|Overall Study||30
8475179|NCT00630539|20886338|P3|STARTED|Overall Study||29
8475180|NCT00630539|20886339|P2|STARTED|Overall Study||33
8475181|NCT00630539|20886340|P1|STARTED|Overall Study||34
8475182|NCT00630487|20886396|P2|NOT COMPLETED|Overall Study||0
8475183|NCT00630487|20886397|P1|NOT COMPLETED|Overall Study||0
8475184|NCT00630487|20886396|P2|COMPLETED|Overall Study||0
8475185|NCT00630487|20886397|P1|COMPLETED|Overall Study||0
8475186|NCT00630487|20886396|P2|STARTED|Overall Study||0
8475187|NCT00630487|20886397|P1|STARTED|Overall Study||0
8475188|NCT00630409|20886431|P1|NOT COMPLETED|Overall Study||1
8475189|NCT00630409|20886431|P1|COMPLETED|Overall Study||4
8475190|NCT00630409|20886431|P1|STARTED|Overall Study||5
8475191|NCT00630396|20886436|P1|NOT COMPLETED|Overall Study||7
8475192|NCT00630396|20886436|P1|COMPLETED|Overall Study||53
8475193|NCT00630396|20886436|P1|STARTED|Overall Study||60
8475194|NCT00630344|20886442|P1|NOT COMPLETED|Overall Study||36
8475195|NCT00630344|20886442|P1|COMPLETED|Overall Study||0
8475196|NCT00630344|20886442|P1|STARTED|Overall Study||36
8475197|NCT00630331|20886454|P3|NOT COMPLETED|Overall Study||188
8475198|NCT00630331|20886455|P2|NOT COMPLETED|Overall Study||166
8475199|NCT00630331|20886456|P1|NOT COMPLETED|Overall Study||206
8475200|NCT00630331|20886454|P3|COMPLETED|Overall Study||3712
8475201|NCT00630331|20886455|P2|COMPLETED|Overall Study||3510
8475202|NCT00630331|20886456|P1|COMPLETED|Overall Study||3622
8475203|NCT00630331|20886454|P3|STARTED|Overall Study||3900
8475204|NCT00630331|20886455|P2|STARTED|Overall Study||3676
8475205|NCT00630331|20886456|P1|STARTED|Overall Study||3828
8475206|NCT00630305|20886497|P1|NOT COMPLETED|Overall Study||2
8475207|NCT00630305|20886497|P1|COMPLETED|Overall Study||35
8475208|NCT00630305|20886497|P1|STARTED|Overall Study||37
8475209|NCT00630292|20886519|P1|NOT COMPLETED|Overall Study||1
8475210|NCT00630292|20886519|P1|COMPLETED|Overall Study||5
8475211|NCT00630292|20886519|P1|STARTED|Overall Study||6
8475212|NCT00630058|20886525|P2|NOT COMPLETED|Overall Study||4
8475213|NCT00630058|20886526|P1|NOT COMPLETED|Overall Study||4
8475214|NCT00630058|20886525|P2|COMPLETED|Overall Study||6
8475215|NCT00630058|20886526|P1|COMPLETED|Overall Study||6
8475216|NCT00630058|20886525|P2|STARTED|Overall Study||10
8475217|NCT00630058|20886526|P1|STARTED|Overall Study||10
8475218|NCT00629850|20886544|P2|NOT COMPLETED|Overall Study||0
8475219|NCT00629850|20886545|P1|NOT COMPLETED|Overall Study||0
8475220|NCT00629850|20886544|P2|COMPLETED|Overall Study||0
8475221|NCT00629850|20886545|P1|COMPLETED|Overall Study||1
8475222|NCT00629850|20886544|P2|STARTED|Overall Study||0
8475223|NCT00629850|20886545|P1|STARTED|Overall Study||1
8475224|NCT00629772|20886557|P2|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
8475225|NCT00629772|20886558|P1|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
8475226|NCT00629772|20886557|P2|COMPLETED|Second Intervention Week 14 - Week 26||10
8475227|NCT00629772|20886558|P1|COMPLETED|Second Intervention Week 14 - Week 26||11
8475228|NCT00629772|20886557|P2|STARTED|Second Intervention Week 14 - Week 26||12
8475229|NCT00629772|20886558|P1|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
8475230|NCT00629772|20886557|P2|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
8475231|NCT00629772|20886558|P1|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
8475232|NCT00629772|20886557|P2|COMPLETED|First Intervention - Day 0 - Week 14||12
8475233|NCT00629772|20886558|P1|COMPLETED|First Intervention - Day 0 - Week 14||12
8475234|NCT00629772|20886557|P2|STARTED|First Intervention - Day 0 - Week 14||12
8475235|NCT00629772|20886558|P1|STARTED|First Intervention - Day 0 - Week 14||12
8475236|NCT00629707|20886578|P2|NOT COMPLETED|Overall Study||2
8475237|NCT00629707|20886579|P1|NOT COMPLETED|Overall Study||0
8475238|NCT00629707|20886578|P2|COMPLETED|Overall Study||8
8475239|NCT00629707|20886579|P1|COMPLETED|Overall Study||10
8475240|NCT00629707|20886578|P2|STARTED|Overall Study||10
8475241|NCT00629707|20886579|P1|STARTED|Overall Study||10
8475242|NCT00629525|20886585|P1|NOT COMPLETED|Overall Study||3
8475243|NCT00629525|20886585|P1|COMPLETED|Overall Study||32
8475244|NCT00629525|20886585|P1|STARTED|Overall Study||35
8475245|NCT00629499|20886593|P1|NOT COMPLETED|Overall Study||0
8475246|NCT00629499|20886593|P1|COMPLETED|Overall Study||63
8475247|NCT00629499|20886593|P1|STARTED|Overall Study||63
8475248|NCT00629265|20886599|P2|NOT COMPLETED|Overall Study||20
8475249|NCT00629265|20886600|P1|NOT COMPLETED|Overall Study||32
8475250|NCT00629265|20886599|P2|COMPLETED|Overall Study||34
8475251|NCT00629265|20886600|P1|COMPLETED|Overall Study||84
8475252|NCT00629265|20886599|P2|STARTED|Overall Study||54
8475253|NCT00629265|20886600|P1|STARTED|Overall Study||116
8475254|NCT00629239|20886610|P2|NOT COMPLETED|Overall Study||4
8475255|NCT00629239|20886611|P1|NOT COMPLETED|Overall Study||8
8475256|NCT00629239|20886610|P2|COMPLETED|Overall Study||28
8475257|NCT00629239|20886611|P1|COMPLETED|Overall Study||26
8475258|NCT00629239|20886610|P2|STARTED|Overall Study||32
8475259|NCT00629239|20886611|P1|STARTED|Overall Study||34
8475260|NCT00629122|20886645|P2|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
8475261|NCT00629122|20886646|P1|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
8475262|NCT00629122|20886645|P2|COMPLETED|Third Period: Day 6-8 (Oral)||3
8475263|NCT00629122|20886646|P1|COMPLETED|Third Period: Day 6-8 (Oral)||2
8475264|NCT00629122|20886645|P2|STARTED|Third Period: Day 6-8 (Oral)||3
8475265|NCT00629122|20886646|P1|STARTED|Third Period: Day 6-8 (Oral)||2
8475266|NCT00629122|20886645|P2|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
8475267|NCT00629122|20886646|P1|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
8475268|NCT00629122|20886645|P2|COMPLETED|Second Period: Day 3-5 (Washout)||3
8475269|NCT00629122|20886646|P1|COMPLETED|Second Period: Day 3-5 (Washout)||2
8475270|NCT00629122|20886645|P2|STARTED|Second Period: Day 3-5 (Washout)||3
8475271|NCT00629122|20886646|P1|STARTED|Second Period: Day 3-5 (Washout)||2
8475272|NCT00629122|20886645|P2|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
8475273|NCT00629122|20886646|P1|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
8475274|NCT00629122|20886645|P2|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
8475275|NCT00629122|20886646|P1|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
8475276|NCT00629122|20886645|P2|STARTED|First Period: Day 1- 3 (Sublingual)||3
8475277|NCT00629122|20886646|P1|STARTED|First Period: Day 1- 3 (Sublingual)||2
8475278|NCT00629083|20886664|P2|NOT COMPLETED|Overall Study||14
8475279|NCT00629083|20886665|P1|NOT COMPLETED|Overall Study||28
8475280|NCT00629083|20886664|P2|COMPLETED|Overall Study||103
8475281|NCT00629083|20886665|P1|COMPLETED|Overall Study||200
8475282|NCT00629083|20886664|P2|STARTED|Overall Study||117
8475283|NCT00629083|20886665|P1|STARTED|Overall Study||228
8475284|NCT00629018|20886685|P2|NOT COMPLETED|Overall Study||0
8475285|NCT00629018|20886686|P1|NOT COMPLETED|Overall Study||0
8475286|NCT00629018|20886685|P2|COMPLETED|Overall Study||55
8475287|NCT00629018|20886686|P1|COMPLETED|Overall Study||55
8475288|NCT00629018|20886685|P2|STARTED|Overall Study||55
8475289|NCT00629018|20886686|P1|STARTED|Overall Study||55
8475290|NCT00628927|20886696|P2|NOT COMPLETED|Overall Study||0
8475291|NCT00628927|20886697|P1|NOT COMPLETED|Overall Study||8
8475292|NCT00628927|20886696|P2|COMPLETED|Overall Study||30
8475293|NCT00628927|20886697|P1|COMPLETED|Overall Study||175
8475294|NCT00628927|20886696|P2|STARTED|Overall Study||30
8475295|NCT00628927|20886697|P1|STARTED|Overall Study||183
8475296|NCT00628901|20886710|P2|NOT COMPLETED|Overall Study||1
8475297|NCT00628901|20886711|P1|NOT COMPLETED|Overall Study||3
8475298|NCT00628901|20886710|P2|COMPLETED|Overall Study||29
8475299|NCT00628901|20886711|P1|COMPLETED|Overall Study||27
8475300|NCT00628901|20886710|P2|STARTED|Overall Study||30
8475301|NCT00628901|20886711|P1|STARTED|Overall Study||30
8475302|NCT00628862|20886742|P3|NOT COMPLETED|Overall Study||22
8475303|NCT00628862|20886743|P2|NOT COMPLETED|Overall Study||17
8475304|NCT00628862|20886744|P1|NOT COMPLETED|Overall Study||11
8475305|NCT00628862|20886742|P3|COMPLETED|Overall Study|randomised patients|186
8475306|NCT00628862|20886743|P2|COMPLETED|Overall Study|randomised patients|182
8475307|NCT00628862|20886744|P1|COMPLETED|Overall Study|randomised patients|195
8475308|NCT00628862|20886742|P3|STARTED|Overall Study|randomised patients|208
8475309|NCT00628862|20886743|P2|STARTED|Overall Study|randomised patients|199
8475310|NCT00628862|20886744|P1|STARTED|Overall Study|randomised patients|206
8475311|NCT00628758|20886790|P2|NOT COMPLETED|Overall Study||42
8475312|NCT00628758|20886791|P1|NOT COMPLETED|Overall Study||44
8475313|NCT00628758|20886790|P2|COMPLETED|Overall Study||179
8475314|NCT00628758|20886791|P1|COMPLETED|Overall Study||165
8475315|NCT00628758|20886790|P2|STARTED|Overall Study||221
8475316|NCT00628758|20886791|P1|STARTED|Overall Study||209
8475317|NCT00628628|20886805|P2|NOT COMPLETED|Overall Study||0
8475318|NCT00628628|20886806|P1|NOT COMPLETED|Overall Study||0
8475319|NCT00628628|20886805|P2|COMPLETED|Overall Study||40
8475320|NCT00628628|20886806|P1|COMPLETED|Overall Study||40
8475321|NCT00628628|20886805|P2|STARTED|Overall Study||40
8475322|NCT00628628|20886806|P1|STARTED|Overall Study||40
8475323|NCT00628589|20886815|P3|NOT COMPLETED|Overall Study||3
8475324|NCT00628589|20886816|P2|NOT COMPLETED|Overall Study||2
8475325|NCT00628589|20886817|P1|NOT COMPLETED|Overall Study||1
8475326|NCT00628589|20886815|P3|COMPLETED|Overall Study||110
8475327|NCT00628589|20886816|P2|COMPLETED|Overall Study||114
8475328|NCT00628589|20886817|P1|COMPLETED|Overall Study||114
8475329|NCT00628589|20886815|P3|STARTED|Overall Study||113
8475330|NCT00628589|20886816|P2|STARTED|Overall Study||116
8475331|NCT00628589|20886817|P1|STARTED|Overall Study||115
8475332|NCT00628498|20886831|P1|NOT COMPLETED|Overall Study||52
8475333|NCT00628498|20886831|P1|COMPLETED|Overall Study||1154
8475334|NCT00628498|20886831|P1|STARTED|Overall Study||1206
8475335|NCT00628446|20886835|P1|NOT COMPLETED|Overall Study||7
8475336|NCT00628446|20886835|P1|COMPLETED|Overall Study||38
8475337|NCT00628446|20886835|P1|STARTED|Overall Study||45
8475338|NCT00628407|20886840|P1|NOT COMPLETED|Overall Study||0
8475339|NCT00628407|20886840|P1|COMPLETED|Overall Study||13
8475340|NCT00628407|20886840|P1|STARTED|Overall Study||13
8475341|NCT00628394|20886848|P4|NOT COMPLETED|Overall Study||3
8475342|NCT00628394|20886849|P3|NOT COMPLETED|Overall Study||2
8475343|NCT00628394|20886850|P2|NOT COMPLETED|Overall Study||4
8475344|NCT00628394|20886851|P1|NOT COMPLETED|Overall Study||4
8475345|NCT00628394|20886848|P4|COMPLETED|Overall Study||10
8475346|NCT00628394|20886849|P3|COMPLETED|Overall Study||11
8475347|NCT00628394|20886850|P2|COMPLETED|Overall Study||9
8475348|NCT00628394|20886851|P1|COMPLETED|Overall Study||10
8475349|NCT00628394|20886848|P4|STARTED|Overall Study||13
8475350|NCT00628394|20886849|P3|STARTED|Overall Study||13
8475351|NCT00628394|20886850|P2|STARTED|Overall Study||13
8475352|NCT00628394|20886851|P1|STARTED|Overall Study||14
8475353|NCT00628355|20886867|P2|NOT COMPLETED|Overall Study||1
8475354|NCT00628355|20886868|P1|NOT COMPLETED|Overall Study||1
8475355|NCT00628355|20886867|P2|COMPLETED|Overall Study||14
8475356|NCT00628355|20886868|P1|COMPLETED|Overall Study||14
8475357|NCT00628355|20886867|P2|STARTED|Overall Study||15
8475358|NCT00628355|20886868|P1|STARTED|Overall Study||15
8475359|NCT00628251|20886879|P3|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25
8475360|NCT00628251|20886880|P2|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20
8475361|NCT00628251|20886881|P1|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22
8475362|NCT00628251|20886879|P3|COMPLETED|Ongoing Initial Study Treatment at DCO|Patients ongoing initial study treatment (Liposomal doxorubicin)|7
8475363|NCT00628251|20886880|P2|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|12
8475364|NCT00628251|20886881|P1|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|10
8475365|NCT00628251|20886879|P3|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9
8475366|NCT00628251|20886880|P2|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
8475367|NCT00628251|20886881|P1|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
8475368|NCT00628251|20886879|P3|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5
8475369|NCT00628251|20886880|P2|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
8475370|NCT00628251|20886881|P1|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
8475371|NCT00628251|20886879|P3|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO|Crossover dosage was 400 mg bd Olaparib|14
8475372|NCT00628251|20886880|P2|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
8475373|NCT00628251|20886881|P1|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
8475374|NCT00628251|20886879|P3|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25
8475375|NCT00628251|20886880|P2|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20
8475376|NCT00628251|20886881|P1|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22
8475377|NCT00628251|20886879|P3|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received Liposomal doxorubicin 50 mg/m2|32
8475378|NCT00628251|20886880|P2|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
8475379|NCT00628251|20886881|P1|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
8475380|NCT00628251|20886879|P3|NOT COMPLETED|Randomised Part||1
8475381|NCT00628251|20886880|P2|NOT COMPLETED|Randomised Part||0
8475382|NCT00628251|20886881|P1|NOT COMPLETED|Randomised Part||0
8475383|NCT00628251|20886879|P3|COMPLETED|Randomised Part|1 of 33 patients did not receive Liposomal Doxorubicin. Patient voluntarily discontinued|32
8475384|NCT00628251|20886880|P2|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
8475385|NCT00628251|20886881|P1|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
8475386|NCT00628251|20886879|P3|STARTED|Randomised Part|Patients randomised|33
8475387|NCT00628251|20886880|P2|STARTED|Randomised Part|Patients randomised|32
8475388|NCT00628251|20886881|P1|STARTED|Randomised Part|Patients randomised|32
8475389|NCT00628212|20886927|P4|NOT COMPLETED|Overall Study||5
8475390|NCT00628212|20886928|P3|NOT COMPLETED|Overall Study||3
8475391|NCT00628212|20886929|P2|NOT COMPLETED|Overall Study||1
8475392|NCT00628212|20886930|P1|NOT COMPLETED|Overall Study||3
8475393|NCT00628212|20886927|P4|COMPLETED|Overall Study||76
8475394|NCT00628212|20886928|P3|COMPLETED|Overall Study||76
8475395|NCT00628212|20886929|P2|COMPLETED|Overall Study||83
8475396|NCT00628212|20886930|P1|COMPLETED|Overall Study||77
8475397|NCT00628212|20886927|P4|STARTED|Overall Study||81
8475398|NCT00628212|20886928|P3|STARTED|Overall Study||79
8475399|NCT00628212|20886929|P2|STARTED|Overall Study||84
8475400|NCT00628212|20886930|P1|STARTED|Overall Study||80
8475401|NCT00628147|20886954|P2|NOT COMPLETED|Overall Study||1
8475402|NCT00628147|20886955|P1|NOT COMPLETED|Overall Study||7
8475403|NCT00628147|20886954|P2|COMPLETED|Overall Study||141
8475404|NCT00628147|20886955|P1|COMPLETED|Overall Study||135
8475405|NCT00628147|20886954|P2|STARTED|Overall Study||142
8475406|NCT00628147|20886955|P1|STARTED|Overall Study||142
8475407|NCT00628134|20886967|P2|NOT COMPLETED|Overall Study||0
8475408|NCT00628134|20886968|P1|NOT COMPLETED|Overall Study||0
8475409|NCT00628134|20886967|P2|COMPLETED|Overall Study||4
8475410|NCT00628134|20886968|P1|COMPLETED|Overall Study||4
8475411|NCT00628134|20886967|P2|STARTED|Overall Study||4
8475412|NCT00628134|20886968|P1|STARTED|Overall Study||4
8475413|NCT00628108|20886978|P2|NOT COMPLETED|Overall Study||3
8475414|NCT00628108|20886979|P1|NOT COMPLETED|Overall Study||1
8475415|NCT00628108|20886978|P2|COMPLETED|Overall Study||43
8475416|NCT00628108|20886979|P1|COMPLETED|Overall Study||22
8475417|NCT00628108|20886978|P2|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
8475418|NCT00628108|20886979|P1|Safety Population|Overall Study||24
8475419|NCT00628108|20886978|P2|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
8475420|NCT00628108|20886979|P1|STARTED|Overall Study||23
8475421|NCT00628030|20887011|P2|NOT COMPLETED|Post to 6 Month Follow-up||30
8475422|NCT00628030|20887012|P1|NOT COMPLETED|Post to 6 Month Follow-up||32
8475423|NCT00628030|20887011|P2|COMPLETED|Post to 6 Month Follow-up||33
8475424|NCT00628030|20887012|P1|COMPLETED|Post to 6 Month Follow-up||27
8475425|NCT00628030|20887011|P2|STARTED|Post to 6 Month Follow-up||63
8475426|NCT00628030|20887012|P1|STARTED|Post to 6 Month Follow-up||59
8475427|NCT00628030|20887011|P2|NOT COMPLETED|Baseline to Post-Assessment||29
8475428|NCT00628030|20887012|P1|NOT COMPLETED|Baseline to Post-Assessment||33
8475429|NCT00628030|20887011|P2|COMPLETED|Baseline to Post-Assessment||63
8475430|NCT00628030|20887012|P1|COMPLETED|Baseline to Post-Assessment||59
8475431|NCT00628030|20887011|P2|STARTED|Baseline to Post-Assessment||92
8475432|NCT00628030|20887012|P1|STARTED|Baseline to Post-Assessment||92
8475433|NCT00627978|20887028|P2|NOT COMPLETED|Overall Study||0
8475434|NCT00627978|20887029|P1|NOT COMPLETED|Overall Study||0
8475435|NCT00627978|20887028|P2|COMPLETED|Overall Study||5
8475436|NCT00627978|20887029|P1|COMPLETED|Overall Study||10
8475437|NCT00627978|20887028|P2|STARTED|Overall Study||5
8475438|NCT00627978|20887029|P1|STARTED|Overall Study||10
8475439|NCT00627926|20887038|P3|NOT COMPLETED|Overall Study||95
8475440|NCT00627926|20887039|P2|NOT COMPLETED|Overall Study||104
8475441|NCT00627926|20887040|P1|NOT COMPLETED|Overall Study||159
8475442|NCT00627926|20887038|P3|COMPLETED|Overall Study||268
8475443|NCT00627926|20887039|P2|COMPLETED|Overall Study||260
8475444|NCT00627926|20887040|P1|COMPLETED|Overall Study||202
8475445|NCT00627926|20887038|P3|STARTED|Overall Study||363
8475446|NCT00627926|20887039|P2|STARTED|Overall Study||364
8475447|NCT00627926|20887040|P1|STARTED|Overall Study||361
8475448|NCT00627861|20887084|P1|NOT COMPLETED|Overall Study||0
8475449|NCT00627861|20887084|P1|COMPLETED|Overall Study||1
8475450|NCT00627861|20887084|P1|STARTED|Overall Study||1
8475451|NCT00627705|20887092|P2|NOT COMPLETED|Overall Study||6
8475452|NCT00627705|20887093|P1|NOT COMPLETED|Overall Study||2
8475453|NCT00627705|20887092|P2|COMPLETED|Overall Study||12
8475454|NCT00627705|20887093|P1|COMPLETED|Overall Study||13
8475455|NCT00627705|20887092|P2|STARTED|Overall Study||18
8475456|NCT00627705|20887093|P1|STARTED|Overall Study||15
8475457|NCT00627679|20887113|P4|NOT COMPLETED|Overall Study||0
8475458|NCT00627679|20887114|P3|NOT COMPLETED|Overall Study||0
8475459|NCT00627679|20887115|P2|NOT COMPLETED|Overall Study||0
8475460|NCT00627679|20887116|P1|NOT COMPLETED|Overall Study||0
8475461|NCT00627679|20887113|P4|COMPLETED|Overall Study||4
8475462|NCT00627679|20887114|P3|COMPLETED|Overall Study||4
8475463|NCT00627679|20887115|P2|COMPLETED|Overall Study||4
8475464|NCT00627679|20887116|P1|COMPLETED|Overall Study||4
8475465|NCT00627679|20887113|P4|STARTED|Overall Study||4
8475466|NCT00627679|20887114|P3|STARTED|Overall Study||4
8475467|NCT00627679|20887115|P2|STARTED|Overall Study||4
8475468|NCT00627679|20887116|P1|STARTED|Overall Study||4
8475469|NCT00627523|20887144|P2|NOT COMPLETED|Overall Study||2
8475470|NCT00627523|20887145|P1|NOT COMPLETED|Overall Study||2
8475471|NCT00627523|20887144|P2|COMPLETED|Overall Study||20
8475472|NCT00627523|20887145|P1|COMPLETED|Overall Study||19
8475473|NCT00627523|20887144|P2|STARTED|Overall Study||22
8475474|NCT00627523|20887145|P1|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
8475475|NCT00627497|20887173|P4|NOT COMPLETED|Overall Study||0
8475476|NCT00627497|20887174|P3|NOT COMPLETED|Overall Study||0
8475477|NCT00627497|20887175|P2|NOT COMPLETED|Overall Study||1
8475478|NCT00627497|20887176|P1|NOT COMPLETED|Overall Study||1
8475479|NCT00627497|20887173|P4|COMPLETED|Overall Study||2
8475480|NCT00627497|20887174|P3|COMPLETED|Overall Study||4
8475481|NCT00627497|20887175|P2|COMPLETED|Overall Study||11
8475482|NCT00627497|20887176|P1|COMPLETED|Overall Study||13
8475483|NCT00627497|20887173|P4|STARTED|Overall Study||2
8475484|NCT00627497|20887174|P3|STARTED|Overall Study||4
8475485|NCT00627497|20887175|P2|STARTED|Overall Study||12
8475486|NCT00627497|20887176|P1|STARTED|Overall Study||14
8475487|NCT00627458|20887237|P3|NOT COMPLETED|Overall Study||6
8475488|NCT00627458|20887238|P2|NOT COMPLETED|Overall Study||7
8475489|NCT00627458|20887239|P1|NOT COMPLETED|Overall Study||4
8475490|NCT00627458|20887237|P3|COMPLETED|Overall Study||133
8475491|NCT00627458|20887238|P2|COMPLETED|Overall Study||130
8475492|NCT00627458|20887239|P1|COMPLETED|Overall Study||123
8475493|NCT00627458|20887237|P3|STARTED|Overall Study||139
8475494|NCT00627458|20887238|P2|STARTED|Overall Study||137
8475495|NCT00627458|20887239|P1|STARTED|Overall Study||127
8475496|NCT00627445|20887314|P2|NOT COMPLETED|Overall Study||12
8475497|NCT00627445|20887315|P1|NOT COMPLETED|Overall Study||9
8475498|NCT00627445|20887314|P2|COMPLETED|Overall Study||210
8475499|NCT00627445|20887315|P1|COMPLETED|Overall Study||210
8475500|NCT00627445|20887314|P2|Exposed to Study Drug|Overall Study||222
8475501|NCT00627445|20887315|P1|Exposed to Study Drug|Overall Study||219
8475502|NCT00627445|20887314|P2|STARTED|Overall Study||222
8475503|NCT00627445|20887315|P1|STARTED|Overall Study||219
8475504|NCT00627406|20887339|P4|NOT COMPLETED|Overall Study||0
8475505|NCT00627406|20887340|P3|NOT COMPLETED|Overall Study||0
8475506|NCT00627406|20887341|P2|NOT COMPLETED|Overall Study||0
8475507|NCT00627406|20887342|P1|NOT COMPLETED|Overall Study||0
8475508|NCT00627406|20887339|P4|COMPLETED|Overall Study||141
8475509|NCT00627406|20887340|P3|COMPLETED|Overall Study||125
8475510|NCT00627406|20887341|P2|COMPLETED|Overall Study||58
8475511|NCT00627406|20887342|P1|COMPLETED|Overall Study||60
8475512|NCT00627406|20887339|P4|STARTED|Overall Study||141
8475513|NCT00627406|20887340|P3|STARTED|Overall Study||125
8475514|NCT00627406|20887341|P2|STARTED|Overall Study||58
8475515|NCT00627406|20887342|P1|STARTED|Overall Study||60
8475516|NCT00627393|20887358|P2|NOT COMPLETED|Per-Protocol Analysis||13
8475517|NCT00627393|20887359|P1|NOT COMPLETED|Per-Protocol Analysis||10
8475518|NCT00627393|20887358|P2|COMPLETED|Per-Protocol Analysis||35
8475519|NCT00627393|20887359|P1|COMPLETED|Per-Protocol Analysis||39
8475520|NCT00627393|20887358|P2|STARTED|Per-Protocol Analysis||48
8475521|NCT00627393|20887359|P1|STARTED|Per-Protocol Analysis||49
8475522|NCT00627393|20887358|P2|NOT COMPLETED|Intention-To-Treat Analysis||8
8475523|NCT00627393|20887359|P1|NOT COMPLETED|Intention-To-Treat Analysis||9
8475524|NCT00627393|20887358|P2|COMPLETED|Intention-To-Treat Analysis||48
8475525|NCT00627393|20887359|P1|COMPLETED|Intention-To-Treat Analysis||49
8475526|NCT00627393|20887358|P2|STARTED|Intention-To-Treat Analysis||56
8475527|NCT00627393|20887359|P1|STARTED|Intention-To-Treat Analysis||58
8475528|NCT00627367|20887380|P2|NOT COMPLETED|Overall Study||0
8475529|NCT00627367|20887381|P1|NOT COMPLETED|Overall Study||0
8475530|NCT00627367|20887380|P2|COMPLETED|Overall Study||112
8475531|NCT00627367|20887381|P1|COMPLETED|Overall Study||112
8475532|NCT00627367|20887380|P2|STARTED|Overall Study||112
8475533|NCT00627367|20887381|P1|STARTED|Overall Study||112
8475534|NCT00627094|20887395|P2|NOT COMPLETED|Overall Study||15
8475535|NCT00627094|20887396|P1|NOT COMPLETED|Overall Study||12
8475536|NCT00627094|20887395|P2|COMPLETED|Overall Study||45
8475537|NCT00627094|20887396|P1|COMPLETED|Overall Study||48
8475538|NCT00627094|20887395|P2|STARTED|Overall Study||60
8475539|NCT00627094|20887396|P1|STARTED|Overall Study||60
8475540|NCT00627042|20887408|P1|NOT COMPLETED|Overall Study||2
8475541|NCT00627042|20887408|P1|COMPLETED|Overall Study||40
8475542|NCT00627042|20887408|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
8475543|NCT00627042|20887408|P1|STARTED|Overall Study||42
8475544|NCT00627016|20887420|P2|NOT COMPLETED|Overall Study||6
8475545|NCT00627016|20887421|P1|NOT COMPLETED|Overall Study||6
8475546|NCT00627016|20887420|P2|COMPLETED|Overall Study||146
8475547|NCT00627016|20887421|P1|COMPLETED|Overall Study||147
8475548|NCT00627016|20887420|P2|STARTED|Overall Study||152
8475549|NCT00627016|20887421|P1|STARTED|Overall Study||153
8475550|NCT00626925|20887433|P2|NOT COMPLETED|Overall Study||9
8475551|NCT00626925|20887434|P1|NOT COMPLETED|Overall Study||12
8475552|NCT00626925|20887433|P2|COMPLETED|Overall Study||62
8475553|NCT00626925|20887434|P1|COMPLETED|Overall Study||55
8475554|NCT00626925|20887433|P2|STARTED|Overall Study||71
8475555|NCT00626925|20887434|P1|STARTED|Overall Study||67
8475556|NCT00626912|20887468|P2|NOT COMPLETED|Overall Study||10
8475557|NCT00626912|20887469|P1|NOT COMPLETED|Overall Study||2
8475558|NCT00626912|20887468|P2|COMPLETED|Overall Study||215
8475559|NCT00626912|20887469|P1|COMPLETED|Overall Study||220
8475560|NCT00626912|20887468|P2|STARTED|Overall Study||225
8475561|NCT00626912|20887469|P1|STARTED|Overall Study||222
8475562|NCT00626886|20887483|P2|NOT COMPLETED|Overall Study||0
8475563|NCT00626886|20887484|P1|NOT COMPLETED|Overall Study||0
8475564|NCT00626886|20887483|P2|COMPLETED|Overall Study||29
8475565|NCT00626886|20887484|P1|COMPLETED|Overall Study||24
8475566|NCT00626886|20887483|P2|STARTED|Overall Study||29
8475567|NCT00626886|20887484|P1|STARTED|Overall Study||24
8475568|NCT00626821|20887508|P1|NOT COMPLETED|Overall Study||221
8475569|NCT00626821|20887508|P1|COMPLETED|Overall Study||2796
8475570|NCT00626821|20887508|P1|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
8475571|NCT00626821|20887508|P1|STARTED|Overall Study||3017
8475572|NCT00626808|20887516|P4|NOT COMPLETED|Overall Study||0
8475573|NCT00626808|20887517|P3|NOT COMPLETED|Overall Study||0
8475574|NCT00626808|20887518|P2|NOT COMPLETED|Overall Study||0
8475575|NCT00626808|20887519|P1|NOT COMPLETED|Overall Study||0
8475576|NCT00626808|20887516|P4|COMPLETED|Overall Study||2906
8475577|NCT00626808|20887517|P3|COMPLETED|Overall Study||30011
8475578|NCT00626808|20887518|P2|COMPLETED|Overall Study||34316
8475579|NCT00626808|20887519|P1|COMPLETED|Overall Study||254464
8475580|NCT00626808|20887516|P4|STARTED|Overall Study||2906
8475581|NCT00626808|20887517|P3|STARTED|Overall Study||30011
8475582|NCT00626808|20887518|P2|STARTED|Overall Study||34316
8475583|NCT00626808|20887519|P1|STARTED|Overall Study||254464
8475584|NCT00626795|20887588|P3|NOT COMPLETED|Blinded Treatment||9
8475585|NCT00626795|20887589|P2|NOT COMPLETED|Blinded Treatment||5
8475586|NCT00626795|20887590|P1|NOT COMPLETED|Blinded Treatment||10
8475587|NCT00626795|20887588|P3|COMPLETED|Blinded Treatment||196
8475588|NCT00626795|20887589|P2|COMPLETED|Blinded Treatment||200
8475589|NCT00626795|20887590|P1|COMPLETED|Blinded Treatment||194
8475590|NCT00626795|20887588|P3|STARTED|Blinded Treatment||205
8475591|NCT00626795|20887589|P2|STARTED|Blinded Treatment||205
8475592|NCT00626795|20887590|P1|STARTED|Blinded Treatment||204
8475593|NCT00626795|20887588|P3|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
8475594|NCT00626795|20887589|P2|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
8475595|NCT00626795|20887590|P1|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
8475596|NCT00626795|20887588|P3|COMPLETED|Open-label TD1414 Cream TID Treatment||0
8475597|NCT00626795|20887589|P2|COMPLETED|Open-label TD1414 Cream TID Treatment||64
8475598|NCT00626795|20887590|P1|COMPLETED|Open-label TD1414 Cream TID Treatment||0
8475599|NCT00626795|20887588|P3|STARTED|Open-label TD1414 Cream TID Treatment||0
8475600|NCT00626795|20887589|P2|STARTED|Open-label TD1414 Cream TID Treatment||65
8475601|NCT00626795|20887590|P1|STARTED|Open-label TD1414 Cream TID Treatment||0
8475602|NCT00626782|20887619|P2|NOT COMPLETED|Overall Study||0
8475603|NCT00626782|20887620|P1|NOT COMPLETED|Overall Study||0
8475604|NCT00626782|20887619|P2|COMPLETED|Overall Study||12
8475605|NCT00626782|20887620|P1|COMPLETED|Overall Study||12
8475606|NCT00626782|20887619|P2|STARTED|Overall Study||12
8475607|NCT00626782|20887620|P1|STARTED|Overall Study||12
8475608|NCT00626743|20887630|P2|NOT COMPLETED|Treatment Period 2||0
8475609|NCT00626743|20887631|P1|NOT COMPLETED|Treatment Period 2||0
8475610|NCT00626743|20887630|P2|COMPLETED|Treatment Period 2||6
8475611|NCT00626743|20887631|P1|COMPLETED|Treatment Period 2||6
8475612|NCT00626743|20887630|P2|STARTED|Treatment Period 2||6
8475613|NCT00626743|20887631|P1|STARTED|Treatment Period 2||6
8475614|NCT00626743|20887630|P2|NOT COMPLETED|Wash-out Period of 6 Days||0
8475615|NCT00626743|20887631|P1|NOT COMPLETED|Wash-out Period of 6 Days||0
8475616|NCT00626743|20887630|P2|COMPLETED|Wash-out Period of 6 Days||6
8475617|NCT00626743|20887631|P1|COMPLETED|Wash-out Period of 6 Days||6
8475618|NCT00626743|20887630|P2|STARTED|Wash-out Period of 6 Days||6
8475619|NCT00626743|20887631|P1|STARTED|Wash-out Period of 6 Days||6
8475620|NCT00626743|20887630|P2|NOT COMPLETED|Treatment Period 1||1
8475621|NCT00626743|20887631|P1|NOT COMPLETED|Treatment Period 1||0
8475622|NCT00626743|20887630|P2|COMPLETED|Treatment Period 1||6
8475623|NCT00626743|20887631|P1|COMPLETED|Treatment Period 1||6
8475624|NCT00626743|20887630|P2|STARTED|Treatment Period 1||7
8475625|NCT00626743|20887631|P1|STARTED|Treatment Period 1||6
8475626|NCT00626639|20887641|P2|NOT COMPLETED|Overall Study||2
8475627|NCT00626639|20887642|P1|NOT COMPLETED|Overall Study||2
8475628|NCT00626639|20887641|P2|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
8475629|NCT00626639|20887642|P1|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
8475630|NCT00626639|20887641|P2|STARTED|Overall Study||3
8475631|NCT00626639|20887642|P1|STARTED|Overall Study||2
8475632|NCT00626626|20887662|P2|NOT COMPLETED|Overall Study||0
8475633|NCT00626626|20887663|P1|NOT COMPLETED|Overall Study||0
8475634|NCT00626626|20887662|P2|COMPLETED|Overall Study||3
8475635|NCT00626626|20887663|P1|COMPLETED|Overall Study||5
8475636|NCT00626626|20887662|P2|STARTED|Overall Study||3
8475637|NCT00626626|20887663|P1|STARTED|Overall Study||5
8475638|NCT00626574|20887675|P2|NOT COMPLETED|Overall Study||0
8475639|NCT00626574|20887676|P1|NOT COMPLETED|Overall Study||0
8475640|NCT00626574|20887675|P2|COMPLETED|Overall Study||1
8475641|NCT00626574|20887676|P1|COMPLETED|Overall Study||2
8475642|NCT00626574|20887675|P2|STARTED|Overall Study||1
8475643|NCT00626574|20887676|P1|STARTED|Overall Study||2
8475644|NCT00626561|20887688|P1|NOT COMPLETED|Overall Study||4
8475645|NCT00626561|20887688|P1|COMPLETED|Overall Study||0
8475646|NCT00626561|20887688|P1|STARTED|Overall Study||4
8475647|NCT00626548|20887694|P2|NOT COMPLETED|Overall Study||716
8475648|NCT00626548|20887695|P1|NOT COMPLETED|Overall Study||705
8475649|NCT00626548|20887694|P2|COMPLETED|Overall Study||0
8475650|NCT00626548|20887695|P1|COMPLETED|Overall Study||0
8475651|NCT00626548|20887694|P2|Patients Received Treatment|Overall Study||712
8475652|NCT00626548|20887695|P1|Patients Received Treatment|Overall Study||703
8475653|NCT00626548|20887694|P2|STARTED|Overall Study||716
8475654|NCT00626548|20887695|P1|STARTED|Overall Study||705
8475655|NCT00626522|20887709|P6|NOT COMPLETED|Overall Study||2
8475656|NCT00626522|20887710|P5|NOT COMPLETED|Overall Study||7
8475657|NCT00626522|20887711|P4|NOT COMPLETED|Overall Study||2
8475658|NCT00626522|20887712|P3|NOT COMPLETED|Overall Study||8
8475659|NCT00626522|20887713|P2|NOT COMPLETED|Overall Study||7
8475660|NCT00626522|20887714|P1|NOT COMPLETED|Overall Study||6
8475661|NCT00626522|20887709|P6|COMPLETED|Overall Study||57
8475662|NCT00626522|20887710|P5|COMPLETED|Overall Study||58
8475663|NCT00626522|20887711|P4|COMPLETED|Overall Study||74
8475664|NCT00626522|20887712|P3|COMPLETED|Overall Study||117
8475665|NCT00626522|20887713|P2|COMPLETED|Overall Study||113
8475666|NCT00626522|20887714|P1|COMPLETED|Overall Study||115
8475667|NCT00626522|20887709|P6|STARTED|Overall Study||59
8475668|NCT00626522|20887710|P5|STARTED|Overall Study||65
8475669|NCT00626522|20887711|P4|STARTED|Overall Study||76
8475670|NCT00626522|20887712|P3|STARTED|Overall Study||125
8475671|NCT00626522|20887713|P2|STARTED|Overall Study||120
8475672|NCT00626522|20887714|P1|STARTED|Overall Study||121
8475673|NCT00626444|20887752|P1|NOT COMPLETED|Overall Study||0
8475674|NCT00626444|20887752|P1|COMPLETED|Overall Study||2
8475675|NCT00626444|20887752|P1|STARTED|Overall Study||2
8475676|NCT00626431|20887759|P2|NOT COMPLETED|Overall Study||45
8475677|NCT00626431|20887760|P1|NOT COMPLETED|Overall Study||17
8475678|NCT00626431|20887759|P2|COMPLETED|Overall Study||114
8475679|NCT00626431|20887760|P1|COMPLETED|Overall Study||134
8475680|NCT00626431|20887759|P2|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
8475681|NCT00626431|20887760|P1|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
8475682|NCT00626405|20887777|P2|NOT COMPLETED|Overall Study||1
8475683|NCT00626405|20887778|P1|NOT COMPLETED|Overall Study||1
8475684|NCT00626405|20887777|P2|COMPLETED|Overall Study||51
8475685|NCT00626405|20887778|P1|COMPLETED|Overall Study||42
8475686|NCT00626405|20887777|P2|STARTED|Overall Study||52
8475687|NCT00626405|20887778|P1|STARTED|Overall Study||43
8475688|NCT00626392|20887794|P6|NOT COMPLETED|Coadministration Period||6
8475689|NCT00626392|20887795|P5|NOT COMPLETED|Coadministration Period||5
8475690|NCT00626392|20887796|P4|NOT COMPLETED|Coadministration Period||7
8475691|NCT00626392|20887797|P3|NOT COMPLETED|Coadministration Period||10
8475692|NCT00626392|20887798|P2|NOT COMPLETED|Coadministration Period||5
8475693|NCT00626392|20887799|P1|NOT COMPLETED|Coadministration Period||4
8475694|NCT00626392|20887794|P6|COMPLETED|Coadministration Period||38
8475695|NCT00626392|20887795|P5|COMPLETED|Coadministration Period||36
8475696|NCT00626392|20887796|P4|COMPLETED|Coadministration Period||36
8475697|NCT00626392|20887797|P3|COMPLETED|Coadministration Period||31
8475698|NCT00626392|20887798|P2|COMPLETED|Coadministration Period||38
8475699|NCT00626392|20887799|P1|COMPLETED|Coadministration Period||40
8475700|NCT00626392|20887794|P6|STARTED|Coadministration Period||44
8475701|NCT00626392|20887795|P5|STARTED|Coadministration Period||41
8475702|NCT00626392|20887796|P4|STARTED|Coadministration Period||43
8475703|NCT00626392|20887797|P3|STARTED|Coadministration Period||41
8475704|NCT00626392|20887798|P2|STARTED|Coadministration Period||43
8475705|NCT00626392|20887799|P1|STARTED|Coadministration Period||44
8475706|NCT00626392|20887794|P6|NOT COMPLETED|Run-in Period||1
8475707|NCT00626392|20887795|P5|NOT COMPLETED|Run-in Period||4
8475708|NCT00626392|20887796|P4|NOT COMPLETED|Run-in Period||1
8475709|NCT00626392|20887797|P3|NOT COMPLETED|Run-in Period||3
8475710|NCT00626392|20887798|P2|NOT COMPLETED|Run-in Period||1
8475711|NCT00626392|20887799|P1|NOT COMPLETED|Run-in Period||1
8475712|NCT00626392|20887794|P6|COMPLETED|Run-in Period||44
8475713|NCT00626392|20887795|P5|COMPLETED|Run-in Period||41
8475714|NCT00626392|20887796|P4|COMPLETED|Run-in Period||43
8475715|NCT00626392|20887797|P3|COMPLETED|Run-in Period||41
8475716|NCT00626392|20887798|P2|COMPLETED|Run-in Period||43
8475717|NCT00626392|20887799|P1|COMPLETED|Run-in Period||44
8475718|NCT00626392|20887794|P6|STARTED|Run-in Period||45
8475719|NCT00626392|20887795|P5|STARTED|Run-in Period||45
8475720|NCT00626392|20887796|P4|STARTED|Run-in Period||44
8475721|NCT00626392|20887797|P3|STARTED|Run-in Period||44
8475722|NCT00626392|20887798|P2|STARTED|Run-in Period||44
8475723|NCT00626392|20887799|P1|STARTED|Run-in Period||45
8475724|NCT00626366|20887813|P2|NOT COMPLETED|Overall Study||0
8475725|NCT00626366|20887814|P1|NOT COMPLETED|Overall Study||0
8475726|NCT00626366|20887813|P2|COMPLETED|Overall Study||9
8475727|NCT00626366|20887814|P1|COMPLETED|Overall Study||9
8475728|NCT00626366|20887813|P2|STARTED|Overall Study||9
8475729|NCT00626366|20887814|P1|STARTED|Overall Study||9
8475730|NCT00626340|20887820|P1|NOT COMPLETED|Overall Study||0
8475731|NCT00626340|20887820|P1|COMPLETED|Overall Study||18
8475732|NCT00626340|20887820|P1|STARTED|Overall Study||18
8475733|NCT00626327|20887827|P3|NOT COMPLETED|Overall Study||88
8475734|NCT00626327|20887828|P2|NOT COMPLETED|Overall Study||59
8475735|NCT00626327|20887829|P1|NOT COMPLETED|Overall Study||78
8475736|NCT00626327|20887827|P3|COMPLETED|Overall Study||422
8475737|NCT00626327|20887828|P2|COMPLETED|Overall Study||557
8475738|NCT00626327|20887829|P1|COMPLETED|Overall Study||426
8475739|NCT00626327|20887827|P3|STARTED|Overall Study||510
8475740|NCT00626327|20887828|P2|STARTED|Overall Study||616
8475741|NCT00626327|20887829|P1|STARTED|Overall Study||504
8475742|NCT00626275|20887855|P8|NOT COMPLETED|Part B||1
8475743|NCT00626275|20887856|P7|NOT COMPLETED|Part B||1
8475744|NCT00626275|20887857|P6|NOT COMPLETED|Part B||0
8475745|NCT00626275|20887858|P5|NOT COMPLETED|Part B||0
8475746|NCT00626275|20887859|P4|NOT COMPLETED|Part B||0
8475747|NCT00626275|20887860|P3|NOT COMPLETED|Part B||0
8475748|NCT00626275|20887861|P2|NOT COMPLETED|Part B||0
8475749|NCT00626275|20887862|P1|NOT COMPLETED|Part B||0
8475750|NCT00626275|20887855|P8|COMPLETED|Part B||23
8475751|NCT00626275|20887856|P7|COMPLETED|Part B||19
8475752|NCT00626275|20887857|P6|COMPLETED|Part B||0
8475753|NCT00626275|20887858|P5|COMPLETED|Part B||0
8475754|NCT00626275|20887859|P4|COMPLETED|Part B||0
8475755|NCT00626275|20887860|P3|COMPLETED|Part B||0
8475756|NCT00626275|20887861|P2|COMPLETED|Part B||0
8475757|NCT00626275|20887862|P1|COMPLETED|Part B||0
8475758|NCT00626275|20887855|P8|STARTED|Part B||24
8475759|NCT00626275|20887856|P7|STARTED|Part B||20
8475760|NCT00626275|20887857|P6|STARTED|Part B||0
8475761|NCT00626275|20887858|P5|STARTED|Part B||0
8475762|NCT00626275|20887859|P4|STARTED|Part B||0
8475763|NCT00626275|20887860|P3|STARTED|Part B||0
8475764|NCT00626275|20887861|P2|STARTED|Part B||0
8475765|NCT00626275|20887862|P1|STARTED|Part B||0
8475766|NCT00626275|20887855|P8|NOT COMPLETED|Re-randomization Period for Part B||0
8475767|NCT00626275|20887856|P7|NOT COMPLETED|Re-randomization Period for Part B||0
8475768|NCT00626275|20887857|P6|NOT COMPLETED|Re-randomization Period for Part B||0
8475769|NCT00626275|20887858|P5|NOT COMPLETED|Re-randomization Period for Part B||0
8475770|NCT00626275|20887859|P4|NOT COMPLETED|Re-randomization Period for Part B||0
8475771|NCT00626275|20887860|P3|NOT COMPLETED|Re-randomization Period for Part B||0
8475772|NCT00626275|20887861|P2|NOT COMPLETED|Re-randomization Period for Part B||0
8475773|NCT00626275|20887862|P1|NOT COMPLETED|Re-randomization Period for Part B||0
8475774|NCT00626275|20887855|P8|COMPLETED|Re-randomization Period for Part B||24
8475775|NCT00626275|20887856|P7|COMPLETED|Re-randomization Period for Part B||20
8475776|NCT00626275|20887857|P6|COMPLETED|Re-randomization Period for Part B||0
8475777|NCT00626275|20887858|P5|COMPLETED|Re-randomization Period for Part B||0
8475778|NCT00626275|20887859|P4|COMPLETED|Re-randomization Period for Part B||0
8475779|NCT00626275|20887860|P3|COMPLETED|Re-randomization Period for Part B||0
8475780|NCT00626275|20887861|P2|COMPLETED|Re-randomization Period for Part B||0
8475781|NCT00626275|20887862|P1|COMPLETED|Re-randomization Period for Part B||0
8475782|NCT00626275|20887855|P8|STARTED|Re-randomization Period for Part B||24
8475783|NCT00626275|20887856|P7|STARTED|Re-randomization Period for Part B||20
8475784|NCT00626275|20887857|P6|STARTED|Re-randomization Period for Part B||0
8475785|NCT00626275|20887858|P5|STARTED|Re-randomization Period for Part B||0
8475786|NCT00626275|20887859|P4|STARTED|Re-randomization Period for Part B||0
8475787|NCT00626275|20887860|P3|STARTED|Re-randomization Period for Part B||0
8475788|NCT00626275|20887861|P2|STARTED|Re-randomization Period for Part B||0
8475789|NCT00626275|20887862|P1|STARTED|Re-randomization Period for Part B||0
8475790|NCT00626275|20887855|P8|NOT COMPLETED|Part A - Treatment Period 3||0
8475791|NCT00626275|20887856|P7|NOT COMPLETED|Part A - Treatment Period 3||0
8475792|NCT00626275|20887857|P6|NOT COMPLETED|Part A - Treatment Period 3||0
8475793|NCT00626275|20887858|P5|NOT COMPLETED|Part A - Treatment Period 3||0
8475794|NCT00626275|20887859|P4|NOT COMPLETED|Part A - Treatment Period 3||0
8475795|NCT00626275|20887860|P3|NOT COMPLETED|Part A - Treatment Period 3||0
8475796|NCT00626275|20887861|P2|NOT COMPLETED|Part A - Treatment Period 3||0
8475797|NCT00626275|20887862|P1|NOT COMPLETED|Part A - Treatment Period 3||0
8475798|NCT00626275|20887855|P8|COMPLETED|Part A - Treatment Period 3||0
8475799|NCT00626275|20887856|P7|COMPLETED|Part A - Treatment Period 3||0
8475800|NCT00626275|20887857|P6|COMPLETED|Part A - Treatment Period 3||8
8475801|NCT00626275|20887858|P5|COMPLETED|Part A - Treatment Period 3||9
8475802|NCT00626275|20887859|P4|COMPLETED|Part A - Treatment Period 3||8
8475803|NCT00626275|20887860|P3|COMPLETED|Part A - Treatment Period 3||6
8475804|NCT00626275|20887861|P2|COMPLETED|Part A - Treatment Period 3||7
8475805|NCT00626275|20887862|P1|COMPLETED|Part A - Treatment Period 3||6
8475806|NCT00626275|20887855|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
8475807|NCT00626275|20887856|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
8475808|NCT00626275|20887857|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
8475809|NCT00626275|20887858|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
8475810|NCT00626275|20887859|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
8475811|NCT00626275|20887860|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
8475812|NCT00626275|20887861|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
8475813|NCT00626275|20887862|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
8475814|NCT00626275|20887855|P8|STARTED|Part A - Treatment Period 3||0
8475815|NCT00626275|20887856|P7|STARTED|Part A - Treatment Period 3||0
8475816|NCT00626275|20887857|P6|STARTED|Part A - Treatment Period 3||8
8475817|NCT00626275|20887858|P5|STARTED|Part A - Treatment Period 3||9
8475818|NCT00626275|20887859|P4|STARTED|Part A - Treatment Period 3||8
8475819|NCT00626275|20887860|P3|STARTED|Part A - Treatment Period 3||6
8475820|NCT00626275|20887861|P2|STARTED|Part A - Treatment Period 3||7
8475821|NCT00626275|20887862|P1|STARTED|Part A - Treatment Period 3||6
8475822|NCT00626275|20887855|P8|NOT COMPLETED|Part A - Washout Period 2||0
8475823|NCT00626275|20887856|P7|NOT COMPLETED|Part A - Washout Period 2||0
8475824|NCT00626275|20887857|P6|NOT COMPLETED|Part A - Washout Period 2||0
8475825|NCT00626275|20887858|P5|NOT COMPLETED|Part A - Washout Period 2||0
8475826|NCT00626275|20887859|P4|NOT COMPLETED|Part A - Washout Period 2||0
8475827|NCT00626275|20887860|P3|NOT COMPLETED|Part A - Washout Period 2||0
8475828|NCT00626275|20887861|P2|NOT COMPLETED|Part A - Washout Period 2||0
8475829|NCT00626275|20887862|P1|NOT COMPLETED|Part A - Washout Period 2||0
8475830|NCT00626275|20887855|P8|COMPLETED|Part A - Washout Period 2||0
8475831|NCT00626275|20887856|P7|COMPLETED|Part A - Washout Period 2||0
8475832|NCT00626275|20887857|P6|COMPLETED|Part A - Washout Period 2||8
8475833|NCT00626275|20887858|P5|COMPLETED|Part A - Washout Period 2||9
8475834|NCT00626275|20887859|P4|COMPLETED|Part A - Washout Period 2||8
8475835|NCT00626275|20887860|P3|COMPLETED|Part A - Washout Period 2||6
8475836|NCT00626275|20887861|P2|COMPLETED|Part A - Washout Period 2||7
8475837|NCT00626275|20887862|P1|COMPLETED|Part A - Washout Period 2||6
8475838|NCT00626275|20887855|P8|STARTED|Part A - Washout Period 2||0
8475839|NCT00626275|20887856|P7|STARTED|Part A - Washout Period 2||0
8475840|NCT00626275|20887857|P6|STARTED|Part A - Washout Period 2||8
8475841|NCT00626275|20887858|P5|STARTED|Part A - Washout Period 2||9
8475842|NCT00626275|20887859|P4|STARTED|Part A - Washout Period 2||8
8475843|NCT00626275|20887860|P3|STARTED|Part A - Washout Period 2||6
8475844|NCT00626275|20887861|P2|STARTED|Part A - Washout Period 2||7
8475845|NCT00626275|20887862|P1|STARTED|Part A - Washout Period 2||6
8475846|NCT00626275|20887855|P8|NOT COMPLETED|Part A - Treatment Period 2||0
8475847|NCT00626275|20887856|P7|NOT COMPLETED|Part A - Treatment Period 2||0
8475848|NCT00626275|20887857|P6|NOT COMPLETED|Part A - Treatment Period 2||0
8475849|NCT00626275|20887858|P5|NOT COMPLETED|Part A - Treatment Period 2||0
8475850|NCT00626275|20887859|P4|NOT COMPLETED|Part A - Treatment Period 2||0
8475851|NCT00626275|20887860|P3|NOT COMPLETED|Part A - Treatment Period 2||0
8475852|NCT00626275|20887861|P2|NOT COMPLETED|Part A - Treatment Period 2||0
8475853|NCT00626275|20887862|P1|NOT COMPLETED|Part A - Treatment Period 2||0
8475854|NCT00626275|20887855|P8|COMPLETED|Part A - Treatment Period 2||0
8475855|NCT00626275|20887856|P7|COMPLETED|Part A - Treatment Period 2||0
8475856|NCT00626275|20887857|P6|COMPLETED|Part A - Treatment Period 2||8
8475857|NCT00626275|20887858|P5|COMPLETED|Part A - Treatment Period 2||9
8475858|NCT00626275|20887859|P4|COMPLETED|Part A - Treatment Period 2||8
8475859|NCT00626275|20887860|P3|COMPLETED|Part A - Treatment Period 2||6
8475860|NCT00626275|20887861|P2|COMPLETED|Part A - Treatment Period 2||7
8475861|NCT00626275|20887862|P1|COMPLETED|Part A - Treatment Period 2||6
8475862|NCT00626275|20887855|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
8475863|NCT00626275|20887856|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
8475864|NCT00626275|20887857|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
8475865|NCT00626275|20887858|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
8475866|NCT00626275|20887859|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
8475867|NCT00626275|20887860|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
8475868|NCT00626275|20887861|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
8475869|NCT00626275|20887862|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
8475870|NCT00626275|20887855|P8|STARTED|Part A - Treatment Period 2||0
8475871|NCT00626275|20887856|P7|STARTED|Part A - Treatment Period 2||0
8475872|NCT00626275|20887857|P6|STARTED|Part A - Treatment Period 2||8
8475873|NCT00626275|20887858|P5|STARTED|Part A - Treatment Period 2||9
8475874|NCT00626275|20887859|P4|STARTED|Part A - Treatment Period 2||8
8475875|NCT00626275|20887860|P3|STARTED|Part A - Treatment Period 2||6
8475876|NCT00626275|20887861|P2|STARTED|Part A - Treatment Period 2||7
8475877|NCT00626275|20887862|P1|STARTED|Part A - Treatment Period 2||6
8475878|NCT00626275|20887855|P8|NOT COMPLETED|Part A - Washout Period 1||0
8475879|NCT00626275|20887856|P7|NOT COMPLETED|Part A - Washout Period 1||0
8475880|NCT00626275|20887857|P6|NOT COMPLETED|Part A - Washout Period 1||0
8475881|NCT00626275|20887858|P5|NOT COMPLETED|Part A - Washout Period 1||0
8475882|NCT00626275|20887859|P4|NOT COMPLETED|Part A - Washout Period 1||0
8475883|NCT00626275|20887860|P3|NOT COMPLETED|Part A - Washout Period 1||0
8475884|NCT00626275|20887861|P2|NOT COMPLETED|Part A - Washout Period 1||0
8475885|NCT00626275|20887862|P1|NOT COMPLETED|Part A - Washout Period 1||0
8475886|NCT00626275|20887855|P8|COMPLETED|Part A - Washout Period 1||0
8475887|NCT00626275|20887856|P7|COMPLETED|Part A - Washout Period 1||0
8475888|NCT00626275|20887857|P6|COMPLETED|Part A - Washout Period 1||8
8475889|NCT00626275|20887858|P5|COMPLETED|Part A - Washout Period 1||9
8475890|NCT00626275|20887859|P4|COMPLETED|Part A - Washout Period 1||8
8475891|NCT00626275|20887860|P3|COMPLETED|Part A - Washout Period 1||6
8475892|NCT00626275|20887861|P2|COMPLETED|Part A - Washout Period 1||7
8475893|NCT00626275|20887862|P1|COMPLETED|Part A - Washout Period 1||6
8475894|NCT00626275|20887855|P8|STARTED|Part A - Washout Period 1||0
8475895|NCT00626275|20887856|P7|STARTED|Part A - Washout Period 1||0
8475896|NCT00626275|20887857|P6|STARTED|Part A - Washout Period 1||8
8475897|NCT00626275|20887858|P5|STARTED|Part A - Washout Period 1||9
8475898|NCT00626275|20887859|P4|STARTED|Part A - Washout Period 1||8
8475899|NCT00626275|20887860|P3|STARTED|Part A - Washout Period 1||6
8475900|NCT00626275|20887861|P2|STARTED|Part A - Washout Period 1||7
8475901|NCT00626275|20887862|P1|STARTED|Part A - Washout Period 1||6
8475902|NCT00626275|20887855|P8|NOT COMPLETED|Part A - Treatment Period 1||0
8475903|NCT00626275|20887856|P7|NOT COMPLETED|Part A - Treatment Period 1||0
8475904|NCT00626275|20887857|P6|NOT COMPLETED|Part A - Treatment Period 1||0
8475905|NCT00626275|20887858|P5|NOT COMPLETED|Part A - Treatment Period 1||0
8475906|NCT00626275|20887859|P4|NOT COMPLETED|Part A - Treatment Period 1||0
8475907|NCT00626275|20887860|P3|NOT COMPLETED|Part A - Treatment Period 1||1
8475908|NCT00626275|20887861|P2|NOT COMPLETED|Part A - Treatment Period 1||0
8475909|NCT00626275|20887862|P1|NOT COMPLETED|Part A - Treatment Period 1||1
8475910|NCT00626275|20887855|P8|COMPLETED|Part A - Treatment Period 1||0
8475911|NCT00626275|20887856|P7|COMPLETED|Part A - Treatment Period 1||0
8475912|NCT00626275|20887857|P6|COMPLETED|Part A - Treatment Period 1||8
8475913|NCT00626275|20887858|P5|COMPLETED|Part A - Treatment Period 1||9
8475914|NCT00626275|20887859|P4|COMPLETED|Part A - Treatment Period 1||8
8475915|NCT00626275|20887860|P3|COMPLETED|Part A - Treatment Period 1||6
8475916|NCT00626275|20887861|P2|COMPLETED|Part A - Treatment Period 1||7
8475917|NCT00626275|20887862|P1|COMPLETED|Part A - Treatment Period 1||6
8475918|NCT00626275|20887855|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
8475919|NCT00626275|20887856|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
8475920|NCT00626275|20887857|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
8475921|NCT00626275|20887858|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
8475922|NCT00626275|20887859|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
8475923|NCT00626275|20887860|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
8475924|NCT00626275|20887861|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
8475925|NCT00626275|20887862|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
8475926|NCT00626275|20887855|P8|STARTED|Part A - Treatment Period 1||0
8475927|NCT00626275|20887856|P7|STARTED|Part A - Treatment Period 1||0
8475928|NCT00626275|20887857|P6|STARTED|Part A - Treatment Period 1||8
8475929|NCT00626275|20887858|P5|STARTED|Part A - Treatment Period 1||9
8475930|NCT00626275|20887859|P4|STARTED|Part A - Treatment Period 1||8
8475931|NCT00626275|20887860|P3|STARTED|Part A - Treatment Period 1||7
8475932|NCT00626275|20887861|P2|STARTED|Part A - Treatment Period 1||7
8475933|NCT00626275|20887862|P1|STARTED|Part A - Treatment Period 1||7
8475934|NCT00626210|20887902|P1|NOT COMPLETED|Overall Study||0
8475935|NCT00626210|20887902|P1|COMPLETED|Overall Study||2
8475936|NCT00626210|20887902|P1|STARTED|Overall Study||2
8475937|NCT00626197|20887909|P3|NOT COMPLETED|Overall Study||77
8475938|NCT00626197|20887910|P2|NOT COMPLETED|Overall Study||54
8475939|NCT00626197|20887911|P1|NOT COMPLETED|Overall Study||44
8475940|NCT00626197|20887909|P3|COMPLETED|Overall Study||49
8475941|NCT00626197|20887910|P2|COMPLETED|Overall Study||74
8475942|NCT00626197|20887911|P1|COMPLETED|Overall Study||83
8475943|NCT00626197|20887909|P3|STARTED|Overall Study||126
8475944|NCT00626197|20887910|P2|STARTED|Overall Study||128
8475945|NCT00626197|20887911|P1|STARTED|Overall Study||127
8475946|NCT00626093|20887988|P1|NOT COMPLETED|Overall Study||23
8475947|NCT00626093|20887988|P1|COMPLETED|Overall Study||54
8475948|NCT00626093|20887988|P1|STARTED|Overall Study||77
8475949|NCT00626028|20887995|P2|NOT COMPLETED|Overall Study||9
8475950|NCT00626028|20887996|P1|NOT COMPLETED|Overall Study||6
8475951|NCT00626028|20887995|P2|COMPLETED|Overall Study||59
8475952|NCT00626028|20887996|P1|COMPLETED|Overall Study||62
8475953|NCT00626028|20887995|P2|STARTED|Overall Study||68
8475954|NCT00626028|20887996|P1|STARTED|Overall Study||68
8475955|NCT00625989|20888010|P2|NOT COMPLETED|Overall Study||0
8475956|NCT00625989|20888011|P1|NOT COMPLETED|Overall Study||0
8475957|NCT00625989|20888010|P2|COMPLETED|Overall Study||6
8475958|NCT00625989|20888011|P1|COMPLETED|Overall Study||6
8475959|NCT00625989|20888010|P2|STARTED|Overall Study||6
8475960|NCT00625989|20888011|P1|STARTED|Overall Study||6
8475961|NCT00625872|20888020|P2|NOT COMPLETED|Overall Study||6
8475962|NCT00625872|20888021|P1|NOT COMPLETED|Overall Study||4
8475963|NCT00625872|20888020|P2|COMPLETED|Overall Study||5
8475964|NCT00625872|20888021|P1|COMPLETED|Overall Study||8
8475965|NCT00625872|20888020|P2|Treated|Overall Study||10
8475966|NCT00625872|20888021|P1|Treated|Overall Study||12
8475967|NCT00625872|20888020|P2|STARTED|Overall Study||11
8475968|NCT00625872|20888021|P1|STARTED|Overall Study||12
8475969|NCT00625846|20888135|P4|NOT COMPLETED|Overall Study||2
8475970|NCT00625846|20888136|P3|NOT COMPLETED|Overall Study||1
8475971|NCT00625846|20888137|P2|NOT COMPLETED|Overall Study||0
8475972|NCT00625846|20888138|P1|NOT COMPLETED|Overall Study||2
8475973|NCT00625846|20888135|P4|COMPLETED|Overall Study||60
8475974|NCT00625846|20888136|P3|COMPLETED|Overall Study||15
8475975|NCT00625846|20888137|P2|COMPLETED|Overall Study||35
8475976|NCT00625846|20888138|P1|COMPLETED|Overall Study||37
8475977|NCT00625846|20888135|P4|STARTED|Overall Study||62
8475978|NCT00625846|20888136|P3|STARTED|Overall Study||16
8475979|NCT00625846|20888137|P2|STARTED|Overall Study||35
8475980|NCT00625846|20888138|P1|STARTED|Overall Study||39
8475981|NCT00625820|20888164|P1|NOT COMPLETED|Overall Study||1
8475982|NCT00625820|20888164|P1|COMPLETED|Overall Study||16
8475983|NCT00625820|20888164|P1|STARTED|Overall Study||17
8475984|NCT00625807|20888172|P2|NOT COMPLETED|Overall Study||8
8475985|NCT00625807|20888173|P1|NOT COMPLETED|Overall Study||2
8475986|NCT00625807|20888172|P2|COMPLETED|Overall Study||20
8475987|NCT00625807|20888173|P1|COMPLETED|Overall Study||20
8475988|NCT00625807|20888172|P2|STARTED|Overall Study||28
8475989|NCT00625807|20888173|P1|STARTED|Overall Study||22
8475990|NCT00625742|20888189|P1|NOT COMPLETED|Overall Study||12
8475991|NCT00625742|20888189|P1|COMPLETED|Overall Study||3
8475992|NCT00625742|20888189|P1|STARTED|Overall Study||15
8475993|NCT00625729|20888194|P1|NOT COMPLETED|Overall Study||0
8475994|NCT00625729|20888194|P1|COMPLETED|Overall Study||6
8475995|NCT00625729|20888194|P1|STARTED|Overall Study||6
8475996|NCT00625703|20888203|P1|NOT COMPLETED|Overall Study||0
8475997|NCT00625703|20888203|P1|COMPLETED|Overall Study||0
8475998|NCT00625703|20888203|P1|STARTED|Overall Study||0
8475999|NCT00625586|20888208|P1|NOT COMPLETED|Overall Study||1
8476000|NCT00625586|20888208|P1|COMPLETED|Overall Study||1
8476001|NCT00625586|20888208|P1|STARTED|Overall Study||2
8476002|NCT00625443|20888221|P3|NOT COMPLETED|Overall Study||5
8476003|NCT00625443|20888222|P2|NOT COMPLETED|Overall Study||11
8476004|NCT00625443|20888223|P1|NOT COMPLETED|Overall Study||2
8476005|NCT00625443|20888221|P3|COMPLETED|Overall Study||10
8476006|NCT00625443|20888222|P2|COMPLETED|Overall Study||15
8476007|NCT00625443|20888223|P1|COMPLETED|Overall Study||10
8476008|NCT00625443|20888221|P3|STARTED|Overall Study||15
8476009|NCT00625443|20888222|P2|STARTED|Overall Study||26
8476010|NCT00625443|20888223|P1|STARTED|Overall Study||12
8476011|NCT00625404|20888253|P2|NOT COMPLETED|Overall Study||173
8476012|NCT00625404|20888254|P1|NOT COMPLETED|Overall Study||207
8476013|NCT00625404|20888253|P2|COMPLETED|Overall Study||885
8476014|NCT00625404|20888254|P1|COMPLETED|Overall Study||855
8476015|NCT00625404|20888253|P2|STARTED|Overall Study||1058
8476016|NCT00625404|20888254|P1|STARTED|Overall Study||1062
8476017|NCT00625391|20888286|P4|NOT COMPLETED|Overall Study||1
8476018|NCT00625391|20888287|P3|NOT COMPLETED|Overall Study||5
8476019|NCT00625391|20888288|P2|NOT COMPLETED|Overall Study||8
8476020|NCT00625391|20888289|P1|NOT COMPLETED|Overall Study||7
8476021|NCT00625391|20888286|P4|COMPLETED|Overall Study||37
8476022|NCT00625391|20888287|P3|COMPLETED|Overall Study||37
8476023|NCT00625391|20888288|P2|COMPLETED|Overall Study||39
8476024|NCT00625391|20888289|P1|COMPLETED|Overall Study||37
8476025|NCT00625391|20888286|P4|STARTED|Overall Study||38
8476026|NCT00625391|20888287|P3|STARTED|Overall Study||42
8476027|NCT00625391|20888288|P2|STARTED|Overall Study||47
8476028|NCT00625391|20888289|P1|STARTED|Overall Study||44
8476029|NCT00625365|20888303|P1|NOT COMPLETED|Overall Study||7
8476030|NCT00625365|20888303|P1|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
8476031|NCT00625365|20888303|P1|STARTED|Overall Study||1060
8476032|NCT00625183|20888309|P1|NOT COMPLETED|Overall Study||1
8476033|NCT00625183|20888309|P1|COMPLETED|Overall Study||4
8476034|NCT00625183|20888309|P1|STARTED|Overall Study||5
8476035|NCT00625131|20888320|P3|NOT COMPLETED|Overall Study||5
8476036|NCT00625131|20888321|P2|NOT COMPLETED|Overall Study||2
8476037|NCT00625131|20888322|P1|NOT COMPLETED|Overall Study||4
8476038|NCT00625131|20888320|P3|COMPLETED|Overall Study||0
8476039|NCT00625131|20888321|P2|COMPLETED|Overall Study||42
8476040|NCT00625131|20888322|P1|COMPLETED|Overall Study||34
8476041|NCT00625131|20888320|P3|STARTED|Overall Study|These participants were not included in any analyses.|5
8476042|NCT00625131|20888321|P2|STARTED|Overall Study||44
8476043|NCT00625131|20888322|P1|STARTED|Overall Study||38
8476044|NCT00624923|20888334|P2|NOT COMPLETED|Overall Study||23
8476045|NCT00624923|20888335|P1|NOT COMPLETED|Overall Study||38
8476046|NCT00624923|20888334|P2|COMPLETED|Overall Study||101
8476047|NCT00624923|20888335|P1|COMPLETED|Overall Study||89
8476048|NCT00624923|20888334|P2|STARTED|Overall Study||124
8476049|NCT00624923|20888335|P1|STARTED|Overall Study||127
8476059|NCT00624832|20888385|P4|NOT COMPLETED|Overall Study||1
8476060|NCT00624832|20888386|P3|NOT COMPLETED|Overall Study||0
8476061|NCT00624832|20888387|P2|NOT COMPLETED|Overall Study||1
8476062|NCT00624832|20888388|P1|NOT COMPLETED|Overall Study||2
8476063|NCT00624832|20888385|P4|COMPLETED|Overall Study||15
8476064|NCT00624832|20888386|P3|COMPLETED|Overall Study||10
8476065|NCT00624832|20888387|P2|COMPLETED|Overall Study||15
8476066|NCT00624832|20888388|P1|COMPLETED|Overall Study||16
8476067|NCT00624832|20888385|P4|STARTED|Overall Study||16
8476068|NCT00624832|20888386|P3|STARTED|Overall Study||10
8476069|NCT00624832|20888387|P2|STARTED|Overall Study||16
8476070|NCT00624832|20888388|P1|STARTED|Overall Study||18
8476071|NCT00624819|20888404|P4|NOT COMPLETED|Follow-up Period: Year 4||0
8476072|NCT00624819|20888405|P3|NOT COMPLETED|Follow-up Period: Year 4||1
8476073|NCT00624819|20888406|P2|NOT COMPLETED|Follow-up Period: Year 4||1
8476074|NCT00624819|20888407|P1|NOT COMPLETED|Follow-up Period: Year 4||1
8476075|NCT00624819|20888404|P4|COMPLETED|Follow-up Period: Year 4||100
8476076|NCT00624819|20888405|P3|COMPLETED|Follow-up Period: Year 4||64
8476077|NCT00624819|20888406|P2|COMPLETED|Follow-up Period: Year 4||19
8476078|NCT00624819|20888407|P1|COMPLETED|Follow-up Period: Year 4||263
8476079|NCT00624819|20888404|P4|STARTED|Follow-up Period: Year 4||100
8476080|NCT00624819|20888405|P3|STARTED|Follow-up Period: Year 4||65
8476081|NCT00624819|20888406|P2|STARTED|Follow-up Period: Year 4||20
8476082|NCT00624819|20888407|P1|STARTED|Follow-up Period: Year 4||264
8476083|NCT00624819|20888404|P4|NOT COMPLETED|Follow-up Period: Year 2||0
8476084|NCT00624819|20888405|P3|NOT COMPLETED|Follow-up Period: Year 2||0
8476085|NCT00624819|20888406|P2|NOT COMPLETED|Follow-up Period: Year 2||0
8476086|NCT00624819|20888407|P1|NOT COMPLETED|Follow-up Period: Year 2||0
8476087|NCT00624819|20888404|P4|COMPLETED|Follow-up Period: Year 2||0
8476088|NCT00624819|20888405|P3|COMPLETED|Follow-up Period: Year 2||96
8476089|NCT00624819|20888406|P2|COMPLETED|Follow-up Period: Year 2||31
8476090|NCT00624819|20888407|P1|COMPLETED|Follow-up Period: Year 2||370
8476091|NCT00624819|20888404|P4|STARTED|Follow-up Period: Year 2||0
8476092|NCT00624819|20888405|P3|STARTED|Follow-up Period: Year 2||96
8476093|NCT00624819|20888406|P2|STARTED|Follow-up Period: Year 2||31
8476094|NCT00624819|20888407|P1|STARTED|Follow-up Period: Year 2||370
8476095|NCT00624819|20888404|P4|NOT COMPLETED|Follow-up Period: Year 1||0
8476096|NCT00624819|20888405|P3|NOT COMPLETED|Follow-up Period: Year 1||0
8476097|NCT00624819|20888406|P2|NOT COMPLETED|Follow-up Period: Year 1||0
8476098|NCT00624819|20888407|P1|NOT COMPLETED|Follow-up Period: Year 1||0
8476099|NCT00624819|20888404|P4|COMPLETED|Follow-up Period: Year 1||0
8476100|NCT00624819|20888405|P3|COMPLETED|Follow-up Period: Year 1||102
8476101|NCT00624819|20888406|P2|COMPLETED|Follow-up Period: Year 1||31
8476102|NCT00624819|20888407|P1|COMPLETED|Follow-up Period: Year 1||391
8476103|NCT00624819|20888404|P4|STARTED|Follow-up Period: Year 1||0
8476104|NCT00624819|20888405|P3|STARTED|Follow-up Period: Year 1||102
8476105|NCT00624819|20888406|P2|STARTED|Follow-up Period: Year 1||31
8476106|NCT00624819|20888407|P1|STARTED|Follow-up Period: Year 1||391
8476107|NCT00624806|20888567|P2|NOT COMPLETED|Overall Study||0
8476108|NCT00624806|20888568|P1|NOT COMPLETED|Overall Study||0
8476109|NCT00624806|20888567|P2|COMPLETED|Overall Study||8
8476110|NCT00624806|20888568|P1|COMPLETED|Overall Study||10
8476111|NCT00624806|20888567|P2|STARTED|Overall Study||8
8476112|NCT00624806|20888568|P1|STARTED|Overall Study||10
8476113|NCT00624650|20888580|P2|NOT COMPLETED|Overall Study||1
8476114|NCT00624650|20888581|P1|NOT COMPLETED|Overall Study||1
8476115|NCT00624650|20888580|P2|COMPLETED|Overall Study||15
8476116|NCT00624650|20888581|P1|COMPLETED|Overall Study||16
8476117|NCT00624650|20888580|P2|STARTED|Overall Study||16
8476118|NCT00624650|20888581|P1|STARTED|Overall Study||17
8476119|NCT00624585|20888587|P1|NOT COMPLETED|Overall Study||12
8476120|NCT00624585|20888587|P1|COMPLETED|Overall Study||6
8476121|NCT00624585|20888587|P1|STARTED|Overall Study||18
8476122|NCT00624559|20888598|P4|NOT COMPLETED|Overall Study||0
8476123|NCT00624559|20888599|P3|NOT COMPLETED|Overall Study||0
8476124|NCT00624559|20888600|P2|NOT COMPLETED|Overall Study||0
8476125|NCT00624559|20888601|P1|NOT COMPLETED|Overall Study||0
8476126|NCT00624559|20888598|P4|COMPLETED|Overall Study||3
8476127|NCT00624559|20888599|P3|COMPLETED|Overall Study||3
8476128|NCT00624559|20888600|P2|COMPLETED|Overall Study||3
8476129|NCT00624559|20888601|P1|COMPLETED|Overall Study||3
8476130|NCT00624559|20888598|P4|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
8476131|NCT00624559|20888599|P3|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
8476132|NCT00624559|20888600|P2|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
8476133|NCT00624559|20888601|P1|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
8476134|NCT00624520|20888617|P2|NOT COMPLETED|Overall Study||8
8476135|NCT00624520|20888618|P1|NOT COMPLETED|Overall Study||12
8476136|NCT00624520|20888617|P2|COMPLETED|Overall Study||39
8476137|NCT00624520|20888618|P1|COMPLETED|Overall Study||44
8476138|NCT00624520|20888617|P2|STARTED|Overall Study||47
8476139|NCT00624520|20888618|P1|STARTED|Overall Study||56
8476140|NCT00624468|20888645|P4|NOT COMPLETED|Safety Follow-up (SFU) Period||3
8476141|NCT00624468|20888646|P3|NOT COMPLETED|Safety Follow-up (SFU) Period||2
8476142|NCT00624468|20888647|P2|NOT COMPLETED|Safety Follow-up (SFU) Period||0
8476143|NCT00624468|20888648|P1|NOT COMPLETED|Safety Follow-up (SFU) Period||0
8476144|NCT00624468|20888645|P4|COMPLETED|Safety Follow-up (SFU) Period||11
8476145|NCT00624468|20888646|P3|COMPLETED|Safety Follow-up (SFU) Period||11
8476146|NCT00624468|20888647|P2|COMPLETED|Safety Follow-up (SFU) Period||0
8476147|NCT00624468|20888648|P1|COMPLETED|Safety Follow-up (SFU) Period||0
8476148|NCT00624468|20888645|P4|STARTED|Safety Follow-up (SFU) Period||14
8476149|NCT00624468|20888646|P3|STARTED|Safety Follow-up (SFU) Period||13
8476150|NCT00624468|20888647|P2|STARTED|Safety Follow-up (SFU) Period||0
8476151|NCT00624468|20888648|P1|STARTED|Safety Follow-up (SFU) Period||0
8476152|NCT00624468|20888645|P4|NOT COMPLETED|Double-blind Period||0
8476153|NCT00624468|20888646|P3|NOT COMPLETED|Double-blind Period||0
8476154|NCT00624468|20888647|P2|NOT COMPLETED|Double-blind Period||13
8476155|NCT00624468|20888648|P1|NOT COMPLETED|Double-blind Period||14
8476156|NCT00624468|20888645|P4|COMPLETED|Double-blind Period||0
8476157|NCT00624468|20888646|P3|COMPLETED|Double-blind Period||0
8476158|NCT00624468|20888647|P2|COMPLETED|Double-blind Period||4
8476159|NCT00624468|20888648|P1|COMPLETED|Double-blind Period||3
8476160|NCT00624468|20888645|P4|STARTED|Double-blind Period||0
8476161|NCT00624468|20888646|P3|STARTED|Double-blind Period||0
8476162|NCT00624468|20888647|P2|STARTED|Double-blind Period||17
8476163|NCT00624468|20888648|P1|STARTED|Double-blind Period||17
8476179|NCT00624416|20888709|P1|NOT COMPLETED|Overall Study||0
8476180|NCT00624416|20888709|P1|COMPLETED|Overall Study||10
8476181|NCT00624416|20888709|P1|STARTED|Overall Study||10
8476182|NCT00624377|20888715|P1|NOT COMPLETED|Overall Study||644
8476183|NCT00624377|20888715|P1|COMPLETED|Overall Study||1387
8476184|NCT00624377|20888715|P1|STARTED|Overall Study||2031
8476185|NCT00624338|20888729|P3|NOT COMPLETED|Overall Study||46
8476186|NCT00624338|20888730|P2|NOT COMPLETED|Overall Study||83
8476187|NCT00624338|20888731|P1|NOT COMPLETED|Overall Study||47
8476188|NCT00624338|20888729|P3|COMPLETED|Overall Study||111
8476189|NCT00624338|20888730|P2|COMPLETED|Overall Study||62
8476190|NCT00624338|20888731|P1|COMPLETED|Overall Study||112
8476191|NCT00624338|20888729|P3|Treated|Overall Study||154
8476192|NCT00624338|20888730|P2|Treated|Overall Study||144
8476193|NCT00624338|20888731|P1|Treated|Overall Study||157
8476194|NCT00624338|20888729|P3|STARTED|Overall Study||157
8476195|NCT00624338|20888730|P2|STARTED|Overall Study||145
8476196|NCT00624338|20888731|P1|STARTED|Overall Study||159
8476197|NCT00624286|20888753|P2|NOT COMPLETED|Overall Study||27
8476198|NCT00624286|20888754|P1|NOT COMPLETED|Overall Study||25
8476199|NCT00624286|20888753|P2|COMPLETED|Overall Study||178
8476200|NCT00624286|20888754|P1|COMPLETED|Overall Study||186
8476201|NCT00624286|20888753|P2|STARTED|Overall Study||205
8476202|NCT00624286|20888754|P1|STARTED|Overall Study||211
8476203|NCT00624221|20888764|P2|NOT COMPLETED|Overall Study||0
8476204|NCT00624221|20888765|P1|NOT COMPLETED|Overall Study||0
8476205|NCT00624221|20888764|P2|COMPLETED|Overall Study||20
8476206|NCT00624221|20888765|P1|COMPLETED|Overall Study||20
8476207|NCT00624221|20888764|P2|STARTED|Overall Study||20
8476208|NCT00624221|20888765|P1|STARTED|Overall Study||20
8476209|NCT00624195|20888773|P2|NOT COMPLETED|Overall Study||7
8476210|NCT00624195|20888774|P1|NOT COMPLETED|Overall Study||3
8476211|NCT00624195|20888773|P2|COMPLETED|Overall Study||23
8476212|NCT00624195|20888774|P1|COMPLETED|Overall Study||26
8476213|NCT00624195|20888773|P2|STARTED|Overall Study||30
8476214|NCT00624195|20888774|P1|STARTED|Overall Study||29
8476215|NCT00624065|20888782|P2|NOT COMPLETED|Overall Study||24
8476216|NCT00624065|20888783|P1|NOT COMPLETED|Overall Study||19
8476217|NCT00624065|20888782|P2|COMPLETED|Overall Study||192
8476218|NCT00624065|20888783|P1|COMPLETED|Overall Study||197
8476219|NCT00624065|20888782|P2|STARTED|Overall Study||216
8476220|NCT00624065|20888783|P1|STARTED|Overall Study||216
8476221|NCT00624052|20888795|P4|NOT COMPLETED|Overall Study||4
8476222|NCT00624052|20888796|P3|NOT COMPLETED|Overall Study||3
8476223|NCT00624052|20888797|P2|NOT COMPLETED|Overall Study||14
8476224|NCT00624052|20888798|P1|NOT COMPLETED|Overall Study||15
8476225|NCT00624052|20888795|P4|COMPLETED|Overall Study||88
8476226|NCT00624052|20888796|P3|COMPLETED|Overall Study||88
8476227|NCT00624052|20888797|P2|COMPLETED|Overall Study||422
8476228|NCT00624052|20888798|P1|COMPLETED|Overall Study||204
8476229|NCT00624052|20888795|P4|STARTED|Overall Study||92
8476230|NCT00624052|20888796|P3|STARTED|Overall Study||91
8476231|NCT00624052|20888797|P2|STARTED|Overall Study||436
8476232|NCT00624052|20888798|P1|STARTED|Overall Study||219
8476233|NCT00624013|20888849|P2|NOT COMPLETED|Overall Study||6
8476234|NCT00624013|20888850|P1|NOT COMPLETED|Overall Study||8
8476235|NCT00624013|20888849|P2|COMPLETED|Overall Study||39
8476236|NCT00624013|20888850|P1|COMPLETED|Overall Study||36
8476237|NCT00624013|20888849|P2|STARTED|Overall Study||45
8476238|NCT00624013|20888850|P1|STARTED|Overall Study||44
8476239|NCT00623974|20888862|P4|NOT COMPLETED|Overall Study||0
8476240|NCT00623974|20888863|P3|NOT COMPLETED|Overall Study||0
8476241|NCT00623974|20888864|P2|NOT COMPLETED|Overall Study||0
8476242|NCT00623974|20888865|P1|NOT COMPLETED|Overall Study||0
8476243|NCT00623974|20888862|P4|COMPLETED|Overall Study||0
8476244|NCT00623974|20888863|P3|COMPLETED|Overall Study||0
8476245|NCT00623974|20888864|P2|COMPLETED|Overall Study||0
8476246|NCT00623974|20888865|P1|COMPLETED|Overall Study||0
8476247|NCT00623974|20888862|P4|STARTED|Overall Study||0
8476248|NCT00623974|20888863|P3|STARTED|Overall Study||0
8476249|NCT00623974|20888864|P2|STARTED|Overall Study||0
8476250|NCT00623974|20888865|P1|STARTED|Overall Study||0
8476251|NCT00623935|20888875|P1|NOT COMPLETED|Overall Study||2
8476252|NCT00623935|20888875|P1|COMPLETED|Overall Study||54
8476253|NCT00623935|20888875|P1|STARTED|Overall Study||56
8476254|NCT00623831|20888882|P2|NOT COMPLETED|Overall Study||1
8476255|NCT00623831|20888883|P1|NOT COMPLETED|Overall Study||1
8476256|NCT00623831|20888882|P2|COMPLETED|Overall Study||3
8476257|NCT00623831|20888883|P1|COMPLETED|Overall Study||12
8476258|NCT00623831|20888882|P2|STARTED|Overall Study||4
8476259|NCT00623831|20888883|P1|STARTED|Overall Study||13
8476260|NCT00623805|20888895|P2|NOT COMPLETED|Overall Study||22
8476261|NCT00623805|20888896|P1|NOT COMPLETED|Overall Study||20
8476262|NCT00623805|20888895|P2|COMPLETED|Overall Study||39
8476263|NCT00623805|20888896|P1|COMPLETED|Overall Study||42
8476264|NCT00623805|20888895|P2|STARTED|Overall Study||61
8476265|NCT00623805|20888896|P1|STARTED|Overall Study||62
8476266|NCT00623779|20888913|P3|NOT COMPLETED|Overall Study||1
8476267|NCT00623779|20888914|P2|NOT COMPLETED|Overall Study||3
8476268|NCT00623779|20888915|P1|NOT COMPLETED|Overall Study||3
8476269|NCT00623779|20888913|P3|COMPLETED|Overall Study||44
8476270|NCT00623779|20888914|P2|COMPLETED|Overall Study||39
8476271|NCT00623779|20888915|P1|COMPLETED|Overall Study||38
8476272|NCT00623779|20888913|P3|STARTED|Overall Study||45
8476273|NCT00623779|20888914|P2|STARTED|Overall Study||42
8476274|NCT00623779|20888915|P1|STARTED|Overall Study||41
8476275|NCT00623766|20888964|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
8476276|NCT00623766|20888965|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
8476277|NCT00623766|20888964|P2|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
8476278|NCT00623766|20888965|P1|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
8476279|NCT00623766|20888964|P2|STARTED|Maintenance Phase (Week 24 to Year 2)||2
8476280|NCT00623766|20888965|P1|STARTED|Maintenance Phase (Week 24 to Year 2)||11
8476281|NCT00623766|20888964|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
8476282|NCT00623766|20888965|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
8476283|NCT00623766|20888964|P2|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
8476284|NCT00623766|20888965|P1|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
8476285|NCT00623766|20888964|P2|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
8476286|NCT00623766|20888965|P1|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
8476287|NCT00623727|20888989|P2|NOT COMPLETED|Open Label Extension Period||0
8476288|NCT00623727|20888990|P1|NOT COMPLETED|Open Label Extension Period||0
8476289|NCT00623727|20888989|P2|COMPLETED|Open Label Extension Period||0
8476290|NCT00623727|20888990|P1|COMPLETED|Open Label Extension Period||20
8476291|NCT00623727|20888989|P2|STARTED|Open Label Extension Period||0
8476292|NCT00623727|20888990|P1|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
8476293|NCT00623727|20888989|P2|NOT COMPLETED|Open Label Follow-up||8
8476294|NCT00623727|20888990|P1|NOT COMPLETED|Open Label Follow-up||0
8476295|NCT00623727|20888989|P2|COMPLETED|Open Label Follow-up||18
8476296|NCT00623727|20888990|P1|COMPLETED|Open Label Follow-up||0
8476297|NCT00623727|20888989|P2|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
8476298|NCT00623727|20888990|P1|STARTED|Open Label Follow-up||0
8476299|NCT00623727|20888989|P2|NOT COMPLETED|Double Blind (DB)||32
8476300|NCT00623727|20888990|P1|NOT COMPLETED|Double Blind (DB)||36
8476301|NCT00623727|20888989|P2|COMPLETED|Double Blind (DB)||41
8476302|NCT00623727|20888990|P1|COMPLETED|Double Blind (DB)||34
8476303|NCT00623727|20888989|P2|Participants Received Treatment|Double Blind (DB)||72
8476304|NCT00623727|20888990|P1|Participants Received Treatment|Double Blind (DB)||67
8476305|NCT00623727|20888989|P2|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
8476306|NCT00623727|20888990|P1|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
8476307|NCT00623714|20889010|P2|NOT COMPLETED|Period 2||0
8476308|NCT00623714|20889011|P1|NOT COMPLETED|Period 2||0
8476309|NCT00623714|20889010|P2|COMPLETED|Period 2||7
8476310|NCT00623714|20889011|P1|COMPLETED|Period 2||6
8476311|NCT00623714|20889010|P2|STARTED|Period 2||7
8476312|NCT00623714|20889011|P1|STARTED|Period 2||6
8476313|NCT00623714|20889010|P2|NOT COMPLETED|Period 1||0
8476314|NCT00623714|20889011|P1|NOT COMPLETED|Period 1||0
8476315|NCT00623714|20889010|P2|COMPLETED|Period 1||7
8476316|NCT00623714|20889011|P1|COMPLETED|Period 1||6
8476317|NCT00623714|20889010|P2|STARTED|Period 1||7
8476318|NCT00623714|20889011|P1|STARTED|Period 1||6
8476319|NCT00623636|20889021|P2|NOT COMPLETED|Open Label||412
8476320|NCT00623636|20889022|P1|NOT COMPLETED|Open Label||0
8476321|NCT00623636|20889021|P2|COMPLETED|Open Label||263
8476322|NCT00623636|20889022|P1|COMPLETED|Open Label||0
8476323|NCT00623636|20889021|P2|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
8476324|NCT00623636|20889022|P1|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
8476325|NCT00623636|20889021|P2|NOT COMPLETED|Double Blind||28
8476326|NCT00623636|20889022|P1|NOT COMPLETED|Double Blind||33
8476327|NCT00623636|20889021|P2|COMPLETED|Double Blind||422
8476328|NCT00623636|20889022|P1|COMPLETED|Double Blind||419
8476329|NCT00623636|20889021|P2|STARTED|Double Blind||450
8476330|NCT00623636|20889022|P1|STARTED|Double Blind||452
8476331|NCT00623623|20889045|P2|NOT COMPLETED|Overall Study||1
8476332|NCT00623623|20889046|P1|NOT COMPLETED|Overall Study||1
8476333|NCT00623623|20889045|P2|COMPLETED|Overall Study||948
8476334|NCT00623623|20889046|P1|COMPLETED|Overall Study||949
8476335|NCT00623623|20889045|P2|STARTED|Overall Study||949
8476336|NCT00623623|20889046|P1|STARTED|Overall Study||950
8476337|NCT00623597|20889102|P2|NOT COMPLETED|Overall Study||0
8476338|NCT00623597|20889103|P1|NOT COMPLETED|Overall Study||1
8476339|NCT00623597|20889102|P2|COMPLETED|Overall Study||13
8476340|NCT00623597|20889103|P1|COMPLETED|Overall Study||4
8476341|NCT00623597|20889102|P2|STARTED|Overall Study||13
8476342|NCT00623597|20889103|P1|STARTED|Overall Study||5
8476343|NCT00623545|20889166|P1|NOT COMPLETED|Overall Study||10
8476344|NCT00623545|20889166|P1|COMPLETED|Overall Study||18
8476345|NCT00623545|20889166|P1|STARTED|Overall Study||28
8476346|NCT00623506|20889173|P2|NOT COMPLETED|Overall Study||4
8476347|NCT00623506|20889174|P1|NOT COMPLETED|Overall Study||4
8476348|NCT00623506|20889173|P2|COMPLETED|Overall Study||11
8476349|NCT00623506|20889174|P1|COMPLETED|Overall Study||11
8476350|NCT00623506|20889173|P2|Week 4|Overall Study||11
8476351|NCT00623506|20889174|P1|Week 4|Overall Study||11
8476352|NCT00623506|20889173|P2|STARTED|Overall Study||15
8476353|NCT00623506|20889174|P1|STARTED|Overall Study||15
8476354|NCT00623480|20889186|P2|NOT COMPLETED|Overall Study||7
8476355|NCT00623480|20889187|P1|NOT COMPLETED|Overall Study||7
8476356|NCT00623480|20889186|P2|COMPLETED|Overall Study||35
8476357|NCT00623480|20889187|P1|COMPLETED|Overall Study||35
8476358|NCT00623480|20889186|P2|STARTED|Overall Study||42
8476359|NCT00623480|20889187|P1|STARTED|Overall Study||42
8476360|NCT00623467|20889199|P1|NOT COMPLETED|Overall Study||7
8476361|NCT00623467|20889199|P1|COMPLETED|Overall Study||336
8476362|NCT00623467|20889199|P1|STARTED|Overall Study||343
8476363|NCT00623441|20889263|P1|NOT COMPLETED|Overall Study||0
8476364|NCT00623441|20889263|P1|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
8476365|NCT00623441|20889263|P1|STARTED|Overall Study||8314
8476366|NCT00623428|20889269|P2|NOT COMPLETED|Follow-up Period||15
8476367|NCT00623428|20889270|P1|NOT COMPLETED|Follow-up Period||29
8476368|NCT00623428|20889269|P2|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
8476369|NCT00623428|20889270|P1|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
8476370|NCT00623428|20889269|P2|STARTED|Follow-up Period||93
8476371|NCT00623428|20889270|P1|STARTED|Follow-up Period||95
8476372|NCT00623428|20889269|P2|NOT COMPLETED|Treatment Period||27
8476373|NCT00623428|20889270|P1|NOT COMPLETED|Treatment Period||0
8476374|NCT00623428|20889269|P2|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
8476375|NCT00623428|20889270|P1|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
8476376|NCT00623428|20889269|P2|STARTED|Treatment Period||93
8476377|NCT00623428|20889270|P1|STARTED|Treatment Period||95
8476378|NCT00623233|20889288|P1|NOT COMPLETED|Overall Study||24
8476379|NCT00623233|20889288|P1|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
8476380|NCT00623233|20889288|P1|STARTED|Overall Study||52
8476381|NCT00623194|20889295|P1|NOT COMPLETED|Overall Study||5
8476382|NCT00623194|20889295|P1|COMPLETED|Overall Study||141
8476383|NCT00623194|20889295|P1|STARTED|Overall Study||146
8476384|NCT00623181|20889317|P2|NOT COMPLETED|Overall Study||0
8476385|NCT00623181|20889318|P1|NOT COMPLETED|Overall Study||0
8476386|NCT00623181|20889317|P2|COMPLETED|Overall Study||54
8476387|NCT00623181|20889318|P1|COMPLETED|Overall Study||56
8476388|NCT00623181|20889317|P2|STARTED|Overall Study||54
8476389|NCT00623181|20889318|P1|STARTED|Overall Study||56
8476390|NCT00623103|20889332|P2|NOT COMPLETED|Overall Study||113
8476391|NCT00623103|20889333|P1|NOT COMPLETED|Overall Study||111
8476392|NCT00623103|20889332|P2|COMPLETED|Overall Study||175
8476393|NCT00623103|20889333|P1|COMPLETED|Overall Study||184
8476394|NCT00623103|20889332|P2|Safety Set: Received Study Drug|Overall Study||288
8476395|NCT00623103|20889333|P1|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
8476396|NCT00623103|20889332|P2|STARTED|Overall Study||288
8476397|NCT00623103|20889333|P1|STARTED|Overall Study||295
8476398|NCT00623012|20889353|P1|NOT COMPLETED|Overall Study||0
8476399|NCT00623012|20889353|P1|COMPLETED|Overall Study||2
8476400|NCT00623012|20889353|P1|STARTED|Overall Study||2
8476401|NCT00622908|20889361|P2|NOT COMPLETED|Overall Study||10
8476402|NCT00622908|20889362|P1|NOT COMPLETED|Overall Study||3
8476403|NCT00622908|20889361|P2|COMPLETED|Overall Study||122
8476404|NCT00622908|20889362|P1|COMPLETED|Overall Study||134
8476405|NCT00622908|20889361|P2|STARTED|Overall Study|Intent to treat population|132
8476406|NCT00622908|20889362|P1|STARTED|Overall Study|Intent to treat population|137
8476407|NCT00622895|20889374|P1|NOT COMPLETED|Overall Study||0
8476408|NCT00622895|20889374|P1|COMPLETED|Overall Study||3
8476409|NCT00622895|20889374|P1|STARTED|Overall Study||3
8476410|NCT00622869|20889392|P3|NOT COMPLETED|Overall Study||39
8476411|NCT00622869|20889393|P2|NOT COMPLETED|Overall Study||57
8476412|NCT00622869|20889394|P1|NOT COMPLETED|Overall Study||43
8476413|NCT00622869|20889392|P3|COMPLETED|Overall Study||204
8476414|NCT00622869|20889393|P2|COMPLETED|Overall Study||174
8476415|NCT00622869|20889394|P1|COMPLETED|Overall Study||202
8476416|NCT00622869|20889392|P3|STARTED|Overall Study||243
8476417|NCT00622869|20889393|P2|STARTED|Overall Study||231
8476418|NCT00622869|20889394|P1|STARTED|Overall Study||245
8476419|NCT00622739|20889413|P2|NOT COMPLETED|Overall Study||6
8476420|NCT00622739|20889414|P1|NOT COMPLETED|Overall Study||2
8476421|NCT00622739|20889413|P2|COMPLETED|Overall Study||9
8476422|NCT00622739|20889414|P1|COMPLETED|Overall Study||11
8476423|NCT00622739|20889413|P2|STARTED|Overall Study||15
8476424|NCT00622739|20889414|P1|STARTED|Overall Study||13
8476425|NCT00622726|20889432|P2|NOT COMPLETED|August, 2010 to April, 2013||5
8476426|NCT00622726|20889433|P1|NOT COMPLETED|August, 2010 to April, 2013||1
8476427|NCT00622726|20889432|P2|COMPLETED|August, 2010 to April, 2013||68
8476428|NCT00622726|20889433|P1|COMPLETED|August, 2010 to April, 2013||69
8476429|NCT00622726|20889432|P2|STARTED|August, 2010 to April, 2013||73
8476430|NCT00622726|20889433|P1|STARTED|August, 2010 to April, 2013||70
8476431|NCT00622726|20889432|P2|NOT COMPLETED|March, 2008 to August, 2010||2
8476432|NCT00622726|20889433|P1|NOT COMPLETED|March, 2008 to August, 2010||5
8476433|NCT00622726|20889432|P2|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
8476434|NCT00622726|20889433|P1|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
8476435|NCT00622726|20889432|P2|STARTED|March, 2008 to August, 2010||75
8476436|NCT00622726|20889433|P1|STARTED|March, 2008 to August, 2010||75
8476437|NCT00622713|20889443|P1|NOT COMPLETED|Overall Study||59
8476438|NCT00622713|20889443|P1|COMPLETED|Overall Study||169
8476439|NCT00622713|20889443|P1|Intent to Treat (ITT) Population|Overall Study||218
8476440|NCT00622713|20889443|P1|Exposed to Study Drug|Overall Study||226
8476441|NCT00622713|20889443|P1|STARTED|Overall Study||228
8476442|NCT00622700|20889454|P7|NOT COMPLETED|Extension Treatment Period||30
8476443|NCT00622700|20889455|P6|NOT COMPLETED|Extension Treatment Period||17
8476444|NCT00622700|20889456|P5|NOT COMPLETED|Extension Treatment Period||39
8476445|NCT00622700|20889457|P4|NOT COMPLETED|Extension Treatment Period||21
8476446|NCT00622700|20889458|P3|NOT COMPLETED|Extension Treatment Period||0
8476447|NCT00622700|20889459|P2|NOT COMPLETED|Extension Treatment Period||0
8476448|NCT00622700|20889460|P1|NOT COMPLETED|Extension Treatment Period||0
8476449|NCT00622700|20889454|P7|COMPLETED|Extension Treatment Period||120
8476450|NCT00622700|20889455|P6|COMPLETED|Extension Treatment Period||50
8476451|NCT00622700|20889456|P5|COMPLETED|Extension Treatment Period||103
8476452|NCT00622700|20889457|P4|COMPLETED|Extension Treatment Period||43
8476453|NCT00622700|20889458|P3|COMPLETED|Extension Treatment Period||0
8476454|NCT00622700|20889459|P2|COMPLETED|Extension Treatment Period||0
8476455|NCT00622700|20889460|P1|COMPLETED|Extension Treatment Period||0
8476456|NCT00622700|20889454|P7|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
8476457|NCT00622700|20889455|P6|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
8476458|NCT00622700|20889456|P5|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
8476459|NCT00622700|20889457|P4|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
8476460|NCT00622700|20889458|P3|STARTED|Extension Treatment Period||0
8476461|NCT00622700|20889459|P2|STARTED|Extension Treatment Period||0
8476462|NCT00622700|20889460|P1|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
8476463|NCT00622700|20889454|P7|NOT COMPLETED|Core Treatment Period||0
8476464|NCT00622700|20889455|P6|NOT COMPLETED|Core Treatment Period||0
8476465|NCT00622700|20889456|P5|NOT COMPLETED|Core Treatment Period||0
8476466|NCT00622700|20889457|P4|NOT COMPLETED|Core Treatment Period||0
8476467|NCT00622700|20889458|P3|NOT COMPLETED|Core Treatment Period||53
8476468|NCT00622700|20889459|P2|NOT COMPLETED|Core Treatment Period||55
8476469|NCT00622700|20889460|P1|NOT COMPLETED|Core Treatment Period||56
8476470|NCT00622700|20889454|P7|COMPLETED|Core Treatment Period||0
8476471|NCT00622700|20889455|P6|COMPLETED|Core Treatment Period||0
8476472|NCT00622700|20889456|P5|COMPLETED|Core Treatment Period||0
8476473|NCT00622700|20889457|P4|COMPLETED|Core Treatment Period||0
8476474|NCT00622700|20889458|P3|COMPLETED|Core Treatment Period||163
8476475|NCT00622700|20889459|P2|COMPLETED|Core Treatment Period||150
8476476|NCT00622700|20889460|P1|COMPLETED|Core Treatment Period||141
8476477|NCT00622700|20889454|P7|Treated|Core Treatment Period||0
8476478|NCT00622700|20889455|P6|Treated|Core Treatment Period||0
8476479|NCT00622700|20889456|P5|Treated|Core Treatment Period||0
8476480|NCT00622700|20889457|P4|Treated|Core Treatment Period||0
8476481|NCT00622700|20889458|P3|Treated|Core Treatment Period||214
8476482|NCT00622700|20889459|P2|Treated|Core Treatment Period||203
8476483|NCT00622700|20889460|P1|Treated|Core Treatment Period||197
8476484|NCT00622700|20889454|P7|STARTED|Core Treatment Period||0
8476485|NCT00622700|20889455|P6|STARTED|Core Treatment Period||0
8476486|NCT00622700|20889456|P5|STARTED|Core Treatment Period||0
8476487|NCT00622700|20889457|P4|STARTED|Core Treatment Period||0
8476488|NCT00622700|20889458|P3|STARTED|Core Treatment Period||216
8476489|NCT00622700|20889459|P2|STARTED|Core Treatment Period||205
8476490|NCT00622700|20889460|P1|STARTED|Core Treatment Period||197
8476491|NCT00622635|20889519|P6|NOT COMPLETED|Treatment Period 3||0
8476492|NCT00622635|20889520|P5|NOT COMPLETED|Treatment Period 3||0
8476493|NCT00622635|20889521|P4|NOT COMPLETED|Treatment Period 3||3
8476494|NCT00622635|20889522|P3|NOT COMPLETED|Treatment Period 3||0
8476495|NCT00622635|20889523|P2|NOT COMPLETED|Treatment Period 3||0
8476496|NCT00622635|20889524|P1|NOT COMPLETED|Treatment Period 3||0
8476497|NCT00622635|20889519|P6|COMPLETED|Treatment Period 3||10
8476498|NCT00622635|20889520|P5|COMPLETED|Treatment Period 3||9
8476499|NCT00622635|20889521|P4|COMPLETED|Treatment Period 3||10
8476500|NCT00622635|20889522|P3|COMPLETED|Treatment Period 3||10
8476501|NCT00622635|20889523|P2|COMPLETED|Treatment Period 3||10
8476502|NCT00622635|20889524|P1|COMPLETED|Treatment Period 3||12
8476503|NCT00622635|20889519|P6|STARTED|Treatment Period 3||10
8476504|NCT00622635|20889520|P5|STARTED|Treatment Period 3||9
8476505|NCT00622635|20889521|P4|STARTED|Treatment Period 3||13
8476506|NCT00622635|20889522|P3|STARTED|Treatment Period 3||10
8476507|NCT00622635|20889523|P2|STARTED|Treatment Period 3||10
8476508|NCT00622635|20889524|P1|STARTED|Treatment Period 3||12
8476509|NCT00622635|20889519|P6|NOT COMPLETED|Treatment Period 2||0
8476510|NCT00622635|20889520|P5|NOT COMPLETED|Treatment Period 2||0
8476511|NCT00622635|20889521|P4|NOT COMPLETED|Treatment Period 2||0
8476512|NCT00622635|20889522|P3|NOT COMPLETED|Treatment Period 2||0
8476513|NCT00622635|20889523|P2|NOT COMPLETED|Treatment Period 2||0
8476514|NCT00622635|20889524|P1|NOT COMPLETED|Treatment Period 2||1
8476515|NCT00622635|20889519|P6|COMPLETED|Treatment Period 2||10
8476516|NCT00622635|20889520|P5|COMPLETED|Treatment Period 2||9
8476517|NCT00622635|20889521|P4|COMPLETED|Treatment Period 2||13
8476518|NCT00622635|20889522|P3|COMPLETED|Treatment Period 2||10
8476519|NCT00622635|20889523|P2|COMPLETED|Treatment Period 2||10
8476520|NCT00622635|20889524|P1|COMPLETED|Treatment Period 2||12
8476521|NCT00622635|20889519|P6|STARTED|Treatment Period 2||10
8476522|NCT00622635|20889520|P5|STARTED|Treatment Period 2||9
8476523|NCT00622635|20889521|P4|STARTED|Treatment Period 2||13
8476524|NCT00622635|20889522|P3|STARTED|Treatment Period 2||10
8476525|NCT00622635|20889523|P2|STARTED|Treatment Period 2||10
8476526|NCT00622635|20889524|P1|STARTED|Treatment Period 2||13
8476527|NCT00622635|20889519|P6|NOT COMPLETED|Treatment Period 1||0
8476528|NCT00622635|20889520|P5|NOT COMPLETED|Treatment Period 1||1
8476529|NCT00622635|20889521|P4|NOT COMPLETED|Treatment Period 1||0
8476530|NCT00622635|20889522|P3|NOT COMPLETED|Treatment Period 1||1
8476531|NCT00622635|20889523|P2|NOT COMPLETED|Treatment Period 1||1
8476532|NCT00622635|20889524|P1|NOT COMPLETED|Treatment Period 1||0
8476533|NCT00622635|20889519|P6|COMPLETED|Treatment Period 1||10
8476534|NCT00622635|20889520|P5|COMPLETED|Treatment Period 1||9
8476535|NCT00622635|20889521|P4|COMPLETED|Treatment Period 1||13
8476536|NCT00622635|20889522|P3|COMPLETED|Treatment Period 1||10
8476537|NCT00622635|20889523|P2|COMPLETED|Treatment Period 1||10
8476538|NCT00622635|20889524|P1|COMPLETED|Treatment Period 1||13
8476539|NCT00622635|20889519|P6|STARTED|Treatment Period 1||10
8476540|NCT00622635|20889520|P5|STARTED|Treatment Period 1||10
8476541|NCT00622635|20889521|P4|STARTED|Treatment Period 1||13
8476542|NCT00622635|20889522|P3|STARTED|Treatment Period 1||11
8476543|NCT00622635|20889523|P2|STARTED|Treatment Period 1||11
8476544|NCT00622635|20889524|P1|STARTED|Treatment Period 1||13
8476545|NCT00622544|20889589|P1|NOT COMPLETED|Overall Study||9
8476546|NCT00622544|20889589|P1|COMPLETED|Overall Study|35|35
8476547|NCT00622544|20889589|P1|STARTED|Overall Study||44
8476548|NCT00622518|20889596|P2|NOT COMPLETED|Overall Study||0
8476549|NCT00622518|20889597|P1|NOT COMPLETED|Overall Study||0
8476550|NCT00622518|20889596|P2|COMPLETED|Overall Study||60
8476551|NCT00622518|20889597|P1|COMPLETED|Overall Study||59
8476552|NCT00622518|20889596|P2|STARTED|Overall Study||60
8476553|NCT00622518|20889597|P1|STARTED|Overall Study||59
8476554|NCT00622466|20889605|P1|NOT COMPLETED|Overall Study||4
8476555|NCT00622466|20889605|P1|COMPLETED|Overall Study||16
8476556|NCT00622466|20889605|P1|STARTED|Overall Study||20
8476557|NCT00622440|20889618|P2|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
8476558|NCT00622440|20889619|P1|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
8476559|NCT00622440|20889618|P2|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
8476560|NCT00622440|20889619|P1|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
8476561|NCT00622440|20889618|P2|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
8476562|NCT00622440|20889619|P1|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
8476563|NCT00622440|20889618|P2|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
8476564|NCT00622440|20889619|P1|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
8476565|NCT00622440|20889618|P2|COMPLETED|Week 12 - Week 48 (Treatment)||28
8476566|NCT00622440|20889619|P1|COMPLETED|Week 12 - Week 48 (Treatment)||28
8476567|NCT00622440|20889618|P2|STARTED|Week 12 - Week 48 (Treatment)||34
8476568|NCT00622440|20889619|P1|STARTED|Week 12 - Week 48 (Treatment)||31
8476569|NCT00622440|20889618|P2|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
8476570|NCT00622440|20889619|P1|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
8476571|NCT00622440|20889618|P2|COMPLETED|Baseline - Week 12 (Treatment)||34
8476572|NCT00622440|20889619|P1|COMPLETED|Baseline - Week 12 (Treatment)||31
8476573|NCT00622440|20889618|P2|STARTED|Baseline - Week 12 (Treatment)||35
8476574|NCT00622440|20889619|P1|STARTED|Baseline - Week 12 (Treatment)||35
8476575|NCT00622427|20889633|P2|NOT COMPLETED|Overall Study||0
8476576|NCT00622427|20889634|P1|NOT COMPLETED|Overall Study||0
8476577|NCT00622427|20889633|P2|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
8476578|NCT00622427|20889634|P1|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
8476579|NCT00622427|20889633|P2|STARTED|Overall Study||16
8476580|NCT00622427|20889634|P1|STARTED|Overall Study||16
8476581|NCT00622401|20889645|P3|NOT COMPLETED|Overall Study||0
8476582|NCT00622401|20889646|P2|NOT COMPLETED|Overall Study||2
8476583|NCT00622401|20889647|P1|NOT COMPLETED|Overall Study||3
8476584|NCT00622401|20889645|P3|COMPLETED|Overall Study||0
8476585|NCT00622401|20889646|P2|COMPLETED|Overall Study||0
8476586|NCT00622401|20889647|P1|COMPLETED|Overall Study||3
8476587|NCT00622401|20889645|P3|STARTED|Overall Study|Never Opened|0
8476588|NCT00622401|20889646|P2|STARTED|Overall Study||2
8476589|NCT00622401|20889647|P1|STARTED|Overall Study||6
8476590|NCT00622388|20889654|P1|NOT COMPLETED|Overall Study||72
8476591|NCT00622388|20889654|P1|COMPLETED|Overall Study||9
8476592|NCT00622388|20889654|P1|STARTED|Overall Study||81
8476593|NCT00622336|20889672|P1|NOT COMPLETED|Extension Phase||21
8476594|NCT00622336|20889672|P1|COMPLETED|Extension Phase||0
8476595|NCT00622336|20889672|P1|STARTED|Extension Phase||21
8476596|NCT00622336|20889672|P1|NOT COMPLETED|Treatment Phase||309
8476597|NCT00622336|20889672|P1|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
8476598|NCT00622336|20889672|P1|Safety Population|Treatment Phase||330
8476599|NCT00622336|20889672|P1|STARTED|Treatment Phase||330
8476600|NCT00622284|20889683|P2|NOT COMPLETED|Overall Study||171
8476601|NCT00622284|20889684|P1|NOT COMPLETED|Overall Study||189
8476602|NCT00622284|20889683|P2|COMPLETED|Overall Study|Number who completed treatment.|604
8476603|NCT00622284|20889684|P1|COMPLETED|Overall Study|Number who completed treatment.|587
8476604|NCT00622284|20889683|P2|STARTED|Overall Study|Number who started treatment.|775
8476605|NCT00622284|20889684|P1|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
8476606|NCT00622180|20889746|P2|NOT COMPLETED|Overall Study||2
8476607|NCT00622180|20889747|P1|NOT COMPLETED|Overall Study||1
8476608|NCT00622180|20889746|P2|COMPLETED|Overall Study||5
8476609|NCT00622180|20889747|P1|COMPLETED|Overall Study||5
8476610|NCT00622180|20889746|P2|STARTED|Overall Study||7
8476611|NCT00622180|20889747|P1|STARTED|Overall Study||6
8476612|NCT00622167|20889753|P1|NOT COMPLETED|Overall Study||20
8476613|NCT00622167|20889753|P1|COMPLETED|Overall Study||4
8476614|NCT00622167|20889753|P1|STARTED|Overall Study||24
8476615|NCT00621985|20889757|P1|NOT COMPLETED|Dexamethasone Admission||1
8476616|NCT00621985|20889757|P1|COMPLETED|Dexamethasone Admission||4
8476617|NCT00621985|20889757|P1|STARTED|Dexamethasone Admission||5
8476618|NCT00621985|20889757|P1|NOT COMPLETED|Hydrocortisone Admission||0
8476619|NCT00621985|20889757|P1|COMPLETED|Hydrocortisone Admission||5
8476620|NCT00621985|20889757|P1|STARTED|Hydrocortisone Admission||5
8476621|NCT00621959|20889765|P2|NOT COMPLETED|Overall Study||9
8476622|NCT00621959|20889766|P1|NOT COMPLETED|Overall Study||7
8476623|NCT00621959|20889765|P2|COMPLETED|Overall Study||292
8476624|NCT00621959|20889766|P1|COMPLETED|Overall Study||288
8476625|NCT00621959|20889765|P2|STARTED|Overall Study||301
8476626|NCT00621959|20889766|P1|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
8476627|NCT00621946|20889776|P2|NOT COMPLETED|Overall Study||1
8476628|NCT00621946|20889777|P1|NOT COMPLETED|Overall Study||0
8476629|NCT00621946|20889776|P2|COMPLETED|Overall Study||12
8476630|NCT00621946|20889777|P1|COMPLETED|Overall Study||13
8476631|NCT00621946|20889776|P2|STARTED|Overall Study||13
8476632|NCT00621946|20889777|P1|STARTED|Overall Study||13
8476633|NCT00621933|20889793|P1|NOT COMPLETED|Overall Study||0
8476634|NCT00621933|20889793|P1|COMPLETED|Overall Study||399
8476635|NCT00621933|20889793|P1|STARTED|Overall Study||399
8476636|NCT00621855|20889805|P5|NOT COMPLETED|Overall Study||55
8476637|NCT00621855|20889806|P4|NOT COMPLETED|Overall Study||67
8476638|NCT00621855|20889807|P3|NOT COMPLETED|Overall Study||81
8476639|NCT00621855|20889808|P2|NOT COMPLETED|Overall Study||61
8476640|NCT00621855|20889809|P1|NOT COMPLETED|Overall Study||76
8476641|NCT00621855|20889805|P5|COMPLETED|Overall Study|Completed means completed treatment|318
8476642|NCT00621855|20889806|P4|COMPLETED|Overall Study|Completed means completed treatment|284
8476643|NCT00621855|20889807|P3|COMPLETED|Overall Study|Completed means completed treatment|330
8476644|NCT00621855|20889808|P2|COMPLETED|Overall Study|Completed means completed treatment|310
8476645|NCT00621855|20889809|P1|COMPLETED|Overall Study|Completed means completed treatment|296
8476646|NCT00621855|20889805|P5|STARTED|Overall Study|Started means randomised to treatment|373
8476647|NCT00621855|20889806|P4|STARTED|Overall Study|Started means randomised to treatment|351
8476648|NCT00621855|20889807|P3|STARTED|Overall Study|Started means randomised to treatment|411
8476649|NCT00621855|20889808|P2|STARTED|Overall Study|Started means randomised to treatment|371
8476650|NCT00621855|20889809|P1|STARTED|Overall Study|Started means randomised to treatment|372
8476651|NCT00621842|20889851|P1|NOT COMPLETED|Overall Study||19
8476652|NCT00621842|20889851|P1|COMPLETED|Overall Study||38
8476653|NCT00621842|20889851|P1|STARTED|Overall Study||57
8476654|NCT00621777|20889868|P2|NOT COMPLETED|Randomized Phase||19
8476655|NCT00621777|20889869|P1|NOT COMPLETED|Randomized Phase||7
8476656|NCT00621777|20889868|P2|COMPLETED|Randomized Phase||28
8476657|NCT00621777|20889869|P1|COMPLETED|Randomized Phase||33
8476658|NCT00621777|20889868|P2|STARTED|Randomized Phase||47
8476659|NCT00621777|20889869|P1|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
8476660|NCT00621777|20889868|P2|NOT COMPLETED|Open Phase||0
8476661|NCT00621777|20889869|P1|NOT COMPLETED|Open Phase||116
8476662|NCT00621777|20889868|P2|COMPLETED|Open Phase||0
8476663|NCT00621777|20889869|P1|COMPLETED|Open Phase||87
8476664|NCT00621777|20889868|P2|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
8476665|NCT00621777|20889869|P1|STARTED|Open Phase||203
8476666|NCT00621764|20889884|P4|NOT COMPLETED|Overall Study||1
8476667|NCT00621764|20889885|P3|NOT COMPLETED|Overall Study||0
8476668|NCT00621764|20889886|P2|NOT COMPLETED|Overall Study||0
8476669|NCT00621764|20889887|P1|NOT COMPLETED|Overall Study||0
8476670|NCT00621764|20889884|P4|COMPLETED|Overall Study||98
8476671|NCT00621764|20889885|P3|COMPLETED|Overall Study||101
8476672|NCT00621764|20889886|P2|COMPLETED|Overall Study||50
8476673|NCT00621764|20889887|P1|COMPLETED|Overall Study||50
8476674|NCT00621764|20889884|P4|STARTED|Overall Study||99
8476675|NCT00621764|20889885|P3|STARTED|Overall Study||101
8476676|NCT00621764|20889886|P2|STARTED|Overall Study||50
8476677|NCT00621764|20889887|P1|STARTED|Overall Study||50
8476678|NCT00621686|20889919|P2|NOT COMPLETED|Overall Study||0
8476679|NCT00621686|20889920|P1|NOT COMPLETED|Overall Study||0
8476680|NCT00621686|20889919|P2|COMPLETED|Overall Study||35
8476681|NCT00621686|20889920|P1|COMPLETED|Overall Study||19
8476682|NCT00621686|20889919|P2|STARTED|Overall Study||35
8476683|NCT00621686|20889920|P1|STARTED|Overall Study||19
8476684|NCT00621621|20889933|P2|NOT COMPLETED|Overall Study||0
8476685|NCT00621621|20889934|P1|NOT COMPLETED|Overall Study||30
8476686|NCT00621621|20889933|P2|COMPLETED|Overall Study||705
8476687|NCT00621621|20889934|P1|COMPLETED|Overall Study|Treated with the experimental catheter|75
8476688|NCT00621621|20889933|P2|STARTED|Overall Study||705
8476689|NCT00621621|20889934|P1|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
8476690|NCT00621582|20889942|P1|NOT COMPLETED|Overall Study||106
8476691|NCT00621582|20889942|P1|COMPLETED|Overall Study||4812
8476692|NCT00621582|20889942|P1|STARTED|Overall Study||4918
8476693|NCT00621543|20889949|P1|NOT COMPLETED|Overall Study||23
8476694|NCT00621543|20889949|P1|COMPLETED|Overall Study||97
8476695|NCT00621543|20889949|P1|STARTED|Overall Study||120
8476696|NCT00621530|20889956|P2|NOT COMPLETED|Overall Study||3
8476697|NCT00621530|20889957|P1|NOT COMPLETED|Overall Study||2
8476698|NCT00621530|20889956|P2|COMPLETED|Overall Study||29
8476699|NCT00621530|20889957|P1|COMPLETED|Overall Study||28
8476700|NCT00621530|20889956|P2|STARTED|Overall Study||32
8476701|NCT00621530|20889957|P1|STARTED|Overall Study||30
8476702|NCT00621517|20889973|P2|NOT COMPLETED|Overall Study||7
8476703|NCT00621517|20889974|P1|NOT COMPLETED|Overall Study||7
8476704|NCT00621517|20889973|P2|COMPLETED|Overall Study||24
8476705|NCT00621517|20889974|P1|COMPLETED|Overall Study||22
8476706|NCT00621517|20889973|P2|STARTED|Overall Study||31
8476707|NCT00621517|20889974|P1|STARTED|Overall Study||29
8476708|NCT00621504|20889986|P2|NOT COMPLETED|Overall Study||25
8476709|NCT00621504|20889987|P1|NOT COMPLETED|Overall Study||26
8476710|NCT00621504|20889986|P2|COMPLETED|Overall Study||282
8476711|NCT00621504|20889987|P1|COMPLETED|Overall Study||273
8476712|NCT00621504|20889986|P2|STARTED|Overall Study||307
8476713|NCT00621504|20889987|P1|STARTED|Overall Study||299
8476714|NCT00621348|20889996|P3|NOT COMPLETED|Overall Study||0
8476715|NCT00621348|20889997|P2|NOT COMPLETED|Overall Study||0
8476716|NCT00621348|20889998|P1|NOT COMPLETED|Overall Study||0
8476717|NCT00621348|20889996|P3|COMPLETED|Overall Study||56
8476718|NCT00621348|20889997|P2|COMPLETED|Overall Study||53
8476719|NCT00621348|20889998|P1|COMPLETED|Overall Study||58
8476720|NCT00621348|20889996|P3|STARTED|Overall Study||56
8476721|NCT00621348|20889997|P2|STARTED|Overall Study||53
8476722|NCT00621348|20889998|P1|STARTED|Overall Study||58
8476723|NCT00621322|20890021|P6|NOT COMPLETED|Overall Study||4
8476724|NCT00621322|20890022|P5|NOT COMPLETED|Overall Study||1
8476725|NCT00621322|20890023|P4|NOT COMPLETED|Overall Study||3
8476726|NCT00621322|20890024|P3|NOT COMPLETED|Overall Study||2
8476727|NCT00621322|20890025|P2|NOT COMPLETED|Overall Study||0
8476728|NCT00621322|20890026|P1|NOT COMPLETED|Overall Study||1
8476729|NCT00621322|20890021|P6|COMPLETED|Overall Study||36
8476730|NCT00621322|20890022|P5|COMPLETED|Overall Study||39
8476731|NCT00621322|20890023|P4|COMPLETED|Overall Study||37
8476732|NCT00621322|20890024|P3|COMPLETED|Overall Study||38
8476733|NCT00621322|20890025|P2|COMPLETED|Overall Study||10
8476734|NCT00621322|20890026|P1|COMPLETED|Overall Study||9
8476735|NCT00621322|20890021|P6|STARTED|Overall Study||40
8476736|NCT00621322|20890022|P5|STARTED|Overall Study||40
8476737|NCT00621322|20890023|P4|STARTED|Overall Study||40
8476738|NCT00621322|20890024|P3|STARTED|Overall Study||40
8476739|NCT00621322|20890025|P2|STARTED|Overall Study||10
8476740|NCT00621322|20890026|P1|STARTED|Overall Study||10
8476741|NCT00621309|20890106|P6|NOT COMPLETED|Overall Study||1
8476742|NCT00621309|20890107|P5|NOT COMPLETED|Overall Study||1
8476743|NCT00621309|20890108|P4|NOT COMPLETED|Overall Study||1
8476744|NCT00621309|20890109|P3|NOT COMPLETED|Overall Study||1
8476745|NCT00621309|20890110|P2|NOT COMPLETED|Overall Study||0
8476746|NCT00621309|20890111|P1|NOT COMPLETED|Overall Study||2
8476747|NCT00621309|20890106|P6|COMPLETED|Overall Study||3
8476748|NCT00621309|20890107|P5|COMPLETED|Overall Study||3
8476749|NCT00621309|20890108|P4|COMPLETED|Overall Study||5
8476750|NCT00621309|20890109|P3|COMPLETED|Overall Study||4
8476751|NCT00621309|20890110|P2|COMPLETED|Overall Study||4
8476752|NCT00621309|20890111|P1|COMPLETED|Overall Study||4
8476753|NCT00621309|20890106|P6|STARTED|Overall Study||4
8476754|NCT00621309|20890107|P5|STARTED|Overall Study||4
8476755|NCT00621309|20890108|P4|STARTED|Overall Study||6
8476756|NCT00621309|20890109|P3|STARTED|Overall Study||5
8476757|NCT00621309|20890110|P2|STARTED|Overall Study||4
8476758|NCT00621309|20890111|P1|STARTED|Overall Study||6
8476759|NCT00621296|20890117|P1|NOT COMPLETED|Overall Study||14
8476760|NCT00621296|20890117|P1|COMPLETED|Overall Study||1
8476761|NCT00621296|20890117|P1|STARTED|Overall Study||15
8476762|NCT00621257|20890126|P5|NOT COMPLETED|Overall Study||9
8476763|NCT00621257|20890127|P4|NOT COMPLETED|Overall Study||6
8476764|NCT00621257|20890128|P3|NOT COMPLETED|Overall Study||3
8476765|NCT00621257|20890129|P2|NOT COMPLETED|Overall Study||3
8476766|NCT00621257|20890130|P1|NOT COMPLETED|Overall Study||4
8476767|NCT00621257|20890126|P5|COMPLETED|Overall Study||22
8476768|NCT00621257|20890127|P4|COMPLETED|Overall Study||26
8476769|NCT00621257|20890128|P3|COMPLETED|Overall Study||20
8476770|NCT00621257|20890129|P2|COMPLETED|Overall Study||21
8476771|NCT00621257|20890130|P1|COMPLETED|Overall Study||20
8476772|NCT00621257|20890126|P5|STARTED|Overall Study||31
8476773|NCT00621257|20890127|P4|STARTED|Overall Study||32
8476774|NCT00621257|20890128|P3|STARTED|Overall Study||23
8476775|NCT00621257|20890129|P2|STARTED|Overall Study||24
8476776|NCT00621257|20890130|P1|STARTED|Overall Study||24
8476777|NCT00621244|20890146|P4|NOT COMPLETED|Overall Study||23
8476778|NCT00621244|20890147|P3|NOT COMPLETED|Overall Study||33
8476779|NCT00621244|20890148|P2|NOT COMPLETED|Overall Study||34
8476780|NCT00621244|20890149|P1|NOT COMPLETED|Overall Study||86
8476781|NCT00621244|20890146|P4|COMPLETED|Overall Study||0
8476782|NCT00621244|20890147|P3|COMPLETED|Overall Study||0
8476783|NCT00621244|20890148|P2|COMPLETED|Overall Study||0
8476784|NCT00621244|20890149|P1|COMPLETED|Overall Study||0
8476785|NCT00621244|20890146|P4|STARTED|Overall Study||23
8476786|NCT00621244|20890147|P3|STARTED|Overall Study||33
8476787|NCT00621244|20890148|P2|STARTED|Overall Study||34
8476788|NCT00621244|20890149|P1|STARTED|Overall Study||86
8476789|NCT00621192|20890253|P4|NOT COMPLETED|Overall Study||3
8476790|NCT00621192|20890254|P3|NOT COMPLETED|Overall Study||5
8476791|NCT00621192|20890255|P2|NOT COMPLETED|Overall Study||9
8476792|NCT00621192|20890256|P1|NOT COMPLETED|Overall Study||4
8476793|NCT00621192|20890253|P4|COMPLETED|Overall Study||24
8476794|NCT00621192|20890254|P3|COMPLETED|Overall Study||26
8476795|NCT00621192|20890255|P2|COMPLETED|Overall Study||94
8476796|NCT00621192|20890256|P1|COMPLETED|Overall Study||35
8476797|NCT00621192|20890253|P4|Efficacy Population|Overall Study||27
8476798|NCT00621192|20890254|P3|Efficacy Population|Overall Study||28
8476799|NCT00621192|20890255|P2|Efficacy Population|Overall Study||101
8476800|NCT00621192|20890256|P1|Efficacy Population|Overall Study||39
8476801|NCT00621192|20890253|P4|Safety Population|Overall Study||27
8476802|NCT00621192|20890254|P3|Safety Population|Overall Study||31
8476803|NCT00621192|20890255|P2|Safety Population|Overall Study||103
8476804|NCT00621192|20890256|P1|Safety Population|Overall Study||39
8476805|NCT00621192|20890253|P4|STARTED|Overall Study||27
8476806|NCT00621192|20890254|P3|STARTED|Overall Study||31
8476807|NCT00621192|20890255|P2|STARTED|Overall Study||103
8476808|NCT00621192|20890256|P1|STARTED|Overall Study||39
8476821|NCT00621153|20890297|P2|NOT COMPLETED|Overall Study||15
8476822|NCT00621153|20890298|P1|NOT COMPLETED|Overall Study||20
8476823|NCT00621153|20890297|P2|COMPLETED|Overall Study|completed|101
8476824|NCT00621153|20890298|P1|COMPLETED|Overall Study|completed|97
8476825|NCT00621153|20890297|P2|Discontinued|Overall Study||15
8476826|NCT00621153|20890298|P1|Discontinued|Overall Study||20
8476827|NCT00621153|20890297|P2|STARTED|Overall Study|randomised|116
8476828|NCT00621153|20890298|P1|STARTED|Overall Study|randomised|117
8476829|NCT00621140|20890306|P2|NOT COMPLETED|Overall Study||18
8476830|NCT00621140|20890307|P1|NOT COMPLETED|Overall Study||15
8476831|NCT00621140|20890306|P2|COMPLETED|Overall Study|number who completed treatment|318
8476832|NCT00621140|20890307|P1|COMPLETED|Overall Study|number who completed treatment|152
8476833|NCT00621140|20890306|P2|STARTED|Overall Study|number who started treatment|336
8476834|NCT00621140|20890307|P1|STARTED|Overall Study|number who started treatment|167
8476835|NCT00621049|20890341|P2|NOT COMPLETED|Maintenance Treatment||0
8476836|NCT00621049|20890342|P1|NOT COMPLETED|Maintenance Treatment||15
8476837|NCT00621049|20890341|P2|COMPLETED|Maintenance Treatment||0
8476838|NCT00621049|20890342|P1|COMPLETED|Maintenance Treatment||34
8476839|NCT00621049|20890341|P2|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
8476840|NCT00621049|20890342|P1|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
8476841|NCT00621049|20890341|P2|NOT COMPLETED|Adjuvant Treatment||10
8476842|NCT00621049|20890342|P1|NOT COMPLETED|Adjuvant Treatment||3
8476843|NCT00621049|20890341|P2|COMPLETED|Adjuvant Treatment||47
8476844|NCT00621049|20890342|P1|COMPLETED|Adjuvant Treatment||52
8476845|NCT00621049|20890341|P2|STARTED|Adjuvant Treatment||57
8476846|NCT00621049|20890342|P1|STARTED|Adjuvant Treatment||55
8476847|NCT00621023|20890354|P1|NOT COMPLETED|Overall Study||6
8476848|NCT00621023|20890354|P1|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
8476849|NCT00621023|20890354|P1|STARTED|Overall Study||6
8476850|NCT00620945|20890360|P1|NOT COMPLETED|Overall Study||0
8476851|NCT00620945|20890360|P1|COMPLETED|Overall Study||87
8476852|NCT00620945|20890360|P1|STARTED|Overall Study|Total number in the study|87
8476853|NCT00620854|20890371|P6|NOT COMPLETED|Period 3||0
8476854|NCT00620854|20890372|P5|NOT COMPLETED|Period 3||0
8476855|NCT00620854|20890373|P4|NOT COMPLETED|Period 3||0
8476856|NCT00620854|20890374|P3|NOT COMPLETED|Period 3||0
8476857|NCT00620854|20890375|P2|NOT COMPLETED|Period 3||0
8476858|NCT00620854|20890376|P1|NOT COMPLETED|Period 3||0
8476859|NCT00620854|20890371|P6|COMPLETED|Period 3||4
8476860|NCT00620854|20890372|P5|COMPLETED|Period 3||4
8476861|NCT00620854|20890373|P4|COMPLETED|Period 3||3
8476862|NCT00620854|20890374|P3|COMPLETED|Period 3||3
8476863|NCT00620854|20890375|P2|COMPLETED|Period 3||4
8476864|NCT00620854|20890376|P1|COMPLETED|Period 3||4
8476865|NCT00620854|20890371|P6|STARTED|Period 3||4
8476866|NCT00620854|20890372|P5|STARTED|Period 3||4
8476867|NCT00620854|20890373|P4|STARTED|Period 3||3
8476868|NCT00620854|20890374|P3|STARTED|Period 3||3
8476869|NCT00620854|20890375|P2|STARTED|Period 3||4
8476870|NCT00620854|20890376|P1|STARTED|Period 3||4
8476871|NCT00620854|20890371|P6|NOT COMPLETED|Washout 2||0
8476872|NCT00620854|20890372|P5|NOT COMPLETED|Washout 2||0
8476873|NCT00620854|20890373|P4|NOT COMPLETED|Washout 2||0
8476874|NCT00620854|20890374|P3|NOT COMPLETED|Washout 2||0
8476875|NCT00620854|20890375|P2|NOT COMPLETED|Washout 2||0
8476876|NCT00620854|20890376|P1|NOT COMPLETED|Washout 2||0
8476877|NCT00620854|20890371|P6|COMPLETED|Washout 2||4
8476878|NCT00620854|20890372|P5|COMPLETED|Washout 2||4
8476879|NCT00620854|20890373|P4|COMPLETED|Washout 2||3
8476880|NCT00620854|20890374|P3|COMPLETED|Washout 2||3
8476881|NCT00620854|20890375|P2|COMPLETED|Washout 2||4
8476882|NCT00620854|20890376|P1|COMPLETED|Washout 2||4
8476883|NCT00620854|20890371|P6|STARTED|Washout 2||4
8476884|NCT00620854|20890372|P5|STARTED|Washout 2||4
8476885|NCT00620854|20890373|P4|STARTED|Washout 2||3
8476886|NCT00620854|20890374|P3|STARTED|Washout 2||3
8476887|NCT00620854|20890375|P2|STARTED|Washout 2||4
8476888|NCT00620854|20890376|P1|STARTED|Washout 2||4
8476889|NCT00620854|20890371|P6|NOT COMPLETED|Period 2||0
8476890|NCT00620854|20890372|P5|NOT COMPLETED|Period 2||0
8476891|NCT00620854|20890373|P4|NOT COMPLETED|Period 2||0
8476892|NCT00620854|20890374|P3|NOT COMPLETED|Period 2||0
8476893|NCT00620854|20890375|P2|NOT COMPLETED|Period 2||0
8476894|NCT00620854|20890376|P1|NOT COMPLETED|Period 2||0
8476895|NCT00620854|20890371|P6|COMPLETED|Period 2||4
8476896|NCT00620854|20890372|P5|COMPLETED|Period 2||4
8476897|NCT00620854|20890373|P4|COMPLETED|Period 2||3
8476898|NCT00620854|20890374|P3|COMPLETED|Period 2||3
8476899|NCT00620854|20890375|P2|COMPLETED|Period 2||4
8476900|NCT00620854|20890376|P1|COMPLETED|Period 2||4
8476901|NCT00620854|20890371|P6|STARTED|Period 2||4
8476902|NCT00620854|20890372|P5|STARTED|Period 2||4
8476903|NCT00620854|20890373|P4|STARTED|Period 2||3
8476904|NCT00620854|20890374|P3|STARTED|Period 2||3
8476905|NCT00620854|20890375|P2|STARTED|Period 2||4
8476906|NCT00620854|20890376|P1|STARTED|Period 2||4
8476907|NCT00620854|20890371|P6|NOT COMPLETED|Washout 1||0
8476908|NCT00620854|20890372|P5|NOT COMPLETED|Washout 1||0
8476909|NCT00620854|20890373|P4|NOT COMPLETED|Washout 1||1
8476910|NCT00620854|20890374|P3|NOT COMPLETED|Washout 1||1
8476911|NCT00620854|20890375|P2|NOT COMPLETED|Washout 1||0
8476912|NCT00620854|20890376|P1|NOT COMPLETED|Washout 1||0
8476913|NCT00620854|20890371|P6|COMPLETED|Washout 1||4
8476914|NCT00620854|20890372|P5|COMPLETED|Washout 1||4
8476915|NCT00620854|20890373|P4|COMPLETED|Washout 1||3
8476916|NCT00620854|20890374|P3|COMPLETED|Washout 1||3
8476917|NCT00620854|20890375|P2|COMPLETED|Washout 1||4
8476918|NCT00620854|20890376|P1|COMPLETED|Washout 1||4
8476919|NCT00620854|20890371|P6|STARTED|Washout 1||4
8476920|NCT00620854|20890372|P5|STARTED|Washout 1||4
8476921|NCT00620854|20890373|P4|STARTED|Washout 1||4
8476922|NCT00620854|20890374|P3|STARTED|Washout 1||4
8476923|NCT00620854|20890375|P2|STARTED|Washout 1||4
8476924|NCT00620854|20890376|P1|STARTED|Washout 1||4
8476925|NCT00620854|20890371|P6|NOT COMPLETED|Period 1||0
8476926|NCT00620854|20890372|P5|NOT COMPLETED|Period 1||0
8476927|NCT00620854|20890373|P4|NOT COMPLETED|Period 1||0
8476928|NCT00620854|20890374|P3|NOT COMPLETED|Period 1||0
8476929|NCT00620854|20890375|P2|NOT COMPLETED|Period 1||0
8476930|NCT00620854|20890376|P1|NOT COMPLETED|Period 1||0
8476931|NCT00620854|20890371|P6|COMPLETED|Period 1||4
8476932|NCT00620854|20890372|P5|COMPLETED|Period 1||4
8476933|NCT00620854|20890373|P4|COMPLETED|Period 1||4
8476934|NCT00620854|20890374|P3|COMPLETED|Period 1||4
8476935|NCT00620854|20890375|P2|COMPLETED|Period 1||4
8476936|NCT00620854|20890376|P1|COMPLETED|Period 1||4
8476937|NCT00620854|20890371|P6|STARTED|Period 1||4
8476938|NCT00620854|20890372|P5|STARTED|Period 1||4
8476939|NCT00620854|20890373|P4|STARTED|Period 1||4
8476940|NCT00620854|20890374|P3|STARTED|Period 1||4
8476941|NCT00620854|20890375|P2|STARTED|Period 1||4
8476942|NCT00620854|20890376|P1|STARTED|Period 1||4
8476943|NCT00620828|20890389|P2|NOT COMPLETED|Overall Study||0
8476944|NCT00620828|20890390|P1|NOT COMPLETED|Overall Study||0
8476945|NCT00620828|20890389|P2|COMPLETED|Overall Study||35
8476946|NCT00620828|20890390|P1|COMPLETED|Overall Study||32
8476947|NCT00620828|20890389|P2|Number of Subjects Enrolled = 67|Overall Study||35
8476948|NCT00620828|20890390|P1|Number of Subjects Enrolled = 67|Overall Study||32
8476949|NCT00620828|20890389|P2|STARTED|Overall Study||35
8476950|NCT00620828|20890390|P1|STARTED|Overall Study||32
8476951|NCT00620815|20890407|P3|NOT COMPLETED|Overall Study||7
8476952|NCT00620815|20890408|P2|NOT COMPLETED|Overall Study||11
8476953|NCT00620815|20890409|P1|NOT COMPLETED|Overall Study||4
8476954|NCT00620815|20890407|P3|COMPLETED|Overall Study||192
8476955|NCT00620815|20890408|P2|COMPLETED|Overall Study||192
8476956|NCT00620815|20890409|P1|COMPLETED|Overall Study||195
8476957|NCT00620815|20890407|P3|STARTED|Overall Study||199
8476958|NCT00620815|20890408|P2|STARTED|Overall Study||203
8476959|NCT00620815|20890409|P1|STARTED|Overall Study||199
8476960|NCT00620776|20890449|P2|NOT COMPLETED|Overall Study||16
8476961|NCT00620776|20890450|P1|NOT COMPLETED|Overall Study||12
8476962|NCT00620776|20890449|P2|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
8476963|NCT00620776|20890450|P1|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
8476964|NCT00620776|20890449|P2|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
8476965|NCT00620776|20890450|P1|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
8476966|NCT00620776|20890449|P2|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
8476967|NCT00620776|20890450|P1|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
8476968|NCT00620763|20890478|P2|NOT COMPLETED|Period: Second Intervention||0
8476969|NCT00620763|20890479|P1|NOT COMPLETED|Period: Second Intervention||1
8476970|NCT00620763|20890478|P2|COMPLETED|Period: Second Intervention||7
8476971|NCT00620763|20890479|P1|COMPLETED|Period: Second Intervention||9
8476972|NCT00620763|20890478|P2|STARTED|Period: Second Intervention||7
8476973|NCT00620763|20890479|P1|STARTED|Period: Second Intervention||10
8476974|NCT00620763|20890478|P2|NOT COMPLETED|Period: Washout Period of 1 Week||0
8476975|NCT00620763|20890479|P1|NOT COMPLETED|Period: Washout Period of 1 Week||0
8476976|NCT00620763|20890478|P2|COMPLETED|Period: Washout Period of 1 Week||7
8476977|NCT00620763|20890479|P1|COMPLETED|Period: Washout Period of 1 Week||10
8476978|NCT00620763|20890478|P2|STARTED|Period: Washout Period of 1 Week||7
8476979|NCT00620763|20890479|P1|STARTED|Period: Washout Period of 1 Week||10
8476980|NCT00620763|20890478|P2|NOT COMPLETED|Period: First Intervention||5
8476981|NCT00620763|20890479|P1|NOT COMPLETED|Period: First Intervention||0
8476982|NCT00620763|20890478|P2|COMPLETED|Period: First Intervention||7
8476983|NCT00620763|20890479|P1|COMPLETED|Period: First Intervention||10
8476984|NCT00620763|20890478|P2|STARTED|Period: First Intervention||12
8476985|NCT00620763|20890479|P1|STARTED|Period: First Intervention||10
8476986|NCT00620750|20890485|P1|NOT COMPLETED|Overall Study||25
8476987|NCT00620750|20890485|P1|COMPLETED|Overall Study||40
8476988|NCT00620750|20890485|P1|STARTED|Overall Study||65
8476989|NCT00620711|20890489|P1|NOT COMPLETED|Overall Study||0
8476990|NCT00620711|20890489|P1|COMPLETED|Overall Study||4
8476991|NCT00620711|20890489|P1|STARTED|Overall Study||4
8476992|NCT00620698|20890494|P1|NOT COMPLETED|Overall Study||29
8476993|NCT00620698|20890494|P1|COMPLETED|Overall Study||60
8476994|NCT00620698|20890494|P1|STARTED|Overall Study||89
8476995|NCT00620659|20890500|P6|NOT COMPLETED|Treatment Period 3||0
8476996|NCT00620659|20890501|P5|NOT COMPLETED|Treatment Period 3||0
8476997|NCT00620659|20890502|P4|NOT COMPLETED|Treatment Period 3||1
8476998|NCT00620659|20890503|P3|NOT COMPLETED|Treatment Period 3||0
8476999|NCT00620659|20890504|P2|NOT COMPLETED|Treatment Period 3||2
8477000|NCT00620659|20890505|P1|NOT COMPLETED|Treatment Period 3||0
8477001|NCT00620659|20890500|P6|COMPLETED|Treatment Period 3||20
8477002|NCT00620659|20890501|P5|COMPLETED|Treatment Period 3||15
8477003|NCT00620659|20890502|P4|COMPLETED|Treatment Period 3||17
8477004|NCT00620659|20890503|P3|COMPLETED|Treatment Period 3||19
8477005|NCT00620659|20890504|P2|COMPLETED|Treatment Period 3||16
8477006|NCT00620659|20890505|P1|COMPLETED|Treatment Period 3||16
8477007|NCT00620659|20890500|P6|STARTED|Treatment Period 3||20
8477008|NCT00620659|20890501|P5|STARTED|Treatment Period 3||15
8477009|NCT00620659|20890502|P4|STARTED|Treatment Period 3||18
8477010|NCT00620659|20890503|P3|STARTED|Treatment Period 3||19
8477011|NCT00620659|20890504|P2|STARTED|Treatment Period 3||18
8477012|NCT00620659|20890505|P1|STARTED|Treatment Period 3||16
8477013|NCT00620659|20890500|P6|NOT COMPLETED|Placebo Washout Period 2||0
8477014|NCT00620659|20890501|P5|NOT COMPLETED|Placebo Washout Period 2||0
8477015|NCT00620659|20890502|P4|NOT COMPLETED|Placebo Washout Period 2||0
8477016|NCT00620659|20890503|P3|NOT COMPLETED|Placebo Washout Period 2||0
8477017|NCT00620659|20890504|P2|NOT COMPLETED|Placebo Washout Period 2||0
8477018|NCT00620659|20890505|P1|NOT COMPLETED|Placebo Washout Period 2||2
8477019|NCT00620659|20890500|P6|COMPLETED|Placebo Washout Period 2||20
8477020|NCT00620659|20890501|P5|COMPLETED|Placebo Washout Period 2||15
8477021|NCT00620659|20890502|P4|COMPLETED|Placebo Washout Period 2||18
8477022|NCT00620659|20890503|P3|COMPLETED|Placebo Washout Period 2||19
8477023|NCT00620659|20890504|P2|COMPLETED|Placebo Washout Period 2||18
8477024|NCT00620659|20890505|P1|COMPLETED|Placebo Washout Period 2||16
8477025|NCT00620659|20890500|P6|STARTED|Placebo Washout Period 2||20
8477026|NCT00620659|20890501|P5|STARTED|Placebo Washout Period 2||15
8477027|NCT00620659|20890502|P4|STARTED|Placebo Washout Period 2||18
8477028|NCT00620659|20890503|P3|STARTED|Placebo Washout Period 2||19
8477029|NCT00620659|20890504|P2|STARTED|Placebo Washout Period 2||18
8477030|NCT00620659|20890505|P1|STARTED|Placebo Washout Period 2||18
8477031|NCT00620659|20890500|P6|NOT COMPLETED|Treatment Period 2||0
8477032|NCT00620659|20890501|P5|NOT COMPLETED|Treatment Period 2||5
8477033|NCT00620659|20890502|P4|NOT COMPLETED|Treatment Period 2||0
8477034|NCT00620659|20890503|P3|NOT COMPLETED|Treatment Period 2||1
8477035|NCT00620659|20890504|P2|NOT COMPLETED|Treatment Period 2||3
8477036|NCT00620659|20890505|P1|NOT COMPLETED|Treatment Period 2||0
8477037|NCT00620659|20890500|P6|COMPLETED|Treatment Period 2||20
8477038|NCT00620659|20890501|P5|COMPLETED|Treatment Period 2||15
8477039|NCT00620659|20890502|P4|COMPLETED|Treatment Period 2||18
8477040|NCT00620659|20890503|P3|COMPLETED|Treatment Period 2||19
8477041|NCT00620659|20890504|P2|COMPLETED|Treatment Period 2||18
8477042|NCT00620659|20890505|P1|COMPLETED|Treatment Period 2||18
8477043|NCT00620659|20890500|P6|STARTED|Treatment Period 2||20
8477044|NCT00620659|20890501|P5|STARTED|Treatment Period 2||20
8477045|NCT00620659|20890502|P4|STARTED|Treatment Period 2||18
8477046|NCT00620659|20890503|P3|STARTED|Treatment Period 2||20
8477047|NCT00620659|20890504|P2|STARTED|Treatment Period 2||21
8477048|NCT00620659|20890505|P1|STARTED|Treatment Period 2||18
8477049|NCT00620659|20890500|P6|NOT COMPLETED|Placebo Washout Period 1||0
8477050|NCT00620659|20890501|P5|NOT COMPLETED|Placebo Washout Period 1||0
8477051|NCT00620659|20890502|P4|NOT COMPLETED|Placebo Washout Period 1||1
8477052|NCT00620659|20890503|P3|NOT COMPLETED|Placebo Washout Period 1||0
8477053|NCT00620659|20890504|P2|NOT COMPLETED|Placebo Washout Period 1||0
8477054|NCT00620659|20890505|P1|NOT COMPLETED|Placebo Washout Period 1||0
8477055|NCT00620659|20890500|P6|COMPLETED|Placebo Washout Period 1||20
8477056|NCT00620659|20890501|P5|COMPLETED|Placebo Washout Period 1||20
8477057|NCT00620659|20890502|P4|COMPLETED|Placebo Washout Period 1||18
8477058|NCT00620659|20890503|P3|COMPLETED|Placebo Washout Period 1||20
8477059|NCT00620659|20890504|P2|COMPLETED|Placebo Washout Period 1||21
8477060|NCT00620659|20890505|P1|COMPLETED|Placebo Washout Period 1||18
8477061|NCT00620659|20890500|P6|STARTED|Placebo Washout Period 1||20
8477062|NCT00620659|20890501|P5|STARTED|Placebo Washout Period 1||20
8477063|NCT00620659|20890502|P4|STARTED|Placebo Washout Period 1||19
8477064|NCT00620659|20890503|P3|STARTED|Placebo Washout Period 1||20
8477065|NCT00620659|20890504|P2|STARTED|Placebo Washout Period 1||21
8477066|NCT00620659|20890505|P1|STARTED|Placebo Washout Period 1||18
8477067|NCT00620659|20890500|P6|NOT COMPLETED|Treatment Period 1||0
8477068|NCT00620659|20890501|P5|NOT COMPLETED|Treatment Period 1||1
8477069|NCT00620659|20890502|P4|NOT COMPLETED|Treatment Period 1||3
8477070|NCT00620659|20890503|P3|NOT COMPLETED|Treatment Period 1||1
8477071|NCT00620659|20890504|P2|NOT COMPLETED|Treatment Period 1||0
8477072|NCT00620659|20890505|P1|NOT COMPLETED|Treatment Period 1||3
8477073|NCT00620659|20890500|P6|COMPLETED|Treatment Period 1||20
8477074|NCT00620659|20890501|P5|COMPLETED|Treatment Period 1||20
8477075|NCT00620659|20890502|P4|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
8477076|NCT00620659|20890503|P3|COMPLETED|Treatment Period 1||20
8477077|NCT00620659|20890504|P2|COMPLETED|Treatment Period 1||21
8477078|NCT00620659|20890505|P1|COMPLETED|Treatment Period 1||18
8477079|NCT00620659|20890500|P6|STARTED|Treatment Period 1||20
8477080|NCT00620659|20890501|P5|STARTED|Treatment Period 1||21
8477081|NCT00620659|20890502|P4|STARTED|Treatment Period 1||21
8477082|NCT00620659|20890503|P3|STARTED|Treatment Period 1||21
8477083|NCT00620659|20890504|P2|STARTED|Treatment Period 1||21
8477084|NCT00620659|20890505|P1|STARTED|Treatment Period 1||21
8477088|NCT00620542|20890532|P4|NOT COMPLETED|Part B (2 Year Core Study)||144
8477089|NCT00620542|20890533|P3|NOT COMPLETED|Part B (2 Year Core Study)||148
8477090|NCT00620542|20890534|P2|NOT COMPLETED|Part B (2 Year Core Study)||0
8477091|NCT00620542|20890535|P1|NOT COMPLETED|Part B (2 Year Core Study)||0
8477092|NCT00620542|20890532|P4|COMPLETED|Part B (2 Year Core Study)||547
8477093|NCT00620542|20890533|P3|COMPLETED|Part B (2 Year Core Study)||546
8477094|NCT00620542|20890534|P2|COMPLETED|Part B (2 Year Core Study)||0
8477095|NCT00620542|20890535|P1|COMPLETED|Part B (2 Year Core Study)||0
8477096|NCT00620542|20890532|P4|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
8477097|NCT00620542|20890533|P3|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
8477098|NCT00620542|20890534|P2|Intent-to-treat Population|Part B (2 Year Core Study)||0
8477099|NCT00620542|20890535|P1|Intent-to-treat Population|Part B (2 Year Core Study)||0
8477100|NCT00620542|20890532|P4|Received Treatment|Part B (2 Year Core Study)||689
8477101|NCT00620542|20890533|P3|Received Treatment|Part B (2 Year Core Study)||691
8477102|NCT00620542|20890534|P2|Received Treatment|Part B (2 Year Core Study)||0
8477103|NCT00620542|20890535|P1|Received Treatment|Part B (2 Year Core Study)||0
8477104|NCT00620542|20890532|P4|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
8477105|NCT00620542|20890533|P3|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
8477106|NCT00620542|20890534|P2|STARTED|Part B (2 Year Core Study)||0
8477107|NCT00620542|20890535|P1|STARTED|Part B (2 Year Core Study)||0
8477108|NCT00620542|20890532|P4|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
8477109|NCT00620542|20890533|P3|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
8477110|NCT00620542|20890534|P2|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
8477111|NCT00620542|20890535|P1|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
8477112|NCT00620542|20890532|P4|COMPLETED|Part A (Run-in - 2 Weeks)||0
8477113|NCT00620542|20890533|P3|COMPLETED|Part A (Run-in - 2 Weeks)||0
8477114|NCT00620542|20890534|P2|COMPLETED|Part A (Run-in - 2 Weeks)||690
8477115|NCT00620542|20890535|P1|COMPLETED|Part A (Run-in - 2 Weeks)||695
8477116|NCT00620542|20890532|P4|Received Treatment|Part A (Run-in - 2 Weeks)||0
8477117|NCT00620542|20890533|P3|Received Treatment|Part A (Run-in - 2 Weeks)||0
8477118|NCT00620542|20890534|P2|Received Treatment|Part A (Run-in - 2 Weeks)||795
8477119|NCT00620542|20890535|P1|Received Treatment|Part A (Run-in - 2 Weeks)||783
8477120|NCT00620542|20890532|P4|STARTED|Part A (Run-in - 2 Weeks)||0
8477121|NCT00620542|20890533|P3|STARTED|Part A (Run-in - 2 Weeks)||0
8477122|NCT00620542|20890534|P2|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
8477123|NCT00620542|20890535|P1|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
8477124|NCT00620503|20890573|P6|NOT COMPLETED|Follow-up (up to 14 Days)||0
8477125|NCT00620503|20890574|P5|NOT COMPLETED|Follow-up (up to 14 Days)||0
8477126|NCT00620503|20890575|P4|NOT COMPLETED|Follow-up (up to 14 Days)||0
8477127|NCT00620503|20890576|P3|NOT COMPLETED|Follow-up (up to 14 Days)||0
8477128|NCT00620503|20890577|P2|NOT COMPLETED|Follow-up (up to 14 Days)||0
8477129|NCT00620503|20890578|P1|NOT COMPLETED|Follow-up (up to 14 Days)||0
8477130|NCT00620503|20890573|P6|COMPLETED|Follow-up (up to 14 Days)||2
8477131|NCT00620503|20890574|P5|COMPLETED|Follow-up (up to 14 Days)||2
8477132|NCT00620503|20890575|P4|COMPLETED|Follow-up (up to 14 Days)||2
8477133|NCT00620503|20890576|P3|COMPLETED|Follow-up (up to 14 Days)||2
8477134|NCT00620503|20890577|P2|COMPLETED|Follow-up (up to 14 Days)||2
8477135|NCT00620503|20890578|P1|COMPLETED|Follow-up (up to 14 Days)||2
8477136|NCT00620503|20890573|P6|STARTED|Follow-up (up to 14 Days)||2
8477137|NCT00620503|20890574|P5|STARTED|Follow-up (up to 14 Days)||2
8477138|NCT00620503|20890575|P4|STARTED|Follow-up (up to 14 Days)||2
8477139|NCT00620503|20890576|P3|STARTED|Follow-up (up to 14 Days)||2
8477140|NCT00620503|20890577|P2|STARTED|Follow-up (up to 14 Days)||2
8477141|NCT00620503|20890578|P1|STARTED|Follow-up (up to 14 Days)||2
8477142|NCT00620503|20890573|P6|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8477143|NCT00620503|20890574|P5|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8477144|NCT00620503|20890575|P4|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8477145|NCT00620503|20890576|P3|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8477146|NCT00620503|20890577|P2|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8477147|NCT00620503|20890578|P1|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
8477148|NCT00620503|20890573|P6|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8477149|NCT00620503|20890574|P5|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8477150|NCT00620503|20890575|P4|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8477151|NCT00620503|20890576|P3|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8477152|NCT00620503|20890577|P2|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8477153|NCT00620503|20890578|P1|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
8477154|NCT00620503|20890573|P6|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8477155|NCT00620503|20890574|P5|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8477156|NCT00620503|20890575|P4|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8477157|NCT00620503|20890576|P3|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8477158|NCT00620503|20890577|P2|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8477159|NCT00620503|20890578|P1|STARTED|Treatment Period 3 (TP3) (7 Days)||2
8477160|NCT00620503|20890573|P6|NOT COMPLETED|Washout (at Least 1 Day)||0
8477161|NCT00620503|20890574|P5|NOT COMPLETED|Washout (at Least 1 Day)||0
8477162|NCT00620503|20890575|P4|NOT COMPLETED|Washout (at Least 1 Day)||0
8477163|NCT00620503|20890576|P3|NOT COMPLETED|Washout (at Least 1 Day)||0
8477164|NCT00620503|20890577|P2|NOT COMPLETED|Washout (at Least 1 Day)||0
8477165|NCT00620503|20890578|P1|NOT COMPLETED|Washout (at Least 1 Day)||0
8477166|NCT00620503|20890573|P6|COMPLETED|Washout (at Least 1 Day)||2
8477167|NCT00620503|20890574|P5|COMPLETED|Washout (at Least 1 Day)||2
8477168|NCT00620503|20890575|P4|COMPLETED|Washout (at Least 1 Day)||2
8477169|NCT00620503|20890576|P3|COMPLETED|Washout (at Least 1 Day)||2
8477170|NCT00620503|20890577|P2|COMPLETED|Washout (at Least 1 Day)||2
8477171|NCT00620503|20890578|P1|COMPLETED|Washout (at Least 1 Day)||2
8477172|NCT00620503|20890573|P6|STARTED|Washout (at Least 1 Day)||2
8477173|NCT00620503|20890574|P5|STARTED|Washout (at Least 1 Day)||2
8477174|NCT00620503|20890575|P4|STARTED|Washout (at Least 1 Day)||2
8477175|NCT00620503|20890576|P3|STARTED|Washout (at Least 1 Day)||2
8477176|NCT00620503|20890577|P2|STARTED|Washout (at Least 1 Day)||2
8477177|NCT00620503|20890578|P1|STARTED|Washout (at Least 1 Day)||2
8477178|NCT00620503|20890573|P6|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8477179|NCT00620503|20890574|P5|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8477180|NCT00620503|20890575|P4|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8477181|NCT00620503|20890576|P3|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8477182|NCT00620503|20890577|P2|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8477183|NCT00620503|20890578|P1|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
8477184|NCT00620503|20890573|P6|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8477185|NCT00620503|20890574|P5|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8477186|NCT00620503|20890575|P4|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8477187|NCT00620503|20890576|P3|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8477188|NCT00620503|20890577|P2|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8477189|NCT00620503|20890578|P1|COMPLETED|Treatment Period 2 (TP2) (7days)||2
8477190|NCT00620503|20890573|P6|STARTED|Treatment Period 2 (TP2) (7days)||2
8477191|NCT00620503|20890574|P5|STARTED|Treatment Period 2 (TP2) (7days)||2
8477192|NCT00620503|20890575|P4|STARTED|Treatment Period 2 (TP2) (7days)||2
8477193|NCT00620503|20890576|P3|STARTED|Treatment Period 2 (TP2) (7days)||2
8477194|NCT00620503|20890577|P2|STARTED|Treatment Period 2 (TP2) (7days)||2
8477195|NCT00620503|20890578|P1|STARTED|Treatment Period 2 (TP2) (7days)||2
8477196|NCT00620503|20890573|P6|NOT COMPLETED|Washout (at Least 1 Day)||0
8477197|NCT00620503|20890574|P5|NOT COMPLETED|Washout (at Least 1 Day)||0
8477198|NCT00620503|20890575|P4|NOT COMPLETED|Washout (at Least 1 Day)||0
8477199|NCT00620503|20890576|P3|NOT COMPLETED|Washout (at Least 1 Day)||0
8477200|NCT00620503|20890577|P2|NOT COMPLETED|Washout (at Least 1 Day)||0
8477201|NCT00620503|20890578|P1|NOT COMPLETED|Washout (at Least 1 Day)||0
8477202|NCT00620503|20890573|P6|COMPLETED|Washout (at Least 1 Day)||2
8477203|NCT00620503|20890574|P5|COMPLETED|Washout (at Least 1 Day)||2
8477204|NCT00620503|20890575|P4|COMPLETED|Washout (at Least 1 Day)||2
8477205|NCT00620503|20890576|P3|COMPLETED|Washout (at Least 1 Day)||2
8477206|NCT00620503|20890577|P2|COMPLETED|Washout (at Least 1 Day)||2
8477207|NCT00620503|20890578|P1|COMPLETED|Washout (at Least 1 Day)||2
8477208|NCT00620503|20890573|P6|STARTED|Washout (at Least 1 Day)||2
8477209|NCT00620503|20890574|P5|STARTED|Washout (at Least 1 Day)||2
8477210|NCT00620503|20890575|P4|STARTED|Washout (at Least 1 Day)||2
8477211|NCT00620503|20890576|P3|STARTED|Washout (at Least 1 Day)||2
8477212|NCT00620503|20890577|P2|STARTED|Washout (at Least 1 Day)||2
8477213|NCT00620503|20890578|P1|STARTED|Washout (at Least 1 Day)||2
8477214|NCT00620503|20890573|P6|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8477215|NCT00620503|20890574|P5|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8477216|NCT00620503|20890575|P4|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8477217|NCT00620503|20890576|P3|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8477218|NCT00620503|20890577|P2|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8477219|NCT00620503|20890578|P1|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
8477220|NCT00620503|20890573|P6|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8477221|NCT00620503|20890574|P5|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8477222|NCT00620503|20890575|P4|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8477223|NCT00620503|20890576|P3|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8477224|NCT00620503|20890577|P2|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8477225|NCT00620503|20890578|P1|COMPLETED|Treatment Period 1 (TP1) (7days)||2
8477226|NCT00620503|20890573|P6|STARTED|Treatment Period 1 (TP1) (7days)||2
8477227|NCT00620503|20890574|P5|STARTED|Treatment Period 1 (TP1) (7days)||2
8477228|NCT00620503|20890575|P4|STARTED|Treatment Period 1 (TP1) (7days)||2
8477229|NCT00620503|20890576|P3|STARTED|Treatment Period 1 (TP1) (7days)||2
8477230|NCT00620503|20890577|P2|STARTED|Treatment Period 1 (TP1) (7days)||2
8477231|NCT00620503|20890578|P1|STARTED|Treatment Period 1 (TP1) (7days)||2
8477232|NCT00620503|20890573|P6|NOT COMPLETED|Screening (up to 21 Days)||0
8477233|NCT00620503|20890574|P5|NOT COMPLETED|Screening (up to 21 Days)||0
8477234|NCT00620503|20890575|P4|NOT COMPLETED|Screening (up to 21 Days)||0
8477235|NCT00620503|20890576|P3|NOT COMPLETED|Screening (up to 21 Days)||0
8477236|NCT00620503|20890577|P2|NOT COMPLETED|Screening (up to 21 Days)||0
8477237|NCT00620503|20890578|P1|NOT COMPLETED|Screening (up to 21 Days)||0
8477238|NCT00620503|20890573|P6|COMPLETED|Screening (up to 21 Days)||2
8477239|NCT00620503|20890574|P5|COMPLETED|Screening (up to 21 Days)||2
8477240|NCT00620503|20890575|P4|COMPLETED|Screening (up to 21 Days)||2
8477241|NCT00620503|20890576|P3|COMPLETED|Screening (up to 21 Days)||2
8477242|NCT00620503|20890577|P2|COMPLETED|Screening (up to 21 Days)||2
8477243|NCT00620503|20890578|P1|COMPLETED|Screening (up to 21 Days)||2
8477244|NCT00620503|20890573|P6|STARTED|Screening (up to 21 Days)||2
8477245|NCT00620503|20890574|P5|STARTED|Screening (up to 21 Days)||2
8477246|NCT00620503|20890575|P4|STARTED|Screening (up to 21 Days)||2
8477247|NCT00620503|20890576|P3|STARTED|Screening (up to 21 Days)||2
8477248|NCT00620503|20890577|P2|STARTED|Screening (up to 21 Days)||2
8477249|NCT00620503|20890578|P1|STARTED|Screening (up to 21 Days)||2
8477250|NCT00620464|20890600|P2|NOT COMPLETED|Overall Study||24
8477251|NCT00620464|20890601|P1|NOT COMPLETED|Overall Study||20
8477252|NCT00620464|20890600|P2|COMPLETED|Overall Study||32
8477253|NCT00620464|20890601|P1|COMPLETED|Overall Study||32
8477254|NCT00620464|20890600|P2|STARTED|Overall Study||56
8477255|NCT00620464|20890601|P1|STARTED|Overall Study||52
8477256|NCT00620425|20890609|P1|NOT COMPLETED|Overall Study||0
8477257|NCT00620425|20890609|P1|COMPLETED|Overall Study||18
8477258|NCT00620425|20890609|P1|STARTED|Overall Study||18
8477259|NCT00620373|20890620|P1|NOT COMPLETED|Overall Study||33
8477260|NCT00620373|20890620|P1|COMPLETED|Overall Study||936
8477261|NCT00620373|20890620|P1|STARTED|Overall Study||969
8477262|NCT00620321|20890638|P2|NOT COMPLETED|Overall Study||16
8477263|NCT00620321|20890639|P1|NOT COMPLETED|Overall Study||8
8477264|NCT00620321|20890638|P2|COMPLETED|Overall Study||0
8477265|NCT00620321|20890639|P1|COMPLETED|Overall Study||0
8477266|NCT00620321|20890638|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
8477267|NCT00620321|20890639|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8477268|NCT00620321|20890638|P2|STARTED|Overall Study||16
8477269|NCT00620321|20890639|P1|STARTED|Overall Study||8
8477270|NCT00620282|20890658|P3|NOT COMPLETED|Overall Study||1
8477271|NCT00620282|20890659|P2|NOT COMPLETED|Overall Study||2
8477272|NCT00620282|20890660|P1|NOT COMPLETED|Overall Study||0
8477273|NCT00620282|20890658|P3|COMPLETED|Overall Study||16
8477274|NCT00620282|20890659|P2|COMPLETED|Overall Study||14
8477275|NCT00620282|20890660|P1|COMPLETED|Overall Study||16
8477276|NCT00620282|20890658|P3|STARTED|Overall Study||17
8477277|NCT00620282|20890659|P2|STARTED|Overall Study||16
8477278|NCT00620282|20890660|P1|STARTED|Overall Study||16
8477279|NCT00620191|20890709|P2|NOT COMPLETED|Overall Study||8
8477280|NCT00620191|20890710|P1|NOT COMPLETED|Overall Study||7
8477281|NCT00620191|20890709|P2|COMPLETED|Overall Study|12 month follow-up|32
8477282|NCT00620191|20890710|P1|COMPLETED|Overall Study|12 month follow-up|33
8477283|NCT00620191|20890709|P2|9 Month Follow-up|Overall Study||34
8477284|NCT00620191|20890710|P1|9 Month Follow-up|Overall Study||37
8477285|NCT00620191|20890709|P2|6 Month Follow-up|Overall Study||36
8477286|NCT00620191|20890710|P1|6 Month Follow-up|Overall Study||38
8477287|NCT00620191|20890709|P2|3 Month Follow-up|Overall Study||39
8477288|NCT00620191|20890710|P1|3 Month Follow-up|Overall Study||39
8477289|NCT00620191|20890709|P2|STARTED|Overall Study||40
8477290|NCT00620191|20890710|P1|STARTED|Overall Study||40
8477291|NCT00620126|20890724|P2|NOT COMPLETED|Overall Study||5
8477292|NCT00620126|20890725|P1|NOT COMPLETED|Overall Study||11
8477293|NCT00620126|20890724|P2|COMPLETED|Overall Study||17
8477294|NCT00620126|20890725|P1|COMPLETED|Overall Study||14
8477295|NCT00620126|20890724|P2|STARTED|Overall Study||22
8477296|NCT00620126|20890725|P1|STARTED|Overall Study||25
8477297|NCT00620113|20890739|P4|NOT COMPLETED|Overall Study||10
8477298|NCT00620113|20890740|P3|NOT COMPLETED|Overall Study||5
8477299|NCT00620113|20890741|P2|NOT COMPLETED|Overall Study||7
8477300|NCT00620113|20890742|P1|NOT COMPLETED|Overall Study||13
8477301|NCT00620113|20890739|P4|COMPLETED|Overall Study||59
8477302|NCT00620113|20890740|P3|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
8477303|NCT00620113|20890741|P2|COMPLETED|Overall Study||67
8477304|NCT00620113|20890742|P1|COMPLETED|Overall Study||60
8477305|NCT00620113|20890739|P4|Efficacy/Safety Population|Overall Study||69
8477306|NCT00620113|20890740|P3|Efficacy/Safety Population|Overall Study||70
8477307|NCT00620113|20890741|P2|Efficacy/Safety Population|Overall Study||74
8477308|NCT00620113|20890742|P1|Efficacy/Safety Population|Overall Study||73
8477309|NCT00620113|20890739|P4|STARTED|Overall Study||69
8477310|NCT00620113|20890740|P3|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
8477311|NCT00620113|20890741|P2|STARTED|Overall Study||74
8477312|NCT00620113|20890742|P1|STARTED|Overall Study||73
8477313|NCT00620074|20890792|P1|NOT COMPLETED|Overall Study||1
8477314|NCT00620074|20890792|P1|COMPLETED|Overall Study||5
8477315|NCT00620074|20890792|P1|STARTED|Overall Study||6
8477316|NCT00620061|20890800|P1|NOT COMPLETED|Overall Study||153
8477317|NCT00620061|20890800|P1|COMPLETED|Overall Study||286
8477318|NCT00620061|20890800|P1|STARTED|Overall Study||439
8477319|NCT00620035|20890815|P1|NOT COMPLETED|Overall Study||145
8477320|NCT00620035|20890815|P1|COMPLETED|Overall Study||156
8477321|NCT00620035|20890815|P1|STARTED|Overall Study||301
8477322|NCT00620022|20890825|P2|NOT COMPLETED|Treatment Period 2||2
8477323|NCT00620022|20890826|P1|NOT COMPLETED|Treatment Period 2||2
8477324|NCT00620022|20890825|P2|COMPLETED|Treatment Period 2||35
8477325|NCT00620022|20890826|P1|COMPLETED|Treatment Period 2||39
8477326|NCT00620022|20890825|P2|STARTED|Treatment Period 2||37
8477327|NCT00620022|20890826|P1|STARTED|Treatment Period 2||41
8477328|NCT00620022|20890825|P2|NOT COMPLETED|Treatment Period 1||6
8477329|NCT00620022|20890826|P1|NOT COMPLETED|Treatment Period 1||5
8477330|NCT00620022|20890825|P2|COMPLETED|Treatment Period 1||37
8477331|NCT00620022|20890826|P1|COMPLETED|Treatment Period 1||41
8477332|NCT00620022|20890825|P2|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
8477333|NCT00620022|20890826|P1|STARTED|Treatment Period 1||46
8477334|NCT00619983|20890838|P4|NOT COMPLETED|Gabapentin Alone||0
8477335|NCT00619983|20890839|P3|NOT COMPLETED|Gabapentin Alone||0
8477336|NCT00619983|20890840|P2|NOT COMPLETED|Gabapentin Alone||0
8477337|NCT00619983|20890841|P1|NOT COMPLETED|Gabapentin Alone||0
8477338|NCT00619983|20890838|P4|COMPLETED|Gabapentin Alone||3
8477339|NCT00619983|20890839|P3|COMPLETED|Gabapentin Alone||4
8477340|NCT00619983|20890840|P2|COMPLETED|Gabapentin Alone||4
8477341|NCT00619983|20890841|P1|COMPLETED|Gabapentin Alone||3
8477342|NCT00619983|20890838|P4|STARTED|Gabapentin Alone||3
8477343|NCT00619983|20890839|P3|STARTED|Gabapentin Alone||4
8477344|NCT00619983|20890840|P2|STARTED|Gabapentin Alone||4
8477345|NCT00619983|20890841|P1|STARTED|Gabapentin Alone||3
8477346|NCT00619983|20890838|P4|NOT COMPLETED|Test Drug Plus Gabapentin||0
8477347|NCT00619983|20890839|P3|NOT COMPLETED|Test Drug Plus Gabapentin||0
8477348|NCT00619983|20890840|P2|NOT COMPLETED|Test Drug Plus Gabapentin||0
8477349|NCT00619983|20890841|P1|NOT COMPLETED|Test Drug Plus Gabapentin||0
8477350|NCT00619983|20890838|P4|COMPLETED|Test Drug Plus Gabapentin||3
8477351|NCT00619983|20890839|P3|COMPLETED|Test Drug Plus Gabapentin||4
8477352|NCT00619983|20890840|P2|COMPLETED|Test Drug Plus Gabapentin||4
8477353|NCT00619983|20890841|P1|COMPLETED|Test Drug Plus Gabapentin||3
8477354|NCT00619983|20890838|P4|STARTED|Test Drug Plus Gabapentin||3
8477355|NCT00619983|20890839|P3|STARTED|Test Drug Plus Gabapentin||4
8477356|NCT00619983|20890840|P2|STARTED|Test Drug Plus Gabapentin||4
8477357|NCT00619983|20890841|P1|STARTED|Test Drug Plus Gabapentin||3
8477358|NCT00619983|20890838|P4|NOT COMPLETED|Test Drug Alone||3
8477359|NCT00619983|20890839|P3|NOT COMPLETED|Test Drug Alone||2
8477360|NCT00619983|20890840|P2|NOT COMPLETED|Test Drug Alone||1
8477361|NCT00619983|20890841|P1|NOT COMPLETED|Test Drug Alone||2
8477362|NCT00619983|20890838|P4|COMPLETED|Test Drug Alone||3
8477363|NCT00619983|20890839|P3|COMPLETED|Test Drug Alone||4
8477364|NCT00619983|20890840|P2|COMPLETED|Test Drug Alone||4
8477365|NCT00619983|20890841|P1|COMPLETED|Test Drug Alone||3
8477366|NCT00619983|20890838|P4|STARTED|Test Drug Alone||6
8477367|NCT00619983|20890839|P3|STARTED|Test Drug Alone||6
8477368|NCT00619983|20890840|P2|STARTED|Test Drug Alone||5
8477369|NCT00619983|20890841|P1|STARTED|Test Drug Alone||5
8477370|NCT00619970|20890854|P3|NOT COMPLETED|Overall Study||2
8477371|NCT00619970|20890855|P2|NOT COMPLETED|Overall Study||3
8477372|NCT00619970|20890856|P1|NOT COMPLETED|Overall Study||0
8477373|NCT00619970|20890854|P3|COMPLETED|Overall Study||24
8477374|NCT00619970|20890855|P2|COMPLETED|Overall Study||46
8477375|NCT00619970|20890856|P1|COMPLETED|Overall Study||40
8477376|NCT00619970|20890854|P3|STARTED|Overall Study||26
8477377|NCT00619970|20890855|P2|STARTED|Overall Study||49
8477378|NCT00619970|20890856|P1|STARTED|Overall Study||40
8477379|NCT00619957|20890868|P2|NOT COMPLETED|Month 48 Open-Label||17
8477380|NCT00619957|20890869|P1|NOT COMPLETED|Month 48 Open-Label||12
8477381|NCT00619957|20890868|P2|COMPLETED|Month 48 Open-Label||134
8477382|NCT00619957|20890869|P1|COMPLETED|Month 48 Open-Label||55
8477383|NCT00619957|20890868|P2|STARTED|Month 48 Open-Label||151
8477384|NCT00619957|20890869|P1|STARTED|Month 48 Open-Label||67
8477385|NCT00619957|20890868|P2|NOT COMPLETED|Month 24 Double-Blind||17
8477386|NCT00619957|20890869|P1|NOT COMPLETED|Month 24 Double-Blind||18
8477387|NCT00619957|20890868|P2|COMPLETED|Month 24 Double-Blind||175
8477388|NCT00619957|20890869|P1|COMPLETED|Month 24 Double-Blind||75
8477389|NCT00619957|20890868|P2|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
8477390|NCT00619957|20890869|P1|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
8477391|NCT00619957|20890868|P2|STARTED|Month 24 Double-Blind||192
8477392|NCT00619957|20890869|P1|STARTED|Month 24 Double-Blind||93
8477393|NCT00619918|20890951|P2|NOT COMPLETED|Overall Study||22
8477394|NCT00619918|20890952|P1|NOT COMPLETED|Overall Study||20
8477395|NCT00619918|20890951|P2|COMPLETED|Overall Study||195
8477396|NCT00619918|20890952|P1|COMPLETED|Overall Study||210
8477397|NCT00619918|20890951|P2|STARTED|Overall Study||217
8477398|NCT00619918|20890952|P1|STARTED|Overall Study||230
8477399|NCT00619892|20890962|P2|NOT COMPLETED|Overall Study||2
8477400|NCT00619892|20890963|P1|NOT COMPLETED|Overall Study||3
8477401|NCT00619892|20890962|P2|COMPLETED|Overall Study||11
8477402|NCT00619892|20890963|P1|COMPLETED|Overall Study||10
8477403|NCT00619892|20890962|P2|STARTED|Overall Study||13
8477404|NCT00619892|20890963|P1|STARTED|Overall Study||13
8477405|NCT00619866|20890974|P5|NOT COMPLETED|Weeks 13 - 24||2
8477406|NCT00619866|20890975|P4|NOT COMPLETED|Weeks 13 - 24||4
8477407|NCT00619866|20890976|P3|NOT COMPLETED|Weeks 13 - 24||5
8477408|NCT00619866|20890977|P2|NOT COMPLETED|Weeks 13 - 24||7
8477409|NCT00619866|20890978|P1|NOT COMPLETED|Weeks 13 - 24||0
8477410|NCT00619866|20890974|P5|COMPLETED|Weeks 13 - 24||18
8477411|NCT00619866|20890975|P4|COMPLETED|Weeks 13 - 24||14
8477412|NCT00619866|20890976|P3|COMPLETED|Weeks 13 - 24||37
8477413|NCT00619866|20890977|P2|COMPLETED|Weeks 13 - 24||38
8477414|NCT00619866|20890978|P1|COMPLETED|Weeks 13 - 24||0
8477415|NCT00619866|20890974|P5|STARTED|Weeks 13 - 24||20
8477416|NCT00619866|20890975|P4|STARTED|Weeks 13 - 24||18
8477417|NCT00619866|20890976|P3|STARTED|Weeks 13 - 24||42
8477418|NCT00619866|20890977|P2|STARTED|Weeks 13 - 24||45
8477419|NCT00619866|20890978|P1|STARTED|Weeks 13 - 24||0
8477420|NCT00619866|20890974|P5|NOT COMPLETED|Weeks 1 - 12||0
8477421|NCT00619866|20890975|P4|NOT COMPLETED|Weeks 1 - 12||0
8477422|NCT00619866|20890976|P3|NOT COMPLETED|Weeks 1 - 12||10
8477423|NCT00619866|20890977|P2|NOT COMPLETED|Weeks 1 - 12||6
8477424|NCT00619866|20890978|P1|NOT COMPLETED|Weeks 1 - 12||14
8477425|NCT00619866|20890974|P5|COMPLETED|Weeks 1 - 12||0
8477426|NCT00619866|20890975|P4|COMPLETED|Weeks 1 - 12||0
8477427|NCT00619866|20890976|P3|COMPLETED|Weeks 1 - 12||42
8477428|NCT00619866|20890977|P2|COMPLETED|Weeks 1 - 12||45
8477429|NCT00619866|20890978|P1|COMPLETED|Weeks 1 - 12||38
8477430|NCT00619866|20890974|P5|STARTED|Weeks 1 - 12||0
8477431|NCT00619866|20890975|P4|STARTED|Weeks 1 - 12||0
8477432|NCT00619866|20890976|P3|STARTED|Weeks 1 - 12||52
8477433|NCT00619866|20890977|P2|STARTED|Weeks 1 - 12||51
8477434|NCT00619866|20890978|P1|STARTED|Weeks 1 - 12||52
8477435|NCT00619827|20891065|P2|NOT COMPLETED|Overall Study||4
8477436|NCT00619827|20891066|P1|NOT COMPLETED|Overall Study||3
8477437|NCT00619827|20891065|P2|COMPLETED|Overall Study||40
8477438|NCT00619827|20891066|P1|COMPLETED|Overall Study||42
8477439|NCT00619827|20891065|P2|STARTED|Overall Study||44
8477440|NCT00619827|20891066|P1|STARTED|Overall Study||45
8477441|NCT00619801|20891074|P2|NOT COMPLETED|Overall Study||3
8477442|NCT00619801|20891075|P1|NOT COMPLETED|Overall Study||1
8477443|NCT00619801|20891074|P2|COMPLETED|Overall Study||111
8477444|NCT00619801|20891075|P1|COMPLETED|Overall Study||58
8477445|NCT00619801|20891074|P2|Safety Population|Overall Study||114
8477446|NCT00619801|20891075|P1|Safety Population|Overall Study||59
8477447|NCT00619801|20891074|P2|STARTED|Overall Study||114
8477448|NCT00619801|20891075|P1|STARTED|Overall Study||59
8477449|NCT00619762|20891105|P1|NOT COMPLETED|Overall Study||3
8477450|NCT00619762|20891105|P1|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
8477451|NCT00619762|20891105|P1|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
8477452|NCT00619723|20891112|P2|NOT COMPLETED|Overall Study||6
8477453|NCT00619723|20891113|P1|NOT COMPLETED|Overall Study||2
8477454|NCT00619723|20891112|P2|COMPLETED|Overall Study||61
8477455|NCT00619723|20891113|P1|COMPLETED|Overall Study||61
8477456|NCT00619723|20891112|P2|STARTED|Overall Study||67
8477457|NCT00619723|20891113|P1|STARTED|Overall Study||63
8477458|NCT00619684|20891123|P1|NOT COMPLETED|Overall Study||0
8477459|NCT00619684|20891123|P1|COMPLETED|Overall Study||18
8477460|NCT00619684|20891123|P1|STARTED|Overall Study||18
8477461|NCT00619645|20891132|P1|NOT COMPLETED|Overall Study||1
8477462|NCT00619645|20891132|P1|COMPLETED|Overall Study||7
8477463|NCT00619645|20891132|P1|STARTED|Overall Study||8
8477464|NCT00619619|20891146|P8|NOT COMPLETED|Overall Study||3
8477465|NCT00619619|20891147|P7|NOT COMPLETED|Overall Study||1
8477466|NCT00619619|20891148|P6|NOT COMPLETED|Overall Study||0
8477467|NCT00619619|20891149|P5|NOT COMPLETED|Overall Study||2
8477468|NCT00619619|20891150|P4|NOT COMPLETED|Overall Study||1
8477469|NCT00619619|20891151|P3|NOT COMPLETED|Overall Study||1
8477470|NCT00619619|20891152|P2|NOT COMPLETED|Overall Study||0
8477471|NCT00619619|20891153|P1|NOT COMPLETED|Overall Study||0
8477472|NCT00619619|20891146|P8|COMPLETED|Overall Study||5
8477473|NCT00619619|20891147|P7|COMPLETED|Overall Study||7
8477474|NCT00619619|20891148|P6|COMPLETED|Overall Study||7
8477475|NCT00619619|20891149|P5|COMPLETED|Overall Study||5
8477476|NCT00619619|20891150|P4|COMPLETED|Overall Study||6
8477477|NCT00619619|20891151|P3|COMPLETED|Overall Study||8
8477478|NCT00619619|20891152|P2|COMPLETED|Overall Study||7
8477479|NCT00619619|20891153|P1|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
8477480|NCT00619619|20891146|P8|Entered the Extension Study|Overall Study||7
8477481|NCT00619619|20891147|P7|Entered the Extension Study|Overall Study||6
8477482|NCT00619619|20891148|P6|Entered the Extension Study|Overall Study||6
8477483|NCT00619619|20891149|P5|Entered the Extension Study|Overall Study||7
8477484|NCT00619619|20891150|P4|Entered the Extension Study|Overall Study||3
8477485|NCT00619619|20891151|P3|Entered the Extension Study|Overall Study||8
8477486|NCT00619619|20891152|P2|Entered the Extension Study|Overall Study||5
8477487|NCT00619619|20891153|P1|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
8477488|NCT00619619|20891146|P8|STARTED|Overall Study||8
8477489|NCT00619619|20891147|P7|STARTED|Overall Study||8
8477490|NCT00619619|20891148|P6|STARTED|Overall Study||7
8477491|NCT00619619|20891149|P5|STARTED|Overall Study||7
8477492|NCT00619619|20891150|P4|STARTED|Overall Study||7
8477493|NCT00619619|20891151|P3|STARTED|Overall Study||9
8477494|NCT00619619|20891152|P2|STARTED|Overall Study||7
8477495|NCT00619619|20891153|P1|STARTED|Overall Study||6
8477496|NCT00619515|20891238|P1|NOT COMPLETED|Overall Study||73
8477497|NCT00619515|20891238|P1|COMPLETED|Overall Study||0
8477498|NCT00619515|20891238|P1|STARTED|Overall Study||73
8477499|NCT00619502|20891252|P2|NOT COMPLETED|Overall Study||10
8477500|NCT00619502|20891253|P1|NOT COMPLETED|Overall Study||8
8477501|NCT00619502|20891252|P2|COMPLETED|Overall Study||114
8477502|NCT00619502|20891253|P1|COMPLETED|Overall Study||122
8477503|NCT00619502|20891252|P2|STARTED|Overall Study||124
8477504|NCT00619502|20891253|P1|STARTED|Overall Study||130
8477505|NCT00619489|20891265|P2|NOT COMPLETED|Overall Study||34
8477506|NCT00619489|20891266|P1|NOT COMPLETED|Overall Study||23
8477507|NCT00619489|20891265|P2|COMPLETED|Overall Study||1
8477508|NCT00619489|20891266|P1|COMPLETED|Overall Study||14
8477509|NCT00619489|20891265|P2|STARTED|Overall Study||35
8477510|NCT00619489|20891266|P1|STARTED|Overall Study||37
8477511|NCT00619476|20891288|P4|NOT COMPLETED|Overall Study||34
8477512|NCT00619476|20891289|P3|NOT COMPLETED|Overall Study||24
8477513|NCT00619476|20891290|P2|NOT COMPLETED|Overall Study||22
8477514|NCT00619476|20891291|P1|NOT COMPLETED|Overall Study||31
8477515|NCT00619476|20891288|P4|COMPLETED|Overall Study||56
8477516|NCT00619476|20891289|P3|COMPLETED|Overall Study||60
8477517|NCT00619476|20891290|P2|COMPLETED|Overall Study||85
8477518|NCT00619476|20891291|P1|COMPLETED|Overall Study||64
8477519|NCT00619476|20891288|P4|Safety Population|Overall Study||87
8477520|NCT00619476|20891289|P3|Safety Population|Overall Study||82
8477521|NCT00619476|20891290|P2|Safety Population|Overall Study||107
8477522|NCT00619476|20891291|P1|Safety Population|Overall Study||95
8477523|NCT00619476|20891288|P4|Intent-to-Treat Population|Overall Study||87
8477524|NCT00619476|20891289|P3|Intent-to-Treat Population|Overall Study||82
8477525|NCT00619476|20891290|P2|Intent-to-Treat Population|Overall Study||107
8477526|NCT00619476|20891291|P1|Intent-to-Treat Population|Overall Study||95
8477527|NCT00619476|20891288|P4|STARTED|Overall Study||90
8477528|NCT00619476|20891289|P3|STARTED|Overall Study||84
8477529|NCT00619476|20891290|P2|STARTED|Overall Study||107
8477530|NCT00619476|20891291|P1|STARTED|Overall Study||95
8477531|NCT00619385|20891376|P3|NOT COMPLETED|Overall Study||4
8477532|NCT00619385|20891377|P2|NOT COMPLETED|Overall Study||2
8477533|NCT00619385|20891378|P1|NOT COMPLETED|Overall Study||1
8477534|NCT00619385|20891376|P3|COMPLETED|Overall Study||6
8477535|NCT00619385|20891377|P2|COMPLETED|Overall Study||6
8477536|NCT00619385|20891378|P1|COMPLETED|Overall Study||6
8477537|NCT00619385|20891376|P3|STARTED|Overall Study||10
8477538|NCT00619385|20891377|P2|STARTED|Overall Study||8
8477539|NCT00619385|20891378|P1|STARTED|Overall Study||7
8477540|NCT00619359|20891393|P2|NOT COMPLETED|Overall Study||81
8477541|NCT00619359|20891394|P1|NOT COMPLETED|Overall Study||67
8477542|NCT00619359|20891393|P2|COMPLETED|Overall Study||1094
8477543|NCT00619359|20891394|P1|COMPLETED|Overall Study||1080
8477544|NCT00619359|20891393|P2|STARTED|Overall Study||1175
8477545|NCT00619359|20891394|P1|STARTED|Overall Study||1147
8477546|NCT00619307|20891406|P2|NOT COMPLETED|Overall Study||4
8477547|NCT00619307|20891407|P1|NOT COMPLETED|Overall Study||4
8477548|NCT00619307|20891406|P2|COMPLETED|Overall Study||53
8477549|NCT00619307|20891407|P1|COMPLETED|Overall Study||56
8477550|NCT00619307|20891406|P2|STARTED|Overall Study||57
8477551|NCT00619307|20891407|P1|STARTED|Overall Study||60
8477552|NCT00619255|20891423|P2|NOT COMPLETED|Overall Study||0
8477553|NCT00619255|20891424|P1|NOT COMPLETED|Overall Study||2
8477554|NCT00619255|20891423|P2|COMPLETED|Overall Study||61
8477555|NCT00619255|20891424|P1|COMPLETED|Overall Study||57
8477556|NCT00619255|20891423|P2|STARTED|Overall Study||61
8477557|NCT00619255|20891424|P1|STARTED|Overall Study||59
8477558|NCT00619242|20891438|P1|NOT COMPLETED|Overall Study||0
8477559|NCT00619242|20891438|P1|COMPLETED|Overall Study||3
8477560|NCT00619242|20891438|P1|STARTED|Overall Study||3
8477561|NCT00619229|20891444|P2|NOT COMPLETED|Overall Study||2
8477562|NCT00619229|20891445|P1|NOT COMPLETED|Overall Study||4
8477563|NCT00619229|20891444|P2|COMPLETED|Overall Study||16
8477564|NCT00619229|20891445|P1|COMPLETED|Overall Study||14
8477565|NCT00619229|20891444|P2|Full Analysis Set (FAS)|Overall Study||17
8477566|NCT00619229|20891445|P1|Full Analysis Set (FAS)|Overall Study||16
8477567|NCT00619229|20891444|P2|STARTED|Overall Study||18
8477568|NCT00619229|20891445|P1|STARTED|Overall Study||18
8477569|NCT00619190|20891473|P2|NOT COMPLETED|Overall Study||0
8477570|NCT00619190|20891474|P1|NOT COMPLETED|Overall Study||1
8477571|NCT00619190|20891473|P2|COMPLETED|Overall Study||9
8477572|NCT00619190|20891474|P1|COMPLETED|Overall Study||20
8477573|NCT00619190|20891473|P2|STARTED|Overall Study||9
8477574|NCT00619190|20891474|P1|STARTED|Overall Study||21
8477575|NCT00619177|20891484|P1|NOT COMPLETED|Overall Study||508
8477576|NCT00619177|20891484|P1|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
8477577|NCT00619177|20891484|P1|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
8477578|NCT00619151|20891494|P2|NOT COMPLETED|Overall Study||0
8477579|NCT00619151|20891495|P1|NOT COMPLETED|Overall Study||1
8477580|NCT00619151|20891494|P2|COMPLETED|Overall Study||0
8477581|NCT00619151|20891495|P1|COMPLETED|Overall Study||1
8477582|NCT00619151|20891494|P2|STARTED|Overall Study||0
8477583|NCT00619151|20891495|P1|STARTED|Overall Study||2
8477584|NCT00619112|20891505|P2|NOT COMPLETED|Overall Study||2
8477585|NCT00619112|20891506|P1|NOT COMPLETED|Overall Study||1
8477586|NCT00619112|20891505|P2|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
8477587|NCT00619112|20891506|P1|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
8477588|NCT00619112|20891505|P2|STARTED|Overall Study||20
8477589|NCT00619112|20891506|P1|STARTED|Overall Study||40
8477590|NCT00619099|20891527|P2|NOT COMPLETED|Overall Study||19
8477591|NCT00619099|20891528|P1|NOT COMPLETED|Overall Study||33
8477592|NCT00619099|20891527|P2|COMPLETED|Overall Study||4
8477593|NCT00619099|20891528|P1|COMPLETED|Overall Study||11
8477776|NCT00618410|20891867|P1|COMPLETED|Second Intervention||7
8477594|NCT00619099|20891527|P2|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
8477595|NCT00619099|20891528|P1|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
8477596|NCT00619099|20891527|P2|STARTED|Overall Study|All randomized subjects|23
8477597|NCT00619099|20891528|P1|STARTED|Overall Study|All randomized subjects|44
8477598|NCT00619073|20891534|P2|NOT COMPLETED|Second Intervention - 60 Days||0
8477599|NCT00619073|20891535|P1|NOT COMPLETED|Second Intervention - 60 Days||0
8477600|NCT00619073|20891534|P2|COMPLETED|Second Intervention - 60 Days||8
8477601|NCT00619073|20891535|P1|COMPLETED|Second Intervention - 60 Days||8
8477602|NCT00619073|20891534|P2|STARTED|Second Intervention - 60 Days||8
8477603|NCT00619073|20891535|P1|STARTED|Second Intervention - 60 Days||8
8477604|NCT00619073|20891534|P2|NOT COMPLETED|Washout Period (30 Days)||0
8477605|NCT00619073|20891535|P1|NOT COMPLETED|Washout Period (30 Days)||0
8477606|NCT00619073|20891534|P2|COMPLETED|Washout Period (30 Days)||8
8477607|NCT00619073|20891535|P1|COMPLETED|Washout Period (30 Days)||8
8477608|NCT00619073|20891534|P2|STARTED|Washout Period (30 Days)||8
8477609|NCT00619073|20891535|P1|STARTED|Washout Period (30 Days)||8
8477610|NCT00619073|20891534|P2|NOT COMPLETED|First Intervention - 60 Days||0
8477611|NCT00619073|20891535|P1|NOT COMPLETED|First Intervention - 60 Days||0
8477612|NCT00619073|20891534|P2|COMPLETED|First Intervention - 60 Days||8
8477613|NCT00619073|20891535|P1|COMPLETED|First Intervention - 60 Days||8
8477614|NCT00619073|20891534|P2|STARTED|First Intervention - 60 Days||8
8477615|NCT00619073|20891535|P1|STARTED|First Intervention - 60 Days||8
8477616|NCT00619060|20891541|P2|NOT COMPLETED|Overall Study||0
8477617|NCT00619060|20891542|P1|NOT COMPLETED|Overall Study||0
8477618|NCT00619060|20891541|P2|COMPLETED|Overall Study||12
8477619|NCT00619060|20891542|P1|COMPLETED|Overall Study||10
8477620|NCT00619060|20891541|P2|STARTED|Overall Study||12
8477621|NCT00619060|20891542|P1|STARTED|Overall Study||10
8477622|NCT00618995|20891550|P4|NOT COMPLETED|Period 4||0
8477623|NCT00618995|20891551|P3|NOT COMPLETED|Period 4||0
8477624|NCT00618995|20891552|P2|NOT COMPLETED|Period 4||0
8477625|NCT00618995|20891553|P1|NOT COMPLETED|Period 4||1
8477626|NCT00618995|20891550|P4|COMPLETED|Period 4||6
8477627|NCT00618995|20891551|P3|COMPLETED|Period 4||4
8477628|NCT00618995|20891552|P2|COMPLETED|Period 4||6
8477629|NCT00618995|20891553|P1|COMPLETED|Period 4||5
8477630|NCT00618995|20891550|P4|STARTED|Period 4||6
8477631|NCT00618995|20891551|P3|STARTED|Period 4||4
8477632|NCT00618995|20891552|P2|STARTED|Period 4||6
8477633|NCT00618995|20891553|P1|STARTED|Period 4||6
8477634|NCT00618995|20891550|P4|NOT COMPLETED|Period 3||0
8477635|NCT00618995|20891551|P3|NOT COMPLETED|Period 3||0
8477636|NCT00618995|20891552|P2|NOT COMPLETED|Period 3||0
8477637|NCT00618995|20891553|P1|NOT COMPLETED|Period 3||0
8477638|NCT00618995|20891550|P4|COMPLETED|Period 3||6
8477639|NCT00618995|20891551|P3|COMPLETED|Period 3||4
8477640|NCT00618995|20891552|P2|COMPLETED|Period 3||6
8477641|NCT00618995|20891553|P1|COMPLETED|Period 3||6
8477642|NCT00618995|20891550|P4|STARTED|Period 3||6
8477643|NCT00618995|20891551|P3|STARTED|Period 3||4
8477644|NCT00618995|20891552|P2|STARTED|Period 3||6
8477645|NCT00618995|20891553|P1|STARTED|Period 3||6
8477646|NCT00618995|20891550|P4|NOT COMPLETED|Period 2||0
8477647|NCT00618995|20891551|P3|NOT COMPLETED|Period 2||1
8477648|NCT00618995|20891552|P2|NOT COMPLETED|Period 2||0
8477649|NCT00618995|20891553|P1|NOT COMPLETED|Period 2||0
8477650|NCT00618995|20891550|P4|COMPLETED|Period 2||6
8477651|NCT00618995|20891551|P3|COMPLETED|Period 2||4
8477652|NCT00618995|20891552|P2|COMPLETED|Period 2||6
8477653|NCT00618995|20891553|P1|COMPLETED|Period 2||6
8477654|NCT00618995|20891550|P4|STARTED|Period 2||6
8477655|NCT00618995|20891551|P3|STARTED|Period 2||5
8477656|NCT00618995|20891552|P2|STARTED|Period 2||6
8477657|NCT00618995|20891553|P1|STARTED|Period 2||6
8477658|NCT00618995|20891550|P4|NOT COMPLETED|Period 1||0
8477659|NCT00618995|20891551|P3|NOT COMPLETED|Period 1||2
8477660|NCT00618995|20891552|P2|NOT COMPLETED|Period 1||1
8477661|NCT00618995|20891553|P1|NOT COMPLETED|Period 1||0
8477662|NCT00618995|20891550|P4|COMPLETED|Period 1||6
8477663|NCT00618995|20891551|P3|COMPLETED|Period 1||5
8477664|NCT00618995|20891552|P2|COMPLETED|Period 1||6
8477665|NCT00618995|20891553|P1|COMPLETED|Period 1||6
8477666|NCT00618995|20891550|P4|STARTED|Period 1||6
8477667|NCT00618995|20891551|P3|STARTED|Period 1||7
8477668|NCT00618995|20891552|P2|STARTED|Period 1||7
8477669|NCT00618995|20891553|P1|STARTED|Period 1||6
8477670|NCT00618982|20891567|P1|NOT COMPLETED|Overall Study||50
8477671|NCT00618982|20891567|P1|COMPLETED|Overall Study||33
8477672|NCT00618982|20891567|P1|STARTED|Overall Study||83
8477673|NCT00618956|20891590|P2|NOT COMPLETED|Overall Study||50
8477674|NCT00618956|20891591|P1|NOT COMPLETED|Overall Study||25
8477675|NCT00618956|20891590|P2|COMPLETED|Overall Study||160
8477676|NCT00618956|20891591|P1|COMPLETED|Overall Study||86
8477677|NCT00618956|20891590|P2|STARTED|Overall Study||210
8477678|NCT00618956|20891591|P1|STARTED|Overall Study||111
8477679|NCT00618839|20891607|P1|NOT COMPLETED|Overall Study||0
8477680|NCT00618839|20891607|P1|COMPLETED|Overall Study||15
8477681|NCT00618839|20891607|P1|STARTED|Overall Study||15
8477682|NCT00618826|20891616|P1|NOT COMPLETED|Overall Study||1
8477683|NCT00618826|20891616|P1|COMPLETED|Overall Study||13
8477684|NCT00618826|20891616|P1|STARTED|Overall Study||14
8477685|NCT00618813|20891621|P1|NOT COMPLETED|Overall Study||4
8477686|NCT00618813|20891621|P1|COMPLETED|Overall Study||31
8477777|NCT00618410|20891866|P2|STARTED|Second Intervention||5
8477687|NCT00618813|20891621|P1|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
8477688|NCT00618813|20891621|P1|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
8477689|NCT00618813|20891621|P1|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
8477690|NCT00618813|20891621|P1|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
8477691|NCT00618813|20891621|P1|STARTED|Overall Study||35
8477692|NCT00618787|20891631|P2|NOT COMPLETED|Overall Study||2
8477693|NCT00618787|20891632|P1|NOT COMPLETED|Overall Study||3
8477694|NCT00618787|20891631|P2|COMPLETED|Overall Study||21
8477695|NCT00618787|20891632|P1|COMPLETED|Overall Study||19
8477696|NCT00618787|20891631|P2|STARTED|Overall Study||23
8477697|NCT00618787|20891632|P1|STARTED|Overall Study||22
8477698|NCT00618774|20891640|P2|NOT COMPLETED|Overall Study||3
8477699|NCT00618774|20891641|P1|NOT COMPLETED|Overall Study||6
8477700|NCT00618774|20891640|P2|COMPLETED|Overall Study||45
8477701|NCT00618774|20891641|P1|COMPLETED|Overall Study||205
8477702|NCT00618774|20891640|P2|STARTED|Overall Study||48
8477703|NCT00618774|20891641|P1|STARTED|Overall Study||211
8477704|NCT00618748|20891674|P3|NOT COMPLETED|Overall Study||14
8477705|NCT00618748|20891675|P2|NOT COMPLETED|Overall Study||5
8477706|NCT00618748|20891676|P1|NOT COMPLETED|Overall Study||11
8477707|NCT00618748|20891674|P3|COMPLETED|Overall Study||6
8477708|NCT00618748|20891675|P2|COMPLETED|Overall Study||20
8477709|NCT00618748|20891676|P1|COMPLETED|Overall Study||45
8477710|NCT00618748|20891674|P3|STARTED|Overall Study||20
8477711|NCT00618748|20891675|P2|STARTED|Overall Study||25
8477712|NCT00618748|20891676|P1|STARTED|Overall Study||56
8477713|NCT00618722|20891721|P4|NOT COMPLETED|Overall Study||4
8477714|NCT00618722|20891722|P3|NOT COMPLETED|Overall Study||3
8477715|NCT00618722|20891723|P2|NOT COMPLETED|Overall Study||2
8477716|NCT00618722|20891724|P1|NOT COMPLETED|Overall Study||3
8477717|NCT00618722|20891721|P4|COMPLETED|Overall Study||18
8477718|NCT00618722|20891722|P3|COMPLETED|Overall Study||19
8477719|NCT00618722|20891723|P2|COMPLETED|Overall Study||18
8477720|NCT00618722|20891724|P1|COMPLETED|Overall Study||18
8477721|NCT00618722|20891721|P4|Received Treatment|Overall Study||22
8477722|NCT00618722|20891722|P3|Received Treatment|Overall Study||22
8477723|NCT00618722|20891723|P2|Received Treatment|Overall Study||20
8477724|NCT00618722|20891724|P1|Received Treatment|Overall Study||20
8477725|NCT00618722|20891721|P4|STARTED|Overall Study||22
8477726|NCT00618722|20891722|P3|STARTED|Overall Study||22
8477727|NCT00618722|20891723|P2|STARTED|Overall Study||20
8477728|NCT00618722|20891724|P1|STARTED|Overall Study||21
8477729|NCT00618618|20891762|P4|NOT COMPLETED|Overall Study||1
8477730|NCT00618618|20891763|P3|NOT COMPLETED|Overall Study||3
8477731|NCT00618618|20891764|P2|NOT COMPLETED|Overall Study||3
8477732|NCT00618618|20891765|P1|NOT COMPLETED|Overall Study||4
8477733|NCT00618618|20891762|P4|COMPLETED|Overall Study||13
8477734|NCT00618618|20891763|P3|COMPLETED|Overall Study||18
8477735|NCT00618618|20891764|P2|COMPLETED|Overall Study||11
8477736|NCT00618618|20891765|P1|COMPLETED|Overall Study||20
8477737|NCT00618618|20891762|P4|Received Treatment|Overall Study||14
8477738|NCT00618618|20891763|P3|Received Treatment|Overall Study||20
8477739|NCT00618618|20891764|P2|Received Treatment|Overall Study||13
8477740|NCT00618618|20891765|P1|Received Treatment|Overall Study||24
8477741|NCT00618618|20891762|P4|STARTED|Overall Study||14
8477742|NCT00618618|20891763|P3|STARTED|Overall Study||21
8477743|NCT00618618|20891764|P2|STARTED|Overall Study||14
8477744|NCT00618618|20891765|P1|STARTED|Overall Study||24
8477745|NCT00618540|20891811|P1|NOT COMPLETED|Overall Study||0
8477746|NCT00618540|20891811|P1|COMPLETED|Overall Study||1
8477747|NCT00618540|20891811|P1|STARTED|Overall Study||1
8477748|NCT00618514|20891824|P3|NOT COMPLETED|Overall Study||4
8477749|NCT00618514|20891825|P2|NOT COMPLETED|Overall Study||12
8477750|NCT00618514|20891826|P1|NOT COMPLETED|Overall Study||11
8477751|NCT00618514|20891824|P3|COMPLETED|Overall Study||12
8477752|NCT00618514|20891825|P2|COMPLETED|Overall Study||26
8477753|NCT00618514|20891826|P1|COMPLETED|Overall Study||25
8477754|NCT00618514|20891824|P3|STARTED|Overall Study||16
8477755|NCT00618514|20891825|P2|STARTED|Overall Study||38
8477756|NCT00618514|20891826|P1|STARTED|Overall Study||36
8477757|NCT00618449|20891846|P2|NOT COMPLETED|Overall Study||110
8477758|NCT00618449|20891847|P1|NOT COMPLETED|Overall Study||98
8477759|NCT00618449|20891846|P2|COMPLETED|Overall Study||558
8477760|NCT00618449|20891847|P1|COMPLETED|Overall Study||581
8477761|NCT00618449|20891846|P2|1-year, Post-treatment|Overall Study||558
8477762|NCT00618449|20891847|P1|1-year, Post-treatment|Overall Study||581
8477763|NCT00618449|20891846|P2|1-month, Post-treatment|Overall Study||656
8477764|NCT00618449|20891847|P1|1-month, Post-treatment|Overall Study||666
8477765|NCT00618449|20891846|P2|STARTED|Overall Study||668
8477766|NCT00618449|20891847|P1|STARTED|Overall Study||679
8477767|NCT00618436|20891855|P2|NOT COMPLETED|Overall Study||0
8477768|NCT00618436|20891856|P1|NOT COMPLETED|Overall Study||0
8477769|NCT00618436|20891855|P2|COMPLETED|Overall Study||18
8477770|NCT00618436|20891856|P1|COMPLETED|Overall Study||34
8477771|NCT00618436|20891855|P2|STARTED|Overall Study||18
8477772|NCT00618436|20891856|P1|STARTED|Overall Study||34
8477773|NCT00618410|20891866|P2|NOT COMPLETED|Second Intervention||0
8477774|NCT00618410|20891867|P1|NOT COMPLETED|Second Intervention||0
8477775|NCT00618410|20891866|P2|COMPLETED|Second Intervention||5
8477778|NCT00618410|20891867|P1|STARTED|Second Intervention||7
8477779|NCT00618410|20891866|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
8477780|NCT00618410|20891867|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
8477781|NCT00618410|20891866|P2|COMPLETED|Washout Period (2 Weeks)||5
8477782|NCT00618410|20891867|P1|COMPLETED|Washout Period (2 Weeks)||7
8477783|NCT00618410|20891866|P2|STARTED|Washout Period (2 Weeks)||6
8477784|NCT00618410|20891867|P1|STARTED|Washout Period (2 Weeks)||7
8477785|NCT00618410|20891866|P2|NOT COMPLETED|First Intervention||0
8477786|NCT00618410|20891867|P1|NOT COMPLETED|First Intervention||0
8477787|NCT00618410|20891866|P2|COMPLETED|First Intervention||6
8477788|NCT00618410|20891867|P1|COMPLETED|First Intervention||7
8477789|NCT00618410|20891866|P2|STARTED|First Intervention||6
8477790|NCT00618410|20891867|P1|STARTED|First Intervention||7
8477791|NCT00618371|20891883|P1|NOT COMPLETED|Overall Study||2
8477792|NCT00618371|20891883|P1|COMPLETED|Overall Study||10
8477793|NCT00618371|20891883|P1|STARTED|Overall Study||12
8477794|NCT00618332|20891890|P2|NOT COMPLETED|Overall Study||0
8477795|NCT00618332|20891891|P1|NOT COMPLETED|Overall Study||0
8477796|NCT00618332|20891890|P2|COMPLETED|Overall Study||20
8477797|NCT00618332|20891891|P1|COMPLETED|Overall Study||20
8477798|NCT00618332|20891890|P2|STARTED|Overall Study||20
8477799|NCT00618332|20891891|P1|STARTED|Overall Study||20
8477800|NCT00618072|20891916|P3|NOT COMPLETED|Overall Study||4
8477801|NCT00618072|20891917|P2|NOT COMPLETED|Overall Study||1
8477802|NCT00618072|20891918|P1|NOT COMPLETED|Overall Study||2
8477803|NCT00618072|20891916|P3|COMPLETED|Overall Study||11
8477804|NCT00618072|20891917|P2|COMPLETED|Overall Study||14
8477805|NCT00618072|20891918|P1|COMPLETED|Overall Study||14
8477806|NCT00618072|20891916|P3|STARTED|Overall Study||15
8477807|NCT00618072|20891917|P2|STARTED|Overall Study||15
8477808|NCT00618072|20891918|P1|STARTED|Overall Study||16
8477809|NCT00617981|20891952|P2|NOT COMPLETED|Overall Study||102
8477810|NCT00617981|20891953|P1|NOT COMPLETED|Overall Study||110
8477811|NCT00617981|20891952|P2|COMPLETED|Overall Study||245
8477812|NCT00617981|20891953|P1|COMPLETED|Overall Study||244
8477813|NCT00617981|20891952|P2|STARTED|Overall Study||347
8477814|NCT00617981|20891953|P1|STARTED|Overall Study||354
8477815|NCT00617942|20891961|P2|NOT COMPLETED|Overall Study||4
8477816|NCT00617942|20891962|P1|NOT COMPLETED|Overall Study||8
8477817|NCT00617942|20891961|P2|COMPLETED|Overall Study||19
8477818|NCT00617942|20891962|P1|COMPLETED|Overall Study||29
8477819|NCT00617942|20891961|P2|STARTED|Overall Study||23
8477820|NCT00617942|20891962|P1|STARTED|Overall Study||37
8477821|NCT00617929|20891974|P1|NOT COMPLETED|Overall Study||1
8477822|NCT00617929|20891974|P1|COMPLETED|Overall Study||11
8477823|NCT00617929|20891974|P1|STARTED|Overall Study||12
8477824|NCT00617903|20891986|P2|NOT COMPLETED|Overall Study||7
8477825|NCT00617903|20891987|P1|NOT COMPLETED|Overall Study||3
8477826|NCT00617903|20891986|P2|COMPLETED|Overall Study||35
8477827|NCT00617903|20891987|P1|COMPLETED|Overall Study||38
8477828|NCT00617903|20891986|P2|STARTED|Overall Study||42
8477829|NCT00617903|20891987|P1|STARTED|Overall Study||41
8477830|NCT00617890|20892033|P4|NOT COMPLETED|Overall Study||115
8477831|NCT00617890|20892034|P3|NOT COMPLETED|Overall Study||35
8477832|NCT00617890|20892035|P2|NOT COMPLETED|Overall Study||28
8477833|NCT00617890|20892036|P1|NOT COMPLETED|Overall Study||31
8477834|NCT00617890|20892033|P4|COMPLETED|Overall Study||1
8477835|NCT00617890|20892034|P3|COMPLETED|Overall Study||0
8477836|NCT00617890|20892035|P2|COMPLETED|Overall Study||5
8477837|NCT00617890|20892036|P1|COMPLETED|Overall Study||4
8477838|NCT00617890|20892033|P4|Received Treatment|Overall Study||115
8477839|NCT00617890|20892034|P3|Received Treatment|Overall Study||34
8477840|NCT00617890|20892035|P2|Received Treatment|Overall Study||33
8477841|NCT00617890|20892036|P1|Received Treatment|Overall Study||34
8477842|NCT00617890|20892033|P4|STARTED|Overall Study||116
8477843|NCT00617890|20892034|P3|STARTED|Overall Study||35
8477844|NCT00617890|20892035|P2|STARTED|Overall Study||33
8477845|NCT00617890|20892036|P1|STARTED|Overall Study||35
8477846|NCT00617851|20892072|P4|NOT COMPLETED|Overall Study||25
8477847|NCT00617851|20892073|P3|NOT COMPLETED|Overall Study||45
8477848|NCT00617851|20892074|P2|NOT COMPLETED|Overall Study||40
8477849|NCT00617851|20892075|P1|NOT COMPLETED|Overall Study||47
8477850|NCT00617851|20892072|P4|COMPLETED|Overall Study||192
8477851|NCT00617851|20892073|P3|COMPLETED|Overall Study||384
8477852|NCT00617851|20892074|P2|COMPLETED|Overall Study||391
8477853|NCT00617851|20892075|P1|COMPLETED|Overall Study||383
8477854|NCT00617851|20892072|P4|STARTED|Overall Study||217
8477855|NCT00617851|20892073|P3|STARTED|Overall Study||429
8477856|NCT00617851|20892074|P2|STARTED|Overall Study||431
8477857|NCT00617851|20892075|P1|STARTED|Overall Study||430
8477858|NCT00617773|20892113|P1|NOT COMPLETED|Overall Study||24
8477859|NCT00617773|20892113|P1|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
8477860|NCT00617773|20892113|P1|STARTED|Overall Study||31
8477861|NCT00617734|20892130|P2|NOT COMPLETED|Overall Study||6
8477862|NCT00617734|20892131|P1|NOT COMPLETED|Overall Study||8
8477863|NCT00617734|20892130|P2|COMPLETED|Overall Study||42
8477864|NCT00617734|20892131|P1|COMPLETED|Overall Study||41
8477865|NCT00617734|20892130|P2|Received at Least 1 Dose of Study Drug|Overall Study||44
8477866|NCT00617734|20892131|P1|Received at Least 1 Dose of Study Drug|Overall Study||47
8477867|NCT00617734|20892130|P2|STARTED|Overall Study||48
8477868|NCT00617734|20892131|P1|STARTED|Overall Study||49
8477869|NCT00617708|20892152|P3|NOT COMPLETED|Overall Study||64
8477870|NCT00617708|20892153|P2|NOT COMPLETED|Overall Study||60
8477871|NCT00617708|20892154|P1|NOT COMPLETED|Overall Study||10
8477872|NCT00617708|20892152|P3|COMPLETED|Overall Study||0
8477873|NCT00617708|20892153|P2|COMPLETED|Overall Study||0
8477874|NCT00617708|20892154|P1|COMPLETED|Overall Study||0
8477875|NCT00617708|20892152|P3|Eligible and Began Protocol Therapy|Overall Study||59
8477876|NCT00617708|20892153|P2|Eligible and Began Protocol Therapy|Overall Study||57
8477877|NCT00617708|20892154|P1|Eligible and Began Protocol Therapy|Overall Study||9
8477878|NCT00617708|20892152|P3|STARTED|Overall Study||64
8477879|NCT00617708|20892153|P2|STARTED|Overall Study||60
8477880|NCT00617708|20892154|P1|STARTED|Overall Study||10
8477881|NCT00617669|20892171|P2|NOT COMPLETED|Overall Study||451
8477882|NCT00617669|20892172|P1|NOT COMPLETED|Overall Study||430
8477883|NCT00617669|20892171|P2|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
8477884|NCT00617669|20892172|P1|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
8477885|NCT00617669|20892171|P2|Patients Who Received IP|Overall Study||525
8477886|NCT00617669|20892172|P1|Patients Who Received IP|Overall Study||522
8477887|NCT00617669|20892171|P2|STARTED|Overall Study||528
8477888|NCT00617669|20892172|P1|STARTED|Overall Study||524
8477889|NCT00617604|20892194|P2|NOT COMPLETED|Overall Study||20
8477890|NCT00617604|20892195|P1|NOT COMPLETED|Overall Study||18
8477891|NCT00617604|20892194|P2|COMPLETED|Overall Study|Completed Month 6 assessment|88
8477892|NCT00617604|20892195|P1|COMPLETED|Overall Study|Completed Month 6 assessment|92
8477893|NCT00617604|20892194|P2|Completed 12 Weeks of Treatment|Overall Study||83
8477894|NCT00617604|20892195|P1|Completed 12 Weeks of Treatment|Overall Study||89
8477895|NCT00617604|20892194|P2|Received Treatment|Overall Study||105
8477896|NCT00617604|20892195|P1|Received Treatment|Overall Study||107
8477897|NCT00617604|20892194|P2|STARTED|Overall Study||108
8477898|NCT00617604|20892195|P1|STARTED|Overall Study||110
8477899|NCT00617591|20892239|P1|NOT COMPLETED|Overall Study||10
8477900|NCT00617591|20892239|P1|COMPLETED|Overall Study||47
8477901|NCT00617591|20892239|P1|STARTED|Overall Study||57
8477902|NCT00617539|20892247|P1|NOT COMPLETED|Overall Study||0
8477903|NCT00617539|20892247|P1|COMPLETED|Overall Study||30
8477904|NCT00617539|20892247|P1|STARTED|Overall Study||30
8477905|NCT00617461|20892255|P2|NOT COMPLETED|6-Day Down-Titration Period||2
8477906|NCT00617461|20892256|P1|NOT COMPLETED|6-Day Down-Titration Period||2
8477907|NCT00617461|20892255|P2|COMPLETED|6-Day Down-Titration Period||35
8477908|NCT00617461|20892256|P1|COMPLETED|6-Day Down-Titration Period||39
8477909|NCT00617461|20892255|P2|STARTED|6-Day Down-Titration Period||37
8477910|NCT00617461|20892256|P1|STARTED|6-Day Down-Titration Period||41
8477911|NCT00617461|20892255|P2|NOT COMPLETED|Second Treatment Intervention Period||4
8477912|NCT00617461|20892256|P1|NOT COMPLETED|Second Treatment Intervention Period||0
8477913|NCT00617461|20892255|P2|COMPLETED|Second Treatment Intervention Period||37
8477914|NCT00617461|20892256|P1|COMPLETED|Second Treatment Intervention Period||41
8477915|NCT00617461|20892255|P2|STARTED|Second Treatment Intervention Period||41
8477916|NCT00617461|20892256|P1|STARTED|Second Treatment Intervention Period||41
8477917|NCT00617461|20892255|P2|NOT COMPLETED|4-Day Crossover Period||0
8477918|NCT00617461|20892256|P1|NOT COMPLETED|4-Day Crossover Period||1
8477919|NCT00617461|20892255|P2|COMPLETED|4-Day Crossover Period||40
8477920|NCT00617461|20892256|P1|COMPLETED|4-Day Crossover Period||41
8477921|NCT00617461|20892255|P2|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
8477922|NCT00617461|20892256|P1|STARTED|4-Day Crossover Period||42
8477923|NCT00617461|20892255|P2|NOT COMPLETED|First Treatment Intervention Period||3
8477924|NCT00617461|20892256|P1|NOT COMPLETED|First Treatment Intervention Period||10
8477925|NCT00617461|20892255|P2|COMPLETED|First Treatment Intervention Period||41
8477926|NCT00617461|20892256|P1|COMPLETED|First Treatment Intervention Period||42
8477927|NCT00617461|20892255|P2|STARTED|First Treatment Intervention Period||44
8477928|NCT00617461|20892256|P1|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
8477929|NCT00617409|20892312|P3|NOT COMPLETED|Overall Study||27
8477930|NCT00617409|20892313|P2|NOT COMPLETED|Overall Study||18
8477931|NCT00617409|20892314|P1|NOT COMPLETED|Overall Study||16
8477932|NCT00617409|20892312|P3|COMPLETED|Overall Study||4
8477933|NCT00617409|20892313|P2|COMPLETED|Overall Study||2
8477934|NCT00617409|20892314|P1|COMPLETED|Overall Study||2
8477935|NCT00617409|20892312|P3|STARTED|Overall Study||31
8477936|NCT00617409|20892313|P2|STARTED|Overall Study||20
8477937|NCT00617409|20892314|P1|STARTED|Overall Study||18
8477938|NCT00617396|20892325|P1|NOT COMPLETED|Overall Study||0
8477939|NCT00617396|20892325|P1|COMPLETED|Overall Study||25
8477940|NCT00617396|20892325|P1|STARTED|Overall Study||25
8477941|NCT00617357|20892329|P1|NOT COMPLETED|Overall Study||16
8477942|NCT00617357|20892329|P1|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
8477943|NCT00617357|20892329|P1|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
8477944|NCT00617344|20892342|P3|NOT COMPLETED|Overall Study||8
8477945|NCT00617344|20892343|P2|NOT COMPLETED|Overall Study||22
8477946|NCT00617344|20892344|P1|NOT COMPLETED|Overall Study||25
8477947|NCT00617344|20892342|P3|COMPLETED|Overall Study||45
8477948|NCT00617344|20892343|P2|COMPLETED|Overall Study||81
8477949|NCT00617344|20892344|P1|COMPLETED|Overall Study||79
8477950|NCT00617344|20892342|P3|Received Vaccination 3|Overall Study||45
8477951|NCT00617344|20892343|P2|Received Vaccination 3|Overall Study||81
8477952|NCT00617344|20892344|P1|Received Vaccination 3|Overall Study||79
8477953|NCT00617344|20892342|P3|Received Vaccination 2|Overall Study||46
8477954|NCT00617344|20892343|P2|Received Vaccination 2|Overall Study||85
8477955|NCT00617344|20892344|P1|Received Vaccination 2|Overall Study||86
8477956|NCT00617344|20892342|P3|Received Vaccination 1|Overall Study||53
8477957|NCT00617344|20892343|P2|Received Vaccination 1|Overall Study||103
8477958|NCT00617344|20892344|P1|Received Vaccination 1|Overall Study||104
8477959|NCT00617344|20892342|P3|STARTED|Overall Study||53
8477960|NCT00617344|20892343|P2|STARTED|Overall Study||103
8477961|NCT00617344|20892344|P1|STARTED|Overall Study||104
8477962|NCT00617305|20892372|P3|NOT COMPLETED|Overall Study||1
8477963|NCT00617305|20892373|P2|NOT COMPLETED|Overall Study||0
8477964|NCT00617305|20892374|P1|NOT COMPLETED|Overall Study||8
8477965|NCT00617305|20892372|P3|COMPLETED|Overall Study||0
8477966|NCT00617305|20892373|P2|COMPLETED|Overall Study||4
8477967|NCT00617305|20892374|P1|COMPLETED|Overall Study||25
8477968|NCT00617305|20892372|P3|Completed 24-week Primary Analysis|Overall Study||0
8477969|NCT00617305|20892373|P2|Completed 24-week Primary Analysis|Overall Study||4
8477970|NCT00617305|20892374|P1|Completed 24-week Primary Analysis|Overall Study||31
8477971|NCT00617305|20892372|P3|STARTED|Overall Study||1
8477972|NCT00617305|20892373|P2|STARTED|Overall Study||4
8477973|NCT00617305|20892374|P1|STARTED|Overall Study||33
8477974|NCT00617279|20892430|P2|NOT COMPLETED|Overall Study||17
8477975|NCT00617279|20892431|P1|NOT COMPLETED|Overall Study||14
8477976|NCT00617279|20892430|P2|COMPLETED|Overall Study||0
8477977|NCT00617279|20892431|P1|COMPLETED|Overall Study||0
8477978|NCT00617279|20892430|P2|STARTED|Overall Study||17
8477979|NCT00617279|20892431|P1|STARTED|Overall Study||14
8477980|NCT00617240|20892487|P2|NOT COMPLETED|Overall Study||0
8477981|NCT00617240|20892488|P1|NOT COMPLETED|Overall Study||1
8477982|NCT00617240|20892487|P2|COMPLETED|Overall Study||4
8477983|NCT00617240|20892488|P1|COMPLETED|Overall Study||4
8477984|NCT00617240|20892487|P2|STARTED|Overall Study||4
8477985|NCT00617240|20892488|P1|STARTED|Overall Study||5
8477986|NCT00617201|20892508|P2|NOT COMPLETED|Overall Study||13
8477987|NCT00617201|20892509|P1|NOT COMPLETED|Overall Study||9
8477988|NCT00617201|20892508|P2|COMPLETED|Overall Study||12
8477989|NCT00617201|20892509|P1|COMPLETED|Overall Study||16
8477990|NCT00617201|20892508|P2|STARTED|Overall Study||25
8477991|NCT00617201|20892509|P1|STARTED|Overall Study||25
8477992|NCT00617188|20892517|P1|NOT COMPLETED|Overall Study||0
8477993|NCT00617188|20892517|P1|COMPLETED|Overall Study||26
8477994|NCT00617188|20892517|P1|STARTED|Overall Study||26
8477995|NCT00617175|20892528|P2|NOT COMPLETED|Overall Study||0
8477996|NCT00617175|20892529|P1|NOT COMPLETED|Overall Study||0
8477997|NCT00617175|20892528|P2|COMPLETED|Overall Study||948
8477998|NCT00617175|20892529|P1|COMPLETED|Overall Study||954
8477999|NCT00617175|20892528|P2|STARTED|Overall Study||948
8478000|NCT00617175|20892529|P1|STARTED|Overall Study||954
8478001|NCT00617123|20892537|P2|NOT COMPLETED|Study Treatment Period||16
8478002|NCT00617123|20892538|P1|NOT COMPLETED|Study Treatment Period||17
8478003|NCT00617123|20892537|P2|COMPLETED|Study Treatment Period||79
8478004|NCT00617123|20892538|P1|COMPLETED|Study Treatment Period||81
8478005|NCT00617123|20892537|P2|Treated|Study Treatment Period||95
8478006|NCT00617123|20892538|P1|Treated|Study Treatment Period|1 participant was not treated|97
8478007|NCT00617123|20892537|P2|STARTED|Study Treatment Period||95
8478008|NCT00617123|20892538|P1|STARTED|Study Treatment Period||98
8478009|NCT00617123|20892537|P2|NOT COMPLETED|Referral Screening Period||26
8478010|NCT00617123|20892538|P1|NOT COMPLETED|Referral Screening Period||39
8478011|NCT00617123|20892537|P2|COMPLETED|Referral Screening Period||95
8478012|NCT00617123|20892538|P1|COMPLETED|Referral Screening Period||98
8478013|NCT00617123|20892537|P2|STARTED|Referral Screening Period||121
8478014|NCT00617123|20892538|P1|STARTED|Referral Screening Period||137
8478015|NCT00617097|20892554|P2|NOT COMPLETED|Overall Study||0
8478016|NCT00617097|20892555|P1|NOT COMPLETED|Overall Study||0
8478017|NCT00617097|20892554|P2|COMPLETED|Overall Study||25
8478018|NCT00617097|20892555|P1|COMPLETED|Overall Study||25
8478019|NCT00617097|20892554|P2|STARTED|Overall Study||25
8478020|NCT00617097|20892555|P1|STARTED|Overall Study||25
8478021|NCT00617084|20892569|P2|NOT COMPLETED|Overall Study||26
8478022|NCT00617084|20892570|P1|NOT COMPLETED|Overall Study||21
8478023|NCT00617084|20892569|P2|COMPLETED|Overall Study||1126
8478024|NCT00617084|20892570|P1|COMPLETED|Overall Study||1119
8478025|NCT00617084|20892569|P2|STARTED|Overall Study||1152
8478026|NCT00617084|20892570|P1|STARTED|Overall Study||1140
8478027|NCT00617058|20892581|P3|NOT COMPLETED|Overall Study||0
8478028|NCT00617058|20892582|P2|NOT COMPLETED|Overall Study||0
8478029|NCT00617058|20892583|P1|NOT COMPLETED|Overall Study||0
8478030|NCT00617058|20892581|P3|COMPLETED|Overall Study||0
8478031|NCT00617058|20892582|P2|COMPLETED|Overall Study||0
8478032|NCT00617058|20892583|P1|COMPLETED|Overall Study||1
8478033|NCT00617058|20892581|P3|STARTED|Overall Study||0
8478034|NCT00617058|20892582|P2|STARTED|Overall Study||0
8478035|NCT00617058|20892583|P1|STARTED|Overall Study||1
8478045|NCT00616941|20892650|P3|NOT COMPLETED|Overall Study||6
8478046|NCT00616941|20892651|P2|NOT COMPLETED|Overall Study||5
8478047|NCT00616941|20892652|P1|NOT COMPLETED|Overall Study||1
8478048|NCT00616941|20892650|P3|COMPLETED|Overall Study||5
8478049|NCT00616941|20892651|P2|COMPLETED|Overall Study||8
8478050|NCT00616941|20892652|P1|COMPLETED|Overall Study||3
8478051|NCT00616941|20892650|P3|STARTED|Overall Study||11
8478052|NCT00616941|20892651|P2|STARTED|Overall Study||13
8478053|NCT00616941|20892652|P1|STARTED|Overall Study||4
8478054|NCT00616928|20892679|P4|NOT COMPLETED|Overall Study||7
8478055|NCT00616928|20892680|P3|NOT COMPLETED|Overall Study||17
8478056|NCT00616928|20892681|P2|NOT COMPLETED|Overall Study||18
8478057|NCT00616928|20892682|P1|NOT COMPLETED|Overall Study||62
8478058|NCT00616928|20892679|P4|COMPLETED|Overall Study||364
8478059|NCT00616928|20892680|P3|COMPLETED|Overall Study||1101
8478060|NCT00616928|20892681|P2|COMPLETED|Overall Study||750
8478061|NCT00616928|20892682|P1|COMPLETED|Overall Study||2242
8478062|NCT00616928|20892679|P4|STARTED|Overall Study||371
8478063|NCT00616928|20892680|P3|STARTED|Overall Study||1118
8478064|NCT00616928|20892681|P2|STARTED|Overall Study||768
8478065|NCT00616928|20892682|P1|STARTED|Overall Study||2304
8478066|NCT00616902|20892746|P2|NOT COMPLETED|Overall Study||6
8478067|NCT00616902|20892747|P1|NOT COMPLETED|Overall Study||6
8478068|NCT00616902|20892746|P2|COMPLETED|Overall Study||0
8478069|NCT00616902|20892747|P1|COMPLETED|Overall Study||0
8478070|NCT00616902|20892746|P2|STARTED|Overall Study||6
8478071|NCT00616902|20892747|P1|STARTED|Overall Study||6
8478072|NCT00616772|20892773|P2|NOT COMPLETED|Overall Study||102
8478073|NCT00616772|20892774|P1|NOT COMPLETED|Overall Study||115
8478074|NCT00616772|20892773|P2|COMPLETED|Overall Study||240
8478075|NCT00616772|20892774|P1|COMPLETED|Overall Study||225
8478076|NCT00616772|20892773|P2|Treated|Overall Study||339
8478077|NCT00616772|20892774|P1|Treated|Overall Study||337
8478078|NCT00616772|20892773|P2|STARTED|Overall Study||342
8478079|NCT00616772|20892774|P1|STARTED|Overall Study||340
8478086|NCT00616655|20892800|P3|NOT COMPLETED|Overall Study||48
8478087|NCT00616655|20892801|P2|NOT COMPLETED|Overall Study||41
8478088|NCT00616655|20892802|P1|NOT COMPLETED|Overall Study||35
8478089|NCT00616655|20892800|P3|COMPLETED|Overall Study||103
8478090|NCT00616655|20892801|P2|COMPLETED|Overall Study||112
8478091|NCT00616655|20892802|P1|COMPLETED|Overall Study||117
8478092|NCT00616655|20892800|P3|STARTED|Overall Study||151
8478093|NCT00616655|20892801|P2|STARTED|Overall Study||153
8478094|NCT00616655|20892802|P1|STARTED|Overall Study||152
8478095|NCT00616642|20892842|P2|NOT COMPLETED|Overall Study||1
8478096|NCT00616642|20892843|P1|NOT COMPLETED|Overall Study||0
8478097|NCT00616642|20892842|P2|COMPLETED|Overall Study||0
8478098|NCT00616642|20892843|P1|COMPLETED|Overall Study||0
8478099|NCT00616642|20892842|P2|STARTED|Overall Study||1
8478100|NCT00616642|20892843|P1|STARTED|Overall Study||0
8478101|NCT00616629|20892854|P5|NOT COMPLETED|Overall Study||0
8478102|NCT00616629|20892855|P4|NOT COMPLETED|Overall Study||0
8478103|NCT00616629|20892856|P3|NOT COMPLETED|Overall Study||1
8478104|NCT00616629|20892857|P2|NOT COMPLETED|Overall Study||2
8478105|NCT00616629|20892858|P1|NOT COMPLETED|Overall Study||2
8478106|NCT00616629|20892854|P5|COMPLETED|Overall Study||12
8478107|NCT00616629|20892855|P4|COMPLETED|Overall Study||2
8478108|NCT00616629|20892856|P3|COMPLETED|Overall Study||13
8478109|NCT00616629|20892857|P2|COMPLETED|Overall Study||12
8478110|NCT00616629|20892858|P1|COMPLETED|Overall Study||11
8478111|NCT00616629|20892854|P5|STARTED|Overall Study||12
8478112|NCT00616629|20892855|P4|STARTED|Overall Study||2
8478113|NCT00616629|20892856|P3|STARTED|Overall Study|One patient never received study drug|14
8478114|NCT00616629|20892857|P2|STARTED|Overall Study|Two patients never received study drug|14
8478115|NCT00616629|20892858|P1|STARTED|Overall Study|Two patients never received study drug|13
8478116|NCT00616603|20892903|P3|NOT COMPLETED|Overall Study||2
8478117|NCT00616603|20892904|P2|NOT COMPLETED|Overall Study||0
8478118|NCT00616603|20892905|P1|NOT COMPLETED|Overall Study||2
8478119|NCT00616603|20892903|P3|COMPLETED|Overall Study||13
8478120|NCT00616603|20892904|P2|COMPLETED|Overall Study||14
8478121|NCT00616603|20892905|P1|COMPLETED|Overall Study||12
8478122|NCT00616603|20892903|P3|STARTED|Overall Study||15
8478123|NCT00616603|20892904|P2|STARTED|Overall Study||14
8478124|NCT00616603|20892905|P1|STARTED|Overall Study||14
8478125|NCT00616577|20892916|P3|NOT COMPLETED|Overall Study||0
8478126|NCT00616577|20892917|P2|NOT COMPLETED|Overall Study||0
8478127|NCT00616577|20892918|P1|NOT COMPLETED|Overall Study||0
8478128|NCT00616577|20892916|P3|COMPLETED|Overall Study||7
8478129|NCT00616577|20892917|P2|COMPLETED|Overall Study||9
8478130|NCT00616577|20892918|P1|COMPLETED|Overall Study||6
8478131|NCT00616577|20892916|P3|STARTED|Overall Study||7
8478132|NCT00616577|20892917|P2|STARTED|Overall Study||9
8478133|NCT00616577|20892918|P1|STARTED|Overall Study||6
8478134|NCT00616434|20892928|P2|NOT COMPLETED|Overall Study||8
8478135|NCT00616434|20892929|P1|NOT COMPLETED|Overall Study||6
8478136|NCT00616434|20892928|P2|COMPLETED|Overall Study||53
8478137|NCT00616434|20892929|P1|COMPLETED|Overall Study||56
8478138|NCT00616434|20892928|P2|STARTED|Overall Study||61
8478139|NCT00616434|20892929|P1|STARTED|Overall Study||62
8478140|NCT00616421|20892942|P3|NOT COMPLETED|Overall Study||41
8478141|NCT00616421|20892943|P2|NOT COMPLETED|Overall Study||38
8478142|NCT00616421|20892944|P1|NOT COMPLETED|Overall Study||26
8478143|NCT00616421|20892942|P3|COMPLETED|Overall Study||1229
8478144|NCT00616421|20892943|P2|COMPLETED|Overall Study||1240
8478145|NCT00616421|20892944|P1|COMPLETED|Overall Study||333
8478146|NCT00616421|20892942|P3|STARTED|Overall Study||1270
8478147|NCT00616421|20892943|P2|STARTED|Overall Study||1278
8478148|NCT00616421|20892944|P1|STARTED|Overall Study||359
8478149|NCT00616343|20892981|P1|NOT COMPLETED|Overall Study||0
8478150|NCT00616343|20892981|P1|COMPLETED|Overall Study||9
8478151|NCT00616343|20892981|P1|STARTED|Overall Study||9
8478152|NCT00616239|20892985|P1|NOT COMPLETED|Overall Study||2
8478153|NCT00616239|20892985|P1|COMPLETED|Overall Study||18
8478154|NCT00616239|20892985|P1|STARTED|Overall Study||20
8478155|NCT00616200|20892989|P1|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
8478156|NCT00616200|20892989|P1|COMPLETED|Four Week Very Low Carbohydrate Diet||13
8478157|NCT00616200|20892989|P1|STARTED|Four Week Very Low Carbohydrate Diet||16
8478158|NCT00616200|20892989|P1|NOT COMPLETED|Two Week Standard Diet||1
8478159|NCT00616200|20892989|P1|COMPLETED|Two Week Standard Diet||16
8478160|NCT00616200|20892989|P1|STARTED|Two Week Standard Diet||17
8478161|NCT00616122|20892995|P4|NOT COMPLETED|Overall Study||11
8478162|NCT00616122|20892996|P3|NOT COMPLETED|Overall Study||0
8478163|NCT00616122|20892997|P2|NOT COMPLETED|Overall Study||0
8478164|NCT00616122|20892998|P1|NOT COMPLETED|Overall Study||0
8478165|NCT00616122|20892995|P4|COMPLETED|Overall Study||0
8478166|NCT00616122|20892996|P3|COMPLETED|Overall Study||10
8478167|NCT00616122|20892997|P2|COMPLETED|Overall Study||7
8478168|NCT00616122|20892998|P1|COMPLETED|Overall Study||4
8478169|NCT00616122|20892995|P4|STARTED|Overall Study||11
8478170|NCT00616122|20892996|P3|STARTED|Overall Study||10
8478171|NCT00616122|20892997|P2|STARTED|Overall Study||7
8478172|NCT00616122|20892998|P1|STARTED|Overall Study||4
8478173|NCT00616109|20893008|P1|NOT COMPLETED|Overall Study||0
8478174|NCT00616109|20893008|P1|COMPLETED|Overall Study||16
8478175|NCT00616109|20893008|P1|STARTED|Overall Study||16
8478176|NCT00616018|20893015|P1|NOT COMPLETED|Overall Study||3
8478177|NCT00616018|20893015|P1|COMPLETED|Overall Study||24
8478178|NCT00616018|20893015|P1|STARTED|Overall Study||27
8478179|NCT00615992|20893020|P1|NOT COMPLETED|Overall Study||67
8478180|NCT00615992|20893020|P1|COMPLETED|Overall Study||687
8478181|NCT00615992|20893020|P1|STARTED|Overall Study||754
8478182|NCT00615927|20893031|P2|NOT COMPLETED|Overall Study||0
8478183|NCT00615927|20893032|P1|NOT COMPLETED|Overall Study||0
8478184|NCT00615927|20893031|P2|COMPLETED|Overall Study||32
8478185|NCT00615927|20893032|P1|COMPLETED|Overall Study||32
8478186|NCT00615927|20893031|P2|STARTED|Overall Study||32
8478187|NCT00615927|20893032|P1|STARTED|Overall Study||32
8478188|NCT00615914|20893046|P1|NOT COMPLETED|Overall Study||637
8478189|NCT00615914|20893046|P1|COMPLETED|Overall Study||1008
8478190|NCT00615914|20893046|P1|STARTED|Overall Study|The number of patients enrolled|1645
8478191|NCT00615901|20893053|P1|NOT COMPLETED|Overall Study||9
8478192|NCT00615901|20893053|P1|COMPLETED|Overall Study||29
8478193|NCT00615901|20893053|P1|STARTED|Overall Study||38
8478194|NCT00615836|20893061|P5|NOT COMPLETED|Extension Study (FE992026 CS31)||0
8478195|NCT00615836|20893062|P4|NOT COMPLETED|Extension Study (FE992026 CS31)||84
8478196|NCT00615836|20893063|P3|NOT COMPLETED|Extension Study (FE992026 CS31)||73
8478197|NCT00615836|20893064|P2|NOT COMPLETED|Extension Study (FE992026 CS31)||86
8478198|NCT00615836|20893065|P1|NOT COMPLETED|Extension Study (FE992026 CS31)||141
8478199|NCT00615836|20893061|P5|COMPLETED|Extension Study (FE992026 CS31)||0
8478200|NCT00615836|20893062|P4|COMPLETED|Extension Study (FE992026 CS31)||53
8478201|NCT00615836|20893063|P3|COMPLETED|Extension Study (FE992026 CS31)||59
8478202|NCT00615836|20893064|P2|COMPLETED|Extension Study (FE992026 CS31)||58
8478203|NCT00615836|20893065|P1|COMPLETED|Extension Study (FE992026 CS31)||0
8478204|NCT00615836|20893061|P5|STARTED|Extension Study (FE992026 CS31)||0
8478205|NCT00615836|20893062|P4|STARTED|Extension Study (FE992026 CS31)||137
8478206|NCT00615836|20893063|P3|STARTED|Extension Study (FE992026 CS31)||132
8478207|NCT00615836|20893064|P2|STARTED|Extension Study (FE992026 CS31)||144
8478208|NCT00615836|20893065|P1|STARTED|Extension Study (FE992026 CS31)||141
8478209|NCT00615836|20893061|P5|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
8478210|NCT00615836|20893062|P4|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
8478211|NCT00615836|20893063|P3|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
8478212|NCT00615836|20893064|P2|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
8478213|NCT00615836|20893065|P1|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
8478214|NCT00615836|20893061|P5|COMPLETED|Part I of Core Study (FE992026 CS29)||145
8478215|NCT00615836|20893062|P4|COMPLETED|Part I of Core Study (FE992026 CS29)||135
8478216|NCT00615836|20893063|P3|COMPLETED|Part I of Core Study (FE992026 CS29)||138
8478217|NCT00615836|20893064|P2|COMPLETED|Part I of Core Study (FE992026 CS29)||148
8478218|NCT00615836|20893065|P1|COMPLETED|Part I of Core Study (FE992026 CS29)||144
8478219|NCT00615836|20893061|P5|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
8478220|NCT00615836|20893062|P4|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
8478221|NCT00615836|20893063|P3|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
8478222|NCT00615836|20893064|P2|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
8478223|NCT00615836|20893065|P1|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
8478224|NCT00615836|20893061|P5|STARTED|Part I of Core Study (FE992026 CS29)||160
8478225|NCT00615836|20893062|P4|STARTED|Part I of Core Study (FE992026 CS29)||160
8478226|NCT00615836|20893063|P3|STARTED|Part I of Core Study (FE992026 CS29)||158
8478227|NCT00615836|20893064|P2|STARTED|Part I of Core Study (FE992026 CS29)||158
8478228|NCT00615836|20893065|P1|STARTED|Part I of Core Study (FE992026 CS29)||163
8478229|NCT00615784|20893125|P1|NOT COMPLETED|Overall Study||0
8478230|NCT00615784|20893125|P1|COMPLETED|Overall Study||24
8478231|NCT00615784|20893125|P1|STARTED|Overall Study||24
8478232|NCT00615719|20893130|P1|NOT COMPLETED|Overall Study||5
8478233|NCT00615719|20893130|P1|COMPLETED|Overall Study||30
8478234|NCT00615719|20893130|P1|STARTED|Overall Study||35
8478235|NCT00615589|20893134|P1|NOT COMPLETED|Overall Study||0
8478236|NCT00615589|20893134|P1|COMPLETED|Overall Study||22
8478237|NCT00615589|20893134|P1|STARTED|Overall Study||22
8478238|NCT00615550|20893144|P2|NOT COMPLETED|Overall Study||1
8478239|NCT00615550|20893145|P1|NOT COMPLETED|Overall Study||6
8478240|NCT00615550|20893144|P2|COMPLETED|Overall Study||235
8478241|NCT00615550|20893145|P1|COMPLETED|Overall Study||223
8478242|NCT00615550|20893144|P2|STARTED|Overall Study||236
8478243|NCT00615550|20893145|P1|STARTED|Overall Study||229
8478244|NCT00615472|20893161|P2|NOT COMPLETED|Overall Study||0
8478245|NCT00615472|20893162|P1|NOT COMPLETED|Overall Study||0
8478246|NCT00615472|20893161|P2|COMPLETED|Overall Study||28
8478247|NCT00615472|20893162|P1|COMPLETED|Overall Study||30
8478248|NCT00615472|20893161|P2|STARTED|Overall Study||28
8478249|NCT00615472|20893162|P1|STARTED|Overall Study||30
8478250|NCT00615459|20893168|P4|NOT COMPLETED|Period III||0
8478251|NCT00615459|20893169|P3|NOT COMPLETED|Period III||1
8478252|NCT00615459|20893170|P2|NOT COMPLETED|Period III||3
8478253|NCT00615459|20893171|P1|NOT COMPLETED|Period III||0
8478254|NCT00615459|20893168|P4|COMPLETED|Period III||41
8478255|NCT00615459|20893169|P3|COMPLETED|Period III||39
8478256|NCT00615459|20893170|P2|COMPLETED|Period III||37
8478257|NCT00615459|20893171|P1|COMPLETED|Period III||36
8478258|NCT00615459|20893168|P4|STARTED|Period III||41
8478259|NCT00615459|20893169|P3|STARTED|Period III||40
8478260|NCT00615459|20893170|P2|STARTED|Period III||40
8478261|NCT00615459|20893171|P1|STARTED|Period III||36
8478262|NCT00615459|20893168|P4|NOT COMPLETED|Period II||1
8478263|NCT00615459|20893169|P3|NOT COMPLETED|Period II||0
8478264|NCT00615459|20893170|P2|NOT COMPLETED|Period II||0
8478265|NCT00615459|20893171|P1|NOT COMPLETED|Period II||1
8478266|NCT00615459|20893168|P4|COMPLETED|Period II||41
8478267|NCT00615459|20893169|P3|COMPLETED|Period II||40
8478268|NCT00615459|20893170|P2|COMPLETED|Period II||40
8478269|NCT00615459|20893171|P1|COMPLETED|Period II||36
8478270|NCT00615459|20893168|P4|STARTED|Period II||42
8478271|NCT00615459|20893169|P3|STARTED|Period II||40
8478272|NCT00615459|20893170|P2|STARTED|Period II||40
8478273|NCT00615459|20893171|P1|STARTED|Period II||37
8478274|NCT00615459|20893168|P4|NOT COMPLETED|Period I||1
8478275|NCT00615459|20893169|P3|NOT COMPLETED|Period I||2
8478276|NCT00615459|20893170|P2|NOT COMPLETED|Period I||1
8478277|NCT00615459|20893171|P1|NOT COMPLETED|Period I||4
8478278|NCT00615459|20893168|P4|COMPLETED|Period I||42
8478279|NCT00615459|20893169|P3|COMPLETED|Period I||40
8478280|NCT00615459|20893170|P2|COMPLETED|Period I||40
8478281|NCT00615459|20893171|P1|COMPLETED|Period I||37
8478282|NCT00615459|20893168|P4|STARTED|Period I||43
8478283|NCT00615459|20893169|P3|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
8478284|NCT00615459|20893170|P2|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
8478285|NCT00615459|20893171|P1|STARTED|Period I||41
8478286|NCT00615433|20893189|P4|NOT COMPLETED|Overall Study||45
8478287|NCT00615433|20893190|P3|NOT COMPLETED|Overall Study||39
8478288|NCT00615433|20893191|P2|NOT COMPLETED|Overall Study||53
8478289|NCT00615433|20893192|P1|NOT COMPLETED|Overall Study||43
8478290|NCT00615433|20893189|P4|COMPLETED|Overall Study||71
8478291|NCT00615433|20893190|P3|COMPLETED|Overall Study||84
8478292|NCT00615433|20893191|P2|COMPLETED|Overall Study||66
8478293|NCT00615433|20893192|P1|COMPLETED|Overall Study||77
8478294|NCT00615433|20893189|P4|STARTED|Overall Study||116
8478295|NCT00615433|20893190|P3|STARTED|Overall Study||123
8478296|NCT00615433|20893191|P2|STARTED|Overall Study||119
8478297|NCT00615433|20893192|P1|STARTED|Overall Study||120
8478298|NCT00615420|20893208|P2|NOT COMPLETED|Overall Study||27
8478299|NCT00615420|20893209|P1|NOT COMPLETED|Overall Study||31
8478300|NCT00615420|20893208|P2|COMPLETED|Overall Study||25
8478301|NCT00615420|20893209|P1|COMPLETED|Overall Study||23
8478302|NCT00615420|20893208|P2|STARTED|Overall Study||52
8478303|NCT00615420|20893209|P1|STARTED|Overall Study||54
8478304|NCT00615290|20893217|P1|NOT COMPLETED|Overall Study||8
8478305|NCT00615290|20893217|P1|COMPLETED|Overall Study||34
8478306|NCT00615290|20893217|P1|STARTED|Overall Study||42
8478307|NCT00615264|20893231|P2|NOT COMPLETED|Overall Study||52
8478308|NCT00615264|20893232|P1|NOT COMPLETED|Overall Study||50
8478309|NCT00615264|20893231|P2|COMPLETED|Overall Study||180
8478310|NCT00615264|20893232|P1|COMPLETED|Overall Study||175
8478311|NCT00615264|20893231|P2|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
8478312|NCT00615264|20893232|P1|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
8478313|NCT00615264|20893231|P2|Received at Least One Dose (ITT)|Overall Study||231
8478314|NCT00615264|20893232|P1|Received at Least One Dose (ITT)|Overall Study||225
8478315|NCT00615264|20893231|P2|STARTED|Overall Study||232
8478316|NCT00615264|20893232|P1|STARTED|Overall Study||225
8478317|NCT00615199|20893244|P4|NOT COMPLETED|Overall Study||2
8478318|NCT00615199|20893245|P3|NOT COMPLETED|Overall Study||1
8478319|NCT00615199|20893246|P2|NOT COMPLETED|Overall Study||2
8478320|NCT00615199|20893247|P1|NOT COMPLETED|Overall Study||8
8478321|NCT00615199|20893244|P4|COMPLETED|Overall Study||33
8478322|NCT00615199|20893245|P3|COMPLETED|Overall Study||33
8478323|NCT00615199|20893246|P2|COMPLETED|Overall Study||34
8478324|NCT00615199|20893247|P1|COMPLETED|Overall Study||26
8478325|NCT00615199|20893244|P4|STARTED|Overall Study||35
8478326|NCT00615199|20893245|P3|STARTED|Overall Study||34
8478327|NCT00615199|20893246|P2|STARTED|Overall Study||36
8478328|NCT00615199|20893247|P1|STARTED|Overall Study||34
8478329|NCT00615108|20893281|P1|NOT COMPLETED|Overall Study||507
8478330|NCT00615108|20893281|P1|COMPLETED|Overall Study||2641
8478331|NCT00615108|20893281|P1|STARTED|Overall Study||3148
8478332|NCT00615069|20893296|P1|NOT COMPLETED|Overall Study||16
8478333|NCT00615069|20893296|P1|COMPLETED|Overall Study||19
8478334|NCT00615069|20893296|P1|STARTED|Overall Study||35
8478335|NCT00615056|20893305|P4|NOT COMPLETED|Overall Study||35
8478336|NCT00615056|20893306|P3|NOT COMPLETED|Overall Study||36
8478337|NCT00615056|20893307|P2|NOT COMPLETED|Overall Study||51
8478338|NCT00615056|20893308|P1|NOT COMPLETED|Overall Study||49
8478339|NCT00615056|20893305|P4|COMPLETED|Overall Study||0
8478340|NCT00615056|20893306|P3|COMPLETED|Overall Study||0
8478341|NCT00615056|20893307|P2|COMPLETED|Overall Study||0
8478342|NCT00615056|20893308|P1|COMPLETED|Overall Study||0
8478343|NCT00615056|20893305|P4|Treated|Overall Study||35
8478344|NCT00615056|20893306|P3|Treated|Overall Study||36
8478345|NCT00615056|20893307|P2|Treated|Overall Study||51
8478346|NCT00615056|20893308|P1|Treated|Overall Study||46
8478347|NCT00615056|20893305|P4|STARTED|Overall Study||35
8478348|NCT00615056|20893306|P3|STARTED|Overall Study||36
8478349|NCT00615056|20893307|P2|STARTED|Overall Study||51
8478350|NCT00615056|20893308|P1|STARTED|Overall Study||49
8478351|NCT00615030|20893338|P12|NOT COMPLETED|Period III||0
8478352|NCT00615030|20893339|P11|NOT COMPLETED|Period III||0
8478353|NCT00615030|20893340|P10|NOT COMPLETED|Period III||0
8478354|NCT00615030|20893341|P9|NOT COMPLETED|Period III||0
8478355|NCT00615030|20893342|P8|NOT COMPLETED|Period III||0
8478356|NCT00615030|20893343|P7|NOT COMPLETED|Period III||0
8478357|NCT00615030|20893344|P6|NOT COMPLETED|Period III||0
8478358|NCT00615030|20893345|P5|NOT COMPLETED|Period III||0
8478359|NCT00615030|20893346|P4|NOT COMPLETED|Period III||1
8478360|NCT00615030|20893347|P3|NOT COMPLETED|Period III||0
8478361|NCT00615030|20893348|P2|NOT COMPLETED|Period III||0
8478362|NCT00615030|20893349|P1|NOT COMPLETED|Period III||1
8478363|NCT00615030|20893338|P12|COMPLETED|Period III||6
8478364|NCT00615030|20893339|P11|COMPLETED|Period III||7
8478365|NCT00615030|20893340|P10|COMPLETED|Period III||8
8478366|NCT00615030|20893341|P9|COMPLETED|Period III||7
8478367|NCT00615030|20893342|P8|COMPLETED|Period III||7
8478368|NCT00615030|20893343|P7|COMPLETED|Period III||6
8478369|NCT00615030|20893344|P6|COMPLETED|Period III||5
8478370|NCT00615030|20893345|P5|COMPLETED|Period III||8
8478371|NCT00615030|20893346|P4|COMPLETED|Period III||6
8478372|NCT00615030|20893347|P3|COMPLETED|Period III||8
8478373|NCT00615030|20893348|P2|COMPLETED|Period III||8
8478374|NCT00615030|20893349|P1|COMPLETED|Period III||7
8478375|NCT00615030|20893338|P12|STARTED|Period III||6
8478376|NCT00615030|20893339|P11|STARTED|Period III||7
8478377|NCT00615030|20893340|P10|STARTED|Period III||8
8478378|NCT00615030|20893341|P9|STARTED|Period III||7
8478379|NCT00615030|20893342|P8|STARTED|Period III||7
8478380|NCT00615030|20893343|P7|STARTED|Period III||6
8478381|NCT00615030|20893344|P6|STARTED|Period III||5
8478382|NCT00615030|20893345|P5|STARTED|Period III||8
8478383|NCT00615030|20893346|P4|STARTED|Period III||7
8478384|NCT00615030|20893347|P3|STARTED|Period III||8
8478385|NCT00615030|20893348|P2|STARTED|Period III||8
8478386|NCT00615030|20893349|P1|STARTED|Period III||8
8478387|NCT00615030|20893338|P12|NOT COMPLETED|Period II||0
8478388|NCT00615030|20893339|P11|NOT COMPLETED|Period II||0
8478389|NCT00615030|20893340|P10|NOT COMPLETED|Period II||0
8478390|NCT00615030|20893341|P9|NOT COMPLETED|Period II||1
8478391|NCT00615030|20893342|P8|NOT COMPLETED|Period II||0
8478392|NCT00615030|20893343|P7|NOT COMPLETED|Period II||1
8478393|NCT00615030|20893344|P6|NOT COMPLETED|Period II||0
8478394|NCT00615030|20893345|P5|NOT COMPLETED|Period II||0
8478395|NCT00615030|20893346|P4|NOT COMPLETED|Period II||1
8478396|NCT00615030|20893347|P3|NOT COMPLETED|Period II||1
8478397|NCT00615030|20893348|P2|NOT COMPLETED|Period II||0
8478398|NCT00615030|20893349|P1|NOT COMPLETED|Period II||0
8478399|NCT00615030|20893338|P12|COMPLETED|Period II||6
8478400|NCT00615030|20893339|P11|COMPLETED|Period II||7
8478401|NCT00615030|20893340|P10|COMPLETED|Period II||8
8478402|NCT00615030|20893341|P9|COMPLETED|Period II||7
8478403|NCT00615030|20893342|P8|COMPLETED|Period II||7
8478404|NCT00615030|20893343|P7|COMPLETED|Period II||6
8478405|NCT00615030|20893344|P6|COMPLETED|Period II||5
8478406|NCT00615030|20893345|P5|COMPLETED|Period II||8
8478407|NCT00615030|20893346|P4|COMPLETED|Period II||7
8478408|NCT00615030|20893347|P3|COMPLETED|Period II||8
8478409|NCT00615030|20893348|P2|COMPLETED|Period II||8
8478410|NCT00615030|20893349|P1|COMPLETED|Period II||8
8478411|NCT00615030|20893338|P12|STARTED|Period II||6
8478412|NCT00615030|20893339|P11|STARTED|Period II||7
8478413|NCT00615030|20893340|P10|STARTED|Period II||8
8478414|NCT00615030|20893341|P9|STARTED|Period II||8
8478415|NCT00615030|20893342|P8|STARTED|Period II||7
8478416|NCT00615030|20893343|P7|STARTED|Period II||7
8478417|NCT00615030|20893344|P6|STARTED|Period II||5
8478418|NCT00615030|20893345|P5|STARTED|Period II||8
8478419|NCT00615030|20893346|P4|STARTED|Period II||8
8478420|NCT00615030|20893347|P3|STARTED|Period II||9
8478421|NCT00615030|20893348|P2|STARTED|Period II||8
8478422|NCT00615030|20893349|P1|STARTED|Period II||8
8478423|NCT00615030|20893338|P12|NOT COMPLETED|Period I||1
8478424|NCT00615030|20893339|P11|NOT COMPLETED|Period I||1
8478425|NCT00615030|20893340|P10|NOT COMPLETED|Period I||0
8478426|NCT00615030|20893341|P9|NOT COMPLETED|Period I||1
8478427|NCT00615030|20893342|P8|NOT COMPLETED|Period I||0
8478428|NCT00615030|20893343|P7|NOT COMPLETED|Period I||0
8478429|NCT00615030|20893344|P6|NOT COMPLETED|Period I||1
8478430|NCT00615030|20893345|P5|NOT COMPLETED|Period I||1
8478431|NCT00615030|20893346|P4|NOT COMPLETED|Period I||0
8478432|NCT00615030|20893347|P3|NOT COMPLETED|Period I||0
8478433|NCT00615030|20893348|P2|NOT COMPLETED|Period I||0
8478434|NCT00615030|20893349|P1|NOT COMPLETED|Period I||1
8478435|NCT00615030|20893338|P12|COMPLETED|Period I||6
8478436|NCT00615030|20893339|P11|COMPLETED|Period I||7
8478437|NCT00615030|20893340|P10|COMPLETED|Period I||8
8478438|NCT00615030|20893341|P9|COMPLETED|Period I||8
8478439|NCT00615030|20893342|P8|COMPLETED|Period I||7
8478440|NCT00615030|20893343|P7|COMPLETED|Period I||7
8478441|NCT00615030|20893344|P6|COMPLETED|Period I||5
8478442|NCT00615030|20893345|P5|COMPLETED|Period I||8
8478443|NCT00615030|20893346|P4|COMPLETED|Period I||8
8478444|NCT00615030|20893347|P3|COMPLETED|Period I||9
8478445|NCT00615030|20893348|P2|COMPLETED|Period I||8
8478446|NCT00615030|20893349|P1|COMPLETED|Period I||8
8478447|NCT00615030|20893338|P12|STARTED|Period I||7
8478448|NCT00615030|20893339|P11|STARTED|Period I||8
8478449|NCT00615030|20893340|P10|STARTED|Period I||8
8478450|NCT00615030|20893341|P9|STARTED|Period I||9
8478451|NCT00615030|20893342|P8|STARTED|Period I||7
8478452|NCT00615030|20893343|P7|STARTED|Period I||7
8478453|NCT00615030|20893344|P6|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
8478454|NCT00615030|20893345|P5|STARTED|Period I||9
8478455|NCT00615030|20893346|P4|STARTED|Period I||8
8478456|NCT00615030|20893347|P3|STARTED|Period I||9
8478457|NCT00615030|20893348|P2|STARTED|Period I||8
8478458|NCT00615030|20893349|P1|STARTED|Period I||9
8478459|NCT00615017|20893369|P6|NOT COMPLETED|Overall Study||3
8478460|NCT00615017|20893370|P5|NOT COMPLETED|Overall Study||1
8478461|NCT00615017|20893371|P4|NOT COMPLETED|Overall Study||1
8478462|NCT00615017|20893372|P3|NOT COMPLETED|Overall Study||5
8478463|NCT00615017|20893373|P2|NOT COMPLETED|Overall Study||1
8478464|NCT00615017|20893374|P1|NOT COMPLETED|Overall Study||0
8478465|NCT00615017|20893369|P6|COMPLETED|Overall Study|Patient completed the study drug|20
8478466|NCT00615017|20893370|P5|COMPLETED|Overall Study|Patient completed the study drug|7
8478467|NCT00615017|20893371|P4|COMPLETED|Overall Study|Patient completed the study drug|9
8478468|NCT00615017|20893372|P3|COMPLETED|Overall Study|Patient completed the study drug|7
8478469|NCT00615017|20893373|P2|COMPLETED|Overall Study|Patient completed the study drug|8
8478470|NCT00615017|20893374|P1|COMPLETED|Overall Study|Patient completed the study drug|8
8478471|NCT00615017|20893369|P6|STARTED|Overall Study|Patients received treatment|23
8478472|NCT00615017|20893370|P5|STARTED|Overall Study|Patients received treatment|8
8478473|NCT00615017|20893371|P4|STARTED|Overall Study|Patients received treatment|10
8478474|NCT00615017|20893372|P3|STARTED|Overall Study|Patients received treatment|12
8478475|NCT00615017|20893373|P2|STARTED|Overall Study|Patients received treatment|9
8478476|NCT00615017|20893374|P1|STARTED|Overall Study|Patients received treatment|8
8478477|NCT00614991|20893532|P6|NOT COMPLETED|Overall Study||0
8478478|NCT00614991|20893533|P5|NOT COMPLETED|Overall Study||1
8478479|NCT00614991|20893534|P4|NOT COMPLETED|Overall Study||0
8478480|NCT00614991|20893535|P3|NOT COMPLETED|Overall Study||0
8478481|NCT00614991|20893536|P2|NOT COMPLETED|Overall Study||3
8478482|NCT00614991|20893537|P1|NOT COMPLETED|Overall Study||3
8478483|NCT00614991|20893532|P6|COMPLETED|Overall Study||6
8478484|NCT00614991|20893533|P5|COMPLETED|Overall Study||6
8478485|NCT00614991|20893534|P4|COMPLETED|Overall Study||7
8478486|NCT00614991|20893535|P3|COMPLETED|Overall Study||7
8478487|NCT00614991|20893536|P2|COMPLETED|Overall Study||6
8478488|NCT00614991|20893537|P1|COMPLETED|Overall Study||5
8478489|NCT00614991|20893532|P6|STARTED|Overall Study||6
8478490|NCT00614991|20893533|P5|STARTED|Overall Study||7
8478491|NCT00614991|20893534|P4|STARTED|Overall Study||7
8478492|NCT00614991|20893535|P3|STARTED|Overall Study||7
8478493|NCT00614991|20893536|P2|STARTED|Overall Study||9
8478494|NCT00614991|20893537|P1|STARTED|Overall Study||8
8478495|NCT00614939|20893571|P2|NOT COMPLETED|Overall Study||43
8478496|NCT00614939|20893572|P1|NOT COMPLETED|Overall Study||35
8478497|NCT00614939|20893571|P2|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
8478498|NCT00614939|20893572|P1|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
8478499|NCT00614939|20893571|P2|STARTED|Overall Study|Randomized and treated|85
8478500|NCT00614939|20893572|P1|STARTED|Overall Study|Randomized and treated|85
8478501|NCT00614926|20893606|P2|NOT COMPLETED|Overall Study||0
8478502|NCT00614926|20893607|P1|NOT COMPLETED|Overall Study||4
8478503|NCT00614926|20893606|P2|COMPLETED|Overall Study||7
8478504|NCT00614926|20893607|P1|COMPLETED|Overall Study||21
8478505|NCT00614926|20893606|P2|STARTED|Overall Study||7
8478506|NCT00614926|20893607|P1|STARTED|Overall Study||25
8478507|NCT00614913|20893615|P1|NOT COMPLETED|Overall Study||0
8478508|NCT00614913|20893615|P1|COMPLETED|Overall Study||76
8478509|NCT00614913|20893615|P1|STARTED|Overall Study||76
8478510|NCT00614874|20893620|P1|NOT COMPLETED|Overall Study||2
8478511|NCT00614874|20893620|P1|COMPLETED|Overall Study||14
8478512|NCT00614874|20893620|P1|STARTED|Overall Study||16
8478513|NCT00614822|20893627|P1|NOT COMPLETED|Overall Study||3
8478514|NCT00614822|20893627|P1|COMPLETED|Overall Study||47
8478515|NCT00614822|20893627|P1|STARTED|Overall Study||50
8478522|NCT00614614|20893663|P5|NOT COMPLETED|Booster Vaccination Phase||13
8478523|NCT00614614|20893664|P4|NOT COMPLETED|Booster Vaccination Phase||19
8478524|NCT00614614|20893665|P3|NOT COMPLETED|Booster Vaccination Phase||27
8478525|NCT00614614|20893666|P2|NOT COMPLETED|Booster Vaccination Phase||6
8478526|NCT00614614|20893667|P1|NOT COMPLETED|Booster Vaccination Phase||0
8478527|NCT00614614|20893663|P5|COMPLETED|Booster Vaccination Phase||396
8478528|NCT00614614|20893664|P4|COMPLETED|Booster Vaccination Phase||210
8478529|NCT00614614|20893665|P3|COMPLETED|Booster Vaccination Phase||405
8478530|NCT00614614|20893666|P2|COMPLETED|Booster Vaccination Phase||227
8478531|NCT00614614|20893667|P1|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
8478532|NCT00614614|20893663|P5|STARTED|Booster Vaccination Phase||409
8478533|NCT00614614|20893664|P4|STARTED|Booster Vaccination Phase||229
8478534|NCT00614614|20893665|P3|STARTED|Booster Vaccination Phase||432
8478535|NCT00614614|20893666|P2|STARTED|Booster Vaccination Phase||233
8478536|NCT00614614|20893667|P1|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
8478537|NCT00614614|20893663|P5|NOT COMPLETED|Primary Vaccination Phase||0
8478538|NCT00614614|20893664|P4|NOT COMPLETED|Primary Vaccination Phase||0
8478539|NCT00614614|20893665|P3|NOT COMPLETED|Primary Vaccination Phase||0
8478540|NCT00614614|20893666|P2|NOT COMPLETED|Primary Vaccination Phase||17
8478541|NCT00614614|20893667|P1|NOT COMPLETED|Primary Vaccination Phase||90
8478542|NCT00614614|20893663|P5|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8478543|NCT00614614|20893664|P4|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8478544|NCT00614614|20893665|P3|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8478545|NCT00614614|20893666|P2|COMPLETED|Primary Vaccination Phase||265
8478546|NCT00614614|20893667|P1|COMPLETED|Primary Vaccination Phase||1182
8478547|NCT00614614|20893663|P5|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8478548|NCT00614614|20893664|P4|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8478549|NCT00614614|20893665|P3|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
8478550|NCT00614614|20893666|P2|STARTED|Primary Vaccination Phase||282
8478551|NCT00614614|20893667|P1|STARTED|Primary Vaccination Phase||1272
8478552|NCT00614575|20893790|P1|NOT COMPLETED|Overall Study||228
8478553|NCT00614575|20893790|P1|COMPLETED|Overall Study||861
8478554|NCT00614575|20893790|P1|STARTED|Overall Study|The number of patients enrolled.|1089
8478555|NCT00614523|20893801|P2|NOT COMPLETED|Overall Study||131
8478556|NCT00614523|20893802|P1|NOT COMPLETED|Overall Study||63
8478557|NCT00614523|20893801|P2|COMPLETED|Overall Study||36
8478558|NCT00614523|20893802|P1|COMPLETED|Overall Study||20
8478559|NCT00614523|20893801|P2|STARTED|Overall Study||167
8478560|NCT00614523|20893802|P1|STARTED|Overall Study||83
8478561|NCT00614484|20893826|P1|NOT COMPLETED|Overall Study||0
8478562|NCT00614484|20893826|P1|COMPLETED|Overall Study||28
8478563|NCT00614484|20893826|P1|STARTED|Overall Study||28
8478564|NCT00614458|20893831|P1|NOT COMPLETED|Overall Study||0
8478565|NCT00614458|20893831|P1|COMPLETED|Overall Study||6
8478566|NCT00614458|20893831|P1|STARTED|Overall Study||6
8478567|NCT00614445|20893837|P2|NOT COMPLETED|Overall Study||49
8478568|NCT00614445|20893838|P1|NOT COMPLETED|Overall Study||28
8478569|NCT00614445|20893837|P2|COMPLETED|Overall Study||91
8478570|NCT00614445|20893838|P1|COMPLETED|Overall Study||112
8478571|NCT00614445|20893837|P2|STARTED|Overall Study||140
8478572|NCT00614445|20893838|P1|STARTED|Overall Study||140
8478573|NCT00614432|20893846|P2|NOT COMPLETED|Overall Study||0
8478574|NCT00614432|20893847|P1|NOT COMPLETED|Overall Study||0
8478575|NCT00614432|20893846|P2|COMPLETED|Overall Study||6
8478576|NCT00614432|20893847|P1|COMPLETED|Overall Study||4
8478577|NCT00614432|20893846|P2|STARTED|Overall Study||6
8478578|NCT00614432|20893847|P1|STARTED|Overall Study||4
8478579|NCT00614406|20893855|P2|NOT COMPLETED|Overall Study||0
8478580|NCT00614406|20893856|P1|NOT COMPLETED|Overall Study||0
8478581|NCT00614406|20893855|P2|COMPLETED|Overall Study||4
8478582|NCT00614406|20893856|P1|COMPLETED|Overall Study||7
8478583|NCT00614406|20893855|P2|STARTED|Overall Study||4
8478584|NCT00614406|20893856|P1|STARTED|Overall Study||7
8478585|NCT00614393|20893867|P5|NOT COMPLETED|Overall Study||180
8478586|NCT00614393|20893868|P4|NOT COMPLETED|Overall Study||180
8478587|NCT00614393|20893869|P3|NOT COMPLETED|Overall Study||10
8478588|NCT00614393|20893870|P2|NOT COMPLETED|Overall Study||8
8478589|NCT00614393|20893871|P1|NOT COMPLETED|Overall Study||180
8478590|NCT00614393|20893867|P5|COMPLETED|Overall Study||0
8478591|NCT00614393|20893868|P4|COMPLETED|Overall Study||0
8478592|NCT00614393|20893869|P3|COMPLETED|Overall Study||0
8478593|NCT00614393|20893870|P2|COMPLETED|Overall Study||0
8478594|NCT00614393|20893871|P1|COMPLETED|Overall Study||0
8478595|NCT00614393|20893867|P5|Treated|Overall Study||178
8478596|NCT00614393|20893868|P4|Treated|Overall Study||180
8478597|NCT00614393|20893869|P3|Treated|Overall Study||10
8478598|NCT00614393|20893870|P2|Treated|Overall Study||8
8478599|NCT00614393|20893871|P1|Treated|Overall Study||180
8478600|NCT00614393|20893867|P5|STARTED|Overall Study||180
8478601|NCT00614393|20893868|P4|STARTED|Overall Study||180
8478602|NCT00614393|20893869|P3|STARTED|Overall Study||10
8478603|NCT00614393|20893870|P2|STARTED|Overall Study||8
8478604|NCT00614393|20893871|P1|STARTED|Overall Study||180
8478605|NCT00614380|20893917|P4|NOT COMPLETED|Overall Study||2
8478606|NCT00614380|20893918|P3|NOT COMPLETED|Overall Study||1
8478607|NCT00614380|20893919|P2|NOT COMPLETED|Overall Study||8
8478608|NCT00614380|20893920|P1|NOT COMPLETED|Overall Study||35
8478609|NCT00614380|20893917|P4|COMPLETED|Overall Study||179
8478610|NCT00614380|20893918|P3|COMPLETED|Overall Study||24
8478611|NCT00614380|20893919|P2|COMPLETED|Overall Study||198
8478612|NCT00614380|20893920|P1|COMPLETED|Overall Study||529
8478613|NCT00614380|20893917|P4|STARTED|Overall Study||181
8478614|NCT00614380|20893918|P3|STARTED|Overall Study||25
8478615|NCT00614380|20893919|P2|STARTED|Overall Study||206
8478616|NCT00614380|20893920|P1|STARTED|Overall Study||564
8478617|NCT00614315|20893969|P1|NOT COMPLETED|Overall Study||0
8478618|NCT00614315|20893969|P1|COMPLETED|Overall Study||30
8478619|NCT00614315|20893969|P1|STARTED|Overall Study||30
8478620|NCT00614198|20893976|P2|NOT COMPLETED|Stage 2||12
8478621|NCT00614198|20893977|P1|NOT COMPLETED|Stage 2||8
8478622|NCT00614198|20893976|P2|COMPLETED|Stage 2||17
8478623|NCT00614198|20893977|P1|COMPLETED|Stage 2||18
8478624|NCT00614198|20893976|P2|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
8478625|NCT00614198|20893977|P1|STARTED|Stage 2||26
8478626|NCT00614198|20893976|P2|NOT COMPLETED|Stage 1||5
8478627|NCT00614198|20893977|P1|NOT COMPLETED|Stage 1||12
8478628|NCT00614198|20893976|P2|COMPLETED|Stage 1||29
8478629|NCT00614198|20893977|P1|COMPLETED|Stage 1||26
8478630|NCT00614198|20893976|P2|STARTED|Stage 1||34
8478631|NCT00614198|20893977|P1|STARTED|Stage 1||38
8478632|NCT00614120|20893987|P4|NOT COMPLETED|Overall Study||16
8478633|NCT00614120|20893988|P3|NOT COMPLETED|Overall Study||59
8478634|NCT00614120|20893989|P2|NOT COMPLETED|Overall Study||46
8478635|NCT00614120|20893990|P1|NOT COMPLETED|Overall Study||29
8478636|NCT00614120|20893987|P4|COMPLETED|Overall Study||215
8478637|NCT00614120|20893988|P3|COMPLETED|Overall Study||175
8478638|NCT00614120|20893989|P2|COMPLETED|Overall Study||187
8478639|NCT00614120|20893990|P1|COMPLETED|Overall Study||202
8478640|NCT00614120|20893987|P4|Exposed to Study Drug|Overall Study||231
8478641|NCT00614120|20893988|P3|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
8478642|NCT00614120|20893989|P2|Exposed to Study Drug|Overall Study||233
8478643|NCT00614120|20893990|P1|Exposed to Study Drug|Overall Study||231
8478644|NCT00614120|20893987|P4|STARTED|Overall Study|Randomised|231
8478645|NCT00614120|20893988|P3|STARTED|Overall Study|Randomised|234
8478646|NCT00614120|20893989|P2|STARTED|Overall Study|Randomised|233
8478647|NCT00614120|20893990|P1|STARTED|Overall Study|Randomised|231
8478648|NCT00614055|20894031|P3|NOT COMPLETED|Overall Study||5
8478649|NCT00614055|20894032|P2|NOT COMPLETED|Overall Study||6
8478650|NCT00614055|20894033|P1|NOT COMPLETED|Overall Study||4
8478651|NCT00614055|20894031|P3|COMPLETED|Overall Study||55
8478652|NCT00614055|20894032|P2|COMPLETED|Overall Study||53
8478653|NCT00614055|20894033|P1|COMPLETED|Overall Study||55
8478654|NCT00614055|20894031|P3|Exposed|Overall Study||60
8478655|NCT00614055|20894032|P2|Exposed|Overall Study||59
8478656|NCT00614055|20894033|P1|Exposed|Overall Study||59
8478657|NCT00614055|20894031|P3|STARTED|Overall Study||60
8478658|NCT00614055|20894032|P2|STARTED|Overall Study||59
8478659|NCT00614055|20894033|P1|STARTED|Overall Study||59
8478660|NCT00613951|20894080|P3|NOT COMPLETED|Overall Study||5
8478661|NCT00613951|20894081|P2|NOT COMPLETED|Overall Study||5
8478662|NCT00613951|20894082|P1|NOT COMPLETED|Overall Study||7
8478663|NCT00613951|20894080|P3|COMPLETED|Overall Study||57
8478664|NCT00613951|20894081|P2|COMPLETED|Overall Study||54
8478665|NCT00613951|20894082|P1|COMPLETED|Overall Study||54
8478666|NCT00613951|20894080|P3|Exposed|Overall Study||62
8478667|NCT00613951|20894081|P2|Exposed|Overall Study||59
8478668|NCT00613951|20894082|P1|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
8478669|NCT00613951|20894080|P3|STARTED|Overall Study||62
8478670|NCT00613951|20894081|P2|STARTED|Overall Study||59
8478671|NCT00613951|20894082|P1|STARTED|Overall Study||61
8478672|NCT00613938|20894127|P4|NOT COMPLETED|Overall Study||26
8478673|NCT00613938|20894128|P3|NOT COMPLETED|Overall Study||23
8478674|NCT00613938|20894129|P2|NOT COMPLETED|Overall Study||28
8478675|NCT00613938|20894130|P1|NOT COMPLETED|Overall Study||20
8478676|NCT00613938|20894127|P4|COMPLETED|Overall Study||253
8478677|NCT00613938|20894128|P3|COMPLETED|Overall Study||255
8478678|NCT00613938|20894129|P2|COMPLETED|Overall Study||247
8478679|NCT00613938|20894130|P1|COMPLETED|Overall Study||49
8478680|NCT00613938|20894127|P4|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
8478681|NCT00613938|20894128|P3|STARTED|Overall Study||278
8478682|NCT00613938|20894129|P2|STARTED|Overall Study||275
8478683|NCT00613938|20894130|P1|STARTED|Overall Study||69
8478684|NCT00613925|20894162|P2|NOT COMPLETED|Overall Study||1
8478685|NCT00613925|20894163|P1|NOT COMPLETED|Overall Study||0
8478686|NCT00613925|20894162|P2|COMPLETED|Overall Study||32
8478687|NCT00613925|20894163|P1|COMPLETED|Overall Study||37
8478688|NCT00613925|20894162|P2|STARTED|Overall Study||33
8478689|NCT00613925|20894163|P1|STARTED|Overall Study||37
8478690|NCT00613886|20894171|P1|NOT COMPLETED|Overall Study||24
8478691|NCT00613886|20894171|P1|COMPLETED|Overall Study||0
8478692|NCT00613886|20894171|P1|STARTED|Overall Study||24
8478693|NCT00613834|20894178|P2|NOT COMPLETED|Overall Study||3
8478694|NCT00613834|20894179|P1|NOT COMPLETED|Overall Study||0
8478695|NCT00613834|20894178|P2|COMPLETED|Overall Study||26
8478696|NCT00613834|20894179|P1|COMPLETED|Overall Study||29
8478697|NCT00613834|20894178|P2|STARTED|Overall Study||29
8478698|NCT00613834|20894179|P1|STARTED|Overall Study||29
8478699|NCT00613821|20894191|P2|NOT COMPLETED|Overall Study||1
8478700|NCT00613821|20894192|P1|NOT COMPLETED|Overall Study||2
8478701|NCT00613821|20894191|P2|COMPLETED|Overall Study||39
8478702|NCT00613821|20894192|P1|COMPLETED|Overall Study||38
8478703|NCT00613821|20894191|P2|STARTED|Overall Study||40
8478704|NCT00613821|20894192|P1|STARTED|Overall Study||40
8478705|NCT00613730|20894198|P1|NOT COMPLETED|Overall Study||3
8478706|NCT00613730|20894198|P1|COMPLETED|Overall Study||0
8478707|NCT00613730|20894198|P1|STARTED|Overall Study||3
8478708|NCT00613626|20894207|P3|NOT COMPLETED|Overall Study||0
8478709|NCT00613626|20894208|P2|NOT COMPLETED|Overall Study||1
8478710|NCT00613626|20894209|P1|NOT COMPLETED|Overall Study||0
8478711|NCT00613626|20894207|P3|COMPLETED|Overall Study||7
8478712|NCT00613626|20894208|P2|COMPLETED|Overall Study||33
8478713|NCT00613626|20894209|P1|COMPLETED|Overall Study||33
8478714|NCT00613626|20894207|P3|1st Dose ZD6474|Overall Study||7
8478715|NCT00613626|20894208|P2|1st Dose ZD6474|Overall Study||34
8478716|NCT00613626|20894209|P1|1st Dose ZD6474|Overall Study||33
8478717|NCT00613626|20894207|P3|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
8478718|NCT00613626|20894208|P2|STARTED|Overall Study||34
8478719|NCT00613626|20894209|P1|STARTED|Overall Study||33
8478720|NCT00613574|20894225|P1|NOT COMPLETED|Overall Study||6
8478721|NCT00613574|20894225|P1|COMPLETED|Overall Study||401
8478722|NCT00613574|20894225|P1|STARTED|Overall Study||407
8478723|NCT00613509|20894237|P2|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
8478724|NCT00613509|20894238|P1|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
8478725|NCT00613509|20894237|P2|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
8478726|NCT00613509|20894238|P1|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
8478727|NCT00613509|20894237|P2|STARTED|Cycle 2 (Group 2 = Crossover)||4
8478728|NCT00613509|20894238|P1|STARTED|Cycle 2 (Group 2 = Crossover)||11
8478729|NCT00613509|20894237|P2|NOT COMPLETED|Cycle 1||8
8478730|NCT00613509|20894238|P1|NOT COMPLETED|Cycle 1||5
8478731|NCT00613509|20894237|P2|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
8478732|NCT00613509|20894238|P1|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
8478733|NCT00613509|20894237|P2|STARTED|Cycle 1||12
8478734|NCT00613509|20894238|P1|STARTED|Cycle 1||11
8478735|NCT00613405|20894262|P2|NOT COMPLETED|Overall Study||0
8478736|NCT00613405|20894263|P1|NOT COMPLETED|Overall Study||0
8478737|NCT00613405|20894262|P2|COMPLETED|Overall Study||42
8478738|NCT00613405|20894263|P1|COMPLETED|Overall Study||45
8478739|NCT00613405|20894262|P2|STARTED|Overall Study||42
8478740|NCT00613405|20894263|P1|STARTED|Overall Study||45
8478741|NCT00613379|20894272|P3|NOT COMPLETED|Overall Study||0
8478742|NCT00613379|20894273|P2|NOT COMPLETED|Overall Study||0
8478743|NCT00613379|20894274|P1|NOT COMPLETED|Overall Study||0
8478744|NCT00613379|20894272|P3|COMPLETED|Overall Study||11
8478745|NCT00613379|20894273|P2|COMPLETED|Overall Study||10
8478746|NCT00613379|20894274|P1|COMPLETED|Overall Study||10
8478747|NCT00613379|20894272|P3|STARTED|Overall Study||11
8478748|NCT00613379|20894273|P2|STARTED|Overall Study||10
8478749|NCT00613379|20894274|P1|STARTED|Overall Study||10
8478750|NCT00613366|20894284|P2|NOT COMPLETED|Overall Study||2
8478751|NCT00613366|20894285|P1|NOT COMPLETED|Overall Study||3
8478752|NCT00613366|20894284|P2|COMPLETED|Overall Study||18
8478753|NCT00613366|20894285|P1|COMPLETED|Overall Study||17
8478754|NCT00613366|20894284|P2|STARTED|Overall Study||20
8478755|NCT00613366|20894285|P1|STARTED|Overall Study||20
8478756|NCT00613327|20894293|P1|NOT COMPLETED|Overall Study||101
8478757|NCT00613327|20894293|P1|COMPLETED|Overall Study||244
8478758|NCT00613327|20894293|P1|STARTED|Overall Study||345
8478759|NCT00613314|20894312|P1|NOT COMPLETED|Overall Study||155
8478760|NCT00613314|20894312|P1|COMPLETED|Overall Study||15113
8478761|NCT00613314|20894312|P1|STARTED|Overall Study||15268
8478762|NCT00613301|20894320|P1|NOT COMPLETED|Overall Study||228
8478763|NCT00613301|20894320|P1|COMPLETED|Overall Study||188
8478764|NCT00613301|20894320|P1|STARTED|Overall Study||416
8478765|NCT00613106|20894329|P2|NOT COMPLETED|Overall Study||9
8478766|NCT00613106|20894330|P1|NOT COMPLETED|Overall Study||20
8478767|NCT00613106|20894329|P2|COMPLETED|Overall Study||38
8478768|NCT00613106|20894330|P1|COMPLETED|Overall Study||112
8478769|NCT00613106|20894329|P2|STARTED|Overall Study||47
8478770|NCT00613106|20894330|P1|STARTED|Overall Study||132
8478771|NCT00613080|20894336|P1|NOT COMPLETED|Overall Study||11
8478772|NCT00613080|20894336|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
8478773|NCT00613080|20894336|P1|STARTED|Overall Study||79
8478774|NCT00613028|20894350|P2|NOT COMPLETED|Overall Study||1
8478775|NCT00613028|20894351|P1|NOT COMPLETED|Overall Study||0
8478776|NCT00613028|20894350|P2|COMPLETED|Overall Study||12
8478777|NCT00613028|20894351|P1|COMPLETED|Overall Study||10
8478778|NCT00613028|20894350|P2|STARTED|Overall Study||13
8478779|NCT00613028|20894351|P1|STARTED|Overall Study||10
8478780|NCT00613015|20894371|P6|NOT COMPLETED|Overall Study||3
8478781|NCT00613015|20894372|P5|NOT COMPLETED|Overall Study||2
8478782|NCT00613015|20894373|P4|NOT COMPLETED|Overall Study||3
8478783|NCT00613015|20894374|P3|NOT COMPLETED|Overall Study||3
8478784|NCT00613015|20894375|P2|NOT COMPLETED|Overall Study||1
8478785|NCT00613015|20894376|P1|NOT COMPLETED|Overall Study||0
8478786|NCT00613015|20894371|P6|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
8478787|NCT00613015|20894372|P5|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
8478788|NCT00613015|20894373|P4|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
8478789|NCT00613015|20894374|P3|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
8478790|NCT00613015|20894375|P2|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
8478791|NCT00613015|20894376|P1|COMPLETED|Overall Study||13
8478792|NCT00613015|20894371|P6|STARTED|Overall Study||19
8478793|NCT00613015|20894372|P5|STARTED|Overall Study||15
8478794|NCT00613015|20894373|P4|STARTED|Overall Study||24
8478795|NCT00613015|20894374|P3|STARTED|Overall Study||26
8478796|NCT00613015|20894375|P2|STARTED|Overall Study||12
8478797|NCT00613015|20894376|P1|STARTED|Overall Study||13
8478798|NCT00612924|20894398|P2|NOT COMPLETED|Overall Study||9
8478799|NCT00612924|20894399|P1|NOT COMPLETED|Overall Study||7
8478800|NCT00612924|20894398|P2|COMPLETED|Overall Study||85
8478801|NCT00612924|20894399|P1|COMPLETED|Overall Study||94
8478802|NCT00612924|20894398|P2|STARTED|Overall Study||94
8478803|NCT00612924|20894399|P1|STARTED|Overall Study||101
8478804|NCT00612807|20894412|P2|NOT COMPLETED|Overall Study||0
8478805|NCT00612807|20894413|P1|NOT COMPLETED|Overall Study||2
8478806|NCT00612807|20894412|P2|COMPLETED|Overall Study||28
8478807|NCT00612807|20894413|P1|COMPLETED|Overall Study||12
8478808|NCT00612807|20894412|P2|STARTED|Overall Study||28
8478809|NCT00612807|20894413|P1|STARTED|Overall Study||14
8478810|NCT00612768|20894421|P1|NOT COMPLETED|Overall Study||0
8478811|NCT00612768|20894421|P1|COMPLETED|Overall Study||50
8478812|NCT00612768|20894421|P1|STARTED|Overall Study||50
8478813|NCT00612716|20894446|P1|NOT COMPLETED|Overall Study||0
8478814|NCT00612716|20894446|P1|COMPLETED|Overall Study||6
8478815|NCT00612716|20894446|P1|STARTED|Overall Study||6
8478816|NCT00612690|20894460|P2|NOT COMPLETED|Overall Study||118
8478817|NCT00612690|20894461|P1|NOT COMPLETED|Overall Study||115
8478818|NCT00612690|20894460|P2|COMPLETED|Overall Study||89
8478819|NCT00612690|20894461|P1|COMPLETED|Overall Study||160
8478820|NCT00612690|20894460|P2|STARTED|Overall Study||207
8478821|NCT00612690|20894461|P1|STARTED|Overall Study||275
8478822|NCT00612677|20894469|P1|NOT COMPLETED|Overall Study||1
8478823|NCT00612677|20894469|P1|COMPLETED|Overall Study||0
8478824|NCT00612677|20894469|P1|STARTED|Overall Study||1
8478825|NCT00612586|20894477|P2|NOT COMPLETED|Overall Study||41
8478826|NCT00612586|20894478|P1|NOT COMPLETED|Overall Study||43
8478827|NCT00612586|20894477|P2|COMPLETED|Overall Study||18
8478828|NCT00612586|20894478|P1|COMPLETED|Overall Study||15
8478829|NCT00612586|20894477|P2|Received at Least 1 Dose|Overall Study||58
8478830|NCT00612586|20894478|P1|Received at Least 1 Dose|Overall Study||57
8478831|NCT00612586|20894477|P2|STARTED|Overall Study||59
8478832|NCT00612586|20894478|P1|STARTED|Overall Study||58
8478833|NCT00612573|20894496|P4|NOT COMPLETED|Overall Study||13
8478834|NCT00612573|20894497|P3|NOT COMPLETED|Overall Study||9
8478835|NCT00612573|20894498|P2|NOT COMPLETED|Overall Study||14
8478836|NCT00612573|20894499|P1|NOT COMPLETED|Overall Study||12
8478837|NCT00612573|20894496|P4|COMPLETED|Overall Study||54
8478838|NCT00612573|20894497|P3|COMPLETED|Overall Study||52
8478839|NCT00612573|20894498|P2|COMPLETED|Overall Study||51
8478840|NCT00612573|20894499|P1|COMPLETED|Overall Study||52
8478841|NCT00612573|20894496|P4|STARTED|Overall Study||67
8478842|NCT00612573|20894497|P3|STARTED|Overall Study||61
8478843|NCT00612573|20894498|P2|STARTED|Overall Study||65
8478844|NCT00612573|20894499|P1|STARTED|Overall Study||64
8478845|NCT00612560|20894525|P4|NOT COMPLETED|Overall Study||0
8478846|NCT00612560|20894526|P3|NOT COMPLETED|Overall Study||0
8478847|NCT00612560|20894527|P2|NOT COMPLETED|Overall Study||0
8478848|NCT00612560|20894528|P1|NOT COMPLETED|Overall Study||0
8478849|NCT00612560|20894525|P4|COMPLETED|Overall Study||6
8478850|NCT00612560|20894526|P3|COMPLETED|Overall Study||8
8478851|NCT00612560|20894527|P2|COMPLETED|Overall Study||7
8478852|NCT00612560|20894528|P1|COMPLETED|Overall Study||7
8478853|NCT00612560|20894525|P4|STARTED|Overall Study||6
8478854|NCT00612560|20894526|P3|STARTED|Overall Study||8
8478855|NCT00612560|20894527|P2|STARTED|Overall Study||7
8478856|NCT00612560|20894528|P1|STARTED|Overall Study||7
8478857|NCT00612534|20894554|P4|NOT COMPLETED|Overall Study||17
8478858|NCT00612534|20894555|P3|NOT COMPLETED|Overall Study||7
8478859|NCT00612534|20894556|P2|NOT COMPLETED|Overall Study||17
8478860|NCT00612534|20894557|P1|NOT COMPLETED|Overall Study||13
8478861|NCT00612534|20894554|P4|COMPLETED|Overall Study||7
8478862|NCT00612534|20894555|P3|COMPLETED|Overall Study||13
8478863|NCT00612534|20894556|P2|COMPLETED|Overall Study||9
8478864|NCT00612534|20894557|P1|COMPLETED|Overall Study||11
8478865|NCT00612534|20894554|P4|STARTED|Overall Study||24
8478866|NCT00612534|20894555|P3|STARTED|Overall Study||20
8478867|NCT00612534|20894556|P2|STARTED|Overall Study||26
8478868|NCT00612534|20894557|P1|STARTED|Overall Study||24
8478869|NCT00612508|20894569|P2|NOT COMPLETED|Overall Study||4
8478870|NCT00612508|20894570|P1|NOT COMPLETED|Overall Study||3
8478871|NCT00612508|20894569|P2|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
8478872|NCT00612508|20894570|P1|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
8478873|NCT00612508|20894569|P2|STARTED|Overall Study||7
8478874|NCT00612508|20894570|P1|STARTED|Overall Study||7
8478875|NCT00612456|20894581|P3|NOT COMPLETED|Overall Study||0
8478876|NCT00612456|20894582|P2|NOT COMPLETED|Overall Study||2
8478877|NCT00612456|20894583|P1|NOT COMPLETED|Overall Study||2
8478878|NCT00612456|20894581|P3|COMPLETED|Overall Study||16
8478879|NCT00612456|20894582|P2|COMPLETED|Overall Study||25
8478880|NCT00612456|20894583|P1|COMPLETED|Overall Study||25
8478881|NCT00612456|20894581|P3|STARTED|Overall Study||16
8478882|NCT00612456|20894582|P2|STARTED|Overall Study||27
8478883|NCT00612456|20894583|P1|STARTED|Overall Study||27
8478884|NCT00612430|20894629|P2|NOT COMPLETED|Overall Study||0
8478885|NCT00612430|20894630|P1|NOT COMPLETED|Overall Study||0
8478886|NCT00612430|20894629|P2|COMPLETED|Overall Study||27
8478887|NCT00612430|20894630|P1|COMPLETED|Overall Study||32
8478888|NCT00612430|20894629|P2|STARTED|Overall Study||27
8478889|NCT00612430|20894630|P1|STARTED|Overall Study||32
8478890|NCT00612352|20894646|P2|NOT COMPLETED|Overall Study||6
8478891|NCT00612352|20894647|P1|NOT COMPLETED|Overall Study||9
8478892|NCT00612352|20894646|P2|COMPLETED|Overall Study||109
8478893|NCT00612352|20894647|P1|COMPLETED|Overall Study||56
8478894|NCT00612352|20894646|P2|Placebo|Overall Study||4
8478895|NCT00612352|20894647|P1|Placebo|Overall Study||4
8478896|NCT00612352|20894646|P2|40%mg|Overall Study||0
8478897|NCT00612352|20894647|P1|40%mg|Overall Study||1
8478898|NCT00612352|20894646|P2|100%mg|Overall Study||1
8478899|NCT00612352|20894647|P1|100%mg|Overall Study||2
8478900|NCT00612352|20894646|P2|Placebo & 100%mg|Overall Study||0
8478901|NCT00612352|20894647|P1|Placebo & 100%mg|Overall Study||1
8478902|NCT00612352|20894646|P2|40%mg & 100%mg|Overall Study||1
8478903|NCT00612352|20894647|P1|40%mg & 100%mg|Overall Study||1
8478904|NCT00612352|20894646|P2|STARTED|Overall Study||115
8478905|NCT00612352|20894647|P1|STARTED|Overall Study||65
8478906|NCT00612339|20894761|P1|NOT COMPLETED|Overall Study||0
8478907|NCT00612339|20894761|P1|COMPLETED|Overall Study||41
8478908|NCT00612339|20894761|P1|STARTED|Overall Study||41
8478909|NCT00612313|20894767|P2|NOT COMPLETED|Overall Study||13
8478910|NCT00612313|20894768|P1|NOT COMPLETED|Overall Study||17
8478911|NCT00612313|20894767|P2|COMPLETED|Overall Study||62
8478912|NCT00612313|20894768|P1|COMPLETED|Overall Study||52
8478913|NCT00612313|20894767|P2|STARTED|Overall Study||75
8478914|NCT00612313|20894768|P1|STARTED|Overall Study||69
8478915|NCT00612235|20894788|P4|NOT COMPLETED|Overall Study||0
8478916|NCT00612235|20894789|P3|NOT COMPLETED|Overall Study||0
8478917|NCT00612235|20894790|P2|NOT COMPLETED|Overall Study||0
8478918|NCT00612235|20894791|P1|NOT COMPLETED|Overall Study||0
8478919|NCT00612235|20894788|P4|COMPLETED|Overall Study||20
8478920|NCT00612235|20894789|P3|COMPLETED|Overall Study||20
8478921|NCT00612235|20894790|P2|COMPLETED|Overall Study||20
8478922|NCT00612235|20894791|P1|COMPLETED|Overall Study||20
8478923|NCT00612235|20894788|P4|STARTED|Overall Study||20
8478924|NCT00612235|20894789|P3|STARTED|Overall Study||20
8478925|NCT00612235|20894790|P2|STARTED|Overall Study||20
8478926|NCT00612235|20894791|P1|STARTED|Overall Study||20
8478927|NCT00612222|20894802|P1|NOT COMPLETED|Overall Study||0
8478928|NCT00612222|20894802|P1|COMPLETED|Overall Study||4
8478929|NCT00612222|20894802|P1|STARTED|Overall Study||4
8478930|NCT00612105|20894810|P2|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
8478931|NCT00612105|20894811|P1|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
8478932|NCT00612105|20894810|P2|COMPLETED|Period Title 3: 3-Week Taper Phase||58
8478933|NCT00612105|20894811|P1|COMPLETED|Period Title 3: 3-Week Taper Phase||85
8478934|NCT00612105|20894810|P2|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
8478935|NCT00612105|20894811|P1|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
8478936|NCT00612105|20894810|P2|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
8478937|NCT00612105|20894811|P1|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
8478938|NCT00612105|20894810|P2|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
8478939|NCT00612105|20894811|P1|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
8478940|NCT00612105|20894810|P2|STARTED|Period Title 2: 4-Week Maintenance Phase||57
8478941|NCT00612105|20894811|P1|STARTED|Period Title 2: 4-Week Maintenance Phase||89
8478942|NCT00612105|20894810|P2|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
8478943|NCT00612105|20894811|P1|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
8478944|NCT00612105|20894810|P2|COMPLETED|Period Title 1: 6-Week Titration Phase||57
8478945|NCT00612105|20894811|P1|COMPLETED|Period Title 1: 6-Week Titration Phase||89
8478946|NCT00612105|20894810|P2|STARTED|Period Title 1: 6-Week Titration Phase||62
8478947|NCT00612105|20894811|P1|STARTED|Period Title 1: 6-Week Titration Phase||125
8478948|NCT00612066|20894861|P1|NOT COMPLETED|Overall Study||1
8478949|NCT00612066|20894861|P1|COMPLETED|Overall Study||1
8478950|NCT00612066|20894861|P1|STARTED|Overall Study||2
8478951|NCT00612040|20894868|P3|NOT COMPLETED|Overall Study||7
8478952|NCT00612040|20894869|P2|NOT COMPLETED|Overall Study||7
8478953|NCT00612040|20894870|P1|NOT COMPLETED|Overall Study||5
8478954|NCT00612040|20894868|P3|COMPLETED|Overall Study||52
8478955|NCT00612040|20894869|P2|COMPLETED|Overall Study||52
8478956|NCT00612040|20894870|P1|COMPLETED|Overall Study||55
8478957|NCT00612040|20894868|P3|Exposed|Overall Study||59
8478958|NCT00612040|20894869|P2|Exposed|Overall Study||59
8478959|NCT00612040|20894870|P1|Exposed|Overall Study||60
8478960|NCT00612040|20894868|P3|STARTED|Overall Study||59
8478961|NCT00612040|20894869|P2|STARTED|Overall Study||59
8478962|NCT00612040|20894870|P1|STARTED|Overall Study||60
8478963|NCT00611975|20894916|P2|NOT COMPLETED|Overall Study||8
8478964|NCT00611975|20894917|P1|NOT COMPLETED|Overall Study||5
8478965|NCT00611975|20894916|P2|COMPLETED|Overall Study||30
8478966|NCT00611975|20894917|P1|COMPLETED|Overall Study||40
8478967|NCT00611975|20894916|P2|STARTED|Overall Study||38
8478968|NCT00611975|20894917|P1|STARTED|Overall Study||45
8478969|NCT00611923|20894945|P2|NOT COMPLETED|Overall Study||2
8478970|NCT00611923|20894946|P1|NOT COMPLETED|Overall Study||2
8478971|NCT00611923|20894945|P2|COMPLETED|Overall Study||11
8478972|NCT00611923|20894946|P1|COMPLETED|Overall Study||10
8478973|NCT00611923|20894945|P2|STARTED|Overall Study||13
8478974|NCT00611923|20894946|P1|STARTED|Overall Study||12
8478975|NCT00611897|20894962|P2|NOT COMPLETED|Day 2: Crossover Treatment||0
8478976|NCT00611897|20894963|P1|NOT COMPLETED|Day 2: Crossover Treatment||0
8478977|NCT00611897|20894962|P2|COMPLETED|Day 2: Crossover Treatment||8
8478978|NCT00611897|20894963|P1|COMPLETED|Day 2: Crossover Treatment||8
8478979|NCT00611897|20894962|P2|STARTED|Day 2: Crossover Treatment||8
8478980|NCT00611897|20894963|P1|STARTED|Day 2: Crossover Treatment||8
8478981|NCT00611897|20894962|P2|NOT COMPLETED|Day 1: Initial Treatment||0
8478982|NCT00611897|20894963|P1|NOT COMPLETED|Day 1: Initial Treatment||0
8478983|NCT00611897|20894962|P2|COMPLETED|Day 1: Initial Treatment||8
8478984|NCT00611897|20894963|P1|COMPLETED|Day 1: Initial Treatment||8
8478985|NCT00611897|20894962|P2|STARTED|Day 1: Initial Treatment||8
8478986|NCT00611897|20894963|P1|STARTED|Day 1: Initial Treatment||8
8478987|NCT00611884|20894991|P4|NOT COMPLETED|Overall Study||6
8478988|NCT00611884|20894992|P3|NOT COMPLETED|Overall Study||4
8478989|NCT00611884|20894993|P2|NOT COMPLETED|Overall Study||9
8478990|NCT00611884|20894994|P1|NOT COMPLETED|Overall Study||9
8478991|NCT00611884|20894991|P4|COMPLETED|Overall Study||56
8478992|NCT00611884|20894992|P3|COMPLETED|Overall Study||58
8478993|NCT00611884|20894993|P2|COMPLETED|Overall Study||51
8478994|NCT00611884|20894994|P1|COMPLETED|Overall Study||52
8478995|NCT00611884|20894991|P4|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
8478996|NCT00611884|20894992|P3|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
8478997|NCT00611884|20894993|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
8478998|NCT00611884|20894994|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
8478999|NCT00611884|20894991|P4|STARTED|Overall Study||62
8479000|NCT00611884|20894992|P3|STARTED|Overall Study||62
8479001|NCT00611884|20894993|P2|STARTED|Overall Study||60
8479002|NCT00611884|20894994|P1|STARTED|Overall Study||61
8479003|NCT00611858|20895048|P1|NOT COMPLETED|Overall Study||4
8479004|NCT00611858|20895048|P1|COMPLETED|Overall Study||9
8479005|NCT00611858|20895048|P1|STARTED|Overall Study||13
8479006|NCT00611806|20895060|P2|NOT COMPLETED|Overall Study||3
8479007|NCT00611806|20895061|P1|NOT COMPLETED|Overall Study||16
8479008|NCT00611806|20895060|P2|COMPLETED|Overall Study||43
8479009|NCT00611806|20895061|P1|COMPLETED|Overall Study||78
8479010|NCT00611806|20895060|P2|STARTED|Overall Study||46
8479011|NCT00611806|20895061|P1|STARTED|Overall Study||94
8479012|NCT00611767|20895075|P2|NOT COMPLETED|Overall Study||2
8479013|NCT00611767|20895076|P1|NOT COMPLETED|Overall Study||9
8479014|NCT00611767|20895075|P2|COMPLETED|Overall Study||22
8479015|NCT00611767|20895076|P1|COMPLETED|Overall Study||40
8479016|NCT00611767|20895075|P2|Placebo Test Day|Overall Study||1
8479017|NCT00611767|20895076|P1|Placebo Test Day|Overall Study||6
8479018|NCT00611767|20895075|P2|Thiopental Test Day|Overall Study||1
8479019|NCT00611767|20895076|P1|Thiopental Test Day|Overall Study||3
8479020|NCT00611767|20895075|P2|STARTED|Overall Study||24
8479021|NCT00611767|20895076|P1|STARTED|Overall Study||49
8479022|NCT00611715|20895238|P2|NOT COMPLETED|Overall Study||6
8479023|NCT00611715|20895239|P1|NOT COMPLETED|Overall Study||41
8479024|NCT00611715|20895238|P2|COMPLETED|Overall Study||0
8479025|NCT00611715|20895239|P1|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
8479026|NCT00611715|20895238|P2|STARTED|Overall Study||6
8479027|NCT00611715|20895239|P1|STARTED|Overall Study||42
8479028|NCT00611624|20895251|P1|NOT COMPLETED|Overall Study||0
8479029|NCT00611624|20895251|P1|COMPLETED|Overall Study||28
8479030|NCT00611624|20895251|P1|STARTED|Overall Study||28
8479031|NCT00611559|20895259|P3|NOT COMPLETED|Overall Study||1
8479032|NCT00611559|20895260|P2|NOT COMPLETED|Overall Study||1
8479033|NCT00611559|20895261|P1|NOT COMPLETED|Overall Study||1
8479034|NCT00611559|20895259|P3|COMPLETED|Overall Study||56
8479035|NCT00611559|20895260|P2|COMPLETED|Overall Study||114
8479036|NCT00611559|20895261|P1|COMPLETED|Overall Study||110
8479037|NCT00611559|20895259|P3|STARTED|Overall Study||57
8479038|NCT00611559|20895260|P2|STARTED|Overall Study||115
8479039|NCT00611559|20895261|P1|STARTED|Overall Study||111
8479040|NCT00611533|20895320|P2|NOT COMPLETED|Second Intervention (6 Weeks)||2
8479041|NCT00611533|20895321|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8479042|NCT00611533|20895320|P2|COMPLETED|Second Intervention (6 Weeks)||4
8479043|NCT00611533|20895321|P1|COMPLETED|Second Intervention (6 Weeks)||8
8479044|NCT00611533|20895320|P2|STARTED|Second Intervention (6 Weeks)||6
8479045|NCT00611533|20895321|P1|STARTED|Second Intervention (6 Weeks)||8
8479046|NCT00611533|20895320|P2|NOT COMPLETED|First Intervention (6 Weeks)||2
8479047|NCT00611533|20895321|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
8479048|NCT00611533|20895320|P2|COMPLETED|First Intervention (6 Weeks)||6
8479049|NCT00611533|20895321|P1|COMPLETED|First Intervention (6 Weeks)||8
8479050|NCT00611533|20895320|P2|STARTED|First Intervention (6 Weeks)||8
8479051|NCT00611533|20895321|P1|STARTED|First Intervention (6 Weeks)||8
8479052|NCT00611468|20895340|P4|NOT COMPLETED|Overall Study||0
8479053|NCT00611468|20895341|P3|NOT COMPLETED|Overall Study||0
8479054|NCT00611468|20895342|P2|NOT COMPLETED|Overall Study||1
8479055|NCT00611468|20895343|P1|NOT COMPLETED|Overall Study||0
8479056|NCT00611468|20895340|P4|COMPLETED|Overall Study||13
8479057|NCT00611468|20895341|P3|COMPLETED|Overall Study||6
8479058|NCT00611468|20895342|P2|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
8479059|NCT00611468|20895343|P1|COMPLETED|Overall Study||3
8479060|NCT00611468|20895340|P4|STARTED|Overall Study||13
8479061|NCT00611468|20895341|P3|STARTED|Overall Study||6
8479062|NCT00611468|20895342|P2|STARTED|Overall Study||7
8479063|NCT00611468|20895343|P1|STARTED|Overall Study||3
8479064|NCT00611455|20895355|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
8479065|NCT00611455|20895356|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
8479066|NCT00611455|20895357|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
8479067|NCT00611455|20895355|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||49
8479068|NCT00611455|20895356|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
8479069|NCT00611455|20895357|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
8479070|NCT00611455|20895355|P3|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
8479071|NCT00611455|20895356|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
8479072|NCT00611455|20895357|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
8479073|NCT00611455|20895355|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
8479074|NCT00611455|20895356|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
8479075|NCT00611455|20895357|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
8479076|NCT00611455|20895355|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
8479077|NCT00611455|20895356|P2|COMPLETED|OL Treatment Period (120 Weeks)||52
8479078|NCT00611455|20895357|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
8479079|NCT00611455|20895355|P3|STARTED|OL Treatment Period (120 Weeks)||0
8479080|NCT00611455|20895356|P2|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
8479081|NCT00611455|20895357|P1|STARTED|OL Treatment Period (120 Weeks)||0
8479082|NCT00611455|20895355|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
8479083|NCT00611455|20895356|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
8479084|NCT00611455|20895357|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
8479085|NCT00611455|20895355|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
8479086|NCT00611455|20895356|P2|COMPLETED|DB Treatment Period (24 Weeks)||117
8479087|NCT00611455|20895357|P1|COMPLETED|DB Treatment Period (24 Weeks)||121
8479088|NCT00611455|20895355|P3|STARTED|DB Treatment Period (24 Weeks)||0
8479089|NCT00611455|20895356|P2|STARTED|DB Treatment Period (24 Weeks)||131
8479090|NCT00611455|20895357|P1|STARTED|DB Treatment Period (24 Weeks)||134
8479091|NCT00611442|20895485|P2|NOT COMPLETED|Overall Study||2
8479092|NCT00611442|20895486|P1|NOT COMPLETED|Overall Study||1
8479093|NCT00611442|20895485|P2|COMPLETED|Overall Study||94
8479094|NCT00611442|20895486|P1|COMPLETED|Overall Study||94
8479095|NCT00611442|20895485|P2|STARTED|Overall Study||96
8479096|NCT00611442|20895486|P1|STARTED|Overall Study||95
8479097|NCT00611403|20895500|P2|NOT COMPLETED|Post Treatment Extension Phase||1
8479098|NCT00611403|20895501|P1|NOT COMPLETED|Post Treatment Extension Phase||4
8479099|NCT00611403|20895500|P2|COMPLETED|Post Treatment Extension Phase||24
8479100|NCT00611403|20895501|P1|COMPLETED|Post Treatment Extension Phase||22
8479101|NCT00611403|20895500|P2|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
8479102|NCT00611403|20895501|P1|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
8479103|NCT00611403|20895500|P2|NOT COMPLETED|Treatment Phase||11
8479104|NCT00611403|20895501|P1|NOT COMPLETED|Treatment Phase||6
8479105|NCT00611403|20895500|P2|COMPLETED|Treatment Phase||58
8479106|NCT00611403|20895501|P1|COMPLETED|Treatment Phase||62
8479107|NCT00611403|20895500|P2|STARTED|Treatment Phase||69
8479108|NCT00611403|20895501|P1|STARTED|Treatment Phase||68
8479109|NCT00611351|20895511|P1|NOT COMPLETED|Overall Study||2
8479110|NCT00611351|20895511|P1|COMPLETED|Overall Study||3
8479111|NCT00611351|20895511|P1|STARTED|Overall Study||5
8479112|NCT00611325|20895520|P2|NOT COMPLETED|Overall Study||0
8479113|NCT00611325|20895521|P1|NOT COMPLETED|Overall Study||0
8479114|NCT00611325|20895520|P2|COMPLETED|Overall Study||28
8479115|NCT00611325|20895521|P1|COMPLETED|Overall Study||28
8479116|NCT00611325|20895520|P2|STARTED|Overall Study||28
8479117|NCT00611325|20895521|P1|STARTED|Overall Study||28
8479118|NCT00611247|20895537|P2|NOT COMPLETED|Overall Study||21
8479119|NCT00611247|20895538|P1|NOT COMPLETED|Overall Study||2
8479120|NCT00611247|20895537|P2|COMPLETED|Overall Study||10
8479121|NCT00611247|20895538|P1|COMPLETED|Overall Study||3
8479122|NCT00611247|20895537|P2|STARTED|Overall Study||31
8479123|NCT00611247|20895538|P1|STARTED|Overall Study||5
8479124|NCT00611130|20895550|P2|NOT COMPLETED|Overall Study||47
8479125|NCT00611130|20895551|P1|NOT COMPLETED|Overall Study||49
8479126|NCT00611130|20895550|P2|COMPLETED|Overall Study||47
8479127|NCT00611130|20895551|P1|COMPLETED|Overall Study||43
8479128|NCT00611130|20895550|P2|Completed 12 Week Treatment Phase|Overall Study||64
8479129|NCT00611130|20895551|P1|Completed 12 Week Treatment Phase|Overall Study||61
8479130|NCT00611130|20895550|P2|STARTED|Overall Study||94
8479131|NCT00611130|20895551|P1|STARTED|Overall Study||92
8479132|NCT00611026|20895561|P3|NOT COMPLETED|Double-blind Treatment Period||98
8479133|NCT00611026|20895562|P2|NOT COMPLETED|Double-blind Treatment Period||88
8479134|NCT00611026|20895563|P1|NOT COMPLETED|Double-blind Treatment Period||47
8479135|NCT00611026|20895561|P3|COMPLETED|Double-blind Treatment Period||862
8479136|NCT00611026|20895562|P2|COMPLETED|Double-blind Treatment Period||885
8479137|NCT00611026|20895563|P1|COMPLETED|Double-blind Treatment Period||431
8479138|NCT00611026|20895561|P3|STARTED|Double-blind Treatment Period||960
8479139|NCT00611026|20895562|P2|STARTED|Double-blind Treatment Period||973
8479140|NCT00611026|20895563|P1|STARTED|Double-blind Treatment Period||478
8479141|NCT00611026|20895561|P3|NOT COMPLETED|Randomized to Double-blind Treatment||3
8479142|NCT00611026|20895562|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
8479143|NCT00611026|20895563|P1|NOT COMPLETED|Randomized to Double-blind Treatment||2
8479144|NCT00611026|20895561|P3|COMPLETED|Randomized to Double-blind Treatment||960
8479145|NCT00611026|20895562|P2|COMPLETED|Randomized to Double-blind Treatment||973
8479146|NCT00611026|20895563|P1|COMPLETED|Randomized to Double-blind Treatment||478
8479147|NCT00611026|20895561|P3|STARTED|Randomized to Double-blind Treatment||963
8479148|NCT00611026|20895562|P2|STARTED|Randomized to Double-blind Treatment||974
8479149|NCT00611026|20895563|P1|STARTED|Randomized to Double-blind Treatment||480
8479150|NCT00610987|20895629|P2|NOT COMPLETED|Overall Study||0
8479151|NCT00610987|20895630|P1|NOT COMPLETED|Overall Study||0
8479152|NCT00610987|20895629|P2|COMPLETED|Overall Study||71
8479153|NCT00610987|20895630|P1|COMPLETED|Overall Study||75
8479154|NCT00610987|20895629|P2|STARTED|Overall Study||71
8479155|NCT00610987|20895630|P1|STARTED|Overall Study||75
8479156|NCT00610883|20895636|P1|NOT COMPLETED|Overall Study||0
8479157|NCT00610883|20895636|P1|COMPLETED|Overall Study||17
8479158|NCT00610883|20895636|P1|STARTED|Overall Study||17
8479159|NCT00610857|20895640|P1|NOT COMPLETED|Overall Study||2
8479160|NCT00610857|20895640|P1|COMPLETED|Overall Study||35
8479161|NCT00610857|20895640|P1|STARTED|Overall Study||37
8479162|NCT00610740|20895647|P1|NOT COMPLETED|Overall Study||0
8479163|NCT00610740|20895647|P1|COMPLETED|Overall Study||18
8479164|NCT00610740|20895647|P1|STARTED|Overall Study||18
8479165|NCT00610727|20895659|P6|NOT COMPLETED|Overall Study||0
8479166|NCT00610727|20895660|P5|NOT COMPLETED|Overall Study||0
8479167|NCT00610727|20895661|P4|NOT COMPLETED|Overall Study||0
8479168|NCT00610727|20895662|P3|NOT COMPLETED|Overall Study||0
8479169|NCT00610727|20895663|P2|NOT COMPLETED|Overall Study||0
8479170|NCT00610727|20895664|P1|NOT COMPLETED|Overall Study||0
8479171|NCT00610727|20895659|P6|COMPLETED|Overall Study||8
8479172|NCT00610727|20895660|P5|COMPLETED|Overall Study||8
8479173|NCT00610727|20895661|P4|COMPLETED|Overall Study||8
8479174|NCT00610727|20895662|P3|COMPLETED|Overall Study||8
8479175|NCT00610727|20895663|P2|COMPLETED|Overall Study||8
8479176|NCT00610727|20895664|P1|COMPLETED|Overall Study||14
8479177|NCT00610727|20895659|P6|STARTED|Overall Study||8
8479178|NCT00610727|20895660|P5|STARTED|Overall Study||8
8479179|NCT00610727|20895661|P4|STARTED|Overall Study||8
8479180|NCT00610727|20895662|P3|STARTED|Overall Study||8
8479181|NCT00610727|20895663|P2|STARTED|Overall Study||8
8479182|NCT00610727|20895664|P1|STARTED|Overall Study||14
8479183|NCT00610714|20895684|P2|NOT COMPLETED|Overall Study||24
8479184|NCT00610714|20895685|P1|NOT COMPLETED|Overall Study||26
8479185|NCT00610714|20895684|P2|COMPLETED|Overall Study||82
8479186|NCT00610714|20895685|P1|COMPLETED|Overall Study||79
8479187|NCT00610714|20895684|P2|STARTED|Overall Study||106
8479188|NCT00610714|20895685|P1|STARTED|Overall Study||105
8479189|NCT00610701|20895697|P2|NOT COMPLETED|Overall Study||11
8479190|NCT00610701|20895698|P1|NOT COMPLETED|Overall Study||10
8479191|NCT00610701|20895697|P2|COMPLETED|Overall Study||9
8479192|NCT00610701|20895698|P1|COMPLETED|Overall Study||5
8479193|NCT00610701|20895697|P2|STARTED|Overall Study||20
8479194|NCT00610701|20895698|P1|STARTED|Overall Study||15
8479195|NCT00610688|20895707|P3|NOT COMPLETED|Overall Study||8
8479196|NCT00610688|20895708|P2|NOT COMPLETED|Overall Study||13
8479197|NCT00610688|20895709|P1|NOT COMPLETED|Overall Study||9
8479198|NCT00610688|20895707|P3|COMPLETED|Overall Study||55
8479199|NCT00610688|20895708|P2|COMPLETED|Overall Study||52
8479200|NCT00610688|20895709|P1|COMPLETED|Overall Study||55
8479201|NCT00610688|20895707|P3|STARTED|Overall Study||63
8479202|NCT00610688|20895708|P2|STARTED|Overall Study||65
8479203|NCT00610688|20895709|P1|STARTED|Overall Study||64
8479204|NCT00610675|20895723|P1|NOT COMPLETED|Overall Study||220
8479205|NCT00610675|20895723|P1|COMPLETED|Overall Study||126
8479206|NCT00610675|20895723|P1|Treated|Overall Study||342
8479207|NCT00610675|20895723|P1|STARTED|Overall Study||346
8479208|NCT00610649|20895745|P11|NOT COMPLETED|Overall Study||1
8479209|NCT00610649|20895746|P10|NOT COMPLETED|Overall Study||1
8479210|NCT00610649|20895747|P9|NOT COMPLETED|Overall Study||0
8479211|NCT00610649|20895748|P8|NOT COMPLETED|Overall Study||0
8479212|NCT00610649|20895749|P7|NOT COMPLETED|Overall Study||0
8479213|NCT00610649|20895750|P6|NOT COMPLETED|Overall Study||0
8479214|NCT00610649|20895751|P5|NOT COMPLETED|Overall Study||0
8479215|NCT00610649|20895752|P4|NOT COMPLETED|Overall Study||0
8479216|NCT00610649|20895753|P3|NOT COMPLETED|Overall Study||0
8479217|NCT00610649|20895754|P2|NOT COMPLETED|Overall Study||1
8479218|NCT00610649|20895755|P1|NOT COMPLETED|Overall Study||1
8479219|NCT00610649|20895745|P11|COMPLETED|Overall Study||9
8479220|NCT00610649|20895746|P10|COMPLETED|Overall Study||9
8479221|NCT00610649|20895747|P9|COMPLETED|Overall Study||10
8479222|NCT00610649|20895748|P8|COMPLETED|Overall Study||2
8479223|NCT00610649|20895749|P7|COMPLETED|Overall Study||4
8479224|NCT00610649|20895750|P6|COMPLETED|Overall Study||2
8479225|NCT00610649|20895751|P5|COMPLETED|Overall Study||4
8479226|NCT00610649|20895752|P4|COMPLETED|Overall Study||2
8479227|NCT00610649|20895753|P3|COMPLETED|Overall Study||4
8479228|NCT00610649|20895754|P2|COMPLETED|Overall Study||1
8479229|NCT00610649|20895755|P1|COMPLETED|Overall Study||3
8479230|NCT00610649|20895745|P11|STARTED|Overall Study||10
8479231|NCT00610649|20895746|P10|STARTED|Overall Study||10
8479232|NCT00610649|20895747|P9|STARTED|Overall Study||10
8479233|NCT00610649|20895748|P8|STARTED|Overall Study||2
8479234|NCT00610649|20895749|P7|STARTED|Overall Study||4
8479235|NCT00610649|20895750|P6|STARTED|Overall Study||2
8479236|NCT00610649|20895751|P5|STARTED|Overall Study||4
8479237|NCT00610649|20895752|P4|STARTED|Overall Study||2
8479238|NCT00610649|20895753|P3|STARTED|Overall Study||4
8479239|NCT00610649|20895754|P2|STARTED|Overall Study||2
8479240|NCT00610649|20895755|P1|STARTED|Overall Study||4
8479241|NCT00610558|20895812|P3|NOT COMPLETED|Overall Study||6
8479242|NCT00610558|20895813|P2|NOT COMPLETED|Overall Study||6
8479243|NCT00610558|20895814|P1|NOT COMPLETED|Overall Study||5
8479244|NCT00610558|20895812|P3|COMPLETED|Overall Study||14
8479245|NCT00610558|20895813|P2|COMPLETED|Overall Study||14
8479246|NCT00610558|20895814|P1|COMPLETED|Overall Study||15
8479247|NCT00610558|20895812|P3|STARTED|Overall Study||20
8479248|NCT00610558|20895813|P2|STARTED|Overall Study||20
8479249|NCT00610558|20895814|P1|STARTED|Overall Study||20
8479250|NCT00610532|20895822|P1|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
8479251|NCT00610532|20895822|P1|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
8479252|NCT00610532|20895822|P1|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
8479253|NCT00610532|20895822|P1|NOT COMPLETED|Intravenous Phenytoin Alone||0
8479254|NCT00610532|20895822|P1|COMPLETED|Intravenous Phenytoin Alone||8
8479255|NCT00610532|20895822|P1|STARTED|Intravenous Phenytoin Alone||8
8479256|NCT00610480|20895830|P2|NOT COMPLETED|Overall Study||0
8479257|NCT00610480|20895831|P1|NOT COMPLETED|Overall Study||0
8479258|NCT00610480|20895830|P2|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
8479259|NCT00610480|20895831|P1|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
8479260|NCT00610480|20895830|P2|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
8479261|NCT00610480|20895831|P1|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
8479262|NCT00610467|20895839|P2|NOT COMPLETED|Overall Study||0
8479263|NCT00610467|20895840|P1|NOT COMPLETED|Overall Study||0
8479264|NCT00610467|20895839|P2|COMPLETED|Overall Study||1
8479265|NCT00610467|20895840|P1|COMPLETED|Overall Study||1
8479266|NCT00610467|20895839|P2|STARTED|Overall Study||1
8479267|NCT00610467|20895840|P1|STARTED|Overall Study||1
8479268|NCT00610441|20895850|P4|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
8479269|NCT00610441|20895851|P3|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
8479270|NCT00610441|20895852|P2|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
8479271|NCT00610441|20895853|P1|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
8479272|NCT00610441|20895850|P4|COMPLETED|Treatment Period 2 - 3 Weeks||14
8479273|NCT00610441|20895851|P3|COMPLETED|Treatment Period 2 - 3 Weeks||9
8479274|NCT00610441|20895852|P2|COMPLETED|Treatment Period 2 - 3 Weeks||12
8479275|NCT00610441|20895853|P1|COMPLETED|Treatment Period 2 - 3 Weeks||10
8479276|NCT00610441|20895850|P4|STARTED|Treatment Period 2 - 3 Weeks||16
8479277|NCT00610441|20895851|P3|STARTED|Treatment Period 2 - 3 Weeks||9
8479278|NCT00610441|20895852|P2|STARTED|Treatment Period 2 - 3 Weeks||13
8479279|NCT00610441|20895853|P1|STARTED|Treatment Period 2 - 3 Weeks||12
8479280|NCT00610441|20895850|P4|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
8479281|NCT00610441|20895851|P3|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
8479282|NCT00610441|20895852|P2|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
8479283|NCT00610441|20895853|P1|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
8479284|NCT00610441|20895850|P4|COMPLETED|Placebo Washout Period - 2 Weeks||16
8479285|NCT00610441|20895851|P3|COMPLETED|Placebo Washout Period - 2 Weeks||9
8479286|NCT00610441|20895852|P2|COMPLETED|Placebo Washout Period - 2 Weeks||13
8479287|NCT00610441|20895853|P1|COMPLETED|Placebo Washout Period - 2 Weeks||12
8479288|NCT00610441|20895850|P4|STARTED|Placebo Washout Period - 2 Weeks||16
8479289|NCT00610441|20895851|P3|STARTED|Placebo Washout Period - 2 Weeks||11
8479290|NCT00610441|20895852|P2|STARTED|Placebo Washout Period - 2 Weeks||14
8479291|NCT00610441|20895853|P1|STARTED|Placebo Washout Period - 2 Weeks||12
8479292|NCT00610441|20895850|P4|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
8479293|NCT00610441|20895851|P3|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
8479294|NCT00610441|20895852|P2|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
8479295|NCT00610441|20895853|P1|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
8479296|NCT00610441|20895850|P4|COMPLETED|Treatment Period 1 - 3 Weeks||16
8479297|NCT00610441|20895851|P3|COMPLETED|Treatment Period 1 - 3 Weeks||11
8479298|NCT00610441|20895852|P2|COMPLETED|Treatment Period 1 - 3 Weeks||14
8479299|NCT00610441|20895853|P1|COMPLETED|Treatment Period 1 - 3 Weeks||12
8479300|NCT00610441|20895850|P4|STARTED|Treatment Period 1 - 3 Weeks||18
8479301|NCT00610441|20895851|P3|STARTED|Treatment Period 1 - 3 Weeks||18
8479302|NCT00610441|20895852|P2|STARTED|Treatment Period 1 - 3 Weeks||16
8479303|NCT00610441|20895853|P1|STARTED|Treatment Period 1 - 3 Weeks||15
8479304|NCT00610428|20895947|P3|NOT COMPLETED|Overall Study||2
8479305|NCT00610428|20895948|P2|NOT COMPLETED|Overall Study||1
8479306|NCT00610428|20895949|P1|NOT COMPLETED|Overall Study||0
8479307|NCT00610428|20895947|P3|COMPLETED|Overall Study||25
8479308|NCT00610428|20895948|P2|COMPLETED|Overall Study||23
8479309|NCT00610428|20895949|P1|COMPLETED|Overall Study||24
8479310|NCT00610428|20895947|P3|STARTED|Overall Study||27
8479311|NCT00610428|20895948|P2|STARTED|Overall Study||24
8479312|NCT00610428|20895949|P1|STARTED|Overall Study||24
8479313|NCT00610363|20895962|P2|NOT COMPLETED|Overall Study||3
8479314|NCT00610363|20895963|P1|NOT COMPLETED|Overall Study||11
8479315|NCT00610363|20895962|P2|COMPLETED|Overall Study||38
8479316|NCT00610363|20895963|P1|COMPLETED|Overall Study||31
8479317|NCT00610363|20895962|P2|STARTED|Overall Study||41
8479318|NCT00610363|20895963|P1|STARTED|Overall Study||42
8479319|NCT00610311|20895981|P1|NOT COMPLETED|Overall Study||0
8479320|NCT00610311|20895981|P1|COMPLETED|Overall Study||3
8479321|NCT00610311|20895981|P1|STARTED|Overall Study||3
8479322|NCT00610207|20895988|P1|NOT COMPLETED|Overall Study||3
8479323|NCT00610207|20895988|P1|COMPLETED|Overall Study||18
8479324|NCT00610207|20895988|P1|STARTED|Overall Study||21
8479325|NCT00610168|20895995|P2|NOT COMPLETED|Overall Study||0
8479326|NCT00610168|20895996|P1|NOT COMPLETED|Overall Study||2
8479327|NCT00610168|20895995|P2|COMPLETED|Overall Study||7
8479328|NCT00610168|20895996|P1|COMPLETED|Overall Study||73
8479329|NCT00610168|20895995|P2|STARTED|Overall Study||7
8479330|NCT00610168|20895996|P1|STARTED|Overall Study||75
8479331|NCT00610155|20896015|P6|NOT COMPLETED|Period 3||0
8479332|NCT00610155|20896016|P5|NOT COMPLETED|Period 3||0
8479333|NCT00610155|20896017|P4|NOT COMPLETED|Period 3||0
8479334|NCT00610155|20896018|P3|NOT COMPLETED|Period 3||0
8479335|NCT00610155|20896019|P2|NOT COMPLETED|Period 3||0
8479336|NCT00610155|20896020|P1|NOT COMPLETED|Period 3||1
8479337|NCT00610155|20896015|P6|COMPLETED|Period 3||1
8479338|NCT00610155|20896016|P5|COMPLETED|Period 3||3
8479339|NCT00610155|20896017|P4|COMPLETED|Period 3||3
8479340|NCT00610155|20896018|P3|COMPLETED|Period 3||3
8479341|NCT00610155|20896019|P2|COMPLETED|Period 3||3
8479342|NCT00610155|20896020|P1|COMPLETED|Period 3||3
8479343|NCT00610155|20896015|P6|STARTED|Period 3||1
8479344|NCT00610155|20896016|P5|STARTED|Period 3||3
8479345|NCT00610155|20896017|P4|STARTED|Period 3||3
8479346|NCT00610155|20896018|P3|STARTED|Period 3||3
8479347|NCT00610155|20896019|P2|STARTED|Period 3||3
8479348|NCT00610155|20896020|P1|STARTED|Period 3||4
8479349|NCT00610155|20896015|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8479350|NCT00610155|20896016|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8479351|NCT00610155|20896017|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8479352|NCT00610155|20896018|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8479353|NCT00610155|20896019|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8479354|NCT00610155|20896020|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8479355|NCT00610155|20896015|P6|COMPLETED|Washout Period 2 (7 Days)||1
8479356|NCT00610155|20896016|P5|COMPLETED|Washout Period 2 (7 Days)||3
8479357|NCT00610155|20896017|P4|COMPLETED|Washout Period 2 (7 Days)||3
8479358|NCT00610155|20896018|P3|COMPLETED|Washout Period 2 (7 Days)||3
8479359|NCT00610155|20896019|P2|COMPLETED|Washout Period 2 (7 Days)||3
8479360|NCT00610155|20896020|P1|COMPLETED|Washout Period 2 (7 Days)||4
8479361|NCT00610155|20896015|P6|STARTED|Washout Period 2 (7 Days)||1
8479362|NCT00610155|20896016|P5|STARTED|Washout Period 2 (7 Days)||3
8479363|NCT00610155|20896017|P4|STARTED|Washout Period 2 (7 Days)||3
8479364|NCT00610155|20896018|P3|STARTED|Washout Period 2 (7 Days)||3
8479365|NCT00610155|20896019|P2|STARTED|Washout Period 2 (7 Days)||3
8479366|NCT00610155|20896020|P1|STARTED|Washout Period 2 (7 Days)||4
8479367|NCT00610155|20896015|P6|NOT COMPLETED|Period 2||0
8479368|NCT00610155|20896016|P5|NOT COMPLETED|Period 2||0
8479369|NCT00610155|20896017|P4|NOT COMPLETED|Period 2||0
8479370|NCT00610155|20896018|P3|NOT COMPLETED|Period 2||0
8479371|NCT00610155|20896019|P2|NOT COMPLETED|Period 2||0
8479372|NCT00610155|20896020|P1|NOT COMPLETED|Period 2||0
8479373|NCT00610155|20896015|P6|COMPLETED|Period 2||1
8479374|NCT00610155|20896016|P5|COMPLETED|Period 2||3
8479375|NCT00610155|20896017|P4|COMPLETED|Period 2||3
8479376|NCT00610155|20896018|P3|COMPLETED|Period 2||3
8479377|NCT00610155|20896019|P2|COMPLETED|Period 2||3
8479378|NCT00610155|20896020|P1|COMPLETED|Period 2||4
8479379|NCT00610155|20896015|P6|STARTED|Period 2||1
8479380|NCT00610155|20896016|P5|STARTED|Period 2||3
8479381|NCT00610155|20896017|P4|STARTED|Period 2||3
8479382|NCT00610155|20896018|P3|STARTED|Period 2||3
8479383|NCT00610155|20896019|P2|STARTED|Period 2||3
8479384|NCT00610155|20896020|P1|STARTED|Period 2||4
8479385|NCT00610155|20896015|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
8479386|NCT00610155|20896016|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8479387|NCT00610155|20896017|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8479388|NCT00610155|20896018|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8479389|NCT00610155|20896019|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8479390|NCT00610155|20896020|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8479391|NCT00610155|20896015|P6|COMPLETED|Washout Period 1 (7 Days)||1
8479392|NCT00610155|20896016|P5|COMPLETED|Washout Period 1 (7 Days)||3
8479393|NCT00610155|20896017|P4|COMPLETED|Washout Period 1 (7 Days)||3
8479394|NCT00610155|20896018|P3|COMPLETED|Washout Period 1 (7 Days)||3
8479395|NCT00610155|20896019|P2|COMPLETED|Washout Period 1 (7 Days)||3
8479396|NCT00610155|20896020|P1|COMPLETED|Washout Period 1 (7 Days)||4
8479397|NCT00610155|20896015|P6|STARTED|Washout Period 1 (7 Days)||1
8479398|NCT00610155|20896016|P5|STARTED|Washout Period 1 (7 Days)||3
8479399|NCT00610155|20896017|P4|STARTED|Washout Period 1 (7 Days)||3
8479400|NCT00610155|20896018|P3|STARTED|Washout Period 1 (7 Days)||3
8479401|NCT00610155|20896019|P2|STARTED|Washout Period 1 (7 Days)||3
8479402|NCT00610155|20896020|P1|STARTED|Washout Period 1 (7 Days)||4
8479403|NCT00610155|20896015|P6|NOT COMPLETED|Period 1||0
8479404|NCT00610155|20896016|P5|NOT COMPLETED|Period 1||0
8479405|NCT00610155|20896017|P4|NOT COMPLETED|Period 1||0
8479406|NCT00610155|20896018|P3|NOT COMPLETED|Period 1||1
8479407|NCT00610155|20896019|P2|NOT COMPLETED|Period 1||0
8479408|NCT00610155|20896020|P1|NOT COMPLETED|Period 1||0
8479409|NCT00610155|20896015|P6|COMPLETED|Period 1||1
8479410|NCT00610155|20896016|P5|COMPLETED|Period 1||3
8479411|NCT00610155|20896017|P4|COMPLETED|Period 1||3
8479412|NCT00610155|20896018|P3|COMPLETED|Period 1||3
8479413|NCT00610155|20896019|P2|COMPLETED|Period 1||3
8479414|NCT00610155|20896020|P1|COMPLETED|Period 1||4
8479415|NCT00610155|20896015|P6|STARTED|Period 1||1
8479416|NCT00610155|20896016|P5|STARTED|Period 1||3
8479417|NCT00610155|20896017|P4|STARTED|Period 1||3
8479418|NCT00610155|20896018|P3|STARTED|Period 1||4
8479419|NCT00610155|20896019|P2|STARTED|Period 1||3
8479420|NCT00610155|20896020|P1|STARTED|Period 1||4
8479421|NCT00610129|20896067|P1|NOT COMPLETED|Overall Study||3
8479422|NCT00610129|20896067|P1|COMPLETED|Overall Study||25
8479423|NCT00610129|20896067|P1|STARTED|Overall Study||28
8479424|NCT00609986|20896073|P2|NOT COMPLETED|Overall Study||3
8479425|NCT00609986|20896074|P1|NOT COMPLETED|Overall Study||8
8479426|NCT00609986|20896073|P2|COMPLETED|Overall Study||49
8479427|NCT00609986|20896074|P1|COMPLETED|Overall Study||44
8479428|NCT00609986|20896073|P2|Received Transplant|Overall Study||49
8479429|NCT00609986|20896074|P1|Received Transplant|Overall Study||44
8479430|NCT00609986|20896073|P2|STARTED|Overall Study||52
8479431|NCT00609986|20896074|P1|STARTED|Overall Study||52
8479432|NCT00609973|20896088|P2|NOT COMPLETED|Overall Study||6
8479433|NCT00609973|20896089|P1|NOT COMPLETED|Overall Study||8
8479434|NCT00609973|20896088|P2|COMPLETED|Overall Study||10
8479435|NCT00609973|20896089|P1|COMPLETED|Overall Study||9
8479436|NCT00609973|20896088|P2|STARTED|Overall Study||16
8479437|NCT00609973|20896089|P1|STARTED|Overall Study||17
8479438|NCT00609947|20896097|P1|NOT COMPLETED|Overall Study||1
8479439|NCT00609947|20896097|P1|COMPLETED|Overall Study|One death due to automobile accident.|240
8479440|NCT00609947|20896097|P1|STARTED|Overall Study||241
8479441|NCT00609869|20896102|P1|NOT COMPLETED|Overall Study||11
8479442|NCT00609869|20896102|P1|COMPLETED|Overall Study||18
8479443|NCT00609869|20896102|P1|STARTED|Overall Study||29
8479444|NCT00609804|20896110|P2|NOT COMPLETED|Overall Study||28
8479445|NCT00609804|20896111|P1|NOT COMPLETED|Overall Study||25
8479446|NCT00609804|20896110|P2|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
8479447|NCT00609804|20896111|P1|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
8479448|NCT00609804|20896110|P2|STARTED|Overall Study||28
8479449|NCT00609804|20896111|P1|STARTED|Overall Study||25
8479450|NCT00609765|20896121|P1|NOT COMPLETED|Overall Study||1
8479451|NCT00609765|20896121|P1|COMPLETED|Overall Study||0
8479452|NCT00609765|20896121|P1|STARTED|Overall Study||1
8479453|NCT00609739|20896126|P1|NOT COMPLETED|Overall Study||0
8479454|NCT00609739|20896126|P1|COMPLETED|Overall Study||1
8479455|NCT00609739|20896126|P1|STARTED|Overall Study||1
8479456|NCT00609674|20896135|P2|NOT COMPLETED|Overall Study||7
8479457|NCT00609674|20896136|P1|NOT COMPLETED|Overall Study||7
8479458|NCT00609674|20896135|P2|COMPLETED|Overall Study||153
8479459|NCT00609674|20896136|P1|COMPLETED|Overall Study||148
8479460|NCT00609674|20896135|P2|STARTED|Overall Study||160
8479461|NCT00609674|20896136|P1|STARTED|Overall Study||155
8479462|NCT00609622|20896172|P2|NOT COMPLETED|Overall Study||95
8479463|NCT00609622|20896173|P1|NOT COMPLETED|Overall Study||96
8479464|NCT00609622|20896172|P2|COMPLETED|Overall Study||0
8479465|NCT00609622|20896173|P1|COMPLETED|Overall Study||0
8479466|NCT00609622|20896172|P2|STARTED|Overall Study||95
8479467|NCT00609622|20896173|P1|STARTED|Overall Study||96
8479468|NCT00609609|20896195|P2|NOT COMPLETED|Overall Study||2
8479469|NCT00609609|20896196|P1|NOT COMPLETED|Overall Study||6
8479470|NCT00609609|20896195|P2|COMPLETED|Overall Study||49
8479471|NCT00609609|20896196|P1|COMPLETED|Overall Study||24
8479472|NCT00609609|20896195|P2|STARTED|Overall Study||51
8479473|NCT00609609|20896196|P1|STARTED|Overall Study||30
8479474|NCT00609518|20896208|P2|NOT COMPLETED|Overall Study||40
8479475|NCT00609518|20896209|P1|NOT COMPLETED|Overall Study||43
8479476|NCT00609518|20896208|P2|COMPLETED|Overall Study||17
8479477|NCT00609518|20896209|P1|COMPLETED|Overall Study||11
8479478|NCT00609518|20896208|P2|Completed 6 Treatment Cycles|Overall Study||22
8479479|NCT00609518|20896209|P1|Completed 6 Treatment Cycles|Overall Study||19
8479480|NCT00609518|20896208|P2|STARTED|Overall Study||57
8479481|NCT00609518|20896209|P1|STARTED|Overall Study||54
8479482|NCT00609492|20896224|P3|NOT COMPLETED|Overall Study||7
8479483|NCT00609492|20896225|P2|NOT COMPLETED|Overall Study||3
8479484|NCT00609492|20896226|P1|NOT COMPLETED|Overall Study||1
8479485|NCT00609492|20896224|P3|COMPLETED|Overall Study||122
8479486|NCT00609492|20896225|P2|COMPLETED|Overall Study||69
8479487|NCT00609492|20896226|P1|COMPLETED|Overall Study||43
8479488|NCT00609492|20896224|P3|STARTED|Overall Study||129
8479489|NCT00609492|20896225|P2|STARTED|Overall Study||72
8479490|NCT00609492|20896226|P1|STARTED|Overall Study||44
8479491|NCT00609466|20896311|P3|NOT COMPLETED|Overall Study||4
8479492|NCT00609466|20896312|P2|NOT COMPLETED|Overall Study||6
8479493|NCT00609466|20896313|P1|NOT COMPLETED|Overall Study||2
8479494|NCT00609466|20896311|P3|COMPLETED|Overall Study||95
8479495|NCT00609466|20896312|P2|COMPLETED|Overall Study||90
8479496|NCT00609466|20896313|P1|COMPLETED|Overall Study||94
8479497|NCT00609466|20896311|P3|STARTED|Overall Study||99
8479498|NCT00609466|20896312|P2|STARTED|Overall Study||96
8479499|NCT00609466|20896313|P1|STARTED|Overall Study||96
8479500|NCT00609362|20896341|P2|NOT COMPLETED|Overall Study||1
8479501|NCT00609362|20896342|P1|NOT COMPLETED|Overall Study||3
8479502|NCT00609362|20896341|P2|COMPLETED|Overall Study||27
8479503|NCT00609362|20896342|P1|COMPLETED|Overall Study||26
8479504|NCT00609362|20896341|P2|STARTED|Overall Study||28
8479505|NCT00609362|20896342|P1|STARTED|Overall Study||29
8479506|NCT00609336|20896352|P1|NOT COMPLETED|Overall Study||13
8479507|NCT00609336|20896352|P1|COMPLETED|Overall Study||22
8479508|NCT00609336|20896352|P1|Surgery|Overall Study||22
8479509|NCT00609336|20896352|P1|STARTED|Overall Study||35
8479510|NCT00609271|20896366|P2|NOT COMPLETED|Overall Study||13
8479511|NCT00609271|20896367|P1|NOT COMPLETED|Overall Study||16
8479512|NCT00609271|20896366|P2|COMPLETED|Overall Study||60
8479513|NCT00609271|20896367|P1|COMPLETED|Overall Study||59
8479514|NCT00609271|20896366|P2|STARTED|Overall Study||73
8479515|NCT00609271|20896367|P1|STARTED|Overall Study||75
8479516|NCT00609245|20896403|P1|NOT COMPLETED|Overall Study||1
8479517|NCT00609245|20896403|P1|COMPLETED|Overall Study||12
8479518|NCT00609245|20896403|P1|STARTED|Overall Study||13
8479519|NCT00609167|20896411|P2|NOT COMPLETED|Overall Study||7
8479520|NCT00609167|20896412|P1|NOT COMPLETED|Overall Study||8
8479521|NCT00609167|20896411|P2|COMPLETED|Overall Study||23
8479522|NCT00609167|20896412|P1|COMPLETED|Overall Study||25
8479523|NCT00609167|20896411|P2|STARTED|Overall Study||30
8479524|NCT00609167|20896412|P1|STARTED|Overall Study||33
8479525|NCT00609128|20896434|P1|NOT COMPLETED|Overall Study||0
8479526|NCT00609128|20896434|P1|COMPLETED|Overall Study||21
8479527|NCT00609128|20896434|P1|STARTED|Overall Study||21
8479528|NCT00608985|20896443|P4|NOT COMPLETED|Overall Study||9
8479529|NCT00608985|20896444|P3|NOT COMPLETED|Overall Study||6
8479530|NCT00608985|20896445|P2|NOT COMPLETED|Overall Study||13
8479531|NCT00608985|20896446|P1|NOT COMPLETED|Overall Study||16
8479532|NCT00608985|20896443|P4|COMPLETED|Overall Study|Completed follow-up|159
8479533|NCT00608985|20896444|P3|COMPLETED|Overall Study|Completed follow-up|170
8479534|NCT00608985|20896445|P2|COMPLETED|Overall Study|Completed follow-up|173
8479535|NCT00608985|20896446|P1|COMPLETED|Overall Study|Completed follow-up|161
8479536|NCT00608985|20896443|P4|Completed Double-blind Treatment|Overall Study||161
8479537|NCT00608985|20896444|P3|Completed Double-blind Treatment|Overall Study||171
8479538|NCT00608985|20896445|P2|Completed Double-blind Treatment|Overall Study||174
8479539|NCT00608985|20896446|P1|Completed Double-blind Treatment|Overall Study||163
8479540|NCT00608985|20896443|P4|STARTED|Overall Study|Randomized and started double-blind treatment|168
8479541|NCT00608985|20896444|P3|STARTED|Overall Study|Randomized and started double-blind treatment|176
8479542|NCT00608985|20896445|P2|STARTED|Overall Study|Randomized and started double-blind treatment|186
8479543|NCT00608985|20896446|P1|STARTED|Overall Study|Randomized and started double-blind treatment|177
8479544|NCT00608959|20896478|P1|NOT COMPLETED|Part 2||0
8479545|NCT00608959|20896478|P1|COMPLETED|Part 2||25
8479546|NCT00608959|20896478|P1|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
8479547|NCT00608959|20896478|P1|NOT COMPLETED|Part 1||1
8479548|NCT00608959|20896478|P1|COMPLETED|Part 1||24
8479549|NCT00608959|20896478|P1|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
8479550|NCT00608907|20896491|P3|NOT COMPLETED|Overall Study||1
8479551|NCT00608907|20896492|P2|NOT COMPLETED|Overall Study||0
8479552|NCT00608907|20896493|P1|NOT COMPLETED|Overall Study||12
8479553|NCT00608907|20896491|P3|COMPLETED|Overall Study||17
8479554|NCT00608907|20896492|P2|COMPLETED|Overall Study||13
8479555|NCT00608907|20896493|P1|COMPLETED|Overall Study||18
8479556|NCT00608907|20896491|P3|STARTED|Overall Study||18
8479557|NCT00608907|20896492|P2|STARTED|Overall Study||13
8479558|NCT00608907|20896493|P1|STARTED|Overall Study||30
8479559|NCT00608894|20896503|P2|NOT COMPLETED|Overall Study||2
8479560|NCT00608894|20896504|P1|NOT COMPLETED|Overall Study||0
8479561|NCT00608894|20896503|P2|COMPLETED|Overall Study|One patient was granted permission to crossover to LCP-Tacro due to treatment intolerance|4
8479562|NCT00608894|20896504|P1|COMPLETED|Overall Study||7
8479563|NCT00608894|20896503|P2|STARTED|Overall Study||6
8479564|NCT00608894|20896504|P1|STARTED|Overall Study||7
8479565|NCT00608881|20896516|P2|NOT COMPLETED|Overall Study||66
8479566|NCT00608881|20896517|P1|NOT COMPLETED|Overall Study||79
8479567|NCT00608881|20896516|P2|COMPLETED|Overall Study||240
8479568|NCT00608881|20896517|P1|COMPLETED|Overall Study||224
8479569|NCT00608881|20896516|P2|STARTED|Overall Study||306
8479570|NCT00608881|20896517|P1|STARTED|Overall Study||303
8479571|NCT00608868|20896551|P1|NOT COMPLETED|Overall Study||15
8479572|NCT00608868|20896551|P1|COMPLETED|Overall Study||141
8479573|NCT00608868|20896551|P1|Per Protocol (PP) Population|Overall Study||121
8479574|NCT00608868|20896551|P1|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
8479575|NCT00608868|20896551|P1|Treatment Completed|Overall Study||141
8479576|NCT00608868|20896551|P1|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
8479577|NCT00608868|20896551|P1|Enrolled|Overall Study||156
8479578|NCT00608868|20896551|P1|STARTED|Overall Study||156
8479579|NCT00608842|20896562|P4|NOT COMPLETED|Overall Study||1
8479580|NCT00608842|20896563|P3|NOT COMPLETED|Overall Study||2
8479581|NCT00608842|20896564|P2|NOT COMPLETED|Overall Study||1
8479582|NCT00608842|20896565|P1|NOT COMPLETED|Overall Study||1
8479583|NCT00608842|20896562|P4|COMPLETED|Overall Study||16
8479584|NCT00608842|20896563|P3|COMPLETED|Overall Study||13
8479585|NCT00608842|20896564|P2|COMPLETED|Overall Study||14
8479586|NCT00608842|20896565|P1|COMPLETED|Overall Study||14
8479587|NCT00608842|20896562|P4|STARTED|Overall Study||17
8479588|NCT00608842|20896563|P3|STARTED|Overall Study||15
8479589|NCT00608842|20896564|P2|STARTED|Overall Study||15
8479590|NCT00608842|20896565|P1|STARTED|Overall Study||15
8479591|NCT00608829|20896599|P1|NOT COMPLETED|Overall Study||15
8479592|NCT00608829|20896599|P1|COMPLETED|Overall Study||8
8479593|NCT00608829|20896599|P1|STARTED|Overall Study||23
8479594|NCT00608777|20896603|P1|NOT COMPLETED|Overall Study||0
8479595|NCT00608777|20896603|P1|COMPLETED|Overall Study||6
8479596|NCT00608777|20896603|P1|STARTED|Overall Study||6
8479597|NCT00608634|20896610|P3|NOT COMPLETED|Overall Study||1
8479598|NCT00608634|20896611|P2|NOT COMPLETED|Overall Study||1
8479599|NCT00608634|20896612|P1|NOT COMPLETED|Overall Study||2
8479600|NCT00608634|20896610|P3|COMPLETED|Overall Study||27
8479601|NCT00608634|20896611|P2|COMPLETED|Overall Study||26
8479602|NCT00608634|20896612|P1|COMPLETED|Overall Study||26
8479603|NCT00608634|20896610|P3|STARTED|Overall Study||28
8479604|NCT00608634|20896611|P2|STARTED|Overall Study||27
8479605|NCT00608634|20896612|P1|STARTED|Overall Study||28
8479606|NCT00608582|20896625|P2|NOT COMPLETED|Overall Study||4
8479607|NCT00608582|20896626|P1|NOT COMPLETED|Overall Study||4
8479608|NCT00608582|20896625|P2|COMPLETED|Overall Study||7
8479609|NCT00608582|20896626|P1|COMPLETED|Overall Study||10
8479610|NCT00608582|20896625|P2|STARTED|Overall Study||11
8479611|NCT00608582|20896626|P1|STARTED|Overall Study||14
8479612|NCT00608569|20896636|P2|NOT COMPLETED|Overall Study||9
8479613|NCT00608569|20896637|P1|NOT COMPLETED|Overall Study||10
8479614|NCT00608569|20896636|P2|COMPLETED|Overall Study||119
8479615|NCT00608569|20896637|P1|COMPLETED|Overall Study||119
8479616|NCT00608569|20896636|P2|STARTED|Overall Study||128
8479617|NCT00608569|20896637|P1|STARTED|Overall Study||129
8479618|NCT00608543|20896657|P1|NOT COMPLETED|Overall Study||4
8479619|NCT00608543|20896657|P1|COMPLETED|Overall Study||13
8479620|NCT00608543|20896657|P1|STARTED|Overall Study||17
8479621|NCT00608530|20896670|P4|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
8479622|NCT00608530|20896671|P3|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
8479623|NCT00608530|20896672|P2|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
8479624|NCT00608530|20896673|P1|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
8479625|NCT00608530|20896670|P4|COMPLETED|Study 2 Nurse-delivered Treatments||27
8479626|NCT00608530|20896671|P3|COMPLETED|Study 2 Nurse-delivered Treatments||21
8479627|NCT00608530|20896672|P2|COMPLETED|Study 2 Nurse-delivered Treatments||0
8479628|NCT00608530|20896673|P1|COMPLETED|Study 2 Nurse-delivered Treatments||0
8479629|NCT00608530|20896670|P4|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
8479630|NCT00608530|20896671|P3|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
8479631|NCT00608530|20896672|P2|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
8479632|NCT00608530|20896673|P1|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
8479633|NCT00608530|20896670|P4|STARTED|Study 2 Nurse-delivered Treatments||34
8479634|NCT00608530|20896671|P3|STARTED|Study 2 Nurse-delivered Treatments||33
8479635|NCT00608530|20896672|P2|STARTED|Study 2 Nurse-delivered Treatments||0
8479636|NCT00608530|20896673|P1|STARTED|Study 2 Nurse-delivered Treatments||0
8479637|NCT00608530|20896670|P4|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
8479638|NCT00608530|20896671|P3|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
8479639|NCT00608530|20896672|P2|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
8479640|NCT00608530|20896673|P1|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
8479641|NCT00608530|20896670|P4|COMPLETED|Study 1 Psychologist-delivered Treatment||0
8479642|NCT00608530|20896671|P3|COMPLETED|Study 1 Psychologist-delivered Treatment||0
8479643|NCT00608530|20896672|P2|COMPLETED|Study 1 Psychologist-delivered Treatment||28
8479644|NCT00608530|20896673|P1|COMPLETED|Study 1 Psychologist-delivered Treatment||22
8479645|NCT00608530|20896670|P4|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
8479646|NCT00608530|20896671|P3|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
8479647|NCT00608530|20896672|P2|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
8479648|NCT00608530|20896673|P1|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
8479649|NCT00608530|20896670|P4|STARTED|Study 1 Psychologist-delivered Treatment||0
8479650|NCT00608530|20896671|P3|STARTED|Study 1 Psychologist-delivered Treatment||0
8479651|NCT00608530|20896672|P2|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
8479652|NCT00608530|20896673|P1|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
8479653|NCT00608517|20896694|P3|NOT COMPLETED|Overall Study||0
8479654|NCT00608517|20896695|P2|NOT COMPLETED|Overall Study||0
8479655|NCT00608517|20896696|P1|NOT COMPLETED|Overall Study||1
8479656|NCT00608517|20896694|P3|COMPLETED|Overall Study||1
8479657|NCT00608517|20896695|P2|COMPLETED|Overall Study||3
8479658|NCT00608517|20896696|P1|COMPLETED|Overall Study||1
8479659|NCT00608517|20896694|P3|STARTED|Overall Study||1
8479660|NCT00608517|20896695|P2|STARTED|Overall Study||3
8479661|NCT00608517|20896696|P1|STARTED|Overall Study||2
8479662|NCT00608491|20896724|P2|NOT COMPLETED|Overall Study||22
8479663|NCT00608491|20896725|P1|NOT COMPLETED|Overall Study||21
8479664|NCT00608491|20896724|P2|COMPLETED|Overall Study||72
8479665|NCT00608491|20896725|P1|COMPLETED|Overall Study||73
8479666|NCT00608491|20896724|P2|STARTED|Overall Study||94
8479667|NCT00608491|20896725|P1|STARTED|Overall Study||94
8479668|NCT00608465|20896869|P1|NOT COMPLETED|Overall Study||0
8479669|NCT00608465|20896869|P1|COMPLETED|Overall Study||4
8479670|NCT00608465|20896869|P1|STARTED|Overall Study||4
8479671|NCT00608426|20896876|P2|NOT COMPLETED|Overall Study||905
8479672|NCT00608426|20896877|P1|NOT COMPLETED|Overall Study||836
8479673|NCT00608426|20896876|P2|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
8479674|NCT00608426|20896877|P1|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
8479675|NCT00608426|20896876|P2|STARTED|Overall Study||2519
8479676|NCT00608426|20896877|P1|STARTED|Overall Study||2604
8479677|NCT00608322|20896889|P2|NOT COMPLETED|Overall Study||1
8479678|NCT00608322|20896890|P1|NOT COMPLETED|Overall Study||2
8479679|NCT00608322|20896889|P2|COMPLETED|Overall Study||22
8479680|NCT00608322|20896890|P1|COMPLETED|Overall Study||24
8479681|NCT00608322|20896889|P2|STARTED|Overall Study||23
8479682|NCT00608322|20896890|P1|STARTED|Overall Study||26
8479683|NCT00608244|20896896|P1|NOT COMPLETED|Overall Study||2
8479684|NCT00608244|20896896|P1|COMPLETED|Overall Study||57
8479685|NCT00608244|20896896|P1|STARTED|Overall Study||59
8479686|NCT00608205|20896907|P2|NOT COMPLETED|Overall Study||3
8479687|NCT00608205|20896908|P1|NOT COMPLETED|Overall Study||3
8479688|NCT00608205|20896907|P2|COMPLETED|Overall Study||31
8479689|NCT00608205|20896908|P1|COMPLETED|Overall Study||32
8479690|NCT00608205|20896907|P2|STARTED|Overall Study||34
8479691|NCT00608205|20896908|P1|STARTED|Overall Study||35
8479692|NCT00608140|20896998|P2|NOT COMPLETED|Overall Study||1
8479693|NCT00608140|20896999|P1|NOT COMPLETED|Overall Study||1
8479694|NCT00608140|20896998|P2|COMPLETED|Overall Study|Study ended early due to low enrollment|0
8479695|NCT00608140|20896999|P1|COMPLETED|Overall Study|Study ended early due to low enrollment|0
8479696|NCT00608140|20896998|P2|STARTED|Overall Study||1
8479697|NCT00608140|20896999|P1|STARTED|Overall Study||1
8479698|NCT00608062|20897028|P6|NOT COMPLETED|Overall Study||0
8479699|NCT00608062|20897029|P5|NOT COMPLETED|Overall Study||0
8479700|NCT00608062|20897030|P4|NOT COMPLETED|Overall Study||0
8479701|NCT00608062|20897031|P3|NOT COMPLETED|Overall Study||0
8479702|NCT00608062|20897032|P2|NOT COMPLETED|Overall Study||0
8479703|NCT00608062|20897033|P1|NOT COMPLETED|Overall Study||0
8479704|NCT00608062|20897028|P6|COMPLETED|Overall Study||15
8479705|NCT00608062|20897029|P5|COMPLETED|Overall Study||13
8479706|NCT00608062|20897030|P4|COMPLETED|Overall Study||21
8479707|NCT00608062|20897031|P3|COMPLETED|Overall Study||19
8479708|NCT00608062|20897032|P2|COMPLETED|Overall Study||12
8479709|NCT00608062|20897033|P1|COMPLETED|Overall Study||12
8479710|NCT00608062|20897028|P6|STARTED|Overall Study||15
8479711|NCT00608062|20897029|P5|STARTED|Overall Study||13
8479712|NCT00608062|20897030|P4|STARTED|Overall Study||21
8479713|NCT00608062|20897031|P3|STARTED|Overall Study|43 women completed baseline testing, 3 women withdrew prior to randomization|19
8479714|NCT00608062|20897032|P2|STARTED|Overall Study||12
8479715|NCT00608062|20897033|P1|STARTED|Overall Study|25 women completed baseline testing, 4 women withdrew prior to randomization|12
8479716|NCT00608023|20897092|P3|NOT COMPLETED|Overall Study||14
8479717|NCT00608023|20897093|P2|NOT COMPLETED|Overall Study||22
8479718|NCT00608023|20897094|P1|NOT COMPLETED|Overall Study||12
8479719|NCT00608023|20897092|P3|COMPLETED|Overall Study||72
8479720|NCT00608023|20897093|P2|COMPLETED|Overall Study||63
8479721|NCT00608023|20897094|P1|COMPLETED|Overall Study||80
8479722|NCT00608023|20897092|P3|STARTED|Overall Study||86
8479723|NCT00608023|20897093|P2|STARTED|Overall Study||85
8479724|NCT00608023|20897094|P1|STARTED|Overall Study||92
8479725|NCT00607997|20897118|P4|NOT COMPLETED|Overall Study||16
8479726|NCT00607997|20897119|P3|NOT COMPLETED|Overall Study||24
8479727|NCT00607997|20897120|P2|NOT COMPLETED|Overall Study||27
8479728|NCT00607997|20897121|P1|NOT COMPLETED|Overall Study||27
8479729|NCT00607997|20897118|P4|COMPLETED|Overall Study||4
8479730|NCT00607997|20897119|P3|COMPLETED|Overall Study||5
8479731|NCT00607997|20897120|P2|COMPLETED|Overall Study||8
8479732|NCT00607997|20897121|P1|COMPLETED|Overall Study||2
8479733|NCT00607997|20897118|P4|STARTED|Overall Study||20
8479734|NCT00607997|20897119|P3|STARTED|Overall Study||29
8479735|NCT00607997|20897120|P2|STARTED|Overall Study||35
8479736|NCT00607997|20897121|P1|STARTED|Overall Study||29
8479737|NCT00607919|20897179|P2|NOT COMPLETED|Open-Label Phase||12
8479738|NCT00607919|20897180|P1|NOT COMPLETED|Open-Label Phase||10
8479739|NCT00607919|20897179|P2|COMPLETED|Open-Label Phase||59
8479740|NCT00607919|20897180|P1|COMPLETED|Open-Label Phase||74
8479741|NCT00607919|20897179|P2|STARTED|Open-Label Phase||71
8479742|NCT00607919|20897180|P1|STARTED|Open-Label Phase||84
8479743|NCT00607919|20897179|P2|NOT COMPLETED|Acute Phase||16
8479744|NCT00607919|20897180|P1|NOT COMPLETED|Acute Phase||34
8479745|NCT00607919|20897179|P2|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
8479746|NCT00607919|20897180|P1|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
8479747|NCT00607919|20897179|P2|STARTED|Acute Phase||89
8479748|NCT00607919|20897180|P1|STARTED|Acute Phase||120
8479749|NCT00607893|20897238|P2|NOT COMPLETED|Overall Study||4
8479750|NCT00607893|20897239|P1|NOT COMPLETED|Overall Study||6
8479751|NCT00607893|20897238|P2|COMPLETED|Overall Study||72
8479752|NCT00607893|20897239|P1|COMPLETED|Overall Study||71
8479753|NCT00607893|20897238|P2|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
8479754|NCT00607893|20897239|P1|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
8479755|NCT00607893|20897238|P2|Completed 8 Week Visit|Overall Study||72
8479756|NCT00607893|20897239|P1|Completed 8 Week Visit|Overall Study||71
8479757|NCT00607893|20897238|P2|Completed Baseline Visit|Overall Study||75
8479758|NCT00607893|20897239|P1|Completed Baseline Visit|Overall Study||74
8479759|NCT00607893|20897238|P2|STARTED|Overall Study||76
8479760|NCT00607893|20897239|P1|STARTED|Overall Study||77
8479761|NCT00607880|20897267|P2|NOT COMPLETED|Overall Study||0
8479762|NCT00607880|20897268|P1|NOT COMPLETED|Overall Study||1
8479763|NCT00607880|20897267|P2|COMPLETED|Overall Study||50
8479764|NCT00607880|20897268|P1|COMPLETED|Overall Study||49
8479765|NCT00607880|20897267|P2|STARTED|Overall Study||50
8479766|NCT00607880|20897268|P1|STARTED|Overall Study||50
8479767|NCT00607867|20897282|P2|NOT COMPLETED|Overall Study||0
8479768|NCT00607867|20897283|P1|NOT COMPLETED|Overall Study||0
8479769|NCT00607867|20897282|P2|COMPLETED|Overall Study||7
8479770|NCT00607867|20897283|P1|COMPLETED|Overall Study||7
8479771|NCT00607867|20897282|P2|STARTED|Overall Study||7
8479772|NCT00607867|20897283|P1|STARTED|Overall Study||7
8479773|NCT00607815|20897301|P2|NOT COMPLETED|Overall Study||11
8479774|NCT00607815|20897302|P1|NOT COMPLETED|Overall Study||23
8479775|NCT00607815|20897301|P2|COMPLETED|Overall Study||25
8479776|NCT00607815|20897302|P1|COMPLETED|Overall Study||20
8479777|NCT00607815|20897301|P2|STARTED|Overall Study||36
8479778|NCT00607815|20897302|P1|STARTED|Overall Study||43
8479779|NCT00607789|20897318|P2|NOT COMPLETED|Overall Study||6
8479780|NCT00607789|20897319|P1|NOT COMPLETED|Overall Study||7
8479781|NCT00607789|20897318|P2|COMPLETED|Overall Study||14
8479782|NCT00607789|20897319|P1|COMPLETED|Overall Study||13
8479783|NCT00607789|20897318|P2|STARTED|Overall Study||20
8479784|NCT00607789|20897319|P1|STARTED|Overall Study|20 participants were randomized in each group|20
8479785|NCT00607724|20897334|P7|NOT COMPLETED|Stage 2: Expanded Cohort||11
8479786|NCT00607724|20897335|P6|NOT COMPLETED|Stage 2: Expanded Cohort||12
8479787|NCT00607724|20897336|P5|NOT COMPLETED|Stage 2: Expanded Cohort||9
8479788|NCT00607724|20897337|P4|NOT COMPLETED|Stage 2: Expanded Cohort||5
8479789|NCT00607724|20897338|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
8479790|NCT00607724|20897339|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
8479791|NCT00607724|20897340|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
8479792|NCT00607724|20897334|P7|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
8479793|NCT00607724|20897335|P6|COMPLETED|Stage 2: Expanded Cohort||0
8479794|NCT00607724|20897336|P5|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
8479795|NCT00607724|20897337|P4|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|1
8479796|NCT00607724|20897338|P3|COMPLETED|Stage 2: Expanded Cohort||0
8479797|NCT00607724|20897339|P2|COMPLETED|Stage 2: Expanded Cohort||0
8479798|NCT00607724|20897340|P1|COMPLETED|Stage 2: Expanded Cohort||0
8479799|NCT00607724|20897334|P7|STARTED|Stage 2: Expanded Cohort||16
8479800|NCT00607724|20897335|P6|STARTED|Stage 2: Expanded Cohort||12
8479801|NCT00607724|20897336|P5|STARTED|Stage 2: Expanded Cohort||14
8479802|NCT00607724|20897337|P4|STARTED|Stage 2: Expanded Cohort||6
8479803|NCT00607724|20897338|P3|STARTED|Stage 2: Expanded Cohort||0
8479804|NCT00607724|20897339|P2|STARTED|Stage 2: Expanded Cohort||0
8479805|NCT00607724|20897340|P1|STARTED|Stage 2: Expanded Cohort||0
8479806|NCT00607724|20897334|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
8479807|NCT00607724|20897335|P6|NOT COMPLETED|Stage 1: Dose Escalation||0
8479808|NCT00607724|20897336|P5|NOT COMPLETED|Stage 1: Dose Escalation||0
8479809|NCT00607724|20897337|P4|NOT COMPLETED|Stage 1: Dose Escalation||0
8479810|NCT00607724|20897338|P3|NOT COMPLETED|Stage 1: Dose Escalation||4
8479811|NCT00607724|20897339|P2|NOT COMPLETED|Stage 1: Dose Escalation||8
8479812|NCT00607724|20897340|P1|NOT COMPLETED|Stage 1: Dose Escalation||7
8479813|NCT00607724|20897334|P7|COMPLETED|Stage 1: Dose Escalation||0
8479814|NCT00607724|20897335|P6|COMPLETED|Stage 1: Dose Escalation||0
8479815|NCT00607724|20897336|P5|COMPLETED|Stage 1: Dose Escalation||0
8479816|NCT00607724|20897337|P4|COMPLETED|Stage 1: Dose Escalation||0
8479817|NCT00607724|20897338|P3|COMPLETED|Stage 1: Dose Escalation||0
8479818|NCT00607724|20897339|P2|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered 'completers'.|1
8479819|NCT00607724|20897340|P1|COMPLETED|Stage 1: Dose Escalation||0
8479820|NCT00607724|20897334|P7|STARTED|Stage 1: Dose Escalation||0
8479821|NCT00607724|20897335|P6|STARTED|Stage 1: Dose Escalation||0
8479822|NCT00607724|20897336|P5|STARTED|Stage 1: Dose Escalation||0
8479823|NCT00607724|20897337|P4|STARTED|Stage 1: Dose Escalation||0
8479824|NCT00607724|20897338|P3|STARTED|Stage 1: Dose Escalation||4
8479825|NCT00607724|20897339|P2|STARTED|Stage 1: Dose Escalation||9
8479826|NCT00607724|20897340|P1|STARTED|Stage 1: Dose Escalation||7
8479827|NCT00607672|20897419|P3|NOT COMPLETED|Overall Study||5
8479828|NCT00607672|20897420|P2|NOT COMPLETED|Overall Study||3
8479829|NCT00607672|20897421|P1|NOT COMPLETED|Overall Study||4
8479830|NCT00607672|20897419|P3|COMPLETED|Overall Study||22
8479831|NCT00607672|20897420|P2|COMPLETED|Overall Study||24
8479832|NCT00607672|20897421|P1|COMPLETED|Overall Study||28
8479833|NCT00607672|20897419|P3|STARTED|Overall Study||27
8479834|NCT00607672|20897420|P2|STARTED|Overall Study||27
8479835|NCT00607672|20897421|P1|STARTED|Overall Study||32
8479836|NCT00607620|20897467|P2|NOT COMPLETED|Overall Study||0
8479837|NCT00607620|20897468|P1|NOT COMPLETED|Overall Study||0
8479838|NCT00607620|20897467|P2|COMPLETED|Overall Study||469
8479839|NCT00607620|20897468|P1|COMPLETED|Overall Study||409
8479840|NCT00607620|20897467|P2|STARTED|Overall Study||469
8479841|NCT00607620|20897468|P1|STARTED|Overall Study||409
8479842|NCT00607594|20897482|P1|NOT COMPLETED|Overall Study||0
8479843|NCT00607594|20897482|P1|COMPLETED|Overall Study||21
8479844|NCT00607594|20897482|P1|STARTED|Overall Study||21
8479845|NCT00607477|20897496|P2|NOT COMPLETED|Overall Study||0
8479846|NCT00607477|20897497|P1|NOT COMPLETED|Overall Study||0
8479847|NCT00607477|20897496|P2|COMPLETED|Overall Study||2
8479848|NCT00607477|20897497|P1|COMPLETED|Overall Study||0
8479849|NCT00607477|20897496|P2|STARTED|Overall Study||2
8479850|NCT00607477|20897497|P1|STARTED|Overall Study||0
8479854|NCT00607373|20897518|P2|NOT COMPLETED|Follow-up Period||5
8479855|NCT00607373|20897519|P1|NOT COMPLETED|Follow-up Period||1
8479856|NCT00607373|20897518|P2|COMPLETED|Follow-up Period||6
8479857|NCT00607373|20897519|P1|COMPLETED|Follow-up Period||0
8479858|NCT00607373|20897518|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
8479859|NCT00607373|20897519|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
8479860|NCT00607373|20897518|P2|NOT COMPLETED|Treatment Period||6
8479861|NCT00607373|20897519|P1|NOT COMPLETED|Treatment Period||0
8479862|NCT00607373|20897518|P2|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
8479863|NCT00607373|20897519|P1|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
8479864|NCT00607373|20897518|P2|STARTED|Treatment Period||34
8479865|NCT00607373|20897519|P1|STARTED|Treatment Period||17
8479866|NCT00607321|20897563|P1|NOT COMPLETED|Overall Study||0
8479867|NCT00607321|20897563|P1|COMPLETED|Overall Study||60
8479868|NCT00607321|20897563|P1|STARTED|Overall Study||60
8479869|NCT00607269|20897573|P2|NOT COMPLETED|Overall Study||0
8479870|NCT00607269|20897574|P1|NOT COMPLETED|Overall Study||0
8479871|NCT00607269|20897573|P2|COMPLETED|Overall Study||64
8479872|NCT00607269|20897574|P1|COMPLETED|Overall Study||67
8479873|NCT00607269|20897573|P2|STARTED|Overall Study||64
8479874|NCT00607269|20897574|P1|STARTED|Overall Study||67
8479875|NCT00607243|20897588|P2|NOT COMPLETED|Telephone Safety Assessment Period||2
8479876|NCT00607243|20897589|P1|NOT COMPLETED|Telephone Safety Assessment Period||5
8479877|NCT00607243|20897588|P2|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
8479878|NCT00607243|20897589|P1|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
8479879|NCT00607243|20897588|P2|STARTED|Telephone Safety Assessment Period||41
8479880|NCT00607243|20897589|P1|STARTED|Telephone Safety Assessment Period||82
8479881|NCT00607243|20897588|P2|NOT COMPLETED|Initial Post-vaccination Period||0
8479882|NCT00607243|20897589|P1|NOT COMPLETED|Initial Post-vaccination Period||0
8479883|NCT00607243|20897588|P2|COMPLETED|Initial Post-vaccination Period||41
8479884|NCT00607243|20897589|P1|COMPLETED|Initial Post-vaccination Period||82
8479885|NCT00607243|20897588|P2|STARTED|Initial Post-vaccination Period||41
8479886|NCT00607243|20897589|P1|STARTED|Initial Post-vaccination Period||82
8479887|NCT00607126|20897597|P2|NOT COMPLETED|Overall Study||0
8479888|NCT00607126|20897598|P1|NOT COMPLETED|Overall Study||0
8479889|NCT00607126|20897597|P2|COMPLETED|Overall Study||19
8479890|NCT00607126|20897598|P1|COMPLETED|Overall Study||17
8479891|NCT00607126|20897597|P2|STARTED|Overall Study||19
8479892|NCT00607126|20897598|P1|STARTED|Overall Study||17
8479893|NCT00607113|20897612|P2|NOT COMPLETED|Overall Study||0
8479894|NCT00607113|20897613|P1|NOT COMPLETED|Overall Study||0
8479895|NCT00607113|20897612|P2|COMPLETED|Overall Study||20
8479896|NCT00607113|20897613|P1|COMPLETED|Overall Study||19
8479897|NCT00607113|20897612|P2|STARTED|Overall Study||20
8479898|NCT00607113|20897613|P1|STARTED|Overall Study||19
8479899|NCT00607087|20897621|P3|NOT COMPLETED|Period 3||0
8479900|NCT00607087|20897622|P2|NOT COMPLETED|Period 3||2
8479901|NCT00607087|20897623|P1|NOT COMPLETED|Period 3||2
8479902|NCT00607087|20897621|P3|COMPLETED|Period 3||84
8479903|NCT00607087|20897622|P2|COMPLETED|Period 3||84
8479904|NCT00607087|20897623|P1|COMPLETED|Period 3||84
8479905|NCT00607087|20897621|P3|STARTED|Period 3||84
8479906|NCT00607087|20897622|P2|STARTED|Period 3||86
8479907|NCT00607087|20897623|P1|STARTED|Period 3||86
8479908|NCT00607087|20897621|P3|NOT COMPLETED|Period 2||5
8479909|NCT00607087|20897622|P2|NOT COMPLETED|Period 2||3
8479910|NCT00607087|20897623|P1|NOT COMPLETED|Period 2||1
8479911|NCT00607087|20897621|P3|COMPLETED|Period 2||84
8479912|NCT00607087|20897622|P2|COMPLETED|Period 2||86
8479913|NCT00607087|20897623|P1|COMPLETED|Period 2||86
8479914|NCT00607087|20897621|P3|STARTED|Period 2||89
8479915|NCT00607087|20897622|P2|STARTED|Period 2||89
8479916|NCT00607087|20897623|P1|STARTED|Period 2||87
8479917|NCT00607087|20897621|P3|NOT COMPLETED|Period 1||5
8479918|NCT00607087|20897622|P2|NOT COMPLETED|Period 1||6
8479919|NCT00607087|20897623|P1|NOT COMPLETED|Period 1||12
8479920|NCT00607087|20897621|P3|COMPLETED|Period 1||89
8479921|NCT00607087|20897622|P2|COMPLETED|Period 1||89
8479922|NCT00607087|20897623|P1|COMPLETED|Period 1||87
8479923|NCT00607087|20897621|P3|STARTED|Period 1||94
8479924|NCT00607087|20897622|P2|STARTED|Period 1||95
8479925|NCT00607087|20897623|P1|STARTED|Period 1||99
8479926|NCT00607087|20897621|P3|NOT COMPLETED|Overall Study||10
8479927|NCT00607087|20897622|P2|NOT COMPLETED|Overall Study||11
8479928|NCT00607087|20897623|P1|NOT COMPLETED|Overall Study||15
8479929|NCT00607087|20897621|P3|COMPLETED|Overall Study||84
8479930|NCT00607087|20897622|P2|COMPLETED|Overall Study||84
8479931|NCT00607087|20897623|P1|COMPLETED|Overall Study||84
8479932|NCT00607087|20897621|P3|STARTED|Overall Study||94
8479933|NCT00607087|20897622|P2|STARTED|Overall Study||95
8479934|NCT00607087|20897623|P1|STARTED|Overall Study||99
8479935|NCT00607048|20897681|P6|NOT COMPLETED|Overall Study||5
8479936|NCT00607048|20897682|P5|NOT COMPLETED|Overall Study||6
8479937|NCT00607048|20897683|P4|NOT COMPLETED|Overall Study||3
8479938|NCT00607048|20897684|P3|NOT COMPLETED|Overall Study||4
8479939|NCT00607048|20897685|P2|NOT COMPLETED|Overall Study||4
8479940|NCT00607048|20897686|P1|NOT COMPLETED|Overall Study||3
8479941|NCT00607048|20897681|P6|COMPLETED|Overall Study||2
8479942|NCT00607048|20897682|P5|COMPLETED|Overall Study||0
8479943|NCT00607048|20897683|P4|COMPLETED|Overall Study||0
8479944|NCT00607048|20897684|P3|COMPLETED|Overall Study||3
8479945|NCT00607048|20897685|P2|COMPLETED|Overall Study||2
8479946|NCT00607048|20897686|P1|COMPLETED|Overall Study||0
8479947|NCT00607048|20897681|P6|STARTED|Overall Study||7
8479948|NCT00607048|20897682|P5|STARTED|Overall Study||6
8479949|NCT00607048|20897683|P4|STARTED|Overall Study||3
8479950|NCT00607048|20897684|P3|STARTED|Overall Study||7
8479951|NCT00607048|20897685|P2|STARTED|Overall Study||6
8479952|NCT00607048|20897686|P1|STARTED|Overall Study||3
8479953|NCT00607022|20897771|P3|NOT COMPLETED|Overall Study||0
8479954|NCT00607022|20897772|P2|NOT COMPLETED|Overall Study||0
8479955|NCT00607022|20897773|P1|NOT COMPLETED|Overall Study||1
8479956|NCT00607022|20897771|P3|COMPLETED|Overall Study||19
8479957|NCT00607022|20897772|P2|COMPLETED|Overall Study||15
8479958|NCT00607022|20897773|P1|COMPLETED|Overall Study||6
8479959|NCT00607022|20897771|P3|STARTED|Overall Study||19
8479960|NCT00607022|20897772|P2|STARTED|Overall Study||15
8479961|NCT00607022|20897773|P1|STARTED|Overall Study||7
8479962|NCT00606944|20897783|P2|NOT COMPLETED|Overall Study||0
8479963|NCT00606944|20897784|P1|NOT COMPLETED|Overall Study||0
8479964|NCT00606944|20897783|P2|COMPLETED|Overall Study||100
8479965|NCT00606944|20897784|P1|COMPLETED|Overall Study||98
8479966|NCT00606944|20897783|P2|STARTED|Overall Study||100
8479967|NCT00606944|20897784|P1|STARTED|Overall Study||98
8479968|NCT00606931|20897790|P1|NOT COMPLETED|Overall Study||3
8479969|NCT00606931|20897790|P1|COMPLETED|Overall Study||19
8479970|NCT00606931|20897790|P1|STARTED|Overall Study||22
8479971|NCT00606905|20897798|P2|NOT COMPLETED|Overall Study||15
8479972|NCT00606905|20897799|P1|NOT COMPLETED|Overall Study||15
8479973|NCT00606905|20897798|P2|COMPLETED|Overall Study||24
8479974|NCT00606905|20897799|P1|COMPLETED|Overall Study||23
8479975|NCT00606905|20897798|P2|Pregnancy|Overall Study||33
8479976|NCT00606905|20897799|P1|Pregnancy|Overall Study||29
8479977|NCT00606905|20897798|P2|STARTED|Overall Study||39
8479978|NCT00606905|20897799|P1|STARTED|Overall Study||38
8479979|NCT00606892|20897805|P2|NOT COMPLETED|Second Intervention||0
8479980|NCT00606892|20897806|P1|NOT COMPLETED|Second Intervention||0
8479981|NCT00606892|20897805|P2|COMPLETED|Second Intervention||4
8479982|NCT00606892|20897806|P1|COMPLETED|Second Intervention||8
8479983|NCT00606892|20897805|P2|STARTED|Second Intervention||4
8479984|NCT00606892|20897806|P1|STARTED|Second Intervention||8
8479985|NCT00606892|20897805|P2|NOT COMPLETED|Washout Period||0
8479986|NCT00606892|20897806|P1|NOT COMPLETED|Washout Period||0
8479987|NCT00606892|20897805|P2|COMPLETED|Washout Period||4
8479988|NCT00606892|20897806|P1|COMPLETED|Washout Period||8
8479989|NCT00606892|20897805|P2|STARTED|Washout Period||4
8479990|NCT00606892|20897806|P1|STARTED|Washout Period||8
8479991|NCT00606892|20897805|P2|NOT COMPLETED|First Intervention||4
8479992|NCT00606892|20897806|P1|NOT COMPLETED|First Intervention||1
8479993|NCT00606892|20897805|P2|COMPLETED|First Intervention||4
8479994|NCT00606892|20897806|P1|COMPLETED|First Intervention||8
8479995|NCT00606892|20897805|P2|STARTED|First Intervention||8
8479996|NCT00606892|20897806|P1|STARTED|First Intervention||9
8479997|NCT00606892|20897805|P2|NOT COMPLETED|Adaptation||0
8479998|NCT00606892|20897806|P1|NOT COMPLETED|Adaptation||0
8479999|NCT00606892|20897805|P2|COMPLETED|Adaptation||8
8480000|NCT00606892|20897806|P1|COMPLETED|Adaptation||9
8480001|NCT00606892|20897805|P2|STARTED|Adaptation||8
8480002|NCT00606892|20897806|P1|STARTED|Adaptation||9
8480015|NCT00606684|20897869|P7|NOT COMPLETED|Double-Blind Treatment Period||8
8480016|NCT00606684|20897870|P6|NOT COMPLETED|Double-Blind Treatment Period||9
8480017|NCT00606684|20897871|P5|NOT COMPLETED|Double-Blind Treatment Period||9
8480018|NCT00606684|20897872|P4|NOT COMPLETED|Double-Blind Treatment Period||10
8480019|NCT00606684|20897873|P3|NOT COMPLETED|Double-Blind Treatment Period||11
8480020|NCT00606684|20897874|P2|NOT COMPLETED|Double-Blind Treatment Period||16
8480021|NCT00606684|20897875|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8480022|NCT00606684|20897869|P7|COMPLETED|Double-Blind Treatment Period||91
8480023|NCT00606684|20897870|P6|COMPLETED|Double-Blind Treatment Period||92
8480024|NCT00606684|20897871|P5|COMPLETED|Double-Blind Treatment Period||92
8480025|NCT00606684|20897872|P4|COMPLETED|Double-Blind Treatment Period||91
8480026|NCT00606684|20897873|P3|COMPLETED|Double-Blind Treatment Period||88
8480027|NCT00606684|20897874|P2|COMPLETED|Double-Blind Treatment Period||85
8480028|NCT00606684|20897875|P1|COMPLETED|Double-Blind Treatment Period||0
8480029|NCT00606684|20897869|P7|STARTED|Double-Blind Treatment Period||99
8480030|NCT00606684|20897870|P6|STARTED|Double-Blind Treatment Period||101
8480031|NCT00606684|20897871|P5|STARTED|Double-Blind Treatment Period||101
8480032|NCT00606684|20897872|P4|STARTED|Double-Blind Treatment Period||101
8480033|NCT00606684|20897873|P3|STARTED|Double-Blind Treatment Period||99
8480034|NCT00606684|20897874|P2|STARTED|Double-Blind Treatment Period||101
8480035|NCT00606684|20897875|P1|STARTED|Double-Blind Treatment Period||0
8480036|NCT00606684|20897869|P7|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8480037|NCT00606684|20897870|P6|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8480038|NCT00606684|20897871|P5|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8480039|NCT00606684|20897872|P4|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8480040|NCT00606684|20897873|P3|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8480041|NCT00606684|20897874|P2|NOT COMPLETED|2-week Single-Blind Run-in Period||0
8480042|NCT00606684|20897875|P1|NOT COMPLETED|2-week Single-Blind Run-in Period||246
8480043|NCT00606684|20897869|P7|COMPLETED|2-week Single-Blind Run-in Period||0
8480044|NCT00606684|20897870|P6|COMPLETED|2-week Single-Blind Run-in Period||0
8480045|NCT00606684|20897871|P5|COMPLETED|2-week Single-Blind Run-in Period||0
8480046|NCT00606684|20897872|P4|COMPLETED|2-week Single-Blind Run-in Period||0
8480047|NCT00606684|20897873|P3|COMPLETED|2-week Single-Blind Run-in Period||0
8480048|NCT00606684|20897874|P2|COMPLETED|2-week Single-Blind Run-in Period||0
8480049|NCT00606684|20897875|P1|COMPLETED|2-week Single-Blind Run-in Period||605
8480050|NCT00606684|20897869|P7|STARTED|2-week Single-Blind Run-in Period||0
8480051|NCT00606684|20897870|P6|STARTED|2-week Single-Blind Run-in Period||0
8480052|NCT00606684|20897871|P5|STARTED|2-week Single-Blind Run-in Period||0
8480053|NCT00606684|20897872|P4|STARTED|2-week Single-Blind Run-in Period||0
8480054|NCT00606684|20897873|P3|STARTED|2-week Single-Blind Run-in Period||0
8480055|NCT00606684|20897874|P2|STARTED|2-week Single-Blind Run-in Period||0
8480056|NCT00606684|20897875|P1|STARTED|2-week Single-Blind Run-in Period||851
8480057|NCT00606632|20897907|P1|NOT COMPLETED|Overall Study||22
8480058|NCT00606632|20897907|P1|COMPLETED|Overall Study||204
8480059|NCT00606632|20897907|P1|STARTED|Overall Study||226
8480060|NCT00606593|20897920|P10|NOT COMPLETED|Overall Study||0
8480061|NCT00606593|20897921|P9|NOT COMPLETED|Overall Study||1
8480062|NCT00606593|20897922|P8|NOT COMPLETED|Overall Study||2
8480063|NCT00606593|20897923|P7|NOT COMPLETED|Overall Study||1
8480064|NCT00606593|20897924|P6|NOT COMPLETED|Overall Study||0
8480065|NCT00606593|20897925|P5|NOT COMPLETED|Overall Study||1
8480066|NCT00606593|20897926|P4|NOT COMPLETED|Overall Study||1
8480067|NCT00606593|20897927|P3|NOT COMPLETED|Overall Study||2
8480068|NCT00606593|20897928|P2|NOT COMPLETED|Overall Study||0
8480069|NCT00606593|20897929|P1|NOT COMPLETED|Overall Study||1
8480070|NCT00606593|20897920|P10|COMPLETED|Overall Study||11
8480071|NCT00606593|20897921|P9|COMPLETED|Overall Study||11
8480072|NCT00606593|20897922|P8|COMPLETED|Overall Study||9
8480073|NCT00606593|20897923|P7|COMPLETED|Overall Study||10
8480074|NCT00606593|20897924|P6|COMPLETED|Overall Study||11
8480075|NCT00606593|20897925|P5|COMPLETED|Overall Study||11
8480076|NCT00606593|20897926|P4|COMPLETED|Overall Study||10
8480077|NCT00606593|20897927|P3|COMPLETED|Overall Study||9
8480078|NCT00606593|20897928|P2|COMPLETED|Overall Study||11
8480079|NCT00606593|20897929|P1|COMPLETED|Overall Study||10
8480080|NCT00606593|20897920|P10|5th Double-blind Treatment|Overall Study||11
8480081|NCT00606593|20897921|P9|5th Double-blind Treatment|Overall Study||11
8480082|NCT00606593|20897922|P8|5th Double-blind Treatment|Overall Study||9
8480083|NCT00606593|20897923|P7|5th Double-blind Treatment|Overall Study||10
8480084|NCT00606593|20897924|P6|5th Double-blind Treatment|Overall Study||11
8480085|NCT00606593|20897925|P5|5th Double-blind Treatment|Overall Study||11
8480086|NCT00606593|20897926|P4|5th Double-blind Treatment|Overall Study||10
8480087|NCT00606593|20897927|P3|5th Double-blind Treatment|Overall Study||9
8480088|NCT00606593|20897928|P2|5th Double-blind Treatment|Overall Study||11
8480089|NCT00606593|20897929|P1|5th Double-blind Treatment|Overall Study||10
8480090|NCT00606593|20897920|P10|4th Double-blind Treatment|Overall Study||11
8480091|NCT00606593|20897921|P9|4th Double-blind Treatment|Overall Study||11
8480092|NCT00606593|20897922|P8|4th Double-blind Treatment|Overall Study||9
8480093|NCT00606593|20897923|P7|4th Double-blind Treatment|Overall Study||10
8480094|NCT00606593|20897924|P6|4th Double-blind Treatment|Overall Study||11
8480095|NCT00606593|20897925|P5|4th Double-blind Treatment|Overall Study||11
8480096|NCT00606593|20897926|P4|4th Double-blind Treatment|Overall Study||10
8480097|NCT00606593|20897927|P3|4th Double-blind Treatment|Overall Study||10
8480098|NCT00606593|20897928|P2|4th Double-blind Treatment|Overall Study||11
8480099|NCT00606593|20897929|P1|4th Double-blind Treatment|Overall Study||10
8480100|NCT00606593|20897920|P10|3rd Double-blind Treatment|Overall Study||11
8480101|NCT00606593|20897921|P9|3rd Double-blind Treatment|Overall Study||12
8480102|NCT00606593|20897922|P8|3rd Double-blind Treatment|Overall Study||9
8480103|NCT00606593|20897923|P7|3rd Double-blind Treatment|Overall Study||10
8480104|NCT00606593|20897924|P6|3rd Double-blind Treatment|Overall Study||11
8480105|NCT00606593|20897925|P5|3rd Double-blind Treatment|Overall Study||11
8480106|NCT00606593|20897926|P4|3rd Double-blind Treatment|Overall Study||10
8480107|NCT00606593|20897927|P3|3rd Double-blind Treatment|Overall Study||10
8480108|NCT00606593|20897928|P2|3rd Double-blind Treatment|Overall Study||11
8480109|NCT00606593|20897929|P1|3rd Double-blind Treatment|Overall Study||11
8480110|NCT00606593|20897920|P10|2nd Double-blind Treatment|Overall Study||11
8480111|NCT00606593|20897921|P9|2nd Double-blind Treatment|Overall Study||12
8480112|NCT00606593|20897922|P8|2nd Double-blind Treatment|Overall Study||9
8480113|NCT00606593|20897923|P7|2nd Double-blind Treatment|Overall Study||10
8480114|NCT00606593|20897924|P6|2nd Double-blind Treatment|Overall Study||11
8480115|NCT00606593|20897925|P5|2nd Double-blind Treatment|Overall Study||12
8480116|NCT00606593|20897926|P4|2nd Double-blind Treatment|Overall Study||10
8480117|NCT00606593|20897927|P3|2nd Double-blind Treatment|Overall Study||11
8480118|NCT00606593|20897928|P2|2nd Double-blind Treatment|Overall Study||11
8480119|NCT00606593|20897929|P1|2nd Double-blind Treatment|Overall Study||11
8480120|NCT00606593|20897920|P10|1st Double-blind Treatment|Overall Study||11
8480121|NCT00606593|20897921|P9|1st Double-blind Treatment|Overall Study||12
8480122|NCT00606593|20897922|P8|1st Double-blind Treatment|Overall Study||11
8480123|NCT00606593|20897923|P7|1st Double-blind Treatment|Overall Study||11
8480124|NCT00606593|20897924|P6|1st Double-blind Treatment|Overall Study||11
8480125|NCT00606593|20897925|P5|1st Double-blind Treatment|Overall Study||12
8480126|NCT00606593|20897926|P4|1st Double-blind Treatment|Overall Study||11
8480127|NCT00606593|20897927|P3|1st Double-blind Treatment|Overall Study||11
8480128|NCT00606593|20897928|P2|1st Double-blind Treatment|Overall Study||11
8480129|NCT00606593|20897929|P1|1st Double-blind Treatment|Overall Study||11
8480130|NCT00606593|20897920|P10|STARTED|Overall Study|Randomized participants|11
8480131|NCT00606593|20897921|P9|STARTED|Overall Study|Randomized participants|12
8480132|NCT00606593|20897922|P8|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
8480133|NCT00606593|20897923|P7|STARTED|Overall Study|Randomized participants|11
8480134|NCT00606593|20897924|P6|STARTED|Overall Study|Randomized participants|11
8480135|NCT00606593|20897925|P5|STARTED|Overall Study|Randomized participants|12
8480136|NCT00606593|20897926|P4|STARTED|Overall Study|Randomized participants|11
8480137|NCT00606593|20897927|P3|STARTED|Overall Study|Randomized participants|11
8480138|NCT00606593|20897928|P2|STARTED|Overall Study|Randomized participants|11
8480139|NCT00606593|20897929|P1|STARTED|Overall Study|Randomized participants|11
8480140|NCT00606580|20897950|P3|NOT COMPLETED|Overall Study||22
8480141|NCT00606580|20897951|P2|NOT COMPLETED|Overall Study||3
8480142|NCT00606580|20897952|P1|NOT COMPLETED|Overall Study||2
8480143|NCT00606580|20897950|P3|COMPLETED|Overall Study||103
8480144|NCT00606580|20897951|P2|COMPLETED|Overall Study||122
8480145|NCT00606580|20897952|P1|COMPLETED|Overall Study||123
8480146|NCT00606580|20897950|P3|STARTED|Overall Study||125
8480147|NCT00606580|20897951|P2|STARTED|Overall Study||125
8480148|NCT00606580|20897952|P1|STARTED|Overall Study||125
8480149|NCT00606554|20897995|P2|NOT COMPLETED|Overall Study||0
8480150|NCT00606554|20897996|P1|NOT COMPLETED|Overall Study||0
8480151|NCT00606554|20897995|P2|COMPLETED|Overall Study||18
8480152|NCT00606554|20897996|P1|COMPLETED|Overall Study||15
8480153|NCT00606554|20897995|P2|STARTED|Overall Study||18
8480154|NCT00606554|20897996|P1|STARTED|Overall Study||15
8480167|NCT00606489|20898033|P2|NOT COMPLETED|Overall Study||0
8480168|NCT00606489|20898034|P1|NOT COMPLETED|Overall Study||0
8480169|NCT00606489|20898033|P2|COMPLETED|Overall Study||40
8480170|NCT00606489|20898034|P1|COMPLETED|Overall Study||21
8480171|NCT00606489|20898033|P2|STARTED|Overall Study||40
8480172|NCT00606489|20898034|P1|STARTED|Overall Study||21
8480173|NCT00606320|20898040|P1|NOT COMPLETED|Overall Study||37
8480174|NCT00606320|20898040|P1|COMPLETED|Overall Study||22
8480175|NCT00606320|20898040|P1|STARTED|Overall Study||59
8480176|NCT00606307|20898045|P1|NOT COMPLETED|Overall Study||11
8480177|NCT00606307|20898045|P1|COMPLETED|Overall Study||18
8480178|NCT00606307|20898045|P1|STARTED|Overall Study||29
8480185|NCT00606281|20898068|P2|NOT COMPLETED|Overall Study||66
8480186|NCT00606281|20898069|P1|NOT COMPLETED|Overall Study||56
8480187|NCT00606281|20898068|P2|COMPLETED|Overall Study||64
8480188|NCT00606281|20898069|P1|COMPLETED|Overall Study||72
8480189|NCT00606281|20898068|P2|STARTED|Overall Study||130
8480190|NCT00606281|20898069|P1|STARTED|Overall Study||128
8480191|NCT00606229|20898077|P1|NOT COMPLETED|Overall Study||22
8480192|NCT00606229|20898077|P1|COMPLETED|Overall Study||19
8480193|NCT00606229|20898077|P1|STARTED|Overall Study||41
8480194|NCT00606177|20898084|P2|NOT COMPLETED|Overall Study||25
8480195|NCT00606177|20898085|P1|NOT COMPLETED|Overall Study||27
8480196|NCT00606177|20898084|P2|COMPLETED|Overall Study||19
8480197|NCT00606177|20898085|P1|COMPLETED|Overall Study||28
8480198|NCT00606177|20898084|P2|STARTED|Overall Study||44
8480199|NCT00606177|20898085|P1|STARTED|Overall Study||55
8480200|NCT00606138|20898095|P2|NOT COMPLETED|Overall Study||0
8480201|NCT00606138|20898096|P1|NOT COMPLETED|Overall Study||0
8480202|NCT00606138|20898095|P2|COMPLETED|Overall Study||2
8480203|NCT00606138|20898096|P1|COMPLETED|Overall Study||6
8480204|NCT00606138|20898095|P2|STARTED|Overall Study||2
8480205|NCT00606138|20898096|P1|STARTED|Overall Study||6
8480206|NCT00606086|20898112|P2|NOT COMPLETED|Overall Study||15
8480207|NCT00606086|20898113|P1|NOT COMPLETED|Overall Study||12
8480208|NCT00606086|20898112|P2|COMPLETED|Overall Study||53
8480209|NCT00606086|20898113|P1|COMPLETED|Overall Study||60
8480210|NCT00606086|20898112|P2|STARTED|Overall Study||68
8480211|NCT00606086|20898113|P1|STARTED|Overall Study||72
8480212|NCT00606047|20898119|P1|NOT COMPLETED|Overall Study||0
8480213|NCT00606047|20898119|P1|COMPLETED|Overall Study||200
8480214|NCT00606047|20898119|P1|STARTED|Overall Study||200
8480215|NCT00606034|20898123|P1|NOT COMPLETED|Overall Study||1
8480216|NCT00606034|20898123|P1|COMPLETED|Overall Study||20
8480217|NCT00606034|20898123|P1|STARTED|Overall Study||21
8480218|NCT00606021|20898131|P3|NOT COMPLETED|Maintenance Phase||17
8480219|NCT00606021|20898132|P2|NOT COMPLETED|Maintenance Phase||23
8480220|NCT00606021|20898133|P1|NOT COMPLETED|Maintenance Phase||0
8480221|NCT00606021|20898131|P3|COMPLETED|Maintenance Phase||10
8480222|NCT00606021|20898132|P2|COMPLETED|Maintenance Phase||5
8480223|NCT00606021|20898133|P1|COMPLETED|Maintenance Phase||0
8480224|NCT00606021|20898131|P3|STARTED|Maintenance Phase||27
8480225|NCT00606021|20898132|P2|STARTED|Maintenance Phase||28
8480226|NCT00606021|20898133|P1|STARTED|Maintenance Phase||0
8480227|NCT00606021|20898131|P3|NOT COMPLETED|Induction Phase||0
8480228|NCT00606021|20898132|P2|NOT COMPLETED|Induction Phase||0
8480229|NCT00606021|20898133|P1|NOT COMPLETED|Induction Phase||87
8480230|NCT00606021|20898131|P3|COMPLETED|Induction Phase||0
8480231|NCT00606021|20898132|P2|COMPLETED|Induction Phase||0
8480232|NCT00606021|20898133|P1|COMPLETED|Induction Phase||19
8480233|NCT00606021|20898131|P3|STARTED|Induction Phase||0
8480234|NCT00606021|20898132|P2|STARTED|Induction Phase||0
8480235|NCT00606021|20898133|P1|STARTED|Induction Phase||106
8480236|NCT00606008|20898151|P1|NOT COMPLETED|Overall Study||5
8480237|NCT00606008|20898151|P1|COMPLETED|Overall Study||25
8480238|NCT00606008|20898151|P1|STARTED|Overall Study||30
8480239|NCT00605904|20898167|P2|NOT COMPLETED|Infusion Sessions||3
8480240|NCT00605904|20898168|P1|NOT COMPLETED|Infusion Sessions||1
8480241|NCT00605904|20898167|P2|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
8480242|NCT00605904|20898168|P1|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
8480243|NCT00605904|20898167|P2|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
8480244|NCT00605904|20898168|P1|Yohimbine Infusion|Infusion Sessions||12
8480245|NCT00605904|20898167|P2|mCPP Infusion|Infusion Sessions||13
8480246|NCT00605904|20898168|P1|mCPP Infusion|Infusion Sessions||12
8480247|NCT00605904|20898167|P2|Saline Infusion|Infusion Sessions||14
8480248|NCT00605904|20898168|P1|Saline Infusion|Infusion Sessions||13
8480249|NCT00605904|20898167|P2|STARTED|Infusion Sessions||16
8480250|NCT00605904|20898168|P1|STARTED|Infusion Sessions||13
8480251|NCT00605904|20898167|P2|NOT COMPLETED|Baseline Data Collection and Dosing||5
8480252|NCT00605904|20898168|P1|NOT COMPLETED|Baseline Data Collection and Dosing||0
8480253|NCT00605904|20898167|P2|COMPLETED|Baseline Data Collection and Dosing||16
8480254|NCT00605904|20898168|P1|COMPLETED|Baseline Data Collection and Dosing||13
8480255|NCT00605904|20898167|P2|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
8480256|NCT00605904|20898168|P1|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
8480257|NCT00605839|20898181|P3|NOT COMPLETED|Overall Study||0
8480258|NCT00605839|20898182|P2|NOT COMPLETED|Overall Study||0
8480259|NCT00605839|20898183|P1|NOT COMPLETED|Overall Study||1
8480260|NCT00605839|20898181|P3|COMPLETED|Overall Study||28
8480261|NCT00605839|20898182|P2|COMPLETED|Overall Study||37
8480262|NCT00605839|20898183|P1|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
8480263|NCT00605839|20898181|P3|STARTED|Overall Study||28
8480264|NCT00605839|20898182|P2|STARTED|Overall Study||37
8480265|NCT00605839|20898183|P1|STARTED|Overall Study||40
8480266|NCT00605826|20898193|P2|NOT COMPLETED|Overall Study||10
8480267|NCT00605826|20898194|P1|NOT COMPLETED|Overall Study||7
8480268|NCT00605826|20898193|P2|COMPLETED|Overall Study||60
8480269|NCT00605826|20898194|P1|COMPLETED|Overall Study||129
8480270|NCT00605826|20898193|P2|STARTED|Overall Study||70
8480271|NCT00605826|20898194|P1|STARTED|Overall Study||136
8480272|NCT00605722|20898206|P1|NOT COMPLETED|Overall Study||51
8480273|NCT00605722|20898206|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|0
8480274|NCT00605722|20898206|P1|STARTED|Overall Study||51
8480275|NCT00605696|20898218|P2|NOT COMPLETED|Overall Study||0
8480276|NCT00605696|20898219|P1|NOT COMPLETED|Overall Study||0
8480277|NCT00605696|20898218|P2|COMPLETED|Overall Study||11
8480278|NCT00605696|20898219|P1|COMPLETED|Overall Study||7
8480279|NCT00605696|20898218|P2|STARTED|Overall Study||11
8480280|NCT00605696|20898219|P1|STARTED|Overall Study||7
8480281|NCT00605657|20898227|P1|NOT COMPLETED|Overall Study||2
8480282|NCT00605657|20898227|P1|COMPLETED|Overall Study||3
8480283|NCT00605657|20898227|P1|STARTED|Overall Study||5
8480284|NCT00605644|20898237|P5|NOT COMPLETED|Overall Study||8
8480285|NCT00605644|20898238|P4|NOT COMPLETED|Overall Study||5
8480286|NCT00605644|20898239|P3|NOT COMPLETED|Overall Study||2
8480287|NCT00605644|20898240|P2|NOT COMPLETED|Overall Study||1
8480288|NCT00605644|20898241|P1|NOT COMPLETED|Overall Study||1
8480289|NCT00605644|20898237|P5|COMPLETED|Overall Study||22
8480290|NCT00605644|20898238|P4|COMPLETED|Overall Study||25
8480291|NCT00605644|20898239|P3|COMPLETED|Overall Study||18
8480292|NCT00605644|20898240|P2|COMPLETED|Overall Study||18
8480293|NCT00605644|20898241|P1|COMPLETED|Overall Study||28
8480294|NCT00605644|20898237|P5|STARTED|Overall Study||30
8480295|NCT00605644|20898238|P4|STARTED|Overall Study||30
8480296|NCT00605644|20898239|P3|STARTED|Overall Study||20
8480297|NCT00605644|20898240|P2|STARTED|Overall Study||19
8480298|NCT00605644|20898241|P1|STARTED|Overall Study||29
8480299|NCT00605566|20898253|P1|NOT COMPLETED|Overall Study||3
8480300|NCT00605566|20898253|P1|COMPLETED|Overall Study||19
8480301|NCT00605566|20898253|P1|STARTED|Overall Study||22
8480302|NCT00605540|20898261|P1|NOT COMPLETED|Overall Study||38
8480303|NCT00605540|20898261|P1|COMPLETED|Overall Study||95
8480304|NCT00605540|20898261|P1|STARTED|Overall Study||133
8480305|NCT00605475|20898279|P10|NOT COMPLETED|Overall Study||2
8480306|NCT00605475|20898280|P9|NOT COMPLETED|Overall Study||2
8480307|NCT00605475|20898281|P8|NOT COMPLETED|Overall Study||0
8480308|NCT00605475|20898282|P7|NOT COMPLETED|Overall Study||1
8480309|NCT00605475|20898283|P6|NOT COMPLETED|Overall Study||2
8480310|NCT00605475|20898284|P5|NOT COMPLETED|Overall Study||1
8480311|NCT00605475|20898285|P4|NOT COMPLETED|Overall Study||0
8480312|NCT00605475|20898286|P3|NOT COMPLETED|Overall Study||0
8480313|NCT00605475|20898287|P2|NOT COMPLETED|Overall Study||0
8480314|NCT00605475|20898288|P1|NOT COMPLETED|Overall Study||0
8480315|NCT00605475|20898279|P10|COMPLETED|Overall Study||8
8480316|NCT00605475|20898280|P9|COMPLETED|Overall Study||18
8480317|NCT00605475|20898281|P8|COMPLETED|Overall Study||24
8480318|NCT00605475|20898282|P7|COMPLETED|Overall Study||22
8480319|NCT00605475|20898283|P6|COMPLETED|Overall Study||22
8480320|NCT00605475|20898284|P5|COMPLETED|Overall Study||24
8480321|NCT00605475|20898285|P4|COMPLETED|Overall Study||45
8480322|NCT00605475|20898286|P3|COMPLETED|Overall Study||45
8480323|NCT00605475|20898287|P2|COMPLETED|Overall Study||5
8480324|NCT00605475|20898288|P1|COMPLETED|Overall Study||10
8480325|NCT00605475|20898279|P10|STARTED|Overall Study||10
8480326|NCT00605475|20898280|P9|STARTED|Overall Study||20
8480327|NCT00605475|20898281|P8|STARTED|Overall Study||24
8480328|NCT00605475|20898282|P7|STARTED|Overall Study||23
8480329|NCT00605475|20898283|P6|STARTED|Overall Study||24
8480330|NCT00605475|20898284|P5|STARTED|Overall Study||25
8480331|NCT00605475|20898285|P4|STARTED|Overall Study||45
8480332|NCT00605475|20898286|P3|STARTED|Overall Study||45
8480333|NCT00605475|20898287|P2|STARTED|Overall Study||5
8480334|NCT00605475|20898288|P1|STARTED|Overall Study||10
8480335|NCT00605423|20898412|P2|NOT COMPLETED|Overall Study||0
8480336|NCT00605423|20898413|P1|NOT COMPLETED|Overall Study||0
8480337|NCT00605423|20898412|P2|COMPLETED|Overall Study||2
8480338|NCT00605423|20898413|P1|COMPLETED|Overall Study||4
8480339|NCT00605423|20898412|P2|STARTED|Overall Study||2
8480340|NCT00605423|20898413|P1|STARTED|Overall Study||4
8480341|NCT00605384|20898425|P2|NOT COMPLETED|Overall Study||1
8480342|NCT00605384|20898426|P1|NOT COMPLETED|Overall Study||1
8480343|NCT00605384|20898425|P2|COMPLETED|Overall Study|study terminated early|0
8480344|NCT00605384|20898426|P1|COMPLETED|Overall Study|study terminated early|0
8480345|NCT00605384|20898425|P2|STARTED|Overall Study||1
8480346|NCT00605384|20898426|P1|STARTED|Overall Study||1
8480347|NCT00605358|20898456|P2|NOT COMPLETED|Overall Study||0
8480348|NCT00605358|20898457|P1|NOT COMPLETED|Overall Study||0
8480349|NCT00605358|20898456|P2|COMPLETED|Overall Study||80
8480350|NCT00605358|20898457|P1|COMPLETED|Overall Study||81
8480351|NCT00605358|20898456|P2|STARTED|Overall Study||80
8480352|NCT00605358|20898457|P1|STARTED|Overall Study||81
8480353|NCT00605345|20898465|P2|NOT COMPLETED|Overall Study||3
8480354|NCT00605345|20898466|P1|NOT COMPLETED|Overall Study||1
8480355|NCT00605345|20898465|P2|COMPLETED|Overall Study||22
8480356|NCT00605345|20898466|P1|COMPLETED|Overall Study||45
8480357|NCT00605345|20898465|P2|STARTED|Overall Study||25
8480358|NCT00605345|20898466|P1|STARTED|Overall Study||46
8480359|NCT00605319|20898482|P1|NOT COMPLETED|Overall Study||6
8480360|NCT00605319|20898482|P1|COMPLETED|Overall Study||11
8480361|NCT00605319|20898482|P1|STARTED|Overall Study||17
8480362|NCT00605306|20898494|P2|NOT COMPLETED|Overall Study||1
8480363|NCT00605306|20898495|P1|NOT COMPLETED|Overall Study||0
8480364|NCT00605306|20898494|P2|COMPLETED|Overall Study||13
8480365|NCT00605306|20898495|P1|COMPLETED|Overall Study||14
8480366|NCT00605306|20898494|P2|STARTED|Overall Study||14
8480367|NCT00605306|20898495|P1|STARTED|Overall Study||14
8480368|NCT00605293|20898509|P2|NOT COMPLETED|Overall Study||5
8480369|NCT00605293|20898510|P1|NOT COMPLETED|Overall Study||17
8480370|NCT00605293|20898509|P2|COMPLETED|Overall Study||31
8480371|NCT00605293|20898510|P1|COMPLETED|Overall Study||48
8480372|NCT00605293|20898509|P2|STARTED|Overall Study||36
8480373|NCT00605293|20898510|P1|STARTED|Overall Study||65
8480374|NCT00605280|20898530|P4|NOT COMPLETED|Year 3 Extension||9
8480375|NCT00605280|20898531|P3|NOT COMPLETED|Year 3 Extension||0
8480376|NCT00605280|20898532|P2|NOT COMPLETED|Year 3 Extension||0
8480377|NCT00605280|20898533|P1|NOT COMPLETED|Year 3 Extension||8
8480378|NCT00605280|20898530|P4|COMPLETED|Year 3 Extension||45
8480379|NCT00605280|20898531|P3|COMPLETED|Year 3 Extension||0
8480380|NCT00605280|20898532|P2|COMPLETED|Year 3 Extension||0
8480381|NCT00605280|20898533|P1|COMPLETED|Year 3 Extension||38
8480382|NCT00605280|20898530|P4|Received 0.3 mg Treatment|Year 3 Extension||54
8480383|NCT00605280|20898531|P3|Received 0.3 mg Treatment|Year 3 Extension||0
8480384|NCT00605280|20898532|P2|Received 0.3 mg Treatment|Year 3 Extension||0
8480385|NCT00605280|20898533|P1|Received 0.3 mg Treatment|Year 3 Extension||46
8480386|NCT00605280|20898530|P4|STARTED|Year 3 Extension||54
8480387|NCT00605280|20898531|P3|STARTED|Year 3 Extension||0
8480388|NCT00605280|20898532|P2|STARTED|Year 3 Extension||0
8480389|NCT00605280|20898533|P1|STARTED|Year 3 Extension||46
8480390|NCT00605280|20898530|P4|NOT COMPLETED|Year 2||22
8480391|NCT00605280|20898531|P3|NOT COMPLETED|Year 2||6
8480392|NCT00605280|20898532|P2|NOT COMPLETED|Year 2||6
8480393|NCT00605280|20898533|P1|NOT COMPLETED|Year 2||24
8480394|NCT00605280|20898530|P4|COMPLETED|Year 2||102
8480395|NCT00605280|20898531|P3|COMPLETED|Year 2||0
8480396|NCT00605280|20898532|P2|COMPLETED|Year 2||5
8480397|NCT00605280|20898533|P1|COMPLETED|Year 2||102
8480398|NCT00605280|20898530|P4|Received 0.3 mg Treatment|Year 2||0
8480399|NCT00605280|20898531|P3|Received 0.3 mg Treatment|Year 2||2
8480400|NCT00605280|20898532|P2|Received 0.3 mg Treatment|Year 2||3
8480401|NCT00605280|20898533|P1|Received 0.3 mg Treatment|Year 2||126
8480402|NCT00605280|20898530|P4|STARTED|Year 2||124
8480403|NCT00605280|20898531|P3|STARTED|Year 2||6
8480404|NCT00605280|20898532|P2|STARTED|Year 2||11
8480405|NCT00605280|20898533|P1|STARTED|Year 2||126
8480406|NCT00605280|20898530|P4|NOT COMPLETED|Year 1||19
8480407|NCT00605280|20898531|P3|NOT COMPLETED|Year 1||1
8480408|NCT00605280|20898532|P2|NOT COMPLETED|Year 1||11
8480409|NCT00605280|20898533|P1|NOT COMPLETED|Year 1||19
8480410|NCT00605280|20898530|P4|COMPLETED|Year 1||124
8480411|NCT00605280|20898531|P3|COMPLETED|Year 1||6
8480412|NCT00605280|20898532|P2|COMPLETED|Year 1||11
8480413|NCT00605280|20898533|P1|COMPLETED|Year 1||126
8480414|NCT00605280|20898530|P4|Received 0.3 mg Treatment|Year 1||0
8480415|NCT00605280|20898531|P3|Received 0.3 mg Treatment|Year 1||3
8480416|NCT00605280|20898532|P2|Received 0.3 mg Treatment|Year 1||13
8480417|NCT00605280|20898533|P1|Received 0.3 mg Treatment|Year 1||144
8480418|NCT00605280|20898530|P4|STARTED|Year 1||143
8480419|NCT00605280|20898531|P3|STARTED|Year 1||7
8480420|NCT00605280|20898532|P2|STARTED|Year 1||22
8480421|NCT00605280|20898533|P1|STARTED|Year 1||145
8480422|NCT00605267|20898567|P2|NOT COMPLETED|Overall Study||9
8480423|NCT00605267|20898568|P1|NOT COMPLETED|Overall Study||3
8480424|NCT00605267|20898567|P2|COMPLETED|Overall Study|Breast surgery performed|90
8480425|NCT00605267|20898568|P1|COMPLETED|Overall Study|Breast surgery performed|95
8480426|NCT00605267|20898567|P2|STARTED|Overall Study||99
8480427|NCT00605267|20898568|P1|STARTED|Overall Study||98
8480428|NCT00605202|20898606|P2|NOT COMPLETED|Second Intervention||0
8480429|NCT00605202|20898607|P1|NOT COMPLETED|Second Intervention||0
8480430|NCT00605202|20898606|P2|COMPLETED|Second Intervention||5
8480431|NCT00605202|20898607|P1|COMPLETED|Second Intervention||5
8480432|NCT00605202|20898606|P2|STARTED|Second Intervention||5
8480433|NCT00605202|20898607|P1|STARTED|Second Intervention||5
8480434|NCT00605202|20898606|P2|NOT COMPLETED|Washout Period of 3 Weeks||0
8480435|NCT00605202|20898607|P1|NOT COMPLETED|Washout Period of 3 Weeks||0
8480436|NCT00605202|20898606|P2|COMPLETED|Washout Period of 3 Weeks||5
8480437|NCT00605202|20898607|P1|COMPLETED|Washout Period of 3 Weeks||5
8480438|NCT00605202|20898606|P2|STARTED|Washout Period of 3 Weeks||5
8480439|NCT00605202|20898607|P1|STARTED|Washout Period of 3 Weeks||5
8480440|NCT00605202|20898606|P2|NOT COMPLETED|First Intervention||0
8480441|NCT00605202|20898607|P1|NOT COMPLETED|First Intervention||0
8480442|NCT00605202|20898606|P2|COMPLETED|First Intervention||5
8480443|NCT00605202|20898607|P1|COMPLETED|First Intervention||5
8480444|NCT00605202|20898606|P2|STARTED|First Intervention||5
8480445|NCT00605202|20898607|P1|STARTED|First Intervention||5
8480446|NCT00605189|20898616|P3|NOT COMPLETED|Overall Study||0
8480447|NCT00605189|20898617|P2|NOT COMPLETED|Overall Study||2
8480448|NCT00605189|20898618|P1|NOT COMPLETED|Overall Study||3
8480449|NCT00605189|20898616|P3|COMPLETED|Overall Study||9
8480450|NCT00605189|20898617|P2|COMPLETED|Overall Study||19
8480451|NCT00605189|20898618|P1|COMPLETED|Overall Study||17
8480452|NCT00605189|20898616|P3|STARTED|Overall Study||9
8480453|NCT00605189|20898617|P2|STARTED|Overall Study||21
8480454|NCT00605189|20898618|P1|STARTED|Overall Study||20
8480455|NCT00605176|20898629|P3|NOT COMPLETED|Overall Study||9
8480456|NCT00605176|20898630|P2|NOT COMPLETED|Overall Study||6
8480457|NCT00605176|20898631|P1|NOT COMPLETED|Overall Study||11
8480458|NCT00605176|20898629|P3|COMPLETED|Overall Study||150
8480459|NCT00605176|20898630|P2|COMPLETED|Overall Study||154
8480460|NCT00605176|20898631|P1|COMPLETED|Overall Study||149
8480461|NCT00605176|20898629|P3|STARTED|Overall Study||159
8480462|NCT00605176|20898630|P2|STARTED|Overall Study||160
8480463|NCT00605176|20898631|P1|STARTED|Overall Study||160
8480464|NCT00605150|20898648|P1|NOT COMPLETED|Overall Study||1
8480465|NCT00605150|20898648|P1|COMPLETED|Overall Study||10
8480466|NCT00605150|20898648|P1|STARTED|Overall Study|11 started|11
8480467|NCT00605085|20898655|P2|NOT COMPLETED|Overall Study||25
8480468|NCT00605085|20898656|P1|NOT COMPLETED|Overall Study||50
8480469|NCT00605085|20898655|P2|COMPLETED|Overall Study||638
8480470|NCT00605085|20898656|P1|COMPLETED|Overall Study||1962
8480471|NCT00605085|20898655|P2|STARTED|Overall Study||663
8480472|NCT00605085|20898656|P1|STARTED|Overall Study||2012
8480473|NCT00605072|20898665|P3|NOT COMPLETED|Overall Study||4
8480474|NCT00605072|20898666|P2|NOT COMPLETED|Overall Study||11
8480475|NCT00605072|20898667|P1|NOT COMPLETED|Overall Study||7
8480476|NCT00605072|20898665|P3|COMPLETED|Overall Study||11
8480477|NCT00605072|20898666|P2|COMPLETED|Overall Study||9
8480478|NCT00605072|20898667|P1|COMPLETED|Overall Study||11
8480479|NCT00605072|20898665|P3|STARTED|Overall Study||15
8480480|NCT00605072|20898666|P2|STARTED|Overall Study||20
8480481|NCT00605072|20898667|P1|STARTED|Overall Study||18
8480482|NCT00605033|20898689|P2|NOT COMPLETED|Overall Study||8
8480483|NCT00605033|20898690|P1|NOT COMPLETED|Overall Study||7
8480484|NCT00605033|20898689|P2|COMPLETED|Overall Study||90
8480485|NCT00605033|20898690|P1|COMPLETED|Overall Study||136
8480486|NCT00605033|20898689|P2|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
8480487|NCT00605033|20898690|P1|STARTED|Overall Study||143
8480488|NCT00604968|20898696|P1|NOT COMPLETED|Overall Study||0
8480489|NCT00604968|20898696|P1|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
8480490|NCT00604968|20898696|P1|STARTED|Overall Study||25
8480491|NCT00604890|20898713|P4|NOT COMPLETED|Overall Study||4
8480492|NCT00604890|20898714|P3|NOT COMPLETED|Overall Study||1
8480493|NCT00604890|20898715|P2|NOT COMPLETED|Overall Study||0
8480494|NCT00604890|20898716|P1|NOT COMPLETED|Overall Study||3
8480495|NCT00604890|20898713|P4|COMPLETED|Overall Study||42
8480496|NCT00604890|20898714|P3|COMPLETED|Overall Study||47
8480497|NCT00604890|20898715|P2|COMPLETED|Overall Study||45
8480498|NCT00604890|20898716|P1|COMPLETED|Overall Study||44
8480499|NCT00604890|20898713|P4|STARTED|Overall Study||46
8480500|NCT00604890|20898714|P3|STARTED|Overall Study||48
8480501|NCT00604890|20898715|P2|STARTED|Overall Study||45
8480502|NCT00604890|20898716|P1|STARTED|Overall Study||47
8480503|NCT00604825|20898734|P4|NOT COMPLETED|Overall Study||11
8480504|NCT00604825|20898735|P3|NOT COMPLETED|Overall Study||16
8480505|NCT00604825|20898736|P2|NOT COMPLETED|Overall Study||15
8480506|NCT00604825|20898737|P1|NOT COMPLETED|Overall Study||9
8480507|NCT00604825|20898734|P4|COMPLETED|Overall Study||79
8480508|NCT00604825|20898735|P3|COMPLETED|Overall Study||73
8480509|NCT00604825|20898736|P2|COMPLETED|Overall Study||72
8480510|NCT00604825|20898737|P1|COMPLETED|Overall Study||81
8480511|NCT00604825|20898734|P4|STARTED|Overall Study||90
8480512|NCT00604825|20898735|P3|STARTED|Overall Study||89
8480513|NCT00604825|20898736|P2|STARTED|Overall Study||87
8480514|NCT00604825|20898737|P1|STARTED|Overall Study||90
8480515|NCT00604812|20898938|P6|NOT COMPLETED|Overall Study||0
8480516|NCT00604812|20898939|P5|NOT COMPLETED|Overall Study||0
8480517|NCT00604812|20898940|P4|NOT COMPLETED|Overall Study||0
8480518|NCT00604812|20898941|P3|NOT COMPLETED|Overall Study||0
8480519|NCT00604812|20898942|P2|NOT COMPLETED|Overall Study||0
8480520|NCT00604812|20898943|P1|NOT COMPLETED|Overall Study||0
8480521|NCT00604812|20898938|P6|COMPLETED|Overall Study||1
8480522|NCT00604812|20898939|P5|COMPLETED|Overall Study||5
8480523|NCT00604812|20898940|P4|COMPLETED|Overall Study||3
8480524|NCT00604812|20898941|P3|COMPLETED|Overall Study||10
8480525|NCT00604812|20898942|P2|COMPLETED|Overall Study||3
8480526|NCT00604812|20898943|P1|COMPLETED|Overall Study||9
8480527|NCT00604812|20898938|P6|STARTED|Overall Study||1
8480528|NCT00604812|20898939|P5|STARTED|Overall Study||5
8480529|NCT00604812|20898940|P4|STARTED|Overall Study||3
8480530|NCT00604812|20898941|P3|STARTED|Overall Study||10
8480531|NCT00604812|20898942|P2|STARTED|Overall Study||3
8480532|NCT00604812|20898943|P1|STARTED|Overall Study||9
8480533|NCT00604786|20898965|P2|NOT COMPLETED|Overall Study||0
8480534|NCT00604786|20898966|P1|NOT COMPLETED|Overall Study||2
8480535|NCT00604786|20898965|P2|COMPLETED|Overall Study||4
8480536|NCT00604786|20898966|P1|COMPLETED|Overall Study||12
8480537|NCT00604786|20898965|P2|STARTED|Overall Study||4
8480538|NCT00604786|20898966|P1|STARTED|Overall Study||14
8480539|NCT00604721|20898972|P1|NOT COMPLETED|Overall Study||2
8480540|NCT00604721|20898972|P1|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
8480541|NCT00604721|20898972|P1|STARTED|Overall Study||19
8480542|NCT00604708|20898980|P2|NOT COMPLETED|Overall Study||40
8480543|NCT00604708|20898981|P1|NOT COMPLETED|Overall Study||31
8480544|NCT00604708|20898980|P2|COMPLETED|Overall Study||397
8480545|NCT00604708|20898981|P1|COMPLETED|Overall Study||399
8480546|NCT00604708|20898980|P2|STARTED|Overall Study||437
8480547|NCT00604708|20898981|P1|STARTED|Overall Study||430
8480548|NCT00604695|20898991|P2|NOT COMPLETED|Overall Study||4
8480549|NCT00604695|20898992|P1|NOT COMPLETED|Overall Study||0
8480550|NCT00604695|20898991|P2|COMPLETED|Overall Study||16
8480551|NCT00604695|20898992|P1|COMPLETED|Overall Study||20
8480552|NCT00604695|20898991|P2|STARTED|Overall Study||20
8480553|NCT00604695|20898992|P1|STARTED|Overall Study||20
8480554|NCT00604669|20899014|P1|NOT COMPLETED|Overall Study||7
8480555|NCT00604669|20899014|P1|COMPLETED|Overall Study||163
8480556|NCT00604669|20899014|P1|STARTED|Overall Study||170
8480557|NCT00604565|20899020|P2|NOT COMPLETED|Overall Study||3
8480558|NCT00604565|20899021|P1|NOT COMPLETED|Overall Study||0
8480559|NCT00604565|20899020|P2|COMPLETED|Overall Study||4
8480560|NCT00604565|20899021|P1|COMPLETED|Overall Study||4
8480561|NCT00604565|20899020|P2|STARTED|Overall Study||7
8480562|NCT00604565|20899021|P1|STARTED|Overall Study||4
8480563|NCT00604552|20899031|P2|NOT COMPLETED|Overall Study||0
8480564|NCT00604552|20899032|P1|NOT COMPLETED|Overall Study||0
8480565|NCT00604552|20899031|P2|COMPLETED|Overall Study||160
8480566|NCT00604552|20899032|P1|COMPLETED|Overall Study||189
8480567|NCT00604552|20899031|P2|STARTED|Overall Study||160
8480568|NCT00604552|20899032|P1|STARTED|Overall Study||189
8480572|NCT00604461|20899047|P1|NOT COMPLETED|Overall Study||1
8480573|NCT00604461|20899047|P1|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
8480574|NCT00604461|20899047|P1|STARTED|Overall Study||13
8480575|NCT00604383|20899054|P2|NOT COMPLETED|Overall Study||84
8480576|NCT00604383|20899055|P1|NOT COMPLETED|Overall Study||87
8480577|NCT00604383|20899054|P2|COMPLETED|Overall Study||256
8480578|NCT00604383|20899055|P1|COMPLETED|Overall Study||258
8480579|NCT00604383|20899054|P2|Received Extended Treatment|Overall Study||141
8480580|NCT00604383|20899055|P1|Received Extended Treatment|Overall Study||136
8480581|NCT00604383|20899054|P2|Received at Least 1 Dose of Study Drug|Overall Study||340
8480582|NCT00604383|20899055|P1|Received at Least 1 Dose of Study Drug|Overall Study||345
8480583|NCT00604383|20899054|P2|STARTED|Overall Study||340
8480584|NCT00604383|20899055|P1|STARTED|Overall Study||345
8480585|NCT00604279|20899071|P2|NOT COMPLETED|Overall Study||38
8480586|NCT00604279|20899072|P1|NOT COMPLETED|Overall Study||64
8480587|NCT00604279|20899071|P2|COMPLETED|Overall Study||185
8480588|NCT00604279|20899072|P1|COMPLETED|Overall Study||165
8480589|NCT00604279|20899071|P2|STARTED|Overall Study||223
8480590|NCT00604279|20899072|P1|STARTED|Overall Study||229
8480591|NCT00604214|20899088|P2|NOT COMPLETED|Day 91 to Day 180||32
8480592|NCT00604214|20899089|P1|NOT COMPLETED|Day 91 to Day 180||26
8480593|NCT00604214|20899088|P2|COMPLETED|Day 91 to Day 180||521
8480594|NCT00604214|20899089|P1|COMPLETED|Day 91 to Day 180||529
8480595|NCT00604214|20899088|P2|STARTED|Day 91 to Day 180||553
8480596|NCT00604214|20899089|P1|STARTED|Day 91 to Day 180||555
8480597|NCT00604214|20899088|P2|NOT COMPLETED|Day 29 to Day 90||79
8480598|NCT00604214|20899089|P1|NOT COMPLETED|Day 29 to Day 90||68
8480599|NCT00604214|20899088|P2|COMPLETED|Day 29 to Day 90||553
8480600|NCT00604214|20899089|P1|COMPLETED|Day 29 to Day 90||555
8480601|NCT00604214|20899088|P2|STARTED|Day 29 to Day 90||632
8480602|NCT00604214|20899089|P1|STARTED|Day 29 to Day 90||623
8480603|NCT00604214|20899088|P2|NOT COMPLETED|Baseline to Day 28||213
8480604|NCT00604214|20899089|P1|NOT COMPLETED|Baseline to Day 28||228
8480605|NCT00604214|20899088|P2|COMPLETED|Baseline to Day 28||632
8480606|NCT00604214|20899089|P1|COMPLETED|Baseline to Day 28||623
8480607|NCT00604214|20899088|P2|Received Study Drug|Baseline to Day 28||833
8480608|NCT00604214|20899089|P1|Received Study Drug|Baseline to Day 28||833
8480609|NCT00604214|20899088|P2|STARTED|Baseline to Day 28||845
8480610|NCT00604214|20899089|P1|STARTED|Baseline to Day 28||851
8480611|NCT00604201|20899119|P1|NOT COMPLETED|Overall Study||10
8480612|NCT00604201|20899119|P1|COMPLETED|Overall Study||21
8480613|NCT00604201|20899119|P1|STARTED|Overall Study||31
8480614|NCT00604188|20899137|P2|NOT COMPLETED|Overall Study||25
8480615|NCT00604188|20899138|P1|NOT COMPLETED|Overall Study||27
8480616|NCT00604188|20899137|P2|COMPLETED|Overall Study||70
8480617|NCT00604188|20899138|P1|COMPLETED|Overall Study||66
8480618|NCT00604188|20899137|P2|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
8480619|NCT00604188|20899138|P1|STARTED|Overall Study||93
8480620|NCT00604175|20899161|P3|NOT COMPLETED|Week 29 Through Week 72||4
8480621|NCT00604175|20899162|P2|NOT COMPLETED|Week 29 Through Week 72||7
8480622|NCT00604175|20899163|P1|NOT COMPLETED|Week 29 Through Week 72||12
8480623|NCT00604175|20899161|P3|COMPLETED|Week 29 Through Week 72||89
8480624|NCT00604175|20899162|P2|COMPLETED|Week 29 Through Week 72||85
8480625|NCT00604175|20899163|P1|COMPLETED|Week 29 Through Week 72||108
8480626|NCT00604175|20899161|P3|STARTED|Week 29 Through Week 72||93
8480627|NCT00604175|20899162|P2|STARTED|Week 29 Through Week 72||92
8480628|NCT00604175|20899163|P1|STARTED|Week 29 Through Week 72||120
8480629|NCT00604175|20899161|P3|NOT COMPLETED|Entry Through Week 28||1
8480630|NCT00604175|20899162|P2|NOT COMPLETED|Entry Through Week 28||3
8480631|NCT00604175|20899163|P1|NOT COMPLETED|Entry Through Week 28||10
8480632|NCT00604175|20899161|P3|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
8480633|NCT00604175|20899162|P2|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
8480634|NCT00604175|20899163|P1|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
8480635|NCT00604175|20899161|P3|STARTED|Entry Through Week 28||94
8480636|NCT00604175|20899162|P2|STARTED|Entry Through Week 28||95
8480637|NCT00604175|20899163|P1|STARTED|Entry Through Week 28||130
8480638|NCT00604162|20899216|P1|NOT COMPLETED|Overall Study||4
8480639|NCT00604162|20899216|P1|COMPLETED|Overall Study||328
8480640|NCT00604162|20899216|P1|STARTED|Overall Study||332
8480641|NCT00604045|20899229|P2|NOT COMPLETED|Overall Study||1
8480642|NCT00604045|20899230|P1|NOT COMPLETED|Overall Study||1
8480643|NCT00604045|20899229|P2|COMPLETED|Overall Study||9
8480644|NCT00604045|20899230|P1|COMPLETED|Overall Study||14
8480645|NCT00604045|20899229|P2|STARTED|Overall Study||10
8480646|NCT00604045|20899230|P1|STARTED|Overall Study||15
8480647|NCT00604019|20899238|P2|NOT COMPLETED|Overall Study||0
8480648|NCT00604019|20899239|P1|NOT COMPLETED|Overall Study||0
8480649|NCT00604019|20899238|P2|COMPLETED|Overall Study||118
8480650|NCT00604019|20899239|P1|COMPLETED|Overall Study||134
8480651|NCT00604019|20899238|P2|STARTED|Overall Study||118
8480652|NCT00604019|20899239|P1|STARTED|Overall Study||134
8480653|NCT00603993|20899245|P1|NOT COMPLETED|Overall Study||20
8480654|NCT00603993|20899245|P1|COMPLETED|Overall Study||68
8480655|NCT00603993|20899245|P1|STARTED|Overall Study||88
8480656|NCT00603980|20899258|P1|NOT COMPLETED|Main Study||1
8480657|NCT00603980|20899258|P1|COMPLETED|Main Study||14
8480658|NCT00603980|20899258|P1|STARTED|Main Study||15
8480659|NCT00603980|20899258|P1|NOT COMPLETED|Study Qualification||16
8480660|NCT00603980|20899258|P1|COMPLETED|Study Qualification||15
8480661|NCT00603980|20899258|P1|STARTED|Study Qualification||31
8480662|NCT00603941|20899377|P3|NOT COMPLETED|Overall Study||2
8480663|NCT00603941|20899378|P2|NOT COMPLETED|Overall Study||10
8480664|NCT00603941|20899379|P1|NOT COMPLETED|Overall Study||7
8480665|NCT00603941|20899377|P3|COMPLETED|Overall Study||0
8480666|NCT00603941|20899378|P2|COMPLETED|Overall Study||0
8480667|NCT00603941|20899379|P1|COMPLETED|Overall Study||0
8480668|NCT00603941|20899377|P3|STARTED|Overall Study||2
8480669|NCT00603941|20899378|P2|STARTED|Overall Study||10
8480670|NCT00603941|20899379|P1|STARTED|Overall Study||7
8480671|NCT00603915|20899390|P1|NOT COMPLETED|Overall Study||1
8480672|NCT00603915|20899390|P1|COMPLETED|Overall Study||19
8480673|NCT00603915|20899390|P1|STARTED|Overall Study||20
8480674|NCT00603902|20899398|P3|NOT COMPLETED|Overall Study||769
8480675|NCT00603902|20899399|P2|NOT COMPLETED|Overall Study||686
8480676|NCT00603902|20899400|P1|NOT COMPLETED|Overall Study||329
8480677|NCT00603902|20899398|P3|COMPLETED|Overall Study||834
8480678|NCT00603902|20899399|P2|COMPLETED|Overall Study||917
8480679|NCT00603902|20899400|P1|COMPLETED|Overall Study||473
8480680|NCT00603902|20899398|P3|STARTED|Overall Study||1603
8480681|NCT00603902|20899399|P2|STARTED|Overall Study||1603
8480682|NCT00603902|20899400|P1|STARTED|Overall Study||802
8480683|NCT00603889|20899411|P1|NOT COMPLETED|Overall Study||0
8480684|NCT00603889|20899411|P1|COMPLETED|Overall Study||12
8480685|NCT00603889|20899411|P1|STARTED|Overall Study||12
8480686|NCT00603837|20899420|P2|NOT COMPLETED|Overall Study||0
8480687|NCT00603837|20899421|P1|NOT COMPLETED|Overall Study||3
8480688|NCT00603837|20899420|P2|COMPLETED|Overall Study||19
8480689|NCT00603837|20899421|P1|COMPLETED|Overall Study||17
8480690|NCT00603837|20899420|P2|STARTED|Overall Study||19
8480691|NCT00603837|20899421|P1|STARTED|Overall Study||20
8480692|NCT00603798|20899430|P3|NOT COMPLETED|Overall Study||10
8480693|NCT00603798|20899431|P2|NOT COMPLETED|Overall Study||7
8480694|NCT00603798|20899432|P1|NOT COMPLETED|Overall Study||10
8480695|NCT00603798|20899430|P3|COMPLETED|Overall Study||154
8480696|NCT00603798|20899431|P2|COMPLETED|Overall Study||157
8480697|NCT00603798|20899432|P1|COMPLETED|Overall Study||152
8480698|NCT00603798|20899430|P3|STARTED|Overall Study||164
8480699|NCT00603798|20899431|P2|STARTED|Overall Study||164
8480700|NCT00603798|20899432|P1|STARTED|Overall Study||162
8480701|NCT00603746|20899455|P6|NOT COMPLETED|Overall Study||13
8480702|NCT00603746|20899456|P5|NOT COMPLETED|Overall Study||17
8480703|NCT00603746|20899457|P4|NOT COMPLETED|Overall Study||13
8480704|NCT00603746|20899458|P3|NOT COMPLETED|Overall Study||8
8480705|NCT00603746|20899459|P2|NOT COMPLETED|Overall Study||18
8480706|NCT00603746|20899460|P1|NOT COMPLETED|Overall Study||38
8480707|NCT00603746|20899455|P6|COMPLETED|Overall Study||97
8480708|NCT00603746|20899456|P5|COMPLETED|Overall Study||85
8480709|NCT00603746|20899457|P4|COMPLETED|Overall Study||94
8480710|NCT00603746|20899458|P3|COMPLETED|Overall Study||93
8480711|NCT00603746|20899459|P2|COMPLETED|Overall Study||81
8480712|NCT00603746|20899460|P1|COMPLETED|Overall Study||65
8480713|NCT00603746|20899455|P6|STARTED|Overall Study||110
8480714|NCT00603746|20899456|P5|STARTED|Overall Study||102
8480715|NCT00603746|20899457|P4|STARTED|Overall Study||107
8480716|NCT00603746|20899458|P3|STARTED|Overall Study||101
8480717|NCT00603746|20899459|P2|STARTED|Overall Study||99
8480718|NCT00603746|20899460|P1|STARTED|Overall Study||103
8480719|NCT00603733|20899608|P2|NOT COMPLETED|Maintenance Phase ITT||16
8480720|NCT00603733|20899609|P1|NOT COMPLETED|Maintenance Phase ITT||10
8480721|NCT00603733|20899608|P2|COMPLETED|Maintenance Phase ITT||66
8480722|NCT00603733|20899609|P1|COMPLETED|Maintenance Phase ITT||61
8480723|NCT00603733|20899608|P2|STARTED|Maintenance Phase ITT||82
8480724|NCT00603733|20899609|P1|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
8480725|NCT00603733|20899608|P2|NOT COMPLETED|Run-In Phase - 4 Weeks||13
8480726|NCT00603733|20899609|P1|NOT COMPLETED|Run-In Phase - 4 Weeks||14
8480727|NCT00603733|20899608|P2|COMPLETED|Run-In Phase - 4 Weeks||36
8480728|NCT00603733|20899609|P1|COMPLETED|Run-In Phase - 4 Weeks||35
8480729|NCT00603733|20899608|P2|STARTED|Run-In Phase - 4 Weeks||49
8480730|NCT00603733|20899609|P1|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
8480731|NCT00603733|20899608|P2|NOT COMPLETED|Active Phase ITT||17
8480732|NCT00603733|20899609|P1|NOT COMPLETED|Active Phase ITT||11
8480733|NCT00603733|20899608|P2|COMPLETED|Active Phase ITT||78
8480734|NCT00603733|20899609|P1|COMPLETED|Active Phase ITT||84
8480735|NCT00603733|20899608|P2|STARTED|Active Phase ITT||95
8480736|NCT00603733|20899609|P1|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
8480737|NCT00603720|20899624|P5|NOT COMPLETED|Overall Study||0
8480738|NCT00603720|20899625|P4|NOT COMPLETED|Overall Study||0
8480739|NCT00603720|20899626|P3|NOT COMPLETED|Overall Study||0
8480740|NCT00603720|20899627|P2|NOT COMPLETED|Overall Study||0
8480741|NCT00603720|20899628|P1|NOT COMPLETED|Overall Study||0
8480742|NCT00603720|20899624|P5|COMPLETED|Overall Study||12
8480743|NCT00603720|20899625|P4|COMPLETED|Overall Study||10
8480744|NCT00603720|20899626|P3|COMPLETED|Overall Study||12
8480745|NCT00603720|20899627|P2|COMPLETED|Overall Study||10
8480746|NCT00603720|20899628|P1|COMPLETED|Overall Study||10
8480747|NCT00603720|20899624|P5|STARTED|Overall Study||12
8480748|NCT00603720|20899625|P4|STARTED|Overall Study||10
8480749|NCT00603720|20899626|P3|STARTED|Overall Study||12
8480750|NCT00603720|20899627|P2|STARTED|Overall Study||10
8480751|NCT00603720|20899628|P1|STARTED|Overall Study||10
8480752|NCT00603642|20899642|P2|NOT COMPLETED|Overall Study||0
8480753|NCT00603642|20899643|P1|NOT COMPLETED|Overall Study||0
8480754|NCT00603642|20899642|P2|COMPLETED|Overall Study||22
8480755|NCT00603642|20899643|P1|COMPLETED|Overall Study||12
8480756|NCT00603642|20899642|P2|STARTED|Overall Study||22
8480757|NCT00603642|20899643|P1|STARTED|Overall Study||12
8480758|NCT00603590|20899659|P2|NOT COMPLETED|Overall Study||51
8480759|NCT00603590|20899660|P1|NOT COMPLETED|Overall Study||76
8480760|NCT00603590|20899659|P2|COMPLETED|Overall Study||183
8480761|NCT00603590|20899660|P1|COMPLETED|Overall Study||165
8480762|NCT00603590|20899659|P2|Eight Months|Overall Study||194
8480763|NCT00603590|20899660|P1|Eight Months|Overall Study||178
8480764|NCT00603590|20899659|P2|Four Months|Overall Study||200
8480765|NCT00603590|20899660|P1|Four Months|Overall Study||187
8480766|NCT00603590|20899659|P2|One Month|Overall Study||212
8480767|NCT00603590|20899660|P1|One Month|Overall Study||204
8480768|NCT00603590|20899659|P2|STARTED|Overall Study||234
8480769|NCT00603590|20899660|P1|STARTED|Overall Study||241
8480770|NCT00603564|20899672|P2|NOT COMPLETED|Overall Study||0
8480771|NCT00603564|20899673|P1|NOT COMPLETED|Overall Study||0
8480772|NCT00603564|20899672|P2|COMPLETED|Overall Study|February 2008|27
8480773|NCT00603564|20899673|P1|COMPLETED|Overall Study|February 2008|20
8480774|NCT00603564|20899672|P2|STARTED|Overall Study|January 2006|27
8480775|NCT00603564|20899673|P1|STARTED|Overall Study|January 2006|20
8480776|NCT00603538|20899684|P3|NOT COMPLETED|Overall Study||2
8480777|NCT00603538|20899685|P2|NOT COMPLETED|Overall Study||4
8480778|NCT00603538|20899686|P1|NOT COMPLETED|Overall Study||3
8480779|NCT00603538|20899684|P3|COMPLETED|Overall Study||4
8480780|NCT00603538|20899685|P2|COMPLETED|Overall Study||3
8480781|NCT00603538|20899686|P1|COMPLETED|Overall Study||3
8480782|NCT00603538|20899684|P3|STARTED|Overall Study||6
8480783|NCT00603538|20899685|P2|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
8480784|NCT00603538|20899686|P1|STARTED|Overall Study||6
8480785|NCT00603525|20899726|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
8480786|NCT00603525|20899727|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
8480787|NCT00603525|20899728|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
8480788|NCT00603525|20899726|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||13
8480789|NCT00603525|20899727|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
8480790|NCT00603525|20899728|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
8480791|NCT00603525|20899726|P3|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
8480792|NCT00603525|20899727|P2|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
8480793|NCT00603525|20899728|P1|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
8480794|NCT00603525|20899726|P3|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
8480795|NCT00603525|20899727|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
8480796|NCT00603525|20899728|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
8480797|NCT00603525|20899726|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
8480798|NCT00603525|20899727|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
8480799|NCT00603525|20899728|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
8480800|NCT00603525|20899726|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
8480801|NCT00603525|20899727|P2|COMPLETED|OL Treatment Period (120 Weeks)||13
8480802|NCT00603525|20899728|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
8480803|NCT00603525|20899726|P3|STARTED|OL Treatment Period (120 Weeks)||0
8480804|NCT00603525|20899727|P2|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
8480805|NCT00603525|20899728|P1|STARTED|OL Treatment Period (120 Weeks)||0
8480806|NCT00603525|20899726|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
8480807|NCT00603525|20899727|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
8480808|NCT00603525|20899728|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
8480809|NCT00603525|20899726|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
8480810|NCT00603525|20899727|P2|COMPLETED|DB Treatment Period (24 Weeks)||63
8480811|NCT00603525|20899728|P1|COMPLETED|DB Treatment Period (24 Weeks)||67
8480812|NCT00603525|20899726|P3|STARTED|DB Treatment Period (24 Weeks)||0
8480813|NCT00603525|20899727|P2|STARTED|DB Treatment Period (24 Weeks)||85
8480814|NCT00603525|20899728|P1|STARTED|DB Treatment Period (24 Weeks)||84
8480815|NCT00603512|20899860|P5|NOT COMPLETED|Overall Study||5
8480816|NCT00603512|20899861|P4|NOT COMPLETED|Overall Study||7
8480817|NCT00603512|20899862|P3|NOT COMPLETED|Overall Study||5
8480818|NCT00603512|20899863|P2|NOT COMPLETED|Overall Study||5
8480819|NCT00603512|20899864|P1|NOT COMPLETED|Overall Study||2
8480820|NCT00603512|20899860|P5|COMPLETED|Overall Study||23
8480821|NCT00603512|20899861|P4|COMPLETED|Overall Study||21
8480822|NCT00603512|20899862|P3|COMPLETED|Overall Study||23
8480823|NCT00603512|20899863|P2|COMPLETED|Overall Study||23
8480824|NCT00603512|20899864|P1|COMPLETED|Overall Study||26
8480825|NCT00603512|20899860|P5|Treated|Overall Study||28
8480826|NCT00603512|20899861|P4|Treated|Overall Study||26
8480827|NCT00603512|20899862|P3|Treated|Overall Study||27
8480828|NCT00603512|20899863|P2|Treated|Overall Study||27
8480829|NCT00603512|20899864|P1|Treated|Overall Study||28
8480830|NCT00603512|20899860|P5|STARTED|Overall Study||28
8480831|NCT00603512|20899861|P4|STARTED|Overall Study||28
8480832|NCT00603512|20899862|P3|STARTED|Overall Study||28
8480833|NCT00603512|20899863|P2|STARTED|Overall Study||28
8480834|NCT00603512|20899864|P1|STARTED|Overall Study||28
8480838|NCT00603447|20900019|P7|NOT COMPLETED|Overall Study||24
8480839|NCT00603447|20900020|P6|NOT COMPLETED|Overall Study||2
8480840|NCT00603447|20900021|P5|NOT COMPLETED|Overall Study||5
8480841|NCT00603447|20900022|P4|NOT COMPLETED|Overall Study||2
8480842|NCT00603447|20900023|P3|NOT COMPLETED|Overall Study||2
8480843|NCT00603447|20900024|P2|NOT COMPLETED|Overall Study||3
8480844|NCT00603447|20900025|P1|NOT COMPLETED|Overall Study||0
8480845|NCT00603447|20900019|P7|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
8480846|NCT00603447|20900020|P6|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
8480847|NCT00603447|20900021|P5|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
8480848|NCT00603447|20900022|P4|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
8480849|NCT00603447|20900023|P3|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
8480850|NCT00603447|20900024|P2|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
8480851|NCT00603447|20900025|P1|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
8480852|NCT00603447|20900019|P7|STARTED|Overall Study||44
8480853|NCT00603447|20900020|P6|STARTED|Overall Study||8
8480854|NCT00603447|20900021|P5|STARTED|Overall Study||6
8480855|NCT00603447|20900022|P4|STARTED|Overall Study||6
8480856|NCT00603447|20900023|P3|STARTED|Overall Study||8
8480857|NCT00603447|20900024|P2|STARTED|Overall Study||6
8480858|NCT00603447|20900025|P1|STARTED|Overall Study||6
8480859|NCT00603408|20900047|P1|NOT COMPLETED|Overall Study||0
8480860|NCT00603408|20900047|P1|COMPLETED|Overall Study||5
8480861|NCT00603408|20900047|P1|STARTED|Overall Study||5
8480862|NCT00603382|20900064|P6|NOT COMPLETED|Overall Study||18
8480863|NCT00603382|20900065|P5|NOT COMPLETED|Overall Study||9
8480864|NCT00603382|20900066|P4|NOT COMPLETED|Overall Study||12
8480865|NCT00603382|20900067|P3|NOT COMPLETED|Overall Study||9
8480866|NCT00603382|20900068|P2|NOT COMPLETED|Overall Study||14
8480867|NCT00603382|20900069|P1|NOT COMPLETED|Overall Study||18
8480868|NCT00603382|20900064|P6|COMPLETED|Overall Study||84
8480869|NCT00603382|20900065|P5|COMPLETED|Overall Study||86
8480870|NCT00603382|20900066|P4|COMPLETED|Overall Study||98
8480871|NCT00603382|20900067|P3|COMPLETED|Overall Study||91
8480872|NCT00603382|20900068|P2|COMPLETED|Overall Study||83
8480873|NCT00603382|20900069|P1|COMPLETED|Overall Study||76
8480874|NCT00603382|20900064|P6|STARTED|Overall Study||102
8480875|NCT00603382|20900065|P5|STARTED|Overall Study||95
8480876|NCT00603382|20900066|P4|STARTED|Overall Study||110
8480877|NCT00603382|20900067|P3|STARTED|Overall Study||100
8480878|NCT00603382|20900068|P2|STARTED|Overall Study||97
8480879|NCT00603382|20900069|P1|STARTED|Overall Study||94
8480880|NCT00603304|20900217|P2|NOT COMPLETED|Overall Study||31
8480881|NCT00603304|20900218|P1|NOT COMPLETED|Overall Study||32
8480882|NCT00603304|20900217|P2|COMPLETED|Overall Study||155
8480883|NCT00603304|20900218|P1|COMPLETED|Overall Study||151
8480884|NCT00603304|20900217|P2|STARTED|Overall Study||186
8480885|NCT00603304|20900218|P1|STARTED|Overall Study||183
8480886|NCT00603291|20900255|P3|NOT COMPLETED|Overall Study||96
8480887|NCT00603291|20900256|P2|NOT COMPLETED|Overall Study||87
8480888|NCT00603291|20900257|P1|NOT COMPLETED|Overall Study||20
8480889|NCT00603291|20900255|P3|COMPLETED|Overall Study||157
8480890|NCT00603291|20900256|P2|COMPLETED|Overall Study||169
8480891|NCT00603291|20900257|P1|COMPLETED|Overall Study||75
8480892|NCT00603291|20900255|P3|STARTED|Overall Study||253
8480893|NCT00603291|20900256|P2|STARTED|Overall Study||256
8480894|NCT00603291|20900257|P1|STARTED|Overall Study||95
8480895|NCT00603278|20900274|P6|NOT COMPLETED|Overall Study||19
8480896|NCT00603278|20900275|P5|NOT COMPLETED|Overall Study||13
8480897|NCT00603278|20900276|P4|NOT COMPLETED|Overall Study||11
8480898|NCT00603278|20900277|P3|NOT COMPLETED|Overall Study||14
8480899|NCT00603278|20900278|P2|NOT COMPLETED|Overall Study||17
8480900|NCT00603278|20900279|P1|NOT COMPLETED|Overall Study||41
8480901|NCT00603278|20900274|P6|COMPLETED|Overall Study||81
8480902|NCT00603278|20900275|P5|COMPLETED|Overall Study||86
8480903|NCT00603278|20900276|P4|COMPLETED|Overall Study||92
8480904|NCT00603278|20900277|P3|COMPLETED|Overall Study||87
8480905|NCT00603278|20900278|P2|COMPLETED|Overall Study||88
8480906|NCT00603278|20900279|P1|COMPLETED|Overall Study||66
8480907|NCT00603278|20900274|P6|STARTED|Overall Study||100
8480908|NCT00603278|20900275|P5|STARTED|Overall Study||99
8480909|NCT00603278|20900276|P4|STARTED|Overall Study||103
8480910|NCT00603278|20900277|P3|STARTED|Overall Study||101
8480911|NCT00603278|20900278|P2|STARTED|Overall Study||105
8480912|NCT00603278|20900279|P1|STARTED|Overall Study||107
8480913|NCT00603265|20900428|P3|NOT COMPLETED|Overall Study||5
8480914|NCT00603265|20900429|P2|NOT COMPLETED|Overall Study||16
8480915|NCT00603265|20900430|P1|NOT COMPLETED|Overall Study||7
8480916|NCT00603265|20900428|P3|COMPLETED|Overall Study||67
8480917|NCT00603265|20900429|P2|COMPLETED|Overall Study||62
8480918|NCT00603265|20900430|P1|COMPLETED|Overall Study||69
8480919|NCT00603265|20900428|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
8480920|NCT00603265|20900429|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
8480921|NCT00603265|20900430|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
8480922|NCT00603265|20900428|P3|STARTED|Overall Study||72
8480923|NCT00603265|20900429|P2|STARTED|Overall Study||78
8480924|NCT00603265|20900430|P1|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
8480925|NCT00603239|20900458|P2|NOT COMPLETED|Overall Study||4
8480926|NCT00603239|20900459|P1|NOT COMPLETED|Overall Study||15
8480927|NCT00603239|20900458|P2|COMPLETED|Overall Study||50
8480928|NCT00603239|20900459|P1|COMPLETED|Overall Study||96
8480929|NCT00603239|20900458|P2|STARTED|Overall Study||54
8480930|NCT00603239|20900459|P1|STARTED|Overall Study||111
8480931|NCT00603187|20900485|P1|NOT COMPLETED|Overall Study||0
8480932|NCT00603187|20900485|P1|COMPLETED|Overall Study||4
8480933|NCT00603187|20900485|P1|STARTED|Overall Study||4
8480934|NCT00603044|20900493|P2|NOT COMPLETED|Overall Study||0
8480935|NCT00603044|20900494|P1|NOT COMPLETED|Overall Study||0
8480936|NCT00603044|20900493|P2|COMPLETED|Overall Study||13
8480937|NCT00603044|20900494|P1|COMPLETED|Overall Study||11
8480938|NCT00603044|20900493|P2|STARTED|Overall Study||13
8480939|NCT00603044|20900494|P1|STARTED|Overall Study||11
8480940|NCT00603018|20900510|P1|NOT COMPLETED|Overall Study||0
8480941|NCT00603018|20900510|P1|COMPLETED|Overall Study||23
8480942|NCT00603018|20900510|P1|STARTED|Overall Study||23
8480943|NCT00602979|20900520|P5|NOT COMPLETED|Overall Study||3
8480944|NCT00602979|20900521|P4|NOT COMPLETED|Overall Study||3
8480945|NCT00602979|20900522|P3|NOT COMPLETED|Overall Study||3
8480946|NCT00602979|20900523|P2|NOT COMPLETED|Overall Study||3
8480947|NCT00602979|20900524|P1|NOT COMPLETED|Overall Study||3
8480948|NCT00602979|20900520|P5|COMPLETED|Overall Study||45
8480949|NCT00602979|20900521|P4|COMPLETED|Overall Study||45
8480950|NCT00602979|20900522|P3|COMPLETED|Overall Study||45
8480951|NCT00602979|20900523|P2|COMPLETED|Overall Study||45
8480952|NCT00602979|20900524|P1|COMPLETED|Overall Study||45
8480953|NCT00602979|20900520|P5|STARTED|Overall Study||48
8480954|NCT00602979|20900521|P4|STARTED|Overall Study||48
8480955|NCT00602979|20900522|P3|STARTED|Overall Study||48
8480956|NCT00602979|20900523|P2|STARTED|Overall Study||48
8480957|NCT00602979|20900524|P1|STARTED|Overall Study||48
8480958|NCT00602953|20900541|P5|NOT COMPLETED|Overall Study||0
8480959|NCT00602953|20900542|P4|NOT COMPLETED|Overall Study||0
8480960|NCT00602953|20900543|P3|NOT COMPLETED|Overall Study||0
8480961|NCT00602953|20900544|P2|NOT COMPLETED|Overall Study||0
8480962|NCT00602953|20900545|P1|NOT COMPLETED|Overall Study||0
8480963|NCT00602953|20900541|P5|COMPLETED|Overall Study||0
8480964|NCT00602953|20900542|P4|COMPLETED|Overall Study||13
8480965|NCT00602953|20900543|P3|COMPLETED|Overall Study||47
8480966|NCT00602953|20900544|P2|COMPLETED|Overall Study||26
8480967|NCT00602953|20900545|P1|COMPLETED|Overall Study||15
8480968|NCT00602953|20900541|P5|STARTED|Overall Study||0
8480969|NCT00602953|20900542|P4|STARTED|Overall Study||13
8480970|NCT00602953|20900543|P3|STARTED|Overall Study||47
8480971|NCT00602953|20900544|P2|STARTED|Overall Study||26
8480972|NCT00602953|20900545|P1|STARTED|Overall Study||15
8480973|NCT00602927|20900574|P2|NOT COMPLETED|Period 3: 13 Days||3
8480974|NCT00602927|20900575|P1|NOT COMPLETED|Period 3: 13 Days||2
8480975|NCT00602927|20900574|P2|COMPLETED|Period 3: 13 Days||9
8480976|NCT00602927|20900575|P1|COMPLETED|Period 3: 13 Days||13
8480977|NCT00602927|20900574|P2|STARTED|Period 3: 13 Days||12
8480978|NCT00602927|20900575|P1|STARTED|Period 3: 13 Days||15
8480979|NCT00602927|20900574|P2|NOT COMPLETED|Period 2: 14 Days||2
8480980|NCT00602927|20900575|P1|NOT COMPLETED|Period 2: 14 Days||0
8480981|NCT00602927|20900574|P2|COMPLETED|Period 2: 14 Days||12
8480982|NCT00602927|20900575|P1|COMPLETED|Period 2: 14 Days||15
8480983|NCT00602927|20900574|P2|STARTED|Period 2: 14 Days||14
8480984|NCT00602927|20900575|P1|STARTED|Period 2: 14 Days||15
8480985|NCT00602927|20900574|P2|NOT COMPLETED|Period 1: 13 Days||5
8480986|NCT00602927|20900575|P1|NOT COMPLETED|Period 1: 13 Days||4
8480987|NCT00602927|20900574|P2|COMPLETED|Period 1: 13 Days||14
8480988|NCT00602927|20900575|P1|COMPLETED|Period 1: 13 Days||15
8480989|NCT00602927|20900574|P2|STARTED|Period 1: 13 Days||19
8480990|NCT00602927|20900575|P1|STARTED|Period 1: 13 Days||19
8480991|NCT00602836|20900583|P1|NOT COMPLETED|Overall Study||5
8480992|NCT00602836|20900583|P1|COMPLETED|Overall Study||39
8480993|NCT00602836|20900583|P1|STARTED|Overall Study||44
8480994|NCT00602797|20900592|P1|NOT COMPLETED|Overall Study||1
8480995|NCT00602797|20900592|P1|COMPLETED|Overall Study||19
8480996|NCT00602797|20900592|P1|STARTED|Overall Study||20
8480997|NCT00602771|20900600|P2|NOT COMPLETED|Overall Study||0
8480998|NCT00602771|20900601|P1|NOT COMPLETED|Overall Study||1
8480999|NCT00602771|20900600|P2|COMPLETED|Overall Study||21
8481000|NCT00602771|20900601|P1|COMPLETED|Overall Study||62
8481001|NCT00602771|20900600|P2|STARTED|Overall Study||21
8481002|NCT00602771|20900601|P1|STARTED|Overall Study||63
8481003|NCT00602667|20900610|P3|NOT COMPLETED|Overall Study||63
8481004|NCT00602667|20900611|P2|NOT COMPLETED|Overall Study||81
8481005|NCT00602667|20900612|P1|NOT COMPLETED|Overall Study||19
8481006|NCT00602667|20900610|P3|COMPLETED|Overall Study||14
8481007|NCT00602667|20900611|P2|COMPLETED|Overall Study||75
8481008|NCT00602667|20900612|P1|COMPLETED|Overall Study||38
8481009|NCT00602667|20900610|P3|STARTED|Overall Study||77
8481010|NCT00602667|20900611|P2|STARTED|Overall Study||156
8481011|NCT00602667|20900612|P1|STARTED|Overall Study||57
8481020|NCT00602537|20900806|P2|NOT COMPLETED|Follow Up Study Comparison||3
8481021|NCT00602537|20900807|P1|NOT COMPLETED|Follow Up Study Comparison||11
8481022|NCT00602537|20900806|P2|COMPLETED|Follow Up Study Comparison||14
8481023|NCT00602537|20900807|P1|COMPLETED|Follow Up Study Comparison||31
8481024|NCT00602537|20900806|P2|STARTED|Follow Up Study Comparison||17
8481025|NCT00602537|20900807|P1|STARTED|Follow Up Study Comparison||42
8481026|NCT00602537|20900806|P2|NOT COMPLETED|12 Week Double Blind Comparison||47
8481027|NCT00602537|20900807|P1|NOT COMPLETED|12 Week Double Blind Comparison||23
8481028|NCT00602537|20900806|P2|COMPLETED|12 Week Double Blind Comparison||17
8481029|NCT00602537|20900807|P1|COMPLETED|12 Week Double Blind Comparison||42
8481030|NCT00602537|20900806|P2|Responded|12 Week Double Blind Comparison||22
8481031|NCT00602537|20900807|P1|Responded|12 Week Double Blind Comparison||44
8481032|NCT00602537|20900806|P2|STARTED|12 Week Double Blind Comparison||64
8481033|NCT00602537|20900807|P1|STARTED|12 Week Double Blind Comparison||65
8481034|NCT00602472|20900817|P2|NOT COMPLETED|Overall Study||58
8481035|NCT00602472|20900818|P1|NOT COMPLETED|Overall Study||21
8481036|NCT00602472|20900817|P2|COMPLETED|Overall Study|number who completed treatment|734
8481037|NCT00602472|20900818|P1|COMPLETED|Overall Study|number who completed treatment|242
8481038|NCT00602472|20900817|P2|STARTED|Overall Study|3 randomised patients never took medication.|792
8481039|NCT00602472|20900818|P1|STARTED|Overall Study|3 randomised patients never took medication.|263
8481064|NCT00602446|20900876|P1|NOT COMPLETED|Overall Study||0
8481065|NCT00602446|20900876|P1|COMPLETED|Overall Study||3
8481066|NCT00602446|20900876|P1|STARTED|Overall Study||3
8481067|NCT00602420|20900883|P2|NOT COMPLETED|Overall Study||24
8481068|NCT00602420|20900884|P1|NOT COMPLETED|Overall Study||25
8481069|NCT00602420|20900883|P2|COMPLETED|Overall Study||229
8481070|NCT00602420|20900884|P1|COMPLETED|Overall Study||232
8481071|NCT00602420|20900883|P2|STARTED|Overall Study||253
8481072|NCT00602420|20900884|P1|STARTED|Overall Study||257
8481073|NCT00602355|20900893|P3|NOT COMPLETED|Overall Study||10
8481074|NCT00602355|20900894|P2|NOT COMPLETED|Overall Study||18
8481075|NCT00602355|20900895|P1|NOT COMPLETED|Overall Study||9
8481076|NCT00602355|20900893|P3|COMPLETED|Overall Study||43
8481077|NCT00602355|20900894|P2|COMPLETED|Overall Study||38
8481078|NCT00602355|20900895|P1|COMPLETED|Overall Study||44
8481079|NCT00602355|20900893|P3|STARTED|Overall Study||53
8481080|NCT00602355|20900894|P2|STARTED|Overall Study||56
8481081|NCT00602355|20900895|P1|STARTED|Overall Study||53
8481082|NCT00602290|20900918|P3|NOT COMPLETED|Overall Study||1
8481083|NCT00602290|20900919|P2|NOT COMPLETED|Overall Study||2
8481084|NCT00602290|20900920|P1|NOT COMPLETED|Overall Study||2
8481085|NCT00602290|20900918|P3|COMPLETED|Overall Study||46
8481086|NCT00602290|20900919|P2|COMPLETED|Overall Study||46
8481087|NCT00602290|20900920|P1|COMPLETED|Overall Study||46
8481088|NCT00602290|20900918|P3|STARTED|Overall Study||47
8481089|NCT00602290|20900919|P2|STARTED|Overall Study||48
8481090|NCT00602290|20900920|P1|STARTED|Overall Study||48
8481091|NCT00602225|20900931|P1|NOT COMPLETED|Overall Study||0
8481092|NCT00602225|20900931|P1|COMPLETED|Overall Study||50
8481093|NCT00602225|20900931|P1|STARTED|Overall Study||50
8481094|NCT00602043|20900944|P1|NOT COMPLETED|Overall Study||5
8481095|NCT00602043|20900944|P1|COMPLETED|Overall Study||15
8481096|NCT00602043|20900944|P1|STARTED|Overall Study||20
8481097|NCT00601965|20900958|P4|NOT COMPLETED|Overall Study||1
8481098|NCT00601965|20900959|P3|NOT COMPLETED|Overall Study||0
8481099|NCT00601965|20900960|P2|NOT COMPLETED|Overall Study||2
8481100|NCT00601965|20900961|P1|NOT COMPLETED|Overall Study||0
8481101|NCT00601965|20900958|P4|COMPLETED|Overall Study||17
8481102|NCT00601965|20900959|P3|COMPLETED|Overall Study||19
8481103|NCT00601965|20900960|P2|COMPLETED|Overall Study||16
8481104|NCT00601965|20900961|P1|COMPLETED|Overall Study||18
8481105|NCT00601965|20900958|P4|STARTED|Overall Study||18
8481106|NCT00601965|20900959|P3|STARTED|Overall Study||19
8481107|NCT00601965|20900960|P2|STARTED|Overall Study||18
8481108|NCT00601965|20900961|P1|STARTED|Overall Study||18
8481109|NCT00601952|20900977|P2|NOT COMPLETED|Overall Study||0
8481110|NCT00601952|20900978|P1|NOT COMPLETED|Overall Study||2
8481111|NCT00601952|20900977|P2|COMPLETED|Overall Study||17
8481112|NCT00601952|20900978|P1|COMPLETED|Overall Study||12
8481113|NCT00601952|20900977|P2|STARTED|Overall Study||17
8481114|NCT00601952|20900978|P1|STARTED|Overall Study||14
8481115|NCT00601926|20900984|P1|NOT COMPLETED|Overall Study||0
8481116|NCT00601926|20900984|P1|COMPLETED|Overall Study||5
8481117|NCT00601926|20900984|P1|STARTED|Overall Study||5
8481124|NCT00601848|20901007|P1|NOT COMPLETED|Overall Study||9
8481125|NCT00601848|20901007|P1|COMPLETED|Overall Study||0
8481126|NCT00601848|20901007|P1|STARTED|Overall Study||9
8481127|NCT00601835|20901017|P2|NOT COMPLETED|Overall Study||14
8481128|NCT00601835|20901018|P1|NOT COMPLETED|Overall Study||60
8481129|NCT00601835|20901017|P2|COMPLETED|Overall Study||686
8481130|NCT00601835|20901018|P1|COMPLETED|Overall Study||2890
8481131|NCT00601835|20901017|P2|STARTED|Overall Study||700
8481132|NCT00601835|20901018|P1|STARTED|Overall Study||2950
8481133|NCT00601796|20901028|P1|NOT COMPLETED|Overall Study||0
8481134|NCT00601796|20901028|P1|COMPLETED|Overall Study||24
8481135|NCT00601796|20901028|P1|STARTED|Overall Study||24
8481136|NCT00601731|20901047|P4|NOT COMPLETED|Overall Study||1
8481137|NCT00601731|20901048|P3|NOT COMPLETED|Overall Study||15
8481138|NCT00601731|20901049|P2|NOT COMPLETED|Overall Study||0
8481139|NCT00601731|20901050|P1|NOT COMPLETED|Overall Study||23
8481140|NCT00601731|20901047|P4|COMPLETED|Overall Study||29
8481141|NCT00601731|20901048|P3|COMPLETED|Overall Study||151
8481142|NCT00601731|20901049|P2|COMPLETED|Overall Study||43
8481143|NCT00601731|20901050|P1|COMPLETED|Overall Study||120
8481144|NCT00601731|20901047|P4|STARTED|Overall Study||30
8481145|NCT00601731|20901048|P3|STARTED|Overall Study||166
8481146|NCT00601731|20901049|P2|STARTED|Overall Study||43
8481147|NCT00601731|20901050|P1|STARTED|Overall Study||143
8481148|NCT00601718|20901100|P1|NOT COMPLETED|Overall Study||0
8481149|NCT00601718|20901100|P1|COMPLETED|Overall Study||29
8481150|NCT00601718|20901100|P1|STARTED|Overall Study||29
8481151|NCT00601705|20901107|P1|NOT COMPLETED|Overall Study||1
8481152|NCT00601705|20901107|P1|COMPLETED|Overall Study||60
8481153|NCT00601705|20901107|P1|STARTED|Overall Study||61
8481154|NCT00601640|20901119|P3|NOT COMPLETED|Overall Study||10
8481155|NCT00601640|20901120|P2|NOT COMPLETED|Overall Study||5
8481156|NCT00601640|20901121|P1|NOT COMPLETED|Overall Study||5
8481157|NCT00601640|20901119|P3|COMPLETED|Overall Study||42
8481158|NCT00601640|20901120|P2|COMPLETED|Overall Study||47
8481159|NCT00601640|20901121|P1|COMPLETED|Overall Study||47
8481160|NCT00601640|20901119|P3|STARTED|Overall Study||52
8481161|NCT00601640|20901120|P2|STARTED|Overall Study||52
8481162|NCT00601640|20901121|P1|STARTED|Overall Study||52
8481163|NCT00601627|20901135|P1|NOT COMPLETED|Overall Study||0
8481164|NCT00601627|20901135|P1|COMPLETED|Overall Study||51
8481165|NCT00601627|20901135|P1|STARTED|Overall Study||51
8481166|NCT00601523|20901146|P2|NOT COMPLETED|Overall Study||26
8481167|NCT00601523|20901147|P1|NOT COMPLETED|Overall Study||77
8481168|NCT00601523|20901146|P2|COMPLETED|Overall Study||117
8481169|NCT00601523|20901147|P1|COMPLETED|Overall Study||291
8481170|NCT00601523|20901146|P2|STARTED|Overall Study||143
8481171|NCT00601523|20901147|P1|STARTED|Overall Study||368
8481172|NCT00601458|20901182|P3|NOT COMPLETED|Overall Study||2
8481173|NCT00601458|20901183|P2|NOT COMPLETED|Overall Study||5
8481174|NCT00601458|20901184|P1|NOT COMPLETED|Overall Study||4
8481175|NCT00601458|20901182|P3|COMPLETED|Overall Study||28
8481176|NCT00601458|20901183|P2|COMPLETED|Overall Study||29
8481177|NCT00601458|20901184|P1|COMPLETED|Overall Study||32
8481178|NCT00601458|20901182|P3|STARTED|Overall Study||30
8481179|NCT00601458|20901183|P2|STARTED|Overall Study||34
8481180|NCT00601458|20901184|P1|STARTED|Overall Study||36
8481181|NCT00601419|20901195|P1|NOT COMPLETED|Overall Study||4
8481182|NCT00601419|20901195|P1|COMPLETED|Overall Study||226
8481183|NCT00601419|20901195|P1|STARTED|Overall Study||230
8481184|NCT00601367|20901219|P1|NOT COMPLETED|Overall Study||187
8481185|NCT00601367|20901219|P1|COMPLETED|Overall Study||293
8481186|NCT00601367|20901219|P1|STARTED|Overall Study||480
8481187|NCT00601354|20901225|P2|NOT COMPLETED|Overall Study||5
8481188|NCT00601354|20901226|P1|NOT COMPLETED|Overall Study||4
8481189|NCT00601354|20901225|P2|COMPLETED|Overall Study||4
8481190|NCT00601354|20901226|P1|COMPLETED|Overall Study||4
8481191|NCT00601354|20901225|P2|STARTED|Overall Study||9
8481192|NCT00601354|20901226|P1|STARTED|Overall Study||8
8481193|NCT00601250|20901238|P2|NOT COMPLETED|Overall Study||39
8481194|NCT00601250|20901239|P1|NOT COMPLETED|Overall Study||14
8481195|NCT00601250|20901238|P2|COMPLETED|Overall Study|number who completed treatment|484
8481196|NCT00601250|20901239|P1|COMPLETED|Overall Study|number who completed treatment|163
8481339|NCT00600704|20901621|P1|NOT COMPLETED|Overall Study||0
8481197|NCT00601250|20901238|P2|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
8481198|NCT00601250|20901239|P1|STARTED|Overall Study|number who started treatment|177
8481199|NCT00601172|20901275|P2|NOT COMPLETED|Overall Study||127
8481200|NCT00601172|20901276|P1|NOT COMPLETED|Overall Study||141
8481201|NCT00601172|20901275|P2|COMPLETED|Overall Study||228
8481202|NCT00601172|20901276|P1|COMPLETED|Overall Study||214
8481203|NCT00601172|20901275|P2|STARTED|Overall Study||355
8481204|NCT00601172|20901276|P1|STARTED|Overall Study||355
8481205|NCT00601146|20901325|P1|NOT COMPLETED|Overall Study||0
8481206|NCT00601146|20901325|P1|COMPLETED|Overall Study||39
8481207|NCT00601146|20901325|P1|STARTED|Overall Study||39
8481208|NCT00601107|20901333|P4|NOT COMPLETED|Overall Study||12
8481209|NCT00601107|20901334|P3|NOT COMPLETED|Overall Study||12
8481210|NCT00601107|20901335|P2|NOT COMPLETED|Overall Study||9
8481211|NCT00601107|20901336|P1|NOT COMPLETED|Overall Study||13
8481212|NCT00601107|20901333|P4|COMPLETED|Overall Study||13
8481213|NCT00601107|20901334|P3|COMPLETED|Overall Study||16
8481214|NCT00601107|20901335|P2|COMPLETED|Overall Study||22
8481215|NCT00601107|20901336|P1|COMPLETED|Overall Study||14
8481216|NCT00601107|20901333|P4|Treated|Overall Study||25
8481217|NCT00601107|20901334|P3|Treated|Overall Study||28
8481218|NCT00601107|20901335|P2|Treated|Overall Study||31
8481219|NCT00601107|20901336|P1|Treated|Overall Study||27
8481220|NCT00601107|20901333|P4|STARTED|Overall Study||25
8481221|NCT00601107|20901334|P3|STARTED|Overall Study||28
8481222|NCT00601107|20901335|P2|STARTED|Overall Study||31
8481223|NCT00601107|20901336|P1|STARTED|Overall Study|Randomized.|27
8481224|NCT00600938|20901356|P4|NOT COMPLETED|Extension Study||1
8481225|NCT00600938|20901357|P3|NOT COMPLETED|Extension Study||9
8481226|NCT00600938|20901358|P2|NOT COMPLETED|Extension Study||5
8481227|NCT00600938|20901359|P1|NOT COMPLETED|Extension Study||9
8481228|NCT00600938|20901356|P4|COMPLETED|Extension Study||0
8481229|NCT00600938|20901357|P3|COMPLETED|Extension Study||33
8481230|NCT00600938|20901358|P2|COMPLETED|Extension Study||24
8481231|NCT00600938|20901359|P1|COMPLETED|Extension Study||65
8481232|NCT00600938|20901356|P4|Extension Safety Set|Extension Study||1
8481233|NCT00600938|20901357|P3|Extension Safety Set|Extension Study||42
8481234|NCT00600938|20901358|P2|Extension Safety Set|Extension Study||29
8481235|NCT00600938|20901359|P1|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
8481236|NCT00600938|20901356|P4|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
8481237|NCT00600938|20901357|P3|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
8481238|NCT00600938|20901358|P2|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
8481239|NCT00600938|20901359|P1|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
8481240|NCT00600938|20901356|P4|NOT COMPLETED|Core Study||0
8481241|NCT00600938|20901357|P3|NOT COMPLETED|Core Study||0
8481242|NCT00600938|20901358|P2|NOT COMPLETED|Core Study||21
8481243|NCT00600938|20901359|P1|NOT COMPLETED|Core Study||16
8481244|NCT00600938|20901356|P4|COMPLETED|Core Study||0
8481245|NCT00600938|20901357|P3|COMPLETED|Core Study||0
8481246|NCT00600938|20901358|P2|COMPLETED|Core Study||78
8481247|NCT00600938|20901359|P1|COMPLETED|Core Study||82
8481248|NCT00600938|20901356|P4|Per Protocol Set (PPS)|Core Study||0
8481249|NCT00600938|20901357|P3|Per Protocol Set (PPS)|Core Study||0
8481250|NCT00600938|20901358|P2|Per Protocol Set (PPS)|Core Study||81
8481251|NCT00600938|20901359|P1|Per Protocol Set (PPS)|Core Study||91
8481252|NCT00600938|20901356|P4|Core Safety Set|Core Study||0
8481253|NCT00600938|20901357|P3|Core Safety Set|Core Study||0
8481254|NCT00600938|20901358|P2|Core Safety Set|Core Study||91
8481255|NCT00600938|20901359|P1|Core Safety Set|Core Study||96
8481256|NCT00600938|20901356|P4|STARTED|Core Study||0
8481257|NCT00600938|20901357|P3|STARTED|Core Study||0
8481258|NCT00600938|20901358|P2|STARTED|Core Study||99
8481259|NCT00600938|20901359|P1|STARTED|Core Study||98
8481260|NCT00600886|20901423|P2|NOT COMPLETED|Extension - After Crossover (CAS)||13
8481261|NCT00600886|20901424|P1|NOT COMPLETED|Extension - After Crossover (CAS)||62
8481262|NCT00600886|20901423|P2|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
8481263|NCT00600886|20901424|P1|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
8481264|NCT00600886|20901423|P2|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
8481265|NCT00600886|20901424|P1|Discontinued After M26|Extension - After Crossover (CAS)||31
8481266|NCT00600886|20901423|P2|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
8481267|NCT00600886|20901424|P1|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
8481268|NCT00600886|20901423|P2|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
8481269|NCT00600886|20901424|P1|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
8481270|NCT00600886|20901423|P2|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
8481271|NCT00600886|20901424|P1|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
8481272|NCT00600886|20901423|P2|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
8481273|NCT00600886|20901424|P1|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
8481274|NCT00600886|20901423|P2|NOT COMPLETED|Extension - Same Treatment (FAS)||11
8481275|NCT00600886|20901424|P1|NOT COMPLETED|Extension - Same Treatment (FAS)||46
8481276|NCT00600886|20901423|P2|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
8481277|NCT00600886|20901424|P1|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
8481278|NCT00600886|20901423|P2|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
8481279|NCT00600886|20901424|P1|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
8481280|NCT00600886|20901423|P2|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
8481281|NCT00600886|20901424|P1|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
8481282|NCT00600886|20901423|P2|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
8481283|NCT00600886|20901424|P1|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
8481284|NCT00600886|20901423|P2|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
8481285|NCT00600886|20901424|P1|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
8481286|NCT00600886|20901423|P2|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
8481287|NCT00600886|20901424|P1|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
8481288|NCT00600886|20901423|P2|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
8481289|NCT00600886|20901424|P1|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
8481290|NCT00600886|20901423|P2|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
8481291|NCT00600886|20901424|P1|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
8481292|NCT00600886|20901423|P2|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
8481293|NCT00600886|20901424|P1|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
8481294|NCT00600886|20901423|P2|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
8481295|NCT00600886|20901424|P1|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
8481296|NCT00600886|20901423|P2|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
8481297|NCT00600886|20901424|P1|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
8481298|NCT00600886|20901423|P2|STARTED|Core Phase - Full Analysis Set (FAS)||182
8481299|NCT00600886|20901424|P1|STARTED|Core Phase - Full Analysis Set (FAS)||176
8481300|NCT00600821|20901488|P2|NOT COMPLETED|Overall Study||60
8481301|NCT00600821|20901489|P1|NOT COMPLETED|Overall Study||58
8481302|NCT00600821|20901488|P2|COMPLETED|Overall Study||0
8481303|NCT00600821|20901489|P1|COMPLETED|Overall Study||0
8481304|NCT00600821|20901488|P2|Treated|Overall Study||59
8481305|NCT00600821|20901489|P1|Treated|Overall Study||58
8481306|NCT00600821|20901488|P2|STARTED|Overall Study||60
8481307|NCT00600821|20901489|P1|STARTED|Overall Study||58
8481308|NCT00600756|20901517|P2|NOT COMPLETED|Overall Study Analysis After 12 Months||176
8481309|NCT00600756|20901518|P1|NOT COMPLETED|Overall Study Analysis After 12 Months||183
8481310|NCT00600756|20901517|P2|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
8481311|NCT00600756|20901518|P1|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
8481312|NCT00600756|20901517|P2|ITT Analysis|Overall Study Analysis After 12 Months||392
8481313|NCT00600756|20901518|P1|ITT Analysis|Overall Study Analysis After 12 Months||379
8481314|NCT00600756|20901517|P2|Safety Analysis|Overall Study Analysis After 12 Months||402
8481315|NCT00600756|20901518|P1|Safety Analysis|Overall Study Analysis After 12 Months||391
8481316|NCT00600756|20901517|P2|Randomized Analysis|Overall Study Analysis After 12 Months||403
8481317|NCT00600756|20901518|P1|Randomized Analysis|Overall Study Analysis After 12 Months||395
8481318|NCT00600756|20901517|P2|STARTED|Overall Study Analysis After 12 Months||403
8481319|NCT00600756|20901518|P1|STARTED|Overall Study Analysis After 12 Months||395
8481320|NCT00600756|20901517|P2|NOT COMPLETED|Analysis After 6 Months||120
8481321|NCT00600756|20901518|P1|NOT COMPLETED|Analysis After 6 Months||131
8481322|NCT00600756|20901517|P2|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
8481323|NCT00600756|20901518|P1|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
8481324|NCT00600756|20901517|P2|STARTED|Analysis After 6 Months||403
8481325|NCT00600756|20901518|P1|STARTED|Analysis After 6 Months||395
8481326|NCT00600743|20901588|P4|NOT COMPLETED|Overall Study||0
8481327|NCT00600743|20901589|P3|NOT COMPLETED|Overall Study||0
8481328|NCT00600743|20901590|P2|NOT COMPLETED|Overall Study||0
8481329|NCT00600743|20901591|P1|NOT COMPLETED|Overall Study||0
8481330|NCT00600743|20901588|P4|COMPLETED|Overall Study||7
8481331|NCT00600743|20901589|P3|COMPLETED|Overall Study||8
8481332|NCT00600743|20901590|P2|COMPLETED|Overall Study||4
8481333|NCT00600743|20901591|P1|COMPLETED|Overall Study||4
8481334|NCT00600743|20901588|P4|STARTED|Overall Study||7
8481335|NCT00600743|20901589|P3|STARTED|Overall Study||8
8481336|NCT00600743|20901590|P2|STARTED|Overall Study||4
8481337|NCT00600743|20901591|P1|STARTED|Overall Study||4
8481338|NCT00600704|20901620|P2|NOT COMPLETED|Overall Study||0
8481340|NCT00600704|20901620|P2|COMPLETED|Overall Study||92
8481341|NCT00600704|20901621|P1|COMPLETED|Overall Study||100
8481342|NCT00600704|20901620|P2|STARTED|Overall Study||92
8481343|NCT00600704|20901621|P1|STARTED|Overall Study||100
8481344|NCT00600613|20901627|P1|NOT COMPLETED|Overall Study||1
8481345|NCT00600613|20901627|P1|COMPLETED|Overall Study||5
8481346|NCT00600613|20901627|P1|STARTED|Overall Study||6
8481347|NCT00600353|20901633|P2|NOT COMPLETED|Overall Study||1
8481348|NCT00600353|20901634|P1|NOT COMPLETED|Overall Study||1
8481349|NCT00600353|20901633|P2|COMPLETED|Overall Study||9
8481350|NCT00600353|20901634|P1|COMPLETED|Overall Study||9
8481351|NCT00600353|20901633|P2|STARTED|Overall Study||10
8481352|NCT00600353|20901634|P1|STARTED|Overall Study||10
8481353|NCT00600340|20901648|P2|NOT COMPLETED|Overall Study||0
8481354|NCT00600340|20901649|P1|NOT COMPLETED|Overall Study||0
8481355|NCT00600340|20901648|P2|COMPLETED|Overall Study||279
8481356|NCT00600340|20901649|P1|COMPLETED|Overall Study||285
8481357|NCT00600340|20901648|P2|STARTED|Overall Study||279
8481358|NCT00600340|20901649|P1|STARTED|Overall Study||285
8481359|NCT00600171|20901697|P6|NOT COMPLETED|Overall Study||5
8481360|NCT00600171|20901698|P5|NOT COMPLETED|Overall Study||8
8481361|NCT00600171|20901699|P4|NOT COMPLETED|Overall Study||12
8481362|NCT00600171|20901700|P3|NOT COMPLETED|Overall Study||10
8481363|NCT00600171|20901701|P2|NOT COMPLETED|Overall Study||17
8481364|NCT00600171|20901702|P1|NOT COMPLETED|Overall Study||16
8481365|NCT00600171|20901697|P6|COMPLETED|Overall Study||97
8481366|NCT00600171|20901698|P5|COMPLETED|Overall Study||93
8481367|NCT00600171|20901699|P4|COMPLETED|Overall Study||88
8481368|NCT00600171|20901700|P3|COMPLETED|Overall Study||91
8481369|NCT00600171|20901701|P2|COMPLETED|Overall Study||84
8481370|NCT00600171|20901702|P1|COMPLETED|Overall Study||86
8481371|NCT00600171|20901697|P6|STARTED|Overall Study||102
8481372|NCT00600171|20901698|P5|STARTED|Overall Study||101
8481373|NCT00600171|20901699|P4|STARTED|Overall Study||100
8481374|NCT00600171|20901700|P3|STARTED|Overall Study||101
8481375|NCT00600171|20901701|P2|STARTED|Overall Study||101
8481376|NCT00600171|20901702|P1|STARTED|Overall Study||102
8481377|NCT00600119|20901776|P6|NOT COMPLETED|Follow-up Period||1
8481378|NCT00600119|20901777|P5|NOT COMPLETED|Follow-up Period||0
8481379|NCT00600119|20901778|P4|NOT COMPLETED|Follow-up Period||0
8481380|NCT00600119|20901779|P3|NOT COMPLETED|Follow-up Period||0
8481381|NCT00600119|20901780|P2|NOT COMPLETED|Follow-up Period||0
8481382|NCT00600119|20901781|P1|NOT COMPLETED|Follow-up Period||1
8481383|NCT00600119|20901776|P6|COMPLETED|Follow-up Period||20
8481384|NCT00600119|20901777|P5|COMPLETED|Follow-up Period||31
8481385|NCT00600119|20901778|P4|COMPLETED|Follow-up Period||28
8481386|NCT00600119|20901779|P3|COMPLETED|Follow-up Period||27
8481387|NCT00600119|20901780|P2|COMPLETED|Follow-up Period||28
8481388|NCT00600119|20901781|P1|COMPLETED|Follow-up Period||26
8481389|NCT00600119|20901776|P6|STARTED|Follow-up Period||21
8481390|NCT00600119|20901777|P5|STARTED|Follow-up Period||31
8481391|NCT00600119|20901778|P4|STARTED|Follow-up Period||28
8481392|NCT00600119|20901779|P3|STARTED|Follow-up Period||27
8481393|NCT00600119|20901780|P2|STARTED|Follow-up Period||28
8481394|NCT00600119|20901781|P1|STARTED|Follow-up Period||27
8481395|NCT00600119|20901776|P6|NOT COMPLETED|Double-blind Treatment Period||14
8481396|NCT00600119|20901777|P5|NOT COMPLETED|Double-blind Treatment Period||6
8481397|NCT00600119|20901778|P4|NOT COMPLETED|Double-blind Treatment Period||2
8481398|NCT00600119|20901779|P3|NOT COMPLETED|Double-blind Treatment Period||0
8481399|NCT00600119|20901780|P2|NOT COMPLETED|Double-blind Treatment Period||5
8481400|NCT00600119|20901781|P1|NOT COMPLETED|Double-blind Treatment Period||5
8481401|NCT00600119|20901776|P6|COMPLETED|Double-blind Treatment Period||21
8481402|NCT00600119|20901777|P5|COMPLETED|Double-blind Treatment Period||31
8481403|NCT00600119|20901778|P4|COMPLETED|Double-blind Treatment Period||28
8481404|NCT00600119|20901779|P3|COMPLETED|Double-blind Treatment Period||27
8481405|NCT00600119|20901780|P2|COMPLETED|Double-blind Treatment Period||28
8481406|NCT00600119|20901781|P1|COMPLETED|Double-blind Treatment Period||27
8481407|NCT00600119|20901776|P6|STARTED|Double-blind Treatment Period||35
8481408|NCT00600119|20901777|P5|STARTED|Double-blind Treatment Period||37
8481409|NCT00600119|20901778|P4|STARTED|Double-blind Treatment Period||30
8481410|NCT00600119|20901779|P3|STARTED|Double-blind Treatment Period||27
8481411|NCT00600119|20901780|P2|STARTED|Double-blind Treatment Period||33
8481412|NCT00600119|20901781|P1|STARTED|Double-blind Treatment Period||32
8481413|NCT00600119|20901776|P6|NOT COMPLETED|Single-blind Placebo run-in Period||2
8481414|NCT00600119|20901777|P5|NOT COMPLETED|Single-blind Placebo run-in Period||2
8481415|NCT00600119|20901778|P4|NOT COMPLETED|Single-blind Placebo run-in Period||1
8481416|NCT00600119|20901779|P3|NOT COMPLETED|Single-blind Placebo run-in Period||2
8481417|NCT00600119|20901780|P2|NOT COMPLETED|Single-blind Placebo run-in Period||2
8481418|NCT00600119|20901781|P1|NOT COMPLETED|Single-blind Placebo run-in Period||4
8481419|NCT00600119|20901776|P6|COMPLETED|Single-blind Placebo run-in Period||35
8481420|NCT00600119|20901777|P5|COMPLETED|Single-blind Placebo run-in Period||37
8481421|NCT00600119|20901778|P4|COMPLETED|Single-blind Placebo run-in Period||30
8481422|NCT00600119|20901779|P3|COMPLETED|Single-blind Placebo run-in Period||27
8481423|NCT00600119|20901780|P2|COMPLETED|Single-blind Placebo run-in Period||33
8481424|NCT00600119|20901781|P1|COMPLETED|Single-blind Placebo run-in Period||32
8481425|NCT00600119|20901776|P6|STARTED|Single-blind Placebo run-in Period||37
8481426|NCT00600119|20901777|P5|STARTED|Single-blind Placebo run-in Period||39
8481427|NCT00600119|20901778|P4|STARTED|Single-blind Placebo run-in Period||31
8481428|NCT00600119|20901779|P3|STARTED|Single-blind Placebo run-in Period||29
8481429|NCT00600119|20901780|P2|STARTED|Single-blind Placebo run-in Period||35
8481430|NCT00600119|20901781|P1|STARTED|Single-blind Placebo run-in Period||36
8481431|NCT00600106|20901815|P2|NOT COMPLETED|Overall Study||1
8481432|NCT00600106|20901816|P1|NOT COMPLETED|Overall Study||1
8481433|NCT00600106|20901815|P2|COMPLETED|Overall Study||18
8481434|NCT00600106|20901816|P1|COMPLETED|Overall Study||17
8481435|NCT00600106|20901815|P2|STARTED|Overall Study||19
8481436|NCT00600106|20901816|P1|STARTED|Overall Study||18
8481437|NCT00600080|20901848|P2|NOT COMPLETED|Period 2: One-week to Two-weeks||0
8481438|NCT00600080|20901849|P1|NOT COMPLETED|Period 2: One-week to Two-weeks||0
8481439|NCT00600080|20901848|P2|COMPLETED|Period 2: One-week to Two-weeks||32
8481440|NCT00600080|20901849|P1|COMPLETED|Period 2: One-week to Two-weeks||28
8481441|NCT00600080|20901848|P2|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
8481442|NCT00600080|20901849|P1|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
8481443|NCT00600080|20901848|P2|NOT COMPLETED|Period 1: Baseline to One-week||0
8481444|NCT00600080|20901849|P1|NOT COMPLETED|Period 1: Baseline to One-week||0
8481445|NCT00600080|20901848|P2|COMPLETED|Period 1: Baseline to One-week||32
8481446|NCT00600080|20901849|P1|COMPLETED|Period 1: Baseline to One-week||28
8481447|NCT00600080|20901848|P2|STARTED|Period 1: Baseline to One-week||32
8481448|NCT00600080|20901849|P1|STARTED|Period 1: Baseline to One-week||28
8481449|NCT00600067|20901863|P2|NOT COMPLETED|Overall Study||7
8481450|NCT00600067|20901864|P1|NOT COMPLETED|Overall Study||3
8481451|NCT00600067|20901863|P2|COMPLETED|Overall Study||68
8481452|NCT00600067|20901864|P1|COMPLETED|Overall Study||52
8481453|NCT00600067|20901863|P2|STARTED|Overall Study||75
8481454|NCT00600067|20901864|P1|STARTED|Overall Study||55
8481455|NCT00600028|20901874|P2|NOT COMPLETED|Second Intervention (12 Weeks)||2
8481456|NCT00600028|20901875|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
8481457|NCT00600028|20901874|P2|COMPLETED|Second Intervention (12 Weeks)||8
8481458|NCT00600028|20901875|P1|COMPLETED|Second Intervention (12 Weeks)||12
8481459|NCT00600028|20901874|P2|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
8481460|NCT00600028|20901875|P1|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
8481461|NCT00600028|20901874|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
8481462|NCT00600028|20901875|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
8481463|NCT00600028|20901874|P2|COMPLETED|First Intervention (12 Weeks)||10
8481464|NCT00600028|20901875|P1|COMPLETED|First Intervention (12 Weeks)||12
8481465|NCT00600028|20901874|P2|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
8481466|NCT00600028|20901875|P1|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
8481467|NCT00600015|20901889|P2|NOT COMPLETED|Overall Study||35
8481468|NCT00600015|20901890|P1|NOT COMPLETED|Overall Study||60
8481469|NCT00600015|20901889|P2|COMPLETED|Overall Study|Completed >=2 cycles|20
8481470|NCT00600015|20901890|P1|COMPLETED|Overall Study|Completed >=2 cycles|51
8481471|NCT00600015|20901889|P2|STARTED|Overall Study||55
8481472|NCT00600015|20901890|P1|STARTED|Overall Study||111
8481473|NCT00599924|20901905|P7|NOT COMPLETED|Overall Study||5
8481474|NCT00599924|20901906|P6|NOT COMPLETED|Overall Study||4
8481475|NCT00599924|20901907|P5|NOT COMPLETED|Overall Study||6
8481476|NCT00599924|20901908|P4|NOT COMPLETED|Overall Study||8
8481477|NCT00599924|20901909|P3|NOT COMPLETED|Overall Study||2
8481478|NCT00599924|20901910|P2|NOT COMPLETED|Overall Study||5
8481479|NCT00599924|20901911|P1|NOT COMPLETED|Overall Study||3
8481480|NCT00599924|20901905|P7|COMPLETED|Overall Study||3
8481481|NCT00599924|20901906|P6|COMPLETED|Overall Study||2
8481482|NCT00599924|20901907|P5|COMPLETED|Overall Study||3
8481483|NCT00599924|20901908|P4|COMPLETED|Overall Study||4
8481484|NCT00599924|20901909|P3|COMPLETED|Overall Study||3
8481485|NCT00599924|20901910|P2|COMPLETED|Overall Study||4
8481486|NCT00599924|20901911|P1|COMPLETED|Overall Study||1
8481487|NCT00599924|20901905|P7|STARTED|Overall Study||8
8481488|NCT00599924|20901906|P6|STARTED|Overall Study||6
8481489|NCT00599924|20901907|P5|STARTED|Overall Study||9
8481490|NCT00599924|20901908|P4|STARTED|Overall Study||12
8481491|NCT00599924|20901909|P3|STARTED|Overall Study||5
8481492|NCT00599924|20901910|P2|STARTED|Overall Study||9
8481493|NCT00599924|20901911|P1|STARTED|Overall Study||4
8481494|NCT00599872|20901998|P2|NOT COMPLETED|Overall Study||33
8481495|NCT00599872|20901999|P1|NOT COMPLETED|Overall Study||49
8481496|NCT00599872|20901998|P2|COMPLETED|Overall Study||181
8481497|NCT00599872|20901999|P1|COMPLETED|Overall Study||167
8481498|NCT00599872|20901998|P2|STARTED|Overall Study||214
8481499|NCT00599872|20901999|P1|STARTED|Overall Study||216
8481500|NCT00599755|20902015|P1|NOT COMPLETED|Overall Study||19
8481501|NCT00599755|20902015|P1|COMPLETED|Overall Study||49
8481502|NCT00599755|20902015|P1|STARTED|Overall Study||68
8481509|NCT00599339|20902041|P1|NOT COMPLETED|Overall Study||664
8481510|NCT00599339|20902041|P1|COMPLETED|Overall Study||1531
8481511|NCT00599339|20902041|P1|Safety Set|Overall Study||2179
8481512|NCT00599339|20902041|P1|STARTED|Overall Study||2195
8481513|NCT00599326|20902143|P1|NOT COMPLETED|Overall Study||2
8481514|NCT00599326|20902143|P1|COMPLETED|Overall Study||8
8481515|NCT00599326|20902143|P1|STARTED|Overall Study||10
8481516|NCT00599313|20902148|P1|NOT COMPLETED|Overall Study||36
8481517|NCT00599313|20902148|P1|COMPLETED|Overall Study||0
8481518|NCT00599313|20902148|P1|STARTED|Overall Study||36
8481519|NCT00599248|20902159|P4|NOT COMPLETED|Overall Study||0
8481520|NCT00599248|20902160|P3|NOT COMPLETED|Overall Study||0
8481521|NCT00599248|20902161|P2|NOT COMPLETED|Overall Study||0
8481522|NCT00599248|20902162|P1|NOT COMPLETED|Overall Study||0
8481523|NCT00599248|20902159|P4|COMPLETED|Overall Study||3
8481524|NCT00599248|20902160|P3|COMPLETED|Overall Study||3
8481525|NCT00599248|20902161|P2|COMPLETED|Overall Study||3
8481526|NCT00599248|20902162|P1|COMPLETED|Overall Study||3
8481527|NCT00599248|20902159|P4|STARTED|Overall Study||3
8481528|NCT00599248|20902160|P3|STARTED|Overall Study||3
8481529|NCT00599248|20902161|P2|STARTED|Overall Study||3
8481530|NCT00599248|20902162|P1|STARTED|Overall Study||3
8481531|NCT00599196|20902190|P1|NOT COMPLETED|Overall Study||381
8481532|NCT00599196|20902190|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
8481533|NCT00599196|20902190|P1|STARTED|Overall Study||381
8481534|NCT00599131|20902196|P1|NOT COMPLETED|Overall Study||0
8481535|NCT00599131|20902196|P1|COMPLETED|Overall Study||4
8481536|NCT00599131|20902196|P1|STARTED|Overall Study||4
8481537|NCT00599053|20902206|P2|NOT COMPLETED|Overall Study||0
8481538|NCT00599053|20902207|P1|NOT COMPLETED|Overall Study||0
8481539|NCT00599053|20902206|P2|COMPLETED|Overall Study||2
8481540|NCT00599053|20902207|P1|COMPLETED|Overall Study||5
8481541|NCT00599053|20902206|P2|STARTED|Overall Study||2
8481542|NCT00599053|20902207|P1|STARTED|Overall Study||5
8481543|NCT00599027|20902221|P2|NOT COMPLETED|Overall Study||3
8481544|NCT00599027|20902222|P1|NOT COMPLETED|Overall Study||1
8481545|NCT00599027|20902221|P2|COMPLETED|Overall Study||22
8481546|NCT00599027|20902222|P1|COMPLETED|Overall Study||25
8481547|NCT00599027|20902221|P2|STARTED|Overall Study||25
8481548|NCT00599027|20902222|P1|STARTED|Overall Study||26
8481549|NCT00599014|20902228|P1|NOT COMPLETED|Overall Study||0
8481550|NCT00599014|20902228|P1|COMPLETED|Overall Study||335
8481551|NCT00599014|20902228|P1|STARTED|Overall Study||335
8481552|NCT00598871|20902235|P2|NOT COMPLETED|Overall Study||1
8481553|NCT00598871|20902236|P1|NOT COMPLETED|Overall Study||0
8481554|NCT00598871|20902235|P2|COMPLETED|Overall Study||8
8481555|NCT00598871|20902236|P1|COMPLETED|Overall Study||3
8481556|NCT00598871|20902235|P2|STARTED|Overall Study||9
8481557|NCT00598871|20902236|P1|STARTED|Overall Study||3
8481564|NCT00598819|20902261|P1|NOT COMPLETED|Overall Study||0
8481565|NCT00598819|20902261|P1|COMPLETED|Overall Study||14
8481566|NCT00598819|20902261|P1|STARTED|Overall Study||14
8481567|NCT00598806|20902271|P2|NOT COMPLETED|Overall Study||64
8481568|NCT00598806|20902272|P1|NOT COMPLETED|Overall Study||73
8481569|NCT00598806|20902271|P2|COMPLETED|Overall Study||346
8481570|NCT00598806|20902272|P1|COMPLETED|Overall Study||329
8481571|NCT00598806|20902271|P2|STARTED|Overall Study||410
8481572|NCT00598806|20902272|P1|STARTED|Overall Study||402
8481573|NCT00598702|20902300|P8|NOT COMPLETED|Overall Study||0
8481574|NCT00598702|20902301|P7|NOT COMPLETED|Overall Study||1
8481575|NCT00598702|20902302|P6|NOT COMPLETED|Overall Study||12
8481576|NCT00598702|20902303|P5|NOT COMPLETED|Overall Study||3
8481577|NCT00598702|20902304|P4|NOT COMPLETED|Overall Study||8
8481578|NCT00598702|20902305|P3|NOT COMPLETED|Overall Study||2
8481579|NCT00598702|20902306|P2|NOT COMPLETED|Overall Study||2
8481580|NCT00598702|20902307|P1|NOT COMPLETED|Overall Study||0
8481581|NCT00598702|20902300|P8|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
8481582|NCT00598702|20902301|P7|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
8481583|NCT00598702|20902302|P6|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
8481584|NCT00598702|20902303|P5|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
8481585|NCT00598702|20902304|P4|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
8481586|NCT00598702|20902305|P3|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
8481587|NCT00598702|20902306|P2|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
8481588|NCT00598702|20902307|P1|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
8481589|NCT00598702|20902300|P8|STARTED|Overall Study||4
8481590|NCT00598702|20902301|P7|STARTED|Overall Study||1
8481591|NCT00598702|20902302|P6|STARTED|Overall Study||42
8481592|NCT00598702|20902303|P5|STARTED|Overall Study||9
8481593|NCT00598702|20902304|P4|STARTED|Overall Study||33
8481594|NCT00598702|20902305|P3|STARTED|Overall Study||7
8481595|NCT00598702|20902306|P2|STARTED|Overall Study||3
8481596|NCT00598702|20902307|P1|STARTED|Overall Study||1
8481597|NCT00598689|20902351|P2|NOT COMPLETED|Overall Study||0
8481598|NCT00598689|20902352|P1|NOT COMPLETED|Overall Study||0
8481599|NCT00598689|20902351|P2|COMPLETED|Overall Study||40
8481600|NCT00598689|20902352|P1|COMPLETED|Overall Study||40
8481601|NCT00598689|20902351|P2|STARTED|Overall Study||40
8481602|NCT00598689|20902352|P1|STARTED|Overall Study||40
8481603|NCT00598663|20902364|P2|NOT COMPLETED|Second Intervention (6 Months)||1
8481604|NCT00598663|20902365|P1|NOT COMPLETED|Second Intervention (6 Months)||4
8481605|NCT00598663|20902364|P2|COMPLETED|Second Intervention (6 Months)||69
8481606|NCT00598663|20902365|P1|COMPLETED|Second Intervention (6 Months)||69
8481607|NCT00598663|20902364|P2|STARTED|Second Intervention (6 Months)||70
8481608|NCT00598663|20902365|P1|STARTED|Second Intervention (6 Months)||73
8481609|NCT00598663|20902364|P2|NOT COMPLETED|Washout (4 Months)||1
8481610|NCT00598663|20902365|P1|NOT COMPLETED|Washout (4 Months)||0
8481611|NCT00598663|20902364|P2|COMPLETED|Washout (4 Months)||70
8481612|NCT00598663|20902365|P1|COMPLETED|Washout (4 Months)||73
8481613|NCT00598663|20902364|P2|STARTED|Washout (4 Months)||71
8481614|NCT00598663|20902365|P1|STARTED|Washout (4 Months)||73
8481615|NCT00598663|20902364|P2|NOT COMPLETED|First Intervention (6 Months)||6
8481616|NCT00598663|20902365|P1|NOT COMPLETED|First Intervention (6 Months)||3
8481617|NCT00598663|20902364|P2|COMPLETED|First Intervention (6 Months)||71
8481618|NCT00598663|20902365|P1|COMPLETED|First Intervention (6 Months)||73
8481619|NCT00598663|20902364|P2|STARTED|First Intervention (6 Months)||77
8481620|NCT00598663|20902365|P1|STARTED|First Intervention (6 Months)||76
8481621|NCT00598650|20902383|P1|NOT COMPLETED|Overall Study||27
8481622|NCT00598650|20902383|P1|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
8481623|NCT00598650|20902383|P1|STARTED|Overall Study||108
8481624|NCT00598585|20902392|P2|NOT COMPLETED|Overall Study||0
8481625|NCT00598585|20902393|P1|NOT COMPLETED|Overall Study||1
8481626|NCT00598585|20902392|P2|COMPLETED|Overall Study||6
8481627|NCT00598585|20902393|P1|COMPLETED|Overall Study||5
8481628|NCT00598585|20902392|P2|STARTED|Overall Study||6
8481629|NCT00598585|20902393|P1|STARTED|Overall Study||6
8481630|NCT00598559|20902402|P3|NOT COMPLETED|Overall Study||3
8481631|NCT00598559|20902403|P2|NOT COMPLETED|Overall Study||28
8481632|NCT00598559|20902404|P1|NOT COMPLETED|Overall Study||27
8481633|NCT00598559|20902402|P3|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
8481634|NCT00598559|20902403|P2|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
8481635|NCT00598559|20902404|P1|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
8481636|NCT00598559|20902402|P3|STARTED|Overall Study||30
8481637|NCT00598559|20902403|P2|STARTED|Overall Study||91
8481638|NCT00598559|20902404|P1|STARTED|Overall Study||92
8481639|NCT00598507|20902421|P1|NOT COMPLETED|Overall Study||0
8481640|NCT00598507|20902421|P1|COMPLETED|Overall Study||35
8481641|NCT00598507|20902421|P1|STARTED|Overall Study||35
8481642|NCT00598481|20902428|P1|NOT COMPLETED|Treatment||1
8481643|NCT00598481|20902428|P1|COMPLETED|Treatment||11
8481644|NCT00598481|20902428|P1|STARTED|Treatment||12
8481645|NCT00598481|20902428|P1|NOT COMPLETED|Baseline||0
8481646|NCT00598481|20902428|P1|COMPLETED|Baseline||12
8481647|NCT00598481|20902428|P1|STARTED|Baseline||12
8481648|NCT00598442|20902438|P3|NOT COMPLETED|Overall Study||24
8481649|NCT00598442|20902439|P2|NOT COMPLETED|Overall Study||39
8481650|NCT00598442|20902440|P1|NOT COMPLETED|Overall Study||43
8481651|NCT00598442|20902438|P3|COMPLETED|Overall Study||139
8481652|NCT00598442|20902439|P2|COMPLETED|Overall Study||124
8481653|NCT00598442|20902440|P1|COMPLETED|Overall Study||124
8481654|NCT00598442|20902438|P3|STARTED|Overall Study||163
8481655|NCT00598442|20902439|P2|STARTED|Overall Study||163
8481656|NCT00598442|20902440|P1|STARTED|Overall Study||167
8481657|NCT00598273|20902457|P3|NOT COMPLETED|Overall Study||39
8481658|NCT00598273|20902458|P2|NOT COMPLETED|Overall Study||38
8481659|NCT00598273|20902459|P1|NOT COMPLETED|Overall Study||41
8481660|NCT00598273|20902457|P3|COMPLETED|Overall Study||125
8481661|NCT00598273|20902458|P2|COMPLETED|Overall Study||127
8481662|NCT00598273|20902459|P1|COMPLETED|Overall Study||120
8481663|NCT00598273|20902457|P3|STARTED|Overall Study||164
8481664|NCT00598273|20902458|P2|STARTED|Overall Study||165
8481665|NCT00598273|20902459|P1|STARTED|Overall Study||161
8481666|NCT00598078|20902473|P2|NOT COMPLETED|Period 3 (Day 3)||0
8481667|NCT00598078|20902474|P1|NOT COMPLETED|Period 3 (Day 3)||0
8481668|NCT00598078|20902473|P2|COMPLETED|Period 3 (Day 3)||10
8481669|NCT00598078|20902474|P1|COMPLETED|Period 3 (Day 3)||9
8481670|NCT00598078|20902473|P2|STARTED|Period 3 (Day 3)||10
8481671|NCT00598078|20902474|P1|STARTED|Period 3 (Day 3)||9
8481672|NCT00598078|20902473|P2|NOT COMPLETED|Period 2 (Day 2)||0
8481673|NCT00598078|20902474|P1|NOT COMPLETED|Period 2 (Day 2)||1
8481674|NCT00598078|20902473|P2|COMPLETED|Period 2 (Day 2)||10
8481675|NCT00598078|20902474|P1|COMPLETED|Period 2 (Day 2)||9
8481676|NCT00598078|20902473|P2|STARTED|Period 2 (Day 2)||10
8481677|NCT00598078|20902474|P1|STARTED|Period 2 (Day 2)||10
8481678|NCT00598078|20902473|P2|NOT COMPLETED|Period 1 (Day 1)||0
8481679|NCT00598078|20902474|P1|NOT COMPLETED|Period 1 (Day 1)||0
8481680|NCT00598078|20902473|P2|COMPLETED|Period 1 (Day 1)||10
8481681|NCT00598078|20902474|P1|COMPLETED|Period 1 (Day 1)||10
8481682|NCT00598078|20902473|P2|STARTED|Period 1 (Day 1)||10
8481683|NCT00598078|20902474|P1|STARTED|Period 1 (Day 1)||10
8481684|NCT00597935|20902486|P4|NOT COMPLETED|6-Months to 24-Months||8
8481685|NCT00597935|20902487|P3|NOT COMPLETED|6-Months to 24-Months||10
8481686|NCT00597935|20902488|P2|NOT COMPLETED|6-Months to 24-Months||8
8481687|NCT00597935|20902489|P1|NOT COMPLETED|6-Months to 24-Months||17
8481688|NCT00597935|20902486|P4|COMPLETED|6-Months to 24-Months||85
8481689|NCT00597935|20902487|P3|COMPLETED|6-Months to 24-Months||77
8481690|NCT00597935|20902488|P2|COMPLETED|6-Months to 24-Months||79
8481691|NCT00597935|20902489|P1|COMPLETED|6-Months to 24-Months||76
8481692|NCT00597935|20902486|P4|STARTED|6-Months to 24-Months||93
8481693|NCT00597935|20902487|P3|STARTED|6-Months to 24-Months||87
8481694|NCT00597935|20902488|P2|STARTED|6-Months to 24-Months||87
8481695|NCT00597935|20902489|P1|STARTED|6-Months to 24-Months||93
8481696|NCT00597935|20902486|P4|NOT COMPLETED|Baseline to 6-Months||4
8481697|NCT00597935|20902487|P3|NOT COMPLETED|Baseline to 6-Months||4
8481698|NCT00597935|20902488|P2|NOT COMPLETED|Baseline to 6-Months||4
8481699|NCT00597935|20902489|P1|NOT COMPLETED|Baseline to 6-Months||2
8481700|NCT00597935|20902486|P4|COMPLETED|Baseline to 6-Months||93
8481701|NCT00597935|20902487|P3|COMPLETED|Baseline to 6-Months||87
8481702|NCT00597935|20902488|P2|COMPLETED|Baseline to 6-Months||87
8481703|NCT00597935|20902489|P1|COMPLETED|Baseline to 6-Months||93
8481704|NCT00597935|20902486|P4|STARTED|Baseline to 6-Months||97
8481705|NCT00597935|20902487|P3|STARTED|Baseline to 6-Months||91
8481706|NCT00597935|20902488|P2|STARTED|Baseline to 6-Months||91
8481707|NCT00597935|20902489|P1|STARTED|Baseline to 6-Months||95
8481708|NCT00597935|20902486|P4|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
8481709|NCT00597935|20902487|P3|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
8481710|NCT00597935|20902488|P2|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
8481711|NCT00597935|20902489|P1|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
8481712|NCT00597935|20902486|P4|COMPLETED|Randomized to Surgical and BPMT Arms||97
8481713|NCT00597935|20902487|P3|COMPLETED|Randomized to Surgical and BPMT Arms||91
8481714|NCT00597935|20902488|P2|COMPLETED|Randomized to Surgical and BPMT Arms||91
8481715|NCT00597935|20902489|P1|COMPLETED|Randomized to Surgical and BPMT Arms||95
8481716|NCT00597935|20902486|P4|STARTED|Randomized to Surgical and BPMT Arms||97
8481717|NCT00597935|20902487|P3|STARTED|Randomized to Surgical and BPMT Arms||91
8481718|NCT00597935|20902488|P2|STARTED|Randomized to Surgical and BPMT Arms||91
8481719|NCT00597935|20902489|P1|STARTED|Randomized to Surgical and BPMT Arms||95
8481720|NCT00597909|20902546|P3|NOT COMPLETED|Overall Study||0
8481721|NCT00597909|20902547|P2|NOT COMPLETED|Overall Study||0
8481722|NCT00597909|20902548|P1|NOT COMPLETED|Overall Study||0
8481723|NCT00597909|20902546|P3|COMPLETED|Overall Study||0
8481724|NCT00597909|20902547|P2|COMPLETED|Overall Study||0
8481725|NCT00597909|20902548|P1|COMPLETED|Overall Study||0
8481726|NCT00597909|20902546|P3|STARTED|Overall Study||0
8481727|NCT00597909|20902547|P2|STARTED|Overall Study||0
8481728|NCT00597909|20902548|P1|STARTED|Overall Study||0
8481729|NCT00597896|20902558|P2|NOT COMPLETED|Overall Study||2
8481730|NCT00597896|20902559|P1|NOT COMPLETED|Overall Study||3
8481731|NCT00597896|20902558|P2|COMPLETED|Overall Study||24
8481732|NCT00597896|20902559|P1|COMPLETED|Overall Study||21
8481733|NCT00597896|20902558|P2|STARTED|Overall Study||26
8481734|NCT00597896|20902559|P1|STARTED|Overall Study||24
8481735|NCT00597818|20902589|P4|NOT COMPLETED|Overall Study||10
8481736|NCT00597818|20902590|P3|NOT COMPLETED|Overall Study||19
8481737|NCT00597818|20902591|P2|NOT COMPLETED|Overall Study||16
8481738|NCT00597818|20902592|P1|NOT COMPLETED|Overall Study||18
8481739|NCT00597818|20902589|P4|COMPLETED|Overall Study||20
8481740|NCT00597818|20902590|P3|COMPLETED|Overall Study||12
8481741|NCT00597818|20902591|P2|COMPLETED|Overall Study||14
8481742|NCT00597818|20902592|P1|COMPLETED|Overall Study||12
8481743|NCT00597818|20902589|P4|STARTED|Overall Study||30
8481744|NCT00597818|20902590|P3|STARTED|Overall Study||31
8481745|NCT00597818|20902591|P2|STARTED|Overall Study||30
8481746|NCT00597818|20902592|P1|STARTED|Overall Study||30
8481747|NCT00597766|20902617|P3|NOT COMPLETED|Follow-up 3, Week 12||0
8481748|NCT00597766|20902618|P2|NOT COMPLETED|Follow-up 3, Week 12||0
8481749|NCT00597766|20902619|P1|NOT COMPLETED|Follow-up 3, Week 12||0
8481750|NCT00597766|20902617|P3|COMPLETED|Follow-up 3, Week 12||9
8481751|NCT00597766|20902618|P2|COMPLETED|Follow-up 3, Week 12||9
8481752|NCT00597766|20902619|P1|COMPLETED|Follow-up 3, Week 12||8
8481753|NCT00597766|20902617|P3|STARTED|Follow-up 3, Week 12||9
8481754|NCT00597766|20902618|P2|STARTED|Follow-up 3, Week 12||9
8481755|NCT00597766|20902619|P1|STARTED|Follow-up 3, Week 12||8
8481756|NCT00597766|20902617|P3|NOT COMPLETED|Follow-up 2, Week 8||1
8481757|NCT00597766|20902618|P2|NOT COMPLETED|Follow-up 2, Week 8||0
8481758|NCT00597766|20902619|P1|NOT COMPLETED|Follow-up 2, Week 8||0
8481759|NCT00597766|20902617|P3|COMPLETED|Follow-up 2, Week 8||9
8481760|NCT00597766|20902618|P2|COMPLETED|Follow-up 2, Week 8||9
8481761|NCT00597766|20902619|P1|COMPLETED|Follow-up 2, Week 8||8
8481762|NCT00597766|20902617|P3|STARTED|Follow-up 2, Week 8||10
8481763|NCT00597766|20902618|P2|STARTED|Follow-up 2, Week 8||9
8481764|NCT00597766|20902619|P1|STARTED|Follow-up 2, Week 8||8
8481765|NCT00597766|20902617|P3|NOT COMPLETED|Follow-up 1, Week 4||0
8481766|NCT00597766|20902618|P2|NOT COMPLETED|Follow-up 1, Week 4||0
8481767|NCT00597766|20902619|P1|NOT COMPLETED|Follow-up 1, Week 4||1
8481768|NCT00597766|20902617|P3|COMPLETED|Follow-up 1, Week 4||10
8481769|NCT00597766|20902618|P2|COMPLETED|Follow-up 1, Week 4||9
8481770|NCT00597766|20902619|P1|COMPLETED|Follow-up 1, Week 4||8
8481771|NCT00597766|20902617|P3|STARTED|Follow-up 1, Week 4||10
8481772|NCT00597766|20902618|P2|STARTED|Follow-up 1, Week 4||9
8481773|NCT00597766|20902619|P1|STARTED|Follow-up 1, Week 4||9
8481774|NCT00597766|20902617|P3|NOT COMPLETED|Enrolled||0
8481775|NCT00597766|20902618|P2|NOT COMPLETED|Enrolled||0
8481776|NCT00597766|20902619|P1|NOT COMPLETED|Enrolled||0
8481777|NCT00597766|20902617|P3|COMPLETED|Enrolled||10
8481778|NCT00597766|20902618|P2|COMPLETED|Enrolled||9
8481779|NCT00597766|20902619|P1|COMPLETED|Enrolled||9
8481780|NCT00597766|20902617|P3|STARTED|Enrolled||10
8481781|NCT00597766|20902618|P2|STARTED|Enrolled||9
8481782|NCT00597766|20902619|P1|STARTED|Enrolled||9
8481783|NCT00597753|20902638|P2|NOT COMPLETED|Overall Study||69
8481784|NCT00597753|20902639|P1|NOT COMPLETED|Overall Study||166
8481785|NCT00597753|20902638|P2|COMPLETED|Overall Study||202
8481786|NCT00597753|20902639|P1|COMPLETED|Overall Study||366
8481787|NCT00597753|20902638|P2|STARTED|Overall Study||271
8481788|NCT00597753|20902639|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
8481789|NCT00597727|20902653|P5|NOT COMPLETED|Open-label Extended Maintenance Phase||2
8481790|NCT00597727|20902654|P4|NOT COMPLETED|Open-label Extended Maintenance Phase||3
8481791|NCT00597727|20902655|P3|NOT COMPLETED|Open-label Extended Maintenance Phase||6
8481792|NCT00597727|20902656|P2|NOT COMPLETED|Open-label Extended Maintenance Phase||0
8481793|NCT00597727|20902657|P1|NOT COMPLETED|Open-label Extended Maintenance Phase||0
8481794|NCT00597727|20902653|P5|COMPLETED|Open-label Extended Maintenance Phase||1
8481795|NCT00597727|20902654|P4|COMPLETED|Open-label Extended Maintenance Phase||14
8481796|NCT00597727|20902655|P3|COMPLETED|Open-label Extended Maintenance Phase||23
8481797|NCT00597727|20902656|P2|COMPLETED|Open-label Extended Maintenance Phase||0
8481798|NCT00597727|20902657|P1|COMPLETED|Open-label Extended Maintenance Phase||0
8481799|NCT00597727|20902653|P5|STARTED|Open-label Extended Maintenance Phase||3
8481800|NCT00597727|20902654|P4|STARTED|Open-label Extended Maintenance Phase||17
8481801|NCT00597727|20902655|P3|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
8481802|NCT00597727|20902656|P2|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
8481803|NCT00597727|20902657|P1|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
8481804|NCT00597727|20902653|P5|NOT COMPLETED|12 Month Blinded Phase||1
8481805|NCT00597727|20902654|P4|NOT COMPLETED|12 Month Blinded Phase||10
8481806|NCT00597727|20902655|P3|NOT COMPLETED|12 Month Blinded Phase||0
8481807|NCT00597727|20902656|P2|NOT COMPLETED|12 Month Blinded Phase||0
8481808|NCT00597727|20902657|P1|NOT COMPLETED|12 Month Blinded Phase||0
8481809|NCT00597727|20902653|P5|COMPLETED|12 Month Blinded Phase||3
8481810|NCT00597727|20902654|P4|COMPLETED|12 Month Blinded Phase||17
8481811|NCT00597727|20902655|P3|COMPLETED|12 Month Blinded Phase||0
8481812|NCT00597727|20902656|P2|COMPLETED|12 Month Blinded Phase||15
8481813|NCT00597727|20902657|P1|COMPLETED|12 Month Blinded Phase||14
8481814|NCT00597727|20902653|P5|STARTED|12 Month Blinded Phase||4
8481815|NCT00597727|20902654|P4|STARTED|12 Month Blinded Phase||27
8481816|NCT00597727|20902655|P3|STARTED|12 Month Blinded Phase||0
8481817|NCT00597727|20902656|P2|STARTED|12 Month Blinded Phase||15
8481818|NCT00597727|20902657|P1|STARTED|12 Month Blinded Phase||14
8481819|NCT00597714|20902673|P3|NOT COMPLETED|Overall Study||10
8481820|NCT00597714|20902674|P2|NOT COMPLETED|Overall Study||46
8481821|NCT00597714|20902675|P1|NOT COMPLETED|Overall Study||56
8481822|NCT00597714|20902673|P3|COMPLETED|Overall Study||84
8481823|NCT00597714|20902674|P2|COMPLETED|Overall Study||11
8481824|NCT00597714|20902675|P1|COMPLETED|Overall Study||24
8481825|NCT00597714|20902673|P3|STARTED|Overall Study||94
8481826|NCT00597714|20902674|P2|STARTED|Overall Study||57
8481827|NCT00597714|20902675|P1|STARTED|Overall Study||80
8481828|NCT00597701|20902687|P2|NOT COMPLETED|Overall Study||8
8481829|NCT00597701|20902688|P1|NOT COMPLETED|Overall Study||7
8481830|NCT00597701|20902687|P2|COMPLETED|Overall Study||13
8481831|NCT00597701|20902688|P1|COMPLETED|Overall Study||18
8481832|NCT00597701|20902687|P2|STARTED|Overall Study||21
8481833|NCT00597701|20902688|P1|STARTED|Overall Study||25
8481834|NCT00597675|20902696|P2|NOT COMPLETED|Open Label Phase||0
8481835|NCT00597675|20902697|P1|NOT COMPLETED|Open Label Phase||0
8481836|NCT00597675|20902696|P2|COMPLETED|Open Label Phase||5
8481837|NCT00597675|20902697|P1|COMPLETED|Open Label Phase||2
8481838|NCT00597675|20902696|P2|STARTED|Open Label Phase||5
8481839|NCT00597675|20902697|P1|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
8481840|NCT00597675|20902696|P2|NOT COMPLETED|Blinded Phase||1
8481841|NCT00597675|20902697|P1|NOT COMPLETED|Blinded Phase||2
8481842|NCT00597675|20902696|P2|COMPLETED|Blinded Phase||5
8481843|NCT00597675|20902697|P1|COMPLETED|Blinded Phase||2
8481844|NCT00597675|20902696|P2|STARTED|Blinded Phase||6
8481845|NCT00597675|20902697|P1|STARTED|Blinded Phase||4
8481846|NCT00597584|20902710|P2|NOT COMPLETED|Overall Study||63
8481847|NCT00597584|20902711|P1|NOT COMPLETED|Overall Study||128
8481848|NCT00597584|20902710|P2|COMPLETED|Overall Study||211
8481849|NCT00597584|20902711|P1|COMPLETED|Overall Study||421
8481850|NCT00597584|20902710|P2|STARTED|Overall Study||274
8481851|NCT00597584|20902711|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
8481852|NCT00597558|20902721|P1|NOT COMPLETED|Overall Study||4
8481853|NCT00597558|20902721|P1|COMPLETED|Overall Study||9
8481854|NCT00597558|20902721|P1|STARTED|Overall Study||13
8481855|NCT00597545|20902729|P2|NOT COMPLETED|Overall Study||0
8481856|NCT00597545|20902730|P1|NOT COMPLETED|Overall Study||0
8481857|NCT00597545|20902729|P2|COMPLETED|Overall Study||6
8481858|NCT00597545|20902730|P1|COMPLETED|Overall Study||4
8481859|NCT00597545|20902729|P2|STARTED|Overall Study||6
8481860|NCT00597545|20902730|P1|STARTED|Overall Study||4
8481861|NCT00597519|20902736|P1|NOT COMPLETED|Overall Study||1
8481862|NCT00597519|20902736|P1|COMPLETED|Overall Study||27
8481863|NCT00597519|20902736|P1|STARTED|Overall Study||28
8481864|NCT00597506|20902740|P1|NOT COMPLETED|Overall Study||1
8481865|NCT00597506|20902740|P1|COMPLETED|Overall Study||49
8481866|NCT00597506|20902740|P1|STARTED|Overall Study||50
8481867|NCT00597493|20902745|P1|NOT COMPLETED|Overall Study||0
8481868|NCT00597493|20902745|P1|COMPLETED|Overall Study||32
8481869|NCT00597493|20902745|P1|STARTED|Overall Study||32
8481870|NCT00597428|20902764|P2|NOT COMPLETED|Overall Study||71
8481871|NCT00597428|20902765|P1|NOT COMPLETED|Overall Study||61
8481872|NCT00597428|20902764|P2|COMPLETED|Overall Study||152
8481873|NCT00597428|20902765|P1|COMPLETED|Overall Study||153
8481874|NCT00597428|20902764|P2|STARTED|Overall Study||223
8481875|NCT00597428|20902765|P1|STARTED|Overall Study||214
8481876|NCT00597402|20902781|P1|NOT COMPLETED|Overall Study||0
8481877|NCT00597402|20902781|P1|COMPLETED|Overall Study||125
8481878|NCT00597402|20902781|P1|STARTED|Overall Study||125
8481879|NCT00597376|20902790|P2|NOT COMPLETED|Overall Study||4
8481880|NCT00597376|20902791|P1|NOT COMPLETED|Overall Study||8
8481881|NCT00597376|20902790|P2|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
8481882|NCT00597376|20902791|P1|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
8481883|NCT00597376|20902790|P2|STARTED|Overall Study||53
8481884|NCT00597376|20902791|P1|STARTED|Overall Study||51
8481885|NCT00597272|20902808|P7|NOT COMPLETED|Overall Study||0
8481886|NCT00597272|20902809|P6|NOT COMPLETED|Overall Study||0
8481887|NCT00597272|20902810|P5|NOT COMPLETED|Overall Study||0
8481888|NCT00597272|20902811|P4|NOT COMPLETED|Overall Study||0
8481889|NCT00597272|20902812|P3|NOT COMPLETED|Overall Study||0
8481890|NCT00597272|20902813|P2|NOT COMPLETED|Overall Study||0
8481891|NCT00597272|20902814|P1|NOT COMPLETED|Overall Study||0
8481892|NCT00597272|20902808|P7|COMPLETED|Overall Study||10
8481893|NCT00597272|20902809|P6|COMPLETED|Overall Study||10
8481894|NCT00597272|20902810|P5|COMPLETED|Overall Study||1
8481895|NCT00597272|20902811|P4|COMPLETED|Overall Study||1
8481896|NCT00597272|20902812|P3|COMPLETED|Overall Study||10
8481897|NCT00597272|20902813|P2|COMPLETED|Overall Study||1
8481898|NCT00597272|20902814|P1|COMPLETED|Overall Study||1
8481899|NCT00597272|20902808|P7|STARTED|Overall Study||10
8481900|NCT00597272|20902809|P6|STARTED|Overall Study||10
8481901|NCT00597272|20902810|P5|STARTED|Overall Study||1
8481902|NCT00597272|20902811|P4|STARTED|Overall Study||1
8481903|NCT00597272|20902812|P3|STARTED|Overall Study||10
8481904|NCT00597272|20902813|P2|STARTED|Overall Study||1
8481905|NCT00597272|20902814|P1|STARTED|Overall Study||1
8481906|NCT00597246|20902830|P1|NOT COMPLETED|Overall Study||0
8481907|NCT00597246|20902830|P1|COMPLETED|Overall Study||30
8481908|NCT00597246|20902830|P1|STARTED|Overall Study||30
8481909|NCT00597207|20902837|P2|NOT COMPLETED|Overall Study||7
8481910|NCT00597207|20902838|P1|NOT COMPLETED|Overall Study||5
8481911|NCT00597207|20902837|P2|COMPLETED|Overall Study||2125
8481912|NCT00597207|20902838|P1|COMPLETED|Overall Study||2094
8481913|NCT00597207|20902837|P2|STARTED|Overall Study||2132
8481914|NCT00597207|20902838|P1|STARTED|Overall Study||2099
8481915|NCT00597116|20902846|P2|NOT COMPLETED|Overall Study||11
8481916|NCT00597116|20902847|P1|NOT COMPLETED|Overall Study||14
8481917|NCT00597116|20902846|P2|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
8481918|NCT00597116|20902847|P1|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
8481919|NCT00597116|20902846|P2|STARTED|Overall Study||11
8481920|NCT00597116|20902847|P1|STARTED|Overall Study||14
8481921|NCT00597038|20902861|P2|NOT COMPLETED|Overall Study||4
8481922|NCT00597038|20902862|P1|NOT COMPLETED|Overall Study||2
8481923|NCT00597038|20902861|P2|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
8481924|NCT00597038|20902862|P1|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
8481925|NCT00597038|20902861|P2|STARTED|Overall Study||34
8481926|NCT00597038|20902862|P1|STARTED|Overall Study||16
8481927|NCT00597012|20902873|P2|NOT COMPLETED|Overall Study||8
8481928|NCT00597012|20902874|P1|NOT COMPLETED|Overall Study||13
8481929|NCT00597012|20902873|P2|COMPLETED|Overall Study||169
8481930|NCT00597012|20902874|P1|COMPLETED|Overall Study||161
8481931|NCT00597012|20902873|P2|STARTED|Overall Study||177
8481932|NCT00597012|20902874|P1|STARTED|Overall Study||174
8481933|NCT00596960|20902890|P2|NOT COMPLETED|Overall Study||9
8481934|NCT00596960|20902891|P1|NOT COMPLETED|Overall Study||11
8481935|NCT00596960|20902890|P2|COMPLETED|Overall Study||60
8481936|NCT00596960|20902891|P1|COMPLETED|Overall Study||59
8481937|NCT00596960|20902890|P2|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
8481938|NCT00596960|20902891|P1|STARTED|Overall Study||70
8481939|NCT00596947|20902903|P2|NOT COMPLETED|Overall Study||3
8481940|NCT00596947|20902904|P1|NOT COMPLETED|Overall Study||6
8481941|NCT00596947|20902903|P2|COMPLETED|Overall Study||6
8481942|NCT00596947|20902904|P1|COMPLETED|Overall Study||3
8481943|NCT00596947|20902903|P2|STARTED|Overall Study||9
8481944|NCT00596947|20902904|P1|STARTED|Overall Study||9
8481945|NCT00596934|20902944|P1|NOT COMPLETED|Overall Study||2
8481946|NCT00596934|20902944|P1|COMPLETED|Overall Study||7
8481947|NCT00596934|20902944|P1|STARTED|Overall Study||9
8481948|NCT00596830|20902957|P2|NOT COMPLETED|Overall Study||339
8481949|NCT00596830|20902958|P1|NOT COMPLETED|Overall Study||342
8481950|NCT00596830|20902957|P2|COMPLETED|Overall Study||0
8481951|NCT00596830|20902958|P1|COMPLETED|Overall Study||0
8481952|NCT00596830|20902957|P2|Treated|Overall Study||332
8481953|NCT00596830|20902958|P1|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
8481954|NCT00596830|20902957|P2|STARTED|Overall Study||339
8481955|NCT00596830|20902958|P1|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
8481956|NCT00596817|20902984|P2|NOT COMPLETED|Double-blind Period||79
8481957|NCT00596817|20902985|P1|NOT COMPLETED|Double-blind Period||88
8481958|NCT00596817|20902984|P2|COMPLETED|Double-blind Period||125
8481959|NCT00596817|20902985|P1|COMPLETED|Double-blind Period||104
8481960|NCT00596817|20902984|P2|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
8481961|NCT00596817|20902985|P1|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
8481962|NCT00596817|20902984|P2|NOT COMPLETED|Open-label Period to Double-blind Period||92
8481963|NCT00596817|20902985|P1|NOT COMPLETED|Open-label Period to Double-blind Period||0
8481964|NCT00596817|20902984|P2|COMPLETED|Open-label Period to Double-blind Period||400
8481965|NCT00596817|20902985|P1|COMPLETED|Open-label Period to Double-blind Period||0
8481966|NCT00596817|20902984|P2|STARTED|Open-label Period to Double-blind Period||492
8481967|NCT00596817|20902985|P1|STARTED|Open-label Period to Double-blind Period||0
8481968|NCT00596817|20902984|P2|NOT COMPLETED|Open-label Period||147
8481969|NCT00596817|20902985|P1|NOT COMPLETED|Open-label Period||0
8481970|NCT00596817|20902984|P2|COMPLETED|Open-label Period||492
8481971|NCT00596817|20902985|P1|COMPLETED|Open-label Period||0
8481972|NCT00596817|20902984|P2|STARTED|Open-label Period||639
8481973|NCT00596817|20902985|P1|STARTED|Open-label Period||0
8481974|NCT00596752|20903010|P2|NOT COMPLETED|Overall Study||143
8481975|NCT00596752|20903011|P1|NOT COMPLETED|Overall Study||126
8481976|NCT00596752|20903010|P2|COMPLETED|Overall Study||282
8481977|NCT00596752|20903011|P1|COMPLETED|Overall Study||289
8481978|NCT00596752|20903010|P2|Randomized and Treated|Overall Study||424
8481979|NCT00596752|20903011|P1|Randomized and Treated|Overall Study||415
8481980|NCT00596752|20903010|P2|STARTED|Overall Study||425
8481981|NCT00596752|20903011|P1|STARTED|Overall Study||415
8481982|NCT00596687|20903041|P2|NOT COMPLETED|Overall Study||9
8481983|NCT00596687|20903042|P1|NOT COMPLETED|Overall Study||14
8481984|NCT00596687|20903041|P2|COMPLETED|Overall Study||107
8481985|NCT00596687|20903042|P1|COMPLETED|Overall Study||104
8481986|NCT00596687|20903041|P2|STARTED|Overall Study||116
8481987|NCT00596687|20903042|P1|STARTED|Overall Study||118
8481988|NCT00596635|20903053|P3|NOT COMPLETED|Overall Study||8
8481989|NCT00596635|20903054|P2|NOT COMPLETED|Overall Study||13
8481990|NCT00596635|20903055|P1|NOT COMPLETED|Overall Study||7
8481991|NCT00596635|20903053|P3|COMPLETED|Overall Study||11
8481992|NCT00596635|20903054|P2|COMPLETED|Overall Study||7
8481993|NCT00596635|20903055|P1|COMPLETED|Overall Study||10
8481994|NCT00596635|20903053|P3|STARTED|Overall Study||19
8481995|NCT00596635|20903054|P2|STARTED|Overall Study||20
8481996|NCT00596635|20903055|P1|STARTED|Overall Study||17
8481997|NCT00596622|20903072|P1|NOT COMPLETED|Overall Study||13
8481998|NCT00596622|20903072|P1|COMPLETED|Overall Study||33
8481999|NCT00596622|20903072|P1|STARTED|Overall Study||46
8482000|NCT00596466|20903081|P1|NOT COMPLETED|Overall Study||17
8482001|NCT00596466|20903081|P1|COMPLETED|Overall Study||58
8482002|NCT00596466|20903081|P1|Enrolled, Treated|Overall Study||73
8482003|NCT00596466|20903081|P1|STARTED|Overall Study||75
8482004|NCT00596453|20903089|P2|NOT COMPLETED|Overall Study||3
8482005|NCT00596453|20903090|P1|NOT COMPLETED|Overall Study||1
8482006|NCT00596453|20903089|P2|COMPLETED|Overall Study||12
8482007|NCT00596453|20903090|P1|COMPLETED|Overall Study||12
8482008|NCT00596453|20903089|P2|STARTED|Overall Study||15
8482009|NCT00596453|20903090|P1|STARTED|Overall Study||13
8482010|NCT00596440|20903098|P2|NOT COMPLETED|Overall Study||80
8482011|NCT00596440|20903099|P1|NOT COMPLETED|Overall Study||65
8482012|NCT00596440|20903098|P2|COMPLETED|Overall Study||41
8482013|NCT00596440|20903099|P1|COMPLETED|Overall Study||48
8482014|NCT00596440|20903098|P2|Showed to First Treatment Session|Overall Study||52
8482015|NCT00596440|20903099|P1|Showed to First Treatment Session|Overall Study||61
8482016|NCT00596440|20903098|P2|Showed to Eligibility Visit|Overall Study||72
8482017|NCT00596440|20903099|P1|Showed to Eligibility Visit|Overall Study||85
8482018|NCT00596440|20903098|P2|STARTED|Overall Study||121
8482019|NCT00596440|20903099|P1|STARTED|Overall Study||113
8482020|NCT00596427|20903111|P2|NOT COMPLETED|Overall Study||2
8482021|NCT00596427|20903112|P1|NOT COMPLETED|Overall Study||4
8482022|NCT00596427|20903111|P2|COMPLETED|Overall Study||28
8482023|NCT00596427|20903112|P1|COMPLETED|Overall Study||26
8482024|NCT00596427|20903111|P2|STARTED|Overall Study||30
8482025|NCT00596427|20903112|P1|STARTED|Overall Study||30
8482026|NCT00596362|20903140|P1|NOT COMPLETED|Overall Study||1
8482027|NCT00596362|20903140|P1|COMPLETED|Overall Study||0
8482028|NCT00596362|20903140|P1|STARTED|Overall Study||1
8482029|NCT00596271|20903147|P3|NOT COMPLETED|Overall Study||1
8482030|NCT00596271|20903148|P2|NOT COMPLETED|Overall Study||6
8482031|NCT00596271|20903149|P1|NOT COMPLETED|Overall Study||5
8482032|NCT00596271|20903147|P3|COMPLETED|Overall Study||61
8482033|NCT00596271|20903148|P2|COMPLETED|Overall Study||59
8482034|NCT00596271|20903149|P1|COMPLETED|Overall Study||60
8482035|NCT00596271|20903147|P3|STARTED|Overall Study||62
8482036|NCT00596271|20903148|P2|STARTED|Overall Study||65
8482037|NCT00596271|20903149|P1|STARTED|Overall Study||65
8482038|NCT00596167|20903158|P1|NOT COMPLETED|Overall Study||0
8482039|NCT00596167|20903158|P1|COMPLETED|Overall Study||6
8482040|NCT00596167|20903158|P1|STARTED|Overall Study|All recruited subjects completed the study.|6
8482041|NCT00596102|20903165|P3|NOT COMPLETED|Up to Month 60||637
8482042|NCT00596102|20903166|P2|NOT COMPLETED|Up to Month 60||338
8482043|NCT00596102|20903167|P1|NOT COMPLETED|Up to Month 60||2181
8482044|NCT00596102|20903165|P3|COMPLETED|Up to Month 60||0
8482045|NCT00596102|20903166|P2|COMPLETED|Up to Month 60||0
8482046|NCT00596102|20903167|P1|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
8482047|NCT00596102|20903165|P3|STARTED|Up to Month 60||637
8482048|NCT00596102|20903166|P2|STARTED|Up to Month 60||338
8482049|NCT00596102|20903167|P1|STARTED|Up to Month 60||2283
8482050|NCT00596102|20903165|P3|NOT COMPLETED|Up to Month 6||0
8482051|NCT00596102|20903166|P2|NOT COMPLETED|Up to Month 6||0
8482052|NCT00596102|20903167|P1|NOT COMPLETED|Up to Month 6||0
8482053|NCT00596102|20903165|P3|COMPLETED|Up to Month 6||637
8482054|NCT00596102|20903166|P2|COMPLETED|Up to Month 6||338
8482055|NCT00596102|20903167|P1|COMPLETED|Up to Month 6||2283
8482056|NCT00596102|20903165|P3|STARTED|Up to Month 6||637
8482057|NCT00596102|20903166|P2|STARTED|Up to Month 6||338
8482058|NCT00596102|20903167|P1|STARTED|Up to Month 6||2283
8482059|NCT00596011|20903176|P2|NOT COMPLETED|Overall Study||10
8482060|NCT00596011|20903177|P1|NOT COMPLETED|Overall Study||13
8482061|NCT00596011|20903176|P2|COMPLETED|Overall Study||38
8482062|NCT00596011|20903177|P1|COMPLETED|Overall Study||36
8482063|NCT00596011|20903176|P2|STARTED|Overall Study||48
8482064|NCT00596011|20903177|P1|STARTED|Overall Study||49
8482065|NCT00595959|20903193|P1|NOT COMPLETED|Overall Study||2
8482066|NCT00595959|20903193|P1|COMPLETED|Overall Study||63
8482067|NCT00595959|20903193|P1|STARTED|Overall Study||65
8482068|NCT00595946|20903210|P2|NOT COMPLETED|Overall Study||69
8482069|NCT00595946|20903211|P1|NOT COMPLETED|Overall Study||64
8482070|NCT00595946|20903210|P2|COMPLETED|Overall Study||152
8482071|NCT00595946|20903211|P1|COMPLETED|Overall Study||154
8482072|NCT00595946|20903210|P2|STARTED|Overall Study||221
8482073|NCT00595946|20903211|P1|STARTED|Overall Study||218
8482074|NCT00595920|20903227|P1|NOT COMPLETED|Overall Study||116
8482075|NCT00595920|20903227|P1|COMPLETED|Overall Study||0
8482076|NCT00595920|20903227|P1|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
8482077|NCT00595920|20903227|P1|STARTED|Overall Study||116
8482078|NCT00595881|20903231|P1|NOT COMPLETED|Overall Study||0
8482079|NCT00595881|20903231|P1|COMPLETED|Overall Study||420
8482080|NCT00595881|20903231|P1|STARTED|Overall Study||420
8482081|NCT00595868|20903238|P2|NOT COMPLETED|Overall Study||50
8482082|NCT00595868|20903239|P1|NOT COMPLETED|Overall Study||45
8482083|NCT00595868|20903238|P2|COMPLETED|Overall Study||61
8482084|NCT00595868|20903239|P1|COMPLETED|Overall Study||62
8482085|NCT00595868|20903238|P2|STARTED|Overall Study||111
8482086|NCT00595868|20903239|P1|STARTED|Overall Study||107
8482087|NCT00595790|20903250|P3|NOT COMPLETED|Overall Study||3
8482088|NCT00595790|20903251|P2|NOT COMPLETED|Overall Study||1
8482089|NCT00595790|20903252|P1|NOT COMPLETED|Overall Study||2
8482090|NCT00595790|20903250|P3|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
8482091|NCT00595790|20903251|P2|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
8482092|NCT00595790|20903252|P1|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
8482093|NCT00595790|20903250|P3|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
8482094|NCT00595790|20903251|P2|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
8482095|NCT00595790|20903252|P1|STARTED|Overall Study||125
8482096|NCT00595764|20903262|P2|NOT COMPLETED|Overall Study||43
8482097|NCT00595764|20903263|P1|NOT COMPLETED|Overall Study||39
8482098|NCT00595764|20903262|P2|COMPLETED|Overall Study||27
8482099|NCT00595764|20903263|P1|COMPLETED|Overall Study||32
8482100|NCT00595764|20903262|P2|STARTED|Overall Study||70
8482101|NCT00595764|20903263|P1|STARTED|Overall Study||71
8482102|NCT00595621|20903279|P2|NOT COMPLETED|Randomization and Study||1
8482103|NCT00595621|20903280|P1|NOT COMPLETED|Randomization and Study||2
8482104|NCT00595621|20903279|P2|COMPLETED|Randomization and Study||8
8482105|NCT00595621|20903280|P1|COMPLETED|Randomization and Study||8
8482106|NCT00595621|20903279|P2|STARTED|Randomization and Study||9
8482107|NCT00595621|20903280|P1|STARTED|Randomization and Study||10
8482108|NCT00595621|20903279|P2|NOT COMPLETED|Open Label Run in||0
8482109|NCT00595621|20903280|P1|NOT COMPLETED|Open Label Run in||3
8482110|NCT00595621|20903279|P2|COMPLETED|Open Label Run in||0
8482111|NCT00595621|20903280|P1|COMPLETED|Open Label Run in||19
8482112|NCT00595621|20903279|P2|STARTED|Open Label Run in||0
8482113|NCT00595621|20903280|P1|STARTED|Open Label Run in||22
8482114|NCT00595582|20903297|P1|NOT COMPLETED|Overall Study||10
8482115|NCT00595582|20903297|P1|COMPLETED|Overall Study||0
8482116|NCT00595582|20903297|P1|STARTED|Overall Study||10
8482117|NCT00595556|20903303|P2|NOT COMPLETED|Overall Study||1
8482118|NCT00595556|20903304|P1|NOT COMPLETED|Overall Study||3
8482119|NCT00595556|20903303|P2|COMPLETED|Overall Study||19
8482120|NCT00595556|20903304|P1|COMPLETED|Overall Study||17
8482121|NCT00595556|20903303|P2|STARTED|Overall Study||20
8482122|NCT00595556|20903304|P1|STARTED|Overall Study||20
8482123|NCT00595530|20903318|P1|NOT COMPLETED|Overall Study||0
8482124|NCT00595530|20903318|P1|COMPLETED|Overall Study||3
8482125|NCT00595530|20903318|P1|STARTED|Overall Study||3
8482126|NCT00595517|20903323|P1|NOT COMPLETED|Overall Study||19
8482127|NCT00595517|20903323|P1|COMPLETED|Overall Study||111
8482128|NCT00595517|20903323|P1|STARTED|Overall Study||130
8482129|NCT00595504|20903332|P2|NOT COMPLETED|Overall Study||3
8482130|NCT00595504|20903333|P1|NOT COMPLETED|Overall Study||2
8482131|NCT00595504|20903332|P2|COMPLETED|Overall Study||6
8482132|NCT00595504|20903333|P1|COMPLETED|Overall Study||14
8482133|NCT00595504|20903332|P2|STARTED|Overall Study||9
8482134|NCT00595504|20903333|P1|STARTED|Overall Study||16
8482135|NCT00595478|20903345|P2|NOT COMPLETED|36-week Follow-up Period||8
8482136|NCT00595478|20903346|P1|NOT COMPLETED|36-week Follow-up Period||9
8482137|NCT00595478|20903345|P2|COMPLETED|36-week Follow-up Period||30
8482138|NCT00595478|20903346|P1|COMPLETED|36-week Follow-up Period||28
8482139|NCT00595478|20903345|P2|STARTED|36-week Follow-up Period||38
8482140|NCT00595478|20903346|P1|STARTED|36-week Follow-up Period||37
8482141|NCT00595478|20903345|P2|NOT COMPLETED|Treatment||0
8482142|NCT00595478|20903346|P1|NOT COMPLETED|Treatment||0
8482143|NCT00595478|20903345|P2|COMPLETED|Treatment||38
8482144|NCT00595478|20903346|P1|COMPLETED|Treatment||37
8482145|NCT00595478|20903345|P2|STARTED|Treatment||38
8482146|NCT00595478|20903346|P1|STARTED|Treatment||37
8482147|NCT00595465|20903357|P3|NOT COMPLETED|Overall Study||7
8482148|NCT00595465|20903358|P2|NOT COMPLETED|Overall Study||4
8482149|NCT00595465|20903359|P1|NOT COMPLETED|Overall Study||6
8482150|NCT00595465|20903357|P3|COMPLETED|Overall Study||121
8482151|NCT00595465|20903358|P2|COMPLETED|Overall Study||125
8482152|NCT00595465|20903359|P1|COMPLETED|Overall Study||124
8482153|NCT00595465|20903357|P3|STARTED|Overall Study||128
8482154|NCT00595465|20903358|P2|STARTED|Overall Study||129
8482155|NCT00595465|20903359|P1|STARTED|Overall Study||130
8482156|NCT00595413|20903371|P4|NOT COMPLETED|Overall Study||4
8482157|NCT00595413|20903372|P3|NOT COMPLETED|Overall Study||8
8482158|NCT00595413|20903373|P2|NOT COMPLETED|Overall Study||5
8482159|NCT00595413|20903374|P1|NOT COMPLETED|Overall Study||7
8482160|NCT00595413|20903371|P4|COMPLETED|Overall Study||75
8482161|NCT00595413|20903372|P3|COMPLETED|Overall Study||70
8482162|NCT00595413|20903373|P2|COMPLETED|Overall Study||73
8482163|NCT00595413|20903374|P1|COMPLETED|Overall Study||69
8482164|NCT00595413|20903371|P4|STARTED|Overall Study||79
8482165|NCT00595413|20903372|P3|STARTED|Overall Study||78
8482166|NCT00595413|20903373|P2|STARTED|Overall Study||78
8482167|NCT00595413|20903374|P1|STARTED|Overall Study||76
8482168|NCT00595361|20903402|P2|NOT COMPLETED|Overall Study||0
8482169|NCT00595361|20903403|P1|NOT COMPLETED|Overall Study||0
8482170|NCT00595361|20903402|P2|COMPLETED|Overall Study||18
8482171|NCT00595361|20903403|P1|COMPLETED|Overall Study||12
8482172|NCT00595361|20903402|P2|STARTED|Overall Study||18
8482173|NCT00595361|20903403|P1|STARTED|Overall Study||12
8482174|NCT00595335|20903415|P2|NOT COMPLETED|Six Months to Twelve Months||1
8482175|NCT00595335|20903416|P1|NOT COMPLETED|Six Months to Twelve Months||1
8482176|NCT00595335|20903415|P2|COMPLETED|Six Months to Twelve Months||9
8482177|NCT00595335|20903416|P1|COMPLETED|Six Months to Twelve Months||10
8482178|NCT00595335|20903415|P2|STARTED|Six Months to Twelve Months||10
8482179|NCT00595335|20903416|P1|STARTED|Six Months to Twelve Months||11
8482180|NCT00595335|20903415|P2|NOT COMPLETED|Baseline to Six Months||2
8482181|NCT00595335|20903416|P1|NOT COMPLETED|Baseline to Six Months||2
8482182|NCT00595335|20903415|P2|COMPLETED|Baseline to Six Months||10
8482183|NCT00595335|20903416|P1|COMPLETED|Baseline to Six Months||11
8482184|NCT00595335|20903415|P2|STARTED|Baseline to Six Months||12
8482185|NCT00595335|20903416|P1|STARTED|Baseline to Six Months||13
8482186|NCT00595309|20903436|P1|NOT COMPLETED|Overall Study||4
8482187|NCT00595309|20903436|P1|COMPLETED|Overall Study||194
8482188|NCT00595309|20903436|P1|STARTED|Overall Study||198
8482189|NCT00595270|20903443|P3|NOT COMPLETED|Overall Study||8
8482190|NCT00595270|20903444|P2|NOT COMPLETED|Overall Study||10
8482191|NCT00595270|20903445|P1|NOT COMPLETED|Overall Study||6
8482192|NCT00595270|20903443|P3|COMPLETED|Overall Study||108
8482193|NCT00595270|20903444|P2|COMPLETED|Overall Study||107
8482194|NCT00595270|20903445|P1|COMPLETED|Overall Study||110
8482195|NCT00595270|20903443|P3|STARTED|Overall Study||116
8482196|NCT00595270|20903444|P2|STARTED|Overall Study||117
8482197|NCT00595270|20903445|P1|STARTED|Overall Study||116
8482198|NCT00595231|20903455|P2|NOT COMPLETED|Overall Study||5
8482199|NCT00595231|20903456|P1|NOT COMPLETED|Overall Study||5
8482200|NCT00595231|20903455|P2|COMPLETED|Overall Study||114
8482201|NCT00595231|20903456|P1|COMPLETED|Overall Study||115
8482202|NCT00595231|20903455|P2|STARTED|Overall Study||119
8482203|NCT00595231|20903456|P1|STARTED|Overall Study||120
8482204|NCT00595153|20903475|P3|NOT COMPLETED|Overall Study||25
8482205|NCT00595153|20903476|P2|NOT COMPLETED|Overall Study||16
8482206|NCT00595153|20903477|P1|NOT COMPLETED|Overall Study||4
8482207|NCT00595153|20903475|P3|COMPLETED|Overall Study||36
8482208|NCT00595153|20903476|P2|COMPLETED|Overall Study||26
8482209|NCT00595153|20903477|P1|COMPLETED|Overall Study||20
8482210|NCT00595153|20903475|P3|STARTED|Overall Study||61
8482211|NCT00595153|20903476|P2|STARTED|Overall Study||42
8482212|NCT00595153|20903477|P1|STARTED|Overall Study||24
8482213|NCT00595127|20903485|P1|NOT COMPLETED|Overall Study||10
8482214|NCT00595127|20903485|P1|COMPLETED|Overall Study||11
8482215|NCT00595127|20903485|P1|STARTED|Overall Study||21
8482216|NCT00595114|20903491|P2|NOT COMPLETED|Overall Study||0
8482217|NCT00595114|20903492|P1|NOT COMPLETED|Overall Study||0
8482218|NCT00595114|20903491|P2|COMPLETED|Overall Study||19
8482219|NCT00595114|20903492|P1|COMPLETED|Overall Study||24
8482220|NCT00595114|20903491|P2|STARTED|Overall Study||19
8482221|NCT00595114|20903492|P1|STARTED|Overall Study||24
8482222|NCT00595101|20903502|P4|NOT COMPLETED|Overall Study||0
8482223|NCT00595101|20903503|P3|NOT COMPLETED|Overall Study||0
8482224|NCT00595101|20903504|P2|NOT COMPLETED|Overall Study||1
8482225|NCT00595101|20903505|P1|NOT COMPLETED|Overall Study||0
8482226|NCT00595101|20903502|P4|COMPLETED|Overall Study||30
8482227|NCT00595101|20903503|P3|COMPLETED|Overall Study||29
8482228|NCT00595101|20903504|P2|COMPLETED|Overall Study||28
8482229|NCT00595101|20903505|P1|COMPLETED|Overall Study||29
8482230|NCT00595101|20903502|P4|STARTED|Overall Study||30
8482231|NCT00595101|20903503|P3|STARTED|Overall Study||29
8482232|NCT00595101|20903504|P2|STARTED|Overall Study||29
8482233|NCT00595101|20903505|P1|STARTED|Overall Study||29
8482234|NCT00595088|20903523|P1|NOT COMPLETED|Overall Study||40
8482235|NCT00595088|20903523|P1|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
8482236|NCT00595088|20903523|P1|STARTED|Overall Study||47
8482237|NCT00595075|20903531|P2|NOT COMPLETED|Overall Study||0
8482238|NCT00595075|20903532|P1|NOT COMPLETED|Overall Study||1
8482239|NCT00595075|20903531|P2|COMPLETED|Overall Study||5
8482240|NCT00595075|20903532|P1|COMPLETED|Overall Study||5
8482241|NCT00595075|20903531|P2|STARTED|Overall Study||5
8482242|NCT00595075|20903532|P1|STARTED|Overall Study||6
8482243|NCT00594958|20903553|P3|NOT COMPLETED|Overall Study||10
8482244|NCT00594958|20903554|P2|NOT COMPLETED|Overall Study||3
8482245|NCT00594958|20903555|P1|NOT COMPLETED|Overall Study||14
8482246|NCT00594958|20903553|P3|COMPLETED|Overall Study||202
8482247|NCT00594958|20903554|P2|COMPLETED|Overall Study||210
8482248|NCT00594958|20903555|P1|COMPLETED|Overall Study||200
8482249|NCT00594958|20903553|P3|Randomized and at Least 1 Vaccination|Overall Study||211
8482250|NCT00594958|20903554|P2|Randomized and at Least 1 Vaccination|Overall Study||213
8482251|NCT00594958|20903555|P1|Randomized and at Least 1 Vaccination|Overall Study||212
8482252|NCT00594958|20903553|P3|STARTED|Overall Study||212
8482253|NCT00594958|20903554|P2|STARTED|Overall Study||213
8482254|NCT00594958|20903555|P1|STARTED|Overall Study||214
8482255|NCT00594945|20903566|P3|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
8482256|NCT00594945|20903567|P2|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
8482257|NCT00594945|20903568|P1|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
8482258|NCT00594945|20903566|P3|COMPLETED|Cohort 2 / Treatment Period 2||2
8482259|NCT00594945|20903567|P2|COMPLETED|Cohort 2 / Treatment Period 2||3
8482260|NCT00594945|20903568|P1|COMPLETED|Cohort 2 / Treatment Period 2||0
8482261|NCT00594945|20903566|P3|STARTED|Cohort 2 / Treatment Period 2||2
8482262|NCT00594945|20903567|P2|STARTED|Cohort 2 / Treatment Period 2||3
8482263|NCT00594945|20903568|P1|STARTED|Cohort 2 / Treatment Period 2||0
8482264|NCT00594945|20903566|P3|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
8482265|NCT00594945|20903567|P2|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
8482266|NCT00594945|20903568|P1|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
8482267|NCT00594945|20903566|P3|COMPLETED|Cohort 1 / Treatment Period 1||2
8482268|NCT00594945|20903567|P2|COMPLETED|Cohort 1 / Treatment Period 1||0
8482269|NCT00594945|20903568|P1|COMPLETED|Cohort 1 / Treatment Period 1||4
8482270|NCT00594945|20903566|P3|STARTED|Cohort 1 / Treatment Period 1||2
8482271|NCT00594945|20903567|P2|STARTED|Cohort 1 / Treatment Period 1||0
8482272|NCT00594945|20903568|P1|STARTED|Cohort 1 / Treatment Period 1||4
8482273|NCT00594932|20903576|P2|NOT COMPLETED|Final 3 Months||3
8482274|NCT00594932|20903577|P1|NOT COMPLETED|Final 3 Months||4
8482275|NCT00594932|20903576|P2|COMPLETED|Final 3 Months||8
8482276|NCT00594932|20903577|P1|COMPLETED|Final 3 Months||8
8482277|NCT00594932|20903576|P2|STARTED|Final 3 Months||11
8482278|NCT00594932|20903577|P1|STARTED|Final 3 Months||12
8482279|NCT00594932|20903576|P2|NOT COMPLETED|First 3 Months||3
8482280|NCT00594932|20903577|P1|NOT COMPLETED|First 3 Months||1
8482281|NCT00594932|20903576|P2|COMPLETED|First 3 Months||11
8482282|NCT00594932|20903577|P1|COMPLETED|First 3 Months||12
8482283|NCT00594932|20903576|P2|STARTED|First 3 Months||14
8482284|NCT00594932|20903577|P1|STARTED|First 3 Months||13
8482285|NCT00594906|20903589|P2|NOT COMPLETED|Overall Study||2
8482286|NCT00594906|20903590|P1|NOT COMPLETED|Overall Study||1
8482287|NCT00594906|20903589|P2|COMPLETED|Overall Study||1
8482288|NCT00594906|20903590|P1|COMPLETED|Overall Study||6
8482289|NCT00594906|20903589|P2|STARTED|Overall Study||3
8482290|NCT00594906|20903590|P1|STARTED|Overall Study||7
8482291|NCT00594880|20903598|P2|NOT COMPLETED|Overall Study||1
8482292|NCT00594880|20903599|P1|NOT COMPLETED|Overall Study||2
8482293|NCT00594880|20903598|P2|COMPLETED|Overall Study||10
8482294|NCT00594880|20903599|P1|COMPLETED|Overall Study||10
8482295|NCT00594880|20903598|P2|STARTED|Overall Study||11
8482296|NCT00594880|20903599|P1|STARTED|Overall Study||12
8482297|NCT00594854|20903611|P2|NOT COMPLETED|Overall Study||10
8482298|NCT00594854|20903612|P1|NOT COMPLETED|Overall Study||7
8482299|NCT00594854|20903611|P2|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
8482300|NCT00594854|20903612|P1|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
8482301|NCT00594854|20903611|P2|STARTED|Overall Study||11
8482302|NCT00594854|20903612|P1|STARTED|Overall Study||9
8482303|NCT00594815|20903622|P1|NOT COMPLETED|Overall Study||9
8482304|NCT00594815|20903622|P1|COMPLETED|Overall Study||43
8482305|NCT00594815|20903622|P1|STARTED|Overall Study||52
8482306|NCT00594685|20903627|P1|NOT COMPLETED|Overall Study||0
8482307|NCT00594685|20903627|P1|COMPLETED|Overall Study||10
8482308|NCT00594685|20903627|P1|STARTED|Overall Study||10
8482309|NCT00594659|20903647|P3|NOT COMPLETED|Overall Study||7
8482310|NCT00594659|20903648|P2|NOT COMPLETED|Overall Study||9
8482311|NCT00594659|20903649|P1|NOT COMPLETED|Overall Study||13
8482312|NCT00594659|20903647|P3|COMPLETED|Overall Study||9
8482313|NCT00594659|20903648|P2|COMPLETED|Overall Study||21
8482314|NCT00594659|20903649|P1|COMPLETED|Overall Study||16
8482315|NCT00594659|20903647|P3|STARTED|Overall Study||16
8482316|NCT00594659|20903648|P2|STARTED|Overall Study||30
8482317|NCT00594659|20903649|P1|STARTED|Overall Study||29
8482318|NCT00594646|20903660|P1|NOT COMPLETED|Overall Study||16
8482319|NCT00594646|20903660|P1|COMPLETED|Overall Study||84
8482320|NCT00594646|20903660|P1|STARTED|Overall Study||100
8482321|NCT00594568|20903668|P3|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
8482322|NCT00594568|20903669|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
8482323|NCT00594568|20903670|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
8482324|NCT00594568|20903668|P3|COMPLETED|Safety Follow Up (SFU)-Optional||172
8482325|NCT00594568|20903669|P2|COMPLETED|Safety Follow Up (SFU)-Optional||168
8482326|NCT00594568|20903670|P1|COMPLETED|Safety Follow Up (SFU)-Optional||229
8482327|NCT00594568|20903668|P3|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
8482328|NCT00594568|20903669|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
8482329|NCT00594568|20903670|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
8482330|NCT00594568|20903668|P3|NOT COMPLETED|Delayed Start||66
8482331|NCT00594568|20903669|P2|NOT COMPLETED|Delayed Start||77
8482332|NCT00594568|20903670|P1|NOT COMPLETED|Delayed Start||98
8482333|NCT00594568|20903668|P3|COMPLETED|Delayed Start||55
8482334|NCT00594568|20903669|P2|COMPLETED|Delayed Start||76
8482335|NCT00594568|20903670|P1|COMPLETED|Delayed Start||91
8482336|NCT00594568|20903668|P3|STARTED|Delayed Start||121
8482337|NCT00594568|20903669|P2|STARTED|Delayed Start||153
8482338|NCT00594568|20903670|P1|STARTED|Delayed Start||189
8482339|NCT00594568|20903668|P3|NOT COMPLETED|Initial Treatment||408
8482340|NCT00594568|20903669|P2|NOT COMPLETED|Initial Treatment||354
8482341|NCT00594568|20903670|P1|NOT COMPLETED|Initial Treatment||312
8482342|NCT00594568|20903668|P3|COMPLETED|Initial Treatment||121
8482343|NCT00594568|20903669|P2|COMPLETED|Initial Treatment||153
8482344|NCT00594568|20903670|P1|COMPLETED|Initial Treatment||189
8482345|NCT00594568|20903668|P3|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
8482346|NCT00594568|20903669|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
8482347|NCT00594568|20903670|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
8482348|NCT00594568|20903668|P3|STARTED|Initial Treatment||529
8482349|NCT00594568|20903669|P2|STARTED|Initial Treatment||507
8482350|NCT00594568|20903670|P1|STARTED|Initial Treatment||501
8482351|NCT00594516|20903758|P3|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
8482352|NCT00594516|20903759|P2|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
8482353|NCT00594516|20903760|P1|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
8482354|NCT00594516|20903758|P3|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
8482355|NCT00594516|20903759|P2|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
8482356|NCT00594516|20903760|P1|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
8482357|NCT00594516|20903758|P3|STARTED|DB: Tapentadol IR to ER & ER to IR||43
8482358|NCT00594516|20903759|P2|STARTED|DB: Tapentadol IR to ER & ER to IR||44
8482359|NCT00594516|20903760|P1|STARTED|DB: Tapentadol IR to ER & ER to IR||0
8482360|NCT00594516|20903758|P3|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
8482361|NCT00594516|20903759|P2|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
8482362|NCT00594516|20903760|P1|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
8482363|NCT00594516|20903758|P3|COMPLETED|Open Label (OL): Tapentadol IR||0
8482364|NCT00594516|20903759|P2|COMPLETED|Open Label (OL): Tapentadol IR||0
8482365|NCT00594516|20903760|P1|COMPLETED|Open Label (OL): Tapentadol IR||87
8482366|NCT00594516|20903758|P3|STARTED|Open Label (OL): Tapentadol IR||0
8482367|NCT00594516|20903759|P2|STARTED|Open Label (OL): Tapentadol IR||0
8482368|NCT00594516|20903760|P1|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
8482369|NCT00594464|20903768|P1|NOT COMPLETED|Overall Study||3
8482370|NCT00594464|20903768|P1|COMPLETED|Overall Study||11
8482371|NCT00594464|20903768|P1|STARTED|Overall Study||14
8482372|NCT00594425|20903783|P3|NOT COMPLETED|Overall Study||10
8482373|NCT00594425|20903784|P2|NOT COMPLETED|Overall Study||14
8482374|NCT00594425|20903785|P1|NOT COMPLETED|Overall Study||7
8482375|NCT00594425|20903783|P3|COMPLETED|Overall Study||42
8482376|NCT00594425|20903784|P2|COMPLETED|Overall Study||34
8482377|NCT00594425|20903785|P1|COMPLETED|Overall Study||43
8482378|NCT00594425|20903783|P3|STARTED|Overall Study||52
8482379|NCT00594425|20903784|P2|STARTED|Overall Study||48
8482380|NCT00594425|20903785|P1|STARTED|Overall Study||50
8482381|NCT00594399|20903897|P3|NOT COMPLETED|Rerandomization Arm 1 Only||0
8482382|NCT00594399|20903898|P2|NOT COMPLETED|Rerandomization Arm 1 Only||4
8482383|NCT00594399|20903899|P1|NOT COMPLETED|Rerandomization Arm 1 Only||2
8482384|NCT00594399|20903897|P3|COMPLETED|Rerandomization Arm 1 Only||82
8482385|NCT00594399|20903898|P2|COMPLETED|Rerandomization Arm 1 Only||114
8482386|NCT00594399|20903899|P1|COMPLETED|Rerandomization Arm 1 Only||79
8482387|NCT00594399|20903897|P3|Rerandomization|Rerandomization Arm 1 Only||82
8482388|NCT00594399|20903898|P2|Rerandomization|Rerandomization Arm 1 Only||114
8482389|NCT00594399|20903899|P1|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
8482390|NCT00594399|20903897|P3|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
8482391|NCT00594399|20903898|P2|STARTED|Rerandomization Arm 1 Only||118
8482392|NCT00594399|20903899|P1|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
8482393|NCT00594399|20903897|P3|NOT COMPLETED|Initial 3 Month Counseling||0
8482394|NCT00594399|20903898|P2|NOT COMPLETED|Initial 3 Month Counseling||4
8482395|NCT00594399|20903899|P1|NOT COMPLETED|Initial 3 Month Counseling||17
8482396|NCT00594399|20903897|P3|COMPLETED|Initial 3 Month Counseling||0
8482397|NCT00594399|20903898|P2|COMPLETED|Initial 3 Month Counseling||118
8482398|NCT00594399|20903899|P1|COMPLETED|Initial 3 Month Counseling||163
8482399|NCT00594399|20903897|P3|STARTED|Initial 3 Month Counseling||0
8482400|NCT00594399|20903898|P2|STARTED|Initial 3 Month Counseling||122
8482401|NCT00594399|20903899|P1|STARTED|Initial 3 Month Counseling||180
8482402|NCT00594386|20903921|P1|NOT COMPLETED|Overall Study||258
8482403|NCT00594386|20903921|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
8482404|NCT00594386|20903921|P1|STARTED|Overall Study||258
8482405|NCT00594308|20903927|P1|NOT COMPLETED|Overall Study||0
8482406|NCT00594308|20903927|P1|COMPLETED|Overall Study||10
8482407|NCT00594308|20903927|P1|STARTED|Overall Study||10
8482408|NCT00594256|20903935|P1|NOT COMPLETED|Overall Study||0
8482409|NCT00594256|20903935|P1|COMPLETED|Overall Study||8
8482410|NCT00594256|20903935|P1|STARTED|Overall Study||8
8482411|NCT00594230|20903945|P2|NOT COMPLETED|Overall Study||9
8482412|NCT00594230|20903946|P1|NOT COMPLETED|Overall Study||15
8482413|NCT00594230|20903945|P2|COMPLETED|Overall Study||1
8482414|NCT00594230|20903946|P1|COMPLETED|Overall Study||1
8482415|NCT00594230|20903945|P2|STARTED|Overall Study||10
8482416|NCT00594230|20903946|P1|STARTED|Overall Study||16
8482417|NCT00594204|20903954|P2|NOT COMPLETED|Overall Study||45
8482418|NCT00594204|20903955|P1|NOT COMPLETED|Overall Study||58
8482419|NCT00594204|20903954|P2|COMPLETED|Overall Study||154
8482420|NCT00594204|20903955|P1|COMPLETED|Overall Study||336
8482421|NCT00594204|20903954|P2|Received Treatment|Overall Study||198
8482422|NCT00594204|20903955|P1|Received Treatment|Overall Study||390
8482423|NCT00594204|20903954|P2|STARTED|Overall Study||199
8482424|NCT00594204|20903955|P1|STARTED|Overall Study||394
8482425|NCT00594178|20903965|P1|NOT COMPLETED|Overall Study||5
8482426|NCT00594178|20903965|P1|COMPLETED|Overall Study||12
8482427|NCT00594178|20903965|P1|STARTED|Overall Study||17
8482428|NCT00594165|20903970|P1|NOT COMPLETED|Overall Study||217
8482429|NCT00594165|20903970|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
8482430|NCT00594165|20903970|P1|STARTED|Overall Study||217
8482431|NCT00594100|20903976|P1|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
8482432|NCT00594100|20903976|P1|COMPLETED|Follow-up Through 30 Days Post Procedure||224
8482433|NCT00594100|20903976|P1|STARTED|Follow-up Through 30 Days Post Procedure||236
8482434|NCT00594100|20903976|P1|NOT COMPLETED|Procedure||9
8482435|NCT00594100|20903976|P1|COMPLETED|Procedure||236
8482436|NCT00594100|20903976|P1|STARTED|Procedure||245
8482437|NCT00594061|20903985|P1|NOT COMPLETED|Overall Study||0
8482438|NCT00594061|20903985|P1|COMPLETED|Overall Study||9
8482439|NCT00594061|20903985|P1|STARTED|Overall Study||9
8482440|NCT00594035|20903992|P2|NOT COMPLETED|Overall Study||3
8482441|NCT00594035|20903993|P1|NOT COMPLETED|Overall Study||2
8482442|NCT00594035|20903992|P2|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
8482443|NCT00594035|20903993|P1|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
8482444|NCT00594035|20903992|P2|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
8482445|NCT00594035|20903993|P1|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
8482446|NCT00594022|20904001|P2|NOT COMPLETED|Overall Study||0
8482447|NCT00594022|20904002|P1|NOT COMPLETED|Overall Study||0
8482448|NCT00594022|20904001|P2|COMPLETED|Overall Study||173
8482449|NCT00594022|20904002|P1|COMPLETED|Overall Study||176
8482450|NCT00594022|20904001|P2|STARTED|Overall Study||173
8482451|NCT00594022|20904002|P1|STARTED|Overall Study||176
8482452|NCT00594009|20904016|P1|NOT COMPLETED|Overall Study||0
8482453|NCT00594009|20904016|P1|COMPLETED|Overall Study||1
8482454|NCT00594009|20904016|P1|STARTED|Overall Study||1
8482455|NCT00593957|20904023|P3|NOT COMPLETED|Overall Study||2
8482456|NCT00593957|20904024|P2|NOT COMPLETED|Overall Study||1
8482457|NCT00593957|20904025|P1|NOT COMPLETED|Overall Study||0
8482458|NCT00593957|20904023|P3|COMPLETED|Overall Study||10
8482459|NCT00593957|20904024|P2|COMPLETED|Overall Study||12
8482460|NCT00593957|20904025|P1|COMPLETED|Overall Study||13
8482461|NCT00593957|20904023|P3|STARTED|Overall Study||12
8482462|NCT00593957|20904024|P2|STARTED|Overall Study||13
8482463|NCT00593957|20904025|P1|STARTED|Overall Study||13
8482464|NCT00593918|20904049|P2|NOT COMPLETED|Overall Study||24
8482465|NCT00593918|20904050|P1|NOT COMPLETED|Overall Study||5
8482466|NCT00593918|20904049|P2|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
8482467|NCT00593918|20904050|P1|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
8482468|NCT00593918|20904049|P2|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
8482469|NCT00593918|20904050|P1|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
8482470|NCT00593866|20904058|P1|NOT COMPLETED|Overall Study||0
8482471|NCT00593866|20904058|P1|COMPLETED|Overall Study||50
8482472|NCT00593866|20904058|P1|STARTED|Overall Study||50
8482476|NCT00593827|20904075|P2|NOT COMPLETED|Overall Study||2
8482477|NCT00593827|20904076|P1|NOT COMPLETED|Overall Study||0
8482478|NCT00593827|20904075|P2|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
8482479|NCT00593827|20904076|P1|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
8482480|NCT00593827|20904075|P2|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
8482481|NCT00593827|20904076|P1|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
8482482|NCT00593827|20904075|P2|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
8482483|NCT00593827|20904076|P1|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
8482484|NCT00593827|20904075|P2|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
8482485|NCT00593827|20904076|P1|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
8482486|NCT00593814|20904100|P2|NOT COMPLETED|Overall Study||0
8482487|NCT00593814|20904101|P1|NOT COMPLETED|Overall Study||24
8482488|NCT00593814|20904100|P2|COMPLETED|Overall Study||120
8482489|NCT00593814|20904101|P1|COMPLETED|Overall Study||115
8482490|NCT00593814|20904100|P2|STARTED|Overall Study||120
8482491|NCT00593814|20904101|P1|STARTED|Overall Study||139
8482492|NCT00593736|20904113|P4|NOT COMPLETED|Treatment Period and Placebo Run-out||4
8482493|NCT00593736|20904114|P3|NOT COMPLETED|Treatment Period and Placebo Run-out||5
8482494|NCT00593736|20904115|P2|NOT COMPLETED|Treatment Period and Placebo Run-out||2
8482495|NCT00593736|20904116|P1|NOT COMPLETED|Treatment Period and Placebo Run-out||3
8482496|NCT00593736|20904113|P4|COMPLETED|Treatment Period and Placebo Run-out||28
8482497|NCT00593736|20904114|P3|COMPLETED|Treatment Period and Placebo Run-out||30
8482498|NCT00593736|20904115|P2|COMPLETED|Treatment Period and Placebo Run-out||31
8482499|NCT00593736|20904116|P1|COMPLETED|Treatment Period and Placebo Run-out||29
8482500|NCT00593736|20904113|P4|STARTED|Treatment Period and Placebo Run-out||32
8482501|NCT00593736|20904114|P3|STARTED|Treatment Period and Placebo Run-out||35
8482502|NCT00593736|20904115|P2|STARTED|Treatment Period and Placebo Run-out||33
8482503|NCT00593736|20904116|P1|STARTED|Treatment Period and Placebo Run-out||32
8482504|NCT00593736|20904113|P4|NOT COMPLETED|Screening Period and Placebo Run-in||417
8482505|NCT00593736|20904114|P3|NOT COMPLETED|Screening Period and Placebo Run-in||0
8482506|NCT00593736|20904115|P2|NOT COMPLETED|Screening Period and Placebo Run-in||0
8482507|NCT00593736|20904116|P1|NOT COMPLETED|Screening Period and Placebo Run-in||0
8482508|NCT00593736|20904113|P4|COMPLETED|Screening Period and Placebo Run-in||132
8482509|NCT00593736|20904114|P3|COMPLETED|Screening Period and Placebo Run-in||0
8482510|NCT00593736|20904115|P2|COMPLETED|Screening Period and Placebo Run-in||0
8482511|NCT00593736|20904116|P1|COMPLETED|Screening Period and Placebo Run-in||0
8482512|NCT00593736|20904113|P4|STARTED|Screening Period and Placebo Run-in||549
8482513|NCT00593736|20904114|P3|STARTED|Screening Period and Placebo Run-in||0
8482514|NCT00593736|20904115|P2|STARTED|Screening Period and Placebo Run-in||0
8482515|NCT00593736|20904116|P1|STARTED|Screening Period and Placebo Run-in||0
8482516|NCT00593684|20904364|P2|NOT COMPLETED|Overall Study||1
8482517|NCT00593684|20904365|P1|NOT COMPLETED|Overall Study||2
8482518|NCT00593684|20904364|P2|COMPLETED|Overall Study||24
8482519|NCT00593684|20904365|P1|COMPLETED|Overall Study||23
8482520|NCT00593684|20904364|P2|STARTED|Overall Study||25
8482521|NCT00593684|20904365|P1|STARTED|Overall Study||25
8482522|NCT00593645|20904377|P1|NOT COMPLETED|Overall Study||0
8482523|NCT00593645|20904377|P1|COMPLETED|Overall Study||7
8482524|NCT00593645|20904377|P1|STARTED|Overall Study||7
8482525|NCT00593606|20904391|P1|NOT COMPLETED|Overall Study||27
8482526|NCT00593606|20904391|P1|COMPLETED|Overall Study||97
8482527|NCT00593606|20904391|P1|Treatment Period Completed|Overall Study||99
8482528|NCT00593606|20904391|P1|Full Analysis Set|Overall Study||114
8482529|NCT00593606|20904391|P1|Start of Treatment - Safety Set|Overall Study||116
8482530|NCT00593606|20904391|P1|STARTED|Overall Study||124
8482531|NCT00593554|20904489|P2|NOT COMPLETED|Overall Study||5
8482532|NCT00593554|20904490|P1|NOT COMPLETED|Overall Study||3
8482533|NCT00593554|20904489|P2|COMPLETED|Overall Study||0
8482534|NCT00593554|20904490|P1|COMPLETED|Overall Study||0
8482535|NCT00593554|20904489|P2|STARTED|Overall Study||5
8482536|NCT00593554|20904490|P1|STARTED|Overall Study||3
8482537|NCT00593489|20904510|P2|NOT COMPLETED|Analysis||0
8482538|NCT00593489|20904511|P1|NOT COMPLETED|Analysis||0
8482539|NCT00593489|20904510|P2|COMPLETED|Analysis||78
8482540|NCT00593489|20904511|P1|COMPLETED|Analysis||73
8482541|NCT00593489|20904510|P2|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|78
8482542|NCT00593489|20904511|P1|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|73
8482543|NCT00593489|20904510|P2|NOT COMPLETED|Allocation||1
8482544|NCT00593489|20904511|P1|NOT COMPLETED|Allocation||2
8482545|NCT00593489|20904510|P2|COMPLETED|Allocation||78
8482546|NCT00593489|20904511|P1|COMPLETED|Allocation||73
8482547|NCT00593489|20904510|P2|STARTED|Allocation|allocated to usual care group|79
8482548|NCT00593489|20904511|P1|STARTED|Allocation|allocated to intervention group to receive the intervention|75
8482549|NCT00593450|20904541|P4|NOT COMPLETED|Overall Study||29
8482550|NCT00593450|20904542|P3|NOT COMPLETED|Overall Study||13
8482551|NCT00593450|20904543|P2|NOT COMPLETED|Overall Study||21
8482552|NCT00593450|20904544|P1|NOT COMPLETED|Overall Study||17
8482553|NCT00593450|20904541|P4|COMPLETED|Overall Study||271
8482554|NCT00593450|20904542|P3|COMPLETED|Overall Study||285
8482555|NCT00593450|20904543|P2|COMPLETED|Overall Study||265
8482556|NCT00593450|20904544|P1|COMPLETED|Overall Study||284
8482557|NCT00593450|20904541|P4|STARTED|Overall Study||300
8482558|NCT00593450|20904542|P3|STARTED|Overall Study||298
8482559|NCT00593450|20904543|P2|STARTED|Overall Study||286
8482560|NCT00593450|20904544|P1|STARTED|Overall Study||301
8482561|NCT00593385|20904614|P1|NOT COMPLETED|Overall Study||40
8482562|NCT00593385|20904614|P1|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
8482563|NCT00593385|20904614|P1|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
8482564|NCT00593385|20904614|P1|STARTED|Overall Study||165
8482565|NCT00593372|20904651|P2|NOT COMPLETED|Overall Study||0
8482566|NCT00593372|20904652|P1|NOT COMPLETED|Overall Study||0
8482567|NCT00593372|20904651|P2|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
8482568|NCT00593372|20904652|P1|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
8482569|NCT00593372|20904651|P2|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
8482570|NCT00593372|20904652|P1|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
8482571|NCT00593346|20904658|P1|NOT COMPLETED|Overall Study||0
8482572|NCT00593346|20904658|P1|COMPLETED|Overall Study||151
8482573|NCT00593346|20904658|P1|STARTED|Overall Study||151
8482574|NCT00593333|20904675|P2|NOT COMPLETED|Overall Study||11
8482575|NCT00593333|20904676|P1|NOT COMPLETED|Overall Study||10
8482576|NCT00593333|20904675|P2|COMPLETED|Overall Study||45
8482577|NCT00593333|20904676|P1|COMPLETED|Overall Study||44
8482578|NCT00593333|20904675|P2|STARTED|Overall Study||56
8482579|NCT00593333|20904676|P1|STARTED|Overall Study||54
8482580|NCT00593320|20904684|P2|NOT COMPLETED|Overall Study||0
8482581|NCT00593320|20904685|P1|NOT COMPLETED|Overall Study||0
8482582|NCT00593320|20904684|P2|COMPLETED|Overall Study||1
8482583|NCT00593320|20904685|P1|COMPLETED|Overall Study||1
8482584|NCT00593320|20904684|P2|STARTED|Overall Study||1
8482585|NCT00593320|20904685|P1|STARTED|Overall Study||1
8482586|NCT00593112|20904699|P2|NOT COMPLETED|Overall Study||0
8482587|NCT00593112|20904700|P1|NOT COMPLETED|Overall Study||10
8482588|NCT00593112|20904699|P2|COMPLETED|Overall Study||12
8482589|NCT00593112|20904700|P1|COMPLETED|Overall Study||17
8482590|NCT00593112|20904699|P2|STARTED|Overall Study||12
8482591|NCT00593112|20904700|P1|STARTED|Overall Study||27
8482592|NCT00592943|20904712|P2|NOT COMPLETED|Overall Study||0
8482593|NCT00592943|20904713|P1|NOT COMPLETED|Overall Study||0
8482594|NCT00592943|20904712|P2|COMPLETED|Overall Study||6
8482595|NCT00592943|20904713|P1|COMPLETED|Overall Study||6
8482596|NCT00592943|20904712|P2|STARTED|Overall Study||6
8482597|NCT00592943|20904713|P1|STARTED|Overall Study||6
8482598|NCT00592904|20904727|P4|NOT COMPLETED|Overall Study||11
8482599|NCT00592904|20904728|P3|NOT COMPLETED|Overall Study||17
8482600|NCT00592904|20904729|P2|NOT COMPLETED|Overall Study||55
8482601|NCT00592904|20904730|P1|NOT COMPLETED|Overall Study||25
8482602|NCT00592904|20904727|P4|COMPLETED|Overall Study||19
8482603|NCT00592904|20904728|P3|COMPLETED|Overall Study||10
8482604|NCT00592904|20904729|P2|COMPLETED|Overall Study||93
8482605|NCT00592904|20904730|P1|COMPLETED|Overall Study||32
8482606|NCT00592904|20904727|P4|STARTED|Overall Study||30
8482607|NCT00592904|20904728|P3|STARTED|Overall Study||27
8482608|NCT00592904|20904729|P2|STARTED|Overall Study||148
8482609|NCT00592904|20904730|P1|STARTED|Overall Study||57
8482610|NCT00592852|20904756|P1|NOT COMPLETED|Overall Study||6
8482611|NCT00592852|20904756|P1|COMPLETED|Overall Study||7
8482612|NCT00592852|20904756|P1|STARTED|Overall Study||13
8482613|NCT00592839|20904764|P3|NOT COMPLETED|Overall Study||6
8482614|NCT00592839|20904765|P2|NOT COMPLETED|Overall Study||4
8482615|NCT00592839|20904766|P1|NOT COMPLETED|Overall Study||2
8482616|NCT00592839|20904764|P3|COMPLETED|Overall Study||46
8482617|NCT00592839|20904765|P2|COMPLETED|Overall Study||48
8482618|NCT00592839|20904766|P1|COMPLETED|Overall Study||51
8482619|NCT00592839|20904764|P3|STARTED|Overall Study||52
8482620|NCT00592839|20904765|P2|STARTED|Overall Study||52
8482621|NCT00592839|20904766|P1|STARTED|Overall Study||53
8482622|NCT00592774|20904794|P5|NOT COMPLETED|Overall Study||14
8482623|NCT00592774|20904795|P4|NOT COMPLETED|Overall Study||14
8482624|NCT00592774|20904796|P3|NOT COMPLETED|Overall Study||4
8482625|NCT00592774|20904797|P2|NOT COMPLETED|Overall Study||32
8482626|NCT00592774|20904798|P1|NOT COMPLETED|Overall Study||11
8482627|NCT00592774|20904794|P5|COMPLETED|Overall Study||9
8482628|NCT00592774|20904795|P4|COMPLETED|Overall Study||8
8482629|NCT00592774|20904796|P3|COMPLETED|Overall Study||18
8482630|NCT00592774|20904797|P2|COMPLETED|Overall Study||21
8482631|NCT00592774|20904798|P1|COMPLETED|Overall Study||15
8482632|NCT00592774|20904794|P5|STARTED|Overall Study||23
8482633|NCT00592774|20904795|P4|STARTED|Overall Study||22
8482634|NCT00592774|20904796|P3|STARTED|Overall Study||22
8482635|NCT00592774|20904797|P2|STARTED|Overall Study||53
8482636|NCT00592774|20904798|P1|STARTED|Overall Study||26
8482637|NCT00592761|20904855|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8482638|NCT00592761|20904856|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8482639|NCT00592761|20904855|P2|COMPLETED|Second Intervention (2 Weeks)||9
8482640|NCT00592761|20904856|P1|COMPLETED|Second Intervention (2 Weeks)||9
8482641|NCT00592761|20904855|P2|STARTED|Second Intervention (2 Weeks)||9
8482642|NCT00592761|20904856|P1|STARTED|Second Intervention (2 Weeks)||9
8482643|NCT00592761|20904855|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
8482644|NCT00592761|20904856|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8482645|NCT00592761|20904855|P2|COMPLETED|First Intervention (2 Weeks)||9
8482646|NCT00592761|20904856|P1|COMPLETED|First Intervention (2 Weeks)||9
8482647|NCT00592761|20904855|P2|STARTED|First Intervention (2 Weeks)||9
8482648|NCT00592761|20904856|P1|STARTED|First Intervention (2 Weeks)||9
8482649|NCT00592683|20904870|P2|NOT COMPLETED|Overall Study||4
8482650|NCT00592683|20904871|P1|NOT COMPLETED|Overall Study||4
8482651|NCT00592683|20904870|P2|COMPLETED|Overall Study||6
8482652|NCT00592683|20904871|P1|COMPLETED|Overall Study||6
8482653|NCT00592683|20904870|P2|STARTED|Overall Study||10
8482654|NCT00592683|20904871|P1|STARTED|Overall Study||10
8482655|NCT00592631|20904881|P2|NOT COMPLETED|Overall Study||2
8482656|NCT00592631|20904882|P1|NOT COMPLETED|Overall Study||0
8482657|NCT00592631|20904881|P2|COMPLETED|Overall Study||9
8482658|NCT00592631|20904882|P1|COMPLETED|Overall Study||16
8482659|NCT00592631|20904881|P2|STARTED|Overall Study||11
8482660|NCT00592631|20904882|P1|STARTED|Overall Study||16
8482661|NCT00592553|20904891|P3|NOT COMPLETED|Overall Study||0
8482662|NCT00592553|20904892|P2|NOT COMPLETED|Overall Study||0
8482663|NCT00592553|20904893|P1|NOT COMPLETED|Overall Study||1
8482664|NCT00592553|20904891|P3|COMPLETED|Overall Study||57
8482665|NCT00592553|20904892|P2|COMPLETED|Overall Study||57
8482666|NCT00592553|20904893|P1|COMPLETED|Overall Study||59
8482667|NCT00592553|20904891|P3|ITT Population|Overall Study||57
8482668|NCT00592553|20904892|P2|ITT Population|Overall Study||57
8482669|NCT00592553|20904893|P1|ITT Population|Overall Study||60
8482670|NCT00592553|20904891|P3|As-treated Population|Overall Study||57
8482671|NCT00592553|20904892|P2|As-treated Population|Overall Study||57
8482672|NCT00592553|20904893|P1|As-treated Population|Overall Study||60
8482673|NCT00592553|20904891|P3|STARTED|Overall Study||57
8482674|NCT00592553|20904892|P2|STARTED|Overall Study||57
8482675|NCT00592553|20904893|P1|STARTED|Overall Study||60
8482676|NCT00592488|20904969|P2|NOT COMPLETED|Overall Study||0
8482677|NCT00592488|20904970|P1|NOT COMPLETED|Overall Study||0
8482678|NCT00592488|20904969|P2|COMPLETED|Overall Study||7
8482679|NCT00592488|20904970|P1|COMPLETED|Overall Study||6
8482680|NCT00592488|20904969|P2|STARTED|Overall Study||7
8482681|NCT00592488|20904970|P1|STARTED|Overall Study||6
8482682|NCT00592475|20904983|P3|NOT COMPLETED|Overall Study||0
8482683|NCT00592475|20904984|P2|NOT COMPLETED|Overall Study||0
8482684|NCT00592475|20904985|P1|NOT COMPLETED|Overall Study||0
8482685|NCT00592475|20904983|P3|COMPLETED|Overall Study||5
8482686|NCT00592475|20904984|P2|COMPLETED|Overall Study||9
8482687|NCT00592475|20904985|P1|COMPLETED|Overall Study||6
8482688|NCT00592475|20904983|P3|STARTED|Overall Study||5
8482689|NCT00592475|20904984|P2|STARTED|Overall Study||9
8482690|NCT00592475|20904985|P1|STARTED|Overall Study||6
8482691|NCT00592384|20905010|P2|NOT COMPLETED|Overall Study||6
8482692|NCT00592384|20905011|P1|NOT COMPLETED|Overall Study||5
8482693|NCT00592384|20905010|P2|COMPLETED|Overall Study||63
8482694|NCT00592384|20905011|P1|COMPLETED|Overall Study||59
8482695|NCT00592384|20905010|P2|STARTED|Overall Study||69
8482696|NCT00592384|20905011|P1|STARTED|Overall Study||64
8482697|NCT00592358|20905019|P1|NOT COMPLETED|Overall Study||6
8482698|NCT00592358|20905019|P1|COMPLETED|Overall Study||11
8482699|NCT00592358|20905019|P1|STARTED|Overall Study||17
8482700|NCT00592319|20905026|P2|NOT COMPLETED|Overall Study||3
8482701|NCT00592319|20905027|P1|NOT COMPLETED|Overall Study||0
8482702|NCT00592319|20905026|P2|COMPLETED|Overall Study||5
8482703|NCT00592319|20905027|P1|COMPLETED|Overall Study||2
8482704|NCT00592319|20905026|P2|STARTED|Overall Study||8
8482705|NCT00592319|20905027|P1|STARTED|Overall Study||2
8482706|NCT00592176|20905035|P1|NOT COMPLETED|Overall Study||0
8482707|NCT00592176|20905035|P1|COMPLETED|Overall Study||5
8482708|NCT00592176|20905035|P1|STARTED|Overall Study||5
8482709|NCT00592124|20905046|P6|NOT COMPLETED|Overall Study||3
8482710|NCT00592124|20905047|P5|NOT COMPLETED|Overall Study||3
8482711|NCT00592124|20905048|P4|NOT COMPLETED|Overall Study||3
8482712|NCT00592124|20905049|P3|NOT COMPLETED|Overall Study||6
8482713|NCT00592124|20905050|P2|NOT COMPLETED|Overall Study||5
8482714|NCT00592124|20905051|P1|NOT COMPLETED|Overall Study||4
8482715|NCT00592124|20905046|P6|COMPLETED|Overall Study||24
8482716|NCT00592124|20905047|P5|COMPLETED|Overall Study||24
8482717|NCT00592124|20905048|P4|COMPLETED|Overall Study||24
8482718|NCT00592124|20905049|P3|COMPLETED|Overall Study||24
8482719|NCT00592124|20905050|P2|COMPLETED|Overall Study||24
8482720|NCT00592124|20905051|P1|COMPLETED|Overall Study||24
8482721|NCT00592124|20905046|P6|STARTED|Overall Study||27
8482722|NCT00592124|20905047|P5|STARTED|Overall Study||27
8482723|NCT00592124|20905048|P4|STARTED|Overall Study||27
8482724|NCT00592124|20905049|P3|STARTED|Overall Study||30
8482725|NCT00592124|20905050|P2|STARTED|Overall Study||29
8482726|NCT00592124|20905051|P1|STARTED|Overall Study||28
8482727|NCT00592072|20905102|P2|NOT COMPLETED|Second Sequence||0
8482728|NCT00592072|20905103|P1|NOT COMPLETED|Second Sequence||0
8482729|NCT00592072|20905102|P2|COMPLETED|Second Sequence||5
8482730|NCT00592072|20905103|P1|COMPLETED|Second Sequence||5
8482731|NCT00592072|20905102|P2|STARTED|Second Sequence||5
8482732|NCT00592072|20905103|P1|STARTED|Second Sequence||5
8482733|NCT00592072|20905102|P2|NOT COMPLETED|Wash Out Period||1
8482734|NCT00592072|20905103|P1|NOT COMPLETED|Wash Out Period||1
8482735|NCT00592072|20905102|P2|COMPLETED|Wash Out Period||5
8482736|NCT00592072|20905103|P1|COMPLETED|Wash Out Period||5
8482737|NCT00592072|20905102|P2|STARTED|Wash Out Period||6
8482738|NCT00592072|20905103|P1|STARTED|Wash Out Period||6
8482739|NCT00592072|20905102|P2|NOT COMPLETED|First Sequence||0
8482740|NCT00592072|20905103|P1|NOT COMPLETED|First Sequence||0
8482741|NCT00592072|20905102|P2|COMPLETED|First Sequence||6
8482742|NCT00592072|20905103|P1|COMPLETED|First Sequence||6
8482743|NCT00592072|20905102|P2|STARTED|First Sequence||6
8482744|NCT00592072|20905103|P1|STARTED|First Sequence||6
8482745|NCT00592007|20905125|P1|NOT COMPLETED|Overall Study||2
8482746|NCT00592007|20905125|P1|COMPLETED|Overall Study||5
8482747|NCT00592007|20905125|P1|STARTED|Overall Study||7
8482748|NCT00591942|20905130|P2|NOT COMPLETED|Overall Study||0
8482749|NCT00591942|20905131|P1|NOT COMPLETED|Overall Study||0
8482750|NCT00591942|20905130|P2|COMPLETED|Overall Study||36
8482751|NCT00591942|20905131|P1|COMPLETED|Overall Study||36
8482752|NCT00591942|20905130|P2|STARTED|Overall Study||36
8482753|NCT00591942|20905131|P1|STARTED|Overall Study||36
8482754|NCT00591864|20905137|P1|NOT COMPLETED|Overall Study||5
8482755|NCT00591864|20905137|P1|COMPLETED|Overall Study||84
8482756|NCT00591864|20905137|P1|STARTED|Overall Study||89
8482757|NCT00591851|20905143|P1|NOT COMPLETED|Overall Study||6
8482758|NCT00591851|20905143|P1|COMPLETED|Overall Study||64
8482759|NCT00591851|20905143|P1|STARTED|Overall Study||70
8482760|NCT00591838|20905152|P5|NOT COMPLETED|Overall Study||0
8482761|NCT00591838|20905153|P4|NOT COMPLETED|Overall Study||1
8482762|NCT00591838|20905154|P3|NOT COMPLETED|Overall Study||0
8482763|NCT00591838|20905155|P2|NOT COMPLETED|Overall Study||0
8482764|NCT00591838|20905156|P1|NOT COMPLETED|Overall Study||0
8482765|NCT00591838|20905152|P5|COMPLETED|Overall Study||51
8482766|NCT00591838|20905153|P4|COMPLETED|Overall Study||5
8482767|NCT00591838|20905154|P3|COMPLETED|Overall Study||6
8482768|NCT00591838|20905155|P2|COMPLETED|Overall Study||6
8482769|NCT00591838|20905156|P1|COMPLETED|Overall Study||5
8482770|NCT00591838|20905152|P5|STARTED|Overall Study||51
8482771|NCT00591838|20905153|P4|STARTED|Overall Study||6
8482772|NCT00591838|20905154|P3|STARTED|Overall Study||6
8482773|NCT00591838|20905155|P2|STARTED|Overall Study||6
8482774|NCT00591838|20905156|P1|STARTED|Overall Study||5
8482775|NCT00591825|20905181|P4|NOT COMPLETED|Overall Study||0
8482776|NCT00591825|20905182|P3|NOT COMPLETED|Overall Study||0
8482777|NCT00591825|20905183|P2|NOT COMPLETED|Overall Study||0
8482778|NCT00591825|20905184|P1|NOT COMPLETED|Overall Study||0
8482779|NCT00591825|20905181|P4|COMPLETED|Overall Study||14
8482780|NCT00591825|20905182|P3|COMPLETED|Overall Study||13
8482781|NCT00591825|20905183|P2|COMPLETED|Overall Study||13
8482782|NCT00591825|20905184|P1|COMPLETED|Overall Study||14
8482783|NCT00591825|20905181|P4|STARTED|Overall Study||14
8482784|NCT00591825|20905182|P3|STARTED|Overall Study||13
8482785|NCT00591825|20905183|P2|STARTED|Overall Study||13
8482786|NCT00591825|20905184|P1|STARTED|Overall Study||14
8482787|NCT00591786|20905220|P10|NOT COMPLETED|Overall Study||0
8482788|NCT00591786|20905221|P9|NOT COMPLETED|Overall Study||0
8482789|NCT00591786|20905222|P8|NOT COMPLETED|Overall Study||0
8482790|NCT00591786|20905223|P7|NOT COMPLETED|Overall Study||0
8482791|NCT00591786|20905224|P6|NOT COMPLETED|Overall Study||0
8482792|NCT00591786|20905225|P5|NOT COMPLETED|Overall Study||0
8482793|NCT00591786|20905226|P4|NOT COMPLETED|Overall Study||0
8482794|NCT00591786|20905227|P3|NOT COMPLETED|Overall Study||1
8482795|NCT00591786|20905228|P2|NOT COMPLETED|Overall Study||0
8482796|NCT00591786|20905229|P1|NOT COMPLETED|Overall Study||0
8482797|NCT00591786|20905220|P10|COMPLETED|Overall Study||10
8482798|NCT00591786|20905221|P9|COMPLETED|Overall Study||10
8482799|NCT00591786|20905222|P8|COMPLETED|Overall Study||10
8482800|NCT00591786|20905223|P7|COMPLETED|Overall Study||10
8482801|NCT00591786|20905224|P6|COMPLETED|Overall Study||10
8482802|NCT00591786|20905225|P5|COMPLETED|Overall Study||10
8482803|NCT00591786|20905226|P4|COMPLETED|Overall Study||11
8482804|NCT00591786|20905227|P3|COMPLETED|Overall Study||10
8482805|NCT00591786|20905228|P2|COMPLETED|Overall Study||9
8482806|NCT00591786|20905229|P1|COMPLETED|Overall Study||9
8482807|NCT00591786|20905220|P10|Treated Participants|Overall Study||10
8482808|NCT00591786|20905221|P9|Treated Participants|Overall Study||10
8482809|NCT00591786|20905222|P8|Treated Participants|Overall Study||10
8482810|NCT00591786|20905223|P7|Treated Participants|Overall Study||10
8482811|NCT00591786|20905224|P6|Treated Participants|Overall Study||10
8482812|NCT00591786|20905225|P5|Treated Participants|Overall Study||10
8482813|NCT00591786|20905226|P4|Treated Participants|Overall Study||11
8482814|NCT00591786|20905227|P3|Treated Participants|Overall Study||10
8482815|NCT00591786|20905228|P2|Treated Participants|Overall Study||9
8482816|NCT00591786|20905229|P1|Treated Participants|Overall Study||9
8482817|NCT00591786|20905220|P10|STARTED|Overall Study||10
8482818|NCT00591786|20905221|P9|STARTED|Overall Study||10
8482819|NCT00591786|20905222|P8|STARTED|Overall Study||10
8482820|NCT00591786|20905223|P7|STARTED|Overall Study||10
8482821|NCT00591786|20905224|P6|STARTED|Overall Study||10
8482822|NCT00591786|20905225|P5|STARTED|Overall Study||10
8482823|NCT00591786|20905226|P4|STARTED|Overall Study||11
8482824|NCT00591786|20905227|P3|STARTED|Overall Study||11
8482825|NCT00591786|20905228|P2|STARTED|Overall Study||9
8482826|NCT00591786|20905229|P1|STARTED|Overall Study||9
8482827|NCT00591773|20905274|P3|NOT COMPLETED|Overall Study||16
8482828|NCT00591773|20905275|P2|NOT COMPLETED|Overall Study||24
8482829|NCT00591773|20905276|P1|NOT COMPLETED|Overall Study||16
8482830|NCT00591773|20905274|P3|COMPLETED|Overall Study||168
8482831|NCT00591773|20905275|P2|COMPLETED|Overall Study||158
8482832|NCT00591773|20905276|P1|COMPLETED|Overall Study||169
8482833|NCT00591773|20905274|P3|STARTED|Overall Study||184
8482834|NCT00591773|20905275|P2|STARTED|Overall Study||182
8482835|NCT00591773|20905276|P1|STARTED|Overall Study||185
8482836|NCT00591760|20905328|P2|NOT COMPLETED|Overall Study||0
8482837|NCT00591760|20905329|P1|NOT COMPLETED|Overall Study||0
8482838|NCT00591760|20905328|P2|COMPLETED|Overall Study||28
8482839|NCT00591760|20905329|P1|COMPLETED|Overall Study||28
8482840|NCT00591760|20905328|P2|STARTED|Overall Study||28
8482841|NCT00591760|20905329|P1|STARTED|Overall Study||28
8482842|NCT00591734|20905335|P1|NOT COMPLETED|Overall Study||53
8482843|NCT00591734|20905335|P1|COMPLETED|Overall Study||4
8482844|NCT00591734|20905335|P1|STARTED|Overall Study||57
8482845|NCT00591721|20905341|P2|NOT COMPLETED|Overall Study||22
8482846|NCT00591721|20905342|P1|NOT COMPLETED|Overall Study||21
8482847|NCT00591721|20905341|P2|COMPLETED|Overall Study||70
8482848|NCT00591721|20905342|P1|COMPLETED|Overall Study||68
8482849|NCT00591721|20905341|P2|STARTED|Overall Study||92
8482850|NCT00591721|20905342|P1|STARTED|Overall Study||89
8482851|NCT00591591|20905350|P2|NOT COMPLETED|Overall Study||39
8482852|NCT00591591|20905351|P1|NOT COMPLETED|Overall Study||11
8482853|NCT00591591|20905350|P2|COMPLETED|Overall Study||94
8482854|NCT00591591|20905351|P1|COMPLETED|Overall Study||165
8482855|NCT00591591|20905350|P2|STARTED|Overall Study||133
8482856|NCT00591591|20905351|P1|STARTED|Overall Study||176
8482857|NCT00591578|20905368|P3|NOT COMPLETED|Open-Label Extension Phase||0
8482858|NCT00591578|20905369|P2|NOT COMPLETED|Open-Label Extension Phase||10
8482859|NCT00591578|20905370|P1|NOT COMPLETED|Open-Label Extension Phase||6
8482860|NCT00591578|20905368|P3|COMPLETED|Open-Label Extension Phase||0
8482861|NCT00591578|20905369|P2|COMPLETED|Open-Label Extension Phase||105
8482862|NCT00591578|20905370|P1|COMPLETED|Open-Label Extension Phase||49
8482863|NCT00591578|20905368|P3|STARTED|Open-Label Extension Phase||0
8482864|NCT00591578|20905369|P2|STARTED|Open-Label Extension Phase||115
8482865|NCT00591578|20905370|P1|STARTED|Open-Label Extension Phase||55
8482866|NCT00591578|20905368|P3|NOT COMPLETED|Double-Blind Treatment Phase||84
8482867|NCT00591578|20905369|P2|NOT COMPLETED|Double-Blind Treatment Phase||80
8482868|NCT00591578|20905370|P1|NOT COMPLETED|Double-Blind Treatment Phase||78
8482869|NCT00591578|20905368|P3|COMPLETED|Double-Blind Treatment Phase||244
8482870|NCT00591578|20905369|P2|COMPLETED|Double-Blind Treatment Phase||249
8482871|NCT00591578|20905370|P1|COMPLETED|Double-Blind Treatment Phase||249
8482872|NCT00591578|20905368|P3|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
8482873|NCT00591578|20905369|P2|STARTED|Double-Blind Treatment Phase||329
8482874|NCT00591578|20905370|P1|STARTED|Double-Blind Treatment Phase||327
8482875|NCT00591565|20905421|P1|NOT COMPLETED|Overall Study||5
8482876|NCT00591565|20905421|P1|COMPLETED|Overall Study||8
8482877|NCT00591565|20905421|P1|STARTED|Overall Study||13
8482878|NCT00591409|20905435|P10|NOT COMPLETED|Overall Study||1
8482879|NCT00591409|20905436|P9|NOT COMPLETED|Overall Study||0
8482880|NCT00591409|20905437|P8|NOT COMPLETED|Overall Study||0
8482881|NCT00591409|20905438|P7|NOT COMPLETED|Overall Study||0
8482882|NCT00591409|20905439|P6|NOT COMPLETED|Overall Study||0
8482883|NCT00591409|20905440|P5|NOT COMPLETED|Overall Study||1
8482884|NCT00591409|20905441|P4|NOT COMPLETED|Overall Study||0
8482885|NCT00591409|20905442|P3|NOT COMPLETED|Overall Study||0
8482886|NCT00591409|20905443|P2|NOT COMPLETED|Overall Study||0
8482887|NCT00591409|20905444|P1|NOT COMPLETED|Overall Study||0
8482888|NCT00591409|20905435|P10|COMPLETED|Overall Study||10
8482889|NCT00591409|20905436|P9|COMPLETED|Overall Study||9
8482890|NCT00591409|20905437|P8|COMPLETED|Overall Study||10
8482891|NCT00591409|20905438|P7|COMPLETED|Overall Study||10
8482892|NCT00591409|20905439|P6|COMPLETED|Overall Study||10
8482893|NCT00591409|20905440|P5|COMPLETED|Overall Study||9
8482894|NCT00591409|20905441|P4|COMPLETED|Overall Study||10
8482895|NCT00591409|20905442|P3|COMPLETED|Overall Study||10
8482896|NCT00591409|20905443|P2|COMPLETED|Overall Study||10
8482897|NCT00591409|20905444|P1|COMPLETED|Overall Study||10
8482898|NCT00591409|20905435|P10|Treated|Overall Study||10
8482899|NCT00591409|20905436|P9|Treated|Overall Study||9
8482900|NCT00591409|20905437|P8|Treated|Overall Study||10
8482901|NCT00591409|20905438|P7|Treated|Overall Study||10
8482902|NCT00591409|20905439|P6|Treated|Overall Study||10
8482903|NCT00591409|20905440|P5|Treated|Overall Study||9
8482904|NCT00591409|20905441|P4|Treated|Overall Study||10
8482905|NCT00591409|20905442|P3|Treated|Overall Study||10
8482906|NCT00591409|20905443|P2|Treated|Overall Study||10
8482907|NCT00591409|20905444|P1|Treated|Overall Study||10
8482908|NCT00591409|20905435|P10|STARTED|Overall Study||11
8482909|NCT00591409|20905436|P9|STARTED|Overall Study||9
8482910|NCT00591409|20905437|P8|STARTED|Overall Study||10
8482911|NCT00591409|20905438|P7|STARTED|Overall Study||10
8482912|NCT00591409|20905439|P6|STARTED|Overall Study||10
8482913|NCT00591409|20905440|P5|STARTED|Overall Study||10
8482914|NCT00591409|20905441|P4|STARTED|Overall Study||10
8482915|NCT00591409|20905442|P3|STARTED|Overall Study||10
8482916|NCT00591409|20905443|P2|STARTED|Overall Study||10
8482917|NCT00591409|20905444|P1|STARTED|Overall Study||10
8482918|NCT00591370|20905486|P1|NOT COMPLETED|Overall Study||2
8482919|NCT00591370|20905486|P1|COMPLETED|Overall Study||49
8482920|NCT00591370|20905486|P1|STARTED|Overall Study||51
8482921|NCT00591344|20905494|P2|NOT COMPLETED|Overall Study||8
8482922|NCT00591344|20905495|P1|NOT COMPLETED|Overall Study||5
8482923|NCT00591344|20905494|P2|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
8482924|NCT00591344|20905495|P1|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
8482925|NCT00591344|20905494|P2|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
8482926|NCT00591344|20905495|P1|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
8482927|NCT00591344|20905494|P2|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
8482928|NCT00591344|20905495|P1|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
8482929|NCT00591305|20905507|P2|NOT COMPLETED|Overall Study||0
8482930|NCT00591305|20905508|P1|NOT COMPLETED|Overall Study||0
8482931|NCT00591305|20905507|P2|COMPLETED|Overall Study||0
8482932|NCT00591305|20905508|P1|COMPLETED|Overall Study||1
8482933|NCT00591305|20905507|P2|1st Follow-up in 2 Wks After Surgery|Overall Study||0
8482934|NCT00591305|20905508|P1|1st Follow-up in 2 Wks After Surgery|Overall Study||1
8482935|NCT00591305|20905507|P2|STARTED|Overall Study||0
8482936|NCT00591305|20905508|P1|STARTED|Overall Study||1
8482937|NCT00591266|20905521|P3|NOT COMPLETED|Overall Study||14
8482938|NCT00591266|20905522|P2|NOT COMPLETED|Overall Study||11
8482939|NCT00591266|20905523|P1|NOT COMPLETED|Overall Study||9
8482940|NCT00591266|20905521|P3|COMPLETED|Overall Study||175
8482941|NCT00591266|20905522|P2|COMPLETED|Overall Study||177
8482942|NCT00591266|20905523|P1|COMPLETED|Overall Study||180
8482943|NCT00591266|20905521|P3|STARTED|Overall Study|Randomized only|189
8482944|NCT00591266|20905522|P2|STARTED|Overall Study|Randomized only|188
8482945|NCT00591266|20905523|P1|STARTED|Overall Study|Randomized only|189
8482946|NCT00591253|20905576|P3|NOT COMPLETED|Overall Study||15
8482947|NCT00591253|20905577|P2|NOT COMPLETED|Overall Study||21
8482948|NCT00591253|20905578|P1|NOT COMPLETED|Overall Study||14
8482949|NCT00591253|20905576|P3|COMPLETED|Overall Study||123
8482950|NCT00591253|20905577|P2|COMPLETED|Overall Study||116
8482951|NCT00591253|20905578|P1|COMPLETED|Overall Study||126
8482952|NCT00591253|20905576|P3|STARTED|Overall Study|Randomized or Treated|138
8482953|NCT00591253|20905577|P2|STARTED|Overall Study|Randomized or Treated|137
8482954|NCT00591253|20905578|P1|STARTED|Overall Study|Randomized or Treated|140
8482955|NCT00591240|20905630|P2|NOT COMPLETED|Overall Study||0
8482956|NCT00591240|20905631|P1|NOT COMPLETED|Overall Study||0
8482957|NCT00591240|20905630|P2|COMPLETED|Overall Study||222
8482958|NCT00591240|20905631|P1|COMPLETED|Overall Study||116
8482959|NCT00591240|20905630|P2|STARTED|Overall Study||222
8482960|NCT00591240|20905631|P1|STARTED|Overall Study||116
8482961|NCT00591227|20905639|P2|NOT COMPLETED|Overall Study||0
8482962|NCT00591227|20905640|P1|NOT COMPLETED|Overall Study||0
8482963|NCT00591227|20905639|P2|COMPLETED|Overall Study||87
8482964|NCT00591227|20905640|P1|COMPLETED|Overall Study||89
8482965|NCT00591227|20905639|P2|STARTED|Overall Study||87
8482966|NCT00591227|20905640|P1|STARTED|Overall Study||89
8482967|NCT00591214|20905646|P1|NOT COMPLETED|Overall Study||8
8482968|NCT00591214|20905646|P1|COMPLETED|Overall Study||2
8482969|NCT00591214|20905646|P1|STARTED|Overall Study||10
8482970|NCT00591149|20905655|P1|NOT COMPLETED|Overall Study||5
8482971|NCT00591149|20905655|P1|COMPLETED|Overall Study||11
8482972|NCT00591149|20905655|P1|STARTED|Overall Study||16
8482973|NCT00591019|20905659|P2|NOT COMPLETED|Intevention 2 (14 Days)||0
8482974|NCT00591019|20905660|P1|NOT COMPLETED|Intevention 2 (14 Days)||0
8482975|NCT00591019|20905659|P2|COMPLETED|Intevention 2 (14 Days)||3
8482976|NCT00591019|20905660|P1|COMPLETED|Intevention 2 (14 Days)||2
8482977|NCT00591019|20905659|P2|STARTED|Intevention 2 (14 Days)||3
8482978|NCT00591019|20905660|P1|STARTED|Intevention 2 (14 Days)||2
8482979|NCT00591019|20905659|P2|NOT COMPLETED|Intervention 1 (14 Days)||0
8482980|NCT00591019|20905660|P1|NOT COMPLETED|Intervention 1 (14 Days)||0
8482981|NCT00591019|20905659|P2|COMPLETED|Intervention 1 (14 Days)||3
8482982|NCT00591019|20905660|P1|COMPLETED|Intervention 1 (14 Days)||2
8482983|NCT00591019|20905659|P2|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
8482984|NCT00591019|20905660|P1|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
8482985|NCT00591019|20905659|P2|NOT COMPLETED|Baseline (1 Day)||0
8482986|NCT00591019|20905660|P1|NOT COMPLETED|Baseline (1 Day)||0
8482987|NCT00591019|20905659|P2|COMPLETED|Baseline (1 Day)||4
8482988|NCT00591019|20905660|P1|COMPLETED|Baseline (1 Day)||3
8482989|NCT00591019|20905659|P2|STARTED|Baseline (1 Day)||4
8482990|NCT00591019|20905660|P1|STARTED|Baseline (1 Day)||3
8482991|NCT00591006|20905671|P24|NOT COMPLETED|Overall Study||1
8482992|NCT00591006|20905672|P23|NOT COMPLETED|Overall Study||1
8482993|NCT00591006|20905673|P22|NOT COMPLETED|Overall Study||0
8482994|NCT00591006|20905674|P21|NOT COMPLETED|Overall Study||0
8482995|NCT00591006|20905675|P20|NOT COMPLETED|Overall Study||0
8482996|NCT00591006|20905676|P19|NOT COMPLETED|Overall Study||0
8482997|NCT00591006|20905677|P18|NOT COMPLETED|Overall Study||0
8482998|NCT00591006|20905678|P17|NOT COMPLETED|Overall Study||0
8482999|NCT00591006|20905679|P16|NOT COMPLETED|Overall Study||1
8483000|NCT00591006|20905680|P15|NOT COMPLETED|Overall Study||0
8483001|NCT00591006|20905681|P14|NOT COMPLETED|Overall Study||0
8483002|NCT00591006|20905682|P13|NOT COMPLETED|Overall Study||0
8483003|NCT00591006|20905683|P12|NOT COMPLETED|Overall Study||0
8483004|NCT00591006|20905684|P11|NOT COMPLETED|Overall Study||0
8483005|NCT00591006|20905685|P10|NOT COMPLETED|Overall Study||0
8483006|NCT00591006|20905686|P9|NOT COMPLETED|Overall Study||0
8483007|NCT00591006|20905687|P8|NOT COMPLETED|Overall Study||0
8483008|NCT00591006|20905688|P7|NOT COMPLETED|Overall Study||0
8483009|NCT00591006|20905689|P6|NOT COMPLETED|Overall Study||0
8483010|NCT00591006|20905690|P5|NOT COMPLETED|Overall Study||0
8483011|NCT00591006|20905691|P4|NOT COMPLETED|Overall Study||0
8483012|NCT00591006|20905692|P3|NOT COMPLETED|Overall Study||0
8483013|NCT00591006|20905693|P2|NOT COMPLETED|Overall Study||0
8483014|NCT00591006|20905694|P1|NOT COMPLETED|Overall Study||0
8483015|NCT00591006|20905671|P24|COMPLETED|Overall Study||0
8483016|NCT00591006|20905672|P23|COMPLETED|Overall Study||0
8483017|NCT00591006|20905673|P22|COMPLETED|Overall Study||1
8483018|NCT00591006|20905674|P21|COMPLETED|Overall Study||0
8483019|NCT00591006|20905675|P20|COMPLETED|Overall Study||1
8483020|NCT00591006|20905676|P19|COMPLETED|Overall Study||0
8483021|NCT00591006|20905677|P18|COMPLETED|Overall Study||1
8483022|NCT00591006|20905678|P17|COMPLETED|Overall Study||0
8483023|NCT00591006|20905679|P16|COMPLETED|Overall Study||0
8483024|NCT00591006|20905680|P15|COMPLETED|Overall Study||0
8483025|NCT00591006|20905681|P14|COMPLETED|Overall Study||2
8483026|NCT00591006|20905682|P13|COMPLETED|Overall Study||1
8483027|NCT00591006|20905683|P12|COMPLETED|Overall Study||1
8483028|NCT00591006|20905684|P11|COMPLETED|Overall Study||0
8483029|NCT00591006|20905685|P10|COMPLETED|Overall Study||1
8483030|NCT00591006|20905686|P9|COMPLETED|Overall Study||1
8483031|NCT00591006|20905687|P8|COMPLETED|Overall Study||0
8483032|NCT00591006|20905688|P7|COMPLETED|Overall Study||1
8483033|NCT00591006|20905689|P6|COMPLETED|Overall Study||0
8483034|NCT00591006|20905690|P5|COMPLETED|Overall Study||1
8483035|NCT00591006|20905691|P4|COMPLETED|Overall Study||1
8483036|NCT00591006|20905692|P3|COMPLETED|Overall Study||1
8483037|NCT00591006|20905693|P2|COMPLETED|Overall Study||0
8483038|NCT00591006|20905694|P1|COMPLETED|Overall Study||1
8483039|NCT00591006|20905671|P24|Treatment #4|Overall Study||0
8483040|NCT00591006|20905672|P23|Treatment #4|Overall Study||0
8483041|NCT00591006|20905673|P22|Treatment #4|Overall Study||1
8483042|NCT00591006|20905674|P21|Treatment #4|Overall Study||0
8483043|NCT00591006|20905675|P20|Treatment #4|Overall Study||1
8483044|NCT00591006|20905676|P19|Treatment #4|Overall Study||0
8483045|NCT00591006|20905677|P18|Treatment #4|Overall Study||1
8483046|NCT00591006|20905678|P17|Treatment #4|Overall Study||0
8483047|NCT00591006|20905679|P16|Treatment #4|Overall Study||0
8483048|NCT00591006|20905680|P15|Treatment #4|Overall Study||0
8483049|NCT00591006|20905681|P14|Treatment #4|Overall Study||2
8483050|NCT00591006|20905682|P13|Treatment #4|Overall Study||1
8483051|NCT00591006|20905683|P12|Treatment #4|Overall Study||1
8483052|NCT00591006|20905684|P11|Treatment #4|Overall Study||0
8483053|NCT00591006|20905685|P10|Treatment #4|Overall Study||1
8483054|NCT00591006|20905686|P9|Treatment #4|Overall Study||1
8483055|NCT00591006|20905687|P8|Treatment #4|Overall Study||0
8483056|NCT00591006|20905688|P7|Treatment #4|Overall Study||1
8483057|NCT00591006|20905689|P6|Treatment #4|Overall Study||0
8483058|NCT00591006|20905690|P5|Treatment #4|Overall Study||1
8483059|NCT00591006|20905691|P4|Treatment #4|Overall Study||1
8483060|NCT00591006|20905692|P3|Treatment #4|Overall Study||1
8483061|NCT00591006|20905693|P2|Treatment #4|Overall Study||0
8483062|NCT00591006|20905694|P1|Treatment #4|Overall Study||1
8483063|NCT00591006|20905671|P24|Treatment #3|Overall Study||1
8483064|NCT00591006|20905672|P23|Treatment #3|Overall Study||1
8483065|NCT00591006|20905673|P22|Treatment #3|Overall Study||1
8483066|NCT00591006|20905674|P21|Treatment #3|Overall Study||0
8483067|NCT00591006|20905675|P20|Treatment #3|Overall Study||1
8483068|NCT00591006|20905676|P19|Treatment #3|Overall Study||0
8483069|NCT00591006|20905677|P18|Treatment #3|Overall Study||1
8483070|NCT00591006|20905678|P17|Treatment #3|Overall Study||0
8483071|NCT00591006|20905679|P16|Treatment #3|Overall Study||0
8483072|NCT00591006|20905680|P15|Treatment #3|Overall Study||0
8483073|NCT00591006|20905681|P14|Treatment #3|Overall Study||2
8483074|NCT00591006|20905682|P13|Treatment #3|Overall Study||1
8483075|NCT00591006|20905683|P12|Treatment #3|Overall Study||1
8483076|NCT00591006|20905684|P11|Treatment #3|Overall Study||0
8483077|NCT00591006|20905685|P10|Treatment #3|Overall Study||1
8483078|NCT00591006|20905686|P9|Treatment #3|Overall Study||1
8483079|NCT00591006|20905687|P8|Treatment #3|Overall Study||0
8483080|NCT00591006|20905688|P7|Treatment #3|Overall Study||1
8483081|NCT00591006|20905689|P6|Treatment #3|Overall Study||0
8483082|NCT00591006|20905690|P5|Treatment #3|Overall Study||1
8483083|NCT00591006|20905691|P4|Treatment #3|Overall Study||1
8483084|NCT00591006|20905692|P3|Treatment #3|Overall Study||1
8483085|NCT00591006|20905693|P2|Treatment #3|Overall Study||0
8483086|NCT00591006|20905694|P1|Treatment #3|Overall Study||1
8483087|NCT00591006|20905671|P24|Treatment #2|Overall Study||1
8483088|NCT00591006|20905672|P23|Treatment #2|Overall Study||1
8483089|NCT00591006|20905673|P22|Treatment #2|Overall Study||1
8483090|NCT00591006|20905674|P21|Treatment #2|Overall Study||0
8483091|NCT00591006|20905675|P20|Treatment #2|Overall Study||1
8483092|NCT00591006|20905676|P19|Treatment #2|Overall Study||0
8483093|NCT00591006|20905677|P18|Treatment #2|Overall Study||1
8483094|NCT00591006|20905678|P17|Treatment #2|Overall Study||0
8483095|NCT00591006|20905679|P16|Treatment #2|Overall Study||0
8483096|NCT00591006|20905680|P15|Treatment #2|Overall Study||0
8483097|NCT00591006|20905681|P14|Treatment #2|Overall Study||2
8483098|NCT00591006|20905682|P13|Treatment #2|Overall Study||1
8483099|NCT00591006|20905683|P12|Treatment #2|Overall Study||1
8483100|NCT00591006|20905684|P11|Treatment #2|Overall Study||0
8483101|NCT00591006|20905685|P10|Treatment #2|Overall Study||1
8483102|NCT00591006|20905686|P9|Treatment #2|Overall Study||1
8483103|NCT00591006|20905687|P8|Treatment #2|Overall Study||0
8483104|NCT00591006|20905688|P7|Treatment #2|Overall Study||1
8483105|NCT00591006|20905689|P6|Treatment #2|Overall Study||0
8483106|NCT00591006|20905690|P5|Treatment #2|Overall Study||1
8483107|NCT00591006|20905691|P4|Treatment #2|Overall Study||1
8483108|NCT00591006|20905692|P3|Treatment #2|Overall Study||1
8483109|NCT00591006|20905693|P2|Treatment #2|Overall Study||0
8483110|NCT00591006|20905694|P1|Treatment #2|Overall Study||1
8483111|NCT00591006|20905671|P24|STARTED|Overall Study||1
8483112|NCT00591006|20905672|P23|STARTED|Overall Study||1
8483113|NCT00591006|20905673|P22|STARTED|Overall Study||1
8483114|NCT00591006|20905674|P21|STARTED|Overall Study||0
8483115|NCT00591006|20905675|P20|STARTED|Overall Study||1
8483116|NCT00591006|20905676|P19|STARTED|Overall Study||0
8483117|NCT00591006|20905677|P18|STARTED|Overall Study||1
8483118|NCT00591006|20905678|P17|STARTED|Overall Study||0
8483119|NCT00591006|20905679|P16|STARTED|Overall Study||1
8483120|NCT00591006|20905680|P15|STARTED|Overall Study||0
8483121|NCT00591006|20905681|P14|STARTED|Overall Study||2
8483122|NCT00591006|20905682|P13|STARTED|Overall Study||1
8483123|NCT00591006|20905683|P12|STARTED|Overall Study||1
8483124|NCT00591006|20905684|P11|STARTED|Overall Study||0
8483125|NCT00591006|20905685|P10|STARTED|Overall Study||1
8483126|NCT00591006|20905686|P9|STARTED|Overall Study||1
8483127|NCT00591006|20905687|P8|STARTED|Overall Study||0
8483128|NCT00591006|20905688|P7|STARTED|Overall Study||1
8483129|NCT00591006|20905689|P6|STARTED|Overall Study||0
8483130|NCT00591006|20905690|P5|STARTED|Overall Study||1
8483131|NCT00591006|20905691|P4|STARTED|Overall Study||1
8483132|NCT00591006|20905692|P3|STARTED|Overall Study||1
8483133|NCT00591006|20905693|P2|STARTED|Overall Study||0
8483134|NCT00591006|20905694|P1|STARTED|Overall Study||1
8483135|NCT00590980|20905712|P1|NOT COMPLETED|Overall Study||10
8483136|NCT00590980|20905712|P1|COMPLETED|Overall Study||72
8483137|NCT00590980|20905712|P1|STARTED|Overall Study||82
8483138|NCT00590967|20905718|P2|NOT COMPLETED|Overall Study||5
8483139|NCT00590967|20905719|P1|NOT COMPLETED|Overall Study||3
8483140|NCT00590967|20905718|P2|COMPLETED|Overall Study||20
8483141|NCT00590967|20905719|P1|COMPLETED|Overall Study||41
8483142|NCT00590967|20905718|P2|STARTED|Overall Study||25
8483143|NCT00590967|20905719|P1|STARTED|Overall Study||44
8483144|NCT00590954|20905731|P1|NOT COMPLETED|Overall Study||2
8483145|NCT00590954|20905731|P1|COMPLETED|Overall Study||30
8483146|NCT00590954|20905731|P1|STARTED|Overall Study||32
8483147|NCT00590902|20905737|P1|NOT COMPLETED|Overall Study||1
8483148|NCT00590902|20905737|P1|COMPLETED|Overall Study||80
8483149|NCT00590902|20905737|P1|STARTED|Overall Study||81
8483150|NCT00590889|20905743|P2|NOT COMPLETED|Overall Study||299
8483151|NCT00590889|20905744|P1|NOT COMPLETED|Overall Study||286
8483152|NCT00590889|20905743|P2|COMPLETED|Overall Study||104
8483153|NCT00590889|20905744|P1|COMPLETED|Overall Study||118
8483154|NCT00590889|20905743|P2|STARTED|Overall Study||403
8483155|NCT00590889|20905744|P1|STARTED|Overall Study||404
8483156|NCT00590863|20905753|P3|NOT COMPLETED|Overall Study||78
8483157|NCT00590863|20905754|P2|NOT COMPLETED|Overall Study||82
8483158|NCT00590863|20905755|P1|NOT COMPLETED|Overall Study||84
8483159|NCT00590863|20905753|P3|COMPLETED|Overall Study||146
8483160|NCT00590863|20905754|P2|COMPLETED|Overall Study||138
8483161|NCT00590863|20905755|P1|COMPLETED|Overall Study||137
8483162|NCT00590863|20905753|P3|STARTED|Overall Study||224
8483163|NCT00590863|20905754|P2|STARTED|Overall Study||220
8483164|NCT00590863|20905755|P1|STARTED|Overall Study||221
8483165|NCT00590824|20905770|P4|NOT COMPLETED|Overall Study||1
8483166|NCT00590824|20905771|P3|NOT COMPLETED|Overall Study||1
8483167|NCT00590824|20905772|P2|NOT COMPLETED|Overall Study||2
8483168|NCT00590824|20905773|P1|NOT COMPLETED|Overall Study||0
8483169|NCT00590824|20905770|P4|COMPLETED|Overall Study||0
8483170|NCT00590824|20905771|P3|COMPLETED|Overall Study||1
8483171|NCT00590824|20905772|P2|COMPLETED|Overall Study||7
8483172|NCT00590824|20905773|P1|COMPLETED|Overall Study||11
8483173|NCT00590824|20905770|P4|STARTED|Overall Study||1
8483174|NCT00590824|20905771|P3|STARTED|Overall Study||2
8483175|NCT00590824|20905772|P2|STARTED|Overall Study||9
8483176|NCT00590824|20905773|P1|STARTED|Overall Study||11
8483177|NCT00590772|20905793|P1|NOT COMPLETED|Overall Study||0
8483178|NCT00590772|20905793|P1|COMPLETED|Overall Study||31
8483179|NCT00590772|20905793|P1|STARTED|Overall Study||31
8483180|NCT00590759|20905799|P1|NOT COMPLETED|Overall Study||80
8483181|NCT00590759|20905799|P1|COMPLETED|Overall Study||70
8483182|NCT00590759|20905799|P1|STARTED|Overall Study||150
8483183|NCT00590720|20905806|P2|NOT COMPLETED|Overall Study||1
8483184|NCT00590720|20905807|P1|NOT COMPLETED|Overall Study||1
8483185|NCT00590720|20905806|P2|COMPLETED|Overall Study||6
8483186|NCT00590720|20905807|P1|COMPLETED|Overall Study||3
8483187|NCT00590720|20905806|P2|STARTED|Overall Study||7
8483188|NCT00590720|20905807|P1|STARTED|Overall Study||4
8483189|NCT00590707|20905851|P2|NOT COMPLETED|Overall Study||0
8483190|NCT00590707|20905852|P1|NOT COMPLETED|Overall Study||0
8483191|NCT00590707|20905851|P2|COMPLETED|Overall Study||100
8483192|NCT00590707|20905852|P1|COMPLETED|Overall Study||100
8483193|NCT00590707|20905851|P2|STARTED|Overall Study||100
8483194|NCT00590707|20905852|P1|STARTED|Overall Study||100
8483195|NCT00590590|20905869|P3|NOT COMPLETED|Overall Study||6
8483196|NCT00590590|20905870|P2|NOT COMPLETED|Overall Study||6
8483197|NCT00590590|20905871|P1|NOT COMPLETED|Overall Study||7
8483198|NCT00590590|20905869|P3|COMPLETED|Overall Study||21
8483199|NCT00590590|20905870|P2|COMPLETED|Overall Study||33
8483200|NCT00590590|20905871|P1|COMPLETED|Overall Study||32
8483201|NCT00590590|20905869|P3|STARTED|Overall Study||27
8483202|NCT00590590|20905870|P2|STARTED|Overall Study||39
8483203|NCT00590590|20905871|P1|STARTED|Overall Study||39
8483204|NCT00590577|20905898|P4|NOT COMPLETED|Overall Study||93
8483205|NCT00590577|20905899|P3|NOT COMPLETED|Overall Study||73
8483206|NCT00590577|20905900|P2|NOT COMPLETED|Overall Study||76
8483207|NCT00590577|20905901|P1|NOT COMPLETED|Overall Study||77
8483208|NCT00590577|20905898|P4|COMPLETED|Overall Study||71
8483209|NCT00590577|20905899|P3|COMPLETED|Overall Study||90
8483210|NCT00590577|20905900|P2|COMPLETED|Overall Study||89
8483211|NCT00590577|20905901|P1|COMPLETED|Overall Study||83
8483212|NCT00590577|20905898|P4|STARTED|Overall Study||164
8483213|NCT00590577|20905899|P3|STARTED|Overall Study||163
8483214|NCT00590577|20905900|P2|STARTED|Overall Study||165
8483215|NCT00590577|20905901|P1|STARTED|Overall Study||160
8483216|NCT00590564|20905919|P1|NOT COMPLETED|Overall Study||18
8483217|NCT00590564|20905919|P1|COMPLETED|Overall Study||24
8483218|NCT00590564|20905919|P1|STARTED|Overall Study||42
8483219|NCT00590538|20905923|P1|NOT COMPLETED|Overall Study||2
8483220|NCT00590538|20905923|P1|COMPLETED|Overall Study||7
8483221|NCT00590538|20905923|P1|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
8483222|NCT00590460|20905931|P1|NOT COMPLETED|Overall Study||0
8483223|NCT00590460|20905931|P1|COMPLETED|Overall Study||5
8483224|NCT00590460|20905931|P1|STARTED|Overall Study||5
8483225|NCT00590395|20905944|P1|NOT COMPLETED|Overall Study||0
8483226|NCT00590395|20905944|P1|COMPLETED|Overall Study||19
8483227|NCT00590395|20905944|P1|STARTED|Overall Study||19
8483228|NCT00590369|20905950|P2|NOT COMPLETED|Overall Study||0
8483229|NCT00590369|20905951|P1|NOT COMPLETED|Overall Study||0
8483230|NCT00590369|20905950|P2|COMPLETED|Overall Study||5
8483231|NCT00590369|20905951|P1|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
8483232|NCT00590369|20905950|P2|STARTED|Overall Study||5
8483233|NCT00590369|20905951|P1|STARTED|Overall Study||6
8483234|NCT00590317|20905969|P2|NOT COMPLETED|Overall Study||5
8483235|NCT00590317|20905970|P1|NOT COMPLETED|Overall Study||1
8483236|NCT00590317|20905969|P2|COMPLETED|Overall Study||27
8483237|NCT00590317|20905970|P1|COMPLETED|Overall Study||31
8483238|NCT00590317|20905969|P2|STARTED|Overall Study||32
8483239|NCT00590317|20905970|P1|STARTED|Overall Study||32
8483240|NCT00590226|20905982|P2|NOT COMPLETED|Overall Study||0
8483241|NCT00590226|20905983|P1|NOT COMPLETED|Overall Study||0
8483242|NCT00590226|20905982|P2|COMPLETED|Overall Study||63
8483243|NCT00590226|20905983|P1|COMPLETED|Overall Study||67
8483244|NCT00590226|20905982|P2|STARTED|Overall Study||63
8483245|NCT00590226|20905983|P1|STARTED|Overall Study||67
8483246|NCT00590161|20905993|P2|NOT COMPLETED|Overall Study||3
8483247|NCT00590161|20905994|P1|NOT COMPLETED|Overall Study||3
8483248|NCT00590161|20905993|P2|COMPLETED|Overall Study||26
8483249|NCT00590161|20905994|P1|COMPLETED|Overall Study||23
8483250|NCT00590161|20905993|P2|STARTED|Overall Study||29
8483251|NCT00590161|20905994|P1|STARTED|Overall Study||26
8483252|NCT00590135|20906000|P1|NOT COMPLETED|Overall Study||59
8483253|NCT00590135|20906000|P1|COMPLETED|Overall Study||0
8483254|NCT00590135|20906000|P1|STARTED|Overall Study||59
8483255|NCT00590044|20906010|P2|NOT COMPLETED|Overall Study||2
8483256|NCT00590044|20906011|P1|NOT COMPLETED|Overall Study||4
8483257|NCT00590044|20906010|P2|COMPLETED|Overall Study||34
8483258|NCT00590044|20906011|P1|COMPLETED|Overall Study||34
8483259|NCT00590044|20906010|P2|STARTED|Overall Study||36
8483260|NCT00590044|20906011|P1|STARTED|Overall Study||38
8483261|NCT00590031|20906023|P1|NOT COMPLETED|Overall Study||6
8483262|NCT00590031|20906023|P1|COMPLETED|Overall Study||55
8483263|NCT00590031|20906023|P1|STARTED|Overall Study||61
8483264|NCT00590018|20906030|P2|NOT COMPLETED|Overall Study||0
8483265|NCT00590018|20906031|P1|NOT COMPLETED|Overall Study||0
8483266|NCT00590018|20906030|P2|COMPLETED|Overall Study||9
8483267|NCT00590018|20906031|P1|COMPLETED|Overall Study||9
8483268|NCT00590018|20906030|P2|STARTED|Overall Study||9
8483269|NCT00590018|20906031|P1|STARTED|Overall Study||9
8483270|NCT00590005|20906039|P2|NOT COMPLETED|Overall Study||0
8483271|NCT00590005|20906040|P1|NOT COMPLETED|Overall Study||0
8483272|NCT00590005|20906039|P2|COMPLETED|Overall Study||119
8483273|NCT00590005|20906040|P1|COMPLETED|Overall Study||106
8483274|NCT00590005|20906039|P2|STARTED|Overall Study||119
8483275|NCT00590005|20906040|P1|STARTED|Overall Study||106
8483276|NCT00589979|20906050|P3|NOT COMPLETED|Double-Blind Treatment Period 3||1
8483277|NCT00589979|20906051|P2|NOT COMPLETED|Double-Blind Treatment Period 3||1
8483278|NCT00589979|20906052|P1|NOT COMPLETED|Double-Blind Treatment Period 3||0
8483279|NCT00589979|20906050|P3|COMPLETED|Double-Blind Treatment Period 3||38
8483280|NCT00589979|20906051|P2|COMPLETED|Double-Blind Treatment Period 3||46
8483281|NCT00589979|20906052|P1|COMPLETED|Double-Blind Treatment Period 3||0
8483282|NCT00589979|20906050|P3|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
8483283|NCT00589979|20906051|P2|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
8483284|NCT00589979|20906052|P1|STARTED|Double-Blind Treatment Period 3||0
8483285|NCT00589979|20906050|P3|NOT COMPLETED|Double-Blind Treatment Period 2||2
8483286|NCT00589979|20906051|P2|NOT COMPLETED|Double-Blind Treatment Period 2||1
8483287|NCT00589979|20906052|P1|NOT COMPLETED|Double-Blind Treatment Period 2||0
8483288|NCT00589979|20906050|P3|COMPLETED|Double-Blind Treatment Period 2||39
8483289|NCT00589979|20906051|P2|COMPLETED|Double-Blind Treatment Period 2||47
8483290|NCT00589979|20906052|P1|COMPLETED|Double-Blind Treatment Period 2||0
8483291|NCT00589979|20906050|P3|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
8483292|NCT00589979|20906051|P2|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
8483293|NCT00589979|20906052|P1|STARTED|Double-Blind Treatment Period 2||0
8483294|NCT00589979|20906050|P3|NOT COMPLETED|Double-Blind Treatment Period 1||2
8483295|NCT00589979|20906051|P2|NOT COMPLETED|Double-Blind Treatment Period 1||2
8483296|NCT00589979|20906052|P1|NOT COMPLETED|Double-Blind Treatment Period 1||0
8483297|NCT00589979|20906050|P3|COMPLETED|Double-Blind Treatment Period 1||41
8483298|NCT00589979|20906051|P2|COMPLETED|Double-Blind Treatment Period 1||48
8483299|NCT00589979|20906052|P1|COMPLETED|Double-Blind Treatment Period 1||0
8483300|NCT00589979|20906050|P3|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
8483301|NCT00589979|20906051|P2|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
8483302|NCT00589979|20906052|P1|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
8483303|NCT00589979|20906050|P3|NOT COMPLETED|Run-In Period||0
8483304|NCT00589979|20906051|P2|NOT COMPLETED|Run-In Period||0
8483305|NCT00589979|20906052|P1|NOT COMPLETED|Run-In Period||76
8483306|NCT00589979|20906050|P3|COMPLETED|Run-In Period||0
8483307|NCT00589979|20906051|P2|COMPLETED|Run-In Period||0
8483308|NCT00589979|20906052|P1|COMPLETED|Run-In Period||93
8483309|NCT00589979|20906050|P3|STARTED|Run-In Period||0
8483310|NCT00589979|20906051|P2|STARTED|Run-In Period||0
8483311|NCT00589979|20906052|P1|STARTED|Run-In Period||169
8483312|NCT00589914|20906091|P2|NOT COMPLETED|Overall Study||137
8483313|NCT00589914|20906092|P1|NOT COMPLETED|Overall Study||150
8483314|NCT00589914|20906091|P2|COMPLETED|Overall Study||471
8483315|NCT00589914|20906092|P1|COMPLETED|Overall Study||456
8483316|NCT00589914|20906091|P2|STARTED|Overall Study||608
8483317|NCT00589914|20906092|P1|STARTED|Overall Study||606
8483318|NCT00589888|20906102|P5|NOT COMPLETED|64-gram Oral Fat Load||0
8483319|NCT00589888|20906103|P4|NOT COMPLETED|64-gram Oral Fat Load||0
8483320|NCT00589888|20906104|P3|NOT COMPLETED|64-gram Oral Fat Load||0
8483321|NCT00589888|20906105|P2|NOT COMPLETED|64-gram Oral Fat Load||0
8483322|NCT00589888|20906106|P1|NOT COMPLETED|64-gram Oral Fat Load||0
8483323|NCT00589888|20906102|P5|COMPLETED|64-gram Oral Fat Load||13
8483324|NCT00589888|20906103|P4|COMPLETED|64-gram Oral Fat Load||0
8483325|NCT00589888|20906104|P3|COMPLETED|64-gram Oral Fat Load||0
8483326|NCT00589888|20906105|P2|COMPLETED|64-gram Oral Fat Load||0
8483327|NCT00589888|20906106|P1|COMPLETED|64-gram Oral Fat Load||0
8483328|NCT00589888|20906102|P5|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
8483329|NCT00589888|20906103|P4|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
8483330|NCT00589888|20906104|P3|STARTED|64-gram Oral Fat Load||0
8483331|NCT00589888|20906105|P2|STARTED|64-gram Oral Fat Load||0
8483332|NCT00589888|20906106|P1|STARTED|64-gram Oral Fat Load||0
8483333|NCT00589888|20906102|P5|NOT COMPLETED|32-gram Oral Fat Load||0
8483334|NCT00589888|20906103|P4|NOT COMPLETED|32-gram Oral Fat Load||0
8483335|NCT00589888|20906104|P3|NOT COMPLETED|32-gram Oral Fat Load||0
8483336|NCT00589888|20906105|P2|NOT COMPLETED|32-gram Oral Fat Load||0
8483337|NCT00589888|20906106|P1|NOT COMPLETED|32-gram Oral Fat Load||0
8483338|NCT00589888|20906102|P5|COMPLETED|32-gram Oral Fat Load||0
8483339|NCT00589888|20906103|P4|COMPLETED|32-gram Oral Fat Load||13
8483340|NCT00589888|20906104|P3|COMPLETED|32-gram Oral Fat Load||0
8483341|NCT00589888|20906105|P2|COMPLETED|32-gram Oral Fat Load||0
8483342|NCT00589888|20906106|P1|COMPLETED|32-gram Oral Fat Load||0
8483343|NCT00589888|20906102|P5|STARTED|32-gram Oral Fat Load||0
8483344|NCT00589888|20906103|P4|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
8483345|NCT00589888|20906104|P3|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
8483346|NCT00589888|20906105|P2|STARTED|32-gram Oral Fat Load||0
8483347|NCT00589888|20906106|P1|STARTED|32-gram Oral Fat Load||0
8483348|NCT00589888|20906102|P5|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483349|NCT00589888|20906103|P4|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483350|NCT00589888|20906104|P3|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483351|NCT00589888|20906105|P2|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483352|NCT00589888|20906106|P1|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483353|NCT00589888|20906102|P5|COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483354|NCT00589888|20906103|P4|COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483355|NCT00589888|20906104|P3|COMPLETED|Intralipid 20% @ 40cc/Hour||13
8483356|NCT00589888|20906105|P2|COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483357|NCT00589888|20906106|P1|COMPLETED|Intralipid 20% @ 40cc/Hour||0
8483358|NCT00589888|20906102|P5|STARTED|Intralipid 20% @ 40cc/Hour||0
8483359|NCT00589888|20906103|P4|STARTED|Intralipid 20% @ 40cc/Hour||0
8483360|NCT00589888|20906104|P3|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
8483361|NCT00589888|20906105|P2|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
8483362|NCT00589888|20906106|P1|STARTED|Intralipid 20% @ 40cc/Hour||0
8483363|NCT00589888|20906102|P5|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8483364|NCT00589888|20906103|P4|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8483365|NCT00589888|20906104|P3|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8483366|NCT00589888|20906105|P2|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8483367|NCT00589888|20906106|P1|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
8483368|NCT00589888|20906102|P5|COMPLETED|Intralipid 20% @ 20cc/hr||0
8483369|NCT00589888|20906103|P4|COMPLETED|Intralipid 20% @ 20cc/hr||0
8483370|NCT00589888|20906104|P3|COMPLETED|Intralipid 20% @ 20cc/hr||0
8483371|NCT00589888|20906105|P2|COMPLETED|Intralipid 20% @ 20cc/hr||13
8483372|NCT00589888|20906106|P1|COMPLETED|Intralipid 20% @ 20cc/hr||0
8483373|NCT00589888|20906102|P5|STARTED|Intralipid 20% @ 20cc/hr||0
8483374|NCT00589888|20906103|P4|STARTED|Intralipid 20% @ 20cc/hr||0
8483375|NCT00589888|20906104|P3|STARTED|Intralipid 20% @ 20cc/hr||0
8483376|NCT00589888|20906105|P2|STARTED|Intralipid 20% @ 20cc/hr||13
8483377|NCT00589888|20906106|P1|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
8483378|NCT00589888|20906102|P5|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8483379|NCT00589888|20906103|P4|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8483380|NCT00589888|20906104|P3|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8483381|NCT00589888|20906105|P2|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8483382|NCT00589888|20906106|P1|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
8483383|NCT00589888|20906102|P5|COMPLETED|Normal Saline @ 40cc/Hour||0
8483384|NCT00589888|20906103|P4|COMPLETED|Normal Saline @ 40cc/Hour||0
8483385|NCT00589888|20906104|P3|COMPLETED|Normal Saline @ 40cc/Hour||0
8483386|NCT00589888|20906105|P2|COMPLETED|Normal Saline @ 40cc/Hour||0
8483387|NCT00589888|20906106|P1|COMPLETED|Normal Saline @ 40cc/Hour||13
8483388|NCT00589888|20906102|P5|STARTED|Normal Saline @ 40cc/Hour||0
8483389|NCT00589888|20906103|P4|STARTED|Normal Saline @ 40cc/Hour||0
8483390|NCT00589888|20906104|P3|STARTED|Normal Saline @ 40cc/Hour||0
8483391|NCT00589888|20906105|P2|STARTED|Normal Saline @ 40cc/Hour||0
8483392|NCT00589888|20906106|P1|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
8483393|NCT00589849|20906138|P1|NOT COMPLETED|Overall Study||0
8483394|NCT00589849|20906138|P1|COMPLETED|Overall Study||32
8483395|NCT00589849|20906138|P1|STARTED|Overall Study||32
8483396|NCT00589836|20906142|P1|NOT COMPLETED|Overall Study||0
8483397|NCT00589836|20906142|P1|COMPLETED|Overall Study||20
8483398|NCT00589836|20906142|P1|STARTED|Overall Study||20
8483399|NCT00589797|20906148|P2|NOT COMPLETED|Overall Study||23
8483400|NCT00589797|20906149|P1|NOT COMPLETED|Overall Study||73
8483401|NCT00589797|20906148|P2|COMPLETED|Overall Study||89
8483402|NCT00589797|20906149|P1|COMPLETED|Overall Study||191
8483403|NCT00589797|20906148|P2|24 Months|Overall Study||89
8483404|NCT00589797|20906149|P1|24 Months|Overall Study||191
8483405|NCT00589797|20906148|P2|Baseline|Overall Study||106
8483406|NCT00589797|20906149|P1|Baseline|Overall Study||218
8483407|NCT00589797|20906148|P2|STARTED|Overall Study||112
8483408|NCT00589797|20906149|P1|STARTED|Overall Study||264
8483409|NCT00589784|20906173|P2|NOT COMPLETED|Overall Study||10
8483410|NCT00589784|20906174|P1|NOT COMPLETED|Overall Study||1
8483411|NCT00589784|20906173|P2|COMPLETED|Overall Study||4
8483412|NCT00589784|20906174|P1|COMPLETED|Overall Study||35
8483413|NCT00589784|20906173|P2|STARTED|Overall Study||14
8483414|NCT00589784|20906174|P1|STARTED|Overall Study||36
8483415|NCT00589693|20906181|P2|NOT COMPLETED|Overall Study||29
8483416|NCT00589693|20906182|P1|NOT COMPLETED|Overall Study||44
8483417|NCT00589693|20906181|P2|COMPLETED|Overall Study||83
8483418|NCT00589693|20906182|P1|COMPLETED|Overall Study||71
8483419|NCT00589693|20906181|P2|STARTED|Overall Study||112
8483420|NCT00589693|20906182|P1|STARTED|Overall Study||115
8483421|NCT00589667|20906196|P1|NOT COMPLETED|Overall Study||3
8483422|NCT00589667|20906196|P1|COMPLETED|Overall Study||23
8483423|NCT00589667|20906196|P1|STARTED|Overall Study||26
8483424|NCT00589628|20906203|P2|NOT COMPLETED|Overall Study||1
8483425|NCT00589628|20906204|P1|NOT COMPLETED|Overall Study||0
8483426|NCT00589628|20906203|P2|COMPLETED|Overall Study||5
8483427|NCT00589628|20906204|P1|COMPLETED|Overall Study||7
8483428|NCT00589628|20906203|P2|STARTED|Overall Study||6
8483429|NCT00589628|20906204|P1|STARTED|Overall Study||7
8483430|NCT00589602|20906210|P1|NOT COMPLETED|Overall Study||1
8483431|NCT00589602|20906210|P1|COMPLETED|Overall Study||12
8483432|NCT00589602|20906210|P1|STARTED|Overall Study||13
8483433|NCT00589563|20906218|P1|NOT COMPLETED|Overall Study||0
8483434|NCT00589563|20906218|P1|COMPLETED|Overall Study||32
8483435|NCT00589563|20906218|P1|STARTED|Overall Study||32
8483436|NCT00589550|20906235|P1|NOT COMPLETED|Overall Study||1
8483437|NCT00589550|20906235|P1|COMPLETED|Overall Study||0
8483438|NCT00589550|20906235|P1|Withdrew From Study|Overall Study||1
8483439|NCT00589550|20906235|P1|STARTED|Overall Study||1
8483440|NCT00589472|20906245|P1|NOT COMPLETED|Overall Study||1
8483441|NCT00589472|20906245|P1|COMPLETED|Overall Study||18
8483442|NCT00589472|20906245|P1|STARTED|Overall Study||19
8483443|NCT00589329|20906257|P2|NOT COMPLETED|Overall Study||0
8483444|NCT00589329|20906258|P1|NOT COMPLETED|Overall Study||0
8483445|NCT00589329|20906257|P2|COMPLETED|Overall Study||10
8483446|NCT00589329|20906258|P1|COMPLETED|Overall Study||10
8483447|NCT00589329|20906257|P2|STARTED|Overall Study||10
8483448|NCT00589329|20906258|P1|STARTED|Overall Study||10
8483449|NCT00589303|20906268|P2|NOT COMPLETED|Overall Study||1
8483450|NCT00589303|20906269|P1|NOT COMPLETED|Overall Study||2
8483451|NCT00589303|20906268|P2|COMPLETED|Overall Study||12
8483452|NCT00589303|20906269|P1|COMPLETED|Overall Study||12
8483453|NCT00589303|20906268|P2|STARTED|Overall Study||13
8483454|NCT00589303|20906269|P1|STARTED|Overall Study||14
8483455|NCT00589290|20906275|P1|NOT COMPLETED|Overall Study||1
8483456|NCT00589290|20906275|P1|COMPLETED|Overall Study||40
8483457|NCT00589290|20906275|P1|STARTED|Overall Study||41
8483468|NCT00589121|20906298|P2|NOT COMPLETED|Overall Study||7
8483469|NCT00589121|20906299|P1|NOT COMPLETED|Overall Study||2
8483470|NCT00589121|20906298|P2|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
8483471|NCT00589121|20906299|P1|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
8483472|NCT00589121|20906298|P2|STARTED|Overall Study||86
8483473|NCT00589121|20906299|P1|STARTED|Overall Study||12
8483474|NCT00589108|20906321|P3|NOT COMPLETED|Overall Study||5
8483475|NCT00589108|20906322|P2|NOT COMPLETED|Overall Study||4
8483476|NCT00589108|20906323|P1|NOT COMPLETED|Overall Study||4
8483477|NCT00589108|20906321|P3|COMPLETED|Overall Study||75
8483478|NCT00589108|20906322|P2|COMPLETED|Overall Study||76
8483479|NCT00589108|20906323|P1|COMPLETED|Overall Study||76
8483480|NCT00589108|20906321|P3|STARTED|Overall Study||80
8483481|NCT00589108|20906322|P2|STARTED|Overall Study||80
8483482|NCT00589108|20906323|P1|STARTED|Overall Study||80
8483483|NCT00589056|20906343|P1|NOT COMPLETED|Overall Study||3
8483484|NCT00589056|20906343|P1|COMPLETED|Overall Study||52
8483485|NCT00589056|20906343|P1|STARTED|Overall Study||55
8483486|NCT00588965|20906349|P1|NOT COMPLETED|Overall Study||0
8483487|NCT00588965|20906349|P1|COMPLETED|Overall Study||35
8483488|NCT00588965|20906349|P1|STARTED|Overall Study||35
8483489|NCT00588952|20906359|P2|NOT COMPLETED|Overall Study||7
8483490|NCT00588952|20906360|P1|NOT COMPLETED|Overall Study||3
8483491|NCT00588952|20906359|P2|COMPLETED|Overall Study||63
8483492|NCT00588952|20906360|P1|COMPLETED|Overall Study||26
8483493|NCT00588952|20906359|P2|STARTED|Overall Study||70
8483494|NCT00588952|20906360|P1|STARTED|Overall Study||29
8483495|NCT00588900|20906380|P1|NOT COMPLETED|Overall Study||0
8483496|NCT00588900|20906380|P1|COMPLETED|Overall Study||5
8483497|NCT00588900|20906380|P1|STARTED|Overall Study||5
8483498|NCT00588861|20906388|P2|NOT COMPLETED|10 Years||114
8483499|NCT00588861|20906389|P1|NOT COMPLETED|10 Years||107
8483500|NCT00588861|20906388|P2|COMPLETED|10 Years||0
8483501|NCT00588861|20906389|P1|COMPLETED|10 Years||0
8483502|NCT00588861|20906388|P2|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
8483503|NCT00588861|20906389|P1|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
8483504|NCT00588861|20906388|P2|NOT COMPLETED|8 Years||114
8483505|NCT00588861|20906389|P1|NOT COMPLETED|8 Years||105
8483506|NCT00588861|20906388|P2|COMPLETED|8 Years||0
8483507|NCT00588861|20906389|P1|COMPLETED|8 Years||2
8483508|NCT00588861|20906388|P2|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
8483509|NCT00588861|20906389|P1|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
8483510|NCT00588861|20906388|P2|NOT COMPLETED|6 Years||109
8483511|NCT00588861|20906389|P1|NOT COMPLETED|6 Years||104
8483512|NCT00588861|20906388|P2|COMPLETED|6 Years||5
8483513|NCT00588861|20906389|P1|COMPLETED|6 Years||3
8483514|NCT00588861|20906388|P2|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
8483515|NCT00588861|20906389|P1|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
8483516|NCT00588861|20906388|P2|NOT COMPLETED|4 Years||103
8483517|NCT00588861|20906389|P1|NOT COMPLETED|4 Years||91
8483518|NCT00588861|20906388|P2|COMPLETED|4 Years||11
8483519|NCT00588861|20906389|P1|COMPLETED|4 Years||16
8483520|NCT00588861|20906388|P2|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
8483521|NCT00588861|20906389|P1|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
8483522|NCT00588861|20906388|P2|NOT COMPLETED|2 Years||87
8483523|NCT00588861|20906389|P1|NOT COMPLETED|2 Years||92
8483524|NCT00588861|20906388|P2|COMPLETED|2 Years||27
8483525|NCT00588861|20906389|P1|COMPLETED|2 Years||15
8483526|NCT00588861|20906388|P2|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
8483527|NCT00588861|20906389|P1|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
8483528|NCT00588861|20906388|P2|NOT COMPLETED|1 Year||82
8483529|NCT00588861|20906389|P1|NOT COMPLETED|1 Year||89
8483530|NCT00588861|20906388|P2|COMPLETED|1 Year||32
8483531|NCT00588861|20906389|P1|COMPLETED|1 Year||18
8483532|NCT00588861|20906388|P2|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
8483533|NCT00588861|20906389|P1|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
8483534|NCT00588861|20906388|P2|NOT COMPLETED|6 Months||73
8483535|NCT00588861|20906389|P1|NOT COMPLETED|6 Months||98
8483536|NCT00588861|20906388|P2|COMPLETED|6 Months||41
8483537|NCT00588861|20906389|P1|COMPLETED|6 Months||9
8483538|NCT00588861|20906388|P2|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
8483539|NCT00588861|20906389|P1|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
8483540|NCT00588861|20906388|P2|NOT COMPLETED|Pre-Operative||86
8483541|NCT00588861|20906389|P1|NOT COMPLETED|Pre-Operative||95
8483542|NCT00588861|20906388|P2|COMPLETED|Pre-Operative||114
8483543|NCT00588861|20906389|P1|COMPLETED|Pre-Operative||107
8483544|NCT00588861|20906388|P2|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
8483545|NCT00588861|20906389|P1|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
8483546|NCT00588848|20906399|P2|NOT COMPLETED|Overall Study||3
8483547|NCT00588848|20906400|P1|NOT COMPLETED|Overall Study||0
8483548|NCT00588848|20906399|P2|COMPLETED|Overall Study||5
8483549|NCT00588848|20906400|P1|COMPLETED|Overall Study||3
8483550|NCT00588848|20906399|P2|STARTED|Overall Study||8
8483551|NCT00588848|20906400|P1|STARTED|Overall Study||3
8483552|NCT00588822|20906410|P1|NOT COMPLETED|Overall Study||8
8483553|NCT00588822|20906410|P1|COMPLETED|Overall Study||13
8483554|NCT00588822|20906410|P1|STARTED|Overall Study||21
8483555|NCT00588809|20906419|P1|NOT COMPLETED|Overall Study||0
8483556|NCT00588809|20906419|P1|COMPLETED|Overall Study||47
8483557|NCT00588809|20906419|P1|STARTED|Overall Study||47
8483568|NCT00588731|20906443|P2|NOT COMPLETED|Overall Study||2
8483569|NCT00588731|20906444|P1|NOT COMPLETED|Overall Study||3
8483570|NCT00588731|20906443|P2|COMPLETED|Overall Study||18
8483571|NCT00588731|20906444|P1|COMPLETED|Overall Study||18
8483572|NCT00588731|20906443|P2|STARTED|Overall Study||20
8483573|NCT00588731|20906444|P1|STARTED|Overall Study||21
8483574|NCT00588692|20906454|P2|NOT COMPLETED|Overall Study||3
8483575|NCT00588692|20906455|P1|NOT COMPLETED|Overall Study||7
8483576|NCT00588692|20906454|P2|COMPLETED|Overall Study||27
8483577|NCT00588692|20906455|P1|COMPLETED|Overall Study||23
8483578|NCT00588692|20906454|P2|STARTED|Overall Study||30
8483579|NCT00588692|20906455|P1|STARTED|Overall Study||30
8483580|NCT00588666|20906491|P1|NOT COMPLETED|Overall Study||4
8483581|NCT00588666|20906491|P1|COMPLETED|Overall Study||47
8483582|NCT00588666|20906491|P1|STARTED|Overall Study||51
8483583|NCT00588640|20906496|P1|NOT COMPLETED|Overall Study||2
8483584|NCT00588640|20906496|P1|COMPLETED|Overall Study||8
8483585|NCT00588640|20906496|P1|STARTED|Overall Study||10
8483586|NCT00588536|20906500|P1|NOT COMPLETED|Overall Study||0
8483587|NCT00588536|20906500|P1|COMPLETED|Overall Study||5
8483588|NCT00588536|20906500|P1|STARTED|Overall Study||5
8483589|NCT00588471|20906506|P2|NOT COMPLETED|Overall Study||0
8483590|NCT00588471|20906507|P1|NOT COMPLETED|Overall Study||0
8483591|NCT00588471|20906506|P2|COMPLETED|Overall Study||29
8483592|NCT00588471|20906507|P1|COMPLETED|Overall Study||28
8483593|NCT00588471|20906506|P2|STARTED|Overall Study||29
8483594|NCT00588471|20906507|P1|STARTED|Overall Study||28
8483595|NCT00588445|20906515|P1|NOT COMPLETED|Overall Study||15
8483596|NCT00588445|20906515|P1|COMPLETED|Overall Study||50
8483597|NCT00588445|20906515|P1|STARTED|Overall Study||65
8483598|NCT00588406|20906523|P2|NOT COMPLETED|Overall Study||0
8483599|NCT00588406|20906524|P1|NOT COMPLETED|Overall Study||0
8483600|NCT00588406|20906523|P2|COMPLETED|Overall Study||49
8483601|NCT00588406|20906524|P1|COMPLETED|Overall Study||46
8483602|NCT00588406|20906523|P2|STARTED|Overall Study||49
8483603|NCT00588406|20906524|P1|STARTED|Overall Study||46
8483604|NCT00588380|20906532|P1|NOT COMPLETED|Overall Study||0
8483605|NCT00588380|20906532|P1|COMPLETED|Overall Study||88
8483606|NCT00588380|20906532|P1|STARTED|Overall Study||88
8483607|NCT00588354|20906539|P2|NOT COMPLETED|Baseline to 4 Weeks||1
8483608|NCT00588354|20906540|P1|NOT COMPLETED|Baseline to 4 Weeks||0
8483609|NCT00588354|20906539|P2|COMPLETED|Baseline to 4 Weeks||14
8483610|NCT00588354|20906540|P1|COMPLETED|Baseline to 4 Weeks||9
8483611|NCT00588354|20906539|P2|STARTED|Baseline to 4 Weeks||15
8483612|NCT00588354|20906540|P1|STARTED|Baseline to 4 Weeks||9
8483613|NCT00588354|20906539|P2|NOT COMPLETED|Baseline to 2 Weeks||0
8483614|NCT00588354|20906540|P1|NOT COMPLETED|Baseline to 2 Weeks||2
8483615|NCT00588354|20906539|P2|COMPLETED|Baseline to 2 Weeks||15
8483616|NCT00588354|20906540|P1|COMPLETED|Baseline to 2 Weeks||9
8483617|NCT00588354|20906539|P2|STARTED|Baseline to 2 Weeks||15
8483618|NCT00588354|20906540|P1|STARTED|Baseline to 2 Weeks||11
8483619|NCT00588341|20906560|P1|NOT COMPLETED|Overall Study||5
8483620|NCT00588341|20906560|P1|COMPLETED|Overall Study||19
8483621|NCT00588341|20906560|P1|STARTED|Overall Study||24
8483622|NCT00588237|20906564|P1|NOT COMPLETED|Overall Study||4
8483623|NCT00588237|20906564|P1|COMPLETED|Overall Study||38
8483624|NCT00588237|20906564|P1|STARTED|Overall Study||42
8483625|NCT00588159|20906570|P2|NOT COMPLETED|Overall Study||11
8483626|NCT00588159|20906571|P1|NOT COMPLETED|Overall Study||15
8483627|NCT00588159|20906570|P2|COMPLETED|Overall Study||63
8483628|NCT00588159|20906571|P1|COMPLETED|Overall Study||57
8483629|NCT00588159|20906570|P2|STARTED|Overall Study||74
8483630|NCT00588159|20906571|P1|STARTED|Overall Study||72
8483631|NCT00588146|20906587|P2|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
8483632|NCT00588146|20906588|P1|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
8483633|NCT00588146|20906587|P2|COMPLETED|Second Intervention (6 Months to 1 Year)||2
8483634|NCT00588146|20906588|P1|COMPLETED|Second Intervention (6 Months to 1 Year)||1
8483635|NCT00588146|20906587|P2|STARTED|Second Intervention (6 Months to 1 Year)||2
8483636|NCT00588146|20906588|P1|STARTED|Second Intervention (6 Months to 1 Year)||1
8483637|NCT00588146|20906587|P2|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
8483638|NCT00588146|20906588|P1|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
8483639|NCT00588146|20906587|P2|COMPLETED|First Intervention (Baseline to 6 mo)||2
8483640|NCT00588146|20906588|P1|COMPLETED|First Intervention (Baseline to 6 mo)||1
8483641|NCT00588146|20906587|P2|STARTED|First Intervention (Baseline to 6 mo)||5
8483642|NCT00588146|20906588|P1|STARTED|First Intervention (Baseline to 6 mo)||5
8483643|NCT00588094|20906594|P1|NOT COMPLETED|Overall Study||5
8483644|NCT00588094|20906594|P1|COMPLETED|Overall Study||15
8483645|NCT00588094|20906594|P1|STARTED|Overall Study||20
8483646|NCT00587990|20906601|P3|NOT COMPLETED|Overall Study||1
8483647|NCT00587990|20906602|P2|NOT COMPLETED|Overall Study||0
8483648|NCT00587990|20906603|P1|NOT COMPLETED|Overall Study||0
8483649|NCT00587990|20906601|P3|COMPLETED|Overall Study||2
8483650|NCT00587990|20906602|P2|COMPLETED|Overall Study||4
8483651|NCT00587990|20906603|P1|COMPLETED|Overall Study||2
8483652|NCT00587990|20906601|P3|STARTED|Overall Study||3
8483653|NCT00587990|20906602|P2|STARTED|Overall Study||4
8483654|NCT00587990|20906603|P1|STARTED|Overall Study||2
8483655|NCT00587964|20906646|P1|NOT COMPLETED|Overall Study||12
8483656|NCT00587964|20906646|P1|COMPLETED|Overall Study||39
8483657|NCT00587964|20906646|P1|STARTED|Overall Study||51
8483658|NCT00587860|20906652|P2|NOT COMPLETED|Overall Study||5
8483659|NCT00587860|20906653|P1|NOT COMPLETED|Overall Study||5
8483660|NCT00587860|20906652|P2|COMPLETED|Overall Study||30
8483661|NCT00587860|20906653|P1|COMPLETED|Overall Study||30
8483662|NCT00587860|20906652|P2|STARTED|Overall Study||35
8483663|NCT00587860|20906653|P1|STARTED|Overall Study||35
8483664|NCT00587847|20906673|P1|NOT COMPLETED|Overall Study||7
8483665|NCT00587847|20906673|P1|COMPLETED|Overall Study||5
8483666|NCT00587847|20906673|P1|STARTED|Overall Study||12
8483667|NCT00587834|20906678|P1|NOT COMPLETED|Overall Study||0
8483668|NCT00587834|20906678|P1|COMPLETED|Overall Study||96
8483669|NCT00587834|20906678|P1|STARTED|Overall Study||96
8483670|NCT00587795|20906696|P2|NOT COMPLETED|Overall Study||0
8483671|NCT00587795|20906697|P1|NOT COMPLETED|Overall Study||1
8483672|NCT00587795|20906696|P2|COMPLETED|Overall Study||0
8483673|NCT00587795|20906697|P1|COMPLETED|Overall Study||0
8483674|NCT00587795|20906696|P2|STARTED|Overall Study||0
8483675|NCT00587795|20906697|P1|STARTED|Overall Study||1
8483676|NCT00587769|20906703|P1|NOT COMPLETED|Overall Study||0
8483677|NCT00587769|20906703|P1|COMPLETED|Overall Study||38
8483678|NCT00587769|20906703|P1|STARTED|Overall Study||38
8483679|NCT00587678|20906711|P3|NOT COMPLETED|Overall Study||8
8483680|NCT00587678|20906712|P2|NOT COMPLETED|Overall Study||4
8483681|NCT00587678|20906713|P1|NOT COMPLETED|Overall Study||6
8483682|NCT00587678|20906711|P3|COMPLETED|Overall Study||33
8483683|NCT00587678|20906712|P2|COMPLETED|Overall Study||18
8483684|NCT00587678|20906713|P1|COMPLETED|Overall Study||16
8483685|NCT00587678|20906711|P3|STARTED|Overall Study||41
8483686|NCT00587678|20906712|P2|STARTED|Overall Study||22
8483687|NCT00587678|20906713|P1|STARTED|Overall Study||22
8483688|NCT00587639|20906751|P1|NOT COMPLETED|Overall Study||1
8483689|NCT00587639|20906751|P1|COMPLETED|Overall Study||7
8483690|NCT00587639|20906751|P1|STARTED|Overall Study||8
8483691|NCT00587587|20906758|P2|NOT COMPLETED|Overall Study||1
8483692|NCT00587587|20906759|P1|NOT COMPLETED|Overall Study||6
8483693|NCT00587587|20906758|P2|COMPLETED|Overall Study||12
8483694|NCT00587587|20906759|P1|COMPLETED|Overall Study||11
8483695|NCT00587587|20906758|P2|STARTED|Overall Study||13
8483696|NCT00587587|20906759|P1|STARTED|Overall Study||17
8483697|NCT00587483|20906782|P3|NOT COMPLETED|Overall Study||0
8483698|NCT00587483|20906783|P2|NOT COMPLETED|Overall Study||0
8483699|NCT00587483|20906784|P1|NOT COMPLETED|Overall Study||0
8483700|NCT00587483|20906782|P3|COMPLETED|Overall Study||112
8483701|NCT00587483|20906783|P2|COMPLETED|Overall Study||115
8483702|NCT00587483|20906784|P1|COMPLETED|Overall Study||115
8483703|NCT00587483|20906782|P3|STARTED|Overall Study||112
8483704|NCT00587483|20906783|P2|STARTED|Overall Study||115
8483705|NCT00587483|20906784|P1|STARTED|Overall Study||115
8483706|NCT00587457|20906813|P3|NOT COMPLETED|Overall Study||5
8483707|NCT00587457|20906814|P2|NOT COMPLETED|Overall Study||3
8483708|NCT00587457|20906815|P1|NOT COMPLETED|Overall Study||3
8483709|NCT00587457|20906813|P3|COMPLETED|Overall Study||0
8483710|NCT00587457|20906814|P2|COMPLETED|Overall Study||0
8483711|NCT00587457|20906815|P1|COMPLETED|Overall Study||0
8483712|NCT00587457|20906813|P3|STARTED|Overall Study||5
8483713|NCT00587457|20906814|P2|STARTED|Overall Study||3
8483714|NCT00587457|20906815|P1|STARTED|Overall Study||3
8483715|NCT00587431|20906852|P2|NOT COMPLETED|Overall Study||1
8483716|NCT00587431|20906853|P1|NOT COMPLETED|Overall Study||1
8483717|NCT00587431|20906852|P2|COMPLETED|Overall Study||38
8483718|NCT00587431|20906853|P1|COMPLETED|Overall Study||62
8483719|NCT00587431|20906852|P2|STARTED|Overall Study||39
8483720|NCT00587431|20906853|P1|STARTED|Overall Study||63
8483721|NCT00587288|20906864|P2|NOT COMPLETED|Overall Study||9
8483722|NCT00587288|20906865|P1|NOT COMPLETED|Overall Study||3
8483723|NCT00587288|20906864|P2|COMPLETED|Overall Study||44
8483724|NCT00587288|20906865|P1|COMPLETED|Overall Study||50
8483725|NCT00587288|20906864|P2|STARTED|Overall Study||53
8483726|NCT00587288|20906865|P1|STARTED|Overall Study||53
8483727|NCT00587223|20906883|P1|NOT COMPLETED|Overall Study||1
8483728|NCT00587223|20906883|P1|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
8483729|NCT00587223|20906883|P1|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
8483730|NCT00587171|20906900|P2|NOT COMPLETED|Overall Study||1
8483731|NCT00587171|20906901|P1|NOT COMPLETED|Overall Study||1
8483732|NCT00587171|20906900|P2|COMPLETED|Overall Study||9
8483733|NCT00587171|20906901|P1|COMPLETED|Overall Study||8
8483734|NCT00587171|20906900|P2|STARTED|Overall Study||10
8483735|NCT00587171|20906901|P1|STARTED|Overall Study||9
8483736|NCT00587158|20906931|P2|NOT COMPLETED|Overall Study||8
8483737|NCT00587158|20906932|P1|NOT COMPLETED|Overall Study||5
8483738|NCT00587158|20906931|P2|COMPLETED|Overall Study||43
8483739|NCT00587158|20906932|P1|COMPLETED|Overall Study||44
8483740|NCT00587158|20906931|P2|Continued in Study|Overall Study||46
8483741|NCT00587158|20906932|P1|Continued in Study|Overall Study||45
8483742|NCT00587158|20906931|P2|STARTED|Overall Study||51
8483743|NCT00587158|20906932|P1|STARTED|Overall Study||49
8483744|NCT00587132|20906966|P4|NOT COMPLETED|Overall Study||0
8483745|NCT00587132|20906967|P3|NOT COMPLETED|Overall Study||0
8483746|NCT00587132|20906968|P2|NOT COMPLETED|Overall Study||0
8483747|NCT00587132|20906969|P1|NOT COMPLETED|Overall Study||0
8483748|NCT00587132|20906966|P4|COMPLETED|Overall Study||0
8483749|NCT00587132|20906967|P3|COMPLETED|Overall Study||0
8483750|NCT00587132|20906968|P2|COMPLETED|Overall Study||0
8483751|NCT00587132|20906969|P1|COMPLETED|Overall Study||4
8483752|NCT00587132|20906966|P4|STARTED|Overall Study||0
8483753|NCT00587132|20906967|P3|STARTED|Overall Study||0
8483754|NCT00587132|20906968|P2|STARTED|Overall Study||0
8483755|NCT00587132|20906969|P1|STARTED|Overall Study||4
8483759|NCT00587054|20906985|P1|NOT COMPLETED|Overall Study||9
8483760|NCT00587054|20906985|P1|COMPLETED|Overall Study||120
8483761|NCT00587054|20906985|P1|STARTED|Overall Study||129
8483762|NCT00587041|20906992|P3|NOT COMPLETED|Overall Study||0
8483763|NCT00587041|20906993|P2|NOT COMPLETED|Overall Study||0
8483764|NCT00587041|20906994|P1|NOT COMPLETED|Overall Study||0
8483765|NCT00587041|20906992|P3|COMPLETED|Overall Study||14
8483766|NCT00587041|20906993|P2|COMPLETED|Overall Study||14
8483767|NCT00587041|20906994|P1|COMPLETED|Overall Study||12
8483768|NCT00587041|20906992|P3|STARTED|Overall Study||14
8483769|NCT00587041|20906993|P2|STARTED|Overall Study||14
8483770|NCT00587041|20906994|P1|STARTED|Overall Study||12
8483771|NCT00586924|20907011|P6|NOT COMPLETED|Overall Study||33
8483772|NCT00586924|20907012|P5|NOT COMPLETED|Overall Study||4
8483773|NCT00586924|20907013|P4|NOT COMPLETED|Overall Study||3
8483774|NCT00586924|20907014|P3|NOT COMPLETED|Overall Study||3
8483775|NCT00586924|20907015|P2|NOT COMPLETED|Overall Study||3
8483776|NCT00586924|20907016|P1|NOT COMPLETED|Overall Study||3
8483777|NCT00586924|20907011|P6|COMPLETED|Overall Study||0
8483778|NCT00586924|20907012|P5|COMPLETED|Overall Study||0
8483779|NCT00586924|20907013|P4|COMPLETED|Overall Study||0
8483780|NCT00586924|20907014|P3|COMPLETED|Overall Study||0
8483781|NCT00586924|20907015|P2|COMPLETED|Overall Study||0
8483782|NCT00586924|20907016|P1|COMPLETED|Overall Study||0
8483783|NCT00586924|20907011|P6|STARTED|Overall Study||33
8483784|NCT00586924|20907012|P5|STARTED|Overall Study||4
8483785|NCT00586924|20907013|P4|STARTED|Overall Study||3
8483786|NCT00586924|20907014|P3|STARTED|Overall Study||3
8483787|NCT00586924|20907015|P2|STARTED|Overall Study||3
8483788|NCT00586924|20907016|P1|STARTED|Overall Study||3
8483789|NCT00586898|20907216|P1|NOT COMPLETED|Overall Study||7
8483790|NCT00586898|20907216|P1|COMPLETED|Overall Study||29
8483791|NCT00586898|20907216|P1|STARTED|Overall Study||36
8483792|NCT00586846|20907220|P1|NOT COMPLETED|Overall Study||6
8483793|NCT00586846|20907220|P1|COMPLETED|Overall Study||34
8483794|NCT00586846|20907220|P1|STARTED|Overall Study||40
8483795|NCT00586820|20907226|P2|NOT COMPLETED|Overall Study||0
8483796|NCT00586820|20907227|P1|NOT COMPLETED|Overall Study||1
8483797|NCT00586820|20907226|P2|COMPLETED|Overall Study||11
8483798|NCT00586820|20907227|P1|COMPLETED|Overall Study||11
8483799|NCT00586820|20907226|P2|STARTED|Overall Study||11
8483800|NCT00586820|20907227|P1|STARTED|Overall Study||12
8483801|NCT00586729|20907237|P2|NOT COMPLETED|Overall Study||1
8483802|NCT00586729|20907238|P1|NOT COMPLETED|Overall Study||3
8483803|NCT00586729|20907237|P2|COMPLETED|Overall Study||8
8483804|NCT00586729|20907238|P1|COMPLETED|Overall Study||11
8483805|NCT00586729|20907237|P2|STARTED|Overall Study||9
8483806|NCT00586729|20907238|P1|STARTED|Overall Study||14
8483807|NCT00586716|20907250|P2|NOT COMPLETED|Overall Study||0
8483808|NCT00586716|20907251|P1|NOT COMPLETED|Overall Study||0
8483809|NCT00586716|20907250|P2|COMPLETED|Overall Study||8
8483810|NCT00586716|20907251|P1|COMPLETED|Overall Study||14
8483811|NCT00586716|20907250|P2|STARTED|Overall Study||8
8483812|NCT00586716|20907251|P1|STARTED|Overall Study||14
8483813|NCT00586703|20907258|P1|NOT COMPLETED|Overall Study||12
8483814|NCT00586703|20907258|P1|COMPLETED|Overall Study||4
8483815|NCT00586703|20907258|P1|STARTED|Overall Study||16
8483816|NCT00586690|20907265|P2|NOT COMPLETED|Overall Study||0
8483817|NCT00586690|20907266|P1|NOT COMPLETED|Overall Study||16
8483818|NCT00586690|20907265|P2|COMPLETED|Overall Study||22
8483819|NCT00586690|20907266|P1|COMPLETED|Overall Study||5
8483820|NCT00586690|20907265|P2|STARTED|Overall Study||22
8483821|NCT00586690|20907266|P1|STARTED|Overall Study|Four consented subjects were screen failures.|21
8483822|NCT00586664|20907276|P3|NOT COMPLETED|Overall Study||1
8483823|NCT00586664|20907277|P2|NOT COMPLETED|Overall Study||7
8483824|NCT00586664|20907278|P1|NOT COMPLETED|Overall Study||5
8483825|NCT00586664|20907276|P3|COMPLETED|Overall Study||43
8483826|NCT00586664|20907277|P2|COMPLETED|Overall Study||36
8483827|NCT00586664|20907278|P1|COMPLETED|Overall Study||38
8483828|NCT00586664|20907276|P3|STARTED|Overall Study||44
8483829|NCT00586664|20907277|P2|STARTED|Overall Study||43
8483830|NCT00586664|20907278|P1|STARTED|Overall Study||43
8483831|NCT00586625|20907324|P2|NOT COMPLETED|Overall Study||17
8483832|NCT00586625|20907325|P1|NOT COMPLETED|Overall Study||43
8483833|NCT00586625|20907324|P2|COMPLETED|Overall Study||269
8483834|NCT00586625|20907325|P1|COMPLETED|Overall Study||532
8483835|NCT00586625|20907324|P2|STARTED|Overall Study||286
8483836|NCT00586625|20907325|P1|STARTED|Overall Study||575
8483837|NCT00586612|20907333|P2|NOT COMPLETED|Booster Phase||1
8483838|NCT00586612|20907334|P1|NOT COMPLETED|Booster Phase||3
8483839|NCT00586612|20907333|P2|COMPLETED|Booster Phase||143
8483840|NCT00586612|20907334|P1|COMPLETED|Booster Phase||151
8483841|NCT00586612|20907333|P2|STARTED|Booster Phase||144
8483842|NCT00586612|20907334|P1|STARTED|Booster Phase||154
8483843|NCT00586612|20907333|P2|NOT COMPLETED|Primary Phase||3
8483844|NCT00586612|20907334|P1|NOT COMPLETED|Primary Phase||1
8483845|NCT00586612|20907333|P2|COMPLETED|Primary Phase||147
8483846|NCT00586612|20907334|P1|COMPLETED|Primary Phase||162
8483847|NCT00586612|20907333|P2|STARTED|Primary Phase||150
8483848|NCT00586612|20907334|P1|STARTED|Primary Phase||163
8483849|NCT00586573|20907400|P1|NOT COMPLETED|Overall Study||6
8483850|NCT00586573|20907400|P1|COMPLETED|Overall Study||28
8483851|NCT00586573|20907400|P1|STARTED|Overall Study||34
8483852|NCT00586521|20907404|P1|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
8483853|NCT00586521|20907404|P1|COMPLETED|Prophylactic Treatment (Months 8-13)||19
8483854|NCT00586521|20907404|P1|STARTED|Prophylactic Treatment (Months 8-13)||19
8483855|NCT00586521|20907404|P1|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
8483856|NCT00586521|20907404|P1|COMPLETED|On Demand Treatment (Months 1-6)||19
8483857|NCT00586521|20907404|P1|STARTED|On Demand Treatment (Months 1-6)||20
8483858|NCT00586508|20907413|P2|NOT COMPLETED|Overall Study||13
8483859|NCT00586508|20907414|P1|NOT COMPLETED|Overall Study||68
8483860|NCT00586508|20907413|P2|COMPLETED|Overall Study||0
8483861|NCT00586508|20907414|P1|COMPLETED|Overall Study||0
8483862|NCT00586508|20907413|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
8483863|NCT00586508|20907414|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
8483864|NCT00586508|20907413|P2|STARTED|Overall Study||13
8483865|NCT00586508|20907414|P1|STARTED|Overall Study||68
8483866|NCT00586495|20907430|P1|NOT COMPLETED|Follow-up||92
8483867|NCT00586495|20907430|P1|COMPLETED|Follow-up||0
8483868|NCT00586495|20907430|P1|STARTED|Follow-up||92
8483869|NCT00586495|20907430|P1|NOT COMPLETED|Treatment Period||95
8483870|NCT00586495|20907430|P1|COMPLETED|Treatment Period||0
8483871|NCT00586495|20907430|P1|STARTED|Treatment Period||95
8483872|NCT00586482|20907442|P2|NOT COMPLETED|Overall Study||0
8483873|NCT00586482|20907443|P1|NOT COMPLETED|Overall Study||0
8483874|NCT00586482|20907442|P2|COMPLETED|Overall Study||24
8483875|NCT00586482|20907443|P1|COMPLETED|Overall Study||22
8483876|NCT00586482|20907442|P2|STARTED|Overall Study||24
8483877|NCT00586482|20907443|P1|STARTED|Overall Study||22
8483878|NCT00586469|20907459|P2|NOT COMPLETED|Overall Study||1
8483879|NCT00586469|20907460|P1|NOT COMPLETED|Overall Study||0
8483880|NCT00586469|20907459|P2|COMPLETED|Overall Study||499
8483881|NCT00586469|20907460|P1|COMPLETED|Overall Study||500
8483882|NCT00586469|20907459|P2|STARTED|Overall Study||500
8483883|NCT00586469|20907460|P1|STARTED|Overall Study||500
8483884|NCT00586339|20907487|P3|NOT COMPLETED|Overall Study||6
8483885|NCT00586339|20907488|P2|NOT COMPLETED|Overall Study||7
8483886|NCT00586339|20907489|P1|NOT COMPLETED|Overall Study||7
8483887|NCT00586339|20907487|P3|COMPLETED|Overall Study||24
8483888|NCT00586339|20907488|P2|COMPLETED|Overall Study||52
8483889|NCT00586339|20907489|P1|COMPLETED|Overall Study||54
8483890|NCT00586339|20907487|P3|STARTED|Overall Study||30
8483891|NCT00586339|20907488|P2|STARTED|Overall Study||59
8483892|NCT00586339|20907489|P1|STARTED|Overall Study||61
8483893|NCT00586326|20907590|P1|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
8483894|NCT00586326|20907590|P1|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
8483895|NCT00586326|20907590|P1|STARTED|Treated Through 5-yr Follow Up-Treated||100
8483896|NCT00586326|20907590|P1|NOT COMPLETED|Device Placed toTreatment-ITT||18
8483897|NCT00586326|20907590|P1|COMPLETED|Device Placed toTreatment-ITT||100
8483898|NCT00586326|20907590|P1|STARTED|Device Placed toTreatment-ITT||118
8483899|NCT00586326|20907590|P1|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
8483900|NCT00586326|20907590|P1|COMPLETED|Enrollment to Device Placement-Enrolled||118
8483901|NCT00586326|20907590|P1|STARTED|Enrollment to Device Placement-Enrolled||133
8483902|NCT00586313|20907601|P1|NOT COMPLETED|Overall Study||2
8483903|NCT00586313|20907601|P1|COMPLETED|Overall Study||19
8483904|NCT00586313|20907601|P1|STARTED|Overall Study||21
8483905|NCT00586261|20907608|P2|NOT COMPLETED|Overall Study||0
8483906|NCT00586261|20907609|P1|NOT COMPLETED|Overall Study||0
8483907|NCT00586261|20907608|P2|COMPLETED|Overall Study||19
8483908|NCT00586261|20907609|P1|COMPLETED|Overall Study||17
8483909|NCT00586261|20907608|P2|STARTED|Overall Study||19
8483910|NCT00586261|20907609|P1|STARTED|Overall Study||17
8483911|NCT00586196|20907617|P2|NOT COMPLETED|Overall Study||0
8483912|NCT00586196|20907618|P1|NOT COMPLETED|Overall Study||0
8483913|NCT00586196|20907617|P2|COMPLETED|Overall Study||9
8483914|NCT00586196|20907618|P1|COMPLETED|Overall Study||7
8483915|NCT00586196|20907617|P2|STARTED|Overall Study||9
8483916|NCT00586196|20907618|P1|STARTED|Overall Study||7
8483917|NCT00586170|20907628|P2|NOT COMPLETED|Overall Study||0
8483918|NCT00586170|20907629|P1|NOT COMPLETED|Overall Study||0
8483919|NCT00586170|20907628|P2|COMPLETED|Overall Study||3
8483920|NCT00586170|20907629|P1|COMPLETED|Overall Study||5
8483921|NCT00586170|20907628|P2|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
8483922|NCT00586170|20907629|P1|STARTED|Overall Study||5
8483923|NCT00586157|20907637|P2|NOT COMPLETED|Second Intervention||1
8483924|NCT00586157|20907638|P1|NOT COMPLETED|Second Intervention||2
8483925|NCT00586157|20907637|P2|COMPLETED|Second Intervention||14
8483926|NCT00586157|20907638|P1|COMPLETED|Second Intervention||12
8483927|NCT00586157|20907637|P2|STARTED|Second Intervention||15
8483928|NCT00586157|20907638|P1|STARTED|Second Intervention||14
8483929|NCT00586157|20907637|P2|NOT COMPLETED|First Intervention||0
8483930|NCT00586157|20907638|P1|NOT COMPLETED|First Intervention||1
8483931|NCT00586157|20907637|P2|COMPLETED|First Intervention||15
8483932|NCT00586157|20907638|P1|COMPLETED|First Intervention||14
8483933|NCT00586157|20907637|P2|STARTED|First Intervention||15
8483934|NCT00586157|20907638|P1|STARTED|First Intervention||15
8483935|NCT00586105|20907648|P1|NOT COMPLETED|Overall Study||39
8483936|NCT00586105|20907648|P1|COMPLETED|Overall Study||0
8483937|NCT00586105|20907648|P1|STARTED|Overall Study||39
8483938|NCT00586066|20907663|P2|NOT COMPLETED|Overall Study||10
8483939|NCT00586066|20907664|P1|NOT COMPLETED|Overall Study||18
8483940|NCT00586066|20907663|P2|COMPLETED|Overall Study||14
8483941|NCT00586066|20907664|P1|COMPLETED|Overall Study||30
8483942|NCT00586066|20907663|P2|STARTED|Overall Study||24
8483943|NCT00586066|20907664|P1|STARTED|Overall Study||48
8483944|NCT00586001|20907676|P2|NOT COMPLETED|Overall Study||1
8483945|NCT00586001|20907677|P1|NOT COMPLETED|Overall Study||4
8483946|NCT00586001|20907676|P2|COMPLETED|Overall Study||10
8483947|NCT00586001|20907677|P1|COMPLETED|Overall Study||22
8483948|NCT00586001|20907676|P2|STARTED|Overall Study||11
8483949|NCT00586001|20907677|P1|STARTED|Overall Study||26
8483950|NCT00585975|20907721|P2|NOT COMPLETED|Overall Study||13
8483951|NCT00585975|20907722|P1|NOT COMPLETED|Overall Study||15
8483952|NCT00585975|20907721|P2|COMPLETED|Overall Study||278
8483953|NCT00585975|20907722|P1|COMPLETED|Overall Study||262
8483954|NCT00585975|20907721|P2|STARTED|Overall Study||291
8483955|NCT00585975|20907722|P1|STARTED|Overall Study||277
8483956|NCT00585923|20907732|P2|NOT COMPLETED|Overall Study||33
8483957|NCT00585923|20907733|P1|NOT COMPLETED|Overall Study||31
8483958|NCT00585923|20907732|P2|COMPLETED|Overall Study||26
8483959|NCT00585923|20907733|P1|COMPLETED|Overall Study||25
8483960|NCT00585923|20907732|P2|STARTED|Overall Study||59
8483961|NCT00585923|20907733|P1|STARTED|Overall Study||56
8483962|NCT00585910|20907747|P1|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
8483963|NCT00585910|20907747|P1|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
8483964|NCT00585910|20907747|P1|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
8483965|NCT00585910|20907747|P1|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
8483966|NCT00585910|20907747|P1|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
8483967|NCT00585910|20907747|P1|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
8483968|NCT00585780|20907757|P4|NOT COMPLETED|Overall Study||8
8483969|NCT00585780|20907758|P3|NOT COMPLETED|Overall Study||13
8483970|NCT00585780|20907759|P2|NOT COMPLETED|Overall Study||9
8483971|NCT00585780|20907760|P1|NOT COMPLETED|Overall Study||8
8483972|NCT00585780|20907757|P4|COMPLETED|Overall Study||14
8483973|NCT00585780|20907758|P3|COMPLETED|Overall Study||21
8483974|NCT00585780|20907759|P2|COMPLETED|Overall Study||14
8483975|NCT00585780|20907760|P1|COMPLETED|Overall Study||13
8483976|NCT00585780|20907757|P4|STARTED|Overall Study||22
8483977|NCT00585780|20907758|P3|STARTED|Overall Study||34
8483978|NCT00585780|20907759|P2|STARTED|Overall Study||23
8483979|NCT00585780|20907760|P1|STARTED|Overall Study||21
8483980|NCT00585715|20907776|P2|NOT COMPLETED|Overall Study||0
8483981|NCT00585715|20907777|P1|NOT COMPLETED|Overall Study||3
8483982|NCT00585715|20907776|P2|COMPLETED|Overall Study||11
8483983|NCT00585715|20907777|P1|COMPLETED|Overall Study||8
8483984|NCT00585715|20907776|P2|STARTED|Overall Study||11
8483985|NCT00585715|20907777|P1|STARTED|Overall Study||11
8483986|NCT00585689|20907785|P1|NOT COMPLETED|Overall Study||7
8483987|NCT00585689|20907785|P1|COMPLETED|Overall Study||22
8483988|NCT00585689|20907785|P1|STARTED|Overall Study||29
8483995|NCT00585637|20907802|P4|NOT COMPLETED|6-month Time Point||6
8483996|NCT00585637|20907803|P3|NOT COMPLETED|6-month Time Point||11
8483997|NCT00585637|20907804|P2|NOT COMPLETED|6-month Time Point||13
8483998|NCT00585637|20907805|P1|NOT COMPLETED|6-month Time Point||6
8483999|NCT00585637|20907802|P4|COMPLETED|6-month Time Point||77
8484000|NCT00585637|20907803|P3|COMPLETED|6-month Time Point||72
8484001|NCT00585637|20907804|P2|COMPLETED|6-month Time Point||68
8484002|NCT00585637|20907805|P1|COMPLETED|6-month Time Point||75
8484003|NCT00585637|20907802|P4|STARTED|6-month Time Point||83
8484004|NCT00585637|20907803|P3|STARTED|6-month Time Point||83
8484005|NCT00585637|20907804|P2|STARTED|6-month Time Point||81
8484006|NCT00585637|20907805|P1|STARTED|6-month Time Point||81
8484007|NCT00585637|20907802|P4|NOT COMPLETED|3-month Time Point||5
8484008|NCT00585637|20907803|P3|NOT COMPLETED|3-month Time Point||7
8484009|NCT00585637|20907804|P2|NOT COMPLETED|3-month Time Point||14
8484010|NCT00585637|20907805|P1|NOT COMPLETED|3-month Time Point||10
8484011|NCT00585637|20907802|P4|COMPLETED|3-month Time Point||78
8484012|NCT00585637|20907803|P3|COMPLETED|3-month Time Point||76
8484013|NCT00585637|20907804|P2|COMPLETED|3-month Time Point||67
8484014|NCT00585637|20907805|P1|COMPLETED|3-month Time Point||71
8484015|NCT00585637|20907802|P4|STARTED|3-month Time Point||83
8484016|NCT00585637|20907803|P3|STARTED|3-month Time Point||83
8484017|NCT00585637|20907804|P2|STARTED|3-month Time Point||81
8484018|NCT00585637|20907805|P1|STARTED|3-month Time Point||81
8484019|NCT00585637|20907802|P4|NOT COMPLETED|Baseline||0
8484020|NCT00585637|20907803|P3|NOT COMPLETED|Baseline||0
8484021|NCT00585637|20907804|P2|NOT COMPLETED|Baseline||0
8484022|NCT00585637|20907805|P1|NOT COMPLETED|Baseline||0
8484023|NCT00585637|20907802|P4|COMPLETED|Baseline||83
8484024|NCT00585637|20907803|P3|COMPLETED|Baseline||83
8484025|NCT00585637|20907804|P2|COMPLETED|Baseline||81
8484026|NCT00585637|20907805|P1|COMPLETED|Baseline||81
8484027|NCT00585637|20907802|P4|STARTED|Baseline||83
8484028|NCT00585637|20907803|P3|STARTED|Baseline||83
8484029|NCT00585637|20907804|P2|STARTED|Baseline||81
8484030|NCT00585637|20907805|P1|STARTED|Baseline||81
8484031|NCT00585611|20907833|P2|NOT COMPLETED|Overall Study||0
8484032|NCT00585611|20907834|P1|NOT COMPLETED|Overall Study||0
8484033|NCT00585611|20907833|P2|COMPLETED|Overall Study||0
8484034|NCT00585611|20907834|P1|COMPLETED|Overall Study||0
8484035|NCT00585611|20907833|P2|STARTED|Overall Study||0
8484036|NCT00585611|20907834|P1|STARTED|Overall Study||0
8484037|NCT00585585|20907844|P1|NOT COMPLETED|Overall Study||1
8484038|NCT00585585|20907844|P1|COMPLETED|Overall Study||0
8484039|NCT00585585|20907844|P1|Patients Receiving Drug|Overall Study||1
8484040|NCT00585585|20907844|P1|STARTED|Overall Study||1
8484041|NCT00585546|20907848|P1|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
8484042|NCT00585546|20907848|P1|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
8484043|NCT00585546|20907848|P1|STARTED|Clenbuterol Treatment - up to 12 Months||13
8484044|NCT00585546|20907848|P1|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
8484045|NCT00585546|20907848|P1|COMPLETED|LVAD Implantation Required for 4 Months||13
8484046|NCT00585546|20907848|P1|STARTED|LVAD Implantation Required for 4 Months||18
8484047|NCT00585533|20907862|P1|NOT COMPLETED|Overall Study||9
8484048|NCT00585533|20907862|P1|COMPLETED|Overall Study||31
8484049|NCT00585533|20907862|P1|STARTED|Overall Study||40
8484050|NCT00585494|20907867|P1|NOT COMPLETED|Overall Study||56
8484051|NCT00585494|20907867|P1|COMPLETED|Overall Study||244
8484052|NCT00585494|20907867|P1|STARTED|Overall Study||300
8484053|NCT00585468|20907871|P2|NOT COMPLETED|Second Intervention||0
8484054|NCT00585468|20907872|P1|NOT COMPLETED|Second Intervention||0
8484055|NCT00585468|20907871|P2|COMPLETED|Second Intervention||10
8484056|NCT00585468|20907872|P1|COMPLETED|Second Intervention||9
8484057|NCT00585468|20907871|P2|STARTED|Second Intervention||10
8484058|NCT00585468|20907872|P1|STARTED|Second Intervention||9
8484059|NCT00585468|20907871|P2|NOT COMPLETED|First Intervention||1
8484060|NCT00585468|20907872|P1|NOT COMPLETED|First Intervention||1
8484061|NCT00585468|20907871|P2|COMPLETED|First Intervention||10
8484062|NCT00585468|20907872|P1|COMPLETED|First Intervention||9
8484063|NCT00585468|20907871|P2|STARTED|First Intervention||11
8484064|NCT00585468|20907872|P1|STARTED|First Intervention||10
8484065|NCT00585377|20907892|P1|NOT COMPLETED|Overall Study||0
8484066|NCT00585377|20907892|P1|COMPLETED|Overall Study||50
8484067|NCT00585377|20907892|P1|STARTED|Overall Study||50
8484068|NCT00585351|20907904|P8|NOT COMPLETED|Enrollment Period (Intervention)||1
8484069|NCT00585351|20907905|P7|NOT COMPLETED|Enrollment Period (Intervention)||2
8484070|NCT00585351|20907906|P6|NOT COMPLETED|Enrollment Period (Intervention)||2
8484071|NCT00585351|20907907|P5|NOT COMPLETED|Enrollment Period (Intervention)||2
8484072|NCT00585351|20907908|P4|NOT COMPLETED|Enrollment Period (Intervention)||0
8484073|NCT00585351|20907909|P3|NOT COMPLETED|Enrollment Period (Intervention)||0
8484074|NCT00585351|20907910|P2|NOT COMPLETED|Enrollment Period (Intervention)||0
8484075|NCT00585351|20907911|P1|NOT COMPLETED|Enrollment Period (Intervention)||0
8484076|NCT00585351|20907904|P8|COMPLETED|Enrollment Period (Intervention)||2
8484077|NCT00585351|20907905|P7|COMPLETED|Enrollment Period (Intervention)||5
8484078|NCT00585351|20907906|P6|COMPLETED|Enrollment Period (Intervention)||5
8484079|NCT00585351|20907907|P5|COMPLETED|Enrollment Period (Intervention)||3
8484080|NCT00585351|20907908|P4|COMPLETED|Enrollment Period (Intervention)||15
8484081|NCT00585351|20907909|P3|COMPLETED|Enrollment Period (Intervention)||15
8484082|NCT00585351|20907910|P2|COMPLETED|Enrollment Period (Intervention)||0
8484083|NCT00585351|20907911|P1|COMPLETED|Enrollment Period (Intervention)||0
8484084|NCT00585351|20907904|P8|STARTED|Enrollment Period (Intervention)||3
8484085|NCT00585351|20907905|P7|STARTED|Enrollment Period (Intervention)||7
8484086|NCT00585351|20907906|P6|STARTED|Enrollment Period (Intervention)||7
8484087|NCT00585351|20907907|P5|STARTED|Enrollment Period (Intervention)||5
8484088|NCT00585351|20907908|P4|STARTED|Enrollment Period (Intervention)||15
8484089|NCT00585351|20907909|P3|STARTED|Enrollment Period (Intervention)||15
8484090|NCT00585351|20907910|P2|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
8484091|NCT00585351|20907911|P1|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
8484092|NCT00585351|20907904|P8|NOT COMPLETED|Notification Period (Informed Consent)||0
8484093|NCT00585351|20907905|P7|NOT COMPLETED|Notification Period (Informed Consent)||0
8484094|NCT00585351|20907906|P6|NOT COMPLETED|Notification Period (Informed Consent)||0
8484095|NCT00585351|20907907|P5|NOT COMPLETED|Notification Period (Informed Consent)||0
8484096|NCT00585351|20907908|P4|NOT COMPLETED|Notification Period (Informed Consent)||0
8484097|NCT00585351|20907909|P3|NOT COMPLETED|Notification Period (Informed Consent)||0
8484098|NCT00585351|20907910|P2|NOT COMPLETED|Notification Period (Informed Consent)||25
8484099|NCT00585351|20907911|P1|NOT COMPLETED|Notification Period (Informed Consent)||23
8484100|NCT00585351|20907904|P8|COMPLETED|Notification Period (Informed Consent)||0
8484101|NCT00585351|20907905|P7|COMPLETED|Notification Period (Informed Consent)||0
8484102|NCT00585351|20907906|P6|COMPLETED|Notification Period (Informed Consent)||0
8484103|NCT00585351|20907907|P5|COMPLETED|Notification Period (Informed Consent)||0
8484104|NCT00585351|20907908|P4|COMPLETED|Notification Period (Informed Consent)||0
8484105|NCT00585351|20907909|P3|COMPLETED|Notification Period (Informed Consent)||0
8484106|NCT00585351|20907910|P2|COMPLETED|Notification Period (Informed Consent)||25
8484107|NCT00585351|20907911|P1|COMPLETED|Notification Period (Informed Consent)||27
8484108|NCT00585351|20907904|P8|STARTED|Notification Period (Informed Consent)||0
8484109|NCT00585351|20907905|P7|STARTED|Notification Period (Informed Consent)||0
8484110|NCT00585351|20907906|P6|STARTED|Notification Period (Informed Consent)||0
8484111|NCT00585351|20907907|P5|STARTED|Notification Period (Informed Consent)||0
8484112|NCT00585351|20907908|P4|STARTED|Notification Period (Informed Consent)||0
8484113|NCT00585351|20907909|P3|STARTED|Notification Period (Informed Consent)||0
8484114|NCT00585351|20907910|P2|STARTED|Notification Period (Informed Consent)||50
8484115|NCT00585351|20907911|P1|STARTED|Notification Period (Informed Consent)||50
8484116|NCT00585325|20907927|P2|NOT COMPLETED|Overall Study||1
8484117|NCT00585325|20907928|P1|NOT COMPLETED|Overall Study||1
8484118|NCT00585325|20907927|P2|COMPLETED|Overall Study||12
8484119|NCT00585325|20907928|P1|COMPLETED|Overall Study||9
8484120|NCT00585325|20907927|P2|STARTED|Overall Study||13
8484121|NCT00585325|20907928|P1|STARTED|Overall Study||10
8484130|NCT00585286|20907949|P1|NOT COMPLETED|Overall Study||1
8484131|NCT00585286|20907949|P1|COMPLETED|Overall Study||14
8484132|NCT00585286|20907949|P1|STARTED|Overall Study||15
8484133|NCT00585247|20907958|P2|NOT COMPLETED|Overall Study||0
8484134|NCT00585247|20907959|P1|NOT COMPLETED|Overall Study||0
8484135|NCT00585247|20907958|P2|COMPLETED|Overall Study||13
8484136|NCT00585247|20907959|P1|COMPLETED|Overall Study||14
8484137|NCT00585247|20907958|P2|STARTED|Overall Study||13
8484138|NCT00585247|20907959|P1|STARTED|Overall Study||14
8484139|NCT00585221|20907965|P1|NOT COMPLETED|Overall Study||8
8484140|NCT00585221|20907965|P1|COMPLETED|Overall Study||0
8484141|NCT00585221|20907965|P1|STARTED|Overall Study||8
8484142|NCT00585182|20907970|P1|NOT COMPLETED|Overall Study||0
8484143|NCT00585182|20907970|P1|COMPLETED|Overall Study||28
8484144|NCT00585182|20907970|P1|STARTED|Overall Study||28
8484145|NCT00585169|20907975|P1|NOT COMPLETED|Overall Study||1
8484146|NCT00585169|20907975|P1|COMPLETED|Overall Study||28
8484147|NCT00585169|20907975|P1|STARTED|Overall Study||29
8484148|NCT00585104|20907981|P1|NOT COMPLETED|Overall Study||4
8484149|NCT00585104|20907981|P1|COMPLETED|Overall Study||6
8484150|NCT00585104|20907981|P1|STARTED|Overall Study||10
8484151|NCT00585078|20907985|P1|NOT COMPLETED|Overall Study||40
8484152|NCT00585078|20907985|P1|COMPLETED|Overall Study||0
8484153|NCT00585078|20907985|P1|Response Evaluable|Overall Study||24
8484154|NCT00585078|20907985|P1|Toxicity Evaluable|Overall Study||36
8484155|NCT00585078|20907985|P1|Treated|Overall Study||37
8484156|NCT00585078|20907985|P1|STARTED|Overall Study||40
8484157|NCT00585052|20907992|P1|NOT COMPLETED|Overall Study||1
8484158|NCT00585052|20907992|P1|COMPLETED|Overall Study||10
8484159|NCT00585052|20907992|P1|STARTED|Overall Study||11
8484160|NCT00585039|20907999|P2|NOT COMPLETED|Overall Study||0
8484161|NCT00585039|20908000|P1|NOT COMPLETED|Overall Study||2
8484162|NCT00585039|20907999|P2|COMPLETED|Overall Study||44
8484163|NCT00585039|20908000|P1|COMPLETED|Overall Study||55
8484164|NCT00585039|20907999|P2|STARTED|Overall Study||44
8484165|NCT00585039|20908000|P1|STARTED|Overall Study||57
8484166|NCT00585013|20908010|P2|NOT COMPLETED|Overall Study||0
8484167|NCT00585013|20908011|P1|NOT COMPLETED|Overall Study||0
8484168|NCT00585013|20908010|P2|COMPLETED|Overall Study||8
8484169|NCT00585013|20908011|P1|COMPLETED|Overall Study||8
8484170|NCT00585013|20908010|P2|STARTED|Overall Study||8
8484171|NCT00585013|20908011|P1|STARTED|Overall Study||8
8484172|NCT00584987|20908029|P4|NOT COMPLETED|Overall Study||1
8484173|NCT00584987|20908030|P3|NOT COMPLETED|Overall Study||1
8484174|NCT00584987|20908031|P2|NOT COMPLETED|Overall Study||1
8484175|NCT00584987|20908032|P1|NOT COMPLETED|Overall Study||1
8484176|NCT00584987|20908029|P4|COMPLETED|Overall Study||15
8484177|NCT00584987|20908030|P3|COMPLETED|Overall Study||16
8484178|NCT00584987|20908031|P2|COMPLETED|Overall Study||15
8484179|NCT00584987|20908032|P1|COMPLETED|Overall Study||14
8484180|NCT00584987|20908029|P4|STARTED|Overall Study||16
8484181|NCT00584987|20908030|P3|STARTED|Overall Study||17
8484182|NCT00584987|20908031|P2|STARTED|Overall Study||16
8484183|NCT00584987|20908032|P1|STARTED|Overall Study||15
8484184|NCT00584948|20908064|P2|NOT COMPLETED|Overall Study||11
8484185|NCT00584948|20908065|P1|NOT COMPLETED|Overall Study||13
8484186|NCT00584948|20908064|P2|COMPLETED|Overall Study||36
8484187|NCT00584948|20908065|P1|COMPLETED|Overall Study||34
8484188|NCT00584948|20908064|P2|STARTED|Overall Study||47
8484189|NCT00584948|20908065|P1|STARTED|Overall Study||47
8484190|NCT00584935|20908073|P1|NOT COMPLETED|Overall Study||0
8484191|NCT00584935|20908073|P1|COMPLETED|Overall Study||3
8484192|NCT00584935|20908073|P1|STARTED|Overall Study||3
8484193|NCT00584922|20908080|P1|NOT COMPLETED|Overall Study||0
8484194|NCT00584922|20908080|P1|COMPLETED|Overall Study||175
8484195|NCT00584922|20908080|P1|STARTED|Overall Study||175
8484196|NCT00584909|20908084|P1|NOT COMPLETED|Overall Study||4
8484197|NCT00584909|20908084|P1|COMPLETED|Overall Study||9
8484198|NCT00584909|20908084|P1|STARTED|Overall Study||13
8484199|NCT00584857|20908089|P1|NOT COMPLETED|Overall Study||0
8484200|NCT00584857|20908089|P1|COMPLETED|Overall Study||30
8484201|NCT00584857|20908089|P1|STARTED|Overall Study||30
8484202|NCT00584844|20908094|P1|NOT COMPLETED|Overall Study||79
8484203|NCT00584844|20908094|P1|COMPLETED|Overall Study||405
8484204|NCT00584844|20908094|P1|STARTED|Overall Study||484
8484205|NCT00584831|20908104|P19|NOT COMPLETED|Intervention 4||0
8484206|NCT00584831|20908105|P18|NOT COMPLETED|Intervention 4||0
8484207|NCT00584831|20908106|P17|NOT COMPLETED|Intervention 4||0
8484208|NCT00584831|20908107|P16|NOT COMPLETED|Intervention 4||0
8484209|NCT00584831|20908108|P15|NOT COMPLETED|Intervention 4||0
8484210|NCT00584831|20908109|P14|NOT COMPLETED|Intervention 4||0
8484211|NCT00584831|20908110|P13|NOT COMPLETED|Intervention 4||0
8484212|NCT00584831|20908111|P12|NOT COMPLETED|Intervention 4||0
8484213|NCT00584831|20908112|P11|NOT COMPLETED|Intervention 4||0
8484214|NCT00584831|20908113|P10|NOT COMPLETED|Intervention 4||0
8484215|NCT00584831|20908114|P9|NOT COMPLETED|Intervention 4||0
8484216|NCT00584831|20908115|P8|NOT COMPLETED|Intervention 4||0
8484217|NCT00584831|20908116|P7|NOT COMPLETED|Intervention 4||0
8484218|NCT00584831|20908117|P6|NOT COMPLETED|Intervention 4||0
8484219|NCT00584831|20908118|P5|NOT COMPLETED|Intervention 4||0
8484220|NCT00584831|20908119|P4|NOT COMPLETED|Intervention 4||0
8484221|NCT00584831|20908120|P3|NOT COMPLETED|Intervention 4||0
8484222|NCT00584831|20908121|P2|NOT COMPLETED|Intervention 4||0
8484223|NCT00584831|20908122|P1|NOT COMPLETED|Intervention 4||0
8484224|NCT00584831|20908104|P19|COMPLETED|Intervention 4||1
8484225|NCT00584831|20908105|P18|COMPLETED|Intervention 4||1
8484226|NCT00584831|20908106|P17|COMPLETED|Intervention 4||4
8484227|NCT00584831|20908107|P16|COMPLETED|Intervention 4||1
8484228|NCT00584831|20908108|P15|COMPLETED|Intervention 4||2
8484229|NCT00584831|20908109|P14|COMPLETED|Intervention 4||1
8484230|NCT00584831|20908110|P13|COMPLETED|Intervention 4||2
8484231|NCT00584831|20908111|P12|COMPLETED|Intervention 4||1
8484232|NCT00584831|20908112|P11|COMPLETED|Intervention 4||2
8484233|NCT00584831|20908113|P10|COMPLETED|Intervention 4||2
8484234|NCT00584831|20908114|P9|COMPLETED|Intervention 4||3
8484235|NCT00584831|20908115|P8|COMPLETED|Intervention 4||2
8484236|NCT00584831|20908116|P7|COMPLETED|Intervention 4||6
8484237|NCT00584831|20908117|P6|COMPLETED|Intervention 4||1
8484238|NCT00584831|20908118|P5|COMPLETED|Intervention 4||2
8484239|NCT00584831|20908119|P4|COMPLETED|Intervention 4||1
8484240|NCT00584831|20908120|P3|COMPLETED|Intervention 4||2
8484241|NCT00584831|20908121|P2|COMPLETED|Intervention 4||3
8484242|NCT00584831|20908122|P1|COMPLETED|Intervention 4||1
8484243|NCT00584831|20908104|P19|STARTED|Intervention 4||1
8484244|NCT00584831|20908105|P18|STARTED|Intervention 4||1
8484245|NCT00584831|20908106|P17|STARTED|Intervention 4||4
8484246|NCT00584831|20908107|P16|STARTED|Intervention 4||1
8484247|NCT00584831|20908108|P15|STARTED|Intervention 4||2
8484248|NCT00584831|20908109|P14|STARTED|Intervention 4||1
8484249|NCT00584831|20908110|P13|STARTED|Intervention 4||2
8484250|NCT00584831|20908111|P12|STARTED|Intervention 4||1
8484251|NCT00584831|20908112|P11|STARTED|Intervention 4||2
8484252|NCT00584831|20908113|P10|STARTED|Intervention 4||2
8484253|NCT00584831|20908114|P9|STARTED|Intervention 4||3
8484254|NCT00584831|20908115|P8|STARTED|Intervention 4||2
8484255|NCT00584831|20908116|P7|STARTED|Intervention 4||6
8484256|NCT00584831|20908117|P6|STARTED|Intervention 4||1
8484257|NCT00584831|20908118|P5|STARTED|Intervention 4||2
8484258|NCT00584831|20908119|P4|STARTED|Intervention 4||1
8484259|NCT00584831|20908120|P3|STARTED|Intervention 4||2
8484260|NCT00584831|20908121|P2|STARTED|Intervention 4||3
8484261|NCT00584831|20908122|P1|STARTED|Intervention 4||1
8484262|NCT00584831|20908104|P19|NOT COMPLETED|Intervention 3||0
8484263|NCT00584831|20908105|P18|NOT COMPLETED|Intervention 3||0
8484264|NCT00584831|20908106|P17|NOT COMPLETED|Intervention 3||0
8484265|NCT00584831|20908107|P16|NOT COMPLETED|Intervention 3||0
8484266|NCT00584831|20908108|P15|NOT COMPLETED|Intervention 3||0
8484267|NCT00584831|20908109|P14|NOT COMPLETED|Intervention 3||0
8484268|NCT00584831|20908110|P13|NOT COMPLETED|Intervention 3||0
8484269|NCT00584831|20908111|P12|NOT COMPLETED|Intervention 3||0
8484270|NCT00584831|20908112|P11|NOT COMPLETED|Intervention 3||0
8484271|NCT00584831|20908113|P10|NOT COMPLETED|Intervention 3||0
8484272|NCT00584831|20908114|P9|NOT COMPLETED|Intervention 3||0
8484273|NCT00584831|20908115|P8|NOT COMPLETED|Intervention 3||0
8484274|NCT00584831|20908116|P7|NOT COMPLETED|Intervention 3||0
8484275|NCT00584831|20908117|P6|NOT COMPLETED|Intervention 3||0
8484276|NCT00584831|20908118|P5|NOT COMPLETED|Intervention 3||0
8484277|NCT00584831|20908119|P4|NOT COMPLETED|Intervention 3||0
8484278|NCT00584831|20908120|P3|NOT COMPLETED|Intervention 3||0
8484279|NCT00584831|20908121|P2|NOT COMPLETED|Intervention 3||0
8484280|NCT00584831|20908122|P1|NOT COMPLETED|Intervention 3||0
8484281|NCT00584831|20908104|P19|COMPLETED|Intervention 3||1
8484282|NCT00584831|20908105|P18|COMPLETED|Intervention 3||1
8484283|NCT00584831|20908106|P17|COMPLETED|Intervention 3||4
8484284|NCT00584831|20908107|P16|COMPLETED|Intervention 3||1
8484285|NCT00584831|20908108|P15|COMPLETED|Intervention 3||3
8484286|NCT00584831|20908109|P14|COMPLETED|Intervention 3||1
8484287|NCT00584831|20908110|P13|COMPLETED|Intervention 3||2
8484288|NCT00584831|20908111|P12|COMPLETED|Intervention 3||1
8484289|NCT00584831|20908112|P11|COMPLETED|Intervention 3||2
8484290|NCT00584831|20908113|P10|COMPLETED|Intervention 3||2
8484291|NCT00584831|20908114|P9|COMPLETED|Intervention 3||4
8484292|NCT00584831|20908115|P8|COMPLETED|Intervention 3||2
8484293|NCT00584831|20908116|P7|COMPLETED|Intervention 3||6
8484294|NCT00584831|20908117|P6|COMPLETED|Intervention 3||1
8484295|NCT00584831|20908118|P5|COMPLETED|Intervention 3||2
8484296|NCT00584831|20908119|P4|COMPLETED|Intervention 3||1
8484297|NCT00584831|20908120|P3|COMPLETED|Intervention 3||2
8484298|NCT00584831|20908121|P2|COMPLETED|Intervention 3||3
8484299|NCT00584831|20908122|P1|COMPLETED|Intervention 3||1
8484300|NCT00584831|20908104|P19|STARTED|Intervention 3||1
8484301|NCT00584831|20908105|P18|STARTED|Intervention 3||1
8484302|NCT00584831|20908106|P17|STARTED|Intervention 3||4
8484303|NCT00584831|20908107|P16|STARTED|Intervention 3||1
8484304|NCT00584831|20908108|P15|STARTED|Intervention 3||3
8484305|NCT00584831|20908109|P14|STARTED|Intervention 3||1
8484306|NCT00584831|20908110|P13|STARTED|Intervention 3||2
8484307|NCT00584831|20908111|P12|STARTED|Intervention 3||1
8484308|NCT00584831|20908112|P11|STARTED|Intervention 3||2
8484309|NCT00584831|20908113|P10|STARTED|Intervention 3||2
8484310|NCT00584831|20908114|P9|STARTED|Intervention 3||4
8484311|NCT00584831|20908115|P8|STARTED|Intervention 3||2
8484312|NCT00584831|20908116|P7|STARTED|Intervention 3||6
8484313|NCT00584831|20908117|P6|STARTED|Intervention 3||1
8484314|NCT00584831|20908118|P5|STARTED|Intervention 3||2
8484315|NCT00584831|20908119|P4|STARTED|Intervention 3||1
8484316|NCT00584831|20908120|P3|STARTED|Intervention 3||2
8484317|NCT00584831|20908121|P2|STARTED|Intervention 3||3
8484318|NCT00584831|20908122|P1|STARTED|Intervention 3||1
8484319|NCT00584831|20908104|P19|NOT COMPLETED|Intervention 2||0
8484320|NCT00584831|20908105|P18|NOT COMPLETED|Intervention 2||0
8484321|NCT00584831|20908106|P17|NOT COMPLETED|Intervention 2||0
8484322|NCT00584831|20908107|P16|NOT COMPLETED|Intervention 2||0
8484323|NCT00584831|20908108|P15|NOT COMPLETED|Intervention 2||0
8484324|NCT00584831|20908109|P14|NOT COMPLETED|Intervention 2||0
8484325|NCT00584831|20908110|P13|NOT COMPLETED|Intervention 2||0
8484326|NCT00584831|20908111|P12|NOT COMPLETED|Intervention 2||0
8484327|NCT00584831|20908112|P11|NOT COMPLETED|Intervention 2||0
8484328|NCT00584831|20908113|P10|NOT COMPLETED|Intervention 2||0
8484329|NCT00584831|20908114|P9|NOT COMPLETED|Intervention 2||0
8484330|NCT00584831|20908115|P8|NOT COMPLETED|Intervention 2||0
8484331|NCT00584831|20908116|P7|NOT COMPLETED|Intervention 2||0
8484332|NCT00584831|20908117|P6|NOT COMPLETED|Intervention 2||0
8484333|NCT00584831|20908118|P5|NOT COMPLETED|Intervention 2||0
8484334|NCT00584831|20908119|P4|NOT COMPLETED|Intervention 2||0
8484335|NCT00584831|20908120|P3|NOT COMPLETED|Intervention 2||0
8484336|NCT00584831|20908121|P2|NOT COMPLETED|Intervention 2||0
8484337|NCT00584831|20908122|P1|NOT COMPLETED|Intervention 2||0
8484338|NCT00584831|20908104|P19|COMPLETED|Intervention 2||1
8484339|NCT00584831|20908105|P18|COMPLETED|Intervention 2||1
8484340|NCT00584831|20908106|P17|COMPLETED|Intervention 2||4
8484341|NCT00584831|20908107|P16|COMPLETED|Intervention 2||1
8484342|NCT00584831|20908108|P15|COMPLETED|Intervention 2||3
8484343|NCT00584831|20908109|P14|COMPLETED|Intervention 2||1
8484344|NCT00584831|20908110|P13|COMPLETED|Intervention 2||2
8484345|NCT00584831|20908111|P12|COMPLETED|Intervention 2||1
8484346|NCT00584831|20908112|P11|COMPLETED|Intervention 2||2
8484347|NCT00584831|20908113|P10|COMPLETED|Intervention 2||2
8484348|NCT00584831|20908114|P9|COMPLETED|Intervention 2||4
8484349|NCT00584831|20908115|P8|COMPLETED|Intervention 2||2
8484350|NCT00584831|20908116|P7|COMPLETED|Intervention 2||6
8484351|NCT00584831|20908117|P6|COMPLETED|Intervention 2||1
8484352|NCT00584831|20908118|P5|COMPLETED|Intervention 2||2
8484353|NCT00584831|20908119|P4|COMPLETED|Intervention 2||1
8484354|NCT00584831|20908120|P3|COMPLETED|Intervention 2||2
8484355|NCT00584831|20908121|P2|COMPLETED|Intervention 2||3
8484356|NCT00584831|20908122|P1|COMPLETED|Intervention 2||1
8484357|NCT00584831|20908104|P19|STARTED|Intervention 2||1
8484358|NCT00584831|20908105|P18|STARTED|Intervention 2||1
8484359|NCT00584831|20908106|P17|STARTED|Intervention 2||4
8484360|NCT00584831|20908107|P16|STARTED|Intervention 2||1
8484361|NCT00584831|20908108|P15|STARTED|Intervention 2||3
8484362|NCT00584831|20908109|P14|STARTED|Intervention 2||1
8484363|NCT00584831|20908110|P13|STARTED|Intervention 2||2
8484364|NCT00584831|20908111|P12|STARTED|Intervention 2||1
8484365|NCT00584831|20908112|P11|STARTED|Intervention 2||2
8484366|NCT00584831|20908113|P10|STARTED|Intervention 2||2
8484367|NCT00584831|20908114|P9|STARTED|Intervention 2||4
8484368|NCT00584831|20908115|P8|STARTED|Intervention 2||2
8484369|NCT00584831|20908116|P7|STARTED|Intervention 2||6
8484370|NCT00584831|20908117|P6|STARTED|Intervention 2||1
8484371|NCT00584831|20908118|P5|STARTED|Intervention 2||2
8484372|NCT00584831|20908119|P4|STARTED|Intervention 2||1
8484373|NCT00584831|20908120|P3|STARTED|Intervention 2||2
8484374|NCT00584831|20908121|P2|STARTED|Intervention 2||3
8484375|NCT00584831|20908122|P1|STARTED|Intervention 2||1
8484376|NCT00584831|20908104|P19|NOT COMPLETED|Intervention 1||0
8484377|NCT00584831|20908105|P18|NOT COMPLETED|Intervention 1||0
8484378|NCT00584831|20908106|P17|NOT COMPLETED|Intervention 1||0
8484379|NCT00584831|20908107|P16|NOT COMPLETED|Intervention 1||0
8484380|NCT00584831|20908108|P15|NOT COMPLETED|Intervention 1||0
8484381|NCT00584831|20908109|P14|NOT COMPLETED|Intervention 1||0
8484382|NCT00584831|20908110|P13|NOT COMPLETED|Intervention 1||0
8484383|NCT00584831|20908111|P12|NOT COMPLETED|Intervention 1||0
8484384|NCT00584831|20908112|P11|NOT COMPLETED|Intervention 1||0
8484385|NCT00584831|20908113|P10|NOT COMPLETED|Intervention 1||0
8484386|NCT00584831|20908114|P9|NOT COMPLETED|Intervention 1||0
8484387|NCT00584831|20908115|P8|NOT COMPLETED|Intervention 1||0
8484388|NCT00584831|20908116|P7|NOT COMPLETED|Intervention 1||0
8484389|NCT00584831|20908117|P6|NOT COMPLETED|Intervention 1||0
8484390|NCT00584831|20908118|P5|NOT COMPLETED|Intervention 1||0
8484391|NCT00584831|20908119|P4|NOT COMPLETED|Intervention 1||0
8484392|NCT00584831|20908120|P3|NOT COMPLETED|Intervention 1||0
8484393|NCT00584831|20908121|P2|NOT COMPLETED|Intervention 1||0
8484394|NCT00584831|20908122|P1|NOT COMPLETED|Intervention 1||0
8484395|NCT00584831|20908104|P19|COMPLETED|Intervention 1||1
8484396|NCT00584831|20908105|P18|COMPLETED|Intervention 1||1
8484397|NCT00584831|20908106|P17|COMPLETED|Intervention 1||4
8484398|NCT00584831|20908107|P16|COMPLETED|Intervention 1||1
8484399|NCT00584831|20908108|P15|COMPLETED|Intervention 1||3
8484400|NCT00584831|20908109|P14|COMPLETED|Intervention 1||1
8484401|NCT00584831|20908110|P13|COMPLETED|Intervention 1||2
8484402|NCT00584831|20908111|P12|COMPLETED|Intervention 1||1
8484403|NCT00584831|20908112|P11|COMPLETED|Intervention 1||2
8484404|NCT00584831|20908113|P10|COMPLETED|Intervention 1||2
8484405|NCT00584831|20908114|P9|COMPLETED|Intervention 1||4
8484406|NCT00584831|20908115|P8|COMPLETED|Intervention 1||2
8484407|NCT00584831|20908116|P7|COMPLETED|Intervention 1||6
8484408|NCT00584831|20908117|P6|COMPLETED|Intervention 1||1
8484409|NCT00584831|20908118|P5|COMPLETED|Intervention 1||2
8484410|NCT00584831|20908119|P4|COMPLETED|Intervention 1||1
8484411|NCT00584831|20908120|P3|COMPLETED|Intervention 1||2
8484412|NCT00584831|20908121|P2|COMPLETED|Intervention 1||3
8484413|NCT00584831|20908122|P1|COMPLETED|Intervention 1||1
8484414|NCT00584831|20908104|P19|STARTED|Intervention 1||1
8484415|NCT00584831|20908105|P18|STARTED|Intervention 1||1
8484416|NCT00584831|20908106|P17|STARTED|Intervention 1||4
8484417|NCT00584831|20908107|P16|STARTED|Intervention 1||1
8484418|NCT00584831|20908108|P15|STARTED|Intervention 1||3
8484419|NCT00584831|20908109|P14|STARTED|Intervention 1||1
8484420|NCT00584831|20908110|P13|STARTED|Intervention 1||2
8484421|NCT00584831|20908111|P12|STARTED|Intervention 1||1
8484422|NCT00584831|20908112|P11|STARTED|Intervention 1||2
8484423|NCT00584831|20908113|P10|STARTED|Intervention 1||2
8484424|NCT00584831|20908114|P9|STARTED|Intervention 1||4
8484425|NCT00584831|20908115|P8|STARTED|Intervention 1||2
8484426|NCT00584831|20908116|P7|STARTED|Intervention 1||6
8484427|NCT00584831|20908117|P6|STARTED|Intervention 1||1
8484428|NCT00584831|20908118|P5|STARTED|Intervention 1||2
8484429|NCT00584831|20908119|P4|STARTED|Intervention 1||1
8484430|NCT00584831|20908120|P3|STARTED|Intervention 1||2
8484431|NCT00584831|20908121|P2|STARTED|Intervention 1||3
8484432|NCT00584831|20908122|P1|STARTED|Intervention 1||1
8484433|NCT00584805|20908144|P1|NOT COMPLETED|Overall Study||99
8484434|NCT00584805|20908144|P1|COMPLETED|Overall Study||39
8484435|NCT00584805|20908144|P1|STARTED|Overall Study||138
8484436|NCT00584740|20908157|P2|NOT COMPLETED|Overall Study||6
8484437|NCT00584740|20908158|P1|NOT COMPLETED|Overall Study||12
8484438|NCT00584740|20908157|P2|COMPLETED|Overall Study||14
8484439|NCT00584740|20908158|P1|COMPLETED|Overall Study||27
8484440|NCT00584740|20908157|P2|STARTED|Overall Study||20
8484441|NCT00584740|20908158|P1|STARTED|Overall Study||39
8484442|NCT00584727|20908176|P6|NOT COMPLETED|Third Intervention||2
8484443|NCT00584727|20908177|P5|NOT COMPLETED|Third Intervention||4
8484444|NCT00584727|20908178|P4|NOT COMPLETED|Third Intervention||0
8484445|NCT00584727|20908179|P3|NOT COMPLETED|Third Intervention||1
8484446|NCT00584727|20908180|P2|NOT COMPLETED|Third Intervention||0
8484447|NCT00584727|20908181|P1|NOT COMPLETED|Third Intervention||0
8484448|NCT00584727|20908176|P6|COMPLETED|Third Intervention||14
8484449|NCT00584727|20908177|P5|COMPLETED|Third Intervention||12
8484450|NCT00584727|20908178|P4|COMPLETED|Third Intervention||14
8484451|NCT00584727|20908179|P3|COMPLETED|Third Intervention||14
8484452|NCT00584727|20908180|P2|COMPLETED|Third Intervention||17
8484453|NCT00584727|20908181|P1|COMPLETED|Third Intervention||17
8484454|NCT00584727|20908176|P6|STARTED|Third Intervention||16
8484455|NCT00584727|20908177|P5|STARTED|Third Intervention||16
8484456|NCT00584727|20908178|P4|STARTED|Third Intervention||14
8484457|NCT00584727|20908179|P3|STARTED|Third Intervention||15
8484458|NCT00584727|20908180|P2|STARTED|Third Intervention||17
8484459|NCT00584727|20908181|P1|STARTED|Third Intervention||17
8484460|NCT00584727|20908176|P6|NOT COMPLETED|Second Intervention||0
8484461|NCT00584727|20908177|P5|NOT COMPLETED|Second Intervention||0
8484462|NCT00584727|20908178|P4|NOT COMPLETED|Second Intervention||0
8484463|NCT00584727|20908179|P3|NOT COMPLETED|Second Intervention||0
8484464|NCT00584727|20908180|P2|NOT COMPLETED|Second Intervention||0
8484465|NCT00584727|20908181|P1|NOT COMPLETED|Second Intervention||0
8484466|NCT00584727|20908176|P6|COMPLETED|Second Intervention||16
8484467|NCT00584727|20908177|P5|COMPLETED|Second Intervention||16
8484468|NCT00584727|20908178|P4|COMPLETED|Second Intervention||14
8484469|NCT00584727|20908179|P3|COMPLETED|Second Intervention||15
8484470|NCT00584727|20908180|P2|COMPLETED|Second Intervention||17
8484471|NCT00584727|20908181|P1|COMPLETED|Second Intervention||17
8484472|NCT00584727|20908176|P6|STARTED|Second Intervention||16
8484473|NCT00584727|20908177|P5|STARTED|Second Intervention||16
8484474|NCT00584727|20908178|P4|STARTED|Second Intervention||14
8484475|NCT00584727|20908179|P3|STARTED|Second Intervention||15
8484476|NCT00584727|20908180|P2|STARTED|Second Intervention||17
8484477|NCT00584727|20908181|P1|STARTED|Second Intervention||17
8484478|NCT00584727|20908176|P6|NOT COMPLETED|First Intervention||0
8484479|NCT00584727|20908177|P5|NOT COMPLETED|First Intervention||0
8484480|NCT00584727|20908178|P4|NOT COMPLETED|First Intervention||0
8484481|NCT00584727|20908179|P3|NOT COMPLETED|First Intervention||1
8484482|NCT00584727|20908180|P2|NOT COMPLETED|First Intervention||0
8484483|NCT00584727|20908181|P1|NOT COMPLETED|First Intervention||0
8484484|NCT00584727|20908176|P6|COMPLETED|First Intervention||16
8484485|NCT00584727|20908177|P5|COMPLETED|First Intervention||16
8484486|NCT00584727|20908178|P4|COMPLETED|First Intervention||14
8484487|NCT00584727|20908179|P3|COMPLETED|First Intervention||15
8484488|NCT00584727|20908180|P2|COMPLETED|First Intervention||17
8484489|NCT00584727|20908181|P1|COMPLETED|First Intervention||17
8484490|NCT00584727|20908176|P6|STARTED|First Intervention||16
8484491|NCT00584727|20908177|P5|STARTED|First Intervention||16
8484492|NCT00584727|20908178|P4|STARTED|First Intervention||14
8484493|NCT00584727|20908179|P3|STARTED|First Intervention||16
8484494|NCT00584727|20908180|P2|STARTED|First Intervention||17
8484495|NCT00584727|20908181|P1|STARTED|First Intervention||17
8484496|NCT00584701|20908205|P1|NOT COMPLETED|Follow-up||12
8484497|NCT00584701|20908205|P1|COMPLETED|Follow-up||34
8484498|NCT00584701|20908205|P1|STARTED|Follow-up||46
8484499|NCT00584701|20908205|P1|NOT COMPLETED|Active Risperidone||3
8484500|NCT00584701|20908205|P1|COMPLETED|Active Risperidone||46
8484501|NCT00584701|20908205|P1|STARTED|Active Risperidone||49
8484502|NCT00584558|20908210|P1|NOT COMPLETED|Overall Study||0
8484503|NCT00584558|20908210|P1|COMPLETED|Overall Study||2420
8484504|NCT00584558|20908210|P1|STARTED|Overall Study||2420
8484505|NCT00584480|20908215|P1|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
8484506|NCT00584480|20908215|P1|COMPLETED|Second 8 Weeks (40 Treatments)||10
8484507|NCT00584480|20908215|P1|STARTED|Second 8 Weeks (40 Treatments)||10
8484508|NCT00584480|20908215|P1|NOT COMPLETED|4-Week Break From Treatment||0
8484509|NCT00584480|20908215|P1|COMPLETED|4-Week Break From Treatment||10
8484510|NCT00584480|20908215|P1|STARTED|4-Week Break From Treatment||10
8484511|NCT00584480|20908215|P1|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
8484512|NCT00584480|20908215|P1|COMPLETED|First 8 Weeks (40 Treatments)||10
8484513|NCT00584480|20908215|P1|STARTED|First 8 Weeks (40 Treatments)||10
8484514|NCT00584454|20908219|P1|NOT COMPLETED|Overall Study||4
8484515|NCT00584454|20908219|P1|COMPLETED|Overall Study||6
8484516|NCT00584454|20908219|P1|STARTED|Overall Study||10
8484517|NCT00584415|20908223|P1|NOT COMPLETED|Overall Study||7
8484518|NCT00584415|20908223|P1|COMPLETED|Overall Study||112
8484519|NCT00584415|20908223|P1|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
8484520|NCT00584402|20908228|P1|NOT COMPLETED|Overall Study||0
8484521|NCT00584402|20908228|P1|COMPLETED|Overall Study||8
8484522|NCT00584402|20908228|P1|STARTED|Overall Study||8
8484523|NCT00584285|20908233|P1|NOT COMPLETED|Overall Study||0
8484524|NCT00584285|20908233|P1|COMPLETED|Overall Study||18
8484525|NCT00584285|20908233|P1|STARTED|Overall Study||18
8484526|NCT00584220|20908237|P2|NOT COMPLETED|Second Period||0
8484527|NCT00584220|20908238|P1|NOT COMPLETED|Second Period||0
8484528|NCT00584220|20908237|P2|COMPLETED|Second Period||39
8484529|NCT00584220|20908238|P1|COMPLETED|Second Period||48
8484530|NCT00584220|20908237|P2|STARTED|Second Period||39
8484531|NCT00584220|20908238|P1|STARTED|Second Period||48
8484532|NCT00584220|20908237|P2|NOT COMPLETED|First Period||0
8484533|NCT00584220|20908238|P1|NOT COMPLETED|First Period||0
8484534|NCT00584220|20908237|P2|COMPLETED|First Period||39
8484535|NCT00584220|20908238|P1|COMPLETED|First Period||48
8484536|NCT00584220|20908237|P2|STARTED|First Period||39
8484537|NCT00584220|20908238|P1|STARTED|First Period||48
8484538|NCT00584194|20908246|P1|NOT COMPLETED|Overall Study||135
8484539|NCT00584194|20908246|P1|COMPLETED|Overall Study||143
8484540|NCT00584194|20908246|P1|STARTED|Overall Study||278
8484541|NCT00584077|20908254|P1|NOT COMPLETED|Overall Study||0
8484542|NCT00584077|20908254|P1|COMPLETED|Overall Study||15
8484543|NCT00584077|20908254|P1|STARTED|Overall Study||15
8484544|NCT00584012|20908259|P1|NOT COMPLETED|Overall Study||1
8484545|NCT00584012|20908259|P1|COMPLETED|Overall Study||8
8484546|NCT00584012|20908259|P1|STARTED|Overall Study||9
8484547|NCT00583947|20908265|P2|NOT COMPLETED|Open Label Period||0
8484548|NCT00583947|20908266|P1|NOT COMPLETED|Open Label Period||0
8484549|NCT00583947|20908265|P2|COMPLETED|Open Label Period||24
8484550|NCT00583947|20908266|P1|COMPLETED|Open Label Period||22
8484551|NCT00583947|20908265|P2|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
8484552|NCT00583947|20908266|P1|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
8484553|NCT00583947|20908265|P2|NOT COMPLETED|Washout||0
8484554|NCT00583947|20908266|P1|NOT COMPLETED|Washout||0
8484555|NCT00583947|20908265|P2|COMPLETED|Washout||24
8484556|NCT00583947|20908266|P1|COMPLETED|Washout||22
8484557|NCT00583947|20908265|P2|STARTED|Washout||24
8484558|NCT00583947|20908266|P1|STARTED|Washout||22
8484559|NCT00583947|20908265|P2|NOT COMPLETED|Cross-over Period||2
8484560|NCT00583947|20908266|P1|NOT COMPLETED|Cross-over Period||5
8484561|NCT00583947|20908265|P2|COMPLETED|Cross-over Period||24
8484562|NCT00583947|20908266|P1|COMPLETED|Cross-over Period||22
8484563|NCT00583947|20908265|P2|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
8484564|NCT00583947|20908266|P1|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
8484565|NCT00583908|20908316|P12|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484566|NCT00583908|20908317|P11|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484567|NCT00583908|20908318|P10|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484568|NCT00583908|20908319|P9|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484569|NCT00583908|20908320|P8|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484570|NCT00583908|20908321|P7|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484571|NCT00583908|20908322|P6|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484572|NCT00583908|20908323|P5|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484573|NCT00583908|20908324|P4|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484574|NCT00583908|20908325|P3|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484575|NCT00583908|20908326|P2|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484576|NCT00583908|20908327|P1|NOT COMPLETED|Period 4 - Fourth Intervention||0
8484577|NCT00583908|20908316|P12|COMPLETED|Period 4 - Fourth Intervention||1
8484578|NCT00583908|20908317|P11|COMPLETED|Period 4 - Fourth Intervention||1
8484579|NCT00583908|20908318|P10|COMPLETED|Period 4 - Fourth Intervention||1
8484580|NCT00583908|20908319|P9|COMPLETED|Period 4 - Fourth Intervention||1
8484581|NCT00583908|20908320|P8|COMPLETED|Period 4 - Fourth Intervention||1
8484582|NCT00583908|20908321|P7|COMPLETED|Period 4 - Fourth Intervention||1
8484583|NCT00583908|20908322|P6|COMPLETED|Period 4 - Fourth Intervention||1
8484584|NCT00583908|20908323|P5|COMPLETED|Period 4 - Fourth Intervention||2
8484585|NCT00583908|20908324|P4|COMPLETED|Period 4 - Fourth Intervention||1
8484586|NCT00583908|20908325|P3|COMPLETED|Period 4 - Fourth Intervention||1
8484587|NCT00583908|20908326|P2|COMPLETED|Period 4 - Fourth Intervention||2
8484588|NCT00583908|20908327|P1|COMPLETED|Period 4 - Fourth Intervention||1
8484589|NCT00583908|20908316|P12|STARTED|Period 4 - Fourth Intervention||1
8484590|NCT00583908|20908317|P11|STARTED|Period 4 - Fourth Intervention||1
8484591|NCT00583908|20908318|P10|STARTED|Period 4 - Fourth Intervention||1
8484592|NCT00583908|20908319|P9|STARTED|Period 4 - Fourth Intervention||1
8484593|NCT00583908|20908320|P8|STARTED|Period 4 - Fourth Intervention||1
8484594|NCT00583908|20908321|P7|STARTED|Period 4 - Fourth Intervention||1
8484595|NCT00583908|20908322|P6|STARTED|Period 4 - Fourth Intervention||1
8484596|NCT00583908|20908323|P5|STARTED|Period 4 - Fourth Intervention||2
8484597|NCT00583908|20908324|P4|STARTED|Period 4 - Fourth Intervention||1
8484598|NCT00583908|20908325|P3|STARTED|Period 4 - Fourth Intervention||1
8484599|NCT00583908|20908326|P2|STARTED|Period 4 - Fourth Intervention||2
8484600|NCT00583908|20908327|P1|STARTED|Period 4 - Fourth Intervention||1
8484601|NCT00583908|20908316|P12|NOT COMPLETED|Period 3 - Third Intervention||0
8484602|NCT00583908|20908317|P11|NOT COMPLETED|Period 3 - Third Intervention||0
8484603|NCT00583908|20908318|P10|NOT COMPLETED|Period 3 - Third Intervention||0
8484604|NCT00583908|20908319|P9|NOT COMPLETED|Period 3 - Third Intervention||0
8484605|NCT00583908|20908320|P8|NOT COMPLETED|Period 3 - Third Intervention||0
8484606|NCT00583908|20908321|P7|NOT COMPLETED|Period 3 - Third Intervention||0
8484607|NCT00583908|20908322|P6|NOT COMPLETED|Period 3 - Third Intervention||0
8484608|NCT00583908|20908323|P5|NOT COMPLETED|Period 3 - Third Intervention||0
8484609|NCT00583908|20908324|P4|NOT COMPLETED|Period 3 - Third Intervention||0
8484610|NCT00583908|20908325|P3|NOT COMPLETED|Period 3 - Third Intervention||0
8484611|NCT00583908|20908326|P2|NOT COMPLETED|Period 3 - Third Intervention||0
8484612|NCT00583908|20908327|P1|NOT COMPLETED|Period 3 - Third Intervention||0
8484613|NCT00583908|20908316|P12|COMPLETED|Period 3 - Third Intervention||1
8484614|NCT00583908|20908317|P11|COMPLETED|Period 3 - Third Intervention||1
8484615|NCT00583908|20908318|P10|COMPLETED|Period 3 - Third Intervention||1
8484616|NCT00583908|20908319|P9|COMPLETED|Period 3 - Third Intervention||1
8484617|NCT00583908|20908320|P8|COMPLETED|Period 3 - Third Intervention||1
8484618|NCT00583908|20908321|P7|COMPLETED|Period 3 - Third Intervention||1
8484619|NCT00583908|20908322|P6|COMPLETED|Period 3 - Third Intervention||1
8484620|NCT00583908|20908323|P5|COMPLETED|Period 3 - Third Intervention||2
8484621|NCT00583908|20908324|P4|COMPLETED|Period 3 - Third Intervention||1
8484622|NCT00583908|20908325|P3|COMPLETED|Period 3 - Third Intervention||1
8484623|NCT00583908|20908326|P2|COMPLETED|Period 3 - Third Intervention||2
8484624|NCT00583908|20908327|P1|COMPLETED|Period 3 - Third Intervention||1
8484625|NCT00583908|20908316|P12|STARTED|Period 3 - Third Intervention||1
8484626|NCT00583908|20908317|P11|STARTED|Period 3 - Third Intervention||1
8484627|NCT00583908|20908318|P10|STARTED|Period 3 - Third Intervention||1
8484628|NCT00583908|20908319|P9|STARTED|Period 3 - Third Intervention||1
8484629|NCT00583908|20908320|P8|STARTED|Period 3 - Third Intervention||1
8484630|NCT00583908|20908321|P7|STARTED|Period 3 - Third Intervention||1
8484631|NCT00583908|20908322|P6|STARTED|Period 3 - Third Intervention||1
8484632|NCT00583908|20908323|P5|STARTED|Period 3 - Third Intervention||2
8484633|NCT00583908|20908324|P4|STARTED|Period 3 - Third Intervention||1
8484634|NCT00583908|20908325|P3|STARTED|Period 3 - Third Intervention||1
8484635|NCT00583908|20908326|P2|STARTED|Period 3 - Third Intervention||2
8484636|NCT00583908|20908327|P1|STARTED|Period 3 - Third Intervention||1
8484637|NCT00583908|20908316|P12|NOT COMPLETED|Period 2 - Second Intervention||0
8484638|NCT00583908|20908317|P11|NOT COMPLETED|Period 2 - Second Intervention||0
8484639|NCT00583908|20908318|P10|NOT COMPLETED|Period 2 - Second Intervention||0
8484640|NCT00583908|20908319|P9|NOT COMPLETED|Period 2 - Second Intervention||0
8484641|NCT00583908|20908320|P8|NOT COMPLETED|Period 2 - Second Intervention||0
8484642|NCT00583908|20908321|P7|NOT COMPLETED|Period 2 - Second Intervention||0
8484643|NCT00583908|20908322|P6|NOT COMPLETED|Period 2 - Second Intervention||0
8484644|NCT00583908|20908323|P5|NOT COMPLETED|Period 2 - Second Intervention||0
8484645|NCT00583908|20908324|P4|NOT COMPLETED|Period 2 - Second Intervention||0
8484646|NCT00583908|20908325|P3|NOT COMPLETED|Period 2 - Second Intervention||0
8484647|NCT00583908|20908326|P2|NOT COMPLETED|Period 2 - Second Intervention||0
8484648|NCT00583908|20908327|P1|NOT COMPLETED|Period 2 - Second Intervention||0
8484649|NCT00583908|20908316|P12|COMPLETED|Period 2 - Second Intervention||1
8484650|NCT00583908|20908317|P11|COMPLETED|Period 2 - Second Intervention||1
8484651|NCT00583908|20908318|P10|COMPLETED|Period 2 - Second Intervention||1
8484652|NCT00583908|20908319|P9|COMPLETED|Period 2 - Second Intervention||1
8484653|NCT00583908|20908320|P8|COMPLETED|Period 2 - Second Intervention||1
8484654|NCT00583908|20908321|P7|COMPLETED|Period 2 - Second Intervention||1
8484655|NCT00583908|20908322|P6|COMPLETED|Period 2 - Second Intervention||1
8484656|NCT00583908|20908323|P5|COMPLETED|Period 2 - Second Intervention||2
8484657|NCT00583908|20908324|P4|COMPLETED|Period 2 - Second Intervention||1
8484658|NCT00583908|20908325|P3|COMPLETED|Period 2 - Second Intervention||1
8484659|NCT00583908|20908326|P2|COMPLETED|Period 2 - Second Intervention||2
8484660|NCT00583908|20908327|P1|COMPLETED|Period 2 - Second Intervention||1
8484661|NCT00583908|20908316|P12|STARTED|Period 2 - Second Intervention||1
8484662|NCT00583908|20908317|P11|STARTED|Period 2 - Second Intervention||1
8484663|NCT00583908|20908318|P10|STARTED|Period 2 - Second Intervention||1
8484664|NCT00583908|20908319|P9|STARTED|Period 2 - Second Intervention||1
8484665|NCT00583908|20908320|P8|STARTED|Period 2 - Second Intervention||1
8484666|NCT00583908|20908321|P7|STARTED|Period 2 - Second Intervention||1
8484667|NCT00583908|20908322|P6|STARTED|Period 2 - Second Intervention||1
8484668|NCT00583908|20908323|P5|STARTED|Period 2 - Second Intervention||2
8484669|NCT00583908|20908324|P4|STARTED|Period 2 - Second Intervention||1
8484670|NCT00583908|20908325|P3|STARTED|Period 2 - Second Intervention||1
8484671|NCT00583908|20908326|P2|STARTED|Period 2 - Second Intervention||2
8484672|NCT00583908|20908327|P1|STARTED|Period 2 - Second Intervention||1
8484673|NCT00583908|20908316|P12|NOT COMPLETED|Period 1 - First Intervention||0
8484674|NCT00583908|20908317|P11|NOT COMPLETED|Period 1 - First Intervention||0
8484675|NCT00583908|20908318|P10|NOT COMPLETED|Period 1 - First Intervention||0
8484676|NCT00583908|20908319|P9|NOT COMPLETED|Period 1 - First Intervention||0
8484677|NCT00583908|20908320|P8|NOT COMPLETED|Period 1 - First Intervention||0
8484678|NCT00583908|20908321|P7|NOT COMPLETED|Period 1 - First Intervention||0
8484679|NCT00583908|20908322|P6|NOT COMPLETED|Period 1 - First Intervention||0
8484680|NCT00583908|20908323|P5|NOT COMPLETED|Period 1 - First Intervention||0
8484681|NCT00583908|20908324|P4|NOT COMPLETED|Period 1 - First Intervention||0
8484682|NCT00583908|20908325|P3|NOT COMPLETED|Period 1 - First Intervention||0
8484683|NCT00583908|20908326|P2|NOT COMPLETED|Period 1 - First Intervention||0
8484684|NCT00583908|20908327|P1|NOT COMPLETED|Period 1 - First Intervention||0
8484685|NCT00583908|20908316|P12|COMPLETED|Period 1 - First Intervention||1
8484686|NCT00583908|20908317|P11|COMPLETED|Period 1 - First Intervention||1
8484687|NCT00583908|20908318|P10|COMPLETED|Period 1 - First Intervention||1
8484688|NCT00583908|20908319|P9|COMPLETED|Period 1 - First Intervention||1
8484689|NCT00583908|20908320|P8|COMPLETED|Period 1 - First Intervention||1
8484690|NCT00583908|20908321|P7|COMPLETED|Period 1 - First Intervention||1
8484691|NCT00583908|20908322|P6|COMPLETED|Period 1 - First Intervention||1
8484692|NCT00583908|20908323|P5|COMPLETED|Period 1 - First Intervention||2
8484693|NCT00583908|20908324|P4|COMPLETED|Period 1 - First Intervention||1
8484694|NCT00583908|20908325|P3|COMPLETED|Period 1 - First Intervention||1
8484695|NCT00583908|20908326|P2|COMPLETED|Period 1 - First Intervention||2
8484696|NCT00583908|20908327|P1|COMPLETED|Period 1 - First Intervention||1
8484697|NCT00583908|20908316|P12|STARTED|Period 1 - First Intervention||1
8484698|NCT00583908|20908317|P11|STARTED|Period 1 - First Intervention||1
8484699|NCT00583908|20908318|P10|STARTED|Period 1 - First Intervention||1
8484700|NCT00583908|20908319|P9|STARTED|Period 1 - First Intervention||1
8484701|NCT00583908|20908320|P8|STARTED|Period 1 - First Intervention||1
8484702|NCT00583908|20908321|P7|STARTED|Period 1 - First Intervention||1
8484703|NCT00583908|20908322|P6|STARTED|Period 1 - First Intervention||1
8484704|NCT00583908|20908323|P5|STARTED|Period 1 - First Intervention||2
8484705|NCT00583908|20908324|P4|STARTED|Period 1 - First Intervention||1
8484706|NCT00583908|20908325|P3|STARTED|Period 1 - First Intervention||1
8484707|NCT00583908|20908326|P2|STARTED|Period 1 - First Intervention||2
8484708|NCT00583908|20908327|P1|STARTED|Period 1 - First Intervention||1
8484709|NCT00583804|20908381|P1|NOT COMPLETED|Overall Study||0
8484710|NCT00583804|20908381|P1|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
8484711|NCT00583804|20908381|P1|STARTED|Overall Study||10
8484712|NCT00583791|20908387|P1|NOT COMPLETED|Overall Study||73
8484713|NCT00583791|20908387|P1|COMPLETED|Overall Study||18
8484714|NCT00583791|20908387|P1|STARTED|Overall Study||91
8484715|NCT00583713|20908394|P3|NOT COMPLETED|Overall Study||0
8484716|NCT00583713|20908395|P2|NOT COMPLETED|Overall Study||0
8484717|NCT00583713|20908396|P1|NOT COMPLETED|Overall Study||0
8484718|NCT00583713|20908394|P3|COMPLETED|Overall Study||6
8484719|NCT00583713|20908395|P2|COMPLETED|Overall Study||6
8484720|NCT00583713|20908396|P1|COMPLETED|Overall Study||6
8484721|NCT00583713|20908394|P3|STARTED|Overall Study||6
8484722|NCT00583713|20908395|P2|STARTED|Overall Study||6
8484723|NCT00583713|20908396|P1|STARTED|Overall Study||6
8484724|NCT00583700|20908421|P2|NOT COMPLETED|Overall Study||4
8484725|NCT00583700|20908422|P1|NOT COMPLETED|Overall Study||3
8484726|NCT00583700|20908421|P2|COMPLETED|Overall Study||23
8484727|NCT00583700|20908422|P1|COMPLETED|Overall Study||24
8484728|NCT00583700|20908421|P2|STARTED|Overall Study||27
8484729|NCT00583700|20908422|P1|STARTED|Overall Study||27
8484730|NCT00583661|20908430|P1|NOT COMPLETED|Overall Study||0
8484731|NCT00583661|20908430|P1|COMPLETED|Overall Study||48
8484732|NCT00583661|20908430|P1|STARTED|Overall Study||48
8484733|NCT00583622|20908437|P1|NOT COMPLETED|Overall Study||0
8484734|NCT00583622|20908437|P1|COMPLETED|Overall Study||12
8484735|NCT00583622|20908437|P1|STARTED|Overall Study||12
8484736|NCT00583596|20908442|P1|NOT COMPLETED|Overall Study||284
8484737|NCT00583596|20908442|P1|COMPLETED|Overall Study||152
8484738|NCT00583596|20908442|P1|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
8484739|NCT00583557|20908447|P1|NOT COMPLETED|Overall Study||70
8484740|NCT00583557|20908447|P1|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
8484741|NCT00583557|20908447|P1|Received at Least 1 Dose Belimumab|Overall Study||153
8484742|NCT00583557|20908447|P1|STARTED|Overall Study||155
8484743|NCT00583492|20908453|P2|NOT COMPLETED|Overall Study||0
8484744|NCT00583492|20908454|P1|NOT COMPLETED|Overall Study||0
8484745|NCT00583492|20908453|P2|COMPLETED|Overall Study||23
8484746|NCT00583492|20908454|P1|COMPLETED|Overall Study||21
8484747|NCT00583492|20908453|P2|STARTED|Overall Study||23
8484748|NCT00583492|20908454|P1|STARTED|Overall Study||21
8484749|NCT00583466|20908470|P1|NOT COMPLETED|Overall Study||0
8484750|NCT00583466|20908470|P1|COMPLETED|Overall Study||18
8484751|NCT00583466|20908470|P1|STARTED|Overall Study||18
8484752|NCT00583453|20908478|P2|NOT COMPLETED|Overall Study||2
8484753|NCT00583453|20908479|P1|NOT COMPLETED|Overall Study||0
8484754|NCT00583453|20908478|P2|COMPLETED|Overall Study||6
8484755|NCT00583453|20908479|P1|COMPLETED|Overall Study||9
8484756|NCT00583453|20908478|P2|STARTED|Overall Study||8
8484757|NCT00583453|20908479|P1|STARTED|Overall Study||9
8484758|NCT00583414|20908493|P1|NOT COMPLETED|Overall Study||0
8484759|NCT00583414|20908493|P1|COMPLETED|Overall Study||401
8484760|NCT00583414|20908493|P1|STARTED|Overall Study||401
8484761|NCT00583375|20908499|P2|NOT COMPLETED|Overall Study||0
8484762|NCT00583375|20908500|P1|NOT COMPLETED|Overall Study||0
8484763|NCT00583375|20908499|P2|COMPLETED|Overall Study||272
8484764|NCT00583375|20908500|P1|COMPLETED|Overall Study||142
8484765|NCT00583375|20908499|P2|STARTED|Overall Study||272
8484766|NCT00583375|20908500|P1|STARTED|Overall Study||142
8484767|NCT00583362|20908516|P1|NOT COMPLETED|Overall Study||202
8484768|NCT00583362|20908516|P1|COMPLETED|Overall Study||96
8484769|NCT00583362|20908516|P1|STARTED|Overall Study||298
8484770|NCT00583219|20908540|P1|NOT COMPLETED|Phase 2||1
8484771|NCT00583219|20908540|P1|COMPLETED|Phase 2||21
8484772|NCT00583219|20908540|P1|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
8484773|NCT00583219|20908540|P1|NOT COMPLETED|Phase 1||0
8484774|NCT00583219|20908540|P1|COMPLETED|Phase 1||9
8484775|NCT00583219|20908540|P1|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
8484776|NCT00583115|20908557|P1|NOT COMPLETED|Overall Study||1
8484777|NCT00583115|20908557|P1|COMPLETED|Overall Study||0
8484778|NCT00583115|20908557|P1|STARTED|Overall Study||1
8484779|NCT00583102|20908562|P1|NOT COMPLETED|Overall Study||3
8484780|NCT00583102|20908562|P1|COMPLETED|Overall Study||20
8484781|NCT00583102|20908562|P1|STARTED|Overall Study||23
8484782|NCT00583050|20908566|P1|NOT COMPLETED|Overall Study||0
8484783|NCT00583050|20908566|P1|COMPLETED|Overall Study||1366
8484784|NCT00583050|20908566|P1|STARTED|Overall Study||1366
8484785|NCT00582998|20908572|P2|NOT COMPLETED|Overall Study||0
8484786|NCT00582998|20908573|P1|NOT COMPLETED|Overall Study||0
8484787|NCT00582998|20908572|P2|COMPLETED|Overall Study||130
8484788|NCT00582998|20908573|P1|COMPLETED|Overall Study||119
8484789|NCT00582998|20908572|P2|STARTED|Overall Study||130
8484790|NCT00582998|20908573|P1|STARTED|Overall Study||119
8484791|NCT00582972|20908579|P1|NOT COMPLETED|Overall Study||2
8484792|NCT00582972|20908579|P1|COMPLETED|Overall Study||21
8484793|NCT00582972|20908579|P1|STARTED|Overall Study||23
8484794|NCT00582946|20908584|P1|NOT COMPLETED|Overall Study||0
8484795|NCT00582946|20908584|P1|COMPLETED|Overall Study||16
8484796|NCT00582946|20908584|P1|STARTED|Overall Study||16
8484797|NCT00582933|20908588|P1|NOT COMPLETED|Overall Study||3
8484798|NCT00582933|20908588|P1|COMPLETED|Overall Study||92
8484799|NCT00582933|20908588|P1|STARTED|Overall Study||95
8484800|NCT00582907|20908592|P4|NOT COMPLETED|4th Course||0
8484801|NCT00582907|20908593|P3|NOT COMPLETED|4th Course||0
8484802|NCT00582907|20908594|P2|NOT COMPLETED|4th Course||0
8484803|NCT00582907|20908595|P1|NOT COMPLETED|4th Course||0
8484804|NCT00582907|20908592|P4|COMPLETED|4th Course||3
8484805|NCT00582907|20908593|P3|COMPLETED|4th Course||3
8484806|NCT00582907|20908594|P2|COMPLETED|4th Course||3
8484807|NCT00582907|20908595|P1|COMPLETED|4th Course||2
8484808|NCT00582907|20908592|P4|STARTED|4th Course||3
8484809|NCT00582907|20908593|P3|STARTED|4th Course||3
8484810|NCT00582907|20908594|P2|STARTED|4th Course||3
8484811|NCT00582907|20908595|P1|STARTED|4th Course||2
8484812|NCT00582907|20908592|P4|NOT COMPLETED|3rd Course||0
8484813|NCT00582907|20908593|P3|NOT COMPLETED|3rd Course||0
8484814|NCT00582907|20908594|P2|NOT COMPLETED|3rd Course||0
8484815|NCT00582907|20908595|P1|NOT COMPLETED|3rd Course||0
8484816|NCT00582907|20908592|P4|COMPLETED|3rd Course||3
8484817|NCT00582907|20908593|P3|COMPLETED|3rd Course||3
8484818|NCT00582907|20908594|P2|COMPLETED|3rd Course||3
8484819|NCT00582907|20908595|P1|COMPLETED|3rd Course||2
8484820|NCT00582907|20908592|P4|STARTED|3rd Course||3
8484821|NCT00582907|20908593|P3|STARTED|3rd Course||3
8484822|NCT00582907|20908594|P2|STARTED|3rd Course||3
8484823|NCT00582907|20908595|P1|STARTED|3rd Course||2
8484824|NCT00582907|20908592|P4|NOT COMPLETED|2nd Course||0
8484825|NCT00582907|20908593|P3|NOT COMPLETED|2nd Course||0
8484826|NCT00582907|20908594|P2|NOT COMPLETED|2nd Course||0
8484827|NCT00582907|20908595|P1|NOT COMPLETED|2nd Course||1
8484828|NCT00582907|20908592|P4|COMPLETED|2nd Course||3
8484829|NCT00582907|20908593|P3|COMPLETED|2nd Course||3
8484830|NCT00582907|20908594|P2|COMPLETED|2nd Course||3
8484831|NCT00582907|20908595|P1|COMPLETED|2nd Course||2
8484832|NCT00582907|20908592|P4|STARTED|2nd Course||3
8484833|NCT00582907|20908593|P3|STARTED|2nd Course||3
8484834|NCT00582907|20908594|P2|STARTED|2nd Course||3
8484835|NCT00582907|20908595|P1|STARTED|2nd Course||3
8484836|NCT00582907|20908592|P4|NOT COMPLETED|1st Course||1
8484837|NCT00582907|20908593|P3|NOT COMPLETED|1st Course||0
8484838|NCT00582907|20908594|P2|NOT COMPLETED|1st Course||0
8484839|NCT00582907|20908595|P1|NOT COMPLETED|1st Course||1
8484840|NCT00582907|20908592|P4|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
8484841|NCT00582907|20908593|P3|COMPLETED|1st Course||3
8484842|NCT00582907|20908594|P2|COMPLETED|1st Course||3
8484843|NCT00582907|20908595|P1|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
8484844|NCT00582907|20908592|P4|STARTED|1st Course||4
8484845|NCT00582907|20908593|P3|STARTED|1st Course||3
8484846|NCT00582907|20908594|P2|STARTED|1st Course||3
8484847|NCT00582907|20908595|P1|STARTED|1st Course||4
8484848|NCT00582894|20908627|P1|NOT COMPLETED|Overall Study||0
8484849|NCT00582894|20908627|P1|COMPLETED|Overall Study||17
8484850|NCT00582894|20908627|P1|Day 100 Post Transplant|Overall Study||17
8484851|NCT00582894|20908627|P1|STARTED|Overall Study||17
8484852|NCT00582816|20908634|P1|NOT COMPLETED|Overall Study||3
8484853|NCT00582816|20908634|P1|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
8484854|NCT00582816|20908634|P1|STARTED|Overall Study||9
8484855|NCT00582790|20908644|P1|NOT COMPLETED|Overall Study||1
8484856|NCT00582790|20908644|P1|COMPLETED|Overall Study||11
8484857|NCT00582790|20908644|P1|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
8484858|NCT00582738|20908653|P2|NOT COMPLETED|Overall Study||18
8484859|NCT00582738|20908654|P1|NOT COMPLETED|Overall Study||9
8484860|NCT00582738|20908653|P2|COMPLETED|Overall Study||4
8484861|NCT00582738|20908654|P1|COMPLETED|Overall Study||12
8484862|NCT00582738|20908653|P2|STARTED|Overall Study||22
8484863|NCT00582738|20908654|P1|STARTED|Overall Study||21
8484864|NCT00582712|20908678|P1|NOT COMPLETED|Overall Study||4
8484865|NCT00582712|20908678|P1|COMPLETED|Overall Study||1
8484866|NCT00582712|20908678|P1|STARTED|Overall Study||5
8484867|NCT00582660|20908684|P2|NOT COMPLETED|Overall Study||0
8484868|NCT00582660|20908685|P1|NOT COMPLETED|Overall Study||0
8484869|NCT00582660|20908684|P2|COMPLETED|Overall Study||20
8484870|NCT00582660|20908685|P1|COMPLETED|Overall Study||20
8484871|NCT00582660|20908684|P2|STARTED|Overall Study||20
8484872|NCT00582660|20908685|P1|STARTED|Overall Study||20
8484873|NCT00582608|20908693|P1|NOT COMPLETED|Overall Study||12
8484874|NCT00582608|20908693|P1|COMPLETED|Overall Study||0
8484875|NCT00582608|20908693|P1|STARTED|Overall Study||12
8484876|NCT00582556|20908700|P3|NOT COMPLETED|Overall Study||2
8484877|NCT00582556|20908701|P2|NOT COMPLETED|Overall Study||1
8484878|NCT00582556|20908702|P1|NOT COMPLETED|Overall Study||0
8484879|NCT00582556|20908700|P3|COMPLETED|Overall Study||12
8484880|NCT00582556|20908701|P2|COMPLETED|Overall Study||14
8484881|NCT00582556|20908702|P1|COMPLETED|Overall Study||14
8484882|NCT00582556|20908700|P3|STARTED|Overall Study||14
8484883|NCT00582556|20908701|P2|STARTED|Overall Study||15
8484884|NCT00582556|20908702|P1|STARTED|Overall Study||14
8484885|NCT00582517|20908721|P2|NOT COMPLETED|Overall Study||0
8484886|NCT00582517|20908722|P1|NOT COMPLETED|Overall Study||0
8484887|NCT00582517|20908721|P2|COMPLETED|Overall Study||55
8484888|NCT00582517|20908722|P1|COMPLETED|Overall Study||45
8484889|NCT00582517|20908721|P2|STARTED|Overall Study||55
8484890|NCT00582517|20908722|P1|STARTED|Overall Study||45
8484891|NCT00582491|20908730|P2|NOT COMPLETED|Overall Study||0
8484892|NCT00582491|20908731|P1|NOT COMPLETED|Overall Study||1
8484893|NCT00582491|20908730|P2|COMPLETED|Overall Study||10
8484894|NCT00582491|20908731|P1|COMPLETED|Overall Study||10
8484895|NCT00582491|20908730|P2|STARTED|Overall Study||10
8484896|NCT00582491|20908731|P1|STARTED|Overall Study||11
8484897|NCT00582426|20908755|P2|NOT COMPLETED|Overall Study||13
8484898|NCT00582426|20908756|P1|NOT COMPLETED|Overall Study||20
8484899|NCT00582426|20908755|P2|COMPLETED|Overall Study||58
8484900|NCT00582426|20908756|P1|COMPLETED|Overall Study||48
8484901|NCT00582426|20908755|P2|STARTED|Overall Study||71
8484902|NCT00582426|20908756|P1|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
8484903|NCT00582400|20908782|P1|NOT COMPLETED|Overall Study||3
8484904|NCT00582400|20908782|P1|COMPLETED|Overall Study||6
8484905|NCT00582400|20908782|P1|STARTED|Overall Study||9
8484906|NCT00582361|20908791|P2|NOT COMPLETED|Overall Study||0
8484907|NCT00582361|20908792|P1|NOT COMPLETED|Overall Study||0
8484908|NCT00582361|20908791|P2|COMPLETED|Overall Study||38
8484909|NCT00582361|20908792|P1|COMPLETED|Overall Study||25
8484910|NCT00582361|20908791|P2|STARTED|Overall Study||38
8484911|NCT00582361|20908792|P1|STARTED|Overall Study||25
8484912|NCT00582309|20908803|P3|NOT COMPLETED|Overall Study||2
8484913|NCT00582309|20908804|P2|NOT COMPLETED|Overall Study||0
8484914|NCT00582309|20908805|P1|NOT COMPLETED|Overall Study||0
8484915|NCT00582309|20908803|P3|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
8484916|NCT00582309|20908804|P2|COMPLETED|Overall Study||49
8484917|NCT00582309|20908805|P1|COMPLETED|Overall Study||56
8484918|NCT00582309|20908803|P3|STARTED|Overall Study||46
8484919|NCT00582309|20908804|P2|STARTED|Overall Study||49
8484920|NCT00582309|20908805|P1|STARTED|Overall Study||56
8484924|NCT00582166|20908818|P1|NOT COMPLETED|Overall Study||2
8484925|NCT00582166|20908818|P1|COMPLETED|Overall Study||16
8484926|NCT00582166|20908818|P1|STARTED|Overall Study||18
8484927|NCT00582114|20908828|P2|NOT COMPLETED|Overall Study||54
8484928|NCT00582114|20908829|P1|NOT COMPLETED|Overall Study||42
8484929|NCT00582114|20908828|P2|COMPLETED|Overall Study||46
8484930|NCT00582114|20908829|P1|COMPLETED|Overall Study||58
8484931|NCT00582114|20908828|P2|STARTED|Overall Study||100
8484932|NCT00582114|20908829|P1|STARTED|Overall Study||100
8484933|NCT00582075|20908837|P1|NOT COMPLETED|Overall Study||0
8484934|NCT00582075|20908837|P1|COMPLETED|Overall Study||25
8484935|NCT00582075|20908837|P1|STARTED|Overall Study||25
8484936|NCT00582036|20908844|P2|NOT COMPLETED|Overall Study||1
8484937|NCT00582036|20908845|P1|NOT COMPLETED|Overall Study||0
8484938|NCT00582036|20908844|P2|COMPLETED|Overall Study|One patient withdrew consent|5
8484939|NCT00582036|20908845|P1|COMPLETED|Overall Study||5
8484940|NCT00582036|20908844|P2|STARTED|Overall Study||6
8484941|NCT00582036|20908845|P1|STARTED|Overall Study||5
8484942|NCT00582010|20908853|P2|NOT COMPLETED|Overall Study||1
8484943|NCT00582010|20908854|P1|NOT COMPLETED|Overall Study||0
8484944|NCT00582010|20908853|P2|COMPLETED|Overall Study||39
8484945|NCT00582010|20908854|P1|COMPLETED|Overall Study||40
8484946|NCT00582010|20908853|P2|STARTED|Overall Study||40
8484947|NCT00582010|20908854|P1|STARTED|Overall Study||40
8484948|NCT00581971|20908876|P1|NOT COMPLETED|Overall Study||0
8484949|NCT00581971|20908876|P1|COMPLETED|Overall Study||30
8484950|NCT00581971|20908876|P1|STARTED|Overall Study||30
8484951|NCT00581945|20908883|P2|NOT COMPLETED|Overall Study||10
8484952|NCT00581945|20908884|P1|NOT COMPLETED|Overall Study||9
8484953|NCT00581945|20908883|P2|COMPLETED|Overall Study||63
8484954|NCT00581945|20908884|P1|COMPLETED|Overall Study||65
8484955|NCT00581945|20908883|P2|STARTED|Overall Study||73
8484956|NCT00581945|20908884|P1|STARTED|Overall Study||74
8484957|NCT00581919|20908900|P1|NOT COMPLETED|Overall Study||24
8484958|NCT00581919|20908900|P1|COMPLETED|Overall Study||8
8484959|NCT00581919|20908900|P1|STARTED|Overall Study||32
8484960|NCT00581867|20908906|P2|NOT COMPLETED|Second Intervention||0
8484961|NCT00581867|20908907|P1|NOT COMPLETED|Second Intervention||0
8484962|NCT00581867|20908906|P2|COMPLETED|Second Intervention||14
8484963|NCT00581867|20908907|P1|COMPLETED|Second Intervention||15
8484964|NCT00581867|20908906|P2|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
8484965|NCT00581867|20908907|P1|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
8484966|NCT00581867|20908906|P2|NOT COMPLETED|First Intervention||0
8484967|NCT00581867|20908907|P1|NOT COMPLETED|First Intervention||0
8484968|NCT00581867|20908906|P2|COMPLETED|First Intervention||15
8484969|NCT00581867|20908907|P1|COMPLETED|First Intervention||16
8484970|NCT00581867|20908906|P2|STARTED|First Intervention||15
8484971|NCT00581867|20908907|P1|STARTED|First Intervention||16
8484972|NCT00581854|20908915|P1|NOT COMPLETED|Overall Study||0
8484973|NCT00581854|20908915|P1|COMPLETED|Overall Study||22
8484974|NCT00581854|20908915|P1|STARTED|Overall Study||22
8484975|NCT00581828|20908919|P1|NOT COMPLETED|Overall Study||1
8484976|NCT00581828|20908919|P1|COMPLETED|Overall Study||18
8484977|NCT00581828|20908919|P1|STARTED|Overall Study||19
8484978|NCT00581776|20908923|P1|NOT COMPLETED|Overall Study||3
8484979|NCT00581776|20908923|P1|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
8484980|NCT00581776|20908923|P1|STARTED|Overall Study||30
8484981|NCT00581581|20908932|P2|NOT COMPLETED|Overall Study||0
8484982|NCT00581581|20908933|P1|NOT COMPLETED|Overall Study||0
8484983|NCT00581581|20908932|P2|COMPLETED|Overall Study||30
8484984|NCT00581581|20908933|P1|COMPLETED|Overall Study||32
8484985|NCT00581581|20908932|P2|STARTED|Overall Study||30
8484986|NCT00581581|20908933|P1|STARTED|Overall Study||32
8484987|NCT00581555|20908941|P2|NOT COMPLETED|Overall Study||20
8484988|NCT00581555|20908942|P1|NOT COMPLETED|Overall Study||43
8484989|NCT00581555|20908941|P2|COMPLETED|Overall Study||38
8484990|NCT00581555|20908942|P1|COMPLETED|Overall Study||19
8484991|NCT00581555|20908941|P2|STARTED|Overall Study||58
8484992|NCT00581555|20908942|P1|STARTED|Overall Study||62
8484993|NCT00581542|20908966|P2|NOT COMPLETED|Overall Study||23
8484994|NCT00581542|20908967|P1|NOT COMPLETED|Overall Study||11
8484995|NCT00581542|20908966|P2|COMPLETED|Overall Study||39
8484996|NCT00581542|20908967|P1|COMPLETED|Overall Study||51
8484997|NCT00581542|20908966|P2|STARTED|Overall Study||62
8484998|NCT00581542|20908967|P1|STARTED|Overall Study||62
8484999|NCT00581529|20908975|P1|NOT COMPLETED|Overall Study||0
8485000|NCT00581529|20908975|P1|COMPLETED|Overall Study||34
8485001|NCT00581529|20908975|P1|STARTED|Overall Study||34
8485002|NCT00581399|20908984|P2|NOT COMPLETED|Overall Study||0
8485003|NCT00581399|20908985|P1|NOT COMPLETED|Overall Study||0
8485004|NCT00581399|20908984|P2|COMPLETED|Overall Study||48
8485005|NCT00581399|20908985|P1|COMPLETED|Overall Study||46
8485006|NCT00581399|20908984|P2|STARTED|Overall Study||48
8485007|NCT00581399|20908985|P1|STARTED|Overall Study||46
8485008|NCT00581386|20908996|P3|NOT COMPLETED|Overall Study||0
8485009|NCT00581386|20908997|P2|NOT COMPLETED|Overall Study||0
8485010|NCT00581386|20908998|P1|NOT COMPLETED|Overall Study||0
8485011|NCT00581386|20908996|P3|COMPLETED|Overall Study|04/15/2009|72
8485012|NCT00581386|20908997|P2|COMPLETED|Overall Study|04/15/2009|73
8485013|NCT00581386|20908998|P1|COMPLETED|Overall Study|04/15/2009|73
8485014|NCT00581386|20908996|P3|STARTED|Overall Study|05/30/2007|72
8485015|NCT00581386|20908997|P2|STARTED|Overall Study|05/30/2007|73
8485016|NCT00581386|20908998|P1|STARTED|Overall Study|05/30/2007|73
8485017|NCT00581360|20909021|P1|NOT COMPLETED|Overall Study||1
8485018|NCT00581360|20909021|P1|COMPLETED|Overall Study||9
8485019|NCT00581360|20909021|P1|STARTED|Overall Study||10
8485020|NCT00581347|20909031|P2|NOT COMPLETED|Overall Study||0
8485021|NCT00581347|20909032|P1|NOT COMPLETED|Overall Study||0
8485022|NCT00581347|20909031|P2|COMPLETED|Overall Study||3707
8485023|NCT00581347|20909032|P1|COMPLETED|Overall Study||3839
8485024|NCT00581347|20909031|P2|STARTED|Overall Study||3707
8485025|NCT00581347|20909032|P1|STARTED|Overall Study||3839
8485026|NCT00581308|20909040|P1|NOT COMPLETED|60 Months||3
8485027|NCT00581308|20909040|P1|COMPLETED|60 Months||158
8485028|NCT00581308|20909040|P1|STARTED|60 Months||161
8485029|NCT00581308|20909040|P1|NOT COMPLETED|48 Months||9
8485030|NCT00581308|20909040|P1|COMPLETED|48 Months||161
8485031|NCT00581308|20909040|P1|STARTED|48 Months||170
8485032|NCT00581308|20909040|P1|NOT COMPLETED|36 Months||6
8485033|NCT00581308|20909040|P1|COMPLETED|36 Months||170
8485034|NCT00581308|20909040|P1|STARTED|36 Months||176
8485035|NCT00581308|20909040|P1|NOT COMPLETED|24 Months||6
8485036|NCT00581308|20909040|P1|COMPLETED|24 Months||176
8485037|NCT00581308|20909040|P1|STARTED|24 Months||182
8485038|NCT00581308|20909040|P1|NOT COMPLETED|Month 12||20
8485039|NCT00581308|20909040|P1|COMPLETED|Month 12||182
8485040|NCT00581308|20909040|P1|STARTED|Month 12||202
8485041|NCT00581308|20909040|P1|NOT COMPLETED|Month 6||3
8485042|NCT00581308|20909040|P1|COMPLETED|Month 6||202
8485043|NCT00581308|20909040|P1|STARTED|Month 6||205
8485044|NCT00581308|20909040|P1|NOT COMPLETED|Month 1||8
8485045|NCT00581308|20909040|P1|COMPLETED|Month 1||205
8485046|NCT00581308|20909040|P1|STARTED|Month 1||213
8485047|NCT00581308|20909040|P1|NOT COMPLETED|Pre Discharge||2
8485048|NCT00581308|20909040|P1|COMPLETED|Pre Discharge||213
8485049|NCT00581308|20909040|P1|STARTED|Pre Discharge||215
8485050|NCT00581256|20909049|P2|NOT COMPLETED|Overall Study||0
8485051|NCT00581256|20909050|P1|NOT COMPLETED|Overall Study||0
8485052|NCT00581256|20909049|P2|COMPLETED|Overall Study||26
8485053|NCT00581256|20909050|P1|COMPLETED|Overall Study||28
8485054|NCT00581256|20909049|P2|STARTED|Overall Study||26
8485055|NCT00581256|20909050|P1|STARTED|Overall Study||28
8485056|NCT00581230|20909062|P1|NOT COMPLETED|Overall Study||0
8485057|NCT00581230|20909062|P1|COMPLETED|Overall Study||51
8485058|NCT00581230|20909062|P1|Laryngoscopy With RAMP|Overall Study||51
8485059|NCT00581230|20909062|P1|Laryngoscopy Without RAMP|Overall Study||51
8485060|NCT00581230|20909062|P1|STARTED|Overall Study||51
8485061|NCT00581113|20909071|P2|NOT COMPLETED|Overall Study||1
8485062|NCT00581113|20909072|P1|NOT COMPLETED|Overall Study||0
8485063|NCT00581113|20909071|P2|COMPLETED|Overall Study||3
8485064|NCT00581113|20909072|P1|COMPLETED|Overall Study||4
8485065|NCT00581113|20909071|P2|STARTED|Overall Study||4
8485066|NCT00581113|20909072|P1|STARTED|Overall Study||4
8485067|NCT00581100|20909082|P2|NOT COMPLETED|Overall Study||5
8485068|NCT00581100|20909083|P1|NOT COMPLETED|Overall Study||7
8485069|NCT00581100|20909082|P2|COMPLETED|Overall Study||29
8485070|NCT00581100|20909083|P1|COMPLETED|Overall Study||31
8485071|NCT00581100|20909082|P2|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
8485072|NCT00581100|20909083|P1|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
8485073|NCT00581100|20909082|P2|STARTED|Overall Study||34
8485074|NCT00581100|20909083|P1|STARTED|Overall Study||38
8485075|NCT00581061|20909119|P1|NOT COMPLETED|Overall Study||0
8485076|NCT00581061|20909119|P1|COMPLETED|Overall Study||13
8485077|NCT00581061|20909119|P1|STARTED|Overall Study||13
8485078|NCT00581048|20909125|P1|NOT COMPLETED|Overall Study||0
8485079|NCT00581048|20909125|P1|COMPLETED|Overall Study||33
8485080|NCT00581048|20909125|P1|STARTED|Overall Study||33
8485081|NCT00580983|20909136|P1|NOT COMPLETED|Overall Study||7
8485082|NCT00580983|20909136|P1|COMPLETED|Overall Study||73
8485083|NCT00580983|20909136|P1|STARTED|Overall Study||80
8485084|NCT00580970|20909143|P1|NOT COMPLETED|Treatment (Lovastatin)||19
8485085|NCT00580970|20909143|P1|COMPLETED|Treatment (Lovastatin)||53
8485086|NCT00580970|20909143|P1|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
8485087|NCT00580970|20909143|P1|STARTED|Treatment (Lovastatin)||72
8485088|NCT00580970|20909143|P1|NOT COMPLETED|Pre-treatment||1
8485089|NCT00580970|20909143|P1|COMPLETED|Pre-treatment||72
8485090|NCT00580970|20909143|P1|STARTED|Pre-treatment||73
8485091|NCT00580957|20909149|P2|NOT COMPLETED|Overall Study||7
8485092|NCT00580957|20909150|P1|NOT COMPLETED|Overall Study||7
8485093|NCT00580957|20909149|P2|COMPLETED|Overall Study||21
8485094|NCT00580957|20909150|P1|COMPLETED|Overall Study||21
8485095|NCT00580957|20909149|P2|STARTED|Overall Study||28
8485096|NCT00580957|20909150|P1|STARTED|Overall Study||28
8485097|NCT00580866|20909158|P2|NOT COMPLETED|Overall Study||2
8485098|NCT00580866|20909159|P1|NOT COMPLETED|Overall Study||2
8485099|NCT00580866|20909158|P2|COMPLETED|Overall Study||5
8485100|NCT00580866|20909159|P1|COMPLETED|Overall Study||8
8485101|NCT00580866|20909158|P2|STARTED|Overall Study||7
8485102|NCT00580866|20909159|P1|STARTED|Overall Study||10
8485103|NCT00580853|20909170|P3|NOT COMPLETED|Overall Study||0
8485104|NCT00580853|20909171|P2|NOT COMPLETED|Overall Study||0
8485105|NCT00580853|20909172|P1|NOT COMPLETED|Overall Study||0
8485106|NCT00580853|20909170|P3|COMPLETED|Overall Study||21
8485107|NCT00580853|20909171|P2|COMPLETED|Overall Study||21
8485108|NCT00580853|20909172|P1|COMPLETED|Overall Study||20
8485109|NCT00580853|20909170|P3|STARTED|Overall Study||21
8485110|NCT00580853|20909171|P2|STARTED|Overall Study||21
8485111|NCT00580853|20909172|P1|STARTED|Overall Study||20
8485112|NCT00580840|20909183|P4|NOT COMPLETED|Double-Blind||15
8485113|NCT00580840|20909184|P3|NOT COMPLETED|Double-Blind||9
8485114|NCT00580840|20909185|P2|NOT COMPLETED|Double-Blind||7
8485115|NCT00580840|20909186|P1|NOT COMPLETED|Double-Blind||0
8485116|NCT00580840|20909183|P4|COMPLETED|Double-Blind||54
8485117|NCT00580840|20909184|P3|COMPLETED|Double-Blind||61
8485118|NCT00580840|20909185|P2|COMPLETED|Double-Blind||63
8485119|NCT00580840|20909186|P1|COMPLETED|Double-Blind||0
8485120|NCT00580840|20909183|P4|STARTED|Double-Blind||69
8485121|NCT00580840|20909184|P3|STARTED|Double-Blind||70
8485122|NCT00580840|20909185|P2|STARTED|Double-Blind||70
8485123|NCT00580840|20909186|P1|STARTED|Double-Blind||0
8485124|NCT00580840|20909183|P4|NOT COMPLETED|Run-in||0
8485125|NCT00580840|20909184|P3|NOT COMPLETED|Run-in||0
8485126|NCT00580840|20909185|P2|NOT COMPLETED|Run-in||0
8485127|NCT00580840|20909186|P1|NOT COMPLETED|Run-in||124
8485128|NCT00580840|20909183|P4|COMPLETED|Run-in||0
8485129|NCT00580840|20909184|P3|COMPLETED|Run-in||0
8485130|NCT00580840|20909185|P2|COMPLETED|Run-in||0
8485131|NCT00580840|20909186|P1|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
8485132|NCT00580840|20909183|P4|STARTED|Run-in||0
8485133|NCT00580840|20909184|P3|STARTED|Run-in||0
8485134|NCT00580840|20909185|P2|STARTED|Run-in||0
8485135|NCT00580840|20909186|P1|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
8485136|NCT00580801|20909294|P3|NOT COMPLETED|Overall Study||3
8485137|NCT00580801|20909295|P2|NOT COMPLETED|Overall Study||1
8485138|NCT00580801|20909296|P1|NOT COMPLETED|Overall Study||6
8485139|NCT00580801|20909294|P3|COMPLETED|Overall Study||5
8485140|NCT00580801|20909295|P2|COMPLETED|Overall Study||7
8485141|NCT00580801|20909296|P1|COMPLETED|Overall Study||2
8485142|NCT00580801|20909294|P3|STARTED|Overall Study||8
8485143|NCT00580801|20909295|P2|STARTED|Overall Study||8
8485144|NCT00580801|20909296|P1|STARTED|Overall Study||8
8485145|NCT00580788|20909335|P4|NOT COMPLETED|Overall Study||1
8485146|NCT00580788|20909336|P3|NOT COMPLETED|Overall Study||0
8485147|NCT00580788|20909337|P2|NOT COMPLETED|Overall Study||0
8485148|NCT00580788|20909338|P1|NOT COMPLETED|Overall Study||0
8485149|NCT00580788|20909335|P4|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
8485150|NCT00580788|20909336|P3|COMPLETED|Overall Study||3
8485151|NCT00580788|20909337|P2|COMPLETED|Overall Study||6
8485152|NCT00580788|20909338|P1|COMPLETED|Overall Study||3
8485153|NCT00580788|20909335|P4|STARTED|Overall Study||2
8485154|NCT00580788|20909336|P3|STARTED|Overall Study||3
8485155|NCT00580788|20909337|P2|STARTED|Overall Study||6
8485156|NCT00580788|20909338|P1|STARTED|Overall Study||3
8485157|NCT00580723|20909396|P1|NOT COMPLETED|Overall Study||8
8485158|NCT00580723|20909396|P1|COMPLETED|Overall Study||16
8485159|NCT00580723|20909396|P1|STARTED|Overall Study||24
8485160|NCT00580671|20909405|P3|NOT COMPLETED|Overall Study||17
8485161|NCT00580671|20909406|P2|NOT COMPLETED|Overall Study||16
8485162|NCT00580671|20909407|P1|NOT COMPLETED|Overall Study||16
8485163|NCT00580671|20909405|P3|COMPLETED|Overall Study||34
8485164|NCT00580671|20909406|P2|COMPLETED|Overall Study||35
8485165|NCT00580671|20909407|P1|COMPLETED|Overall Study||35
8485166|NCT00580671|20909405|P3|STARTED|Overall Study||51
8485167|NCT00580671|20909406|P2|STARTED|Overall Study||51
8485168|NCT00580671|20909407|P1|STARTED|Overall Study||51
8485169|NCT00580645|20909424|P3|NOT COMPLETED|Overall Study||0
8485170|NCT00580645|20909425|P2|NOT COMPLETED|Overall Study||0
8485171|NCT00580645|20909426|P1|NOT COMPLETED|Overall Study||0
8485172|NCT00580645|20909424|P3|COMPLETED|Overall Study||20
8485173|NCT00580645|20909425|P2|COMPLETED|Overall Study||20
8485174|NCT00580645|20909426|P1|COMPLETED|Overall Study||20
8485175|NCT00580645|20909424|P3|STARTED|Overall Study||20
8485176|NCT00580645|20909425|P2|STARTED|Overall Study||20
8485177|NCT00580645|20909426|P1|STARTED|Overall Study||20
8485178|NCT00580606|20909439|P2|NOT COMPLETED|Open Label (OL)||12
8485179|NCT00580606|20909440|P1|NOT COMPLETED|Open Label (OL)||9
8485180|NCT00580606|20909439|P2|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
8485181|NCT00580606|20909440|P1|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
8485182|NCT00580606|20909439|P2|Had Week 172 Oral Food Challenge|Open Label (OL)||2
8485183|NCT00580606|20909440|P1|Had Week 172 Oral Food Challenge|Open Label (OL)||2
8485184|NCT00580606|20909439|P2|Had Week 164 Oral Food Challenge|Open Label (OL)||5
8485185|NCT00580606|20909440|P1|Had Week 164 Oral Food Challenge|Open Label (OL)||9
8485186|NCT00580606|20909439|P2|Had Week 116 Oral Food Challenge|Open Label (OL)||6
8485187|NCT00580606|20909440|P1|Had Week 116 Oral Food Challenge|Open Label (OL)||13
8485188|NCT00580606|20909439|P2|Had Week 68 Oral Food Challenge|Open Label (OL)||12
8485189|NCT00580606|20909440|P1|Had Week 68 Oral Food Challenge|Open Label (OL)||15
8485190|NCT00580606|20909439|P2|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
8485191|NCT00580606|20909440|P1|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
8485192|NCT00580606|20909439|P2|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
8485193|NCT00580606|20909440|P1|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
8485194|NCT00580606|20909439|P2|NOT COMPLETED|Double Blind (DB)||0
8485195|NCT00580606|20909440|P1|NOT COMPLETED|Double Blind (DB)||0
8485196|NCT00580606|20909439|P2|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
8485197|NCT00580606|20909440|P1|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
8485198|NCT00580606|20909439|P2|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
8485199|NCT00580606|20909440|P1|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
8485200|NCT00580606|20909439|P2|STARTED|Double Blind (DB)||20
8485201|NCT00580606|20909440|P1|STARTED|Double Blind (DB)||20
8485202|NCT00580502|20909458|P1|NOT COMPLETED|Overall Study||0
8485203|NCT00580502|20909458|P1|COMPLETED|Overall Study||50
8485204|NCT00580502|20909458|P1|STARTED|Overall Study||50
8485205|NCT00580398|20909467|P2|NOT COMPLETED|Overall Study||0
8485206|NCT00580398|20909468|P1|NOT COMPLETED|Overall Study||0
8485207|NCT00580398|20909467|P2|COMPLETED|Overall Study||32
8485208|NCT00580398|20909468|P1|COMPLETED|Overall Study||17
8485209|NCT00580398|20909467|P2|STARTED|Overall Study||32
8485210|NCT00580398|20909468|P1|STARTED|Overall Study||17
8485211|NCT00580372|20909476|P1|NOT COMPLETED|Overall Study||0
8485212|NCT00580372|20909476|P1|COMPLETED|Overall Study||231
8485213|NCT00580372|20909476|P1|STARTED|Overall Study||231
8485217|NCT00580294|20909487|P1|NOT COMPLETED|Overall Study||0
8485218|NCT00580294|20909487|P1|COMPLETED|Overall Study||12
8485219|NCT00580294|20909487|P1|STARTED|Overall Study||12
8485220|NCT00580229|20909491|P1|NOT COMPLETED|Overall Study||0
8485221|NCT00580229|20909491|P1|COMPLETED|Overall Study||50
8485222|NCT00580229|20909491|P1|STARTED|Overall Study||50
8485223|NCT00580151|20909499|P2|NOT COMPLETED|Overall Study||0
8485224|NCT00580151|20909500|P1|NOT COMPLETED|Overall Study||0
8485225|NCT00580151|20909499|P2|COMPLETED|Overall Study||0
8485226|NCT00580151|20909500|P1|COMPLETED|Overall Study||9
8485227|NCT00580151|20909499|P2|STARTED|Overall Study||0
8485228|NCT00580151|20909500|P1|STARTED|Overall Study||9
8485229|NCT00580138|20909508|P1|NOT COMPLETED|Overall Study||0
8485230|NCT00580138|20909508|P1|COMPLETED|Overall Study||30
8485231|NCT00580138|20909508|P1|STARTED|Overall Study||30
8485232|NCT00580073|20909512|P1|NOT COMPLETED|Overall Study||0
8485233|NCT00580073|20909512|P1|COMPLETED|Overall Study||6
8485234|NCT00580073|20909512|P1|STARTED|Overall Study||6
8485235|NCT00580047|20909521|P3|NOT COMPLETED|Overall Study||2
8485236|NCT00580047|20909522|P2|NOT COMPLETED|Overall Study||2
8485237|NCT00580047|20909523|P1|NOT COMPLETED|Overall Study||3
8485238|NCT00580047|20909521|P3|COMPLETED|Overall Study||10
8485239|NCT00580047|20909522|P2|COMPLETED|Overall Study||21
8485240|NCT00580047|20909523|P1|COMPLETED|Overall Study||21
8485241|NCT00580047|20909521|P3|STARTED|Overall Study||12
8485242|NCT00580047|20909522|P2|STARTED|Overall Study||23
8485243|NCT00580047|20909523|P1|STARTED|Overall Study||24
8485244|NCT00580034|20909534|P2|NOT COMPLETED|Overall Study||0
8485245|NCT00580034|20909535|P1|NOT COMPLETED|Overall Study||10
8485246|NCT00580034|20909534|P2|COMPLETED|Overall Study||88
8485247|NCT00580034|20909535|P1|COMPLETED|Overall Study||78
8485248|NCT00580034|20909534|P2|STARTED|Overall Study||88
8485249|NCT00580034|20909535|P1|STARTED|Overall Study||88
8485250|NCT00579982|20909541|P1|NOT COMPLETED|Overall Study||8
8485251|NCT00579982|20909541|P1|COMPLETED|Overall Study||89
8485252|NCT00579982|20909541|P1|STARTED|Overall Study||97
8485262|NCT00579826|20909575|P2|NOT COMPLETED|Overall Study||3
8485263|NCT00579826|20909576|P1|NOT COMPLETED|Overall Study||5
8485264|NCT00579826|20909575|P2|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
8485265|NCT00579826|20909576|P1|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
8485266|NCT00579826|20909575|P2|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
8485267|NCT00579826|20909576|P1|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
8485268|NCT00579826|20909575|P2|STARTED|Overall Study||26
8485269|NCT00579826|20909576|P1|STARTED|Overall Study||29
8485270|NCT00579813|20909588|P2|NOT COMPLETED|Overall Study||0
8485271|NCT00579813|20909589|P1|NOT COMPLETED|Overall Study||0
8485272|NCT00579813|20909588|P2|COMPLETED|Overall Study||10
8485273|NCT00579813|20909589|P1|COMPLETED|Overall Study||60
8485274|NCT00579813|20909588|P2|STARTED|Overall Study||10
8485275|NCT00579813|20909589|P1|STARTED|Overall Study||60
8485301|NCT00579527|20909826|P1|NOT COMPLETED|Overall Study||4
8485302|NCT00579527|20909826|P1|COMPLETED|Overall Study||10
8485303|NCT00579527|20909826|P1|STARTED|Overall Study||14
8485304|NCT00579501|20909838|P1|NOT COMPLETED|Overall Study||29
8485305|NCT00579501|20909838|P1|COMPLETED|Overall Study||0
8485306|NCT00579501|20909838|P1|STARTED|Overall Study||29
8485307|NCT00579436|20909845|P2|NOT COMPLETED|Overall Study||0
8485308|NCT00579436|20909846|P1|NOT COMPLETED|Overall Study||0
8485309|NCT00579436|20909845|P2|COMPLETED|Overall Study||14
8485310|NCT00579436|20909846|P1|COMPLETED|Overall Study||19
8485311|NCT00579436|20909845|P2|STARTED|Overall Study||14
8485312|NCT00579436|20909846|P1|STARTED|Overall Study||19
8485313|NCT00579345|20909866|P8|NOT COMPLETED|Overall Study||2
8485314|NCT00579345|20909867|P7|NOT COMPLETED|Overall Study||0
8485315|NCT00579345|20909868|P6|NOT COMPLETED|Overall Study||0
8485316|NCT00579345|20909869|P5|NOT COMPLETED|Overall Study||0
8485317|NCT00579345|20909870|P4|NOT COMPLETED|Overall Study||1
8485318|NCT00579345|20909871|P3|NOT COMPLETED|Overall Study||2
8485319|NCT00579345|20909872|P2|NOT COMPLETED|Overall Study||1
8485320|NCT00579345|20909873|P1|NOT COMPLETED|Overall Study||5
8485321|NCT00579345|20909866|P8|COMPLETED|Overall Study||42
8485322|NCT00579345|20909867|P7|COMPLETED|Overall Study||57
8485323|NCT00579345|20909868|P6|COMPLETED|Overall Study||78
8485324|NCT00579345|20909869|P5|COMPLETED|Overall Study||90
8485325|NCT00579345|20909870|P4|COMPLETED|Overall Study||143
8485326|NCT00579345|20909871|P3|COMPLETED|Overall Study||389
8485327|NCT00579345|20909872|P2|COMPLETED|Overall Study||168
8485328|NCT00579345|20909873|P1|COMPLETED|Overall Study||544
8485329|NCT00579345|20909866|P8|STARTED|Overall Study||44
8485330|NCT00579345|20909867|P7|STARTED|Overall Study||57
8485331|NCT00579345|20909868|P6|STARTED|Overall Study||78
8485332|NCT00579345|20909869|P5|STARTED|Overall Study||90
8485333|NCT00579345|20909870|P4|STARTED|Overall Study||144
8485334|NCT00579345|20909871|P3|STARTED|Overall Study||391
8485335|NCT00579345|20909872|P2|STARTED|Overall Study||169
8485336|NCT00579345|20909873|P1|STARTED|Overall Study||549
8485337|NCT00579280|20909908|P3|NOT COMPLETED|Overall Study||0
8485338|NCT00579280|20909909|P2|NOT COMPLETED|Overall Study||3
8485339|NCT00579280|20909910|P1|NOT COMPLETED|Overall Study||2
8485340|NCT00579280|20909908|P3|COMPLETED|Overall Study|LOCF evaluable sample|51
8485341|NCT00579280|20909909|P2|COMPLETED|Overall Study|LOCF evaluable sample|46
8485342|NCT00579280|20909910|P1|COMPLETED|Overall Study|LOCF evaluable sample|47
8485343|NCT00579280|20909908|P3|STARTED|Overall Study||51
8485344|NCT00579280|20909909|P2|STARTED|Overall Study||49
8485345|NCT00579280|20909910|P1|STARTED|Overall Study||49
8485346|NCT00579137|20909948|P1|NOT COMPLETED|Overall Study||0
8485347|NCT00579137|20909948|P1|COMPLETED|Overall Study||3
8485348|NCT00579137|20909948|P1|STARTED|Overall Study||3
8485349|NCT00579111|20909957|P2|NOT COMPLETED|Overall Study||1
8485350|NCT00579111|20909958|P1|NOT COMPLETED|Overall Study||2
8485351|NCT00579111|20909957|P2|COMPLETED|Overall Study||0
8485352|NCT00579111|20909958|P1|COMPLETED|Overall Study||1
8485353|NCT00579111|20909957|P2|STARTED|Overall Study||1
8485354|NCT00579111|20909958|P1|STARTED|Overall Study||3
8485355|NCT00579098|20909968|P2|NOT COMPLETED|Overall Study||8
8485356|NCT00579098|20909969|P1|NOT COMPLETED|Overall Study||9
8485357|NCT00579098|20909968|P2|COMPLETED|Overall Study||55
8485358|NCT00579098|20909969|P1|COMPLETED|Overall Study||53
8485359|NCT00579098|20909968|P2|STARTED|Overall Study||63
8485360|NCT00579098|20909969|P1|STARTED|Overall Study||62
8485361|NCT00579059|20909985|P2|NOT COMPLETED|Overall Study||10
8485362|NCT00579059|20909986|P1|NOT COMPLETED|Overall Study||21
8485363|NCT00579059|20909985|P2|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
8485447|NCT00578786|20910166|P2|COMPLETED|Overall Study||124
8485364|NCT00579059|20909986|P1|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
8485365|NCT00579059|20909985|P2|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
8485366|NCT00579059|20909986|P1|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
8485367|NCT00579059|20909985|P2|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
8485368|NCT00579059|20909986|P1|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
8485369|NCT00579059|20909985|P2|1 Year|Overall Study|7 patients didn't return for follow-up.|3
8485370|NCT00579059|20909986|P1|1 Year|Overall Study|13 patients didn't return for follow-up.|8
8485371|NCT00579059|20909985|P2|6 Months|Overall Study|6 patients didn't return for follow-up.|4
8485372|NCT00579059|20909986|P1|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
8485373|NCT00579059|20909985|P2|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
8485374|NCT00579059|20909986|P1|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
8485375|NCT00579059|20909985|P2|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
8485376|NCT00579059|20909986|P1|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
8485377|NCT00578968|20909997|P3|NOT COMPLETED|Intervention||0
8485378|NCT00578968|20909998|P2|NOT COMPLETED|Intervention||0
8485379|NCT00578968|20909999|P1|NOT COMPLETED|Intervention||0
8485380|NCT00578968|20909997|P3|COMPLETED|Intervention||0
8485381|NCT00578968|20909998|P2|COMPLETED|Intervention||12
8485382|NCT00578968|20909999|P1|COMPLETED|Intervention||12
8485383|NCT00578968|20909997|P3|STARTED|Intervention||0
8485384|NCT00578968|20909998|P2|STARTED|Intervention||12
8485385|NCT00578968|20909999|P1|STARTED|Intervention||12
8485386|NCT00578968|20909997|P3|NOT COMPLETED|Baseline (Prior to Intervention)||0
8485387|NCT00578968|20909998|P2|NOT COMPLETED|Baseline (Prior to Intervention)||0
8485388|NCT00578968|20909999|P1|NOT COMPLETED|Baseline (Prior to Intervention)||0
8485389|NCT00578968|20909997|P3|COMPLETED|Baseline (Prior to Intervention)||12
8485390|NCT00578968|20909998|P2|COMPLETED|Baseline (Prior to Intervention)||12
8485391|NCT00578968|20909999|P1|COMPLETED|Baseline (Prior to Intervention)||12
8485392|NCT00578968|20909997|P3|STARTED|Baseline (Prior to Intervention)||12
8485393|NCT00578968|20909998|P2|STARTED|Baseline (Prior to Intervention)||12
8485394|NCT00578968|20909999|P1|STARTED|Baseline (Prior to Intervention)||12
8485395|NCT00578942|20910060|P1|NOT COMPLETED|Overall Study||1
8485396|NCT00578942|20910060|P1|COMPLETED|Overall Study||47
8485397|NCT00578942|20910060|P1|STARTED|Overall Study||48
8485398|NCT00578929|20910070|P4|NOT COMPLETED|Randomized Period||14
8485399|NCT00578929|20910071|P3|NOT COMPLETED|Randomized Period||8
8485400|NCT00578929|20910072|P2|NOT COMPLETED|Randomized Period||14
8485401|NCT00578929|20910073|P1|NOT COMPLETED|Randomized Period||17
8485402|NCT00578929|20910070|P4|COMPLETED|Randomized Period||283
8485403|NCT00578929|20910071|P3|COMPLETED|Randomized Period||288
8485404|NCT00578929|20910072|P2|COMPLETED|Randomized Period||283
8485405|NCT00578929|20910073|P1|COMPLETED|Randomized Period||281
8485406|NCT00578929|20910070|P4|STARTED|Randomized Period||297
8485407|NCT00578929|20910071|P3|STARTED|Randomized Period||296
8485408|NCT00578929|20910072|P2|STARTED|Randomized Period||297
8485409|NCT00578929|20910073|P1|STARTED|Randomized Period||298
8485410|NCT00578929|20910070|P4|NOT COMPLETED|Vehicle Run-In Period||0
8485411|NCT00578929|20910071|P3|NOT COMPLETED|Vehicle Run-In Period||0
8485412|NCT00578929|20910072|P2|NOT COMPLETED|Vehicle Run-In Period||0
8485413|NCT00578929|20910073|P1|NOT COMPLETED|Vehicle Run-In Period||0
8485414|NCT00578929|20910070|P4|COMPLETED|Vehicle Run-In Period||0
8485415|NCT00578929|20910071|P3|COMPLETED|Vehicle Run-In Period||0
8485416|NCT00578929|20910072|P2|COMPLETED|Vehicle Run-In Period||2388
8485417|NCT00578929|20910073|P1|COMPLETED|Vehicle Run-In Period||0
8485418|NCT00578929|20910070|P4|STARTED|Vehicle Run-In Period||0
8485419|NCT00578929|20910071|P3|STARTED|Vehicle Run-In Period||0
8485420|NCT00578929|20910072|P2|STARTED|Vehicle Run-In Period||2388
8485421|NCT00578929|20910073|P1|STARTED|Vehicle Run-In Period||0
8485422|NCT00578903|20910088|P1|NOT COMPLETED|Overall Study||0
8485423|NCT00578903|20910088|P1|COMPLETED|Overall Study||22
8485424|NCT00578903|20910088|P1|STARTED|Overall Study||22
8485425|NCT00578877|20910099|P2|NOT COMPLETED|Overall Study||128
8485426|NCT00578877|20910100|P1|NOT COMPLETED|Overall Study||81
8485427|NCT00578877|20910099|P2|COMPLETED|Overall Study||172
8485428|NCT00578877|20910100|P1|COMPLETED|Overall Study||69
8485429|NCT00578877|20910099|P2|STARTED|Overall Study||300
8485430|NCT00578877|20910100|P1|STARTED|Overall Study||150
8485431|NCT00578864|20910108|P2|NOT COMPLETED|Overall Study||0
8485432|NCT00578864|20910109|P1|NOT COMPLETED|Overall Study||1
8485433|NCT00578864|20910108|P2|COMPLETED|Overall Study||6
8485434|NCT00578864|20910109|P1|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
8485435|NCT00578864|20910108|P2|STARTED|Overall Study||6
8485436|NCT00578864|20910109|P1|STARTED|Overall Study||7
8485437|NCT00578812|20910125|P2|NOT COMPLETED|Overall Study||7
8485438|NCT00578812|20910126|P1|NOT COMPLETED|Overall Study||6
8485439|NCT00578812|20910125|P2|COMPLETED|Overall Study||185
8485440|NCT00578812|20910126|P1|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
8485441|NCT00578812|20910125|P2|STARTED|Overall Study||192
8485442|NCT00578812|20910126|P1|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
8485443|NCT00578786|20910165|P3|NOT COMPLETED|Overall Study||30
8485444|NCT00578786|20910166|P2|NOT COMPLETED|Overall Study||66
8485445|NCT00578786|20910167|P1|NOT COMPLETED|Overall Study||39
8485446|NCT00578786|20910165|P3|COMPLETED|Overall Study||67
8485448|NCT00578786|20910167|P1|COMPLETED|Overall Study||57
8485449|NCT00578786|20910165|P3|STARTED|Overall Study||97
8485450|NCT00578786|20910166|P2|STARTED|Overall Study||190
8485451|NCT00578786|20910167|P1|STARTED|Overall Study||96
8485452|NCT00578734|20910248|P2|NOT COMPLETED|Overall Study||0
8485453|NCT00578734|20910249|P1|NOT COMPLETED|Overall Study||0
8485454|NCT00578734|20910248|P2|COMPLETED|Overall Study||81
8485455|NCT00578734|20910249|P1|COMPLETED|Overall Study||84
8485456|NCT00578734|20910248|P2|STARTED|Overall Study||81
8485457|NCT00578734|20910249|P1|STARTED|Overall Study||84
8485458|NCT00578669|20910259|P2|NOT COMPLETED|Overall Study||0
8485459|NCT00578669|20910260|P1|NOT COMPLETED|Overall Study||0
8485460|NCT00578669|20910259|P2|COMPLETED|Overall Study||99
8485461|NCT00578669|20910260|P1|COMPLETED|Overall Study||107
8485462|NCT00578669|20910259|P2|STARTED|Overall Study||99
8485463|NCT00578669|20910260|P1|STARTED|Overall Study||107
8485464|NCT00578643|20910268|P1|NOT COMPLETED|Overall Study||2
8485465|NCT00578643|20910268|P1|COMPLETED|Overall Study||13
8485466|NCT00578643|20910268|P1|STARTED|Overall Study||15
8485467|NCT00578617|20910277|P2|NOT COMPLETED|Overall Study||0
8485468|NCT00578617|20910278|P1|NOT COMPLETED|Overall Study||0
8485469|NCT00578617|20910277|P2|COMPLETED|Overall Study||29
8485470|NCT00578617|20910278|P1|COMPLETED|Overall Study||31
8485471|NCT00578617|20910277|P2|STARTED|Overall Study||29
8485472|NCT00578617|20910278|P1|STARTED|Overall Study||31
8485473|NCT00578565|20910284|P1|NOT COMPLETED|Overall Study||3
8485474|NCT00578565|20910284|P1|COMPLETED|Overall Study||7
8485475|NCT00578565|20910284|P1|STARTED|Overall Study||10
8485476|NCT00578552|20910296|P3|NOT COMPLETED|Overall Study||15
8485477|NCT00578552|20910297|P2|NOT COMPLETED|Overall Study||14
8485478|NCT00578552|20910298|P1|NOT COMPLETED|Overall Study||15
8485479|NCT00578552|20910296|P3|COMPLETED|Overall Study||11
8485480|NCT00578552|20910297|P2|COMPLETED|Overall Study||13
8485481|NCT00578552|20910298|P1|COMPLETED|Overall Study||12
8485482|NCT00578552|20910296|P3|STARTED|Overall Study||26
8485483|NCT00578552|20910297|P2|STARTED|Overall Study||27
8485484|NCT00578552|20910298|P1|STARTED|Overall Study||27
8485485|NCT00578539|20910306|P1|NOT COMPLETED|Overall Study||0
8485486|NCT00578539|20910306|P1|COMPLETED|Overall Study||24
8485487|NCT00578539|20910306|P1|STARTED|Overall Study||24
8485488|NCT00578461|20910310|P1|NOT COMPLETED|Overall Study||0
8485489|NCT00578461|20910310|P1|COMPLETED|Overall Study||26
8485490|NCT00578461|20910310|P1|STARTED|Overall Study||26
8485491|NCT00578448|20910314|P1|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
8485492|NCT00578448|20910314|P1|COMPLETED|1 Year Long Term Extension (LTE)||8
8485493|NCT00578448|20910314|P1|STARTED|1 Year Long Term Extension (LTE)||9
8485494|NCT00578448|20910314|P1|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
8485495|NCT00578448|20910314|P1|COMPLETED|Day 1 up to 3 Years of Planned Study||9
8485496|NCT00578448|20910314|P1|STARTED|Day 1 up to 3 Years of Planned Study||12
8485497|NCT00578383|20910332|P4|NOT COMPLETED|Overall Study||6
8485498|NCT00578383|20910333|P3|NOT COMPLETED|Overall Study||6
8485499|NCT00578383|20910334|P2|NOT COMPLETED|Overall Study||16
8485500|NCT00578383|20910335|P1|NOT COMPLETED|Overall Study||16
8485501|NCT00578383|20910332|P4|COMPLETED|Overall Study||9
8485502|NCT00578383|20910333|P3|COMPLETED|Overall Study||13
8485503|NCT00578383|20910334|P2|COMPLETED|Overall Study||20
8485504|NCT00578383|20910335|P1|COMPLETED|Overall Study||21
8485505|NCT00578383|20910332|P4|STARTED|Overall Study||15
8485506|NCT00578383|20910333|P3|STARTED|Overall Study||19
8485507|NCT00578383|20910334|P2|STARTED|Overall Study||36
8485508|NCT00578383|20910335|P1|STARTED|Overall Study||37
8485509|NCT00578344|20910365|P1|NOT COMPLETED|Overall Study||2
8485510|NCT00578344|20910365|P1|COMPLETED|Overall Study||6
8485511|NCT00578344|20910365|P1|STARTED|Overall Study||8
8485512|NCT00578331|20910373|P2|NOT COMPLETED|Overall Study||125
8485513|NCT00578331|20910374|P1|NOT COMPLETED|Overall Study||116
8485514|NCT00578331|20910373|P2|COMPLETED|Overall Study||320
8485515|NCT00578331|20910374|P1|COMPLETED|Overall Study||329
8485516|NCT00578331|20910373|P2|STARTED|Overall Study||445
8485517|NCT00578331|20910374|P1|STARTED|Overall Study||445
8485518|NCT00578318|20910384|P2|NOT COMPLETED|Overall Study||0
8485519|NCT00578318|20910385|P1|NOT COMPLETED|Overall Study||3
8485520|NCT00578318|20910384|P2|COMPLETED|Overall Study||8
8485521|NCT00578318|20910385|P1|COMPLETED|Overall Study||5
8485522|NCT00578318|20910384|P2|STARTED|Overall Study||8
8485523|NCT00578318|20910385|P1|STARTED|Overall Study||8
8485524|NCT00578305|20910394|P3|NOT COMPLETED|Safety Follow-up Phase||46
8485525|NCT00578305|20910395|P2|NOT COMPLETED|Safety Follow-up Phase||45
8485526|NCT00578305|20910396|P1|NOT COMPLETED|Safety Follow-up Phase||46
8485527|NCT00578305|20910394|P3|COMPLETED|Safety Follow-up Phase||8
8485528|NCT00578305|20910395|P2|COMPLETED|Safety Follow-up Phase||9
8485529|NCT00578305|20910396|P1|COMPLETED|Safety Follow-up Phase||11
8485530|NCT00578305|20910394|P3|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
8485531|NCT00578305|20910395|P2|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
8485532|NCT00578305|20910396|P1|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
8485533|NCT00578305|20910394|P3|NOT COMPLETED|Extension Phase||3
8485534|NCT00578305|20910395|P2|NOT COMPLETED|Extension Phase||1
8485535|NCT00578305|20910396|P1|NOT COMPLETED|Extension Phase||4
8485536|NCT00578305|20910394|P3|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
8485537|NCT00578305|20910395|P2|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
8485538|NCT00578305|20910396|P1|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
8485539|NCT00578305|20910394|P3|STARTED|Extension Phase||43
8485540|NCT00578305|20910395|P2|STARTED|Extension Phase||50
8485541|NCT00578305|20910396|P1|STARTED|Extension Phase||53
8485542|NCT00578305|20910394|P3|NOT COMPLETED|Double-blind Treatment Phase||14
8485543|NCT00578305|20910395|P2|NOT COMPLETED|Double-blind Treatment Phase||4
8485544|NCT00578305|20910396|P1|NOT COMPLETED|Double-blind Treatment Phase||3
8485545|NCT00578305|20910394|P3|COMPLETED|Double-blind Treatment Phase||49
8485546|NCT00578305|20910395|P2|COMPLETED|Double-blind Treatment Phase||56
8485547|NCT00578305|20910396|P1|COMPLETED|Double-blind Treatment Phase||59
8485548|NCT00578305|20910394|P3|Treated|Double-blind Treatment Phase||63
8485549|NCT00578305|20910395|P2|Treated|Double-blind Treatment Phase||60
8485550|NCT00578305|20910396|P1|Treated|Double-blind Treatment Phase||62
8485551|NCT00578305|20910394|P3|STARTED|Double-blind Treatment Phase||63
8485552|NCT00578305|20910395|P2|STARTED|Double-blind Treatment Phase||60
8485553|NCT00578305|20910396|P1|STARTED|Double-blind Treatment Phase||62
8485554|NCT00578292|20910455|P1|NOT COMPLETED|Overall Study||3
8485555|NCT00578292|20910455|P1|COMPLETED|Overall Study||7
8485556|NCT00578292|20910455|P1|STARTED|Overall Study||10
8485557|NCT00578279|20910469|P2|NOT COMPLETED|Overall Study||0
8485558|NCT00578279|20910470|P1|NOT COMPLETED|Overall Study||0
8485559|NCT00578279|20910469|P2|COMPLETED|Overall Study||10
8485560|NCT00578279|20910470|P1|COMPLETED|Overall Study||10
8485561|NCT00578279|20910469|P2|STARTED|Overall Study||10
8485562|NCT00578279|20910470|P1|STARTED|Overall Study||10
8485563|NCT00578227|20910479|P3|NOT COMPLETED|Overall Study||4
8485564|NCT00578227|20910480|P2|NOT COMPLETED|Overall Study||2
8485565|NCT00578227|20910481|P1|NOT COMPLETED|Overall Study||5
8485566|NCT00578227|20910479|P3|COMPLETED|Overall Study||267
8485567|NCT00578227|20910480|P2|COMPLETED|Overall Study||268
8485568|NCT00578227|20910481|P1|COMPLETED|Overall Study||267
8485569|NCT00578227|20910479|P3|STARTED|Overall Study||271
8485570|NCT00578227|20910480|P2|STARTED|Overall Study||270
8485571|NCT00578227|20910481|P1|STARTED|Overall Study||272
8485572|NCT00578214|20910554|P3|NOT COMPLETED|Overall Study||0
8485573|NCT00578214|20910555|P2|NOT COMPLETED|Overall Study||0
8485574|NCT00578214|20910556|P1|NOT COMPLETED|Overall Study||0
8485575|NCT00578214|20910554|P3|COMPLETED|Overall Study||31
8485576|NCT00578214|20910555|P2|COMPLETED|Overall Study||22
8485577|NCT00578214|20910556|P1|COMPLETED|Overall Study||22
8485578|NCT00578214|20910554|P3|STARTED|Overall Study||31
8485579|NCT00578214|20910555|P2|STARTED|Overall Study||22
8485580|NCT00578214|20910556|P1|STARTED|Overall Study||22
8485581|NCT00578175|20910606|P3|NOT COMPLETED|Overall Study||24
8485582|NCT00578175|20910607|P2|NOT COMPLETED|Overall Study||43
8485583|NCT00578175|20910608|P1|NOT COMPLETED|Overall Study||70
8485584|NCT00578175|20910606|P3|COMPLETED|Overall Study||365
8485585|NCT00578175|20910607|P2|COMPLETED|Overall Study||646
8485586|NCT00578175|20910608|P1|COMPLETED|Overall Study||635
8485587|NCT00578175|20910606|P3|STARTED|Overall Study||389
8485588|NCT00578175|20910607|P2|STARTED|Overall Study||689
8485589|NCT00578175|20910608|P1|STARTED|Overall Study||705
8485590|NCT00578136|20910687|P2|NOT COMPLETED|Overall Study||1
8485591|NCT00578136|20910688|P1|NOT COMPLETED|Overall Study||1
8485592|NCT00578136|20910687|P2|COMPLETED|Overall Study||26
8485593|NCT00578136|20910688|P1|COMPLETED|Overall Study||26
8485594|NCT00578136|20910687|P2|STARTED|Overall Study||27
8485595|NCT00578136|20910688|P1|STARTED|Overall Study||27
8485596|NCT00578071|20910696|P1|NOT COMPLETED|Overall Study||0
8485597|NCT00578071|20910696|P1|COMPLETED|Overall Study||29
8485598|NCT00578071|20910696|P1|STARTED|Overall Study||29
8485599|NCT00577993|20910706|P3|NOT COMPLETED|Overall Study||3
8485600|NCT00577993|20910707|P2|NOT COMPLETED|Overall Study||10
8485601|NCT00577993|20910708|P1|NOT COMPLETED|Overall Study||7
8485602|NCT00577993|20910706|P3|COMPLETED|Overall Study||32
8485603|NCT00577993|20910707|P2|COMPLETED|Overall Study||80
8485604|NCT00577993|20910708|P1|COMPLETED|Overall Study||78
8485605|NCT00577993|20910706|P3|STARTED|Overall Study||35
8485606|NCT00577993|20910707|P2|STARTED|Overall Study||90
8485607|NCT00577993|20910708|P1|STARTED|Overall Study||85
8485608|NCT00577889|20910719|P3|NOT COMPLETED|Overall Study||0
8485609|NCT00577889|20910720|P2|NOT COMPLETED|Overall Study||0
8485610|NCT00577889|20910721|P1|NOT COMPLETED|Overall Study||1
8485611|NCT00577889|20910719|P3|COMPLETED|Overall Study||6
8485612|NCT00577889|20910720|P2|COMPLETED|Overall Study||6
8485613|NCT00577889|20910721|P1|COMPLETED|Overall Study||8
8485614|NCT00577889|20910719|P3|STARTED|Overall Study||6
8485615|NCT00577889|20910720|P2|STARTED|Overall Study||6
8485616|NCT00577889|20910721|P1|STARTED|Overall Study||9
8485617|NCT00577863|20910740|P2|NOT COMPLETED|Overall Study||14
8485618|NCT00577863|20910741|P1|NOT COMPLETED|Overall Study||10
8485619|NCT00577863|20910740|P2|COMPLETED|Overall Study||94
8485620|NCT00577863|20910741|P1|COMPLETED|Overall Study||82
8485621|NCT00577863|20910740|P2|Received at Least One Injection|Overall Study||107
8485622|NCT00577863|20910741|P1|Received at Least One Injection|Overall Study||92
8485623|NCT00577863|20910740|P2|STARTED|Overall Study||108
8485624|NCT00577863|20910741|P1|STARTED|Overall Study||92
8485625|NCT00577824|20910783|P3|NOT COMPLETED|Overall Study||2
8485626|NCT00577824|20910784|P2|NOT COMPLETED|Overall Study||20
8485627|NCT00577824|20910785|P1|NOT COMPLETED|Overall Study||7
8485628|NCT00577824|20910783|P3|COMPLETED|Overall Study||34
8485629|NCT00577824|20910784|P2|COMPLETED|Overall Study||53
8485630|NCT00577824|20910785|P1|COMPLETED|Overall Study||65
8485631|NCT00577824|20910783|P3|Full Analysis Set|Overall Study||35
8485632|NCT00577824|20910784|P2|Full Analysis Set|Overall Study||72
8485633|NCT00577824|20910785|P1|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
8485634|NCT00577824|20910783|P3|STARTED|Overall Study||36
8485635|NCT00577824|20910784|P2|STARTED|Overall Study||73
8485636|NCT00577824|20910785|P1|STARTED|Overall Study|Started=Randomized|72
8485637|NCT00577772|20910843|P2|NOT COMPLETED|Overall Study||1
8485638|NCT00577772|20910844|P1|NOT COMPLETED|Overall Study||0
8485639|NCT00577772|20910843|P2|COMPLETED|Overall Study||6
8485640|NCT00577772|20910844|P1|COMPLETED|Overall Study||10
8485641|NCT00577772|20910843|P2|STARTED|Overall Study||7
8485642|NCT00577772|20910844|P1|STARTED|Overall Study||10
8485643|NCT00577720|20910854|P4|NOT COMPLETED|Overall Study||7
8485644|NCT00577720|20910855|P3|NOT COMPLETED|Overall Study||1
8485645|NCT00577720|20910856|P2|NOT COMPLETED|Overall Study||1
8485646|NCT00577720|20910857|P1|NOT COMPLETED|Overall Study||4
8485647|NCT00577720|20910854|P4|COMPLETED|Overall Study||65
8485648|NCT00577720|20910855|P3|COMPLETED|Overall Study||35
8485649|NCT00577720|20910856|P2|COMPLETED|Overall Study||35
8485650|NCT00577720|20910857|P1|COMPLETED|Overall Study||33
8485651|NCT00577720|20910854|P4|ITT (Intent to Treat) Population|Overall Study||65
8485652|NCT00577720|20910855|P3|ITT (Intent to Treat) Population|Overall Study||35
8485653|NCT00577720|20910856|P2|ITT (Intent to Treat) Population|Overall Study||35
8485654|NCT00577720|20910857|P1|ITT (Intent to Treat) Population|Overall Study||34
8485655|NCT00577720|20910854|P4|STARTED|Overall Study||72
8485656|NCT00577720|20910855|P3|STARTED|Overall Study||36
8485657|NCT00577720|20910856|P2|STARTED|Overall Study||36
8485658|NCT00577720|20910857|P1|STARTED|Overall Study||37
8485659|NCT00577707|20910875|P1|NOT COMPLETED|Overall Study||3
8485660|NCT00577707|20910875|P1|COMPLETED|Overall Study||6
8485661|NCT00577707|20910875|P1|STARTED|Overall Study||9
8485662|NCT00577655|20910883|P2|NOT COMPLETED|Overall Study||4
8485663|NCT00577655|20910884|P1|NOT COMPLETED|Overall Study||1
8485664|NCT00577655|20910883|P2|COMPLETED|Overall Study||47
8485665|NCT00577655|20910884|P1|COMPLETED|Overall Study||51
8485666|NCT00577655|20910883|P2|STARTED|Overall Study|This number represents the number of participants randomized.|51
8485667|NCT00577655|20910884|P1|STARTED|Overall Study|This number represents the number of participants randomized.|52
8485668|NCT00577642|20910922|P1|NOT COMPLETED|Overall Study||1
8485669|NCT00577642|20910922|P1|COMPLETED|Overall Study||28
8485670|NCT00577642|20910922|P1|STARTED|Overall Study||29
8485671|NCT00577629|20910926|P1|NOT COMPLETED|Long Term Follow-Up||25
8485672|NCT00577629|20910926|P1|COMPLETED|Long Term Follow-Up||13
8485673|NCT00577629|20910926|P1|STARTED|Long Term Follow-Up||38
8485674|NCT00577629|20910926|P1|NOT COMPLETED|Treatment Period||1
8485675|NCT00577629|20910926|P1|COMPLETED|Treatment Period||38
8485676|NCT00577629|20910926|P1|STARTED|Treatment Period||39
8485677|NCT00577590|20910937|P3|NOT COMPLETED|Overall Study||0
8485678|NCT00577590|20910938|P2|NOT COMPLETED|Overall Study||0
8485679|NCT00577590|20910939|P1|NOT COMPLETED|Overall Study||0
8485680|NCT00577590|20910937|P3|COMPLETED|Overall Study||23
8485681|NCT00577590|20910938|P2|COMPLETED|Overall Study||27
8485682|NCT00577590|20910939|P1|COMPLETED|Overall Study||28
8485683|NCT00577590|20910937|P3|STARTED|Overall Study||23
8485684|NCT00577590|20910938|P2|STARTED|Overall Study||27
8485685|NCT00577590|20910939|P1|STARTED|Overall Study||28
8485686|NCT00577512|20910947|P1|NOT COMPLETED|Overall Study||4
8485687|NCT00577512|20910947|P1|COMPLETED|Overall Study||0
8485688|NCT00577512|20910947|P1|STARTED|Overall Study||4
8485689|NCT00577473|20910953|P2|NOT COMPLETED|Overall Study||24
8485690|NCT00577473|20910954|P1|NOT COMPLETED|Overall Study||21
8485691|NCT00577473|20910953|P2|COMPLETED|Overall Study||123
8485692|NCT00577473|20910954|P1|COMPLETED|Overall Study||133
8485693|NCT00577473|20910953|P2|ITT Population|Overall Study||136
8485694|NCT00577473|20910954|P1|ITT Population|Overall Study||150
8485695|NCT00577473|20910953|P2|STARTED|Overall Study||147
8485696|NCT00577473|20910954|P1|STARTED|Overall Study||154
8485697|NCT00577460|20910985|P3|NOT COMPLETED|Overall Study||27
8485698|NCT00577460|20910986|P2|NOT COMPLETED|Overall Study||19
8485699|NCT00577460|20910987|P1|NOT COMPLETED|Overall Study||16
8485700|NCT00577460|20910985|P3|COMPLETED|Overall Study||112
8485701|NCT00577460|20910986|P2|COMPLETED|Overall Study||104
8485702|NCT00577460|20910987|P1|COMPLETED|Overall Study||113
8485703|NCT00577460|20910985|P3|STARTED|Overall Study||139
8485704|NCT00577460|20910986|P2|STARTED|Overall Study||123
8485705|NCT00577460|20910987|P1|STARTED|Overall Study||129
8485706|NCT00577408|20911096|P2|NOT COMPLETED|Overall Study||23
8485707|NCT00577408|20911097|P1|NOT COMPLETED|Overall Study||12
8485708|NCT00577408|20911096|P2|COMPLETED|Overall Study||9
8485709|NCT00577408|20911097|P1|COMPLETED|Overall Study||16
8485710|NCT00577408|20911096|P2|STARTED|Overall Study||32
8485711|NCT00577408|20911097|P1|STARTED|Overall Study||28
8485712|NCT00577395|20911105|P2|NOT COMPLETED|Overall Study||6
8485713|NCT00577395|20911106|P1|NOT COMPLETED|Overall Study||7
8485714|NCT00577395|20911105|P2|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
8485715|NCT00577395|20911106|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
8485716|NCT00577395|20911105|P2|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
8485800|NCT00576927|20911351|P1|COMPLETED|Clinical Assessment||43
8485717|NCT00577395|20911106|P1|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
8485718|NCT00577382|20911116|P2|NOT COMPLETED|Overall Study||31
8485719|NCT00577382|20911117|P1|NOT COMPLETED|Overall Study||21
8485720|NCT00577382|20911116|P2|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
8485721|NCT00577382|20911117|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
8485722|NCT00577382|20911116|P2|STARTED|Overall Study||31
8485723|NCT00577382|20911117|P1|STARTED|Overall Study||21
8485724|NCT00577356|20911129|P1|NOT COMPLETED|Overall Study||0
8485725|NCT00577356|20911129|P1|COMPLETED|Overall Study||6
8485726|NCT00577356|20911129|P1|STARTED|Overall Study||6
8485727|NCT00577135|20911137|P4|NOT COMPLETED|Overall Study||0
8485728|NCT00577135|20911138|P3|NOT COMPLETED|Overall Study||0
8485729|NCT00577135|20911139|P2|NOT COMPLETED|Overall Study||0
8485730|NCT00577135|20911140|P1|NOT COMPLETED|Overall Study||0
8485731|NCT00577135|20911137|P4|COMPLETED|Overall Study||75
8485732|NCT00577135|20911138|P3|COMPLETED|Overall Study||77
8485733|NCT00577135|20911139|P2|COMPLETED|Overall Study||82
8485734|NCT00577135|20911140|P1|COMPLETED|Overall Study||74
8485735|NCT00577135|20911137|P4|STARTED|Overall Study||75
8485736|NCT00577135|20911138|P3|STARTED|Overall Study||77
8485737|NCT00577135|20911139|P2|STARTED|Overall Study||82
8485738|NCT00577135|20911140|P1|STARTED|Overall Study||74
8485739|NCT00577122|20911260|P2|NOT COMPLETED|Overall Study||16
8485740|NCT00577122|20911261|P1|NOT COMPLETED|Overall Study||14
8485741|NCT00577122|20911260|P2|COMPLETED|Overall Study||0
8485742|NCT00577122|20911261|P1|COMPLETED|Overall Study||0
8485743|NCT00577122|20911260|P2|STARTED|Overall Study||16
8485744|NCT00577122|20911261|P1|STARTED|Overall Study||14
8485745|NCT00577096|20911275|P2|NOT COMPLETED|Long Term Participation||0
8485746|NCT00577096|20911276|P1|NOT COMPLETED|Long Term Participation||0
8485747|NCT00577096|20911275|P2|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
8485748|NCT00577096|20911276|P1|COMPLETED|Long Term Participation||34
8485749|NCT00577096|20911275|P2|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
8485750|NCT00577096|20911276|P1|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
8485751|NCT00577096|20911275|P2|NOT COMPLETED|Short Term Participation||8
8485752|NCT00577096|20911276|P1|NOT COMPLETED|Short Term Participation||7
8485753|NCT00577096|20911275|P2|COMPLETED|Short Term Participation||58
8485754|NCT00577096|20911276|P1|COMPLETED|Short Term Participation||62
8485755|NCT00577096|20911275|P2|STARTED|Short Term Participation||66
8485756|NCT00577096|20911276|P1|STARTED|Short Term Participation||69
8485757|NCT00577083|20911302|P2|NOT COMPLETED|Second Intervention (14days)||0
8485758|NCT00577083|20911303|P1|NOT COMPLETED|Second Intervention (14days)||0
8485759|NCT00577083|20911302|P2|COMPLETED|Second Intervention (14days)||52
8485760|NCT00577083|20911303|P1|COMPLETED|Second Intervention (14days)||48
8485761|NCT00577083|20911302|P2|STARTED|Second Intervention (14days)||52
8485762|NCT00577083|20911303|P1|STARTED|Second Intervention (14days)||48
8485763|NCT00577083|20911302|P2|NOT COMPLETED|Washout (14 Days)||0
8485764|NCT00577083|20911303|P1|NOT COMPLETED|Washout (14 Days)||0
8485765|NCT00577083|20911302|P2|COMPLETED|Washout (14 Days)||52
8485766|NCT00577083|20911303|P1|COMPLETED|Washout (14 Days)||48
8485767|NCT00577083|20911302|P2|STARTED|Washout (14 Days)||52
8485768|NCT00577083|20911303|P1|STARTED|Washout (14 Days)||48
8485769|NCT00577083|20911302|P2|NOT COMPLETED|First Intervention (14 Days)||0
8485770|NCT00577083|20911303|P1|NOT COMPLETED|First Intervention (14 Days)||0
8485771|NCT00577083|20911302|P2|COMPLETED|First Intervention (14 Days)||52
8485772|NCT00577083|20911303|P1|COMPLETED|First Intervention (14 Days)||48
8485773|NCT00577083|20911302|P2|STARTED|First Intervention (14 Days)||52
8485774|NCT00577083|20911303|P1|STARTED|First Intervention (14 Days)||48
8485775|NCT00577031|20911315|P1|NOT COMPLETED|Overall Study||205
8485776|NCT00577031|20911315|P1|COMPLETED|Overall Study||0
8485777|NCT00577031|20911315|P1|STARTED|Overall Study||205
8485778|NCT00577005|20911336|P2|NOT COMPLETED|Overall Study||3
8485779|NCT00577005|20911337|P1|NOT COMPLETED|Overall Study||5
8485780|NCT00577005|20911336|P2|COMPLETED|Overall Study||9
8485781|NCT00577005|20911337|P1|COMPLETED|Overall Study||11
8485782|NCT00577005|20911336|P2|STARTED|Overall Study||12
8485783|NCT00577005|20911337|P1|STARTED|Overall Study||16
8485784|NCT00576927|20911351|P1|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
8485785|NCT00576927|20911351|P1|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
8485786|NCT00576927|20911351|P1|STARTED|Randomization 1:1 Placebo or Active Drug||22
8485787|NCT00576927|20911351|P1|NOT COMPLETED|Sleep Hygiene With Study Drug||0
8485788|NCT00576927|20911351|P1|COMPLETED|Sleep Hygiene With Study Drug||22
8485789|NCT00576927|20911351|P1|STARTED|Sleep Hygiene With Study Drug||22
8485790|NCT00576927|20911351|P1|NOT COMPLETED|Sleep Hygiene With the Placebo||1
8485791|NCT00576927|20911351|P1|COMPLETED|Sleep Hygiene With the Placebo||22
8485792|NCT00576927|20911351|P1|STARTED|Sleep Hygiene With the Placebo||23
8485793|NCT00576927|20911351|P1|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
8485794|NCT00576927|20911351|P1|COMPLETED|Sleep Hygiene Behavioral Intervention||23
8485795|NCT00576927|20911351|P1|STARTED|Sleep Hygiene Behavioral Intervention||30
8485796|NCT00576927|20911351|P1|NOT COMPLETED|Baseline||13
8485797|NCT00576927|20911351|P1|COMPLETED|Baseline||30
8485798|NCT00576927|20911351|P1|STARTED|Baseline||43
8485799|NCT00576927|20911351|P1|NOT COMPLETED|Clinical Assessment||36
8485801|NCT00576927|20911351|P1|STARTED|Clinical Assessment||79
8485802|NCT00576901|20911363|P1|NOT COMPLETED|Overall Study||3
8485803|NCT00576901|20911363|P1|COMPLETED|Overall Study||20
8485804|NCT00576901|20911363|P1|STARTED|Overall Study||23
8485805|NCT00576836|20911371|P2|NOT COMPLETED|Overall Study||2
8485806|NCT00576836|20911372|P1|NOT COMPLETED|Overall Study||0
8485807|NCT00576836|20911371|P2|COMPLETED|Overall Study||5
8485808|NCT00576836|20911372|P1|COMPLETED|Overall Study||0
8485809|NCT00576836|20911371|P2|STARTED|Overall Study||7
8485810|NCT00576836|20911372|P1|STARTED|Overall Study||0
8485811|NCT00576823|20911387|P3|NOT COMPLETED|40-week Safety Extension Phase||0
8485812|NCT00576823|20911388|P2|NOT COMPLETED|40-week Safety Extension Phase||0
8485813|NCT00576823|20911389|P1|NOT COMPLETED|40-week Safety Extension Phase||1
8485814|NCT00576823|20911387|P3|COMPLETED|40-week Safety Extension Phase||6
8485815|NCT00576823|20911388|P2|COMPLETED|40-week Safety Extension Phase||6
8485816|NCT00576823|20911389|P1|COMPLETED|40-week Safety Extension Phase||10
8485817|NCT00576823|20911387|P3|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
8485818|NCT00576823|20911388|P2|STARTED|40-week Safety Extension Phase||6
8485819|NCT00576823|20911389|P1|STARTED|40-week Safety Extension Phase||11
8485820|NCT00576823|20911387|P3|NOT COMPLETED|12-week Efficacy Phase||0
8485821|NCT00576823|20911388|P2|NOT COMPLETED|12-week Efficacy Phase||0
8485822|NCT00576823|20911389|P1|NOT COMPLETED|12-week Efficacy Phase||1
8485823|NCT00576823|20911387|P3|COMPLETED|12-week Efficacy Phase||7
8485824|NCT00576823|20911388|P2|COMPLETED|12-week Efficacy Phase||6
8485825|NCT00576823|20911389|P1|COMPLETED|12-week Efficacy Phase||11
8485826|NCT00576823|20911387|P3|STARTED|12-week Efficacy Phase||7
8485827|NCT00576823|20911388|P2|STARTED|12-week Efficacy Phase||6
8485828|NCT00576823|20911389|P1|STARTED|12-week Efficacy Phase||12
8485829|NCT00576758|20911405|P2|NOT COMPLETED|Follow-up Period||17
8485830|NCT00576758|20911406|P1|NOT COMPLETED|Follow-up Period||27
8485831|NCT00576758|20911405|P2|COMPLETED|Follow-up Period||34
8485832|NCT00576758|20911406|P1|COMPLETED|Follow-up Period||28
8485833|NCT00576758|20911405|P2|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
8485834|NCT00576758|20911406|P1|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
8485835|NCT00576758|20911405|P2|NOT COMPLETED|Extension Treatment Period||43
8485836|NCT00576758|20911406|P1|NOT COMPLETED|Extension Treatment Period||42
8485837|NCT00576758|20911405|P2|COMPLETED|Extension Treatment Period||30
8485838|NCT00576758|20911406|P1|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
8485839|NCT00576758|20911405|P2|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
8485840|NCT00576758|20911406|P1|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
8485841|NCT00576758|20911405|P2|NOT COMPLETED|Induction Treatment Period||5
8485842|NCT00576758|20911406|P1|NOT COMPLETED|Induction Treatment Period||8
8485843|NCT00576758|20911405|P2|COMPLETED|Induction Treatment Period||83
8485844|NCT00576758|20911406|P1|COMPLETED|Induction Treatment Period||79
8485845|NCT00576758|20911405|P2|Received Treatment|Induction Treatment Period||87
8485846|NCT00576758|20911406|P1|Received Treatment|Induction Treatment Period||86
8485847|NCT00576758|20911405|P2|STARTED|Induction Treatment Period||88
8485848|NCT00576758|20911406|P1|STARTED|Induction Treatment Period||87
8485849|NCT00576732|20911452|P6|NOT COMPLETED|OPEN LABEL||8
8485850|NCT00576732|20911453|P5|NOT COMPLETED|OPEN LABEL||4
8485851|NCT00576732|20911454|P4|NOT COMPLETED|OPEN LABEL||11
8485852|NCT00576732|20911455|P3|NOT COMPLETED|OPEN LABEL||0
8485853|NCT00576732|20911456|P2|NOT COMPLETED|OPEN LABEL||0
8485854|NCT00576732|20911457|P1|NOT COMPLETED|OPEN LABEL||0
8485855|NCT00576732|20911452|P6|COMPLETED|OPEN LABEL||17
8485856|NCT00576732|20911453|P5|COMPLETED|OPEN LABEL||20
8485857|NCT00576732|20911454|P4|COMPLETED|OPEN LABEL||19
8485858|NCT00576732|20911455|P3|COMPLETED|OPEN LABEL||0
8485859|NCT00576732|20911456|P2|COMPLETED|OPEN LABEL||0
8485860|NCT00576732|20911457|P1|COMPLETED|OPEN LABEL||0
8485861|NCT00576732|20911452|P6|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
8485862|NCT00576732|20911453|P5|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
8485863|NCT00576732|20911454|P4|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
8485864|NCT00576732|20911455|P3|STARTED|OPEN LABEL||0
8485865|NCT00576732|20911456|P2|STARTED|OPEN LABEL||0
8485866|NCT00576732|20911457|P1|STARTED|OPEN LABEL||0
8485867|NCT00576732|20911452|P6|NOT COMPLETED|DOUBLE BLIND||0
8485868|NCT00576732|20911453|P5|NOT COMPLETED|DOUBLE BLIND||0
8485869|NCT00576732|20911454|P4|NOT COMPLETED|DOUBLE BLIND||0
8485870|NCT00576732|20911455|P3|NOT COMPLETED|DOUBLE BLIND||6
8485871|NCT00576732|20911456|P2|NOT COMPLETED|DOUBLE BLIND||5
8485872|NCT00576732|20911457|P1|NOT COMPLETED|DOUBLE BLIND||8
8485873|NCT00576732|20911452|P6|COMPLETED|DOUBLE BLIND||0
8485874|NCT00576732|20911453|P5|COMPLETED|DOUBLE BLIND||0
8485875|NCT00576732|20911454|P4|COMPLETED|DOUBLE BLIND||0
8485876|NCT00576732|20911455|P3|COMPLETED|DOUBLE BLIND||25
8485877|NCT00576732|20911456|P2|COMPLETED|DOUBLE BLIND||25
8485878|NCT00576732|20911457|P1|COMPLETED|DOUBLE BLIND||27
8485879|NCT00576732|20911452|P6|STARTED|DOUBLE BLIND||0
8485880|NCT00576732|20911453|P5|STARTED|DOUBLE BLIND||0
8485881|NCT00576732|20911454|P4|STARTED|DOUBLE BLIND||0
8485882|NCT00576732|20911455|P3|STARTED|DOUBLE BLIND||31
8485883|NCT00576732|20911456|P2|STARTED|DOUBLE BLIND||30
8485884|NCT00576732|20911457|P1|STARTED|DOUBLE BLIND||35
8485885|NCT00576693|20911489|P2|NOT COMPLETED|Overall Study||24
8485886|NCT00576693|20911490|P1|NOT COMPLETED|Overall Study||10
8485887|NCT00576693|20911489|P2|COMPLETED|Overall Study||203
8485888|NCT00576693|20911490|P1|COMPLETED|Overall Study||214
8485889|NCT00576693|20911489|P2|STARTED|Overall Study||227
8485890|NCT00576693|20911490|P1|STARTED|Overall Study||224
8485891|NCT00576680|20911496|P1|NOT COMPLETED|Overall Study||0
8485892|NCT00576680|20911496|P1|COMPLETED|Overall Study||43
8485893|NCT00576680|20911496|P1|STARTED|Overall Study||43
8485894|NCT00576628|20911502|P1|NOT COMPLETED|Overall Study||43
8485895|NCT00576628|20911502|P1|COMPLETED|Overall Study||82
8485896|NCT00576628|20911502|P1|STARTED|Overall Study||125
8485897|NCT00576576|20911522|P1|NOT COMPLETED|Overall Study||7
8485898|NCT00576576|20911522|P1|COMPLETED|Overall Study||20
8485899|NCT00576576|20911522|P1|STARTED|Overall Study||27
8485900|NCT00576524|20911530|P2|NOT COMPLETED|Overall Study||0
8485901|NCT00576524|20911531|P1|NOT COMPLETED|Overall Study||0
8485902|NCT00576524|20911530|P2|COMPLETED|Overall Study||0
8485903|NCT00576524|20911531|P1|COMPLETED|Overall Study||2
8485904|NCT00576524|20911530|P2|STARTED|Overall Study||0
8485905|NCT00576524|20911531|P1|STARTED|Overall Study||2
8485906|NCT00576472|20911556|P15|NOT COMPLETED|MPH Home Maintenance Phase||23
8485907|NCT00576472|20911557|P14|NOT COMPLETED|MPH Home Maintenance Phase||27
8485908|NCT00576472|20911558|P13|NOT COMPLETED|MPH Home Maintenance Phase||0
8485909|NCT00576472|20911559|P12|NOT COMPLETED|MPH Home Maintenance Phase||0
8485910|NCT00576472|20911560|P11|NOT COMPLETED|MPH Home Maintenance Phase||0
8485911|NCT00576472|20911561|P10|NOT COMPLETED|MPH Home Maintenance Phase||0
8485912|NCT00576472|20911562|P9|NOT COMPLETED|MPH Home Maintenance Phase||0
8485913|NCT00576472|20911563|P8|NOT COMPLETED|MPH Home Maintenance Phase||0
8485914|NCT00576472|20911564|P7|NOT COMPLETED|MPH Home Maintenance Phase||0
8485915|NCT00576472|20911565|P6|NOT COMPLETED|MPH Home Maintenance Phase||0
8485916|NCT00576472|20911566|P5|NOT COMPLETED|MPH Home Maintenance Phase||0
8485917|NCT00576472|20911567|P4|NOT COMPLETED|MPH Home Maintenance Phase||0
8485918|NCT00576472|20911568|P3|NOT COMPLETED|MPH Home Maintenance Phase||0
8485919|NCT00576472|20911569|P2|NOT COMPLETED|MPH Home Maintenance Phase||0
8485920|NCT00576472|20911570|P1|NOT COMPLETED|MPH Home Maintenance Phase||0
8485921|NCT00576472|20911556|P15|COMPLETED|MPH Home Maintenance Phase||68
8485922|NCT00576472|20911557|P14|COMPLETED|MPH Home Maintenance Phase||0
8485923|NCT00576472|20911558|P13|COMPLETED|MPH Home Maintenance Phase||0
8485924|NCT00576472|20911559|P12|COMPLETED|MPH Home Maintenance Phase||0
8485925|NCT00576472|20911560|P11|COMPLETED|MPH Home Maintenance Phase||0
8485926|NCT00576472|20911561|P10|COMPLETED|MPH Home Maintenance Phase||0
8485927|NCT00576472|20911562|P9|COMPLETED|MPH Home Maintenance Phase||0
8485928|NCT00576472|20911563|P8|COMPLETED|MPH Home Maintenance Phase||0
8485929|NCT00576472|20911564|P7|COMPLETED|MPH Home Maintenance Phase||0
8485930|NCT00576472|20911565|P6|COMPLETED|MPH Home Maintenance Phase||0
8485931|NCT00576472|20911566|P5|COMPLETED|MPH Home Maintenance Phase||0
8485932|NCT00576472|20911567|P4|COMPLETED|MPH Home Maintenance Phase||0
8485933|NCT00576472|20911568|P3|COMPLETED|MPH Home Maintenance Phase||0
8485934|NCT00576472|20911569|P2|COMPLETED|MPH Home Maintenance Phase||0
8485935|NCT00576472|20911570|P1|COMPLETED|MPH Home Maintenance Phase||0
8485936|NCT00576472|20911556|P15|STARTED|MPH Home Maintenance Phase||91
8485937|NCT00576472|20911557|P14|STARTED|MPH Home Maintenance Phase||27
8485938|NCT00576472|20911558|P13|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485939|NCT00576472|20911559|P12|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485940|NCT00576472|20911560|P11|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485941|NCT00576472|20911561|P10|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485942|NCT00576472|20911562|P9|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485943|NCT00576472|20911563|P8|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485944|NCT00576472|20911564|P7|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485945|NCT00576472|20911565|P6|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485946|NCT00576472|20911566|P5|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485947|NCT00576472|20911567|P4|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485948|NCT00576472|20911568|P3|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485949|NCT00576472|20911569|P2|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485950|NCT00576472|20911570|P1|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
8485951|NCT00576472|20911556|P15|NOT COMPLETED|MPH Cross Over Phase||0
8485952|NCT00576472|20911557|P14|NOT COMPLETED|MPH Cross Over Phase||0
8485953|NCT00576472|20911558|P13|NOT COMPLETED|MPH Cross Over Phase||0
8485954|NCT00576472|20911559|P12|NOT COMPLETED|MPH Cross Over Phase||1
8485955|NCT00576472|20911560|P11|NOT COMPLETED|MPH Cross Over Phase||1
8485956|NCT00576472|20911561|P10|NOT COMPLETED|MPH Cross Over Phase||0
8485957|NCT00576472|20911562|P9|NOT COMPLETED|MPH Cross Over Phase||2
8485958|NCT00576472|20911563|P8|NOT COMPLETED|MPH Cross Over Phase||0
8485959|NCT00576472|20911564|P7|NOT COMPLETED|MPH Cross Over Phase||12
8485960|NCT00576472|20911565|P6|NOT COMPLETED|MPH Cross Over Phase||0
8485961|NCT00576472|20911566|P5|NOT COMPLETED|MPH Cross Over Phase||0
8485962|NCT00576472|20911567|P4|NOT COMPLETED|MPH Cross Over Phase||0
8485963|NCT00576472|20911568|P3|NOT COMPLETED|MPH Cross Over Phase||0
8485964|NCT00576472|20911569|P2|NOT COMPLETED|MPH Cross Over Phase||0
8485965|NCT00576472|20911570|P1|NOT COMPLETED|MPH Cross Over Phase||0
8485966|NCT00576472|20911556|P15|COMPLETED|MPH Cross Over Phase||0
8485967|NCT00576472|20911557|P14|COMPLETED|MPH Cross Over Phase||0
8485968|NCT00576472|20911558|P13|COMPLETED|MPH Cross Over Phase||21
8485969|NCT00576472|20911559|P12|COMPLETED|MPH Cross Over Phase||17
8485970|NCT00576472|20911560|P11|COMPLETED|MPH Cross Over Phase||22
8485971|NCT00576472|20911561|P10|COMPLETED|MPH Cross Over Phase||22
8485972|NCT00576472|20911562|P9|COMPLETED|MPH Cross Over Phase||16
8485973|NCT00576472|20911563|P8|COMPLETED|MPH Cross Over Phase||20
8485974|NCT00576472|20911564|P7|COMPLETED|MPH Cross Over Phase||0
8485975|NCT00576472|20911565|P6|COMPLETED|MPH Cross Over Phase||0
8485976|NCT00576472|20911566|P5|COMPLETED|MPH Cross Over Phase||0
8485977|NCT00576472|20911567|P4|COMPLETED|MPH Cross Over Phase||0
8485978|NCT00576472|20911568|P3|COMPLETED|MPH Cross Over Phase||0
8485979|NCT00576472|20911569|P2|COMPLETED|MPH Cross Over Phase||0
8485980|NCT00576472|20911570|P1|COMPLETED|MPH Cross Over Phase||0
8485981|NCT00576472|20911556|P15|STARTED|MPH Cross Over Phase||0
8485982|NCT00576472|20911557|P14|STARTED|MPH Cross Over Phase||0
8485983|NCT00576472|20911558|P13|STARTED|MPH Cross Over Phase||21
8485984|NCT00576472|20911559|P12|STARTED|MPH Cross Over Phase||18
8485985|NCT00576472|20911560|P11|STARTED|MPH Cross Over Phase||23
8485986|NCT00576472|20911561|P10|STARTED|MPH Cross Over Phase||22
8485987|NCT00576472|20911562|P9|STARTED|MPH Cross Over Phase||18
8485988|NCT00576472|20911563|P8|STARTED|MPH Cross Over Phase||20
8485989|NCT00576472|20911564|P7|STARTED|MPH Cross Over Phase||12
8485990|NCT00576472|20911565|P6|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8485991|NCT00576472|20911566|P5|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8485992|NCT00576472|20911567|P4|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8485993|NCT00576472|20911568|P3|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8485994|NCT00576472|20911569|P2|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8485995|NCT00576472|20911570|P1|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
8485996|NCT00576472|20911556|P15|NOT COMPLETED|MPH In-Lab Phase||0
8485997|NCT00576472|20911557|P14|NOT COMPLETED|MPH In-Lab Phase||0
8485998|NCT00576472|20911558|P13|NOT COMPLETED|MPH In-Lab Phase||0
8485999|NCT00576472|20911559|P12|NOT COMPLETED|MPH In-Lab Phase||0
8486000|NCT00576472|20911560|P11|NOT COMPLETED|MPH In-Lab Phase||0
8486001|NCT00576472|20911561|P10|NOT COMPLETED|MPH In-Lab Phase||0
8486002|NCT00576472|20911562|P9|NOT COMPLETED|MPH In-Lab Phase||0
8486003|NCT00576472|20911563|P8|NOT COMPLETED|MPH In-Lab Phase||0
8486004|NCT00576472|20911564|P7|NOT COMPLETED|MPH In-Lab Phase||0
8486005|NCT00576472|20911565|P6|NOT COMPLETED|MPH In-Lab Phase||0
8486006|NCT00576472|20911566|P5|NOT COMPLETED|MPH In-Lab Phase||0
8486007|NCT00576472|20911567|P4|NOT COMPLETED|MPH In-Lab Phase||335
8486008|NCT00576472|20911568|P3|NOT COMPLETED|MPH In-Lab Phase||0
8486009|NCT00576472|20911569|P2|NOT COMPLETED|MPH In-Lab Phase||0
8486010|NCT00576472|20911570|P1|NOT COMPLETED|MPH In-Lab Phase||0
8486011|NCT00576472|20911556|P15|COMPLETED|MPH In-Lab Phase||0
8486012|NCT00576472|20911557|P14|COMPLETED|MPH In-Lab Phase||0
8486013|NCT00576472|20911558|P13|COMPLETED|MPH In-Lab Phase||0
8486014|NCT00576472|20911559|P12|COMPLETED|MPH In-Lab Phase||0
8486015|NCT00576472|20911560|P11|COMPLETED|MPH In-Lab Phase||0
8486016|NCT00576472|20911561|P10|COMPLETED|MPH In-Lab Phase||0
8486017|NCT00576472|20911562|P9|COMPLETED|MPH In-Lab Phase||0
8486018|NCT00576472|20911563|P8|COMPLETED|MPH In-Lab Phase||0
8486019|NCT00576472|20911564|P7|COMPLETED|MPH In-Lab Phase||0
8486020|NCT00576472|20911565|P6|COMPLETED|MPH In-Lab Phase||67
8486021|NCT00576472|20911566|P5|COMPLETED|MPH In-Lab Phase||67
8486022|NCT00576472|20911567|P4|COMPLETED|MPH In-Lab Phase||0
8486023|NCT00576472|20911568|P3|COMPLETED|MPH In-Lab Phase||0
8486024|NCT00576472|20911569|P2|COMPLETED|MPH In-Lab Phase||0
8486025|NCT00576472|20911570|P1|COMPLETED|MPH In-Lab Phase||0
8486026|NCT00576472|20911556|P15|STARTED|MPH In-Lab Phase||0
8486027|NCT00576472|20911557|P14|STARTED|MPH In-Lab Phase||0
8486028|NCT00576472|20911558|P13|STARTED|MPH In-Lab Phase||0
8486029|NCT00576472|20911559|P12|STARTED|MPH In-Lab Phase||0
8486030|NCT00576472|20911560|P11|STARTED|MPH In-Lab Phase||0
8486031|NCT00576472|20911561|P10|STARTED|MPH In-Lab Phase||0
8486032|NCT00576472|20911562|P9|STARTED|MPH In-Lab Phase||0
8486033|NCT00576472|20911563|P8|STARTED|MPH In-Lab Phase||0
8486034|NCT00576472|20911564|P7|STARTED|MPH In-Lab Phase||0
8486035|NCT00576472|20911565|P6|STARTED|MPH In-Lab Phase||67
8486036|NCT00576472|20911566|P5|STARTED|MPH In-Lab Phase||67
8486037|NCT00576472|20911567|P4|STARTED|MPH In-Lab Phase||335
8486038|NCT00576472|20911568|P3|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
8486039|NCT00576472|20911569|P2|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
8486040|NCT00576472|20911570|P1|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
8486041|NCT00576472|20911556|P15|NOT COMPLETED|Initial Screening||0
8486042|NCT00576472|20911557|P14|NOT COMPLETED|Initial Screening||0
8486043|NCT00576472|20911558|P13|NOT COMPLETED|Initial Screening||0
8486044|NCT00576472|20911559|P12|NOT COMPLETED|Initial Screening||0
8486045|NCT00576472|20911560|P11|NOT COMPLETED|Initial Screening||0
8486046|NCT00576472|20911561|P10|NOT COMPLETED|Initial Screening||0
8486047|NCT00576472|20911562|P9|NOT COMPLETED|Initial Screening||0
8486048|NCT00576472|20911563|P8|NOT COMPLETED|Initial Screening||0
8486049|NCT00576472|20911564|P7|NOT COMPLETED|Initial Screening||0
8486050|NCT00576472|20911565|P6|NOT COMPLETED|Initial Screening||0
8486051|NCT00576472|20911566|P5|NOT COMPLETED|Initial Screening||0
8486052|NCT00576472|20911567|P4|NOT COMPLETED|Initial Screening||0
8486053|NCT00576472|20911568|P3|NOT COMPLETED|Initial Screening||0
8486054|NCT00576472|20911569|P2|NOT COMPLETED|Initial Screening||0
8486055|NCT00576472|20911570|P1|NOT COMPLETED|Initial Screening||0
8486056|NCT00576472|20911556|P15|COMPLETED|Initial Screening||0
8486057|NCT00576472|20911557|P14|COMPLETED|Initial Screening||0
8486058|NCT00576472|20911558|P13|COMPLETED|Initial Screening||0
8486059|NCT00576472|20911559|P12|COMPLETED|Initial Screening||0
8486060|NCT00576472|20911560|P11|COMPLETED|Initial Screening||0
8486061|NCT00576472|20911561|P10|COMPLETED|Initial Screening||0
8486062|NCT00576472|20911562|P9|COMPLETED|Initial Screening||0
8486063|NCT00576472|20911563|P8|COMPLETED|Initial Screening||0
8486064|NCT00576472|20911564|P7|COMPLETED|Initial Screening||0
8486065|NCT00576472|20911565|P6|COMPLETED|Initial Screening||0
8486066|NCT00576472|20911566|P5|COMPLETED|Initial Screening||0
8486067|NCT00576472|20911567|P4|COMPLETED|Initial Screening||0
8486068|NCT00576472|20911568|P3|COMPLETED|Initial Screening||199
8486069|NCT00576472|20911569|P2|COMPLETED|Initial Screening||40
8486070|NCT00576472|20911570|P1|COMPLETED|Initial Screening||230
8486071|NCT00576472|20911556|P15|STARTED|Initial Screening||0
8486072|NCT00576472|20911557|P14|STARTED|Initial Screening||0
8486073|NCT00576472|20911558|P13|STARTED|Initial Screening||0
8486074|NCT00576472|20911559|P12|STARTED|Initial Screening||0
8486075|NCT00576472|20911560|P11|STARTED|Initial Screening||0
8486076|NCT00576472|20911561|P10|STARTED|Initial Screening||0
8486077|NCT00576472|20911562|P9|STARTED|Initial Screening||0
8486078|NCT00576472|20911563|P8|STARTED|Initial Screening||0
8486079|NCT00576472|20911564|P7|STARTED|Initial Screening||0
8486080|NCT00576472|20911565|P6|STARTED|Initial Screening||0
8486081|NCT00576472|20911566|P5|STARTED|Initial Screening||0
8486082|NCT00576472|20911567|P4|STARTED|Initial Screening||0
8486083|NCT00576472|20911568|P3|STARTED|Initial Screening||199
8486084|NCT00576472|20911569|P2|STARTED|Initial Screening||40
8486085|NCT00576472|20911570|P1|STARTED|Initial Screening||230
8486086|NCT00576420|20911663|P3|NOT COMPLETED|Overall Study||1
8486087|NCT00576420|20911664|P2|NOT COMPLETED|Overall Study||0
8486088|NCT00576420|20911665|P1|NOT COMPLETED|Overall Study||0
8486089|NCT00576420|20911663|P3|COMPLETED|Overall Study||22
8486090|NCT00576420|20911664|P2|COMPLETED|Overall Study||24
8486091|NCT00576420|20911665|P1|COMPLETED|Overall Study||26
8486092|NCT00576420|20911663|P3|STARTED|Overall Study||23
8486093|NCT00576420|20911664|P2|STARTED|Overall Study||24
8486094|NCT00576420|20911665|P1|STARTED|Overall Study||26
8486095|NCT00576407|20911830|P1|NOT COMPLETED|Overall Study||8
8486096|NCT00576407|20911830|P1|COMPLETED|Overall Study||18
8486097|NCT00576407|20911830|P1|STARTED|Overall Study||26
8486098|NCT00576381|20911842|P1|NOT COMPLETED|Overall Study||7
8486099|NCT00576381|20911842|P1|COMPLETED|Overall Study||23
8486100|NCT00576381|20911842|P1|STARTED|Overall Study||30
8486101|NCT00576316|20911846|P1|NOT COMPLETED|Overall Study||20
8486102|NCT00576316|20911846|P1|COMPLETED|Overall Study|Number of patients who completed study|181
8486103|NCT00576316|20911846|P1|STARTED|Overall Study|Number of patients recruited|201
8486104|NCT00576303|20911851|P1|NOT COMPLETED|Long Term Safety Period||16
8486105|NCT00576303|20911851|P1|COMPLETED|Long Term Safety Period||162
8486106|NCT00576303|20911851|P1|STARTED|Long Term Safety Period||178
8486107|NCT00576303|20911851|P1|NOT COMPLETED|Efficacy Evaluation Period||5
8486108|NCT00576303|20911851|P1|COMPLETED|Efficacy Evaluation Period||178
8486109|NCT00576303|20911851|P1|STARTED|Efficacy Evaluation Period||183
8486110|NCT00576303|20911851|P1|NOT COMPLETED|Dose Titration Period||17
8486111|NCT00576303|20911851|P1|COMPLETED|Dose Titration Period||183
8486112|NCT00576303|20911851|P1|STARTED|Dose Titration Period||200
8486113|NCT00576251|20911862|P2|NOT COMPLETED|Overall Study||1
8486114|NCT00576251|20911863|P1|NOT COMPLETED|Overall Study||1
8486115|NCT00576251|20911862|P2|COMPLETED|Overall Study||111
8486116|NCT00576251|20911863|P1|COMPLETED|Overall Study||108
8486117|NCT00576251|20911862|P2|STARTED|Overall Study||112
8486118|NCT00576251|20911863|P1|STARTED|Overall Study||109
8486119|NCT00576199|20911869|P1|NOT COMPLETED|Overall Study||30
8486120|NCT00576199|20911869|P1|COMPLETED|Overall Study||0
8486121|NCT00576199|20911869|P1|STARTED|Overall Study||30
8486122|NCT00576147|20911878|P1|NOT COMPLETED|Overall Study||0
8486123|NCT00576147|20911878|P1|COMPLETED|Overall Study||431
8486124|NCT00576147|20911878|P1|STARTED|Overall Study||431
8486125|NCT00576056|20911882|P1|NOT COMPLETED|Overall Study||14
8486126|NCT00576056|20911882|P1|COMPLETED|Overall Study||5
8486127|NCT00576056|20911882|P1|STARTED|Overall Study||19
8486128|NCT00575965|20911887|P1|NOT COMPLETED|Overall Study||0
8486129|NCT00575965|20911887|P1|COMPLETED|Overall Study||18
8486130|NCT00575965|20911887|P1|STARTED|Overall Study||18
8486131|NCT00575887|20911892|P1|NOT COMPLETED|Overall Study||0
8486132|NCT00575887|20911892|P1|COMPLETED|Overall Study||25
8486133|NCT00575887|20911892|P1|STARTED|Overall Study||25
8486134|NCT00575666|20911898|P2|NOT COMPLETED|Overall Study||3
8486135|NCT00575666|20911899|P1|NOT COMPLETED|Overall Study||4
8486136|NCT00575666|20911898|P2|COMPLETED|Overall Study||21
8486137|NCT00575666|20911899|P1|COMPLETED|Overall Study||17
8486138|NCT00575666|20911898|P2|STARTED|Overall Study||24
8486139|NCT00575666|20911899|P1|STARTED|Overall Study||21
8486140|NCT00575588|20911939|P2|NOT COMPLETED|Overall Study||283
8486141|NCT00575588|20911940|P1|NOT COMPLETED|Overall Study||263
8486142|NCT00575588|20911939|P2|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
8486143|NCT00575588|20911940|P1|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
8486144|NCT00575588|20911939|P2|STARTED|Overall Study|Randomized and treated|430
8486145|NCT00575588|20911940|P1|STARTED|Overall Study|Randomized and treated|428
8486146|NCT00575510|20911963|P3|NOT COMPLETED|Overall Study||17
8486147|NCT00575510|20911964|P2|NOT COMPLETED|Overall Study||13
8486148|NCT00575510|20911965|P1|NOT COMPLETED|Overall Study||12
8486149|NCT00575510|20911963|P3|COMPLETED|Overall Study||96
8486150|NCT00575510|20911964|P2|COMPLETED|Overall Study||101
8486151|NCT00575510|20911965|P1|COMPLETED|Overall Study||102
8486152|NCT00575510|20911963|P3|STARTED|Overall Study||113
8486153|NCT00575510|20911964|P2|STARTED|Overall Study||114
8486154|NCT00575510|20911965|P1|STARTED|Overall Study||114
8486155|NCT00575380|20911978|P2|NOT COMPLETED|Overall Study||3
8486156|NCT00575380|20911979|P1|NOT COMPLETED|Overall Study||1
8486157|NCT00575380|20911978|P2|COMPLETED|Overall Study||55
8486158|NCT00575380|20911979|P1|COMPLETED|Overall Study||57
8486159|NCT00575380|20911978|P2|STARTED|Overall Study||58
8486160|NCT00575380|20911979|P1|STARTED|Overall Study||58
8486161|NCT00575367|20911989|P2|NOT COMPLETED|Overall Study||0
8486162|NCT00575367|20911990|P1|NOT COMPLETED|Overall Study||0
8486163|NCT00575367|20911989|P2|COMPLETED|Overall Study||18
8486164|NCT00575367|20911990|P1|COMPLETED|Overall Study||19
8486165|NCT00575367|20911989|P2|STARTED|Overall Study||18
8486166|NCT00575367|20911990|P1|STARTED|Overall Study||19
8486167|NCT00575328|20911998|P2|NOT COMPLETED|Overall Study||2
8486168|NCT00575328|20911999|P1|NOT COMPLETED|Overall Study||3
8486169|NCT00575328|20911998|P2|COMPLETED|Overall Study||2
8486170|NCT00575328|20911999|P1|COMPLETED|Overall Study||1
8486171|NCT00575328|20911998|P2|STARTED|Overall Study||4
8486172|NCT00575328|20911999|P1|STARTED|Overall Study||4
8486173|NCT00575185|20912009|P2|NOT COMPLETED|Overall Study||0
8486174|NCT00575185|20912010|P1|NOT COMPLETED|Overall Study||0
8486175|NCT00575185|20912009|P2|COMPLETED|Overall Study||11
8486176|NCT00575185|20912010|P1|COMPLETED|Overall Study||12
8486177|NCT00575185|20912009|P2|STARTED|Overall Study||11
8486178|NCT00575185|20912010|P1|STARTED|Overall Study||12
8486179|NCT00575159|20912018|P1|NOT COMPLETED|Overall Study||0
8486180|NCT00575159|20912018|P1|COMPLETED|Overall Study||10
8486181|NCT00575159|20912018|P1|STARTED|Overall Study||10
8486182|NCT00575146|20912126|P1|NOT COMPLETED|Overall Study||3
8486183|NCT00575146|20912126|P1|COMPLETED|Overall Study||17
8486184|NCT00575146|20912126|P1|STARTED|Overall Study||20
8486185|NCT00575094|20912132|P1|NOT COMPLETED|Overall Study||3
8486186|NCT00575094|20912132|P1|COMPLETED|Overall Study||6
8486187|NCT00575094|20912132|P1|STARTED|Overall Study||9
8486188|NCT00575042|20912136|P1|NOT COMPLETED|Overall Study||3
8486189|NCT00575042|20912136|P1|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
8486190|NCT00575042|20912136|P1|STARTED|Overall Study||20
8486191|NCT00575029|20912141|P1|NOT COMPLETED|Overall Study||0
8486192|NCT00575029|20912141|P1|COMPLETED|Overall Study||7
8486193|NCT00575029|20912141|P1|STARTED|Overall Study||7
8486194|NCT00575016|20912150|P4|NOT COMPLETED|Treatment Cycle 2||0
8486195|NCT00575016|20912151|P3|NOT COMPLETED|Treatment Cycle 2||0
8486196|NCT00575016|20912152|P2|NOT COMPLETED|Treatment Cycle 2||0
8486197|NCT00575016|20912153|P1|NOT COMPLETED|Treatment Cycle 2||1
8486198|NCT00575016|20912150|P4|COMPLETED|Treatment Cycle 2||0
8486199|NCT00575016|20912151|P3|COMPLETED|Treatment Cycle 2||0
8486200|NCT00575016|20912152|P2|COMPLETED|Treatment Cycle 2||0
8486201|NCT00575016|20912153|P1|COMPLETED|Treatment Cycle 2||30
8486202|NCT00575016|20912150|P4|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
8486203|NCT00575016|20912151|P3|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
8486204|NCT00575016|20912152|P2|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
8486205|NCT00575016|20912153|P1|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
8486206|NCT00575016|20912150|P4|NOT COMPLETED|Treatment Cycle 1||5
8486207|NCT00575016|20912151|P3|NOT COMPLETED|Treatment Cycle 1||4
8486208|NCT00575016|20912152|P2|NOT COMPLETED|Treatment Cycle 1||5
8486209|NCT00575016|20912153|P1|NOT COMPLETED|Treatment Cycle 1||9
8486210|NCT00575016|20912150|P4|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
8486211|NCT00575016|20912151|P3|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
8486212|NCT00575016|20912152|P2|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
8486213|NCT00575016|20912153|P1|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
8486214|NCT00575016|20912150|P4|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
8486215|NCT00575016|20912151|P3|STARTED|Treatment Cycle 1||19
8486216|NCT00575016|20912152|P2|STARTED|Treatment Cycle 1||21
8486217|NCT00575016|20912153|P1|STARTED|Treatment Cycle 1||17
8486218|NCT00574990|20912174|P3|NOT COMPLETED|Overall Study||0
8486219|NCT00574990|20912175|P2|NOT COMPLETED|Overall Study||0
8486220|NCT00574990|20912176|P1|NOT COMPLETED|Overall Study||0
8486221|NCT00574990|20912174|P3|COMPLETED|Overall Study||8
8486222|NCT00574990|20912175|P2|COMPLETED|Overall Study||19
8486223|NCT00574990|20912176|P1|COMPLETED|Overall Study||12
8486224|NCT00574990|20912174|P3|STARTED|Overall Study||8
8486225|NCT00574990|20912175|P2|STARTED|Overall Study||19
8486226|NCT00574990|20912176|P1|STARTED|Overall Study||12
8486227|NCT00574951|20912187|P1|NOT COMPLETED|Overall Study||1
8486228|NCT00574951|20912187|P1|COMPLETED|Overall Study||22
8486229|NCT00574951|20912187|P1|STARTED|Overall Study||23
8486230|NCT00574912|20912195|P1|NOT COMPLETED|Overall Study||8
8486231|NCT00574912|20912195|P1|COMPLETED|Overall Study||12
8486232|NCT00574912|20912195|P1|Completed 2.0|Overall Study||12
8486233|NCT00574912|20912195|P1|Completed 1.5|Overall Study||12
8486234|NCT00574912|20912195|P1|Completed 1.0|Overall Study||12
8486235|NCT00574912|20912195|P1|Completed 0.5|Overall Study||12
8486236|NCT00574912|20912195|P1|Completed Placebo|Overall Study|12 original participants started the trial.|12
8486237|NCT00574912|20912195|P1|STARTED|Overall Study||20
8486238|NCT00574873|20912209|P2|NOT COMPLETED|Overall Study||251
8486239|NCT00574873|20912210|P1|NOT COMPLETED|Overall Study||238
8486240|NCT00574873|20912209|P2|COMPLETED|Overall Study||1
8486241|NCT00574873|20912210|P1|COMPLETED|Overall Study||12
8486242|NCT00574873|20912209|P2|Treated|Overall Study||251
8486243|NCT00574873|20912210|P1|Treated|Overall Study||248
8486244|NCT00574873|20912209|P2|STARTED|Overall Study||252
8486245|NCT00574873|20912210|P1|STARTED|Overall Study||250
8486246|NCT00574847|20912228|P2|NOT COMPLETED|Overall Study||7
8486247|NCT00574847|20912229|P1|NOT COMPLETED|Overall Study||8
8486248|NCT00574847|20912228|P2|COMPLETED|Overall Study||56
8486249|NCT00574847|20912229|P1|COMPLETED|Overall Study||56
8486250|NCT00574847|20912228|P2|STARTED|Overall Study||63
8486251|NCT00574847|20912229|P1|STARTED|Overall Study||64
8486252|NCT00574834|20912264|P3|NOT COMPLETED|Overall Study||0
8486253|NCT00574834|20912265|P2|NOT COMPLETED|Overall Study||0
8486254|NCT00574834|20912266|P1|NOT COMPLETED|Overall Study||0
8486255|NCT00574834|20912264|P3|COMPLETED|Overall Study||4
8486256|NCT00574834|20912265|P2|COMPLETED|Overall Study||4
8486257|NCT00574834|20912266|P1|COMPLETED|Overall Study||9
8486258|NCT00574834|20912264|P3|STARTED|Overall Study||4
8486259|NCT00574834|20912265|P2|STARTED|Overall Study||4
8486260|NCT00574834|20912266|P1|STARTED|Overall Study||9
8486261|NCT00574795|20912274|P1|NOT COMPLETED|Toddler Dose||1
8486262|NCT00574795|20912274|P1|COMPLETED|Toddler Dose||184
8486263|NCT00574795|20912274|P1|STARTED|Toddler Dose||185
8486264|NCT00574795|20912274|P1|NOT COMPLETED|After Infant Series||3
8486265|NCT00574795|20912274|P1|COMPLETED|After Infant Series||185
8486266|NCT00574795|20912274|P1|STARTED|After Infant Series||188
8486267|NCT00574795|20912274|P1|NOT COMPLETED|Infant Series||5
8486268|NCT00574795|20912274|P1|COMPLETED|Infant Series||188
8486269|NCT00574795|20912274|P1|Vaccinated Dose 3|Infant Series||190
8486270|NCT00574795|20912274|P1|Vaccinated Dose 2|Infant Series||190
8486271|NCT00574795|20912274|P1|Vaccinated Dose 1|Infant Series||193
8486272|NCT00574795|20912274|P1|STARTED|Infant Series||193
8486273|NCT00574704|20912295|P4|NOT COMPLETED|Overall Study||0
8486274|NCT00574704|20912296|P3|NOT COMPLETED|Overall Study||1
8486275|NCT00574704|20912297|P2|NOT COMPLETED|Overall Study||0
8486276|NCT00574704|20912298|P1|NOT COMPLETED|Overall Study||0
8486277|NCT00574704|20912295|P4|COMPLETED|Overall Study||10
8486278|NCT00574704|20912296|P3|COMPLETED|Overall Study||9
8486279|NCT00574704|20912297|P2|COMPLETED|Overall Study||10
8486280|NCT00574704|20912298|P1|COMPLETED|Overall Study||10
8486281|NCT00574704|20912295|P4|STARTED|Overall Study||10
8486282|NCT00574704|20912296|P3|STARTED|Overall Study||10
8486283|NCT00574704|20912297|P2|STARTED|Overall Study||10
8486284|NCT00574704|20912298|P1|STARTED|Overall Study||10
8486285|NCT00574587|20912312|P4|NOT COMPLETED|Overall Study||0
8486286|NCT00574587|20912313|P3|NOT COMPLETED|Overall Study||0
8486287|NCT00574587|20912314|P2|NOT COMPLETED|Overall Study||0
8486288|NCT00574587|20912315|P1|NOT COMPLETED|Overall Study||0
8486289|NCT00574587|20912312|P4|COMPLETED|Overall Study||13
8486290|NCT00574587|20912313|P3|COMPLETED|Overall Study||16
8486291|NCT00574587|20912314|P2|COMPLETED|Overall Study||23
8486292|NCT00574587|20912315|P1|COMPLETED|Overall Study||3
8486293|NCT00574587|20912312|P4|STARTED|Overall Study||13
8486294|NCT00574587|20912313|P3|STARTED|Overall Study||16
8486295|NCT00574587|20912314|P2|STARTED|Overall Study||23
8486296|NCT00574587|20912315|P1|STARTED|Overall Study||3
8486297|NCT00574548|20912328|P2|NOT COMPLETED|Overall Study||16
8486298|NCT00574548|20912329|P1|NOT COMPLETED|Overall Study||61
8486299|NCT00574548|20912328|P2|COMPLETED|Overall Study||222
8486300|NCT00574548|20912329|P1|COMPLETED|Overall Study||421
8486301|NCT00574548|20912328|P2|Completed Vax 2 (6 Month Contact)|Overall Study||222
8486302|NCT00574548|20912329|P1|Completed Vax 2 (6 Month Contact)|Overall Study||421
8486303|NCT00574548|20912328|P2|Received Vax 2|Overall Study||223
8486304|NCT00574548|20912329|P1|Received Vax 2|Overall Study||427
8486305|NCT00574548|20912328|P2|Withdrawn Before Vax 2|Overall Study||11
8486306|NCT00574548|20912329|P1|Withdrawn Before Vax 2|Overall Study||41
8486307|NCT00574548|20912328|P2|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
8486308|NCT00574548|20912329|P1|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
8486309|NCT00574548|20912328|P2|Completed Vax 1 (6 Month Contact)|Overall Study||234
8486310|NCT00574548|20912329|P1|Completed Vax 1 (6 Month Contact)|Overall Study||468
8486311|NCT00574548|20912328|P2|Received Vaccination 1 (Vax 1)|Overall Study||237
8486312|NCT00574548|20912329|P1|Received Vaccination 1 (Vax 1)|Overall Study||478
8486313|NCT00574548|20912328|P2|STARTED|Overall Study||238
8486314|NCT00574548|20912329|P1|STARTED|Overall Study||482
8486315|NCT00574405|20912375|P2|NOT COMPLETED|Overall Study||2
8486316|NCT00574405|20912376|P1|NOT COMPLETED|Overall Study||3
8486317|NCT00574405|20912375|P2|COMPLETED|Overall Study||10
8486318|NCT00574405|20912376|P1|COMPLETED|Overall Study||9
8486319|NCT00574405|20912375|P2|STARTED|Overall Study||12
8486320|NCT00574405|20912376|P1|STARTED|Overall Study||12
8486321|NCT00574340|20912382|P2|NOT COMPLETED|Study 2 (2 Days)||0
8486322|NCT00574340|20912383|P1|NOT COMPLETED|Study 2 (2 Days)||0
8486323|NCT00574340|20912382|P2|COMPLETED|Study 2 (2 Days)||6
8486324|NCT00574340|20912383|P1|COMPLETED|Study 2 (2 Days)||6
8486325|NCT00574340|20912382|P2|STARTED|Study 2 (2 Days)||6
8486326|NCT00574340|20912383|P1|STARTED|Study 2 (2 Days)||6
8486327|NCT00574340|20912382|P2|NOT COMPLETED|Study 1 (2 Days)||0
8486328|NCT00574340|20912383|P1|NOT COMPLETED|Study 1 (2 Days)||0
8486329|NCT00574340|20912382|P2|COMPLETED|Study 1 (2 Days)||10
8486330|NCT00574340|20912383|P1|COMPLETED|Study 1 (2 Days)||10
8486331|NCT00574340|20912382|P2|STARTED|Study 1 (2 Days)||10
8486332|NCT00574340|20912383|P1|STARTED|Study 1 (2 Days)||10
8486333|NCT00574288|20912396|P7|NOT COMPLETED|Overall Study||28
8486334|NCT00574288|20912397|P6|NOT COMPLETED|Overall Study||26
8486335|NCT00574288|20912398|P5|NOT COMPLETED|Overall Study||2
8486336|NCT00574288|20912399|P4|NOT COMPLETED|Overall Study||2
8486337|NCT00574288|20912400|P3|NOT COMPLETED|Overall Study||3
8486338|NCT00574288|20912401|P2|NOT COMPLETED|Overall Study||3
8486339|NCT00574288|20912402|P1|NOT COMPLETED|Overall Study||20
8486340|NCT00574288|20912396|P7|COMPLETED|Overall Study||14
8486341|NCT00574288|20912397|P6|COMPLETED|Overall Study||4
8486342|NCT00574288|20912398|P5|COMPLETED|Overall Study||1
8486343|NCT00574288|20912399|P4|COMPLETED|Overall Study||1
8486344|NCT00574288|20912400|P3|COMPLETED|Overall Study||0
8486345|NCT00574288|20912401|P2|COMPLETED|Overall Study||0
8486346|NCT00574288|20912402|P1|COMPLETED|Overall Study||0
8486347|NCT00574288|20912396|P7|STARTED|Overall Study||42
8486348|NCT00574288|20912397|P6|STARTED|Overall Study||30
8486349|NCT00574288|20912398|P5|STARTED|Overall Study||3
8486350|NCT00574288|20912399|P4|STARTED|Overall Study||3
8486351|NCT00574288|20912400|P3|STARTED|Overall Study||3
8486352|NCT00574288|20912401|P2|STARTED|Overall Study||3
8486353|NCT00574288|20912402|P1|STARTED|Overall Study||20
8486354|NCT00574275|20912440|P2|NOT COMPLETED|Overall Study||271
8486355|NCT00574275|20912441|P1|NOT COMPLETED|Overall Study||275
8486356|NCT00574275|20912440|P2|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
8486357|NCT00574275|20912441|P1|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
8486358|NCT00574275|20912440|P2|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
8486359|NCT00574275|20912441|P1|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
8486360|NCT00574275|20912440|P2|TREATED|Overall Study||268
8486361|NCT00574275|20912441|P1|TREATED|Overall Study||273
8486362|NCT00574275|20912440|P2|STARTED|Overall Study||271
8486363|NCT00574275|20912441|P1|STARTED|Overall Study||275
8486364|NCT00574249|20912459|P2|NOT COMPLETED|Overall Study||28
8486365|NCT00574249|20912460|P1|NOT COMPLETED|Overall Study||26
8486366|NCT00574249|20912459|P2|COMPLETED|Overall Study||338
8486367|NCT00574249|20912460|P1|COMPLETED|Overall Study||338
8486368|NCT00574249|20912459|P2|STARTED|Overall Study||366
8486369|NCT00574249|20912460|P1|STARTED|Overall Study||364
8486370|NCT00574236|20912500|P1|NOT COMPLETED|Overall Study||0
8486371|NCT00574236|20912500|P1|COMPLETED|Overall Study||4
8486372|NCT00574236|20912500|P1|STARTED|Overall Study||4
8486373|NCT00574197|20912505|P1|NOT COMPLETED|Overall Study||5
8486374|NCT00574197|20912505|P1|COMPLETED|Overall Study||6
8486375|NCT00574197|20912505|P1|STARTED|Overall Study||11
8486376|NCT00574171|20912510|P1|NOT COMPLETED|Overall Study||0
8486377|NCT00574171|20912510|P1|COMPLETED|Overall Study||29
8486378|NCT00574171|20912510|P1|STARTED|Overall Study||29
8486379|NCT00574145|20912516|P2|NOT COMPLETED|Overall Study||1
8486380|NCT00574145|20912517|P1|NOT COMPLETED|Overall Study||2
8486381|NCT00574145|20912516|P2|COMPLETED|Overall Study||21
8486382|NCT00574145|20912517|P1|COMPLETED|Overall Study||20
8486383|NCT00574145|20912516|P2|STARTED|Overall Study||22
8486384|NCT00574145|20912517|P1|STARTED|Overall Study||22
8486385|NCT00574119|20912527|P1|NOT COMPLETED|Overall Study||4
8486386|NCT00574119|20912527|P1|COMPLETED|Overall Study||12
8486387|NCT00574119|20912527|P1|STARTED|Overall Study||16
8486388|NCT00574080|20912541|P2|NOT COMPLETED|Overall Study||10
8486389|NCT00574080|20912542|P1|NOT COMPLETED|Overall Study||10
8486390|NCT00574080|20912541|P2|COMPLETED|Overall Study||0
8486391|NCT00574080|20912542|P1|COMPLETED|Overall Study||0
8486392|NCT00574080|20912541|P2|STARTED|Overall Study||10
8486393|NCT00574080|20912542|P1|STARTED|Overall Study||10
8486394|NCT00574067|20912552|P4|NOT COMPLETED|Overall Study||0
8486395|NCT00574067|20912553|P3|NOT COMPLETED|Overall Study||0
8486396|NCT00574067|20912554|P2|NOT COMPLETED|Overall Study||1
8486397|NCT00574067|20912555|P1|NOT COMPLETED|Overall Study||1
8486398|NCT00574067|20912552|P4|COMPLETED|Overall Study||53
8486399|NCT00574067|20912553|P3|COMPLETED|Overall Study||54
8486400|NCT00574067|20912554|P2|COMPLETED|Overall Study||52
8486401|NCT00574067|20912555|P1|COMPLETED|Overall Study||52
8486402|NCT00574067|20912552|P4|STARTED|Overall Study||53
8486403|NCT00574067|20912553|P3|STARTED|Overall Study||54
8486404|NCT00574067|20912554|P2|STARTED|Overall Study||53
8486405|NCT00574067|20912555|P1|STARTED|Overall Study||53
8486406|NCT00573989|20912589|P4|NOT COMPLETED|Erlotinib 125mg- Phase II||0
8486407|NCT00573989|20912590|P3|NOT COMPLETED|Erlotinib 125mg- Phase II||0
8486408|NCT00573989|20912591|P2|NOT COMPLETED|Erlotinib 125mg- Phase II||0
8486409|NCT00573989|20912592|P1|NOT COMPLETED|Erlotinib 125mg- Phase II||0
8486410|NCT00573989|20912589|P4|COMPLETED|Erlotinib 125mg- Phase II||12
8486411|NCT00573989|20912590|P3|COMPLETED|Erlotinib 125mg- Phase II||0
8486412|NCT00573989|20912591|P2|COMPLETED|Erlotinib 125mg- Phase II||0
8486413|NCT00573989|20912592|P1|COMPLETED|Erlotinib 125mg- Phase II||0
8486414|NCT00573989|20912589|P4|STARTED|Erlotinib 125mg- Phase II||12
8486415|NCT00573989|20912590|P3|STARTED|Erlotinib 125mg- Phase II||0
8486416|NCT00573989|20912591|P2|STARTED|Erlotinib 125mg- Phase II||0
8486417|NCT00573989|20912592|P1|STARTED|Erlotinib 125mg- Phase II||0
8486418|NCT00573989|20912589|P4|NOT COMPLETED|Erlotinib Phase I||0
8486419|NCT00573989|20912590|P3|NOT COMPLETED|Erlotinib Phase I||0
8486420|NCT00573989|20912591|P2|NOT COMPLETED|Erlotinib Phase I||0
8486421|NCT00573989|20912592|P1|NOT COMPLETED|Erlotinib Phase I||0
8486422|NCT00573989|20912589|P4|COMPLETED|Erlotinib Phase I||0
8486423|NCT00573989|20912590|P3|COMPLETED|Erlotinib Phase I||5
8486424|NCT00573989|20912591|P2|COMPLETED|Erlotinib Phase I||6
8486425|NCT00573989|20912592|P1|COMPLETED|Erlotinib Phase I||4
8486426|NCT00573989|20912589|P4|STARTED|Erlotinib Phase I||0
8486427|NCT00573989|20912590|P3|STARTED|Erlotinib Phase I||5
8486428|NCT00573989|20912591|P2|STARTED|Erlotinib Phase I||6
8486429|NCT00573989|20912592|P1|STARTED|Erlotinib Phase I||4
8486430|NCT00573937|20912611|P2|NOT COMPLETED|Overall Study||1
8486431|NCT00573937|20912612|P1|NOT COMPLETED|Overall Study||0
8486432|NCT00573937|20912611|P2|COMPLETED|Overall Study||0
8486433|NCT00573937|20912612|P1|COMPLETED|Overall Study||0
8486434|NCT00573937|20912611|P2|STARTED|Overall Study||1
8486435|NCT00573937|20912612|P1|STARTED|Overall Study||0
8486436|NCT00573872|20912620|P1|NOT COMPLETED|Overall Study||11
8486437|NCT00573872|20912620|P1|COMPLETED|Overall Study|# of patients that completed treatment|32
8486438|NCT00573872|20912620|P1|STARTED|Overall Study|# of patients that signed consent|43
8486439|NCT00573859|20912626|P1|NOT COMPLETED|Smoking Versus Abstinence||12
8486440|NCT00573859|20912626|P1|COMPLETED|Smoking Versus Abstinence||15
8486441|NCT00573859|20912626|P1|STARTED|Smoking Versus Abstinence||27
8486442|NCT00573859|20912626|P1|NOT COMPLETED|Medication Versus Placebo||12
8486443|NCT00573859|20912626|P1|COMPLETED|Medication Versus Placebo||15
8486444|NCT00573859|20912626|P1|STARTED|Medication Versus Placebo||27
8486445|NCT00573833|20912632|P1|NOT COMPLETED|Overall Study||2
8486446|NCT00573833|20912632|P1|COMPLETED|Overall Study||21
8486447|NCT00573833|20912632|P1|STARTED|Overall Study||23
8486451|NCT00573768|20912670|P3|NOT COMPLETED|Overall Study||4
8486452|NCT00573768|20912671|P2|NOT COMPLETED|Overall Study||2
8486453|NCT00573768|20912672|P1|NOT COMPLETED|Overall Study||2
8486454|NCT00573768|20912670|P3|COMPLETED|Overall Study||87
8486455|NCT00573768|20912671|P2|COMPLETED|Overall Study||89
8486456|NCT00573768|20912672|P1|COMPLETED|Overall Study||87
8486457|NCT00573768|20912670|P3|STARTED|Overall Study||91
8486458|NCT00573768|20912671|P2|STARTED|Overall Study||91
8486459|NCT00573768|20912672|P1|STARTED|Overall Study||89
8486460|NCT00573755|20912682|P2|NOT COMPLETED|Overall Study||0
8486461|NCT00573755|20912683|P1|NOT COMPLETED|Overall Study||1
8486462|NCT00573755|20912682|P2|COMPLETED|Overall Study||2
8486463|NCT00573755|20912683|P1|COMPLETED|Overall Study||1
8486464|NCT00573755|20912682|P2|STARTED|Overall Study||2
8486465|NCT00573755|20912683|P1|STARTED|Overall Study||2
8486466|NCT00573534|20912699|P1|NOT COMPLETED|Overall Study||3
8486467|NCT00573534|20912699|P1|COMPLETED|Overall Study||5
8486468|NCT00573534|20912699|P1|STARTED|Overall Study||8
8486469|NCT00573508|20912706|P2|NOT COMPLETED|Overall Study||41
8486470|NCT00573508|20912707|P1|NOT COMPLETED|Overall Study||64
8486471|NCT00573508|20912706|P2|COMPLETED|Overall Study||345
8486472|NCT00573508|20912707|P1|COMPLETED|Overall Study||318
8486473|NCT00573508|20912706|P2|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
8486474|NCT00573508|20912707|P1|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
8486475|NCT00573508|20912706|P2|STARTED|Overall Study||386
8486476|NCT00573508|20912707|P1|STARTED|Overall Study||382
8486477|NCT00573469|20912740|P3|NOT COMPLETED|Overall Study||4
8486478|NCT00573469|20912741|P2|NOT COMPLETED|Overall Study||4
8486479|NCT00573469|20912742|P1|NOT COMPLETED|Overall Study||6
8486480|NCT00573469|20912740|P3|COMPLETED|Overall Study||22
8486481|NCT00573469|20912741|P2|COMPLETED|Overall Study||21
8486482|NCT00573469|20912742|P1|COMPLETED|Overall Study||20
8486483|NCT00573469|20912740|P3|STARTED|Overall Study||26
8486484|NCT00573469|20912741|P2|STARTED|Overall Study||25
8486485|NCT00573469|20912742|P1|STARTED|Overall Study||26
8486486|NCT00573443|20912765|P3|NOT COMPLETED|Open-Label Extension Phase||0
8486487|NCT00573443|20912766|P2|NOT COMPLETED|Open-Label Extension Phase||0
8486488|NCT00573443|20912767|P1|NOT COMPLETED|Open-Label Extension Phase||18
8486489|NCT00573443|20912765|P3|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486490|NCT00573443|20912766|P2|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486491|NCT00573443|20912767|P1|COMPLETED|Open-Label Extension Phase||235
8486492|NCT00573443|20912765|P3|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486493|NCT00573443|20912766|P2|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486494|NCT00573443|20912767|P1|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
8486495|NCT00573443|20912765|P3|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486496|NCT00573443|20912766|P2|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486497|NCT00573443|20912767|P1|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
8486585|NCT00573170|20912913|P2|STARTED|Third Treatment Period||54
8486498|NCT00573443|20912765|P3|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486499|NCT00573443|20912766|P2|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
8486500|NCT00573443|20912767|P1|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
8486501|NCT00573443|20912765|P3|NOT COMPLETED|Double-Blind Phase||15
8486502|NCT00573443|20912766|P2|NOT COMPLETED|Double-Blind Phase||19
8486503|NCT00573443|20912767|P1|NOT COMPLETED|Double-Blind Phase||9
8486504|NCT00573443|20912765|P3|COMPLETED|Double-Blind Phase||94
8486505|NCT00573443|20912766|P2|COMPLETED|Double-Blind Phase||88
8486506|NCT00573443|20912767|P1|COMPLETED|Double-Blind Phase||101
8486507|NCT00573443|20912765|P3|Subjects With PBA Secondary to MS|Double-Blind Phase||45
8486508|NCT00573443|20912766|P2|Subjects With PBA Secondary to MS|Double-Blind Phase||39
8486509|NCT00573443|20912767|P1|Subjects With PBA Secondary to MS|Double-Blind Phase||45
8486510|NCT00573443|20912765|P3|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
8486511|NCT00573443|20912766|P2|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
8486512|NCT00573443|20912767|P1|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
8486513|NCT00573443|20912765|P3|STARTED|Double-Blind Phase||109
8486514|NCT00573443|20912766|P2|STARTED|Double-Blind Phase||107
8486515|NCT00573443|20912767|P1|STARTED|Double-Blind Phase||110
8486516|NCT00573430|20912797|P3|NOT COMPLETED|Overall Study||10
8486517|NCT00573430|20912798|P2|NOT COMPLETED|Overall Study||5
8486518|NCT00573430|20912799|P1|NOT COMPLETED|Overall Study||1
8486519|NCT00573430|20912797|P3|COMPLETED|Overall Study||33
8486520|NCT00573430|20912798|P2|COMPLETED|Overall Study||40
8486521|NCT00573430|20912799|P1|COMPLETED|Overall Study||39
8486522|NCT00573430|20912797|P3|STARTED|Overall Study|randomized|43
8486523|NCT00573430|20912798|P2|STARTED|Overall Study|randomized|45
8486524|NCT00573430|20912799|P1|STARTED|Overall Study|randomized|40
8486525|NCT00573391|20912821|P2|NOT COMPLETED|Overall Study||2
8486526|NCT00573391|20912822|P1|NOT COMPLETED|Overall Study||3
8486527|NCT00573391|20912821|P2|COMPLETED|Overall Study||0
8486528|NCT00573391|20912822|P1|COMPLETED|Overall Study||0
8486529|NCT00573391|20912821|P2|STARTED|Overall Study||2
8486530|NCT00573391|20912822|P1|STARTED|Overall Study||3
8486531|NCT00573313|20912832|P4|NOT COMPLETED|Overall Study||0
8486532|NCT00573313|20912833|P3|NOT COMPLETED|Overall Study||6
8486533|NCT00573313|20912834|P2|NOT COMPLETED|Overall Study||0
8486534|NCT00573313|20912835|P1|NOT COMPLETED|Overall Study||5
8486535|NCT00573313|20912832|P4|COMPLETED|Overall Study||26
8486536|NCT00573313|20912833|P3|COMPLETED|Overall Study||13
8486537|NCT00573313|20912834|P2|COMPLETED|Overall Study||28
8486538|NCT00573313|20912835|P1|COMPLETED|Overall Study||13
8486539|NCT00573313|20912832|P4|STARTED|Overall Study||26
8486540|NCT00573313|20912833|P3|STARTED|Overall Study|Nineteen recruited to start.|19
8486541|NCT00573313|20912834|P2|STARTED|Overall Study||28
8486542|NCT00573313|20912835|P1|STARTED|Overall Study|Eighteen participants recruited to start.|18
8486543|NCT00573287|20912845|P2|NOT COMPLETED|Overall Study||3
8486544|NCT00573287|20912846|P1|NOT COMPLETED|Overall Study||4
8486545|NCT00573287|20912845|P2|COMPLETED|Overall Study||4
8486546|NCT00573287|20912846|P1|COMPLETED|Overall Study||3
8486547|NCT00573287|20912845|P2|STARTED|Overall Study||7
8486548|NCT00573287|20912846|P1|STARTED|Overall Study||7
8486549|NCT00573261|20912856|P2|NOT COMPLETED|Overall Study||5
8486550|NCT00573261|20912857|P1|NOT COMPLETED|Overall Study||6
8486551|NCT00573261|20912856|P2|COMPLETED|Overall Study||15
8486552|NCT00573261|20912857|P1|COMPLETED|Overall Study||14
8486553|NCT00573261|20912856|P2|STARTED|Overall Study||20
8486554|NCT00573261|20912857|P1|STARTED|Overall Study||20
8486555|NCT00573248|20912885|P2|NOT COMPLETED|Overall Study||11
8486556|NCT00573248|20912886|P1|NOT COMPLETED|Overall Study||15
8486557|NCT00573248|20912885|P2|COMPLETED|Overall Study||27
8486558|NCT00573248|20912886|P1|COMPLETED|Overall Study||25
8486559|NCT00573248|20912885|P2|Nicotine Patches and Placebo Patches|Overall Study||27
8486560|NCT00573248|20912886|P1|Nicotine Patches and Placebo Patches|Overall Study||25
8486561|NCT00573248|20912885|P2|STARTED|Overall Study||38
8486562|NCT00573248|20912886|P1|STARTED|Overall Study||40
8486563|NCT00573183|20912900|P2|NOT COMPLETED|Overall Study||63
8486564|NCT00573183|20912901|P1|NOT COMPLETED|Overall Study||72
8486565|NCT00573183|20912900|P2|COMPLETED|Overall Study||174
8486566|NCT00573183|20912901|P1|COMPLETED|Overall Study||162
8486567|NCT00573183|20912900|P2|STARTED|Overall Study||237
8486568|NCT00573183|20912901|P1|STARTED|Overall Study||234
8486569|NCT00573170|20912909|P6|NOT COMPLETED|Third Treatment Period||2
8486570|NCT00573170|20912910|P5|NOT COMPLETED|Third Treatment Period||0
8486571|NCT00573170|20912911|P4|NOT COMPLETED|Third Treatment Period||0
8486572|NCT00573170|20912912|P3|NOT COMPLETED|Third Treatment Period||0
8486573|NCT00573170|20912913|P2|NOT COMPLETED|Third Treatment Period||0
8486574|NCT00573170|20912914|P1|NOT COMPLETED|Third Treatment Period||1
8486575|NCT00573170|20912909|P6|COMPLETED|Third Treatment Period||51
8486576|NCT00573170|20912910|P5|COMPLETED|Third Treatment Period||51
8486577|NCT00573170|20912911|P4|COMPLETED|Third Treatment Period||56
8486578|NCT00573170|20912912|P3|COMPLETED|Third Treatment Period||55
8486579|NCT00573170|20912913|P2|COMPLETED|Third Treatment Period||54
8486580|NCT00573170|20912914|P1|COMPLETED|Third Treatment Period||50
8486581|NCT00573170|20912909|P6|STARTED|Third Treatment Period||53
8486582|NCT00573170|20912910|P5|STARTED|Third Treatment Period||51
8486583|NCT00573170|20912911|P4|STARTED|Third Treatment Period||56
8486584|NCT00573170|20912912|P3|STARTED|Third Treatment Period||55
8486586|NCT00573170|20912914|P1|STARTED|Third Treatment Period||51
8486587|NCT00573170|20912909|P6|NOT COMPLETED|Second Washout Period||2
8486588|NCT00573170|20912910|P5|NOT COMPLETED|Second Washout Period||8
8486589|NCT00573170|20912911|P4|NOT COMPLETED|Second Washout Period||5
8486590|NCT00573170|20912912|P3|NOT COMPLETED|Second Washout Period||4
8486591|NCT00573170|20912913|P2|NOT COMPLETED|Second Washout Period||4
8486592|NCT00573170|20912914|P1|NOT COMPLETED|Second Washout Period||5
8486593|NCT00573170|20912909|P6|COMPLETED|Second Washout Period||53
8486594|NCT00573170|20912910|P5|COMPLETED|Second Washout Period||51
8486595|NCT00573170|20912911|P4|COMPLETED|Second Washout Period||56
8486596|NCT00573170|20912912|P3|COMPLETED|Second Washout Period||55
8486597|NCT00573170|20912913|P2|COMPLETED|Second Washout Period||54
8486598|NCT00573170|20912914|P1|COMPLETED|Second Washout Period||51
8486599|NCT00573170|20912909|P6|STARTED|Second Washout Period||55
8486600|NCT00573170|20912910|P5|STARTED|Second Washout Period||59
8486601|NCT00573170|20912911|P4|STARTED|Second Washout Period||61
8486602|NCT00573170|20912912|P3|STARTED|Second Washout Period||59
8486603|NCT00573170|20912913|P2|STARTED|Second Washout Period||58
8486604|NCT00573170|20912914|P1|STARTED|Second Washout Period||56
8486605|NCT00573170|20912909|P6|NOT COMPLETED|Second Treatment Period||0
8486606|NCT00573170|20912910|P5|NOT COMPLETED|Second Treatment Period||0
8486607|NCT00573170|20912911|P4|NOT COMPLETED|Second Treatment Period||0
8486608|NCT00573170|20912912|P3|NOT COMPLETED|Second Treatment Period||0
8486609|NCT00573170|20912913|P2|NOT COMPLETED|Second Treatment Period||0
8486610|NCT00573170|20912914|P1|NOT COMPLETED|Second Treatment Period||0
8486611|NCT00573170|20912909|P6|COMPLETED|Second Treatment Period||55
8486612|NCT00573170|20912910|P5|COMPLETED|Second Treatment Period||59
8486613|NCT00573170|20912911|P4|COMPLETED|Second Treatment Period||61
8486614|NCT00573170|20912912|P3|COMPLETED|Second Treatment Period||59
8486615|NCT00573170|20912913|P2|COMPLETED|Second Treatment Period||58
8486616|NCT00573170|20912914|P1|COMPLETED|Second Treatment Period||56
8486617|NCT00573170|20912909|P6|STARTED|Second Treatment Period||55
8486618|NCT00573170|20912910|P5|STARTED|Second Treatment Period||59
8486619|NCT00573170|20912911|P4|STARTED|Second Treatment Period||61
8486620|NCT00573170|20912912|P3|STARTED|Second Treatment Period||59
8486621|NCT00573170|20912913|P2|STARTED|Second Treatment Period||58
8486622|NCT00573170|20912914|P1|STARTED|Second Treatment Period||56
8486623|NCT00573170|20912909|P6|NOT COMPLETED|First Washout Period||7
8486624|NCT00573170|20912910|P5|NOT COMPLETED|First Washout Period||3
8486625|NCT00573170|20912911|P4|NOT COMPLETED|First Washout Period||5
8486626|NCT00573170|20912912|P3|NOT COMPLETED|First Washout Period||1
8486627|NCT00573170|20912913|P2|NOT COMPLETED|First Washout Period||2
8486628|NCT00573170|20912914|P1|NOT COMPLETED|First Washout Period||8
8486629|NCT00573170|20912909|P6|COMPLETED|First Washout Period||55
8486630|NCT00573170|20912910|P5|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
8486631|NCT00573170|20912911|P4|COMPLETED|First Washout Period||61
8486632|NCT00573170|20912912|P3|COMPLETED|First Washout Period||59
8486633|NCT00573170|20912913|P2|COMPLETED|First Washout Period||58
8486634|NCT00573170|20912914|P1|COMPLETED|First Washout Period||56
8486635|NCT00573170|20912909|P6|STARTED|First Washout Period||62
8486636|NCT00573170|20912910|P5|STARTED|First Washout Period||62
8486637|NCT00573170|20912911|P4|STARTED|First Washout Period||66
8486638|NCT00573170|20912912|P3|STARTED|First Washout Period||60
8486639|NCT00573170|20912913|P2|STARTED|First Washout Period||60
8486640|NCT00573170|20912914|P1|STARTED|First Washout Period||64
8486641|NCT00573170|20912909|P6|NOT COMPLETED|First Treatment Period||0
8486642|NCT00573170|20912910|P5|NOT COMPLETED|First Treatment Period||1
8486643|NCT00573170|20912911|P4|NOT COMPLETED|First Treatment Period||0
8486644|NCT00573170|20912912|P3|NOT COMPLETED|First Treatment Period||0
8486645|NCT00573170|20912913|P2|NOT COMPLETED|First Treatment Period||0
8486646|NCT00573170|20912914|P1|NOT COMPLETED|First Treatment Period||0
8486647|NCT00573170|20912909|P6|COMPLETED|First Treatment Period||62
8486648|NCT00573170|20912910|P5|COMPLETED|First Treatment Period||62
8486649|NCT00573170|20912911|P4|COMPLETED|First Treatment Period||66
8486650|NCT00573170|20912912|P3|COMPLETED|First Treatment Period||60
8486651|NCT00573170|20912913|P2|COMPLETED|First Treatment Period||60
8486652|NCT00573170|20912914|P1|COMPLETED|First Treatment Period||64
8486653|NCT00573170|20912909|P6|STARTED|First Treatment Period||62
8486654|NCT00573170|20912910|P5|STARTED|First Treatment Period||63
8486655|NCT00573170|20912911|P4|STARTED|First Treatment Period||66
8486656|NCT00573170|20912912|P3|STARTED|First Treatment Period||60
8486657|NCT00573170|20912913|P2|STARTED|First Treatment Period||60
8486658|NCT00573170|20912914|P1|STARTED|First Treatment Period||64
8486659|NCT00573157|20912990|P2|NOT COMPLETED|Overall Study||2
8486660|NCT00573157|20912991|P1|NOT COMPLETED|Overall Study||4
8486661|NCT00573157|20912990|P2|COMPLETED|Overall Study||0
8486662|NCT00573157|20912991|P1|COMPLETED|Overall Study||0
8486663|NCT00573157|20912990|P2|STARTED|Overall Study||2
8486664|NCT00573157|20912991|P1|STARTED|Overall Study||4
8486665|NCT00573144|20913003|P2|NOT COMPLETED|Overall Study||3
8486666|NCT00573144|20913004|P1|NOT COMPLETED|Overall Study||2
8486667|NCT00573144|20913003|P2|COMPLETED|Overall Study||25
8486668|NCT00573144|20913004|P1|COMPLETED|Overall Study||28
8486669|NCT00573144|20913003|P2|STARTED|Overall Study||28
8486670|NCT00573144|20913004|P1|STARTED|Overall Study||30
8486671|NCT00573131|20913016|P2|NOT COMPLETED|Overall Study||8
8486672|NCT00573131|20913017|P1|NOT COMPLETED|Overall Study||10
8486673|NCT00573131|20913016|P2|COMPLETED|Overall Study||57
8486674|NCT00573131|20913017|P1|COMPLETED|Overall Study||62
8486675|NCT00573131|20913016|P2|STARTED|Overall Study||65
8486676|NCT00573131|20913017|P1|STARTED|Overall Study||72
8486677|NCT00573066|20913023|P1|NOT COMPLETED|Overall Study||20
8486678|NCT00573066|20913023|P1|COMPLETED|Overall Study||36
8486679|NCT00573066|20913023|P1|STARTED|Overall Study||56
8486680|NCT00572936|20913027|P6|NOT COMPLETED|Third Intervention||0
8486681|NCT00572936|20913028|P5|NOT COMPLETED|Third Intervention||0
8486682|NCT00572936|20913029|P4|NOT COMPLETED|Third Intervention||0
8486683|NCT00572936|20913030|P3|NOT COMPLETED|Third Intervention||0
8486684|NCT00572936|20913031|P2|NOT COMPLETED|Third Intervention||0
8486685|NCT00572936|20913032|P1|NOT COMPLETED|Third Intervention||0
8486686|NCT00572936|20913027|P6|COMPLETED|Third Intervention||5
8486687|NCT00572936|20913028|P5|COMPLETED|Third Intervention||3
8486688|NCT00572936|20913029|P4|COMPLETED|Third Intervention||5
8486689|NCT00572936|20913030|P3|COMPLETED|Third Intervention||4
8486690|NCT00572936|20913031|P2|COMPLETED|Third Intervention||3
8486691|NCT00572936|20913032|P1|COMPLETED|Third Intervention||4
8486692|NCT00572936|20913027|P6|STARTED|Third Intervention||5
8486693|NCT00572936|20913028|P5|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
8486694|NCT00572936|20913029|P4|STARTED|Third Intervention||5
8486695|NCT00572936|20913030|P3|STARTED|Third Intervention||4
8486696|NCT00572936|20913031|P2|STARTED|Third Intervention||3
8486697|NCT00572936|20913032|P1|STARTED|Third Intervention||4
8486698|NCT00572936|20913027|P6|NOT COMPLETED|Second Intervention||0
8486699|NCT00572936|20913028|P5|NOT COMPLETED|Second Intervention||0
8486700|NCT00572936|20913029|P4|NOT COMPLETED|Second Intervention||0
8486701|NCT00572936|20913030|P3|NOT COMPLETED|Second Intervention||0
8486702|NCT00572936|20913031|P2|NOT COMPLETED|Second Intervention||0
8486703|NCT00572936|20913032|P1|NOT COMPLETED|Second Intervention||0
8486704|NCT00572936|20913027|P6|COMPLETED|Second Intervention||5
8486705|NCT00572936|20913028|P5|COMPLETED|Second Intervention||4
8486706|NCT00572936|20913029|P4|COMPLETED|Second Intervention||5
8486707|NCT00572936|20913030|P3|COMPLETED|Second Intervention||4
8486708|NCT00572936|20913031|P2|COMPLETED|Second Intervention||3
8486709|NCT00572936|20913032|P1|COMPLETED|Second Intervention||4
8486710|NCT00572936|20913027|P6|STARTED|Second Intervention||5
8486711|NCT00572936|20913028|P5|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
8486712|NCT00572936|20913029|P4|STARTED|Second Intervention||5
8486713|NCT00572936|20913030|P3|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
8486714|NCT00572936|20913031|P2|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
8486715|NCT00572936|20913032|P1|STARTED|Second Intervention||4
8486716|NCT00572936|20913027|P6|NOT COMPLETED|First Intervention||0
8486717|NCT00572936|20913028|P5|NOT COMPLETED|First Intervention||0
8486718|NCT00572936|20913029|P4|NOT COMPLETED|First Intervention||0
8486719|NCT00572936|20913030|P3|NOT COMPLETED|First Intervention||0
8486720|NCT00572936|20913031|P2|NOT COMPLETED|First Intervention||0
8486721|NCT00572936|20913032|P1|NOT COMPLETED|First Intervention||0
8486722|NCT00572936|20913027|P6|COMPLETED|First Intervention||5
8486723|NCT00572936|20913028|P5|COMPLETED|First Intervention||5
8486724|NCT00572936|20913029|P4|COMPLETED|First Intervention||5
8486725|NCT00572936|20913030|P3|COMPLETED|First Intervention||5
8486726|NCT00572936|20913031|P2|COMPLETED|First Intervention||4
8486727|NCT00572936|20913032|P1|COMPLETED|First Intervention||4
8486728|NCT00572936|20913027|P6|STARTED|First Intervention||5
8486729|NCT00572936|20913028|P5|STARTED|First Intervention||5
8486730|NCT00572936|20913029|P4|STARTED|First Intervention||5
8486731|NCT00572936|20913030|P3|STARTED|First Intervention||5
8486732|NCT00572936|20913031|P2|STARTED|First Intervention||4
8486733|NCT00572936|20913032|P1|STARTED|First Intervention||4
8486734|NCT00572910|20913067|P11|NOT COMPLETED|Overall Study||3
8486735|NCT00572910|20913068|P10|NOT COMPLETED|Overall Study||6
8486736|NCT00572910|20913069|P9|NOT COMPLETED|Overall Study||3
8486737|NCT00572910|20913070|P8|NOT COMPLETED|Overall Study||4
8486738|NCT00572910|20913071|P7|NOT COMPLETED|Overall Study||4
8486739|NCT00572910|20913072|P6|NOT COMPLETED|Overall Study||3
8486740|NCT00572910|20913073|P5|NOT COMPLETED|Overall Study||2
8486741|NCT00572910|20913074|P4|NOT COMPLETED|Overall Study||4
8486742|NCT00572910|20913075|P3|NOT COMPLETED|Overall Study||2
8486743|NCT00572910|20913076|P2|NOT COMPLETED|Overall Study||3
8486744|NCT00572910|20913077|P1|NOT COMPLETED|Overall Study||4
8486745|NCT00572910|20913067|P11|COMPLETED|Overall Study||15
8486746|NCT00572910|20913068|P10|COMPLETED|Overall Study||13
8486747|NCT00572910|20913069|P9|COMPLETED|Overall Study||16
8486748|NCT00572910|20913070|P8|COMPLETED|Overall Study||15
8486749|NCT00572910|20913071|P7|COMPLETED|Overall Study||15
8486750|NCT00572910|20913072|P6|COMPLETED|Overall Study||16
8486751|NCT00572910|20913073|P5|COMPLETED|Overall Study||17
8486752|NCT00572910|20913074|P4|COMPLETED|Overall Study||14
8486753|NCT00572910|20913075|P3|COMPLETED|Overall Study||17
8486754|NCT00572910|20913076|P2|COMPLETED|Overall Study||15
8486755|NCT00572910|20913077|P1|COMPLETED|Overall Study||15
8486756|NCT00572910|20913067|P11|STARTED|Overall Study||18
8486757|NCT00572910|20913068|P10|STARTED|Overall Study||19
8486758|NCT00572910|20913069|P9|STARTED|Overall Study||19
8486759|NCT00572910|20913070|P8|STARTED|Overall Study||19
8486760|NCT00572910|20913071|P7|STARTED|Overall Study||19
8486761|NCT00572910|20913072|P6|STARTED|Overall Study||19
8486762|NCT00572910|20913073|P5|STARTED|Overall Study||19
8486763|NCT00572910|20913074|P4|STARTED|Overall Study||18
8486764|NCT00572910|20913075|P3|STARTED|Overall Study||19
8486765|NCT00572910|20913076|P2|STARTED|Overall Study||18
8486766|NCT00572910|20913077|P1|STARTED|Overall Study||19
8486767|NCT00572897|20913125|P2|NOT COMPLETED|Overall Study||0
8486768|NCT00572897|20913126|P1|NOT COMPLETED|Overall Study||0
8486769|NCT00572897|20913125|P2|COMPLETED|Overall Study||34
8486770|NCT00572897|20913126|P1|COMPLETED|Overall Study||32
8486771|NCT00572897|20913125|P2|STARTED|Overall Study||34
8486772|NCT00572897|20913126|P1|STARTED|Overall Study||32
8486773|NCT00572832|20913144|P2|NOT COMPLETED|Overall Study||12
8486774|NCT00572832|20913145|P1|NOT COMPLETED|Overall Study||0
8486775|NCT00572832|20913144|P2|COMPLETED|Overall Study||88
8486776|NCT00572832|20913145|P1|COMPLETED|Overall Study||100
8486777|NCT00572832|20913144|P2|STARTED|Overall Study||100
8486778|NCT00572832|20913145|P1|STARTED|Overall Study||100
8486779|NCT00572728|20913151|P1|NOT COMPLETED|Overall Study||39
8486780|NCT00572728|20913151|P1|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
8486781|NCT00572728|20913151|P1|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
8486782|NCT00572728|20913151|P1|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
8486783|NCT00572728|20913151|P1|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
8486784|NCT00572728|20913151|P1|Pathology Complete|Overall Study||51
8486785|NCT00572728|20913151|P1|Second Chemotherapy Initiated After FLT2|Overall Study||52
8486786|NCT00572728|20913151|P1|Second Chemotherapy Initiated|Overall Study||59
8486787|NCT00572728|20913151|P1|Completed FLT2 Scan|Overall Study||60
8486788|NCT00572728|20913151|P1|First Therapy Initiated|Overall Study||65
8486789|NCT00572728|20913151|P1|Completed FLT1 Scan|Overall Study||67
8486790|NCT00572728|20913151|P1|On Study|Overall Study||71
8486791|NCT00572728|20913151|P1|Did Not Withdraw|Overall Study||72
8486792|NCT00572728|20913151|P1|Enrolled Under Amendment 5 or Later|Overall Study||82
8486793|NCT00572728|20913151|P1|Eligible|Overall Study||87
8486794|NCT00572728|20913151|P1|STARTED|Overall Study|Registered|90
8486795|NCT00572624|20913165|P2|NOT COMPLETED|Overall Study||4
8486796|NCT00572624|20913166|P1|NOT COMPLETED|Overall Study||17
8486797|NCT00572624|20913165|P2|COMPLETED|Overall Study||10
8486798|NCT00572624|20913166|P1|COMPLETED|Overall Study||20
8486799|NCT00572624|20913165|P2|STARTED|Overall Study||14
8486800|NCT00572624|20913166|P1|STARTED|Overall Study||37
8486801|NCT00572572|20913194|P2|NOT COMPLETED|Overall Study||6
8486802|NCT00572572|20913195|P1|NOT COMPLETED|Overall Study||3
8486803|NCT00572572|20913194|P2|COMPLETED|Overall Study||28
8486804|NCT00572572|20913195|P1|COMPLETED|Overall Study||32
8486805|NCT00572572|20913194|P2|STARTED|Overall Study||34
8486806|NCT00572572|20913195|P1|STARTED|Overall Study||35
8486807|NCT00572533|20913213|P2|NOT COMPLETED|Overall Study||3
8486808|NCT00572533|20913214|P1|NOT COMPLETED|Overall Study||7
8486809|NCT00572533|20913213|P2|COMPLETED|Overall Study||28
8486810|NCT00572533|20913214|P1|COMPLETED|Overall Study||24
8486811|NCT00572533|20913213|P2|STARTED|Overall Study||31
8486812|NCT00572533|20913214|P1|STARTED|Overall Study||31
8486813|NCT00572468|20913236|P2|NOT COMPLETED|Overall Study||4
8486814|NCT00572468|20913237|P1|NOT COMPLETED|Overall Study||2
8486815|NCT00572468|20913236|P2|COMPLETED|Overall Study||16
8486816|NCT00572468|20913237|P1|COMPLETED|Overall Study||20
8486817|NCT00572468|20913236|P2|STARTED|Overall Study||20
8486818|NCT00572468|20913237|P1|STARTED|Overall Study||22
8486819|NCT00572260|20913245|P1|NOT COMPLETED|Overall Study||0
8486820|NCT00572260|20913245|P1|COMPLETED|Overall Study||11
8486821|NCT00572260|20913245|P1|STARTED|Overall Study||11
8486822|NCT00572234|20913251|P2|NOT COMPLETED|Overall Study||5
8486823|NCT00572234|20913252|P1|NOT COMPLETED|Overall Study||1
8486824|NCT00572234|20913251|P2|COMPLETED|Overall Study||16
8486825|NCT00572234|20913252|P1|COMPLETED|Overall Study||18
8486826|NCT00572234|20913251|P2|STARTED|Overall Study||21
8486827|NCT00572234|20913252|P1|STARTED|Overall Study||19
8486828|NCT00572195|20913258|P1|NOT COMPLETED|Overall Study||68
8486829|NCT00572195|20913258|P1|COMPLETED|Overall Study||162
8486830|NCT00572195|20913258|P1|STARTED|Overall Study||230
8486831|NCT00572156|20913270|P4|NOT COMPLETED|Overall Study||25
8486832|NCT00572156|20913271|P3|NOT COMPLETED|Overall Study||27
8486833|NCT00572156|20913272|P2|NOT COMPLETED|Overall Study||26
8486834|NCT00572156|20913273|P1|NOT COMPLETED|Overall Study||26
8486835|NCT00572156|20913270|P4|COMPLETED|Overall Study||1
8486836|NCT00572156|20913271|P3|COMPLETED|Overall Study||0
8486837|NCT00572156|20913272|P2|COMPLETED|Overall Study||1
8486838|NCT00572156|20913273|P1|COMPLETED|Overall Study||0
8486839|NCT00572156|20913270|P4|STARTED|Overall Study||26
8486840|NCT00572156|20913271|P3|STARTED|Overall Study||27
8486841|NCT00572156|20913272|P2|STARTED|Overall Study||27
8486842|NCT00572156|20913273|P1|STARTED|Overall Study||26
8486843|NCT00572117|20913333|P2|NOT COMPLETED|Overall Study||2
8486844|NCT00572117|20913334|P1|NOT COMPLETED|Overall Study||2
8486845|NCT00572117|20913333|P2|COMPLETED|Overall Study||5
8486846|NCT00572117|20913334|P1|COMPLETED|Overall Study||3
8486847|NCT00572117|20913333|P2|STARTED|Overall Study||7
8486848|NCT00572117|20913334|P1|STARTED|Overall Study||5
8486849|NCT00572039|20913344|P2|NOT COMPLETED|Overall Study||10
8486850|NCT00572039|20913345|P1|NOT COMPLETED|Overall Study||16
8486851|NCT00572039|20913344|P2|COMPLETED|Overall Study||110
8486852|NCT00572039|20913345|P1|COMPLETED|Overall Study||105
8486853|NCT00572039|20913344|P2|STARTED|Overall Study||120
8486854|NCT00572039|20913345|P1|STARTED|Overall Study||121
8486855|NCT00571987|20913357|P1|NOT COMPLETED|Overall Study||7
8486856|NCT00571987|20913357|P1|COMPLETED|Overall Study||100
8486857|NCT00571987|20913357|P1|STARTED|Overall Study||107
8486858|NCT00571974|20913364|P2|NOT COMPLETED|Phase II||4
8486859|NCT00571974|20913365|P1|NOT COMPLETED|Phase II||0
8486860|NCT00571974|20913364|P2|COMPLETED|Phase II||17
8486861|NCT00571974|20913365|P1|COMPLETED|Phase II||0
8486862|NCT00571974|20913364|P2|STARTED|Phase II|3 participants are from phase I|21
8486863|NCT00571974|20913365|P1|STARTED|Phase II||0
8486864|NCT00571974|20913364|P2|NOT COMPLETED|Phase I||0
8486865|NCT00571974|20913365|P1|NOT COMPLETED|Phase I||0
8486866|NCT00571974|20913364|P2|COMPLETED|Phase I||0
8486867|NCT00571974|20913365|P1|COMPLETED|Phase I||9
8486868|NCT00571974|20913364|P2|STARTED|Phase I||0
8486869|NCT00571974|20913365|P1|STARTED|Phase I||9
8486870|NCT00571961|20913371|P1|NOT COMPLETED|Overall Study||0
8486871|NCT00571961|20913371|P1|COMPLETED|Overall Study||12
8486872|NCT00571961|20913371|P1|STARTED|Overall Study||12
8486873|NCT00571948|20913377|P2|NOT COMPLETED|Overall Study||14
8486874|NCT00571948|20913378|P1|NOT COMPLETED|Overall Study||11
8486875|NCT00571948|20913377|P2|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
8486876|NCT00571948|20913378|P1|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
8486877|NCT00571948|20913377|P2|STARTED|Overall Study||66
8486878|NCT00571948|20913378|P1|STARTED|Overall Study||66
8486879|NCT00571922|20913386|P2|NOT COMPLETED|Overall Study||36
8486880|NCT00571922|20913387|P1|NOT COMPLETED|Overall Study||36
8486881|NCT00571922|20913386|P2|COMPLETED|Overall Study||0
8486882|NCT00571922|20913387|P1|COMPLETED|Overall Study||0
8486883|NCT00571922|20913386|P2|STARTED|Overall Study||36
8486884|NCT00571922|20913387|P1|STARTED|Overall Study||36
8486885|NCT00571701|20913397|P2|NOT COMPLETED|Second Intervention 12 Months||1
8486886|NCT00571701|20913398|P1|NOT COMPLETED|Second Intervention 12 Months||3
8486887|NCT00571701|20913397|P2|COMPLETED|Second Intervention 12 Months||20
8486888|NCT00571701|20913398|P1|COMPLETED|Second Intervention 12 Months||13
8486889|NCT00571701|20913397|P2|STARTED|Second Intervention 12 Months||21
8486890|NCT00571701|20913398|P1|STARTED|Second Intervention 12 Months||16
8486891|NCT00571701|20913397|P2|NOT COMPLETED|First Intervention 12 Months||1
8486892|NCT00571701|20913398|P1|NOT COMPLETED|First Intervention 12 Months||3
8486893|NCT00571701|20913397|P2|COMPLETED|First Intervention 12 Months||21
8486894|NCT00571701|20913398|P1|COMPLETED|First Intervention 12 Months||16
8486895|NCT00571701|20913397|P2|STARTED|First Intervention 12 Months||22
8486896|NCT00571701|20913398|P1|STARTED|First Intervention 12 Months||19
8486897|NCT00571688|20913424|P2|NOT COMPLETED|Overall Study||6
8486898|NCT00571688|20913425|P1|NOT COMPLETED|Overall Study||5
8486899|NCT00571688|20913424|P2|COMPLETED|Overall Study||19
8486900|NCT00571688|20913425|P1|COMPLETED|Overall Study||20
8486901|NCT00571688|20913424|P2|STARTED|Overall Study||25
8486902|NCT00571688|20913425|P1|STARTED|Overall Study||25
8486903|NCT00571662|20913431|P1|NOT COMPLETED|Overall Study||8
8486904|NCT00571662|20913431|P1|COMPLETED|Overall Study||68
8486905|NCT00571662|20913431|P1|STARTED|Overall Study||76
8486906|NCT00571649|20913442|P2|NOT COMPLETED|Follow-up Period||528
8486907|NCT00571649|20913443|P1|NOT COMPLETED|Follow-up Period||545
8486908|NCT00571649|20913442|P2|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
8486909|NCT00571649|20913443|P1|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
8486910|NCT00571649|20913442|P2|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
8486911|NCT00571649|20913443|P1|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
8486912|NCT00571649|20913442|P2|NOT COMPLETED|Treatment Period||1004
8486913|NCT00571649|20913443|P1|NOT COMPLETED|Treatment Period||1092
8486914|NCT00571649|20913442|P2|COMPLETED|Treatment Period||3047
8486915|NCT00571649|20913443|P1|COMPLETED|Treatment Period||2958
8486916|NCT00571649|20913442|P2|Day 35|Treatment Period||3115
8486917|NCT00571649|20913443|P1|Day 35|Treatment Period||3033
8486918|NCT00571649|20913442|P2|Day 10|Treatment Period||3499
8486919|NCT00571649|20913443|P1|Day 10|Treatment Period||3454
8486920|NCT00571649|20913442|P2|Participants Received Treatment|Treatment Period||4001
8486921|NCT00571649|20913443|P1|Participants Received Treatment|Treatment Period||3997
8486922|NCT00571649|20913442|P2|STARTED|Treatment Period||4051
8486923|NCT00571649|20913443|P1|STARTED|Treatment Period||4050
8486924|NCT00571493|20913475|P7|NOT COMPLETED|Overall Study||0
8486925|NCT00571493|20913476|P6|NOT COMPLETED|Overall Study||0
8486926|NCT00571493|20913477|P5|NOT COMPLETED|Overall Study||0
8486927|NCT00571493|20913478|P4|NOT COMPLETED|Overall Study||0
8486928|NCT00571493|20913479|P3|NOT COMPLETED|Overall Study||0
8486929|NCT00571493|20913480|P2|NOT COMPLETED|Overall Study||0
8486930|NCT00571493|20913481|P1|NOT COMPLETED|Overall Study||0
8486931|NCT00571493|20913475|P7|COMPLETED|Overall Study||6
8486932|NCT00571493|20913476|P6|COMPLETED|Overall Study||12
8486933|NCT00571493|20913477|P5|COMPLETED|Overall Study||11
8486934|NCT00571493|20913478|P4|COMPLETED|Overall Study||3
8486935|NCT00571493|20913479|P3|COMPLETED|Overall Study||3
8486936|NCT00571493|20913480|P2|COMPLETED|Overall Study||4
8486937|NCT00571493|20913481|P1|COMPLETED|Overall Study||3
8486938|NCT00571493|20913475|P7|STARTED|Overall Study||6
8486939|NCT00571493|20913476|P6|STARTED|Overall Study||12
8486940|NCT00571493|20913477|P5|STARTED|Overall Study||11
8486941|NCT00571493|20913478|P4|STARTED|Overall Study||3
8486942|NCT00571493|20913479|P3|STARTED|Overall Study||3
8486943|NCT00571493|20913480|P2|STARTED|Overall Study||4
8486944|NCT00571493|20913481|P1|STARTED|Overall Study||3
8486945|NCT00571428|20913491|P2|NOT COMPLETED|Overall Study||0
8486946|NCT00571428|20913492|P1|NOT COMPLETED|Overall Study||0
8486947|NCT00571428|20913491|P2|COMPLETED|Overall Study||18
8486948|NCT00571428|20913492|P1|COMPLETED|Overall Study||15
8486949|NCT00571428|20913491|P2|STARTED|Overall Study||18
8486950|NCT00571428|20913492|P1|STARTED|Overall Study||15
8486951|NCT00571324|20913524|P2|NOT COMPLETED|Intervention 2 (7 Hours)||0
8486952|NCT00571324|20913525|P1|NOT COMPLETED|Intervention 2 (7 Hours)||0
8486953|NCT00571324|20913524|P2|COMPLETED|Intervention 2 (7 Hours)||4
8486954|NCT00571324|20913525|P1|COMPLETED|Intervention 2 (7 Hours)||5
8486955|NCT00571324|20913524|P2|STARTED|Intervention 2 (7 Hours)||4
8486956|NCT00571324|20913525|P1|STARTED|Intervention 2 (7 Hours)||5
8486957|NCT00571324|20913524|P2|NOT COMPLETED|Intervention 1 (7 Hours)||0
8486958|NCT00571324|20913525|P1|NOT COMPLETED|Intervention 1 (7 Hours)||0
8486959|NCT00571324|20913524|P2|COMPLETED|Intervention 1 (7 Hours)||4
8486960|NCT00571324|20913525|P1|COMPLETED|Intervention 1 (7 Hours)||5
8486961|NCT00571324|20913524|P2|STARTED|Intervention 1 (7 Hours)||4
8486962|NCT00571324|20913525|P1|STARTED|Intervention 1 (7 Hours)||5
8486963|NCT00571194|20913537|P1|NOT COMPLETED|Overall Study||0
8486964|NCT00571194|20913537|P1|COMPLETED|Overall Study||7
8486965|NCT00571194|20913537|P1|STARTED|Overall Study||7
8486966|NCT00571103|20913541|P1|NOT COMPLETED|Overall Study||2
8486967|NCT00571103|20913541|P1|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
8486968|NCT00571103|20913541|P1|STARTED|Overall Study||28
8486969|NCT00571064|20913546|P1|NOT COMPLETED|Overall Study||21
8486970|NCT00571064|20913546|P1|COMPLETED|Overall Study||76
8486971|NCT00571064|20913546|P1|STARTED|Overall Study||97
8486972|NCT00571038|20913561|P2|NOT COMPLETED|Overall Study||14
8486973|NCT00571038|20913562|P1|NOT COMPLETED|Overall Study||11
8486974|NCT00571038|20913561|P2|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
8486975|NCT00571038|20913562|P1|COMPLETED|Overall Study|"7 died 2 moved
~1 asked to be withdrawn
~1 unable to reach"|208
8486976|NCT00571038|20913561|P2|18 Month Survey Only|Overall Study||163
8486977|NCT00571038|20913562|P1|18 Month Survey Only|Overall Study||199
8486978|NCT00571038|20913561|P2|6 Month Follow up|Overall Study||176
8486979|NCT00571038|20913562|P1|6 Month Follow up|Overall Study||208
8486980|NCT00571038|20913561|P2|STARTED|Overall Study||185
8486981|NCT00571038|20913562|P1|STARTED|Overall Study||219
8486982|NCT00570960|20913610|P2|NOT COMPLETED|Overall Study||0
8486983|NCT00570960|20913611|P1|NOT COMPLETED|Overall Study||0
8486984|NCT00570960|20913610|P2|COMPLETED|Overall Study||4
8486985|NCT00570960|20913611|P1|COMPLETED|Overall Study||4
8486986|NCT00570960|20913610|P2|STARTED|Overall Study||4
8486987|NCT00570960|20913611|P1|STARTED|Overall Study||4
8486988|NCT00570921|20913617|P1|NOT COMPLETED|Overall Study||2
8486989|NCT00570921|20913617|P1|COMPLETED|Overall Study||31
8486990|NCT00570921|20913617|P1|STARTED|Overall Study||33
8486991|NCT00570908|20913623|P1|NOT COMPLETED|Overall Study||7
8486992|NCT00570908|20913623|P1|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
8486993|NCT00570908|20913623|P1|STARTED|Overall Study||12
8486994|NCT00570778|20913627|P4|NOT COMPLETED|Overall Study||4
8486995|NCT00570778|20913628|P3|NOT COMPLETED|Overall Study||7
8486996|NCT00570778|20913629|P2|NOT COMPLETED|Overall Study||4
8486997|NCT00570778|20913630|P1|NOT COMPLETED|Overall Study||4
8486998|NCT00570778|20913627|P4|COMPLETED|Overall Study||34
8486999|NCT00570778|20913628|P3|COMPLETED|Overall Study||30
8487000|NCT00570778|20913629|P2|COMPLETED|Overall Study||34
8487001|NCT00570778|20913630|P1|COMPLETED|Overall Study||37
8487002|NCT00570778|20913627|P4|Modified Intent-to-treat Population|Overall Study||37
8487003|NCT00570778|20913628|P3|Modified Intent-to-treat Population|Overall Study||35
8487004|NCT00570778|20913629|P2|Modified Intent-to-treat Population|Overall Study||37
8487005|NCT00570778|20913630|P1|Modified Intent-to-treat Population|Overall Study||40
8487006|NCT00570778|20913627|P4|Safety Population: Received Study Drug|Overall Study||38
8487007|NCT00570778|20913628|P3|Safety Population: Received Study Drug|Overall Study||36
8487008|NCT00570778|20913629|P2|Safety Population: Received Study Drug|Overall Study||38
8487009|NCT00570778|20913630|P1|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
8487010|NCT00570778|20913627|P4|STARTED|Overall Study||38
8487011|NCT00570778|20913628|P3|STARTED|Overall Study||37
8487012|NCT00570778|20913629|P2|STARTED|Overall Study||38
8487013|NCT00570778|20913630|P1|STARTED|Overall Study||41
8487023|NCT00570739|20913671|P4|NOT COMPLETED|Overall Study||12
8487024|NCT00570739|20913672|P3|NOT COMPLETED|Overall Study||16
8487025|NCT00570739|20913673|P2|NOT COMPLETED|Overall Study||21
8487026|NCT00570739|20913674|P1|NOT COMPLETED|Overall Study||21
8487027|NCT00570739|20913671|P4|COMPLETED|Overall Study||96
8487028|NCT00570739|20913672|P3|COMPLETED|Overall Study||92
8487029|NCT00570739|20913673|P2|COMPLETED|Overall Study||124
8487030|NCT00570739|20913674|P1|COMPLETED|Overall Study||120
8487031|NCT00570739|20913671|P4|STARTED|Overall Study||108
8487032|NCT00570739|20913672|P3|STARTED|Overall Study||108
8487033|NCT00570739|20913673|P2|STARTED|Overall Study||145
8487034|NCT00570739|20913674|P1|STARTED|Overall Study||141
8487035|NCT00570713|20913826|P2|NOT COMPLETED|Overall Study||77
8487036|NCT00570713|20913827|P1|NOT COMPLETED|Overall Study||78
8487037|NCT00570713|20913826|P2|COMPLETED|Overall Study||0
8487038|NCT00570713|20913827|P1|COMPLETED|Overall Study||0
8487039|NCT00570713|20913826|P2|STARTED|Overall Study||77
8487040|NCT00570713|20913827|P1|STARTED|Overall Study||78
8487041|NCT00570700|20913837|P1|NOT COMPLETED|Overall Study||11
8487042|NCT00570700|20913837|P1|COMPLETED|Overall Study||27
8487043|NCT00570700|20913837|P1|STARTED|Overall Study||38
8487044|NCT00570687|20913845|P10|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487045|NCT00570687|20913846|P9|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487046|NCT00570687|20913847|P8|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487047|NCT00570687|20913848|P7|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487048|NCT00570687|20913849|P6|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487049|NCT00570687|20913850|P5|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487050|NCT00570687|20913851|P4|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487051|NCT00570687|20913852|P3|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487052|NCT00570687|20913853|P2|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487053|NCT00570687|20913854|P1|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487054|NCT00570687|20913845|P10|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487055|NCT00570687|20913846|P9|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487056|NCT00570687|20913847|P8|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487057|NCT00570687|20913848|P7|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487058|NCT00570687|20913849|P6|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487059|NCT00570687|20913850|P5|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
8487060|NCT00570687|20913851|P4|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
8487061|NCT00570687|20913852|P3|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
8487062|NCT00570687|20913853|P2|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
8487063|NCT00570687|20913854|P1|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
8487064|NCT00570687|20913845|P10|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8487065|NCT00570687|20913846|P9|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8487066|NCT00570687|20913847|P8|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8487067|NCT00570687|20913848|P7|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8487068|NCT00570687|20913849|P6|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8487069|NCT00570687|20913850|P5|STARTED|Clamp 2 (1 Day) - Amendment 1||0
8487070|NCT00570687|20913851|P4|STARTED|Clamp 2 (1 Day) - Amendment 1||4
8487071|NCT00570687|20913852|P3|STARTED|Clamp 2 (1 Day) - Amendment 1||2
8487072|NCT00570687|20913853|P2|STARTED|Clamp 2 (1 Day) - Amendment 1||2
8487073|NCT00570687|20913854|P1|STARTED|Clamp 2 (1 Day) - Amendment 1||4
8487074|NCT00570687|20913845|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487075|NCT00570687|20913846|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487076|NCT00570687|20913847|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487077|NCT00570687|20913848|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487078|NCT00570687|20913849|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487079|NCT00570687|20913850|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487080|NCT00570687|20913851|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487081|NCT00570687|20913852|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487082|NCT00570687|20913853|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487083|NCT00570687|20913854|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487084|NCT00570687|20913845|P10|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487085|NCT00570687|20913846|P9|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487086|NCT00570687|20913847|P8|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487087|NCT00570687|20913848|P7|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487088|NCT00570687|20913849|P6|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487089|NCT00570687|20913850|P5|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
8487090|NCT00570687|20913851|P4|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
8487091|NCT00570687|20913852|P3|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
8487092|NCT00570687|20913853|P2|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
8487093|NCT00570687|20913854|P1|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
8487094|NCT00570687|20913845|P10|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8487095|NCT00570687|20913846|P9|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8487096|NCT00570687|20913847|P8|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8487097|NCT00570687|20913848|P7|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8487098|NCT00570687|20913849|P6|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8487099|NCT00570687|20913850|P5|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
8487100|NCT00570687|20913851|P4|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
8487101|NCT00570687|20913852|P3|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
8487102|NCT00570687|20913853|P2|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
8487103|NCT00570687|20913854|P1|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
8487104|NCT00570687|20913845|P10|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487105|NCT00570687|20913846|P9|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487106|NCT00570687|20913847|P8|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487107|NCT00570687|20913848|P7|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487108|NCT00570687|20913849|P6|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487109|NCT00570687|20913850|P5|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487110|NCT00570687|20913851|P4|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487111|NCT00570687|20913852|P3|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487112|NCT00570687|20913853|P2|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487113|NCT00570687|20913854|P1|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487114|NCT00570687|20913845|P10|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487115|NCT00570687|20913846|P9|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487116|NCT00570687|20913847|P8|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487117|NCT00570687|20913848|P7|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487118|NCT00570687|20913849|P6|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487119|NCT00570687|20913850|P5|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
8487120|NCT00570687|20913851|P4|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
8487121|NCT00570687|20913852|P3|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
8487122|NCT00570687|20913853|P2|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
8487123|NCT00570687|20913854|P1|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
8487124|NCT00570687|20913845|P10|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8487125|NCT00570687|20913846|P9|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8487126|NCT00570687|20913847|P8|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8487127|NCT00570687|20913848|P7|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8487128|NCT00570687|20913849|P6|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8487129|NCT00570687|20913850|P5|STARTED|Clamp 1 (1 Day) - Amendment 1||0
8487130|NCT00570687|20913851|P4|STARTED|Clamp 1 (1 Day) - Amendment 1||4
8487131|NCT00570687|20913852|P3|STARTED|Clamp 1 (1 Day) - Amendment 1||2
8487132|NCT00570687|20913853|P2|STARTED|Clamp 1 (1 Day) - Amendment 1||2
8487133|NCT00570687|20913854|P1|STARTED|Clamp 1 (1 Day) - Amendment 1||4
8487134|NCT00570687|20913845|P10|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487135|NCT00570687|20913846|P9|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487136|NCT00570687|20913847|P8|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487137|NCT00570687|20913848|P7|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487138|NCT00570687|20913849|P6|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487139|NCT00570687|20913850|P5|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487140|NCT00570687|20913851|P4|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487141|NCT00570687|20913852|P3|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487142|NCT00570687|20913853|P2|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487143|NCT00570687|20913854|P1|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487144|NCT00570687|20913845|P10|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487145|NCT00570687|20913846|P9|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487146|NCT00570687|20913847|P8|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487147|NCT00570687|20913848|P7|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487148|NCT00570687|20913849|P6|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487149|NCT00570687|20913850|P5|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
8487150|NCT00570687|20913851|P4|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
8487151|NCT00570687|20913852|P3|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
8487152|NCT00570687|20913853|P2|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
8487153|NCT00570687|20913854|P1|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
8487154|NCT00570687|20913845|P10|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8487155|NCT00570687|20913846|P9|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8487156|NCT00570687|20913847|P8|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8487157|NCT00570687|20913848|P7|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8487158|NCT00570687|20913849|P6|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8487159|NCT00570687|20913850|P5|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
8487160|NCT00570687|20913851|P4|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
8487161|NCT00570687|20913852|P3|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
8487162|NCT00570687|20913853|P2|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
8487163|NCT00570687|20913854|P1|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
8487164|NCT00570687|20913845|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487165|NCT00570687|20913846|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487166|NCT00570687|20913847|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487167|NCT00570687|20913848|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487168|NCT00570687|20913849|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487169|NCT00570687|20913850|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487170|NCT00570687|20913851|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487171|NCT00570687|20913852|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487172|NCT00570687|20913853|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487173|NCT00570687|20913854|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487174|NCT00570687|20913845|P10|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487175|NCT00570687|20913846|P9|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487176|NCT00570687|20913847|P8|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487177|NCT00570687|20913848|P7|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487178|NCT00570687|20913849|P6|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487179|NCT00570687|20913850|P5|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487180|NCT00570687|20913851|P4|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
8487181|NCT00570687|20913852|P3|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
8487182|NCT00570687|20913853|P2|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
8487183|NCT00570687|20913854|P1|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
8487184|NCT00570687|20913845|P10|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487185|NCT00570687|20913846|P9|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487186|NCT00570687|20913847|P8|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487187|NCT00570687|20913848|P7|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487188|NCT00570687|20913849|P6|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487569|NCT00570674|20913881|P6|PEG Evaluable|Overall Study||10
8487189|NCT00570687|20913850|P5|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
8487190|NCT00570687|20913851|P4|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
8487191|NCT00570687|20913852|P3|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
8487192|NCT00570687|20913853|P2|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
8487193|NCT00570687|20913854|P1|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
8487194|NCT00570687|20913845|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487195|NCT00570687|20913846|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487196|NCT00570687|20913847|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487197|NCT00570687|20913848|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487198|NCT00570687|20913849|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487199|NCT00570687|20913850|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487200|NCT00570687|20913851|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487201|NCT00570687|20913852|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487202|NCT00570687|20913853|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487203|NCT00570687|20913854|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487204|NCT00570687|20913845|P10|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487205|NCT00570687|20913846|P9|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487206|NCT00570687|20913847|P8|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487207|NCT00570687|20913848|P7|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487208|NCT00570687|20913849|P6|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487209|NCT00570687|20913850|P5|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
8487210|NCT00570687|20913851|P4|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
8487211|NCT00570687|20913852|P3|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
8487212|NCT00570687|20913853|P2|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
8487213|NCT00570687|20913854|P1|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
8487214|NCT00570687|20913845|P10|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8487215|NCT00570687|20913846|P9|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8487216|NCT00570687|20913847|P8|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8487217|NCT00570687|20913848|P7|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8487218|NCT00570687|20913849|P6|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8487219|NCT00570687|20913850|P5|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
8487220|NCT00570687|20913851|P4|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
8487221|NCT00570687|20913852|P3|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
8487222|NCT00570687|20913853|P2|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
8487223|NCT00570687|20913854|P1|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
8487224|NCT00570687|20913845|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487225|NCT00570687|20913846|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487226|NCT00570687|20913847|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487227|NCT00570687|20913848|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487228|NCT00570687|20913849|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487229|NCT00570687|20913850|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487230|NCT00570687|20913851|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487231|NCT00570687|20913852|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487232|NCT00570687|20913853|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487233|NCT00570687|20913854|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487234|NCT00570687|20913845|P10|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487235|NCT00570687|20913846|P9|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487236|NCT00570687|20913847|P8|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487237|NCT00570687|20913848|P7|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487238|NCT00570687|20913849|P6|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487239|NCT00570687|20913850|P5|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487240|NCT00570687|20913851|P4|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
8487241|NCT00570687|20913852|P3|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
8487242|NCT00570687|20913853|P2|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
8487243|NCT00570687|20913854|P1|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
8487244|NCT00570687|20913845|P10|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487245|NCT00570687|20913846|P9|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487246|NCT00570687|20913847|P8|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487247|NCT00570687|20913848|P7|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487248|NCT00570687|20913849|P6|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487249|NCT00570687|20913850|P5|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
8487250|NCT00570687|20913851|P4|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
8487251|NCT00570687|20913852|P3|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
8487252|NCT00570687|20913853|P2|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
8487253|NCT00570687|20913854|P1|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
8487254|NCT00570687|20913845|P10|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487255|NCT00570687|20913846|P9|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487256|NCT00570687|20913847|P8|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487257|NCT00570687|20913848|P7|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
8487258|NCT00570687|20913849|P6|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487259|NCT00570687|20913850|P5|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487260|NCT00570687|20913851|P4|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487261|NCT00570687|20913852|P3|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487262|NCT00570687|20913853|P2|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487263|NCT00570687|20913854|P1|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487264|NCT00570687|20913845|P10|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487265|NCT00570687|20913846|P9|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487266|NCT00570687|20913847|P8|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487267|NCT00570687|20913848|P7|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487268|NCT00570687|20913849|P6|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487269|NCT00570687|20913850|P5|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487270|NCT00570687|20913851|P4|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487271|NCT00570687|20913852|P3|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487272|NCT00570687|20913853|P2|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487273|NCT00570687|20913854|P1|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
8487274|NCT00570687|20913845|P10|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487275|NCT00570687|20913846|P9|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487276|NCT00570687|20913847|P8|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487277|NCT00570687|20913848|P7|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
8487278|NCT00570687|20913849|P6|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487279|NCT00570687|20913850|P5|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487280|NCT00570687|20913851|P4|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487281|NCT00570687|20913852|P3|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487282|NCT00570687|20913853|P2|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487283|NCT00570687|20913854|P1|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
8487284|NCT00570687|20913845|P10|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487285|NCT00570687|20913846|P9|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487286|NCT00570687|20913847|P8|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487287|NCT00570687|20913848|P7|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487288|NCT00570687|20913849|P6|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487289|NCT00570687|20913850|P5|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487290|NCT00570687|20913851|P4|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487291|NCT00570687|20913852|P3|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487292|NCT00570687|20913853|P2|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487293|NCT00570687|20913854|P1|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487294|NCT00570687|20913845|P10|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487295|NCT00570687|20913846|P9|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487296|NCT00570687|20913847|P8|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487297|NCT00570687|20913848|P7|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
8487298|NCT00570687|20913849|P6|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487299|NCT00570687|20913850|P5|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487300|NCT00570687|20913851|P4|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487301|NCT00570687|20913852|P3|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487302|NCT00570687|20913853|P2|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487303|NCT00570687|20913854|P1|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
8487304|NCT00570687|20913845|P10|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487305|NCT00570687|20913846|P9|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487306|NCT00570687|20913847|P8|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487307|NCT00570687|20913848|P7|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
8487308|NCT00570687|20913849|P6|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487309|NCT00570687|20913850|P5|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487310|NCT00570687|20913851|P4|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487311|NCT00570687|20913852|P3|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487312|NCT00570687|20913853|P2|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487313|NCT00570687|20913854|P1|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
8487314|NCT00570687|20913845|P10|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487315|NCT00570687|20913846|P9|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
8487316|NCT00570687|20913847|P8|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487317|NCT00570687|20913848|P7|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487318|NCT00570687|20913849|P6|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487319|NCT00570687|20913850|P5|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487320|NCT00570687|20913851|P4|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487321|NCT00570687|20913852|P3|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487322|NCT00570687|20913853|P2|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487323|NCT00570687|20913854|P1|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487324|NCT00570687|20913845|P10|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487325|NCT00570687|20913846|P9|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487326|NCT00570687|20913847|P8|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487327|NCT00570687|20913848|P7|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
8487328|NCT00570687|20913849|P6|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487329|NCT00570687|20913850|P5|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487330|NCT00570687|20913851|P4|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487331|NCT00570687|20913852|P3|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487332|NCT00570687|20913853|P2|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487333|NCT00570687|20913854|P1|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
8487334|NCT00570687|20913845|P10|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487335|NCT00570687|20913846|P9|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
8487336|NCT00570687|20913847|P8|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487337|NCT00570687|20913848|P7|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
8487338|NCT00570687|20913849|P6|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487339|NCT00570687|20913850|P5|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487340|NCT00570687|20913851|P4|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487341|NCT00570687|20913852|P3|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487342|NCT00570687|20913853|P2|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487343|NCT00570687|20913854|P1|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
8487344|NCT00570687|20913845|P10|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487345|NCT00570687|20913846|P9|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487346|NCT00570687|20913847|P8|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487347|NCT00570687|20913848|P7|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487348|NCT00570687|20913849|P6|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487349|NCT00570687|20913850|P5|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487350|NCT00570687|20913851|P4|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487351|NCT00570687|20913852|P3|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487352|NCT00570687|20913853|P2|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487353|NCT00570687|20913854|P1|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487354|NCT00570687|20913845|P10|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487355|NCT00570687|20913846|P9|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
8487356|NCT00570687|20913847|P8|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487357|NCT00570687|20913848|P7|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
8487358|NCT00570687|20913849|P6|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487359|NCT00570687|20913850|P5|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487360|NCT00570687|20913851|P4|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487361|NCT00570687|20913852|P3|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487362|NCT00570687|20913853|P2|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487363|NCT00570687|20913854|P1|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
8487364|NCT00570687|20913845|P10|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487365|NCT00570687|20913846|P9|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
8487366|NCT00570687|20913847|P8|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487367|NCT00570687|20913848|P7|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
8487368|NCT00570687|20913849|P6|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487369|NCT00570687|20913850|P5|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487370|NCT00570687|20913851|P4|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487371|NCT00570687|20913852|P3|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487372|NCT00570687|20913853|P2|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487373|NCT00570687|20913854|P1|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
8487374|NCT00570687|20913845|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
8487375|NCT00570687|20913846|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
8487376|NCT00570687|20913847|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
8487377|NCT00570687|20913848|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
8487378|NCT00570687|20913849|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
8487379|NCT00570687|20913850|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
8487380|NCT00570687|20913851|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487381|NCT00570687|20913852|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487382|NCT00570687|20913853|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487383|NCT00570687|20913854|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487384|NCT00570687|20913845|P10|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487385|NCT00570687|20913846|P9|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
8487386|NCT00570687|20913847|P8|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487387|NCT00570687|20913848|P7|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
8487388|NCT00570687|20913849|P6|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487389|NCT00570687|20913850|P5|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487390|NCT00570687|20913851|P4|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487391|NCT00570687|20913852|P3|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487392|NCT00570687|20913853|P2|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487393|NCT00570687|20913854|P1|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
8487394|NCT00570687|20913845|P10|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8487395|NCT00570687|20913846|P9|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8487396|NCT00570687|20913847|P8|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8487397|NCT00570687|20913848|P7|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8487398|NCT00570687|20913849|P6|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8487399|NCT00570687|20913850|P5|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
8487400|NCT00570687|20913851|P4|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
8487401|NCT00570687|20913852|P3|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
8487402|NCT00570687|20913853|P2|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
8487403|NCT00570687|20913854|P1|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
8487404|NCT00570687|20913845|P10|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487405|NCT00570687|20913846|P9|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487406|NCT00570687|20913847|P8|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487407|NCT00570687|20913848|P7|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487408|NCT00570687|20913849|P6|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487409|NCT00570687|20913850|P5|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487410|NCT00570687|20913851|P4|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487411|NCT00570687|20913852|P3|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487412|NCT00570687|20913853|P2|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487413|NCT00570687|20913854|P1|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487414|NCT00570687|20913845|P10|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487415|NCT00570687|20913846|P9|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487416|NCT00570687|20913847|P8|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487417|NCT00570687|20913848|P7|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487418|NCT00570687|20913849|P6|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487419|NCT00570687|20913850|P5|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487420|NCT00570687|20913851|P4|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487421|NCT00570687|20913852|P3|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487422|NCT00570687|20913853|P2|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487423|NCT00570687|20913854|P1|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487424|NCT00570687|20913845|P10|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487425|NCT00570687|20913846|P9|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487426|NCT00570687|20913847|P8|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487427|NCT00570687|20913848|P7|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487428|NCT00570687|20913849|P6|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487429|NCT00570687|20913850|P5|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
8487430|NCT00570687|20913851|P4|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487431|NCT00570687|20913852|P3|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487432|NCT00570687|20913853|P2|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487433|NCT00570687|20913854|P1|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
8487434|NCT00570687|20913845|P10|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487435|NCT00570687|20913846|P9|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487436|NCT00570687|20913847|P8|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487437|NCT00570687|20913848|P7|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487438|NCT00570687|20913849|P6|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487439|NCT00570687|20913850|P5|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487440|NCT00570687|20913851|P4|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487441|NCT00570687|20913852|P3|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487442|NCT00570687|20913853|P2|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487443|NCT00570687|20913854|P1|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487444|NCT00570687|20913845|P10|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8487445|NCT00570687|20913846|P9|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8487446|NCT00570687|20913847|P8|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8487447|NCT00570687|20913848|P7|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8487448|NCT00570687|20913849|P6|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8487449|NCT00570687|20913850|P5|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
8487450|NCT00570687|20913851|P4|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487451|NCT00570687|20913852|P3|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487452|NCT00570687|20913853|P2|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487453|NCT00570687|20913854|P1|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
8487454|NCT00570687|20913845|P10|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8487455|NCT00570687|20913846|P9|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8487456|NCT00570687|20913847|P8|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8487457|NCT00570687|20913848|P7|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8487458|NCT00570687|20913849|P6|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8487459|NCT00570687|20913850|P5|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
8487460|NCT00570687|20913851|P4|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
8487461|NCT00570687|20913852|P3|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
8487462|NCT00570687|20913853|P2|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
8487463|NCT00570687|20913854|P1|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
8487464|NCT00570687|20913845|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487465|NCT00570687|20913846|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487466|NCT00570687|20913847|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487467|NCT00570687|20913848|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487468|NCT00570687|20913849|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487469|NCT00570687|20913850|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487470|NCT00570687|20913851|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487471|NCT00570687|20913852|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487472|NCT00570687|20913853|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487473|NCT00570687|20913854|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487474|NCT00570687|20913845|P10|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487475|NCT00570687|20913846|P9|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487476|NCT00570687|20913847|P8|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487477|NCT00570687|20913848|P7|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487478|NCT00570687|20913849|P6|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487479|NCT00570687|20913850|P5|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487480|NCT00570687|20913851|P4|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487481|NCT00570687|20913852|P3|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487482|NCT00570687|20913853|P2|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487483|NCT00570687|20913854|P1|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487484|NCT00570687|20913845|P10|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487485|NCT00570687|20913846|P9|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487486|NCT00570687|20913847|P8|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487487|NCT00570687|20913848|P7|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487488|NCT00570687|20913849|P6|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487489|NCT00570687|20913850|P5|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
8487490|NCT00570687|20913851|P4|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487491|NCT00570687|20913852|P3|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487492|NCT00570687|20913853|P2|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487493|NCT00570687|20913854|P1|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
8487494|NCT00570687|20913845|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487495|NCT00570687|20913846|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487496|NCT00570687|20913847|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487497|NCT00570687|20913848|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487498|NCT00570687|20913849|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487499|NCT00570687|20913850|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487500|NCT00570687|20913851|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487501|NCT00570687|20913852|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487502|NCT00570687|20913853|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487503|NCT00570687|20913854|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487504|NCT00570687|20913845|P10|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8487505|NCT00570687|20913846|P9|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8487506|NCT00570687|20913847|P8|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8487507|NCT00570687|20913848|P7|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8487508|NCT00570687|20913849|P6|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8487509|NCT00570687|20913850|P5|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
8487510|NCT00570687|20913851|P4|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487511|NCT00570687|20913852|P3|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487512|NCT00570687|20913853|P2|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487513|NCT00570687|20913854|P1|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
8487514|NCT00570687|20913845|P10|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8487515|NCT00570687|20913846|P9|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8487516|NCT00570687|20913847|P8|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8487517|NCT00570687|20913848|P7|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8487518|NCT00570687|20913849|P6|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8487519|NCT00570687|20913850|P5|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
8487520|NCT00570687|20913851|P4|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
8487521|NCT00570687|20913852|P3|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
8487522|NCT00570687|20913853|P2|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
8487523|NCT00570687|20913854|P1|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
8487524|NCT00570687|20913845|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487525|NCT00570687|20913846|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487526|NCT00570687|20913847|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487527|NCT00570687|20913848|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487528|NCT00570687|20913849|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487529|NCT00570687|20913850|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487530|NCT00570687|20913851|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487531|NCT00570687|20913852|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487532|NCT00570687|20913853|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487533|NCT00570687|20913854|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487534|NCT00570687|20913845|P10|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487535|NCT00570687|20913846|P9|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487536|NCT00570687|20913847|P8|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487537|NCT00570687|20913848|P7|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487538|NCT00570687|20913849|P6|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487539|NCT00570687|20913850|P5|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487540|NCT00570687|20913851|P4|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487541|NCT00570687|20913852|P3|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487542|NCT00570687|20913853|P2|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487543|NCT00570687|20913854|P1|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487544|NCT00570687|20913845|P10|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487545|NCT00570687|20913846|P9|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487546|NCT00570687|20913847|P8|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487547|NCT00570687|20913848|P7|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487548|NCT00570687|20913849|P6|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487549|NCT00570687|20913850|P5|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
8487550|NCT00570687|20913851|P4|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487551|NCT00570687|20913852|P3|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487552|NCT00570687|20913853|P2|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487553|NCT00570687|20913854|P1|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
8487554|NCT00570674|20913880|P7|NOT COMPLETED|Overall Study||0
8487555|NCT00570674|20913881|P6|NOT COMPLETED|Overall Study||0
8487556|NCT00570674|20913882|P5|NOT COMPLETED|Overall Study||0
8487557|NCT00570674|20913883|P4|NOT COMPLETED|Overall Study||0
8487558|NCT00570674|20913884|P3|NOT COMPLETED|Overall Study||1
8487559|NCT00570674|20913885|P2|NOT COMPLETED|Overall Study||0
8487560|NCT00570674|20913886|P1|NOT COMPLETED|Overall Study||0
8487561|NCT00570674|20913880|P7|COMPLETED|Overall Study||0
8487562|NCT00570674|20913881|P6|COMPLETED|Overall Study||10
8487563|NCT00570674|20913882|P5|COMPLETED|Overall Study||3
8487564|NCT00570674|20913883|P4|COMPLETED|Overall Study||3
8487565|NCT00570674|20913884|P3|COMPLETED|Overall Study||3
8487566|NCT00570674|20913885|P2|COMPLETED|Overall Study||3
8487567|NCT00570674|20913886|P1|COMPLETED|Overall Study||6
8487568|NCT00570674|20913880|P7|PEG Evaluable|Overall Study||0
8487570|NCT00570674|20913882|P5|PEG Evaluable|Overall Study||2
8487571|NCT00570674|20913883|P4|PEG Evaluable|Overall Study||3
8487572|NCT00570674|20913884|P3|PEG Evaluable|Overall Study||3
8487573|NCT00570674|20913885|P2|PEG Evaluable|Overall Study||3
8487574|NCT00570674|20913886|P1|PEG Evaluable|Overall Study||6
8487575|NCT00570674|20913880|P7|Treated|Overall Study||0
8487576|NCT00570674|20913881|P6|Treated|Overall Study||10
8487577|NCT00570674|20913882|P5|Treated|Overall Study||3
8487578|NCT00570674|20913883|P4|Treated|Overall Study||3
8487579|NCT00570674|20913884|P3|Treated|Overall Study||3
8487580|NCT00570674|20913885|P2|Treated|Overall Study||3
8487581|NCT00570674|20913886|P1|Treated|Overall Study||6
8487582|NCT00570674|20913880|P7|STARTED|Overall Study|The study did not continue beyond phase I.|0
8487583|NCT00570674|20913881|P6|STARTED|Overall Study||10
8487584|NCT00570674|20913882|P5|STARTED|Overall Study||3
8487585|NCT00570674|20913883|P4|STARTED|Overall Study||3
8487586|NCT00570674|20913884|P3|STARTED|Overall Study||4
8487587|NCT00570674|20913885|P2|STARTED|Overall Study||3
8487588|NCT00570674|20913886|P1|STARTED|Overall Study||6
8487589|NCT00570531|20913903|P1|NOT COMPLETED|Overall Study||0
8487590|NCT00570531|20913903|P1|COMPLETED|Overall Study||6
8487591|NCT00570531|20913903|P1|STARTED|Overall Study||6
8487592|NCT00570505|20913909|P1|NOT COMPLETED|Overall Study||41
8487593|NCT00570505|20913909|P1|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
8487594|NCT00570505|20913909|P1|STARTED|Overall Study||149
8487595|NCT00570492|20913922|P3|NOT COMPLETED|52-week Double-blind Treatment Period||51
8487596|NCT00570492|20913923|P2|NOT COMPLETED|52-week Double-blind Treatment Period||50
8487597|NCT00570492|20913924|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
8487598|NCT00570492|20913922|P3|COMPLETED|52-week Double-blind Treatment Period||186
8487599|NCT00570492|20913923|P2|COMPLETED|52-week Double-blind Treatment Period||187
8487600|NCT00570492|20913924|P1|COMPLETED|52-week Double-blind Treatment Period||0
8487601|NCT00570492|20913922|P3|STARTED|52-week Double-blind Treatment Period||237
8487602|NCT00570492|20913923|P2|STARTED|52-week Double-blind Treatment Period||237
8487603|NCT00570492|20913924|P1|STARTED|52-week Double-blind Treatment Period||0
8487604|NCT00570492|20913922|P3|NOT COMPLETED|16-week Single-blind Baseline Period||0
8487605|NCT00570492|20913923|P2|NOT COMPLETED|16-week Single-blind Baseline Period||0
8487606|NCT00570492|20913924|P1|NOT COMPLETED|16-week Single-blind Baseline Period||436
8487607|NCT00570492|20913922|P3|COMPLETED|16-week Single-blind Baseline Period||0
8487608|NCT00570492|20913923|P2|COMPLETED|16-week Single-blind Baseline Period||0
8487609|NCT00570492|20913924|P1|COMPLETED|16-week Single-blind Baseline Period||474
8487610|NCT00570492|20913922|P3|STARTED|16-week Single-blind Baseline Period||0
8487611|NCT00570492|20913923|P2|STARTED|16-week Single-blind Baseline Period||0
8487612|NCT00570492|20913924|P1|STARTED|16-week Single-blind Baseline Period||910
8487613|NCT00570401|20913962|P1|NOT COMPLETED|Overall Study||2
8487614|NCT00570401|20913962|P1|COMPLETED|Overall Study||19
8487615|NCT00570401|20913962|P1|STARTED|Overall Study||21
8487616|NCT00570362|20913968|P2|NOT COMPLETED|Overall Study||0
8487617|NCT00570362|20913969|P1|NOT COMPLETED|Overall Study||0
8487618|NCT00570362|20913968|P2|COMPLETED|Overall Study||30
8487619|NCT00570362|20913969|P1|COMPLETED|Overall Study||19
8487620|NCT00570362|20913968|P2|STARTED|Overall Study||30
8487621|NCT00570362|20913969|P1|STARTED|Overall Study||19
8487622|NCT00570349|20913978|P3|NOT COMPLETED|Overall Study||0
8487623|NCT00570349|20913979|P2|NOT COMPLETED|Overall Study||0
8487624|NCT00570349|20913980|P1|NOT COMPLETED|Overall Study||0
8487625|NCT00570349|20913978|P3|COMPLETED|Overall Study||6
8487626|NCT00570349|20913979|P2|COMPLETED|Overall Study||6
8487627|NCT00570349|20913980|P1|COMPLETED|Overall Study||6
8487628|NCT00570349|20913978|P3|STARTED|Overall Study||6
8487629|NCT00570349|20913979|P2|STARTED|Overall Study||6
8487630|NCT00570349|20913980|P1|STARTED|Overall Study||6
8487631|NCT00570323|20913996|P2|NOT COMPLETED|Complete Study After Start||1
8487632|NCT00570323|20913997|P1|NOT COMPLETED|Complete Study After Start||3
8487633|NCT00570323|20913996|P2|COMPLETED|Complete Study After Start||34
8487634|NCT00570323|20913997|P1|COMPLETED|Complete Study After Start||31
8487635|NCT00570323|20913996|P2|STARTED|Complete Study After Start||35
8487636|NCT00570323|20913997|P1|STARTED|Complete Study After Start||34
8487637|NCT00570323|20913996|P2|NOT COMPLETED|Started Treatment After Randomization||1
8487638|NCT00570323|20913997|P1|NOT COMPLETED|Started Treatment After Randomization||2
8487639|NCT00570323|20913996|P2|COMPLETED|Started Treatment After Randomization||35
8487640|NCT00570323|20913997|P1|COMPLETED|Started Treatment After Randomization||34
8487641|NCT00570323|20913996|P2|STARTED|Started Treatment After Randomization||36
8487642|NCT00570323|20913997|P1|STARTED|Started Treatment After Randomization||36
8487643|NCT00570310|20914009|P2|NOT COMPLETED|Overall Study||6
8487644|NCT00570310|20914010|P1|NOT COMPLETED|Overall Study||2
8487645|NCT00570310|20914009|P2|COMPLETED|Overall Study||45
8487646|NCT00570310|20914010|P1|COMPLETED|Overall Study||51
8487647|NCT00570310|20914009|P2|STARTED|Overall Study||51
8487648|NCT00570310|20914010|P1|STARTED|Overall Study||53
8487655|NCT00570232|20914029|P1|NOT COMPLETED|Overall Study||23
8487656|NCT00570232|20914029|P1|COMPLETED|Overall Study||8
8487657|NCT00570232|20914029|P1|STARTED|Overall Study||31
8487658|NCT00570141|20914035|P1|NOT COMPLETED|Overall Study||3
8487659|NCT00570141|20914035|P1|COMPLETED|Overall Study||10
8487660|NCT00570141|20914035|P1|STARTED|Overall Study||13
8487661|NCT00570089|20914040|P2|NOT COMPLETED|Perod 2||0
8487662|NCT00570089|20914041|P1|NOT COMPLETED|Perod 2||0
8487663|NCT00570089|20914040|P2|COMPLETED|Perod 2||10
8487664|NCT00570089|20914041|P1|COMPLETED|Perod 2||10
8487665|NCT00570089|20914040|P2|STARTED|Perod 2||10
8487666|NCT00570089|20914041|P1|STARTED|Perod 2||10
8487667|NCT00570089|20914040|P2|NOT COMPLETED|Period 1||0
8487668|NCT00570089|20914041|P1|NOT COMPLETED|Period 1||0
8487669|NCT00570089|20914040|P2|COMPLETED|Period 1||10
8487670|NCT00570089|20914041|P1|COMPLETED|Period 1||10
8487671|NCT00570089|20914040|P2|STARTED|Period 1||10
8487672|NCT00570089|20914041|P1|STARTED|Period 1||10
8487673|NCT00570063|20914051|P2|NOT COMPLETED|Overall Study||8
8487674|NCT00570063|20914052|P1|NOT COMPLETED|Overall Study||15
8487675|NCT00570063|20914051|P2|COMPLETED|Overall Study||3
8487676|NCT00570063|20914052|P1|COMPLETED|Overall Study||9
8487677|NCT00570063|20914051|P2|STARTED|Overall Study||11
8487678|NCT00570063|20914052|P1|STARTED|Overall Study||24
8487679|NCT00570037|20914118|P2|NOT COMPLETED|Overall Study||69
8487680|NCT00570037|20914119|P1|NOT COMPLETED|Overall Study||44
8487681|NCT00570037|20914118|P2|COMPLETED|Overall Study||237
8487682|NCT00570037|20914119|P1|COMPLETED|Overall Study||194
8487683|NCT00570037|20914118|P2|STARTED|Overall Study||306
8487684|NCT00570037|20914119|P1|STARTED|Overall Study||238
8487685|NCT00569946|20914129|P1|NOT COMPLETED|Overall Study||59
8487686|NCT00569946|20914129|P1|COMPLETED|Overall Study||5
8487687|NCT00569946|20914129|P1|STARTED|Overall Study||64
8487688|NCT00569868|20914145|P1|NOT COMPLETED|Overall Study||0
8487689|NCT00569868|20914145|P1|COMPLETED|Overall Study||11
8487690|NCT00569868|20914145|P1|STARTED|Overall Study||11
8487691|NCT00569855|20914149|P1|NOT COMPLETED|Overall Study||0
8487692|NCT00569855|20914149|P1|COMPLETED|Overall Study|785 subjects treated with study drug|785
8487693|NCT00569855|20914149|P1|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
8487694|NCT00569803|20914161|P8|NOT COMPLETED|Overall Study||1
8487695|NCT00569803|20914162|P7|NOT COMPLETED|Overall Study||0
8487696|NCT00569803|20914163|P6|NOT COMPLETED|Overall Study||0
8487697|NCT00569803|20914164|P5|NOT COMPLETED|Overall Study||0
8487698|NCT00569803|20914165|P4|NOT COMPLETED|Overall Study||1
8487699|NCT00569803|20914166|P3|NOT COMPLETED|Overall Study||0
8487700|NCT00569803|20914167|P2|NOT COMPLETED|Overall Study||0
8487701|NCT00569803|20914168|P1|NOT COMPLETED|Overall Study||1
8487702|NCT00569803|20914161|P8|COMPLETED|Overall Study||5
8487703|NCT00569803|20914162|P7|COMPLETED|Overall Study||10
8487704|NCT00569803|20914163|P6|COMPLETED|Overall Study||5
8487705|NCT00569803|20914164|P5|COMPLETED|Overall Study||5
8487706|NCT00569803|20914165|P4|COMPLETED|Overall Study||5
8487707|NCT00569803|20914166|P3|COMPLETED|Overall Study||5
8487708|NCT00569803|20914167|P2|COMPLETED|Overall Study||5
8487709|NCT00569803|20914168|P1|COMPLETED|Overall Study||4
8487710|NCT00569803|20914161|P8|STARTED|Overall Study||6
8487711|NCT00569803|20914162|P7|STARTED|Overall Study||10
8487712|NCT00569803|20914163|P6|STARTED|Overall Study||5
8487713|NCT00569803|20914164|P5|STARTED|Overall Study||5
8487714|NCT00569803|20914165|P4|STARTED|Overall Study||6
8487715|NCT00569803|20914166|P3|STARTED|Overall Study||5
8487716|NCT00569803|20914167|P2|STARTED|Overall Study||5
8487717|NCT00569803|20914168|P1|STARTED|Overall Study||5
8487718|NCT00569777|20914295|P2|NOT COMPLETED|Overall Study||3
8487719|NCT00569777|20914296|P1|NOT COMPLETED|Overall Study||10
8487720|NCT00569777|20914295|P2|COMPLETED|Overall Study||101
8487721|NCT00569777|20914296|P1|COMPLETED|Overall Study||196
8487722|NCT00569777|20914295|P2|STARTED|Overall Study||104
8487723|NCT00569777|20914296|P1|STARTED|Overall Study||206
8487724|NCT00569673|20914338|P1|NOT COMPLETED|Overall Study||0
8487725|NCT00569673|20914338|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
8487726|NCT00569673|20914338|P1|STARTED|Overall Study|Total number participants enrolled on study|71
8487727|NCT00569660|20914343|P1|NOT COMPLETED|Overall Study||0
8487728|NCT00569660|20914343|P1|COMPLETED|Overall Study||34
8487729|NCT00569660|20914343|P1|STARTED|Overall Study||34
8487730|NCT00569582|20914347|P1|NOT COMPLETED|Overall Study||16
8487731|NCT00569582|20914347|P1|COMPLETED|Overall Study||34
8487732|NCT00569582|20914347|P1|STARTED|Overall Study||50
8487739|NCT00569374|20914363|P1|NOT COMPLETED|Overall Study||4
8487740|NCT00569374|20914363|P1|COMPLETED|Overall Study||4
8487741|NCT00569374|20914363|P1|STARTED|Overall Study||8
8487742|NCT00569309|20914373|P1|NOT COMPLETED|Overall Study||0
8487743|NCT00569309|20914373|P1|COMPLETED|Overall Study||30
8487744|NCT00569309|20914373|P1|STARTED|Overall Study||30
8487745|NCT00569270|20914382|P2|NOT COMPLETED|Period: Second Intervention||0
8487746|NCT00569270|20914383|P1|NOT COMPLETED|Period: Second Intervention||0
8487747|NCT00569270|20914382|P2|COMPLETED|Period: Second Intervention||14
8487748|NCT00569270|20914383|P1|COMPLETED|Period: Second Intervention||15
8487749|NCT00569270|20914382|P2|29 Days|Period: Second Intervention||14
8487750|NCT00569270|20914383|P1|29 Days|Period: Second Intervention||15
8487751|NCT00569270|20914382|P2|STARTED|Period: Second Intervention||14
8487752|NCT00569270|20914383|P1|STARTED|Period: Second Intervention||15
8487753|NCT00569270|20914382|P2|NOT COMPLETED|Period: First Intervention||1
8487754|NCT00569270|20914383|P1|NOT COMPLETED|Period: First Intervention||0
8487755|NCT00569270|20914382|P2|COMPLETED|Period: First Intervention||14
8487756|NCT00569270|20914383|P1|COMPLETED|Period: First Intervention||15
8487757|NCT00569270|20914382|P2|STARTED|Period: First Intervention||15
8487758|NCT00569270|20914383|P1|STARTED|Period: First Intervention|randomized cross over study|15
8487759|NCT00569231|20914418|P1|NOT COMPLETED|Overall Study||7
8487760|NCT00569231|20914418|P1|COMPLETED|Overall Study||11
8487761|NCT00569231|20914418|P1|STARTED|Overall Study||18
8487762|NCT00569192|20914428|P3|NOT COMPLETED|Overall Study||25
8487763|NCT00569192|20914429|P2|NOT COMPLETED|Overall Study||20
8487764|NCT00569192|20914430|P1|NOT COMPLETED|Overall Study||23
8487765|NCT00569192|20914428|P3|COMPLETED|Overall Study||99
8487766|NCT00569192|20914429|P2|COMPLETED|Overall Study||105
8487767|NCT00569192|20914430|P1|COMPLETED|Overall Study||88
8487768|NCT00569192|20914428|P3|STARTED|Overall Study||124
8487769|NCT00569192|20914429|P2|STARTED|Overall Study||125
8487770|NCT00569192|20914430|P1|STARTED|Overall Study||111
8487771|NCT00569166|20914456|P3|NOT COMPLETED|Overall Study||4
8487772|NCT00569166|20914457|P2|NOT COMPLETED|Overall Study||6
8487773|NCT00569166|20914458|P1|NOT COMPLETED|Overall Study||9
8487774|NCT00569166|20914456|P3|COMPLETED|Overall Study||27
8487775|NCT00569166|20914457|P2|COMPLETED|Overall Study||25
8487776|NCT00569166|20914458|P1|COMPLETED|Overall Study||21
8487777|NCT00569166|20914456|P3|STARTED|Overall Study||31
8487778|NCT00569166|20914457|P2|STARTED|Overall Study||31
8487779|NCT00569166|20914458|P1|STARTED|Overall Study||30
8487788|NCT00569010|20914513|P4|NOT COMPLETED|Overall Study||0
8487789|NCT00569010|20914514|P3|NOT COMPLETED|Overall Study||0
8487790|NCT00569010|20914515|P2|NOT COMPLETED|Overall Study||0
8487791|NCT00569010|20914516|P1|NOT COMPLETED|Overall Study||0
8487792|NCT00569010|20914513|P4|COMPLETED|Overall Study||11
8487793|NCT00569010|20914514|P3|COMPLETED|Overall Study||11
8487794|NCT00569010|20914515|P2|COMPLETED|Overall Study||6
8487795|NCT00569010|20914516|P1|COMPLETED|Overall Study||6
8487796|NCT00569010|20914513|P4|STARTED|Overall Study||11
8487797|NCT00569010|20914514|P3|STARTED|Overall Study||11
8487798|NCT00569010|20914515|P2|STARTED|Overall Study||6
8487799|NCT00569010|20914516|P1|STARTED|Overall Study||6
8487800|NCT00568958|20914528|P2|NOT COMPLETED|Follow-Up||7
8487801|NCT00568958|20914529|P1|NOT COMPLETED|Follow-Up||9
8487802|NCT00568958|20914528|P2|COMPLETED|Follow-Up||60
8487803|NCT00568958|20914529|P1|COMPLETED|Follow-Up||52
8487804|NCT00568958|20914528|P2|STARTED|Follow-Up||67
8487805|NCT00568958|20914529|P1|STARTED|Follow-Up||61
8487806|NCT00568958|20914528|P2|NOT COMPLETED|Allocation||3
8487807|NCT00568958|20914529|P1|NOT COMPLETED|Allocation||9
8487808|NCT00568958|20914528|P2|COMPLETED|Allocation||67
8487809|NCT00568958|20914529|P1|COMPLETED|Allocation||61
8487810|NCT00568958|20914528|P2|STARTED|Allocation||70
8487811|NCT00568958|20914529|P1|STARTED|Allocation||70
8487812|NCT00568854|20914549|P2|NOT COMPLETED|Overall Study||0
8487813|NCT00568854|20914550|P1|NOT COMPLETED|Overall Study||0
8487814|NCT00568854|20914549|P2|COMPLETED|Overall Study||4
8487815|NCT00568854|20914550|P1|COMPLETED|Overall Study||6
8487816|NCT00568854|20914549|P2|STARTED|Overall Study||4
8487817|NCT00568854|20914550|P1|STARTED|Overall Study||6
8487818|NCT00568802|20914558|P1|NOT COMPLETED|Overall Study||3
8487819|NCT00568802|20914558|P1|COMPLETED|Overall Study||24
8487820|NCT00568802|20914558|P1|STARTED|Overall Study||27
8487821|NCT00568776|20914576|P4|NOT COMPLETED|Overall Study||72
8487822|NCT00568776|20914577|P3|NOT COMPLETED|Overall Study||74
8487823|NCT00568776|20914578|P2|NOT COMPLETED|Overall Study||36
8487824|NCT00568776|20914579|P1|NOT COMPLETED|Overall Study||30
8487825|NCT00568776|20914576|P4|COMPLETED|Overall Study||19
8487826|NCT00568776|20914577|P3|COMPLETED|Overall Study||15
8487827|NCT00568776|20914578|P2|COMPLETED|Overall Study||52
8487828|NCT00568776|20914579|P1|COMPLETED|Overall Study||53
8487829|NCT00568776|20914576|P4|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
8487830|NCT00568776|20914577|P3|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
8487831|NCT00568776|20914578|P2|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
8487832|NCT00568776|20914579|P1|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
8487833|NCT00568698|20914613|P1|NOT COMPLETED|Overall Study||11
8487834|NCT00568698|20914613|P1|COMPLETED|Overall Study||18
8487835|NCT00568698|20914613|P1|STARTED|Overall Study||29
8487836|NCT00568685|20914628|P3|NOT COMPLETED|Overall Study||5
8487837|NCT00568685|20914629|P2|NOT COMPLETED|Overall Study||5
8487838|NCT00568685|20914630|P1|NOT COMPLETED|Overall Study||10
8487839|NCT00568685|20914628|P3|COMPLETED|Overall Study||46
8487840|NCT00568685|20914629|P2|COMPLETED|Overall Study||46
8487841|NCT00568685|20914630|P1|COMPLETED|Overall Study||41
8487842|NCT00568685|20914628|P3|STARTED|Overall Study||51
8487843|NCT00568685|20914629|P2|STARTED|Overall Study||51
8487844|NCT00568685|20914630|P1|STARTED|Overall Study||51
8487845|NCT00568633|20914664|P2|NOT COMPLETED|Overall Study||0
8487846|NCT00568633|20914665|P1|NOT COMPLETED|Overall Study||0
8487847|NCT00568633|20914664|P2|COMPLETED|Overall Study||33
8487848|NCT00568633|20914665|P1|COMPLETED|Overall Study||25
8487849|NCT00568633|20914664|P2|STARTED|Overall Study||33
8487850|NCT00568633|20914665|P1|STARTED|Overall Study||25
8487851|NCT00568555|20914687|P2|NOT COMPLETED|Overall Study||1
8487852|NCT00568555|20914688|P1|NOT COMPLETED|Overall Study||1
8487853|NCT00568555|20914687|P2|COMPLETED|Overall Study||14
8487854|NCT00568555|20914688|P1|COMPLETED|Overall Study||15
8487855|NCT00568555|20914687|P2|STARTED|Overall Study||15
8487856|NCT00568555|20914688|P1|STARTED|Overall Study||16
8487857|NCT00568451|20914706|P4|NOT COMPLETED|Overall Study||7
8487858|NCT00568451|20914707|P3|NOT COMPLETED|Overall Study||2
8487859|NCT00568451|20914708|P2|NOT COMPLETED|Overall Study||0
8487860|NCT00568451|20914709|P1|NOT COMPLETED|Overall Study||0
8487861|NCT00568451|20914706|P4|COMPLETED|Overall Study||2
8487862|NCT00568451|20914707|P3|COMPLETED|Overall Study||0
8487863|NCT00568451|20914708|P2|COMPLETED|Overall Study||0
8487864|NCT00568451|20914709|P1|COMPLETED|Overall Study||0
8487865|NCT00568451|20914706|P4|STARTED|Overall Study||9
8487866|NCT00568451|20914707|P3|STARTED|Overall Study||2
8487867|NCT00568451|20914708|P2|STARTED|Overall Study||0
8487868|NCT00568451|20914709|P1|STARTED|Overall Study||0
8487869|NCT00568399|20914725|P1|NOT COMPLETED|Overall Study||15
8487870|NCT00568399|20914725|P1|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
8487871|NCT00568399|20914725|P1|STARTED|Overall Study||37
8487872|NCT00568386|20914731|P2|NOT COMPLETED|Overall Study||0
8487873|NCT00568386|20914732|P1|NOT COMPLETED|Overall Study||0
8487874|NCT00568386|20914731|P2|COMPLETED|Overall Study||20
8487875|NCT00568386|20914732|P1|COMPLETED|Overall Study||20
8487876|NCT00568386|20914731|P2|STARTED|Overall Study||20
8487877|NCT00568386|20914732|P1|STARTED|Overall Study||20
8487878|NCT00568334|20914740|P2|NOT COMPLETED|Overall Study||1
8487879|NCT00568334|20914741|P1|NOT COMPLETED|Overall Study||1
8487880|NCT00568334|20914740|P2|COMPLETED|Overall Study||121
8487881|NCT00568334|20914741|P1|COMPLETED|Overall Study||121
8487882|NCT00568334|20914740|P2|STARTED|Overall Study||122
8487883|NCT00568334|20914741|P1|STARTED|Overall Study||122
8487884|NCT00568178|20914767|P6|NOT COMPLETED|Open Label Extension||80
8487885|NCT00568178|20914768|P5|NOT COMPLETED|Open Label Extension||79
8487886|NCT00568178|20914769|P4|NOT COMPLETED|Open Label Extension||0
8487887|NCT00568178|20914770|P3|NOT COMPLETED|Open Label Extension||0
8487888|NCT00568178|20914771|P2|NOT COMPLETED|Open Label Extension||0
8487889|NCT00568178|20914772|P1|NOT COMPLETED|Open Label Extension||0
8487890|NCT00568178|20914767|P6|COMPLETED|Open Label Extension||54
8487891|NCT00568178|20914768|P5|COMPLETED|Open Label Extension||55
8487892|NCT00568178|20914769|P4|COMPLETED|Open Label Extension||0
8487893|NCT00568178|20914770|P3|COMPLETED|Open Label Extension||0
8487894|NCT00568178|20914771|P2|COMPLETED|Open Label Extension||0
8487895|NCT00568178|20914772|P1|COMPLETED|Open Label Extension||0
8487896|NCT00568178|20914767|P6|STARTED|Open Label Extension||134
8487897|NCT00568178|20914768|P5|STARTED|Open Label Extension||134
8487898|NCT00568178|20914769|P4|STARTED|Open Label Extension||0
8487899|NCT00568178|20914770|P3|STARTED|Open Label Extension||0
8487900|NCT00568178|20914771|P2|STARTED|Open Label Extension||0
8487901|NCT00568178|20914772|P1|STARTED|Open Label Extension||0
8487902|NCT00568178|20914767|P6|NOT COMPLETED|Double Blind Base Study||0
8487903|NCT00568178|20914768|P5|NOT COMPLETED|Double Blind Base Study||0
8487904|NCT00568178|20914769|P4|NOT COMPLETED|Double Blind Base Study||5
8487905|NCT00568178|20914770|P3|NOT COMPLETED|Double Blind Base Study||1
8487906|NCT00568178|20914771|P2|NOT COMPLETED|Double Blind Base Study||6
8487907|NCT00568178|20914772|P1|NOT COMPLETED|Double Blind Base Study||6
8487908|NCT00568178|20914767|P6|COMPLETED|Double Blind Base Study||0
8487909|NCT00568178|20914768|P5|COMPLETED|Double Blind Base Study||0
8487910|NCT00568178|20914769|P4|COMPLETED|Double Blind Base Study||25
8487911|NCT00568178|20914770|P3|COMPLETED|Double Blind Base Study||29
8487912|NCT00568178|20914771|P2|COMPLETED|Double Blind Base Study||118
8487913|NCT00568178|20914772|P1|COMPLETED|Double Blind Base Study||116
8487914|NCT00568178|20914767|P6|STARTED|Double Blind Base Study||0
8487915|NCT00568178|20914768|P5|STARTED|Double Blind Base Study||0
8487916|NCT00568178|20914769|P4|STARTED|Double Blind Base Study||30
8487917|NCT00568178|20914770|P3|STARTED|Double Blind Base Study||30
8487918|NCT00568178|20914771|P2|STARTED|Double Blind Base Study||124
8487919|NCT00568178|20914772|P1|STARTED|Double Blind Base Study||122
8487920|NCT00568126|20914790|P2|NOT COMPLETED|Overall Study||9
8487921|NCT00568126|20914791|P1|NOT COMPLETED|Overall Study||11
8487922|NCT00568126|20914790|P2|COMPLETED|Overall Study||12
8487923|NCT00568126|20914791|P1|COMPLETED|Overall Study||13
8487924|NCT00568126|20914790|P2|STARTED|Overall Study||21
8487925|NCT00568126|20914791|P1|STARTED|Overall Study||24
8487926|NCT00568087|20914801|P2|NOT COMPLETED|Overall Study||7
8487927|NCT00568087|20914802|P1|NOT COMPLETED|Overall Study||7
8487928|NCT00568087|20914801|P2|COMPLETED|Overall Study||17
8487929|NCT00568087|20914802|P1|COMPLETED|Overall Study||15
8487930|NCT00568087|20914801|P2|Received Intervention|Overall Study||23
8487931|NCT00568087|20914802|P1|Received Intervention|Overall Study||21
8487932|NCT00568087|20914801|P2|STARTED|Overall Study||24
8487933|NCT00568087|20914802|P1|STARTED|Overall Study||22
8487934|NCT00568061|20914816|P2|NOT COMPLETED|Overall Study||2
8487935|NCT00568061|20914817|P1|NOT COMPLETED|Overall Study||5
8487936|NCT00568061|20914816|P2|COMPLETED|Overall Study||14
8487937|NCT00568061|20914817|P1|COMPLETED|Overall Study||8
8487938|NCT00568061|20914816|P2|STARTED|Overall Study||16
8487939|NCT00568061|20914817|P1|STARTED|Overall Study||13
8487940|NCT00568022|20914845|P3|NOT COMPLETED|Overall Study||0
8487941|NCT00568022|20914846|P2|NOT COMPLETED|Overall Study||0
8487942|NCT00568022|20914847|P1|NOT COMPLETED|Overall Study||0
8487943|NCT00568022|20914845|P3|COMPLETED|Overall Study||3
8487944|NCT00568022|20914846|P2|COMPLETED|Overall Study||3
8487945|NCT00568022|20914847|P1|COMPLETED|Overall Study||3
8487946|NCT00568022|20914845|P3|STARTED|Overall Study||3
8487947|NCT00568022|20914846|P2|STARTED|Overall Study||3
8487948|NCT00568022|20914847|P1|STARTED|Overall Study||3
8487949|NCT00567996|20914880|P3|NOT COMPLETED|Overall Study||70
8487950|NCT00567996|20914881|P2|NOT COMPLETED|Overall Study||50
8487951|NCT00567996|20914882|P1|NOT COMPLETED|Overall Study||44
8487952|NCT00567996|20914880|P3|COMPLETED|Overall Study||265
8487953|NCT00567996|20914881|P2|COMPLETED|Overall Study||284
8487954|NCT00567996|20914882|P1|COMPLETED|Overall Study||289
8487955|NCT00567996|20914880|P3|Intent-to-treat: Received Study Drug|Overall Study||335
8487956|NCT00567996|20914881|P2|Intent-to-treat: Received Study Drug|Overall Study||333
8487957|NCT00567996|20914882|P1|Intent-to-treat: Received Study Drug|Overall Study||330
8487958|NCT00567996|20914880|P3|STARTED|Overall Study||335
8487959|NCT00567996|20914881|P2|STARTED|Overall Study||334
8487960|NCT00567996|20914882|P1|STARTED|Overall Study|Randomized participants|333
8487961|NCT00567892|20914898|P4|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
8487962|NCT00567892|20914899|P3|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
8487963|NCT00567892|20914900|P2|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
8487964|NCT00567892|20914901|P1|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
8487965|NCT00567892|20914898|P4|COMPLETED|Second Treatment (2 or 4 Weeks)||5
8487966|NCT00567892|20914899|P3|COMPLETED|Second Treatment (2 or 4 Weeks)||9
8487967|NCT00567892|20914900|P2|COMPLETED|Second Treatment (2 or 4 Weeks)||7
8487968|NCT00567892|20914901|P1|COMPLETED|Second Treatment (2 or 4 Weeks)||7
8487969|NCT00567892|20914898|P4|STARTED|Second Treatment (2 or 4 Weeks)||6
8487970|NCT00567892|20914899|P3|STARTED|Second Treatment (2 or 4 Weeks)||9
8487971|NCT00567892|20914900|P2|STARTED|Second Treatment (2 or 4 Weeks)||7
8487972|NCT00567892|20914901|P1|STARTED|Second Treatment (2 or 4 Weeks)||7
8487973|NCT00567892|20914898|P4|NOT COMPLETED|Washout (2 Weeks)||0
8487974|NCT00567892|20914899|P3|NOT COMPLETED|Washout (2 Weeks)||0
8487975|NCT00567892|20914900|P2|NOT COMPLETED|Washout (2 Weeks)||0
8487976|NCT00567892|20914901|P1|NOT COMPLETED|Washout (2 Weeks)||0
8487977|NCT00567892|20914898|P4|COMPLETED|Washout (2 Weeks)||6
8487978|NCT00567892|20914899|P3|COMPLETED|Washout (2 Weeks)||9
8487979|NCT00567892|20914900|P2|COMPLETED|Washout (2 Weeks)||7
8487980|NCT00567892|20914901|P1|COMPLETED|Washout (2 Weeks)||7
8487981|NCT00567892|20914898|P4|STARTED|Washout (2 Weeks)||6
8487982|NCT00567892|20914899|P3|STARTED|Washout (2 Weeks)||9
8487983|NCT00567892|20914900|P2|STARTED|Washout (2 Weeks)||7
8487984|NCT00567892|20914901|P1|STARTED|Washout (2 Weeks)||7
8487985|NCT00567892|20914898|P4|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
8487986|NCT00567892|20914899|P3|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
8487987|NCT00567892|20914900|P2|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
8487988|NCT00567892|20914901|P1|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
8487989|NCT00567892|20914898|P4|COMPLETED|First Treatment (2 or 4 Weeks)||6
8487990|NCT00567892|20914899|P3|COMPLETED|First Treatment (2 or 4 Weeks)||9
8487991|NCT00567892|20914900|P2|COMPLETED|First Treatment (2 or 4 Weeks)||7
8487992|NCT00567892|20914901|P1|COMPLETED|First Treatment (2 or 4 Weeks)||7
8487993|NCT00567892|20914898|P4|STARTED|First Treatment (2 or 4 Weeks)||10
8487994|NCT00567892|20914899|P3|STARTED|First Treatment (2 or 4 Weeks)||10
8487995|NCT00567892|20914900|P2|STARTED|First Treatment (2 or 4 Weeks)||7
8487996|NCT00567892|20914901|P1|STARTED|First Treatment (2 or 4 Weeks)||7
8487997|NCT00567879|20914919|P6|NOT COMPLETED|Overall Study||3
8487998|NCT00567879|20914920|P5|NOT COMPLETED|Overall Study||12
8487999|NCT00567879|20914921|P4|NOT COMPLETED|Overall Study||6
8488000|NCT00567879|20914922|P3|NOT COMPLETED|Overall Study||21
8488001|NCT00567879|20914923|P2|NOT COMPLETED|Overall Study||7
8488002|NCT00567879|20914924|P1|NOT COMPLETED|Overall Study||7
8488003|NCT00567879|20914919|P6|COMPLETED|Overall Study||0
8488004|NCT00567879|20914920|P5|COMPLETED|Overall Study||0
8488005|NCT00567879|20914921|P4|COMPLETED|Overall Study||0
8488006|NCT00567879|20914922|P3|COMPLETED|Overall Study||0
8488007|NCT00567879|20914923|P2|COMPLETED|Overall Study||0
8488008|NCT00567879|20914924|P1|COMPLETED|Overall Study||0
8488009|NCT00567879|20914919|P6|Maximum Tolerated Dose Determining Set|Overall Study||3
8488010|NCT00567879|20914920|P5|Maximum Tolerated Dose Determining Set|Overall Study||12
8488011|NCT00567879|20914921|P4|Maximum Tolerated Dose Determining Set|Overall Study||6
8488012|NCT00567879|20914922|P3|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
8488013|NCT00567879|20914923|P2|Maximum Tolerated Dose Determining Set|Overall Study||7
8488014|NCT00567879|20914924|P1|Maximum Tolerated Dose Determining Set|Overall Study||5
8488015|NCT00567879|20914919|P6|STARTED|Overall Study||3
8488016|NCT00567879|20914920|P5|STARTED|Overall Study||12
8488017|NCT00567879|20914921|P4|STARTED|Overall Study||6
8488018|NCT00567879|20914922|P3|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
8488019|NCT00567879|20914923|P2|STARTED|Overall Study||7
8488020|NCT00567879|20914924|P1|STARTED|Overall Study||7
8488021|NCT00567840|20914950|P5|NOT COMPLETED|Overall Study||0
8488022|NCT00567840|20914951|P4|NOT COMPLETED|Overall Study||1
8488023|NCT00567840|20914952|P3|NOT COMPLETED|Overall Study||1
8488024|NCT00567840|20914953|P2|NOT COMPLETED|Overall Study||0
8488025|NCT00567840|20914954|P1|NOT COMPLETED|Overall Study||2
8488026|NCT00567840|20914950|P5|COMPLETED|Overall Study||8
8488027|NCT00567840|20914951|P4|COMPLETED|Overall Study||14
8488028|NCT00567840|20914952|P3|COMPLETED|Overall Study||15
8488029|NCT00567840|20914953|P2|COMPLETED|Overall Study||15
8488030|NCT00567840|20914954|P1|COMPLETED|Overall Study||13
8488031|NCT00567840|20914950|P5|STARTED|Overall Study||8
8488032|NCT00567840|20914951|P4|STARTED|Overall Study||15
8488033|NCT00567840|20914952|P3|STARTED|Overall Study||16
8488034|NCT00567840|20914953|P2|STARTED|Overall Study||15
8488035|NCT00567840|20914954|P1|STARTED|Overall Study||15
8488036|NCT00567593|20914991|P1|NOT COMPLETED|Overall Study||2
8488037|NCT00567593|20914991|P1|COMPLETED|Overall Study||10
8488038|NCT00567593|20914991|P1|STARTED|Overall Study||12
8488039|NCT00567567|20914998|P3|NOT COMPLETED|Overall Study||278
8488040|NCT00567567|20914999|P2|NOT COMPLETED|Overall Study||134
8488041|NCT00567567|20915000|P1|NOT COMPLETED|Overall Study||152
8488042|NCT00567567|20914998|P3|COMPLETED|Overall Study||1
8488043|NCT00567567|20914999|P2|COMPLETED|Overall Study||42
8488044|NCT00567567|20915000|P1|COMPLETED|Overall Study||58
8488045|NCT00567567|20914998|P3|STARTED|Overall Study||279
8488046|NCT00567567|20914999|P2|STARTED|Overall Study||176
8488047|NCT00567567|20915000|P1|STARTED|Overall Study||210
8488048|NCT00567541|20915048|P2|NOT COMPLETED|Overall Study||1
8488049|NCT00567541|20915049|P1|NOT COMPLETED|Overall Study||0
8488050|NCT00567541|20915048|P2|COMPLETED|Overall Study||8
8488051|NCT00567541|20915049|P1|COMPLETED|Overall Study||7
8488052|NCT00567541|20915048|P2|STARTED|Overall Study||9
8488053|NCT00567541|20915049|P1|STARTED|Overall Study||7
8488070|NCT00567489|20915099|P2|NOT COMPLETED|Overall Study||23
8488071|NCT00567489|20915100|P1|NOT COMPLETED|Overall Study||7
8488072|NCT00567489|20915099|P2|COMPLETED|Overall Study||101
8488073|NCT00567489|20915100|P1|COMPLETED|Overall Study||120
8488074|NCT00567489|20915099|P2|STARTED|Overall Study||124
8488075|NCT00567489|20915100|P1|STARTED|Overall Study||127
8488076|NCT00567476|20915150|P2|NOT COMPLETED|Overall Study||4
8488077|NCT00567476|20915151|P1|NOT COMPLETED|Overall Study||8
8488078|NCT00567476|20915150|P2|COMPLETED|Overall Study||34
8488079|NCT00567476|20915151|P1|COMPLETED|Overall Study||70
8488080|NCT00567476|20915150|P2|STARTED|Overall Study||38
8488081|NCT00567476|20915151|P1|STARTED|Overall Study||78
8488082|NCT00567398|20915177|P2|NOT COMPLETED|Overall Study||23
8488083|NCT00567398|20915178|P1|NOT COMPLETED|Overall Study||7
8488084|NCT00567398|20915177|P2|COMPLETED|Overall Study||101
8488085|NCT00567398|20915178|P1|COMPLETED|Overall Study||120
8488086|NCT00567398|20915177|P2|STARTED|Overall Study||124
8488087|NCT00567398|20915178|P1|STARTED|Overall Study||127
8488088|NCT00567359|20915226|P1|NOT COMPLETED|Overall Study||1
8488089|NCT00567359|20915226|P1|COMPLETED|Overall Study||99
8488090|NCT00567359|20915226|P1|STARTED|Overall Study||100
8488091|NCT00567320|20915235|P2|NOT COMPLETED|Overall Study||0
8488092|NCT00567320|20915236|P1|NOT COMPLETED|Overall Study||0
8488093|NCT00567320|20915235|P2|COMPLETED|Overall Study||18
8488094|NCT00567320|20915236|P1|COMPLETED|Overall Study||13
8488095|NCT00567320|20915235|P2|STARTED|Overall Study||18
8488096|NCT00567320|20915236|P1|STARTED|Overall Study||13
8488097|NCT00567307|20915244|P2|NOT COMPLETED|Overall Study||1
8488098|NCT00567307|20915245|P1|NOT COMPLETED|Overall Study||12
8488099|NCT00567307|20915244|P2|COMPLETED|Overall Study||104
8488100|NCT00567307|20915245|P1|COMPLETED|Overall Study||99
8488101|NCT00567307|20915244|P2|STARTED|Overall Study||105
8488102|NCT00567307|20915245|P1|STARTED|Overall Study||111
8488106|NCT00567255|20915302|P2|NOT COMPLETED|Overall Study||228
8488107|NCT00567255|20915303|P1|NOT COMPLETED|Overall Study||463
8488108|NCT00567255|20915302|P2|COMPLETED|Overall Study||267
8488109|NCT00567255|20915303|P1|COMPLETED|Overall Study||538
8488110|NCT00567255|20915302|P2|STARTED|Overall Study||495
8488111|NCT00567255|20915303|P1|STARTED|Overall Study||1001
8488112|NCT00567242|20915349|P2|NOT COMPLETED|Overall Study||0
8488113|NCT00567242|20915350|P1|NOT COMPLETED|Overall Study||0
8488114|NCT00567242|20915349|P2|COMPLETED|Overall Study||7
8488115|NCT00567242|20915350|P1|COMPLETED|Overall Study||7
8488116|NCT00567242|20915349|P2|STARTED|Overall Study||7
8488117|NCT00567242|20915350|P1|STARTED|Overall Study||7
8488118|NCT00567229|20915360|P1|NOT COMPLETED|Overall Study||0
8488119|NCT00567229|20915360|P1|COMPLETED|Overall Study||3
8488120|NCT00567229|20915360|P1|STARTED|Overall Study||3
8488121|NCT00567190|20915366|P2|NOT COMPLETED|Overall Study||333
8488122|NCT00567190|20915367|P1|NOT COMPLETED|Overall Study||283
8488123|NCT00567190|20915366|P2|COMPLETED|Overall Study||73
8488124|NCT00567190|20915367|P1|COMPLETED|Overall Study||119
8488125|NCT00567190|20915366|P2|Crossover From Placebo to Pertuzumab|Overall Study|From July 2012, 50 participants randomized to Placebo arm crossed over to open-label pertuzumab.|50
8488126|NCT00567190|20915367|P1|Crossover From Placebo to Pertuzumab|Overall Study||0
8488127|NCT00567190|20915366|P2|Received at Least One Dose of Placebo|Overall Study||395
8488128|NCT00567190|20915367|P1|Received at Least One Dose of Placebo|Overall Study|1 participant randomized to the Pertuzumab arm actually received placebo at every treatment cycle.|1
8488129|NCT00567190|20915366|P2|Received at Least One Dose of Pertuzumab|Overall Study|9 participants randomized to the Placebo arm actually received at least one dose of pertuzumab.|9
8488130|NCT00567190|20915367|P1|Received at Least One Dose of Pertuzumab|Overall Study||399
8488131|NCT00567190|20915366|P2|Did Not Receive Any Study Treatment|Overall Study||2
8488132|NCT00567190|20915367|P1|Did Not Receive Any Study Treatment|Overall Study||2
8488133|NCT00567190|20915366|P2|STARTED|Overall Study||406
8488134|NCT00567190|20915367|P1|STARTED|Overall Study||402
8488135|NCT00567164|20915418|P3|NOT COMPLETED|Overall Study||72
8488136|NCT00567164|20915419|P2|NOT COMPLETED|Overall Study||73
8488137|NCT00567164|20915420|P1|NOT COMPLETED|Overall Study||546
8488138|NCT00567164|20915418|P3|COMPLETED|Overall Study||160
8488139|NCT00567164|20915419|P2|COMPLETED|Overall Study||161
8488140|NCT00567164|20915420|P1|COMPLETED|Overall Study||875
8488141|NCT00567164|20915418|P3|Subjects Received Treatment|Overall Study|Full Analysis Set|226
8488142|NCT00567164|20915419|P2|Subjects Received Treatment|Overall Study|Full Analysis Set|232
8488143|NCT00567164|20915420|P1|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
8488144|NCT00567164|20915418|P3|STARTED|Overall Study||232
8488145|NCT00567164|20915419|P2|STARTED|Overall Study||234
8488146|NCT00567164|20915420|P1|STARTED|Overall Study||1421
8488147|NCT00567112|20915492|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8488148|NCT00567112|20915493|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8488149|NCT00567112|20915494|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
8488150|NCT00567112|20915492|P3|COMPLETED|Treatment Period 4 (3 Days)||3
8488151|NCT00567112|20915493|P2|COMPLETED|Treatment Period 4 (3 Days)||7
8488152|NCT00567112|20915494|P1|COMPLETED|Treatment Period 4 (3 Days)||4
8488153|NCT00567112|20915492|P3|STARTED|Treatment Period 4 (3 Days)||3
8488154|NCT00567112|20915493|P2|STARTED|Treatment Period 4 (3 Days)||7
8488155|NCT00567112|20915494|P1|STARTED|Treatment Period 4 (3 Days)||4
8488156|NCT00567112|20915492|P3|NOT COMPLETED|Washout Period 3 (3 Days)||0
8488157|NCT00567112|20915493|P2|NOT COMPLETED|Washout Period 3 (3 Days)||0
8488158|NCT00567112|20915494|P1|NOT COMPLETED|Washout Period 3 (3 Days)||3
8488159|NCT00567112|20915492|P3|COMPLETED|Washout Period 3 (3 Days)||3
8488160|NCT00567112|20915493|P2|COMPLETED|Washout Period 3 (3 Days)||7
8488161|NCT00567112|20915494|P1|COMPLETED|Washout Period 3 (3 Days)||4
8488162|NCT00567112|20915492|P3|STARTED|Washout Period 3 (3 Days)||3
8488163|NCT00567112|20915493|P2|STARTED|Washout Period 3 (3 Days)||7
8488164|NCT00567112|20915494|P1|STARTED|Washout Period 3 (3 Days)||7
8488165|NCT00567112|20915492|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8488166|NCT00567112|20915493|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8488167|NCT00567112|20915494|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
8488168|NCT00567112|20915492|P3|COMPLETED|Treatment Period 3 (3 Days)||3
8488169|NCT00567112|20915493|P2|COMPLETED|Treatment Period 3 (3 Days)||7
8488170|NCT00567112|20915494|P1|COMPLETED|Treatment Period 3 (3 Days)||7
8488171|NCT00567112|20915492|P3|STARTED|Treatment Period 3 (3 Days)||3
8488172|NCT00567112|20915493|P2|STARTED|Treatment Period 3 (3 Days)||7
8488173|NCT00567112|20915494|P1|STARTED|Treatment Period 3 (3 Days)||7
8488174|NCT00567112|20915492|P3|NOT COMPLETED|Washout Period 2 (3 Days)||0
8488175|NCT00567112|20915493|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
8488176|NCT00567112|20915494|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
8488177|NCT00567112|20915492|P3|COMPLETED|Washout Period 2 (3 Days)||3
8488178|NCT00567112|20915493|P2|COMPLETED|Washout Period 2 (3 Days)||7
8488179|NCT00567112|20915494|P1|COMPLETED|Washout Period 2 (3 Days)||7
8488180|NCT00567112|20915492|P3|STARTED|Washout Period 2 (3 Days)||3
8488181|NCT00567112|20915493|P2|STARTED|Washout Period 2 (3 Days)||7
8488182|NCT00567112|20915494|P1|STARTED|Washout Period 2 (3 Days)||7
8488183|NCT00567112|20915492|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8488184|NCT00567112|20915493|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||1
8488185|NCT00567112|20915494|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
8488186|NCT00567112|20915492|P3|COMPLETED|Treatment Period 2 (3 Days)||3
8488187|NCT00567112|20915493|P2|COMPLETED|Treatment Period 2 (3 Days)||7
8488188|NCT00567112|20915494|P1|COMPLETED|Treatment Period 2 (3 Days)||7
8488189|NCT00567112|20915492|P3|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
8488190|NCT00567112|20915493|P2|STARTED|Treatment Period 2 (3 Days)||8
8488191|NCT00567112|20915494|P1|STARTED|Treatment Period 2 (3 Days)||7
8488192|NCT00567112|20915492|P3|NOT COMPLETED|Washout Period 1 (3 Days)||0
8488193|NCT00567112|20915493|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
8488194|NCT00567112|20915494|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
8488195|NCT00567112|20915492|P3|COMPLETED|Washout Period 1 (3 Days)||0
8488196|NCT00567112|20915493|P2|COMPLETED|Washout Period 1 (3 Days)||8
8488197|NCT00567112|20915494|P1|COMPLETED|Washout Period 1 (3 Days)||7
8488198|NCT00567112|20915492|P3|STARTED|Washout Period 1 (3 Days)||0
8488199|NCT00567112|20915493|P2|STARTED|Washout Period 1 (3 Days)||8
8488200|NCT00567112|20915494|P1|STARTED|Washout Period 1 (3 Days)||7
8488201|NCT00567112|20915492|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8488202|NCT00567112|20915493|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8488203|NCT00567112|20915494|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
8488204|NCT00567112|20915492|P3|COMPLETED|Treatment Period 1 (3 Days)||0
8488205|NCT00567112|20915493|P2|COMPLETED|Treatment Period 1 (3 Days)||8
8488206|NCT00567112|20915494|P1|COMPLETED|Treatment Period 1 (3 Days)||7
8488207|NCT00567112|20915492|P3|STARTED|Treatment Period 1 (3 Days)||0
8488208|NCT00567112|20915493|P2|STARTED|Treatment Period 1 (3 Days)||8
8488209|NCT00567112|20915494|P1|STARTED|Treatment Period 1 (3 Days)||7
8488210|NCT00567008|20915518|P2|NOT COMPLETED|Overall Study||1
8488211|NCT00567008|20915519|P1|NOT COMPLETED|Overall Study||1
8488212|NCT00567008|20915518|P2|COMPLETED|Overall Study||18
8488213|NCT00567008|20915519|P1|COMPLETED|Overall Study||17
8488214|NCT00567008|20915518|P2|STARTED|Overall Study||19
8488215|NCT00567008|20915519|P1|STARTED|Overall Study||18
8488216|NCT00566995|20915525|P1|NOT COMPLETED|Overall Study||7
8488217|NCT00566995|20915525|P1|COMPLETED|Overall Study||30
8488218|NCT00566995|20915525|P1|STARTED|Overall Study||37
8488219|NCT00566982|20915540|P2|NOT COMPLETED|Overall Study||69
8488220|NCT00566982|20915541|P1|NOT COMPLETED|Overall Study||8
8488221|NCT00566982|20915540|P2|COMPLETED|Overall Study||294
8488222|NCT00566982|20915541|P1|COMPLETED|Overall Study||55
8488223|NCT00566982|20915540|P2|STARTED|Overall Study||363
8488224|NCT00566982|20915541|P1|STARTED|Overall Study||63
8488225|NCT00566969|20915566|P3|NOT COMPLETED|Overall Study||12
8488226|NCT00566969|20915567|P2|NOT COMPLETED|Overall Study||9
8488227|NCT00566969|20915568|P1|NOT COMPLETED|Overall Study||15
8488228|NCT00566969|20915566|P3|COMPLETED|Overall Study||23
8488229|NCT00566969|20915567|P2|COMPLETED|Overall Study||28
8488230|NCT00566969|20915568|P1|COMPLETED|Overall Study||19
8488231|NCT00566969|20915566|P3|STARTED|Overall Study||35
8488232|NCT00566969|20915567|P2|STARTED|Overall Study||37
8488233|NCT00566969|20915568|P1|STARTED|Overall Study||34
8488234|NCT00566943|20915578|P2|NOT COMPLETED|Overall Study||0
8488235|NCT00566943|20915579|P1|NOT COMPLETED|Overall Study||0
8488236|NCT00566943|20915578|P2|COMPLETED|Overall Study||49
8488237|NCT00566943|20915579|P1|COMPLETED|Overall Study||52
8488238|NCT00566943|20915578|P2|STARTED|Overall Study||49
8488239|NCT00566943|20915579|P1|STARTED|Overall Study||52
8488240|NCT00566930|20915594|P3|NOT COMPLETED|Overall Study||1
8488241|NCT00566930|20915595|P2|NOT COMPLETED|Overall Study||4
8488242|NCT00566930|20915596|P1|NOT COMPLETED|Overall Study||2
8488243|NCT00566930|20915594|P3|COMPLETED|Overall Study||32
8488244|NCT00566930|20915595|P2|COMPLETED|Overall Study||32
8488245|NCT00566930|20915596|P1|COMPLETED|Overall Study||27
8488246|NCT00566930|20915594|P3|STARTED|Overall Study||33
8488247|NCT00566930|20915595|P2|STARTED|Overall Study||36
8488248|NCT00566930|20915596|P1|STARTED|Overall Study||29
8488249|NCT00566852|20915606|P2|NOT COMPLETED|Overall Study||198
8488250|NCT00566852|20915607|P1|NOT COMPLETED|Overall Study||207
8488251|NCT00566852|20915606|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
8488252|NCT00566852|20915607|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
8488253|NCT00566852|20915606|P2|STARTED|Overall Study||276
8488254|NCT00566852|20915607|P1|STARTED|Overall Study||278
8488261|NCT00566735|20915638|P2|NOT COMPLETED|Overall Study||7
8488262|NCT00566735|20915639|P1|NOT COMPLETED|Overall Study||2
8488263|NCT00566735|20915638|P2|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
8488264|NCT00566735|20915639|P1|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
8488265|NCT00566735|20915638|P2|Withdrew Before Baseline Measures|Overall Study||7
8488266|NCT00566735|20915639|P1|Withdrew Before Baseline Measures|Overall Study||2
8488267|NCT00566735|20915638|P2|STARTED|Overall Study||19
8488268|NCT00566735|20915639|P1|STARTED|Overall Study||20
8488269|NCT00566722|20915652|P3|NOT COMPLETED|Overall Study||9
8488270|NCT00566722|20915653|P2|NOT COMPLETED|Overall Study||5
8488271|NCT00566722|20915654|P1|NOT COMPLETED|Overall Study||2
8488272|NCT00566722|20915652|P3|COMPLETED|Overall Study||73
8488273|NCT00566722|20915653|P2|COMPLETED|Overall Study||24
8488274|NCT00566722|20915654|P1|COMPLETED|Overall Study||39
8488275|NCT00566722|20915652|P3|STARTED|Overall Study||82
8488276|NCT00566722|20915653|P2|STARTED|Overall Study||29
8488277|NCT00566722|20915654|P1|STARTED|Overall Study||41
8488278|NCT00566709|20915700|P2|NOT COMPLETED|Overall Study||0
8488279|NCT00566709|20915701|P1|NOT COMPLETED|Overall Study||5
8488280|NCT00566709|20915700|P2|COMPLETED|Overall Study||51
8488281|NCT00566709|20915701|P1|COMPLETED|Overall Study||46
8488282|NCT00566709|20915700|P2|STARTED|Overall Study||51
8488283|NCT00566709|20915701|P1|STARTED|Overall Study||51
8488284|NCT00566696|20915717|P1|NOT COMPLETED|Overall Study||42
8488285|NCT00566696|20915717|P1|COMPLETED|Overall Study||31
8488286|NCT00566696|20915717|P1|STARTED|Overall Study||73
8488287|NCT00566631|20915727|P1|NOT COMPLETED|Part 2: Extension Phase||82
8488288|NCT00566631|20915727|P1|COMPLETED|Part 2: Extension Phase||57
8488289|NCT00566631|20915727|P1|STARTED|Part 2: Extension Phase||139
8488290|NCT00566631|20915727|P1|NOT COMPLETED|Between Treatment and Extension Phase||95
8488291|NCT00566631|20915727|P1|COMPLETED|Between Treatment and Extension Phase||139
8488292|NCT00566631|20915727|P1|STARTED|Between Treatment and Extension Phase||234
8488293|NCT00566631|20915727|P1|NOT COMPLETED|Part 1: Core Treatment Phase||60
8488294|NCT00566631|20915727|P1|COMPLETED|Part 1: Core Treatment Phase||234
8488295|NCT00566631|20915727|P1|STARTED|Part 1: Core Treatment Phase||294
8488296|NCT00566579|20915744|P2|NOT COMPLETED|Overall Study||0
8488297|NCT00566579|20915745|P1|NOT COMPLETED|Overall Study||0
8488298|NCT00566579|20915744|P2|COMPLETED|Overall Study||31
8488299|NCT00566579|20915745|P1|COMPLETED|Overall Study||29
8488300|NCT00566579|20915744|P2|STARTED|Overall Study||31
8488301|NCT00566579|20915745|P1|STARTED|Overall Study||29
8488302|NCT00566527|20915754|P3|NOT COMPLETED|Overall Study||78
8488303|NCT00566527|20915755|P2|NOT COMPLETED|Overall Study||66
8488304|NCT00566527|20915756|P1|NOT COMPLETED|Overall Study||17
8488305|NCT00566527|20915754|P3|COMPLETED|Overall Study||461
8488306|NCT00566527|20915755|P2|COMPLETED|Overall Study||474
8488307|NCT00566527|20915756|P1|COMPLETED|Overall Study||524
8488308|NCT00566527|20915754|P3|Received ProQuad® Dose 2|Overall Study||462
8488309|NCT00566527|20915755|P2|Received ProQuad® Dose 2|Overall Study||478
8488310|NCT00566527|20915756|P1|Received ProQuad® Dose 2|Overall Study||525
8488311|NCT00566527|20915754|P3|Received ProQuad® Dose 1|Overall Study||470
8488312|NCT00566527|20915755|P2|Received ProQuad® Dose 1|Overall Study||484
8488313|NCT00566527|20915756|P1|Received ProQuad® Dose 1|Overall Study||529
8488314|NCT00566527|20915754|P3|STARTED|Overall Study|Number randomized.|539
8488315|NCT00566527|20915755|P2|STARTED|Overall Study|Number randomized.|540
8488316|NCT00566527|20915756|P1|STARTED|Overall Study|Number randomized.|541
8488317|NCT00566501|20915797|P2|NOT COMPLETED|Overall Study||126
8488318|NCT00566501|20915798|P1|NOT COMPLETED|Overall Study||156
8488319|NCT00566501|20915797|P2|COMPLETED|Overall Study||210
8488320|NCT00566501|20915798|P1|COMPLETED|Overall Study||423
8488321|NCT00566501|20915797|P2|Not Determined|Overall Study||0
8488322|NCT00566501|20915798|P1|Not Determined|Overall Study||1
8488323|NCT00566501|20915797|P2|Other ( Not Specified)|Overall Study||21
8488324|NCT00566501|20915798|P1|Other ( Not Specified)|Overall Study||24
8488325|NCT00566501|20915797|P2|Medication Non-compliance|Overall Study||0
8488326|NCT00566501|20915798|P1|Medication Non-compliance|Overall Study||5
8488327|NCT00566501|20915797|P2|Protocol Violation|Overall Study||2
8488328|NCT00566501|20915798|P1|Protocol Violation|Overall Study||2
8488329|NCT00566501|20915797|P2|Request of Investigator or Sponsor|Overall Study||7
8488330|NCT00566501|20915798|P1|Request of Investigator or Sponsor|Overall Study||6
8488331|NCT00566501|20915797|P2|Withdraw of Consent by Subject|Overall Study||30
8488332|NCT00566501|20915798|P1|Withdraw of Consent by Subject|Overall Study||33
8488333|NCT00566501|20915797|P2|Lack of Efficacy|Overall Study||3
8488334|NCT00566501|20915798|P1|Lack of Efficacy|Overall Study||8
8488335|NCT00566501|20915797|P2|Adverse Event|Overall Study||59
8488336|NCT00566501|20915798|P1|Adverse Event|Overall Study||68
8488337|NCT00566501|20915797|P2|Discontinued|Overall Study||122
8488338|NCT00566501|20915798|P1|Discontinued|Overall Study||146
8488339|NCT00566501|20915797|P2|Safety Population|Overall Study||332
8488340|NCT00566501|20915798|P1|Safety Population|Overall Study||570
8488341|NCT00566501|20915797|P2|STARTED|Overall Study||336
8488342|NCT00566501|20915798|P1|STARTED|Overall Study||579
8488343|NCT00566462|20915806|P2|NOT COMPLETED|Overall Study||0
8488344|NCT00566462|20915807|P1|NOT COMPLETED|Overall Study||0
8488345|NCT00566462|20915806|P2|COMPLETED|Overall Study||0
8488346|NCT00566462|20915807|P1|COMPLETED|Overall Study||1
8488347|NCT00566462|20915806|P2|STARTED|Overall Study||0
8488348|NCT00566462|20915807|P1|STARTED|Overall Study||1
8488349|NCT00566254|20915817|P2|NOT COMPLETED|Overall Study||14
8488350|NCT00566254|20915818|P1|NOT COMPLETED|Overall Study||10
8488351|NCT00566254|20915817|P2|COMPLETED|Overall Study||93
8488352|NCT00566254|20915818|P1|COMPLETED|Overall Study||90
8488353|NCT00566254|20915817|P2|STARTED|Overall Study||107
8488354|NCT00566254|20915818|P1|STARTED|Overall Study||100
8488355|NCT00566228|20915832|P2|NOT COMPLETED|Overall Study||5
8488356|NCT00566228|20915833|P1|NOT COMPLETED|Overall Study||6
8488357|NCT00566228|20915832|P2|COMPLETED|Overall Study||55
8488358|NCT00566228|20915833|P1|COMPLETED|Overall Study||56
8488359|NCT00566228|20915832|P2|STARTED|Overall Study||60
8488360|NCT00566228|20915833|P1|STARTED|Overall Study||62
8488361|NCT00566150|20915851|P2|NOT COMPLETED|Overall Study||5
8488362|NCT00566150|20915852|P1|NOT COMPLETED|Overall Study||9
8488363|NCT00566150|20915851|P2|COMPLETED|Overall Study||11
8488364|NCT00566150|20915852|P1|COMPLETED|Overall Study||10
8488365|NCT00566150|20915851|P2|STARTED|Overall Study||16
8488366|NCT00566150|20915852|P1|STARTED|Overall Study||19
8488367|NCT00566111|20915866|P2|NOT COMPLETED|Overall Study||2
8488368|NCT00566111|20915867|P1|NOT COMPLETED|Overall Study||0
8488369|NCT00566111|20915866|P2|COMPLETED|Overall Study||1
8488370|NCT00566111|20915867|P1|COMPLETED|Overall Study||2
8488371|NCT00566111|20915866|P2|STARTED|Overall Study||3
8488372|NCT00566111|20915867|P1|STARTED|Overall Study||2
8488373|NCT00566098|20915881|P1|NOT COMPLETED|Administration of ASCT+MILs||18
8488374|NCT00566098|20915881|P1|COMPLETED|Administration of ASCT+MILs||4
8488375|NCT00566098|20915881|P1|STARTED|Administration of ASCT+MILs||22
8488376|NCT00566098|20915881|P1|NOT COMPLETED|Generation of MILs Product||1
8488377|NCT00566098|20915881|P1|COMPLETED|Generation of MILs Product||22
8488378|NCT00566098|20915881|P1|STARTED|Generation of MILs Product||23
8488379|NCT00566098|20915881|P1|NOT COMPLETED|Collection of MILs||2
8488380|NCT00566098|20915881|P1|COMPLETED|Collection of MILs||23
8488381|NCT00566098|20915881|P1|STARTED|Collection of MILs||25
8488382|NCT00566020|20915891|P2|NOT COMPLETED|46-week Long-term Administration Phase||17
8488383|NCT00566020|20915892|P1|NOT COMPLETED|46-week Long-term Administration Phase||0
8488384|NCT00566020|20915891|P2|COMPLETED|46-week Long-term Administration Phase||68
8488385|NCT00566020|20915892|P1|COMPLETED|46-week Long-term Administration Phase||0
8488386|NCT00566020|20915891|P2|STARTED|46-week Long-term Administration Phase||85
8488387|NCT00566020|20915892|P1|STARTED|46-week Long-term Administration Phase||0
8488388|NCT00566020|20915891|P2|NOT COMPLETED|6-week Dosage Adjustment Phase||0
8488389|NCT00566020|20915892|P1|NOT COMPLETED|6-week Dosage Adjustment Phase||7
8488390|NCT00566020|20915891|P2|COMPLETED|6-week Dosage Adjustment Phase||0
8488391|NCT00566020|20915892|P1|COMPLETED|6-week Dosage Adjustment Phase||85
8488392|NCT00566020|20915891|P2|STARTED|6-week Dosage Adjustment Phase||0
8488393|NCT00566020|20915892|P1|STARTED|6-week Dosage Adjustment Phase||92
8488394|NCT00565916|20915919|P2|NOT COMPLETED|Overall Study||0
8488395|NCT00565916|20915920|P1|NOT COMPLETED|Overall Study||0
8488396|NCT00565916|20915919|P2|COMPLETED|Overall Study||11
8488397|NCT00565916|20915920|P1|COMPLETED|Overall Study||11
8488398|NCT00565916|20915919|P2|STARTED|Overall Study||11
8488399|NCT00565916|20915920|P1|STARTED|Overall Study||11
8488400|NCT00565864|20915929|P3|NOT COMPLETED|Overall Study||11
8488401|NCT00565864|20915930|P2|NOT COMPLETED|Overall Study||12
8488402|NCT00565864|20915931|P1|NOT COMPLETED|Overall Study||12
8488403|NCT00565864|20915929|P3|COMPLETED|Overall Study||45
8488404|NCT00565864|20915930|P2|COMPLETED|Overall Study||47
8488405|NCT00565864|20915931|P1|COMPLETED|Overall Study||46
8488406|NCT00565864|20915929|P3|STARTED|Overall Study||56
8488407|NCT00565864|20915930|P2|STARTED|Overall Study||59
8488408|NCT00565864|20915931|P1|STARTED|Overall Study||58
8488409|NCT00565812|20915981|P3|NOT COMPLETED|Overall Study||130
8488410|NCT00565812|20915982|P2|NOT COMPLETED|Overall Study||135
8488411|NCT00565812|20915983|P1|NOT COMPLETED|Overall Study||144
8488412|NCT00565812|20915981|P3|COMPLETED|Overall Study||356
8488413|NCT00565812|20915982|P2|COMPLETED|Overall Study||351
8488414|NCT00565812|20915983|P1|COMPLETED|Overall Study||341
8488415|NCT00565812|20915981|P3|STARTED|Overall Study||486
8488416|NCT00565812|20915982|P2|STARTED|Overall Study||486
8488417|NCT00565812|20915983|P1|STARTED|Overall Study||485
8488418|NCT00565773|20916120|P1|NOT COMPLETED|Overall Study||2
8488419|NCT00565773|20916120|P1|COMPLETED|Overall Study||38
8488420|NCT00565773|20916120|P1|STARTED|Overall Study||40
8488421|NCT00565747|20916132|P2|NOT COMPLETED|Overall Study||73
8488422|NCT00565747|20916133|P1|NOT COMPLETED|Overall Study||67
8488423|NCT00565747|20916132|P2|COMPLETED|Overall Study|Completed with an embryo transfer|605
8488424|NCT00565747|20916133|P1|COMPLETED|Overall Study|Completed with an embryo transfer|587
8488425|NCT00565747|20916132|P2|STARTED|Overall Study||678
8488426|NCT00565747|20916133|P1|STARTED|Overall Study||654
8488427|NCT00565721|20916143|P1|NOT COMPLETED|Overall Study||17
8488428|NCT00565721|20916143|P1|COMPLETED|Overall Study||16
8488429|NCT00565721|20916143|P1|STARTED|Overall Study||33
8488430|NCT00565669|20916164|P2|NOT COMPLETED|Overall Study||0
8488431|NCT00565669|20916165|P1|NOT COMPLETED|Overall Study||0
8488432|NCT00565669|20916164|P2|COMPLETED|Overall Study||9
8488433|NCT00565669|20916165|P1|COMPLETED|Overall Study||11
8488434|NCT00565669|20916164|P2|STARTED|Overall Study||9
8488435|NCT00565669|20916165|P1|STARTED|Overall Study||11
8488436|NCT00565643|20916173|P2|NOT COMPLETED|Overall Study||0
8488437|NCT00565643|20916174|P1|NOT COMPLETED|Overall Study||0
8488438|NCT00565643|20916173|P2|COMPLETED|Overall Study||373
8488439|NCT00565643|20916174|P1|COMPLETED|Overall Study||380
8488440|NCT00565643|20916173|P2|Primary Outcome (Subsequent Cesarean)|Overall Study||92
8488441|NCT00565643|20916174|P1|Primary Outcome (Subsequent Cesarean)|Overall Study||80
8488442|NCT00565643|20916173|P2|Safety Data|Overall Study||373
8488443|NCT00565643|20916174|P1|Safety Data|Overall Study||380
8488444|NCT00565643|20916173|P2|STARTED|Overall Study||373
8488445|NCT00565643|20916174|P1|STARTED|Overall Study||380
8488449|NCT00565604|20916196|P1|NOT COMPLETED|Overall Study||4
8488450|NCT00565604|20916196|P1|COMPLETED|Overall Study||39
8488451|NCT00565604|20916196|P1|6 Month|Overall Study||39
8488452|NCT00565604|20916196|P1|6 Week|Overall Study||39
8488453|NCT00565604|20916196|P1|2 Week|Overall Study||41
8488454|NCT00565604|20916196|P1|7 Day|Overall Study||41
8488455|NCT00565604|20916196|P1|STARTED|Overall Study||43
8488456|NCT00565461|20916207|P4|NOT COMPLETED|Overall Study||3
8488457|NCT00565461|20916208|P3|NOT COMPLETED|Overall Study||1
8488458|NCT00565461|20916209|P2|NOT COMPLETED|Overall Study||1
8488459|NCT00565461|20916210|P1|NOT COMPLETED|Overall Study||0
8488460|NCT00565461|20916207|P4|COMPLETED|Overall Study||37
8488461|NCT00565461|20916208|P3|COMPLETED|Overall Study||39
8488462|NCT00565461|20916209|P2|COMPLETED|Overall Study||39
8488463|NCT00565461|20916210|P1|COMPLETED|Overall Study||40
8488464|NCT00565461|20916207|P4|STARTED|Overall Study||40
8488465|NCT00565461|20916208|P3|STARTED|Overall Study||40
8488466|NCT00565461|20916209|P2|STARTED|Overall Study||40
8488467|NCT00565461|20916210|P1|STARTED|Overall Study||40
8488468|NCT00565448|20916242|P2|NOT COMPLETED|Overall Study||2
8488469|NCT00565448|20916243|P1|NOT COMPLETED|Overall Study||3
8488470|NCT00565448|20916242|P2|COMPLETED|Overall Study|Completed induction period as per protocol.|23
8488471|NCT00565448|20916243|P1|COMPLETED|Overall Study|Completed induction period as per protocol.|47
8488472|NCT00565448|20916242|P2|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
8488473|NCT00565448|20916243|P1|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
8488474|NCT00565409|20916254|P4|NOT COMPLETED|Period 2 Double-Blind||59
8488475|NCT00565409|20916255|P3|NOT COMPLETED|Period 2 Double-Blind||27
8488476|NCT00565409|20916256|P2|NOT COMPLETED|Period 2 Double-Blind||21
8488477|NCT00565409|20916257|P1|NOT COMPLETED|Period 2 Double-Blind||0
8488478|NCT00565409|20916254|P4|COMPLETED|Period 2 Double-Blind||141
8488479|NCT00565409|20916255|P3|COMPLETED|Period 2 Double-Blind||175
8488480|NCT00565409|20916256|P2|COMPLETED|Period 2 Double-Blind||181
8488481|NCT00565409|20916257|P1|COMPLETED|Period 2 Double-Blind||0
8488482|NCT00565409|20916254|P4|STARTED|Period 2 Double-Blind||200
8488483|NCT00565409|20916255|P3|STARTED|Period 2 Double-Blind||202
8488484|NCT00565409|20916256|P2|STARTED|Period 2 Double-Blind||202
8488485|NCT00565409|20916257|P1|STARTED|Period 2 Double-Blind||0
8488486|NCT00565409|20916254|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
8488487|NCT00565409|20916255|P3|NOT COMPLETED|After Period 1, Prior to Period 2||0
8488488|NCT00565409|20916256|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
8488489|NCT00565409|20916257|P1|NOT COMPLETED|After Period 1, Prior to Period 2||152
8488490|NCT00565409|20916254|P4|COMPLETED|After Period 1, Prior to Period 2||0
8488491|NCT00565409|20916255|P3|COMPLETED|After Period 1, Prior to Period 2||0
8488492|NCT00565409|20916256|P2|COMPLETED|After Period 1, Prior to Period 2||0
8488493|NCT00565409|20916257|P1|COMPLETED|After Period 1, Prior to Period 2||604
8488494|NCT00565409|20916254|P4|STARTED|After Period 1, Prior to Period 2||0
8488495|NCT00565409|20916255|P3|STARTED|After Period 1, Prior to Period 2||0
8488496|NCT00565409|20916256|P2|STARTED|After Period 1, Prior to Period 2||0
8488497|NCT00565409|20916257|P1|STARTED|After Period 1, Prior to Period 2||756
8488498|NCT00565409|20916254|P4|NOT COMPLETED|Period 1 Open Label||0
8488499|NCT00565409|20916255|P3|NOT COMPLETED|Period 1 Open Label||0
8488500|NCT00565409|20916256|P2|NOT COMPLETED|Period 1 Open Label||0
8488501|NCT00565409|20916257|P1|NOT COMPLETED|Period 1 Open Label||78
8488502|NCT00565409|20916254|P4|COMPLETED|Period 1 Open Label||0
8488503|NCT00565409|20916255|P3|COMPLETED|Period 1 Open Label||0
8488504|NCT00565409|20916256|P2|COMPLETED|Period 1 Open Label||0
8488505|NCT00565409|20916257|P1|COMPLETED|Period 1 Open Label||756
8488506|NCT00565409|20916254|P4|STARTED|Period 1 Open Label||0
8488507|NCT00565409|20916255|P3|STARTED|Period 1 Open Label||0
8488508|NCT00565409|20916256|P2|STARTED|Period 1 Open Label||0
8488509|NCT00565409|20916257|P1|STARTED|Period 1 Open Label||834
8488510|NCT00565370|20916359|P1|NOT COMPLETED|Overall Study||0
8488511|NCT00565370|20916359|P1|COMPLETED|Overall Study||21
8488512|NCT00565370|20916359|P1|STARTED|Overall Study||21
8488513|NCT00565266|20916367|P1|NOT COMPLETED|Overall Study||36
8488514|NCT00565266|20916367|P1|COMPLETED|Overall Study||174
8488515|NCT00565266|20916367|P1|STARTED|Overall Study||210
8488516|NCT00565136|20916393|P1|NOT COMPLETED|Overall Study||3
8488517|NCT00565136|20916393|P1|COMPLETED|Overall Study||26
8488518|NCT00565136|20916393|P1|STARTED|Overall Study||29
8488519|NCT00565110|20916413|P2|NOT COMPLETED|Overall Study||131
8488520|NCT00565110|20916414|P1|NOT COMPLETED|Overall Study||131
8488521|NCT00565110|20916413|P2|COMPLETED|Overall Study||111
8488522|NCT00565110|20916414|P1|COMPLETED|Overall Study||99
8488523|NCT00565110|20916413|P2|12-Month|Overall Study||144
8488524|NCT00565110|20916414|P1|12-Month|Overall Study||114
8488525|NCT00565110|20916413|P2|STARTED|Overall Study||242
8488526|NCT00565110|20916414|P1|STARTED|Overall Study||230
8488527|NCT00565084|20916422|P3|NOT COMPLETED|Third Treatment Period||0
8488528|NCT00565084|20916423|P2|NOT COMPLETED|Third Treatment Period||0
8488529|NCT00565084|20916424|P1|NOT COMPLETED|Third Treatment Period||0
8488530|NCT00565084|20916422|P3|COMPLETED|Third Treatment Period||11
8488531|NCT00565084|20916423|P2|COMPLETED|Third Treatment Period||11
8488532|NCT00565084|20916424|P1|COMPLETED|Third Treatment Period||11
8488533|NCT00565084|20916422|P3|STARTED|Third Treatment Period||11
8488534|NCT00565084|20916423|P2|STARTED|Third Treatment Period||11
8488535|NCT00565084|20916424|P1|STARTED|Third Treatment Period||11
8488536|NCT00565084|20916422|P3|NOT COMPLETED|Second Treatment Period||0
8488537|NCT00565084|20916423|P2|NOT COMPLETED|Second Treatment Period||0
8488538|NCT00565084|20916424|P1|NOT COMPLETED|Second Treatment Period||0
8488539|NCT00565084|20916422|P3|COMPLETED|Second Treatment Period||11
8488540|NCT00565084|20916423|P2|COMPLETED|Second Treatment Period||11
8488541|NCT00565084|20916424|P1|COMPLETED|Second Treatment Period||11
8488542|NCT00565084|20916422|P3|STARTED|Second Treatment Period||11
8488543|NCT00565084|20916423|P2|STARTED|Second Treatment Period||11
8488544|NCT00565084|20916424|P1|STARTED|Second Treatment Period||11
8488545|NCT00565084|20916422|P3|NOT COMPLETED|First Treatment Period||0
8488546|NCT00565084|20916423|P2|NOT COMPLETED|First Treatment Period||0
8488547|NCT00565084|20916424|P1|NOT COMPLETED|First Treatment Period||0
8488548|NCT00565084|20916422|P3|COMPLETED|First Treatment Period||11
8488549|NCT00565084|20916423|P2|COMPLETED|First Treatment Period||11
8488550|NCT00565084|20916424|P1|COMPLETED|First Treatment Period||11
8488551|NCT00565084|20916422|P3|STARTED|First Treatment Period||11
8488552|NCT00565084|20916423|P2|STARTED|First Treatment Period||11
8488553|NCT00565084|20916424|P1|STARTED|First Treatment Period||11
8488554|NCT00565058|20916434|P2|NOT COMPLETED|Overall Study||0
8488555|NCT00565058|20916435|P1|NOT COMPLETED|Overall Study||1
8488556|NCT00565058|20916434|P2|COMPLETED|Overall Study||15
8488557|NCT00565058|20916435|P1|COMPLETED|Overall Study||9
8488558|NCT00565058|20916434|P2|STARTED|Overall Study||15
8488559|NCT00565058|20916435|P1|STARTED|Overall Study||10
8488560|NCT00565045|20916445|P2|NOT COMPLETED|Overall Study||3
8488561|NCT00565045|20916446|P1|NOT COMPLETED|Overall Study||1
8488562|NCT00565045|20916445|P2|COMPLETED|Overall Study||8
8488563|NCT00565045|20916446|P1|COMPLETED|Overall Study||9
8488564|NCT00565045|20916445|P2|STARTED|Overall Study||11
8488565|NCT00565045|20916446|P1|STARTED|Overall Study||10
8488566|NCT00564954|20916462|P2|NOT COMPLETED|Period 2- 1 Week||0
8488567|NCT00564954|20916463|P1|NOT COMPLETED|Period 2- 1 Week||0
8488568|NCT00564954|20916462|P2|COMPLETED|Period 2- 1 Week||42
8488569|NCT00564954|20916463|P1|COMPLETED|Period 2- 1 Week||44
8488570|NCT00564954|20916462|P2|STARTED|Period 2- 1 Week||42
8488571|NCT00564954|20916463|P1|STARTED|Period 2- 1 Week||44
8488572|NCT00564954|20916462|P2|NOT COMPLETED|Period 1- 1 Week||0
8488573|NCT00564954|20916463|P1|NOT COMPLETED|Period 1- 1 Week||0
8488574|NCT00564954|20916462|P2|COMPLETED|Period 1- 1 Week||42
8488575|NCT00564954|20916463|P1|COMPLETED|Period 1- 1 Week||44
8488576|NCT00564954|20916462|P2|STARTED|Period 1- 1 Week||42
8488577|NCT00564954|20916463|P1|STARTED|Period 1- 1 Week||44
8488578|NCT00564902|20916482|P3|NOT COMPLETED|Overall Study||4
8488579|NCT00564902|20916483|P2|NOT COMPLETED|Overall Study||4
8488580|NCT00564902|20916484|P1|NOT COMPLETED|Overall Study||1
8488581|NCT00564902|20916482|P3|COMPLETED|Overall Study||21
8488582|NCT00564902|20916483|P2|COMPLETED|Overall Study||21
8488583|NCT00564902|20916484|P1|COMPLETED|Overall Study||9
8488584|NCT00564902|20916482|P3|12 Months|Overall Study||21
8488585|NCT00564902|20916483|P2|12 Months|Overall Study||21
8488586|NCT00564902|20916484|P1|12 Months|Overall Study||9
8488587|NCT00564902|20916482|P3|8 Months|Overall Study||21
8488588|NCT00564902|20916483|P2|8 Months|Overall Study||22
8488589|NCT00564902|20916484|P1|8 Months|Overall Study||9
8488590|NCT00564902|20916482|P3|4 Months|Overall Study||23
8488591|NCT00564902|20916483|P2|4 Months|Overall Study||24
8488592|NCT00564902|20916484|P1|4 Months|Overall Study||9
8488593|NCT00564902|20916482|P3|STARTED|Overall Study||25
8488594|NCT00564902|20916483|P2|STARTED|Overall Study||25
8488595|NCT00564902|20916484|P1|STARTED|Overall Study||10
8488596|NCT00564889|20916516|P1|NOT COMPLETED|Overall Study||29
8488597|NCT00564889|20916516|P1|COMPLETED|Overall Study||6
8488598|NCT00564889|20916516|P1|STARTED|Overall Study||35
8488599|NCT00564876|20916524|P1|NOT COMPLETED|Overall Study||0
8488600|NCT00564876|20916524|P1|COMPLETED|Overall Study||2
8488601|NCT00564876|20916524|P1|STARTED|Overall Study||2
8488602|NCT00564850|20916531|P1|NOT COMPLETED|Overall Study||2
8488603|NCT00564850|20916531|P1|COMPLETED|Overall Study||35
8488604|NCT00564850|20916531|P1|STARTED|Overall Study||37
8488605|NCT00564733|20916549|P1|NOT COMPLETED|Overall Study||9
8488606|NCT00564733|20916549|P1|COMPLETED|Overall Study||46
8488607|NCT00564733|20916549|P1|STARTED|Overall Study||55
8488608|NCT00564681|20916557|P4|NOT COMPLETED|Overall Study||2
8488609|NCT00564681|20916558|P3|NOT COMPLETED|Overall Study||3
8488610|NCT00564681|20916559|P2|NOT COMPLETED|Overall Study||3
8488611|NCT00564681|20916560|P1|NOT COMPLETED|Overall Study||11
8488612|NCT00564681|20916557|P4|COMPLETED|Overall Study||19
8488613|NCT00564681|20916558|P3|COMPLETED|Overall Study||40
8488614|NCT00564681|20916559|P2|COMPLETED|Overall Study||58
8488615|NCT00564681|20916560|P1|COMPLETED|Overall Study||106
8488616|NCT00564681|20916557|P4|STARTED|Overall Study||21
8488617|NCT00564681|20916558|P3|STARTED|Overall Study||43
8488618|NCT00564681|20916559|P2|STARTED|Overall Study||61
8488619|NCT00564681|20916560|P1|STARTED|Overall Study||117
8488620|NCT00564629|20916583|P2|NOT COMPLETED|Overall Study||9
8488621|NCT00564629|20916584|P1|NOT COMPLETED|Overall Study||15
8488622|NCT00564629|20916583|P2|COMPLETED|Overall Study||45
8488623|NCT00564629|20916584|P1|COMPLETED|Overall Study||36
8488624|NCT00564629|20916583|P2|STARTED|Overall Study||54
8488625|NCT00564629|20916584|P1|STARTED|Overall Study||51
8488626|NCT00564486|20916609|P4|NOT COMPLETED|Overall Study||7
8488627|NCT00564486|20916610|P3|NOT COMPLETED|Overall Study||3
8488628|NCT00564486|20916611|P2|NOT COMPLETED|Overall Study||1
8488629|NCT00564486|20916612|P1|NOT COMPLETED|Overall Study||7
8488630|NCT00564486|20916609|P4|COMPLETED|Overall Study||60
8488631|NCT00564486|20916610|P3|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
8488632|NCT00564486|20916611|P2|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
8488633|NCT00564486|20916612|P1|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
8488634|NCT00564486|20916609|P4|STARTED|Overall Study||67
8488635|NCT00564486|20916610|P3|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
8488636|NCT00564486|20916611|P2|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
8488637|NCT00564486|20916612|P1|STARTED|Overall Study||43
8488638|NCT00564447|20916636|P8|NOT COMPLETED|Overall Study||0
8488639|NCT00564447|20916637|P7|NOT COMPLETED|Overall Study||0
8488640|NCT00564447|20916638|P6|NOT COMPLETED|Overall Study||0
8488641|NCT00564447|20916639|P5|NOT COMPLETED|Overall Study||0
8488642|NCT00564447|20916640|P4|NOT COMPLETED|Overall Study||0
8488643|NCT00564447|20916641|P3|NOT COMPLETED|Overall Study||0
8488644|NCT00564447|20916642|P2|NOT COMPLETED|Overall Study||0
8488645|NCT00564447|20916643|P1|NOT COMPLETED|Overall Study||0
8488646|NCT00564447|20916636|P8|COMPLETED|Overall Study||6
8488647|NCT00564447|20916637|P7|COMPLETED|Overall Study||6
8488648|NCT00564447|20916638|P6|COMPLETED|Overall Study||6
8488649|NCT00564447|20916639|P5|COMPLETED|Overall Study||6
8488650|NCT00564447|20916640|P4|COMPLETED|Overall Study||6
8488651|NCT00564447|20916641|P3|COMPLETED|Overall Study||6
8488652|NCT00564447|20916642|P2|COMPLETED|Overall Study||6
8488653|NCT00564447|20916643|P1|COMPLETED|Overall Study||6
8488654|NCT00564447|20916636|P8|STARTED|Overall Study||6
8488655|NCT00564447|20916637|P7|STARTED|Overall Study||6
8488656|NCT00564447|20916638|P6|STARTED|Overall Study||6
8488657|NCT00564447|20916639|P5|STARTED|Overall Study||6
8488658|NCT00564447|20916640|P4|STARTED|Overall Study||6
8488659|NCT00564447|20916641|P3|STARTED|Overall Study||6
8488660|NCT00564447|20916642|P2|STARTED|Overall Study||6
8488661|NCT00564447|20916643|P1|STARTED|Overall Study||6
8488662|NCT00564395|20916661|P2|NOT COMPLETED|Second Intervention (10 Days)||0
8488663|NCT00564395|20916662|P1|NOT COMPLETED|Second Intervention (10 Days)||0
8488664|NCT00564395|20916661|P2|COMPLETED|Second Intervention (10 Days)||7
8488665|NCT00564395|20916662|P1|COMPLETED|Second Intervention (10 Days)||7
8488666|NCT00564395|20916661|P2|STARTED|Second Intervention (10 Days)||7
8488667|NCT00564395|20916662|P1|STARTED|Second Intervention (10 Days)||7
8488668|NCT00564395|20916661|P2|NOT COMPLETED|First Intervention (10 Days)||2
8488669|NCT00564395|20916662|P1|NOT COMPLETED|First Intervention (10 Days)||2
8488670|NCT00564395|20916661|P2|COMPLETED|First Intervention (10 Days)||7
8488671|NCT00564395|20916662|P1|COMPLETED|First Intervention (10 Days)||7
8488672|NCT00564395|20916661|P2|Received Intervention|First Intervention (10 Days)||7
8488673|NCT00564395|20916662|P1|Received Intervention|First Intervention (10 Days)||7
8488674|NCT00564395|20916661|P2|STARTED|First Intervention (10 Days)||9
8488675|NCT00564395|20916662|P1|STARTED|First Intervention (10 Days)||9
8488682|NCT00564265|20916687|P1|NOT COMPLETED|Overall Study||0
8488683|NCT00564265|20916687|P1|COMPLETED|Overall Study||24
8488684|NCT00564265|20916687|P1|STARTED|Overall Study||24
8488685|NCT00564070|20916693|P2|NOT COMPLETED|Overall Study||7
8488686|NCT00564070|20916694|P1|NOT COMPLETED|Overall Study||12
8488687|NCT00564070|20916693|P2|COMPLETED|Overall Study||38
8488688|NCT00564070|20916694|P1|COMPLETED|Overall Study||30
8488689|NCT00564070|20916693|P2|STARTED|Overall Study||45
8488690|NCT00564070|20916694|P1|STARTED|Overall Study||42
8488691|NCT00564018|20916721|P3|NOT COMPLETED|Overall Study||1
8488692|NCT00564018|20916722|P2|NOT COMPLETED|Overall Study||3
8488693|NCT00564018|20916723|P1|NOT COMPLETED|Overall Study||2
8488694|NCT00564018|20916721|P3|COMPLETED|Overall Study||11
8488695|NCT00564018|20916722|P2|COMPLETED|Overall Study||7
8488696|NCT00564018|20916723|P1|COMPLETED|Overall Study||9
8488697|NCT00564018|20916721|P3|STARTED|Overall Study||12
8488698|NCT00564018|20916722|P2|STARTED|Overall Study||10
8488699|NCT00564018|20916723|P1|STARTED|Overall Study||11
8488700|NCT00563797|20916736|P2|NOT COMPLETED|Overall Study||2
8488701|NCT00563797|20916737|P1|NOT COMPLETED|Overall Study||7
8488702|NCT00563797|20916736|P2|COMPLETED|Overall Study||8
8488703|NCT00563797|20916737|P1|COMPLETED|Overall Study||4
8488704|NCT00563797|20916736|P2|Follow-Up|Overall Study||10
8488705|NCT00563797|20916737|P1|Follow-Up|Overall Study||11
8488706|NCT00563797|20916736|P2|Received Allocated Intervention|Overall Study||10
8488707|NCT00563797|20916737|P1|Received Allocated Intervention|Overall Study||11
8488708|NCT00563797|20916736|P2|STARTED|Overall Study||10
8488709|NCT00563797|20916737|P1|STARTED|Overall Study||11
8488710|NCT00563784|20916749|P1|NOT COMPLETED|Overall Study||22
8488711|NCT00563784|20916749|P1|COMPLETED|Overall Study||46
8488712|NCT00563784|20916749|P1|STARTED|Overall Study||68
8488713|NCT00563706|20916763|P9|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488714|NCT00563706|20916764|P8|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488715|NCT00563706|20916765|P7|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488716|NCT00563706|20916766|P6|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488717|NCT00563706|20916767|P5|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488718|NCT00563706|20916768|P4|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488719|NCT00563706|20916769|P3|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488720|NCT00563706|20916770|P2|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488721|NCT00563706|20916771|P1|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
8488722|NCT00563706|20916763|P9|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
8488723|NCT00563706|20916764|P8|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
8488724|NCT00563706|20916765|P7|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
8488725|NCT00563706|20916766|P6|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
8488726|NCT00563706|20916767|P5|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
8488727|NCT00563706|20916768|P4|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
8488728|NCT00563706|20916769|P3|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
8488729|NCT00563706|20916770|P2|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
8488730|NCT00563706|20916771|P1|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
8488731|NCT00563706|20916763|P9|STARTED|Taper Phase (Day 29 up to Day 35)||32
8488732|NCT00563706|20916764|P8|STARTED|Taper Phase (Day 29 up to Day 35)||16
8488733|NCT00563706|20916765|P7|STARTED|Taper Phase (Day 29 up to Day 35)||9
8488734|NCT00563706|20916766|P6|STARTED|Taper Phase (Day 29 up to Day 35)||14
8488735|NCT00563706|20916767|P5|STARTED|Taper Phase (Day 29 up to Day 35)||11
8488736|NCT00563706|20916768|P4|STARTED|Taper Phase (Day 29 up to Day 35)||9
8488737|NCT00563706|20916769|P3|STARTED|Taper Phase (Day 29 up to Day 35)||3
8488738|NCT00563706|20916770|P2|STARTED|Taper Phase (Day 29 up to Day 35)||13
8488739|NCT00563706|20916771|P1|STARTED|Taper Phase (Day 29 up to Day 35)||20
8488740|NCT00563706|20916763|P9|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
8488741|NCT00563706|20916764|P8|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
8488742|NCT00563706|20916765|P7|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
8488743|NCT00563706|20916766|P6|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
8488744|NCT00563706|20916767|P5|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
8488745|NCT00563706|20916768|P4|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
8488746|NCT00563706|20916769|P3|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
8488747|NCT00563706|20916770|P2|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
8488748|NCT00563706|20916771|P1|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
8488749|NCT00563706|20916763|P9|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
8488750|NCT00563706|20916764|P8|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
8488751|NCT00563706|20916765|P7|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
8488752|NCT00563706|20916766|P6|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
8488753|NCT00563706|20916767|P5|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
8488754|NCT00563706|20916768|P4|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
8488755|NCT00563706|20916769|P3|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
8488756|NCT00563706|20916770|P2|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
8488757|NCT00563706|20916771|P1|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
8488758|NCT00563706|20916763|P9|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
8488759|NCT00563706|20916764|P8|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
8488760|NCT00563706|20916765|P7|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
8488761|NCT00563706|20916766|P6|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
8488762|NCT00563706|20916767|P5|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
8488763|NCT00563706|20916768|P4|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
8488764|NCT00563706|20916769|P3|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
8488765|NCT00563706|20916770|P2|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
8488766|NCT00563706|20916771|P1|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
8488767|NCT00563576|20916874|P2|NOT COMPLETED|Overall Study||14
8488768|NCT00563576|20916875|P1|NOT COMPLETED|Overall Study||14
8488769|NCT00563576|20916874|P2|COMPLETED|Overall Study||22
8488770|NCT00563576|20916875|P1|COMPLETED|Overall Study||21
8488771|NCT00563576|20916874|P2|STARTED|Overall Study||36
8488772|NCT00563576|20916875|P1|STARTED|Overall Study||35
8488773|NCT00563381|20916889|P2|NOT COMPLETED|Overall Study||648
8488774|NCT00563381|20916890|P1|NOT COMPLETED|Overall Study||585
8488775|NCT00563381|20916889|P2|COMPLETED|Overall Study|Completed treatment|3021
8488776|NCT00563381|20916890|P1|COMPLETED|Overall Study|Completed treatment|3122
8488777|NCT00563381|20916889|P2|STARTED|Overall Study|Started treatment|3669
8488778|NCT00563381|20916890|P1|STARTED|Overall Study|Started treatment|3707
8488779|NCT00563368|20916963|P7|NOT COMPLETED|Overall Study||33
8488780|NCT00563368|20916964|P6|NOT COMPLETED|Overall Study||30
8488781|NCT00563368|20916965|P5|NOT COMPLETED|Overall Study||28
8488782|NCT00563368|20916966|P4|NOT COMPLETED|Overall Study||29
8488783|NCT00563368|20916967|P3|NOT COMPLETED|Overall Study||30
8488784|NCT00563368|20916968|P2|NOT COMPLETED|Overall Study||30
8488785|NCT00563368|20916969|P1|NOT COMPLETED|Overall Study||35
8488786|NCT00563368|20916963|P7|COMPLETED|Overall Study||75
8488787|NCT00563368|20916964|P6|COMPLETED|Overall Study||77
8488788|NCT00563368|20916965|P5|COMPLETED|Overall Study||80
8488789|NCT00563368|20916966|P4|COMPLETED|Overall Study||78
8488790|NCT00563368|20916967|P3|COMPLETED|Overall Study||78
8488791|NCT00563368|20916968|P2|COMPLETED|Overall Study||79
8488792|NCT00563368|20916969|P1|COMPLETED|Overall Study||74
8488793|NCT00563368|20916963|P7|STARTED|Overall Study||108
8488794|NCT00563368|20916964|P6|STARTED|Overall Study||107
8488795|NCT00563368|20916965|P5|STARTED|Overall Study||108
8488796|NCT00563368|20916966|P4|STARTED|Overall Study||107
8488797|NCT00563368|20916967|P3|STARTED|Overall Study||108
8488798|NCT00563368|20916968|P2|STARTED|Overall Study||109
8488799|NCT00563368|20916969|P1|STARTED|Overall Study||109
8488800|NCT00563316|20916992|P1|NOT COMPLETED|Overall Study||12
8488801|NCT00563316|20916992|P1|COMPLETED|Overall Study||16
8488802|NCT00563316|20916992|P1|Received Investigational Product|Overall Study||27
8488803|NCT00563316|20916992|P1|STARTED|Overall Study||28
8488804|NCT00563290|20917005|P2|NOT COMPLETED|Overall Study||0
8488805|NCT00563290|20917006|P1|NOT COMPLETED|Overall Study||0
8488806|NCT00563290|20917005|P2|COMPLETED|Overall Study||4
8488807|NCT00563290|20917006|P1|COMPLETED|Overall Study||3
8488808|NCT00563290|20917005|P2|STARTED|Overall Study||4
8488809|NCT00563290|20917006|P1|STARTED|Overall Study||3
8488810|NCT00563186|20917017|P2|NOT COMPLETED|Overall Study||75
8488811|NCT00563186|20917018|P1|NOT COMPLETED|Overall Study||98
8488812|NCT00563186|20917017|P2|COMPLETED|Overall Study||604
8488813|NCT00563186|20917018|P1|COMPLETED|Overall Study||910
8488814|NCT00563186|20917017|P2|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
8488815|NCT00563186|20917018|P1|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
8488816|NCT00562965|20917029|P2|NOT COMPLETED|Overall Study||6
8488817|NCT00562965|20917030|P1|NOT COMPLETED|Overall Study||3
8488818|NCT00562965|20917029|P2|COMPLETED|Overall Study||8
8488819|NCT00562965|20917030|P1|COMPLETED|Overall Study||12
8488820|NCT00562965|20917029|P2|Treated|Overall Study||13
8488821|NCT00562965|20917030|P1|Treated|Overall Study||15
8488822|NCT00562965|20917029|P2|STARTED|Overall Study||14
8488823|NCT00562965|20917030|P1|STARTED|Overall Study||15
8488824|NCT00562861|20917051|P2|NOT COMPLETED|Overall Study||11
8488825|NCT00562861|20917052|P1|NOT COMPLETED|Overall Study||20
8488826|NCT00562861|20917051|P2|COMPLETED|Overall Study||48
8488827|NCT00562861|20917052|P1|COMPLETED|Overall Study||40
8488828|NCT00562861|20917051|P2|STARTED|Overall Study||59
8488829|NCT00562861|20917052|P1|STARTED|Overall Study||60
8488830|NCT00562718|20917058|P1|NOT COMPLETED|Overall Study||11
8488831|NCT00562718|20917058|P1|COMPLETED|Overall Study||39
8488832|NCT00562718|20917058|P1|STARTED|Overall Study||50
8488833|NCT00562627|20917067|P3|NOT COMPLETED|Overall Study||1
8488834|NCT00562627|20917068|P2|NOT COMPLETED|Overall Study||1
8488835|NCT00562627|20917069|P1|NOT COMPLETED|Overall Study||1
8488836|NCT00562627|20917067|P3|COMPLETED|Overall Study||33
8488837|NCT00562627|20917068|P2|COMPLETED|Overall Study||33
8488838|NCT00562627|20917069|P1|COMPLETED|Overall Study||33
8488839|NCT00562627|20917067|P3|STARTED|Overall Study||34
8488840|NCT00562627|20917068|P2|STARTED|Overall Study||34
8488841|NCT00562627|20917069|P1|STARTED|Overall Study||34
8488842|NCT00562588|20917085|P2|NOT COMPLETED|Overall Study||99
8488843|NCT00562588|20917086|P1|NOT COMPLETED|Overall Study||92
8488844|NCT00562588|20917085|P2|COMPLETED|Overall Study||184
8488845|NCT00562588|20917086|P1|COMPLETED|Overall Study||168
8488846|NCT00562588|20917085|P2|STARTED|Overall Study||283
8488847|NCT00562588|20917086|P1|STARTED|Overall Study||260
8488848|NCT00562484|20917116|P2|NOT COMPLETED|Overall Study||104
8488849|NCT00562484|20917117|P1|NOT COMPLETED|Overall Study||206
8488850|NCT00562484|20917116|P2|COMPLETED|Overall Study||4907
8488851|NCT00562484|20917117|P1|COMPLETED|Overall Study||9827
8488852|NCT00562484|20917116|P2|STARTED|Overall Study||5011
8488853|NCT00562484|20917117|P1|STARTED|Overall Study||10033
8488854|NCT00562354|20917149|P2|NOT COMPLETED|Overall Study||2
8488855|NCT00562354|20917150|P1|NOT COMPLETED|Overall Study||0
8488856|NCT00562354|20917149|P2|COMPLETED|Overall Study||135
8488857|NCT00562354|20917150|P1|COMPLETED|Overall Study||134
8488858|NCT00562354|20917149|P2|Evaluable Immunogenicity Population|Overall Study||134
8488859|NCT00562354|20917150|P1|Evaluable Immunogenicity Population|Overall Study||134
8488860|NCT00562354|20917149|P2|Received Study Treatment|Overall Study||136
8488861|NCT00562354|20917150|P1|Received Study Treatment|Overall Study||134
8488862|NCT00562354|20917149|P2|STARTED|Overall Study||137
8488863|NCT00562354|20917150|P1|STARTED|Overall Study||134
8488864|NCT00562328|20917191|P1|NOT COMPLETED|Overall Study||0
8488865|NCT00562328|20917191|P1|COMPLETED|Overall Study||33
8488866|NCT00562328|20917191|P1|STARTED|Overall Study||33
8488867|NCT00562315|20917199|P1|NOT COMPLETED|Overall Study||0
8488868|NCT00562315|20917199|P1|COMPLETED|Overall Study||93
8488869|NCT00562315|20917199|P1|STARTED|Overall Study||93
8488870|NCT00562302|20917216|P2|NOT COMPLETED|Overall Study||32
8488871|NCT00562302|20917217|P1|NOT COMPLETED|Overall Study||20
8488872|NCT00562302|20917216|P2|COMPLETED|Overall Study||137
8488873|NCT00562302|20917217|P1|COMPLETED|Overall Study||150
8488874|NCT00562302|20917216|P2|STARTED|Overall Study||169
8488875|NCT00562302|20917217|P1|STARTED|Overall Study||170
8488876|NCT00562159|20917239|P2|NOT COMPLETED|Overall Study||33
8488877|NCT00562159|20917240|P1|NOT COMPLETED|Overall Study||38
8488878|NCT00562159|20917239|P2|COMPLETED|Overall Study||192
8488879|NCT00562159|20917240|P1|COMPLETED|Overall Study||175
8488880|NCT00562159|20917239|P2|STARTED|Overall Study||225
8488881|NCT00562159|20917240|P1|STARTED|Overall Study||213
8488882|NCT00562120|20917252|P4|NOT COMPLETED|Fourth Intervention Period||0
8488883|NCT00562120|20917253|P3|NOT COMPLETED|Fourth Intervention Period||0
8488884|NCT00562120|20917254|P2|NOT COMPLETED|Fourth Intervention Period||0
8488885|NCT00562120|20917255|P1|NOT COMPLETED|Fourth Intervention Period||0
8488886|NCT00562120|20917252|P4|COMPLETED|Fourth Intervention Period||5
8488887|NCT00562120|20917253|P3|COMPLETED|Fourth Intervention Period||5
8488888|NCT00562120|20917254|P2|COMPLETED|Fourth Intervention Period||5
8488889|NCT00562120|20917255|P1|COMPLETED|Fourth Intervention Period||4
8488890|NCT00562120|20917252|P4|STARTED|Fourth Intervention Period||5
8488891|NCT00562120|20917253|P3|STARTED|Fourth Intervention Period||5
8488892|NCT00562120|20917254|P2|STARTED|Fourth Intervention Period||5
8488893|NCT00562120|20917255|P1|STARTED|Fourth Intervention Period||4
8488894|NCT00562120|20917252|P4|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
8488895|NCT00562120|20917253|P3|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
8488896|NCT00562120|20917254|P2|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
8488897|NCT00562120|20917255|P1|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
8488898|NCT00562120|20917252|P4|COMPLETED|Washout Period 3 (At Least 14 Days)||5
8488899|NCT00562120|20917253|P3|COMPLETED|Washout Period 3 (At Least 14 Days)||5
8488900|NCT00562120|20917254|P2|COMPLETED|Washout Period 3 (At Least 14 Days)||5
8488901|NCT00562120|20917255|P1|COMPLETED|Washout Period 3 (At Least 14 Days)||4
8488902|NCT00562120|20917252|P4|STARTED|Washout Period 3 (At Least 14 Days)||5
8488903|NCT00562120|20917253|P3|STARTED|Washout Period 3 (At Least 14 Days)||5
8488904|NCT00562120|20917254|P2|STARTED|Washout Period 3 (At Least 14 Days)||5
8488905|NCT00562120|20917255|P1|STARTED|Washout Period 3 (At Least 14 Days)||4
8488906|NCT00562120|20917252|P4|NOT COMPLETED|Third Intervention Period||0
8488907|NCT00562120|20917253|P3|NOT COMPLETED|Third Intervention Period||0
8488908|NCT00562120|20917254|P2|NOT COMPLETED|Third Intervention Period||0
8488909|NCT00562120|20917255|P1|NOT COMPLETED|Third Intervention Period||0
8488910|NCT00562120|20917252|P4|COMPLETED|Third Intervention Period||5
8488911|NCT00562120|20917253|P3|COMPLETED|Third Intervention Period||5
8488912|NCT00562120|20917254|P2|COMPLETED|Third Intervention Period||5
8488913|NCT00562120|20917255|P1|COMPLETED|Third Intervention Period||4
8488914|NCT00562120|20917252|P4|STARTED|Third Intervention Period||5
8488915|NCT00562120|20917253|P3|STARTED|Third Intervention Period||5
8488916|NCT00562120|20917254|P2|STARTED|Third Intervention Period||5
8488917|NCT00562120|20917255|P1|STARTED|Third Intervention Period||4
8488918|NCT00562120|20917252|P4|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
8488919|NCT00562120|20917253|P3|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
8488920|NCT00562120|20917254|P2|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
8488921|NCT00562120|20917255|P1|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
8488922|NCT00562120|20917252|P4|COMPLETED|Washout Period 2 (At Least 14 Days)||5
8488923|NCT00562120|20917253|P3|COMPLETED|Washout Period 2 (At Least 14 Days)||5
8488924|NCT00562120|20917254|P2|COMPLETED|Washout Period 2 (At Least 14 Days)||5
8488925|NCT00562120|20917255|P1|COMPLETED|Washout Period 2 (At Least 14 Days)||4
8488926|NCT00562120|20917252|P4|STARTED|Washout Period 2 (At Least 14 Days)||5
8488927|NCT00562120|20917253|P3|STARTED|Washout Period 2 (At Least 14 Days)||5
8488928|NCT00562120|20917254|P2|STARTED|Washout Period 2 (At Least 14 Days)||5
8488929|NCT00562120|20917255|P1|STARTED|Washout Period 2 (At Least 14 Days)||4
8488930|NCT00562120|20917252|P4|NOT COMPLETED|Second Intervention Period||0
8488931|NCT00562120|20917253|P3|NOT COMPLETED|Second Intervention Period||0
8488932|NCT00562120|20917254|P2|NOT COMPLETED|Second Intervention Period||0
8488933|NCT00562120|20917255|P1|NOT COMPLETED|Second Intervention Period||0
8488934|NCT00562120|20917252|P4|COMPLETED|Second Intervention Period||5
8488935|NCT00562120|20917253|P3|COMPLETED|Second Intervention Period||5
8488936|NCT00562120|20917254|P2|COMPLETED|Second Intervention Period||5
8488937|NCT00562120|20917255|P1|COMPLETED|Second Intervention Period||4
8488938|NCT00562120|20917252|P4|STARTED|Second Intervention Period||5
8488939|NCT00562120|20917253|P3|STARTED|Second Intervention Period||5
8488940|NCT00562120|20917254|P2|STARTED|Second Intervention Period||5
8488941|NCT00562120|20917255|P1|STARTED|Second Intervention Period||4
8488942|NCT00562120|20917252|P4|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
8488943|NCT00562120|20917253|P3|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
8488944|NCT00562120|20917254|P2|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
8488945|NCT00562120|20917255|P1|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
8488946|NCT00562120|20917252|P4|COMPLETED|Washout Period 1 (At Least 14 Days)||5
8488947|NCT00562120|20917253|P3|COMPLETED|Washout Period 1 (At Least 14 Days)||5
8488948|NCT00562120|20917254|P2|COMPLETED|Washout Period 1 (At Least 14 Days)||5
8488949|NCT00562120|20917255|P1|COMPLETED|Washout Period 1 (At Least 14 Days)||4
8488950|NCT00562120|20917252|P4|STARTED|Washout Period 1 (At Least 14 Days)||5
8488951|NCT00562120|20917253|P3|STARTED|Washout Period 1 (At Least 14 Days)||5
8488952|NCT00562120|20917254|P2|STARTED|Washout Period 1 (At Least 14 Days)||5
8488953|NCT00562120|20917255|P1|STARTED|Washout Period 1 (At Least 14 Days)||4
8488954|NCT00562120|20917252|P4|NOT COMPLETED|First Intervention Period||0
8488955|NCT00562120|20917253|P3|NOT COMPLETED|First Intervention Period||0
8488956|NCT00562120|20917254|P2|NOT COMPLETED|First Intervention Period||0
8488957|NCT00562120|20917255|P1|NOT COMPLETED|First Intervention Period||2
8488958|NCT00562120|20917252|P4|COMPLETED|First Intervention Period||5
8488959|NCT00562120|20917253|P3|COMPLETED|First Intervention Period||5
8488960|NCT00562120|20917254|P2|COMPLETED|First Intervention Period||5
8488961|NCT00562120|20917255|P1|COMPLETED|First Intervention Period||4
8488962|NCT00562120|20917252|P4|Treated|First Intervention Period||5
8488963|NCT00562120|20917253|P3|Treated|First Intervention Period||5
8488964|NCT00562120|20917254|P2|Treated|First Intervention Period||5
8488965|NCT00562120|20917255|P1|Treated|First Intervention Period||5
8488966|NCT00562120|20917252|P4|STARTED|First Intervention Period||5
8488967|NCT00562120|20917253|P3|STARTED|First Intervention Period||5
8488968|NCT00562120|20917254|P2|STARTED|First Intervention Period||5
8488969|NCT00562120|20917255|P1|STARTED|First Intervention Period||6
8488970|NCT00562094|20917287|P1|NOT COMPLETED|Overall Study||62
8488971|NCT00562094|20917287|P1|COMPLETED|Overall Study||8554
8488972|NCT00562094|20917287|P1|STARTED|Overall Study||8616
8488973|NCT00561977|20917302|P3|NOT COMPLETED|Overall Study||2
8488974|NCT00561977|20917303|P2|NOT COMPLETED|Overall Study||3
8488975|NCT00561977|20917304|P1|NOT COMPLETED|Overall Study||0
8488976|NCT00561977|20917302|P3|COMPLETED|Overall Study||10
8488977|NCT00561977|20917303|P2|COMPLETED|Overall Study||9
8488978|NCT00561977|20917304|P1|COMPLETED|Overall Study||12
8488979|NCT00561977|20917302|P3|STARTED|Overall Study||12
8488980|NCT00561977|20917303|P2|STARTED|Overall Study||12
8488981|NCT00561977|20917304|P1|STARTED|Overall Study||12
8488982|NCT00561951|20917330|P3|NOT COMPLETED|Overall Study||32
8488983|NCT00561951|20917331|P2|NOT COMPLETED|Overall Study||34
8488984|NCT00561951|20917332|P1|NOT COMPLETED|Overall Study||33
8488985|NCT00561951|20917330|P3|COMPLETED|Overall Study||281
8488986|NCT00561951|20917331|P2|COMPLETED|Overall Study||286
8488987|NCT00561951|20917332|P1|COMPLETED|Overall Study||285
8488988|NCT00561951|20917330|P3|STARTED|Overall Study||313
8488989|NCT00561951|20917331|P2|STARTED|Overall Study||320
8488990|NCT00561951|20917332|P1|STARTED|Overall Study||318
8488991|NCT00561925|20917388|P5|NOT COMPLETED|Open-Label Extension Period||50
8488992|NCT00561925|20917389|P4|NOT COMPLETED|Open-Label Extension Period||43
8488993|NCT00561925|20917390|P3|NOT COMPLETED|Open-Label Extension Period||0
8488994|NCT00561925|20917391|P2|NOT COMPLETED|Open-Label Extension Period||0
8488995|NCT00561925|20917392|P1|NOT COMPLETED|Open-Label Extension Period||0
8488996|NCT00561925|20917388|P5|COMPLETED|Open-Label Extension Period||328
8488997|NCT00561925|20917389|P4|COMPLETED|Open-Label Extension Period||315
8488998|NCT00561925|20917390|P3|COMPLETED|Open-Label Extension Period||0
8488999|NCT00561925|20917391|P2|COMPLETED|Open-Label Extension Period||1
8489000|NCT00561925|20917392|P1|COMPLETED|Open-Label Extension Period||0
8489001|NCT00561925|20917388|P5|STARTED|Open-Label Extension Period||378
8489002|NCT00561925|20917389|P4|STARTED|Open-Label Extension Period||358
8489003|NCT00561925|20917390|P3|STARTED|Open-Label Extension Period||0
8489004|NCT00561925|20917391|P2|STARTED|Open-Label Extension Period||1
8489005|NCT00561925|20917392|P1|STARTED|Open-Label Extension Period||0
8489006|NCT00561925|20917388|P5|NOT COMPLETED|144-week Double-blind, Double-dummy||0
8489007|NCT00561925|20917389|P4|NOT COMPLETED|144-week Double-blind, Double-dummy||0
8489008|NCT00561925|20917390|P3|NOT COMPLETED|144-week Double-blind, Double-dummy||127
8489009|NCT00561925|20917391|P2|NOT COMPLETED|144-week Double-blind, Double-dummy||150
8489010|NCT00561925|20917392|P1|NOT COMPLETED|144-week Double-blind, Double-dummy||0
8489011|NCT00561925|20917388|P5|COMPLETED|144-week Double-blind, Double-dummy||0
8489012|NCT00561925|20917389|P4|COMPLETED|144-week Double-blind, Double-dummy||0
8489013|NCT00561925|20917390|P3|COMPLETED|144-week Double-blind, Double-dummy||378
8489014|NCT00561925|20917391|P2|COMPLETED|144-week Double-blind, Double-dummy||358
8489015|NCT00561925|20917392|P1|COMPLETED|144-week Double-blind, Double-dummy||0
8489016|NCT00561925|20917388|P5|STARTED|144-week Double-blind, Double-dummy||0
8489017|NCT00561925|20917389|P4|STARTED|144-week Double-blind, Double-dummy||0
8489018|NCT00561925|20917390|P3|STARTED|144-week Double-blind, Double-dummy||505
8489019|NCT00561925|20917391|P2|STARTED|144-week Double-blind, Double-dummy||508
8489020|NCT00561925|20917392|P1|STARTED|144-week Double-blind, Double-dummy||0
8489021|NCT00561925|20917388|P5|NOT COMPLETED|14 Day Lead-In Period||0
8489022|NCT00561925|20917389|P4|NOT COMPLETED|14 Day Lead-In Period||0
8489023|NCT00561925|20917390|P3|NOT COMPLETED|14 Day Lead-In Period||0
8489024|NCT00561925|20917391|P2|NOT COMPLETED|14 Day Lead-In Period||0
8489025|NCT00561925|20917392|P1|NOT COMPLETED|14 Day Lead-In Period||55
8489026|NCT00561925|20917388|P5|COMPLETED|14 Day Lead-In Period||0
8489027|NCT00561925|20917389|P4|COMPLETED|14 Day Lead-In Period||0
8489028|NCT00561925|20917390|P3|COMPLETED|14 Day Lead-In Period||0
8489029|NCT00561925|20917391|P2|COMPLETED|14 Day Lead-In Period||0
8489030|NCT00561925|20917392|P1|COMPLETED|14 Day Lead-In Period||1013
8489031|NCT00561925|20917388|P5|STARTED|14 Day Lead-In Period||0
8489032|NCT00561925|20917389|P4|STARTED|14 Day Lead-In Period||0
8489033|NCT00561925|20917390|P3|STARTED|14 Day Lead-In Period||0
8489034|NCT00561925|20917391|P2|STARTED|14 Day Lead-In Period||0
8489035|NCT00561925|20917392|P1|STARTED|14 Day Lead-In Period||1068
8489036|NCT00561912|20917441|P1|NOT COMPLETED|Overall Study||1
8489037|NCT00561912|20917441|P1|COMPLETED|Overall Study||1
8489038|NCT00561912|20917441|P1|STARTED|Overall Study||2
8489039|NCT00561834|20917445|P1|NOT COMPLETED|Overall Study||0
8489040|NCT00561834|20917445|P1|COMPLETED|Overall Study||2
8489041|NCT00561834|20917445|P1|STARTED|Overall Study||2
8489042|NCT00561821|20917453|P4|NOT COMPLETED|Overall Study||3
8489043|NCT00561821|20917454|P3|NOT COMPLETED|Overall Study||2
8489044|NCT00561821|20917455|P2|NOT COMPLETED|Overall Study||6
8489045|NCT00561821|20917456|P1|NOT COMPLETED|Overall Study||5
8489046|NCT00561821|20917453|P4|COMPLETED|Overall Study||133
8489047|NCT00561821|20917454|P3|COMPLETED|Overall Study||132
8489048|NCT00561821|20917455|P2|COMPLETED|Overall Study||130
8489049|NCT00561821|20917456|P1|COMPLETED|Overall Study||127
8489050|NCT00561821|20917453|P4|Treated|Overall Study||136
8489051|NCT00561821|20917454|P3|Treated|Overall Study||133
8489052|NCT00561821|20917455|P2|Treated|Overall Study||136
8489053|NCT00561821|20917456|P1|Treated|Overall Study||132
8489054|NCT00561821|20917453|P4|STARTED|Overall Study||136
8489055|NCT00561821|20917454|P3|STARTED|Overall Study||134
8489056|NCT00561821|20917455|P2|STARTED|Overall Study||136
8489057|NCT00561821|20917456|P1|STARTED|Overall Study||132
8489058|NCT00561795|20917532|P4|NOT COMPLETED|Overall Study||0
8489059|NCT00561795|20917533|P3|NOT COMPLETED|Overall Study||0
8489060|NCT00561795|20917534|P2|NOT COMPLETED|Overall Study||6
8489061|NCT00561795|20917535|P1|NOT COMPLETED|Overall Study||4
8489062|NCT00561795|20917532|P4|COMPLETED|Overall Study||0
8489063|NCT00561795|20917533|P3|COMPLETED|Overall Study||0
8489064|NCT00561795|20917534|P2|COMPLETED|Overall Study||0
8489065|NCT00561795|20917535|P1|COMPLETED|Overall Study||2
8489066|NCT00561795|20917532|P4|STARTED|Overall Study||0
8489067|NCT00561795|20917533|P3|STARTED|Overall Study||0
8489068|NCT00561795|20917534|P2|STARTED|Overall Study||6
8489069|NCT00561795|20917535|P1|STARTED|Overall Study||6
8489070|NCT00561730|20917555|P1|NOT COMPLETED|Overall Study||9
8489071|NCT00561730|20917555|P1|COMPLETED|Overall Study||1986
8489072|NCT00561730|20917555|P1|STARTED|Overall Study||1995
8489073|NCT00561678|20917571|P2|NOT COMPLETED|Overall Study||6
8489074|NCT00561678|20917572|P1|NOT COMPLETED|Overall Study||8
8489075|NCT00561678|20917571|P2|COMPLETED|Overall Study||201
8489076|NCT00561678|20917572|P1|COMPLETED|Overall Study||189
8489077|NCT00561678|20917571|P2|STARTED|Overall Study||207
8489078|NCT00561678|20917572|P1|STARTED|Overall Study||197
8489079|NCT00561652|20917590|P2|NOT COMPLETED|Overall Study||1
8489080|NCT00561652|20917591|P1|NOT COMPLETED|Overall Study||0
8489081|NCT00561652|20917590|P2|COMPLETED|Overall Study||19
8489082|NCT00561652|20917591|P1|COMPLETED|Overall Study||10
8489083|NCT00561652|20917590|P2|STARTED|Overall Study||20
8489084|NCT00561652|20917591|P1|STARTED|Overall Study||10
8489085|NCT00561600|20917611|P2|NOT COMPLETED|Overall Study||16
8489086|NCT00561600|20917612|P1|NOT COMPLETED|Overall Study||18
8489087|NCT00561600|20917611|P2|COMPLETED|Overall Study||119
8489088|NCT00561600|20917612|P1|COMPLETED|Overall Study||112
8489089|NCT00561600|20917611|P2|STARTED|Overall Study||135
8489090|NCT00561600|20917612|P1|STARTED|Overall Study||130
8489091|NCT00561574|20917674|P2|NOT COMPLETED|Overall Study||58
8489092|NCT00561574|20917675|P1|NOT COMPLETED|Overall Study||48
8489093|NCT00561574|20917674|P2|COMPLETED|Overall Study||73
8489094|NCT00561574|20917675|P1|COMPLETED|Overall Study||80
8489095|NCT00561574|20917674|P2|STARTED|Overall Study||131
8489096|NCT00561574|20917675|P1|STARTED|Overall Study||128
8489097|NCT00561470|20917701|P2|NOT COMPLETED|Overall Study||612
8489098|NCT00561470|20917702|P1|NOT COMPLETED|Overall Study||614
8489099|NCT00561470|20917701|P2|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
8489100|NCT00561470|20917702|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
8489101|NCT00561470|20917701|P2|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
8489102|NCT00561470|20917702|P1|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
8489103|NCT00561470|20917701|P2|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
8489104|NCT00561470|20917702|P1|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
8489105|NCT00561470|20917701|P2|TREATED|Overall Study||607
8489106|NCT00561470|20917702|P1|TREATED|Overall Study||609
8489107|NCT00561470|20917701|P2|STARTED|Overall Study||612
8489108|NCT00561470|20917702|P1|STARTED|Overall Study||614
8489109|NCT00561457|20917716|P1|NOT COMPLETED|Overall Study||24
8489110|NCT00561457|20917716|P1|COMPLETED|Overall Study||110
8489111|NCT00561457|20917716|P1|STARTED|Overall Study||134
8489112|NCT00561431|20917722|P2|NOT COMPLETED|Overall Study||0
8489113|NCT00561431|20917723|P1|NOT COMPLETED|Overall Study||0
8489114|NCT00561431|20917722|P2|COMPLETED|Overall Study||100
8489115|NCT00561431|20917723|P1|COMPLETED|Overall Study||100
8489116|NCT00561431|20917722|P2|STARTED|Overall Study||100
8489117|NCT00561431|20917723|P1|STARTED|Overall Study||100
8489118|NCT00561418|20917731|P1|NOT COMPLETED|Overall Study||0
8489119|NCT00561418|20917731|P1|COMPLETED|Overall Study||23
8489120|NCT00561418|20917731|P1|STARTED|Overall Study||23
8489121|NCT00561392|20917738|P1|NOT COMPLETED|Overall Study||53
8489122|NCT00561392|20917738|P1|COMPLETED|Overall Study||155
8489123|NCT00561392|20917738|P1|STARTED|Overall Study||208
8489124|NCT00561353|20917760|P10|NOT COMPLETED|Overall Study||2
8489125|NCT00561353|20917761|P9|NOT COMPLETED|Overall Study||7
8489126|NCT00561353|20917762|P8|NOT COMPLETED|Overall Study||4
8489127|NCT00561353|20917763|P7|NOT COMPLETED|Overall Study||6
8489128|NCT00561353|20917764|P6|NOT COMPLETED|Overall Study||6
8489129|NCT00561353|20917765|P5|NOT COMPLETED|Overall Study||1
8489130|NCT00561353|20917766|P4|NOT COMPLETED|Overall Study||6
8489131|NCT00561353|20917767|P3|NOT COMPLETED|Overall Study||3
8489132|NCT00561353|20917768|P2|NOT COMPLETED|Overall Study||3
8489133|NCT00561353|20917769|P1|NOT COMPLETED|Overall Study||5
8489134|NCT00561353|20917760|P10|COMPLETED|Overall Study||3
8489135|NCT00561353|20917761|P9|COMPLETED|Overall Study||2
8489136|NCT00561353|20917762|P8|COMPLETED|Overall Study||6
8489137|NCT00561353|20917763|P7|COMPLETED|Overall Study||3
8489138|NCT00561353|20917764|P6|COMPLETED|Overall Study||3
8489139|NCT00561353|20917765|P5|COMPLETED|Overall Study||5
8489140|NCT00561353|20917766|P4|COMPLETED|Overall Study||12
8489141|NCT00561353|20917767|P3|COMPLETED|Overall Study||10
8489142|NCT00561353|20917768|P2|COMPLETED|Overall Study||16
8489143|NCT00561353|20917769|P1|COMPLETED|Overall Study||13
8489144|NCT00561353|20917760|P10|STARTED|Overall Study||5
8489145|NCT00561353|20917761|P9|STARTED|Overall Study||9
8489146|NCT00561353|20917762|P8|STARTED|Overall Study||10
8489147|NCT00561353|20917763|P7|STARTED|Overall Study||9
8489148|NCT00561353|20917764|P6|STARTED|Overall Study||9
8489149|NCT00561353|20917765|P5|STARTED|Overall Study||6
8489150|NCT00561353|20917766|P4|STARTED|Overall Study||18
8489151|NCT00561353|20917767|P3|STARTED|Overall Study||13
8489152|NCT00561353|20917768|P2|STARTED|Overall Study||19
8489153|NCT00561353|20917769|P1|STARTED|Overall Study||18
8489154|NCT00561340|20917924|P2|NOT COMPLETED|Overall Study||0
8489155|NCT00561340|20917925|P1|NOT COMPLETED|Overall Study||6
8489156|NCT00561340|20917924|P2|COMPLETED|Overall Study||16
8489157|NCT00561340|20917925|P1|COMPLETED|Overall Study||7
8489158|NCT00561340|20917924|P2|STARTED|Overall Study||16
8489159|NCT00561340|20917925|P1|STARTED|Overall Study||13
8489160|NCT00561145|20917935|P2|NOT COMPLETED|Overall Study||0
8489161|NCT00561145|20917936|P1|NOT COMPLETED|Overall Study||0
8489162|NCT00561145|20917935|P2|COMPLETED|Overall Study||17
8489163|NCT00561145|20917936|P1|COMPLETED|Overall Study||15
8489164|NCT00561145|20917935|P2|STARTED|Overall Study||17
8489165|NCT00561145|20917936|P1|STARTED|Overall Study||15
8489166|NCT00561080|20917945|P3|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
8489167|NCT00561080|20917946|P2|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
8489168|NCT00561080|20917947|P1|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
8489169|NCT00561080|20917945|P3|COMPLETED|36 Month Post Last Dose Follow-up||0
8489170|NCT00561080|20917946|P2|COMPLETED|36 Month Post Last Dose Follow-up||0
8489171|NCT00561080|20917947|P1|COMPLETED|36 Month Post Last Dose Follow-up||0
8489172|NCT00561080|20917945|P3|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8489173|NCT00561080|20917946|P2|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8489174|NCT00561080|20917947|P1|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8489175|NCT00561080|20917945|P3|NOT COMPLETED|24-month Post Last Dose Follow-up||0
8489176|NCT00561080|20917946|P2|NOT COMPLETED|24-month Post Last Dose Follow-up||0
8489177|NCT00561080|20917947|P1|NOT COMPLETED|24-month Post Last Dose Follow-up||0
8489178|NCT00561080|20917945|P3|COMPLETED|24-month Post Last Dose Follow-up||0
8489179|NCT00561080|20917946|P2|COMPLETED|24-month Post Last Dose Follow-up||0
8489180|NCT00561080|20917947|P1|COMPLETED|24-month Post Last Dose Follow-up||0
8489181|NCT00561080|20917945|P3|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8489182|NCT00561080|20917946|P2|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8489183|NCT00561080|20917947|P1|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
8489184|NCT00561080|20917945|P3|NOT COMPLETED|12-month Post Last Dose Follow-up||10
8489185|NCT00561080|20917946|P2|NOT COMPLETED|12-month Post Last Dose Follow-up||9
8489186|NCT00561080|20917947|P1|NOT COMPLETED|12-month Post Last Dose Follow-up||7
8489187|NCT00561080|20917945|P3|COMPLETED|12-month Post Last Dose Follow-up||215
8489188|NCT00561080|20917946|P2|COMPLETED|12-month Post Last Dose Follow-up||220
8489189|NCT00561080|20917947|P1|COMPLETED|12-month Post Last Dose Follow-up||243
8489190|NCT00561080|20917945|P3|STARTED|12-month Post Last Dose Follow-up||225
8489191|NCT00561080|20917946|P2|STARTED|12-month Post Last Dose Follow-up||229
8489192|NCT00561080|20917947|P1|STARTED|12-month Post Last Dose Follow-up||250
8489193|NCT00561080|20917945|P3|NOT COMPLETED|Vaccination Period (up to Month 4)||26
8489194|NCT00561080|20917946|P2|NOT COMPLETED|Vaccination Period (up to Month 4)||26
8489195|NCT00561080|20917947|P1|NOT COMPLETED|Vaccination Period (up to Month 4)||3
8489196|NCT00561080|20917945|P3|COMPLETED|Vaccination Period (up to Month 4)||225
8489197|NCT00561080|20917946|P2|COMPLETED|Vaccination Period (up to Month 4)||229
8489198|NCT00561080|20917947|P1|COMPLETED|Vaccination Period (up to Month 4)||250
8489199|NCT00561080|20917945|P3|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
8489200|NCT00561080|20917946|P2|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
8489201|NCT00561080|20917947|P1|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
8489202|NCT00561080|20917945|P3|STARTED|Vaccination Period (up to Month 4)||251
8489203|NCT00561080|20917946|P2|STARTED|Vaccination Period (up to Month 4)||255
8489204|NCT00561080|20917947|P1|STARTED|Vaccination Period (up to Month 4)||253
8489205|NCT00561015|20918024|P6|NOT COMPLETED|Overall Study||3
8489206|NCT00561015|20918025|P5|NOT COMPLETED|Overall Study||1
8489207|NCT00561015|20918026|P4|NOT COMPLETED|Overall Study||1
8489208|NCT00561015|20918027|P3|NOT COMPLETED|Overall Study||0
8489209|NCT00561015|20918028|P2|NOT COMPLETED|Overall Study||0
8489210|NCT00561015|20918029|P1|NOT COMPLETED|Overall Study||4
8489211|NCT00561015|20918024|P6|COMPLETED|Overall Study||6
8489212|NCT00561015|20918025|P5|COMPLETED|Overall Study||8
8489213|NCT00561015|20918026|P4|COMPLETED|Overall Study||7
8489214|NCT00561015|20918027|P3|COMPLETED|Overall Study||9
8489215|NCT00561015|20918028|P2|COMPLETED|Overall Study||5
8489216|NCT00561015|20918029|P1|COMPLETED|Overall Study||5
8489217|NCT00561015|20918024|P6|STARTED|Overall Study||9
8489218|NCT00561015|20918025|P5|STARTED|Overall Study||9
8489219|NCT00561015|20918026|P4|STARTED|Overall Study||8
8489220|NCT00561015|20918027|P3|STARTED|Overall Study||9
8489221|NCT00561015|20918028|P2|STARTED|Overall Study||5
8489222|NCT00561015|20918029|P1|STARTED|Overall Study||9
8489223|NCT00561002|20918105|P2|NOT COMPLETED|Overall Study||0
8489224|NCT00561002|20918106|P1|NOT COMPLETED|Overall Study||0
8489225|NCT00561002|20918105|P2|COMPLETED|Overall Study||9
8489226|NCT00561002|20918106|P1|COMPLETED|Overall Study||23
8489227|NCT00561002|20918105|P2|STARTED|Overall Study||9
8489228|NCT00561002|20918106|P1|STARTED|Overall Study||23
8489229|NCT00560950|20918120|P2|NOT COMPLETED|Overall Study||0
8489230|NCT00560950|20918121|P1|NOT COMPLETED|Overall Study||1
8489231|NCT00560950|20918120|P2|COMPLETED|Overall Study||71
8489232|NCT00560950|20918121|P1|COMPLETED|Overall Study||71
8489233|NCT00560950|20918120|P2|STARTED|Overall Study||71
8489234|NCT00560950|20918121|P1|STARTED|Overall Study||72
8489235|NCT00560937|20918159|P2|NOT COMPLETED|Overall Study||2
8489236|NCT00560937|20918160|P1|NOT COMPLETED|Overall Study||1
8489237|NCT00560937|20918159|P2|COMPLETED|Overall Study||9
8489238|NCT00560937|20918160|P1|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
8489239|NCT00560937|20918159|P2|STARTED|Overall Study||11
8489240|NCT00560937|20918160|P1|STARTED|Overall Study||10
8489241|NCT00560885|20918176|P1|NOT COMPLETED|Overall Study||8
8489242|NCT00560885|20918176|P1|COMPLETED|Overall Study||47
8489243|NCT00560885|20918176|P1|2 Year Follow-up|Overall Study||47
8489244|NCT00560885|20918176|P1|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
8489245|NCT00560885|20918176|P1|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
8489246|NCT00560885|20918176|P1|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
8489247|NCT00560885|20918176|P1|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
8489248|NCT00560885|20918176|P1|STARTED|Overall Study||55
8489249|NCT00560859|20918185|P2|NOT COMPLETED|Overall Study||24
8489250|NCT00560859|20918186|P1|NOT COMPLETED|Overall Study||32
8489251|NCT00560859|20918185|P2|COMPLETED|Overall Study||203
8489252|NCT00560859|20918186|P1|COMPLETED|Overall Study||194
8489253|NCT00560859|20918185|P2|STARTED|Overall Study||227
8489254|NCT00560859|20918186|P1|STARTED|Overall Study||226
8489255|NCT00560833|20918201|P5|NOT COMPLETED|Overall Study||42
8489256|NCT00560833|20918202|P4|NOT COMPLETED|Overall Study||31
8489257|NCT00560833|20918203|P3|NOT COMPLETED|Overall Study||39
8489258|NCT00560833|20918204|P2|NOT COMPLETED|Overall Study||26
8489259|NCT00560833|20918205|P1|NOT COMPLETED|Overall Study||44
8489260|NCT00560833|20918201|P5|COMPLETED|Overall Study||114
8489261|NCT00560833|20918202|P4|COMPLETED|Overall Study||124
8489262|NCT00560833|20918203|P3|COMPLETED|Overall Study||121
8489263|NCT00560833|20918204|P2|COMPLETED|Overall Study||129
8489264|NCT00560833|20918205|P1|COMPLETED|Overall Study||273
8489265|NCT00560833|20918201|P5|Treated|Overall Study|One participant was randomized but not treated|155
8489266|NCT00560833|20918202|P4|Treated|Overall Study||155
8489267|NCT00560833|20918203|P3|Treated|Overall Study||160
8489268|NCT00560833|20918204|P2|Treated|Overall Study|One participant was randomized but not treated|154
8489269|NCT00560833|20918205|P1|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
8489270|NCT00560833|20918201|P5|STARTED|Overall Study||156
8489271|NCT00560833|20918202|P4|STARTED|Overall Study||155
8489272|NCT00560833|20918203|P3|STARTED|Overall Study||160
8489273|NCT00560833|20918204|P2|STARTED|Overall Study||155
8489274|NCT00560833|20918205|P1|STARTED|Overall Study||317
8489275|NCT00560794|20918237|P1|NOT COMPLETED|Overall Study||11
8489276|NCT00560794|20918237|P1|COMPLETED|Overall Study||10
8489277|NCT00560794|20918237|P1|Completed 1 Treatment Cycle|Overall Study||20
8489278|NCT00560794|20918237|P1|STARTED|Overall Study||21
8489279|NCT00560755|20918254|P1|NOT COMPLETED|Overall Study||60
8489280|NCT00560755|20918254|P1|COMPLETED|Overall Study||3328
8489281|NCT00560755|20918254|P1|ProQuad® Dose 1 and Dose 2|Overall Study||3346
8489282|NCT00560755|20918254|P1|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
8489289|NCT00560612|20918286|P2|NOT COMPLETED|Overall Study||0
8489290|NCT00560612|20918287|P1|NOT COMPLETED|Overall Study||0
8489291|NCT00560612|20918286|P2|COMPLETED|Overall Study||7
8489292|NCT00560612|20918287|P1|COMPLETED|Overall Study||5
8489293|NCT00560612|20918286|P2|STARTED|Overall Study||7
8489294|NCT00560612|20918287|P1|STARTED|Overall Study||5
8489295|NCT00560573|20918299|P6|NOT COMPLETED|Overall Study||13
8489296|NCT00560573|20918300|P5|NOT COMPLETED|Overall Study||7
8489297|NCT00560573|20918301|P4|NOT COMPLETED|Overall Study||10
8489298|NCT00560573|20918302|P3|NOT COMPLETED|Overall Study||6
8489299|NCT00560573|20918303|P2|NOT COMPLETED|Overall Study||3
8489300|NCT00560573|20918304|P1|NOT COMPLETED|Overall Study||6
8489301|NCT00560573|20918299|P6|COMPLETED|Overall Study||0
8489302|NCT00560573|20918300|P5|COMPLETED|Overall Study||1
8489303|NCT00560573|20918301|P4|COMPLETED|Overall Study||0
8489304|NCT00560573|20918302|P3|COMPLETED|Overall Study||0
8489305|NCT00560573|20918303|P2|COMPLETED|Overall Study||0
8489306|NCT00560573|20918304|P1|COMPLETED|Overall Study||0
8489307|NCT00560573|20918299|P6|Treated|Overall Study||13
8489308|NCT00560573|20918300|P5|Treated|Overall Study||7
8489309|NCT00560573|20918301|P4|Treated|Overall Study||10
8489310|NCT00560573|20918302|P3|Treated|Overall Study||6
8489311|NCT00560573|20918303|P2|Treated|Overall Study||3
8489312|NCT00560573|20918304|P1|Treated|Overall Study||6
8489313|NCT00560573|20918299|P6|STARTED|Overall Study||13
8489314|NCT00560573|20918300|P5|STARTED|Overall Study||8
8489315|NCT00560573|20918301|P4|STARTED|Overall Study||10
8489316|NCT00560573|20918302|P3|STARTED|Overall Study||6
8489317|NCT00560573|20918303|P2|STARTED|Overall Study||3
8489318|NCT00560573|20918304|P1|STARTED|Overall Study||6
8489319|NCT00560560|20918358|P2|NOT COMPLETED|Overall Study||83
8489320|NCT00560560|20918359|P1|NOT COMPLETED|Overall Study||85
8489321|NCT00560560|20918358|P2|COMPLETED|Overall Study||0
8489322|NCT00560560|20918359|P1|COMPLETED|Overall Study||0
8489323|NCT00560560|20918358|P2|STARTED|Overall Study||83
8489324|NCT00560560|20918359|P1|STARTED|Overall Study||85
8489325|NCT00560508|20918381|P2|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
8489326|NCT00560508|20918382|P1|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
8489327|NCT00560508|20918381|P2|COMPLETED|52-week Open-label Period Pramipexole ER||42
8489328|NCT00560508|20918382|P1|COMPLETED|52-week Open-label Period Pramipexole ER||43
8489329|NCT00560508|20918381|P2|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
8489330|NCT00560508|20918382|P1|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
8489331|NCT00560508|20918381|P2|NOT COMPLETED|12 Week Double-blind Period||3
8489332|NCT00560508|20918382|P1|NOT COMPLETED|12 Week Double-blind Period||5
8489333|NCT00560508|20918381|P2|COMPLETED|12 Week Double-blind Period||53
8489334|NCT00560508|20918382|P1|COMPLETED|12 Week Double-blind Period||51
8489335|NCT00560508|20918381|P2|STARTED|12 Week Double-blind Period||56
8489336|NCT00560508|20918382|P1|STARTED|12 Week Double-blind Period||56
8489337|NCT00560417|20918441|P2|NOT COMPLETED|Overall Study||17
8489338|NCT00560417|20918442|P1|NOT COMPLETED|Overall Study||17
8489339|NCT00560417|20918441|P2|COMPLETED|Overall Study||151
8489340|NCT00560417|20918442|P1|COMPLETED|Overall Study||154
8489341|NCT00560417|20918441|P2|Intention to Treat (ITT) Population|Overall Study||167
8489342|NCT00560417|20918442|P1|Intention to Treat (ITT) Population|Overall Study||170
8489343|NCT00560417|20918441|P2|STARTED|Overall Study||168
8489344|NCT00560417|20918442|P1|STARTED|Overall Study||171
8489345|NCT00560404|20918470|P2|NOT COMPLETED|Overall Study||21
8489346|NCT00560404|20918471|P1|NOT COMPLETED|Overall Study||36
8489347|NCT00560404|20918470|P2|COMPLETED|Overall Study||100
8489348|NCT00560404|20918471|P1|COMPLETED|Overall Study||76
8489349|NCT00560404|20918470|P2|STARTED|Overall Study||121
8489350|NCT00560404|20918471|P1|STARTED|Overall Study||112
8489351|NCT00560391|20918518|P5|NOT COMPLETED|Overall Study||2
8489352|NCT00560391|20918519|P4|NOT COMPLETED|Overall Study||1
8489353|NCT00560391|20918520|P3|NOT COMPLETED|Overall Study||0
8489354|NCT00560391|20918521|P2|NOT COMPLETED|Overall Study||0
8489355|NCT00560391|20918522|P1|NOT COMPLETED|Overall Study||0
8489356|NCT00560391|20918518|P5|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
8489357|NCT00560391|20918519|P4|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
8489358|NCT00560391|20918520|P3|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
8489359|NCT00560391|20918521|P2|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
8489360|NCT00560391|20918522|P1|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
8489361|NCT00560391|20918518|P5|STARTED|Overall Study|Participants who received treatment|17
8489362|NCT00560391|20918519|P4|STARTED|Overall Study|Participants who received treatment|6
8489363|NCT00560391|20918520|P3|STARTED|Overall Study|Participants who received treatment|3
8489364|NCT00560391|20918521|P2|STARTED|Overall Study|Participants who received treatment|3
8489365|NCT00560391|20918522|P1|STARTED|Overall Study|Participants who received treatment|6
8489366|NCT00560352|20918578|P3|NOT COMPLETED|Overall Study||4
8489367|NCT00560352|20918579|P2|NOT COMPLETED|Overall Study||3
8489368|NCT00560352|20918580|P1|NOT COMPLETED|Overall Study||7
8489369|NCT00560352|20918578|P3|COMPLETED|Overall Study||0
8489370|NCT00560352|20918579|P2|COMPLETED|Overall Study||0
8489371|NCT00560352|20918580|P1|COMPLETED|Overall Study||0
8489372|NCT00560352|20918578|P3|STARTED|Overall Study||4
8489373|NCT00560352|20918579|P2|STARTED|Overall Study||3
8489374|NCT00560352|20918580|P1|STARTED|Overall Study||7
8489375|NCT00560313|20918597|P1|NOT COMPLETED|Overall Study||6
8489376|NCT00560313|20918597|P1|COMPLETED|Overall Study||48
8489377|NCT00560313|20918597|P1|STARTED|Overall Study||54
8489378|NCT00560235|20918624|P3|NOT COMPLETED|Phase 2||97
8489379|NCT00560235|20918625|P2|NOT COMPLETED|Phase 2||0
8489380|NCT00560235|20918626|P1|NOT COMPLETED|Phase 2||0
8489381|NCT00560235|20918624|P3|COMPLETED|Phase 2||10
8489382|NCT00560235|20918625|P2|COMPLETED|Phase 2||0
8489383|NCT00560235|20918626|P1|COMPLETED|Phase 2||0
8489384|NCT00560235|20918624|P3|STARTED|Phase 2||107
8489385|NCT00560235|20918625|P2|STARTED|Phase 2||0
8489386|NCT00560235|20918626|P1|STARTED|Phase 2||0
8489387|NCT00560235|20918624|P3|NOT COMPLETED|Phase 1B||0
8489388|NCT00560235|20918625|P2|NOT COMPLETED|Phase 1B||19
8489389|NCT00560235|20918626|P1|NOT COMPLETED|Phase 1B||0
8489390|NCT00560235|20918624|P3|COMPLETED|Phase 1B||0
8489391|NCT00560235|20918625|P2|COMPLETED|Phase 1B||2
8489392|NCT00560235|20918626|P1|COMPLETED|Phase 1B||0
8489393|NCT00560235|20918624|P3|STARTED|Phase 1B||0
8489394|NCT00560235|20918625|P2|STARTED|Phase 1B||21
8489395|NCT00560235|20918626|P1|STARTED|Phase 1B||0
8489396|NCT00560235|20918624|P3|NOT COMPLETED|Phase 1||0
8489397|NCT00560235|20918625|P2|NOT COMPLETED|Phase 1||0
8489398|NCT00560235|20918626|P1|NOT COMPLETED|Phase 1||8
8489399|NCT00560235|20918624|P3|COMPLETED|Phase 1||0
8489400|NCT00560235|20918625|P2|COMPLETED|Phase 1||0
8489401|NCT00560235|20918626|P1|COMPLETED|Phase 1||2
8489402|NCT00560235|20918624|P3|STARTED|Phase 1||0
8489403|NCT00560235|20918625|P2|STARTED|Phase 1||0
8489404|NCT00560235|20918626|P1|STARTED|Phase 1||10
8489405|NCT00560105|20918657|P2|NOT COMPLETED|Overall Study||2
8489406|NCT00560105|20918658|P1|NOT COMPLETED|Overall Study||1
8489407|NCT00560105|20918657|P2|COMPLETED|Overall Study||18
8489408|NCT00560105|20918658|P1|COMPLETED|Overall Study||19
8489409|NCT00560105|20918657|P2|STARTED|Overall Study||20
8489410|NCT00560105|20918658|P1|STARTED|Overall Study||20
8489411|NCT00560066|20918672|P2|NOT COMPLETED|Overall Study||22
8489412|NCT00560066|20918673|P1|NOT COMPLETED|Overall Study||6
8489413|NCT00560066|20918672|P2|COMPLETED|Overall Study||980
8489414|NCT00560066|20918673|P1|COMPLETED|Overall Study||390
8489415|NCT00560066|20918672|P2|STARTED|Overall Study||1002
8489416|NCT00560066|20918673|P1|STARTED|Overall Study||396
8489417|NCT00559988|20918705|P2|NOT COMPLETED|Overall Study||352
8489418|NCT00559988|20918706|P1|NOT COMPLETED|Overall Study||351
8489419|NCT00559988|20918705|P2|COMPLETED|Overall Study||1009
8489420|NCT00559988|20918706|P1|COMPLETED|Overall Study||1006
8489421|NCT00559988|20918705|P2|STARTED|Overall Study||1361
8489422|NCT00559988|20918706|P1|STARTED|Overall Study||1357
8489423|NCT00559962|20918736|P8|NOT COMPLETED|Overall Study||4
8489424|NCT00559962|20918737|P7|NOT COMPLETED|Overall Study||5
8489425|NCT00559962|20918738|P6|NOT COMPLETED|Overall Study||5
8489426|NCT00559962|20918739|P5|NOT COMPLETED|Overall Study||14
8489427|NCT00559962|20918740|P4|NOT COMPLETED|Overall Study||5
8489428|NCT00559962|20918741|P3|NOT COMPLETED|Overall Study||10
8489429|NCT00559962|20918742|P2|NOT COMPLETED|Overall Study||9
8489430|NCT00559962|20918743|P1|NOT COMPLETED|Overall Study||2
8489431|NCT00559962|20918736|P8|COMPLETED|Overall Study||25
8489432|NCT00559962|20918737|P7|COMPLETED|Overall Study||28
8489433|NCT00559962|20918738|P6|COMPLETED|Overall Study||23
8489434|NCT00559962|20918739|P5|COMPLETED|Overall Study||21
8489435|NCT00559962|20918740|P4|COMPLETED|Overall Study||29
8489436|NCT00559962|20918741|P3|COMPLETED|Overall Study||24
8489437|NCT00559962|20918742|P2|COMPLETED|Overall Study||25
8489438|NCT00559962|20918743|P1|COMPLETED|Overall Study||31
8489439|NCT00559962|20918736|P8|STARTED|Overall Study||29
8489440|NCT00559962|20918737|P7|STARTED|Overall Study||33
8489441|NCT00559962|20918738|P6|STARTED|Overall Study||28
8489442|NCT00559962|20918739|P5|STARTED|Overall Study||35
8489443|NCT00559962|20918740|P4|STARTED|Overall Study||34
8489444|NCT00559962|20918741|P3|STARTED|Overall Study||34
8489445|NCT00559962|20918742|P2|STARTED|Overall Study||34
8489446|NCT00559962|20918743|P1|STARTED|Overall Study||33
8489447|NCT00559949|20918763|P1|NOT COMPLETED|Overall Study||7
8489448|NCT00559949|20918763|P1|COMPLETED|Overall Study||32
8489449|NCT00559949|20918763|P1|STARTED|Overall Study||39
8489450|NCT00559936|20918770|P1|NOT COMPLETED|Overall Study||4
8489451|NCT00559936|20918770|P1|COMPLETED|Overall Study||20
8489452|NCT00559936|20918770|P1|STARTED|Overall Study||24
8489453|NCT00559897|20918775|P1|NOT COMPLETED|Overall Study||0
8489454|NCT00559897|20918775|P1|COMPLETED|Overall Study||6
8489455|NCT00559897|20918775|P1|STARTED|Overall Study||6
8489456|NCT00559845|20918779|P1|NOT COMPLETED|Overall Study||7
8489457|NCT00559845|20918779|P1|COMPLETED|Overall Study||49
8489458|NCT00559845|20918779|P1|STARTED|Overall Study||56
8489459|NCT00559754|20918788|P1|NOT COMPLETED|Overall Study||11
8489460|NCT00559754|20918788|P1|COMPLETED|Overall Study||61
8489461|NCT00559754|20918788|P1|STARTED|Overall Study||72
8489462|NCT00559637|20918812|P1|NOT COMPLETED|Overall Study||54
8489463|NCT00559637|20918812|P1|COMPLETED|Overall Study||130
8489464|NCT00559637|20918812|P1|STARTED|Overall Study||184
8489465|NCT00559585|20918825|P2|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
8489466|NCT00559585|20918826|P1|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
8489467|NCT00559585|20918825|P2|COMPLETED|Open Label LT Period Main + Sub-Study||0
8489468|NCT00559585|20918826|P1|COMPLETED|Open Label LT Period Main + Sub-Study||945
8489469|NCT00559585|20918825|P2|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
8489470|NCT00559585|20918826|P1|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
8489471|NCT00559585|20918825|P2|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
8489472|NCT00559585|20918826|P1|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
8489473|NCT00559585|20918825|P2|COMPLETED|Anti-TNF Sub-Study in ST Period||9
8489474|NCT00559585|20918826|P1|COMPLETED|Anti-TNF Sub-Study in ST Period||7
8489475|NCT00559585|20918825|P2|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
8489476|NCT00559585|20918826|P1|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
8489477|NCT00559585|20918825|P2|NOT COMPLETED|Double Blind ST Period Main Study||45
8489478|NCT00559585|20918826|P1|NOT COMPLETED|Double Blind ST Period Main Study||43
8489479|NCT00559585|20918825|P2|COMPLETED|Double Blind ST Period Main Study||676
8489480|NCT00559585|20918826|P1|COMPLETED|Double Blind ST Period Main Study||693
8489481|NCT00559585|20918825|P2|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
8489482|NCT00559585|20918826|P1|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
8489483|NCT00559507|20918886|P1|NOT COMPLETED|Overall Study||3
8489484|NCT00559507|20918886|P1|COMPLETED|Overall Study||9
8489485|NCT00559507|20918886|P1|STARTED|Overall Study||12
8489486|NCT00559468|20918894|P2|NOT COMPLETED|Overall Study||1
8489487|NCT00559468|20918895|P1|NOT COMPLETED|Overall Study||0
8489488|NCT00559468|20918894|P2|COMPLETED|Overall Study||25
8489489|NCT00559468|20918895|P1|COMPLETED|Overall Study||26
8489490|NCT00559468|20918894|P2|Treated|Overall Study||25
8489491|NCT00559468|20918895|P1|Treated|Overall Study||26
8489492|NCT00559468|20918894|P2|STARTED|Overall Study||26
8489493|NCT00559468|20918895|P1|STARTED|Overall Study||26
8489494|NCT00559377|20918905|P1|NOT COMPLETED|Overall Study||9
8489495|NCT00559377|20918905|P1|COMPLETED|Overall Study||7
8489496|NCT00559377|20918905|P1|STARTED|Overall Study||16
8489497|NCT00559364|20918915|P2|NOT COMPLETED|Overall Study||0
8489498|NCT00559364|20918916|P1|NOT COMPLETED|Overall Study||1
8489499|NCT00559364|20918915|P2|COMPLETED|Overall Study||20
8489500|NCT00559364|20918916|P1|COMPLETED|Overall Study||29
8489501|NCT00559364|20918915|P2|STARTED|Overall Study||20
8489502|NCT00559364|20918916|P1|STARTED|Overall Study||30
8489503|NCT00559273|20918928|P2|NOT COMPLETED|Evaluation Period (8 Weeks)||5
8489504|NCT00559273|20918929|P1|NOT COMPLETED|Evaluation Period (8 Weeks)||3
8489505|NCT00559273|20918928|P2|COMPLETED|Evaluation Period (8 Weeks)||137
8489506|NCT00559273|20918929|P1|COMPLETED|Evaluation Period (8 Weeks)||141
8489507|NCT00559273|20918928|P2|STARTED|Evaluation Period (8 Weeks)||142
8489508|NCT00559273|20918929|P1|STARTED|Evaluation Period (8 Weeks)||144
8489509|NCT00559273|20918928|P2|NOT COMPLETED|Correction Period (20 Weeks)||12
8489510|NCT00559273|20918929|P1|NOT COMPLETED|Correction Period (20 Weeks)||9
8489511|NCT00559273|20918928|P2|COMPLETED|Correction Period (20 Weeks)||142
8489512|NCT00559273|20918929|P1|COMPLETED|Correction Period (20 Weeks)||144
8489513|NCT00559273|20918928|P2|Treated|Correction Period (20 Weeks)||154
8489514|NCT00559273|20918929|P1|Treated|Correction Period (20 Weeks)||151
8489515|NCT00559273|20918928|P2|STARTED|Correction Period (20 Weeks)||154
8489516|NCT00559273|20918929|P1|STARTED|Correction Period (20 Weeks)||153
8489517|NCT00559104|20918951|P2|NOT COMPLETED|Overall Study||0
8489518|NCT00559104|20918952|P1|NOT COMPLETED|Overall Study||9
8489519|NCT00559104|20918951|P2|COMPLETED|Overall Study||5
8489520|NCT00559104|20918952|P1|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
8489521|NCT00559104|20918951|P2|STARTED|Overall Study||5
8489522|NCT00559104|20918952|P1|STARTED|Overall Study||55
8489523|NCT00559013|20918962|P1|NOT COMPLETED|Overall Study||0
8489524|NCT00559013|20918962|P1|COMPLETED|Overall Study||38
8489525|NCT00559013|20918962|P1|STARTED|Overall Study||38
8489526|NCT00558896|20918973|P7|NOT COMPLETED|Overall Study||24
8489527|NCT00558896|20918974|P6|NOT COMPLETED|Overall Study||52
8489528|NCT00558896|20918975|P5|NOT COMPLETED|Overall Study||23
8489529|NCT00558896|20918976|P4|NOT COMPLETED|Overall Study||12
8489530|NCT00558896|20918977|P3|NOT COMPLETED|Overall Study||5
8489531|NCT00558896|20918978|P2|NOT COMPLETED|Overall Study||7
8489532|NCT00558896|20918979|P1|NOT COMPLETED|Overall Study||21
8489533|NCT00558896|20918973|P7|COMPLETED|Overall Study||9
8489534|NCT00558896|20918974|P6|COMPLETED|Overall Study||68
8489535|NCT00558896|20918975|P5|COMPLETED|Overall Study||37
8489536|NCT00558896|20918976|P4|COMPLETED|Overall Study||23
8489537|NCT00558896|20918977|P3|COMPLETED|Overall Study||30
8489538|NCT00558896|20918978|P2|COMPLETED|Overall Study||27
8489539|NCT00558896|20918979|P1|COMPLETED|Overall Study||39
8489540|NCT00558896|20918973|P7|STARTED|Overall Study||33
8489541|NCT00558896|20918974|P6|STARTED|Overall Study||120
8489542|NCT00558896|20918975|P5|STARTED|Overall Study||60
8489543|NCT00558896|20918976|P4|STARTED|Overall Study||35
8489544|NCT00558896|20918977|P3|STARTED|Overall Study||35
8489545|NCT00558896|20918978|P2|STARTED|Overall Study||34
8489546|NCT00558896|20918979|P1|STARTED|Overall Study||60
8489547|NCT00558870|20919011|P2|NOT COMPLETED|Overall Study||0
8489548|NCT00558870|20919012|P1|NOT COMPLETED|Overall Study||0
8489549|NCT00558870|20919011|P2|COMPLETED|Overall Study||2
8489550|NCT00558870|20919012|P1|COMPLETED|Overall Study||2
8489551|NCT00558870|20919011|P2|STARTED|Overall Study||2
8489552|NCT00558870|20919012|P1|STARTED|Overall Study||2
8489553|NCT00558844|20919025|P5|NOT COMPLETED|Overall Study||1
8489554|NCT00558844|20919026|P4|NOT COMPLETED|Overall Study||0
8489555|NCT00558844|20919027|P3|NOT COMPLETED|Overall Study||1
8489556|NCT00558844|20919028|P2|NOT COMPLETED|Overall Study||0
8489557|NCT00558844|20919029|P1|NOT COMPLETED|Overall Study||3
8489558|NCT00558844|20919025|P5|COMPLETED|Overall Study||6
8489559|NCT00558844|20919026|P4|COMPLETED|Overall Study||5
8489560|NCT00558844|20919027|P3|COMPLETED|Overall Study||6
8489561|NCT00558844|20919028|P2|COMPLETED|Overall Study||7
8489562|NCT00558844|20919029|P1|COMPLETED|Overall Study||12
8489563|NCT00558844|20919025|P5|STARTED|Overall Study||7
8489564|NCT00558844|20919026|P4|STARTED|Overall Study||5
8489565|NCT00558844|20919027|P3|STARTED|Overall Study||7
8489566|NCT00558844|20919028|P2|STARTED|Overall Study||7
8489567|NCT00558844|20919029|P1|STARTED|Overall Study||15
8489568|NCT00558831|20919081|P1|NOT COMPLETED|Overall Study||1
8489569|NCT00558831|20919081|P1|COMPLETED|Overall Study||10
8489570|NCT00558831|20919081|P1|STARTED|Overall Study||11
8489571|NCT00558792|20919090|P3|NOT COMPLETED|Overall Study||0
8489572|NCT00558792|20919091|P2|NOT COMPLETED|Overall Study||0
8489573|NCT00558792|20919092|P1|NOT COMPLETED|Overall Study||0
8489574|NCT00558792|20919090|P3|COMPLETED|Overall Study||60
8489575|NCT00558792|20919091|P2|COMPLETED|Overall Study||63
8489576|NCT00558792|20919092|P1|COMPLETED|Overall Study||68
8489577|NCT00558792|20919090|P3|STARTED|Overall Study||60
8489578|NCT00558792|20919091|P2|STARTED|Overall Study||63
8489579|NCT00558792|20919092|P1|STARTED|Overall Study||68
8489580|NCT00558753|20919138|P2|NOT COMPLETED|Overall Study||7
8489581|NCT00558753|20919139|P1|NOT COMPLETED|Overall Study||5
8489582|NCT00558753|20919138|P2|COMPLETED|Overall Study||113
8489583|NCT00558753|20919139|P1|COMPLETED|Overall Study||115
8489584|NCT00558753|20919138|P2|STARTED|Overall Study||120
8489585|NCT00558753|20919139|P1|STARTED|Overall Study||120
8489586|NCT00558701|20919151|P2|NOT COMPLETED|Overall Study||4
8489587|NCT00558701|20919152|P1|NOT COMPLETED|Overall Study||1
8489588|NCT00558701|20919151|P2|COMPLETED|Overall Study||11
8489589|NCT00558701|20919152|P1|COMPLETED|Overall Study||14
8489590|NCT00558701|20919151|P2|STARTED|Overall Study||15
8489591|NCT00558701|20919152|P1|STARTED|Overall Study||15
8489592|NCT00558636|20919160|P2|NOT COMPLETED|Follow-up||7
8489593|NCT00558636|20919161|P1|NOT COMPLETED|Follow-up||12
8489594|NCT00558636|20919160|P2|COMPLETED|Follow-up|Study was prematurely terminated|0
8489595|NCT00558636|20919161|P1|COMPLETED|Follow-up|Study was prematurely terminated|0
8489596|NCT00558636|20919160|P2|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
8489597|NCT00558636|20919161|P1|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
8489598|NCT00558636|20919160|P2|NOT COMPLETED|Treatment||44
8489599|NCT00558636|20919161|P1|NOT COMPLETED|Treatment||47
8489600|NCT00558636|20919160|P2|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
8489601|NCT00558636|20919161|P1|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
8489602|NCT00558636|20919160|P2|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
8489603|NCT00558636|20919161|P1|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
8489604|NCT00558636|20919160|P2|STARTED|Treatment||44
8489605|NCT00558636|20919161|P1|STARTED|Treatment|up to 6 cycles of combination therapy|47
8489606|NCT00558571|20919183|P4|NOT COMPLETED|Overall Study||0
8489607|NCT00558571|20919184|P3|NOT COMPLETED|Overall Study||0
8489608|NCT00558571|20919185|P2|NOT COMPLETED|Overall Study||0
8489609|NCT00558571|20919186|P1|NOT COMPLETED|Overall Study||0
8489610|NCT00558571|20919183|P4|COMPLETED|Overall Study||30
8489611|NCT00558571|20919184|P3|COMPLETED|Overall Study||16
8489612|NCT00558571|20919185|P2|COMPLETED|Overall Study||16
8489613|NCT00558571|20919186|P1|COMPLETED|Overall Study||16
8489614|NCT00558571|20919183|P4|STARTED|Overall Study||30
8489615|NCT00558571|20919184|P3|STARTED|Overall Study||16
8489616|NCT00558571|20919185|P2|STARTED|Overall Study||16
8489617|NCT00558571|20919186|P1|STARTED|Overall Study||16
8489618|NCT00558558|20919261|P1|NOT COMPLETED|Overall Study||6
8489619|NCT00558558|20919261|P1|COMPLETED|Overall Study||0
8489620|NCT00558558|20919261|P1|STARTED|Overall Study||6
8489624|NCT00558467|20919275|P2|NOT COMPLETED|Overall Study||4
8489625|NCT00558467|20919276|P1|NOT COMPLETED|Overall Study||1
8489626|NCT00558467|20919275|P2|COMPLETED|Overall Study||39
8489627|NCT00558467|20919276|P1|COMPLETED|Overall Study||19
8489628|NCT00558467|20919275|P2|STARTED|Overall Study||43
8489629|NCT00558467|20919276|P1|STARTED|Overall Study||20
8489630|NCT00558428|20919336|P4|NOT COMPLETED|Overall Study||11
8489631|NCT00558428|20919337|P3|NOT COMPLETED|Overall Study||4
8489632|NCT00558428|20919338|P2|NOT COMPLETED|Overall Study||24
8489633|NCT00558428|20919339|P1|NOT COMPLETED|Overall Study||12
8489634|NCT00558428|20919336|P4|COMPLETED|Overall Study||266
8489635|NCT00558428|20919337|P3|COMPLETED|Overall Study||273
8489636|NCT00558428|20919338|P2|COMPLETED|Overall Study||252
8489637|NCT00558428|20919339|P1|COMPLETED|Overall Study||255
8489638|NCT00558428|20919336|P4|STARTED|Overall Study||277
8489639|NCT00558428|20919337|P3|STARTED|Overall Study||277
8489640|NCT00558428|20919338|P2|STARTED|Overall Study||276
8489641|NCT00558428|20919339|P1|STARTED|Overall Study||267
8489642|NCT00558363|20919379|P2|NOT COMPLETED|Overall Study||36
8489643|NCT00558363|20919380|P1|NOT COMPLETED|Overall Study||71
8489644|NCT00558363|20919379|P2|COMPLETED|Overall Study||111
8489645|NCT00558363|20919380|P1|COMPLETED|Overall Study||76
8489646|NCT00558363|20919379|P2|STARTED|Overall Study||147
8489647|NCT00558363|20919380|P1|STARTED|Overall Study||147
8489648|NCT00558285|20919435|P5|NOT COMPLETED|Overall Study||4
8489649|NCT00558285|20919436|P4|NOT COMPLETED|Overall Study||4
8489650|NCT00558285|20919437|P3|NOT COMPLETED|Overall Study||5
8489651|NCT00558285|20919438|P2|NOT COMPLETED|Overall Study||3
8489652|NCT00558285|20919439|P1|NOT COMPLETED|Overall Study||6
8489653|NCT00558285|20919435|P5|COMPLETED|Overall Study||49
8489654|NCT00558285|20919436|P4|COMPLETED|Overall Study||48
8489655|NCT00558285|20919437|P3|COMPLETED|Overall Study||46
8489656|NCT00558285|20919438|P2|COMPLETED|Overall Study||48
8489657|NCT00558285|20919439|P1|COMPLETED|Overall Study||44
8489658|NCT00558285|20919435|P5|Safety: Received Study Drug|Overall Study||53
8489659|NCT00558285|20919436|P4|Safety: Received Study Drug|Overall Study||51
8489660|NCT00558285|20919437|P3|Safety: Received Study Drug|Overall Study||51
8489661|NCT00558285|20919438|P2|Safety: Received Study Drug|Overall Study||51
8489662|NCT00558285|20919439|P1|Safety: Received Study Drug|Overall Study||49
8489663|NCT00558285|20919435|P5|STARTED|Overall Study||53
8489664|NCT00558285|20919436|P4|STARTED|Overall Study||52
8489665|NCT00558285|20919437|P3|STARTED|Overall Study||51
8489666|NCT00558285|20919438|P2|STARTED|Overall Study||51
8489667|NCT00558285|20919439|P1|STARTED|Overall Study||50
8489668|NCT00558272|20919483|P2|NOT COMPLETED|Overall Study||2
8489669|NCT00558272|20919484|P1|NOT COMPLETED|Overall Study||13
8489670|NCT00558272|20919483|P2|COMPLETED|Overall Study|4-week treatment period|68
8489671|NCT00558272|20919484|P1|COMPLETED|Overall Study|4-week treatment period|56
8489672|NCT00558272|20919483|P2|30 Days Follow-up|Overall Study|30 days after last dose|67
8489673|NCT00558272|20919484|P1|30 Days Follow-up|Overall Study|30 days after last dose|41
8489674|NCT00558272|20919483|P2|STARTED|Overall Study|Randomised|70
8489675|NCT00558272|20919484|P1|STARTED|Overall Study|Randomised|69
8489676|NCT00558259|20919524|P2|NOT COMPLETED|Overall Study||99
8489677|NCT00558259|20919525|P1|NOT COMPLETED|Overall Study||71
8489678|NCT00558259|20919524|P2|COMPLETED|Overall Study|Completed treatment.|563
8489679|NCT00558259|20919525|P1|COMPLETED|Overall Study|Completed treatment.|610
8489680|NCT00558259|20919524|P2|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
8489681|NCT00558259|20919525|P1|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
8489682|NCT00558246|20919545|P1|NOT COMPLETED|Overall Study||0
8489683|NCT00558246|20919545|P1|COMPLETED|Overall Study||79
8489684|NCT00558246|20919545|P1|STARTED|Overall Study||79
8489685|NCT00558103|20919565|P6|NOT COMPLETED|Monotherapy Extension Phase||9
8489686|NCT00558103|20919566|P5|NOT COMPLETED|Monotherapy Extension Phase||0
8489687|NCT00558103|20919567|P4|NOT COMPLETED|Monotherapy Extension Phase||0
8489688|NCT00558103|20919568|P3|NOT COMPLETED|Monotherapy Extension Phase||0
8489689|NCT00558103|20919569|P2|NOT COMPLETED|Monotherapy Extension Phase||0
8489690|NCT00558103|20919570|P1|NOT COMPLETED|Monotherapy Extension Phase||0
8489691|NCT00558103|20919565|P6|COMPLETED|Monotherapy Extension Phase||0
8489692|NCT00558103|20919566|P5|COMPLETED|Monotherapy Extension Phase||0
8489693|NCT00558103|20919567|P4|COMPLETED|Monotherapy Extension Phase||0
8489694|NCT00558103|20919568|P3|COMPLETED|Monotherapy Extension Phase||0
8489695|NCT00558103|20919569|P2|COMPLETED|Monotherapy Extension Phase||0
8489696|NCT00558103|20919570|P1|COMPLETED|Monotherapy Extension Phase||0
8489784|NCT00557856|20919680|P9|COMPLETED|Part 1: Dose Escalation Phase||0
8489697|NCT00558103|20919565|P6|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
8489698|NCT00558103|20919566|P5|STARTED|Monotherapy Extension Phase||0
8489699|NCT00558103|20919567|P4|STARTED|Monotherapy Extension Phase||0
8489700|NCT00558103|20919568|P3|STARTED|Monotherapy Extension Phase||0
8489701|NCT00558103|20919569|P2|STARTED|Monotherapy Extension Phase||0
8489702|NCT00558103|20919570|P1|STARTED|Monotherapy Extension Phase||0
8489703|NCT00558103|20919565|P6|NOT COMPLETED|Randomized Treatment Phase||0
8489704|NCT00558103|20919566|P5|NOT COMPLETED|Randomized Treatment Phase||5
8489705|NCT00558103|20919567|P4|NOT COMPLETED|Randomized Treatment Phase||2
8489706|NCT00558103|20919568|P3|NOT COMPLETED|Randomized Treatment Phase||3
8489707|NCT00558103|20919569|P2|NOT COMPLETED|Randomized Treatment Phase||4
8489708|NCT00558103|20919570|P1|NOT COMPLETED|Randomized Treatment Phase||5
8489709|NCT00558103|20919565|P6|COMPLETED|Randomized Treatment Phase||0
8489710|NCT00558103|20919566|P5|COMPLETED|Randomized Treatment Phase||33
8489711|NCT00558103|20919567|P4|COMPLETED|Randomized Treatment Phase||11
8489712|NCT00558103|20919568|P3|COMPLETED|Randomized Treatment Phase||33
8489713|NCT00558103|20919569|P2|COMPLETED|Randomized Treatment Phase||34
8489714|NCT00558103|20919570|P1|COMPLETED|Randomized Treatment Phase||33
8489715|NCT00558103|20919565|P6|STARTED|Randomized Treatment Phase||0
8489716|NCT00558103|20919566|P5|STARTED|Randomized Treatment Phase||38
8489717|NCT00558103|20919567|P4|STARTED|Randomized Treatment Phase||13
8489718|NCT00558103|20919568|P3|STARTED|Randomized Treatment Phase||36
8489719|NCT00558103|20919569|P2|STARTED|Randomized Treatment Phase||38
8489720|NCT00558103|20919570|P1|STARTED|Randomized Treatment Phase||38
8489721|NCT00558064|20919600|P2|NOT COMPLETED|Overall Study||5
8489722|NCT00558064|20919601|P1|NOT COMPLETED|Overall Study||5
8489723|NCT00558064|20919600|P2|COMPLETED|Overall Study||257
8489724|NCT00558064|20919601|P1|COMPLETED|Overall Study||264
8489725|NCT00558064|20919600|P2|STARTED|Overall Study||262
8489726|NCT00558064|20919601|P1|STARTED|Overall Study||269
8489727|NCT00558025|20919623|P2|NOT COMPLETED|Overall Study||3
8489728|NCT00558025|20919624|P1|NOT COMPLETED|Overall Study||4
8489729|NCT00558025|20919623|P2|COMPLETED|Overall Study||49
8489730|NCT00558025|20919624|P1|COMPLETED|Overall Study||100
8489731|NCT00558025|20919623|P2|STARTED|Overall Study||52
8489732|NCT00558025|20919624|P1|STARTED|Overall Study||104
8489733|NCT00558012|20919648|P2|NOT COMPLETED|Overall Study||18
8489734|NCT00558012|20919649|P1|NOT COMPLETED|Overall Study||25
8489735|NCT00558012|20919648|P2|COMPLETED|Overall Study||74
8489736|NCT00558012|20919649|P1|COMPLETED|Overall Study||64
8489737|NCT00558012|20919648|P2|STARTED|Overall Study||92
8489738|NCT00558012|20919649|P1|STARTED|Overall Study||89
8489739|NCT00557947|20919655|P1|NOT COMPLETED|Overall Study||0
8489740|NCT00557947|20919655|P1|COMPLETED|Overall Study||83
8489741|NCT00557947|20919655|P1|STARTED|Overall Study||83
8489742|NCT00557882|20919673|P2|NOT COMPLETED|Overall Study||0
8489743|NCT00557882|20919674|P1|NOT COMPLETED|Overall Study||5
8489744|NCT00557882|20919673|P2|COMPLETED|Overall Study||33
8489745|NCT00557882|20919674|P1|COMPLETED|Overall Study||27
8489746|NCT00557882|20919673|P2|STARTED|Overall Study||33
8489747|NCT00557882|20919674|P1|STARTED|Overall Study||32
8489748|NCT00557856|20919680|P9|NOT COMPLETED|Part 2: Exploratory Phase||24
8489749|NCT00557856|20919681|P8|NOT COMPLETED|Part 2: Exploratory Phase||0
8489750|NCT00557856|20919682|P7|NOT COMPLETED|Part 2: Exploratory Phase||0
8489751|NCT00557856|20919683|P6|NOT COMPLETED|Part 2: Exploratory Phase||0
8489752|NCT00557856|20919684|P5|NOT COMPLETED|Part 2: Exploratory Phase||0
8489753|NCT00557856|20919685|P4|NOT COMPLETED|Part 2: Exploratory Phase||0
8489754|NCT00557856|20919686|P3|NOT COMPLETED|Part 2: Exploratory Phase||0
8489755|NCT00557856|20919687|P2|NOT COMPLETED|Part 2: Exploratory Phase||0
8489756|NCT00557856|20919688|P1|NOT COMPLETED|Part 2: Exploratory Phase||0
8489757|NCT00557856|20919680|P9|COMPLETED|Part 2: Exploratory Phase||0
8489758|NCT00557856|20919681|P8|COMPLETED|Part 2: Exploratory Phase||0
8489759|NCT00557856|20919682|P7|COMPLETED|Part 2: Exploratory Phase||0
8489760|NCT00557856|20919683|P6|COMPLETED|Part 2: Exploratory Phase||0
8489761|NCT00557856|20919684|P5|COMPLETED|Part 2: Exploratory Phase||0
8489762|NCT00557856|20919685|P4|COMPLETED|Part 2: Exploratory Phase||0
8489763|NCT00557856|20919686|P3|COMPLETED|Part 2: Exploratory Phase||0
8489764|NCT00557856|20919687|P2|COMPLETED|Part 2: Exploratory Phase||0
8489765|NCT00557856|20919688|P1|COMPLETED|Part 2: Exploratory Phase||0
8489766|NCT00557856|20919680|P9|STARTED|Part 2: Exploratory Phase||24
8489767|NCT00557856|20919681|P8|STARTED|Part 2: Exploratory Phase||0
8489768|NCT00557856|20919682|P7|STARTED|Part 2: Exploratory Phase||0
8489769|NCT00557856|20919683|P6|STARTED|Part 2: Exploratory Phase||0
8489770|NCT00557856|20919684|P5|STARTED|Part 2: Exploratory Phase||0
8489771|NCT00557856|20919685|P4|STARTED|Part 2: Exploratory Phase||0
8489772|NCT00557856|20919686|P3|STARTED|Part 2: Exploratory Phase||0
8489773|NCT00557856|20919687|P2|STARTED|Part 2: Exploratory Phase||0
8489774|NCT00557856|20919688|P1|STARTED|Part 2: Exploratory Phase||0
8489775|NCT00557856|20919680|P9|NOT COMPLETED|Part 1: Dose Escalation Phase||0
8489776|NCT00557856|20919681|P8|NOT COMPLETED|Part 1: Dose Escalation Phase||6
8489777|NCT00557856|20919682|P7|NOT COMPLETED|Part 1: Dose Escalation Phase||7
8489778|NCT00557856|20919683|P6|NOT COMPLETED|Part 1: Dose Escalation Phase||8
8489779|NCT00557856|20919684|P5|NOT COMPLETED|Part 1: Dose Escalation Phase||4
8489780|NCT00557856|20919685|P4|NOT COMPLETED|Part 1: Dose Escalation Phase||3
8489781|NCT00557856|20919686|P3|NOT COMPLETED|Part 1: Dose Escalation Phase||6
8489782|NCT00557856|20919687|P2|NOT COMPLETED|Part 1: Dose Escalation Phase||5
8489783|NCT00557856|20919688|P1|NOT COMPLETED|Part 1: Dose Escalation Phase||7
8489785|NCT00557856|20919681|P8|COMPLETED|Part 1: Dose Escalation Phase||0
8489786|NCT00557856|20919682|P7|COMPLETED|Part 1: Dose Escalation Phase||0
8489787|NCT00557856|20919683|P6|COMPLETED|Part 1: Dose Escalation Phase||0
8489788|NCT00557856|20919684|P5|COMPLETED|Part 1: Dose Escalation Phase||0
8489789|NCT00557856|20919685|P4|COMPLETED|Part 1: Dose Escalation Phase||0
8489790|NCT00557856|20919686|P3|COMPLETED|Part 1: Dose Escalation Phase||0
8489791|NCT00557856|20919687|P2|COMPLETED|Part 1: Dose Escalation Phase||0
8489792|NCT00557856|20919688|P1|COMPLETED|Part 1: Dose Escalation Phase||0
8489793|NCT00557856|20919680|P9|Treated|Part 1: Dose Escalation Phase||0
8489794|NCT00557856|20919681|P8|Treated|Part 1: Dose Escalation Phase||6
8489795|NCT00557856|20919682|P7|Treated|Part 1: Dose Escalation Phase||7
8489796|NCT00557856|20919683|P6|Treated|Part 1: Dose Escalation Phase||8
8489797|NCT00557856|20919684|P5|Treated|Part 1: Dose Escalation Phase||4
8489798|NCT00557856|20919685|P4|Treated|Part 1: Dose Escalation Phase||3
8489799|NCT00557856|20919686|P3|Treated|Part 1: Dose Escalation Phase||6
8489800|NCT00557856|20919687|P2|Treated|Part 1: Dose Escalation Phase||5
8489801|NCT00557856|20919688|P1|Treated|Part 1: Dose Escalation Phase||5
8489802|NCT00557856|20919680|P9|STARTED|Part 1: Dose Escalation Phase||0
8489803|NCT00557856|20919681|P8|STARTED|Part 1: Dose Escalation Phase||6
8489804|NCT00557856|20919682|P7|STARTED|Part 1: Dose Escalation Phase||7
8489805|NCT00557856|20919683|P6|STARTED|Part 1: Dose Escalation Phase||8
8489806|NCT00557856|20919684|P5|STARTED|Part 1: Dose Escalation Phase||4
8489807|NCT00557856|20919685|P4|STARTED|Part 1: Dose Escalation Phase||3
8489808|NCT00557856|20919686|P3|STARTED|Part 1: Dose Escalation Phase||6
8489809|NCT00557856|20919687|P2|STARTED|Part 1: Dose Escalation Phase||5
8489810|NCT00557856|20919688|P1|STARTED|Part 1: Dose Escalation Phase||7
8489811|NCT00557830|20919887|P3|NOT COMPLETED|Treatment Phase||0
8489812|NCT00557830|20919888|P2|NOT COMPLETED|Treatment Phase||0
8489813|NCT00557830|20919889|P1|NOT COMPLETED|Treatment Phase||0
8489814|NCT00557830|20919887|P3|COMPLETED|Treatment Phase||2
8489815|NCT00557830|20919888|P2|COMPLETED|Treatment Phase||4
8489816|NCT00557830|20919889|P1|COMPLETED|Treatment Phase||0
8489817|NCT00557830|20919887|P3|STARTED|Treatment Phase||2
8489818|NCT00557830|20919888|P2|STARTED|Treatment Phase||4
8489819|NCT00557830|20919889|P1|STARTED|Treatment Phase||0
8489820|NCT00557830|20919887|P3|NOT COMPLETED|Screening Treatment Phase||0
8489821|NCT00557830|20919888|P2|NOT COMPLETED|Screening Treatment Phase||0
8489822|NCT00557830|20919889|P1|NOT COMPLETED|Screening Treatment Phase||6
8489823|NCT00557830|20919887|P3|COMPLETED|Screening Treatment Phase||0
8489824|NCT00557830|20919888|P2|COMPLETED|Screening Treatment Phase||0
8489825|NCT00557830|20919889|P1|COMPLETED|Screening Treatment Phase||6
8489826|NCT00557830|20919887|P3|STARTED|Screening Treatment Phase||0
8489827|NCT00557830|20919888|P2|STARTED|Screening Treatment Phase||0
8489828|NCT00557830|20919889|P1|STARTED|Screening Treatment Phase||12
8489829|NCT00557622|20919911|P2|NOT COMPLETED|12-Week Treatment Phase||1
8489830|NCT00557622|20919912|P1|NOT COMPLETED|12-Week Treatment Phase||0
8489831|NCT00557622|20919911|P2|COMPLETED|12-Week Treatment Phase||1
8489832|NCT00557622|20919912|P1|COMPLETED|12-Week Treatment Phase||1
8489833|NCT00557622|20919911|P2|STARTED|12-Week Treatment Phase||2
8489834|NCT00557622|20919912|P1|STARTED|12-Week Treatment Phase||1
8489835|NCT00557622|20919911|P2|NOT COMPLETED|4-Week Run-in Phase||0
8489836|NCT00557622|20919912|P1|NOT COMPLETED|4-Week Run-in Phase||2
8489837|NCT00557622|20919911|P2|COMPLETED|4-Week Run-in Phase||0
8489838|NCT00557622|20919912|P1|COMPLETED|4-Week Run-in Phase||3
8489839|NCT00557622|20919911|P2|STARTED|4-Week Run-in Phase||0
8489840|NCT00557622|20919912|P1|STARTED|4-Week Run-in Phase||5
8489841|NCT00557505|20919941|P9|NOT COMPLETED|Overall Study||17
8489842|NCT00557505|20919942|P8|NOT COMPLETED|Overall Study||5
8489843|NCT00557505|20919943|P7|NOT COMPLETED|Overall Study||3
8489844|NCT00557505|20919944|P6|NOT COMPLETED|Overall Study||3
8489845|NCT00557505|20919945|P5|NOT COMPLETED|Overall Study||2
8489846|NCT00557505|20919946|P4|NOT COMPLETED|Overall Study||3
8489847|NCT00557505|20919947|P3|NOT COMPLETED|Overall Study||4
8489848|NCT00557505|20919948|P2|NOT COMPLETED|Overall Study||3
8489849|NCT00557505|20919949|P1|NOT COMPLETED|Overall Study||3
8489850|NCT00557505|20919941|P9|COMPLETED|Overall Study||0
8489851|NCT00557505|20919942|P8|COMPLETED|Overall Study||0
8489852|NCT00557505|20919943|P7|COMPLETED|Overall Study||0
8489853|NCT00557505|20919944|P6|COMPLETED|Overall Study||0
8489854|NCT00557505|20919945|P5|COMPLETED|Overall Study||0
8489855|NCT00557505|20919946|P4|COMPLETED|Overall Study||0
8489856|NCT00557505|20919947|P3|COMPLETED|Overall Study||0
8489857|NCT00557505|20919948|P2|COMPLETED|Overall Study||0
8489858|NCT00557505|20919949|P1|COMPLETED|Overall Study||0
8489859|NCT00557505|20919941|P9|STARTED|Overall Study||17
8489860|NCT00557505|20919942|P8|STARTED|Overall Study||5
8489861|NCT00557505|20919943|P7|STARTED|Overall Study||3
8489862|NCT00557505|20919944|P6|STARTED|Overall Study||3
8489863|NCT00557505|20919945|P5|STARTED|Overall Study||2
8489864|NCT00557505|20919946|P4|STARTED|Overall Study||3
8489865|NCT00557505|20919947|P3|STARTED|Overall Study||4
8489866|NCT00557505|20919948|P2|STARTED|Overall Study||3
8489867|NCT00557505|20919949|P1|STARTED|Overall Study||3
8489868|NCT00557492|20920113|P1|NOT COMPLETED|Overall Study||1
8489869|NCT00557492|20920113|P1|COMPLETED|Overall Study|Evaluable for outcomes|58
8489870|NCT00557492|20920113|P1|STARTED|Overall Study||59
8489871|NCT00557466|20920131|P6|NOT COMPLETED|Overall Study||6
8489872|NCT00557466|20920132|P5|NOT COMPLETED|Overall Study||3
8489873|NCT00557466|20920133|P4|NOT COMPLETED|Overall Study||4
8489874|NCT00557466|20920134|P3|NOT COMPLETED|Overall Study||6
8489875|NCT00557466|20920135|P2|NOT COMPLETED|Overall Study||5
8489876|NCT00557466|20920136|P1|NOT COMPLETED|Overall Study||4
8489877|NCT00557466|20920131|P6|COMPLETED|Overall Study||85
8489878|NCT00557466|20920132|P5|COMPLETED|Overall Study||87
8489879|NCT00557466|20920133|P4|COMPLETED|Overall Study||92
8489880|NCT00557466|20920134|P3|COMPLETED|Overall Study||95
8489881|NCT00557466|20920135|P2|COMPLETED|Overall Study||87
8489882|NCT00557466|20920136|P1|COMPLETED|Overall Study||94
8489883|NCT00557466|20920131|P6|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
8489884|NCT00557466|20920132|P5|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
8489885|NCT00557466|20920133|P4|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
8489886|NCT00557466|20920134|P3|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
8489887|NCT00557466|20920135|P2|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
8489888|NCT00557466|20920136|P1|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
8489889|NCT00557466|20920131|P6|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
8489890|NCT00557466|20920132|P5|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
8489891|NCT00557466|20920133|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
8489892|NCT00557466|20920134|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
8489893|NCT00557466|20920135|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
8489894|NCT00557466|20920136|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
8489895|NCT00557466|20920131|P6|STARTED|Overall Study||91
8489896|NCT00557466|20920132|P5|STARTED|Overall Study||90
8489897|NCT00557466|20920133|P4|STARTED|Overall Study||96
8489898|NCT00557466|20920134|P3|STARTED|Overall Study||101
8489899|NCT00557466|20920135|P2|STARTED|Overall Study||92
8489900|NCT00557466|20920136|P1|STARTED|Overall Study||98
8489901|NCT00557440|20920189|P3|NOT COMPLETED|Treatment Period 3||0
8489902|NCT00557440|20920190|P2|NOT COMPLETED|Treatment Period 3||0
8489903|NCT00557440|20920191|P1|NOT COMPLETED|Treatment Period 3||0
8489904|NCT00557440|20920189|P3|COMPLETED|Treatment Period 3||12
8489905|NCT00557440|20920190|P2|COMPLETED|Treatment Period 3||12
8489906|NCT00557440|20920191|P1|COMPLETED|Treatment Period 3||12
8489907|NCT00557440|20920189|P3|STARTED|Treatment Period 3||12
8489908|NCT00557440|20920190|P2|STARTED|Treatment Period 3||12
8489909|NCT00557440|20920191|P1|STARTED|Treatment Period 3||12
8489910|NCT00557440|20920189|P3|NOT COMPLETED|Treatment Period 2||0
8489911|NCT00557440|20920190|P2|NOT COMPLETED|Treatment Period 2||0
8489912|NCT00557440|20920191|P1|NOT COMPLETED|Treatment Period 2||0
8489913|NCT00557440|20920189|P3|COMPLETED|Treatment Period 2||12
8489914|NCT00557440|20920190|P2|COMPLETED|Treatment Period 2||12
8489915|NCT00557440|20920191|P1|COMPLETED|Treatment Period 2||12
8489916|NCT00557440|20920189|P3|STARTED|Treatment Period 2||12
8489917|NCT00557440|20920190|P2|STARTED|Treatment Period 2||12
8489918|NCT00557440|20920191|P1|STARTED|Treatment Period 2||12
8489919|NCT00557440|20920189|P3|NOT COMPLETED|Treatment Period 1||1
8489920|NCT00557440|20920190|P2|NOT COMPLETED|Treatment Period 1||0
8489921|NCT00557440|20920191|P1|NOT COMPLETED|Treatment Period 1||0
8489922|NCT00557440|20920189|P3|COMPLETED|Treatment Period 1||12
8489923|NCT00557440|20920190|P2|COMPLETED|Treatment Period 1||12
8489924|NCT00557440|20920191|P1|COMPLETED|Treatment Period 1||12
8489925|NCT00557440|20920189|P3|STARTED|Treatment Period 1||13
8489926|NCT00557440|20920190|P2|STARTED|Treatment Period 1||12
8489927|NCT00557440|20920191|P1|STARTED|Treatment Period 1||12
8489928|NCT00557362|20920215|P4|NOT COMPLETED|Overall Study||3
8489929|NCT00557362|20920216|P3|NOT COMPLETED|Overall Study||4
8489930|NCT00557362|20920217|P2|NOT COMPLETED|Overall Study||2
8489931|NCT00557362|20920218|P1|NOT COMPLETED|Overall Study||2
8489932|NCT00557362|20920215|P4|COMPLETED|Overall Study||27
8489933|NCT00557362|20920216|P3|COMPLETED|Overall Study||26
8489934|NCT00557362|20920217|P2|COMPLETED|Overall Study||28
8489935|NCT00557362|20920218|P1|COMPLETED|Overall Study||28
8489936|NCT00557362|20920215|P4|STARTED|Overall Study||30
8489937|NCT00557362|20920216|P3|STARTED|Overall Study||30
8489938|NCT00557362|20920217|P2|STARTED|Overall Study||30
8489939|NCT00557362|20920218|P1|STARTED|Overall Study||30
8489940|NCT00557349|20920236|P2|NOT COMPLETED|Overall Study||5
8489941|NCT00557349|20920237|P1|NOT COMPLETED|Overall Study||5
8489942|NCT00557349|20920236|P2|COMPLETED|Overall Study||13
8489943|NCT00557349|20920237|P1|COMPLETED|Overall Study||17
8489944|NCT00557349|20920236|P2|STARTED|Overall Study||18
8489945|NCT00557349|20920237|P1|STARTED|Overall Study|omeprazole/bicarb|22
8489949|NCT00557310|20920250|P1|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
8489950|NCT00557310|20920250|P1|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
8489951|NCT00557310|20920250|P1|STARTED|Extension Phase (18 - 24 Months)||30
8489952|NCT00557310|20920250|P1|NOT COMPLETED|Main Study (0 - 18 Months)||5
8490211|NCT00555971|20920903|P2|NOT COMPLETED|Overall Study||1
8489953|NCT00557310|20920250|P1|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
8489954|NCT00557310|20920250|P1|STARTED|Main Study (0 - 18 Months)||35
8489955|NCT00557284|20920272|P2|NOT COMPLETED|Overall Study||0
8489956|NCT00557284|20920273|P1|NOT COMPLETED|Overall Study||0
8489957|NCT00557284|20920272|P2|COMPLETED|Overall Study||11
8489958|NCT00557284|20920273|P1|COMPLETED|Overall Study||9
8489959|NCT00557284|20920272|P2|STARTED|Overall Study||11
8489960|NCT00557284|20920273|P1|STARTED|Overall Study||9
8489961|NCT00557245|20920296|P3|NOT COMPLETED|Overall Study||12
8489962|NCT00557245|20920297|P2|NOT COMPLETED|Overall Study||12
8489963|NCT00557245|20920298|P1|NOT COMPLETED|Overall Study||12
8489964|NCT00557245|20920296|P3|COMPLETED|Overall Study||1574
8489965|NCT00557245|20920297|P2|COMPLETED|Overall Study||1571
8489966|NCT00557245|20920298|P1|COMPLETED|Overall Study||1577
8489967|NCT00557245|20920296|P3|STARTED|Overall Study||1586
8489968|NCT00557245|20920297|P2|STARTED|Overall Study||1583
8489969|NCT00557245|20920298|P1|STARTED|Overall Study||1589
8490006|NCT00557076|20920381|P2|NOT COMPLETED|Overall Study||1
8490007|NCT00557076|20920382|P1|NOT COMPLETED|Overall Study||0
8490008|NCT00557076|20920381|P2|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
8490009|NCT00557076|20920382|P1|COMPLETED|Overall Study||8
8490010|NCT00557076|20920381|P2|STARTED|Overall Study||8
8490011|NCT00557076|20920382|P1|STARTED|Overall Study||8
8490012|NCT00556998|20920390|P1|NOT COMPLETED|Voriconazole Oral||2
8490013|NCT00556998|20920390|P1|COMPLETED|Voriconazole Oral||20
8490014|NCT00556998|20920390|P1|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
8490015|NCT00556998|20920390|P1|NOT COMPLETED|Voriconazole Intravenous (IV)||5
8490016|NCT00556998|20920390|P1|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
8490017|NCT00556998|20920390|P1|Treated|Voriconazole Intravenous (IV)||26
8490018|NCT00556998|20920390|P1|STARTED|Voriconazole Intravenous (IV)||26
8490019|NCT00556972|20920410|P1|NOT COMPLETED|Overall Study||0
8490020|NCT00556972|20920410|P1|COMPLETED|Overall Study||4
8490021|NCT00556972|20920410|P1|STARTED|Overall Study||4
8490022|NCT00556946|20920417|P1|NOT COMPLETED|Overall Study||1
8490023|NCT00556946|20920417|P1|COMPLETED|Overall Study||16
8490024|NCT00556946|20920417|P1|STARTED|Overall Study||17
8490025|NCT00556933|20920425|P4|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
8490026|NCT00556933|20920426|P3|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
8490027|NCT00556933|20920427|P2|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
8490028|NCT00556933|20920428|P1|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
8490029|NCT00556933|20920425|P4|COMPLETED|CNI Withdrawal vs. Minimization||41
8490030|NCT00556933|20920426|P3|COMPLETED|CNI Withdrawal vs. Minimization||36
8490031|NCT00556933|20920427|P2|COMPLETED|CNI Withdrawal vs. Minimization||33
8490032|NCT00556933|20920428|P1|COMPLETED|CNI Withdrawal vs. Minimization||42
8490033|NCT00556933|20920425|P4|STARTED|CNI Withdrawal vs. Minimization||43
8490034|NCT00556933|20920426|P3|STARTED|CNI Withdrawal vs. Minimization||39
8490035|NCT00556933|20920427|P2|STARTED|CNI Withdrawal vs. Minimization||37
8490036|NCT00556933|20920428|P1|STARTED|CNI Withdrawal vs. Minimization||43
8490037|NCT00556933|20920425|P4|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
8490038|NCT00556933|20920426|P3|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
8490039|NCT00556933|20920427|P2|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
8490040|NCT00556933|20920428|P1|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
8490041|NCT00556933|20920425|P4|COMPLETED|Single vs. Divided-dose rATG Induction||43
8490042|NCT00556933|20920426|P3|COMPLETED|Single vs. Divided-dose rATG Induction||39
8490043|NCT00556933|20920427|P2|COMPLETED|Single vs. Divided-dose rATG Induction||37
8490044|NCT00556933|20920428|P1|COMPLETED|Single vs. Divided-dose rATG Induction||43
8490045|NCT00556933|20920425|P4|STARTED|Single vs. Divided-dose rATG Induction||45
8490046|NCT00556933|20920426|P3|STARTED|Single vs. Divided-dose rATG Induction||45
8490047|NCT00556933|20920427|P2|STARTED|Single vs. Divided-dose rATG Induction||45
8490048|NCT00556933|20920428|P1|STARTED|Single vs. Divided-dose rATG Induction||45
8490049|NCT00556894|20920485|P3|NOT COMPLETED|Overall Study||19
8490050|NCT00556894|20920486|P2|NOT COMPLETED|Overall Study||19
8490051|NCT00556894|20920487|P1|NOT COMPLETED|Overall Study||16
8490052|NCT00556894|20920485|P3|COMPLETED|Overall Study||65
8490053|NCT00556894|20920486|P2|COMPLETED|Overall Study||68
8490054|NCT00556894|20920487|P1|COMPLETED|Overall Study||66
8490055|NCT00556894|20920485|P3|STARTED|Overall Study||84
8490056|NCT00556894|20920486|P2|STARTED|Overall Study||87
8490057|NCT00556894|20920487|P1|STARTED|Overall Study||82
8490058|NCT00556842|20920497|P2|NOT COMPLETED|Overall Study||23
8490059|NCT00556842|20920498|P1|NOT COMPLETED|Overall Study||31
8490060|NCT00556842|20920497|P2|COMPLETED|Overall Study||723
8490061|NCT00556842|20920498|P1|COMPLETED|Overall Study||718
8490062|NCT00556842|20920497|P2|STARTED|Overall Study||746
8490063|NCT00556842|20920498|P1|STARTED|Overall Study||749
8490064|NCT00556712|20920516|P2|NOT COMPLETED|Overall Study||438
8490065|NCT00556712|20920517|P1|NOT COMPLETED|Overall Study||451
8490066|NCT00556712|20920516|P2|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
8490067|NCT00556712|20920517|P1|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
8490068|NCT00556712|20920516|P2|STARTED|Overall Study||438
8490069|NCT00556712|20920517|P1|STARTED|Overall Study||451
8490070|NCT00556673|20920595|P2|NOT COMPLETED|Overall Study||2
8490071|NCT00556673|20920596|P1|NOT COMPLETED|Overall Study||3
8490072|NCT00556673|20920595|P2|COMPLETED|Overall Study||13
8490073|NCT00556673|20920596|P1|COMPLETED|Overall Study||13
8490074|NCT00556673|20920595|P2|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
8490075|NCT00556673|20920596|P1|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
8490076|NCT00556673|20920595|P2|STARTED|Overall Study||15
8490077|NCT00556673|20920596|P1|STARTED|Overall Study||16
8490078|NCT00556543|20920632|P1|NOT COMPLETED|Overall Study||0
8490079|NCT00556543|20920632|P1|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
8490080|NCT00556543|20920632|P1|STARTED|Overall Study||10
8490081|NCT00556504|20920650|P2|NOT COMPLETED|Overall Study||9
8490082|NCT00556504|20920651|P1|NOT COMPLETED|Overall Study||8
8490083|NCT00556504|20920650|P2|COMPLETED|Overall Study||33
8490084|NCT00556504|20920651|P1|COMPLETED|Overall Study||34
8490085|NCT00556504|20920650|P2|Safety Population|Overall Study||42
8490086|NCT00556504|20920651|P1|Safety Population|Overall Study||41
8490087|NCT00556504|20920650|P2|Intend-to Treat Population|Overall Study||42
8490088|NCT00556504|20920651|P1|Intend-to Treat Population|Overall Study||42
8490089|NCT00556504|20920650|P2|STARTED|Overall Study||42
8490090|NCT00556504|20920651|P1|STARTED|Overall Study||42
8490091|NCT00556491|20920671|P2|NOT COMPLETED|Overall Study||1
8490092|NCT00556491|20920672|P1|NOT COMPLETED|Overall Study||1
8490093|NCT00556491|20920671|P2|COMPLETED|Overall Study||19
8490094|NCT00556491|20920672|P1|COMPLETED|Overall Study||19
8490095|NCT00556491|20920671|P2|STARTED|Overall Study||20
8490096|NCT00556491|20920672|P1|STARTED|Overall Study|January 2008|20
8490097|NCT00556478|20920690|P2|NOT COMPLETED|Open-Label Phase||10
8490098|NCT00556478|20920691|P1|NOT COMPLETED|Open-Label Phase||14
8490099|NCT00556478|20920690|P2|COMPLETED|Open-Label Phase||67
8490100|NCT00556478|20920691|P1|COMPLETED|Open-Label Phase||132
8490101|NCT00556478|20920690|P2|Treated in Open-label|Open-Label Phase||71
8490102|NCT00556478|20920691|P1|Treated in Open-label|Open-Label Phase||142
8490103|NCT00556478|20920690|P2|STARTED|Open-Label Phase||77
8490104|NCT00556478|20920691|P1|STARTED|Open-Label Phase||146
8490105|NCT00556478|20920690|P2|NOT COMPLETED|Double-blind Phase||8
8490106|NCT00556478|20920691|P1|NOT COMPLETED|Double-blind Phase||21
8490107|NCT00556478|20920690|P2|COMPLETED|Double-blind Phase||77
8490108|NCT00556478|20920691|P1|COMPLETED|Double-blind Phase||150
8490109|NCT00556478|20920690|P2|ITT|Double-blind Phase||82
8490110|NCT00556478|20920691|P1|ITT|Double-blind Phase||167
8490111|NCT00556478|20920690|P2|STARTED|Double-blind Phase||85
8490112|NCT00556478|20920691|P1|STARTED|Double-blind Phase||171
8490113|NCT00556452|20920719|P3|NOT COMPLETED|Overall Study||0
8490114|NCT00556452|20920720|P2|NOT COMPLETED|Overall Study||0
8490115|NCT00556452|20920721|P1|NOT COMPLETED|Overall Study||0
8490116|NCT00556452|20920719|P3|COMPLETED|Overall Study||19
8490117|NCT00556452|20920720|P2|COMPLETED|Overall Study||21
8490118|NCT00556452|20920721|P1|COMPLETED|Overall Study||6
8490119|NCT00556452|20920719|P3|STARTED|Overall Study||19
8490120|NCT00556452|20920720|P2|STARTED|Overall Study||21
8490121|NCT00556452|20920721|P1|STARTED|Overall Study||6
8490122|NCT00556439|20920732|P4|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
8490123|NCT00556439|20920733|P3|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
8490124|NCT00556439|20920734|P2|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
8490125|NCT00556439|20920735|P1|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
8490126|NCT00556439|20920732|P4|COMPLETED|After Week 12 (Randomized Study Period)||14
8490127|NCT00556439|20920733|P3|COMPLETED|After Week 12 (Randomized Study Period)||11
8490128|NCT00556439|20920734|P2|COMPLETED|After Week 12 (Randomized Study Period)||17
8490129|NCT00556439|20920735|P1|COMPLETED|After Week 12 (Randomized Study Period)||17
8490130|NCT00556439|20920732|P4|STARTED|After Week 12 (Randomized Study Period)||15
8490131|NCT00556439|20920733|P3|STARTED|After Week 12 (Randomized Study Period)||11
8490132|NCT00556439|20920734|P2|STARTED|After Week 12 (Randomized Study Period)||21
8490133|NCT00556439|20920735|P1|STARTED|After Week 12 (Randomized Study Period)||20
8490134|NCT00556439|20920732|P4|NOT COMPLETED|Study Entry to Week 12||0
8490135|NCT00556439|20920733|P3|NOT COMPLETED|Study Entry to Week 12||8
8490136|NCT00556439|20920734|P2|NOT COMPLETED|Study Entry to Week 12||0
8490137|NCT00556439|20920735|P1|NOT COMPLETED|Study Entry to Week 12||8
8490138|NCT00556439|20920732|P4|COMPLETED|Study Entry to Week 12||0
8490139|NCT00556439|20920733|P3|COMPLETED|Study Entry to Week 12||26
8490140|NCT00556439|20920734|P2|COMPLETED|Study Entry to Week 12||0
8490141|NCT00556439|20920735|P1|COMPLETED|Study Entry to Week 12||41
8490142|NCT00556439|20920732|P4|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
8490143|NCT00556439|20920733|P3|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
8490144|NCT00556439|20920734|P2|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
8490145|NCT00556439|20920735|P1|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
8490146|NCT00556426|20920745|P1|NOT COMPLETED|Overall Study||9
8490147|NCT00556426|20920745|P1|COMPLETED|Overall Study||91
8490148|NCT00556426|20920745|P1|STARTED|Overall Study||100
8490149|NCT00556400|20920755|P2|NOT COMPLETED|Overall Study||0
8490150|NCT00556400|20920756|P1|NOT COMPLETED|Overall Study||0
8490151|NCT00556400|20920755|P2|COMPLETED|Overall Study||0
8490152|NCT00556400|20920756|P1|COMPLETED|Overall Study||1
8490153|NCT00556400|20920755|P2|STARTED|Overall Study||0
8490154|NCT00556400|20920756|P1|STARTED|Overall Study||1
8490163|NCT00556322|20920788|P2|NOT COMPLETED|Overall Study||203
8490164|NCT00556322|20920789|P1|NOT COMPLETED|Overall Study||221
8490165|NCT00556322|20920788|P2|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
8490166|NCT00556322|20920789|P1|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
8490167|NCT00556322|20920788|P2|STARTED|Overall Study||203
8490168|NCT00556322|20920789|P1|STARTED|Overall Study||221
8490169|NCT00556166|20920837|P1|NOT COMPLETED|Overall Study||1
8490170|NCT00556166|20920837|P1|COMPLETED|Overall Study||3
8490171|NCT00556166|20920837|P1|STARTED|Overall Study||4
8490172|NCT00556140|20920842|P1|NOT COMPLETED|Overall Study||3
8490173|NCT00556140|20920842|P1|COMPLETED|Overall Study||13
8490174|NCT00556140|20920842|P1|STARTED|Overall Study||16
8490175|NCT00556075|20920850|P3|NOT COMPLETED|Overall Study||8
8490176|NCT00556075|20920851|P2|NOT COMPLETED|Overall Study||9
8490177|NCT00556075|20920852|P1|NOT COMPLETED|Overall Study||13
8490178|NCT00556075|20920850|P3|COMPLETED|Overall Study||15
8490179|NCT00556075|20920851|P2|COMPLETED|Overall Study||13
8490180|NCT00556075|20920852|P1|COMPLETED|Overall Study||9
8490181|NCT00556075|20920850|P3|STARTED|Overall Study||23
8490182|NCT00556075|20920851|P2|STARTED|Overall Study||22
8490183|NCT00556075|20920852|P1|STARTED|Overall Study||22
8490184|NCT00556049|20920875|P1|NOT COMPLETED|Overall Study||0
8490185|NCT00556049|20920875|P1|COMPLETED|Overall Study||72
8490186|NCT00556049|20920875|P1|STARTED|Overall Study||72
8490187|NCT00555997|20920882|P4|NOT COMPLETED|Phase 2 SPCD||3
8490188|NCT00555997|20920883|P3|NOT COMPLETED|Phase 2 SPCD||7
8490189|NCT00555997|20920884|P2|NOT COMPLETED|Phase 2 SPCD||0
8490190|NCT00555997|20920885|P1|NOT COMPLETED|Phase 2 SPCD||0
8490191|NCT00555997|20920882|P4|COMPLETED|Phase 2 SPCD||22
8490192|NCT00555997|20920883|P3|COMPLETED|Phase 2 SPCD||31
8490193|NCT00555997|20920884|P2|COMPLETED|Phase 2 SPCD||0
8490194|NCT00555997|20920885|P1|COMPLETED|Phase 2 SPCD||0
8490195|NCT00555997|20920882|P4|STARTED|Phase 2 SPCD||25
8490196|NCT00555997|20920883|P3|STARTED|Phase 2 SPCD||38
8490197|NCT00555997|20920884|P2|STARTED|Phase 2 SPCD||0
8490198|NCT00555997|20920885|P1|STARTED|Phase 2 SPCD||0
8490199|NCT00555997|20920882|P4|NOT COMPLETED|Phase 1 SPCD||0
8490200|NCT00555997|20920883|P3|NOT COMPLETED|Phase 1 SPCD||0
8490201|NCT00555997|20920884|P2|NOT COMPLETED|Phase 1 SPCD||15
8490202|NCT00555997|20920885|P1|NOT COMPLETED|Phase 1 SPCD||12
8490203|NCT00555997|20920882|P4|COMPLETED|Phase 1 SPCD||0
8490204|NCT00555997|20920883|P3|COMPLETED|Phase 1 SPCD||0
8490205|NCT00555997|20920884|P2|COMPLETED|Phase 1 SPCD||76
8490206|NCT00555997|20920885|P1|COMPLETED|Phase 1 SPCD||17
8490207|NCT00555997|20920882|P4|STARTED|Phase 1 SPCD||0
8490208|NCT00555997|20920883|P3|STARTED|Phase 1 SPCD||0
8490209|NCT00555997|20920884|P2|STARTED|Phase 1 SPCD||91
8490210|NCT00555997|20920885|P1|STARTED|Phase 1 SPCD||29
8490212|NCT00555971|20920904|P1|NOT COMPLETED|Overall Study||1
8490213|NCT00555971|20920903|P2|COMPLETED|Overall Study||7
8490214|NCT00555971|20920904|P1|COMPLETED|Overall Study||4
8490215|NCT00555971|20920903|P2|STARTED|Overall Study||8
8490216|NCT00555971|20920904|P1|STARTED|Overall Study||5
8490217|NCT00555906|20920915|P5|NOT COMPLETED|Phase 2||32
8490218|NCT00555906|20920916|P4|NOT COMPLETED|Phase 2||0
8490219|NCT00555906|20920917|P3|NOT COMPLETED|Phase 2||0
8490220|NCT00555906|20920918|P2|NOT COMPLETED|Phase 2||0
8490221|NCT00555906|20920919|P1|NOT COMPLETED|Phase 2||0
8490222|NCT00555906|20920915|P5|COMPLETED|Phase 2||0
8490223|NCT00555906|20920916|P4|COMPLETED|Phase 2||0
8490224|NCT00555906|20920917|P3|COMPLETED|Phase 2||0
8490225|NCT00555906|20920918|P2|COMPLETED|Phase 2||0
8490226|NCT00555906|20920919|P1|COMPLETED|Phase 2||0
8490227|NCT00555906|20920915|P5|Treated|Phase 2||30
8490228|NCT00555906|20920916|P4|Treated|Phase 2||0
8490229|NCT00555906|20920917|P3|Treated|Phase 2||0
8490230|NCT00555906|20920918|P2|Treated|Phase 2||0
8490231|NCT00555906|20920919|P1|Treated|Phase 2||0
8490232|NCT00555906|20920915|P5|STARTED|Phase 2||32
8490233|NCT00555906|20920916|P4|STARTED|Phase 2||0
8490234|NCT00555906|20920917|P3|STARTED|Phase 2||0
8490235|NCT00555906|20920918|P2|STARTED|Phase 2||0
8490236|NCT00555906|20920919|P1|STARTED|Phase 2||0
8490237|NCT00555906|20920915|P5|NOT COMPLETED|Phase 1||0
8490238|NCT00555906|20920916|P4|NOT COMPLETED|Phase 1||5
8490239|NCT00555906|20920917|P3|NOT COMPLETED|Phase 1||7
8490240|NCT00555906|20920918|P2|NOT COMPLETED|Phase 1||6
8490241|NCT00555906|20920919|P1|NOT COMPLETED|Phase 1||3
8490242|NCT00555906|20920915|P5|COMPLETED|Phase 1||0
8490243|NCT00555906|20920916|P4|COMPLETED|Phase 1||0
8490244|NCT00555906|20920917|P3|COMPLETED|Phase 1||0
8490245|NCT00555906|20920918|P2|COMPLETED|Phase 1||0
8490246|NCT00555906|20920919|P1|COMPLETED|Phase 1||0
8490247|NCT00555906|20920915|P5|STARTED|Phase 1||0
8490248|NCT00555906|20920916|P4|STARTED|Phase 1||5
8490249|NCT00555906|20920917|P3|STARTED|Phase 1||7
8490250|NCT00555906|20920918|P2|STARTED|Phase 1||6
8490251|NCT00555906|20920919|P1|STARTED|Phase 1||3
8490252|NCT00555893|20920951|P2|NOT COMPLETED|Overall Study||0
8490253|NCT00555893|20920952|P1|NOT COMPLETED|Overall Study||0
8490254|NCT00555893|20920951|P2|COMPLETED|Overall Study||63
8490255|NCT00555893|20920952|P1|COMPLETED|Overall Study||130
8490256|NCT00555893|20920951|P2|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
8490257|NCT00555893|20920952|P1|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
8490258|NCT00555893|20920951|P2|STARTED|Overall Study||63
8490259|NCT00555893|20920952|P1|STARTED|Overall Study||130
8490278|NCT00555750|20921008|P2|NOT COMPLETED|Overall Study||0
8490279|NCT00555750|20921009|P1|NOT COMPLETED|Overall Study||0
8490280|NCT00555750|20921008|P2|COMPLETED|Overall Study||10
8490281|NCT00555750|20921009|P1|COMPLETED|Overall Study||10
8490282|NCT00555750|20921008|P2|STARTED|Overall Study||10
8490283|NCT00555750|20921009|P1|STARTED|Overall Study||10
8490284|NCT00555672|20921041|P2|NOT COMPLETED|Overall Study||10
8490285|NCT00555672|20921042|P1|NOT COMPLETED|Overall Study||24
8490286|NCT00555672|20921041|P2|COMPLETED|Overall Study||0
8490287|NCT00555672|20921042|P1|COMPLETED|Overall Study||0
8490288|NCT00555672|20921041|P2|STARTED|Overall Study||10
8490289|NCT00555672|20921042|P1|STARTED|Overall Study||24
8490290|NCT00555620|20921067|P6|NOT COMPLETED|Overall Study||22
8490291|NCT00555620|20921068|P5|NOT COMPLETED|Overall Study||3
8490292|NCT00555620|20921069|P4|NOT COMPLETED|Overall Study||23
8490293|NCT00555620|20921070|P3|NOT COMPLETED|Overall Study||15
8490294|NCT00555620|20921071|P2|NOT COMPLETED|Overall Study||7
8490295|NCT00555620|20921072|P1|NOT COMPLETED|Overall Study||6
8490296|NCT00555620|20921067|P6|COMPLETED|Overall Study||0
8490297|NCT00555620|20921068|P5|COMPLETED|Overall Study||0
8490298|NCT00555620|20921069|P4|COMPLETED|Overall Study||0
8490299|NCT00555620|20921070|P3|COMPLETED|Overall Study||0
8490300|NCT00555620|20921071|P2|COMPLETED|Overall Study||0
8490301|NCT00555620|20921072|P1|COMPLETED|Overall Study||0
8490302|NCT00555620|20921067|P6|STARTED|Overall Study||22
8490303|NCT00555620|20921068|P5|STARTED|Overall Study||3
8490304|NCT00555620|20921069|P4|STARTED|Overall Study||23
8490305|NCT00555620|20921070|P3|STARTED|Overall Study||15
8490306|NCT00555620|20921071|P2|STARTED|Overall Study||7
8490307|NCT00555620|20921072|P1|STARTED|Overall Study||6
8490308|NCT00555581|20921184|P1|NOT COMPLETED|Overall Study||6
8490309|NCT00555581|20921184|P1|COMPLETED|Overall Study||24
8490310|NCT00555581|20921184|P1|STARTED|Overall Study||30
8490311|NCT00555568|20921196|P3|NOT COMPLETED|Overall Study||16
8490312|NCT00555568|20921197|P2|NOT COMPLETED|Overall Study||16
8490313|NCT00555568|20921198|P1|NOT COMPLETED|Overall Study||26
8490314|NCT00555568|20921196|P3|COMPLETED|Overall Study||84
8490315|NCT00555568|20921197|P2|COMPLETED|Overall Study||82
8490316|NCT00555568|20921198|P1|COMPLETED|Overall Study||74
8490317|NCT00555568|20921196|P3|STARTED|Overall Study||100
8490318|NCT00555568|20921197|P2|STARTED|Overall Study||98
8490319|NCT00555568|20921198|P1|STARTED|Overall Study||100
8490320|NCT00555477|20921220|P2|NOT COMPLETED|Overall Study||13
8490321|NCT00555477|20921221|P1|NOT COMPLETED|Overall Study||2
8490322|NCT00555477|20921220|P2|COMPLETED|Overall Study||32
8490323|NCT00555477|20921221|P1|COMPLETED|Overall Study||12
8490324|NCT00555477|20921220|P2|STARTED|Overall Study||45
8490325|NCT00555477|20921221|P1|STARTED|Overall Study||14
8490326|NCT00555464|20921228|P2|NOT COMPLETED|Overall Study||3
8490327|NCT00555464|20921229|P1|NOT COMPLETED|Overall Study||0
8490328|NCT00555464|20921228|P2|COMPLETED|Overall Study||1
8490329|NCT00555464|20921229|P1|COMPLETED|Overall Study||4
8490330|NCT00555464|20921228|P2|STARTED|Overall Study||4
8490331|NCT00555464|20921229|P1|STARTED|Overall Study||4
8490332|NCT00555438|20921237|P1|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
8490333|NCT00555438|20921237|P1|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
8490334|NCT00555438|20921237|P1|STARTED|Between 10 Days and 30 Days Postoperativ||438
8490335|NCT00555438|20921237|P1|NOT COMPLETED|10 Days Post-operative||4
8490336|NCT00555438|20921237|P1|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
8490337|NCT00555438|20921237|P1|STARTED|10 Days Post-operative||442
8490338|NCT00555425|20921247|P2|NOT COMPLETED|Overall Study||19
8490339|NCT00555425|20921248|P1|NOT COMPLETED|Overall Study||51
8490340|NCT00555425|20921247|P2|COMPLETED|Overall Study||37
8490341|NCT00555425|20921248|P1|COMPLETED|Overall Study||6
8490342|NCT00555425|20921247|P2|STARTED|Overall Study||56
8490343|NCT00555425|20921248|P1|STARTED|Overall Study||57
8490344|NCT00555360|20921268|P2|NOT COMPLETED|Overall Study||36
8490345|NCT00555360|20921269|P1|NOT COMPLETED|Overall Study||27
8490346|NCT00555360|20921268|P2|COMPLETED|Overall Study||153
8490347|NCT00555360|20921269|P1|COMPLETED|Overall Study||156
8490348|NCT00555360|20921268|P2|STARTED|Overall Study||189
8490349|NCT00555360|20921269|P1|STARTED|Overall Study||183
8490350|NCT00555321|20921284|P5|NOT COMPLETED|Long-term Extension Phase||26
8490351|NCT00555321|20921285|P4|NOT COMPLETED|Long-term Extension Phase||38
8490352|NCT00555321|20921286|P3|NOT COMPLETED|Long-term Extension Phase||24
8490353|NCT00555321|20921287|P2|NOT COMPLETED|Long-term Extension Phase||27
8490354|NCT00555321|20921288|P1|NOT COMPLETED|Long-term Extension Phase||30
8490355|NCT00555321|20921284|P5|COMPLETED|Long-term Extension Phase||0
8490356|NCT00555321|20921285|P4|COMPLETED|Long-term Extension Phase||0
8490357|NCT00555321|20921286|P3|COMPLETED|Long-term Extension Phase||0
8490358|NCT00555321|20921287|P2|COMPLETED|Long-term Extension Phase||0
8490359|NCT00555321|20921288|P1|COMPLETED|Long-term Extension Phase||0
8490360|NCT00555321|20921284|P5|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
8490361|NCT00555321|20921285|P4|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
8490362|NCT00555321|20921286|P3|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
8490363|NCT00555321|20921287|P2|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
8490364|NCT00555321|20921288|P1|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
8490365|NCT00555321|20921284|P5|NOT COMPLETED|Treatment Phase up to 12-months||22
8490366|NCT00555321|20921285|P4|NOT COMPLETED|Treatment Phase up to 12-months||7
8490367|NCT00555321|20921286|P3|NOT COMPLETED|Treatment Phase up to 12-months||24
8490368|NCT00555321|20921287|P2|NOT COMPLETED|Treatment Phase up to 12-months||22
8490369|NCT00555321|20921288|P1|NOT COMPLETED|Treatment Phase up to 12-months||21
8490370|NCT00555321|20921284|P5|COMPLETED|Treatment Phase up to 12-months||32
8490371|NCT00555321|20921285|P4|COMPLETED|Treatment Phase up to 12-months||46
8490372|NCT00555321|20921286|P3|COMPLETED|Treatment Phase up to 12-months||26
8490373|NCT00555321|20921287|P2|COMPLETED|Treatment Phase up to 12-months||29
8490374|NCT00555321|20921288|P1|COMPLETED|Treatment Phase up to 12-months||31
8490375|NCT00555321|20921284|P5|Received Transplant and Treated|Treatment Phase up to 12-months||50
8490376|NCT00555321|20921285|P4|Received Transplant and Treated|Treatment Phase up to 12-months||53
8490377|NCT00555321|20921286|P3|Received Transplant and Treated|Treatment Phase up to 12-months||49
8490378|NCT00555321|20921287|P2|Received Transplant and Treated|Treatment Phase up to 12-months||48
8490379|NCT00555321|20921288|P1|Received Transplant and Treated|Treatment Phase up to 12-months||50
8490380|NCT00555321|20921284|P5|STARTED|Treatment Phase up to 12-months||54
8490381|NCT00555321|20921285|P4|STARTED|Treatment Phase up to 12-months||53
8490382|NCT00555321|20921286|P3|STARTED|Treatment Phase up to 12-months||50
8490383|NCT00555321|20921287|P2|STARTED|Treatment Phase up to 12-months||51
8490384|NCT00555321|20921288|P1|STARTED|Treatment Phase up to 12-months||52
8490385|NCT00555217|20921592|P2|NOT COMPLETED|Overall Study||68
8490386|NCT00555217|20921593|P1|NOT COMPLETED|Overall Study||75
8490387|NCT00555217|20921592|P2|COMPLETED|Overall Study||656
8490388|NCT00555217|20921593|P1|COMPLETED|Overall Study||649
8490389|NCT00555217|20921592|P2|STARTED|Overall Study||724
8490390|NCT00555217|20921593|P1|STARTED|Overall Study||724
8490391|NCT00555152|20921605|P4|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8490392|NCT00555152|20921606|P3|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8490393|NCT00555152|20921607|P2|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8490394|NCT00555152|20921608|P1|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8490395|NCT00555152|20921605|P4|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
8490396|NCT00555152|20921606|P3|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8490397|NCT00555152|20921607|P2|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
8490398|NCT00555152|20921608|P1|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8490399|NCT00555152|20921605|P4|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
8490400|NCT00555152|20921606|P3|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
8490401|NCT00555152|20921607|P2|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
8490402|NCT00555152|20921608|P1|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
8490403|NCT00555152|20921605|P4|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8490404|NCT00555152|20921606|P3|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8490405|NCT00555152|20921607|P2|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8490406|NCT00555152|20921608|P1|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8490407|NCT00555152|20921605|P4|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
8490408|NCT00555152|20921606|P3|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8490409|NCT00555152|20921607|P2|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
8490410|NCT00555152|20921608|P1|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
8490411|NCT00555152|20921605|P4|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
8490412|NCT00555152|20921606|P3|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
8490413|NCT00555152|20921607|P2|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
8490414|NCT00555152|20921608|P1|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
8490415|NCT00555061|20921630|P1|NOT COMPLETED|Overall Study||9
8490416|NCT00555061|20921630|P1|COMPLETED|Overall Study||78
8490417|NCT00555061|20921630|P1|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
8490418|NCT00555048|20921637|P1|NOT COMPLETED|Overall Study||0
8490419|NCT00555048|20921637|P1|COMPLETED|Overall Study||1
8490420|NCT00555048|20921637|P1|STARTED|Overall Study||1
8490421|NCT00555009|20921649|P2|NOT COMPLETED|Overall Study||6
8490422|NCT00555009|20921650|P1|NOT COMPLETED|Overall Study||2
8490423|NCT00555009|20921649|P2|COMPLETED|Overall Study||0
8490424|NCT00555009|20921650|P1|COMPLETED|Overall Study||2
8490425|NCT00555009|20921649|P2|STARTED|Overall Study||6
8490426|NCT00555009|20921650|P1|STARTED|Overall Study||4
8490427|NCT00554996|20921672|P1|NOT COMPLETED|Overall Study||0
8490428|NCT00554996|20921672|P1|COMPLETED|Overall Study||10
8490429|NCT00554996|20921672|P1|STARTED|Overall Study||10
8490430|NCT00554970|20921680|P4|NOT COMPLETED|Period 2||0
8490431|NCT00554970|20921681|P3|NOT COMPLETED|Period 2||1
8490432|NCT00554970|20921682|P2|NOT COMPLETED|Period 2||0
8490433|NCT00554970|20921683|P1|NOT COMPLETED|Period 2||0
8490434|NCT00554970|20921680|P4|COMPLETED|Period 2||8
8490435|NCT00554970|20921681|P3|COMPLETED|Period 2||7
8490436|NCT00554970|20921682|P2|COMPLETED|Period 2||8
8490437|NCT00554970|20921683|P1|COMPLETED|Period 2||7
8490438|NCT00554970|20921680|P4|STARTED|Period 2||8
8490439|NCT00554970|20921681|P3|STARTED|Period 2||8
8490440|NCT00554970|20921682|P2|STARTED|Period 2||8
8490441|NCT00554970|20921683|P1|STARTED|Period 2||7
8490442|NCT00554970|20921680|P4|NOT COMPLETED|Period 1||0
8490443|NCT00554970|20921681|P3|NOT COMPLETED|Period 1||0
8490444|NCT00554970|20921682|P2|NOT COMPLETED|Period 1||0
8490445|NCT00554970|20921683|P1|NOT COMPLETED|Period 1||1
8490446|NCT00554970|20921680|P4|COMPLETED|Period 1||8
8490447|NCT00554970|20921681|P3|COMPLETED|Period 1||8
8490448|NCT00554970|20921682|P2|COMPLETED|Period 1||8
8490449|NCT00554970|20921683|P1|COMPLETED|Period 1||7
8490450|NCT00554970|20921680|P4|STARTED|Period 1||8
8490451|NCT00554970|20921681|P3|STARTED|Period 1||8
8490452|NCT00554970|20921682|P2|STARTED|Period 1||8
8490453|NCT00554970|20921683|P1|STARTED|Period 1||8
8490454|NCT00554853|20921715|P2|NOT COMPLETED|Crossover Arm (3 Months)||2
8490455|NCT00554853|20921716|P1|NOT COMPLETED|Crossover Arm (3 Months)||3
8490456|NCT00554853|20921715|P2|COMPLETED|Crossover Arm (3 Months)||55
8490457|NCT00554853|20921716|P1|COMPLETED|Crossover Arm (3 Months)||53
8490458|NCT00554853|20921715|P2|STARTED|Crossover Arm (3 Months)||57
8490459|NCT00554853|20921716|P1|STARTED|Crossover Arm (3 Months)||56
8490460|NCT00554853|20921715|P2|NOT COMPLETED|Washout Period (2 Weeks)||7
8490461|NCT00554853|20921716|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
8490462|NCT00554853|20921715|P2|COMPLETED|Washout Period (2 Weeks)||57
8490463|NCT00554853|20921716|P1|COMPLETED|Washout Period (2 Weeks)||56
8490464|NCT00554853|20921715|P2|STARTED|Washout Period (2 Weeks)||64
8490465|NCT00554853|20921716|P1|STARTED|Washout Period (2 Weeks)||56
8490466|NCT00554853|20921715|P2|NOT COMPLETED|First Arm of Study||7
8490467|NCT00554853|20921716|P1|NOT COMPLETED|First Arm of Study||16
8490468|NCT00554853|20921715|P2|COMPLETED|First Arm of Study||64
8490469|NCT00554853|20921716|P1|COMPLETED|First Arm of Study||56
8490470|NCT00554853|20921715|P2|STARTED|First Arm of Study||71
8490471|NCT00554853|20921716|P1|STARTED|First Arm of Study||72
8490472|NCT00554840|20921730|P2|NOT COMPLETED|Overall Study||1
8490473|NCT00554840|20921731|P1|NOT COMPLETED|Overall Study||0
8490474|NCT00554840|20921730|P2|COMPLETED|Overall Study||4
8490475|NCT00554840|20921731|P1|COMPLETED|Overall Study||4
8490476|NCT00554840|20921730|P2|STARTED|Overall Study||5
8490477|NCT00554840|20921731|P1|STARTED|Overall Study||4
8490478|NCT00554801|20921749|P2|NOT COMPLETED|Overall Study||0
8490479|NCT00554801|20921750|P1|NOT COMPLETED|Overall Study||19
8490480|NCT00554801|20921749|P2|COMPLETED|Overall Study||29
8490481|NCT00554801|20921750|P1|COMPLETED|Overall Study||36
8490482|NCT00554801|20921749|P2|STARTED|Overall Study||29
8490483|NCT00554801|20921750|P1|STARTED|Overall Study||55
8490493|NCT00554749|20921775|P1|NOT COMPLETED|Overall Study||0
8490494|NCT00554749|20921775|P1|COMPLETED|Overall Study||7
8490495|NCT00554749|20921775|P1|STARTED|Overall Study||7
8490496|NCT00554671|20921782|P2|NOT COMPLETED|Overall Study||16
8490497|NCT00554671|20921783|P1|NOT COMPLETED|Overall Study||20
8490498|NCT00554671|20921782|P2|COMPLETED|Overall Study||117
8490499|NCT00554671|20921783|P1|COMPLETED|Overall Study||97
8490500|NCT00554671|20921782|P2|STARTED|Overall Study||133
8490501|NCT00554671|20921783|P1|STARTED|Overall Study||117
8490502|NCT00554619|20921795|P1|NOT COMPLETED|Overall Study||3
8490503|NCT00554619|20921795|P1|COMPLETED|Overall Study||18
8490504|NCT00554619|20921795|P1|STARTED|Overall Study||21
8490509|NCT00554463|20921836|P1|NOT COMPLETED|Overall Study||0
8490510|NCT00554463|20921836|P1|COMPLETED|Overall Study||5
8490511|NCT00554463|20921836|P1|STARTED|Overall Study||5
8490512|NCT00554372|20921848|P2|NOT COMPLETED|Overall Study||0
8490513|NCT00554372|20921849|P1|NOT COMPLETED|Overall Study||0
8490514|NCT00554372|20921848|P2|COMPLETED|Overall Study||16
8490515|NCT00554372|20921849|P1|COMPLETED|Overall Study||14
8490516|NCT00554372|20921848|P2|STARTED|Overall Study||16
8490517|NCT00554372|20921849|P1|STARTED|Overall Study||14
8490518|NCT00554294|20921863|P2|NOT COMPLETED|Overall Study||80
8490519|NCT00554294|20921864|P1|NOT COMPLETED|Overall Study||160
8490520|NCT00554294|20921863|P2|COMPLETED|Overall Study||1641
8490521|NCT00554294|20921864|P1|COMPLETED|Overall Study||1309
8490522|NCT00554294|20921863|P2|STARTED|Overall Study||1721
8490523|NCT00554294|20921864|P1|STARTED|Overall Study||1469
8490524|NCT00554229|20921870|P2|NOT COMPLETED|Overall Study||225
8490525|NCT00554229|20921871|P1|NOT COMPLETED|Overall Study||226
8490526|NCT00554229|20921870|P2|COMPLETED|Overall Study||70
8490527|NCT00554229|20921871|P1|COMPLETED|Overall Study||73
8490528|NCT00554229|20921870|P2|Patients Who Received Treatment|Overall Study||295
8490529|NCT00554229|20921871|P1|Patients Who Received Treatment|Overall Study||298
8490530|NCT00554229|20921870|P2|STARTED|Overall Study||295
8490531|NCT00554229|20921871|P1|STARTED|Overall Study||299
8490532|NCT00554216|20921896|P3|NOT COMPLETED|Overall Study||172
8490533|NCT00554216|20921897|P2|NOT COMPLETED|Overall Study||94
8490534|NCT00554216|20921898|P1|NOT COMPLETED|Overall Study||242
8490535|NCT00554216|20921896|P3|COMPLETED|Overall Study||340
8490536|NCT00554216|20921897|P2|COMPLETED|Overall Study||147
8490537|NCT00554216|20921898|P1|COMPLETED|Overall Study||272
8490538|NCT00554216|20921896|P3|STARTED|Overall Study||512
8490539|NCT00554216|20921897|P2|STARTED|Overall Study||241
8490540|NCT00554216|20921898|P1|STARTED|Overall Study||514
8490541|NCT00554190|20921909|P1|NOT COMPLETED|Overall Study||10
8490542|NCT00554190|20921909|P1|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
8490543|NCT00554190|20921909|P1|STARTED|Overall Study|29 subjects treated.|29
8490544|NCT00554099|20921918|P3|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
8490545|NCT00554099|20921919|P2|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
8490546|NCT00554099|20921920|P1|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
8490547|NCT00554099|20921918|P3|COMPLETED|Non-Treatment Phase (9 Months)||24
8490548|NCT00554099|20921919|P2|COMPLETED|Non-Treatment Phase (9 Months)||27
8490549|NCT00554099|20921920|P1|COMPLETED|Non-Treatment Phase (9 Months)||22
8490550|NCT00554099|20921918|P3|STARTED|Non-Treatment Phase (9 Months)||27
8490551|NCT00554099|20921919|P2|STARTED|Non-Treatment Phase (9 Months)||32
8490552|NCT00554099|20921920|P1|STARTED|Non-Treatment Phase (9 Months)||29
8490553|NCT00554099|20921918|P3|NOT COMPLETED|Treatment Period (12 Weeks)||9
8490554|NCT00554099|20921919|P2|NOT COMPLETED|Treatment Period (12 Weeks)||8
8490555|NCT00554099|20921920|P1|NOT COMPLETED|Treatment Period (12 Weeks)||12
8490556|NCT00554099|20921918|P3|COMPLETED|Treatment Period (12 Weeks)||27
8490557|NCT00554099|20921919|P2|COMPLETED|Treatment Period (12 Weeks)||32
8490558|NCT00554099|20921920|P1|COMPLETED|Treatment Period (12 Weeks)||29
8490559|NCT00554099|20921918|P3|STARTED|Treatment Period (12 Weeks)||36
8490560|NCT00554099|20921919|P2|STARTED|Treatment Period (12 Weeks)||40
8490561|NCT00554099|20921920|P1|STARTED|Treatment Period (12 Weeks)||41
8490562|NCT00553969|20921953|P4|NOT COMPLETED|Overall Study||1
8490563|NCT00553969|20921954|P3|NOT COMPLETED|Overall Study||1
8490564|NCT00553969|20921955|P2|NOT COMPLETED|Overall Study||0
8490565|NCT00553969|20921956|P1|NOT COMPLETED|Overall Study||8
8490566|NCT00553969|20921953|P4|COMPLETED|Overall Study||23
8490567|NCT00553969|20921954|P3|COMPLETED|Overall Study||21
8490568|NCT00553969|20921955|P2|COMPLETED|Overall Study||24
8490569|NCT00553969|20921956|P1|COMPLETED|Overall Study||23
8490570|NCT00553969|20921953|P4|STARTED|Overall Study||24
8490571|NCT00553969|20921954|P3|STARTED|Overall Study||22
8490572|NCT00553969|20921955|P2|STARTED|Overall Study||24
8490573|NCT00553969|20921956|P1|STARTED|Overall Study||31
8490574|NCT00553839|20921966|P1|NOT COMPLETED|Overall Study||0
8490575|NCT00553839|20921966|P1|COMPLETED|Overall Study||21
8490576|NCT00553839|20921966|P1|STARTED|Overall Study||21
8490577|NCT00553787|20921975|P3|NOT COMPLETED|Overall Study||262
8490578|NCT00553787|20921976|P2|NOT COMPLETED|Overall Study||124
8490579|NCT00553787|20921977|P1|NOT COMPLETED|Overall Study||378
8490580|NCT00553787|20921975|P3|COMPLETED|Overall Study||733
8490581|NCT00553787|20921976|P2|COMPLETED|Overall Study||374
8490582|NCT00553787|20921977|P1|COMPLETED|Overall Study||616
8490583|NCT00553787|20921975|P3|STARTED|Overall Study||995
8490584|NCT00553787|20921976|P2|STARTED|Overall Study||498
8490585|NCT00553787|20921977|P1|STARTED|Overall Study||994
8490586|NCT00553735|20921988|P1|NOT COMPLETED|Overall Study||7
8490587|NCT00553735|20921988|P1|COMPLETED|Overall Study||1
8490588|NCT00553735|20921988|P1|STARTED|Overall Study||8
8490589|NCT00553696|20922009|P4|NOT COMPLETED|Overall Study||1
8490590|NCT00553696|20922010|P3|NOT COMPLETED|Overall Study||6
8490591|NCT00553696|20922011|P2|NOT COMPLETED|Overall Study||16
8490592|NCT00553696|20922012|P1|NOT COMPLETED|Overall Study||4
8490593|NCT00553696|20922009|P4|COMPLETED|Overall Study||0
8490594|NCT00553696|20922010|P3|COMPLETED|Overall Study||0
8490595|NCT00553696|20922011|P2|COMPLETED|Overall Study||0
8490596|NCT00553696|20922012|P1|COMPLETED|Overall Study||0
8490597|NCT00553696|20922009|P4|STARTED|Overall Study||1
8490598|NCT00553696|20922010|P3|STARTED|Overall Study||6
8490599|NCT00553696|20922011|P2|STARTED|Overall Study||16
8490600|NCT00553696|20922012|P1|STARTED|Overall Study||4
8490601|NCT00553644|20922050|P1|NOT COMPLETED|Overall Study||28
8490602|NCT00553644|20922050|P1|COMPLETED|Overall Study||25
8490603|NCT00553644|20922050|P1|STARTED|Overall Study||53
8490610|NCT00553605|20922082|P2|NOT COMPLETED|Overall Study||3
8490611|NCT00553605|20922083|P1|NOT COMPLETED|Overall Study||4
8490612|NCT00553605|20922082|P2|COMPLETED|Overall Study||161
8490613|NCT00553605|20922083|P1|COMPLETED|Overall Study||172
8490614|NCT00553605|20922082|P2|Treated|Overall Study||164
8490615|NCT00553605|20922083|P1|Treated|Overall Study||174
8490616|NCT00553605|20922082|P2|STARTED|Overall Study||164
8490617|NCT00553605|20922083|P1|STARTED|Overall Study||176
8490618|NCT00553540|20922109|P2|NOT COMPLETED|Overall Study||5
8490619|NCT00553540|20922110|P1|NOT COMPLETED|Overall Study||2
8490620|NCT00553540|20922109|P2|COMPLETED|Overall Study||20
8490621|NCT00553540|20922110|P1|COMPLETED|Overall Study||23
8490622|NCT00553540|20922109|P2|STARTED|Overall Study||25
8490623|NCT00553540|20922110|P1|STARTED|Overall Study||25
8490624|NCT00553514|20922121|P5|NOT COMPLETED|Overall Study||7
8490625|NCT00553514|20922122|P4|NOT COMPLETED|Overall Study||7
8490626|NCT00553514|20922123|P3|NOT COMPLETED|Overall Study||6
8490627|NCT00553514|20922124|P2|NOT COMPLETED|Overall Study||8
8490628|NCT00553514|20922125|P1|NOT COMPLETED|Overall Study||8
8490629|NCT00553514|20922121|P5|COMPLETED|Overall Study||8
8490630|NCT00553514|20922122|P4|COMPLETED|Overall Study||6
8490631|NCT00553514|20922123|P3|COMPLETED|Overall Study||9
8490632|NCT00553514|20922124|P2|COMPLETED|Overall Study||6
8490633|NCT00553514|20922125|P1|COMPLETED|Overall Study||6
8490634|NCT00553514|20922121|P5|STARTED|Overall Study||15
8490635|NCT00553514|20922122|P4|STARTED|Overall Study||13
8490636|NCT00553514|20922123|P3|STARTED|Overall Study||15
8490637|NCT00553514|20922124|P2|STARTED|Overall Study||14
8490638|NCT00553514|20922125|P1|STARTED|Overall Study||14
8490639|NCT00553501|20922162|P1|NOT COMPLETED|Overall Study||4
8490640|NCT00553501|20922162|P1|COMPLETED|Overall Study||55
8490641|NCT00553501|20922162|P1|STARTED|Overall Study||59
8490642|NCT00553475|20922171|P3|NOT COMPLETED|Overall Study||13
8490643|NCT00553475|20922172|P2|NOT COMPLETED|Overall Study||20
8490644|NCT00553475|20922173|P1|NOT COMPLETED|Overall Study||16
8490645|NCT00553475|20922171|P3|COMPLETED|Overall Study||32
8490646|NCT00553475|20922172|P2|COMPLETED|Overall Study||114
8490647|NCT00553475|20922173|P1|COMPLETED|Overall Study||119
8490648|NCT00553475|20922171|P3|STARTED|Overall Study||45
8490649|NCT00553475|20922172|P2|STARTED|Overall Study||134
8490650|NCT00553475|20922173|P1|STARTED|Overall Study||135
8490651|NCT00553462|20922295|P1|NOT COMPLETED|Overall Study||14
8490652|NCT00553462|20922295|P1|COMPLETED|Overall Study||61
8490653|NCT00553462|20922295|P1|STARTED|Overall Study||75
8490654|NCT00553436|20922301|P1|NOT COMPLETED|Overall Study||1
8490655|NCT00553436|20922301|P1|COMPLETED|Overall Study|09 April 2009|6
8490656|NCT00553436|20922301|P1|STARTED|Overall Study|20 August 2007|7
8490657|NCT00553410|20922309|P2|NOT COMPLETED|Overall Study||18
8490658|NCT00553410|20922310|P1|NOT COMPLETED|Overall Study||15
8490659|NCT00553410|20922309|P2|COMPLETED|Overall Study||2425
8490660|NCT00553410|20922310|P1|COMPLETED|Overall Study||2426
8490661|NCT00553410|20922309|P2|STARTED|Overall Study||2443
8490662|NCT00553410|20922310|P1|STARTED|Overall Study||2441
8490672|NCT00553332|20922353|P1|NOT COMPLETED|Overall Study||1
8490673|NCT00553332|20922353|P1|COMPLETED|Overall Study|evaluable for response|28
8490674|NCT00553332|20922353|P1|STARTED|Overall Study||29
8490675|NCT00553319|20922365|P3|NOT COMPLETED|Overall Study||9
8490676|NCT00553319|20922366|P2|NOT COMPLETED|Overall Study||10
8490677|NCT00553319|20922367|P1|NOT COMPLETED|Overall Study||14
8490678|NCT00553319|20922365|P3|COMPLETED|Overall Study||34
8490679|NCT00553319|20922366|P2|COMPLETED|Overall Study||30
8490680|NCT00553319|20922367|P1|COMPLETED|Overall Study||29
8490681|NCT00553319|20922365|P3|STARTED|Overall Study||43
8490682|NCT00553319|20922366|P2|STARTED|Overall Study||40
8490683|NCT00553319|20922367|P1|STARTED|Overall Study||43
8490684|NCT00553280|20922378|P1|NOT COMPLETED|Overall Study||26
8490685|NCT00553280|20922378|P1|COMPLETED|Overall Study||97
8490686|NCT00553280|20922378|P1|STARTED|Overall Study||123
8490687|NCT00553267|20922390|P3|NOT COMPLETED|Overall Study||10
8490688|NCT00553267|20922391|P2|NOT COMPLETED|Overall Study||18
8490689|NCT00553267|20922392|P1|NOT COMPLETED|Overall Study||14
8490690|NCT00553267|20922390|P3|COMPLETED|Overall Study||307
8490691|NCT00553267|20922391|P2|COMPLETED|Overall Study||297
8490692|NCT00553267|20922392|P1|COMPLETED|Overall Study||301
8490693|NCT00553267|20922390|P3|STARTED|Overall Study||317
8490694|NCT00553267|20922391|P2|STARTED|Overall Study||315
8490695|NCT00553267|20922392|P1|STARTED|Overall Study||315
8490696|NCT00553254|20922429|P3|NOT COMPLETED|Overall Study||43
8490697|NCT00553254|20922430|P2|NOT COMPLETED|Overall Study||6
8490698|NCT00553254|20922431|P1|NOT COMPLETED|Overall Study||6
8490699|NCT00553254|20922429|P3|COMPLETED|Overall Study||0
8490700|NCT00553254|20922430|P2|COMPLETED|Overall Study||0
8490701|NCT00553254|20922431|P1|COMPLETED|Overall Study||0
8490702|NCT00553254|20922429|P3|STARTED|Overall Study||43
8490703|NCT00553254|20922430|P2|STARTED|Overall Study||6
8490704|NCT00553254|20922431|P1|STARTED|Overall Study||6
8490705|NCT00553202|20922473|P1|NOT COMPLETED|Overall Study||68
8490706|NCT00553202|20922473|P1|COMPLETED|Overall Study||90
8490707|NCT00553202|20922473|P1|STARTED|Overall Study||158
8490708|NCT00553163|20922483|P2|NOT COMPLETED|Overall Study||0
8490709|NCT00553163|20922484|P1|NOT COMPLETED|Overall Study||0
8490710|NCT00553163|20922483|P2|COMPLETED|Overall Study||10
8490711|NCT00553163|20922484|P1|COMPLETED|Overall Study||16
8490712|NCT00553163|20922483|P2|STARTED|Overall Study||10
8490713|NCT00553163|20922484|P1|STARTED|Overall Study||16
8490714|NCT00553150|20922500|P4|NOT COMPLETED|Overall Study||4
8490715|NCT00553150|20922501|P3|NOT COMPLETED|Overall Study||0
8490716|NCT00553150|20922502|P2|NOT COMPLETED|Overall Study||0
8490717|NCT00553150|20922503|P1|NOT COMPLETED|Overall Study||0
8490718|NCT00553150|20922500|P4|COMPLETED|Overall Study||100
8490719|NCT00553150|20922501|P3|COMPLETED|Overall Study||6
8490720|NCT00553150|20922502|P2|COMPLETED|Overall Study||6
8490721|NCT00553150|20922503|P1|COMPLETED|Overall Study||6
8490722|NCT00553150|20922500|P4|STARTED|Overall Study||104
8490723|NCT00553150|20922501|P3|STARTED|Overall Study||6
8490724|NCT00553150|20922502|P2|STARTED|Overall Study||6
8490725|NCT00553150|20922503|P1|STARTED|Overall Study||6
8490726|NCT00553098|20922515|P1|NOT COMPLETED|Overall Study||1
8490727|NCT00553098|20922515|P1|COMPLETED|Overall Study||28
8490728|NCT00553098|20922515|P1|STARTED|Overall Study||29
8490729|NCT00553059|20922531|P2|NOT COMPLETED|Overall Study||2
8490730|NCT00553059|20922532|P1|NOT COMPLETED|Overall Study||1
8490731|NCT00553059|20922531|P2|COMPLETED|Overall Study||29
8490732|NCT00553059|20922532|P1|COMPLETED|Overall Study||30
8490733|NCT00553059|20922531|P2|STARTED|Overall Study||31
8490734|NCT00553059|20922532|P1|STARTED|Overall Study||31
8490735|NCT00552929|20922560|P10|NOT COMPLETED|Overall Study||0
8490736|NCT00552929|20922561|P9|NOT COMPLETED|Overall Study||1
8490737|NCT00552929|20922562|P8|NOT COMPLETED|Overall Study||0
8490738|NCT00552929|20922563|P7|NOT COMPLETED|Overall Study||0
8490739|NCT00552929|20922564|P6|NOT COMPLETED|Overall Study||1
8490740|NCT00552929|20922565|P5|NOT COMPLETED|Overall Study||0
8490741|NCT00552929|20922566|P4|NOT COMPLETED|Overall Study||0
8490742|NCT00552929|20922567|P3|NOT COMPLETED|Overall Study||0
8490743|NCT00552929|20922568|P2|NOT COMPLETED|Overall Study||0
8490744|NCT00552929|20922569|P1|NOT COMPLETED|Overall Study||0
8490745|NCT00552929|20922560|P10|COMPLETED|Overall Study||11
8490746|NCT00552929|20922561|P9|COMPLETED|Overall Study||9
8490747|NCT00552929|20922562|P8|COMPLETED|Overall Study||11
8490748|NCT00552929|20922563|P7|COMPLETED|Overall Study||10
8490749|NCT00552929|20922564|P6|COMPLETED|Overall Study||9
8490750|NCT00552929|20922565|P5|COMPLETED|Overall Study||10
8490751|NCT00552929|20922566|P4|COMPLETED|Overall Study||11
8490752|NCT00552929|20922567|P3|COMPLETED|Overall Study||10
8490753|NCT00552929|20922568|P2|COMPLETED|Overall Study||10
8490754|NCT00552929|20922569|P1|COMPLETED|Overall Study||9
8490755|NCT00552929|20922560|P10|Participants as Treated|Overall Study||11
8490756|NCT00552929|20922561|P9|Participants as Treated|Overall Study||10
8490757|NCT00552929|20922562|P8|Participants as Treated|Overall Study||11
8490758|NCT00552929|20922563|P7|Participants as Treated|Overall Study||10
8490759|NCT00552929|20922564|P6|Participants as Treated|Overall Study||9
8490760|NCT00552929|20922565|P5|Participants as Treated|Overall Study||10
8490848|NCT00552617|20922691|P8|STARTED|Overall Study||10
8490761|NCT00552929|20922566|P4|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11
8490762|NCT00552929|20922567|P3|Participants as Treated|Overall Study||10
8490763|NCT00552929|20922568|P2|Participants as Treated|Overall Study||10
8490764|NCT00552929|20922569|P1|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9
8490765|NCT00552929|20922560|P10|STARTED|Overall Study||11
8490766|NCT00552929|20922561|P9|STARTED|Overall Study||10
8490767|NCT00552929|20922562|P8|STARTED|Overall Study||11
8490768|NCT00552929|20922563|P7|STARTED|Overall Study||10
8490769|NCT00552929|20922564|P6|STARTED|Overall Study||10
8490770|NCT00552929|20922565|P5|STARTED|Overall Study||10
8490771|NCT00552929|20922566|P4|STARTED|Overall Study||11
8490772|NCT00552929|20922567|P3|STARTED|Overall Study||10
8490773|NCT00552929|20922568|P2|STARTED|Overall Study||10
8490774|NCT00552929|20922569|P1|STARTED|Overall Study||9
8490775|NCT00552812|20922621|P1|NOT COMPLETED|Overall Study||20
8490776|NCT00552812|20922621|P1|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
8490777|NCT00552812|20922621|P1|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
8490778|NCT00552786|20922629|P2|NOT COMPLETED|Second Intervention||0
8490779|NCT00552786|20922630|P1|NOT COMPLETED|Second Intervention||0
8490780|NCT00552786|20922629|P2|COMPLETED|Second Intervention||28
8490781|NCT00552786|20922630|P1|COMPLETED|Second Intervention||25
8490782|NCT00552786|20922629|P2|STARTED|Second Intervention||28
8490783|NCT00552786|20922630|P1|STARTED|Second Intervention||25
8490784|NCT00552786|20922629|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8490785|NCT00552786|20922630|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8490786|NCT00552786|20922629|P2|COMPLETED|Washout Period of 2 Weeks||28
8490787|NCT00552786|20922630|P1|COMPLETED|Washout Period of 2 Weeks||25
8490788|NCT00552786|20922629|P2|STARTED|Washout Period of 2 Weeks||28
8490789|NCT00552786|20922630|P1|STARTED|Washout Period of 2 Weeks||25
8490790|NCT00552786|20922629|P2|NOT COMPLETED|First Intervention||0
8490791|NCT00552786|20922630|P1|NOT COMPLETED|First Intervention||0
8490792|NCT00552786|20922629|P2|COMPLETED|First Intervention||28
8490793|NCT00552786|20922630|P1|COMPLETED|First Intervention||25
8490794|NCT00552786|20922629|P2|Medication and Hearing Evaluation|First Intervention||28
8490795|NCT00552786|20922630|P1|Medication and Hearing Evaluation|First Intervention||25
8490796|NCT00552786|20922629|P2|STARTED|First Intervention||28
8490797|NCT00552786|20922630|P1|STARTED|First Intervention||25
8490798|NCT00552760|20922640|P2|NOT COMPLETED|Overall Study||33
8490799|NCT00552760|20922641|P1|NOT COMPLETED|Overall Study||26
8490800|NCT00552760|20922640|P2|COMPLETED|Overall Study||8
8490801|NCT00552760|20922641|P1|COMPLETED|Overall Study||16
8490802|NCT00552760|20922640|P2|STARTED|Overall Study||41
8490803|NCT00552760|20922641|P1|STARTED|Overall Study||42
8490804|NCT00552695|20922657|P2|NOT COMPLETED|Overall Study||0
8490805|NCT00552695|20922658|P1|NOT COMPLETED|Overall Study||0
8490806|NCT00552695|20922657|P2|COMPLETED|Overall Study|September 2007|23
8490807|NCT00552695|20922658|P1|COMPLETED|Overall Study|September 2007|22
8490808|NCT00552695|20922657|P2|STARTED|Overall Study|August 2007|23
8490809|NCT00552695|20922658|P1|STARTED|Overall Study|August 2007|22
8490810|NCT00552669|20922668|P2|NOT COMPLETED|Overall Study||7
8490811|NCT00552669|20922669|P1|NOT COMPLETED|Overall Study||3
8490812|NCT00552669|20922668|P2|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
8490813|NCT00552669|20922669|P1|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
8490814|NCT00552669|20922668|P2|STARTED|Overall Study|patients|100
8490815|NCT00552669|20922669|P1|STARTED|Overall Study|patients|100
8490816|NCT00552617|20922689|P10|NOT COMPLETED|Overall Study||1
8490817|NCT00552617|20922690|P9|NOT COMPLETED|Overall Study||2
8490818|NCT00552617|20922691|P8|NOT COMPLETED|Overall Study||0
8490819|NCT00552617|20922692|P7|NOT COMPLETED|Overall Study||0
8490820|NCT00552617|20922693|P6|NOT COMPLETED|Overall Study||2
8490821|NCT00552617|20922694|P5|NOT COMPLETED|Overall Study||0
8490822|NCT00552617|20922695|P4|NOT COMPLETED|Overall Study||1
8490823|NCT00552617|20922696|P3|NOT COMPLETED|Overall Study||1
8490824|NCT00552617|20922697|P2|NOT COMPLETED|Overall Study||0
8490825|NCT00552617|20922698|P1|NOT COMPLETED|Overall Study||0
8490826|NCT00552617|20922689|P10|COMPLETED|Overall Study||9
8490827|NCT00552617|20922690|P9|COMPLETED|Overall Study||8
8490828|NCT00552617|20922691|P8|COMPLETED|Overall Study||10
8490829|NCT00552617|20922692|P7|COMPLETED|Overall Study||10
8490830|NCT00552617|20922693|P6|COMPLETED|Overall Study||8
8490831|NCT00552617|20922694|P5|COMPLETED|Overall Study||10
8490832|NCT00552617|20922695|P4|COMPLETED|Overall Study||9
8490833|NCT00552617|20922696|P3|COMPLETED|Overall Study||9
8490834|NCT00552617|20922697|P2|COMPLETED|Overall Study||10
8490835|NCT00552617|20922698|P1|COMPLETED|Overall Study||10
8490836|NCT00552617|20922689|P10|Treated|Overall Study||9
8490837|NCT00552617|20922690|P9|Treated|Overall Study||10
8490838|NCT00552617|20922691|P8|Treated|Overall Study||10
8490839|NCT00552617|20922692|P7|Treated|Overall Study||10
8490840|NCT00552617|20922693|P6|Treated|Overall Study||10
8490841|NCT00552617|20922694|P5|Treated|Overall Study||10
8490842|NCT00552617|20922695|P4|Treated|Overall Study||10
8490843|NCT00552617|20922696|P3|Treated|Overall Study||9
8490844|NCT00552617|20922697|P2|Treated|Overall Study||10
8490845|NCT00552617|20922698|P1|Treated|Overall Study||10
8490846|NCT00552617|20922689|P10|STARTED|Overall Study||10
8490847|NCT00552617|20922690|P9|STARTED|Overall Study||10
8490849|NCT00552617|20922692|P7|STARTED|Overall Study||10
8490850|NCT00552617|20922693|P6|STARTED|Overall Study||10
8490851|NCT00552617|20922694|P5|STARTED|Overall Study||10
8490852|NCT00552617|20922695|P4|STARTED|Overall Study||10
8490853|NCT00552617|20922696|P3|STARTED|Overall Study||10
8490854|NCT00552617|20922697|P2|STARTED|Overall Study||10
8490855|NCT00552617|20922698|P1|STARTED|Overall Study||10
8490856|NCT00552578|20922742|P2|NOT COMPLETED|Overall Study||1
8490857|NCT00552578|20922743|P1|NOT COMPLETED|Overall Study||1
8490858|NCT00552578|20922742|P2|COMPLETED|Overall Study||5
8490859|NCT00552578|20922743|P1|COMPLETED|Overall Study||5
8490860|NCT00552578|20922742|P2|STARTED|Overall Study||6
8490861|NCT00552578|20922743|P1|STARTED|Overall Study||6
8490862|NCT00552513|20922755|P2|NOT COMPLETED|Overall Study||1
8490863|NCT00552513|20922756|P1|NOT COMPLETED|Overall Study||5
8490864|NCT00552513|20922755|P2|COMPLETED|Overall Study||1437
8490865|NCT00552513|20922756|P1|COMPLETED|Overall Study||1588
8490866|NCT00552513|20922755|P2|STARTED|Overall Study||1438
8490867|NCT00552513|20922756|P1|STARTED|Overall Study||1593
8490868|NCT00552448|20922768|P2|NOT COMPLETED|Overall Study||0
8490869|NCT00552448|20922769|P1|NOT COMPLETED|Overall Study||1
8490870|NCT00552448|20922768|P2|COMPLETED|Overall Study||16
8490871|NCT00552448|20922769|P1|COMPLETED|Overall Study||19
8490872|NCT00552448|20922768|P2|STARTED|Overall Study||16
8490873|NCT00552448|20922769|P1|STARTED|Overall Study||20
8490874|NCT00552422|20922781|P1|NOT COMPLETED|Overall Study||0
8490875|NCT00552422|20922781|P1|COMPLETED|Overall Study||6
8490876|NCT00552422|20922781|P1|STARTED|Overall Study||6
8490877|NCT00552409|20922787|P2|NOT COMPLETED|Overall Study||2
8490878|NCT00552409|20922788|P1|NOT COMPLETED|Overall Study||1
8490879|NCT00552409|20922787|P2|COMPLETED|Overall Study||9
8490880|NCT00552409|20922788|P1|COMPLETED|Overall Study||10
8490881|NCT00552409|20922787|P2|STARTED|Overall Study||11
8490882|NCT00552409|20922788|P1|STARTED|Overall Study||11
8490883|NCT00552396|20922801|P7|NOT COMPLETED|Overall Study||9
8490884|NCT00552396|20922802|P6|NOT COMPLETED|Overall Study||3
8490885|NCT00552396|20922803|P5|NOT COMPLETED|Overall Study||3
8490886|NCT00552396|20922804|P4|NOT COMPLETED|Overall Study||6
8490887|NCT00552396|20922805|P3|NOT COMPLETED|Overall Study||3
8490888|NCT00552396|20922806|P2|NOT COMPLETED|Overall Study||3
8490889|NCT00552396|20922807|P1|NOT COMPLETED|Overall Study||3
8490890|NCT00552396|20922801|P7|COMPLETED|Overall Study||1
8490891|NCT00552396|20922802|P6|COMPLETED|Overall Study||0
8490892|NCT00552396|20922803|P5|COMPLETED|Overall Study||0
8490893|NCT00552396|20922804|P4|COMPLETED|Overall Study||0
8490894|NCT00552396|20922805|P3|COMPLETED|Overall Study||0
8490895|NCT00552396|20922806|P2|COMPLETED|Overall Study||0
8490896|NCT00552396|20922807|P1|COMPLETED|Overall Study||1
8490897|NCT00552396|20922801|P7|STARTED|Overall Study||10
8490898|NCT00552396|20922802|P6|STARTED|Overall Study||3
8490899|NCT00552396|20922803|P5|STARTED|Overall Study||3
8490900|NCT00552396|20922804|P4|STARTED|Overall Study||6
8490901|NCT00552396|20922805|P3|STARTED|Overall Study||3
8490902|NCT00552396|20922806|P2|STARTED|Overall Study||3
8490903|NCT00552396|20922807|P1|STARTED|Overall Study||4
8490904|NCT00552344|20922844|P1|NOT COMPLETED|Overall Study||315
8490905|NCT00552344|20922844|P1|COMPLETED|Overall Study||87
8490906|NCT00552344|20922844|P1|STARTED|Overall Study||402
8490907|NCT00552305|20922853|P1|NOT COMPLETED|Overall Study||250
8490908|NCT00552305|20922853|P1|COMPLETED|Overall Study||120
8490909|NCT00552305|20922853|P1|STARTED|Overall Study||370
8490910|NCT00552279|20922863|P2|NOT COMPLETED|Overall Study||3
8490911|NCT00552279|20922864|P1|NOT COMPLETED|Overall Study||14
8490912|NCT00552279|20922863|P2|COMPLETED|Overall Study||398
8490913|NCT00552279|20922864|P1|COMPLETED|Overall Study||389
8490914|NCT00552279|20922863|P2|STARTED|Overall Study||401
8490915|NCT00552279|20922864|P1|STARTED|Overall Study||403
8490916|NCT00552240|20922890|P2|NOT COMPLETED|Overall Study||18
8490917|NCT00552240|20922891|P1|NOT COMPLETED|Overall Study||24
8490918|NCT00552240|20922890|P2|COMPLETED|Overall Study||59
8490919|NCT00552240|20922891|P1|COMPLETED|Overall Study||51
8490920|NCT00552240|20922890|P2|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
8490921|NCT00552240|20922891|P1|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
8490922|NCT00552188|20922993|P2|NOT COMPLETED|Overall Study||5
8490923|NCT00552188|20922994|P1|NOT COMPLETED|Overall Study||2
8490924|NCT00552188|20922993|P2|COMPLETED|Overall Study||21
8490925|NCT00552188|20922994|P1|COMPLETED|Overall Study||24
8490926|NCT00552188|20922993|P2|STARTED|Overall Study||26
8490927|NCT00552188|20922994|P1|STARTED|Overall Study||26
8490928|NCT00552175|20923005|P3|NOT COMPLETED|Overall Study||14
8490929|NCT00552175|20923006|P2|NOT COMPLETED|Overall Study||13
8490930|NCT00552175|20923007|P1|NOT COMPLETED|Overall Study||17
8490931|NCT00552175|20923005|P3|COMPLETED|Overall Study||72
8490932|NCT00552175|20923006|P2|COMPLETED|Overall Study||73
8490933|NCT00552175|20923007|P1|COMPLETED|Overall Study||150
8490934|NCT00552175|20923005|P3|Full Analysis Set Population|Overall Study||86
8490935|NCT00552175|20923006|P2|Full Analysis Set Population|Overall Study||85
8490936|NCT00552175|20923007|P1|Full Analysis Set Population|Overall Study||167
8490937|NCT00552175|20923005|P3|STARTED|Overall Study||86
8490938|NCT00552175|20923006|P2|STARTED|Overall Study||86
8490939|NCT00552175|20923007|P1|STARTED|Overall Study||167
8490940|NCT00552110|20923047|P5|NOT COMPLETED|Overall Study||9
8490941|NCT00552110|20923048|P4|NOT COMPLETED|Overall Study||8
8490942|NCT00552110|20923049|P3|NOT COMPLETED|Overall Study||2
8490943|NCT00552110|20923050|P2|NOT COMPLETED|Overall Study||5
8492001|NCT00546273|20926295|P5|STARTED|IV||2
8490944|NCT00552110|20923051|P1|NOT COMPLETED|Overall Study||4
8490945|NCT00552110|20923047|P5|COMPLETED|Overall Study||133
8490946|NCT00552110|20923048|P4|COMPLETED|Overall Study||133
8490947|NCT00552110|20923049|P3|COMPLETED|Overall Study||137
8490948|NCT00552110|20923050|P2|COMPLETED|Overall Study||134
8490949|NCT00552110|20923051|P1|COMPLETED|Overall Study||142
8490950|NCT00552110|20923047|P5|STARTED|Overall Study||142
8490951|NCT00552110|20923048|P4|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
8490952|NCT00552110|20923049|P3|STARTED|Overall Study||139
8490953|NCT00552110|20923050|P2|STARTED|Overall Study||139
8490954|NCT00552110|20923051|P1|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
8490955|NCT00552084|20923070|P2|NOT COMPLETED|Overall Study||9
8490956|NCT00552084|20923071|P1|NOT COMPLETED|Overall Study||8
8490957|NCT00552084|20923070|P2|COMPLETED|Overall Study||55
8490958|NCT00552084|20923071|P1|COMPLETED|Overall Study||118
8490959|NCT00552084|20923070|P2|STARTED|Overall Study||64
8490960|NCT00552084|20923071|P1|STARTED|Overall Study||126
8490961|NCT00552071|20923079|P2|NOT COMPLETED|Overall Study||2
8490962|NCT00552071|20923080|P1|NOT COMPLETED|Overall Study||4
8490963|NCT00552071|20923079|P2|COMPLETED|Overall Study||9
8490964|NCT00552071|20923080|P1|COMPLETED|Overall Study||6
8490965|NCT00552071|20923079|P2|STARTED|Overall Study||11
8490966|NCT00552071|20923080|P1|STARTED|Overall Study||10
8490967|NCT00552058|20923090|P2|NOT COMPLETED|Overall Study||24
8490968|NCT00552058|20923091|P1|NOT COMPLETED|Overall Study||16
8490969|NCT00552058|20923090|P2|COMPLETED|Overall Study||192
8490970|NCT00552058|20923091|P1|COMPLETED|Overall Study||207
8490971|NCT00552058|20923090|P2|STARTED|Overall Study||216
8490972|NCT00552058|20923091|P1|STARTED|Overall Study||223
8490973|NCT00552032|20923131|P2|NOT COMPLETED|Overall Study||19
8490974|NCT00552032|20923132|P1|NOT COMPLETED|Overall Study||17
8490975|NCT00552032|20923131|P2|COMPLETED|Overall Study||47
8490976|NCT00552032|20923132|P1|COMPLETED|Overall Study||49
8490977|NCT00552032|20923131|P2|STARTED|Overall Study||66
8490978|NCT00552032|20923132|P1|STARTED|Overall Study||66
8490979|NCT00551759|20923176|P1|NOT COMPLETED|Overall Study||13
8490980|NCT00551759|20923176|P1|COMPLETED|Overall Study||9
8490981|NCT00551759|20923176|P1|Received Adjuvant Therapy|Overall Study||12
8490982|NCT00551759|20923176|P1|Underwent Surgery|Overall Study||17
8490983|NCT00551759|20923176|P1|Eligible and Began Treatment|Overall Study||21
8490984|NCT00551759|20923176|P1|STARTED|Overall Study||22
8490985|NCT00551746|20923182|P2|NOT COMPLETED|Overall Study||8
8490986|NCT00551746|20923183|P1|NOT COMPLETED|Overall Study||11
8490987|NCT00551746|20923182|P2|COMPLETED|Overall Study||26
8490988|NCT00551746|20923183|P1|COMPLETED|Overall Study||25
8490989|NCT00551746|20923182|P2|STARTED|Overall Study||34
8490990|NCT00551746|20923183|P1|STARTED|Overall Study||36
8490991|NCT00551707|20923194|P5|NOT COMPLETED|Overall Study||1
8490992|NCT00551707|20923195|P4|NOT COMPLETED|Overall Study||4
8490993|NCT00551707|20923196|P3|NOT COMPLETED|Overall Study||3
8490994|NCT00551707|20923197|P2|NOT COMPLETED|Overall Study||6
8490995|NCT00551707|20923198|P1|NOT COMPLETED|Overall Study||0
8490996|NCT00551707|20923194|P5|COMPLETED|Overall Study||3
8490997|NCT00551707|20923195|P4|COMPLETED|Overall Study||4
8490998|NCT00551707|20923196|P3|COMPLETED|Overall Study||10
8490999|NCT00551707|20923197|P2|COMPLETED|Overall Study||16
8491000|NCT00551707|20923198|P1|COMPLETED|Overall Study||4
8491001|NCT00551707|20923194|P5|STARTED|Overall Study||4
8491002|NCT00551707|20923195|P4|STARTED|Overall Study||8
8491003|NCT00551707|20923196|P3|STARTED|Overall Study||13
8491004|NCT00551707|20923197|P2|STARTED|Overall Study||22
8491005|NCT00551707|20923198|P1|STARTED|Overall Study||4
8491012|NCT00551525|20923224|P1|NOT COMPLETED|Overall Study||5
8491013|NCT00551525|20923224|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
8491014|NCT00551525|20923224|P1|STARTED|Overall Study||67
8491015|NCT00551460|20923233|P1|NOT COMPLETED|Overall Study||18
8491016|NCT00551460|20923233|P1|COMPLETED|Overall Study||60
8491017|NCT00551460|20923233|P1|STARTED|Overall Study||78
8491018|NCT00551421|20923239|P1|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
8491019|NCT00551421|20923239|P1|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
8491020|NCT00551421|20923239|P1|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
8491021|NCT00551421|20923239|P1|NOT COMPLETED|Original Protocol, Dose Level 1||0
8491022|NCT00551421|20923239|P1|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
8491023|NCT00551421|20923239|P1|STARTED|Original Protocol, Dose Level 1||3
8491024|NCT00551369|20923246|P1|NOT COMPLETED|Overall Study||7
8491025|NCT00551369|20923246|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
8491026|NCT00551369|20923246|P1|STARTED|Overall Study||33
8491027|NCT00551291|20923255|P1|NOT COMPLETED|Overall Study||1
8491028|NCT00551291|20923255|P1|COMPLETED|Overall Study||9
8491029|NCT00551291|20923255|P1|STARTED|Overall Study||10
8491030|NCT00551213|20923263|P2|NOT COMPLETED|Overall Study||17
8491031|NCT00551213|20923264|P1|NOT COMPLETED|Overall Study||50
8491032|NCT00551213|20923263|P2|COMPLETED|Overall Study||0
8491033|NCT00551213|20923264|P1|COMPLETED|Overall Study||0
8491034|NCT00551213|20923263|P2|Treated|Overall Study||15
8491035|NCT00551213|20923264|P1|Treated|Overall Study||49
8491036|NCT00551213|20923263|P2|STARTED|Overall Study||17
8491037|NCT00551213|20923264|P1|STARTED|Overall Study||50
8491038|NCT00551200|20923280|P1|NOT COMPLETED|Overall Study||4
8491039|NCT00551200|20923280|P1|COMPLETED|Overall Study||10
8491040|NCT00551200|20923280|P1|STARTED|Overall Study||14
8491041|NCT00551174|20923295|P2|NOT COMPLETED|Overall Study||6
8491042|NCT00551174|20923296|P1|NOT COMPLETED|Overall Study||19
8491043|NCT00551174|20923295|P2|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
8491044|NCT00551174|20923296|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
8491045|NCT00551174|20923295|P2|STARTED|Overall Study||400
8491046|NCT00551174|20923296|P1|STARTED|Overall Study||381
8491047|NCT00551161|20923308|P1|NOT COMPLETED|Overall Study||1
8491048|NCT00551161|20923308|P1|COMPLETED|Overall Study||11
8491049|NCT00551161|20923308|P1|STARTED|Overall Study||12
8491050|NCT00551135|20923316|P4|NOT COMPLETED|Overall Study||5
8491051|NCT00551135|20923317|P3|NOT COMPLETED|Overall Study||5
8491052|NCT00551135|20923318|P2|NOT COMPLETED|Overall Study||2
8491053|NCT00551135|20923319|P1|NOT COMPLETED|Overall Study||5
8491054|NCT00551135|20923316|P4|COMPLETED|Overall Study||103
8491055|NCT00551135|20923317|P3|COMPLETED|Overall Study||98
8491056|NCT00551135|20923318|P2|COMPLETED|Overall Study||104
8491057|NCT00551135|20923319|P1|COMPLETED|Overall Study||103
8491058|NCT00551135|20923316|P4|STARTED|Overall Study||108
8491059|NCT00551135|20923317|P3|STARTED|Overall Study||103
8491060|NCT00551135|20923318|P2|STARTED|Overall Study||106
8491061|NCT00551135|20923319|P1|STARTED|Overall Study||108
8491062|NCT00551070|20923433|P1|NOT COMPLETED|Overall Study||0
8491063|NCT00551070|20923433|P1|COMPLETED|Overall Study||52
8491064|NCT00551070|20923433|P1|STARTED|Overall Study||52
8491065|NCT00551031|20923448|P5|NOT COMPLETED|Overall Study||1
8491066|NCT00551031|20923449|P4|NOT COMPLETED|Overall Study||3
8491067|NCT00551031|20923450|P3|NOT COMPLETED|Overall Study||2
8491068|NCT00551031|20923451|P2|NOT COMPLETED|Overall Study||11
8491069|NCT00551031|20923452|P1|NOT COMPLETED|Overall Study||2
8491070|NCT00551031|20923448|P5|COMPLETED|Overall Study||185
8491071|NCT00551031|20923449|P4|COMPLETED|Overall Study||317
8491072|NCT00551031|20923450|P3|COMPLETED|Overall Study||317
8491073|NCT00551031|20923451|P2|COMPLETED|Overall Study||625
8491074|NCT00551031|20923452|P1|COMPLETED|Overall Study||635
8491075|NCT00551031|20923448|P5|STARTED|Overall Study||186
8491076|NCT00551031|20923449|P4|STARTED|Overall Study||320
8491077|NCT00551031|20923450|P3|STARTED|Overall Study||319
8491078|NCT00551031|20923451|P2|STARTED|Overall Study||636
8491079|NCT00551031|20923452|P1|STARTED|Overall Study||637
8491080|NCT00550953|20923481|P2|NOT COMPLETED|Overall Study||6
8491081|NCT00550953|20923482|P1|NOT COMPLETED|Overall Study||6
8491082|NCT00550953|20923481|P2|COMPLETED|Overall Study||152
8491083|NCT00550953|20923482|P1|COMPLETED|Overall Study||150
8491084|NCT00550953|20923481|P2|STARTED|Overall Study||158
8491085|NCT00550953|20923482|P1|STARTED|Overall Study||156
8491086|NCT00550862|20923506|P4|NOT COMPLETED|Overall Study||1
8491087|NCT00550862|20923507|P3|NOT COMPLETED|Overall Study||16
8491088|NCT00550862|20923508|P2|NOT COMPLETED|Overall Study||6
8491089|NCT00550862|20923509|P1|NOT COMPLETED|Overall Study||6
8491090|NCT00550862|20923506|P4|COMPLETED|Overall Study||37
8491091|NCT00550862|20923507|P3|COMPLETED|Overall Study||25
8491092|NCT00550862|20923508|P2|COMPLETED|Overall Study||42
8491093|NCT00550862|20923509|P1|COMPLETED|Overall Study||32
8491094|NCT00550862|20923506|P4|STARTED|Overall Study||38
8491095|NCT00550862|20923507|P3|STARTED|Overall Study||41
8491096|NCT00550862|20923508|P2|STARTED|Overall Study||48
8491097|NCT00550862|20923509|P1|STARTED|Overall Study||38
8491098|NCT00550836|20923529|P2|NOT COMPLETED|Overall Study||9
8491099|NCT00550836|20923530|P1|NOT COMPLETED|Overall Study||3
8491100|NCT00550836|20923529|P2|COMPLETED|Overall Study||46
8491101|NCT00550836|20923530|P1|COMPLETED|Overall Study||46
8491102|NCT00550836|20923529|P2|STARTED|Overall Study||55
8491103|NCT00550836|20923530|P1|STARTED|Overall Study||49
8491104|NCT00550771|20923546|P2|NOT COMPLETED|Overall Study||10
8491105|NCT00550771|20923547|P1|NOT COMPLETED|Overall Study||17
8491106|NCT00550771|20923546|P2|COMPLETED|Overall Study||50
8491107|NCT00550771|20923547|P1|COMPLETED|Overall Study||104
8491108|NCT00550771|20923546|P2|STARTED|Overall Study||60
8491109|NCT00550771|20923547|P1|STARTED|Overall Study||121
8491110|NCT00550745|20923561|P2|NOT COMPLETED|Overall Study||60
8491111|NCT00550745|20923562|P1|NOT COMPLETED|Overall Study||87
8491112|NCT00550745|20923561|P2|COMPLETED|Overall Study||5939
8491113|NCT00550745|20923562|P1|COMPLETED|Overall Study||5913
8491114|NCT00550745|20923561|P2|STARTED|Overall Study||5999
8491115|NCT00550745|20923562|P1|STARTED|Overall Study||6000
8491116|NCT00550732|20923570|P1|NOT COMPLETED|Overall Study||11
8491117|NCT00550732|20923570|P1|COMPLETED|Overall Study||29
8491118|NCT00550732|20923570|P1|STARTED|Overall Study||40
8491119|NCT00550680|20923581|P1|NOT COMPLETED|Overall Study||56
8491120|NCT00550680|20923581|P1|COMPLETED|Overall Study||152
8491121|NCT00550680|20923581|P1|STARTED|Overall Study||208
8491122|NCT00550654|20923590|P1|NOT COMPLETED|Overall Study||0
8491123|NCT00550654|20923590|P1|COMPLETED|Overall Study||1
8491124|NCT00550654|20923590|P1|STARTED|Overall Study||1
8491125|NCT00550615|20923602|P4|NOT COMPLETED|Overall Study||10
8491126|NCT00550615|20923603|P3|NOT COMPLETED|Overall Study||4
8491127|NCT00550615|20923604|P2|NOT COMPLETED|Overall Study||0
8491128|NCT00550615|20923605|P1|NOT COMPLETED|Overall Study||0
8491129|NCT00550615|20923602|P4|COMPLETED|Overall Study||12
8491130|NCT00550615|20923603|P3|COMPLETED|Overall Study||6
8491131|NCT00550615|20923604|P2|COMPLETED|Overall Study||3
8491132|NCT00550615|20923605|P1|COMPLETED|Overall Study||3
8491133|NCT00550615|20923602|P4|STARTED|Overall Study||22
8491134|NCT00550615|20923603|P3|STARTED|Overall Study||10
8491135|NCT00550615|20923604|P2|STARTED|Overall Study||3
8491136|NCT00550615|20923605|P1|STARTED|Overall Study||3
8491137|NCT00550589|20923611|P1|NOT COMPLETED|Overall Study||0
8491138|NCT00550589|20923611|P1|COMPLETED|Overall Study||33
8491139|NCT00550589|20923611|P1|STARTED|Overall Study||33
8491140|NCT00550550|20923624|P2|NOT COMPLETED|Overall Study||29
8491141|NCT00550550|20923625|P1|NOT COMPLETED|Overall Study||34
8491142|NCT00550550|20923624|P2|COMPLETED|Overall Study||140
8491143|NCT00550550|20923625|P1|COMPLETED|Overall Study||142
8491144|NCT00550550|20923624|P2|Number Treated|Overall Study||169
8491145|NCT00550550|20923625|P1|Number Treated|Overall Study||175
8491146|NCT00550550|20923624|P2|STARTED|Overall Study||169
8491147|NCT00550550|20923625|P1|STARTED|Overall Study||176
8491148|NCT00550537|20923637|P1|NOT COMPLETED|Overall Study||104
8491149|NCT00550537|20923637|P1|COMPLETED|Overall Study||12
8491150|NCT00550537|20923637|P1|STARTED|Overall Study||116
8491151|NCT00550459|20923654|P2|NOT COMPLETED|Overall Study||3
8491152|NCT00550459|20923655|P1|NOT COMPLETED|Overall Study||1
8491153|NCT00550459|20923654|P2|COMPLETED|Overall Study||26
8491154|NCT00550459|20923655|P1|COMPLETED|Overall Study||27
8491155|NCT00550459|20923654|P2|STARTED|Overall Study||29
8491156|NCT00550459|20923655|P1|STARTED|Overall Study||28
8491157|NCT00550446|20923724|P11|NOT COMPLETED|Post Week 12||1
8491158|NCT00550446|20923725|P10|NOT COMPLETED|Post Week 12||7
8491159|NCT00550446|20923726|P9|NOT COMPLETED|Post Week 12||2
8491160|NCT00550446|20923727|P8|NOT COMPLETED|Post Week 12||1
8491161|NCT00550446|20923728|P7|NOT COMPLETED|Post Week 12||2
8491162|NCT00550446|20923729|P6|NOT COMPLETED|Post Week 12||1
8491163|NCT00550446|20923730|P5|NOT COMPLETED|Post Week 12||2
8491164|NCT00550446|20923731|P4|NOT COMPLETED|Post Week 12||3
8491165|NCT00550446|20923732|P3|NOT COMPLETED|Post Week 12||3
8491166|NCT00550446|20923733|P2|NOT COMPLETED|Post Week 12||2
8491167|NCT00550446|20923734|P1|NOT COMPLETED|Post Week 12||3
8491168|NCT00550446|20923724|P11|COMPLETED|Post Week 12||24
8491169|NCT00550446|20923725|P10|COMPLETED|Post Week 12||37
8491170|NCT00550446|20923726|P9|COMPLETED|Post Week 12||15
8491171|NCT00550446|20923727|P8|COMPLETED|Post Week 12||16
8491172|NCT00550446|20923728|P7|COMPLETED|Post Week 12||19
8491173|NCT00550446|20923729|P6|COMPLETED|Post Week 12||0
8491174|NCT00550446|20923730|P5|COMPLETED|Post Week 12||52
8491175|NCT00550446|20923731|P4|COMPLETED|Post Week 12||55
8491176|NCT00550446|20923732|P3|COMPLETED|Post Week 12||43
8491177|NCT00550446|20923733|P2|COMPLETED|Post Week 12||28
8491178|NCT00550446|20923734|P1|COMPLETED|Post Week 12||24
8491179|NCT00550446|20923724|P11|STARTED|Post Week 12||25
8491180|NCT00550446|20923725|P10|STARTED|Post Week 12||44
8491181|NCT00550446|20923726|P9|STARTED|Post Week 12||17
8491182|NCT00550446|20923727|P8|STARTED|Post Week 12||17
8491183|NCT00550446|20923728|P7|STARTED|Post Week 12||21
8491184|NCT00550446|20923729|P6|STARTED|Post Week 12||1
8491185|NCT00550446|20923730|P5|STARTED|Post Week 12||54
8491186|NCT00550446|20923731|P4|STARTED|Post Week 12||58
8491187|NCT00550446|20923732|P3|STARTED|Post Week 12||46
8491188|NCT00550446|20923733|P2|STARTED|Post Week 12||30
8491189|NCT00550446|20923734|P1|STARTED|Post Week 12||27
8491190|NCT00550446|20923724|P11|NOT COMPLETED|Up To Week 12||0
8491191|NCT00550446|20923725|P10|NOT COMPLETED|Up To Week 12||0
8491192|NCT00550446|20923726|P9|NOT COMPLETED|Up To Week 12||0
8491193|NCT00550446|20923727|P8|NOT COMPLETED|Up To Week 12||0
8491194|NCT00550446|20923728|P7|NOT COMPLETED|Up To Week 12||13
8491195|NCT00550446|20923729|P6|NOT COMPLETED|Up To Week 12||8
8491196|NCT00550446|20923730|P5|NOT COMPLETED|Up To Week 12||3
8491197|NCT00550446|20923731|P4|NOT COMPLETED|Up To Week 12||3
8491198|NCT00550446|20923732|P3|NOT COMPLETED|Up To Week 12||4
8491199|NCT00550446|20923733|P2|NOT COMPLETED|Up To Week 12||5
8491200|NCT00550446|20923734|P1|NOT COMPLETED|Up To Week 12||10
8491201|NCT00550446|20923724|P11|COMPLETED|Up To Week 12||0
8491202|NCT00550446|20923725|P10|COMPLETED|Up To Week 12||0
8491203|NCT00550446|20923726|P9|COMPLETED|Up To Week 12||0
8491204|NCT00550446|20923727|P8|COMPLETED|Up To Week 12||0
8491205|NCT00550446|20923728|P7|COMPLETED|Up To Week 12||46
8491206|NCT00550446|20923729|P6|COMPLETED|Up To Week 12||45
8491207|NCT00550446|20923730|P5|COMPLETED|Up To Week 12||54
8491208|NCT00550446|20923731|P4|COMPLETED|Up To Week 12||58
8491209|NCT00550446|20923732|P3|COMPLETED|Up To Week 12||46
8491210|NCT00550446|20923733|P2|COMPLETED|Up To Week 12||47
8491211|NCT00550446|20923734|P1|COMPLETED|Up To Week 12||44
8491212|NCT00550446|20923724|P11|Treated|Up To Week 12||0
8491213|NCT00550446|20923725|P10|Treated|Up To Week 12||0
8491214|NCT00550446|20923726|P9|Treated|Up To Week 12||0
8491215|NCT00550446|20923727|P8|Treated|Up To Week 12||0
8491216|NCT00550446|20923728|P7|Treated|Up To Week 12||59
8491217|NCT00550446|20923729|P6|Treated|Up To Week 12||53
8491218|NCT00550446|20923730|P5|Treated|Up To Week 12||57
8491219|NCT00550446|20923731|P4|Treated|Up To Week 12||61
8491220|NCT00550446|20923732|P3|Treated|Up To Week 12||49
8491221|NCT00550446|20923733|P2|Treated|Up To Week 12||51
8491222|NCT00550446|20923734|P1|Treated|Up To Week 12||54
8491223|NCT00550446|20923724|P11|STARTED|Up To Week 12||0
8491224|NCT00550446|20923725|P10|STARTED|Up To Week 12||0
8492002|NCT00546273|20926296|P4|STARTED|IV||4
8491225|NCT00550446|20923726|P9|STARTED|Up To Week 12||0
8491226|NCT00550446|20923727|P8|STARTED|Up To Week 12||0
8491227|NCT00550446|20923728|P7|STARTED|Up To Week 12||59
8491228|NCT00550446|20923729|P6|STARTED|Up To Week 12||53
8491229|NCT00550446|20923730|P5|STARTED|Up To Week 12||57
8491230|NCT00550446|20923731|P4|STARTED|Up To Week 12||61
8491231|NCT00550446|20923732|P3|STARTED|Up To Week 12||50
8491232|NCT00550446|20923733|P2|STARTED|Up To Week 12||52
8491233|NCT00550446|20923734|P1|STARTED|Up To Week 12||54
8491234|NCT00550420|20924166|P1|NOT COMPLETED|Overall Study||305
8491235|NCT00550420|20924166|P1|COMPLETED|Overall Study||26
8491236|NCT00550420|20924166|P1|STARTED|Overall Study||331
8491237|NCT00550407|20924189|P3|NOT COMPLETED|26-Week Randomized Phase||24
8491238|NCT00550407|20924190|P2|NOT COMPLETED|26-Week Randomized Phase||43
8491239|NCT00550407|20924191|P1|NOT COMPLETED|26-Week Randomized Phase||0
8491240|NCT00550407|20924189|P3|COMPLETED|26-Week Randomized Phase||21
8491241|NCT00550407|20924190|P2|COMPLETED|26-Week Randomized Phase||15
8491242|NCT00550407|20924191|P1|COMPLETED|26-Week Randomized Phase||0
8491243|NCT00550407|20924189|P3|STARTED|26-Week Randomized Phase||45
8491244|NCT00550407|20924190|P2|STARTED|26-Week Randomized Phase||58
8491245|NCT00550407|20924191|P1|STARTED|26-Week Randomized Phase||0
8491246|NCT00550407|20924189|P3|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
8491247|NCT00550407|20924190|P2|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
8491248|NCT00550407|20924191|P1|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
8491249|NCT00550407|20924189|P3|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
8491250|NCT00550407|20924190|P2|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
8491251|NCT00550407|20924191|P1|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
8491252|NCT00550407|20924189|P3|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
8491253|NCT00550407|20924190|P2|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
8491254|NCT00550407|20924191|P1|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
8491255|NCT00550394|20924226|P2|NOT COMPLETED|Overall Study||13
8491256|NCT00550394|20924227|P1|NOT COMPLETED|Overall Study||12
8491257|NCT00550394|20924226|P2|COMPLETED|Overall Study||5
8491258|NCT00550394|20924227|P1|COMPLETED|Overall Study||9
8491259|NCT00550394|20924226|P2|STARTED|Overall Study||18
8491260|NCT00550394|20924227|P1|STARTED|Overall Study||21
8491261|NCT00550368|20924241|P2|NOT COMPLETED|Overall Study||0
8491262|NCT00550368|20924242|P1|NOT COMPLETED|Overall Study||0
8491263|NCT00550368|20924241|P2|COMPLETED|Overall Study||19
8491264|NCT00550368|20924242|P1|COMPLETED|Overall Study||26
8491265|NCT00550368|20924241|P2|STARTED|Overall Study||19
8491266|NCT00550368|20924242|P1|STARTED|Overall Study||26
8491267|NCT00550290|20924252|P2|NOT COMPLETED|Overall Study||0
8491268|NCT00550290|20924253|P1|NOT COMPLETED|Overall Study||0
8491269|NCT00550290|20924252|P2|COMPLETED|Overall Study||8
8491270|NCT00550290|20924253|P1|COMPLETED|Overall Study||10
8491271|NCT00550290|20924252|P2|STARTED|Overall Study||8
8491272|NCT00550290|20924253|P1|STARTED|Overall Study||10
8491273|NCT00550277|20924259|P1|NOT COMPLETED|Overall Study||9
8491274|NCT00550277|20924259|P1|COMPLETED|Overall Study||11
8491275|NCT00550277|20924259|P1|STARTED|Overall Study||20
8491276|NCT00550238|20924263|P1|NOT COMPLETED|Overall Study||459
8491277|NCT00550238|20924263|P1|COMPLETED|Overall Study||0
8491278|NCT00550238|20924263|P1|STARTED|Overall Study||459
8491279|NCT00550173|20924270|P3|NOT COMPLETED|Overall Study||73
8491280|NCT00550173|20924271|P2|NOT COMPLETED|Overall Study||63
8491281|NCT00550173|20924272|P1|NOT COMPLETED|Overall Study||72
8491282|NCT00550173|20924270|P3|COMPLETED|Overall Study||11
8491283|NCT00550173|20924271|P2|COMPLETED|Overall Study||19
8491284|NCT00550173|20924272|P1|COMPLETED|Overall Study||9
8491285|NCT00550173|20924270|P3|Not Discontinued at 18 Months|Overall Study||11
8491286|NCT00550173|20924271|P2|Not Discontinued at 18 Months|Overall Study||19
8491287|NCT00550173|20924272|P1|Not Discontinued at 18 Months|Overall Study||9
8491288|NCT00550173|20924270|P3|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
8491289|NCT00550173|20924271|P2|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
8491290|NCT00550173|20924272|P1|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
8491291|NCT00550173|20924270|P3|STARTED|Overall Study||84
8491292|NCT00550173|20924271|P2|STARTED|Overall Study||82
8491293|NCT00550173|20924272|P1|STARTED|Overall Study||81
8491294|NCT00550147|20924301|P1|NOT COMPLETED|Quetiapine Addition Treatment Period||6
8491295|NCT00550147|20924301|P1|COMPLETED|Quetiapine Addition Treatment Period||18
8491296|NCT00550147|20924301|P1|STARTED|Quetiapine Addition Treatment Period||24
8491297|NCT00550147|20924301|P1|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
8491298|NCT00550147|20924301|P1|COMPLETED|OROS Methylphenidate Monotherapy||24
8491299|NCT00550147|20924301|P1|STARTED|OROS Methylphenidate Monotherapy||30
8491300|NCT00550043|20924324|P5|NOT COMPLETED|Overall Study||1
8491301|NCT00550043|20924325|P4|NOT COMPLETED|Overall Study||2
8491302|NCT00550043|20924326|P3|NOT COMPLETED|Overall Study||1
8491303|NCT00550043|20924327|P2|NOT COMPLETED|Overall Study||3
8491304|NCT00550043|20924328|P1|NOT COMPLETED|Overall Study||0
8491305|NCT00550043|20924324|P5|COMPLETED|Overall Study||9
8491306|NCT00550043|20924325|P4|COMPLETED|Overall Study||8
8491307|NCT00550043|20924326|P3|COMPLETED|Overall Study||8
8491308|NCT00550043|20924327|P2|COMPLETED|Overall Study||9
8491309|NCT00550043|20924328|P1|COMPLETED|Overall Study||9
8491310|NCT00550043|20924324|P5|STARTED|Overall Study||10
8491311|NCT00550043|20924325|P4|STARTED|Overall Study||10
8491312|NCT00550043|20924326|P3|STARTED|Overall Study||9
8492003|NCT00546273|20926297|P3|STARTED|IV||0
8491313|NCT00550043|20924327|P2|STARTED|Overall Study||12
8491314|NCT00550043|20924328|P1|STARTED|Overall Study||9
8491315|NCT00549939|20924383|P3|NOT COMPLETED|40-week Open Label Treatment Period||5
8491316|NCT00549939|20924384|P2|NOT COMPLETED|40-week Open Label Treatment Period||5
8491317|NCT00549939|20924385|P1|NOT COMPLETED|40-week Open Label Treatment Period||0
8491318|NCT00549939|20924383|P3|COMPLETED|40-week Open Label Treatment Period||78
8491319|NCT00549939|20924384|P2|COMPLETED|40-week Open Label Treatment Period||75
8491320|NCT00549939|20924385|P1|COMPLETED|40-week Open Label Treatment Period||0
8491321|NCT00549939|20924383|P3|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
8491322|NCT00549939|20924384|P2|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
8491323|NCT00549939|20924385|P1|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
8491324|NCT00549939|20924383|P3|NOT COMPLETED|12-week Double Blind Treatment Period||2
8491325|NCT00549939|20924384|P2|NOT COMPLETED|12-week Double Blind Treatment Period||2
8491326|NCT00549939|20924385|P1|NOT COMPLETED|12-week Double Blind Treatment Period||1
8491327|NCT00549939|20924383|P3|COMPLETED|12-week Double Blind Treatment Period||56
8491328|NCT00549939|20924384|P2|COMPLETED|12-week Double Blind Treatment Period||55
8491329|NCT00549939|20924385|P1|COMPLETED|12-week Double Blind Treatment Period||56
8491330|NCT00549939|20924383|P3|STARTED|12-week Double Blind Treatment Period||58
8491331|NCT00549939|20924384|P2|STARTED|12-week Double Blind Treatment Period||57
8491332|NCT00549939|20924385|P1|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
8491333|NCT00549900|20924412|P1|NOT COMPLETED|Overall Study||1
8491334|NCT00549900|20924412|P1|COMPLETED|Overall Study||29
8491335|NCT00549900|20924412|P1|STARTED|Overall Study||30
8491336|NCT00549822|20924421|P1|NOT COMPLETED|Overall Study||0
8491337|NCT00549822|20924421|P1|COMPLETED|Overall Study||3
8491338|NCT00549822|20924421|P1|STARTED|Overall Study||3
8491339|NCT00549783|20924429|P2|NOT COMPLETED|Overall Study||13
8491340|NCT00549783|20924430|P1|NOT COMPLETED|Overall Study||8
8491341|NCT00549783|20924429|P2|COMPLETED|Overall Study||122
8491342|NCT00549783|20924430|P1|COMPLETED|Overall Study||131
8491343|NCT00549783|20924429|P2|STARTED|Overall Study||135
8491344|NCT00549783|20924430|P1|STARTED|Overall Study||139
8491345|NCT00549770|20924468|P8|NOT COMPLETED|Overall Study||25
8491346|NCT00549770|20924469|P7|NOT COMPLETED|Overall Study||14
8491347|NCT00549770|20924470|P6|NOT COMPLETED|Overall Study||13
8491348|NCT00549770|20924471|P5|NOT COMPLETED|Overall Study||17
8491349|NCT00549770|20924472|P4|NOT COMPLETED|Overall Study||16
8491350|NCT00549770|20924473|P3|NOT COMPLETED|Overall Study||10
8491351|NCT00549770|20924474|P2|NOT COMPLETED|Overall Study||11
8491352|NCT00549770|20924475|P1|NOT COMPLETED|Overall Study||7
8491353|NCT00549770|20924468|P8|COMPLETED|Overall Study||148
8491354|NCT00549770|20924469|P7|COMPLETED|Overall Study||151
8491355|NCT00549770|20924470|P6|COMPLETED|Overall Study||151
8491356|NCT00549770|20924471|P5|COMPLETED|Overall Study||149
8491357|NCT00549770|20924472|P4|COMPLETED|Overall Study||147
8491358|NCT00549770|20924473|P3|COMPLETED|Overall Study||162
8491359|NCT00549770|20924474|P2|COMPLETED|Overall Study||158
8491360|NCT00549770|20924475|P1|COMPLETED|Overall Study||149
8491361|NCT00549770|20924468|P8|Ambulatory Blood Pressure Monitoring|Overall Study||57
8491362|NCT00549770|20924469|P7|Ambulatory Blood Pressure Monitoring|Overall Study||50
8491363|NCT00549770|20924470|P6|Ambulatory Blood Pressure Monitoring|Overall Study||54
8491364|NCT00549770|20924471|P5|Ambulatory Blood Pressure Monitoring|Overall Study||49
8491365|NCT00549770|20924472|P4|Ambulatory Blood Pressure Monitoring|Overall Study||55
8491366|NCT00549770|20924473|P3|Ambulatory Blood Pressure Monitoring|Overall Study||53
8491367|NCT00549770|20924474|P2|Ambulatory Blood Pressure Monitoring|Overall Study||61
8491368|NCT00549770|20924475|P1|Ambulatory Blood Pressure Monitoring|Overall Study||48
8491369|NCT00549770|20924468|P8|Intent-to-treat Population|Overall Study||172
8491370|NCT00549770|20924469|P7|Intent-to-treat Population|Overall Study||164
8491371|NCT00549770|20924470|P6|Intent-to-treat Population|Overall Study||163
8491372|NCT00549770|20924471|P5|Intent-to-treat Population|Overall Study||163
8491373|NCT00549770|20924472|P4|Intent-to-treat Population|Overall Study||163
8491374|NCT00549770|20924473|P3|Intent-to-treat Population|Overall Study||170
8491375|NCT00549770|20924474|P2|Intent-to-treat Population|Overall Study||168
8491376|NCT00549770|20924475|P1|Intent-to-treat Population|Overall Study||154
8491377|NCT00549770|20924468|P8|STARTED|Overall Study||173
8491378|NCT00549770|20924469|P7|STARTED|Overall Study||165
8491379|NCT00549770|20924470|P6|STARTED|Overall Study||164
8491380|NCT00549770|20924471|P5|STARTED|Overall Study||166
8491381|NCT00549770|20924472|P4|STARTED|Overall Study||163
8491382|NCT00549770|20924473|P3|STARTED|Overall Study||172
8491383|NCT00549770|20924474|P2|STARTED|Overall Study||169
8491384|NCT00549770|20924475|P1|STARTED|Overall Study||156
8491385|NCT00549757|20924559|P2|NOT COMPLETED|Extension Period (in Average 9 Months)||635
8491386|NCT00549757|20924560|P1|NOT COMPLETED|Extension Period (in Average 9 Months)||625
8491387|NCT00549757|20924559|P2|COMPLETED|Extension Period (in Average 9 Months)||3182
8491388|NCT00549757|20924560|P1|COMPLETED|Extension Period (in Average 9 Months)||3148
8491389|NCT00549757|20924559|P2|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
8491390|NCT00549757|20924560|P1|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
8491391|NCT00549757|20924559|P2|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
8491392|NCT00549757|20924560|P1|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
8491393|NCT00549757|20924559|P2|COMPLETED|Active Treatment Phase: Max. 50 Months||0
8491394|NCT00549757|20924560|P1|COMPLETED|Active Treatment Phase: Max. 50 Months||0
8491395|NCT00549757|20924559|P2|Safety Set|Active Treatment Phase: Max. 50 Months||4285
8491396|NCT00549757|20924560|P1|Safety Set|Active Treatment Phase: Max. 50 Months||4272
8491397|NCT00549757|20924559|P2|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
8491398|NCT00549757|20924560|P1|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
8491399|NCT00549757|20924559|P2|STARTED|Active Treatment Phase: Max. 50 Months||4310
8491400|NCT00549757|20924560|P1|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
8491401|NCT00549718|20924622|P4|NOT COMPLETED|Overall Study||55
8491402|NCT00549718|20924623|P3|NOT COMPLETED|Overall Study||39
8491403|NCT00549718|20924624|P2|NOT COMPLETED|Overall Study||37
8491404|NCT00549718|20924625|P1|NOT COMPLETED|Overall Study||41
8491405|NCT00549718|20924622|P4|COMPLETED|Overall Study||73
8491406|NCT00549718|20924623|P3|COMPLETED|Overall Study||85
8491407|NCT00549718|20924624|P2|COMPLETED|Overall Study||86
8491408|NCT00549718|20924625|P1|COMPLETED|Overall Study||84
8491409|NCT00549718|20924622|P4|STARTED|Overall Study||128
8491410|NCT00549718|20924623|P3|STARTED|Overall Study||124
8491411|NCT00549718|20924624|P2|STARTED|Overall Study||123
8491412|NCT00549718|20924625|P1|STARTED|Overall Study||125
8491413|NCT00549640|20924641|P2|NOT COMPLETED|Overall Study||16
8491414|NCT00549640|20924642|P1|NOT COMPLETED|Overall Study||18
8491415|NCT00549640|20924641|P2|COMPLETED|Overall Study||24
8491416|NCT00549640|20924642|P1|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
8491417|NCT00549640|20924641|P2|STARTED|Overall Study||40
8491418|NCT00549640|20924642|P1|STARTED|Overall Study||40
8491419|NCT00549601|20924655|P3|NOT COMPLETED|Received Study Drug||4
8491420|NCT00549601|20924656|P2|NOT COMPLETED|Received Study Drug||11
8491421|NCT00549601|20924657|P1|NOT COMPLETED|Received Study Drug||7
8491422|NCT00549601|20924655|P3|COMPLETED|Received Study Drug||45
8491423|NCT00549601|20924656|P2|COMPLETED|Received Study Drug||36
8491424|NCT00549601|20924657|P1|COMPLETED|Received Study Drug||36
8491425|NCT00549601|20924655|P3|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
8491426|NCT00549601|20924656|P2|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
8491427|NCT00549601|20924657|P1|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
8491428|NCT00549601|20924655|P3|NOT COMPLETED|Randomized||2
8491429|NCT00549601|20924656|P2|NOT COMPLETED|Randomized||1
8491430|NCT00549601|20924657|P1|NOT COMPLETED|Randomized||0
8491431|NCT00549601|20924655|P3|COMPLETED|Randomized||49
8491432|NCT00549601|20924656|P2|COMPLETED|Randomized||47
8491433|NCT00549601|20924657|P1|COMPLETED|Randomized||43
8491434|NCT00549601|20924655|P3|STARTED|Randomized||51
8491435|NCT00549601|20924656|P2|STARTED|Randomized||48
8491436|NCT00549601|20924657|P1|STARTED|Randomized||43
8491437|NCT00549562|20924679|P1|NOT COMPLETED|Overall Study||2
8491438|NCT00549562|20924679|P1|COMPLETED|Overall Study||23
8491439|NCT00549562|20924679|P1|STARTED|Overall Study||25
8491456|NCT00549445|20924762|P2|NOT COMPLETED|Overall Study||17
8491457|NCT00549445|20924763|P1|NOT COMPLETED|Overall Study||15
8491458|NCT00549445|20924762|P2|COMPLETED|Overall Study||13
8491459|NCT00549445|20924763|P1|COMPLETED|Overall Study||8
8491460|NCT00549445|20924762|P2|STARTED|Overall Study||30
8491461|NCT00549445|20924763|P1|STARTED|Overall Study||23
8491462|NCT00549393|20924771|P2|NOT COMPLETED|Period 3 (6 Months)||0
8491463|NCT00549393|20924772|P1|NOT COMPLETED|Period 3 (6 Months)||0
8491464|NCT00549393|20924771|P2|COMPLETED|Period 3 (6 Months)||1326
8491465|NCT00549393|20924772|P1|COMPLETED|Period 3 (6 Months)||1103
8491466|NCT00549393|20924771|P2|Per Protocol|Period 3 (6 Months)||1326
8491467|NCT00549393|20924772|P1|Per Protocol|Period 3 (6 Months)||667
8491468|NCT00549393|20924771|P2|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
8491469|NCT00549393|20924772|P1|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
8491470|NCT00549393|20924771|P2|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
8491471|NCT00549393|20924772|P1|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
8491472|NCT00549393|20924771|P2|COMPLETED|Period 2 Washout (2 Weeks)||0
8491473|NCT00549393|20924772|P1|COMPLETED|Period 2 Washout (2 Weeks)||0
8491474|NCT00549393|20924771|P2|STARTED|Period 2 Washout (2 Weeks)||0
8491475|NCT00549393|20924772|P1|STARTED|Period 2 Washout (2 Weeks)||0
8491476|NCT00549393|20924771|P2|NOT COMPLETED|Period 1 (6 Months)||0
8492004|NCT00546273|20926298|P2|STARTED|IV||0
8491477|NCT00549393|20924772|P1|NOT COMPLETED|Period 1 (6 Months)||0
8491478|NCT00549393|20924771|P2|COMPLETED|Period 1 (6 Months)||1199
8491479|NCT00549393|20924772|P1|COMPLETED|Period 1 (6 Months)||1319
8491480|NCT00549393|20924771|P2|Per Protocol|Period 1 (6 Months)||1199
8491481|NCT00549393|20924772|P1|Per Protocol|Period 1 (6 Months)||880
8491482|NCT00549393|20924771|P2|STARTED|Period 1 (6 Months)|ITT|1199
8491483|NCT00549393|20924772|P1|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
8491484|NCT00549328|20924782|P1|NOT COMPLETED|Overall Study||14
8491485|NCT00549328|20924782|P1|COMPLETED|Overall Study||0
8491486|NCT00549328|20924782|P1|STARTED|Overall Study||14
8491487|NCT00549302|20924793|P3|NOT COMPLETED|Open-Label||69
8491488|NCT00549302|20924794|P2|NOT COMPLETED|Open-Label||0
8491489|NCT00549302|20924795|P1|NOT COMPLETED|Open-Label||0
8491490|NCT00549302|20924793|P3|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
8491491|NCT00549302|20924794|P2|COMPLETED|Open-Label||0
8491492|NCT00549302|20924795|P1|COMPLETED|Open-Label||0
8491493|NCT00549302|20924793|P3|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
8491494|NCT00549302|20924794|P2|STARTED|Open-Label||0
8491495|NCT00549302|20924795|P1|STARTED|Open-Label||0
8491496|NCT00549302|20924793|P3|NOT COMPLETED|Double-Blind||0
8491497|NCT00549302|20924794|P2|NOT COMPLETED|Double-Blind||53
8491498|NCT00549302|20924795|P1|NOT COMPLETED|Double-Blind||11
8491499|NCT00549302|20924793|P3|COMPLETED|Double-Blind||0
8491500|NCT00549302|20924794|P2|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
8491501|NCT00549302|20924795|P1|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
8491502|NCT00549302|20924793|P3|Received at Least One Dose of Study Drug|Double-Blind||0
8491503|NCT00549302|20924794|P2|Received at Least One Dose of Study Drug|Double-Blind||294
8491504|NCT00549302|20924795|P1|Received at Least One Dose of Study Drug|Double-Blind||63
8491505|NCT00549302|20924793|P3|STARTED|Double-Blind||0
8491506|NCT00549302|20924794|P2|STARTED|Double-Blind||294
8491507|NCT00549302|20924795|P1|STARTED|Double-Blind||63
8491508|NCT00549198|20924807|P2|NOT COMPLETED|Overall Study||63
8491509|NCT00549198|20924808|P1|NOT COMPLETED|Overall Study||80
8491510|NCT00549198|20924807|P2|COMPLETED|Overall Study||134
8491511|NCT00549198|20924808|P1|COMPLETED|Overall Study||115
8491512|NCT00549198|20924807|P2|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
8491513|NCT00549198|20924808|P1|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
8491514|NCT00549172|20924930|P2|NOT COMPLETED|Overall Study||0
8491515|NCT00549172|20924931|P1|NOT COMPLETED|Overall Study||0
8491516|NCT00549172|20924930|P2|COMPLETED|Overall Study||76
8491517|NCT00549172|20924931|P1|COMPLETED|Overall Study||70
8491518|NCT00549172|20924930|P2|STARTED|Overall Study||76
8491519|NCT00549172|20924931|P1|STARTED|Overall Study||70
8491520|NCT00549055|20924945|P1|NOT COMPLETED|Overall Study||35
8491521|NCT00549055|20924945|P1|COMPLETED|Overall Study||3
8491522|NCT00549055|20924945|P1|STARTED|Overall Study||38
8491523|NCT00549042|20924957|P2|NOT COMPLETED|Double-blind Phase||90
8491524|NCT00549042|20924958|P1|NOT COMPLETED|Double-blind Phase||68
8491525|NCT00549042|20924957|P2|COMPLETED|Double-blind Phase||44
8491526|NCT00549042|20924958|P1|COMPLETED|Double-blind Phase||66
8491527|NCT00549042|20924957|P2|STARTED|Double-blind Phase||134
8491528|NCT00549042|20924958|P1|STARTED|Double-blind Phase||134
8491529|NCT00549042|20924957|P2|NOT COMPLETED|Conversion and Titration Phase||0
8491530|NCT00549042|20924958|P1|NOT COMPLETED|Conversion and Titration Phase||191
8491531|NCT00549042|20924957|P2|COMPLETED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
8491532|NCT00549042|20924958|P1|COMPLETED|Conversion and Titration Phase||268
8491533|NCT00549042|20924957|P2|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
8491534|NCT00549042|20924958|P1|STARTED|Conversion and Titration Phase||459
8491535|NCT00548886|20924975|P1|NOT COMPLETED|Overall Study||0
8491536|NCT00548886|20924975|P1|COMPLETED|Overall Study||7
8491537|NCT00548886|20924975|P1|STARTED|Overall Study||7
8491538|NCT00548860|20924982|P2|NOT COMPLETED|Overall Study||175
8491539|NCT00548860|20924983|P1|NOT COMPLETED|Overall Study||136
8491540|NCT00548860|20924982|P2|COMPLETED|Overall Study||847
8491541|NCT00548860|20924983|P1|COMPLETED|Overall Study||860
8491542|NCT00548860|20924982|P2|STARTED|Overall Study||1022
8491543|NCT00548860|20924983|P1|STARTED|Overall Study||996
8491544|NCT00548847|20924989|P1|NOT COMPLETED|Overall Study||7
8491545|NCT00548847|20924989|P1|COMPLETED|Overall Study||8
8491546|NCT00548847|20924989|P1|STARTED|Overall Study||15
8491547|NCT00548808|20924996|P2|NOT COMPLETED|Overall Study||26
8491548|NCT00548808|20924997|P1|NOT COMPLETED|Overall Study||42
8491549|NCT00548808|20924996|P2|COMPLETED|Overall Study||186
8491550|NCT00548808|20924997|P1|COMPLETED|Overall Study||172
8491551|NCT00548808|20924996|P2|Per-Protocol Set|Overall Study||184
8491552|NCT00548808|20924997|P1|Per-Protocol Set|Overall Study||177
8491553|NCT00548808|20924996|P2|Full Analysis Set|Overall Study||212
8491554|NCT00548808|20924997|P1|Full Analysis Set|Overall Study||211
8491555|NCT00548808|20924996|P2|STARTED|Overall Study||212
8491556|NCT00548808|20924997|P1|STARTED|Overall Study||214
8491557|NCT00548717|20925021|P2|NOT COMPLETED|Overall Study||2
8491558|NCT00548717|20925022|P1|NOT COMPLETED|Overall Study||9
8491559|NCT00548717|20925021|P2|COMPLETED|Overall Study||0
8491560|NCT00548717|20925022|P1|COMPLETED|Overall Study||4
8491561|NCT00548717|20925021|P2|STARTED|Overall Study||2
8491562|NCT00548717|20925022|P1|STARTED|Overall Study||13
8491563|NCT00548691|20925041|P2|NOT COMPLETED|Overall Study||9
8491564|NCT00548691|20925042|P1|NOT COMPLETED|Overall Study||7
8491565|NCT00548691|20925041|P2|COMPLETED|Overall Study||250
8491566|NCT00548691|20925042|P1|COMPLETED|Overall Study||251
8491567|NCT00548691|20925041|P2|STARTED|Overall Study||259
8491568|NCT00548691|20925042|P1|STARTED|Overall Study||258
8491569|NCT00548652|20925051|P3|NOT COMPLETED|Overall Study||11
8491570|NCT00548652|20925052|P2|NOT COMPLETED|Overall Study||9
8491571|NCT00548652|20925053|P1|NOT COMPLETED|Overall Study||2
8491572|NCT00548652|20925051|P3|COMPLETED|Overall Study||34
8491573|NCT00548652|20925052|P2|COMPLETED|Overall Study||29
8491574|NCT00548652|20925053|P1|COMPLETED|Overall Study||16
8491575|NCT00548652|20925051|P3|STARTED|Overall Study||45
8491576|NCT00548652|20925052|P2|STARTED|Overall Study||38
8491577|NCT00548652|20925053|P1|STARTED|Overall Study||18
8491578|NCT00548548|20925066|P2|NOT COMPLETED|Overall Study||366
8491579|NCT00548548|20925067|P1|NOT COMPLETED|Overall Study||362
8491580|NCT00548548|20925066|P2|COMPLETED|Overall Study||21
8491581|NCT00548548|20925067|P1|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
8491582|NCT00548548|20925066|P2|Safety Population|Overall Study||381
8491583|NCT00548548|20925067|P1|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
8491584|NCT00548548|20925066|P2|Treated|Overall Study||384
8491585|NCT00548548|20925067|P1|Treated|Overall Study||383
8491586|NCT00548548|20925066|P2|STARTED|Overall Study||387
8491587|NCT00548548|20925067|P1|STARTED|Overall Study||387
8491588|NCT00548470|20925087|P1|NOT COMPLETED|Overall Study||2
8491589|NCT00548470|20925087|P1|COMPLETED|Overall Study||12
8491590|NCT00548470|20925087|P1|STARTED|Overall Study||14
8491591|NCT00548431|20925095|P1|NOT COMPLETED|Overall Study||0
8491592|NCT00548431|20925095|P1|COMPLETED|Overall Study||38
8491593|NCT00548431|20925095|P1|STARTED|Overall Study||38
8491594|NCT00548418|20925099|P1|NOT COMPLETED|Overall Study||0
8491595|NCT00548418|20925099|P1|COMPLETED|Overall Study||27
8491596|NCT00548418|20925099|P1|STARTED|Overall Study||27
8491597|NCT00548405|20925110|P3|NOT COMPLETED|Overall Study||9
8491598|NCT00548405|20925111|P2|NOT COMPLETED|Overall Study||20
8491599|NCT00548405|20925112|P1|NOT COMPLETED|Overall Study||56
8491600|NCT00548405|20925110|P3|COMPLETED|Overall Study||164
8491601|NCT00548405|20925111|P2|COMPLETED|Overall Study||416
8491602|NCT00548405|20925112|P1|COMPLETED|Overall Study||175
8491603|NCT00548405|20925110|P3|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
8491604|NCT00548405|20925111|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
8491605|NCT00548405|20925112|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
8491606|NCT00548405|20925110|P3|STARTED|Overall Study|Randomized.|173
8491607|NCT00548405|20925111|P2|STARTED|Overall Study|Randomized.|436
8491608|NCT00548405|20925112|P1|STARTED|Overall Study|Randomized.|231
8491609|NCT00548340|20925133|P3|NOT COMPLETED|Overall Study||9
8491610|NCT00548340|20925134|P2|NOT COMPLETED|Overall Study||11
8491611|NCT00548340|20925135|P1|NOT COMPLETED|Overall Study||8
8491612|NCT00548340|20925133|P3|COMPLETED|Overall Study||95
8491613|NCT00548340|20925134|P2|COMPLETED|Overall Study||98
8491614|NCT00548340|20925135|P1|COMPLETED|Overall Study||101
8491615|NCT00548340|20925133|P3|STARTED|Overall Study||104
8491616|NCT00548340|20925134|P2|STARTED|Overall Study||109
8491617|NCT00548340|20925135|P1|STARTED|Overall Study||109
8491618|NCT00548327|20925154|P2|NOT COMPLETED|Overall Study||1
8491619|NCT00548327|20925155|P1|NOT COMPLETED|Overall Study||0
8491620|NCT00548327|20925154|P2|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
8491621|NCT00548327|20925155|P1|COMPLETED|Overall Study||6
8491622|NCT00548327|20925154|P2|STARTED|Overall Study||5
8491623|NCT00548327|20925155|P1|STARTED|Overall Study||6
8491624|NCT00548262|20925173|P1|NOT COMPLETED|Overall Study||32
8491625|NCT00548262|20925173|P1|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
8491626|NCT00548262|20925173|P1|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
8491627|NCT00548249|20925203|P5|NOT COMPLETED|Overall Study||21
8491628|NCT00548249|20925204|P4|NOT COMPLETED|Overall Study||13
8491629|NCT00548249|20925205|P3|NOT COMPLETED|Overall Study||20
8491630|NCT00548249|20925206|P2|NOT COMPLETED|Overall Study||13
8491631|NCT00548249|20925207|P1|NOT COMPLETED|Overall Study||16
8491632|NCT00548249|20925203|P5|COMPLETED|Overall Study||7
8491633|NCT00548249|20925204|P4|COMPLETED|Overall Study||9
8491634|NCT00548249|20925205|P3|COMPLETED|Overall Study||9
8491635|NCT00548249|20925206|P2|COMPLETED|Overall Study||13
8491636|NCT00548249|20925207|P1|COMPLETED|Overall Study||10
8491637|NCT00548249|20925203|P5|STARTED|Overall Study||28
8491638|NCT00548249|20925204|P4|STARTED|Overall Study||22
8491639|NCT00548249|20925205|P3|STARTED|Overall Study||29
8491640|NCT00548249|20925206|P2|STARTED|Overall Study||26
8491641|NCT00548249|20925207|P1|STARTED|Overall Study||26
8491642|NCT00548197|20925246|P2|NOT COMPLETED|Overall Study||0
8491643|NCT00548197|20925247|P1|NOT COMPLETED|Overall Study||0
8491644|NCT00548197|20925246|P2|COMPLETED|Overall Study||22
8491645|NCT00548197|20925247|P1|COMPLETED|Overall Study||18
8491646|NCT00548197|20925246|P2|STARTED|Overall Study||22
8491647|NCT00548197|20925247|P1|STARTED|Overall Study||18
8491648|NCT00548184|20925255|P1|NOT COMPLETED|Overall Study||5
8492005|NCT00546273|20926299|P1|STARTED|IV||0
8491649|NCT00548184|20925255|P1|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
8491650|NCT00548184|20925255|P1|STARTED|Overall Study||65
8491651|NCT00548171|20925261|P2|NOT COMPLETED|Overall Study||0
8491652|NCT00548171|20925262|P1|NOT COMPLETED|Overall Study||0
8491653|NCT00548171|20925261|P2|COMPLETED|Overall Study||39
8491654|NCT00548171|20925262|P1|COMPLETED|Overall Study||164
8491655|NCT00548171|20925261|P2|STARTED|Overall Study||39
8491656|NCT00548171|20925262|P1|STARTED|Overall Study||164
8491657|NCT00548145|20925303|P2|NOT COMPLETED|Overall Study||4
8491658|NCT00548145|20925304|P1|NOT COMPLETED|Overall Study||1
8491659|NCT00548145|20925303|P2|COMPLETED|Overall Study||16
8491660|NCT00548145|20925304|P1|COMPLETED|Overall Study||17
8491661|NCT00548145|20925303|P2|STARTED|Overall Study||20
8491662|NCT00548145|20925304|P1|STARTED|Overall Study||18
8491663|NCT00548132|20925312|P2|NOT COMPLETED|Overall Study||0
8491664|NCT00548132|20925313|P1|NOT COMPLETED|Overall Study||0
8491665|NCT00548132|20925312|P2|COMPLETED|Overall Study||554
8491666|NCT00548132|20925313|P1|COMPLETED|Overall Study||534
8491667|NCT00548132|20925312|P2|Consented to Study|Overall Study||554
8491668|NCT00548132|20925313|P1|Consented to Study|Overall Study||534
8491669|NCT00548132|20925312|P2|STARTED|Overall Study||554
8491670|NCT00548132|20925313|P1|STARTED|Overall Study||534
8491671|NCT00548093|20925323|P2|NOT COMPLETED|Overall Study||16
8491672|NCT00548093|20925324|P1|NOT COMPLETED|Overall Study||50
8491673|NCT00548093|20925323|P2|COMPLETED|Overall Study||0
8491674|NCT00548093|20925324|P1|COMPLETED|Overall Study||0
8491675|NCT00548093|20925323|P2|STARTED|Overall Study||16
8491676|NCT00548093|20925324|P1|STARTED|Overall Study||50
8491677|NCT00548041|20925354|P1|NOT COMPLETED|Overall Study||0
8491678|NCT00548041|20925354|P1|COMPLETED|Overall Study||100
8491679|NCT00548041|20925354|P1|STARTED|Overall Study||100
8491680|NCT00547911|20925362|P6|NOT COMPLETED|Overall Study||0
8491681|NCT00547911|20925363|P5|NOT COMPLETED|Overall Study||0
8491682|NCT00547911|20925364|P4|NOT COMPLETED|Overall Study||1
8491683|NCT00547911|20925365|P3|NOT COMPLETED|Overall Study||0
8491684|NCT00547911|20925366|P2|NOT COMPLETED|Overall Study||0
8491685|NCT00547911|20925367|P1|NOT COMPLETED|Overall Study||0
8491686|NCT00547911|20925362|P6|COMPLETED|Overall Study||3
8491687|NCT00547911|20925363|P5|COMPLETED|Overall Study||3
8491688|NCT00547911|20925364|P4|COMPLETED|Overall Study||1
8491689|NCT00547911|20925365|P3|COMPLETED|Overall Study||2
8491690|NCT00547911|20925366|P2|COMPLETED|Overall Study||2
8491691|NCT00547911|20925367|P1|COMPLETED|Overall Study||2
8491692|NCT00547911|20925362|P6|STARTED|Overall Study||3
8491693|NCT00547911|20925363|P5|STARTED|Overall Study||3
8491694|NCT00547911|20925364|P4|STARTED|Overall Study||2
8491695|NCT00547911|20925365|P3|STARTED|Overall Study||2
8491696|NCT00547911|20925366|P2|STARTED|Overall Study||2
8491697|NCT00547911|20925367|P1|STARTED|Overall Study||2
8491698|NCT00547898|20925400|P4|NOT COMPLETED|Overall Study||6
8491699|NCT00547898|20925401|P3|NOT COMPLETED|Overall Study||0
8491700|NCT00547898|20925402|P2|NOT COMPLETED|Overall Study||10
8491701|NCT00547898|20925403|P1|NOT COMPLETED|Overall Study||9
8491702|NCT00547898|20925400|P4|COMPLETED|Overall Study||40
8491703|NCT00547898|20925401|P3|COMPLETED|Overall Study||54
8491704|NCT00547898|20925402|P2|COMPLETED|Overall Study||126
8491705|NCT00547898|20925403|P1|COMPLETED|Overall Study||129
8491706|NCT00547898|20925400|P4|STARTED|Overall Study||46
8491707|NCT00547898|20925401|P3|STARTED|Overall Study||54
8491708|NCT00547898|20925402|P2|STARTED|Overall Study||136
8491709|NCT00547898|20925403|P1|STARTED|Overall Study||138
8491710|NCT00547703|20925417|P2|NOT COMPLETED|Overall Study||0
8491711|NCT00547703|20925418|P1|NOT COMPLETED|Overall Study||1
8491712|NCT00547703|20925417|P2|COMPLETED|Overall Study||1
8491713|NCT00547703|20925418|P1|COMPLETED|Overall Study||3
8491714|NCT00547703|20925417|P2|STARTED|Overall Study||1
8491715|NCT00547703|20925418|P1|STARTED|Overall Study||4
8491716|NCT00547638|20925426|P2|NOT COMPLETED|Overall Study||14
8491717|NCT00547638|20925427|P1|NOT COMPLETED|Overall Study||24
8491718|NCT00547638|20925426|P2|COMPLETED|Overall Study||59
8491719|NCT00547638|20925427|P1|COMPLETED|Overall Study||119
8491720|NCT00547638|20925426|P2|STARTED|Overall Study||73
8491721|NCT00547638|20925427|P1|STARTED|Overall Study||143
8491722|NCT00547586|20925448|P5|NOT COMPLETED|Overall Study||3
8491723|NCT00547586|20925449|P4|NOT COMPLETED|Overall Study||6
8491724|NCT00547586|20925450|P3|NOT COMPLETED|Overall Study||1
8491725|NCT00547586|20925451|P2|NOT COMPLETED|Overall Study||1
8491726|NCT00547586|20925452|P1|NOT COMPLETED|Overall Study||5
8491727|NCT00547586|20925448|P5|COMPLETED|Overall Study||32
8491728|NCT00547586|20925449|P4|COMPLETED|Overall Study||27
8491729|NCT00547586|20925450|P3|COMPLETED|Overall Study||13
8491730|NCT00547586|20925451|P2|COMPLETED|Overall Study||6
8491731|NCT00547586|20925452|P1|COMPLETED|Overall Study||28
8491732|NCT00547586|20925448|P5|STARTED|Overall Study||35
8491733|NCT00547586|20925449|P4|STARTED|Overall Study||33
8491734|NCT00547586|20925450|P3|STARTED|Overall Study||14
8491735|NCT00547586|20925451|P2|STARTED|Overall Study||7
8491736|NCT00547586|20925452|P1|STARTED|Overall Study||33
8491737|NCT00547534|20925464|P1|NOT COMPLETED|Overall Study||11
8491738|NCT00547534|20925464|P1|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
8491739|NCT00547534|20925464|P1|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
8491740|NCT00547521|20925472|P2|NOT COMPLETED|Long Term Extension (LTE) Study||31
8491741|NCT00547521|20925473|P1|NOT COMPLETED|Long Term Extension (LTE) Study||0
8491742|NCT00547521|20925472|P2|COMPLETED|Long Term Extension (LTE) Study||59
8491743|NCT00547521|20925473|P1|COMPLETED|Long Term Extension (LTE) Study||0
8491744|NCT00547521|20925472|P2|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
8491745|NCT00547521|20925473|P1|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
8491746|NCT00547521|20925472|P2|NOT COMPLETED|Short Term Study (4 Months)||4
8491747|NCT00547521|20925473|P1|NOT COMPLETED|Short Term Study (4 Months)||1
8491748|NCT00547521|20925472|P2|COMPLETED|Short Term Study (4 Months)||45
8491749|NCT00547521|20925473|P1|COMPLETED|Short Term Study (4 Months)||50
8491750|NCT00547521|20925472|P2|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
8491751|NCT00547521|20925473|P1|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
8491752|NCT00547456|20925543|P1|NOT COMPLETED|Overall Study||0
8491753|NCT00547456|20925543|P1|COMPLETED|Overall Study||20
8491754|NCT00547456|20925543|P1|STARTED|Overall Study||20
8491755|NCT00547378|20925550|P3|NOT COMPLETED|All Implanted Cohort||70
8491756|NCT00547378|20925551|P2|NOT COMPLETED|All Implanted Cohort||18
8491757|NCT00547378|20925552|P1|NOT COMPLETED|All Implanted Cohort||15
8491758|NCT00547378|20925550|P3|COMPLETED|All Implanted Cohort||111
8491759|NCT00547378|20925551|P2|COMPLETED|All Implanted Cohort||22
8491760|NCT00547378|20925552|P1|COMPLETED|All Implanted Cohort||36
8491761|NCT00547378|20925550|P3|Month 60|All Implanted Cohort||114
8491762|NCT00547378|20925551|P2|Month 60|All Implanted Cohort||23
8491763|NCT00547378|20925552|P1|Month 60|All Implanted Cohort||36
8491764|NCT00547378|20925550|P3|Month 48|All Implanted Cohort||136
8491765|NCT00547378|20925551|P2|Month 48|All Implanted Cohort||27
8491766|NCT00547378|20925552|P1|Month 48|All Implanted Cohort||38
8491767|NCT00547378|20925550|P3|Month 36|All Implanted Cohort||146
8491768|NCT00547378|20925551|P2|Month 36|All Implanted Cohort||29
8491769|NCT00547378|20925552|P1|Month 36|All Implanted Cohort||42
8491770|NCT00547378|20925550|P3|Month 24|All Implanted Cohort||161
8491771|NCT00547378|20925551|P2|Month 24|All Implanted Cohort||30
8491772|NCT00547378|20925552|P1|Month 24|All Implanted Cohort||42
8491773|NCT00547378|20925550|P3|Month 12|All Implanted Cohort||175
8491774|NCT00547378|20925551|P2|Month 12|All Implanted Cohort||32
8491775|NCT00547378|20925552|P1|Month 12|All Implanted Cohort||48
8491776|NCT00547378|20925550|P3|Month 6|All Implanted Cohort||178
8491777|NCT00547378|20925551|P2|Month 6|All Implanted Cohort||36
8491778|NCT00547378|20925552|P1|Month 6|All Implanted Cohort||50
8491779|NCT00547378|20925550|P3|Month 3|All Implanted Cohort||178
8491780|NCT00547378|20925551|P2|Month 3|All Implanted Cohort||39
8491781|NCT00547378|20925552|P1|Month 3|All Implanted Cohort||51
8491782|NCT00547378|20925550|P3|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
8491783|NCT00547378|20925551|P2|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
8491784|NCT00547378|20925552|P1|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
8491785|NCT00547378|20925550|P3|NOT COMPLETED|Randomized Cohort||0
8491786|NCT00547378|20925551|P2|NOT COMPLETED|Randomized Cohort||6
8491787|NCT00547378|20925552|P1|NOT COMPLETED|Randomized Cohort||11
8491788|NCT00547378|20925550|P3|COMPLETED|Randomized Cohort||0
8491789|NCT00547378|20925551|P2|COMPLETED|Randomized Cohort||71
8491790|NCT00547378|20925552|P1|COMPLETED|Randomized Cohort||59
8491791|NCT00547378|20925550|P3|Month 6|Randomized Cohort||0
8491792|NCT00547378|20925551|P2|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
8491793|NCT00547378|20925552|P1|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
8491794|NCT00547378|20925550|P3|Month 3|Randomized Cohort||0
8491795|NCT00547378|20925551|P2|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
8491796|NCT00547378|20925552|P1|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
8491797|NCT00547378|20925550|P3|STARTED|Randomized Cohort||0
8491798|NCT00547378|20925551|P2|STARTED|Randomized Cohort||77
8491799|NCT00547378|20925552|P1|STARTED|Randomized Cohort||70
8491800|NCT00547365|20925562|P1|NOT COMPLETED|Overall Study||8
8491801|NCT00547365|20925562|P1|COMPLETED|Overall Study||2
8491802|NCT00547365|20925562|P1|STARTED|Overall Study||10
8491803|NCT00547300|20925569|P2|NOT COMPLETED|Overall Study||26
8491804|NCT00547300|20925570|P1|NOT COMPLETED|Overall Study||25
8491805|NCT00547300|20925569|P2|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
8491806|NCT00547300|20925570|P1|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
8491807|NCT00547300|20925569|P2|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26
8491808|NCT00547300|20925570|P1|STARTED|Overall Study||25
8491809|NCT00547248|20925584|P4|NOT COMPLETED|Overall Study||2
8491810|NCT00547248|20925585|P3|NOT COMPLETED|Overall Study||10
8491811|NCT00547248|20925586|P2|NOT COMPLETED|Overall Study||0
8491812|NCT00547248|20925587|P1|NOT COMPLETED|Overall Study||0
8491813|NCT00547248|20925584|P4|COMPLETED|Overall Study||96
8491814|NCT00547248|20925585|P3|COMPLETED|Overall Study||275
8491815|NCT00547248|20925586|P2|COMPLETED|Overall Study||93
8491816|NCT00547248|20925587|P1|COMPLETED|Overall Study||280
8491817|NCT00547248|20925584|P4|STARTED|Overall Study||98
8491818|NCT00547248|20925585|P3|STARTED|Overall Study||285
8491819|NCT00547248|20925586|P2|STARTED|Overall Study||93
8491820|NCT00547248|20925587|P1|STARTED|Overall Study||280
8491821|NCT00547157|20925705|P2|NOT COMPLETED|Overall Study||23
8491822|NCT00547157|20925706|P1|NOT COMPLETED|Overall Study||49
8491823|NCT00547157|20925705|P2|COMPLETED|Overall Study||39
8491824|NCT00547157|20925706|P1|COMPLETED|Overall Study||41
8491825|NCT00547157|20925705|P2|STARTED|Overall Study||62
8491826|NCT00547157|20925706|P1|STARTED|Overall Study||90
8491827|NCT00547118|20925724|P2|NOT COMPLETED|Overall Study||9
8491828|NCT00547118|20925725|P1|NOT COMPLETED|Overall Study||8
8491829|NCT00547118|20925724|P2|COMPLETED|Overall Study||0
8491830|NCT00547118|20925725|P1|COMPLETED|Overall Study||0
8491831|NCT00547118|20925724|P2|STARTED|Overall Study||9
8491832|NCT00547118|20925725|P1|STARTED|Overall Study||8
8491833|NCT00547105|20925757|P1|NOT COMPLETED|Overall Study||0
8491834|NCT00547105|20925757|P1|COMPLETED|Overall Study||24
8491835|NCT00547105|20925757|P1|STARTED|Overall Study||24
8491836|NCT00546910|20925769|P2|NOT COMPLETED|Overall Study||11
8491837|NCT00546910|20925770|P1|NOT COMPLETED|Overall Study||9
8491838|NCT00546910|20925769|P2|COMPLETED|Overall Study||51
8491839|NCT00546910|20925770|P1|COMPLETED|Overall Study||54
8491840|NCT00546910|20925769|P2|STARTED|Overall Study||62
8491841|NCT00546910|20925770|P1|STARTED|Overall Study||63
8491842|NCT00546897|20925790|P2|NOT COMPLETED|Overall Study||0
8491843|NCT00546897|20925791|P1|NOT COMPLETED|Overall Study||0
8491844|NCT00546897|20925790|P2|COMPLETED|Overall Study||33
8491845|NCT00546897|20925791|P1|COMPLETED|Overall Study||15
8491846|NCT00546897|20925790|P2|STARTED|Overall Study||33
8491847|NCT00546897|20925791|P1|STARTED|Overall Study||15
8491848|NCT00546884|20925829|P2|NOT COMPLETED|Overall Study||0
8491849|NCT00546884|20925830|P1|NOT COMPLETED|Overall Study||0
8491850|NCT00546884|20925829|P2|COMPLETED|Overall Study||117
8491851|NCT00546884|20925830|P1|COMPLETED|Overall Study||145
8491852|NCT00546884|20925829|P2|STARTED|Overall Study||117
8491853|NCT00546884|20925830|P1|STARTED|Overall Study||145
8491884|NCT00546819|20925942|P2|NOT COMPLETED|Overall Study||6
8491885|NCT00546819|20925943|P1|NOT COMPLETED|Overall Study||8
8491886|NCT00546819|20925942|P2|COMPLETED|Overall Study||96
8491887|NCT00546819|20925943|P1|COMPLETED|Overall Study||199
8491888|NCT00546819|20925942|P2|VACCINATED|Overall Study||100
8491889|NCT00546819|20925943|P1|VACCINATED|Overall Study||206
8491890|NCT00546819|20925942|P2|STARTED|Overall Study||102
8491891|NCT00546819|20925943|P1|STARTED|Overall Study||207
8491892|NCT00546754|20925955|P2|NOT COMPLETED|Overall Study||49
8491893|NCT00546754|20925956|P1|NOT COMPLETED|Overall Study||50
8491894|NCT00546754|20925955|P2|COMPLETED|Overall Study||334
8491895|NCT00546754|20925956|P1|COMPLETED|Overall Study||375
8491896|NCT00546754|20925955|P2|Week 12|Overall Study||334
8491897|NCT00546754|20925956|P1|Week 12|Overall Study||375
8491898|NCT00546754|20925955|P2|Week 6|Overall Study||347
8491899|NCT00546754|20925956|P1|Week 6|Overall Study||396
8491900|NCT00546754|20925955|P2|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
8491901|NCT00546754|20925956|P1|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
8491902|NCT00546754|20925955|P2|STARTED|Overall Study|Number of patients enrolled and randomized|383
8491903|NCT00546754|20925956|P1|STARTED|Overall Study|Number of patients enrolled and randomized|425
8491904|NCT00546728|20925988|P2|NOT COMPLETED|Overall Study||0
8491905|NCT00546728|20925989|P1|NOT COMPLETED|Overall Study||0
8491906|NCT00546728|20925988|P2|COMPLETED|Overall Study||25
8491907|NCT00546728|20925989|P1|COMPLETED|Overall Study||25
8491908|NCT00546728|20925988|P2|STARTED|Overall Study||25
8491909|NCT00546728|20925989|P1|STARTED|Overall Study||25
8491910|NCT00546715|20925999|P4|NOT COMPLETED|Overall Study||0
8491911|NCT00546715|20926000|P3|NOT COMPLETED|Overall Study||0
8491912|NCT00546715|20926001|P2|NOT COMPLETED|Overall Study||1
8491913|NCT00546715|20926002|P1|NOT COMPLETED|Overall Study||0
8491914|NCT00546715|20925999|P4|COMPLETED|Overall Study||2
8491915|NCT00546715|20926000|P3|COMPLETED|Overall Study||5
8491916|NCT00546715|20926001|P2|COMPLETED|Overall Study||4
8491917|NCT00546715|20926002|P1|COMPLETED|Overall Study||6
8491918|NCT00546715|20925999|P4|STARTED|Overall Study||2
8491919|NCT00546715|20926000|P3|STARTED|Overall Study||5
8491920|NCT00546715|20926001|P2|STARTED|Overall Study||5
8491921|NCT00546715|20926002|P1|STARTED|Overall Study||6
8491922|NCT00546637|20926057|P2|NOT COMPLETED|Overall Study||49
8491923|NCT00546637|20926058|P1|NOT COMPLETED|Overall Study||73
8491924|NCT00546637|20926057|P2|COMPLETED|Overall Study||424
8491925|NCT00546637|20926058|P1|COMPLETED|Overall Study||401
8491926|NCT00546637|20926057|P2|Received Treatment|Overall Study||472
8491927|NCT00546637|20926058|P1|Received Treatment|Overall Study||471
8491928|NCT00546637|20926057|P2|STARTED|Overall Study||473
8491929|NCT00546637|20926058|P1|STARTED|Overall Study||474
8491930|NCT00546572|20926132|P2|NOT COMPLETED|Vax 2 / Year 1||2
8491931|NCT00546572|20926133|P1|NOT COMPLETED|Vax 2 / Year 1||4
8491932|NCT00546572|20926132|P2|COMPLETED|Vax 2 / Year 1||402
8491933|NCT00546572|20926133|P1|COMPLETED|Vax 2 / Year 1||387
8491934|NCT00546572|20926132|P2|Received Vax 2|Vax 2 / Year 1||404
8491935|NCT00546572|20926133|P1|Received Vax 2|Vax 2 / Year 1||391
8491936|NCT00546572|20926132|P2|STARTED|Vax 2 / Year 1||404
8491937|NCT00546572|20926133|P1|STARTED|Vax 2 / Year 1||391
8491938|NCT00546572|20926132|P2|NOT COMPLETED|Vax 1 / Year 0||70
8491939|NCT00546572|20926133|P1|NOT COMPLETED|Vax 1 / Year 0||73
8491940|NCT00546572|20926132|P2|COMPLETED|Vax 1 / Year 0||404
8491941|NCT00546572|20926133|P1|COMPLETED|Vax 1 / Year 0||391
8491942|NCT00546572|20926132|P2|Received Vax 1|Vax 1 / Year 0||473
8491943|NCT00546572|20926133|P1|Received Vax 1|Vax 1 / Year 0||463
8491944|NCT00546572|20926132|P2|STARTED|Vax 1 / Year 0||474
8491945|NCT00546572|20926133|P1|STARTED|Vax 1 / Year 0||464
8491946|NCT00546481|20926177|P3|NOT COMPLETED|Maintenance Phase (CERA)||4
8491947|NCT00546481|20926178|P2|NOT COMPLETED|Maintenance Phase (CERA)||0
8491948|NCT00546481|20926179|P1|NOT COMPLETED|Maintenance Phase (CERA)||0
8491949|NCT00546481|20926177|P3|COMPLETED|Maintenance Phase (CERA)||50
8491950|NCT00546481|20926178|P2|COMPLETED|Maintenance Phase (CERA)||0
8491951|NCT00546481|20926179|P1|COMPLETED|Maintenance Phase (CERA)||0
8491952|NCT00546481|20926177|P3|STARTED|Maintenance Phase (CERA)||54
8491953|NCT00546481|20926178|P2|STARTED|Maintenance Phase (CERA)||0
8491954|NCT00546481|20926179|P1|STARTED|Maintenance Phase (CERA)||0
8491955|NCT00546481|20926177|P3|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
8491956|NCT00546481|20926178|P2|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
8491957|NCT00546481|20926179|P1|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
8491958|NCT00546481|20926177|P3|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
8491959|NCT00546481|20926178|P2|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
8491960|NCT00546481|20926179|P1|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
8491961|NCT00546481|20926177|P3|STARTED|Correction Phase (CERA or Epoetin Beta)||0
8491962|NCT00546481|20926178|P2|STARTED|Correction Phase (CERA or Epoetin Beta)||41
8491963|NCT00546481|20926179|P1|STARTED|Correction Phase (CERA or Epoetin Beta)||39
8491964|NCT00546429|20926202|P1|NOT COMPLETED|Overall Study||30
8491965|NCT00546429|20926202|P1|COMPLETED|Overall Study||32
8491966|NCT00546429|20926202|P1|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
8491967|NCT00546390|20926208|P2|NOT COMPLETED|Overall Study||0
8491968|NCT00546390|20926209|P1|NOT COMPLETED|Overall Study||0
8491969|NCT00546390|20926208|P2|COMPLETED|Overall Study||28
8491970|NCT00546390|20926209|P1|COMPLETED|Overall Study||27
8491971|NCT00546390|20926208|P2|STARTED|Overall Study||28
8491972|NCT00546390|20926209|P1|STARTED|Overall Study||27
8491973|NCT00546377|20926217|P1|NOT COMPLETED|Overall Study||7
8491974|NCT00546377|20926217|P1|COMPLETED|Overall Study||43
8491975|NCT00546377|20926217|P1|STARTED|Overall Study||50
8491976|NCT00546364|20926225|P3|NOT COMPLETED|Overall Study||17
8491977|NCT00546364|20926226|P2|NOT COMPLETED|Overall Study||18
8491978|NCT00546364|20926227|P1|NOT COMPLETED|Overall Study||17
8491979|NCT00546364|20926225|P3|COMPLETED|Overall Study|Still on treatment|3
8491980|NCT00546364|20926226|P2|COMPLETED|Overall Study|Still on treatment|4
8491981|NCT00546364|20926227|P1|COMPLETED|Overall Study|Still on treatment|3
8491982|NCT00546364|20926225|P3|Never Treated|Overall Study||0
8491983|NCT00546364|20926226|P2|Never Treated|Overall Study||0
8491984|NCT00546364|20926227|P1|Never Treated|Overall Study||0
8491985|NCT00546364|20926225|P3|STARTED|Overall Study||20
8491986|NCT00546364|20926226|P2|STARTED|Overall Study||22
8491987|NCT00546364|20926227|P1|STARTED|Overall Study||20
8491988|NCT00546351|20926262|P1|NOT COMPLETED|Overall Study||236
8491989|NCT00546351|20926262|P1|COMPLETED|Overall Study||385
8491990|NCT00546351|20926262|P1|STARTED|Overall Study||621
8491991|NCT00546273|20926295|P5|NOT COMPLETED|IV||0
8491992|NCT00546273|20926296|P4|NOT COMPLETED|IV||0
8491993|NCT00546273|20926297|P3|NOT COMPLETED|IV||0
8491994|NCT00546273|20926298|P2|NOT COMPLETED|IV||0
8491995|NCT00546273|20926299|P1|NOT COMPLETED|IV||0
8491996|NCT00546273|20926295|P5|COMPLETED|IV||2
8491997|NCT00546273|20926296|P4|COMPLETED|IV||4
8491998|NCT00546273|20926297|P3|COMPLETED|IV||0
8491999|NCT00546273|20926298|P2|COMPLETED|IV||0
8492000|NCT00546273|20926299|P1|COMPLETED|IV||0
8492006|NCT00546273|20926295|P5|NOT COMPLETED|III||0
8492007|NCT00546273|20926296|P4|NOT COMPLETED|III||0
8492008|NCT00546273|20926297|P3|NOT COMPLETED|III||0
8492009|NCT00546273|20926298|P2|NOT COMPLETED|III||0
8492010|NCT00546273|20926299|P1|NOT COMPLETED|III||0
8492011|NCT00546273|20926295|P5|COMPLETED|III||2
8492012|NCT00546273|20926296|P4|COMPLETED|III||0
8492013|NCT00546273|20926297|P3|COMPLETED|III||4
8492014|NCT00546273|20926298|P2|COMPLETED|III||0
8492015|NCT00546273|20926299|P1|COMPLETED|III||0
8492016|NCT00546273|20926295|P5|STARTED|III||2
8492017|NCT00546273|20926296|P4|STARTED|III||0
8492018|NCT00546273|20926297|P3|STARTED|III||4
8492019|NCT00546273|20926298|P2|STARTED|III||0
8492020|NCT00546273|20926299|P1|STARTED|III||0
8492021|NCT00546273|20926295|P5|NOT COMPLETED|II||0
8492022|NCT00546273|20926296|P4|NOT COMPLETED|II||0
8492023|NCT00546273|20926297|P3|NOT COMPLETED|II||0
8492024|NCT00546273|20926298|P2|NOT COMPLETED|II||0
8492025|NCT00546273|20926299|P1|NOT COMPLETED|II||0
8492026|NCT00546273|20926295|P5|COMPLETED|II||2
8492027|NCT00546273|20926296|P4|COMPLETED|II||0
8492028|NCT00546273|20926297|P3|COMPLETED|II||0
8492029|NCT00546273|20926298|P2|COMPLETED|II||4
8492030|NCT00546273|20926299|P1|COMPLETED|II||0
8492031|NCT00546273|20926295|P5|STARTED|II||2
8492032|NCT00546273|20926296|P4|STARTED|II||0
8492033|NCT00546273|20926297|P3|STARTED|II||0
8492034|NCT00546273|20926298|P2|STARTED|II||4
8492035|NCT00546273|20926299|P1|STARTED|II||0
8492036|NCT00546273|20926295|P5|NOT COMPLETED|I||0
8492037|NCT00546273|20926296|P4|NOT COMPLETED|I||0
8492038|NCT00546273|20926297|P3|NOT COMPLETED|I||0
8492039|NCT00546273|20926298|P2|NOT COMPLETED|I||0
8492040|NCT00546273|20926299|P1|NOT COMPLETED|I||0
8492041|NCT00546273|20926295|P5|COMPLETED|I||2
8492042|NCT00546273|20926296|P4|COMPLETED|I||0
8492043|NCT00546273|20926297|P3|COMPLETED|I||0
8492044|NCT00546273|20926298|P2|COMPLETED|I||0
8492045|NCT00546273|20926299|P1|COMPLETED|I||4
8492046|NCT00546273|20926295|P5|STARTED|I||2
8492047|NCT00546273|20926296|P4|STARTED|I||0
8492048|NCT00546273|20926297|P3|STARTED|I||0
8492049|NCT00546273|20926298|P2|STARTED|I||0
8492050|NCT00546273|20926299|P1|STARTED|I||4
8492051|NCT00546260|20926308|P2|NOT COMPLETED|Overall Study||2
8492052|NCT00546260|20926309|P1|NOT COMPLETED|Overall Study||8
8492053|NCT00546260|20926308|P2|COMPLETED|Overall Study||32
8492054|NCT00546260|20926309|P1|COMPLETED|Overall Study||28
8492055|NCT00546260|20926308|P2|STARTED|Overall Study||34
8492056|NCT00546260|20926309|P1|STARTED|Overall Study||36
8492063|NCT00546117|20926331|P2|NOT COMPLETED|Overall Study||0
8492064|NCT00546117|20926332|P1|NOT COMPLETED|Overall Study||4
8492065|NCT00546117|20926331|P2|COMPLETED|Overall Study||7
8492066|NCT00546117|20926332|P1|COMPLETED|Overall Study||5
8492067|NCT00546117|20926331|P2|STARTED|Overall Study||7
8492068|NCT00546117|20926332|P1|STARTED|Overall Study||9
8492069|NCT00546104|20926346|P1|NOT COMPLETED|Overall Study||0
8492070|NCT00546104|20926346|P1|COMPLETED|Overall Study||31
8492071|NCT00546104|20926346|P1|STARTED|Overall Study||31
8492072|NCT00546078|20926357|P2|NOT COMPLETED|Overall Study||7
8492073|NCT00546078|20926358|P1|NOT COMPLETED|Overall Study||4
8492074|NCT00546078|20926357|P2|COMPLETED|Overall Study||43
8492075|NCT00546078|20926358|P1|COMPLETED|Overall Study||61
8492076|NCT00546078|20926357|P2|Month 18|Overall Study||45
8492077|NCT00546078|20926358|P1|Month 18|Overall Study||61
8492078|NCT00546078|20926357|P2|STARTED|Overall Study||50
8492079|NCT00546078|20926358|P1|STARTED|Overall Study||65
8492080|NCT00546052|20926396|P1|NOT COMPLETED|Overall Study||227
8492081|NCT00546052|20926396|P1|COMPLETED|Overall Study||1511
8492082|NCT00546052|20926396|P1|Week 52|Overall Study||1511
8492083|NCT00546052|20926396|P1|Week 32|Overall Study||1583
8492084|NCT00546052|20926396|P1|Week 12|Overall Study||1650
8492085|NCT00546052|20926396|P1|Week 8|Overall Study||1680
8492086|NCT00546052|20926396|P1|Week 4|Overall Study||1714
8492087|NCT00546052|20926396|P1|STARTED|Overall Study||1738
8492088|NCT00546000|20926414|P1|NOT COMPLETED|Overall Study||4
8492089|NCT00546000|20926414|P1|COMPLETED|Overall Study||52
8492090|NCT00546000|20926414|P1|STARTED|Overall Study||56
8492091|NCT00545974|20926421|P2|NOT COMPLETED|Overall Study||3
8492092|NCT00545974|20926422|P1|NOT COMPLETED|Overall Study||2
8492093|NCT00545974|20926421|P2|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
8492094|NCT00545974|20926422|P1|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
8492095|NCT00545974|20926421|P2|STARTED|Overall Study|subjects randomized to placebo cohort|42
8492096|NCT00545974|20926422|P1|STARTED|Overall Study|subjects randomized to memantine cohort|39
8492097|NCT00545948|20926439|P3|NOT COMPLETED|Overall Study||7
8492098|NCT00545948|20926440|P2|NOT COMPLETED|Overall Study||1
8492099|NCT00545948|20926441|P1|NOT COMPLETED|Overall Study||1
8492100|NCT00545948|20926439|P3|COMPLETED|Overall Study||0
8492101|NCT00545948|20926440|P2|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
8492102|NCT00545948|20926441|P1|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
8492103|NCT00545948|20926439|P3|Assigned Treatment|Overall Study||0
8492104|NCT00545948|20926440|P2|Assigned Treatment|Overall Study||15
8492105|NCT00545948|20926441|P1|Assigned Treatment|Overall Study||9
8492106|NCT00545948|20926439|P3|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
8492107|NCT00545948|20926440|P2|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
8492108|NCT00545948|20926441|P1|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
8492109|NCT00545844|20926451|P1|NOT COMPLETED|Overall Study||12
8492110|NCT00545844|20926451|P1|COMPLETED|Overall Study||301
8492111|NCT00545844|20926451|P1|STARTED|Overall Study||313
8492112|NCT00545818|20926467|P2|NOT COMPLETED|Overall Study||7
8492113|NCT00545818|20926468|P1|NOT COMPLETED|Overall Study||3
8492114|NCT00545818|20926467|P2|COMPLETED|Overall Study||39
8492115|NCT00545818|20926468|P1|COMPLETED|Overall Study||46
8492116|NCT00545818|20926467|P2|STARTED|Overall Study||46
8492117|NCT00545818|20926468|P1|STARTED|Overall Study||49
8492118|NCT00545792|20926482|P1|NOT COMPLETED|Overall Study||1
8492119|NCT00545792|20926482|P1|COMPLETED|Overall Study||20
8492120|NCT00545792|20926482|P1|STARTED|Overall Study||21
8492121|NCT00545779|20926487|P1|NOT COMPLETED|Overall Study||44
8492122|NCT00545779|20926487|P1|COMPLETED|Overall Study||633
8492123|NCT00545779|20926487|P1|STARTED|Overall Study||677
8492124|NCT00545766|20926500|P1|NOT COMPLETED|Overall Study||5
8492125|NCT00545766|20926500|P1|COMPLETED|Overall Study||36
8492126|NCT00545766|20926500|P1|STARTED|Overall Study||41
8492127|NCT00545753|20926507|P3|NOT COMPLETED|Overall Study||26
8492128|NCT00545753|20926508|P2|NOT COMPLETED|Overall Study||5
8492129|NCT00545753|20926509|P1|NOT COMPLETED|Overall Study||16
8492130|NCT00545753|20926507|P3|COMPLETED|Overall Study||230
8492131|NCT00545753|20926508|P2|COMPLETED|Overall Study||54
8492132|NCT00545753|20926509|P1|COMPLETED|Overall Study||227
8492133|NCT00545753|20926507|P3|STARTED|Overall Study||256
8492134|NCT00545753|20926508|P2|STARTED|Overall Study||59
8492135|NCT00545753|20926509|P1|STARTED|Overall Study||243
8492148|NCT00545714|20926559|P1|NOT COMPLETED|Maintenance Phase (36 Months)||32
8492149|NCT00545714|20926559|P1|COMPLETED|Maintenance Phase (36 Months)||42
8492150|NCT00545714|20926559|P1|STARTED|Maintenance Phase (36 Months)||74
8492151|NCT00545714|20926559|P1|NOT COMPLETED|Induction Phase (6 Months)||12
8492152|NCT00545714|20926559|P1|COMPLETED|Induction Phase (6 Months)||74
8492153|NCT00545714|20926559|P1|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84
8492154|NCT00545714|20926559|P1|Safety Population|Induction Phase (6 Months)||86
8492155|NCT00545714|20926559|P1|STARTED|Induction Phase (6 Months)||86
8492156|NCT00545688|20926580|P4|NOT COMPLETED|Follow-Up Period||27
8492157|NCT00545688|20926581|P3|NOT COMPLETED|Follow-Up Period||20
8492158|NCT00545688|20926582|P2|NOT COMPLETED|Follow-Up Period||19
8492159|NCT00545688|20926583|P1|NOT COMPLETED|Follow-Up Period||21
8492160|NCT00545688|20926580|P4|COMPLETED|Follow-Up Period||60
8492161|NCT00545688|20926581|P3|COMPLETED|Follow-Up Period||78
8492162|NCT00545688|20926582|P2|COMPLETED|Follow-Up Period||83
8492163|NCT00545688|20926583|P1|COMPLETED|Follow-Up Period||77
8492164|NCT00545688|20926580|P4|STARTED|Follow-Up Period||87
8492165|NCT00545688|20926581|P3|STARTED|Follow-Up Period||98
8492166|NCT00545688|20926582|P2|STARTED|Follow-Up Period||102
8492167|NCT00545688|20926583|P1|STARTED|Follow-Up Period||98
8492168|NCT00545688|20926580|P4|NOT COMPLETED|Adjuvant Treatment Period||14
8492169|NCT00545688|20926581|P3|NOT COMPLETED|Adjuvant Treatment Period||4
8492170|NCT00545688|20926582|P2|NOT COMPLETED|Adjuvant Treatment Period||8
8492171|NCT00545688|20926583|P1|NOT COMPLETED|Adjuvant Treatment Period||5
8492172|NCT00545688|20926580|P4|COMPLETED|Adjuvant Treatment Period||74
8492173|NCT00545688|20926581|P3|COMPLETED|Adjuvant Treatment Period||90
8492174|NCT00545688|20926582|P2|COMPLETED|Adjuvant Treatment Period||94
8492175|NCT00545688|20926583|P1|COMPLETED|Adjuvant Treatment Period||98
8492176|NCT00545688|20926580|P4|STARTED|Adjuvant Treatment Period||88
8492177|NCT00545688|20926581|P3|STARTED|Adjuvant Treatment Period||94
8492178|NCT00545688|20926582|P2|STARTED|Adjuvant Treatment Period||102
8492179|NCT00545688|20926583|P1|STARTED|Adjuvant Treatment Period||103
8492180|NCT00545688|20926580|P4|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
8492181|NCT00545688|20926581|P3|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
8492182|NCT00545688|20926582|P2|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
8492183|NCT00545688|20926583|P1|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
8492184|NCT00545688|20926580|P4|COMPLETED|Neo-Adjuvant Treatment Period||88
8492185|NCT00545688|20926581|P3|COMPLETED|Neo-Adjuvant Treatment Period||94
8492186|NCT00545688|20926582|P2|COMPLETED|Neo-Adjuvant Treatment Period||102
8492187|NCT00545688|20926583|P1|COMPLETED|Neo-Adjuvant Treatment Period||103
8492188|NCT00545688|20926580|P4|STARTED|Neo-Adjuvant Treatment Period||94
8492189|NCT00545688|20926581|P3|STARTED|Neo-Adjuvant Treatment Period||108
8492190|NCT00545688|20926582|P2|STARTED|Neo-Adjuvant Treatment Period||107
8492191|NCT00545688|20926583|P1|STARTED|Neo-Adjuvant Treatment Period||107
8492192|NCT00545662|20926655|P2|NOT COMPLETED|Overall Study||79
8492193|NCT00545662|20926656|P1|NOT COMPLETED|Overall Study||85
8492194|NCT00545662|20926655|P2|COMPLETED|Overall Study||528
8492195|NCT00545662|20926656|P1|COMPLETED|Overall Study||521
8492196|NCT00545662|20926655|P2|STARTED|Overall Study||607
8492197|NCT00545662|20926656|P1|STARTED|Overall Study||606
8492198|NCT00545623|20926666|P4|NOT COMPLETED|Overall Study||11
8492199|NCT00545623|20926667|P3|NOT COMPLETED|Overall Study||13
8492200|NCT00545623|20926668|P2|NOT COMPLETED|Overall Study||10
8492201|NCT00545623|20926669|P1|NOT COMPLETED|Overall Study||7
8492202|NCT00545623|20926666|P4|COMPLETED|Overall Study||23
8492203|NCT00545623|20926667|P3|COMPLETED|Overall Study||20
8492204|NCT00545623|20926668|P2|COMPLETED|Overall Study||21
8492205|NCT00545623|20926669|P1|COMPLETED|Overall Study||25
8492206|NCT00545623|20926666|P4|STARTED|Overall Study||34
8492207|NCT00545623|20926667|P3|STARTED|Overall Study||33
8492208|NCT00545623|20926668|P2|STARTED|Overall Study||31
8492209|NCT00545623|20926669|P1|STARTED|Overall Study||32
8492210|NCT00545584|20926682|P3|NOT COMPLETED|Overall Study||56
8492211|NCT00545584|20926683|P2|NOT COMPLETED|Overall Study||80
8492212|NCT00545584|20926684|P1|NOT COMPLETED|Overall Study||79
8492213|NCT00545584|20926682|P3|COMPLETED|Overall Study||250
8492214|NCT00545584|20926683|P2|COMPLETED|Overall Study||334
8492215|NCT00545584|20926684|P1|COMPLETED|Overall Study||333
8492216|NCT00545584|20926682|P3|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
8492217|NCT00545584|20926683|P2|STARTED|Overall Study||414
8492218|NCT00545584|20926684|P1|STARTED|Overall Study||412
8492219|NCT00545571|20926695|P1|NOT COMPLETED|Overall Study||67
8492220|NCT00545571|20926695|P1|COMPLETED|Overall Study||53
8492221|NCT00545571|20926695|P1|STARTED|Overall Study||120
8492222|NCT00545532|20926710|P2|NOT COMPLETED|Overall Study||10
8492223|NCT00545532|20926711|P1|NOT COMPLETED|Overall Study||6
8492224|NCT00545532|20926710|P2|COMPLETED|Overall Study||100
8492225|NCT00545532|20926711|P1|COMPLETED|Overall Study||99
8492226|NCT00545532|20926710|P2|STARTED|Overall Study||110
8492227|NCT00545532|20926711|P1|STARTED|Overall Study||105
8492228|NCT00545506|20926793|P2|NOT COMPLETED|Overall Study||0
8492229|NCT00545506|20926794|P1|NOT COMPLETED|Overall Study||0
8492230|NCT00545506|20926793|P2|COMPLETED|Overall Study||3
8492231|NCT00545506|20926794|P1|COMPLETED|Overall Study||3
8492232|NCT00545506|20926793|P2|STARTED|Overall Study||3
8492233|NCT00545506|20926794|P1|STARTED|Overall Study||3
8492234|NCT00545441|20926802|P2|NOT COMPLETED|Overall Study||16
8492235|NCT00545441|20926803|P1|NOT COMPLETED|Overall Study||18
8492236|NCT00545441|20926802|P2|COMPLETED|Overall Study||26
8492237|NCT00545441|20926803|P1|COMPLETED|Overall Study||26
8492238|NCT00545441|20926802|P2|STARTED|Overall Study||42
8492239|NCT00545441|20926803|P1|STARTED|Overall Study||44
8492240|NCT00545402|20926811|P2|NOT COMPLETED|Overall Study||29
8492241|NCT00545402|20926812|P1|NOT COMPLETED|Overall Study||34
8492242|NCT00545402|20926811|P2|COMPLETED|Overall Study||61
8492243|NCT00545402|20926812|P1|COMPLETED|Overall Study||56
8492244|NCT00545402|20926811|P2|STARTED|Overall Study||90
8492245|NCT00545402|20926812|P1|STARTED|Overall Study||90
8492246|NCT00545363|20926830|P2|NOT COMPLETED|Overall Study||15
8492247|NCT00545363|20926831|P1|NOT COMPLETED|Overall Study||19
8492248|NCT00545363|20926830|P2|COMPLETED|Overall Study||343
8492249|NCT00545363|20926831|P1|COMPLETED|Overall Study||339
8492250|NCT00545363|20926830|P2|Treated|Overall Study||357
8492251|NCT00545363|20926831|P1|Treated|Overall Study||354
8492252|NCT00545363|20926830|P2|STARTED|Overall Study||358
8492253|NCT00545363|20926831|P1|STARTED|Overall Study||358
8492254|NCT00545298|20926846|P3|NOT COMPLETED|Overall Study||1
8492255|NCT00545298|20926847|P2|NOT COMPLETED|Overall Study||0
8492256|NCT00545298|20926848|P1|NOT COMPLETED|Overall Study||2
8492257|NCT00545298|20926846|P3|COMPLETED|Overall Study||0
8492258|NCT00545298|20926847|P2|COMPLETED|Overall Study||1
8492259|NCT00545298|20926848|P1|COMPLETED|Overall Study||0
8492260|NCT00545298|20926846|P3|STARTED|Overall Study||1
8492261|NCT00545298|20926847|P2|STARTED|Overall Study||1
8492262|NCT00545298|20926848|P1|STARTED|Overall Study||2
8492263|NCT00545272|20926865|P6|NOT COMPLETED|Overall Study||3
8492264|NCT00545272|20926866|P5|NOT COMPLETED|Overall Study||2
8492265|NCT00545272|20926867|P4|NOT COMPLETED|Overall Study||1
8492266|NCT00545272|20926868|P3|NOT COMPLETED|Overall Study||1
8492267|NCT00545272|20926869|P2|NOT COMPLETED|Overall Study||1
8492268|NCT00545272|20926870|P1|NOT COMPLETED|Overall Study||0
8492269|NCT00545272|20926865|P6|COMPLETED|Overall Study||59
8492270|NCT00545272|20926866|P5|COMPLETED|Overall Study||62
8492271|NCT00545272|20926867|P4|COMPLETED|Overall Study||71
8492272|NCT00545272|20926868|P3|COMPLETED|Overall Study||64
8492273|NCT00545272|20926869|P2|COMPLETED|Overall Study||67
8492274|NCT00545272|20926870|P1|COMPLETED|Overall Study||61
8492275|NCT00545272|20926865|P6|STARTED|Overall Study||62
8492276|NCT00545272|20926866|P5|STARTED|Overall Study||64
8492277|NCT00545272|20926867|P4|STARTED|Overall Study||72
8492278|NCT00545272|20926868|P3|STARTED|Overall Study||65
8492279|NCT00545272|20926869|P2|STARTED|Overall Study||68
8492280|NCT00545272|20926870|P1|STARTED|Overall Study||61
8492281|NCT00545233|20926922|P2|NOT COMPLETED|Overall Study||35
8492282|NCT00545233|20926923|P1|NOT COMPLETED|Overall Study||46
8492283|NCT00545233|20926922|P2|COMPLETED|Overall Study||41
8492284|NCT00545233|20926923|P1|COMPLETED|Overall Study||33
8492285|NCT00545233|20926922|P2|Intent-to-Treat (ITT)|Overall Study||73
8492286|NCT00545233|20926923|P1|Intent-to-Treat (ITT)|Overall Study||77
8492287|NCT00545233|20926922|P2|Safety Set|Overall Study||75
8492288|NCT00545233|20926923|P1|Safety Set|Overall Study||77
8492289|NCT00545233|20926922|P2|STARTED|Overall Study||76
8492290|NCT00545233|20926923|P1|STARTED|Overall Study||79
8492291|NCT00545181|20926972|P2|NOT COMPLETED|Overall Study||0
8492292|NCT00545181|20926973|P1|NOT COMPLETED|Overall Study||0
8492293|NCT00545181|20926972|P2|COMPLETED|Overall Study||25
8492294|NCT00545181|20926973|P1|COMPLETED|Overall Study||29
8492295|NCT00545181|20926972|P2|STARTED|Overall Study||25
8492296|NCT00545181|20926973|P1|STARTED|Overall Study||29
8492297|NCT00545168|20926982|P3|NOT COMPLETED|Overall Study||21
8492298|NCT00545168|20926983|P2|NOT COMPLETED|Overall Study||5
8492299|NCT00545168|20926984|P1|NOT COMPLETED|Overall Study||16
8492300|NCT00545168|20926982|P3|COMPLETED|Overall Study||193
8492301|NCT00545168|20926983|P2|COMPLETED|Overall Study||58
8492302|NCT00545168|20926984|P1|COMPLETED|Overall Study||187
8492303|NCT00545168|20926982|P3|STARTED|Overall Study||214
8492304|NCT00545168|20926983|P2|STARTED|Overall Study||63
8492305|NCT00545168|20926984|P1|STARTED|Overall Study||203
8492306|NCT00545155|20926993|P1|NOT COMPLETED|Overall Study||0
8492307|NCT00545155|20926993|P1|COMPLETED|Overall Study||187
8492308|NCT00545155|20926993|P1|STARTED|Overall Study||187
8492321|NCT00545077|20927049|P2|NOT COMPLETED|Overall Study||155
8492322|NCT00545077|20927050|P1|NOT COMPLETED|Overall Study||148
8492323|NCT00545077|20927049|P2|COMPLETED|Overall Study||36
8492324|NCT00545077|20927050|P1|COMPLETED|Overall Study||41
8492325|NCT00545077|20927049|P2|STARTED|Overall Study||191
8492326|NCT00545077|20927050|P1|STARTED|Overall Study||189
8492327|NCT00545064|20927066|P1|NOT COMPLETED|Overall Study||8
8492328|NCT00545064|20927066|P1|COMPLETED|Overall Study||170
8492329|NCT00545064|20927066|P1|Visit 3 (Week 8)|Overall Study|8 patients didn't complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
8492330|NCT00545064|20927066|P1|Visit 2 (Week 4)|Overall Study||169
8492331|NCT00545064|20927066|P1|Visit 1 (Baseline)|Overall Study||178
8492332|NCT00545064|20927066|P1|STARTED|Overall Study||178
8492333|NCT00545051|20927077|P2|NOT COMPLETED|Overall Study||7
8492334|NCT00545051|20927078|P1|NOT COMPLETED|Overall Study||9
8492335|NCT00545051|20927077|P2|COMPLETED|Overall Study||65
8492336|NCT00545051|20927078|P1|COMPLETED|Overall Study||59
8492337|NCT00545051|20927077|P2|STARTED|Overall Study||72
8492338|NCT00545051|20927078|P1|STARTED|Overall Study||68
8492339|NCT00545025|20927094|P2|NOT COMPLETED|Overall Study||0
8492340|NCT00545025|20927095|P1|NOT COMPLETED|Overall Study||0
8492341|NCT00545025|20927094|P2|COMPLETED|Overall Study||83
8492342|NCT00545025|20927095|P1|COMPLETED|Overall Study||160
8492343|NCT00545025|20927094|P2|STARTED|Overall Study||83
8492344|NCT00545025|20927095|P1|STARTED|Overall Study||160
8492345|NCT00544908|20927115|P1|NOT COMPLETED|Overall Study||0
8492346|NCT00544908|20927115|P1|COMPLETED|Overall Study||7
8492347|NCT00544908|20927115|P1|STARTED|Overall Study||7
8492348|NCT00544882|20927122|P3|NOT COMPLETED|Cycle 3: Follow-up||0
8492349|NCT00544882|20927123|P2|NOT COMPLETED|Cycle 3: Follow-up||2
8492350|NCT00544882|20927124|P1|NOT COMPLETED|Cycle 3: Follow-up||0
8492351|NCT00544882|20927122|P3|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
8492352|NCT00544882|20927123|P2|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
8492353|NCT00544882|20927124|P1|COMPLETED|Cycle 3: Follow-up||0
8492354|NCT00544882|20927122|P3|STARTED|Cycle 3: Follow-up||28
8492355|NCT00544882|20927123|P2|STARTED|Cycle 3: Follow-up||28
8492356|NCT00544882|20927124|P1|STARTED|Cycle 3: Follow-up||0
8492357|NCT00544882|20927122|P3|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
8492358|NCT00544882|20927123|P2|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
8492359|NCT00544882|20927124|P1|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
8492360|NCT00544882|20927122|P3|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
8492361|NCT00544882|20927123|P2|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
8492362|NCT00544882|20927124|P1|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
8492363|NCT00544882|20927122|P3|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
8492364|NCT00544882|20927123|P2|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
8492365|NCT00544882|20927124|P1|Treated|Cycle 2: Randomized Treatment Cycle||0
8492366|NCT00544882|20927122|P3|STARTED|Cycle 2: Randomized Treatment Cycle||29
8492367|NCT00544882|20927123|P2|STARTED|Cycle 2: Randomized Treatment Cycle||29
8492368|NCT00544882|20927124|P1|STARTED|Cycle 2: Randomized Treatment Cycle||0
8492369|NCT00544882|20927122|P3|NOT COMPLETED|Cycle 1: Run-in Cycle||0
8492370|NCT00544882|20927123|P2|NOT COMPLETED|Cycle 1: Run-in Cycle||0
8492371|NCT00544882|20927124|P1|NOT COMPLETED|Cycle 1: Run-in Cycle||3
8492372|NCT00544882|20927122|P3|COMPLETED|Cycle 1: Run-in Cycle||0
8492373|NCT00544882|20927123|P2|COMPLETED|Cycle 1: Run-in Cycle||0
8492374|NCT00544882|20927124|P1|COMPLETED|Cycle 1: Run-in Cycle||58
8492375|NCT00544882|20927122|P3|STARTED|Cycle 1: Run-in Cycle||0
8492376|NCT00544882|20927123|P2|STARTED|Cycle 1: Run-in Cycle||0
8492377|NCT00544882|20927124|P1|STARTED|Cycle 1: Run-in Cycle||61
8492378|NCT00544869|20927149|P3|NOT COMPLETED|Overall Study||0
8492379|NCT00544869|20927150|P2|NOT COMPLETED|Overall Study||2
8492380|NCT00544869|20927151|P1|NOT COMPLETED|Overall Study||12
8492381|NCT00544869|20927149|P3|COMPLETED|Overall Study||2
8492382|NCT00544869|20927150|P2|COMPLETED|Overall Study||12
8492383|NCT00544869|20927151|P1|COMPLETED|Overall Study||24
8492384|NCT00544869|20927149|P3|STARTED|Overall Study||2
8492385|NCT00544869|20927150|P2|STARTED|Overall Study||14
8492386|NCT00544869|20927151|P1|STARTED|Overall Study||36
8492387|NCT00544817|20927159|P1|NOT COMPLETED|Follow-up Systemic Therapy||19
8492388|NCT00544817|20927159|P1|COMPLETED|Follow-up Systemic Therapy||9
8492389|NCT00544817|20927159|P1|STARTED|Follow-up Systemic Therapy||28
8492390|NCT00544817|20927159|P1|NOT COMPLETED|No Treatment Interval||12
8492391|NCT00544817|20927159|P1|COMPLETED|No Treatment Interval||28
8492392|NCT00544817|20927159|P1|STARTED|No Treatment Interval||40
8492393|NCT00544817|20927159|P1|NOT COMPLETED|Combined Modality||7
8492394|NCT00544817|20927159|P1|COMPLETED|Combined Modality||40
8492395|NCT00544817|20927159|P1|STARTED|Combined Modality||47
8492396|NCT00544778|20927165|P1|NOT COMPLETED|Overall Study||0
8492397|NCT00544778|20927165|P1|COMPLETED|Overall Study||7
8492398|NCT00544778|20927165|P1|STARTED|Overall Study||7
8492399|NCT00544713|20927171|P2|NOT COMPLETED|Overall Study||5
8492400|NCT00544713|20927172|P1|NOT COMPLETED|Overall Study||3
8492401|NCT00544713|20927171|P2|COMPLETED|Overall Study||109
8492402|NCT00544713|20927172|P1|COMPLETED|Overall Study||111
8492403|NCT00544713|20927171|P2|STARTED|Overall Study||114
8492404|NCT00544713|20927172|P1|STARTED|Overall Study||114
8492405|NCT00544674|20927202|P1|NOT COMPLETED|Overall Study||1
8492406|NCT00544674|20927202|P1|COMPLETED|Overall Study||4
8492407|NCT00544674|20927202|P1|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
8492408|NCT00544648|20927208|P2|NOT COMPLETED|Overall Study||1
8492409|NCT00544648|20927209|P1|NOT COMPLETED|Overall Study||3
8492410|NCT00544648|20927208|P2|COMPLETED|Overall Study||1
8492411|NCT00544648|20927209|P1|COMPLETED|Overall Study||8
8492412|NCT00544648|20927208|P2|STARTED|Overall Study||2
8492413|NCT00544648|20927209|P1|STARTED|Overall Study||11
8492414|NCT00544557|20927223|P1|NOT COMPLETED|Overall Study||434
8492415|NCT00544557|20927223|P1|COMPLETED|Overall Study||1251
8492416|NCT00544557|20927223|P1|STARTED|Overall Study||1685
8492417|NCT00544544|20927254|P1|NOT COMPLETED|Overall Study||3
8492418|NCT00544544|20927254|P1|COMPLETED|Overall Study||11
8492419|NCT00544544|20927254|P1|STARTED|Overall Study||14
8492420|NCT00544440|20927261|P1|NOT COMPLETED|Overall Study||57
8492421|NCT00544440|20927261|P1|COMPLETED|Overall Study||0
8492422|NCT00544440|20927261|P1|STARTED|Overall Study||57
8492423|NCT00544167|20927268|P1|NOT COMPLETED|Overall Study||29
8492424|NCT00544167|20927268|P1|COMPLETED|Overall Study||16
8492425|NCT00544167|20927268|P1|STARTED|Overall Study||45
8492426|NCT00544076|20927275|P3|NOT COMPLETED|Overall Study||11
8492427|NCT00544076|20927276|P2|NOT COMPLETED|Overall Study||16
8492428|NCT00544076|20927277|P1|NOT COMPLETED|Overall Study||17
8492429|NCT00544076|20927275|P3|COMPLETED|Overall Study||20
8492430|NCT00544076|20927276|P2|COMPLETED|Overall Study||19
8492431|NCT00544076|20927277|P1|COMPLETED|Overall Study||17
8492432|NCT00544076|20927275|P3|STARTED|Overall Study||31
8492433|NCT00544076|20927276|P2|STARTED|Overall Study||35
8492434|NCT00544076|20927277|P1|STARTED|Overall Study||34
8492435|NCT00543985|20927294|P1|NOT COMPLETED|Overall Study||4
8492436|NCT00543985|20927294|P1|COMPLETED|Overall Study||32
8492437|NCT00543985|20927294|P1|STARTED|Overall Study||36
8492438|NCT00543855|20927305|P4|NOT COMPLETED|Overall Study||4
8492439|NCT00543855|20927306|P3|NOT COMPLETED|Overall Study||6
8492440|NCT00543855|20927307|P2|NOT COMPLETED|Overall Study||2
8492441|NCT00543855|20927308|P1|NOT COMPLETED|Overall Study||4
8492442|NCT00543855|20927305|P4|COMPLETED|Overall Study||30
8492443|NCT00543855|20927306|P3|COMPLETED|Overall Study||31
8492444|NCT00543855|20927307|P2|COMPLETED|Overall Study||31
8492445|NCT00543855|20927308|P1|COMPLETED|Overall Study||31
8492446|NCT00543855|20927305|P4|STARTED|Overall Study||34
8492447|NCT00543855|20927306|P3|STARTED|Overall Study||37
8492448|NCT00543855|20927307|P2|STARTED|Overall Study||33
8492449|NCT00543855|20927308|P1|STARTED|Overall Study||35
8492450|NCT00543803|20927330|P1|NOT COMPLETED|Overall Study||142
8492451|NCT00543803|20927330|P1|COMPLETED|Overall Study||192
8492452|NCT00543803|20927330|P1|STARTED|Overall Study||334
8492453|NCT00543764|20927349|P2|NOT COMPLETED|Overall Study||0
8492454|NCT00543764|20927350|P1|NOT COMPLETED|Overall Study||0
8492455|NCT00543764|20927349|P2|COMPLETED|Overall Study||50
8492456|NCT00543764|20927350|P1|COMPLETED|Overall Study||100
8492457|NCT00543764|20927349|P2|STARTED|Overall Study||50
8492458|NCT00543764|20927350|P1|STARTED|Overall Study||100
8492459|NCT00543725|20927358|P2|NOT COMPLETED|Overall Study||74
8492460|NCT00543725|20927359|P1|NOT COMPLETED|Overall Study||68
8492461|NCT00543725|20927358|P2|COMPLETED|Overall Study||264
8492462|NCT00543725|20927359|P1|COMPLETED|Overall Study||272
8492463|NCT00543725|20927358|P2|STARTED|Overall Study||338
8492464|NCT00543725|20927359|P1|STARTED|Overall Study||340
8492465|NCT00543569|20927385|P4|NOT COMPLETED|Overall Study||9
8492466|NCT00543569|20927386|P3|NOT COMPLETED|Overall Study||20
8492467|NCT00543569|20927387|P2|NOT COMPLETED|Overall Study||8
8492468|NCT00543569|20927388|P1|NOT COMPLETED|Overall Study||12
8492469|NCT00543569|20927385|P4|COMPLETED|Overall Study||72
8492470|NCT00543569|20927386|P3|COMPLETED|Overall Study||60
8492471|NCT00543569|20927387|P2|COMPLETED|Overall Study||72
8492472|NCT00543569|20927388|P1|COMPLETED|Overall Study||70
8492473|NCT00543569|20927385|P4|Received Treatment|Overall Study||78
8492474|NCT00543569|20927386|P3|Received Treatment|Overall Study||75
8492475|NCT00543569|20927387|P2|Received Treatment|Overall Study||77
8492476|NCT00543569|20927388|P1|Received Treatment|Overall Study||79
8492477|NCT00543569|20927385|P4|STARTED|Overall Study||81
8492478|NCT00543569|20927386|P3|STARTED|Overall Study||80
8492479|NCT00543569|20927387|P2|STARTED|Overall Study||80
8492480|NCT00543569|20927388|P1|STARTED|Overall Study||82
8492481|NCT00543543|20927494|P4|NOT COMPLETED|Extension Study||226
8492482|NCT00543543|20927495|P3|NOT COMPLETED|Extension Study||0
8492483|NCT00543543|20927496|P2|NOT COMPLETED|Extension Study||0
8492484|NCT00543543|20927497|P1|NOT COMPLETED|Extension Study||0
8492485|NCT00543543|20927494|P4|COMPLETED|Extension Study||2824
8492486|NCT00543543|20927495|P3|COMPLETED|Extension Study||0
8492487|NCT00543543|20927496|P2|COMPLETED|Extension Study||150
8492488|NCT00543543|20927497|P1|COMPLETED|Extension Study||0
8492489|NCT00543543|20927494|P4|STARTED|Extension Study|Cohort 2|3050
8492490|NCT00543543|20927495|P3|STARTED|Extension Study|This group did not participate in the Extension Study|0
8492491|NCT00543543|20927496|P2|STARTED|Extension Study|Cohort 1|150
8492492|NCT00543543|20927497|P1|STARTED|Extension Study|This group did not participate in the Extension Study|0
8492493|NCT00543543|20927494|P4|NOT COMPLETED|Base Study||1222
8492494|NCT00543543|20927495|P3|NOT COMPLETED|Base Study||14
8492495|NCT00543543|20927496|P2|NOT COMPLETED|Base Study||1252
8492496|NCT00543543|20927497|P1|NOT COMPLETED|Base Study||20
8492497|NCT00543543|20927494|P4|COMPLETED|Base Study|Follow-up was up to 54 months|5887
8492498|NCT00543543|20927495|P3|COMPLETED|Base Study|Follow-up was up to 7 months|296
8492499|NCT00543543|20927496|P2|COMPLETED|Base Study|Follow-up was up to 54 months|5854
8492500|NCT00543543|20927497|P1|COMPLETED|Base Study|Follow-up was up to 7 months|295
8492501|NCT00543543|20927494|P4|Completed 3 Vaccinations|Base Study||6934
8492502|NCT00543543|20927495|P3|Completed 3 Vaccinations|Base Study||297
8492503|NCT00543543|20927496|P2|Completed 3 Vaccinations|Base Study||6928
8492504|NCT00543543|20927497|P1|Completed 3 Vaccinations|Base Study||300
8492505|NCT00543543|20927494|P4|STARTED|Base Study||7109
8492506|NCT00543543|20927495|P3|STARTED|Base Study||310
8492507|NCT00543543|20927496|P2|STARTED|Base Study||7106
8492508|NCT00543543|20927497|P1|STARTED|Base Study||315
8492509|NCT00543439|20927541|P3|NOT COMPLETED|Period 2||2
8492510|NCT00543439|20927542|P2|NOT COMPLETED|Period 2||1
8492511|NCT00543439|20927543|P1|NOT COMPLETED|Period 2||1
8492512|NCT00543439|20927541|P3|COMPLETED|Period 2||23
8492513|NCT00543439|20927542|P2|COMPLETED|Period 2||25
8492514|NCT00543439|20927543|P1|COMPLETED|Period 2||8
8492515|NCT00543439|20927541|P3|STARTED|Period 2||25
8492516|NCT00543439|20927542|P2|STARTED|Period 2||26
8492517|NCT00543439|20927543|P1|STARTED|Period 2||9
8492518|NCT00543439|20927541|P3|NOT COMPLETED|Period 1||2
8492519|NCT00543439|20927542|P2|NOT COMPLETED|Period 1||3
8492520|NCT00543439|20927543|P1|NOT COMPLETED|Period 1||1
8492521|NCT00543439|20927541|P3|COMPLETED|Period 1||25
8492522|NCT00543439|20927542|P2|COMPLETED|Period 1||26
8492523|NCT00543439|20927543|P1|COMPLETED|Period 1||9
8492524|NCT00543439|20927541|P3|Treated|Period 1||27
8492525|NCT00543439|20927542|P2|Treated|Period 1||29
8492526|NCT00543439|20927543|P1|Treated|Period 1||9
8492527|NCT00543439|20927541|P3|STARTED|Period 1||27
8492528|NCT00543439|20927542|P2|STARTED|Period 1||29
8492529|NCT00543439|20927543|P1|STARTED|Period 1||10
8492530|NCT00543400|20927590|P4|NOT COMPLETED|Overall Study||5
8492531|NCT00543400|20927591|P3|NOT COMPLETED|Overall Study||4
8492532|NCT00543400|20927592|P2|NOT COMPLETED|Overall Study||1
8492533|NCT00543400|20927593|P1|NOT COMPLETED|Overall Study||5
8492534|NCT00543400|20927590|P4|COMPLETED|Overall Study||151
8492535|NCT00543400|20927591|P3|COMPLETED|Overall Study||148
8492536|NCT00543400|20927592|P2|COMPLETED|Overall Study||43
8492537|NCT00543400|20927593|P1|COMPLETED|Overall Study||146
8492538|NCT00543400|20927590|P4|STARTED|Overall Study||156
8492539|NCT00543400|20927591|P3|STARTED|Overall Study||152
8492540|NCT00543400|20927592|P2|STARTED|Overall Study||44
8492541|NCT00543400|20927593|P1|STARTED|Overall Study||151
8492542|NCT00543387|20927612|P11|NOT COMPLETED|Crossover Participants||3
8492543|NCT00543387|20927613|P10|NOT COMPLETED|Crossover Participants||1
8492544|NCT00543387|20927614|P9|NOT COMPLETED|Crossover Participants||0
8492545|NCT00543387|20927615|P8|NOT COMPLETED|Crossover Participants||0
8492546|NCT00543387|20927616|P7|NOT COMPLETED|Crossover Participants||0
8492547|NCT00543387|20927617|P6|NOT COMPLETED|Crossover Participants||0
8492548|NCT00543387|20927618|P5|NOT COMPLETED|Crossover Participants||0
8492549|NCT00543387|20927619|P4|NOT COMPLETED|Crossover Participants||0
8492550|NCT00543387|20927620|P3|NOT COMPLETED|Crossover Participants||0
8492551|NCT00543387|20927621|P2|NOT COMPLETED|Crossover Participants||0
8492552|NCT00543387|20927622|P1|NOT COMPLETED|Crossover Participants||0
8492553|NCT00543387|20927612|P11|COMPLETED|Crossover Participants||0
8492554|NCT00543387|20927613|P10|COMPLETED|Crossover Participants||0
8492555|NCT00543387|20927614|P9|COMPLETED|Crossover Participants||0
8492556|NCT00543387|20927615|P8|COMPLETED|Crossover Participants||0
8492557|NCT00543387|20927616|P7|COMPLETED|Crossover Participants||0
8492558|NCT00543387|20927617|P6|COMPLETED|Crossover Participants||0
8492559|NCT00543387|20927618|P5|COMPLETED|Crossover Participants||0
8492560|NCT00543387|20927619|P4|COMPLETED|Crossover Participants||0
8492561|NCT00543387|20927620|P3|COMPLETED|Crossover Participants||0
8492562|NCT00543387|20927621|P2|COMPLETED|Crossover Participants||0
8492563|NCT00543387|20927622|P1|COMPLETED|Crossover Participants||0
8492564|NCT00543387|20927612|P11|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
8492565|NCT00543387|20927613|P10|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
8492566|NCT00543387|20927614|P9|STARTED|Crossover Participants||0
8492567|NCT00543387|20927615|P8|STARTED|Crossover Participants||0
8492568|NCT00543387|20927616|P7|STARTED|Crossover Participants||0
8492569|NCT00543387|20927617|P6|STARTED|Crossover Participants||0
8492570|NCT00543387|20927618|P5|STARTED|Crossover Participants||0
8492571|NCT00543387|20927619|P4|STARTED|Crossover Participants||0
8492572|NCT00543387|20927620|P3|STARTED|Crossover Participants||0
8492573|NCT00543387|20927621|P2|STARTED|Crossover Participants||0
8492574|NCT00543387|20927622|P1|STARTED|Crossover Participants||0
8492575|NCT00543387|20927612|P11|NOT COMPLETED|Panel 1 + Panel 2||0
8492576|NCT00543387|20927613|P10|NOT COMPLETED|Panel 1 + Panel 2||0
8492577|NCT00543387|20927614|P9|NOT COMPLETED|Panel 1 + Panel 2||5
8492578|NCT00543387|20927615|P8|NOT COMPLETED|Panel 1 + Panel 2||6
8492579|NCT00543387|20927616|P7|NOT COMPLETED|Panel 1 + Panel 2||6
8492580|NCT00543387|20927617|P6|NOT COMPLETED|Panel 1 + Panel 2||3
8492581|NCT00543387|20927618|P5|NOT COMPLETED|Panel 1 + Panel 2||3
8492582|NCT00543387|20927619|P4|NOT COMPLETED|Panel 1 + Panel 2||3
8492583|NCT00543387|20927620|P3|NOT COMPLETED|Panel 1 + Panel 2||3
8492584|NCT00543387|20927621|P2|NOT COMPLETED|Panel 1 + Panel 2||3
8492585|NCT00543387|20927622|P1|NOT COMPLETED|Panel 1 + Panel 2||3
8492586|NCT00543387|20927612|P11|COMPLETED|Panel 1 + Panel 2||0
8492587|NCT00543387|20927613|P10|COMPLETED|Panel 1 + Panel 2||0
8492588|NCT00543387|20927614|P9|COMPLETED|Panel 1 + Panel 2||0
8492589|NCT00543387|20927615|P8|COMPLETED|Panel 1 + Panel 2||0
8492590|NCT00543387|20927616|P7|COMPLETED|Panel 1 + Panel 2||0
8492591|NCT00543387|20927617|P6|COMPLETED|Panel 1 + Panel 2||0
8492592|NCT00543387|20927618|P5|COMPLETED|Panel 1 + Panel 2||0
8492593|NCT00543387|20927619|P4|COMPLETED|Panel 1 + Panel 2||0
8492594|NCT00543387|20927620|P3|COMPLETED|Panel 1 + Panel 2||0
8492595|NCT00543387|20927621|P2|COMPLETED|Panel 1 + Panel 2||0
8492596|NCT00543387|20927622|P1|COMPLETED|Panel 1 + Panel 2||0
8492597|NCT00543387|20927612|P11|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492598|NCT00543387|20927613|P10|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492599|NCT00543387|20927614|P9|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492600|NCT00543387|20927615|P8|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492601|NCT00543387|20927616|P7|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492602|NCT00543387|20927617|P6|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
8492603|NCT00543387|20927618|P5|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
8492604|NCT00543387|20927619|P4|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492605|NCT00543387|20927620|P3|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492606|NCT00543387|20927621|P2|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
8492607|NCT00543387|20927622|P1|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
8492608|NCT00543387|20927612|P11|STARTED|Panel 1 + Panel 2||0
8492609|NCT00543387|20927613|P10|STARTED|Panel 1 + Panel 2||0
8492610|NCT00543387|20927614|P9|STARTED|Panel 1 + Panel 2||5
8492611|NCT00543387|20927615|P8|STARTED|Panel 1 + Panel 2||6
8492612|NCT00543387|20927616|P7|STARTED|Panel 1 + Panel 2||6
8492613|NCT00543387|20927617|P6|STARTED|Panel 1 + Panel 2||3
8492614|NCT00543387|20927618|P5|STARTED|Panel 1 + Panel 2||3
8492615|NCT00543387|20927619|P4|STARTED|Panel 1 + Panel 2||3
8492616|NCT00543387|20927620|P3|STARTED|Panel 1 + Panel 2||3
8492617|NCT00543387|20927621|P2|STARTED|Panel 1 + Panel 2||3
8492618|NCT00543387|20927622|P1|STARTED|Panel 1 + Panel 2||3
8492619|NCT00543309|20927660|P3|NOT COMPLETED|Overall Study||0
8492620|NCT00543309|20927661|P2|NOT COMPLETED|Overall Study||1
8492621|NCT00543309|20927662|P1|NOT COMPLETED|Overall Study||0
8492622|NCT00543309|20927660|P3|COMPLETED|Overall Study||35
8492623|NCT00543309|20927661|P2|COMPLETED|Overall Study||35
8492624|NCT00543309|20927662|P1|COMPLETED|Overall Study||35
8492625|NCT00543309|20927660|P3|STARTED|Overall Study||35
8492626|NCT00543309|20927661|P2|STARTED|Overall Study||36
8492627|NCT00543309|20927662|P1|STARTED|Overall Study||35
8492628|NCT00543296|20927712|P1|NOT COMPLETED|Overall Study||7
8492629|NCT00543296|20927712|P1|COMPLETED|Overall Study||14
8492630|NCT00543296|20927712|P1|STARTED|Overall Study||21
8492631|NCT00543140|20927719|P1|NOT COMPLETED|Overall Study||72
8492632|NCT00543140|20927719|P1|COMPLETED|Overall Study||231
8492633|NCT00543140|20927719|P1|STARTED|Overall Study||303
8492634|NCT00543127|20927729|P2|NOT COMPLETED|Overall Study||87
8492635|NCT00543127|20927730|P1|NOT COMPLETED|Overall Study||130
8492636|NCT00543127|20927729|P2|COMPLETED|Overall Study||350
8492637|NCT00543127|20927730|P1|COMPLETED|Overall Study||303
8492638|NCT00543127|20927729|P2|STARTED|Overall Study||437
8492639|NCT00543127|20927730|P1|STARTED|Overall Study||433
8492640|NCT00543101|20927744|P2|NOT COMPLETED|Overall Study||0
8492641|NCT00543101|20927745|P1|NOT COMPLETED|Overall Study||0
8492642|NCT00543101|20927744|P2|COMPLETED|Overall Study||12
8492643|NCT00543101|20927745|P1|COMPLETED|Overall Study||12
8492644|NCT00543101|20927744|P2|STARTED|Overall Study||12
8492645|NCT00543101|20927745|P1|STARTED|Overall Study||12
8492646|NCT00543062|20927757|P4|NOT COMPLETED|Overall Study||1
8492647|NCT00543062|20927758|P3|NOT COMPLETED|Overall Study||3
8492648|NCT00543062|20927759|P2|NOT COMPLETED|Overall Study||1
8492649|NCT00543062|20927760|P1|NOT COMPLETED|Overall Study||2
8492650|NCT00543062|20927757|P4|COMPLETED|Overall Study||11
8492651|NCT00543062|20927758|P3|COMPLETED|Overall Study||9
8492652|NCT00543062|20927759|P2|COMPLETED|Overall Study||11
8492653|NCT00543062|20927760|P1|COMPLETED|Overall Study||10
8492654|NCT00543062|20927757|P4|STARTED|Overall Study||12
8492655|NCT00543062|20927758|P3|STARTED|Overall Study||12
8492656|NCT00543062|20927759|P2|STARTED|Overall Study||12
8492657|NCT00543062|20927760|P1|STARTED|Overall Study||12
8492658|NCT00542997|20927782|P1|NOT COMPLETED|Efficacy Period||3
8492659|NCT00542997|20927782|P1|COMPLETED|Efficacy Period||43
8492660|NCT00542997|20927782|P1|STARTED|Efficacy Period||46
8492661|NCT00542997|20927782|P1|NOT COMPLETED|Wash in / Wash Out Period||5
8492662|NCT00542997|20927782|P1|COMPLETED|Wash in / Wash Out Period||46
8492663|NCT00542997|20927782|P1|STARTED|Wash in / Wash Out Period||51
8492664|NCT00542971|20927797|P1|NOT COMPLETED|Overall Study||0
8492665|NCT00542971|20927797|P1|COMPLETED|Overall Study||75
8492666|NCT00542971|20927797|P1|STARTED|Overall Study||75
8492667|NCT00542919|20927805|P3|NOT COMPLETED|Overall Study||6
8492668|NCT00542919|20927806|P2|NOT COMPLETED|Overall Study||7
8492669|NCT00542919|20927807|P1|NOT COMPLETED|Overall Study||7
8492670|NCT00542919|20927805|P3|COMPLETED|Overall Study||9
8492671|NCT00542919|20927806|P2|COMPLETED|Overall Study||12
8492672|NCT00542919|20927807|P1|COMPLETED|Overall Study||16
8492673|NCT00542919|20927805|P3|Death|Overall Study||2
8492674|NCT00542919|20927806|P2|Death|Overall Study||1
8492675|NCT00542919|20927807|P1|Death|Overall Study||1
8492676|NCT00542919|20927805|P3|Progressive Disease|Overall Study||7
8492677|NCT00542919|20927806|P2|Progressive Disease|Overall Study||11
8492678|NCT00542919|20927807|P1|Progressive Disease|Overall Study||15
8492679|NCT00542919|20927805|P3|Received At Least One Dose of Study Drug|Overall Study||15
8492680|NCT00542919|20927806|P2|Received At Least One Dose of Study Drug|Overall Study||19
8492681|NCT00542919|20927807|P1|Received At Least One Dose of Study Drug|Overall Study||23
8492682|NCT00542919|20927805|P3|STARTED|Overall Study||15
8492683|NCT00542919|20927806|P2|STARTED|Overall Study||19
8492684|NCT00542919|20927807|P1|STARTED|Overall Study||23
8492685|NCT00542880|20927852|P2|NOT COMPLETED|Period 3||2
8492686|NCT00542880|20927853|P1|NOT COMPLETED|Period 3||0
8492687|NCT00542880|20927852|P2|COMPLETED|Period 3||201
8492688|NCT00542880|20927853|P1|COMPLETED|Period 3||204
8492689|NCT00542880|20927852|P2|STARTED|Period 3||203
8492690|NCT00542880|20927853|P1|STARTED|Period 3||204
8492691|NCT00542880|20927852|P2|NOT COMPLETED|Period 2||10
8492692|NCT00542880|20927853|P1|NOT COMPLETED|Period 2||7
8492693|NCT00542880|20927852|P2|COMPLETED|Period 2||203
8492694|NCT00542880|20927853|P1|COMPLETED|Period 2||204
8492695|NCT00542880|20927852|P2|STARTED|Period 2||213
8492696|NCT00542880|20927853|P1|STARTED|Period 2||211
8492697|NCT00542880|20927852|P2|NOT COMPLETED|Period 1||12
8492698|NCT00542880|20927853|P1|NOT COMPLETED|Period 1||6
8492699|NCT00542880|20927852|P2|COMPLETED|Period 1||213
8492700|NCT00542880|20927853|P1|COMPLETED|Period 1||211
8492701|NCT00542880|20927852|P2|STARTED|Period 1||225
8492702|NCT00542880|20927853|P1|STARTED|Period 1|This was a cross-over study|217
8492703|NCT00542828|20927889|P1|NOT COMPLETED|Overall Study||13
8492704|NCT00542828|20927889|P1|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
8492705|NCT00542828|20927889|P1|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
8492706|NCT00542815|20927907|P3|NOT COMPLETED|Overall Study||32
8492707|NCT00542815|20927908|P2|NOT COMPLETED|Overall Study||32
8492708|NCT00542815|20927909|P1|NOT COMPLETED|Overall Study||106
8492709|NCT00542815|20927907|P3|COMPLETED|Overall Study||92
8492710|NCT00542815|20927908|P2|COMPLETED|Overall Study||44
8492711|NCT00542815|20927909|P1|COMPLETED|Overall Study||326
8492712|NCT00542815|20927907|P3|STARTED|Overall Study||124
8492713|NCT00542815|20927908|P2|STARTED|Overall Study||76
8492714|NCT00542815|20927909|P1|STARTED|Overall Study||432
8492715|NCT00542789|20927922|P2|NOT COMPLETED|Overall Study||78
8492716|NCT00542789|20927923|P1|NOT COMPLETED|Overall Study||41
8492717|NCT00542789|20927922|P2|COMPLETED|Overall Study||90
8492718|NCT00542789|20927923|P1|COMPLETED|Overall Study||134
8492719|NCT00542789|20927922|P2|STARTED|Overall Study|Randomised|168
8492720|NCT00542789|20927923|P1|STARTED|Overall Study|Randomised|175
8492721|NCT00542750|20927933|P1|NOT COMPLETED|Overall Study||0
8492722|NCT00542750|20927933|P1|COMPLETED|Overall Study||24
8492723|NCT00542750|20927933|P1|STARTED|Overall Study||24
8492724|NCT00542620|20927939|P2|NOT COMPLETED|Overall Study||0
8492725|NCT00542620|20927940|P1|NOT COMPLETED|Overall Study||0
8492726|NCT00542620|20927939|P2|COMPLETED|Overall Study||12
8492727|NCT00542620|20927940|P1|COMPLETED|Overall Study||13
8492728|NCT00542620|20927939|P2|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
8492729|NCT00542620|20927940|P1|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
8492730|NCT00542620|20927939|P2|STARTED|Overall Study||12
8492731|NCT00542620|20927940|P1|STARTED|Overall Study||13
8492732|NCT00542542|20928006|P2|NOT COMPLETED|Overall Study||0
8492733|NCT00542542|20928007|P1|NOT COMPLETED|Overall Study||0
8492734|NCT00542542|20928006|P2|COMPLETED|Overall Study||44
8492735|NCT00542542|20928007|P1|COMPLETED|Overall Study||44
8492736|NCT00542542|20928006|P2|STARTED|Overall Study||44
8492737|NCT00542542|20928007|P1|STARTED|Overall Study||44
8492738|NCT00542490|20928013|P1|NOT COMPLETED|Overall Study||2
8492739|NCT00542490|20928013|P1|COMPLETED|Overall Study||21
8492740|NCT00542490|20928013|P1|STARTED|Overall Study||23
8492741|NCT00542425|20928023|P5|NOT COMPLETED|Extended 24 Weeks of Treatment||1
8492742|NCT00542425|20928024|P4|NOT COMPLETED|Extended 24 Weeks of Treatment||1
8492743|NCT00542425|20928025|P3|NOT COMPLETED|Extended 24 Weeks of Treatment||2
8492744|NCT00542425|20928026|P2|NOT COMPLETED|Extended 24 Weeks of Treatment||2
8492745|NCT00542425|20928027|P1|NOT COMPLETED|Extended 24 Weeks of Treatment||1
8492746|NCT00542425|20928023|P5|COMPLETED|Extended 24 Weeks of Treatment||13
8492747|NCT00542425|20928024|P4|COMPLETED|Extended 24 Weeks of Treatment||6
8492748|NCT00542425|20928025|P3|COMPLETED|Extended 24 Weeks of Treatment||8
8492749|NCT00542425|20928026|P2|COMPLETED|Extended 24 Weeks of Treatment||11
8492750|NCT00542425|20928027|P1|COMPLETED|Extended 24 Weeks of Treatment||10
8492751|NCT00542425|20928023|P5|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
8492752|NCT00542425|20928024|P4|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
8492753|NCT00542425|20928025|P3|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
8492754|NCT00542425|20928026|P2|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
8492755|NCT00542425|20928027|P1|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
8492756|NCT00542425|20928023|P5|NOT COMPLETED|Initial 24 Weeks||6
8492757|NCT00542425|20928024|P4|NOT COMPLETED|Initial 24 Weeks||11
8492758|NCT00542425|20928025|P3|NOT COMPLETED|Initial 24 Weeks||7
8492759|NCT00542425|20928026|P2|NOT COMPLETED|Initial 24 Weeks||10
8492760|NCT00542425|20928027|P1|NOT COMPLETED|Initial 24 Weeks||4
8492761|NCT00542425|20928023|P5|COMPLETED|Initial 24 Weeks||39
8492762|NCT00542425|20928024|P4|COMPLETED|Initial 24 Weeks||34
8492763|NCT00542425|20928025|P3|COMPLETED|Initial 24 Weeks||36
8492764|NCT00542425|20928026|P2|COMPLETED|Initial 24 Weeks||33
8492765|NCT00542425|20928027|P1|COMPLETED|Initial 24 Weeks||42
8492766|NCT00542425|20928023|P5|STARTED|Initial 24 Weeks||45
8492767|NCT00542425|20928024|P4|STARTED|Initial 24 Weeks||45
8492768|NCT00542425|20928025|P3|STARTED|Initial 24 Weeks||43
8492769|NCT00542425|20928026|P2|STARTED|Initial 24 Weeks||43
8492770|NCT00542425|20928027|P1|STARTED|Initial 24 Weeks||46
8492771|NCT00542386|20928065|P6|NOT COMPLETED|Overall Study||50
8492772|NCT00542386|20928066|P5|NOT COMPLETED|Overall Study||40
8492773|NCT00542386|20928067|P4|NOT COMPLETED|Overall Study||38
8492774|NCT00542386|20928068|P3|NOT COMPLETED|Overall Study||33
8492775|NCT00542386|20928069|P2|NOT COMPLETED|Overall Study||28
8492776|NCT00542386|20928070|P1|NOT COMPLETED|Overall Study||43
8492777|NCT00542386|20928065|P6|COMPLETED|Overall Study||82
8492778|NCT00542386|20928066|P5|COMPLETED|Overall Study||62
8492779|NCT00542386|20928067|P4|COMPLETED|Overall Study||65
8492780|NCT00542386|20928068|P3|COMPLETED|Overall Study||66
8492781|NCT00542386|20928069|P2|COMPLETED|Overall Study||74
8492782|NCT00542386|20928070|P1|COMPLETED|Overall Study||61
8492783|NCT00542386|20928065|P6|STARTED|Overall Study||132
8492784|NCT00542386|20928066|P5|STARTED|Overall Study||102
8492785|NCT00542386|20928067|P4|STARTED|Overall Study||103
8492786|NCT00542386|20928068|P3|STARTED|Overall Study||99
8492787|NCT00542386|20928069|P2|STARTED|Overall Study||102
8492788|NCT00542386|20928070|P1|STARTED|Overall Study||104
8492789|NCT00542321|20928092|P2|NOT COMPLETED|Overall Study||1
8492790|NCT00542321|20928093|P1|NOT COMPLETED|Overall Study||0
8492791|NCT00542321|20928092|P2|COMPLETED|Overall Study||7
8492792|NCT00542321|20928093|P1|COMPLETED|Overall Study||8
8492793|NCT00542321|20928092|P2|STARTED|Overall Study||8
8492794|NCT00542321|20928093|P1|STARTED|Overall Study||8
8492795|NCT00542308|20928107|P1|NOT COMPLETED|Overall Study||0
8492796|NCT00542308|20928107|P1|COMPLETED|Overall Study||90
8492797|NCT00542308|20928107|P1|STARTED|Overall Study||90
8492798|NCT00542269|20928115|P3|NOT COMPLETED|Overall Study||6
8492799|NCT00542269|20928116|P2|NOT COMPLETED|Overall Study||6
8492800|NCT00542269|20928117|P1|NOT COMPLETED|Overall Study||13
8492801|NCT00542269|20928115|P3|COMPLETED|Overall Study||51
8492802|NCT00542269|20928116|P2|COMPLETED|Overall Study||54
8492803|NCT00542269|20928117|P1|COMPLETED|Overall Study||48
8492804|NCT00542269|20928115|P3|STARTED|Overall Study||57
8492805|NCT00542269|20928116|P2|STARTED|Overall Study||60
8492806|NCT00542269|20928117|P1|STARTED|Overall Study||61
8492810|NCT00542178|20928156|P8|NOT COMPLETED|Overall Study||85
8492811|NCT00542178|20928157|P7|NOT COMPLETED|Overall Study||87
8492812|NCT00542178|20928158|P6|NOT COMPLETED|Overall Study||89
8492813|NCT00542178|20928159|P5|NOT COMPLETED|Overall Study||64
8492814|NCT00542178|20928160|P4|NOT COMPLETED|Overall Study||62
8492815|NCT00542178|20928161|P3|NOT COMPLETED|Overall Study||74
8492816|NCT00542178|20928162|P2|NOT COMPLETED|Overall Study||80
8492817|NCT00542178|20928163|P1|NOT COMPLETED|Overall Study||75
8492818|NCT00542178|20928156|P8|COMPLETED|Overall Study||381
8492819|NCT00542178|20928157|P7|COMPLETED|Overall Study||406
8492820|NCT00542178|20928158|P6|COMPLETED|Overall Study||406
8492821|NCT00542178|20928159|P5|COMPLETED|Overall Study||400
8492822|NCT00542178|20928160|P4|COMPLETED|Overall Study||308
8492823|NCT00542178|20928161|P3|COMPLETED|Overall Study||308
8492824|NCT00542178|20928162|P2|COMPLETED|Overall Study||332
8492825|NCT00542178|20928163|P1|COMPLETED|Overall Study||315
8492826|NCT00542178|20928156|P8|STARTED|Overall Study||466
8492827|NCT00542178|20928157|P7|STARTED|Overall Study||493
8492828|NCT00542178|20928158|P6|STARTED|Overall Study||495
8492829|NCT00542178|20928159|P5|STARTED|Overall Study||464
8492830|NCT00542178|20928160|P4|STARTED|Overall Study||370
8492831|NCT00542178|20928161|P3|STARTED|Overall Study||382
8492832|NCT00542178|20928162|P2|STARTED|Overall Study||412
8492833|NCT00542178|20928163|P1|STARTED|Overall Study||390
8492834|NCT00541970|20928199|P4|NOT COMPLETED|Month 60||72
8492835|NCT00541970|20928200|P3|NOT COMPLETED|Month 60||82
8492836|NCT00541970|20928201|P2|NOT COMPLETED|Month 60||77
8492837|NCT00541970|20928202|P1|NOT COMPLETED|Month 60||78
8492838|NCT00541970|20928199|P4|COMPLETED|Month 60||167
8492839|NCT00541970|20928200|P3|COMPLETED|Month 60||158
8492840|NCT00541970|20928201|P2|COMPLETED|Month 60||164
8492841|NCT00541970|20928202|P1|COMPLETED|Month 60||162
8492842|NCT00541970|20928199|P4|STARTED|Month 60||239
8492843|NCT00541970|20928200|P3|STARTED|Month 60||240
8492844|NCT00541970|20928201|P2|STARTED|Month 60||241
8492845|NCT00541970|20928202|P1|STARTED|Month 60||240
8492846|NCT00541970|20928199|P4|NOT COMPLETED|Month 48||75
8492847|NCT00541970|20928200|P3|NOT COMPLETED|Month 48||73
8492848|NCT00541970|20928201|P2|NOT COMPLETED|Month 48||73
8492849|NCT00541970|20928202|P1|NOT COMPLETED|Month 48||71
8492850|NCT00541970|20928199|P4|COMPLETED|Month 48||164
8492851|NCT00541970|20928200|P3|COMPLETED|Month 48||167
8492852|NCT00541970|20928201|P2|COMPLETED|Month 48||168
8492853|NCT00541970|20928202|P1|COMPLETED|Month 48||169
8492854|NCT00541970|20928199|P4|STARTED|Month 48||239
8492855|NCT00541970|20928200|P3|STARTED|Month 48||240
8492856|NCT00541970|20928201|P2|STARTED|Month 48||241
8492857|NCT00541970|20928202|P1|STARTED|Month 48||240
8492858|NCT00541970|20928199|P4|NOT COMPLETED|Month 36||60
8492859|NCT00541970|20928200|P3|NOT COMPLETED|Month 36||66
8492860|NCT00541970|20928201|P2|NOT COMPLETED|Month 36||66
8492861|NCT00541970|20928202|P1|NOT COMPLETED|Month 36||61
8492862|NCT00541970|20928199|P4|COMPLETED|Month 36||179
8492863|NCT00541970|20928200|P3|COMPLETED|Month 36||174
8492864|NCT00541970|20928201|P2|COMPLETED|Month 36||175
8492865|NCT00541970|20928202|P1|COMPLETED|Month 36||179
8492866|NCT00541970|20928199|P4|STARTED|Month 36||239
8492867|NCT00541970|20928200|P3|STARTED|Month 36||240
8492868|NCT00541970|20928201|P2|STARTED|Month 36||241
8492869|NCT00541970|20928202|P1|STARTED|Month 36||240
8492870|NCT00541970|20928199|P4|NOT COMPLETED|Month 24||22
8492871|NCT00541970|20928200|P3|NOT COMPLETED|Month 24||32
8492872|NCT00541970|20928201|P2|NOT COMPLETED|Month 24||32
8492873|NCT00541970|20928202|P1|NOT COMPLETED|Month 24||29
8492874|NCT00541970|20928199|P4|COMPLETED|Month 24||217
8492875|NCT00541970|20928200|P3|COMPLETED|Month 24||208
8492876|NCT00541970|20928201|P2|COMPLETED|Month 24||209
8492877|NCT00541970|20928202|P1|COMPLETED|Month 24||211
8492878|NCT00541970|20928199|P4|STARTED|Month 24||239
8492879|NCT00541970|20928200|P3|STARTED|Month 24||240
8492880|NCT00541970|20928201|P2|STARTED|Month 24||241
8492881|NCT00541970|20928202|P1|STARTED|Month 24||240
8492882|NCT00541970|20928199|P4|NOT COMPLETED|Month 18||17
8492883|NCT00541970|20928200|P3|NOT COMPLETED|Month 18||25
8492884|NCT00541970|20928201|P2|NOT COMPLETED|Month 18||24
8492885|NCT00541970|20928202|P1|NOT COMPLETED|Month 18||14
8492886|NCT00541970|20928199|P4|COMPLETED|Month 18||222
8492887|NCT00541970|20928200|P3|COMPLETED|Month 18||215
8492888|NCT00541970|20928201|P2|COMPLETED|Month 18||217
8492889|NCT00541970|20928202|P1|COMPLETED|Month 18||226
8492890|NCT00541970|20928199|P4|STARTED|Month 18||239
8492891|NCT00541970|20928200|P3|STARTED|Month 18||240
8492892|NCT00541970|20928201|P2|STARTED|Month 18||241
8492893|NCT00541970|20928202|P1|STARTED|Month 18||240
8492894|NCT00541970|20928199|P4|NOT COMPLETED|Month 12||16
8492895|NCT00541970|20928200|P3|NOT COMPLETED|Month 12||21
8492896|NCT00541970|20928201|P2|NOT COMPLETED|Month 12||22
8492897|NCT00541970|20928202|P1|NOT COMPLETED|Month 12||12
8492898|NCT00541970|20928199|P4|COMPLETED|Month 12||223
8492899|NCT00541970|20928200|P3|COMPLETED|Month 12||219
8492900|NCT00541970|20928201|P2|COMPLETED|Month 12||219
8492901|NCT00541970|20928202|P1|COMPLETED|Month 12||228
8492902|NCT00541970|20928199|P4|STARTED|Month 12||239
8492903|NCT00541970|20928200|P3|STARTED|Month 12||240
8492904|NCT00541970|20928201|P2|STARTED|Month 12||241
8492905|NCT00541970|20928202|P1|STARTED|Month 12||240
8492906|NCT00541970|20928199|P4|NOT COMPLETED|Month 7||5
8492907|NCT00541970|20928200|P3|NOT COMPLETED|Month 7||11
8492908|NCT00541970|20928201|P2|NOT COMPLETED|Month 7||13
8492909|NCT00541970|20928202|P1|NOT COMPLETED|Month 7||9
8492910|NCT00541970|20928199|P4|COMPLETED|Month 7||234
8492911|NCT00541970|20928200|P3|COMPLETED|Month 7||229
8492912|NCT00541970|20928201|P2|COMPLETED|Month 7||228
8492913|NCT00541970|20928202|P1|COMPLETED|Month 7||231
8492914|NCT00541970|20928199|P4|STARTED|Month 7||239
8492915|NCT00541970|20928200|P3|STARTED|Month 7||240
8492916|NCT00541970|20928201|P2|STARTED|Month 7||241
8492917|NCT00541970|20928202|P1|STARTED|Month 7||240
8492918|NCT00541931|20928353|P2|NOT COMPLETED|Overall Study||4
8492919|NCT00541931|20928354|P1|NOT COMPLETED|Overall Study||5
8492920|NCT00541931|20928353|P2|COMPLETED|Overall Study||11
8492921|NCT00541931|20928354|P1|COMPLETED|Overall Study||17
8492922|NCT00541931|20928353|P2|STARTED|Overall Study||15
8492923|NCT00541931|20928354|P1|STARTED|Overall Study||22
8492924|NCT00541866|20928367|P5|NOT COMPLETED|Overall Study||15
8492925|NCT00541866|20928368|P4|NOT COMPLETED|Overall Study||16
8492926|NCT00541866|20928369|P3|NOT COMPLETED|Overall Study||15
8492927|NCT00541866|20928370|P2|NOT COMPLETED|Overall Study||18
8492928|NCT00541866|20928371|P1|NOT COMPLETED|Overall Study||34
8492929|NCT00541866|20928367|P5|COMPLETED|Overall Study||3
8492930|NCT00541866|20928368|P4|COMPLETED|Overall Study||0
8492931|NCT00541866|20928369|P3|COMPLETED|Overall Study||2
8492932|NCT00541866|20928370|P2|COMPLETED|Overall Study||0
8492933|NCT00541866|20928371|P1|COMPLETED|Overall Study||7
8492934|NCT00541866|20928367|P5|STARTED|Overall Study||18
8492935|NCT00541866|20928368|P4|STARTED|Overall Study||16
8492936|NCT00541866|20928369|P3|STARTED|Overall Study||17
8492937|NCT00541866|20928370|P2|STARTED|Overall Study||18
8492938|NCT00541866|20928371|P1|STARTED|Overall Study|41 started, but only 39 treated|41
8492939|NCT00541775|20928412|P3|NOT COMPLETED|Overall Study||8
8492940|NCT00541775|20928413|P2|NOT COMPLETED|Overall Study||2
8492941|NCT00541775|20928414|P1|NOT COMPLETED|Overall Study||9
8492942|NCT00541775|20928412|P3|COMPLETED|Overall Study||84
8492943|NCT00541775|20928413|P2|COMPLETED|Overall Study||85
8492944|NCT00541775|20928414|P1|COMPLETED|Overall Study||85
8492945|NCT00541775|20928412|P3|STARTED|Overall Study||92
8492946|NCT00541775|20928413|P2|STARTED|Overall Study||87
8492947|NCT00541775|20928414|P1|STARTED|Overall Study||94
8492948|NCT00541671|20928430|P2|NOT COMPLETED|Overall Study||0
8492949|NCT00541671|20928431|P1|NOT COMPLETED|Overall Study||0
8492950|NCT00541671|20928430|P2|COMPLETED|Overall Study||12
8492951|NCT00541671|20928431|P1|COMPLETED|Overall Study||13
8492952|NCT00541671|20928430|P2|STARTED|Overall Study||12
8492953|NCT00541671|20928431|P1|STARTED|Overall Study||13
8492954|NCT00541658|20928440|P3|NOT COMPLETED|Overall Study||68
8492955|NCT00541658|20928441|P2|NOT COMPLETED|Overall Study||73
8492956|NCT00541658|20928442|P1|NOT COMPLETED|Overall Study||60
8492957|NCT00541658|20928440|P3|COMPLETED|Overall Study||240
8492958|NCT00541658|20928441|P2|COMPLETED|Overall Study||234
8492959|NCT00541658|20928442|P1|COMPLETED|Overall Study||248
8492960|NCT00541658|20928440|P3|ITT Population|Overall Study||308
8492961|NCT00541658|20928441|P2|ITT Population|Overall Study||307
8492962|NCT00541658|20928442|P1|ITT Population|Overall Study||307
8492963|NCT00541658|20928440|P3|STARTED|Overall Study||308
8492964|NCT00541658|20928441|P2|STARTED|Overall Study||307
8492965|NCT00541658|20928442|P1|STARTED|Overall Study||308
8492966|NCT00541593|20928599|P1|NOT COMPLETED|Overall Study||0
8492967|NCT00541593|20928599|P1|COMPLETED|Overall Study||5
8492968|NCT00541593|20928599|P1|STARTED|Overall Study||5
8492969|NCT00541450|20928605|P2|NOT COMPLETED|Phase B||31
8492970|NCT00541450|20928606|P1|NOT COMPLETED|Phase B||37
8492971|NCT00541450|20928605|P2|COMPLETED|Phase B||200
8492972|NCT00541450|20928606|P1|COMPLETED|Phase B||187
8492973|NCT00541450|20928605|P2|STARTED|Phase B||231
8492974|NCT00541450|20928606|P1|STARTED|Phase B||224
8492975|NCT00541450|20928605|P2|NOT COMPLETED|Phase A||17
8492976|NCT00541450|20928606|P1|NOT COMPLETED|Phase A||20
8492977|NCT00541450|20928605|P2|COMPLETED|Phase A||231
8492978|NCT00541450|20928606|P1|COMPLETED|Phase A||224
8492979|NCT00541450|20928605|P2|STARTED|Phase A||248
8492980|NCT00541450|20928606|P1|STARTED|Phase A||244
8492981|NCT00541346|20928624|P1|NOT COMPLETED|Follow-up||1
8492982|NCT00541346|20928624|P1|COMPLETED|Follow-up||15
8492983|NCT00541346|20928624|P1|STARTED|Follow-up||16
8492984|NCT00541346|20928624|P1|NOT COMPLETED|Baseline||0
8492985|NCT00541346|20928624|P1|COMPLETED|Baseline||16
8492986|NCT00541346|20928624|P1|STARTED|Baseline||16
8492987|NCT00541307|20928638|P1|NOT COMPLETED|Overall Study||24
8492988|NCT00541307|20928638|P1|COMPLETED|Overall Study||95
8492989|NCT00541307|20928638|P1|STARTED|Overall Study||119
8492990|NCT00541242|20928648|P2|NOT COMPLETED|Treatment Period 2||7
8492991|NCT00541242|20928649|P1|NOT COMPLETED|Treatment Period 2||9
8492992|NCT00541242|20928648|P2|COMPLETED|Treatment Period 2||266
8492993|NCT00541242|20928649|P1|COMPLETED|Treatment Period 2||261
8492994|NCT00541242|20928648|P2|STARTED|Treatment Period 2||273
8492995|NCT00541242|20928649|P1|STARTED|Treatment Period 2||270
8492996|NCT00541242|20928648|P2|NOT COMPLETED|Treatment Period 1||0
8492997|NCT00541242|20928649|P1|NOT COMPLETED|Treatment Period 1||0
8492998|NCT00541242|20928648|P2|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
8492999|NCT00541242|20928649|P1|COMPLETED|Treatment Period 1||0
8493000|NCT00541242|20928648|P2|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
8493001|NCT00541242|20928649|P1|STARTED|Treatment Period 1||0
8493002|NCT00541229|20928663|P6|NOT COMPLETED|Treatment Period III (Week 11)||1
8493003|NCT00541229|20928664|P5|NOT COMPLETED|Treatment Period III (Week 11)||1
8493004|NCT00541229|20928665|P4|NOT COMPLETED|Treatment Period III (Week 11)||0
8493005|NCT00541229|20928666|P3|NOT COMPLETED|Treatment Period III (Week 11)||1
8493006|NCT00541229|20928667|P2|NOT COMPLETED|Treatment Period III (Week 11)||0
8493007|NCT00541229|20928668|P1|NOT COMPLETED|Treatment Period III (Week 11)||0
8493008|NCT00541229|20928663|P6|COMPLETED|Treatment Period III (Week 11)||4
8493009|NCT00541229|20928664|P5|COMPLETED|Treatment Period III (Week 11)||6
8493010|NCT00541229|20928665|P4|COMPLETED|Treatment Period III (Week 11)||8
8493011|NCT00541229|20928666|P3|COMPLETED|Treatment Period III (Week 11)||9
8493012|NCT00541229|20928667|P2|COMPLETED|Treatment Period III (Week 11)||8
8493013|NCT00541229|20928668|P1|COMPLETED|Treatment Period III (Week 11)||7
8493014|NCT00541229|20928663|P6|STARTED|Treatment Period III (Week 11)||5
8493015|NCT00541229|20928664|P5|STARTED|Treatment Period III (Week 11)||7
8493016|NCT00541229|20928665|P4|STARTED|Treatment Period III (Week 11)||8
8493017|NCT00541229|20928666|P3|STARTED|Treatment Period III (Week 11)||10
8493018|NCT00541229|20928667|P2|STARTED|Treatment Period III (Week 11)||8
8493019|NCT00541229|20928668|P1|STARTED|Treatment Period III (Week 11)||7
8493020|NCT00541229|20928663|P6|NOT COMPLETED|Washout Period II (Week 7-10)||3
8493021|NCT00541229|20928664|P5|NOT COMPLETED|Washout Period II (Week 7-10)||4
8493022|NCT00541229|20928665|P4|NOT COMPLETED|Washout Period II (Week 7-10)||4
8493023|NCT00541229|20928666|P3|NOT COMPLETED|Washout Period II (Week 7-10)||2
8493024|NCT00541229|20928667|P2|NOT COMPLETED|Washout Period II (Week 7-10)||4
8493025|NCT00541229|20928668|P1|NOT COMPLETED|Washout Period II (Week 7-10)||4
8493026|NCT00541229|20928663|P6|COMPLETED|Washout Period II (Week 7-10)||5
8493027|NCT00541229|20928664|P5|COMPLETED|Washout Period II (Week 7-10)||7
8493028|NCT00541229|20928665|P4|COMPLETED|Washout Period II (Week 7-10)||8
8493029|NCT00541229|20928666|P3|COMPLETED|Washout Period II (Week 7-10)||10
8493030|NCT00541229|20928667|P2|COMPLETED|Washout Period II (Week 7-10)||8
8493031|NCT00541229|20928668|P1|COMPLETED|Washout Period II (Week 7-10)||7
8493032|NCT00541229|20928663|P6|STARTED|Washout Period II (Week 7-10)||8
8493033|NCT00541229|20928664|P5|STARTED|Washout Period II (Week 7-10)||11
8493034|NCT00541229|20928665|P4|STARTED|Washout Period II (Week 7-10)||12
8493035|NCT00541229|20928666|P3|STARTED|Washout Period II (Week 7-10)||12
8493036|NCT00541229|20928667|P2|STARTED|Washout Period II (Week 7-10)||12
8493037|NCT00541229|20928668|P1|STARTED|Washout Period II (Week 7-10)||11
8493038|NCT00541229|20928663|P6|NOT COMPLETED|Treatment Period II (Week 6)||3
8493039|NCT00541229|20928664|P5|NOT COMPLETED|Treatment Period II (Week 6)||2
8493040|NCT00541229|20928665|P4|NOT COMPLETED|Treatment Period II (Week 6)||1
8493041|NCT00541229|20928666|P3|NOT COMPLETED|Treatment Period II (Week 6)||1
8493042|NCT00541229|20928667|P2|NOT COMPLETED|Treatment Period II (Week 6)||1
8493043|NCT00541229|20928668|P1|NOT COMPLETED|Treatment Period II (Week 6)||2
8493044|NCT00541229|20928663|P6|COMPLETED|Treatment Period II (Week 6)||8
8493045|NCT00541229|20928664|P5|COMPLETED|Treatment Period II (Week 6)||11
8493046|NCT00541229|20928665|P4|COMPLETED|Treatment Period II (Week 6)||12
8493047|NCT00541229|20928666|P3|COMPLETED|Treatment Period II (Week 6)||12
8493048|NCT00541229|20928667|P2|COMPLETED|Treatment Period II (Week 6)||12
8493049|NCT00541229|20928668|P1|COMPLETED|Treatment Period II (Week 6)||11
8493050|NCT00541229|20928663|P6|STARTED|Treatment Period II (Week 6)||11
8493051|NCT00541229|20928664|P5|STARTED|Treatment Period II (Week 6)||13
8493052|NCT00541229|20928665|P4|STARTED|Treatment Period II (Week 6)||13
8493053|NCT00541229|20928666|P3|STARTED|Treatment Period II (Week 6)||13
8493054|NCT00541229|20928667|P2|STARTED|Treatment Period II (Week 6)||13
8493055|NCT00541229|20928668|P1|STARTED|Treatment Period II (Week 6)||13
8493056|NCT00541229|20928663|P6|NOT COMPLETED|Washout Period I (Week 2-5)||5
8493057|NCT00541229|20928664|P5|NOT COMPLETED|Washout Period I (Week 2-5)||1
8493058|NCT00541229|20928665|P4|NOT COMPLETED|Washout Period I (Week 2-5)||4
8493059|NCT00541229|20928666|P3|NOT COMPLETED|Washout Period I (Week 2-5)||4
8493060|NCT00541229|20928667|P2|NOT COMPLETED|Washout Period I (Week 2-5)||2
8493061|NCT00541229|20928668|P1|NOT COMPLETED|Washout Period I (Week 2-5)||4
8493062|NCT00541229|20928663|P6|COMPLETED|Washout Period I (Week 2-5)||11
8493063|NCT00541229|20928664|P5|COMPLETED|Washout Period I (Week 2-5)||13
8493064|NCT00541229|20928665|P4|COMPLETED|Washout Period I (Week 2-5)||13
8493065|NCT00541229|20928666|P3|COMPLETED|Washout Period I (Week 2-5)||13
8493066|NCT00541229|20928667|P2|COMPLETED|Washout Period I (Week 2-5)||13
8493067|NCT00541229|20928668|P1|COMPLETED|Washout Period I (Week 2-5)||13
8493068|NCT00541229|20928663|P6|STARTED|Washout Period I (Week 2-5)||16
8493069|NCT00541229|20928664|P5|STARTED|Washout Period I (Week 2-5)||14
8493070|NCT00541229|20928665|P4|STARTED|Washout Period I (Week 2-5)||17
8493071|NCT00541229|20928666|P3|STARTED|Washout Period I (Week 2-5)||17
8493072|NCT00541229|20928667|P2|STARTED|Washout Period I (Week 2-5)||15
8493073|NCT00541229|20928668|P1|STARTED|Washout Period I (Week 2-5)||17
8493074|NCT00541229|20928663|P6|NOT COMPLETED|Treatment Period I (Week 1)||2
8493075|NCT00541229|20928664|P5|NOT COMPLETED|Treatment Period I (Week 1)||0
8493076|NCT00541229|20928665|P4|NOT COMPLETED|Treatment Period I (Week 1)||1
8493077|NCT00541229|20928666|P3|NOT COMPLETED|Treatment Period I (Week 1)||3
8493078|NCT00541229|20928667|P2|NOT COMPLETED|Treatment Period I (Week 1)||1
8493079|NCT00541229|20928668|P1|NOT COMPLETED|Treatment Period I (Week 1)||0
8493080|NCT00541229|20928663|P6|COMPLETED|Treatment Period I (Week 1)||16
8493081|NCT00541229|20928664|P5|COMPLETED|Treatment Period I (Week 1)||14
8493082|NCT00541229|20928665|P4|COMPLETED|Treatment Period I (Week 1)||17
8493083|NCT00541229|20928666|P3|COMPLETED|Treatment Period I (Week 1)||17
8493084|NCT00541229|20928667|P2|COMPLETED|Treatment Period I (Week 1)||15
8493085|NCT00541229|20928668|P1|COMPLETED|Treatment Period I (Week 1)||17
8493086|NCT00541229|20928663|P6|STARTED|Treatment Period I (Week 1)||18
8493087|NCT00541229|20928664|P5|STARTED|Treatment Period I (Week 1)||14
8493088|NCT00541229|20928665|P4|STARTED|Treatment Period I (Week 1)||18
8493089|NCT00541229|20928666|P3|STARTED|Treatment Period I (Week 1)||20
8493090|NCT00541229|20928667|P2|STARTED|Treatment Period I (Week 1)||16
8493091|NCT00541229|20928668|P1|STARTED|Treatment Period I (Week 1)||17
8493092|NCT00541190|20928678|P2|NOT COMPLETED|Overall Study||0
8493093|NCT00541190|20928679|P1|NOT COMPLETED|Overall Study||0
8493094|NCT00541190|20928678|P2|COMPLETED|Overall Study||11
8493095|NCT00541190|20928679|P1|COMPLETED|Overall Study||10
8493096|NCT00541190|20928678|P2|STARTED|Overall Study||11
8493097|NCT00541190|20928679|P1|STARTED|Overall Study||10
8493098|NCT00541099|20928687|P1|NOT COMPLETED|Overall Study||3
8493099|NCT00541099|20928687|P1|COMPLETED|Overall Study||8
8493100|NCT00541099|20928687|P1|STARTED|Overall Study||11
8493101|NCT00541034|20928695|P1|NOT COMPLETED|Overall Study||3
8493102|NCT00541034|20928695|P1|COMPLETED|Overall Study||46
8493103|NCT00541034|20928695|P1|STARTED|Overall Study||49
8493104|NCT00540982|20928699|P1|NOT COMPLETED|Overall Study||0
8493105|NCT00540982|20928699|P1|COMPLETED|Overall Study||47
8493106|NCT00540982|20928699|P1|Severe Liver Dysfunction|Overall Study||12
8493107|NCT00540982|20928699|P1|Moderate Liver Dysfunction|Overall Study||18
8493108|NCT00540982|20928699|P1|Mild Liver Dysfunction|Overall Study||6
8493109|NCT00540982|20928699|P1|Normal Liver Function|Overall Study||11
8493110|NCT00540982|20928699|P1|STARTED|Overall Study||47
8493111|NCT00540969|20928723|P2|NOT COMPLETED|Overall Study||0
8493112|NCT00540969|20928724|P1|NOT COMPLETED|Overall Study||0
8493113|NCT00540969|20928723|P2|COMPLETED|Overall Study||1
8493114|NCT00540969|20928724|P1|COMPLETED|Overall Study||2
8493115|NCT00540969|20928723|P2|STARTED|Overall Study||1
8493116|NCT00540969|20928724|P1|STARTED|Overall Study||2
8493117|NCT00540722|20928734|P1|NOT COMPLETED|Overall Study||0
8493118|NCT00540722|20928734|P1|COMPLETED|Overall Study||56
8493119|NCT00540722|20928734|P1|STARTED|Overall Study||56
8493120|NCT00540644|20928744|P2|NOT COMPLETED|Overall Study||9
8493121|NCT00540644|20928745|P1|NOT COMPLETED|Overall Study||9
8493122|NCT00540644|20928744|P2|COMPLETED|Overall Study||13
8493123|NCT00540644|20928745|P1|COMPLETED|Overall Study||39
8493124|NCT00540644|20928744|P2|STARTED|Overall Study||22
8493125|NCT00540644|20928745|P1|STARTED|Overall Study||48
8493126|NCT00540592|20928765|P10|NOT COMPLETED|Overall Study||2
8493127|NCT00540592|20928766|P9|NOT COMPLETED|Overall Study||1
8493128|NCT00540592|20928767|P8|NOT COMPLETED|Overall Study||1
8493129|NCT00540592|20928768|P7|NOT COMPLETED|Overall Study||0
8493130|NCT00540592|20928769|P6|NOT COMPLETED|Overall Study||0
8493131|NCT00540592|20928770|P5|NOT COMPLETED|Overall Study||1
8493132|NCT00540592|20928771|P4|NOT COMPLETED|Overall Study||1
8493133|NCT00540592|20928772|P3|NOT COMPLETED|Overall Study||1
8493134|NCT00540592|20928773|P2|NOT COMPLETED|Overall Study||1
8493135|NCT00540592|20928774|P1|NOT COMPLETED|Overall Study||2
8493136|NCT00540592|20928765|P10|COMPLETED|Overall Study||201
8493137|NCT00540592|20928766|P9|COMPLETED|Overall Study||199
8493138|NCT00540592|20928767|P8|COMPLETED|Overall Study||198
8493139|NCT00540592|20928768|P7|COMPLETED|Overall Study||198
8493140|NCT00540592|20928769|P6|COMPLETED|Overall Study||198
8493141|NCT00540592|20928770|P5|COMPLETED|Overall Study||198
8493142|NCT00540592|20928771|P4|COMPLETED|Overall Study||201
8493143|NCT00540592|20928772|P3|COMPLETED|Overall Study||201
8493144|NCT00540592|20928773|P2|COMPLETED|Overall Study||201
8493145|NCT00540592|20928774|P1|COMPLETED|Overall Study||202
8493146|NCT00540592|20928765|P10|Completed at Day 180|Overall Study||189
8493147|NCT00540592|20928766|P9|Completed at Day 180|Overall Study||198
8493148|NCT00540592|20928767|P8|Completed at Day 180|Overall Study||193
8493149|NCT00540592|20928768|P7|Completed at Day 180|Overall Study||196
8493150|NCT00540592|20928769|P6|Completed at Day 180|Overall Study||198
8493151|NCT00540592|20928770|P5|Completed at Day 180|Overall Study||195
8493152|NCT00540592|20928771|P4|Completed at Day 180|Overall Study||197
8493153|NCT00540592|20928772|P3|Completed at Day 180|Overall Study||197
8493154|NCT00540592|20928773|P2|Completed at Day 180|Overall Study||201
8493155|NCT00540592|20928774|P1|Completed at Day 180|Overall Study||200
8493156|NCT00540592|20928765|P10|STARTED|Overall Study||203
8493157|NCT00540592|20928766|P9|STARTED|Overall Study||200
8493158|NCT00540592|20928767|P8|STARTED|Overall Study||199
8493159|NCT00540592|20928768|P7|STARTED|Overall Study||198
8493160|NCT00540592|20928769|P6|STARTED|Overall Study||198
8493161|NCT00540592|20928770|P5|STARTED|Overall Study||199
8493162|NCT00540592|20928771|P4|STARTED|Overall Study||202
8493163|NCT00540592|20928772|P3|STARTED|Overall Study||202
8493164|NCT00540592|20928773|P2|STARTED|Overall Study||202
8493165|NCT00540592|20928774|P1|STARTED|Overall Study||204
8493166|NCT00540579|20929006|P1|NOT COMPLETED|Overall Study||0
8493167|NCT00540579|20929006|P1|COMPLETED|Overall Study||23
8493168|NCT00540579|20929006|P1|STARTED|Overall Study||23
8493169|NCT00540514|20929013|P2|NOT COMPLETED|Overall Study||266
8493170|NCT00540514|20929014|P1|NOT COMPLETED|Overall Study||246
8493171|NCT00540514|20929013|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
8493172|NCT00540514|20929014|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
8493173|NCT00540514|20929013|P2|Biomarker Population|Overall Study||36
8493174|NCT00540514|20929014|P1|Biomarker Population|Overall Study||35
8493175|NCT00540514|20929013|P2|Treated|Overall Study||524
8493176|NCT00540514|20929014|P1|Treated|Overall Study||514
8493177|NCT00540514|20929013|P2|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
8493178|NCT00540514|20929014|P1|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
8493179|NCT00540449|20929046|P2|NOT COMPLETED|Overall Study||78
8493180|NCT00540449|20929047|P1|NOT COMPLETED|Overall Study||84
8493181|NCT00540449|20929046|P2|COMPLETED|Overall Study||266
8493182|NCT00540449|20929047|P1|COMPLETED|Overall Study||262
8493183|NCT00540449|20929046|P2|STARTED|Overall Study||344
8493184|NCT00540449|20929047|P1|STARTED|Overall Study||346
8493185|NCT00540436|20929069|P1|NOT COMPLETED|Second 12-Week Treatment Period||1
8493186|NCT00540436|20929069|P1|COMPLETED|Second 12-Week Treatment Period||21
8493187|NCT00540436|20929069|P1|STARTED|Second 12-Week Treatment Period||22
8493188|NCT00540436|20929069|P1|NOT COMPLETED|First 12-Week Treatment Period||3
8493189|NCT00540436|20929069|P1|COMPLETED|First 12-Week Treatment Period||22
8493190|NCT00540436|20929069|P1|STARTED|First 12-Week Treatment Period||25
8493191|NCT00540423|20929084|P3|NOT COMPLETED|Open-Label Treatment Period||2
8493192|NCT00540423|20929085|P2|NOT COMPLETED|Open-Label Treatment Period||0
8493193|NCT00540423|20929086|P1|NOT COMPLETED|Open-Label Treatment Period||0
8493194|NCT00540423|20929084|P3|COMPLETED|Open-Label Treatment Period||20
8493195|NCT00540423|20929085|P2|COMPLETED|Open-Label Treatment Period||0
8493196|NCT00540423|20929086|P1|COMPLETED|Open-Label Treatment Period||0
8493197|NCT00540423|20929084|P3|STARTED|Open-Label Treatment Period||22
8493198|NCT00540423|20929085|P2|STARTED|Open-Label Treatment Period||0
8493199|NCT00540423|20929086|P1|STARTED|Open-Label Treatment Period||0
8493200|NCT00540423|20929084|P3|NOT COMPLETED|Double-Blind Treatment Period||0
8493201|NCT00540423|20929085|P2|NOT COMPLETED|Double-Blind Treatment Period||1
8493202|NCT00540423|20929086|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8493203|NCT00540423|20929084|P3|COMPLETED|Double-Blind Treatment Period||0
8493204|NCT00540423|20929085|P2|COMPLETED|Double-Blind Treatment Period||14
8493205|NCT00540423|20929086|P1|COMPLETED|Double-Blind Treatment Period||8
8493206|NCT00540423|20929084|P3|STARTED|Double-Blind Treatment Period||0
8493207|NCT00540423|20929085|P2|STARTED|Double-Blind Treatment Period||15
8493208|NCT00540423|20929086|P1|STARTED|Double-Blind Treatment Period||8
8493212|NCT00540228|20929184|P5|NOT COMPLETED|Overall Study||0
8493213|NCT00540228|20929185|P4|NOT COMPLETED|Overall Study||0
8493214|NCT00540228|20929186|P3|NOT COMPLETED|Overall Study||0
8493215|NCT00540228|20929187|P2|NOT COMPLETED|Overall Study||1
8493216|NCT00540228|20929188|P1|NOT COMPLETED|Overall Study||3
8493217|NCT00540228|20929184|P5|COMPLETED|Overall Study||202
8493218|NCT00540228|20929185|P4|COMPLETED|Overall Study||202
8493219|NCT00540228|20929186|P3|COMPLETED|Overall Study||204
8493220|NCT00540228|20929187|P2|COMPLETED|Overall Study||197
8493221|NCT00540228|20929188|P1|COMPLETED|Overall Study||197
8493222|NCT00540228|20929184|P5|STARTED|Overall Study||202
8493223|NCT00540228|20929185|P4|STARTED|Overall Study||202
8493224|NCT00540228|20929186|P3|STARTED|Overall Study||204
8493225|NCT00540228|20929187|P2|STARTED|Overall Study||198
8493226|NCT00540228|20929188|P1|STARTED|Overall Study||200
8493227|NCT00540124|20929258|P3|NOT COMPLETED|Overall Study||1
8493228|NCT00540124|20929259|P2|NOT COMPLETED|Overall Study||3
8493229|NCT00540124|20929260|P1|NOT COMPLETED|Overall Study||4
8493230|NCT00540124|20929258|P3|COMPLETED|Overall Study||48
8493231|NCT00540124|20929259|P2|COMPLETED|Overall Study||48
8493232|NCT00540124|20929260|P1|COMPLETED|Overall Study||47
8493233|NCT00540124|20929258|P3|STARTED|Overall Study||49
8493234|NCT00540124|20929259|P2|STARTED|Overall Study||51
8493235|NCT00540124|20929260|P1|STARTED|Overall Study||51
8493236|NCT00540046|20929306|P2|NOT COMPLETED|Overall Study||23
8493237|NCT00540046|20929307|P1|NOT COMPLETED|Overall Study||33
8493238|NCT00540046|20929306|P2|COMPLETED|Overall Study||88
8493239|NCT00540046|20929307|P1|COMPLETED|Overall Study||71
8493240|NCT00540046|20929306|P2|STARTED|Overall Study||111
8493241|NCT00540046|20929307|P1|STARTED|Overall Study||104
8493242|NCT00540007|20929317|P2|NOT COMPLETED|Overall Study||0
8493243|NCT00540007|20929318|P1|NOT COMPLETED|Overall Study||0
8493244|NCT00540007|20929317|P2|COMPLETED|Overall Study||42
8493245|NCT00540007|20929318|P1|COMPLETED|Overall Study||38
8493246|NCT00540007|20929317|P2|STARTED|Overall Study||42
8493247|NCT00540007|20929318|P1|STARTED|Overall Study||38
8493248|NCT00539994|20929343|P3|NOT COMPLETED|Overall Study||2
8493249|NCT00539994|20929344|P2|NOT COMPLETED|Overall Study||1
8493250|NCT00539994|20929345|P1|NOT COMPLETED|Overall Study||3
8493251|NCT00539994|20929343|P3|COMPLETED|Overall Study||13
8493252|NCT00539994|20929344|P2|COMPLETED|Overall Study||18
8493253|NCT00539994|20929345|P1|COMPLETED|Overall Study||20
8493254|NCT00539994|20929343|P3|STARTED|Overall Study||15
8493255|NCT00539994|20929344|P2|STARTED|Overall Study||19
8493256|NCT00539994|20929345|P1|STARTED|Overall Study||23
8493257|NCT00539942|20929384|P2|NOT COMPLETED|Overall Study||0
8493258|NCT00539942|20929385|P1|NOT COMPLETED|Overall Study||0
8493259|NCT00539942|20929384|P2|COMPLETED|Overall Study||3
8493260|NCT00539942|20929385|P1|COMPLETED|Overall Study||4
8493261|NCT00539942|20929384|P2|STARTED|Overall Study||3
8493262|NCT00539942|20929385|P1|STARTED|Overall Study||4
8493263|NCT00539864|20929395|P2|NOT COMPLETED|Overall Study||2
8493264|NCT00539864|20929396|P1|NOT COMPLETED|Overall Study||1
8493265|NCT00539864|20929395|P2|COMPLETED|Overall Study||300
8493266|NCT00539864|20929396|P1|COMPLETED|Overall Study||299
8493267|NCT00539864|20929395|P2|STARTED|Overall Study||302
8493268|NCT00539864|20929396|P1|STARTED|Overall Study||300
8493269|NCT00539838|20929411|P3|NOT COMPLETED|Overall Study||9
8493270|NCT00539838|20929412|P2|NOT COMPLETED|Overall Study||6
8493271|NCT00539838|20929413|P1|NOT COMPLETED|Overall Study||7
8493272|NCT00539838|20929411|P3|COMPLETED|Overall Study||1
8493273|NCT00539838|20929412|P2|COMPLETED|Overall Study||5
8493274|NCT00539838|20929413|P1|COMPLETED|Overall Study||5
8493275|NCT00539838|20929411|P3|STARTED|Overall Study||10
8493276|NCT00539838|20929412|P2|STARTED|Overall Study||11
8493277|NCT00539838|20929413|P1|STARTED|Overall Study||12
8493278|NCT00539734|20929463|P1|NOT COMPLETED|Overall Study||1
8493279|NCT00539734|20929463|P1|COMPLETED|Overall Study||25
8493280|NCT00539734|20929463|P1|STARTED|Overall Study||26
8493281|NCT00539695|20929468|P1|NOT COMPLETED|Overall Study||13
8493282|NCT00539695|20929468|P1|COMPLETED|Overall Study||12
8493283|NCT00539695|20929468|P1|Evaluable Patients|Overall Study|Patients who received IL-2.|22
8493284|NCT00539695|20929468|P1|STARTED|Overall Study||25
8493285|NCT00539656|20929474|P1|NOT COMPLETED|Overall Study||0
8493286|NCT00539656|20929474|P1|COMPLETED|Overall Study||3
8493287|NCT00539656|20929474|P1|STARTED|Overall Study||3
8493288|NCT00539617|20929480|P1|NOT COMPLETED|Treatment Period||0
8493289|NCT00539617|20929480|P1|COMPLETED|Treatment Period||3
8493290|NCT00539617|20929480|P1|STARTED|Treatment Period||3
8493291|NCT00539617|20929480|P1|NOT COMPLETED|Run-In Period||1
8493292|NCT00539617|20929480|P1|COMPLETED|Run-In Period||3
8493293|NCT00539617|20929480|P1|STARTED|Run-In Period||4
8493294|NCT00539617|20929480|P1|NOT COMPLETED|Pre-screening Period||3
8493295|NCT00539617|20929480|P1|COMPLETED|Pre-screening Period||4
8493296|NCT00539617|20929480|P1|STARTED|Pre-screening Period||7
8493306|NCT00539539|20929601|P2|NOT COMPLETED|Overall Study||0
8493307|NCT00539539|20929602|P1|NOT COMPLETED|Overall Study||0
8493308|NCT00539539|20929601|P2|COMPLETED|Overall Study||771
8493309|NCT00539539|20929602|P1|COMPLETED|Overall Study||815
8493310|NCT00539539|20929601|P2|STARTED|Overall Study||771
8493311|NCT00539539|20929602|P1|STARTED|Overall Study||815
8493312|NCT00539526|20929625|P3|NOT COMPLETED|Overall Study||2
8493313|NCT00539526|20929626|P2|NOT COMPLETED|Overall Study||2
8493314|NCT00539526|20929627|P1|NOT COMPLETED|Overall Study||3
8493315|NCT00539526|20929625|P3|COMPLETED|Overall Study||36
8493316|NCT00539526|20929626|P2|COMPLETED|Overall Study||31
8493317|NCT00539526|20929627|P1|COMPLETED|Overall Study||32
8493318|NCT00539526|20929625|P3|STARTED|Overall Study||38
8493319|NCT00539526|20929626|P2|STARTED|Overall Study||33
8493320|NCT00539526|20929627|P1|STARTED|Overall Study||35
8493321|NCT00539513|20929643|P2|NOT COMPLETED|Overall Study||2
8493322|NCT00539513|20929644|P1|NOT COMPLETED|Overall Study||2
8493323|NCT00539513|20929643|P2|COMPLETED|Overall Study||3
8493324|NCT00539513|20929644|P1|COMPLETED|Overall Study||3
8493325|NCT00539513|20929643|P2|Received Allocated Intervention|Overall Study||4
8493326|NCT00539513|20929644|P1|Received Allocated Intervention|Overall Study||3
8493327|NCT00539513|20929643|P2|STARTED|Overall Study||5
8493328|NCT00539513|20929644|P1|STARTED|Overall Study||5
8493329|NCT00539500|20929656|P1|NOT COMPLETED|Overall Study||3
8493330|NCT00539500|20929656|P1|COMPLETED|Overall Study||0
8493331|NCT00539500|20929656|P1|STARTED|Overall Study||3
8493332|NCT00539305|20929664|P2|NOT COMPLETED|Overall Study||2
8493333|NCT00539305|20929665|P1|NOT COMPLETED|Overall Study||1
8493334|NCT00539305|20929664|P2|COMPLETED|Overall Study||10
8493335|NCT00539305|20929665|P1|COMPLETED|Overall Study||9
8493336|NCT00539305|20929664|P2|STARTED|Overall Study||12
8493337|NCT00539305|20929665|P1|STARTED|Overall Study||10
8493338|NCT00539279|20929679|P2|NOT COMPLETED|6-Month Follow-Up Assessment||7
8493339|NCT00539279|20929680|P1|NOT COMPLETED|6-Month Follow-Up Assessment||1
8493340|NCT00539279|20929679|P2|COMPLETED|6-Month Follow-Up Assessment||22
8493341|NCT00539279|20929680|P1|COMPLETED|6-Month Follow-Up Assessment||17
8493342|NCT00539279|20929679|P2|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
8493343|NCT00539279|20929680|P1|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
8493344|NCT00539279|20929679|P2|NOT COMPLETED|Post-Treatment Assessment||9
8493345|NCT00539279|20929680|P1|NOT COMPLETED|Post-Treatment Assessment||12
8493346|NCT00539279|20929679|P2|COMPLETED|Post-Treatment Assessment||29
8493347|NCT00539279|20929680|P1|COMPLETED|Post-Treatment Assessment||18
8493348|NCT00539279|20929679|P2|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
8493349|NCT00539279|20929680|P1|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
8493350|NCT00539279|20929679|P2|NOT COMPLETED|Treatment||8
8493351|NCT00539279|20929680|P1|NOT COMPLETED|Treatment||11
8493352|NCT00539279|20929679|P2|COMPLETED|Treatment||38
8493353|NCT00539279|20929680|P1|COMPLETED|Treatment||30
8493354|NCT00539279|20929679|P2|STARTED|Treatment||46
8493355|NCT00539279|20929680|P1|STARTED|Treatment||41
8493356|NCT00539253|20929698|P1|NOT COMPLETED|Overall Study||26
8493357|NCT00539253|20929698|P1|COMPLETED|Overall Study||19
8493358|NCT00539253|20929698|P1|STARTED|Overall Study||45
8493359|NCT00539240|20929706|P3|NOT COMPLETED|Overall Study||15
8493360|NCT00539240|20929707|P2|NOT COMPLETED|Overall Study||7
8493361|NCT00539240|20929708|P1|NOT COMPLETED|Overall Study||6
8493362|NCT00539240|20929706|P3|COMPLETED|Overall Study||39
8493363|NCT00539240|20929707|P2|COMPLETED|Overall Study||48
8493364|NCT00539240|20929708|P1|COMPLETED|Overall Study||53
8493365|NCT00539240|20929706|P3|STARTED|Overall Study||54
8493366|NCT00539240|20929707|P2|STARTED|Overall Study||55
8493367|NCT00539240|20929708|P1|STARTED|Overall Study||59
8493368|NCT00539188|20929727|P2|NOT COMPLETED|Overall Study||1
8493369|NCT00539188|20929728|P1|NOT COMPLETED|Overall Study||3
8493370|NCT00539188|20929727|P2|COMPLETED|Overall Study||1
8493371|NCT00539188|20929728|P1|COMPLETED|Overall Study||1
8493372|NCT00539188|20929727|P2|Received Allocated Intervention|Overall Study||2
8493373|NCT00539188|20929728|P1|Received Allocated Intervention|Overall Study||3
8493374|NCT00539188|20929727|P2|STARTED|Overall Study||2
8493375|NCT00539188|20929728|P1|STARTED|Overall Study||4
8493376|NCT00539110|20929742|P2|NOT COMPLETED|Overall Study||0
8493377|NCT00539110|20929743|P1|NOT COMPLETED|Overall Study||0
8493378|NCT00539110|20929742|P2|COMPLETED|Overall Study||5
8493379|NCT00539110|20929743|P1|COMPLETED|Overall Study||5
8493380|NCT00539110|20929742|P2|STARTED|Overall Study||5
8493381|NCT00539110|20929743|P1|STARTED|Overall Study||5
8493382|NCT00539032|20929751|P2|NOT COMPLETED|Overall Study||1
8493383|NCT00539032|20929752|P1|NOT COMPLETED|Overall Study||2
8493384|NCT00539032|20929751|P2|COMPLETED|Overall Study||84
8493385|NCT00539032|20929752|P1|COMPLETED|Overall Study||151
8493386|NCT00539032|20929751|P2|STARTED|Overall Study||85
8493387|NCT00539032|20929752|P1|STARTED|Overall Study||153
8493388|NCT00539006|20929766|P4|NOT COMPLETED|Post-Study||0
8493389|NCT00539006|20929767|P3|NOT COMPLETED|Post-Study||0
8493390|NCT00539006|20929768|P2|NOT COMPLETED|Post-Study||0
8493391|NCT00539006|20929769|P1|NOT COMPLETED|Post-Study||0
8493392|NCT00539006|20929766|P4|COMPLETED|Post-Study||81
8493393|NCT00539006|20929767|P3|COMPLETED|Post-Study||77
8493394|NCT00539006|20929768|P2|COMPLETED|Post-Study||83
8493395|NCT00539006|20929769|P1|COMPLETED|Post-Study||75
8493396|NCT00539006|20929766|P4|STARTED|Post-Study||81
8493397|NCT00539006|20929767|P3|STARTED|Post-Study||77
8493398|NCT00539006|20929768|P2|STARTED|Post-Study||83
8493399|NCT00539006|20929769|P1|STARTED|Post-Study||75
8493400|NCT00539006|20929766|P4|NOT COMPLETED|Treatment Period 2||0
8493401|NCT00539006|20929767|P3|NOT COMPLETED|Treatment Period 2||0
8493402|NCT00539006|20929768|P2|NOT COMPLETED|Treatment Period 2||1
8493403|NCT00539006|20929769|P1|NOT COMPLETED|Treatment Period 2||1
8493404|NCT00539006|20929766|P4|COMPLETED|Treatment Period 2||81
8493405|NCT00539006|20929767|P3|COMPLETED|Treatment Period 2||77
8493406|NCT00539006|20929768|P2|COMPLETED|Treatment Period 2||83
8493407|NCT00539006|20929769|P1|COMPLETED|Treatment Period 2||75
8493408|NCT00539006|20929766|P4|STARTED|Treatment Period 2||81
8493409|NCT00539006|20929767|P3|STARTED|Treatment Period 2||77
8493410|NCT00539006|20929768|P2|STARTED|Treatment Period 2||84
8493411|NCT00539006|20929769|P1|STARTED|Treatment Period 2||76
8493412|NCT00539006|20929766|P4|NOT COMPLETED|Washout||9
8493413|NCT00539006|20929767|P3|NOT COMPLETED|Washout||16
8493414|NCT00539006|20929768|P2|NOT COMPLETED|Washout||10
8493415|NCT00539006|20929769|P1|NOT COMPLETED|Washout||20
8493416|NCT00539006|20929766|P4|COMPLETED|Washout||81
8493417|NCT00539006|20929767|P3|COMPLETED|Washout||77
8493418|NCT00539006|20929768|P2|COMPLETED|Washout||84
8493419|NCT00539006|20929769|P1|COMPLETED|Washout||76
8493420|NCT00539006|20929766|P4|STARTED|Washout||90
8493421|NCT00539006|20929767|P3|STARTED|Washout||93
8493422|NCT00539006|20929768|P2|STARTED|Washout||94
8493423|NCT00539006|20929769|P1|STARTED|Washout||96
8493424|NCT00539006|20929766|P4|NOT COMPLETED|Treatment Period 1||1
8493425|NCT00539006|20929767|P3|NOT COMPLETED|Treatment Period 1||2
8493426|NCT00539006|20929768|P2|NOT COMPLETED|Treatment Period 1||0
8493427|NCT00539006|20929769|P1|NOT COMPLETED|Treatment Period 1||0
8493428|NCT00539006|20929766|P4|COMPLETED|Treatment Period 1||90
8493429|NCT00539006|20929767|P3|COMPLETED|Treatment Period 1||93
8493430|NCT00539006|20929768|P2|COMPLETED|Treatment Period 1||94
8493431|NCT00539006|20929769|P1|COMPLETED|Treatment Period 1||96
8493432|NCT00539006|20929766|P4|STARTED|Treatment Period 1||91
8493433|NCT00539006|20929767|P3|STARTED|Treatment Period 1||95
8493434|NCT00539006|20929768|P2|STARTED|Treatment Period 1||94
8493435|NCT00539006|20929769|P1|STARTED|Treatment Period 1||96
8493436|NCT00539006|20929766|P4|NOT COMPLETED|Pre-treatment||0
8493437|NCT00539006|20929767|P3|NOT COMPLETED|Pre-treatment||0
8493438|NCT00539006|20929768|P2|NOT COMPLETED|Pre-treatment||1
8493439|NCT00539006|20929769|P1|NOT COMPLETED|Pre-treatment||0
8493440|NCT00539006|20929766|P4|COMPLETED|Pre-treatment||91
8493441|NCT00539006|20929767|P3|COMPLETED|Pre-treatment||95
8493442|NCT00539006|20929768|P2|COMPLETED|Pre-treatment||94
8493443|NCT00539006|20929769|P1|COMPLETED|Pre-treatment||96
8493444|NCT00539006|20929766|P4|STARTED|Pre-treatment||91
8493445|NCT00539006|20929767|P3|STARTED|Pre-treatment||95
8493446|NCT00539006|20929768|P2|STARTED|Pre-treatment||95
8493447|NCT00539006|20929769|P1|STARTED|Pre-treatment||96
8493448|NCT00538980|20929799|P1|NOT COMPLETED|Overall Study||10
8493449|NCT00538980|20929799|P1|COMPLETED|Overall Study||0
8493450|NCT00538980|20929799|P1|STARTED|Overall Study||10
8493454|NCT00538902|20929814|P3|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
8493455|NCT00538902|20929815|P2|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
8493456|NCT00538902|20929816|P1|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
8493457|NCT00538902|20929814|P3|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
8493458|NCT00538902|20929815|P2|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
8493459|NCT00538902|20929816|P1|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
8493460|NCT00538902|20929814|P3|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
8493461|NCT00538902|20929815|P2|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
8493462|NCT00538902|20929816|P1|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
8493463|NCT00538902|20929814|P3|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
8493464|NCT00538902|20929815|P2|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
8493465|NCT00538902|20929816|P1|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
8493466|NCT00538902|20929814|P3|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
8493467|NCT00538902|20929815|P2|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
8493468|NCT00538902|20929816|P1|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
8493469|NCT00538902|20929814|P3|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
8493470|NCT00538902|20929815|P2|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
8493471|NCT00538902|20929816|P1|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
8493472|NCT00538863|20929851|P1|NOT COMPLETED|Open-label Maintenance||106
8493473|NCT00538863|20929851|P1|COMPLETED|Open-label Maintenance||163
8493474|NCT00538863|20929851|P1|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
8493475|NCT00538863|20929851|P1|NOT COMPLETED|Open-label Titration||45
8493476|NCT00538863|20929851|P1|COMPLETED|Open-label Titration||184
8493477|NCT00538863|20929851|P1|STARTED|Open-label Titration||229
8493478|NCT00538850|20929857|P3|NOT COMPLETED|Placebo - Double-blind||3
8493479|NCT00538850|20929858|P2|NOT COMPLETED|Placebo - Double-blind||0
8493480|NCT00538850|20929859|P1|NOT COMPLETED|Placebo - Double-blind||0
8493481|NCT00538850|20929857|P3|COMPLETED|Placebo - Double-blind||95
8493482|NCT00538850|20929858|P2|COMPLETED|Placebo - Double-blind||0
8493483|NCT00538850|20929859|P1|COMPLETED|Placebo - Double-blind||0
8493484|NCT00538850|20929857|P3|STARTED|Placebo - Double-blind||98
8493485|NCT00538850|20929858|P2|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
8493486|NCT00538850|20929859|P1|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
8493487|NCT00538850|20929857|P3|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
8493488|NCT00538850|20929858|P2|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
8493489|NCT00538850|20929859|P1|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
8493490|NCT00538850|20929857|P3|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
8493491|NCT00538850|20929858|P2|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
8493492|NCT00538850|20929859|P1|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
8493493|NCT00538850|20929857|P3|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
8493494|NCT00538850|20929858|P2|STARTED|Fentanyl Sublingual Spray - Double-blind||98
8493495|NCT00538850|20929859|P1|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
8493496|NCT00538850|20929857|P3|NOT COMPLETED|Titration Period||0
8493497|NCT00538850|20929858|P2|NOT COMPLETED|Titration Period||0
8493498|NCT00538850|20929859|P1|NOT COMPLETED|Titration Period||32
8493499|NCT00538850|20929857|P3|COMPLETED|Titration Period||0
8493500|NCT00538850|20929858|P2|COMPLETED|Titration Period||0
8493501|NCT00538850|20929859|P1|COMPLETED|Titration Period||98
8493502|NCT00538850|20929857|P3|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
8493503|NCT00538850|20929858|P2|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
8493504|NCT00538850|20929859|P1|STARTED|Titration Period||130
8493505|NCT00538824|20929871|P1|NOT COMPLETED|Overall Study||0
8493506|NCT00538824|20929871|P1|COMPLETED|Overall Study||5
8493507|NCT00538824|20929871|P1|Progression of Disease|Overall Study||2
8493508|NCT00538824|20929871|P1|STARTED|Overall Study||5
8493509|NCT00538785|20929877|P2|NOT COMPLETED|Overall Study||17
8493510|NCT00538785|20929878|P1|NOT COMPLETED|Overall Study||19
8493511|NCT00538785|20929877|P2|COMPLETED|Overall Study||595
8493512|NCT00538785|20929878|P1|COMPLETED|Overall Study||604
8493513|NCT00538785|20929877|P2|STARTED|Overall Study||612
8493514|NCT00538785|20929878|P1|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
8493515|NCT00538759|20929901|P2|NOT COMPLETED|Overall Study||0
8493516|NCT00538759|20929902|P1|NOT COMPLETED|Overall Study||0
8493517|NCT00538759|20929901|P2|COMPLETED|Overall Study||8
8493518|NCT00538759|20929902|P1|COMPLETED|Overall Study||13
8493519|NCT00538759|20929901|P2|STARTED|Overall Study||8
8493520|NCT00538759|20929902|P1|STARTED|Overall Study||13
8493527|NCT00538681|20929932|P4|NOT COMPLETED|Overall Study||11
8493528|NCT00538681|20929933|P3|NOT COMPLETED|Overall Study||11
8493529|NCT00538681|20929934|P2|NOT COMPLETED|Overall Study||4
8493530|NCT00538681|20929935|P1|NOT COMPLETED|Overall Study||9
8493531|NCT00538681|20929932|P4|COMPLETED|Overall Study||0
8493532|NCT00538681|20929933|P3|COMPLETED|Overall Study||0
8493533|NCT00538681|20929934|P2|COMPLETED|Overall Study||0
8493534|NCT00538681|20929935|P1|COMPLETED|Overall Study||0
8493535|NCT00538681|20929932|P4|Received ≥1 Dose of Any Study Drug|Overall Study||11
8493536|NCT00538681|20929933|P3|Received ≥1 Dose of Any Study Drug|Overall Study||11
8493537|NCT00538681|20929934|P2|Received ≥1 Dose of Any Study Drug|Overall Study||4
8493538|NCT00538681|20929935|P1|Received ≥1 Dose of Any Study Drug|Overall Study||9
8493539|NCT00538681|20929932|P4|STARTED|Overall Study|One (1) participant received pemetrexed and cisplatin only before the study was closed.|11
8493540|NCT00538681|20929933|P3|STARTED|Overall Study||11
8493541|NCT00538681|20929934|P2|STARTED|Overall Study||4
8493542|NCT00538681|20929935|P1|STARTED|Overall Study||9
8493543|NCT00538642|20929960|P2|NOT COMPLETED|Overall Study||5
8493544|NCT00538642|20929961|P1|NOT COMPLETED|Overall Study||1
8493545|NCT00538642|20929960|P2|COMPLETED|Overall Study||9
8493546|NCT00538642|20929961|P1|COMPLETED|Overall Study||9
8493547|NCT00538642|20929960|P2|STARTED|Overall Study||14
8493548|NCT00538642|20929961|P1|STARTED|Overall Study||10
8493549|NCT00538629|20930001|P1|NOT COMPLETED|Overall Study||22
8493550|NCT00538629|20930001|P1|COMPLETED|Overall Study||449
8493551|NCT00538629|20930001|P1|STARTED|Overall Study||471
8493552|NCT00538616|20930048|P2|NOT COMPLETED|Overall Study||0
8493553|NCT00538616|20930049|P1|NOT COMPLETED|Overall Study||0
8493554|NCT00538616|20930048|P2|COMPLETED|Overall Study||3
8493555|NCT00538616|20930049|P1|COMPLETED|Overall Study||5
8493556|NCT00538616|20930048|P2|STARTED|Overall Study||3
8493557|NCT00538616|20930049|P1|STARTED|Overall Study||5
8493558|NCT00538590|20930057|P2|NOT COMPLETED|Overall Study||0
8493559|NCT00538590|20930058|P1|NOT COMPLETED|Overall Study||1
8493560|NCT00538590|20930057|P2|COMPLETED|Overall Study||10
8493561|NCT00538590|20930058|P1|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
8493562|NCT00538590|20930057|P2|STARTED|Overall Study||10
8493563|NCT00538590|20930058|P1|STARTED|Overall Study||10
8493564|NCT00538512|20930075|P3|NOT COMPLETED|Overall Study||13
8493565|NCT00538512|20930076|P2|NOT COMPLETED|Overall Study||30
8493566|NCT00538512|20930077|P1|NOT COMPLETED|Overall Study||27
8493567|NCT00538512|20930075|P3|COMPLETED|Overall Study||312
8493568|NCT00538512|20930076|P2|COMPLETED|Overall Study||783
8493569|NCT00538512|20930077|P1|COMPLETED|Overall Study||787
8493570|NCT00538512|20930075|P3|STARTED|Overall Study||325
8493571|NCT00538512|20930076|P2|STARTED|Overall Study||813
8493572|NCT00538512|20930077|P1|STARTED|Overall Study||814
8493573|NCT00538473|20930096|P2|NOT COMPLETED|Overall Study||0
8493574|NCT00538473|20930097|P1|NOT COMPLETED|Overall Study||1
8493575|NCT00538473|20930096|P2|COMPLETED|Overall Study||35
8493576|NCT00538473|20930097|P1|COMPLETED|Overall Study||32
8493577|NCT00538473|20930096|P2|STARTED|Overall Study||35
8493578|NCT00538473|20930097|P1|STARTED|Overall Study||33
8493579|NCT00538434|20930133|P4|NOT COMPLETED|Overall Study||6
8493580|NCT00538434|20930134|P3|NOT COMPLETED|Overall Study||7
8493581|NCT00538434|20930135|P2|NOT COMPLETED|Overall Study||11
8493582|NCT00538434|20930136|P1|NOT COMPLETED|Overall Study||9
8493583|NCT00538434|20930133|P4|COMPLETED|Overall Study|Completed all scheduled study visits|51
8493584|NCT00538434|20930134|P3|COMPLETED|Overall Study|Completed all scheduled study visits|50
8493585|NCT00538434|20930135|P2|COMPLETED|Overall Study|Completed all scheduled study visits|46
8493586|NCT00538434|20930136|P1|COMPLETED|Overall Study|Completed all scheduled study visits|47
8493587|NCT00538434|20930133|P4|Intent-to-treat (ITT) Population|Overall Study||57
8493588|NCT00538434|20930134|P3|Intent-to-treat (ITT) Population|Overall Study||57
8493589|NCT00538434|20930135|P2|Intent-to-treat (ITT) Population|Overall Study||57
8493590|NCT00538434|20930136|P1|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
8493591|NCT00538434|20930133|P4|STARTED|Overall Study||57
8493592|NCT00538434|20930134|P3|STARTED|Overall Study||57
8493593|NCT00538434|20930135|P2|STARTED|Overall Study||57
8493594|NCT00538434|20930136|P1|STARTED|Overall Study||56
8493595|NCT00538304|20930160|P2|NOT COMPLETED|Overall Study||5
8493596|NCT00538304|20930161|P1|NOT COMPLETED|Overall Study||7
8493597|NCT00538304|20930160|P2|COMPLETED|Overall Study||66
8493598|NCT00538304|20930161|P1|COMPLETED|Overall Study||144
8493599|NCT00538304|20930160|P2|STARTED|Overall Study||71
8493600|NCT00538304|20930161|P1|STARTED|Overall Study||151
8493601|NCT00538291|20930177|P1|NOT COMPLETED|Overall Study||3
8493602|NCT00538291|20930177|P1|COMPLETED|Overall Study||10
8493603|NCT00538291|20930177|P1|STARTED|Overall Study||13
8493604|NCT00538213|20930184|P3|NOT COMPLETED|Overall Study||0
8493605|NCT00538213|20930185|P2|NOT COMPLETED|Overall Study||0
8493606|NCT00538213|20930186|P1|NOT COMPLETED|Overall Study||0
8493607|NCT00538213|20930184|P3|COMPLETED|Overall Study||38
8493608|NCT00538213|20930185|P2|COMPLETED|Overall Study||40
8493609|NCT00538213|20930186|P1|COMPLETED|Overall Study||55
8493610|NCT00538213|20930184|P3|STARTED|Overall Study||38
8493611|NCT00538213|20930185|P2|STARTED|Overall Study||40
8493612|NCT00538213|20930186|P1|STARTED|Overall Study||55
8493613|NCT00537979|20930235|P2|NOT COMPLETED|Overall Study||20
8493614|NCT00537979|20930236|P1|NOT COMPLETED|Overall Study||6
8493615|NCT00537979|20930235|P2|COMPLETED|Overall Study||89
8493616|NCT00537979|20930236|P1|COMPLETED|Overall Study||32
8493617|NCT00537979|20930235|P2|STARTED|Overall Study||109
8493618|NCT00537979|20930236|P1|STARTED|Overall Study||38
8493619|NCT00537940|20930252|P2|NOT COMPLETED|Overall Study||179
8493620|NCT00537940|20930253|P1|NOT COMPLETED|Overall Study||183
8493621|NCT00537940|20930252|P2|COMPLETED|Overall Study||62
8493622|NCT00537940|20930253|P1|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
8493623|NCT00537940|20930252|P2|Entered Opt Blinded Continuation Phase|Overall Study||139
8493624|NCT00537940|20930253|P1|Entered Opt Blinded Continuation Phase|Overall Study||140
8493625|NCT00537940|20930252|P2|Completed Maintenance Phase|Overall Study||172
8493626|NCT00537940|20930253|P1|Completed Maintenance Phase|Overall Study||187
8493627|NCT00537940|20930252|P2|Completed Titration Phase|Overall Study||210
8493628|NCT00537940|20930253|P1|Completed Titration Phase|Overall Study||213
8493629|NCT00537940|20930252|P2|STARTED|Overall Study||241
8493630|NCT00537940|20930253|P1|STARTED|Overall Study||241
8493631|NCT00537823|20930277|P2|NOT COMPLETED|Overall Study||0
8493632|NCT00537823|20930278|P1|NOT COMPLETED|Overall Study||2
8493633|NCT00537823|20930277|P2|COMPLETED|Overall Study||2
8493634|NCT00537823|20930278|P1|COMPLETED|Overall Study||5
8493635|NCT00537823|20930277|P2|STARTED|Overall Study||2
8493636|NCT00537823|20930278|P1|STARTED|Overall Study||7
8493649|NCT00537771|20930323|P2|NOT COMPLETED|Overall Study||61
8493650|NCT00537771|20930324|P1|NOT COMPLETED|Overall Study||29
8493651|NCT00537771|20930323|P2|COMPLETED|Overall Study||114
8493652|NCT00537771|20930324|P1|COMPLETED|Overall Study||149
8493653|NCT00537771|20930323|P2|STARTED|Overall Study||175
8493654|NCT00537771|20930324|P1|STARTED|Overall Study||178
8493655|NCT00537745|20930334|P1|NOT COMPLETED|Overall Study||5
8493656|NCT00537745|20930334|P1|COMPLETED|Overall Study||9
8493657|NCT00537745|20930334|P1|Began Intervention|Overall Study||11
8493658|NCT00537745|20930334|P1|STARTED|Overall Study|There were three screen fails and two early terminations.|14
8493659|NCT00537680|20930342|P3|NOT COMPLETED|Overall Study||0
8493660|NCT00537680|20930343|P2|NOT COMPLETED|Overall Study||2
8493661|NCT00537680|20930344|P1|NOT COMPLETED|Overall Study||0
8493662|NCT00537680|20930342|P3|COMPLETED|Overall Study||24
8493663|NCT00537680|20930343|P2|COMPLETED|Overall Study||22
8493664|NCT00537680|20930344|P1|COMPLETED|Overall Study||22
8493665|NCT00537680|20930342|P3|STARTED|Overall Study||24
8493666|NCT00537680|20930343|P2|STARTED|Overall Study||24
8493667|NCT00537680|20930344|P1|STARTED|Overall Study||22
8493668|NCT00537576|20930358|P6|NOT COMPLETED|Overall Study||0
8493669|NCT00537576|20930359|P5|NOT COMPLETED|Overall Study||0
8493670|NCT00537576|20930360|P4|NOT COMPLETED|Overall Study||0
8493671|NCT00537576|20930361|P3|NOT COMPLETED|Overall Study||0
8493672|NCT00537576|20930362|P2|NOT COMPLETED|Overall Study||0
8493673|NCT00537576|20930363|P1|NOT COMPLETED|Overall Study||0
8493674|NCT00537576|20930358|P6|COMPLETED|Overall Study||1
8493675|NCT00537576|20930359|P5|COMPLETED|Overall Study||1
8493676|NCT00537576|20930360|P4|COMPLETED|Overall Study||1
8493677|NCT00537576|20930361|P3|COMPLETED|Overall Study||3
8493678|NCT00537576|20930362|P2|COMPLETED|Overall Study||3
8493679|NCT00537576|20930363|P1|COMPLETED|Overall Study||3
8493680|NCT00537576|20930358|P6|STARTED|Overall Study||1
8493681|NCT00537576|20930359|P5|STARTED|Overall Study||1
8493682|NCT00537576|20930360|P4|STARTED|Overall Study||1
8493683|NCT00537576|20930361|P3|STARTED|Overall Study||3
8493684|NCT00537576|20930362|P2|STARTED|Overall Study||3
8493685|NCT00537576|20930363|P1|STARTED|Overall Study||3
8493686|NCT00537511|20930389|P1|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
8493687|NCT00537511|20930389|P1|COMPLETED|Maintenance Phase (Monotherapy)||0
8493688|NCT00537511|20930389|P1|STARTED|Maintenance Phase (Monotherapy)||8
8493689|NCT00537511|20930389|P1|NOT COMPLETED|Recovery Period (Monotherapy)||8
8493690|NCT00537511|20930389|P1|COMPLETED|Recovery Period (Monotherapy)||3
8493691|NCT00537511|20930389|P1|STARTED|Recovery Period (Monotherapy)||11
8493692|NCT00537511|20930389|P1|NOT COMPLETED|Extension Period (Combination)||6
8493693|NCT00537511|20930389|P1|COMPLETED|Extension Period (Combination)||11
8493694|NCT00537511|20930389|P1|STARTED|Extension Period (Combination)||17
8493695|NCT00537511|20930389|P1|NOT COMPLETED|Treatment Period (Combination)||5
8493696|NCT00537511|20930389|P1|COMPLETED|Treatment Period (Combination)||17
8493697|NCT00537511|20930389|P1|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
8493698|NCT00537511|20930389|P1|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
8493699|NCT00537511|20930389|P1|STARTED|Treatment Period (Combination)||22
8493700|NCT00537485|20930416|P2|NOT COMPLETED|Overall Study||10
8493701|NCT00537485|20930417|P1|NOT COMPLETED|Overall Study||15
8493702|NCT00537485|20930416|P2|COMPLETED|Overall Study||80
8493703|NCT00537485|20930417|P1|COMPLETED|Overall Study||75
8493704|NCT00537485|20930416|P2|STARTED|Overall Study||90
8493705|NCT00537485|20930417|P1|STARTED|Overall Study||90
8493706|NCT00537446|20930441|P1|NOT COMPLETED|Overall Study||0
8493707|NCT00537446|20930441|P1|COMPLETED|Overall Study||8
8493708|NCT00537446|20930441|P1|STARTED|Overall Study||8
8493709|NCT00537407|20930456|P5|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
8493710|NCT00537407|20930457|P4|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
8493711|NCT00537407|20930458|P3|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
8493712|NCT00537407|20930459|P2|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
8493713|NCT00537407|20930460|P1|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
8493714|NCT00537407|20930456|P5|COMPLETED|Part 2 Weeks 5-48 or 72||3
8493715|NCT00537407|20930457|P4|COMPLETED|Part 2 Weeks 5-48 or 72||4
8493716|NCT00537407|20930458|P3|COMPLETED|Part 2 Weeks 5-48 or 72||2
8493717|NCT00537407|20930459|P2|COMPLETED|Part 2 Weeks 5-48 or 72||1
8493718|NCT00537407|20930460|P1|COMPLETED|Part 2 Weeks 5-48 or 72||2
8493719|NCT00537407|20930456|P5|STARTED|Part 2 Weeks 5-48 or 72||10
8493720|NCT00537407|20930457|P4|STARTED|Part 2 Weeks 5-48 or 72||10
8493721|NCT00537407|20930458|P3|STARTED|Part 2 Weeks 5-48 or 72||11
8493722|NCT00537407|20930459|P2|STARTED|Part 2 Weeks 5-48 or 72||9
8493723|NCT00537407|20930460|P1|STARTED|Part 2 Weeks 5-48 or 72||10
8493724|NCT00537407|20930456|P5|NOT COMPLETED|Part 1 Weeks 1-4||0
8493725|NCT00537407|20930457|P4|NOT COMPLETED|Part 1 Weeks 1-4||0
8493726|NCT00537407|20930458|P3|NOT COMPLETED|Part 1 Weeks 1-4||0
8493727|NCT00537407|20930459|P2|NOT COMPLETED|Part 1 Weeks 1-4||0
8493728|NCT00537407|20930460|P1|NOT COMPLETED|Part 1 Weeks 1-4||0
8493729|NCT00537407|20930456|P5|COMPLETED|Part 1 Weeks 1-4||10
8493730|NCT00537407|20930457|P4|COMPLETED|Part 1 Weeks 1-4||10
8493731|NCT00537407|20930458|P3|COMPLETED|Part 1 Weeks 1-4||11
8493732|NCT00537407|20930459|P2|COMPLETED|Part 1 Weeks 1-4||9
8493733|NCT00537407|20930460|P1|COMPLETED|Part 1 Weeks 1-4||10
8493734|NCT00537407|20930456|P5|STARTED|Part 1 Weeks 1-4||10
8493735|NCT00537407|20930457|P4|STARTED|Part 1 Weeks 1-4||10
8493736|NCT00537407|20930458|P3|STARTED|Part 1 Weeks 1-4||11
8493737|NCT00537407|20930459|P2|STARTED|Part 1 Weeks 1-4||9
8493738|NCT00537407|20930460|P1|STARTED|Part 1 Weeks 1-4||10
8493739|NCT00537394|20930500|P3|NOT COMPLETED|2nd Year of Follow-up||6
8493740|NCT00537394|20930501|P2|NOT COMPLETED|2nd Year of Follow-up||9
8493741|NCT00537394|20930502|P1|NOT COMPLETED|2nd Year of Follow-up||11
8493742|NCT00537394|20930500|P3|COMPLETED|2nd Year of Follow-up||44
8493743|NCT00537394|20930501|P2|COMPLETED|2nd Year of Follow-up||159
8493744|NCT00537394|20930502|P1|COMPLETED|2nd Year of Follow-up||158
8493745|NCT00537394|20930500|P3|STARTED|2nd Year of Follow-up||50
8493746|NCT00537394|20930501|P2|STARTED|2nd Year of Follow-up||168
8493747|NCT00537394|20930502|P1|STARTED|2nd Year of Follow-up||169
8493748|NCT00537394|20930500|P3|NOT COMPLETED|First Year of Follow-up||3
8493749|NCT00537394|20930501|P2|NOT COMPLETED|First Year of Follow-up||11
8493750|NCT00537394|20930502|P1|NOT COMPLETED|First Year of Follow-up||12
8493751|NCT00537394|20930500|P3|COMPLETED|First Year of Follow-up||50
8493752|NCT00537394|20930501|P2|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
8493753|NCT00537394|20930502|P1|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
8493754|NCT00537394|20930500|P3|STARTED|First Year of Follow-up||53
8493755|NCT00537394|20930501|P2|STARTED|First Year of Follow-up||179
8493756|NCT00537394|20930502|P1|STARTED|First Year of Follow-up||181
8493757|NCT00537381|20930538|P2|NOT COMPLETED|Overall Study||62
8493758|NCT00537381|20930539|P1|NOT COMPLETED|Overall Study||56
8493759|NCT00537381|20930538|P2|COMPLETED|Overall Study||4
8493760|NCT00537381|20930539|P1|COMPLETED|Overall Study||9
8493761|NCT00537381|20930538|P2|STARTED|Overall Study||66
8493762|NCT00537381|20930539|P1|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
8493763|NCT00537329|20930559|P1|NOT COMPLETED|Overall Study||26
8493764|NCT00537329|20930559|P1|COMPLETED|Overall Study||17
8493765|NCT00537329|20930559|P1|STARTED|Overall Study||43
8493766|NCT00537316|20930579|P7|NOT COMPLETED|Part 2||2
8493767|NCT00537316|20930580|P6|NOT COMPLETED|Part 2||4
8493768|NCT00537316|20930581|P5|NOT COMPLETED|Part 2||1
8493769|NCT00537316|20930582|P4|NOT COMPLETED|Part 2||3
8493770|NCT00537316|20930583|P3|NOT COMPLETED|Part 2||32
8493771|NCT00537316|20930584|P2|NOT COMPLETED|Part 2||9
8493772|NCT00537316|20930585|P1|NOT COMPLETED|Part 2||26
8493773|NCT00537316|20930579|P7|COMPLETED|Part 2||0
8493774|NCT00537316|20930580|P6|COMPLETED|Part 2||0
8493775|NCT00537316|20930581|P5|COMPLETED|Part 2||1
8493776|NCT00537316|20930582|P4|COMPLETED|Part 2||2
8493777|NCT00537316|20930583|P3|COMPLETED|Part 2||16
8493778|NCT00537316|20930584|P2|COMPLETED|Part 2||1
8493779|NCT00537316|20930585|P1|COMPLETED|Part 2||11
8493780|NCT00537316|20930579|P7|STARTED|Part 2||2
8493781|NCT00537316|20930580|P6|STARTED|Part 2||4
8493782|NCT00537316|20930581|P5|STARTED|Part 2||2
8493783|NCT00537316|20930582|P4|STARTED|Part 2||5
8493784|NCT00537316|20930583|P3|STARTED|Part 2||48
8493785|NCT00537316|20930584|P2|STARTED|Part 2||10
8493786|NCT00537316|20930585|P1|STARTED|Part 2||37
8493787|NCT00537316|20930579|P7|NOT COMPLETED|Part 1||0
8493788|NCT00537316|20930580|P6|NOT COMPLETED|Part 1||0
8493789|NCT00537316|20930581|P5|NOT COMPLETED|Part 1||0
8493790|NCT00537316|20930582|P4|NOT COMPLETED|Part 1||0
8493791|NCT00537316|20930583|P3|NOT COMPLETED|Part 1||17
8493792|NCT00537316|20930584|P2|NOT COMPLETED|Part 1||27
8493793|NCT00537316|20930585|P1|NOT COMPLETED|Part 1||14
8493794|NCT00537316|20930579|P7|COMPLETED|Part 1||0
8493795|NCT00537316|20930580|P6|COMPLETED|Part 1||0
8493796|NCT00537316|20930581|P5|COMPLETED|Part 1||0
8493797|NCT00537316|20930582|P4|COMPLETED|Part 1||0
8493798|NCT00537316|20930583|P3|COMPLETED|Part 1||63
8493799|NCT00537316|20930584|P2|COMPLETED|Part 1||53
8493800|NCT00537316|20930585|P1|COMPLETED|Part 1||65
8493801|NCT00537316|20930579|P7|STARTED|Part 1||0
8493802|NCT00537316|20930580|P6|STARTED|Part 1||0
8493803|NCT00537316|20930581|P5|STARTED|Part 1||0
8493804|NCT00537316|20930582|P4|STARTED|Part 1||0
8493805|NCT00537316|20930583|P3|STARTED|Part 1||80
8493806|NCT00537316|20930584|P2|STARTED|Part 1||80
8493807|NCT00537316|20930585|P1|STARTED|Part 1||79
8493808|NCT00537303|20930612|P2|NOT COMPLETED|Overall Study||25
8493809|NCT00537303|20930613|P1|NOT COMPLETED|Overall Study||26
8493810|NCT00537303|20930612|P2|COMPLETED|Overall Study||125
8493811|NCT00537303|20930613|P1|COMPLETED|Overall Study||120
8493812|NCT00537303|20930612|P2|STARTED|Overall Study||150
8493813|NCT00537303|20930613|P1|STARTED|Overall Study||146
8493814|NCT00537290|20930629|P1|NOT COMPLETED|Overall Study||0
8493815|NCT00537290|20930629|P1|COMPLETED|Overall Study||19
8493816|NCT00537290|20930629|P1|STARTED|Overall Study||19
8493817|NCT00537277|20930634|P1|NOT COMPLETED|Overall Study||49
8493818|NCT00537277|20930634|P1|COMPLETED|Overall Study||112
8493819|NCT00537277|20930634|P1|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
8493820|NCT00537277|20930634|P1|STARTED|Overall Study||161
8493821|NCT00537199|20930643|P1|NOT COMPLETED|Overall Study||1
8493822|NCT00537199|20930643|P1|COMPLETED|Overall Study||0
8493823|NCT00537199|20930643|P1|STARTED|Overall Study||1
8493830|NCT00537082|20930665|P3|NOT COMPLETED|Overall Study||6
8493831|NCT00537082|20930666|P2|NOT COMPLETED|Overall Study||9
8493832|NCT00537082|20930667|P1|NOT COMPLETED|Overall Study||9
8493833|NCT00537082|20930665|P3|COMPLETED|Overall Study||51
8493834|NCT00537082|20930666|P2|COMPLETED|Overall Study||48
8493835|NCT00537082|20930667|P1|COMPLETED|Overall Study||48
8493836|NCT00537082|20930665|P3|STARTED|Overall Study||57
8493837|NCT00537082|20930666|P2|STARTED|Overall Study||57
8493838|NCT00537082|20930667|P1|STARTED|Overall Study||57
8493839|NCT00537056|20930684|P1|NOT COMPLETED|12-month Follow-up||0
8493840|NCT00537056|20930684|P1|COMPLETED|12-month Follow-up||17
8493841|NCT00537056|20930684|P1|STARTED|12-month Follow-up||17
8493842|NCT00537056|20930684|P1|NOT COMPLETED|Interim PET/CT||5
8493843|NCT00537056|20930684|P1|COMPLETED|Interim PET/CT||12
8493844|NCT00537056|20930684|P1|STARTED|Interim PET/CT||17
8493845|NCT00537056|20930684|P1|NOT COMPLETED|Baseline PET/CT||0
8493846|NCT00537056|20930684|P1|COMPLETED|Baseline PET/CT||17
8493847|NCT00537056|20930684|P1|STARTED|Baseline PET/CT||17
8493848|NCT00537030|20930696|P1|NOT COMPLETED|Overall Study||16
8493849|NCT00537030|20930696|P1|COMPLETED|Overall Study||43
8493850|NCT00537030|20930696|P1|STARTED|Overall Study||59
8493857|NCT00536991|20930714|P1|NOT COMPLETED|Overall Study||13
8493858|NCT00536991|20930714|P1|COMPLETED|Overall Study||38
8493859|NCT00536991|20930714|P1|STARTED|Overall Study||51
8493860|NCT00536978|20930721|P1|NOT COMPLETED|Overall Study||22
8493861|NCT00536978|20930721|P1|COMPLETED|Overall Study||0
8493862|NCT00536978|20930721|P1|STARTED|Overall Study||22
8493863|NCT00536939|20930725|P2|NOT COMPLETED|Overall Study||0
8493864|NCT00536939|20930726|P1|NOT COMPLETED|Overall Study||2
8493865|NCT00536939|20930725|P2|COMPLETED|Overall Study||0
8493866|NCT00536939|20930726|P1|COMPLETED|Overall Study||0
8493867|NCT00536939|20930725|P2|Randomized|Overall Study||0
8493868|NCT00536939|20930726|P1|Randomized|Overall Study||0
8493869|NCT00536939|20930725|P2|Entered Safety lead-in|Overall Study||0
8493870|NCT00536939|20930726|P1|Entered Safety lead-in|Overall Study||2
8493871|NCT00536939|20930725|P2|STARTED|Overall Study||0
8493872|NCT00536939|20930726|P1|STARTED|Overall Study||2
8493873|NCT00536913|20930734|P2|NOT COMPLETED|Overall Study||0
8493874|NCT00536913|20930735|P1|NOT COMPLETED|Overall Study||0
8493875|NCT00536913|20930734|P2|COMPLETED|Overall Study||52
8493876|NCT00536913|20930735|P1|COMPLETED|Overall Study||55
8493877|NCT00536913|20930734|P2|STARTED|Overall Study||52
8493878|NCT00536913|20930735|P1|STARTED|Overall Study||55
8493879|NCT00536874|20930757|P1|NOT COMPLETED|Overall Study||4
8493880|NCT00536874|20930757|P1|COMPLETED|Overall Study||35
8493881|NCT00536874|20930757|P1|STARTED|Overall Study||39
8493882|NCT00536809|20930767|P1|NOT COMPLETED|Phase II||2
8493883|NCT00536809|20930767|P1|COMPLETED|Phase II||0
8493884|NCT00536809|20930767|P1|STARTED|Phase II||2
8493885|NCT00536809|20930767|P1|NOT COMPLETED|Phase I (Dose-finding Phase)||0
8493886|NCT00536809|20930767|P1|COMPLETED|Phase I (Dose-finding Phase)||10
8493887|NCT00536809|20930767|P1|STARTED|Phase I (Dose-finding Phase)||10
8493888|NCT00536744|20930790|P2|NOT COMPLETED|Overall Study||28
8493889|NCT00536744|20930791|P1|NOT COMPLETED|Overall Study||29
8493890|NCT00536744|20930790|P2|COMPLETED|Overall Study||71
8493891|NCT00536744|20930791|P1|COMPLETED|Overall Study||78
8493892|NCT00536744|20930790|P2|STARTED|Overall Study||99
8493893|NCT00536744|20930791|P1|STARTED|Overall Study||107
8493894|NCT00536731|20930800|P3|NOT COMPLETED|Overall Study||5
8493895|NCT00536731|20930801|P2|NOT COMPLETED|Overall Study||5
8493896|NCT00536731|20930802|P1|NOT COMPLETED|Overall Study||4
8493897|NCT00536731|20930800|P3|COMPLETED|Overall Study||238
8493898|NCT00536731|20930801|P2|COMPLETED|Overall Study||241
8493899|NCT00536731|20930802|P1|COMPLETED|Overall Study||249
8493900|NCT00536731|20930800|P3|STARTED|Overall Study||243
8493901|NCT00536731|20930801|P2|STARTED|Overall Study||246
8493902|NCT00536731|20930802|P1|STARTED|Overall Study||253
8493903|NCT00536575|20930846|P1|NOT COMPLETED|Overall Study||2
8493904|NCT00536575|20930846|P1|COMPLETED|Overall Study||11
8493905|NCT00536575|20930846|P1|STARTED|Overall Study||13
8493906|NCT00536510|20930852|P2|NOT COMPLETED|Overall Study||29
8493907|NCT00536510|20930853|P1|NOT COMPLETED|Overall Study||82
8493908|NCT00536510|20930852|P2|COMPLETED|Overall Study||295
8493909|NCT00536510|20930853|P1|COMPLETED|Overall Study||240
8493910|NCT00536510|20930852|P2|STARTED|Overall Study||324
8493911|NCT00536510|20930853|P1|STARTED|Overall Study||322
8493912|NCT00536484|20930863|P2|NOT COMPLETED|Overall Study||56
8493913|NCT00536484|20930864|P1|NOT COMPLETED|Overall Study||60
8493914|NCT00536484|20930863|P2|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
8493915|NCT00536484|20930864|P1|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
8493916|NCT00536484|20930863|P2|STARTED|Overall Study|448 participants randomised; 10 not treated|438
8493917|NCT00536484|20930864|P1|STARTED|Overall Study|448 participants randomised; 3 not treated|445
8493918|NCT00536471|20930898|P4|NOT COMPLETED|Overall Study||74
8493919|NCT00536471|20930899|P3|NOT COMPLETED|Overall Study||139
8493920|NCT00536471|20930900|P2|NOT COMPLETED|Overall Study||84
8493921|NCT00536471|20930901|P1|NOT COMPLETED|Overall Study||156
8493922|NCT00536471|20930898|P4|COMPLETED|Overall Study||57
8493923|NCT00536471|20930899|P3|COMPLETED|Overall Study||122
8493924|NCT00536471|20930900|P2|COMPLETED|Overall Study||43
8493925|NCT00536471|20930901|P1|COMPLETED|Overall Study||101
8493926|NCT00536471|20930898|P4|STARTED|Overall Study||131
8493927|NCT00536471|20930899|P3|STARTED|Overall Study||261
8493928|NCT00536471|20930900|P2|STARTED|Overall Study||127
8493929|NCT00536471|20930901|P1|STARTED|Overall Study||257
8493930|NCT00536380|20931146|P3|NOT COMPLETED|Overall Study||10
8493931|NCT00536380|20931147|P2|NOT COMPLETED|Overall Study||9
8493932|NCT00536380|20931148|P1|NOT COMPLETED|Overall Study||12
8493933|NCT00536380|20931146|P3|COMPLETED|Overall Study||94
8493934|NCT00536380|20931147|P2|COMPLETED|Overall Study||95
8493935|NCT00536380|20931148|P1|COMPLETED|Overall Study||94
8493936|NCT00536380|20931146|P3|STARTED|Overall Study||104
8493937|NCT00536380|20931147|P2|STARTED|Overall Study||104
8493938|NCT00536380|20931148|P1|STARTED|Overall Study||106
8493939|NCT00536341|20931158|P2|NOT COMPLETED|Overall Study||11
8493940|NCT00536341|20931159|P1|NOT COMPLETED|Overall Study||5
8493941|NCT00536341|20931158|P2|COMPLETED|Overall Study||43
8493942|NCT00536341|20931159|P1|COMPLETED|Overall Study||5
8493943|NCT00536341|20931158|P2|STARTED|Overall Study||54
8493944|NCT00536341|20931159|P1|STARTED|Overall Study||10
8493945|NCT00536263|20931172|P3|NOT COMPLETED|Overall Study||21
8493946|NCT00536263|20931173|P2|NOT COMPLETED|Overall Study||14
8493947|NCT00536263|20931174|P1|NOT COMPLETED|Overall Study||11
8493948|NCT00536263|20931172|P3|COMPLETED|Overall Study||204
8493949|NCT00536263|20931173|P2|COMPLETED|Overall Study||207
8493950|NCT00536263|20931174|P1|COMPLETED|Overall Study||214
8493951|NCT00536263|20931172|P3|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
8493952|NCT00536263|20931173|P2|STARTED|Overall Study||221
8493953|NCT00536263|20931174|P1|STARTED|Overall Study||225
8493954|NCT00536198|20931214|P2|NOT COMPLETED|Overall Study||39
8493955|NCT00536198|20931215|P1|NOT COMPLETED|Overall Study||37
8493956|NCT00536198|20931214|P2|COMPLETED|Overall Study||88
8493957|NCT00536198|20931215|P1|COMPLETED|Overall Study||88
8493958|NCT00536198|20931214|P2|Cycle 6|Overall Study||88
8493959|NCT00536198|20931215|P1|Cycle 6|Overall Study||88
8493960|NCT00536198|20931214|P2|Cycle 5|Overall Study||85
8493961|NCT00536198|20931215|P1|Cycle 5|Overall Study||88
8493962|NCT00536198|20931214|P2|Cycle 4|Overall Study||98
8493963|NCT00536198|20931215|P1|Cycle 4|Overall Study||95
8493964|NCT00536198|20931214|P2|Cycle 3|Overall Study||101
8493965|NCT00536198|20931215|P1|Cycle 3|Overall Study||100
8493966|NCT00536198|20931214|P2|Cycle 2|Overall Study||112
8493967|NCT00536198|20931215|P1|Cycle 2|Overall Study||104
8493968|NCT00536198|20931214|P2|Cycle 1|Overall Study||123
8493969|NCT00536198|20931215|P1|Cycle 1|Overall Study||110
8493970|NCT00536198|20931214|P2|STARTED|Overall Study||127
8493971|NCT00536198|20931215|P1|STARTED|Overall Study||125
8493972|NCT00536172|20931245|P2|NOT COMPLETED|Overall Study||9
8493973|NCT00536172|20931246|P1|NOT COMPLETED|Overall Study||14
8493974|NCT00536172|20931245|P2|COMPLETED|Overall Study||65
8493975|NCT00536172|20931246|P1|COMPLETED|Overall Study||60
8493976|NCT00536172|20931245|P2|STARTED|Overall Study||74
8493977|NCT00536172|20931246|P1|STARTED|Overall Study||74
8493978|NCT00536120|20931254|P2|NOT COMPLETED|Overall Study||3
8493979|NCT00536120|20931255|P1|NOT COMPLETED|Overall Study||6
8493980|NCT00536120|20931254|P2|COMPLETED|Overall Study||27
8493981|NCT00536120|20931255|P1|COMPLETED|Overall Study||24
8493982|NCT00536120|20931254|P2|STARTED|Overall Study||30
8493983|NCT00536120|20931255|P1|STARTED|Overall Study||30
8493984|NCT00536107|20931269|P2|NOT COMPLETED|Overall Study||6
8493985|NCT00536107|20931270|P1|NOT COMPLETED|Overall Study||8
8493986|NCT00536107|20931269|P2|COMPLETED|Overall Study||0
8493987|NCT00536107|20931270|P1|COMPLETED|Overall Study||0
8493988|NCT00536107|20931269|P2|STARTED|Overall Study||6
8493989|NCT00536107|20931270|P1|STARTED|Overall Study||8
8493990|NCT00535938|20931280|P2|NOT COMPLETED|Overall Study||462
8493991|NCT00535938|20931281|P1|NOT COMPLETED|Overall Study||391
8493992|NCT00535938|20931280|P2|COMPLETED|Overall Study||404
8493993|NCT00535938|20931281|P1|COMPLETED|Overall Study||115
8493994|NCT00535938|20931280|P2|STARTED|Overall Study||866
8493995|NCT00535938|20931281|P1|STARTED|Overall Study||506
8493996|NCT00535925|20931319|P2|NOT COMPLETED|Overall Study||8
8493997|NCT00535925|20931320|P1|NOT COMPLETED|Overall Study||19
8493998|NCT00535925|20931319|P2|COMPLETED|Overall Study||199
8493999|NCT00535925|20931320|P1|COMPLETED|Overall Study||169
8494000|NCT00535925|20931319|P2|STARTED|Overall Study||207
8494001|NCT00535925|20931320|P1|STARTED|Overall Study||188
8494002|NCT00535873|20931328|P1|NOT COMPLETED|Overall Study||0
8494003|NCT00535873|20931328|P1|COMPLETED|Overall Study||60
8494004|NCT00535873|20931328|P1|STARTED|Overall Study||60
8494005|NCT00535847|20931335|P3|NOT COMPLETED|Overall Study||2
8494006|NCT00535847|20931336|P2|NOT COMPLETED|Overall Study||14
8494007|NCT00535847|20931337|P1|NOT COMPLETED|Overall Study||22
8494008|NCT00535847|20931335|P3|COMPLETED|Overall Study||0
8494009|NCT00535847|20931336|P2|COMPLETED|Overall Study||20
8494010|NCT00535847|20931337|P1|COMPLETED|Overall Study||59
8494011|NCT00535847|20931335|P3|STARTED|Overall Study||2
8494012|NCT00535847|20931336|P2|STARTED|Overall Study||34
8494013|NCT00535847|20931337|P1|STARTED|Overall Study||81
8494014|NCT00535821|20931363|P2|NOT COMPLETED|Overall Study||0
8494015|NCT00535821|20931364|P1|NOT COMPLETED|Overall Study||0
8494016|NCT00535821|20931363|P2|COMPLETED|Overall Study||3
8494017|NCT00535821|20931364|P1|COMPLETED|Overall Study||2
8494018|NCT00535821|20931363|P2|STARTED|Overall Study||3
8494019|NCT00535821|20931364|P1|STARTED|Overall Study||2
8494020|NCT00535782|20931372|P3|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
8494021|NCT00535782|20931373|P2|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
8494022|NCT00535782|20931374|P1|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
8494023|NCT00535782|20931372|P3|COMPLETED|Part 2: 80-Week Open-label Period||98
8494024|NCT00535782|20931373|P2|COMPLETED|Part 2: 80-Week Open-label Period||0
8494025|NCT00535782|20931374|P1|COMPLETED|Part 2: 80-Week Open-label Period||0
8494026|NCT00535782|20931372|P3|STARTED|Part 2: 80-Week Open-label Period||124
8494027|NCT00535782|20931373|P2|STARTED|Part 2: 80-Week Open-label Period||0
8494028|NCT00535782|20931374|P1|STARTED|Part 2: 80-Week Open-label Period||0
8494029|NCT00535782|20931372|P3|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
8494030|NCT00535782|20931373|P2|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
8494031|NCT00535782|20931374|P1|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
8494032|NCT00535782|20931372|P3|COMPLETED|Part 1: 24-Week Double-blind Period||0
8494033|NCT00535782|20931373|P2|COMPLETED|Part 1: 24-Week Double-blind Period||59
8494034|NCT00535782|20931374|P1|COMPLETED|Part 1: 24-Week Double-blind Period||65
8494035|NCT00535782|20931372|P3|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
8494036|NCT00535782|20931373|P2|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
8494037|NCT00535782|20931374|P1|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
8494038|NCT00535782|20931372|P3|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
8494039|NCT00535782|20931373|P2|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
8494040|NCT00535782|20931374|P1|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
8494041|NCT00535782|20931372|P3|STARTED|Part 1: 24-Week Double-blind Period||0
8494042|NCT00535782|20931373|P2|STARTED|Part 1: 24-Week Double-blind Period||63
8494043|NCT00535782|20931374|P1|STARTED|Part 1: 24-Week Double-blind Period||69
8494044|NCT00535769|20931391|P2|NOT COMPLETED|Overall Study||0
8494045|NCT00535769|20931392|P1|NOT COMPLETED|Overall Study||0
8494046|NCT00535769|20931391|P2|COMPLETED|Overall Study||35
8494047|NCT00535769|20931392|P1|COMPLETED|Overall Study||35
8494048|NCT00535769|20931391|P2|STARTED|Overall Study||35
8494049|NCT00535769|20931392|P1|STARTED|Overall Study||35
8494050|NCT00535743|20931425|P24|NOT COMPLETED|Overall Study||0
8494051|NCT00535743|20931426|P23|NOT COMPLETED|Overall Study||0
8494052|NCT00535743|20931427|P22|NOT COMPLETED|Overall Study||1
8494053|NCT00535743|20931428|P21|NOT COMPLETED|Overall Study||0
8494054|NCT00535743|20931429|P20|NOT COMPLETED|Overall Study||0
8494055|NCT00535743|20931430|P19|NOT COMPLETED|Overall Study||0
8494056|NCT00535743|20931431|P18|NOT COMPLETED|Overall Study||0
8494057|NCT00535743|20931432|P17|NOT COMPLETED|Overall Study||0
8494058|NCT00535743|20931433|P16|NOT COMPLETED|Overall Study||0
8494059|NCT00535743|20931434|P15|NOT COMPLETED|Overall Study||0
8494060|NCT00535743|20931435|P14|NOT COMPLETED|Overall Study||0
8494061|NCT00535743|20931436|P13|NOT COMPLETED|Overall Study||0
8494062|NCT00535743|20931437|P12|NOT COMPLETED|Overall Study||0
8494063|NCT00535743|20931438|P11|NOT COMPLETED|Overall Study||0
8494064|NCT00535743|20931439|P10|NOT COMPLETED|Overall Study||1
8494065|NCT00535743|20931440|P9|NOT COMPLETED|Overall Study||1
8494066|NCT00535743|20931441|P8|NOT COMPLETED|Overall Study||0
8494067|NCT00535743|20931442|P7|NOT COMPLETED|Overall Study||0
8494068|NCT00535743|20931443|P6|NOT COMPLETED|Overall Study||0
8494069|NCT00535743|20931444|P5|NOT COMPLETED|Overall Study||0
8494070|NCT00535743|20931445|P4|NOT COMPLETED|Overall Study||0
8494071|NCT00535743|20931446|P3|NOT COMPLETED|Overall Study||0
8494072|NCT00535743|20931447|P2|NOT COMPLETED|Overall Study||0
8494073|NCT00535743|20931448|P1|NOT COMPLETED|Overall Study||0
8494074|NCT00535743|20931425|P24|COMPLETED|Overall Study||5
8494075|NCT00535743|20931426|P23|COMPLETED|Overall Study||6
8494076|NCT00535743|20931427|P22|COMPLETED|Overall Study||4
8494077|NCT00535743|20931428|P21|COMPLETED|Overall Study||5
8494078|NCT00535743|20931429|P20|COMPLETED|Overall Study||5
8494079|NCT00535743|20931430|P19|COMPLETED|Overall Study||3
8494080|NCT00535743|20931431|P18|COMPLETED|Overall Study||11
8494081|NCT00535743|20931432|P17|COMPLETED|Overall Study||10
8494082|NCT00535743|20931433|P16|COMPLETED|Overall Study||13
8494083|NCT00535743|20931434|P15|COMPLETED|Overall Study||9
8494084|NCT00535743|20931435|P14|COMPLETED|Overall Study||10
8494085|NCT00535743|20931436|P13|COMPLETED|Overall Study||5
8494086|NCT00535743|20931437|P12|COMPLETED|Overall Study||5
8494087|NCT00535743|20931438|P11|COMPLETED|Overall Study||5
8494088|NCT00535743|20931439|P10|COMPLETED|Overall Study||4
8494089|NCT00535743|20931440|P9|COMPLETED|Overall Study||4
8494090|NCT00535743|20931441|P8|COMPLETED|Overall Study||5
8494091|NCT00535743|20931442|P7|COMPLETED|Overall Study||3
8494092|NCT00535743|20931443|P6|COMPLETED|Overall Study||10
8494093|NCT00535743|20931444|P5|COMPLETED|Overall Study||11
8494094|NCT00535743|20931445|P4|COMPLETED|Overall Study||11
8494095|NCT00535743|20931446|P3|COMPLETED|Overall Study||11
8494096|NCT00535743|20931447|P2|COMPLETED|Overall Study||11
8494097|NCT00535743|20931448|P1|COMPLETED|Overall Study||5
8494098|NCT00535743|20931425|P24|Treated|Overall Study||5
8494099|NCT00535743|20931426|P23|Treated|Overall Study|N=1 (randomized to Arm Q) rec'd 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6
8494100|NCT00535743|20931427|P22|Treated|Overall Study||5
8494101|NCT00535743|20931428|P21|Treated|Overall Study||5
8494102|NCT00535743|20931429|P20|Treated|Overall Study||5
8494103|NCT00535743|20931430|P19|Treated|Overall Study||3
8494104|NCT00535743|20931431|P18|Treated|Overall Study||11
8494105|NCT00535743|20931432|P17|Treated|Overall Study||10
8494106|NCT00535743|20931433|P16|Treated|Overall Study|N=2 (randomized to Arm O) rec'd 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13
8494107|NCT00535743|20931434|P15|Treated|Overall Study||9
8494108|NCT00535743|20931435|P14|Treated|Overall Study||10
8494109|NCT00535743|20931436|P13|Treated|Overall Study||5
8494110|NCT00535743|20931437|P12|Treated|Overall Study||5
8494111|NCT00535743|20931438|P11|Treated|Overall Study||5
8494112|NCT00535743|20931439|P10|Treated|Overall Study||5
8494113|NCT00535743|20931440|P9|Treated|Overall Study||4
8494114|NCT00535743|20931441|P8|Treated|Overall Study||5
8494115|NCT00535743|20931442|P7|Treated|Overall Study||3
8494116|NCT00535743|20931443|P6|Treated|Overall Study||10
8494117|NCT00535743|20931444|P5|Treated|Overall Study||11
8494118|NCT00535743|20931445|P4|Treated|Overall Study||11
8494119|NCT00535743|20931446|P3|Treated|Overall Study||11
8494120|NCT00535743|20931447|P2|Treated|Overall Study||11
8494121|NCT00535743|20931448|P1|Treated|Overall Study||5
8494122|NCT00535743|20931425|P24|STARTED|Overall Study||5
8494123|NCT00535743|20931426|P23|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6
8494124|NCT00535743|20931427|P22|STARTED|Overall Study||5
8494125|NCT00535743|20931428|P21|STARTED|Overall Study||5
8494126|NCT00535743|20931429|P20|STARTED|Overall Study||5
8494127|NCT00535743|20931430|P19|STARTED|Overall Study||3
8494128|NCT00535743|20931431|P18|STARTED|Overall Study||11
8494129|NCT00535743|20931432|P17|STARTED|Overall Study||10
8494130|NCT00535743|20931433|P16|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13
8494131|NCT00535743|20931434|P15|STARTED|Overall Study||9
8494132|NCT00535743|20931435|P14|STARTED|Overall Study||10
8494133|NCT00535743|20931436|P13|STARTED|Overall Study||5
8494134|NCT00535743|20931437|P12|STARTED|Overall Study||5
8494135|NCT00535743|20931438|P11|STARTED|Overall Study||5
8494136|NCT00535743|20931439|P10|STARTED|Overall Study||5
8494137|NCT00535743|20931440|P9|STARTED|Overall Study||5
8494138|NCT00535743|20931441|P8|STARTED|Overall Study||5
8494139|NCT00535743|20931442|P7|STARTED|Overall Study||3
8494140|NCT00535743|20931443|P6|STARTED|Overall Study||10
8494141|NCT00535743|20931444|P5|STARTED|Overall Study||11
8494142|NCT00535743|20931445|P4|STARTED|Overall Study||11
8494143|NCT00535743|20931446|P3|STARTED|Overall Study||11
8494144|NCT00535743|20931447|P2|STARTED|Overall Study||11
8494145|NCT00535743|20931448|P1|STARTED|Overall Study||5
8494146|NCT00535730|20931572|P2|NOT COMPLETED|Overall Study||7
8494147|NCT00535730|20931573|P1|NOT COMPLETED|Overall Study||2
8494148|NCT00535730|20931572|P2|COMPLETED|Overall Study||230
8494149|NCT00535730|20931573|P1|COMPLETED|Overall Study||234
8494150|NCT00535730|20931572|P2|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
8494151|NCT00535730|20931573|P1|STARTED|Overall Study||236
8494152|NCT00535652|20931590|P1|NOT COMPLETED|Overall Study||3
8494153|NCT00535652|20931590|P1|COMPLETED|Overall Study||20
8494154|NCT00535652|20931590|P1|STARTED|Overall Study||23
8494155|NCT00535626|20931594|P1|NOT COMPLETED|Overall Study||105
8494156|NCT00535626|20931594|P1|COMPLETED|Overall Study||85
8494157|NCT00535626|20931594|P1|STARTED|Overall Study||190
8494158|NCT00535613|20931606|P2|NOT COMPLETED|Overall Study||0
8494159|NCT00535613|20931607|P1|NOT COMPLETED|Overall Study||0
8494160|NCT00535613|20931606|P2|COMPLETED|Overall Study||50
8494161|NCT00535613|20931607|P1|COMPLETED|Overall Study||49
8494162|NCT00535613|20931606|P2|STARTED|Overall Study||50
8494163|NCT00535613|20931607|P1|STARTED|Overall Study||49
8494164|NCT00535587|20931621|P4|NOT COMPLETED|Overall Study||13
8494165|NCT00535587|20931622|P3|NOT COMPLETED|Overall Study||8
8494166|NCT00535587|20931623|P2|NOT COMPLETED|Overall Study||11
8494167|NCT00535587|20931624|P1|NOT COMPLETED|Overall Study||10
8494168|NCT00535587|20931621|P4|COMPLETED|Overall Study||41
8494169|NCT00535587|20931622|P3|COMPLETED|Overall Study||39
8494170|NCT00535587|20931623|P2|COMPLETED|Overall Study||42
8494171|NCT00535587|20931624|P1|COMPLETED|Overall Study||43
8494172|NCT00535587|20931621|P4|STARTED|Overall Study||54
8494173|NCT00535587|20931622|P3|STARTED|Overall Study||47
8494174|NCT00535587|20931623|P2|STARTED|Overall Study||53
8494175|NCT00535587|20931624|P1|STARTED|Overall Study||53
8494176|NCT00535496|20931634|P4|NOT COMPLETED|Overall Study||0
8494177|NCT00535496|20931635|P3|NOT COMPLETED|Overall Study||0
8494178|NCT00535496|20931636|P2|NOT COMPLETED|Overall Study||2
8494179|NCT00535496|20931637|P1|NOT COMPLETED|Overall Study||0
8494180|NCT00535496|20931634|P4|COMPLETED|Overall Study||31
8494181|NCT00535496|20931635|P3|COMPLETED|Overall Study||30
8494182|NCT00535496|20931636|P2|COMPLETED|Overall Study||13
8494183|NCT00535496|20931637|P1|COMPLETED|Overall Study||15
8494184|NCT00535496|20931634|P4|All-Subjects-Treated (AST) Group|Overall Study||31
8494185|NCT00535496|20931635|P3|All-Subjects-Treated (AST) Group|Overall Study||30
8494186|NCT00535496|20931636|P2|All-Subjects-Treated (AST) Group|Overall Study||14
8494187|NCT00535496|20931637|P1|All-Subjects-Treated (AST) Group|Overall Study||15
8494188|NCT00535496|20931634|P4|STARTED|Overall Study||31
8494189|NCT00535496|20931635|P3|STARTED|Overall Study||30
8494190|NCT00535496|20931636|P2|STARTED|Overall Study||15
8494191|NCT00535496|20931637|P1|STARTED|Overall Study||15
8494192|NCT00535405|20931657|P5|NOT COMPLETED|Overall Study||16
8494193|NCT00535405|20931658|P4|NOT COMPLETED|Overall Study||22
8494194|NCT00535405|20931659|P3|NOT COMPLETED|Overall Study||18
8494195|NCT00535405|20931660|P2|NOT COMPLETED|Overall Study||26
8494196|NCT00535405|20931661|P1|NOT COMPLETED|Overall Study||17
8494197|NCT00535405|20931657|P5|COMPLETED|Overall Study||241
8494198|NCT00535405|20931658|P4|COMPLETED|Overall Study||235
8494199|NCT00535405|20931659|P3|COMPLETED|Overall Study||241
8494200|NCT00535405|20931660|P2|COMPLETED|Overall Study||233
8494201|NCT00535405|20931661|P1|COMPLETED|Overall Study||240
8494202|NCT00535405|20931657|P5|STARTED|Overall Study||257
8494203|NCT00535405|20931658|P4|STARTED|Overall Study||257
8494204|NCT00535405|20931659|P3|STARTED|Overall Study||259
8494205|NCT00535405|20931660|P2|STARTED|Overall Study||259
8494206|NCT00535405|20931661|P1|STARTED|Overall Study||257
8494207|NCT00535392|20931698|P1|NOT COMPLETED|Overall Study||0
8494208|NCT00535392|20931698|P1|COMPLETED|Overall Study||33
8494209|NCT00535392|20931698|P1|STARTED|Overall Study||33
8494210|NCT00535301|20931706|P2|NOT COMPLETED|Overall Study||5
8494211|NCT00535301|20931707|P1|NOT COMPLETED|Overall Study||5
8494212|NCT00535301|20931706|P2|COMPLETED|Overall Study||33
8494213|NCT00535301|20931707|P1|COMPLETED|Overall Study||33
8494214|NCT00535301|20931706|P2|STARTED|Overall Study||38
8494215|NCT00535301|20931707|P1|STARTED|Overall Study||38
8494216|NCT00535288|20931722|P5|NOT COMPLETED|Overall Study||42
8494217|NCT00535288|20931723|P4|NOT COMPLETED|Overall Study||29
8494218|NCT00535288|20931724|P3|NOT COMPLETED|Overall Study||33
8494219|NCT00535288|20931725|P2|NOT COMPLETED|Overall Study||32
8494220|NCT00535288|20931726|P1|NOT COMPLETED|Overall Study||54
8494221|NCT00535288|20931722|P5|COMPLETED|Overall Study||116
8494222|NCT00535288|20931723|P4|COMPLETED|Overall Study||122
8494223|NCT00535288|20931724|P3|COMPLETED|Overall Study||127
8494224|NCT00535288|20931725|P2|COMPLETED|Overall Study||130
8494225|NCT00535288|20931726|P1|COMPLETED|Overall Study||260
8494226|NCT00535288|20931722|P5|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
8494227|NCT00535288|20931723|P4|STARTED|Overall Study||151
8494228|NCT00535288|20931724|P3|STARTED|Overall Study||160
8494229|NCT00535288|20931725|P2|STARTED|Overall Study||162
8494230|NCT00535288|20931726|P1|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
8494231|NCT00535262|20931803|P1|NOT COMPLETED|Overall Study||3
8494232|NCT00535262|20931803|P1|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
8494233|NCT00535262|20931803|P1|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
8494234|NCT00535236|20931817|P10|NOT COMPLETED|Overall Study||4
8494235|NCT00535236|20931818|P9|NOT COMPLETED|Overall Study||13
8494236|NCT00535236|20931819|P8|NOT COMPLETED|Overall Study||1
8494237|NCT00535236|20931820|P7|NOT COMPLETED|Overall Study||11
8494238|NCT00535236|20931821|P6|NOT COMPLETED|Overall Study||1
8494239|NCT00535236|20931822|P5|NOT COMPLETED|Overall Study||12
8494240|NCT00535236|20931823|P4|NOT COMPLETED|Overall Study||4
8494241|NCT00535236|20931824|P3|NOT COMPLETED|Overall Study||12
8494242|NCT00535236|20931825|P2|NOT COMPLETED|Overall Study||2
8494243|NCT00535236|20931826|P1|NOT COMPLETED|Overall Study||7
8494244|NCT00535236|20931817|P10|COMPLETED|Overall Study||16
8494245|NCT00535236|20931818|P9|COMPLETED|Overall Study||47
8494246|NCT00535236|20931819|P8|COMPLETED|Overall Study||18
8494247|NCT00535236|20931820|P7|COMPLETED|Overall Study||51
8494248|NCT00535236|20931821|P6|COMPLETED|Overall Study||19
8494249|NCT00535236|20931822|P5|COMPLETED|Overall Study||47
8494250|NCT00535236|20931823|P4|COMPLETED|Overall Study||6
8494251|NCT00535236|20931824|P3|COMPLETED|Overall Study||29
8494252|NCT00535236|20931825|P2|COMPLETED|Overall Study||8
8494253|NCT00535236|20931826|P1|COMPLETED|Overall Study||33
8494254|NCT00535236|20931817|P10|Vaccination 4|Overall Study||17
8494255|NCT00535236|20931818|P9|Vaccination 4|Overall Study||50
8494256|NCT00535236|20931819|P8|Vaccination 4|Overall Study||18
8494257|NCT00535236|20931820|P7|Vaccination 4|Overall Study||51
8494258|NCT00535236|20931821|P6|Vaccination 4|Overall Study||19
8494259|NCT00535236|20931822|P5|Vaccination 4|Overall Study||47
8494260|NCT00535236|20931823|P4|Vaccination 4|Overall Study||6
8494261|NCT00535236|20931824|P3|Vaccination 4|Overall Study||32
8494262|NCT00535236|20931825|P2|Vaccination 4|Overall Study||10
8494263|NCT00535236|20931826|P1|Vaccination 4|Overall Study||34
8494264|NCT00535236|20931817|P10|Vaccination 3|Overall Study||18
8494265|NCT00535236|20931818|P9|Vaccination 3|Overall Study||53
8494266|NCT00535236|20931819|P8|Vaccination 3|Overall Study||18
8494267|NCT00535236|20931820|P7|Vaccination 3|Overall Study||51
8494268|NCT00535236|20931821|P6|Vaccination 3|Overall Study||19
8494269|NCT00535236|20931822|P5|Vaccination 3|Overall Study||48
8494270|NCT00535236|20931823|P4|Vaccination 3|Overall Study||8
8494271|NCT00535236|20931824|P3|Vaccination 3|Overall Study||35
8494272|NCT00535236|20931825|P2|Vaccination 3|Overall Study||10
8494273|NCT00535236|20931826|P1|Vaccination 3|Overall Study||34
8494274|NCT00535236|20931817|P10|Vaccination 2|Overall Study||19
8494275|NCT00535236|20931818|P9|Vaccination 2|Overall Study||57
8494276|NCT00535236|20931819|P8|Vaccination 2|Overall Study||19
8494277|NCT00535236|20931820|P7|Vaccination 2|Overall Study||58
8494278|NCT00535236|20931821|P6|Vaccination 2|Overall Study||19
8494279|NCT00535236|20931822|P5|Vaccination 2|Overall Study||52
8494280|NCT00535236|20931823|P4|Vaccination 2|Overall Study||8
8494281|NCT00535236|20931824|P3|Vaccination 2|Overall Study||37
8494282|NCT00535236|20931825|P2|Vaccination 2|Overall Study||10
8494283|NCT00535236|20931826|P1|Vaccination 2|Overall Study||35
8494284|NCT00535236|20931817|P10|Vaccination 1|Overall Study||20
8494285|NCT00535236|20931818|P9|Vaccination 1|Overall Study||60
8494286|NCT00535236|20931819|P8|Vaccination 1|Overall Study||19
8494287|NCT00535236|20931820|P7|Vaccination 1|Overall Study||61
8494288|NCT00535236|20931821|P6|Vaccination 1|Overall Study||19
8494289|NCT00535236|20931822|P5|Vaccination 1|Overall Study||58
8494290|NCT00535236|20931823|P4|Vaccination 1|Overall Study||10
8494291|NCT00535236|20931824|P3|Vaccination 1|Overall Study||40
8494292|NCT00535236|20931825|P2|Vaccination 1|Overall Study||10
8494293|NCT00535236|20931826|P1|Vaccination 1|Overall Study||40
8494294|NCT00535236|20931817|P10|STARTED|Overall Study||20
8494295|NCT00535236|20931818|P9|STARTED|Overall Study||60
8494296|NCT00535236|20931819|P8|STARTED|Overall Study||19
8494297|NCT00535236|20931820|P7|STARTED|Overall Study||62
8494298|NCT00535236|20931821|P6|STARTED|Overall Study||20
8494299|NCT00535236|20931822|P5|STARTED|Overall Study||59
8494300|NCT00535236|20931823|P4|STARTED|Overall Study||10
8494301|NCT00535236|20931824|P3|STARTED|Overall Study||41
8494302|NCT00535236|20931825|P2|STARTED|Overall Study||10
8494303|NCT00535236|20931826|P1|STARTED|Overall Study||40
8494304|NCT00535223|20931886|P2|NOT COMPLETED|Overall Study||1
8494305|NCT00535223|20931887|P1|NOT COMPLETED|Overall Study||4
8494306|NCT00535223|20931886|P2|COMPLETED|Overall Study||39
8494307|NCT00535223|20931887|P1|COMPLETED|Overall Study||37
8494308|NCT00535223|20931886|P2|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
8494309|NCT00535223|20931887|P1|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
8494310|NCT00535145|20931895|P1|NOT COMPLETED|Phase II||15
8494311|NCT00535145|20931895|P1|COMPLETED|Phase II||69
8494312|NCT00535145|20931895|P1|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
8494313|NCT00535145|20931895|P1|NOT COMPLETED|Phase I||29
8494314|NCT00535145|20931895|P1|COMPLETED|Phase I||85
8494315|NCT00535145|20931895|P1|STARTED|Phase I||114
8494316|NCT00535132|20931907|P2|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
8494317|NCT00535132|20931908|P1|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
8494318|NCT00535132|20931907|P2|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
8494319|NCT00535132|20931908|P1|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
8494320|NCT00535132|20931907|P2|STARTED|Intent-to-Treat (ITT) Analysis Set||99
8494321|NCT00535132|20931908|P1|STARTED|Intent-to-Treat (ITT) Analysis Set||98
8494322|NCT00535132|20931907|P2|NOT COMPLETED|Safety Analysis Set||2
8494323|NCT00535132|20931908|P1|NOT COMPLETED|Safety Analysis Set||2
8494324|NCT00535132|20931907|P2|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
8494325|NCT00535132|20931908|P1|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
8494326|NCT00535132|20931907|P2|STARTED|Safety Analysis Set||101
8494327|NCT00535132|20931908|P1|STARTED|Safety Analysis Set||100
8494328|NCT00535132|20931907|P2|NOT COMPLETED|Randomized Population||0
8494329|NCT00535132|20931908|P1|NOT COMPLETED|Randomized Population||0
8494330|NCT00535132|20931907|P2|COMPLETED|Randomized Population||101
8494331|NCT00535132|20931908|P1|COMPLETED|Randomized Population||100
8494332|NCT00535132|20931907|P2|STARTED|Randomized Population|Number of Subjects Randomized|101
8494333|NCT00535132|20931908|P1|STARTED|Randomized Population|Number of Subjects Randomized|100
8494334|NCT00535002|20931966|P8|NOT COMPLETED|Overall Study||0
8494335|NCT00535002|20931967|P7|NOT COMPLETED|Overall Study||0
8494336|NCT00535002|20931968|P6|NOT COMPLETED|Overall Study||0
8494337|NCT00535002|20931969|P5|NOT COMPLETED|Overall Study||0
8494338|NCT00535002|20931970|P4|NOT COMPLETED|Overall Study||0
8494339|NCT00535002|20931971|P3|NOT COMPLETED|Overall Study||0
8494340|NCT00535002|20931972|P2|NOT COMPLETED|Overall Study||0
8494341|NCT00535002|20931973|P1|NOT COMPLETED|Overall Study||0
8494342|NCT00535002|20931966|P8|COMPLETED|Overall Study||16
8494343|NCT00535002|20931967|P7|COMPLETED|Overall Study||12
8494344|NCT00535002|20931968|P6|COMPLETED|Overall Study||17
8494345|NCT00535002|20931969|P5|COMPLETED|Overall Study||9
8494346|NCT00535002|20931970|P4|COMPLETED|Overall Study||14
8494347|NCT00535002|20931971|P3|COMPLETED|Overall Study||13
8494348|NCT00535002|20931972|P2|COMPLETED|Overall Study||12
8494349|NCT00535002|20931973|P1|COMPLETED|Overall Study||19
8494350|NCT00535002|20931966|P8|STARTED|Overall Study||16
8494351|NCT00535002|20931967|P7|STARTED|Overall Study||12
8494352|NCT00535002|20931968|P6|STARTED|Overall Study||17
8494353|NCT00535002|20931969|P5|STARTED|Overall Study||9
8494354|NCT00535002|20931970|P4|STARTED|Overall Study||14
8494355|NCT00535002|20931971|P3|STARTED|Overall Study||13
8494356|NCT00535002|20931972|P2|STARTED|Overall Study||12
8494357|NCT00535002|20931973|P1|STARTED|Overall Study||19
8494358|NCT00534976|20931989|P2|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
8494359|NCT00534976|20931990|P1|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
8494360|NCT00534976|20931989|P2|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
8494361|NCT00534976|20931990|P1|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
8494362|NCT00534976|20931989|P2|STARTED|Period 3: Crossover Placebo/ Montelukast||32
8494363|NCT00534976|20931990|P1|STARTED|Period 3: Crossover Placebo/ Montelukast||33
8494364|NCT00534976|20931989|P2|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
8494365|NCT00534976|20931990|P1|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
8494366|NCT00534976|20931989|P2|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
8494367|NCT00534976|20931990|P1|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
8494368|NCT00534976|20931989|P2|STARTED|Period 2: Treatment Montelukast/ Placebo||33
8494369|NCT00534976|20931990|P1|STARTED|Period 2: Treatment Montelukast/ Placebo||33
8494370|NCT00534976|20931989|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
8494371|NCT00534976|20931990|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
8494372|NCT00534976|20931989|P2|COMPLETED|Period 1: Placebo Run-in||33
8494373|NCT00534976|20931990|P1|COMPLETED|Period 1: Placebo Run-in||33
8494374|NCT00534976|20931989|P2|STARTED|Period 1: Placebo Run-in||33
8494375|NCT00534976|20931990|P1|STARTED|Period 1: Placebo Run-in||33
8494376|NCT00534937|20932012|P2|NOT COMPLETED|Overall Study||12
8494377|NCT00534937|20932013|P1|NOT COMPLETED|Overall Study||8
8494378|NCT00534937|20932012|P2|COMPLETED|Overall Study||35
8494379|NCT00534937|20932013|P1|COMPLETED|Overall Study||34
8494380|NCT00534937|20932012|P2|STARTED|Overall Study||47
8494381|NCT00534937|20932013|P1|STARTED|Overall Study||42
8494382|NCT00534833|20932027|P2|NOT COMPLETED|Overall Study||0
8494383|NCT00534833|20932028|P1|NOT COMPLETED|Overall Study||0
8494384|NCT00534833|20932027|P2|COMPLETED|Overall Study||180
8494385|NCT00534833|20932028|P1|COMPLETED|Overall Study||182
8494386|NCT00534833|20932027|P2|STARTED|Overall Study||180
8494387|NCT00534833|20932028|P1|STARTED|Overall Study||182
8494388|NCT00534794|20932040|P2|NOT COMPLETED|Overall Study||0
8494389|NCT00534794|20932041|P1|NOT COMPLETED|Overall Study||0
8494390|NCT00534794|20932040|P2|COMPLETED|Overall Study||39
8494391|NCT00534794|20932041|P1|COMPLETED|Overall Study||40
8494392|NCT00534794|20932040|P2|STARTED|Overall Study||39
8494393|NCT00534794|20932041|P1|STARTED|Overall Study||40
8494394|NCT00534703|20932051|P2|NOT COMPLETED|Overall Study||0
8494395|NCT00534703|20932052|P1|NOT COMPLETED|Overall Study||0
8494396|NCT00534703|20932051|P2|COMPLETED|Overall Study||1
8494397|NCT00534703|20932052|P1|COMPLETED|Overall Study||4
8494398|NCT00534703|20932051|P2|STARTED|Overall Study||1
8494399|NCT00534703|20932052|P1|STARTED|Overall Study||4
8494400|NCT00534638|20932070|P2|NOT COMPLETED|Overall Study||11791
8494401|NCT00534638|20932071|P1|NOT COMPLETED|Overall Study||6491
8494402|NCT00534638|20932070|P2|COMPLETED|Overall Study||5547
8494403|NCT00534638|20932071|P1|COMPLETED|Overall Study||8346
8494404|NCT00534638|20932070|P2|STARTED|Overall Study||17338
8494405|NCT00534638|20932071|P1|STARTED|Overall Study||14837
8494406|NCT00534599|20932109|P2|NOT COMPLETED|Overall Study||32
8494407|NCT00534599|20932110|P1|NOT COMPLETED|Overall Study||57
8494408|NCT00534599|20932109|P2|COMPLETED|Overall Study||168
8494409|NCT00534599|20932110|P1|COMPLETED|Overall Study||152
8494410|NCT00534599|20932109|P2|STARTED|Overall Study|Randomized|200
8494411|NCT00534599|20932110|P1|STARTED|Overall Study|Randomized|209
8494412|NCT00534495|20932146|P3|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
8494413|NCT00534495|20932147|P2|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
8494414|NCT00534495|20932148|P1|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
8494415|NCT00534495|20932146|P3|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
8494416|NCT00534495|20932147|P2|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
8494417|NCT00534495|20932148|P1|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
8494418|NCT00534495|20932146|P3|STARTED|Long Term Ext. Phase Week 24-month 21||40
8494419|NCT00534495|20932147|P2|STARTED|Long Term Ext. Phase Week 24-month 21||0
8494420|NCT00534495|20932148|P1|STARTED|Long Term Ext. Phase Week 24-month 21||0
8494421|NCT00534495|20932146|P3|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
8494422|NCT00534495|20932147|P2|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
8494423|NCT00534495|20932148|P1|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
8494424|NCT00534495|20932146|P3|COMPLETED|All Active Treatment Phase Week 4-24||0
8494425|NCT00534495|20932147|P2|COMPLETED|All Active Treatment Phase Week 4-24||25
8494426|NCT00534495|20932148|P1|COMPLETED|All Active Treatment Phase Week 4-24||32
8494427|NCT00534495|20932146|P3|STARTED|All Active Treatment Phase Week 4-24||0
8494428|NCT00534495|20932147|P2|STARTED|All Active Treatment Phase Week 4-24||34
8494429|NCT00534495|20932148|P1|STARTED|All Active Treatment Phase Week 4-24||36
8494430|NCT00534495|20932146|P3|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
8494431|NCT00534495|20932147|P2|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
8494432|NCT00534495|20932148|P1|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
8494433|NCT00534495|20932146|P3|COMPLETED|Double Blind Placebo Phase Week 0-4||0
8494434|NCT00534495|20932147|P2|COMPLETED|Double Blind Placebo Phase Week 0-4||34
8494435|NCT00534495|20932148|P1|COMPLETED|Double Blind Placebo Phase Week 0-4||36
8494436|NCT00534495|20932146|P3|STARTED|Double Blind Placebo Phase Week 0-4||0
8494437|NCT00534495|20932147|P2|STARTED|Double Blind Placebo Phase Week 0-4||35
8494438|NCT00534495|20932148|P1|STARTED|Double Blind Placebo Phase Week 0-4||36
8494439|NCT00534417|20932171|P1|NOT COMPLETED|Overall Study||0
8494440|NCT00534417|20932171|P1|COMPLETED|Overall Study||41
8494441|NCT00534417|20932171|P1|STARTED|Overall Study||41
8494442|NCT00534404|20932186|P3|NOT COMPLETED|Overall Study||242
8494443|NCT00534404|20932187|P2|NOT COMPLETED|Overall Study||143
8494444|NCT00534404|20932188|P1|NOT COMPLETED|Overall Study||180
8494445|NCT00534404|20932186|P3|COMPLETED|Overall Study||586
8494446|NCT00534404|20932187|P2|COMPLETED|Overall Study||687
8494447|NCT00534404|20932188|P1|COMPLETED|Overall Study||647
8494448|NCT00534404|20932186|P3|3-month Follow up Completed|Overall Study||593
8494449|NCT00534404|20932187|P2|3-month Follow up Completed|Overall Study||731
8494450|NCT00534404|20932188|P1|3-month Follow up Completed|Overall Study||682
8494451|NCT00534404|20932186|P3|1-month Follow up Completed|Overall Study||626
8494452|NCT00534404|20932187|P2|1-month Follow up Completed|Overall Study||781
8494453|NCT00534404|20932188|P1|1-month Follow up Completed|Overall Study||742
8494454|NCT00534404|20932186|P3|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
8494455|NCT00534404|20932187|P2|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
8494456|NCT00534404|20932188|P1|Completed at Least 1 Counseling Call|Overall Study||813
8494457|NCT00534404|20932186|P3|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
8494458|NCT00534404|20932187|P2|Completed Second NRT Order|Overall Study||789
8494459|NCT00534404|20932188|P1|Completed Second NRT Order|Overall Study||640
8494460|NCT00534404|20932186|P3|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
8494461|NCT00534404|20932187|P2|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
8494462|NCT00534404|20932188|P1|Completed First NRT Order|Overall Study||765
8494463|NCT00534404|20932186|P3|Completed at Least 1 Online Session|Overall Study||658
8494464|NCT00534404|20932187|P2|Completed at Least 1 Online Session|Overall Study||813
8494465|NCT00534404|20932188|P1|Completed at Least 1 Online Session|Overall Study||781
8494466|NCT00534404|20932186|P3|STARTED|Overall Study||828
8494467|NCT00534404|20932187|P2|STARTED|Overall Study||830
8494468|NCT00534404|20932188|P1|STARTED|Overall Study||827
8494469|NCT00534365|20932204|P2|NOT COMPLETED|Overall Study||7
8494470|NCT00534365|20932205|P1|NOT COMPLETED|Overall Study||0
8494471|NCT00534365|20932204|P2|COMPLETED|Overall Study||129
8494472|NCT00534365|20932205|P1|COMPLETED|Overall Study||127
8494473|NCT00534365|20932204|P2|Included in Intent to Treat Analysis|Overall Study||136
8494474|NCT00534365|20932205|P1|Included in Intent to Treat Analysis|Overall Study||127
8494475|NCT00534365|20932204|P2|Follow up at 12 Months or More|Overall Study||128
8494476|NCT00534365|20932205|P1|Follow up at 12 Months or More|Overall Study||119
8494477|NCT00534365|20932204|P2|Any Follow up|Overall Study||135
8494478|NCT00534365|20932205|P1|Any Follow up|Overall Study||126
8494479|NCT00534365|20932204|P2|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
8494480|NCT00534365|20932205|P1|Received Procedure|Overall Study||127
8494481|NCT00534365|20932204|P2|STARTED|Overall Study||136
8494482|NCT00534365|20932205|P1|STARTED|Overall Study||127
8494483|NCT00534352|20932219|P1|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
8494484|NCT00534352|20932219|P1|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
8494485|NCT00534352|20932219|P1|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
8494486|NCT00534352|20932219|P1|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
8494487|NCT00534352|20932219|P1|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
8494488|NCT00534352|20932219|P1|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
8494489|NCT00534352|20932219|P1|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
8494490|NCT00534352|20932219|P1|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
8494491|NCT00534352|20932219|P1|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
8494492|NCT00534352|20932219|P1|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
8494493|NCT00534352|20932219|P1|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
8494494|NCT00534352|20932219|P1|STARTED|Treatment A: TMC125 + TDF/FTC||23
8494495|NCT00534313|20932263|P4|NOT COMPLETED|Long-term Period||33
8494496|NCT00534313|20932264|P3|NOT COMPLETED|Long-term Period||43
8494497|NCT00534313|20932265|P2|NOT COMPLETED|Long-term Period||34
8494498|NCT00534313|20932266|P1|NOT COMPLETED|Long-term Period||37
8494499|NCT00534313|20932263|P4|COMPLETED|Long-term Period||0
8494500|NCT00534313|20932264|P3|COMPLETED|Long-term Period||0
8494501|NCT00534313|20932265|P2|COMPLETED|Long-term Period||0
8494502|NCT00534313|20932266|P1|COMPLETED|Long-term Period||0
8494503|NCT00534313|20932263|P4|STARTED|Long-term Period||33
8494504|NCT00534313|20932264|P3|STARTED|Long-term Period||43
8494505|NCT00534313|20932265|P2|STARTED|Long-term Period||34
8494506|NCT00534313|20932266|P1|STARTED|Long-term Period||37
8494507|NCT00534313|20932263|P4|NOT COMPLETED|Short-term Period||9
8494508|NCT00534313|20932264|P3|NOT COMPLETED|Short-term Period||2
8494509|NCT00534313|20932265|P2|NOT COMPLETED|Short-term Period||6
8494510|NCT00534313|20932266|P1|NOT COMPLETED|Short-term Period||6
8494511|NCT00534313|20932263|P4|COMPLETED|Short-term Period|Completed the short-term study|33
8494512|NCT00534313|20932264|P3|COMPLETED|Short-term Period|Completed the short-term study|43
8494513|NCT00534313|20932265|P2|COMPLETED|Short-term Period|Completed the short-term study|34
8494514|NCT00534313|20932266|P1|COMPLETED|Short-term Period|Completed the short-term study|37
8494515|NCT00534313|20932263|P4|STARTED|Short-term Period||42
8494516|NCT00534313|20932264|P3|STARTED|Short-term Period||45
8494517|NCT00534313|20932265|P2|STARTED|Short-term Period||40
8494518|NCT00534313|20932266|P1|STARTED|Short-term Period||43
8494519|NCT00534248|20932361|P2|NOT COMPLETED|Overall Study||673
8494520|NCT00534248|20932362|P1|NOT COMPLETED|Overall Study||661
8494521|NCT00534248|20932361|P2|COMPLETED|Overall Study||10555
8494522|NCT00534248|20932362|P1|COMPLETED|Overall Study||10550
8494523|NCT00534248|20932361|P2|VACCINATED|Overall Study||11210
8494524|NCT00534248|20932362|P1|VACCINATED|Overall Study||11186
8494525|NCT00534248|20932361|P2|STARTED|Overall Study||11228
8494526|NCT00534248|20932362|P1|STARTED|Overall Study||11211
8494527|NCT00534235|20932374|P2|NOT COMPLETED|Overall Study||23
8494528|NCT00534235|20932375|P1|NOT COMPLETED|Overall Study||16
8494529|NCT00534235|20932374|P2|COMPLETED|Overall Study||192
8494530|NCT00534235|20932375|P1|COMPLETED|Overall Study||91
8494531|NCT00534235|20932374|P2|STARTED|Overall Study||215
8494532|NCT00534235|20932375|P1|STARTED|Overall Study||107
8494533|NCT00534209|20932499|P1|NOT COMPLETED|Overall Study||0
8494534|NCT00534209|20932499|P1|COMPLETED|Overall Study||1
8494535|NCT00534209|20932499|P1|STARTED|Overall Study||1
8494536|NCT00534118|20932519|P2|NOT COMPLETED|Overall Study||0
8494537|NCT00534118|20932520|P1|NOT COMPLETED|Overall Study||0
8494538|NCT00534118|20932519|P2|COMPLETED|Overall Study||22
8494539|NCT00534118|20932520|P1|COMPLETED|Overall Study||17
8494540|NCT00534118|20932519|P2|STARTED|Overall Study||22
8494541|NCT00534118|20932520|P1|STARTED|Overall Study||17
8494542|NCT00534105|20932532|P2|NOT COMPLETED|Overall Study||39
8494543|NCT00534105|20932533|P1|NOT COMPLETED|Overall Study||23
8494544|NCT00534105|20932532|P2|COMPLETED|Overall Study||20
8494545|NCT00534105|20932533|P1|COMPLETED|Overall Study||24
8494546|NCT00534105|20932532|P2|STARTED|Overall Study||59
8494547|NCT00534105|20932533|P1|STARTED|Overall Study||47
8494548|NCT00534092|20932547|P2|NOT COMPLETED|Overall Study||0
8494549|NCT00534092|20932548|P1|NOT COMPLETED|Overall Study||2
8494550|NCT00534092|20932547|P2|COMPLETED|Overall Study||14
8494551|NCT00534092|20932548|P1|COMPLETED|Overall Study||53
8494552|NCT00534092|20932547|P2|STARTED|Overall Study||14
8494553|NCT00534092|20932548|P1|STARTED|Overall Study||55
8494554|NCT00534001|20932573|P2|NOT COMPLETED|Overall Study||4
8494555|NCT00534001|20932574|P1|NOT COMPLETED|Overall Study||5
8494556|NCT00534001|20932573|P2|COMPLETED|Overall Study||43
8494557|NCT00534001|20932574|P1|COMPLETED|Overall Study||43
8494558|NCT00534001|20932573|P2|STARTED|Overall Study||47
8494559|NCT00534001|20932574|P1|STARTED|Overall Study||48
8494560|NCT00533949|20932586|P4|NOT COMPLETED|Overall Study||10
8494561|NCT00533949|20932587|P3|NOT COMPLETED|Overall Study||10
8494562|NCT00533949|20932588|P2|NOT COMPLETED|Overall Study||14
8494563|NCT00533949|20932589|P1|NOT COMPLETED|Overall Study||15
8494564|NCT00533949|20932586|P4|COMPLETED|Overall Study||100
8494565|NCT00533949|20932587|P3|COMPLETED|Overall Study||137
8494566|NCT00533949|20932588|P2|COMPLETED|Overall Study||107
8494567|NCT00533949|20932589|P1|COMPLETED|Overall Study||151
8494568|NCT00533949|20932586|P4|STARTED|Overall Study||110
8494569|NCT00533949|20932587|P3|STARTED|Overall Study||147
8494570|NCT00533949|20932588|P2|STARTED|Overall Study||121
8494571|NCT00533949|20932589|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
8494572|NCT00533910|20932629|P2|NOT COMPLETED|Overall Study||0
8494573|NCT00533910|20932630|P1|NOT COMPLETED|Overall Study||0
8494574|NCT00533910|20932629|P2|COMPLETED|Overall Study||21
8494575|NCT00533910|20932630|P1|COMPLETED|Overall Study||21
8494576|NCT00533910|20932629|P2|STARTED|Overall Study||21
8494577|NCT00533910|20932630|P1|STARTED|Overall Study||21
8494578|NCT00533897|20932643|P8|NOT COMPLETED|Long Term Extension (LTE)||25
8494579|NCT00533897|20932644|P7|NOT COMPLETED|Long Term Extension (LTE)||13
8494580|NCT00533897|20932645|P6|NOT COMPLETED|Long Term Extension (LTE)||0
8494581|NCT00533897|20932646|P5|NOT COMPLETED|Long Term Extension (LTE)||0
8494582|NCT00533897|20932647|P4|NOT COMPLETED|Long Term Extension (LTE)||0
8494583|NCT00533897|20932648|P3|NOT COMPLETED|Long Term Extension (LTE)||0
8494584|NCT00533897|20932649|P2|NOT COMPLETED|Long Term Extension (LTE)||0
8494585|NCT00533897|20932650|P1|NOT COMPLETED|Long Term Extension (LTE)||0
8494586|NCT00533897|20932643|P8|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
8494587|NCT00533897|20932644|P7|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
8494588|NCT00533897|20932645|P6|COMPLETED|Long Term Extension (LTE)||0
8494589|NCT00533897|20932646|P5|COMPLETED|Long Term Extension (LTE)||0
8494590|NCT00533897|20932647|P4|COMPLETED|Long Term Extension (LTE)||0
8494591|NCT00533897|20932648|P3|COMPLETED|Long Term Extension (LTE)||0
8494592|NCT00533897|20932649|P2|COMPLETED|Long Term Extension (LTE)||0
8494593|NCT00533897|20932650|P1|COMPLETED|Long Term Extension (LTE)||0
8494594|NCT00533897|20932643|P8|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
8494595|NCT00533897|20932644|P7|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
8494596|NCT00533897|20932645|P6|STARTED|Long Term Extension (LTE)||0
8494597|NCT00533897|20932646|P5|STARTED|Long Term Extension (LTE)||0
8494598|NCT00533897|20932647|P4|STARTED|Long Term Extension (LTE)||0
8494599|NCT00533897|20932648|P3|STARTED|Long Term Extension (LTE)||0
8494600|NCT00533897|20932649|P2|STARTED|Long Term Extension (LTE)||0
8494601|NCT00533897|20932650|P1|STARTED|Long Term Extension (LTE)||0
8494602|NCT00533897|20932643|P8|NOT COMPLETED|Re-introduction (RI) Period 3||0
8494603|NCT00533897|20932644|P7|NOT COMPLETED|Re-introduction (RI) Period 3||0
8494604|NCT00533897|20932645|P6|NOT COMPLETED|Re-introduction (RI) Period 3||2
8494605|NCT00533897|20932646|P5|NOT COMPLETED|Re-introduction (RI) Period 3||0
8494606|NCT00533897|20932647|P4|NOT COMPLETED|Re-introduction (RI) Period 3||0
8494607|NCT00533897|20932648|P3|NOT COMPLETED|Re-introduction (RI) Period 3||0
8494608|NCT00533897|20932649|P2|NOT COMPLETED|Re-introduction (RI) Period 3||0
8494609|NCT00533897|20932650|P1|NOT COMPLETED|Re-introduction (RI) Period 3||0
8494610|NCT00533897|20932643|P8|COMPLETED|Re-introduction (RI) Period 3||0
8494611|NCT00533897|20932644|P7|COMPLETED|Re-introduction (RI) Period 3||0
8494612|NCT00533897|20932645|P6|COMPLETED|Re-introduction (RI) Period 3||42
8494613|NCT00533897|20932646|P5|COMPLETED|Re-introduction (RI) Period 3||35
8494614|NCT00533897|20932647|P4|COMPLETED|Re-introduction (RI) Period 3||40
8494615|NCT00533897|20932648|P3|COMPLETED|Re-introduction (RI) Period 3||0
8494616|NCT00533897|20932649|P2|COMPLETED|Re-introduction (RI) Period 3||0
8494617|NCT00533897|20932650|P1|COMPLETED|Re-introduction (RI) Period 3||0
8494618|NCT00533897|20932643|P8|STARTED|Re-introduction (RI) Period 3||0
8494619|NCT00533897|20932644|P7|STARTED|Re-introduction (RI) Period 3||0
8494620|NCT00533897|20932645|P6|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
8494621|NCT00533897|20932646|P5|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
8494622|NCT00533897|20932647|P4|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
8494623|NCT00533897|20932648|P3|STARTED|Re-introduction (RI) Period 3||0
8494624|NCT00533897|20932649|P2|STARTED|Re-introduction (RI) Period 3||0
8494625|NCT00533897|20932650|P1|STARTED|Re-introduction (RI) Period 3||0
8494626|NCT00533897|20932643|P8|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494627|NCT00533897|20932644|P7|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494628|NCT00533897|20932645|P6|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494629|NCT00533897|20932646|P5|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494630|NCT00533897|20932647|P4|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494631|NCT00533897|20932648|P3|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
8494632|NCT00533897|20932649|P2|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
8494633|NCT00533897|20932650|P1|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494634|NCT00533897|20932643|P8|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494635|NCT00533897|20932644|P7|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494636|NCT00533897|20932645|P6|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494637|NCT00533897|20932646|P5|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494638|NCT00533897|20932647|P4|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494639|NCT00533897|20932648|P3|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
8494640|NCT00533897|20932649|P2|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
8494641|NCT00533897|20932650|P1|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
8494642|NCT00533897|20932643|P8|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8494643|NCT00533897|20932644|P7|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8494644|NCT00533897|20932645|P6|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8494645|NCT00533897|20932646|P5|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8494646|NCT00533897|20932647|P4|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8494647|NCT00533897|20932648|P3|STARTED|Double-blind Withdrawal (DBW) Period 2||80
8494648|NCT00533897|20932649|P2|STARTED|Double-blind Withdrawal (DBW) Period 2||40
8494649|NCT00533897|20932650|P1|STARTED|Double-blind Withdrawal (DBW) Period 2||0
8494650|NCT00533897|20932643|P8|NOT COMPLETED|Lead-in (LI) Period 1||0
8494651|NCT00533897|20932644|P7|NOT COMPLETED|Lead-in (LI) Period 1||0
8494652|NCT00533897|20932645|P6|NOT COMPLETED|Lead-in (LI) Period 1||0
8494653|NCT00533897|20932646|P5|NOT COMPLETED|Lead-in (LI) Period 1||0
8494654|NCT00533897|20932647|P4|NOT COMPLETED|Lead-in (LI) Period 1||0
8494655|NCT00533897|20932648|P3|NOT COMPLETED|Lead-in (LI) Period 1||0
8494656|NCT00533897|20932649|P2|NOT COMPLETED|Lead-in (LI) Period 1||0
8494657|NCT00533897|20932650|P1|NOT COMPLETED|Lead-in (LI) Period 1||10
8494658|NCT00533897|20932643|P8|COMPLETED|Lead-in (LI) Period 1||0
8494659|NCT00533897|20932644|P7|COMPLETED|Lead-in (LI) Period 1||0
8494660|NCT00533897|20932645|P6|COMPLETED|Lead-in (LI) Period 1||0
8494661|NCT00533897|20932646|P5|COMPLETED|Lead-in (LI) Period 1||0
8494662|NCT00533897|20932647|P4|COMPLETED|Lead-in (LI) Period 1||0
8494663|NCT00533897|20932648|P3|COMPLETED|Lead-in (LI) Period 1||0
8494664|NCT00533897|20932649|P2|COMPLETED|Lead-in (LI) Period 1||0
8494665|NCT00533897|20932650|P1|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
8494666|NCT00533897|20932643|P8|STARTED|Lead-in (LI) Period 1||0
8494667|NCT00533897|20932644|P7|STARTED|Lead-in (LI) Period 1||0
8494668|NCT00533897|20932645|P6|STARTED|Lead-in (LI) Period 1||0
8494669|NCT00533897|20932646|P5|STARTED|Lead-in (LI) Period 1||0
8494670|NCT00533897|20932647|P4|STARTED|Lead-in (LI) Period 1||0
8494671|NCT00533897|20932648|P3|STARTED|Lead-in (LI) Period 1||0
8494672|NCT00533897|20932649|P2|STARTED|Lead-in (LI) Period 1||0
8494673|NCT00533897|20932650|P1|STARTED|Lead-in (LI) Period 1||167
8494674|NCT00533845|20932790|P2|NOT COMPLETED|Overall Study||0
8494675|NCT00533845|20932791|P1|NOT COMPLETED|Overall Study||1
8494676|NCT00533845|20932790|P2|COMPLETED|Overall Study||15
8494677|NCT00533845|20932791|P1|COMPLETED|Overall Study||14
8494678|NCT00533845|20932790|P2|STARTED|Overall Study||15
8494679|NCT00533845|20932791|P1|STARTED|Overall Study||15
8494680|NCT00533702|20932799|P2|NOT COMPLETED|Overall Study||2
8494681|NCT00533702|20932800|P1|NOT COMPLETED|Overall Study||5
8494682|NCT00533702|20932799|P2|COMPLETED|Overall Study||50
8494683|NCT00533702|20932800|P1|COMPLETED|Overall Study||49
8494684|NCT00533702|20932799|P2|Received Any Quantity of Study Drug|Overall Study||50
8494685|NCT00533702|20932800|P1|Received Any Quantity of Study Drug|Overall Study||52
8494686|NCT00533702|20932799|P2|STARTED|Overall Study||52
8494687|NCT00533702|20932800|P1|STARTED|Overall Study||54
8494688|NCT00533546|20932824|P1|NOT COMPLETED|Overall Study||0
8494689|NCT00533546|20932824|P1|COMPLETED|Overall Study||12
8494690|NCT00533546|20932824|P1|STARTED|Overall Study||12
8494691|NCT00533507|20932831|P1|NOT COMPLETED|Overall Study||1
8494692|NCT00533507|20932831|P1|COMPLETED|Overall Study||229
8494693|NCT00533507|20932831|P1|STARTED|Overall Study||230
8494694|NCT00533442|20932852|P2|NOT COMPLETED|Follow-up||10
8494695|NCT00533442|20932853|P1|NOT COMPLETED|Follow-up||9
8494696|NCT00533442|20932852|P2|COMPLETED|Follow-up||74
8494697|NCT00533442|20932853|P1|COMPLETED|Follow-up||77
8494698|NCT00533442|20932852|P2|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
8494699|NCT00533442|20932853|P1|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
8494700|NCT00533442|20932852|P2|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
8494701|NCT00533442|20932853|P1|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
8494702|NCT00533442|20932852|P2|COMPLETED|Allocation and Intent to Treat Analysis||84
8494703|NCT00533442|20932853|P1|COMPLETED|Allocation and Intent to Treat Analysis||86
8494704|NCT00533442|20932852|P2|STARTED|Allocation and Intent to Treat Analysis||84
8494705|NCT00533442|20932853|P1|STARTED|Allocation and Intent to Treat Analysis||86
8494706|NCT00533351|20932865|P2|NOT COMPLETED|Period 3||0
8494707|NCT00533351|20932866|P1|NOT COMPLETED|Period 3||0
8494708|NCT00533351|20932865|P2|COMPLETED|Period 3||0
8494709|NCT00533351|20932866|P1|COMPLETED|Period 3||3
8494710|NCT00533351|20932865|P2|STARTED|Period 3|No patients continued to Period 3|0
8494711|NCT00533351|20932866|P1|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
8494712|NCT00533351|20932865|P2|NOT COMPLETED|Period 2||0
8494713|NCT00533351|20932866|P1|NOT COMPLETED|Period 2||0
8494714|NCT00533351|20932865|P2|COMPLETED|Period 2||1
8494715|NCT00533351|20932866|P1|COMPLETED|Period 2||5
8494716|NCT00533351|20932865|P2|STARTED|Period 2||1
8494717|NCT00533351|20932866|P1|STARTED|Period 2||5
8494718|NCT00533351|20932865|P2|NOT COMPLETED|Period 1||1
8494719|NCT00533351|20932866|P1|NOT COMPLETED|Period 1||2
8494720|NCT00533351|20932865|P2|COMPLETED|Period 1||1
8494721|NCT00533351|20932866|P1|COMPLETED|Period 1||5
8494722|NCT00533351|20932865|P2|STARTED|Period 1||2
8494723|NCT00533351|20932866|P1|STARTED|Period 1||7
8494724|NCT00533273|20932876|P2|NOT COMPLETED|Open-label||0
8494725|NCT00533273|20932877|P1|NOT COMPLETED|Open-label||6
8494726|NCT00533273|20932876|P2|COMPLETED|Open-label||0
8494727|NCT00533273|20932877|P1|COMPLETED|Open-label||58
8494728|NCT00533273|20932876|P2|STARTED|Open-label|no placebo - this phase was open label|0
8494729|NCT00533273|20932877|P1|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
8494730|NCT00533273|20932876|P2|NOT COMPLETED|Double-blind||2
8494731|NCT00533273|20932877|P1|NOT COMPLETED|Double-blind||0
8494732|NCT00533273|20932876|P2|COMPLETED|Double-blind||19
8494733|NCT00533273|20932877|P1|COMPLETED|Double-blind||45
8494734|NCT00533273|20932876|P2|STARTED|Double-blind||21
8494735|NCT00533273|20932877|P1|STARTED|Double-blind||45
8494736|NCT00533117|20932912|P4|NOT COMPLETED|Overall Study||5
8494737|NCT00533117|20932913|P3|NOT COMPLETED|Overall Study||6
8494738|NCT00533117|20932914|P2|NOT COMPLETED|Overall Study||5
8494739|NCT00533117|20932915|P1|NOT COMPLETED|Overall Study||4
8494740|NCT00533117|20932912|P4|COMPLETED|Overall Study||13
8494741|NCT00533117|20932913|P3|COMPLETED|Overall Study||14
8494742|NCT00533117|20932914|P2|COMPLETED|Overall Study||14
8494743|NCT00533117|20932915|P1|COMPLETED|Overall Study||14
8494744|NCT00533117|20932912|P4|STARTED|Overall Study||18
8494745|NCT00533117|20932913|P3|STARTED|Overall Study||20
8494746|NCT00533117|20932914|P2|STARTED|Overall Study||19
8494747|NCT00533117|20932915|P1|STARTED|Overall Study||18
8494748|NCT00532948|20932928|P3|NOT COMPLETED|Overall Study||4
8494749|NCT00532948|20932929|P2|NOT COMPLETED|Overall Study||5
8494750|NCT00532948|20932930|P1|NOT COMPLETED|Overall Study||4
8494751|NCT00532948|20932928|P3|COMPLETED|Overall Study||2
8494752|NCT00532948|20932929|P2|COMPLETED|Overall Study||9
8494753|NCT00532948|20932930|P1|COMPLETED|Overall Study||0
8494754|NCT00532948|20932928|P3|STARTED|Overall Study||6
8494755|NCT00532948|20932929|P2|STARTED|Overall Study||14
8494756|NCT00532948|20932930|P1|STARTED|Overall Study||4
8494757|NCT00532935|20932962|P2|NOT COMPLETED|Overall Study||52
8494758|NCT00532935|20932963|P1|NOT COMPLETED|Overall Study||51
8494759|NCT00532935|20932962|P2|COMPLETED|Overall Study||204
8494760|NCT00532935|20932963|P1|COMPLETED|Overall Study||210
8494761|NCT00532935|20932962|P2|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
8494762|NCT00532935|20932963|P1|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
8494763|NCT00532883|20932981|P4|NOT COMPLETED|Overall Study||5
8494764|NCT00532883|20932982|P3|NOT COMPLETED|Overall Study||4
8494765|NCT00532883|20932983|P2|NOT COMPLETED|Overall Study||7
8494766|NCT00532883|20932984|P1|NOT COMPLETED|Overall Study||6
8494767|NCT00532883|20932981|P4|COMPLETED|Overall Study|Study terminated early.|6
8494768|NCT00532883|20932982|P3|COMPLETED|Overall Study|Study terminated early.|6
8494769|NCT00532883|20932983|P2|COMPLETED|Overall Study|Study terminated early.|5
8494770|NCT00532883|20932984|P1|COMPLETED|Overall Study|Study terminated early.|5
8494771|NCT00532883|20932981|P4|STARTED|Overall Study||11
8494772|NCT00532883|20932982|P3|STARTED|Overall Study||10
8494773|NCT00532883|20932983|P2|STARTED|Overall Study||12
8494774|NCT00532883|20932984|P1|STARTED|Overall Study||11
8494775|NCT00532779|20932997|P3|NOT COMPLETED|Overall Study||291
8494776|NCT00532779|20932998|P2|NOT COMPLETED|Overall Study||287
8494777|NCT00532779|20932999|P1|NOT COMPLETED|Overall Study||294
8494778|NCT00532779|20932997|P3|COMPLETED|Overall Study||290
8494779|NCT00532779|20932998|P2|COMPLETED|Overall Study||296
8494780|NCT00532779|20932999|P1|COMPLETED|Overall Study||284
8494781|NCT00532779|20932997|P3|STARTED|Overall Study||581
8494782|NCT00532779|20932998|P2|STARTED|Overall Study||583
8494783|NCT00532779|20932999|P1|STARTED|Overall Study||578
8494784|NCT00532493|20933060|P2|NOT COMPLETED|Overall Study||29
8494785|NCT00532493|20933061|P1|NOT COMPLETED|Overall Study||30
8494786|NCT00532493|20933060|P2|COMPLETED|Overall Study||123
8494787|NCT00532493|20933061|P1|COMPLETED|Overall Study||122
8494788|NCT00532493|20933060|P2|STARTED|Overall Study||152
8494789|NCT00532493|20933061|P1|STARTED|Overall Study||152
8494790|NCT00532480|20933091|P1|NOT COMPLETED|Overall Study||3
8494791|NCT00532480|20933091|P1|COMPLETED|Overall Study||7
8494792|NCT00532480|20933091|P1|STARTED|Overall Study||10
8494793|NCT00532441|20933095|P2|NOT COMPLETED|Overall Study||0
8494794|NCT00532441|20933096|P1|NOT COMPLETED|Overall Study||1
8494795|NCT00532441|20933095|P2|COMPLETED|Overall Study||11
8494796|NCT00532441|20933096|P1|COMPLETED|Overall Study||13
8494797|NCT00532441|20933095|P2|STARTED|Overall Study||11
8494798|NCT00532441|20933096|P1|STARTED|Overall Study||14
8494799|NCT00532298|20933111|P6|NOT COMPLETED|Overall Study||2
8494800|NCT00532298|20933112|P5|NOT COMPLETED|Overall Study||1
8494801|NCT00532298|20933113|P4|NOT COMPLETED|Overall Study||0
8494802|NCT00532298|20933114|P3|NOT COMPLETED|Overall Study||1
8494803|NCT00532298|20933115|P2|NOT COMPLETED|Overall Study||1
8494804|NCT00532298|20933116|P1|NOT COMPLETED|Overall Study||2
8494805|NCT00532298|20933111|P6|COMPLETED|Overall Study||261
8494806|NCT00532298|20933112|P5|COMPLETED|Overall Study||267
8494807|NCT00532298|20933113|P4|COMPLETED|Overall Study||264
8494808|NCT00532298|20933114|P3|COMPLETED|Overall Study||263
8494809|NCT00532298|20933115|P2|COMPLETED|Overall Study||265
8494810|NCT00532298|20933116|P1|COMPLETED|Overall Study||267
8494811|NCT00532298|20933111|P6|STARTED|Overall Study||263
8494812|NCT00532298|20933112|P5|STARTED|Overall Study||268
8494813|NCT00532298|20933113|P4|STARTED|Overall Study||264
8494814|NCT00532298|20933114|P3|STARTED|Overall Study||264
8494815|NCT00532298|20933115|P2|STARTED|Overall Study||266
8494816|NCT00532298|20933116|P1|STARTED|Overall Study||269
8494817|NCT00532259|20933196|P1|NOT COMPLETED|Overall Study||32
8494818|NCT00532259|20933196|P1|COMPLETED|Overall Study||40
8494819|NCT00532259|20933196|P1|STARTED|Overall Study||72
8494820|NCT00532155|20933203|P2|NOT COMPLETED|Overall Study||456
8494821|NCT00532155|20933204|P1|NOT COMPLETED|Overall Study||457
8494822|NCT00532155|20933203|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
8494823|NCT00532155|20933204|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
8494824|NCT00532155|20933203|P2|SAFETY POPULATION|Overall Study||450
8494825|NCT00532155|20933204|P1|SAFETY POPULATION|Overall Study||455
8494826|NCT00532155|20933203|P2|STARTED|Overall Study||456
8494827|NCT00532155|20933204|P1|STARTED|Overall Study||457
8494828|NCT00532129|20933218|P1|NOT COMPLETED|Follow-up Period||65
8494829|NCT00532129|20933218|P1|COMPLETED|Follow-up Period||33
8494830|NCT00532129|20933218|P1|STARTED|Follow-up Period||98
8494831|NCT00532129|20933218|P1|NOT COMPLETED|Treatment Period||49
8494832|NCT00532129|20933218|P1|COMPLETED|Treatment Period||51
8494833|NCT00532129|20933218|P1|STARTED|Treatment Period||100
8494834|NCT00531960|20933238|P2|NOT COMPLETED|Overall Study||63
8494835|NCT00531960|20933239|P1|NOT COMPLETED|Overall Study||61
8494836|NCT00531960|20933238|P2|COMPLETED|Overall Study||0
8494837|NCT00531960|20933239|P1|COMPLETED|Overall Study||0
8494838|NCT00531960|20933238|P2|STARTED|Overall Study||63
8494839|NCT00531960|20933239|P1|STARTED|Overall Study||61
8494840|NCT00531947|20933257|P2|NOT COMPLETED|Overall Study||51
8494841|NCT00531947|20933258|P1|NOT COMPLETED|Overall Study||42
8494842|NCT00531947|20933257|P2|COMPLETED|Overall Study||101
8494843|NCT00531947|20933258|P1|COMPLETED|Overall Study||114
8494844|NCT00531947|20933257|P2|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
8494845|NCT00531947|20933258|P1|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
8494846|NCT00531934|20933302|P2|NOT COMPLETED|Overall Study||63
8494847|NCT00531934|20933303|P1|NOT COMPLETED|Overall Study||66
8494848|NCT00531934|20933302|P2|COMPLETED|Overall Study||11
8494849|NCT00531934|20933303|P1|COMPLETED|Overall Study||7
8494850|NCT00531934|20933302|P2|STARTED|Overall Study||74
8494851|NCT00531934|20933303|P1|STARTED|Overall Study||73
8494852|NCT00531882|20933374|P3|NOT COMPLETED|Overall Study||0
8494853|NCT00531882|20933375|P2|NOT COMPLETED|Overall Study||0
8494854|NCT00531882|20933376|P1|NOT COMPLETED|Overall Study||0
8494855|NCT00531882|20933374|P3|COMPLETED|Overall Study||5
8494856|NCT00531882|20933375|P2|COMPLETED|Overall Study||10
8494857|NCT00531882|20933376|P1|COMPLETED|Overall Study||10
8494858|NCT00531882|20933374|P3|STARTED|Overall Study||5
8494859|NCT00531882|20933375|P2|STARTED|Overall Study||10
8494860|NCT00531882|20933376|P1|STARTED|Overall Study||10
8494861|NCT00531843|20933386|P2|NOT COMPLETED|Overall Study||0
8494862|NCT00531843|20933387|P1|NOT COMPLETED|Overall Study||0
8494863|NCT00531843|20933386|P2|COMPLETED|Overall Study||6
8494864|NCT00531843|20933387|P1|COMPLETED|Overall Study||81
8494865|NCT00531843|20933386|P2|STARTED|Overall Study||6
8494866|NCT00531843|20933387|P1|STARTED|Overall Study||81
8494867|NCT00531817|20933399|P2|NOT COMPLETED|Entered Extended Treatment Period||57
8494868|NCT00531817|20933400|P1|NOT COMPLETED|Entered Extended Treatment Period||137
8494869|NCT00531817|20933399|P2|COMPLETED|Entered Extended Treatment Period||113
8494870|NCT00531817|20933400|P1|COMPLETED|Entered Extended Treatment Period||206
8494871|NCT00531817|20933399|P2|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|170
8494872|NCT00531817|20933400|P1|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|343
8494873|NCT00531817|20933399|P2|NOT COMPLETED|Randomized||34
8494874|NCT00531817|20933400|P1|NOT COMPLETED|Randomized||59
8494875|NCT00531817|20933399|P2|COMPLETED|Randomized||173
8494876|NCT00531817|20933400|P1|COMPLETED|Randomized||353
8494877|NCT00531817|20933399|P2|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
8494960|NCT00531284|20933607|P16|NOT COMPLETED|Overall Study||12
8494878|NCT00531817|20933400|P1|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
8494879|NCT00531817|20933399|P2|STARTED|Randomized||207
8494880|NCT00531817|20933400|P1|STARTED|Randomized||412
8494881|NCT00531752|20933431|P4|NOT COMPLETED|Second Double-blind Intervention Period||2
8494882|NCT00531752|20933432|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
8494883|NCT00531752|20933433|P2|NOT COMPLETED|Second Double-blind Intervention Period||2
8494884|NCT00531752|20933434|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
8494885|NCT00531752|20933431|P4|COMPLETED|Second Double-blind Intervention Period||11
8494886|NCT00531752|20933432|P3|COMPLETED|Second Double-blind Intervention Period||9
8494887|NCT00531752|20933433|P2|COMPLETED|Second Double-blind Intervention Period||11
8494888|NCT00531752|20933434|P1|COMPLETED|Second Double-blind Intervention Period||9
8494889|NCT00531752|20933431|P4|STARTED|Second Double-blind Intervention Period||13
8494890|NCT00531752|20933432|P3|STARTED|Second Double-blind Intervention Period||9
8494891|NCT00531752|20933433|P2|STARTED|Second Double-blind Intervention Period||13
8494892|NCT00531752|20933434|P1|STARTED|Second Double-blind Intervention Period||11
8494893|NCT00531752|20933431|P4|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8494894|NCT00531752|20933432|P3|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8494895|NCT00531752|20933433|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8494896|NCT00531752|20933434|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
8494897|NCT00531752|20933431|P4|COMPLETED|Wash-out Period (at Least 7 Days)||13
8494898|NCT00531752|20933432|P3|COMPLETED|Wash-out Period (at Least 7 Days)||9
8494899|NCT00531752|20933433|P2|COMPLETED|Wash-out Period (at Least 7 Days)||13
8494900|NCT00531752|20933434|P1|COMPLETED|Wash-out Period (at Least 7 Days)||11
8494901|NCT00531752|20933431|P4|STARTED|Wash-out Period (at Least 7 Days)||13
8494902|NCT00531752|20933432|P3|STARTED|Wash-out Period (at Least 7 Days)||9
8494903|NCT00531752|20933433|P2|STARTED|Wash-out Period (at Least 7 Days)||13
8494904|NCT00531752|20933434|P1|STARTED|Wash-out Period (at Least 7 Days)||11
8494905|NCT00531752|20933431|P4|NOT COMPLETED|First Double-blind Intervention Period||3
8494906|NCT00531752|20933432|P3|NOT COMPLETED|First Double-blind Intervention Period||7
8494907|NCT00531752|20933433|P2|NOT COMPLETED|First Double-blind Intervention Period||4
8494908|NCT00531752|20933434|P1|NOT COMPLETED|First Double-blind Intervention Period||6
8494909|NCT00531752|20933431|P4|COMPLETED|First Double-blind Intervention Period||13
8494910|NCT00531752|20933432|P3|COMPLETED|First Double-blind Intervention Period||9
8494911|NCT00531752|20933433|P2|COMPLETED|First Double-blind Intervention Period||13
8494912|NCT00531752|20933434|P1|COMPLETED|First Double-blind Intervention Period||11
8494913|NCT00531752|20933431|P4|Treated|First Double-blind Intervention Period||16
8494914|NCT00531752|20933432|P3|Treated|First Double-blind Intervention Period||16
8494915|NCT00531752|20933433|P2|Treated|First Double-blind Intervention Period||17
8494916|NCT00531752|20933434|P1|Treated|First Double-blind Intervention Period||16
8494917|NCT00531752|20933431|P4|STARTED|First Double-blind Intervention Period||16
8494918|NCT00531752|20933432|P3|STARTED|First Double-blind Intervention Period||16
8494919|NCT00531752|20933433|P2|STARTED|First Double-blind Intervention Period||17
8494920|NCT00531752|20933434|P1|STARTED|First Double-blind Intervention Period||17
8494921|NCT00531661|20933513|P2|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
8494922|NCT00531661|20933514|P1|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
8494923|NCT00531661|20933513|P2|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
8494924|NCT00531661|20933514|P1|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
8494925|NCT00531661|20933513|P2|STARTED|Study Duration: 15 Months Avg. Follow-up||254
8494926|NCT00531661|20933514|P1|STARTED|Study Duration: 15 Months Avg. Follow-up||244
8494927|NCT00531661|20933513|P2|NOT COMPLETED|6 Months||26
8494928|NCT00531661|20933514|P1|NOT COMPLETED|6 Months||26
8494929|NCT00531661|20933513|P2|COMPLETED|6 Months||254
8494930|NCT00531661|20933514|P1|COMPLETED|6 Months||244
8494931|NCT00531661|20933513|P2|STARTED|6 Months||280
8494932|NCT00531661|20933514|P1|STARTED|6 Months||270
8494933|NCT00531518|20933536|P2|NOT COMPLETED|Overall Study||71
8494934|NCT00531518|20933537|P1|NOT COMPLETED|Overall Study||32
8494935|NCT00531518|20933536|P2|COMPLETED|Overall Study||134
8494936|NCT00531518|20933537|P1|COMPLETED|Overall Study||55
8494937|NCT00531518|20933536|P2|STARTED|Overall Study||205
8494938|NCT00531518|20933537|P1|STARTED|Overall Study||87
8494939|NCT00531479|20933545|P2|NOT COMPLETED|Overall Study||83
8494940|NCT00531479|20933546|P1|NOT COMPLETED|Overall Study||76
8494941|NCT00531479|20933545|P2|COMPLETED|Overall Study||146
8494942|NCT00531479|20933546|P1|COMPLETED|Overall Study||154
8494943|NCT00531479|20933545|P2|Treated|Overall Study||226
8494944|NCT00531479|20933546|P1|Treated|Overall Study||228
8494945|NCT00531479|20933545|P2|STARTED|Overall Study||229
8494946|NCT00531479|20933546|P1|STARTED|Overall Study||230
8494947|NCT00531453|20933566|P2|NOT COMPLETED|Overall Study||0
8494948|NCT00531453|20933567|P1|NOT COMPLETED|Overall Study||0
8494949|NCT00531453|20933566|P2|COMPLETED|Overall Study|10 April 2009|49
8494950|NCT00531453|20933567|P1|COMPLETED|Overall Study|10 April 2009|49
8494951|NCT00531453|20933566|P2|STARTED|Overall Study|02 October 2007|49
8494952|NCT00531453|20933567|P1|STARTED|Overall Study|02 October 2007|49
8494953|NCT00531427|20933577|P2|NOT COMPLETED|Overall Study||94
8494954|NCT00531427|20933578|P1|NOT COMPLETED|Overall Study||73
8494955|NCT00531427|20933577|P2|COMPLETED|Overall Study||191
8494956|NCT00531427|20933578|P1|COMPLETED|Overall Study||209
8494957|NCT00531427|20933577|P2|STARTED|Overall Study||285
8494958|NCT00531427|20933578|P1|STARTED|Overall Study||282
8494959|NCT00531284|20933606|P17|NOT COMPLETED|Overall Study||8
8494961|NCT00531284|20933608|P15|NOT COMPLETED|Overall Study||4
8494962|NCT00531284|20933609|P14|NOT COMPLETED|Overall Study||3
8494963|NCT00531284|20933610|P13|NOT COMPLETED|Overall Study||2
8494964|NCT00531284|20933611|P12|NOT COMPLETED|Overall Study||24
8494965|NCT00531284|20933612|P11|NOT COMPLETED|Overall Study||3
8494966|NCT00531284|20933613|P10|NOT COMPLETED|Overall Study||4
8494967|NCT00531284|20933614|P9|NOT COMPLETED|Overall Study||11
8494968|NCT00531284|20933615|P8|NOT COMPLETED|Overall Study||10
8494969|NCT00531284|20933616|P7|NOT COMPLETED|Overall Study||6
8494970|NCT00531284|20933617|P6|NOT COMPLETED|Overall Study||7
8494971|NCT00531284|20933618|P5|NOT COMPLETED|Overall Study||6
8494972|NCT00531284|20933619|P4|NOT COMPLETED|Overall Study||63
8494973|NCT00531284|20933620|P3|NOT COMPLETED|Overall Study||6
8494974|NCT00531284|20933621|P2|NOT COMPLETED|Overall Study||4
8494975|NCT00531284|20933622|P1|NOT COMPLETED|Overall Study||3
8494976|NCT00531284|20933606|P17|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494977|NCT00531284|20933607|P16|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
8494978|NCT00531284|20933608|P15|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
8494979|NCT00531284|20933609|P14|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494980|NCT00531284|20933610|P13|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494981|NCT00531284|20933611|P12|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494982|NCT00531284|20933612|P11|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494983|NCT00531284|20933613|P10|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494984|NCT00531284|20933614|P9|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494985|NCT00531284|20933615|P8|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494986|NCT00531284|20933616|P7|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494987|NCT00531284|20933617|P6|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494988|NCT00531284|20933618|P5|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
8494989|NCT00531284|20933619|P4|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
8494990|NCT00531284|20933620|P3|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
8494991|NCT00531284|20933621|P2|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
8494992|NCT00531284|20933622|P1|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
8494993|NCT00531284|20933606|P17|STARTED|Overall Study||8
8494994|NCT00531284|20933607|P16|STARTED|Overall Study||14
8494995|NCT00531284|20933608|P15|STARTED|Overall Study||7
8494996|NCT00531284|20933609|P14|STARTED|Overall Study||3
8494997|NCT00531284|20933610|P13|STARTED|Overall Study||2
8494998|NCT00531284|20933611|P12|STARTED|Overall Study||24
8494999|NCT00531284|20933612|P11|STARTED|Overall Study||3
8495000|NCT00531284|20933613|P10|STARTED|Overall Study||4
8495001|NCT00531284|20933614|P9|STARTED|Overall Study||11
8495002|NCT00531284|20933615|P8|STARTED|Overall Study||10
8495003|NCT00531284|20933616|P7|STARTED|Overall Study||6
8495004|NCT00531284|20933617|P6|STARTED|Overall Study||7
8495005|NCT00531284|20933618|P5|STARTED|Overall Study||6
8495006|NCT00531284|20933619|P4|STARTED|Overall Study||65
8495007|NCT00531284|20933620|P3|STARTED|Overall Study||7
8495008|NCT00531284|20933621|P2|STARTED|Overall Study||4
8495009|NCT00531284|20933622|P1|STARTED|Overall Study||3
8495010|NCT00531206|20933772|P1|NOT COMPLETED|Overall Study||20
8495011|NCT00531206|20933772|P1|COMPLETED|Overall Study||45
8495012|NCT00531206|20933772|P1|STARTED|Overall Study||65
8495013|NCT00531050|20933802|P6|NOT COMPLETED|Part 2: Period 3||1
8495014|NCT00531050|20933803|P5|NOT COMPLETED|Part 2: Period 3||0
8495015|NCT00531050|20933804|P4|NOT COMPLETED|Part 2: Period 3||0
8495016|NCT00531050|20933805|P3|NOT COMPLETED|Part 2: Period 3||0
8495017|NCT00531050|20933806|P2|NOT COMPLETED|Part 2: Period 3||0
8495018|NCT00531050|20933807|P1|NOT COMPLETED|Part 2: Period 3||1
8495019|NCT00531050|20933802|P6|COMPLETED|Part 2: Period 3||3
8495020|NCT00531050|20933803|P5|COMPLETED|Part 2: Period 3||4
8495021|NCT00531050|20933804|P4|COMPLETED|Part 2: Period 3||4
8495022|NCT00531050|20933805|P3|COMPLETED|Part 2: Period 3||4
8495023|NCT00531050|20933806|P2|COMPLETED|Part 2: Period 3||4
8495024|NCT00531050|20933807|P1|COMPLETED|Part 2: Period 3||2
8495025|NCT00531050|20933802|P6|STARTED|Part 2: Period 3||4
8495026|NCT00531050|20933803|P5|STARTED|Part 2: Period 3||4
8495027|NCT00531050|20933804|P4|STARTED|Part 2: Period 3||4
8495028|NCT00531050|20933805|P3|STARTED|Part 2: Period 3||4
8495029|NCT00531050|20933806|P2|STARTED|Part 2: Period 3||4
8495030|NCT00531050|20933807|P1|STARTED|Part 2: Period 3||3
8495031|NCT00531050|20933802|P6|NOT COMPLETED|Part 2: Period 2||0
8495032|NCT00531050|20933803|P5|NOT COMPLETED|Part 2: Period 2||0
8495033|NCT00531050|20933804|P4|NOT COMPLETED|Part 2: Period 2||0
8495034|NCT00531050|20933805|P3|NOT COMPLETED|Part 2: Period 2||0
8495035|NCT00531050|20933806|P2|NOT COMPLETED|Part 2: Period 2||0
8495036|NCT00531050|20933807|P1|NOT COMPLETED|Part 2: Period 2||0
8495037|NCT00531050|20933802|P6|COMPLETED|Part 2: Period 2||4
8495038|NCT00531050|20933803|P5|COMPLETED|Part 2: Period 2||4
8495039|NCT00531050|20933804|P4|COMPLETED|Part 2: Period 2||4
8495040|NCT00531050|20933805|P3|COMPLETED|Part 2: Period 2||4
8495041|NCT00531050|20933806|P2|COMPLETED|Part 2: Period 2||4
8495042|NCT00531050|20933807|P1|COMPLETED|Part 2: Period 2||3
8495043|NCT00531050|20933802|P6|STARTED|Part 2: Period 2||4
8495044|NCT00531050|20933803|P5|STARTED|Part 2: Period 2||4
8495045|NCT00531050|20933804|P4|STARTED|Part 2: Period 2||4
8495046|NCT00531050|20933805|P3|STARTED|Part 2: Period 2||4
8495047|NCT00531050|20933806|P2|STARTED|Part 2: Period 2||4
8495048|NCT00531050|20933807|P1|STARTED|Part 2: Period 2||3
8495049|NCT00531050|20933802|P6|NOT COMPLETED|Part 2: Period 1||1
8495050|NCT00531050|20933803|P5|NOT COMPLETED|Part 2: Period 1||0
8495051|NCT00531050|20933804|P4|NOT COMPLETED|Part 2: Period 1||0
8495052|NCT00531050|20933805|P3|NOT COMPLETED|Part 2: Period 1||0
8495053|NCT00531050|20933806|P2|NOT COMPLETED|Part 2: Period 1||0
8495054|NCT00531050|20933807|P1|NOT COMPLETED|Part 2: Period 1||0
8495055|NCT00531050|20933802|P6|COMPLETED|Part 2: Period 1||4
8495056|NCT00531050|20933803|P5|COMPLETED|Part 2: Period 1||4
8495057|NCT00531050|20933804|P4|COMPLETED|Part 2: Period 1||4
8495058|NCT00531050|20933805|P3|COMPLETED|Part 2: Period 1||4
8495059|NCT00531050|20933806|P2|COMPLETED|Part 2: Period 1||4
8495060|NCT00531050|20933807|P1|COMPLETED|Part 2: Period 1||3
8495061|NCT00531050|20933802|P6|STARTED|Part 2: Period 1||5
8495062|NCT00531050|20933803|P5|STARTED|Part 2: Period 1||4
8495063|NCT00531050|20933804|P4|STARTED|Part 2: Period 1||4
8495064|NCT00531050|20933805|P3|STARTED|Part 2: Period 1||4
8495065|NCT00531050|20933806|P2|STARTED|Part 2: Period 1||4
8495066|NCT00531050|20933807|P1|STARTED|Part 2: Period 1||3
8495067|NCT00531050|20933802|P6|NOT COMPLETED|Part 1: Period 3||0
8495068|NCT00531050|20933803|P5|NOT COMPLETED|Part 1: Period 3||0
8495069|NCT00531050|20933804|P4|NOT COMPLETED|Part 1: Period 3||0
8495070|NCT00531050|20933805|P3|NOT COMPLETED|Part 1: Period 3||0
8495071|NCT00531050|20933806|P2|NOT COMPLETED|Part 1: Period 3||0
8495072|NCT00531050|20933807|P1|NOT COMPLETED|Part 1: Period 3||1
8495073|NCT00531050|20933802|P6|COMPLETED|Part 1: Period 3||5
8495074|NCT00531050|20933803|P5|COMPLETED|Part 1: Period 3||4
8495075|NCT00531050|20933804|P4|COMPLETED|Part 1: Period 3||4
8495076|NCT00531050|20933805|P3|COMPLETED|Part 1: Period 3||4
8495077|NCT00531050|20933806|P2|COMPLETED|Part 1: Period 3||4
8495078|NCT00531050|20933807|P1|COMPLETED|Part 1: Period 3||3
8495079|NCT00531050|20933802|P6|STARTED|Part 1: Period 3||5
8495080|NCT00531050|20933803|P5|STARTED|Part 1: Period 3||4
8495081|NCT00531050|20933804|P4|STARTED|Part 1: Period 3||4
8495082|NCT00531050|20933805|P3|STARTED|Part 1: Period 3||4
8495083|NCT00531050|20933806|P2|STARTED|Part 1: Period 3||4
8495084|NCT00531050|20933807|P1|STARTED|Part 1: Period 3||4
8495085|NCT00531050|20933802|P6|NOT COMPLETED|Part 1: Period 2||0
8495086|NCT00531050|20933803|P5|NOT COMPLETED|Part 1: Period 2||0
8495087|NCT00531050|20933804|P4|NOT COMPLETED|Part 1: Period 2||0
8495088|NCT00531050|20933805|P3|NOT COMPLETED|Part 1: Period 2||0
8495089|NCT00531050|20933806|P2|NOT COMPLETED|Part 1: Period 2||0
8495090|NCT00531050|20933807|P1|NOT COMPLETED|Part 1: Period 2||0
8495091|NCT00531050|20933802|P6|COMPLETED|Part 1: Period 2||5
8495092|NCT00531050|20933803|P5|COMPLETED|Part 1: Period 2||4
8495093|NCT00531050|20933804|P4|COMPLETED|Part 1: Period 2||4
8495094|NCT00531050|20933805|P3|COMPLETED|Part 1: Period 2||4
8495095|NCT00531050|20933806|P2|COMPLETED|Part 1: Period 2||4
8495096|NCT00531050|20933807|P1|COMPLETED|Part 1: Period 2||4
8495097|NCT00531050|20933802|P6|STARTED|Part 1: Period 2||5
8495098|NCT00531050|20933803|P5|STARTED|Part 1: Period 2||4
8495099|NCT00531050|20933804|P4|STARTED|Part 1: Period 2||4
8495100|NCT00531050|20933805|P3|STARTED|Part 1: Period 2||4
8495101|NCT00531050|20933806|P2|STARTED|Part 1: Period 2||4
8495102|NCT00531050|20933807|P1|STARTED|Part 1: Period 2||4
8495103|NCT00531050|20933802|P6|NOT COMPLETED|Part 1: Period 1||0
8495104|NCT00531050|20933803|P5|NOT COMPLETED|Part 1: Period 1||0
8495105|NCT00531050|20933804|P4|NOT COMPLETED|Part 1: Period 1||1
8495106|NCT00531050|20933805|P3|NOT COMPLETED|Part 1: Period 1||0
8495107|NCT00531050|20933806|P2|NOT COMPLETED|Part 1: Period 1||1
8495108|NCT00531050|20933807|P1|NOT COMPLETED|Part 1: Period 1||0
8495109|NCT00531050|20933802|P6|COMPLETED|Part 1: Period 1||5
8495110|NCT00531050|20933803|P5|COMPLETED|Part 1: Period 1||4
8495111|NCT00531050|20933804|P4|COMPLETED|Part 1: Period 1||4
8495112|NCT00531050|20933805|P3|COMPLETED|Part 1: Period 1||4
8495113|NCT00531050|20933806|P2|COMPLETED|Part 1: Period 1||4
8495114|NCT00531050|20933807|P1|COMPLETED|Part 1: Period 1||4
8495115|NCT00531050|20933802|P6|STARTED|Part 1: Period 1||5
8495116|NCT00531050|20933803|P5|STARTED|Part 1: Period 1||4
8495117|NCT00531050|20933804|P4|STARTED|Part 1: Period 1||5
8495118|NCT00531050|20933805|P3|STARTED|Part 1: Period 1||4
8495119|NCT00531050|20933806|P2|STARTED|Part 1: Period 1||5
8495120|NCT00531050|20933807|P1|STARTED|Part 1: Period 1||4
8495121|NCT00531011|20933836|P2|NOT COMPLETED|Overall Study||7
8495122|NCT00531011|20933837|P1|NOT COMPLETED|Overall Study||4
8495123|NCT00531011|20933836|P2|COMPLETED|Overall Study||90
8495124|NCT00531011|20933837|P1|COMPLETED|Overall Study||99
8495125|NCT00531011|20933836|P2|STARTED|Overall Study||97
8495126|NCT00531011|20933837|P1|STARTED|Overall Study||103
8495127|NCT00530920|20933882|P3|NOT COMPLETED|Overall Study||4
8495128|NCT00530920|20933883|P2|NOT COMPLETED|Overall Study||2
8495129|NCT00530920|20933884|P1|NOT COMPLETED|Overall Study||0
8495130|NCT00530920|20933882|P3|COMPLETED|Overall Study||24
8495131|NCT00530920|20933883|P2|COMPLETED|Overall Study||25
8495132|NCT00530920|20933884|P1|COMPLETED|Overall Study||30
8495133|NCT00530920|20933882|P3|STARTED|Overall Study||28
8495134|NCT00530920|20933883|P2|STARTED|Overall Study||27
8495135|NCT00530920|20933884|P1|STARTED|Overall Study||30
8495136|NCT00530894|20933944|P4|NOT COMPLETED|Overall Study||94
8495137|NCT00530894|20933945|P3|NOT COMPLETED|Overall Study||55
8495138|NCT00530894|20933946|P2|NOT COMPLETED|Overall Study||115
8495139|NCT00530894|20933947|P1|NOT COMPLETED|Overall Study||88
8495140|NCT00530894|20933944|P4|COMPLETED|Overall Study||85
8495141|NCT00530894|20933945|P3|COMPLETED|Overall Study||124
8495142|NCT00530894|20933946|P2|COMPLETED|Overall Study||236
8495143|NCT00530894|20933947|P1|COMPLETED|Overall Study||260
8495144|NCT00530894|20933944|P4|STARTED|Overall Study||179
8495145|NCT00530894|20933945|P3|STARTED|Overall Study||179
8495146|NCT00530894|20933946|P2|STARTED|Overall Study||351
8495147|NCT00530894|20933947|P1|STARTED|Overall Study||348
8495148|NCT00530855|20933975|P1|NOT COMPLETED|Overall Study||112
8495149|NCT00530855|20933975|P1|COMPLETED|Overall Study||210
8495150|NCT00530855|20933975|P1|STARTED|Overall Study||322
8495151|NCT00530842|20933984|P2|NOT COMPLETED|Period 2||9
8495152|NCT00530842|20933985|P1|NOT COMPLETED|Period 2||8
8495153|NCT00530842|20933984|P2|COMPLETED|Period 2||151
8495154|NCT00530842|20933985|P1|COMPLETED|Period 2||149
8495155|NCT00530842|20933984|P2|STARTED|Period 2||160
8495156|NCT00530842|20933985|P1|STARTED|Period 2||157
8495157|NCT00530842|20933984|P2|NOT COMPLETED|Period 1||11
8495158|NCT00530842|20933985|P1|NOT COMPLETED|Period 1||14
8495159|NCT00530842|20933984|P2|COMPLETED|Period 1||161
8495160|NCT00530842|20933985|P1|COMPLETED|Period 1||158
8495161|NCT00530842|20933984|P2|STARTED|Period 1||172
8495162|NCT00530842|20933985|P1|STARTED|Period 1||172
8495163|NCT00530842|20933984|P2|NOT COMPLETED|Overall Study||21
8495164|NCT00530842|20933985|P1|NOT COMPLETED|Overall Study||23
8495165|NCT00530842|20933984|P2|COMPLETED|Overall Study||151
8495166|NCT00530842|20933985|P1|COMPLETED|Overall Study||149
8495167|NCT00530842|20933984|P2|STARTED|Overall Study||172
8495168|NCT00530842|20933985|P1|STARTED|Overall Study||172
8495169|NCT00530816|20934112|P3|NOT COMPLETED|Overall Study||41
8495170|NCT00530816|20934113|P2|NOT COMPLETED|Overall Study||42
8495171|NCT00530816|20934114|P1|NOT COMPLETED|Overall Study||26
8495172|NCT00530816|20934112|P3|COMPLETED|Overall Study||29
8495173|NCT00530816|20934113|P2|COMPLETED|Overall Study||17
8495174|NCT00530816|20934114|P1|COMPLETED|Overall Study||9
8495175|NCT00530816|20934112|P3|STARTED|Overall Study||70
8495176|NCT00530816|20934113|P2|STARTED|Overall Study||59
8495177|NCT00530816|20934114|P1|STARTED|Overall Study||35
8495178|NCT00530803|20934142|P2|NOT COMPLETED|Overall Study||0
8495179|NCT00530803|20934143|P1|NOT COMPLETED|Overall Study||0
8495180|NCT00530803|20934142|P2|COMPLETED|Overall Study||50
8495181|NCT00530803|20934143|P1|COMPLETED|Overall Study||50
8495182|NCT00530803|20934142|P2|STARTED|Overall Study||50
8495183|NCT00530803|20934143|P1|STARTED|Overall Study||50
8495184|NCT00530790|20934157|P1|NOT COMPLETED|Overall Study||5
8495185|NCT00530790|20934157|P1|COMPLETED|Overall Study||30
8495186|NCT00530790|20934157|P1|STARTED|Overall Study||35
8495187|NCT00530777|20934179|P2|NOT COMPLETED|Overall Study||5
8495188|NCT00530777|20934180|P1|NOT COMPLETED|Overall Study||7
8495189|NCT00530777|20934179|P2|COMPLETED|Overall Study||69
8495190|NCT00530777|20934180|P1|COMPLETED|Overall Study||67
8495191|NCT00530777|20934179|P2|STARTED|Overall Study||74
8495192|NCT00530777|20934180|P1|STARTED|Overall Study||74
8495193|NCT00530764|20934192|P4|NOT COMPLETED|Overall Study||25
8495194|NCT00530764|20934193|P3|NOT COMPLETED|Overall Study||20
8495195|NCT00530764|20934194|P2|NOT COMPLETED|Overall Study||21
8495196|NCT00530764|20934195|P1|NOT COMPLETED|Overall Study||31
8495197|NCT00530764|20934192|P4|COMPLETED|Overall Study||66
8495198|NCT00530764|20934193|P3|COMPLETED|Overall Study||71
8495199|NCT00530764|20934194|P2|COMPLETED|Overall Study||67
8495200|NCT00530764|20934195|P1|COMPLETED|Overall Study||59
8495201|NCT00530764|20934192|P4|STARTED|Overall Study||91
8495202|NCT00530764|20934193|P3|STARTED|Overall Study||91
8495203|NCT00530764|20934194|P2|STARTED|Overall Study||88
8495204|NCT00530764|20934195|P1|STARTED|Overall Study||90
8495205|NCT00530712|20934237|P1|NOT COMPLETED|12 Month Follow-up Visit||24
8495206|NCT00530712|20934237|P1|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
8495207|NCT00530712|20934237|P1|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
8495208|NCT00530712|20934237|P1|NOT COMPLETED|6 Month Follow-up Visit||12
8495209|NCT00530712|20934237|P1|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
8495210|NCT00530712|20934237|P1|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
8495211|NCT00530712|20934237|P1|NOT COMPLETED|30 Day Follow-up Visit||7
8495212|NCT00530712|20934237|P1|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
8495213|NCT00530712|20934237|P1|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
8495214|NCT00530712|20934237|P1|NOT COMPLETED|Enrollment||0
8495215|NCT00530712|20934237|P1|COMPLETED|Enrollment|Subjects Available at Discharge|287
8495216|NCT00530712|20934237|P1|STARTED|Enrollment|Total Enrolled Subjects|287
8495217|NCT00530634|20934254|P1|NOT COMPLETED|Overall Study||0
8495218|NCT00530634|20934254|P1|COMPLETED|Overall Study||3
8495219|NCT00530634|20934254|P1|STARTED|Overall Study||3
8495220|NCT00530621|20934260|P2|NOT COMPLETED|Overall Study||80
8495221|NCT00530621|20934261|P1|NOT COMPLETED|Overall Study||80
8495222|NCT00530621|20934260|P2|COMPLETED|Overall Study||0
8495223|NCT00530621|20934261|P1|COMPLETED|Overall Study||0
8495224|NCT00530621|20934260|P2|Received at Least 1 Dose of Study Drug|Overall Study||80
8495225|NCT00530621|20934261|P1|Received at Least 1 Dose of Study Drug|Overall Study||79
8495226|NCT00530621|20934260|P2|STARTED|Overall Study||80
8495227|NCT00530621|20934261|P1|STARTED|Overall Study||80
8495228|NCT00530504|20934282|P1|NOT COMPLETED|Overall Study||152
8495229|NCT00530504|20934282|P1|COMPLETED|Overall Study||1348
8495230|NCT00530504|20934282|P1|STARTED|Overall Study||1500
8495231|NCT00530439|20934288|P2|NOT COMPLETED|Overall Study||26
8495232|NCT00530439|20934289|P1|NOT COMPLETED|Overall Study||30
8495233|NCT00530439|20934288|P2|COMPLETED|Overall Study||154
8495234|NCT00530439|20934289|P1|COMPLETED|Overall Study||150
8495235|NCT00530439|20934288|P2|STARTED|Overall Study||180
8495236|NCT00530439|20934289|P1|STARTED|Overall Study||180
8495237|NCT00530348|20934297|P2|NOT COMPLETED|Overall Study||19
8495238|NCT00530348|20934298|P1|NOT COMPLETED|Overall Study||22
8495239|NCT00530348|20934297|P2|COMPLETED|Overall Study||367
8495240|NCT00530348|20934298|P1|COMPLETED|Overall Study||173
8495241|NCT00530348|20934297|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
8495242|NCT00530348|20934298|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
8495243|NCT00530348|20934297|P2|STARTED|Overall Study|Randomized.|386
8495244|NCT00530348|20934298|P1|STARTED|Overall Study|Randomized.|195
8495245|NCT00530335|20934314|P1|NOT COMPLETED|Overall Study||6
8495246|NCT00530335|20934314|P1|COMPLETED|Overall Study||39
8495247|NCT00530335|20934314|P1|STARTED|Overall Study||45
8495248|NCT00530270|20934331|P2|NOT COMPLETED|Overall Study||0
8495249|NCT00530270|20934332|P1|NOT COMPLETED|Overall Study||1
8495250|NCT00530270|20934331|P2|COMPLETED|Overall Study||6
8495251|NCT00530270|20934332|P1|COMPLETED|Overall Study||5
8495252|NCT00530270|20934331|P2|STARTED|Overall Study||6
8495253|NCT00530270|20934332|P1|STARTED|Overall Study||6
8495254|NCT00530257|20934346|P1|NOT COMPLETED|Overall Study||1
8495255|NCT00530257|20934346|P1|COMPLETED|Overall Study||30
8495256|NCT00530257|20934346|P1|STARTED|Overall Study||31
8495257|NCT00530218|20934374|P1|NOT COMPLETED|Overall Study||25
8495258|NCT00530218|20934374|P1|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
8495259|NCT00530218|20934374|P1|STARTED|Overall Study||61
8495260|NCT00530088|20934381|P1|NOT COMPLETED|Overall Study||10
8495261|NCT00530088|20934381|P1|COMPLETED|Overall Study||20
8495262|NCT00530088|20934381|P1|STARTED|Overall Study||30
8495263|NCT00530075|20934386|P1|NOT COMPLETED|Overall Study||7
8495264|NCT00530075|20934386|P1|COMPLETED|Overall Study||38
8495265|NCT00530075|20934386|P1|STARTED|Overall Study||45
8495266|NCT00530023|20934399|P2|NOT COMPLETED|Overall Study||1
8495267|NCT00530023|20934400|P1|NOT COMPLETED|Overall Study||0
8495268|NCT00530023|20934399|P2|COMPLETED|Overall Study||14
8495269|NCT00530023|20934400|P1|COMPLETED|Overall Study||14
8495270|NCT00530023|20934399|P2|STARTED|Overall Study||15
8495271|NCT00530023|20934400|P1|STARTED|Overall Study||14
8495290|NCT00529802|20934460|P1|NOT COMPLETED|Evaluable for Secondary Endpoint||2
8495291|NCT00529802|20934460|P1|COMPLETED|Evaluable for Secondary Endpoint||48
8495292|NCT00529802|20934460|P1|STARTED|Evaluable for Secondary Endpoint||50
8495293|NCT00529802|20934460|P1|NOT COMPLETED|Evaluable for Primary Endpoint||10
8495294|NCT00529802|20934460|P1|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
8495295|NCT00529802|20934460|P1|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
8495296|NCT00529789|20934466|P1|NOT COMPLETED|Study Period IV||6
8495297|NCT00529789|20934466|P1|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
8495298|NCT00529789|20934466|P1|STARTED|Study Period IV||48
8495299|NCT00529789|20934466|P1|NOT COMPLETED|Study Period II/III||24
8495300|NCT00529789|20934466|P1|COMPLETED|Study Period II/III||48
8495301|NCT00529789|20934466|P1|STARTED|Study Period II/III||72
8495302|NCT00529763|20934491|P3|NOT COMPLETED|Overall Study||7
8495303|NCT00529763|20934492|P2|NOT COMPLETED|Overall Study||33
8495304|NCT00529763|20934493|P1|NOT COMPLETED|Overall Study||10
8495305|NCT00529763|20934491|P3|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
8495306|NCT00529763|20934492|P2|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
8495397|NCT00529399|20934852|P1|NOT COMPLETED|Overall Study||2
8495307|NCT00529763|20934493|P1|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
8495308|NCT00529763|20934491|P3|STARTED|Overall Study||59
8495309|NCT00529763|20934492|P2|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
8495310|NCT00529763|20934493|P1|STARTED|Overall Study||25
8495311|NCT00529659|20934531|P2|NOT COMPLETED|Overall Study||23
8495312|NCT00529659|20934532|P1|NOT COMPLETED|Overall Study||11
8495313|NCT00529659|20934531|P2|COMPLETED|Overall Study||66
8495314|NCT00529659|20934532|P1|COMPLETED|Overall Study||70
8495315|NCT00529659|20934531|P2|STARTED|Overall Study||89
8495316|NCT00529659|20934532|P1|STARTED|Overall Study||81
8495317|NCT00529633|20934550|P2|NOT COMPLETED|Overall Study||1
8495318|NCT00529633|20934551|P1|NOT COMPLETED|Overall Study||1
8495319|NCT00529633|20934550|P2|COMPLETED|Overall Study||1
8495320|NCT00529633|20934551|P1|COMPLETED|Overall Study||1
8495321|NCT00529633|20934550|P2|STARTED|Overall Study||2
8495322|NCT00529633|20934551|P1|STARTED|Overall Study||2
8495323|NCT00529568|20934563|P3|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
8495324|NCT00529568|20934564|P2|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
8495325|NCT00529568|20934565|P1|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
8495326|NCT00529568|20934563|P3|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
8495327|NCT00529568|20934564|P2|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
8495328|NCT00529568|20934565|P1|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
8495329|NCT00529568|20934563|P3|STARTED|Double-bilnd Antiviral Treatment Phase||506
8495330|NCT00529568|20934564|P2|STARTED|Double-bilnd Antiviral Treatment Phase||253
8495331|NCT00529568|20934565|P1|STARTED|Double-bilnd Antiviral Treatment Phase||0
8495332|NCT00529568|20934563|P3|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
8495333|NCT00529568|20934564|P2|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
8495334|NCT00529568|20934565|P1|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
8495335|NCT00529568|20934563|P3|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
8495336|NCT00529568|20934564|P2|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
8495337|NCT00529568|20934565|P1|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
8495338|NCT00529568|20934563|P3|STARTED|Open-label Pre-Antiviral Treatment Phase||0
8495339|NCT00529568|20934564|P2|STARTED|Open-label Pre-Antiviral Treatment Phase||0
8495340|NCT00529568|20934565|P1|STARTED|Open-label Pre-Antiviral Treatment Phase||805
8495341|NCT00529555|20934616|P3|NOT COMPLETED|Overall Study||26
8495342|NCT00529555|20934617|P2|NOT COMPLETED|Overall Study||30
8495343|NCT00529555|20934618|P1|NOT COMPLETED|Overall Study||29
8495344|NCT00529555|20934616|P3|COMPLETED|Overall Study||174
8495345|NCT00529555|20934617|P2|COMPLETED|Overall Study||172
8495346|NCT00529555|20934618|P1|COMPLETED|Overall Study||171
8495347|NCT00529555|20934616|P3|STARTED|Overall Study||200
8495348|NCT00529555|20934617|P2|STARTED|Overall Study||202
8495349|NCT00529555|20934618|P1|STARTED|Overall Study||200
8495350|NCT00529542|20934628|P2|NOT COMPLETED|Overall Study||1
8495351|NCT00529542|20934629|P1|NOT COMPLETED|Overall Study||1
8495352|NCT00529542|20934628|P2|COMPLETED|Overall Study||10
8495353|NCT00529542|20934629|P1|COMPLETED|Overall Study||8
8495354|NCT00529542|20934628|P2|STARTED|Overall Study||11
8495355|NCT00529542|20934629|P1|STARTED|Overall Study||9
8495356|NCT00529529|20934672|P3|NOT COMPLETED|Overall Study||31
8495357|NCT00529529|20934673|P2|NOT COMPLETED|Overall Study||43
8495358|NCT00529529|20934674|P1|NOT COMPLETED|Overall Study||43
8495359|NCT00529529|20934672|P3|COMPLETED|Overall Study||238
8495360|NCT00529529|20934673|P2|COMPLETED|Overall Study||225
8495361|NCT00529529|20934674|P1|COMPLETED|Overall Study||225
8495362|NCT00529529|20934672|P3|STARTED|Overall Study||269
8495363|NCT00529529|20934673|P2|STARTED|Overall Study||268
8495364|NCT00529529|20934674|P1|STARTED|Overall Study||268
8495365|NCT00529516|20934733|P3|NOT COMPLETED|Overall Study||1
8495366|NCT00529516|20934734|P2|NOT COMPLETED|Overall Study||2
8495367|NCT00529516|20934735|P1|NOT COMPLETED|Overall Study||3
8495368|NCT00529516|20934733|P3|COMPLETED|Overall Study||288
8495369|NCT00529516|20934734|P2|COMPLETED|Overall Study||486
8495370|NCT00529516|20934735|P1|COMPLETED|Overall Study||472
8495371|NCT00529516|20934733|P3|STARTED|Overall Study||289
8495372|NCT00529516|20934734|P2|STARTED|Overall Study||488
8495373|NCT00529516|20934735|P1|STARTED|Overall Study||475
8495374|NCT00529464|20934806|P3|NOT COMPLETED|Overall Study||0
8495375|NCT00529464|20934807|P2|NOT COMPLETED|Overall Study||0
8495376|NCT00529464|20934808|P1|NOT COMPLETED|Overall Study||0
8495377|NCT00529464|20934806|P3|COMPLETED|Overall Study||0
8495378|NCT00529464|20934807|P2|COMPLETED|Overall Study||0
8495379|NCT00529464|20934808|P1|COMPLETED|Overall Study||0
8495380|NCT00529464|20934806|P3|STARTED|Overall Study||0
8495381|NCT00529464|20934807|P2|STARTED|Overall Study||0
8495382|NCT00529464|20934808|P1|STARTED|Overall Study||0
8495383|NCT00529451|20934820|P4|NOT COMPLETED|Overall Study||31
8495384|NCT00529451|20934821|P3|NOT COMPLETED|Overall Study||40
8495385|NCT00529451|20934822|P2|NOT COMPLETED|Overall Study||48
8495386|NCT00529451|20934823|P1|NOT COMPLETED|Overall Study||37
8495387|NCT00529451|20934820|P4|COMPLETED|Overall Study||299
8495388|NCT00529451|20934821|P3|COMPLETED|Overall Study||292
8495389|NCT00529451|20934822|P2|COMPLETED|Overall Study||275
8495390|NCT00529451|20934823|P1|COMPLETED|Overall Study||294
8495391|NCT00529451|20934820|P4|STARTED|Overall Study||330
8495392|NCT00529451|20934821|P3|STARTED|Overall Study||332
8495393|NCT00529451|20934822|P2|STARTED|Overall Study||323
8495394|NCT00529451|20934823|P1|STARTED|Overall Study||331
8495395|NCT00529399|20934850|P3|NOT COMPLETED|Overall Study||2
8495396|NCT00529399|20934851|P2|NOT COMPLETED|Overall Study||1
8495398|NCT00529399|20934850|P3|COMPLETED|Overall Study||46
8495399|NCT00529399|20934851|P2|COMPLETED|Overall Study||48
8495400|NCT00529399|20934852|P1|COMPLETED|Overall Study||46
8495401|NCT00529399|20934850|P3|STARTED|Overall Study||48
8495402|NCT00529399|20934851|P2|STARTED|Overall Study||49
8495403|NCT00529399|20934852|P1|STARTED|Overall Study||48
8495404|NCT00529386|20934860|P1|NOT COMPLETED|Overall Study||1
8495405|NCT00529386|20934860|P1|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6
8495406|NCT00529386|20934860|P1|STARTED|Overall Study|Study has been discontinued|7
8495407|NCT00529373|20934866|P2|NOT COMPLETED|Second Extension Study||197
8495408|NCT00529373|20934867|P1|NOT COMPLETED|Second Extension Study||300
8495409|NCT00529373|20934866|P2|COMPLETED|Second Extension Study||2112
8495410|NCT00529373|20934867|P1|COMPLETED|Second Extension Study||2844
8495411|NCT00529373|20934866|P2|STARTED|Second Extension Study||2309
8495412|NCT00529373|20934867|P1|STARTED|Second Extension Study||3144
8495413|NCT00529373|20934866|P2|NOT COMPLETED|First Extension Study||1651
8495414|NCT00529373|20934867|P1|NOT COMPLETED|First Extension Study||1153
8495415|NCT00529373|20934866|P2|COMPLETED|First Extension Study||2309
8495416|NCT00529373|20934867|P1|COMPLETED|First Extension Study||3144
8495417|NCT00529373|20934866|P2|STARTED|First Extension Study||3960
8495418|NCT00529373|20934867|P1|STARTED|First Extension Study||4297
8495419|NCT00529373|20934866|P2|NOT COMPLETED|Base Study||4068
8495420|NCT00529373|20934867|P1|NOT COMPLETED|Base Study||3746
8495421|NCT00529373|20934866|P2|COMPLETED|Base Study||3960
8495422|NCT00529373|20934867|P1|COMPLETED|Base Study||4297
8495423|NCT00529373|20934866|P2|STARTED|Base Study||8028
8495424|NCT00529373|20934867|P1|STARTED|Base Study||8043
8495425|NCT00529308|20935061|P2|NOT COMPLETED|Overall Study||1
8495426|NCT00529308|20935062|P1|NOT COMPLETED|Overall Study||1
8495427|NCT00529308|20935061|P2|COMPLETED|Overall Study||10
8495428|NCT00529308|20935062|P1|COMPLETED|Overall Study||8
8495429|NCT00529308|20935061|P2|STARTED|Overall Study||11
8495430|NCT00529308|20935062|P1|STARTED|Overall Study||9
8495431|NCT00529282|20935078|P2|NOT COMPLETED|Overall Study||0
8495432|NCT00529282|20935079|P1|NOT COMPLETED|Overall Study||0
8495433|NCT00529282|20935078|P2|COMPLETED|Overall Study||2
8495434|NCT00529282|20935079|P1|COMPLETED|Overall Study||0
8495435|NCT00529282|20935078|P2|STARTED|Overall Study||2
8495436|NCT00529282|20935079|P1|STARTED|Overall Study||0
8495437|NCT00529243|20935091|P1|NOT COMPLETED|Overall Study||3
8495438|NCT00529243|20935091|P1|COMPLETED|Overall Study||49
8495439|NCT00529243|20935091|P1|STARTED|Overall Study||52
8495440|NCT00529217|20935096|P1|NOT COMPLETED|Overall Study||4
8495441|NCT00529217|20935096|P1|COMPLETED|Overall Study||8
8495442|NCT00529217|20935096|P1|STARTED|Overall Study||12
8495443|NCT00529204|20935101|P1|NOT COMPLETED|Overall Study||0
8495444|NCT00529204|20935101|P1|COMPLETED|Overall Study||1
8495445|NCT00529204|20935101|P1|STARTED|Overall Study||1
8495446|NCT00529191|20935109|P2|NOT COMPLETED|Overall Study||0
8495447|NCT00529191|20935110|P1|NOT COMPLETED|Overall Study||3
8495448|NCT00529191|20935109|P2|COMPLETED|Overall Study||13
8495449|NCT00529191|20935110|P1|COMPLETED|Overall Study||24
8495450|NCT00529191|20935109|P2|STARTED|Overall Study||13
8495451|NCT00529191|20935110|P1|STARTED|Overall Study||27
8495452|NCT00529152|20935132|P1|NOT COMPLETED|Overall Study||5
8495453|NCT00529152|20935132|P1|COMPLETED|Overall Study||95
8495454|NCT00529152|20935132|P1|STARTED|Overall Study||100
8495467|NCT00529100|20935156|P2|NOT COMPLETED|Overall Study||9
8495468|NCT00529100|20935157|P1|NOT COMPLETED|Overall Study||0
8495469|NCT00529100|20935156|P2|COMPLETED|Overall Study||24
8495470|NCT00529100|20935157|P1|COMPLETED|Overall Study||16
8495471|NCT00529100|20935156|P2|Received at Least 1 Dose of Study Drug|Overall Study||33
8495472|NCT00529100|20935157|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
8495473|NCT00529100|20935156|P2|STARTED|Overall Study||33
8495474|NCT00529100|20935157|P1|STARTED|Overall Study||16
8495475|NCT00529087|20935174|P3|NOT COMPLETED|Overall Study||16
8495476|NCT00529087|20935175|P2|NOT COMPLETED|Overall Study||28
8495477|NCT00529087|20935176|P1|NOT COMPLETED|Overall Study||28
8495478|NCT00529087|20935174|P3|COMPLETED|Overall Study||146
8495479|NCT00529087|20935175|P2|COMPLETED|Overall Study||120
8495480|NCT00529087|20935176|P1|COMPLETED|Overall Study||122
8495481|NCT00529087|20935174|P3|STARTED|Overall Study||162
8495482|NCT00529087|20935175|P2|STARTED|Overall Study||148
8495483|NCT00529087|20935176|P1|STARTED|Overall Study||150
8495484|NCT00529035|20935240|P1|NOT COMPLETED|Overall Study||1
8495485|NCT00529035|20935240|P1|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
8495486|NCT00529035|20935240|P1|STARTED|Overall Study|29 enrolled|29
8495487|NCT00528970|20935254|P3|NOT COMPLETED|Overall Study||20
8495488|NCT00528970|20935255|P2|NOT COMPLETED|Overall Study||15
8495489|NCT00528970|20935256|P1|NOT COMPLETED|Overall Study||14
8495490|NCT00528970|20935254|P3|COMPLETED|Overall Study||105
8495491|NCT00528970|20935255|P2|COMPLETED|Overall Study||110
8495492|NCT00528970|20935256|P1|COMPLETED|Overall Study||110
8495493|NCT00528970|20935254|P3|Received at Least 1 Dose of Study Drug|Overall Study||124
8495494|NCT00528970|20935255|P2|Received at Least 1 Dose of Study Drug|Overall Study||125
8495495|NCT00528970|20935256|P1|Received at Least 1 Dose of Study Drug|Overall Study||124
8495496|NCT00528970|20935254|P3|STARTED|Overall Study||125
8495497|NCT00528970|20935255|P2|STARTED|Overall Study||125
8495498|NCT00528970|20935256|P1|STARTED|Overall Study||124
8495499|NCT00528957|20935275|P2|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
8495500|NCT00528957|20935276|P1|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
8495501|NCT00528957|20935275|P2|COMPLETED|Long-Term Extension (Week 336 and On)||8
8495502|NCT00528957|20935276|P1|COMPLETED|Long-Term Extension (Week 336 and On)||9
8495503|NCT00528957|20935275|P2|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
8495504|NCT00528957|20935276|P1|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
8495505|NCT00528957|20935275|P2|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
8495506|NCT00528957|20935276|P1|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
8495507|NCT00528957|20935275|P2|COMPLETED|Third Extension (Week 240 to Week 336)||27
8495508|NCT00528957|20935276|P1|COMPLETED|Third Extension (Week 240 to Week 336)||21
8495509|NCT00528957|20935275|P2|STARTED|Third Extension (Week 240 to Week 336)||37
8495510|NCT00528957|20935276|P1|STARTED|Third Extension (Week 240 to Week 336)||27
8495511|NCT00528957|20935275|P2|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
8495512|NCT00528957|20935276|P1|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
8495513|NCT00528957|20935275|P2|COMPLETED|Second Extension (Week 144 to Week 240)||37
8495514|NCT00528957|20935276|P1|COMPLETED|Second Extension (Week 144 to Week 240)||27
8495515|NCT00528957|20935275|P2|STARTED|Second Extension (Week 144 to Week 240)||40
8495516|NCT00528957|20935276|P1|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
8495517|NCT00528957|20935275|P2|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
8495518|NCT00528957|20935276|P1|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
8495519|NCT00528957|20935275|P2|COMPLETED|First Extension (Week 48 to Week 144)||40
8495520|NCT00528957|20935276|P1|COMPLETED|First Extension (Week 48 to Week 144)||35
8495521|NCT00528957|20935275|P2|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
8495522|NCT00528957|20935276|P1|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
8495523|NCT00528957|20935275|P2|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
8495524|NCT00528957|20935276|P1|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
8495525|NCT00528957|20935275|P2|COMPLETED|Randomized Phase (Baseline to Week 48)||48
8495526|NCT00528957|20935276|P1|COMPLETED|Randomized Phase (Baseline to Week 48)||44
8495527|NCT00528957|20935275|P2|STARTED|Randomized Phase (Baseline to Week 48)||49
8495528|NCT00528957|20935276|P1|STARTED|Randomized Phase (Baseline to Week 48)||48
8495529|NCT00528931|20935417|P1|NOT COMPLETED|Overall Study||1
8495530|NCT00528931|20935417|P1|COMPLETED|Overall Study||15
8495531|NCT00528931|20935417|P1|STARTED|Overall Study||16
8495532|NCT00528879|20935429|P4|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
8495533|NCT00528879|20935430|P3|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
8495534|NCT00528879|20935431|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
8495535|NCT00528879|20935432|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
8495536|NCT00528879|20935429|P4|COMPLETED|Long-term Period (Weeks 24 to 102)||95
8495537|NCT00528879|20935430|P3|COMPLETED|Long-term Period (Weeks 24 to 102)||89
8495538|NCT00528879|20935431|P2|COMPLETED|Long-term Period (Weeks 24 to 102)||82
8495539|NCT00528879|20935432|P1|COMPLETED|Long-term Period (Weeks 24 to 102)||73
8495540|NCT00528879|20935429|P4|STARTED|Long-term Period (Weeks 24 to 102)||119
8495541|NCT00528879|20935430|P3|STARTED|Long-term Period (Weeks 24 to 102)||122
8495542|NCT00528879|20935431|P2|STARTED|Long-term Period (Weeks 24 to 102)||120
8495543|NCT00528879|20935432|P1|STARTED|Long-term Period (Weeks 24 to 102)||115
8495544|NCT00528879|20935429|P4|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
8495545|NCT00528879|20935430|P3|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
8495546|NCT00528879|20935431|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
8495547|NCT00528879|20935432|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
8495548|NCT00528879|20935429|P4|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
8495549|NCT00528879|20935430|P3|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
8495550|NCT00528879|20935431|P2|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
8495551|NCT00528879|20935432|P1|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
8495552|NCT00528879|20935429|P4|Completed the Period|Short-term Period (Day 1 to Week 24)||121
8495553|NCT00528879|20935430|P3|Completed the Period|Short-term Period (Day 1 to Week 24)||122
8495554|NCT00528879|20935431|P2|Completed the Period|Short-term Period (Day 1 to Week 24)||121
8495555|NCT00528879|20935432|P1|Completed the Period|Short-term Period (Day 1 to Week 24)||119
8495556|NCT00528879|20935429|P4|STARTED|Short-term Period (Day 1 to Week 24)||135
8495557|NCT00528879|20935430|P3|STARTED|Short-term Period (Day 1 to Week 24)||137
8495558|NCT00528879|20935431|P2|STARTED|Short-term Period (Day 1 to Week 24)||137
8495559|NCT00528879|20935432|P1|STARTED|Short-term Period (Day 1 to Week 24)||137
8495560|NCT00528866|20935498|P1|NOT COMPLETED|Overall Study||6
8495653|NCT00528372|20935855|P8|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
8495561|NCT00528866|20935498|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
8495562|NCT00528866|20935498|P1|STARTED|Overall Study||80
8495563|NCT00528840|20935511|P1|NOT COMPLETED|Overall Study||33
8495564|NCT00528840|20935511|P1|COMPLETED|Overall Study||168
8495565|NCT00528840|20935511|P1|STARTED|Overall Study||201
8495566|NCT00528801|20935525|P2|NOT COMPLETED|Overall Study||11
8495567|NCT00528801|20935526|P1|NOT COMPLETED|Overall Study||27
8495568|NCT00528801|20935525|P2|COMPLETED|Overall Study||41
8495569|NCT00528801|20935526|P1|COMPLETED|Overall Study||133
8495570|NCT00528801|20935525|P2|STARTED|Overall Study||52
8495571|NCT00528801|20935526|P1|STARTED|Overall Study||160
8495572|NCT00528788|20935536|P1|NOT COMPLETED|Overall Study||4
8495573|NCT00528788|20935536|P1|COMPLETED|Overall Study||20
8495574|NCT00528788|20935536|P1|STARTED|Overall Study||24
8495575|NCT00528775|20935540|P1|NOT COMPLETED|Overall Study||1
8495576|NCT00528775|20935540|P1|COMPLETED|Overall Study||5
8495577|NCT00528775|20935540|P1|STARTED|Overall Study||6
8495578|NCT00528645|20935548|P1|NOT COMPLETED|Overall Study||3
8495579|NCT00528645|20935548|P1|COMPLETED|Overall Study||20
8495580|NCT00528645|20935548|P1|STARTED|Overall Study||23
8495581|NCT00528606|20935557|P2|NOT COMPLETED|Overall Study||4
8495582|NCT00528606|20935558|P1|NOT COMPLETED|Overall Study||13
8495583|NCT00528606|20935557|P2|COMPLETED|Overall Study||100
8495584|NCT00528606|20935558|P1|COMPLETED|Overall Study||191
8495585|NCT00528606|20935557|P2|STARTED|Overall Study||104
8495586|NCT00528606|20935558|P1|STARTED|Overall Study||204
8495587|NCT00528580|20935582|P2|NOT COMPLETED|Overall Study||0
8495588|NCT00528580|20935583|P1|NOT COMPLETED|Overall Study||0
8495589|NCT00528580|20935582|P2|COMPLETED|Overall Study||34
8495590|NCT00528580|20935583|P1|COMPLETED|Overall Study||34
8495591|NCT00528580|20935582|P2|STARTED|Overall Study||34
8495592|NCT00528580|20935583|P1|STARTED|Overall Study||34
8495593|NCT00528567|20935591|P2|NOT COMPLETED|Overall Study||308
8495594|NCT00528567|20935592|P1|NOT COMPLETED|Overall Study||431
8495595|NCT00528567|20935591|P2|COMPLETED|Overall Study||982
8495596|NCT00528567|20935592|P1|COMPLETED|Overall Study||870
8495597|NCT00528567|20935591|P2|Safety Population|Overall Study||1271
8495598|NCT00528567|20935592|P1|Safety Population|Overall Study||1288
8495599|NCT00528567|20935591|P2|Intention to Treat|Overall Study||1290
8495600|NCT00528567|20935592|P1|Intention to Treat|Overall Study||1301
8495601|NCT00528567|20935591|P2|STARTED|Overall Study||1290
8495602|NCT00528567|20935592|P1|STARTED|Overall Study||1301
8495603|NCT00528541|20935632|P2|NOT COMPLETED|Overall Study||1
8495604|NCT00528541|20935633|P1|NOT COMPLETED|Overall Study||2
8495605|NCT00528541|20935632|P2|COMPLETED|Overall Study||69
8495606|NCT00528541|20935633|P1|COMPLETED|Overall Study||73
8495607|NCT00528541|20935632|P2|STARTED|Overall Study||70
8495608|NCT00528541|20935633|P1|STARTED|Overall Study||75
8495609|NCT00528528|20935659|P4|NOT COMPLETED|Overall Study||3
8495610|NCT00528528|20935660|P3|NOT COMPLETED|Overall Study||3
8495611|NCT00528528|20935661|P2|NOT COMPLETED|Overall Study||3
8495612|NCT00528528|20935662|P1|NOT COMPLETED|Overall Study||3
8495613|NCT00528528|20935659|P4|COMPLETED|Overall Study||36
8495614|NCT00528528|20935660|P3|COMPLETED|Overall Study||37
8495615|NCT00528528|20935661|P2|COMPLETED|Overall Study||39
8495616|NCT00528528|20935662|P1|COMPLETED|Overall Study||37
8495617|NCT00528528|20935659|P4|Ongoing at Time of Cut-off|Overall Study||0
8495618|NCT00528528|20935660|P3|Ongoing at Time of Cut-off|Overall Study||1
8495619|NCT00528528|20935661|P2|Ongoing at Time of Cut-off|Overall Study||0
8495620|NCT00528528|20935662|P1|Ongoing at Time of Cut-off|Overall Study||0
8495621|NCT00528528|20935659|P4|STARTED|Overall Study||39
8495622|NCT00528528|20935660|P3|STARTED|Overall Study||40
8495623|NCT00528528|20935661|P2|STARTED|Overall Study||42
8495624|NCT00528528|20935662|P1|STARTED|Overall Study||40
8495625|NCT00528450|20935696|P1|NOT COMPLETED|Overall Study||0
8495626|NCT00528450|20935696|P1|COMPLETED|Overall Study||1
8495627|NCT00528450|20935696|P1|STARTED|Overall Study||1
8495628|NCT00528424|20935700|P1|NOT COMPLETED|Overall Study||29
8495629|NCT00528424|20935700|P1|COMPLETED|Overall Study||257
8495630|NCT00528424|20935700|P1|STARTED|Overall Study||286
8495631|NCT00528411|20935715|P3|NOT COMPLETED|Overall Study||1
8495632|NCT00528411|20935716|P2|NOT COMPLETED|Overall Study||3
8495633|NCT00528411|20935717|P1|NOT COMPLETED|Overall Study||5
8495634|NCT00528411|20935715|P3|COMPLETED|Overall Study||11
8495635|NCT00528411|20935716|P2|COMPLETED|Overall Study||51
8495636|NCT00528411|20935717|P1|COMPLETED|Overall Study||52
8495637|NCT00528411|20935715|P3|STARTED|Overall Study||12
8495638|NCT00528411|20935716|P2|STARTED|Overall Study||54
8495639|NCT00528411|20935717|P1|STARTED|Overall Study||57
8495640|NCT00528398|20935840|P1|NOT COMPLETED|Overall Study||0
8495641|NCT00528398|20935840|P1|COMPLETED|Overall Study||111
8495642|NCT00528398|20935840|P1|STARTED|Overall Study||111
8495643|NCT00528372|20935854|P9|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
8495644|NCT00528372|20935855|P8|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
8495645|NCT00528372|20935856|P7|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
8495646|NCT00528372|20935857|P6|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
8495647|NCT00528372|20935858|P5|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
8495648|NCT00528372|20935859|P4|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
8495649|NCT00528372|20935860|P3|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
8495650|NCT00528372|20935861|P2|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
8495651|NCT00528372|20935862|P1|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
8495652|NCT00528372|20935854|P9|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
8495654|NCT00528372|20935856|P7|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
8495655|NCT00528372|20935857|P6|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
8495656|NCT00528372|20935858|P5|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
8495657|NCT00528372|20935859|P4|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
8495658|NCT00528372|20935860|P3|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
8495659|NCT00528372|20935861|P2|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
8495660|NCT00528372|20935862|P1|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
8495661|NCT00528372|20935854|P9|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
8495662|NCT00528372|20935855|P8|STARTED|Long-term (LT) Period (Weeks 24-102)||28
8495663|NCT00528372|20935856|P7|STARTED|Long-term (LT) Period (Weeks 24-102)||65
8495664|NCT00528372|20935857|P6|STARTED|Long-term (LT) Period (Weeks 24-102)||57
8495665|NCT00528372|20935858|P5|STARTED|Long-term (LT) Period (Weeks 24-102)||58
8495666|NCT00528372|20935859|P4|STARTED|Long-term (LT) Period (Weeks 24-102)||56
8495667|NCT00528372|20935860|P3|STARTED|Long-term (LT) Period (Weeks 24-102)||51
8495668|NCT00528372|20935861|P2|STARTED|Long-term (LT) Period (Weeks 24-102)||59
8495669|NCT00528372|20935862|P1|STARTED|Long-term (LT) Period (Weeks 24-102)||62
8495670|NCT00528372|20935854|P9|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
8495671|NCT00528372|20935855|P8|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
8495672|NCT00528372|20935856|P7|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
8495673|NCT00528372|20935857|P6|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
8495674|NCT00528372|20935858|P5|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
8495675|NCT00528372|20935859|P4|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
8495676|NCT00528372|20935860|P3|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
8495677|NCT00528372|20935861|P2|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
8495678|NCT00528372|20935862|P1|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
8495679|NCT00528372|20935854|P9|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
8495680|NCT00528372|20935855|P8|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
8495681|NCT00528372|20935856|P7|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
8495682|NCT00528372|20935857|P6|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
8495683|NCT00528372|20935858|P5|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
8495684|NCT00528372|20935859|P4|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
8495685|NCT00528372|20935860|P3|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
8495686|NCT00528372|20935861|P2|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
8495687|NCT00528372|20935862|P1|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
8495688|NCT00528372|20935854|P9|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
8495689|NCT00528372|20935855|P8|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
8495690|NCT00528372|20935856|P7|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
8495691|NCT00528372|20935857|P6|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
8495692|NCT00528372|20935858|P5|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
8495693|NCT00528372|20935859|P4|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
8495694|NCT00528372|20935860|P3|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
8495695|NCT00528372|20935861|P2|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
8495696|NCT00528372|20935862|P1|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
8495697|NCT00528268|20935976|P2|NOT COMPLETED|Overall Study||1
8495698|NCT00528268|20935977|P1|NOT COMPLETED|Overall Study||1
8495699|NCT00528268|20935976|P2|COMPLETED|Overall Study||7
8495700|NCT00528268|20935977|P1|COMPLETED|Overall Study||5
8495701|NCT00528268|20935976|P2|STARTED|Overall Study||8
8495702|NCT00528268|20935977|P1|STARTED|Overall Study||6
8495703|NCT00528190|20935985|P2|NOT COMPLETED|Overall Study||1
8495704|NCT00528190|20935986|P1|NOT COMPLETED|Overall Study||0
8495705|NCT00528190|20935985|P2|COMPLETED|Overall Study||16
8495706|NCT00528190|20935986|P1|COMPLETED|Overall Study||18
8495707|NCT00528190|20935985|P2|STARTED|Overall Study||17
8495708|NCT00528190|20935986|P1|STARTED|Overall Study||18
8495709|NCT00528112|20935994|P2|NOT COMPLETED|Extension Phase||157
8495710|NCT00528112|20935995|P1|NOT COMPLETED|Extension Phase||0
8495711|NCT00528112|20935994|P2|COMPLETED|Extension Phase||550
8495712|NCT00528112|20935995|P1|COMPLETED|Extension Phase||0
8495713|NCT00528112|20935994|P2|STARTED|Extension Phase||707
8495714|NCT00528112|20935995|P1|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
8495715|NCT00528112|20935994|P2|NOT COMPLETED|Treatment up to 3 Years||583
8495716|NCT00528112|20935995|P1|NOT COMPLETED|Treatment up to 3 Years||613
8495717|NCT00528112|20935994|P2|COMPLETED|Treatment up to 3 Years||870
8495718|NCT00528112|20935995|P1|COMPLETED|Treatment up to 3 Years||819
8495719|NCT00528112|20935994|P2|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
8495720|NCT00528112|20935995|P1|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
8495721|NCT00528112|20935994|P2|STARTED|Treatment up to 3 Years||1453
8495722|NCT00528112|20935995|P1|STARTED|Treatment up to 3 Years||1432
8495723|NCT00528021|20936053|P4|NOT COMPLETED|Overall Study||9
8495724|NCT00528021|20936054|P3|NOT COMPLETED|Overall Study||7
8495725|NCT00528021|20936055|P2|NOT COMPLETED|Overall Study||13
8495726|NCT00528021|20936056|P1|NOT COMPLETED|Overall Study||17
8495727|NCT00528021|20936053|P4|COMPLETED|Overall Study||47
8495728|NCT00528021|20936054|P3|COMPLETED|Overall Study||49
8495729|NCT00528021|20936055|P2|COMPLETED|Overall Study||46
8495730|NCT00528021|20936056|P1|COMPLETED|Overall Study||42
8495731|NCT00528021|20936053|P4|STARTED|Overall Study||56
8495732|NCT00528021|20936054|P3|STARTED|Overall Study||56
8495733|NCT00528021|20936055|P2|STARTED|Overall Study||59
8495734|NCT00528021|20936056|P1|STARTED|Overall Study||59
8495735|NCT00527982|20936068|P2|NOT COMPLETED|Overall Study||0
8495736|NCT00527982|20936069|P1|NOT COMPLETED|Overall Study||1
8495737|NCT00527982|20936068|P2|COMPLETED|Overall Study||0
8495738|NCT00527982|20936069|P1|COMPLETED|Overall Study||0
8495739|NCT00527982|20936068|P2|STARTED|Overall Study||0
8495740|NCT00527982|20936069|P1|STARTED|Overall Study||1
8495741|NCT00527943|20936077|P2|NOT COMPLETED|Overall Study||146
8495742|NCT00527943|20936078|P1|NOT COMPLETED|Overall Study||160
8495743|NCT00527943|20936077|P2|COMPLETED|Overall Study||6327
8495744|NCT00527943|20936078|P1|COMPLETED|Overall Study||6311
8495745|NCT00527943|20936077|P2|Received Treatment|Overall Study||6446
8495746|NCT00527943|20936078|P1|Received Treatment|Overall Study||6441
8495747|NCT00527943|20936077|P2|STARTED|Overall Study||6473
8495748|NCT00527943|20936078|P1|STARTED|Overall Study||6471
8495749|NCT00527904|20936110|P1|NOT COMPLETED|Overall Study||96
8495750|NCT00527904|20936110|P1|COMPLETED|Overall Study||143
8495751|NCT00527904|20936110|P1|STARTED|Overall Study||239
8495752|NCT00527878|20936114|P2|NOT COMPLETED|Intervention 2||0
8495753|NCT00527878|20936115|P1|NOT COMPLETED|Intervention 2||0
8495754|NCT00527878|20936114|P2|COMPLETED|Intervention 2||4
8495755|NCT00527878|20936115|P1|COMPLETED|Intervention 2||5
8495756|NCT00527878|20936114|P2|STARTED|Intervention 2||4
8495757|NCT00527878|20936115|P1|STARTED|Intervention 2||5
8495758|NCT00527878|20936114|P2|NOT COMPLETED|Intervention 1||3
8495759|NCT00527878|20936115|P1|NOT COMPLETED|Intervention 1||2
8495760|NCT00527878|20936114|P2|COMPLETED|Intervention 1||4
8495761|NCT00527878|20936115|P1|COMPLETED|Intervention 1||5
8495762|NCT00527878|20936114|P2|STARTED|Intervention 1||7
8495763|NCT00527878|20936115|P1|STARTED|Intervention 1||7
8495764|NCT00527826|20936129|P2|NOT COMPLETED|Overall Study||26
8495765|NCT00527826|20936130|P1|NOT COMPLETED|Overall Study||21
8495766|NCT00527826|20936129|P2|COMPLETED|Overall Study||80
8495767|NCT00527826|20936130|P1|COMPLETED|Overall Study||87
8495768|NCT00527826|20936129|P2|STARTED|Overall Study||106
8495769|NCT00527826|20936130|P1|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
8495770|NCT00527787|20936179|P2|NOT COMPLETED|Overall Study||63
8495771|NCT00527787|20936180|P1|NOT COMPLETED|Overall Study||38
8495772|NCT00527787|20936179|P2|COMPLETED|Overall Study||153
8495773|NCT00527787|20936180|P1|COMPLETED|Overall Study||180
8495774|NCT00527787|20936179|P2|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
8495775|NCT00527787|20936180|P1|STARTED|Overall Study||218
8495776|NCT00527748|20936202|P1|NOT COMPLETED|Overall Study||3
8495777|NCT00527748|20936202|P1|COMPLETED|Overall Study||23
8495778|NCT00527748|20936202|P1|STARTED|Overall Study||26
8495779|NCT00527735|20936209|P3|NOT COMPLETED|Overall Study||107
8495780|NCT00527735|20936210|P2|NOT COMPLETED|Overall Study||107
8495781|NCT00527735|20936211|P1|NOT COMPLETED|Overall Study||108
8495782|NCT00527735|20936209|P3|COMPLETED|Overall Study|Still on treatment|2
8495783|NCT00527735|20936210|P2|COMPLETED|Overall Study|Still on treatment|2
8495784|NCT00527735|20936211|P1|COMPLETED|Overall Study|Still on treatment|5
8495785|NCT00527735|20936209|P3|STARTED|Overall Study|Treated|109
8495786|NCT00527735|20936210|P2|STARTED|Overall Study|Treated|109
8495787|NCT00527735|20936211|P1|STARTED|Overall Study|Treated|113
8495788|NCT00527722|20936285|P2|NOT COMPLETED|Overall Study||0
8495789|NCT00527722|20936286|P1|NOT COMPLETED|Overall Study||0
8495790|NCT00527722|20936285|P2|COMPLETED|Overall Study||25
8495791|NCT00527722|20936286|P1|COMPLETED|Overall Study||22
8495792|NCT00527722|20936285|P2|STARTED|Overall Study||25
8495793|NCT00527722|20936286|P1|STARTED|Overall Study||22
8495794|NCT00527644|20936292|P1|NOT COMPLETED|Overall Study||0
8495795|NCT00527644|20936292|P1|COMPLETED|Overall Study||14
8495796|NCT00527644|20936292|P1|STARTED|Overall Study||14
8495797|NCT00527618|20936297|P2|NOT COMPLETED|Week 15-18 (Second Intervention)||3
8495798|NCT00527618|20936298|P1|NOT COMPLETED|Week 15-18 (Second Intervention)||0
8495799|NCT00527618|20936297|P2|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
8495800|NCT00527618|20936298|P1|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
8495801|NCT00527618|20936297|P2|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
8495802|NCT00527618|20936298|P1|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
8495803|NCT00527618|20936297|P2|NOT COMPLETED|Week 13-14 (Washout)||0
8495804|NCT00527618|20936298|P1|NOT COMPLETED|Week 13-14 (Washout)||1
8495805|NCT00527618|20936297|P2|COMPLETED|Week 13-14 (Washout)||16
8495806|NCT00527618|20936298|P1|COMPLETED|Week 13-14 (Washout)||12
8495807|NCT00527618|20936297|P2|STARTED|Week 13-14 (Washout)||16
8495808|NCT00527618|20936298|P1|STARTED|Week 13-14 (Washout)||13
8495809|NCT00527618|20936297|P2|NOT COMPLETED|Week 1-12 (First Intervention)||2
8495810|NCT00527618|20936298|P1|NOT COMPLETED|Week 1-12 (First Intervention)||3
8495811|NCT00527618|20936297|P2|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
8495812|NCT00527618|20936298|P1|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
8495813|NCT00527618|20936297|P2|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
8495814|NCT00527618|20936298|P1|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
8495815|NCT00527605|20936313|P2|NOT COMPLETED|Overall Study||11
8495816|NCT00527605|20936314|P1|NOT COMPLETED|Overall Study||13
8495817|NCT00527605|20936313|P2|COMPLETED|Overall Study||116
8495818|NCT00527605|20936314|P1|COMPLETED|Overall Study||113
8495819|NCT00527605|20936313|P2|STARTED|Overall Study||127
8495820|NCT00527605|20936314|P1|STARTED|Overall Study||126
8495821|NCT00527592|20936350|P1|NOT COMPLETED|Overall Study||0
8495822|NCT00527592|20936350|P1|COMPLETED|Overall Study||54
8495823|NCT00527592|20936350|P1|STARTED|Overall Study||54
8495824|NCT00527566|20936356|P1|NOT COMPLETED|Overall Study||0
8495825|NCT00527566|20936356|P1|COMPLETED|Overall Study||10
8495826|NCT00527566|20936356|P1|STARTED|Overall Study||10
8495827|NCT00527514|20936365|P1|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
8495828|NCT00527514|20936365|P1|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
8495829|NCT00527514|20936365|P1|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
8495830|NCT00527514|20936365|P1|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
8495831|NCT00527514|20936365|P1|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
8495832|NCT00527514|20936365|P1|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
8495833|NCT00527514|20936365|P1|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
8495834|NCT00527514|20936365|P1|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
8495835|NCT00527514|20936365|P1|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
8495836|NCT00527514|20936365|P1|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
8495837|NCT00527514|20936365|P1|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
8495838|NCT00527514|20936365|P1|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
8495839|NCT00527488|20936381|P4|NOT COMPLETED|Overall Study||0
8495840|NCT00527488|20936382|P3|NOT COMPLETED|Overall Study||1
8495841|NCT00527488|20936383|P2|NOT COMPLETED|Overall Study||1
8495842|NCT00527488|20936384|P1|NOT COMPLETED|Overall Study||0
8495843|NCT00527488|20936381|P4|COMPLETED|Overall Study||13
8495844|NCT00527488|20936382|P3|COMPLETED|Overall Study||12
8495845|NCT00527488|20936383|P2|COMPLETED|Overall Study||12
8495846|NCT00527488|20936384|P1|COMPLETED|Overall Study||13
8495847|NCT00527488|20936381|P4|STARTED|Overall Study||13
8495848|NCT00527488|20936382|P3|STARTED|Overall Study||13
8495849|NCT00527488|20936383|P2|STARTED|Overall Study||13
8495850|NCT00527488|20936384|P1|STARTED|Overall Study||13
8495851|NCT00527475|20936460|P2|NOT COMPLETED|Overall Study||1
8495852|NCT00527475|20936461|P1|NOT COMPLETED|Overall Study||3
8495853|NCT00527475|20936460|P2|COMPLETED|Overall Study||29
8495854|NCT00527475|20936461|P1|COMPLETED|Overall Study||27
8495855|NCT00527475|20936460|P2|STARTED|Overall Study||30
8495856|NCT00527475|20936461|P1|STARTED|Overall Study||30
8495857|NCT00527423|20936467|P1|NOT COMPLETED|Overall Study||37
8495858|NCT00527423|20936467|P1|COMPLETED|Overall Study||120
8495859|NCT00527423|20936467|P1|STARTED|Overall Study||157
8495860|NCT00527397|20936473|P1|NOT COMPLETED|Overall Study||24
8495861|NCT00527397|20936473|P1|COMPLETED|Overall Study||0
8495862|NCT00527397|20936473|P1|STARTED|Overall Study||24
8495863|NCT00527332|20936499|P2|NOT COMPLETED|Overall Study||9
8495864|NCT00527332|20936500|P1|NOT COMPLETED|Overall Study||9
8495865|NCT00527332|20936499|P2|COMPLETED|Overall Study||80
8495866|NCT00527332|20936500|P1|COMPLETED|Overall Study||82
8495867|NCT00527332|20936499|P2|STARTED|Overall Study||89
8495868|NCT00527332|20936500|P1|STARTED|Overall Study||91
8495869|NCT00527319|20936509|P3|NOT COMPLETED|Overall Study||6
8495870|NCT00527319|20936510|P2|NOT COMPLETED|Overall Study||4
8495871|NCT00527319|20936511|P1|NOT COMPLETED|Overall Study||6
8495872|NCT00527319|20936509|P3|COMPLETED|Overall Study||7
8495873|NCT00527319|20936510|P2|COMPLETED|Overall Study||8
8495874|NCT00527319|20936511|P1|COMPLETED|Overall Study||6
8495875|NCT00527319|20936509|P3|STARTED|Overall Study||13
8495876|NCT00527319|20936510|P2|STARTED|Overall Study||12
8495877|NCT00527319|20936511|P1|STARTED|Overall Study||12
8495878|NCT00527124|20936524|P2|NOT COMPLETED|Overall Study||0
8495879|NCT00527124|20936525|P1|NOT COMPLETED|Overall Study||0
8495880|NCT00527124|20936524|P2|COMPLETED|Overall Study||28
8495881|NCT00527124|20936525|P1|COMPLETED|Overall Study||29
8495882|NCT00527124|20936524|P2|STARTED|Overall Study||28
8495883|NCT00527124|20936525|P1|STARTED|Overall Study||29
8495884|NCT00527111|20936541|P2|NOT COMPLETED|Overall Study||22
8495885|NCT00527111|20936542|P1|NOT COMPLETED|Overall Study||20
8495886|NCT00527111|20936541|P2|COMPLETED|Overall Study||47
8495887|NCT00527111|20936542|P1|COMPLETED|Overall Study||50
8495888|NCT00527111|20936541|P2|STARTED|Overall Study||69
8495889|NCT00527111|20936542|P1|STARTED|Overall Study||70
8495890|NCT00527098|20936558|P2|NOT COMPLETED|Overall Study||0
8495891|NCT00527098|20936559|P1|NOT COMPLETED|Overall Study||0
8495892|NCT00527098|20936558|P2|COMPLETED|Overall Study||83
8495893|NCT00527098|20936559|P1|COMPLETED|Overall Study||36
8495894|NCT00527098|20936558|P2|STARTED|Overall Study||83
8495895|NCT00527098|20936559|P1|STARTED|Overall Study||36
8495896|NCT00527072|20936564|P1|NOT COMPLETED|Overall Study||36
8495897|NCT00527072|20936564|P1|COMPLETED|Overall Study||179
8495898|NCT00527072|20936564|P1|STARTED|Overall Study||215
8495899|NCT00526994|20936573|P3|NOT COMPLETED|Overall Study||107
8495900|NCT00526994|20936574|P2|NOT COMPLETED|Overall Study||121
8495901|NCT00526994|20936575|P1|NOT COMPLETED|Overall Study||108
8495902|NCT00526994|20936573|P3|COMPLETED|Overall Study||791
8495903|NCT00526994|20936574|P2|COMPLETED|Overall Study||772
8495904|NCT00526994|20936575|P1|COMPLETED|Overall Study||801
8495905|NCT00526994|20936573|P3|STARTED|Overall Study||898
8495906|NCT00526994|20936574|P2|STARTED|Overall Study||893
8495907|NCT00526994|20936575|P1|STARTED|Overall Study||909
8495908|NCT00526890|20936592|P1|NOT COMPLETED|Overall Study||2
8495909|NCT00526890|20936592|P1|COMPLETED|Overall Study||14
8495910|NCT00526890|20936592|P1|STARTED|Overall Study||16
8495911|NCT00526799|20936604|P2|NOT COMPLETED|Overall Study||1
8495912|NCT00526799|20936605|P1|NOT COMPLETED|Overall Study||1
8495913|NCT00526799|20936604|P2|COMPLETED|Overall Study||13
8495914|NCT00526799|20936605|P1|COMPLETED|Overall Study||15
8495915|NCT00526799|20936604|P2|STARTED|Overall Study||14
8495916|NCT00526799|20936605|P1|STARTED|Overall Study||16
8495917|NCT00526669|20936613|P2|NOT COMPLETED|Combined Treatment Phase||8
8495918|NCT00526669|20936614|P1|NOT COMPLETED|Combined Treatment Phase||0
8495919|NCT00526669|20936613|P2|COMPLETED|Combined Treatment Phase||59
8495920|NCT00526669|20936614|P1|COMPLETED|Combined Treatment Phase||0
8495921|NCT00526669|20936613|P2|STARTED|Combined Treatment Phase||67
8495922|NCT00526669|20936614|P1|STARTED|Combined Treatment Phase||0
8495923|NCT00526669|20936613|P2|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
8495924|NCT00526669|20936614|P1|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
8495925|NCT00526669|20936613|P2|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
8495926|NCT00526669|20936614|P1|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
8495927|NCT00526669|20936613|P2|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
8495928|NCT00526669|20936614|P1|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
8495929|NCT00526656|20936643|P1|NOT COMPLETED|Overall Study||2
8495930|NCT00526656|20936643|P1|COMPLETED|Overall Study||7
8495931|NCT00526656|20936643|P1|STARTED|Overall Study||9
8495932|NCT00526630|20936649|P2|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
8495933|NCT00526630|20936650|P1|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
8495934|NCT00526630|20936649|P2|COMPLETED|Second Intervention Period - 12 Weeks||7
8495935|NCT00526630|20936650|P1|COMPLETED|Second Intervention Period - 12 Weeks||10
8495936|NCT00526630|20936649|P2|STARTED|Second Intervention Period - 12 Weeks||8
8495937|NCT00526630|20936650|P1|STARTED|Second Intervention Period - 12 Weeks||12
8495938|NCT00526630|20936649|P2|NOT COMPLETED|First Intervention Period - 12 Weeks||3
8495939|NCT00526630|20936650|P1|NOT COMPLETED|First Intervention Period - 12 Weeks||0
8495940|NCT00526630|20936649|P2|COMPLETED|First Intervention Period - 12 Weeks||8
8495941|NCT00526630|20936650|P1|COMPLETED|First Intervention Period - 12 Weeks||12
8495942|NCT00526630|20936649|P2|STARTED|First Intervention Period - 12 Weeks||11
8495943|NCT00526630|20936650|P1|STARTED|First Intervention Period - 12 Weeks||12
8495944|NCT00526591|20936680|P2|NOT COMPLETED|Overall Study||0
8495945|NCT00526591|20936681|P1|NOT COMPLETED|Overall Study||0
8495946|NCT00526591|20936680|P2|COMPLETED|Overall Study||9
8495947|NCT00526591|20936681|P1|COMPLETED|Overall Study||8
8495948|NCT00526591|20936680|P2|STARTED|Overall Study||9
8495949|NCT00526591|20936681|P1|STARTED|Overall Study||8
8495950|NCT00526474|20936693|P2|NOT COMPLETED|Overall Study||272
8495951|NCT00526474|20936694|P1|NOT COMPLETED|Overall Study||292
8495952|NCT00526474|20936693|P2|COMPLETED|Overall Study||12953
8495953|NCT00526474|20936694|P1|COMPLETED|Overall Study||12932
8495954|NCT00526474|20936693|P2|Received Study Drug|Overall Study||13186
8495955|NCT00526474|20936694|P1|Received Study Drug|Overall Study||13166
8495956|NCT00526474|20936693|P2|STARTED|Overall Study||13225
8495957|NCT00526474|20936694|P1|STARTED|Overall Study||13224
8495958|NCT00526331|20936762|P1|NOT COMPLETED|Overall Study||55
8495959|NCT00526331|20936762|P1|COMPLETED|Overall Study||0
8495960|NCT00526331|20936762|P1|STARTED|Overall Study||55
8495961|NCT00526292|20936766|P1|NOT COMPLETED|Overall Study||0
8495962|NCT00526292|20936766|P1|COMPLETED|Overall Study||6
8495963|NCT00526292|20936766|P1|STARTED|Overall Study||6
8495964|NCT00526227|20936770|P1|NOT COMPLETED|Overall Study||2
8495965|NCT00526227|20936770|P1|COMPLETED|Overall Study||79
8495966|NCT00526227|20936770|P1|STARTED|Overall Study||81
8495967|NCT00526188|20936777|P1|NOT COMPLETED|Overall Study||0
8495968|NCT00526188|20936777|P1|COMPLETED|Overall Study||234
8495969|NCT00526188|20936777|P1|STARTED|Overall Study||234
8495970|NCT00526162|20936783|P1|NOT COMPLETED|Overall Study||3
8495971|NCT00526162|20936783|P1|COMPLETED|Overall Study||80
8495972|NCT00526162|20936783|P1|STARTED|Overall Study||83
8495973|NCT00526123|20936793|P2|NOT COMPLETED|Overall Study||246
8495974|NCT00526123|20936794|P1|NOT COMPLETED|Overall Study||264
8495975|NCT00526123|20936793|P2|COMPLETED|Overall Study||50
8495976|NCT00526123|20936794|P1|COMPLETED|Overall Study||39
8495977|NCT00526123|20936793|P2|STARTED|Overall Study|Intent-to-Treat population|296
8495978|NCT00526123|20936794|P1|STARTED|Overall Study|Intent-to-Treat population|303
8495979|NCT00526110|20936816|P2|NOT COMPLETED|Overall Study||41
8495980|NCT00526110|20936817|P1|NOT COMPLETED|Overall Study||2
8495981|NCT00526110|20936816|P2|COMPLETED|Overall Study||4
8495982|NCT00526110|20936817|P1|COMPLETED|Overall Study||51
8495983|NCT00526110|20936816|P2|STARTED|Overall Study||45
8495984|NCT00526110|20936817|P1|STARTED|Overall Study||53
8495985|NCT00526097|20936826|P2|NOT COMPLETED|Overall Study||56
8495986|NCT00526097|20936827|P1|NOT COMPLETED|Overall Study||15
8495987|NCT00526097|20936826|P2|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
8495988|NCT00526097|20936827|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
8495989|NCT00526097|20936826|P2|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
8495990|NCT00526097|20936827|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
8495991|NCT00526071|20937003|P1|NOT COMPLETED|Overall Study||6
8495992|NCT00526071|20937003|P1|COMPLETED|Overall Study||17
8495993|NCT00526071|20937003|P1|Non-amenable Population; Women|Overall Study||4
8495994|NCT00526071|20937003|P1|Non-amenable Population; Men|Overall Study||3
8495995|NCT00526071|20937003|P1|Amenable Population; Women|Overall Study||5
8495996|NCT00526071|20937003|P1|Amenable Population; Men|Overall Study||11
8495997|NCT00526071|20937003|P1|Pharmacodynamic (PD) Population|Overall Study||23
8495998|NCT00526071|20937003|P1|Safety Population|Overall Study||23
8495999|NCT00526071|20937003|P1|STARTED|Overall Study||23
8496000|NCT00526058|20937014|P2|NOT COMPLETED|Period: Second Intervention||0
8496001|NCT00526058|20937015|P1|NOT COMPLETED|Period: Second Intervention||0
8496002|NCT00526058|20937014|P2|COMPLETED|Period: Second Intervention||9
8496003|NCT00526058|20937015|P1|COMPLETED|Period: Second Intervention||9
8496004|NCT00526058|20937014|P2|STARTED|Period: Second Intervention||9
8496005|NCT00526058|20937015|P1|STARTED|Period: Second Intervention||9
8496006|NCT00526058|20937014|P2|NOT COMPLETED|Period: First Intervention||0
8496007|NCT00526058|20937015|P1|NOT COMPLETED|Period: First Intervention||0
8496008|NCT00526058|20937014|P2|COMPLETED|Period: First Intervention||9
8496009|NCT00526058|20937015|P1|COMPLETED|Period: First Intervention||9
8496010|NCT00526058|20937014|P2|STARTED|Period: First Intervention||9
8496011|NCT00526058|20937015|P1|STARTED|Period: First Intervention||9
8496012|NCT00525915|20937029|P2|NOT COMPLETED|Overall Study||9
8496013|NCT00525915|20937030|P1|NOT COMPLETED|Overall Study||8
8496014|NCT00525915|20937029|P2|COMPLETED|Overall Study||54
8496015|NCT00525915|20937030|P1|COMPLETED|Overall Study|Participants who underwent surgery.|55
8496016|NCT00525915|20937029|P2|STARTED|Overall Study||63
8496017|NCT00525915|20937030|P1|STARTED|Overall Study||63
8496018|NCT00525902|20937036|P1|NOT COMPLETED|Overall Study||1
8496019|NCT00525902|20937036|P1|COMPLETED|Overall Study||30
8496020|NCT00525902|20937036|P1|50 Weeks|Overall Study||12
8496021|NCT00525902|20937036|P1|10 Weeks|Overall Study||30
8496022|NCT00525902|20937036|P1|STARTED|Overall Study||31
8496023|NCT00525876|20937043|P2|NOT COMPLETED|Overall Study||0
8496024|NCT00525876|20937044|P1|NOT COMPLETED|Overall Study||0
8496025|NCT00525876|20937043|P2|COMPLETED|Overall Study||20
8496026|NCT00525876|20937044|P1|COMPLETED|Overall Study||16
8496027|NCT00525876|20937043|P2|STARTED|Overall Study||20
8496028|NCT00525876|20937044|P1|STARTED|Overall Study||16
8496029|NCT00525837|20937050|P1|NOT COMPLETED|Overall Study||4
8496030|NCT00525837|20937050|P1|COMPLETED|Overall Study||14
8496031|NCT00525837|20937050|P1|STARTED|Overall Study||18
8496032|NCT00525824|20937060|P4|NOT COMPLETED|Overall Study||15
8496033|NCT00525824|20937061|P3|NOT COMPLETED|Overall Study||19
8496034|NCT00525824|20937062|P2|NOT COMPLETED|Overall Study||28
8496035|NCT00525824|20937063|P1|NOT COMPLETED|Overall Study||19
8496036|NCT00525824|20937060|P4|COMPLETED|Overall Study||188
8496037|NCT00525824|20937061|P3|COMPLETED|Overall Study||183
8496038|NCT00525824|20937062|P2|COMPLETED|Overall Study||186
8496039|NCT00525824|20937063|P1|COMPLETED|Overall Study||195
8496040|NCT00525824|20937060|P4|STARTED|Overall Study|Randomized population|203
8496041|NCT00525824|20937061|P3|STARTED|Overall Study|Randomized population|202
8496042|NCT00525824|20937062|P2|STARTED|Overall Study|Randomized population|214
8496043|NCT00525824|20937063|P1|STARTED|Overall Study|Randomized population|214
8496044|NCT00525798|20937127|P2|NOT COMPLETED|Overall Study||599
8496045|NCT00525798|20937128|P1|NOT COMPLETED|Overall Study||756
8496046|NCT00525798|20937127|P2|COMPLETED|Overall Study||1732
8496047|NCT00525798|20937128|P1|COMPLETED|Overall Study||1578
8496048|NCT00525798|20937127|P2|STARTED|Overall Study||2331
8496049|NCT00525798|20937128|P1|STARTED|Overall Study||2334
8496050|NCT00525785|20937136|P1|NOT COMPLETED|Overall Study||3
8496051|NCT00525785|20937136|P1|COMPLETED|Overall Study||55
8496052|NCT00525785|20937136|P1|STARTED|Overall Study||58
8496053|NCT00525733|20937142|P2|NOT COMPLETED|Overall Study||3
8496054|NCT00525733|20937143|P1|NOT COMPLETED|Overall Study||3
8496055|NCT00525733|20937142|P2|COMPLETED|Overall Study||23
8496056|NCT00525733|20937143|P1|COMPLETED|Overall Study||11
8496057|NCT00525733|20937142|P2|STARTED|Overall Study||26
8496058|NCT00525733|20937143|P1|STARTED|Overall Study||14
8496059|NCT00525629|20937149|P2|NOT COMPLETED|Second Intervention||15
8496060|NCT00525629|20937150|P1|NOT COMPLETED|Second Intervention||15
8496061|NCT00525629|20937149|P2|COMPLETED|Second Intervention||0
8496062|NCT00525629|20937150|P1|COMPLETED|Second Intervention||0
8496063|NCT00525629|20937149|P2|STARTED|Second Intervention||15
8496064|NCT00525629|20937150|P1|STARTED|Second Intervention||15
8496065|NCT00525629|20937149|P2|NOT COMPLETED|Washout||0
8496066|NCT00525629|20937150|P1|NOT COMPLETED|Washout||0
8496067|NCT00525629|20937149|P2|COMPLETED|Washout||15
8496068|NCT00525629|20937150|P1|COMPLETED|Washout||15
8496069|NCT00525629|20937149|P2|STARTED|Washout||15
8496070|NCT00525629|20937150|P1|STARTED|Washout||15
8496071|NCT00525629|20937149|P2|NOT COMPLETED|First Intervention||5
8496072|NCT00525629|20937150|P1|NOT COMPLETED|First Intervention||5
8496073|NCT00525629|20937149|P2|COMPLETED|First Intervention||15
8496074|NCT00525629|20937150|P1|COMPLETED|First Intervention||15
8496075|NCT00525629|20937149|P2|STARTED|First Intervention||20
8496076|NCT00525629|20937150|P1|STARTED|First Intervention||20
8496077|NCT00525603|20937156|P1|NOT COMPLETED|Overall Study||0
8496078|NCT00525603|20937156|P1|COMPLETED|Overall Study||60
8496079|NCT00525603|20937156|P1|STARTED|Overall Study||60
8496080|NCT00525590|20937160|P1|NOT COMPLETED|Overall Study||45
8496081|NCT00525590|20937160|P1|COMPLETED|Overall Study||14
8496082|NCT00525590|20937160|P1|STARTED|Overall Study||59
8496083|NCT00525525|20937178|P2|NOT COMPLETED|Overall Study||0
8496084|NCT00525525|20937179|P1|NOT COMPLETED|Overall Study||0
8496085|NCT00525525|20937178|P2|COMPLETED|Overall Study||15
8496086|NCT00525525|20937179|P1|COMPLETED|Overall Study||59
8496087|NCT00525525|20937178|P2|STARTED|Overall Study||15
8496088|NCT00525525|20937179|P1|STARTED|Overall Study||59
8496089|NCT00525512|20937188|P4|NOT COMPLETED|Open-Label Phase||5
8496090|NCT00525512|20937189|P3|NOT COMPLETED|Open-Label Phase||6
8496091|NCT00525512|20937190|P2|NOT COMPLETED|Open-Label Phase||0
8496092|NCT00525512|20937191|P1|NOT COMPLETED|Open-Label Phase||0
8496093|NCT00525512|20937188|P4|COMPLETED|Open-Label Phase||189
8496094|NCT00525512|20937189|P3|COMPLETED|Open-Label Phase||158
8496095|NCT00525512|20937190|P2|COMPLETED|Open-Label Phase||0
8496096|NCT00525512|20937191|P1|COMPLETED|Open-Label Phase||0
8496097|NCT00525512|20937188|P4|STARTED|Open-Label Phase||194
8496098|NCT00525512|20937189|P3|STARTED|Open-Label Phase||164
8496099|NCT00525512|20937190|P2|STARTED|Open-Label Phase||0
8496100|NCT00525512|20937191|P1|STARTED|Open-Label Phase||0
8496101|NCT00525512|20937188|P4|NOT COMPLETED|Double-Blind Phase||0
8496102|NCT00525512|20937189|P3|NOT COMPLETED|Double-Blind Phase||0
8496103|NCT00525512|20937190|P2|NOT COMPLETED|Double-Blind Phase||66
8496104|NCT00525512|20937191|P1|NOT COMPLETED|Double-Blind Phase||96
8496105|NCT00525512|20937188|P4|COMPLETED|Double-Blind Phase||0
8496106|NCT00525512|20937189|P3|COMPLETED|Double-Blind Phase||0
8496107|NCT00525512|20937190|P2|COMPLETED|Double-Blind Phase||194
8496108|NCT00525512|20937191|P1|COMPLETED|Double-Blind Phase||163
8496109|NCT00525512|20937188|P4|STARTED|Double-Blind Phase||0
8496110|NCT00525512|20937189|P3|STARTED|Double-Blind Phase||0
8496111|NCT00525512|20937190|P2|STARTED|Double-Blind Phase||260
8496112|NCT00525512|20937191|P1|STARTED|Double-Blind Phase||259
8496113|NCT00525499|20937333|P4|NOT COMPLETED|Overall Study||7
8496114|NCT00525499|20937334|P3|NOT COMPLETED|Overall Study||7
8496115|NCT00525499|20937335|P2|NOT COMPLETED|Overall Study||7
8496116|NCT00525499|20937336|P1|NOT COMPLETED|Overall Study||7
8496117|NCT00525499|20937333|P4|COMPLETED|Overall Study||39
8496118|NCT00525499|20937334|P3|COMPLETED|Overall Study||40
8496119|NCT00525499|20937335|P2|COMPLETED|Overall Study||39
8496120|NCT00525499|20937336|P1|COMPLETED|Overall Study||40
8496121|NCT00525499|20937333|P4|STARTED|Overall Study||46
8496122|NCT00525499|20937334|P3|STARTED|Overall Study||47
8496123|NCT00525499|20937335|P2|STARTED|Overall Study||46
8496124|NCT00525499|20937336|P1|STARTED|Overall Study||47
8496125|NCT00525421|20937352|P2|NOT COMPLETED|Overall Study||0
8496126|NCT00525421|20937353|P1|NOT COMPLETED|Overall Study||0
8496127|NCT00525421|20937352|P2|COMPLETED|Overall Study||10
8496128|NCT00525421|20937353|P1|COMPLETED|Overall Study||10
8496129|NCT00525421|20937352|P2|STARTED|Overall Study||10
8496130|NCT00525421|20937353|P1|STARTED|Overall Study|Enrollment started october 2007|10
8496131|NCT00525265|20937363|P2|NOT COMPLETED|Overall Study||0
8496132|NCT00525265|20937364|P1|NOT COMPLETED|Overall Study||1
8496133|NCT00525265|20937363|P2|COMPLETED|Overall Study||10
8496134|NCT00525265|20937364|P1|COMPLETED|Overall Study||9
8496135|NCT00525265|20937363|P2|STARTED|Overall Study||10
8496136|NCT00525265|20937364|P1|STARTED|Overall Study||10
8496137|NCT00525174|20937372|P2|NOT COMPLETED|Overall Study||8
8496138|NCT00525174|20937373|P1|NOT COMPLETED|Overall Study||9
8496139|NCT00525174|20937372|P2|COMPLETED|Overall Study||81
8496140|NCT00525174|20937373|P1|COMPLETED|Overall Study||88
8496141|NCT00525174|20937372|P2|STARTED|Overall Study||89
8496142|NCT00525174|20937373|P1|STARTED|Overall Study||97
8496143|NCT00525161|20937421|P1|NOT COMPLETED|Overall Study||1
8496144|NCT00525161|20937421|P1|COMPLETED|Overall Study||10
8496145|NCT00525161|20937421|P1|STARTED|Overall Study||11
8496146|NCT00525148|20937431|P4|NOT COMPLETED|Overall Study||61
8496147|NCT00525148|20937432|P3|NOT COMPLETED|Overall Study||7
8496148|NCT00525148|20937433|P2|NOT COMPLETED|Overall Study||38
8496149|NCT00525148|20937434|P1|NOT COMPLETED|Overall Study||23
8496150|NCT00525148|20937431|P4|COMPLETED|Overall Study||0
8496151|NCT00525148|20937432|P3|COMPLETED|Overall Study||0
8496152|NCT00525148|20937433|P2|COMPLETED|Overall Study||0
8496153|NCT00525148|20937434|P1|COMPLETED|Overall Study||0
8496154|NCT00525148|20937431|P4|STARTED|Overall Study|entered and treated|61
8496155|NCT00525148|20937432|P3|STARTED|Overall Study|entered and treated|7
8496156|NCT00525148|20937433|P2|STARTED|Overall Study|entered and treated|38
8496157|NCT00525148|20937434|P1|STARTED|Overall Study|entered and treated|23
8496158|NCT00525135|20937452|P1|NOT COMPLETED|Overall Study||0
8496159|NCT00525135|20937452|P1|COMPLETED|Overall Study||5
8496160|NCT00525135|20937452|P1|STARTED|Overall Study||5
8496161|NCT00525057|20937462|P2|NOT COMPLETED|Overall Study||0
8496162|NCT00525057|20937463|P1|NOT COMPLETED|Overall Study||0
8496163|NCT00525057|20937462|P2|COMPLETED|Overall Study||25
8496164|NCT00525057|20937463|P1|COMPLETED|Overall Study||25
8496165|NCT00525057|20937462|P2|STARTED|Overall Study||25
8496166|NCT00525057|20937463|P1|STARTED|Overall Study||25
8496167|NCT00525044|20937475|P2|NOT COMPLETED|Overall Study||1
8496168|NCT00525044|20937476|P1|NOT COMPLETED|Overall Study||0
8496169|NCT00525044|20937475|P2|COMPLETED|Overall Study||124
8496170|NCT00525044|20937476|P1|COMPLETED|Overall Study||124
8496171|NCT00525044|20937475|P2|STARTED|Overall Study||125
8496172|NCT00525044|20937476|P1|STARTED|Overall Study||124
8496173|NCT00525031|20937492|P2|NOT COMPLETED|Overall Study||1
8496174|NCT00525031|20937493|P1|NOT COMPLETED|Overall Study||1
8496175|NCT00525031|20937492|P2|COMPLETED|Overall Study||24
8496176|NCT00525031|20937493|P1|COMPLETED|Overall Study||26
8496177|NCT00525031|20937492|P2|STARTED|Overall Study||25
8496178|NCT00525031|20937493|P1|STARTED|Overall Study||27
8496179|NCT00524940|20937500|P1|NOT COMPLETED|Overall Study||0
8496180|NCT00524940|20937500|P1|COMPLETED|Overall Study||124
8496181|NCT00524940|20937500|P1|STARTED|Overall Study||124
8496182|NCT00524771|20937507|P2|NOT COMPLETED|Overall Study||585
8496183|NCT00524771|20937508|P1|NOT COMPLETED|Overall Study||220
8496184|NCT00524771|20937507|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
8496185|NCT00524771|20937508|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
8496186|NCT00524771|20937507|P2|STARTED|Overall Study||17016
8496187|NCT00524771|20937508|P1|STARTED|Overall Study||17084
8496188|NCT00524745|20937522|P4|NOT COMPLETED|Overall Study||22
8496189|NCT00524745|20937523|P3|NOT COMPLETED|Overall Study||29
8496190|NCT00524745|20937524|P2|NOT COMPLETED|Overall Study||13
8496191|NCT00524745|20937525|P1|NOT COMPLETED|Overall Study||34
8496192|NCT00524745|20937522|P4|COMPLETED|Overall Study||205
8496193|NCT00524745|20937523|P3|COMPLETED|Overall Study||212
8496194|NCT00524745|20937524|P2|COMPLETED|Overall Study||193
8496195|NCT00524745|20937525|P1|COMPLETED|Overall Study||195
8496196|NCT00524745|20937522|P4|STARTED|Overall Study||227
8496197|NCT00524745|20937523|P3|STARTED|Overall Study||241
8496198|NCT00524745|20937524|P2|STARTED|Overall Study||206
8496199|NCT00524745|20937525|P1|STARTED|Overall Study||229
8496200|NCT00524680|20937551|P4|NOT COMPLETED|Overall Study||6
8496201|NCT00524680|20937552|P3|NOT COMPLETED|Overall Study||3
8496202|NCT00524680|20937553|P2|NOT COMPLETED|Overall Study||1
8496203|NCT00524680|20937554|P1|NOT COMPLETED|Overall Study||3
8496204|NCT00524680|20937551|P4|COMPLETED|Overall Study||34
8496205|NCT00524680|20937552|P3|COMPLETED|Overall Study||33
8496206|NCT00524680|20937553|P2|COMPLETED|Overall Study||34
8496207|NCT00524680|20937554|P1|COMPLETED|Overall Study||34
8496208|NCT00524680|20937551|P4|STARTED|Overall Study||40
8496209|NCT00524680|20937552|P3|STARTED|Overall Study||36
8496210|NCT00524680|20937553|P2|STARTED|Overall Study||35
8496211|NCT00524680|20937554|P1|STARTED|Overall Study||37
8496212|NCT00524589|20937576|P1|NOT COMPLETED|Overall Study||18
8496213|NCT00524589|20937576|P1|COMPLETED|Overall Study||0
8496214|NCT00524589|20937576|P1|STARTED|Overall Study||18
8496215|NCT00524576|20937583|P2|NOT COMPLETED|Overall Study||0
8496216|NCT00524576|20937584|P1|NOT COMPLETED|Overall Study||0
8496217|NCT00524576|20937583|P2|COMPLETED|Overall Study||47
8496218|NCT00524576|20937584|P1|COMPLETED|Overall Study||97
8496219|NCT00524576|20937583|P2|STARTED|Overall Study||47
8496220|NCT00524576|20937584|P1|STARTED|Overall Study||97
8496221|NCT00524537|20937602|P1|NOT COMPLETED|Overall Study||2574
8496222|NCT00524537|20937602|P1|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
8496223|NCT00524537|20937602|P1|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
8496224|NCT00524537|20937602|P1|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
8496225|NCT00524537|20937602|P1|Discontinued|Overall Study|Discontinued from study|2811
8496226|NCT00524537|20937602|P1|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
8496227|NCT00524511|20937618|P2|NOT COMPLETED|Overall Study||7
8496228|NCT00524511|20937619|P1|NOT COMPLETED|Overall Study||4
8496229|NCT00524511|20937618|P2|COMPLETED|Overall Study||61
8496230|NCT00524511|20937619|P1|COMPLETED|Overall Study||64
8496231|NCT00524511|20937618|P2|STARTED|Overall Study||68
8496232|NCT00524511|20937619|P1|STARTED|Overall Study||68
8496233|NCT00524485|20937627|P1|NOT COMPLETED|Overall Study||5
8496234|NCT00524485|20937627|P1|COMPLETED|Overall Study||7
8496235|NCT00524485|20937627|P1|STARTED|Overall Study||12
8496236|NCT00524472|20937639|P2|NOT COMPLETED|Overall Study||0
8496237|NCT00524472|20937640|P1|NOT COMPLETED|Overall Study||0
8496238|NCT00524472|20937639|P2|COMPLETED|Overall Study||730
8496239|NCT00524472|20937640|P1|COMPLETED|Overall Study||709
8496240|NCT00524472|20937639|P2|STARTED|Overall Study||730
8496241|NCT00524472|20937640|P1|STARTED|Overall Study||709
8496242|NCT00524459|20937656|P1|NOT COMPLETED|Overall Study||2
8496243|NCT00524459|20937656|P1|COMPLETED|Overall Study||4
8496244|NCT00524459|20937656|P1|STARTED|Overall Study||6
8496245|NCT00524420|20937666|P2|NOT COMPLETED|Overall Study||0
8496246|NCT00524420|20937667|P1|NOT COMPLETED|Overall Study||1
8496247|NCT00524420|20937666|P2|COMPLETED|Overall Study||11
8496248|NCT00524420|20937667|P1|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
8496249|NCT00524420|20937666|P2|STARTED|Overall Study||11
8496250|NCT00524420|20937667|P1|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
8496251|NCT00524394|20937679|P1|NOT COMPLETED|Overall Study||1
8496252|NCT00524394|20937679|P1|COMPLETED|Overall Study||1
8496253|NCT00524394|20937679|P1|STARTED|Overall Study||2
8496254|NCT00524368|20937685|P2|NOT COMPLETED|Overall Study||48
8496255|NCT00524368|20937686|P1|NOT COMPLETED|Overall Study||41
8496256|NCT00524368|20937685|P2|COMPLETED|Overall Study||248
8496257|NCT00524368|20937686|P1|COMPLETED|Overall Study||253
8496258|NCT00524368|20937685|P2|STARTED|Overall Study||296
8496259|NCT00524368|20937686|P1|STARTED|Overall Study||294
8496260|NCT00524342|20937714|P1|NOT COMPLETED|Overall Study||0
8496261|NCT00524342|20937714|P1|COMPLETED|Overall Study||7
8496262|NCT00524342|20937714|P1|STARTED|Overall Study||7
8496263|NCT00524316|20937720|P1|NOT COMPLETED|Overall Study||16
8496264|NCT00524316|20937720|P1|COMPLETED|Overall Study||0
8496265|NCT00524316|20937720|P1|STARTED|Overall Study||16
8496266|NCT00524303|20937732|P3|NOT COMPLETED|Overall Study||18
8496267|NCT00524303|20937733|P2|NOT COMPLETED|Overall Study||10
8496268|NCT00524303|20937734|P1|NOT COMPLETED|Overall Study||12
8496269|NCT00524303|20937732|P3|COMPLETED|Overall Study||15
8496270|NCT00524303|20937733|P2|COMPLETED|Overall Study||24
8496271|NCT00524303|20937734|P1|COMPLETED|Overall Study||21
8496272|NCT00524303|20937732|P3|STARTED|Overall Study||33
8496273|NCT00524303|20937733|P2|STARTED|Overall Study||34
8496274|NCT00524303|20937734|P1|STARTED|Overall Study||33
8496275|NCT00524264|20937764|P2|NOT COMPLETED|Overall Study||27
8496276|NCT00524264|20937765|P1|NOT COMPLETED|Overall Study||20
8496277|NCT00524264|20937764|P2|COMPLETED|Overall Study||57
8496278|NCT00524264|20937765|P1|COMPLETED|Overall Study||144
8496279|NCT00524264|20937764|P2|STARTED|Overall Study||84
8496280|NCT00524264|20937765|P1|STARTED|Overall Study||164
8496281|NCT00524225|20937777|P1|NOT COMPLETED|Overall Study||0
8496282|NCT00524225|20937777|P1|COMPLETED|Overall Study||3
8496283|NCT00524225|20937777|P1|STARTED|Overall Study||3
8496284|NCT00524173|20937786|P2|NOT COMPLETED|Overall Study||2
8496285|NCT00524173|20937787|P1|NOT COMPLETED|Overall Study||5
8496286|NCT00524173|20937786|P2|COMPLETED|Overall Study||13
8496287|NCT00524173|20937787|P1|COMPLETED|Overall Study||12
8496288|NCT00524173|20937786|P2|STARTED|Overall Study||15
8496289|NCT00524173|20937787|P1|STARTED|Overall Study||17
8496290|NCT00524134|20937799|P1|NOT COMPLETED|Overall Study||2
8496291|NCT00524134|20937799|P1|COMPLETED|Overall Study||4
8496292|NCT00524134|20937799|P1|STARTED|Overall Study||6
8496293|NCT00524121|20937806|P1|NOT COMPLETED|Overall Study||19
8496294|NCT00524121|20937806|P1|COMPLETED|Overall Study||3
8496295|NCT00524121|20937806|P1|STARTED|Overall Study||22
8496296|NCT00524043|20937826|P3|NOT COMPLETED|Overall Study||31
8496297|NCT00524043|20937827|P2|NOT COMPLETED|Overall Study||28
8496298|NCT00524043|20937828|P1|NOT COMPLETED|Overall Study||30
8496299|NCT00524043|20937826|P3|COMPLETED|Overall Study||35
8496300|NCT00524043|20937827|P2|COMPLETED|Overall Study||42
8496301|NCT00524043|20937828|P1|COMPLETED|Overall Study||34
8496302|NCT00524043|20937826|P3|STARTED|Overall Study||66
8496303|NCT00524043|20937827|P2|STARTED|Overall Study||70
8496304|NCT00524043|20937828|P1|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
8496305|NCT00524030|20937850|P2|NOT COMPLETED|Overall Study||59
8496306|NCT00524030|20937851|P1|NOT COMPLETED|Overall Study||17
8496307|NCT00524030|20937850|P2|COMPLETED|Overall Study||70
8496308|NCT00524030|20937851|P1|COMPLETED|Overall Study||15
8496309|NCT00524030|20937850|P2|Completed Taper/Titration Phase|Overall Study||70
8496310|NCT00524030|20937851|P1|Completed Taper/Titration Phase|Overall Study||15
8496311|NCT00524030|20937850|P2|Completed Double-Blind Treatment Phase|Overall Study||70
8496312|NCT00524030|20937851|P1|Completed Double-Blind Treatment Phase|Overall Study||15
8496313|NCT00524030|20937850|P2|STARTED|Overall Study||129
8496314|NCT00524030|20937851|P1|STARTED|Overall Study||32
8496315|NCT00524017|20937871|P2|NOT COMPLETED|Overall Study||1
8496316|NCT00524017|20937872|P1|NOT COMPLETED|Overall Study||0
8496317|NCT00524017|20937871|P2|COMPLETED|Overall Study||5
8496318|NCT00524017|20937872|P1|COMPLETED|Overall Study||13
8496319|NCT00524017|20937871|P2|STARTED|Overall Study||6
8496320|NCT00524017|20937872|P1|STARTED|Overall Study||13
8496321|NCT00523991|20937890|P2|NOT COMPLETED|Overall Study||27
8496322|NCT00523991|20937891|P1|NOT COMPLETED|Overall Study||21
8496323|NCT00523991|20937890|P2|COMPLETED|Overall Study||211
8496324|NCT00523991|20937891|P1|COMPLETED|Overall Study||198
8496325|NCT00523991|20937890|P2|STARTED|Overall Study||238
8496326|NCT00523991|20937891|P1|STARTED|Overall Study||219
8496327|NCT00523978|20938171|P2|NOT COMPLETED|Overall Study||8
8496328|NCT00523978|20938172|P1|NOT COMPLETED|Overall Study||9
8496329|NCT00523978|20938171|P2|COMPLETED|Overall Study||79
8496330|NCT00523978|20938172|P1|COMPLETED|Overall Study||162
8496331|NCT00523978|20938171|P2|STARTED|Overall Study||87
8496332|NCT00523978|20938172|P1|STARTED|Overall Study||171
8496333|NCT00523939|20938186|P2|NOT COMPLETED|Overall Study||0
8496334|NCT00523939|20938187|P1|NOT COMPLETED|Overall Study||0
8496335|NCT00523939|20938186|P2|COMPLETED|Overall Study||2
8496336|NCT00523939|20938187|P1|COMPLETED|Overall Study||2
8496337|NCT00523939|20938186|P2|STARTED|Overall Study||2
8496338|NCT00523939|20938187|P1|STARTED|Overall Study||2
8496339|NCT00523848|20938194|P1|NOT COMPLETED|Overall Study||24
8496340|NCT00523848|20938194|P1|COMPLETED|Overall Study||22
8496341|NCT00523848|20938194|P1|Treated With Study Therapy|Overall Study||44
8496342|NCT00523848|20938194|P1|STARTED|Overall Study||46
8496343|NCT00523809|20938200|P1|NOT COMPLETED|Overall Study||0
8496344|NCT00523809|20938200|P1|COMPLETED|Overall Study||5
8496345|NCT00523809|20938200|P1|STARTED|Overall Study||5
8496346|NCT00523744|20938204|P1|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
8496347|NCT00523744|20938204|P1|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
8496348|NCT00523744|20938204|P1|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
8496349|NCT00523744|20938204|P1|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
8496350|NCT00523744|20938204|P1|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
8496351|NCT00523744|20938204|P1|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
8496352|NCT00523744|20938204|P1|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
8496353|NCT00523744|20938204|P1|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
8496354|NCT00523744|20938204|P1|STARTED|Phase 1 - Amlodipine+Olmesartan||257
8496355|NCT00523718|20938223|P2|NOT COMPLETED|Overall Study||0
8496356|NCT00523718|20938224|P1|NOT COMPLETED|Overall Study||3
8496357|NCT00523718|20938223|P2|COMPLETED|Overall Study||18
8496358|NCT00523718|20938224|P1|COMPLETED|Overall Study||17
8496359|NCT00523718|20938223|P2|STARTED|Overall Study||18
8496360|NCT00523718|20938224|P1|STARTED|Overall Study||20
8496361|NCT00523705|20938238|P2|NOT COMPLETED|Overall Study||1
8496362|NCT00523705|20938239|P1|NOT COMPLETED|Overall Study||0
8496363|NCT00523705|20938238|P2|COMPLETED|Overall Study|1 withdrew due to no time|3
8496364|NCT00523705|20938239|P1|COMPLETED|Overall Study||7
8496365|NCT00523705|20938238|P2|STARTED|Overall Study||4
8496366|NCT00523705|20938239|P1|STARTED|Overall Study||7
8496367|NCT00523640|20938251|P1|NOT COMPLETED|Overall Study||1
8496368|NCT00523640|20938251|P1|COMPLETED|Overall Study|1 patient died before starting treatment|29
8496369|NCT00523640|20938251|P1|STARTED|Overall Study||30
8496370|NCT00523614|20938259|P2|NOT COMPLETED|Overall Study||0
8496371|NCT00523614|20938260|P1|NOT COMPLETED|Overall Study||0
8496372|NCT00523614|20938259|P2|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
8496373|NCT00523614|20938260|P1|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
8496374|NCT00523614|20938259|P2|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
8496375|NCT00523614|20938260|P1|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
8496376|NCT00523549|20938268|P2|NOT COMPLETED|Overall Study||16
8496377|NCT00523549|20938269|P1|NOT COMPLETED|Overall Study||19
8496378|NCT00523549|20938268|P2|COMPLETED|Overall Study||99
8496379|NCT00523549|20938269|P1|COMPLETED|Overall Study||95
8496380|NCT00523549|20938268|P2|STARTED|Overall Study||115
8496381|NCT00523549|20938269|P1|STARTED|Overall Study||114
8496382|NCT00523419|20938287|P1|NOT COMPLETED|Overall Study||32
8496383|NCT00523419|20938287|P1|COMPLETED|Overall Study||0
8496384|NCT00523419|20938287|P1|STARTED|Overall Study||32
8496385|NCT00523367|20938297|P1|NOT COMPLETED|Overall Study||23
8496386|NCT00523367|20938297|P1|COMPLETED|Overall Study||2
8496387|NCT00523367|20938297|P1|STARTED|Overall Study||25
8496388|NCT00523341|20938303|P2|NOT COMPLETED|Overall Study||1000
8496389|NCT00523341|20938304|P1|NOT COMPLETED|Overall Study||924
8496390|NCT00523341|20938303|P2|COMPLETED|Overall Study||1343
8496391|NCT00523341|20938304|P1|COMPLETED|Overall Study||1283
8496392|NCT00523341|20938303|P2|Received Treatment|Overall Study||2343
8496393|NCT00523341|20938304|P1|Received Treatment|Overall Study||2206
8496394|NCT00523341|20938303|P2|STARTED|Overall Study||2343
8496395|NCT00523341|20938304|P1|STARTED|Overall Study||2207
8496396|NCT00523302|20938406|P2|NOT COMPLETED|Overall Study||0
8496397|NCT00523302|20938407|P1|NOT COMPLETED|Overall Study||0
8496398|NCT00523302|20938406|P2|COMPLETED|Overall Study||10
8496399|NCT00523302|20938407|P1|COMPLETED|Overall Study||10
8496400|NCT00523302|20938406|P2|STARTED|Overall Study||10
8496401|NCT00523302|20938407|P1|STARTED|Overall Study||10
8496402|NCT00523237|20938417|P1|NOT COMPLETED|Overall Study||0
8496403|NCT00523237|20938417|P1|COMPLETED|Overall Study||14
8496404|NCT00523237|20938417|P1|STARTED|Overall Study||14
8496405|NCT00522951|20938421|P2|NOT COMPLETED|Period 2||1
8496406|NCT00522951|20938422|P1|NOT COMPLETED|Period 2||2
8496407|NCT00522951|20938421|P2|COMPLETED|Period 2||75
8496408|NCT00522951|20938422|P1|COMPLETED|Period 2||84
8496409|NCT00522951|20938421|P2|Subjects Received Treatment|Period 2||75
8496410|NCT00522951|20938422|P1|Subjects Received Treatment|Period 2||84
8496411|NCT00522951|20938421|P2|STARTED|Period 2||76
8496412|NCT00522951|20938422|P1|STARTED|Period 2||86
8496413|NCT00522951|20938421|P2|NOT COMPLETED|Washout Period||2
8496414|NCT00522951|20938422|P1|NOT COMPLETED|Washout Period||0
8496415|NCT00522951|20938421|P2|COMPLETED|Washout Period||76
8496416|NCT00522951|20938422|P1|COMPLETED|Washout Period||86
8496417|NCT00522951|20938421|P2|STARTED|Washout Period||78
8496418|NCT00522951|20938422|P1|STARTED|Washout Period||86
8496419|NCT00522951|20938421|P2|NOT COMPLETED|Period 1||1
8496420|NCT00522951|20938422|P1|NOT COMPLETED|Period 1||0
8496421|NCT00522951|20938421|P2|COMPLETED|Period 1||78
8496422|NCT00522951|20938422|P1|COMPLETED|Period 1||86
8496423|NCT00522951|20938421|P2|Received Treatment|Period 1||78
8496424|NCT00522951|20938422|P1|Received Treatment|Period 1||86
8496425|NCT00522951|20938421|P2|STARTED|Period 1||79
8496426|NCT00522951|20938422|P1|STARTED|Period 1||86
8496427|NCT00522925|20938465|P3|NOT COMPLETED|Overall Study||2
8496428|NCT00522925|20938466|P2|NOT COMPLETED|Overall Study||1
8496429|NCT00522925|20938467|P1|NOT COMPLETED|Overall Study||8
8496430|NCT00522925|20938465|P3|COMPLETED|Overall Study||36
8496431|NCT00522925|20938466|P2|COMPLETED|Overall Study||38
8496432|NCT00522925|20938467|P1|COMPLETED|Overall Study||28
8496433|NCT00522925|20938465|P3|STARTED|Overall Study||38
8496434|NCT00522925|20938466|P2|STARTED|Overall Study||39
8496435|NCT00522925|20938467|P1|STARTED|Overall Study||36
8496436|NCT00522873|20938477|P2|NOT COMPLETED|Overall Study||44
8496437|NCT00522873|20938478|P1|NOT COMPLETED|Overall Study||96
8496438|NCT00522873|20938477|P2|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
8496439|NCT00522873|20938478|P1|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
8496440|NCT00522873|20938477|P2|Received Treatment|Overall Study||172
8496441|NCT00522873|20938478|P1|Received Treatment|Overall Study||489
8496442|NCT00522873|20938477|P2|STARTED|Overall Study||172
8496443|NCT00522873|20938478|P1|STARTED|Overall Study||490
8496444|NCT00522795|20938487|P1|NOT COMPLETED|Overall Study||0
8496445|NCT00522795|20938487|P1|COMPLETED|Overall Study||40
8496446|NCT00522795|20938487|P1|STARTED|Overall Study||40
8496447|NCT00522626|20938491|P1|NOT COMPLETED|Overall Study||7
8496448|NCT00522626|20938491|P1|COMPLETED|Overall Study||12
8496449|NCT00522626|20938491|P1|STARTED|Overall Study||19
8496450|NCT00522548|20938497|P2|NOT COMPLETED|Overall Study||4
8496451|NCT00522548|20938498|P1|NOT COMPLETED|Overall Study||2
8496452|NCT00522548|20938497|P2|COMPLETED|Overall Study||15
8496453|NCT00522548|20938498|P1|COMPLETED|Overall Study||16
8496454|NCT00522548|20938497|P2|Completed 2/2 PK Visits|Overall Study||5
8496455|NCT00522548|20938498|P1|Completed 2/2 PK Visits|Overall Study||7
8496456|NCT00522548|20938497|P2|Completed 1/2 PK Visits|Overall Study||1
8496457|NCT00522548|20938498|P1|Completed 1/2 PK Visits|Overall Study||1
8496458|NCT00522548|20938497|P2|Completed 0/2 PK Visits|Overall Study||4
8496459|NCT00522548|20938498|P1|Completed 0/2 PK Visits|Overall Study||3
8496460|NCT00522548|20938497|P2|Consented to Pharmacokinetic Study|Overall Study||10
8496461|NCT00522548|20938498|P1|Consented to Pharmacokinetic Study|Overall Study||11
8496462|NCT00522548|20938497|P2|STARTED|Overall Study||19
8496463|NCT00522548|20938498|P1|STARTED|Overall Study||18
8496464|NCT00522457|20938526|P1|NOT COMPLETED|Overall Study||18
8496465|NCT00522457|20938526|P1|COMPLETED|Overall Study||1
8496466|NCT00522457|20938526|P1|STARTED|Overall Study||19
8496467|NCT00522431|20938532|P1|NOT COMPLETED|Overall Study||11
8496468|NCT00522431|20938532|P1|COMPLETED|Overall Study||138
8496469|NCT00522431|20938532|P1|STARTED|Overall Study||149
8496470|NCT00522418|20938539|P2|NOT COMPLETED|Overall Study||58
8496471|NCT00522418|20938540|P1|NOT COMPLETED|Overall Study||57
8496472|NCT00522418|20938539|P2|COMPLETED|Overall Study|Completed 2-year follow-up|5
8496473|NCT00522418|20938540|P1|COMPLETED|Overall Study|Completed 2-year follow-up|2
8496474|NCT00522418|20938539|P2|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
8496475|NCT00522418|20938540|P1|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
8496476|NCT00522418|20938539|P2|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
8496477|NCT00522418|20938540|P1|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
8496478|NCT00522418|20938539|P2|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
8496479|NCT00522418|20938540|P1|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
8496480|NCT00522418|20938539|P2|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
8496481|NCT00522418|20938540|P1|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
8496482|NCT00522418|20938539|P2|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
8496483|NCT00522418|20938540|P1|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
8496484|NCT00522418|20938539|P2|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|58
8496485|NCT00522418|20938540|P1|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|54
8496486|NCT00522418|20938539|P2|STARTED|Overall Study||63
8496487|NCT00522418|20938540|P1|STARTED|Overall Study||59
8496488|NCT00522392|20938588|P2|NOT COMPLETED|Overall Study||13
8496489|NCT00522392|20938589|P1|NOT COMPLETED|Overall Study||8
8496490|NCT00522392|20938588|P2|COMPLETED|Overall Study||12
8496491|NCT00522392|20938589|P1|COMPLETED|Overall Study||15
8496492|NCT00522392|20938588|P2|Pts w/ QOL Assessments Complete|Overall Study||8
8496493|NCT00522392|20938589|P1|Pts w/ QOL Assessments Complete|Overall Study||12
8496494|NCT00522392|20938588|P2|Pts w/ Measurable Disease at Baseline|Overall Study||16
8496495|NCT00522392|20938589|P1|Pts w/ Measurable Disease at Baseline|Overall Study||16
8496496|NCT00522392|20938588|P2|STARTED|Overall Study||25
8496497|NCT00522392|20938589|P1|STARTED|Overall Study||23
8496498|NCT00522379|20938606|P5|NOT COMPLETED|Overall Study||27
8496499|NCT00522379|20938607|P4|NOT COMPLETED|Overall Study||14
8496500|NCT00522379|20938608|P3|NOT COMPLETED|Overall Study||22
8496501|NCT00522379|20938609|P2|NOT COMPLETED|Overall Study||23
8496502|NCT00522379|20938610|P1|NOT COMPLETED|Overall Study||22
8496503|NCT00522379|20938606|P5|COMPLETED|Overall Study||81
8496504|NCT00522379|20938607|P4|COMPLETED|Overall Study||80
8496505|NCT00522379|20938608|P3|COMPLETED|Overall Study||82
8496506|NCT00522379|20938609|P2|COMPLETED|Overall Study||84
8496507|NCT00522379|20938610|P1|COMPLETED|Overall Study||79
8496508|NCT00522379|20938606|P5|STARTED|Overall Study||108
8496509|NCT00522379|20938607|P4|STARTED|Overall Study||94
8496510|NCT00522379|20938608|P3|STARTED|Overall Study||104
8496511|NCT00522379|20938609|P2|STARTED|Overall Study||107
8496512|NCT00522379|20938610|P1|STARTED|Overall Study||101
8496513|NCT00522301|20938712|P1|NOT COMPLETED|Overall Study||6
8496514|NCT00522301|20938712|P1|COMPLETED|Overall Study||0
8496515|NCT00522301|20938712|P1|STARTED|Overall Study||6
8496516|NCT00522275|20938716|P1|NOT COMPLETED|Overall Study||170
8496517|NCT00522275|20938716|P1|COMPLETED|Overall Study||138
8496518|NCT00522275|20938716|P1|STARTED|Overall Study||308
8496519|NCT00522171|20938726|P2|NOT COMPLETED|Overall Study||0
8496520|NCT00522171|20938727|P1|NOT COMPLETED|Overall Study||0
8496521|NCT00522171|20938726|P2|COMPLETED|Overall Study||15
8496522|NCT00522171|20938727|P1|COMPLETED|Overall Study||15
8496523|NCT00522171|20938726|P2|STARTED|Overall Study||15
8496524|NCT00522171|20938727|P1|STARTED|Overall Study||15
8496525|NCT00522041|20938737|P2|NOT COMPLETED|Overall Study||12
8496526|NCT00522041|20938738|P1|NOT COMPLETED|Overall Study||17
8496527|NCT00522041|20938737|P2|COMPLETED|Overall Study||113
8496528|NCT00522041|20938738|P1|COMPLETED|Overall Study||106
8496529|NCT00522041|20938737|P2|Received Treatment|Overall Study||124
8496530|NCT00522041|20938738|P1|Received Treatment|Overall Study||123
8496531|NCT00522041|20938737|P2|STARTED|Overall Study||125
8496532|NCT00522041|20938738|P1|STARTED|Overall Study||123
8496533|NCT00521989|20938753|P5|NOT COMPLETED|Overall Study||23
8496534|NCT00521989|20938754|P4|NOT COMPLETED|Overall Study||12
8496535|NCT00521989|20938755|P3|NOT COMPLETED|Overall Study||16
8496536|NCT00521989|20938756|P2|NOT COMPLETED|Overall Study||17
8496537|NCT00521989|20938757|P1|NOT COMPLETED|Overall Study||20
8496538|NCT00521989|20938753|P5|COMPLETED|Overall Study||35
8496539|NCT00521989|20938754|P4|COMPLETED|Overall Study||42
8496540|NCT00521989|20938755|P3|COMPLETED|Overall Study||41
8496541|NCT00521989|20938756|P2|COMPLETED|Overall Study||37
8496542|NCT00521989|20938757|P1|COMPLETED|Overall Study||36
8496543|NCT00521989|20938753|P5|STARTED|Overall Study||58
8496544|NCT00521989|20938754|P4|STARTED|Overall Study||54
8496545|NCT00521989|20938755|P3|STARTED|Overall Study||57
8496546|NCT00521989|20938756|P2|STARTED|Overall Study||54
8496547|NCT00521989|20938757|P1|STARTED|Overall Study||56
8496548|NCT00521976|20938769|P1|NOT COMPLETED|Overall Study||0
8496549|NCT00521976|20938769|P1|COMPLETED|Overall Study||871
8496550|NCT00521976|20938769|P1|STARTED|Overall Study||871
8496551|NCT00521924|20938776|P2|NOT COMPLETED|Overall Study||4
8496552|NCT00521924|20938777|P1|NOT COMPLETED|Overall Study||4
8496553|NCT00521924|20938776|P2|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
8496554|NCT00521924|20938777|P1|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
8496555|NCT00521924|20938776|P2|STARTED|Overall Study|Subjects randomized|4
8496556|NCT00521924|20938777|P1|STARTED|Overall Study|Subjects randomized|4
8496557|NCT00521885|20938785|P2|NOT COMPLETED|Overall Study||0
8496558|NCT00521885|20938786|P1|NOT COMPLETED|Overall Study||0
8496559|NCT00521885|20938785|P2|COMPLETED|Overall Study||0
8496560|NCT00521885|20938786|P1|COMPLETED|Overall Study||0
8496561|NCT00521885|20938785|P2|STARTED|Overall Study||0
8496562|NCT00521885|20938786|P1|STARTED|Overall Study||0
8496563|NCT00521599|20938797|P3|NOT COMPLETED|Overall Study||36
8496564|NCT00521599|20938798|P2|NOT COMPLETED|Overall Study||29
8496565|NCT00521599|20938799|P1|NOT COMPLETED|Overall Study||25
8496566|NCT00521599|20938797|P3|COMPLETED|Overall Study||100
8496567|NCT00521599|20938798|P2|COMPLETED|Overall Study||239
8496568|NCT00521599|20938799|P1|COMPLETED|Overall Study||243
8496569|NCT00521599|20938797|P3|STARTED|Overall Study||136
8496570|NCT00521599|20938798|P2|STARTED|Overall Study||268
8496571|NCT00521599|20938799|P1|STARTED|Overall Study||268
8496572|NCT00521586|20938810|P2|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
8496573|NCT00521586|20938811|P1|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
8496574|NCT00521586|20938810|P2|COMPLETED|Revaccination With 13vPnC (Year 5)||351
8496575|NCT00521586|20938811|P1|COMPLETED|Revaccination With 13vPnC (Year 5)||361
8496576|NCT00521586|20938810|P2|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
8496577|NCT00521586|20938811|P1|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
8496578|NCT00521586|20938810|P2|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
8496579|NCT00521586|20938811|P1|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
8496580|NCT00521586|20938810|P2|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
8496581|NCT00521586|20938811|P1|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
8496582|NCT00521586|20938810|P2|STARTED|Revaccination With 13vPnC (Year 5)||363
8496583|NCT00521586|20938811|P1|STARTED|Revaccination With 13vPnC (Year 5)||364
8496584|NCT00521586|20938810|P2|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
8496585|NCT00521586|20938811|P1|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
8496586|NCT00521586|20938810|P2|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
8496587|NCT00521586|20938811|P1|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
8496588|NCT00521586|20938810|P2|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
8496589|NCT00521586|20938811|P1|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
8496590|NCT00521586|20938810|P2|NOT COMPLETED|Initial Vaccination (Year 0)||29
8496591|NCT00521586|20938811|P1|NOT COMPLETED|Initial Vaccination (Year 0)||21
8496592|NCT00521586|20938810|P2|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
8496593|NCT00521586|20938811|P1|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
8496594|NCT00521586|20938810|P2|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
8496595|NCT00521586|20938811|P1|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
8496596|NCT00521586|20938810|P2|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
8496597|NCT00521586|20938811|P1|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
8496598|NCT00521586|20938810|P2|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
8496599|NCT00521586|20938811|P1|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
8496600|NCT00521586|20938810|P2|STARTED|Initial Vaccination (Year 0)||562
8496601|NCT00521586|20938811|P1|STARTED|Initial Vaccination (Year 0)||554
8496602|NCT00521456|20938871|P2|NOT COMPLETED|Overall Study||28
8496603|NCT00521456|20938872|P1|NOT COMPLETED|Overall Study||13
8496604|NCT00521456|20938871|P2|COMPLETED|Overall Study||59
8496605|NCT00521456|20938872|P1|COMPLETED|Overall Study||163
8496606|NCT00521456|20938871|P2|STARTED|Overall Study||87
8496607|NCT00521456|20938872|P1|STARTED|Overall Study||176
8496611|NCT00521365|20938893|P1|NOT COMPLETED|Overall Study||20
8496612|NCT00521365|20938893|P1|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
8496613|NCT00521365|20938893|P1|Safety Analysis Set|Overall Study|All participants who received study treatment|88
8496614|NCT00521365|20938893|P1|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
8496615|NCT00521365|20938893|P1|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
8496616|NCT00521365|20938893|P1|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
8496617|NCT00521352|20938912|P2|NOT COMPLETED|Overall Study||3
8496618|NCT00521352|20938913|P1|NOT COMPLETED|Overall Study||1
8496619|NCT00521352|20938912|P2|COMPLETED|Overall Study||10
8496620|NCT00521352|20938913|P1|COMPLETED|Overall Study||11
8496621|NCT00521352|20938912|P2|STARTED|Overall Study||13
8496622|NCT00521352|20938913|P1|STARTED|Overall Study||12
8496623|NCT00521339|20938923|P3|NOT COMPLETED|Observational Follow Up Phase||0
8496624|NCT00521339|20938924|P2|NOT COMPLETED|Observational Follow Up Phase||0
8496625|NCT00521339|20938925|P1|NOT COMPLETED|Observational Follow Up Phase||0
8496626|NCT00521339|20938923|P3|COMPLETED|Observational Follow Up Phase||4
8496627|NCT00521339|20938924|P2|COMPLETED|Observational Follow Up Phase||4
8496628|NCT00521339|20938925|P1|COMPLETED|Observational Follow Up Phase||14
8496629|NCT00521339|20938923|P3|STARTED|Observational Follow Up Phase||4
8496630|NCT00521339|20938924|P2|STARTED|Observational Follow Up Phase||4
8496631|NCT00521339|20938925|P1|STARTED|Observational Follow Up Phase||14
8496632|NCT00521339|20938923|P3|NOT COMPLETED|Treatment Extension Phase||3
8496633|NCT00521339|20938924|P2|NOT COMPLETED|Treatment Extension Phase||0
8496634|NCT00521339|20938925|P1|NOT COMPLETED|Treatment Extension Phase||0
8496635|NCT00521339|20938923|P3|COMPLETED|Treatment Extension Phase||4
8496636|NCT00521339|20938924|P2|COMPLETED|Treatment Extension Phase||4
8496637|NCT00521339|20938925|P1|COMPLETED|Treatment Extension Phase||0
8496638|NCT00521339|20938923|P3|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
8496639|NCT00521339|20938924|P2|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
8496640|NCT00521339|20938925|P1|STARTED|Treatment Extension Phase||0
8496641|NCT00521339|20938923|P3|NOT COMPLETED|Treatment Phase||0
8496642|NCT00521339|20938924|P2|NOT COMPLETED|Treatment Phase||0
8496643|NCT00521339|20938925|P1|NOT COMPLETED|Treatment Phase||12
8496644|NCT00521339|20938923|P3|COMPLETED|Treatment Phase||0
8496645|NCT00521339|20938924|P2|COMPLETED|Treatment Phase||0
8496646|NCT00521339|20938925|P1|COMPLETED|Treatment Phase||19
8496647|NCT00521339|20938923|P3|Received Apremilast|Treatment Phase||0
8496648|NCT00521339|20938924|P2|Received Apremilast|Treatment Phase||0
8496649|NCT00521339|20938925|P1|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
8496650|NCT00521339|20938923|P3|STARTED|Treatment Phase||0
8496651|NCT00521339|20938924|P2|STARTED|Treatment Phase||0
8496652|NCT00521339|20938925|P1|STARTED|Treatment Phase||31
8496653|NCT00521144|20938993|P5|NOT COMPLETED|Overall Study||7
8496654|NCT00521144|20938994|P4|NOT COMPLETED|Overall Study||1
8496655|NCT00521144|20938995|P3|NOT COMPLETED|Overall Study||2
8496656|NCT00521144|20938996|P2|NOT COMPLETED|Overall Study||3
8496657|NCT00521144|20938997|P1|NOT COMPLETED|Overall Study||4
8496658|NCT00521144|20938993|P5|COMPLETED|Overall Study||0
8496659|NCT00521144|20938994|P4|COMPLETED|Overall Study||0
8496660|NCT00521144|20938995|P3|COMPLETED|Overall Study||1
8496661|NCT00521144|20938996|P2|COMPLETED|Overall Study||2
8496662|NCT00521144|20938997|P1|COMPLETED|Overall Study||2
8496663|NCT00521144|20938993|P5|STARTED|Overall Study||7
8496664|NCT00521144|20938994|P4|STARTED|Overall Study||1
8496665|NCT00521144|20938995|P3|STARTED|Overall Study||3
8496666|NCT00521144|20938996|P2|STARTED|Overall Study||5
8496667|NCT00521144|20938997|P1|STARTED|Overall Study||6
8496668|NCT00521079|20939011|P2|NOT COMPLETED|Overall Study||5
8496669|NCT00521079|20939012|P1|NOT COMPLETED|Overall Study||14
8496670|NCT00521079|20939011|P2|COMPLETED|Overall Study||97
8496671|NCT00521079|20939012|P1|COMPLETED|Overall Study||178
8496672|NCT00521079|20939011|P2|Surgical Roll-In|Overall Study||5
8496673|NCT00521079|20939012|P1|Surgical Roll-In|Overall Study||9
8496674|NCT00521079|20939011|P2|STARTED|Overall Study||102
8496675|NCT00521079|20939012|P1|STARTED|Overall Study||192
8496676|NCT00521053|20939022|P1|NOT COMPLETED|Observation Phase||68
8496677|NCT00521053|20939022|P1|COMPLETED|Observation Phase||12
8496678|NCT00521053|20939022|P1|STARTED|Observation Phase||80
8496679|NCT00521053|20939022|P1|NOT COMPLETED|Treatment Phase||0
8496680|NCT00521053|20939022|P1|COMPLETED|Treatment Phase||80
8496681|NCT00521053|20939022|P1|Received 4 Cycles of PV-10|Treatment Phase||3
8496682|NCT00521053|20939022|P1|Received 3 Cycles of PV-10|Treatment Phase||16
8496683|NCT00521053|20939022|P1|Received 2 Cycles of PV-10|Treatment Phase||26
8496684|NCT00521053|20939022|P1|Received 1 Cycle of PV-10|Treatment Phase||35
8496685|NCT00521053|20939022|P1|STARTED|Treatment Phase||80
8496686|NCT00521014|20939032|P1|NOT COMPLETED|Overall Study||1
8496687|NCT00521014|20939032|P1|COMPLETED|Overall Study||13
8496688|NCT00521014|20939032|P1|STARTED|Overall Study||14
8496689|NCT00521001|20939036|P1|NOT COMPLETED|Overall Study||1
8496690|NCT00521001|20939036|P1|COMPLETED|Overall Study||48
8496691|NCT00521001|20939036|P1|STARTED|Overall Study||49
8496692|NCT00520975|20939045|P2|NOT COMPLETED|Overall Study||48
8496693|NCT00520975|20939046|P1|NOT COMPLETED|Overall Study||48
8496694|NCT00520975|20939045|P2|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
8496695|NCT00520975|20939046|P1|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
8496696|NCT00520975|20939045|P2|Treated and Reported Adverse Events Data|Overall Study||45
8496697|NCT00520975|20939046|P1|Treated and Reported Adverse Events Data|Overall Study||47
8496698|NCT00520975|20939045|P2|STARTED|Overall Study||48
8496699|NCT00520975|20939046|P1|STARTED|Overall Study||48
8496700|NCT00520936|20939078|P8|NOT COMPLETED|Overall Study||1
8496701|NCT00520936|20939079|P7|NOT COMPLETED|Overall Study||4
8496702|NCT00520936|20939080|P6|NOT COMPLETED|Overall Study||0
8496703|NCT00520936|20939081|P5|NOT COMPLETED|Overall Study||1
8496704|NCT00520936|20939082|P4|NOT COMPLETED|Overall Study||0
8496705|NCT00520936|20939083|P3|NOT COMPLETED|Overall Study||2
8496706|NCT00520936|20939084|P2|NOT COMPLETED|Overall Study||4
8496707|NCT00520936|20939085|P1|NOT COMPLETED|Overall Study||0
8496708|NCT00520936|20939078|P8|COMPLETED|Overall Study||9
8496709|NCT00520936|20939079|P7|COMPLETED|Overall Study||7
8496710|NCT00520936|20939080|P6|COMPLETED|Overall Study||10
8496711|NCT00520936|20939081|P5|COMPLETED|Overall Study||5
8496712|NCT00520936|20939082|P4|COMPLETED|Overall Study||5
8496713|NCT00520936|20939083|P3|COMPLETED|Overall Study||7
8496714|NCT00520936|20939084|P2|COMPLETED|Overall Study||7
8496715|NCT00520936|20939085|P1|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
8496716|NCT00520936|20939078|P8|STARTED|Overall Study||10
8496717|NCT00520936|20939079|P7|STARTED|Overall Study||11
8496718|NCT00520936|20939080|P6|STARTED|Overall Study||10
8496719|NCT00520936|20939081|P5|STARTED|Overall Study||6
8496720|NCT00520936|20939082|P4|STARTED|Overall Study||5
8496721|NCT00520936|20939083|P3|STARTED|Overall Study||9
8496722|NCT00520936|20939084|P2|STARTED|Overall Study||11
8496723|NCT00520936|20939085|P1|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
8496724|NCT00520910|20939114|P2|NOT COMPLETED|Overall Study||0
8496725|NCT00520910|20939115|P1|NOT COMPLETED|Overall Study||0
8496726|NCT00520910|20939114|P2|COMPLETED|Overall Study||5
8496727|NCT00520910|20939115|P1|COMPLETED|Overall Study||5
8496728|NCT00520910|20939114|P2|STARTED|Overall Study||5
8496729|NCT00520910|20939115|P1|STARTED|Overall Study||5
8496730|NCT00520884|20939125|P4|NOT COMPLETED|Overall Study||0
8496731|NCT00520884|20939126|P3|NOT COMPLETED|Overall Study||0
8496732|NCT00520884|20939127|P2|NOT COMPLETED|Overall Study||0
8496733|NCT00520884|20939128|P1|NOT COMPLETED|Overall Study||0
8496734|NCT00520884|20939125|P4|COMPLETED|Overall Study||3
8496735|NCT00520884|20939126|P3|COMPLETED|Overall Study||2
8496736|NCT00520884|20939127|P2|COMPLETED|Overall Study||2
8496737|NCT00520884|20939128|P1|COMPLETED|Overall Study||3
8496738|NCT00520884|20939125|P4|STARTED|Overall Study||3
8496739|NCT00520884|20939126|P3|STARTED|Overall Study||2
8496740|NCT00520884|20939127|P2|STARTED|Overall Study||2
8496741|NCT00520884|20939128|P1|STARTED|Overall Study||3
8496742|NCT00520845|20939140|P1|NOT COMPLETED|Overall Study||22
8496743|NCT00520845|20939140|P1|COMPLETED|Overall Study||1
8496744|NCT00520845|20939140|P1|STARTED|Overall Study||23
8496748|NCT00520741|20939154|P2|NOT COMPLETED|Overall Study||125
8496749|NCT00520741|20939155|P1|NOT COMPLETED|Overall Study||37
8496750|NCT00520741|20939154|P2|COMPLETED|Overall Study||194
8496751|NCT00520741|20939155|P1|COMPLETED|Overall Study||69
8496752|NCT00520741|20939154|P2|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
8496753|NCT00520741|20939155|P1|STARTED|Overall Study||106
8496754|NCT00520676|20939173|P2|NOT COMPLETED|Overall Study||103
8496755|NCT00520676|20939174|P1|NOT COMPLETED|Overall Study||101
8496756|NCT00520676|20939173|P2|COMPLETED|Overall Study||29
8496757|NCT00520676|20939174|P1|COMPLETED|Overall Study||27
8496758|NCT00520676|20939173|P2|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
8496759|NCT00520676|20939174|P1|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
8496760|NCT00520676|20939173|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
8496761|NCT00520676|20939174|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
8496762|NCT00520676|20939173|P2|STARTED|Overall Study||132
8496763|NCT00520676|20939174|P1|STARTED|Overall Study||128
8496764|NCT00520572|20939200|P6|NOT COMPLETED|Overall Study||2
8496765|NCT00520572|20939201|P5|NOT COMPLETED|Overall Study||12
8496766|NCT00520572|20939202|P4|NOT COMPLETED|Overall Study||14
8496767|NCT00520572|20939203|P3|NOT COMPLETED|Overall Study||15
8496768|NCT00520572|20939204|P2|NOT COMPLETED|Overall Study||14
8496769|NCT00520572|20939205|P1|NOT COMPLETED|Overall Study||12
8496770|NCT00520572|20939200|P6|COMPLETED|Overall Study|Participants completed the study.|62
8496771|NCT00520572|20939201|P5|COMPLETED|Overall Study|Participants completed the study.|53
8496772|NCT00520572|20939202|P4|COMPLETED|Overall Study|Participants completed the study.|50
8496773|NCT00520572|20939203|P3|COMPLETED|Overall Study|Participants completed the study.|49
8496774|NCT00520572|20939204|P2|COMPLETED|Overall Study|Participants completed the study.|50
8496775|NCT00520572|20939205|P1|COMPLETED|Overall Study|Participants completed the study.|52
8496776|NCT00520572|20939200|P6|STARTED|Overall Study|Participants randomised.|64
8496777|NCT00520572|20939201|P5|STARTED|Overall Study|Participants randomised.|65
8496778|NCT00520572|20939202|P4|STARTED|Overall Study|Participants randomised.|64
8496779|NCT00520572|20939203|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
8496780|NCT00520572|20939204|P2|STARTED|Overall Study|Participants randomised.|64
8496781|NCT00520572|20939205|P1|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
8496782|NCT00520546|20939243|P1|NOT COMPLETED|Overall Study||6
8496783|NCT00520546|20939243|P1|COMPLETED|Overall Study||38
8496784|NCT00520546|20939243|P1|STARTED|Overall Study||44
8496785|NCT00520494|20939258|P1|NOT COMPLETED|Overall Study||1
8496786|NCT00520494|20939258|P1|COMPLETED|Overall Study||17
8496787|NCT00520494|20939258|P1|STARTED|Overall Study||18
8496788|NCT00520481|20939283|P2|NOT COMPLETED|Overall Study||1
8496789|NCT00520481|20939284|P1|NOT COMPLETED|Overall Study||7
8496790|NCT00520481|20939283|P2|COMPLETED|Overall Study||9
8496791|NCT00520481|20939284|P1|COMPLETED|Overall Study||24
8496792|NCT00520481|20939283|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
8496793|NCT00520481|20939284|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
8496794|NCT00520481|20939283|P2|STARTED|Overall Study||10
8496795|NCT00520481|20939284|P1|STARTED|Overall Study||31
8496796|NCT00520468|20939304|P1|NOT COMPLETED|Overall Study||0
8496797|NCT00520468|20939304|P1|COMPLETED|Overall Study||14
8496798|NCT00520468|20939304|P1|STARTED|Overall Study||14
8496799|NCT00520403|20939308|P1|NOT COMPLETED|Bevacizumab Monotherapy||2
8496800|NCT00520403|20939308|P1|COMPLETED|Bevacizumab Monotherapy||0
8496801|NCT00520403|20939308|P1|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
8496802|NCT00520403|20939308|P1|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
8496803|NCT00520403|20939308|P1|COMPLETED|Bevacizumab + IFN/Vinblastine||7
8496804|NCT00520403|20939308|P1|STARTED|Bevacizumab + IFN/Vinblastine||25
8496805|NCT00520351|20939317|P2|NOT COMPLETED|Second Intervention||0
8496806|NCT00520351|20939318|P1|NOT COMPLETED|Second Intervention||0
8496807|NCT00520351|20939317|P2|COMPLETED|Second Intervention||14
8496808|NCT00520351|20939318|P1|COMPLETED|Second Intervention||14
8496809|NCT00520351|20939317|P2|STARTED|Second Intervention||14
8496810|NCT00520351|20939318|P1|STARTED|Second Intervention||14
8496811|NCT00520351|20939317|P2|NOT COMPLETED|First Intervention||1
8496812|NCT00520351|20939318|P1|NOT COMPLETED|First Intervention||1
8496813|NCT00520351|20939317|P2|COMPLETED|First Intervention|End date is Feb.25, 2008|14
8496814|NCT00520351|20939318|P1|COMPLETED|First Intervention|End date is Feb.25, 2008|14
8496815|NCT00520351|20939317|P2|STARTED|First Intervention|Start date is Sep.06, 2007|15
8496816|NCT00520351|20939318|P1|STARTED|First Intervention|Start date is Sep.06, 2007|15
8496817|NCT00520299|20939333|P3|NOT COMPLETED|Overall Study||6
8496818|NCT00520299|20939334|P2|NOT COMPLETED|Overall Study||3
8496819|NCT00520299|20939335|P1|NOT COMPLETED|Overall Study||0
8496820|NCT00520299|20939333|P3|COMPLETED|Overall Study||13
8496821|NCT00520299|20939334|P2|COMPLETED|Overall Study||3
8496822|NCT00520299|20939335|P1|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
8496823|NCT00520299|20939333|P3|STARTED|Overall Study||19
8496824|NCT00520299|20939334|P2|STARTED|Overall Study||6
8496825|NCT00520299|20939335|P1|STARTED|Overall Study||6
8496826|NCT00520286|20939366|P2|NOT COMPLETED|Overall Study||32
8496827|NCT00520286|20939367|P1|NOT COMPLETED|Overall Study||66
8496828|NCT00520286|20939366|P2|COMPLETED|Overall Study||36
8496829|NCT00520286|20939367|P1|COMPLETED|Overall Study||76
8496830|NCT00520286|20939366|P2|STARTED|Overall Study||68
8496831|NCT00520286|20939367|P1|STARTED|Overall Study||142
8496832|NCT00520234|20939377|P2|NOT COMPLETED|Overall Study||2
8496833|NCT00520234|20939378|P1|NOT COMPLETED|Overall Study||1
8496834|NCT00520234|20939377|P2|COMPLETED|Overall Study||102
8496835|NCT00520234|20939378|P1|COMPLETED|Overall Study||117
8496836|NCT00520234|20939377|P2|STARTED|Overall Study||104
8496837|NCT00520234|20939378|P1|STARTED|Overall Study||118
8496838|NCT00520130|20939390|P2|NOT COMPLETED|Overall Study||1
8496839|NCT00520130|20939391|P1|NOT COMPLETED|Overall Study||5
8496840|NCT00520130|20939390|P2|COMPLETED|Overall Study||44
8496841|NCT00520130|20939391|P1|COMPLETED|Overall Study||39
8496842|NCT00520130|20939390|P2|STARTED|Overall Study||45
8496843|NCT00520130|20939391|P1|STARTED|Overall Study||44
8496844|NCT00520039|20939433|P2|NOT COMPLETED|Overall Study||5
8496845|NCT00520039|20939434|P1|NOT COMPLETED|Overall Study||7
8496846|NCT00520039|20939433|P2|COMPLETED|Overall Study||19
8496847|NCT00520039|20939434|P1|COMPLETED|Overall Study||21
8496848|NCT00520039|20939433|P2|STARTED|Overall Study||24
8496849|NCT00520039|20939434|P1|STARTED|Overall Study||28
8496850|NCT00520013|20939447|P3|NOT COMPLETED|Overall Study||11
8496851|NCT00520013|20939448|P2|NOT COMPLETED|Overall Study||15
8496852|NCT00520013|20939449|P1|NOT COMPLETED|Overall Study||12
8496853|NCT00520013|20939447|P3|COMPLETED|Overall Study||0
8496854|NCT00520013|20939448|P2|COMPLETED|Overall Study||10
8496855|NCT00520013|20939449|P1|COMPLETED|Overall Study||11
8496856|NCT00520013|20939447|P3|Treated|Overall Study||11
8496857|NCT00520013|20939448|P2|Treated|Overall Study||25
8496858|NCT00520013|20939449|P1|Treated|Overall Study||23
8496859|NCT00520013|20939447|P3|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
8496860|NCT00520013|20939448|P2|STARTED|Overall Study||25
8496861|NCT00520013|20939449|P1|STARTED|Overall Study||23
8496862|NCT00519896|20939459|P1|NOT COMPLETED|Overall Study||2
8496863|NCT00519896|20939459|P1|COMPLETED|Overall Study||33
8496864|NCT00519896|20939459|P1|STARTED|Overall Study||35
8496865|NCT00519831|20939465|P1|NOT COMPLETED|Overall Study||3
8496866|NCT00519831|20939465|P1|COMPLETED|Overall Study||13
8496867|NCT00519831|20939465|P1|STARTED|Overall Study||16
8496868|NCT00519818|20939472|P1|NOT COMPLETED|Overall Study||0
8496869|NCT00519818|20939472|P1|COMPLETED|Overall Study||14
8496870|NCT00519818|20939472|P1|STARTED|Overall Study||14
8496871|NCT00519779|20939482|P2|NOT COMPLETED|Overall Study||1
8496872|NCT00519779|20939483|P1|NOT COMPLETED|Overall Study||0
8496873|NCT00519779|20939482|P2|COMPLETED|Overall Study||33
8496874|NCT00519779|20939483|P1|COMPLETED|Overall Study||34
8496875|NCT00519779|20939482|P2|STARTED|Overall Study||34
8496876|NCT00519779|20939483|P1|STARTED|Overall Study||34
8496877|NCT00519649|20939499|P1|NOT COMPLETED|Overall Study||1
8496878|NCT00519649|20939499|P1|COMPLETED|Overall Study||299
8496879|NCT00519649|20939499|P1|STARTED|Overall Study||300
8496880|NCT00519636|20939512|P4|NOT COMPLETED|Post Study Period||1
8496881|NCT00519636|20939513|P3|NOT COMPLETED|Post Study Period||0
8496882|NCT00519636|20939514|P2|NOT COMPLETED|Post Study Period||0
8496883|NCT00519636|20939515|P1|NOT COMPLETED|Post Study Period||0
8496884|NCT00519636|20939512|P4|COMPLETED|Post Study Period||85
8496885|NCT00519636|20939513|P3|COMPLETED|Post Study Period||74
8496886|NCT00519636|20939514|P2|COMPLETED|Post Study Period||71
8496887|NCT00519636|20939515|P1|COMPLETED|Post Study Period||69
8496888|NCT00519636|20939512|P4|STARTED|Post Study Period||86
8496889|NCT00519636|20939513|P3|STARTED|Post Study Period||74
8496890|NCT00519636|20939514|P2|STARTED|Post Study Period||71
8496891|NCT00519636|20939515|P1|STARTED|Post Study Period||69
8496892|NCT00519636|20939512|P4|NOT COMPLETED|Treatment Period 2||2
8496893|NCT00519636|20939513|P3|NOT COMPLETED|Treatment Period 2||1
8496894|NCT00519636|20939514|P2|NOT COMPLETED|Treatment Period 2||1
8496895|NCT00519636|20939515|P1|NOT COMPLETED|Treatment Period 2||0
8496896|NCT00519636|20939512|P4|COMPLETED|Treatment Period 2||86
8496897|NCT00519636|20939513|P3|COMPLETED|Treatment Period 2||74
8496898|NCT00519636|20939514|P2|COMPLETED|Treatment Period 2||71
8496899|NCT00519636|20939515|P1|COMPLETED|Treatment Period 2||69
8496900|NCT00519636|20939512|P4|STARTED|Treatment Period 2||88
8496901|NCT00519636|20939513|P3|STARTED|Treatment Period 2||75
8496902|NCT00519636|20939514|P2|STARTED|Treatment Period 2||72
8496903|NCT00519636|20939515|P1|STARTED|Treatment Period 2||69
8496904|NCT00519636|20939512|P4|NOT COMPLETED|Washout Period||5
8496905|NCT00519636|20939513|P3|NOT COMPLETED|Washout Period||14
8496906|NCT00519636|20939514|P2|NOT COMPLETED|Washout Period||14
8496907|NCT00519636|20939515|P1|NOT COMPLETED|Washout Period||20
8496908|NCT00519636|20939512|P4|COMPLETED|Washout Period||88
8496909|NCT00519636|20939513|P3|COMPLETED|Washout Period||75
8496910|NCT00519636|20939514|P2|COMPLETED|Washout Period||72
8496911|NCT00519636|20939515|P1|COMPLETED|Washout Period||69
8496912|NCT00519636|20939512|P4|STARTED|Washout Period||93
8496913|NCT00519636|20939513|P3|STARTED|Washout Period||89
8496914|NCT00519636|20939514|P2|STARTED|Washout Period||86
8496915|NCT00519636|20939515|P1|STARTED|Washout Period||89
8496916|NCT00519636|20939512|P4|NOT COMPLETED|Treatment Period 1||0
8496917|NCT00519636|20939513|P3|NOT COMPLETED|Treatment Period 1||1
8496918|NCT00519636|20939514|P2|NOT COMPLETED|Treatment Period 1||0
8496919|NCT00519636|20939515|P1|NOT COMPLETED|Treatment Period 1||2
8496920|NCT00519636|20939512|P4|COMPLETED|Treatment Period 1||93
8496921|NCT00519636|20939513|P3|COMPLETED|Treatment Period 1||89
8496922|NCT00519636|20939514|P2|COMPLETED|Treatment Period 1||86
8496923|NCT00519636|20939515|P1|COMPLETED|Treatment Period 1||89
8496924|NCT00519636|20939512|P4|STARTED|Treatment Period 1||93
8496925|NCT00519636|20939513|P3|STARTED|Treatment Period 1||90
8496926|NCT00519636|20939514|P2|STARTED|Treatment Period 1||86
8496927|NCT00519636|20939515|P1|STARTED|Treatment Period 1||91
8496928|NCT00519623|20939545|P1|NOT COMPLETED|Overall Study||1
8496929|NCT00519623|20939545|P1|COMPLETED|Overall Study||8
8496930|NCT00519623|20939545|P1|STARTED|Overall Study||9
8496931|NCT00519584|20939554|P4|NOT COMPLETED|Overall Study||0
8496932|NCT00519584|20939555|P3|NOT COMPLETED|Overall Study||0
8496933|NCT00519584|20939556|P2|NOT COMPLETED|Overall Study||0
8496934|NCT00519584|20939557|P1|NOT COMPLETED|Overall Study||0
8496935|NCT00519584|20939554|P4|COMPLETED|Overall Study||56
8496936|NCT00519584|20939555|P3|COMPLETED|Overall Study||54
8496937|NCT00519584|20939556|P2|COMPLETED|Overall Study||54
8496938|NCT00519584|20939557|P1|COMPLETED|Overall Study||54
8496939|NCT00519584|20939554|P4|STARTED|Overall Study||56
8496940|NCT00519584|20939555|P3|STARTED|Overall Study||54
8496941|NCT00519584|20939556|P2|STARTED|Overall Study||54
8496942|NCT00519584|20939557|P1|STARTED|Overall Study||54
8496943|NCT00519532|20939579|P1|NOT COMPLETED|Overall Study||18
8496944|NCT00519532|20939579|P1|COMPLETED|Overall Study||66
8496945|NCT00519532|20939579|P1|STARTED|Overall Study||84
8496946|NCT00519428|20939589|P3|NOT COMPLETED|Overall Study||25
8496947|NCT00519428|20939590|P2|NOT COMPLETED|Overall Study||15
8496948|NCT00519428|20939591|P1|NOT COMPLETED|Overall Study||21
8496949|NCT00519428|20939589|P3|COMPLETED|Overall Study||58
8496950|NCT00519428|20939590|P2|COMPLETED|Overall Study||69
8496951|NCT00519428|20939591|P1|COMPLETED|Overall Study||57
8496952|NCT00519428|20939589|P3|STARTED|Overall Study||83
8496953|NCT00519428|20939590|P2|STARTED|Overall Study||84
8496954|NCT00519428|20939591|P1|STARTED|Overall Study||78
8496955|NCT00519376|20939611|P16|NOT COMPLETED|Treatment Period 4||0
8496956|NCT00519376|20939612|P15|NOT COMPLETED|Treatment Period 4||0
8496957|NCT00519376|20939613|P14|NOT COMPLETED|Treatment Period 4||0
8496958|NCT00519376|20939614|P13|NOT COMPLETED|Treatment Period 4||0
8496959|NCT00519376|20939615|P12|NOT COMPLETED|Treatment Period 4||0
8496960|NCT00519376|20939616|P11|NOT COMPLETED|Treatment Period 4||0
8496961|NCT00519376|20939617|P10|NOT COMPLETED|Treatment Period 4||0
8496962|NCT00519376|20939618|P9|NOT COMPLETED|Treatment Period 4||0
8496963|NCT00519376|20939619|P8|NOT COMPLETED|Treatment Period 4||0
8496964|NCT00519376|20939620|P7|NOT COMPLETED|Treatment Period 4||0
8496965|NCT00519376|20939621|P6|NOT COMPLETED|Treatment Period 4||0
8496966|NCT00519376|20939622|P5|NOT COMPLETED|Treatment Period 4||0
8496967|NCT00519376|20939623|P4|NOT COMPLETED|Treatment Period 4||0
8496968|NCT00519376|20939624|P3|NOT COMPLETED|Treatment Period 4||1
8496969|NCT00519376|20939625|P2|NOT COMPLETED|Treatment Period 4||0
8496970|NCT00519376|20939626|P1|NOT COMPLETED|Treatment Period 4||0
8496971|NCT00519376|20939611|P16|COMPLETED|Treatment Period 4||1
8496972|NCT00519376|20939612|P15|COMPLETED|Treatment Period 4||1
8496973|NCT00519376|20939613|P14|COMPLETED|Treatment Period 4||1
8496974|NCT00519376|20939614|P13|COMPLETED|Treatment Period 4||0
8496975|NCT00519376|20939615|P12|COMPLETED|Treatment Period 4||1
8496976|NCT00519376|20939616|P11|COMPLETED|Treatment Period 4||1
8496977|NCT00519376|20939617|P10|COMPLETED|Treatment Period 4||1
8496978|NCT00519376|20939618|P9|COMPLETED|Treatment Period 4||1
8496979|NCT00519376|20939619|P8|COMPLETED|Treatment Period 4||1
8496980|NCT00519376|20939620|P7|COMPLETED|Treatment Period 4||1
8496981|NCT00519376|20939621|P6|COMPLETED|Treatment Period 4||1
8496982|NCT00519376|20939622|P5|COMPLETED|Treatment Period 4||1
8496983|NCT00519376|20939623|P4|COMPLETED|Treatment Period 4||2
8496984|NCT00519376|20939624|P3|COMPLETED|Treatment Period 4||1
8496985|NCT00519376|20939625|P2|COMPLETED|Treatment Period 4||2
8496986|NCT00519376|20939626|P1|COMPLETED|Treatment Period 4||2
8496987|NCT00519376|20939611|P16|STARTED|Treatment Period 4||1
8496988|NCT00519376|20939612|P15|STARTED|Treatment Period 4||1
8496989|NCT00519376|20939613|P14|STARTED|Treatment Period 4||1
8496990|NCT00519376|20939614|P13|STARTED|Treatment Period 4||0
8496991|NCT00519376|20939615|P12|STARTED|Treatment Period 4||1
8496992|NCT00519376|20939616|P11|STARTED|Treatment Period 4||1
8496993|NCT00519376|20939617|P10|STARTED|Treatment Period 4||1
8496994|NCT00519376|20939618|P9|STARTED|Treatment Period 4||1
8496995|NCT00519376|20939619|P8|STARTED|Treatment Period 4||1
8496996|NCT00519376|20939620|P7|STARTED|Treatment Period 4||1
8496997|NCT00519376|20939621|P6|STARTED|Treatment Period 4||1
8496998|NCT00519376|20939622|P5|STARTED|Treatment Period 4||1
8496999|NCT00519376|20939623|P4|STARTED|Treatment Period 4||2
8497000|NCT00519376|20939624|P3|STARTED|Treatment Period 4||2
8497001|NCT00519376|20939625|P2|STARTED|Treatment Period 4||2
8497002|NCT00519376|20939626|P1|STARTED|Treatment Period 4||2
8497003|NCT00519376|20939611|P16|NOT COMPLETED|Washout Period 3||0
8497004|NCT00519376|20939612|P15|NOT COMPLETED|Washout Period 3||0
8497005|NCT00519376|20939613|P14|NOT COMPLETED|Washout Period 3||0
8497006|NCT00519376|20939614|P13|NOT COMPLETED|Washout Period 3||0
8497007|NCT00519376|20939615|P12|NOT COMPLETED|Washout Period 3||0
8497008|NCT00519376|20939616|P11|NOT COMPLETED|Washout Period 3||0
8497009|NCT00519376|20939617|P10|NOT COMPLETED|Washout Period 3||0
8497010|NCT00519376|20939618|P9|NOT COMPLETED|Washout Period 3||0
8497011|NCT00519376|20939619|P8|NOT COMPLETED|Washout Period 3||0
8497012|NCT00519376|20939620|P7|NOT COMPLETED|Washout Period 3||0
8497013|NCT00519376|20939621|P6|NOT COMPLETED|Washout Period 3||0
8497014|NCT00519376|20939622|P5|NOT COMPLETED|Washout Period 3||0
8497015|NCT00519376|20939623|P4|NOT COMPLETED|Washout Period 3||0
8497016|NCT00519376|20939624|P3|NOT COMPLETED|Washout Period 3||0
8497017|NCT00519376|20939625|P2|NOT COMPLETED|Washout Period 3||0
8497018|NCT00519376|20939626|P1|NOT COMPLETED|Washout Period 3||0
8497019|NCT00519376|20939611|P16|COMPLETED|Washout Period 3||1
8497020|NCT00519376|20939612|P15|COMPLETED|Washout Period 3||1
8497021|NCT00519376|20939613|P14|COMPLETED|Washout Period 3||1
8497022|NCT00519376|20939614|P13|COMPLETED|Washout Period 3||0
8497023|NCT00519376|20939615|P12|COMPLETED|Washout Period 3||1
8497024|NCT00519376|20939616|P11|COMPLETED|Washout Period 3||1
8497025|NCT00519376|20939617|P10|COMPLETED|Washout Period 3||1
8497026|NCT00519376|20939618|P9|COMPLETED|Washout Period 3||1
8497027|NCT00519376|20939619|P8|COMPLETED|Washout Period 3||1
8497028|NCT00519376|20939620|P7|COMPLETED|Washout Period 3||1
8497029|NCT00519376|20939621|P6|COMPLETED|Washout Period 3||1
8497030|NCT00519376|20939622|P5|COMPLETED|Washout Period 3||1
8497031|NCT00519376|20939623|P4|COMPLETED|Washout Period 3||2
8497032|NCT00519376|20939624|P3|COMPLETED|Washout Period 3||2
8497033|NCT00519376|20939625|P2|COMPLETED|Washout Period 3||2
8497034|NCT00519376|20939626|P1|COMPLETED|Washout Period 3||2
8497035|NCT00519376|20939611|P16|STARTED|Washout Period 3||1
8497036|NCT00519376|20939612|P15|STARTED|Washout Period 3||1
8497037|NCT00519376|20939613|P14|STARTED|Washout Period 3||1
8497038|NCT00519376|20939614|P13|STARTED|Washout Period 3||0
8497039|NCT00519376|20939615|P12|STARTED|Washout Period 3||1
8497040|NCT00519376|20939616|P11|STARTED|Washout Period 3||1
8497041|NCT00519376|20939617|P10|STARTED|Washout Period 3||1
8497042|NCT00519376|20939618|P9|STARTED|Washout Period 3||1
8497043|NCT00519376|20939619|P8|STARTED|Washout Period 3||1
8497044|NCT00519376|20939620|P7|STARTED|Washout Period 3||1
8497045|NCT00519376|20939621|P6|STARTED|Washout Period 3||1
8497046|NCT00519376|20939622|P5|STARTED|Washout Period 3||1
8497047|NCT00519376|20939623|P4|STARTED|Washout Period 3||2
8497048|NCT00519376|20939624|P3|STARTED|Washout Period 3||2
8497049|NCT00519376|20939625|P2|STARTED|Washout Period 3||2
8497050|NCT00519376|20939626|P1|STARTED|Washout Period 3||2
8497051|NCT00519376|20939611|P16|NOT COMPLETED|Treatment Period 3||0
8497052|NCT00519376|20939612|P15|NOT COMPLETED|Treatment Period 3||0
8497053|NCT00519376|20939613|P14|NOT COMPLETED|Treatment Period 3||0
8497054|NCT00519376|20939614|P13|NOT COMPLETED|Treatment Period 3||0
8497055|NCT00519376|20939615|P12|NOT COMPLETED|Treatment Period 3||0
8497056|NCT00519376|20939616|P11|NOT COMPLETED|Treatment Period 3||0
8497057|NCT00519376|20939617|P10|NOT COMPLETED|Treatment Period 3||0
8497058|NCT00519376|20939618|P9|NOT COMPLETED|Treatment Period 3||0
8497059|NCT00519376|20939619|P8|NOT COMPLETED|Treatment Period 3||0
8497060|NCT00519376|20939620|P7|NOT COMPLETED|Treatment Period 3||0
8497061|NCT00519376|20939621|P6|NOT COMPLETED|Treatment Period 3||0
8497062|NCT00519376|20939622|P5|NOT COMPLETED|Treatment Period 3||0
8497063|NCT00519376|20939623|P4|NOT COMPLETED|Treatment Period 3||0
8497064|NCT00519376|20939624|P3|NOT COMPLETED|Treatment Period 3||0
8497065|NCT00519376|20939625|P2|NOT COMPLETED|Treatment Period 3||0
8497066|NCT00519376|20939626|P1|NOT COMPLETED|Treatment Period 3||0
8497067|NCT00519376|20939611|P16|COMPLETED|Treatment Period 3||1
8497068|NCT00519376|20939612|P15|COMPLETED|Treatment Period 3||1
8497069|NCT00519376|20939613|P14|COMPLETED|Treatment Period 3||1
8497070|NCT00519376|20939614|P13|COMPLETED|Treatment Period 3||0
8497071|NCT00519376|20939615|P12|COMPLETED|Treatment Period 3||1
8497072|NCT00519376|20939616|P11|COMPLETED|Treatment Period 3||1
8497073|NCT00519376|20939617|P10|COMPLETED|Treatment Period 3||1
8497074|NCT00519376|20939618|P9|COMPLETED|Treatment Period 3||1
8497075|NCT00519376|20939619|P8|COMPLETED|Treatment Period 3||1
8497076|NCT00519376|20939620|P7|COMPLETED|Treatment Period 3||1
8497077|NCT00519376|20939621|P6|COMPLETED|Treatment Period 3||1
8497078|NCT00519376|20939622|P5|COMPLETED|Treatment Period 3||1
8497079|NCT00519376|20939623|P4|COMPLETED|Treatment Period 3||2
8497080|NCT00519376|20939624|P3|COMPLETED|Treatment Period 3||2
8497081|NCT00519376|20939625|P2|COMPLETED|Treatment Period 3||2
8497082|NCT00519376|20939626|P1|COMPLETED|Treatment Period 3||2
8497083|NCT00519376|20939611|P16|STARTED|Treatment Period 3||1
8497084|NCT00519376|20939612|P15|STARTED|Treatment Period 3||1
8497085|NCT00519376|20939613|P14|STARTED|Treatment Period 3||1
8497086|NCT00519376|20939614|P13|STARTED|Treatment Period 3||0
8497087|NCT00519376|20939615|P12|STARTED|Treatment Period 3||1
8497088|NCT00519376|20939616|P11|STARTED|Treatment Period 3||1
8497089|NCT00519376|20939617|P10|STARTED|Treatment Period 3||1
8497090|NCT00519376|20939618|P9|STARTED|Treatment Period 3||1
8497091|NCT00519376|20939619|P8|STARTED|Treatment Period 3||1
8497092|NCT00519376|20939620|P7|STARTED|Treatment Period 3||1
8497093|NCT00519376|20939621|P6|STARTED|Treatment Period 3||1
8497094|NCT00519376|20939622|P5|STARTED|Treatment Period 3||1
8497095|NCT00519376|20939623|P4|STARTED|Treatment Period 3||2
8497096|NCT00519376|20939624|P3|STARTED|Treatment Period 3||2
8497097|NCT00519376|20939625|P2|STARTED|Treatment Period 3||2
8497098|NCT00519376|20939626|P1|STARTED|Treatment Period 3||2
8497099|NCT00519376|20939611|P16|NOT COMPLETED|Washout Period 2||0
8497100|NCT00519376|20939612|P15|NOT COMPLETED|Washout Period 2||0
8497101|NCT00519376|20939613|P14|NOT COMPLETED|Washout Period 2||0
8497102|NCT00519376|20939614|P13|NOT COMPLETED|Washout Period 2||0
8497103|NCT00519376|20939615|P12|NOT COMPLETED|Washout Period 2||0
8497104|NCT00519376|20939616|P11|NOT COMPLETED|Washout Period 2||0
8497105|NCT00519376|20939617|P10|NOT COMPLETED|Washout Period 2||0
8497106|NCT00519376|20939618|P9|NOT COMPLETED|Washout Period 2||0
8497107|NCT00519376|20939619|P8|NOT COMPLETED|Washout Period 2||0
8497108|NCT00519376|20939620|P7|NOT COMPLETED|Washout Period 2||0
8497109|NCT00519376|20939621|P6|NOT COMPLETED|Washout Period 2||0
8497110|NCT00519376|20939622|P5|NOT COMPLETED|Washout Period 2||0
8497111|NCT00519376|20939623|P4|NOT COMPLETED|Washout Period 2||0
8497112|NCT00519376|20939624|P3|NOT COMPLETED|Washout Period 2||0
8497113|NCT00519376|20939625|P2|NOT COMPLETED|Washout Period 2||0
8497114|NCT00519376|20939626|P1|NOT COMPLETED|Washout Period 2||0
8497115|NCT00519376|20939611|P16|COMPLETED|Washout Period 2||1
8497116|NCT00519376|20939612|P15|COMPLETED|Washout Period 2||1
8497117|NCT00519376|20939613|P14|COMPLETED|Washout Period 2||1
8497118|NCT00519376|20939614|P13|COMPLETED|Washout Period 2||0
8497119|NCT00519376|20939615|P12|COMPLETED|Washout Period 2||1
8497120|NCT00519376|20939616|P11|COMPLETED|Washout Period 2||1
8497121|NCT00519376|20939617|P10|COMPLETED|Washout Period 2||1
8497122|NCT00519376|20939618|P9|COMPLETED|Washout Period 2||1
8497123|NCT00519376|20939619|P8|COMPLETED|Washout Period 2||1
8497124|NCT00519376|20939620|P7|COMPLETED|Washout Period 2||1
8497125|NCT00519376|20939621|P6|COMPLETED|Washout Period 2||1
8497126|NCT00519376|20939622|P5|COMPLETED|Washout Period 2||1
8497127|NCT00519376|20939623|P4|COMPLETED|Washout Period 2||2
8497128|NCT00519376|20939624|P3|COMPLETED|Washout Period 2||2
8497129|NCT00519376|20939625|P2|COMPLETED|Washout Period 2||2
8497130|NCT00519376|20939626|P1|COMPLETED|Washout Period 2||2
8497131|NCT00519376|20939611|P16|STARTED|Washout Period 2||1
8497132|NCT00519376|20939612|P15|STARTED|Washout Period 2||1
8497133|NCT00519376|20939613|P14|STARTED|Washout Period 2||1
8497134|NCT00519376|20939614|P13|STARTED|Washout Period 2||0
8497135|NCT00519376|20939615|P12|STARTED|Washout Period 2||1
8497136|NCT00519376|20939616|P11|STARTED|Washout Period 2||1
8497137|NCT00519376|20939617|P10|STARTED|Washout Period 2||1
8497138|NCT00519376|20939618|P9|STARTED|Washout Period 2||1
8497139|NCT00519376|20939619|P8|STARTED|Washout Period 2||1
8497140|NCT00519376|20939620|P7|STARTED|Washout Period 2||1
8497141|NCT00519376|20939621|P6|STARTED|Washout Period 2||1
8497142|NCT00519376|20939622|P5|STARTED|Washout Period 2||1
8497143|NCT00519376|20939623|P4|STARTED|Washout Period 2||2
8497144|NCT00519376|20939624|P3|STARTED|Washout Period 2||2
8497145|NCT00519376|20939625|P2|STARTED|Washout Period 2||2
8497146|NCT00519376|20939626|P1|STARTED|Washout Period 2||2
8497147|NCT00519376|20939611|P16|NOT COMPLETED|Treatment Period 2||0
8497148|NCT00519376|20939612|P15|NOT COMPLETED|Treatment Period 2||0
8497149|NCT00519376|20939613|P14|NOT COMPLETED|Treatment Period 2||0
8497150|NCT00519376|20939614|P13|NOT COMPLETED|Treatment Period 2||1
8497151|NCT00519376|20939615|P12|NOT COMPLETED|Treatment Period 2||0
8497152|NCT00519376|20939616|P11|NOT COMPLETED|Treatment Period 2||0
8497153|NCT00519376|20939617|P10|NOT COMPLETED|Treatment Period 2||0
8497154|NCT00519376|20939618|P9|NOT COMPLETED|Treatment Period 2||0
8497155|NCT00519376|20939619|P8|NOT COMPLETED|Treatment Period 2||0
8497156|NCT00519376|20939620|P7|NOT COMPLETED|Treatment Period 2||0
8497157|NCT00519376|20939621|P6|NOT COMPLETED|Treatment Period 2||0
8497158|NCT00519376|20939622|P5|NOT COMPLETED|Treatment Period 2||0
8497159|NCT00519376|20939623|P4|NOT COMPLETED|Treatment Period 2||0
8497160|NCT00519376|20939624|P3|NOT COMPLETED|Treatment Period 2||0
8497161|NCT00519376|20939625|P2|NOT COMPLETED|Treatment Period 2||0
8497162|NCT00519376|20939626|P1|NOT COMPLETED|Treatment Period 2||0
8497163|NCT00519376|20939611|P16|COMPLETED|Treatment Period 2||1
8497164|NCT00519376|20939612|P15|COMPLETED|Treatment Period 2||1
8497165|NCT00519376|20939613|P14|COMPLETED|Treatment Period 2||1
8497166|NCT00519376|20939614|P13|COMPLETED|Treatment Period 2||0
8497167|NCT00519376|20939615|P12|COMPLETED|Treatment Period 2||1
8497168|NCT00519376|20939616|P11|COMPLETED|Treatment Period 2||1
8497169|NCT00519376|20939617|P10|COMPLETED|Treatment Period 2||1
8497170|NCT00519376|20939618|P9|COMPLETED|Treatment Period 2||1
8497171|NCT00519376|20939619|P8|COMPLETED|Treatment Period 2||1
8497172|NCT00519376|20939620|P7|COMPLETED|Treatment Period 2||1
8497173|NCT00519376|20939621|P6|COMPLETED|Treatment Period 2||1
8497174|NCT00519376|20939622|P5|COMPLETED|Treatment Period 2||1
8497175|NCT00519376|20939623|P4|COMPLETED|Treatment Period 2||2
8497176|NCT00519376|20939624|P3|COMPLETED|Treatment Period 2||2
8497177|NCT00519376|20939625|P2|COMPLETED|Treatment Period 2||2
8497178|NCT00519376|20939626|P1|COMPLETED|Treatment Period 2||2
8497179|NCT00519376|20939611|P16|STARTED|Treatment Period 2||1
8497180|NCT00519376|20939612|P15|STARTED|Treatment Period 2||1
8497181|NCT00519376|20939613|P14|STARTED|Treatment Period 2||1
8497182|NCT00519376|20939614|P13|STARTED|Treatment Period 2||1
8497183|NCT00519376|20939615|P12|STARTED|Treatment Period 2||1
8497184|NCT00519376|20939616|P11|STARTED|Treatment Period 2||1
8497185|NCT00519376|20939617|P10|STARTED|Treatment Period 2||1
8497186|NCT00519376|20939618|P9|STARTED|Treatment Period 2||1
8497187|NCT00519376|20939619|P8|STARTED|Treatment Period 2||1
8497188|NCT00519376|20939620|P7|STARTED|Treatment Period 2||1
8497189|NCT00519376|20939621|P6|STARTED|Treatment Period 2||1
8497190|NCT00519376|20939622|P5|STARTED|Treatment Period 2||1
8497191|NCT00519376|20939623|P4|STARTED|Treatment Period 2||2
8497192|NCT00519376|20939624|P3|STARTED|Treatment Period 2||2
8497193|NCT00519376|20939625|P2|STARTED|Treatment Period 2||2
8497194|NCT00519376|20939626|P1|STARTED|Treatment Period 2||2
8497195|NCT00519376|20939611|P16|NOT COMPLETED|Washout Period 1||0
8497196|NCT00519376|20939612|P15|NOT COMPLETED|Washout Period 1||0
8497197|NCT00519376|20939613|P14|NOT COMPLETED|Washout Period 1||0
8497198|NCT00519376|20939614|P13|NOT COMPLETED|Washout Period 1||0
8497199|NCT00519376|20939615|P12|NOT COMPLETED|Washout Period 1||0
8497200|NCT00519376|20939616|P11|NOT COMPLETED|Washout Period 1||0
8497201|NCT00519376|20939617|P10|NOT COMPLETED|Washout Period 1||0
8497202|NCT00519376|20939618|P9|NOT COMPLETED|Washout Period 1||0
8497203|NCT00519376|20939619|P8|NOT COMPLETED|Washout Period 1||0
8497204|NCT00519376|20939620|P7|NOT COMPLETED|Washout Period 1||0
8497205|NCT00519376|20939621|P6|NOT COMPLETED|Washout Period 1||0
8497206|NCT00519376|20939622|P5|NOT COMPLETED|Washout Period 1||0
8497207|NCT00519376|20939623|P4|NOT COMPLETED|Washout Period 1||0
8497208|NCT00519376|20939624|P3|NOT COMPLETED|Washout Period 1||0
8497209|NCT00519376|20939625|P2|NOT COMPLETED|Washout Period 1||0
8497210|NCT00519376|20939626|P1|NOT COMPLETED|Washout Period 1||0
8497211|NCT00519376|20939611|P16|COMPLETED|Washout Period 1||1
8497212|NCT00519376|20939612|P15|COMPLETED|Washout Period 1||1
8497213|NCT00519376|20939613|P14|COMPLETED|Washout Period 1||1
8497214|NCT00519376|20939614|P13|COMPLETED|Washout Period 1||1
8497215|NCT00519376|20939615|P12|COMPLETED|Washout Period 1||1
8497216|NCT00519376|20939616|P11|COMPLETED|Washout Period 1||1
8497217|NCT00519376|20939617|P10|COMPLETED|Washout Period 1||1
8497218|NCT00519376|20939618|P9|COMPLETED|Washout Period 1||1
8497219|NCT00519376|20939619|P8|COMPLETED|Washout Period 1||1
8497220|NCT00519376|20939620|P7|COMPLETED|Washout Period 1||1
8497221|NCT00519376|20939621|P6|COMPLETED|Washout Period 1||1
8497222|NCT00519376|20939622|P5|COMPLETED|Washout Period 1||1
8497223|NCT00519376|20939623|P4|COMPLETED|Washout Period 1||2
8497224|NCT00519376|20939624|P3|COMPLETED|Washout Period 1||2
8497225|NCT00519376|20939625|P2|COMPLETED|Washout Period 1||2
8497226|NCT00519376|20939626|P1|COMPLETED|Washout Period 1||2
8497227|NCT00519376|20939611|P16|STARTED|Washout Period 1||1
8497228|NCT00519376|20939612|P15|STARTED|Washout Period 1||1
8497229|NCT00519376|20939613|P14|STARTED|Washout Period 1||1
8497230|NCT00519376|20939614|P13|STARTED|Washout Period 1||1
8497231|NCT00519376|20939615|P12|STARTED|Washout Period 1||1
8497232|NCT00519376|20939616|P11|STARTED|Washout Period 1||1
8497233|NCT00519376|20939617|P10|STARTED|Washout Period 1||1
8497234|NCT00519376|20939618|P9|STARTED|Washout Period 1||1
8497235|NCT00519376|20939619|P8|STARTED|Washout Period 1||1
8497236|NCT00519376|20939620|P7|STARTED|Washout Period 1||1
8497237|NCT00519376|20939621|P6|STARTED|Washout Period 1||1
8497238|NCT00519376|20939622|P5|STARTED|Washout Period 1||1
8497239|NCT00519376|20939623|P4|STARTED|Washout Period 1||2
8497240|NCT00519376|20939624|P3|STARTED|Washout Period 1||2
8497241|NCT00519376|20939625|P2|STARTED|Washout Period 1||2
8497242|NCT00519376|20939626|P1|STARTED|Washout Period 1||2
8497243|NCT00519376|20939611|P16|NOT COMPLETED|Treatment Period 1||0
8497244|NCT00519376|20939612|P15|NOT COMPLETED|Treatment Period 1||0
8497245|NCT00519376|20939613|P14|NOT COMPLETED|Treatment Period 1||0
8497246|NCT00519376|20939614|P13|NOT COMPLETED|Treatment Period 1||0
8497247|NCT00519376|20939615|P12|NOT COMPLETED|Treatment Period 1||0
8497248|NCT00519376|20939616|P11|NOT COMPLETED|Treatment Period 1||0
8497249|NCT00519376|20939617|P10|NOT COMPLETED|Treatment Period 1||0
8497250|NCT00519376|20939618|P9|NOT COMPLETED|Treatment Period 1||0
8497251|NCT00519376|20939619|P8|NOT COMPLETED|Treatment Period 1||0
8497252|NCT00519376|20939620|P7|NOT COMPLETED|Treatment Period 1||0
8497253|NCT00519376|20939621|P6|NOT COMPLETED|Treatment Period 1||0
8497254|NCT00519376|20939622|P5|NOT COMPLETED|Treatment Period 1||0
8497255|NCT00519376|20939623|P4|NOT COMPLETED|Treatment Period 1||0
8497256|NCT00519376|20939624|P3|NOT COMPLETED|Treatment Period 1||0
8497257|NCT00519376|20939625|P2|NOT COMPLETED|Treatment Period 1||0
8497258|NCT00519376|20939626|P1|NOT COMPLETED|Treatment Period 1||0
8497259|NCT00519376|20939611|P16|COMPLETED|Treatment Period 1||1
8497260|NCT00519376|20939612|P15|COMPLETED|Treatment Period 1||1
8497261|NCT00519376|20939613|P14|COMPLETED|Treatment Period 1||1
8497262|NCT00519376|20939614|P13|COMPLETED|Treatment Period 1||1
8497263|NCT00519376|20939615|P12|COMPLETED|Treatment Period 1||1
8497264|NCT00519376|20939616|P11|COMPLETED|Treatment Period 1||1
8497265|NCT00519376|20939617|P10|COMPLETED|Treatment Period 1||1
8497266|NCT00519376|20939618|P9|COMPLETED|Treatment Period 1||1
8497267|NCT00519376|20939619|P8|COMPLETED|Treatment Period 1||1
8497268|NCT00519376|20939620|P7|COMPLETED|Treatment Period 1||1
8497269|NCT00519376|20939621|P6|COMPLETED|Treatment Period 1||1
8497270|NCT00519376|20939622|P5|COMPLETED|Treatment Period 1||1
8497271|NCT00519376|20939623|P4|COMPLETED|Treatment Period 1||2
8497272|NCT00519376|20939624|P3|COMPLETED|Treatment Period 1||2
8497273|NCT00519376|20939625|P2|COMPLETED|Treatment Period 1||2
8497274|NCT00519376|20939626|P1|COMPLETED|Treatment Period 1||2
8497275|NCT00519376|20939611|P16|STARTED|Treatment Period 1||1
8497276|NCT00519376|20939612|P15|STARTED|Treatment Period 1||1
8497277|NCT00519376|20939613|P14|STARTED|Treatment Period 1||1
8497278|NCT00519376|20939614|P13|STARTED|Treatment Period 1||1
8497279|NCT00519376|20939615|P12|STARTED|Treatment Period 1||1
8497280|NCT00519376|20939616|P11|STARTED|Treatment Period 1||1
8497281|NCT00519376|20939617|P10|STARTED|Treatment Period 1||1
8497282|NCT00519376|20939618|P9|STARTED|Treatment Period 1||1
8497283|NCT00519376|20939619|P8|STARTED|Treatment Period 1||1
8497284|NCT00519376|20939620|P7|STARTED|Treatment Period 1||1
8497285|NCT00519376|20939621|P6|STARTED|Treatment Period 1||1
8497286|NCT00519376|20939622|P5|STARTED|Treatment Period 1||1
8497287|NCT00519376|20939623|P4|STARTED|Treatment Period 1||2
8497288|NCT00519376|20939624|P3|STARTED|Treatment Period 1||2
8497289|NCT00519376|20939625|P2|STARTED|Treatment Period 1||2
8497290|NCT00519376|20939626|P1|STARTED|Treatment Period 1||2
8497291|NCT00519285|20939750|P2|NOT COMPLETED|Overall Study||612
8497292|NCT00519285|20939751|P1|NOT COMPLETED|Overall Study||612
8497293|NCT00519285|20939750|P2|COMPLETED|Overall Study||0
8497294|NCT00519285|20939751|P1|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
8497295|NCT00519285|20939750|P2|Still Treated at Cut-off Date|Overall Study||2
8497296|NCT00519285|20939751|P1|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
8497297|NCT00519285|20939750|P2|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
8497298|NCT00519285|20939751|P1|TREATED|Overall Study|Received at least part of one dose of placebo|604
8497299|NCT00519285|20939750|P2|STARTED|Overall Study|Randomized|612
8497300|NCT00519285|20939751|P1|STARTED|Overall Study|Randomized|612
8497301|NCT00519194|20939777|P1|NOT COMPLETED|Overall Study||21
8497302|NCT00519194|20939777|P1|COMPLETED|Overall Study||91
8497303|NCT00519194|20939777|P1|STARTED|Overall Study||112
8497304|NCT00519090|20939783|P2|NOT COMPLETED|Overall Study||0
8497305|NCT00519090|20939784|P1|NOT COMPLETED|Overall Study||0
8497306|NCT00519090|20939783|P2|COMPLETED|Overall Study||4
8497307|NCT00519090|20939784|P1|COMPLETED|Overall Study||2
8497308|NCT00519090|20939783|P2|STARTED|Overall Study||4
8497309|NCT00519090|20939784|P1|STARTED|Overall Study||2
8497310|NCT00519077|20939792|P1|NOT COMPLETED|Overall Study||8
8497311|NCT00519077|20939792|P1|COMPLETED|Overall Study||36
8497312|NCT00519077|20939792|P1|STARTED|Overall Study||44
8497313|NCT00518986|20939799|P2|NOT COMPLETED|Overall Study||26
8497314|NCT00518986|20939800|P1|NOT COMPLETED|Overall Study||26
8497315|NCT00518986|20939799|P2|COMPLETED|Overall Study||98
8497316|NCT00518986|20939800|P1|COMPLETED|Overall Study||99
8497317|NCT00518986|20939799|P2|STARTED|Overall Study||124
8497318|NCT00518986|20939800|P1|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
8497319|NCT00518973|20939926|P2|NOT COMPLETED|Overall Study||2
8497320|NCT00518973|20939927|P1|NOT COMPLETED|Overall Study||3
8497321|NCT00518973|20939926|P2|COMPLETED|Overall Study||4
8497322|NCT00518973|20939927|P1|COMPLETED|Overall Study||6
8497323|NCT00518973|20939926|P2|STARTED|Overall Study||6
8497324|NCT00518973|20939927|P1|STARTED|Overall Study||9
8497325|NCT00518882|20939943|P2|NOT COMPLETED|Open-Label Extension, Week 26-78||49
8497326|NCT00518882|20939944|P1|NOT COMPLETED|Open-Label Extension, Week 26-78||41
8497327|NCT00518882|20939943|P2|COMPLETED|Open-Label Extension, Week 26-78||138
8497328|NCT00518882|20939944|P1|COMPLETED|Open-Label Extension, Week 26-78||161
8497329|NCT00518882|20939943|P2|STARTED|Open-Label Extension, Week 26-78||187
8497330|NCT00518882|20939944|P1|STARTED|Open-Label Extension, Week 26-78||202
8497331|NCT00518882|20939943|P2|NOT COMPLETED|Double-Blind, Week 0-26||45
8497332|NCT00518882|20939944|P1|NOT COMPLETED|Double-Blind, Week 0-26||33
8497333|NCT00518882|20939943|P2|COMPLETED|Double-Blind, Week 0-26||187
8497334|NCT00518882|20939944|P1|COMPLETED|Double-Blind, Week 0-26||202
8497335|NCT00518882|20939943|P2|Randomised|Double-Blind, Week 0-26||231
8497336|NCT00518882|20939944|P1|Randomised|Double-Blind, Week 0-26||233
8497337|NCT00518882|20939943|P2|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
8497338|NCT00518882|20939944|P1|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
8497339|NCT00518713|20940062|P4|NOT COMPLETED|Overall Study||18
8497340|NCT00518713|20940063|P3|NOT COMPLETED|Overall Study||18
8497341|NCT00518713|20940064|P2|NOT COMPLETED|Overall Study||17
8497342|NCT00518713|20940065|P1|NOT COMPLETED|Overall Study||8
8497343|NCT00518713|20940062|P4|COMPLETED|Overall Study||41
8497344|NCT00518713|20940063|P3|COMPLETED|Overall Study||41
8497345|NCT00518713|20940064|P2|COMPLETED|Overall Study||45
8497346|NCT00518713|20940065|P1|COMPLETED|Overall Study||50
8497347|NCT00518713|20940062|P4|Modified Intent-to-Treat Population|Overall Study||57
8497348|NCT00518713|20940063|P3|Modified Intent-to-Treat Population|Overall Study||49
8497349|NCT00518713|20940064|P2|Modified Intent-to-Treat Population|Overall Study||58
8497350|NCT00518713|20940065|P1|Modified Intent-to-Treat Population|Overall Study||53
8497351|NCT00518713|20940062|P4|STARTED|Overall Study||59
8497352|NCT00518713|20940063|P3|STARTED|Overall Study||59
8497353|NCT00518713|20940064|P2|STARTED|Overall Study||62
8497354|NCT00518713|20940065|P1|STARTED|Overall Study||58
8497355|NCT00518687|20940125|P2|NOT COMPLETED|Overall Study||1420
8497356|NCT00518687|20940126|P1|NOT COMPLETED|Overall Study||1437
8497357|NCT00518687|20940125|P2|COMPLETED|Overall Study||2585
8497358|NCT00518687|20940126|P1|COMPLETED|Overall Study||2568
8497359|NCT00518687|20940125|P2|Vaccinated|Overall Study||3982
8497360|NCT00518687|20940126|P1|Vaccinated|Overall Study||3981
8497361|NCT00518687|20940125|P2|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
8497362|NCT00518687|20940126|P1|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
8497363|NCT00518622|20940146|P8|NOT COMPLETED|Overall Study||0
8497364|NCT00518622|20940147|P7|NOT COMPLETED|Overall Study||0
8497365|NCT00518622|20940148|P6|NOT COMPLETED|Overall Study||0
8497366|NCT00518622|20940149|P5|NOT COMPLETED|Overall Study||0
8497367|NCT00518622|20940150|P4|NOT COMPLETED|Overall Study||0
8497368|NCT00518622|20940151|P3|NOT COMPLETED|Overall Study||1
8497369|NCT00518622|20940152|P2|NOT COMPLETED|Overall Study||1
8497370|NCT00518622|20940153|P1|NOT COMPLETED|Overall Study||0
8497371|NCT00518622|20940146|P8|COMPLETED|Overall Study||5
8497372|NCT00518622|20940147|P7|COMPLETED|Overall Study||4
8497373|NCT00518622|20940148|P6|COMPLETED|Overall Study||5
8497374|NCT00518622|20940149|P5|COMPLETED|Overall Study||6
8497375|NCT00518622|20940150|P4|COMPLETED|Overall Study||5
8497376|NCT00518622|20940151|P3|COMPLETED|Overall Study||5
8497377|NCT00518622|20940152|P2|COMPLETED|Overall Study||5
8497378|NCT00518622|20940153|P1|COMPLETED|Overall Study||3
8497379|NCT00518622|20940146|P8|Discontinued Therapy|Overall Study||0
8497380|NCT00518622|20940147|P7|Discontinued Therapy|Overall Study||0
8497381|NCT00518622|20940148|P6|Discontinued Therapy|Overall Study||0
8497382|NCT00518622|20940149|P5|Discontinued Therapy|Overall Study||0
8497383|NCT00518622|20940150|P4|Discontinued Therapy|Overall Study||0
8497384|NCT00518622|20940151|P3|Discontinued Therapy|Overall Study||0
8497385|NCT00518622|20940152|P2|Discontinued Therapy|Overall Study||1
8497386|NCT00518622|20940153|P1|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
8497387|NCT00518622|20940146|P8|Completed Therapy|Overall Study||5
8497388|NCT00518622|20940147|P7|Completed Therapy|Overall Study||4
8497389|NCT00518622|20940148|P6|Completed Therapy|Overall Study||5
8497390|NCT00518622|20940149|P5|Completed Therapy|Overall Study||6
8497391|NCT00518622|20940150|P4|Completed Therapy|Overall Study||5
8497392|NCT00518622|20940151|P3|Completed Therapy|Overall Study||6
8497393|NCT00518622|20940152|P2|Completed Therapy|Overall Study||5
8497394|NCT00518622|20940153|P1|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
8497395|NCT00518622|20940146|P8|STARTED|Overall Study||5
8497396|NCT00518622|20940147|P7|STARTED|Overall Study||4
8497397|NCT00518622|20940148|P6|STARTED|Overall Study||5
8497398|NCT00518622|20940149|P5|STARTED|Overall Study||6
8497399|NCT00518622|20940150|P4|STARTED|Overall Study||5
8497400|NCT00518622|20940151|P3|STARTED|Overall Study||6
8497401|NCT00518622|20940152|P2|STARTED|Overall Study||6
8497402|NCT00518622|20940153|P1|STARTED|Overall Study||3
8497403|NCT00518531|20940181|P2|NOT COMPLETED|Treatment Period 2||20
8497404|NCT00518531|20940182|P1|NOT COMPLETED|Treatment Period 2||3
8497405|NCT00518531|20940181|P2|COMPLETED|Treatment Period 2||95
8497406|NCT00518531|20940182|P1|COMPLETED|Treatment Period 2||103
8497407|NCT00518531|20940181|P2|Received Treatment|Treatment Period 2||110
8497408|NCT00518531|20940182|P1|Received Treatment|Treatment Period 2||106
8497409|NCT00518531|20940181|P2|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
8497410|NCT00518531|20940182|P1|STARTED|Treatment Period 2||106
8497411|NCT00518531|20940181|P2|NOT COMPLETED|Treatment Period 1||12
8497412|NCT00518531|20940182|P1|NOT COMPLETED|Treatment Period 1||18
8497413|NCT00518531|20940181|P2|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
8497414|NCT00518531|20940182|P1|COMPLETED|Treatment Period 1||106
8497415|NCT00518531|20940181|P2|Received Treatment|Treatment Period 1||124
8497416|NCT00518531|20940182|P1|Received Treatment|Treatment Period 1||119
8497417|NCT00518531|20940181|P2|STARTED|Treatment Period 1||126
8497418|NCT00518531|20940182|P1|STARTED|Treatment Period 1||124
8497419|NCT00518349|20940218|P2|NOT COMPLETED|Overall Study||0
8497420|NCT00518349|20940219|P1|NOT COMPLETED|Overall Study||0
8497421|NCT00518349|20940218|P2|COMPLETED|Overall Study||60
8497422|NCT00518349|20940219|P1|COMPLETED|Overall Study||60
8497423|NCT00518349|20940218|P2|STARTED|Overall Study||60
8497424|NCT00518349|20940219|P1|STARTED|Overall Study||60
8497425|NCT00518336|20940227|P2|NOT COMPLETED|Year 9||1
8497426|NCT00518336|20940228|P1|NOT COMPLETED|Year 9||5
8497427|NCT00518336|20940227|P2|COMPLETED|Year 9||212
8497428|NCT00518336|20940228|P1|COMPLETED|Year 9||219
8497429|NCT00518336|20940227|P2|STARTED|Year 9||213
8497430|NCT00518336|20940228|P1|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
8497431|NCT00518336|20940227|P2|NOT COMPLETED|Year 8||2
8497432|NCT00518336|20940228|P1|NOT COMPLETED|Year 8||1
8497433|NCT00518336|20940227|P2|COMPLETED|Year 8||211
8497434|NCT00518336|20940228|P1|COMPLETED|Year 8||222
8497435|NCT00518336|20940227|P2|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
8497436|NCT00518336|20940228|P1|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
8497437|NCT00518336|20940227|P2|NOT COMPLETED|Year 7||3
8497438|NCT00518336|20940228|P1|NOT COMPLETED|Year 7||2
8497439|NCT00518336|20940227|P2|COMPLETED|Year 7||208
8497440|NCT00518336|20940228|P1|COMPLETED|Year 7||220
8497441|NCT00518336|20940227|P2|STARTED|Year 7||211
8497442|NCT00518336|20940228|P1|STARTED|Year 7||222
8497443|NCT00518323|20940394|P4|NOT COMPLETED|Overall Study||25
8497444|NCT00518323|20940395|P3|NOT COMPLETED|Overall Study||11
8497445|NCT00518323|20940396|P2|NOT COMPLETED|Overall Study||8
8497446|NCT00518323|20940397|P1|NOT COMPLETED|Overall Study||19
8497447|NCT00518323|20940394|P4|COMPLETED|Overall Study||26
8497448|NCT00518323|20940395|P3|COMPLETED|Overall Study||37
8497449|NCT00518323|20940396|P2|COMPLETED|Overall Study||40
8497450|NCT00518323|20940397|P1|COMPLETED|Overall Study||35
8497451|NCT00518323|20940394|P4|STARTED|Overall Study||51
8497452|NCT00518323|20940395|P3|STARTED|Overall Study||48
8497453|NCT00518323|20940396|P2|STARTED|Overall Study||48
8497454|NCT00518323|20940397|P1|STARTED|Overall Study||54
8497455|NCT00518284|20940427|P4|NOT COMPLETED|Overall Study||2
8497456|NCT00518284|20940428|P3|NOT COMPLETED|Overall Study||1
8497457|NCT00518284|20940429|P2|NOT COMPLETED|Overall Study||3
8497458|NCT00518284|20940430|P1|NOT COMPLETED|Overall Study||0
8497459|NCT00518284|20940427|P4|COMPLETED|Overall Study||0
8497460|NCT00518284|20940428|P3|COMPLETED|Overall Study||0
8497461|NCT00518284|20940429|P2|COMPLETED|Overall Study||0
8497462|NCT00518284|20940430|P1|COMPLETED|Overall Study||0
8497463|NCT00518284|20940427|P4|STARTED|Overall Study||2
8497464|NCT00518284|20940428|P3|STARTED|Overall Study||1
8497465|NCT00518284|20940429|P2|STARTED|Overall Study||3
8497466|NCT00518284|20940430|P1|STARTED|Overall Study||0
8497467|NCT00518206|20940486|P2|NOT COMPLETED|Overall Study||6
8497468|NCT00518206|20940487|P1|NOT COMPLETED|Overall Study||11
8497469|NCT00518206|20940486|P2|COMPLETED|Overall Study||13
8497470|NCT00518206|20940487|P1|COMPLETED|Overall Study||16
8497471|NCT00518206|20940486|P2|STARTED|Overall Study||19
8497472|NCT00518206|20940487|P1|STARTED|Overall Study||27
8497473|NCT00518180|20940504|P3|NOT COMPLETED|Overall Study||82
8497474|NCT00518180|20940505|P2|NOT COMPLETED|Overall Study||69
8497475|NCT00518180|20940506|P1|NOT COMPLETED|Overall Study||65
8497476|NCT00518180|20940504|P3|COMPLETED|Overall Study||457
8497477|NCT00518180|20940505|P2|COMPLETED|Overall Study||472
8497478|NCT00518180|20940506|P1|COMPLETED|Overall Study||475
8497479|NCT00518180|20940504|P3|STARTED|Overall Study||539
8497480|NCT00518180|20940505|P2|STARTED|Overall Study||541
8497481|NCT00518180|20940506|P1|STARTED|Overall Study||540
8497482|NCT00518154|20940548|P1|NOT COMPLETED|Overall Study||0
8497483|NCT00518154|20940548|P1|COMPLETED|Overall Study||7
8497484|NCT00518154|20940548|P1|STARTED|Overall Study||7
8497485|NCT00518115|20940562|P10|NOT COMPLETED|Overall Study||15
8497486|NCT00518115|20940563|P9|NOT COMPLETED|Overall Study||5
8497487|NCT00518115|20940564|P8|NOT COMPLETED|Overall Study||15
8497488|NCT00518115|20940565|P7|NOT COMPLETED|Overall Study||8
8497489|NCT00518115|20940566|P6|NOT COMPLETED|Overall Study||15
8497490|NCT00518115|20940567|P5|NOT COMPLETED|Overall Study||10
8497491|NCT00518115|20940568|P4|NOT COMPLETED|Overall Study||11
8497492|NCT00518115|20940569|P3|NOT COMPLETED|Overall Study||17
8497493|NCT00518115|20940570|P2|NOT COMPLETED|Overall Study||6
8497494|NCT00518115|20940571|P1|NOT COMPLETED|Overall Study||12
8497495|NCT00518115|20940562|P10|COMPLETED|Overall Study||20
8497496|NCT00518115|20940563|P9|COMPLETED|Overall Study||30
8497497|NCT00518115|20940564|P8|COMPLETED|Overall Study||20
8497498|NCT00518115|20940565|P7|COMPLETED|Overall Study||25
8497499|NCT00518115|20940566|P6|COMPLETED|Overall Study||19
8497500|NCT00518115|20940567|P5|COMPLETED|Overall Study||21
8497501|NCT00518115|20940568|P4|COMPLETED|Overall Study||24
8497502|NCT00518115|20940569|P3|COMPLETED|Overall Study||19
8497503|NCT00518115|20940570|P2|COMPLETED|Overall Study||29
8497504|NCT00518115|20940571|P1|COMPLETED|Overall Study||40
8497505|NCT00518115|20940562|P10|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
8497506|NCT00518115|20940563|P9|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8497507|NCT00518115|20940564|P8|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8497508|NCT00518115|20940565|P7|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
8497509|NCT00518115|20940566|P6|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
8497510|NCT00518115|20940567|P5|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
8497511|NCT00518115|20940568|P4|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8497512|NCT00518115|20940569|P3|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8497513|NCT00518115|20940570|P2|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
8497514|NCT00518115|20940571|P1|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
8497515|NCT00518115|20940562|P10|STARTED|Overall Study||35
8497516|NCT00518115|20940563|P9|STARTED|Overall Study||35
8497517|NCT00518115|20940564|P8|STARTED|Overall Study||35
8497518|NCT00518115|20940565|P7|STARTED|Overall Study||33
8497519|NCT00518115|20940566|P6|STARTED|Overall Study||34
8497520|NCT00518115|20940567|P5|STARTED|Overall Study||31
8497521|NCT00518115|20940568|P4|STARTED|Overall Study||35
8497522|NCT00518115|20940569|P3|STARTED|Overall Study||36
8497523|NCT00518115|20940570|P2|STARTED|Overall Study||35
8497524|NCT00518115|20940571|P1|STARTED|Overall Study||52
8497525|NCT00518089|20940729|P2|NOT COMPLETED|Overall Study||31
8497526|NCT00518089|20940730|P1|NOT COMPLETED|Overall Study||28
8497527|NCT00518089|20940729|P2|COMPLETED|Overall Study||398
8497528|NCT00518089|20940730|P1|COMPLETED|Overall Study||402
8497529|NCT00518089|20940729|P2|STARTED|Overall Study||429
8497530|NCT00518089|20940730|P1|STARTED|Overall Study||430
8497531|NCT00518011|20940746|P2|NOT COMPLETED|Overall Study||8
8497532|NCT00518011|20940747|P1|NOT COMPLETED|Overall Study||9
8497533|NCT00518011|20940746|P2|COMPLETED|Overall Study||0
8497534|NCT00518011|20940747|P1|COMPLETED|Overall Study||0
8497535|NCT00518011|20940746|P2|STARTED|Overall Study||8
8497536|NCT00518011|20940747|P1|STARTED|Overall Study||9
8497537|NCT00517933|20940769|P2|NOT COMPLETED|Period 2||13
8497538|NCT00517933|20940770|P1|NOT COMPLETED|Period 2||6
8497539|NCT00517933|20940769|P2|COMPLETED|Period 2||70
8497540|NCT00517933|20940770|P1|COMPLETED|Period 2||73
8497541|NCT00517933|20940769|P2|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
8497542|NCT00517933|20940770|P1|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
8497543|NCT00517933|20940769|P2|NOT COMPLETED|Period 1||6
8497544|NCT00517933|20940770|P1|NOT COMPLETED|Period 1||8
8497545|NCT00517933|20940769|P2|COMPLETED|Period 1||85
8497546|NCT00517933|20940770|P1|COMPLETED|Period 1||81
8497547|NCT00517933|20940769|P2|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
8497548|NCT00517933|20940770|P1|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
8497549|NCT00517881|20940834|P1|NOT COMPLETED|Overall Study||5
8497550|NCT00517881|20940834|P1|COMPLETED|Overall Study||24
8497551|NCT00517881|20940834|P1|STARTED|Overall Study||29
8497552|NCT00517829|20940846|P2|NOT COMPLETED|Overall Study||75
8497553|NCT00517829|20940847|P1|NOT COMPLETED|Overall Study||75
8497554|NCT00517829|20940846|P2|COMPLETED|Overall Study||0
8497555|NCT00517829|20940847|P1|COMPLETED|Overall Study||0
8497556|NCT00517829|20940846|P2|STARTED|Overall Study||75
8497557|NCT00517829|20940847|P1|STARTED|Overall Study||75
8497558|NCT00517751|20940861|P1|NOT COMPLETED|Overall Study||129
8497559|NCT00517751|20940861|P1|COMPLETED|Overall Study||33
8497560|NCT00517751|20940861|P1|STARTED|Overall Study||162
8497561|NCT00517699|20940884|P1|NOT COMPLETED|Overall Study||5
8497562|NCT00517699|20940884|P1|COMPLETED|Overall Study||0
8497563|NCT00517699|20940884|P1|STARTED|Overall Study||5
8497564|NCT00517634|20940892|P6|NOT COMPLETED|Third Treatment Period||0
8497565|NCT00517634|20940893|P5|NOT COMPLETED|Third Treatment Period||0
8497566|NCT00517634|20940894|P4|NOT COMPLETED|Third Treatment Period||0
8497567|NCT00517634|20940895|P3|NOT COMPLETED|Third Treatment Period||0
8497568|NCT00517634|20940896|P2|NOT COMPLETED|Third Treatment Period||0
8497569|NCT00517634|20940897|P1|NOT COMPLETED|Third Treatment Period||0
8497570|NCT00517634|20940892|P6|COMPLETED|Third Treatment Period||4
8497571|NCT00517634|20940893|P5|COMPLETED|Third Treatment Period||3
8497572|NCT00517634|20940894|P4|COMPLETED|Third Treatment Period||3
8497573|NCT00517634|20940895|P3|COMPLETED|Third Treatment Period||4
8497574|NCT00517634|20940896|P2|COMPLETED|Third Treatment Period||4
8497575|NCT00517634|20940897|P1|COMPLETED|Third Treatment Period||4
8497576|NCT00517634|20940892|P6|STARTED|Third Treatment Period||4
8497577|NCT00517634|20940893|P5|STARTED|Third Treatment Period||3
8497578|NCT00517634|20940894|P4|STARTED|Third Treatment Period||3
8497579|NCT00517634|20940895|P3|STARTED|Third Treatment Period||4
8497580|NCT00517634|20940896|P2|STARTED|Third Treatment Period||4
8497581|NCT00517634|20940897|P1|STARTED|Third Treatment Period||4
8497582|NCT00517634|20940892|P6|NOT COMPLETED|Second Treatment Period||0
8497583|NCT00517634|20940893|P5|NOT COMPLETED|Second Treatment Period||1
8497584|NCT00517634|20940894|P4|NOT COMPLETED|Second Treatment Period||0
8497585|NCT00517634|20940895|P3|NOT COMPLETED|Second Treatment Period||0
8497586|NCT00517634|20940896|P2|NOT COMPLETED|Second Treatment Period||0
8497587|NCT00517634|20940897|P1|NOT COMPLETED|Second Treatment Period||0
8497588|NCT00517634|20940892|P6|COMPLETED|Second Treatment Period||4
8497589|NCT00517634|20940893|P5|COMPLETED|Second Treatment Period||3
8497590|NCT00517634|20940894|P4|COMPLETED|Second Treatment Period||3
8497591|NCT00517634|20940895|P3|COMPLETED|Second Treatment Period||4
8497592|NCT00517634|20940896|P2|COMPLETED|Second Treatment Period||4
8497593|NCT00517634|20940897|P1|COMPLETED|Second Treatment Period||4
8497594|NCT00517634|20940892|P6|STARTED|Second Treatment Period||4
8497595|NCT00517634|20940893|P5|STARTED|Second Treatment Period||4
8497596|NCT00517634|20940894|P4|STARTED|Second Treatment Period||3
8497597|NCT00517634|20940895|P3|STARTED|Second Treatment Period||4
8497598|NCT00517634|20940896|P2|STARTED|Second Treatment Period||4
8497599|NCT00517634|20940897|P1|STARTED|Second Treatment Period||4
8497600|NCT00517634|20940892|P6|NOT COMPLETED|First Treatment Period||0
8497601|NCT00517634|20940893|P5|NOT COMPLETED|First Treatment Period||0
8497602|NCT00517634|20940894|P4|NOT COMPLETED|First Treatment Period||0
8497603|NCT00517634|20940895|P3|NOT COMPLETED|First Treatment Period||0
8497604|NCT00517634|20940896|P2|NOT COMPLETED|First Treatment Period||0
8497605|NCT00517634|20940897|P1|NOT COMPLETED|First Treatment Period||0
8497606|NCT00517634|20940892|P6|COMPLETED|First Treatment Period||4
8497607|NCT00517634|20940893|P5|COMPLETED|First Treatment Period||4
8497608|NCT00517634|20940894|P4|COMPLETED|First Treatment Period||3
8497609|NCT00517634|20940895|P3|COMPLETED|First Treatment Period||4
8497610|NCT00517634|20940896|P2|COMPLETED|First Treatment Period||4
8497611|NCT00517634|20940897|P1|COMPLETED|First Treatment Period||4
8497612|NCT00517634|20940892|P6|STARTED|First Treatment Period||4
8497613|NCT00517634|20940893|P5|STARTED|First Treatment Period||4
8497614|NCT00517634|20940894|P4|STARTED|First Treatment Period||3
8497615|NCT00517634|20940895|P3|STARTED|First Treatment Period||4
8497616|NCT00517634|20940896|P2|STARTED|First Treatment Period||4
8497617|NCT00517634|20940897|P1|STARTED|First Treatment Period||4
8497618|NCT00517595|20940908|P1|NOT COMPLETED|Overall Study||0
8497619|NCT00517595|20940908|P1|COMPLETED|Overall Study||48
8497620|NCT00517595|20940908|P1|STARTED|Overall Study||48
8497621|NCT00517556|20940919|P2|NOT COMPLETED|Overall Study||5
8497622|NCT00517556|20940920|P1|NOT COMPLETED|Overall Study||4
8497623|NCT00517556|20940919|P2|COMPLETED|Overall Study||14
8497624|NCT00517556|20940920|P1|COMPLETED|Overall Study||15
8497625|NCT00517556|20940919|P2|STARTED|Overall Study||19
8497626|NCT00517556|20940920|P1|STARTED|Overall Study||19
8497627|NCT00517530|20940933|P7|NOT COMPLETED|Overall Study||19
8497628|NCT00517530|20940934|P6|NOT COMPLETED|Overall Study||19
8497629|NCT00517530|20940935|P5|NOT COMPLETED|Overall Study||20
8497630|NCT00517530|20940936|P4|NOT COMPLETED|Overall Study||21
8497631|NCT00517530|20940937|P3|NOT COMPLETED|Overall Study||18
8497632|NCT00517530|20940938|P2|NOT COMPLETED|Overall Study||13
8497633|NCT00517530|20940939|P1|NOT COMPLETED|Overall Study||19
8497634|NCT00517530|20940933|P7|COMPLETED|Overall Study||1
8497635|NCT00517530|20940934|P6|COMPLETED|Overall Study||0
8497636|NCT00517530|20940935|P5|COMPLETED|Overall Study||1
8497637|NCT00517530|20940936|P4|COMPLETED|Overall Study||1
8497638|NCT00517530|20940937|P3|COMPLETED|Overall Study||0
8497639|NCT00517530|20940938|P2|COMPLETED|Overall Study||0
8497640|NCT00517530|20940939|P1|COMPLETED|Overall Study||2
8497641|NCT00517530|20940933|P7|Retreated Population|Overall Study||0
8497642|NCT00517530|20940934|P6|Retreated Population|Overall Study||2
8497643|NCT00517530|20940935|P5|Retreated Population|Overall Study||2
8497644|NCT00517530|20940936|P4|Retreated Population|Overall Study||4
8497645|NCT00517530|20940937|P3|Retreated Population|Overall Study||1
8497646|NCT00517530|20940938|P2|Retreated Population|Overall Study||2
8497647|NCT00517530|20940939|P1|Retreated Population|Overall Study||2
8497648|NCT00517530|20940933|P7|Completed Follow-up|Overall Study||1
8497649|NCT00517530|20940934|P6|Completed Follow-up|Overall Study||0
8497650|NCT00517530|20940935|P5|Completed Follow-up|Overall Study||0
8497651|NCT00517530|20940936|P4|Completed Follow-up|Overall Study||1
8497652|NCT00517530|20940937|P3|Completed Follow-up|Overall Study||0
8497653|NCT00517530|20940938|P2|Completed Follow-up|Overall Study||0
8497654|NCT00517530|20940939|P1|Completed Follow-up|Overall Study||2
8497655|NCT00517530|20940933|P7|Started Follow-up|Overall Study||19
8497656|NCT00517530|20940934|P6|Started Follow-up|Overall Study||16
8497657|NCT00517530|20940935|P5|Started Follow-up|Overall Study||17
8497658|NCT00517530|20940936|P4|Started Follow-up|Overall Study||21
8497659|NCT00517530|20940937|P3|Started Follow-up|Overall Study||17
8497660|NCT00517530|20940938|P2|Started Follow-up|Overall Study||13
8497661|NCT00517530|20940939|P1|Started Follow-up|Overall Study||20
8497662|NCT00517530|20940933|P7|Completed Treatment|Overall Study||13
8497663|NCT00517530|20940934|P6|Completed Treatment|Overall Study||9
8497664|NCT00517530|20940935|P5|Completed Treatment|Overall Study||9
8497665|NCT00517530|20940936|P4|Completed Treatment|Overall Study||18
8497666|NCT00517530|20940937|P3|Completed Treatment|Overall Study||13
8497667|NCT00517530|20940938|P2|Completed Treatment|Overall Study||13
8497668|NCT00517530|20940939|P1|Completed Treatment|Overall Study||11
8497669|NCT00517530|20940933|P7|STARTED|Overall Study||20
8497670|NCT00517530|20940934|P6|STARTED|Overall Study||19
8497671|NCT00517530|20940935|P5|STARTED|Overall Study||21
8497672|NCT00517530|20940936|P4|STARTED|Overall Study||22
8497673|NCT00517530|20940937|P3|STARTED|Overall Study||18
8497674|NCT00517530|20940938|P2|STARTED|Overall Study||13
8497675|NCT00517530|20940939|P1|STARTED|Overall Study||21
8497676|NCT00517413|20940999|P1|NOT COMPLETED|Overall Study||61
8497677|NCT00517413|20940999|P1|COMPLETED|Overall Study||102
8497678|NCT00517413|20940999|P1|STARTED|Overall Study||163
8497679|NCT00517361|20941020|P1|NOT COMPLETED|Overall Study||11
8497680|NCT00517361|20941020|P1|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
8497681|NCT00517361|20941020|P1|STARTED|Overall Study||11
8497682|NCT00517296|20941029|P2|NOT COMPLETED|Overall Study||0
8497683|NCT00517296|20941030|P1|NOT COMPLETED|Overall Study||1
8497684|NCT00517296|20941029|P2|COMPLETED|Overall Study||11
8497685|NCT00517296|20941030|P1|COMPLETED|Overall Study||9
8497686|NCT00517296|20941029|P2|STARTED|Overall Study||11
8497687|NCT00517296|20941030|P1|STARTED|Overall Study||10
8497688|NCT00517192|20941042|P2|NOT COMPLETED|Overall Study||20
8497689|NCT00517192|20941043|P1|NOT COMPLETED|Overall Study||19
8497690|NCT00517192|20941042|P2|COMPLETED|Overall Study||0
8497691|NCT00517192|20941043|P1|COMPLETED|Overall Study||0
8497692|NCT00517192|20941042|P2|STARTED|Overall Study||20
8497693|NCT00517192|20941043|P1|STARTED|Overall Study||19
8497694|NCT00517075|20941095|P4|NOT COMPLETED|Overall Study||0
8497695|NCT00517075|20941096|P3|NOT COMPLETED|Overall Study||0
8497696|NCT00517075|20941097|P2|NOT COMPLETED|Overall Study||0
8497697|NCT00517075|20941098|P1|NOT COMPLETED|Overall Study||0
8497698|NCT00517075|20941095|P4|COMPLETED|Overall Study||0
8497699|NCT00517075|20941096|P3|COMPLETED|Overall Study||0
8497700|NCT00517075|20941097|P2|COMPLETED|Overall Study||0
8497701|NCT00517075|20941098|P1|COMPLETED|Overall Study||0
8497702|NCT00517075|20941095|P4|STARTED|Overall Study||0
8497703|NCT00517075|20941096|P3|STARTED|Overall Study||0
8497704|NCT00517075|20941097|P2|STARTED|Overall Study||0
8497705|NCT00517075|20941098|P1|STARTED|Overall Study||0
8497706|NCT00517010|20941136|P1|NOT COMPLETED|Overall Study||1
8497707|NCT00517010|20941136|P1|COMPLETED|Overall Study||5
8497708|NCT00517010|20941136|P1|STARTED|Overall Study||6
8497709|NCT00516919|20941141|P2|NOT COMPLETED|Overall Study||7
8497710|NCT00516919|20941142|P1|NOT COMPLETED|Overall Study||10
8497711|NCT00516919|20941141|P2|COMPLETED|Overall Study||32
8497712|NCT00516919|20941142|P1|COMPLETED|Overall Study||30
8497713|NCT00516919|20941141|P2|STARTED|Overall Study||39
8497714|NCT00516919|20941142|P1|STARTED|Overall Study||40
8497715|NCT00516906|20941150|P2|NOT COMPLETED|Overall Study||2
8497716|NCT00516906|20941151|P1|NOT COMPLETED|Overall Study||6
8497717|NCT00516906|20941150|P2|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
8497718|NCT00516906|20941151|P1|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
8497719|NCT00516906|20941150|P2|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
8497720|NCT00516906|20941151|P1|STARTED|Overall Study||36
8497721|NCT00516893|20941161|P1|NOT COMPLETED|Overall Study||21
8497722|NCT00516893|20941161|P1|COMPLETED|Overall Study||92
8497723|NCT00516893|20941161|P1|Received Study Treatment|Overall Study||112
8497724|NCT00516893|20941161|P1|STARTED|Overall Study||113
8497725|NCT00516737|20941170|P2|NOT COMPLETED|Overall Study||8
8497726|NCT00516737|20941171|P1|NOT COMPLETED|Overall Study||11
8497727|NCT00516737|20941170|P2|COMPLETED|Overall Study||96
8497728|NCT00516737|20941171|P1|COMPLETED|Overall Study||92
8497729|NCT00516737|20941170|P2|STARTED|Overall Study||104
8497730|NCT00516737|20941171|P1|STARTED|Overall Study||103
8497731|NCT00516503|20941191|P2|NOT COMPLETED|Overall Study||0
8497732|NCT00516503|20941192|P1|NOT COMPLETED|Overall Study||0
8497733|NCT00516503|20941191|P2|COMPLETED|Overall Study||102
8497734|NCT00516503|20941192|P1|COMPLETED|Overall Study||101
8497735|NCT00516503|20941191|P2|STARTED|Overall Study||102
8497736|NCT00516503|20941192|P1|STARTED|Overall Study||101
8497737|NCT00516386|20941210|P1|NOT COMPLETED|Overall Study||6
8497738|NCT00516386|20941210|P1|COMPLETED|Overall Study||10
8497739|NCT00516386|20941210|P1|STARTED|Overall Study||16
8497740|NCT00516321|20941217|P3|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
8497741|NCT00516321|20941218|P2|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
8497742|NCT00516321|20941219|P1|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
8497743|NCT00516321|20941217|P3|COMPLETED|Double-blind (DB) Antiviral Treatment||396
8497744|NCT00516321|20941218|P2|COMPLETED|Double-blind (DB) Antiviral Treatment||197
8497745|NCT00516321|20941219|P1|COMPLETED|Double-blind (DB) Antiviral Treatment||0
8497746|NCT00516321|20941217|P3|STARTED|Double-blind (DB) Antiviral Treatment||450
8497747|NCT00516321|20941218|P2|STARTED|Double-blind (DB) Antiviral Treatment||232
8497748|NCT00516321|20941219|P1|STARTED|Double-blind (DB) Antiviral Treatment||0
8497749|NCT00516321|20941217|P3|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
8497750|NCT00516321|20941218|P2|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
8497751|NCT00516321|20941219|P1|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
8497752|NCT00516321|20941217|P3|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
8497753|NCT00516321|20941218|P2|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
8497754|NCT00516321|20941219|P1|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
8497755|NCT00516321|20941217|P3|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
8497756|NCT00516321|20941218|P2|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
8497757|NCT00516321|20941219|P1|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
8497758|NCT00516295|20941270|P3|NOT COMPLETED|Overall Study||0
8497759|NCT00516295|20941271|P2|NOT COMPLETED|Overall Study||0
8497760|NCT00516295|20941272|P1|NOT COMPLETED|Overall Study||3
8497761|NCT00516295|20941270|P3|COMPLETED|Overall Study||0
8497762|NCT00516295|20941271|P2|COMPLETED|Overall Study||0
8497763|NCT00516295|20941272|P1|COMPLETED|Overall Study||4
8497764|NCT00516295|20941270|P3|STARTED|Overall Study||0
8497765|NCT00516295|20941271|P2|STARTED|Overall Study||0
8497766|NCT00516295|20941272|P1|STARTED|Overall Study||7
8497767|NCT00516269|20941285|P2|NOT COMPLETED|Overall Study||3
8497768|NCT00516269|20941286|P1|NOT COMPLETED|Overall Study||2
8497769|NCT00516269|20941285|P2|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
8497770|NCT00516269|20941286|P1|COMPLETED|Overall Study|2 patients had an early termination|17
8497771|NCT00516269|20941285|P2|STARTED|Overall Study||19
8497772|NCT00516269|20941286|P1|STARTED|Overall Study||19
8497773|NCT00516217|20941292|P1|NOT COMPLETED|Overall Study||0
8497774|NCT00516217|20941292|P1|COMPLETED|Overall Study||29
8497775|NCT00516217|20941292|P1|STARTED|Overall Study||29
8497776|NCT00516165|20941298|P1|NOT COMPLETED|Overall Study||0
8497777|NCT00516165|20941298|P1|COMPLETED|Overall Study||28
8497778|NCT00516165|20941298|P1|STARTED|Overall Study||28
8497779|NCT00516139|20941307|P1|NOT COMPLETED|Overall Study||38
8497780|NCT00516139|20941307|P1|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
8497781|NCT00516139|20941307|P1|STARTED|Overall Study||122
8497782|NCT00516074|20941338|P2|NOT COMPLETED|Overall Study||3
8497783|NCT00516074|20941339|P1|NOT COMPLETED|Overall Study||6
8497784|NCT00516074|20941338|P2|COMPLETED|Overall Study||23
8497785|NCT00516074|20941339|P1|COMPLETED|Overall Study||22
8497786|NCT00516074|20941338|P2|STARTED|Overall Study||26
8497787|NCT00516074|20941339|P1|STARTED|Overall Study||28
8497788|NCT00516048|20941357|P3|NOT COMPLETED|Overall Study||1
8497789|NCT00516048|20941358|P2|NOT COMPLETED|Overall Study||2
8497790|NCT00516048|20941359|P1|NOT COMPLETED|Overall Study||0
8497791|NCT00516048|20941357|P3|COMPLETED|Overall Study||0
8497792|NCT00516048|20941358|P2|COMPLETED|Overall Study||40
8497793|NCT00516048|20941359|P1|COMPLETED|Overall Study||15
8497794|NCT00516048|20941357|P3|STARTED|Overall Study||1
8497795|NCT00516048|20941358|P2|STARTED|Overall Study||42
8497796|NCT00516048|20941359|P1|STARTED|Overall Study||15
8497797|NCT00515879|20941375|P2|NOT COMPLETED|Overall Study||20
8497798|NCT00515879|20941376|P1|NOT COMPLETED|Overall Study||25
8497799|NCT00515879|20941375|P2|COMPLETED|Overall Study||62
8497800|NCT00515879|20941376|P1|COMPLETED|Overall Study||62
8497801|NCT00515879|20941375|P2|STARTED|Overall Study||82
8497802|NCT00515879|20941376|P1|STARTED|Overall Study||87
8497803|NCT00515827|20941394|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
8497804|NCT00515827|20941395|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
8497805|NCT00515827|20941394|P2|COMPLETED|Second Intervention (12 Weeks)||25
8497806|NCT00515827|20941395|P1|COMPLETED|Second Intervention (12 Weeks)||25
8497807|NCT00515827|20941394|P2|STARTED|Second Intervention (12 Weeks)||25
8497808|NCT00515827|20941395|P1|STARTED|Second Intervention (12 Weeks)||26
8497809|NCT00515827|20941394|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
8497810|NCT00515827|20941395|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
8497811|NCT00515827|20941394|P2|COMPLETED|First Intervention (12 Weeks)||25
8497812|NCT00515827|20941395|P1|COMPLETED|First Intervention (12 Weeks)||26
8497813|NCT00515827|20941394|P2|STARTED|First Intervention (12 Weeks)||26
8497814|NCT00515827|20941395|P1|STARTED|First Intervention (12 Weeks)||27
8497815|NCT00515723|20941421|P4|NOT COMPLETED|Overall Study||6
8497816|NCT00515723|20941422|P3|NOT COMPLETED|Overall Study||1
8497817|NCT00515723|20941423|P2|NOT COMPLETED|Overall Study||1
8497818|NCT00515723|20941424|P1|NOT COMPLETED|Overall Study||5
8497819|NCT00515723|20941421|P4|COMPLETED|Overall Study||21
8497820|NCT00515723|20941422|P3|COMPLETED|Overall Study||21
8497821|NCT00515723|20941423|P2|COMPLETED|Overall Study||21
8497822|NCT00515723|20941424|P1|COMPLETED|Overall Study||20
8497823|NCT00515723|20941421|P4|STARTED|Overall Study||27
8497824|NCT00515723|20941422|P3|STARTED|Overall Study||22
8497825|NCT00515723|20941423|P2|STARTED|Overall Study||22
8497826|NCT00515723|20941424|P1|STARTED|Overall Study||25
8497827|NCT00515697|20941440|P1|NOT COMPLETED|Overall Study||0
8497828|NCT00515697|20941440|P1|COMPLETED|Overall Study||39
8497829|NCT00515697|20941440|P1|Received at Least 1 Dose of Study Drug|Overall Study||39
8497830|NCT00515697|20941440|P1|STARTED|Overall Study||39
8497831|NCT00515671|20941453|P2|NOT COMPLETED|Overall Study||17
8497832|NCT00515671|20941454|P1|NOT COMPLETED|Overall Study||17
8497833|NCT00515671|20941453|P2|COMPLETED|Overall Study||41
8497834|NCT00515671|20941454|P1|COMPLETED|Overall Study||43
8497835|NCT00515671|20941453|P2|STARTED|Overall Study||58
8497836|NCT00515671|20941454|P1|STARTED|Overall Study||60
8497837|NCT00515619|20941462|P1|NOT COMPLETED|Overall Study||216
8497838|NCT00515619|20941462|P1|COMPLETED|Overall Study||160
8497839|NCT00515619|20941462|P1|Safety Set|Overall Study||376
8497840|NCT00515619|20941462|P1|STARTED|Overall Study||376
8497841|NCT00515541|20941474|P4|NOT COMPLETED|Overall Study||5
8497842|NCT00515541|20941475|P3|NOT COMPLETED|Overall Study||0
8497843|NCT00515541|20941476|P2|NOT COMPLETED|Overall Study||5
8497844|NCT00515541|20941477|P1|NOT COMPLETED|Overall Study||0
8497845|NCT00515541|20941474|P4|COMPLETED|Overall Study||6
8497846|NCT00515541|20941475|P3|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
8497847|NCT00515541|20941476|P2|COMPLETED|Overall Study||7
8497848|NCT00515541|20941477|P1|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
8497849|NCT00515541|20941474|P4|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
8497850|NCT00515541|20941475|P3|24 Weeks (8 gm Lovaza)|Overall Study||10
8497851|NCT00515541|20941476|P2|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
8497852|NCT00515541|20941477|P1|24 Weeks (8 gm Lovaza)|Overall Study||10
8497853|NCT00515541|20941474|P4|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
8497854|NCT00515541|20941475|P3|18 Weeks (4 gm Lovaza)|Overall Study||10
8497944|NCT00515502|20941517|P3|STARTED|Washout Period 3||4
8497855|NCT00515541|20941476|P2|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
8497856|NCT00515541|20941477|P1|18 Weeks (4 gm Lovaza)|Overall Study||10
8497857|NCT00515541|20941474|P4|12 Weeks (2 gm Lovaza)|Overall Study||10
8497858|NCT00515541|20941475|P3|12 Weeks (2 gm Lovaza)|Overall Study||10
8497859|NCT00515541|20941476|P2|12 Weeks (2 gm Lovaza)|Overall Study||10
8497860|NCT00515541|20941477|P1|12 Weeks (2 gm Lovaza)|Overall Study||10
8497861|NCT00515541|20941474|P4|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
8497862|NCT00515541|20941475|P3|6 Weeks (1 gm Lovaza)|Overall Study||10
8497863|NCT00515541|20941476|P2|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
8497864|NCT00515541|20941477|P1|6 Weeks (1 gm Lovaza)|Overall Study||10
8497865|NCT00515541|20941474|P4|STARTED|Overall Study||11
8497866|NCT00515541|20941475|P3|STARTED|Overall Study||10
8497867|NCT00515541|20941476|P2|STARTED|Overall Study||12
8497868|NCT00515541|20941477|P1|STARTED|Overall Study||10
8497869|NCT00515528|20941501|P2|NOT COMPLETED|Overall Study||0
8497870|NCT00515528|20941502|P1|NOT COMPLETED|Overall Study||0
8497871|NCT00515528|20941501|P2|COMPLETED|Overall Study||7
8497872|NCT00515528|20941502|P1|COMPLETED|Overall Study||10
8497873|NCT00515528|20941501|P2|STARTED|Overall Study||7
8497874|NCT00515528|20941502|P1|STARTED|Overall Study||10
8497875|NCT00515502|20941508|P12|NOT COMPLETED|Treatment Period 4||0
8497876|NCT00515502|20941509|P11|NOT COMPLETED|Treatment Period 4||0
8497877|NCT00515502|20941510|P10|NOT COMPLETED|Treatment Period 4||0
8497878|NCT00515502|20941511|P9|NOT COMPLETED|Treatment Period 4||0
8497879|NCT00515502|20941512|P8|NOT COMPLETED|Treatment Period 4||0
8497880|NCT00515502|20941513|P7|NOT COMPLETED|Treatment Period 4||0
8497881|NCT00515502|20941514|P6|NOT COMPLETED|Treatment Period 4||0
8497882|NCT00515502|20941515|P5|NOT COMPLETED|Treatment Period 4||0
8497883|NCT00515502|20941516|P4|NOT COMPLETED|Treatment Period 4||0
8497884|NCT00515502|20941517|P3|NOT COMPLETED|Treatment Period 4||0
8497885|NCT00515502|20941518|P2|NOT COMPLETED|Treatment Period 4||0
8497886|NCT00515502|20941519|P1|NOT COMPLETED|Treatment Period 4||0
8497887|NCT00515502|20941508|P12|COMPLETED|Treatment Period 4||0
8497888|NCT00515502|20941509|P11|COMPLETED|Treatment Period 4||1
8497889|NCT00515502|20941510|P10|COMPLETED|Treatment Period 4||2
8497890|NCT00515502|20941511|P9|COMPLETED|Treatment Period 4||0
8497891|NCT00515502|20941512|P8|COMPLETED|Treatment Period 4||1
8497892|NCT00515502|20941513|P7|COMPLETED|Treatment Period 4||1
8497893|NCT00515502|20941514|P6|COMPLETED|Treatment Period 4||1
8497894|NCT00515502|20941515|P5|COMPLETED|Treatment Period 4||3
8497895|NCT00515502|20941516|P4|COMPLETED|Treatment Period 4||3
8497896|NCT00515502|20941517|P3|COMPLETED|Treatment Period 4||4
8497897|NCT00515502|20941518|P2|COMPLETED|Treatment Period 4||3
8497898|NCT00515502|20941519|P1|COMPLETED|Treatment Period 4||1
8497899|NCT00515502|20941508|P12|STARTED|Treatment Period 4||0
8497900|NCT00515502|20941509|P11|STARTED|Treatment Period 4||1
8497901|NCT00515502|20941510|P10|STARTED|Treatment Period 4||2
8497902|NCT00515502|20941511|P9|STARTED|Treatment Period 4||0
8497903|NCT00515502|20941512|P8|STARTED|Treatment Period 4||1
8497904|NCT00515502|20941513|P7|STARTED|Treatment Period 4||1
8497905|NCT00515502|20941514|P6|STARTED|Treatment Period 4||1
8497906|NCT00515502|20941515|P5|STARTED|Treatment Period 4||3
8497907|NCT00515502|20941516|P4|STARTED|Treatment Period 4||3
8497908|NCT00515502|20941517|P3|STARTED|Treatment Period 4||4
8497909|NCT00515502|20941518|P2|STARTED|Treatment Period 4||3
8497910|NCT00515502|20941519|P1|STARTED|Treatment Period 4||1
8497911|NCT00515502|20941508|P12|NOT COMPLETED|Washout Period 3||0
8497912|NCT00515502|20941509|P11|NOT COMPLETED|Washout Period 3||0
8497913|NCT00515502|20941510|P10|NOT COMPLETED|Washout Period 3||0
8497914|NCT00515502|20941511|P9|NOT COMPLETED|Washout Period 3||0
8497915|NCT00515502|20941512|P8|NOT COMPLETED|Washout Period 3||0
8497916|NCT00515502|20941513|P7|NOT COMPLETED|Washout Period 3||0
8497917|NCT00515502|20941514|P6|NOT COMPLETED|Washout Period 3||0
8497918|NCT00515502|20941515|P5|NOT COMPLETED|Washout Period 3||0
8497919|NCT00515502|20941516|P4|NOT COMPLETED|Washout Period 3||0
8497920|NCT00515502|20941517|P3|NOT COMPLETED|Washout Period 3||0
8497921|NCT00515502|20941518|P2|NOT COMPLETED|Washout Period 3||0
8497922|NCT00515502|20941519|P1|NOT COMPLETED|Washout Period 3||0
8497923|NCT00515502|20941508|P12|COMPLETED|Washout Period 3||0
8497924|NCT00515502|20941509|P11|COMPLETED|Washout Period 3||1
8497925|NCT00515502|20941510|P10|COMPLETED|Washout Period 3||2
8497926|NCT00515502|20941511|P9|COMPLETED|Washout Period 3||0
8497927|NCT00515502|20941512|P8|COMPLETED|Washout Period 3||1
8497928|NCT00515502|20941513|P7|COMPLETED|Washout Period 3||1
8497929|NCT00515502|20941514|P6|COMPLETED|Washout Period 3||1
8497930|NCT00515502|20941515|P5|COMPLETED|Washout Period 3||3
8497931|NCT00515502|20941516|P4|COMPLETED|Washout Period 3||3
8497932|NCT00515502|20941517|P3|COMPLETED|Washout Period 3||4
8497933|NCT00515502|20941518|P2|COMPLETED|Washout Period 3||3
8497934|NCT00515502|20941519|P1|COMPLETED|Washout Period 3||1
8497935|NCT00515502|20941508|P12|STARTED|Washout Period 3||0
8497936|NCT00515502|20941509|P11|STARTED|Washout Period 3||1
8497937|NCT00515502|20941510|P10|STARTED|Washout Period 3||2
8497938|NCT00515502|20941511|P9|STARTED|Washout Period 3||0
8497939|NCT00515502|20941512|P8|STARTED|Washout Period 3||1
8497940|NCT00515502|20941513|P7|STARTED|Washout Period 3||1
8497941|NCT00515502|20941514|P6|STARTED|Washout Period 3||1
8497942|NCT00515502|20941515|P5|STARTED|Washout Period 3||3
8497943|NCT00515502|20941516|P4|STARTED|Washout Period 3||3
8497945|NCT00515502|20941518|P2|STARTED|Washout Period 3||3
8497946|NCT00515502|20941519|P1|STARTED|Washout Period 3||1
8497947|NCT00515502|20941508|P12|NOT COMPLETED|Treatment Period 3||0
8497948|NCT00515502|20941509|P11|NOT COMPLETED|Treatment Period 3||0
8497949|NCT00515502|20941510|P10|NOT COMPLETED|Treatment Period 3||0
8497950|NCT00515502|20941511|P9|NOT COMPLETED|Treatment Period 3||0
8497951|NCT00515502|20941512|P8|NOT COMPLETED|Treatment Period 3||0
8497952|NCT00515502|20941513|P7|NOT COMPLETED|Treatment Period 3||0
8497953|NCT00515502|20941514|P6|NOT COMPLETED|Treatment Period 3||0
8497954|NCT00515502|20941515|P5|NOT COMPLETED|Treatment Period 3||0
8497955|NCT00515502|20941516|P4|NOT COMPLETED|Treatment Period 3||0
8497956|NCT00515502|20941517|P3|NOT COMPLETED|Treatment Period 3||0
8497957|NCT00515502|20941518|P2|NOT COMPLETED|Treatment Period 3||0
8497958|NCT00515502|20941519|P1|NOT COMPLETED|Treatment Period 3||0
8497959|NCT00515502|20941508|P12|COMPLETED|Treatment Period 3||0
8497960|NCT00515502|20941509|P11|COMPLETED|Treatment Period 3||1
8497961|NCT00515502|20941510|P10|COMPLETED|Treatment Period 3||2
8497962|NCT00515502|20941511|P9|COMPLETED|Treatment Period 3||0
8497963|NCT00515502|20941512|P8|COMPLETED|Treatment Period 3||1
8497964|NCT00515502|20941513|P7|COMPLETED|Treatment Period 3||1
8497965|NCT00515502|20941514|P6|COMPLETED|Treatment Period 3||1
8497966|NCT00515502|20941515|P5|COMPLETED|Treatment Period 3||3
8497967|NCT00515502|20941516|P4|COMPLETED|Treatment Period 3||3
8497968|NCT00515502|20941517|P3|COMPLETED|Treatment Period 3||4
8497969|NCT00515502|20941518|P2|COMPLETED|Treatment Period 3||3
8497970|NCT00515502|20941519|P1|COMPLETED|Treatment Period 3||1
8497971|NCT00515502|20941508|P12|STARTED|Treatment Period 3||0
8497972|NCT00515502|20941509|P11|STARTED|Treatment Period 3||1
8497973|NCT00515502|20941510|P10|STARTED|Treatment Period 3||2
8497974|NCT00515502|20941511|P9|STARTED|Treatment Period 3||0
8497975|NCT00515502|20941512|P8|STARTED|Treatment Period 3||1
8497976|NCT00515502|20941513|P7|STARTED|Treatment Period 3||1
8497977|NCT00515502|20941514|P6|STARTED|Treatment Period 3||1
8497978|NCT00515502|20941515|P5|STARTED|Treatment Period 3||3
8497979|NCT00515502|20941516|P4|STARTED|Treatment Period 3||3
8497980|NCT00515502|20941517|P3|STARTED|Treatment Period 3||4
8497981|NCT00515502|20941518|P2|STARTED|Treatment Period 3||3
8497982|NCT00515502|20941519|P1|STARTED|Treatment Period 3||1
8497983|NCT00515502|20941508|P12|NOT COMPLETED|Washout Period 2||0
8497984|NCT00515502|20941509|P11|NOT COMPLETED|Washout Period 2||0
8497985|NCT00515502|20941510|P10|NOT COMPLETED|Washout Period 2||0
8497986|NCT00515502|20941511|P9|NOT COMPLETED|Washout Period 2||0
8497987|NCT00515502|20941512|P8|NOT COMPLETED|Washout Period 2||0
8497988|NCT00515502|20941513|P7|NOT COMPLETED|Washout Period 2||0
8497989|NCT00515502|20941514|P6|NOT COMPLETED|Washout Period 2||0
8497990|NCT00515502|20941515|P5|NOT COMPLETED|Washout Period 2||0
8497991|NCT00515502|20941516|P4|NOT COMPLETED|Washout Period 2||0
8497992|NCT00515502|20941517|P3|NOT COMPLETED|Washout Period 2||0
8497993|NCT00515502|20941518|P2|NOT COMPLETED|Washout Period 2||0
8497994|NCT00515502|20941519|P1|NOT COMPLETED|Washout Period 2||0
8497995|NCT00515502|20941508|P12|COMPLETED|Washout Period 2||0
8497996|NCT00515502|20941509|P11|COMPLETED|Washout Period 2||1
8497997|NCT00515502|20941510|P10|COMPLETED|Washout Period 2||2
8497998|NCT00515502|20941511|P9|COMPLETED|Washout Period 2||0
8497999|NCT00515502|20941512|P8|COMPLETED|Washout Period 2||1
8498000|NCT00515502|20941513|P7|COMPLETED|Washout Period 2||1
8498001|NCT00515502|20941514|P6|COMPLETED|Washout Period 2||1
8498002|NCT00515502|20941515|P5|COMPLETED|Washout Period 2||3
8498003|NCT00515502|20941516|P4|COMPLETED|Washout Period 2||3
8498004|NCT00515502|20941517|P3|COMPLETED|Washout Period 2||4
8498005|NCT00515502|20941518|P2|COMPLETED|Washout Period 2||3
8498006|NCT00515502|20941519|P1|COMPLETED|Washout Period 2||1
8498007|NCT00515502|20941508|P12|STARTED|Washout Period 2||0
8498008|NCT00515502|20941509|P11|STARTED|Washout Period 2||1
8498009|NCT00515502|20941510|P10|STARTED|Washout Period 2||2
8498010|NCT00515502|20941511|P9|STARTED|Washout Period 2||0
8498011|NCT00515502|20941512|P8|STARTED|Washout Period 2||1
8498012|NCT00515502|20941513|P7|STARTED|Washout Period 2||1
8498013|NCT00515502|20941514|P6|STARTED|Washout Period 2||1
8498014|NCT00515502|20941515|P5|STARTED|Washout Period 2||3
8498015|NCT00515502|20941516|P4|STARTED|Washout Period 2||3
8498016|NCT00515502|20941517|P3|STARTED|Washout Period 2||4
8498017|NCT00515502|20941518|P2|STARTED|Washout Period 2||3
8498018|NCT00515502|20941519|P1|STARTED|Washout Period 2||1
8498019|NCT00515502|20941508|P12|NOT COMPLETED|Treatment Period 2||0
8498020|NCT00515502|20941509|P11|NOT COMPLETED|Treatment Period 2||0
8498021|NCT00515502|20941510|P10|NOT COMPLETED|Treatment Period 2||0
8498022|NCT00515502|20941511|P9|NOT COMPLETED|Treatment Period 2||0
8498023|NCT00515502|20941512|P8|NOT COMPLETED|Treatment Period 2||0
8498024|NCT00515502|20941513|P7|NOT COMPLETED|Treatment Period 2||0
8498025|NCT00515502|20941514|P6|NOT COMPLETED|Treatment Period 2||0
8498026|NCT00515502|20941515|P5|NOT COMPLETED|Treatment Period 2||0
8498027|NCT00515502|20941516|P4|NOT COMPLETED|Treatment Period 2||0
8498028|NCT00515502|20941517|P3|NOT COMPLETED|Treatment Period 2||0
8498029|NCT00515502|20941518|P2|NOT COMPLETED|Treatment Period 2||1
8498030|NCT00515502|20941519|P1|NOT COMPLETED|Treatment Period 2||0
8498031|NCT00515502|20941508|P12|COMPLETED|Treatment Period 2||0
8498032|NCT00515502|20941509|P11|COMPLETED|Treatment Period 2||1
8498033|NCT00515502|20941510|P10|COMPLETED|Treatment Period 2||2
8498034|NCT00515502|20941511|P9|COMPLETED|Treatment Period 2||0
8498035|NCT00515502|20941512|P8|COMPLETED|Treatment Period 2||1
8498036|NCT00515502|20941513|P7|COMPLETED|Treatment Period 2||1
8498037|NCT00515502|20941514|P6|COMPLETED|Treatment Period 2||1
8498038|NCT00515502|20941515|P5|COMPLETED|Treatment Period 2||3
8498039|NCT00515502|20941516|P4|COMPLETED|Treatment Period 2||3
8498040|NCT00515502|20941517|P3|COMPLETED|Treatment Period 2||4
8498041|NCT00515502|20941518|P2|COMPLETED|Treatment Period 2||3
8498042|NCT00515502|20941519|P1|COMPLETED|Treatment Period 2||1
8498043|NCT00515502|20941508|P12|STARTED|Treatment Period 2||0
8498044|NCT00515502|20941509|P11|STARTED|Treatment Period 2||1
8498045|NCT00515502|20941510|P10|STARTED|Treatment Period 2||2
8498046|NCT00515502|20941511|P9|STARTED|Treatment Period 2||0
8498047|NCT00515502|20941512|P8|STARTED|Treatment Period 2||1
8498048|NCT00515502|20941513|P7|STARTED|Treatment Period 2||1
8498049|NCT00515502|20941514|P6|STARTED|Treatment Period 2||1
8498050|NCT00515502|20941515|P5|STARTED|Treatment Period 2||3
8498051|NCT00515502|20941516|P4|STARTED|Treatment Period 2||3
8498052|NCT00515502|20941517|P3|STARTED|Treatment Period 2||4
8498053|NCT00515502|20941518|P2|STARTED|Treatment Period 2||4
8498054|NCT00515502|20941519|P1|STARTED|Treatment Period 2||1
8498055|NCT00515502|20941508|P12|NOT COMPLETED|Washout Period 1||0
8498056|NCT00515502|20941509|P11|NOT COMPLETED|Washout Period 1||0
8498057|NCT00515502|20941510|P10|NOT COMPLETED|Washout Period 1||0
8498058|NCT00515502|20941511|P9|NOT COMPLETED|Washout Period 1||0
8498059|NCT00515502|20941512|P8|NOT COMPLETED|Washout Period 1||0
8498060|NCT00515502|20941513|P7|NOT COMPLETED|Washout Period 1||0
8498061|NCT00515502|20941514|P6|NOT COMPLETED|Washout Period 1||0
8498062|NCT00515502|20941515|P5|NOT COMPLETED|Washout Period 1||0
8498063|NCT00515502|20941516|P4|NOT COMPLETED|Washout Period 1||0
8498064|NCT00515502|20941517|P3|NOT COMPLETED|Washout Period 1||0
8498065|NCT00515502|20941518|P2|NOT COMPLETED|Washout Period 1||0
8498066|NCT00515502|20941519|P1|NOT COMPLETED|Washout Period 1||0
8498067|NCT00515502|20941508|P12|COMPLETED|Washout Period 1||0
8498068|NCT00515502|20941509|P11|COMPLETED|Washout Period 1||1
8498069|NCT00515502|20941510|P10|COMPLETED|Washout Period 1||2
8498070|NCT00515502|20941511|P9|COMPLETED|Washout Period 1||0
8498071|NCT00515502|20941512|P8|COMPLETED|Washout Period 1||1
8498072|NCT00515502|20941513|P7|COMPLETED|Washout Period 1||1
8498073|NCT00515502|20941514|P6|COMPLETED|Washout Period 1||1
8498074|NCT00515502|20941515|P5|COMPLETED|Washout Period 1||3
8498075|NCT00515502|20941516|P4|COMPLETED|Washout Period 1||3
8498076|NCT00515502|20941517|P3|COMPLETED|Washout Period 1||4
8498077|NCT00515502|20941518|P2|COMPLETED|Washout Period 1||4
8498078|NCT00515502|20941519|P1|COMPLETED|Washout Period 1||1
8498079|NCT00515502|20941508|P12|STARTED|Washout Period 1||0
8498080|NCT00515502|20941509|P11|STARTED|Washout Period 1||1
8498081|NCT00515502|20941510|P10|STARTED|Washout Period 1||2
8498082|NCT00515502|20941511|P9|STARTED|Washout Period 1||0
8498083|NCT00515502|20941512|P8|STARTED|Washout Period 1||1
8498084|NCT00515502|20941513|P7|STARTED|Washout Period 1||1
8498085|NCT00515502|20941514|P6|STARTED|Washout Period 1||1
8498086|NCT00515502|20941515|P5|STARTED|Washout Period 1||3
8498087|NCT00515502|20941516|P4|STARTED|Washout Period 1||3
8498088|NCT00515502|20941517|P3|STARTED|Washout Period 1||4
8498089|NCT00515502|20941518|P2|STARTED|Washout Period 1||4
8498090|NCT00515502|20941519|P1|STARTED|Washout Period 1||1
8498091|NCT00515502|20941508|P12|NOT COMPLETED|Treatment Period 1||1
8498092|NCT00515502|20941509|P11|NOT COMPLETED|Treatment Period 1||0
8498093|NCT00515502|20941510|P10|NOT COMPLETED|Treatment Period 1||0
8498094|NCT00515502|20941511|P9|NOT COMPLETED|Treatment Period 1||1
8498095|NCT00515502|20941512|P8|NOT COMPLETED|Treatment Period 1||0
8498096|NCT00515502|20941513|P7|NOT COMPLETED|Treatment Period 1||1
8498097|NCT00515502|20941514|P6|NOT COMPLETED|Treatment Period 1||0
8498098|NCT00515502|20941515|P5|NOT COMPLETED|Treatment Period 1||0
8498099|NCT00515502|20941516|P4|NOT COMPLETED|Treatment Period 1||0
8498100|NCT00515502|20941517|P3|NOT COMPLETED|Treatment Period 1||0
8498101|NCT00515502|20941518|P2|NOT COMPLETED|Treatment Period 1||0
8498102|NCT00515502|20941519|P1|NOT COMPLETED|Treatment Period 1||0
8498103|NCT00515502|20941508|P12|COMPLETED|Treatment Period 1||0
8498104|NCT00515502|20941509|P11|COMPLETED|Treatment Period 1||1
8498105|NCT00515502|20941510|P10|COMPLETED|Treatment Period 1||2
8498106|NCT00515502|20941511|P9|COMPLETED|Treatment Period 1||0
8498107|NCT00515502|20941512|P8|COMPLETED|Treatment Period 1||1
8498108|NCT00515502|20941513|P7|COMPLETED|Treatment Period 1||1
8498109|NCT00515502|20941514|P6|COMPLETED|Treatment Period 1||1
8498110|NCT00515502|20941515|P5|COMPLETED|Treatment Period 1||3
8498111|NCT00515502|20941516|P4|COMPLETED|Treatment Period 1||3
8498112|NCT00515502|20941517|P3|COMPLETED|Treatment Period 1||4
8498113|NCT00515502|20941518|P2|COMPLETED|Treatment Period 1||4
8498114|NCT00515502|20941519|P1|COMPLETED|Treatment Period 1||1
8498115|NCT00515502|20941508|P12|STARTED|Treatment Period 1||1
8498116|NCT00515502|20941509|P11|STARTED|Treatment Period 1||1
8498117|NCT00515502|20941510|P10|STARTED|Treatment Period 1||2
8498118|NCT00515502|20941511|P9|STARTED|Treatment Period 1||1
8498119|NCT00515502|20941512|P8|STARTED|Treatment Period 1||1
8498120|NCT00515502|20941513|P7|STARTED|Treatment Period 1||2
8498121|NCT00515502|20941514|P6|STARTED|Treatment Period 1||1
8498122|NCT00515502|20941515|P5|STARTED|Treatment Period 1||3
8498123|NCT00515502|20941516|P4|STARTED|Treatment Period 1||3
8498124|NCT00515502|20941517|P3|STARTED|Treatment Period 1||4
8498125|NCT00515502|20941518|P2|STARTED|Treatment Period 1||4
8498126|NCT00515502|20941519|P1|STARTED|Treatment Period 1||1
8498127|NCT00515463|20941679|P2|NOT COMPLETED|Overall Study||14
8498128|NCT00515463|20941680|P1|NOT COMPLETED|Overall Study||14
8498129|NCT00515463|20941679|P2|COMPLETED|Overall Study||142
8498130|NCT00515463|20941680|P1|COMPLETED|Overall Study||141
8498131|NCT00515463|20941679|P2|Received Study Medication|Overall Study||156
8498132|NCT00515463|20941680|P1|Received Study Medication|Overall Study||154
8498133|NCT00515463|20941679|P2|STARTED|Overall Study||156
8498134|NCT00515463|20941680|P1|STARTED|Overall Study||155
8498135|NCT00515437|20941834|P4|NOT COMPLETED|Overall Study||1
8498136|NCT00515437|20941835|P3|NOT COMPLETED|Overall Study||0
8498137|NCT00515437|20941836|P2|NOT COMPLETED|Overall Study||0
8498138|NCT00515437|20941837|P1|NOT COMPLETED|Overall Study||0
8498139|NCT00515437|20941834|P4|COMPLETED|Overall Study||14
8498140|NCT00515437|20941835|P3|COMPLETED|Overall Study||13
8498141|NCT00515437|20941836|P2|COMPLETED|Overall Study||12
8498142|NCT00515437|20941837|P1|COMPLETED|Overall Study||14
8498143|NCT00515437|20941834|P4|STARTED|Overall Study||15
8498144|NCT00515437|20941835|P3|STARTED|Overall Study||13
8498145|NCT00515437|20941836|P2|STARTED|Overall Study||12
8498146|NCT00515437|20941837|P1|STARTED|Overall Study||14
8498147|NCT00515411|20941862|P3|NOT COMPLETED|Overall Study||0
8498148|NCT00515411|20941863|P2|NOT COMPLETED|Overall Study||0
8498149|NCT00515411|20941864|P1|NOT COMPLETED|Overall Study||0
8498150|NCT00515411|20941862|P3|COMPLETED|Overall Study||26
8498151|NCT00515411|20941863|P2|COMPLETED|Overall Study||31
8498152|NCT00515411|20941864|P1|COMPLETED|Overall Study||54
8498153|NCT00515411|20941862|P3|STARTED|Overall Study||26
8498154|NCT00515411|20941863|P2|STARTED|Overall Study||31
8498155|NCT00515411|20941864|P1|STARTED|Overall Study||54
8498156|NCT00515294|20941879|P4|NOT COMPLETED|Overall Study||4
8498157|NCT00515294|20941880|P3|NOT COMPLETED|Overall Study||11
8498158|NCT00515294|20941881|P2|NOT COMPLETED|Overall Study||3
8498159|NCT00515294|20941882|P1|NOT COMPLETED|Overall Study||9
8498160|NCT00515294|20941879|P4|COMPLETED|Overall Study||35
8498161|NCT00515294|20941880|P3|COMPLETED|Overall Study||27
8498162|NCT00515294|20941881|P2|COMPLETED|Overall Study||36
8498163|NCT00515294|20941882|P1|COMPLETED|Overall Study||29
8498164|NCT00515294|20941879|P4|STARTED|Overall Study||39
8498165|NCT00515294|20941880|P3|STARTED|Overall Study||38
8498166|NCT00515294|20941881|P2|STARTED|Overall Study||39
8498167|NCT00515294|20941882|P1|STARTED|Overall Study||38
8498168|NCT00515216|20941896|P1|NOT COMPLETED|Overall Study||1
8498169|NCT00515216|20941896|P1|COMPLETED|Overall Study||25
8498170|NCT00515216|20941896|P1|STARTED|Overall Study||26
8498171|NCT00515203|20941920|P2|NOT COMPLETED|Overall Study||0
8498172|NCT00515203|20941921|P1|NOT COMPLETED|Overall Study||0
8498173|NCT00515203|20941920|P2|COMPLETED|Overall Study||5
8498174|NCT00515203|20941921|P1|COMPLETED|Overall Study||17
8498175|NCT00515203|20941920|P2|STARTED|Overall Study||5
8498176|NCT00515203|20941921|P1|STARTED|Overall Study||17
8498177|NCT00515177|20941939|P2|NOT COMPLETED|Overall Study||1
8498178|NCT00515177|20941940|P1|NOT COMPLETED|Overall Study||2
8498179|NCT00515177|20941939|P2|COMPLETED|Overall Study||9
8498180|NCT00515177|20941940|P1|COMPLETED|Overall Study||18
8498181|NCT00515177|20941939|P2|STARTED|Overall Study||10
8498182|NCT00515177|20941940|P1|STARTED|Overall Study||20
8498183|NCT00515112|20941958|P2|NOT COMPLETED|Overall Study||3
8498184|NCT00515112|20941959|P1|NOT COMPLETED|Overall Study||3
8498185|NCT00515112|20941958|P2|COMPLETED|Overall Study||0
8498186|NCT00515112|20941959|P1|COMPLETED|Overall Study||0
8498187|NCT00515112|20941958|P2|STARTED|Overall Study||3
8498188|NCT00515112|20941959|P1|STARTED|Overall Study||3
8498189|NCT00515099|20941969|P2|NOT COMPLETED|Overall Study||4
8498190|NCT00515099|20941970|P1|NOT COMPLETED|Overall Study||3
8498191|NCT00515099|20941969|P2|COMPLETED|Overall Study||16
8498192|NCT00515099|20941970|P1|COMPLETED|Overall Study||35
8498193|NCT00515099|20941969|P2|STARTED|Overall Study||20
8498194|NCT00515099|20941970|P1|STARTED|Overall Study||38
8498195|NCT00515086|20941992|P4|NOT COMPLETED|Overall Study||6
8498196|NCT00515086|20941993|P3|NOT COMPLETED|Overall Study||5
8498197|NCT00515086|20941994|P2|NOT COMPLETED|Overall Study||6
8498198|NCT00515086|20941995|P1|NOT COMPLETED|Overall Study||24
8498199|NCT00515086|20941992|P4|COMPLETED|Overall Study||0
8498200|NCT00515086|20941993|P3|COMPLETED|Overall Study||0
8498201|NCT00515086|20941994|P2|COMPLETED|Overall Study||0
8498202|NCT00515086|20941995|P1|COMPLETED|Overall Study||0
8498203|NCT00515086|20941992|P4|STARTED|Overall Study||6
8498204|NCT00515086|20941993|P3|STARTED|Overall Study||5
8498205|NCT00515086|20941994|P2|STARTED|Overall Study||6
8498206|NCT00515086|20941995|P1|STARTED|Overall Study||24
8498207|NCT00515073|20942022|P1|NOT COMPLETED|Overall Study||2
8498208|NCT00515073|20942022|P1|COMPLETED|Overall Study||28
8498209|NCT00515073|20942022|P1|STARTED|Overall Study||30
8498210|NCT00515034|20942030|P4|NOT COMPLETED|Overall Study||5
8498211|NCT00515034|20942031|P3|NOT COMPLETED|Overall Study||8
8498212|NCT00515034|20942032|P2|NOT COMPLETED|Overall Study||2
8498213|NCT00515034|20942033|P1|NOT COMPLETED|Overall Study||8
8498214|NCT00515034|20942030|P4|COMPLETED|Overall Study||15
8498215|NCT00515034|20942031|P3|COMPLETED|Overall Study||54
8498216|NCT00515034|20942032|P2|COMPLETED|Overall Study||13
8498217|NCT00515034|20942033|P1|COMPLETED|Overall Study||41
8498218|NCT00515034|20942030|P4|TREATED|Overall Study||19
8498219|NCT00515034|20942031|P3|TREATED|Overall Study||61
8498220|NCT00515034|20942032|P2|TREATED|Overall Study||15
8498221|NCT00515034|20942033|P1|TREATED|Overall Study||48
8498222|NCT00515034|20942030|P4|STARTED|Overall Study||20
8498223|NCT00515034|20942031|P3|STARTED|Overall Study||62
8498224|NCT00515034|20942032|P2|STARTED|Overall Study||15
8498225|NCT00515034|20942033|P1|STARTED|Overall Study||49
8498226|NCT00515021|20942053|P2|NOT COMPLETED|Overall Study||0
8498227|NCT00515021|20942054|P1|NOT COMPLETED|Overall Study||0
8498228|NCT00515021|20942053|P2|COMPLETED|Overall Study||11
8498229|NCT00515021|20942054|P1|COMPLETED|Overall Study||9
8498230|NCT00515021|20942053|P2|STARTED|Overall Study||11
8498231|NCT00515021|20942054|P1|STARTED|Overall Study||9
8498232|NCT00515008|20942064|P2|NOT COMPLETED|Overall Study||4
8498233|NCT00515008|20942065|P1|NOT COMPLETED|Overall Study||3
8498234|NCT00515008|20942064|P2|COMPLETED|Overall Study||29
8498235|NCT00515008|20942065|P1|COMPLETED|Overall Study||30
8498236|NCT00515008|20942064|P2|Completed 12 Week Evaluation|Overall Study||29
8498237|NCT00515008|20942065|P1|Completed 12 Week Evaluation|Overall Study||32
8498238|NCT00515008|20942064|P2|STARTED|Overall Study||33
8498239|NCT00515008|20942065|P1|STARTED|Overall Study||33
8498240|NCT00514943|20942089|P2|NOT COMPLETED|Stage 2||36
8498241|NCT00514943|20942090|P1|NOT COMPLETED|Stage 2||32
8498242|NCT00514943|20942089|P2|COMPLETED|Stage 2||0
8498243|NCT00514943|20942090|P1|COMPLETED|Stage 2||0
8498244|NCT00514943|20942089|P2|STARTED|Stage 2||36
8498245|NCT00514943|20942090|P1|STARTED|Stage 2||32
8498246|NCT00514943|20942089|P2|NOT COMPLETED|Stage 1||26
8498247|NCT00514943|20942090|P1|NOT COMPLETED|Stage 1||30
8498248|NCT00514943|20942089|P2|COMPLETED|Stage 1||36
8498249|NCT00514943|20942090|P1|COMPLETED|Stage 1||32
8498250|NCT00514943|20942089|P2|STARTED|Stage 1|2 randomized patients were not treated|62
8498251|NCT00514943|20942090|P1|STARTED|Stage 1|1 randomized patient was not treated|62
8498252|NCT00514917|20942148|P2|NOT COMPLETED|Overall Study||115
8498253|NCT00514917|20942149|P1|NOT COMPLETED|Overall Study||126
8498254|NCT00514917|20942148|P2|COMPLETED|Overall Study||91
8498255|NCT00514917|20942149|P1|COMPLETED|Overall Study||81
8498256|NCT00514917|20942148|P2|Testosterone-Specific Evaluable|Overall Study||124
8498257|NCT00514917|20942149|P1|Testosterone-Specific Evaluable|Overall Study||122
8498258|NCT00514917|20942148|P2|Completed Study Treatment|Overall Study||182
8498259|NCT00514917|20942149|P1|Completed Study Treatment|Overall Study||170
8498260|NCT00514917|20942148|P2|Treated|Overall Study||204
8498261|NCT00514917|20942149|P1|Treated|Overall Study||196
8498262|NCT00514917|20942148|P2|STARTED|Overall Study||206
8498263|NCT00514917|20942149|P1|STARTED|Overall Study||207
8498264|NCT00514904|20942177|P2|NOT COMPLETED|Overall Study||5
8498265|NCT00514904|20942178|P1|NOT COMPLETED|Overall Study||24
8498266|NCT00514904|20942177|P2|COMPLETED|Overall Study||371
8498267|NCT00514904|20942178|P1|COMPLETED|Overall Study||1101
8498268|NCT00514904|20942177|P2|STARTED|Overall Study||376
8498269|NCT00514904|20942178|P1|STARTED|Overall Study||1125
8498270|NCT00514852|20942214|P2|NOT COMPLETED|Overall Study||5
8498271|NCT00514852|20942215|P1|NOT COMPLETED|Overall Study||5
8498272|NCT00514852|20942214|P2|COMPLETED|Overall Study||154
8498273|NCT00514852|20942215|P1|COMPLETED|Overall Study||152
8498274|NCT00514852|20942214|P2|STARTED|Overall Study||159
8498275|NCT00514852|20942215|P1|STARTED|Overall Study||157
8498288|NCT00514735|20942266|P2|NOT COMPLETED|Overall Study||6
8498289|NCT00514735|20942267|P1|NOT COMPLETED|Overall Study||14
8498290|NCT00514735|20942266|P2|COMPLETED|Overall Study||66
8498291|NCT00514735|20942267|P1|COMPLETED|Overall Study||124
8498292|NCT00514735|20942266|P2|STARTED|Overall Study||72
8498293|NCT00514735|20942267|P1|STARTED|Overall Study||138
8498294|NCT00514709|20942287|P2|NOT COMPLETED|Overall Study||0
8498295|NCT00514709|20942288|P1|NOT COMPLETED|Overall Study||0
8498296|NCT00514709|20942287|P2|COMPLETED|Overall Study||613
8498297|NCT00514709|20942288|P1|COMPLETED|Overall Study||1230
8498298|NCT00514709|20942287|P2|STARTED|Overall Study||613
8498299|NCT00514709|20942288|P1|STARTED|Overall Study||1230
8498300|NCT00514683|20942303|P5|NOT COMPLETED|Overall Study||33
8498301|NCT00514683|20942304|P4|NOT COMPLETED|Overall Study||14
8498302|NCT00514683|20942305|P3|NOT COMPLETED|Overall Study||18
8498303|NCT00514683|20942306|P2|NOT COMPLETED|Overall Study||25
8498304|NCT00514683|20942307|P1|NOT COMPLETED|Overall Study||26
8498305|NCT00514683|20942303|P5|COMPLETED|Overall Study||53
8498306|NCT00514683|20942304|P4|COMPLETED|Overall Study||72
8498307|NCT00514683|20942305|P3|COMPLETED|Overall Study||68
8498308|NCT00514683|20942306|P2|COMPLETED|Overall Study||62
8498309|NCT00514683|20942307|P1|COMPLETED|Overall Study||61
8498310|NCT00514683|20942303|P5|STARTED|Overall Study|Randomised|86
8498311|NCT00514683|20942304|P4|STARTED|Overall Study|Randomised|86
8498312|NCT00514683|20942305|P3|STARTED|Overall Study|Randomised|86
8498313|NCT00514683|20942306|P2|STARTED|Overall Study|Randomised|87
8498314|NCT00514683|20942307|P1|STARTED|Overall Study|Randomised|87
8498315|NCT00514592|20942498|P1|NOT COMPLETED|Overall Study||0
8498316|NCT00514592|20942498|P1|COMPLETED|Overall Study||230
8498317|NCT00514592|20942498|P1|STARTED|Overall Study||230
8498318|NCT00514540|20942503|P1|NOT COMPLETED|Second-Line||31
8498319|NCT00514540|20942503|P1|COMPLETED|Second-Line||74
8498320|NCT00514540|20942503|P1|STARTED|Second-Line||105
8498321|NCT00514540|20942503|P1|NOT COMPLETED|First-Line Chemo||8
8498322|NCT00514540|20942503|P1|COMPLETED|First-Line Chemo||105
8498323|NCT00514540|20942503|P1|STARTED|First-Line Chemo||113
8498324|NCT00514514|20942514|P3|NOT COMPLETED|Extension - 4 Years||21
8498325|NCT00514514|20942515|P2|NOT COMPLETED|Extension - 4 Years||22
8498326|NCT00514514|20942516|P1|NOT COMPLETED|Extension - 4 Years||37
8498327|NCT00514514|20942514|P3|COMPLETED|Extension - 4 Years||113
8498328|NCT00514514|20942515|P2|COMPLETED|Extension - 4 Years||117
8498329|NCT00514514|20942516|P1|COMPLETED|Extension - 4 Years||108
8498330|NCT00514514|20942514|P3|Non-randomized (Followed)|Extension - 4 Years||0
8498331|NCT00514514|20942515|P2|Non-randomized (Followed)|Extension - 4 Years||0
8498332|NCT00514514|20942516|P1|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
8498333|NCT00514514|20942514|P3|STARTED|Extension - 4 Years||134
8498334|NCT00514514|20942515|P2|STARTED|Extension - 4 Years||139
8498335|NCT00514514|20942516|P1|STARTED|Extension - 4 Years||145
8498336|NCT00514514|20942514|P3|NOT COMPLETED|Randomized - 9 Month||38
8498337|NCT00514514|20942515|P2|NOT COMPLETED|Randomized - 9 Month||61
8498338|NCT00514514|20942516|P1|NOT COMPLETED|Randomized - 9 Month||39
8498339|NCT00514514|20942514|P3|COMPLETED|Randomized - 9 Month||124
8498340|NCT00514514|20942515|P2|COMPLETED|Randomized - 9 Month||110
8498341|NCT00514514|20942516|P1|COMPLETED|Randomized - 9 Month||127
8498342|NCT00514514|20942514|P3|Randomized - Received Treatment|Randomized - 9 Month||161
8498343|NCT00514514|20942515|P2|Randomized - Received Treatment|Randomized - 9 Month||171
8498344|NCT00514514|20942516|P1|Randomized - Received Treatment|Randomized - 9 Month||165
8498345|NCT00514514|20942514|P3|STARTED|Randomized - 9 Month||162
8498346|NCT00514514|20942515|P2|STARTED|Randomized - 9 Month||171
8498347|NCT00514514|20942516|P1|STARTED|Randomized - 9 Month||166
8498348|NCT00514514|20942514|P3|NOT COMPLETED|Pre-phase||0
8498349|NCT00514514|20942515|P2|NOT COMPLETED|Pre-phase||0
8498350|NCT00514514|20942516|P1|NOT COMPLETED|Pre-phase||303
8498351|NCT00514514|20942514|P3|COMPLETED|Pre-phase||0
8498352|NCT00514514|20942515|P2|COMPLETED|Pre-phase||0
8498353|NCT00514514|20942516|P1|COMPLETED|Pre-phase||499
8498354|NCT00514514|20942514|P3|STARTED|Pre-phase||0
8498355|NCT00514514|20942515|P2|STARTED|Pre-phase||0
8498356|NCT00514514|20942516|P1|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
8498357|NCT00514501|20942560|P1|NOT COMPLETED|Overall Study||3
8498358|NCT00514501|20942560|P1|COMPLETED|Overall Study||507
8498359|NCT00514501|20942560|P1|STARTED|Overall Study||510
8498360|NCT00514449|20942568|P2|NOT COMPLETED|Overall Study||4
8498361|NCT00514449|20942569|P1|NOT COMPLETED|Overall Study||3
8498362|NCT00514449|20942568|P2|COMPLETED|Overall Study||8
8498363|NCT00514449|20942569|P1|COMPLETED|Overall Study||9
8498364|NCT00514449|20942568|P2|STARTED|Overall Study||12
8498365|NCT00514449|20942569|P1|STARTED|Overall Study||12
8498366|NCT00514215|20942579|P1|NOT COMPLETED|Overall Study||0
8498367|NCT00514215|20942579|P1|COMPLETED|Overall Study||8
8498368|NCT00514215|20942579|P1|STARTED|Overall Study||8
8498369|NCT00514137|20942586|P1|NOT COMPLETED|Overall Study||0
8498370|NCT00514137|20942586|P1|COMPLETED|Overall Study||13
8498371|NCT00514137|20942586|P1|STARTED|Overall Study||13
8498372|NCT00514046|20942602|P9|NOT COMPLETED|Overall Study||1
8498373|NCT00514046|20942603|P8|NOT COMPLETED|Overall Study||1
8498374|NCT00514046|20942604|P7|NOT COMPLETED|Overall Study||0
8498375|NCT00514046|20942605|P6|NOT COMPLETED|Overall Study||1
8498376|NCT00514046|20942606|P5|NOT COMPLETED|Overall Study||1
8498377|NCT00514046|20942607|P4|NOT COMPLETED|Overall Study||0
8498378|NCT00514046|20942608|P3|NOT COMPLETED|Overall Study||5
8498379|NCT00514046|20942609|P2|NOT COMPLETED|Overall Study||1
8498380|NCT00514046|20942610|P1|NOT COMPLETED|Overall Study||3
8498381|NCT00514046|20942602|P9|COMPLETED|Overall Study||0
8498382|NCT00514046|20942603|P8|COMPLETED|Overall Study||0
8498383|NCT00514046|20942604|P7|COMPLETED|Overall Study||1
8498384|NCT00514046|20942605|P6|COMPLETED|Overall Study||0
8498385|NCT00514046|20942606|P5|COMPLETED|Overall Study||0
8498386|NCT00514046|20942607|P4|COMPLETED|Overall Study||1
8498387|NCT00514046|20942608|P3|COMPLETED|Overall Study||0
8498388|NCT00514046|20942609|P2|COMPLETED|Overall Study||0
8498389|NCT00514046|20942610|P1|COMPLETED|Overall Study||2
8498390|NCT00514046|20942602|P9|STARTED|Overall Study||1
8498391|NCT00514046|20942603|P8|STARTED|Overall Study||1
8498392|NCT00514046|20942604|P7|STARTED|Overall Study||1
8498393|NCT00514046|20942605|P6|STARTED|Overall Study||1
8498394|NCT00514046|20942606|P5|STARTED|Overall Study||1
8498395|NCT00514046|20942607|P4|STARTED|Overall Study||1
8498396|NCT00514046|20942608|P3|STARTED|Overall Study||5
8498397|NCT00514046|20942609|P2|STARTED|Overall Study||1
8498398|NCT00514046|20942610|P1|STARTED|Overall Study||5
8498399|NCT00514020|20942652|P1|NOT COMPLETED|Overall Study||28
8498400|NCT00514020|20942652|P1|COMPLETED|Overall Study||5
8498401|NCT00514020|20942652|P1|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
8498402|NCT00513799|20942660|P4|NOT COMPLETED|Four-Month Follow-Up||3
8498403|NCT00513799|20942661|P3|NOT COMPLETED|Four-Month Follow-Up||7
8498404|NCT00513799|20942662|P2|NOT COMPLETED|Four-Month Follow-Up||5
8498405|NCT00513799|20942663|P1|NOT COMPLETED|Four-Month Follow-Up||0
8498406|NCT00513799|20942660|P4|COMPLETED|Four-Month Follow-Up||51
8498407|NCT00513799|20942661|P3|COMPLETED|Four-Month Follow-Up||57
8498408|NCT00513799|20942662|P2|COMPLETED|Four-Month Follow-Up||57
8498409|NCT00513799|20942663|P1|COMPLETED|Four-Month Follow-Up||64
8498410|NCT00513799|20942660|P4|STARTED|Four-Month Follow-Up||54
8498411|NCT00513799|20942661|P3|STARTED|Four-Month Follow-Up||64
8498412|NCT00513799|20942662|P2|STARTED|Four-Month Follow-Up||62
8498413|NCT00513799|20942663|P1|STARTED|Four-Month Follow-Up||64
8498414|NCT00513799|20942660|P4|NOT COMPLETED|One-Month Follow-Up||21
8498415|NCT00513799|20942661|P3|NOT COMPLETED|One-Month Follow-Up||11
8498416|NCT00513799|20942662|P2|NOT COMPLETED|One-Month Follow-Up||13
8498417|NCT00513799|20942663|P1|NOT COMPLETED|One-Month Follow-Up||11
8498418|NCT00513799|20942660|P4|COMPLETED|One-Month Follow-Up||54
8498419|NCT00513799|20942661|P3|COMPLETED|One-Month Follow-Up||64
8498420|NCT00513799|20942662|P2|COMPLETED|One-Month Follow-Up||62
8498421|NCT00513799|20942663|P1|COMPLETED|One-Month Follow-Up||64
8498422|NCT00513799|20942660|P4|STARTED|One-Month Follow-Up||75
8498423|NCT00513799|20942661|P3|STARTED|One-Month Follow-Up||75
8498424|NCT00513799|20942662|P2|STARTED|One-Month Follow-Up||75
8498425|NCT00513799|20942663|P1|STARTED|One-Month Follow-Up||75
8498426|NCT00513747|20942684|P3|NOT COMPLETED|Overall Study||0
8498427|NCT00513747|20942685|P2|NOT COMPLETED|Overall Study||0
8498428|NCT00513747|20942686|P1|NOT COMPLETED|Overall Study||0
8498429|NCT00513747|20942684|P3|COMPLETED|Overall Study||55
8498430|NCT00513747|20942685|P2|COMPLETED|Overall Study||11
8498431|NCT00513747|20942686|P1|COMPLETED|Overall Study||17
8498432|NCT00513747|20942684|P3|Received at Least One Dose of Treatment|Overall Study||40
8498433|NCT00513747|20942685|P2|Received at Least One Dose of Treatment|Overall Study||11
8498434|NCT00513747|20942686|P1|Received at Least One Dose of Treatment|Overall Study||9
8498435|NCT00513747|20942684|P3|STARTED|Overall Study||55
8498436|NCT00513747|20942685|P2|STARTED|Overall Study||11
8498437|NCT00513747|20942686|P1|STARTED|Overall Study||17
8498438|NCT00513708|20942706|P3|NOT COMPLETED|Overall Study||4
8498439|NCT00513708|20942707|P2|NOT COMPLETED|Overall Study||4
8498440|NCT00513708|20942708|P1|NOT COMPLETED|Overall Study||4
8498441|NCT00513708|20942706|P3|COMPLETED|Overall Study||46
8498442|NCT00513708|20942707|P2|COMPLETED|Overall Study||46
8498443|NCT00513708|20942708|P1|COMPLETED|Overall Study||46
8498444|NCT00513708|20942706|P3|STARTED|Overall Study||50
8498445|NCT00513708|20942707|P2|STARTED|Overall Study||50
8498446|NCT00513708|20942708|P1|STARTED|Overall Study||50
8498447|NCT00513695|20942722|P1|NOT COMPLETED|Overall Study||5
8498448|NCT00513695|20942722|P1|COMPLETED|Overall Study||63
8498449|NCT00513695|20942722|P1|STARTED|Overall Study||68
8498450|NCT00513682|20942731|P1|NOT COMPLETED|Treatment Phase||0
8498451|NCT00513682|20942731|P1|COMPLETED|Treatment Phase||7
8498452|NCT00513682|20942731|P1|STARTED|Treatment Phase||7
8498453|NCT00513682|20942731|P1|NOT COMPLETED|Washout Phase||2
8498454|NCT00513682|20942731|P1|COMPLETED|Washout Phase||7
8498455|NCT00513682|20942731|P1|STARTED|Washout Phase||9
8498456|NCT00513682|20942731|P1|NOT COMPLETED|Screening Phase||0
8498457|NCT00513682|20942731|P1|COMPLETED|Screening Phase||9
8498458|NCT00513682|20942731|P1|STARTED|Screening Phase||9
8498459|NCT00513617|20942743|P3|NOT COMPLETED|Overall Study||8
8498460|NCT00513617|20942744|P2|NOT COMPLETED|Overall Study||10
8498461|NCT00513617|20942745|P1|NOT COMPLETED|Overall Study||11
8498462|NCT00513617|20942743|P3|COMPLETED|Overall Study||30
8498463|NCT00513617|20942744|P2|COMPLETED|Overall Study||25
8498464|NCT00513617|20942745|P1|COMPLETED|Overall Study||25
8498465|NCT00513617|20942743|P3|STARTED|Overall Study||38
8498466|NCT00513617|20942744|P2|STARTED|Overall Study||35
8498467|NCT00513617|20942745|P1|STARTED|Overall Study||36
8498468|NCT00513604|20942761|P5|NOT COMPLETED|Overall Study||0
8498469|NCT00513604|20942762|P4|NOT COMPLETED|Overall Study||0
8498470|NCT00513604|20942763|P3|NOT COMPLETED|Overall Study||3
8498471|NCT00513604|20942764|P2|NOT COMPLETED|Overall Study||3
8498472|NCT00513604|20942765|P1|NOT COMPLETED|Overall Study||2
8498473|NCT00513604|20942761|P5|COMPLETED|Overall Study||35
8498474|NCT00513604|20942762|P4|COMPLETED|Overall Study||34
8498475|NCT00513604|20942763|P3|COMPLETED|Overall Study||21
8498476|NCT00513604|20942764|P2|COMPLETED|Overall Study||36
8498477|NCT00513604|20942765|P1|COMPLETED|Overall Study||24
8498478|NCT00513604|20942761|P5|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
8498479|NCT00513604|20942762|P4|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
8498480|NCT00513604|20942763|P3|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
8498481|NCT00513604|20942764|P2|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
8498482|NCT00513604|20942765|P1|STARTED|Overall Study|Cohort 1 = unselected TIL|26
8498483|NCT00513526|20942782|P1|NOT COMPLETED|Overall Study||17
8498484|NCT00513526|20942782|P1|COMPLETED|Overall Study||92
8498485|NCT00513526|20942782|P1|STARTED|Overall Study||109
8498486|NCT00513500|20942799|P2|NOT COMPLETED|Overall Study||54
8498487|NCT00513500|20942800|P1|NOT COMPLETED|Overall Study||41
8498488|NCT00513500|20942799|P2|COMPLETED|Overall Study||2054
8498489|NCT00513500|20942800|P1|COMPLETED|Overall Study||976
8498490|NCT00513500|20942799|P2|STARTED|Overall Study||2108
8498491|NCT00513500|20942800|P1|STARTED|Overall Study||1017
8498492|NCT00513474|20942812|P2|NOT COMPLETED|Overall Study||9
8498493|NCT00513474|20942813|P1|NOT COMPLETED|Overall Study||7
8498494|NCT00513474|20942812|P2|COMPLETED|Overall Study||12
8498495|NCT00513474|20942813|P1|COMPLETED|Overall Study||18
8498496|NCT00513474|20942812|P2|Received Rasburicase Per Protocol|Overall Study||0
8498497|NCT00513474|20942813|P1|Received Rasburicase Per Protocol|Overall Study||24
8498498|NCT00513474|20942812|P2|STARTED|Overall Study||21
8498499|NCT00513474|20942813|P1|STARTED|Overall Study||25
8498500|NCT00513461|20942827|P2|NOT COMPLETED|Overall Study||10
8498501|NCT00513461|20942828|P1|NOT COMPLETED|Overall Study||13
8498502|NCT00513461|20942827|P2|COMPLETED|Overall Study||43
8498503|NCT00513461|20942828|P1|COMPLETED|Overall Study||44
8498504|NCT00513461|20942827|P2|STARTED|Overall Study||53
8498505|NCT00513461|20942828|P1|STARTED|Overall Study||57
8498506|NCT00513435|20942862|P1|NOT COMPLETED|Overall Study||0
8498507|NCT00513435|20942862|P1|COMPLETED|Overall Study||9
8498508|NCT00513435|20942862|P1|STARTED|Overall Study||9
8498509|NCT00513409|20942869|P2|NOT COMPLETED|Overall Study||6
8498510|NCT00513409|20942870|P1|NOT COMPLETED|Overall Study||2
8498511|NCT00513409|20942869|P2|COMPLETED|Overall Study||73
8498512|NCT00513409|20942870|P1|COMPLETED|Overall Study||82
8498513|NCT00513409|20942869|P2|STARTED|Overall Study||79
8498514|NCT00513409|20942870|P1|STARTED|Overall Study||84
8498515|NCT00513370|20942896|P1|NOT COMPLETED|Overall Study||24
8498516|NCT00513370|20942896|P1|COMPLETED|Overall Study||179
8498517|NCT00513370|20942896|P1|STARTED|Overall Study||203
8498518|NCT00513357|20942926|P2|NOT COMPLETED|Overall Study||10
8498519|NCT00513357|20942927|P1|NOT COMPLETED|Overall Study||15
8498520|NCT00513357|20942926|P2|COMPLETED|Overall Study||25
8498521|NCT00513357|20942927|P1|COMPLETED|Overall Study||23
8498522|NCT00513357|20942926|P2|STARTED|Overall Study||35
8498523|NCT00513357|20942927|P1|STARTED|Overall Study||38
8498524|NCT00513344|20942933|P1|NOT COMPLETED|3rd Intervention 1 Day||0
8498525|NCT00513344|20942933|P1|COMPLETED|3rd Intervention 1 Day||5
8498526|NCT00513344|20942933|P1|STARTED|3rd Intervention 1 Day||5
8498527|NCT00513344|20942933|P1|NOT COMPLETED|Washout Period 3 Days||0
8498528|NCT00513344|20942933|P1|COMPLETED|Washout Period 3 Days||5
8498529|NCT00513344|20942933|P1|STARTED|Washout Period 3 Days||5
8498530|NCT00513344|20942933|P1|NOT COMPLETED|2nd Intervention 1 Day||0
8498531|NCT00513344|20942933|P1|COMPLETED|2nd Intervention 1 Day||5
8498532|NCT00513344|20942933|P1|STARTED|2nd Intervention 1 Day||5
8498533|NCT00513344|20942933|P1|NOT COMPLETED|Washout Period 3 Days||0
8498534|NCT00513344|20942933|P1|COMPLETED|Washout Period 3 Days||5
8498535|NCT00513344|20942933|P1|STARTED|Washout Period 3 Days||5
8498536|NCT00513344|20942933|P1|NOT COMPLETED|1st Intervention 1 Day||0
8498537|NCT00513344|20942933|P1|COMPLETED|1st Intervention 1 Day||5
8498538|NCT00513344|20942933|P1|STARTED|1st Intervention 1 Day||5
8498539|NCT00513344|20942933|P1|NOT COMPLETED|Diet Restriction (3 Days)||0
8498540|NCT00513344|20942933|P1|COMPLETED|Diet Restriction (3 Days)||5
8498541|NCT00513344|20942933|P1|STARTED|Diet Restriction (3 Days)||5
8498542|NCT00513305|20942946|P2|NOT COMPLETED|Overall Study||27
8498543|NCT00513305|20942947|P1|NOT COMPLETED|Overall Study||28
8498544|NCT00513305|20942946|P2|COMPLETED|Overall Study||7
8498545|NCT00513305|20942947|P1|COMPLETED|Overall Study||5
8498546|NCT00513305|20942946|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
8498547|NCT00513305|20942947|P1|STARTED|Overall Study||33
8498548|NCT00513292|20942965|P2|NOT COMPLETED|Overall Study||0
8498549|NCT00513292|20942966|P1|NOT COMPLETED|Overall Study||0
8498550|NCT00513292|20942965|P2|COMPLETED|Overall Study||142
8498551|NCT00513292|20942966|P1|COMPLETED|Overall Study||138
8498552|NCT00513292|20942965|P2|STARTED|Overall Study||142
8498553|NCT00513292|20942966|P1|STARTED|Overall Study||138
8498554|NCT00513240|20942990|P2|NOT COMPLETED|Overall Study||7
8498555|NCT00513240|20942991|P1|NOT COMPLETED|Overall Study||13
8498556|NCT00513240|20942990|P2|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
8498557|NCT00513240|20942991|P1|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
8498558|NCT00513240|20942990|P2|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
8498559|NCT00513240|20942991|P1|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
8498560|NCT00513240|20942990|P2|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
8498561|NCT00513240|20942991|P1|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
8498562|NCT00513071|20943004|P1|NOT COMPLETED|Overall Study||5
8498563|NCT00513071|20943004|P1|COMPLETED|Overall Study||23
8498564|NCT00513071|20943004|P1|STARTED|Overall Study||28
8498565|NCT00513019|20943016|P2|NOT COMPLETED|Overall Study||5
8498566|NCT00513019|20943017|P1|NOT COMPLETED|Overall Study||5
8498567|NCT00513019|20943016|P2|COMPLETED|Overall Study||13
8498568|NCT00513019|20943017|P1|COMPLETED|Overall Study||12
8498569|NCT00513019|20943016|P2|STARTED|Overall Study||18
8498570|NCT00513019|20943017|P1|STARTED|Overall Study||17
8498571|NCT00512902|20943023|P1|NOT COMPLETED|Overall Study||8
8498572|NCT00512902|20943023|P1|COMPLETED|Overall Study||12
8498573|NCT00512902|20943023|P1|STARTED|Overall Study||20
8498574|NCT00512876|20943031|P1|NOT COMPLETED|Overall Study||4
8498575|NCT00512876|20943031|P1|COMPLETED|Overall Study||20
8498576|NCT00512876|20943031|P1|STARTED|Overall Study||24
8498577|NCT00512798|20943038|P2|NOT COMPLETED|Overall Study||27
8498578|NCT00512798|20943039|P1|NOT COMPLETED|Overall Study||19
8498579|NCT00512798|20943038|P2|COMPLETED|Overall Study||1
8498580|NCT00512798|20943039|P1|COMPLETED|Overall Study||0
8498581|NCT00512798|20943038|P2|STARTED|Overall Study||28
8498582|NCT00512798|20943039|P1|STARTED|Overall Study||19
8498583|NCT00512707|20943050|P2|NOT COMPLETED|Overall Study||12
8498584|NCT00512707|20943051|P1|NOT COMPLETED|Overall Study||10
8498585|NCT00512707|20943050|P2|COMPLETED|Overall Study||58
8498586|NCT00512707|20943051|P1|COMPLETED|Overall Study||60
8498587|NCT00512707|20943050|P2|STARTED|Overall Study||70
8498588|NCT00512707|20943051|P1|STARTED|Overall Study||70
8498589|NCT00512278|20943083|P2|NOT COMPLETED|Overall Study||17
8498590|NCT00512278|20943084|P1|NOT COMPLETED|Overall Study||28
8498591|NCT00512278|20943083|P2|COMPLETED|Overall Study||56
8498592|NCT00512278|20943084|P1|COMPLETED|Overall Study||45
8498593|NCT00512278|20943083|P2|STARTED|Overall Study||73
8498594|NCT00512278|20943084|P1|STARTED|Overall Study||73
8498595|NCT00512252|20943101|P3|NOT COMPLETED|Overall Study||3
8498596|NCT00512252|20943102|P2|NOT COMPLETED|Overall Study||0
8498597|NCT00512252|20943103|P1|NOT COMPLETED|Overall Study||0
8498598|NCT00512252|20943101|P3|COMPLETED|Overall Study||43
8498599|NCT00512252|20943102|P2|COMPLETED|Overall Study||3
8498600|NCT00512252|20943103|P1|COMPLETED|Overall Study||3
8498601|NCT00512252|20943101|P3|STARTED|Overall Study||46
8498602|NCT00512252|20943102|P2|STARTED|Overall Study||3
8498603|NCT00512252|20943103|P1|STARTED|Overall Study||3
8498604|NCT00512148|20943131|P1|NOT COMPLETED|Long Term Follow Up Period||6
8498605|NCT00512148|20943131|P1|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
8498606|NCT00512148|20943131|P1|STARTED|Long Term Follow Up Period||6
8498607|NCT00512148|20943131|P1|NOT COMPLETED|Primay Study Period||1
8498608|NCT00512148|20943131|P1|COMPLETED|Primay Study Period||6
8498609|NCT00512148|20943131|P1|STARTED|Primay Study Period||7
8498610|NCT00512096|20943137|P1|NOT COMPLETED|Overall Study||7
8498611|NCT00512096|20943137|P1|COMPLETED|Overall Study||23
8498612|NCT00512096|20943137|P1|STARTED|Overall Study||30
8498613|NCT00511992|20943141|P1|NOT COMPLETED|Overall Study||7
8498614|NCT00511992|20943141|P1|COMPLETED|Overall Study||13
8498615|NCT00511992|20943141|P1|STARTED|Overall Study||20
8498616|NCT00511914|20943148|P2|NOT COMPLETED|Overall Study||0
8498617|NCT00511914|20943149|P1|NOT COMPLETED|Overall Study||0
8498618|NCT00511914|20943148|P2|COMPLETED|Overall Study||67
8498619|NCT00511914|20943149|P1|COMPLETED|Overall Study||68
8498620|NCT00511914|20943148|P2|STARTED|Overall Study||67
8498621|NCT00511914|20943149|P1|STARTED|Overall Study||68
8498622|NCT00511901|20943165|P2|NOT COMPLETED|Overall Study||3
8498623|NCT00511901|20943166|P1|NOT COMPLETED|Overall Study||1
8498624|NCT00511901|20943165|P2|COMPLETED|Overall Study||8
8498625|NCT00511901|20943166|P1|COMPLETED|Overall Study||10
8498626|NCT00511901|20943165|P2|STARTED|Overall Study||11
8498627|NCT00511901|20943166|P1|STARTED|Overall Study||11
8498628|NCT00511875|20943188|P2|NOT COMPLETED|Overall Study||0
8498629|NCT00511875|20943189|P1|NOT COMPLETED|Overall Study||5
8498630|NCT00511875|20943188|P2|COMPLETED|Overall Study||15
8498631|NCT00511875|20943189|P1|COMPLETED|Overall Study||10
8498632|NCT00511875|20943188|P2|STARTED|Overall Study||15
8498633|NCT00511875|20943189|P1|STARTED|Overall Study||15
8498643|NCT00511836|20943229|P2|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
8498644|NCT00511836|20943230|P1|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
8498645|NCT00511836|20943229|P2|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
8498646|NCT00511836|20943230|P1|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
8498647|NCT00511836|20943229|P2|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
8498648|NCT00511836|20943230|P1|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
8498649|NCT00511836|20943229|P2|NOT COMPLETED|Double-blind Period||0
8498650|NCT00511836|20943230|P1|NOT COMPLETED|Double-blind Period||1
8498651|NCT00511836|20943229|P2|COMPLETED|Double-blind Period||15
8498652|NCT00511836|20943230|P1|COMPLETED|Double-blind Period||15
8498653|NCT00511836|20943229|P2|STARTED|Double-blind Period||15
8498654|NCT00511836|20943230|P1|STARTED|Double-blind Period||16
8498655|NCT00511810|20943247|P2|NOT COMPLETED|Overall Study||5
8498656|NCT00511810|20943248|P1|NOT COMPLETED|Overall Study||1
8498657|NCT00511810|20943247|P2|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
8498658|NCT00511810|20943248|P1|COMPLETED|Overall Study||7
8498659|NCT00511810|20943247|P2|STARTED|Overall Study||12
8498660|NCT00511810|20943248|P1|STARTED|Overall Study||8
8498661|NCT00511797|20943258|P4|NOT COMPLETED|Overall Study||15
8498662|NCT00511797|20943259|P3|NOT COMPLETED|Overall Study||11
8498663|NCT00511797|20943260|P2|NOT COMPLETED|Overall Study||8
8498664|NCT00511797|20943261|P1|NOT COMPLETED|Overall Study||7
8498665|NCT00511797|20943258|P4|COMPLETED|Overall Study||47
8498666|NCT00511797|20943259|P3|COMPLETED|Overall Study||51
8498667|NCT00511797|20943260|P2|COMPLETED|Overall Study||55
8498668|NCT00511797|20943261|P1|COMPLETED|Overall Study||55
8498669|NCT00511797|20943258|P4|Subjects Received Treatment|Overall Study|FAS|58
8498670|NCT00511797|20943259|P3|Subjects Received Treatment|Overall Study|FAS|61
8498671|NCT00511797|20943260|P2|Subjects Received Treatment|Overall Study|FAS|62
8498672|NCT00511797|20943261|P1|Subjects Received Treatment|Overall Study|FAS|61
8498673|NCT00511797|20943258|P4|Subjects Dispensed Drugs|Overall Study||59
8498674|NCT00511797|20943259|P3|Subjects Dispensed Drugs|Overall Study||61
8498675|NCT00511797|20943260|P2|Subjects Dispensed Drugs|Overall Study||63
8498676|NCT00511797|20943261|P1|Subjects Dispensed Drugs|Overall Study||61
8498677|NCT00511797|20943258|P4|STARTED|Overall Study||62
8498678|NCT00511797|20943259|P3|STARTED|Overall Study||62
8498679|NCT00511797|20943260|P2|STARTED|Overall Study||63
8498680|NCT00511797|20943261|P1|STARTED|Overall Study||62
8498681|NCT00511706|20943365|P2|NOT COMPLETED|Overall Study||5
8498682|NCT00511706|20943366|P1|NOT COMPLETED|Overall Study||8
8498683|NCT00511706|20943365|P2|COMPLETED|Overall Study||115
8498684|NCT00511706|20943366|P1|COMPLETED|Overall Study||115
8498685|NCT00511706|20943365|P2|STARTED|Overall Study||120
8498686|NCT00511706|20943366|P1|STARTED|Overall Study||123
8498687|NCT00511667|20943380|P2|NOT COMPLETED|Overall Study||3
8498688|NCT00511667|20943381|P1|NOT COMPLETED|Overall Study||12
8498689|NCT00511667|20943380|P2|COMPLETED|Overall Study||15
8498690|NCT00511667|20943381|P1|COMPLETED|Overall Study||40
8498691|NCT00511667|20943380|P2|STARTED|Overall Study||18
8498692|NCT00511667|20943381|P1|STARTED|Overall Study||52
8498693|NCT00511472|20943416|P2|NOT COMPLETED|Overall Study||6
8498694|NCT00511472|20943417|P1|NOT COMPLETED|Overall Study||3
8498695|NCT00511472|20943416|P2|COMPLETED|Overall Study||17
8498696|NCT00511472|20943417|P1|COMPLETED|Overall Study||44
8498697|NCT00511472|20943416|P2|STARTED|Overall Study||23
8498698|NCT00511472|20943417|P1|STARTED|Overall Study||47
8498699|NCT00511433|20943436|P2|NOT COMPLETED|Overall Study||1
8498700|NCT00511433|20943437|P1|NOT COMPLETED|Overall Study||6
8498701|NCT00511433|20943436|P2|COMPLETED|Overall Study||15
8498702|NCT00511433|20943437|P1|COMPLETED|Overall Study||26
8498703|NCT00511433|20943436|P2|STARTED|Overall Study||16
8498704|NCT00511433|20943437|P1|STARTED|Overall Study||32
8498705|NCT00511355|20943477|P2|NOT COMPLETED|Overall Study||9
8498706|NCT00511355|20943478|P1|NOT COMPLETED|Overall Study||7
8498707|NCT00511355|20943477|P2|COMPLETED|Overall Study||52
8498708|NCT00511355|20943478|P1|COMPLETED|Overall Study||53
8498709|NCT00511355|20943477|P2|STARTED|Overall Study||61
8498710|NCT00511355|20943478|P1|STARTED|Overall Study||60
8498711|NCT00511342|20943578|P2|NOT COMPLETED|Overall Study||22
8498712|NCT00511342|20943579|P1|NOT COMPLETED|Overall Study||13
8498713|NCT00511342|20943578|P2|COMPLETED|Overall Study||32
8498714|NCT00511342|20943579|P1|COMPLETED|Overall Study||43
8498715|NCT00511342|20943578|P2|STARTED|Overall Study||54
8498716|NCT00511342|20943579|P1|STARTED|Overall Study||56
8498717|NCT00511329|20943603|P1|NOT COMPLETED|Overall Study||0
8498718|NCT00511329|20943603|P1|COMPLETED|Overall Study||0
8498719|NCT00511329|20943603|P1|STARTED|Overall Study||0
8498720|NCT00511238|20943610|P2|NOT COMPLETED|Overall Study||226
8498721|NCT00511238|20943611|P1|NOT COMPLETED|Overall Study||42
8498722|NCT00511238|20943610|P2|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
8498723|NCT00511238|20943611|P1|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
8498724|NCT00511238|20943610|P2|STARTED|Overall Study||266
8498725|NCT00511238|20943611|P1|STARTED|Overall Study||46
8498726|NCT00511199|20943630|P2|NOT COMPLETED|Overall Study||125
8498727|NCT00511199|20943631|P1|NOT COMPLETED|Overall Study||449
8498728|NCT00511199|20943630|P2|COMPLETED|Overall Study||410
8498729|NCT00511199|20943631|P1|COMPLETED|Overall Study||1142
8498730|NCT00511199|20943630|P2|STARTED|Overall Study||535
8498731|NCT00511199|20943631|P1|STARTED|Overall Study||1591
8498732|NCT00511173|20943655|P1|NOT COMPLETED|Overall Study||0
8498733|NCT00511173|20943655|P1|COMPLETED|Overall Study||102
8498734|NCT00511173|20943655|P1|STARTED|Overall Study||102
8498735|NCT00511147|20943660|P1|NOT COMPLETED|Overall Study||7
8498736|NCT00511147|20943660|P1|COMPLETED|Overall Study||57
8498737|NCT00511147|20943660|P1|STARTED|Overall Study||64
8498738|NCT00511134|20943669|P2|NOT COMPLETED|Overall Study||2
8498739|NCT00511134|20943670|P1|NOT COMPLETED|Overall Study||0
8498740|NCT00511134|20943669|P2|COMPLETED|Overall Study||1
8498741|NCT00511134|20943670|P1|COMPLETED|Overall Study||1
8498742|NCT00511134|20943669|P2|STARTED|Overall Study||3
8498743|NCT00511134|20943670|P1|STARTED|Overall Study||1
8498744|NCT00511108|20943682|P4|NOT COMPLETED|Overall Study||5
8498745|NCT00511108|20943683|P3|NOT COMPLETED|Overall Study||5
8498746|NCT00511108|20943684|P2|NOT COMPLETED|Overall Study||2
8498747|NCT00511108|20943685|P1|NOT COMPLETED|Overall Study||6
8498748|NCT00511108|20943682|P4|COMPLETED|Overall Study||48
8498749|NCT00511108|20943683|P3|COMPLETED|Overall Study||47
8498750|NCT00511108|20943684|P2|COMPLETED|Overall Study||52
8498751|NCT00511108|20943685|P1|COMPLETED|Overall Study||46
8498752|NCT00511108|20943682|P4|STARTED|Overall Study||53
8498753|NCT00511108|20943683|P3|STARTED|Overall Study||52
8498754|NCT00511108|20943684|P2|STARTED|Overall Study||54
8498755|NCT00511108|20943685|P1|STARTED|Overall Study||52
8498756|NCT00511095|20943703|P1|NOT COMPLETED|Overall Study||11
8498757|NCT00511095|20943703|P1|COMPLETED|Overall Study||196
8498758|NCT00511095|20943703|P1|STARTED|Overall Study||207
8498759|NCT00511004|20943716|P3|NOT COMPLETED|Overall Study||4
8498760|NCT00511004|20943717|P2|NOT COMPLETED|Overall Study||0
8498761|NCT00511004|20943718|P1|NOT COMPLETED|Overall Study||0
8498762|NCT00511004|20943716|P3|COMPLETED|Overall Study||10
8498763|NCT00511004|20943717|P2|COMPLETED|Overall Study||13
8498764|NCT00511004|20943718|P1|COMPLETED|Overall Study||13
8498765|NCT00511004|20943716|P3|STARTED|Overall Study||14
8498766|NCT00511004|20943717|P2|STARTED|Overall Study||13
8498767|NCT00511004|20943718|P1|STARTED|Overall Study||13
8498768|NCT00510952|20943737|P2|NOT COMPLETED|Overall Study||16
8498769|NCT00510952|20943738|P1|NOT COMPLETED|Overall Study||26
8498770|NCT00510952|20943737|P2|COMPLETED|Overall Study||220
8498771|NCT00510952|20943738|P1|COMPLETED|Overall Study||209
8498772|NCT00510952|20943737|P2|Full Analysis Set (Intent to Treat)|Overall Study||229
8498773|NCT00510952|20943738|P1|Full Analysis Set (Intent to Treat)|Overall Study||229
8498774|NCT00510952|20943737|P2|STARTED|Overall Study||236
8498775|NCT00510952|20943738|P1|STARTED|Overall Study||235
8498776|NCT00510887|20943764|P1|NOT COMPLETED|Overall Study||1
8498777|NCT00510887|20943764|P1|COMPLETED|Overall Study||11
8498778|NCT00510887|20943764|P1|STARTED|Overall Study||12
8498779|NCT00510874|20943780|P7|NOT COMPLETED|Overall Study||1
8498780|NCT00510874|20943781|P6|NOT COMPLETED|Overall Study||0
8498781|NCT00510874|20943782|P5|NOT COMPLETED|Overall Study||7
8498782|NCT00510874|20943783|P4|NOT COMPLETED|Overall Study||3
8498783|NCT00510874|20943784|P3|NOT COMPLETED|Overall Study||1
8498784|NCT00510874|20943785|P2|NOT COMPLETED|Overall Study||4
8498785|NCT00510874|20943786|P1|NOT COMPLETED|Overall Study||3
8498786|NCT00510874|20943780|P7|COMPLETED|Overall Study|Upto Day 182|49
8498787|NCT00510874|20943781|P6|COMPLETED|Overall Study|Upto Day 182|50
8498788|NCT00510874|20943782|P5|COMPLETED|Overall Study|Upto Day 182|141
8498789|NCT00510874|20943783|P4|COMPLETED|Overall Study|Upto Day 182|148
8498790|NCT00510874|20943784|P3|COMPLETED|Overall Study|Upto Day 182|150
8498791|NCT00510874|20943785|P2|COMPLETED|Overall Study|Upto Day 182|148
8498792|NCT00510874|20943786|P1|COMPLETED|Overall Study|Upto Day 182|75
8498793|NCT00510874|20943780|P7|STARTED|Overall Study||50
8498794|NCT00510874|20943781|P6|STARTED|Overall Study||50
8498795|NCT00510874|20943782|P5|STARTED|Overall Study||148
8498796|NCT00510874|20943783|P4|STARTED|Overall Study||151
8498797|NCT00510874|20943784|P3|STARTED|Overall Study||151
8498798|NCT00510874|20943785|P2|STARTED|Overall Study||152
8498799|NCT00510874|20943786|P1|STARTED|Overall Study||78
8498800|NCT00510835|20943889|P3|NOT COMPLETED|Overall Study||2
8498801|NCT00510835|20943890|P2|NOT COMPLETED|Overall Study||2
8498802|NCT00510835|20943891|P1|NOT COMPLETED|Overall Study||6
8498803|NCT00510835|20943889|P3|COMPLETED|Overall Study||456
8498804|NCT00510835|20943890|P2|COMPLETED|Overall Study||446
8498805|NCT00510835|20943891|P1|COMPLETED|Overall Study||439
8498806|NCT00510835|20943889|P3|STARTED|Overall Study||458
8498807|NCT00510835|20943890|P2|STARTED|Overall Study||448
8498808|NCT00510835|20943891|P1|STARTED|Overall Study||445
8498809|NCT00510809|20943902|P3|NOT COMPLETED|Overall Study||0
8498810|NCT00510809|20943903|P2|NOT COMPLETED|Overall Study||0
8498811|NCT00510809|20943904|P1|NOT COMPLETED|Overall Study||0
8498812|NCT00510809|20943902|P3|COMPLETED|Overall Study||18
8498813|NCT00510809|20943903|P2|COMPLETED|Overall Study||18
8498814|NCT00510809|20943904|P1|COMPLETED|Overall Study||18
8498815|NCT00510809|20943902|P3|STARTED|Overall Study||18
8498816|NCT00510809|20943903|P2|STARTED|Overall Study||18
8498817|NCT00510809|20943904|P1|STARTED|Overall Study||18
8498818|NCT00510783|20943917|P2|NOT COMPLETED|Overall Study||29
8498819|NCT00510783|20943918|P1|NOT COMPLETED|Overall Study||31
8498820|NCT00510783|20943917|P2|COMPLETED|Overall Study||47
8498821|NCT00510783|20943918|P1|COMPLETED|Overall Study||51
8498822|NCT00510783|20943917|P2|STARTED|Overall Study||76
8498823|NCT00510783|20943918|P1|STARTED|Overall Study||82
8498824|NCT00510744|20943924|P1|NOT COMPLETED|Overall Study||0
8498825|NCT00510744|20943924|P1|COMPLETED|Overall Study||5
8498826|NCT00510744|20943924|P1|STARTED|Overall Study||5
8498827|NCT00510718|20943935|P2|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32
8498828|NCT00510718|20943936|P1|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15
8498829|NCT00510718|20943935|P2|COMPLETED|Multiple Dose Period: 12 Weeks||43
8498830|NCT00510718|20943936|P1|COMPLETED|Multiple Dose Period: 12 Weeks||50
8498831|NCT00510718|20943935|P2|600 mg/Day|Multiple Dose Period: 12 Weeks||3
8498832|NCT00510718|20943936|P1|600 mg/Day|Multiple Dose Period: 12 Weeks||0
8498833|NCT00510718|20943935|P2|480 mg/Day|Multiple Dose Period: 12 Weeks||22
8498834|NCT00510718|20943936|P1|480 mg/Day|Multiple Dose Period: 12 Weeks||0
8498835|NCT00510718|20943935|P2|360 mg/Day|Multiple Dose Period: 12 Weeks||13
8498836|NCT00510718|20943936|P1|360 mg/Day|Multiple Dose Period: 12 Weeks||15
8498837|NCT00510718|20943935|P2|240 mg/Day|Multiple Dose Period: 12 Weeks||12
8498838|NCT00510718|20943936|P1|240 mg/Day|Multiple Dose Period: 12 Weeks||17
8498839|NCT00510718|20943935|P2|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13
8498840|NCT00510718|20943936|P1|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15
8498841|NCT00510718|20943935|P2|60 mg/Day|Multiple Dose Period: 12 Weeks||12
8498842|NCT00510718|20943936|P1|60 mg/Day|Multiple Dose Period: 12 Weeks||15
8498843|NCT00510718|20943935|P2|30 mg/Day|Multiple Dose Period: 12 Weeks||0
8498844|NCT00510718|20943936|P1|30 mg/Day|Multiple Dose Period: 12 Weeks||3
8498845|NCT00510718|20943935|P2|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75
8498846|NCT00510718|20943936|P1|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65
8498847|NCT00510718|20943935|P2|NOT COMPLETED|Single Dose Period: 1 Week||0
8498848|NCT00510718|20943936|P1|NOT COMPLETED|Single Dose Period: 1 Week||0
8498849|NCT00510718|20943935|P2|COMPLETED|Single Dose Period: 1 Week||12
8498850|NCT00510718|20943936|P1|COMPLETED|Single Dose Period: 1 Week||15
8498851|NCT00510718|20943935|P2|600 mg/Day|Single Dose Period: 1 Week||3
8498852|NCT00510718|20943936|P1|600 mg/Day|Single Dose Period: 1 Week||0
8498853|NCT00510718|20943935|P2|480 mg/Day|Single Dose Period: 1 Week||6
8498854|NCT00510718|20943936|P1|480 mg/Day|Single Dose Period: 1 Week||0
8498855|NCT00510718|20943935|P2|360 mg/Day|Single Dose Period: 1 Week||2
8498856|NCT00510718|20943936|P1|360 mg/Day|Single Dose Period: 1 Week||4
8498857|NCT00510718|20943935|P2|240 mg/Day|Single Dose Period: 1 Week||0
8498858|NCT00510718|20943936|P1|240 mg/Day|Single Dose Period: 1 Week||3
8498859|NCT00510718|20943935|P2|150/160 mg/Day|Single Dose Period: 1 Week||1
8498860|NCT00510718|20943936|P1|150/160 mg/Day|Single Dose Period: 1 Week||2
8498861|NCT00510718|20943935|P2|60 mg/Day|Single Dose Period: 1 Week||0
8498862|NCT00510718|20943936|P1|60 mg/Day|Single Dose Period: 1 Week||3
8498863|NCT00510718|20943935|P2|30 mg/Day|Single Dose Period: 1 Week||0
8498864|NCT00510718|20943936|P1|30 mg/Day|Single Dose Period: 1 Week||3
8498865|NCT00510718|20943935|P2|STARTED|Single Dose Period: 1 Week||12
8498866|NCT00510718|20943936|P1|STARTED|Single Dose Period: 1 Week||15
8498867|NCT00510692|20944062|P2|NOT COMPLETED|Overall Study||3
8498868|NCT00510692|20944063|P1|NOT COMPLETED|Overall Study||2
8498869|NCT00510692|20944062|P2|COMPLETED|Overall Study||26
8498870|NCT00510692|20944063|P1|COMPLETED|Overall Study||27
8498871|NCT00510692|20944062|P2|STARTED|Overall Study||29
8498872|NCT00510692|20944063|P1|STARTED|Overall Study||29
8498873|NCT00510653|20944077|P1|NOT COMPLETED|Overall Study||11
8498874|NCT00510653|20944077|P1|COMPLETED|Overall Study||13
8498875|NCT00510653|20944077|P1|STARTED|Overall Study||24
8498876|NCT00510510|20944084|P3|NOT COMPLETED|Overall Study||17
8498877|NCT00510510|20944085|P2|NOT COMPLETED|Overall Study||9
8498878|NCT00510510|20944086|P1|NOT COMPLETED|Overall Study||5
8498879|NCT00510510|20944084|P3|COMPLETED|Overall Study||74
8498880|NCT00510510|20944085|P2|COMPLETED|Overall Study||89
8498881|NCT00510510|20944086|P1|COMPLETED|Overall Study||87
8498882|NCT00510510|20944084|P3|STARTED|Overall Study||91
8498883|NCT00510510|20944085|P2|STARTED|Overall Study||98
8498884|NCT00510510|20944086|P1|STARTED|Overall Study||92
8498885|NCT00510497|20944097|P1|NOT COMPLETED|Overall Study||3
8498886|NCT00510497|20944097|P1|COMPLETED|Overall Study||8
8498887|NCT00510497|20944097|P1|STARTED|Overall Study||11
8498888|NCT00510484|20944104|P2|NOT COMPLETED|Period 2||0
8498889|NCT00510484|20944105|P1|NOT COMPLETED|Period 2||0
8498890|NCT00510484|20944104|P2|COMPLETED|Period 2||15
8498891|NCT00510484|20944105|P1|COMPLETED|Period 2||16
8498892|NCT00510484|20944104|P2|STARTED|Period 2||15
8498893|NCT00510484|20944105|P1|STARTED|Period 2||16
8498894|NCT00510484|20944104|P2|NOT COMPLETED|Wash-out Period||1
8498895|NCT00510484|20944105|P1|NOT COMPLETED|Wash-out Period||0
8498896|NCT00510484|20944104|P2|COMPLETED|Wash-out Period||15
8498897|NCT00510484|20944105|P1|COMPLETED|Wash-out Period||16
8498898|NCT00510484|20944104|P2|STARTED|Wash-out Period||16
8498899|NCT00510484|20944105|P1|STARTED|Wash-out Period||16
8498900|NCT00510484|20944104|P2|NOT COMPLETED|Period 1||0
8498901|NCT00510484|20944105|P1|NOT COMPLETED|Period 1||0
8498902|NCT00510484|20944104|P2|COMPLETED|Period 1||16
8498903|NCT00510484|20944105|P1|COMPLETED|Period 1||16
8498904|NCT00510484|20944104|P2|STARTED|Period 1||16
8498905|NCT00510484|20944105|P1|STARTED|Period 1||16
8498906|NCT00510458|20944125|P1|NOT COMPLETED|Overall Study||47
8498907|NCT00510458|20944125|P1|COMPLETED|Overall Study||27
8498908|NCT00510458|20944125|P1|STARTED|Overall Study||74
8498909|NCT00510289|20944138|P1|NOT COMPLETED|Overall Study||12
8498910|NCT00510289|20944138|P1|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
8498911|NCT00510289|20944138|P1|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
8498912|NCT00510289|20944138|P1|STARTED|Overall Study|All patients who consented|19
8498913|NCT00510276|20944148|P2|NOT COMPLETED|Extension Open-Label Phase||48
8498914|NCT00510276|20944149|P1|NOT COMPLETED|Extension Open-Label Phase||33
8498915|NCT00510276|20944148|P2|COMPLETED|Extension Open-Label Phase||81
8498916|NCT00510276|20944149|P1|COMPLETED|Extension Open-Label Phase||78
8498917|NCT00510276|20944148|P2|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
8498918|NCT00510276|20944149|P1|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
8498919|NCT00510276|20944148|P2|NOT COMPLETED|Acute Double-Blind Phase||95
8498920|NCT00510276|20944149|P1|NOT COMPLETED|Acute Double-Blind Phase||105
8498921|NCT00510276|20944148|P2|COMPLETED|Acute Double-Blind Phase||130
8498922|NCT00510276|20944149|P1|COMPLETED|Acute Double-Blind Phase||115
8498923|NCT00510276|20944148|P2|STARTED|Acute Double-Blind Phase||225
8498924|NCT00510276|20944149|P1|STARTED|Acute Double-Blind Phase||220
8498925|NCT00510224|20944234|P1|NOT COMPLETED|Overall Study||3
8498926|NCT00510224|20944234|P1|COMPLETED|Overall Study||10
8498927|NCT00510224|20944234|P1|STARTED|Overall Study||13
8498928|NCT00510198|20944243|P2|NOT COMPLETED|Overall Study||4
8498929|NCT00510198|20944244|P1|NOT COMPLETED|Overall Study||5
8498930|NCT00510198|20944243|P2|COMPLETED|Overall Study||54
8498931|NCT00510198|20944244|P1|COMPLETED|Overall Study||54
8498932|NCT00510198|20944243|P2|STARTED|Overall Study||58
8498933|NCT00510198|20944244|P1|STARTED|Overall Study||59
8498934|NCT00510146|20944258|P2|NOT COMPLETED|Open-Label Treatment||26
8498935|NCT00510146|20944259|P1|NOT COMPLETED|Open-Label Treatment||71
8498936|NCT00510146|20944258|P2|COMPLETED|Open-Label Treatment||96
8498937|NCT00510146|20944259|P1|COMPLETED|Open-Label Treatment||196
8498938|NCT00510146|20944258|P2|STARTED|Open-Label Treatment||122
8498939|NCT00510146|20944259|P1|STARTED|Open-Label Treatment||267
8498940|NCT00510146|20944258|P2|NOT COMPLETED|Double-Blind Treatment||49
8498941|NCT00510146|20944259|P1|NOT COMPLETED|Double-Blind Treatment||76
8498942|NCT00510146|20944258|P2|COMPLETED|Double-Blind Treatment||122
8498943|NCT00510146|20944259|P1|COMPLETED|Double-Blind Treatment||267
8498944|NCT00510146|20944258|P2|STARTED|Double-Blind Treatment||171
8498945|NCT00510146|20944259|P1|STARTED|Double-Blind Treatment||343
8498946|NCT00510068|20944348|P2|NOT COMPLETED|Open-label Period||0
8498947|NCT00510068|20944349|P1|NOT COMPLETED|Open-label Period||225
8498948|NCT00510068|20944348|P2|COMPLETED|Open-label Period||0
8498949|NCT00510068|20944349|P1|COMPLETED|Open-label Period||0
8498950|NCT00510068|20944348|P2|STARTED|Open-label Period||0
8498951|NCT00510068|20944349|P1|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
8498952|NCT00510068|20944348|P2|NOT COMPLETED|Double-blind Period||203
8498953|NCT00510068|20944349|P1|NOT COMPLETED|Double-blind Period||207
8498954|NCT00510068|20944348|P2|COMPLETED|Double-blind Period||0
8498955|NCT00510068|20944349|P1|COMPLETED|Double-blind Period||0
8498956|NCT00510068|20944348|P2|Safety Population|Double-blind Period||203
8498957|NCT00510068|20944349|P1|Safety Population|Double-blind Period||204
8498958|NCT00510068|20944348|P2|STARTED|Double-blind Period||203
8498959|NCT00510068|20944349|P1|STARTED|Double-blind Period||207
8498960|NCT00509925|20944390|P2|NOT COMPLETED|Overall Study||1
8498961|NCT00509925|20944391|P1|NOT COMPLETED|Overall Study||0
8498962|NCT00509925|20944390|P2|COMPLETED|Overall Study||10
8498963|NCT00509925|20944391|P1|COMPLETED|Overall Study||12
8498964|NCT00509925|20944390|P2|STARTED|Overall Study||11
8498965|NCT00509925|20944391|P1|STARTED|Overall Study||12
8498966|NCT00509899|20944439|P8|NOT COMPLETED|Overall Study||1
8498967|NCT00509899|20944440|P7|NOT COMPLETED|Overall Study||1
8498968|NCT00509899|20944441|P6|NOT COMPLETED|Overall Study||10
8498969|NCT00509899|20944442|P5|NOT COMPLETED|Overall Study||5
8498970|NCT00509899|20944443|P4|NOT COMPLETED|Overall Study||4
8498971|NCT00509899|20944444|P3|NOT COMPLETED|Overall Study||20
8498972|NCT00509899|20944445|P2|NOT COMPLETED|Overall Study||9
8498973|NCT00509899|20944446|P1|NOT COMPLETED|Overall Study||16
8498974|NCT00509899|20944439|P8|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
8498975|NCT00509899|20944440|P7|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
8498976|NCT00509899|20944441|P6|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
8498977|NCT00509899|20944442|P5|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
8498978|NCT00509899|20944443|P4|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
8498979|NCT00509899|20944444|P3|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
8498980|NCT00509899|20944445|P2|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
8498981|NCT00509899|20944446|P1|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
8498982|NCT00509899|20944439|P8|STARTED|Overall Study||3
8498983|NCT00509899|20944440|P7|STARTED|Overall Study||6
8498984|NCT00509899|20944441|P6|STARTED|Overall Study||22
8498985|NCT00509899|20944442|P5|STARTED|Overall Study||6
8498986|NCT00509899|20944443|P4|STARTED|Overall Study||5
8498987|NCT00509899|20944444|P3|STARTED|Overall Study||47
8498988|NCT00509899|20944445|P2|STARTED|Overall Study||35
8498989|NCT00509899|20944446|P1|STARTED|Overall Study||30
8498990|NCT00509873|20944486|P2|NOT COMPLETED|Overall Study||15
8498991|NCT00509873|20944487|P1|NOT COMPLETED|Overall Study||11
8498992|NCT00509873|20944486|P2|COMPLETED|Overall Study||276
8498993|NCT00509873|20944487|P1|COMPLETED|Overall Study||276
8498994|NCT00509873|20944486|P2|STARTED|Overall Study||291
8498995|NCT00509873|20944487|P1|STARTED|Overall Study||287
8498996|NCT00509821|20944503|P2|NOT COMPLETED|Study Period 4 (Follow Up)||0
8498997|NCT00509821|20944504|P1|NOT COMPLETED|Study Period 4 (Follow Up)||0
8498998|NCT00509821|20944503|P2|COMPLETED|Study Period 4 (Follow Up)||50
8498999|NCT00509821|20944504|P1|COMPLETED|Study Period 4 (Follow Up)||2
8499000|NCT00509821|20944503|P2|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50
8499001|NCT00509821|20944504|P1|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2
8499002|NCT00509821|20944503|P2|NOT COMPLETED|Study Period 3 (Maintenance)||49
8499003|NCT00509821|20944504|P1|NOT COMPLETED|Study Period 3 (Maintenance)||0
8499004|NCT00509821|20944503|P2|COMPLETED|Study Period 3 (Maintenance)||0
8499005|NCT00509821|20944504|P1|COMPLETED|Study Period 3 (Maintenance)||3
8499006|NCT00509821|20944503|P2|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49
8499007|NCT00509821|20944504|P1|STARTED|Study Period 3 (Maintenance)||3
8499008|NCT00509821|20944503|P2|NOT COMPLETED|Study Period 2 (Radiation)||53
8499009|NCT00509821|20944504|P1|NOT COMPLETED|Study Period 2 (Radiation)||0
8499010|NCT00509821|20944503|P2|COMPLETED|Study Period 2 (Radiation)||0
8499011|NCT00509821|20944504|P1|COMPLETED|Study Period 2 (Radiation)||3
8499012|NCT00509821|20944503|P2|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53
8499013|NCT00509821|20944504|P1|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3
8499014|NCT00509821|20944503|P2|NOT COMPLETED|Study Period 1 (Induction)||4
8499015|NCT00509821|20944504|P1|NOT COMPLETED|Study Period 1 (Induction)||0
8499016|NCT00509821|20944503|P2|COMPLETED|Study Period 1 (Induction)||53
8499017|NCT00509821|20944504|P1|COMPLETED|Study Period 1 (Induction)||3
8499018|NCT00509821|20944503|P2|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57
8499019|NCT00509821|20944504|P1|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3
8499020|NCT00509821|20944503|P2|STARTED|Study Period 1 (Induction)||57
8499021|NCT00509821|20944504|P1|STARTED|Study Period 1 (Induction)||3
8499022|NCT00509795|20944522|P4|NOT COMPLETED|Overall Study||27
8499023|NCT00509795|20944523|P3|NOT COMPLETED|Overall Study||27
8499024|NCT00509795|20944524|P2|NOT COMPLETED|Overall Study||11
8499025|NCT00509795|20944525|P1|NOT COMPLETED|Overall Study||22
8499026|NCT00509795|20944522|P4|COMPLETED|Overall Study||276
8499027|NCT00509795|20944523|P3|COMPLETED|Overall Study||277
8499028|NCT00509795|20944524|P2|COMPLETED|Overall Study||293
8499029|NCT00509795|20944525|P1|COMPLETED|Overall Study||284
8499030|NCT00509795|20944522|P4|Per Protocol Set (PPS) Population|Overall Study||265
8499031|NCT00509795|20944523|P3|Per Protocol Set (PPS) Population|Overall Study||270
8499032|NCT00509795|20944524|P2|Per Protocol Set (PPS) Population|Overall Study||285
8499033|NCT00509795|20944525|P1|Per Protocol Set (PPS) Population|Overall Study||269
8499034|NCT00509795|20944522|P4|Full Analysis Set (FAS) Population|Overall Study||301
8499035|NCT00509795|20944523|P3|Full Analysis Set (FAS) Population|Overall Study||301
8499036|NCT00509795|20944524|P2|Full Analysis Set (FAS) Population|Overall Study||304
8499037|NCT00509795|20944525|P1|Full Analysis Set (FAS) Population|Overall Study||304
8499038|NCT00509795|20944522|P4|Patients Received Treatment (SAF)|Overall Study||303
8499039|NCT00509795|20944523|P3|Patients Received Treatment (SAF)|Overall Study||304
8499040|NCT00509795|20944524|P2|Patients Received Treatment (SAF)|Overall Study||304
8499041|NCT00509795|20944525|P1|Patients Received Treatment (SAF)|Overall Study||304
8499042|NCT00509795|20944522|P4|STARTED|Overall Study||303
8499043|NCT00509795|20944523|P3|STARTED|Overall Study||304
8499044|NCT00509795|20944524|P2|STARTED|Overall Study||304
8499045|NCT00509795|20944525|P1|STARTED|Overall Study||306
8499046|NCT00509769|20944556|P1|NOT COMPLETED|Overall Study||91
8499047|NCT00509769|20944556|P1|COMPLETED|Overall Study||21
8499048|NCT00509769|20944556|P1|STARTED|Overall Study||112
8499049|NCT00509665|20944565|P1|NOT COMPLETED|Overall Study||0
8499050|NCT00509665|20944565|P1|COMPLETED|Overall Study||18
8499051|NCT00509665|20944565|P1|STARTED|Overall Study||18
8499052|NCT00509600|20944575|P1|NOT COMPLETED|Overall Study||1
8499053|NCT00509600|20944575|P1|COMPLETED|Overall Study||0
8499054|NCT00509600|20944575|P1|STARTED|Overall Study||1
8499055|NCT00509587|20944579|P1|NOT COMPLETED|Overall Study||0
8499056|NCT00509587|20944579|P1|COMPLETED|Overall Study||21
8499057|NCT00509587|20944579|P1|STARTED|Overall Study||21
8499058|NCT00509496|20944590|P2|NOT COMPLETED|Overall Study||0
8499059|NCT00509496|20944591|P1|NOT COMPLETED|Overall Study||0
8499060|NCT00509496|20944590|P2|COMPLETED|Overall Study||2
8499061|NCT00509496|20944591|P1|COMPLETED|Overall Study||19
8499062|NCT00509496|20944590|P2|STARTED|Overall Study||2
8499063|NCT00509496|20944591|P1|STARTED|Overall Study||19
8499064|NCT00509392|20944601|P3|NOT COMPLETED|Overall Study||0
8499065|NCT00509392|20944602|P2|NOT COMPLETED|Overall Study||0
8499066|NCT00509392|20944603|P1|NOT COMPLETED|Overall Study||0
8499067|NCT00509392|20944601|P3|COMPLETED|Overall Study||4
8499068|NCT00509392|20944602|P2|COMPLETED|Overall Study||33
8499069|NCT00509392|20944603|P1|COMPLETED|Overall Study||32
8499070|NCT00509392|20944601|P3|STARTED|Overall Study||4
8499071|NCT00509392|20944602|P2|STARTED|Overall Study||33
8499072|NCT00509392|20944603|P1|STARTED|Overall Study||32
8499073|NCT00509366|20944654|P5|NOT COMPLETED|Overall Study||0
8499074|NCT00509366|20944655|P4|NOT COMPLETED|Overall Study||0
8499075|NCT00509366|20944656|P3|NOT COMPLETED|Overall Study||1
8499076|NCT00509366|20944657|P2|NOT COMPLETED|Overall Study||1
8499077|NCT00509366|20944658|P1|NOT COMPLETED|Overall Study||1
8499078|NCT00509366|20944654|P5|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
8499079|NCT00509366|20944655|P4|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
8499080|NCT00509366|20944656|P3|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
8499081|NCT00509366|20944657|P2|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
8499082|NCT00509366|20944658|P1|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
8499083|NCT00509366|20944654|P5|Assigned Treatment|Overall Study||0
8499084|NCT00509366|20944655|P4|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
8499085|NCT00509366|20944656|P3|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
8499086|NCT00509366|20944657|P2|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
8499087|NCT00509366|20944658|P1|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
8499088|NCT00509366|20944654|P5|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
8499089|NCT00509366|20944655|P4|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
8499090|NCT00509366|20944656|P3|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
8499091|NCT00509366|20944657|P2|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
8499092|NCT00509366|20944658|P1|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
8499093|NCT00509288|20944671|P2|NOT COMPLETED|Overall Study||0
8499094|NCT00509288|20944672|P1|NOT COMPLETED|Overall Study||0
8499095|NCT00509288|20944671|P2|COMPLETED|Overall Study||3
8499096|NCT00509288|20944672|P1|COMPLETED|Overall Study||21
8499097|NCT00509288|20944671|P2|STARTED|Overall Study||3
8499098|NCT00509288|20944672|P1|STARTED|Overall Study||21
8499099|NCT00509262|20944682|P2|NOT COMPLETED|Overall Study||42
8499100|NCT00509262|20944683|P1|NOT COMPLETED|Overall Study||47
8499101|NCT00509262|20944682|P2|COMPLETED|Overall Study||170
8499102|NCT00509262|20944683|P1|COMPLETED|Overall Study||164
8499103|NCT00509262|20944682|P2|STARTED|Overall Study||212
8499104|NCT00509262|20944683|P1|STARTED|Overall Study||211
8499105|NCT00509249|20944695|P1|NOT COMPLETED|Overall Study||0
8499106|NCT00509249|20944695|P1|COMPLETED|Overall Study||18
8499107|NCT00509249|20944695|P1|STARTED|Overall Study||18
8499108|NCT00509236|20944701|P2|NOT COMPLETED|Overall Study||20
8499109|NCT00509236|20944702|P1|NOT COMPLETED|Overall Study||17
8499110|NCT00509236|20944701|P2|COMPLETED|Overall Study||45
8499111|NCT00509236|20944702|P1|COMPLETED|Overall Study||47
8499112|NCT00509236|20944701|P2|STARTED|Overall Study||65
8499113|NCT00509236|20944702|P1|STARTED|Overall Study||64
8499114|NCT00509223|20944717|P2|NOT COMPLETED|Overall Study||72
8499115|NCT00509223|20944718|P1|NOT COMPLETED|Overall Study||88
8499116|NCT00509223|20944717|P2|COMPLETED|Overall Study||137
8499117|NCT00509223|20944718|P1|COMPLETED|Overall Study||119
8499118|NCT00509223|20944717|P2|STARTED|Overall Study||209
8499119|NCT00509223|20944718|P1|STARTED|Overall Study||207
8499120|NCT00509197|20944726|P2|NOT COMPLETED|Overall Study||0
8499121|NCT00509197|20944727|P1|NOT COMPLETED|Overall Study||0
8499122|NCT00509197|20944726|P2|COMPLETED|Overall Study||6
8499123|NCT00509197|20944727|P1|COMPLETED|Overall Study||6
8499124|NCT00509197|20944726|P2|STARTED|Overall Study||6
8499125|NCT00509197|20944727|P1|STARTED|Overall Study||6
8499126|NCT00509171|20944741|P2|NOT COMPLETED|Overall Study||0
8499127|NCT00509171|20944742|P1|NOT COMPLETED|Overall Study||0
8499128|NCT00509171|20944741|P2|COMPLETED|Overall Study||11
8499129|NCT00509171|20944742|P1|COMPLETED|Overall Study||11
8499130|NCT00509171|20944741|P2|STARTED|Overall Study||11
8499131|NCT00509171|20944742|P1|STARTED|Overall Study||11
8499132|NCT00509106|20944750|P2|NOT COMPLETED|Overall Study||29
8499133|NCT00509106|20944751|P1|NOT COMPLETED|Overall Study||31
8499134|NCT00509106|20944750|P2|COMPLETED|Overall Study||278
8499135|NCT00509106|20944751|P1|COMPLETED|Overall Study||284
8499136|NCT00509106|20944750|P2|STARTED|Overall Study||307
8499137|NCT00509106|20944751|P1|STARTED|Overall Study||315
8499138|NCT00509093|20944757|P1|NOT COMPLETED|Overall Study||24
8499139|NCT00509093|20944757|P1|COMPLETED|Overall Study||8
8499140|NCT00509093|20944757|P1|STARTED|Overall Study||32
8499141|NCT00509067|20944767|P2|NOT COMPLETED|Overall Study||5
8499142|NCT00509067|20944768|P1|NOT COMPLETED|Overall Study||4
8499143|NCT00509067|20944767|P2|COMPLETED|Overall Study||19
8499144|NCT00509067|20944768|P1|COMPLETED|Overall Study||15
8499145|NCT00509067|20944767|P2|STARTED|Overall Study||24
8499146|NCT00509067|20944768|P1|STARTED|Overall Study||19
8499147|NCT00509041|20944778|P1|NOT COMPLETED|Overall Study||0
8499148|NCT00509041|20944778|P1|COMPLETED|Overall Study||43
8499149|NCT00509041|20944778|P1|STARTED|Overall Study||43
8499150|NCT00509028|20944787|P2|NOT COMPLETED|Overall Study||7
8499151|NCT00509028|20944788|P1|NOT COMPLETED|Overall Study||12
8499152|NCT00509028|20944787|P2|COMPLETED|Overall Study||113
8499153|NCT00509028|20944788|P1|COMPLETED|Overall Study||109
8499154|NCT00509028|20944787|P2|STARTED|Overall Study||120
8499155|NCT00509028|20944788|P1|STARTED|Overall Study||121
8499156|NCT00509002|20944820|P1|NOT COMPLETED|Overall Study||0
8499157|NCT00509002|20944820|P1|COMPLETED|Overall Study||37
8499158|NCT00509002|20944820|P1|STARTED|Overall Study||37
8499159|NCT00508924|20944828|P4|NOT COMPLETED|Overall Study||1
8499160|NCT00508924|20944829|P3|NOT COMPLETED|Overall Study||1
8499161|NCT00508924|20944830|P2|NOT COMPLETED|Overall Study||0
8499162|NCT00508924|20944831|P1|NOT COMPLETED|Overall Study||0
8499163|NCT00508924|20944828|P4|COMPLETED|Overall Study||33
8499164|NCT00508924|20944829|P3|COMPLETED|Overall Study||31
8499165|NCT00508924|20944830|P2|COMPLETED|Overall Study||38
8499166|NCT00508924|20944831|P1|COMPLETED|Overall Study||36
8499167|NCT00508924|20944828|P4|STARTED|Overall Study||34
8499168|NCT00508924|20944829|P3|STARTED|Overall Study||32
8499169|NCT00508924|20944830|P2|STARTED|Overall Study||38
8499170|NCT00508924|20944831|P1|STARTED|Overall Study||36
8499171|NCT00508872|20944845|P1|NOT COMPLETED|Overall Study||2
8499172|NCT00508872|20944845|P1|COMPLETED|Overall Study||0
8499173|NCT00508872|20944845|P1|STARTED|Overall Study||2
8499174|NCT00508820|20944851|P2|NOT COMPLETED|Overall Study||64
8499175|NCT00508820|20944852|P1|NOT COMPLETED|Overall Study||55
8499176|NCT00508820|20944851|P2|COMPLETED|Overall Study||175
8499177|NCT00508820|20944852|P1|COMPLETED|Overall Study||113
8499178|NCT00508820|20944851|P2|STARTED|Overall Study||239
8499179|NCT00508820|20944852|P1|STARTED|Overall Study||168
8499180|NCT00508755|20944862|P1|NOT COMPLETED|Overall Study||1
8499181|NCT00508755|20944862|P1|COMPLETED|Overall Study||5
8499182|NCT00508755|20944862|P1|STARTED|Overall Study||6
8499183|NCT00508742|20944870|P2|NOT COMPLETED|Period 3: Toddler Dose||15
8499184|NCT00508742|20944871|P1|NOT COMPLETED|Period 3: Toddler Dose||25
8499185|NCT00508742|20944870|P2|COMPLETED|Period 3: Toddler Dose||863
8499186|NCT00508742|20944871|P1|COMPLETED|Period 3: Toddler Dose||858
8499187|NCT00508742|20944870|P2|STARTED|Period 3: Toddler Dose||878
8499188|NCT00508742|20944871|P1|STARTED|Period 3: Toddler Dose||883
8499189|NCT00508742|20944870|P2|NOT COMPLETED|Period 2: After Infant Series||11
8499190|NCT00508742|20944871|P1|NOT COMPLETED|Period 2: After Infant Series||7
8499191|NCT00508742|20944870|P2|COMPLETED|Period 2: After Infant Series||878
8499192|NCT00508742|20944871|P1|COMPLETED|Period 2: After Infant Series||883
8499193|NCT00508742|20944870|P2|STARTED|Period 2: After Infant Series||889
8499194|NCT00508742|20944871|P1|STARTED|Period 2: After Infant Series||890
8499195|NCT00508742|20944870|P2|NOT COMPLETED|Period 1: Infant Series||45
8499196|NCT00508742|20944871|P1|NOT COMPLETED|Period 1: Infant Series||42
8499197|NCT00508742|20944870|P2|COMPLETED|Period 1: Infant Series||889
8499198|NCT00508742|20944871|P1|COMPLETED|Period 1: Infant Series||890
8499199|NCT00508742|20944870|P2|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
8499288|NCT00508261|20945086|P3|STARTED|Overall Study||224
8499200|NCT00508742|20944871|P1|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
8499201|NCT00508742|20944870|P2|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
8499202|NCT00508742|20944871|P1|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
8499203|NCT00508742|20944870|P2|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
8499204|NCT00508742|20944871|P1|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
8499205|NCT00508742|20944870|P2|STARTED|Period 1: Infant Series||934
8499206|NCT00508742|20944871|P1|STARTED|Period 1: Infant Series||932
8499207|NCT00508716|20944887|P2|NOT COMPLETED|Overall Study||0
8499208|NCT00508716|20944888|P1|NOT COMPLETED|Overall Study||0
8499209|NCT00508716|20944887|P2|COMPLETED|Overall Study||63
8499210|NCT00508716|20944888|P1|COMPLETED|Overall Study||61
8499211|NCT00508716|20944887|P2|STARTED|Overall Study||63
8499212|NCT00508716|20944888|P1|STARTED|Overall Study||61
8499213|NCT00508651|20944896|P2|NOT COMPLETED|Overall Study||2
8499214|NCT00508651|20944897|P1|NOT COMPLETED|Overall Study||4
8499215|NCT00508651|20944896|P2|COMPLETED|Overall Study||8
8499216|NCT00508651|20944897|P1|COMPLETED|Overall Study||16
8499217|NCT00508651|20944896|P2|STARTED|Overall Study||10
8499218|NCT00508651|20944897|P1|STARTED|Overall Study||20
8499219|NCT00508521|20944971|P1|NOT COMPLETED|Overall Study||0
8499220|NCT00508521|20944971|P1|COMPLETED|Overall Study||4
8499221|NCT00508521|20944971|P1|STARTED|Overall Study||4
8499222|NCT00508482|20944978|P3|NOT COMPLETED|at the 12th Week of Follow-up||0
8499223|NCT00508482|20944979|P2|NOT COMPLETED|at the 12th Week of Follow-up||0
8499224|NCT00508482|20944980|P1|NOT COMPLETED|at the 12th Week of Follow-up||0
8499225|NCT00508482|20944978|P3|COMPLETED|at the 12th Week of Follow-up||98
8499226|NCT00508482|20944979|P2|COMPLETED|at the 12th Week of Follow-up||96
8499227|NCT00508482|20944980|P1|COMPLETED|at the 12th Week of Follow-up||196
8499228|NCT00508482|20944978|P3|STARTED|at the 12th Week of Follow-up||98
8499229|NCT00508482|20944979|P2|STARTED|at the 12th Week of Follow-up||96
8499230|NCT00508482|20944980|P1|STARTED|at the 12th Week of Follow-up||196
8499231|NCT00508482|20944978|P3|NOT COMPLETED|at the 4th Week of Follow-up||1
8499232|NCT00508482|20944979|P2|NOT COMPLETED|at the 4th Week of Follow-up||6
8499233|NCT00508482|20944980|P1|NOT COMPLETED|at the 4th Week of Follow-up||20
8499234|NCT00508482|20944978|P3|COMPLETED|at the 4th Week of Follow-up||98
8499235|NCT00508482|20944979|P2|COMPLETED|at the 4th Week of Follow-up||96
8499236|NCT00508482|20944980|P1|COMPLETED|at the 4th Week of Follow-up||196
8499237|NCT00508482|20944978|P3|STARTED|at the 4th Week of Follow-up||99
8499238|NCT00508482|20944979|P2|STARTED|at the 4th Week of Follow-up||102
8499239|NCT00508482|20944980|P1|STARTED|at the 4th Week of Follow-up||216
8499240|NCT00508482|20944978|P3|NOT COMPLETED|Over 4 Weeks of Treatment||20
8499241|NCT00508482|20944979|P2|NOT COMPLETED|Over 4 Weeks of Treatment||17
8499242|NCT00508482|20944980|P1|NOT COMPLETED|Over 4 Weeks of Treatment||21
8499243|NCT00508482|20944978|P3|COMPLETED|Over 4 Weeks of Treatment||99
8499244|NCT00508482|20944979|P2|COMPLETED|Over 4 Weeks of Treatment||102
8499245|NCT00508482|20944980|P1|COMPLETED|Over 4 Weeks of Treatment||216
8499246|NCT00508482|20944978|P3|STARTED|Over 4 Weeks of Treatment||119
8499247|NCT00508482|20944979|P2|STARTED|Over 4 Weeks of Treatment||119
8499248|NCT00508482|20944980|P1|STARTED|Over 4 Weeks of Treatment||237
8499249|NCT00508469|20945017|P2|NOT COMPLETED|Overall Study||10
8499250|NCT00508469|20945018|P1|NOT COMPLETED|Overall Study||17
8499251|NCT00508469|20945017|P2|COMPLETED|Overall Study||40
8499252|NCT00508469|20945018|P1|COMPLETED|Overall Study||35
8499253|NCT00508469|20945017|P2|STARTED|Overall Study||50
8499254|NCT00508469|20945018|P1|STARTED|Overall Study||52
8499255|NCT00508404|20945024|P1|NOT COMPLETED|Overall Study||42
8499256|NCT00508404|20945024|P1|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
8499257|NCT00508404|20945024|P1|STARTED|Overall Study||154
8499258|NCT00508391|20945051|P2|NOT COMPLETED|Second Treatment||0
8499259|NCT00508391|20945052|P1|NOT COMPLETED|Second Treatment||2
8499260|NCT00508391|20945051|P2|COMPLETED|Second Treatment||59
8499261|NCT00508391|20945052|P1|COMPLETED|Second Treatment||52
8499262|NCT00508391|20945051|P2|STARTED|Second Treatment||59
8499263|NCT00508391|20945052|P1|STARTED|Second Treatment||54
8499264|NCT00508391|20945051|P2|NOT COMPLETED|First Treatment||3
8499265|NCT00508391|20945052|P1|NOT COMPLETED|First Treatment||6
8499266|NCT00508391|20945051|P2|COMPLETED|First Treatment||59
8499267|NCT00508391|20945052|P1|COMPLETED|First Treatment||54
8499268|NCT00508391|20945051|P2|STARTED|First Treatment||62
8499269|NCT00508391|20945052|P1|STARTED|First Treatment||60
8499270|NCT00508300|20945065|P2|NOT COMPLETED|Overall Study||4
8499271|NCT00508300|20945066|P1|NOT COMPLETED|Overall Study||2
8499272|NCT00508300|20945065|P2|COMPLETED|Overall Study||57
8499273|NCT00508300|20945066|P1|COMPLETED|Overall Study||65
8499274|NCT00508300|20945065|P2|STARTED|Overall Study||61
8499275|NCT00508300|20945066|P1|STARTED|Overall Study||67
8499279|NCT00508261|20945085|P4|NOT COMPLETED|Overall Study||1
8499280|NCT00508261|20945086|P3|NOT COMPLETED|Overall Study||6
8499281|NCT00508261|20945087|P2|NOT COMPLETED|Overall Study||8
8499282|NCT00508261|20945088|P1|NOT COMPLETED|Overall Study||3
8499283|NCT00508261|20945085|P4|COMPLETED|Overall Study||126
8499284|NCT00508261|20945086|P3|COMPLETED|Overall Study||218
8499285|NCT00508261|20945087|P2|COMPLETED|Overall Study||212
8499286|NCT00508261|20945088|P1|COMPLETED|Overall Study||219
8499287|NCT00508261|20945085|P4|STARTED|Overall Study||127
8499289|NCT00508261|20945087|P2|STARTED|Overall Study||220
8499290|NCT00508261|20945088|P1|STARTED|Overall Study||222
8499291|NCT00508196|20945198|P2|NOT COMPLETED|Overall Study||0
8499292|NCT00508196|20945199|P1|NOT COMPLETED|Overall Study||0
8499293|NCT00508196|20945198|P2|COMPLETED|Overall Study||11
8499294|NCT00508196|20945199|P1|COMPLETED|Overall Study||11
8499295|NCT00508196|20945198|P2|STARTED|Overall Study||11
8499296|NCT00508196|20945199|P1|STARTED|Overall Study||11
8499297|NCT00508183|20945211|P2|NOT COMPLETED|Overall Study||8
8499298|NCT00508183|20945212|P1|NOT COMPLETED|Overall Study||9
8499299|NCT00508183|20945211|P2|COMPLETED|Overall Study||34
8499300|NCT00508183|20945212|P1|COMPLETED|Overall Study||39
8499301|NCT00508183|20945211|P2|STARTED|Overall Study||42
8499302|NCT00508183|20945212|P1|STARTED|Overall Study||48
8499303|NCT00508157|20945228|P2|NOT COMPLETED|Overall Study||3
8499304|NCT00508157|20945229|P1|NOT COMPLETED|Overall Study||2
8499305|NCT00508157|20945228|P2|COMPLETED|Overall Study||23
8499306|NCT00508157|20945229|P1|COMPLETED|Overall Study||24
8499307|NCT00508157|20945228|P2|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
8499308|NCT00508157|20945229|P1|Safety Sample|Overall Study||26
8499309|NCT00508157|20945228|P2|Randomized Sample|Overall Study||26
8499310|NCT00508157|20945229|P1|Randomized Sample|Overall Study||26
8499311|NCT00508157|20945228|P2|STARTED|Overall Study||26
8499312|NCT00508157|20945229|P1|STARTED|Overall Study||26
8499313|NCT00508144|20945251|P1|NOT COMPLETED|Overall Study||11
8499314|NCT00508144|20945251|P1|COMPLETED|Overall Study||53
8499315|NCT00508144|20945251|P1|STARTED|Overall Study||64
8499316|NCT00508118|20945257|P2|NOT COMPLETED|Overall Study||0
8499317|NCT00508118|20945258|P1|NOT COMPLETED|Overall Study||0
8499318|NCT00508118|20945257|P2|COMPLETED|Overall Study||4
8499319|NCT00508118|20945258|P1|COMPLETED|Overall Study||3
8499320|NCT00508118|20945257|P2|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
8499321|NCT00508118|20945258|P1|STARTED|Overall Study||3
8499322|NCT00508105|20945279|P2|NOT COMPLETED|Overall Study||6
8499323|NCT00508105|20945280|P1|NOT COMPLETED|Overall Study||4
8499324|NCT00508105|20945279|P2|COMPLETED|Overall Study||37
8499325|NCT00508105|20945280|P1|COMPLETED|Overall Study||40
8499326|NCT00508105|20945279|P2|STARTED|Overall Study||43
8499327|NCT00508105|20945280|P1|STARTED|Overall Study||44
8499328|NCT00508027|20945290|P1|NOT COMPLETED|Dose Level 3||0
8499329|NCT00508027|20945290|P1|COMPLETED|Dose Level 3||2
8499330|NCT00508027|20945290|P1|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
8499331|NCT00508027|20945290|P1|NOT COMPLETED|Dose Level 2||4
8499332|NCT00508027|20945290|P1|COMPLETED|Dose Level 2||16
8499333|NCT00508027|20945290|P1|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
8499334|NCT00508027|20945290|P1|NOT COMPLETED|Dose Level 1||8
8499335|NCT00508027|20945290|P1|COMPLETED|Dose Level 1||12
8499336|NCT00508027|20945290|P1|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
8499337|NCT00508001|20945331|P3|NOT COMPLETED|Overall Study||7
8499338|NCT00508001|20945332|P2|NOT COMPLETED|Overall Study||12
8499339|NCT00508001|20945333|P1|NOT COMPLETED|Overall Study||19
8499340|NCT00508001|20945331|P3|COMPLETED|Overall Study||16
8499341|NCT00508001|20945332|P2|COMPLETED|Overall Study||13
8499342|NCT00508001|20945333|P1|COMPLETED|Overall Study||0
8499343|NCT00508001|20945331|P3|Secondary Treatment Phase|Overall Study||16
8499344|NCT00508001|20945332|P2|Secondary Treatment Phase|Overall Study||13
8499345|NCT00508001|20945333|P1|Secondary Treatment Phase|Overall Study||0
8499346|NCT00508001|20945331|P3|STARTED|Overall Study||23
8499347|NCT00508001|20945332|P2|STARTED|Overall Study||25
8499348|NCT00508001|20945333|P1|STARTED|Overall Study||19
8499349|NCT00507819|20945350|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8499350|NCT00507819|20945351|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8499351|NCT00507819|20945350|P2|COMPLETED|Second Intervention (6 Weeks)||14
8499352|NCT00507819|20945351|P1|COMPLETED|Second Intervention (6 Weeks)||13
8499353|NCT00507819|20945350|P2|STARTED|Second Intervention (6 Weeks)||14
8499354|NCT00507819|20945351|P1|STARTED|Second Intervention (6 Weeks)||13
8499355|NCT00507819|20945350|P2|NOT COMPLETED|Washout (6 Weeks)||0
8499356|NCT00507819|20945351|P1|NOT COMPLETED|Washout (6 Weeks)||1
8499357|NCT00507819|20945350|P2|COMPLETED|Washout (6 Weeks)||14
8499358|NCT00507819|20945351|P1|COMPLETED|Washout (6 Weeks)||13
8499359|NCT00507819|20945350|P2|STARTED|Washout (6 Weeks)||14
8499360|NCT00507819|20945351|P1|STARTED|Washout (6 Weeks)||14
8499361|NCT00507819|20945350|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
8499362|NCT00507819|20945351|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
8499363|NCT00507819|20945350|P2|COMPLETED|First Intervention (6 Weeks)||14
8499364|NCT00507819|20945351|P1|COMPLETED|First Intervention (6 Weeks)||14
8499365|NCT00507819|20945350|P2|STARTED|First Intervention (6 Weeks)||14
8499366|NCT00507819|20945351|P1|STARTED|First Intervention (6 Weeks)||14
8499367|NCT00507767|20945363|P1|NOT COMPLETED|Overall Study||0
8499368|NCT00507767|20945363|P1|COMPLETED|Overall Study||15
8499369|NCT00507767|20945363|P1|STARTED|Overall Study||15
8499370|NCT00507689|20945370|P2|NOT COMPLETED|Randomized Period||2
8499371|NCT00507689|20945371|P1|NOT COMPLETED|Randomized Period||1
8499372|NCT00507689|20945370|P2|COMPLETED|Randomized Period||16
8499373|NCT00507689|20945371|P1|COMPLETED|Randomized Period||18
8499374|NCT00507689|20945370|P2|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
8499553|NCT00506454|20945840|P2|COMPLETED|Overall Study||10
8499375|NCT00507689|20945371|P1|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
8499376|NCT00507689|20945370|P2|NOT COMPLETED|Pre-Randomization Period||0
8499377|NCT00507689|20945371|P1|NOT COMPLETED|Pre-Randomization Period||3
8499378|NCT00507689|20945370|P2|COMPLETED|Pre-Randomization Period||0
8499379|NCT00507689|20945371|P1|COMPLETED|Pre-Randomization Period||37
8499380|NCT00507689|20945370|P2|STARTED|Pre-Randomization Period||0
8499381|NCT00507689|20945371|P1|STARTED|Pre-Randomization Period||40
8499382|NCT00507559|20945388|P1|NOT COMPLETED|Overall Study||71
8499383|NCT00507559|20945388|P1|COMPLETED|Overall Study||84
8499384|NCT00507559|20945388|P1|STARTED|Overall Study||155
8499385|NCT00507546|20945403|P2|NOT COMPLETED|Overall Study||1
8499386|NCT00507546|20945404|P1|NOT COMPLETED|Overall Study||2
8499387|NCT00507546|20945403|P2|COMPLETED|Overall Study||3
8499388|NCT00507546|20945404|P1|COMPLETED|Overall Study||2
8499389|NCT00507546|20945403|P2|STARTED|Overall Study||4
8499390|NCT00507546|20945404|P1|STARTED|Overall Study||4
8499391|NCT00507507|20945414|P2|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
8499392|NCT00507507|20945415|P1|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
8499393|NCT00507507|20945414|P2|COMPLETED|24-week Treatment-free Follow-up Period||12
8499394|NCT00507507|20945415|P1|COMPLETED|24-week Treatment-free Follow-up Period||16
8499395|NCT00507507|20945414|P2|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
8499396|NCT00507507|20945415|P1|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
8499397|NCT00507507|20945414|P2|NOT COMPLETED|Treatment Period||53
8499398|NCT00507507|20945415|P1|NOT COMPLETED|Treatment Period||52
8499399|NCT00507507|20945414|P2|COMPLETED|Treatment Period||9
8499400|NCT00507507|20945415|P1|COMPLETED|Treatment Period||12
8499401|NCT00507507|20945414|P2|Completed 192 Weeks of Treatment|Treatment Period||52
8499402|NCT00507507|20945415|P1|Completed 192 Weeks of Treatment|Treatment Period||52
8499403|NCT00507507|20945414|P2|STARTED|Treatment Period||62
8499404|NCT00507507|20945415|P1|STARTED|Treatment Period||64
8499405|NCT00507455|20945450|P3|NOT COMPLETED|Overall Study||12
8499406|NCT00507455|20945451|P2|NOT COMPLETED|Overall Study||6
8499407|NCT00507455|20945452|P1|NOT COMPLETED|Overall Study||12
8499408|NCT00507455|20945450|P3|COMPLETED|Overall Study||62
8499409|NCT00507455|20945451|P2|COMPLETED|Overall Study||68
8499410|NCT00507455|20945452|P1|COMPLETED|Overall Study||62
8499411|NCT00507455|20945450|P3|STARTED|Overall Study||74
8499412|NCT00507455|20945451|P2|STARTED|Overall Study||74
8499413|NCT00507455|20945452|P1|STARTED|Overall Study||74
8499414|NCT00507442|20945515|P4|NOT COMPLETED|Overall Study||5
8499415|NCT00507442|20945516|P3|NOT COMPLETED|Overall Study||15
8499416|NCT00507442|20945517|P2|NOT COMPLETED|Overall Study||27
8499417|NCT00507442|20945518|P1|NOT COMPLETED|Overall Study||16
8499418|NCT00507442|20945515|P4|COMPLETED|Overall Study||12
8499419|NCT00507442|20945516|P3|COMPLETED|Overall Study||18
8499420|NCT00507442|20945517|P2|COMPLETED|Overall Study||39
8499421|NCT00507442|20945518|P1|COMPLETED|Overall Study||26
8499422|NCT00507442|20945515|P4|STARTED|Overall Study||17
8499423|NCT00507442|20945516|P3|STARTED|Overall Study||33
8499424|NCT00507442|20945517|P2|STARTED|Overall Study||66
8499425|NCT00507442|20945518|P1|STARTED|Overall Study||42
8499426|NCT00507429|20945570|P2|NOT COMPLETED|Maintenance Phase||0
8499427|NCT00507429|20945571|P1|NOT COMPLETED|Maintenance Phase||14
8499428|NCT00507429|20945570|P2|COMPLETED|Maintenance Phase||0
8499429|NCT00507429|20945571|P1|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
8499430|NCT00507429|20945570|P2|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
8499431|NCT00507429|20945571|P1|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
8499432|NCT00507429|20945570|P2|NOT COMPLETED|Treatment Phase||18
8499433|NCT00507429|20945571|P1|NOT COMPLETED|Treatment Phase||37
8499434|NCT00507429|20945570|P2|COMPLETED|Treatment Phase||7
8499435|NCT00507429|20945571|P1|COMPLETED|Treatment Phase||18
8499436|NCT00507429|20945570|P2|STARTED|Treatment Phase|Randomized|25
8499437|NCT00507429|20945571|P1|STARTED|Treatment Phase|Randomized|55
8499438|NCT00507416|20945582|P3|NOT COMPLETED|Overall Study||114
8499439|NCT00507416|20945583|P2|NOT COMPLETED|Overall Study||125
8499440|NCT00507416|20945584|P1|NOT COMPLETED|Overall Study||118
8499441|NCT00507416|20945582|P3|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
8499442|NCT00507416|20945583|P2|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
8499443|NCT00507416|20945584|P1|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
8499444|NCT00507416|20945582|P3|Completed 8 Treatment Cycles|Overall Study||69
8499445|NCT00507416|20945583|P2|Completed 8 Treatment Cycles|Overall Study||60
8499446|NCT00507416|20945584|P1|Completed 8 Treatment Cycles|Overall Study||82
8499447|NCT00507416|20945582|P3|Treated (Safety Population)|Overall Study||163
8499448|NCT00507416|20945583|P2|Treated (Safety Population)|Overall Study||158
8499449|NCT00507416|20945584|P1|Treated (Safety Population)|Overall Study||165
8499450|NCT00507416|20945582|P3|STARTED|Overall Study||167
8499451|NCT00507416|20945583|P2|STARTED|Overall Study||167
8499452|NCT00507416|20945584|P1|STARTED|Overall Study||168
8499453|NCT00507208|20945615|P2|NOT COMPLETED|Overall Study||0
8499454|NCT00507208|20945616|P1|NOT COMPLETED|Overall Study||0
8499455|NCT00507208|20945615|P2|COMPLETED|Overall Study||26
8499456|NCT00507208|20945616|P1|COMPLETED|Overall Study||27
8499457|NCT00507208|20945615|P2|Received Dynasplint in Crossover|Overall Study||3
8499458|NCT00507208|20945616|P1|Received Dynasplint in Crossover|Overall Study||0
8499459|NCT00507208|20945615|P2|STARTED|Overall Study||26
8499460|NCT00507208|20945616|P1|STARTED|Overall Study||27
8499461|NCT00507130|20945626|P4|NOT COMPLETED|Overall Study||1
8499462|NCT00507130|20945627|P3|NOT COMPLETED|Overall Study||1
8499463|NCT00507130|20945628|P2|NOT COMPLETED|Overall Study||0
8499464|NCT00507130|20945629|P1|NOT COMPLETED|Overall Study||1
8499465|NCT00507130|20945626|P4|COMPLETED|Overall Study||8
8499466|NCT00507130|20945627|P3|COMPLETED|Overall Study||8
8499467|NCT00507130|20945628|P2|COMPLETED|Overall Study||9
8499468|NCT00507130|20945629|P1|COMPLETED|Overall Study||8
8499469|NCT00507130|20945626|P4|STARTED|Overall Study||9
8499470|NCT00507130|20945627|P3|STARTED|Overall Study||9
8499471|NCT00507130|20945628|P2|STARTED|Overall Study||9
8499472|NCT00507130|20945629|P1|STARTED|Overall Study||9
8499473|NCT00506948|20945671|P1|NOT COMPLETED|Overall Study||10
8499474|NCT00506948|20945671|P1|COMPLETED|Overall Study||0
8499475|NCT00506948|20945671|P1|STARTED|Overall Study||10
8499476|NCT00506922|20945680|P5|NOT COMPLETED|Overall Study||1
8499477|NCT00506922|20945681|P4|NOT COMPLETED|Overall Study||2
8499478|NCT00506922|20945682|P3|NOT COMPLETED|Overall Study||0
8499479|NCT00506922|20945683|P2|NOT COMPLETED|Overall Study||0
8499480|NCT00506922|20945684|P1|NOT COMPLETED|Overall Study||0
8499481|NCT00506922|20945680|P5|COMPLETED|Overall Study||10
8499482|NCT00506922|20945681|P4|COMPLETED|Overall Study||61
8499483|NCT00506922|20945682|P3|COMPLETED|Overall Study||29
8499484|NCT00506922|20945683|P2|COMPLETED|Overall Study||10
8499485|NCT00506922|20945684|P1|COMPLETED|Overall Study||37
8499486|NCT00506922|20945680|P5|STARTED|Overall Study||11
8499487|NCT00506922|20945681|P4|STARTED|Overall Study||63
8499488|NCT00506922|20945682|P3|STARTED|Overall Study||29
8499489|NCT00506922|20945683|P2|STARTED|Overall Study||10
8499490|NCT00506922|20945684|P1|STARTED|Overall Study||37
8499491|NCT00506909|20945692|P1|NOT COMPLETED|Overall Study||0
8499492|NCT00506909|20945692|P1|COMPLETED|Overall Study||0
8499493|NCT00506909|20945692|P1|STARTED|Overall Study||0
8499494|NCT00506883|20945711|P3|NOT COMPLETED|Overall Study||4
8499495|NCT00506883|20945712|P2|NOT COMPLETED|Overall Study||3
8499496|NCT00506883|20945713|P1|NOT COMPLETED|Overall Study||7
8499497|NCT00506883|20945711|P3|COMPLETED|Overall Study||55
8499498|NCT00506883|20945712|P2|COMPLETED|Overall Study||71
8499499|NCT00506883|20945713|P1|COMPLETED|Overall Study||45
8499500|NCT00506883|20945711|P3|STARTED|Overall Study||59
8499501|NCT00506883|20945712|P2|STARTED|Overall Study||74
8499502|NCT00506883|20945713|P1|STARTED|Overall Study||52
8499503|NCT00506857|20945721|P1|NOT COMPLETED|Overall Study||0
8499504|NCT00506857|20945721|P1|COMPLETED|Overall Study||80
8499505|NCT00506857|20945721|P1|STARTED|Overall Study||80
8499506|NCT00506831|20945726|P1|NOT COMPLETED|Overall Study||2
8499507|NCT00506831|20945726|P1|COMPLETED|Overall Study||7
8499508|NCT00506831|20945726|P1|STARTED|Overall Study||9
8499509|NCT00506779|20945739|P4|NOT COMPLETED|Overall Study||1
8499510|NCT00506779|20945740|P3|NOT COMPLETED|Overall Study||2
8499511|NCT00506779|20945741|P2|NOT COMPLETED|Overall Study||1
8499512|NCT00506779|20945742|P1|NOT COMPLETED|Overall Study||1
8499513|NCT00506779|20945739|P4|COMPLETED|Overall Study||4
8499514|NCT00506779|20945740|P3|COMPLETED|Overall Study||0
8499515|NCT00506779|20945741|P2|COMPLETED|Overall Study||5
8499516|NCT00506779|20945742|P1|COMPLETED|Overall Study||3
8499517|NCT00506779|20945739|P4|STARTED|Overall Study||5
8499518|NCT00506779|20945740|P3|STARTED|Overall Study||2
8499519|NCT00506779|20945741|P2|STARTED|Overall Study||6
8499520|NCT00506779|20945742|P1|STARTED|Overall Study||4
8499521|NCT00506753|20945757|P2|NOT COMPLETED|Overall Study||15
8499522|NCT00506753|20945758|P1|NOT COMPLETED|Overall Study||21
8499523|NCT00506753|20945757|P2|COMPLETED|Overall Study||84
8499524|NCT00506753|20945758|P1|COMPLETED|Overall Study||79
8499525|NCT00506753|20945757|P2|STARTED|Overall Study||99
8499526|NCT00506753|20945758|P1|STARTED|Overall Study||100
8499527|NCT00506714|20945770|P2|NOT COMPLETED|Overall Study||0
8499528|NCT00506714|20945771|P1|NOT COMPLETED|Overall Study||0
8499529|NCT00506714|20945770|P2|COMPLETED|Overall Study||13
8499530|NCT00506714|20945771|P1|COMPLETED|Overall Study||13
8499531|NCT00506714|20945770|P2|STARTED|Overall Study||13
8499532|NCT00506714|20945771|P1|STARTED|Overall Study||13
8499533|NCT00506675|20945781|P2|NOT COMPLETED|Overall Study||0
8499534|NCT00506675|20945782|P1|NOT COMPLETED|Overall Study||0
8499535|NCT00506675|20945781|P2|COMPLETED|Overall Study||28
8499536|NCT00506675|20945782|P1|COMPLETED|Overall Study||27
8499537|NCT00506675|20945781|P2|STARTED|Overall Study||28
8499538|NCT00506675|20945782|P1|STARTED|Overall Study||27
8499539|NCT00506662|20945796|P2|NOT COMPLETED|Overall Study||28
8499540|NCT00506662|20945797|P1|NOT COMPLETED|Overall Study||17
8499541|NCT00506662|20945796|P2|COMPLETED|Overall Study||20
8499542|NCT00506662|20945797|P1|COMPLETED|Overall Study||21
8499543|NCT00506662|20945796|P2|STARTED|Overall Study||48
8499544|NCT00506662|20945797|P1|STARTED|Overall Study||38
8499545|NCT00506597|20945827|P1|NOT COMPLETED|Overall Study||0
8499546|NCT00506597|20945827|P1|COMPLETED|Overall Study||33
8499547|NCT00506597|20945827|P1|STARTED|Overall Study||33
8499548|NCT00506493|20945831|P1|NOT COMPLETED|Overall Study||11
8499549|NCT00506493|20945831|P1|COMPLETED|Overall Study||64
8499550|NCT00506493|20945831|P1|STARTED|Overall Study||75
8499551|NCT00506454|20945840|P2|NOT COMPLETED|Overall Study||1
8499552|NCT00506454|20945841|P1|NOT COMPLETED|Overall Study||1
8499554|NCT00506454|20945841|P1|COMPLETED|Overall Study||10
8499555|NCT00506454|20945840|P2|STARTED|Overall Study||11
8499556|NCT00506454|20945841|P1|STARTED|Overall Study||11
8499557|NCT00506441|20945847|P2|NOT COMPLETED|Period 2; Double-blind Period||5
8499558|NCT00506441|20945848|P1|NOT COMPLETED|Period 2; Double-blind Period||3
8499559|NCT00506441|20945847|P2|COMPLETED|Period 2; Double-blind Period||79
8499560|NCT00506441|20945848|P1|COMPLETED|Period 2; Double-blind Period||82
8499561|NCT00506441|20945847|P2|STARTED|Period 2; Double-blind Period||84
8499562|NCT00506441|20945848|P1|STARTED|Period 2; Double-blind Period||85
8499563|NCT00506441|20945847|P2|NOT COMPLETED|Period 1; Open-label Period||0
8499564|NCT00506441|20945848|P1|NOT COMPLETED|Period 1; Open-label Period||76
8499565|NCT00506441|20945847|P2|COMPLETED|Period 1; Open-label Period||0
8499566|NCT00506441|20945848|P1|COMPLETED|Period 1; Open-label Period||169
8499567|NCT00506441|20945847|P2|STARTED|Period 1; Open-label Period||0
8499568|NCT00506441|20945848|P1|STARTED|Period 1; Open-label Period||245
8499569|NCT00506415|20945856|P4|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
8499570|NCT00506415|20945857|P3|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8499571|NCT00506415|20945858|P2|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8499572|NCT00506415|20945859|P1|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8499573|NCT00506415|20945856|P4|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
8499574|NCT00506415|20945857|P3|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8499575|NCT00506415|20945858|P2|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8499576|NCT00506415|20945859|P1|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
8499577|NCT00506415|20945856|P4|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
8499578|NCT00506415|20945857|P3|STARTED|Extended Open Label (Maximum 48 Weeks)||0
8499579|NCT00506415|20945858|P2|STARTED|Extended Open Label (Maximum 48 Weeks)||0
8499580|NCT00506415|20945859|P1|STARTED|Extended Open Label (Maximum 48 Weeks)||0
8499581|NCT00506415|20945856|P4|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
8499582|NCT00506415|20945857|P3|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
8499583|NCT00506415|20945858|P2|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
8499584|NCT00506415|20945859|P1|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
8499585|NCT00506415|20945856|P4|COMPLETED|Double Blind (Maximum 48 Weeks )||0
8499586|NCT00506415|20945857|P3|COMPLETED|Double Blind (Maximum 48 Weeks )||207
8499587|NCT00506415|20945858|P2|COMPLETED|Double Blind (Maximum 48 Weeks )||203
8499588|NCT00506415|20945859|P1|COMPLETED|Double Blind (Maximum 48 Weeks )||0
8499589|NCT00506415|20945856|P4|STARTED|Double Blind (Maximum 48 Weeks )||0
8499590|NCT00506415|20945857|P3|STARTED|Double Blind (Maximum 48 Weeks )||280
8499591|NCT00506415|20945858|P2|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
8499592|NCT00506415|20945859|P1|STARTED|Double Blind (Maximum 48 Weeks )||0
8499593|NCT00506415|20945856|P4|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8499594|NCT00506415|20945857|P3|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8499595|NCT00506415|20945858|P2|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8499596|NCT00506415|20945859|P1|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
8499597|NCT00506415|20945856|P4|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8499598|NCT00506415|20945857|P3|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8499599|NCT00506415|20945858|P2|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
8499600|NCT00506415|20945859|P1|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
8499601|NCT00506415|20945856|P4|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
8499602|NCT00506415|20945857|P3|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
8499603|NCT00506415|20945858|P2|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
8499604|NCT00506415|20945859|P1|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
8499605|NCT00506415|20945856|P4|STARTED|Initial Open Label (Maximum 48 Weeks)||0
8499606|NCT00506415|20945857|P3|STARTED|Initial Open Label (Maximum 48 Weeks)||0
8499607|NCT00506415|20945858|P2|STARTED|Initial Open Label (Maximum 48 Weeks)||0
8499608|NCT00506415|20945859|P1|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
8499609|NCT00506389|20945884|P3|NOT COMPLETED|Follow-up Period||0
8499610|NCT00506389|20945885|P2|NOT COMPLETED|Follow-up Period||0
8499611|NCT00506389|20945886|P1|NOT COMPLETED|Follow-up Period||0
8499612|NCT00506389|20945884|P3|COMPLETED|Follow-up Period||136
8499613|NCT00506389|20945885|P2|COMPLETED|Follow-up Period||138
8499614|NCT00506389|20945886|P1|COMPLETED|Follow-up Period||139
8499615|NCT00506389|20945884|P3|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
8499616|NCT00506389|20945885|P2|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
8499617|NCT00506389|20945886|P1|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
8499618|NCT00506389|20945884|P3|NOT COMPLETED|In-treatment Period||12
8499619|NCT00506389|20945885|P2|NOT COMPLETED|In-treatment Period||15
8499620|NCT00506389|20945886|P1|NOT COMPLETED|In-treatment Period||26
8499621|NCT00506389|20945884|P3|COMPLETED|In-treatment Period||125
8499622|NCT00506389|20945885|P2|COMPLETED|In-treatment Period||124
8499623|NCT00506389|20945886|P1|COMPLETED|In-treatment Period||117
8499624|NCT00506389|20945884|P3|All Participants Treated|In-treatment Period||136
8499625|NCT00506389|20945885|P2|All Participants Treated|In-treatment Period||138
8499626|NCT00506389|20945886|P1|All Participants Treated|In-treatment Period||139
8499627|NCT00506389|20945884|P3|STARTED|In-treatment Period||137
8499628|NCT00506389|20945885|P2|STARTED|In-treatment Period||139
8499629|NCT00506389|20945886|P1|STARTED|In-treatment Period||143
8499630|NCT00506350|20945912|P9|NOT COMPLETED|Overall Study||5
8499631|NCT00506350|20945913|P8|NOT COMPLETED|Overall Study||5
8499632|NCT00506350|20945914|P7|NOT COMPLETED|Overall Study||2
8499633|NCT00506350|20945915|P6|NOT COMPLETED|Overall Study||2
8499634|NCT00506350|20945916|P5|NOT COMPLETED|Overall Study||10
8499635|NCT00506350|20945917|P4|NOT COMPLETED|Overall Study||2
8499636|NCT00506350|20945918|P3|NOT COMPLETED|Overall Study||6
8499637|NCT00506350|20945919|P2|NOT COMPLETED|Overall Study||3
8499638|NCT00506350|20945920|P1|NOT COMPLETED|Overall Study||3
8499639|NCT00506350|20945912|P9|COMPLETED|Overall Study||30
8499640|NCT00506350|20945913|P8|COMPLETED|Overall Study||36
8499641|NCT00506350|20945914|P7|COMPLETED|Overall Study||33
8499642|NCT00506350|20945915|P6|COMPLETED|Overall Study||38
8499643|NCT00506350|20945916|P5|COMPLETED|Overall Study||40
8499644|NCT00506350|20945917|P4|COMPLETED|Overall Study||34
8499645|NCT00506350|20945918|P3|COMPLETED|Overall Study||31
8499646|NCT00506350|20945919|P2|COMPLETED|Overall Study||37
8499647|NCT00506350|20945920|P1|COMPLETED|Overall Study||33
8499648|NCT00506350|20945912|P9|STARTED|Overall Study||35
8499649|NCT00506350|20945913|P8|STARTED|Overall Study||41
8499650|NCT00506350|20945914|P7|STARTED|Overall Study||35
8499651|NCT00506350|20945915|P6|STARTED|Overall Study||40
8499652|NCT00506350|20945916|P5|STARTED|Overall Study||50
8499653|NCT00506350|20945917|P4|STARTED|Overall Study||36
8499654|NCT00506350|20945918|P3|STARTED|Overall Study||37
8499655|NCT00506350|20945919|P2|STARTED|Overall Study||40
8499656|NCT00506350|20945920|P1|STARTED|Overall Study||36
8499657|NCT00506285|20946067|P2|NOT COMPLETED|6-month Open Label Phase||12
8499658|NCT00506285|20946068|P1|NOT COMPLETED|6-month Open Label Phase||10
8499659|NCT00506285|20946067|P2|COMPLETED|6-month Open Label Phase||19
8499660|NCT00506285|20946068|P1|COMPLETED|6-month Open Label Phase||10
8499661|NCT00506285|20946067|P2|STARTED|6-month Open Label Phase||31
8499662|NCT00506285|20946068|P1|STARTED|6-month Open Label Phase||20
8499663|NCT00506285|20946067|P2|NOT COMPLETED|Double Blind Cross-Over Phase||5
8499664|NCT00506285|20946068|P1|NOT COMPLETED|Double Blind Cross-Over Phase||9
8499665|NCT00506285|20946067|P2|COMPLETED|Double Blind Cross-Over Phase||31
8499666|NCT00506285|20946068|P1|COMPLETED|Double Blind Cross-Over Phase||20
8499667|NCT00506285|20946067|P2|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
8499668|NCT00506285|20946068|P1|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
8499669|NCT00506285|20946067|P2|STARTED|Double Blind Cross-Over Phase||36
8499670|NCT00506285|20946068|P1|STARTED|Double Blind Cross-Over Phase||29
8499671|NCT00506285|20946067|P2|NOT COMPLETED|3 Week Screening Phase||10
8499672|NCT00506285|20946068|P1|NOT COMPLETED|3 Week Screening Phase||17
8499673|NCT00506285|20946067|P2|COMPLETED|3 Week Screening Phase||36
8499674|NCT00506285|20946068|P1|COMPLETED|3 Week Screening Phase||29
8499675|NCT00506285|20946067|P2|STARTED|3 Week Screening Phase||46
8499676|NCT00506285|20946068|P1|STARTED|3 Week Screening Phase||46
8499677|NCT00506155|20946076|P1|NOT COMPLETED|Overall Study||0
8499678|NCT00506155|20946076|P1|COMPLETED|Overall Study||60
8499679|NCT00506155|20946076|P1|STARTED|Overall Study||60
8499680|NCT00506142|20946083|P2|NOT COMPLETED|Overall Study||19
8499681|NCT00506142|20946084|P1|NOT COMPLETED|Overall Study||35
8499682|NCT00506142|20946083|P2|COMPLETED|Overall Study||0
8499683|NCT00506142|20946084|P1|COMPLETED|Overall Study||0
8499684|NCT00506142|20946083|P2|STARTED|Overall Study||19
8499685|NCT00506142|20946084|P1|STARTED|Overall Study||35
8499686|NCT00506129|20946090|P1|NOT COMPLETED|Overall Study||22
8499687|NCT00506129|20946090|P1|COMPLETED|Overall Study||11
8499688|NCT00506129|20946090|P1|STARTED|Overall Study||33
8499689|NCT00506077|20946097|P2|NOT COMPLETED|Treatment Period 2||1
8499690|NCT00506077|20946098|P1|NOT COMPLETED|Treatment Period 2||1
8499691|NCT00506077|20946097|P2|COMPLETED|Treatment Period 2||23
8499692|NCT00506077|20946098|P1|COMPLETED|Treatment Period 2||23
8499693|NCT00506077|20946097|P2|STARTED|Treatment Period 2||24
8499694|NCT00506077|20946098|P1|STARTED|Treatment Period 2||24
8499695|NCT00506077|20946097|P2|NOT COMPLETED|Washout||0
8499696|NCT00506077|20946098|P1|NOT COMPLETED|Washout||0
8499697|NCT00506077|20946097|P2|COMPLETED|Washout||24
8499698|NCT00506077|20946098|P1|COMPLETED|Washout||24
8499699|NCT00506077|20946097|P2|STARTED|Washout||24
8499700|NCT00506077|20946098|P1|STARTED|Washout||24
8499701|NCT00506077|20946097|P2|NOT COMPLETED|Treatment Period 1||3
8499702|NCT00506077|20946098|P1|NOT COMPLETED|Treatment Period 1||4
8499703|NCT00506077|20946097|P2|COMPLETED|Treatment Period 1||24
8499704|NCT00506077|20946098|P1|COMPLETED|Treatment Period 1||24
8499705|NCT00506077|20946097|P2|STARTED|Treatment Period 1||27
8499706|NCT00506077|20946098|P1|STARTED|Treatment Period 1||28
8499707|NCT00506064|20946120|P2|NOT COMPLETED|Overall Study||0
8499708|NCT00506064|20946121|P1|NOT COMPLETED|Overall Study||0
8499709|NCT00506064|20946120|P2|COMPLETED|Overall Study||0
8499710|NCT00506064|20946121|P1|COMPLETED|Overall Study||1
8499711|NCT00506064|20946120|P2|STARTED|Overall Study||0
8499712|NCT00506064|20946121|P1|STARTED|Overall Study||1
8499713|NCT00506025|20946130|P3|NOT COMPLETED|Overall Study||0
8499714|NCT00506025|20946131|P2|NOT COMPLETED|Overall Study||0
8499715|NCT00506025|20946132|P1|NOT COMPLETED|Overall Study||0
8499716|NCT00506025|20946130|P3|COMPLETED|Overall Study||8
8499717|NCT00506025|20946131|P2|COMPLETED|Overall Study||9
8499718|NCT00506025|20946132|P1|COMPLETED|Overall Study||10
8499719|NCT00506025|20946130|P3|STARTED|Overall Study||8
8499720|NCT00506025|20946131|P2|STARTED|Overall Study||9
8499721|NCT00506025|20946132|P1|STARTED|Overall Study||10
8499722|NCT00505934|20946140|P1|NOT COMPLETED|Overall Study||3
8499723|NCT00505934|20946140|P1|COMPLETED|Overall Study||16
8499724|NCT00505934|20946140|P1|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
8499725|NCT00505921|20946146|P1|NOT COMPLETED|Overall Study||9
8499726|NCT00505921|20946146|P1|COMPLETED|Overall Study||18
8499727|NCT00505921|20946146|P1|STARTED|Overall Study||27
8499728|NCT00505895|20946152|P2|NOT COMPLETED|Overall Study||0
8499729|NCT00505895|20946153|P1|NOT COMPLETED|Overall Study||0
8499730|NCT00505895|20946152|P2|COMPLETED|Overall Study||23
8499731|NCT00505895|20946153|P1|COMPLETED|Overall Study||27
8499732|NCT00505895|20946152|P2|STARTED|Overall Study||23
8499733|NCT00505895|20946153|P1|STARTED|Overall Study||27
8499734|NCT00505778|20946163|P2|NOT COMPLETED|Overall Study||135
8499735|NCT00505778|20946164|P1|NOT COMPLETED|Overall Study||134
8499736|NCT00505778|20946163|P2|COMPLETED|Overall Study||378
8499737|NCT00505778|20946164|P1|COMPLETED|Overall Study||380
8499738|NCT00505778|20946163|P2|Intent to Treat (ITT) Population|Overall Study||511
8499739|NCT00505778|20946164|P1|Intent to Treat (ITT) Population|Overall Study||512
8499740|NCT00505778|20946163|P2|STARTED|Overall Study||513
8499741|NCT00505778|20946164|P1|STARTED|Overall Study||514
8499742|NCT00505765|20946183|P3|NOT COMPLETED|Overall Study||3
8499743|NCT00505765|20946184|P2|NOT COMPLETED|Overall Study||3
8499744|NCT00505765|20946185|P1|NOT COMPLETED|Overall Study||2
8499745|NCT00505765|20946183|P3|COMPLETED|Overall Study||19
8499746|NCT00505765|20946184|P2|COMPLETED|Overall Study||17
8499747|NCT00505765|20946185|P1|COMPLETED|Overall Study||19
8499748|NCT00505765|20946183|P3|Mid-Point Assessment|Overall Study||21
8499749|NCT00505765|20946184|P2|Mid-Point Assessment|Overall Study||19
8499750|NCT00505765|20946185|P1|Mid-Point Assessment|Overall Study||20
8499751|NCT00505765|20946183|P3|STARTED|Overall Study||22
8499752|NCT00505765|20946184|P2|STARTED|Overall Study||20
8499753|NCT00505765|20946185|P1|STARTED|Overall Study||21
8499754|NCT00505752|20946212|P4|NOT COMPLETED|Overall Study||6
8499755|NCT00505752|20946213|P3|NOT COMPLETED|Overall Study||8
8499756|NCT00505752|20946214|P2|NOT COMPLETED|Overall Study||9
8499757|NCT00505752|20946215|P1|NOT COMPLETED|Overall Study||6
8499758|NCT00505752|20946212|P4|COMPLETED|Overall Study||126
8499759|NCT00505752|20946213|P3|COMPLETED|Overall Study||120
8499760|NCT00505752|20946214|P2|COMPLETED|Overall Study||119
8499761|NCT00505752|20946215|P1|COMPLETED|Overall Study||126
8499762|NCT00505752|20946212|P4|STARTED|Overall Study||132
8499763|NCT00505752|20946213|P3|STARTED|Overall Study||128
8499764|NCT00505752|20946214|P2|STARTED|Overall Study||128
8499765|NCT00505752|20946215|P1|STARTED|Overall Study||132
8499766|NCT00505687|20946229|P1|NOT COMPLETED|Overall Study||95
8499767|NCT00505687|20946229|P1|COMPLETED|Overall Study||91
8499768|NCT00505687|20946229|P1|STARTED|Overall Study||186
8499769|NCT00505661|20946235|P1|NOT COMPLETED|Overall Study||4
8499770|NCT00505661|20946235|P1|COMPLETED|Overall Study||12
8499771|NCT00505661|20946235|P1|STARTED|Overall Study||16
8499772|NCT00505635|20946239|P1|NOT COMPLETED|Overall Study||0
8499773|NCT00505635|20946239|P1|COMPLETED|Overall Study||5
8499774|NCT00505635|20946239|P1|STARTED|Overall Study||5
8499775|NCT00505622|20946246|P3|NOT COMPLETED|Overall Study||96
8499776|NCT00505622|20946247|P2|NOT COMPLETED|Overall Study||108
8499777|NCT00505622|20946248|P1|NOT COMPLETED|Overall Study||121
8499778|NCT00505622|20946246|P3|COMPLETED|Overall Study||0
8499779|NCT00505622|20946247|P2|COMPLETED|Overall Study||0
8499780|NCT00505622|20946248|P1|COMPLETED|Overall Study||0
8499781|NCT00505622|20946246|P3|STARTED|Overall Study||96
8499782|NCT00505622|20946247|P2|STARTED|Overall Study||108
8499783|NCT00505622|20946248|P1|STARTED|Overall Study||121
8499784|NCT00505518|20946265|P1|NOT COMPLETED|Overall Study||0
8499785|NCT00505518|20946265|P1|COMPLETED|Overall Study||9
8499786|NCT00505518|20946265|P1|STARTED|Overall Study||9
8499787|NCT00505414|20946273|P5|NOT COMPLETED|Maintenance Phase||0
8499788|NCT00505414|20946274|P4|NOT COMPLETED|Maintenance Phase||0
8499789|NCT00505414|20946275|P3|NOT COMPLETED|Maintenance Phase||8
8499790|NCT00505414|20946276|P2|NOT COMPLETED|Maintenance Phase||5
8499791|NCT00505414|20946277|P1|NOT COMPLETED|Maintenance Phase||6
8499792|NCT00505414|20946273|P5|COMPLETED|Maintenance Phase||0
8499793|NCT00505414|20946274|P4|COMPLETED|Maintenance Phase||0
8499794|NCT00505414|20946275|P3|COMPLETED|Maintenance Phase||6
8499795|NCT00505414|20946276|P2|COMPLETED|Maintenance Phase||10
8499796|NCT00505414|20946277|P1|COMPLETED|Maintenance Phase||12
8499797|NCT00505414|20946273|P5|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
8499798|NCT00505414|20946274|P4|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
8499799|NCT00505414|20946275|P3|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
8499800|NCT00505414|20946276|P2|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
8499801|NCT00505414|20946277|P1|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
8499802|NCT00505414|20946273|P5|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
8499803|NCT00505414|20946274|P4|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
8499804|NCT00505414|20946275|P3|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
8499805|NCT00505414|20946276|P2|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
8499806|NCT00505414|20946277|P1|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
8499807|NCT00505414|20946273|P5|NOT COMPLETED|Titration Phase||12
8499808|NCT00505414|20946274|P4|NOT COMPLETED|Titration Phase||30
8499809|NCT00505414|20946275|P3|NOT COMPLETED|Titration Phase||0
8499810|NCT00505414|20946276|P2|NOT COMPLETED|Titration Phase||0
8499811|NCT00505414|20946277|P1|NOT COMPLETED|Titration Phase||0
8499812|NCT00505414|20946273|P5|COMPLETED|Titration Phase||19
8499813|NCT00505414|20946274|P4|COMPLETED|Titration Phase||32
8499814|NCT00505414|20946275|P3|COMPLETED|Titration Phase||0
8499815|NCT00505414|20946276|P2|COMPLETED|Titration Phase||0
8499816|NCT00505414|20946277|P1|COMPLETED|Titration Phase||0
8499817|NCT00505414|20946273|P5|STARTED|Titration Phase||31
8499818|NCT00505414|20946274|P4|STARTED|Titration Phase||62
8499819|NCT00505414|20946275|P3|STARTED|Titration Phase||0
8499820|NCT00505414|20946276|P2|STARTED|Titration Phase||0
8499821|NCT00505414|20946277|P1|STARTED|Titration Phase||0
8499822|NCT00505375|20946294|P2|NOT COMPLETED|Overall Study||5
8499823|NCT00505375|20946295|P1|NOT COMPLETED|Overall Study||4
8499824|NCT00505375|20946294|P2|COMPLETED|Overall Study||30
8499825|NCT00505375|20946295|P1|COMPLETED|Overall Study||73
8499826|NCT00505375|20946294|P2|STARTED|Overall Study||35
8499827|NCT00505375|20946295|P1|STARTED|Overall Study||77
8499828|NCT00505362|20946303|P2|NOT COMPLETED|Overall Study||0
8499829|NCT00505362|20946304|P1|NOT COMPLETED|Overall Study||0
8499830|NCT00505362|20946303|P2|COMPLETED|Overall Study||28
8499831|NCT00505362|20946304|P1|COMPLETED|Overall Study||35
8499832|NCT00505362|20946303|P2|STARTED|Overall Study||28
8499833|NCT00505362|20946304|P1|STARTED|Overall Study||35
8499834|NCT00505284|20946317|P5|NOT COMPLETED|Overall Study||33
8499835|NCT00505284|20946318|P4|NOT COMPLETED|Overall Study||19
8499836|NCT00505284|20946319|P3|NOT COMPLETED|Overall Study||12
8499837|NCT00505284|20946320|P2|NOT COMPLETED|Overall Study||16
8499838|NCT00505284|20946321|P1|NOT COMPLETED|Overall Study||10
8499839|NCT00505284|20946317|P5|COMPLETED|Overall Study||37
8499840|NCT00505284|20946318|P4|COMPLETED|Overall Study||49
8499841|NCT00505284|20946319|P3|COMPLETED|Overall Study||57
8499842|NCT00505284|20946320|P2|COMPLETED|Overall Study||56
8499843|NCT00505284|20946321|P1|COMPLETED|Overall Study||63
8499844|NCT00505284|20946317|P5|STARTED|Overall Study||70
8499845|NCT00505284|20946318|P4|STARTED|Overall Study||68
8499846|NCT00505284|20946319|P3|STARTED|Overall Study||69
8499847|NCT00505284|20946320|P2|STARTED|Overall Study||72
8499848|NCT00505284|20946321|P1|STARTED|Overall Study||73
8499849|NCT00505076|20946391|P3|NOT COMPLETED|Overall Study||5
8499850|NCT00505076|20946392|P2|NOT COMPLETED|Overall Study||2
8499851|NCT00505076|20946393|P1|NOT COMPLETED|Overall Study||3
8499852|NCT00505076|20946391|P3|COMPLETED|Overall Study||17
8499853|NCT00505076|20946392|P2|COMPLETED|Overall Study||17
8499854|NCT00505076|20946393|P1|COMPLETED|Overall Study||19
8499855|NCT00505076|20946391|P3|STARTED|Overall Study||22
8499856|NCT00505076|20946392|P2|STARTED|Overall Study||19
8499857|NCT00505076|20946393|P1|STARTED|Overall Study||22
8499858|NCT00504985|20946407|P1|NOT COMPLETED|Overall Study||0
8499859|NCT00504985|20946407|P1|COMPLETED|Overall Study||14
8499860|NCT00504985|20946407|P1|STARTED|Overall Study||14
8499867|NCT00504881|20946422|P2|NOT COMPLETED|Overall Study||36
8499868|NCT00504881|20946423|P1|NOT COMPLETED|Overall Study||10
8499869|NCT00504881|20946422|P2|COMPLETED|Overall Study||323
8499870|NCT00504881|20946423|P1|COMPLETED|Overall Study||111
8499871|NCT00504881|20946422|P2|STARTED|Overall Study||359
8499872|NCT00504881|20946423|P1|STARTED|Overall Study||121
8499873|NCT00504829|20946476|P3|NOT COMPLETED|Overall Study||10
8499874|NCT00504829|20946477|P2|NOT COMPLETED|Overall Study||4
8499875|NCT00504829|20946478|P1|NOT COMPLETED|Overall Study||6
8499876|NCT00504829|20946476|P3|COMPLETED|Overall Study||63
8499877|NCT00504829|20946477|P2|COMPLETED|Overall Study||70
8499878|NCT00504829|20946478|P1|COMPLETED|Overall Study||67
8499879|NCT00504829|20946476|P3|STARTED|Overall Study||73
8499880|NCT00504829|20946477|P2|STARTED|Overall Study||74
8499881|NCT00504829|20946478|P1|STARTED|Overall Study||73
8499882|NCT00504777|20946487|P1|NOT COMPLETED|Overall Study||1
8499883|NCT00504777|20946487|P1|COMPLETED|Overall Study||35
8499884|NCT00504777|20946487|P1|STARTED|Overall Study||36
8499885|NCT00504751|20946494|P1|NOT COMPLETED|Overall Study||0
8499886|NCT00504751|20946494|P1|COMPLETED|Overall Study||15
8499887|NCT00504751|20946494|P1|STARTED|Overall Study||15
8499888|NCT00504725|20946500|P2|NOT COMPLETED|Overall Study||0
8499889|NCT00504725|20946501|P1|NOT COMPLETED|Overall Study||1
8499890|NCT00504725|20946500|P2|COMPLETED|Overall Study||20
8499891|NCT00504725|20946501|P1|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
8499892|NCT00504725|20946500|P2|STARTED|Overall Study||20
8499893|NCT00504725|20946501|P1|STARTED|Overall Study||21
8499894|NCT00504660|20946513|P2|NOT COMPLETED|Overall Study||0
8499895|NCT00504660|20946514|P1|NOT COMPLETED|Overall Study||0
8499896|NCT00504660|20946513|P2|COMPLETED|Overall Study||43
8499897|NCT00504660|20946514|P1|COMPLETED|Overall Study||31
8499898|NCT00504660|20946513|P2|STARTED|Overall Study||43
8499899|NCT00504660|20946514|P1|STARTED|Overall Study||31
8499900|NCT00504595|20946524|P4|NOT COMPLETED|Overall Study||0
8499901|NCT00504595|20946525|P3|NOT COMPLETED|Overall Study||2
8499902|NCT00504595|20946526|P2|NOT COMPLETED|Overall Study||0
8499903|NCT00504595|20946527|P1|NOT COMPLETED|Overall Study||1
8499904|NCT00504595|20946524|P4|COMPLETED|Overall Study||10
8499905|NCT00504595|20946525|P3|COMPLETED|Overall Study||8
8499906|NCT00504595|20946526|P2|COMPLETED|Overall Study||10
8499907|NCT00504595|20946527|P1|COMPLETED|Overall Study||49
8499908|NCT00504595|20946524|P4|STARTED|Overall Study||10
8499909|NCT00504595|20946525|P3|STARTED|Overall Study||10
8499910|NCT00504595|20946526|P2|STARTED|Overall Study||10
8499911|NCT00504595|20946527|P1|STARTED|Overall Study||50
8499912|NCT00504556|20946544|P5|NOT COMPLETED|Overall Study||25
8499913|NCT00504556|20946545|P4|NOT COMPLETED|Overall Study||128
8499914|NCT00504556|20946546|P3|NOT COMPLETED|Overall Study||31
8499915|NCT00504556|20946547|P2|NOT COMPLETED|Overall Study||38
8499916|NCT00504556|20946548|P1|NOT COMPLETED|Overall Study||35
8499917|NCT00504556|20946544|P5|COMPLETED|Overall Study||226
8499918|NCT00504556|20946545|P4|COMPLETED|Overall Study||52
8499919|NCT00504556|20946546|P3|COMPLETED|Overall Study||204
8499920|NCT00504556|20946547|P2|COMPLETED|Overall Study||207
8499921|NCT00504556|20946548|P1|COMPLETED|Overall Study||200
8499922|NCT00504556|20946544|P5|Pharmacodynamic Analysis Set|Overall Study||244
8499923|NCT00504556|20946545|P4|Pharmacodynamic Analysis Set|Overall Study||170
8499924|NCT00504556|20946546|P3|Pharmacodynamic Analysis Set|Overall Study||228
8499925|NCT00504556|20946547|P2|Pharmacodynamic Analysis Set|Overall Study||236
8499926|NCT00504556|20946548|P1|Pharmacodynamic Analysis Set|Overall Study||230
8499927|NCT00504556|20946544|P5|Per Protocol Analysis Set|Overall Study||250
8499928|NCT00504556|20946545|P4|Per Protocol Analysis Set|Overall Study||180
8499929|NCT00504556|20946546|P3|Per Protocol Analysis Set|Overall Study||234
8499930|NCT00504556|20946547|P2|Per Protocol Analysis Set|Overall Study||243
8499931|NCT00504556|20946548|P1|Per Protocol Analysis Set|Overall Study||235
8499932|NCT00504556|20946544|P5|Safety Analysis Set|Overall Study||250
8499933|NCT00504556|20946545|P4|Safety Analysis Set|Overall Study||180
8499934|NCT00504556|20946546|P3|Safety Analysis Set|Overall Study||234
8499935|NCT00504556|20946547|P2|Safety Analysis Set|Overall Study||244
8499936|NCT00504556|20946548|P1|Safety Analysis Set|Overall Study||235
8499937|NCT00504556|20946544|P5|STARTED|Overall Study||251
8499938|NCT00504556|20946545|P4|STARTED|Overall Study||180
8499939|NCT00504556|20946546|P3|STARTED|Overall Study||235
8499940|NCT00504556|20946547|P2|STARTED|Overall Study||245
8499941|NCT00504556|20946548|P1|STARTED|Overall Study||235
8499942|NCT00504504|20946608|P1|NOT COMPLETED|Overall Study||0
8499943|NCT00504504|20946608|P1|COMPLETED|Overall Study||82
8499944|NCT00504504|20946608|P1|STARTED|Overall Study||82
8499945|NCT00504426|20946616|P4|NOT COMPLETED|Overall Study||0
8499946|NCT00504426|20946617|P3|NOT COMPLETED|Overall Study||4
8499947|NCT00504426|20946618|P2|NOT COMPLETED|Overall Study||1
8499948|NCT00504426|20946619|P1|NOT COMPLETED|Overall Study||3
8499949|NCT00504426|20946616|P4|COMPLETED|Overall Study||24
8499950|NCT00504426|20946617|P3|COMPLETED|Overall Study||18
8499951|NCT00504426|20946618|P2|COMPLETED|Overall Study||22
8499952|NCT00504426|20946619|P1|COMPLETED|Overall Study||29
8499953|NCT00504426|20946616|P4|STARTED|Overall Study||24
8499954|NCT00504426|20946617|P3|STARTED|Overall Study||22
8499955|NCT00504426|20946618|P2|STARTED|Overall Study||23
8499956|NCT00504426|20946619|P1|STARTED|Overall Study||32
8499957|NCT00504348|20946633|P1|NOT COMPLETED|Overall Study||8
8499958|NCT00504348|20946633|P1|COMPLETED|Overall Study||17
8499959|NCT00504348|20946633|P1|STARTED|Overall Study||25
8499960|NCT00504309|20946644|P6|NOT COMPLETED|Overall Study||0
8499961|NCT00504309|20946645|P5|NOT COMPLETED|Overall Study||1
8499962|NCT00504309|20946646|P4|NOT COMPLETED|Overall Study||0
8499963|NCT00504309|20946647|P3|NOT COMPLETED|Overall Study||1
8499964|NCT00504309|20946648|P2|NOT COMPLETED|Overall Study||0
8499965|NCT00504309|20946649|P1|NOT COMPLETED|Overall Study||0
8499966|NCT00504309|20946644|P6|COMPLETED|Overall Study||3
8499967|NCT00504309|20946645|P5|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
8499968|NCT00504309|20946646|P4|COMPLETED|Overall Study||3
8499969|NCT00504309|20946647|P3|COMPLETED|Overall Study|Participant dropped out during second period|1
8499970|NCT00504309|20946648|P2|COMPLETED|Overall Study||5
8499971|NCT00504309|20946649|P1|COMPLETED|Overall Study||7
8499972|NCT00504309|20946644|P6|STARTED|Overall Study||3
8499973|NCT00504309|20946645|P5|STARTED|Overall Study||8
8499974|NCT00504309|20946646|P4|STARTED|Overall Study||3
8499975|NCT00504309|20946647|P3|STARTED|Overall Study||2
8499976|NCT00504309|20946648|P2|STARTED|Overall Study||5
8499977|NCT00504309|20946649|P1|STARTED|Overall Study||7
8499978|NCT00504257|20946687|P1|NOT COMPLETED|Overall Study||4
8499979|NCT00504257|20946687|P1|COMPLETED|Overall Study||41
8499980|NCT00504257|20946687|P1|STARTED|Overall Study||45
8499981|NCT00504231|20946699|P4|NOT COMPLETED|Overall Study||0
8499982|NCT00504231|20946700|P3|NOT COMPLETED|Overall Study||1
8499983|NCT00504231|20946701|P2|NOT COMPLETED|Overall Study||0
8499984|NCT00504231|20946702|P1|NOT COMPLETED|Overall Study||0
8499985|NCT00504231|20946699|P4|COMPLETED|Overall Study||65
8499986|NCT00504231|20946700|P3|COMPLETED|Overall Study||63
8499987|NCT00504231|20946701|P2|COMPLETED|Overall Study||64
8499988|NCT00504231|20946702|P1|COMPLETED|Overall Study||65
8499989|NCT00504231|20946699|P4|STARTED|Overall Study||65
8499990|NCT00504231|20946700|P3|STARTED|Overall Study||64
8499991|NCT00504231|20946701|P2|STARTED|Overall Study||64
8499992|NCT00504231|20946702|P1|STARTED|Overall Study||65
8499993|NCT00504166|20946722|P2|NOT COMPLETED|Overall Study||14
8499994|NCT00504166|20946723|P1|NOT COMPLETED|Overall Study||6
8499995|NCT00504166|20946722|P2|COMPLETED|Overall Study||13
8499996|NCT00504166|20946723|P1|COMPLETED|Overall Study||20
8499997|NCT00504166|20946722|P2|STARTED|Overall Study||27
8499998|NCT00504166|20946723|P1|STARTED|Overall Study||26
8499999|NCT00504153|20946729|P1|NOT COMPLETED|Overall Study||6
8500000|NCT00504153|20946729|P1|COMPLETED|Overall Study||13
8500001|NCT00504153|20946729|P1|STARTED|Overall Study||19
8500002|NCT00504075|20946737|P1|NOT COMPLETED|Overall Study||8
8500003|NCT00504075|20946737|P1|COMPLETED|Overall Study||27
8500004|NCT00504075|20946737|P1|STARTED|Overall Study||35
8500005|NCT00504023|20946743|P1|NOT COMPLETED|Overall Study||0
8500006|NCT00504023|20946743|P1|COMPLETED|Overall Study||8
8500007|NCT00504023|20946743|P1|STARTED|Overall Study||8
8500008|NCT00503997|20946747|P1|NOT COMPLETED|Overall Study||8
8500009|NCT00503997|20946747|P1|COMPLETED|Overall Study||34
8500010|NCT00503997|20946747|P1|STARTED|Overall Study||42
8500011|NCT00503984|20946753|P6|NOT COMPLETED|Overall Study||0
8500012|NCT00503984|20946754|P5|NOT COMPLETED|Overall Study||1
8500013|NCT00503984|20946755|P4|NOT COMPLETED|Overall Study||0
8500014|NCT00503984|20946756|P3|NOT COMPLETED|Overall Study||0
8500015|NCT00503984|20946757|P2|NOT COMPLETED|Overall Study||2
8500016|NCT00503984|20946758|P1|NOT COMPLETED|Overall Study||0
8500017|NCT00503984|20946753|P6|COMPLETED|Overall Study||1
8500018|NCT00503984|20946754|P5|COMPLETED|Overall Study||5
8500019|NCT00503984|20946755|P4|COMPLETED|Overall Study||6
8500020|NCT00503984|20946756|P3|COMPLETED|Overall Study||3
8500021|NCT00503984|20946757|P2|COMPLETED|Overall Study||1
8500022|NCT00503984|20946758|P1|COMPLETED|Overall Study||3
8500023|NCT00503984|20946753|P6|STARTED|Overall Study||1
8500024|NCT00503984|20946754|P5|STARTED|Overall Study||6
8500025|NCT00503984|20946755|P4|STARTED|Overall Study||6
8500026|NCT00503984|20946756|P3|STARTED|Overall Study||3
8500027|NCT00503984|20946757|P2|STARTED|Overall Study||3
8500028|NCT00503984|20946758|P1|STARTED|Overall Study||3
8500029|NCT00503906|20946784|P1|NOT COMPLETED|Overall Study||1
8500030|NCT00503906|20946784|P1|COMPLETED|Overall Study||29
8500031|NCT00503906|20946784|P1|STARTED|Overall Study||30
8500032|NCT00503880|20946793|P5|NOT COMPLETED|Overall Study||0
8500033|NCT00503880|20946794|P4|NOT COMPLETED|Overall Study||0
8500034|NCT00503880|20946795|P3|NOT COMPLETED|Overall Study||0
8500035|NCT00503880|20946796|P2|NOT COMPLETED|Overall Study||0
8500036|NCT00503880|20946797|P1|NOT COMPLETED|Overall Study||2
8500037|NCT00503880|20946793|P5|COMPLETED|Overall Study||0
8500038|NCT00503880|20946794|P4|COMPLETED|Overall Study||0
8500039|NCT00503880|20946795|P3|COMPLETED|Overall Study||0
8500040|NCT00503880|20946796|P2|COMPLETED|Overall Study||0
8500041|NCT00503880|20946797|P1|COMPLETED|Overall Study||0
8500042|NCT00503880|20946793|P5|STARTED|Overall Study||0
8500043|NCT00503880|20946794|P4|STARTED|Overall Study||0
8500044|NCT00503880|20946795|P3|STARTED|Overall Study||0
8500045|NCT00503880|20946796|P2|STARTED|Overall Study||0
8500046|NCT00503880|20946797|P1|STARTED|Overall Study||2
8500047|NCT00503867|20946806|P1|NOT COMPLETED|Overall Study||2
8500048|NCT00503867|20946806|P1|COMPLETED|Overall Study||8
8500049|NCT00503867|20946806|P1|STARTED|Overall Study||10
8500050|NCT00503841|20946814|P1|NOT COMPLETED|Overall Study||44
8500051|NCT00503841|20946814|P1|COMPLETED|Overall Study||0
8500052|NCT00503841|20946814|P1|STARTED|Overall Study||44
8500053|NCT00503776|20946825|P4|NOT COMPLETED|Overall Study||2
8500054|NCT00503776|20946826|P3|NOT COMPLETED|Overall Study||2
8500055|NCT00503776|20946827|P2|NOT COMPLETED|Overall Study||0
8500056|NCT00503776|20946828|P1|NOT COMPLETED|Overall Study||1
8500057|NCT00503776|20946825|P4|COMPLETED|Overall Study||8
8500058|NCT00503776|20946826|P3|COMPLETED|Overall Study||10
8500059|NCT00503776|20946827|P2|COMPLETED|Overall Study||12
8500060|NCT00503776|20946828|P1|COMPLETED|Overall Study||7
8500061|NCT00503776|20946825|P4|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
8500062|NCT00503776|20946826|P3|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
8500063|NCT00503776|20946827|P2|STARTED|Overall Study||12
8500064|NCT00503776|20946828|P1|STARTED|Overall Study||8
8500065|NCT00503750|20946854|P1|NOT COMPLETED|Overall Study||0
8500066|NCT00503750|20946854|P1|COMPLETED|Overall Study||27
8500067|NCT00503750|20946854|P1|STARTED|Overall Study||27
8500068|NCT00503698|20946861|P2|NOT COMPLETED|Overall Study||355
8500069|NCT00503698|20946862|P1|NOT COMPLETED|Overall Study||357
8500070|NCT00503698|20946861|P2|COMPLETED|Overall Study|Trial prematurely terminated|0
8500071|NCT00503698|20946862|P1|COMPLETED|Overall Study|Trial prematurely terminated|0
8500072|NCT00503698|20946861|P2|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
8500073|NCT00503698|20946862|P1|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
8500074|NCT00503698|20946861|P2|STARTED|Overall Study|Randomised|355
8500075|NCT00503698|20946862|P1|STARTED|Overall Study|Randomised|357
8500076|NCT00503685|20946879|P3|NOT COMPLETED|Overall Study||2
8500077|NCT00503685|20946880|P2|NOT COMPLETED|Overall Study||3
8500078|NCT00503685|20946881|P1|NOT COMPLETED|Overall Study||0
8500079|NCT00503685|20946879|P3|COMPLETED|Overall Study||18
8500080|NCT00503685|20946880|P2|COMPLETED|Overall Study||19
8500081|NCT00503685|20946881|P1|COMPLETED|Overall Study||23
8500082|NCT00503685|20946879|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
8500083|NCT00503685|20946880|P2|Received at Least 1 Dose of Study Drug|Overall Study||21
8500084|NCT00503685|20946881|P1|Received at Least 1 Dose of Study Drug|Overall Study||23
8500085|NCT00503685|20946879|P3|STARTED|Overall Study||20
8500086|NCT00503685|20946880|P2|STARTED|Overall Study||22
8500087|NCT00503685|20946881|P1|STARTED|Overall Study||23
8500088|NCT00503581|20946926|P3|NOT COMPLETED|Overall Study||2
8500089|NCT00503581|20946927|P2|NOT COMPLETED|Overall Study||4
8500090|NCT00503581|20946928|P1|NOT COMPLETED|Overall Study||3
8500091|NCT00503581|20946926|P3|COMPLETED|Overall Study||0
8500092|NCT00503581|20946927|P2|COMPLETED|Overall Study||0
8500093|NCT00503581|20946928|P1|COMPLETED|Overall Study||0
8500094|NCT00503581|20946926|P3|STARTED|Overall Study||2
8500095|NCT00503581|20946927|P2|STARTED|Overall Study||4
8500096|NCT00503581|20946928|P1|STARTED|Overall Study||3
8500097|NCT00503425|20946939|P1|NOT COMPLETED|Overall Study||54
8500098|NCT00503425|20946939|P1|COMPLETED|Overall Study||161
8500099|NCT00503425|20946939|P1|STARTED|Overall Study||215
8500100|NCT00503399|20946949|P2|NOT COMPLETED|Overall Study||8
8500101|NCT00503399|20946950|P1|NOT COMPLETED|Overall Study||7
8500102|NCT00503399|20946949|P2|COMPLETED|Overall Study||39
8500103|NCT00503399|20946950|P1|COMPLETED|Overall Study||38
8500104|NCT00503399|20946949|P2|STARTED|Overall Study||47
8500105|NCT00503399|20946950|P1|STARTED|Overall Study||45
8500106|NCT00503308|20946974|P2|NOT COMPLETED|Overall Study||1
8500107|NCT00503308|20946975|P1|NOT COMPLETED|Overall Study||2
8500108|NCT00503308|20946974|P2|COMPLETED|Overall Study||134
8500109|NCT00503308|20946975|P1|COMPLETED|Overall Study||144
8500110|NCT00503308|20946974|P2|STARTED|Overall Study||135
8500111|NCT00503308|20946975|P1|STARTED|Overall Study||146
8500112|NCT00503139|20946981|P1|NOT COMPLETED|Overall Study||8
8500113|NCT00503139|20946981|P1|COMPLETED|Overall Study||676
8500114|NCT00503139|20946981|P1|STARTED|Overall Study||684
8500115|NCT00503113|20946995|P3|NOT COMPLETED|Overall Study||28
8500116|NCT00503113|20946996|P2|NOT COMPLETED|Overall Study||28
8500117|NCT00503113|20946997|P1|NOT COMPLETED|Overall Study||33
8500118|NCT00503113|20946995|P3|COMPLETED|Overall Study||241
8500119|NCT00503113|20946996|P2|COMPLETED|Overall Study||236
8500120|NCT00503113|20946997|P1|COMPLETED|Overall Study||235
8500121|NCT00503113|20946995|P3|Safety Population|Overall Study||267
8500122|NCT00503113|20946996|P2|Safety Population|Overall Study||263
8500123|NCT00503113|20946997|P1|Safety Population|Overall Study||263
8500124|NCT00503113|20946995|P3|Per Protocol Population (PP)|Overall Study||241
8500125|NCT00503113|20946996|P2|Per Protocol Population (PP)|Overall Study||243
8500126|NCT00503113|20946997|P1|Per Protocol Population (PP)|Overall Study||246
8500127|NCT00503113|20946995|P3|Intent to Treat Population (ITT)|Overall Study||268
8500128|NCT00503113|20946996|P2|Intent to Treat Population (ITT)|Overall Study||261
8500129|NCT00503113|20946997|P1|Intent to Treat Population (ITT)|Overall Study||262
8500130|NCT00503113|20946995|P3|STARTED|Overall Study||269
8500131|NCT00503113|20946996|P2|STARTED|Overall Study||264
8500132|NCT00503113|20946997|P1|STARTED|Overall Study||268
8500133|NCT00503009|20947029|P3|NOT COMPLETED|Overall Study||3
8500134|NCT00503009|20947030|P2|NOT COMPLETED|Overall Study||2
8500135|NCT00503009|20947031|P1|NOT COMPLETED|Overall Study||1
8500136|NCT00503009|20947029|P3|COMPLETED|Overall Study||3
8500137|NCT00503009|20947030|P2|COMPLETED|Overall Study||3
8500138|NCT00503009|20947031|P1|COMPLETED|Overall Study||4
8500139|NCT00503009|20947029|P3|STARTED|Overall Study||6
8500140|NCT00503009|20947030|P2|STARTED|Overall Study||5
8500141|NCT00503009|20947031|P1|STARTED|Overall Study||5
8500142|NCT00502996|20947048|P1|NOT COMPLETED|Overall Study||44
8500143|NCT00502996|20947048|P1|COMPLETED|Overall Study||188
8500144|NCT00502996|20947048|P1|STARTED|Overall Study||232
8500145|NCT00502944|20947074|P2|NOT COMPLETED|Overall Study||1766
8500146|NCT00502944|20947075|P1|NOT COMPLETED|Overall Study||1064
8500147|NCT00502944|20947074|P2|COMPLETED|Overall Study||643
8500148|NCT00502944|20947075|P1|COMPLETED|Overall Study||1382
8500149|NCT00502944|20947074|P2|STARTED|Overall Study||2409
8500150|NCT00502944|20947075|P1|STARTED|Overall Study||2446
8500151|NCT00502905|20947087|P1|NOT COMPLETED|Overall Study||0
8500152|NCT00502905|20947087|P1|COMPLETED|Overall Study||196
8500153|NCT00502905|20947087|P1|STARTED|Overall Study||196
8500154|NCT00502853|20947091|P1|NOT COMPLETED|Overall Study||0
8500155|NCT00502853|20947091|P1|COMPLETED|Overall Study||10
8500156|NCT00502853|20947091|P1|STARTED|Overall Study||10
8500157|NCT00502840|20947116|P1|NOT COMPLETED|Overall Study||100
8500158|NCT00502840|20947116|P1|COMPLETED|Overall Study||93
8500159|NCT00502840|20947116|P1|STARTED|Overall Study||193
8500160|NCT00502801|20947144|P1|NOT COMPLETED|End of Therapy to Test of Cure||8
8500161|NCT00502801|20947144|P1|COMPLETED|End of Therapy to Test of Cure||121
8500162|NCT00502801|20947144|P1|STARTED|End of Therapy to Test of Cure||129
8500163|NCT00502801|20947144|P1|NOT COMPLETED|Treatment Period||54
8500164|NCT00502801|20947144|P1|COMPLETED|Treatment Period||129
8500165|NCT00502801|20947144|P1|STARTED|Treatment Period||183
8500166|NCT00502775|20947152|P3|NOT COMPLETED|Overall Study||13
8500167|NCT00502775|20947153|P2|NOT COMPLETED|Overall Study||15
8500168|NCT00502775|20947154|P1|NOT COMPLETED|Overall Study||10
8500169|NCT00502775|20947152|P3|COMPLETED|Overall Study||214
8500170|NCT00502775|20947153|P2|COMPLETED|Overall Study||209
8500171|NCT00502775|20947154|P1|COMPLETED|Overall Study||219
8500172|NCT00502775|20947152|P3|STARTED|Overall Study||227
8500173|NCT00502775|20947153|P2|STARTED|Overall Study||224
8500174|NCT00502775|20947154|P1|STARTED|Overall Study||229
8500175|NCT00502697|20947197|P2|NOT COMPLETED|Overall Study||12
8500176|NCT00502697|20947198|P1|NOT COMPLETED|Overall Study||13
8500177|NCT00502697|20947197|P2|COMPLETED|Overall Study||102
8500178|NCT00502697|20947198|P1|COMPLETED|Overall Study||109
8500179|NCT00502697|20947197|P2|STARTED|Overall Study||114
8500180|NCT00502697|20947198|P1|STARTED|Overall Study||122
8500181|NCT00502671|20947206|P1|NOT COMPLETED|Overall Study||77
8500182|NCT00502671|20947206|P1|COMPLETED|Overall Study||151
8500183|NCT00502671|20947206|P1|STARTED|Overall Study||228
8500184|NCT00502593|20947223|P12|NOT COMPLETED|Overall Study||0
8500185|NCT00502593|20947224|P11|NOT COMPLETED|Overall Study||2
8500186|NCT00502593|20947225|P10|NOT COMPLETED|Overall Study||0
8500187|NCT00502593|20947226|P9|NOT COMPLETED|Overall Study||6
8500188|NCT00502593|20947227|P8|NOT COMPLETED|Overall Study||0
8500189|NCT00502593|20947228|P7|NOT COMPLETED|Overall Study||5
8500190|NCT00502593|20947229|P6|NOT COMPLETED|Overall Study||0
8500191|NCT00502593|20947230|P5|NOT COMPLETED|Overall Study||4
8500192|NCT00502593|20947231|P4|NOT COMPLETED|Overall Study||4
8500193|NCT00502593|20947232|P3|NOT COMPLETED|Overall Study||10
8500194|NCT00502593|20947233|P2|NOT COMPLETED|Overall Study||2
8500195|NCT00502593|20947234|P1|NOT COMPLETED|Overall Study||3
8500196|NCT00502593|20947223|P12|COMPLETED|Overall Study||18
8500197|NCT00502593|20947224|P11|COMPLETED|Overall Study||47
8500198|NCT00502593|20947225|P10|COMPLETED|Overall Study||17
8500199|NCT00502593|20947226|P9|COMPLETED|Overall Study||43
8500200|NCT00502593|20947227|P8|COMPLETED|Overall Study||17
8500201|NCT00502593|20947228|P7|COMPLETED|Overall Study||44
8500202|NCT00502593|20947229|P6|COMPLETED|Overall Study||17
8500203|NCT00502593|20947230|P5|COMPLETED|Overall Study||47
8500204|NCT00502593|20947231|P4|COMPLETED|Overall Study||14
8500205|NCT00502593|20947232|P3|COMPLETED|Overall Study||41
8500206|NCT00502593|20947233|P2|COMPLETED|Overall Study||16
8500207|NCT00502593|20947234|P1|COMPLETED|Overall Study||48
8500208|NCT00502593|20947223|P12|STARTED|Overall Study||18
8500209|NCT00502593|20947224|P11|STARTED|Overall Study||49
8500210|NCT00502593|20947225|P10|STARTED|Overall Study||17
8500211|NCT00502593|20947226|P9|STARTED|Overall Study||49
8500212|NCT00502593|20947227|P8|STARTED|Overall Study||17
8500213|NCT00502593|20947228|P7|STARTED|Overall Study||49
8500214|NCT00502593|20947229|P6|STARTED|Overall Study||17
8500215|NCT00502593|20947230|P5|STARTED|Overall Study||51
8500216|NCT00502593|20947231|P4|STARTED|Overall Study||18
8500217|NCT00502593|20947232|P3|STARTED|Overall Study||51
8500218|NCT00502593|20947233|P2|STARTED|Overall Study||18
8500219|NCT00502593|20947234|P1|STARTED|Overall Study||51
8500220|NCT00502320|20947750|P2|NOT COMPLETED|Overall Study||7
8500221|NCT00502320|20947751|P1|NOT COMPLETED|Overall Study||6
8500222|NCT00502320|20947750|P2|COMPLETED|Overall Study||18
8500223|NCT00502320|20947751|P1|COMPLETED|Overall Study||19
8500224|NCT00502320|20947750|P2|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
8500225|NCT00502320|20947751|P1|Screening Visit|Overall Study||25
8500226|NCT00502320|20947750|P2|STARTED|Overall Study||25
8500227|NCT00502320|20947751|P1|STARTED|Overall Study||25
8500228|NCT00502307|20947761|P3|NOT COMPLETED|Maintenance Period||0
8500229|NCT00502307|20947762|P2|NOT COMPLETED|Maintenance Period||0
8500230|NCT00502307|20947763|P1|NOT COMPLETED|Maintenance Period||148
8500231|NCT00502307|20947761|P3|COMPLETED|Maintenance Period||0
8500232|NCT00502307|20947762|P2|COMPLETED|Maintenance Period||0
8500233|NCT00502307|20947763|P1|COMPLETED|Maintenance Period||0
8500234|NCT00502307|20947761|P3|STARTED|Maintenance Period||0
8500235|NCT00502307|20947762|P2|STARTED|Maintenance Period||0
8500236|NCT00502307|20947763|P1|STARTED|Maintenance Period||148
8500237|NCT00502307|20947761|P3|NOT COMPLETED|Double-Blind Period (12 Weeks)||9
8500238|NCT00502307|20947762|P2|NOT COMPLETED|Double-Blind Period (12 Weeks)||26
8500239|NCT00502307|20947763|P1|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
8500240|NCT00502307|20947761|P3|COMPLETED|Double-Blind Period (12 Weeks)||48
8500241|NCT00502307|20947762|P2|COMPLETED|Double-Blind Period (12 Weeks)||35
8500242|NCT00502307|20947763|P1|COMPLETED|Double-Blind Period (12 Weeks)||0
8500243|NCT00502307|20947761|P3|STARTED|Double-Blind Period (12 Weeks)||57
8500244|NCT00502307|20947762|P2|STARTED|Double-Blind Period (12 Weeks)||61
8500245|NCT00502307|20947763|P1|STARTED|Double-Blind Period (12 Weeks)||0
8500246|NCT00502307|20947761|P3|NOT COMPLETED|Open Label Period (16 Weeks)||0
8500247|NCT00502307|20947762|P2|NOT COMPLETED|Open Label Period (16 Weeks)||0
8500248|NCT00502307|20947763|P1|NOT COMPLETED|Open Label Period (16 Weeks)||76
8500249|NCT00502307|20947761|P3|COMPLETED|Open Label Period (16 Weeks)||0
8500250|NCT00502307|20947762|P2|COMPLETED|Open Label Period (16 Weeks)||0
8500251|NCT00502307|20947763|P1|COMPLETED|Open Label Period (16 Weeks)||196
8500252|NCT00502307|20947761|P3|STARTED|Open Label Period (16 Weeks)||0
8500253|NCT00502307|20947762|P2|STARTED|Open Label Period (16 Weeks)||0
8500254|NCT00502307|20947763|P1|STARTED|Open Label Period (16 Weeks)||272
8500255|NCT00502242|20947790|P2|NOT COMPLETED|Overall Study||56
8500256|NCT00502242|20947791|P1|NOT COMPLETED|Overall Study||51
8500257|NCT00502242|20947790|P2|COMPLETED|Overall Study||84
8500258|NCT00502242|20947791|P1|COMPLETED|Overall Study||104
8500259|NCT00502242|20947790|P2|STARTED|Overall Study||140
8500260|NCT00502242|20947791|P1|STARTED|Overall Study||155
8500261|NCT00502216|20947844|P2|NOT COMPLETED|Overall Study||0
8500262|NCT00502216|20947845|P1|NOT COMPLETED|Overall Study||0
8500263|NCT00502216|20947844|P2|COMPLETED|Overall Study||19
8500264|NCT00502216|20947845|P1|COMPLETED|Overall Study||21
8500265|NCT00502216|20947844|P2|STARTED|Overall Study||19
8500266|NCT00502216|20947845|P1|STARTED|Overall Study||21
8500267|NCT00502203|20947855|P1|NOT COMPLETED|Overall Study||1
8500268|NCT00502203|20947855|P1|COMPLETED|Overall Study||22
8500269|NCT00502203|20947855|P1|STARTED|Overall Study||23
8500270|NCT00501995|20947859|P1|NOT COMPLETED|Overall Study||1
8500271|NCT00501995|20947859|P1|COMPLETED|Overall Study||5
8500272|NCT00501995|20947859|P1|STARTED|Overall Study||6
8500273|NCT00501969|20947864|P1|NOT COMPLETED|Overall Study||206
8500274|NCT00501969|20947864|P1|COMPLETED|Overall Study||189
8500275|NCT00501969|20947864|P1|STARTED|Overall Study||395
8500276|NCT00501943|20947872|P2|NOT COMPLETED|Overall Study||3
8500277|NCT00501943|20947873|P1|NOT COMPLETED|Overall Study||2
8500278|NCT00501943|20947872|P2|COMPLETED|Overall Study||18
8500279|NCT00501943|20947873|P1|COMPLETED|Overall Study||20
8500280|NCT00501943|20947872|P2|STARTED|Overall Study||21
8500281|NCT00501943|20947873|P1|STARTED|Overall Study||22
8500282|NCT00501891|20947889|P1|NOT COMPLETED|Overall Study||0
8500283|NCT00501891|20947889|P1|COMPLETED|Overall Study||32
8500284|NCT00501891|20947889|P1|STARTED|Overall Study||32
8500285|NCT00501852|20947896|P1|NOT COMPLETED|Overall Study||5
8500286|NCT00501852|20947896|P1|COMPLETED|Overall Study||78
8500287|NCT00501852|20947896|P1|Tiotropium|Overall Study||55
8500288|NCT00501852|20947896|P1|Placebo|Overall Study||55
8500289|NCT00501852|20947896|P1|NVA237 100µg|Overall Study||54
8500290|NCT00501852|20947896|P1|NVA237 50µg|Overall Study||53
8500291|NCT00501852|20947896|P1|NVA237 25µg|Overall Study||51
8500292|NCT00501852|20947896|P1|NVA237 12.5µg|Overall Study||55
8500293|NCT00501852|20947896|P1|STARTED|Overall Study||83
8500294|NCT00501644|20947916|P1|NOT COMPLETED|Overall Study||5
8500295|NCT00501644|20947916|P1|COMPLETED|Overall Study||54
8500296|NCT00501644|20947916|P1|STARTED|Overall Study||59
8500297|NCT00501631|20947922|P2|NOT COMPLETED|Part B (Open-label Period)||51
8500298|NCT00501631|20947923|P1|NOT COMPLETED|Part B (Open-label Period)||53
8500299|NCT00501631|20947922|P2|COMPLETED|Part B (Open-label Period)||48
8500300|NCT00501631|20947923|P1|COMPLETED|Part B (Open-label Period)||37
8500301|NCT00501631|20947922|P2|STARTED|Part B (Open-label Period)||99
8500302|NCT00501631|20947923|P1|STARTED|Part B (Open-label Period)||90
8500303|NCT00501631|20947922|P2|NOT COMPLETED|Part A (Double-blind Period)||49
8500304|NCT00501631|20947923|P1|NOT COMPLETED|Part A (Double-blind Period)||62
8500305|NCT00501631|20947922|P2|COMPLETED|Part A (Double-blind Period)||99
8500306|NCT00501631|20947923|P1|COMPLETED|Part A (Double-blind Period)||90
8500307|NCT00501631|20947922|P2|STARTED|Part A (Double-blind Period)||148
8500308|NCT00501631|20947923|P1|STARTED|Part A (Double-blind Period)||152
8500309|NCT00501592|20947932|P3|NOT COMPLETED|Overall Study||3
8500310|NCT00501592|20947933|P2|NOT COMPLETED|Overall Study||5
8500311|NCT00501592|20947934|P1|NOT COMPLETED|Overall Study||0
8500312|NCT00501592|20947932|P3|COMPLETED|Overall Study||20
8500313|NCT00501592|20947933|P2|COMPLETED|Overall Study||16
8500314|NCT00501592|20947934|P1|COMPLETED|Overall Study||20
8500315|NCT00501592|20947932|P3|STARTED|Overall Study||23
8500316|NCT00501592|20947933|P2|STARTED|Overall Study||21
8500317|NCT00501592|20947934|P1|STARTED|Overall Study||20
8500318|NCT00501540|20947945|P1|NOT COMPLETED|Overall Study||5
8500319|NCT00501540|20947945|P1|COMPLETED|Overall Study||10
8500320|NCT00501540|20947945|P1|STARTED|Overall Study||15
8500321|NCT00501345|20947951|P1|NOT COMPLETED|Overall Study||0
8500322|NCT00501345|20947951|P1|COMPLETED|Overall Study||5
8500323|NCT00501345|20947951|P1|STARTED|Overall Study||5
8500324|NCT00501293|20947957|P2|NOT COMPLETED|Maintenance Period||28
8500325|NCT00501293|20947958|P1|NOT COMPLETED|Maintenance Period||46
8500326|NCT00501293|20947957|P2|COMPLETED|Maintenance Period||25
8500327|NCT00501293|20947958|P1|COMPLETED|Maintenance Period||63
8500328|NCT00501293|20947957|P2|STARTED|Maintenance Period||53
8500329|NCT00501293|20947958|P1|STARTED|Maintenance Period||109
8500330|NCT00501293|20947957|P2|NOT COMPLETED|Optimization Period||0
8500331|NCT00501293|20947958|P1|NOT COMPLETED|Optimization Period||1
8500332|NCT00501293|20947957|P2|COMPLETED|Optimization Period||53
8500333|NCT00501293|20947958|P1|COMPLETED|Optimization Period||109
8500334|NCT00501293|20947957|P2|STARTED|Optimization Period||53
8500335|NCT00501293|20947958|P1|STARTED|Optimization Period||110
8500336|NCT00501228|20947985|P1|NOT COMPLETED|Overall Study||1
8500337|NCT00501228|20947985|P1|COMPLETED|Overall Study||1
8500338|NCT00501228|20947985|P1|STARTED|Overall Study||2
8500339|NCT00501085|20947989|P1|NOT COMPLETED|Overall Study||432
8500340|NCT00501085|20947989|P1|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
8500341|NCT00501085|20947989|P1|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
8500342|NCT00501059|20947999|P2|NOT COMPLETED|Overall Study||1892
8500343|NCT00501059|20948000|P1|NOT COMPLETED|Overall Study||1868
8500344|NCT00501059|20947999|P2|COMPLETED|Overall Study||4384
8500345|NCT00501059|20948000|P1|COMPLETED|Overall Study||4402
8500346|NCT00501059|20947999|P2|STARTED|Overall Study||6276
8500347|NCT00501059|20948000|P1|STARTED|Overall Study||6270
8500348|NCT00501046|20948024|P2|NOT COMPLETED|Overall Study||294
8500349|NCT00501046|20948025|P1|NOT COMPLETED|Overall Study||270
8500350|NCT00501046|20948024|P2|COMPLETED|Overall Study||213
8500351|NCT00501046|20948025|P1|COMPLETED|Overall Study||238
8500352|NCT00501046|20948024|P2|STARTED|Overall Study||507
8500353|NCT00501046|20948025|P1|STARTED|Overall Study||508
8500354|NCT00501007|20948031|P2|NOT COMPLETED|Overall Study||25
8500355|NCT00501007|20948032|P1|NOT COMPLETED|Overall Study||29
8500356|NCT00501007|20948031|P2|COMPLETED|Overall Study||78
8500357|NCT00501007|20948032|P1|COMPLETED|Overall Study||71
8500358|NCT00501007|20948031|P2|STARTED|Overall Study||103
8500359|NCT00501007|20948032|P1|STARTED|Overall Study||100
8500360|NCT00500903|20948041|P3|NOT COMPLETED|Overall Study||20
8500361|NCT00500903|20948042|P2|NOT COMPLETED|Overall Study||2
8500362|NCT00500903|20948043|P1|NOT COMPLETED|Overall Study||65
8500363|NCT00500903|20948041|P3|COMPLETED|Overall Study||0
8500364|NCT00500903|20948042|P2|COMPLETED|Overall Study||0
8500365|NCT00500903|20948043|P1|COMPLETED|Overall Study||0
8500366|NCT00500903|20948041|P3|STARTED|Overall Study||20
8500367|NCT00500903|20948042|P2|STARTED|Overall Study||2
8500368|NCT00500903|20948043|P1|STARTED|Overall Study||65
8500369|NCT00500890|20948224|P2|NOT COMPLETED|Overall Study||0
8500370|NCT00500890|20948225|P1|NOT COMPLETED|Overall Study||0
8500371|NCT00500890|20948224|P2|COMPLETED|Overall Study||1
8500372|NCT00500890|20948225|P1|COMPLETED|Overall Study||1
8500373|NCT00500890|20948224|P2|STARTED|Overall Study||1
8500374|NCT00500890|20948225|P1|STARTED|Overall Study||1
8500375|NCT00500760|20948239|P2|NOT COMPLETED|Overall Study||24
8500376|NCT00500760|20948240|P1|NOT COMPLETED|Overall Study||43
8500377|NCT00500760|20948239|P2|COMPLETED|Overall Study||40
8500378|NCT00500760|20948240|P1|COMPLETED|Overall Study||46
8500379|NCT00500760|20948239|P2|Received Treatment|Overall Study||63
8500380|NCT00500760|20948240|P1|Received Treatment|Overall Study||87
8500381|NCT00500760|20948239|P2|STARTED|Overall Study||64
8500382|NCT00500760|20948240|P1|STARTED|Overall Study||89
8500383|NCT00500682|20948260|P2|NOT COMPLETED|Overall Study||287
8500384|NCT00500682|20948261|P1|NOT COMPLETED|Overall Study||306
8500385|NCT00500682|20948260|P2|COMPLETED|Overall Study||223
8500386|NCT00500682|20948261|P1|COMPLETED|Overall Study||204
8500387|NCT00500682|20948260|P2|STARTED|Overall Study||510
8500388|NCT00500682|20948261|P1|STARTED|Overall Study||510
8500413|NCT00500578|20948288|P2|NOT COMPLETED|Overall Study||0
8500414|NCT00500578|20948289|P1|NOT COMPLETED|Overall Study||0
8500415|NCT00500578|20948288|P2|COMPLETED|Overall Study|All completed|32
8500416|NCT00500578|20948289|P1|COMPLETED|Overall Study|All completed|18
8500417|NCT00500578|20948288|P2|STARTED|Overall Study||32
8500418|NCT00500578|20948289|P1|STARTED|Overall Study||18
8500419|NCT00500539|20948295|P1|NOT COMPLETED|Follow-up Period (16 Weeks)||12
8500420|NCT00500539|20948295|P1|COMPLETED|Follow-up Period (16 Weeks)||136
8500421|NCT00500539|20948295|P1|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
8500422|NCT00500539|20948295|P1|NOT COMPLETED|Treatment Period (24 Weeks)||15
8500423|NCT00500539|20948295|P1|COMPLETED|Treatment Period (24 Weeks)||140
8500424|NCT00500539|20948295|P1|STARTED|Treatment Period (24 Weeks)||155
8500425|NCT00500448|20948304|P2|NOT COMPLETED|Overall Study||0
8500426|NCT00500448|20948305|P1|NOT COMPLETED|Overall Study||0
8500427|NCT00500448|20948304|P2|COMPLETED|Overall Study||16
8500428|NCT00500448|20948305|P1|COMPLETED|Overall Study||14
8500429|NCT00500448|20948304|P2|STARTED|Overall Study||16
8500430|NCT00500448|20948305|P1|STARTED|Overall Study||14
8500431|NCT00500370|20948321|P2|NOT COMPLETED|Overall Study||34
8500432|NCT00500370|20948322|P1|NOT COMPLETED|Overall Study||33
8500433|NCT00500370|20948321|P2|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
8500434|NCT00500370|20948322|P1|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
8500435|NCT00500370|20948321|P2|Treatment Complete (Week 24)|Overall Study||54
8500436|NCT00500370|20948322|P1|Treatment Complete (Week 24)|Overall Study||48
8500437|NCT00500370|20948321|P2|Treatment Start-Baseline (Week 0)|Overall Study||79
8500438|NCT00500370|20948322|P1|Treatment Start-Baseline (Week 0)|Overall Study||73
8500439|NCT00500370|20948321|P2|STARTED|Overall Study||83
8500440|NCT00500370|20948322|P1|STARTED|Overall Study||80
8500441|NCT00500357|20948358|P1|NOT COMPLETED|Overall Study||1
8500442|NCT00500357|20948358|P1|COMPLETED|Overall Study||104
8500443|NCT00500357|20948358|P1|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
8500444|NCT00500357|20948358|P1|Received 13vPnC (Vax 3)|Overall Study||105
8500445|NCT00500357|20948358|P1|STARTED|Overall Study||105
8500446|NCT00500331|20948384|P7|NOT COMPLETED|Overall Study||2
8500447|NCT00500331|20948385|P6|NOT COMPLETED|Overall Study||5
8500448|NCT00500331|20948386|P5|NOT COMPLETED|Overall Study||4
8500449|NCT00500331|20948387|P4|NOT COMPLETED|Overall Study||10
8500450|NCT00500331|20948388|P3|NOT COMPLETED|Overall Study||5
8500451|NCT00500331|20948389|P2|NOT COMPLETED|Overall Study||5
8500452|NCT00500331|20948390|P1|NOT COMPLETED|Overall Study||15
8500453|NCT00500331|20948384|P7|COMPLETED|Overall Study||46
8500454|NCT00500331|20948385|P6|COMPLETED|Overall Study||42
8500455|NCT00500331|20948386|P5|COMPLETED|Overall Study||44
8500456|NCT00500331|20948387|P4|COMPLETED|Overall Study||38
8500457|NCT00500331|20948388|P3|COMPLETED|Overall Study||43
8500458|NCT00500331|20948389|P2|COMPLETED|Overall Study||42
8500459|NCT00500331|20948390|P1|COMPLETED|Overall Study||33
8500460|NCT00500331|20948384|P7|STARTED|Overall Study||48
8500461|NCT00500331|20948385|P6|STARTED|Overall Study||47
8500462|NCT00500331|20948386|P5|STARTED|Overall Study||48
8500463|NCT00500331|20948387|P4|STARTED|Overall Study||48
8500464|NCT00500331|20948388|P3|STARTED|Overall Study||48
8500465|NCT00500331|20948389|P2|STARTED|Overall Study||47
8500466|NCT00500331|20948390|P1|STARTED|Overall Study||48
8500467|NCT00500318|20948527|P2|NOT COMPLETED|Overall Study||17
8500468|NCT00500318|20948528|P1|NOT COMPLETED|Overall Study||5
8500469|NCT00500318|20948527|P2|COMPLETED|Overall Study||78
8500470|NCT00500318|20948528|P1|COMPLETED|Overall Study||81
8500471|NCT00500318|20948527|P2|STARTED|Overall Study||95
8500472|NCT00500318|20948528|P1|STARTED|Overall Study||86
8500473|NCT00500292|20948545|P3|NOT COMPLETED|Overall Study||27
8500474|NCT00500292|20948546|P2|NOT COMPLETED|Overall Study||31
8500475|NCT00500292|20948547|P1|NOT COMPLETED|Overall Study||25
8500476|NCT00500292|20948545|P3|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
8500477|NCT00500292|20948546|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
8500478|NCT00500292|20948547|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
8500479|NCT00500292|20948545|P3|STARTED|Overall Study|randomised patients|37
8500480|NCT00500292|20948546|P2|STARTED|Overall Study|randomised patients|35
8500481|NCT00500292|20948547|P1|STARTED|Overall Study|randomised patients|32
8500482|NCT00500240|20948557|P2|NOT COMPLETED|Overall Study||0
8500483|NCT00500240|20948558|P1|NOT COMPLETED|Overall Study||0
8500484|NCT00500240|20948557|P2|COMPLETED|Overall Study||26
8500485|NCT00500240|20948558|P1|COMPLETED|Overall Study||25
8500486|NCT00500240|20948557|P2|STARTED|Overall Study||26
8500487|NCT00500240|20948558|P1|STARTED|Overall Study||25
8500506|NCT00500110|20948577|P1|NOT COMPLETED|Overall Study||3
8500507|NCT00500110|20948577|P1|COMPLETED|Overall Study||36
8500508|NCT00500110|20948577|P1|STARTED|Overall Study||39
8500518|NCT00500045|20948590|P1|NOT COMPLETED|Overall Study||0
8500519|NCT00500045|20948590|P1|COMPLETED|Overall Study||0
8500520|NCT00500045|20948590|P1|STARTED|Overall Study||0
8500521|NCT00499915|20948597|P2|NOT COMPLETED|Overall Study||6
8500522|NCT00499915|20948598|P1|NOT COMPLETED|Overall Study||15
8500523|NCT00499915|20948597|P2|COMPLETED|Overall Study||76
8500524|NCT00499915|20948598|P1|COMPLETED|Overall Study||68
8500525|NCT00499915|20948597|P2|STARTED|Overall Study||82
8500526|NCT00499915|20948598|P1|STARTED|Overall Study||83
8500527|NCT00499889|20948604|P1|NOT COMPLETED|Overall Study||1
8500528|NCT00499889|20948604|P1|COMPLETED|Overall Study||41
8500529|NCT00499889|20948604|P1|STARTED|Overall Study||42
8500530|NCT00499863|20948612|P2|NOT COMPLETED|Overall Study||43
8500531|NCT00499863|20948613|P1|NOT COMPLETED|Overall Study||50
8500532|NCT00499863|20948612|P2|COMPLETED|Overall Study||29
8500533|NCT00499863|20948613|P1|COMPLETED|Overall Study||95
8500534|NCT00499863|20948612|P2|STARTED|Overall Study||72
8500535|NCT00499863|20948613|P1|STARTED|Overall Study||145
8500536|NCT00500266|20948641|P1|NOT COMPLETED|Overall Study||13
8500537|NCT00500266|20948641|P1|COMPLETED|Overall Study||1040
8500538|NCT00500266|20948641|P1|Treated|Overall Study||1049
8500539|NCT00500266|20948641|P1|STARTED|Overall Study||1053
8500540|NCT00499746|20948648|P1|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
8500541|NCT00499746|20948648|P1|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
8500542|NCT00499746|20948648|P1|STARTED|Phase 3 (9-14 One Day Sessions)||8
8500543|NCT00499746|20948648|P1|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
8500544|NCT00499746|20948648|P1|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
8500545|NCT00499746|20948648|P1|STARTED|Phase 2 (6-9 One Day Sessions)||8
8500546|NCT00499746|20948648|P1|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
8500547|NCT00499746|20948648|P1|COMPLETED|Phase 1(6-9 One Day Sessions)||8
8500548|NCT00499746|20948648|P1|STARTED|Phase 1(6-9 One Day Sessions)||20
8500549|NCT00499694|20948717|P1|NOT COMPLETED|Overall Study||1
8500550|NCT00499694|20948717|P1|COMPLETED|Overall Study||30
8500551|NCT00499694|20948717|P1|STARTED|Overall Study||31
8500552|NCT00499681|20948726|P2|NOT COMPLETED|Overall Study||2
8500553|NCT00499681|20948727|P1|NOT COMPLETED|Overall Study||0
8500554|NCT00499681|20948726|P2|COMPLETED|Overall Study||0
8500555|NCT00499681|20948727|P1|COMPLETED|Overall Study||4
8500556|NCT00499681|20948726|P2|STARTED|Overall Study||2
8500557|NCT00499681|20948727|P1|STARTED|Overall Study||4
8500558|NCT00499655|20948735|P2|NOT COMPLETED|Overall Study||0
8500559|NCT00499655|20948736|P1|NOT COMPLETED|Overall Study||0
8500560|NCT00499655|20948735|P2|COMPLETED|Overall Study||54
8500561|NCT00499655|20948736|P1|COMPLETED|Overall Study||53
8500562|NCT00499655|20948735|P2|STARTED|Overall Study||54
8500563|NCT00499655|20948736|P1|STARTED|Overall Study||53
8500576|NCT00499603|20948802|P2|NOT COMPLETED|Overall Study||1
8500577|NCT00499603|20948803|P1|NOT COMPLETED|Overall Study||0
8500578|NCT00499603|20948802|P2|COMPLETED|Overall Study||22
8500579|NCT00499603|20948803|P1|COMPLETED|Overall Study||27
8500580|NCT00499603|20948802|P2|STARTED|Overall Study||23
8500581|NCT00499603|20948803|P1|STARTED|Overall Study||27
8500582|NCT00499590|20948816|P3|NOT COMPLETED|Overall Study||113
8500583|NCT00499590|20948817|P2|NOT COMPLETED|Overall Study||112
8500584|NCT00499590|20948818|P1|NOT COMPLETED|Overall Study||113
8500585|NCT00499590|20948816|P3|COMPLETED|Overall Study||0
8500586|NCT00499590|20948817|P2|COMPLETED|Overall Study||0
8500587|NCT00499590|20948818|P1|COMPLETED|Overall Study||0
8500588|NCT00499590|20948816|P3|STARTED|Overall Study||113
8500589|NCT00499590|20948817|P2|STARTED|Overall Study||112
8500590|NCT00499590|20948818|P1|STARTED|Overall Study||113
8500591|NCT00499486|20948829|P1|NOT COMPLETED|Overall Study||16
8500592|NCT00499486|20948829|P1|COMPLETED|Overall Study||31
8500593|NCT00499486|20948829|P1|STARTED|Overall Study||47
8500594|NCT00499473|20948837|P2|NOT COMPLETED|Overall Study||0
8500595|NCT00499473|20948838|P1|NOT COMPLETED|Overall Study||6
8500596|NCT00499473|20948837|P2|COMPLETED|Overall Study||4
8500597|NCT00499473|20948838|P1|COMPLETED|Overall Study|Patients evaluable|21
8500598|NCT00499473|20948837|P2|STARTED|Overall Study||4
8500599|NCT00499473|20948838|P1|STARTED|Overall Study||27
8500600|NCT00499460|20948856|P2|NOT COMPLETED|Intervention 2 (30 Days)||1
8500601|NCT00499460|20948857|P1|NOT COMPLETED|Intervention 2 (30 Days)||0
8500602|NCT00499460|20948856|P2|COMPLETED|Intervention 2 (30 Days)||6
8500603|NCT00499460|20948857|P1|COMPLETED|Intervention 2 (30 Days)||6
8500604|NCT00499460|20948856|P2|STARTED|Intervention 2 (30 Days)||7
8500605|NCT00499460|20948857|P1|STARTED|Intervention 2 (30 Days)||6
8500606|NCT00499460|20948856|P2|NOT COMPLETED|Intervention 1 (30 Days)||0
8500607|NCT00499460|20948857|P1|NOT COMPLETED|Intervention 1 (30 Days)||2
8500608|NCT00499460|20948856|P2|COMPLETED|Intervention 1 (30 Days)||7
8500609|NCT00499460|20948857|P1|COMPLETED|Intervention 1 (30 Days)||6
8500610|NCT00499460|20948856|P2|STARTED|Intervention 1 (30 Days)||7
8500611|NCT00499460|20948857|P1|STARTED|Intervention 1 (30 Days)||8
8500612|NCT00499447|20948873|P1|NOT COMPLETED|Overall Study||0
8500613|NCT00499447|20948873|P1|COMPLETED|Overall Study||13
8500614|NCT00499447|20948873|P1|STARTED|Overall Study||13
8500615|NCT00499408|20948877|P1|NOT COMPLETED|Overall Study||0
8500616|NCT00499408|20948877|P1|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
8500617|NCT00499408|20948877|P1|STARTED|Overall Study||26
8500618|NCT00499369|20948890|P5|NOT COMPLETED|Overall Study||12
8500619|NCT00499369|20948891|P4|NOT COMPLETED|Overall Study||9
8500620|NCT00499369|20948892|P3|NOT COMPLETED|Overall Study||17
8500621|NCT00499369|20948893|P2|NOT COMPLETED|Overall Study||18
8500622|NCT00499369|20948894|P1|NOT COMPLETED|Overall Study||16
8500623|NCT00499369|20948890|P5|COMPLETED|Overall Study||0
8500624|NCT00499369|20948891|P4|COMPLETED|Overall Study||0
8500625|NCT00499369|20948892|P3|COMPLETED|Overall Study||0
8500626|NCT00499369|20948893|P2|COMPLETED|Overall Study||0
8500627|NCT00499369|20948894|P1|COMPLETED|Overall Study||0
8500628|NCT00499369|20948890|P5|Eligible|Overall Study||12
8500629|NCT00499369|20948891|P4|Eligible|Overall Study||8
8500630|NCT00499369|20948892|P3|Eligible|Overall Study||16
8500631|NCT00499369|20948893|P2|Eligible|Overall Study||16
8500632|NCT00499369|20948894|P1|Eligible|Overall Study||14
8500633|NCT00499369|20948890|P5|STARTED|Overall Study||12
8500634|NCT00499369|20948891|P4|STARTED|Overall Study||9
8500635|NCT00499369|20948892|P3|STARTED|Overall Study||17
8500636|NCT00499369|20948893|P2|STARTED|Overall Study||18
8500637|NCT00499369|20948894|P1|STARTED|Overall Study||16
8500638|NCT00499343|20948923|P2|NOT COMPLETED|Overall Study||0
8500639|NCT00499343|20948924|P1|NOT COMPLETED|Overall Study||0
8500640|NCT00499343|20948923|P2|COMPLETED|Overall Study||43
8500641|NCT00499343|20948924|P1|COMPLETED|Overall Study||41
8500642|NCT00499343|20948923|P2|STARTED|Overall Study||43
8500643|NCT00499343|20948924|P1|STARTED|Overall Study||41
8500644|NCT00499252|20948930|P1|NOT COMPLETED|Overall Study||12
8500645|NCT00499252|20948930|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
8500646|NCT00499252|20948930|P1|STARTED|Overall Study||51
8500647|NCT00499122|20948940|P1|NOT COMPLETED|Overall Study||2
8500648|NCT00499122|20948940|P1|COMPLETED|Overall Study||39
8500649|NCT00499122|20948940|P1|STARTED|Overall Study||41
8500650|NCT00499109|20948948|P2|NOT COMPLETED|Overall Study||7
8500651|NCT00499109|20948949|P1|NOT COMPLETED|Overall Study||18
8500652|NCT00499109|20948948|P2|COMPLETED|Overall Study||85
8500653|NCT00499109|20948949|P1|COMPLETED|Overall Study||165
8500654|NCT00499109|20948948|P2|STARTED|Overall Study||92
8500655|NCT00499109|20948949|P1|STARTED|Overall Study||183
8500656|NCT00499096|20948964|P2|NOT COMPLETED|Overall Study||20
8500657|NCT00499096|20948965|P1|NOT COMPLETED|Overall Study||23
8500658|NCT00499096|20948964|P2|COMPLETED|Overall Study||40
8500659|NCT00499096|20948965|P1|COMPLETED|Overall Study||35
8500660|NCT00499096|20948964|P2|STARTED|Overall Study||60
8500661|NCT00499096|20948965|P1|STARTED|Overall Study||58
8500662|NCT00499083|20948983|P1|NOT COMPLETED|Overall Study||3
8500663|NCT00499083|20948983|P1|COMPLETED|Overall Study||14
8500664|NCT00499083|20948983|P1|Participants at Moffitt Cancer Center|Overall Study||14
8500665|NCT00499083|20948983|P1|Participants at UNMC|Overall Study||3
8500666|NCT00499083|20948983|P1|STARTED|Overall Study||17
8500667|NCT00499031|20948990|P1|NOT COMPLETED|Overall Study||3
8500668|NCT00499031|20948990|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
8500669|NCT00499031|20948990|P1|STARTED|Overall Study|Total number participants enrolled on study|38
8500670|NCT00498940|20948997|P2|NOT COMPLETED|Overall Study||0
8500671|NCT00498940|20948998|P1|NOT COMPLETED|Overall Study||0
8500672|NCT00498940|20948997|P2|COMPLETED|Overall Study||31
8500673|NCT00498940|20948998|P1|COMPLETED|Overall Study||30
8500674|NCT00498940|20948997|P2|STARTED|Overall Study||31
8500675|NCT00498940|20948998|P1|STARTED|Overall Study||30
8500676|NCT00498927|20949006|P1|NOT COMPLETED|Overall Study||0
8500677|NCT00498927|20949006|P1|COMPLETED|Overall Study||47
8500678|NCT00498927|20949006|P1|STARTED|Overall Study||47
8500679|NCT00498797|20949013|P2|NOT COMPLETED|Overall Study||29
8500680|NCT00498797|20949014|P1|NOT COMPLETED|Overall Study||38
8500681|NCT00498797|20949013|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
8500682|NCT00498797|20949014|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
8500683|NCT00498797|20949013|P2|STARTED|Overall Study|randomised patients|43
8500684|NCT00498797|20949014|P1|STARTED|Overall Study|randomised patients|43
8500685|NCT00498706|20949024|P2|NOT COMPLETED|Overall Study||0
8500686|NCT00498706|20949025|P1|NOT COMPLETED|Overall Study||0
8500687|NCT00498706|20949024|P2|COMPLETED|Overall Study||162
8500688|NCT00498706|20949025|P1|COMPLETED|Overall Study||163
8500689|NCT00498706|20949024|P2|Post Treatment Week 18|Overall Study||162
8500690|NCT00498706|20949025|P1|Post Treatment Week 18|Overall Study||163
8500691|NCT00498706|20949024|P2|STARTED|Overall Study||162
8500692|NCT00498706|20949025|P1|STARTED|Overall Study||163
8500693|NCT00498628|20949039|P2|NOT COMPLETED|Overall Study||21
8500694|NCT00498628|20949040|P1|NOT COMPLETED|Overall Study||15
8500695|NCT00498628|20949039|P2|COMPLETED|Overall Study||92
8500696|NCT00498628|20949040|P1|COMPLETED|Overall Study||90
8500697|NCT00498628|20949039|P2|STARTED|Overall Study||113
8500698|NCT00498628|20949040|P1|STARTED|Overall Study||105
8500699|NCT00498615|20949072|P6|NOT COMPLETED|Placebo||0
8500700|NCT00498615|20949073|P5|NOT COMPLETED|Placebo||0
8500701|NCT00498615|20949074|P4|NOT COMPLETED|Placebo||0
8500702|NCT00498615|20949075|P3|NOT COMPLETED|Placebo||0
8500703|NCT00498615|20949076|P2|NOT COMPLETED|Placebo||0
8500704|NCT00498615|20949077|P1|NOT COMPLETED|Placebo||0
8500705|NCT00498615|20949072|P6|COMPLETED|Placebo||3
8500706|NCT00498615|20949073|P5|COMPLETED|Placebo||3
8500707|NCT00498615|20949074|P4|COMPLETED|Placebo||2
8500708|NCT00498615|20949075|P3|COMPLETED|Placebo||3
8500709|NCT00498615|20949076|P2|COMPLETED|Placebo||4
8500710|NCT00498615|20949077|P1|COMPLETED|Placebo||2
8500711|NCT00498615|20949072|P6|STARTED|Placebo||3
8500712|NCT00498615|20949073|P5|STARTED|Placebo||3
8500713|NCT00498615|20949074|P4|STARTED|Placebo||2
8500714|NCT00498615|20949075|P3|STARTED|Placebo||3
8500715|NCT00498615|20949076|P2|STARTED|Placebo||4
8500716|NCT00498615|20949077|P1|STARTED|Placebo||2
8500717|NCT00498615|20949072|P6|NOT COMPLETED|Fasudil 40mg||0
8500718|NCT00498615|20949073|P5|NOT COMPLETED|Fasudil 40mg||0
8500719|NCT00498615|20949074|P4|NOT COMPLETED|Fasudil 40mg||0
8500720|NCT00498615|20949075|P3|NOT COMPLETED|Fasudil 40mg||0
8500721|NCT00498615|20949076|P2|NOT COMPLETED|Fasudil 40mg||0
8500722|NCT00498615|20949077|P1|NOT COMPLETED|Fasudil 40mg||0
8500723|NCT00498615|20949072|P6|COMPLETED|Fasudil 40mg||3
8500724|NCT00498615|20949073|P5|COMPLETED|Fasudil 40mg||3
8500725|NCT00498615|20949074|P4|COMPLETED|Fasudil 40mg||2
8500726|NCT00498615|20949075|P3|COMPLETED|Fasudil 40mg||3
8500727|NCT00498615|20949076|P2|COMPLETED|Fasudil 40mg||4
8500728|NCT00498615|20949077|P1|COMPLETED|Fasudil 40mg||2
8500729|NCT00498615|20949072|P6|STARTED|Fasudil 40mg||3
8500730|NCT00498615|20949073|P5|STARTED|Fasudil 40mg||3
8500731|NCT00498615|20949074|P4|STARTED|Fasudil 40mg||2
8500732|NCT00498615|20949075|P3|STARTED|Fasudil 40mg||3
8500733|NCT00498615|20949076|P2|STARTED|Fasudil 40mg||4
8500734|NCT00498615|20949077|P1|STARTED|Fasudil 40mg||2
8500735|NCT00498615|20949072|P6|NOT COMPLETED|Fasudil 80mg||0
8500736|NCT00498615|20949073|P5|NOT COMPLETED|Fasudil 80mg||0
8500737|NCT00498615|20949074|P4|NOT COMPLETED|Fasudil 80mg||0
8500738|NCT00498615|20949075|P3|NOT COMPLETED|Fasudil 80mg||0
8500739|NCT00498615|20949076|P2|NOT COMPLETED|Fasudil 80mg||0
8500740|NCT00498615|20949077|P1|NOT COMPLETED|Fasudil 80mg||0
8500741|NCT00498615|20949072|P6|COMPLETED|Fasudil 80mg||3
8500742|NCT00498615|20949073|P5|COMPLETED|Fasudil 80mg||3
8500743|NCT00498615|20949074|P4|COMPLETED|Fasudil 80mg||2
8500744|NCT00498615|20949075|P3|COMPLETED|Fasudil 80mg||3
8500745|NCT00498615|20949076|P2|COMPLETED|Fasudil 80mg||4
8500746|NCT00498615|20949077|P1|COMPLETED|Fasudil 80mg||2
8500747|NCT00498615|20949072|P6|STARTED|Fasudil 80mg||3
8500748|NCT00498615|20949073|P5|STARTED|Fasudil 80mg||3
8500749|NCT00498615|20949074|P4|STARTED|Fasudil 80mg||2
8500750|NCT00498615|20949075|P3|STARTED|Fasudil 80mg||3
8500751|NCT00498615|20949076|P2|STARTED|Fasudil 80mg||4
8500752|NCT00498615|20949077|P1|STARTED|Fasudil 80mg||2
8500753|NCT00498602|20949098|P7|NOT COMPLETED|Overall Study||2
8500754|NCT00498602|20949099|P6|NOT COMPLETED|Overall Study||13
8500755|NCT00498602|20949100|P5|NOT COMPLETED|Overall Study||4
8500756|NCT00498602|20949101|P4|NOT COMPLETED|Overall Study||5
8500757|NCT00498602|20949102|P3|NOT COMPLETED|Overall Study||8
8500758|NCT00498602|20949103|P2|NOT COMPLETED|Overall Study||10
8500759|NCT00498602|20949104|P1|NOT COMPLETED|Overall Study||10
8500760|NCT00498602|20949098|P7|COMPLETED|Overall Study||15
8500761|NCT00498602|20949099|P6|COMPLETED|Overall Study||31
8500762|NCT00498602|20949100|P5|COMPLETED|Overall Study||8
8500763|NCT00498602|20949101|P4|COMPLETED|Overall Study||30
8500764|NCT00498602|20949102|P3|COMPLETED|Overall Study||32
8500765|NCT00498602|20949103|P2|COMPLETED|Overall Study||51
8500766|NCT00498602|20949104|P1|COMPLETED|Overall Study||26
8500767|NCT00498602|20949098|P7|Treated|Overall Study||17
8500768|NCT00498602|20949099|P6|Treated|Overall Study||44
8500769|NCT00498602|20949100|P5|Treated|Overall Study||12
8500770|NCT00498602|20949101|P4|Treated|Overall Study||35
8500771|NCT00498602|20949102|P3|Treated|Overall Study||40
8500772|NCT00498602|20949103|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
8500773|NCT00498602|20949104|P1|Treated|Overall Study||36
8500774|NCT00498602|20949098|P7|STARTED|Overall Study||17
8500775|NCT00498602|20949099|P6|STARTED|Overall Study||44
8500776|NCT00498602|20949100|P5|STARTED|Overall Study||12
8500777|NCT00498602|20949101|P4|STARTED|Overall Study||35
8500778|NCT00498602|20949102|P3|STARTED|Overall Study||40
8500779|NCT00498602|20949103|P2|STARTED|Overall Study||61
8500780|NCT00498602|20949104|P1|STARTED|Overall Study||36
8500781|NCT00498550|20949143|P2|NOT COMPLETED|Overall Study||1
8500782|NCT00498550|20949144|P1|NOT COMPLETED|Overall Study||0
8500783|NCT00498550|20949143|P2|COMPLETED|Overall Study||15
8500784|NCT00498550|20949144|P1|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
8500785|NCT00498550|20949143|P2|STARTED|Overall Study||16
8500786|NCT00498550|20949144|P1|STARTED|Overall Study||15
8500787|NCT00498485|20949152|P2|NOT COMPLETED|Overall Study||5
8500788|NCT00498485|20949153|P1|NOT COMPLETED|Overall Study||1
8500789|NCT00498485|20949152|P2|COMPLETED|Overall Study||5
8500790|NCT00498485|20949153|P1|COMPLETED|Overall Study||6
8500791|NCT00498485|20949152|P2|STARTED|Overall Study||10
8500792|NCT00498485|20949153|P1|STARTED|Overall Study||7
8500793|NCT00498433|20949164|P3|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
8500794|NCT00498433|20949165|P2|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
8500795|NCT00498433|20949166|P1|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
8500796|NCT00498433|20949164|P3|COMPLETED|Part 2: Double Blind (12 Weeks)||8
8500797|NCT00498433|20949165|P2|COMPLETED|Part 2: Double Blind (12 Weeks)||8
8500798|NCT00498433|20949166|P1|COMPLETED|Part 2: Double Blind (12 Weeks)||0
8500799|NCT00498433|20949164|P3|STARTED|Part 2: Double Blind (12 Weeks)||8
8500800|NCT00498433|20949165|P2|STARTED|Part 2: Double Blind (12 Weeks)||8
8500801|NCT00498433|20949166|P1|STARTED|Part 2: Double Blind (12 Weeks)||0
8500802|NCT00498433|20949164|P3|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
8500803|NCT00498433|20949165|P2|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
8500804|NCT00498433|20949166|P1|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
8500805|NCT00498433|20949164|P3|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
8500806|NCT00498433|20949165|P2|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
8500807|NCT00498433|20949166|P1|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
8500808|NCT00498433|20949164|P3|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
8500809|NCT00498433|20949165|P2|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
8500810|NCT00498433|20949166|P1|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
8500811|NCT00498433|20949164|P3|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8500812|NCT00498433|20949165|P2|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8500813|NCT00498433|20949166|P1|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8500814|NCT00498433|20949164|P3|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
8500815|NCT00498433|20949165|P2|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8500816|NCT00498433|20949166|P1|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8500817|NCT00498433|20949164|P3|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
8500818|NCT00498433|20949165|P2|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8500819|NCT00498433|20949166|P1|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
8500820|NCT00498433|20949164|P3|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8500821|NCT00498433|20949165|P2|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8500822|NCT00498433|20949166|P1|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8500823|NCT00498433|20949164|P3|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8500824|NCT00498433|20949165|P2|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
8500825|NCT00498433|20949166|P1|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8500826|NCT00498433|20949164|P3|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8500827|NCT00498433|20949165|P2|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
8500828|NCT00498433|20949166|P1|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
8500829|NCT00498433|20949164|P3|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8500830|NCT00498433|20949165|P2|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8500831|NCT00498433|20949166|P1|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8500832|NCT00498433|20949164|P3|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8500833|NCT00498433|20949165|P2|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8500834|NCT00498433|20949166|P1|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
8500835|NCT00498433|20949164|P3|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8500836|NCT00498433|20949165|P2|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
8500837|NCT00498433|20949166|P1|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
8500838|NCT00498368|20949211|P2|NOT COMPLETED|Overall Study||2
8500839|NCT00498368|20949212|P1|NOT COMPLETED|Overall Study||3
8500840|NCT00498368|20949211|P2|COMPLETED|Overall Study||15
8500841|NCT00498368|20949212|P1|COMPLETED|Overall Study||14
8500842|NCT00498368|20949211|P2|STARTED|Overall Study||17
8500843|NCT00498368|20949212|P1|STARTED|Overall Study||17
8500844|NCT00498355|20949224|P1|NOT COMPLETED|Overall Study||1
8500845|NCT00498355|20949224|P1|COMPLETED|Overall Study||6
8500846|NCT00498355|20949224|P1|STARTED|Overall Study||7
8500847|NCT00498186|20949232|P1|NOT COMPLETED|Overall Study||173
8500848|NCT00498186|20949232|P1|COMPLETED|Overall Study||122
8500849|NCT00498186|20949232|P1|STARTED|Overall Study||295
8500850|NCT00498173|20949239|P3|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8500851|NCT00498173|20949240|P2|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8500852|NCT00498173|20949241|P1|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8500853|NCT00498173|20949239|P3|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
8500854|NCT00498173|20949240|P2|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8500855|NCT00498173|20949241|P1|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8500856|NCT00498173|20949239|P3|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
8500857|NCT00498173|20949240|P2|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8500858|NCT00498173|20949241|P1|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
8500859|NCT00498173|20949239|P3|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
8500860|NCT00498173|20949240|P2|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
8500861|NCT00498173|20949241|P1|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
8500862|NCT00498173|20949239|P3|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
8500863|NCT00498173|20949240|P2|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
8500864|NCT00498173|20949241|P1|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
8500865|NCT00498173|20949239|P3|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
8500866|NCT00498173|20949240|P2|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
8500867|NCT00498173|20949241|P1|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
8500880|NCT00497770|20949323|P4|NOT COMPLETED|Overall Study||0
8500881|NCT00497770|20949324|P3|NOT COMPLETED|Overall Study||0
8500882|NCT00497770|20949325|P2|NOT COMPLETED|Overall Study||0
8500883|NCT00497770|20949326|P1|NOT COMPLETED|Overall Study||0
8500884|NCT00497770|20949323|P4|COMPLETED|Overall Study||28
8500885|NCT00497770|20949324|P3|COMPLETED|Overall Study||37
8500886|NCT00497770|20949325|P2|COMPLETED|Overall Study||65
8500887|NCT00497770|20949326|P1|COMPLETED|Overall Study||304
8500888|NCT00497770|20949323|P4|STARTED|Overall Study||28
8500889|NCT00497770|20949324|P3|STARTED|Overall Study||37
8500890|NCT00497770|20949325|P2|STARTED|Overall Study||65
8500891|NCT00497770|20949326|P1|STARTED|Overall Study||304
8500892|NCT00497198|20949378|P2|NOT COMPLETED|Overall Study||5
8500893|NCT00497198|20949379|P1|NOT COMPLETED|Overall Study||5
8500894|NCT00497198|20949378|P2|COMPLETED|Overall Study||86
8500895|NCT00497198|20949379|P1|COMPLETED|Overall Study||87
8500896|NCT00497198|20949378|P2|STARTED|Overall Study||91
8500897|NCT00497198|20949379|P1|STARTED|Overall Study||92
8500898|NCT00497146|20949395|P2|NOT COMPLETED|Long-term Follow-up Period||6
8500899|NCT00497146|20949396|P1|NOT COMPLETED|Long-term Follow-up Period||15
8500900|NCT00497146|20949395|P2|COMPLETED|Long-term Follow-up Period||66
8500901|NCT00497146|20949396|P1|COMPLETED|Long-term Follow-up Period||50
8500902|NCT00497146|20949395|P2|STARTED|Long-term Follow-up Period||72
8500903|NCT00497146|20949396|P1|STARTED|Long-term Follow-up Period||65
8500904|NCT00497146|20949395|P2|NOT COMPLETED|Treatment Period||21
8500905|NCT00497146|20949396|P1|NOT COMPLETED|Treatment Period||27
8500906|NCT00497146|20949395|P2|COMPLETED|Treatment Period||91
8500907|NCT00497146|20949396|P1|COMPLETED|Treatment Period||88
8500908|NCT00497146|20949395|P2|STARTED|Treatment Period||112
8500909|NCT00497146|20949396|P1|STARTED|Treatment Period||115
8500910|NCT00497081|20949438|P2|NOT COMPLETED|Overall Study||2
8500911|NCT00497081|20949439|P1|NOT COMPLETED|Overall Study||2
8500912|NCT00497081|20949438|P2|COMPLETED|Overall Study||28
8500913|NCT00497081|20949439|P1|COMPLETED|Overall Study||28
8500914|NCT00497081|20949438|P2|STARTED|Overall Study||30
8500915|NCT00497081|20949439|P1|STARTED|Overall Study||30
8500916|NCT00497055|20949451|P2|NOT COMPLETED|Overall Study||5
8500917|NCT00497055|20949452|P1|NOT COMPLETED|Overall Study||10
8500918|NCT00497055|20949451|P2|COMPLETED|Overall Study||40
8500919|NCT00497055|20949452|P1|COMPLETED|Overall Study||35
8500920|NCT00497055|20949451|P2|STARTED|Overall Study||45
8500921|NCT00497055|20949452|P1|STARTED|Overall Study||45
8500922|NCT00496964|20949464|P2|NOT COMPLETED|Overall Study||1
8500923|NCT00496964|20949465|P1|NOT COMPLETED|Overall Study||0
8500924|NCT00496964|20949464|P2|COMPLETED|Overall Study||3
8500925|NCT00496964|20949465|P1|COMPLETED|Overall Study||1
8500926|NCT00496964|20949464|P2|STARTED|Overall Study||4
8500927|NCT00496964|20949465|P1|STARTED|Overall Study||1
8500928|NCT00496873|20949483|P1|NOT COMPLETED|Overall Study||7
8500929|NCT00496873|20949483|P1|COMPLETED|Overall Study||78
8500930|NCT00496873|20949483|P1|STARTED|Overall Study||85
8500931|NCT00496860|20949492|P3|NOT COMPLETED|Overall Study||0
8500932|NCT00496860|20949493|P2|NOT COMPLETED|Overall Study||1
8500933|NCT00496860|20949494|P1|NOT COMPLETED|Overall Study||1
8500934|NCT00496860|20949492|P3|COMPLETED|Overall Study||6
8500935|NCT00496860|20949493|P2|COMPLETED|Overall Study||15
8500936|NCT00496860|20949494|P1|COMPLETED|Overall Study||3
8500937|NCT00496860|20949492|P3|STARTED|Overall Study||6
8500938|NCT00496860|20949493|P2|STARTED|Overall Study||16
8500939|NCT00496860|20949494|P1|STARTED|Overall Study||4
8500940|NCT00496834|20949516|P2|NOT COMPLETED|Overall Study||13
8500941|NCT00496834|20949517|P1|NOT COMPLETED|Overall Study||18
8500942|NCT00496834|20949516|P2|COMPLETED|Overall Study||87
8500943|NCT00496834|20949517|P1|COMPLETED|Overall Study||83
8500944|NCT00496834|20949516|P2|STARTED|Overall Study||100
8500945|NCT00496834|20949517|P1|STARTED|Overall Study||101
8500946|NCT00496808|20949529|P1|NOT COMPLETED|Overall Study||0
8500947|NCT00496808|20949529|P1|COMPLETED|Overall Study||69
8500948|NCT00496808|20949529|P1|STARTED|Overall Study||69
8500949|NCT00496782|20949536|P2|NOT COMPLETED|Overall Study||2
8500950|NCT00496782|20949537|P1|NOT COMPLETED|Overall Study||1
8500951|NCT00496782|20949536|P2|COMPLETED|Overall Study||5
8500952|NCT00496782|20949537|P1|COMPLETED|Overall Study||8
8500953|NCT00496782|20949536|P2|STARTED|Overall Study||7
8500954|NCT00496782|20949537|P1|STARTED|Overall Study||9
8500955|NCT00496769|20949571|P3|NOT COMPLETED|Open Label||1011
8500956|NCT00496769|20949572|P2|NOT COMPLETED|Open Label||0
8500957|NCT00496769|20949573|P1|NOT COMPLETED|Open Label||0
8500958|NCT00496769|20949571|P3|COMPLETED|Open Label||2264
8500959|NCT00496769|20949572|P2|COMPLETED|Open Label||0
8500960|NCT00496769|20949573|P1|COMPLETED|Open Label||0
8500961|NCT00496769|20949571|P3|STARTED|Open Label||3275
8500962|NCT00496769|20949572|P2|STARTED|Open Label||0
8500963|NCT00496769|20949573|P1|STARTED|Open Label||0
8500964|NCT00496769|20949571|P3|NOT COMPLETED|Double Blind||0
8500965|NCT00496769|20949572|P2|NOT COMPLETED|Double Blind||649
8500966|NCT00496769|20949573|P1|NOT COMPLETED|Double Blind||558
8500967|NCT00496769|20949571|P3|COMPLETED|Double Blind||0
8500968|NCT00496769|20949572|P2|COMPLETED|Double Blind||2142
8500969|NCT00496769|20949573|P1|COMPLETED|Double Blind||2249
8500970|NCT00496769|20949571|P3|Received Treatment|Double Blind||0
8500971|NCT00496769|20949572|P2|Received Treatment|Double Blind||2708
8500972|NCT00496769|20949573|P1|Received Treatment|Double Blind||2798
8500973|NCT00496769|20949571|P3|STARTED|Double Blind||0
8500974|NCT00496769|20949572|P2|STARTED|Double Blind|Randomized|2791
8500975|NCT00496769|20949573|P1|STARTED|Double Blind|Randomized|2807
8500976|NCT00496756|20949596|P1|NOT COMPLETED|Overall Study||3
8500977|NCT00496756|20949596|P1|COMPLETED|Overall Study||11
8500978|NCT00496756|20949596|P1|STARTED|Overall Study||14
8500979|NCT00496730|20949603|P2|NOT COMPLETED|Overall Study||5
8500980|NCT00496730|20949604|P1|NOT COMPLETED|Overall Study||6
8500981|NCT00496730|20949603|P2|COMPLETED|Overall Study||121
8500982|NCT00496730|20949604|P1|COMPLETED|Overall Study||124
8500983|NCT00496730|20949603|P2|STARTED|Overall Study||126
8500984|NCT00496730|20949604|P1|STARTED|Overall Study||130
8500985|NCT00496626|20949616|P2|NOT COMPLETED|Overall Study||6
8500986|NCT00496626|20949617|P1|NOT COMPLETED|Overall Study||6
8500987|NCT00496626|20949616|P2|COMPLETED|Overall Study||292
8500988|NCT00496626|20949617|P1|COMPLETED|Overall Study||296
8500989|NCT00496626|20949616|P2|STARTED|Overall Study||298
8500990|NCT00496626|20949617|P1|STARTED|Overall Study||302
8500991|NCT00496587|20949629|P1|NOT COMPLETED|Overall Study||31
8500992|NCT00496587|20949629|P1|COMPLETED|Overall Study||3
8500993|NCT00496587|20949629|P1|STARTED|Overall Study||34
8500994|NCT00496483|20949635|P1|NOT COMPLETED|Overall Study||12
8500995|NCT00496483|20949635|P1|COMPLETED|Overall Study||48
8500996|NCT00496483|20949635|P1|Dosed|Overall Study||51
8500997|NCT00496483|20949635|P1|STARTED|Overall Study||60
8500998|NCT00496470|20949652|P2|NOT COMPLETED|Overall Study||29
8500999|NCT00496470|20949653|P1|NOT COMPLETED|Overall Study||26
8501000|NCT00496470|20949652|P2|COMPLETED|Overall Study||302
8501001|NCT00496470|20949653|P1|COMPLETED|Overall Study||303
8501002|NCT00496470|20949652|P2|Received Study Medication|Overall Study||330
8501003|NCT00496470|20949653|P1|Received Study Medication|Overall Study||329
8501004|NCT00496470|20949652|P2|STARTED|Overall Study||331
8501005|NCT00496470|20949653|P1|STARTED|Overall Study||329
8501006|NCT00496379|20949731|P1|NOT COMPLETED|Overall Study||0
8501007|NCT00496379|20949731|P1|COMPLETED|Overall Study||15
8501008|NCT00496379|20949731|P1|STARTED|Overall Study||15
8501009|NCT00496366|20949739|P1|NOT COMPLETED|Overall Study||1
8501010|NCT00496366|20949739|P1|COMPLETED|Overall Study||10
8501011|NCT00496366|20949739|P1|STARTED|Overall Study||11
8501012|NCT00496340|20949744|P1|NOT COMPLETED|Overall Study||0
8501013|NCT00496340|20949744|P1|COMPLETED|Overall Study||42
8501014|NCT00496340|20949744|P1|STARTED|Overall Study||42
8501015|NCT00496262|20949757|P1|NOT COMPLETED|Overall Study||0
8501016|NCT00496262|20949757|P1|COMPLETED|Overall Study||15
8501017|NCT00496262|20949757|P1|STARTED|Overall Study||15
8501018|NCT00496197|20949770|P1|NOT COMPLETED|Overall Study||122
8501019|NCT00496197|20949770|P1|COMPLETED|Overall Study||160
8501020|NCT00496197|20949770|P1|STARTED|Overall Study||282
8501021|NCT00496080|20949797|P1|NOT COMPLETED|Overall Study||27
8501022|NCT00496080|20949797|P1|COMPLETED|Overall Study||60
8501023|NCT00496080|20949797|P1|STARTED|Overall Study||87
8501024|NCT00496054|20949807|P1|NOT COMPLETED|Overall Study||8
8501025|NCT00496054|20949807|P1|COMPLETED|Overall Study||102
8501026|NCT00496054|20949807|P1|STARTED|Overall Study||110
8501027|NCT00496015|20949839|P5|NOT COMPLETED|Overall Study||0
8501028|NCT00496015|20949840|P4|NOT COMPLETED|Overall Study||1
8501029|NCT00496015|20949841|P3|NOT COMPLETED|Overall Study||0
8501030|NCT00496015|20949842|P2|NOT COMPLETED|Overall Study||0
8501031|NCT00496015|20949843|P1|NOT COMPLETED|Overall Study||1
8501032|NCT00496015|20949839|P5|COMPLETED|Overall Study||336
8501033|NCT00496015|20949840|P4|COMPLETED|Overall Study||36
8501034|NCT00496015|20949841|P3|COMPLETED|Overall Study||172
8501035|NCT00496015|20949842|P2|COMPLETED|Overall Study||27
8501036|NCT00496015|20949843|P1|COMPLETED|Overall Study||177
8501037|NCT00496015|20949839|P5|STARTED|Overall Study||336
8501038|NCT00496015|20949840|P4|STARTED|Overall Study||37
8501039|NCT00496015|20949841|P3|STARTED|Overall Study||172
8501040|NCT00496015|20949842|P2|STARTED|Overall Study||27
8501041|NCT00496015|20949843|P1|STARTED|Overall Study||178
8501042|NCT00495820|20949967|P2|NOT COMPLETED|Overall Study||1
8501043|NCT00495820|20949968|P1|NOT COMPLETED|Overall Study||1
8501044|NCT00495820|20949967|P2|COMPLETED|Overall Study||29
8501045|NCT00495820|20949968|P1|COMPLETED|Overall Study||29
8501046|NCT00495820|20949967|P2|STARTED|Overall Study||30
8501047|NCT00495820|20949968|P1|STARTED|Overall Study||30
8501048|NCT00495794|20949980|P2|NOT COMPLETED|Overall Study||0
8501049|NCT00495794|20949981|P1|NOT COMPLETED|Overall Study||522
8501050|NCT00495794|20949980|P2|COMPLETED|Overall Study||2303
8501051|NCT00495794|20949981|P1|COMPLETED|Overall Study||1797
8501052|NCT00495794|20949980|P2|STARTED|Overall Study||2303
8501053|NCT00495794|20949981|P1|STARTED|Overall Study||2319
8501054|NCT00495755|20949991|P1|NOT COMPLETED|Overall Study||3
8501055|NCT00495755|20949991|P1|COMPLETED|Overall Study||10
8501056|NCT00495755|20949991|P1|STARTED|Overall Study||13
8501057|NCT00495716|20949998|P2|NOT COMPLETED|Overall Study||13
8501058|NCT00495716|20949999|P1|NOT COMPLETED|Overall Study||15
8501059|NCT00495716|20949998|P2|COMPLETED|Overall Study||24
8501060|NCT00495716|20949999|P1|COMPLETED|Overall Study||20
8501061|NCT00495716|20949998|P2|STARTED|Overall Study||37
8501062|NCT00495716|20949999|P1|STARTED|Overall Study||35
8501063|NCT00495677|20950012|P7|NOT COMPLETED|Stage 2 (25 Days)||0
8501064|NCT00495677|20950013|P6|NOT COMPLETED|Stage 2 (25 Days)||0
8501065|NCT00495677|20950014|P5|NOT COMPLETED|Stage 2 (25 Days)||0
8501066|NCT00495677|20950015|P4|NOT COMPLETED|Stage 2 (25 Days)||0
8501067|NCT00495677|20950016|P3|NOT COMPLETED|Stage 2 (25 Days)||0
8501068|NCT00495677|20950017|P2|NOT COMPLETED|Stage 2 (25 Days)||0
8501069|NCT00495677|20950018|P1|NOT COMPLETED|Stage 2 (25 Days)||0
8501070|NCT00495677|20950012|P7|COMPLETED|Stage 2 (25 Days)||7
8501071|NCT00495677|20950013|P6|COMPLETED|Stage 2 (25 Days)||8
8501072|NCT00495677|20950014|P5|COMPLETED|Stage 2 (25 Days)||8
8501073|NCT00495677|20950015|P4|COMPLETED|Stage 2 (25 Days)||0
8501074|NCT00495677|20950016|P3|COMPLETED|Stage 2 (25 Days)||0
8501075|NCT00495677|20950017|P2|COMPLETED|Stage 2 (25 Days)||0
8501076|NCT00495677|20950018|P1|COMPLETED|Stage 2 (25 Days)||0
8501077|NCT00495677|20950012|P7|STARTED|Stage 2 (25 Days)||7
8501078|NCT00495677|20950013|P6|STARTED|Stage 2 (25 Days)||8
8501079|NCT00495677|20950014|P5|STARTED|Stage 2 (25 Days)||8
8501080|NCT00495677|20950015|P4|STARTED|Stage 2 (25 Days)||0
8501081|NCT00495677|20950016|P3|STARTED|Stage 2 (25 Days)||0
8501082|NCT00495677|20950017|P2|STARTED|Stage 2 (25 Days)||0
8501083|NCT00495677|20950018|P1|STARTED|Stage 2 (25 Days)||0
8501084|NCT00495677|20950012|P7|NOT COMPLETED|Stage 1 (25 Days)||0
8501085|NCT00495677|20950013|P6|NOT COMPLETED|Stage 1 (25 Days)||0
8501086|NCT00495677|20950014|P5|NOT COMPLETED|Stage 1 (25 Days)||0
8501087|NCT00495677|20950015|P4|NOT COMPLETED|Stage 1 (25 Days)||0
8501088|NCT00495677|20950016|P3|NOT COMPLETED|Stage 1 (25 Days)||1
8501089|NCT00495677|20950017|P2|NOT COMPLETED|Stage 1 (25 Days)||0
8501090|NCT00495677|20950018|P1|NOT COMPLETED|Stage 1 (25 Days)||0
8501091|NCT00495677|20950012|P7|COMPLETED|Stage 1 (25 Days)||0
8501092|NCT00495677|20950013|P6|COMPLETED|Stage 1 (25 Days)||0
8501093|NCT00495677|20950014|P5|COMPLETED|Stage 1 (25 Days)||0
8501094|NCT00495677|20950015|P4|COMPLETED|Stage 1 (25 Days)||6
8501095|NCT00495677|20950016|P3|COMPLETED|Stage 1 (25 Days)||5
8501096|NCT00495677|20950017|P2|COMPLETED|Stage 1 (25 Days)||6
8501097|NCT00495677|20950018|P1|COMPLETED|Stage 1 (25 Days)||2
8501098|NCT00495677|20950012|P7|STARTED|Stage 1 (25 Days)||0
8501099|NCT00495677|20950013|P6|STARTED|Stage 1 (25 Days)||0
8501100|NCT00495677|20950014|P5|STARTED|Stage 1 (25 Days)||0
8501101|NCT00495677|20950015|P4|STARTED|Stage 1 (25 Days)||6
8501102|NCT00495677|20950016|P3|STARTED|Stage 1 (25 Days)||6
8501103|NCT00495677|20950017|P2|STARTED|Stage 1 (25 Days)||6
8501104|NCT00495677|20950018|P1|STARTED|Stage 1 (25 Days)||2
8501105|NCT00495625|20950073|P1|NOT COMPLETED|Overall Study||10
8501106|NCT00495625|20950073|P1|COMPLETED|Overall Study||23
8501107|NCT00495625|20950073|P1|STARTED|Overall Study||33
8501108|NCT00495612|20950084|P2|NOT COMPLETED|Overall Study||0
8501109|NCT00495612|20950085|P1|NOT COMPLETED|Overall Study||4
8501110|NCT00495612|20950084|P2|COMPLETED|Overall Study||33
8501111|NCT00495612|20950085|P1|COMPLETED|Overall Study||32
8501112|NCT00495612|20950084|P2|STARTED|Overall Study||33
8501113|NCT00495612|20950085|P1|STARTED|Overall Study||36
8501114|NCT00495586|20950103|P2|NOT COMPLETED|Overall Study||4
8501115|NCT00495586|20950104|P1|NOT COMPLETED|Overall Study||4
8501116|NCT00495586|20950103|P2|COMPLETED|Overall Study||158
8501117|NCT00495586|20950104|P1|COMPLETED|Overall Study||152
8501118|NCT00495586|20950103|P2|STARTED|Overall Study||162
8501119|NCT00495586|20950104|P1|STARTED|Overall Study||156
8501120|NCT00495521|20950114|P2|NOT COMPLETED|Overall Study||1
8501121|NCT00495521|20950115|P1|NOT COMPLETED|Overall Study||0
8501122|NCT00495521|20950114|P2|COMPLETED|Overall Study||0
8501123|NCT00495521|20950115|P1|COMPLETED|Overall Study||1
8501124|NCT00495521|20950114|P2|STARTED|Overall Study||1
8501125|NCT00495521|20950115|P1|STARTED|Overall Study||1
8501126|NCT00495495|20950145|P1|NOT COMPLETED|Overall Study||99
8501127|NCT00495495|20950145|P1|COMPLETED|Overall Study||295
8501128|NCT00495495|20950145|P1|STARTED|Overall Study||394
8501129|NCT00495469|20950165|P7|NOT COMPLETED|Overall Study||5
8501130|NCT00495469|20950166|P6|NOT COMPLETED|Overall Study||5
8501131|NCT00495469|20950167|P5|NOT COMPLETED|Overall Study||5
8501132|NCT00495469|20950168|P4|NOT COMPLETED|Overall Study||4
8501133|NCT00495469|20950169|P3|NOT COMPLETED|Overall Study||7
8501134|NCT00495469|20950170|P2|NOT COMPLETED|Overall Study||7
8501135|NCT00495469|20950171|P1|NOT COMPLETED|Overall Study||6
8501136|NCT00495469|20950165|P7|COMPLETED|Overall Study||30
8501137|NCT00495469|20950166|P6|COMPLETED|Overall Study||31
8501138|NCT00495469|20950167|P5|COMPLETED|Overall Study||31
8501139|NCT00495469|20950168|P4|COMPLETED|Overall Study||32
8501140|NCT00495469|20950169|P3|COMPLETED|Overall Study||27
8501141|NCT00495469|20950170|P2|COMPLETED|Overall Study||30
8501142|NCT00495469|20950171|P1|COMPLETED|Overall Study||30
8501143|NCT00495469|20950165|P7|STARTED|Overall Study||35
8501144|NCT00495469|20950166|P6|STARTED|Overall Study||36
8501145|NCT00495469|20950167|P5|STARTED|Overall Study||36
8501146|NCT00495469|20950168|P4|STARTED|Overall Study||36
8501147|NCT00495469|20950169|P3|STARTED|Overall Study||34
8501148|NCT00495469|20950170|P2|STARTED|Overall Study||37
8501149|NCT00495469|20950171|P1|STARTED|Overall Study||36
8501150|NCT00495391|20950315|P2|NOT COMPLETED|Overall Study||21
8501151|NCT00495391|20950316|P1|NOT COMPLETED|Overall Study||36
8501152|NCT00495391|20950315|P2|COMPLETED|Overall Study||1
8501153|NCT00495391|20950316|P1|COMPLETED|Overall Study||6
8501154|NCT00495391|20950315|P2|From Baseline to End of Follow up|Overall Study||1
8501155|NCT00495391|20950316|P1|From Baseline to End of Follow up|Overall Study||6
8501156|NCT00495391|20950315|P2|From Baseline to End of Treatment|Overall Study||1
8501157|NCT00495391|20950316|P1|From Baseline to End of Treatment|Overall Study||6
8501158|NCT00495391|20950315|P2|From Baseline to Week 16|Overall Study||11
8501159|NCT00495391|20950316|P1|From Baseline to Week 16|Overall Study||24
8501160|NCT00495391|20950315|P2|From Baseline to Week 8|Overall Study||20
8501161|NCT00495391|20950316|P1|From Baseline to Week 8|Overall Study||31
8501162|NCT00495391|20950315|P2|STARTED|Overall Study||22
8501163|NCT00495391|20950316|P1|STARTED|Overall Study||42
8501164|NCT00495222|20950336|P1|NOT COMPLETED|Overall Study||0
8501165|NCT00495222|20950336|P1|COMPLETED|Overall Study||9
8501166|NCT00495222|20950336|P1|STARTED|Overall Study||9
8501167|NCT00495170|20950339|P1|NOT COMPLETED|Overall Study||20
8501168|NCT00495170|20950339|P1|COMPLETED|Overall Study||64
8501169|NCT00495170|20950339|P1|STARTED|Overall Study||84
8501170|NCT00495157|20950346|P3|NOT COMPLETED|Overall Study||13
8501171|NCT00495157|20950347|P2|NOT COMPLETED|Overall Study||23
8501172|NCT00495157|20950348|P1|NOT COMPLETED|Overall Study||16
8501173|NCT00495157|20950346|P3|COMPLETED|Overall Study||101
8501174|NCT00495157|20950347|P2|COMPLETED|Overall Study||92
8501175|NCT00495157|20950348|P1|COMPLETED|Overall Study||97
8501176|NCT00495157|20950346|P3|STARTED|Overall Study||114
8501177|NCT00495157|20950347|P2|STARTED|Overall Study||115
8501178|NCT00495157|20950348|P1|STARTED|Overall Study||113
8501179|NCT00495131|20950358|P2|NOT COMPLETED|Overall Study||6
8501180|NCT00495131|20950359|P1|NOT COMPLETED|Overall Study||7
8501181|NCT00495131|20950358|P2|COMPLETED|Overall Study||148
8501182|NCT00495131|20950359|P1|COMPLETED|Overall Study||147
8501183|NCT00495131|20950358|P2|STARTED|Overall Study||154
8501184|NCT00495131|20950359|P1|STARTED|Overall Study||154
8501188|NCT00495040|20950376|P1|NOT COMPLETED|Overall Study||3
8501189|NCT00495040|20950376|P1|COMPLETED|Overall Study||35
8501190|NCT00495040|20950376|P1|STARTED|Overall Study||38
8501191|NCT00494975|20950382|P2|NOT COMPLETED|Overall Study||1
8501192|NCT00494975|20950383|P1|NOT COMPLETED|Overall Study||2
8501193|NCT00494975|20950382|P2|COMPLETED|Overall Study||10
8501194|NCT00494975|20950383|P1|COMPLETED|Overall Study||8
8501195|NCT00494975|20950382|P2|STARTED|Overall Study||11
8501196|NCT00494975|20950383|P1|STARTED|Overall Study||10
8501197|NCT00494871|20950391|P2|NOT COMPLETED|Follow-up (FU) Period||23
8501198|NCT00494871|20950392|P1|NOT COMPLETED|Follow-up (FU) Period||29
8501199|NCT00494871|20950391|P2|COMPLETED|Follow-up (FU) Period||616
8501200|NCT00494871|20950392|P1|COMPLETED|Follow-up (FU) Period||610
8501201|NCT00494871|20950391|P2|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
8501202|NCT00494871|20950392|P1|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
8501203|NCT00494871|20950391|P2|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
8501204|NCT00494871|20950392|P1|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
8501205|NCT00494871|20950391|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||172
8501206|NCT00494871|20950392|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||160
8501207|NCT00494871|20950391|P2|COMPLETED|Double-blind (DB) Treatment Period||468
8501208|NCT00494871|20950392|P1|COMPLETED|Double-blind (DB) Treatment Period||480
8501209|NCT00494871|20950391|P2|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
8501210|NCT00494871|20950392|P1|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
8501211|NCT00494871|20950391|P2|STARTED|Double-blind (DB) Treatment Period||640
8501212|NCT00494871|20950392|P1|STARTED|Double-blind (DB) Treatment Period||640
8501213|NCT00494806|20950424|P2|NOT COMPLETED|Overall Study||0
8501214|NCT00494806|20950425|P1|NOT COMPLETED|Overall Study||0
8501215|NCT00494806|20950424|P2|COMPLETED|Overall Study||32
8501216|NCT00494806|20950425|P1|COMPLETED|Overall Study||34
8501217|NCT00494806|20950424|P2|STARTED|Overall Study||32
8501218|NCT00494806|20950425|P1|STARTED|Overall Study||34
8501219|NCT00494780|20950433|P2|NOT COMPLETED|Overall Study||13
8501220|NCT00494780|20950434|P1|NOT COMPLETED|Overall Study||11
8501221|NCT00494780|20950433|P2|COMPLETED|Overall Study||17
8501222|NCT00494780|20950434|P1|COMPLETED|Overall Study||18
8501223|NCT00494780|20950433|P2|STARTED|Overall Study||30
8501224|NCT00494780|20950434|P1|STARTED|Overall Study||29
8501225|NCT00494676|20950472|P2|NOT COMPLETED|Second Intervention||1
8501226|NCT00494676|20950473|P1|NOT COMPLETED|Second Intervention||1
8501227|NCT00494676|20950472|P2|COMPLETED|Second Intervention||28
8501228|NCT00494676|20950473|P1|COMPLETED|Second Intervention||33
8501229|NCT00494676|20950472|P2|STARTED|Second Intervention||29
8501230|NCT00494676|20950473|P1|STARTED|Second Intervention||34
8501231|NCT00494676|20950472|P2|NOT COMPLETED|First Intervention||3
8501232|NCT00494676|20950473|P1|NOT COMPLETED|First Intervention||1
8501233|NCT00494676|20950472|P2|COMPLETED|First Intervention||29
8501234|NCT00494676|20950473|P1|COMPLETED|First Intervention||34
8501235|NCT00494676|20950472|P2|STARTED|First Intervention||32
8501236|NCT00494676|20950473|P1|STARTED|First Intervention||35
8501237|NCT00494676|20950472|P2|NOT COMPLETED|Allocation||4
8501238|NCT00494676|20950473|P1|NOT COMPLETED|Allocation||2
8501239|NCT00494676|20950472|P2|COMPLETED|Allocation||32
8501240|NCT00494676|20950473|P1|COMPLETED|Allocation||35
8501241|NCT00494676|20950472|P2|STARTED|Allocation||36
8501242|NCT00494676|20950473|P1|STARTED|Allocation||37
8501243|NCT00494585|20950480|P1|NOT COMPLETED|Overall Study||0
8501244|NCT00494585|20950480|P1|COMPLETED|Overall Study||22
8501245|NCT00494585|20950480|P1|STARTED|Overall Study||22
8501246|NCT00494507|20950488|P4|NOT COMPLETED|Open-Label Phase||5
8501247|NCT00494507|20950489|P3|NOT COMPLETED|Open-Label Phase||5
8501248|NCT00494507|20950490|P2|NOT COMPLETED|Open-Label Phase||1
8501249|NCT00494507|20950491|P1|NOT COMPLETED|Open-Label Phase||0
8501250|NCT00494507|20950488|P4|COMPLETED|Open-Label Phase||14
8501251|NCT00494507|20950489|P3|COMPLETED|Open-Label Phase||17
8501252|NCT00494507|20950490|P2|COMPLETED|Open-Label Phase||7
8501253|NCT00494507|20950491|P1|COMPLETED|Open-Label Phase||9
8501254|NCT00494507|20950488|P4|STARTED|Open-Label Phase||19
8501255|NCT00494507|20950489|P3|STARTED|Open-Label Phase||22
8501256|NCT00494507|20950490|P2|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
8501257|NCT00494507|20950491|P1|STARTED|Open-Label Phase||9
8501258|NCT00494507|20950488|P4|NOT COMPLETED|Double-Blind Phase||1
8501259|NCT00494507|20950489|P3|NOT COMPLETED|Double-Blind Phase||2
8501260|NCT00494507|20950490|P2|NOT COMPLETED|Double-Blind Phase||0
8501261|NCT00494507|20950491|P1|NOT COMPLETED|Double-Blind Phase||3
8501262|NCT00494507|20950488|P4|COMPLETED|Double-Blind Phase||19
8501263|NCT00494507|20950489|P3|COMPLETED|Double-Blind Phase||22
8501264|NCT00494507|20950490|P2|COMPLETED|Double-Blind Phase||9
8501265|NCT00494507|20950491|P1|COMPLETED|Double-Blind Phase||9
8501266|NCT00494507|20950488|P4|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
8501267|NCT00494507|20950489|P3|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
8501268|NCT00494507|20950490|P2|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
8501269|NCT00494507|20950491|P1|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
8501270|NCT00494507|20950488|P4|STARTED|Double-Blind Phase||20
8501271|NCT00494507|20950489|P3|STARTED|Double-Blind Phase||24
8501272|NCT00494507|20950490|P2|STARTED|Double-Blind Phase||9
8501273|NCT00494507|20950491|P1|STARTED|Double-Blind Phase||12
8501274|NCT00494494|20950541|P2|NOT COMPLETED|Overall Study||0
8501275|NCT00494494|20950542|P1|NOT COMPLETED|Overall Study||0
8501276|NCT00494494|20950541|P2|COMPLETED|Overall Study||39
8501277|NCT00494494|20950542|P1|COMPLETED|Overall Study||40
8501278|NCT00494494|20950541|P2|STARTED|Overall Study||39
8501279|NCT00494494|20950542|P1|STARTED|Overall Study||40
8501280|NCT00494481|20950558|P2|NOT COMPLETED|Overall Study||24
8501281|NCT00494481|20950559|P1|NOT COMPLETED|Overall Study||29
8501282|NCT00494481|20950558|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
8501283|NCT00494481|20950559|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
8501284|NCT00494481|20950558|P2|STARTED|Overall Study|randomised patients|29
8501285|NCT00494481|20950559|P1|STARTED|Overall Study|randomised patients|35
8501286|NCT00494442|20950567|P2|NOT COMPLETED|Overall Study||16
8501287|NCT00494442|20950568|P1|NOT COMPLETED|Overall Study||17
8501288|NCT00494442|20950567|P2|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
8501289|NCT00494442|20950568|P1|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
8501290|NCT00494442|20950567|P2|STARTED|Overall Study|Patients received treatment|33
8501291|NCT00494442|20950568|P1|STARTED|Overall Study|Patients received treatment|24
8501292|NCT00494299|20950584|P2|NOT COMPLETED|Overall Study||229
8501293|NCT00494299|20950585|P1|NOT COMPLETED|Overall Study||229
8501294|NCT00494299|20950584|P2|COMPLETED|Overall Study||0
8501295|NCT00494299|20950585|P1|COMPLETED|Overall Study||0
8501296|NCT00494299|20950584|P2|Received Treatment|Overall Study||227
8501297|NCT00494299|20950585|P1|Received Treatment|Overall Study||229
8501298|NCT00494299|20950584|P2|STARTED|Overall Study||229
8501299|NCT00494299|20950585|P1|STARTED|Overall Study||229
8501306|NCT00494221|20950617|P3|NOT COMPLETED|Overall Study||14
8501307|NCT00494221|20950618|P2|NOT COMPLETED|Overall Study||11
8501308|NCT00494221|20950619|P1|NOT COMPLETED|Overall Study||16
8501309|NCT00494221|20950617|P3|COMPLETED|Overall Study||44
8501310|NCT00494221|20950618|P2|COMPLETED|Overall Study||45
8501311|NCT00494221|20950619|P1|COMPLETED|Overall Study||42
8501312|NCT00494221|20950617|P3|STARTED|Overall Study||58
8501313|NCT00494221|20950618|P2|STARTED|Overall Study||56
8501314|NCT00494221|20950619|P1|STARTED|Overall Study||58
8501315|NCT00494143|20950639|P6|NOT COMPLETED|Overall Study||0
8501316|NCT00494143|20950640|P5|NOT COMPLETED|Overall Study||0
8501317|NCT00494143|20950641|P4|NOT COMPLETED|Overall Study||0
8501318|NCT00494143|20950642|P3|NOT COMPLETED|Overall Study||0
8501319|NCT00494143|20950643|P2|NOT COMPLETED|Overall Study||0
8501320|NCT00494143|20950644|P1|NOT COMPLETED|Overall Study||0
8501321|NCT00494143|20950639|P6|COMPLETED|Overall Study||0
8501322|NCT00494143|20950640|P5|COMPLETED|Overall Study||1
8501323|NCT00494143|20950641|P4|COMPLETED|Overall Study||0
8501324|NCT00494143|20950642|P3|COMPLETED|Overall Study||3
8501325|NCT00494143|20950643|P2|COMPLETED|Overall Study||2
8501326|NCT00494143|20950644|P1|COMPLETED|Overall Study||1
8501327|NCT00494143|20950639|P6|STARTED|Overall Study||0
8501328|NCT00494143|20950640|P5|STARTED|Overall Study||1
8501329|NCT00494143|20950641|P4|STARTED|Overall Study||0
8501330|NCT00494143|20950642|P3|STARTED|Overall Study||3
8501331|NCT00494143|20950643|P2|STARTED|Overall Study||2
8501332|NCT00494143|20950644|P1|STARTED|Overall Study||1
8501333|NCT00494091|20950660|P2|NOT COMPLETED|Overall Study||76
8501334|NCT00494091|20950661|P1|NOT COMPLETED|Overall Study||6
8501335|NCT00494091|20950660|P2|COMPLETED|Overall Study||0
8501336|NCT00494091|20950661|P1|COMPLETED|Overall Study||0
8501337|NCT00494091|20950660|P2|STARTED|Overall Study||76
8501338|NCT00494091|20950661|P1|STARTED|Overall Study||6
8501339|NCT00494026|20950683|P1|NOT COMPLETED|Overall Study||4
8501340|NCT00494026|20950683|P1|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
8501341|NCT00494026|20950683|P1|STARTED|Overall Study||4
8501342|NCT00494013|20950693|P2|NOT COMPLETED|Overall Study||36
8501343|NCT00494013|20950694|P1|NOT COMPLETED|Overall Study||30
8501344|NCT00494013|20950693|P2|COMPLETED|Overall Study||183
8501345|NCT00494013|20950694|P1|COMPLETED|Overall Study||193
8501346|NCT00494013|20950693|P2|Full Analysis Set (Intent to Treat)|Overall Study||210
8501347|NCT00494013|20950694|P1|Full Analysis Set (Intent to Treat)|Overall Study||219
8501348|NCT00494013|20950693|P2|STARTED|Overall Study||219
8501349|NCT00494013|20950694|P1|STARTED|Overall Study||223
8501350|NCT00493974|20950724|P2|NOT COMPLETED|Overall Study||14
8501351|NCT00493974|20950725|P1|NOT COMPLETED|Overall Study||13
8501352|NCT00493974|20950724|P2|COMPLETED|Overall Study||45
8501353|NCT00493974|20950725|P1|COMPLETED|Overall Study||47
8501354|NCT00493974|20950724|P2|STARTED|Overall Study||59
8501355|NCT00493974|20950725|P1|STARTED|Overall Study||60
8501356|NCT00493805|20950743|P2|NOT COMPLETED|Overall Study||0
8501357|NCT00493805|20950744|P1|NOT COMPLETED|Overall Study||0
8501358|NCT00493805|20950743|P2|COMPLETED|Overall Study||42
8501359|NCT00493805|20950744|P1|COMPLETED|Overall Study||17
8501360|NCT00493805|20950743|P2|STARTED|Overall Study||42
8501361|NCT00493805|20950744|P1|STARTED|Overall Study||17
8501362|NCT00493779|20950752|P1|NOT COMPLETED|Overall Study||1
8501363|NCT00493779|20950752|P1|COMPLETED|Overall Study|Completed follow-up phase|97
8501364|NCT00493779|20950752|P1|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
8501365|NCT00493649|20950759|P1|NOT COMPLETED|Overall Study||82
8501366|NCT00493649|20950759|P1|COMPLETED|Overall Study||411
8501367|NCT00493649|20950759|P1|STARTED|Overall Study||493
8501368|NCT00493636|20950772|P2|NOT COMPLETED|Overall Study||2
8501369|NCT00493636|20950773|P1|NOT COMPLETED|Overall Study||2
8501370|NCT00493636|20950772|P2|COMPLETED|Overall Study||77
8501371|NCT00493636|20950773|P1|COMPLETED|Overall Study||79
8501372|NCT00493636|20950772|P2|STARTED|Overall Study||79
8501373|NCT00493636|20950773|P1|STARTED|Overall Study||81
8501374|NCT00493467|20950787|P1|NOT COMPLETED|Overall Study||1
8501375|NCT00493467|20950787|P1|COMPLETED|Overall Study||30
8501376|NCT00493467|20950787|P1|STARTED|Overall Study||31
8501377|NCT00493454|20950792|P1|NOT COMPLETED|Overall Study||1
8501378|NCT00493454|20950792|P1|COMPLETED|Overall Study||5
8501379|NCT00493454|20950792|P1|STARTED|Overall Study||6
8501380|NCT00493311|20950798|P2|NOT COMPLETED|Overall Study||2
8501381|NCT00493311|20950799|P1|NOT COMPLETED|Overall Study||2
8501382|NCT00493311|20950798|P2|COMPLETED|Overall Study||29
8501383|NCT00493311|20950799|P1|COMPLETED|Overall Study||27
8501384|NCT00493311|20950798|P2|STARTED|Overall Study||31
8501385|NCT00493311|20950799|P1|STARTED|Overall Study||29
8501386|NCT00493285|20950819|P6|NOT COMPLETED|Overall Study||0
8501387|NCT00493285|20950820|P5|NOT COMPLETED|Overall Study||1
8501388|NCT00493285|20950821|P4|NOT COMPLETED|Overall Study||0
8501389|NCT00493285|20950822|P3|NOT COMPLETED|Overall Study||0
8501390|NCT00493285|20950823|P2|NOT COMPLETED|Overall Study||0
8501391|NCT00493285|20950824|P1|NOT COMPLETED|Overall Study||0
8501392|NCT00493285|20950819|P6|COMPLETED|Overall Study||5
8501393|NCT00493285|20950820|P5|COMPLETED|Overall Study||9
8501394|NCT00493285|20950821|P4|COMPLETED|Overall Study||6
8501395|NCT00493285|20950822|P3|COMPLETED|Overall Study||9
8501396|NCT00493285|20950823|P2|COMPLETED|Overall Study||6
8501397|NCT00493285|20950824|P1|COMPLETED|Overall Study||13
8501398|NCT00493285|20950819|P6|STARTED|Overall Study||5
8501399|NCT00493285|20950820|P5|STARTED|Overall Study||10
8501400|NCT00493285|20950821|P4|STARTED|Overall Study||6
8501401|NCT00493285|20950822|P3|STARTED|Overall Study||9
8501402|NCT00493285|20950823|P2|STARTED|Overall Study||6
8501403|NCT00493285|20950824|P1|STARTED|Overall Study||13
8501404|NCT00493246|20951056|P8|NOT COMPLETED|Overall Study||0
8501405|NCT00493246|20951057|P7|NOT COMPLETED|Overall Study||1
8501406|NCT00493246|20951058|P6|NOT COMPLETED|Overall Study||1
8501407|NCT00493246|20951059|P5|NOT COMPLETED|Overall Study||1
8501408|NCT00493246|20951060|P4|NOT COMPLETED|Overall Study||0
8501409|NCT00493246|20951061|P3|NOT COMPLETED|Overall Study||0
8501410|NCT00493246|20951062|P2|NOT COMPLETED|Overall Study||0
8501411|NCT00493246|20951063|P1|NOT COMPLETED|Overall Study||0
8501412|NCT00493246|20951056|P8|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
8501413|NCT00493246|20951057|P7|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
8501414|NCT00493246|20951058|P6|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
8501415|NCT00493246|20951059|P5|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
8501416|NCT00493246|20951060|P4|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
8501417|NCT00493246|20951061|P3|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
8501418|NCT00493246|20951062|P2|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
8501419|NCT00493246|20951063|P1|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
8501420|NCT00493246|20951056|P8|STARTED|Overall Study|All subjects who were randomized.|10
8501421|NCT00493246|20951057|P7|STARTED|Overall Study|All subjects who were randomized.|12
8501422|NCT00493246|20951058|P6|STARTED|Overall Study|All subjects who were randomized.|16
8501423|NCT00493246|20951059|P5|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
8501424|NCT00493246|20951060|P4|STARTED|Overall Study||13
8501425|NCT00493246|20951061|P3|STARTED|Overall Study||12
8501426|NCT00493246|20951062|P2|STARTED|Overall Study||1
8501427|NCT00493246|20951063|P1|STARTED|Overall Study||2
8501428|NCT00493220|20951127|P6|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8501429|NCT00493220|20951128|P5|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8501430|NCT00493220|20951129|P4|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8501431|NCT00493220|20951130|P3|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8501432|NCT00493220|20951131|P2|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8501433|NCT00493220|20951132|P1|NOT COMPLETED|Final 7-Day Safety Follow-up||0
8501434|NCT00493220|20951127|P6|COMPLETED|Final 7-Day Safety Follow-up||5
8501435|NCT00493220|20951128|P5|COMPLETED|Final 7-Day Safety Follow-up||5
8501436|NCT00493220|20951129|P4|COMPLETED|Final 7-Day Safety Follow-up||5
8501437|NCT00493220|20951130|P3|COMPLETED|Final 7-Day Safety Follow-up||5
8501438|NCT00493220|20951131|P2|COMPLETED|Final 7-Day Safety Follow-up||5
8501439|NCT00493220|20951132|P1|COMPLETED|Final 7-Day Safety Follow-up||4
8501440|NCT00493220|20951127|P6|STARTED|Final 7-Day Safety Follow-up||5
8501441|NCT00493220|20951128|P5|STARTED|Final 7-Day Safety Follow-up||5
8501442|NCT00493220|20951129|P4|STARTED|Final 7-Day Safety Follow-up||5
8501443|NCT00493220|20951130|P3|STARTED|Final 7-Day Safety Follow-up||5
8501444|NCT00493220|20951131|P2|STARTED|Final 7-Day Safety Follow-up||5
8501445|NCT00493220|20951132|P1|STARTED|Final 7-Day Safety Follow-up||4
8501446|NCT00493220|20951127|P6|NOT COMPLETED|Third Intervention||0
8501447|NCT00493220|20951128|P5|NOT COMPLETED|Third Intervention||0
8501448|NCT00493220|20951129|P4|NOT COMPLETED|Third Intervention||0
8501449|NCT00493220|20951130|P3|NOT COMPLETED|Third Intervention||0
8501450|NCT00493220|20951131|P2|NOT COMPLETED|Third Intervention||0
8501451|NCT00493220|20951132|P1|NOT COMPLETED|Third Intervention||1
8501452|NCT00493220|20951127|P6|COMPLETED|Third Intervention||5
8501453|NCT00493220|20951128|P5|COMPLETED|Third Intervention||5
8501454|NCT00493220|20951129|P4|COMPLETED|Third Intervention||5
8501455|NCT00493220|20951130|P3|COMPLETED|Third Intervention||5
8501456|NCT00493220|20951131|P2|COMPLETED|Third Intervention||5
8501457|NCT00493220|20951132|P1|COMPLETED|Third Intervention||4
8501458|NCT00493220|20951127|P6|STARTED|Third Intervention||5
8501459|NCT00493220|20951128|P5|STARTED|Third Intervention||5
8501460|NCT00493220|20951129|P4|STARTED|Third Intervention||5
8501461|NCT00493220|20951130|P3|STARTED|Third Intervention||5
8501462|NCT00493220|20951131|P2|STARTED|Third Intervention||5
8501463|NCT00493220|20951132|P1|STARTED|Third Intervention||5
8501464|NCT00493220|20951127|P6|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8501465|NCT00493220|20951128|P5|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8501466|NCT00493220|20951129|P4|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8501467|NCT00493220|20951130|P3|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8501468|NCT00493220|20951131|P2|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8501469|NCT00493220|20951132|P1|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
8501470|NCT00493220|20951127|P6|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8501471|NCT00493220|20951128|P5|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8501472|NCT00493220|20951129|P4|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8501473|NCT00493220|20951130|P3|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8501474|NCT00493220|20951131|P2|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8501475|NCT00493220|20951132|P1|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
8501476|NCT00493220|20951127|P6|STARTED|Second 7-Day Washout & Safety Follow-up||5
8501477|NCT00493220|20951128|P5|STARTED|Second 7-Day Washout & Safety Follow-up||5
8501478|NCT00493220|20951129|P4|STARTED|Second 7-Day Washout & Safety Follow-up||5
8501479|NCT00493220|20951130|P3|STARTED|Second 7-Day Washout & Safety Follow-up||5
8501480|NCT00493220|20951131|P2|STARTED|Second 7-Day Washout & Safety Follow-up||5
8501481|NCT00493220|20951132|P1|STARTED|Second 7-Day Washout & Safety Follow-up||5
8501482|NCT00493220|20951127|P6|NOT COMPLETED|Second Intervention||0
8501483|NCT00493220|20951128|P5|NOT COMPLETED|Second Intervention||0
8501484|NCT00493220|20951129|P4|NOT COMPLETED|Second Intervention||0
8501485|NCT00493220|20951130|P3|NOT COMPLETED|Second Intervention||0
8501486|NCT00493220|20951131|P2|NOT COMPLETED|Second Intervention||0
8501487|NCT00493220|20951132|P1|NOT COMPLETED|Second Intervention||0
8501488|NCT00493220|20951127|P6|COMPLETED|Second Intervention||5
8501489|NCT00493220|20951128|P5|COMPLETED|Second Intervention||5
8501490|NCT00493220|20951129|P4|COMPLETED|Second Intervention||5
8501491|NCT00493220|20951130|P3|COMPLETED|Second Intervention||5
8501492|NCT00493220|20951131|P2|COMPLETED|Second Intervention||5
8501493|NCT00493220|20951132|P1|COMPLETED|Second Intervention||5
8501494|NCT00493220|20951127|P6|STARTED|Second Intervention||5
8501495|NCT00493220|20951128|P5|STARTED|Second Intervention||5
8501496|NCT00493220|20951129|P4|STARTED|Second Intervention||5
8501497|NCT00493220|20951130|P3|STARTED|Second Intervention||5
8501498|NCT00493220|20951131|P2|STARTED|Second Intervention||5
8501499|NCT00493220|20951132|P1|STARTED|Second Intervention||5
8501500|NCT00493220|20951127|P6|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8501501|NCT00493220|20951128|P5|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8501502|NCT00493220|20951129|P4|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8501503|NCT00493220|20951130|P3|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8501504|NCT00493220|20951131|P2|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8501505|NCT00493220|20951132|P1|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
8501506|NCT00493220|20951127|P6|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8501507|NCT00493220|20951128|P5|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8501508|NCT00493220|20951129|P4|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8501509|NCT00493220|20951130|P3|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8501510|NCT00493220|20951131|P2|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8501511|NCT00493220|20951132|P1|COMPLETED|First 7-Day Washout & Safety Follow-up||5
8501512|NCT00493220|20951127|P6|STARTED|First 7-Day Washout & Safety Follow-up||5
8501513|NCT00493220|20951128|P5|STARTED|First 7-Day Washout & Safety Follow-up||5
8501514|NCT00493220|20951129|P4|STARTED|First 7-Day Washout & Safety Follow-up||5
8501515|NCT00493220|20951130|P3|STARTED|First 7-Day Washout & Safety Follow-up||5
8501516|NCT00493220|20951131|P2|STARTED|First 7-Day Washout & Safety Follow-up||5
8501517|NCT00493220|20951132|P1|STARTED|First 7-Day Washout & Safety Follow-up||5
8501518|NCT00493220|20951127|P6|NOT COMPLETED|First Intervention||0
8501519|NCT00493220|20951128|P5|NOT COMPLETED|First Intervention||0
8501520|NCT00493220|20951129|P4|NOT COMPLETED|First Intervention||0
8501521|NCT00493220|20951130|P3|NOT COMPLETED|First Intervention||0
8501522|NCT00493220|20951131|P2|NOT COMPLETED|First Intervention||0
8501523|NCT00493220|20951132|P1|NOT COMPLETED|First Intervention||0
8501524|NCT00493220|20951127|P6|COMPLETED|First Intervention||5
8501525|NCT00493220|20951128|P5|COMPLETED|First Intervention||5
8501526|NCT00493220|20951129|P4|COMPLETED|First Intervention||5
8501527|NCT00493220|20951130|P3|COMPLETED|First Intervention||5
8501528|NCT00493220|20951131|P2|COMPLETED|First Intervention||5
8501529|NCT00493220|20951132|P1|COMPLETED|First Intervention||5
8501530|NCT00493220|20951127|P6|STARTED|First Intervention||5
8501531|NCT00493220|20951128|P5|STARTED|First Intervention||5
8501532|NCT00493220|20951129|P4|STARTED|First Intervention||5
8501533|NCT00493220|20951130|P3|STARTED|First Intervention||5
8501534|NCT00493220|20951131|P2|STARTED|First Intervention||5
8501535|NCT00493220|20951132|P1|STARTED|First Intervention||5
8501536|NCT00493181|20951149|P1|NOT COMPLETED|Overall Study||0
8501537|NCT00493181|20951149|P1|COMPLETED|Overall Study||8
8501538|NCT00493181|20951149|P1|STARTED|Overall Study||8
8501539|NCT00493064|20951153|P1|NOT COMPLETED|Overall Study||11
8501540|NCT00493064|20951153|P1|COMPLETED|Overall Study||52
8501541|NCT00493064|20951153|P1|STARTED|Overall Study||63
8501542|NCT00493038|20951160|P2|NOT COMPLETED|Follow-up||0
8501543|NCT00493038|20951161|P1|NOT COMPLETED|Follow-up||1
8501544|NCT00493038|20951160|P2|COMPLETED|Follow-up||126
8501545|NCT00493038|20951161|P1|COMPLETED|Follow-up||122
8501546|NCT00493038|20951160|P2|STARTED|Follow-up||126
8501547|NCT00493038|20951161|P1|STARTED|Follow-up||123
8501548|NCT00493038|20951160|P2|NOT COMPLETED|Treatment||20
8501549|NCT00493038|20951161|P1|NOT COMPLETED|Treatment||24
8501550|NCT00493038|20951160|P2|COMPLETED|Treatment||126
8501551|NCT00493038|20951161|P1|COMPLETED|Treatment||123
8501552|NCT00493038|20951160|P2|Test-of-Cure Visit|Treatment||126
8501553|NCT00493038|20951161|P1|Test-of-Cure Visit|Treatment||123
8501554|NCT00493038|20951160|P2|Treated With Study Medication|Treatment||142
8501555|NCT00493038|20951161|P1|Treated With Study Medication|Treatment||145
8501556|NCT00493038|20951160|P2|Randomization|Treatment||146
8501557|NCT00493038|20951161|P1|Randomization|Treatment||147
8501558|NCT00493038|20951160|P2|STARTED|Treatment||146
8501559|NCT00493038|20951161|P1|STARTED|Treatment||147
8501560|NCT00493025|20951175|P1|NOT COMPLETED|Overall Study||19
8501561|NCT00493025|20951175|P1|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
8501562|NCT00493025|20951175|P1|STARTED|Overall Study||19
8501563|NCT00493012|20951186|P2|NOT COMPLETED|Overall Study||17
8501564|NCT00493012|20951187|P1|NOT COMPLETED|Overall Study||18
8501565|NCT00493012|20951186|P2|COMPLETED|Overall Study||83
8501566|NCT00493012|20951187|P1|COMPLETED|Overall Study||82
8501567|NCT00493012|20951186|P2|STARTED|Overall Study||100
8501568|NCT00493012|20951187|P1|STARTED|Overall Study||100
8501569|NCT00492973|20951215|P2|NOT COMPLETED|Overall Study||1
8501570|NCT00492973|20951216|P1|NOT COMPLETED|Overall Study||0
8501571|NCT00492973|20951215|P2|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
8501572|NCT00492973|20951216|P1|COMPLETED|Overall Study||37
8501573|NCT00492973|20951215|P2|STARTED|Overall Study||39
8501574|NCT00492973|20951216|P1|STARTED|Overall Study||37
8501575|NCT00492921|20951230|P3|NOT COMPLETED|Overall Study||1
8501576|NCT00492921|20951231|P2|NOT COMPLETED|Overall Study||0
8501577|NCT00492921|20951232|P1|NOT COMPLETED|Overall Study||1
8501578|NCT00492921|20951230|P3|COMPLETED|Overall Study||2
8501579|NCT00492921|20951231|P2|COMPLETED|Overall Study||4
8501580|NCT00492921|20951232|P1|COMPLETED|Overall Study||4
8501581|NCT00492921|20951230|P3|STARTED|Overall Study||3
8501582|NCT00492921|20951231|P2|STARTED|Overall Study||4
8501583|NCT00492921|20951232|P1|STARTED|Overall Study||5
8501584|NCT00492856|20951243|P4|NOT COMPLETED|Post-consolidation||1
8501585|NCT00492856|20951244|P3|NOT COMPLETED|Post-consolidation||27
8501586|NCT00492856|20951245|P2|NOT COMPLETED|Post-consolidation||12
8501587|NCT00492856|20951246|P1|NOT COMPLETED|Post-consolidation||0
8501588|NCT00492856|20951243|P4|COMPLETED|Post-consolidation||0
8501589|NCT00492856|20951244|P3|COMPLETED|Post-consolidation||0
8501590|NCT00492856|20951245|P2|COMPLETED|Post-consolidation||29
8501591|NCT00492856|20951246|P1|COMPLETED|Post-consolidation||0
8501592|NCT00492856|20951243|P4|STARTED|Post-consolidation||1
8501593|NCT00492856|20951244|P3|STARTED|Post-consolidation||27
8501594|NCT00492856|20951245|P2|STARTED|Post-consolidation||41
8501595|NCT00492856|20951246|P1|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
8501596|NCT00492856|20951243|P4|NOT COMPLETED|Consolidation||0
8501597|NCT00492856|20951244|P3|NOT COMPLETED|Consolidation||0
8501598|NCT00492856|20951245|P2|NOT COMPLETED|Consolidation||0
8501599|NCT00492856|20951246|P1|NOT COMPLETED|Consolidation||9
8501600|NCT00492856|20951243|P4|COMPLETED|Consolidation||0
8501601|NCT00492856|20951244|P3|COMPLETED|Consolidation||0
8501602|NCT00492856|20951245|P2|COMPLETED|Consolidation||0
8501603|NCT00492856|20951246|P1|COMPLETED|Consolidation||83
8501604|NCT00492856|20951243|P4|STARTED|Consolidation||0
8501605|NCT00492856|20951244|P3|STARTED|Consolidation||0
8501606|NCT00492856|20951245|P2|STARTED|Consolidation||0
8501607|NCT00492856|20951246|P1|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
8501608|NCT00492856|20951243|P4|NOT COMPLETED|Induction||0
8501609|NCT00492856|20951244|P3|NOT COMPLETED|Induction||0
8501610|NCT00492856|20951245|P2|NOT COMPLETED|Induction||0
8501611|NCT00492856|20951246|P1|NOT COMPLETED|Induction||6
8501612|NCT00492856|20951243|P4|COMPLETED|Induction||0
8501613|NCT00492856|20951244|P3|COMPLETED|Induction||0
8501614|NCT00492856|20951245|P2|COMPLETED|Induction||0
8501615|NCT00492856|20951246|P1|COMPLETED|Induction||99
8501616|NCT00492856|20951243|P4|STARTED|Induction||0
8501617|NCT00492856|20951244|P3|STARTED|Induction||0
8501618|NCT00492856|20951245|P2|STARTED|Induction||0
8501619|NCT00492856|20951246|P1|STARTED|Induction||105
8501620|NCT00492752|20951260|P4|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
8501621|NCT00492752|20951261|P3|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
8501622|NCT00492752|20951262|P2|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
8501623|NCT00492752|20951263|P1|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
8501624|NCT00492752|20951260|P4|COMPLETED|Follow-up and/or Open Label Sorafenib||0
8501625|NCT00492752|20951261|P3|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
8501626|NCT00492752|20951262|P2|COMPLETED|Follow-up and/or Open Label Sorafenib||0
8501627|NCT00492752|20951263|P1|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
8501628|NCT00492752|20951260|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
8501629|NCT00492752|20951261|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
8501630|NCT00492752|20951262|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
8501631|NCT00492752|20951263|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
8501632|NCT00492752|20951260|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
8501633|NCT00492752|20951261|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
8501634|NCT00492752|20951262|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
8501635|NCT00492752|20951263|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
8501636|NCT00492752|20951260|P4|STARTED|Follow-up and/or Open Label Sorafenib||6
8501637|NCT00492752|20951261|P3|STARTED|Follow-up and/or Open Label Sorafenib||67
8501638|NCT00492752|20951262|P2|STARTED|Follow-up and/or Open Label Sorafenib||16
8501639|NCT00492752|20951263|P1|STARTED|Follow-up and/or Open Label Sorafenib||120
8501640|NCT00492752|20951260|P4|NOT COMPLETED|Double Blind Treatment||0
8501641|NCT00492752|20951261|P3|NOT COMPLETED|Double Blind Treatment||3
8501642|NCT00492752|20951262|P2|NOT COMPLETED|Double Blind Treatment||0
8501643|NCT00492752|20951263|P1|NOT COMPLETED|Double Blind Treatment||14
8501644|NCT00492752|20951260|P4|COMPLETED|Double Blind Treatment||6
8501645|NCT00492752|20951261|P3|COMPLETED|Double Blind Treatment||67
8501646|NCT00492752|20951262|P2|COMPLETED|Double Blind Treatment||16
8501647|NCT00492752|20951263|P1|COMPLETED|Double Blind Treatment||120
8501648|NCT00492752|20951260|P4|Received Treatment|Double Blind Treatment|Safety Population|6
8501649|NCT00492752|20951261|P3|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
8501650|NCT00492752|20951262|P2|Received Treatment|Double Blind Treatment|Safety Population|16
8501651|NCT00492752|20951263|P1|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
8501652|NCT00492752|20951260|P4|STARTED|Double Blind Treatment||6
8501653|NCT00492752|20951261|P3|STARTED|Double Blind Treatment||70
8501654|NCT00492752|20951262|P2|STARTED|Double Blind Treatment||16
8501655|NCT00492752|20951263|P1|STARTED|Double Blind Treatment||134
8501656|NCT00492726|20951298|P2|NOT COMPLETED|Overall Study||36
8501657|NCT00492726|20951299|P1|NOT COMPLETED|Overall Study||50
8501658|NCT00492726|20951298|P2|COMPLETED|Overall Study||358
8501659|NCT00492726|20951299|P1|COMPLETED|Overall Study||360
8501660|NCT00492726|20951298|P2|End of Study|Overall Study||358
8501661|NCT00492726|20951299|P1|End of Study|Overall Study||360
8501662|NCT00492726|20951298|P2|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
8501663|NCT00492726|20951299|P1|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
8501664|NCT00492726|20951298|P2|STARTED|Overall Study||394
8501665|NCT00492726|20951299|P1|STARTED|Overall Study||410
8501666|NCT00492648|20951325|P2|NOT COMPLETED|Month 42 (109674 Study)||0
8501667|NCT00492648|20951326|P1|NOT COMPLETED|Month 42 (109674 Study)||0
8501668|NCT00492648|20951325|P2|COMPLETED|Month 42 (109674 Study)||20
8501669|NCT00492648|20951326|P1|COMPLETED|Month 42 (109674 Study)||3
8501670|NCT00492648|20951325|P2|STARTED|Month 42 (109674 Study)||20
8501671|NCT00492648|20951326|P1|STARTED|Month 42 (109674 Study)||3
8501672|NCT00492648|20951325|P2|NOT COMPLETED|Month 30 (109671 Study)||1
8501673|NCT00492648|20951326|P1|NOT COMPLETED|Month 30 (109671 Study)||0
8501674|NCT00492648|20951325|P2|COMPLETED|Month 30 (109671 Study)||29
8501675|NCT00492648|20951326|P1|COMPLETED|Month 30 (109671 Study)||4
8501676|NCT00492648|20951325|P2|STARTED|Month 30 (109671 Study)||30
8501677|NCT00492648|20951326|P1|STARTED|Month 30 (109671 Study)||4
8501678|NCT00492622|20951352|P1|NOT COMPLETED|Overall Study||0
8501679|NCT00492622|20951352|P1|COMPLETED|Overall Study||12
8501680|NCT00492622|20951352|P1|STARTED|Overall Study|all subjects received the immediate release formulation|12
8501681|NCT00492583|20951364|P2|NOT COMPLETED|Overall Study||0
8501682|NCT00492583|20951365|P1|NOT COMPLETED|Overall Study||0
8501683|NCT00492583|20951364|P2|COMPLETED|Overall Study||87
8501684|NCT00492583|20951365|P1|COMPLETED|Overall Study||95
8501685|NCT00492583|20951364|P2|STARTED|Overall Study||87
8501686|NCT00492583|20951365|P1|STARTED|Overall Study||95
8501687|NCT00492557|20951373|P2|NOT COMPLETED|Overall Study||23
8501688|NCT00492557|20951374|P1|NOT COMPLETED|Overall Study||24
8501689|NCT00492557|20951373|P2|COMPLETED|Overall Study||557
8501690|NCT00492557|20951374|P1|COMPLETED|Overall Study||556
8501691|NCT00492557|20951373|P2|Vaccinated Dose 2|Overall Study||558
8501692|NCT00492557|20951374|P1|Vaccinated Dose 2|Overall Study||560
8501693|NCT00492557|20951373|P2|Vaccinated Dose 1|Overall Study||575
8501694|NCT00492557|20951374|P1|Vaccinated Dose 1|Overall Study||577
8501695|NCT00492557|20951373|P2|STARTED|Overall Study||580
8501696|NCT00492557|20951374|P1|STARTED|Overall Study||580
8501697|NCT00492544|20951390|P1|NOT COMPLETED|Overall Study||0
8501698|NCT00492544|20951390|P1|COMPLETED|Overall Study||100
8501699|NCT00492544|20951390|P1|STARTED|Overall Study||100
8501700|NCT00492531|20951404|P2|NOT COMPLETED|Overall Study||23
8501701|NCT00492531|20951405|P1|NOT COMPLETED|Overall Study||22
8501702|NCT00492531|20951404|P2|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
8501703|NCT00492531|20951405|P1|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
8501704|NCT00492531|20951404|P2|STARTED|Overall Study||37
8501705|NCT00492531|20951405|P1|STARTED|Overall Study||37
8501706|NCT00492401|20951417|P1|NOT COMPLETED|Overall Study||0
8501707|NCT00492401|20951417|P1|COMPLETED|Overall Study||55
8501708|NCT00492401|20951417|P1|STARTED|Overall Study||55
8501709|NCT00492349|20951428|P2|NOT COMPLETED|Overall Study||7
8501710|NCT00492349|20951429|P1|NOT COMPLETED|Overall Study||3
8501711|NCT00492349|20951428|P2|COMPLETED|Overall Study||27
8501712|NCT00492349|20951429|P1|COMPLETED|Overall Study||32
8501713|NCT00492349|20951428|P2|Week 8|Overall Study||27
8501714|NCT00492349|20951429|P1|Week 8|Overall Study||32
8501715|NCT00492349|20951428|P2|Week 2|Overall Study||33
8501716|NCT00492349|20951429|P1|Week 2|Overall Study||32
8501717|NCT00492349|20951428|P2|STARTED|Overall Study||34
8501718|NCT00492349|20951429|P1|STARTED|Overall Study||35
8501719|NCT00492336|20951451|P2|NOT COMPLETED|Overall Study||6
8501720|NCT00492336|20951452|P1|NOT COMPLETED|Overall Study||2
8501721|NCT00492336|20951451|P2|COMPLETED|Overall Study||23
8501722|NCT00492336|20951452|P1|COMPLETED|Overall Study||26
8501723|NCT00492336|20951451|P2|STARTED|Overall Study||29
8501724|NCT00492336|20951452|P1|STARTED|Overall Study||28
8501725|NCT00492297|20951478|P1|NOT COMPLETED|Survival Only Follow-up||59
8501726|NCT00492297|20951478|P1|COMPLETED|Survival Only Follow-up||0
8501727|NCT00492297|20951478|P1|STARTED|Survival Only Follow-up||59
8501728|NCT00492297|20951478|P1|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
8501729|NCT00492297|20951478|P1|COMPLETED|Active Follow-up 30(+4) Days Duration||59
8501730|NCT00492297|20951478|P1|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
8501731|NCT00492297|20951478|P1|NOT COMPLETED|Treatment||5
8501732|NCT00492297|20951478|P1|COMPLETED|Treatment||78
8501733|NCT00492297|20951478|P1|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
8501734|NCT00492297|20951478|P1|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
8501735|NCT00492297|20951478|P1|STARTED|Treatment||83
8501736|NCT00492284|20951496|P4|NOT COMPLETED|Overall Study||10
8501737|NCT00492284|20951497|P3|NOT COMPLETED|Overall Study||6
8501738|NCT00492284|20951498|P2|NOT COMPLETED|Overall Study||4
8501739|NCT00492284|20951499|P1|NOT COMPLETED|Overall Study||1
8501740|NCT00492284|20951496|P4|COMPLETED|Overall Study||31
8501741|NCT00492284|20951497|P3|COMPLETED|Overall Study||37
8501742|NCT00492284|20951498|P2|COMPLETED|Overall Study||35
8501743|NCT00492284|20951499|P1|COMPLETED|Overall Study||38
8501744|NCT00492284|20951496|P4|STARTED|Overall Study||41
8501745|NCT00492284|20951497|P3|STARTED|Overall Study||43
8501746|NCT00492284|20951498|P2|STARTED|Overall Study||39
8501747|NCT00492284|20951499|P1|STARTED|Overall Study||39
8501748|NCT00492232|20951543|P2|NOT COMPLETED|Open-Label Treatment||0
8501749|NCT00492232|20951544|P1|NOT COMPLETED|Open-Label Treatment||1
8501750|NCT00492232|20951543|P2|COMPLETED|Open-Label Treatment||0
8501751|NCT00492232|20951544|P1|COMPLETED|Open-Label Treatment||88
8501752|NCT00492232|20951543|P2|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
8501753|NCT00492232|20951544|P1|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
8501754|NCT00492232|20951543|P2|NOT COMPLETED|Double-Blind Treatment||25
8501755|NCT00492232|20951544|P1|NOT COMPLETED|Double-Blind Treatment||18
8501756|NCT00492232|20951543|P2|COMPLETED|Double-Blind Treatment||45
8501757|NCT00492232|20951544|P1|COMPLETED|Double-Blind Treatment||47
8501758|NCT00492232|20951543|P2|STARTED|Double-Blind Treatment||70
8501759|NCT00492232|20951544|P1|STARTED|Double-Blind Treatment||65
8501760|NCT00492232|20951543|P2|NOT COMPLETED|Placebo Run-in||70
8501761|NCT00492232|20951544|P1|NOT COMPLETED|Placebo Run-in||0
8501762|NCT00492232|20951543|P2|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
8501763|NCT00492232|20951544|P1|COMPLETED|Placebo Run-in||0
8501764|NCT00492232|20951543|P2|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
8501765|NCT00492232|20951544|P1|STARTED|Placebo Run-in||0
8501766|NCT00492206|20951576|P1|NOT COMPLETED|Overall Study||0
8501767|NCT00492206|20951576|P1|COMPLETED|Overall Study||40
8501768|NCT00492206|20951576|P1|STARTED|Overall Study||40
8501769|NCT00492115|20951585|P2|NOT COMPLETED|Overall Study||4
8501770|NCT00492115|20951586|P1|NOT COMPLETED|Overall Study||3
8501771|NCT00492115|20951585|P2|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
8501772|NCT00492115|20951586|P1|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
8501773|NCT00492115|20951585|P2|STARTED|Overall Study||19
8501774|NCT00492115|20951586|P1|STARTED|Overall Study||19
8501775|NCT00492089|20951596|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8501776|NCT00492089|20951597|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8501777|NCT00492089|20951596|P2|COMPLETED|Second Intervention (6 Weeks)||6
8501778|NCT00492089|20951597|P1|COMPLETED|Second Intervention (6 Weeks)||5
8501779|NCT00492089|20951596|P2|STARTED|Second Intervention (6 Weeks)||6
8501780|NCT00492089|20951597|P1|STARTED|Second Intervention (6 Weeks)||5
8501781|NCT00492089|20951596|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
8501782|NCT00492089|20951597|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
8501783|NCT00492089|20951596|P2|COMPLETED|First Intervention (6 Weeks)||6
8501784|NCT00492089|20951597|P1|COMPLETED|First Intervention (6 Weeks)||5
8501785|NCT00492089|20951596|P2|STARTED|First Intervention (6 Weeks)||6
8501786|NCT00492089|20951597|P1|STARTED|First Intervention (6 Weeks)||5
8501787|NCT00492063|20951607|P4|NOT COMPLETED|Overall Study||10
8501788|NCT00492063|20951608|P3|NOT COMPLETED|Overall Study||11
8501789|NCT00492063|20951609|P2|NOT COMPLETED|Overall Study||14
8501790|NCT00492063|20951610|P1|NOT COMPLETED|Overall Study||10
8501791|NCT00492063|20951607|P4|COMPLETED|Overall Study||666
8501792|NCT00492063|20951608|P3|COMPLETED|Overall Study||667
8501793|NCT00492063|20951609|P2|COMPLETED|Overall Study||634
8501794|NCT00492063|20951610|P1|COMPLETED|Overall Study||642
8501795|NCT00492063|20951607|P4|STARTED|Overall Study||676
8501796|NCT00492063|20951608|P3|STARTED|Overall Study||678
8501797|NCT00492063|20951609|P2|STARTED|Overall Study||648
8501798|NCT00492063|20951610|P1|STARTED|Overall Study||652
8501799|NCT00492024|20951634|P2|NOT COMPLETED|Follow up||2
8501800|NCT00492024|20951635|P1|NOT COMPLETED|Follow up||1
8501801|NCT00492024|20951634|P2|COMPLETED|Follow up||99
8501802|NCT00492024|20951635|P1|COMPLETED|Follow up||221
8501803|NCT00492024|20951634|P2|STARTED|Follow up||101
8501804|NCT00492024|20951635|P1|STARTED|Follow up||222
8501805|NCT00492024|20951634|P2|NOT COMPLETED|Treatment||22
8501806|NCT00492024|20951635|P1|NOT COMPLETED|Treatment||29
8501807|NCT00492024|20951634|P2|COMPLETED|Treatment||101
8501808|NCT00492024|20951635|P1|COMPLETED|Treatment||222
8501809|NCT00492024|20951634|P2|STARTED|Treatment||123
8501810|NCT00492024|20951635|P1|STARTED|Treatment||251
8501811|NCT00491894|20951651|P1|NOT COMPLETED|Overall Study||34
8501812|NCT00491894|20951651|P1|COMPLETED|Overall Study||103
8501813|NCT00491894|20951651|P1|STARTED|Overall Study||137
8501814|NCT00491829|20951662|P3|NOT COMPLETED|Overall Study||75
8501815|NCT00491829|20951663|P2|NOT COMPLETED|Overall Study||114
8501816|NCT00491829|20951664|P1|NOT COMPLETED|Overall Study||95
8501817|NCT00491829|20951662|P3|COMPLETED|Overall Study||243
8501818|NCT00491829|20951663|P2|COMPLETED|Overall Study||202
8501819|NCT00491829|20951664|P1|COMPLETED|Overall Study||216
8501820|NCT00491829|20951662|P3|STARTED|Overall Study||318
8501821|NCT00491829|20951663|P2|STARTED|Overall Study||316
8501822|NCT00491829|20951664|P1|STARTED|Overall Study||311
8501823|NCT00491764|20951678|P6|NOT COMPLETED|Overall Study||9
8501824|NCT00491764|20951679|P5|NOT COMPLETED|Overall Study||3
8501825|NCT00491764|20951680|P4|NOT COMPLETED|Overall Study||8
8501826|NCT00491764|20951681|P3|NOT COMPLETED|Overall Study||8
8501827|NCT00491764|20951682|P2|NOT COMPLETED|Overall Study||7
8501828|NCT00491764|20951683|P1|NOT COMPLETED|Overall Study||5
8501829|NCT00491764|20951678|P6|COMPLETED|Overall Study||27
8501830|NCT00491764|20951679|P5|COMPLETED|Overall Study||33
8501831|NCT00491764|20951680|P4|COMPLETED|Overall Study||28
8501832|NCT00491764|20951681|P3|COMPLETED|Overall Study||28
8501833|NCT00491764|20951682|P2|COMPLETED|Overall Study||30
8501834|NCT00491764|20951683|P1|COMPLETED|Overall Study||32
8501835|NCT00491764|20951678|P6|STARTED|Overall Study||36
8501836|NCT00491764|20951679|P5|STARTED|Overall Study||36
8501837|NCT00491764|20951680|P4|STARTED|Overall Study||36
8501838|NCT00491764|20951681|P3|STARTED|Overall Study||36
8501839|NCT00491764|20951682|P2|STARTED|Overall Study||37
8501840|NCT00491764|20951683|P1|STARTED|Overall Study||37
8501841|NCT00491751|20951712|P3|NOT COMPLETED|Overall Study||0
8501842|NCT00491751|20951713|P2|NOT COMPLETED|Overall Study||0
8501843|NCT00491751|20951714|P1|NOT COMPLETED|Overall Study||0
8501844|NCT00491751|20951712|P3|COMPLETED|Overall Study||42
8501845|NCT00491751|20951713|P2|COMPLETED|Overall Study||44
8501846|NCT00491751|20951714|P1|COMPLETED|Overall Study||22
8501847|NCT00491751|20951712|P3|STARTED|Overall Study||42
8501848|NCT00491751|20951713|P2|STARTED|Overall Study||44
8501849|NCT00491751|20951714|P1|STARTED|Overall Study||22
8501850|NCT00491738|20951726|P2|NOT COMPLETED|Overall Study||0
8501851|NCT00491738|20951727|P1|NOT COMPLETED|Overall Study||0
8501852|NCT00491738|20951726|P2|COMPLETED|Overall Study||9
8501853|NCT00491738|20951727|P1|COMPLETED|Overall Study||7
8501854|NCT00491738|20951726|P2|STARTED|Overall Study||9
8501855|NCT00491738|20951727|P1|STARTED|Overall Study||7
8501856|NCT00491608|20951731|P1|NOT COMPLETED|Overall Study||3
8501857|NCT00491608|20951731|P1|COMPLETED|Overall Study||206
8501858|NCT00491608|20951731|P1|STARTED|Overall Study|Participants who received treatment|209
8501859|NCT00491556|20951742|P2|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
8501860|NCT00491556|20951743|P1|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
8501861|NCT00491556|20951742|P2|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
8501862|NCT00491556|20951743|P1|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
8501863|NCT00491556|20951742|P2|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
8501864|NCT00491556|20951743|P1|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
8501865|NCT00491556|20951742|P2|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
8501866|NCT00491556|20951743|P1|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
8501867|NCT00491556|20951742|P2|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
8501868|NCT00491556|20951743|P1|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
8501869|NCT00491556|20951742|P2|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
8501870|NCT00491556|20951743|P1|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
8501871|NCT00491556|20951742|P2|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
8501872|NCT00491556|20951743|P1|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
8501873|NCT00491530|20951802|P3|NOT COMPLETED|Overall Study||5
8501874|NCT00491530|20951803|P2|NOT COMPLETED|Overall Study||6
8501875|NCT00491530|20951804|P1|NOT COMPLETED|Overall Study||12
8501876|NCT00491530|20951802|P3|COMPLETED|Overall Study||81
8501877|NCT00491530|20951803|P2|COMPLETED|Overall Study||44
8501878|NCT00491530|20951804|P1|COMPLETED|Overall Study||162
8501879|NCT00491530|20951802|P3|STARTED|Overall Study||86
8501880|NCT00491530|20951803|P2|STARTED|Overall Study||50
8501881|NCT00491530|20951804|P1|STARTED|Overall Study||174
8501882|NCT00491504|20951834|P4|NOT COMPLETED|Overall Study||4
8501883|NCT00491504|20951835|P3|NOT COMPLETED|Overall Study||4
8501884|NCT00491504|20951836|P2|NOT COMPLETED|Overall Study||1
8501885|NCT00491504|20951837|P1|NOT COMPLETED|Overall Study||0
8501886|NCT00491504|20951834|P4|COMPLETED|Overall Study||73
8501887|NCT00491504|20951835|P3|COMPLETED|Overall Study||74
8501888|NCT00491504|20951836|P2|COMPLETED|Overall Study||77
8501889|NCT00491504|20951837|P1|COMPLETED|Overall Study||77
8501890|NCT00491504|20951834|P4|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
8501891|NCT00491504|20951835|P3|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
8501892|NCT00491504|20951836|P2|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
8501893|NCT00491504|20951837|P1|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
8501894|NCT00491491|20951847|P2|NOT COMPLETED|Overall Study||0
8501895|NCT00491491|20951848|P1|NOT COMPLETED|Overall Study||0
8501896|NCT00491491|20951847|P2|COMPLETED|Overall Study||21
8501897|NCT00491491|20951848|P1|COMPLETED|Overall Study||22
8501898|NCT00491491|20951847|P2|STARTED|Overall Study||21
8501899|NCT00491491|20951848|P1|STARTED|Overall Study||22
8501900|NCT00491400|20951866|P2|NOT COMPLETED|Overall Study||4
8501901|NCT00491400|20951867|P1|NOT COMPLETED|Overall Study||5
8501902|NCT00491400|20951866|P2|COMPLETED|Overall Study||9
8501903|NCT00491400|20951867|P1|COMPLETED|Overall Study||10
8501904|NCT00491400|20951866|P2|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
8501905|NCT00491400|20951867|P1|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
8501906|NCT00491400|20951866|P2|Started Second Treatment|Overall Study|None withdrew during the washout period|9
8501907|NCT00491400|20951867|P1|Started Second Treatment|Overall Study|2 withdrew during washout period|12
8501908|NCT00491400|20951866|P2|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
8501909|NCT00491400|20951867|P1|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
8501910|NCT00491400|20951866|P2|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
8501911|NCT00491400|20951867|P1|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
8501912|NCT00491400|20951866|P2|STARTED|Overall Study||13
8501913|NCT00491400|20951867|P1|STARTED|Overall Study||15
8501914|NCT00491387|20951875|P1|NOT COMPLETED|Overall Study||20
8501915|NCT00491387|20951875|P1|COMPLETED|Overall Study||4
8501916|NCT00491387|20951875|P1|Study Enrollment|Overall Study||24
8501917|NCT00491387|20951875|P1|STARTED|Overall Study||24
8501918|NCT00491374|20951881|P2|NOT COMPLETED|Overall Study||0
8501919|NCT00491374|20951882|P1|NOT COMPLETED|Overall Study||0
8501920|NCT00491374|20951881|P2|COMPLETED|Overall Study||0
8501921|NCT00491374|20951882|P1|COMPLETED|Overall Study||0
8501922|NCT00491374|20951881|P2|STARTED|Overall Study||0
8501923|NCT00491374|20951882|P1|STARTED|Overall Study||0
8501924|NCT00491322|20951890|P2|NOT COMPLETED|Overall Study||1
8501925|NCT00491322|20951891|P1|NOT COMPLETED|Overall Study||1
8501926|NCT00491322|20951890|P2|COMPLETED|Overall Study||50
8501927|NCT00491322|20951891|P1|COMPLETED|Overall Study||40
8501928|NCT00491322|20951890|P2|STARTED|Overall Study||51
8501929|NCT00491322|20951891|P1|STARTED|Overall Study||41
8501930|NCT00491244|20951899|P2|NOT COMPLETED|Overall Study||20
8501931|NCT00491244|20951900|P1|NOT COMPLETED|Overall Study||27
8501932|NCT00491244|20951899|P2|COMPLETED|Overall Study||168
8501933|NCT00491244|20951900|P1|COMPLETED|Overall Study||162
8501934|NCT00491244|20951899|P2|STARTED|Overall Study||188
8501935|NCT00491244|20951900|P1|STARTED|Overall Study||189
8501936|NCT00491179|20951910|P2|NOT COMPLETED|Overall Study||2
8501937|NCT00491179|20951911|P1|NOT COMPLETED|Overall Study||7
8501938|NCT00491179|20951910|P2|COMPLETED|Overall Study||8
8501939|NCT00491179|20951911|P1|COMPLETED|Overall Study||18
8501940|NCT00491179|20951910|P2|STARTED|Overall Study||10
8501941|NCT00491179|20951911|P1|STARTED|Overall Study||25
8501942|NCT00491075|20951919|P1|NOT COMPLETED|Overall Study||2
8501943|NCT00491075|20951919|P1|COMPLETED|Overall Study||14
8501944|NCT00491075|20951919|P1|STARTED|Overall Study||16
8501945|NCT00490971|20951925|P5|NOT COMPLETED|Maintenance||39
8501946|NCT00490971|20951926|P4|NOT COMPLETED|Maintenance||53
8501947|NCT00490971|20951927|P3|NOT COMPLETED|Maintenance||51
8501948|NCT00490971|20951928|P2|NOT COMPLETED|Maintenance||0
8501949|NCT00490971|20951929|P1|NOT COMPLETED|Maintenance||0
8501950|NCT00490971|20951925|P5|COMPLETED|Maintenance||44
8501951|NCT00490971|20951926|P4|COMPLETED|Maintenance||96
8501952|NCT00490971|20951927|P3|COMPLETED|Maintenance||96
8501953|NCT00490971|20951928|P2|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
8501954|NCT00490971|20951929|P1|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
8501955|NCT00490971|20951925|P5|STARTED|Maintenance||83
8501956|NCT00490971|20951926|P4|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
8501957|NCT00490971|20951927|P3|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
8501958|NCT00490971|20951928|P2|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
8501959|NCT00490971|20951929|P1|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
8501960|NCT00490971|20951925|P5|NOT COMPLETED|Acute/Continuation||0
8501961|NCT00490971|20951926|P4|NOT COMPLETED|Acute/Continuation||0
8501962|NCT00490971|20951927|P3|NOT COMPLETED|Acute/Continuation||0
8501963|NCT00490971|20951928|P2|NOT COMPLETED|Acute/Continuation||62
8501964|NCT00490971|20951929|P1|NOT COMPLETED|Acute/Continuation||306
8501965|NCT00490971|20951925|P5|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8501966|NCT00490971|20951926|P4|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8501967|NCT00490971|20951927|P3|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8501968|NCT00490971|20951928|P2|COMPLETED|Acute/Continuation||86
8501969|NCT00490971|20951929|P1|COMPLETED|Acute/Continuation||308
8501970|NCT00490971|20951925|P5|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8501971|NCT00490971|20951926|P4|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8501972|NCT00490971|20951927|P3|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
8501973|NCT00490971|20951928|P2|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
8501974|NCT00490971|20951929|P1|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
8501975|NCT00490945|20951976|P5|NOT COMPLETED|Overall Study||0
8501976|NCT00490945|20951977|P4|NOT COMPLETED|Overall Study||0
8501977|NCT00490945|20951978|P3|NOT COMPLETED|Overall Study||0
8501978|NCT00490945|20951979|P2|NOT COMPLETED|Overall Study||1
8501979|NCT00490945|20951980|P1|NOT COMPLETED|Overall Study||0
8501980|NCT00490945|20951976|P5|COMPLETED|Overall Study||7
8501981|NCT00490945|20951977|P4|COMPLETED|Overall Study||7
8501982|NCT00490945|20951978|P3|COMPLETED|Overall Study||8
8501983|NCT00490945|20951979|P2|COMPLETED|Overall Study||8
8501984|NCT00490945|20951980|P1|COMPLETED|Overall Study||8
8501985|NCT00490945|20951976|P5|STARTED|Overall Study||7
8501986|NCT00490945|20951977|P4|STARTED|Overall Study||7
8501987|NCT00490945|20951978|P3|STARTED|Overall Study||8
8501988|NCT00490945|20951979|P2|STARTED|Overall Study||9
8501989|NCT00490945|20951980|P1|STARTED|Overall Study||8
8501990|NCT00490919|20952016|P3|NOT COMPLETED|Double-blind Phase||84
8501991|NCT00490919|20952017|P2|NOT COMPLETED|Double-blind Phase||86
8501992|NCT00490919|20952018|P1|NOT COMPLETED|Double-blind Phase||0
8501993|NCT00490919|20952016|P3|COMPLETED|Double-blind Phase||199
8501994|NCT00490919|20952017|P2|COMPLETED|Double-blind Phase||170
8501995|NCT00490919|20952018|P1|COMPLETED|Double-blind Phase||0
8501996|NCT00490919|20952016|P3|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
8501997|NCT00490919|20952017|P2|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
8501998|NCT00490919|20952018|P1|STARTED|Double-blind Phase||0
8501999|NCT00490919|20952016|P3|NOT COMPLETED|Open-label Run-in Period||0
8502000|NCT00490919|20952017|P2|NOT COMPLETED|Open-label Run-in Period||0
8502001|NCT00490919|20952018|P1|NOT COMPLETED|Open-label Run-in Period||483
8502002|NCT00490919|20952016|P3|COMPLETED|Open-label Run-in Period||0
8502003|NCT00490919|20952017|P2|COMPLETED|Open-label Run-in Period||0
8502004|NCT00490919|20952018|P1|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
8502005|NCT00490919|20952016|P3|STARTED|Open-label Run-in Period||0
8502006|NCT00490919|20952017|P2|STARTED|Open-label Run-in Period||0
8502007|NCT00490919|20952018|P1|STARTED|Open-label Run-in Period||1024
8502008|NCT00490841|20952029|P1|NOT COMPLETED|Overall Study||13
8502009|NCT00490841|20952029|P1|COMPLETED|Overall Study||189
8502010|NCT00490841|20952029|P1|STARTED|Overall Study||202
8502011|NCT00490815|20952051|P2|NOT COMPLETED|Overall Study||9
8502012|NCT00490815|20952052|P1|NOT COMPLETED|Overall Study||8
8502013|NCT00490815|20952051|P2|COMPLETED|Overall Study||8
8502014|NCT00490815|20952052|P1|COMPLETED|Overall Study||12
8502015|NCT00490815|20952051|P2|STARTED|Overall Study||17
8502016|NCT00490815|20952052|P1|STARTED|Overall Study||20
8502017|NCT00490802|20952062|P2|NOT COMPLETED|Overall Study||2
8502018|NCT00490802|20952063|P1|NOT COMPLETED|Overall Study||1
8502019|NCT00490802|20952062|P2|COMPLETED|Overall Study||7
8502020|NCT00490802|20952063|P1|COMPLETED|Overall Study||9
8502021|NCT00490802|20952062|P2|STARTED|Overall Study||9
8502022|NCT00490802|20952063|P1|STARTED|Overall Study||10
8502023|NCT00490724|20952080|P3|NOT COMPLETED|Period II||3
8502024|NCT00490724|20952081|P2|NOT COMPLETED|Period II||1
8502025|NCT00490724|20952082|P1|NOT COMPLETED|Period II||3
8502026|NCT00490724|20952080|P3|COMPLETED|Period II||16
8502027|NCT00490724|20952081|P2|COMPLETED|Period II||19
8502028|NCT00490724|20952082|P1|COMPLETED|Period II||18
8502029|NCT00490724|20952080|P3|STARTED|Period II||19
8502030|NCT00490724|20952081|P2|STARTED|Period II||20
8502031|NCT00490724|20952082|P1|STARTED|Period II||21
8502032|NCT00490724|20952080|P3|NOT COMPLETED|Period I||1
8502033|NCT00490724|20952081|P2|NOT COMPLETED|Period I||0
8502034|NCT00490724|20952082|P1|NOT COMPLETED|Period I||0
8502035|NCT00490724|20952080|P3|COMPLETED|Period I||19
8502036|NCT00490724|20952081|P2|COMPLETED|Period I||20
8502037|NCT00490724|20952082|P1|COMPLETED|Period I||21
8502038|NCT00490724|20952080|P3|STARTED|Period I||20
8502039|NCT00490724|20952081|P2|STARTED|Period I||20
8502040|NCT00490724|20952082|P1|STARTED|Period I||21
8502041|NCT00490698|20952147|P1|NOT COMPLETED|Overall Study||10
8502042|NCT00490698|20952147|P1|COMPLETED|Overall Study||1
8502043|NCT00490698|20952147|P1|STARTED|Overall Study||11
8502044|NCT00490646|20952153|P2|NOT COMPLETED|Overall Study||2
8502045|NCT00490646|20952154|P1|NOT COMPLETED|Overall Study||2
8502046|NCT00490646|20952153|P2|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
8502047|NCT00490646|20952154|P1|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
8502048|NCT00490646|20952153|P2|Treated|Overall Study||24
8502049|NCT00490646|20952154|P1|Treated|Overall Study||24
8502050|NCT00490646|20952153|P2|STARTED|Overall Study||25
8502051|NCT00490646|20952154|P1|STARTED|Overall Study||25
8502052|NCT00490568|20952174|P1|NOT COMPLETED|Overall Study||1364
8502053|NCT00490568|20952174|P1|COMPLETED|Overall Study||97
8502054|NCT00490568|20952174|P1|STARTED|Overall Study||1461
8502055|NCT00490555|20952198|P4|NOT COMPLETED|Overall Study||0
8502056|NCT00490555|20952199|P3|NOT COMPLETED|Overall Study||2
8502057|NCT00490555|20952200|P2|NOT COMPLETED|Overall Study||0
8502058|NCT00490555|20952201|P1|NOT COMPLETED|Overall Study||0
8502059|NCT00490555|20952198|P4|COMPLETED|Overall Study||7
8502060|NCT00490555|20952199|P3|COMPLETED|Overall Study||7
8502061|NCT00490555|20952200|P2|COMPLETED|Overall Study||8
8502062|NCT00490555|20952201|P1|COMPLETED|Overall Study||8
8502063|NCT00490555|20952198|P4|STARTED|Overall Study||7
8502064|NCT00490555|20952199|P3|STARTED|Overall Study||9
8502065|NCT00490555|20952200|P2|STARTED|Overall Study||8
8502066|NCT00490555|20952201|P1|STARTED|Overall Study||8
8502067|NCT00490542|20952229|P2|NOT COMPLETED|Overall Study||4
8502068|NCT00490542|20952230|P1|NOT COMPLETED|Overall Study||7
8502069|NCT00490542|20952229|P2|COMPLETED|Overall Study||31
8502070|NCT00490542|20952230|P1|COMPLETED|Overall Study||31
8502071|NCT00490542|20952229|P2|STARTED|Overall Study||35
8502072|NCT00490542|20952230|P1|STARTED|Overall Study||38
8502073|NCT00490529|20952236|P1|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1
8502074|NCT00490529|20952236|P1|COMPLETED|Treatment With CpG-MCL Vaccine||47
8502075|NCT00490529|20952236|P1|STARTED|Treatment With CpG-MCL Vaccine||48
8502076|NCT00490529|20952236|P1|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11
8502077|NCT00490529|20952236|P1|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48
8502078|NCT00490529|20952236|P1|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59
8502079|NCT00490490|20952244|P1|NOT COMPLETED|Completed Assessment for TTP||3
8502080|NCT00490490|20952244|P1|COMPLETED|Completed Assessment for TTP||5
8502081|NCT00490490|20952244|P1|STARTED|Completed Assessment for TTP||8
8502082|NCT00490490|20952244|P1|NOT COMPLETED|Completed Assessment for CR||0
8502083|NCT00490490|20952244|P1|COMPLETED|Completed Assessment for CR||8
8502084|NCT00490490|20952244|P1|STARTED|Completed Assessment for CR||8
8502085|NCT00490477|20952252|P2|NOT COMPLETED|Overall Study||0
8502086|NCT00490477|20952253|P1|NOT COMPLETED|Overall Study||0
8502087|NCT00490477|20952252|P2|COMPLETED|Overall Study||8
8502088|NCT00490477|20952253|P1|COMPLETED|Overall Study||8
8502089|NCT00490477|20952252|P2|STARTED|Overall Study||8
8502090|NCT00490477|20952253|P1|STARTED|Overall Study||8
8502091|NCT00490451|20952261|P2|NOT COMPLETED|Overall Study||38
8502092|NCT00490451|20952262|P1|NOT COMPLETED|Overall Study||63
8502093|NCT00490451|20952261|P2|COMPLETED|Overall Study||0
8502094|NCT00490451|20952262|P1|COMPLETED|Overall Study||0
8502095|NCT00490451|20952261|P2|STARTED|Overall Study||38
8502096|NCT00490451|20952262|P1|STARTED|Overall Study||63
8502097|NCT00490282|20952282|P1|NOT COMPLETED|Overall Study||3
8502098|NCT00490282|20952282|P1|COMPLETED|Overall Study||22
8502099|NCT00490282|20952282|P1|STARTED|Overall Study||25
8502100|NCT00490269|20952290|P2|NOT COMPLETED|Placebo Then Dronabinol||0
8502101|NCT00490269|20952291|P1|NOT COMPLETED|Placebo Then Dronabinol||0
8502102|NCT00490269|20952290|P2|COMPLETED|Placebo Then Dronabinol||6
8502103|NCT00490269|20952291|P1|COMPLETED|Placebo Then Dronabinol||6
8502104|NCT00490269|20952290|P2|STARTED|Placebo Then Dronabinol||6
8502105|NCT00490269|20952291|P1|STARTED|Placebo Then Dronabinol||6
8502106|NCT00490269|20952290|P2|NOT COMPLETED|Dronabinol Then Placebo||0
8502107|NCT00490269|20952291|P1|NOT COMPLETED|Dronabinol Then Placebo||0
8502108|NCT00490269|20952290|P2|COMPLETED|Dronabinol Then Placebo||6
8502109|NCT00490269|20952291|P1|COMPLETED|Dronabinol Then Placebo||6
8502110|NCT00490269|20952290|P2|STARTED|Dronabinol Then Placebo||6
8502111|NCT00490269|20952291|P1|STARTED|Dronabinol Then Placebo||6
8502112|NCT00490256|20952299|P2|NOT COMPLETED|Overall Study||0
8502113|NCT00490256|20952300|P1|NOT COMPLETED|Overall Study||0
8502114|NCT00490256|20952299|P2|COMPLETED|Overall Study||7
8502115|NCT00490256|20952300|P1|COMPLETED|Overall Study||7
8502116|NCT00490256|20952299|P2|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
8502117|NCT00490256|20952300|P1|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
8502118|NCT00490256|20952299|P2|STARTED|Overall Study||7
8502119|NCT00490256|20952300|P1|STARTED|Overall Study||7
8502132|NCT00490100|20952343|P1|NOT COMPLETED|Overall Study||3
8502133|NCT00490100|20952343|P1|COMPLETED|Overall Study||3
8502134|NCT00490100|20952343|P1|STARTED|Overall Study||6
8502135|NCT00490061|20952348|P1|NOT COMPLETED|Overall Study||1
8502136|NCT00490061|20952348|P1|COMPLETED|Overall Study||16
8502137|NCT00490061|20952348|P1|STARTED|Overall Study||17
8502150|NCT00490022|20952460|P2|NOT COMPLETED|Overall Study||3
8502151|NCT00490022|20952461|P1|NOT COMPLETED|Overall Study||1
8502152|NCT00490022|20952460|P2|COMPLETED|Overall Study||12
8502153|NCT00490022|20952461|P1|COMPLETED|Overall Study||15
8502154|NCT00490022|20952460|P2|STARTED|Overall Study||15
8502155|NCT00490022|20952461|P1|STARTED|Overall Study||16
8502156|NCT00490009|20952469|P1|NOT COMPLETED|Overall Study||0
8502157|NCT00490009|20952469|P1|COMPLETED|Overall Study||9
8502158|NCT00490009|20952469|P1|STARTED|Overall Study||9
8502159|NCT00489970|20952478|P3|NOT COMPLETED|Persistence Year 9||5
8502160|NCT00489970|20952479|P2|NOT COMPLETED|Persistence Year 9||2
8502161|NCT00489970|20952480|P1|NOT COMPLETED|Persistence Year 9||3
8502162|NCT00489970|20952478|P3|COMPLETED|Persistence Year 9||357
8502163|NCT00489970|20952479|P2|COMPLETED|Persistence Year 9||136
8502164|NCT00489970|20952480|P1|COMPLETED|Persistence Year 9||306
8502165|NCT00489970|20952478|P3|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362
8502166|NCT00489970|20952479|P2|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138
8502167|NCT00489970|20952480|P1|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309
8502168|NCT00489970|20952478|P3|NOT COMPLETED|Persistence Year 5||0
8502169|NCT00489970|20952479|P2|NOT COMPLETED|Persistence Year 5||0
8502170|NCT00489970|20952480|P1|NOT COMPLETED|Persistence Year 5||0
8502171|NCT00489970|20952478|P3|COMPLETED|Persistence Year 5||0
8502172|NCT00489970|20952479|P2|COMPLETED|Persistence Year 5||401
8502173|NCT00489970|20952480|P1|COMPLETED|Persistence Year 5||856
8502174|NCT00489970|20952478|P3|STARTED|Persistence Year 5||0
8502175|NCT00489970|20952479|P2|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
8502176|NCT00489970|20952480|P1|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
8502177|NCT00489970|20952478|P3|NOT COMPLETED|Persistence Year 3||0
8502178|NCT00489970|20952479|P2|NOT COMPLETED|Persistence Year 3||0
8502179|NCT00489970|20952480|P1|NOT COMPLETED|Persistence Year 3||0
8502180|NCT00489970|20952478|P3|COMPLETED|Persistence Year 3||0
8502181|NCT00489970|20952479|P2|COMPLETED|Persistence Year 3||486
8502182|NCT00489970|20952480|P1|COMPLETED|Persistence Year 3||1019
8502183|NCT00489970|20952478|P3|STARTED|Persistence Year 3||0
8502184|NCT00489970|20952479|P2|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
8502185|NCT00489970|20952480|P1|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
8502186|NCT00489970|20952478|P3|NOT COMPLETED|Persistence Year 1||0
8502187|NCT00489970|20952479|P2|NOT COMPLETED|Persistence Year 1||0
8502188|NCT00489970|20952480|P1|NOT COMPLETED|Persistence Year 1||0
8502189|NCT00489970|20952478|P3|COMPLETED|Persistence Year 1||0
8502190|NCT00489970|20952479|P2|COMPLETED|Persistence Year 1||523
8502191|NCT00489970|20952480|P1|COMPLETED|Persistence Year 1||1069
8502192|NCT00489970|20952478|P3|STARTED|Persistence Year 1||0
8502193|NCT00489970|20952479|P2|STARTED|Persistence Year 1||523
8502194|NCT00489970|20952480|P1|STARTED|Persistence Year 1||1069
8502195|NCT00489918|20952584|P5|NOT COMPLETED|Overall Study||1
8502196|NCT00489918|20952585|P4|NOT COMPLETED|Overall Study||1
8502197|NCT00489918|20952586|P3|NOT COMPLETED|Overall Study||4
8502198|NCT00489918|20952587|P2|NOT COMPLETED|Overall Study||2
8502199|NCT00489918|20952588|P1|NOT COMPLETED|Overall Study||2
8502200|NCT00489918|20952584|P5|COMPLETED|Overall Study||32
8502201|NCT00489918|20952585|P4|COMPLETED|Overall Study||32
8502202|NCT00489918|20952586|P3|COMPLETED|Overall Study||28
8502203|NCT00489918|20952587|P2|COMPLETED|Overall Study||32
8502204|NCT00489918|20952588|P1|COMPLETED|Overall Study||31
8502205|NCT00489918|20952584|P5|STARTED|Overall Study||33
8502206|NCT00489918|20952585|P4|STARTED|Overall Study||33
8502207|NCT00489918|20952586|P3|STARTED|Overall Study||32
8502208|NCT00489918|20952587|P2|STARTED|Overall Study||34
8502209|NCT00489918|20952588|P1|STARTED|Overall Study||33
8502210|NCT00489866|20952622|P2|NOT COMPLETED|Overall Study||0
8502211|NCT00489866|20952623|P1|NOT COMPLETED|Overall Study||2
8502212|NCT00489866|20952622|P2|COMPLETED|Overall Study||7
8502213|NCT00489866|20952623|P1|COMPLETED|Overall Study||5
8502214|NCT00489866|20952622|P2|STARTED|Overall Study||7
8502215|NCT00489866|20952623|P1|STARTED|Overall Study||7
8502216|NCT00489853|20952637|P3|NOT COMPLETED|Follow-up Period||0
8502217|NCT00489853|20952638|P2|NOT COMPLETED|Follow-up Period||0
8502218|NCT00489853|20952639|P1|NOT COMPLETED|Follow-up Period||0
8502219|NCT00489853|20952637|P3|COMPLETED|Follow-up Period||33
8502220|NCT00489853|20952638|P2|COMPLETED|Follow-up Period||29
8502221|NCT00489853|20952639|P1|COMPLETED|Follow-up Period||29
8502222|NCT00489853|20952637|P3|STARTED|Follow-up Period||33
8502223|NCT00489853|20952638|P2|STARTED|Follow-up Period||29
8502224|NCT00489853|20952639|P1|STARTED|Follow-up Period||29
8502225|NCT00489853|20952637|P3|NOT COMPLETED|Treatment Period 3||0
8502226|NCT00489853|20952638|P2|NOT COMPLETED|Treatment Period 3||1
8502227|NCT00489853|20952639|P1|NOT COMPLETED|Treatment Period 3||0
8502228|NCT00489853|20952637|P3|COMPLETED|Treatment Period 3||33
8502229|NCT00489853|20952638|P2|COMPLETED|Treatment Period 3||29
8502230|NCT00489853|20952639|P1|COMPLETED|Treatment Period 3||29
8502231|NCT00489853|20952637|P3|STARTED|Treatment Period 3||33
8502232|NCT00489853|20952638|P2|STARTED|Treatment Period 3||30
8502233|NCT00489853|20952639|P1|STARTED|Treatment Period 3||29
8502234|NCT00489853|20952637|P3|NOT COMPLETED|Wash-out Period 2||2
8502235|NCT00489853|20952638|P2|NOT COMPLETED|Wash-out Period 2||3
8502236|NCT00489853|20952639|P1|NOT COMPLETED|Wash-out Period 2||4
8502237|NCT00489853|20952637|P3|COMPLETED|Wash-out Period 2||31
8502238|NCT00489853|20952638|P2|COMPLETED|Wash-out Period 2||32
8502239|NCT00489853|20952639|P1|COMPLETED|Wash-out Period 2||29
8502240|NCT00489853|20952637|P3|STARTED|Wash-out Period 2||33
8502241|NCT00489853|20952638|P2|STARTED|Wash-out Period 2||35
8502242|NCT00489853|20952639|P1|STARTED|Wash-out Period 2||33
8502243|NCT00489853|20952637|P3|NOT COMPLETED|Treatment Period 2||0
8502244|NCT00489853|20952638|P2|NOT COMPLETED|Treatment Period 2||0
8502245|NCT00489853|20952639|P1|NOT COMPLETED|Treatment Period 2||0
8502246|NCT00489853|20952637|P3|COMPLETED|Treatment Period 2||33
8502247|NCT00489853|20952638|P2|COMPLETED|Treatment Period 2||35
8502248|NCT00489853|20952639|P1|COMPLETED|Treatment Period 2||33
8502249|NCT00489853|20952637|P3|STARTED|Treatment Period 2||33
8502250|NCT00489853|20952638|P2|STARTED|Treatment Period 2||35
8502251|NCT00489853|20952639|P1|STARTED|Treatment Period 2||33
8502252|NCT00489853|20952637|P3|NOT COMPLETED|Wash-out Period 1||6
8502253|NCT00489853|20952638|P2|NOT COMPLETED|Wash-out Period 1||3
8502254|NCT00489853|20952639|P1|NOT COMPLETED|Wash-out Period 1||1
8502255|NCT00489853|20952637|P3|COMPLETED|Wash-out Period 1||32
8502256|NCT00489853|20952638|P2|COMPLETED|Wash-out Period 1||34
8502257|NCT00489853|20952639|P1|COMPLETED|Wash-out Period 1||35
8502258|NCT00489853|20952637|P3|STARTED|Wash-out Period 1||38
8502259|NCT00489853|20952638|P2|STARTED|Wash-out Period 1||37
8502260|NCT00489853|20952639|P1|STARTED|Wash-out Period 1||36
8502261|NCT00489853|20952637|P3|NOT COMPLETED|Treatment Period 1||0
8502262|NCT00489853|20952638|P2|NOT COMPLETED|Treatment Period 1||0
8502263|NCT00489853|20952639|P1|NOT COMPLETED|Treatment Period 1||0
8502264|NCT00489853|20952637|P3|COMPLETED|Treatment Period 1||38
8502265|NCT00489853|20952638|P2|COMPLETED|Treatment Period 1||37
8502266|NCT00489853|20952639|P1|COMPLETED|Treatment Period 1||36
8502267|NCT00489853|20952637|P3|STARTED|Treatment Period 1||38
8502268|NCT00489853|20952638|P2|STARTED|Treatment Period 1||37
8502269|NCT00489853|20952639|P1|STARTED|Treatment Period 1||36
8502276|NCT00489736|20952761|P2|NOT COMPLETED|Overall Study||69
8502277|NCT00489736|20952762|P1|NOT COMPLETED|Overall Study||96
8502278|NCT00489736|20952761|P2|COMPLETED|Overall Study|completed study drug period|186
8502279|NCT00489736|20952762|P1|COMPLETED|Overall Study|completed study drug period|153
8502280|NCT00489736|20952761|P2|STARTED|Overall Study|Randomized and treated patients|255
8502281|NCT00489736|20952762|P1|STARTED|Overall Study|Randomized and treated patients|249
8502282|NCT00489554|20952772|P1|NOT COMPLETED|Overall Study||4
8502283|NCT00489554|20952772|P1|COMPLETED|Overall Study||226
8502284|NCT00489554|20952772|P1|STARTED|Overall Study||230
8502285|NCT00489541|20952792|P2|NOT COMPLETED|9-Month Angiographic Follow-up||17
8502286|NCT00489541|20952793|P1|NOT COMPLETED|9-Month Angiographic Follow-up||27
8502287|NCT00489541|20952792|P2|COMPLETED|9-Month Angiographic Follow-up||108
8502288|NCT00489541|20952793|P1|COMPLETED|9-Month Angiographic Follow-up||197
8502289|NCT00489541|20952792|P2|STARTED|9-Month Angiographic Follow-up||125
8502290|NCT00489541|20952793|P1|STARTED|9-Month Angiographic Follow-up||224
8502291|NCT00489541|20952792|P2|NOT COMPLETED|12-Month Clinical Follow-up||5
8502292|NCT00489541|20952793|P1|NOT COMPLETED|12-Month Clinical Follow-up||9
8502293|NCT00489541|20952792|P2|COMPLETED|12-Month Clinical Follow-up||120
8502294|NCT00489541|20952793|P1|COMPLETED|12-Month Clinical Follow-up||215
8502295|NCT00489541|20952792|P2|STARTED|12-Month Clinical Follow-up||125
8502296|NCT00489541|20952793|P1|STARTED|12-Month Clinical Follow-up||224
8502297|NCT00489489|20952804|P3|NOT COMPLETED|Overall Study||3
8502298|NCT00489489|20952805|P2|NOT COMPLETED|Overall Study||5
8502299|NCT00489489|20952806|P1|NOT COMPLETED|Overall Study||3
8502300|NCT00489489|20952804|P3|COMPLETED|Overall Study|completed treatment period|37
8502301|NCT00489489|20952805|P2|COMPLETED|Overall Study|completed treatment period|32
8502302|NCT00489489|20952806|P1|COMPLETED|Overall Study|completed treatment period|38
8502303|NCT00489489|20952804|P3|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
8502304|NCT00489489|20952805|P2|Treated|Overall Study||36
8502305|NCT00489489|20952806|P1|Treated|Overall Study||41
8502306|NCT00489489|20952804|P3|STARTED|Overall Study|randomized|40
8502307|NCT00489489|20952805|P2|STARTED|Overall Study|randomized|37
8502308|NCT00489489|20952806|P1|STARTED|Overall Study|randomized|41
8502309|NCT00489476|20952838|P4|NOT COMPLETED|Overall Study||0
8502310|NCT00489476|20952839|P3|NOT COMPLETED|Overall Study||0
8502311|NCT00489476|20952840|P2|NOT COMPLETED|Overall Study||1
8502312|NCT00489476|20952841|P1|NOT COMPLETED|Overall Study||0
8502313|NCT00489476|20952838|P4|COMPLETED|Overall Study||43
8502314|NCT00489476|20952839|P3|COMPLETED|Overall Study||43
8502315|NCT00489476|20952840|P2|COMPLETED|Overall Study||42
8502316|NCT00489476|20952841|P1|COMPLETED|Overall Study||39
8502317|NCT00489476|20952838|P4|STARTED|Overall Study||43
8502318|NCT00489476|20952839|P3|STARTED|Overall Study||43
8502319|NCT00489476|20952840|P2|STARTED|Overall Study||43
8502320|NCT00489476|20952841|P1|STARTED|Overall Study||39
8502321|NCT00489424|20952862|P3|NOT COMPLETED|Overall Study||5
8502322|NCT00489424|20952863|P2|NOT COMPLETED|Overall Study||5
8502323|NCT00489424|20952864|P1|NOT COMPLETED|Overall Study||4
8502324|NCT00489424|20952862|P3|COMPLETED|Overall Study||257
8502325|NCT00489424|20952863|P2|COMPLETED|Overall Study||259
8502326|NCT00489424|20952864|P1|COMPLETED|Overall Study||263
8502327|NCT00489424|20952862|P3|STARTED|Overall Study||262
8502328|NCT00489424|20952863|P2|STARTED|Overall Study||264
8502329|NCT00489424|20952864|P1|STARTED|Overall Study||267
8502330|NCT00489411|20952895|P2|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
8502331|NCT00489411|20952896|P1|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
8502332|NCT00489411|20952895|P2|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
8502333|NCT00489411|20952896|P1|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
8502334|NCT00489411|20952895|P2|STARTED|Crossover Treatment Period (Weeks 8-12)||93
8502335|NCT00489411|20952896|P1|STARTED|Crossover Treatment Period (Weeks 8-12)||85
8502336|NCT00489411|20952895|P2|NOT COMPLETED|Washout Period (Weeks 6-7)||1
8502337|NCT00489411|20952896|P1|NOT COMPLETED|Washout Period (Weeks 6-7)||2
8502338|NCT00489411|20952895|P2|COMPLETED|Washout Period (Weeks 6-7)||93
8502339|NCT00489411|20952896|P1|COMPLETED|Washout Period (Weeks 6-7)||85
8502340|NCT00489411|20952895|P2|STARTED|Washout Period (Weeks 6-7)||94
8502341|NCT00489411|20952896|P1|STARTED|Washout Period (Weeks 6-7)||87
8502342|NCT00489411|20952895|P2|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
8502343|NCT00489411|20952896|P1|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
8502344|NCT00489411|20952895|P2|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
8502345|NCT00489411|20952896|P1|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
8502346|NCT00489411|20952895|P2|STARTED|Initial Treatment Period (Weeks 1-5)||116
8502347|NCT00489411|20952896|P1|STARTED|Initial Treatment Period (Weeks 1-5)||115
8502348|NCT00489359|20952910|P2|NOT COMPLETED|Overall Study||29
8502349|NCT00489359|20952911|P1|NOT COMPLETED|Overall Study||7
8502350|NCT00489359|20952910|P2|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
8502351|NCT00489359|20952911|P1|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
8502352|NCT00489359|20952910|P2|STARTED|Overall Study||66
8502353|NCT00489359|20952911|P1|STARTED|Overall Study||20
8502354|NCT00489281|20952936|P2|NOT COMPLETED|Overall Study||0
8502355|NCT00489281|20952937|P1|NOT COMPLETED|Overall Study||0
8502356|NCT00489281|20952936|P2|COMPLETED|Overall Study||13
8502357|NCT00489281|20952937|P1|COMPLETED|Overall Study||29
8502358|NCT00489281|20952936|P2|STARTED|Overall Study||13
8502359|NCT00489281|20952937|P1|STARTED|Overall Study||29
8502360|NCT00489268|20952954|P5|NOT COMPLETED|Overall Study||20
8502361|NCT00489268|20952955|P4|NOT COMPLETED|Overall Study||0
8502362|NCT00489268|20952956|P3|NOT COMPLETED|Overall Study||1
8502363|NCT00489268|20952957|P2|NOT COMPLETED|Overall Study||0
8502364|NCT00489268|20952958|P1|NOT COMPLETED|Overall Study||0
8502365|NCT00489268|20952954|P5|COMPLETED|Overall Study||50
8502366|NCT00489268|20952955|P4|COMPLETED|Overall Study||11
8502367|NCT00489268|20952956|P3|COMPLETED|Overall Study||9
8502368|NCT00489268|20952957|P2|COMPLETED|Overall Study||10
8502369|NCT00489268|20952958|P1|COMPLETED|Overall Study||1
8502370|NCT00489268|20952954|P5|STARTED|Overall Study||70
8502371|NCT00489268|20952955|P4|STARTED|Overall Study||11
8502372|NCT00489268|20952956|P3|STARTED|Overall Study||10
8502373|NCT00489268|20952957|P2|STARTED|Overall Study||10
8502374|NCT00489268|20952958|P1|STARTED|Overall Study||1
8502375|NCT00489255|20952987|P2|NOT COMPLETED|Period 3: Days 57 to 84||4
8502376|NCT00489255|20952988|P1|NOT COMPLETED|Period 3: Days 57 to 84||4
8502377|NCT00489255|20952987|P2|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
8502378|NCT00489255|20952988|P1|COMPLETED|Period 3: Days 57 to 84||24
8502379|NCT00489255|20952987|P2|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
8502380|NCT00489255|20952988|P1|STARTED|Period 3: Days 57 to 84||28
8502381|NCT00489255|20952987|P2|NOT COMPLETED|Period 2: Days 29 to 56||4
8502382|NCT00489255|20952988|P1|NOT COMPLETED|Period 2: Days 29 to 56||3
8502383|NCT00489255|20952987|P2|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
8502384|NCT00489255|20952988|P1|COMPLETED|Period 2: Days 29 to 56||61
8502385|NCT00489255|20952987|P2|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
8502386|NCT00489255|20952988|P1|Completed But Discontinued Study|Period 2: Days 29 to 56||3
8502387|NCT00489255|20952987|P2|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
8502476|NCT00488826|20953080|P1|STARTED|Overall Study||300
8502388|NCT00489255|20952988|P1|Completed and Follow Period 3|Period 2: Days 29 to 56||58
8502389|NCT00489255|20952987|P2|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
8502390|NCT00489255|20952988|P1|STARTED|Period 2: Days 29 to 56||64
8502391|NCT00489255|20952987|P2|NOT COMPLETED|Period 1: Days 1 to 28||12
8502392|NCT00489255|20952988|P1|NOT COMPLETED|Period 1: Days 1 to 28||29
8502393|NCT00489255|20952987|P2|COMPLETED|Period 1: Days 1 to 28||34
8502394|NCT00489255|20952988|P1|COMPLETED|Period 1: Days 1 to 28||107
8502395|NCT00489255|20952987|P2|Completed But Discontinued Study|Period 1: Days 1 to 28||5
8502396|NCT00489255|20952988|P1|Completed But Discontinued Study|Period 1: Days 1 to 28||13
8502397|NCT00489255|20952987|P2|Completed and Follow Period 2|Period 1: Days 1 to 28||29
8502398|NCT00489255|20952988|P1|Completed and Follow Period 2|Period 1: Days 1 to 28||94
8502399|NCT00489255|20952987|P2|STARTED|Period 1: Days 1 to 28||46
8502400|NCT00489255|20952988|P1|STARTED|Period 1: Days 1 to 28||136
8502401|NCT00489255|20952987|P2|NOT COMPLETED|Screening and Initial Randomization||3
8502402|NCT00489255|20952988|P1|NOT COMPLETED|Screening and Initial Randomization||9
8502403|NCT00489255|20952987|P2|COMPLETED|Screening and Initial Randomization||46
8502404|NCT00489255|20952988|P1|COMPLETED|Screening and Initial Randomization||136
8502405|NCT00489255|20952987|P2|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
8502406|NCT00489255|20952988|P1|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
8502407|NCT00489216|20953036|P1|NOT COMPLETED|Overall Study||1
8502408|NCT00489216|20953036|P1|COMPLETED|Overall Study||1
8502409|NCT00489216|20953036|P1|STARTED|Overall Study||2
8502410|NCT00489086|20953045|P1|NOT COMPLETED|Overall Study||23
8502411|NCT00489086|20953045|P1|COMPLETED|Overall Study||13
8502412|NCT00489086|20953045|P1|Completed 18 Months|Overall Study||23
8502413|NCT00489086|20953045|P1|STARTED|Overall Study||36
8502414|NCT00488982|20953053|P3|NOT COMPLETED|Response to Course 3||3
8502415|NCT00488982|20953054|P2|NOT COMPLETED|Response to Course 3||1
8502416|NCT00488982|20953055|P1|NOT COMPLETED|Response to Course 3||0
8502417|NCT00488982|20953053|P3|COMPLETED|Response to Course 3||0
8502418|NCT00488982|20953054|P2|COMPLETED|Response to Course 3||1
8502419|NCT00488982|20953055|P1|COMPLETED|Response to Course 3||0
8502420|NCT00488982|20953053|P3|STARTED|Response to Course 3||3
8502421|NCT00488982|20953054|P2|STARTED|Response to Course 3||2
8502422|NCT00488982|20953055|P1|STARTED|Response to Course 3||0
8502423|NCT00488982|20953053|P3|NOT COMPLETED|Course 3||5
8502424|NCT00488982|20953054|P2|NOT COMPLETED|Course 3||2
8502425|NCT00488982|20953055|P1|NOT COMPLETED|Course 3||0
8502426|NCT00488982|20953053|P3|COMPLETED|Course 3||3
8502427|NCT00488982|20953054|P2|COMPLETED|Course 3||2
8502428|NCT00488982|20953055|P1|COMPLETED|Course 3||0
8502429|NCT00488982|20953053|P3|STARTED|Course 3||8
8502430|NCT00488982|20953054|P2|STARTED|Course 3||4
8502431|NCT00488982|20953055|P1|STARTED|Course 3||0
8502432|NCT00488982|20953053|P3|NOT COMPLETED|Course 2||5
8502433|NCT00488982|20953054|P2|NOT COMPLETED|Course 2||9
8502434|NCT00488982|20953055|P1|NOT COMPLETED|Course 2||0
8502435|NCT00488982|20953053|P3|COMPLETED|Course 2||8
8502436|NCT00488982|20953054|P2|COMPLETED|Course 2||4
8502437|NCT00488982|20953055|P1|COMPLETED|Course 2||0
8502438|NCT00488982|20953053|P3|STARTED|Course 2||13
8502439|NCT00488982|20953054|P2|STARTED|Course 2||13
8502440|NCT00488982|20953055|P1|STARTED|Course 2||0
8502441|NCT00488982|20953053|P3|NOT COMPLETED|Course 1||14
8502442|NCT00488982|20953054|P2|NOT COMPLETED|Course 1||12
8502443|NCT00488982|20953055|P1|NOT COMPLETED|Course 1||0
8502444|NCT00488982|20953053|P3|COMPLETED|Course 1||13
8502445|NCT00488982|20953054|P2|COMPLETED|Course 1||13
8502446|NCT00488982|20953055|P1|COMPLETED|Course 1||0
8502447|NCT00488982|20953053|P3|STARTED|Course 1||27
8502448|NCT00488982|20953054|P2|STARTED|Course 1||25
8502449|NCT00488982|20953055|P1|STARTED|Course 1||0
8502450|NCT00488982|20953053|P3|NOT COMPLETED|Induction Chemotherapy||0
8502451|NCT00488982|20953054|P2|NOT COMPLETED|Induction Chemotherapy||0
8502452|NCT00488982|20953055|P1|NOT COMPLETED|Induction Chemotherapy||73
8502453|NCT00488982|20953053|P3|COMPLETED|Induction Chemotherapy||0
8502454|NCT00488982|20953054|P2|COMPLETED|Induction Chemotherapy||0
8502455|NCT00488982|20953055|P1|COMPLETED|Induction Chemotherapy||52
8502456|NCT00488982|20953053|P3|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
8502457|NCT00488982|20953054|P2|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
8502458|NCT00488982|20953055|P1|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52
8502459|NCT00488982|20953053|P3|6 Cycles Completed|Induction Chemotherapy||0
8502460|NCT00488982|20953054|P2|6 Cycles Completed|Induction Chemotherapy||0
8502461|NCT00488982|20953055|P1|6 Cycles Completed|Induction Chemotherapy||94
8502462|NCT00488982|20953053|P3|STARTED|Induction Chemotherapy||0
8502463|NCT00488982|20953054|P2|STARTED|Induction Chemotherapy||0
8502464|NCT00488982|20953055|P1|STARTED|Induction Chemotherapy||125
8502465|NCT00488865|20953069|P1|NOT COMPLETED|Overall Study||0
8502466|NCT00488865|20953069|P1|COMPLETED|Overall Study||100
8502467|NCT00488865|20953069|P1|STARTED|Overall Study||100
8502468|NCT00488826|20953078|P3|NOT COMPLETED|Overall Study||26
8502469|NCT00488826|20953079|P2|NOT COMPLETED|Overall Study||52
8502470|NCT00488826|20953080|P1|NOT COMPLETED|Overall Study||56
8502471|NCT00488826|20953078|P3|COMPLETED|Overall Study||178
8502472|NCT00488826|20953079|P2|COMPLETED|Overall Study||244
8502473|NCT00488826|20953080|P1|COMPLETED|Overall Study||244
8502474|NCT00488826|20953078|P3|STARTED|Overall Study||204
8502475|NCT00488826|20953079|P2|STARTED|Overall Study||296
8502477|NCT00488774|20953095|P4|NOT COMPLETED|Overall Study||3
8502478|NCT00488774|20953096|P3|NOT COMPLETED|Overall Study||5
8502479|NCT00488774|20953097|P2|NOT COMPLETED|Overall Study||5
8502480|NCT00488774|20953098|P1|NOT COMPLETED|Overall Study||8
8502481|NCT00488774|20953095|P4|COMPLETED|Overall Study||74
8502482|NCT00488774|20953096|P3|COMPLETED|Overall Study||70
8502483|NCT00488774|20953097|P2|COMPLETED|Overall Study||57
8502484|NCT00488774|20953098|P1|COMPLETED|Overall Study||69
8502485|NCT00488774|20953095|P4|STARTED|Overall Study||77
8502486|NCT00488774|20953096|P3|STARTED|Overall Study||75
8502487|NCT00488774|20953097|P2|STARTED|Overall Study||62
8502488|NCT00488774|20953098|P1|STARTED|Overall Study||77
8502489|NCT00488683|20953115|P3|NOT COMPLETED|Overall Study||2
8502490|NCT00488683|20953116|P2|NOT COMPLETED|Overall Study||6
8502491|NCT00488683|20953117|P1|NOT COMPLETED|Overall Study||12
8502492|NCT00488683|20953115|P3|COMPLETED|Overall Study||52
8502493|NCT00488683|20953116|P2|COMPLETED|Overall Study||48
8502494|NCT00488683|20953117|P1|COMPLETED|Overall Study||96
8502495|NCT00488683|20953115|P3|STARTED|Overall Study||54
8502496|NCT00488683|20953116|P2|STARTED|Overall Study||54
8502497|NCT00488683|20953117|P1|STARTED|Overall Study||108
8502498|NCT00488644|20953176|P1|NOT COMPLETED|Overall Study||2
8502499|NCT00488644|20953176|P1|COMPLETED|Overall Study||10
8502500|NCT00488644|20953176|P1|STARTED|Overall Study||12
8502501|NCT00488631|20953186|P10|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
8502502|NCT00488631|20953187|P9|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
8502503|NCT00488631|20953188|P8|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
8502504|NCT00488631|20953189|P7|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
8502505|NCT00488631|20953190|P6|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8502506|NCT00488631|20953191|P5|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8502507|NCT00488631|20953192|P4|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8502508|NCT00488631|20953193|P3|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8502509|NCT00488631|20953194|P2|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8502510|NCT00488631|20953195|P1|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
8502511|NCT00488631|20953186|P10|COMPLETED|Open Label Study Extension (Week 54-228)||4
8502512|NCT00488631|20953187|P9|COMPLETED|Open Label Study Extension (Week 54-228)||288
8502513|NCT00488631|20953188|P8|COMPLETED|Open Label Study Extension (Week 54-228)||66
8502514|NCT00488631|20953189|P7|COMPLETED|Open Label Study Extension (Week 54-228)||16
8502515|NCT00488631|20953190|P6|COMPLETED|Open Label Study Extension (Week 54-228)||0
8502516|NCT00488631|20953191|P5|COMPLETED|Open Label Study Extension (Week 54-228)||0
8502517|NCT00488631|20953192|P4|COMPLETED|Open Label Study Extension (Week 54-228)||0
8502518|NCT00488631|20953193|P3|COMPLETED|Open Label Study Extension (Week 54-228)||0
8502519|NCT00488631|20953194|P2|COMPLETED|Open Label Study Extension (Week 54-228)||0
8502520|NCT00488631|20953195|P1|COMPLETED|Open Label Study Extension (Week 54-228)||0
8502521|NCT00488631|20953186|P10|STARTED|Open Label Study Extension (Week 54-228)||7
8502522|NCT00488631|20953187|P9|STARTED|Open Label Study Extension (Week 54-228)||470
8502523|NCT00488631|20953188|P8|STARTED|Open Label Study Extension (Week 54-228)||93
8502524|NCT00488631|20953189|P7|STARTED|Open Label Study Extension (Week 54-228)||96
8502525|NCT00488631|20953190|P6|STARTED|Open Label Study Extension (Week 54-228)||0
8502526|NCT00488631|20953191|P5|STARTED|Open Label Study Extension (Week 54-228)||0
8502527|NCT00488631|20953192|P4|STARTED|Open Label Study Extension (Week 54-228)||0
8502528|NCT00488631|20953193|P3|STARTED|Open Label Study Extension (Week 54-228)||0
8502529|NCT00488631|20953194|P2|STARTED|Open Label Study Extension (Week 54-228)||0
8502530|NCT00488631|20953195|P1|STARTED|Open Label Study Extension (Week 54-228)||0
8502531|NCT00488631|20953186|P10|NOT COMPLETED|Double Blind Period (Week 0-54)||0
8502532|NCT00488631|20953187|P9|NOT COMPLETED|Double Blind Period (Week 0-54)||0
8502533|NCT00488631|20953188|P8|NOT COMPLETED|Double Blind Period (Week 0-54)||0
8502534|NCT00488631|20953189|P7|NOT COMPLETED|Double Blind Period (Week 0-54)||0
8502535|NCT00488631|20953190|P6|NOT COMPLETED|Double Blind Period (Week 0-54)||216
8502536|NCT00488631|20953191|P5|NOT COMPLETED|Double Blind Period (Week 0-54)||103
8502537|NCT00488631|20953192|P4|NOT COMPLETED|Double Blind Period (Week 0-54)||41
8502538|NCT00488631|20953193|P3|NOT COMPLETED|Double Blind Period (Week 0-54)||45
8502539|NCT00488631|20953194|P2|NOT COMPLETED|Double Blind Period (Week 0-54)||43
8502540|NCT00488631|20953195|P1|NOT COMPLETED|Double Blind Period (Week 0-54)||43
8502541|NCT00488631|20953186|P10|COMPLETED|Double Blind Period (Week 0-54)||0
8502542|NCT00488631|20953187|P9|COMPLETED|Double Blind Period (Week 0-54)||0
8502543|NCT00488631|20953188|P8|COMPLETED|Double Blind Period (Week 0-54)||0
8502544|NCT00488631|20953189|P7|COMPLETED|Double Blind Period (Week 0-54)||0
8502545|NCT00488631|20953190|P6|COMPLETED|Double Blind Period (Week 0-54)||189
8502546|NCT00488631|20953191|P5|COMPLETED|Double Blind Period (Week 0-54)||127
8502547|NCT00488631|20953192|P4|COMPLETED|Double Blind Period (Week 0-54)||88
8502548|NCT00488631|20953193|P3|COMPLETED|Double Blind Period (Week 0-54)||109
8502549|NCT00488631|20953194|P2|COMPLETED|Double Blind Period (Week 0-54)||111
8502550|NCT00488631|20953195|P1|COMPLETED|Double Blind Period (Week 0-54)||113
8502551|NCT00488631|20953186|P10|STARTED|Double Blind Period (Week 0-54)||0
8502552|NCT00488631|20953187|P9|STARTED|Double Blind Period (Week 0-54)||0
8502553|NCT00488631|20953188|P8|STARTED|Double Blind Period (Week 0-54)||0
8502554|NCT00488631|20953189|P7|STARTED|Double Blind Period (Week 0-54)||0
8502555|NCT00488631|20953190|P6|STARTED|Double Blind Period (Week 0-54)||405
8502556|NCT00488631|20953191|P5|STARTED|Double Blind Period (Week 0-54)||230
8502557|NCT00488631|20953192|P4|STARTED|Double Blind Period (Week 0-54)||129
8502558|NCT00488631|20953193|P3|STARTED|Double Blind Period (Week 0-54)||154
8502559|NCT00488631|20953194|P2|STARTED|Double Blind Period (Week 0-54)||154
8502560|NCT00488631|20953195|P1|STARTED|Double Blind Period (Week 0-54)||156
8502561|NCT00488618|20953232|P2|NOT COMPLETED|Overall Study||43
8502562|NCT00488618|20953233|P1|NOT COMPLETED|Overall Study||47
8502563|NCT00488618|20953232|P2|COMPLETED|Overall Study||75
8502564|NCT00488618|20953233|P1|COMPLETED|Overall Study||73
8502565|NCT00488618|20953232|P2|Safety Population: Received Study Drug|Overall Study||118
8502566|NCT00488618|20953233|P1|Safety Population: Received Study Drug|Overall Study||118
8502567|NCT00488618|20953232|P2|STARTED|Overall Study||118
8502568|NCT00488618|20953233|P1|STARTED|Overall Study||120
8502572|NCT00488514|20953245|P1|NOT COMPLETED|Overall Study||293
8502573|NCT00488514|20953245|P1|COMPLETED|Overall Study||363
8502574|NCT00488514|20953245|P1|STARTED|Overall Study||656
8502575|NCT00488488|20953318|P1|NOT COMPLETED|Overall Study||268
8502576|NCT00488488|20953318|P1|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
8502577|NCT00488488|20953318|P1|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
8502578|NCT00488488|20953318|P1|STARTED|Overall Study||1028
8502579|NCT00488475|20953333|P1|NOT COMPLETED|Overall Study||1754
8502580|NCT00488475|20953333|P1|COMPLETED|Overall Study||3191
8502581|NCT00488475|20953333|P1|STARTED|Overall Study||4945
8502582|NCT00488345|20953362|P3|NOT COMPLETED|Overall Study||3
8502583|NCT00488345|20953363|P2|NOT COMPLETED|Overall Study||4
8502584|NCT00488345|20953364|P1|NOT COMPLETED|Overall Study||0
8502585|NCT00488345|20953362|P3|COMPLETED|Overall Study||17
8502586|NCT00488345|20953363|P2|COMPLETED|Overall Study||17
8502587|NCT00488345|20953364|P1|COMPLETED|Overall Study||17
8502588|NCT00488345|20953362|P3|STARTED|Overall Study||20
8502589|NCT00488345|20953363|P2|STARTED|Overall Study||21
8502590|NCT00488345|20953364|P1|STARTED|Overall Study||17
8502591|NCT00488319|20953390|P3|NOT COMPLETED|Overall Study||122
8502592|NCT00488319|20953391|P2|NOT COMPLETED|Overall Study||43
8502593|NCT00488319|20953392|P1|NOT COMPLETED|Overall Study||15
8502594|NCT00488319|20953390|P3|COMPLETED|Overall Study||121
8502595|NCT00488319|20953391|P2|COMPLETED|Overall Study||75
8502596|NCT00488319|20953392|P1|COMPLETED|Overall Study||24
8502597|NCT00488319|20953390|P3|STARTED|Overall Study||243
8502598|NCT00488319|20953391|P2|STARTED|Overall Study||118
8502599|NCT00488319|20953392|P1|STARTED|Overall Study||39
8502600|NCT00488293|20953479|P2|NOT COMPLETED|Overall Study||30
8502601|NCT00488293|20953480|P1|NOT COMPLETED|Overall Study||36
8502602|NCT00488293|20953479|P2|COMPLETED|Overall Study||166
8502603|NCT00488293|20953480|P1|COMPLETED|Overall Study||160
8502604|NCT00488293|20953479|P2|STARTED|Overall Study||196
8502605|NCT00488293|20953480|P1|STARTED|Overall Study||196
8502606|NCT00488059|20953504|P3|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
8502607|NCT00488059|20953505|P2|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8502608|NCT00488059|20953506|P1|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8502609|NCT00488059|20953504|P3|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
8502610|NCT00488059|20953505|P2|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8502611|NCT00488059|20953506|P1|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8502612|NCT00488059|20953504|P3|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
8502613|NCT00488059|20953505|P2|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8502614|NCT00488059|20953506|P1|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
8502615|NCT00488059|20953504|P3|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8502616|NCT00488059|20953505|P2|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
8502617|NCT00488059|20953506|P1|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8502618|NCT00488059|20953504|P3|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8502619|NCT00488059|20953505|P2|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
8502620|NCT00488059|20953506|P1|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8502621|NCT00488059|20953504|P3|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8502622|NCT00488059|20953505|P2|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
8502623|NCT00488059|20953506|P1|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
8502624|NCT00488059|20953504|P3|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
8502625|NCT00488059|20953505|P2|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
8502626|NCT00488059|20953506|P1|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
8502627|NCT00488059|20953504|P3|COMPLETED|Phase I: ENF 90mg SC BID||0
8502628|NCT00488059|20953505|P2|COMPLETED|Phase I: ENF 90mg SC BID||0
8502629|NCT00488059|20953506|P1|COMPLETED|Phase I: ENF 90mg SC BID||14
8502630|NCT00488059|20953504|P3|STARTED|Phase I: ENF 90mg SC BID||0
8502631|NCT00488059|20953505|P2|STARTED|Phase I: ENF 90mg SC BID||0
8502632|NCT00488059|20953506|P1|STARTED|Phase I: ENF 90mg SC BID||29
8502633|NCT00488033|20953525|P2|NOT COMPLETED|Overall Study||0
8502634|NCT00488033|20953526|P1|NOT COMPLETED|Overall Study||1
8502635|NCT00488033|20953525|P2|COMPLETED|Overall Study||452
8502636|NCT00488033|20953526|P1|COMPLETED|Overall Study||447
8502637|NCT00488033|20953525|P2|STARTED|Overall Study||452
8502638|NCT00488033|20953526|P1|STARTED|Overall Study||448
8502639|NCT00487981|20953542|P1|NOT COMPLETED|Overall Study||1
8502640|NCT00487981|20953542|P1|COMPLETED|Overall Study||0
8502641|NCT00487981|20953542|P1|STARTED|Overall Study||1
8502642|NCT00487942|20953550|P4|NOT COMPLETED|Overall Study||2
8502643|NCT00487942|20953551|P3|NOT COMPLETED|Overall Study||3
8502644|NCT00487942|20953552|P2|NOT COMPLETED|Overall Study||3
8502645|NCT00487942|20953553|P1|NOT COMPLETED|Overall Study||3
8502646|NCT00487942|20953550|P4|COMPLETED|Overall Study||13
8502647|NCT00487942|20953551|P3|COMPLETED|Overall Study||12
8502648|NCT00487942|20953552|P2|COMPLETED|Overall Study||12
8502649|NCT00487942|20953553|P1|COMPLETED|Overall Study||12
8502650|NCT00487942|20953550|P4|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
8502651|NCT00487942|20953551|P3|STARTED|Overall Study||15
8502652|NCT00487942|20953552|P2|STARTED|Overall Study||15
8502653|NCT00487942|20953553|P1|STARTED|Overall Study||15
8502654|NCT00487825|20953937|P2|NOT COMPLETED|Overall Study||5
8502655|NCT00487825|20953938|P1|NOT COMPLETED|Overall Study||6
8502656|NCT00487825|20953937|P2|COMPLETED|Overall Study||21
8502657|NCT00487825|20953938|P1|COMPLETED|Overall Study||46
8502658|NCT00487825|20953937|P2|STARTED|Overall Study||26
8502659|NCT00487825|20953938|P1|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
8502660|NCT00487747|20953950|P1|NOT COMPLETED|Overall Study||11
8502661|NCT00487747|20953950|P1|COMPLETED|Overall Study||7
8502662|NCT00487747|20953950|P1|STARTED|Overall Study||18
8502663|NCT00487721|20953961|P2|NOT COMPLETED|Overall Study||0
8502664|NCT00487721|20953962|P1|NOT COMPLETED|Overall Study||0
8502665|NCT00487721|20953961|P2|COMPLETED|Overall Study||6
8502666|NCT00487721|20953962|P1|COMPLETED|Overall Study||6
8502667|NCT00487721|20953961|P2|STARTED|Overall Study||6
8502668|NCT00487721|20953962|P1|STARTED|Overall Study||6
8502681|NCT00487669|20953984|P1|NOT COMPLETED|Overall Study||0
8502682|NCT00487669|20953984|P1|COMPLETED|Overall Study||12
8502683|NCT00487669|20953984|P1|STARTED|Overall Study||12
8502684|NCT00487578|20953996|P2|NOT COMPLETED|Overall Study||4
8502685|NCT00487578|20953997|P1|NOT COMPLETED|Overall Study||1
8502686|NCT00487578|20953996|P2|COMPLETED|Overall Study||5
8502687|NCT00487578|20953997|P1|COMPLETED|Overall Study||2
8502688|NCT00487578|20953996|P2|STARTED|Overall Study||9
8502689|NCT00487578|20953997|P1|STARTED|Overall Study||3
8502690|NCT00487565|20954013|P1|NOT COMPLETED|Overall Study||28
8502691|NCT00487565|20954013|P1|COMPLETED|Overall Study||182
8502692|NCT00487565|20954013|P1|STARTED|Overall Study||210
8502693|NCT00487552|20954017|P1|NOT COMPLETED|Overall Study||6
8502694|NCT00487552|20954017|P1|COMPLETED|Overall Study||12
8502695|NCT00487552|20954017|P1|STARTED|Overall Study||18
8502696|NCT00487539|20954026|P4|NOT COMPLETED|Overall Study||4
8502697|NCT00487539|20954027|P3|NOT COMPLETED|Overall Study||3
8502698|NCT00487539|20954028|P2|NOT COMPLETED|Overall Study||3
8502699|NCT00487539|20954029|P1|NOT COMPLETED|Overall Study||7
8502700|NCT00487539|20954026|P4|COMPLETED|Overall Study||327
8502701|NCT00487539|20954027|P3|COMPLETED|Overall Study||328
8502702|NCT00487539|20954028|P2|COMPLETED|Overall Study||69
8502703|NCT00487539|20954029|P1|COMPLETED|Overall Study||324
8502704|NCT00487539|20954026|P4|STARTED|Overall Study||331
8502705|NCT00487539|20954027|P3|STARTED|Overall Study||331
8502706|NCT00487539|20954028|P2|STARTED|Overall Study||72
8502707|NCT00487539|20954029|P1|STARTED|Overall Study||331
8502708|NCT00487461|20954050|P3|NOT COMPLETED|Overall Study||4
8502709|NCT00487461|20954051|P2|NOT COMPLETED|Overall Study||2
8502710|NCT00487461|20954052|P1|NOT COMPLETED|Overall Study||0
8502711|NCT00487461|20954050|P3|COMPLETED|Overall Study||7
8502712|NCT00487461|20954051|P2|COMPLETED|Overall Study||10
8502713|NCT00487461|20954052|P1|COMPLETED|Overall Study||2
8502714|NCT00487461|20954050|P3|STARTED|Overall Study||11
8502715|NCT00487461|20954051|P2|STARTED|Overall Study||12
8502716|NCT00487461|20954052|P1|STARTED|Overall Study||2
8502717|NCT00487435|20954063|P1|NOT COMPLETED|Overall Study||485
8502718|NCT00487435|20954063|P1|COMPLETED|Overall Study||669
8502719|NCT00487435|20954063|P1|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
8502720|NCT00487396|20954068|P1|NOT COMPLETED|Overall Study||3
8502721|NCT00487396|20954068|P1|COMPLETED|Overall Study||95
8502722|NCT00487396|20954068|P1|STARTED|Overall Study||98
8502723|NCT00487279|20954079|P2|NOT COMPLETED|Overall Study||2
8502724|NCT00487279|20954080|P1|NOT COMPLETED|Overall Study||1
8502725|NCT00487279|20954079|P2|COMPLETED|Overall Study||35
8502726|NCT00487279|20954080|P1|COMPLETED|Overall Study||43
8502727|NCT00487279|20954079|P2|STARTED|Overall Study||37
8502728|NCT00487279|20954080|P1|STARTED|Overall Study||44
8502729|NCT00487240|20954090|P2|NOT COMPLETED|Overall Study||26
8502730|NCT00487240|20954091|P1|NOT COMPLETED|Overall Study||31
8502731|NCT00487240|20954090|P2|COMPLETED|Overall Study||166
8502732|NCT00487240|20954091|P1|COMPLETED|Overall Study||164
8502733|NCT00487240|20954090|P2|Full Analysis Set (ITT Population)|Overall Study||189
8502734|NCT00487240|20954091|P1|Full Analysis Set (ITT Population)|Overall Study||192
8502735|NCT00487240|20954090|P2|STARTED|Overall Study||192
8502736|NCT00487240|20954091|P1|STARTED|Overall Study||195
8502737|NCT00487188|20954119|P3|NOT COMPLETED|Maintenance Phase||1
8502738|NCT00487188|20954120|P2|NOT COMPLETED|Maintenance Phase||0
8502739|NCT00487188|20954121|P1|NOT COMPLETED|Maintenance Phase||3
8502740|NCT00487188|20954119|P3|COMPLETED|Maintenance Phase||8
8502741|NCT00487188|20954120|P2|COMPLETED|Maintenance Phase||8
8502742|NCT00487188|20954121|P1|COMPLETED|Maintenance Phase||7
8502743|NCT00487188|20954119|P3|STARTED|Maintenance Phase||9
8502744|NCT00487188|20954120|P2|STARTED|Maintenance Phase||8
8502745|NCT00487188|20954121|P1|STARTED|Maintenance Phase||10
8502746|NCT00487188|20954119|P3|NOT COMPLETED|Induction Phase||0
8502747|NCT00487188|20954120|P2|NOT COMPLETED|Induction Phase||7
8502748|NCT00487188|20954121|P1|NOT COMPLETED|Induction Phase||9
8502749|NCT00487188|20954119|P3|COMPLETED|Induction Phase||0
8502750|NCT00487188|20954120|P2|COMPLETED|Induction Phase||9
8502751|NCT00487188|20954121|P1|COMPLETED|Induction Phase||22
8502752|NCT00487188|20954119|P3|Safety Population|Induction Phase||0
8502753|NCT00487188|20954120|P2|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
8502754|NCT00487188|20954121|P1|Safety Population|Induction Phase||29
8502755|NCT00487188|20954119|P3|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
8502756|NCT00487188|20954120|P2|STARTED|Induction Phase||16
8502757|NCT00487188|20954121|P1|STARTED|Induction Phase||31
8502758|NCT00487162|20954160|P2|NOT COMPLETED|Overall Study||5
8502759|NCT00487162|20954161|P1|NOT COMPLETED|Overall Study||2
8502760|NCT00487162|20954160|P2|COMPLETED|Overall Study||21
8502761|NCT00487162|20954161|P1|COMPLETED|Overall Study||28
8502762|NCT00487162|20954160|P2|STARTED|Overall Study||26
8502763|NCT00487162|20954161|P1|STARTED|Overall Study||30
8502764|NCT00487084|20954172|P3|NOT COMPLETED|Overall Study||5
8502765|NCT00487084|20954173|P2|NOT COMPLETED|Overall Study||3
8502766|NCT00487084|20954174|P1|NOT COMPLETED|Overall Study||4
8502767|NCT00487084|20954172|P3|COMPLETED|Overall Study||28
8502768|NCT00487084|20954173|P2|COMPLETED|Overall Study||30
8502769|NCT00487084|20954174|P1|COMPLETED|Overall Study||29
8502770|NCT00487084|20954172|P3|STARTED|Overall Study||33
8502771|NCT00487084|20954173|P2|STARTED|Overall Study||33
8502772|NCT00487084|20954174|P1|STARTED|Overall Study||33
8502773|NCT00486954|20954195|P5|NOT COMPLETED|Randomized Part||14
8502774|NCT00486954|20954196|P4|NOT COMPLETED|Randomized Part||20
8502775|NCT00486954|20954197|P3|NOT COMPLETED|Randomized Part||0
8502776|NCT00486954|20954198|P2|NOT COMPLETED|Randomized Part||0
8502777|NCT00486954|20954199|P1|NOT COMPLETED|Randomized Part||0
8502778|NCT00486954|20954195|P5|COMPLETED|Randomized Part||115
8502779|NCT00486954|20954196|P4|COMPLETED|Randomized Part||112
8502780|NCT00486954|20954197|P3|COMPLETED|Randomized Part||0
8502781|NCT00486954|20954198|P2|COMPLETED|Randomized Part||0
8502782|NCT00486954|20954199|P1|COMPLETED|Randomized Part||0
8502783|NCT00486954|20954195|P5|STARTED|Randomized Part||129
8502784|NCT00486954|20954196|P4|STARTED|Randomized Part||132
8502785|NCT00486954|20954197|P3|STARTED|Randomized Part||0
8502786|NCT00486954|20954198|P2|STARTED|Randomized Part||0
8502787|NCT00486954|20954199|P1|STARTED|Randomized Part||0
8502788|NCT00486954|20954195|P5|NOT COMPLETED|Pilot Part||0
8502789|NCT00486954|20954196|P4|NOT COMPLETED|Pilot Part||0
8502790|NCT00486954|20954197|P3|NOT COMPLETED|Pilot Part||6
8502791|NCT00486954|20954198|P2|NOT COMPLETED|Pilot Part||0
8502792|NCT00486954|20954199|P1|NOT COMPLETED|Pilot Part||6
8502793|NCT00486954|20954195|P5|COMPLETED|Pilot Part||0
8502794|NCT00486954|20954196|P4|COMPLETED|Pilot Part||0
8502795|NCT00486954|20954197|P3|COMPLETED|Pilot Part||0
8502796|NCT00486954|20954198|P2|COMPLETED|Pilot Part||0
8502797|NCT00486954|20954199|P1|COMPLETED|Pilot Part||0
8502798|NCT00486954|20954195|P5|STARTED|Pilot Part||0
8502799|NCT00486954|20954196|P4|STARTED|Pilot Part||0
8502800|NCT00486954|20954197|P3|STARTED|Pilot Part||6
8502801|NCT00486954|20954198|P2|STARTED|Pilot Part||0
8502802|NCT00486954|20954199|P1|STARTED|Pilot Part||6
8502803|NCT00486902|20954297|P2|NOT COMPLETED|Overall Study||5
8502804|NCT00486902|20954298|P1|NOT COMPLETED|Overall Study||9
8502805|NCT00486902|20954297|P2|COMPLETED|Overall Study||89
8502806|NCT00486902|20954298|P1|COMPLETED|Overall Study||85
8502807|NCT00486902|20954297|P2|STARTED|Overall Study||94
8502808|NCT00486902|20954298|P1|STARTED|Overall Study||94
8502809|NCT00486863|20954320|P2|NOT COMPLETED|Overall Study||3
8502810|NCT00486863|20954321|P1|NOT COMPLETED|Overall Study||1
8502811|NCT00486863|20954320|P2|COMPLETED|Overall Study||183
8502812|NCT00486863|20954321|P1|COMPLETED|Overall Study||183
8502813|NCT00486863|20954320|P2|STARTED|Overall Study||186
8502814|NCT00486863|20954321|P1|STARTED|Overall Study||184
8502815|NCT00486837|20954365|P2|NOT COMPLETED|Overall Study||7
8502816|NCT00486837|20954366|P1|NOT COMPLETED|Overall Study||9
8502817|NCT00486837|20954365|P2|COMPLETED|Overall Study||28
8502818|NCT00486837|20954366|P1|COMPLETED|Overall Study||28
8502819|NCT00486837|20954365|P2|STARTED|Overall Study||35
8502820|NCT00486837|20954366|P1|STARTED|Overall Study||37
8502821|NCT00486824|20954384|P2|NOT COMPLETED|Overall Study||2
8502822|NCT00486824|20954385|P1|NOT COMPLETED|Overall Study||2
8502823|NCT00486824|20954384|P2|COMPLETED|Overall Study||3
8502824|NCT00486824|20954385|P1|COMPLETED|Overall Study||3
8502825|NCT00486824|20954384|P2|STARTED|Overall Study||5
8502826|NCT00486824|20954385|P1|STARTED|Overall Study||5
8502827|NCT00486811|20954406|P3|NOT COMPLETED|Overall Study||214
8502828|NCT00486811|20954407|P2|NOT COMPLETED|Overall Study||141
8502829|NCT00486811|20954408|P1|NOT COMPLETED|Overall Study||122
8502830|NCT00486811|20954406|P3|COMPLETED|Overall Study||119
8502831|NCT00486811|20954407|P2|COMPLETED|Overall Study||179
8502832|NCT00486811|20954408|P1|COMPLETED|Overall Study||215
8502833|NCT00486811|20954406|P3|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
8502834|NCT00486811|20954407|P2|STARTED|Overall Study|One participant was not eligible to be dosed.|320
8502835|NCT00486811|20954408|P1|STARTED|Overall Study||337
8502836|NCT00486759|20954451|P2|NOT COMPLETED|Safety Follow-up||118
8502837|NCT00486759|20954452|P1|NOT COMPLETED|Safety Follow-up||139
8502838|NCT00486759|20954451|P2|COMPLETED|Safety Follow-up||142
8502839|NCT00486759|20954452|P1|COMPLETED|Safety Follow-up||64
8502840|NCT00486759|20954451|P2|STARTED|Safety Follow-up||260
8502841|NCT00486759|20954452|P1|STARTED|Safety Follow-up||203
8502842|NCT00486759|20954451|P2|NOT COMPLETED|Treatment||137
8502843|NCT00486759|20954452|P1|NOT COMPLETED|Treatment||187
8502844|NCT00486759|20954451|P2|COMPLETED|Treatment||260
8502845|NCT00486759|20954452|P1|COMPLETED|Treatment||203
8502846|NCT00486759|20954451|P2|STARTED|Treatment||397
8502847|NCT00486759|20954452|P1|STARTED|Treatment||390
8502848|NCT00486720|20954464|P2|NOT COMPLETED|Overall Study||12
8502849|NCT00486720|20954465|P1|NOT COMPLETED|Overall Study||10
8502850|NCT00486720|20954464|P2|COMPLETED|Overall Study||0
8502851|NCT00486720|20954465|P1|COMPLETED|Overall Study||0
8502852|NCT00486720|20954464|P2|STARTED|Overall Study||12
8502853|NCT00486720|20954465|P1|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
8502854|NCT00486642|20954475|P2|NOT COMPLETED|Overall Study||0
8502855|NCT00486642|20954476|P1|NOT COMPLETED|Overall Study||0
8502856|NCT00486642|20954475|P2|COMPLETED|Overall Study||13
8502857|NCT00486642|20954476|P1|COMPLETED|Overall Study||10
8502858|NCT00486642|20954475|P2|STARTED|Overall Study||13
8502859|NCT00486642|20954476|P1|STARTED|Overall Study||10
8502860|NCT00486603|20954500|P5|NOT COMPLETED|Overall Study||0
8502861|NCT00486603|20954501|P4|NOT COMPLETED|Overall Study||0
8502862|NCT00486603|20954502|P3|NOT COMPLETED|Overall Study||0
8502863|NCT00486603|20954503|P2|NOT COMPLETED|Overall Study||1
8502864|NCT00486603|20954504|P1|NOT COMPLETED|Overall Study||1
8502865|NCT00486603|20954500|P5|COMPLETED|Overall Study||76
8502866|NCT00486603|20954501|P4|COMPLETED|Overall Study||3
8502867|NCT00486603|20954502|P3|COMPLETED|Overall Study||3
8502868|NCT00486603|20954503|P2|COMPLETED|Overall Study||6
8502869|NCT00486603|20954504|P1|COMPLETED|Overall Study||2
8502870|NCT00486603|20954500|P5|STARTED|Overall Study||76
8502871|NCT00486603|20954501|P4|STARTED|Overall Study||3
8502872|NCT00486603|20954502|P3|STARTED|Overall Study||3
8502873|NCT00486603|20954503|P2|STARTED|Overall Study||7
8502874|NCT00486603|20954504|P1|STARTED|Overall Study||3
8502875|NCT00486525|20954528|P2|NOT COMPLETED|Overall Study||13
8502876|NCT00486525|20954529|P1|NOT COMPLETED|Overall Study||6
8502877|NCT00486525|20954528|P2|COMPLETED|Overall Study||87
8502878|NCT00486525|20954529|P1|COMPLETED|Overall Study||94
8502879|NCT00486525|20954528|P2|STARTED|Overall Study||100
8502880|NCT00486525|20954529|P1|STARTED|Overall Study||100
8502881|NCT00486447|20954545|P1|NOT COMPLETED|Overall Study||0
8502882|NCT00486447|20954545|P1|COMPLETED|Overall Study||249
8502883|NCT00486447|20954545|P1|STARTED|Overall Study||249
8502884|NCT00486434|20954552|P2|NOT COMPLETED|Overall Study||134
8502885|NCT00486434|20954553|P1|NOT COMPLETED|Overall Study||194
8502886|NCT00486434|20954552|P2|COMPLETED|Overall Study||454
8502887|NCT00486434|20954553|P1|COMPLETED|Overall Study||394
8502888|NCT00486434|20954552|P2|STARTED|Overall Study||588
8502889|NCT00486434|20954553|P1|STARTED|Overall Study||588
8502890|NCT00486330|20954572|P1|NOT COMPLETED|Overall Study||2
8502891|NCT00486330|20954572|P1|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
8502892|NCT00486330|20954572|P1|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
8502893|NCT00486291|20954578|P2|NOT COMPLETED|Overall Study||29
8502894|NCT00486291|20954579|P1|NOT COMPLETED|Overall Study||16
8502895|NCT00486291|20954578|P2|COMPLETED|Overall Study||76
8502896|NCT00486291|20954579|P1|COMPLETED|Overall Study||89
8502897|NCT00486291|20954578|P2|STARTED|Overall Study|1 subject discontinued prior to first dose|105
8502898|NCT00486291|20954579|P1|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
8502899|NCT00486278|20954587|P1|NOT COMPLETED|Overall Study||9
8502900|NCT00486278|20954587|P1|COMPLETED|Overall Study||42
8502901|NCT00486278|20954587|P1|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
8502902|NCT00486265|20954721|P1|NOT COMPLETED|Overall Study||9
8502903|NCT00486265|20954721|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
8502904|NCT00486265|20954721|P1|STARTED|Overall Study|Partipants dosed on day 1.|9
8502908|NCT00486226|20954740|P1|NOT COMPLETED|Overall Study||13
8502909|NCT00486226|20954740|P1|COMPLETED|Overall Study||92
8502910|NCT00486226|20954740|P1|STARTED|Overall Study||105
8502911|NCT00486044|20954750|P2|NOT COMPLETED|Overall Study||3
8502912|NCT00486044|20954751|P1|NOT COMPLETED|Overall Study||2
8502913|NCT00486044|20954750|P2|COMPLETED|Overall Study|21 completed MRI sub-study|46
8502914|NCT00486044|20954751|P1|COMPLETED|Overall Study|27 completed MRI sub-study|49
8502915|NCT00486044|20954750|P2|STARTED|Overall Study|23 in MRI sub-study|49
8502916|NCT00486044|20954751|P1|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
8502917|NCT00486031|20954763|P1|NOT COMPLETED|Overall Study||3
8502918|NCT00486031|20954763|P1|COMPLETED|Overall Study||440
8502919|NCT00486031|20954763|P1|STARTED|Overall Study||443
8502920|NCT00486018|20954771|P3|NOT COMPLETED|Overall Study||6
8502921|NCT00486018|20954772|P2|NOT COMPLETED|Overall Study||6
8502922|NCT00486018|20954773|P1|NOT COMPLETED|Overall Study||9
8502923|NCT00486018|20954771|P3|COMPLETED|Overall Study||125
8502924|NCT00486018|20954772|P2|COMPLETED|Overall Study||128
8502925|NCT00486018|20954773|P1|COMPLETED|Overall Study||123
8502926|NCT00486018|20954771|P3|Received Drug (Safety Population)|Overall Study||130
8502927|NCT00486018|20954772|P2|Received Drug (Safety Population)|Overall Study||134
8502928|NCT00486018|20954773|P1|Received Drug (Safety Population)|Overall Study||131
8502929|NCT00486018|20954771|P3|STARTED|Overall Study||131
8502930|NCT00486018|20954772|P2|STARTED|Overall Study||134
8502931|NCT00486018|20954773|P1|STARTED|Overall Study||132
8502932|NCT00485953|20954801|P2|NOT COMPLETED|Overall Study||7
8502933|NCT00485953|20954802|P1|NOT COMPLETED|Overall Study||7
8502934|NCT00485953|20954801|P2|COMPLETED|Overall Study||47
8502935|NCT00485953|20954802|P1|COMPLETED|Overall Study||48
8502936|NCT00485953|20954801|P2|STARTED|Overall Study||54
8502937|NCT00485953|20954802|P1|STARTED|Overall Study||55
8502938|NCT00485836|20954815|P3|NOT COMPLETED|Overall Study||11
8502939|NCT00485836|20954816|P2|NOT COMPLETED|Overall Study||3
8502940|NCT00485836|20954817|P1|NOT COMPLETED|Overall Study||15
8502941|NCT00485836|20954815|P3|COMPLETED|Overall Study||119
8502942|NCT00485836|20954816|P2|COMPLETED|Overall Study||129
8502943|NCT00485836|20954817|P1|COMPLETED|Overall Study||115
8502944|NCT00485836|20954815|P3|Received Study Drug (Safety Population)|Overall Study||129
8502945|NCT00485836|20954816|P2|Received Study Drug (Safety Population)|Overall Study||132
8502946|NCT00485836|20954817|P1|Received Study Drug (Safety Population)|Overall Study||129
8502947|NCT00485836|20954815|P3|STARTED|Overall Study||130
8502948|NCT00485836|20954816|P2|STARTED|Overall Study||132
8502949|NCT00485836|20954817|P1|STARTED|Overall Study||130
8502950|NCT00485758|20954845|P2|NOT COMPLETED|Overall Study||65
8502951|NCT00485758|20954846|P1|NOT COMPLETED|Overall Study||156
8502952|NCT00485758|20954845|P2|COMPLETED|Overall Study||277
8502953|NCT00485758|20954846|P1|COMPLETED|Overall Study||298
8502954|NCT00485758|20954845|P2|STARTED|Overall Study||342
8502955|NCT00485758|20954846|P1|STARTED|Overall Study||454
8502956|NCT00485732|20954858|P2|NOT COMPLETED|Overall Study||9
8502957|NCT00485732|20954859|P1|NOT COMPLETED|Overall Study||8
8502958|NCT00485732|20954858|P2|COMPLETED|Overall Study||67
8502959|NCT00485732|20954859|P1|COMPLETED|Overall Study||141
8502960|NCT00485732|20954858|P2|STARTED|Overall Study||76
8502961|NCT00485732|20954859|P1|STARTED|Overall Study||149
8502968|NCT00485589|20954894|P3|NOT COMPLETED|Overall Study||18
8502969|NCT00485589|20954895|P2|NOT COMPLETED|Overall Study||20
8502970|NCT00485589|20954896|P1|NOT COMPLETED|Overall Study||27
8502971|NCT00485589|20954894|P3|COMPLETED|Overall Study||185
8502972|NCT00485589|20954895|P2|COMPLETED|Overall Study||180
8502973|NCT00485589|20954896|P1|COMPLETED|Overall Study||183
8502974|NCT00485589|20954894|P3|STARTED|Overall Study||203
8502975|NCT00485589|20954895|P2|STARTED|Overall Study||200
8502976|NCT00485589|20954896|P1|STARTED|Overall Study||210
8502977|NCT00485485|20954922|P1|NOT COMPLETED|Overall Study||0
8502978|NCT00485485|20954922|P1|COMPLETED|Overall Study||7
8502979|NCT00485485|20954922|P1|STARTED|Overall Study||7
8502980|NCT00485472|20954928|P2|NOT COMPLETED|Overall Study||12
8502981|NCT00485472|20954929|P1|NOT COMPLETED|Overall Study||16
8502982|NCT00485472|20954928|P2|COMPLETED|Overall Study||64
8502983|NCT00485472|20954929|P1|COMPLETED|Overall Study||57
8502984|NCT00485472|20954928|P2|Entered Maintenance Phase|Overall Study||67
8502985|NCT00485472|20954929|P1|Entered Maintenance Phase|Overall Study||65
8502986|NCT00485472|20954928|P2|STARTED|Overall Study||76
8502987|NCT00485472|20954929|P1|STARTED|Overall Study||73
8503000|NCT00485303|20954966|P1|NOT COMPLETED|Overall Study||56
8503001|NCT00485303|20954966|P1|COMPLETED|Overall Study||2
8503002|NCT00485303|20954966|P1|STARTED|Overall Study||58
8503003|NCT00485264|20954984|P6|NOT COMPLETED|Overall Study||7
8503004|NCT00485264|20954985|P5|NOT COMPLETED|Overall Study||6
8503005|NCT00485264|20954986|P4|NOT COMPLETED|Overall Study||4
8503006|NCT00485264|20954987|P3|NOT COMPLETED|Overall Study||6
8503007|NCT00485264|20954988|P2|NOT COMPLETED|Overall Study||7
8503008|NCT00485264|20954989|P1|NOT COMPLETED|Overall Study||36
8503009|NCT00485264|20954984|P6|COMPLETED|Overall Study||5
8503010|NCT00485264|20954985|P5|COMPLETED|Overall Study||9
8503011|NCT00485264|20954986|P4|COMPLETED|Overall Study||17
8503012|NCT00485264|20954987|P3|COMPLETED|Overall Study||12
8503013|NCT00485264|20954988|P2|COMPLETED|Overall Study||9
8503014|NCT00485264|20954989|P1|COMPLETED|Overall Study||35
8503015|NCT00485264|20954984|P6|Completed Week 24|Overall Study||11
8503016|NCT00485264|20954985|P5|Completed Week 24|Overall Study||14
8503017|NCT00485264|20954986|P4|Completed Week 24|Overall Study||21
8503018|NCT00485264|20954987|P3|Completed Week 24|Overall Study||18
8503019|NCT00485264|20954988|P2|Completed Week 24|Overall Study||16
8503020|NCT00485264|20954989|P1|Completed Week 24|Overall Study||67
8503021|NCT00485264|20954984|P6|STARTED|Overall Study||12
8503022|NCT00485264|20954985|P5|STARTED|Overall Study||15
8503023|NCT00485264|20954986|P4|STARTED|Overall Study||21
8503024|NCT00485264|20954987|P3|STARTED|Overall Study||18
8503025|NCT00485264|20954988|P2|STARTED|Overall Study||16
8503026|NCT00485264|20954989|P1|STARTED|Overall Study||71
8503027|NCT00485173|20955077|P2|NOT COMPLETED|Overall Study||64
8503028|NCT00485173|20955078|P1|NOT COMPLETED|Overall Study||36
8503029|NCT00485173|20955077|P2|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
8503030|NCT00485173|20955078|P1|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
8503031|NCT00485173|20955077|P2|STARTED|Overall Study||486
8503032|NCT00485173|20955078|P1|STARTED|Overall Study||224
8503033|NCT00485134|20955126|P8|NOT COMPLETED|Overall Study||1
8503034|NCT00485134|20955127|P7|NOT COMPLETED|Overall Study||3
8503035|NCT00485134|20955128|P6|NOT COMPLETED|Overall Study||4
8503036|NCT00485134|20955129|P5|NOT COMPLETED|Overall Study||3
8503037|NCT00485134|20955130|P4|NOT COMPLETED|Overall Study||1
8503038|NCT00485134|20955131|P3|NOT COMPLETED|Overall Study||3
8503039|NCT00485134|20955132|P2|NOT COMPLETED|Overall Study||2
8503040|NCT00485134|20955133|P1|NOT COMPLETED|Overall Study||1
8503041|NCT00485134|20955126|P8|COMPLETED|Overall Study||20
8503042|NCT00485134|20955127|P7|COMPLETED|Overall Study||28
8503043|NCT00485134|20955128|P6|COMPLETED|Overall Study||3
8503044|NCT00485134|20955129|P5|COMPLETED|Overall Study||7
8503045|NCT00485134|20955130|P4|COMPLETED|Overall Study||7
8503046|NCT00485134|20955131|P3|COMPLETED|Overall Study||9
8503047|NCT00485134|20955132|P2|COMPLETED|Overall Study||10
8503048|NCT00485134|20955133|P1|COMPLETED|Overall Study||11
8503049|NCT00485134|20955126|P8|STARTED|Overall Study||21
8503050|NCT00485134|20955127|P7|STARTED|Overall Study||31
8503051|NCT00485134|20955128|P6|STARTED|Overall Study||7
8503052|NCT00485134|20955129|P5|STARTED|Overall Study||10
8503053|NCT00485134|20955130|P4|STARTED|Overall Study||8
8503054|NCT00485134|20955131|P3|STARTED|Overall Study||12
8503055|NCT00485134|20955132|P2|STARTED|Overall Study||12
8503056|NCT00485134|20955133|P1|STARTED|Overall Study||12
8503057|NCT00485069|20955155|P2|NOT COMPLETED|Overall Study||12
8503058|NCT00485069|20955156|P1|NOT COMPLETED|Overall Study||18
8503059|NCT00485069|20955155|P2|COMPLETED|Overall Study||46
8503060|NCT00485069|20955156|P1|COMPLETED|Overall Study||47
8503061|NCT00485069|20955155|P2|STARTED|Overall Study||58
8503062|NCT00485069|20955156|P1|STARTED|Overall Study||65
8503063|NCT00484939|20955201|P2|NOT COMPLETED|Overall Study||140
8503064|NCT00484939|20955202|P1|NOT COMPLETED|Overall Study||140
8503065|NCT00484939|20955201|P2|COMPLETED|Overall Study||0
8503066|NCT00484939|20955202|P1|COMPLETED|Overall Study||0
8503067|NCT00484939|20955201|P2|STARTED|Overall Study||140
8503068|NCT00484939|20955202|P1|STARTED|Overall Study||140
8503069|NCT00484874|20955222|P1|NOT COMPLETED|Overall Study||0
8503070|NCT00484874|20955222|P1|COMPLETED|Overall Study||12
8503071|NCT00484874|20955222|P1|STARTED|Overall Study||12
8503072|NCT00484679|20955229|P1|NOT COMPLETED|Overall Study||3
8503073|NCT00484679|20955229|P1|COMPLETED|Overall Study||15
8503074|NCT00484679|20955229|P1|STARTED|Overall Study||18
8503075|NCT00484419|20955236|P3|NOT COMPLETED|Overall Study||11
8503076|NCT00484419|20955237|P2|NOT COMPLETED|Overall Study||5
8503077|NCT00484419|20955238|P1|NOT COMPLETED|Overall Study||12
8503078|NCT00484419|20955236|P3|COMPLETED|Overall Study||45
8503079|NCT00484419|20955237|P2|COMPLETED|Overall Study||51
8503080|NCT00484419|20955238|P1|COMPLETED|Overall Study||45
8503081|NCT00484419|20955236|P3|STARTED|Overall Study||56
8503082|NCT00484419|20955237|P2|STARTED|Overall Study||56
8503083|NCT00484419|20955238|P1|STARTED|Overall Study||57
8503084|NCT00484393|20955296|P2|NOT COMPLETED|Overall Study||0
8503085|NCT00484393|20955297|P1|NOT COMPLETED|Overall Study||0
8503086|NCT00484393|20955296|P2|COMPLETED|Overall Study||3
8503087|NCT00484393|20955297|P1|COMPLETED|Overall Study||4
8503088|NCT00484393|20955296|P2|STARTED|Overall Study||3
8503089|NCT00484393|20955297|P1|STARTED|Overall Study||4
8503090|NCT00484354|20955305|P2|NOT COMPLETED|Overall Study||2
8503091|NCT00484354|20955306|P1|NOT COMPLETED|Overall Study||1
8503092|NCT00484354|20955305|P2|COMPLETED|Overall Study||57
8503093|NCT00484354|20955306|P1|COMPLETED|Overall Study||63
8503094|NCT00484354|20955305|P2|STARTED|Overall Study||59
8503095|NCT00484354|20955306|P1|STARTED|Overall Study||64
8503096|NCT00484315|20955322|P2|NOT COMPLETED|9-Month Angiographic Follow-up||13
8503097|NCT00484315|20955323|P1|NOT COMPLETED|9-Month Angiographic Follow-up||28
8503098|NCT00484315|20955322|P2|COMPLETED|9-Month Angiographic Follow-up||61
8503099|NCT00484315|20955323|P1|COMPLETED|9-Month Angiographic Follow-up||228
8503100|NCT00484315|20955322|P2|STARTED|9-Month Angiographic Follow-up||74
8503101|NCT00484315|20955323|P1|STARTED|9-Month Angiographic Follow-up||256
8503102|NCT00484315|20955322|P2|NOT COMPLETED|12-Month Clinical Follow-up||9
8503103|NCT00484315|20955323|P1|NOT COMPLETED|12-Month Clinical Follow-up||28
8503104|NCT00484315|20955322|P2|COMPLETED|12-Month Clinical Follow-up||311
8503105|NCT00484315|20955323|P1|COMPLETED|12-Month Clinical Follow-up||914
8503106|NCT00484315|20955322|P2|STARTED|12-Month Clinical Follow-up||320
8503107|NCT00484315|20955323|P1|STARTED|12-Month Clinical Follow-up||942
8503108|NCT00484289|20955334|P3|NOT COMPLETED|Post Marketing Phase||0
8503109|NCT00484289|20955335|P2|NOT COMPLETED|Post Marketing Phase||1
8503110|NCT00484289|20955336|P1|NOT COMPLETED|Post Marketing Phase||0
8503111|NCT00484289|20955334|P3|COMPLETED|Post Marketing Phase||10
8503112|NCT00484289|20955335|P2|COMPLETED|Post Marketing Phase||141
8503113|NCT00484289|20955336|P1|COMPLETED|Post Marketing Phase||10
8503114|NCT00484289|20955334|P3|STARTED|Post Marketing Phase||10
8503115|NCT00484289|20955335|P2|STARTED|Post Marketing Phase||142
8503116|NCT00484289|20955336|P1|STARTED|Post Marketing Phase||10
8503117|NCT00484289|20955334|P3|NOT COMPLETED|Long Term Phase||16
8503118|NCT00484289|20955335|P2|NOT COMPLETED|Long Term Phase||36
8503119|NCT00484289|20955336|P1|NOT COMPLETED|Long Term Phase||3
8503120|NCT00484289|20955334|P3|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
8503121|NCT00484289|20955335|P2|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
8503122|NCT00484289|20955336|P1|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
8503123|NCT00484289|20955334|P3|STARTED|Long Term Phase||26
8503124|NCT00484289|20955335|P2|STARTED|Long Term Phase||178
8503125|NCT00484289|20955336|P1|STARTED|Long Term Phase||13
8503126|NCT00484185|20955408|P1|NOT COMPLETED|Overall Study||71
8503127|NCT00484185|20955408|P1|COMPLETED|Overall Study||112
8503128|NCT00484185|20955408|P1|Treated|Overall Study||178
8503129|NCT00484185|20955408|P1|STARTED|Overall Study||183
8503130|NCT00484159|20955430|P3|NOT COMPLETED|Overall Study||0
8503131|NCT00484159|20955431|P2|NOT COMPLETED|Overall Study||1
8503132|NCT00484159|20955432|P1|NOT COMPLETED|Overall Study||1
8503133|NCT00484159|20955430|P3|COMPLETED|Overall Study||51
8503134|NCT00484159|20955431|P2|COMPLETED|Overall Study||49
8503135|NCT00484159|20955432|P1|COMPLETED|Overall Study||49
8503136|NCT00484159|20955430|P3|STARTED|Overall Study||51
8503137|NCT00484159|20955431|P2|STARTED|Overall Study||50
8503138|NCT00484159|20955432|P1|STARTED|Overall Study||50
8503139|NCT00484094|20955443|P1|NOT COMPLETED|Overall Study||42
8503140|NCT00484094|20955443|P1|COMPLETED|Overall Study||167
8503141|NCT00484094|20955443|P1|STARTED|Overall Study||209
8503142|NCT00483938|20955459|P7|NOT COMPLETED|Overall Study||40
8503143|NCT00483938|20955460|P6|NOT COMPLETED|Overall Study||8
8503144|NCT00483938|20955461|P5|NOT COMPLETED|Overall Study||2
8503145|NCT00483938|20955462|P4|NOT COMPLETED|Overall Study||6
8503146|NCT00483938|20955463|P3|NOT COMPLETED|Overall Study||0
8503147|NCT00483938|20955464|P2|NOT COMPLETED|Overall Study||19
8503148|NCT00483938|20955465|P1|NOT COMPLETED|Overall Study||5
8503149|NCT00483938|20955459|P7|COMPLETED|Overall Study||0
8503150|NCT00483938|20955460|P6|COMPLETED|Overall Study||18
8503151|NCT00483938|20955461|P5|COMPLETED|Overall Study||23
8503152|NCT00483938|20955462|P4|COMPLETED|Overall Study||25
8503153|NCT00483938|20955463|P3|COMPLETED|Overall Study||30
8503154|NCT00483938|20955464|P2|COMPLETED|Overall Study||24
8503155|NCT00483938|20955465|P1|COMPLETED|Overall Study||36
8503156|NCT00483938|20955459|P7|STARTED|Overall Study||40
8503157|NCT00483938|20955460|P6|STARTED|Overall Study||26
8503158|NCT00483938|20955461|P5|STARTED|Overall Study||25
8503159|NCT00483938|20955462|P4|STARTED|Overall Study||31
8503160|NCT00483938|20955463|P3|STARTED|Overall Study||30
8503161|NCT00483938|20955464|P2|STARTED|Overall Study||43
8503162|NCT00483938|20955465|P1|STARTED|Overall Study||41
8503163|NCT00483756|20955489|P3|NOT COMPLETED|Overall Study||52
8503164|NCT00483756|20955490|P2|NOT COMPLETED|Overall Study||50
8503165|NCT00483756|20955491|P1|NOT COMPLETED|Overall Study||33
8503166|NCT00483756|20955489|P3|COMPLETED|Overall Study||59
8503167|NCT00483756|20955490|P2|COMPLETED|Overall Study||60
8503168|NCT00483756|20955491|P1|COMPLETED|Overall Study||77
8503169|NCT00483756|20955489|P3|Treated|Overall Study||107
8503170|NCT00483756|20955490|P2|Treated|Overall Study||106
8503171|NCT00483756|20955491|P1|Treated|Overall Study||109
8503172|NCT00483756|20955489|P3|STARTED|Overall Study||111
8503173|NCT00483756|20955490|P2|STARTED|Overall Study||110
8503174|NCT00483756|20955491|P1|STARTED|Overall Study||110
8503175|NCT00483717|20955555|P2|NOT COMPLETED|Overall Study||21
8503176|NCT00483717|20955556|P1|NOT COMPLETED|Overall Study||24
8503177|NCT00483717|20955555|P2|COMPLETED|Overall Study||65
8503178|NCT00483717|20955556|P1|COMPLETED|Overall Study||63
8503179|NCT00483717|20955555|P2|STARTED|Overall Study||86
8503180|NCT00483717|20955556|P1|STARTED|Overall Study||87
8503181|NCT00483704|20955579|P3|NOT COMPLETED|Treatment||156
8503182|NCT00483704|20955580|P2|NOT COMPLETED|Treatment||129
8503183|NCT00483704|20955581|P1|NOT COMPLETED|Treatment||129
8503184|NCT00483704|20955579|P3|COMPLETED|Treatment||399
8503185|NCT00483704|20955580|P2|COMPLETED|Treatment||420
8503186|NCT00483704|20955581|P1|COMPLETED|Treatment||444
8503187|NCT00483704|20955579|P3|STARTED|Treatment||555
8503188|NCT00483704|20955580|P2|STARTED|Treatment||549
8503189|NCT00483704|20955581|P1|STARTED|Treatment||573
8503190|NCT00483704|20955579|P3|NOT COMPLETED|Randomization||91
8503191|NCT00483704|20955580|P2|NOT COMPLETED|Randomization||96
8503192|NCT00483704|20955581|P1|NOT COMPLETED|Randomization||71
8503193|NCT00483704|20955579|P3|COMPLETED|Randomization||555
8503194|NCT00483704|20955580|P2|COMPLETED|Randomization||549
8503195|NCT00483704|20955581|P1|COMPLETED|Randomization||573
8503196|NCT00483704|20955579|P3|STARTED|Randomization||646
8503197|NCT00483704|20955580|P2|STARTED|Randomization||645
8503198|NCT00483704|20955581|P1|STARTED|Randomization||644
8503199|NCT00483652|20955627|P2|NOT COMPLETED|Post-study Follow-up||0
8503200|NCT00483652|20955628|P1|NOT COMPLETED|Post-study Follow-up||0
8503201|NCT00483652|20955627|P2|COMPLETED|Post-study Follow-up||114
8503202|NCT00483652|20955628|P1|COMPLETED|Post-study Follow-up||113
8503203|NCT00483652|20955627|P2|STARTED|Post-study Follow-up||114
8503204|NCT00483652|20955628|P1|STARTED|Post-study Follow-up||113
8503205|NCT00483652|20955627|P2|NOT COMPLETED|Double-blind Treatment Period||5
8503206|NCT00483652|20955628|P1|NOT COMPLETED|Double-blind Treatment Period||7
8503207|NCT00483652|20955627|P2|COMPLETED|Double-blind Treatment Period||114
8503208|NCT00483652|20955628|P1|COMPLETED|Double-blind Treatment Period||113
8503209|NCT00483652|20955627|P2|STARTED|Double-blind Treatment Period||119
8503210|NCT00483652|20955628|P1|STARTED|Double-blind Treatment Period||120
8503211|NCT00483574|20955638|P2|NOT COMPLETED|Overall Study||13
8503212|NCT00483574|20955639|P1|NOT COMPLETED|Overall Study||102
8503213|NCT00483574|20955638|P2|COMPLETED|Overall Study||308
8503214|NCT00483574|20955639|P1|COMPLETED|Overall Study||951
8503215|NCT00483574|20955638|P2|STARTED|Overall Study||321
8503216|NCT00483574|20955639|P1|STARTED|Overall Study||1053
8503217|NCT00483561|20955647|P1|NOT COMPLETED|Overall Study||11
8503218|NCT00483561|20955647|P1|COMPLETED|Overall Study||15
8503219|NCT00483561|20955647|P1|STARTED|Overall Study||26
8503228|NCT00483509|20955693|P1|NOT COMPLETED|Overall Study||0
8503229|NCT00483509|20955693|P1|COMPLETED|Overall Study||28
8503230|NCT00483509|20955693|P1|STARTED|Overall Study||28
8503231|NCT00483496|20955701|P1|NOT COMPLETED|Overall Study||1
8503232|NCT00483496|20955701|P1|COMPLETED|Overall Study||15
8503233|NCT00483496|20955701|P1|STARTED|Overall Study||16
8503234|NCT00483405|20955713|P1|NOT COMPLETED|Overall Study||28
8503235|NCT00483405|20955713|P1|COMPLETED|Overall Study||0
8503236|NCT00483405|20955713|P1|STARTED|Overall Study||28
8503237|NCT00483379|20955722|P2|NOT COMPLETED|Extension Period||0
8503238|NCT00483379|20955723|P1|NOT COMPLETED|Extension Period||0
8503239|NCT00483379|20955722|P2|COMPLETED|Extension Period||2
8503240|NCT00483379|20955723|P1|COMPLETED|Extension Period||1
8503241|NCT00483379|20955722|P2|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
8503242|NCT00483379|20955723|P1|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
8503243|NCT00483379|20955722|P2|NOT COMPLETED|Treatment Period||0
8503244|NCT00483379|20955723|P1|NOT COMPLETED|Treatment Period||2
8503245|NCT00483379|20955722|P2|COMPLETED|Treatment Period||7
8503246|NCT00483379|20955723|P1|COMPLETED|Treatment Period||4
8503247|NCT00483379|20955722|P2|STARTED|Treatment Period||7
8503248|NCT00483379|20955723|P1|STARTED|Treatment Period||6
8503249|NCT00483327|20955759|P1|NOT COMPLETED|Overall Study||10
8503250|NCT00483327|20955759|P1|COMPLETED|Overall Study||20
8503251|NCT00483327|20955759|P1|STARTED|Overall Study||30
8503252|NCT00483262|20955770|P2|NOT COMPLETED|Overall Study||0
8503253|NCT00483262|20955771|P1|NOT COMPLETED|Overall Study||0
8503254|NCT00483262|20955770|P2|COMPLETED|Overall Study||43
8503255|NCT00483262|20955771|P1|COMPLETED|Overall Study||20
8503256|NCT00483262|20955770|P2|STARTED|Overall Study||43
8503257|NCT00483262|20955771|P1|STARTED|Overall Study||20
8503258|NCT00483223|20955781|P1|NOT COMPLETED|Overall Study||0
8503259|NCT00483223|20955781|P1|COMPLETED|Overall Study||86
8503260|NCT00483223|20955781|P1|STARTED|Overall Study||86
8503261|NCT00483184|20955791|P3|NOT COMPLETED|Overall Study||3
8503262|NCT00483184|20955792|P2|NOT COMPLETED|Overall Study||4
8503263|NCT00483184|20955793|P1|NOT COMPLETED|Overall Study||5
8503264|NCT00483184|20955791|P3|COMPLETED|Overall Study||23
8503265|NCT00483184|20955792|P2|COMPLETED|Overall Study||27
8503266|NCT00483184|20955793|P1|COMPLETED|Overall Study||22
8503267|NCT00483184|20955791|P3|STARTED|Overall Study||26
8503268|NCT00483184|20955792|P2|STARTED|Overall Study||31
8503269|NCT00483184|20955793|P1|STARTED|Overall Study||27
8503270|NCT00483119|20955803|P2|NOT COMPLETED|Overall Study||1
8503271|NCT00483119|20955804|P1|NOT COMPLETED|Overall Study||1
8503272|NCT00483119|20955803|P2|COMPLETED|Overall Study||3
8503273|NCT00483119|20955804|P1|COMPLETED|Overall Study||4
8503274|NCT00483119|20955803|P2|STARTED|Overall Study||4
8503275|NCT00483119|20955804|P1|STARTED|Overall Study||5
8503276|NCT00483041|20955818|P2|NOT COMPLETED|Overall Study||1
8503277|NCT00483041|20955819|P1|NOT COMPLETED|Overall Study||0
8503278|NCT00483041|20955818|P2|COMPLETED|Overall Study||5
8503279|NCT00483041|20955819|P1|COMPLETED|Overall Study||5
8503280|NCT00483041|20955818|P2|STARTED|Overall Study||6
8503281|NCT00483041|20955819|P1|STARTED|Overall Study||5
8503282|NCT00483002|20955849|P1|NOT COMPLETED|Overall Study||2554
8503283|NCT00483002|20955849|P1|COMPLETED|Overall Study||1165
8503284|NCT00483002|20955849|P1|STARTED|Overall Study||3719
8503285|NCT00482911|20955857|P2|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
8503286|NCT00482911|20955858|P1|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
8503287|NCT00482911|20955857|P2|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
8503288|NCT00482911|20955858|P1|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
8503289|NCT00482911|20955857|P2|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
8503290|NCT00482911|20955858|P1|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
8503291|NCT00482911|20955857|P2|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
8503292|NCT00482911|20955858|P1|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
8503293|NCT00482911|20955857|P2|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
8503294|NCT00482911|20955858|P1|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
8503295|NCT00482911|20955857|P2|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
8503296|NCT00482911|20955858|P1|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
8503297|NCT00482911|20955857|P2|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
8503298|NCT00482911|20955858|P1|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
8503299|NCT00482911|20955857|P2|COMPLETED|Dosing Schedule 1: Len & Cyc||0
8503300|NCT00482911|20955858|P1|COMPLETED|Dosing Schedule 1: Len & Cyc||3
8503301|NCT00482911|20955857|P2|STARTED|Dosing Schedule 1: Len & Cyc||0
8503302|NCT00482911|20955858|P1|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
8503303|NCT00482729|20955874|P2|NOT COMPLETED|Overall Study||218
8503304|NCT00482729|20955875|P1|NOT COMPLETED|Overall Study||217
8503305|NCT00482729|20955874|P2|COMPLETED|Overall Study||406
8503306|NCT00482729|20955875|P1|COMPLETED|Overall Study||409
8503307|NCT00482729|20955874|P2|Completed Phase B|Overall Study||406
8503308|NCT00482729|20955875|P1|Completed Phase B|Overall Study||409
8503309|NCT00482729|20955874|P2|Completed Phase A|Overall Study||482
8503310|NCT00482729|20955875|P1|Completed Phase A|Overall Study||484
8503311|NCT00482729|20955874|P2|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
8503312|NCT00482729|20955875|P1|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
8503313|NCT00482703|20955891|P2|NOT COMPLETED|Overall Study||0
8503314|NCT00482703|20955892|P1|NOT COMPLETED|Overall Study||1
8503315|NCT00482703|20955891|P2|COMPLETED|Overall Study||12
8503316|NCT00482703|20955892|P1|COMPLETED|Overall Study||10
8503317|NCT00482703|20955891|P2|STARTED|Overall Study|number enrolled, randomized and treated|12
8503318|NCT00482703|20955892|P1|STARTED|Overall Study|number enrolled, randomized and treated|11
8503319|NCT00482677|20955939|P2|NOT COMPLETED|Overall Study||0
8503320|NCT00482677|20955940|P1|NOT COMPLETED|Overall Study||0
8503321|NCT00482677|20955939|P2|COMPLETED|Overall Study||281
8503322|NCT00482677|20955940|P1|COMPLETED|Overall Study||281
8503323|NCT00482677|20955939|P2|STARTED|Overall Study||281
8503324|NCT00482677|20955940|P1|STARTED|Overall Study||281
8503325|NCT00482625|20955950|P1|NOT COMPLETED|Overall Study||0
8503326|NCT00482625|20955950|P1|COMPLETED|Overall Study||6
8503327|NCT00482625|20955950|P1|STARTED|Overall Study||6
8503328|NCT00482612|20955963|P4|NOT COMPLETED|Follow-up Period||8
8503329|NCT00482612|20955964|P3|NOT COMPLETED|Follow-up Period||22
8503330|NCT00482612|20955965|P2|NOT COMPLETED|Follow-up Period||18
8503331|NCT00482612|20955966|P1|NOT COMPLETED|Follow-up Period||14
8503332|NCT00482612|20955963|P4|COMPLETED|Follow-up Period||127
8503333|NCT00482612|20955964|P3|COMPLETED|Follow-up Period||106
8503334|NCT00482612|20955965|P2|COMPLETED|Follow-up Period||107
8503335|NCT00482612|20955966|P1|COMPLETED|Follow-up Period||123
8503336|NCT00482612|20955963|P4|STARTED|Follow-up Period||135
8503337|NCT00482612|20955964|P3|STARTED|Follow-up Period||128
8503338|NCT00482612|20955965|P2|STARTED|Follow-up Period||125
8503339|NCT00482612|20955966|P1|STARTED|Follow-up Period||137
8503340|NCT00482612|20955963|P4|NOT COMPLETED|In-treatment Period||0
8503341|NCT00482612|20955964|P3|NOT COMPLETED|In-treatment Period||1
8503342|NCT00482612|20955965|P2|NOT COMPLETED|In-treatment Period||0
8503343|NCT00482612|20955966|P1|NOT COMPLETED|In-treatment Period||0
8503344|NCT00482612|20955963|P4|COMPLETED|In-treatment Period||135
8503345|NCT00482612|20955964|P3|COMPLETED|In-treatment Period||128
8503346|NCT00482612|20955965|P2|COMPLETED|In-treatment Period||125
8503347|NCT00482612|20955966|P1|COMPLETED|In-treatment Period||137
8503348|NCT00482612|20955963|P4|Treated|In-treatment Period||135
8503349|NCT00482612|20955964|P3|Treated|In-treatment Period||128
8503350|NCT00482612|20955965|P2|Treated|In-treatment Period||125
8503351|NCT00482612|20955966|P1|Treated|In-treatment Period||137
8503352|NCT00482612|20955963|P4|STARTED|In-treatment Period||135
8503353|NCT00482612|20955964|P3|STARTED|In-treatment Period||129
8503354|NCT00482612|20955965|P2|STARTED|In-treatment Period||125
8503355|NCT00482612|20955966|P1|STARTED|In-treatment Period||137
8503356|NCT00482547|20955994|P2|NOT COMPLETED|Overall Study||161
8503357|NCT00482547|20955995|P1|NOT COMPLETED|Overall Study||173
8503358|NCT00482547|20955994|P2|COMPLETED|Overall Study||428
8503359|NCT00482547|20955995|P1|COMPLETED|Overall Study||426
8503360|NCT00482547|20955994|P2|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
8503361|NCT00482547|20955995|P1|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
8503362|NCT00482547|20955994|P2|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
8503363|NCT00482547|20955995|P1|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
8503364|NCT00482547|20955994|P2|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
8503365|NCT00482547|20955995|P1|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
8503366|NCT00482391|20956015|P1|NOT COMPLETED|Overall Study||3
8503367|NCT00482391|20956015|P1|COMPLETED|Overall Study||92
8503368|NCT00482391|20956015|P1|STARTED|Overall Study||95
8503369|NCT00482274|20956020|P1|NOT COMPLETED|Overall Study||1
8503370|NCT00482274|20956020|P1|COMPLETED|Overall Study||2
8503371|NCT00482274|20956020|P1|STARTED|Overall Study||3
8503372|NCT00482170|20956030|P2|NOT COMPLETED|Overall Study||20
8503373|NCT00482170|20956031|P1|NOT COMPLETED|Overall Study||15
8503374|NCT00482170|20956030|P2|COMPLETED|Overall Study||194
8503375|NCT00482170|20956031|P1|COMPLETED|Overall Study||192
8503376|NCT00482170|20956030|P2|Treated|Overall Study||211
8503377|NCT00482170|20956031|P1|Treated|Overall Study||207
8503378|NCT00482170|20956030|P2|STARTED|Overall Study||214
8503379|NCT00482170|20956031|P1|STARTED|Overall Study||207
8503380|NCT00482053|20956149|P1|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
8503381|NCT00482053|20956149|P1|COMPLETED|Allogeneic Peripheral Stem Cells||2
8503382|NCT00482053|20956149|P1|STARTED|Allogeneic Peripheral Stem Cells||2
8503383|NCT00482053|20956149|P1|NOT COMPLETED|Inter-treatment Period||1
8503384|NCT00482053|20956149|P1|COMPLETED|Inter-treatment Period||2
8503385|NCT00482053|20956149|P1|STARTED|Inter-treatment Period||3
8503386|NCT00482053|20956149|P1|NOT COMPLETED|Autologous Peripheral Stem Cells||0
8503387|NCT00482053|20956149|P1|COMPLETED|Autologous Peripheral Stem Cells||3
8503388|NCT00482053|20956149|P1|STARTED|Autologous Peripheral Stem Cells||3
8503389|NCT00482014|20956163|P4|NOT COMPLETED|Overall Study||23
8503390|NCT00482014|20956164|P3|NOT COMPLETED|Overall Study||11
8503391|NCT00482014|20956165|P2|NOT COMPLETED|Overall Study||6
8503392|NCT00482014|20956166|P1|NOT COMPLETED|Overall Study||7
8503393|NCT00482014|20956163|P4|COMPLETED|Overall Study||29
8503394|NCT00482014|20956164|P3|COMPLETED|Overall Study||35
8503395|NCT00482014|20956165|P2|COMPLETED|Overall Study||7
8503396|NCT00482014|20956166|P1|COMPLETED|Overall Study||2
8503397|NCT00482014|20956163|P4|STARTED|Overall Study||52
8503398|NCT00482014|20956164|P3|STARTED|Overall Study||46
8503399|NCT00482014|20956165|P2|STARTED|Overall Study||13
8503400|NCT00482014|20956166|P1|STARTED|Overall Study||9
8503401|NCT00482001|20956190|P2|NOT COMPLETED|Overall Study||1
8503402|NCT00482001|20956191|P1|NOT COMPLETED|Overall Study||1
8503403|NCT00482001|20956190|P2|COMPLETED|Overall Study||10
8503404|NCT00482001|20956191|P1|COMPLETED|Overall Study||10
8503405|NCT00482001|20956190|P2|STARTED|Overall Study||11
8503406|NCT00482001|20956191|P1|STARTED|Overall Study||11
8503407|NCT00481988|20956211|P2|NOT COMPLETED|Overall Study||1
8503408|NCT00481988|20956212|P1|NOT COMPLETED|Overall Study||1
8503409|NCT00481988|20956211|P2|COMPLETED|Overall Study||8
8503410|NCT00481988|20956212|P1|COMPLETED|Overall Study||11
8503411|NCT00481988|20956211|P2|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
8503412|NCT00481988|20956212|P1|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
8503413|NCT00481988|20956211|P2|STARTED|Overall Study|one patient was dropped from the study before randomization|9
8503414|NCT00481988|20956212|P1|STARTED|Overall Study||12
8503415|NCT00481871|20956225|P5|NOT COMPLETED|Overall Study||0
8503416|NCT00481871|20956226|P4|NOT COMPLETED|Overall Study||0
8503417|NCT00481871|20956227|P3|NOT COMPLETED|Overall Study||1
8503418|NCT00481871|20956228|P2|NOT COMPLETED|Overall Study||0
8503419|NCT00481871|20956229|P1|NOT COMPLETED|Overall Study||0
8503420|NCT00481871|20956225|P5|COMPLETED|Overall Study||34
8503421|NCT00481871|20956226|P4|COMPLETED|Overall Study||38
8503422|NCT00481871|20956227|P3|COMPLETED|Overall Study||17
8503423|NCT00481871|20956228|P2|COMPLETED|Overall Study||10
8503424|NCT00481871|20956229|P1|COMPLETED|Overall Study||7
8503425|NCT00481871|20956225|P5|STARTED|Overall Study||34
8503426|NCT00481871|20956226|P4|STARTED|Overall Study||38
8503427|NCT00481871|20956227|P3|STARTED|Overall Study||18
8503428|NCT00481871|20956228|P2|STARTED|Overall Study||10
8503429|NCT00481871|20956229|P1|STARTED|Overall Study||7
8503430|NCT00481845|20956245|P2|NOT COMPLETED|Overall Study||0
8503431|NCT00481845|20956246|P1|NOT COMPLETED|Overall Study||0
8503432|NCT00481845|20956245|P2|COMPLETED|Overall Study||0
8503433|NCT00481845|20956246|P1|COMPLETED|Overall Study||1
8503434|NCT00481845|20956245|P2|STARTED|Overall Study||0
8503435|NCT00481845|20956246|P1|STARTED|Overall Study||1
8503436|NCT00481832|20956254|P1|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
8503437|NCT00481832|20956254|P1|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
8503438|NCT00481832|20956254|P1|STARTED|Allogenic Hematopoietic Cell Transplant||13
8503439|NCT00481832|20956254|P1|NOT COMPLETED|Inter-transplant Period||27
8503440|NCT00481832|20956254|P1|COMPLETED|Inter-transplant Period||13
8503441|NCT00481832|20956254|P1|STARTED|Inter-transplant Period||40
8503442|NCT00481832|20956254|P1|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
8503443|NCT00481832|20956254|P1|COMPLETED|Autologous Hematopoietic Cell Transplant||40
8503444|NCT00481832|20956254|P1|STARTED|Autologous Hematopoietic Cell Transplant||40
8503445|NCT00481832|20956254|P1|NOT COMPLETED|Enrollment||10
8503446|NCT00481832|20956254|P1|COMPLETED|Enrollment||40
8503447|NCT00481832|20956254|P1|STARTED|Enrollment||50
8503448|NCT00481767|20956269|P2|NOT COMPLETED|Overall Study||21
8503449|NCT00481767|20956270|P1|NOT COMPLETED|Overall Study||32
8503450|NCT00481767|20956269|P2|COMPLETED|Overall Study||205
8503451|NCT00481767|20956270|P1|COMPLETED|Overall Study||418
8503452|NCT00481767|20956269|P2|STARTED|Overall Study||226
8503453|NCT00481767|20956270|P1|STARTED|Overall Study||450
8503454|NCT00481676|20956304|P2|NOT COMPLETED|Overall Study||5
8503455|NCT00481676|20956305|P1|NOT COMPLETED|Overall Study||2
8503456|NCT00481676|20956304|P2|COMPLETED|Overall Study||17
8503457|NCT00481676|20956305|P1|COMPLETED|Overall Study||25
8503458|NCT00481676|20956304|P2|STARTED|Overall Study||22
8503459|NCT00481676|20956305|P1|STARTED|Overall Study||27
8503460|NCT00481507|20956329|P2|NOT COMPLETED|Overall Study||0
8503461|NCT00481507|20956330|P1|NOT COMPLETED|Overall Study||0
8503462|NCT00481507|20956329|P2|COMPLETED|Overall Study||61
8503463|NCT00481507|20956330|P1|COMPLETED|Overall Study||64
8503464|NCT00481507|20956329|P2|STARTED|Overall Study||61
8503465|NCT00481507|20956330|P1|STARTED|Overall Study||64
8503466|NCT00481351|20956340|P2|NOT COMPLETED|Overall Study||0
8503467|NCT00481351|20956341|P1|NOT COMPLETED|Overall Study||0
8503468|NCT00481351|20956340|P2|COMPLETED|Overall Study||12
8503469|NCT00481351|20956341|P1|COMPLETED|Overall Study||13
8503470|NCT00481351|20956340|P2|STARTED|Overall Study||12
8503471|NCT00481351|20956341|P1|STARTED|Overall Study||13
8503472|NCT00481247|20956357|P2|NOT COMPLETED|Overall Study||260
8503473|NCT00481247|20956358|P1|NOT COMPLETED|Overall Study||259
8503474|NCT00481247|20956357|P2|COMPLETED|Overall Study||0
8503475|NCT00481247|20956358|P1|COMPLETED|Overall Study||0
8503476|NCT00481247|20956357|P2|Received Treatment|Overall Study||258
8503477|NCT00481247|20956358|P1|Received Treatment|Overall Study||258
8503478|NCT00481247|20956357|P2|STARTED|Overall Study|Randomized|260
8503479|NCT00481247|20956358|P1|STARTED|Overall Study|Randomized|259
8503480|NCT00481195|20956382|P2|NOT COMPLETED|Overall Study||39
8503481|NCT00481195|20956383|P1|NOT COMPLETED|Overall Study||39
8503482|NCT00481195|20956382|P2|COMPLETED|Overall Study||90
8503483|NCT00481195|20956383|P1|COMPLETED|Overall Study||89
8503484|NCT00481195|20956382|P2|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
8503485|NCT00481195|20956383|P1|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
8503486|NCT00481078|20956469|P2|NOT COMPLETED|Overall Study||20
8503487|NCT00481078|20956470|P1|NOT COMPLETED|Overall Study||42
8503488|NCT00481078|20956469|P2|COMPLETED|Overall Study||12
8503489|NCT00481078|20956470|P1|COMPLETED|Overall Study||20
8503490|NCT00481078|20956469|P2|STARTED|Overall Study||32
8503491|NCT00481078|20956470|P1|STARTED|Overall Study||62
8503492|NCT00481065|20956488|P8|NOT COMPLETED|Overall Study||19
8503493|NCT00481065|20956489|P7|NOT COMPLETED|Overall Study||16
8503494|NCT00481065|20956490|P6|NOT COMPLETED|Overall Study||24
8503495|NCT00481065|20956491|P5|NOT COMPLETED|Overall Study||23
8503496|NCT00481065|20956492|P4|NOT COMPLETED|Overall Study||15
8503497|NCT00481065|20956493|P3|NOT COMPLETED|Overall Study||19
8503498|NCT00481065|20956494|P2|NOT COMPLETED|Overall Study||17
8503499|NCT00481065|20956495|P1|NOT COMPLETED|Overall Study||22
8503500|NCT00481065|20956488|P8|COMPLETED|Overall Study||30
8503501|NCT00481065|20956489|P7|COMPLETED|Overall Study||34
8503502|NCT00481065|20956490|P6|COMPLETED|Overall Study||27
8503503|NCT00481065|20956491|P5|COMPLETED|Overall Study||28
8503504|NCT00481065|20956492|P4|COMPLETED|Overall Study||37
8503505|NCT00481065|20956493|P3|COMPLETED|Overall Study||32
8503506|NCT00481065|20956494|P2|COMPLETED|Overall Study||33
8503507|NCT00481065|20956495|P1|COMPLETED|Overall Study||29
8503508|NCT00481065|20956488|P8|STARTED|Overall Study||49
8503509|NCT00481065|20956489|P7|STARTED|Overall Study||50
8503510|NCT00481065|20956490|P6|STARTED|Overall Study||51
8503511|NCT00481065|20956491|P5|STARTED|Overall Study||51
8503512|NCT00481065|20956492|P4|STARTED|Overall Study||52
8503513|NCT00481065|20956493|P3|STARTED|Overall Study||51
8503514|NCT00481065|20956494|P2|STARTED|Overall Study||50
8503515|NCT00481065|20956495|P1|STARTED|Overall Study||51
8503516|NCT00480987|20956581|P1|NOT COMPLETED|Overall Study||0
8503517|NCT00480987|20956581|P1|COMPLETED|Overall Study||27
8503518|NCT00480987|20956581|P1|STARTED|Overall Study||27
8503519|NCT00480857|20956585|P1|NOT COMPLETED|Overall Study||2
8503520|NCT00480857|20956585|P1|COMPLETED|Overall Study||17
8503521|NCT00480857|20956585|P1|STARTED|Overall Study||19
8503522|NCT00480779|20956595|P2|NOT COMPLETED|Overall Study||3
8503523|NCT00480779|20956596|P1|NOT COMPLETED|Overall Study||2
8503524|NCT00480779|20956595|P2|COMPLETED|Overall Study||19
8503525|NCT00480779|20956596|P1|COMPLETED|Overall Study||24
8503526|NCT00480779|20956595|P2|STARTED|Overall Study||22
8503527|NCT00480779|20956596|P1|STARTED|Overall Study||26
8503528|NCT00480740|20956623|P3|NOT COMPLETED|Overall Study||0
8503529|NCT00480740|20956624|P2|NOT COMPLETED|Overall Study||0
8503530|NCT00480740|20956625|P1|NOT COMPLETED|Overall Study||0
8503531|NCT00480740|20956623|P3|COMPLETED|Overall Study||6
8503532|NCT00480740|20956624|P2|COMPLETED|Overall Study||9
8503533|NCT00480740|20956625|P1|COMPLETED|Overall Study||26
8503534|NCT00480740|20956623|P3|STARTED|Overall Study||6
8503535|NCT00480740|20956624|P2|STARTED|Overall Study||9
8503536|NCT00480740|20956625|P1|STARTED|Overall Study||26
8503537|NCT00480636|20956633|P1|NOT COMPLETED|Overall Study||19
8503538|NCT00480636|20956633|P1|COMPLETED|Overall Study||83
8503539|NCT00480636|20956633|P1|STARTED|Overall Study||102
8503540|NCT00480532|20956645|P4|NOT COMPLETED|Overall Study||1
8503541|NCT00480532|20956646|P3|NOT COMPLETED|Overall Study||4
8503542|NCT00480532|20956647|P2|NOT COMPLETED|Overall Study||4
8503543|NCT00480532|20956648|P1|NOT COMPLETED|Overall Study||2
8503544|NCT00480532|20956645|P4|COMPLETED|Overall Study||31
8503545|NCT00480532|20956646|P3|COMPLETED|Overall Study||29
8503546|NCT00480532|20956647|P2|COMPLETED|Overall Study||29
8503547|NCT00480532|20956648|P1|COMPLETED|Overall Study||31
8503548|NCT00480532|20956645|P4|STARTED|Overall Study||32
8503549|NCT00480532|20956646|P3|STARTED|Overall Study||33
8503550|NCT00480532|20956647|P2|STARTED|Overall Study||33
8503551|NCT00480532|20956648|P1|STARTED|Overall Study||33
8503552|NCT00480493|20956668|P2|NOT COMPLETED|Overall Study||7
8503553|NCT00480493|20956669|P1|NOT COMPLETED|Overall Study||2
8503554|NCT00480493|20956668|P2|COMPLETED|Overall Study||21
8503555|NCT00480493|20956669|P1|COMPLETED|Overall Study||30
8503556|NCT00480493|20956668|P2|Randomized|Overall Study||28
8503557|NCT00480493|20956669|P1|Randomized|Overall Study||32
8503558|NCT00480493|20956668|P2|STARTED|Overall Study||28
8503559|NCT00480493|20956669|P1|STARTED|Overall Study||32
8503560|NCT00480441|20956681|P3|NOT COMPLETED|Randomization||2
8503561|NCT00480441|20956682|P2|NOT COMPLETED|Randomization||7
8503562|NCT00480441|20956683|P1|NOT COMPLETED|Randomization||0
8503563|NCT00480441|20956681|P3|COMPLETED|Randomization||9
8503564|NCT00480441|20956682|P2|COMPLETED|Randomization||6
8503565|NCT00480441|20956683|P1|COMPLETED|Randomization||0
8503566|NCT00480441|20956681|P3|STARTED|Randomization||11
8503567|NCT00480441|20956682|P2|STARTED|Randomization||13
8503568|NCT00480441|20956683|P1|STARTED|Randomization||0
8503569|NCT00480441|20956681|P3|NOT COMPLETED|Baseline Functional MRI||0
8503570|NCT00480441|20956682|P2|NOT COMPLETED|Baseline Functional MRI||0
8503571|NCT00480441|20956683|P1|NOT COMPLETED|Baseline Functional MRI||12
8503572|NCT00480441|20956681|P3|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
8503573|NCT00480441|20956682|P2|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
8503574|NCT00480441|20956683|P1|COMPLETED|Baseline Functional MRI||12
8503575|NCT00480441|20956681|P3|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
8503576|NCT00480441|20956682|P2|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
8503577|NCT00480441|20956683|P1|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24
8503578|NCT00480441|20956681|P3|NOT COMPLETED|Screening||0
8503579|NCT00480441|20956682|P2|NOT COMPLETED|Screening||0
8503580|NCT00480441|20956683|P1|NOT COMPLETED|Screening||37
8503581|NCT00480441|20956681|P3|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
8503582|NCT00480441|20956682|P2|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
8503583|NCT00480441|20956683|P1|COMPLETED|Screening||24
8503584|NCT00480441|20956681|P3|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
8503585|NCT00480441|20956682|P2|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
8503586|NCT00480441|20956683|P1|STARTED|Screening||61
8503587|NCT00480324|20956692|P2|NOT COMPLETED|Overall Study||16
8503588|NCT00480324|20956693|P1|NOT COMPLETED|Overall Study||32
8503589|NCT00480324|20956692|P2|COMPLETED|Overall Study||241
8503590|NCT00480324|20956693|P1|COMPLETED|Overall Study||476
8503591|NCT00480324|20956692|P2|STARTED|Overall Study||257
8503592|NCT00480324|20956693|P1|STARTED|Overall Study||508
8503593|NCT00480077|20956721|P2|NOT COMPLETED|Overall Study||26
8503594|NCT00480077|20956722|P1|NOT COMPLETED|Overall Study||31
8503595|NCT00480077|20956721|P2|COMPLETED|Overall Study||141
8503596|NCT00480077|20956722|P1|COMPLETED|Overall Study||137
8503597|NCT00480077|20956721|P2|STARTED|Overall Study||167
8503598|NCT00480077|20956722|P1|STARTED|Overall Study||168
8503599|NCT00480025|20956730|P2|NOT COMPLETED|Overall Study||369
8503600|NCT00480025|20956731|P1|NOT COMPLETED|Overall Study||752
8503601|NCT00480025|20956730|P2|COMPLETED|Overall Study||388
8503602|NCT00480025|20956731|P1|COMPLETED|Overall Study||763
8503603|NCT00480025|20956730|P2|STARTED|Overall Study||757
8503604|NCT00480025|20956731|P1|STARTED|Overall Study||1515
8503605|NCT00479882|20956803|P4|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
8503606|NCT00479882|20956804|P3|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
8503607|NCT00479882|20956805|P2|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
8503608|NCT00479882|20956806|P1|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
8503609|NCT00479882|20956803|P4|COMPLETED|Crossover: Period III (Weeks 13-20)||447
8503610|NCT00479882|20956804|P3|COMPLETED|Crossover: Period III (Weeks 13-20)||420
8503611|NCT00479882|20956805|P2|COMPLETED|Crossover: Period III (Weeks 13-20)||419
8503612|NCT00479882|20956806|P1|COMPLETED|Crossover: Period III (Weeks 13-20)||447
8503613|NCT00479882|20956803|P4|STARTED|Crossover: Period III (Weeks 13-20)||465
8503614|NCT00479882|20956804|P3|STARTED|Crossover: Period III (Weeks 13-20)||440
8503615|NCT00479882|20956805|P2|STARTED|Crossover: Period III (Weeks 13-20)||440
8503616|NCT00479882|20956806|P1|STARTED|Crossover: Period III (Weeks 13-20)||472
8503617|NCT00479882|20956803|P4|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
8503618|NCT00479882|20956804|P3|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
8503619|NCT00479882|20956805|P2|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
8503620|NCT00479882|20956806|P1|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
8503621|NCT00479882|20956803|P4|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
8503622|NCT00479882|20956804|P3|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
8503623|NCT00479882|20956805|P2|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
8503624|NCT00479882|20956806|P1|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
8503625|NCT00479882|20956803|P4|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
8503626|NCT00479882|20956804|P3|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
8503627|NCT00479882|20956805|P2|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
8503628|NCT00479882|20956806|P1|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
8503629|NCT00479856|20956936|P1|NOT COMPLETED|Overall Study||3
8503630|NCT00479856|20956936|P1|COMPLETED|Overall Study||6
8503631|NCT00479856|20956936|P1|STARTED|Overall Study||9
8503632|NCT00479765|20956945|P1|NOT COMPLETED|Overall Study||4
8503633|NCT00479765|20956945|P1|COMPLETED|Overall Study||0
8503634|NCT00479765|20956945|P1|STARTED|Overall Study||4
8503635|NCT00479713|20956951|P2|NOT COMPLETED|Overall Study||9
8503636|NCT00479713|20956952|P1|NOT COMPLETED|Overall Study||13
8503637|NCT00479713|20956951|P2|COMPLETED|Overall Study||295
8503638|NCT00479713|20956952|P1|COMPLETED|Overall Study||301
8503639|NCT00479713|20956951|P2|STARTED|Overall Study||304
8503640|NCT00479713|20956952|P1|STARTED|Overall Study||314
8503641|NCT00479674|20956976|P1|NOT COMPLETED|Overall Study||41
8503642|NCT00479674|20956976|P1|COMPLETED|Overall Study||0
8503643|NCT00479674|20956976|P1|STARTED|Overall Study||41
8503644|NCT00479557|20956991|P7|NOT COMPLETED|Overall Study||2
8503645|NCT00479557|20956992|P6|NOT COMPLETED|Overall Study||13
8503646|NCT00479557|20956993|P5|NOT COMPLETED|Overall Study||4
8503647|NCT00479557|20956994|P4|NOT COMPLETED|Overall Study||5
8503648|NCT00479557|20956995|P3|NOT COMPLETED|Overall Study||8
8503649|NCT00479557|20956996|P2|NOT COMPLETED|Overall Study||10
8503650|NCT00479557|20956997|P1|NOT COMPLETED|Overall Study||10
8503651|NCT00479557|20956991|P7|COMPLETED|Overall Study||15
8503652|NCT00479557|20956992|P6|COMPLETED|Overall Study||31
8503653|NCT00479557|20956993|P5|COMPLETED|Overall Study||8
8503654|NCT00479557|20956994|P4|COMPLETED|Overall Study||30
8503655|NCT00479557|20956995|P3|COMPLETED|Overall Study||32
8503656|NCT00479557|20956996|P2|COMPLETED|Overall Study||51
8503657|NCT00479557|20956997|P1|COMPLETED|Overall Study||26
8503658|NCT00479557|20956991|P7|Treated|Overall Study||17
8503659|NCT00479557|20956992|P6|Treated|Overall Study||44
8503660|NCT00479557|20956993|P5|Treated|Overall Study||12
8503661|NCT00479557|20956994|P4|Treated|Overall Study||35
8503662|NCT00479557|20956995|P3|Treated|Overall Study||40
8503663|NCT00479557|20956996|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
8503664|NCT00479557|20956997|P1|Treated|Overall Study||36
8503665|NCT00479557|20956991|P7|STARTED|Overall Study||17
8503666|NCT00479557|20956992|P6|STARTED|Overall Study||44
8503667|NCT00479557|20956993|P5|STARTED|Overall Study||12
8503668|NCT00479557|20956994|P4|STARTED|Overall Study||35
8503669|NCT00479557|20956995|P3|STARTED|Overall Study||40
8503670|NCT00479557|20956996|P2|STARTED|Overall Study||61
8503671|NCT00479557|20956997|P1|STARTED|Overall Study||36
8503672|NCT00479466|20957040|P6|NOT COMPLETED|Overall Study||4
8503673|NCT00479466|20957041|P5|NOT COMPLETED|Overall Study||8
8503674|NCT00479466|20957042|P4|NOT COMPLETED|Overall Study||3
8503675|NCT00479466|20957043|P3|NOT COMPLETED|Overall Study||3
8503676|NCT00479466|20957044|P2|NOT COMPLETED|Overall Study||8
8503677|NCT00479466|20957045|P1|NOT COMPLETED|Overall Study||13
8503678|NCT00479466|20957040|P6|COMPLETED|Overall Study||53
8503679|NCT00479466|20957041|P5|COMPLETED|Overall Study||48
8503680|NCT00479466|20957042|P4|COMPLETED|Overall Study||55
8503681|NCT00479466|20957043|P3|COMPLETED|Overall Study||54
8503682|NCT00479466|20957044|P2|COMPLETED|Overall Study||49
8503683|NCT00479466|20957045|P1|COMPLETED|Overall Study||44
8503684|NCT00479466|20957040|P6|STARTED|Overall Study||57
8503685|NCT00479466|20957041|P5|STARTED|Overall Study||56
8503686|NCT00479466|20957042|P4|STARTED|Overall Study||58
8503687|NCT00479466|20957043|P3|STARTED|Overall Study||57
8503688|NCT00479466|20957044|P2|STARTED|Overall Study||57
8503689|NCT00479466|20957045|P1|STARTED|Overall Study||57
8503690|NCT00479401|20957074|P3|NOT COMPLETED|Overall Study||12
8503691|NCT00479401|20957075|P2|NOT COMPLETED|Overall Study||37
8503692|NCT00479401|20957076|P1|NOT COMPLETED|Overall Study||49
8503693|NCT00479401|20957074|P3|COMPLETED|Overall Study||91
8503694|NCT00479401|20957075|P2|COMPLETED|Overall Study||176
8503695|NCT00479401|20957076|P1|COMPLETED|Overall Study||174
8503696|NCT00479401|20957074|P3|STARTED|Overall Study||103
8503697|NCT00479401|20957075|P2|STARTED|Overall Study||213
8503698|NCT00479401|20957076|P1|STARTED|Overall Study||223
8503699|NCT00479388|20957131|P2|NOT COMPLETED|Overall Study||73
8503700|NCT00479388|20957132|P1|NOT COMPLETED|Overall Study||132
8503701|NCT00479388|20957131|P2|COMPLETED|Overall Study||537
8503702|NCT00479388|20957132|P1|COMPLETED|Overall Study||474
8503703|NCT00479388|20957131|P2|STARTED|Overall Study||610
8503704|NCT00479388|20957132|P1|STARTED|Overall Study||606
8503705|NCT00479336|20957146|P4|NOT COMPLETED|Overall Study||5
8503706|NCT00479336|20957147|P3|NOT COMPLETED|Overall Study||1
8503707|NCT00479336|20957148|P2|NOT COMPLETED|Overall Study||6
8503708|NCT00479336|20957149|P1|NOT COMPLETED|Overall Study||4
8503709|NCT00479336|20957146|P4|COMPLETED|Overall Study||21
8503710|NCT00479336|20957147|P3|COMPLETED|Overall Study||24
8503711|NCT00479336|20957148|P2|COMPLETED|Overall Study||20
8503712|NCT00479336|20957149|P1|COMPLETED|Overall Study||23
8503713|NCT00479336|20957146|P4|STARTED|Overall Study||26
8503714|NCT00479336|20957147|P3|STARTED|Overall Study||25
8503715|NCT00479336|20957148|P2|STARTED|Overall Study||26
8503716|NCT00479336|20957149|P1|STARTED|Overall Study||27
8503717|NCT00479258|20957165|P2|NOT COMPLETED|Overall Study||0
8503718|NCT00479258|20957166|P1|NOT COMPLETED|Overall Study||0
8503719|NCT00479258|20957165|P2|COMPLETED|Overall Study||0
8503720|NCT00479258|20957166|P1|COMPLETED|Overall Study||0
8503721|NCT00479258|20957165|P2|STARTED|Overall Study||0
8503722|NCT00479258|20957166|P1|STARTED|Overall Study||0
8503723|NCT00479232|20957172|P6|NOT COMPLETED|Overall Study||30
8503724|NCT00479232|20957173|P5|NOT COMPLETED|Overall Study||4
8503725|NCT00479232|20957174|P4|NOT COMPLETED|Overall Study||3
8503726|NCT00479232|20957175|P3|NOT COMPLETED|Overall Study||28
8503727|NCT00479232|20957176|P2|NOT COMPLETED|Overall Study||3
8503728|NCT00479232|20957177|P1|NOT COMPLETED|Overall Study||3
8503729|NCT00479232|20957172|P6|COMPLETED|Overall Study||0
8503730|NCT00479232|20957173|P5|COMPLETED|Overall Study||0
8503731|NCT00479232|20957174|P4|COMPLETED|Overall Study||0
8503732|NCT00479232|20957175|P3|COMPLETED|Overall Study||0
8503733|NCT00479232|20957176|P2|COMPLETED|Overall Study||0
8503734|NCT00479232|20957177|P1|COMPLETED|Overall Study||0
8503735|NCT00479232|20957172|P6|STARTED|Overall Study||30
8503736|NCT00479232|20957173|P5|STARTED|Overall Study||4
8503737|NCT00479232|20957174|P4|STARTED|Overall Study||3
8503738|NCT00479232|20957175|P3|STARTED|Overall Study||28
8503739|NCT00479232|20957176|P2|STARTED|Overall Study||3
8503740|NCT00479232|20957177|P1|STARTED|Overall Study||3
8503741|NCT00479154|20957197|P2|NOT COMPLETED|Overall Study||0
8503742|NCT00479154|20957198|P1|NOT COMPLETED|Overall Study||0
8503743|NCT00479154|20957197|P2|COMPLETED|Overall Study||3
8503744|NCT00479154|20957198|P1|COMPLETED|Overall Study||3
8503745|NCT00479154|20957197|P2|STARTED|Overall Study||3
8503746|NCT00479154|20957198|P1|STARTED|Overall Study||3
8503747|NCT00479115|20957204|P1|NOT COMPLETED|Overall Study||0
8503748|NCT00479115|20957204|P1|COMPLETED|Overall Study||1
8503749|NCT00479115|20957204|P1|STARTED|Overall Study||1
8503750|NCT00479089|20957215|P2|NOT COMPLETED|Overall Study||0
8503751|NCT00479089|20957216|P1|NOT COMPLETED|Overall Study||0
8503752|NCT00479089|20957215|P2|COMPLETED|Overall Study||25
8503753|NCT00479089|20957216|P1|COMPLETED|Overall Study||25
8503754|NCT00479089|20957215|P2|STARTED|Overall Study||25
8503755|NCT00479089|20957216|P1|STARTED|Overall Study||25
8503756|NCT00479037|20957228|P2|NOT COMPLETED|Overall Study||6
8503757|NCT00479037|20957229|P1|NOT COMPLETED|Overall Study||3
8503758|NCT00479037|20957228|P2|COMPLETED|Overall Study||34
8503759|NCT00479037|20957229|P1|COMPLETED|Overall Study||38
8503760|NCT00479037|20957228|P2|STARTED|Overall Study||40
8503761|NCT00479037|20957229|P1|STARTED|Overall Study||41
8503762|NCT00478933|20957239|P1|NOT COMPLETED|Overall Study||78
8503763|NCT00478933|20957239|P1|COMPLETED|Overall Study||1145
8503764|NCT00478933|20957239|P1|STARTED|Overall Study||1223
8503765|NCT00478881|20957265|P2|NOT COMPLETED|Overall Study||22
8503766|NCT00478881|20957266|P1|NOT COMPLETED|Overall Study||39
8503767|NCT00478881|20957265|P2|COMPLETED|Overall Study||176
8503768|NCT00478881|20957266|P1|COMPLETED|Overall Study||160
8503769|NCT00478881|20957265|P2|Received Medication|Overall Study||198
8503770|NCT00478881|20957266|P1|Received Medication|Overall Study||198
8503771|NCT00478881|20957265|P2|STARTED|Overall Study||198
8503772|NCT00478881|20957266|P1|STARTED|Overall Study||199
8503773|NCT00478777|20957290|P1|NOT COMPLETED|Overall Study||77
8503774|NCT00478777|20957290|P1|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
8503775|NCT00478777|20957290|P1|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
8503776|NCT00478777|20957290|P1|STARTED|Overall Study||150
8503777|NCT00478673|20957297|P1|NOT COMPLETED|12-Months Post-Procedure||64
8503778|NCT00478673|20957297|P1|COMPLETED|12-Months Post-Procedure||231
8503779|NCT00478673|20957297|P1|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
8503780|NCT00478673|20957297|P1|NOT COMPLETED|30-Days Post-Procedure||10
8503781|NCT00478673|20957297|P1|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
8503782|NCT00478673|20957297|P1|STARTED|30-Days Post-Procedure||298
8503786|NCT00478608|20957310|P1|NOT COMPLETED|Overall Study||20
8503787|NCT00478608|20957310|P1|COMPLETED|Overall Study||59
8503788|NCT00478608|20957310|P1|STARTED|Overall Study||79
8503789|NCT00478569|20957318|P1|NOT COMPLETED|Overall Study||409
8503790|NCT00478569|20957318|P1|COMPLETED|Overall Study||761
8503791|NCT00478569|20957318|P1|STARTED|Overall Study||1170
8503792|NCT00478556|20957334|P2|NOT COMPLETED|Overall Study||0
8503793|NCT00478556|20957335|P1|NOT COMPLETED|Overall Study||0
8503794|NCT00478556|20957334|P2|COMPLETED|Overall Study||149
8503795|NCT00478556|20957335|P1|COMPLETED|Overall Study||151
8503796|NCT00478556|20957334|P2|STARTED|Overall Study||149
8503797|NCT00478556|20957335|P1|STARTED|Overall Study||151
8503798|NCT00478426|20957343|P1|NOT COMPLETED|Overall Study||1
8503799|NCT00478426|20957343|P1|COMPLETED|Overall Study||33
8503800|NCT00478426|20957343|P1|STARTED|Overall Study||34
8503801|NCT00478361|20957351|P1|NOT COMPLETED|Overall Study||0
8503802|NCT00478361|20957351|P1|COMPLETED|Overall Study||39
8503803|NCT00478361|20957351|P1|STARTED|Overall Study||39
8503804|NCT00478335|20957359|P2|NOT COMPLETED|Period 2 (4 Days)||0
8503805|NCT00478335|20957360|P1|NOT COMPLETED|Period 2 (4 Days)||0
8503806|NCT00478335|20957359|P2|COMPLETED|Period 2 (4 Days)||2
8503807|NCT00478335|20957360|P1|COMPLETED|Period 2 (4 Days)||2
8503808|NCT00478335|20957359|P2|STARTED|Period 2 (4 Days)||2
8503809|NCT00478335|20957360|P1|STARTED|Period 2 (4 Days)||2
8503810|NCT00478335|20957359|P2|NOT COMPLETED|Period 1 (4 Days)||0
8503811|NCT00478335|20957360|P1|NOT COMPLETED|Period 1 (4 Days)||0
8503812|NCT00478335|20957359|P2|COMPLETED|Period 1 (4 Days)||2
8503813|NCT00478335|20957360|P1|COMPLETED|Period 1 (4 Days)||2
8503814|NCT00478335|20957359|P2|STARTED|Period 1 (4 Days)||2
8503815|NCT00478335|20957360|P1|STARTED|Period 1 (4 Days)||2
8503816|NCT00478257|20957368|P2|NOT COMPLETED|Overall Study||3
8503817|NCT00478257|20957369|P1|NOT COMPLETED|Overall Study||8
8503818|NCT00478257|20957368|P2|COMPLETED|Overall Study||13
8503819|NCT00478257|20957369|P1|COMPLETED|Overall Study||15
8503820|NCT00478257|20957368|P2|STARTED|Overall Study||16
8503821|NCT00478257|20957369|P1|STARTED|Overall Study||23
8503822|NCT00478244|20957375|P1|NOT COMPLETED|Overall Study||1
8503823|NCT00478244|20957375|P1|COMPLETED|Overall Study||6
8503824|NCT00478244|20957375|P1|STARTED|Overall Study||7
8503825|NCT00478231|20957388|P1|NOT COMPLETED|Overall Study||84
8503826|NCT00478231|20957388|P1|COMPLETED|Overall Study||125
8503827|NCT00478231|20957388|P1|Treated|Overall Study||206
8503828|NCT00478231|20957388|P1|STARTED|Overall Study||209
8503829|NCT00478218|20957409|P2|NOT COMPLETED|Overall Study||0
8503830|NCT00478218|20957410|P1|NOT COMPLETED|Overall Study||0
8503831|NCT00478218|20957409|P2|COMPLETED|Overall Study||19
8503832|NCT00478218|20957410|P1|COMPLETED|Overall Study||34
8503833|NCT00478218|20957409|P2|STARTED|Overall Study||19
8503834|NCT00478218|20957410|P1|STARTED|Overall Study||34
8503835|NCT00478205|20957424|P2|NOT COMPLETED|Overall Study||87
8503836|NCT00478205|20957425|P1|NOT COMPLETED|Overall Study||296
8503837|NCT00478205|20957424|P2|COMPLETED|Overall Study||399
8503838|NCT00478205|20957425|P1|COMPLETED|Overall Study||685
8503839|NCT00478205|20957424|P2|STARTED|Overall Study||486
8503840|NCT00478205|20957425|P1|STARTED|Overall Study||981
8503841|NCT00478192|20957440|P3|NOT COMPLETED|Overall Study||2
8503842|NCT00478192|20957441|P2|NOT COMPLETED|Overall Study||5
8503843|NCT00478192|20957442|P1|NOT COMPLETED|Overall Study||4
8503844|NCT00478192|20957440|P3|COMPLETED|Overall Study||8
8503845|NCT00478192|20957441|P2|COMPLETED|Overall Study||15
8503846|NCT00478192|20957442|P1|COMPLETED|Overall Study||16
8503847|NCT00478192|20957440|P3|End of Treatment|Overall Study||8
8503848|NCT00478192|20957441|P2|End of Treatment|Overall Study||16
8503849|NCT00478192|20957442|P1|End of Treatment|Overall Study||18
8503850|NCT00478192|20957440|P3|Full Analysis Set / Safety Analysis Set|Overall Study||9
8503851|NCT00478192|20957441|P2|Full Analysis Set / Safety Analysis Set|Overall Study||20
8503852|NCT00478192|20957442|P1|Full Analysis Set / Safety Analysis Set|Overall Study||20
8503853|NCT00478192|20957440|P3|STARTED|Overall Study||10
8503854|NCT00478192|20957441|P2|STARTED|Overall Study||20
8503855|NCT00478192|20957442|P1|STARTED|Overall Study||20
8503856|NCT00478140|20957469|P1|NOT COMPLETED|Overall Study||1
8503857|NCT00478140|20957469|P1|COMPLETED|Overall Study||3
8503858|NCT00478140|20957469|P1|STARTED|Overall Study||4
8503859|NCT00478062|20957476|P1|NOT COMPLETED|Overall Study||0
8503860|NCT00478062|20957476|P1|COMPLETED|Overall Study||1
8503861|NCT00478062|20957476|P1|STARTED|Overall Study||1
8503862|NCT00478036|20957486|P3|NOT COMPLETED|Overall Study||0
8503863|NCT00478036|20957487|P2|NOT COMPLETED|Overall Study||0
8503864|NCT00478036|20957488|P1|NOT COMPLETED|Overall Study||0
8503865|NCT00478036|20957486|P3|COMPLETED|Overall Study||14
8503866|NCT00478036|20957487|P2|COMPLETED|Overall Study||7
8503867|NCT00478036|20957488|P1|COMPLETED|Overall Study||10
8503868|NCT00478036|20957486|P3|STARTED|Overall Study||14
8503869|NCT00478036|20957487|P2|STARTED|Overall Study||7
8503870|NCT00478036|20957488|P1|STARTED|Overall Study||10
8503871|NCT00478023|20957501|P5|NOT COMPLETED|Overall Study||55
8503872|NCT00478023|20957502|P4|NOT COMPLETED|Overall Study||30
8503873|NCT00478023|20957503|P3|NOT COMPLETED|Overall Study||20
8503874|NCT00478023|20957504|P2|NOT COMPLETED|Overall Study||24
8503875|NCT00478023|20957505|P1|NOT COMPLETED|Overall Study||35
8503876|NCT00478023|20957501|P5|COMPLETED|Overall Study||114
8503877|NCT00478023|20957502|P4|COMPLETED|Overall Study||146
8503878|NCT00478023|20957503|P3|COMPLETED|Overall Study||151
8503879|NCT00478023|20957504|P2|COMPLETED|Overall Study||144
8503880|NCT00478023|20957505|P1|COMPLETED|Overall Study||135
8503881|NCT00478023|20957501|P5|STARTED|Overall Study||169
8503882|NCT00478023|20957502|P4|STARTED|Overall Study||176
8503883|NCT00478023|20957503|P3|STARTED|Overall Study||171
8503884|NCT00478023|20957504|P2|STARTED|Overall Study||168
8503885|NCT00478023|20957505|P1|STARTED|Overall Study||170
8503886|NCT00477971|20957524|P2|NOT COMPLETED|Overall Study||6
8503887|NCT00477971|20957525|P1|NOT COMPLETED|Overall Study||17
8503888|NCT00477971|20957524|P2|COMPLETED|Overall Study||49
8503889|NCT00477971|20957525|P1|COMPLETED|Overall Study||17
8503890|NCT00477971|20957524|P2|STARTED|Overall Study||55
8503891|NCT00477971|20957525|P1|STARTED|Overall Study||34
8503892|NCT00477750|20957537|P1|NOT COMPLETED|Overall Study||11
8503893|NCT00477750|20957537|P1|COMPLETED|Overall Study||15
8503894|NCT00477750|20957537|P1|STARTED|Overall Study||26
8503895|NCT00477685|20957545|P1|NOT COMPLETED|Overall Study||0
8503896|NCT00477685|20957545|P1|COMPLETED|Overall Study||10
8503897|NCT00477685|20957545|P1|STARTED|Overall Study||10
8503898|NCT00477672|20957553|P3|NOT COMPLETED|Overall Study||16
8503899|NCT00477672|20957554|P2|NOT COMPLETED|Overall Study||16
8503900|NCT00477672|20957555|P1|NOT COMPLETED|Overall Study||7
8503901|NCT00477672|20957553|P3|COMPLETED|Overall Study||83
8503902|NCT00477672|20957554|P2|COMPLETED|Overall Study||85
8503903|NCT00477672|20957555|P1|COMPLETED|Overall Study||91
8503904|NCT00477672|20957553|P3|STARTED|Overall Study||99
8503905|NCT00477672|20957554|P2|STARTED|Overall Study||101
8503906|NCT00477672|20957555|P1|STARTED|Overall Study||98
8503907|NCT00477633|20957566|P1|NOT COMPLETED|Overall Study||709
8503908|NCT00477633|20957566|P1|COMPLETED|Overall Study||991
8503909|NCT00477633|20957566|P1|STARTED|Overall Study||1700
8503910|NCT00477607|20957574|P2|NOT COMPLETED|Overall Study||7
8503911|NCT00477607|20957575|P1|NOT COMPLETED|Overall Study||7
8503912|NCT00477607|20957574|P2|COMPLETED|Overall Study||13
8503913|NCT00477607|20957575|P1|COMPLETED|Overall Study||12
8503914|NCT00477607|20957574|P2|STARTED|Overall Study||20
8503915|NCT00477607|20957575|P1|STARTED|Overall Study||19
8503916|NCT00477594|20957587|P2|NOT COMPLETED|Follow-up Period||1
8503917|NCT00477594|20957588|P1|NOT COMPLETED|Follow-up Period||3
8503918|NCT00477594|20957587|P2|COMPLETED|Follow-up Period||4
8503919|NCT00477594|20957588|P1|COMPLETED|Follow-up Period||13
8503920|NCT00477594|20957587|P2|STARTED|Follow-up Period||5
8503921|NCT00477594|20957588|P1|STARTED|Follow-up Period||16
8503922|NCT00477594|20957587|P2|NOT COMPLETED|Year 3||0
8503923|NCT00477594|20957588|P1|NOT COMPLETED|Year 3||2
8503924|NCT00477594|20957587|P2|COMPLETED|Year 3||0
8503925|NCT00477594|20957588|P1|COMPLETED|Year 3||2
8503926|NCT00477594|20957587|P2|STARTED|Year 3||0
8503927|NCT00477594|20957588|P1|STARTED|Year 3||4
8503928|NCT00477594|20957587|P2|NOT COMPLETED|Year 1 and Year 2||4
8503929|NCT00477594|20957588|P1|NOT COMPLETED|Year 1 and Year 2||9
8503930|NCT00477594|20957587|P2|COMPLETED|Year 1 and Year 2||1
8503931|NCT00477594|20957588|P1|COMPLETED|Year 1 and Year 2||7
8503932|NCT00477594|20957587|P2|STARTED|Year 1 and Year 2||5
8503933|NCT00477594|20957588|P1|STARTED|Year 1 and Year 2||16
8503934|NCT00477490|20957649|P9|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
8503935|NCT00477490|20957650|P8|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
8503936|NCT00477490|20957651|P7|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
8503937|NCT00477490|20957652|P6|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
8503938|NCT00477490|20957653|P5|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
8503939|NCT00477490|20957654|P4|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
8503940|NCT00477490|20957655|P3|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
8503941|NCT00477490|20957656|P2|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
8503942|NCT00477490|20957657|P1|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
8503943|NCT00477490|20957649|P9|COMPLETED|Part II: Extension Week 5 up to Day 169||26
8503944|NCT00477490|20957650|P8|COMPLETED|Part II: Extension Week 5 up to Day 169||29
8503945|NCT00477490|20957651|P7|COMPLETED|Part II: Extension Week 5 up to Day 169||32
8503946|NCT00477490|20957652|P6|COMPLETED|Part II: Extension Week 5 up to Day 169||25
8503947|NCT00477490|20957653|P5|COMPLETED|Part II: Extension Week 5 up to Day 169||107
8503948|NCT00477490|20957654|P4|COMPLETED|Part II: Extension Week 5 up to Day 169||120
8503949|NCT00477490|20957655|P3|COMPLETED|Part II: Extension Week 5 up to Day 169||120
8503950|NCT00477490|20957656|P2|COMPLETED|Part II: Extension Week 5 up to Day 169||107
8503951|NCT00477490|20957657|P1|COMPLETED|Part II: Extension Week 5 up to Day 169||0
8503952|NCT00477490|20957649|P9|STARTED|Part II: Extension Week 5 up to Day 169||34
8503953|NCT00477490|20957650|P8|STARTED|Part II: Extension Week 5 up to Day 169||34
8503954|NCT00477490|20957651|P7|STARTED|Part II: Extension Week 5 up to Day 169||37
8503955|NCT00477490|20957652|P6|STARTED|Part II: Extension Week 5 up to Day 169||31
8503956|NCT00477490|20957653|P5|STARTED|Part II: Extension Week 5 up to Day 169||127
8503957|NCT00477490|20957654|P4|STARTED|Part II: Extension Week 5 up to Day 169||132
8503958|NCT00477490|20957655|P3|STARTED|Part II: Extension Week 5 up to Day 169||135
8503959|NCT00477490|20957656|P2|STARTED|Part II: Extension Week 5 up to Day 169||135
8503960|NCT00477490|20957657|P1|STARTED|Part II: Extension Week 5 up to Day 169||0
8503961|NCT00477490|20957649|P9|NOT COMPLETED|Part I: 4 Week Efficacy||0
8503962|NCT00477490|20957650|P8|NOT COMPLETED|Part I: 4 Week Efficacy||0
8503963|NCT00477490|20957651|P7|NOT COMPLETED|Part I: 4 Week Efficacy||0
8503964|NCT00477490|20957652|P6|NOT COMPLETED|Part I: 4 Week Efficacy||0
8503965|NCT00477490|20957653|P5|NOT COMPLETED|Part I: 4 Week Efficacy||25
8503966|NCT00477490|20957654|P4|NOT COMPLETED|Part I: 4 Week Efficacy||20
8503967|NCT00477490|20957655|P3|NOT COMPLETED|Part I: 4 Week Efficacy||10
8503968|NCT00477490|20957656|P2|NOT COMPLETED|Part I: 4 Week Efficacy||19
8503969|NCT00477490|20957657|P1|NOT COMPLETED|Part I: 4 Week Efficacy||15
8503970|NCT00477490|20957649|P9|COMPLETED|Part I: 4 Week Efficacy||0
8503971|NCT00477490|20957650|P8|COMPLETED|Part I: 4 Week Efficacy||0
8503972|NCT00477490|20957651|P7|COMPLETED|Part I: 4 Week Efficacy||0
8503973|NCT00477490|20957652|P6|COMPLETED|Part I: 4 Week Efficacy||0
8503974|NCT00477490|20957653|P5|COMPLETED|Part I: 4 Week Efficacy||135
8503975|NCT00477490|20957654|P4|COMPLETED|Part I: 4 Week Efficacy||138
8503976|NCT00477490|20957655|P3|COMPLETED|Part I: 4 Week Efficacy||148
8503977|NCT00477490|20957656|P2|COMPLETED|Part I: 4 Week Efficacy||144
8503978|NCT00477490|20957657|P1|COMPLETED|Part I: 4 Week Efficacy||145
8503979|NCT00477490|20957649|P9|ITT Population|Part I: 4 Week Efficacy||0
8503980|NCT00477490|20957650|P8|ITT Population|Part I: 4 Week Efficacy||0
8503981|NCT00477490|20957651|P7|ITT Population|Part I: 4 Week Efficacy||0
8503982|NCT00477490|20957652|P6|ITT Population|Part I: 4 Week Efficacy||0
8503983|NCT00477490|20957653|P5|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
8503984|NCT00477490|20957654|P4|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
8503985|NCT00477490|20957655|P3|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
8503986|NCT00477490|20957656|P2|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
8503987|NCT00477490|20957657|P1|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
8503988|NCT00477490|20957649|P9|STARTED|Part I: 4 Week Efficacy||0
8503989|NCT00477490|20957650|P8|STARTED|Part I: 4 Week Efficacy||0
8503990|NCT00477490|20957651|P7|STARTED|Part I: 4 Week Efficacy||0
8503991|NCT00477490|20957652|P6|STARTED|Part I: 4 Week Efficacy||0
8503992|NCT00477490|20957653|P5|STARTED|Part I: 4 Week Efficacy||160
8503993|NCT00477490|20957654|P4|STARTED|Part I: 4 Week Efficacy||158
8503994|NCT00477490|20957655|P3|STARTED|Part I: 4 Week Efficacy||158
8503995|NCT00477490|20957656|P2|STARTED|Part I: 4 Week Efficacy||163
8503996|NCT00477490|20957657|P1|STARTED|Part I: 4 Week Efficacy||160
8503997|NCT00477464|20957741|P1|NOT COMPLETED|Overall Study||51
8503998|NCT00477464|20957741|P1|COMPLETED|Overall Study||0
8503999|NCT00477464|20957741|P1|STARTED|Overall Study||51
8504000|NCT00477451|20957768|P4|NOT COMPLETED|Overall Study||0
8504001|NCT00477451|20957769|P3|NOT COMPLETED|Overall Study||0
8504002|NCT00477451|20957770|P2|NOT COMPLETED|Overall Study||0
8504003|NCT00477451|20957771|P1|NOT COMPLETED|Overall Study||0
8504004|NCT00477451|20957768|P4|COMPLETED|Overall Study||2
8504005|NCT00477451|20957769|P3|COMPLETED|Overall Study||7
8504006|NCT00477451|20957770|P2|COMPLETED|Overall Study||20
8504007|NCT00477451|20957771|P1|COMPLETED|Overall Study||20
8504008|NCT00477451|20957768|P4|STARTED|Overall Study||2
8504009|NCT00477451|20957769|P3|STARTED|Overall Study||7
8504010|NCT00477451|20957770|P2|STARTED|Overall Study||20
8504011|NCT00477451|20957771|P1|STARTED|Overall Study||20
8504012|NCT00477386|20957785|P2|NOT COMPLETED|Overall Study||17
8504013|NCT00477386|20957786|P1|NOT COMPLETED|Overall Study||11
8504014|NCT00477386|20957785|P2|COMPLETED|Overall Study||0
8504015|NCT00477386|20957786|P1|COMPLETED|Overall Study||0
8504016|NCT00477386|20957785|P2|STARTED|Overall Study||17
8504017|NCT00477386|20957786|P1|STARTED|Overall Study||11
8504018|NCT00477334|20957796|P2|NOT COMPLETED|Overall Study||76
8504019|NCT00477334|20957797|P1|NOT COMPLETED|Overall Study||170
8504020|NCT00477334|20957796|P2|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
8504021|NCT00477334|20957797|P1|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
8504022|NCT00477334|20957796|P2|Modified Intent to Treat Population|Overall Study||78
8504023|NCT00477334|20957797|P1|Modified Intent to Treat Population|Overall Study||152
8504024|NCT00477334|20957796|P2|Participants Completing First Recurrence|Overall Study||92
8504025|NCT00477334|20957797|P1|Participants Completing First Recurrence|Overall Study||187
8504026|NCT00477334|20957796|P2|Intent to Treat Population|Overall Study||98
8504027|NCT00477334|20957797|P1|Intent to Treat Population|Overall Study||201
8504028|NCT00477334|20957796|P2|Randomized and Took Study Drug|Overall Study||98
8504029|NCT00477334|20957797|P1|Randomized and Took Study Drug|Overall Study||206
8504030|NCT00477334|20957796|P2|STARTED|Overall Study||151
8504031|NCT00477334|20957797|P1|STARTED|Overall Study||312
8504032|NCT00477295|20957823|P2|NOT COMPLETED|Overall Study||109
8504033|NCT00477295|20957824|P1|NOT COMPLETED|Overall Study||121
8504034|NCT00477295|20957823|P2|COMPLETED|Overall Study||192
8504035|NCT00477295|20957824|P1|COMPLETED|Overall Study||161
8504036|NCT00477295|20957823|P2|STARTED|Overall Study||301
8504037|NCT00477295|20957824|P1|STARTED|Overall Study||282
8504038|NCT00477269|20957852|P3|NOT COMPLETED|Open Label Extension||13
8504039|NCT00477269|20957853|P2|NOT COMPLETED|Open Label Extension||0
8504040|NCT00477269|20957854|P1|NOT COMPLETED|Open Label Extension||0
8504041|NCT00477269|20957852|P3|COMPLETED|Open Label Extension||9
8504042|NCT00477269|20957853|P2|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
8504043|NCT00477269|20957854|P1|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
8504044|NCT00477269|20957852|P3|STARTED|Open Label Extension||22
8504045|NCT00477269|20957853|P2|STARTED|Open Label Extension|Arm in the Core study not extension|0
8504046|NCT00477269|20957854|P1|STARTED|Open Label Extension|Arm in the Core study not extension|0
8504047|NCT00477269|20957852|P3|NOT COMPLETED|Core Study||0
8504048|NCT00477269|20957853|P2|NOT COMPLETED|Core Study||8
8504049|NCT00477269|20957854|P1|NOT COMPLETED|Core Study||9
8504050|NCT00477269|20957852|P3|COMPLETED|Core Study||0
8504051|NCT00477269|20957853|P2|COMPLETED|Core Study||23
8504052|NCT00477269|20957854|P1|COMPLETED|Core Study||19
8504053|NCT00477269|20957852|P3|STARTED|Core Study||0
8504054|NCT00477269|20957853|P2|STARTED|Core Study||31
8504055|NCT00477269|20957854|P1|STARTED|Core Study||28
8504056|NCT00477230|20957908|P2|NOT COMPLETED|Overall Study||31
8504057|NCT00477230|20957909|P1|NOT COMPLETED|Overall Study||20
8504058|NCT00477230|20957908|P2|COMPLETED|Overall Study||1
8504059|NCT00477230|20957909|P1|COMPLETED|Overall Study||12
8504060|NCT00477230|20957908|P2|STARTED|Overall Study||32
8504061|NCT00477230|20957909|P1|STARTED|Overall Study||32
8504062|NCT00477204|20957917|P2|NOT COMPLETED|Overall Study||0
8504063|NCT00477204|20957918|P1|NOT COMPLETED|Overall Study||0
8504064|NCT00477204|20957917|P2|COMPLETED|Overall Study||5
8504065|NCT00477204|20957918|P1|COMPLETED|Overall Study||4
8504066|NCT00477204|20957917|P2|STARTED|Overall Study||5
8504067|NCT00477204|20957918|P1|STARTED|Overall Study||4
8504068|NCT00477191|20957924|P1|NOT COMPLETED|Overall Study||5
8504069|NCT00477191|20957924|P1|COMPLETED|Overall Study||13
8504070|NCT00477191|20957924|P1|STARTED|Overall Study||18
8504071|NCT00477165|20957933|P2|NOT COMPLETED|Overall Study||2
8504072|NCT00477165|20957934|P1|NOT COMPLETED|Overall Study||7
8504073|NCT00477165|20957933|P2|COMPLETED|Overall Study||25
8504074|NCT00477165|20957934|P1|COMPLETED|Overall Study||20
8504075|NCT00477165|20957933|P2|STARTED|Overall Study||27
8504076|NCT00477165|20957934|P1|STARTED|Overall Study||27
8504077|NCT00477152|20957946|P1|NOT COMPLETED|Overall Study||3
8504078|NCT00477152|20957946|P1|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
8504079|NCT00477152|20957946|P1|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
8504080|NCT00477087|20957953|P1|NOT COMPLETED|Overall Study||0
8504081|NCT00477087|20957953|P1|COMPLETED|Overall Study||10
8504082|NCT00477087|20957953|P1|STARTED|Overall Study||10
8504083|NCT00476996|20957962|P4|NOT COMPLETED|OLE Phase (From Week 48)||664
8504084|NCT00476996|20957963|P3|NOT COMPLETED|OLE Phase (From Week 48)||0
8504085|NCT00476996|20957964|P2|NOT COMPLETED|OLE Phase (From Week 48)||0
8504086|NCT00476996|20957965|P1|NOT COMPLETED|OLE Phase (From Week 48)||0
8504087|NCT00476996|20957962|P4|COMPLETED|OLE Phase (From Week 48)||0
8504088|NCT00476996|20957963|P3|COMPLETED|OLE Phase (From Week 48)||0
8504089|NCT00476996|20957964|P2|COMPLETED|OLE Phase (From Week 48)||0
8504090|NCT00476996|20957965|P1|COMPLETED|OLE Phase (From Week 48)||0
8504091|NCT00476996|20957962|P4|STARTED|OLE Phase (From Week 48)||664
8504092|NCT00476996|20957963|P3|STARTED|OLE Phase (From Week 48)||0
8504093|NCT00476996|20957964|P2|STARTED|OLE Phase (From Week 48)||0
8504094|NCT00476996|20957965|P1|STARTED|OLE Phase (From Week 48)||0
8504095|NCT00476996|20957962|P4|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0
8504096|NCT00476996|20957963|P3|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45
8504097|NCT00476996|20957964|P2|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55
8504098|NCT00476996|20957965|P1|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72
8504099|NCT00476996|20957962|P4|COMPLETED|Blinded Treatment Phase (up to Week 48)||0
8504100|NCT00476996|20957963|P3|COMPLETED|Blinded Treatment Phase (up to Week 48)||237
8504101|NCT00476996|20957964|P2|COMPLETED|Blinded Treatment Phase (up to Week 48)||222
8504102|NCT00476996|20957965|P1|COMPLETED|Blinded Treatment Phase (up to Week 48)||205
8504103|NCT00476996|20957962|P4|STARTED|Blinded Treatment Phase (up to Week 48)||0
8504104|NCT00476996|20957963|P3|STARTED|Blinded Treatment Phase (up to Week 48)||282
8504105|NCT00476996|20957964|P2|STARTED|Blinded Treatment Phase (up to Week 48)||277
8504106|NCT00476996|20957965|P1|STARTED|Blinded Treatment Phase (up to Week 48)||277
8504107|NCT00476957|20957997|P2|NOT COMPLETED|Overall Study||193
8504108|NCT00476957|20957998|P1|NOT COMPLETED|Overall Study||176
8504109|NCT00476957|20957997|P2|COMPLETED|Overall Study||4159
8504110|NCT00476957|20957998|P1|COMPLETED|Overall Study||4181
8504111|NCT00476957|20957997|P2|STARTED|Overall Study||4352
8504112|NCT00476957|20957998|P1|STARTED|Overall Study||4357
8504113|NCT00476827|20958012|P6|NOT COMPLETED|Overall Study||0
8504114|NCT00476827|20958013|P5|NOT COMPLETED|Overall Study||0
8504115|NCT00476827|20958014|P4|NOT COMPLETED|Overall Study||0
8504116|NCT00476827|20958015|P3|NOT COMPLETED|Overall Study||0
8504117|NCT00476827|20958016|P2|NOT COMPLETED|Overall Study||0
8504118|NCT00476827|20958017|P1|NOT COMPLETED|Overall Study||0
8504119|NCT00476827|20958012|P6|COMPLETED|Overall Study||2
8504120|NCT00476827|20958013|P5|COMPLETED|Overall Study||2
8504121|NCT00476827|20958014|P4|COMPLETED|Overall Study||0
8504122|NCT00476827|20958015|P3|COMPLETED|Overall Study||1
8504123|NCT00476827|20958016|P2|COMPLETED|Overall Study||0
8504124|NCT00476827|20958017|P1|COMPLETED|Overall Study||3
8504125|NCT00476827|20958012|P6|STARTED|Overall Study||2
8504126|NCT00476827|20958013|P5|STARTED|Overall Study||2
8504127|NCT00476827|20958014|P4|STARTED|Overall Study||0
8504128|NCT00476827|20958015|P3|STARTED|Overall Study||1
8504129|NCT00476827|20958016|P2|STARTED|Overall Study||0
8504130|NCT00476827|20958017|P1|STARTED|Overall Study||3
8504131|NCT00476788|20958047|P1|NOT COMPLETED|Overall Study||3
8504132|NCT00476788|20958047|P1|COMPLETED|Overall Study||11
8504133|NCT00476788|20958047|P1|STARTED|Overall Study||14
8504134|NCT00476645|20958052|P1|NOT COMPLETED|Overall Study||0
8504135|NCT00476645|20958052|P1|COMPLETED|Overall Study||10
8504136|NCT00476645|20958052|P1|STARTED|Overall Study||10
8504137|NCT00476593|20958062|P4|NOT COMPLETED|Overall Study||22
8504138|NCT00476593|20958063|P3|NOT COMPLETED|Overall Study||8
8504139|NCT00476593|20958064|P2|NOT COMPLETED|Overall Study||2
8504140|NCT00476593|20958065|P1|NOT COMPLETED|Overall Study||10
8504141|NCT00476593|20958062|P4|COMPLETED|Overall Study||107
8504142|NCT00476593|20958063|P3|COMPLETED|Overall Study||30
8504143|NCT00476593|20958064|P2|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
8504144|NCT00476593|20958065|P1|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
8504145|NCT00476593|20958062|P4|STARTED|Overall Study||129
8504146|NCT00476593|20958063|P3|STARTED|Overall Study||38
8504147|NCT00476593|20958064|P2|STARTED|Overall Study||19
8504148|NCT00476593|20958065|P1|STARTED|Overall Study||32
8504149|NCT00476476|20958077|P2|NOT COMPLETED|Overall Study||24
8504150|NCT00476476|20958078|P1|NOT COMPLETED|Overall Study||2
8504151|NCT00476476|20958077|P2|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
8504152|NCT00476476|20958078|P1|COMPLETED|Overall Study||15
8504153|NCT00476476|20958077|P2|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
8504154|NCT00476476|20958078|P1|Response Evaluable|Overall Study||17
8504155|NCT00476476|20958077|P2|STARTED|Overall Study||24
8504156|NCT00476476|20958078|P1|STARTED|Overall Study||17
8504157|NCT00476242|20958085|P2|NOT COMPLETED|Overall Study||16
8504158|NCT00476242|20958086|P1|NOT COMPLETED|Overall Study||8
8504159|NCT00476242|20958085|P2|COMPLETED|Overall Study||12
8504160|NCT00476242|20958086|P1|COMPLETED|Overall Study||19
8504161|NCT00476242|20958085|P2|STARTED|Overall Study||28
8504162|NCT00476242|20958086|P1|STARTED|Overall Study||27
8504163|NCT00476229|20958096|P1|NOT COMPLETED|Overall Study||1
8504164|NCT00476229|20958096|P1|COMPLETED|Overall Study||19
8504165|NCT00476229|20958096|P1|STARTED|Overall Study||20
8504166|NCT00476151|20958102|P2|NOT COMPLETED|Overall Study||7
8504167|NCT00476151|20958103|P1|NOT COMPLETED|Overall Study||3
8504168|NCT00476151|20958102|P2|COMPLETED|Overall Study||107
8504169|NCT00476151|20958103|P1|COMPLETED|Overall Study||109
8504170|NCT00476151|20958102|P2|STARTED|Overall Study||114
8504171|NCT00476151|20958103|P1|STARTED|Overall Study||112
8504172|NCT00476086|20958109|P1|NOT COMPLETED|Overall Study||5
8504173|NCT00476086|20958109|P1|COMPLETED|Overall Study||15
8504174|NCT00476086|20958109|P1|Received Radiation|Overall Study||15
8504175|NCT00476086|20958109|P1|Received Chemotherapy|Overall Study||19
8504176|NCT00476086|20958109|P1|STARTED|Overall Study||20
8504177|NCT00476047|20958115|P1|NOT COMPLETED|Overall Study||1
8504178|NCT00476047|20958115|P1|COMPLETED|Overall Study||15
8504179|NCT00476047|20958115|P1|Completed Treatment|Overall Study||16
8504180|NCT00476047|20958115|P1|STARTED|Overall Study||16
8504181|NCT00476021|20958124|P2|NOT COMPLETED|Overall Study||0
8504182|NCT00476021|20958125|P1|NOT COMPLETED|Overall Study||0
8504183|NCT00476021|20958124|P2|COMPLETED|Overall Study||51
8504184|NCT00476021|20958125|P1|COMPLETED|Overall Study||51
8504185|NCT00476021|20958124|P2|STARTED|Overall Study||51
8504186|NCT00476021|20958125|P1|STARTED|Overall Study||51
8504187|NCT00476008|20958141|P2|NOT COMPLETED|Overall Study||8
8504188|NCT00476008|20958142|P1|NOT COMPLETED|Overall Study||9
8504189|NCT00476008|20958141|P2|COMPLETED|Overall Study||13
8504190|NCT00476008|20958142|P1|COMPLETED|Overall Study||13
8504191|NCT00476008|20958141|P2|6 Month Testing|Overall Study||14
8504192|NCT00476008|20958142|P1|6 Month Testing|Overall Study||15
8504193|NCT00476008|20958141|P2|STARTED|Overall Study||21
8504194|NCT00476008|20958142|P1|STARTED|Overall Study||22
8504195|NCT00475982|20958168|P2|NOT COMPLETED|Overall Study||3
8504196|NCT00475982|20958169|P1|NOT COMPLETED|Overall Study||7
8504197|NCT00475982|20958168|P2|COMPLETED|Overall Study||18
8504198|NCT00475982|20958169|P1|COMPLETED|Overall Study||16
8504199|NCT00475982|20958168|P2|STARTED|Overall Study||21
8504200|NCT00475982|20958169|P1|STARTED|Overall Study||23
8504201|NCT00475904|20958190|P3|NOT COMPLETED|Overall Study||4
8504202|NCT00475904|20958191|P2|NOT COMPLETED|Overall Study||13
8504203|NCT00475904|20958192|P1|NOT COMPLETED|Overall Study||15
8504204|NCT00475904|20958190|P3|COMPLETED|Overall Study||72
8504205|NCT00475904|20958191|P2|COMPLETED|Overall Study||131
8504206|NCT00475904|20958192|P1|COMPLETED|Overall Study||125
8504207|NCT00475904|20958190|P3|STARTED|Overall Study||76
8504208|NCT00475904|20958191|P2|STARTED|Overall Study||144
8504209|NCT00475904|20958192|P1|STARTED|Overall Study||140
8504210|NCT00475878|20958205|P2|NOT COMPLETED|Overall Study||0
8504211|NCT00475878|20958206|P1|NOT COMPLETED|Overall Study||0
8504212|NCT00475878|20958205|P2|COMPLETED|Overall Study||72
8504213|NCT00475878|20958206|P1|COMPLETED|Overall Study||75
8504214|NCT00475878|20958205|P2|STARTED|Overall Study||72
8504215|NCT00475878|20958206|P1|STARTED|Overall Study||75
8504216|NCT00475865|20958217|P3|NOT COMPLETED|Overall Study||6
8504217|NCT00475865|20958218|P2|NOT COMPLETED|Overall Study||5
8504218|NCT00475865|20958219|P1|NOT COMPLETED|Overall Study||2
8504219|NCT00475865|20958217|P3|COMPLETED|Overall Study|completed treatment period|34
8504220|NCT00475865|20958218|P2|COMPLETED|Overall Study|completed treatment period|37
8504221|NCT00475865|20958219|P1|COMPLETED|Overall Study||39
8504222|NCT00475865|20958217|P3|Treated|Overall Study||40
8504223|NCT00475865|20958218|P2|Treated|Overall Study||42
8504224|NCT00475865|20958219|P1|Treated|Overall Study|completed treatment period|41
8504225|NCT00475865|20958217|P3|STARTED|Overall Study|randomized|40
8504226|NCT00475865|20958218|P2|STARTED|Overall Study|randomized|42
8504227|NCT00475865|20958219|P1|STARTED|Overall Study|randomized|41
8504228|NCT00475852|20958249|P2|NOT COMPLETED|Overall Study||548
8504229|NCT00475852|20958250|P1|NOT COMPLETED|Overall Study||517
8504230|NCT00475852|20958249|P2|COMPLETED|Overall Study||3029
8504231|NCT00475852|20958250|P1|COMPLETED|Overall Study||3047
8504232|NCT00475852|20958249|P2|STARTED|Overall Study||3577
8504233|NCT00475852|20958250|P1|STARTED|Overall Study||3564
8504234|NCT00475787|20958280|P2|NOT COMPLETED|Overall Study||7
8504235|NCT00475787|20958281|P1|NOT COMPLETED|Overall Study||8
8504236|NCT00475787|20958280|P2|COMPLETED|Overall Study||60
8504237|NCT00475787|20958281|P1|COMPLETED|Overall Study||61
8504238|NCT00475787|20958280|P2|STARTED|Overall Study||67
8504239|NCT00475787|20958281|P1|STARTED|Overall Study||69
8504240|NCT00475735|20958301|P6|NOT COMPLETED|Treatment Period 2||1
8504241|NCT00475735|20958302|P5|NOT COMPLETED|Treatment Period 2||1
8504242|NCT00475735|20958303|P4|NOT COMPLETED|Treatment Period 2||2
8504243|NCT00475735|20958304|P3|NOT COMPLETED|Treatment Period 2||0
8504244|NCT00475735|20958305|P2|NOT COMPLETED|Treatment Period 2||1
8504245|NCT00475735|20958306|P1|NOT COMPLETED|Treatment Period 2||0
8504246|NCT00475735|20958301|P6|COMPLETED|Treatment Period 2||13
8504247|NCT00475735|20958302|P5|COMPLETED|Treatment Period 2||15
8504248|NCT00475735|20958303|P4|COMPLETED|Treatment Period 2||4
8504249|NCT00475735|20958304|P3|COMPLETED|Treatment Period 2||7
8504250|NCT00475735|20958305|P2|COMPLETED|Treatment Period 2||9
8504251|NCT00475735|20958306|P1|COMPLETED|Treatment Period 2||10
8504252|NCT00475735|20958301|P6|STARTED|Treatment Period 2||14
8504253|NCT00475735|20958302|P5|STARTED|Treatment Period 2||16
8504254|NCT00475735|20958303|P4|STARTED|Treatment Period 2||6
8504255|NCT00475735|20958304|P3|STARTED|Treatment Period 2||7
8504256|NCT00475735|20958305|P2|STARTED|Treatment Period 2||10
8504257|NCT00475735|20958306|P1|STARTED|Treatment Period 2||10
8504258|NCT00475735|20958301|P6|NOT COMPLETED|Treatment Washout||0
8504259|NCT00475735|20958302|P5|NOT COMPLETED|Treatment Washout||0
8504260|NCT00475735|20958303|P4|NOT COMPLETED|Treatment Washout||0
8504261|NCT00475735|20958304|P3|NOT COMPLETED|Treatment Washout||0
8504262|NCT00475735|20958305|P2|NOT COMPLETED|Treatment Washout||2
8504263|NCT00475735|20958306|P1|NOT COMPLETED|Treatment Washout||0
8504264|NCT00475735|20958301|P6|COMPLETED|Treatment Washout||14
8504265|NCT00475735|20958302|P5|COMPLETED|Treatment Washout||16
8504266|NCT00475735|20958303|P4|COMPLETED|Treatment Washout||6
8504267|NCT00475735|20958304|P3|COMPLETED|Treatment Washout||7
8504268|NCT00475735|20958305|P2|COMPLETED|Treatment Washout||10
8504269|NCT00475735|20958306|P1|COMPLETED|Treatment Washout||10
8504270|NCT00475735|20958301|P6|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
8504271|NCT00475735|20958302|P5|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
8504272|NCT00475735|20958303|P4|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
8504273|NCT00475735|20958304|P3|STARTED|Treatment Washout||7
8504274|NCT00475735|20958305|P2|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
8504275|NCT00475735|20958306|P1|STARTED|Treatment Washout||10
8504276|NCT00475735|20958301|P6|NOT COMPLETED|Treatment Period 1||3
8504277|NCT00475735|20958302|P5|NOT COMPLETED|Treatment Period 1||2
8504278|NCT00475735|20958303|P4|NOT COMPLETED|Treatment Period 1||2
8504279|NCT00475735|20958304|P3|NOT COMPLETED|Treatment Period 1||0
8504280|NCT00475735|20958305|P2|NOT COMPLETED|Treatment Period 1||2
8504281|NCT00475735|20958306|P1|NOT COMPLETED|Treatment Period 1||4
8504282|NCT00475735|20958301|P6|COMPLETED|Treatment Period 1||12
8504283|NCT00475735|20958302|P5|COMPLETED|Treatment Period 1||14
8504284|NCT00475735|20958303|P4|COMPLETED|Treatment Period 1||5
8504285|NCT00475735|20958304|P3|COMPLETED|Treatment Period 1||7
8504286|NCT00475735|20958305|P2|COMPLETED|Treatment Period 1||11
8504287|NCT00475735|20958306|P1|COMPLETED|Treatment Period 1||10
8504288|NCT00475735|20958301|P6|STARTED|Treatment Period 1||15
8504289|NCT00475735|20958302|P5|STARTED|Treatment Period 1||16
8504290|NCT00475735|20958303|P4|STARTED|Treatment Period 1||7
8504291|NCT00475735|20958304|P3|STARTED|Treatment Period 1||7
8504292|NCT00475735|20958305|P2|STARTED|Treatment Period 1||13
8504293|NCT00475735|20958306|P1|STARTED|Treatment Period 1||14
8504294|NCT00475722|20958319|P2|NOT COMPLETED|Overall Study||12
8504295|NCT00475722|20958320|P1|NOT COMPLETED|Overall Study||15
8504296|NCT00475722|20958319|P2|COMPLETED|Overall Study||47
8504297|NCT00475722|20958320|P1|COMPLETED|Overall Study||46
8504298|NCT00475722|20958319|P2|STARTED|Overall Study||59
8504299|NCT00475722|20958320|P1|STARTED|Overall Study||61
8504300|NCT00475709|20958326|P1|NOT COMPLETED|Overall Study||76
8504301|NCT00475709|20958326|P1|COMPLETED|Overall Study||946
8504302|NCT00475709|20958326|P1|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
8504303|NCT00475709|20958326|P1|STARTED|Overall Study||1022
8504304|NCT00475670|20958334|P2|NOT COMPLETED|Overall Study||41
8504305|NCT00475670|20958335|P1|NOT COMPLETED|Overall Study||3
8504306|NCT00475670|20958334|P2|COMPLETED|Overall Study||0
8504307|NCT00475670|20958335|P1|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
8504308|NCT00475670|20958334|P2|STARTED|Overall Study||41
8504309|NCT00475670|20958335|P1|STARTED|Overall Study||3
8504310|NCT00475657|20958359|P1|NOT COMPLETED|Overall Study||4
8504311|NCT00475657|20958359|P1|COMPLETED|Overall Study||1
8504312|NCT00475657|20958359|P1|STARTED|Overall Study||5
8504313|NCT00475644|20958367|P1|NOT COMPLETED|Overall Study||13
8504314|NCT00475644|20958367|P1|COMPLETED|Overall Study||53
8504315|NCT00475644|20958367|P1|Received at Least One Dose of Study Drug|Overall Study||66
8504316|NCT00475644|20958367|P1|STARTED|Overall Study||66
8504317|NCT00475501|20958379|P4|NOT COMPLETED|Overall Study||4
8504318|NCT00475501|20958380|P3|NOT COMPLETED|Overall Study||4
8504319|NCT00475501|20958381|P2|NOT COMPLETED|Overall Study||5
8504320|NCT00475501|20958382|P1|NOT COMPLETED|Overall Study||7
8504321|NCT00475501|20958379|P4|COMPLETED|Overall Study||12
8504322|NCT00475501|20958380|P3|COMPLETED|Overall Study||13
8504323|NCT00475501|20958381|P2|COMPLETED|Overall Study||8
8504324|NCT00475501|20958382|P1|COMPLETED|Overall Study||7
8504325|NCT00475501|20958379|P4|STARTED|Overall Study||16
8504326|NCT00475501|20958380|P3|STARTED|Overall Study||17
8504327|NCT00475501|20958381|P2|STARTED|Overall Study||13
8504328|NCT00475501|20958382|P1|STARTED|Overall Study||14
8504329|NCT00475423|20958432|P1|NOT COMPLETED|Overall Study||32
8504330|NCT00475423|20958432|P1|COMPLETED|Overall Study||90
8504331|NCT00475423|20958432|P1|STARTED|Overall Study||122
8504332|NCT00475332|20958453|P1|NOT COMPLETED|Overall Study||0
8504333|NCT00475332|20958453|P1|COMPLETED|Overall Study||2
8504334|NCT00475332|20958453|P1|STARTED|Overall Study||2
8504335|NCT00475319|20958461|P3|NOT COMPLETED|Overall Study||4
8504336|NCT00475319|20958462|P2|NOT COMPLETED|Overall Study||1
8504337|NCT00475319|20958463|P1|NOT COMPLETED|Overall Study||2
8504338|NCT00475319|20958461|P3|COMPLETED|Overall Study||99
8504339|NCT00475319|20958462|P2|COMPLETED|Overall Study||101
8504340|NCT00475319|20958463|P1|COMPLETED|Overall Study||101
8504341|NCT00475319|20958461|P3|STARTED|Overall Study||103
8504342|NCT00475319|20958462|P2|STARTED|Overall Study||102
8504343|NCT00475319|20958463|P1|STARTED|Overall Study||103
8504344|NCT00475306|20958478|P4|NOT COMPLETED|Overall Study||1
8504345|NCT00475306|20958479|P3|NOT COMPLETED|Overall Study||0
8504346|NCT00475306|20958480|P2|NOT COMPLETED|Overall Study||1
8504347|NCT00475306|20958481|P1|NOT COMPLETED|Overall Study||1
8504348|NCT00475306|20958478|P4|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
8504349|NCT00475306|20958479|P3|COMPLETED|Overall Study||72
8504350|NCT00475306|20958480|P2|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
8504351|NCT00475306|20958481|P1|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
8504352|NCT00475306|20958478|P4|STARTED|Overall Study||72
8504353|NCT00475306|20958479|P3|STARTED|Overall Study||72
8504354|NCT00475306|20958480|P2|STARTED|Overall Study||72
8504355|NCT00475306|20958481|P1|STARTED|Overall Study||73
8504356|NCT00475241|20958497|P2|NOT COMPLETED|Overall Study||3
8504357|NCT00475241|20958498|P1|NOT COMPLETED|Overall Study||7
8504358|NCT00475241|20958497|P2|COMPLETED|Overall Study||15
8504359|NCT00475241|20958498|P1|COMPLETED|Overall Study||11
8504360|NCT00475241|20958497|P2|STARTED|Overall Study||18
8504361|NCT00475241|20958498|P1|STARTED|Overall Study||18
8504362|NCT00475228|20958512|P2|NOT COMPLETED|Overall Study||17
8504363|NCT00475228|20958513|P1|NOT COMPLETED|Overall Study||17
8504364|NCT00475228|20958512|P2|COMPLETED|Overall Study||27
8504365|NCT00475228|20958513|P1|COMPLETED|Overall Study||27
8504366|NCT00475228|20958512|P2|STARTED|Overall Study||44
8504367|NCT00475228|20958513|P1|STARTED|Overall Study||44
8504368|NCT00475215|20958525|P2|NOT COMPLETED|Overall Study||4
8504369|NCT00475215|20958526|P1|NOT COMPLETED|Overall Study||5
8504370|NCT00475215|20958525|P2|COMPLETED|Overall Study||38
8504371|NCT00475215|20958526|P1|COMPLETED|Overall Study||39
8504372|NCT00475215|20958525|P2|Treated|Overall Study||38
8504373|NCT00475215|20958526|P1|Treated|Overall Study||39
8504374|NCT00475215|20958525|P2|STARTED|Overall Study||42
8504375|NCT00475215|20958526|P1|STARTED|Overall Study||44
8504376|NCT00475176|20958552|P1|NOT COMPLETED|Overall Study||4
8504377|NCT00475176|20958552|P1|COMPLETED|Overall Study||20
8504378|NCT00475176|20958552|P1|STARTED|Overall Study||24
8504379|NCT00475150|20958559|P2|NOT COMPLETED|Overall Study||0
8504380|NCT00475150|20958560|P1|NOT COMPLETED|Overall Study||0
8504381|NCT00475150|20958559|P2|COMPLETED|Overall Study||16
8504382|NCT00475150|20958560|P1|COMPLETED|Overall Study||23
8504383|NCT00475150|20958559|P2|STARTED|Overall Study||16
8504384|NCT00475150|20958560|P1|STARTED|Overall Study||23
8504385|NCT00475085|20958577|P4|NOT COMPLETED|Overall Study||20
8504386|NCT00475085|20958578|P3|NOT COMPLETED|Overall Study||19
8504387|NCT00475085|20958579|P2|NOT COMPLETED|Overall Study||20
8504388|NCT00475085|20958580|P1|NOT COMPLETED|Overall Study||18
8504389|NCT00475085|20958577|P4|COMPLETED|Overall Study||234
8504390|NCT00475085|20958578|P3|COMPLETED|Overall Study||241
8504391|NCT00475085|20958579|P2|COMPLETED|Overall Study||234
8504392|NCT00475085|20958580|P1|COMPLETED|Overall Study||235
8504393|NCT00475085|20958577|P4|STARTED|Overall Study||254
8504394|NCT00475085|20958578|P3|STARTED|Overall Study||260
8504395|NCT00475085|20958579|P2|STARTED|Overall Study||254
8504396|NCT00475085|20958580|P1|STARTED|Overall Study||253
8504397|NCT00475033|20958592|P2|NOT COMPLETED|Toddler Dose||0
8504398|NCT00475033|20958593|P1|NOT COMPLETED|Toddler Dose||4
8504399|NCT00475033|20958592|P2|COMPLETED|Toddler Dose||282
8504400|NCT00475033|20958593|P1|COMPLETED|Toddler Dose||283
8504401|NCT00475033|20958592|P2|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
8504402|NCT00475033|20958593|P1|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
8504403|NCT00475033|20958592|P2|NOT COMPLETED|After the Infant Series||8
8504404|NCT00475033|20958593|P1|NOT COMPLETED|After the Infant Series||6
8504405|NCT00475033|20958592|P2|COMPLETED|After the Infant Series||282
8504406|NCT00475033|20958593|P1|COMPLETED|After the Infant Series||287
8504407|NCT00475033|20958592|P2|Withdrawn After Infant Series|After the Infant Series||8
8504408|NCT00475033|20958593|P1|Withdrawn After Infant Series|After the Infant Series||6
8504409|NCT00475033|20958592|P2|STARTED|After the Infant Series||290
8504410|NCT00475033|20958593|P1|STARTED|After the Infant Series||293
8504411|NCT00475033|20958592|P2|NOT COMPLETED|Infant Series||13
8504412|NCT00475033|20958593|P1|NOT COMPLETED|Infant Series||7
8504413|NCT00475033|20958592|P2|COMPLETED|Infant Series||290
8504414|NCT00475033|20958593|P1|COMPLETED|Infant Series||293
8504415|NCT00475033|20958592|P2|Vaccinated Dose 3|Infant Series||294
8504416|NCT00475033|20958593|P1|Vaccinated Dose 3|Infant Series||293
8504417|NCT00475033|20958592|P2|Vaccinated Dose 2|Infant Series||296
8504418|NCT00475033|20958593|P1|Vaccinated Dose 2|Infant Series||297
8504419|NCT00475033|20958592|P2|Vaccinated Dose 1|Infant Series||303
8504420|NCT00475033|20958593|P1|Vaccinated Dose 1|Infant Series||300
8504421|NCT00475033|20958592|P2|STARTED|Infant Series||303
8504422|NCT00475033|20958593|P1|STARTED|Infant Series||300
8504423|NCT00475020|20958641|P1|NOT COMPLETED|Overall Study||5
8504424|NCT00475020|20958641|P1|COMPLETED|Overall Study||58
8504425|NCT00475020|20958641|P1|STARTED|Overall Study||63
8504426|NCT00474994|20958646|P1|NOT COMPLETED|Overall Study||5
8504427|NCT00474994|20958646|P1|COMPLETED|Overall Study||48
8504428|NCT00474994|20958646|P1|STARTED|Overall Study||53
8504429|NCT00474968|20958652|P2|NOT COMPLETED|Overall Study||16
8504430|NCT00474968|20958653|P1|NOT COMPLETED|Overall Study||18
8504431|NCT00474968|20958652|P2|COMPLETED|Overall Study||355
8504432|NCT00474968|20958653|P1|COMPLETED|Overall Study||348
8504433|NCT00474968|20958652|P2|STARTED|Overall Study||371
8504434|NCT00474968|20958653|P1|STARTED|Overall Study||366
8504435|NCT00474955|20958663|P1|NOT COMPLETED|Overall Study||8
8504436|NCT00474955|20958663|P1|COMPLETED|Overall Study||19
8504437|NCT00474955|20958663|P1|STARTED|Overall Study||27
8504438|NCT00474929|20958679|P5|NOT COMPLETED|Overall Study||0
8504439|NCT00474929|20958680|P4|NOT COMPLETED|Overall Study||2
8504440|NCT00474929|20958681|P3|NOT COMPLETED|Overall Study||2
8504441|NCT00474929|20958682|P2|NOT COMPLETED|Overall Study||1
8504442|NCT00474929|20958683|P1|NOT COMPLETED|Overall Study||0
8504443|NCT00474929|20958679|P5|COMPLETED|Overall Study||77
8504444|NCT00474929|20958680|P4|COMPLETED|Overall Study||5
8504445|NCT00474929|20958681|P3|COMPLETED|Overall Study||5
8504446|NCT00474929|20958682|P2|COMPLETED|Overall Study||5
8504447|NCT00474929|20958683|P1|COMPLETED|Overall Study||6
8504448|NCT00474929|20958679|P5|STARTED|Overall Study||77
8504449|NCT00474929|20958680|P4|STARTED|Overall Study||7
8504450|NCT00474929|20958681|P3|STARTED|Overall Study||7
8504451|NCT00474929|20958682|P2|STARTED|Overall Study||6
8504452|NCT00474929|20958683|P1|STARTED|Overall Study||6
8504453|NCT00474903|20958700|P3|NOT COMPLETED|Overall Study||2
8504454|NCT00474903|20958701|P2|NOT COMPLETED|Overall Study||5
8504455|NCT00474903|20958702|P1|NOT COMPLETED|Overall Study||1
8504456|NCT00474903|20958700|P3|COMPLETED|Overall Study||43
8504457|NCT00474903|20958701|P2|COMPLETED|Overall Study||42
8504458|NCT00474903|20958702|P1|COMPLETED|Overall Study||29
8504459|NCT00474903|20958700|P3|STARTED|Overall Study||45
8504460|NCT00474903|20958701|P2|STARTED|Overall Study||47
8504461|NCT00474903|20958702|P1|STARTED|Overall Study||30
8504462|NCT00474851|20958715|P2|NOT COMPLETED|Overall Study||11
8504463|NCT00474851|20958716|P1|NOT COMPLETED|Overall Study||8
8504464|NCT00474851|20958715|P2|COMPLETED|Overall Study||16
8504465|NCT00474851|20958716|P1|COMPLETED|Overall Study||18
8504466|NCT00474851|20958715|P2|Completed Baseline|Overall Study||26
8504467|NCT00474851|20958716|P1|Completed Baseline|Overall Study||25
8504468|NCT00474851|20958715|P2|STARTED|Overall Study||27
8504469|NCT00474851|20958716|P1|STARTED|Overall Study||26
8504470|NCT00474812|20958724|P1|NOT COMPLETED|Overall Study||7
8504471|NCT00474812|20958724|P1|COMPLETED|Overall Study||44
8504472|NCT00474812|20958724|P1|STARTED|Overall Study||51
8504473|NCT00474786|20958734|P2|NOT COMPLETED|Overall Study||253
8504474|NCT00474786|20958735|P1|NOT COMPLETED|Overall Study||259
8504475|NCT00474786|20958734|P2|COMPLETED|Overall Study||0
8504476|NCT00474786|20958735|P1|COMPLETED|Overall Study||0
8504477|NCT00474786|20958734|P2|STARTED|Overall Study||253
8504478|NCT00474786|20958735|P1|STARTED|Overall Study||259
8504479|NCT00474760|20958760|P7|NOT COMPLETED|Overall Study||10
8504480|NCT00474760|20958761|P6|NOT COMPLETED|Overall Study||29
8504481|NCT00474760|20958762|P5|NOT COMPLETED|Overall Study||12
8504482|NCT00474760|20958763|P4|NOT COMPLETED|Overall Study||3
8504483|NCT00474760|20958764|P3|NOT COMPLETED|Overall Study||3
8504484|NCT00474760|20958765|P2|NOT COMPLETED|Overall Study||3
8504485|NCT00474760|20958766|P1|NOT COMPLETED|Overall Study||3
8504486|NCT00474760|20958760|P7|COMPLETED|Overall Study||1
8504487|NCT00474760|20958761|P6|COMPLETED|Overall Study||0
8504488|NCT00474760|20958762|P5|COMPLETED|Overall Study||1
8504489|NCT00474760|20958763|P4|COMPLETED|Overall Study||0
8504490|NCT00474760|20958764|P3|COMPLETED|Overall Study||0
8504491|NCT00474760|20958765|P2|COMPLETED|Overall Study||0
8504492|NCT00474760|20958766|P1|COMPLETED|Overall Study||0
8504493|NCT00474760|20958760|P7|STARTED|Overall Study||11
8504494|NCT00474760|20958761|P6|STARTED|Overall Study||29
8504495|NCT00474760|20958762|P5|STARTED|Overall Study||13
8504496|NCT00474760|20958763|P4|STARTED|Overall Study||3
8504497|NCT00474760|20958764|P3|STARTED|Overall Study||3
8504498|NCT00474760|20958765|P2|STARTED|Overall Study||3
8504499|NCT00474760|20958766|P1|STARTED|Overall Study||3
8504500|NCT00474708|20958873|P2|NOT COMPLETED|Overall Study||25
8504501|NCT00474708|20958874|P1|NOT COMPLETED|Overall Study||57
8504502|NCT00474708|20958873|P2|COMPLETED|Overall Study||342
8504503|NCT00474708|20958874|P1|COMPLETED|Overall Study||734
8504504|NCT00474708|20958873|P2|STARTED|Overall Study||367
8504505|NCT00474708|20958874|P1|STARTED|Overall Study||791
8504506|NCT00474630|20958884|P2|NOT COMPLETED|Overall Study||70
8504507|NCT00474630|20958885|P1|NOT COMPLETED|Overall Study||160
8504508|NCT00474630|20958884|P2|COMPLETED|Overall Study||100
8504509|NCT00474630|20958885|P1|COMPLETED|Overall Study||175
8504510|NCT00474630|20958884|P2|STARTED|Overall Study||170
8504511|NCT00474630|20958885|P1|STARTED|Overall Study||335
8504512|NCT00474617|20958942|P3|NOT COMPLETED|Overall Study||2
8504513|NCT00474617|20958943|P2|NOT COMPLETED|Overall Study||3
8504514|NCT00474617|20958944|P1|NOT COMPLETED|Overall Study||8
8504515|NCT00474617|20958942|P3|COMPLETED|Overall Study||40
8504516|NCT00474617|20958943|P2|COMPLETED|Overall Study||61
8504517|NCT00474617|20958944|P1|COMPLETED|Overall Study||48
8504518|NCT00474617|20958942|P3|Treated|Overall Study||40
8504519|NCT00474617|20958943|P2|Treated|Overall Study||62
8504520|NCT00474617|20958944|P1|Treated|Overall Study||48
8504521|NCT00474617|20958942|P3|STARTED|Overall Study||42
8504522|NCT00474617|20958943|P2|STARTED|Overall Study||64
8504523|NCT00474617|20958944|P1|STARTED|Overall Study||56
8504524|NCT00474539|20958978|P2|NOT COMPLETED|Toddler Dose||0
8504525|NCT00474539|20958979|P1|NOT COMPLETED|Toddler Dose||1
8504526|NCT00474539|20958978|P2|COMPLETED|Toddler Dose||220
8504527|NCT00474539|20958979|P1|COMPLETED|Toddler Dose||208
8504528|NCT00474539|20958978|P2|STARTED|Toddler Dose||220
8504529|NCT00474539|20958979|P1|STARTED|Toddler Dose||209
8504530|NCT00474539|20958978|P2|NOT COMPLETED|After Infant Series||0
8504531|NCT00474539|20958979|P1|NOT COMPLETED|After Infant Series||4
8504532|NCT00474539|20958978|P2|COMPLETED|After Infant Series||220
8504533|NCT00474539|20958979|P1|COMPLETED|After Infant Series||209
8504534|NCT00474539|20958978|P2|STARTED|After Infant Series||220
8504535|NCT00474539|20958979|P1|STARTED|After Infant Series||213
8504536|NCT00474539|20958978|P2|NOT COMPLETED|Infant Series||6
8504537|NCT00474539|20958979|P1|NOT COMPLETED|Infant Series||10
8504538|NCT00474539|20958978|P2|COMPLETED|Infant Series||220
8504539|NCT00474539|20958979|P1|COMPLETED|Infant Series||213
8504540|NCT00474539|20958978|P2|Vaccinated Dose 3|Infant Series||221
8504541|NCT00474539|20958979|P1|Vaccinated Dose 3|Infant Series||214
8504542|NCT00474539|20958978|P2|Vaccinated Dose 2|Infant Series||222
8504543|NCT00474539|20958979|P1|Vaccinated Dose 2|Infant Series||217
8504544|NCT00474539|20958978|P2|Vaccinated Dose 1|Infant Series||226
8504545|NCT00474539|20958979|P1|Vaccinated Dose 1|Infant Series||218
8504546|NCT00474539|20958978|P2|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
8504547|NCT00474539|20958979|P1|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
8504548|NCT00474526|20959044|P17|NOT COMPLETED|Overall Study||9
8504549|NCT00474526|20959045|P16|NOT COMPLETED|Overall Study||18
8504550|NCT00474526|20959046|P15|NOT COMPLETED|Overall Study||77
8504551|NCT00474526|20959047|P14|NOT COMPLETED|Overall Study||156
8504552|NCT00474526|20959048|P13|NOT COMPLETED|Overall Study||15
8504553|NCT00474526|20959049|P12|NOT COMPLETED|Overall Study||11
8504554|NCT00474526|20959050|P11|NOT COMPLETED|Overall Study||10
8504555|NCT00474526|20959051|P10|NOT COMPLETED|Overall Study||27
8504556|NCT00474526|20959052|P9|NOT COMPLETED|Overall Study||6
8504557|NCT00474526|20959053|P8|NOT COMPLETED|Overall Study||6
8504558|NCT00474526|20959054|P7|NOT COMPLETED|Overall Study||25
8504559|NCT00474526|20959055|P6|NOT COMPLETED|Overall Study||16
8504560|NCT00474526|20959056|P5|NOT COMPLETED|Overall Study||68
8504561|NCT00474526|20959057|P4|NOT COMPLETED|Overall Study||119
8504562|NCT00474526|20959058|P3|NOT COMPLETED|Overall Study||49
8504563|NCT00474526|20959059|P2|NOT COMPLETED|Overall Study||46
8504564|NCT00474526|20959060|P1|NOT COMPLETED|Overall Study||33
8504565|NCT00474526|20959044|P17|COMPLETED|Overall Study||174
8504566|NCT00474526|20959045|P16|COMPLETED|Overall Study||152
8504567|NCT00474526|20959046|P15|COMPLETED|Overall Study||281
8504568|NCT00474526|20959047|P14|COMPLETED|Overall Study||1270
8504569|NCT00474526|20959048|P13|COMPLETED|Overall Study||135
8504570|NCT00474526|20959049|P12|COMPLETED|Overall Study||139
8504571|NCT00474526|20959050|P11|COMPLETED|Overall Study||141
8504572|NCT00474526|20959051|P10|COMPLETED|Overall Study||121
8504573|NCT00474526|20959052|P9|COMPLETED|Overall Study||144
8504574|NCT00474526|20959053|P8|COMPLETED|Overall Study||145
8504575|NCT00474526|20959054|P7|COMPLETED|Overall Study||178
8504576|NCT00474526|20959055|P6|COMPLETED|Overall Study||54
8504577|NCT00474526|20959056|P5|COMPLETED|Overall Study||8
8504578|NCT00474526|20959057|P4|COMPLETED|Overall Study||561
8504579|NCT00474526|20959058|P3|COMPLETED|Overall Study||110
8504580|NCT00474526|20959059|P2|COMPLETED|Overall Study||120
8504581|NCT00474526|20959060|P1|COMPLETED|Overall Study||121
8504582|NCT00474526|20959044|P17|STARTED|Overall Study||183
8504583|NCT00474526|20959045|P16|STARTED|Overall Study||170
8504584|NCT00474526|20959046|P15|STARTED|Overall Study||358
8504585|NCT00474526|20959047|P14|STARTED|Overall Study||1426
8504586|NCT00474526|20959048|P13|STARTED|Overall Study||150
8504587|NCT00474526|20959049|P12|STARTED|Overall Study||150
8504588|NCT00474526|20959050|P11|STARTED|Overall Study||151
8504589|NCT00474526|20959051|P10|STARTED|Overall Study||148
8504590|NCT00474526|20959052|P9|STARTED|Overall Study||150
8504591|NCT00474526|20959053|P8|STARTED|Overall Study||151
8504592|NCT00474526|20959054|P7|STARTED|Overall Study||203
8504593|NCT00474526|20959055|P6|STARTED|Overall Study||70
8504594|NCT00474526|20959056|P5|STARTED|Overall Study||76
8504595|NCT00474526|20959057|P4|STARTED|Overall Study||680
8504596|NCT00474526|20959058|P3|STARTED|Overall Study||159
8504597|NCT00474526|20959059|P2|STARTED|Overall Study||166
8504598|NCT00474526|20959060|P1|STARTED|Overall Study||154
8504599|NCT00474487|20959225|P4|NOT COMPLETED|Overall Study||0
8504600|NCT00474487|20959226|P3|NOT COMPLETED|Overall Study||14
8504601|NCT00474487|20959227|P2|NOT COMPLETED|Overall Study||2
8504602|NCT00474487|20959228|P1|NOT COMPLETED|Overall Study||30
8504603|NCT00474487|20959225|P4|COMPLETED|Overall Study||109
8504604|NCT00474487|20959226|P3|COMPLETED|Overall Study||885
8504605|NCT00474487|20959227|P2|COMPLETED|Overall Study||215
8504606|NCT00474487|20959228|P1|COMPLETED|Overall Study||1576
8504607|NCT00474487|20959225|P4|STARTED|Overall Study||109
8504608|NCT00474487|20959226|P3|STARTED|Overall Study||899
8504609|NCT00474487|20959227|P2|STARTED|Overall Study||217
8504610|NCT00474487|20959228|P1|STARTED|Overall Study||1606
8504611|NCT00474383|20959248|P2|NOT COMPLETED|Extension||5
8504612|NCT00474383|20959249|P1|NOT COMPLETED|Extension||0
8504613|NCT00474383|20959248|P2|COMPLETED|Extension||0
8504614|NCT00474383|20959249|P1|COMPLETED|Extension||0
8504615|NCT00474383|20959248|P2|STARTED|Extension||5
8504616|NCT00474383|20959249|P1|STARTED|Extension||0
8504617|NCT00474383|20959248|P2|NOT COMPLETED|Between Main Study and Extension||0
8504618|NCT00474383|20959249|P1|NOT COMPLETED|Between Main Study and Extension||6
8504619|NCT00474383|20959248|P2|COMPLETED|Between Main Study and Extension||0
8504620|NCT00474383|20959249|P1|COMPLETED|Between Main Study and Extension||5
8504621|NCT00474383|20959248|P2|STARTED|Between Main Study and Extension||0
8504622|NCT00474383|20959249|P1|STARTED|Between Main Study and Extension||11
8504623|NCT00474383|20959248|P2|NOT COMPLETED|Main Study||0
8504624|NCT00474383|20959249|P1|NOT COMPLETED|Main Study||36
8504625|NCT00474383|20959248|P2|COMPLETED|Main Study||0
8504626|NCT00474383|20959249|P1|COMPLETED|Main Study||11
8504627|NCT00474383|20959248|P2|STARTED|Main Study||0
8504628|NCT00474383|20959249|P1|STARTED|Main Study||47
8504629|NCT00474266|20959264|P4|NOT COMPLETED|Overall Study||7
8504630|NCT00474266|20959265|P3|NOT COMPLETED|Overall Study||4
8504631|NCT00474266|20959266|P2|NOT COMPLETED|Overall Study||20
8504632|NCT00474266|20959267|P1|NOT COMPLETED|Overall Study||7
8504633|NCT00474266|20959264|P4|COMPLETED|Overall Study||118
8504634|NCT00474266|20959265|P3|COMPLETED|Overall Study||122
8504635|NCT00474266|20959266|P2|COMPLETED|Overall Study||354
8504636|NCT00474266|20959267|P1|COMPLETED|Overall Study||368
8504637|NCT00474266|20959264|P4|STARTED|Overall Study||125
8504638|NCT00474266|20959265|P3|STARTED|Overall Study||126
8504639|NCT00474266|20959266|P2|STARTED|Overall Study||374
8504640|NCT00474266|20959267|P1|STARTED|Overall Study||375
8504641|NCT00474253|20959371|P2|NOT COMPLETED|Overall Study||4
8504642|NCT00474253|20959372|P1|NOT COMPLETED|Overall Study||3
8504643|NCT00474253|20959371|P2|COMPLETED|Overall Study|Based on actual treatment received.|53
8504644|NCT00474253|20959372|P1|COMPLETED|Overall Study|Based on actual treatment received.|55
8504645|NCT00474253|20959371|P2|Treated|Overall Study|Based on actual treatment received.|54
8504646|NCT00474253|20959372|P1|Treated|Overall Study|Based on actual treatment received.|56
8504647|NCT00474253|20959371|P2|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57
8504648|NCT00474253|20959372|P1|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58
8504649|NCT00474240|20959396|P6|NOT COMPLETED|Overall Study||18
8504650|NCT00474240|20959397|P5|NOT COMPLETED|Overall Study||8
8504651|NCT00474240|20959398|P4|NOT COMPLETED|Overall Study||16
8504652|NCT00474240|20959399|P3|NOT COMPLETED|Overall Study||9
8504653|NCT00474240|20959400|P2|NOT COMPLETED|Overall Study||1
8504654|NCT00474240|20959401|P1|NOT COMPLETED|Overall Study||1
8504655|NCT00474240|20959396|P6|COMPLETED|Overall Study||8
8504656|NCT00474240|20959397|P5|COMPLETED|Overall Study||18
8504657|NCT00474240|20959398|P4|COMPLETED|Overall Study||10
8504658|NCT00474240|20959399|P3|COMPLETED|Overall Study||17
8504659|NCT00474240|20959400|P2|COMPLETED|Overall Study||25
8504660|NCT00474240|20959401|P1|COMPLETED|Overall Study||26
8504661|NCT00474240|20959396|P6|STARTED|Overall Study||26
8504662|NCT00474240|20959397|P5|STARTED|Overall Study||26
8504663|NCT00474240|20959398|P4|STARTED|Overall Study||26
8504664|NCT00474240|20959399|P3|STARTED|Overall Study||26
8504665|NCT00474240|20959400|P2|STARTED|Overall Study||26
8504666|NCT00474240|20959401|P1|STARTED|Overall Study||27
8504667|NCT00474201|20959421|P1|NOT COMPLETED|Overall Study||0
8504668|NCT00474201|20959421|P1|COMPLETED|Overall Study||15
8504669|NCT00474201|20959421|P1|STARTED|Overall Study||15
8504670|NCT00474188|20959426|P1|NOT COMPLETED|Overall Study||6
8504671|NCT00474188|20959426|P1|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
8504672|NCT00474188|20959426|P1|STARTED|Overall Study||26
8504673|NCT00474175|20959436|P3|NOT COMPLETED|Overall Study||4
8504674|NCT00474175|20959437|P2|NOT COMPLETED|Overall Study||7
8504675|NCT00474175|20959438|P1|NOT COMPLETED|Overall Study||1
8504676|NCT00474175|20959436|P3|COMPLETED|Overall Study||225
8504677|NCT00474175|20959437|P2|COMPLETED|Overall Study||226
8504678|NCT00474175|20959438|P1|COMPLETED|Overall Study||114
8504679|NCT00474175|20959436|P3|Treated|Overall Study||228
8504680|NCT00474175|20959437|P2|Treated|Overall Study||233
8504681|NCT00474175|20959438|P1|Treated|Overall Study||115
8504682|NCT00474175|20959436|P3|STARTED|Overall Study||229
8504683|NCT00474175|20959437|P2|STARTED|Overall Study||233
8504684|NCT00474175|20959438|P1|STARTED|Overall Study||115
8504685|NCT00474123|20959475|P2|NOT COMPLETED|Overall Study||0
8504686|NCT00474123|20959476|P1|NOT COMPLETED|Overall Study||0
8504687|NCT00474123|20959475|P2|COMPLETED|Overall Study||40
8504688|NCT00474123|20959476|P1|COMPLETED|Overall Study||38
8504689|NCT00474123|20959475|P2|STARTED|Overall Study||40
8504690|NCT00474123|20959476|P1|STARTED|Overall Study||38
8504691|NCT00474058|20959502|P2|NOT COMPLETED|Overall Study||17
8504692|NCT00474058|20959503|P1|NOT COMPLETED|Overall Study||24
8504693|NCT00474058|20959502|P2|COMPLETED|Overall Study||80
8504694|NCT00474058|20959503|P1|COMPLETED|Overall Study||166
8504695|NCT00474058|20959502|P2|STARTED|Overall Study||97
8504696|NCT00474058|20959503|P1|STARTED|Overall Study||190
8504697|NCT00474045|20959517|P2|NOT COMPLETED|Overall Study||101
8504698|NCT00474045|20959518|P1|NOT COMPLETED|Overall Study||106
8504699|NCT00474045|20959517|P2|COMPLETED|Overall Study||136
8504700|NCT00474045|20959518|P1|COMPLETED|Overall Study||127
8504701|NCT00474045|20959517|P2|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
8504702|NCT00474045|20959518|P1|Pregnancies (for Exposed-pregnant)|Overall Study||152
8504703|NCT00474045|20959517|P2|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
8504704|NCT00474045|20959518|P1|Exposed-Pregnant Subjects|Overall Study||152
8504705|NCT00474045|20959517|P2|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
8504706|NCT00474045|20959518|P1|Exposed-All Subjects|Overall Study||233
8504707|NCT00474045|20959517|P2|STARTED|Overall Study||237
8504708|NCT00474045|20959518|P1|STARTED|Overall Study||233
8504709|NCT00473889|20959618|P2|NOT COMPLETED|Overall Study||64
8504710|NCT00473889|20959619|P1|NOT COMPLETED|Overall Study||83
8504711|NCT00473889|20959618|P2|COMPLETED|Overall Study||63
8504712|NCT00473889|20959619|P1|COMPLETED|Overall Study||43
8504713|NCT00473889|20959618|P2|STARTED|Overall Study||127
8504714|NCT00473889|20959619|P1|STARTED|Overall Study||126
8504715|NCT00473876|20959631|P2|NOT COMPLETED|Overall Study||1
8504716|NCT00473876|20959632|P1|NOT COMPLETED|Overall Study||3
8504717|NCT00473876|20959631|P2|COMPLETED|Overall Study||22
8504718|NCT00473876|20959632|P1|COMPLETED|Overall Study||36
8504719|NCT00473876|20959631|P2|STARTED|Overall Study||23
8504720|NCT00473876|20959632|P1|STARTED|Overall Study||39
8504721|NCT00473837|20959642|P2|NOT COMPLETED|Overall Study||3
8504722|NCT00473837|20959643|P1|NOT COMPLETED|Overall Study||1
8504723|NCT00473837|20959642|P2|COMPLETED|Overall Study||43
8504724|NCT00473837|20959643|P1|COMPLETED|Overall Study||49
8504725|NCT00473837|20959642|P2|STARTED|Overall Study||46
8504726|NCT00473837|20959643|P1|STARTED|Overall Study||50
8504733|NCT00473746|20959663|P5|NOT COMPLETED|Period 2 (Phase 2)||27
8504734|NCT00473746|20959664|P4|NOT COMPLETED|Period 2 (Phase 2)||0
8504735|NCT00473746|20959665|P3|NOT COMPLETED|Period 2 (Phase 2)||0
8504736|NCT00473746|20959666|P2|NOT COMPLETED|Period 2 (Phase 2)||0
8504737|NCT00473746|20959667|P1|NOT COMPLETED|Period 2 (Phase 2)||0
8504738|NCT00473746|20959663|P5|COMPLETED|Period 2 (Phase 2)||6
8504739|NCT00473746|20959664|P4|COMPLETED|Period 2 (Phase 2)||0
8504740|NCT00473746|20959665|P3|COMPLETED|Period 2 (Phase 2)||0
8504741|NCT00473746|20959666|P2|COMPLETED|Period 2 (Phase 2)||0
8504742|NCT00473746|20959667|P1|COMPLETED|Period 2 (Phase 2)||0
8504743|NCT00473746|20959663|P5|STARTED|Period 2 (Phase 2)||33
8504744|NCT00473746|20959664|P4|STARTED|Period 2 (Phase 2)||0
8504745|NCT00473746|20959665|P3|STARTED|Period 2 (Phase 2)||0
8504746|NCT00473746|20959666|P2|STARTED|Period 2 (Phase 2)||0
8504747|NCT00473746|20959667|P1|STARTED|Period 2 (Phase 2)||0
8504748|NCT00473746|20959663|P5|NOT COMPLETED|Period 1 (Phase 1)||0
8504749|NCT00473746|20959664|P4|NOT COMPLETED|Period 1 (Phase 1)||10
8504750|NCT00473746|20959665|P3|NOT COMPLETED|Period 1 (Phase 1)||6
8504751|NCT00473746|20959666|P2|NOT COMPLETED|Period 1 (Phase 1)||9
8504752|NCT00473746|20959667|P1|NOT COMPLETED|Period 1 (Phase 1)||6
8504753|NCT00473746|20959663|P5|COMPLETED|Period 1 (Phase 1)||0
8504754|NCT00473746|20959664|P4|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
8504755|NCT00473746|20959665|P3|COMPLETED|Period 1 (Phase 1)||0
8504756|NCT00473746|20959666|P2|COMPLETED|Period 1 (Phase 1)||0
8504757|NCT00473746|20959667|P1|COMPLETED|Period 1 (Phase 1)||0
8504758|NCT00473746|20959663|P5|STARTED|Period 1 (Phase 1)||0
8504759|NCT00473746|20959664|P4|STARTED|Period 1 (Phase 1)||12
8504760|NCT00473746|20959665|P3|STARTED|Period 1 (Phase 1)||6
8504761|NCT00473746|20959666|P2|STARTED|Period 1 (Phase 1)||9
8504762|NCT00473746|20959667|P1|STARTED|Period 1 (Phase 1)||6
8504763|NCT00473694|20959716|P4|NOT COMPLETED|Overall Study||7
8504764|NCT00473694|20959717|P3|NOT COMPLETED|Overall Study||5
8504765|NCT00473694|20959718|P2|NOT COMPLETED|Overall Study||4
8504766|NCT00473694|20959719|P1|NOT COMPLETED|Overall Study||11
8504767|NCT00473694|20959716|P4|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35
8504768|NCT00473694|20959717|P3|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46
8504769|NCT00473694|20959718|P2|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
8504770|NCT00473694|20959719|P1|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
8504771|NCT00473694|20959716|P4|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36
8504772|NCT00473694|20959717|P3|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46
8504773|NCT00473694|20959718|P2|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38
8504774|NCT00473694|20959719|P1|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37
8504775|NCT00473694|20959716|P4|STARTED|Overall Study||42
8504776|NCT00473694|20959717|P3|STARTED|Overall Study||51
8504777|NCT00473694|20959718|P2|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41
8504778|NCT00473694|20959719|P1|STARTED|Overall Study||48
8504779|NCT00473668|20959760|P3|NOT COMPLETED|Overall Study||10
8504780|NCT00473668|20959761|P2|NOT COMPLETED|Overall Study||11
8504781|NCT00473668|20959762|P1|NOT COMPLETED|Overall Study||5
8504782|NCT00473668|20959760|P3|COMPLETED|Overall Study||89
8504783|NCT00473668|20959761|P2|COMPLETED|Overall Study||89
8504784|NCT00473668|20959762|P1|COMPLETED|Overall Study||95
8504785|NCT00473668|20959760|P3|STARTED|Overall Study||99
8504786|NCT00473668|20959761|P2|STARTED|Overall Study||100
8504787|NCT00473668|20959762|P1|STARTED|Overall Study||100
8504788|NCT00473655|20959815|P3|NOT COMPLETED|Overall Study||8
8504789|NCT00473655|20959816|P2|NOT COMPLETED|Overall Study||5
8504790|NCT00473655|20959817|P1|NOT COMPLETED|Overall Study||9
8504791|NCT00473655|20959815|P3|COMPLETED|Overall Study|8 participants were lost of follow up|103
8504792|NCT00473655|20959816|P2|COMPLETED|Overall Study|5 participants were lost of follow up|107
8504793|NCT00473655|20959817|P1|COMPLETED|Overall Study|9 participants were lost of follow up|102
8504794|NCT00473655|20959815|P3|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
8504795|NCT00473655|20959816|P2|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
8504796|NCT00473655|20959817|P1|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
8504797|NCT00473642|20959852|P3|NOT COMPLETED|Overall Study||2
8504798|NCT00473642|20959853|P2|NOT COMPLETED|Overall Study||1
8504799|NCT00473642|20959854|P1|NOT COMPLETED|Overall Study||2
8504800|NCT00473642|20959852|P3|COMPLETED|Overall Study||8
8504801|NCT00473642|20959853|P2|COMPLETED|Overall Study||10
8504802|NCT00473642|20959854|P1|COMPLETED|Overall Study||8
8504803|NCT00473642|20959852|P3|STARTED|Overall Study||10
8504804|NCT00473642|20959853|P2|STARTED|Overall Study||11
8504805|NCT00473642|20959854|P1|STARTED|Overall Study||10
8504806|NCT00473590|20959878|P2|NOT COMPLETED|Overall Study||38
8504807|NCT00473590|20959879|P1|NOT COMPLETED|Overall Study||45
8504808|NCT00473590|20959878|P2|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
8504809|NCT00473590|20959879|P1|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
8504810|NCT00473590|20959878|P2|Safety Population|Overall Study||50
8504811|NCT00473590|20959879|P1|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
8504812|NCT00473590|20959878|P2|Treated|Overall Study||48
8504813|NCT00473590|20959879|P1|Treated|Overall Study||52
8504814|NCT00473590|20959878|P2|STARTED|Overall Study||49
8504815|NCT00473590|20959879|P1|STARTED|Overall Study||53
8504816|NCT00473564|20959895|P1|NOT COMPLETED|Overall Study||23
8504817|NCT00473564|20959895|P1|COMPLETED|Overall Study||147
8504818|NCT00473564|20959895|P1|STARTED|Overall Study||170
8504819|NCT00473512|20959905|P5|NOT COMPLETED|Period 2 (Phase 2)||2
8504820|NCT00473512|20959906|P4|NOT COMPLETED|Period 2 (Phase 2)||23
8504821|NCT00473512|20959907|P3|NOT COMPLETED|Period 2 (Phase 2)||2
8504822|NCT00473512|20959908|P2|NOT COMPLETED|Period 2 (Phase 2)||2
8504823|NCT00473512|20959909|P1|NOT COMPLETED|Period 2 (Phase 2)||1
8504824|NCT00473512|20959905|P5|COMPLETED|Period 2 (Phase 2)||0
8504825|NCT00473512|20959906|P4|COMPLETED|Period 2 (Phase 2)||0
8504826|NCT00473512|20959907|P3|COMPLETED|Period 2 (Phase 2)||0
8504827|NCT00473512|20959908|P2|COMPLETED|Period 2 (Phase 2)||0
8504828|NCT00473512|20959909|P1|COMPLETED|Period 2 (Phase 2)||0
8504829|NCT00473512|20959905|P5|STARTED|Period 2 (Phase 2)||2
8504830|NCT00473512|20959906|P4|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
8504831|NCT00473512|20959907|P3|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
8504832|NCT00473512|20959908|P2|STARTED|Period 2 (Phase 2)||2
8504833|NCT00473512|20959909|P1|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
8504834|NCT00473512|20959905|P5|NOT COMPLETED|Period 1 (Phase 1)||1
8504835|NCT00473512|20959906|P4|NOT COMPLETED|Period 1 (Phase 1)||17
8504836|NCT00473512|20959907|P3|NOT COMPLETED|Period 1 (Phase 1)||0
8504837|NCT00473512|20959908|P2|NOT COMPLETED|Period 1 (Phase 1)||1
8504838|NCT00473512|20959909|P1|NOT COMPLETED|Period 1 (Phase 1)||1
8504839|NCT00473512|20959905|P5|COMPLETED|Period 1 (Phase 1)||2
8504840|NCT00473512|20959906|P4|COMPLETED|Period 1 (Phase 1)||25
8504841|NCT00473512|20959907|P3|COMPLETED|Period 1 (Phase 1)||3
8504842|NCT00473512|20959908|P2|COMPLETED|Period 1 (Phase 1)||2
8504843|NCT00473512|20959909|P1|COMPLETED|Period 1 (Phase 1)||2
8504844|NCT00473512|20959905|P5|STARTED|Period 1 (Phase 1)||3
8504845|NCT00473512|20959906|P4|STARTED|Period 1 (Phase 1)||42
8504846|NCT00473512|20959907|P3|STARTED|Period 1 (Phase 1)||3
8504847|NCT00473512|20959908|P2|STARTED|Period 1 (Phase 1)||3
8504848|NCT00473512|20959909|P1|STARTED|Period 1 (Phase 1)||3
8504849|NCT00473434|20959967|P1|NOT COMPLETED|Overall Study||32
8504850|NCT00473434|20959967|P1|COMPLETED|Overall Study||32
8504851|NCT00473434|20959967|P1|STARTED|Overall Study||64
8504852|NCT00473382|20960032|P3|NOT COMPLETED|Open-label Extension Through Month 60||82
8504853|NCT00473382|20960033|P2|NOT COMPLETED|Open-label Extension Through Month 60||82
8504854|NCT00473382|20960034|P1|NOT COMPLETED|Open-label Extension Through Month 60||86
8504855|NCT00473382|20960032|P3|COMPLETED|Open-label Extension Through Month 60||2
8504856|NCT00473382|20960033|P2|COMPLETED|Open-label Extension Through Month 60||1
8504857|NCT00473382|20960034|P1|COMPLETED|Open-label Extension Through Month 60||2
8504858|NCT00473382|20960032|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
8504859|NCT00473382|20960033|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
8504860|NCT00473382|20960034|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
8504861|NCT00473382|20960032|P3|NOT COMPLETED|Open-label Extension Through Month 48||47
8504862|NCT00473382|20960033|P2|NOT COMPLETED|Open-label Extension Through Month 48||41
8504863|NCT00473382|20960034|P1|NOT COMPLETED|Open-label Extension Through Month 48||50
8504864|NCT00473382|20960032|P3|COMPLETED|Open-label Extension Through Month 48||37
8504865|NCT00473382|20960033|P2|COMPLETED|Open-label Extension Through Month 48||42
8504866|NCT00473382|20960034|P1|COMPLETED|Open-label Extension Through Month 48||38
8504867|NCT00473382|20960032|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
8504868|NCT00473382|20960033|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
8504869|NCT00473382|20960034|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
8504870|NCT00473382|20960032|P3|NOT COMPLETED|Core Study||29
8504871|NCT00473382|20960033|P2|NOT COMPLETED|Core Study||27
8504872|NCT00473382|20960034|P1|NOT COMPLETED|Core Study||28
8504873|NCT00473382|20960032|P3|COMPLETED|Core Study||98
8504874|NCT00473382|20960033|P2|COMPLETED|Core Study||98
8504875|NCT00473382|20960034|P1|COMPLETED|Core Study||102
8504876|NCT00473382|20960032|P3|STARTED|Core Study||127
8504877|NCT00473382|20960033|P2|STARTED|Core Study||125
8504878|NCT00473382|20960034|P1|STARTED|Core Study||130
8504879|NCT00473330|20960092|P3|NOT COMPLETED|Open-label Extension Through Month 60||77
8504880|NCT00473330|20960093|P2|NOT COMPLETED|Open-label Extension Through Month 60||78
8504881|NCT00473330|20960094|P1|NOT COMPLETED|Open-label Extension Through Month 60||88
8504882|NCT00473330|20960092|P3|COMPLETED|Open-label Extension Through Month 60||0
8504967|NCT00472420|20960291|P1|COMPLETED|Induction Treatment Period||32
8504883|NCT00473330|20960093|P2|COMPLETED|Open-label Extension Through Month 60||1
8504884|NCT00473330|20960094|P1|COMPLETED|Open-label Extension Through Month 60||1
8504885|NCT00473330|20960092|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
8504886|NCT00473330|20960093|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
8504887|NCT00473330|20960094|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
8504888|NCT00473330|20960092|P3|NOT COMPLETED|Open-label Extension Through Month 48||27
8504889|NCT00473330|20960093|P2|NOT COMPLETED|Open-label Extension Through Month 48||20
8504890|NCT00473330|20960094|P1|NOT COMPLETED|Open-label Extension Through Month 48||26
8504891|NCT00473330|20960092|P3|COMPLETED|Open-label Extension Through Month 48||50
8504892|NCT00473330|20960093|P2|COMPLETED|Open-label Extension Through Month 48||59
8504893|NCT00473330|20960094|P1|COMPLETED|Open-label Extension Through Month 48||63
8504894|NCT00473330|20960092|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
8504895|NCT00473330|20960093|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
8504896|NCT00473330|20960094|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
8504897|NCT00473330|20960092|P3|NOT COMPLETED|Core Study||41
8504898|NCT00473330|20960093|P2|NOT COMPLETED|Core Study||25
8504899|NCT00473330|20960094|P1|NOT COMPLETED|Core Study||27
8504900|NCT00473330|20960092|P3|COMPLETED|Core Study||86
8504901|NCT00473330|20960093|P2|COMPLETED|Core Study||100
8504902|NCT00473330|20960094|P1|COMPLETED|Core Study||98
8504903|NCT00473330|20960092|P3|STARTED|Core Study||127
8504904|NCT00473330|20960093|P2|STARTED|Core Study||125
8504905|NCT00473330|20960094|P1|STARTED|Core Study||125
8504906|NCT00473265|20960149|P1|NOT COMPLETED|Overall Study||20
8504907|NCT00473265|20960149|P1|COMPLETED|Overall Study||48
8504908|NCT00473265|20960149|P1|STARTED|Overall Study||68
8504909|NCT00473083|20960161|P3|NOT COMPLETED|Overall Study||0
8504910|NCT00473083|20960162|P2|NOT COMPLETED|Overall Study||0
8504911|NCT00473083|20960163|P1|NOT COMPLETED|Overall Study||1
8504912|NCT00473083|20960161|P3|COMPLETED|Overall Study||50
8504913|NCT00473083|20960162|P2|COMPLETED|Overall Study||50
8504914|NCT00473083|20960163|P1|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
8504915|NCT00473083|20960161|P3|STARTED|Overall Study||50
8504916|NCT00473083|20960162|P2|STARTED|Overall Study||50
8504917|NCT00473083|20960163|P1|STARTED|Overall Study||50
8504918|NCT00472849|20960191|P2|NOT COMPLETED|Overall Study||0
8504919|NCT00472849|20960192|P1|NOT COMPLETED|Overall Study||0
8504920|NCT00472849|20960191|P2|COMPLETED|Overall Study||78
8504921|NCT00472849|20960192|P1|COMPLETED|Overall Study||12
8504922|NCT00472849|20960191|P2|STARTED|Overall Study||78
8504923|NCT00472849|20960192|P1|STARTED|Overall Study||12
8504924|NCT00472797|20960200|P2|NOT COMPLETED|Overall Study||1
8504925|NCT00472797|20960201|P1|NOT COMPLETED|Overall Study||4
8504926|NCT00472797|20960200|P2|COMPLETED|Overall Study||112
8504927|NCT00472797|20960201|P1|COMPLETED|Overall Study||115
8504928|NCT00472797|20960200|P2|STARTED|Overall Study||113
8504929|NCT00472797|20960201|P1|STARTED|Overall Study||119
8504930|NCT00472732|20960227|P2|NOT COMPLETED|Overall Study||0
8504931|NCT00472732|20960228|P1|NOT COMPLETED|Overall Study||0
8504932|NCT00472732|20960227|P2|COMPLETED|Overall Study||22
8504933|NCT00472732|20960228|P1|COMPLETED|Overall Study||24
8504934|NCT00472732|20960227|P2|STARTED|Overall Study||22
8504935|NCT00472732|20960228|P1|STARTED|Overall Study||24
8504936|NCT00472641|20960238|P1|NOT COMPLETED|Overall Study||7
8504937|NCT00472641|20960238|P1|COMPLETED|Overall Study||18
8504938|NCT00472641|20960238|P1|STARTED|Overall Study||25
8504939|NCT00472576|20960245|P2|NOT COMPLETED|Second Intervention||0
8504940|NCT00472576|20960246|P1|NOT COMPLETED|Second Intervention||0
8504941|NCT00472576|20960245|P2|COMPLETED|Second Intervention||3
8504942|NCT00472576|20960246|P1|COMPLETED|Second Intervention||2
8504943|NCT00472576|20960245|P2|STARTED|Second Intervention||3
8504944|NCT00472576|20960246|P1|STARTED|Second Intervention||2
8504945|NCT00472576|20960245|P2|NOT COMPLETED|First Intervention||0
8504946|NCT00472576|20960246|P1|NOT COMPLETED|First Intervention||0
8504947|NCT00472576|20960245|P2|COMPLETED|First Intervention||3
8504948|NCT00472576|20960246|P1|COMPLETED|First Intervention||2
8504949|NCT00472576|20960245|P2|STARTED|First Intervention||3
8504950|NCT00472576|20960246|P1|STARTED|First Intervention||2
8504951|NCT00472446|20960258|P4|NOT COMPLETED|Overall Study||6
8504952|NCT00472446|20960259|P3|NOT COMPLETED|Overall Study||7
8504953|NCT00472446|20960260|P2|NOT COMPLETED|Overall Study||6
8504954|NCT00472446|20960261|P1|NOT COMPLETED|Overall Study||5
8504955|NCT00472446|20960258|P4|COMPLETED|Overall Study||39
8504956|NCT00472446|20960259|P3|COMPLETED|Overall Study||38
8504957|NCT00472446|20960260|P2|COMPLETED|Overall Study||41
8504958|NCT00472446|20960261|P1|COMPLETED|Overall Study||41
8504959|NCT00472446|20960258|P4|STARTED|Overall Study||45
8504960|NCT00472446|20960259|P3|STARTED|Overall Study||45
8504961|NCT00472446|20960260|P2|STARTED|Overall Study||47
8504962|NCT00472446|20960261|P1|STARTED|Overall Study||46
8504963|NCT00472420|20960291|P1|NOT COMPLETED|Follow-up Period||17
8504964|NCT00472420|20960291|P1|COMPLETED|Follow-up Period||15
8504965|NCT00472420|20960291|P1|STARTED|Follow-up Period||32
8504966|NCT00472420|20960291|P1|NOT COMPLETED|Induction Treatment Period||16
8504968|NCT00472420|20960291|P1|STARTED|Induction Treatment Period||48
8504969|NCT00472303|20960299|P3|NOT COMPLETED|Maintenance Phase||17
8504970|NCT00472303|20960300|P2|NOT COMPLETED|Maintenance Phase||16
8504971|NCT00472303|20960301|P1|NOT COMPLETED|Maintenance Phase||17
8504972|NCT00472303|20960299|P3|COMPLETED|Maintenance Phase||95
8504973|NCT00472303|20960300|P2|COMPLETED|Maintenance Phase||93
8504974|NCT00472303|20960301|P1|COMPLETED|Maintenance Phase||89
8504975|NCT00472303|20960299|P3|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
8504976|NCT00472303|20960300|P2|STARTED|Maintenance Phase||109
8504977|NCT00472303|20960301|P1|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
8504978|NCT00472303|20960299|P3|NOT COMPLETED|Discontinuations After Titration Phase||0
8504979|NCT00472303|20960300|P2|NOT COMPLETED|Discontinuations After Titration Phase||20
8504980|NCT00472303|20960301|P1|NOT COMPLETED|Discontinuations After Titration Phase||61
8504981|NCT00472303|20960299|P3|COMPLETED|Discontinuations After Titration Phase||0
8504982|NCT00472303|20960300|P2|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
8504983|NCT00472303|20960301|P1|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
8504984|NCT00472303|20960299|P3|STARTED|Discontinuations After Titration Phase||0
8504985|NCT00472303|20960300|P2|STARTED|Discontinuations After Titration Phase||129
8504986|NCT00472303|20960301|P1|STARTED|Discontinuations After Titration Phase||279
8504987|NCT00472303|20960299|P3|NOT COMPLETED|Titration Phase||0
8504988|NCT00472303|20960300|P2|NOT COMPLETED|Titration Phase||29
8504989|NCT00472303|20960301|P1|NOT COMPLETED|Titration Phase||59
8504990|NCT00472303|20960299|P3|COMPLETED|Titration Phase||0
8504991|NCT00472303|20960300|P2|COMPLETED|Titration Phase||129
8504992|NCT00472303|20960301|P1|COMPLETED|Titration Phase||279
8504993|NCT00472303|20960299|P3|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
8504994|NCT00472303|20960300|P2|STARTED|Titration Phase||158
8504995|NCT00472303|20960301|P1|STARTED|Titration Phase||338
8504996|NCT00472290|20960364|P1|NOT COMPLETED|Overall Study||72
8504997|NCT00472290|20960364|P1|COMPLETED|Overall Study||0
8504998|NCT00472290|20960364|P1|STARTED|Overall Study||72
8504999|NCT00472199|20960376|P2|NOT COMPLETED|Overall Study||60
8505000|NCT00472199|20960377|P1|NOT COMPLETED|Overall Study||35
8505001|NCT00472199|20960376|P2|COMPLETED|Overall Study||103
8505002|NCT00472199|20960377|P1|COMPLETED|Overall Study||131
8505003|NCT00472199|20960376|P2|STARTED|Overall Study||163
8505004|NCT00472199|20960377|P1|STARTED|Overall Study||166
8505005|NCT00472082|20960443|P1|NOT COMPLETED|Overall Study||5
8505006|NCT00472082|20960443|P1|COMPLETED|Overall Study||0
8505007|NCT00472082|20960443|P1|STARTED|Overall Study||5
8505008|NCT00472056|20960452|P4|NOT COMPLETED|Overall Study||0
8505009|NCT00472056|20960453|P3|NOT COMPLETED|Overall Study||0
8505010|NCT00472056|20960454|P2|NOT COMPLETED|Overall Study||0
8505011|NCT00472056|20960455|P1|NOT COMPLETED|Overall Study||0
8505012|NCT00472056|20960452|P4|COMPLETED|Overall Study||17
8505013|NCT00472056|20960453|P3|COMPLETED|Overall Study||32
8505014|NCT00472056|20960454|P2|COMPLETED|Overall Study||19
8505015|NCT00472056|20960455|P1|COMPLETED|Overall Study||25
8505016|NCT00472056|20960452|P4|STARTED|Overall Study||17
8505017|NCT00472056|20960453|P3|STARTED|Overall Study||32
8505018|NCT00472056|20960454|P2|STARTED|Overall Study||19
8505019|NCT00472056|20960455|P1|STARTED|Overall Study||25
8505020|NCT00472030|20960465|P2|NOT COMPLETED|Overall Study||0
8505021|NCT00472030|20960466|P1|NOT COMPLETED|Overall Study||1
8505022|NCT00472030|20960465|P2|COMPLETED|Overall Study||0
8505023|NCT00472030|20960466|P1|COMPLETED|Overall Study||1
8505024|NCT00472030|20960465|P2|STARTED|Overall Study||0
8505025|NCT00472030|20960466|P1|STARTED|Overall Study||2
8505026|NCT00471887|20960482|P1|NOT COMPLETED|Overall Study||9
8505027|NCT00471887|20960482|P1|COMPLETED|Overall Study||23
8505028|NCT00471887|20960482|P1|STARTED|Overall Study||32
8505029|NCT00471822|20960491|P1|NOT COMPLETED|Overall Study||2
8505030|NCT00471822|20960491|P1|COMPLETED|Overall Study||9705
8505031|NCT00471822|20960491|P1|Treated|Overall Study||9705
8505032|NCT00471822|20960491|P1|STARTED|Overall Study||9707
8505033|NCT00471718|20960499|P1|NOT COMPLETED|Overall Study||27
8505034|NCT00471718|20960499|P1|COMPLETED|Overall Study||0
8505035|NCT00471718|20960499|P1|STARTED|Overall Study||27
8505036|NCT00471705|20960511|P3|NOT COMPLETED|Overall Study||15
8505037|NCT00471705|20960512|P2|NOT COMPLETED|Overall Study||22
8505038|NCT00471705|20960513|P1|NOT COMPLETED|Overall Study||24
8505039|NCT00471705|20960511|P3|COMPLETED|Overall Study||134
8505040|NCT00471705|20960512|P2|COMPLETED|Overall Study||121
8505041|NCT00471705|20960513|P1|COMPLETED|Overall Study||121
8505042|NCT00471705|20960511|P3|STARTED|Overall Study||149
8505043|NCT00471705|20960512|P2|STARTED|Overall Study||143
8505044|NCT00471705|20960513|P1|STARTED|Overall Study||145
8505045|NCT00471536|20960527|P1|NOT COMPLETED|Overall Study||1
8505046|NCT00471536|20960527|P1|COMPLETED|Overall Study||18
8505047|NCT00471536|20960527|P1|STARTED|Overall Study||19
8505048|NCT00471497|20960539|P3|NOT COMPLETED|Extension Phase||1
8505049|NCT00471497|20960540|P2|NOT COMPLETED|Extension Phase||14
8505050|NCT00471497|20960541|P1|NOT COMPLETED|Extension Phase||27
8505051|NCT00471497|20960539|P3|COMPLETED|Extension Phase||2
8505052|NCT00471497|20960540|P2|COMPLETED|Extension Phase||12
8505053|NCT00471497|20960541|P1|COMPLETED|Extension Phase||21
8505054|NCT00471497|20960539|P3|STARTED|Extension Phase||3
8505055|NCT00471497|20960540|P2|STARTED|Extension Phase||26
8505056|NCT00471497|20960541|P1|STARTED|Extension Phase||48
8505057|NCT00471497|20960539|P3|NOT COMPLETED|Core Treatment Phase||182
8505058|NCT00471497|20960540|P2|NOT COMPLETED|Core Treatment Phase||175
8505059|NCT00471497|20960541|P1|NOT COMPLETED|Core Treatment Phase||184
8505060|NCT00471497|20960539|P3|COMPLETED|Core Treatment Phase||99
8505061|NCT00471497|20960540|P2|COMPLETED|Core Treatment Phase||107
8505062|NCT00471497|20960541|P1|COMPLETED|Core Treatment Phase||99
8505063|NCT00471497|20960539|P3|Discontinued Core/Entered Ext.|Core Treatment Phase||3
8505064|NCT00471497|20960540|P2|Discontinued Core/Entered Ext.|Core Treatment Phase||26
8505065|NCT00471497|20960541|P1|Discontinued Core/Entered Ext.|Core Treatment Phase||48
8505066|NCT00471497|20960539|P3|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||278
8505067|NCT00471497|20960540|P2|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||256
8505068|NCT00471497|20960541|P1|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||235
8505069|NCT00471497|20960539|P3|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|277
8505070|NCT00471497|20960540|P2|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|279
8505071|NCT00471497|20960541|P1|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|280
8505072|NCT00471497|20960539|P3|STARTED|Core Treatment Phase||281
8505073|NCT00471497|20960540|P2|STARTED|Core Treatment Phase||282
8505074|NCT00471497|20960541|P1|STARTED|Core Treatment Phase||283
8505075|NCT00471445|20960637|P2|NOT COMPLETED|Overall Study||2
8505076|NCT00471445|20960638|P1|NOT COMPLETED|Overall Study||2
8505077|NCT00471445|20960637|P2|COMPLETED|Overall Study||231
8505078|NCT00471445|20960638|P1|COMPLETED|Overall Study||227
8505079|NCT00471445|20960637|P2|STARTED|Overall Study||233
8505080|NCT00471445|20960638|P1|STARTED|Overall Study||229
8505081|NCT00471380|20960644|P2|NOT COMPLETED|Third Intervention||2
8505082|NCT00471380|20960645|P1|NOT COMPLETED|Third Intervention||1
8505083|NCT00471380|20960644|P2|COMPLETED|Third Intervention||14
8505084|NCT00471380|20960645|P1|COMPLETED|Third Intervention||17
8505085|NCT00471380|20960644|P2|STARTED|Third Intervention||16
8505086|NCT00471380|20960645|P1|STARTED|Third Intervention||18
8505087|NCT00471380|20960644|P2|NOT COMPLETED|Second Intervention||4
8505088|NCT00471380|20960645|P1|NOT COMPLETED|Second Intervention||0
8505089|NCT00471380|20960644|P2|COMPLETED|Second Intervention||16
8505090|NCT00471380|20960645|P1|COMPLETED|Second Intervention||18
8505091|NCT00471380|20960644|P2|STARTED|Second Intervention||20
8505092|NCT00471380|20960645|P1|STARTED|Second Intervention||18
8505093|NCT00471380|20960644|P2|NOT COMPLETED|First Intervention||4
8505094|NCT00471380|20960645|P1|NOT COMPLETED|First Intervention||4
8505095|NCT00471380|20960644|P2|COMPLETED|First Intervention||20
8505096|NCT00471380|20960645|P1|COMPLETED|First Intervention||18
8505097|NCT00471380|20960644|P2|STARTED|First Intervention||24
8505098|NCT00471380|20960645|P1|STARTED|First Intervention||22
8505099|NCT00471354|20960651|P1|NOT COMPLETED|Overall Study||52
8505100|NCT00471354|20960651|P1|COMPLETED|Overall Study||176
8505101|NCT00471354|20960651|P1|STARTED|Overall Study||228
8505102|NCT00471328|20960663|P2|NOT COMPLETED|Extension Phase||67
8505103|NCT00471328|20960664|P1|NOT COMPLETED|Extension Phase||41
8505104|NCT00471328|20960663|P2|COMPLETED|Extension Phase||0
8505105|NCT00471328|20960664|P1|COMPLETED|Extension Phase||0
8505106|NCT00471328|20960663|P2|Started:CrossOver During Extension|Extension Phase||10
8505107|NCT00471328|20960664|P1|Started:CrossOver During Extension|Extension Phase||0
8505108|NCT00471328|20960663|P2|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
8505109|NCT00471328|20960664|P1|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
8505110|NCT00471328|20960663|P2|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
8505111|NCT00471328|20960664|P1|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
8505112|NCT00471328|20960663|P2|STARTED|Extension Phase||67
8505113|NCT00471328|20960664|P1|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
8505114|NCT00471328|20960663|P2|NOT COMPLETED|Core Phase||67
8505115|NCT00471328|20960664|P1|NOT COMPLETED|Core Phase||107
8505116|NCT00471328|20960663|P2|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
8505117|NCT00471328|20960664|P1|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
8505118|NCT00471328|20960663|P2|Crossover to Nilotinib:Started Extension|Core Phase||53
8505119|NCT00471328|20960664|P1|Crossover to Nilotinib:Started Extension|Core Phase||0
8505120|NCT00471328|20960663|P2|STARTED|Core Phase||83
8505121|NCT00471328|20960664|P1|STARTED|Core Phase||165
8505122|NCT00471315|20960683|P1|NOT COMPLETED|Overall Study||8
8505123|NCT00471315|20960683|P1|COMPLETED|Overall Study||10
8505124|NCT00471315|20960683|P1|STARTED|Overall Study||18
8505125|NCT00471276|20960688|P1|NOT COMPLETED|Overall Study||83
8505126|NCT00471276|20960688|P1|COMPLETED|Overall Study||0
8505127|NCT00471276|20960688|P1|STARTED|Overall Study||83
8505128|NCT00471237|20960718|P7|NOT COMPLETED|Overall Study||3
8505129|NCT00471237|20960719|P6|NOT COMPLETED|Overall Study||39
8505130|NCT00471237|20960720|P5|NOT COMPLETED|Overall Study||41
8505131|NCT00471237|20960721|P4|NOT COMPLETED|Overall Study||45
8505132|NCT00471237|20960722|P3|NOT COMPLETED|Overall Study||34
8505133|NCT00471237|20960723|P2|NOT COMPLETED|Overall Study||42
8505134|NCT00471237|20960724|P1|NOT COMPLETED|Overall Study||41
8505135|NCT00471237|20960718|P7|COMPLETED|Overall Study||38
8505136|NCT00471237|20960719|P6|COMPLETED|Overall Study||50
8505137|NCT00471237|20960720|P5|COMPLETED|Overall Study||46
8505138|NCT00471237|20960721|P4|COMPLETED|Overall Study||43
8505139|NCT00471237|20960722|P3|COMPLETED|Overall Study||48
8505140|NCT00471237|20960723|P2|COMPLETED|Overall Study||45
8505141|NCT00471237|20960724|P1|COMPLETED|Overall Study||49
8505142|NCT00471237|20960718|P7|STARTED|Overall Study||41
8505143|NCT00471237|20960719|P6|STARTED|Overall Study||89
8505144|NCT00471237|20960720|P5|STARTED|Overall Study||87
8505145|NCT00471237|20960721|P4|STARTED|Overall Study||88
8505146|NCT00471237|20960722|P3|STARTED|Overall Study||82
8505147|NCT00471237|20960723|P2|STARTED|Overall Study||87
8505148|NCT00471237|20960724|P1|STARTED|Overall Study||90
8505149|NCT00471146|20960874|P2|NOT COMPLETED|Overall Study||174
8505150|NCT00471146|20960875|P1|NOT COMPLETED|Overall Study||172
8505151|NCT00471146|20960874|P2|COMPLETED|Overall Study||142
8505152|NCT00471146|20960875|P1|COMPLETED|Overall Study||142
8505153|NCT00471146|20960874|P2|Treated|Overall Study||308
8505154|NCT00471146|20960875|P1|Treated|Overall Study||305
8505155|NCT00471146|20960874|P2|STARTED|Overall Study||316
8505156|NCT00471146|20960875|P1|STARTED|Overall Study||314
8505157|NCT00471107|20960900|P3|NOT COMPLETED|Overall Study||3
8505158|NCT00471107|20960901|P2|NOT COMPLETED|Overall Study||1
8505159|NCT00471107|20960902|P1|NOT COMPLETED|Overall Study||3
8505160|NCT00471107|20960900|P3|COMPLETED|Overall Study||12
8505161|NCT00471107|20960901|P2|COMPLETED|Overall Study||14
8505162|NCT00471107|20960902|P1|COMPLETED|Overall Study||12
8505163|NCT00471107|20960900|P3|STARTED|Overall Study||15
8505164|NCT00471107|20960901|P2|STARTED|Overall Study||15
8505165|NCT00471107|20960902|P1|STARTED|Overall Study||15
8505166|NCT00471081|20960912|P2|NOT COMPLETED|Extended Safety Follow-Up||13
8505167|NCT00471081|20960913|P1|NOT COMPLETED|Extended Safety Follow-Up||2
8505168|NCT00471081|20960912|P2|COMPLETED|Extended Safety Follow-Up||176
8505169|NCT00471081|20960913|P1|COMPLETED|Extended Safety Follow-Up||158
8505170|NCT00471081|20960912|P2|STARTED|Extended Safety Follow-Up||189
8505171|NCT00471081|20960913|P1|STARTED|Extended Safety Follow-Up||160
8505172|NCT00471081|20960912|P2|NOT COMPLETED|Active Phase||13
8505173|NCT00471081|20960913|P1|NOT COMPLETED|Active Phase||2
8505174|NCT00471081|20960912|P2|COMPLETED|Active Phase||176
8505175|NCT00471081|20960913|P1|COMPLETED|Active Phase||158
8505176|NCT00471081|20960912|P2|STARTED|Active Phase||189
8505177|NCT00471081|20960913|P1|STARTED|Active Phase||160
8505178|NCT00471068|20960952|P2|NOT COMPLETED|Overall Study||1
8505179|NCT00471068|20960953|P1|NOT COMPLETED|Overall Study||1
8505180|NCT00471068|20960952|P2|COMPLETED|Overall Study||24
8505181|NCT00471068|20960953|P1|COMPLETED|Overall Study||20
8505182|NCT00471068|20960952|P2|STARTED|Overall Study||25
8505183|NCT00471068|20960953|P1|STARTED|Overall Study||21
8505184|NCT00470847|20960959|P1|NOT COMPLETED|Overall Study||1
8505185|NCT00470847|20960959|P1|COMPLETED|Overall Study||34
8505186|NCT00470847|20960959|P1|STARTED|Overall Study||35
8505187|NCT00470834|20960972|P2|NOT COMPLETED|Extension Period (24 Months)||23
8505188|NCT00470834|20960973|P1|NOT COMPLETED|Extension Period (24 Months)||15
8505189|NCT00470834|20960972|P2|COMPLETED|Extension Period (24 Months)||7
8505190|NCT00470834|20960973|P1|COMPLETED|Extension Period (24 Months)||11
8505191|NCT00470834|20960972|P2|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
8505192|NCT00470834|20960973|P1|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
8505193|NCT00470834|20960972|P2|NOT COMPLETED|Treatment Period (18 Months)||31
8505194|NCT00470834|20960973|P1|NOT COMPLETED|Treatment Period (18 Months)||38
8505195|NCT00470834|20960972|P2|COMPLETED|Treatment Period (18 Months)||31
8505196|NCT00470834|20960973|P1|COMPLETED|Treatment Period (18 Months)||27
8505197|NCT00470834|20960972|P2|STARTED|Treatment Period (18 Months)||62
8505198|NCT00470834|20960973|P1|STARTED|Treatment Period (18 Months)||65
8505199|NCT00470626|20960987|P1|NOT COMPLETED|Overall Study||17
8505200|NCT00470626|20960987|P1|COMPLETED|Overall Study||112
8505201|NCT00470626|20960987|P1|STARTED|Overall Study||129
8505202|NCT00470600|20960995|P2|NOT COMPLETED|Overall Study||0
8505203|NCT00470600|20960996|P1|NOT COMPLETED|Overall Study||0
8505204|NCT00470600|20960995|P2|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
8505205|NCT00470600|20960996|P1|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
8505206|NCT00470600|20960995|P2|STARTED|Overall Study||99
8505207|NCT00470600|20960996|P1|STARTED|Overall Study||86
8505208|NCT00470574|20961006|P1|NOT COMPLETED|Overall Study||0
8505209|NCT00470574|20961006|P1|COMPLETED|Overall Study||7
8505210|NCT00470574|20961006|P1|STARTED|Overall Study||7
8505211|NCT00470548|20961014|P4|NOT COMPLETED|Overall Study||0
8505212|NCT00470548|20961015|P3|NOT COMPLETED|Overall Study||0
8505213|NCT00470548|20961016|P2|NOT COMPLETED|Overall Study||0
8505214|NCT00470548|20961017|P1|NOT COMPLETED|Overall Study||0
8505215|NCT00470548|20961014|P4|COMPLETED|Overall Study||37
8505216|NCT00470548|20961015|P3|COMPLETED|Overall Study||6
8505217|NCT00470548|20961016|P2|COMPLETED|Overall Study||3
8505218|NCT00470548|20961017|P1|COMPLETED|Overall Study||3
8505219|NCT00470548|20961014|P4|STARTED|Overall Study||37
8505220|NCT00470548|20961015|P3|STARTED|Overall Study||6
8505221|NCT00470548|20961016|P2|STARTED|Overall Study||3
8505222|NCT00470548|20961017|P1|STARTED|Overall Study||3
8505223|NCT00470535|20961035|P1|NOT COMPLETED|Overall Study||18
8505224|NCT00470535|20961035|P1|COMPLETED|Overall Study||0
8505225|NCT00470535|20961035|P1|STARTED|Overall Study||18
8505226|NCT00470470|20961044|P1|NOT COMPLETED|Overall Study||5
8505227|NCT00470470|20961044|P1|COMPLETED|Overall Study||25
8505228|NCT00470470|20961044|P1|STARTED|Overall Study||30
8505229|NCT00470418|20961051|P2|NOT COMPLETED|Overall Study||0
8505230|NCT00470418|20961052|P1|NOT COMPLETED|Overall Study||1
8505231|NCT00470418|20961051|P2|COMPLETED|Overall Study||3
8505232|NCT00470418|20961052|P1|COMPLETED|Overall Study||6
8505233|NCT00470418|20961051|P2|STARTED|Overall Study||3
8505234|NCT00470418|20961052|P1|STARTED|Overall Study||7
8505235|NCT00470392|20961062|P2|NOT COMPLETED|Overall Study||0
8505236|NCT00470392|20961063|P1|NOT COMPLETED|Overall Study||0
8505237|NCT00470392|20961062|P2|COMPLETED|Overall Study||2
8505238|NCT00470392|20961063|P1|COMPLETED|Overall Study||7
8505239|NCT00470392|20961062|P2|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
8505240|NCT00470392|20961063|P1|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
8505241|NCT00470366|20961073|P1|NOT COMPLETED|Overall Study||4
8505242|NCT00470366|20961073|P1|COMPLETED|Overall Study||56
8505243|NCT00470366|20961073|P1|STARTED|Overall Study||60
8505247|NCT00470275|20961084|P1|NOT COMPLETED|Overall Study||10
8505248|NCT00470275|20961084|P1|COMPLETED|Overall Study||0
8505249|NCT00470275|20961084|P1|STARTED|Overall Study||10
8505250|NCT00470262|20961090|P2|NOT COMPLETED|Overall Study||0
8505251|NCT00470262|20961091|P1|NOT COMPLETED|Overall Study||2
8505252|NCT00470262|20961090|P2|COMPLETED|Overall Study||12
8505253|NCT00470262|20961091|P1|COMPLETED|Overall Study||13
8505254|NCT00470262|20961090|P2|STARTED|Overall Study||12
8505255|NCT00470262|20961091|P1|STARTED|Overall Study||15
8505256|NCT00470184|20961099|P1|NOT COMPLETED|Overall Study||22
8505257|NCT00470184|20961099|P1|COMPLETED|Overall Study||19
8505258|NCT00470184|20961099|P1|Treated With Study Therapy|Overall Study||36
8505259|NCT00470184|20961099|P1|STARTED|Overall Study||41
8505260|NCT00470158|20961111|P5|NOT COMPLETED|Overall Study||6
8505261|NCT00470158|20961112|P4|NOT COMPLETED|Overall Study||5
8505262|NCT00470158|20961113|P3|NOT COMPLETED|Overall Study||8
8505263|NCT00470158|20961114|P2|NOT COMPLETED|Overall Study||8
8505264|NCT00470158|20961115|P1|NOT COMPLETED|Overall Study||8
8505265|NCT00470158|20961111|P5|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
8505266|NCT00470158|20961112|P4|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
8505267|NCT00470158|20961113|P3|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
8505268|NCT00470158|20961114|P2|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
8505269|NCT00470158|20961115|P1|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
8505270|NCT00470158|20961111|P5|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
8505271|NCT00470158|20961112|P4|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
8505272|NCT00470158|20961113|P3|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
8505273|NCT00470158|20961114|P2|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
8505274|NCT00470158|20961115|P1|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
8505275|NCT00470106|20961131|P4|NOT COMPLETED|Overall Study||2
8505276|NCT00470106|20961132|P3|NOT COMPLETED|Overall Study||7
8505277|NCT00470106|20961133|P2|NOT COMPLETED|Overall Study||5
8505278|NCT00470106|20961134|P1|NOT COMPLETED|Overall Study||3
8505279|NCT00470106|20961131|P4|COMPLETED|Overall Study||19
8505280|NCT00470106|20961132|P3|COMPLETED|Overall Study||14
8505281|NCT00470106|20961133|P2|COMPLETED|Overall Study||19
8505282|NCT00470106|20961134|P1|COMPLETED|Overall Study||16
8505283|NCT00470106|20961131|P4|STARTED|Overall Study||21
8505284|NCT00470106|20961132|P3|STARTED|Overall Study||21
8505285|NCT00470106|20961133|P2|STARTED|Overall Study||24
8505286|NCT00470106|20961134|P1|STARTED|Overall Study||19
8505287|NCT00470093|20961148|P1|NOT COMPLETED|Overall Study||2
8505288|NCT00470093|20961148|P1|COMPLETED|Overall Study||0
8505289|NCT00470093|20961148|P1|STARTED|Overall Study||2
8505290|NCT00470067|20961155|P1|NOT COMPLETED|Overall Study||7
8505291|NCT00470067|20961155|P1|COMPLETED|Overall Study||2
8505292|NCT00470067|20961155|P1|STARTED|Overall Study||9
8505293|NCT00470054|20961159|P1|NOT COMPLETED|Overall Study||1
8505294|NCT00470054|20961159|P1|COMPLETED|Overall Study||43
8505295|NCT00470054|20961159|P1|STARTED|Overall Study||44
8505296|NCT00469911|20961169|P2|NOT COMPLETED|Overall Study||0
8505297|NCT00469911|20961170|P1|NOT COMPLETED|Overall Study||0
8505298|NCT00469911|20961169|P2|COMPLETED|Overall Study||10
8505299|NCT00469911|20961170|P1|COMPLETED|Overall Study||8
8505300|NCT00469911|20961169|P2|STARTED|Overall Study||10
8505301|NCT00469911|20961170|P1|STARTED|Overall Study||8
8505302|NCT00469898|20961175|P1|NOT COMPLETED|Overall Study||25
8505303|NCT00469898|20961175|P1|COMPLETED|Overall Study||25
8505304|NCT00469898|20961175|P1|STARTED|Overall Study||50
8505305|NCT00469859|20961184|P2|NOT COMPLETED|Overall Study||2
8505306|NCT00469859|20961185|P1|NOT COMPLETED|Overall Study||0
8505307|NCT00469859|20961184|P2|COMPLETED|Overall Study||6
8505308|NCT00469859|20961185|P1|COMPLETED|Overall Study||6
8505309|NCT00469859|20961184|P2|STARTED|Overall Study||8
8505310|NCT00469859|20961185|P1|STARTED|Overall Study||6
8505311|NCT00469833|20961193|P1|NOT COMPLETED|Overall Study||2
8505312|NCT00469833|20961193|P1|COMPLETED|Overall Study||15
8505313|NCT00469833|20961193|P1|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
8505314|NCT00469612|20961205|P2|NOT COMPLETED|Overall Study||0
8505315|NCT00469612|20961206|P1|NOT COMPLETED|Overall Study||2
8505316|NCT00469612|20961205|P2|COMPLETED|Overall Study||0
8505317|NCT00469612|20961206|P1|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
8505318|NCT00469612|20961205|P2|STARTED|Overall Study||0
8505319|NCT00469612|20961206|P1|STARTED|Overall Study||2
8505320|NCT00469508|20961218|P2|NOT COMPLETED|Overall Study||24
8505321|NCT00469508|20961219|P1|NOT COMPLETED|Overall Study||20
8505322|NCT00469508|20961218|P2|COMPLETED|Overall Study||13
8505323|NCT00469508|20961219|P1|COMPLETED|Overall Study||14
8505324|NCT00469508|20961218|P2|STARTED|Overall Study||37
8505325|NCT00469508|20961219|P1|STARTED|Overall Study||34
8505326|NCT00469456|20961233|P2|NOT COMPLETED|Overall Study||4
8505327|NCT00469456|20961234|P1|NOT COMPLETED|Overall Study||9
8505328|NCT00469456|20961233|P2|COMPLETED|Overall Study||131
8505329|NCT00469456|20961234|P1|COMPLETED|Overall Study||120
8505330|NCT00469456|20961233|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
8505331|NCT00469456|20961234|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
8505332|NCT00469391|20961244|P2|NOT COMPLETED|Overall Study||5
8505333|NCT00469391|20961245|P1|NOT COMPLETED|Overall Study||14
8505334|NCT00469391|20961244|P2|COMPLETED|Overall Study||24
8505335|NCT00469391|20961245|P1|COMPLETED|Overall Study||13
8505336|NCT00469391|20961244|P2|Patient Preference|Overall Study||1
8505337|NCT00469391|20961245|P1|Patient Preference|Overall Study||0
8505338|NCT00469391|20961244|P2|Lost to Follow up|Overall Study||1
8505339|NCT00469391|20961245|P1|Lost to Follow up|Overall Study||0
8505340|NCT00469391|20961244|P2|Adverse Event|Overall Study||0
8505341|NCT00469391|20961245|P1|Adverse Event|Overall Study||8
8505342|NCT00469391|20961244|P2|Unsuccessful Implant Procedure|Overall Study||0
8505343|NCT00469391|20961245|P1|Unsuccessful Implant Procedure|Overall Study||4
8505344|NCT00469391|20961244|P2|Discontinued Prior to Procedure|Overall Study||3
8505345|NCT00469391|20961245|P1|Discontinued Prior to Procedure|Overall Study||2
8505346|NCT00469391|20961244|P2|STARTED|Overall Study||29
8505347|NCT00469391|20961245|P1|STARTED|Overall Study||27
8505348|NCT00469274|20961253|P2|NOT COMPLETED|Overall Study||0
8505349|NCT00469274|20961254|P1|NOT COMPLETED|Overall Study||0
8505350|NCT00469274|20961253|P2|COMPLETED|Overall Study||42
8505351|NCT00469274|20961254|P1|COMPLETED|Overall Study||44
8505352|NCT00469274|20961253|P2|STARTED|Overall Study||42
8505353|NCT00469274|20961254|P1|STARTED|Overall Study||44
8505354|NCT00469209|20961263|P3|NOT COMPLETED|Overall Study||1
8505355|NCT00469209|20961264|P2|NOT COMPLETED|Overall Study||0
8505356|NCT00469209|20961265|P1|NOT COMPLETED|Overall Study||1
8505357|NCT00469209|20961263|P3|COMPLETED|Overall Study||19
8505358|NCT00469209|20961264|P2|COMPLETED|Overall Study||20
8505359|NCT00469209|20961265|P1|COMPLETED|Overall Study||19
8505360|NCT00469209|20961263|P3|STARTED|Overall Study||20
8505361|NCT00469209|20961264|P2|STARTED|Overall Study||20
8505362|NCT00469209|20961265|P1|STARTED|Overall Study||20
8505363|NCT00469144|20961275|P2|NOT COMPLETED|Overall Study||6
8505364|NCT00469144|20961276|P1|NOT COMPLETED|Overall Study||6
8505365|NCT00469144|20961275|P2|COMPLETED|Overall Study||105
8505366|NCT00469144|20961276|P1|COMPLETED|Overall Study||108
8505367|NCT00469144|20961275|P2|STARTED|Overall Study||111
8505368|NCT00469144|20961276|P1|STARTED|Overall Study|Eight assigned to Fixed Dose without randomization.|114
8505369|NCT00469092|20961288|P2|NOT COMPLETED|Overall Study||21
8505370|NCT00469092|20961289|P1|NOT COMPLETED|Overall Study||26
8505371|NCT00469092|20961288|P2|COMPLETED|Overall Study||220
8505372|NCT00469092|20961289|P1|COMPLETED|Overall Study||213
8505373|NCT00469092|20961288|P2|Exposed to Study Drug|Overall Study||238
8505374|NCT00469092|20961289|P1|Exposed to Study Drug|Overall Study||231
8505375|NCT00469092|20961288|P2|STARTED|Overall Study||241
8505376|NCT00469092|20961289|P1|STARTED|Overall Study||239
8505377|NCT00469079|20961308|P3|NOT COMPLETED|Overall Study||19
8505378|NCT00469079|20961309|P2|NOT COMPLETED|Overall Study||22
8505379|NCT00469079|20961310|P1|NOT COMPLETED|Overall Study||9
8505380|NCT00469079|20961308|P3|COMPLETED|Overall Study||32
8505381|NCT00469079|20961309|P2|COMPLETED|Overall Study||30
8505382|NCT00469079|20961310|P1|COMPLETED|Overall Study||18
8505383|NCT00469079|20961308|P3|STARTED|Overall Study||51
8505384|NCT00469079|20961309|P2|STARTED|Overall Study||52
8505385|NCT00469079|20961310|P1|STARTED|Overall Study||27
8505386|NCT00469014|20961331|P4|NOT COMPLETED|Adaptive Randomization||1
8505387|NCT00469014|20961332|P3|NOT COMPLETED|Adaptive Randomization||1
8505388|NCT00469014|20961333|P2|NOT COMPLETED|Adaptive Randomization||1
8505389|NCT00469014|20961334|P1|NOT COMPLETED|Adaptive Randomization||1
8505390|NCT00469014|20961331|P4|COMPLETED|Adaptive Randomization||10
8505391|NCT00469014|20961332|P3|COMPLETED|Adaptive Randomization||23
8505392|NCT00469014|20961333|P2|COMPLETED|Adaptive Randomization||2
8505393|NCT00469014|20961334|P1|COMPLETED|Adaptive Randomization||12
8505394|NCT00469014|20961331|P4|STARTED|Adaptive Randomization||11
8505395|NCT00469014|20961332|P3|STARTED|Adaptive Randomization||24
8505396|NCT00469014|20961333|P2|STARTED|Adaptive Randomization||3
8505397|NCT00469014|20961334|P1|STARTED|Adaptive Randomization||13
8505398|NCT00469014|20961331|P4|NOT COMPLETED|Initial Phase Randomization||1
8505399|NCT00469014|20961332|P3|NOT COMPLETED|Initial Phase Randomization||1
8505400|NCT00469014|20961333|P2|NOT COMPLETED|Initial Phase Randomization||1
8505401|NCT00469014|20961334|P1|NOT COMPLETED|Initial Phase Randomization||1
8505402|NCT00469014|20961331|P4|COMPLETED|Initial Phase Randomization||5
8505403|NCT00469014|20961332|P3|COMPLETED|Initial Phase Randomization||4
8505404|NCT00469014|20961333|P2|COMPLETED|Initial Phase Randomization||3
8505405|NCT00469014|20961334|P1|COMPLETED|Initial Phase Randomization||4
8505406|NCT00469014|20961331|P4|STARTED|Initial Phase Randomization||6
8505407|NCT00469014|20961332|P3|STARTED|Initial Phase Randomization||5
8505408|NCT00469014|20961333|P2|STARTED|Initial Phase Randomization||4
8505409|NCT00469014|20961334|P1|STARTED|Initial Phase Randomization||5
8505410|NCT00468910|20961346|P2|NOT COMPLETED|Overall Study||3
8505411|NCT00468910|20961347|P1|NOT COMPLETED|Overall Study||4
8505412|NCT00468910|20961346|P2|COMPLETED|Overall Study||36
8505413|NCT00468910|20961347|P1|COMPLETED|Overall Study||36
8505414|NCT00468910|20961346|P2|Follow-up|Overall Study||36
8505415|NCT00468910|20961347|P1|Follow-up|Overall Study||36
8505416|NCT00468910|20961346|P2|Post-Treatment Biopsy|Overall Study||36
8505417|NCT00468910|20961347|P1|Post-Treatment Biopsy|Overall Study||36
8505418|NCT00468910|20961346|P2|Treatment|Overall Study||36
8505419|NCT00468910|20961347|P1|Treatment|Overall Study||36
8505420|NCT00468910|20961346|P2|Randomization|Overall Study||39
8505421|NCT00468910|20961347|P1|Randomization|Overall Study||40
8505422|NCT00468910|20961346|P2|STARTED|Overall Study||39
8505423|NCT00468910|20961347|P1|STARTED|Overall Study||40
8505424|NCT00468858|20961366|P3|NOT COMPLETED|Overall Study||14
8505425|NCT00468858|20961367|P2|NOT COMPLETED|Overall Study||10
8505426|NCT00468858|20961368|P1|NOT COMPLETED|Overall Study||9
8505427|NCT00468858|20961366|P3|COMPLETED|Overall Study||199
8505428|NCT00468858|20961367|P2|COMPLETED|Overall Study||202
8505429|NCT00468858|20961368|P1|COMPLETED|Overall Study||202
8505430|NCT00468858|20961366|P3|STARTED|Overall Study||213
8505431|NCT00468858|20961367|P2|STARTED|Overall Study||212
8505432|NCT00468858|20961368|P1|STARTED|Overall Study||211
8505445|NCT00468819|20961628|P3|NOT COMPLETED|Overall Study||2
8505446|NCT00468819|20961629|P2|NOT COMPLETED|Overall Study||0
8505447|NCT00468819|20961630|P1|NOT COMPLETED|Overall Study||6
8505448|NCT00468819|20961628|P3|COMPLETED|Overall Study||46
8505449|NCT00468819|20961629|P2|COMPLETED|Overall Study||44
8505450|NCT00468819|20961630|P1|COMPLETED|Overall Study||42
8505451|NCT00468819|20961628|P3|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
8505452|NCT00468819|20961629|P2|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
8505453|NCT00468819|20961630|P1|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
8505454|NCT00468819|20961628|P3|STARTED|Overall Study|Enrolled participants|48
8505455|NCT00468819|20961629|P2|STARTED|Overall Study|Enrolled participants|44
8505456|NCT00468819|20961630|P1|STARTED|Overall Study|Enrolled participants|48
8505457|NCT00468728|20961710|P2|NOT COMPLETED|Follow-up||31
8505458|NCT00468728|20961711|P1|NOT COMPLETED|Follow-up||34
8505459|NCT00468728|20961710|P2|COMPLETED|Follow-up||222
8505460|NCT00468728|20961711|P1|COMPLETED|Follow-up||222
8505461|NCT00468728|20961710|P2|STARTED|Follow-up||253
8505462|NCT00468728|20961711|P1|STARTED|Follow-up||256
8505463|NCT00468728|20961710|P2|NOT COMPLETED|Treatment||11
8505464|NCT00468728|20961711|P1|NOT COMPLETED|Treatment||4
8505465|NCT00468728|20961710|P2|COMPLETED|Treatment||253
8505466|NCT00468728|20961711|P1|COMPLETED|Treatment||256
8505467|NCT00468728|20961710|P2|STARTED|Treatment||264
8505468|NCT00468728|20961711|P1|STARTED|Treatment||260
8505469|NCT00468728|20961710|P2|NOT COMPLETED|Enrollment||7
8505470|NCT00468728|20961711|P1|NOT COMPLETED|Enrollment||4
8505471|NCT00468728|20961710|P2|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
8505472|NCT00468728|20961711|P1|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
8505473|NCT00468728|20961710|P2|STARTED|Enrollment||271
8505474|NCT00468728|20961711|P1|STARTED|Enrollment||264
8505475|NCT00468676|20961723|P2|NOT COMPLETED|Overall Study||12
8505476|NCT00468676|20961724|P1|NOT COMPLETED|Overall Study||16
8505477|NCT00468676|20961723|P2|COMPLETED|Overall Study||94
8505478|NCT00468676|20961724|P1|COMPLETED|Overall Study||92
8505479|NCT00468676|20961723|P2|STARTED|Overall Study||106
8505480|NCT00468676|20961724|P1|STARTED|Overall Study||108
8505484|NCT00468585|20961789|P4|NOT COMPLETED|Overall Study||1
8505485|NCT00468585|20961790|P3|NOT COMPLETED|Overall Study||5
8505486|NCT00468585|20961791|P2|NOT COMPLETED|Overall Study||0
8505487|NCT00468585|20961792|P1|NOT COMPLETED|Overall Study||1
8505488|NCT00468585|20961789|P4|COMPLETED|Overall Study||5
8505489|NCT00468585|20961790|P3|COMPLETED|Overall Study||45
8505490|NCT00468585|20961791|P2|COMPLETED|Overall Study||3
8505491|NCT00468585|20961792|P1|COMPLETED|Overall Study||3
8505492|NCT00468585|20961789|P4|STARTED|Overall Study||6
8505493|NCT00468585|20961790|P3|STARTED|Overall Study||50
8505494|NCT00468585|20961791|P2|STARTED|Overall Study||3
8505495|NCT00468585|20961792|P1|STARTED|Overall Study||4
8505496|NCT00468559|20961804|P3|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
8505497|NCT00468559|20961805|P2|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
8505498|NCT00468559|20961806|P1|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
8505499|NCT00468559|20961804|P3|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
8505500|NCT00468559|20961805|P2|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
8505501|NCT00468559|20961806|P1|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
8505502|NCT00468559|20961804|P3|STARTED|Double-blind, Treatment-withdrawal Phase||41
8505503|NCT00468559|20961805|P2|STARTED|Double-blind, Treatment-withdrawal Phase||39
8505504|NCT00468559|20961806|P1|STARTED|Double-blind, Treatment-withdrawal Phase||0
8505505|NCT00468559|20961804|P3|NOT COMPLETED|Open-label Treatment Phase||0
8505506|NCT00468559|20961805|P2|NOT COMPLETED|Open-label Treatment Phase||0
8505507|NCT00468559|20961806|P1|NOT COMPLETED|Open-label Treatment Phase||18
8505508|NCT00468559|20961804|P3|COMPLETED|Open-label Treatment Phase||0
8505509|NCT00468559|20961805|P2|COMPLETED|Open-label Treatment Phase||0
8505510|NCT00468559|20961806|P1|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
8505511|NCT00468559|20961804|P3|STARTED|Open-label Treatment Phase||0
8505512|NCT00468559|20961805|P2|STARTED|Open-label Treatment Phase||0
8505513|NCT00468559|20961806|P1|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
8505514|NCT00468546|20961834|P2|NOT COMPLETED|Week 24 to Week 104 Analysis||225
8505515|NCT00468546|20961835|P1|NOT COMPLETED|Week 24 to Week 104 Analysis||105
8505516|NCT00468546|20961834|P2|COMPLETED|Week 24 to Week 104 Analysis||83
8505517|NCT00468546|20961835|P1|COMPLETED|Week 24 to Week 104 Analysis||103
8505518|NCT00468546|20961834|P2|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
8505519|NCT00468546|20961835|P1|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
8505520|NCT00468546|20961834|P2|NOT COMPLETED|Week 24 Analysis||55
8505521|NCT00468546|20961835|P1|NOT COMPLETED|Week 24 Analysis||97
8505522|NCT00468546|20961834|P2|COMPLETED|Week 24 Analysis||253
8505523|NCT00468546|20961835|P1|COMPLETED|Week 24 Analysis||111
8505524|NCT00468546|20961834|P2|STARTED|Week 24 Analysis||308
8505525|NCT00468546|20961835|P1|STARTED|Week 24 Analysis||208
8505526|NCT00468481|20961865|P2|NOT COMPLETED|Overall Study||24
8505527|NCT00468481|20961866|P1|NOT COMPLETED|Overall Study||88
8505528|NCT00468481|20961865|P2|COMPLETED|Overall Study||70
8505529|NCT00468481|20961866|P1|COMPLETED|Overall Study||203
8505530|NCT00468481|20961865|P2|Subjects Treated|Overall Study||94
8505531|NCT00468481|20961866|P1|Subjects Treated|Overall Study||285
8505532|NCT00468481|20961865|P2|STARTED|Overall Study||94
8505533|NCT00468481|20961866|P1|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
8505534|NCT00468312|20961966|P2|NOT COMPLETED|Overall Study||5
8505535|NCT00468312|20961967|P1|NOT COMPLETED|Overall Study||4
8505536|NCT00468312|20961966|P2|COMPLETED|Overall Study||204
8505537|NCT00468312|20961967|P1|COMPLETED|Overall Study||216
8505538|NCT00468312|20961966|P2|STARTED|Overall Study||209
8505539|NCT00468312|20961967|P1|STARTED|Overall Study||220
8505540|NCT00468299|20961983|P2|NOT COMPLETED|Overall Study||1
8505541|NCT00468299|20961984|P1|NOT COMPLETED|Overall Study||0
8505542|NCT00468299|20961983|P2|COMPLETED|Overall Study||7
8505543|NCT00468299|20961984|P1|COMPLETED|Overall Study||9
8505544|NCT00468299|20961983|P2|STARTED|Overall Study||8
8505545|NCT00468299|20961984|P1|STARTED|Overall Study||9
8505546|NCT00468286|20961994|P2|NOT COMPLETED|Overall Study||12
8505547|NCT00468286|20961995|P1|NOT COMPLETED|Overall Study||7
8505548|NCT00468286|20961994|P2|COMPLETED|Overall Study||54
8505549|NCT00468286|20961995|P1|COMPLETED|Overall Study||60
8505550|NCT00468286|20961994|P2|STARTED|Overall Study||66
8505551|NCT00468286|20961995|P1|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
8505552|NCT00468208|20962017|P1|NOT COMPLETED|Overall Study||0
8505553|NCT00468208|20962017|P1|COMPLETED|Overall Study|All patients reached common closing or early termination|20
8505554|NCT00468208|20962017|P1|STARTED|Overall Study||20
8505555|NCT00468169|20962027|P2|NOT COMPLETED|Overall Study||0
8505556|NCT00468169|20962028|P1|NOT COMPLETED|Overall Study||1
8505557|NCT00468169|20962027|P2|COMPLETED|Overall Study||53
8505558|NCT00468169|20962028|P1|COMPLETED|Overall Study||56
8505559|NCT00468169|20962027|P2|STARTED|Overall Study||53
8505560|NCT00468169|20962028|P1|STARTED|Overall Study||57
8505561|NCT00468143|20962044|P2|NOT COMPLETED|Second Intervention (3 Weeks)||3
8505562|NCT00468143|20962045|P1|NOT COMPLETED|Second Intervention (3 Weeks)||3
8505563|NCT00468143|20962044|P2|COMPLETED|Second Intervention (3 Weeks)||24
8505564|NCT00468143|20962045|P1|COMPLETED|Second Intervention (3 Weeks)||25
8505565|NCT00468143|20962044|P2|STARTED|Second Intervention (3 Weeks)||27
8505566|NCT00468143|20962045|P1|STARTED|Second Intervention (3 Weeks)||28
8505567|NCT00468143|20962044|P2|NOT COMPLETED|First Intervention (3 Weeks)||4
8505568|NCT00468143|20962045|P1|NOT COMPLETED|First Intervention (3 Weeks)||3
8505569|NCT00468143|20962044|P2|COMPLETED|First Intervention (3 Weeks)||27
8505570|NCT00468143|20962045|P1|COMPLETED|First Intervention (3 Weeks)||28
8505571|NCT00468143|20962044|P2|STARTED|First Intervention (3 Weeks)||31
8505572|NCT00468143|20962045|P1|STARTED|First Intervention (3 Weeks)||31
8505573|NCT00468104|20962059|P2|NOT COMPLETED|Second Intervention||4
8505574|NCT00468104|20962060|P1|NOT COMPLETED|Second Intervention||5
8505575|NCT00468104|20962059|P2|COMPLETED|Second Intervention||37
8505576|NCT00468104|20962060|P1|COMPLETED|Second Intervention||3
8505577|NCT00468104|20962059|P2|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
8505578|NCT00468104|20962060|P1|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
8505579|NCT00468104|20962059|P2|NOT COMPLETED|First Intervention||1
8505580|NCT00468104|20962060|P1|NOT COMPLETED|First Intervention||9
8505581|NCT00468104|20962059|P2|COMPLETED|First Intervention||45
8505582|NCT00468104|20962060|P1|COMPLETED|First Intervention||45
8505583|NCT00468104|20962059|P2|STARTED|First Intervention||46
8505584|NCT00468104|20962060|P1|STARTED|First Intervention||54
8505585|NCT00468052|20962077|P2|NOT COMPLETED|Overall Study||8
8505586|NCT00468052|20962078|P1|NOT COMPLETED|Overall Study||7
8505587|NCT00468052|20962077|P2|COMPLETED|Overall Study||61
8505588|NCT00468052|20962078|P1|COMPLETED|Overall Study||61
8505589|NCT00468052|20962077|P2|Target Enrollment|Overall Study||70
8505590|NCT00468052|20962078|P1|Target Enrollment|Overall Study||70
8505591|NCT00468052|20962077|P2|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
8505592|NCT00468052|20962078|P1|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
8505593|NCT00467961|20962096|P1|NOT COMPLETED|Overall Study||7
8505594|NCT00467961|20962096|P1|COMPLETED|Overall Study||24
8505595|NCT00467961|20962096|P1|STARTED|Overall Study||31
8505596|NCT00467896|20962100|P1|NOT COMPLETED|Overall Study||51
8505597|NCT00467896|20962100|P1|COMPLETED|Overall Study||11
8505598|NCT00467896|20962100|P1|STARTED|Overall Study||62
8505599|NCT00467870|20962126|P6|NOT COMPLETED|Overall Study||2
8505600|NCT00467870|20962127|P5|NOT COMPLETED|Overall Study||37
8505601|NCT00467870|20962128|P4|NOT COMPLETED|Overall Study||33
8505602|NCT00467870|20962129|P3|NOT COMPLETED|Overall Study||4
8505603|NCT00467870|20962130|P2|NOT COMPLETED|Overall Study||43
8505604|NCT00467870|20962131|P1|NOT COMPLETED|Overall Study||45
8505605|NCT00467870|20962126|P6|COMPLETED|Overall Study||21
8505606|NCT00467870|20962127|P5|COMPLETED|Overall Study||93
8505607|NCT00467870|20962128|P4|COMPLETED|Overall Study||79
8505608|NCT00467870|20962129|P3|COMPLETED|Overall Study||18
8505609|NCT00467870|20962130|P2|COMPLETED|Overall Study||74
8505610|NCT00467870|20962131|P1|COMPLETED|Overall Study||75
8505611|NCT00467870|20962126|P6|STARTED|Overall Study||23
8505612|NCT00467870|20962127|P5|STARTED|Overall Study||130
8505613|NCT00467870|20962128|P4|STARTED|Overall Study||112
8505614|NCT00467870|20962129|P3|STARTED|Overall Study||22
8505615|NCT00467870|20962130|P2|STARTED|Overall Study||117
8505616|NCT00467870|20962131|P1|STARTED|Overall Study||120
8505617|NCT00467857|20962174|P2|NOT COMPLETED|Overall Study||8
8505618|NCT00467857|20962175|P1|NOT COMPLETED|Overall Study||3
8505619|NCT00467857|20962174|P2|COMPLETED|Overall Study||139
8505620|NCT00467857|20962175|P1|COMPLETED|Overall Study||143
8505621|NCT00467857|20962174|P2|STARTED|Overall Study||147
8505622|NCT00467857|20962175|P1|STARTED|Overall Study||146
8505623|NCT00467844|20962210|P3|NOT COMPLETED|Overall Study||14
8505624|NCT00467844|20962211|P2|NOT COMPLETED|Overall Study||20
8505625|NCT00467844|20962212|P1|NOT COMPLETED|Overall Study||19
8505626|NCT00467844|20962210|P3|COMPLETED|Overall Study||38
8505627|NCT00467844|20962211|P2|COMPLETED|Overall Study||34
8505628|NCT00467844|20962212|P1|COMPLETED|Overall Study||34
8505629|NCT00467844|20962210|P3|STARTED|Overall Study||52
8505630|NCT00467844|20962211|P2|STARTED|Overall Study||54
8505631|NCT00467844|20962212|P1|STARTED|Overall Study||53
8505632|NCT00467831|20962223|P1|NOT COMPLETED|Overall Study||3
8505633|NCT00467831|20962223|P1|COMPLETED|Overall Study||0
8505634|NCT00467831|20962223|P1|STARTED|Overall Study||3
8505635|NCT00467818|20962229|P2|NOT COMPLETED|Overall Study||2
8505636|NCT00467818|20962230|P1|NOT COMPLETED|Overall Study||3
8505637|NCT00467818|20962229|P2|COMPLETED|Overall Study||6
8505638|NCT00467818|20962230|P1|COMPLETED|Overall Study||6
8505639|NCT00467818|20962229|P2|STARTED|Overall Study||8
8505640|NCT00467818|20962230|P1|STARTED|Overall Study||9
8505641|NCT00467779|20962259|P15|NOT COMPLETED|Stage 3||17
8505642|NCT00467779|20962260|P14|NOT COMPLETED|Stage 3||0
8505643|NCT00467779|20962261|P13|NOT COMPLETED|Stage 3||0
8505644|NCT00467779|20962262|P12|NOT COMPLETED|Stage 3||0
8505645|NCT00467779|20962263|P11|NOT COMPLETED|Stage 3||0
8505646|NCT00467779|20962264|P10|NOT COMPLETED|Stage 3||0
8505647|NCT00467779|20962265|P9|NOT COMPLETED|Stage 3||0
8505648|NCT00467779|20962266|P8|NOT COMPLETED|Stage 3||0
8505649|NCT00467779|20962267|P7|NOT COMPLETED|Stage 3||0
8505650|NCT00467779|20962268|P6|NOT COMPLETED|Stage 3||0
8505651|NCT00467779|20962269|P5|NOT COMPLETED|Stage 3||0
8505652|NCT00467779|20962270|P4|NOT COMPLETED|Stage 3||0
8505653|NCT00467779|20962271|P3|NOT COMPLETED|Stage 3||0
8505654|NCT00467779|20962272|P2|NOT COMPLETED|Stage 3||0
8505655|NCT00467779|20962273|P1|NOT COMPLETED|Stage 3||0
8505656|NCT00467779|20962259|P15|COMPLETED|Stage 3||3
8505657|NCT00467779|20962260|P14|COMPLETED|Stage 3||0
8505658|NCT00467779|20962261|P13|COMPLETED|Stage 3||0
8505659|NCT00467779|20962262|P12|COMPLETED|Stage 3||0
8505660|NCT00467779|20962263|P11|COMPLETED|Stage 3||0
8505661|NCT00467779|20962264|P10|COMPLETED|Stage 3||0
8505662|NCT00467779|20962265|P9|COMPLETED|Stage 3||0
8505663|NCT00467779|20962266|P8|COMPLETED|Stage 3||0
8505664|NCT00467779|20962267|P7|COMPLETED|Stage 3||0
8505665|NCT00467779|20962268|P6|COMPLETED|Stage 3||0
8505666|NCT00467779|20962269|P5|COMPLETED|Stage 3||0
8505667|NCT00467779|20962270|P4|COMPLETED|Stage 3||0
8505668|NCT00467779|20962271|P3|COMPLETED|Stage 3||0
8505669|NCT00467779|20962272|P2|COMPLETED|Stage 3||0
8505670|NCT00467779|20962273|P1|COMPLETED|Stage 3||0
8505671|NCT00467779|20962259|P15|STARTED|Stage 3||20
8505672|NCT00467779|20962260|P14|STARTED|Stage 3||0
8505673|NCT00467779|20962261|P13|STARTED|Stage 3||0
8505674|NCT00467779|20962262|P12|STARTED|Stage 3||0
8505675|NCT00467779|20962263|P11|STARTED|Stage 3||0
8505676|NCT00467779|20962264|P10|STARTED|Stage 3||0
8505677|NCT00467779|20962265|P9|STARTED|Stage 3||0
8505678|NCT00467779|20962266|P8|STARTED|Stage 3||0
8505679|NCT00467779|20962267|P7|STARTED|Stage 3||0
8505680|NCT00467779|20962268|P6|STARTED|Stage 3||0
8505681|NCT00467779|20962269|P5|STARTED|Stage 3||0
8505682|NCT00467779|20962270|P4|STARTED|Stage 3||0
8505683|NCT00467779|20962271|P3|STARTED|Stage 3||0
8505684|NCT00467779|20962272|P2|STARTED|Stage 3||0
8505685|NCT00467779|20962273|P1|STARTED|Stage 3||0
8505686|NCT00467779|20962259|P15|NOT COMPLETED|Stage 2A||0
8505687|NCT00467779|20962260|P14|NOT COMPLETED|Stage 2A||21
8505688|NCT00467779|20962261|P13|NOT COMPLETED|Stage 2A||0
8505689|NCT00467779|20962262|P12|NOT COMPLETED|Stage 2A||0
8505690|NCT00467779|20962263|P11|NOT COMPLETED|Stage 2A||0
8505691|NCT00467779|20962264|P10|NOT COMPLETED|Stage 2A||0
8505692|NCT00467779|20962265|P9|NOT COMPLETED|Stage 2A||0
8505693|NCT00467779|20962266|P8|NOT COMPLETED|Stage 2A||0
8505694|NCT00467779|20962267|P7|NOT COMPLETED|Stage 2A||0
8505695|NCT00467779|20962268|P6|NOT COMPLETED|Stage 2A||0
8505696|NCT00467779|20962269|P5|NOT COMPLETED|Stage 2A||0
8505697|NCT00467779|20962270|P4|NOT COMPLETED|Stage 2A||0
8505698|NCT00467779|20962271|P3|NOT COMPLETED|Stage 2A||0
8505699|NCT00467779|20962272|P2|NOT COMPLETED|Stage 2A||0
8505700|NCT00467779|20962273|P1|NOT COMPLETED|Stage 2A||0
8505701|NCT00467779|20962259|P15|COMPLETED|Stage 2A||0
8505702|NCT00467779|20962260|P14|COMPLETED|Stage 2A||1
8505703|NCT00467779|20962261|P13|COMPLETED|Stage 2A||0
8505704|NCT00467779|20962262|P12|COMPLETED|Stage 2A||0
8505705|NCT00467779|20962263|P11|COMPLETED|Stage 2A||0
8505706|NCT00467779|20962264|P10|COMPLETED|Stage 2A||0
8505707|NCT00467779|20962265|P9|COMPLETED|Stage 2A||0
8505708|NCT00467779|20962266|P8|COMPLETED|Stage 2A||0
8505709|NCT00467779|20962267|P7|COMPLETED|Stage 2A||0
8505710|NCT00467779|20962268|P6|COMPLETED|Stage 2A||0
8505711|NCT00467779|20962269|P5|COMPLETED|Stage 2A||0
8505712|NCT00467779|20962270|P4|COMPLETED|Stage 2A||0
8505713|NCT00467779|20962271|P3|COMPLETED|Stage 2A||0
8505714|NCT00467779|20962272|P2|COMPLETED|Stage 2A||0
8505715|NCT00467779|20962273|P1|COMPLETED|Stage 2A||0
8505716|NCT00467779|20962259|P15|STARTED|Stage 2A||0
8505717|NCT00467779|20962260|P14|STARTED|Stage 2A||22
8505718|NCT00467779|20962261|P13|STARTED|Stage 2A||0
8505719|NCT00467779|20962262|P12|STARTED|Stage 2A||0
8505720|NCT00467779|20962263|P11|STARTED|Stage 2A||0
8505721|NCT00467779|20962264|P10|STARTED|Stage 2A||0
8505722|NCT00467779|20962265|P9|STARTED|Stage 2A||0
8505723|NCT00467779|20962266|P8|STARTED|Stage 2A||0
8505724|NCT00467779|20962267|P7|STARTED|Stage 2A||0
8505725|NCT00467779|20962268|P6|STARTED|Stage 2A||0
8505726|NCT00467779|20962269|P5|STARTED|Stage 2A||0
8505727|NCT00467779|20962270|P4|STARTED|Stage 2A||0
8505728|NCT00467779|20962271|P3|STARTED|Stage 2A||0
8505729|NCT00467779|20962272|P2|STARTED|Stage 2A||0
8505730|NCT00467779|20962273|P1|STARTED|Stage 2A||0
8505731|NCT00467779|20962259|P15|NOT COMPLETED|Stage 2||0
8505732|NCT00467779|20962260|P14|NOT COMPLETED|Stage 2||0
8505733|NCT00467779|20962261|P13|NOT COMPLETED|Stage 2||0
8505734|NCT00467779|20962262|P12|NOT COMPLETED|Stage 2||0
8505735|NCT00467779|20962263|P11|NOT COMPLETED|Stage 2||0
8505736|NCT00467779|20962264|P10|NOT COMPLETED|Stage 2||0
8505737|NCT00467779|20962265|P9|NOT COMPLETED|Stage 2||21
8505738|NCT00467779|20962266|P8|NOT COMPLETED|Stage 2||0
8505739|NCT00467779|20962267|P7|NOT COMPLETED|Stage 2||0
8505740|NCT00467779|20962268|P6|NOT COMPLETED|Stage 2||0
8505741|NCT00467779|20962269|P5|NOT COMPLETED|Stage 2||0
8505742|NCT00467779|20962270|P4|NOT COMPLETED|Stage 2||0
8505743|NCT00467779|20962271|P3|NOT COMPLETED|Stage 2||0
8505744|NCT00467779|20962272|P2|NOT COMPLETED|Stage 2||0
8505745|NCT00467779|20962273|P1|NOT COMPLETED|Stage 2||0
8505746|NCT00467779|20962259|P15|COMPLETED|Stage 2||0
8505747|NCT00467779|20962260|P14|COMPLETED|Stage 2||0
8505748|NCT00467779|20962261|P13|COMPLETED|Stage 2||0
8505749|NCT00467779|20962262|P12|COMPLETED|Stage 2||0
8505750|NCT00467779|20962263|P11|COMPLETED|Stage 2||0
8505751|NCT00467779|20962264|P10|COMPLETED|Stage 2||0
8505752|NCT00467779|20962265|P9|COMPLETED|Stage 2||0
8505753|NCT00467779|20962266|P8|COMPLETED|Stage 2||0
8505754|NCT00467779|20962267|P7|COMPLETED|Stage 2||0
8505755|NCT00467779|20962268|P6|COMPLETED|Stage 2||0
8505756|NCT00467779|20962269|P5|COMPLETED|Stage 2||0
8505757|NCT00467779|20962270|P4|COMPLETED|Stage 2||0
8505758|NCT00467779|20962271|P3|COMPLETED|Stage 2||0
8505759|NCT00467779|20962272|P2|COMPLETED|Stage 2||0
8505760|NCT00467779|20962273|P1|COMPLETED|Stage 2||0
8505761|NCT00467779|20962259|P15|STARTED|Stage 2||0
8505762|NCT00467779|20962260|P14|STARTED|Stage 2||0
8505763|NCT00467779|20962261|P13|STARTED|Stage 2||0
8505764|NCT00467779|20962262|P12|STARTED|Stage 2||0
8505765|NCT00467779|20962263|P11|STARTED|Stage 2||0
8505766|NCT00467779|20962264|P10|STARTED|Stage 2||0
8505767|NCT00467779|20962265|P9|STARTED|Stage 2||21
8505768|NCT00467779|20962266|P8|STARTED|Stage 2||0
8505769|NCT00467779|20962267|P7|STARTED|Stage 2||0
8505770|NCT00467779|20962268|P6|STARTED|Stage 2||0
8505771|NCT00467779|20962269|P5|STARTED|Stage 2||0
8505772|NCT00467779|20962270|P4|STARTED|Stage 2||0
8505773|NCT00467779|20962271|P3|STARTED|Stage 2||0
8505774|NCT00467779|20962272|P2|STARTED|Stage 2||0
8505775|NCT00467779|20962273|P1|STARTED|Stage 2||0
8505776|NCT00467779|20962259|P15|NOT COMPLETED|Stage 1A||0
8505777|NCT00467779|20962260|P14|NOT COMPLETED|Stage 1A||0
8505778|NCT00467779|20962261|P13|NOT COMPLETED|Stage 1A||6
8505779|NCT00467779|20962262|P12|NOT COMPLETED|Stage 1A||8
8505780|NCT00467779|20962263|P11|NOT COMPLETED|Stage 1A||3
8505781|NCT00467779|20962264|P10|NOT COMPLETED|Stage 1A||3
8505782|NCT00467779|20962265|P9|NOT COMPLETED|Stage 1A||0
8505783|NCT00467779|20962266|P8|NOT COMPLETED|Stage 1A||0
8505784|NCT00467779|20962267|P7|NOT COMPLETED|Stage 1A||0
8505785|NCT00467779|20962268|P6|NOT COMPLETED|Stage 1A||0
8505786|NCT00467779|20962269|P5|NOT COMPLETED|Stage 1A||0
8505787|NCT00467779|20962270|P4|NOT COMPLETED|Stage 1A||0
8505788|NCT00467779|20962271|P3|NOT COMPLETED|Stage 1A||0
8505789|NCT00467779|20962272|P2|NOT COMPLETED|Stage 1A||0
8505790|NCT00467779|20962273|P1|NOT COMPLETED|Stage 1A||0
8505791|NCT00467779|20962259|P15|COMPLETED|Stage 1A||0
8505792|NCT00467779|20962260|P14|COMPLETED|Stage 1A||0
8505793|NCT00467779|20962261|P13|COMPLETED|Stage 1A||0
8505794|NCT00467779|20962262|P12|COMPLETED|Stage 1A||0
8505795|NCT00467779|20962263|P11|COMPLETED|Stage 1A||0
8505796|NCT00467779|20962264|P10|COMPLETED|Stage 1A||0
8505797|NCT00467779|20962265|P9|COMPLETED|Stage 1A||0
8505798|NCT00467779|20962266|P8|COMPLETED|Stage 1A||0
8505799|NCT00467779|20962267|P7|COMPLETED|Stage 1A||0
8505800|NCT00467779|20962268|P6|COMPLETED|Stage 1A||0
8505801|NCT00467779|20962269|P5|COMPLETED|Stage 1A||0
8505802|NCT00467779|20962270|P4|COMPLETED|Stage 1A||0
8505803|NCT00467779|20962271|P3|COMPLETED|Stage 1A||0
8505804|NCT00467779|20962272|P2|COMPLETED|Stage 1A||0
8505805|NCT00467779|20962273|P1|COMPLETED|Stage 1A||0
8505806|NCT00467779|20962259|P15|STARTED|Stage 1A||0
8505807|NCT00467779|20962260|P14|STARTED|Stage 1A||0
8505808|NCT00467779|20962261|P13|STARTED|Stage 1A||6
8505809|NCT00467779|20962262|P12|STARTED|Stage 1A||8
8505810|NCT00467779|20962263|P11|STARTED|Stage 1A||3
8505811|NCT00467779|20962264|P10|STARTED|Stage 1A||3
8505812|NCT00467779|20962265|P9|STARTED|Stage 1A||0
8505813|NCT00467779|20962266|P8|STARTED|Stage 1A||0
8505814|NCT00467779|20962267|P7|STARTED|Stage 1A||0
8505815|NCT00467779|20962268|P6|STARTED|Stage 1A||0
8505816|NCT00467779|20962269|P5|STARTED|Stage 1A||0
8505817|NCT00467779|20962270|P4|STARTED|Stage 1A||0
8505818|NCT00467779|20962271|P3|STARTED|Stage 1A||0
8505819|NCT00467779|20962272|P2|STARTED|Stage 1A||0
8505820|NCT00467779|20962273|P1|STARTED|Stage 1A||0
8505821|NCT00467779|20962259|P15|NOT COMPLETED|Stage 1||0
8505822|NCT00467779|20962260|P14|NOT COMPLETED|Stage 1||0
8505823|NCT00467779|20962261|P13|NOT COMPLETED|Stage 1||0
8505824|NCT00467779|20962262|P12|NOT COMPLETED|Stage 1||0
8505825|NCT00467779|20962263|P11|NOT COMPLETED|Stage 1||0
8505826|NCT00467779|20962264|P10|NOT COMPLETED|Stage 1||0
8505827|NCT00467779|20962265|P9|NOT COMPLETED|Stage 1||0
8505828|NCT00467779|20962266|P8|NOT COMPLETED|Stage 1||7
8505829|NCT00467779|20962267|P7|NOT COMPLETED|Stage 1||7
8505830|NCT00467779|20962268|P6|NOT COMPLETED|Stage 1||5
8505831|NCT00467779|20962269|P5|NOT COMPLETED|Stage 1||3
8505832|NCT00467779|20962270|P4|NOT COMPLETED|Stage 1||3
8505833|NCT00467779|20962271|P3|NOT COMPLETED|Stage 1||3
8505834|NCT00467779|20962272|P2|NOT COMPLETED|Stage 1||3
8505835|NCT00467779|20962273|P1|NOT COMPLETED|Stage 1||4
8505836|NCT00467779|20962259|P15|COMPLETED|Stage 1||0
8505837|NCT00467779|20962260|P14|COMPLETED|Stage 1||0
8505838|NCT00467779|20962261|P13|COMPLETED|Stage 1||0
8505839|NCT00467779|20962262|P12|COMPLETED|Stage 1||0
8505840|NCT00467779|20962263|P11|COMPLETED|Stage 1||0
8505841|NCT00467779|20962264|P10|COMPLETED|Stage 1||0
8505842|NCT00467779|20962265|P9|COMPLETED|Stage 1||0
8505843|NCT00467779|20962266|P8|COMPLETED|Stage 1||0
8505844|NCT00467779|20962267|P7|COMPLETED|Stage 1||0
8505845|NCT00467779|20962268|P6|COMPLETED|Stage 1||1
8505846|NCT00467779|20962269|P5|COMPLETED|Stage 1||0
8505847|NCT00467779|20962270|P4|COMPLETED|Stage 1||0
8505848|NCT00467779|20962271|P3|COMPLETED|Stage 1||0
8505849|NCT00467779|20962272|P2|COMPLETED|Stage 1||0
8505850|NCT00467779|20962273|P1|COMPLETED|Stage 1||0
8505851|NCT00467779|20962259|P15|STARTED|Stage 1||0
8505852|NCT00467779|20962260|P14|STARTED|Stage 1||0
8505853|NCT00467779|20962261|P13|STARTED|Stage 1||0
8505854|NCT00467779|20962262|P12|STARTED|Stage 1||0
8505855|NCT00467779|20962263|P11|STARTED|Stage 1||0
8505856|NCT00467779|20962264|P10|STARTED|Stage 1||0
8505857|NCT00467779|20962265|P9|STARTED|Stage 1||0
8505858|NCT00467779|20962266|P8|STARTED|Stage 1||7
8505859|NCT00467779|20962267|P7|STARTED|Stage 1||7
8505860|NCT00467779|20962268|P6|STARTED|Stage 1||6
8505861|NCT00467779|20962269|P5|STARTED|Stage 1||3
8505862|NCT00467779|20962270|P4|STARTED|Stage 1||3
8505863|NCT00467779|20962271|P3|STARTED|Stage 1||3
8505864|NCT00467779|20962272|P2|STARTED|Stage 1||3
8505865|NCT00467779|20962273|P1|STARTED|Stage 1||4
8505866|NCT00467753|20962447|P2|NOT COMPLETED|Overall Study||2
8505867|NCT00467753|20962448|P1|NOT COMPLETED|Overall Study||3
8505868|NCT00467753|20962447|P2|COMPLETED|Overall Study||0
8505869|NCT00467753|20962448|P1|COMPLETED|Overall Study||0
8505870|NCT00467753|20962447|P2|STARTED|Overall Study||2
8505871|NCT00467753|20962448|P1|STARTED|Overall Study||3
8505872|NCT00467740|20962465|P5|NOT COMPLETED|Overall Study||0
8505873|NCT00467740|20962466|P4|NOT COMPLETED|Overall Study||1
8505874|NCT00467740|20962467|P3|NOT COMPLETED|Overall Study||2
8505875|NCT00467740|20962468|P2|NOT COMPLETED|Overall Study||3
8505876|NCT00467740|20962469|P1|NOT COMPLETED|Overall Study||1
8505877|NCT00467740|20962465|P5|COMPLETED|Overall Study||61
8505878|NCT00467740|20962466|P4|COMPLETED|Overall Study||59
8505879|NCT00467740|20962467|P3|COMPLETED|Overall Study||58
8505880|NCT00467740|20962468|P2|COMPLETED|Overall Study||58
8505881|NCT00467740|20962469|P1|COMPLETED|Overall Study||53
8505882|NCT00467740|20962465|P5|STARTED|Overall Study||61
8505883|NCT00467740|20962466|P4|STARTED|Overall Study||60
8505884|NCT00467740|20962467|P3|STARTED|Overall Study||60
8505885|NCT00467740|20962468|P2|STARTED|Overall Study||61
8505886|NCT00467740|20962469|P1|STARTED|Overall Study||54
8505887|NCT00467649|20962658|P6|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
8505888|NCT00467649|20962659|P5|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8505889|NCT00467649|20962660|P4|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
8505890|NCT00467649|20962661|P3|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8505891|NCT00467649|20962662|P2|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8505892|NCT00467649|20962663|P1|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8505893|NCT00467649|20962658|P6|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
8505894|NCT00467649|20962659|P5|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
8505895|NCT00467649|20962660|P4|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
8505896|NCT00467649|20962661|P3|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
8505897|NCT00467649|20962662|P2|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8505898|NCT00467649|20962663|P1|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
8505899|NCT00467649|20962658|P6|STARTED|Phase 2 (Intent-to-Treat Population)||36
8505900|NCT00467649|20962659|P5|STARTED|Phase 2 (Intent-to-Treat Population)||14
8505901|NCT00467649|20962660|P4|STARTED|Phase 2 (Intent-to-Treat Population)||31
8505902|NCT00467649|20962661|P3|STARTED|Phase 2 (Intent-to-Treat Population)||17
8505903|NCT00467649|20962662|P2|STARTED|Phase 2 (Intent-to-Treat Population)||0
8505904|NCT00467649|20962663|P1|STARTED|Phase 2 (Intent-to-Treat Population)||0
8505905|NCT00467649|20962658|P6|NOT COMPLETED|Phase 1 (Randomized Population)||0
8505906|NCT00467649|20962659|P5|NOT COMPLETED|Phase 1 (Randomized Population)||0
8505907|NCT00467649|20962660|P4|NOT COMPLETED|Phase 1 (Randomized Population)||0
8505908|NCT00467649|20962661|P3|NOT COMPLETED|Phase 1 (Randomized Population)||0
8505909|NCT00467649|20962662|P2|NOT COMPLETED|Phase 1 (Randomized Population)||6
8505910|NCT00467649|20962663|P1|NOT COMPLETED|Phase 1 (Randomized Population)||9
8505911|NCT00467649|20962658|P6|COMPLETED|Phase 1 (Randomized Population)||0
8505912|NCT00467649|20962659|P5|COMPLETED|Phase 1 (Randomized Population)||0
8505913|NCT00467649|20962660|P4|COMPLETED|Phase 1 (Randomized Population)||0
8505914|NCT00467649|20962661|P3|COMPLETED|Phase 1 (Randomized Population)||0
8505915|NCT00467649|20962662|P2|COMPLETED|Phase 1 (Randomized Population)||50
8505916|NCT00467649|20962663|P1|COMPLETED|Phase 1 (Randomized Population)||48
8505917|NCT00467649|20962658|P6|Intent to Treat|Phase 1 (Randomized Population)||0
8505918|NCT00467649|20962659|P5|Intent to Treat|Phase 1 (Randomized Population)||0
8505919|NCT00467649|20962660|P4|Intent to Treat|Phase 1 (Randomized Population)||0
8505920|NCT00467649|20962661|P3|Intent to Treat|Phase 1 (Randomized Population)||0
8505921|NCT00467649|20962662|P2|Intent to Treat|Phase 1 (Randomized Population)||56
8505922|NCT00467649|20962663|P1|Intent to Treat|Phase 1 (Randomized Population)||56
8505923|NCT00467649|20962658|P6|STARTED|Phase 1 (Randomized Population)||0
8505924|NCT00467649|20962659|P5|STARTED|Phase 1 (Randomized Population)||0
8505925|NCT00467649|20962660|P4|STARTED|Phase 1 (Randomized Population)||0
8505926|NCT00467649|20962661|P3|STARTED|Phase 1 (Randomized Population)||0
8505927|NCT00467649|20962662|P2|STARTED|Phase 1 (Randomized Population)||56
8505928|NCT00467649|20962663|P1|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
8505929|NCT00467610|20962703|P1|NOT COMPLETED|Overall Study||1
8505930|NCT00467610|20962703|P1|COMPLETED|Overall Study||5
8505931|NCT00467610|20962703|P1|STARTED|Overall Study||6
8505932|NCT00467597|20962714|P2|NOT COMPLETED|Overall Study||0
8505933|NCT00467597|20962715|P1|NOT COMPLETED|Overall Study||2
8505934|NCT00467597|20962714|P2|COMPLETED|Overall Study||6
8505935|NCT00467597|20962715|P1|COMPLETED|Overall Study||24
8505936|NCT00467597|20962714|P2|STARTED|Overall Study||6
8505937|NCT00467597|20962715|P1|STARTED|Overall Study||26
8505938|NCT00467584|20962728|P3|NOT COMPLETED|Overall Study||1
8505939|NCT00467584|20962729|P2|NOT COMPLETED|Overall Study||5
8505940|NCT00467584|20962730|P1|NOT COMPLETED|Overall Study||4
8505941|NCT00467584|20962728|P3|COMPLETED|Overall Study||20
8505942|NCT00467584|20962729|P2|COMPLETED|Overall Study||15
8505943|NCT00467584|20962730|P1|COMPLETED|Overall Study||17
8505944|NCT00467584|20962728|P3|STARTED|Overall Study||21
8505945|NCT00467584|20962729|P2|STARTED|Overall Study||20
8505946|NCT00467584|20962730|P1|STARTED|Overall Study||21
8505947|NCT00467558|20962740|P2|NOT COMPLETED|Overall Study||0
8505948|NCT00467558|20962741|P1|NOT COMPLETED|Overall Study||2
8505949|NCT00467558|20962740|P2|COMPLETED|Overall Study||3
8505950|NCT00467558|20962741|P1|COMPLETED|Overall Study||2
8505951|NCT00467558|20962740|P2|STARTED|Overall Study||3
8505952|NCT00467558|20962741|P1|STARTED|Overall Study||4
8505953|NCT00467519|20962751|P2|NOT COMPLETED|Overall Study||23
8505954|NCT00467519|20962752|P1|NOT COMPLETED|Overall Study||14
8505955|NCT00467519|20962751|P2|COMPLETED|Overall Study||488
8505956|NCT00467519|20962752|P1|COMPLETED|Overall Study||517
8505957|NCT00467519|20962751|P2|STARTED|Overall Study||511
8505958|NCT00467519|20962752|P1|STARTED|Overall Study||531
8505959|NCT00467389|20962768|P2|NOT COMPLETED|Overall Study||0
8505960|NCT00467389|20962769|P1|NOT COMPLETED|Overall Study||0
8505961|NCT00467389|20962768|P2|COMPLETED|Overall Study||6
8505962|NCT00467389|20962769|P1|COMPLETED|Overall Study||6
8505963|NCT00467389|20962768|P2|STARTED|Overall Study||6
8505964|NCT00467389|20962769|P1|STARTED|Overall Study||6
8505965|NCT00467363|20962781|P2|NOT COMPLETED|Overall Study||70
8505966|NCT00467363|20962782|P1|NOT COMPLETED|Overall Study||80
8505967|NCT00467363|20962781|P2|COMPLETED|Overall Study||543
8505968|NCT00467363|20962782|P1|COMPLETED|Overall Study||535
8505969|NCT00467363|20962781|P2|STARTED|Overall Study||613
8505970|NCT00467363|20962782|P1|STARTED|Overall Study||615
8505971|NCT00467350|20962818|P2|NOT COMPLETED|Overall Study||0
8505972|NCT00467350|20962819|P1|NOT COMPLETED|Overall Study||1
8505973|NCT00467350|20962818|P2|COMPLETED|Overall Study||39
8505974|NCT00467350|20962819|P1|COMPLETED|Overall Study||40
8505975|NCT00467350|20962818|P2|STARTED|Overall Study||39
8505976|NCT00467350|20962819|P1|STARTED|Overall Study||41
8505977|NCT00467298|20962827|P2|NOT COMPLETED|Overall Study||6
8505978|NCT00467298|20962828|P1|NOT COMPLETED|Overall Study||4
8505979|NCT00467298|20962827|P2|COMPLETED|Overall Study||38
8505980|NCT00467298|20962828|P1|COMPLETED|Overall Study||42
8505981|NCT00467298|20962827|P2|STARTED|Overall Study||44
8505982|NCT00467298|20962828|P1|STARTED|Overall Study||46
8505983|NCT00467285|20962838|P2|NOT COMPLETED|Overall Study||4
8505984|NCT00467285|20962839|P1|NOT COMPLETED|Overall Study||4
8505985|NCT00467285|20962838|P2|COMPLETED|Overall Study||60
8505986|NCT00467285|20962839|P1|COMPLETED|Overall Study||28
8505987|NCT00467285|20962838|P2|STARTED|Overall Study||64
8505988|NCT00467285|20962839|P1|STARTED|Overall Study||32
8505989|NCT00467259|20962859|P2|NOT COMPLETED|Overall Study||242
8505990|NCT00467259|20962860|P1|NOT COMPLETED|Overall Study||75
8505991|NCT00467259|20962859|P2|COMPLETED|Overall Study||778
8505992|NCT00467259|20962860|P1|COMPLETED|Overall Study||176
8505993|NCT00467259|20962859|P2|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
8505994|NCT00467259|20962860|P1|ITT Population|Overall Study||251
8505995|NCT00467259|20962859|P2|STARTED|Overall Study||1020
8505996|NCT00467259|20962860|P1|STARTED|Overall Study||251
8505997|NCT00467077|20962870|P1|NOT COMPLETED|Overall Study||0
8505998|NCT00467077|20962870|P1|COMPLETED|Overall Study||21
8505999|NCT00467077|20962870|P1|STARTED|Overall Study||21
8506000|NCT00467051|20962877|P1|NOT COMPLETED|Overall Study||2
8506001|NCT00467051|20962877|P1|COMPLETED|Overall Study||18
8506002|NCT00467051|20962877|P1|STARTED|Overall Study||20
8506003|NCT00467038|20962884|P2|NOT COMPLETED|Overall Study||0
8506004|NCT00467038|20962885|P1|NOT COMPLETED|Overall Study||0
8506005|NCT00467038|20962884|P2|COMPLETED|Overall Study||11
8506006|NCT00467038|20962885|P1|COMPLETED|Overall Study||11
8506007|NCT00467038|20962884|P2|STARTED|Overall Study||11
8506008|NCT00467038|20962885|P1|STARTED|Overall Study||11
8506009|NCT00466960|20962893|P1|NOT COMPLETED|Overall Study||0
8506010|NCT00466960|20962893|P1|COMPLETED|Overall Study||21
8506011|NCT00466960|20962893|P1|STARTED|Overall Study||21
8506012|NCT00466947|20962904|P2|NOT COMPLETED|Study End Analysis Period||2534
8506013|NCT00466947|20962905|P1|NOT COMPLETED|Study End Analysis Period||2496
8506014|NCT00466947|20962904|P2|COMPLETED|Study End Analysis Period||9265
8506015|NCT00466947|20962905|P1|COMPLETED|Study End Analysis Period||9302
8506016|NCT00466947|20962904|P2|STARTED|Study End Analysis Period||11799
8506017|NCT00466947|20962905|P1|STARTED|Study End Analysis Period||11798
8506018|NCT00466947|20962904|P2|NOT COMPLETED|Primary Outcome Analysis Period||11863
8506019|NCT00466947|20962905|P1|NOT COMPLETED|Primary Outcome Analysis Period||11875
8506020|NCT00466947|20962904|P2|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
8506021|NCT00466947|20962905|P1|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
8506022|NCT00466947|20962904|P2|Ongoing|Primary Outcome Analysis Period||11863
8506023|NCT00466947|20962905|P1|Ongoing|Primary Outcome Analysis Period||11875
8506024|NCT00466947|20962904|P2|STARTED|Primary Outcome Analysis Period||11863
8506025|NCT00466947|20962905|P1|STARTED|Primary Outcome Analysis Period||11875
8506026|NCT00466921|20963027|P1|NOT COMPLETED|Follow up for a Minimum of 1 Year||6
8506027|NCT00466921|20963027|P1|COMPLETED|Follow up for a Minimum of 1 Year||27
8506028|NCT00466921|20963027|P1|STARTED|Follow up for a Minimum of 1 Year||33
8506029|NCT00466921|20963027|P1|NOT COMPLETED|Continued Treatment||0
8506030|NCT00466921|20963027|P1|COMPLETED|Continued Treatment||21
8506031|NCT00466921|20963027|P1|STARTED|Continued Treatment||21
8506032|NCT00466921|20963027|P1|NOT COMPLETED|Completed 4 Cycles/Reached 1st Response||5
8506033|NCT00466921|20963027|P1|COMPLETED|Completed 4 Cycles/Reached 1st Response||21
8506034|NCT00466921|20963027|P1|Completed 4 Cycles/1st Response|Completed 4 Cycles/Reached 1st Response||21
8506035|NCT00466921|20963027|P1|STARTED|Completed 4 Cycles/Reached 1st Response||26
8506036|NCT00466921|20963027|P1|NOT COMPLETED|First 3 Cycles of Treatment||7
8506037|NCT00466921|20963027|P1|COMPLETED|First 3 Cycles of Treatment||26
8506038|NCT00466921|20963027|P1|Completed 3 Cycles|First 3 Cycles of Treatment||26
8506039|NCT00466921|20963027|P1|Started Cycle 2|First 3 Cycles of Treatment||31
8506040|NCT00466921|20963027|P1|Completed 1 Cycle|First 3 Cycles of Treatment||32
8506041|NCT00466921|20963027|P1|STARTED|First 3 Cycles of Treatment|One patient completed only a few days of treatment|33
8506042|NCT00466817|20963036|P2|NOT COMPLETED|Overall Study||4
8506043|NCT00466817|20963037|P1|NOT COMPLETED|Overall Study||5
8506044|NCT00466817|20963036|P2|COMPLETED|Overall Study||43
8506045|NCT00466817|20963037|P1|COMPLETED|Overall Study||44
8506046|NCT00466817|20963036|P2|STARTED|Overall Study||47
8506047|NCT00466817|20963037|P1|STARTED|Overall Study||49
8506048|NCT00466752|20963092|P2|NOT COMPLETED|Overall Study||0
8506049|NCT00466752|20963093|P1|NOT COMPLETED|Overall Study||0
8506050|NCT00466752|20963092|P2|COMPLETED|Overall Study||0
8506051|NCT00466752|20963093|P1|COMPLETED|Overall Study||5
8506052|NCT00466752|20963092|P2|STARTED|Overall Study||0
8506053|NCT00466752|20963093|P1|STARTED|Overall Study||5
8506054|NCT00466726|20963103|P1|NOT COMPLETED|Overall Study||14
8506055|NCT00466726|20963103|P1|COMPLETED|Overall Study||43
8506056|NCT00466726|20963103|P1|STARTED|Overall Study||57
8506057|NCT00466687|20963109|P1|NOT COMPLETED|Overall Study||34
8506058|NCT00466687|20963109|P1|COMPLETED|Overall Study||0
8506059|NCT00466687|20963109|P1|STARTED|Overall Study||34
8506060|NCT00466661|20963118|P2|NOT COMPLETED|Overall Study||6
8506061|NCT00466661|20963119|P1|NOT COMPLETED|Overall Study||4
8506062|NCT00466661|20963118|P2|COMPLETED|Overall Study||11
8506063|NCT00466661|20963119|P1|COMPLETED|Overall Study||12
8506064|NCT00466661|20963118|P2|At Least 1 Postrandomization Visit|Overall Study||16
8506065|NCT00466661|20963119|P1|At Least 1 Postrandomization Visit|Overall Study||14
8506066|NCT00466661|20963118|P2|STARTED|Overall Study||17
8506067|NCT00466661|20963119|P1|STARTED|Overall Study||16
8506068|NCT00466505|20963141|P1|NOT COMPLETED|Overall Study||17
8506069|NCT00466505|20963141|P1|COMPLETED|Overall Study||0
8506070|NCT00466505|20963141|P1|STARTED|Overall Study||17
8506071|NCT00466440|20963156|P3|NOT COMPLETED|Overall Study||12
8506072|NCT00466440|20963157|P2|NOT COMPLETED|Overall Study||12
8506073|NCT00466440|20963158|P1|NOT COMPLETED|Overall Study||14
8506074|NCT00466440|20963156|P3|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|34
8506075|NCT00466440|20963157|P2|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|36
8506076|NCT00466440|20963158|P1|COMPLETED|Overall Study||0
8506077|NCT00466440|20963156|P3|Received at Least One Dose of Study Drug|Overall Study||41
8506078|NCT00466440|20963157|P2|Received at Least One Dose of Study Drug|Overall Study||47
8506079|NCT00466440|20963158|P1|Received at Least One Dose of Study Drug|Overall Study||14
8506080|NCT00466440|20963156|P3|STARTED|Overall Study||46
8506081|NCT00466440|20963157|P2|STARTED|Overall Study||48
8506082|NCT00466440|20963158|P1|STARTED|Overall Study||14
8506083|NCT00466323|20963197|P2|NOT COMPLETED|Overall Study||23
8506084|NCT00466323|20963198|P1|NOT COMPLETED|Overall Study||28
8506085|NCT00466323|20963197|P2|COMPLETED|Overall Study||92
8506086|NCT00466323|20963198|P1|COMPLETED|Overall Study||89
8506087|NCT00466323|20963197|P2|STARTED|Overall Study||115
8506088|NCT00466323|20963198|P1|STARTED|Overall Study||117
8506089|NCT00466310|20963213|P3|NOT COMPLETED|Overall Study||0
8506090|NCT00466310|20963214|P2|NOT COMPLETED|Overall Study||0
8506091|NCT00466310|20963215|P1|NOT COMPLETED|Overall Study||0
8506092|NCT00466310|20963213|P3|COMPLETED|Overall Study||31
8506093|NCT00466310|20963214|P2|COMPLETED|Overall Study||20
8506094|NCT00466310|20963215|P1|COMPLETED|Overall Study||20
8506095|NCT00466310|20963213|P3|STARTED|Overall Study||31
8506096|NCT00466310|20963214|P2|STARTED|Overall Study||20
8506097|NCT00466310|20963215|P1|STARTED|Overall Study||20
8506098|NCT00466206|20963223|P1|NOT COMPLETED|Overall Study||0
8506099|NCT00466206|20963223|P1|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
8506100|NCT00466206|20963223|P1|STARTED|Overall Study||10
8506101|NCT00466193|20963233|P2|NOT COMPLETED|Overall Study||8
8506102|NCT00466193|20963234|P1|NOT COMPLETED|Overall Study||12
8506103|NCT00466193|20963233|P2|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
8506104|NCT00466193|20963234|P1|COMPLETED|Overall Study||138
8506105|NCT00466193|20963233|P2|STARTED|Overall Study||145
8506106|NCT00466193|20963234|P1|STARTED|Overall Study||150
8506107|NCT00466167|20963261|P3|NOT COMPLETED|Overall Study||21
8506108|NCT00466167|20963262|P2|NOT COMPLETED|Overall Study||12
8506109|NCT00466167|20963263|P1|NOT COMPLETED|Overall Study||20
8506110|NCT00466167|20963261|P3|COMPLETED|Overall Study||157
8506111|NCT00466167|20963262|P2|COMPLETED|Overall Study||163
8506112|NCT00466167|20963263|P1|COMPLETED|Overall Study||145
8506113|NCT00466167|20963261|P3|STARTED|Overall Study||178
8506114|NCT00466167|20963262|P2|STARTED|Overall Study||175
8506115|NCT00466167|20963263|P1|STARTED|Overall Study||165
8506116|NCT00465998|20963319|P1|NOT COMPLETED|Overall Study||0
8506117|NCT00465998|20963319|P1|COMPLETED|Overall Study||275
8506118|NCT00465998|20963319|P1|STARTED|Overall Study||275
8506119|NCT00465985|20963324|P2|NOT COMPLETED|Part III - Open-label Treatment Period||0
8506120|NCT00465985|20963325|P1|NOT COMPLETED|Part III - Open-label Treatment Period||2
8506121|NCT00465985|20963324|P2|COMPLETED|Part III - Open-label Treatment Period||0
8506122|NCT00465985|20963325|P1|COMPLETED|Part III - Open-label Treatment Period||29
8506123|NCT00465985|20963324|P2|STARTED|Part III - Open-label Treatment Period||0
8506124|NCT00465985|20963325|P1|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
8506125|NCT00465985|20963324|P2|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
8506126|NCT00465985|20963325|P1|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
8506127|NCT00465985|20963324|P2|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
8506128|NCT00465985|20963325|P1|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
8506129|NCT00465985|20963324|P2|STARTED|Part II - 1:1 ACZ885:Placebo||16
8506130|NCT00465985|20963325|P1|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
8506131|NCT00465985|20963324|P2|NOT COMPLETED|Part I - Open-label Treatment Period||0
8506132|NCT00465985|20963325|P1|NOT COMPLETED|Part I - Open-label Treatment Period||4
8506133|NCT00465985|20963324|P2|COMPLETED|Part I - Open-label Treatment Period||0
8506134|NCT00465985|20963325|P1|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
8506135|NCT00465985|20963324|P2|STARTED|Part I - Open-label Treatment Period||0
8506136|NCT00465985|20963325|P1|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
8506137|NCT00465972|20963348|P2|NOT COMPLETED|Overall Study||1
8506138|NCT00465972|20963349|P1|NOT COMPLETED|Overall Study||2
8506139|NCT00465972|20963348|P2|COMPLETED|Overall Study||23
8506140|NCT00465972|20963349|P1|COMPLETED|Overall Study||18
8506141|NCT00465972|20963348|P2|STARTED|Overall Study||24
8506142|NCT00465972|20963349|P1|STARTED|Overall Study||20
8506143|NCT00465894|20963359|P2|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
8506144|NCT00465894|20963360|P1|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
8506145|NCT00465894|20963359|P2|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
8506146|NCT00465894|20963360|P1|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
8506147|NCT00465894|20963359|P2|STARTED|Treatment From 24 Weeks to 52 Weeks||14
8506148|NCT00465894|20963360|P1|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
8506149|NCT00465894|20963359|P2|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
8506150|NCT00465894|20963360|P1|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
8506151|NCT00465894|20963359|P2|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
8506152|NCT00465894|20963360|P1|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
8506153|NCT00465894|20963359|P2|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
8506154|NCT00465894|20963360|P1|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
8506155|NCT00465894|20963359|P2|NOT COMPLETED|Treatment For 12 Weeks||3
8506156|NCT00465894|20963360|P1|NOT COMPLETED|Treatment For 12 Weeks||5
8506157|NCT00465894|20963359|P2|COMPLETED|Treatment For 12 Weeks||25
8506158|NCT00465894|20963360|P1|COMPLETED|Treatment For 12 Weeks||25
8506159|NCT00465894|20963359|P2|STARTED|Treatment For 12 Weeks||28
8506160|NCT00465894|20963360|P1|STARTED|Treatment For 12 Weeks||30
8506161|NCT00465816|20963393|P3|NOT COMPLETED|Overall Study||2
8506162|NCT00465816|20963394|P2|NOT COMPLETED|Overall Study||0
8506163|NCT00465816|20963395|P1|NOT COMPLETED|Overall Study||0
8506164|NCT00465816|20963393|P3|COMPLETED|Overall Study||120
8506165|NCT00465816|20963394|P2|COMPLETED|Overall Study||122
8506166|NCT00465816|20963395|P1|COMPLETED|Overall Study||367
8506167|NCT00465816|20963393|P3|STARTED|Overall Study||122
8506168|NCT00465816|20963394|P2|STARTED|Overall Study||122
8506169|NCT00465816|20963395|P1|STARTED|Overall Study||367
8506170|NCT00465738|20963458|P2|NOT COMPLETED|Overall Study||6
8506171|NCT00465738|20963459|P1|NOT COMPLETED|Overall Study||6
8506172|NCT00465738|20963458|P2|COMPLETED|Overall Study||89
8506173|NCT00465738|20963459|P1|COMPLETED|Overall Study||91
8506174|NCT00465738|20963458|P2|STARTED|Overall Study||95
8506175|NCT00465738|20963459|P1|STARTED|Overall Study||97
8506176|NCT00465647|20963553|P4|NOT COMPLETED|Overall Study||13
8506177|NCT00465647|20963554|P3|NOT COMPLETED|Overall Study||11
8506178|NCT00465647|20963555|P2|NOT COMPLETED|Overall Study||8
8506179|NCT00465647|20963556|P1|NOT COMPLETED|Overall Study||13
8506180|NCT00465647|20963553|P4|COMPLETED|Overall Study||12
8506181|NCT00465647|20963554|P3|COMPLETED|Overall Study||18
8506182|NCT00465647|20963555|P2|COMPLETED|Overall Study||15
8506183|NCT00465647|20963556|P1|COMPLETED|Overall Study||26
8506184|NCT00465647|20963553|P4|STARTED|Overall Study||25
8506185|NCT00465647|20963554|P3|STARTED|Overall Study||29
8506186|NCT00465647|20963555|P2|STARTED|Overall Study||23
8506187|NCT00465647|20963556|P1|STARTED|Overall Study||39
8506188|NCT00465595|20963581|P2|NOT COMPLETED|Overall Study||5
8506189|NCT00465595|20963582|P1|NOT COMPLETED|Overall Study||5
8506190|NCT00465595|20963581|P2|COMPLETED|Overall Study||24
8506191|NCT00465595|20963582|P1|COMPLETED|Overall Study||22
8506192|NCT00465595|20963581|P2|STARTED|Overall Study||29
8506193|NCT00465595|20963582|P1|STARTED|Overall Study||27
8506194|NCT00465569|20963604|P2|NOT COMPLETED|Overall Study||0
8506195|NCT00465569|20963605|P1|NOT COMPLETED|Overall Study||1
8506196|NCT00465569|20963604|P2|COMPLETED|Overall Study||7
8506197|NCT00465569|20963605|P1|COMPLETED|Overall Study||12
8506198|NCT00465569|20963604|P2|STARTED|Overall Study||7
8506199|NCT00465569|20963605|P1|STARTED|Overall Study||13
8506200|NCT00465530|20963617|P2|NOT COMPLETED|Overall Study||4
8506201|NCT00465530|20963618|P1|NOT COMPLETED|Overall Study||2
8506202|NCT00465530|20963617|P2|COMPLETED|Overall Study||15
8506203|NCT00465530|20963618|P1|COMPLETED|Overall Study||19
8506204|NCT00465530|20963617|P2|STARTED|Overall Study||19
8506205|NCT00465530|20963618|P1|STARTED|Overall Study||21
8506206|NCT00465361|20963628|P1|NOT COMPLETED|Post-Intervention Assessment||0
8506207|NCT00465361|20963628|P1|COMPLETED|Post-Intervention Assessment||3
8506208|NCT00465361|20963628|P1|STARTED|Post-Intervention Assessment||3
8506209|NCT00465361|20963628|P1|NOT COMPLETED|Baseline Assessment||4
8506210|NCT00465361|20963628|P1|COMPLETED|Baseline Assessment||3
8506211|NCT00465361|20963628|P1|STARTED|Baseline Assessment||7
8506212|NCT00465270|20963634|P2|NOT COMPLETED|Overall Study||160
8506213|NCT00465270|20963635|P1|NOT COMPLETED|Overall Study||104
8506214|NCT00465270|20963634|P2|COMPLETED|Overall Study||321
8506215|NCT00465270|20963635|P1|COMPLETED|Overall Study||395
8506216|NCT00465270|20963634|P2|STARTED|Overall Study||481
8506217|NCT00465270|20963635|P1|STARTED|Overall Study||499
8506218|NCT00465179|20963644|P1|NOT COMPLETED|Overall Study||53
8506219|NCT00465179|20963644|P1|COMPLETED|Overall Study||4
8506220|NCT00465179|20963644|P1|STARTED|Overall Study||57
8506221|NCT00465101|20963650|P1|NOT COMPLETED|Overall Study||59
8506222|NCT00465101|20963650|P1|COMPLETED|Overall Study||91
8506223|NCT00465101|20963650|P1|STARTED|Overall Study||150
8506224|NCT00465088|20963685|P2|NOT COMPLETED|Overall Study||9
8506225|NCT00465088|20963686|P1|NOT COMPLETED|Overall Study||32
8506226|NCT00465088|20963685|P2|COMPLETED|Overall Study||70
8506227|NCT00465088|20963686|P1|COMPLETED|Overall Study||82
8506228|NCT00465088|20963685|P2|STARTED|Overall Study||79
8506229|NCT00465088|20963686|P1|STARTED|Overall Study|For both arms, started means treated.|114
8506230|NCT00464945|20963720|P2|NOT COMPLETED|Toddler Dose||1
8506231|NCT00464945|20963721|P1|NOT COMPLETED|Toddler Dose||0
8506232|NCT00464945|20963720|P2|COMPLETED|Toddler Dose||130
8506233|NCT00464945|20963721|P1|COMPLETED|Toddler Dose||131
8506234|NCT00464945|20963720|P2|STARTED|Toddler Dose||131
8506235|NCT00464945|20963721|P1|STARTED|Toddler Dose||131
8506236|NCT00464945|20963720|P2|NOT COMPLETED|After Infant Series||2
8506237|NCT00464945|20963721|P1|NOT COMPLETED|After Infant Series||0
8506238|NCT00464945|20963720|P2|COMPLETED|After Infant Series||131
8506239|NCT00464945|20963721|P1|COMPLETED|After Infant Series||131
8506240|NCT00464945|20963720|P2|STARTED|After Infant Series||133
8506241|NCT00464945|20963721|P1|STARTED|After Infant Series||131
8506242|NCT00464945|20963720|P2|NOT COMPLETED|Infant Series||1
8506243|NCT00464945|20963721|P1|NOT COMPLETED|Infant Series||4
8506244|NCT00464945|20963720|P2|COMPLETED|Infant Series||133
8506245|NCT00464945|20963721|P1|COMPLETED|Infant Series||131
8506246|NCT00464945|20963720|P2|Vaccinated Dose 3|Infant Series||133
8506247|NCT00464945|20963721|P1|Vaccinated Dose 3|Infant Series||132
8506248|NCT00464945|20963720|P2|Vaccinated Dose 2|Infant Series||133
8506249|NCT00464945|20963721|P1|Vaccinated Dose 2|Infant Series||132
8506250|NCT00464945|20963720|P2|Vaccinated Dose 1|Infant Series||134
8506251|NCT00464945|20963721|P1|Vaccinated Dose 1|Infant Series||134
8506252|NCT00464945|20963720|P2|STARTED|Infant Series||134
8506253|NCT00464945|20963721|P1|STARTED|Infant Series||135
8506254|NCT00464815|20963751|P2|NOT COMPLETED|Overall Study||3
8506255|NCT00464815|20963752|P1|NOT COMPLETED|Overall Study||6
8506256|NCT00464815|20963751|P2|COMPLETED|Overall Study||254
8506257|NCT00464815|20963752|P1|COMPLETED|Overall Study||762
8506258|NCT00464815|20963751|P2|STARTED|Overall Study||257
8506259|NCT00464815|20963752|P1|STARTED|Overall Study||768
8506260|NCT00464737|20963785|P3|NOT COMPLETED|Overall Study||55
8506261|NCT00464737|20963786|P2|NOT COMPLETED|Overall Study||32
8506262|NCT00464737|20963787|P1|NOT COMPLETED|Overall Study||32
8506263|NCT00464737|20963785|P3|COMPLETED|Overall Study||19
8506264|NCT00464737|20963786|P2|COMPLETED|Overall Study||42
8506265|NCT00464737|20963787|P1|COMPLETED|Overall Study||50
8506266|NCT00464737|20963785|P3|STARTED|Overall Study||74
8506267|NCT00464737|20963786|P2|STARTED|Overall Study||74
8506268|NCT00464737|20963787|P1|STARTED|Overall Study||82
8506269|NCT00464711|20963834|P1|NOT COMPLETED|Overall Study||15
8506270|NCT00464711|20963834|P1|COMPLETED|Overall Study||25
8506271|NCT00464711|20963834|P1|STARTED|Overall Study||40
8506272|NCT00464698|20963838|P1|NOT COMPLETED|Period 3: 120mg||2
8506273|NCT00464698|20963838|P1|COMPLETED|Period 3: 120mg||12
8506274|NCT00464698|20963838|P1|STARTED|Period 3: 120mg||14
8506275|NCT00464698|20963838|P1|NOT COMPLETED|Period 2: 60 mg||0
8506276|NCT00464698|20963838|P1|COMPLETED|Period 2: 60 mg||17
8506277|NCT00464698|20963838|P1|STARTED|Period 2: 60 mg||17
8506278|NCT00464698|20963838|P1|NOT COMPLETED|Period 1: 30 mg||3
8506279|NCT00464698|20963838|P1|COMPLETED|Period 1: 30 mg||17
8506280|NCT00464698|20963838|P1|STARTED|Period 1: 30 mg||20
8506281|NCT00464685|20963850|P2|NOT COMPLETED|Overall Study||33
8506282|NCT00464685|20963851|P1|NOT COMPLETED|Overall Study||23
8506283|NCT00464685|20963850|P2|COMPLETED|Overall Study||94
8506284|NCT00464685|20963851|P1|COMPLETED|Overall Study||103
8506285|NCT00464685|20963850|P2|STARTED|Overall Study||127
8506286|NCT00464685|20963851|P1|STARTED|Overall Study||126
8506287|NCT00464672|20963867|P6|NOT COMPLETED|Overall Study||4
8506288|NCT00464672|20963868|P5|NOT COMPLETED|Overall Study||10
8506289|NCT00464672|20963869|P4|NOT COMPLETED|Overall Study||1
8506290|NCT00464672|20963870|P3|NOT COMPLETED|Overall Study||0
8506291|NCT00464672|20963871|P2|NOT COMPLETED|Overall Study||10
8506292|NCT00464672|20963872|P1|NOT COMPLETED|Overall Study||25
8506293|NCT00464672|20963867|P6|COMPLETED|Overall Study||195
8506294|NCT00464672|20963868|P5|COMPLETED|Overall Study||392
8506295|NCT00464672|20963869|P4|COMPLETED|Overall Study||199
8506296|NCT00464672|20963870|P3|COMPLETED|Overall Study||400
8506297|NCT00464672|20963871|P2|COMPLETED|Overall Study||222
8506298|NCT00464672|20963872|P1|COMPLETED|Overall Study||435
8506299|NCT00464672|20963867|P6|STARTED|Overall Study||199
8506300|NCT00464672|20963868|P5|STARTED|Overall Study||402
8506301|NCT00464672|20963869|P4|STARTED|Overall Study||200
8506302|NCT00464672|20963870|P3|STARTED|Overall Study||400
8506303|NCT00464672|20963871|P2|STARTED|Overall Study||232
8506304|NCT00464672|20963872|P1|STARTED|Overall Study||460
8506311|NCT00464620|20963951|P3|NOT COMPLETED|Overall Study||7
8506312|NCT00464620|20963952|P2|NOT COMPLETED|Overall Study||2
8506313|NCT00464620|20963953|P1|NOT COMPLETED|Overall Study||2
8506314|NCT00464620|20963951|P3|COMPLETED|Overall Study||109
8506315|NCT00464620|20963952|P2|COMPLETED|Overall Study||198
8506316|NCT00464620|20963953|P1|COMPLETED|Overall Study|48 patients were evaluable.|48
8506317|NCT00464620|20963951|P3|STARTED|Overall Study||116
8506318|NCT00464620|20963952|P2|STARTED|Overall Study||200
8506319|NCT00464620|20963953|P1|STARTED|Overall Study||50
8506320|NCT00464568|20963980|P1|NOT COMPLETED|Overall Study||2
8506321|NCT00464568|20963980|P1|COMPLETED|Overall Study||30
8506322|NCT00464568|20963980|P1|STARTED|Overall Study||32
8506323|NCT00464542|20964053|P1|NOT COMPLETED|Post-treatment||0
8506324|NCT00464542|20964053|P1|COMPLETED|Post-treatment||10
8506325|NCT00464542|20964053|P1|STARTED|Post-treatment||10
8506326|NCT00464542|20964053|P1|NOT COMPLETED|Pre-treatment||2
8506327|NCT00464542|20964053|P1|COMPLETED|Pre-treatment||10
8506328|NCT00464542|20964053|P1|STARTED|Pre-treatment||12
8506329|NCT00464490|20964060|P2|NOT COMPLETED|Overall Study||11
8506330|NCT00464490|20964061|P1|NOT COMPLETED|Overall Study||11
8506331|NCT00464490|20964060|P2|COMPLETED|Overall Study||10
8506332|NCT00464490|20964061|P1|COMPLETED|Overall Study||10
8506333|NCT00464490|20964060|P2|STARTED|Overall Study||21
8506334|NCT00464490|20964061|P1|STARTED|Overall Study||21
8506335|NCT00464464|20964069|P2|NOT COMPLETED|Overall Study||3
8506336|NCT00464464|20964070|P1|NOT COMPLETED|Overall Study||5
8506337|NCT00464464|20964069|P2|COMPLETED|Overall Study||36
8506338|NCT00464464|20964070|P1|COMPLETED|Overall Study||36
8506339|NCT00464464|20964069|P2|STARTED|Overall Study||39
8506340|NCT00464464|20964070|P1|STARTED|Overall Study||41
8506341|NCT00464438|20964084|P2|NOT COMPLETED|Overall Study||6
8506342|NCT00464438|20964085|P1|NOT COMPLETED|Overall Study||2
8506343|NCT00464438|20964084|P2|COMPLETED|Overall Study||80
8506344|NCT00464438|20964085|P1|COMPLETED|Overall Study||83
8506345|NCT00464438|20964084|P2|STARTED|Overall Study||86
8506346|NCT00464438|20964085|P1|STARTED|Overall Study||85
8506347|NCT00464334|20964108|P11|NOT COMPLETED|Overall Study||4
8506348|NCT00464334|20964109|P10|NOT COMPLETED|Overall Study||1
8506349|NCT00464334|20964110|P9|NOT COMPLETED|Overall Study||6
8506350|NCT00464334|20964111|P8|NOT COMPLETED|Overall Study||1
8506351|NCT00464334|20964112|P7|NOT COMPLETED|Overall Study||3
8506352|NCT00464334|20964113|P6|NOT COMPLETED|Overall Study||4
8506353|NCT00464334|20964114|P5|NOT COMPLETED|Overall Study||4
8506354|NCT00464334|20964115|P4|NOT COMPLETED|Overall Study||4
8506355|NCT00464334|20964116|P3|NOT COMPLETED|Overall Study||5
8506356|NCT00464334|20964117|P2|NOT COMPLETED|Overall Study||8
8506357|NCT00464334|20964118|P1|NOT COMPLETED|Overall Study||1
8506358|NCT00464334|20964108|P11|COMPLETED|Overall Study||4
8506359|NCT00464334|20964109|P10|COMPLETED|Overall Study||4
8506360|NCT00464334|20964110|P9|COMPLETED|Overall Study||2
8506361|NCT00464334|20964111|P8|COMPLETED|Overall Study||7
8506362|NCT00464334|20964112|P7|COMPLETED|Overall Study||6
8506363|NCT00464334|20964113|P6|COMPLETED|Overall Study||3
8506364|NCT00464334|20964114|P5|COMPLETED|Overall Study||3
8506365|NCT00464334|20964115|P4|COMPLETED|Overall Study||4
8506366|NCT00464334|20964116|P3|COMPLETED|Overall Study||3
8506367|NCT00464334|20964117|P2|COMPLETED|Overall Study||5
8506368|NCT00464334|20964118|P1|COMPLETED|Overall Study||4
8506369|NCT00464334|20964108|P11|STARTED|Overall Study||8
8506370|NCT00464334|20964109|P10|STARTED|Overall Study||5
8506371|NCT00464334|20964110|P9|STARTED|Overall Study||8
8506372|NCT00464334|20964111|P8|STARTED|Overall Study||8
8506373|NCT00464334|20964112|P7|STARTED|Overall Study||9
8506374|NCT00464334|20964113|P6|STARTED|Overall Study||7
8506375|NCT00464334|20964114|P5|STARTED|Overall Study||7
8506376|NCT00464334|20964115|P4|STARTED|Overall Study||8
8506377|NCT00464334|20964116|P3|STARTED|Overall Study||8
8506378|NCT00464334|20964117|P2|STARTED|Overall Study||13
8506379|NCT00464334|20964118|P1|STARTED|Overall Study||5
8506380|NCT00464308|20964178|P3|NOT COMPLETED|Overall Study||59
8506381|NCT00464308|20964179|P2|NOT COMPLETED|Overall Study||63
8506382|NCT00464308|20964180|P1|NOT COMPLETED|Overall Study||69
8506383|NCT00464308|20964178|P3|COMPLETED|Overall Study||400
8506384|NCT00464308|20964179|P2|COMPLETED|Overall Study||406
8506385|NCT00464308|20964180|P1|COMPLETED|Overall Study||395
8506386|NCT00464308|20964178|P3|STARTED|Overall Study||459
8506387|NCT00464308|20964179|P2|STARTED|Overall Study||469
8506388|NCT00464308|20964180|P1|STARTED|Overall Study||464
8506401|NCT00464204|20964313|P2|NOT COMPLETED|Overall Study||32
8506402|NCT00464204|20964314|P1|NOT COMPLETED|Overall Study||49
8506403|NCT00464204|20964313|P2|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
8506404|NCT00464204|20964314|P1|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
8506405|NCT00464204|20964313|P2|Withdrawal Due to Discharge From ICU|Overall Study||11
8506406|NCT00464204|20964314|P1|Withdrawal Due to Discharge From ICU|Overall Study||18
8506407|NCT00464204|20964313|P2|Day 90 Follow-up Performed|Overall Study||74
8506408|NCT00464204|20964314|P1|Day 90 Follow-up Performed|Overall Study||69
8506409|NCT00464204|20964313|P2|Day 30 Follow-up Performed|Overall Study||83
8506410|NCT00464204|20964314|P1|Day 30 Follow-up Performed|Overall Study||89
8506411|NCT00464204|20964313|P2|Completed Treatment|Overall Study||83
8506412|NCT00464204|20964314|P1|Completed Treatment|Overall Study||81
8506413|NCT00464204|20964313|P2|STARTED|Overall Study||96
8506414|NCT00464204|20964314|P1|STARTED|Overall Study||100
8506415|NCT00464087|20964351|P3|NOT COMPLETED|Overall Study||29
8506416|NCT00464087|20964352|P2|NOT COMPLETED|Overall Study||0
8506417|NCT00464087|20964353|P1|NOT COMPLETED|Overall Study||0
8506418|NCT00464087|20964351|P3|COMPLETED|Overall Study||0
8506419|NCT00464087|20964352|P2|COMPLETED|Overall Study||51
8506420|NCT00464087|20964353|P1|COMPLETED|Overall Study||49
8506421|NCT00464087|20964351|P3|STARTED|Overall Study||29
8506422|NCT00464087|20964352|P2|STARTED|Overall Study||51
8506423|NCT00464087|20964353|P1|STARTED|Overall Study||49
8506424|NCT00463866|20964371|P2|NOT COMPLETED|Overall Study||340
8506425|NCT00463866|20964372|P1|NOT COMPLETED|Overall Study||309
8506426|NCT00463866|20964371|P2|COMPLETED|Overall Study||3705
8506427|NCT00463866|20964372|P1|COMPLETED|Overall Study||3699
8506428|NCT00463866|20964371|P2|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
8506429|NCT00463866|20964372|P1|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
8506430|NCT00463840|20964392|P1|NOT COMPLETED|Overall Study||12
8506431|NCT00463840|20964392|P1|COMPLETED|Overall Study||12
8506432|NCT00463840|20964392|P1|STARTED|Overall Study||24
8506433|NCT00463801|20964397|P1|NOT COMPLETED|Overall Study||13
8506434|NCT00463801|20964397|P1|COMPLETED|Overall Study||39
8506435|NCT00463801|20964397|P1|STARTED|Overall Study||52
8506436|NCT00463788|20964403|P2|NOT COMPLETED|Overall Study||54
8506437|NCT00463788|20964404|P1|NOT COMPLETED|Overall Study||109
8506438|NCT00463788|20964403|P2|COMPLETED|Overall Study||4
8506439|NCT00463788|20964404|P1|COMPLETED|Overall Study||6
8506440|NCT00463788|20964403|P2|Treated|Overall Study||57
8506441|NCT00463788|20964404|P1|Treated|Overall Study||114
8506442|NCT00463788|20964403|P2|STARTED|Overall Study||58
8506443|NCT00463788|20964404|P1|STARTED|Overall Study||115
8506444|NCT00463684|20964419|P1|NOT COMPLETED|Overall Study||4
8506445|NCT00463684|20964419|P1|COMPLETED|Overall Study||274
8506446|NCT00463684|20964419|P1|STARTED|Overall Study||278
8506447|NCT00463606|20964437|P3|NOT COMPLETED|Overall Study||20
8506448|NCT00463606|20964438|P2|NOT COMPLETED|Overall Study||34
8506449|NCT00463606|20964439|P1|NOT COMPLETED|Overall Study||41
8506450|NCT00463606|20964437|P3|COMPLETED|Overall Study||231
8506451|NCT00463606|20964438|P2|COMPLETED|Overall Study||220
8506452|NCT00463606|20964439|P1|COMPLETED|Overall Study||212
8506453|NCT00463606|20964437|P3|STARTED|Overall Study||251
8506454|NCT00463606|20964438|P2|STARTED|Overall Study||254
8506455|NCT00463606|20964439|P1|STARTED|Overall Study||253
8506456|NCT00463580|20964464|P2|NOT COMPLETED|Overall Study||2
8506457|NCT00463580|20964465|P1|NOT COMPLETED|Overall Study||3
8506458|NCT00463580|20964464|P2|COMPLETED|Overall Study||28
8506459|NCT00463580|20964465|P1|COMPLETED|Overall Study||27
8506460|NCT00463580|20964464|P2|STARTED|Overall Study||30
8506461|NCT00463580|20964465|P1|STARTED|Overall Study||30
8506462|NCT00463567|20964498|P7|NOT COMPLETED|Overall Study||11
8506463|NCT00463567|20964499|P6|NOT COMPLETED|Overall Study||21
8506464|NCT00463567|20964500|P5|NOT COMPLETED|Overall Study||23
8506465|NCT00463567|20964501|P4|NOT COMPLETED|Overall Study||131
8506466|NCT00463567|20964502|P3|NOT COMPLETED|Overall Study||89
8506467|NCT00463567|20964503|P2|NOT COMPLETED|Overall Study||77
8506468|NCT00463567|20964504|P1|NOT COMPLETED|Overall Study||95
8506469|NCT00463567|20964498|P7|COMPLETED|Overall Study||112
8506470|NCT00463567|20964499|P6|COMPLETED|Overall Study||102
8506471|NCT00463567|20964500|P5|COMPLETED|Overall Study||107
8506472|NCT00463567|20964501|P4|COMPLETED|Overall Study||294
8506473|NCT00463567|20964502|P3|COMPLETED|Overall Study||331
8506474|NCT00463567|20964503|P2|COMPLETED|Overall Study||341
8506475|NCT00463567|20964504|P1|COMPLETED|Overall Study||325
8506476|NCT00463567|20964498|P7|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
8506477|NCT00463567|20964499|P6|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
8506478|NCT00463567|20964500|P5|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
8506479|NCT00463567|20964501|P4|Safety Population: Received Study Drug|Overall Study||418
8506480|NCT00463567|20964502|P3|Safety Population: Received Study Drug|Overall Study||415
8506481|NCT00463567|20964503|P2|Safety Population: Received Study Drug|Overall Study||416
8506482|NCT00463567|20964504|P1|Safety Population: Received Study Drug|Overall Study||416
8506483|NCT00463567|20964498|P7|STARTED|Overall Study||123
8506484|NCT00463567|20964499|P6|STARTED|Overall Study||123
8506485|NCT00463567|20964500|P5|STARTED|Overall Study||130
8506486|NCT00463567|20964501|P4|STARTED|Overall Study||425
8506487|NCT00463567|20964502|P3|STARTED|Overall Study||420
8506488|NCT00463567|20964503|P2|STARTED|Overall Study||418
8506489|NCT00463567|20964504|P1|STARTED|Overall Study|Randomized Participants|420
8506490|NCT00463476|20964537|P2|NOT COMPLETED|Overall Study||3
8506491|NCT00463476|20964538|P1|NOT COMPLETED|Overall Study||2
8506492|NCT00463476|20964537|P2|COMPLETED|Overall Study||151
8506493|NCT00463476|20964538|P1|COMPLETED|Overall Study||149
8506494|NCT00463476|20964537|P2|STARTED|Overall Study||154
8506495|NCT00463476|20964538|P1|STARTED|Overall Study||151
8506496|NCT00463437|20964558|P4|NOT COMPLETED|Overall Study||7
8506497|NCT00463437|20964559|P3|NOT COMPLETED|Overall Study||6
8506498|NCT00463437|20964560|P2|NOT COMPLETED|Overall Study||11
8506499|NCT00463437|20964561|P1|NOT COMPLETED|Overall Study||4
8506500|NCT00463437|20964558|P4|COMPLETED|Overall Study||350
8506501|NCT00463437|20964559|P3|COMPLETED|Overall Study||352
8506502|NCT00463437|20964560|P2|COMPLETED|Overall Study||352
8506503|NCT00463437|20964561|P1|COMPLETED|Overall Study||355
8506504|NCT00463437|20964558|P4|STARTED|Overall Study||357
8506505|NCT00463437|20964559|P3|STARTED|Overall Study||358
8506506|NCT00463437|20964560|P2|STARTED|Overall Study||363
8506507|NCT00463437|20964561|P1|STARTED|Overall Study||359
8506508|NCT00463385|20964627|P4|NOT COMPLETED|Overall Study||22
8506509|NCT00463385|20964628|P3|NOT COMPLETED|Overall Study||22
8506510|NCT00463385|20964629|P2|NOT COMPLETED|Overall Study||22
8506511|NCT00463385|20964630|P1|NOT COMPLETED|Overall Study||22
8506512|NCT00463385|20964627|P4|COMPLETED|Overall Study||0
8506513|NCT00463385|20964628|P3|COMPLETED|Overall Study||0
8506514|NCT00463385|20964629|P2|COMPLETED|Overall Study||0
8506515|NCT00463385|20964630|P1|COMPLETED|Overall Study||0
8506516|NCT00463385|20964627|P4|Treated|Overall Study||22
8506517|NCT00463385|20964628|P3|Treated|Overall Study||19
8506518|NCT00463385|20964629|P2|Treated|Overall Study||22
8506519|NCT00463385|20964630|P1|Treated|Overall Study||22
8506520|NCT00463385|20964627|P4|STARTED|Overall Study||22
8506521|NCT00463385|20964628|P3|STARTED|Overall Study||22
8506522|NCT00463385|20964629|P2|STARTED|Overall Study||22
8506523|NCT00463385|20964630|P1|STARTED|Overall Study||22
8506524|NCT00463346|20964682|P2|NOT COMPLETED|Overall Study||3
8506525|NCT00463346|20964683|P1|NOT COMPLETED|Overall Study||3
8506526|NCT00463346|20964682|P2|COMPLETED|Overall Study||8
8506527|NCT00463346|20964683|P1|COMPLETED|Overall Study||9
8506528|NCT00463346|20964682|P2|STARTED|Overall Study||11
8506529|NCT00463346|20964683|P1|STARTED|Overall Study||12
8506530|NCT00463229|20964693|P2|NOT COMPLETED|Overall Study||10
8506531|NCT00463229|20964694|P1|NOT COMPLETED|Overall Study||9
8506532|NCT00463229|20964693|P2|COMPLETED|Overall Study||39
8506533|NCT00463229|20964694|P1|COMPLETED|Overall Study||43
8506534|NCT00463229|20964693|P2|STARTED|Overall Study||49
8506535|NCT00463229|20964694|P1|STARTED|Overall Study||52
8506536|NCT00463060|20964714|P1|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
8506537|NCT00463060|20964714|P1|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
8506538|NCT00463060|20964714|P1|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
8506539|NCT00463060|20964714|P1|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
8506540|NCT00463060|20964714|P1|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
8506541|NCT00463060|20964714|P1|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
8506542|NCT00463060|20964714|P1|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
8506543|NCT00463060|20964714|P1|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
8506544|NCT00463060|20964714|P1|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
8506545|NCT00463060|20964714|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
8506546|NCT00463060|20964714|P1|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
8506547|NCT00463060|20964714|P1|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
8506548|NCT00463060|20964714|P1|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
8506549|NCT00463060|20964714|P1|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
8506550|NCT00463060|20964714|P1|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
8506551|NCT00463047|20964728|P2|NOT COMPLETED|Double-Blind Treatment Period 2||2
8506552|NCT00463047|20964729|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
8506553|NCT00463047|20964728|P2|COMPLETED|Double-Blind Treatment Period 2||88
8506554|NCT00463047|20964729|P1|COMPLETED|Double-Blind Treatment Period 2||92
8506555|NCT00463047|20964728|P2|STARTED|Double-Blind Treatment Period 2||90
8506556|NCT00463047|20964729|P1|STARTED|Double-Blind Treatment Period 2||93
8506557|NCT00463047|20964728|P2|NOT COMPLETED|Double-Blind Treatment Period 1||4
8506558|NCT00463047|20964729|P1|NOT COMPLETED|Double-Blind Treatment Period 1||3
8506559|NCT00463047|20964728|P2|COMPLETED|Double-Blind Treatment Period 1||90
8506560|NCT00463047|20964729|P1|COMPLETED|Double-Blind Treatment Period 1||93
8506561|NCT00463047|20964728|P2|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
8506562|NCT00463047|20964729|P1|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
8506563|NCT00463047|20964728|P2|NOT COMPLETED|Titration Period 2||23
8506564|NCT00463047|20964729|P1|NOT COMPLETED|Titration Period 2||30
8506565|NCT00463047|20964728|P2|COMPLETED|Titration Period 2||98
8506566|NCT00463047|20964729|P1|COMPLETED|Titration Period 2||93
8506567|NCT00463047|20964728|P2|STARTED|Titration Period 2||121
8506568|NCT00463047|20964729|P1|STARTED|Titration Period 2||123
8506569|NCT00463047|20964728|P2|NOT COMPLETED|Titration Period 1||39
8506570|NCT00463047|20964729|P1|NOT COMPLETED|Titration Period 1||37
8506571|NCT00463047|20964728|P2|COMPLETED|Titration Period 1||121
8506572|NCT00463047|20964729|P1|COMPLETED|Titration Period 1||123
8506573|NCT00463047|20964728|P2|STARTED|Titration Period 1||160
8506574|NCT00463047|20964729|P1|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
8506575|NCT00462982|20964814|P1|NOT COMPLETED|Overall Study||3
8506576|NCT00462982|20964814|P1|COMPLETED|Overall Study||5
8506577|NCT00462982|20964814|P1|STARTED|Overall Study||8
8506578|NCT00462943|20964821|P3|NOT COMPLETED|Overall Study||23
8506579|NCT00462943|20964822|P2|NOT COMPLETED|Overall Study||30
8506580|NCT00462943|20964823|P1|NOT COMPLETED|Overall Study||45
8506581|NCT00462943|20964821|P3|COMPLETED|Overall Study||0
8506582|NCT00462943|20964822|P2|COMPLETED|Overall Study||1
8506583|NCT00462943|20964823|P1|COMPLETED|Overall Study||1
8506584|NCT00462943|20964821|P3|STARTED|Overall Study||23
8506585|NCT00462943|20964822|P2|STARTED|Overall Study||31
8506586|NCT00462943|20964823|P1|STARTED|Overall Study||46
8506587|NCT00462917|20964894|P4|NOT COMPLETED|Overall Study||11
8506588|NCT00462917|20964895|P3|NOT COMPLETED|Overall Study||12
8506589|NCT00462917|20964896|P2|NOT COMPLETED|Overall Study||10
8506590|NCT00462917|20964897|P1|NOT COMPLETED|Overall Study||10
8506591|NCT00462917|20964894|P4|COMPLETED|Overall Study||66
8506592|NCT00462917|20964895|P3|COMPLETED|Overall Study||54
8506593|NCT00462917|20964896|P2|COMPLETED|Overall Study||65
8506594|NCT00462917|20964897|P1|COMPLETED|Overall Study||62
8506595|NCT00462917|20964894|P4|Completed 6 Month Follow-up|Overall Study||66
8506596|NCT00462917|20964895|P3|Completed 6 Month Follow-up|Overall Study||55
8506597|NCT00462917|20964896|P2|Completed 6 Month Follow-up|Overall Study||68
8506598|NCT00462917|20964897|P1|Completed 6 Month Follow-up|Overall Study||63
8506599|NCT00462917|20964894|P4|Completed 6 Week Follow-up|Overall Study||68
8506600|NCT00462917|20964895|P3|Completed 6 Week Follow-up|Overall Study||55
8506601|NCT00462917|20964896|P2|Completed 6 Week Follow-up|Overall Study||70
8506602|NCT00462917|20964897|P1|Completed 6 Week Follow-up|Overall Study||63
8506603|NCT00462917|20964894|P4|Received Risk Information|Overall Study||68
8506604|NCT00462917|20964895|P3|Received Risk Information|Overall Study||55
8506605|NCT00462917|20964896|P2|Received Risk Information|Overall Study||70
8506606|NCT00462917|20964897|P1|Received Risk Information|Overall Study||64
8506607|NCT00462917|20964894|P4|Met With Genetic Counselor|Overall Study||71
8506608|NCT00462917|20964895|P3|Met With Genetic Counselor|Overall Study||56
8506609|NCT00462917|20964896|P2|Met With Genetic Counselor|Overall Study||71
8506610|NCT00462917|20964897|P1|Met With Genetic Counselor|Overall Study||66
8506611|NCT00462917|20964894|P4|STARTED|Overall Study||77
8506612|NCT00462917|20964895|P3|STARTED|Overall Study||66
8506613|NCT00462917|20964896|P2|STARTED|Overall Study||75
8506614|NCT00462917|20964897|P1|STARTED|Overall Study||72
8506615|NCT00462904|20964915|P1|NOT COMPLETED|Overall Study||1
8506616|NCT00462904|20964915|P1|COMPLETED|Overall Study||3
8506617|NCT00462904|20964915|P1|STARTED|Overall Study||4
8506618|NCT00462865|20964920|P1|NOT COMPLETED|Overall Study||1
8506619|NCT00462865|20964920|P1|COMPLETED|Overall Study||17
8506620|NCT00462865|20964920|P1|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
8506621|NCT00462839|20964927|P2|NOT COMPLETED|Viewed Second||0
8506622|NCT00462839|20964928|P1|NOT COMPLETED|Viewed Second||0
8506623|NCT00462839|20964927|P2|COMPLETED|Viewed Second||53
8506624|NCT00462839|20964928|P1|COMPLETED|Viewed Second||53
8506625|NCT00462839|20964927|P2|STARTED|Viewed Second||53
8506626|NCT00462839|20964928|P1|STARTED|Viewed Second||53
8506627|NCT00462839|20964927|P2|NOT COMPLETED|Viewed First||0
8506628|NCT00462839|20964928|P1|NOT COMPLETED|Viewed First||0
8506629|NCT00462839|20964927|P2|COMPLETED|Viewed First||53
8506630|NCT00462839|20964928|P1|COMPLETED|Viewed First||53
8506631|NCT00462839|20964927|P2|STARTED|Viewed First||53
8506632|NCT00462839|20964928|P1|STARTED|Viewed First||53
8506633|NCT00462826|20964940|P1|NOT COMPLETED|Overall Study||5
8506634|NCT00462826|20964940|P1|COMPLETED|Overall Study||44
8506635|NCT00462826|20964940|P1|STARTED|Overall Study||49
8506636|NCT00462761|20964953|P1|NOT COMPLETED|Overall Study||76
8506637|NCT00462761|20964953|P1|COMPLETED|Overall Study||0
8506638|NCT00462761|20964953|P1|STARTED|Overall Study||76
8506639|NCT00462748|20965028|P3|NOT COMPLETED|Overall Study||11
8506640|NCT00462748|20965029|P2|NOT COMPLETED|Overall Study||11
8506641|NCT00462748|20965030|P1|NOT COMPLETED|Overall Study||12
8506642|NCT00462748|20965028|P3|COMPLETED|Overall Study||251
8506643|NCT00462748|20965029|P2|COMPLETED|Overall Study||252
8506644|NCT00462748|20965030|P1|COMPLETED|Overall Study||249
8506645|NCT00462748|20965028|P3|STARTED|Overall Study||262
8506646|NCT00462748|20965029|P2|STARTED|Overall Study||263
8506647|NCT00462748|20965030|P1|STARTED|Overall Study||261
8506648|NCT00462735|20965038|P1|NOT COMPLETED|Overall Study||0
8506649|NCT00462735|20965038|P1|COMPLETED|Overall Study||33
8506650|NCT00462735|20965038|P1|STARTED|Overall Study||33
8506651|NCT00462722|20965049|P3|NOT COMPLETED|Overall Study||12
8506652|NCT00462722|20965050|P2|NOT COMPLETED|Overall Study||4
8506653|NCT00462722|20965051|P1|NOT COMPLETED|Overall Study||13
8506654|NCT00462722|20965049|P3|COMPLETED|Overall Study||42
8506655|NCT00462722|20965050|P2|COMPLETED|Overall Study||51
8506656|NCT00462722|20965051|P1|COMPLETED|Overall Study||37
8506657|NCT00462722|20965049|P3|STARTED|Overall Study||54
8506658|NCT00462722|20965050|P2|STARTED|Overall Study||55
8506659|NCT00462722|20965051|P1|STARTED|Overall Study||50
8506663|NCT00462670|20965092|P2|NOT COMPLETED|Overall Study||7
8506664|NCT00462670|20965093|P1|NOT COMPLETED|Overall Study||5
8506665|NCT00462670|20965092|P2|COMPLETED|Overall Study||46
8506666|NCT00462670|20965093|P1|COMPLETED|Overall Study||52
8506667|NCT00462670|20965092|P2|STARTED|Overall Study||53
8506668|NCT00462670|20965093|P1|STARTED|Overall Study||57
8506669|NCT00462644|20965103|P2|NOT COMPLETED|Overall Study||0
8506670|NCT00462644|20965104|P1|NOT COMPLETED|Overall Study||0
8506671|NCT00462644|20965103|P2|COMPLETED|Overall Study||12
8506672|NCT00462644|20965104|P1|COMPLETED|Overall Study||18
8506673|NCT00462644|20965103|P2|STARTED|Overall Study||12
8506674|NCT00462644|20965104|P1|STARTED|Overall Study||18
8506675|NCT00462605|20965122|P1|NOT COMPLETED|Overall Study||14
8506676|NCT00462605|20965122|P1|COMPLETED|Overall Study||10
8506677|NCT00462605|20965122|P1|STARTED|Overall Study||24
8506678|NCT00462501|20965130|P1|NOT COMPLETED|Overall Study||5
8506679|NCT00462501|20965130|P1|COMPLETED|Overall Study||30
8506680|NCT00462501|20965130|P1|STARTED|Overall Study||35
8506681|NCT00462488|20965136|P2|NOT COMPLETED|Overall Study||17
8506682|NCT00462488|20965137|P1|NOT COMPLETED|Overall Study||20
8506683|NCT00462488|20965136|P2|COMPLETED|Overall Study||6
8506684|NCT00462488|20965137|P1|COMPLETED|Overall Study||3
8506685|NCT00462488|20965136|P2|Completed Maintenance 2|Overall Study||6
8506686|NCT00462488|20965137|P1|Completed Maintenance 2|Overall Study||7
8506687|NCT00462488|20965136|P2|Completed Induction 2/Maintenance 1|Overall Study||9
8506688|NCT00462488|20965137|P1|Completed Induction 2/Maintenance 1|Overall Study||18
8506689|NCT00462488|20965136|P2|Completed Induction Phase|Overall Study||23
8506690|NCT00462488|20965137|P1|Completed Induction Phase|Overall Study||22
8506691|NCT00462488|20965136|P2|STARTED|Overall Study||23
8506692|NCT00462488|20965137|P1|STARTED|Overall Study||23
8506693|NCT00462462|20965145|P2|NOT COMPLETED|Overall Study||1
8506694|NCT00462462|20965146|P1|NOT COMPLETED|Overall Study||0
8506695|NCT00462462|20965145|P2|COMPLETED|Overall Study||13
8506696|NCT00462462|20965146|P1|COMPLETED|Overall Study||17
8506697|NCT00462462|20965145|P2|STARTED|Overall Study||14
8506698|NCT00462462|20965146|P1|STARTED|Overall Study||17
8506699|NCT00462449|20965156|P2|NOT COMPLETED|Overall Study||0
8506700|NCT00462449|20965157|P1|NOT COMPLETED|Overall Study||0
8506701|NCT00462449|20965156|P2|COMPLETED|Overall Study||10
8506702|NCT00462449|20965157|P1|COMPLETED|Overall Study||13
8506703|NCT00462449|20965156|P2|STARTED|Overall Study||10
8506704|NCT00462449|20965157|P1|STARTED|Overall Study||13
8506705|NCT00462423|20965167|P1|NOT COMPLETED|Overall Study||0
8506706|NCT00462423|20965167|P1|COMPLETED|Overall Study||50
8506707|NCT00462423|20965167|P1|STARTED|Overall Study||50
8506708|NCT00462384|20965174|P1|NOT COMPLETED|Overall Study||9
8506709|NCT00462384|20965174|P1|COMPLETED|Overall Study||30
8506710|NCT00462384|20965174|P1|STARTED|Overall Study||39
8506711|NCT00462345|20965182|P1|NOT COMPLETED|Overall Study||3
8506712|NCT00462345|20965182|P1|COMPLETED|Overall Study||37
8506713|NCT00462345|20965182|P1|Completed First Course|Overall Study||38
8506714|NCT00462345|20965182|P1|STARTED|Overall Study||40
8506715|NCT00462332|20965206|P2|NOT COMPLETED|Overall Study||0
8506716|NCT00462332|20965207|P1|NOT COMPLETED|Overall Study||0
8506717|NCT00462332|20965206|P2|COMPLETED|Overall Study||41
8506718|NCT00462332|20965207|P1|COMPLETED|Overall Study||45
8506719|NCT00462332|20965206|P2|STARTED|Overall Study||41
8506720|NCT00462332|20965207|P1|STARTED|Overall Study||45
8506721|NCT00462306|20965217|P2|NOT COMPLETED|Overall Study||13
8506722|NCT00462306|20965218|P1|NOT COMPLETED|Overall Study||0
8506723|NCT00462306|20965217|P2|COMPLETED|Overall Study||490
8506724|NCT00462306|20965218|P1|COMPLETED|Overall Study||4074
8506725|NCT00462306|20965217|P2|STARTED|Overall Study||503
8506726|NCT00462306|20965218|P1|STARTED|Overall Study||4074
8506727|NCT00462280|20965230|P4|NOT COMPLETED|Overall Study||3
8506728|NCT00462280|20965231|P3|NOT COMPLETED|Overall Study||0
8506729|NCT00462280|20965232|P2|NOT COMPLETED|Overall Study||7
8506730|NCT00462280|20965233|P1|NOT COMPLETED|Overall Study||10
8506731|NCT00462280|20965230|P4|COMPLETED|Overall Study||4
8506732|NCT00462280|20965231|P3|COMPLETED|Overall Study||7
8506733|NCT00462280|20965232|P2|COMPLETED|Overall Study||25
8506734|NCT00462280|20965233|P1|COMPLETED|Overall Study||24
8506735|NCT00462280|20965230|P4|STARTED|Overall Study||7
8506736|NCT00462280|20965231|P3|STARTED|Overall Study||7
8506737|NCT00462280|20965232|P2|STARTED|Overall Study||32
8506738|NCT00462280|20965233|P1|STARTED|Overall Study||34
8506739|NCT00462228|20965293|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
8506740|NCT00462228|20965293|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
8506741|NCT00462228|20965293|P1|STARTED|No Treatment (Washout) 4 Weeks||11
8506742|NCT00462228|20965293|P1|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
8506743|NCT00462228|20965293|P1|COMPLETED|Placebo or Memantine 12 Weeks||11
8506744|NCT00462228|20965293|P1|STARTED|Placebo or Memantine 12 Weeks||11
8506745|NCT00462228|20965293|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
8506746|NCT00462228|20965293|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
8506747|NCT00462228|20965293|P1|STARTED|No Treatment (Washout) 4 Weeks||11
8506748|NCT00462228|20965293|P1|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
8506749|NCT00462228|20965293|P1|COMPLETED|Memantine or Placebo 12 Weeks||11
8506750|NCT00462228|20965293|P1|STARTED|Memantine or Placebo 12 Weeks||11
8506751|NCT00462124|20965314|P1|NOT COMPLETED|Overall Study||1
8506752|NCT00462124|20965314|P1|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6
8506753|NCT00462124|20965314|P1|STARTED|Overall Study||7
8506754|NCT00462072|20965322|P3|NOT COMPLETED|Week 10||0
8506755|NCT00462072|20965323|P2|NOT COMPLETED|Week 10||0
8506756|NCT00462072|20965324|P1|NOT COMPLETED|Week 10||0
8506757|NCT00462072|20965322|P3|COMPLETED|Week 10||9
8506758|NCT00462072|20965323|P2|COMPLETED|Week 10||12
8506759|NCT00462072|20965324|P1|COMPLETED|Week 10||10
8506760|NCT00462072|20965322|P3|STARTED|Week 10||9
8506761|NCT00462072|20965323|P2|STARTED|Week 10||12
8506762|NCT00462072|20965324|P1|STARTED|Week 10||10
8506763|NCT00462072|20965322|P3|NOT COMPLETED|Baseline (Week 0)||0
8506764|NCT00462072|20965323|P2|NOT COMPLETED|Baseline (Week 0)||0
8506765|NCT00462072|20965324|P1|NOT COMPLETED|Baseline (Week 0)||0
8506766|NCT00462072|20965322|P3|COMPLETED|Baseline (Week 0)||9
8506767|NCT00462072|20965323|P2|COMPLETED|Baseline (Week 0)||12
8506768|NCT00462072|20965324|P1|COMPLETED|Baseline (Week 0)||10
8506769|NCT00462072|20965322|P3|STARTED|Baseline (Week 0)||9
8506770|NCT00462072|20965323|P2|STARTED|Baseline (Week 0)||12
8506771|NCT00462072|20965324|P1|STARTED|Baseline (Week 0)||10
8506778|NCT00461981|20965349|P2|NOT COMPLETED|Overall Study||9
8506779|NCT00461981|20965350|P1|NOT COMPLETED|Overall Study||11
8506780|NCT00461981|20965349|P2|COMPLETED|Overall Study||42
8506781|NCT00461981|20965350|P1|COMPLETED|Overall Study||39
8506782|NCT00461981|20965349|P2|STARTED|Overall Study||51
8506783|NCT00461981|20965350|P1|STARTED|Overall Study||50
8506784|NCT00461851|20965460|P1|NOT COMPLETED|Overall Study||0
8506785|NCT00461851|20965460|P1|COMPLETED|Overall Study||17
8506786|NCT00461851|20965460|P1|STARTED|Overall Study||17
8506787|NCT00461812|20965466|P1|NOT COMPLETED|Overall Study||10
8506788|NCT00461812|20965466|P1|COMPLETED|Overall Study||0
8506789|NCT00461812|20965466|P1|STARTED|Overall Study||10
8506790|NCT00461786|20965471|P1|NOT COMPLETED|Overall Study||3
8506791|NCT00461786|20965471|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
8506792|NCT00461786|20965471|P1|STARTED|Overall Study||51
8506793|NCT00461734|20965481|P2|NOT COMPLETED|Overall Study||60
8506794|NCT00461734|20965482|P1|NOT COMPLETED|Overall Study||58
8506795|NCT00461734|20965481|P2|COMPLETED|Overall Study||60
8506796|NCT00461734|20965482|P1|COMPLETED|Overall Study||62
8506797|NCT00461734|20965481|P2|STARTED|Overall Study||120
8506798|NCT00461734|20965482|P1|STARTED|Overall Study||120
8506799|NCT00461708|20965516|P2|NOT COMPLETED|Overall Study||38
8506800|NCT00461708|20965517|P1|NOT COMPLETED|Overall Study||115
8506801|NCT00461708|20965516|P2|COMPLETED|Overall Study||0
8506802|NCT00461708|20965517|P1|COMPLETED|Overall Study||0
8506803|NCT00461708|20965516|P2|STARTED|Overall Study||38
8506804|NCT00461708|20965517|P1|STARTED|Overall Study||115
8506805|NCT00461682|20965543|P1|NOT COMPLETED|Overall Study||1
8506806|NCT00461682|20965543|P1|COMPLETED|Overall Study||0
8506807|NCT00461682|20965543|P1|STARTED|Overall Study||1
8506808|NCT00461630|20965571|P2|NOT COMPLETED|Overall Study||827
8506809|NCT00461630|20965572|P1|NOT COMPLETED|Overall Study||906
8506810|NCT00461630|20965571|P2|COMPLETED|Overall Study||12008
8506811|NCT00461630|20965572|P1|COMPLETED|Overall Study||11932
8506812|NCT00461630|20965571|P2|STARTED|Overall Study||12835
8506813|NCT00461630|20965572|P1|STARTED|Overall Study||12838
8506820|NCT00461552|20965611|P2|NOT COMPLETED|Overall Study||2
8506821|NCT00461552|20965612|P1|NOT COMPLETED|Overall Study||0
8506822|NCT00461552|20965611|P2|COMPLETED|Overall Study||5
8506823|NCT00461552|20965612|P1|COMPLETED|Overall Study||7
8506824|NCT00461552|20965611|P2|STARTED|Overall Study||7
8506825|NCT00461552|20965612|P1|STARTED|Overall Study||7
8506826|NCT00461513|20965622|P2|NOT COMPLETED|Overall Study||25
8506827|NCT00461513|20965623|P1|NOT COMPLETED|Overall Study||22
8506828|NCT00461513|20965622|P2|COMPLETED|Overall Study||172
8506829|NCT00461513|20965623|P1|COMPLETED|Overall Study||165
8506830|NCT00461513|20965622|P2|STARTED|Overall Study|2 patients dropped at time of randomization|197
8506831|NCT00461513|20965623|P1|STARTED|Overall Study|6 patients dropped at time of randomization|187
8506832|NCT00461500|20965635|P2|NOT COMPLETED|Overall Study||6
8506833|NCT00461500|20965636|P1|NOT COMPLETED|Overall Study||7
8506834|NCT00461500|20965635|P2|COMPLETED|Overall Study||38
8506835|NCT00461500|20965636|P1|COMPLETED|Overall Study||30
8506836|NCT00461500|20965635|P2|STARTED|Overall Study||44
8506837|NCT00461500|20965636|P1|STARTED|Overall Study||37
8506838|NCT00461331|20965666|P2|NOT COMPLETED|Intervention 2||0
8506839|NCT00461331|20965667|P1|NOT COMPLETED|Intervention 2||0
8506840|NCT00461331|20965666|P2|COMPLETED|Intervention 2||10
8506841|NCT00461331|20965667|P1|COMPLETED|Intervention 2||10
8506842|NCT00461331|20965666|P2|STARTED|Intervention 2||10
8506843|NCT00461331|20965667|P1|STARTED|Intervention 2||10
8506844|NCT00461331|20965666|P2|NOT COMPLETED|Washout||0
8506845|NCT00461331|20965667|P1|NOT COMPLETED|Washout||0
8506846|NCT00461331|20965666|P2|COMPLETED|Washout||10
8506847|NCT00461331|20965667|P1|COMPLETED|Washout||10
8506848|NCT00461331|20965666|P2|STARTED|Washout||10
8506849|NCT00461331|20965667|P1|STARTED|Washout||10
8506850|NCT00461331|20965666|P2|NOT COMPLETED|Intervention 1||0
8506851|NCT00461331|20965667|P1|NOT COMPLETED|Intervention 1||0
8506852|NCT00461331|20965666|P2|COMPLETED|Intervention 1||10
8506853|NCT00461331|20965667|P1|COMPLETED|Intervention 1||10
8506854|NCT00461331|20965666|P2|STARTED|Intervention 1||10
8506855|NCT00461331|20965667|P1|STARTED|Intervention 1||10
8506856|NCT00461305|20965679|P2|NOT COMPLETED|Continued Treatment||0
8506857|NCT00461305|20965680|P1|NOT COMPLETED|Continued Treatment||95
8506858|NCT00461305|20965679|P2|COMPLETED|Continued Treatment||0
8506859|NCT00461305|20965680|P1|COMPLETED|Continued Treatment||254
8506860|NCT00461305|20965679|P2|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
8506861|NCT00461305|20965680|P1|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
8506862|NCT00461305|20965679|P2|NOT COMPLETED|Treatment||9
8506863|NCT00461305|20965680|P1|NOT COMPLETED|Treatment||101
8506864|NCT00461305|20965679|P2|COMPLETED|Treatment||56
8506865|NCT00461305|20965680|P1|COMPLETED|Treatment||254
8506866|NCT00461305|20965679|P2|Subjects Received Treatment|Treatment|FAS, safety population|65
8506867|NCT00461305|20965680|P1|Subjects Received Treatment|Treatment|FAS, safety population|349
8506868|NCT00461305|20965679|P2|Subjects Dispensed Drugs|Treatment||65
8506869|NCT00461305|20965680|P1|Subjects Dispensed Drugs|Treatment||350
8506870|NCT00461305|20965679|P2|STARTED|Treatment|Enrolled|65
8506871|NCT00461305|20965680|P1|STARTED|Treatment|Enrolled|355
8506872|NCT00461292|20965743|P3|NOT COMPLETED|Treatment Cycle 2||0
8506873|NCT00461292|20965744|P2|NOT COMPLETED|Treatment Cycle 2||2
8506874|NCT00461292|20965745|P1|NOT COMPLETED|Treatment Cycle 2||5
8506875|NCT00461292|20965743|P3|COMPLETED|Treatment Cycle 2||0
8506876|NCT00461292|20965744|P2|COMPLETED|Treatment Cycle 2||72
8506877|NCT00461292|20965745|P1|COMPLETED|Treatment Cycle 2||58
8506878|NCT00461292|20965743|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
8506879|NCT00461292|20965744|P2|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
8506880|NCT00461292|20965745|P1|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
8506881|NCT00461292|20965743|P3|NOT COMPLETED|Treatment Cycle 1||11
8506882|NCT00461292|20965744|P2|NOT COMPLETED|Treatment Cycle 1||12
8506883|NCT00461292|20965745|P1|NOT COMPLETED|Treatment Cycle 1||15
8506884|NCT00461292|20965743|P3|COMPLETED|Treatment Cycle 1||81
8506885|NCT00461292|20965744|P2|COMPLETED|Treatment Cycle 1||80
8506886|NCT00461292|20965745|P1|COMPLETED|Treatment Cycle 1||76
8506887|NCT00461292|20965743|P3|STARTED|Treatment Cycle 1||92
8506888|NCT00461292|20965744|P2|STARTED|Treatment Cycle 1||92
8506889|NCT00461292|20965745|P1|STARTED|Treatment Cycle 1||91
8506890|NCT00461253|20965764|P2|NOT COMPLETED|Overall Study||19798
8506891|NCT00461253|20965765|P1|NOT COMPLETED|Overall Study||4980
8506892|NCT00461253|20965764|P2|COMPLETED|Overall Study|Analyzed controls|20452
8506893|NCT00461253|20965765|P1|COMPLETED|Overall Study|Analyzed cases|5113
8506894|NCT00461253|20965764|P2|STARTED|Overall Study|Identified controls|40250
8506895|NCT00461253|20965765|P1|STARTED|Overall Study|Identified cases|10093
8506896|NCT00461175|20965773|P2|NOT COMPLETED|Overall Study||365
8506897|NCT00461175|20965774|P1|NOT COMPLETED|Overall Study||522
8506898|NCT00461175|20965773|P2|COMPLETED|Overall Study||18370
8506899|NCT00461175|20965774|P1|COMPLETED|Overall Study||43078
8506900|NCT00461175|20965773|P2|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
8506901|NCT00461175|20965774|P1|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
8506902|NCT00461123|20965784|P2|NOT COMPLETED|Overall Study||6
8506903|NCT00461123|20965785|P1|NOT COMPLETED|Overall Study||6
8506904|NCT00461123|20965784|P2|COMPLETED|Overall Study||19
8506905|NCT00461123|20965785|P1|COMPLETED|Overall Study||19
8506906|NCT00461123|20965784|P2|STARTED|Overall Study||25
8506907|NCT00461123|20965785|P1|STARTED|Overall Study||25
8506908|NCT00461097|20965801|P2|NOT COMPLETED|Overall Study||0
8506909|NCT00461097|20965802|P1|NOT COMPLETED|Overall Study||0
8506910|NCT00461097|20965801|P2|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
8506911|NCT00461097|20965802|P1|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
8506912|NCT00461097|20965801|P2|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
8506913|NCT00461097|20965802|P1|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
8506914|NCT00461097|20965801|P2|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
8506915|NCT00461097|20965802|P1|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
8506916|NCT00461097|20965801|P2|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
8506917|NCT00461097|20965802|P1|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
8506918|NCT00461097|20965801|P2|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
8506919|NCT00461097|20965802|P1|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
8506920|NCT00461097|20965801|P2|STARTED|Overall Study||15
8506921|NCT00461097|20965802|P1|STARTED|Overall Study||40
8506922|NCT00461045|20965818|P1|NOT COMPLETED|Overall Study||0
8506923|NCT00461045|20965818|P1|COMPLETED|Overall Study||15
8506924|NCT00461045|20965818|P1|STARTED|Overall Study||15
8506925|NCT00461032|20965830|P2|NOT COMPLETED|Overall Study||44
8506926|NCT00461032|20965831|P1|NOT COMPLETED|Overall Study||37
8506927|NCT00461032|20965830|P2|COMPLETED|Overall Study||536
8506928|NCT00461032|20965831|P1|COMPLETED|Overall Study||545
8506929|NCT00461032|20965830|P2|STARTED|Overall Study||580
8506930|NCT00461032|20965831|P1|STARTED|Overall Study||582
8506931|NCT00460993|20965845|P2|NOT COMPLETED|Phase 2 (6 Days)||0
8506932|NCT00460993|20965846|P1|NOT COMPLETED|Phase 2 (6 Days)||0
8506933|NCT00460993|20965845|P2|COMPLETED|Phase 2 (6 Days)||17
8506934|NCT00460993|20965846|P1|COMPLETED|Phase 2 (6 Days)||14
8506935|NCT00460993|20965845|P2|STARTED|Phase 2 (6 Days)||17
8506936|NCT00460993|20965846|P1|STARTED|Phase 2 (6 Days)||14
8506937|NCT00460993|20965845|P2|NOT COMPLETED|Phase 1 (6 Days)||0
8506938|NCT00460993|20965846|P1|NOT COMPLETED|Phase 1 (6 Days)||0
8506939|NCT00460993|20965845|P2|COMPLETED|Phase 1 (6 Days)||17
8506940|NCT00460993|20965846|P1|COMPLETED|Phase 1 (6 Days)||14
8506941|NCT00460993|20965845|P2|STARTED|Phase 1 (6 Days)||17
8506942|NCT00460993|20965846|P1|STARTED|Phase 1 (6 Days)||14
8506943|NCT00460811|20965857|P5|NOT COMPLETED|Overall Study||20
8506944|NCT00460811|20965858|P4|NOT COMPLETED|Overall Study||18
8506945|NCT00460811|20965859|P3|NOT COMPLETED|Overall Study||14
8506946|NCT00460811|20965860|P2|NOT COMPLETED|Overall Study||15
8506947|NCT00460811|20965861|P1|NOT COMPLETED|Overall Study||16
8506948|NCT00460811|20965857|P5|COMPLETED|Overall Study||65
8506949|NCT00460811|20965858|P4|COMPLETED|Overall Study||71
8506950|NCT00460811|20965859|P3|COMPLETED|Overall Study||71
8506951|NCT00460811|20965860|P2|COMPLETED|Overall Study||67
8506952|NCT00460811|20965861|P1|COMPLETED|Overall Study||63
8506953|NCT00460811|20965857|P5|STARTED|Overall Study||85
8506954|NCT00460811|20965858|P4|STARTED|Overall Study||89
8506955|NCT00460811|20965859|P3|STARTED|Overall Study||85
8506956|NCT00460811|20965860|P2|STARTED|Overall Study||82
8506957|NCT00460811|20965861|P1|STARTED|Overall Study||79
8506958|NCT00460798|20965903|P1|NOT COMPLETED|Overall Study||340
8506959|NCT00460798|20965903|P1|COMPLETED|Overall Study||108
8506960|NCT00460798|20965903|P1|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
8506961|NCT00460798|20965903|P1|STARTED|Overall Study||448
8506962|NCT00460746|20965911|P1|NOT COMPLETED|Overall Study||2
8506963|NCT00460746|20965911|P1|COMPLETED|Overall Study||8
8506964|NCT00460746|20965911|P1|STARTED|Overall Study||10
8506965|NCT00460655|20965926|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
8506966|NCT00460655|20965927|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
8506967|NCT00460655|20965928|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8506968|NCT00460655|20965929|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8506969|NCT00460655|20965926|P4|COMPLETED|Open-Label Phase (36 Weeks)||52
8506970|NCT00460655|20965927|P3|COMPLETED|Open-Label Phase (36 Weeks)||45
8506971|NCT00460655|20965928|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
8506972|NCT00460655|20965929|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
8506973|NCT00460655|20965926|P4|STARTED|Open-Label Phase (36 Weeks)||61
8506974|NCT00460655|20965927|P3|STARTED|Open-Label Phase (36 Weeks)||52
8506975|NCT00460655|20965928|P2|STARTED|Open-Label Phase (36 Weeks)||0
8506976|NCT00460655|20965929|P1|STARTED|Open-Label Phase (36 Weeks)||0
8506977|NCT00460655|20965926|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8506978|NCT00460655|20965927|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8506979|NCT00460655|20965928|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
8506980|NCT00460655|20965929|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
8506981|NCT00460655|20965926|P4|COMPLETED|Double-Blind Phase (12 Weeks)||0
8506982|NCT00460655|20965927|P3|COMPLETED|Double-Blind Phase (12 Weeks)||0
8506983|NCT00460655|20965928|P2|COMPLETED|Double-Blind Phase (12 Weeks)||61
8506984|NCT00460655|20965929|P1|COMPLETED|Double-Blind Phase (12 Weeks)||52
8506985|NCT00460655|20965926|P4|STARTED|Double-Blind Phase (12 Weeks)||0
8506986|NCT00460655|20965927|P3|STARTED|Double-Blind Phase (12 Weeks)||0
8506987|NCT00460655|20965928|P2|STARTED|Double-Blind Phase (12 Weeks)||62
8506988|NCT00460655|20965929|P1|STARTED|Double-Blind Phase (12 Weeks)||58
8506989|NCT00460603|20965973|P12|NOT COMPLETED|Phase 2||41
8506990|NCT00460603|20965974|P11|NOT COMPLETED|Phase 2||43
8506991|NCT00460603|20965975|P10|NOT COMPLETED|Phase 2||42
8506992|NCT00460603|20965976|P9|NOT COMPLETED|Phase 2||0
8506993|NCT00460603|20965977|P8|NOT COMPLETED|Phase 2||0
8506994|NCT00460603|20965978|P7|NOT COMPLETED|Phase 2||0
8506995|NCT00460603|20965979|P6|NOT COMPLETED|Phase 2||0
8506996|NCT00460603|20965980|P5|NOT COMPLETED|Phase 2||0
8506997|NCT00460603|20965981|P4|NOT COMPLETED|Phase 2||0
8506998|NCT00460603|20965982|P3|NOT COMPLETED|Phase 2||0
8506999|NCT00460603|20965983|P2|NOT COMPLETED|Phase 2||0
8507000|NCT00460603|20965984|P1|NOT COMPLETED|Phase 2||0
8507001|NCT00460603|20965973|P12|COMPLETED|Phase 2||0
8507002|NCT00460603|20965974|P11|COMPLETED|Phase 2||0
8507003|NCT00460603|20965975|P10|COMPLETED|Phase 2||0
8507004|NCT00460603|20965976|P9|COMPLETED|Phase 2||0
8507005|NCT00460603|20965977|P8|COMPLETED|Phase 2||0
8507006|NCT00460603|20965978|P7|COMPLETED|Phase 2||0
8507007|NCT00460603|20965979|P6|COMPLETED|Phase 2||0
8507008|NCT00460603|20965980|P5|COMPLETED|Phase 2||0
8507009|NCT00460603|20965981|P4|COMPLETED|Phase 2||0
8507010|NCT00460603|20965982|P3|COMPLETED|Phase 2||0
8507011|NCT00460603|20965983|P2|COMPLETED|Phase 2||0
8507012|NCT00460603|20965984|P1|COMPLETED|Phase 2||0
8507013|NCT00460603|20965973|P12|Treated|Phase 2||41
8507014|NCT00460603|20965974|P11|Treated|Phase 2||43
8507015|NCT00460603|20965975|P10|Treated|Phase 2||39
8507016|NCT00460603|20965976|P9|Treated|Phase 2||0
8507017|NCT00460603|20965977|P8|Treated|Phase 2||0
8507018|NCT00460603|20965978|P7|Treated|Phase 2||0
8507019|NCT00460603|20965979|P6|Treated|Phase 2||0
8507020|NCT00460603|20965980|P5|Treated|Phase 2||0
8507021|NCT00460603|20965981|P4|Treated|Phase 2||0
8507022|NCT00460603|20965982|P3|Treated|Phase 2||0
8507023|NCT00460603|20965983|P2|Treated|Phase 2||0
8507024|NCT00460603|20965984|P1|Treated|Phase 2||0
8507025|NCT00460603|20965973|P12|STARTED|Phase 2||41
8507026|NCT00460603|20965974|P11|STARTED|Phase 2||43
8507027|NCT00460603|20965975|P10|STARTED|Phase 2||42
8507028|NCT00460603|20965976|P9|STARTED|Phase 2||0
8507029|NCT00460603|20965977|P8|STARTED|Phase 2||0
8507030|NCT00460603|20965978|P7|STARTED|Phase 2||0
8507031|NCT00460603|20965979|P6|STARTED|Phase 2||0
8507032|NCT00460603|20965980|P5|STARTED|Phase 2||0
8507033|NCT00460603|20965981|P4|STARTED|Phase 2||0
8507034|NCT00460603|20965982|P3|STARTED|Phase 2||0
8507035|NCT00460603|20965983|P2|STARTED|Phase 2||0
8507036|NCT00460603|20965984|P1|STARTED|Phase 2||0
8507037|NCT00460603|20965973|P12|NOT COMPLETED|Phase 1||0
8507038|NCT00460603|20965974|P11|NOT COMPLETED|Phase 1||0
8507039|NCT00460603|20965975|P10|NOT COMPLETED|Phase 1||0
8507040|NCT00460603|20965976|P9|NOT COMPLETED|Phase 1||18
8507041|NCT00460603|20965977|P8|NOT COMPLETED|Phase 1||3
8507042|NCT00460603|20965978|P7|NOT COMPLETED|Phase 1||6
8507043|NCT00460603|20965979|P6|NOT COMPLETED|Phase 1||4
8507044|NCT00460603|20965980|P5|NOT COMPLETED|Phase 1||6
8507045|NCT00460603|20965981|P4|NOT COMPLETED|Phase 1||8
8507046|NCT00460603|20965982|P3|NOT COMPLETED|Phase 1||4
8507047|NCT00460603|20965983|P2|NOT COMPLETED|Phase 1||6
8507048|NCT00460603|20965984|P1|NOT COMPLETED|Phase 1||6
8507049|NCT00460603|20965973|P12|COMPLETED|Phase 1||0
8507050|NCT00460603|20965974|P11|COMPLETED|Phase 1||0
8507051|NCT00460603|20965975|P10|COMPLETED|Phase 1||0
8507052|NCT00460603|20965976|P9|COMPLETED|Phase 1||0
8507053|NCT00460603|20965977|P8|COMPLETED|Phase 1||0
8507054|NCT00460603|20965978|P7|COMPLETED|Phase 1||0
8507055|NCT00460603|20965979|P6|COMPLETED|Phase 1||0
8507056|NCT00460603|20965980|P5|COMPLETED|Phase 1||0
8507057|NCT00460603|20965981|P4|COMPLETED|Phase 1||0
8507058|NCT00460603|20965982|P3|COMPLETED|Phase 1||0
8507059|NCT00460603|20965983|P2|COMPLETED|Phase 1||0
8507060|NCT00460603|20965984|P1|COMPLETED|Phase 1||0
8507061|NCT00460603|20965973|P12|STARTED|Phase 1||0
8507062|NCT00460603|20965974|P11|STARTED|Phase 1||0
8507063|NCT00460603|20965975|P10|STARTED|Phase 1||0
8507064|NCT00460603|20965976|P9|STARTED|Phase 1||18
8507065|NCT00460603|20965977|P8|STARTED|Phase 1||3
8507066|NCT00460603|20965978|P7|STARTED|Phase 1||6
8507067|NCT00460603|20965979|P6|STARTED|Phase 1||4
8507068|NCT00460603|20965980|P5|STARTED|Phase 1||6
8507069|NCT00460603|20965981|P4|STARTED|Phase 1||8
8507070|NCT00460603|20965982|P3|STARTED|Phase 1||4
8507071|NCT00460603|20965983|P2|STARTED|Phase 1||6
8507072|NCT00460603|20965984|P1|STARTED|Phase 1||6
8507073|NCT00460577|20966078|P2|NOT COMPLETED|Overall Study||6
8507074|NCT00460577|20966079|P1|NOT COMPLETED|Overall Study||2
8507075|NCT00460577|20966078|P2|COMPLETED|Overall Study||24
8507076|NCT00460577|20966079|P1|COMPLETED|Overall Study||28
8507077|NCT00460577|20966078|P2|STARTED|Overall Study||30
8507078|NCT00460577|20966079|P1|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
8507079|NCT00460564|20966097|P8|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8507080|NCT00460564|20966098|P7|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
8507081|NCT00460564|20966099|P6|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
8507082|NCT00460564|20966100|P5|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
8507083|NCT00460564|20966101|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8507084|NCT00460564|20966102|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8507085|NCT00460564|20966103|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8507086|NCT00460564|20966104|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
8507087|NCT00460564|20966097|P8|COMPLETED|Open-Label Phase (36 Weeks)||11
8507088|NCT00460564|20966098|P7|COMPLETED|Open-Label Phase (36 Weeks)||19
8507089|NCT00460564|20966099|P6|COMPLETED|Open-Label Phase (36 Weeks)||19
8507090|NCT00460564|20966100|P5|COMPLETED|Open-Label Phase (36 Weeks)||38
8507091|NCT00460564|20966101|P4|COMPLETED|Open-Label Phase (36 Weeks)||0
8507092|NCT00460564|20966102|P3|COMPLETED|Open-Label Phase (36 Weeks)||0
8507093|NCT00460564|20966103|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
8507094|NCT00460564|20966104|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
8507095|NCT00460564|20966097|P8|STARTED|Open-Label Phase (36 Weeks)||11
8507096|NCT00460564|20966098|P7|STARTED|Open-Label Phase (36 Weeks)||21
8507097|NCT00460564|20966099|P6|STARTED|Open-Label Phase (36 Weeks)||25
8507098|NCT00460564|20966100|P5|STARTED|Open-Label Phase (36 Weeks)||47
8507099|NCT00460564|20966101|P4|STARTED|Open-Label Phase (36 Weeks)||0
8507100|NCT00460564|20966102|P3|STARTED|Open-Label Phase (36 Weeks)||0
8507101|NCT00460564|20966103|P2|STARTED|Open-Label Phase (36 Weeks)||0
8507102|NCT00460564|20966104|P1|STARTED|Open-Label Phase (36 Weeks)||0
8507103|NCT00460564|20966097|P8|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8507104|NCT00460564|20966098|P7|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8507105|NCT00460564|20966099|P6|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8507106|NCT00460564|20966100|P5|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8507107|NCT00460564|20966101|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8507108|NCT00460564|20966102|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
8507109|NCT00460564|20966103|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
8507110|NCT00460564|20966104|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
8507111|NCT00460564|20966097|P8|COMPLETED|Double-Blind Phase (12 Weeks)||0
8507112|NCT00460564|20966098|P7|COMPLETED|Double-Blind Phase (12 Weeks)||0
8507113|NCT00460564|20966099|P6|COMPLETED|Double-Blind Phase (12 Weeks)||0
8507114|NCT00460564|20966100|P5|COMPLETED|Double-Blind Phase (12 Weeks)||0
8507115|NCT00460564|20966101|P4|COMPLETED|Double-Blind Phase (12 Weeks)||11
8507116|NCT00460564|20966102|P3|COMPLETED|Double-Blind Phase (12 Weeks)||21
8507117|NCT00460564|20966103|P2|COMPLETED|Double-Blind Phase (12 Weeks)||25
8507118|NCT00460564|20966104|P1|COMPLETED|Double-Blind Phase (12 Weeks)||47
8507119|NCT00460564|20966097|P8|STARTED|Double-Blind Phase (12 Weeks)||0
8507120|NCT00460564|20966098|P7|STARTED|Double-Blind Phase (12 Weeks)||0
8507121|NCT00460564|20966099|P6|STARTED|Double-Blind Phase (12 Weeks)||0
8507122|NCT00460564|20966100|P5|STARTED|Double-Blind Phase (12 Weeks)||0
8507123|NCT00460564|20966101|P4|STARTED|Double-Blind Phase (12 Weeks)||11
8507124|NCT00460564|20966102|P3|STARTED|Double-Blind Phase (12 Weeks)||21
8507125|NCT00460564|20966103|P2|STARTED|Double-Blind Phase (12 Weeks)||26
8507126|NCT00460564|20966104|P1|STARTED|Double-Blind Phase (12 Weeks)||51
8507127|NCT00460551|20966198|P1|NOT COMPLETED|Overall Study||0
8507128|NCT00460551|20966198|P1|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
8507129|NCT00460551|20966198|P1|STARTED|Overall Study||13
8507130|NCT00460525|20966205|P2|NOT COMPLETED|Overall Study||5
8507131|NCT00460525|20966206|P1|NOT COMPLETED|Overall Study||11
8507132|NCT00460525|20966205|P2|COMPLETED|Overall Study||194
8507133|NCT00460525|20966206|P1|COMPLETED|Overall Study||190
8507134|NCT00460525|20966205|P2|STARTED|Overall Study||199
8507135|NCT00460525|20966206|P1|STARTED|Overall Study||201
8507136|NCT00460434|20966248|P2|NOT COMPLETED|Overall Study||7
8507137|NCT00460434|20966249|P1|NOT COMPLETED|Overall Study||3
8507138|NCT00460434|20966248|P2|COMPLETED|Overall Study||165
8507139|NCT00460434|20966249|P1|COMPLETED|Overall Study||162
8507140|NCT00460434|20966248|P2|12 Months|Overall Study||165
8507141|NCT00460434|20966249|P1|12 Months|Overall Study||162
8507142|NCT00460434|20966248|P2|3 Months|Overall Study||171
8507143|NCT00460434|20966249|P1|3 Months|Overall Study||163
8507144|NCT00460434|20966248|P2|STARTED|Overall Study||172
8507145|NCT00460434|20966249|P1|STARTED|Overall Study||165
8507146|NCT00460421|20966278|P3|NOT COMPLETED|Overall Study||0
8507147|NCT00460421|20966279|P2|NOT COMPLETED|Overall Study||0
8507148|NCT00460421|20966280|P1|NOT COMPLETED|Overall Study||0
8507149|NCT00460421|20966278|P3|COMPLETED|Overall Study||9
8507150|NCT00460421|20966279|P2|COMPLETED|Overall Study||9
8507151|NCT00460421|20966280|P1|COMPLETED|Overall Study||9
8507152|NCT00460421|20966278|P3|STARTED|Overall Study||9
8507153|NCT00460421|20966279|P2|STARTED|Overall Study||9
8507154|NCT00460421|20966280|P1|STARTED|Overall Study||9
8507155|NCT00460408|20966328|P4|NOT COMPLETED|Overall Study||0
8507156|NCT00460408|20966329|P3|NOT COMPLETED|Overall Study||6
8507157|NCT00460408|20966330|P2|NOT COMPLETED|Overall Study||3
8507158|NCT00460408|20966331|P1|NOT COMPLETED|Overall Study||67
8507159|NCT00460408|20966328|P4|COMPLETED|Overall Study||7
8507160|NCT00460408|20966329|P3|COMPLETED|Overall Study||69
8507161|NCT00460408|20966330|P2|COMPLETED|Overall Study||13
8507162|NCT00460408|20966331|P1|COMPLETED|Overall Study||336
8507163|NCT00460408|20966328|P4|STARTED|Overall Study||7
8507164|NCT00460408|20966329|P3|STARTED|Overall Study||75
8507165|NCT00460408|20966330|P2|STARTED|Overall Study||16
8507166|NCT00460408|20966331|P1|STARTED|Overall Study||403
8507167|NCT00460265|20966368|P2|NOT COMPLETED|Overall Study||89
8507168|NCT00460265|20966369|P1|NOT COMPLETED|Overall Study||85
8507169|NCT00460265|20966368|P2|COMPLETED|Overall Study|Completed study=death|241
8507170|NCT00460265|20966369|P1|COMPLETED|Overall Study|Completed study=death|243
8507171|NCT00460265|20966368|P2|Received Study Medication|Overall Study||325
8507172|NCT00460265|20966369|P1|Received Study Medication|Overall Study||325
8507173|NCT00460265|20966368|P2|Randomized While Alive|Overall Study||330
8507174|NCT00460265|20966369|P1|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
8507175|NCT00460265|20966368|P2|STARTED|Overall Study||330
8507176|NCT00460265|20966369|P1|STARTED|Overall Study||328
8507177|NCT00460239|20966385|P9|NOT COMPLETED|Overall Study||0
8507178|NCT00460239|20966386|P8|NOT COMPLETED|Overall Study||0
8507179|NCT00460239|20966387|P7|NOT COMPLETED|Overall Study||0
8507180|NCT00460239|20966388|P6|NOT COMPLETED|Overall Study||3
8507181|NCT00460239|20966389|P5|NOT COMPLETED|Overall Study||0
8507182|NCT00460239|20966390|P4|NOT COMPLETED|Overall Study||0
8507183|NCT00460239|20966391|P3|NOT COMPLETED|Overall Study||0
8507184|NCT00460239|20966392|P2|NOT COMPLETED|Overall Study||1
8507185|NCT00460239|20966393|P1|NOT COMPLETED|Overall Study||0
8507186|NCT00460239|20966385|P9|COMPLETED|Overall Study||1
8507187|NCT00460239|20966386|P8|COMPLETED|Overall Study||1
8507188|NCT00460239|20966387|P7|COMPLETED|Overall Study||1
8507189|NCT00460239|20966388|P6|COMPLETED|Overall Study||1
8507190|NCT00460239|20966389|P5|COMPLETED|Overall Study||1
8507191|NCT00460239|20966390|P4|COMPLETED|Overall Study||0
8507192|NCT00460239|20966391|P3|COMPLETED|Overall Study||1
8507193|NCT00460239|20966392|P2|COMPLETED|Overall Study||2
8507194|NCT00460239|20966393|P1|COMPLETED|Overall Study||0
8507195|NCT00460239|20966385|P9|STARTED|Overall Study||1
8507196|NCT00460239|20966386|P8|STARTED|Overall Study||1
8507197|NCT00460239|20966387|P7|STARTED|Overall Study||1
8507198|NCT00460239|20966388|P6|STARTED|Overall Study||4
8507199|NCT00460239|20966389|P5|STARTED|Overall Study||1
8507200|NCT00460239|20966390|P4|STARTED|Overall Study||0
8507201|NCT00460239|20966391|P3|STARTED|Overall Study||1
8507202|NCT00460239|20966392|P2|STARTED|Overall Study||3
8507203|NCT00460239|20966393|P1|STARTED|Overall Study||0
8507204|NCT00460109|20966462|P1|NOT COMPLETED|Overall Study||1
8507205|NCT00460109|20966462|P1|COMPLETED|Overall Study||23
8507206|NCT00460109|20966462|P1|STARTED|Overall Study||24
8507207|NCT00460031|20966470|P1|NOT COMPLETED|Overall Study||11
8507208|NCT00460031|20966470|P1|COMPLETED|Overall Study||23
8507209|NCT00460031|20966470|P1|STARTED|Overall Study||34
8507210|NCT00459979|20966478|P1|NOT COMPLETED|Overall Study||2
8507211|NCT00459979|20966478|P1|COMPLETED|Overall Study||28
8507212|NCT00459979|20966478|P1|STARTED|Overall Study||30
8507213|NCT00459953|20966490|P2|NOT COMPLETED|Overall Study||1
8507214|NCT00459953|20966491|P1|NOT COMPLETED|Overall Study||1
8507215|NCT00459953|20966490|P2|COMPLETED|Overall Study||70
8507216|NCT00459953|20966491|P1|COMPLETED|Overall Study||71
8507217|NCT00459953|20966490|P2|STARTED|Overall Study||71
8507218|NCT00459953|20966491|P1|STARTED|Overall Study||72
8507219|NCT00459875|20966497|P1|NOT COMPLETED|Overall Study||3
8507220|NCT00459875|20966497|P1|COMPLETED|Overall Study||21
8507221|NCT00459875|20966497|P1|STARTED|Overall Study||24
8507222|NCT00459862|20966501|P1|NOT COMPLETED|Overall Study||0
8507223|NCT00459862|20966501|P1|COMPLETED|Overall Study||34
8507224|NCT00459862|20966501|P1|STARTED|Overall Study||34
8507225|NCT00459810|20966510|P1|NOT COMPLETED|Overall Study||0
8507226|NCT00459810|20966510|P1|COMPLETED|Overall Study||21
8507227|NCT00459810|20966510|P1|STARTED|Overall Study||21
8507228|NCT00459732|20966520|P2|NOT COMPLETED|Overall Study||3
8507229|NCT00459732|20966521|P1|NOT COMPLETED|Overall Study||4
8507230|NCT00459732|20966520|P2|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
8507231|NCT00459732|20966521|P1|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
8507232|NCT00459732|20966520|P2|STARTED|Overall Study||17
8507233|NCT00459732|20966521|P1|STARTED|Overall Study||23
8507234|NCT00459706|20966533|P2|NOT COMPLETED|Overall Study||21
8507235|NCT00459706|20966534|P1|NOT COMPLETED|Overall Study||26
8507236|NCT00459706|20966533|P2|COMPLETED|Overall Study||294
8507237|NCT00459706|20966534|P1|COMPLETED|Overall Study||299
8507238|NCT00459706|20966533|P2|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
8507239|NCT00459706|20966534|P1|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
8507240|NCT00459706|20966533|P2|STARTED|Overall Study||315
8507241|NCT00459706|20966534|P1|STARTED|Overall Study||325
8507242|NCT00459667|20966677|P3|NOT COMPLETED|Overall Study||20
8507243|NCT00459667|20966678|P2|NOT COMPLETED|Overall Study||47
8507244|NCT00459667|20966679|P1|NOT COMPLETED|Overall Study||38
8507245|NCT00459667|20966677|P3|COMPLETED|Overall Study||161
8507246|NCT00459667|20966678|P2|COMPLETED|Overall Study||600
8507247|NCT00459667|20966679|P1|COMPLETED|Overall Study||554
8507248|NCT00459667|20966677|P3|Started Treatment|Overall Study||180
8507249|NCT00459667|20966678|P2|Started Treatment|Overall Study||644
8507250|NCT00459667|20966679|P1|Started Treatment|Overall Study||586
8507251|NCT00459667|20966677|P3|Study Medication Dispensed|Overall Study||180
8507252|NCT00459667|20966678|P2|Study Medication Dispensed|Overall Study||645
8507253|NCT00459667|20966679|P1|Study Medication Dispensed|Overall Study||586
8507254|NCT00459667|20966677|P3|STARTED|Overall Study||181
8507255|NCT00459667|20966678|P2|STARTED|Overall Study||647
8507256|NCT00459667|20966679|P1|STARTED|Overall Study||592
8507257|NCT00459537|20966701|P2|NOT COMPLETED|Overall Study||76
8507258|NCT00459537|20966702|P1|NOT COMPLETED|Overall Study||66
8507259|NCT00459537|20966701|P2|COMPLETED|Overall Study||446
8507260|NCT00459537|20966702|P1|COMPLETED|Overall Study||441
8507261|NCT00459537|20966701|P2|Safety Population|Overall Study||512
8507262|NCT00459537|20966702|P1|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
8507263|NCT00459537|20966701|P2|STARTED|Overall Study||522
8507264|NCT00459537|20966702|P1|STARTED|Overall Study||507
8507265|NCT00459381|20966716|P1|NOT COMPLETED|Overall Study||0
8507266|NCT00459381|20966716|P1|COMPLETED|Overall Study||35
8507267|NCT00459381|20966716|P1|STARTED|Overall Study||35
8507268|NCT00459368|20966728|P2|NOT COMPLETED|Overall Study||329
8507269|NCT00459368|20966729|P1|NOT COMPLETED|Overall Study||295
8507270|NCT00459368|20966728|P2|COMPLETED|Overall Study||1034
8507271|NCT00459368|20966729|P1|COMPLETED|Overall Study||1040
8507272|NCT00459368|20966728|P2|STARTED|Overall Study||1363
8507273|NCT00459368|20966729|P1|STARTED|Overall Study||1335
8507274|NCT00459355|20966737|P2|NOT COMPLETED|Overall Study||18
8507275|NCT00459355|20966738|P1|NOT COMPLETED|Overall Study||20
8507276|NCT00459355|20966737|P2|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
8507277|NCT00459355|20966738|P1|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
8507278|NCT00459355|20966737|P2|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
8507279|NCT00459355|20966738|P1|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
8507280|NCT00459342|20966750|P1|NOT COMPLETED|Overall Study||1
8507281|NCT00459342|20966750|P1|COMPLETED|Overall Study||34
8507282|NCT00459342|20966750|P1|STARTED|Overall Study||35
8507283|NCT00459316|20966763|P3|NOT COMPLETED|Step 3||1
8507284|NCT00459316|20966764|P2|NOT COMPLETED|Step 3||0
8507285|NCT00459316|20966765|P1|NOT COMPLETED|Step 3||3
8507286|NCT00459316|20966763|P3|COMPLETED|Step 3||39
8507287|NCT00459316|20966764|P2|COMPLETED|Step 3||0
8507288|NCT00459316|20966765|P1|COMPLETED|Step 3||149
8507289|NCT00459316|20966763|P3|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
8507290|NCT00459316|20966764|P2|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
8507291|NCT00459316|20966765|P1|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
8507292|NCT00459316|20966763|P3|NOT COMPLETED|Steps 1 & 2||2
8507293|NCT00459316|20966764|P2|NOT COMPLETED|Steps 1 & 2||7
8507294|NCT00459316|20966765|P1|NOT COMPLETED|Steps 1 & 2||21
8507295|NCT00459316|20966763|P3|COMPLETED|Steps 1 & 2||57
8507296|NCT00459316|20966764|P2|COMPLETED|Steps 1 & 2||32
8507297|NCT00459316|20966765|P1|COMPLETED|Steps 1 & 2||259
8507298|NCT00459316|20966763|P3|STARTED|Steps 1 & 2||59
8507299|NCT00459316|20966764|P2|STARTED|Steps 1 & 2||39
8507300|NCT00459316|20966765|P1|STARTED|Steps 1 & 2||280
8507301|NCT00459303|20966819|P1|NOT COMPLETED|Overall Study||0
8507302|NCT00459303|20966819|P1|COMPLETED|Overall Study||20
8507303|NCT00459303|20966819|P1|STARTED|Overall Study||20
8507304|NCT00459290|20966830|P1|NOT COMPLETED|Overall Study||5
8507305|NCT00459290|20966830|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
8507306|NCT00459290|20966830|P1|STARTED|Overall Study||24
8507307|NCT00459186|20966845|P1|NOT COMPLETED|Combination RAD001 + Docetaxel||0
8507308|NCT00459186|20966845|P1|COMPLETED|Combination RAD001 + Docetaxel||15
8507309|NCT00459186|20966845|P1|STARTED|Combination RAD001 + Docetaxel||15
8507310|NCT00459186|20966845|P1|NOT COMPLETED|PET Imaging and Assessment||3
8507311|NCT00459186|20966845|P1|COMPLETED|PET Imaging and Assessment||15
8507312|NCT00459186|20966845|P1|STARTED|PET Imaging and Assessment||18
8507313|NCT00459186|20966845|P1|NOT COMPLETED|Single Agent RAD001||1
8507314|NCT00459186|20966845|P1|COMPLETED|Single Agent RAD001||18
8507315|NCT00459186|20966845|P1|STARTED|Single Agent RAD001||19
8507316|NCT00459134|20966852|P2|NOT COMPLETED|Overall Study||25
8507317|NCT00459134|20966853|P1|NOT COMPLETED|Overall Study||23
8507318|NCT00459134|20966852|P2|COMPLETED|Overall Study||67
8507319|NCT00459134|20966853|P1|COMPLETED|Overall Study||71
8507320|NCT00459134|20966852|P2|STARTED|Overall Study||92
8507321|NCT00459134|20966853|P1|STARTED|Overall Study||94
8507322|NCT00459121|20966861|P1|NOT COMPLETED|Overall Study||0
8507323|NCT00459121|20966861|P1|COMPLETED|Overall Study||2
8507324|NCT00459121|20966861|P1|STARTED|Overall Study||2
8507325|NCT00459108|20966869|P1|NOT COMPLETED|Overall Study||11
8507326|NCT00459108|20966869|P1|COMPLETED|Overall Study||14
8507327|NCT00459108|20966869|P1|STARTED|Overall Study||25
8507328|NCT00459056|20966879|P2|NOT COMPLETED|Second Intervention (Final Three Months)||0
8507329|NCT00459056|20966880|P1|NOT COMPLETED|Second Intervention (Final Three Months)||0
8507330|NCT00459056|20966879|P2|COMPLETED|Second Intervention (Final Three Months)||14
8507331|NCT00459056|20966880|P1|COMPLETED|Second Intervention (Final Three Months)||9
8507332|NCT00459056|20966879|P2|STARTED|Second Intervention (Final Three Months)||14
8507333|NCT00459056|20966880|P1|STARTED|Second Intervention (Final Three Months)||9
8507334|NCT00459056|20966879|P2|NOT COMPLETED|Washout (1 Month)||0
8507335|NCT00459056|20966880|P1|NOT COMPLETED|Washout (1 Month)||0
8507336|NCT00459056|20966879|P2|COMPLETED|Washout (1 Month)||14
8507337|NCT00459056|20966880|P1|COMPLETED|Washout (1 Month)||9
8507338|NCT00459056|20966879|P2|STARTED|Washout (1 Month)||14
8507339|NCT00459056|20966880|P1|STARTED|Washout (1 Month)||9
8507340|NCT00459056|20966879|P2|NOT COMPLETED|First Intervention (First Three Months)||1
8507341|NCT00459056|20966880|P1|NOT COMPLETED|First Intervention (First Three Months)||1
8507342|NCT00459056|20966879|P2|COMPLETED|First Intervention (First Three Months)||14
8507343|NCT00459056|20966880|P1|COMPLETED|First Intervention (First Three Months)||9
8507344|NCT00459056|20966879|P2|STARTED|First Intervention (First Three Months)||15
8507345|NCT00459056|20966880|P1|STARTED|First Intervention (First Three Months)||10
8507346|NCT00459043|20966888|P2|NOT COMPLETED|Overall Study||0
8507347|NCT00459043|20966889|P1|NOT COMPLETED|Overall Study||1
8507348|NCT00459043|20966888|P2|COMPLETED|Overall Study||15
8507349|NCT00459043|20966889|P1|COMPLETED|Overall Study||14
8507350|NCT00459043|20966888|P2|STARTED|Overall Study||15
8507351|NCT00459043|20966889|P1|STARTED|Overall Study||15
8507352|NCT00458952|20966901|P2|NOT COMPLETED|Overall Study||5
8507353|NCT00458952|20966902|P1|NOT COMPLETED|Overall Study||2
8507354|NCT00458952|20966901|P2|COMPLETED|Overall Study||9
8507355|NCT00458952|20966902|P1|COMPLETED|Overall Study||5
8507356|NCT00458952|20966901|P2|STARTED|Overall Study||14
8507357|NCT00458952|20966902|P1|STARTED|Overall Study||7
8507358|NCT00458848|20966906|P1|NOT COMPLETED|Overall Study||0
8507359|NCT00458848|20966906|P1|COMPLETED|Overall Study||51
8507360|NCT00458848|20966906|P1|STARTED|Overall Study||51
8507361|NCT00458822|20966912|P1|NOT COMPLETED|Overall Study||0
8507362|NCT00458822|20966912|P1|COMPLETED|Overall Study||40
8507363|NCT00458822|20966912|P1|STARTED|Overall Study||40
8507364|NCT00458705|20966916|P1|NOT COMPLETED|Overall Study||5
8507365|NCT00458705|20966916|P1|COMPLETED|Overall Study||40
8507366|NCT00458705|20966916|P1|STARTED|Overall Study||45
8507370|NCT00458484|20966931|P7|NOT COMPLETED|Overall Study||0
8507371|NCT00458484|20966932|P6|NOT COMPLETED|Overall Study||1
8507372|NCT00458484|20966933|P5|NOT COMPLETED|Overall Study||0
8507373|NCT00458484|20966934|P4|NOT COMPLETED|Overall Study||0
8507374|NCT00458484|20966935|P3|NOT COMPLETED|Overall Study||0
8507375|NCT00458484|20966936|P2|NOT COMPLETED|Overall Study||0
8507376|NCT00458484|20966937|P1|NOT COMPLETED|Overall Study||0
8507377|NCT00458484|20966931|P7|COMPLETED|Overall Study||3
8507378|NCT00458484|20966932|P6|COMPLETED|Overall Study||4
8507379|NCT00458484|20966933|P5|COMPLETED|Overall Study||4
8507380|NCT00458484|20966934|P4|COMPLETED|Overall Study||6
8507381|NCT00458484|20966935|P3|COMPLETED|Overall Study||3
8507382|NCT00458484|20966936|P2|COMPLETED|Overall Study||6
8507383|NCT00458484|20966937|P1|COMPLETED|Overall Study||4
8507384|NCT00458484|20966931|P7|STARTED|Overall Study||3
8507385|NCT00458484|20966932|P6|STARTED|Overall Study||5
8507386|NCT00458484|20966933|P5|STARTED|Overall Study||4
8507387|NCT00458484|20966934|P4|STARTED|Overall Study||6
8507388|NCT00458484|20966935|P3|STARTED|Overall Study||3
8507389|NCT00458484|20966936|P2|STARTED|Overall Study||6
8507390|NCT00458484|20966937|P1|STARTED|Overall Study||4
8507391|NCT00458406|20966978|P2|NOT COMPLETED|Month 3||0
8507392|NCT00458406|20966979|P1|NOT COMPLETED|Month 3||0
8507393|NCT00458406|20966978|P2|COMPLETED|Month 3||13
8507394|NCT00458406|20966979|P1|COMPLETED|Month 3||43
8507395|NCT00458406|20966978|P2|STARTED|Month 3||13
8507396|NCT00458406|20966979|P1|STARTED|Month 3||43
8507397|NCT00458406|20966978|P2|NOT COMPLETED|Month 1||0
8507398|NCT00458406|20966979|P1|NOT COMPLETED|Month 1||0
8507399|NCT00458406|20966978|P2|COMPLETED|Month 1||13
8507400|NCT00458406|20966979|P1|COMPLETED|Month 1||43
8507401|NCT00458406|20966978|P2|STARTED|Month 1||13
8507402|NCT00458406|20966979|P1|STARTED|Month 1||43
8507403|NCT00458393|20967003|P2|NOT COMPLETED|Overall Study||295
8507404|NCT00458393|20967004|P1|NOT COMPLETED|Overall Study||309
8507405|NCT00458393|20967003|P2|COMPLETED|Overall Study||953
8507406|NCT00458393|20967004|P1|COMPLETED|Overall Study||942
8507407|NCT00458393|20967003|P2|STARTED|Overall Study||1248
8507408|NCT00458393|20967004|P1|STARTED|Overall Study||1251
8507409|NCT00458341|20967052|P2|NOT COMPLETED|Cycle 2||0
8507410|NCT00458341|20967053|P1|NOT COMPLETED|Cycle 2||0
8507411|NCT00458341|20967052|P2|COMPLETED|Cycle 2||15
8507412|NCT00458341|20967053|P1|COMPLETED|Cycle 2||15
8507413|NCT00458341|20967052|P2|Received at Least 1 Dose of Study Drug|Cycle 2||15
8507414|NCT00458341|20967053|P1|Received at Least 1 Dose of Study Drug|Cycle 2||15
8507415|NCT00458341|20967052|P2|STARTED|Cycle 2||15
8507416|NCT00458341|20967053|P1|STARTED|Cycle 2|The participant who did not complete Cycle 1 was eligible for Cycle 2 and completed Cycle 2.|15
8507417|NCT00458341|20967052|P2|NOT COMPLETED|Cycle 1||0
8507418|NCT00458341|20967053|P1|NOT COMPLETED|Cycle 1||1
8507419|NCT00458341|20967052|P2|COMPLETED|Cycle 1||15
8507420|NCT00458341|20967053|P1|COMPLETED|Cycle 1|1 participant did not complete Cycle 1 since all procedures were not performed due to adverse event.|14
8507421|NCT00458341|20967052|P2|Received at Least 1 Dose of Study Drug|Cycle 1||15
8507422|NCT00458341|20967053|P1|Received at Least 1 Dose of Study Drug|Cycle 1||15
8507423|NCT00458341|20967052|P2|STARTED|Cycle 1||15
8507424|NCT00458341|20967053|P1|STARTED|Cycle 1||15
8507425|NCT00458302|20967093|P2|NOT COMPLETED|Overall Study||24
8507426|NCT00458302|20967094|P1|NOT COMPLETED|Overall Study||20
8507427|NCT00458302|20967093|P2|COMPLETED|Overall Study||103
8507428|NCT00458302|20967094|P1|COMPLETED|Overall Study||109
8507429|NCT00458302|20967093|P2|STARTED|Overall Study||127
8507430|NCT00458302|20967094|P1|STARTED|Overall Study||129
8507431|NCT00458237|20967128|P3|NOT COMPLETED|Overall Study||0
8507432|NCT00458237|20967129|P2|NOT COMPLETED|Overall Study||0
8507433|NCT00458237|20967130|P1|NOT COMPLETED|Overall Study||0
8507434|NCT00458237|20967128|P3|COMPLETED|Overall Study||5
8507435|NCT00458237|20967129|P2|COMPLETED|Overall Study||3
8507436|NCT00458237|20967130|P1|COMPLETED|Overall Study||3
8507437|NCT00458237|20967128|P3|STARTED|Overall Study||5
8507438|NCT00458237|20967129|P2|STARTED|Overall Study||3
8507439|NCT00458237|20967130|P1|STARTED|Overall Study||3
8507440|NCT00458211|20967139|P1|NOT COMPLETED|Overall Study||16
8507441|NCT00458211|20967139|P1|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
8507442|NCT00458211|20967139|P1|STARTED|Overall Study||40
8507443|NCT00457977|20967160|P2|NOT COMPLETED|Overall Study||25
8507444|NCT00457977|20967161|P1|NOT COMPLETED|Overall Study||28
8507445|NCT00457977|20967160|P2|COMPLETED|Overall Study||66
8507446|NCT00457977|20967161|P1|COMPLETED|Overall Study||62
8507447|NCT00457977|20967160|P2|2-Year|Overall Study||66
8507448|NCT00457977|20967161|P1|2-Year|Overall Study||62
8507449|NCT00457977|20967160|P2|1-Year|Overall Study||76
8507450|NCT00457977|20967161|P1|1-Year|Overall Study||69
8507451|NCT00457977|20967160|P2|1-Month|Overall Study||87
8507452|NCT00457977|20967161|P1|1-Month|Overall Study||88
8507453|NCT00457977|20967160|P2|STARTED|Overall Study||91
8507454|NCT00457977|20967161|P1|STARTED|Overall Study||90
8507455|NCT00457951|20967172|P3|NOT COMPLETED|Overall Study||12
8507456|NCT00457951|20967173|P2|NOT COMPLETED|Overall Study||16
8507457|NCT00457951|20967174|P1|NOT COMPLETED|Overall Study||0
8507458|NCT00457951|20967172|P3|COMPLETED|Overall Study||60
8507459|NCT00457951|20967173|P2|COMPLETED|Overall Study||50
8507460|NCT00457951|20967174|P1|COMPLETED|Overall Study||13
8507461|NCT00457951|20967172|P3|STARTED|Overall Study||72
8507462|NCT00457951|20967173|P2|STARTED|Overall Study||66
8507463|NCT00457951|20967174|P1|STARTED|Overall Study||13
8507464|NCT00457821|20967189|P8|NOT COMPLETED|Part 2||1
8507465|NCT00457821|20967190|P7|NOT COMPLETED|Part 2||0
8507466|NCT00457821|20967191|P6|NOT COMPLETED|Part 2||0
8507467|NCT00457821|20967192|P5|NOT COMPLETED|Part 2||0
8507468|NCT00457821|20967193|P4|NOT COMPLETED|Part 2||0
8507469|NCT00457821|20967194|P3|NOT COMPLETED|Part 2||0
8507470|NCT00457821|20967195|P2|NOT COMPLETED|Part 2||0
8507471|NCT00457821|20967196|P1|NOT COMPLETED|Part 2||0
8507472|NCT00457821|20967189|P8|COMPLETED|Part 2||4
8507473|NCT00457821|20967190|P7|COMPLETED|Part 2||7
8507474|NCT00457821|20967191|P6|COMPLETED|Part 2||8
8507475|NCT00457821|20967192|P5|COMPLETED|Part 2||0
8507476|NCT00457821|20967193|P4|COMPLETED|Part 2||0
8507477|NCT00457821|20967194|P3|COMPLETED|Part 2||0
8507478|NCT00457821|20967195|P2|COMPLETED|Part 2||0
8507479|NCT00457821|20967196|P1|COMPLETED|Part 2||0
8507480|NCT00457821|20967189|P8|Completed Study Drug Treatment|Part 2||4
8507481|NCT00457821|20967190|P7|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
8507482|NCT00457821|20967191|P6|Completed Study Drug Treatment|Part 2||8
8507483|NCT00457821|20967192|P5|Completed Study Drug Treatment|Part 2||0
8507484|NCT00457821|20967193|P4|Completed Study Drug Treatment|Part 2||0
8507485|NCT00457821|20967194|P3|Completed Study Drug Treatment|Part 2||0
8507486|NCT00457821|20967195|P2|Completed Study Drug Treatment|Part 2||0
8507487|NCT00457821|20967196|P1|Completed Study Drug Treatment|Part 2||0
8507488|NCT00457821|20967189|P8|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
8507489|NCT00457821|20967190|P7|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
8507490|NCT00457821|20967191|P6|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
8507491|NCT00457821|20967192|P5|STARTED|Part 2|Arm in Part 1 only|0
8507492|NCT00457821|20967193|P4|STARTED|Part 2|Arm in Part 1 only|0
8507493|NCT00457821|20967194|P3|STARTED|Part 2|Arm in Part 1 only|0
8507494|NCT00457821|20967195|P2|STARTED|Part 2|Arm in Part 1 only|0
8507495|NCT00457821|20967196|P1|STARTED|Part 2|Arm in Part 1 only|0
8507496|NCT00457821|20967189|P8|NOT COMPLETED|Part 1||0
8507497|NCT00457821|20967190|P7|NOT COMPLETED|Part 1||0
8507498|NCT00457821|20967191|P6|NOT COMPLETED|Part 1||0
8507499|NCT00457821|20967192|P5|NOT COMPLETED|Part 1||0
8507500|NCT00457821|20967193|P4|NOT COMPLETED|Part 1||0
8507501|NCT00457821|20967194|P3|NOT COMPLETED|Part 1||1
8507502|NCT00457821|20967195|P2|NOT COMPLETED|Part 1||0
8507503|NCT00457821|20967196|P1|NOT COMPLETED|Part 1||0
8507504|NCT00457821|20967189|P8|COMPLETED|Part 1||0
8507505|NCT00457821|20967190|P7|COMPLETED|Part 1||0
8507506|NCT00457821|20967191|P6|COMPLETED|Part 1||0
8507507|NCT00457821|20967192|P5|COMPLETED|Part 1||4
8507508|NCT00457821|20967193|P4|COMPLETED|Part 1||4
8507509|NCT00457821|20967194|P3|COMPLETED|Part 1||4
8507510|NCT00457821|20967195|P2|COMPLETED|Part 1||4
8507511|NCT00457821|20967196|P1|COMPLETED|Part 1||4
8507512|NCT00457821|20967189|P8|STARTED|Part 1|Arm in Part 2 only|0
8507513|NCT00457821|20967190|P7|STARTED|Part 1|Arm in Part 2 only|0
8507514|NCT00457821|20967191|P6|STARTED|Part 1|Arm in Part 2 only|0
8507515|NCT00457821|20967192|P5|STARTED|Part 1|Number of subjects randomized|4
8507516|NCT00457821|20967193|P4|STARTED|Part 1|Number of subjects randomized|4
8507517|NCT00457821|20967194|P3|STARTED|Part 1|Number of subjects randomized|5
8507518|NCT00457821|20967195|P2|STARTED|Part 1|Number of subjects randomized|4
8507519|NCT00457821|20967196|P1|STARTED|Part 1|Number of subjects randomized|4
8507520|NCT00457795|20967225|P1|NOT COMPLETED|Overall Study||0
8507521|NCT00457795|20967225|P1|COMPLETED|Overall Study||15
8507522|NCT00457795|20967225|P1|STARTED|Overall Study||15
8507523|NCT00457743|20967235|P3|NOT COMPLETED|Overall Study||3
8507524|NCT00457743|20967236|P2|NOT COMPLETED|Overall Study||27
8507525|NCT00457743|20967237|P1|NOT COMPLETED|Overall Study||3
8507526|NCT00457743|20967235|P3|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
8507527|NCT00457743|20967236|P2|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
8507528|NCT00457743|20967237|P1|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
8507529|NCT00457743|20967235|P3|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
8507530|NCT00457743|20967236|P2|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
8507531|NCT00457743|20967237|P1|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
8507532|NCT00457743|20967235|P3|Completed Phase 1|Overall Study||3
8507533|NCT00457743|20967236|P2|Completed Phase 1|Overall Study||6
8507534|NCT00457743|20967237|P1|Completed Phase 1|Overall Study||3
8507535|NCT00457743|20967235|P3|Enrolled in Phase 1|Overall Study||3
8507536|NCT00457743|20967236|P2|Enrolled in Phase 1|Overall Study||6
8507537|NCT00457743|20967237|P1|Enrolled in Phase 1|Overall Study||3
8507538|NCT00457743|20967235|P3|STARTED|Overall Study|Overall study|3
8507539|NCT00457743|20967236|P2|STARTED|Overall Study|Overall study|30
8507540|NCT00457743|20967237|P1|STARTED|Overall Study|Overall study|3
8507541|NCT00457730|20967281|P2|NOT COMPLETED|Overall Study||1
8507542|NCT00457730|20967282|P1|NOT COMPLETED|Overall Study||4
8507543|NCT00457730|20967281|P2|COMPLETED|Overall Study||19
8507544|NCT00457730|20967282|P1|COMPLETED|Overall Study||14
8507545|NCT00457730|20967281|P2|STARTED|Overall Study||20
8507546|NCT00457730|20967282|P1|STARTED|Overall Study||18
8507547|NCT00457691|20967294|P2|NOT COMPLETED|Overall Study||382
8507548|NCT00457691|20967295|P1|NOT COMPLETED|Overall Study||386
8507549|NCT00457691|20967294|P2|COMPLETED|Overall Study||0
8507550|NCT00457691|20967295|P1|COMPLETED|Overall Study||0
8507551|NCT00457691|20967294|P2|STARTED|Overall Study||382
8507552|NCT00457691|20967295|P1|STARTED|Overall Study||386
8507553|NCT00457665|20967317|P2|NOT COMPLETED|24 Months||8
8507554|NCT00457665|20967318|P1|NOT COMPLETED|24 Months||5
8507555|NCT00457665|20967317|P2|COMPLETED|24 Months||11
8507556|NCT00457665|20967318|P1|COMPLETED|24 Months||15
8507557|NCT00457665|20967317|P2|STARTED|24 Months||19
8507558|NCT00457665|20967318|P1|STARTED|24 Months||20
8507559|NCT00457665|20967317|P2|NOT COMPLETED|12 Months||9
8507560|NCT00457665|20967318|P1|NOT COMPLETED|12 Months||8
8507561|NCT00457665|20967317|P2|COMPLETED|12 Months||19
8507562|NCT00457665|20967318|P1|COMPLETED|12 Months||20
8507563|NCT00457665|20967317|P2|STARTED|12 Months||28
8507564|NCT00457665|20967318|P1|STARTED|12 Months||28
8507565|NCT00457639|20967324|P2|NOT COMPLETED|Intervention 2 (6 Months)||1
8507566|NCT00457639|20967325|P1|NOT COMPLETED|Intervention 2 (6 Months)||0
8507567|NCT00457639|20967324|P2|COMPLETED|Intervention 2 (6 Months)||6
8507568|NCT00457639|20967325|P1|COMPLETED|Intervention 2 (6 Months)||6
8507569|NCT00457639|20967324|P2|STARTED|Intervention 2 (6 Months)||7
8507570|NCT00457639|20967325|P1|STARTED|Intervention 2 (6 Months)||6
8507571|NCT00457639|20967324|P2|NOT COMPLETED|Intervention 1 (6 Months)||2
8507572|NCT00457639|20967325|P1|NOT COMPLETED|Intervention 1 (6 Months)||3
8507573|NCT00457639|20967324|P2|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7
8507574|NCT00457639|20967325|P1|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6
8507575|NCT00457639|20967324|P2|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9
8507576|NCT00457639|20967325|P1|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9
8507577|NCT00457418|20967333|P1|NOT COMPLETED|Post PK Maintenance||28
8507578|NCT00457418|20967333|P1|COMPLETED|Post PK Maintenance||3
8507579|NCT00457418|20967333|P1|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
8507580|NCT00457418|20967333|P1|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
8507581|NCT00457418|20967333|P1|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
8507582|NCT00457418|20967333|P1|STARTED|Pharmacokinetic (PK) Sampling Phase||32
8507583|NCT00457392|20967345|P2|NOT COMPLETED|Overall Study||480
8507584|NCT00457392|20967346|P1|NOT COMPLETED|Overall Study||480
8507585|NCT00457392|20967345|P2|COMPLETED|Overall Study||0
8507586|NCT00457392|20967346|P1|COMPLETED|Overall Study||0
8507587|NCT00457392|20967345|P2|Treated|Overall Study||477
8507588|NCT00457392|20967346|P1|Treated|Overall Study||473
8507589|NCT00457392|20967345|P2|STARTED|Overall Study||480
8507590|NCT00457392|20967346|P1|STARTED|Overall Study||480
8507591|NCT00457366|20967364|P2|NOT COMPLETED|Overall Study||0
8507592|NCT00457366|20967365|P1|NOT COMPLETED|Overall Study||0
8507593|NCT00457366|20967364|P2|COMPLETED|Overall Study||32
8507594|NCT00457366|20967365|P1|COMPLETED|Overall Study||40
8507595|NCT00457366|20967364|P2|STARTED|Overall Study||32
8507596|NCT00457366|20967365|P1|STARTED|Overall Study||40
8507597|NCT00457301|20967373|P2|NOT COMPLETED|Overall Study||24
8507598|NCT00457301|20967374|P1|NOT COMPLETED|Overall Study||23
8507599|NCT00457301|20967373|P2|COMPLETED|Overall Study||84
8507600|NCT00457301|20967374|P1|COMPLETED|Overall Study||82
8507601|NCT00457301|20967373|P2|STARTED|Overall Study||108
8507602|NCT00457301|20967374|P1|STARTED|Overall Study||105
8507603|NCT00457249|20967388|P2|NOT COMPLETED|Overall Study||2
8507604|NCT00457249|20967389|P1|NOT COMPLETED|Overall Study||12
8507605|NCT00457249|20967388|P2|COMPLETED|Overall Study||389
8507606|NCT00457249|20967389|P1|COMPLETED|Overall Study||1158
8507607|NCT00457249|20967388|P2|STARTED|Overall Study||391
8507608|NCT00457249|20967389|P1|STARTED|Overall Study||1170
8507609|NCT00457197|20967403|P2|NOT COMPLETED|Overall Study||1
8507610|NCT00457197|20967404|P1|NOT COMPLETED|Overall Study||1
8507611|NCT00457197|20967403|P2|COMPLETED|Overall Study||44
8507612|NCT00457197|20967404|P1|COMPLETED|Overall Study||44
8507613|NCT00457197|20967403|P2|STARTED|Overall Study||45
8507614|NCT00457197|20967404|P1|STARTED|Overall Study||45
8507621|NCT00457002|20967445|P2|NOT COMPLETED|Overall Study||757
8507622|NCT00457002|20967446|P1|NOT COMPLETED|Overall Study||813
8507623|NCT00457002|20967445|P2|COMPLETED|Overall Study||2516
8507624|NCT00457002|20967446|P1|COMPLETED|Overall Study||2442
8507625|NCT00457002|20967445|P2|STARTED|Overall Study||3273
8507626|NCT00457002|20967446|P1|STARTED|Overall Study||3255
8507627|NCT00456989|20967514|P1|NOT COMPLETED|Overall Study||0
8507628|NCT00456989|20967514|P1|COMPLETED|Overall Study||39
8507629|NCT00456989|20967514|P1|STARTED|Overall Study||39
8507630|NCT00456885|20967519|P2|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
8507631|NCT00456885|20967520|P1|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
8507632|NCT00456885|20967519|P2|COMPLETED|Second Treatment Period, 16 Weeks||17
8507633|NCT00456885|20967520|P1|COMPLETED|Second Treatment Period, 16 Weeks||23
8507634|NCT00456885|20967519|P2|STARTED|Second Treatment Period, 16 Weeks||17
8507635|NCT00456885|20967520|P1|STARTED|Second Treatment Period, 16 Weeks||24
8507636|NCT00456885|20967519|P2|NOT COMPLETED|Washout, 3 Weeks||0
8507637|NCT00456885|20967520|P1|NOT COMPLETED|Washout, 3 Weeks||0
8507638|NCT00456885|20967519|P2|COMPLETED|Washout, 3 Weeks||17
8507639|NCT00456885|20967520|P1|COMPLETED|Washout, 3 Weeks||24
8507640|NCT00456885|20967519|P2|STARTED|Washout, 3 Weeks||17
8507641|NCT00456885|20967520|P1|STARTED|Washout, 3 Weeks||24
8507642|NCT00456885|20967519|P2|NOT COMPLETED|First Treatment Period, 16 Weeks||0
8507643|NCT00456885|20967520|P1|NOT COMPLETED|First Treatment Period, 16 Weeks||0
8507644|NCT00456885|20967519|P2|COMPLETED|First Treatment Period, 16 Weeks||17
8507645|NCT00456885|20967520|P1|COMPLETED|First Treatment Period, 16 Weeks||24
8507646|NCT00456885|20967519|P2|STARTED|First Treatment Period, 16 Weeks||17
8507647|NCT00456885|20967520|P1|STARTED|First Treatment Period, 16 Weeks||24
8507648|NCT00456846|20967551|P2|NOT COMPLETED|Overall Study||28
8507649|NCT00456846|20967552|P1|NOT COMPLETED|Overall Study||16
8507650|NCT00456846|20967551|P2|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
8507651|NCT00456846|20967552|P1|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
8507652|NCT00456846|20967551|P2|STARTED|Overall Study||76
8507653|NCT00456846|20967552|P1|STARTED|Overall Study||47
8507654|NCT00456807|20967574|P2|NOT COMPLETED|Overall Study||0
8507655|NCT00456807|20967575|P1|NOT COMPLETED|Overall Study||1
8507656|NCT00456807|20967574|P2|COMPLETED|Overall Study||47
8507657|NCT00456807|20967575|P1|COMPLETED|Overall Study||52
8507658|NCT00456807|20967574|P2|STARTED|Overall Study||47
8507659|NCT00456807|20967575|P1|STARTED|Overall Study||53
8507660|NCT00456755|20967593|P2|NOT COMPLETED|Overall Study||1
8507661|NCT00456755|20967594|P1|NOT COMPLETED|Overall Study||2
8507662|NCT00456755|20967593|P2|COMPLETED|Overall Study||62
8507663|NCT00456755|20967594|P1|COMPLETED|Overall Study||61
8507664|NCT00456755|20967593|P2|STARTED|Overall Study||63
8507665|NCT00456755|20967594|P1|STARTED|Overall Study||63
8507666|NCT00456625|20967602|P1|NOT COMPLETED|Overall Study||0
8507667|NCT00456625|20967602|P1|COMPLETED|Overall Study||76
8507668|NCT00456625|20967602|P1|STARTED|Overall Study||76
8507669|NCT00456612|20967608|P1|NOT COMPLETED|Overall Study||3
8507670|NCT00456612|20967608|P1|COMPLETED|Overall Study||1
8507671|NCT00456612|20967608|P1|STARTED|Overall Study||4
8507672|NCT00456599|20967613|P1|NOT COMPLETED|Overall Study||3
8507673|NCT00456599|20967613|P1|COMPLETED|Overall Study||68
8507674|NCT00456599|20967613|P1|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
8507675|NCT00456599|20967613|P1|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
8507676|NCT00456599|20967613|P1|Completed Resection|Overall Study|43 patients underwent resection.|43
8507677|NCT00456599|20967613|P1|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
8507678|NCT00456599|20967613|P1|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
8507679|NCT00456599|20967613|P1|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
8507680|NCT00456599|20967613|P1|STARTED|Overall Study||71
8507681|NCT00456547|20967621|P2|NOT COMPLETED|Overall Study||0
8507682|NCT00456547|20967622|P1|NOT COMPLETED|Overall Study||0
8507683|NCT00456547|20967621|P2|COMPLETED|Overall Study||12
8507684|NCT00456547|20967622|P1|COMPLETED|Overall Study||12
8507685|NCT00456547|20967621|P2|STARTED|Overall Study||12
8507686|NCT00456547|20967622|P1|STARTED|Overall Study||12
8507687|NCT00456521|20967636|P2|NOT COMPLETED|Overall Study||84
8507688|NCT00456521|20967637|P1|NOT COMPLETED|Overall Study||249
8507689|NCT00456521|20967636|P2|COMPLETED|Overall Study||118
8507690|NCT00456521|20967637|P1|COMPLETED|Overall Study||342
8507691|NCT00456521|20967636|P2|STARTED|Overall Study||202
8507692|NCT00456521|20967637|P1|STARTED|Overall Study||591
8507696|NCT00456495|20967683|P1|NOT COMPLETED|Overall Study||2
8507697|NCT00456495|20967683|P1|COMPLETED|Overall Study||3
8507698|NCT00456495|20967683|P1|STARTED|Overall Study||5
8507699|NCT00456365|20967690|P2|NOT COMPLETED|Overall Study||12
8507700|NCT00456365|20967691|P1|NOT COMPLETED|Overall Study||7
8507701|NCT00456365|20967690|P2|COMPLETED|Overall Study||42
8507702|NCT00456365|20967691|P1|COMPLETED|Overall Study||49
8507703|NCT00456365|20967690|P2|STARTED|Overall Study||54
8507704|NCT00456365|20967691|P1|STARTED|Overall Study||56
8507705|NCT00456300|20967703|P2|NOT COMPLETED|Overall Study||0
8507706|NCT00456300|20967704|P1|NOT COMPLETED|Overall Study||1
8507707|NCT00456300|20967703|P2|COMPLETED|Overall Study||4
8507708|NCT00456300|20967704|P1|COMPLETED|Overall Study||4
8507709|NCT00456300|20967703|P2|STARTED|Overall Study||4
8507710|NCT00456300|20967704|P1|STARTED|Overall Study||5
8507711|NCT00456261|20967714|P2|NOT COMPLETED|Maintenance Therapy||0
8507712|NCT00456261|20967715|P1|NOT COMPLETED|Maintenance Therapy||0
8507713|NCT00456261|20967714|P2|COMPLETED|Maintenance Therapy||29
8507714|NCT00456261|20967715|P1|COMPLETED|Maintenance Therapy||3
8507715|NCT00456261|20967714|P2|STARTED|Maintenance Therapy||29
8507716|NCT00456261|20967715|P1|STARTED|Maintenance Therapy||3
8507717|NCT00456261|20967714|P2|NOT COMPLETED|Combination Therapy||26
8507718|NCT00456261|20967715|P1|NOT COMPLETED|Combination Therapy||52
8507719|NCT00456261|20967714|P2|COMPLETED|Combination Therapy||29
8507720|NCT00456261|20967715|P1|COMPLETED|Combination Therapy||3
8507721|NCT00456261|20967714|P2|STARTED|Combination Therapy||55
8507722|NCT00456261|20967715|P1|STARTED|Combination Therapy||55
8507723|NCT00456092|20967728|P5|NOT COMPLETED|Treatment Phase (12 Weeks)||0
8507724|NCT00456092|20967729|P4|NOT COMPLETED|Treatment Phase (12 Weeks)||0
8507725|NCT00456092|20967730|P3|NOT COMPLETED|Treatment Phase (12 Weeks)||18
8507726|NCT00456092|20967731|P2|NOT COMPLETED|Treatment Phase (12 Weeks)||14
8507727|NCT00456092|20967732|P1|NOT COMPLETED|Treatment Phase (12 Weeks)||7
8507728|NCT00456092|20967728|P5|COMPLETED|Treatment Phase (12 Weeks)||0
8507729|NCT00456092|20967729|P4|COMPLETED|Treatment Phase (12 Weeks)||0
8507730|NCT00456092|20967730|P3|COMPLETED|Treatment Phase (12 Weeks)||50
8507731|NCT00456092|20967731|P2|COMPLETED|Treatment Phase (12 Weeks)||55
8507732|NCT00456092|20967732|P1|COMPLETED|Treatment Phase (12 Weeks)||60
8507733|NCT00456092|20967728|P5|STARTED|Treatment Phase (12 Weeks)||0
8507734|NCT00456092|20967729|P4|STARTED|Treatment Phase (12 Weeks)||0
8507735|NCT00456092|20967730|P3|STARTED|Treatment Phase (12 Weeks)||68
8507736|NCT00456092|20967731|P2|STARTED|Treatment Phase (12 Weeks)||69
8507737|NCT00456092|20967732|P1|STARTED|Treatment Phase (12 Weeks)||67
8507738|NCT00456092|20967728|P5|NOT COMPLETED|Extension Phase||7
8507739|NCT00456092|20967729|P4|NOT COMPLETED|Extension Phase||1
8507740|NCT00456092|20967730|P3|NOT COMPLETED|Extension Phase||0
8507741|NCT00456092|20967731|P2|NOT COMPLETED|Extension Phase||4
8507742|NCT00456092|20967732|P1|NOT COMPLETED|Extension Phase||11
8507743|NCT00456092|20967728|P5|COMPLETED|Extension Phase||13
8507744|NCT00456092|20967729|P4|COMPLETED|Extension Phase||19
8507745|NCT00456092|20967730|P3|COMPLETED|Extension Phase||0
8507746|NCT00456092|20967731|P2|COMPLETED|Extension Phase||36
8507747|NCT00456092|20967732|P1|COMPLETED|Extension Phase||35
8507748|NCT00456092|20967728|P5|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
8507749|NCT00456092|20967729|P4|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
8507750|NCT00456092|20967730|P3|STARTED|Extension Phase||0
8507751|NCT00456092|20967731|P2|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40
8507752|NCT00456092|20967732|P1|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46
8507753|NCT00456014|20967882|P1|NOT COMPLETED|Tricyclic Phase||3
8507754|NCT00456014|20967882|P1|COMPLETED|Tricyclic Phase||1
8507755|NCT00456014|20967882|P1|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
8507756|NCT00456014|20967882|P1|NOT COMPLETED|SSRI Phase||9
8507757|NCT00456014|20967882|P1|COMPLETED|SSRI Phase||28
8507758|NCT00456014|20967882|P1|STARTED|SSRI Phase||37
8507759|NCT00455975|20967890|P2|NOT COMPLETED|Overall Study||21
8507760|NCT00455975|20967891|P1|NOT COMPLETED|Overall Study||18
8507761|NCT00455975|20967890|P2|COMPLETED|Overall Study||40
8507762|NCT00455975|20967891|P1|COMPLETED|Overall Study||40
8507763|NCT00455975|20967890|P2|STARTED|Overall Study||61
8507764|NCT00455975|20967891|P1|STARTED|Overall Study||58
8507765|NCT00455962|20967905|P2|NOT COMPLETED|Overall Study||0
8507766|NCT00455962|20967906|P1|NOT COMPLETED|Overall Study||0
8507767|NCT00455962|20967905|P2|COMPLETED|Overall Study||13
8507768|NCT00455962|20967906|P1|COMPLETED|Overall Study||10
8507769|NCT00455962|20967905|P2|STARTED|Overall Study||13
8507770|NCT00455962|20967906|P1|STARTED|Overall Study||10
8507771|NCT00455923|20967914|P2|NOT COMPLETED|Overall Study||3
8507772|NCT00455923|20967915|P1|NOT COMPLETED|Overall Study||3
8507773|NCT00455923|20967914|P2|COMPLETED|Overall Study||47
8507774|NCT00455923|20967915|P1|COMPLETED|Overall Study||47
8507775|NCT00455923|20967914|P2|STARTED|Overall Study||50
8507776|NCT00455923|20967915|P1|STARTED|Overall Study||50
8507777|NCT00455858|20967931|P1|NOT COMPLETED|Overall Study||6
8507778|NCT00455858|20967931|P1|COMPLETED|Overall Study||81
8507779|NCT00455858|20967931|P1|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
8507780|NCT00455741|20967941|P2|NOT COMPLETED|Overall Study||1
8507781|NCT00455741|20967942|P1|NOT COMPLETED|Overall Study||0
8507782|NCT00455741|20967941|P2|COMPLETED|Overall Study||11
8507783|NCT00455741|20967942|P1|COMPLETED|Overall Study||13
8507784|NCT00455741|20967941|P2|STARTED|Overall Study||12
8507785|NCT00455741|20967942|P1|STARTED|Overall Study||13
8507786|NCT00455702|20967960|P2|NOT COMPLETED|Overall Study||3
8507787|NCT00455702|20967961|P1|NOT COMPLETED|Overall Study||3
8507788|NCT00455702|20967960|P2|COMPLETED|Overall Study||16
8507789|NCT00455702|20967961|P1|COMPLETED|Overall Study||16
8507790|NCT00455702|20967960|P2|STARTED|Overall Study||19
8507791|NCT00455702|20967961|P1|STARTED|Overall Study||19
8507792|NCT00455689|20967971|P2|NOT COMPLETED|Overall Study||0
8507793|NCT00455689|20967972|P1|NOT COMPLETED|Overall Study||0
8507794|NCT00455689|20967971|P2|COMPLETED|Overall Study||6
8507795|NCT00455689|20967972|P1|COMPLETED|Overall Study||14
8507796|NCT00455689|20967971|P2|STARTED|Overall Study||6
8507797|NCT00455689|20967972|P1|STARTED|Overall Study||14
8507798|NCT00455663|20967982|P3|NOT COMPLETED|Overall Study||3
8507799|NCT00455663|20967983|P2|NOT COMPLETED|Overall Study||4
8507800|NCT00455663|20967984|P1|NOT COMPLETED|Overall Study||3
8507801|NCT00455663|20967982|P3|COMPLETED|Overall Study||29
8507802|NCT00455663|20967983|P2|COMPLETED|Overall Study||32
8507803|NCT00455663|20967984|P1|COMPLETED|Overall Study||34
8507804|NCT00455663|20967982|P3|STARTED|Overall Study||32
8507805|NCT00455663|20967983|P2|STARTED|Overall Study||36
8507806|NCT00455663|20967984|P1|STARTED|Overall Study||37
8507807|NCT00455650|20968003|P6|NOT COMPLETED|Week 3||0
8507808|NCT00455650|20968004|P5|NOT COMPLETED|Week 3||0
8507809|NCT00455650|20968005|P4|NOT COMPLETED|Week 3||0
8507810|NCT00455650|20968006|P3|NOT COMPLETED|Week 3||0
8507811|NCT00455650|20968007|P2|NOT COMPLETED|Week 3||0
8507812|NCT00455650|20968008|P1|NOT COMPLETED|Week 3||0
8507813|NCT00455650|20968003|P6|COMPLETED|Week 3||13
8507814|NCT00455650|20968004|P5|COMPLETED|Week 3||14
8507815|NCT00455650|20968005|P4|COMPLETED|Week 3||14
8507816|NCT00455650|20968006|P3|COMPLETED|Week 3||10
8507817|NCT00455650|20968007|P2|COMPLETED|Week 3||10
8507818|NCT00455650|20968008|P1|COMPLETED|Week 3||10
8507819|NCT00455650|20968003|P6|STARTED|Week 3||13
8507820|NCT00455650|20968004|P5|STARTED|Week 3||14
8507821|NCT00455650|20968005|P4|STARTED|Week 3||14
8507822|NCT00455650|20968006|P3|STARTED|Week 3||10
8507823|NCT00455650|20968007|P2|STARTED|Week 3||10
8507824|NCT00455650|20968008|P1|STARTED|Week 3||10
8507825|NCT00455650|20968003|P6|NOT COMPLETED|Week 2||0
8507826|NCT00455650|20968004|P5|NOT COMPLETED|Week 2||0
8507827|NCT00455650|20968005|P4|NOT COMPLETED|Week 2||0
8507828|NCT00455650|20968006|P3|NOT COMPLETED|Week 2||0
8507829|NCT00455650|20968007|P2|NOT COMPLETED|Week 2||0
8507830|NCT00455650|20968008|P1|NOT COMPLETED|Week 2||0
8507831|NCT00455650|20968003|P6|COMPLETED|Week 2||13
8507832|NCT00455650|20968004|P5|COMPLETED|Week 2||14
8507833|NCT00455650|20968005|P4|COMPLETED|Week 2||14
8507834|NCT00455650|20968006|P3|COMPLETED|Week 2||10
8507835|NCT00455650|20968007|P2|COMPLETED|Week 2||10
8507836|NCT00455650|20968008|P1|COMPLETED|Week 2||10
8507837|NCT00455650|20968003|P6|STARTED|Week 2||13
8507838|NCT00455650|20968004|P5|STARTED|Week 2||14
8507839|NCT00455650|20968005|P4|STARTED|Week 2||14
8507840|NCT00455650|20968006|P3|STARTED|Week 2||10
8507841|NCT00455650|20968007|P2|STARTED|Week 2||10
8507842|NCT00455650|20968008|P1|STARTED|Week 2||10
8507843|NCT00455650|20968003|P6|NOT COMPLETED|Week 1||0
8507844|NCT00455650|20968004|P5|NOT COMPLETED|Week 1||0
8507845|NCT00455650|20968005|P4|NOT COMPLETED|Week 1||0
8507846|NCT00455650|20968006|P3|NOT COMPLETED|Week 1||0
8507847|NCT00455650|20968007|P2|NOT COMPLETED|Week 1||0
8507848|NCT00455650|20968008|P1|NOT COMPLETED|Week 1||0
8507849|NCT00455650|20968003|P6|COMPLETED|Week 1||13
8507850|NCT00455650|20968004|P5|COMPLETED|Week 1||14
8507851|NCT00455650|20968005|P4|COMPLETED|Week 1||14
8507852|NCT00455650|20968006|P3|COMPLETED|Week 1||10
8507853|NCT00455650|20968007|P2|COMPLETED|Week 1||10
8507854|NCT00455650|20968008|P1|COMPLETED|Week 1||10
8507855|NCT00455650|20968003|P6|STARTED|Week 1||13
8507856|NCT00455650|20968004|P5|STARTED|Week 1||14
8507857|NCT00455650|20968005|P4|STARTED|Week 1||14
8507858|NCT00455650|20968006|P3|STARTED|Week 1||10
8507859|NCT00455650|20968007|P2|STARTED|Week 1||10
8507860|NCT00455650|20968008|P1|STARTED|Week 1||10
8507861|NCT00455533|20968038|P3|NOT COMPLETED|Period Two: Randomized Period||6
8507862|NCT00455533|20968039|P2|NOT COMPLETED|Period Two: Randomized Period||6
8507863|NCT00455533|20968040|P1|NOT COMPLETED|Period Two: Randomized Period||0
8507864|NCT00455533|20968038|P3|COMPLETED|Period Two: Randomized Period||138
8507865|NCT00455533|20968039|P2|COMPLETED|Period Two: Randomized Period||139
8507866|NCT00455533|20968040|P1|COMPLETED|Period Two: Randomized Period||0
8507867|NCT00455533|20968038|P3|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
8507868|NCT00455533|20968039|P2|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
8507869|NCT00455533|20968040|P1|STARTED|Period Two: Randomized Period||0
8507870|NCT00455533|20968038|P3|NOT COMPLETED|Period One: Initial Chemotherapy||0
8507871|NCT00455533|20968039|P2|NOT COMPLETED|Period One: Initial Chemotherapy||0
8507872|NCT00455533|20968040|P1|NOT COMPLETED|Period One: Initial Chemotherapy||18
8507873|NCT00455533|20968038|P3|COMPLETED|Period One: Initial Chemotherapy||0
8507874|NCT00455533|20968039|P2|COMPLETED|Period One: Initial Chemotherapy||0
8507875|NCT00455533|20968040|P1|COMPLETED|Period One: Initial Chemotherapy||295
8507876|NCT00455533|20968038|P3|STARTED|Period One: Initial Chemotherapy||0
8507877|NCT00455533|20968039|P2|STARTED|Period One: Initial Chemotherapy||0
8507878|NCT00455533|20968040|P1|STARTED|Period One: Initial Chemotherapy||313
8507879|NCT00455520|20968089|P2|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
8507880|NCT00455520|20968090|P1|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
8507881|NCT00455520|20968089|P2|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
8507882|NCT00455520|20968090|P1|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
8507883|NCT00455520|20968089|P2|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
8507884|NCT00455520|20968090|P1|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
8507885|NCT00455520|20968089|P2|NOT COMPLETED|Open Label Tapentadol Extended Release||0
8507886|NCT00455520|20968090|P1|NOT COMPLETED|Open Label Tapentadol Extended Release||196
8507887|NCT00455520|20968089|P2|COMPLETED|Open Label Tapentadol Extended Release||0
8507888|NCT00455520|20968090|P1|COMPLETED|Open Label Tapentadol Extended Release||395
8507889|NCT00455520|20968089|P2|STARTED|Open Label Tapentadol Extended Release||0
8507890|NCT00455520|20968090|P1|STARTED|Open Label Tapentadol Extended Release||591
8507891|NCT00455455|20968106|P2|NOT COMPLETED|Second Intervention||0
8507892|NCT00455455|20968107|P1|NOT COMPLETED|Second Intervention||0
8507893|NCT00455455|20968106|P2|COMPLETED|Second Intervention||24
8507894|NCT00455455|20968107|P1|COMPLETED|Second Intervention||24
8507895|NCT00455455|20968106|P2|STARTED|Second Intervention||24
8507896|NCT00455455|20968107|P1|STARTED|Second Intervention||24
8507897|NCT00455455|20968106|P2|NOT COMPLETED|Washout||0
8507898|NCT00455455|20968107|P1|NOT COMPLETED|Washout||1
8507899|NCT00455455|20968106|P2|COMPLETED|Washout||24
8507900|NCT00455455|20968107|P1|COMPLETED|Washout||24
8507901|NCT00455455|20968106|P2|STARTED|Washout||24
8507902|NCT00455455|20968107|P1|STARTED|Washout||25
8507903|NCT00455455|20968106|P2|NOT COMPLETED|First Intervention||0
8507904|NCT00455455|20968107|P1|NOT COMPLETED|First Intervention||0
8507905|NCT00455455|20968106|P2|COMPLETED|First Intervention||24
8507906|NCT00455455|20968107|P1|COMPLETED|First Intervention||25
8507907|NCT00455455|20968106|P2|STARTED|First Intervention||24
8507908|NCT00455455|20968107|P1|STARTED|First Intervention||25
8507909|NCT00455455|20968106|P2|NOT COMPLETED|Washout||1
8507910|NCT00455455|20968107|P1|NOT COMPLETED|Washout||0
8507911|NCT00455455|20968106|P2|COMPLETED|Washout||24
8507912|NCT00455455|20968107|P1|COMPLETED|Washout||25
8507913|NCT00455455|20968106|P2|STARTED|Washout||25
8507914|NCT00455455|20968107|P1|STARTED|Washout||25
8507915|NCT00455429|20968127|P4|NOT COMPLETED|Overall Study||14
8507916|NCT00455429|20968128|P3|NOT COMPLETED|Overall Study||1
8507917|NCT00455429|20968129|P2|NOT COMPLETED|Overall Study||5
8507918|NCT00455429|20968130|P1|NOT COMPLETED|Overall Study||2
8507919|NCT00455429|20968127|P4|COMPLETED|Overall Study||20
8507920|NCT00455429|20968128|P3|COMPLETED|Overall Study||16
8507921|NCT00455429|20968129|P2|COMPLETED|Overall Study||10
8507922|NCT00455429|20968130|P1|COMPLETED|Overall Study||16
8507923|NCT00455429|20968127|P4|Treated|Overall Study||32
8507924|NCT00455429|20968128|P3|Treated|Overall Study||17
8507925|NCT00455429|20968129|P2|Treated|Overall Study||15
8507926|NCT00455429|20968130|P1|Treated|Overall Study||18
8507927|NCT00455429|20968127|P4|STARTED|Overall Study||34
8507928|NCT00455429|20968128|P3|STARTED|Overall Study||17
8507929|NCT00455429|20968129|P2|STARTED|Overall Study||15
8507930|NCT00455429|20968130|P1|STARTED|Overall Study||18
8507931|NCT00455312|20968189|P2|NOT COMPLETED|Overall Study||1
8507932|NCT00455312|20968190|P1|NOT COMPLETED|Overall Study||0
8507933|NCT00455312|20968189|P2|COMPLETED|Overall Study||20
8507934|NCT00455312|20968190|P1|COMPLETED|Overall Study||15
8507935|NCT00455312|20968189|P2|STARTED|Overall Study||21
8507936|NCT00455312|20968190|P1|STARTED|Overall Study||15
8507937|NCT00455195|20968216|P2|NOT COMPLETED|Extension Study AGLU03206||0
8507938|NCT00455195|20968217|P1|NOT COMPLETED|Extension Study AGLU03206||0
8507939|NCT00455195|20968216|P2|COMPLETED|Extension Study AGLU03206||26
8507940|NCT00455195|20968217|P1|COMPLETED|Extension Study AGLU03206||55
8507941|NCT00455195|20968216|P2|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
8507942|NCT00455195|20968217|P1|STARTED|Extension Study AGLU03206||55
8507943|NCT00455195|20968216|P2|NOT COMPLETED|Double-blind Study AGLU02704||4
8507944|NCT00455195|20968217|P1|NOT COMPLETED|Double-blind Study AGLU02704||5
8507945|NCT00455195|20968216|P2|COMPLETED|Double-blind Study AGLU02704||26
8507946|NCT00455195|20968217|P1|COMPLETED|Double-blind Study AGLU02704||55
8507947|NCT00455195|20968216|P2|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
8507948|NCT00455195|20968217|P1|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
8507949|NCT00455143|20968231|P1|NOT COMPLETED|Overall Study||6
8507950|NCT00455143|20968231|P1|COMPLETED|Overall Study||21
8507951|NCT00455143|20968231|P1|STARTED|Overall Study||27
8507952|NCT00455013|20968255|P3|NOT COMPLETED|Long Term Extension (LTE)||7
8507953|NCT00455013|20968256|P2|NOT COMPLETED|Long Term Extension (LTE)||3
8507954|NCT00455013|20968257|P1|NOT COMPLETED|Long Term Extension (LTE)||2
8507955|NCT00455013|20968255|P3|COMPLETED|Long Term Extension (LTE)||20
8507956|NCT00455013|20968256|P2|COMPLETED|Long Term Extension (LTE)||16
8507957|NCT00455013|20968257|P1|COMPLETED|Long Term Extension (LTE)||25
8507958|NCT00455013|20968255|P3|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
8507959|NCT00455013|20968256|P2|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
8507960|NCT00455013|20968257|P1|STARTED|Long Term Extension (LTE)||27
8507961|NCT00455013|20968255|P3|NOT COMPLETED|Short Term Period||2
8507962|NCT00455013|20968256|P2|NOT COMPLETED|Short Term Period||5
8507963|NCT00455013|20968257|P1|NOT COMPLETED|Short Term Period||6
8507964|NCT00455013|20968255|P3|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
8507965|NCT00455013|20968256|P2|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
8507966|NCT00455013|20968257|P1|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
8507967|NCT00455013|20968255|P3|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
8507968|NCT00455013|20968256|P2|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
8507969|NCT00455013|20968257|P1|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
8507970|NCT00454987|20968325|P3|NOT COMPLETED|Year 4 (NCT00454987)||0
8507971|NCT00454987|20968326|P2|NOT COMPLETED|Year 4 (NCT00454987)||0
8507972|NCT00454987|20968327|P1|NOT COMPLETED|Year 4 (NCT00454987)||0
8507973|NCT00454987|20968325|P3|COMPLETED|Year 4 (NCT00454987)||0
8507974|NCT00454987|20968326|P2|COMPLETED|Year 4 (NCT00454987)||62
8507975|NCT00454987|20968327|P1|COMPLETED|Year 4 (NCT00454987)||206
8507976|NCT00454987|20968325|P3|STARTED|Year 4 (NCT00454987)||0
8507977|NCT00454987|20968326|P2|STARTED|Year 4 (NCT00454987)||62
8507978|NCT00454987|20968327|P1|STARTED|Year 4 (NCT00454987)||206
8507979|NCT00454987|20968325|P3|NOT COMPLETED|Year 2 (NCT00454987)||0
8507980|NCT00454987|20968326|P2|NOT COMPLETED|Year 2 (NCT00454987)||0
8507981|NCT00454987|20968327|P1|NOT COMPLETED|Year 2 (NCT00454987)||0
8507982|NCT00454987|20968325|P3|COMPLETED|Year 2 (NCT00454987)||74
8507983|NCT00454987|20968326|P2|COMPLETED|Year 2 (NCT00454987)||77
8507984|NCT00454987|20968327|P1|COMPLETED|Year 2 (NCT00454987)||235
8507985|NCT00454987|20968325|P3|STARTED|Year 2 (NCT00454987)||74
8507986|NCT00454987|20968326|P2|STARTED|Year 2 (NCT00454987)||77
8507987|NCT00454987|20968327|P1|STARTED|Year 2 (NCT00454987)||235
8507988|NCT00454987|20968325|P3|NOT COMPLETED|Year 1 (NCT00454987)||0
8507989|NCT00454987|20968326|P2|NOT COMPLETED|Year 1 (NCT00454987)||0
8507990|NCT00454987|20968327|P1|NOT COMPLETED|Year 1 (NCT00454987)||0
8507991|NCT00454987|20968325|P3|COMPLETED|Year 1 (NCT00454987)||0
8507992|NCT00454987|20968326|P2|COMPLETED|Year 1 (NCT00454987)||67
8507993|NCT00454987|20968327|P1|COMPLETED|Year 1 (NCT00454987)||221
8507994|NCT00454987|20968325|P3|STARTED|Year 1 (NCT00454987)||0
8507995|NCT00454987|20968326|P2|STARTED|Year 1 (NCT00454987)||67
8507996|NCT00454987|20968327|P1|STARTED|Year 1 (NCT00454987)||221
8507997|NCT00454987|20968325|P3|NOT COMPLETED|Booster Period (NCT00258700)||0
8507998|NCT00454987|20968326|P2|NOT COMPLETED|Booster Period (NCT00258700)||1
8507999|NCT00454987|20968327|P1|NOT COMPLETED|Booster Period (NCT00258700)||2
8508000|NCT00454987|20968325|P3|COMPLETED|Booster Period (NCT00258700)||0
8508001|NCT00454987|20968326|P2|COMPLETED|Booster Period (NCT00258700)||116
8508002|NCT00454987|20968327|P1|COMPLETED|Booster Period (NCT00258700)||357
8508003|NCT00454987|20968325|P3|STARTED|Booster Period (NCT00258700)||0
8508004|NCT00454987|20968326|P2|STARTED|Booster Period (NCT00258700)||117
8508005|NCT00454987|20968327|P1|STARTED|Booster Period (NCT00258700)||359
8508006|NCT00454909|20968401|P3|NOT COMPLETED|Overall Study||2
8508007|NCT00454909|20968402|P2|NOT COMPLETED|Overall Study||3
8508008|NCT00454909|20968403|P1|NOT COMPLETED|Overall Study||7
8508009|NCT00454909|20968401|P3|COMPLETED|Overall Study||86
8508010|NCT00454909|20968402|P2|COMPLETED|Overall Study||194
8508011|NCT00454909|20968403|P1|COMPLETED|Overall Study||580
8508012|NCT00454909|20968401|P3|STARTED|Overall Study||88
8508013|NCT00454909|20968402|P2|STARTED|Overall Study||197
8508014|NCT00454909|20968403|P1|STARTED|Overall Study||587
8508015|NCT00454857|20968441|P1|NOT COMPLETED|Overall Study||54
8508016|NCT00454857|20968441|P1|COMPLETED|Overall Study||272
8508017|NCT00454857|20968441|P1|Completed ≥1 Observational Study Visit|Overall Study||319
8508018|NCT00454857|20968441|P1|Completed Retrospective Chart Review|Overall Study||324
8508019|NCT00454857|20968441|P1|STARTED|Overall Study||326
8508020|NCT00454818|20968466|P5|NOT COMPLETED|Phase 2: Randomized Double-blind||4
8508021|NCT00454818|20968467|P4|NOT COMPLETED|Phase 2: Randomized Double-blind||1
8508022|NCT00454818|20968468|P3|NOT COMPLETED|Phase 2: Randomized Double-blind||3
8508023|NCT00454818|20968469|P2|NOT COMPLETED|Phase 2: Randomized Double-blind||2
8508024|NCT00454818|20968470|P1|NOT COMPLETED|Phase 2: Randomized Double-blind||0
8508025|NCT00454818|20968466|P5|COMPLETED|Phase 2: Randomized Double-blind||10
8508026|NCT00454818|20968467|P4|COMPLETED|Phase 2: Randomized Double-blind||8
8508027|NCT00454818|20968468|P3|COMPLETED|Phase 2: Randomized Double-blind||5
8508028|NCT00454818|20968469|P2|COMPLETED|Phase 2: Randomized Double-blind||6
8508029|NCT00454818|20968470|P1|COMPLETED|Phase 2: Randomized Double-blind||0
8508030|NCT00454818|20968466|P5|STARTED|Phase 2: Randomized Double-blind||14
8508031|NCT00454818|20968467|P4|STARTED|Phase 2: Randomized Double-blind||9
8508032|NCT00454818|20968468|P3|STARTED|Phase 2: Randomized Double-blind||8
8508033|NCT00454818|20968469|P2|STARTED|Phase 2: Randomized Double-blind||8
8508034|NCT00454818|20968470|P1|STARTED|Phase 2: Randomized Double-blind||0
8508035|NCT00454818|20968466|P5|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
8508036|NCT00454818|20968467|P4|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
8508037|NCT00454818|20968468|P3|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
8508038|NCT00454818|20968469|P2|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
8508039|NCT00454818|20968470|P1|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
8508040|NCT00454818|20968466|P5|COMPLETED|Phase I: Open-label Dose-escalation||0
8508041|NCT00454818|20968467|P4|COMPLETED|Phase I: Open-label Dose-escalation||2
8508042|NCT00454818|20968468|P3|COMPLETED|Phase I: Open-label Dose-escalation||2
8508043|NCT00454818|20968469|P2|COMPLETED|Phase I: Open-label Dose-escalation||2
8508044|NCT00454818|20968470|P1|COMPLETED|Phase I: Open-label Dose-escalation||2
8508045|NCT00454818|20968466|P5|STARTED|Phase I: Open-label Dose-escalation||0
8508046|NCT00454818|20968467|P4|STARTED|Phase I: Open-label Dose-escalation||3
8508047|NCT00454818|20968468|P3|STARTED|Phase I: Open-label Dose-escalation||3
8508048|NCT00454818|20968469|P2|STARTED|Phase I: Open-label Dose-escalation||3
8508049|NCT00454818|20968470|P1|STARTED|Phase I: Open-label Dose-escalation||3
8508050|NCT00454805|20968549|P2|NOT COMPLETED|Overall Study||23
8508051|NCT00454805|20968550|P1|NOT COMPLETED|Overall Study||26
8508052|NCT00454805|20968549|P2|COMPLETED|Overall Study|Ongoing at data cut-off|8
8508053|NCT00454805|20968550|P1|COMPLETED|Overall Study|Ongoing at data cut-off|5
8508054|NCT00454805|20968549|P2|STARTED|Overall Study|Randomised|31
8508055|NCT00454805|20968550|P1|STARTED|Overall Study|Randomised|31
8508056|NCT00454779|20968566|P2|NOT COMPLETED|Second-line Treatment Phase||3
8508057|NCT00454779|20968567|P1|NOT COMPLETED|Second-line Treatment Phase||0
8508058|NCT00454779|20968566|P2|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
8508059|NCT00454779|20968567|P1|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
8508060|NCT00454779|20968566|P2|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
8508061|NCT00454779|20968567|P1|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
8508062|NCT00454779|20968566|P2|NOT COMPLETED|First-line Treatment Phase||8
8508063|NCT00454779|20968567|P1|NOT COMPLETED|First-line Treatment Phase||5
8508064|NCT00454779|20968566|P2|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
8508065|NCT00454779|20968567|P1|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
8508066|NCT00454779|20968566|P2|Received Study Medication|First-line Treatment Phase||55
8508067|NCT00454779|20968567|P1|Received Study Medication|First-line Treatment Phase||56
8508068|NCT00454779|20968566|P2|STARTED|First-line Treatment Phase||57
8508069|NCT00454779|20968567|P1|STARTED|First-line Treatment Phase||56
8508070|NCT00454649|20968605|P10|NOT COMPLETED|Overall Study||5
8508071|NCT00454649|20968606|P9|NOT COMPLETED|Overall Study||20
8508072|NCT00454649|20968607|P8|NOT COMPLETED|Overall Study||19
8508073|NCT00454649|20968608|P7|NOT COMPLETED|Overall Study||9
8508074|NCT00454649|20968609|P6|NOT COMPLETED|Overall Study||7
8508075|NCT00454649|20968610|P5|NOT COMPLETED|Overall Study||1
8508076|NCT00454649|20968611|P4|NOT COMPLETED|Overall Study||6
8508077|NCT00454649|20968612|P3|NOT COMPLETED|Overall Study||19
8508078|NCT00454649|20968613|P2|NOT COMPLETED|Overall Study||4
8508079|NCT00454649|20968614|P1|NOT COMPLETED|Overall Study||3
8508080|NCT00454649|20968605|P10|COMPLETED|Overall Study||1
8508081|NCT00454649|20968606|P9|COMPLETED|Overall Study||1
8508082|NCT00454649|20968607|P8|COMPLETED|Overall Study||0
8508083|NCT00454649|20968608|P7|COMPLETED|Overall Study||0
8508084|NCT00454649|20968609|P6|COMPLETED|Overall Study||0
8508085|NCT00454649|20968610|P5|COMPLETED|Overall Study||0
8508086|NCT00454649|20968611|P4|COMPLETED|Overall Study||1
8508087|NCT00454649|20968612|P3|COMPLETED|Overall Study||1
8508088|NCT00454649|20968613|P2|COMPLETED|Overall Study||1
8508089|NCT00454649|20968614|P1|COMPLETED|Overall Study||0
8508090|NCT00454649|20968605|P10|STARTED|Overall Study||6
8508091|NCT00454649|20968606|P9|STARTED|Overall Study||21
8508092|NCT00454649|20968607|P8|STARTED|Overall Study||19
8508093|NCT00454649|20968608|P7|STARTED|Overall Study||9
8508094|NCT00454649|20968609|P6|STARTED|Overall Study||7
8508095|NCT00454649|20968610|P5|STARTED|Overall Study||1
8508096|NCT00454649|20968611|P4|STARTED|Overall Study||7
8508097|NCT00454649|20968612|P3|STARTED|Overall Study||20
8508098|NCT00454649|20968613|P2|STARTED|Overall Study||5
8508099|NCT00454649|20968614|P1|STARTED|Overall Study||3
8508100|NCT00454636|20968743|P4|NOT COMPLETED|Overall Study||32
8508101|NCT00454636|20968744|P3|NOT COMPLETED|Overall Study||20
8508102|NCT00454636|20968745|P2|NOT COMPLETED|Overall Study||23
8508103|NCT00454636|20968746|P1|NOT COMPLETED|Overall Study||31
8508104|NCT00454636|20968743|P4|COMPLETED|Overall Study||26
8508105|NCT00454636|20968744|P3|COMPLETED|Overall Study||7
8508106|NCT00454636|20968745|P2|COMPLETED|Overall Study||9
8508107|NCT00454636|20968746|P1|COMPLETED|Overall Study||10
8508108|NCT00454636|20968743|P4|STARTED|Overall Study||58
8508109|NCT00454636|20968744|P3|STARTED|Overall Study||27
8508110|NCT00454636|20968745|P2|STARTED|Overall Study||32
8508111|NCT00454636|20968746|P1|STARTED|Overall Study||41
8508112|NCT00454584|20968779|P6|NOT COMPLETED|After Controlled Period||32
8508113|NCT00454584|20968780|P5|NOT COMPLETED|After Controlled Period||12
8508114|NCT00454584|20968781|P4|NOT COMPLETED|After Controlled Period||26
8508115|NCT00454584|20968782|P3|NOT COMPLETED|After Controlled Period||0
8508116|NCT00454584|20968783|P2|NOT COMPLETED|After Controlled Period||0
8508117|NCT00454584|20968784|P1|NOT COMPLETED|After Controlled Period||0
8508118|NCT00454584|20968779|P6|COMPLETED|After Controlled Period||310
8508119|NCT00454584|20968780|P5|COMPLETED|After Controlled Period||189
8508120|NCT00454584|20968781|P4|COMPLETED|After Controlled Period||310
8508121|NCT00454584|20968782|P3|COMPLETED|After Controlled Period||0
8508122|NCT00454584|20968783|P2|COMPLETED|After Controlled Period||0
8508123|NCT00454584|20968784|P1|COMPLETED|After Controlled Period||0
8508124|NCT00454584|20968779|P6|STARTED|After Controlled Period||342
8508125|NCT00454584|20968780|P5|STARTED|After Controlled Period||201
8508126|NCT00454584|20968781|P4|STARTED|After Controlled Period||336
8508127|NCT00454584|20968782|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8508128|NCT00454584|20968783|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8508129|NCT00454584|20968784|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8508130|NCT00454584|20968779|P6|NOT COMPLETED|Controlled Period||0
8508131|NCT00454584|20968780|P5|NOT COMPLETED|Controlled Period||0
8508132|NCT00454584|20968781|P4|NOT COMPLETED|Controlled Period||0
8508133|NCT00454584|20968782|P3|NOT COMPLETED|Controlled Period||5
8508134|NCT00454584|20968783|P2|NOT COMPLETED|Controlled Period||8
8508135|NCT00454584|20968784|P1|NOT COMPLETED|Controlled Period||11
8508136|NCT00454584|20968779|P6|COMPLETED|Controlled Period||0
8508137|NCT00454584|20968780|P5|COMPLETED|Controlled Period||0
8508138|NCT00454584|20968781|P4|COMPLETED|Controlled Period||0
8508139|NCT00454584|20968782|P3|COMPLETED|Controlled Period||342
8508140|NCT00454584|20968783|P2|COMPLETED|Controlled Period||201
8508141|NCT00454584|20968784|P1|COMPLETED|Controlled Period||336
8508142|NCT00454584|20968779|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8508143|NCT00454584|20968780|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8508144|NCT00454584|20968781|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8508145|NCT00454584|20968782|P3|STARTED|Controlled Period||347
8508146|NCT00454584|20968783|P2|STARTED|Controlled Period||209
8508147|NCT00454584|20968784|P1|STARTED|Controlled Period||347
8508148|NCT00454571|20968806|P2|NOT COMPLETED|Overall Study||6
8508149|NCT00454571|20968807|P1|NOT COMPLETED|Overall Study||13
8508150|NCT00454571|20968806|P2|COMPLETED|Overall Study||13
8508151|NCT00454571|20968807|P1|COMPLETED|Overall Study||5
8508152|NCT00454571|20968806|P2|STARTED|Overall Study||19
8508153|NCT00454571|20968807|P1|STARTED|Overall Study||18
8508154|NCT00454532|20968819|P4|NOT COMPLETED|Overall Study||0
8508155|NCT00454532|20968820|P3|NOT COMPLETED|Overall Study||0
8508156|NCT00454532|20968821|P2|NOT COMPLETED|Overall Study||0
8508157|NCT00454532|20968822|P1|NOT COMPLETED|Overall Study||0
8508158|NCT00454532|20968819|P4|COMPLETED|Overall Study||7
8508159|NCT00454532|20968820|P3|COMPLETED|Overall Study||3
8508160|NCT00454532|20968821|P2|COMPLETED|Overall Study||6
8508161|NCT00454532|20968822|P1|COMPLETED|Overall Study||11
8508162|NCT00454532|20968819|P4|STARTED|Overall Study||7
8508163|NCT00454532|20968820|P3|STARTED|Overall Study||3
8508164|NCT00454532|20968821|P2|STARTED|Overall Study||6
8508165|NCT00454532|20968822|P1|STARTED|Overall Study||11
8508166|NCT00454363|20968842|P2|NOT COMPLETED|Overall Study||2
8508167|NCT00454363|20968843|P1|NOT COMPLETED|Overall Study||5
8508168|NCT00454363|20968842|P2|COMPLETED|Overall Study||29
8508169|NCT00454363|20968843|P1|COMPLETED|Overall Study||15
8508170|NCT00454363|20968842|P2|STARTED|Overall Study||31
8508171|NCT00454363|20968843|P1|STARTED|Overall Study||20
8508172|NCT00454324|20968856|P2|NOT COMPLETED|Overall Study||0
8508173|NCT00454324|20968857|P1|NOT COMPLETED|Overall Study||0
8508174|NCT00454324|20968856|P2|COMPLETED|Overall Study||13
8508175|NCT00454324|20968857|P1|COMPLETED|Overall Study||14
8508176|NCT00454324|20968856|P2|STARTED|Overall Study||13
8508177|NCT00454324|20968857|P1|STARTED|Overall Study||14
8508178|NCT00454246|20968872|P3|NOT COMPLETED|Overall Study||9
8508179|NCT00454246|20968873|P2|NOT COMPLETED|Overall Study||29
8508180|NCT00454246|20968874|P1|NOT COMPLETED|Overall Study||73
8508181|NCT00454246|20968872|P3|COMPLETED|Overall Study||0
8508182|NCT00454246|20968873|P2|COMPLETED|Overall Study||0
8508183|NCT00454246|20968874|P1|COMPLETED|Overall Study||0
8508184|NCT00454246|20968872|P3|STARTED|Overall Study||9
8508185|NCT00454246|20968873|P2|STARTED|Overall Study||29
8508186|NCT00454246|20968874|P1|STARTED|Overall Study||73
8508193|NCT00454194|20968936|P2|NOT COMPLETED|Overall Study||14
8508194|NCT00454194|20968937|P1|NOT COMPLETED|Overall Study||22
8508195|NCT00454194|20968936|P2|COMPLETED|Overall Study||37
8508196|NCT00454194|20968937|P1|COMPLETED|Overall Study||25
8508197|NCT00454194|20968936|P2|STARTED|Overall Study||51
8508198|NCT00454194|20968937|P1|STARTED|Overall Study||47
8508199|NCT00454181|20968955|P2|NOT COMPLETED|Overall Study||3
8508200|NCT00454181|20968956|P1|NOT COMPLETED|Overall Study||15
8508201|NCT00454181|20968955|P2|COMPLETED|Overall Study||11
8508202|NCT00454181|20968956|P1|COMPLETED|Overall Study||30
8508203|NCT00454181|20968955|P2|STARTED|Overall Study||14
8508204|NCT00454181|20968956|P1|STARTED|Overall Study||45
8508205|NCT00454142|20968972|P1|NOT COMPLETED|Overall Study||1
8508206|NCT00454142|20968972|P1|COMPLETED|Overall Study||32
8508207|NCT00454142|20968972|P1|STARTED|Overall Study||33
8508208|NCT00454116|20968990|P3|NOT COMPLETED|Overall Study||28
8508209|NCT00454116|20968991|P2|NOT COMPLETED|Overall Study||29
8508210|NCT00454116|20968992|P1|NOT COMPLETED|Overall Study||27
8508211|NCT00454116|20968990|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
8508212|NCT00454116|20968991|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
8508213|NCT00454116|20968992|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
8508214|NCT00454116|20968990|P3|STARTED|Overall Study|randomised patients|35
8508215|NCT00454116|20968991|P2|STARTED|Overall Study|randomised patients|36
8508216|NCT00454116|20968992|P1|STARTED|Overall Study|randomised patients|35
8508217|NCT00454051|20969002|P2|NOT COMPLETED|Overall Study||3
8508218|NCT00454051|20969003|P1|NOT COMPLETED|Overall Study||3
8508219|NCT00454051|20969002|P2|COMPLETED|Overall Study||8
8508220|NCT00454051|20969003|P1|COMPLETED|Overall Study||17
8508221|NCT00454051|20969002|P2|STARTED|Overall Study||11
8508222|NCT00454051|20969003|P1|STARTED|Overall Study||20
8508223|NCT00453999|20969036|P3|NOT COMPLETED|Overall Study||3
8508224|NCT00453999|20969037|P2|NOT COMPLETED|Overall Study||5
8508225|NCT00453999|20969038|P1|NOT COMPLETED|Overall Study||5
8508226|NCT00453999|20969036|P3|COMPLETED|Overall Study||43
8508227|NCT00453999|20969037|P2|COMPLETED|Overall Study||41
8508228|NCT00453999|20969038|P1|COMPLETED|Overall Study||40
8508229|NCT00453999|20969036|P3|STARTED|Overall Study||46
8508230|NCT00453999|20969037|P2|STARTED|Overall Study||46
8508231|NCT00453999|20969038|P1|STARTED|Overall Study||45
8508232|NCT00453986|20969066|P5|NOT COMPLETED|Overall Study||0
8508233|NCT00453986|20969067|P4|NOT COMPLETED|Overall Study||2
8508234|NCT00453986|20969068|P3|NOT COMPLETED|Overall Study||6
8508235|NCT00453986|20969069|P2|NOT COMPLETED|Overall Study||5
8508236|NCT00453986|20969070|P1|NOT COMPLETED|Overall Study||6
8508237|NCT00453986|20969066|P5|COMPLETED|Overall Study||105
8508238|NCT00453986|20969067|P4|COMPLETED|Overall Study||310
8508239|NCT00453986|20969068|P3|COMPLETED|Overall Study||307
8508240|NCT00453986|20969069|P2|COMPLETED|Overall Study||306
8508241|NCT00453986|20969070|P1|COMPLETED|Overall Study||305
8508242|NCT00453986|20969066|P5|STARTED|Overall Study||105
8508243|NCT00453986|20969067|P4|STARTED|Overall Study||312
8508244|NCT00453986|20969068|P3|STARTED|Overall Study||313
8508245|NCT00453986|20969069|P2|STARTED|Overall Study||311
8508246|NCT00453986|20969070|P1|STARTED|Overall Study||311
8508247|NCT00453973|20969163|P2|NOT COMPLETED|Overall Study||48
8508248|NCT00453973|20969164|P1|NOT COMPLETED|Overall Study||51
8508249|NCT00453973|20969163|P2|COMPLETED|Overall Study||15
8508250|NCT00453973|20969164|P1|COMPLETED|Overall Study||0
8508251|NCT00453973|20969163|P2|STARTED|Overall Study||63
8508252|NCT00453973|20969164|P1|STARTED|Overall Study||51
8508253|NCT00453921|20969174|P4|NOT COMPLETED|Overall Study||1
8508254|NCT00453921|20969175|P3|NOT COMPLETED|Overall Study||2
8508255|NCT00453921|20969176|P2|NOT COMPLETED|Overall Study||1
8508256|NCT00453921|20969177|P1|NOT COMPLETED|Overall Study||1
8508257|NCT00453921|20969174|P4|COMPLETED|Overall Study||18
8508258|NCT00453921|20969175|P3|COMPLETED|Overall Study||18
8508259|NCT00453921|20969176|P2|COMPLETED|Overall Study||17
8508260|NCT00453921|20969177|P1|COMPLETED|Overall Study||18
8508261|NCT00453921|20969174|P4|STARTED|Overall Study||19
8508262|NCT00453921|20969175|P3|STARTED|Overall Study||20
8508263|NCT00453921|20969176|P2|STARTED|Overall Study||18
8508264|NCT00453921|20969177|P1|STARTED|Overall Study||19
8508265|NCT00453895|20969211|P1|NOT COMPLETED|Overall Study||0
8508266|NCT00453895|20969211|P1|COMPLETED|Overall Study||39
8508267|NCT00453895|20969211|P1|STARTED|Overall Study||39
8508268|NCT00453479|20969222|P3|NOT COMPLETED|Overall Study||0
8508269|NCT00453479|20969223|P2|NOT COMPLETED|Overall Study||0
8508270|NCT00453479|20969224|P1|NOT COMPLETED|Overall Study||0
8508271|NCT00453479|20969222|P3|COMPLETED|Overall Study||8
8508272|NCT00453479|20969223|P2|COMPLETED|Overall Study||9
8508273|NCT00453479|20969224|P1|COMPLETED|Overall Study||6
8508274|NCT00453479|20969222|P3|STARTED|Overall Study||8
8508275|NCT00453479|20969223|P2|STARTED|Overall Study||9
8508276|NCT00453479|20969224|P1|STARTED|Overall Study||6
8508277|NCT00453388|20969299|P4|NOT COMPLETED|Overall Study||0
8508278|NCT00453388|20969300|P3|NOT COMPLETED|Overall Study||0
8508279|NCT00453388|20969301|P2|NOT COMPLETED|Overall Study||0
8508280|NCT00453388|20969302|P1|NOT COMPLETED|Overall Study||0
8508281|NCT00453388|20969299|P4|COMPLETED|Overall Study||0
8508282|NCT00453388|20969300|P3|COMPLETED|Overall Study||1
8508283|NCT00453388|20969301|P2|COMPLETED|Overall Study||5
8508284|NCT00453388|20969302|P1|COMPLETED|Overall Study||0
8508285|NCT00453388|20969299|P4|STARTED|Overall Study||0
8508286|NCT00453388|20969300|P3|STARTED|Overall Study||1
8508287|NCT00453388|20969301|P2|STARTED|Overall Study||5
8508288|NCT00453388|20969302|P1|STARTED|Overall Study||0
8508289|NCT00453362|20969324|P1|NOT COMPLETED|Overall Study||87
8508290|NCT00453362|20969324|P1|COMPLETED|Overall Study||1
8508291|NCT00453362|20969324|P1|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
8508292|NCT00453362|20969324|P1|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
8508293|NCT00453362|20969324|P1|Treated With Erlotinib|Overall Study||74
8508294|NCT00453362|20969324|P1|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
8508295|NCT00453349|20969350|P2|NOT COMPLETED|Completed Study||34
8508296|NCT00453349|20969351|P1|NOT COMPLETED|Completed Study||27
8508297|NCT00453349|20969350|P2|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
8508298|NCT00453349|20969351|P1|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
8508299|NCT00453349|20969350|P2|Completed Study Treatment|Completed Study|23 terminated prematurely|209
8508300|NCT00453349|20969351|P1|Completed Study Treatment|Completed Study|25 terminated prematurely|203
8508301|NCT00453349|20969350|P2|STARTED|Completed Study||232
8508302|NCT00453349|20969351|P1|STARTED|Completed Study||228
8508303|NCT00453349|20969350|P2|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
8508304|NCT00453349|20969351|P1|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
8508305|NCT00453349|20969350|P2|COMPLETED|Reaching of Primary Endpoint (TOC)||219
8508306|NCT00453349|20969351|P1|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
8508307|NCT00453349|20969350|P2|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
8508308|NCT00453349|20969351|P1|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
8508309|NCT00453349|20969350|P2|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
8508310|NCT00453349|20969351|P1|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
8508311|NCT00453349|20969350|P2|NOT COMPLETED|Randomized||23
8508312|NCT00453349|20969351|P1|NOT COMPLETED|Randomized||25
8508313|NCT00453349|20969350|P2|COMPLETED|Randomized||209
8508314|NCT00453349|20969351|P1|COMPLETED|Randomized||203
8508315|NCT00453349|20969350|P2|STARTED|Randomized||232
8508316|NCT00453349|20969351|P1|STARTED|Randomized||228
8508317|NCT00453336|20969377|P1|NOT COMPLETED|Overall Study||0
8508318|NCT00453336|20969377|P1|COMPLETED|Overall Study||45
8508319|NCT00453336|20969377|P1|STARTED|Overall Study||45
8508320|NCT00453310|20969382|P1|NOT COMPLETED|Overall Study||10
8508321|NCT00453310|20969382|P1|COMPLETED|Overall Study||0
8508322|NCT00453310|20969382|P1|STARTED|Overall Study||10
8508323|NCT00453206|20969386|P1|NOT COMPLETED|Overall Study||1
8508324|NCT00453206|20969386|P1|COMPLETED|Overall Study||65
8508325|NCT00453206|20969386|P1|STARTED|Overall Study||66
8508326|NCT00453193|20969390|P1|NOT COMPLETED|Overall Study||0
8508327|NCT00453193|20969390|P1|COMPLETED|Overall Study||24
8508328|NCT00453193|20969390|P1|STARTED|Overall Study||24
8508329|NCT00453180|20969396|P2|NOT COMPLETED|Overall Study||3
8508330|NCT00453180|20969397|P1|NOT COMPLETED|Overall Study||3
8508331|NCT00453180|20969396|P2|COMPLETED|Overall Study||12
8508332|NCT00453180|20969397|P1|COMPLETED|Overall Study||13
8508333|NCT00453180|20969396|P2|STARTED|Overall Study||15
8508334|NCT00453180|20969397|P1|STARTED|Overall Study||16
8508335|NCT00453154|20969416|P4|NOT COMPLETED|Open Label Sunitinib Crossover||0
8508336|NCT00453154|20969417|P3|NOT COMPLETED|Open Label Sunitinib Crossover||0
8508337|NCT00453154|20969418|P2|NOT COMPLETED|Open Label Sunitinib Crossover||0
8508338|NCT00453154|20969419|P1|NOT COMPLETED|Open Label Sunitinib Crossover||0
8508339|NCT00453154|20969416|P4|COMPLETED|Open Label Sunitinib Crossover||0
8508340|NCT00453154|20969417|P3|COMPLETED|Open Label Sunitinib Crossover||18
8508341|NCT00453154|20969418|P2|COMPLETED|Open Label Sunitinib Crossover||0
8508342|NCT00453154|20969419|P1|COMPLETED|Open Label Sunitinib Crossover||0
8508343|NCT00453154|20969416|P4|STARTED|Open Label Sunitinib Crossover||0
8508344|NCT00453154|20969417|P3|STARTED|Open Label Sunitinib Crossover||18
8508345|NCT00453154|20969418|P2|STARTED|Open Label Sunitinib Crossover||0
8508346|NCT00453154|20969419|P1|STARTED|Open Label Sunitinib Crossover||0
8508347|NCT00453154|20969416|P4|NOT COMPLETED|Double BIind Maintenance||49
8508348|NCT00453154|20969417|P3|NOT COMPLETED|Double BIind Maintenance||46
8508349|NCT00453154|20969418|P2|NOT COMPLETED|Double BIind Maintenance||0
8508350|NCT00453154|20969419|P1|NOT COMPLETED|Double BIind Maintenance||0
8508351|NCT00453154|20969416|P4|COMPLETED|Double BIind Maintenance||0
8508352|NCT00453154|20969417|P3|COMPLETED|Double BIind Maintenance||0
8508353|NCT00453154|20969418|P2|COMPLETED|Double BIind Maintenance||0
8508354|NCT00453154|20969419|P1|COMPLETED|Double BIind Maintenance||0
8508355|NCT00453154|20969416|P4|STARTED|Double BIind Maintenance||49
8508356|NCT00453154|20969417|P3|STARTED|Double BIind Maintenance||46
8508357|NCT00453154|20969418|P2|STARTED|Double BIind Maintenance||0
8508358|NCT00453154|20969419|P1|STARTED|Double BIind Maintenance||0
8508359|NCT00453154|20969416|P4|NOT COMPLETED|Combination Chemotherapy||0
8508360|NCT00453154|20969417|P3|NOT COMPLETED|Combination Chemotherapy||0
8508361|NCT00453154|20969418|P2|NOT COMPLETED|Combination Chemotherapy||49
8508362|NCT00453154|20969419|P1|NOT COMPLETED|Combination Chemotherapy||0
8508363|NCT00453154|20969416|P4|COMPLETED|Combination Chemotherapy||0
8508364|NCT00453154|20969417|P3|COMPLETED|Combination Chemotherapy||0
8508365|NCT00453154|20969418|P2|COMPLETED|Combination Chemotherapy||95
8508366|NCT00453154|20969419|P1|COMPLETED|Combination Chemotherapy||12
8508367|NCT00453154|20969416|P4|STARTED|Combination Chemotherapy||0
8508368|NCT00453154|20969417|P3|STARTED|Combination Chemotherapy||0
8508369|NCT00453154|20969418|P2|STARTED|Combination Chemotherapy||144
8508370|NCT00453154|20969419|P1|STARTED|Combination Chemotherapy||12
8508371|NCT00453102|20969432|P1|NOT COMPLETED|Overall Study||2
8508372|NCT00453102|20969432|P1|COMPLETED|Overall Study||16
8508373|NCT00453102|20969432|P1|STARTED|Overall Study||18
8508374|NCT00453063|20969443|P2|NOT COMPLETED|Overall Study||3
8508375|NCT00453063|20969444|P1|NOT COMPLETED|Overall Study||3
8508376|NCT00453063|20969443|P2|COMPLETED|Overall Study||212
8508377|NCT00453063|20969444|P1|COMPLETED|Overall Study||208
8508378|NCT00453063|20969443|P2|STARTED|Overall Study||215
8508379|NCT00453063|20969444|P1|STARTED|Overall Study||211
8508380|NCT00452868|20969458|P1|NOT COMPLETED|Overall Study||2
8508381|NCT00452868|20969458|P1|COMPLETED|Overall Study||11
8508382|NCT00452868|20969458|P1|STARTED|Overall Study||13
8508383|NCT00452790|20969464|P2|NOT COMPLETED|Toddler Dose||2
8508384|NCT00452790|20969465|P1|NOT COMPLETED|Toddler Dose||0
8508385|NCT00452790|20969464|P2|COMPLETED|Toddler Dose||198
8508386|NCT00452790|20969465|P1|COMPLETED|Toddler Dose||198
8508387|NCT00452790|20969464|P2|STARTED|Toddler Dose||200
8508388|NCT00452790|20969465|P1|STARTED|Toddler Dose||198
8508389|NCT00452790|20969464|P2|NOT COMPLETED|After Infant Series||14
8508390|NCT00452790|20969465|P1|NOT COMPLETED|After Infant Series||21
8508391|NCT00452790|20969464|P2|COMPLETED|After Infant Series||200
8508392|NCT00452790|20969465|P1|COMPLETED|After Infant Series||198
8508393|NCT00452790|20969464|P2|STARTED|After Infant Series||214
8508394|NCT00452790|20969465|P1|STARTED|After Infant Series||219
8508395|NCT00452790|20969464|P2|NOT COMPLETED|Infant Series||141
8508396|NCT00452790|20969465|P1|NOT COMPLETED|Infant Series||135
8508397|NCT00452790|20969464|P2|COMPLETED|Infant Series||214
8508398|NCT00452790|20969465|P1|COMPLETED|Infant Series||219
8508399|NCT00452790|20969464|P2|Vaccinated Dose 3|Infant Series||218
8508400|NCT00452790|20969465|P1|Vaccinated Dose 3|Infant Series||221
8508401|NCT00452790|20969464|P2|Vaccinated Dose 2|Infant Series||300
8508402|NCT00452790|20969465|P1|Vaccinated Dose 2|Infant Series||300
8508403|NCT00452790|20969464|P2|Vaccinated Dose 1|Infant Series||353
8508404|NCT00452790|20969465|P1|Vaccinated Dose 1|Infant Series||353
8508405|NCT00452790|20969464|P2|STARTED|Infant Series||355
8508406|NCT00452790|20969465|P1|STARTED|Infant Series||354
8508407|NCT00452699|20969501|P2|NOT COMPLETED|Overall Study||73
8508408|NCT00452699|20969502|P1|NOT COMPLETED|Overall Study||81
8508409|NCT00452699|20969501|P2|COMPLETED|Overall Study||242
8508410|NCT00452699|20969502|P1|COMPLETED|Overall Study||225
8508411|NCT00452699|20969501|P2|STARTED|Overall Study||315
8508412|NCT00452699|20969502|P1|STARTED|Overall Study||306
8508413|NCT00452673|20969518|P5|NOT COMPLETED|Dose Expansion Period||21
8508414|NCT00452673|20969519|P4|NOT COMPLETED|Dose Expansion Period||0
8508415|NCT00452673|20969520|P3|NOT COMPLETED|Dose Expansion Period||0
8508416|NCT00452673|20969521|P2|NOT COMPLETED|Dose Expansion Period||0
8508417|NCT00452673|20969522|P1|NOT COMPLETED|Dose Expansion Period||0
8508418|NCT00452673|20969518|P5|COMPLETED|Dose Expansion Period||0
8508419|NCT00452673|20969519|P4|COMPLETED|Dose Expansion Period||0
8508420|NCT00452673|20969520|P3|COMPLETED|Dose Expansion Period||0
8508421|NCT00452673|20969521|P2|COMPLETED|Dose Expansion Period||0
8508422|NCT00452673|20969522|P1|COMPLETED|Dose Expansion Period||0
8508423|NCT00452673|20969518|P5|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
8508424|NCT00452673|20969519|P4|STARTED|Dose Expansion Period||0
8508425|NCT00452673|20969520|P3|STARTED|Dose Expansion Period||0
8508426|NCT00452673|20969521|P2|STARTED|Dose Expansion Period||0
8508427|NCT00452673|20969522|P1|STARTED|Dose Expansion Period||0
8508428|NCT00452673|20969518|P5|NOT COMPLETED|Dose Escalation Period||0
8508429|NCT00452673|20969519|P4|NOT COMPLETED|Dose Escalation Period||9
8508430|NCT00452673|20969520|P3|NOT COMPLETED|Dose Escalation Period||6
8508431|NCT00452673|20969521|P2|NOT COMPLETED|Dose Escalation Period||9
8508432|NCT00452673|20969522|P1|NOT COMPLETED|Dose Escalation Period||7
8508433|NCT00452673|20969518|P5|COMPLETED|Dose Escalation Period||0
8508434|NCT00452673|20969519|P4|COMPLETED|Dose Escalation Period||0
8508435|NCT00452673|20969520|P3|COMPLETED|Dose Escalation Period||0
8508436|NCT00452673|20969521|P2|COMPLETED|Dose Escalation Period||0
8508437|NCT00452673|20969522|P1|COMPLETED|Dose Escalation Period||0
8508438|NCT00452673|20969518|P5|STARTED|Dose Escalation Period||0
8508439|NCT00452673|20969519|P4|STARTED|Dose Escalation Period||9
8508440|NCT00452673|20969520|P3|STARTED|Dose Escalation Period||6
8508441|NCT00452673|20969521|P2|STARTED|Dose Escalation Period||9
8508442|NCT00452673|20969522|P1|STARTED|Dose Escalation Period||7
8508443|NCT00452543|20969554|P2|NOT COMPLETED|Overall Study||6
8508444|NCT00452543|20969555|P1|NOT COMPLETED|Overall Study||5
8508445|NCT00452543|20969554|P2|COMPLETED|Overall Study||5
8508446|NCT00452543|20969555|P1|COMPLETED|Overall Study||7
8508447|NCT00452543|20969554|P2|STARTED|Overall Study||11
8508448|NCT00452543|20969555|P1|STARTED|Overall Study||12
8508449|NCT00452530|20969569|P2|NOT COMPLETED|Overall Study||136
8508450|NCT00452530|20969570|P1|NOT COMPLETED|Overall Study||136
8508451|NCT00452530|20969569|P2|COMPLETED|Overall Study||1393
8508452|NCT00452530|20969570|P1|COMPLETED|Overall Study||1392
8508453|NCT00452530|20969569|P2|Primary Participants|Overall Study||997
8508454|NCT00452530|20969570|P1|Primary Participants|Overall Study||976
8508455|NCT00452530|20969569|P2|Evaluable Participants|Overall Study||921
8508456|NCT00452530|20969570|P1|Evaluable Participants|Overall Study||907
8508457|NCT00452530|20969569|P2|Received Treatment|Overall Study||1508
8508458|NCT00452530|20969570|P1|Received Treatment|Overall Study||1501
8508459|NCT00452530|20969569|P2|STARTED|Overall Study|Randomized|1529
8508460|NCT00452530|20969570|P1|STARTED|Overall Study|Randomized|1528
8508461|NCT00452452|20969591|P3|NOT COMPLETED|Overall Study||1
8508462|NCT00452452|20969592|P2|NOT COMPLETED|Overall Study||0
8508463|NCT00452452|20969593|P1|NOT COMPLETED|Overall Study||2
8508464|NCT00452452|20969591|P3|COMPLETED|Overall Study||152
8508465|NCT00452452|20969592|P2|COMPLETED|Overall Study||112
8508466|NCT00452452|20969593|P1|COMPLETED|Overall Study||88
8508467|NCT00452452|20969591|P3|Vaccinated Dose 3|Overall Study||0
8508468|NCT00452452|20969592|P2|Vaccinated Dose 3|Overall Study||0
8508469|NCT00452452|20969593|P1|Vaccinated Dose 3|Overall Study||89
8508470|NCT00452452|20969591|P3|Vaccinated Dose 2|Overall Study||0
8508471|NCT00452452|20969592|P2|Vaccinated Dose 2|Overall Study||112
8508472|NCT00452452|20969593|P1|Vaccinated Dose 2|Overall Study||90
8508473|NCT00452452|20969591|P3|Vaccinated Dose 1|Overall Study||152
8508474|NCT00452452|20969592|P2|Vaccinated Dose 1|Overall Study||112
8508475|NCT00452452|20969593|P1|Vaccinated Dose 1|Overall Study||90
8508476|NCT00452452|20969591|P3|STARTED|Overall Study||153
8508477|NCT00452452|20969592|P2|STARTED|Overall Study||112
8508478|NCT00452452|20969593|P1|STARTED|Overall Study||90
8508479|NCT00452439|20969618|P2|NOT COMPLETED|Overall Study||7
8508480|NCT00452439|20969619|P1|NOT COMPLETED|Overall Study||14
8508481|NCT00452439|20969618|P2|COMPLETED|Overall Study||29
8508482|NCT00452439|20969619|P1|COMPLETED|Overall Study||22
8508483|NCT00452439|20969618|P2|STARTED|Overall Study||36
8508484|NCT00452439|20969619|P1|STARTED|Overall Study||36
8508485|NCT00452426|20969629|P2|NOT COMPLETED|Overall Study||11
8508486|NCT00452426|20969630|P1|NOT COMPLETED|Overall Study||7
8508487|NCT00452426|20969629|P2|COMPLETED|Overall Study||493
8508488|NCT00452426|20969630|P1|COMPLETED|Overall Study||489
8508489|NCT00452426|20969629|P2|STARTED|Overall Study||504
8508490|NCT00452426|20969630|P1|STARTED|Overall Study||496
8508491|NCT00452400|20969649|P5|NOT COMPLETED|Overall Study||3
8508492|NCT00452400|20969650|P4|NOT COMPLETED|Overall Study||1
8508493|NCT00452400|20969651|P3|NOT COMPLETED|Overall Study||7
8508494|NCT00452400|20969652|P2|NOT COMPLETED|Overall Study||1
8508495|NCT00452400|20969653|P1|NOT COMPLETED|Overall Study||5
8508496|NCT00452400|20969649|P5|COMPLETED|Overall Study||76
8508497|NCT00452400|20969650|P4|COMPLETED|Overall Study||85
8508498|NCT00452400|20969651|P3|COMPLETED|Overall Study||73
8508499|NCT00452400|20969652|P2|COMPLETED|Overall Study||80
8508500|NCT00452400|20969653|P1|COMPLETED|Overall Study||74
8508501|NCT00452400|20969649|P5|STARTED|Overall Study||79
8508502|NCT00452400|20969650|P4|STARTED|Overall Study||86
8508503|NCT00452400|20969651|P3|STARTED|Overall Study||80
8508504|NCT00452400|20969652|P2|STARTED|Overall Study||81
8508505|NCT00452400|20969653|P1|STARTED|Overall Study||79
8508506|NCT00452387|20969825|P1|NOT COMPLETED|Overall Study||0
8508507|NCT00452387|20969825|P1|COMPLETED|Overall Study||22
8508508|NCT00452387|20969825|P1|STARTED|Overall Study||22
8508509|NCT00452374|20969833|P1|NOT COMPLETED|Overall Study||0
8508510|NCT00452374|20969833|P1|COMPLETED|Overall Study||48
8508511|NCT00452374|20969833|P1|STARTED|Overall Study||48
8508512|NCT00452361|20969840|P2|NOT COMPLETED|Overall Study||10
8508513|NCT00452361|20969841|P1|NOT COMPLETED|Overall Study||21
8508514|NCT00452361|20969840|P2|COMPLETED|Overall Study||0
8508515|NCT00452361|20969841|P1|COMPLETED|Overall Study||0
8508516|NCT00452361|20969840|P2|STARTED|Overall Study||10
8508517|NCT00452361|20969841|P1|STARTED|Overall Study||21
8508518|NCT00452348|20969885|P2|NOT COMPLETED|Overall Study||84
8508519|NCT00452348|20969886|P1|NOT COMPLETED|Overall Study||79
8508520|NCT00452348|20969885|P2|COMPLETED|Overall Study||234
8508521|NCT00452348|20969886|P1|COMPLETED|Overall Study||231
8508522|NCT00452348|20969885|P2|STARTED|Overall Study||318
8508523|NCT00452348|20969886|P1|STARTED|Overall Study||310
8508524|NCT00452335|20969901|P3|NOT COMPLETED|Overall Study||9
8508525|NCT00452335|20969902|P2|NOT COMPLETED|Overall Study||4
8508526|NCT00452335|20969903|P1|NOT COMPLETED|Overall Study||2
8508527|NCT00452335|20969901|P3|COMPLETED|Overall Study||23
8508528|NCT00452335|20969902|P2|COMPLETED|Overall Study||61
8508529|NCT00452335|20969903|P1|COMPLETED|Overall Study||25
8508530|NCT00452335|20969901|P3|STARTED|Overall Study||32
8508531|NCT00452335|20969902|P2|STARTED|Overall Study||65
8508532|NCT00452335|20969903|P1|STARTED|Overall Study||27
8508533|NCT00452114|20969940|P2|NOT COMPLETED|Overall Study||3
8508534|NCT00452114|20969941|P1|NOT COMPLETED|Overall Study||3
8508535|NCT00452114|20969940|P2|COMPLETED|Overall Study||10
8508536|NCT00452114|20969941|P1|COMPLETED|Overall Study||12
8508537|NCT00452114|20969940|P2|STARTED|Overall Study||13
8508538|NCT00452114|20969941|P1|STARTED|Overall Study||15
8508539|NCT00451958|20969957|P5|NOT COMPLETED|CS21A (NCT00451958)||0
8508540|NCT00451958|20969958|P4|NOT COMPLETED|CS21A (NCT00451958)||39
8508541|NCT00451958|20969959|P3|NOT COMPLETED|CS21A (NCT00451958)||42
8508542|NCT00451958|20969960|P2|NOT COMPLETED|CS21A (NCT00451958)||77
8508543|NCT00451958|20969961|P1|NOT COMPLETED|CS21A (NCT00451958)||65
8508544|NCT00451958|20969957|P5|COMPLETED|CS21A (NCT00451958)||0
8508545|NCT00451958|20969958|P4|COMPLETED|CS21A (NCT00451958)||27
8508546|NCT00451958|20969959|P3|COMPLETED|CS21A (NCT00451958)||27
8508547|NCT00451958|20969960|P2|COMPLETED|CS21A (NCT00451958)||49
8508548|NCT00451958|20969961|P1|COMPLETED|CS21A (NCT00451958)||60
8508549|NCT00451958|20969957|P5|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
8508550|NCT00451958|20969958|P4|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
8508551|NCT00451958|20969959|P3|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
8508552|NCT00451958|20969960|P2|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
8508553|NCT00451958|20969961|P1|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
8508554|NCT00451958|20969957|P5|NOT COMPLETED|CS21 (NCT00295750)||32
8508555|NCT00451958|20969958|P4|NOT COMPLETED|CS21 (NCT00295750)||0
8508556|NCT00451958|20969959|P3|NOT COMPLETED|CS21 (NCT00295750)||0
8508557|NCT00451958|20969960|P2|NOT COMPLETED|CS21 (NCT00295750)||43
8508558|NCT00451958|20969961|P1|NOT COMPLETED|CS21 (NCT00295750)||41
8508559|NCT00451958|20969957|P5|COMPLETED|CS21 (NCT00295750)||172
8508560|NCT00451958|20969958|P4|COMPLETED|CS21 (NCT00295750)||0
8508561|NCT00451958|20969959|P3|COMPLETED|CS21 (NCT00295750)||0
8508562|NCT00451958|20969960|P2|COMPLETED|CS21 (NCT00295750)||163
8508563|NCT00451958|20969961|P1|COMPLETED|CS21 (NCT00295750)||169
8508564|NCT00451958|20969957|P5|STARTED|CS21 (NCT00295750)||204
8508565|NCT00451958|20969958|P4|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
8508566|NCT00451958|20969959|P3|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
8508567|NCT00451958|20969960|P2|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
8508568|NCT00451958|20969961|P1|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
8508569|NCT00451906|20969991|P1|NOT COMPLETED|Overall Study||2239
8508570|NCT00451906|20969991|P1|COMPLETED|Overall Study||13
8508571|NCT00451906|20969991|P1|STARTED|Overall Study||2252
8508572|NCT00451698|20970001|P2|NOT COMPLETED|Overall Study||0
8508573|NCT00451698|20970002|P1|NOT COMPLETED|Overall Study||0
8508574|NCT00451698|20970001|P2|COMPLETED|Overall Study||6
8508575|NCT00451698|20970002|P1|COMPLETED|Overall Study||3
8508576|NCT00451698|20970001|P2|STARTED|Overall Study||6
8508577|NCT00451698|20970002|P1|STARTED|Overall Study||3
8508578|NCT00451555|20970019|P2|NOT COMPLETED|Overall Study||4
8508579|NCT00451555|20970020|P1|NOT COMPLETED|Overall Study||13
8508580|NCT00451555|20970019|P2|COMPLETED|Overall Study||56
8508581|NCT00451555|20970020|P1|COMPLETED|Overall Study||83
8508582|NCT00451555|20970019|P2|Death|Overall Study||0
8508583|NCT00451555|20970020|P1|Death|Overall Study||2
8508584|NCT00451555|20970019|P2|Progressive Disease|Overall Study||54
8508585|NCT00451555|20970020|P1|Progressive Disease|Overall Study||75
8508586|NCT00451555|20970019|P2|Enzastaurin Once Daily Dosing (QD)|Overall Study||0
8508587|NCT00451555|20970020|P1|Enzastaurin Once Daily Dosing (QD)|Overall Study||55
8508588|NCT00451555|20970019|P2|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0
8508589|NCT00451555|20970020|P1|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39
8508590|NCT00451555|20970019|P2|Received at Least One Dose of Study Drug|Overall Study||58
8508591|NCT00451555|20970020|P1|Received at Least One Dose of Study Drug|Overall Study||94
8508592|NCT00451555|20970019|P2|STARTED|Overall Study||60
8508593|NCT00451555|20970020|P1|STARTED|Overall Study||96
8508594|NCT00451451|20970054|P4|NOT COMPLETED|Overall Study||58
8508595|NCT00451451|20970055|P3|NOT COMPLETED|Overall Study||72
8508596|NCT00451451|20970056|P2|NOT COMPLETED|Overall Study||75
8508597|NCT00451451|20970057|P1|NOT COMPLETED|Overall Study||85
8508598|NCT00451451|20970054|P4|COMPLETED|Overall Study||292
8508599|NCT00451451|20970055|P3|COMPLETED|Overall Study||273
8508600|NCT00451451|20970056|P2|COMPLETED|Overall Study||284
8508601|NCT00451451|20970057|P1|COMPLETED|Overall Study||278
8508602|NCT00451451|20970054|P4|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
8508603|NCT00451451|20970055|P3|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
8508604|NCT00451451|20970056|P2|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
8508605|NCT00451451|20970057|P1|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
8508606|NCT00451321|20970092|P8|NOT COMPLETED|Overall Study||6
8508607|NCT00451321|20970093|P7|NOT COMPLETED|Overall Study||6
8508608|NCT00451321|20970094|P6|NOT COMPLETED|Overall Study||9
8508609|NCT00451321|20970095|P5|NOT COMPLETED|Overall Study||7
8508610|NCT00451321|20970096|P4|NOT COMPLETED|Overall Study||12
8508611|NCT00451321|20970097|P3|NOT COMPLETED|Overall Study||18
8508612|NCT00451321|20970098|P2|NOT COMPLETED|Overall Study||5
8508613|NCT00451321|20970099|P1|NOT COMPLETED|Overall Study||7
8508614|NCT00451321|20970092|P8|COMPLETED|Overall Study||0
8508615|NCT00451321|20970093|P7|COMPLETED|Overall Study||0
8508616|NCT00451321|20970094|P6|COMPLETED|Overall Study||0
8508617|NCT00451321|20970095|P5|COMPLETED|Overall Study||0
8508618|NCT00451321|20970096|P4|COMPLETED|Overall Study||7
8508619|NCT00451321|20970097|P3|COMPLETED|Overall Study||0
8508620|NCT00451321|20970098|P2|COMPLETED|Overall Study||10
8508621|NCT00451321|20970099|P1|COMPLETED|Overall Study||1
8508622|NCT00451321|20970092|P8|STARTED|Overall Study||6
8508623|NCT00451321|20970093|P7|STARTED|Overall Study||6
8508624|NCT00451321|20970094|P6|STARTED|Overall Study||9
8508625|NCT00451321|20970095|P5|STARTED|Overall Study||7
8508626|NCT00451321|20970096|P4|STARTED|Overall Study||19
8508627|NCT00451321|20970097|P3|STARTED|Overall Study||18
8508628|NCT00451321|20970098|P2|STARTED|Overall Study||15
8508629|NCT00451321|20970099|P1|STARTED|Overall Study||8
8508630|NCT00451282|20970271|P2|NOT COMPLETED|Overall Study||5
8508631|NCT00451282|20970272|P1|NOT COMPLETED|Overall Study||6
8508632|NCT00451282|20970271|P2|COMPLETED|Overall Study||34
8508633|NCT00451282|20970272|P1|COMPLETED|Overall Study||40
8508634|NCT00451282|20970271|P2|STARTED|Overall Study||39
8508635|NCT00451282|20970272|P1|STARTED|Overall Study||46
8508636|NCT00451217|20970288|P4|NOT COMPLETED|Overall Study||5
8508637|NCT00451217|20970289|P3|NOT COMPLETED|Overall Study||4
8508638|NCT00451217|20970290|P2|NOT COMPLETED|Overall Study||2
8508639|NCT00451217|20970291|P1|NOT COMPLETED|Overall Study||2
8508640|NCT00451217|20970288|P4|COMPLETED|Overall Study||44
8508641|NCT00451217|20970289|P3|COMPLETED|Overall Study||47
8508642|NCT00451217|20970290|P2|COMPLETED|Overall Study||47
8508643|NCT00451217|20970291|P1|COMPLETED|Overall Study||47
8508644|NCT00451217|20970288|P4|Treated|Overall Study||45
8508645|NCT00451217|20970289|P3|Treated|Overall Study||48
8508646|NCT00451217|20970290|P2|Treated|Overall Study||48
8508647|NCT00451217|20970291|P1|Treated|Overall Study||48
8508648|NCT00451217|20970288|P4|STARTED|Overall Study||49
8508649|NCT00451217|20970289|P3|STARTED|Overall Study||51
8508650|NCT00451217|20970290|P2|STARTED|Overall Study||49
8508651|NCT00451217|20970291|P1|STARTED|Overall Study||49
8508652|NCT00451204|20970319|P2|NOT COMPLETED|Overall Study||20
8508653|NCT00451204|20970320|P1|NOT COMPLETED|Overall Study||22
8508654|NCT00451204|20970319|P2|COMPLETED|Overall Study||56
8508655|NCT00451204|20970320|P1|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
8508656|NCT00451204|20970319|P2|STARTED|Overall Study||76
8508657|NCT00451204|20970320|P1|STARTED|Overall Study||82
8508658|NCT00451191|20970338|P2|NOT COMPLETED|Overall Study||11
8508659|NCT00451191|20970339|P1|NOT COMPLETED|Overall Study||15
8508660|NCT00451191|20970338|P2|COMPLETED|Overall Study||55
8508661|NCT00451191|20970339|P1|COMPLETED|Overall Study||53
8508662|NCT00451191|20970338|P2|STARTED|Overall Study||66
8508663|NCT00451191|20970339|P1|STARTED|Overall Study||68
8508664|NCT00451178|20970347|P2|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||26
8508665|NCT00451178|20970348|P1|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||6
8508666|NCT00451178|20970347|P2|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
8508667|NCT00451178|20970348|P1|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
8508668|NCT00451178|20970347|P2|STARTED|Long-Term Follow-Up (Up to 2 Years)||26
8508669|NCT00451178|20970348|P1|STARTED|Long-Term Follow-Up (Up to 2 Years)||6
8508670|NCT00451178|20970347|P2|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||0
8508671|NCT00451178|20970348|P1|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||30
8508672|NCT00451178|20970347|P2|COMPLETED|Maintenance Therapy (up to 3 Years)||0
8508673|NCT00451178|20970348|P1|COMPLETED|Maintenance Therapy (up to 3 Years)||6
8508674|NCT00451178|20970347|P2|STARTED|Maintenance Therapy (up to 3 Years)|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
8508675|NCT00451178|20970348|P1|STARTED|Maintenance Therapy (up to 3 Years)||36
8508676|NCT00451178|20970347|P2|NOT COMPLETED|Prior to Maintenance Therapy||0
8508677|NCT00451178|20970348|P1|NOT COMPLETED|Prior to Maintenance Therapy||4
8508678|NCT00451178|20970347|P2|COMPLETED|Prior to Maintenance Therapy||0
8508679|NCT00451178|20970348|P1|COMPLETED|Prior to Maintenance Therapy||36
8508680|NCT00451178|20970347|P2|STARTED|Prior to Maintenance Therapy|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
8508681|NCT00451178|20970348|P1|STARTED|Prior to Maintenance Therapy||40
8508682|NCT00451178|20970347|P2|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||17
8508683|NCT00451178|20970348|P1|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||18
8508684|NCT00451178|20970347|P2|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||26
8508685|NCT00451178|20970348|P1|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||40
8508686|NCT00451178|20970347|P2|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||43
8508687|NCT00451178|20970348|P1|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||57
8508688|NCT00451178|20970347|P2|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||43
8508689|NCT00451178|20970348|P1|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||58
8508690|NCT00451048|20970374|P1|NOT COMPLETED|Overall Study||0
8508691|NCT00451048|20970374|P1|COMPLETED|Overall Study||10
8508692|NCT00451048|20970374|P1|STARTED|Overall Study||10
8508693|NCT00450983|20970383|P1|NOT COMPLETED|Overall Study||0
8508694|NCT00450983|20970383|P1|COMPLETED|Overall Study||1
8508695|NCT00450983|20970383|P1|STARTED|Overall Study||1
8508696|NCT00450866|20970395|P2|NOT COMPLETED|Overall Study||3
8508697|NCT00450866|20970396|P1|NOT COMPLETED|Overall Study||7
8508698|NCT00450866|20970395|P2|COMPLETED|Overall Study||7
8508699|NCT00450866|20970396|P1|COMPLETED|Overall Study||38
8508700|NCT00450866|20970395|P2|STARTED|Overall Study||10
8508701|NCT00450866|20970396|P1|STARTED|Overall Study||45
8508702|NCT00450814|20970416|P11|NOT COMPLETED|Overall Study||0
8508703|NCT00450814|20970417|P10|NOT COMPLETED|Overall Study||1
8508704|NCT00450814|20970418|P9|NOT COMPLETED|Overall Study||0
8508705|NCT00450814|20970419|P8|NOT COMPLETED|Overall Study||0
8508706|NCT00450814|20970420|P7|NOT COMPLETED|Overall Study||0
8508707|NCT00450814|20970421|P6|NOT COMPLETED|Overall Study||1
8508708|NCT00450814|20970422|P5|NOT COMPLETED|Overall Study||1
8508709|NCT00450814|20970423|P4|NOT COMPLETED|Overall Study||1
8508710|NCT00450814|20970424|P3|NOT COMPLETED|Overall Study||0
8508711|NCT00450814|20970425|P2|NOT COMPLETED|Overall Study||0
8508712|NCT00450814|20970426|P1|NOT COMPLETED|Overall Study||0
8508713|NCT00450814|20970416|P11|COMPLETED|Overall Study||4
8508714|NCT00450814|20970417|P10|COMPLETED|Overall Study||11
8508715|NCT00450814|20970418|P9|COMPLETED|Overall Study||2
8508716|NCT00450814|20970419|P8|COMPLETED|Overall Study||3
8508717|NCT00450814|20970420|P7|COMPLETED|Overall Study||3
8508718|NCT00450814|20970421|P6|COMPLETED|Overall Study||6
8508719|NCT00450814|20970422|P5|COMPLETED|Overall Study||3
8508720|NCT00450814|20970423|P4|COMPLETED|Overall Study||3
8508721|NCT00450814|20970424|P3|COMPLETED|Overall Study||3
8508722|NCT00450814|20970425|P2|COMPLETED|Overall Study||3
8508723|NCT00450814|20970426|P1|COMPLETED|Overall Study||3
8508724|NCT00450814|20970416|P11|STARTED|Overall Study||4
8508725|NCT00450814|20970417|P10|STARTED|Overall Study||12
8508726|NCT00450814|20970418|P9|STARTED|Overall Study||2
8508727|NCT00450814|20970419|P8|STARTED|Overall Study||3
8508728|NCT00450814|20970420|P7|STARTED|Overall Study||3
8508729|NCT00450814|20970421|P6|STARTED|Overall Study||7
8508730|NCT00450814|20970422|P5|STARTED|Overall Study||4
8508731|NCT00450814|20970423|P4|STARTED|Overall Study||4
8508732|NCT00450814|20970424|P3|STARTED|Overall Study||3
8508733|NCT00450814|20970425|P2|STARTED|Overall Study||3
8508734|NCT00450814|20970426|P1|STARTED|Overall Study||3
8508735|NCT00450801|20970460|P1|NOT COMPLETED|Overall Study||1
8508736|NCT00450801|20970460|P1|COMPLETED|Overall Study||21
8508737|NCT00450801|20970460|P1|STARTED|Overall Study||22
8508738|NCT00450749|20970474|P3|NOT COMPLETED|Overall Study||2
8508739|NCT00450749|20970475|P2|NOT COMPLETED|Overall Study||1
8508740|NCT00450749|20970476|P1|NOT COMPLETED|Overall Study||0
8508741|NCT00450749|20970474|P3|COMPLETED|Overall Study||2
8508742|NCT00450749|20970475|P2|COMPLETED|Overall Study||2
8508743|NCT00450749|20970476|P1|COMPLETED|Overall Study||3
8508744|NCT00450749|20970474|P3|STARTED|Overall Study||4
8508745|NCT00450749|20970475|P2|STARTED|Overall Study||3
8508746|NCT00450749|20970476|P1|STARTED|Overall Study||3
8508747|NCT00450723|20970514|P1|NOT COMPLETED|Overall Study||5
8508748|NCT00450723|20970514|P1|COMPLETED|Overall Study||34
8508749|NCT00450723|20970514|P1|STARTED|Overall Study||39
8508750|NCT00450658|20970522|P2|NOT COMPLETED|Overall Study||90
8508751|NCT00450658|20970523|P1|NOT COMPLETED|Overall Study||143
8508752|NCT00450658|20970522|P2|COMPLETED|Overall Study||122
8508753|NCT00450658|20970523|P1|COMPLETED|Overall Study||272
8508754|NCT00450658|20970522|P2|STARTED|Overall Study||212
8508755|NCT00450658|20970523|P1|STARTED|Overall Study||415
8508756|NCT00450619|20970537|P2|NOT COMPLETED|Overall Study||1
8508757|NCT00450619|20970538|P1|NOT COMPLETED|Overall Study||4
8508758|NCT00450619|20970537|P2|COMPLETED|Overall Study||21
8508759|NCT00450619|20970538|P1|COMPLETED|Overall Study||18
8508760|NCT00450619|20970537|P2|STARTED|Overall Study||22
8508761|NCT00450619|20970538|P1|STARTED|Overall Study||22
8508762|NCT00450580|20970564|P2|NOT COMPLETED|Overall Study||16
8508763|NCT00450580|20970565|P1|NOT COMPLETED|Overall Study||16
8508764|NCT00450580|20970564|P2|COMPLETED|Overall Study||90
8508765|NCT00450580|20970565|P1|COMPLETED|Overall Study||90
8508766|NCT00450580|20970564|P2|STARTED|Overall Study||106
8508767|NCT00450580|20970565|P1|STARTED|Overall Study||106
8508768|NCT00450463|20970585|P2|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
8508769|NCT00450463|20970586|P1|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
8508770|NCT00450463|20970585|P2|COMPLETED|Progressed to Receive Vaccine Alone||0
8508771|NCT00450463|20970586|P1|COMPLETED|Progressed to Receive Vaccine Alone||11
8508772|NCT00450463|20970585|P2|STARTED|Progressed to Receive Vaccine Alone||0
8508773|NCT00450463|20970586|P1|STARTED|Progressed to Receive Vaccine Alone||11
8508774|NCT00450463|20970585|P2|NOT COMPLETED|Initial Drug Administration||0
8508775|NCT00450463|20970586|P1|NOT COMPLETED|Initial Drug Administration||0
8508776|NCT00450463|20970585|P2|COMPLETED|Initial Drug Administration||31
8508777|NCT00450463|20970586|P1|COMPLETED|Initial Drug Administration||33
8508778|NCT00450463|20970585|P2|STARTED|Initial Drug Administration||31
8508779|NCT00450463|20970586|P1|STARTED|Initial Drug Administration||33
8508786|NCT00450437|20970627|P4|NOT COMPLETED|Overall Study||11
8508787|NCT00450437|20970628|P3|NOT COMPLETED|Overall Study||24
8508788|NCT00450437|20970629|P2|NOT COMPLETED|Overall Study||16
8508789|NCT00450437|20970630|P1|NOT COMPLETED|Overall Study||46
8508790|NCT00450437|20970627|P4|COMPLETED|Overall Study||325
8508791|NCT00450437|20970628|P3|COMPLETED|Overall Study||999
8508792|NCT00450437|20970629|P2|COMPLETED|Overall Study||524
8508793|NCT00450437|20970630|P1|COMPLETED|Overall Study||1594
8508794|NCT00450437|20970627|P4|STARTED|Overall Study||336
8508795|NCT00450437|20970628|P3|STARTED|Overall Study||1023
8508796|NCT00450437|20970629|P2|STARTED|Overall Study||540
8508797|NCT00450437|20970630|P1|STARTED|Overall Study||1640
8508798|NCT00450424|20970654|P2|NOT COMPLETED|Overall Study||11
8508799|NCT00450424|20970655|P1|NOT COMPLETED|Overall Study||20
8508800|NCT00450424|20970654|P2|COMPLETED|Overall Study||106
8508801|NCT00450424|20970655|P1|COMPLETED|Overall Study||102
8508802|NCT00450424|20970654|P2|STARTED|Overall Study||117
8508803|NCT00450424|20970655|P1|STARTED|Overall Study||122
8508807|NCT00450385|20970666|P1|NOT COMPLETED|Overall Study||13
8508808|NCT00450385|20970666|P1|COMPLETED|Overall Study||44
8508809|NCT00450385|20970666|P1|STARTED|Overall Study||57
8508810|NCT00450372|20970675|P1|NOT COMPLETED|Overall Study||1
8508811|NCT00450372|20970675|P1|COMPLETED|Overall Study||37
8508812|NCT00450372|20970675|P1|STARTED|Overall Study||38
8508825|NCT00450294|20970709|P1|NOT COMPLETED|Overall Study||0
8508826|NCT00450294|20970709|P1|COMPLETED|Overall Study||10
8508827|NCT00450294|20970709|P1|STARTED|Overall Study||10
8508828|NCT00450255|20970714|P1|NOT COMPLETED|Overall Study||1
8508829|NCT00450255|20970714|P1|COMPLETED|Overall Study||40
8508830|NCT00450255|20970714|P1|STARTED|Overall Study||41
8508831|NCT00450242|20970724|P2|NOT COMPLETED|Overall Study||1
8508832|NCT00450242|20970725|P1|NOT COMPLETED|Overall Study||3
8508833|NCT00450242|20970724|P2|COMPLETED|Overall Study||6
8508834|NCT00450242|20970725|P1|COMPLETED|Overall Study||4
8508835|NCT00450242|20970724|P2|STARTED|Overall Study||7
8508836|NCT00450242|20970725|P1|STARTED|Overall Study||7
8508837|NCT00450216|20970739|P2|NOT COMPLETED|Overall Study||129
8508838|NCT00450216|20970740|P1|NOT COMPLETED|Overall Study||174
8508839|NCT00450216|20970739|P2|COMPLETED|Overall Study||170
8508840|NCT00450216|20970740|P1|COMPLETED|Overall Study||433
8508841|NCT00450216|20970739|P2|STARTED|Overall Study||299
8508842|NCT00450216|20970740|P1|STARTED|Overall Study||607
8508843|NCT00450190|20970752|P1|NOT COMPLETED|Overall Study||2
8508844|NCT00450190|20970752|P1|COMPLETED|Overall Study||18
8508845|NCT00450190|20970752|P1|STARTED|Overall Study||20
8508846|NCT00450177|20970762|P2|NOT COMPLETED|Overall Study||11
8508847|NCT00450177|20970763|P1|NOT COMPLETED|Overall Study||9
8508848|NCT00450177|20970762|P2|COMPLETED|Overall Study||92
8508849|NCT00450177|20970763|P1|COMPLETED|Overall Study||88
8508850|NCT00450177|20970762|P2|STARTED|Overall Study||103
8508851|NCT00450177|20970763|P1|STARTED|Overall Study||97
8508852|NCT00450112|20970789|P2|NOT COMPLETED|Overall Study||6
8508853|NCT00450112|20970790|P1|NOT COMPLETED|Overall Study||13
8508854|NCT00450112|20970789|P2|COMPLETED|Overall Study||71
8508855|NCT00450112|20970790|P1|COMPLETED|Overall Study||112
8508856|NCT00450112|20970789|P2|Analyzed Participants|Overall Study||74
8508857|NCT00450112|20970790|P1|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
8508858|NCT00450112|20970789|P2|Received Injection|Overall Study||74
8508859|NCT00450112|20970790|P1|Received Injection|Overall Study||125
8508860|NCT00450112|20970789|P2|STARTED|Overall Study||77
8508861|NCT00450112|20970790|P1|STARTED|Overall Study||125
8508862|NCT00450073|20970815|P3|NOT COMPLETED|Overall Study||1
8508863|NCT00450073|20970816|P2|NOT COMPLETED|Overall Study||0
8508864|NCT00450073|20970817|P1|NOT COMPLETED|Overall Study||1
8508865|NCT00450073|20970815|P3|COMPLETED|Overall Study||9
8508866|NCT00450073|20970816|P2|COMPLETED|Overall Study||10
8508867|NCT00450073|20970817|P1|COMPLETED|Overall Study||9
8508868|NCT00450073|20970815|P3|STARTED|Overall Study||10
8508869|NCT00450073|20970816|P2|STARTED|Overall Study||10
8508870|NCT00450073|20970817|P1|STARTED|Overall Study||10
8508871|NCT00449956|20970828|P3|NOT COMPLETED|Overall Study||9
8508872|NCT00449956|20970829|P2|NOT COMPLETED|Overall Study||4
8508873|NCT00449956|20970830|P1|NOT COMPLETED|Overall Study||10
8508874|NCT00449956|20970828|P3|COMPLETED|Overall Study||184
8508875|NCT00449956|20970829|P2|COMPLETED|Overall Study||88
8508876|NCT00449956|20970830|P1|COMPLETED|Overall Study||179
8508877|NCT00449956|20970828|P3|STARTED|Overall Study||193
8508878|NCT00449956|20970829|P2|STARTED|Overall Study||92
8508879|NCT00449956|20970830|P1|STARTED|Overall Study||189
8508880|NCT00449930|20970846|P2|NOT COMPLETED|Overall Study||75
8508881|NCT00449930|20970847|P1|NOT COMPLETED|Overall Study||61
8508882|NCT00449930|20970846|P2|COMPLETED|Overall Study||447
8508883|NCT00449930|20970847|P1|COMPLETED|Overall Study||467
8508884|NCT00449930|20970846|P2|STARTED|Overall Study||522
8508885|NCT00449930|20970847|P1|STARTED|Overall Study||528
8508886|NCT00449865|20970863|P2|NOT COMPLETED|Overall Study||534
8508887|NCT00449865|20970864|P1|NOT COMPLETED|Overall Study||522
8508888|NCT00449865|20970863|P2|COMPLETED|Overall Study|477 Expected at Year 5|340
8508889|NCT00449865|20970864|P1|COMPLETED|Overall Study|478 Expected at Year 5|345
8508890|NCT00449865|20970863|P2|Completed Year 4|Overall Study|686 Expected at Year 4|523
8508891|NCT00449865|20970864|P1|Completed Year 4|Overall Study|679 Expected at Year 4|521
8508892|NCT00449865|20970863|P2|Completed Year 3|Overall Study|874 Expected at Year 3|715
8508893|NCT00449865|20970864|P1|Completed Year 3|Overall Study|867 Expected at Year 3|719
8508894|NCT00449865|20970863|P2|Completed Year 2|Overall Study|874 Expected at Year 2|766
8508895|NCT00449865|20970864|P1|Completed Year 2|Overall Study|867 Expected at Year 2|768
8508896|NCT00449865|20970863|P2|Completed Year 1|Overall Study|874 Expected at Year 1|822
8508897|NCT00449865|20970864|P1|Completed Year 1|Overall Study|867 Expected at Year 1|802
8508898|NCT00449865|20970863|P2|STARTED|Overall Study||874
8508899|NCT00449865|20970864|P1|STARTED|Overall Study||867
8508900|NCT00449787|20970872|P2|NOT COMPLETED|Overall Study||100
8508901|NCT00449787|20970873|P1|NOT COMPLETED|Overall Study||105
8508902|NCT00449787|20970872|P2|COMPLETED|Overall Study||98
8508903|NCT00449787|20970873|P1|COMPLETED|Overall Study||98
8508904|NCT00449787|20970872|P2|STARTED|Overall Study||198
8508905|NCT00449787|20970873|P1|STARTED|Overall Study||203
8508906|NCT00449748|20970883|P1|NOT COMPLETED|Overall Study||0
8508907|NCT00449748|20970883|P1|COMPLETED|Overall Study||10
8508908|NCT00449748|20970883|P1|STARTED|Overall Study||10
8508909|NCT00449696|20970889|P2|NOT COMPLETED|Overall Study||9
8508910|NCT00449696|20970890|P1|NOT COMPLETED|Overall Study||20
8508911|NCT00449696|20970889|P2|COMPLETED|Overall Study||119
8508912|NCT00449696|20970890|P1|COMPLETED|Overall Study||231
8508913|NCT00449696|20970889|P2|Analyzed Participants|Overall Study||128
8508914|NCT00449696|20970890|P1|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
8508915|NCT00449696|20970889|P2|Received Injection|Overall Study||128
8508916|NCT00449696|20970890|P1|Received Injection|Overall Study||249
8508917|NCT00449696|20970889|P2|STARTED|Overall Study||128
8508918|NCT00449696|20970890|P1|STARTED|Overall Study||251
8508919|NCT00449670|20970914|P2|NOT COMPLETED|Booster Phase (Study no.109873)||3
8508920|NCT00449670|20970915|P1|NOT COMPLETED|Booster Phase (Study no.109873)||0
8508921|NCT00449670|20970914|P2|COMPLETED|Booster Phase (Study no.109873)||233
8508922|NCT00449670|20970915|P1|COMPLETED|Booster Phase (Study no.109873)||265
8508923|NCT00449670|20970914|P2|STARTED|Booster Phase (Study no.109873)||236
8508924|NCT00449670|20970915|P1|STARTED|Booster Phase (Study no.109873)||265
8508925|NCT00449670|20970914|P2|NOT COMPLETED|Primary Phase (Study no.109630)||2
8508926|NCT00449670|20970915|P1|NOT COMPLETED|Primary Phase (Study no.109630)||14
8508927|NCT00449670|20970914|P2|COMPLETED|Primary Phase (Study no.109630)||243
8508928|NCT00449670|20970915|P1|COMPLETED|Primary Phase (Study no.109630)||947
8508929|NCT00449670|20970914|P2|STARTED|Primary Phase (Study no.109630)||245
8508930|NCT00449670|20970915|P1|STARTED|Primary Phase (Study no.109630)||961
8508931|NCT00449644|20971028|P4|NOT COMPLETED|Overall Study||32
8508932|NCT00449644|20971029|P3|NOT COMPLETED|Overall Study||29
8508933|NCT00449644|20971030|P2|NOT COMPLETED|Overall Study||13
8508934|NCT00449644|20971031|P1|NOT COMPLETED|Overall Study||10
8508935|NCT00449644|20971028|P4|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
8508936|NCT00449644|20971029|P3|COMPLETED|Overall Study||50
8508937|NCT00449644|20971030|P2|COMPLETED|Overall Study||11
8508938|NCT00449644|20971031|P1|COMPLETED|Overall Study||13
8508939|NCT00449644|20971028|P4|Rollover|Overall Study||1
8508940|NCT00449644|20971029|P3|Rollover|Overall Study||0
8508941|NCT00449644|20971030|P2|Rollover|Overall Study||0
8508942|NCT00449644|20971031|P1|Rollover|Overall Study||0
8508943|NCT00449644|20971028|P4|STARTED|Overall Study||81
8508944|NCT00449644|20971029|P3|STARTED|Overall Study||79
8508945|NCT00449644|20971030|P2|STARTED|Overall Study||24
8508946|NCT00449644|20971031|P1|STARTED|Overall Study||23
8508947|NCT00449540|20971051|P3|NOT COMPLETED|Treatment Phase||17
8508948|NCT00449540|20971052|P2|NOT COMPLETED|Treatment Phase||20
8508949|NCT00449540|20971053|P1|NOT COMPLETED|Treatment Phase||0
8508950|NCT00449540|20971051|P3|COMPLETED|Treatment Phase||82
8508951|NCT00449540|20971052|P2|COMPLETED|Treatment Phase||82
8508952|NCT00449540|20971053|P1|COMPLETED|Treatment Phase||0
8508953|NCT00449540|20971051|P3|STARTED|Treatment Phase||99
8508954|NCT00449540|20971052|P2|STARTED|Treatment Phase||102
8508955|NCT00449540|20971053|P1|STARTED|Treatment Phase||0
8508956|NCT00449540|20971051|P3|NOT COMPLETED|Pretreatment Phase||0
8508957|NCT00449540|20971052|P2|NOT COMPLETED|Pretreatment Phase||0
8508958|NCT00449540|20971053|P1|NOT COMPLETED|Pretreatment Phase||66
8508959|NCT00449540|20971051|P3|COMPLETED|Pretreatment Phase||0
8508960|NCT00449540|20971052|P2|COMPLETED|Pretreatment Phase||0
8508961|NCT00449540|20971053|P1|COMPLETED|Pretreatment Phase||201
8508962|NCT00449540|20971051|P3|STARTED|Pretreatment Phase||0
8508963|NCT00449540|20971052|P2|STARTED|Pretreatment Phase||0
8508964|NCT00449540|20971053|P1|STARTED|Pretreatment Phase||267
8508965|NCT00449176|20971070|P3|NOT COMPLETED|Overall Study||167
8508966|NCT00449176|20971071|P2|NOT COMPLETED|Overall Study||195
8508967|NCT00449176|20971072|P1|NOT COMPLETED|Overall Study||152
8508968|NCT00449176|20971070|P3|COMPLETED|Overall Study||152
8508969|NCT00449176|20971071|P2|COMPLETED|Overall Study||133
8508970|NCT00449176|20971072|P1|COMPLETED|Overall Study||166
8508971|NCT00449176|20971070|P3|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
8508972|NCT00449176|20971071|P2|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
8508973|NCT00449176|20971072|P1|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
8508974|NCT00449163|20971098|P1|NOT COMPLETED|Overall Study||3
8508975|NCT00449163|20971098|P1|COMPLETED|Overall Study||22
8508976|NCT00449163|20971098|P1|STARTED|Overall Study||25
8508977|NCT00449150|20971108|P3|NOT COMPLETED|Overall Study||47
8508978|NCT00449150|20971109|P2|NOT COMPLETED|Overall Study||53
8508979|NCT00449150|20971110|P1|NOT COMPLETED|Overall Study||46
8508980|NCT00449150|20971108|P3|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
8508981|NCT00449150|20971109|P2|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
8508982|NCT00449150|20971110|P1|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
8508983|NCT00449150|20971108|P3|STARTED|Overall Study||218
8508984|NCT00449150|20971109|P2|STARTED|Overall Study||230
8508985|NCT00449150|20971110|P1|STARTED|Overall Study||219
8508986|NCT00449072|20971123|P2|NOT COMPLETED|Overall Study||42
8508987|NCT00449072|20971124|P1|NOT COMPLETED|Overall Study||41
8508988|NCT00449072|20971123|P2|COMPLETED|Overall Study||109
8508989|NCT00449072|20971124|P1|COMPLETED|Overall Study||107
8508990|NCT00449072|20971123|P2|STARTED|Overall Study||151
8508991|NCT00449072|20971124|P1|STARTED|Overall Study||148
8508992|NCT00449046|20971148|P1|NOT COMPLETED|Overall Study||0
8508993|NCT00449046|20971148|P1|COMPLETED|Overall Study||40
8508994|NCT00449046|20971148|P1|STARTED|Overall Study||40
8508995|NCT00449033|20971161|P2|NOT COMPLETED|Follow-up Period||434
8508996|NCT00449033|20971162|P1|NOT COMPLETED|Follow-up Period||425
8508997|NCT00449033|20971161|P2|COMPLETED|Follow-up Period||0
8508998|NCT00449033|20971162|P1|COMPLETED|Follow-up Period||0
8508999|NCT00449033|20971161|P2|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
8509000|NCT00449033|20971162|P1|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
8509001|NCT00449033|20971161|P2|NOT COMPLETED|Treatment Period||452
8509002|NCT00449033|20971162|P1|NOT COMPLETED|Treatment Period||452
8509003|NCT00449033|20971161|P2|COMPLETED|Treatment Period||0
8509004|NCT00449033|20971162|P1|COMPLETED|Treatment Period||0
8509005|NCT00449033|20971161|P2|Received Treatment|Treatment Period||449
8509006|NCT00449033|20971162|P1|Received Treatment|Treatment Period||452
8509007|NCT00449033|20971161|P2|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
8509008|NCT00449033|20971162|P1|STARTED|Treatment Period||452
8509009|NCT00448916|20971200|P4|NOT COMPLETED|Overall Study||6
8509010|NCT00448916|20971201|P3|NOT COMPLETED|Overall Study||6
8509011|NCT00448916|20971202|P2|NOT COMPLETED|Overall Study||6
8509012|NCT00448916|20971203|P1|NOT COMPLETED|Overall Study||7
8509013|NCT00448916|20971200|P4|COMPLETED|Overall Study||5
8509014|NCT00448916|20971201|P3|COMPLETED|Overall Study||6
8509015|NCT00448916|20971202|P2|COMPLETED|Overall Study||9
8509016|NCT00448916|20971203|P1|COMPLETED|Overall Study||9
8509017|NCT00448916|20971200|P4|STARTED|Overall Study||11
8509018|NCT00448916|20971201|P3|STARTED|Overall Study||12
8509019|NCT00448916|20971202|P2|STARTED|Overall Study||15
8509020|NCT00448916|20971203|P1|STARTED|Overall Study||16
8509021|NCT00448864|20971277|P3|NOT COMPLETED|Overall Study||1
8509022|NCT00448864|20971278|P2|NOT COMPLETED|Overall Study||5
8509023|NCT00448864|20971279|P1|NOT COMPLETED|Overall Study||5
8509024|NCT00448864|20971277|P3|COMPLETED|Overall Study||18
8509025|NCT00448864|20971278|P2|COMPLETED|Overall Study||24
8509026|NCT00448864|20971279|P1|COMPLETED|Overall Study||22
8509027|NCT00448864|20971277|P3|Completed Post-operative Period|Overall Study||18
8509028|NCT00448864|20971278|P2|Completed Post-operative Period|Overall Study||25
8509029|NCT00448864|20971279|P1|Completed Post-operative Period|Overall Study||26
8509030|NCT00448864|20971277|P3|Started Post-operative Period|Overall Study||18
8509031|NCT00448864|20971278|P2|Started Post-operative Period|Overall Study||25
8509032|NCT00448864|20971279|P1|Started Post-operative Period|Overall Study||26
8509033|NCT00448864|20971277|P3|Received at Least 1 Dose of Study Drug|Overall Study||18
8509034|NCT00448864|20971278|P2|Received at Least 1 Dose of Study Drug|Overall Study||25
8509035|NCT00448864|20971279|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
8509036|NCT00448864|20971277|P3|STARTED|Overall Study||19
8509037|NCT00448864|20971278|P2|STARTED|Overall Study||29
8509038|NCT00448864|20971279|P1|STARTED|Overall Study||27
8509039|NCT00448760|20971295|P1|NOT COMPLETED|Overall Study||3
8509040|NCT00448760|20971295|P1|COMPLETED|Overall Study||26
8509041|NCT00448760|20971295|P1|STARTED|Overall Study||29
8509042|NCT00448747|20971304|P2|NOT COMPLETED|Overall Study||0
8509043|NCT00448747|20971305|P1|NOT COMPLETED|Overall Study||1
8509044|NCT00448747|20971304|P2|COMPLETED|Overall Study||48
8509045|NCT00448747|20971305|P1|COMPLETED|Overall Study||52
8509046|NCT00448747|20971304|P2|Per Protocol Population (PPS)|Overall Study||48
8509047|NCT00448747|20971305|P1|Per Protocol Population (PPS)|Overall Study||50
8509048|NCT00448747|20971304|P2|Received L-ARG-GHRH and AEZS-130|Overall Study||10
8509049|NCT00448747|20971305|P1|Received L-ARG-GHRH and AEZS-130|Overall Study||42
8509050|NCT00448747|20971304|P2|Received L-ARG-GHRH|Overall Study||10
8509051|NCT00448747|20971305|P1|Received L-ARG-GHRH|Overall Study||43
8509052|NCT00448747|20971304|P2|Received AEZS-130|Overall Study||48
8509053|NCT00448747|20971305|P1|Received AEZS-130|Overall Study||52
8509054|NCT00448747|20971304|P2|Received Second Drug Administration|Overall Study||10
8509055|NCT00448747|20971305|P1|Received Second Drug Administration|Overall Study||42
8509056|NCT00448747|20971304|P2|Received First Drug Administration|Overall Study||48
8509057|NCT00448747|20971305|P1|Received First Drug Administration|Overall Study||53
8509058|NCT00448747|20971304|P2|STARTED|Overall Study||48
8509059|NCT00448747|20971305|P1|STARTED|Overall Study||53
8509060|NCT00448708|20971323|P2|NOT COMPLETED|Overall Study||31
8509061|NCT00448708|20971324|P1|NOT COMPLETED|Overall Study||35
8509062|NCT00448708|20971323|P2|COMPLETED|Overall Study||79
8509063|NCT00448708|20971324|P1|COMPLETED|Overall Study||77
8509064|NCT00448708|20971323|P2|STARTED|Overall Study||110
8509065|NCT00448708|20971324|P1|STARTED|Overall Study||112
8509066|NCT00448682|20971332|P1|NOT COMPLETED|Overall Study||0
8509067|NCT00448682|20971332|P1|COMPLETED|Overall Study||25
8509068|NCT00448682|20971332|P1|STARTED|Overall Study||25
8509069|NCT00448669|20971340|P2|NOT COMPLETED|Overall Study||198
8509070|NCT00448669|20971341|P1|NOT COMPLETED|Overall Study||218
8509071|NCT00448669|20971340|P2|COMPLETED|Overall Study||410
8509072|NCT00448669|20971341|P1|COMPLETED|Overall Study||393
8509073|NCT00448669|20971340|P2|STARTED|Overall Study||608
8509074|NCT00448669|20971341|P1|STARTED|Overall Study||611
8509078|NCT00448591|20971402|P1|NOT COMPLETED|Overall Study||2296
8509079|NCT00448591|20971402|P1|COMPLETED|Overall Study||0
8509080|NCT00448591|20971402|P1|STARTED|Overall Study||2296
8509081|NCT00448539|20971413|P2|NOT COMPLETED|Overall Study||152
8509082|NCT00448539|20971414|P1|NOT COMPLETED|Overall Study||134
8509083|NCT00448539|20971413|P2|COMPLETED|Overall Study||0
8509084|NCT00448539|20971414|P1|COMPLETED|Overall Study||0
8509085|NCT00448539|20971413|P2|STARTED|Overall Study||152
8509086|NCT00448539|20971414|P1|STARTED|Overall Study||134
8509087|NCT00448448|20971422|P2|NOT COMPLETED|Overall Study||41
8509088|NCT00448448|20971423|P1|NOT COMPLETED|Overall Study||100
8509089|NCT00448448|20971422|P2|COMPLETED|Overall Study||96
8509090|NCT00448448|20971423|P1|COMPLETED|Overall Study||146
8509091|NCT00448448|20971422|P2|STARTED|Overall Study||137
8509092|NCT00448448|20971423|P1|STARTED|Overall Study||246
8509093|NCT00448435|20971429|P2|NOT COMPLETED|Extension Period - 20 Weeks||0
8509094|NCT00448435|20971430|P1|NOT COMPLETED|Extension Period - 20 Weeks||0
8509095|NCT00448435|20971429|P2|COMPLETED|Extension Period - 20 Weeks||0
8509096|NCT00448435|20971430|P1|COMPLETED|Extension Period - 20 Weeks||50
8509097|NCT00448435|20971429|P2|STARTED|Extension Period - 20 Weeks||0
8509098|NCT00448435|20971430|P1|STARTED|Extension Period - 20 Weeks||50
8509099|NCT00448435|20971429|P2|NOT COMPLETED|Treatment Period II - 4 Weeks||0
8509100|NCT00448435|20971430|P1|NOT COMPLETED|Treatment Period II - 4 Weeks||0
8509101|NCT00448435|20971429|P2|COMPLETED|Treatment Period II - 4 Weeks||25
8509102|NCT00448435|20971430|P1|COMPLETED|Treatment Period II - 4 Weeks||25
8509103|NCT00448435|20971429|P2|STARTED|Treatment Period II - 4 Weeks||25
8509104|NCT00448435|20971430|P1|STARTED|Treatment Period II - 4 Weeks||25
8509105|NCT00448435|20971429|P2|NOT COMPLETED|Washout Period - 2 Weeks||0
8509106|NCT00448435|20971430|P1|NOT COMPLETED|Washout Period - 2 Weeks||1
8509107|NCT00448435|20971429|P2|COMPLETED|Washout Period - 2 Weeks||25
8509108|NCT00448435|20971430|P1|COMPLETED|Washout Period - 2 Weeks||25
8509109|NCT00448435|20971429|P2|STARTED|Washout Period - 2 Weeks||25
8509110|NCT00448435|20971430|P1|STARTED|Washout Period - 2 Weeks||26
8509111|NCT00448435|20971429|P2|NOT COMPLETED|Treatment Period I - 4 Weeks||0
8509112|NCT00448435|20971430|P1|NOT COMPLETED|Treatment Period I - 4 Weeks||0
8509113|NCT00448435|20971429|P2|COMPLETED|Treatment Period I - 4 Weeks||25
8509114|NCT00448435|20971430|P1|COMPLETED|Treatment Period I - 4 Weeks||26
8509115|NCT00448435|20971429|P2|STARTED|Treatment Period I - 4 Weeks||25
8509116|NCT00448435|20971430|P1|STARTED|Treatment Period I - 4 Weeks||26
8509117|NCT00448357|20971456|P1|NOT COMPLETED|Overall Study||0
8509118|NCT00448357|20971456|P1|COMPLETED|Overall Study||54
8509119|NCT00448357|20971456|P1|STARTED|Overall Study||54
8509120|NCT00448344|20971481|P2|NOT COMPLETED|Overall Study||36
8509121|NCT00448344|20971482|P1|NOT COMPLETED|Overall Study||30
8509122|NCT00448344|20971481|P2|COMPLETED|Overall Study||200
8509123|NCT00448344|20971482|P1|COMPLETED|Overall Study||205
8509124|NCT00448344|20971481|P2|STARTED|Overall Study||236
8509125|NCT00448344|20971482|P1|STARTED|Overall Study||235
8509126|NCT00448279|20971492|P2|NOT COMPLETED|Overall Study||29
8509127|NCT00448279|20971493|P1|NOT COMPLETED|Overall Study||29
8509128|NCT00448279|20971492|P2|COMPLETED|Overall Study||0
8509129|NCT00448279|20971493|P1|COMPLETED|Overall Study||0
8509130|NCT00448279|20971492|P2|STARTED|Overall Study||29
8509131|NCT00448279|20971493|P1|STARTED|Overall Study||29
8509132|NCT00448227|20971509|P1|NOT COMPLETED|Overall Study||0
8509133|NCT00448227|20971509|P1|COMPLETED|Overall Study||18
8509134|NCT00448227|20971509|P1|STARTED|Overall Study||18
8509135|NCT00448201|20971536|P1|NOT COMPLETED|Overall Study||0
8509136|NCT00448201|20971536|P1|COMPLETED|Overall Study||71
8509137|NCT00448201|20971536|P1|STARTED|Overall Study||71
8509138|NCT00448175|20971547|P2|NOT COMPLETED|Continued PTNS Through 12 Months||0
8509139|NCT00448175|20971548|P1|NOT COMPLETED|Continued PTNS Through 12 Months||10
8509140|NCT00448175|20971547|P2|COMPLETED|Continued PTNS Through 12 Months||0
8509141|NCT00448175|20971548|P1|COMPLETED|Continued PTNS Through 12 Months||25
8509142|NCT00448175|20971547|P2|STARTED|Continued PTNS Through 12 Months||0
8509143|NCT00448175|20971548|P1|STARTED|Continued PTNS Through 12 Months||35
8509144|NCT00448175|20971547|P2|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
8509145|NCT00448175|20971548|P1|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
8509146|NCT00448175|20971547|P2|COMPLETED|12 Weeks PTNS vs. Drug||43
8509147|NCT00448175|20971548|P1|COMPLETED|12 Weeks PTNS vs. Drug||41
8509148|NCT00448175|20971547|P2|STARTED|12 Weeks PTNS vs. Drug||50
8509149|NCT00448175|20971548|P1|STARTED|12 Weeks PTNS vs. Drug||50
8509150|NCT00448136|20971556|P2|NOT COMPLETED|Overall Study||8
8509151|NCT00448136|20971557|P1|NOT COMPLETED|Overall Study||4
8509152|NCT00448136|20971556|P2|COMPLETED|Overall Study||41
8509153|NCT00448136|20971557|P1|COMPLETED|Overall Study||30
8509154|NCT00448136|20971556|P2|STARTED|Overall Study||49
8509155|NCT00448136|20971557|P1|STARTED|Overall Study||34
8509156|NCT00448123|20971595|P2|NOT COMPLETED|Overall Study||12
8509157|NCT00448123|20971596|P1|NOT COMPLETED|Overall Study||15
8509158|NCT00448123|20971595|P2|COMPLETED|Overall Study||53
8509159|NCT00448123|20971596|P1|COMPLETED|Overall Study||47
8509160|NCT00448123|20971595|P2|STARTED|Overall Study||65
8509161|NCT00448123|20971596|P1|STARTED|Overall Study||62
8509162|NCT00448019|20971606|P1|NOT COMPLETED|Overall Study||7
8509163|NCT00448019|20971606|P1|COMPLETED|Overall Study||57
8509164|NCT00448019|20971606|P1|STARTED|Overall Study||64
8509165|NCT00447902|20971614|P2|NOT COMPLETED|Overall Study||6
8509166|NCT00447902|20971615|P1|NOT COMPLETED|Overall Study||4
8509167|NCT00447902|20971614|P2|COMPLETED|Overall Study||0
8509168|NCT00447902|20971615|P1|COMPLETED|Overall Study||1
8509169|NCT00447902|20971614|P2|STARTED|Overall Study||6
8509170|NCT00447902|20971615|P1|STARTED|Overall Study||5
8509171|NCT00447876|20971657|P2|NOT COMPLETED|Overall Study||4
8509172|NCT00447876|20971658|P1|NOT COMPLETED|Overall Study||3
8509173|NCT00447876|20971657|P2|COMPLETED|Overall Study||16
8509174|NCT00447876|20971658|P1|COMPLETED|Overall Study||17
8509175|NCT00447876|20971657|P2|STARTED|Overall Study||20
8509176|NCT00447876|20971658|P1|STARTED|Overall Study||20
8509177|NCT00447772|20971688|P1|NOT COMPLETED|Overall Study||27
8509178|NCT00447772|20971688|P1|COMPLETED|Overall Study||489
8509179|NCT00447772|20971688|P1|STARTED|Overall Study||516
8509180|NCT00447603|20971708|P3|NOT COMPLETED|Filter Period||15
8509181|NCT00447603|20971709|P2|NOT COMPLETED|Filter Period||4
8509182|NCT00447603|20971710|P1|NOT COMPLETED|Filter Period||0
8509183|NCT00447603|20971708|P3|COMPLETED|Filter Period||0
8509184|NCT00447603|20971709|P2|COMPLETED|Filter Period||0
8509185|NCT00447603|20971710|P1|COMPLETED|Filter Period||0
8509186|NCT00447603|20971708|P3|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
8509187|NCT00447603|20971709|P2|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
8509188|NCT00447603|20971710|P1|STARTED|Filter Period||0
8509189|NCT00447603|20971708|P3|NOT COMPLETED|Screening||0
8509190|NCT00447603|20971709|P2|NOT COMPLETED|Screening||0
8509191|NCT00447603|20971710|P1|NOT COMPLETED|Screening||21
8509192|NCT00447603|20971708|P3|COMPLETED|Screening||0
8509193|NCT00447603|20971709|P2|COMPLETED|Screening||0
8509194|NCT00447603|20971710|P1|COMPLETED|Screening||19
8509195|NCT00447603|20971708|P3|STARTED|Screening||0
8509196|NCT00447603|20971709|P2|STARTED|Screening||0
8509197|NCT00447603|20971710|P1|STARTED|Screening||40
8509198|NCT00447590|20971730|P1|NOT COMPLETED|Overall Study||60
8509199|NCT00447590|20971730|P1|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
8509200|NCT00447590|20971730|P1|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
8509201|NCT00447499|20971739|P1|NOT COMPLETED|Overall Study||7
8509202|NCT00447499|20971739|P1|COMPLETED|Overall Study||52
8509203|NCT00447499|20971739|P1|STARTED|Overall Study||59
8509204|NCT00447421|20971749|P1|NOT COMPLETED|Overall Study||6
8509205|NCT00447421|20971749|P1|COMPLETED|Overall Study||3
8509206|NCT00447421|20971749|P1|STARTED|Overall Study||9
8509207|NCT00447382|20971761|P2|NOT COMPLETED|Overall Study||6
8509208|NCT00447382|20971762|P1|NOT COMPLETED|Overall Study||6
8509209|NCT00447382|20971761|P2|COMPLETED|Overall Study||160
8509210|NCT00447382|20971762|P1|COMPLETED|Overall Study||158
8509211|NCT00447382|20971761|P2|STARTED|Overall Study||166
8509212|NCT00447382|20971762|P1|STARTED|Overall Study||164
8509213|NCT00447330|20971814|P1|NOT COMPLETED|Overall Study||2
8509214|NCT00447330|20971814|P1|COMPLETED|Overall Study||58
8509215|NCT00447330|20971814|P1|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
8509216|NCT00447278|20971823|P2|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
8509217|NCT00447278|20971824|P1|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
8509218|NCT00447278|20971823|P2|COMPLETED|Period III (Optional 6 Month Extension)||140
8509219|NCT00447278|20971824|P1|COMPLETED|Period III (Optional 6 Month Extension)||109
8509220|NCT00447278|20971823|P2|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
8509221|NCT00447278|20971824|P1|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
8509222|NCT00447278|20971823|P2|NOT COMPLETED|Period II (6 Month Open-Label)||29
8509223|NCT00447278|20971824|P1|NOT COMPLETED|Period II (6 Month Open-Label)||42
8509224|NCT00447278|20971823|P2|COMPLETED|Period II (6 Month Open-Label)||171
8509225|NCT00447278|20971824|P1|COMPLETED|Period II (6 Month Open-Label)||157
8509226|NCT00447278|20971823|P2|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
8509227|NCT00447278|20971824|P1|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
8509228|NCT00447278|20971823|P2|STARTED|Period II (6 Month Open-Label)||200
8509229|NCT00447278|20971824|P1|STARTED|Period II (6 Month Open-Label)||199
8509230|NCT00447265|20971845|P2|NOT COMPLETED|Overall Study||0
8509231|NCT00447265|20971846|P1|NOT COMPLETED|Overall Study||1
8509232|NCT00447265|20971845|P2|COMPLETED|Overall Study||0
8509233|NCT00447265|20971846|P1|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
8509234|NCT00447265|20971845|P2|STARTED|Overall Study||0
8509235|NCT00447265|20971846|P1|STARTED|Overall Study||1
8509236|NCT00447226|20971859|P2|NOT COMPLETED|Double-blind Phase||3
8509237|NCT00447226|20971860|P1|NOT COMPLETED|Double-blind Phase||4
8509238|NCT00447226|20971859|P2|COMPLETED|Double-blind Phase||0
8509239|NCT00447226|20971860|P1|COMPLETED|Double-blind Phase||0
8509240|NCT00447226|20971859|P2|STARTED|Double-blind Phase||3
8509241|NCT00447226|20971860|P1|STARTED|Double-blind Phase||4
8509242|NCT00447226|20971859|P2|NOT COMPLETED|12-Week Open-label Phase||25
8509243|NCT00447226|20971860|P1|NOT COMPLETED|12-Week Open-label Phase||0
8509244|NCT00447226|20971859|P2|COMPLETED|12-Week Open-label Phase||7
8509245|NCT00447226|20971860|P1|COMPLETED|12-Week Open-label Phase||0
8509246|NCT00447226|20971859|P2|STARTED|12-Week Open-label Phase||32
8509247|NCT00447226|20971860|P1|STARTED|12-Week Open-label Phase||0
8509248|NCT00447122|20971878|P1|NOT COMPLETED|Overall Study||2
8509249|NCT00447122|20971878|P1|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
8509250|NCT00447122|20971878|P1|STARTED|Overall Study||31
8509251|NCT00447083|20971884|P4|NOT COMPLETED|Phase II||1
8509252|NCT00447083|20971885|P3|NOT COMPLETED|Phase II||1
8509253|NCT00447083|20971886|P2|NOT COMPLETED|Phase II||0
8509254|NCT00447083|20971887|P1|NOT COMPLETED|Phase II||0
8509255|NCT00447083|20971884|P4|COMPLETED|Phase II||7
8509256|NCT00447083|20971885|P3|COMPLETED|Phase II||7
8509257|NCT00447083|20971886|P2|COMPLETED|Phase II||0
8509258|NCT00447083|20971887|P1|COMPLETED|Phase II||0
8509259|NCT00447083|20971884|P4|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
8509260|NCT00447083|20971885|P3|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
8509261|NCT00447083|20971886|P2|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
8509262|NCT00447083|20971887|P1|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
8509263|NCT00447083|20971884|P4|NOT COMPLETED|Phase I||0
8509264|NCT00447083|20971885|P3|NOT COMPLETED|Phase I||0
8509265|NCT00447083|20971886|P2|NOT COMPLETED|Phase I||0
8509266|NCT00447083|20971887|P1|NOT COMPLETED|Phase I||0
8509267|NCT00447083|20971884|P4|COMPLETED|Phase I||0
8509268|NCT00447083|20971885|P3|COMPLETED|Phase I||0
8509269|NCT00447083|20971886|P2|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
8509270|NCT00447083|20971887|P1|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
8509271|NCT00447083|20971884|P4|STARTED|Phase I||0
8509272|NCT00447083|20971885|P3|STARTED|Phase I||0
8509273|NCT00447083|20971886|P2|STARTED|Phase I||9
8509274|NCT00447083|20971887|P1|STARTED|Phase I||10
8509275|NCT00447057|20971903|P4|NOT COMPLETED|Overall Study||26
8509276|NCT00447057|20971904|P3|NOT COMPLETED|Overall Study||19
8509277|NCT00447057|20971905|P2|NOT COMPLETED|Overall Study||73
8509278|NCT00447057|20971906|P1|NOT COMPLETED|Overall Study||83
8509279|NCT00447057|20971903|P4|COMPLETED|Overall Study||0
8509280|NCT00447057|20971904|P3|COMPLETED|Overall Study||0
8509281|NCT00447057|20971905|P2|COMPLETED|Overall Study||3
8509282|NCT00447057|20971906|P1|COMPLETED|Overall Study||0
8509283|NCT00447057|20971903|P4|STARTED|Overall Study||26
8509284|NCT00447057|20971904|P3|STARTED|Overall Study||19
8509285|NCT00447057|20971905|P2|STARTED|Overall Study||76
8509286|NCT00447057|20971906|P1|STARTED|Overall Study||83
8509287|NCT00447005|20971924|P1|NOT COMPLETED|Overall Study||12
8509288|NCT00447005|20971924|P1|COMPLETED|Overall Study||0
8509289|NCT00447005|20971924|P1|STARTED|Overall Study||12
8509290|NCT00446992|20971938|P1|NOT COMPLETED|Overall Study||16
8509291|NCT00446992|20971938|P1|COMPLETED|Overall Study|Intervention Completion|14
8509292|NCT00446992|20971938|P1|STARTED|Overall Study|Beginning of Intervention|30
8509293|NCT00446966|20971952|P2|NOT COMPLETED|Overall Study||7
8509294|NCT00446966|20971953|P1|NOT COMPLETED|Overall Study||10
8509295|NCT00446966|20971952|P2|COMPLETED|Overall Study||123
8509296|NCT00446966|20971953|P1|COMPLETED|Overall Study||120
8509297|NCT00446966|20971952|P2|STARTED|Overall Study||130
8509298|NCT00446966|20971953|P1|STARTED|Overall Study||130
8509311|NCT00446654|20972018|P2|NOT COMPLETED|Overall Study||0
8509312|NCT00446654|20972019|P1|NOT COMPLETED|Overall Study||2
8509313|NCT00446654|20972018|P2|COMPLETED|Overall Study||22
8509314|NCT00446654|20972019|P1|COMPLETED|Overall Study||19
8509315|NCT00446654|20972018|P2|STARTED|Overall Study||22
8509316|NCT00446654|20972019|P1|STARTED|Overall Study||21
8509317|NCT00446641|20972027|P2|NOT COMPLETED|Overall Study||10
8509318|NCT00446641|20972028|P1|NOT COMPLETED|Overall Study||17
8509319|NCT00446641|20972027|P2|COMPLETED|Overall Study||109
8509320|NCT00446641|20972028|P1|COMPLETED|Overall Study||108
8509321|NCT00446641|20972027|P2|STARTED|Overall Study||119
8509322|NCT00446641|20972028|P1|STARTED|Overall Study||125
8509323|NCT00446563|20972048|P2|NOT COMPLETED|Overall Study||9
8509324|NCT00446563|20972049|P1|NOT COMPLETED|Overall Study||7
8509325|NCT00446563|20972048|P2|COMPLETED|Overall Study||38
8509326|NCT00446563|20972049|P1|COMPLETED|Overall Study||36
8509327|NCT00446563|20972048|P2|STARTED|Overall Study||47
8509328|NCT00446563|20972049|P1|STARTED|Overall Study||43
8509329|NCT00446550|20972085|P2|NOT COMPLETED|Overall Study||0
8509330|NCT00446550|20972086|P1|NOT COMPLETED|Overall Study||1
8509331|NCT00446550|20972085|P2|COMPLETED|Overall Study||8
8509332|NCT00446550|20972086|P1|COMPLETED|Overall Study||10
8509333|NCT00446550|20972085|P2|PD Population|Overall Study||8
8509334|NCT00446550|20972086|P1|PD Population|Overall Study||11
8509335|NCT00446550|20972085|P2|Safety Population|Overall Study||8
8509336|NCT00446550|20972086|P1|Safety Population|Overall Study||11
8509337|NCT00446550|20972085|P2|STARTED|Overall Study||8
8509338|NCT00446550|20972086|P1|STARTED|Overall Study||11
8509339|NCT00446511|20972098|P4|NOT COMPLETED|Overall Study||6
8509340|NCT00446511|20972099|P3|NOT COMPLETED|Overall Study||7
8509341|NCT00446511|20972100|P2|NOT COMPLETED|Overall Study||2
8509342|NCT00446511|20972101|P1|NOT COMPLETED|Overall Study||10
8509343|NCT00446511|20972098|P4|COMPLETED|Overall Study||103
8509344|NCT00446511|20972099|P3|COMPLETED|Overall Study||96
8509345|NCT00446511|20972100|P2|COMPLETED|Overall Study||15
8509346|NCT00446511|20972101|P1|COMPLETED|Overall Study||11
8509347|NCT00446511|20972098|P4|STARTED|Overall Study||109
8509348|NCT00446511|20972099|P3|STARTED|Overall Study||103
8509349|NCT00446511|20972100|P2|STARTED|Overall Study||17
8509350|NCT00446511|20972101|P1|STARTED|Overall Study||21
8509351|NCT00446459|20972125|P1|NOT COMPLETED|12 Months||18
8509352|NCT00446459|20972125|P1|COMPLETED|12 Months|4 subjects remained at month 12|4
8509353|NCT00446459|20972125|P1|STARTED|12 Months|22 subjects remained on-study at month 8|22
8509354|NCT00446459|20972125|P1|NOT COMPLETED|8 Months||12
8509355|NCT00446459|20972125|P1|COMPLETED|8 Months|22 subjects were on study at month 8.|22
8509356|NCT00446459|20972125|P1|STARTED|8 Months|34 subjects received any amount of MMF.|34
8509357|NCT00446446|20972133|P1|NOT COMPLETED|Overall Study||24
8509358|NCT00446446|20972133|P1|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
8509359|NCT00446446|20972133|P1|STARTED|Overall Study||52
8509360|NCT00446290|20972144|P1|NOT COMPLETED|Overall Study||0
8509361|NCT00446290|20972144|P1|COMPLETED|Overall Study||22
8509362|NCT00446290|20972144|P1|STARTED|Overall Study||22
8509363|NCT00446264|20972148|P1|NOT COMPLETED|Overall Study||0
8509364|NCT00446264|20972148|P1|COMPLETED|Overall Study||14
8509365|NCT00446264|20972148|P1|STARTED|Overall Study||14
8509366|NCT00446251|20972157|P1|NOT COMPLETED|Overall Study||5
8509367|NCT00446251|20972157|P1|COMPLETED|Overall Study||9
8509368|NCT00446251|20972157|P1|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
8509369|NCT00446199|20972167|P4|NOT COMPLETED|Overall Study||30
8509370|NCT00446199|20972168|P3|NOT COMPLETED|Overall Study||27
8509371|NCT00446199|20972169|P2|NOT COMPLETED|Overall Study||20
8509372|NCT00446199|20972170|P1|NOT COMPLETED|Overall Study||23
8509373|NCT00446199|20972167|P4|COMPLETED|Overall Study||153
8509374|NCT00446199|20972168|P3|COMPLETED|Overall Study||158
8509375|NCT00446199|20972169|P2|COMPLETED|Overall Study||164
8509376|NCT00446199|20972170|P1|COMPLETED|Overall Study||160
8509377|NCT00446199|20972167|P4|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
8509378|NCT00446199|20972168|P3|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
8509379|NCT00446199|20972169|P2|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
8509380|NCT00446199|20972170|P1|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
8509381|NCT00446199|20972167|P4|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
8509382|NCT00446199|20972168|P3|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
8509383|NCT00446199|20972169|P2|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
8509384|NCT00446199|20972170|P1|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
8509385|NCT00446199|20972167|P4|STARTED|Overall Study||183
8509386|NCT00446199|20972168|P3|STARTED|Overall Study||185
8509387|NCT00446199|20972169|P2|STARTED|Overall Study||184
8509388|NCT00446199|20972170|P1|STARTED|Overall Study||183
8509389|NCT00446147|20972250|P2|NOT COMPLETED|Overall Study||14
8509390|NCT00446147|20972251|P1|NOT COMPLETED|Overall Study||15
8509391|NCT00446147|20972250|P2|COMPLETED|Overall Study||180
8509392|NCT00446147|20972251|P1|COMPLETED|Overall Study||180
8509393|NCT00446147|20972250|P2|STARTED|Overall Study||194
8509394|NCT00446147|20972251|P1|STARTED|Overall Study||195
8509395|NCT00446134|20972263|P4|NOT COMPLETED|Overall Study||45
8509396|NCT00446134|20972264|P3|NOT COMPLETED|Overall Study||43
8509397|NCT00446134|20972265|P2|NOT COMPLETED|Overall Study||45
8509398|NCT00446134|20972266|P1|NOT COMPLETED|Overall Study||34
8509399|NCT00446134|20972263|P4|COMPLETED|Overall Study||25
8509400|NCT00446134|20972264|P3|COMPLETED|Overall Study||26
8509401|NCT00446134|20972265|P2|COMPLETED|Overall Study||25
8509402|NCT00446134|20972266|P1|COMPLETED|Overall Study||35
8509403|NCT00446134|20972263|P4|STARTED|Overall Study||70
8509404|NCT00446134|20972264|P3|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
8509405|NCT00446134|20972265|P2|STARTED|Overall Study||70
8509406|NCT00446134|20972266|P1|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
8509407|NCT00446095|20972293|P5|NOT COMPLETED|Phase I (28 Days)||3
8509408|NCT00446095|20972294|P4|NOT COMPLETED|Phase I (28 Days)||1
8509409|NCT00446095|20972295|P3|NOT COMPLETED|Phase I (28 Days)||0
8509410|NCT00446095|20972296|P2|NOT COMPLETED|Phase I (28 Days)||0
8509411|NCT00446095|20972297|P1|NOT COMPLETED|Phase I (28 Days)||0
8509412|NCT00446095|20972293|P5|COMPLETED|Phase I (28 Days)||4
8509413|NCT00446095|20972294|P4|COMPLETED|Phase I (28 Days)||5
8509414|NCT00446095|20972295|P3|COMPLETED|Phase I (28 Days)||0
8509415|NCT00446095|20972296|P2|COMPLETED|Phase I (28 Days)||0
8509416|NCT00446095|20972297|P1|COMPLETED|Phase I (28 Days)||0
8509417|NCT00446095|20972293|P5|STARTED|Phase I (28 Days)||7
8509418|NCT00446095|20972294|P4|STARTED|Phase I (28 Days)||6
8509419|NCT00446095|20972295|P3|STARTED|Phase I (28 Days)||0
8509420|NCT00446095|20972296|P2|STARTED|Phase I (28 Days)||0
8509421|NCT00446095|20972297|P1|STARTED|Phase I (28 Days)||0
8509422|NCT00446095|20972293|P5|NOT COMPLETED|Phase II (8 Weeks)||0
8509423|NCT00446095|20972294|P4|NOT COMPLETED|Phase II (8 Weeks)||0
8509424|NCT00446095|20972295|P3|NOT COMPLETED|Phase II (8 Weeks)||3
8509425|NCT00446095|20972296|P2|NOT COMPLETED|Phase II (8 Weeks)||3
8509426|NCT00446095|20972297|P1|NOT COMPLETED|Phase II (8 Weeks)||12
8509427|NCT00446095|20972293|P5|COMPLETED|Phase II (8 Weeks)||0
8509428|NCT00446095|20972294|P4|COMPLETED|Phase II (8 Weeks)||0
8509429|NCT00446095|20972295|P3|COMPLETED|Phase II (8 Weeks)||21
8509430|NCT00446095|20972296|P2|COMPLETED|Phase II (8 Weeks)||18
8509431|NCT00446095|20972297|P1|COMPLETED|Phase II (8 Weeks)||11
8509432|NCT00446095|20972293|P5|STARTED|Phase II (8 Weeks)||0
8509433|NCT00446095|20972294|P4|STARTED|Phase II (8 Weeks)||0
8509434|NCT00446095|20972295|P3|STARTED|Phase II (8 Weeks)||24
8509435|NCT00446095|20972296|P2|STARTED|Phase II (8 Weeks)||21
8509436|NCT00446095|20972297|P1|STARTED|Phase II (8 Weeks)||23
8509437|NCT00446030|20972320|P2|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
8509438|NCT00446030|20972321|P1|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
8509439|NCT00446030|20972320|P2|COMPLETED|FOLLOW-UP (up to 2-years)||25
8509440|NCT00446030|20972321|P1|COMPLETED|FOLLOW-UP (up to 2-years)||63
8509441|NCT00446030|20972320|P2|STARTED|FOLLOW-UP (up to 2-years)||34
8509442|NCT00446030|20972321|P1|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
8509443|NCT00446030|20972320|P2|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
8509444|NCT00446030|20972321|P1|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
8509445|NCT00446030|20972320|P2|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
8509446|NCT00446030|20972321|P1|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
8509447|NCT00446030|20972320|P2|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
8509448|NCT00446030|20972321|P1|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
8509449|NCT00446030|20972320|P2|STARTED|TREATMENT (up to 52 Weeks)||34
8509450|NCT00446030|20972321|P1|STARTED|TREATMENT (up to 52 Weeks)||93
8509451|NCT00445939|20972332|P4|NOT COMPLETED|Period B - Week 4 - Week 8||1
8509452|NCT00445939|20972333|P3|NOT COMPLETED|Period B - Week 4 - Week 8||0
8509453|NCT00445939|20972334|P2|NOT COMPLETED|Period B - Week 4 - Week 8||0
8509454|NCT00445939|20972335|P1|NOT COMPLETED|Period B - Week 4 - Week 8||2
8509455|NCT00445939|20972332|P4|COMPLETED|Period B - Week 4 - Week 8||20
8509456|NCT00445939|20972333|P3|COMPLETED|Period B - Week 4 - Week 8||0
8509457|NCT00445939|20972334|P2|COMPLETED|Period B - Week 4 - Week 8||0
8509458|NCT00445939|20972335|P1|COMPLETED|Period B - Week 4 - Week 8||14
8509459|NCT00445939|20972332|P4|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
8509460|NCT00445939|20972333|P3|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
8509461|NCT00445939|20972334|P2|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
8509462|NCT00445939|20972335|P1|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
8509463|NCT00445939|20972332|P4|NOT COMPLETED|Period A - Week 0 - Week 4||0
8509464|NCT00445939|20972333|P3|NOT COMPLETED|Period A - Week 0 - Week 4||0
8509465|NCT00445939|20972334|P2|NOT COMPLETED|Period A - Week 0 - Week 4||2
8509466|NCT00445939|20972335|P1|NOT COMPLETED|Period A - Week 0 - Week 4||1
8509467|NCT00445939|20972332|P4|COMPLETED|Period A - Week 0 - Week 4||0
8509468|NCT00445939|20972333|P3|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
8509469|NCT00445939|20972334|P2|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
8509470|NCT00445939|20972335|P1|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
8509471|NCT00445939|20972332|P4|STARTED|Period A - Week 0 - Week 4||0
8509472|NCT00445939|20972333|P3|STARTED|Period A - Week 0 - Week 4||23
8509473|NCT00445939|20972334|P2|STARTED|Period A - Week 0 - Week 4||34
8509474|NCT00445939|20972335|P1|STARTED|Period A - Week 0 - Week 4||33
8509475|NCT00445887|20972360|P2|NOT COMPLETED|Overall Study||0
8509476|NCT00445887|20972361|P1|NOT COMPLETED|Overall Study||0
8509477|NCT00445887|20972360|P2|COMPLETED|Overall Study||31
8509478|NCT00445887|20972361|P1|COMPLETED|Overall Study||33
8509479|NCT00445887|20972360|P2|STARTED|Overall Study||31
8509480|NCT00445887|20972361|P1|STARTED|Overall Study||33
8509481|NCT00445848|20972383|P1|NOT COMPLETED|Overall Study||85
8509482|NCT00445848|20972383|P1|COMPLETED|Overall Study||0
8509483|NCT00445848|20972383|P1|STARTED|Overall Study||85
8509484|NCT00445770|20972393|P3|NOT COMPLETED|Overall Study||31
8509485|NCT00445770|20972394|P2|NOT COMPLETED|Overall Study||35
8509486|NCT00445770|20972395|P1|NOT COMPLETED|Overall Study||53
8509487|NCT00445770|20972393|P3|COMPLETED|Overall Study||151
8509488|NCT00445770|20972394|P2|COMPLETED|Overall Study||157
8509489|NCT00445770|20972395|P1|COMPLETED|Overall Study||123
8509490|NCT00445770|20972393|P3|STARTED|Overall Study||182
8509491|NCT00445770|20972394|P2|STARTED|Overall Study||192
8509492|NCT00445770|20972395|P1|STARTED|Overall Study||176
8509493|NCT00445744|20972462|P1|NOT COMPLETED|Overall Study||1
8509494|NCT00445744|20972462|P1|COMPLETED|Overall Study||51
8509495|NCT00445744|20972462|P1|STARTED|Overall Study||52
8509496|NCT00445705|20972471|P4|NOT COMPLETED|Overall Study||14
8509497|NCT00445705|20972472|P3|NOT COMPLETED|Overall Study||11
8509498|NCT00445705|20972473|P2|NOT COMPLETED|Overall Study||11
8509499|NCT00445705|20972474|P1|NOT COMPLETED|Overall Study||9
8509500|NCT00445705|20972471|P4|COMPLETED|Overall Study||39
8509501|NCT00445705|20972472|P3|COMPLETED|Overall Study||41
8509502|NCT00445705|20972473|P2|COMPLETED|Overall Study||42
8509503|NCT00445705|20972474|P1|COMPLETED|Overall Study||44
8509504|NCT00445705|20972471|P4|STARTED|Overall Study||53
8509505|NCT00445705|20972472|P3|STARTED|Overall Study||52
8509506|NCT00445705|20972473|P2|STARTED|Overall Study||53
8509507|NCT00445705|20972474|P1|STARTED|Overall Study||53
8509508|NCT00445692|20972496|P1|NOT COMPLETED|Overall Study||16
8509509|NCT00445692|20972496|P1|COMPLETED|Overall Study||15
8509510|NCT00445692|20972496|P1|STARTED|Overall Study||31
8509511|NCT00445679|20972506|P4|NOT COMPLETED|Overall Study||47
8509512|NCT00445679|20972507|P3|NOT COMPLETED|Overall Study||66
8509513|NCT00445679|20972508|P2|NOT COMPLETED|Overall Study||46
8509514|NCT00445679|20972509|P1|NOT COMPLETED|Overall Study||48
8509515|NCT00445679|20972506|P4|COMPLETED|Overall Study||149
8509516|NCT00445679|20972507|P3|COMPLETED|Overall Study||139
8509517|NCT00445679|20972508|P2|COMPLETED|Overall Study||157
8509518|NCT00445679|20972509|P1|COMPLETED|Overall Study||155
8509519|NCT00445679|20972506|P4|STARTED|Overall Study||196
8509520|NCT00445679|20972507|P3|STARTED|Overall Study||205
8509521|NCT00445679|20972508|P2|STARTED|Overall Study||203
8509522|NCT00445679|20972509|P1|STARTED|Overall Study||203
8509523|NCT00445601|20972545|P2|NOT COMPLETED|Overall Study||28
8509524|NCT00445601|20972546|P1|NOT COMPLETED|Overall Study||33
8509525|NCT00445601|20972545|P2|COMPLETED|Overall Study||177
8509526|NCT00445601|20972546|P1|COMPLETED|Overall Study||168
8509527|NCT00445601|20972545|P2|Received TURBT|Overall Study||193
8509528|NCT00445601|20972546|P1|Received TURBT|Overall Study||190
8509529|NCT00445601|20972545|P2|STARTED|Overall Study||205
8509530|NCT00445601|20972546|P1|STARTED|Overall Study||201
8509531|NCT00445588|20972558|P1|NOT COMPLETED|Overall Study||0
8509532|NCT00445588|20972558|P1|COMPLETED|Overall Study||56
8509533|NCT00445588|20972558|P1|STARTED|Overall Study||56
8509534|NCT00445549|20972563|P1|NOT COMPLETED|Overall Study||12
8509535|NCT00445549|20972563|P1|COMPLETED|Overall Study||0
8509536|NCT00445549|20972563|P1|STARTED|Overall Study||12
8509537|NCT00445484|20972570|P2|NOT COMPLETED|Overall Study||1
8509538|NCT00445484|20972571|P1|NOT COMPLETED|Overall Study||4
8509539|NCT00445484|20972570|P2|COMPLETED|Overall Study||10
8509540|NCT00445484|20972571|P1|COMPLETED|Overall Study||7
8509541|NCT00445484|20972570|P2|STARTED|Overall Study||11
8509542|NCT00445484|20972571|P1|STARTED|Overall Study||11
8509543|NCT00445458|20972587|P4|NOT COMPLETED|Overall Study||28
8509544|NCT00445458|20972588|P3|NOT COMPLETED|Overall Study||68
8509545|NCT00445458|20972589|P2|NOT COMPLETED|Overall Study||5
8509546|NCT00445458|20972590|P1|NOT COMPLETED|Overall Study||3
8509547|NCT00445458|20972587|P4|COMPLETED|Overall Study||3
8509548|NCT00445458|20972588|P3|COMPLETED|Overall Study||3
8509549|NCT00445458|20972589|P2|COMPLETED|Overall Study||0
8509550|NCT00445458|20972590|P1|COMPLETED|Overall Study||0
8509551|NCT00445458|20972587|P4|STARTED|Overall Study||31
8509552|NCT00445458|20972588|P3|STARTED|Overall Study||71
8509553|NCT00445458|20972589|P2|STARTED|Overall Study||5
8509554|NCT00445458|20972590|P1|STARTED|Overall Study||3
8509555|NCT00445432|20972608|P4|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
8509556|NCT00445432|20972609|P3|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
8509557|NCT00445432|20972610|P2|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
8509558|NCT00445432|20972611|P1|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
8509559|NCT00445432|20972608|P4|COMPLETED|148 Weeks of Adalimumab Treatment||35
8509560|NCT00445432|20972609|P3|COMPLETED|148 Weeks of Adalimumab Treatment||0
8509561|NCT00445432|20972610|P2|COMPLETED|148 Weeks of Adalimumab Treatment||0
8509562|NCT00445432|20972611|P1|COMPLETED|148 Weeks of Adalimumab Treatment||0
8509563|NCT00445432|20972608|P4|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
8509564|NCT00445432|20972609|P3|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
8509565|NCT00445432|20972610|P2|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
8509566|NCT00445432|20972611|P1|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
8509567|NCT00445432|20972608|P4|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
8509568|NCT00445432|20972609|P3|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
8509569|NCT00445432|20972610|P2|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
8509570|NCT00445432|20972611|P1|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
8509571|NCT00445432|20972608|P4|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
8509572|NCT00445432|20972609|P3|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
8509573|NCT00445432|20972610|P2|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
8509574|NCT00445432|20972611|P1|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
8509575|NCT00445432|20972608|P4|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
8509576|NCT00445432|20972609|P3|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
8509577|NCT00445432|20972610|P2|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
8509578|NCT00445432|20972611|P1|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
8509579|NCT00445341|20972644|P1|NOT COMPLETED|Overall Study||2
8509580|NCT00445341|20972644|P1|COMPLETED|Overall Study||26
8509581|NCT00445341|20972644|P1|STARTED|Overall Study||28
8509582|NCT00445328|20972651|P2|NOT COMPLETED|Overall Study||6
8509583|NCT00445328|20972652|P1|NOT COMPLETED|Overall Study||3
8509584|NCT00445328|20972651|P2|COMPLETED|Overall Study||36
8509585|NCT00445328|20972652|P1|COMPLETED|Overall Study||39
8509586|NCT00445328|20972651|P2|Received Treatment|Overall Study||42
8509587|NCT00445328|20972652|P1|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
8509588|NCT00445328|20972651|P2|STARTED|Overall Study||42
8509589|NCT00445328|20972652|P1|STARTED|Overall Study||42
8509590|NCT00445315|20972675|P5|NOT COMPLETED|Overall Study||0
8509591|NCT00445315|20972676|P4|NOT COMPLETED|Overall Study||0
8509592|NCT00445315|20972677|P3|NOT COMPLETED|Overall Study||0
8509593|NCT00445315|20972678|P2|NOT COMPLETED|Overall Study||0
8509594|NCT00445315|20972679|P1|NOT COMPLETED|Overall Study||0
8509595|NCT00445315|20972675|P5|COMPLETED|Overall Study||8
8509596|NCT00445315|20972676|P4|COMPLETED|Overall Study||6
8509597|NCT00445315|20972677|P3|COMPLETED|Overall Study||6
8509598|NCT00445315|20972678|P2|COMPLETED|Overall Study||6
8509599|NCT00445315|20972679|P1|COMPLETED|Overall Study||6
8509600|NCT00445315|20972675|P5|STARTED|Overall Study||8
8509601|NCT00445315|20972676|P4|STARTED|Overall Study||6
8509602|NCT00445315|20972677|P3|STARTED|Overall Study||6
8509603|NCT00445315|20972678|P2|STARTED|Overall Study||6
8509604|NCT00445315|20972679|P1|STARTED|Overall Study||6
8509605|NCT00445302|20972773|P4|NOT COMPLETED|Overall Study||0
8509606|NCT00445302|20972774|P3|NOT COMPLETED|Overall Study||0
8509607|NCT00445302|20972775|P2|NOT COMPLETED|Overall Study||0
8509608|NCT00445302|20972776|P1|NOT COMPLETED|Overall Study||0
8509609|NCT00445302|20972773|P4|COMPLETED|Overall Study||6
8509610|NCT00445302|20972774|P3|COMPLETED|Overall Study||6
8509611|NCT00445302|20972775|P2|COMPLETED|Overall Study||5
8509612|NCT00445302|20972776|P1|COMPLETED|Overall Study||6
8509613|NCT00445302|20972773|P4|STARTED|Overall Study||6
8509614|NCT00445302|20972774|P3|STARTED|Overall Study||6
8509615|NCT00445302|20972775|P2|STARTED|Overall Study||5
8509616|NCT00445302|20972776|P1|STARTED|Overall Study||6
8509617|NCT00445263|20972804|P2|NOT COMPLETED|Overall Study||1
8509618|NCT00445263|20972805|P1|NOT COMPLETED|Overall Study||0
8509619|NCT00445263|20972804|P2|COMPLETED|Overall Study||86
8509620|NCT00445263|20972805|P1|COMPLETED|Overall Study||83
8509621|NCT00445263|20972804|P2|STARTED|Overall Study||87
8509622|NCT00445263|20972805|P1|STARTED|Overall Study||83
8509623|NCT00445224|20972813|P2|NOT COMPLETED|Combined Exercises||0
8509624|NCT00445224|20972814|P1|NOT COMPLETED|Combined Exercises||0
8509625|NCT00445224|20972813|P2|COMPLETED|Combined Exercises||13
8509626|NCT00445224|20972814|P1|COMPLETED|Combined Exercises||13
8509627|NCT00445224|20972813|P2|STARTED|Combined Exercises||13
8509628|NCT00445224|20972814|P1|STARTED|Combined Exercises||13
8509629|NCT00445224|20972813|P2|NOT COMPLETED|Specific Exercises||3
8509630|NCT00445224|20972814|P1|NOT COMPLETED|Specific Exercises||4
8509631|NCT00445224|20972813|P2|COMPLETED|Specific Exercises|No adverse event occurred|13
8509632|NCT00445224|20972814|P1|COMPLETED|Specific Exercises|No adverse event occurred|13
8509633|NCT00445224|20972813|P2|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
8509634|NCT00445224|20972814|P1|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
8509635|NCT00445224|20972813|P2|Baseline|Specific Exercises||16
8509636|NCT00445224|20972814|P1|Baseline|Specific Exercises||17
8509637|NCT00445224|20972813|P2|STARTED|Specific Exercises||16
8509638|NCT00445224|20972814|P1|STARTED|Specific Exercises||17
8509639|NCT00445211|20972826|P2|NOT COMPLETED|Overall Study||0
8509640|NCT00445211|20972827|P1|NOT COMPLETED|Overall Study||0
8509641|NCT00445211|20972826|P2|COMPLETED|Overall Study||23
8509642|NCT00445211|20972827|P1|COMPLETED|Overall Study||23
8509643|NCT00445211|20972826|P2|STARTED|Overall Study||23
8509644|NCT00445211|20972827|P1|STARTED|Overall Study||23
8509645|NCT00445146|20972841|P1|NOT COMPLETED|Overall Study||119
8509646|NCT00445146|20972841|P1|COMPLETED|Overall Study||73
8509647|NCT00445146|20972841|P1|STARTED|Overall Study||192
8509648|NCT00445003|20972863|P3|NOT COMPLETED|Overall Study||4
8509649|NCT00445003|20972864|P2|NOT COMPLETED|Overall Study||10
8509650|NCT00445003|20972865|P1|NOT COMPLETED|Overall Study||5
8509651|NCT00445003|20972863|P3|COMPLETED|Overall Study||105
8509652|NCT00445003|20972864|P2|COMPLETED|Overall Study||103
8509653|NCT00445003|20972865|P1|COMPLETED|Overall Study||118
8509654|NCT00445003|20972863|P3|STARTED|Overall Study||109
8509655|NCT00445003|20972864|P2|STARTED|Overall Study||113
8509656|NCT00445003|20972865|P1|STARTED|Overall Study||123
8509657|NCT00444964|20972894|P1|NOT COMPLETED|Overall Study||0
8509658|NCT00444964|20972894|P1|COMPLETED|Overall Study||11
8509659|NCT00444964|20972894|P1|STARTED|Overall Study||11
8509660|NCT00444951|20972903|P3|NOT COMPLETED|Overall Study||3
8509661|NCT00444951|20972904|P2|NOT COMPLETED|Overall Study||6
8509662|NCT00444951|20972905|P1|NOT COMPLETED|Overall Study||5
8509663|NCT00444951|20972903|P3|COMPLETED|Overall Study||160
8509664|NCT00444951|20972904|P2|COMPLETED|Overall Study||136
8509665|NCT00444951|20972905|P1|COMPLETED|Overall Study||140
8509666|NCT00444951|20972903|P3|STARTED|Overall Study||163
8509667|NCT00444951|20972904|P2|STARTED|Overall Study||142
8509668|NCT00444951|20972905|P1|STARTED|Overall Study||145
8509669|NCT00444925|20972922|P3|NOT COMPLETED|Double-blind Treatment Period||81
8509670|NCT00444925|20972923|P2|NOT COMPLETED|Double-blind Treatment Period||56
8509671|NCT00444925|20972924|P1|NOT COMPLETED|Double-blind Treatment Period||30
8509672|NCT00444925|20972922|P3|COMPLETED|Double-blind Treatment Period||598
8509673|NCT00444925|20972923|P2|COMPLETED|Double-blind Treatment Period||628
8509674|NCT00444925|20972924|P1|COMPLETED|Double-blind Treatment Period||304
8509675|NCT00444925|20972922|P3|STARTED|Double-blind Treatment Period||679
8509676|NCT00444925|20972923|P2|STARTED|Double-blind Treatment Period||684
8509677|NCT00444925|20972924|P1|STARTED|Double-blind Treatment Period||334
8509678|NCT00444925|20972922|P3|NOT COMPLETED|Randomized to Double-blind Treatment||6
8509679|NCT00444925|20972923|P2|NOT COMPLETED|Randomized to Double-blind Treatment||6
8509680|NCT00444925|20972924|P1|NOT COMPLETED|Randomized to Double-blind Treatment||3
8509681|NCT00444925|20972922|P3|COMPLETED|Randomized to Double-blind Treatment||679
8509682|NCT00444925|20972923|P2|COMPLETED|Randomized to Double-blind Treatment||684
8509683|NCT00444925|20972924|P1|COMPLETED|Randomized to Double-blind Treatment||334
8509684|NCT00444925|20972922|P3|STARTED|Randomized to Double-blind Treatment||685
8509685|NCT00444925|20972923|P2|STARTED|Randomized to Double-blind Treatment||690
8509686|NCT00444925|20972924|P1|STARTED|Randomized to Double-blind Treatment||337
8509687|NCT00444925|20972922|P3|NOT COMPLETED|Single-blind Placebo Run-In Period||0
8509688|NCT00444925|20972923|P2|NOT COMPLETED|Single-blind Placebo Run-In Period||0
8509689|NCT00444925|20972924|P1|NOT COMPLETED|Single-blind Placebo Run-In Period||734
8509690|NCT00444925|20972922|P3|COMPLETED|Single-blind Placebo Run-In Period||0
8509691|NCT00444925|20972923|P2|COMPLETED|Single-blind Placebo Run-In Period||0
8509692|NCT00444925|20972924|P1|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
8509693|NCT00444925|20972922|P3|STARTED|Single-blind Placebo Run-In Period||0
8509694|NCT00444925|20972923|P2|STARTED|Single-blind Placebo Run-In Period||0
8509695|NCT00444925|20972924|P1|STARTED|Single-blind Placebo Run-In Period||2446
8509696|NCT00444912|20972988|P2|NOT COMPLETED|Overall Study||2
8509697|NCT00444912|20972989|P1|NOT COMPLETED|Overall Study||3
8509698|NCT00444912|20972988|P2|COMPLETED|Overall Study||13
8509699|NCT00444912|20972989|P1|COMPLETED|Overall Study||12
8509700|NCT00444912|20972988|P2|Received Transplant|Overall Study||14
8509701|NCT00444912|20972989|P1|Received Transplant|Overall Study||14
8509702|NCT00444912|20972988|P2|Received Plerixafor|Overall Study||15
8509703|NCT00444912|20972989|P1|Received Plerixafor|Overall Study||15
8509704|NCT00444912|20972988|P2|STARTED|Overall Study||15
8509705|NCT00444912|20972989|P1|STARTED|Overall Study||15
8509706|NCT00444821|20973019|P2|NOT COMPLETED|Overall Study||366
8509707|NCT00444821|20973020|P1|NOT COMPLETED|Overall Study||362
8509708|NCT00444821|20973019|P2|COMPLETED|Overall Study||0
8509709|NCT00444821|20973020|P1|COMPLETED|Overall Study||0
8509710|NCT00444821|20973019|P2|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
8509711|NCT00444821|20973020|P1|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
8509712|NCT00444821|20973019|P2|STARTED|Overall Study||366
8509713|NCT00444821|20973020|P1|STARTED|Overall Study||362
8509714|NCT00444795|20973030|P1|NOT COMPLETED|Overall Study||3
8509715|NCT00444795|20973030|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
8509716|NCT00444795|20973030|P1|STARTED|Overall Study||620
8509717|NCT00444678|20973035|P1|NOT COMPLETED|Overall Study||31
8509718|NCT00444678|20973035|P1|COMPLETED|Overall Study||5
8509719|NCT00444678|20973035|P1|STARTED|Overall Study||36
8509720|NCT00444626|20973042|P1|NOT COMPLETED|Repeat Treatment Period||0
8509721|NCT00444626|20973042|P1|COMPLETED|Repeat Treatment Period||105
8509722|NCT00444626|20973042|P1|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
8509723|NCT00444626|20973042|P1|NOT COMPLETED|Initial Treatment Period||12
8509724|NCT00444626|20973042|P1|COMPLETED|Initial Treatment Period||128
8509725|NCT00444626|20973042|P1|STARTED|Initial Treatment Period||140
8509726|NCT00444600|20973072|P4|NOT COMPLETED|Overall Study||10
8509727|NCT00444600|20973073|P3|NOT COMPLETED|Overall Study||10
8509728|NCT00444600|20973074|P2|NOT COMPLETED|Overall Study||16
8509729|NCT00444600|20973075|P1|NOT COMPLETED|Overall Study||19
8509730|NCT00444600|20973072|P4|COMPLETED|Overall Study|Number of eyes|176
8509731|NCT00444600|20973073|P3|COMPLETED|Overall Study|Number of eyes|178
8509732|NCT00444600|20973074|P2|COMPLETED|Overall Study|Number of eyes|171
8509733|NCT00444600|20973075|P1|COMPLETED|Overall Study|Number of eyes|274
8509734|NCT00444600|20973072|P4|STARTED|Overall Study|Number of eyes|186
8509735|NCT00444600|20973073|P3|STARTED|Overall Study|Number of eyes|188
8509736|NCT00444600|20973074|P2|STARTED|Overall Study|Number of eyes|187
8509737|NCT00444600|20973075|P1|STARTED|Overall Study|Number of eyes|293
8509738|NCT00444587|20973167|P2|NOT COMPLETED|Overall Study||15
8509739|NCT00444587|20973168|P1|NOT COMPLETED|Overall Study||83
8509740|NCT00444587|20973167|P2|COMPLETED|Overall Study||1
8509741|NCT00444587|20973168|P1|COMPLETED|Overall Study||10
8509742|NCT00444587|20973167|P2|STARTED|Overall Study||16
8509743|NCT00444587|20973168|P1|STARTED|Overall Study||93
8509747|NCT00444457|20973200|P4|NOT COMPLETED|Toddler Dose||8
8509748|NCT00444457|20973201|P3|NOT COMPLETED|Toddler Dose||4
8509749|NCT00444457|20973202|P2|NOT COMPLETED|Toddler Dose||6
8509750|NCT00444457|20973203|P1|NOT COMPLETED|Toddler Dose||7
8509751|NCT00444457|20973200|P4|COMPLETED|Toddler Dose||200
8509752|NCT00444457|20973201|P3|COMPLETED|Toddler Dose||404
8509753|NCT00444457|20973202|P2|COMPLETED|Toddler Dose||391
8509754|NCT00444457|20973203|P1|COMPLETED|Toddler Dose||408
8509755|NCT00444457|20973200|P4|STARTED|Toddler Dose|Vaccinated toddler dose|208
8509756|NCT00444457|20973201|P3|STARTED|Toddler Dose|Vaccinated toddler dose|408
8509757|NCT00444457|20973202|P2|STARTED|Toddler Dose|Vaccinated toddler dose|397
8509758|NCT00444457|20973203|P1|STARTED|Toddler Dose|Vaccinated toddler dose|415
8509759|NCT00444457|20973200|P4|NOT COMPLETED|After Infant Series||10
8509760|NCT00444457|20973201|P3|NOT COMPLETED|After Infant Series||19
8509761|NCT00444457|20973202|P2|NOT COMPLETED|After Infant Series||30
8509762|NCT00444457|20973203|P1|NOT COMPLETED|After Infant Series||20
8509763|NCT00444457|20973200|P4|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
8509764|NCT00444457|20973201|P3|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
8509765|NCT00444457|20973202|P2|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
8509766|NCT00444457|20973203|P1|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
8509767|NCT00444457|20973200|P4|STARTED|After Infant Series||218
8509768|NCT00444457|20973201|P3|STARTED|After Infant Series||427
8509769|NCT00444457|20973202|P2|STARTED|After Infant Series||427
8509770|NCT00444457|20973203|P1|STARTED|After Infant Series||435
8509771|NCT00444457|20973200|P4|NOT COMPLETED|Infant Series||28
8509772|NCT00444457|20973201|P3|NOT COMPLETED|Infant Series||61
8509773|NCT00444457|20973202|P2|NOT COMPLETED|Infant Series||61
8509774|NCT00444457|20973203|P1|NOT COMPLETED|Infant Series||54
8509775|NCT00444457|20973200|P4|COMPLETED|Infant Series||218
8509776|NCT00444457|20973201|P3|COMPLETED|Infant Series||428
8509777|NCT00444457|20973202|P2|COMPLETED|Infant Series||427
8509778|NCT00444457|20973203|P1|COMPLETED|Infant Series||435
8509779|NCT00444457|20973200|P4|Vaccinated Dose 3|Infant Series||225
8509780|NCT00444457|20973201|P3|Vaccinated Dose 3|Infant Series||438
8509781|NCT00444457|20973202|P2|Vaccinated Dose 3|Infant Series||435
8509782|NCT00444457|20973203|P1|Vaccinated Dose 3|Infant Series||442
8509783|NCT00444457|20973200|P4|Vaccinated Dose 2|Infant Series||228
8509784|NCT00444457|20973201|P3|Vaccinated Dose 2|Infant Series||455
8509785|NCT00444457|20973202|P2|Vaccinated Dose 2|Infant Series||447
8509786|NCT00444457|20973203|P1|Vaccinated Dose 2|Infant Series||455
8509787|NCT00444457|20973200|P4|Vaccinated Dose 1|Infant Series||244
8509788|NCT00444457|20973201|P3|Vaccinated Dose 1|Infant Series||485
8509789|NCT00444457|20973202|P2|Vaccinated Dose 1|Infant Series||484
8509790|NCT00444457|20973203|P1|Vaccinated Dose 1|Infant Series||486
8509791|NCT00444457|20973200|P4|STARTED|Infant Series||246
8509792|NCT00444457|20973201|P3|STARTED|Infant Series||489
8509793|NCT00444457|20973202|P2|STARTED|Infant Series||488
8509794|NCT00444457|20973203|P1|STARTED|Infant Series||489
8509795|NCT00444275|20973268|P5|NOT COMPLETED|Maintenance Treatment Phase||179
8509796|NCT00444275|20973269|P4|NOT COMPLETED|Maintenance Treatment Phase||133
8509797|NCT00444275|20973270|P3|NOT COMPLETED|Maintenance Treatment Phase||161
8509798|NCT00444275|20973271|P2|NOT COMPLETED|Maintenance Treatment Phase||0
8509799|NCT00444275|20973272|P1|NOT COMPLETED|Maintenance Treatment Phase||0
8509800|NCT00444275|20973268|P5|COMPLETED|Maintenance Treatment Phase||701
8509801|NCT00444275|20973269|P4|COMPLETED|Maintenance Treatment Phase||764
8509802|NCT00444275|20973270|P3|COMPLETED|Maintenance Treatment Phase||747
8509803|NCT00444275|20973271|P2|COMPLETED|Maintenance Treatment Phase||0
8509804|NCT00444275|20973272|P1|COMPLETED|Maintenance Treatment Phase||0
8509805|NCT00444275|20973268|P5|STARTED|Maintenance Treatment Phase||880
8509806|NCT00444275|20973269|P4|STARTED|Maintenance Treatment Phase||897
8509807|NCT00444275|20973270|P3|STARTED|Maintenance Treatment Phase||908
8509808|NCT00444275|20973271|P2|STARTED|Maintenance Treatment Phase||0
8509809|NCT00444275|20973272|P1|STARTED|Maintenance Treatment Phase||0
8509810|NCT00444275|20973268|P5|NOT COMPLETED|Initial Treatment Phase||0
8509811|NCT00444275|20973269|P4|NOT COMPLETED|Initial Treatment Phase||0
8509812|NCT00444275|20973270|P3|NOT COMPLETED|Initial Treatment Phase||0
8509813|NCT00444275|20973271|P2|NOT COMPLETED|Initial Treatment Phase||96
8509814|NCT00444275|20973272|P1|NOT COMPLETED|Initial Treatment Phase||248
8509815|NCT00444275|20973268|P5|COMPLETED|Initial Treatment Phase||0
8509816|NCT00444275|20973269|P4|COMPLETED|Initial Treatment Phase||0
8509817|NCT00444275|20973270|P3|COMPLETED|Initial Treatment Phase||0
8509818|NCT00444275|20973271|P2|COMPLETED|Initial Treatment Phase||777
8509819|NCT00444275|20973272|P1|COMPLETED|Initial Treatment Phase||1908
8509820|NCT00444275|20973268|P5|STARTED|Initial Treatment Phase||0
8509821|NCT00444275|20973269|P4|STARTED|Initial Treatment Phase||0
8509822|NCT00444275|20973270|P3|STARTED|Initial Treatment Phase||0
8509823|NCT00444275|20973271|P2|STARTED|Initial Treatment Phase||873
8509824|NCT00444275|20973272|P1|STARTED|Initial Treatment Phase||2156
8509825|NCT00444145|20973322|P1|NOT COMPLETED|Overall Study||19
8509826|NCT00444145|20973322|P1|COMPLETED|Overall Study||19
8509827|NCT00444145|20973322|P1|STARTED|Overall Study||38
8509828|NCT00444106|20973329|P3|NOT COMPLETED|Overall Study||1
8509829|NCT00444106|20973330|P2|NOT COMPLETED|Overall Study||1
8509830|NCT00444106|20973331|P1|NOT COMPLETED|Overall Study||2
8509831|NCT00444106|20973329|P3|COMPLETED|Overall Study||52
8509832|NCT00444106|20973330|P2|COMPLETED|Overall Study||52
8509833|NCT00444106|20973331|P1|COMPLETED|Overall Study||157
8509834|NCT00444106|20973329|P3|Completed Treatment Period|Overall Study||53
8509835|NCT00444106|20973330|P2|Completed Treatment Period|Overall Study||53
8509836|NCT00444106|20973331|P1|Completed Treatment Period|Overall Study||159
8509837|NCT00444106|20973329|P3|STARTED|Overall Study||53
8509838|NCT00444106|20973330|P2|STARTED|Overall Study||53
8509839|NCT00444106|20973331|P1|STARTED|Overall Study||159
8509840|NCT00444080|20973348|P2|NOT COMPLETED|Overall Study||0
8509841|NCT00444080|20973349|P1|NOT COMPLETED|Overall Study||0
8509842|NCT00444080|20973348|P2|COMPLETED|Overall Study||59
8509843|NCT00444080|20973349|P1|COMPLETED|Overall Study||61
8509844|NCT00444080|20973348|P2|STARTED|Overall Study||59
8509845|NCT00444080|20973349|P1|STARTED|Overall Study||61
8509846|NCT00444067|20973363|P2|NOT COMPLETED|Overall Study||1
8509847|NCT00444067|20973364|P1|NOT COMPLETED|Overall Study||0
8509848|NCT00444067|20973363|P2|COMPLETED|Overall Study||23
8509849|NCT00444067|20973364|P1|COMPLETED|Overall Study||74
8509850|NCT00444067|20973363|P2|STARTED|Overall Study||24
8509851|NCT00444067|20973364|P1|STARTED|Overall Study||74
8509852|NCT00444028|20973380|P6|NOT COMPLETED|Overall Study||0
8509853|NCT00444028|20973381|P5|NOT COMPLETED|Overall Study||0
8509854|NCT00444028|20973382|P4|NOT COMPLETED|Overall Study||0
8509855|NCT00444028|20973383|P3|NOT COMPLETED|Overall Study||0
8509856|NCT00444028|20973384|P2|NOT COMPLETED|Overall Study||0
8509857|NCT00444028|20973385|P1|NOT COMPLETED|Overall Study||0
8509858|NCT00444028|20973380|P6|COMPLETED|Overall Study||8
8509859|NCT00444028|20973381|P5|COMPLETED|Overall Study||7
8509860|NCT00444028|20973382|P4|COMPLETED|Overall Study||6
8509861|NCT00444028|20973383|P3|COMPLETED|Overall Study||8
8509862|NCT00444028|20973384|P2|COMPLETED|Overall Study||7
8509863|NCT00444028|20973385|P1|COMPLETED|Overall Study||14
8509864|NCT00444028|20973380|P6|STARTED|Overall Study||8
8509865|NCT00444028|20973381|P5|STARTED|Overall Study||7
8509866|NCT00444028|20973382|P4|STARTED|Overall Study||6
8509867|NCT00444028|20973383|P3|STARTED|Overall Study||8
8509868|NCT00444028|20973384|P2|STARTED|Overall Study||7
8509869|NCT00444028|20973385|P1|STARTED|Overall Study||14
8509870|NCT00443898|20973427|P4|NOT COMPLETED|Overall Study||18
8509871|NCT00443898|20973428|P3|NOT COMPLETED|Overall Study||29
8509872|NCT00443898|20973429|P2|NOT COMPLETED|Overall Study||25
8509873|NCT00443898|20973430|P1|NOT COMPLETED|Overall Study||24
8509874|NCT00443898|20973427|P4|COMPLETED|Overall Study||110
8509875|NCT00443898|20973428|P3|COMPLETED|Overall Study||107
8509876|NCT00443898|20973429|P2|COMPLETED|Overall Study||103
8509877|NCT00443898|20973430|P1|COMPLETED|Overall Study||102
8509878|NCT00443898|20973427|P4|STARTED|Overall Study||128
8509879|NCT00443898|20973428|P3|STARTED|Overall Study||136
8509880|NCT00443898|20973429|P2|STARTED|Overall Study||128
8509881|NCT00443898|20973430|P1|STARTED|Overall Study||126
8509882|NCT00443872|20973452|P1|NOT COMPLETED|Overall Study||17
8509883|NCT00443872|20973452|P1|COMPLETED|Overall Study||60
8509884|NCT00443872|20973452|P1|STARTED|Overall Study||77
8509885|NCT00443846|20973467|P2|NOT COMPLETED|Overall Study||6
8509886|NCT00443846|20973468|P1|NOT COMPLETED|Overall Study||11
8509887|NCT00443846|20973467|P2|COMPLETED|Overall Study||117
8509888|NCT00443846|20973468|P1|COMPLETED|Overall Study||113
8509889|NCT00443846|20973467|P2|Vaccinated|Overall Study||123
8509890|NCT00443846|20973468|P1|Vaccinated|Overall Study||116
8509891|NCT00443846|20973467|P2|STARTED|Overall Study||123
8509892|NCT00443846|20973468|P1|STARTED|Overall Study||124
8509893|NCT00443820|20973478|P4|NOT COMPLETED|Overall Study||17
8509894|NCT00443820|20973479|P3|NOT COMPLETED|Overall Study||18
8509895|NCT00443820|20973480|P2|NOT COMPLETED|Overall Study||19
8509896|NCT00443820|20973481|P1|NOT COMPLETED|Overall Study||21
8509897|NCT00443820|20973478|P4|COMPLETED|Overall Study||111
8509898|NCT00443820|20973479|P3|COMPLETED|Overall Study||117
8509899|NCT00443820|20973480|P2|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
8509900|NCT00443820|20973481|P1|COMPLETED|Overall Study||112
8509901|NCT00443820|20973478|P4|Safety Population|Overall Study||126
8509902|NCT00443820|20973479|P3|Safety Population|Overall Study||134
8509903|NCT00443820|20973480|P2|Safety Population|Overall Study||129
8509904|NCT00443820|20973481|P1|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
8509905|NCT00443820|20973478|P4|STARTED|Overall Study||128
8509906|NCT00443820|20973479|P3|STARTED|Overall Study||135
8509907|NCT00443820|20973480|P2|STARTED|Overall Study||130
8509908|NCT00443820|20973481|P1|STARTED|Overall Study||133
8509909|NCT00443781|20973503|P1|NOT COMPLETED|Overall Study||25
8509910|NCT00443781|20973503|P1|COMPLETED|Overall Study||37
8509911|NCT00443781|20973503|P1|STARTED|Overall Study||62
8509912|NCT00443755|20973509|P2|NOT COMPLETED|Overall Study||1
8509913|NCT00443755|20973510|P1|NOT COMPLETED|Overall Study||2
8509914|NCT00443755|20973509|P2|COMPLETED|Overall Study||13
8509915|NCT00443755|20973510|P1|COMPLETED|Overall Study||12
8509916|NCT00443755|20973509|P2|STARTED|Overall Study||14
8509917|NCT00443755|20973510|P1|STARTED|Overall Study||14
8509918|NCT00443729|20973544|P2|NOT COMPLETED|Overall Study||7
8509919|NCT00443729|20973545|P1|NOT COMPLETED|Overall Study||10
8509920|NCT00443729|20973544|P2|COMPLETED|Overall Study||172
8509921|NCT00443729|20973545|P1|COMPLETED|Overall Study||166
8509922|NCT00443729|20973544|P2|Treated|Overall Study||178
8509923|NCT00443729|20973545|P1|Treated|Overall Study||176
8509924|NCT00443729|20973544|P2|STARTED|Overall Study||179
8509925|NCT00443729|20973545|P1|STARTED|Overall Study||176
8509926|NCT00443703|20973593|P2|NOT COMPLETED|Overall Study||18
8509927|NCT00443703|20973594|P1|NOT COMPLETED|Overall Study||28
8509928|NCT00443703|20973593|P2|COMPLETED|Overall Study||157
8509929|NCT00443703|20973594|P1|COMPLETED|Overall Study||149
8509930|NCT00443703|20973593|P2|Treated|Overall Study||174
8509931|NCT00443703|20973594|P1|Treated|Overall Study||174
8509932|NCT00443703|20973593|P2|STARTED|Overall Study||175
8509933|NCT00443703|20973594|P1|STARTED|Overall Study||177
8509934|NCT00443651|20973646|P2|NOT COMPLETED|Overall Study||58
8509935|NCT00443651|20973647|P1|NOT COMPLETED|Overall Study||95
8509936|NCT00443651|20973646|P2|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
8509937|NCT00443651|20973647|P1|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
8509938|NCT00443651|20973646|P2|Week 48|Overall Study||134
8509939|NCT00443651|20973647|P1|Week 48|Overall Study||338
8509940|NCT00443651|20973646|P2|Week 24|Overall Study||160
8509941|NCT00443651|20973647|P1|Week 24|Overall Study||376
8509942|NCT00443651|20973646|P2|STARTED|Overall Study||176
8509943|NCT00443651|20973647|P1|STARTED|Overall Study||401
8509950|NCT00443560|20973702|P2|NOT COMPLETED|Overall Study||30
8509951|NCT00443560|20973703|P1|NOT COMPLETED|Overall Study||60
8509952|NCT00443560|20973702|P2|COMPLETED|Overall Study||1051
8509953|NCT00443560|20973703|P1|COMPLETED|Overall Study||1021
8509954|NCT00443560|20973702|P2|STARTED|Overall Study||1081
8509955|NCT00443560|20973703|P1|STARTED|Overall Study||1081
8509956|NCT00443547|20973717|P4|NOT COMPLETED|Overall Study||2
8509957|NCT00443547|20973718|P3|NOT COMPLETED|Overall Study||21
8509958|NCT00443547|20973719|P2|NOT COMPLETED|Overall Study||42
8509959|NCT00443547|20973720|P1|NOT COMPLETED|Overall Study||45
8509960|NCT00443547|20973717|P4|COMPLETED|Overall Study||4
8509961|NCT00443547|20973718|P3|COMPLETED|Overall Study||27
8509962|NCT00443547|20973719|P2|COMPLETED|Overall Study||46
8509963|NCT00443547|20973720|P1|COMPLETED|Overall Study||44
8509964|NCT00443547|20973717|P4|Evaluated at 12 Months|Overall Study||5
8509965|NCT00443547|20973718|P3|Evaluated at 12 Months|Overall Study||37
8509966|NCT00443547|20973719|P2|Evaluated at 12 Months|Overall Study||55
8509967|NCT00443547|20973720|P1|Evaluated at 12 Months|Overall Study||58
8509968|NCT00443547|20973717|P4|STARTED|Overall Study|Enrolled and Treated Per Protocol|6
8509969|NCT00443547|20973718|P3|STARTED|Overall Study|Enrolled and Treated Per Protocol|48
8509970|NCT00443547|20973719|P2|STARTED|Overall Study|Enrolled and Treated Per Protocol|88
8509971|NCT00443547|20973720|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|89
8509972|NCT00443534|20973738|P1|NOT COMPLETED|Overall Study||123
8509973|NCT00443534|20973738|P1|COMPLETED|Overall Study||0
8509974|NCT00443534|20973738|P1|Treated|Overall Study||122
8509975|NCT00443534|20973738|P1|STARTED|Overall Study||123
8509976|NCT00443456|20973745|P1|NOT COMPLETED|Overall Study||18
8509977|NCT00443456|20973745|P1|COMPLETED|Overall Study||116
8509978|NCT00443456|20973745|P1|STARTED|Overall Study||134
8509979|NCT00443430|20973780|P2|NOT COMPLETED|Overall Study||4
8509980|NCT00443430|20973781|P1|NOT COMPLETED|Overall Study||4
8509981|NCT00443430|20973780|P2|COMPLETED|Overall Study||38
8509982|NCT00443430|20973781|P1|COMPLETED|Overall Study||39
8509983|NCT00443430|20973780|P2|STARTED|Overall Study||42
8509984|NCT00443430|20973781|P1|STARTED|Overall Study||43
8509985|NCT00443352|20973791|P1|NOT COMPLETED|Overall Study||5
8509986|NCT00443352|20973791|P1|COMPLETED|Overall Study||22
8509987|NCT00443352|20973791|P1|STARTED|Overall Study||27
8509988|NCT00443261|20973795|P1|NOT COMPLETED|Overall Study||1
8509989|NCT00443261|20973795|P1|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
8509990|NCT00443261|20973795|P1|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
8509991|NCT00443261|20973795|P1|STARTED|Overall Study||1
8509992|NCT00443209|20973801|P2|NOT COMPLETED|Months 13 to 18 Treatment Period||47
8509993|NCT00443209|20973802|P1|NOT COMPLETED|Months 13 to 18 Treatment Period||99
8509994|NCT00443209|20973801|P2|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
8509995|NCT00443209|20973802|P1|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
8509996|NCT00443209|20973801|P2|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
8509997|NCT00443209|20973802|P1|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
8509998|NCT00443209|20973801|P2|NOT COMPLETED|Months 1 to 12 Treatment Period||154
8509999|NCT00443209|20973802|P1|NOT COMPLETED|Months 1 to 12 Treatment Period||345
8510000|NCT00443209|20973801|P2|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
8510001|NCT00443209|20973802|P1|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
8510002|NCT00443209|20973801|P2|Treated|Months 1 to 12 Treatment Period||313
8510003|NCT00443209|20973802|P1|Treated|Months 1 to 12 Treatment Period||641
8510004|NCT00443209|20973801|P2|STARTED|Months 1 to 12 Treatment Period||356
8510005|NCT00443209|20973802|P1|STARTED|Months 1 to 12 Treatment Period||712
8510006|NCT00443118|20973819|P3|NOT COMPLETED|Overall Study||0
8510007|NCT00443118|20973820|P2|NOT COMPLETED|Overall Study||1
8510008|NCT00443118|20973821|P1|NOT COMPLETED|Overall Study||4
8510009|NCT00443118|20973819|P3|COMPLETED|Overall Study||226
8510010|NCT00443118|20973820|P2|COMPLETED|Overall Study||290
8510011|NCT00443118|20973821|P1|COMPLETED|Overall Study||511
8510012|NCT00443118|20973819|P3|STARTED|Overall Study||226
8510013|NCT00443118|20973820|P2|STARTED|Overall Study||291
8510014|NCT00443118|20973821|P1|STARTED|Overall Study||515
8510015|NCT00443053|20973870|P2|NOT COMPLETED|Overall Study||33
8510016|NCT00443053|20973871|P1|NOT COMPLETED|Overall Study||21
8510017|NCT00443053|20973870|P2|COMPLETED|Overall Study||1467
8510018|NCT00443053|20973871|P1|COMPLETED|Overall Study||1481
8510019|NCT00443053|20973870|P2|STARTED|Overall Study||1500
8510020|NCT00443053|20973871|P1|STARTED|Overall Study||1502
8510021|NCT00443040|20973892|P3|NOT COMPLETED|Overall Study||1
8510022|NCT00443040|20973893|P2|NOT COMPLETED|Overall Study||0
8510023|NCT00443040|20973894|P1|NOT COMPLETED|Overall Study||4
8510024|NCT00443040|20973892|P3|COMPLETED|Overall Study||9
8510025|NCT00443040|20973893|P2|COMPLETED|Overall Study||11
8510026|NCT00443040|20973894|P1|COMPLETED|Overall Study||10
8510027|NCT00443040|20973892|P3|STARTED|Overall Study||10
8510028|NCT00443040|20973893|P2|STARTED|Overall Study||11
8510029|NCT00443040|20973894|P1|STARTED|Overall Study||14
8510030|NCT00442962|20973902|P1|NOT COMPLETED|Overall Study||8
8510031|NCT00442962|20973902|P1|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
8510032|NCT00442962|20973902|P1|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
8510033|NCT00442962|20973902|P1|STARTED|Overall Study||54
8510034|NCT00442936|20973920|P4|NOT COMPLETED|Overall Study||1
8510035|NCT00442936|20973921|P3|NOT COMPLETED|Overall Study||1
8510036|NCT00442936|20973922|P2|NOT COMPLETED|Overall Study||0
8510037|NCT00442936|20973923|P1|NOT COMPLETED|Overall Study||1
8510038|NCT00442936|20973920|P4|COMPLETED|Overall Study||347
8510039|NCT00442936|20973921|P3|COMPLETED|Overall Study||344
8510040|NCT00442936|20973922|P2|COMPLETED|Overall Study||354
8510041|NCT00442936|20973923|P1|COMPLETED|Overall Study||332
8510042|NCT00442936|20973920|P4|STARTED|Overall Study||348
8510043|NCT00442936|20973921|P3|STARTED|Overall Study||345
8510044|NCT00442936|20973922|P2|STARTED|Overall Study||354
8510045|NCT00442936|20973923|P1|STARTED|Overall Study||333
8510046|NCT00442897|20973971|P2|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
8510047|NCT00442897|20973972|P1|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
8510048|NCT00442897|20973971|P2|COMPLETED|24 Weeks Follow-up (3 Centers)||28
8510049|NCT00442897|20973972|P1|COMPLETED|24 Weeks Follow-up (3 Centers)||29
8510050|NCT00442897|20973971|P2|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
8510051|NCT00442897|20973972|P1|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
8510052|NCT00442897|20973971|P2|NOT COMPLETED|Base Study (12 Week Follow-up)||12
8510053|NCT00442897|20973972|P1|NOT COMPLETED|Base Study (12 Week Follow-up)||17
8510054|NCT00442897|20973971|P2|COMPLETED|Base Study (12 Week Follow-up)||99
8510055|NCT00442897|20973972|P1|COMPLETED|Base Study (12 Week Follow-up)||101
8510056|NCT00442897|20973971|P2|STARTED|Base Study (12 Week Follow-up)||111
8510057|NCT00442897|20973972|P1|STARTED|Base Study (12 Week Follow-up)||118
8510058|NCT00442767|20973980|P1|NOT COMPLETED|Overall Study||0
8510059|NCT00442767|20973980|P1|COMPLETED|Overall Study||8
8510060|NCT00442767|20973980|P1|STARTED|Overall Study||8
8510061|NCT00442702|20973990|P2|NOT COMPLETED|Evaluation Period||4
8510062|NCT00442702|20973991|P1|NOT COMPLETED|Evaluation Period||5
8510063|NCT00442702|20973990|P2|COMPLETED|Evaluation Period||107
8510064|NCT00442702|20973991|P1|COMPLETED|Evaluation Period||97
8510065|NCT00442702|20973990|P2|STARTED|Evaluation Period||111
8510066|NCT00442702|20973991|P1|STARTED|Evaluation Period||102
8510067|NCT00442702|20973990|P2|NOT COMPLETED|Titration Period||3
8510068|NCT00442702|20973991|P1|NOT COMPLETED|Titration Period||12
8510069|NCT00442702|20973990|P2|COMPLETED|Titration Period||111
8510070|NCT00442702|20973991|P1|COMPLETED|Titration Period||102
8510071|NCT00442702|20973990|P2|Safety Population|Titration Period||113
8510072|NCT00442702|20973991|P1|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
8510073|NCT00442702|20973990|P2|STARTED|Titration Period||114
8510074|NCT00442702|20973991|P1|STARTED|Titration Period||114
8510075|NCT00442689|20974006|P3|NOT COMPLETED|Overall Study||9
8510076|NCT00442689|20974007|P2|NOT COMPLETED|Overall Study||11
8510077|NCT00442689|20974008|P1|NOT COMPLETED|Overall Study||10
8510078|NCT00442689|20974006|P3|COMPLETED|Overall Study||13
8510079|NCT00442689|20974007|P2|COMPLETED|Overall Study||13
8510080|NCT00442689|20974008|P1|COMPLETED|Overall Study||11
8510081|NCT00442689|20974006|P3|STARTED|Overall Study||22
8510082|NCT00442689|20974007|P2|STARTED|Overall Study||24
8510083|NCT00442689|20974008|P1|STARTED|Overall Study||21
8510084|NCT00442611|20974036|P2|NOT COMPLETED|Overall Study||0
8510085|NCT00442611|20974037|P1|NOT COMPLETED|Overall Study||1
8510086|NCT00442611|20974036|P2|COMPLETED|Overall Study||3
8510087|NCT00442611|20974037|P1|COMPLETED|Overall Study||6
8510088|NCT00442611|20974036|P2|STARTED|Overall Study||3
8510089|NCT00442611|20974037|P1|STARTED|Overall Study||7
8510090|NCT00442598|20974056|P3|NOT COMPLETED|Overall Study||0
8510091|NCT00442598|20974057|P2|NOT COMPLETED|Overall Study||8
8510092|NCT00442598|20974058|P1|NOT COMPLETED|Overall Study||6
8510093|NCT00442598|20974056|P3|COMPLETED|Overall Study||0
8510094|NCT00442598|20974057|P2|COMPLETED|Overall Study||2
8510095|NCT00442598|20974058|P1|COMPLETED|Overall Study||1
8510096|NCT00442598|20974056|P3|Two Cycles|Overall Study||0
8510097|NCT00442598|20974057|P2|Two Cycles|Overall Study||6
8510098|NCT00442598|20974058|P1|Two Cycles|Overall Study||5
8510099|NCT00442598|20974056|P3|STARTED|Overall Study||0
8510100|NCT00442598|20974057|P2|STARTED|Overall Study||10
8510101|NCT00442598|20974058|P1|STARTED|Overall Study||7
8510102|NCT00442572|20974076|P2|NOT COMPLETED|Overall Study||3
8510103|NCT00442572|20974077|P1|NOT COMPLETED|Overall Study||8
8510104|NCT00442572|20974076|P2|COMPLETED|Overall Study||1
8510105|NCT00442572|20974077|P1|COMPLETED|Overall Study||9
8510106|NCT00442572|20974076|P2|STARTED|Overall Study||4
8510107|NCT00442572|20974077|P1|STARTED|Overall Study||17
8510108|NCT00442559|20974117|P2|NOT COMPLETED|Overall Study||35
8510109|NCT00442559|20974118|P1|NOT COMPLETED|Overall Study||34
8510110|NCT00442559|20974117|P2|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
8510111|NCT00442559|20974118|P1|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
8510112|NCT00442559|20974117|P2|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
8510113|NCT00442559|20974118|P1|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
8510114|NCT00442559|20974117|P2|STARTED|Overall Study||91
8510115|NCT00442559|20974118|P1|STARTED|Overall Study||100
8510116|NCT00442546|20974133|P3|NOT COMPLETED|Overall Study||33
8510117|NCT00442546|20974134|P2|NOT COMPLETED|Overall Study||37
8510118|NCT00442546|20974135|P1|NOT COMPLETED|Overall Study||26
8510119|NCT00442546|20974133|P3|COMPLETED|Overall Study||71
8510120|NCT00442546|20974134|P2|COMPLETED|Overall Study||63
8510121|NCT00442546|20974135|P1|COMPLETED|Overall Study||77
8510122|NCT00442546|20974133|P3|Received Treatment|Overall Study||98
8510123|NCT00442546|20974134|P2|Received Treatment|Overall Study||96
8510124|NCT00442546|20974135|P1|Received Treatment|Overall Study||98
8510125|NCT00442546|20974133|P3|STARTED|Overall Study||104
8510126|NCT00442546|20974134|P2|STARTED|Overall Study||100
8510127|NCT00442546|20974135|P1|STARTED|Overall Study||103
8510128|NCT00442507|20974257|P1|NOT COMPLETED|Overall Study||0
8510129|NCT00442507|20974257|P1|COMPLETED|Overall Study||6
8510130|NCT00442507|20974257|P1|STARTED|Overall Study||6
8510131|NCT00442468|20974264|P1|NOT COMPLETED|Overall Study||183
8510132|NCT00442468|20974264|P1|COMPLETED|Overall Study||1100
8510133|NCT00442468|20974264|P1|STARTED|Overall Study||1283
8510134|NCT00442416|20974294|P2|NOT COMPLETED|Overall Study||39
8510135|NCT00442416|20974295|P1|NOT COMPLETED|Overall Study||37
8510136|NCT00442416|20974294|P2|COMPLETED|Overall Study||2
8510137|NCT00442416|20974295|P1|COMPLETED|Overall Study||2
8510138|NCT00442416|20974294|P2|STARTED|Overall Study||41
8510139|NCT00442416|20974295|P1|STARTED|Overall Study||39
8510143|NCT00442351|20974334|P2|NOT COMPLETED|Overall Study||6
8510144|NCT00442351|20974335|P1|NOT COMPLETED|Overall Study||7
8510145|NCT00442351|20974334|P2|COMPLETED|Overall Study||3
8510146|NCT00442351|20974335|P1|COMPLETED|Overall Study||10
8510147|NCT00442351|20974334|P2|STARTED|Overall Study||9
8510148|NCT00442351|20974335|P1|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
8510149|NCT00442338|20974344|P3|NOT COMPLETED|Overall Study||0
8510150|NCT00442338|20974345|P2|NOT COMPLETED|Overall Study||0
8510151|NCT00442338|20974346|P1|NOT COMPLETED|Overall Study||0
8510152|NCT00442338|20974344|P3|COMPLETED|Overall Study||31
8510153|NCT00442338|20974345|P2|COMPLETED|Overall Study||30
8510154|NCT00442338|20974346|P1|COMPLETED|Overall Study||30
8510155|NCT00442338|20974344|P3|STARTED|Overall Study||31
8510156|NCT00442338|20974345|P2|STARTED|Overall Study||30
8510157|NCT00442338|20974346|P1|STARTED|Overall Study||30
8510158|NCT00442286|20974357|P2|NOT COMPLETED|Overall Study||2
8510159|NCT00442286|20974358|P1|NOT COMPLETED|Overall Study||7
8510160|NCT00442286|20974357|P2|COMPLETED|Overall Study||82
8510161|NCT00442286|20974358|P1|COMPLETED|Overall Study||174
8510162|NCT00442286|20974357|P2|12 Months|Overall Study||82
8510163|NCT00442286|20974358|P1|12 Months|Overall Study||174
8510164|NCT00442286|20974357|P2|6 Months|Overall Study||83
8510165|NCT00442286|20974358|P1|6 Months|Overall Study||177
8510166|NCT00442286|20974357|P2|STARTED|Overall Study||84
8510167|NCT00442286|20974358|P1|STARTED|Overall Study||181
8510168|NCT00442260|20974369|P1|NOT COMPLETED|Overall Study||0
8510169|NCT00442260|20974369|P1|COMPLETED|Overall Study||2
8510170|NCT00442260|20974369|P1|STARTED|Overall Study||2
8510171|NCT00442169|20974379|P6|NOT COMPLETED|Part 2||0
8510172|NCT00442169|20974380|P5|NOT COMPLETED|Part 2||0
8510173|NCT00442169|20974381|P4|NOT COMPLETED|Part 2||0
8510174|NCT00442169|20974382|P3|NOT COMPLETED|Part 2||0
8510175|NCT00442169|20974383|P2|NOT COMPLETED|Part 2||0
8510176|NCT00442169|20974384|P1|NOT COMPLETED|Part 2||0
8510177|NCT00442169|20974379|P6|COMPLETED|Part 2||57
8510178|NCT00442169|20974380|P5|COMPLETED|Part 2||25
8510179|NCT00442169|20974381|P4|COMPLETED|Part 2||0
8510180|NCT00442169|20974382|P3|COMPLETED|Part 2||0
8510181|NCT00442169|20974383|P2|COMPLETED|Part 2||0
8510182|NCT00442169|20974384|P1|COMPLETED|Part 2||0
8510183|NCT00442169|20974379|P6|STARTED|Part 2||57
8510184|NCT00442169|20974380|P5|STARTED|Part 2||25
8510185|NCT00442169|20974381|P4|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
8510186|NCT00442169|20974382|P3|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
8510187|NCT00442169|20974383|P2|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
8510188|NCT00442169|20974384|P1|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
8510189|NCT00442169|20974379|P6|NOT COMPLETED|Part 1||0
8510190|NCT00442169|20974380|P5|NOT COMPLETED|Part 1||0
8510191|NCT00442169|20974381|P4|NOT COMPLETED|Part 1||0
8510192|NCT00442169|20974382|P3|NOT COMPLETED|Part 1||0
8510193|NCT00442169|20974383|P2|NOT COMPLETED|Part 1||0
8510194|NCT00442169|20974384|P1|NOT COMPLETED|Part 1||0
8510195|NCT00442169|20974379|P6|COMPLETED|Part 1||0
8510196|NCT00442169|20974380|P5|COMPLETED|Part 1||0
8510197|NCT00442169|20974381|P4|COMPLETED|Part 1||31
8510198|NCT00442169|20974382|P3|COMPLETED|Part 1||40
8510199|NCT00442169|20974383|P2|COMPLETED|Part 1||24
8510200|NCT00442169|20974384|P1|COMPLETED|Part 1||17
8510201|NCT00442169|20974379|P6|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
8510202|NCT00442169|20974380|P5|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
8510203|NCT00442169|20974381|P4|STARTED|Part 1||31
8510204|NCT00442169|20974382|P3|STARTED|Part 1||40
8510205|NCT00442169|20974383|P2|STARTED|Part 1||24
8510206|NCT00442169|20974384|P1|STARTED|Part 1||17
8510207|NCT00442117|20974424|P2|NOT COMPLETED|Overall Study||38
8510208|NCT00442117|20974425|P1|NOT COMPLETED|Overall Study||38
8510209|NCT00442117|20974424|P2|COMPLETED|Overall Study||49
8510210|NCT00442117|20974425|P1|COMPLETED|Overall Study||47
8510211|NCT00442117|20974424|P2|STARTED|Overall Study||87
8510212|NCT00442117|20974425|P1|STARTED|Overall Study||85
8510213|NCT00442013|20974439|P2|NOT COMPLETED|Overall Study||17
8510214|NCT00442013|20974440|P1|NOT COMPLETED|Overall Study||26
8510215|NCT00442013|20974439|P2|COMPLETED|Overall Study||132
8510216|NCT00442013|20974440|P1|COMPLETED|Overall Study||131
8510217|NCT00442013|20974439|P2|STARTED|Overall Study||149
8510218|NCT00442013|20974440|P1|STARTED|Overall Study||157
8510219|NCT00441974|20974456|P1|NOT COMPLETED|Overall Study||128
8510220|NCT00441974|20974456|P1|COMPLETED|Overall Study||1342
8510221|NCT00441974|20974456|P1|STARTED|Overall Study||1470
8510222|NCT00441883|20974475|P5|NOT COMPLETED|Overall Study||2
8510223|NCT00441883|20974476|P4|NOT COMPLETED|Overall Study||0
8510224|NCT00441883|20974477|P3|NOT COMPLETED|Overall Study||0
8510225|NCT00441883|20974478|P2|NOT COMPLETED|Overall Study||0
8510226|NCT00441883|20974479|P1|NOT COMPLETED|Overall Study||1
8510227|NCT00441883|20974475|P5|COMPLETED|Overall Study||43
8510228|NCT00441883|20974476|P4|COMPLETED|Overall Study||28
8510229|NCT00441883|20974477|P3|COMPLETED|Overall Study||28
8510230|NCT00441883|20974478|P2|COMPLETED|Overall Study||32
8510231|NCT00441883|20974479|P1|COMPLETED|Overall Study||42
8510232|NCT00441883|20974475|P5|Safety Population|Overall Study||45
8510233|NCT00441883|20974476|P4|Safety Population|Overall Study||28
8510234|NCT00441883|20974477|P3|Safety Population|Overall Study||28
8510235|NCT00441883|20974478|P2|Safety Population|Overall Study||32
8510236|NCT00441883|20974479|P1|Safety Population|Overall Study||43
8510237|NCT00441883|20974475|P5|Per Protocol Population|Overall Study||38
8510238|NCT00441883|20974476|P4|Per Protocol Population|Overall Study||24
8510239|NCT00441883|20974477|P3|Per Protocol Population|Overall Study||25
8510240|NCT00441883|20974478|P2|Per Protocol Population|Overall Study||29
8510241|NCT00441883|20974479|P1|Per Protocol Population|Overall Study||38
8510242|NCT00441883|20974475|P5|ITT Population|Overall Study||43
8510243|NCT00441883|20974476|P4|ITT Population|Overall Study||30
8510244|NCT00441883|20974477|P3|ITT Population|Overall Study||30
8510245|NCT00441883|20974478|P2|ITT Population|Overall Study||30
8510246|NCT00441883|20974479|P1|ITT Population|Overall Study||43
8510247|NCT00441883|20974475|P5|STARTED|Overall Study||45
8510248|NCT00441883|20974476|P4|STARTED|Overall Study||28
8510249|NCT00441883|20974477|P3|STARTED|Overall Study||28
8510250|NCT00441883|20974478|P2|STARTED|Overall Study||32
8510251|NCT00441883|20974479|P1|STARTED|Overall Study||43
8510252|NCT00441792|20974503|P2|NOT COMPLETED|Overall Study||2
8510253|NCT00441792|20974504|P1|NOT COMPLETED|Overall Study||0
8510254|NCT00441792|20974503|P2|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
8510255|NCT00441792|20974504|P1|COMPLETED|Overall Study||59
8510256|NCT00441792|20974503|P2|STARTED|Overall Study||63
8510257|NCT00441792|20974504|P1|STARTED|Overall Study||59
8510258|NCT00441766|20974516|P4|NOT COMPLETED|Overall Study||6
8510259|NCT00441766|20974517|P3|NOT COMPLETED|Overall Study||9
8510260|NCT00441766|20974518|P2|NOT COMPLETED|Overall Study||7
8510261|NCT00441766|20974519|P1|NOT COMPLETED|Overall Study||14
8510262|NCT00441766|20974516|P4|COMPLETED|Overall Study||48
8510263|NCT00441766|20974517|P3|COMPLETED|Overall Study||44
8510264|NCT00441766|20974518|P2|COMPLETED|Overall Study||46
8510265|NCT00441766|20974519|P1|COMPLETED|Overall Study||39
8510266|NCT00441766|20974516|P4|STARTED|Overall Study||54
8510267|NCT00441766|20974517|P3|STARTED|Overall Study||53
8510268|NCT00441766|20974518|P2|STARTED|Overall Study||53
8510269|NCT00441766|20974519|P1|STARTED|Overall Study||53
8510270|NCT00441727|20974544|P3|NOT COMPLETED|Overall Study||168
8510271|NCT00441727|20974545|P2|NOT COMPLETED|Overall Study||118
8510272|NCT00441727|20974546|P1|NOT COMPLETED|Overall Study||106
8510273|NCT00441727|20974544|P3|COMPLETED|Overall Study|ITT/randomised|637
8510274|NCT00441727|20974545|P2|COMPLETED|Overall Study|ITT/randomised|686
8510275|NCT00441727|20974546|P1|COMPLETED|Overall Study|ITT/randomised|711
8510276|NCT00441727|20974544|P3|STARTED|Overall Study|ITT/randomised|805
8510277|NCT00441727|20974545|P2|STARTED|Overall Study|ITT/randomised|804
8510278|NCT00441727|20974546|P1|STARTED|Overall Study|ITT/randomised|817
8510279|NCT00441701|20974579|P10|NOT COMPLETED|Overall Study||0
8510280|NCT00441701|20974580|P9|NOT COMPLETED|Overall Study||0
8510281|NCT00441701|20974581|P8|NOT COMPLETED|Overall Study||0
8510282|NCT00441701|20974582|P7|NOT COMPLETED|Overall Study||0
8510283|NCT00441701|20974583|P6|NOT COMPLETED|Overall Study||3
8510284|NCT00441701|20974584|P5|NOT COMPLETED|Overall Study||2
8510285|NCT00441701|20974585|P4|NOT COMPLETED|Overall Study||3
8510286|NCT00441701|20974586|P3|NOT COMPLETED|Overall Study||4
8510287|NCT00441701|20974587|P2|NOT COMPLETED|Overall Study||4
8510288|NCT00441701|20974588|P1|NOT COMPLETED|Overall Study||5
8510289|NCT00441701|20974579|P10|COMPLETED|Overall Study||0
8510290|NCT00441701|20974580|P9|COMPLETED|Overall Study||0
8510291|NCT00441701|20974581|P8|COMPLETED|Overall Study||0
8510292|NCT00441701|20974582|P7|COMPLETED|Overall Study||0
8510293|NCT00441701|20974583|P6|COMPLETED|Overall Study||8
8510294|NCT00441701|20974584|P5|COMPLETED|Overall Study||20
8510295|NCT00441701|20974585|P4|COMPLETED|Overall Study||8
8510296|NCT00441701|20974586|P3|COMPLETED|Overall Study||18
8510297|NCT00441701|20974587|P2|COMPLETED|Overall Study||7
8510298|NCT00441701|20974588|P1|COMPLETED|Overall Study||17
8510299|NCT00441701|20974579|P10|STARTED|Overall Study||0
8510300|NCT00441701|20974580|P9|STARTED|Overall Study||0
8510301|NCT00441701|20974581|P8|STARTED|Overall Study||0
8510302|NCT00441701|20974582|P7|STARTED|Overall Study||0
8510303|NCT00441701|20974583|P6|STARTED|Overall Study||11
8510304|NCT00441701|20974584|P5|STARTED|Overall Study||22
8510305|NCT00441701|20974585|P4|STARTED|Overall Study||11
8510306|NCT00441701|20974586|P3|STARTED|Overall Study||22
8510307|NCT00441701|20974587|P2|STARTED|Overall Study||11
8510308|NCT00441701|20974588|P1|STARTED|Overall Study||22
8510309|NCT00441584|20974670|P1|NOT COMPLETED|Overall Study||105
8510310|NCT00441584|20974670|P1|COMPLETED|Overall Study||12
8510311|NCT00441584|20974670|P1|STARTED|Overall Study||117
8510312|NCT00441558|20974674|P1|NOT COMPLETED|Overall Study||1056
8510313|NCT00441558|20974674|P1|COMPLETED|Overall Study||667
8510314|NCT00441558|20974674|P1|STARTED|Overall Study||1723
8510333|NCT00441480|20974693|P2|NOT COMPLETED|Overall Study||4
8510334|NCT00441480|20974694|P1|NOT COMPLETED|Overall Study||3
8510335|NCT00441480|20974693|P2|COMPLETED|Overall Study||41
8510336|NCT00441480|20974694|P1|COMPLETED|Overall Study||43
8510337|NCT00441480|20974693|P2|STARTED|Overall Study||45
8510338|NCT00441480|20974694|P1|STARTED|Overall Study||46
8510339|NCT00441467|20974726|P1|NOT COMPLETED|Overall Study||18
8510340|NCT00441467|20974726|P1|COMPLETED|Overall Study||4
8510341|NCT00441467|20974726|P1|4 Cycles|Overall Study||7
8510342|NCT00441467|20974726|P1|2 Cycles|Overall Study||17
8510343|NCT00441467|20974726|P1|STARTED|Overall Study||22
8510344|NCT00441441|20974734|P2|NOT COMPLETED|Overall Study||14
8510345|NCT00441441|20974735|P1|NOT COMPLETED|Overall Study||11
8510346|NCT00441441|20974734|P2|COMPLETED|Overall Study||163
8510347|NCT00441441|20974735|P1|COMPLETED|Overall Study||162
8510348|NCT00441441|20974734|P2|STARTED|Overall Study||177
8510349|NCT00441441|20974735|P1|STARTED|Overall Study||173
8510350|NCT00441363|20974795|P2|NOT COMPLETED|Overall Study||15
8510351|NCT00441363|20974796|P1|NOT COMPLETED|Overall Study||17
8510352|NCT00441363|20974795|P2|COMPLETED|Overall Study||19
8510353|NCT00441363|20974796|P1|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
8510354|NCT00441363|20974795|P2|STARTED|Overall Study||34
8510355|NCT00441363|20974796|P1|STARTED|Overall Study||32
8510356|NCT00441337|20974808|P4|NOT COMPLETED|Overall Study||21
8510357|NCT00441337|20974809|P3|NOT COMPLETED|Overall Study||6
8510358|NCT00441337|20974810|P2|NOT COMPLETED|Overall Study||6
8510359|NCT00441337|20974811|P1|NOT COMPLETED|Overall Study||6
8510360|NCT00441337|20974808|P4|COMPLETED|Overall Study||0
8510361|NCT00441337|20974809|P3|COMPLETED|Overall Study||0
8510362|NCT00441337|20974810|P2|COMPLETED|Overall Study||0
8510363|NCT00441337|20974811|P1|COMPLETED|Overall Study||0
8510364|NCT00441337|20974808|P4|STARTED|Overall Study||21
8510365|NCT00441337|20974809|P3|STARTED|Overall Study||6
8510366|NCT00441337|20974810|P2|STARTED|Overall Study||6
8510367|NCT00441337|20974811|P1|STARTED|Overall Study||6
8510368|NCT00441285|20974894|P5|NOT COMPLETED|Overall Study||0
8510369|NCT00441285|20974895|P4|NOT COMPLETED|Overall Study||0
8510370|NCT00441285|20974896|P3|NOT COMPLETED|Overall Study||0
8510371|NCT00441285|20974897|P2|NOT COMPLETED|Overall Study||0
8510372|NCT00441285|20974898|P1|NOT COMPLETED|Overall Study||0
8510373|NCT00441285|20974894|P5|COMPLETED|Overall Study||43
8510374|NCT00441285|20974895|P4|COMPLETED|Overall Study||40
8510375|NCT00441285|20974896|P3|COMPLETED|Overall Study||41
8510376|NCT00441285|20974897|P2|COMPLETED|Overall Study||16
8510377|NCT00441285|20974898|P1|COMPLETED|Overall Study||16
8510378|NCT00441285|20974894|P5|STARTED|Overall Study||43
8510379|NCT00441285|20974895|P4|STARTED|Overall Study||40
8510380|NCT00441285|20974896|P3|STARTED|Overall Study||41
8510381|NCT00441285|20974897|P2|STARTED|Overall Study||16
8510382|NCT00441285|20974898|P1|STARTED|Overall Study||16
8510383|NCT00441272|20974924|P2|NOT COMPLETED|Overall Study||25
8510384|NCT00441272|20974925|P1|NOT COMPLETED|Overall Study||25
8510385|NCT00441272|20974924|P2|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
8510386|NCT00441272|20974925|P1|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
8510387|NCT00441272|20974924|P2|STARTED|Overall Study||25
8510388|NCT00441272|20974925|P1|STARTED|Overall Study||25
8510389|NCT00441259|20974933|P2|NOT COMPLETED|Overall Study||0
8510390|NCT00441259|20974934|P1|NOT COMPLETED|Overall Study||0
8510391|NCT00441259|20974933|P2|COMPLETED|Overall Study||48
8510392|NCT00441259|20974934|P1|COMPLETED|Overall Study||48
8510393|NCT00441259|20974933|P2|STARTED|Overall Study||48
8510394|NCT00441259|20974934|P1|STARTED|Overall Study||48
8510395|NCT00441168|20974952|P2|NOT COMPLETED|Follow-up Period||9
8510396|NCT00441168|20974953|P1|NOT COMPLETED|Follow-up Period||12
8510397|NCT00441168|20974952|P2|COMPLETED|Follow-up Period||4
8510398|NCT00441168|20974953|P1|COMPLETED|Follow-up Period||5
8510485|NCT00440947|20975171|P1|COMPLETED|Optional 60-Week Extension Phase||0
8510399|NCT00441168|20974952|P2|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
8510400|NCT00441168|20974953|P1|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
8510401|NCT00441168|20974952|P2|NOT COMPLETED|Treatment Period||6
8510402|NCT00441168|20974953|P1|NOT COMPLETED|Treatment Period||11
8510403|NCT00441168|20974952|P2|COMPLETED|Treatment Period||7
8510404|NCT00441168|20974953|P1|COMPLETED|Treatment Period||6
8510405|NCT00441168|20974952|P2|TREATED|Treatment Period||13
8510406|NCT00441168|20974953|P1|TREATED|Treatment Period||16
8510407|NCT00441168|20974952|P2|STARTED|Treatment Period||13
8510408|NCT00441168|20974953|P1|STARTED|Treatment Period||17
8510409|NCT00441142|20974967|P4|NOT COMPLETED|Overall Study||68
8510410|NCT00441142|20974968|P3|NOT COMPLETED|Overall Study||22
8510411|NCT00441142|20974969|P2|NOT COMPLETED|Overall Study||7
8510412|NCT00441142|20974970|P1|NOT COMPLETED|Overall Study||6
8510413|NCT00441142|20974967|P4|COMPLETED|Overall Study||1
8510414|NCT00441142|20974968|P3|COMPLETED|Overall Study||7
8510415|NCT00441142|20974969|P2|COMPLETED|Overall Study||0
8510416|NCT00441142|20974970|P1|COMPLETED|Overall Study||0
8510417|NCT00441142|20974967|P4|STARTED|Overall Study||69
8510418|NCT00441142|20974968|P3|STARTED|Overall Study||29
8510419|NCT00441142|20974969|P2|STARTED|Overall Study||7
8510420|NCT00441142|20974970|P1|STARTED|Overall Study||6
8510421|NCT00441129|20974992|P2|NOT COMPLETED|Overall Study||14
8510422|NCT00441129|20974993|P1|NOT COMPLETED|Overall Study||6
8510423|NCT00441129|20974992|P2|COMPLETED|Overall Study||41
8510424|NCT00441129|20974993|P1|COMPLETED|Overall Study||54
8510425|NCT00441129|20974992|P2|STARTED|Overall Study||55
8510426|NCT00441129|20974993|P1|STARTED|Overall Study||60
8510427|NCT00441116|20975005|P2|NOT COMPLETED|Overall Study||2
8510428|NCT00441116|20975006|P1|NOT COMPLETED|Overall Study||3
8510429|NCT00441116|20975005|P2|COMPLETED|Overall Study||75
8510430|NCT00441116|20975006|P1|COMPLETED|Overall Study||73
8510431|NCT00441116|20975005|P2|STARTED|Overall Study||77
8510432|NCT00441116|20975006|P1|STARTED|Overall Study||76
8510433|NCT00441103|20975074|P2|NOT COMPLETED|Overall Study||4
8510434|NCT00441103|20975075|P1|NOT COMPLETED|Overall Study||11
8510435|NCT00441103|20975074|P2|COMPLETED|Overall Study||56
8510436|NCT00441103|20975075|P1|COMPLETED|Overall Study||109
8510437|NCT00441103|20975074|P2|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
8510438|NCT00441103|20975075|P1|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
8510439|NCT00441090|20975091|P5|NOT COMPLETED|Overall Study||0
8510440|NCT00441090|20975092|P4|NOT COMPLETED|Overall Study||2
8510441|NCT00441090|20975093|P3|NOT COMPLETED|Overall Study||2
8510442|NCT00441090|20975094|P2|NOT COMPLETED|Overall Study||1
8510443|NCT00441090|20975095|P1|NOT COMPLETED|Overall Study||2
8510444|NCT00441090|20975091|P5|COMPLETED|Overall Study||5
8510445|NCT00441090|20975092|P4|COMPLETED|Overall Study||13
8510446|NCT00441090|20975093|P3|COMPLETED|Overall Study||12
8510447|NCT00441090|20975094|P2|COMPLETED|Overall Study||14
8510448|NCT00441090|20975095|P1|COMPLETED|Overall Study||13
8510449|NCT00441090|20975091|P5|STARTED|Overall Study||5
8510450|NCT00441090|20975092|P4|STARTED|Overall Study||15
8510451|NCT00441090|20975093|P3|STARTED|Overall Study||14
8510452|NCT00441090|20975094|P2|STARTED|Overall Study||15
8510453|NCT00441090|20975095|P1|STARTED|Overall Study||15
8510454|NCT00441064|20975139|P2|NOT COMPLETED|Overall Study||7
8510455|NCT00441064|20975140|P1|NOT COMPLETED|Overall Study||10
8510456|NCT00441064|20975139|P2|COMPLETED|Overall Study||56
8510457|NCT00441064|20975140|P1|COMPLETED|Overall Study||59
8510458|NCT00441064|20975139|P2|Intent-to-treat (ITT) Population|Overall Study||57
8510459|NCT00441064|20975140|P1|Intent-to-treat (ITT) Population|Overall Study||61
8510460|NCT00441064|20975139|P2|Safety Population (SP)|Overall Study||63
8510461|NCT00441064|20975140|P1|Safety Population (SP)|Overall Study||69
8510462|NCT00441064|20975139|P2|STARTED|Overall Study||63
8510463|NCT00441064|20975140|P1|STARTED|Overall Study||69
8510464|NCT00441012|20975152|P2|NOT COMPLETED|Overall Study||13
8510465|NCT00441012|20975153|P1|NOT COMPLETED|Overall Study||18
8510466|NCT00441012|20975152|P2|COMPLETED|Overall Study||263
8510467|NCT00441012|20975153|P1|COMPLETED|Overall Study||252
8510468|NCT00441012|20975152|P2|Vaccination Visit 3|Overall Study||269
8510469|NCT00441012|20975153|P1|Vaccination Visit 3|Overall Study||265
8510470|NCT00441012|20975152|P2|Vaccination Visit 2|Overall Study||272
8510471|NCT00441012|20975153|P1|Vaccination Visit 2|Overall Study||267
8510472|NCT00441012|20975152|P2|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
8510473|NCT00441012|20975153|P1|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
8510474|NCT00441012|20975152|P2|STARTED|Overall Study||276
8510475|NCT00441012|20975153|P1|STARTED|Overall Study||270
8510476|NCT00440947|20975167|P5|NOT COMPLETED|Optional 60-Week Extension Phase||26
8510477|NCT00440947|20975168|P4|NOT COMPLETED|Optional 60-Week Extension Phase||29
8510478|NCT00440947|20975169|P3|NOT COMPLETED|Optional 60-Week Extension Phase||0
8510479|NCT00440947|20975170|P2|NOT COMPLETED|Optional 60-Week Extension Phase||0
8510480|NCT00440947|20975171|P1|NOT COMPLETED|Optional 60-Week Extension Phase||0
8510481|NCT00440947|20975167|P5|COMPLETED|Optional 60-Week Extension Phase||154
8510482|NCT00440947|20975168|P4|COMPLETED|Optional 60-Week Extension Phase||160
8510483|NCT00440947|20975169|P3|COMPLETED|Optional 60-Week Extension Phase||0
8510484|NCT00440947|20975170|P2|COMPLETED|Optional 60-Week Extension Phase||0
8510486|NCT00440947|20975167|P5|STARTED|Optional 60-Week Extension Phase||180
8510487|NCT00440947|20975168|P4|STARTED|Optional 60-Week Extension Phase||189
8510488|NCT00440947|20975169|P3|STARTED|Optional 60-Week Extension Phase||0
8510489|NCT00440947|20975170|P2|STARTED|Optional 60-Week Extension Phase||0
8510490|NCT00440947|20975171|P1|STARTED|Optional 60-Week Extension Phase||0
8510491|NCT00440947|20975167|P5|NOT COMPLETED|48-Week Randomization Phase||0
8510492|NCT00440947|20975168|P4|NOT COMPLETED|48-Week Randomization Phase||0
8510493|NCT00440947|20975169|P3|NOT COMPLETED|48-Week Randomization Phase||24
8510494|NCT00440947|20975170|P2|NOT COMPLETED|48-Week Randomization Phase||16
8510495|NCT00440947|20975171|P1|NOT COMPLETED|48-Week Randomization Phase||0
8510496|NCT00440947|20975167|P5|COMPLETED|48-Week Randomization Phase||0
8510497|NCT00440947|20975168|P4|COMPLETED|48-Week Randomization Phase||0
8510498|NCT00440947|20975169|P3|COMPLETED|48-Week Randomization Phase||185
8510499|NCT00440947|20975170|P2|COMPLETED|48-Week Randomization Phase||194
8510500|NCT00440947|20975171|P1|COMPLETED|48-Week Randomization Phase||0
8510501|NCT00440947|20975167|P5|STARTED|48-Week Randomization Phase||0
8510502|NCT00440947|20975168|P4|STARTED|48-Week Randomization Phase||0
8510503|NCT00440947|20975169|P3|STARTED|48-Week Randomization Phase||209
8510504|NCT00440947|20975170|P2|STARTED|48-Week Randomization Phase||210
8510505|NCT00440947|20975171|P1|STARTED|48-Week Randomization Phase||0
8510506|NCT00440947|20975167|P5|NOT COMPLETED|36-Week Induction Phase||0
8510507|NCT00440947|20975168|P4|NOT COMPLETED|36-Week Induction Phase||0
8510508|NCT00440947|20975169|P3|NOT COMPLETED|36-Week Induction Phase||0
8510509|NCT00440947|20975170|P2|NOT COMPLETED|36-Week Induction Phase||0
8510510|NCT00440947|20975171|P1|NOT COMPLETED|36-Week Induction Phase||73
8510511|NCT00440947|20975167|P5|COMPLETED|36-Week Induction Phase||0
8510512|NCT00440947|20975168|P4|COMPLETED|36-Week Induction Phase||0
8510513|NCT00440947|20975169|P3|COMPLETED|36-Week Induction Phase||0
8510514|NCT00440947|20975170|P2|COMPLETED|36-Week Induction Phase||0
8510515|NCT00440947|20975171|P1|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn't be randomized but weren't withdrawn.|442
8510516|NCT00440947|20975167|P5|STARTED|36-Week Induction Phase||0
8510517|NCT00440947|20975168|P4|STARTED|36-Week Induction Phase||0
8510518|NCT00440947|20975169|P3|STARTED|36-Week Induction Phase||0
8510519|NCT00440947|20975170|P2|STARTED|36-Week Induction Phase||0
8510520|NCT00440947|20975171|P1|STARTED|36-Week Induction Phase||515
8510521|NCT00440830|20975226|P4|NOT COMPLETED|Overall Study||0
8510522|NCT00440830|20975227|P3|NOT COMPLETED|Overall Study||0
8510523|NCT00440830|20975228|P2|NOT COMPLETED|Overall Study||0
8510524|NCT00440830|20975229|P1|NOT COMPLETED|Overall Study||0
8510525|NCT00440830|20975226|P4|COMPLETED|Overall Study||10
8510526|NCT00440830|20975227|P3|COMPLETED|Overall Study||30
8510527|NCT00440830|20975228|P2|COMPLETED|Overall Study||8
8510528|NCT00440830|20975229|P1|COMPLETED|Overall Study||20
8510529|NCT00440830|20975226|P4|STARTED|Overall Study||10
8510530|NCT00440830|20975227|P3|STARTED|Overall Study||30
8510531|NCT00440830|20975228|P2|STARTED|Overall Study||8
8510532|NCT00440830|20975229|P1|STARTED|Overall Study||20
8510533|NCT00440726|20975246|P3|NOT COMPLETED|Phase 2||2
8510534|NCT00440726|20975247|P2|NOT COMPLETED|Phase 2||0
8510535|NCT00440726|20975248|P1|NOT COMPLETED|Phase 2||0
8510536|NCT00440726|20975246|P3|COMPLETED|Phase 2||20
8510537|NCT00440726|20975247|P2|COMPLETED|Phase 2||0
8510538|NCT00440726|20975248|P1|COMPLETED|Phase 2||0
8510539|NCT00440726|20975246|P3|STARTED|Phase 2||22
8510540|NCT00440726|20975247|P2|STARTED|Phase 2||0
8510541|NCT00440726|20975248|P1|STARTED|Phase 2||0
8510542|NCT00440726|20975246|P3|NOT COMPLETED|Phase 1||0
8510543|NCT00440726|20975247|P2|NOT COMPLETED|Phase 1||1
8510544|NCT00440726|20975248|P1|NOT COMPLETED|Phase 1||1
8510545|NCT00440726|20975246|P3|COMPLETED|Phase 1||0
8510546|NCT00440726|20975247|P2|COMPLETED|Phase 1||5
8510547|NCT00440726|20975248|P1|COMPLETED|Phase 1||3
8510548|NCT00440726|20975246|P3|STARTED|Phase 1||0
8510549|NCT00440726|20975247|P2|STARTED|Phase 1||6
8510550|NCT00440726|20975248|P1|STARTED|Phase 1||4
8510551|NCT00440700|20975262|P3|NOT COMPLETED|Overall Study||4
8510552|NCT00440700|20975263|P2|NOT COMPLETED|Overall Study||8
8510553|NCT00440700|20975264|P1|NOT COMPLETED|Overall Study||8
8510554|NCT00440700|20975262|P3|COMPLETED|Overall Study||120
8510555|NCT00440700|20975263|P2|COMPLETED|Overall Study||110
8510556|NCT00440700|20975264|P1|COMPLETED|Overall Study||114
8510557|NCT00440700|20975262|P3|STARTED|Overall Study||124
8510558|NCT00440700|20975263|P2|STARTED|Overall Study||118
8510559|NCT00440700|20975264|P1|STARTED|Overall Study||122
8510560|NCT00440596|20975286|P2|NOT COMPLETED|Overall Study||11
8510561|NCT00440596|20975287|P1|NOT COMPLETED|Overall Study||7
8510562|NCT00440596|20975286|P2|COMPLETED|Overall Study||17
8510563|NCT00440596|20975287|P1|COMPLETED|Overall Study||21
8510564|NCT00440596|20975286|P2|STARTED|Overall Study||28
8510565|NCT00440596|20975287|P1|STARTED|Overall Study||28
8510566|NCT00440557|20975298|P3|NOT COMPLETED|Overall Study||35
8510567|NCT00440557|20975299|P2|NOT COMPLETED|Overall Study||29
8510568|NCT00440557|20975300|P1|NOT COMPLETED|Overall Study||25
8510569|NCT00440557|20975298|P3|COMPLETED|Overall Study||90
8510570|NCT00440557|20975299|P2|COMPLETED|Overall Study||96
8510571|NCT00440557|20975300|P1|COMPLETED|Overall Study||98
8510572|NCT00440557|20975298|P3|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
8510573|NCT00440557|20975299|P2|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
8510662|NCT00440505|20975376|P3|STARTED|First Intervention||1
8510574|NCT00440557|20975300|P1|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
8510575|NCT00440531|20975332|P3|NOT COMPLETED|Overall Study||7
8510576|NCT00440531|20975333|P2|NOT COMPLETED|Overall Study||5
8510577|NCT00440531|20975334|P1|NOT COMPLETED|Overall Study||10
8510578|NCT00440531|20975332|P3|COMPLETED|Overall Study||165
8510579|NCT00440531|20975333|P2|COMPLETED|Overall Study||178
8510580|NCT00440531|20975334|P1|COMPLETED|Overall Study||175
8510581|NCT00440531|20975332|P3|Vaccination 3|Overall Study||166
8510582|NCT00440531|20975333|P2|Vaccination 3|Overall Study||178
8510583|NCT00440531|20975334|P1|Vaccination 3|Overall Study||176
8510584|NCT00440531|20975332|P3|Vaccination 2|Overall Study||171
8510585|NCT00440531|20975333|P2|Vaccination 2|Overall Study||182
8510586|NCT00440531|20975334|P1|Vaccination 2|Overall Study||181
8510587|NCT00440531|20975332|P3|Vaccination 1|Overall Study||172
8510588|NCT00440531|20975333|P2|Vaccination 1|Overall Study||183
8510589|NCT00440531|20975334|P1|Vaccination 1|Overall Study||183
8510590|NCT00440531|20975332|P3|STARTED|Overall Study||172
8510591|NCT00440531|20975333|P2|STARTED|Overall Study||183
8510592|NCT00440531|20975334|P1|STARTED|Overall Study||185
8510593|NCT00440518|20975351|P3|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
8510594|NCT00440518|20975352|P2|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
8510595|NCT00440518|20975353|P1|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
8510596|NCT00440518|20975351|P3|COMPLETED|Maintenance and Safety Follow-up Periods||55
8510597|NCT00440518|20975352|P2|COMPLETED|Maintenance and Safety Follow-up Periods||51
8510598|NCT00440518|20975353|P1|COMPLETED|Maintenance and Safety Follow-up Periods||52
8510599|NCT00440518|20975351|P3|STARTED|Maintenance and Safety Follow-up Periods||70
8510600|NCT00440518|20975352|P2|STARTED|Maintenance and Safety Follow-up Periods||63
8510601|NCT00440518|20975353|P1|STARTED|Maintenance and Safety Follow-up Periods||59
8510602|NCT00440518|20975351|P3|NOT COMPLETED|Randomized /Titration Period||4
8510603|NCT00440518|20975352|P2|NOT COMPLETED|Randomized /Titration Period||9
8510604|NCT00440518|20975353|P1|NOT COMPLETED|Randomized /Titration Period||13
8510605|NCT00440518|20975351|P3|COMPLETED|Randomized /Titration Period||70
8510606|NCT00440518|20975352|P2|COMPLETED|Randomized /Titration Period||63
8510607|NCT00440518|20975353|P1|COMPLETED|Randomized /Titration Period||59
8510608|NCT00440518|20975351|P3|STARTED|Randomized /Titration Period||74
8510609|NCT00440518|20975352|P2|STARTED|Randomized /Titration Period||72
8510610|NCT00440518|20975353|P1|STARTED|Randomized /Titration Period||72
8510611|NCT00440505|20975373|P6|NOT COMPLETED|Third Intervention||0
8510612|NCT00440505|20975374|P5|NOT COMPLETED|Third Intervention||0
8510613|NCT00440505|20975375|P4|NOT COMPLETED|Third Intervention||1
8510614|NCT00440505|20975376|P3|NOT COMPLETED|Third Intervention||0
8510615|NCT00440505|20975377|P2|NOT COMPLETED|Third Intervention||0
8510616|NCT00440505|20975378|P1|NOT COMPLETED|Third Intervention||0
8510617|NCT00440505|20975373|P6|COMPLETED|Third Intervention||5
8510618|NCT00440505|20975374|P5|COMPLETED|Third Intervention||5
8510619|NCT00440505|20975375|P4|COMPLETED|Third Intervention||1
8510620|NCT00440505|20975376|P3|COMPLETED|Third Intervention||1
8510621|NCT00440505|20975377|P2|COMPLETED|Third Intervention||2
8510622|NCT00440505|20975378|P1|COMPLETED|Third Intervention||5
8510623|NCT00440505|20975373|P6|STARTED|Third Intervention||5
8510624|NCT00440505|20975374|P5|STARTED|Third Intervention||5
8510625|NCT00440505|20975375|P4|STARTED|Third Intervention||2
8510626|NCT00440505|20975376|P3|STARTED|Third Intervention||1
8510627|NCT00440505|20975377|P2|STARTED|Third Intervention||2
8510628|NCT00440505|20975378|P1|STARTED|Third Intervention||5
8510629|NCT00440505|20975373|P6|NOT COMPLETED|Second Intervention||0
8510630|NCT00440505|20975374|P5|NOT COMPLETED|Second Intervention||0
8510631|NCT00440505|20975375|P4|NOT COMPLETED|Second Intervention||0
8510632|NCT00440505|20975376|P3|NOT COMPLETED|Second Intervention||0
8510633|NCT00440505|20975377|P2|NOT COMPLETED|Second Intervention||0
8510634|NCT00440505|20975378|P1|NOT COMPLETED|Second Intervention||0
8510635|NCT00440505|20975373|P6|COMPLETED|Second Intervention||5
8510636|NCT00440505|20975374|P5|COMPLETED|Second Intervention||5
8510637|NCT00440505|20975375|P4|COMPLETED|Second Intervention||2
8510638|NCT00440505|20975376|P3|COMPLETED|Second Intervention||1
8510639|NCT00440505|20975377|P2|COMPLETED|Second Intervention||2
8510640|NCT00440505|20975378|P1|COMPLETED|Second Intervention||5
8510641|NCT00440505|20975373|P6|STARTED|Second Intervention||5
8510642|NCT00440505|20975374|P5|STARTED|Second Intervention||5
8510643|NCT00440505|20975375|P4|STARTED|Second Intervention||2
8510644|NCT00440505|20975376|P3|STARTED|Second Intervention||1
8510645|NCT00440505|20975377|P2|STARTED|Second Intervention||2
8510646|NCT00440505|20975378|P1|STARTED|Second Intervention||5
8510647|NCT00440505|20975373|P6|NOT COMPLETED|First Intervention||0
8510648|NCT00440505|20975374|P5|NOT COMPLETED|First Intervention||0
8510649|NCT00440505|20975375|P4|NOT COMPLETED|First Intervention||0
8510650|NCT00440505|20975376|P3|NOT COMPLETED|First Intervention||0
8510651|NCT00440505|20975377|P2|NOT COMPLETED|First Intervention||0
8510652|NCT00440505|20975378|P1|NOT COMPLETED|First Intervention||0
8510653|NCT00440505|20975373|P6|COMPLETED|First Intervention||5
8510654|NCT00440505|20975374|P5|COMPLETED|First Intervention||5
8510655|NCT00440505|20975375|P4|COMPLETED|First Intervention||2
8510656|NCT00440505|20975376|P3|COMPLETED|First Intervention||1
8510657|NCT00440505|20975377|P2|COMPLETED|First Intervention||2
8510658|NCT00440505|20975378|P1|COMPLETED|First Intervention||5
8510659|NCT00440505|20975373|P6|STARTED|First Intervention||5
8510660|NCT00440505|20975374|P5|STARTED|First Intervention||5
8510661|NCT00440505|20975375|P4|STARTED|First Intervention||2
8510663|NCT00440505|20975377|P2|STARTED|First Intervention||2
8510664|NCT00440505|20975378|P1|STARTED|First Intervention||5
8510665|NCT00440466|20975398|P3|NOT COMPLETED|Overall Study||41
8510666|NCT00440466|20975399|P2|NOT COMPLETED|Overall Study||15
8510667|NCT00440466|20975400|P1|NOT COMPLETED|Overall Study||13
8510668|NCT00440466|20975398|P3|COMPLETED|Overall Study||174
8510669|NCT00440466|20975399|P2|COMPLETED|Overall Study||92
8510670|NCT00440466|20975400|P1|COMPLETED|Overall Study||95
8510671|NCT00440466|20975398|P3|STARTED|Overall Study||215
8510672|NCT00440466|20975399|P2|STARTED|Overall Study||107
8510673|NCT00440466|20975400|P1|STARTED|Overall Study||108
8510674|NCT00440401|20975434|P2|NOT COMPLETED|Overall Study||6
8510675|NCT00440401|20975435|P1|NOT COMPLETED|Overall Study||4
8510676|NCT00440401|20975434|P2|COMPLETED|Overall Study||54
8510677|NCT00440401|20975435|P1|COMPLETED|Overall Study||55
8510678|NCT00440401|20975434|P2|STARTED|Overall Study||60
8510679|NCT00440401|20975435|P1|STARTED|Overall Study||59
8510680|NCT00440310|20975445|P2|NOT COMPLETED|Overall Study||30
8510681|NCT00440310|20975446|P1|NOT COMPLETED|Overall Study||28
8510682|NCT00440310|20975445|P2|COMPLETED|Overall Study||209
8510683|NCT00440310|20975446|P1|COMPLETED|Overall Study||216
8510684|NCT00440310|20975445|P2|Treated|Overall Study||232
8510685|NCT00440310|20975446|P1|Treated|Overall Study||222
8510686|NCT00440310|20975445|P2|STARTED|Overall Study||239
8510687|NCT00440310|20975446|P1|STARTED|Overall Study||244
8510688|NCT00440297|20975454|P2|NOT COMPLETED|Overall Study||18
8510689|NCT00440297|20975455|P1|NOT COMPLETED|Overall Study||23
8510690|NCT00440297|20975454|P2|COMPLETED|Overall Study||120
8510691|NCT00440297|20975455|P1|COMPLETED|Overall Study||116
8510692|NCT00440297|20975454|P2|Vaccination Visit 4|Overall Study||122
8510693|NCT00440297|20975455|P1|Vaccination Visit 4|Overall Study||116
8510694|NCT00440297|20975454|P2|Vaccination Visit 3|Overall Study||125
8510695|NCT00440297|20975455|P1|Vaccination Visit 3|Overall Study||124
8510696|NCT00440297|20975454|P2|Vaccination Visit 2|Overall Study||134
8510697|NCT00440297|20975455|P1|Vaccination Visit 2|Overall Study||136
8510698|NCT00440297|20975454|P2|Vaccination Visit 1|Overall Study||138
8510699|NCT00440297|20975455|P1|Vaccination Visit 1|Overall Study||138
8510700|NCT00440297|20975454|P2|STARTED|Overall Study||138
8510701|NCT00440297|20975455|P1|STARTED|Overall Study||139
8510702|NCT00440271|20975471|P2|NOT COMPLETED|Overall Study||15
8510703|NCT00440271|20975472|P1|NOT COMPLETED|Overall Study||12
8510704|NCT00440271|20975471|P2|COMPLETED|Overall Study||3
8510705|NCT00440271|20975472|P1|COMPLETED|Overall Study||3
8510706|NCT00440271|20975471|P2|STARTED|Overall Study||18
8510707|NCT00440271|20975472|P1|STARTED|Overall Study||15
8510708|NCT00440232|20975506|P2|NOT COMPLETED|Overall Study||4
8510709|NCT00440232|20975507|P1|NOT COMPLETED|Overall Study||3
8510710|NCT00440232|20975506|P2|COMPLETED|Overall Study||34
8510711|NCT00440232|20975507|P1|COMPLETED|Overall Study||33
8510712|NCT00440232|20975506|P2|STARTED|Overall Study||38
8510713|NCT00440232|20975507|P1|STARTED|Overall Study||36
8510714|NCT00440193|20975517|P2|NOT COMPLETED|Observational Period||38
8510715|NCT00440193|20975518|P1|NOT COMPLETED|Observational Period||45
8510716|NCT00440193|20975517|P2|COMPLETED|Observational Period||1369
8510717|NCT00440193|20975518|P1|COMPLETED|Observational Period||1380
8510718|NCT00440193|20975517|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
8510719|NCT00440193|20975518|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
8510720|NCT00440193|20975517|P2|NOT COMPLETED|Treatment Period||351
8510721|NCT00440193|20975518|P1|NOT COMPLETED|Treatment Period||305
8510722|NCT00440193|20975517|P2|COMPLETED|Treatment Period||1367
8510723|NCT00440193|20975518|P1|COMPLETED|Treatment Period||1426
8510724|NCT00440193|20975517|P2|Participants Received Treatment|Treatment Period||1711
8510725|NCT00440193|20975518|P1|Participants Received Treatment|Treatment Period||1718
8510726|NCT00440193|20975517|P2|STARTED|Treatment Period||1718
8510727|NCT00440193|20975518|P1|STARTED|Treatment Period||1731
8510728|NCT00440180|20975554|P2|NOT COMPLETED|Overall Study||0
8510729|NCT00440180|20975555|P1|NOT COMPLETED|Overall Study||0
8510730|NCT00440180|20975554|P2|COMPLETED|Overall Study||10
8510731|NCT00440180|20975555|P1|COMPLETED|Overall Study||10
8510732|NCT00440180|20975554|P2|STARTED|Overall Study||10
8510733|NCT00440180|20975555|P1|STARTED|Overall Study||10
8510734|NCT00440115|20975564|P3|NOT COMPLETED|Overall Study||6
8510735|NCT00440115|20975565|P2|NOT COMPLETED|Overall Study||11
8510736|NCT00440115|20975566|P1|NOT COMPLETED|Overall Study||7
8510737|NCT00440115|20975564|P3|COMPLETED|Overall Study||244
8510738|NCT00440115|20975565|P2|COMPLETED|Overall Study||238
8510739|NCT00440115|20975566|P1|COMPLETED|Overall Study||244
8510740|NCT00440115|20975564|P3|STARTED|Overall Study||250
8510741|NCT00440115|20975565|P2|STARTED|Overall Study||249
8510742|NCT00440115|20975566|P1|STARTED|Overall Study||251
8510743|NCT00440050|20975582|P2|NOT COMPLETED|Overall Study||67
8510744|NCT00440050|20975583|P1|NOT COMPLETED|Overall Study||40
8510745|NCT00440050|20975582|P2|COMPLETED|Overall Study||171
8510746|NCT00440050|20975583|P1|COMPLETED|Overall Study||124
8510747|NCT00440050|20975582|P2|STARTED|Overall Study||238
8510748|NCT00440050|20975583|P1|STARTED|Overall Study||164
8510749|NCT00440037|20975595|P1|NOT COMPLETED|Overall Study||9
8510750|NCT00440037|20975595|P1|COMPLETED|Overall Study||35
8510751|NCT00440037|20975595|P1|STARTED|Overall Study||44
8510752|NCT00440011|20975605|P2|NOT COMPLETED|Overall Study||3
8510753|NCT00440011|20975606|P1|NOT COMPLETED|Overall Study||4
8510754|NCT00440011|20975605|P2|COMPLETED|Overall Study||132
8510755|NCT00440011|20975606|P1|COMPLETED|Overall Study||127
8510756|NCT00440011|20975605|P2|STARTED|Overall Study||135
8510757|NCT00440011|20975606|P1|STARTED|Overall Study||131
8510758|NCT00439946|20975614|P1|NOT COMPLETED|Overall Study||0
8510759|NCT00439946|20975614|P1|COMPLETED|Overall Study||8
8510760|NCT00439946|20975614|P1|STARTED|Overall Study||8
8510761|NCT00439777|20975633|P2|NOT COMPLETED|Observational Period||41
8510762|NCT00439777|20975634|P1|NOT COMPLETED|Observational Period||41
8510763|NCT00439777|20975633|P2|COMPLETED|Observational Period||2156
8510764|NCT00439777|20975634|P1|COMPLETED|Observational Period||2165
8510765|NCT00439777|20975633|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
8510766|NCT00439777|20975634|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
8510767|NCT00439777|20975633|P2|NOT COMPLETED|Treatment Period||459
8510768|NCT00439777|20975634|P1|NOT COMPLETED|Treatment Period||419
8510769|NCT00439777|20975633|P2|COMPLETED|Treatment Period||1954
8510770|NCT00439777|20975634|P1|COMPLETED|Treatment Period||2001
8510771|NCT00439777|20975633|P2|Participants Received Treatment|Treatment Period||2405
8510772|NCT00439777|20975634|P1|Participants Received Treatment|Treatment Period||2412
8510773|NCT00439777|20975633|P2|STARTED|Treatment Period||2413
8510774|NCT00439777|20975634|P1|STARTED|Treatment Period||2420
8510775|NCT00439738|20975672|P2|NOT COMPLETED|Overall Study||28
8510776|NCT00439738|20975673|P1|NOT COMPLETED|Overall Study||36
8510777|NCT00439738|20975672|P2|COMPLETED|Overall Study||178
8510778|NCT00439738|20975673|P1|COMPLETED|Overall Study||170
8510779|NCT00439738|20975672|P2|STARTED|Overall Study||206
8510780|NCT00439738|20975673|P1|STARTED|Overall Study||206
8510781|NCT00439725|20975691|P2|NOT COMPLETED|Observational Period||7
8510782|NCT00439725|20975692|P1|NOT COMPLETED|Observational Period||8
8510783|NCT00439725|20975691|P2|COMPLETED|Observational Period||553
8510784|NCT00439725|20975692|P1|COMPLETED|Observational Period||569
8510785|NCT00439725|20975691|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
8510786|NCT00439725|20975692|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
8510787|NCT00439725|20975691|P2|NOT COMPLETED|Treatment Period||246
8510788|NCT00439725|20975692|P1|NOT COMPLETED|Treatment Period||236
8510789|NCT00439725|20975691|P2|COMPLETED|Treatment Period||349
8510790|NCT00439725|20975692|P1|COMPLETED|Treatment Period||366
8510791|NCT00439725|20975691|P2|Participants Received Treatment|Treatment Period|Safety population|590
8510792|NCT00439725|20975692|P1|Participants Received Treatment|Treatment Period|Safety population|598
8510793|NCT00439725|20975691|P2|STARTED|Treatment Period||595
8510794|NCT00439725|20975692|P1|STARTED|Treatment Period||602
8510795|NCT00439673|20975736|P1|NOT COMPLETED|Overall Study||36
8510796|NCT00439673|20975736|P1|COMPLETED|Overall Study||26
8510797|NCT00439673|20975736|P1|STARTED|Overall Study||62
8510798|NCT00439647|20975743|P2|NOT COMPLETED|Overall Study||71
8510799|NCT00439647|20975744|P1|NOT COMPLETED|Overall Study||58
8510800|NCT00439647|20975743|P2|COMPLETED|Overall Study||540
8510801|NCT00439647|20975744|P1|COMPLETED|Overall Study||530
8510802|NCT00439647|20975743|P2|Modified Intent to Treat (mITT)|Overall Study||574
8510803|NCT00439647|20975744|P1|Modified Intent to Treat (mITT)|Overall Study||553
8510804|NCT00439647|20975743|P2|STARTED|Overall Study||611
8510805|NCT00439647|20975744|P1|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
8510806|NCT00439608|20975776|P1|NOT COMPLETED|Overall Study||0
8510807|NCT00439608|20975776|P1|COMPLETED|Overall Study||60
8510808|NCT00439608|20975776|P1|STARTED|Overall Study||60
8510809|NCT00439569|20975781|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
8510810|NCT00439569|20975781|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
8510811|NCT00439569|20975781|P1|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
8510812|NCT00439569|20975781|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
8510813|NCT00439569|20975781|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
8510814|NCT00439569|20975781|P1|STARTED|Cohort 1 (500 mg/kg/Day)||7
8510815|NCT00439556|20975795|P3|NOT COMPLETED|Overall Study||0
8510816|NCT00439556|20975796|P2|NOT COMPLETED|Overall Study||1
8510817|NCT00439556|20975797|P1|NOT COMPLETED|Overall Study||0
8510818|NCT00439556|20975795|P3|COMPLETED|Overall Study||0
8510819|NCT00439556|20975796|P2|COMPLETED|Overall Study||3
8510820|NCT00439556|20975797|P1|COMPLETED|Overall Study||36
8510821|NCT00439556|20975795|P3|STARTED|Overall Study||0
8510822|NCT00439556|20975796|P2|STARTED|Overall Study||4
8510823|NCT00439556|20975797|P1|STARTED|Overall Study||36
8510824|NCT00439517|20975810|P2|NOT COMPLETED|Overall Study||0
8510825|NCT00439517|20975811|P1|NOT COMPLETED|Overall Study||2
8510826|NCT00439517|20975810|P2|COMPLETED|Overall Study||150
8510827|NCT00439517|20975811|P1|COMPLETED|Overall Study||150
8510828|NCT00439517|20975810|P2|STARTED|Overall Study||150
8510829|NCT00439517|20975811|P1|STARTED|Overall Study||152
8510830|NCT00439465|20975833|P1|NOT COMPLETED|Overall Study||4
8510831|NCT00439465|20975833|P1|COMPLETED|Overall Study||19
8510832|NCT00439465|20975833|P1|STARTED|Overall Study||23
8510833|NCT00439413|20975845|P2|NOT COMPLETED|Overall Study||37
8510834|NCT00439413|20975846|P1|NOT COMPLETED|Overall Study||31
8510835|NCT00439413|20975845|P2|COMPLETED|Overall Study||88
8510836|NCT00439413|20975846|P1|COMPLETED|Overall Study||90
8510837|NCT00439413|20975845|P2|STARTED|Overall Study||125
8510838|NCT00439413|20975846|P1|STARTED|Overall Study||121
8510839|NCT00439374|20975856|P2|NOT COMPLETED|Overall Study||0
8510840|NCT00439374|20975857|P1|NOT COMPLETED|Overall Study||0
8510841|NCT00439374|20975856|P2|COMPLETED|Overall Study||330
8510842|NCT00439374|20975857|P1|COMPLETED|Overall Study||327
8510843|NCT00439374|20975856|P2|STARTED|Overall Study||330
8510844|NCT00439374|20975857|P1|STARTED|Overall Study||327
8510845|NCT00439335|20975917|P2|NOT COMPLETED|Overall Study||0
8510846|NCT00439335|20975918|P1|NOT COMPLETED|Overall Study||2
8510847|NCT00439335|20975917|P2|COMPLETED|Overall Study||114
8510848|NCT00439335|20975918|P1|COMPLETED|Overall Study||111
8510849|NCT00439335|20975917|P2|STARTED|Overall Study||114
8510850|NCT00439335|20975918|P1|STARTED|Overall Study||113
8510851|NCT00439309|20975950|P2|NOT COMPLETED|Follow-Up||2
8510852|NCT00439309|20975951|P1|NOT COMPLETED|Follow-Up||3
8510853|NCT00439309|20975950|P2|COMPLETED|Follow-Up||13
8510854|NCT00439309|20975951|P1|COMPLETED|Follow-Up||51
8510855|NCT00439309|20975950|P2|STARTED|Follow-Up||15
8510856|NCT00439309|20975951|P1|STARTED|Follow-Up||54
8510857|NCT00439309|20975950|P2|NOT COMPLETED|Treatment||0
8510858|NCT00439309|20975951|P1|NOT COMPLETED|Treatment||0
8510859|NCT00439309|20975950|P2|COMPLETED|Treatment||15
8510860|NCT00439309|20975951|P1|COMPLETED|Treatment||54
8510861|NCT00439309|20975950|P2|STARTED|Treatment||15
8510862|NCT00439309|20975951|P1|STARTED|Treatment||54
8510873|NCT00439270|20975983|P5|NOT COMPLETED|Phase 2 (51.6 Months)||0
8510874|NCT00439270|20975984|P4|NOT COMPLETED|Phase 2 (51.6 Months)||34
8510875|NCT00439270|20975985|P3|NOT COMPLETED|Phase 2 (51.6 Months)||0
8510876|NCT00439270|20975986|P2|NOT COMPLETED|Phase 2 (51.6 Months)||0
8510877|NCT00439270|20975987|P1|NOT COMPLETED|Phase 2 (51.6 Months)||0
8510878|NCT00439270|20975983|P5|COMPLETED|Phase 2 (51.6 Months)||0
8510879|NCT00439270|20975984|P4|COMPLETED|Phase 2 (51.6 Months)||0
8510880|NCT00439270|20975985|P3|COMPLETED|Phase 2 (51.6 Months)||0
8510881|NCT00439270|20975986|P2|COMPLETED|Phase 2 (51.6 Months)||0
8510882|NCT00439270|20975987|P1|COMPLETED|Phase 2 (51.6 Months)||0
8510883|NCT00439270|20975983|P5|STARTED|Phase 2 (51.6 Months)||0
8510884|NCT00439270|20975984|P4|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
8510885|NCT00439270|20975985|P3|STARTED|Phase 2 (51.6 Months)||0
8510886|NCT00439270|20975986|P2|STARTED|Phase 2 (51.6 Months)||0
8510887|NCT00439270|20975987|P1|STARTED|Phase 2 (51.6 Months)||0
8510888|NCT00439270|20975983|P5|NOT COMPLETED|Phase 1 (18.1 Months)||3
8510889|NCT00439270|20975984|P4|NOT COMPLETED|Phase 1 (18.1 Months)||0
8510890|NCT00439270|20975985|P3|NOT COMPLETED|Phase 1 (18.1 Months)||3
8510891|NCT00439270|20975986|P2|NOT COMPLETED|Phase 1 (18.1 Months)||3
8510892|NCT00439270|20975987|P1|NOT COMPLETED|Phase 1 (18.1 Months)||3
8510893|NCT00439270|20975983|P5|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
8510894|NCT00439270|20975984|P4|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
8510895|NCT00439270|20975985|P3|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
8510896|NCT00439270|20975986|P2|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
8510897|NCT00439270|20975987|P1|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
8510898|NCT00439270|20975983|P5|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
8510899|NCT00439270|20975984|P4|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
8510900|NCT00439270|20975985|P3|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
8510901|NCT00439270|20975986|P2|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
8510902|NCT00439270|20975987|P1|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
8510903|NCT00439244|20976029|P3|NOT COMPLETED|Overall Study||7
8510904|NCT00439244|20976030|P2|NOT COMPLETED|Overall Study||6
8510905|NCT00439244|20976031|P1|NOT COMPLETED|Overall Study||11
8510906|NCT00439244|20976029|P3|COMPLETED|Overall Study||131
8510907|NCT00439244|20976030|P2|COMPLETED|Overall Study||131
8510908|NCT00439244|20976031|P1|COMPLETED|Overall Study||126
8510909|NCT00439244|20976029|P3|Safety Population|Overall Study||137
8510910|NCT00439244|20976030|P2|Safety Population|Overall Study||137
8510911|NCT00439244|20976031|P1|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
8510912|NCT00439244|20976029|P3|STARTED|Overall Study||138
8510913|NCT00439244|20976030|P2|STARTED|Overall Study||137
8510914|NCT00439244|20976031|P1|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
8510915|NCT00439231|20976051|P1|NOT COMPLETED|Overall Study||28
8510916|NCT00439231|20976051|P1|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
8510917|NCT00439231|20976051|P1|STARTED|Overall Study||33
8510918|NCT00439218|20976055|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
8510919|NCT00439218|20976055|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
8510920|NCT00439218|20976055|P1|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
8510921|NCT00439218|20976055|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
8510922|NCT00439218|20976055|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
8510923|NCT00439218|20976055|P1|STARTED|Cohort 1 (500 mg/kg/Day)||4
8510924|NCT00439179|20976070|P4|NOT COMPLETED|Overall Study||0
8510925|NCT00439179|20976071|P3|NOT COMPLETED|Overall Study||0
8510926|NCT00439179|20976072|P2|NOT COMPLETED|Overall Study||2
8510927|NCT00439179|20976073|P1|NOT COMPLETED|Overall Study||0
8510928|NCT00439179|20976070|P4|COMPLETED|Overall Study||5
8510929|NCT00439179|20976071|P3|COMPLETED|Overall Study||6
8510930|NCT00439179|20976072|P2|COMPLETED|Overall Study||11
8510931|NCT00439179|20976073|P1|COMPLETED|Overall Study||3
8510932|NCT00439179|20976070|P4|STARTED|Overall Study|2 with biliry|5
8510933|NCT00439179|20976071|P3|STARTED|Overall Study|2 with biliary|6
8510934|NCT00439179|20976072|P2|STARTED|Overall Study|2 with biliary|13
8510935|NCT00439179|20976073|P1|STARTED|Overall Study|1 with biliary|3
8510936|NCT00439140|20976090|P3|NOT COMPLETED|Treatment Cycle 2||0
8510937|NCT00439140|20976091|P2|NOT COMPLETED|Treatment Cycle 2||1
8510938|NCT00439140|20976092|P1|NOT COMPLETED|Treatment Cycle 2||2
8510939|NCT00439140|20976090|P3|COMPLETED|Treatment Cycle 2||0
8510940|NCT00439140|20976091|P2|COMPLETED|Treatment Cycle 2||6
8510941|NCT00439140|20976092|P1|COMPLETED|Treatment Cycle 2||11
8510942|NCT00439140|20976090|P3|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
8510943|NCT00439140|20976091|P2|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
8510944|NCT00439140|20976092|P1|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
8510945|NCT00439140|20976090|P3|NOT COMPLETED|Treatment Cycle 1||1
8510946|NCT00439140|20976091|P2|NOT COMPLETED|Treatment Cycle 1||4
8510947|NCT00439140|20976092|P1|NOT COMPLETED|Treatment Cycle 1||1
8510948|NCT00439140|20976090|P3|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
8510949|NCT00439140|20976091|P2|COMPLETED|Treatment Cycle 1||10
8510950|NCT00439140|20976092|P1|COMPLETED|Treatment Cycle 1||14
8510951|NCT00439140|20976090|P3|STARTED|Treatment Cycle 1||12
8510952|NCT00439140|20976091|P2|STARTED|Treatment Cycle 1||14
8510953|NCT00439140|20976092|P1|STARTED|Treatment Cycle 1||15
8510954|NCT00438971|20976121|P1|NOT COMPLETED|Overall Study||2
8510955|NCT00438971|20976121|P1|COMPLETED|Overall Study||15
8510956|NCT00438971|20976121|P1|STARTED|Overall Study||17
8510957|NCT00438932|20976136|P4|NOT COMPLETED|Overall Study||0
8510958|NCT00438932|20976137|P3|NOT COMPLETED|Overall Study||0
8510959|NCT00438932|20976138|P2|NOT COMPLETED|Overall Study||0
8510960|NCT00438932|20976139|P1|NOT COMPLETED|Overall Study||0
8510961|NCT00438932|20976136|P4|COMPLETED|Overall Study||4
8510962|NCT00438932|20976137|P3|COMPLETED|Overall Study||4
8510963|NCT00438932|20976138|P2|COMPLETED|Overall Study||4
8510964|NCT00438932|20976139|P1|COMPLETED|Overall Study||4
8510965|NCT00438932|20976136|P4|STARTED|Overall Study||4
8510966|NCT00438932|20976137|P3|STARTED|Overall Study||4
8510967|NCT00438932|20976138|P2|STARTED|Overall Study||4
8510968|NCT00438932|20976139|P1|STARTED|Overall Study||4
8510969|NCT00438880|20976155|P2|NOT COMPLETED|Overall Study||0
8510970|NCT00438880|20976156|P1|NOT COMPLETED|Overall Study||0
8510971|NCT00438880|20976155|P2|COMPLETED|Overall Study||8
8510972|NCT00438880|20976156|P1|COMPLETED|Overall Study||30
8510973|NCT00438880|20976155|P2|STARTED|Overall Study||8
8510974|NCT00438880|20976156|P1|STARTED|Overall Study||30
8510975|NCT00438854|20976168|P1|NOT COMPLETED|Overall Study||0
8510976|NCT00438854|20976168|P1|COMPLETED|Overall Study||15
8510977|NCT00438854|20976168|P1|STARTED|Overall Study||15
8510981|NCT00438802|20976188|P3|NOT COMPLETED|Overall Study||0
8510982|NCT00438802|20976189|P2|NOT COMPLETED|Overall Study||0
8510983|NCT00438802|20976190|P1|NOT COMPLETED|Overall Study||0
8510984|NCT00438802|20976188|P3|COMPLETED|Overall Study||9
8510985|NCT00438802|20976189|P2|COMPLETED|Overall Study||8
8510986|NCT00438802|20976190|P1|COMPLETED|Overall Study||6
8510987|NCT00438802|20976188|P3|STARTED|Overall Study||9
8510988|NCT00438802|20976189|P2|STARTED|Overall Study||8
8510989|NCT00438802|20976190|P1|STARTED|Overall Study||6
8510990|NCT00438750|20976204|P2|NOT COMPLETED|Overall Study||9
8510991|NCT00438750|20976205|P1|NOT COMPLETED|Overall Study||9
8510992|NCT00438750|20976204|P2|COMPLETED|Overall Study||37
8510993|NCT00438750|20976205|P1|COMPLETED|Overall Study||39
8510994|NCT00438750|20976204|P2|STARTED|Overall Study||46
8510995|NCT00438750|20976205|P1|STARTED|Overall Study||48
8510996|NCT00438672|20976225|P2|NOT COMPLETED|Overall Study||9
8510997|NCT00438672|20976226|P1|NOT COMPLETED|Overall Study||7
8510998|NCT00438672|20976225|P2|COMPLETED|Overall Study||24
8510999|NCT00438672|20976226|P1|COMPLETED|Overall Study||24
8511000|NCT00438672|20976225|P2|STARTED|Overall Study||33
8511001|NCT00438672|20976226|P1|STARTED|Overall Study||31
8511002|NCT00438659|20976236|P2|NOT COMPLETED|Overall Study||4
8511003|NCT00438659|20976237|P1|NOT COMPLETED|Overall Study||6
8511004|NCT00438659|20976236|P2|COMPLETED|Overall Study||82
8511005|NCT00438659|20976237|P1|COMPLETED|Overall Study||84
8511006|NCT00438659|20976236|P2|STARTED|Overall Study||86
8511007|NCT00438659|20976237|P1|STARTED|Overall Study||90
8511008|NCT00438633|20976261|P2|NOT COMPLETED|Overall Study||17
8511009|NCT00438633|20976262|P1|NOT COMPLETED|Overall Study||16
8511010|NCT00438633|20976261|P2|COMPLETED|Overall Study||14
8511011|NCT00438633|20976262|P1|COMPLETED|Overall Study||16
8511012|NCT00438633|20976261|P2|3-month Follow-up|Overall Study||24
8511013|NCT00438633|20976262|P1|3-month Follow-up|Overall Study||26
8511014|NCT00438633|20976261|P2|STARTED|Overall Study||31
8511015|NCT00438633|20976262|P1|STARTED|Overall Study||32
8511016|NCT00438490|20976278|P2|NOT COMPLETED|Overall Study||0
8511017|NCT00438490|20976279|P1|NOT COMPLETED|Overall Study||0
8511018|NCT00438490|20976278|P2|COMPLETED|Overall Study||9
8511019|NCT00438490|20976279|P1|COMPLETED|Overall Study||12
8511020|NCT00438490|20976278|P2|STARTED|Overall Study||9
8511021|NCT00438490|20976279|P1|STARTED|Overall Study||12
8511022|NCT00438464|20976293|P2|NOT COMPLETED|Overall Study||7
8511023|NCT00438464|20976294|P1|NOT COMPLETED|Overall Study||14
8511024|NCT00438464|20976293|P2|COMPLETED|Overall Study||94
8511025|NCT00438464|20976294|P1|COMPLETED|Overall Study||89
8511026|NCT00438464|20976293|P2|Received Assigned Intervention|Overall Study||94
8511027|NCT00438464|20976294|P1|Received Assigned Intervention|Overall Study||89
8511028|NCT00438464|20976293|P2|STARTED|Overall Study||101
8511029|NCT00438464|20976294|P1|STARTED|Overall Study||103
8511030|NCT00438451|20976349|P3|NOT COMPLETED|Overall Study||53
8511031|NCT00438451|20976350|P2|NOT COMPLETED|Overall Study||66
8511032|NCT00438451|20976351|P1|NOT COMPLETED|Overall Study||47
8511033|NCT00438451|20976349|P3|COMPLETED|Overall Study||65
8511034|NCT00438451|20976350|P2|COMPLETED|Overall Study||55
8511035|NCT00438451|20976351|P1|COMPLETED|Overall Study||75
8511036|NCT00438451|20976349|P3|Maintenance Phase (Week 7-58)|Overall Study||93
8511037|NCT00438451|20976350|P2|Maintenance Phase (Week 7-58)|Overall Study||89
8511038|NCT00438451|20976351|P1|Maintenance Phase (Week 7-58)|Overall Study||93
8511039|NCT00438451|20976349|P3|ITT Population|Overall Study||117
8511040|NCT00438451|20976350|P2|ITT Population|Overall Study||120
8511041|NCT00438451|20976351|P1|ITT Population|Overall Study||122
8511042|NCT00438451|20976349|P3|Safety Population|Overall Study||117
8511043|NCT00438451|20976350|P2|Safety Population|Overall Study||121
8511044|NCT00438451|20976351|P1|Safety Population|Overall Study||122
8511045|NCT00438451|20976349|P3|STARTED|Overall Study||118
8511046|NCT00438451|20976350|P2|STARTED|Overall Study||121
8511047|NCT00438451|20976351|P1|STARTED|Overall Study||122
8511072|NCT00438360|20976411|P2|NOT COMPLETED|Overall Study||43
8511073|NCT00438360|20976412|P1|NOT COMPLETED|Overall Study||72
8511074|NCT00438360|20976411|P2|COMPLETED|Overall Study||38
8511075|NCT00438360|20976412|P1|COMPLETED|Overall Study||90
8511076|NCT00438360|20976411|P2|Intention to Treat (ITT) Population|Overall Study||79
8511077|NCT00438360|20976412|P1|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
8511078|NCT00438360|20976411|P2|STARTED|Overall Study||81
8511079|NCT00438360|20976412|P1|STARTED|Overall Study|"Started indicates randomized patients."|162
8511080|NCT00438256|20976426|P4|NOT COMPLETED|Overall Study||9
8511081|NCT00438256|20976427|P3|NOT COMPLETED|Overall Study||1
8511082|NCT00438256|20976428|P2|NOT COMPLETED|Overall Study||1
8511083|NCT00438256|20976429|P1|NOT COMPLETED|Overall Study||2
8511084|NCT00438256|20976426|P4|COMPLETED|Overall Study||32
8511085|NCT00438256|20976427|P3|COMPLETED|Overall Study||2
8511086|NCT00438256|20976428|P2|COMPLETED|Overall Study||2
8511087|NCT00438256|20976429|P1|COMPLETED|Overall Study||1
8511088|NCT00438256|20976426|P4|Surgical Resection|Overall Study||34
8511089|NCT00438256|20976427|P3|Surgical Resection|Overall Study||2
8511090|NCT00438256|20976428|P2|Surgical Resection|Overall Study||2
8511091|NCT00438256|20976429|P1|Surgical Resection|Overall Study||1
8511092|NCT00438256|20976426|P4|STARTED|Overall Study||41
8511093|NCT00438256|20976427|P3|STARTED|Overall Study||3
8511094|NCT00438256|20976428|P2|STARTED|Overall Study||3
8511095|NCT00438256|20976429|P1|STARTED|Overall Study||3
8511099|NCT00438191|20976455|P2|NOT COMPLETED|Overall Study||14
8511100|NCT00438191|20976456|P1|NOT COMPLETED|Overall Study||11
8511101|NCT00438191|20976455|P2|COMPLETED|Overall Study||26
8511102|NCT00438191|20976456|P1|COMPLETED|Overall Study||32
8511103|NCT00438191|20976455|P2|STARTED|Overall Study||40
8511104|NCT00438191|20976456|P1|STARTED|Overall Study||43
8511105|NCT00438100|20976470|P2|NOT COMPLETED|Overall Study||4
8511106|NCT00438100|20976471|P1|NOT COMPLETED|Overall Study||2
8511107|NCT00438100|20976470|P2|COMPLETED|Overall Study||65
8511108|NCT00438100|20976471|P1|COMPLETED|Overall Study||71
8511109|NCT00438100|20976470|P2|STARTED|Overall Study||69
8511110|NCT00438100|20976471|P1|STARTED|Overall Study||73
8511111|NCT00437983|20976479|P2|NOT COMPLETED|Overall Study||13
8511112|NCT00437983|20976480|P1|NOT COMPLETED|Overall Study||13
8511113|NCT00437983|20976479|P2|COMPLETED|Overall Study||65
8511114|NCT00437983|20976480|P1|COMPLETED|Overall Study||66
8511115|NCT00437983|20976479|P2|STARTED|Overall Study||78
8511116|NCT00437983|20976480|P1|STARTED|Overall Study||79
8511117|NCT00437658|20976493|P3|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
8511118|NCT00437658|20976494|P2|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
8511119|NCT00437658|20976495|P1|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
8511120|NCT00437658|20976493|P3|COMPLETED|Post-treatment Period (24 Weeks)||37
8511121|NCT00437658|20976494|P2|COMPLETED|Post-treatment Period (24 Weeks)||54
8511122|NCT00437658|20976495|P1|COMPLETED|Post-treatment Period (24 Weeks)||32
8511123|NCT00437658|20976493|P3|STARTED|Post-treatment Period (24 Weeks)||51
8511124|NCT00437658|20976494|P2|STARTED|Post-treatment Period (24 Weeks)||62
8511125|NCT00437658|20976495|P1|STARTED|Post-treatment Period (24 Weeks)||56
8511126|NCT00437658|20976493|P3|NOT COMPLETED|Treatment Period (24 Weeks)||33
8511127|NCT00437658|20976494|P2|NOT COMPLETED|Treatment Period (24 Weeks)||22
8511128|NCT00437658|20976495|P1|NOT COMPLETED|Treatment Period (24 Weeks)||28
8511129|NCT00437658|20976493|P3|COMPLETED|Treatment Period (24 Weeks)||51
8511130|NCT00437658|20976494|P2|COMPLETED|Treatment Period (24 Weeks)||62
8511131|NCT00437658|20976495|P1|COMPLETED|Treatment Period (24 Weeks)||56
8511132|NCT00437658|20976493|P3|Received Study Drug|Treatment Period (24 Weeks)||84
8511133|NCT00437658|20976494|P2|Received Study Drug|Treatment Period (24 Weeks)||84
8511134|NCT00437658|20976495|P1|Received Study Drug|Treatment Period (24 Weeks)||84
8511135|NCT00437658|20976493|P3|STARTED|Treatment Period (24 Weeks)||84
8511136|NCT00437658|20976494|P2|STARTED|Treatment Period (24 Weeks)||84
8511137|NCT00437658|20976495|P1|STARTED|Treatment Period (24 Weeks)||84
8511138|NCT00437645|20976589|P2|NOT COMPLETED|Overall Study||115
8511139|NCT00437645|20976590|P1|NOT COMPLETED|Overall Study||35
8511140|NCT00437645|20976589|P2|COMPLETED|Overall Study||476
8511141|NCT00437645|20976590|P1|COMPLETED|Overall Study||557
8511142|NCT00437645|20976589|P2|STARTED|Overall Study||591
8511143|NCT00437645|20976590|P1|STARTED|Overall Study||592
8511144|NCT00437489|20976606|P2|NOT COMPLETED|Overall Study||22
8511145|NCT00437489|20976607|P1|NOT COMPLETED|Overall Study||23
8511146|NCT00437489|20976606|P2|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
8511147|NCT00437489|20976607|P1|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
8511148|NCT00437489|20976606|P2|STARTED|Overall Study||24
8511149|NCT00437489|20976607|P1|STARTED|Overall Study||25
8511150|NCT00437398|20976619|P1|NOT COMPLETED|Overall Study||0
8511151|NCT00437398|20976619|P1|COMPLETED|Overall Study||2
8511152|NCT00437398|20976619|P1|STARTED|Overall Study||2
8511153|NCT00437294|20976626|P2|NOT COMPLETED|Overall Study||43
8511154|NCT00437294|20976627|P1|NOT COMPLETED|Overall Study||43
8511155|NCT00437294|20976626|P2|COMPLETED|Overall Study||0
8511156|NCT00437294|20976627|P1|COMPLETED|Overall Study||0
8511157|NCT00437294|20976626|P2|Received at Least 1 Dose of Study Drug|Overall Study||43
8511158|NCT00437294|20976627|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
8511159|NCT00437294|20976626|P2|STARTED|Overall Study||43
8511160|NCT00437294|20976627|P1|STARTED|Overall Study||43
8511221|NCT00437268|20976983|P2|NOT COMPLETED|Overall Study||13
8511222|NCT00437268|20976984|P1|NOT COMPLETED|Overall Study||13
8511223|NCT00437268|20976983|P2|COMPLETED|Overall Study||0
8511224|NCT00437268|20976984|P1|COMPLETED|Overall Study||0
8511225|NCT00437268|20976983|P2|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|12
8511226|NCT00437268|20976984|P1|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|13
8511227|NCT00437268|20976983|P2|Received at Least 1 Dose of Study Drug|Overall Study||13
8511228|NCT00437268|20976984|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
8511229|NCT00437268|20976983|P2|STARTED|Overall Study||13
8511230|NCT00437268|20976984|P1|STARTED|Overall Study||13
8511231|NCT00437203|20977010|P10|NOT COMPLETED|Overall Study||4
8511232|NCT00437203|20977011|P9|NOT COMPLETED|Overall Study||3
8511233|NCT00437203|20977012|P8|NOT COMPLETED|Overall Study||3
8511234|NCT00437203|20977013|P7|NOT COMPLETED|Overall Study||7
8511235|NCT00437203|20977014|P6|NOT COMPLETED|Overall Study||3
8511236|NCT00437203|20977015|P5|NOT COMPLETED|Overall Study||3
8511237|NCT00437203|20977016|P4|NOT COMPLETED|Overall Study||3
8511238|NCT00437203|20977017|P3|NOT COMPLETED|Overall Study||3
8511239|NCT00437203|20977018|P2|NOT COMPLETED|Overall Study||8
8511240|NCT00437203|20977019|P1|NOT COMPLETED|Overall Study||6
8511241|NCT00437203|20977010|P10|COMPLETED|Overall Study||0
8511242|NCT00437203|20977011|P9|COMPLETED|Overall Study||0
8511243|NCT00437203|20977012|P8|COMPLETED|Overall Study||0
8511244|NCT00437203|20977013|P7|COMPLETED|Overall Study||0
8511245|NCT00437203|20977014|P6|COMPLETED|Overall Study||0
8511246|NCT00437203|20977015|P5|COMPLETED|Overall Study||0
8511247|NCT00437203|20977016|P4|COMPLETED|Overall Study||0
8511248|NCT00437203|20977017|P3|COMPLETED|Overall Study||0
8511249|NCT00437203|20977018|P2|COMPLETED|Overall Study||0
8511250|NCT00437203|20977019|P1|COMPLETED|Overall Study||0
8511251|NCT00437203|20977010|P10|STARTED|Overall Study||4
8511252|NCT00437203|20977011|P9|STARTED|Overall Study||3
8511253|NCT00437203|20977012|P8|STARTED|Overall Study||3
8511254|NCT00437203|20977013|P7|STARTED|Overall Study||7
8511255|NCT00437203|20977014|P6|STARTED|Overall Study||3
8511256|NCT00437203|20977015|P5|STARTED|Overall Study||3
8511257|NCT00437203|20977016|P4|STARTED|Overall Study||3
8511258|NCT00437203|20977017|P3|STARTED|Overall Study||3
8511259|NCT00437203|20977018|P2|STARTED|Overall Study||8
8511260|NCT00437203|20977019|P1|STARTED|Overall Study||6
8511261|NCT00437125|20977123|P1|NOT COMPLETED|Overall Study||32
8511262|NCT00437125|20977123|P1|COMPLETED|Overall Study||119
8511263|NCT00437125|20977123|P1|STARTED|Overall Study||151
8511264|NCT00437073|20977144|P2|NOT COMPLETED|Overall Study||1
8511265|NCT00437073|20977145|P1|NOT COMPLETED|Overall Study||1
8511266|NCT00437073|20977144|P2|COMPLETED|Overall Study||8
8511267|NCT00437073|20977145|P1|COMPLETED|Overall Study||12
8511268|NCT00437073|20977144|P2|STARTED|Overall Study||9
8511269|NCT00437073|20977145|P1|STARTED|Overall Study||13
8511273|NCT00436982|20977179|P2|NOT COMPLETED|Overall Study||4
8511274|NCT00436982|20977180|P1|NOT COMPLETED|Overall Study||4
8511275|NCT00436982|20977179|P2|COMPLETED|Overall Study||26
8511276|NCT00436982|20977180|P1|COMPLETED|Overall Study||26
8511277|NCT00436982|20977179|P2|STARTED|Overall Study||30
8511278|NCT00436982|20977180|P1|STARTED|Overall Study||30
8511279|NCT00436969|20977202|P2|NOT COMPLETED|Overall Study||52
8511280|NCT00436969|20977203|P1|NOT COMPLETED|Overall Study||22
8511281|NCT00436969|20977202|P2|COMPLETED|Overall Study||134
8511282|NCT00436969|20977203|P1|COMPLETED|Overall Study||66
8511283|NCT00436969|20977202|P2|Randomized But Not Treated|Overall Study||3
8511284|NCT00436969|20977203|P1|Randomized But Not Treated|Overall Study||1
8511285|NCT00436969|20977202|P2|STARTED|Overall Study||186
8511286|NCT00436969|20977203|P1|STARTED|Overall Study||88
8511287|NCT00436956|20977251|P2|NOT COMPLETED|Overall Study||0
8511288|NCT00436956|20977252|P1|NOT COMPLETED|Overall Study||1
8511289|NCT00436956|20977251|P2|COMPLETED|Overall Study||23
8511290|NCT00436956|20977252|P1|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
8511291|NCT00436956|20977251|P2|STARTED|Overall Study||23
8511292|NCT00436956|20977252|P1|STARTED|Overall Study||36
8511293|NCT00436917|20977266|P1|NOT COMPLETED|Overall Study||21
8511294|NCT00436917|20977266|P1|COMPLETED|Overall Study||32
8511295|NCT00436917|20977266|P1|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53
8511296|NCT00436904|20977281|P1|NOT COMPLETED|Overall Study||0
8511297|NCT00436904|20977281|P1|COMPLETED|Overall Study||30
8511298|NCT00436904|20977281|P1|STARTED|Overall Study||30
8511299|NCT00436852|20977292|P2|NOT COMPLETED|Overall Study||45
8511300|NCT00436852|20977293|P1|NOT COMPLETED|Overall Study||35
8511301|NCT00436852|20977292|P2|COMPLETED|Overall Study||2
8511302|NCT00436852|20977293|P1|COMPLETED|Overall Study||10
8511303|NCT00436852|20977292|P2|STARTED|Overall Study||47
8511304|NCT00436852|20977293|P1|STARTED|Overall Study||45
8511305|NCT00436826|20977312|P6|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
8511306|NCT00436826|20977313|P5|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
8511307|NCT00436826|20977314|P4|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511308|NCT00436826|20977315|P3|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511309|NCT00436826|20977316|P2|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511310|NCT00436826|20977317|P1|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511311|NCT00436826|20977312|P6|COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511312|NCT00436826|20977313|P5|COMPLETED|Ext. Period (No Cladribine Treatment)||1
8511313|NCT00436826|20977314|P4|COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511314|NCT00436826|20977315|P3|COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511315|NCT00436826|20977316|P2|COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511316|NCT00436826|20977317|P1|COMPLETED|Ext. Period (No Cladribine Treatment)||0
8511317|NCT00436826|20977312|P6|STARTED|Ext. Period (No Cladribine Treatment)||7
8511318|NCT00436826|20977313|P5|STARTED|Ext. Period (No Cladribine Treatment)||52
8511319|NCT00436826|20977314|P4|STARTED|Ext. Period (No Cladribine Treatment)||0
8511320|NCT00436826|20977315|P3|STARTED|Ext. Period (No Cladribine Treatment)||0
8511321|NCT00436826|20977316|P2|STARTED|Ext. Period (No Cladribine Treatment)||0
8511322|NCT00436826|20977317|P1|STARTED|Ext. Period (No Cladribine Treatment)||0
8511323|NCT00436826|20977312|P6|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511324|NCT00436826|20977313|P5|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511325|NCT00436826|20977314|P4|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||26
8511326|NCT00436826|20977315|P3|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||46
8511327|NCT00436826|20977316|P2|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511328|NCT00436826|20977317|P1|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511329|NCT00436826|20977312|P6|COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511330|NCT00436826|20977313|P5|COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511331|NCT00436826|20977314|P4|COMPLETED|Ext. Period (With Cladribine Treatment)||2
8511332|NCT00436826|20977315|P3|COMPLETED|Ext. Period (With Cladribine Treatment)||1
8511333|NCT00436826|20977316|P2|COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511334|NCT00436826|20977317|P1|COMPLETED|Ext. Period (With Cladribine Treatment)||0
8511335|NCT00436826|20977312|P6|STARTED|Ext. Period (With Cladribine Treatment)||0
8511336|NCT00436826|20977313|P5|STARTED|Ext. Period (With Cladribine Treatment)||0
8511337|NCT00436826|20977314|P4|STARTED|Ext. Period (With Cladribine Treatment)||28
8511338|NCT00436826|20977315|P3|STARTED|Ext. Period (With Cladribine Treatment)||47
8511339|NCT00436826|20977316|P2|STARTED|Ext. Period (With Cladribine Treatment)||0
8511340|NCT00436826|20977317|P1|STARTED|Ext. Period (With Cladribine Treatment)||0
8511341|NCT00436826|20977312|P6|NOT COMPLETED|Double Blind Period (DBP)||0
8511342|NCT00436826|20977313|P5|NOT COMPLETED|Double Blind Period (DBP)||0
8511343|NCT00436826|20977314|P4|NOT COMPLETED|Double Blind Period (DBP)||0
8511344|NCT00436826|20977315|P3|NOT COMPLETED|Double Blind Period (DBP)||0
8511345|NCT00436826|20977316|P2|NOT COMPLETED|Double Blind Period (DBP)||11
8511346|NCT00436826|20977317|P1|NOT COMPLETED|Double Blind Period (DBP)||13
8511347|NCT00436826|20977312|P6|COMPLETED|Double Blind Period (DBP)||0
8511348|NCT00436826|20977313|P5|COMPLETED|Double Blind Period (DBP)||0
8511349|NCT00436826|20977314|P4|COMPLETED|Double Blind Period (DBP)||0
8511350|NCT00436826|20977315|P3|COMPLETED|Double Blind Period (DBP)||0
8511351|NCT00436826|20977316|P2|COMPLETED|Double Blind Period (DBP)||37
8511352|NCT00436826|20977317|P1|COMPLETED|Double Blind Period (DBP)||111
8511353|NCT00436826|20977312|P6|STARTED|Double Blind Period (DBP)||0
8511354|NCT00436826|20977313|P5|STARTED|Double Blind Period (DBP)||0
8511355|NCT00436826|20977314|P4|STARTED|Double Blind Period (DBP)||0
8511356|NCT00436826|20977315|P3|STARTED|Double Blind Period (DBP)||0
8511357|NCT00436826|20977316|P2|STARTED|Double Blind Period (DBP)||48
8511358|NCT00436826|20977317|P1|STARTED|Double Blind Period (DBP)||124
8511359|NCT00436748|20977415|P2|NOT COMPLETED|Overall Study||12
8511360|NCT00436748|20977416|P1|NOT COMPLETED|Overall Study||11
8511361|NCT00436748|20977415|P2|COMPLETED|Overall Study||45
8511362|NCT00436748|20977416|P1|COMPLETED|Overall Study||48
8511363|NCT00436748|20977415|P2|Received Treatment|Overall Study||56
8511364|NCT00436748|20977416|P1|Received Treatment|Overall Study||58
8511365|NCT00436748|20977415|P2|STARTED|Overall Study||57
8511366|NCT00436748|20977416|P1|STARTED|Overall Study||59
8511367|NCT00436644|20977450|P1|NOT COMPLETED|Overall Study||3
8511368|NCT00436644|20977450|P1|COMPLETED|Overall Study||15
8511369|NCT00436644|20977450|P1|STARTED|Overall Study||18
8511370|NCT00436618|20977460|P3|NOT COMPLETED|Overall Study||61
8511371|NCT00436618|20977461|P2|NOT COMPLETED|Overall Study||27
8511372|NCT00436618|20977462|P1|NOT COMPLETED|Overall Study||30
8511373|NCT00436618|20977460|P3|COMPLETED|Overall Study||46
8511374|NCT00436618|20977461|P2|COMPLETED|Overall Study||28
8511375|NCT00436618|20977462|P1|COMPLETED|Overall Study||84
8511376|NCT00436618|20977460|P3|STARTED|Overall Study||107
8511377|NCT00436618|20977461|P2|STARTED|Overall Study||55
8511378|NCT00436618|20977462|P1|STARTED|Overall Study||114
8511379|NCT00436605|20977479|P1|NOT COMPLETED|Overall Study||3
8511380|NCT00436605|20977479|P1|COMPLETED|Overall Study||36
8511381|NCT00436605|20977479|P1|STARTED|Overall Study||39
8511382|NCT00436566|20977484|P1|NOT COMPLETED|Overall Study||3
8511383|NCT00436566|20977484|P1|COMPLETED|Overall Study||109
8511384|NCT00436566|20977484|P1|STARTED|Overall Study||112
8511385|NCT00436553|20977491|P3|NOT COMPLETED|Overall Study||10
8511386|NCT00436553|20977492|P2|NOT COMPLETED|Overall Study||12
8511387|NCT00436553|20977493|P1|NOT COMPLETED|Overall Study||13
8511388|NCT00436553|20977491|P3|COMPLETED|Overall Study||102
8511389|NCT00436553|20977492|P2|COMPLETED|Overall Study||93
8511390|NCT00436553|20977493|P1|COMPLETED|Overall Study|Completed the 12 month study phase.|91
8511391|NCT00436553|20977491|P3|STARTED|Overall Study||112
8511392|NCT00436553|20977492|P2|STARTED|Overall Study||105
8511393|NCT00436553|20977493|P1|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
8511394|NCT00436501|20977514|P2|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
8511395|NCT00436501|20977515|P1|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
8511396|NCT00436501|20977514|P2|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
8511397|NCT00436501|20977515|P1|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
8511398|NCT00436501|20977514|P2|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
8511399|NCT00436501|20977515|P1|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
8511400|NCT00436501|20977514|P2|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
8511401|NCT00436501|20977515|P1|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
8511402|NCT00436501|20977514|P2|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
8511403|NCT00436501|20977515|P1|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
8511404|NCT00436501|20977514|P2|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
8511405|NCT00436501|20977515|P1|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
8511406|NCT00436501|20977514|P2|NOT COMPLETED|Complete Study Participation||0
8511407|NCT00436501|20977515|P1|NOT COMPLETED|Complete Study Participation||0
8511408|NCT00436501|20977514|P2|COMPLETED|Complete Study Participation||49
8511409|NCT00436501|20977515|P1|COMPLETED|Complete Study Participation||9
8511410|NCT00436501|20977514|P2|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
8511411|NCT00436501|20977515|P1|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
8511412|NCT00436475|20977534|P4|NOT COMPLETED|Overall Study||2
8511413|NCT00436475|20977535|P3|NOT COMPLETED|Overall Study||1
8511414|NCT00436475|20977536|P2|NOT COMPLETED|Overall Study||1
8511415|NCT00436475|20977537|P1|NOT COMPLETED|Overall Study||0
8511416|NCT00436475|20977534|P4|COMPLETED|Overall Study||22
8511417|NCT00436475|20977535|P3|COMPLETED|Overall Study||21
8511418|NCT00436475|20977536|P2|COMPLETED|Overall Study||22
8511419|NCT00436475|20977537|P1|COMPLETED|Overall Study||23
8511420|NCT00436475|20977534|P4|STARTED|Overall Study||24
8511421|NCT00436475|20977535|P3|STARTED|Overall Study||22
8511422|NCT00436475|20977536|P2|STARTED|Overall Study||23
8511423|NCT00436475|20977537|P1|STARTED|Overall Study||23
8511424|NCT00436436|20977551|P1|NOT COMPLETED|Overall Study||12
8511425|NCT00436436|20977551|P1|COMPLETED|Overall Study||0
8511426|NCT00436436|20977551|P1|STARTED|Overall Study||12
8511427|NCT00436345|20977562|P2|NOT COMPLETED|Overall Study||0
8511428|NCT00436345|20977563|P1|NOT COMPLETED|Overall Study||3
8511429|NCT00436345|20977562|P2|COMPLETED|Overall Study||18
8511430|NCT00436345|20977563|P1|COMPLETED|Overall Study||18
8511431|NCT00436345|20977562|P2|STARTED|Overall Study||18
8511432|NCT00436345|20977563|P1|STARTED|Overall Study||21
8511433|NCT00436332|20977616|P1|NOT COMPLETED|Overall Study||83
8511434|NCT00436332|20977616|P1|COMPLETED|Overall Study||1
8511435|NCT00436332|20977616|P1|Eligible and Began Protocol Therapy|Overall Study||79
8511436|NCT00436332|20977616|P1|Eligible|Overall Study||82
8511437|NCT00436332|20977616|P1|STARTED|Overall Study||84
8511438|NCT00436280|20977623|P1|NOT COMPLETED|Period 3: Maintenance||18
8511439|NCT00436280|20977623|P1|COMPLETED|Period 3: Maintenance||5
8511440|NCT00436280|20977623|P1|STARTED|Period 3: Maintenance||23
8511441|NCT00436280|20977623|P1|NOT COMPLETED|Period 2: Consolidation||17
8511442|NCT00436280|20977623|P1|COMPLETED|Period 2: Consolidation||23
8511443|NCT00436280|20977623|P1|STARTED|Period 2: Consolidation||40
8511444|NCT00436280|20977623|P1|NOT COMPLETED|Period 1: Induction||28
8511445|NCT00436280|20977623|P1|COMPLETED|Period 1: Induction||40
8511446|NCT00436280|20977623|P1|Received at Least 1 Dose of Study Drug|Period 1: Induction||68
8511447|NCT00436280|20977623|P1|STARTED|Period 1: Induction||68
8511448|NCT00436215|20977637|P1|NOT COMPLETED|Overall Study||4
8511449|NCT00436215|20977637|P1|COMPLETED|Overall Study||51
8511450|NCT00436215|20977637|P1|STARTED|Overall Study||55
8511451|NCT00436163|20977643|P1|NOT COMPLETED|Overall Study||3
8511452|NCT00436163|20977643|P1|COMPLETED|Overall Study||36
8511453|NCT00436163|20977643|P1|STARTED|Overall Study||39
8511454|NCT00436046|20977657|P3|NOT COMPLETED|Overall Study||0
8511455|NCT00436046|20977658|P2|NOT COMPLETED|Overall Study||0
8511456|NCT00436046|20977659|P1|NOT COMPLETED|Overall Study||0
8511457|NCT00436046|20977657|P3|COMPLETED|Overall Study||31
8511458|NCT00436046|20977658|P2|COMPLETED|Overall Study||32
8511459|NCT00436046|20977659|P1|COMPLETED|Overall Study||32
8511460|NCT00436046|20977657|P3|STARTED|Overall Study||31
8511461|NCT00436046|20977658|P2|STARTED|Overall Study||32
8511462|NCT00436046|20977659|P1|STARTED|Overall Study||32
8511463|NCT00436007|20977691|P3|NOT COMPLETED|Overall Study||23
8511464|NCT00436007|20977692|P2|NOT COMPLETED|Overall Study||14
8511465|NCT00436007|20977693|P1|NOT COMPLETED|Overall Study||19
8511466|NCT00436007|20977691|P3|COMPLETED|Overall Study||148
8511467|NCT00436007|20977692|P2|COMPLETED|Overall Study||156
8511468|NCT00436007|20977693|P1|COMPLETED|Overall Study||151
8511469|NCT00436007|20977691|P3|STARTED|Overall Study||171
8511470|NCT00436007|20977692|P2|STARTED|Overall Study||170
8511471|NCT00436007|20977693|P1|STARTED|Overall Study||170
8511472|NCT00435994|20977741|P3|NOT COMPLETED|Overall Study||0
8511473|NCT00435994|20977742|P2|NOT COMPLETED|Overall Study||0
8511474|NCT00435994|20977743|P1|NOT COMPLETED|Overall Study||7
8511475|NCT00435994|20977741|P3|COMPLETED|Overall Study||12
8511476|NCT00435994|20977742|P2|COMPLETED|Overall Study||25
8511477|NCT00435994|20977743|P1|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
8511478|NCT00435994|20977741|P3|STARTED|Overall Study||12
8511479|NCT00435994|20977742|P2|STARTED|Overall Study||25
8511480|NCT00435994|20977743|P1|STARTED|Overall Study||22
8511481|NCT00435942|20977754|P2|NOT COMPLETED|Overall Study||27
8511482|NCT00435942|20977755|P1|NOT COMPLETED|Overall Study||23
8511483|NCT00435942|20977754|P2|COMPLETED|Overall Study||33
8511484|NCT00435942|20977755|P1|COMPLETED|Overall Study||97
8511485|NCT00435942|20977754|P2|STARTED|Overall Study||60
8511486|NCT00435942|20977755|P1|STARTED|Overall Study||120
8511487|NCT00435929|20977764|P2|NOT COMPLETED|Overall Study||0
8511488|NCT00435929|20977765|P1|NOT COMPLETED|Overall Study||0
8511489|NCT00435929|20977764|P2|COMPLETED|Overall Study||9
8511490|NCT00435929|20977765|P1|COMPLETED|Overall Study||7
8511491|NCT00435929|20977764|P2|STARTED|Overall Study||9
8511492|NCT00435929|20977765|P1|STARTED|Overall Study||7
8511493|NCT00435825|20977795|P4|NOT COMPLETED|Overall Study||16
8511494|NCT00435825|20977796|P3|NOT COMPLETED|Overall Study||11
8511495|NCT00435825|20977797|P2|NOT COMPLETED|Overall Study||12
8511496|NCT00435825|20977798|P1|NOT COMPLETED|Overall Study||18
8511497|NCT00435825|20977795|P4|COMPLETED|Overall Study||120
8511498|NCT00435825|20977796|P3|COMPLETED|Overall Study||127
8511499|NCT00435825|20977797|P2|COMPLETED|Overall Study||124
8511500|NCT00435825|20977798|P1|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
8511501|NCT00435825|20977795|P4|Completed 48 Weeks Treatment|Overall Study||117
8511502|NCT00435825|20977796|P3|Completed 48 Weeks Treatment|Overall Study||124
8511503|NCT00435825|20977797|P2|Completed 48 Weeks Treatment|Overall Study||0
8511504|NCT00435825|20977798|P1|Completed 48 Weeks Treatment|Overall Study||0
8511505|NCT00435825|20977795|P4|Completed 24 Weeks Treatment|Overall Study||131
8511506|NCT00435825|20977796|P3|Completed 24 Weeks Treatment|Overall Study||134
8511507|NCT00435825|20977797|P2|Completed 24 Weeks Treatment|Overall Study||126
8511508|NCT00435825|20977798|P1|Completed 24 Weeks Treatment|Overall Study||128
8511509|NCT00435825|20977795|P4|Entered Follow-up|Overall Study||133
8511510|NCT00435825|20977796|P3|Entered Follow-up|Overall Study||135
8511511|NCT00435825|20977797|P2|Entered Follow-up|Overall Study||132
8511512|NCT00435825|20977798|P1|Entered Follow-up|Overall Study||140
8511513|NCT00435825|20977795|P4|Received Study Drug|Overall Study||136
8511514|NCT00435825|20977796|P3|Received Study Drug|Overall Study||136
8511515|NCT00435825|20977797|P2|Received Study Drug|Overall Study||136
8511516|NCT00435825|20977798|P1|Received Study Drug|Overall Study||140
8511517|NCT00435825|20977795|P4|STARTED|Overall Study||136
8511518|NCT00435825|20977796|P3|STARTED|Overall Study||138
8511519|NCT00435825|20977797|P2|STARTED|Overall Study||136
8511520|NCT00435825|20977798|P1|STARTED|Overall Study||141
8511521|NCT00435812|20977854|P2|NOT COMPLETED|Overall Study||18
8511522|NCT00435812|20977855|P1|NOT COMPLETED|Overall Study||63
8511523|NCT00435812|20977854|P2|COMPLETED|Overall Study||590
8511524|NCT00435812|20977855|P1|COMPLETED|Overall Study||1757
8511525|NCT00435812|20977854|P2|STARTED|Overall Study||608
8511526|NCT00435812|20977855|P1|STARTED|Overall Study||1820
8511527|NCT00435591|20977867|P4|NOT COMPLETED|Overall Study||11
8511528|NCT00435591|20977868|P3|NOT COMPLETED|Overall Study||5
8511529|NCT00435591|20977869|P2|NOT COMPLETED|Overall Study||4
8511530|NCT00435591|20977870|P1|NOT COMPLETED|Overall Study||7
8511531|NCT00435591|20977867|P4|COMPLETED|Overall Study||19
8511532|NCT00435591|20977868|P3|COMPLETED|Overall Study||25
8511533|NCT00435591|20977869|P2|COMPLETED|Overall Study||27
8511534|NCT00435591|20977870|P1|COMPLETED|Overall Study||23
8511535|NCT00435591|20977867|P4|End of Treatment|Overall Study||23
8511536|NCT00435591|20977868|P3|End of Treatment|Overall Study||27
8511537|NCT00435591|20977869|P2|End of Treatment|Overall Study||27
8511538|NCT00435591|20977870|P1|End of Treatment|Overall Study||25
8511539|NCT00435591|20977867|P4|Full Analysis Set|Overall Study||29
8511540|NCT00435591|20977868|P3|Full Analysis Set|Overall Study||30
8511541|NCT00435591|20977869|P2|Full Analysis Set|Overall Study||29
8511542|NCT00435591|20977870|P1|Full Analysis Set|Overall Study||28
8511543|NCT00435591|20977867|P4|Safety Analysis Set|Overall Study||29
8511544|NCT00435591|20977868|P3|Safety Analysis Set|Overall Study||30
8511545|NCT00435591|20977869|P2|Safety Analysis Set|Overall Study||30
8511546|NCT00435591|20977870|P1|Safety Analysis Set|Overall Study||28
8511547|NCT00435591|20977867|P4|STARTED|Overall Study||30
8511548|NCT00435591|20977868|P3|STARTED|Overall Study||30
8511549|NCT00435591|20977869|P2|STARTED|Overall Study||31
8511550|NCT00435591|20977870|P1|STARTED|Overall Study||30
8511551|NCT00435539|20977900|P5|NOT COMPLETED|Overall Study||0
8511552|NCT00435539|20977901|P4|NOT COMPLETED|Overall Study||0
8511553|NCT00435539|20977902|P3|NOT COMPLETED|Overall Study||0
8511554|NCT00435539|20977903|P2|NOT COMPLETED|Overall Study||0
8511555|NCT00435539|20977904|P1|NOT COMPLETED|Overall Study||0
8511556|NCT00435539|20977900|P5|COMPLETED|Overall Study||12
8511557|NCT00435539|20977901|P4|COMPLETED|Overall Study||12
8511558|NCT00435539|20977902|P3|COMPLETED|Overall Study||11
8511559|NCT00435539|20977903|P2|COMPLETED|Overall Study||13
8511560|NCT00435539|20977904|P1|COMPLETED|Overall Study||12
8511561|NCT00435539|20977900|P5|STARTED|Overall Study||12
8511562|NCT00435539|20977901|P4|STARTED|Overall Study||12
8511563|NCT00435539|20977902|P3|STARTED|Overall Study||11
8511564|NCT00435539|20977903|P2|STARTED|Overall Study||13
8511565|NCT00435539|20977904|P1|STARTED|Overall Study||12
8511566|NCT00435487|20977921|P2|NOT COMPLETED|Overall Study||15
8511567|NCT00435487|20977922|P1|NOT COMPLETED|Overall Study||12
8511568|NCT00435487|20977921|P2|COMPLETED|Overall Study||71
8511569|NCT00435487|20977922|P1|COMPLETED|Overall Study||76
8511570|NCT00435487|20977921|P2|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
8511571|NCT00435487|20977922|P1|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
8511572|NCT00435487|20977921|P2|STARTED|Overall Study||86
8511573|NCT00435487|20977922|P1|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
8511574|NCT00435461|20977941|P3|NOT COMPLETED|Overall Study||24
8511575|NCT00435461|20977942|P2|NOT COMPLETED|Overall Study||14
8511576|NCT00435461|20977943|P1|NOT COMPLETED|Overall Study||23
8511577|NCT00435461|20977941|P3|COMPLETED|Overall Study||287
8511578|NCT00435461|20977942|P2|COMPLETED|Overall Study||298
8511579|NCT00435461|20977943|P1|COMPLETED|Overall Study||290
8511580|NCT00435461|20977941|P3|STARTED|Overall Study||311
8511581|NCT00435461|20977942|P2|STARTED|Overall Study||312
8511582|NCT00435461|20977943|P1|STARTED|Overall Study||313
8511583|NCT00435409|20977980|P3|NOT COMPLETED|Overall Study||78
8511584|NCT00435409|20977981|P2|NOT COMPLETED|Overall Study||143
8511585|NCT00435409|20977982|P1|NOT COMPLETED|Overall Study||221
8511586|NCT00435409|20977980|P3|COMPLETED|Overall Study||0
8511587|NCT00435409|20977981|P2|COMPLETED|Overall Study||0
8511588|NCT00435409|20977982|P1|COMPLETED|Overall Study||0
8511589|NCT00435409|20977980|P3|Treated|Overall Study||78
8511590|NCT00435409|20977981|P2|Treated|Overall Study||139
8511591|NCT00435409|20977982|P1|Treated|Overall Study||217
8511592|NCT00435409|20977980|P3|STARTED|Overall Study||78
8511593|NCT00435409|20977981|P2|STARTED|Overall Study||143
8511594|NCT00435409|20977982|P1|STARTED|Overall Study||221
8511595|NCT00435370|20978004|P2|NOT COMPLETED|Overall Study||20
8511596|NCT00435370|20978005|P1|NOT COMPLETED|Overall Study||22
8511597|NCT00435370|20978004|P2|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
8511598|NCT00435370|20978005|P1|COMPLETED|Overall Study||68
8511599|NCT00435370|20978004|P2|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
8511600|NCT00435370|20978005|P1|STARTED|Overall Study||90
8511601|NCT00435188|20978013|P2|NOT COMPLETED|Overall Study||23
8511602|NCT00435188|20978014|P1|NOT COMPLETED|Overall Study||22
8511603|NCT00435188|20978013|P2|COMPLETED|Overall Study||176
8511604|NCT00435188|20978014|P1|COMPLETED|Overall Study||177
8511605|NCT00435188|20978013|P2|STARTED|Overall Study||199
8511606|NCT00435188|20978014|P1|STARTED|Overall Study||199
8511607|NCT00435162|20978057|P6|NOT COMPLETED|Period 2 (2 Weeks)||0
8511608|NCT00435162|20978058|P5|NOT COMPLETED|Period 2 (2 Weeks)||0
8511609|NCT00435162|20978059|P4|NOT COMPLETED|Period 2 (2 Weeks)||0
8511610|NCT00435162|20978060|P3|NOT COMPLETED|Period 2 (2 Weeks)||0
8511611|NCT00435162|20978061|P2|NOT COMPLETED|Period 2 (2 Weeks)||1
8511612|NCT00435162|20978062|P1|NOT COMPLETED|Period 2 (2 Weeks)||0
8511613|NCT00435162|20978057|P6|COMPLETED|Period 2 (2 Weeks)||15
8511614|NCT00435162|20978058|P5|COMPLETED|Period 2 (2 Weeks)||15
8511615|NCT00435162|20978059|P4|COMPLETED|Period 2 (2 Weeks)||8
8511616|NCT00435162|20978060|P3|COMPLETED|Period 2 (2 Weeks)||6
8511617|NCT00435162|20978061|P2|COMPLETED|Period 2 (2 Weeks)||14
8511618|NCT00435162|20978062|P1|COMPLETED|Period 2 (2 Weeks)||15
8511619|NCT00435162|20978057|P6|STARTED|Period 2 (2 Weeks)||15
8511620|NCT00435162|20978058|P5|STARTED|Period 2 (2 Weeks)||15
8511621|NCT00435162|20978059|P4|STARTED|Period 2 (2 Weeks)||8
8511622|NCT00435162|20978060|P3|STARTED|Period 2 (2 Weeks)||6
8511623|NCT00435162|20978061|P2|STARTED|Period 2 (2 Weeks)||15
8511624|NCT00435162|20978062|P1|STARTED|Period 2 (2 Weeks)||15
8511625|NCT00435162|20978057|P6|NOT COMPLETED|Period 1 (6 Weeks)||0
8511626|NCT00435162|20978058|P5|NOT COMPLETED|Period 1 (6 Weeks)||0
8511627|NCT00435162|20978059|P4|NOT COMPLETED|Period 1 (6 Weeks)||0
8511628|NCT00435162|20978060|P3|NOT COMPLETED|Period 1 (6 Weeks)||0
8511629|NCT00435162|20978061|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
8511630|NCT00435162|20978062|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
8511631|NCT00435162|20978057|P6|COMPLETED|Period 1 (6 Weeks)||15
8511632|NCT00435162|20978058|P5|COMPLETED|Period 1 (6 Weeks)||15
8511633|NCT00435162|20978059|P4|COMPLETED|Period 1 (6 Weeks)||8
8511634|NCT00435162|20978060|P3|COMPLETED|Period 1 (6 Weeks)||6
8511635|NCT00435162|20978061|P2|COMPLETED|Period 1 (6 Weeks)||15
8511636|NCT00435162|20978062|P1|COMPLETED|Period 1 (6 Weeks)||15
8511637|NCT00435162|20978057|P6|STARTED|Period 1 (6 Weeks)||15
8511638|NCT00435162|20978058|P5|STARTED|Period 1 (6 Weeks)||15
8511639|NCT00435162|20978059|P4|STARTED|Period 1 (6 Weeks)||8
8511640|NCT00435162|20978060|P3|STARTED|Period 1 (6 Weeks)||6
8511641|NCT00435162|20978061|P2|STARTED|Period 1 (6 Weeks)||15
8511642|NCT00435162|20978062|P1|STARTED|Period 1 (6 Weeks)||15
8511643|NCT00435045|20978082|P2|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
8511644|NCT00435045|20978083|P1|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
8511645|NCT00435045|20978082|P2|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
8511646|NCT00435045|20978083|P1|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
8511647|NCT00435045|20978082|P2|STARTED|Weeks 13-16 / 40mg Dose Level||113
8511648|NCT00435045|20978083|P1|STARTED|Weeks 13-16 / 40mg Dose Level||113
8511649|NCT00435045|20978082|P2|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
8511650|NCT00435045|20978083|P1|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
8511651|NCT00435045|20978082|P2|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
8511652|NCT00435045|20978083|P1|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
8511653|NCT00435045|20978082|P2|STARTED|Weeks 9-12 / 20mg Dose Level||118
8511654|NCT00435045|20978083|P1|STARTED|Weeks 9-12 / 20mg Dose Level||118
8511655|NCT00435045|20978082|P2|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
8511656|NCT00435045|20978083|P1|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
8511657|NCT00435045|20978082|P2|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
8511658|NCT00435045|20978083|P1|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
8511659|NCT00435045|20978082|P2|STARTED|Weeks 1-8 / 10 mg Dose Level||122
8511660|NCT00435045|20978083|P1|STARTED|Weeks 1-8 / 10 mg Dose Level||123
8511661|NCT00435019|20978139|P2|NOT COMPLETED|Overall Study||10
8511662|NCT00435019|20978140|P1|NOT COMPLETED|Overall Study||13
8511663|NCT00435019|20978139|P2|COMPLETED|Overall Study||161
8511664|NCT00435019|20978140|P1|COMPLETED|Overall Study||164
8511665|NCT00435019|20978139|P2|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
8511666|NCT00435019|20978140|P1|Exposed to Study Drug|Overall Study||177
8511667|NCT00435019|20978139|P2|STARTED|Overall Study|Randomised|171
8511668|NCT00435019|20978140|P1|STARTED|Overall Study|Randomised|177
8511669|NCT00434993|20978152|P2|NOT COMPLETED|Overall Study||0
8511670|NCT00434993|20978153|P1|NOT COMPLETED|Overall Study||0
8511671|NCT00434993|20978152|P2|COMPLETED|Overall Study||130
8511672|NCT00434993|20978153|P1|COMPLETED|Overall Study||152
8511673|NCT00434993|20978152|P2|STARTED|Overall Study||130
8511674|NCT00434993|20978153|P1|STARTED|Overall Study||152
8511675|NCT00434967|20978181|P4|NOT COMPLETED|Overall Study||14
8511676|NCT00434967|20978182|P3|NOT COMPLETED|Overall Study||9
8511677|NCT00434967|20978183|P2|NOT COMPLETED|Overall Study||8
8511678|NCT00434967|20978184|P1|NOT COMPLETED|Overall Study||7
8511679|NCT00434967|20978181|P4|COMPLETED|Overall Study||478
8511680|NCT00434967|20978182|P3|COMPLETED|Overall Study||461
8511681|NCT00434967|20978183|P2|COMPLETED|Overall Study||457
8511682|NCT00434967|20978184|P1|COMPLETED|Overall Study||90
8511683|NCT00434967|20978181|P4|STARTED|Overall Study||492
8511684|NCT00434967|20978182|P3|STARTED|Overall Study||470
8511685|NCT00434967|20978183|P2|STARTED|Overall Study||465
8511686|NCT00434967|20978184|P1|STARTED|Overall Study||97
8511687|NCT00434954|20978204|P2|NOT COMPLETED|Overall Study||71
8511688|NCT00434954|20978205|P1|NOT COMPLETED|Overall Study||82
8511689|NCT00434954|20978204|P2|COMPLETED|Overall Study||175
8511690|NCT00434954|20978205|P1|COMPLETED|Overall Study||166
8511691|NCT00434954|20978204|P2|Completed - Previous Treatment MET + SU|Overall Study||38
8511692|NCT00434954|20978205|P1|Completed - Previous Treatment MET + SU|Overall Study||31
8511693|NCT00434954|20978204|P2|Completed - Previous Treatment MET Only|Overall Study||137
8511694|NCT00434954|20978205|P1|Completed - Previous Treatment MET Only|Overall Study||135
8511695|NCT00434954|20978204|P2|FAS - Previous Treatment MET + SU|Overall Study||60
8511696|NCT00434954|20978205|P1|FAS - Previous Treatment MET + SU|Overall Study||66
8511697|NCT00434954|20978204|P2|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
8511698|NCT00434954|20978205|P1|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
8511699|NCT00434954|20978204|P2|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
8511700|NCT00434954|20978205|P1|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
8511701|NCT00434954|20978204|P2|Started - Previous Treatment MET + SU|Overall Study||65
8511702|NCT00434954|20978205|P1|Started - Previous Treatment MET + SU|Overall Study||66
8511703|NCT00434954|20978204|P2|Started - Previous Treatment MET Only|Overall Study||181
8511704|NCT00434954|20978205|P1|Started - Previous Treatment MET Only|Overall Study||182
8511705|NCT00434954|20978204|P2|STARTED|Overall Study||246
8511706|NCT00434954|20978205|P1|STARTED|Overall Study||248
8511707|NCT00434876|20978235|P2|NOT COMPLETED|Overall Study||1
8511708|NCT00434876|20978236|P1|NOT COMPLETED|Overall Study||1
8511709|NCT00434876|20978235|P2|COMPLETED|Overall Study||10
8511710|NCT00434876|20978236|P1|COMPLETED|Overall Study||10
8511711|NCT00434876|20978235|P2|STARTED|Overall Study||11
8511712|NCT00434876|20978236|P1|STARTED|Overall Study||11
8511713|NCT00434759|20978250|P2|NOT COMPLETED|Overall Study||5
8511714|NCT00434759|20978251|P1|NOT COMPLETED|Overall Study||24
8511715|NCT00434759|20978250|P2|COMPLETED|Overall Study||38
8511716|NCT00434759|20978251|P1|COMPLETED|Overall Study||22
8511717|NCT00434759|20978250|P2|STARTED|Overall Study||43
8511718|NCT00434759|20978251|P1|STARTED|Overall Study||46
8511719|NCT00434642|20978267|P2|NOT COMPLETED|Open-label Treatment Phase||11
8511720|NCT00434642|20978268|P1|NOT COMPLETED|Open-label Treatment Phase||0
8511721|NCT00434642|20978267|P2|COMPLETED|Open-label Treatment Phase||1
8511722|NCT00434642|20978268|P1|COMPLETED|Open-label Treatment Phase||0
8511820|NCT00434434|20978588|P1|COMPLETED|Overall Study||21
8511723|NCT00434642|20978267|P2|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
8511724|NCT00434642|20978268|P1|STARTED|Open-label Treatment Phase||0
8511725|NCT00434642|20978267|P2|NOT COMPLETED|Blinded Treatment Phase||229
8511726|NCT00434642|20978268|P1|NOT COMPLETED|Blinded Treatment Phase||242
8511727|NCT00434642|20978267|P2|COMPLETED|Blinded Treatment Phase||13
8511728|NCT00434642|20978268|P1|COMPLETED|Blinded Treatment Phase||0
8511729|NCT00434642|20978267|P2|STARTED|Blinded Treatment Phase||242
8511730|NCT00434642|20978268|P1|STARTED|Blinded Treatment Phase||242
8511731|NCT00434590|20978286|P2|NOT COMPLETED|Overall Study||5
8511732|NCT00434590|20978287|P1|NOT COMPLETED|Overall Study||5
8511733|NCT00434590|20978286|P2|COMPLETED|Overall Study||0
8511734|NCT00434590|20978287|P1|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
8511735|NCT00434590|20978286|P2|STARTED|Overall Study||5
8511736|NCT00434590|20978287|P1|STARTED|Overall Study||5
8511737|NCT00434577|20978298|P5|NOT COMPLETED|Month 36||0
8511738|NCT00434577|20978299|P4|NOT COMPLETED|Month 36||0
8511739|NCT00434577|20978300|P3|NOT COMPLETED|Month 36||0
8511740|NCT00434577|20978301|P2|NOT COMPLETED|Month 36||0
8511741|NCT00434577|20978302|P1|NOT COMPLETED|Month 36||0
8511742|NCT00434577|20978298|P5|COMPLETED|Month 36||47
8511743|NCT00434577|20978299|P4|COMPLETED|Month 36||155
8511744|NCT00434577|20978300|P3|COMPLETED|Month 36||150
8511745|NCT00434577|20978301|P2|COMPLETED|Month 36||147
8511746|NCT00434577|20978302|P1|COMPLETED|Month 36||147
8511747|NCT00434577|20978298|P5|STARTED|Month 36||47
8511748|NCT00434577|20978299|P4|STARTED|Month 36||155
8511749|NCT00434577|20978300|P3|STARTED|Month 36||150
8511750|NCT00434577|20978301|P2|STARTED|Month 36||147
8511751|NCT00434577|20978302|P1|STARTED|Month 36||147
8511752|NCT00434577|20978298|P5|NOT COMPLETED|Month 24||0
8511753|NCT00434577|20978299|P4|NOT COMPLETED|Month 24||0
8511754|NCT00434577|20978300|P3|NOT COMPLETED|Month 24||0
8511755|NCT00434577|20978301|P2|NOT COMPLETED|Month 24||0
8511756|NCT00434577|20978302|P1|NOT COMPLETED|Month 24||0
8511757|NCT00434577|20978298|P5|COMPLETED|Month 24||49
8511758|NCT00434577|20978299|P4|COMPLETED|Month 24||157
8511759|NCT00434577|20978300|P3|COMPLETED|Month 24||154
8511760|NCT00434577|20978301|P2|COMPLETED|Month 24||155
8511761|NCT00434577|20978302|P1|COMPLETED|Month 24||150
8511762|NCT00434577|20978298|P5|STARTED|Month 24||49
8511763|NCT00434577|20978299|P4|STARTED|Month 24||157
8511764|NCT00434577|20978300|P3|STARTED|Month 24||154
8511765|NCT00434577|20978301|P2|STARTED|Month 24||155
8511766|NCT00434577|20978302|P1|STARTED|Month 24||150
8511767|NCT00434577|20978298|P5|NOT COMPLETED|Month 12||0
8511768|NCT00434577|20978299|P4|NOT COMPLETED|Month 12||0
8511769|NCT00434577|20978300|P3|NOT COMPLETED|Month 12||0
8511770|NCT00434577|20978301|P2|NOT COMPLETED|Month 12||0
8511771|NCT00434577|20978302|P1|NOT COMPLETED|Month 12||0
8511772|NCT00434577|20978298|P5|COMPLETED|Month 12||50
8511773|NCT00434577|20978299|P4|COMPLETED|Month 12||161
8511774|NCT00434577|20978300|P3|COMPLETED|Month 12||159
8511775|NCT00434577|20978301|P2|COMPLETED|Month 12||159
8511776|NCT00434577|20978302|P1|COMPLETED|Month 12||156
8511777|NCT00434577|20978298|P5|STARTED|Month 12||50
8511778|NCT00434577|20978299|P4|STARTED|Month 12||161
8511779|NCT00434577|20978300|P3|STARTED|Month 12||159
8511780|NCT00434577|20978301|P2|STARTED|Month 12||159
8511781|NCT00434577|20978302|P1|STARTED|Month 12||156
8511782|NCT00434577|20978298|P5|NOT COMPLETED|Months 0-3||3
8511783|NCT00434577|20978299|P4|NOT COMPLETED|Months 0-3||1
8511784|NCT00434577|20978300|P3|NOT COMPLETED|Months 0-3||4
8511785|NCT00434577|20978301|P2|NOT COMPLETED|Months 0-3||2
8511786|NCT00434577|20978302|P1|NOT COMPLETED|Months 0-3||3
8511787|NCT00434577|20978298|P5|COMPLETED|Months 0-3||51
8511788|NCT00434577|20978299|P4|COMPLETED|Months 0-3||164
8511789|NCT00434577|20978300|P3|COMPLETED|Months 0-3||161
8511790|NCT00434577|20978301|P2|COMPLETED|Months 0-3||164
8511791|NCT00434577|20978302|P1|COMPLETED|Months 0-3||161
8511792|NCT00434577|20978298|P5|STARTED|Months 0-3||54
8511793|NCT00434577|20978299|P4|STARTED|Months 0-3||165
8511794|NCT00434577|20978300|P3|STARTED|Months 0-3||165
8511795|NCT00434577|20978301|P2|STARTED|Months 0-3||166
8511796|NCT00434577|20978302|P1|STARTED|Months 0-3||164
8511797|NCT00434512|20978480|P6|NOT COMPLETED|Overall Study||1
8511798|NCT00434512|20978481|P5|NOT COMPLETED|Overall Study||1
8511799|NCT00434512|20978482|P4|NOT COMPLETED|Overall Study||1
8511800|NCT00434512|20978483|P3|NOT COMPLETED|Overall Study||0
8511801|NCT00434512|20978484|P2|NOT COMPLETED|Overall Study||1
8511802|NCT00434512|20978485|P1|NOT COMPLETED|Overall Study||0
8511803|NCT00434512|20978480|P6|COMPLETED|Overall Study||49
8511804|NCT00434512|20978481|P5|COMPLETED|Overall Study||49
8511805|NCT00434512|20978482|P4|COMPLETED|Overall Study||49
8511806|NCT00434512|20978483|P3|COMPLETED|Overall Study||10
8511807|NCT00434512|20978484|P2|COMPLETED|Overall Study||9
8511808|NCT00434512|20978485|P1|COMPLETED|Overall Study||10
8511809|NCT00434512|20978480|P6|STARTED|Overall Study||50
8511810|NCT00434512|20978481|P5|STARTED|Overall Study||50
8511811|NCT00434512|20978482|P4|STARTED|Overall Study||50
8511812|NCT00434512|20978483|P3|STARTED|Overall Study||10
8511813|NCT00434512|20978484|P2|STARTED|Overall Study||10
8511814|NCT00434512|20978485|P1|STARTED|Overall Study||10
8511815|NCT00434434|20978586|P3|NOT COMPLETED|Overall Study||1
8511816|NCT00434434|20978587|P2|NOT COMPLETED|Overall Study||0
8511817|NCT00434434|20978588|P1|NOT COMPLETED|Overall Study||2
8511818|NCT00434434|20978586|P3|COMPLETED|Overall Study||13
8511819|NCT00434434|20978587|P2|COMPLETED|Overall Study||24
8511821|NCT00434434|20978586|P3|STARTED|Overall Study||14
8511822|NCT00434434|20978587|P2|STARTED|Overall Study||24
8511823|NCT00434434|20978588|P1|STARTED|Overall Study||23
8511824|NCT00434421|20978599|P1|NOT COMPLETED|Overall Study||2
8511825|NCT00434421|20978599|P1|COMPLETED|Overall Study||26
8511826|NCT00434421|20978599|P1|STARTED|Overall Study||28
8511827|NCT00434356|20978605|P2|NOT COMPLETED|Overall Study||23
8511828|NCT00434356|20978606|P1|NOT COMPLETED|Overall Study||23
8511829|NCT00434356|20978605|P2|COMPLETED|Overall Study||0
8511830|NCT00434356|20978606|P1|COMPLETED|Overall Study||0
8511831|NCT00434356|20978605|P2|STARTED|Overall Study||23
8511832|NCT00434356|20978606|P1|STARTED|Overall Study||23
8511833|NCT00434330|20978627|P6|NOT COMPLETED|Overall Study||1
8511834|NCT00434330|20978628|P5|NOT COMPLETED|Overall Study||1
8511835|NCT00434330|20978629|P4|NOT COMPLETED|Overall Study||2
8511836|NCT00434330|20978630|P3|NOT COMPLETED|Overall Study||3
8511837|NCT00434330|20978631|P2|NOT COMPLETED|Overall Study||0
8511838|NCT00434330|20978632|P1|NOT COMPLETED|Overall Study||1
8511839|NCT00434330|20978627|P6|COMPLETED|Overall Study||14
8511840|NCT00434330|20978628|P5|COMPLETED|Overall Study||14
8511841|NCT00434330|20978629|P4|COMPLETED|Overall Study||13
8511842|NCT00434330|20978630|P3|COMPLETED|Overall Study||13
8511843|NCT00434330|20978631|P2|COMPLETED|Overall Study||15
8511844|NCT00434330|20978632|P1|COMPLETED|Overall Study||14
8511845|NCT00434330|20978627|P6|STARTED|Overall Study||15
8511846|NCT00434330|20978628|P5|STARTED|Overall Study||15
8511847|NCT00434330|20978629|P4|STARTED|Overall Study||15
8511848|NCT00434330|20978630|P3|STARTED|Overall Study||16
8511849|NCT00434330|20978631|P2|STARTED|Overall Study||15
8511850|NCT00434330|20978632|P1|STARTED|Overall Study||15
8511851|NCT00434304|20978664|P1|NOT COMPLETED|Overall Study||20
8511852|NCT00434304|20978664|P1|COMPLETED|Overall Study||42
8511853|NCT00434304|20978664|P1|STARTED|Overall Study||62
8511854|NCT00434278|20978702|P2|NOT COMPLETED|Overall Study||0
8511855|NCT00434278|20978703|P1|NOT COMPLETED|Overall Study||2
8511856|NCT00434278|20978702|P2|COMPLETED|Overall Study||13
8511857|NCT00434278|20978703|P1|COMPLETED|Overall Study||12
8511858|NCT00434278|20978702|P2|STARTED|Overall Study||13
8511859|NCT00434278|20978703|P1|STARTED|Overall Study||14
8511860|NCT00434252|20978713|P2|NOT COMPLETED|Overall Study||131
8511861|NCT00434252|20978714|P1|NOT COMPLETED|Overall Study||64
8511862|NCT00434252|20978713|P2|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
8511863|NCT00434252|20978714|P1|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
8511864|NCT00434252|20978713|P2|Treated|Overall Study||143
8511865|NCT00434252|20978714|P1|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
8511866|NCT00434252|20978713|P2|STARTED|Overall Study||143
8511867|NCT00434252|20978714|P1|STARTED|Overall Study||71
8511868|NCT00434226|20978736|P2|NOT COMPLETED|Overall Study||26
8511869|NCT00434226|20978737|P1|NOT COMPLETED|Overall Study||30
8511870|NCT00434226|20978736|P2|COMPLETED|Overall Study||0
8511871|NCT00434226|20978737|P1|COMPLETED|Overall Study||0
8511872|NCT00434226|20978736|P2|STARTED|Overall Study||26
8511873|NCT00434226|20978737|P1|STARTED|Overall Study||30
8511874|NCT00434213|20978748|P1|NOT COMPLETED|Overall Study||49
8511875|NCT00434213|20978748|P1|COMPLETED|Overall Study||260
8511876|NCT00434213|20978748|P1|STARTED|Overall Study||309
8511877|NCT00434161|20978756|P3|NOT COMPLETED|Overall Study||11
8511878|NCT00434161|20978757|P2|NOT COMPLETED|Overall Study||3
8511879|NCT00434161|20978758|P1|NOT COMPLETED|Overall Study||10
8511880|NCT00434161|20978756|P3|COMPLETED|Overall Study||104
8511881|NCT00434161|20978757|P2|COMPLETED|Overall Study||54
8511882|NCT00434161|20978758|P1|COMPLETED|Overall Study||99
8511883|NCT00434161|20978756|P3|STARTED|Overall Study||115
8511884|NCT00434161|20978757|P2|STARTED|Overall Study||57
8511885|NCT00434161|20978758|P1|STARTED|Overall Study||109
8511886|NCT00434148|20978802|P2|NOT COMPLETED|Overall Study||73
8511887|NCT00434148|20978803|P1|NOT COMPLETED|Overall Study||69
8511888|NCT00434148|20978802|P2|COMPLETED|Overall Study||7
8511889|NCT00434148|20978803|P1|COMPLETED|Overall Study||13
8511890|NCT00434148|20978802|P2|Completed Month 12; Entered Extension|Overall Study||32
8511891|NCT00434148|20978803|P1|Completed Month 12; Entered Extension|Overall Study||26
8511892|NCT00434148|20978802|P2|Completed m. 12; Did Not Enter Extension|Overall Study||7
8511893|NCT00434148|20978803|P1|Completed m. 12; Did Not Enter Extension|Overall Study||13
8511894|NCT00434148|20978802|P2|Completed Month 12|Overall Study||39
8511895|NCT00434148|20978803|P1|Completed Month 12|Overall Study||39
8511896|NCT00434148|20978802|P2|STARTED|Overall Study||80
8511897|NCT00434148|20978803|P1|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
8511898|NCT00434122|20978839|P2|NOT COMPLETED|Overall Study||7
8511899|NCT00434122|20978840|P1|NOT COMPLETED|Overall Study||6
8511900|NCT00434122|20978839|P2|COMPLETED|Overall Study||36
8511901|NCT00434122|20978840|P1|COMPLETED|Overall Study||36
8511902|NCT00434122|20978839|P2|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
8511903|NCT00434122|20978840|P1|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
8511904|NCT00434122|20978839|P2|STARTED|Overall Study|Randomised|43
8511905|NCT00434122|20978840|P1|STARTED|Overall Study|Randomised|42
8511906|NCT00434109|20978849|P1|NOT COMPLETED|Overall Study||18
8511907|NCT00434109|20978849|P1|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
8511908|NCT00434109|20978849|P1|STARTED|Overall Study||39
8511909|NCT00434057|20978858|P1|NOT COMPLETED|Overall Study||1
8511910|NCT00434057|20978858|P1|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
8511911|NCT00434057|20978858|P1|STARTED|Overall Study||1383
8511912|NCT00434018|20978864|P2|NOT COMPLETED|Overall Study||12
8511913|NCT00434018|20978865|P1|NOT COMPLETED|Overall Study||17
8511914|NCT00434018|20978864|P2|COMPLETED|Overall Study||57
8511915|NCT00434018|20978865|P1|COMPLETED|Overall Study||52
8511916|NCT00434018|20978864|P2|STARTED|Overall Study||69
8511917|NCT00434018|20978865|P1|STARTED|Overall Study||69
8511918|NCT00433992|20978883|P2|NOT COMPLETED|Overall Study||8
8511919|NCT00433992|20978884|P1|NOT COMPLETED|Overall Study||9
8511920|NCT00433992|20978883|P2|COMPLETED|Overall Study||20
8511921|NCT00433992|20978884|P1|COMPLETED|Overall Study||19
8511922|NCT00433992|20978883|P2|STARTED|Overall Study||28
8511923|NCT00433992|20978884|P1|STARTED|Overall Study||28
8511924|NCT00433966|20978896|P4|NOT COMPLETED|Stent Intervention/Randomization||62
8511925|NCT00433966|20978897|P3|NOT COMPLETED|Stent Intervention/Randomization||154
8511926|NCT00433966|20978898|P2|NOT COMPLETED|Stent Intervention/Randomization||0
8511927|NCT00433966|20978899|P1|NOT COMPLETED|Stent Intervention/Randomization||0
8511928|NCT00433966|20978896|P4|COMPLETED|Stent Intervention/Randomization||687
8511929|NCT00433966|20978897|P3|COMPLETED|Stent Intervention/Randomization||2103
8511930|NCT00433966|20978898|P2|COMPLETED|Stent Intervention/Randomization||0
8511931|NCT00433966|20978899|P1|COMPLETED|Stent Intervention/Randomization||0
8511932|NCT00433966|20978896|P4|3-Year Follow-up|Stent Intervention/Randomization||687
8511933|NCT00433966|20978897|P3|3-Year Follow-up|Stent Intervention/Randomization||2103
8511934|NCT00433966|20978898|P2|3-Year Follow-up|Stent Intervention/Randomization||0
8511935|NCT00433966|20978899|P1|3-Year Follow-up|Stent Intervention/Randomization||0
8511936|NCT00433966|20978896|P4|1-Year Follow-up|Stent Intervention/Randomization||715
8511937|NCT00433966|20978897|P3|1-Year Follow-up|Stent Intervention/Randomization||2186
8511938|NCT00433966|20978898|P2|1-Year Follow-up|Stent Intervention/Randomization||0
8511939|NCT00433966|20978899|P1|1-Year Follow-up|Stent Intervention/Randomization||0
8511940|NCT00433966|20978896|P4|STARTED|Stent Intervention/Randomization||749
8511941|NCT00433966|20978897|P3|STARTED|Stent Intervention/Randomization||2257
8511942|NCT00433966|20978898|P2|STARTED|Stent Intervention/Randomization||0
8511943|NCT00433966|20978899|P1|STARTED|Stent Intervention/Randomization||0
8511944|NCT00433966|20978896|P4|NOT COMPLETED|Pharmacology Intervention/Randomization||0
8511945|NCT00433966|20978897|P3|NOT COMPLETED|Pharmacology Intervention/Randomization||0
8511946|NCT00433966|20978898|P2|NOT COMPLETED|Pharmacology Intervention/Randomization||174
8511947|NCT00433966|20978899|P1|NOT COMPLETED|Pharmacology Intervention/Randomization||166
8511948|NCT00433966|20978896|P4|COMPLETED|Pharmacology Intervention/Randomization||0
8511949|NCT00433966|20978897|P3|COMPLETED|Pharmacology Intervention/Randomization||0
8511950|NCT00433966|20978898|P2|COMPLETED|Pharmacology Intervention/Randomization||1628
8511951|NCT00433966|20978899|P1|COMPLETED|Pharmacology Intervention/Randomization||1634
8511952|NCT00433966|20978896|P4|3-Year Follow-up|Pharmacology Intervention/Randomization||0
8511953|NCT00433966|20978897|P3|3-Year Follow-up|Pharmacology Intervention/Randomization||0
8511954|NCT00433966|20978898|P2|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
8511955|NCT00433966|20978899|P1|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
8511956|NCT00433966|20978896|P4|1-Year Follow-up|Pharmacology Intervention/Randomization||0
8511957|NCT00433966|20978897|P3|1-Year Follow-up|Pharmacology Intervention/Randomization||0
8511958|NCT00433966|20978898|P2|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
8511959|NCT00433966|20978899|P1|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
8511960|NCT00433966|20978896|P4|30-Day Follow-up|Pharmacology Intervention/Randomization||0
8511961|NCT00433966|20978897|P3|30-Day Follow-up|Pharmacology Intervention/Randomization||0
8511962|NCT00433966|20978898|P2|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
8511963|NCT00433966|20978899|P1|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
8511964|NCT00433966|20978896|P4|STARTED|Pharmacology Intervention/Randomization||0
8511965|NCT00433966|20978897|P3|STARTED|Pharmacology Intervention/Randomization||0
8511966|NCT00433966|20978898|P2|STARTED|Pharmacology Intervention/Randomization||1802
8511967|NCT00433966|20978899|P1|STARTED|Pharmacology Intervention/Randomization||1800
8511968|NCT00433914|20978921|P2|NOT COMPLETED|Overall Study||3
8511969|NCT00433914|20978922|P1|NOT COMPLETED|Overall Study||0
8511970|NCT00433914|20978921|P2|COMPLETED|Overall Study||27
8511971|NCT00433914|20978922|P1|COMPLETED|Overall Study||30
8511972|NCT00433914|20978921|P2|STARTED|Overall Study||30
8511973|NCT00433914|20978922|P1|STARTED|Overall Study||30
8511974|NCT00433836|20978942|P2|NOT COMPLETED|Overall Study||6
8511975|NCT00433836|20978943|P1|NOT COMPLETED|Overall Study||13
8511976|NCT00433836|20978942|P2|COMPLETED|Overall Study||143
8511977|NCT00433836|20978943|P1|COMPLETED|Overall Study||138
8511978|NCT00433836|20978942|P2|STARTED|Overall Study||149
8511979|NCT00433836|20978943|P1|STARTED|Overall Study||151
8511980|NCT00433771|20978955|P1|NOT COMPLETED|Overall Study||19
8511981|NCT00433771|20978955|P1|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
8511982|NCT00433771|20978955|P1|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
8511983|NCT00433745|20978971|P1|NOT COMPLETED|Overall Study||0
8511984|NCT00433745|20978971|P1|COMPLETED|Overall Study||4
8511985|NCT00433745|20978971|P1|STARTED|Overall Study||4
8511986|NCT00433654|20978978|P2|NOT COMPLETED|Overall Study||5
8511987|NCT00433654|20978979|P1|NOT COMPLETED|Overall Study||15
8511988|NCT00433654|20978978|P2|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
8512071|NCT00433290|20979092|P1|STARTED|Overall Study||128
8511989|NCT00433654|20978979|P1|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
8511990|NCT00433654|20978978|P2|STARTED|Overall Study||206
8511991|NCT00433654|20978979|P1|STARTED|Overall Study||258
8511992|NCT00433550|20979013|P3|NOT COMPLETED|Overall Study||0
8511993|NCT00433550|20979014|P2|NOT COMPLETED|Overall Study||0
8511994|NCT00433550|20979015|P1|NOT COMPLETED|Overall Study||0
8511995|NCT00433550|20979013|P3|COMPLETED|Overall Study||6
8511996|NCT00433550|20979014|P2|COMPLETED|Overall Study||10
8511997|NCT00433550|20979015|P1|COMPLETED|Overall Study||17
8511998|NCT00433550|20979013|P3|STARTED|Overall Study||6
8511999|NCT00433550|20979014|P2|STARTED|Overall Study||10
8512000|NCT00433550|20979015|P1|STARTED|Overall Study||17
8512001|NCT00433537|20979025|P3|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
8512002|NCT00433537|20979026|P2|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
8512003|NCT00433537|20979027|P1|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
8512004|NCT00433537|20979025|P3|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
8512005|NCT00433537|20979026|P2|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
8512006|NCT00433537|20979027|P1|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
8512007|NCT00433537|20979025|P3|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
8512008|NCT00433537|20979026|P2|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
8512009|NCT00433537|20979027|P1|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
8512010|NCT00433537|20979025|P3|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
8512011|NCT00433537|20979026|P2|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
8512012|NCT00433537|20979027|P1|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
8512013|NCT00433537|20979025|P3|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
8512014|NCT00433537|20979026|P2|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
8512015|NCT00433537|20979027|P1|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
8512016|NCT00433537|20979025|P3|COMPLETED|Step 1 - VcR-CVAD Induction||1
8512017|NCT00433537|20979026|P2|COMPLETED|Step 1 - VcR-CVAD Induction||22
8512018|NCT00433537|20979027|P1|COMPLETED|Step 1 - VcR-CVAD Induction||44
8512019|NCT00433537|20979025|P3|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
8512020|NCT00433537|20979026|P2|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
8512021|NCT00433537|20979027|P1|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
8512022|NCT00433537|20979025|P3|STARTED|Step 1 - VcR-CVAD Induction||10
8512023|NCT00433537|20979026|P2|STARTED|Step 1 - VcR-CVAD Induction||22
8512024|NCT00433537|20979027|P1|STARTED|Step 1 - VcR-CVAD Induction||45
8512052|NCT00433446|20979055|P1|NOT COMPLETED|Overall Study||61
8512053|NCT00433446|20979055|P1|COMPLETED|Overall Study||1
8512054|NCT00433446|20979055|P1|Eligible and Began Protocol Therapy|Overall Study||53
8512055|NCT00433446|20979055|P1|Eligible|Overall Study||53
8512056|NCT00433446|20979055|P1|STARTED|Overall Study||62
8512057|NCT00433381|20979065|P2|NOT COMPLETED|Overall Study||3
8512058|NCT00433381|20979066|P1|NOT COMPLETED|Overall Study||3
8512059|NCT00433381|20979065|P2|COMPLETED|Overall Study||57
8512060|NCT00433381|20979066|P1|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
8512061|NCT00433381|20979065|P2|STARTED|Overall Study||60
8512062|NCT00433381|20979066|P1|STARTED|Overall Study||63
8512063|NCT00433329|20979085|P1|NOT COMPLETED|Overall Study||21
8512064|NCT00433329|20979085|P1|COMPLETED|Overall Study||79
8512065|NCT00433329|20979085|P1|STARTED|Overall Study||100
8512066|NCT00433290|20979091|P2|NOT COMPLETED|Overall Study||17
8512067|NCT00433290|20979092|P1|NOT COMPLETED|Overall Study||35
8512068|NCT00433290|20979091|P2|COMPLETED|Overall Study||111
8512069|NCT00433290|20979092|P1|COMPLETED|Overall Study||93
8512070|NCT00433290|20979091|P2|STARTED|Overall Study||128
8512072|NCT00433199|20979161|P2|NOT COMPLETED|Open-Label Period||34
8512073|NCT00433199|20979162|P1|NOT COMPLETED|Open-Label Period||0
8512074|NCT00433199|20979161|P2|COMPLETED|Open-Label Period||185
8512075|NCT00433199|20979162|P1|COMPLETED|Open-Label Period||0
8512076|NCT00433199|20979161|P2|STARTED|Open-Label Period||219
8512077|NCT00433199|20979162|P1|STARTED|Open-Label Period||0
8512078|NCT00433199|20979161|P2|NOT COMPLETED|Double-Blind Period||66
8512079|NCT00433199|20979162|P1|NOT COMPLETED|Double-Blind Period||12
8512080|NCT00433199|20979161|P2|COMPLETED|Double-Blind Period||168
8512081|NCT00433199|20979162|P1|COMPLETED|Double-Blind Period||28
8512082|NCT00433199|20979161|P2|STARTED|Double-Blind Period||234
8512083|NCT00433199|20979162|P1|STARTED|Double-Blind Period||40
8512084|NCT00433160|20979182|P2|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
8512085|NCT00433160|20979183|P1|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
8512086|NCT00433160|20979182|P2|COMPLETED|104 Weeks, 28-Week OL Period||47
8512087|NCT00433160|20979183|P1|COMPLETED|104 Weeks, 28-Week OL Period||92
8512088|NCT00433160|20979182|P2|Received Treatment|104 Weeks, 28-Week OL Period||50
8512089|NCT00433160|20979183|P1|Received Treatment|104 Weeks, 28-Week OL Period||102
8512090|NCT00433160|20979182|P2|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
8512091|NCT00433160|20979183|P1|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
8512092|NCT00433160|20979182|P2|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
8512093|NCT00433160|20979183|P1|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
8512094|NCT00433160|20979182|P2|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
8512095|NCT00433160|20979183|P1|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
8512096|NCT00433160|20979182|P2|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
8512097|NCT00433160|20979183|P1|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
8512098|NCT00433160|20979182|P2|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
8512099|NCT00433160|20979183|P1|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
8512100|NCT00433160|20979182|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
8512101|NCT00433160|20979183|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
8512102|NCT00433160|20979182|P2|COMPLETED|52-Week Double-Blind (DB) Period||60
8512103|NCT00433160|20979183|P1|COMPLETED|52-Week Double-Blind (DB) Period||120
8512104|NCT00433160|20979182|P2|Received Treatment|52-Week Double-Blind (DB) Period||68
8512105|NCT00433160|20979183|P1|Received Treatment|52-Week Double-Blind (DB) Period||136
8512106|NCT00433160|20979182|P2|STARTED|52-Week Double-Blind (DB) Period||70
8512107|NCT00433160|20979183|P1|STARTED|52-Week Double-Blind (DB) Period||137
8512108|NCT00433147|20979235|P4|NOT COMPLETED|Overall Study||0
8512109|NCT00433147|20979236|P3|NOT COMPLETED|Overall Study||0
8512110|NCT00433147|20979237|P2|NOT COMPLETED|Overall Study||1
8512111|NCT00433147|20979238|P1|NOT COMPLETED|Overall Study||0
8512112|NCT00433147|20979235|P4|COMPLETED|Overall Study||7
8512113|NCT00433147|20979236|P3|COMPLETED|Overall Study||9
8512114|NCT00433147|20979237|P2|COMPLETED|Overall Study||6
8512115|NCT00433147|20979238|P1|COMPLETED|Overall Study||7
8512116|NCT00433147|20979235|P4|Received at Least One Dose of Study Drug|Overall Study||7
8512117|NCT00433147|20979236|P3|Received at Least One Dose of Study Drug|Overall Study||9
8512118|NCT00433147|20979237|P2|Received at Least One Dose of Study Drug|Overall Study||7
8512119|NCT00433147|20979238|P1|Received at Least One Dose of Study Drug|Overall Study||7
8512120|NCT00433147|20979235|P4|PD Population|Overall Study||7
8512121|NCT00433147|20979236|P3|PD Population|Overall Study||9
8512122|NCT00433147|20979237|P2|PD Population|Overall Study||6
8512123|NCT00433147|20979238|P1|PD Population|Overall Study||7
8512124|NCT00433147|20979235|P4|Safety Population|Overall Study||7
8512125|NCT00433147|20979236|P3|Safety Population|Overall Study||9
8512126|NCT00433147|20979237|P2|Safety Population|Overall Study||7
8512127|NCT00433147|20979238|P1|Safety Population|Overall Study||7
8512128|NCT00433147|20979235|P4|STARTED|Overall Study||7
8512129|NCT00433147|20979236|P3|STARTED|Overall Study||9
8512130|NCT00433147|20979237|P2|STARTED|Overall Study||7
8512131|NCT00433147|20979238|P1|STARTED|Overall Study||7
8512132|NCT00433017|20979254|P2|NOT COMPLETED|Overall Study||101
8512133|NCT00433017|20979255|P1|NOT COMPLETED|Overall Study||96
8512134|NCT00433017|20979254|P2|COMPLETED|Overall Study||32
8512135|NCT00433017|20979255|P1|COMPLETED|Overall Study||26
8512136|NCT00433017|20979254|P2|Completed 12 Month Phase|Overall Study||126
8512137|NCT00433017|20979255|P1|Completed 12 Month Phase|Overall Study||114
8512138|NCT00433017|20979254|P2|STARTED|Overall Study||133
8512139|NCT00433017|20979255|P1|STARTED|Overall Study||122
8512140|NCT00433004|20979271|P2|NOT COMPLETED|Overall Study||7
8512141|NCT00433004|20979272|P1|NOT COMPLETED|Overall Study||5
8512142|NCT00433004|20979271|P2|COMPLETED|Overall Study||16
8512143|NCT00433004|20979272|P1|COMPLETED|Overall Study||22
8512144|NCT00433004|20979271|P2|STARTED|Overall Study||23
8512145|NCT00433004|20979272|P1|STARTED|Overall Study||27
8512146|NCT00432991|20979284|P2|NOT COMPLETED|Overall Study||12
8512147|NCT00432991|20979285|P1|NOT COMPLETED|Overall Study||7
8512148|NCT00432991|20979284|P2|COMPLETED|Overall Study||19
8512149|NCT00432991|20979285|P1|COMPLETED|Overall Study||15
8512150|NCT00432991|20979284|P2|STARTED|Overall Study||31
8512151|NCT00432991|20979285|P1|STARTED|Overall Study||22
8512152|NCT00432965|20979297|P2|NOT COMPLETED|Overall Study||86
8512153|NCT00432965|20979298|P1|NOT COMPLETED|Overall Study||94
8512154|NCT00432965|20979297|P2|COMPLETED|Overall Study||80
8512155|NCT00432965|20979298|P1|COMPLETED|Overall Study||75
8512156|NCT00432965|20979297|P2|STARTED|Overall Study||166
8512157|NCT00432965|20979298|P1|STARTED|Overall Study||169
8512158|NCT00432835|20979306|P2|NOT COMPLETED|Overall Study||7
8512159|NCT00432835|20979307|P1|NOT COMPLETED|Overall Study||6
8512160|NCT00432835|20979306|P2|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
8512161|NCT00432835|20979307|P1|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
8512162|NCT00432835|20979306|P2|Completed 2nd Intervention|Overall Study||23
8512163|NCT00432835|20979307|P1|Completed 2nd Intervention|Overall Study||22
8512164|NCT00432835|20979306|P2|Completed 1st Intervention|Overall Study||23
8512165|NCT00432835|20979307|P1|Completed 1st Intervention|Overall Study||22
8512166|NCT00432835|20979306|P2|STARTED|Overall Study||30
8512167|NCT00432835|20979307|P1|STARTED|Overall Study||28
8512168|NCT00432809|20979320|P3|NOT COMPLETED|2 Year Sub-study||1
8512169|NCT00432809|20979321|P2|NOT COMPLETED|2 Year Sub-study||2
8512170|NCT00432809|20979322|P1|NOT COMPLETED|2 Year Sub-study||3
8512171|NCT00432809|20979320|P3|COMPLETED|2 Year Sub-study||19
8512172|NCT00432809|20979321|P2|COMPLETED|2 Year Sub-study||18
8512173|NCT00432809|20979322|P1|COMPLETED|2 Year Sub-study||17
8512174|NCT00432809|20979320|P3|STARTED|2 Year Sub-study||20
8512175|NCT00432809|20979321|P2|STARTED|2 Year Sub-study||20
8512176|NCT00432809|20979322|P1|STARTED|2 Year Sub-study||20
8512177|NCT00432809|20979320|P3|NOT COMPLETED|1 Year Follow-up||1
8512178|NCT00432809|20979321|P2|NOT COMPLETED|1 Year Follow-up||0
8512179|NCT00432809|20979322|P1|NOT COMPLETED|1 Year Follow-up||9
8512180|NCT00432809|20979320|P3|COMPLETED|1 Year Follow-up||49
8512181|NCT00432809|20979321|P2|COMPLETED|1 Year Follow-up||50
8512182|NCT00432809|20979322|P1|COMPLETED|1 Year Follow-up||41
8512183|NCT00432809|20979320|P3|STARTED|1 Year Follow-up||50
8512184|NCT00432809|20979321|P2|STARTED|1 Year Follow-up||50
8512185|NCT00432809|20979322|P1|STARTED|1 Year Follow-up||50
8512186|NCT00432744|20979395|P2|NOT COMPLETED|Months 7 - 12||1
8512187|NCT00432744|20979396|P1|NOT COMPLETED|Months 7 - 12||1
8512188|NCT00432744|20979395|P2|COMPLETED|Months 7 - 12||7
8512189|NCT00432744|20979396|P1|COMPLETED|Months 7 - 12||6
8512190|NCT00432744|20979395|P2|STARTED|Months 7 - 12||8
8512191|NCT00432744|20979396|P1|STARTED|Months 7 - 12||7
8512192|NCT00432744|20979395|P2|NOT COMPLETED|Months 0-6||4
8512193|NCT00432744|20979396|P1|NOT COMPLETED|Months 0-6||5
8512194|NCT00432744|20979395|P2|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
8512195|NCT00432744|20979396|P1|COMPLETED|Months 0-6||7
8512196|NCT00432744|20979395|P2|STARTED|Months 0-6||12
8512197|NCT00432744|20979396|P1|STARTED|Months 0-6||12
8512198|NCT00432679|20979408|P2|NOT COMPLETED|Overall Study||3
8512199|NCT00432679|20979409|P1|NOT COMPLETED|Overall Study||5
8512200|NCT00432679|20979408|P2|COMPLETED|Overall Study||72
8512201|NCT00432679|20979409|P1|COMPLETED|Overall Study||69
8512202|NCT00432679|20979408|P2|STARTED|Overall Study||75
8512203|NCT00432679|20979409|P1|STARTED|Overall Study||74
8512204|NCT00432666|20979433|P2|NOT COMPLETED|Open-Label Extension Period||0
8512205|NCT00432666|20979434|P1|NOT COMPLETED|Open-Label Extension Period||25
8512206|NCT00432666|20979433|P2|COMPLETED|Open-Label Extension Period||0
8512207|NCT00432666|20979434|P1|COMPLETED|Open-Label Extension Period||120
8512208|NCT00432666|20979433|P2|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
8512209|NCT00432666|20979434|P1|STARTED|Open-Label Extension Period||145
8512210|NCT00432666|20979433|P2|NOT COMPLETED|Main Period||1
8512211|NCT00432666|20979434|P1|NOT COMPLETED|Main Period||2
8512212|NCT00432666|20979433|P2|COMPLETED|Main Period||74
8512213|NCT00432666|20979434|P1|COMPLETED|Main Period||71
8512214|NCT00432666|20979433|P2|STARTED|Main Period||75
8512215|NCT00432666|20979434|P1|STARTED|Main Period||73
8512216|NCT00432601|20979598|P2|NOT COMPLETED|Time 2 to Time 3||22
8512217|NCT00432601|20979599|P1|NOT COMPLETED|Time 2 to Time 3||19
8512218|NCT00432601|20979598|P2|COMPLETED|Time 2 to Time 3||122
8512219|NCT00432601|20979599|P1|COMPLETED|Time 2 to Time 3||122
8512220|NCT00432601|20979598|P2|STARTED|Time 2 to Time 3||144
8512221|NCT00432601|20979599|P1|STARTED|Time 2 to Time 3||141
8512222|NCT00432601|20979598|P2|NOT COMPLETED|Time 1 to Time 2||368
8512223|NCT00432601|20979599|P1|NOT COMPLETED|Time 1 to Time 2||369
8512224|NCT00432601|20979598|P2|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
8512225|NCT00432601|20979599|P1|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
8512226|NCT00432601|20979598|P2|STARTED|Time 1 to Time 2||512
8512227|NCT00432601|20979599|P1|STARTED|Time 1 to Time 2||510
8512228|NCT00432562|20979607|P2|NOT COMPLETED|Overall Study||0
8512229|NCT00432562|20979608|P1|NOT COMPLETED|Overall Study||3
8512230|NCT00432562|20979607|P2|COMPLETED|Overall Study||15
8512231|NCT00432562|20979608|P1|COMPLETED|Overall Study||13
8512232|NCT00432562|20979607|P2|STARTED|Overall Study||15
8512233|NCT00432562|20979608|P1|STARTED|Overall Study||16
8512234|NCT00432458|20979634|P2|NOT COMPLETED|Overall Study||1
8512235|NCT00432458|20979635|P1|NOT COMPLETED|Overall Study||5
8512236|NCT00432458|20979634|P2|COMPLETED|Overall Study||32
8512237|NCT00432458|20979635|P1|COMPLETED|Overall Study||30
8512238|NCT00432458|20979634|P2|STARTED|Overall Study||33
8512239|NCT00432458|20979635|P1|STARTED|Overall Study||35
8512240|NCT00432445|20979653|P1|NOT COMPLETED|Overall Study||0
8512241|NCT00432445|20979653|P1|COMPLETED|Overall Study||2
8512242|NCT00432445|20979653|P1|STARTED|Overall Study||2
8512243|NCT00432380|20979660|P3|NOT COMPLETED|Overall Study||1
8512244|NCT00432380|20979661|P2|NOT COMPLETED|Overall Study||4
8512245|NCT00432380|20979662|P1|NOT COMPLETED|Overall Study||4
8512246|NCT00432380|20979660|P3|COMPLETED|Overall Study||74
8512247|NCT00432380|20979661|P2|COMPLETED|Overall Study||146
8512248|NCT00432380|20979662|P1|COMPLETED|Overall Study||146
8512249|NCT00432380|20979660|P3|STARTED|Overall Study||75
8512250|NCT00432380|20979661|P2|STARTED|Overall Study||150
8512251|NCT00432380|20979662|P1|STARTED|Overall Study||150
8512252|NCT00432341|20979688|P2|NOT COMPLETED|Overall Study||0
8512253|NCT00432341|20979689|P1|NOT COMPLETED|Overall Study||0
8512254|NCT00432341|20979688|P2|COMPLETED|Overall Study||30
8512255|NCT00432341|20979689|P1|COMPLETED|Overall Study||24
8512256|NCT00432341|20979688|P2|STARTED|Overall Study||30
8512257|NCT00432341|20979689|P1|STARTED|Overall Study||24
8512258|NCT00432276|20979715|P2|NOT COMPLETED|Overall Study||156
8512259|NCT00432276|20979716|P1|NOT COMPLETED|Overall Study||121
8512260|NCT00432276|20979715|P2|COMPLETED|Overall Study||243
8512261|NCT00432276|20979716|P1|COMPLETED|Overall Study||283
8512262|NCT00432276|20979715|P2|Per Protocol Set|Overall Study||306
8512263|NCT00432276|20979716|P1|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
8512264|NCT00432276|20979715|P2|STARTED|Overall Study||399
8512265|NCT00432276|20979716|P1|STARTED|Overall Study||404
8512266|NCT00432237|20979806|P4|NOT COMPLETED|Overall Study||124
8512267|NCT00432237|20979807|P3|NOT COMPLETED|Overall Study||109
8512268|NCT00432237|20979808|P2|NOT COMPLETED|Overall Study||101
8512269|NCT00432237|20979809|P1|NOT COMPLETED|Overall Study||67
8512270|NCT00432237|20979806|P4|COMPLETED|Overall Study||366
8512271|NCT00432237|20979807|P3|COMPLETED|Overall Study||375
8512272|NCT00432237|20979808|P2|COMPLETED|Overall Study||384
8512273|NCT00432237|20979809|P1|COMPLETED|Overall Study||177
8512274|NCT00432237|20979806|P4|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
8512275|NCT00432237|20979807|P3|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
8512276|NCT00432237|20979808|P2|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
8512277|NCT00432237|20979809|P1|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
8512278|NCT00432237|20979806|P4|Completed--With Data|Overall Study||365
8512279|NCT00432237|20979807|P3|Completed--With Data|Overall Study||370
8512280|NCT00432237|20979808|P2|Completed--With Data|Overall Study||381
8512281|NCT00432237|20979809|P1|Completed--With Data|Overall Study||176
8512282|NCT00432237|20979806|P4|STARTED|Overall Study||490
8512283|NCT00432237|20979807|P3|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
8512284|NCT00432237|20979808|P2|STARTED|Overall Study||485
8512285|NCT00432237|20979809|P1|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
8512286|NCT00432172|20979851|P4|NOT COMPLETED|Overall Study||7
8512287|NCT00432172|20979852|P3|NOT COMPLETED|Overall Study||11
8512288|NCT00432172|20979853|P2|NOT COMPLETED|Overall Study||7
8512289|NCT00432172|20979854|P1|NOT COMPLETED|Overall Study||6
8512290|NCT00432172|20979851|P4|COMPLETED|Overall Study||41
8512291|NCT00432172|20979852|P3|COMPLETED|Overall Study||35
8512292|NCT00432172|20979853|P2|COMPLETED|Overall Study||41
8512293|NCT00432172|20979854|P1|COMPLETED|Overall Study||41
8512294|NCT00432172|20979851|P4|STARTED|Overall Study||48
8512295|NCT00432172|20979852|P3|STARTED|Overall Study||46
8512296|NCT00432172|20979853|P2|STARTED|Overall Study||48
8512297|NCT00432172|20979854|P1|STARTED|Overall Study||47
8512298|NCT00432159|20979879|P5|NOT COMPLETED|Overall Study||10
8512299|NCT00432159|20979880|P4|NOT COMPLETED|Overall Study||5
8512300|NCT00432159|20979881|P3|NOT COMPLETED|Overall Study||4
8512301|NCT00432159|20979882|P2|NOT COMPLETED|Overall Study||30
8512302|NCT00432159|20979883|P1|NOT COMPLETED|Overall Study||22
8512303|NCT00432159|20979879|P5|COMPLETED|Overall Study|Actual (Complete efficacy)|79
8512304|NCT00432159|20979880|P4|COMPLETED|Overall Study|Actual (Complete efficacy)|15
8512305|NCT00432159|20979881|P3|COMPLETED|Overall Study|Actual (Complete efficacy)|35
8512306|NCT00432159|20979882|P2|COMPLETED|Overall Study|Actual (Complete efficacy)|137
8512307|NCT00432159|20979883|P1|COMPLETED|Overall Study|Actual (Complete efficacy)|163
8512308|NCT00432159|20979879|P5|STARTED|Overall Study||89
8512309|NCT00432159|20979880|P4|STARTED|Overall Study||20
8512310|NCT00432159|20979881|P3|STARTED|Overall Study||39
8512311|NCT00432159|20979882|P2|STARTED|Overall Study||167
8512312|NCT00432159|20979883|P1|STARTED|Overall Study||185
8512313|NCT00432042|20979990|P3|NOT COMPLETED|Overall Study||2
8512314|NCT00432042|20979991|P2|NOT COMPLETED|Overall Study||1
8512315|NCT00432042|20979992|P1|NOT COMPLETED|Overall Study||7
8512316|NCT00432042|20979990|P3|COMPLETED|Overall Study||239
8512317|NCT00432042|20979991|P2|COMPLETED|Overall Study||234
8512318|NCT00432042|20979992|P1|COMPLETED|Overall Study||472
8512319|NCT00432042|20979990|P3|Vaccinated|Overall Study||240
8512320|NCT00432042|20979991|P2|Vaccinated|Overall Study||235
8512321|NCT00432042|20979992|P1|Vaccinated|Overall Study||477
8512322|NCT00432042|20979990|P3|STARTED|Overall Study|Number randomized.|241
8512323|NCT00432042|20979991|P2|STARTED|Overall Study|Number randomized.|235
8512324|NCT00432042|20979992|P1|STARTED|Overall Study|Number randomized.|479
8512325|NCT00431964|20980005|P2|NOT COMPLETED|Overall Study||8
8512326|NCT00431964|20980006|P1|NOT COMPLETED|Overall Study||6
8512327|NCT00431964|20980005|P2|COMPLETED|Overall Study||124
8512328|NCT00431964|20980006|P1|COMPLETED|Overall Study||125
8512329|NCT00431964|20980005|P2|Withdrew From Study|Overall Study||5
8512330|NCT00431964|20980006|P1|Withdrew From Study|Overall Study||6
8512331|NCT00431964|20980005|P2|Did Not Receive Drug|Overall Study||3
8512332|NCT00431964|20980006|P1|Did Not Receive Drug|Overall Study||0
8512333|NCT00431964|20980005|P2|Randomized/Received Drug|Overall Study||129
8512334|NCT00431964|20980006|P1|Randomized/Received Drug|Overall Study||131
8512335|NCT00431964|20980005|P2|STARTED|Overall Study||132
8512336|NCT00431964|20980006|P1|STARTED|Overall Study||131
8512337|NCT00431951|20980016|P4|NOT COMPLETED|Overall Study||2
8512338|NCT00431951|20980017|P3|NOT COMPLETED|Overall Study||2
8512339|NCT00431951|20980018|P2|NOT COMPLETED|Overall Study||2
8512340|NCT00431951|20980019|P1|NOT COMPLETED|Overall Study||1
8512341|NCT00431951|20980016|P4|COMPLETED|Overall Study||4
8512342|NCT00431951|20980017|P3|COMPLETED|Overall Study||6
8512343|NCT00431951|20980018|P2|COMPLETED|Overall Study||6
8512344|NCT00431951|20980019|P1|COMPLETED|Overall Study||7
8512345|NCT00431951|20980016|P4|STARTED|Overall Study||6
8512346|NCT00431951|20980017|P3|STARTED|Overall Study||8
8512347|NCT00431951|20980018|P2|STARTED|Overall Study||8
8512348|NCT00431951|20980019|P1|STARTED|Overall Study||8
8512349|NCT00431847|20980081|P5|NOT COMPLETED|Overall Study||1
8512350|NCT00431847|20980082|P4|NOT COMPLETED|Overall Study||14
8512351|NCT00431847|20980083|P3|NOT COMPLETED|Overall Study||4
8512352|NCT00431847|20980084|P2|NOT COMPLETED|Overall Study||3
8512353|NCT00431847|20980085|P1|NOT COMPLETED|Overall Study||6
8512354|NCT00431847|20980081|P5|COMPLETED|Overall Study||0
8512355|NCT00431847|20980082|P4|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
8512356|NCT00431847|20980083|P3|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
8512357|NCT00431847|20980084|P2|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
8512358|NCT00431847|20980085|P1|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
8512359|NCT00431847|20980081|P5|STARTED|Overall Study||1
8512360|NCT00431847|20980082|P4|STARTED|Overall Study||184
8512361|NCT00431847|20980083|P3|STARTED|Overall Study||24
8512362|NCT00431847|20980084|P2|STARTED|Overall Study||45
8512363|NCT00431847|20980085|P1|STARTED|Overall Study||132
8512364|NCT00431834|20980159|P1|NOT COMPLETED|Overall Study||13
8512365|NCT00431834|20980159|P1|COMPLETED|Overall Study||62
8512366|NCT00431834|20980159|P1|STARTED|Overall Study||75
8512367|NCT00431626|20980168|P2|NOT COMPLETED|Overall Study||0
8512368|NCT00431626|20980169|P1|NOT COMPLETED|Overall Study||0
8512369|NCT00431626|20980168|P2|COMPLETED|Overall Study||0
8512370|NCT00431626|20980169|P1|COMPLETED|Overall Study||4
8512371|NCT00431626|20980168|P2|STARTED|Overall Study||0
8512372|NCT00431626|20980169|P1|STARTED|Overall Study||4
8512373|NCT00431496|20980175|P1|NOT COMPLETED|Overall Study||11
8512374|NCT00431496|20980175|P1|COMPLETED|Overall Study||60
8512375|NCT00431496|20980175|P1|STARTED|Overall Study||71
8512376|NCT00431444|20980186|P2|NOT COMPLETED|Overall Study||7
8512377|NCT00431444|20980187|P1|NOT COMPLETED|Overall Study||5
8512378|NCT00431444|20980186|P2|COMPLETED|Overall Study||46
8512379|NCT00431444|20980187|P1|COMPLETED|Overall Study||51
8512380|NCT00431444|20980186|P2|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
8512381|NCT00431444|20980187|P1|STARTED|Overall Study||56
8512382|NCT00431184|20980213|P2|NOT COMPLETED|Second Intervention (Day 2)||0
8512383|NCT00431184|20980214|P1|NOT COMPLETED|Second Intervention (Day 2)||0
8512384|NCT00431184|20980213|P2|COMPLETED|Second Intervention (Day 2)||9
8512385|NCT00431184|20980214|P1|COMPLETED|Second Intervention (Day 2)||10
8512386|NCT00431184|20980213|P2|STARTED|Second Intervention (Day 2)||9
8512387|NCT00431184|20980214|P1|STARTED|Second Intervention (Day 2)||10
8512388|NCT00431184|20980213|P2|NOT COMPLETED|1st Intervention (Day 1)||0
8512389|NCT00431184|20980214|P1|NOT COMPLETED|1st Intervention (Day 1)||0
8512390|NCT00431184|20980213|P2|COMPLETED|1st Intervention (Day 1)||9
8512391|NCT00431184|20980214|P1|COMPLETED|1st Intervention (Day 1)||10
8512392|NCT00431184|20980213|P2|STARTED|1st Intervention (Day 1)||9
8512393|NCT00431184|20980214|P1|STARTED|1st Intervention (Day 1)||10
8512394|NCT00431132|20980222|P1|NOT COMPLETED|Overall Study||44
8512395|NCT00431132|20980222|P1|COMPLETED|Overall Study||292
8512396|NCT00431132|20980222|P1|STARTED|Overall Study||336
8512397|NCT00431067|20980227|P1|NOT COMPLETED|Overall Study||41
8512398|NCT00431067|20980227|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
8512399|NCT00431067|20980227|P1|STARTED|Overall Study|52 patients screened, 41 treated|41
8512400|NCT00431041|20980237|P2|NOT COMPLETED|Overall Study||24
8512401|NCT00431041|20980238|P1|NOT COMPLETED|Overall Study||16
8512402|NCT00431041|20980237|P2|COMPLETED|Overall Study||40
8512403|NCT00431041|20980238|P1|COMPLETED|Overall Study||52
8512404|NCT00431041|20980237|P2|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
8512405|NCT00431041|20980238|P1|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
8512406|NCT00430989|20980252|P2|NOT COMPLETED|Overall Study||60
8512407|NCT00430989|20980253|P1|NOT COMPLETED|Overall Study||60
8512408|NCT00430989|20980252|P2|COMPLETED|Overall Study||3509
8512409|NCT00430989|20980253|P1|COMPLETED|Overall Study||3483
8512410|NCT00430989|20980252|P2|STARTED|Overall Study||3569
8512411|NCT00430989|20980253|P1|STARTED|Overall Study||3543
8512412|NCT00430950|20980273|P2|NOT COMPLETED|Overall Study||13
8512413|NCT00430950|20980274|P1|NOT COMPLETED|Overall Study||13
8512414|NCT00430950|20980273|P2|COMPLETED|Overall Study||495
8512415|NCT00430950|20980274|P1|COMPLETED|Overall Study||489
8512416|NCT00430950|20980273|P2|STARTED|Overall Study||508
8512417|NCT00430950|20980274|P1|STARTED|Overall Study||502
8512418|NCT00430937|20980288|P2|NOT COMPLETED|Overall Study||28
8512419|NCT00430937|20980289|P1|NOT COMPLETED|Overall Study||27
8512420|NCT00430937|20980288|P2|COMPLETED|Overall Study||64
8512421|NCT00430937|20980289|P1|COMPLETED|Overall Study||70
8512422|NCT00430937|20980288|P2|STARTED|Overall Study||92
8512423|NCT00430937|20980289|P1|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
8512424|NCT00430781|20980300|P3|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
8512425|NCT00430781|20980301|P2|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
8512426|NCT00430781|20980302|P1|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
8512427|NCT00430781|20980300|P3|COMPLETED|End-of-Study Analysis; 28 July 2011||54
8512428|NCT00430781|20980301|P2|COMPLETED|End-of-Study Analysis; 28 July 2011||59
8512429|NCT00430781|20980302|P1|COMPLETED|End-of-Study Analysis; 28 July 2011||53
8512430|NCT00430781|20980300|P3|STARTED|End-of-Study Analysis; 28 July 2011||74
8512431|NCT00430781|20980301|P2|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
8512432|NCT00430781|20980302|P1|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
8512433|NCT00430781|20980300|P3|NOT COMPLETED|Final Analysis; 31 July 2008||48
8512434|NCT00430781|20980301|P2|NOT COMPLETED|Final Analysis; 31 July 2008||39
8512435|NCT00430781|20980302|P1|NOT COMPLETED|Final Analysis; 31 July 2008||0
8512436|NCT00430781|20980300|P3|COMPLETED|Final Analysis; 31 July 2008||26
8512437|NCT00430781|20980301|P2|COMPLETED|Final Analysis; 31 July 2008||39
8512438|NCT00430781|20980302|P1|COMPLETED|Final Analysis; 31 July 2008||0
8512439|NCT00430781|20980300|P3|Ongoing|Final Analysis; 31 July 2008||32
8512440|NCT00430781|20980301|P2|Ongoing|Final Analysis; 31 July 2008||29
8512441|NCT00430781|20980302|P1|Ongoing|Final Analysis; 31 July 2008||0
8512442|NCT00430781|20980300|P3|STARTED|Final Analysis; 31 July 2008||74
8512443|NCT00430781|20980301|P2|STARTED|Final Analysis; 31 July 2008||78
8512444|NCT00430781|20980302|P1|STARTED|Final Analysis; 31 July 2008||0
8512445|NCT00430781|20980300|P3|NOT COMPLETED|Interim Analysis; 11 February 2008||60
8512446|NCT00430781|20980301|P2|NOT COMPLETED|Interim Analysis; 11 February 2008||58
8512447|NCT00430781|20980302|P1|NOT COMPLETED|Interim Analysis; 11 February 2008||59
8512448|NCT00430781|20980300|P3|COMPLETED|Interim Analysis; 11 February 2008||0
8512449|NCT00430781|20980301|P2|COMPLETED|Interim Analysis; 11 February 2008||0
8512450|NCT00430781|20980302|P1|COMPLETED|Interim Analysis; 11 February 2008||0
8512451|NCT00430781|20980300|P3|Ongoing|Interim Analysis; 11 February 2008||25
8512452|NCT00430781|20980301|P2|Ongoing|Interim Analysis; 11 February 2008||20
8512453|NCT00430781|20980302|P1|Ongoing|Interim Analysis; 11 February 2008||23
8512454|NCT00430781|20980300|P3|STARTED|Interim Analysis; 11 February 2008||60
8512455|NCT00430781|20980301|P2|STARTED|Interim Analysis; 11 February 2008||58
8512456|NCT00430781|20980302|P1|STARTED|Interim Analysis; 11 February 2008||59
8512457|NCT00430768|20980328|P3|NOT COMPLETED|Overall Study||0
8512458|NCT00430768|20980329|P2|NOT COMPLETED|Overall Study||0
8512459|NCT00430768|20980330|P1|NOT COMPLETED|Overall Study||0
8512460|NCT00430768|20980328|P3|COMPLETED|Overall Study||3
8512461|NCT00430768|20980329|P2|COMPLETED|Overall Study||3
8512462|NCT00430768|20980330|P1|COMPLETED|Overall Study||3
8512463|NCT00430768|20980328|P3|STARTED|Overall Study||3
8512464|NCT00430768|20980329|P2|STARTED|Overall Study||3
8512465|NCT00430768|20980330|P1|STARTED|Overall Study||3
8512466|NCT00430755|20980344|P1|NOT COMPLETED|Overall Study||53
8512467|NCT00430755|20980344|P1|COMPLETED|Overall Study||45
8512468|NCT00430755|20980344|P1|STARTED|Overall Study||98
8512469|NCT00430716|20980351|P3|NOT COMPLETED|Open Label Phase||7
8512470|NCT00430716|20980352|P2|NOT COMPLETED|Open Label Phase||7
8512471|NCT00430716|20980353|P1|NOT COMPLETED|Open Label Phase||9
8512472|NCT00430716|20980351|P3|COMPLETED|Open Label Phase||32
8512473|NCT00430716|20980352|P2|COMPLETED|Open Label Phase||31
8512474|NCT00430716|20980353|P1|COMPLETED|Open Label Phase||27
8512475|NCT00430716|20980351|P3|STARTED|Open Label Phase||39
8512476|NCT00430716|20980352|P2|STARTED|Open Label Phase||38
8512477|NCT00430716|20980353|P1|STARTED|Open Label Phase||36
8512478|NCT00430716|20980351|P3|NOT COMPLETED|Double Blind Phase||6
8512479|NCT00430716|20980352|P2|NOT COMPLETED|Double Blind Phase||5
8512480|NCT00430716|20980353|P1|NOT COMPLETED|Double Blind Phase||6
8512481|NCT00430716|20980351|P3|COMPLETED|Double Blind Phase||39
8512482|NCT00430716|20980352|P2|COMPLETED|Double Blind Phase||38
8512483|NCT00430716|20980353|P1|COMPLETED|Double Blind Phase||36
8512484|NCT00430716|20980351|P3|Treated|Double Blind Phase||45
8512485|NCT00430716|20980352|P2|Treated|Double Blind Phase||43
8512486|NCT00430716|20980353|P1|Treated|Double Blind Phase||41
8512487|NCT00430716|20980351|P3|STARTED|Double Blind Phase||45
8512488|NCT00430716|20980352|P2|STARTED|Double Blind Phase||43
8512489|NCT00430716|20980353|P1|STARTED|Double Blind Phase||42
8512490|NCT00430677|20980385|P3|NOT COMPLETED|Long-term Extension Period||63
8512491|NCT00430677|20980386|P2|NOT COMPLETED|Long-term Extension Period||58
8512492|NCT00430677|20980387|P1|NOT COMPLETED|Long-term Extension Period||60
8512493|NCT00430677|20980385|P3|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
8512494|NCT00430677|20980386|P2|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
8512495|NCT00430677|20980387|P1|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
8512496|NCT00430677|20980385|P3|STARTED|Long-term Extension Period||74
8512497|NCT00430677|20980386|P2|STARTED|Long-term Extension Period||67
8512498|NCT00430677|20980387|P1|STARTED|Long-term Extension Period||70
8512499|NCT00430677|20980385|P3|NOT COMPLETED|Short-term Period||22
8512500|NCT00430677|20980386|P2|NOT COMPLETED|Short-term Period||25
8512501|NCT00430677|20980387|P1|NOT COMPLETED|Short-term Period||23
8512502|NCT00430677|20980385|P3|COMPLETED|Short-term Period|Completed the short-term period|78
8512503|NCT00430677|20980386|P2|COMPLETED|Short-term Period|Completed the short-term period|74
8512504|NCT00430677|20980387|P1|COMPLETED|Short-term Period|Completed the short-term period|76
8512505|NCT00430677|20980385|P3|STARTED|Short-term Period||100
8512506|NCT00430677|20980386|P2|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
8512507|NCT00430677|20980387|P1|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
8512508|NCT00430638|20980510|P2|NOT COMPLETED|Overall Study||48
8512509|NCT00430638|20980511|P1|NOT COMPLETED|Overall Study||78
8512510|NCT00430638|20980510|P2|COMPLETED|Overall Study||92
8512511|NCT00430638|20980511|P1|COMPLETED|Overall Study||60
8512512|NCT00430638|20980510|P2|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
8512513|NCT00430638|20980511|P1|STARTED|Overall Study||138
8512520|NCT00430573|20980546|P1|NOT COMPLETED|Overall Study||5
8512521|NCT00430573|20980546|P1|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
8512522|NCT00430573|20980546|P1|STARTED|Overall Study||10
8512523|NCT00430521|20980559|P8|NOT COMPLETED|Overall Study||12
8512524|NCT00430521|20980560|P7|NOT COMPLETED|Overall Study||10
8512525|NCT00430521|20980561|P6|NOT COMPLETED|Overall Study||5
8512526|NCT00430521|20980562|P5|NOT COMPLETED|Overall Study||5
8512527|NCT00430521|20980563|P4|NOT COMPLETED|Overall Study||8
8512528|NCT00430521|20980564|P3|NOT COMPLETED|Overall Study||3
8512529|NCT00430521|20980565|P2|NOT COMPLETED|Overall Study||9
8512530|NCT00430521|20980566|P1|NOT COMPLETED|Overall Study||11
8512531|NCT00430521|20980559|P8|COMPLETED|Overall Study||51
8512532|NCT00430521|20980560|P7|COMPLETED|Overall Study||55
8512533|NCT00430521|20980561|P6|COMPLETED|Overall Study||59
8512534|NCT00430521|20980562|P5|COMPLETED|Overall Study||59
8512535|NCT00430521|20980563|P4|COMPLETED|Overall Study||55
8512536|NCT00430521|20980564|P3|COMPLETED|Overall Study||61
8512537|NCT00430521|20980565|P2|COMPLETED|Overall Study||57
8512538|NCT00430521|20980566|P1|COMPLETED|Overall Study||52
8512539|NCT00430521|20980559|P8|STARTED|Overall Study||63
8512540|NCT00430521|20980560|P7|STARTED|Overall Study||65
8512541|NCT00430521|20980561|P6|STARTED|Overall Study||64
8512542|NCT00430521|20980562|P5|STARTED|Overall Study||64
8512543|NCT00430521|20980563|P4|STARTED|Overall Study||63
8512544|NCT00430521|20980564|P3|STARTED|Overall Study||64
8512545|NCT00430521|20980565|P2|STARTED|Overall Study||66
8512546|NCT00430521|20980566|P1|STARTED|Overall Study||63
8512547|NCT00430508|20980808|P4|NOT COMPLETED|Overall Study||5
8512548|NCT00430508|20980809|P3|NOT COMPLETED|Overall Study||13
8512549|NCT00430508|20980810|P2|NOT COMPLETED|Overall Study||6
8512550|NCT00430508|20980811|P1|NOT COMPLETED|Overall Study||3
8512551|NCT00430508|20980808|P4|COMPLETED|Overall Study||269
8512552|NCT00430508|20980809|P3|COMPLETED|Overall Study||266
8512553|NCT00430508|20980810|P2|COMPLETED|Overall Study||272
8512554|NCT00430508|20980811|P1|COMPLETED|Overall Study||137
8512555|NCT00430508|20980808|P4|STARTED|Overall Study||274
8512556|NCT00430508|20980809|P3|STARTED|Overall Study||279
8512557|NCT00430508|20980810|P2|STARTED|Overall Study||278
8512558|NCT00430508|20980811|P1|STARTED|Overall Study||140
8512559|NCT00430495|20980849|P4|NOT COMPLETED|Overall Study||4
8512560|NCT00430495|20980850|P3|NOT COMPLETED|Overall Study||13
8512561|NCT00430495|20980851|P2|NOT COMPLETED|Overall Study||7
8512562|NCT00430495|20980852|P1|NOT COMPLETED|Overall Study||14
8512563|NCT00430495|20980849|P4|COMPLETED|Overall Study||60
8512564|NCT00430495|20980850|P3|COMPLETED|Overall Study||49
8512565|NCT00430495|20980851|P2|COMPLETED|Overall Study||59
8512566|NCT00430495|20980852|P1|COMPLETED|Overall Study||50
8512567|NCT00430495|20980849|P4|Treated|Overall Study||64
8512568|NCT00430495|20980850|P3|Treated|Overall Study||62
8512569|NCT00430495|20980851|P2|Treated|Overall Study||66
8512570|NCT00430495|20980852|P1|Treated|Overall Study||62
8512571|NCT00430495|20980849|P4|STARTED|Overall Study||64
8512572|NCT00430495|20980850|P3|STARTED|Overall Study||62
8512573|NCT00430495|20980851|P2|STARTED|Overall Study||66
8512574|NCT00430495|20980852|P1|STARTED|Overall Study||64
8512575|NCT00430482|20980892|P2|NOT COMPLETED|Completed 2 Follow-Up Visits||6
8512576|NCT00430482|20980893|P1|NOT COMPLETED|Completed 2 Follow-Up Visits||5
8512577|NCT00430482|20980892|P2|COMPLETED|Completed 2 Follow-Up Visits||20
8512578|NCT00430482|20980893|P1|COMPLETED|Completed 2 Follow-Up Visits||29
8512579|NCT00430482|20980892|P2|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20
8512580|NCT00430482|20980893|P1|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29
8512581|NCT00430482|20980892|P2|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20
8512582|NCT00430482|20980893|P1|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27
8512583|NCT00430482|20980892|P2|STARTED|Completed 2 Follow-Up Visits||26
8512584|NCT00430482|20980893|P1|STARTED|Completed 2 Follow-Up Visits||34
8512585|NCT00430482|20980892|P2|NOT COMPLETED|Completed Treatment||11
8512586|NCT00430482|20980893|P1|NOT COMPLETED|Completed Treatment||7
8512587|NCT00430482|20980892|P2|COMPLETED|Completed Treatment||26
8512588|NCT00430482|20980893|P1|COMPLETED|Completed Treatment||34
8512589|NCT00430482|20980892|P2|Completed ASI at Midpoint|Completed Treatment||29
8512590|NCT00430482|20980893|P1|Completed ASI at Midpoint|Completed Treatment||35
8512591|NCT00430482|20980892|P2|STARTED|Completed Treatment||37
8512592|NCT00430482|20980893|P1|STARTED|Completed Treatment||41
8512593|NCT00430352|20980901|P1|NOT COMPLETED|Overall Study||138
8512594|NCT00430352|20980901|P1|COMPLETED|Overall Study||407
8512595|NCT00430352|20980901|P1|STARTED|Overall Study||545
8512596|NCT00430300|20980919|P4|NOT COMPLETED|Overall Study||2
8512597|NCT00430300|20980920|P3|NOT COMPLETED|Overall Study||6
8512598|NCT00430300|20980921|P2|NOT COMPLETED|Overall Study||2
8512599|NCT00430300|20980922|P1|NOT COMPLETED|Overall Study||2
8512600|NCT00430300|20980919|P4|COMPLETED|Overall Study||15
8512601|NCT00430300|20980920|P3|COMPLETED|Overall Study||29
8512602|NCT00430300|20980921|P2|COMPLETED|Overall Study||16
8512603|NCT00430300|20980922|P1|COMPLETED|Overall Study||15
8512604|NCT00430300|20980919|P4|STARTED|Overall Study||17
8512605|NCT00430300|20980920|P3|STARTED|Overall Study||35
8512606|NCT00430300|20980921|P2|STARTED|Overall Study||18
8512607|NCT00430300|20980922|P1|STARTED|Overall Study||17
8512608|NCT00430248|20981027|P3|NOT COMPLETED|Overall Study||135
8512609|NCT00430248|20981028|P2|NOT COMPLETED|Overall Study||158
8512610|NCT00430248|20981029|P1|NOT COMPLETED|Overall Study||125
8512611|NCT00430248|20981027|P3|COMPLETED|Overall Study||621
8512612|NCT00430248|20981028|P2|COMPLETED|Overall Study||598
8512613|NCT00430248|20981029|P1|COMPLETED|Overall Study||632
8512614|NCT00430248|20981027|P3|STARTED|Overall Study||756
8512615|NCT00430248|20981028|P2|STARTED|Overall Study||756
8512616|NCT00430248|20981029|P1|STARTED|Overall Study||757
8512617|NCT00430183|20981087|P2|NOT COMPLETED|Overall Study||0
8512618|NCT00430183|20981088|P1|NOT COMPLETED|Overall Study||0
8512619|NCT00430183|20981087|P2|COMPLETED|Overall Study||397
8512620|NCT00430183|20981088|P1|COMPLETED|Overall Study||391
8512621|NCT00430183|20981087|P2|STARTED|Overall Study||397
8512622|NCT00430183|20981088|P1|STARTED|Overall Study||391
8512623|NCT00430092|20981097|P3|NOT COMPLETED|Overall Study||57
8512624|NCT00430092|20981098|P2|NOT COMPLETED|Overall Study||4
8512625|NCT00430092|20981099|P1|NOT COMPLETED|Overall Study||6
8512626|NCT00430092|20981097|P3|COMPLETED|Overall Study||56
8512627|NCT00430092|20981098|P2|COMPLETED|Overall Study||48
8512628|NCT00430092|20981099|P1|COMPLETED|Overall Study||48
8512629|NCT00430092|20981097|P3|STARTED|Overall Study||113
8512630|NCT00430092|20981098|P2|STARTED|Overall Study||52
8512631|NCT00430092|20981099|P1|STARTED|Overall Study||54
8512632|NCT00430027|20981104|P1|NOT COMPLETED|Overall Study||8
8512633|NCT00430027|20981104|P1|COMPLETED|Overall Study||0
8512634|NCT00430027|20981104|P1|STARTED|Overall Study||8
8512635|NCT00429949|20981108|P1|NOT COMPLETED|Overall Study||0
8512636|NCT00429949|20981108|P1|COMPLETED|Overall Study||21
8512637|NCT00429949|20981108|P1|STARTED|Overall Study||21
8512638|NCT00429923|20981121|P3|NOT COMPLETED|Overall Study||39
8512639|NCT00429923|20981122|P2|NOT COMPLETED|Overall Study||4
8512640|NCT00429923|20981123|P1|NOT COMPLETED|Overall Study||5
8512641|NCT00429923|20981121|P3|COMPLETED|Overall Study||68
8512642|NCT00429923|20981122|P2|COMPLETED|Overall Study||51
8512643|NCT00429923|20981123|P1|COMPLETED|Overall Study||52
8512644|NCT00429923|20981121|P3|STARTED|Overall Study||107
8512645|NCT00429923|20981122|P2|STARTED|Overall Study||55
8512646|NCT00429923|20981123|P1|STARTED|Overall Study||57
8512647|NCT00429858|20981128|P1|NOT COMPLETED|Overall Study||2
8512648|NCT00429858|20981128|P1|COMPLETED|Overall Study||19
8512649|NCT00429858|20981128|P1|STARTED|Overall Study||21
8512650|NCT00429793|20981139|P1|NOT COMPLETED|Overall Study||6
8512651|NCT00429793|20981139|P1|COMPLETED|Overall Study||54
8512652|NCT00429793|20981139|P1|STARTED|Overall Study||60
8512653|NCT00429702|20981155|P2|NOT COMPLETED|Overall Study||0
8512654|NCT00429702|20981156|P1|NOT COMPLETED|Overall Study||0
8512655|NCT00429702|20981155|P2|COMPLETED|Overall Study||4
8512656|NCT00429702|20981156|P1|COMPLETED|Overall Study||3
8512657|NCT00429702|20981155|P2|STARTED|Overall Study||4
8512658|NCT00429702|20981156|P1|STARTED|Overall Study||3
8512659|NCT00429663|20981166|P2|NOT COMPLETED|Overall Study||39
8512660|NCT00429663|20981167|P1|NOT COMPLETED|Overall Study||36
8512661|NCT00429663|20981166|P2|COMPLETED|Overall Study||41
8512662|NCT00429663|20981167|P1|COMPLETED|Overall Study||40
8512663|NCT00429663|20981166|P2|STARTED|Overall Study||80
8512664|NCT00429663|20981167|P1|STARTED|Overall Study||76
8512665|NCT00429572|20981181|P1|NOT COMPLETED|Overall Study||1
8512666|NCT00429572|20981181|P1|COMPLETED|Overall Study||18
8512667|NCT00429572|20981181|P1|STARTED|Overall Study||19
8512668|NCT00429507|20981189|P1|NOT COMPLETED|Overall Study||0
8512669|NCT00429507|20981189|P1|COMPLETED|Overall Study||12
8512670|NCT00429507|20981189|P1|STARTED|Overall Study||12
8512671|NCT00429494|20981193|P1|NOT COMPLETED|Overall Study||15
8512672|NCT00429494|20981193|P1|COMPLETED|Overall Study||44
8512673|NCT00429494|20981193|P1|STARTED|Overall Study||59
8512674|NCT00429416|20981197|P1|NOT COMPLETED|Overall Study||1
8512675|NCT00429416|20981197|P1|COMPLETED|Overall Study||13
8512676|NCT00429416|20981197|P1|STARTED|Overall Study||14
8512677|NCT00429403|20981207|P2|NOT COMPLETED|Overall Study||0
8512678|NCT00429403|20981208|P1|NOT COMPLETED|Overall Study||0
8512679|NCT00429403|20981207|P2|COMPLETED|Overall Study||0
8512680|NCT00429403|20981208|P1|COMPLETED|Overall Study||1
8512681|NCT00429403|20981207|P2|STARTED|Overall Study||0
8512682|NCT00429403|20981208|P1|STARTED|Overall Study||1
8512683|NCT00429364|20981216|P2|NOT COMPLETED|Overall Study||33
8512684|NCT00429364|20981217|P1|NOT COMPLETED|Overall Study||32
8512685|NCT00429364|20981216|P2|COMPLETED|Overall Study||272
8512686|NCT00429364|20981217|P1|COMPLETED|Overall Study||271
8512687|NCT00429364|20981216|P2|STARTED|Overall Study||305
8512688|NCT00429364|20981217|P1|STARTED|Overall Study||303
8512689|NCT00429299|20981276|P3|NOT COMPLETED|Overall Study||4
8512690|NCT00429299|20981277|P2|NOT COMPLETED|Overall Study||7
8512691|NCT00429299|20981278|P1|NOT COMPLETED|Overall Study||4
8512692|NCT00429299|20981276|P3|COMPLETED|Overall Study||42
8512693|NCT00429299|20981277|P2|COMPLETED|Overall Study||32
8512694|NCT00429299|20981278|P1|COMPLETED|Overall Study||32
8512695|NCT00429299|20981276|P3|STARTED|Overall Study||46
8512696|NCT00429299|20981277|P2|STARTED|Overall Study||39
8512697|NCT00429299|20981278|P1|STARTED|Overall Study||36
8512707|NCT00429182|20981320|P1|NOT COMPLETED|Overall Study||7
8512708|NCT00429182|20981320|P1|COMPLETED|Overall Study||25
8512709|NCT00429182|20981320|P1|STARTED|Overall Study||32
8512710|NCT00429169|20981327|P2|NOT COMPLETED|Overall Study||2
8512711|NCT00429169|20981328|P1|NOT COMPLETED|Overall Study||2
8512712|NCT00429169|20981327|P2|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
8512713|NCT00429169|20981328|P1|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
8512714|NCT00429169|20981327|P2|STARTED|Overall Study||40
8512715|NCT00429169|20981328|P1|STARTED|Overall Study||38
8512716|NCT00429143|20981340|P1|NOT COMPLETED|Overall Study||0
8512717|NCT00429143|20981340|P1|COMPLETED|Overall Study||27
8512718|NCT00429143|20981340|P1|STARTED|Overall Study||27
8512719|NCT00429104|20981348|P1|NOT COMPLETED|Overall Study||1
8512720|NCT00429104|20981348|P1|COMPLETED|Overall Study||17
8512721|NCT00429104|20981348|P1|STARTED|Overall Study||18
8512722|NCT00429026|20981353|P1|NOT COMPLETED|Overall Study||40
8512723|NCT00429026|20981353|P1|COMPLETED|Overall Study||0
8512724|NCT00429026|20981353|P1|STARTED|Overall Study||40
8512725|NCT00428974|20981361|P4|NOT COMPLETED|Overall Study||3
8512726|NCT00428974|20981362|P3|NOT COMPLETED|Overall Study||1
8512727|NCT00428974|20981363|P2|NOT COMPLETED|Overall Study||0
8512728|NCT00428974|20981364|P1|NOT COMPLETED|Overall Study||8
8512729|NCT00428974|20981361|P4|COMPLETED|Overall Study||16
8512730|NCT00428974|20981362|P3|COMPLETED|Overall Study||14
8512731|NCT00428974|20981363|P2|COMPLETED|Overall Study||17
8512732|NCT00428974|20981364|P1|COMPLETED|Overall Study||17
8512733|NCT00428974|20981361|P4|STARTED|Overall Study||19
8512734|NCT00428974|20981362|P3|STARTED|Overall Study||15
8512735|NCT00428974|20981363|P2|STARTED|Overall Study||17
8512736|NCT00428974|20981364|P1|STARTED|Overall Study|one patient was randomized but never received study treatment|25
8512737|NCT00428948|20981380|P2|NOT COMPLETED|Overall Study||67
8512738|NCT00428948|20981381|P1|NOT COMPLETED|Overall Study||221
8512739|NCT00428948|20981380|P2|COMPLETED|Overall Study||417
8512740|NCT00428948|20981381|P1|COMPLETED|Overall Study||740
8512741|NCT00428948|20981380|P2|Received Treatment|Overall Study||483
8512742|NCT00428948|20981381|P1|Received Treatment|Overall Study||961
8512743|NCT00428948|20981380|P2|STARTED|Overall Study||484
8512744|NCT00428948|20981381|P1|STARTED|Overall Study||961
8512745|NCT00428922|20981399|P1|NOT COMPLETED|Overall Study||0
8512746|NCT00428922|20981399|P1|COMPLETED|Overall Study||26
8512747|NCT00428922|20981399|P1|STARTED|Overall Study||26
8512748|NCT00428844|20981409|P3|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
8512749|NCT00428844|20981410|P2|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
8512750|NCT00428844|20981411|P1|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
8512751|NCT00428844|20981409|P3|COMPLETED|Completed Test of Cure (TOC) Visit||17
8512752|NCT00428844|20981410|P2|COMPLETED|Completed Test of Cure (TOC) Visit||16
8512753|NCT00428844|20981411|P1|COMPLETED|Completed Test of Cure (TOC) Visit||20
8512754|NCT00428844|20981409|P3|STARTED|Completed Test of Cure (TOC) Visit||19
8512755|NCT00428844|20981410|P2|STARTED|Completed Test of Cure (TOC) Visit||18
8512756|NCT00428844|20981411|P1|STARTED|Completed Test of Cure (TOC) Visit||23
8512757|NCT00428844|20981409|P3|NOT COMPLETED|Completed Study Drug Treatment||7
8512758|NCT00428844|20981410|P2|NOT COMPLETED|Completed Study Drug Treatment||6
8512759|NCT00428844|20981411|P1|NOT COMPLETED|Completed Study Drug Treatment||2
8512760|NCT00428844|20981409|P3|COMPLETED|Completed Study Drug Treatment||19
8512761|NCT00428844|20981410|P2|COMPLETED|Completed Study Drug Treatment||18
8512762|NCT00428844|20981411|P1|COMPLETED|Completed Study Drug Treatment||23
8512763|NCT00428844|20981409|P3|Received First Dose|Completed Study Drug Treatment||25
8512764|NCT00428844|20981410|P2|Received First Dose|Completed Study Drug Treatment||24
8512765|NCT00428844|20981411|P1|Received First Dose|Completed Study Drug Treatment||25
8512766|NCT00428844|20981409|P3|STARTED|Completed Study Drug Treatment||26
8512767|NCT00428844|20981410|P2|STARTED|Completed Study Drug Treatment||24
8512768|NCT00428844|20981411|P1|STARTED|Completed Study Drug Treatment||25
8512769|NCT00428792|20981434|P2|NOT COMPLETED|Overall Study||4
8512770|NCT00428792|20981435|P1|NOT COMPLETED|Overall Study||1
8512771|NCT00428792|20981434|P2|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
8512861|NCT00428116|20981662|P1|COMPLETED|Overall Study||18
8512772|NCT00428792|20981435|P1|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
8512773|NCT00428792|20981434|P2|STARTED|Overall Study||70
8512774|NCT00428792|20981435|P1|STARTED|Overall Study||80
8512775|NCT00428714|20981461|P2|NOT COMPLETED|Overall Study||42
8512776|NCT00428714|20981462|P1|NOT COMPLETED|Overall Study||31
8512777|NCT00428714|20981461|P2|COMPLETED|Overall Study||0
8512778|NCT00428714|20981462|P1|COMPLETED|Overall Study||0
8512779|NCT00428714|20981461|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
8512780|NCT00428714|20981462|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
8512781|NCT00428714|20981461|P2|STARTED|Overall Study||42
8512782|NCT00428714|20981462|P1|STARTED|Overall Study||31
8512783|NCT00428610|20981481|P3|NOT COMPLETED|Overall Study||32
8512784|NCT00428610|20981482|P2|NOT COMPLETED|Overall Study||18
8512785|NCT00428610|20981483|P1|NOT COMPLETED|Overall Study||53
8512786|NCT00428610|20981481|P3|COMPLETED|Overall Study||0
8512787|NCT00428610|20981482|P2|COMPLETED|Overall Study||0
8512788|NCT00428610|20981483|P1|COMPLETED|Overall Study||0
8512789|NCT00428610|20981481|P3|Received at Least One Dose of Study Drug|Overall Study||32
8512790|NCT00428610|20981482|P2|Received at Least One Dose of Study Drug|Overall Study||18
8512791|NCT00428610|20981483|P1|Received at Least One Dose of Study Drug|Overall Study||53
8512792|NCT00428610|20981481|P3|STARTED|Overall Study||32
8512793|NCT00428610|20981482|P2|STARTED|Overall Study||18
8512794|NCT00428610|20981483|P1|STARTED|Overall Study||53
8512795|NCT00428597|20981517|P2|NOT COMPLETED|Overall Study||85
8512796|NCT00428597|20981518|P1|NOT COMPLETED|Overall Study||86
8512797|NCT00428597|20981517|P2|COMPLETED|Overall Study||0
8512798|NCT00428597|20981518|P1|COMPLETED|Overall Study||0
8512799|NCT00428597|20981517|P2|Received Treatment|Overall Study||82
8512800|NCT00428597|20981518|P1|Received Treatment|Overall Study||83
8512801|NCT00428597|20981517|P2|STARTED|Overall Study||85
8512802|NCT00428597|20981518|P1|STARTED|Overall Study||86
8512803|NCT00428584|20981560|P2|NOT COMPLETED|Extension Phase||29
8512804|NCT00428584|20981561|P1|NOT COMPLETED|Extension Phase||21
8512805|NCT00428584|20981560|P2|COMPLETED|Extension Phase||34
8512806|NCT00428584|20981561|P1|COMPLETED|Extension Phase||35
8512807|NCT00428584|20981560|P2|STARTED|Extension Phase||63
8512808|NCT00428584|20981561|P1|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
8512809|NCT00428584|20981560|P2|NOT COMPLETED|Comparative Phase||1
8512810|NCT00428584|20981561|P1|NOT COMPLETED|Comparative Phase||9
8512811|NCT00428584|20981560|P2|COMPLETED|Comparative Phase||63
8512812|NCT00428584|20981561|P1|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
8512813|NCT00428584|20981560|P2|STARTED|Comparative Phase||64
8512814|NCT00428584|20981561|P1|STARTED|Comparative Phase||65
8512815|NCT00428441|20981585|P1|NOT COMPLETED|Overall Study||1
8512816|NCT00428441|20981585|P1|COMPLETED|Overall Study||74
8512817|NCT00428441|20981585|P1|STARTED|Overall Study||75
8512818|NCT00428389|20981591|P2|NOT COMPLETED|Extension Phase||26
8512819|NCT00428389|20981592|P1|NOT COMPLETED|Extension Phase||32
8512820|NCT00428389|20981591|P2|COMPLETED|Extension Phase||91
8512821|NCT00428389|20981592|P1|COMPLETED|Extension Phase||85
8512822|NCT00428389|20981591|P2|STARTED|Extension Phase||117
8512823|NCT00428389|20981592|P1|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
8512824|NCT00428389|20981591|P2|NOT COMPLETED|Core Phase||11
8512825|NCT00428389|20981592|P1|NOT COMPLETED|Core Phase||11
8512826|NCT00428389|20981591|P2|COMPLETED|Core Phase||120
8512827|NCT00428389|20981592|P1|COMPLETED|Core Phase||120
8512828|NCT00428389|20981591|P2|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
8512829|NCT00428389|20981592|P1|Intent-to-treat Population|Core Phase||131
8512830|NCT00428389|20981591|P2|STARTED|Core Phase||131
8512831|NCT00428389|20981592|P1|STARTED|Core Phase||131
8512832|NCT00428298|20981612|P2|NOT COMPLETED|Overall Study||11
8512833|NCT00428298|20981613|P1|NOT COMPLETED|Overall Study||14
8512834|NCT00428298|20981612|P2|COMPLETED|Overall Study||19
8512835|NCT00428298|20981613|P1|COMPLETED|Overall Study||16
8512836|NCT00428298|20981612|P2|Second RBANS at Study Exit|Overall Study||3
8512837|NCT00428298|20981613|P1|Second RBANS at Study Exit|Overall Study||3
8512838|NCT00428298|20981612|P2|STARTED|Overall Study||30
8512839|NCT00428298|20981613|P1|STARTED|Overall Study||30
8512840|NCT00428246|20981626|P3|NOT COMPLETED|Overall Study||1
8512841|NCT00428246|20981627|P2|NOT COMPLETED|Overall Study||0
8512842|NCT00428246|20981628|P1|NOT COMPLETED|Overall Study||1
8512843|NCT00428246|20981626|P3|COMPLETED|Overall Study||7
8512844|NCT00428246|20981627|P2|COMPLETED|Overall Study||8
8512845|NCT00428246|20981628|P1|COMPLETED|Overall Study||7
8512846|NCT00428246|20981626|P3|STARTED|Overall Study||8
8512847|NCT00428246|20981627|P2|STARTED|Overall Study||8
8512848|NCT00428246|20981628|P1|STARTED|Overall Study||8
8512849|NCT00428220|20981636|P1|NOT COMPLETED|Overall Study||223
8512850|NCT00428220|20981636|P1|COMPLETED|Overall Study||0
8512851|NCT00428220|20981636|P1|STARTED|Overall Study||223
8512852|NCT00428207|20981652|P2|NOT COMPLETED|Overall Study||0
8512853|NCT00428207|20981653|P1|NOT COMPLETED|Overall Study||0
8512854|NCT00428207|20981652|P2|COMPLETED|Overall Study||2
8512855|NCT00428207|20981653|P1|COMPLETED|Overall Study||2
8512856|NCT00428207|20981652|P2|STARTED|Overall Study||2
8512857|NCT00428207|20981653|P1|STARTED|Overall Study||2
8512858|NCT00428116|20981661|P2|NOT COMPLETED|Overall Study||0
8512859|NCT00428116|20981662|P1|NOT COMPLETED|Overall Study||3
8512860|NCT00428116|20981661|P2|COMPLETED|Overall Study||21
8512862|NCT00428116|20981661|P2|STARTED|Overall Study||21
8512863|NCT00428116|20981662|P1|STARTED|Overall Study||21
8512864|NCT00428090|20981674|P4|NOT COMPLETED|Overall Study||28
8512865|NCT00428090|20981675|P3|NOT COMPLETED|Overall Study||38
8512866|NCT00428090|20981676|P2|NOT COMPLETED|Overall Study||31
8512867|NCT00428090|20981677|P1|NOT COMPLETED|Overall Study||34
8512868|NCT00428090|20981674|P4|COMPLETED|Overall Study||55
8512869|NCT00428090|20981675|P3|COMPLETED|Overall Study||127
8512870|NCT00428090|20981676|P2|COMPLETED|Overall Study||135
8512871|NCT00428090|20981677|P1|COMPLETED|Overall Study||131
8512872|NCT00428090|20981674|P4|STARTED|Overall Study||83
8512873|NCT00428090|20981675|P3|STARTED|Overall Study||165
8512874|NCT00428090|20981676|P2|STARTED|Overall Study||166
8512875|NCT00428090|20981677|P1|STARTED|Overall Study||165
8512876|NCT00428077|20981791|P1|NOT COMPLETED|Overall Study||0
8512877|NCT00428077|20981791|P1|COMPLETED|Overall Study||4
8512878|NCT00428077|20981791|P1|STARTED|Overall Study||4
8512879|NCT00427999|20981795|P1|NOT COMPLETED|Overall Study||32
8512880|NCT00427999|20981795|P1|COMPLETED|Overall Study||33
8512881|NCT00427999|20981795|P1|Extension Follow-up|Overall Study||19
8512882|NCT00427999|20981795|P1|Intent to Treat (ITT)|Overall Study||61
8512883|NCT00427999|20981795|P1|STARTED|Overall Study||65
8512884|NCT00427973|20981804|P1|NOT COMPLETED|Overall Study||0
8512885|NCT00427973|20981804|P1|COMPLETED|Overall Study||17
8512886|NCT00427973|20981804|P1|STARTED|Overall Study||17
8512887|NCT00427960|20981813|P2|NOT COMPLETED|Overall Study||4
8512888|NCT00427960|20981814|P1|NOT COMPLETED|Overall Study||2
8512889|NCT00427960|20981813|P2|COMPLETED|Overall Study||21
8512890|NCT00427960|20981814|P1|COMPLETED|Overall Study||28
8512891|NCT00427960|20981813|P2|STARTED|Overall Study||25
8512892|NCT00427960|20981814|P1|STARTED|Overall Study||30
8512893|NCT00427934|20981852|P4|NOT COMPLETED|Overall Study||15
8512894|NCT00427934|20981853|P3|NOT COMPLETED|Overall Study||23
8512895|NCT00427934|20981854|P2|NOT COMPLETED|Overall Study||0
8512896|NCT00427934|20981855|P1|NOT COMPLETED|Overall Study||1
8512897|NCT00427934|20981852|P4|COMPLETED|Overall Study||19
8512898|NCT00427934|20981853|P3|COMPLETED|Overall Study||55
8512899|NCT00427934|20981854|P2|COMPLETED|Overall Study||8
8512900|NCT00427934|20981855|P1|COMPLETED|Overall Study||7
8512901|NCT00427934|20981852|P4|Treated|Overall Study||33
8512902|NCT00427934|20981853|P3|Treated|Overall Study||77
8512903|NCT00427934|20981854|P2|Treated|Overall Study||8
8512904|NCT00427934|20981855|P1|Treated|Overall Study||8
8512905|NCT00427934|20981852|P4|STARTED|Overall Study||34
8512906|NCT00427934|20981853|P3|STARTED|Overall Study||78
8512907|NCT00427934|20981854|P2|STARTED|Overall Study||8
8512908|NCT00427934|20981855|P1|STARTED|Overall Study||8
8512909|NCT00427921|20981923|P1|NOT COMPLETED|Overall Study||50
8512910|NCT00427921|20981923|P1|COMPLETED|Overall Study||254
8512911|NCT00427921|20981923|P1|STARTED|Overall Study||304
8512912|NCT00427908|20981946|P4|NOT COMPLETED|Persistence Phase Year 5||0
8512913|NCT00427908|20981947|P3|NOT COMPLETED|Persistence Phase Year 5||0
8512914|NCT00427908|20981948|P2|NOT COMPLETED|Persistence Phase Year 5||0
8512915|NCT00427908|20981949|P1|NOT COMPLETED|Persistence Phase Year 5||0
8512916|NCT00427908|20981946|P4|COMPLETED|Persistence Phase Year 5||13
8512917|NCT00427908|20981947|P3|COMPLETED|Persistence Phase Year 5||12
8512918|NCT00427908|20981948|P2|COMPLETED|Persistence Phase Year 5||99
8512919|NCT00427908|20981949|P1|COMPLETED|Persistence Phase Year 5||52
8512920|NCT00427908|20981946|P4|STARTED|Persistence Phase Year 5||13
8512921|NCT00427908|20981947|P3|STARTED|Persistence Phase Year 5||12
8512922|NCT00427908|20981948|P2|STARTED|Persistence Phase Year 5||99
8512923|NCT00427908|20981949|P1|STARTED|Persistence Phase Year 5||52
8512924|NCT00427908|20981946|P4|NOT COMPLETED|Persistence Phase Year 4||0
8512925|NCT00427908|20981947|P3|NOT COMPLETED|Persistence Phase Year 4||0
8512926|NCT00427908|20981948|P2|NOT COMPLETED|Persistence Phase Year 4||0
8512927|NCT00427908|20981949|P1|NOT COMPLETED|Persistence Phase Year 4||0
8512928|NCT00427908|20981946|P4|COMPLETED|Persistence Phase Year 4||32
8512929|NCT00427908|20981947|P3|COMPLETED|Persistence Phase Year 4||34
8512930|NCT00427908|20981948|P2|COMPLETED|Persistence Phase Year 4||192
8512931|NCT00427908|20981949|P1|COMPLETED|Persistence Phase Year 4||165
8512932|NCT00427908|20981946|P4|STARTED|Persistence Phase Year 4||32
8512933|NCT00427908|20981947|P3|STARTED|Persistence Phase Year 4||34
8512934|NCT00427908|20981948|P2|STARTED|Persistence Phase Year 4||192
8512935|NCT00427908|20981949|P1|STARTED|Persistence Phase Year 4||165
8512936|NCT00427908|20981946|P4|NOT COMPLETED|Persistence Phase Year 3||0
8512937|NCT00427908|20981947|P3|NOT COMPLETED|Persistence Phase Year 3||0
8512938|NCT00427908|20981948|P2|NOT COMPLETED|Persistence Phase Year 3||0
8512939|NCT00427908|20981949|P1|NOT COMPLETED|Persistence Phase Year 3||0
8512940|NCT00427908|20981946|P4|COMPLETED|Persistence Phase Year 3||38
8512941|NCT00427908|20981947|P3|COMPLETED|Persistence Phase Year 3||38
8512942|NCT00427908|20981948|P2|COMPLETED|Persistence Phase Year 3||201
8512943|NCT00427908|20981949|P1|COMPLETED|Persistence Phase Year 3||185
8512944|NCT00427908|20981946|P4|STARTED|Persistence Phase Year 3||38
8512945|NCT00427908|20981947|P3|STARTED|Persistence Phase Year 3||38
8512946|NCT00427908|20981948|P2|STARTED|Persistence Phase Year 3||201
8512947|NCT00427908|20981949|P1|STARTED|Persistence Phase Year 3||185
8512948|NCT00427908|20981946|P4|NOT COMPLETED|Persistence Phase Year 2||0
8512949|NCT00427908|20981947|P3|NOT COMPLETED|Persistence Phase Year 2||0
8512950|NCT00427908|20981948|P2|NOT COMPLETED|Persistence Phase Year 2||0
8512951|NCT00427908|20981949|P1|NOT COMPLETED|Persistence Phase Year 2||0
8512952|NCT00427908|20981946|P4|COMPLETED|Persistence Phase Year 2||61
8512953|NCT00427908|20981947|P3|COMPLETED|Persistence Phase Year 2||53
8512954|NCT00427908|20981948|P2|COMPLETED|Persistence Phase Year 2||215
8512955|NCT00427908|20981949|P1|COMPLETED|Persistence Phase Year 2||208
8512956|NCT00427908|20981946|P4|STARTED|Persistence Phase Year 2||61
8512957|NCT00427908|20981947|P3|STARTED|Persistence Phase Year 2||53
8512958|NCT00427908|20981948|P2|STARTED|Persistence Phase Year 2||215
8512959|NCT00427908|20981949|P1|STARTED|Persistence Phase Year 2||208
8512960|NCT00427908|20981946|P4|NOT COMPLETED|Persistence Phase Year 1||0
8512961|NCT00427908|20981947|P3|NOT COMPLETED|Persistence Phase Year 1||0
8512962|NCT00427908|20981948|P2|NOT COMPLETED|Persistence Phase Year 1||0
8512963|NCT00427908|20981949|P1|NOT COMPLETED|Persistence Phase Year 1||0
8512964|NCT00427908|20981946|P4|COMPLETED|Persistence Phase Year 1||78
8512965|NCT00427908|20981947|P3|COMPLETED|Persistence Phase Year 1||71
8512966|NCT00427908|20981948|P2|COMPLETED|Persistence Phase Year 1||221
8512967|NCT00427908|20981949|P1|COMPLETED|Persistence Phase Year 1||222
8512968|NCT00427908|20981946|P4|STARTED|Persistence Phase Year 1||78
8512969|NCT00427908|20981947|P3|STARTED|Persistence Phase Year 1||71
8512970|NCT00427908|20981948|P2|STARTED|Persistence Phase Year 1||221
8512971|NCT00427908|20981949|P1|STARTED|Persistence Phase Year 1||222
8512972|NCT00427908|20981946|P4|NOT COMPLETED|Primary Phase||0
8512973|NCT00427908|20981947|P3|NOT COMPLETED|Primary Phase||3
8512974|NCT00427908|20981948|P2|NOT COMPLETED|Primary Phase||3
8512975|NCT00427908|20981949|P1|NOT COMPLETED|Primary Phase||5
8512976|NCT00427908|20981946|P4|COMPLETED|Primary Phase||78
8512977|NCT00427908|20981947|P3|COMPLETED|Primary Phase||72
8512978|NCT00427908|20981948|P2|COMPLETED|Primary Phase||228
8512979|NCT00427908|20981949|P1|COMPLETED|Primary Phase||224
8512980|NCT00427908|20981946|P4|STARTED|Primary Phase||78
8512981|NCT00427908|20981947|P3|STARTED|Primary Phase||75
8512982|NCT00427908|20981948|P2|STARTED|Primary Phase||231
8512983|NCT00427908|20981949|P1|STARTED|Primary Phase||229
8512984|NCT00427895|20982149|P8|NOT COMPLETED|Vax 2/Year 3 to 4||2
8512985|NCT00427895|20982150|P7|NOT COMPLETED|Vax 2/Year 3 to 4||0
8512986|NCT00427895|20982151|P6|NOT COMPLETED|Vax 2/Year 3 to 4||0
8512987|NCT00427895|20982152|P5|NOT COMPLETED|Vax 2/Year 3 to 4||1
8512988|NCT00427895|20982153|P4|NOT COMPLETED|Vax 2/Year 3 to 4||0
8512989|NCT00427895|20982154|P3|NOT COMPLETED|Vax 2/Year 3 to 4||0
8512990|NCT00427895|20982155|P2|NOT COMPLETED|Vax 2/Year 3 to 4||0
8512991|NCT00427895|20982156|P1|NOT COMPLETED|Vax 2/Year 3 to 4||0
8512992|NCT00427895|20982149|P8|COMPLETED|Vax 2/Year 3 to 4||212
8512993|NCT00427895|20982150|P7|COMPLETED|Vax 2/Year 3 to 4||189
8512994|NCT00427895|20982151|P6|COMPLETED|Vax 2/Year 3 to 4||108
8512995|NCT00427895|20982152|P5|COMPLETED|Vax 2/Year 3 to 4||107
8512996|NCT00427895|20982153|P4|COMPLETED|Vax 2/Year 3 to 4||0
8512997|NCT00427895|20982154|P3|COMPLETED|Vax 2/Year 3 to 4||0
8512998|NCT00427895|20982155|P2|COMPLETED|Vax 2/Year 3 to 4||0
8512999|NCT00427895|20982156|P1|COMPLETED|Vax 2/Year 3 to 4||0
8513000|NCT00427895|20982149|P8|STARTED|Vax 2/Year 3 to 4||214
8513001|NCT00427895|20982150|P7|STARTED|Vax 2/Year 3 to 4||189
8513002|NCT00427895|20982151|P6|STARTED|Vax 2/Year 3 to 4||108
8513003|NCT00427895|20982152|P5|STARTED|Vax 2/Year 3 to 4||108
8513004|NCT00427895|20982153|P4|STARTED|Vax 2/Year 3 to 4||0
8513005|NCT00427895|20982154|P3|STARTED|Vax 2/Year 3 to 4||0
8513006|NCT00427895|20982155|P2|STARTED|Vax 2/Year 3 to 4||0
8513007|NCT00427895|20982156|P1|STARTED|Vax 2/Year 3 to 4||0
8513008|NCT00427895|20982149|P8|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513009|NCT00427895|20982150|P7|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513010|NCT00427895|20982151|P6|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513011|NCT00427895|20982152|P5|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513012|NCT00427895|20982153|P4|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
8513013|NCT00427895|20982154|P3|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
8513014|NCT00427895|20982155|P2|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
8513015|NCT00427895|20982156|P1|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
8513016|NCT00427895|20982149|P8|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513017|NCT00427895|20982150|P7|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513018|NCT00427895|20982151|P6|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513019|NCT00427895|20982152|P5|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513020|NCT00427895|20982153|P4|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
8513021|NCT00427895|20982154|P3|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
8513022|NCT00427895|20982155|P2|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
8513023|NCT00427895|20982156|P1|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
8513024|NCT00427895|20982149|P8|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
8513025|NCT00427895|20982150|P7|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
8513026|NCT00427895|20982151|P6|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
8513027|NCT00427895|20982152|P5|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
8513028|NCT00427895|20982153|P4|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
8513029|NCT00427895|20982154|P3|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
8513030|NCT00427895|20982155|P2|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
8513031|NCT00427895|20982156|P1|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
8513032|NCT00427895|20982149|P8|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
8513033|NCT00427895|20982150|P7|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
8513034|NCT00427895|20982151|P6|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
8513035|NCT00427895|20982152|P5|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
8513036|NCT00427895|20982153|P4|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
8513037|NCT00427895|20982154|P3|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
8513038|NCT00427895|20982155|P2|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
8513039|NCT00427895|20982156|P1|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
8513040|NCT00427895|20982149|P8|COMPLETED|Vax 1/Year 1 Follow-up||0
8513041|NCT00427895|20982150|P7|COMPLETED|Vax 1/Year 1 Follow-up||0
8513042|NCT00427895|20982151|P6|COMPLETED|Vax 1/Year 1 Follow-up||0
8513043|NCT00427895|20982152|P5|COMPLETED|Vax 1/Year 1 Follow-up||0
8513044|NCT00427895|20982153|P4|COMPLETED|Vax 1/Year 1 Follow-up||469
8513045|NCT00427895|20982154|P3|COMPLETED|Vax 1/Year 1 Follow-up||373
8513046|NCT00427895|20982155|P2|COMPLETED|Vax 1/Year 1 Follow-up||396
8513047|NCT00427895|20982156|P1|COMPLETED|Vax 1/Year 1 Follow-up||404
8513048|NCT00427895|20982149|P8|STARTED|Vax 1/Year 1 Follow-up||0
8513049|NCT00427895|20982150|P7|STARTED|Vax 1/Year 1 Follow-up||0
8513050|NCT00427895|20982151|P6|STARTED|Vax 1/Year 1 Follow-up||0
8513051|NCT00427895|20982152|P5|STARTED|Vax 1/Year 1 Follow-up||0
8513052|NCT00427895|20982153|P4|STARTED|Vax 1/Year 1 Follow-up||502
8513053|NCT00427895|20982154|P3|STARTED|Vax 1/Year 1 Follow-up||392
8513054|NCT00427895|20982155|P2|STARTED|Vax 1/Year 1 Follow-up||411
8513055|NCT00427895|20982156|P1|STARTED|Vax 1/Year 1 Follow-up||411
8513056|NCT00427895|20982149|P8|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8513057|NCT00427895|20982150|P7|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8513058|NCT00427895|20982151|P6|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8513059|NCT00427895|20982152|P5|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8513060|NCT00427895|20982153|P4|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
8513061|NCT00427895|20982154|P3|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8513062|NCT00427895|20982155|P2|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8513063|NCT00427895|20982156|P1|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
8513064|NCT00427895|20982149|P8|COMPLETED|Between 6-Month Follow-up - Year 1||0
8513065|NCT00427895|20982150|P7|COMPLETED|Between 6-Month Follow-up - Year 1||0
8513066|NCT00427895|20982151|P6|COMPLETED|Between 6-Month Follow-up - Year 1||0
8513067|NCT00427895|20982152|P5|COMPLETED|Between 6-Month Follow-up - Year 1||0
8513068|NCT00427895|20982153|P4|COMPLETED|Between 6-Month Follow-up - Year 1||502
8513069|NCT00427895|20982154|P3|COMPLETED|Between 6-Month Follow-up - Year 1||392
8513070|NCT00427895|20982155|P2|COMPLETED|Between 6-Month Follow-up - Year 1||411
8513071|NCT00427895|20982156|P1|COMPLETED|Between 6-Month Follow-up - Year 1||411
8513072|NCT00427895|20982149|P8|STARTED|Between 6-Month Follow-up - Year 1||0
8513073|NCT00427895|20982150|P7|STARTED|Between 6-Month Follow-up - Year 1||0
8513074|NCT00427895|20982151|P6|STARTED|Between 6-Month Follow-up - Year 1||0
8513075|NCT00427895|20982152|P5|STARTED|Between 6-Month Follow-up - Year 1||0
8513076|NCT00427895|20982153|P4|STARTED|Between 6-Month Follow-up - Year 1||854
8513077|NCT00427895|20982154|P3|STARTED|Between 6-Month Follow-up - Year 1||392
8513078|NCT00427895|20982155|P2|STARTED|Between 6-Month Follow-up - Year 1||411
8513079|NCT00427895|20982156|P1|STARTED|Between 6-Month Follow-up - Year 1||411
8513080|NCT00427895|20982149|P8|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513081|NCT00427895|20982150|P7|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513082|NCT00427895|20982151|P6|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513083|NCT00427895|20982152|P5|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513084|NCT00427895|20982153|P4|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
8513085|NCT00427895|20982154|P3|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
8513086|NCT00427895|20982155|P2|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
8513087|NCT00427895|20982156|P1|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
8513088|NCT00427895|20982149|P8|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513089|NCT00427895|20982150|P7|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513090|NCT00427895|20982151|P6|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513091|NCT00427895|20982152|P5|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
8513092|NCT00427895|20982153|P4|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
8513093|NCT00427895|20982154|P3|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
8513094|NCT00427895|20982155|P2|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
8513095|NCT00427895|20982156|P1|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
8513096|NCT00427895|20982149|P8|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
8513097|NCT00427895|20982150|P7|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
8513098|NCT00427895|20982151|P6|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
8513099|NCT00427895|20982152|P5|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
8513100|NCT00427895|20982153|P4|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
8513101|NCT00427895|20982154|P3|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
8513102|NCT00427895|20982155|P2|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
8513103|NCT00427895|20982156|P1|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
8513104|NCT00427895|20982149|P8|STARTED|Vax 1 Baseline/6-Month Follow-up||0
8513105|NCT00427895|20982150|P7|STARTED|Vax 1 Baseline/6-Month Follow-up||0
8513106|NCT00427895|20982151|P6|STARTED|Vax 1 Baseline/6-Month Follow-up||0
8513107|NCT00427895|20982152|P5|STARTED|Vax 1 Baseline/6-Month Follow-up||0
8513108|NCT00427895|20982153|P4|STARTED|Vax 1 Baseline/6-Month Follow-up||900
8513109|NCT00427895|20982154|P3|STARTED|Vax 1 Baseline/6-Month Follow-up||406
8513110|NCT00427895|20982155|P2|STARTED|Vax 1 Baseline/6-Month Follow-up||417
8513111|NCT00427895|20982156|P1|STARTED|Vax 1 Baseline/6-Month Follow-up||418
8513112|NCT00427804|20982213|P2|NOT COMPLETED|Overall Study||0
8513113|NCT00427804|20982214|P1|NOT COMPLETED|Overall Study||0
8513114|NCT00427804|20982213|P2|COMPLETED|Overall Study||5
8513115|NCT00427804|20982214|P1|COMPLETED|Overall Study||4
8513116|NCT00427804|20982213|P2|STARTED|Overall Study||5
8513117|NCT00427804|20982214|P1|STARTED|Overall Study||4
8513118|NCT00427791|20982222|P2|NOT COMPLETED|Overall Study||0
8513119|NCT00427791|20982223|P1|NOT COMPLETED|Overall Study||0
8513120|NCT00427791|20982222|P2|COMPLETED|Overall Study||13
8513121|NCT00427791|20982223|P1|COMPLETED|Overall Study||10
8513122|NCT00427791|20982222|P2|STARTED|Overall Study||13
8513123|NCT00427791|20982223|P1|STARTED|Overall Study||10
8513124|NCT00427778|20982231|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
8513125|NCT00427778|20982232|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8513126|NCT00427778|20982231|P2|COMPLETED|Second Intervention (4 Weeks)||14
8513127|NCT00427778|20982232|P1|COMPLETED|Second Intervention (4 Weeks)||10
8513128|NCT00427778|20982231|P2|STARTED|Second Intervention (4 Weeks)||14
8513129|NCT00427778|20982232|P1|STARTED|Second Intervention (4 Weeks)||10
8513130|NCT00427778|20982231|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
8513131|NCT00427778|20982232|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
8513132|NCT00427778|20982231|P2|COMPLETED|Wash Out (2 Weeks)||14
8513133|NCT00427778|20982232|P1|COMPLETED|Wash Out (2 Weeks)||10
8513134|NCT00427778|20982231|P2|STARTED|Wash Out (2 Weeks)||14
8513135|NCT00427778|20982232|P1|STARTED|Wash Out (2 Weeks)||10
8513136|NCT00427778|20982231|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
8513137|NCT00427778|20982232|P1|NOT COMPLETED|First Intervention (4 Weeks)||4
8513138|NCT00427778|20982231|P2|COMPLETED|First Intervention (4 Weeks)||14
8513139|NCT00427778|20982232|P1|COMPLETED|First Intervention (4 Weeks)||10
8513140|NCT00427778|20982231|P2|STARTED|First Intervention (4 Weeks)||15
8513141|NCT00427778|20982232|P1|STARTED|First Intervention (4 Weeks)||14
8513142|NCT00427765|20982251|P1|NOT COMPLETED|Overall Study||0
8513143|NCT00427765|20982251|P1|COMPLETED|Overall Study||164
8513144|NCT00427765|20982251|P1|STARTED|Overall Study||164
8513145|NCT00427700|20982257|P2|NOT COMPLETED|Overall Study||11
8513146|NCT00427700|20982258|P1|NOT COMPLETED|Overall Study||3
8513147|NCT00427700|20982257|P2|COMPLETED|Overall Study||31
8513148|NCT00427700|20982258|P1|COMPLETED|Overall Study||37
8513149|NCT00427700|20982257|P2|STARTED|Overall Study||42
8513150|NCT00427700|20982258|P1|STARTED|Overall Study||40
8513151|NCT00427661|20982266|P1|NOT COMPLETED|Overall Study||0
8513152|NCT00427661|20982266|P1|COMPLETED|Overall Study||8
8513153|NCT00427661|20982266|P1|STARTED|Overall Study||8
8513154|NCT00427648|20982274|P2|NOT COMPLETED|Overall Study||3
8513155|NCT00427648|20982275|P1|NOT COMPLETED|Overall Study||1
8513156|NCT00427648|20982274|P2|COMPLETED|Overall Study||7
8513157|NCT00427648|20982275|P1|COMPLETED|Overall Study||11
8513158|NCT00427648|20982274|P2|STARTED|Overall Study||10
8513159|NCT00427648|20982275|P1|STARTED|Overall Study||12
8513160|NCT00427635|20982295|P2|NOT COMPLETED|Study Completion to Safety Follow-up||1
8513161|NCT00427635|20982296|P1|NOT COMPLETED|Study Completion to Safety Follow-up||0
8513162|NCT00427635|20982295|P2|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
8513163|NCT00427635|20982296|P1|COMPLETED|Study Completion to Safety Follow-up||25
8513164|NCT00427635|20982295|P2|STARTED|Study Completion to Safety Follow-up||26
8513165|NCT00427635|20982296|P1|STARTED|Study Completion to Safety Follow-up||25
8513166|NCT00427635|20982295|P2|NOT COMPLETED|Treatment Phase||0
8513167|NCT00427635|20982296|P1|NOT COMPLETED|Treatment Phase||1
8513168|NCT00427635|20982295|P2|COMPLETED|Treatment Phase|ITT population|26
8513169|NCT00427635|20982296|P1|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
8513170|NCT00427635|20982295|P2|STARTED|Treatment Phase|Randomised|26
8513171|NCT00427635|20982296|P1|STARTED|Treatment Phase|Randomised|26
8513172|NCT00427557|20982324|P1|NOT COMPLETED|Overall Study||0
8513173|NCT00427557|20982324|P1|COMPLETED|Overall Study||30
8513174|NCT00427557|20982324|P1|STARTED|Overall Study||30
8513175|NCT00427349|20982328|P1|NOT COMPLETED|Overall Study||46
8513176|NCT00427349|20982328|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
8513177|NCT00427349|20982328|P1|Eligible and Treated|Overall Study||44
8513178|NCT00427349|20982328|P1|Treated|Overall Study||45
8513179|NCT00427349|20982328|P1|Eligible|Overall Study||45
8513180|NCT00427349|20982328|P1|STARTED|Overall Study||46
8513181|NCT00427336|20982334|P1|NOT COMPLETED|Overall Study||0
8513182|NCT00427336|20982334|P1|COMPLETED|Overall Study||9
8513183|NCT00427336|20982334|P1|STARTED|Overall Study||9
8513184|NCT00427297|20982340|P2|NOT COMPLETED|Overall Study||0
8513185|NCT00427297|20982341|P1|NOT COMPLETED|Overall Study||0
8513186|NCT00427297|20982340|P2|COMPLETED|Overall Study||17
8513187|NCT00427297|20982341|P1|COMPLETED|Overall Study||17
8513188|NCT00427297|20982340|P2|STARTED|Overall Study||17
8513189|NCT00427297|20982341|P1|STARTED|Overall Study||17
8513196|NCT00427037|20982376|P2|NOT COMPLETED|Overall Study||7
8513197|NCT00427037|20982377|P1|NOT COMPLETED|Overall Study||7
8513198|NCT00427037|20982376|P2|COMPLETED|Overall Study||10
8513199|NCT00427037|20982377|P1|COMPLETED|Overall Study||10
8513200|NCT00427037|20982376|P2|STARTED|Overall Study||17
8513201|NCT00427037|20982377|P1|STARTED|Overall Study||17
8513202|NCT00427011|20982385|P1|NOT COMPLETED|Overall Study||25
8513203|NCT00427011|20982385|P1|COMPLETED|Overall Study||0
8513204|NCT00427011|20982385|P1|STARTED|Overall Study||25
8513205|NCT00426855|20982396|P1|NOT COMPLETED|Overall Study||0
8513206|NCT00426855|20982396|P1|COMPLETED|Overall Study||12
8513207|NCT00426855|20982396|P1|STARTED|Overall Study||12
8513208|NCT00426842|20982400|P1|NOT COMPLETED|Overall Study||1
8513209|NCT00426842|20982400|P1|COMPLETED|Overall Study||10
8513210|NCT00426842|20982400|P1|STARTED|Overall Study||11
8513211|NCT00426764|20982406|P1|NOT COMPLETED|Overall Study||131
8513212|NCT00426764|20982406|P1|COMPLETED|Overall Study||0
8513213|NCT00426764|20982406|P1|Discontinued at End of or After Cycle 6|Overall Study||33
8513214|NCT00426764|20982406|P1|Discontinued Prior to or During Cycle 6|Overall Study||98
8513215|NCT00426764|20982406|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
8513216|NCT00426751|20982423|P2|NOT COMPLETED|Overall Study||20
8513217|NCT00426751|20982424|P1|NOT COMPLETED|Overall Study||22
8513218|NCT00426751|20982423|P2|COMPLETED|Overall Study||183
8513219|NCT00426751|20982424|P1|COMPLETED|Overall Study||204
8513220|NCT00426751|20982423|P2|STARTED|Overall Study||203
8513221|NCT00426751|20982424|P1|STARTED|Overall Study||226
8513222|NCT00426660|20982468|P1|NOT COMPLETED|Overall Study||131
8513223|NCT00426660|20982468|P1|COMPLETED|Overall Study||916
8513224|NCT00426660|20982468|P1|Safety Analysis Set|Overall Study||1032
8513225|NCT00426660|20982468|P1|Treated|Overall Study||1032
8513226|NCT00426660|20982468|P1|STARTED|Overall Study||1047
8513227|NCT00426556|20982499|P4|NOT COMPLETED|Phase II - Extension Phase||23
8513228|NCT00426556|20982500|P3|NOT COMPLETED|Phase II - Extension Phase||0
8513229|NCT00426556|20982501|P2|NOT COMPLETED|Phase II - Extension Phase||0
8513230|NCT00426556|20982502|P1|NOT COMPLETED|Phase II - Extension Phase||0
8513231|NCT00426556|20982499|P4|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
8513232|NCT00426556|20982500|P3|COMPLETED|Phase II - Extension Phase||0
8513233|NCT00426556|20982501|P2|COMPLETED|Phase II - Extension Phase||0
8513234|NCT00426556|20982502|P1|COMPLETED|Phase II - Extension Phase||0
8513235|NCT00426556|20982499|P4|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
8513236|NCT00426556|20982500|P3|STARTED|Phase II - Extension Phase||0
8513237|NCT00426556|20982501|P2|STARTED|Phase II - Extension Phase||0
8513238|NCT00426556|20982502|P1|STARTED|Phase II - Extension Phase||0
8513239|NCT00426556|20982499|P4|NOT COMPLETED|Phase II - Core Phase||27
8513240|NCT00426556|20982500|P3|NOT COMPLETED|Phase II - Core Phase||0
8513241|NCT00426556|20982501|P2|NOT COMPLETED|Phase II - Core Phase||0
8513242|NCT00426556|20982502|P1|NOT COMPLETED|Phase II - Core Phase||0
8513243|NCT00426556|20982499|P4|COMPLETED|Phase II - Core Phase||28
8513244|NCT00426556|20982500|P3|COMPLETED|Phase II - Core Phase||0
8513245|NCT00426556|20982501|P2|COMPLETED|Phase II - Core Phase||0
8513246|NCT00426556|20982502|P1|COMPLETED|Phase II - Core Phase||0
8513247|NCT00426556|20982499|P4|STARTED|Phase II - Core Phase||55
8513248|NCT00426556|20982500|P3|STARTED|Phase II - Core Phase||0
8513249|NCT00426556|20982501|P2|STARTED|Phase II - Core Phase||0
8513250|NCT00426556|20982502|P1|STARTED|Phase II - Core Phase||0
8513251|NCT00426556|20982499|P4|NOT COMPLETED|Phase I - Extension Phase||0
8513252|NCT00426556|20982500|P3|NOT COMPLETED|Phase I - Extension Phase||7
8513253|NCT00426556|20982501|P2|NOT COMPLETED|Phase I - Extension Phase||6
8513254|NCT00426556|20982502|P1|NOT COMPLETED|Phase I - Extension Phase||5
8513255|NCT00426556|20982499|P4|COMPLETED|Phase I - Extension Phase||0
8513256|NCT00426556|20982500|P3|COMPLETED|Phase I - Extension Phase||0
8513257|NCT00426556|20982501|P2|COMPLETED|Phase I - Extension Phase||1
8513258|NCT00426556|20982502|P1|COMPLETED|Phase I - Extension Phase||0
8513259|NCT00426556|20982499|P4|STARTED|Phase I - Extension Phase||0
8513260|NCT00426556|20982500|P3|STARTED|Phase I - Extension Phase||7
8513261|NCT00426556|20982501|P2|STARTED|Phase I - Extension Phase||7
8513262|NCT00426556|20982502|P1|STARTED|Phase I - Extension Phase||5
8513263|NCT00426556|20982499|P4|NOT COMPLETED|Phase I - Core Phase||0
8513264|NCT00426556|20982500|P3|NOT COMPLETED|Phase I - Core Phase||3
8513265|NCT00426556|20982501|P2|NOT COMPLETED|Phase I - Core Phase||10
8513266|NCT00426556|20982502|P1|NOT COMPLETED|Phase I - Core Phase||1
8513267|NCT00426556|20982499|P4|COMPLETED|Phase I - Core Phase||0
8513268|NCT00426556|20982500|P3|COMPLETED|Phase I - Core Phase||7
8513269|NCT00426556|20982501|P2|COMPLETED|Phase I - Core Phase||7
8513270|NCT00426556|20982502|P1|COMPLETED|Phase I - Core Phase||5
8513271|NCT00426556|20982499|P4|STARTED|Phase I - Core Phase||0
8513272|NCT00426556|20982500|P3|STARTED|Phase I - Core Phase||10
8513273|NCT00426556|20982501|P2|STARTED|Phase I - Core Phase||17
8513274|NCT00426556|20982502|P1|STARTED|Phase I - Core Phase||6
8513275|NCT00426361|20982527|P3|NOT COMPLETED|Overall Study||5
8513276|NCT00426361|20982528|P2|NOT COMPLETED|Overall Study||5
8513277|NCT00426361|20982529|P1|NOT COMPLETED|Overall Study||4
8513278|NCT00426361|20982527|P3|COMPLETED|Overall Study||243
8513279|NCT00426361|20982528|P2|COMPLETED|Overall Study||250
8513280|NCT00426361|20982529|P1|COMPLETED|Overall Study||244
8513281|NCT00426361|20982527|P3|STARTED|Overall Study||248
8513282|NCT00426361|20982528|P2|STARTED|Overall Study||255
8513283|NCT00426361|20982529|P1|STARTED|Overall Study||248
8513284|NCT00426283|20982581|P2|NOT COMPLETED|Overall Study||1
8513285|NCT00426283|20982582|P1|NOT COMPLETED|Overall Study||5
8513286|NCT00426283|20982581|P2|COMPLETED|Overall Study||13
8513287|NCT00426283|20982582|P1|COMPLETED|Overall Study||23
8513288|NCT00426283|20982581|P2|STARTED|Overall Study||14
8513289|NCT00426283|20982582|P1|STARTED|Overall Study||28
8513290|NCT00426270|20982596|P1|NOT COMPLETED|Overall Study||6
8513291|NCT00426270|20982596|P1|COMPLETED|Overall Study||110
8513292|NCT00426270|20982596|P1|STARTED|Overall Study||116
8513293|NCT00426231|20982606|P2|NOT COMPLETED|Overall Study||12
8513294|NCT00426231|20982607|P1|NOT COMPLETED|Overall Study||9
8513295|NCT00426231|20982606|P2|COMPLETED|Overall Study|For the 6-month endpoint|25
8513296|NCT00426231|20982607|P1|COMPLETED|Overall Study|For the 6 month endpoint|27
8513297|NCT00426231|20982606|P2|STARTED|Overall Study||37
8513298|NCT00426231|20982607|P1|STARTED|Overall Study||36
8513299|NCT00426153|20982617|P2|NOT COMPLETED|Overall Study||0
8513300|NCT00426153|20982618|P1|NOT COMPLETED|Overall Study||0
8513301|NCT00426153|20982617|P2|COMPLETED|Overall Study||14
8513302|NCT00426153|20982618|P1|COMPLETED|Overall Study||28
8513303|NCT00426153|20982617|P2|STARTED|Overall Study||14
8513304|NCT00426153|20982618|P1|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
8513305|NCT00426127|20982630|P1|NOT COMPLETED|Overall Study||2
8513306|NCT00426127|20982630|P1|COMPLETED|Overall Study||0
8513307|NCT00426127|20982630|P1|STARTED|Overall Study||2
8513308|NCT00425945|20982638|P2|NOT COMPLETED|Overall Study||5
8513309|NCT00425945|20982639|P1|NOT COMPLETED|Overall Study||4
8513310|NCT00425945|20982638|P2|COMPLETED|Overall Study||61
8513311|NCT00425945|20982639|P1|COMPLETED|Overall Study||60
8513312|NCT00425945|20982638|P2|STARTED|Overall Study||66
8513313|NCT00425945|20982639|P1|STARTED|Overall Study||64
8513314|NCT00425854|20982677|P2|NOT COMPLETED|Overall Study||21
8513315|NCT00425854|20982678|P1|NOT COMPLETED|Overall Study||29
8513316|NCT00425854|20982677|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
8513317|NCT00425854|20982678|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
8513318|NCT00425854|20982677|P2|STARTED|Overall Study|Treated|21
8513319|NCT00425854|20982678|P1|STARTED|Overall Study|Treated|29
8513320|NCT00425802|20982699|P1|NOT COMPLETED|Overall Study||0
8513321|NCT00425802|20982699|P1|COMPLETED|Overall Study||61
8513322|NCT00425802|20982699|P1|STARTED|Overall Study||61
8513323|NCT00425750|20982711|P1|NOT COMPLETED|Overall Study||25
8513324|NCT00425750|20982711|P1|COMPLETED|Overall Study||0
8513325|NCT00425750|20982711|P1|STARTED|Overall Study||25
8513326|NCT00425698|20982719|P2|NOT COMPLETED|Overall Study||2
8513327|NCT00425698|20982720|P1|NOT COMPLETED|Overall Study||3
8513328|NCT00425698|20982719|P2|COMPLETED|Overall Study||42
8513329|NCT00425698|20982720|P1|COMPLETED|Overall Study||41
8513330|NCT00425698|20982719|P2|STARTED|Overall Study||44
8513331|NCT00425698|20982720|P1|STARTED|Overall Study||44
8513332|NCT00425672|20982726|P1|NOT COMPLETED|Overall Study||1
8513333|NCT00425672|20982726|P1|COMPLETED|Overall Study||14
8513334|NCT00425672|20982726|P1|STARTED|Overall Study||15
8513335|NCT00425607|20982735|P1|NOT COMPLETED|Overall Study||2
8513336|NCT00425607|20982735|P1|COMPLETED|Overall Study||27
8513337|NCT00425607|20982735|P1|Received Treatment|Overall Study||28
8513338|NCT00425607|20982735|P1|STARTED|Overall Study||29
8513339|NCT00425503|20982739|P1|NOT COMPLETED|Overall Study||3
8513340|NCT00425503|20982739|P1|COMPLETED|Overall Study||37
8513341|NCT00425503|20982739|P1|STARTED|Overall Study||40
8513342|NCT00425477|20982743|P1|NOT COMPLETED|Overall Study||13
8513343|NCT00425477|20982743|P1|COMPLETED|Overall Study||13
8513344|NCT00425477|20982743|P1|STARTED|Overall Study||26
8513345|NCT00425438|20982751|P2|NOT COMPLETED|Overall Study||27
8513346|NCT00425438|20982752|P1|NOT COMPLETED|Overall Study||25
8513347|NCT00425438|20982751|P2|COMPLETED|Overall Study||0
8513348|NCT00425438|20982752|P1|COMPLETED|Overall Study||0
8513349|NCT00425438|20982751|P2|STARTED|Overall Study||27
8513350|NCT00425438|20982752|P1|STARTED|Overall Study||25
8513351|NCT00425386|20982768|P1|NOT COMPLETED|Overall Study||3
8513352|NCT00425386|20982768|P1|COMPLETED|Overall Study||43
8513353|NCT00425386|20982768|P1|STARTED|Overall Study||46
8513354|NCT00425373|20982786|P9|NOT COMPLETED|Overall Study||18
8513355|NCT00425373|20982787|P8|NOT COMPLETED|Overall Study||10
8513356|NCT00425373|20982788|P7|NOT COMPLETED|Overall Study||7
8513357|NCT00425373|20982789|P6|NOT COMPLETED|Overall Study||9
8513358|NCT00425373|20982790|P5|NOT COMPLETED|Overall Study||10
8513359|NCT00425373|20982791|P4|NOT COMPLETED|Overall Study||2
8513360|NCT00425373|20982792|P3|NOT COMPLETED|Overall Study||3
8513361|NCT00425373|20982793|P2|NOT COMPLETED|Overall Study||3
8513362|NCT00425373|20982794|P1|NOT COMPLETED|Overall Study||5
8513363|NCT00425373|20982786|P9|COMPLETED|Overall Study||148
8513364|NCT00425373|20982787|P8|COMPLETED|Overall Study||151
8513365|NCT00425373|20982788|P7|COMPLETED|Overall Study||154
8513366|NCT00425373|20982789|P6|COMPLETED|Overall Study||154
8513367|NCT00425373|20982790|P5|COMPLETED|Overall Study||159
8513368|NCT00425373|20982791|P4|COMPLETED|Overall Study||160
8513369|NCT00425373|20982792|P3|COMPLETED|Overall Study||157
8513370|NCT00425373|20982793|P2|COMPLETED|Overall Study||164
8513371|NCT00425373|20982794|P1|COMPLETED|Overall Study||154
8513372|NCT00425373|20982786|P9|STARTED|Overall Study||166
8513373|NCT00425373|20982787|P8|STARTED|Overall Study||161
8513374|NCT00425373|20982788|P7|STARTED|Overall Study||161
8513375|NCT00425373|20982789|P6|STARTED|Overall Study||163
8513376|NCT00425373|20982790|P5|STARTED|Overall Study||169
8513377|NCT00425373|20982791|P4|STARTED|Overall Study||162
8513378|NCT00425373|20982792|P3|STARTED|Overall Study||160
8513379|NCT00425373|20982793|P2|STARTED|Overall Study||167
8513380|NCT00425373|20982794|P1|STARTED|Overall Study||159
8513381|NCT00425308|20982852|P2|NOT COMPLETED|Overall Study||1
8513382|NCT00425308|20982853|P1|NOT COMPLETED|Overall Study||4
8513383|NCT00425308|20982852|P2|COMPLETED|Overall Study||14
8513384|NCT00425308|20982853|P1|COMPLETED|Overall Study||11
8513385|NCT00425308|20982852|P2|STARTED|Overall Study||15
8513386|NCT00425308|20982853|P1|STARTED|Overall Study||15
8513387|NCT00425269|20982883|P2|NOT COMPLETED|Overall Study||20
8513388|NCT00425269|20982884|P1|NOT COMPLETED|Overall Study||19
8513389|NCT00425269|20982883|P2|COMPLETED|Overall Study||77
8513390|NCT00425269|20982884|P1|COMPLETED|Overall Study||82
8513391|NCT00425269|20982883|P2|STARTED|Overall Study||97
8513392|NCT00425269|20982884|P1|STARTED|Overall Study||101
8513393|NCT00425113|20982962|P2|NOT COMPLETED|Overall Study||2
8513394|NCT00425113|20982963|P1|NOT COMPLETED|Overall Study||2
8513395|NCT00425113|20982962|P2|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
8513396|NCT00425113|20982963|P1|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
8513397|NCT00425113|20982962|P2|Exposed to Study Drug|Overall Study||17
8513398|NCT00425113|20982963|P1|Exposed to Study Drug|Overall Study||16
8513399|NCT00425113|20982962|P2|STARTED|Overall Study||18
8513400|NCT00425113|20982963|P1|STARTED|Overall Study||17
8513401|NCT00425100|20982971|P1|NOT COMPLETED|Overall Study||53
8513402|NCT00425100|20982971|P1|COMPLETED|Overall Study||463
8513403|NCT00425100|20982971|P1|STARTED|Overall Study||516
8513404|NCT00425061|20983015|P7|NOT COMPLETED|Overall Study||19
8513405|NCT00425061|20983016|P6|NOT COMPLETED|Overall Study||4
8513406|NCT00425061|20983017|P5|NOT COMPLETED|Overall Study||26
8513407|NCT00425061|20983018|P4|NOT COMPLETED|Overall Study||2
8513408|NCT00425061|20983019|P3|NOT COMPLETED|Overall Study||0
8513409|NCT00425061|20983020|P2|NOT COMPLETED|Overall Study||2
8513410|NCT00425061|20983021|P1|NOT COMPLETED|Overall Study||2
8513411|NCT00425061|20983015|P7|COMPLETED|Overall Study||26
8513412|NCT00425061|20983016|P6|COMPLETED|Overall Study||0
8513413|NCT00425061|20983017|P5|COMPLETED|Overall Study||19
8513414|NCT00425061|20983018|P4|COMPLETED|Overall Study||14
8513415|NCT00425061|20983019|P3|COMPLETED|Overall Study||16
8513416|NCT00425061|20983020|P2|COMPLETED|Overall Study||15
8513417|NCT00425061|20983021|P1|COMPLETED|Overall Study||14
8513418|NCT00425061|20983015|P7|STARTED|Overall Study||45
8513419|NCT00425061|20983016|P6|STARTED|Overall Study||4
8513420|NCT00425061|20983017|P5|STARTED|Overall Study||45
8513421|NCT00425061|20983018|P4|STARTED|Overall Study||16
8513422|NCT00425061|20983019|P3|STARTED|Overall Study||16
8513423|NCT00425061|20983020|P2|STARTED|Overall Study||17
8513424|NCT00425061|20983021|P1|STARTED|Overall Study||16
8513425|NCT00424840|20983137|P3|NOT COMPLETED|Overall Study||0
8513426|NCT00424840|20983138|P2|NOT COMPLETED|Overall Study||0
8513427|NCT00424840|20983139|P1|NOT COMPLETED|Overall Study||0
8513428|NCT00424840|20983137|P3|COMPLETED|Overall Study||5
8513429|NCT00424840|20983138|P2|COMPLETED|Overall Study||4
8513430|NCT00424840|20983139|P1|COMPLETED|Overall Study||3
8513431|NCT00424840|20983137|P3|STARTED|Overall Study||5
8513432|NCT00424840|20983138|P2|STARTED|Overall Study||4
8513433|NCT00424840|20983139|P1|STARTED|Overall Study||3
8513434|NCT00424827|20983145|P1|NOT COMPLETED|Overall Study||1
8513435|NCT00424827|20983145|P1|COMPLETED|Overall Study||10
8513436|NCT00424827|20983145|P1|STARTED|Overall Study||11
8513437|NCT00424775|20983153|P2|NOT COMPLETED|Overall Study||0
8513438|NCT00424775|20983154|P1|NOT COMPLETED|Overall Study||3
8513439|NCT00424775|20983153|P2|COMPLETED|Overall Study||0
8513440|NCT00424775|20983154|P1|COMPLETED|Overall Study||0
8513441|NCT00424775|20983153|P2|STARTED|Overall Study||0
8513442|NCT00424775|20983154|P1|STARTED|Overall Study||3
8513443|NCT00424762|20983164|P2|NOT COMPLETED|Overall Study||22
8513444|NCT00424762|20983165|P1|NOT COMPLETED|Overall Study||20
8513445|NCT00424762|20983164|P2|COMPLETED|Overall Study||54
8513446|NCT00424762|20983165|P1|COMPLETED|Overall Study||54
8513447|NCT00424762|20983164|P2|STARTED|Overall Study||76
8513448|NCT00424762|20983165|P1|STARTED|Overall Study||74
8513449|NCT00424749|20983175|P1|NOT COMPLETED|Overall Study||1
8513450|NCT00424749|20983175|P1|COMPLETED|Overall Study||3
8513451|NCT00424749|20983175|P1|STARTED|Overall Study||4
8513452|NCT00424645|20983182|P2|NOT COMPLETED|Overall Study||0
8513453|NCT00424645|20983183|P1|NOT COMPLETED|Overall Study||1
8513454|NCT00424645|20983182|P2|COMPLETED|Overall Study||0
8513455|NCT00424645|20983183|P1|COMPLETED|Overall Study||2
8513456|NCT00424645|20983182|P2|STARTED|Overall Study||0
8513457|NCT00424645|20983183|P1|STARTED|Overall Study||3
8513458|NCT00424632|20983191|P10|NOT COMPLETED|Overall Study||6
8513459|NCT00424632|20983192|P9|NOT COMPLETED|Overall Study||16
8513460|NCT00424632|20983193|P8|NOT COMPLETED|Overall Study||3
8513461|NCT00424632|20983194|P7|NOT COMPLETED|Overall Study||7
8513462|NCT00424632|20983195|P6|NOT COMPLETED|Overall Study||15
8513463|NCT00424632|20983196|P5|NOT COMPLETED|Overall Study||3
8513464|NCT00424632|20983197|P4|NOT COMPLETED|Overall Study||4
8513465|NCT00424632|20983198|P3|NOT COMPLETED|Overall Study||1
8513466|NCT00424632|20983199|P2|NOT COMPLETED|Overall Study||1
8513467|NCT00424632|20983200|P1|NOT COMPLETED|Overall Study||1
8513468|NCT00424632|20983191|P10|COMPLETED|Overall Study||0
8513469|NCT00424632|20983192|P9|COMPLETED|Overall Study||0
8513470|NCT00424632|20983193|P8|COMPLETED|Overall Study||0
8513471|NCT00424632|20983194|P7|COMPLETED|Overall Study||0
8513472|NCT00424632|20983195|P6|COMPLETED|Overall Study||0
8513473|NCT00424632|20983196|P5|COMPLETED|Overall Study||0
8513474|NCT00424632|20983197|P4|COMPLETED|Overall Study||0
8513475|NCT00424632|20983198|P3|COMPLETED|Overall Study||0
8513476|NCT00424632|20983199|P2|COMPLETED|Overall Study||0
8513477|NCT00424632|20983200|P1|COMPLETED|Overall Study||0
8513478|NCT00424632|20983191|P10|STARTED|Overall Study||6
8513479|NCT00424632|20983192|P9|STARTED|Overall Study||16
8513480|NCT00424632|20983193|P8|STARTED|Overall Study||3
8513481|NCT00424632|20983194|P7|STARTED|Overall Study||7
8513482|NCT00424632|20983195|P6|STARTED|Overall Study||15
8513483|NCT00424632|20983196|P5|STARTED|Overall Study||3
8513484|NCT00424632|20983197|P4|STARTED|Overall Study||4
8513485|NCT00424632|20983198|P3|STARTED|Overall Study||1
8513486|NCT00424632|20983199|P2|STARTED|Overall Study||1
8513487|NCT00424632|20983200|P1|STARTED|Overall Study||1
8513488|NCT00424619|20983334|P3|NOT COMPLETED|3 Month||0
8513489|NCT00424619|20983335|P2|NOT COMPLETED|3 Month||0
8513490|NCT00424619|20983336|P1|NOT COMPLETED|3 Month||0
8513491|NCT00424619|20983334|P3|COMPLETED|3 Month||17
8513492|NCT00424619|20983335|P2|COMPLETED|3 Month||18
8513493|NCT00424619|20983336|P1|COMPLETED|3 Month||12
8513494|NCT00424619|20983334|P3|STARTED|3 Month||17
8513495|NCT00424619|20983335|P2|STARTED|3 Month||18
8513496|NCT00424619|20983336|P1|STARTED|3 Month||12
8513497|NCT00424619|20983334|P3|NOT COMPLETED|4 Week||0
8513498|NCT00424619|20983335|P2|NOT COMPLETED|4 Week||0
8513499|NCT00424619|20983336|P1|NOT COMPLETED|4 Week||0
8513500|NCT00424619|20983334|P3|COMPLETED|4 Week||17
8513501|NCT00424619|20983335|P2|COMPLETED|4 Week||17
8513502|NCT00424619|20983336|P1|COMPLETED|4 Week||18
8513503|NCT00424619|20983334|P3|STARTED|4 Week||17
8513504|NCT00424619|20983335|P2|STARTED|4 Week||17
8513505|NCT00424619|20983336|P1|STARTED|4 Week||18
8513506|NCT00424619|20983334|P3|NOT COMPLETED|Baseline||1
8513507|NCT00424619|20983335|P2|NOT COMPLETED|Baseline||0
8513508|NCT00424619|20983336|P1|NOT COMPLETED|Baseline||0
8513509|NCT00424619|20983334|P3|COMPLETED|Baseline||20
8513510|NCT00424619|20983335|P2|COMPLETED|Baseline||22
8513511|NCT00424619|20983336|P1|COMPLETED|Baseline||22
8513512|NCT00424619|20983334|P3|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
8513513|NCT00424619|20983335|P2|STARTED|Baseline||22
8513514|NCT00424619|20983336|P1|STARTED|Baseline||22
8513515|NCT00424593|20983370|P2|NOT COMPLETED|Dose-Blind Extension Period||0
8513516|NCT00424593|20983371|P1|NOT COMPLETED|Dose-Blind Extension Period||64
8513517|NCT00424593|20983370|P2|COMPLETED|Dose-Blind Extension Period||0
8513518|NCT00424593|20983371|P1|COMPLETED|Dose-Blind Extension Period||117
8513519|NCT00424593|20983370|P2|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
8513520|NCT00424593|20983371|P1|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
8513521|NCT00424593|20983370|P2|NOT COMPLETED|Acute Double-Blind Period||23
8513522|NCT00424593|20983371|P1|NOT COMPLETED|Acute Double-Blind Period||31
8513523|NCT00424593|20983370|P2|COMPLETED|Acute Double-Blind Period||98
8513524|NCT00424593|20983371|P1|COMPLETED|Acute Double-Blind Period||84
8513525|NCT00424593|20983370|P2|STARTED|Acute Double-Blind Period||121
8513526|NCT00424593|20983371|P1|STARTED|Acute Double-Blind Period||115
8513527|NCT00424554|20983417|P2|NOT COMPLETED|Overall Study||0
8513528|NCT00424554|20983418|P1|NOT COMPLETED|Overall Study||0
8513529|NCT00424554|20983417|P2|COMPLETED|Overall Study||6
8513530|NCT00424554|20983418|P1|COMPLETED|Overall Study||34
8513531|NCT00424554|20983417|P2|STARTED|Overall Study||6
8513532|NCT00424554|20983418|P1|STARTED|Overall Study||34
8513533|NCT00424528|20983435|P3|NOT COMPLETED|Overall Study||4
8513534|NCT00424528|20983436|P2|NOT COMPLETED|Overall Study||4
8513535|NCT00424528|20983437|P1|NOT COMPLETED|Overall Study||5
8513536|NCT00424528|20983435|P3|COMPLETED|Overall Study||74
8513537|NCT00424528|20983436|P2|COMPLETED|Overall Study||76
8513538|NCT00424528|20983437|P1|COMPLETED|Overall Study||71
8513539|NCT00424528|20983435|P3|STARTED|Overall Study||78
8513540|NCT00424528|20983436|P2|STARTED|Overall Study||80
8513541|NCT00424528|20983437|P1|STARTED|Overall Study||76
8513542|NCT00424515|20983492|P2|NOT COMPLETED|Overall Study||13
8513543|NCT00424515|20983493|P1|NOT COMPLETED|Overall Study||11
8513544|NCT00424515|20983492|P2|COMPLETED|Overall Study||0
8513545|NCT00424515|20983493|P1|COMPLETED|Overall Study||0
8513546|NCT00424515|20983492|P2|STARTED|Overall Study||13
8513547|NCT00424515|20983493|P1|STARTED|Overall Study||11
8513548|NCT00424502|20983503|P1|NOT COMPLETED|Overall Study||0
8513549|NCT00424502|20983503|P1|COMPLETED|Overall Study||20
8513550|NCT00424502|20983503|P1|STARTED|Overall Study||20
8513551|NCT00424489|20983512|P1|NOT COMPLETED|Overall Study||3
8513552|NCT00424489|20983512|P1|COMPLETED|Overall Study||6
8513553|NCT00424489|20983512|P1|STARTED|Overall Study||9
8513554|NCT00424476|20983519|P3|NOT COMPLETED|Overall Study||49
8513555|NCT00424476|20983520|P2|NOT COMPLETED|Overall Study||48
8513556|NCT00424476|20983521|P1|NOT COMPLETED|Overall Study||61
8513557|NCT00424476|20983519|P3|COMPLETED|Overall Study||241
8513558|NCT00424476|20983520|P2|COMPLETED|Overall Study||240
8513559|NCT00424476|20983521|P1|COMPLETED|Overall Study||226
8513560|NCT00424476|20983519|P3|STARTED|Overall Study||290
8513561|NCT00424476|20983520|P2|STARTED|Overall Study||288
8513562|NCT00424476|20983521|P1|STARTED|Overall Study||287
8513563|NCT00424463|20983547|P3|NOT COMPLETED|Overall Study||16
8513564|NCT00424463|20983548|P2|NOT COMPLETED|Overall Study||14
8513565|NCT00424463|20983549|P1|NOT COMPLETED|Overall Study||7
8513566|NCT00424463|20983547|P3|COMPLETED|Overall Study||72
8513567|NCT00424463|20983548|P2|COMPLETED|Overall Study||34
8513568|NCT00424463|20983549|P1|COMPLETED|Overall Study||38
8513569|NCT00424463|20983547|P3|STARTED|Overall Study||88
8513570|NCT00424463|20983548|P2|STARTED|Overall Study||48
8513571|NCT00424463|20983549|P1|STARTED|Overall Study||45
8513572|NCT00424398|20983578|P3|NOT COMPLETED|Overall Study||0
8513573|NCT00424398|20983579|P2|NOT COMPLETED|Overall Study||1
8513574|NCT00424398|20983580|P1|NOT COMPLETED|Overall Study||3
8513575|NCT00424398|20983578|P3|COMPLETED|Overall Study||36
8513576|NCT00424398|20983579|P2|COMPLETED|Overall Study||35
8513577|NCT00424398|20983580|P1|COMPLETED|Overall Study||32
8513578|NCT00424398|20983578|P3|STARTED|Overall Study||36
8513579|NCT00424398|20983579|P2|STARTED|Overall Study||36
8513580|NCT00424398|20983580|P1|STARTED|Overall Study||35
8513581|NCT00424385|20983624|P1|NOT COMPLETED|Cohort 1||1
8513582|NCT00424385|20983624|P1|COMPLETED|Cohort 1||4
8513583|NCT00424385|20983624|P1|STARTED|Cohort 1||5
8513584|NCT00424385|20983624|P1|NOT COMPLETED|Cohort 0||6
8513585|NCT00424385|20983624|P1|COMPLETED|Cohort 0||6
8513586|NCT00424385|20983624|P1|STARTED|Cohort 0||12
8513590|NCT00424346|20983643|P4|NOT COMPLETED|Extension Phase||55
8513591|NCT00424346|20983644|P3|NOT COMPLETED|Extension Phase||55
8513592|NCT00424346|20983645|P2|NOT COMPLETED|Extension Phase||102
8513593|NCT00424346|20983646|P1|NOT COMPLETED|Extension Phase||0
8513594|NCT00424346|20983643|P4|COMPLETED|Extension Phase||3
8513595|NCT00424346|20983644|P3|COMPLETED|Extension Phase||4
8513596|NCT00424346|20983645|P2|COMPLETED|Extension Phase||8
8513597|NCT00424346|20983646|P1|COMPLETED|Extension Phase||0
8513598|NCT00424346|20983643|P4|STARTED|Extension Phase||58
8513599|NCT00424346|20983644|P3|STARTED|Extension Phase||59
8513600|NCT00424346|20983645|P2|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
8513601|NCT00424346|20983646|P1|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
8513602|NCT00424346|20983643|P4|NOT COMPLETED|Core Study||7
8513603|NCT00424346|20983644|P3|NOT COMPLETED|Core Study||4
8513604|NCT00424346|20983645|P2|NOT COMPLETED|Core Study||8
8513605|NCT00424346|20983646|P1|NOT COMPLETED|Core Study||9
8513606|NCT00424346|20983643|P4|COMPLETED|Core Study||63
8513607|NCT00424346|20983644|P3|COMPLETED|Core Study||65
8513608|NCT00424346|20983645|P2|COMPLETED|Core Study||56
8513609|NCT00424346|20983646|P1|COMPLETED|Core Study||62
8513610|NCT00424346|20983643|P4|STARTED|Core Study||70
8513611|NCT00424346|20983644|P3|STARTED|Core Study||69
8513612|NCT00424346|20983645|P2|STARTED|Core Study||64
8513613|NCT00424346|20983646|P1|STARTED|Core Study||71
8513614|NCT00424294|20983761|P2|NOT COMPLETED|Overall Study||15
8513615|NCT00424294|20983762|P1|NOT COMPLETED|Overall Study||8
8513616|NCT00424294|20983761|P2|COMPLETED|Overall Study||19
8513617|NCT00424294|20983762|P1|COMPLETED|Overall Study||28
8513618|NCT00424294|20983761|P2|Treated|Overall Study||34
8513619|NCT00424294|20983762|P1|Treated|Overall Study||35
8513620|NCT00424294|20983761|P2|STARTED|Overall Study||34
8513621|NCT00424294|20983762|P1|STARTED|Overall Study||36
8513622|NCT00424268|20983812|P2|NOT COMPLETED|Overall Study||39
8513623|NCT00424268|20983813|P1|NOT COMPLETED|Overall Study||62
8513624|NCT00424268|20983812|P2|COMPLETED|Overall Study||333
8513625|NCT00424268|20983813|P1|COMPLETED|Overall Study||309
8513626|NCT00424268|20983812|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
8513627|NCT00424268|20983813|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
8513628|NCT00424255|20983829|P2|NOT COMPLETED|Overall Study||346
8513629|NCT00424255|20983830|P1|NOT COMPLETED|Overall Study||342
8513630|NCT00424255|20983829|P2|COMPLETED|Overall Study||0
8513631|NCT00424255|20983830|P1|COMPLETED|Overall Study||0
8513632|NCT00424255|20983829|P2|STARTED|Overall Study||346
8513633|NCT00424255|20983830|P1|STARTED|Overall Study||342
8513634|NCT00424190|20983878|P2|NOT COMPLETED|Overall Study||30
8513635|NCT00424190|20983879|P1|NOT COMPLETED|Overall Study||22
8513636|NCT00424190|20983878|P2|COMPLETED|Overall Study||317
8513637|NCT00424190|20983879|P1|COMPLETED|Overall Study||329
8513638|NCT00424190|20983878|P2|STARTED|Overall Study||347
8513639|NCT00424190|20983879|P1|STARTED|Overall Study||351
8513640|NCT00424177|20983885|P1|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
8513641|NCT00424177|20983885|P1|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
8513642|NCT00424177|20983885|P1|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
8513643|NCT00424177|20983885|P1|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
8513644|NCT00424177|20983885|P1|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
8513645|NCT00424177|20983885|P1|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
8513646|NCT00424177|20983885|P1|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
8513647|NCT00424177|20983885|P1|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
8513648|NCT00424177|20983885|P1|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
8513649|NCT00424047|20983914|P2|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
8513650|NCT00424047|20983915|P1|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
8513651|NCT00424047|20983914|P2|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
8513652|NCT00424047|20983915|P1|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
8513653|NCT00424047|20983914|P2|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
8513654|NCT00424047|20983915|P1|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
8513655|NCT00424047|20983914|P2|NOT COMPLETED|On Study at Time of Unblinding||167
8513656|NCT00424047|20983915|P1|NOT COMPLETED|On Study at Time of Unblinding||155
8513657|NCT00424047|20983914|P2|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
8513658|NCT00424047|20983915|P1|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
8513659|NCT00424047|20983914|P2|STARTED|On Study at Time of Unblinding||175
8513660|NCT00424047|20983915|P1|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
8513661|NCT00424047|20983914|P2|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
8513662|NCT00424047|20983915|P1|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
8513663|NCT00424047|20983914|P2|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
8513664|NCT00424047|20983915|P1|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
8513665|NCT00424047|20983914|P2|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
8513666|NCT00424047|20983915|P1|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
8513667|NCT00424047|20983914|P2|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
8513668|NCT00424047|20983915|P1|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
8513669|NCT00424047|20983914|P2|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
8513670|NCT00424047|20983915|P1|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
8513671|NCT00424021|20983947|P4|NOT COMPLETED|AMB-220-E Study Period||10
8513672|NCT00424021|20983948|P3|NOT COMPLETED|AMB-220-E Study Period||5
8513673|NCT00424021|20983949|P2|NOT COMPLETED|AMB-220-E Study Period||2
8513674|NCT00424021|20983950|P1|NOT COMPLETED|AMB-220-E Study Period||1
8513675|NCT00424021|20983947|P4|COMPLETED|AMB-220-E Study Period||16
8513676|NCT00424021|20983948|P3|COMPLETED|AMB-220-E Study Period||14
8513677|NCT00424021|20983949|P2|COMPLETED|AMB-220-E Study Period||5
8513678|NCT00424021|20983950|P1|COMPLETED|AMB-220-E Study Period||1
8513679|NCT00424021|20983947|P4|STARTED|AMB-220-E Study Period||26
8513680|NCT00424021|20983948|P3|STARTED|AMB-220-E Study Period||19
8513681|NCT00424021|20983949|P2|STARTED|AMB-220-E Study Period||7
8513682|NCT00424021|20983950|P1|STARTED|AMB-220-E Study Period||2
8513683|NCT00424021|20983947|P4|NOT COMPLETED|NCT00046319 Study Period||1
8513684|NCT00424021|20983948|P3|NOT COMPLETED|NCT00046319 Study Period||1
8513685|NCT00424021|20983949|P2|NOT COMPLETED|NCT00046319 Study Period||3
8513686|NCT00424021|20983950|P1|NOT COMPLETED|NCT00046319 Study Period||1
8513687|NCT00424021|20983947|P4|COMPLETED|NCT00046319 Study Period||12
8513688|NCT00424021|20983948|P3|COMPLETED|NCT00046319 Study Period||15
8513689|NCT00424021|20983949|P2|COMPLETED|NCT00046319 Study Period||16
8513690|NCT00424021|20983950|P1|COMPLETED|NCT00046319 Study Period||15
8513691|NCT00424021|20983947|P4|STARTED|NCT00046319 Study Period||13
8513692|NCT00424021|20983948|P3|STARTED|NCT00046319 Study Period||16
8513693|NCT00424021|20983949|P2|STARTED|NCT00046319 Study Period||19
8513694|NCT00424021|20983950|P1|STARTED|NCT00046319 Study Period||16
8513695|NCT00424008|20983993|P2|NOT COMPLETED|Overall Study||335
8513696|NCT00424008|20983994|P1|NOT COMPLETED|Overall Study||349
8513697|NCT00424008|20983993|P2|COMPLETED|Overall Study||16
8513698|NCT00424008|20983994|P1|COMPLETED|Overall Study||22
8513699|NCT00424008|20983993|P2|STARTED|Overall Study||351
8513700|NCT00424008|20983994|P1|STARTED|Overall Study||371
8513701|NCT00423943|20984009|P2|NOT COMPLETED|Overall Study||1
8513702|NCT00423943|20984010|P1|NOT COMPLETED|Overall Study||3
8513703|NCT00423943|20984009|P2|COMPLETED|Overall Study||13
8513704|NCT00423943|20984010|P1|COMPLETED|Overall Study||16
8513705|NCT00423943|20984009|P2|STARTED|Overall Study||14
8513706|NCT00423943|20984010|P1|STARTED|Overall Study||19
8513707|NCT00423930|20984024|P1|NOT COMPLETED|Overall Study||2
8513708|NCT00423930|20984024|P1|COMPLETED|Overall Study||42
8513709|NCT00423930|20984024|P1|STARTED|Overall Study||44
8513710|NCT00423917|20984029|P1|NOT COMPLETED|Overall Study||3
8513711|NCT00423917|20984029|P1|COMPLETED|Overall Study||33
8513712|NCT00423917|20984029|P1|STARTED|Overall Study||36
8513713|NCT00423891|20984042|P3|NOT COMPLETED|Post-Dosing Follow Up||2
8513714|NCT00423891|20984043|P2|NOT COMPLETED|Post-Dosing Follow Up||3
8513715|NCT00423891|20984044|P1|NOT COMPLETED|Post-Dosing Follow Up||2
8513716|NCT00423891|20984042|P3|COMPLETED|Post-Dosing Follow Up||3
8513717|NCT00423891|20984043|P2|COMPLETED|Post-Dosing Follow Up||15
8513718|NCT00423891|20984044|P1|COMPLETED|Post-Dosing Follow Up||20
8513719|NCT00423891|20984042|P3|STARTED|Post-Dosing Follow Up||5
8513720|NCT00423891|20984043|P2|STARTED|Post-Dosing Follow Up||18
8513721|NCT00423891|20984044|P1|STARTED|Post-Dosing Follow Up||22
8513722|NCT00423891|20984042|P3|NOT COMPLETED|Treatment||0
8513723|NCT00423891|20984043|P2|NOT COMPLETED|Treatment||0
8513724|NCT00423891|20984044|P1|NOT COMPLETED|Treatment||2
8513725|NCT00423891|20984042|P3|COMPLETED|Treatment||5
8513726|NCT00423891|20984043|P2|COMPLETED|Treatment||19
8513727|NCT00423891|20984044|P1|COMPLETED|Treatment||22
8513728|NCT00423891|20984042|P3|STARTED|Treatment||5
8513729|NCT00423891|20984043|P2|STARTED|Treatment||19
8513730|NCT00423891|20984044|P1|STARTED|Treatment||24
8513731|NCT00423891|20984042|P3|NOT COMPLETED|Enrolled||3
8513732|NCT00423891|20984043|P2|NOT COMPLETED|Enrolled||2
8513733|NCT00423891|20984044|P1|NOT COMPLETED|Enrolled||11
8513734|NCT00423891|20984042|P3|COMPLETED|Enrolled||5
8513735|NCT00423891|20984043|P2|COMPLETED|Enrolled||19
8513736|NCT00423891|20984044|P1|COMPLETED|Enrolled||24
8513737|NCT00423891|20984042|P3|STARTED|Enrolled||8
8513738|NCT00423891|20984043|P2|STARTED|Enrolled||21
8513739|NCT00423891|20984044|P1|STARTED|Enrolled||35
8513740|NCT00423878|20984113|P2|NOT COMPLETED|Overall Study||8
8513741|NCT00423878|20984114|P1|NOT COMPLETED|Overall Study||20
8513742|NCT00423878|20984113|P2|COMPLETED|Overall Study||98
8513743|NCT00423878|20984114|P1|COMPLETED|Overall Study||89
8513744|NCT00423878|20984113|P2|STARTED|Overall Study||106
8513745|NCT00423878|20984114|P1|STARTED|Overall Study||109
8513746|NCT00423852|20984122|P1|NOT COMPLETED|Overall Study||3
8513747|NCT00423852|20984122|P1|COMPLETED|Overall Study||23
8513748|NCT00423852|20984122|P1|STARTED|Overall Study||26
8513749|NCT00423813|20984130|P3|NOT COMPLETED|Overall Study||74
8513750|NCT00423813|20984131|P2|NOT COMPLETED|Overall Study||66
8513751|NCT00423813|20984132|P1|NOT COMPLETED|Overall Study||57
8513752|NCT00423813|20984130|P3|COMPLETED|Overall Study||116
8513753|NCT00423813|20984131|P2|COMPLETED|Overall Study||129
8513754|NCT00423813|20984132|P1|COMPLETED|Overall Study||131
8513755|NCT00423813|20984130|P3|Treated|Overall Study||189
8513756|NCT00423813|20984131|P2|Treated|Overall Study||194
8513757|NCT00423813|20984132|P1|Treated|Overall Study||188
8513758|NCT00423813|20984130|P3|STARTED|Overall Study||190
8513759|NCT00423813|20984131|P2|STARTED|Overall Study||195
8513760|NCT00423813|20984132|P1|STARTED|Overall Study||188
8513761|NCT00423800|20984142|P2|NOT COMPLETED|Overall Study||1
8513762|NCT00423800|20984143|P1|NOT COMPLETED|Overall Study||0
8513763|NCT00423800|20984142|P2|COMPLETED|Overall Study||1
8513764|NCT00423800|20984143|P1|COMPLETED|Overall Study||3
8513765|NCT00423800|20984142|P2|STARTED|Overall Study||2
8513766|NCT00423800|20984143|P1|STARTED|Overall Study||3
8513767|NCT00423735|20984155|P3|NOT COMPLETED|Overall Study||0
8513768|NCT00423735|20984156|P2|NOT COMPLETED|Overall Study||6
8513769|NCT00423735|20984157|P1|NOT COMPLETED|Overall Study||8
8513770|NCT00423735|20984155|P3|COMPLETED|Overall Study||0
8513771|NCT00423735|20984156|P2|COMPLETED|Overall Study||29
8513772|NCT00423735|20984157|P1|COMPLETED|Overall Study||21
8513773|NCT00423735|20984155|P3|STARTED|Overall Study||0
8513774|NCT00423735|20984156|P2|STARTED|Overall Study||35
8513775|NCT00423735|20984157|P1|STARTED|Overall Study||29
8513776|NCT00423722|20984180|P2|NOT COMPLETED|Overall Study||13
8513777|NCT00423722|20984181|P1|NOT COMPLETED|Overall Study||14
8513778|NCT00423722|20984180|P2|COMPLETED|Overall Study||53
8513779|NCT00423722|20984181|P1|COMPLETED|Overall Study||49
8513780|NCT00423722|20984180|P2|STARTED|Overall Study||66
8513781|NCT00423722|20984181|P1|STARTED|Overall Study||63
8513782|NCT00423683|20984203|P2|NOT COMPLETED|Overall Study||0
8513783|NCT00423683|20984204|P1|NOT COMPLETED|Overall Study||1
8513784|NCT00423683|20984203|P2|COMPLETED|Overall Study||33
8513785|NCT00423683|20984204|P1|COMPLETED|Overall Study||30
8513786|NCT00423683|20984203|P2|STARTED|Overall Study||33
8513787|NCT00423683|20984204|P1|STARTED|Overall Study||31
8513788|NCT00423670|20984223|P8|NOT COMPLETED|Follow-up Period||3
8513789|NCT00423670|20984224|P7|NOT COMPLETED|Follow-up Period||9
8513790|NCT00423670|20984225|P6|NOT COMPLETED|Follow-up Period||0
8513791|NCT00423670|20984226|P5|NOT COMPLETED|Follow-up Period||2
8513792|NCT00423670|20984227|P4|NOT COMPLETED|Follow-up Period||5
8513793|NCT00423670|20984228|P3|NOT COMPLETED|Follow-up Period||11
8513794|NCT00423670|20984229|P2|NOT COMPLETED|Follow-up Period||16
8513795|NCT00423670|20984230|P1|NOT COMPLETED|Follow-up Period||3
8513796|NCT00423670|20984223|P8|COMPLETED|Follow-up Period||32
8513797|NCT00423670|20984224|P7|COMPLETED|Follow-up Period||41
8513798|NCT00423670|20984225|P6|COMPLETED|Follow-up Period||14
8513799|NCT00423670|20984226|P5|COMPLETED|Follow-up Period||89
8513800|NCT00423670|20984227|P4|COMPLETED|Follow-up Period||91
8513801|NCT00423670|20984228|P3|COMPLETED|Follow-up Period||85
8513802|NCT00423670|20984229|P2|COMPLETED|Follow-up Period||84
8513803|NCT00423670|20984230|P1|COMPLETED|Follow-up Period||94
8513804|NCT00423670|20984223|P8|STARTED|Follow-up Period||35
8513805|NCT00423670|20984224|P7|STARTED|Follow-up Period||50
8513806|NCT00423670|20984225|P6|STARTED|Follow-up Period||14
8513807|NCT00423670|20984226|P5|STARTED|Follow-up Period||91
8513808|NCT00423670|20984227|P4|STARTED|Follow-up Period||96
8513809|NCT00423670|20984228|P3|STARTED|Follow-up Period||96
8513810|NCT00423670|20984229|P2|STARTED|Follow-up Period||100
8513811|NCT00423670|20984230|P1|STARTED|Follow-up Period||97
8513812|NCT00423670|20984223|P8|NOT COMPLETED|Treatment Period||21
8513813|NCT00423670|20984224|P7|NOT COMPLETED|Treatment Period||31
8513814|NCT00423670|20984225|P6|NOT COMPLETED|Treatment Period||8
8513815|NCT00423670|20984226|P5|NOT COMPLETED|Treatment Period||27
8513816|NCT00423670|20984227|P4|NOT COMPLETED|Treatment Period||40
8513817|NCT00423670|20984228|P3|NOT COMPLETED|Treatment Period||27
8513818|NCT00423670|20984229|P2|NOT COMPLETED|Treatment Period||30
8513819|NCT00423670|20984230|P1|NOT COMPLETED|Treatment Period||52
8513820|NCT00423670|20984223|P8|COMPLETED|Treatment Period||15
8513821|NCT00423670|20984224|P7|COMPLETED|Treatment Period||28
8513822|NCT00423670|20984225|P6|COMPLETED|Treatment Period||8
8513823|NCT00423670|20984226|P5|COMPLETED|Treatment Period||76
8513824|NCT00423670|20984227|P4|COMPLETED|Treatment Period||63
8513825|NCT00423670|20984228|P3|COMPLETED|Treatment Period||76
8513826|NCT00423670|20984229|P2|COMPLETED|Treatment Period||77
8513827|NCT00423670|20984230|P1|COMPLETED|Treatment Period||52
8513828|NCT00423670|20984223|P8|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
8513829|NCT00423670|20984224|P7|STARTED|Treatment Period||59
8513830|NCT00423670|20984225|P6|STARTED|Treatment Period||16
8513831|NCT00423670|20984226|P5|STARTED|Treatment Period||103
8513832|NCT00423670|20984227|P4|STARTED|Treatment Period||103
8513833|NCT00423670|20984228|P3|STARTED|Treatment Period||103
8513834|NCT00423670|20984229|P2|STARTED|Treatment Period||107
8513835|NCT00423670|20984230|P1|STARTED|Treatment Period||104
8513836|NCT00423657|20984288|P2|NOT COMPLETED|Overall Study||25
8513837|NCT00423657|20984289|P1|NOT COMPLETED|Overall Study||26
8513838|NCT00423657|20984288|P2|COMPLETED|Overall Study||313
8513839|NCT00423657|20984289|P1|COMPLETED|Overall Study||316
8513840|NCT00423657|20984288|P2|STARTED|Overall Study||338
8513841|NCT00423657|20984289|P1|STARTED|Overall Study||342
8513842|NCT00423605|20984295|P1|NOT COMPLETED|Overall Study||241
8513843|NCT00423605|20984295|P1|COMPLETED|Overall Study||319
8513844|NCT00423605|20984295|P1|STARTED|Overall Study||560
8513845|NCT00423592|20984299|P1|NOT COMPLETED|Overall Study||7
8513846|NCT00423592|20984299|P1|COMPLETED|Overall Study|Completed study|29
8513847|NCT00423592|20984299|P1|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
8513848|NCT00423592|20984299|P1|STARTED|Overall Study|Enrolled|36
8513849|NCT00423579|20984320|P2|NOT COMPLETED|Overall Study||4
8513850|NCT00423579|20984321|P1|NOT COMPLETED|Overall Study||4
8513851|NCT00423579|20984320|P2|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
8513852|NCT00423579|20984321|P1|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
8513853|NCT00423579|20984320|P2|STARTED|Overall Study||60
8513854|NCT00423579|20984321|P1|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
8513855|NCT00423488|20984329|P2|NOT COMPLETED|Overall Study||1
8513856|NCT00423488|20984330|P1|NOT COMPLETED|Overall Study||5
8513857|NCT00423488|20984329|P2|COMPLETED|Overall Study||50
8513858|NCT00423488|20984330|P1|COMPLETED|Overall Study||37
8513859|NCT00423488|20984329|P2|STARTED|Overall Study||51
8513860|NCT00423488|20984330|P1|STARTED|Overall Study||42
8513861|NCT00423449|20984336|P5|NOT COMPLETED|Overall Study||7
8513862|NCT00423449|20984337|P4|NOT COMPLETED|Overall Study||22
8513863|NCT00423449|20984338|P3|NOT COMPLETED|Overall Study||15
8513864|NCT00423449|20984339|P2|NOT COMPLETED|Overall Study||4
8513865|NCT00423449|20984340|P1|NOT COMPLETED|Overall Study||3
8513866|NCT00423449|20984336|P5|COMPLETED|Overall Study||0
8513867|NCT00423449|20984337|P4|COMPLETED|Overall Study||5
8513868|NCT00423449|20984338|P3|COMPLETED|Overall Study||2
8513869|NCT00423449|20984339|P2|COMPLETED|Overall Study||2
8513870|NCT00423449|20984340|P1|COMPLETED|Overall Study||1
8513871|NCT00423449|20984336|P5|STARTED|Overall Study||7
8513872|NCT00423449|20984337|P4|STARTED|Overall Study||27
8513873|NCT00423449|20984338|P3|STARTED|Overall Study||17
8513874|NCT00423449|20984339|P2|STARTED|Overall Study||6
8513875|NCT00423449|20984340|P1|STARTED|Overall Study||4
8513876|NCT00423436|20984365|P2|NOT COMPLETED|Overall Study||0
8513877|NCT00423436|20984366|P1|NOT COMPLETED|Overall Study||0
8513878|NCT00423436|20984365|P2|COMPLETED|Overall Study||33
8513879|NCT00423436|20984366|P1|COMPLETED|Overall Study||35
8513880|NCT00423436|20984365|P2|STARTED|Overall Study||33
8513881|NCT00423436|20984366|P1|STARTED|Overall Study||35
8513882|NCT00423358|20984374|P2|NOT COMPLETED|Overall Study||0
8513883|NCT00423358|20984375|P1|NOT COMPLETED|Overall Study||0
8513884|NCT00423358|20984374|P2|COMPLETED|Overall Study||11
8513885|NCT00423358|20984375|P1|COMPLETED|Overall Study||11
8513886|NCT00423358|20984374|P2|STARTED|Overall Study||11
8513887|NCT00423358|20984375|P1|STARTED|Overall Study||11
8513888|NCT00423332|20984387|P2|NOT COMPLETED|Overall Study||7
8513889|NCT00423332|20984388|P1|NOT COMPLETED|Overall Study||9
8513890|NCT00423332|20984387|P2|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
8513891|NCT00423332|20984388|P1|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
8513892|NCT00423332|20984387|P2|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
8513893|NCT00423332|20984388|P1|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
8513894|NCT00423332|20984387|P2|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
8513895|NCT00423332|20984388|P1|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
8513896|NCT00423332|20984387|P2|STARTED|Overall Study|Number randomised|18
8513897|NCT00423332|20984388|P1|STARTED|Overall Study|Randomised|53
8513898|NCT00423319|20984407|P2|NOT COMPLETED|Overall Study||252
8513899|NCT00423319|20984408|P1|NOT COMPLETED|Overall Study||224
8513900|NCT00423319|20984407|P2|COMPLETED|Overall Study||2447
8513901|NCT00423319|20984408|P1|COMPLETED|Overall Study||2484
8513902|NCT00423319|20984407|P2|Participants Who Received Treatment|Overall Study||2659
8513903|NCT00423319|20984408|P1|Participants Who Received Treatment|Overall Study||2673
8513904|NCT00423319|20984407|P2|STARTED|Overall Study|Randomized|2699
8513905|NCT00423319|20984408|P1|STARTED|Overall Study|Randomized|2708
8513906|NCT00423293|20984440|P1|NOT COMPLETED|Overall Study||11
8513907|NCT00423293|20984440|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
8513908|NCT00423293|20984440|P1|STARTED|Overall Study||63
8513909|NCT00423267|20984457|P2|NOT COMPLETED|Period B||0
8513910|NCT00423267|20984458|P1|NOT COMPLETED|Period B||0
8513911|NCT00423267|20984457|P2|COMPLETED|Period B||0
8513912|NCT00423267|20984458|P1|COMPLETED|Period B||12
8513913|NCT00423267|20984457|P2|STARTED|Period B||0
8513914|NCT00423267|20984458|P1|STARTED|Period B||12
8513915|NCT00423267|20984457|P2|NOT COMPLETED|Period A||1
8513916|NCT00423267|20984458|P1|NOT COMPLETED|Period A||2
8513917|NCT00423267|20984457|P2|COMPLETED|Period A||6
8513918|NCT00423267|20984458|P1|COMPLETED|Period A||7
8513919|NCT00423267|20984457|P2|STARTED|Period A||7
8513920|NCT00423267|20984458|P1|STARTED|Period A||9
8513921|NCT00423189|20984478|P3|NOT COMPLETED|Overall Study||0
8513922|NCT00423189|20984479|P2|NOT COMPLETED|Overall Study||1
8513923|NCT00423189|20984480|P1|NOT COMPLETED|Overall Study||0
8513924|NCT00423189|20984478|P3|COMPLETED|Overall Study||2
8513925|NCT00423189|20984479|P2|COMPLETED|Overall Study||2
8513926|NCT00423189|20984480|P1|COMPLETED|Overall Study||2
8513927|NCT00423189|20984478|P3|STARTED|Overall Study||2
8513928|NCT00423189|20984479|P2|STARTED|Overall Study||3
8513929|NCT00423189|20984480|P1|STARTED|Overall Study||2
8513930|NCT00423176|20984502|P2|NOT COMPLETED|Overall Study||29
8513931|NCT00423176|20984503|P1|NOT COMPLETED|Overall Study||16
8513932|NCT00423176|20984502|P2|COMPLETED|Overall Study||94
8513933|NCT00423176|20984503|P1|COMPLETED|Overall Study||98
8513934|NCT00423176|20984502|P2|STARTED|Overall Study||123
8513935|NCT00423176|20984503|P1|STARTED|Overall Study||114
8513936|NCT00423150|20984511|P1|NOT COMPLETED|Overall Study||86
8513937|NCT00423150|20984511|P1|COMPLETED|Overall Study||0
8513938|NCT00423150|20984511|P1|STARTED|Overall Study||86
8513939|NCT00423098|20984517|P2|NOT COMPLETED|Overall Study||4
8513940|NCT00423098|20984518|P1|NOT COMPLETED|Overall Study||3
8513941|NCT00423098|20984517|P2|COMPLETED|Overall Study||35
8513942|NCT00423098|20984518|P1|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
8513943|NCT00423098|20984517|P2|STARTED|Overall Study||39
8513944|NCT00423098|20984518|P1|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
8513945|NCT00423085|20984545|P4|NOT COMPLETED|52-Week Open-Label Extension Phase||163
8513946|NCT00423085|20984546|P3|NOT COMPLETED|52-Week Open-Label Extension Phase||0
8513947|NCT00423085|20984547|P2|NOT COMPLETED|52-Week Open-Label Extension Phase||0
8513948|NCT00423085|20984548|P1|NOT COMPLETED|52-Week Open-Label Extension Phase||0
8513949|NCT00423085|20984545|P4|COMPLETED|52-Week Open-Label Extension Phase||474
8513950|NCT00423085|20984546|P3|COMPLETED|52-Week Open-Label Extension Phase||0
8513951|NCT00423085|20984547|P2|COMPLETED|52-Week Open-Label Extension Phase||0
8513952|NCT00423085|20984548|P1|COMPLETED|52-Week Open-Label Extension Phase||0
8513953|NCT00423085|20984545|P4|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
8513954|NCT00423085|20984546|P3|STARTED|52-Week Open-Label Extension Phase||0
8513955|NCT00423085|20984547|P2|STARTED|52-Week Open-Label Extension Phase||0
8513956|NCT00423085|20984548|P1|STARTED|52-Week Open-Label Extension Phase||0
8513957|NCT00423085|20984545|P4|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
8513958|NCT00423085|20984546|P3|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
8513959|NCT00423085|20984547|P2|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
8513960|NCT00423085|20984548|P1|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
8513961|NCT00423085|20984545|P4|COMPLETED|24-Week Double-Blind Treatment Phase||0
8513962|NCT00423085|20984546|P3|COMPLETED|24-Week Double-Blind Treatment Phase||228
8513963|NCT00423085|20984547|P2|COMPLETED|24-Week Double-Blind Treatment Phase||220
8513964|NCT00423085|20984548|P1|COMPLETED|24-Week Double-Blind Treatment Phase||242
8513965|NCT00423085|20984545|P4|STARTED|24-Week Double-Blind Treatment Phase||0
8513966|NCT00423085|20984546|P3|STARTED|24-Week Double-Blind Treatment Phase||287
8513967|NCT00423085|20984547|P2|STARTED|24-Week Double-Blind Treatment Phase||284
8513968|NCT00423085|20984548|P1|STARTED|24-Week Double-Blind Treatment Phase||288
8513969|NCT00423046|20984577|P2|NOT COMPLETED|Overall Study||345
8513970|NCT00423046|20984578|P1|NOT COMPLETED|Overall Study||340
8513971|NCT00423046|20984577|P2|COMPLETED|Overall Study|Completed until Month 60|208
8513972|NCT00423046|20984578|P1|COMPLETED|Overall Study|Completed until Month 60|213
8513973|NCT00423046|20984577|P2|STARTED|Overall Study||553
8513974|NCT00423046|20984578|P1|STARTED|Overall Study||553
8513975|NCT00422942|20984644|P1|NOT COMPLETED|Overall Study||3
8513976|NCT00422942|20984644|P1|COMPLETED|Overall Study||0
8513977|NCT00422942|20984644|P1|STARTED|Overall Study||3
8513978|NCT00422903|20984663|P2|NOT COMPLETED|Overall Study||5
8513979|NCT00422903|20984664|P1|NOT COMPLETED|Overall Study||4
8513980|NCT00422903|20984663|P2|COMPLETED|Overall Study||38
8513981|NCT00422903|20984664|P1|COMPLETED|Overall Study||45
8513982|NCT00422903|20984663|P2|STARTED|Overall Study||43
8513983|NCT00422903|20984664|P1|STARTED|Overall Study||49
8513984|NCT00422812|20984692|P4|NOT COMPLETED|Overall Study||2
8513985|NCT00422812|20984693|P3|NOT COMPLETED|Overall Study||2
8513986|NCT00422812|20984694|P2|NOT COMPLETED|Overall Study||1
8513987|NCT00422812|20984695|P1|NOT COMPLETED|Overall Study||0
8513988|NCT00422812|20984692|P4|COMPLETED|Overall Study||103
8513989|NCT00422812|20984693|P3|COMPLETED|Overall Study||91
8513990|NCT00422812|20984694|P2|COMPLETED|Overall Study||103
8513991|NCT00422812|20984695|P1|COMPLETED|Overall Study||98
8513992|NCT00422812|20984692|P4|STARTED|Overall Study||105
8513993|NCT00422812|20984693|P3|STARTED|Overall Study||93
8513994|NCT00422812|20984694|P2|STARTED|Overall Study||104
8513995|NCT00422812|20984695|P1|STARTED|Overall Study||98
8513996|NCT00422799|20984713|P1|NOT COMPLETED|Overall Study||13
8513997|NCT00422799|20984713|P1|COMPLETED|Overall Study||50
8513998|NCT00422799|20984713|P1|STARTED|Overall Study||63
8513999|NCT00422734|20984722|P2|NOT COMPLETED|Overall Study||21
8514000|NCT00422734|20984723|P1|NOT COMPLETED|Overall Study||14
8514001|NCT00422734|20984722|P2|COMPLETED|Overall Study||243
8514002|NCT00422734|20984723|P1|COMPLETED|Overall Study||64
8514003|NCT00422734|20984722|P2|STARTED|Overall Study||264
8514004|NCT00422734|20984723|P1|STARTED|Overall Study||78
8514005|NCT00422695|20984757|P2|NOT COMPLETED|Overall Study||0
8514006|NCT00422695|20984758|P1|NOT COMPLETED|Overall Study||0
8514007|NCT00422695|20984757|P2|COMPLETED|Overall Study||38
8514008|NCT00422695|20984758|P1|COMPLETED|Overall Study||105
8514009|NCT00422695|20984757|P2|STARTED|Overall Study||38
8514010|NCT00422695|20984758|P1|STARTED|Overall Study||105
8514011|NCT00422669|20984769|P3|NOT COMPLETED|Overall Study||7
8514012|NCT00422669|20984770|P2|NOT COMPLETED|Overall Study||100
8514013|NCT00422669|20984771|P1|NOT COMPLETED|Overall Study||98
8514014|NCT00422669|20984769|P3|COMPLETED|Overall Study||0
8514015|NCT00422669|20984770|P2|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
8514199|NCT00422097|20985129|P3|COMPLETED|Dose Level 3||3
8514016|NCT00422669|20984771|P1|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
8514017|NCT00422669|20984769|P3|STARTED|Overall Study||7
8514018|NCT00422669|20984770|P2|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
8514019|NCT00422669|20984771|P1|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
8514020|NCT00422656|20984792|P1|NOT COMPLETED|Overall Study||0
8514021|NCT00422656|20984792|P1|COMPLETED|Overall Study||37
8514022|NCT00422656|20984792|P1|STARTED|Overall Study||37
8514023|NCT00422591|20984799|P1|NOT COMPLETED|Overall Study||6
8514024|NCT00422591|20984799|P1|COMPLETED|Overall Study||169
8514025|NCT00422591|20984799|P1|STARTED|Overall Study||175
8514026|NCT00422513|20984807|P2|NOT COMPLETED|Overall Study||106
8514027|NCT00422513|20984808|P1|NOT COMPLETED|Overall Study||107
8514028|NCT00422513|20984807|P2|COMPLETED|Overall Study||24
8514029|NCT00422513|20984808|P1|COMPLETED|Overall Study||23
8514030|NCT00422513|20984807|P2|STARTED|Overall Study||130
8514031|NCT00422513|20984808|P1|STARTED|Overall Study||130
8514032|NCT00422448|20984820|P1|NOT COMPLETED|Overall Study||0
8514033|NCT00422448|20984820|P1|COMPLETED|Overall Study||43
8514034|NCT00422448|20984820|P1|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
8514035|NCT00422422|20984825|P1|NOT COMPLETED|Overall Study||10
8514036|NCT00422422|20984825|P1|COMPLETED|Overall Study||90
8514037|NCT00422422|20984825|P1|STARTED|Overall Study||100
8514038|NCT00422383|20984842|P5|NOT COMPLETED|Overall Study||3
8514039|NCT00422383|20984843|P4|NOT COMPLETED|Overall Study||2
8514040|NCT00422383|20984844|P3|NOT COMPLETED|Overall Study||4
8514041|NCT00422383|20984845|P2|NOT COMPLETED|Overall Study||14
8514042|NCT00422383|20984846|P1|NOT COMPLETED|Overall Study||15
8514043|NCT00422383|20984842|P5|COMPLETED|Overall Study||22
8514044|NCT00422383|20984843|P4|COMPLETED|Overall Study||4
8514045|NCT00422383|20984844|P3|COMPLETED|Overall Study||89
8514046|NCT00422383|20984845|P2|COMPLETED|Overall Study||106
8514047|NCT00422383|20984846|P1|COMPLETED|Overall Study||119
8514048|NCT00422383|20984842|P5|STARTED|Overall Study||25
8514049|NCT00422383|20984843|P4|STARTED|Overall Study||6
8514050|NCT00422383|20984844|P3|STARTED|Overall Study||93
8514051|NCT00422383|20984845|P2|STARTED|Overall Study||120
8514052|NCT00422383|20984846|P1|STARTED|Overall Study||134
8514053|NCT00422292|20984989|P4|NOT COMPLETED|Overall Study||24
8514054|NCT00422292|20984990|P3|NOT COMPLETED|Overall Study||22
8514055|NCT00422292|20984991|P2|NOT COMPLETED|Overall Study||66
8514056|NCT00422292|20984992|P1|NOT COMPLETED|Overall Study||18
8514057|NCT00422292|20984989|P4|COMPLETED|Overall Study||452
8514058|NCT00422292|20984990|P3|COMPLETED|Overall Study||224
8514059|NCT00422292|20984991|P2|COMPLETED|Overall Study||598
8514060|NCT00422292|20984992|P1|COMPLETED|Overall Study||239
8514061|NCT00422292|20984989|P4|STARTED|Overall Study||476
8514062|NCT00422292|20984990|P3|STARTED|Overall Study||246
8514063|NCT00422292|20984991|P2|STARTED|Overall Study||664
8514064|NCT00422292|20984992|P1|STARTED|Overall Study||257
8514065|NCT00422279|20985020|P2|NOT COMPLETED|Overall Study||0
8514066|NCT00422279|20985021|P1|NOT COMPLETED|Overall Study||0
8514067|NCT00422279|20985020|P2|COMPLETED|Overall Study||2
8514068|NCT00422279|20985021|P1|COMPLETED|Overall Study||2
8514069|NCT00422279|20985020|P2|24 Month After Loading Period|Overall Study||2
8514070|NCT00422279|20985021|P1|24 Month After Loading Period|Overall Study||2
8514071|NCT00422279|20985020|P2|STARTED|Overall Study||2
8514072|NCT00422279|20985021|P1|STARTED|Overall Study||2
8514073|NCT00422227|20985031|P2|NOT COMPLETED|Overall Study||15
8514074|NCT00422227|20985032|P1|NOT COMPLETED|Overall Study||4
8514075|NCT00422227|20985031|P2|COMPLETED|Overall Study||88
8514076|NCT00422227|20985032|P1|COMPLETED|Overall Study||193
8514077|NCT00422227|20985031|P2|STARTED|Overall Study||103
8514078|NCT00422227|20985032|P1|STARTED|Overall Study||197
8514079|NCT00422201|20985056|P1|NOT COMPLETED|Overall Study||11
8514080|NCT00422201|20985056|P1|COMPLETED|Overall Study||7
8514081|NCT00422201|20985056|P1|STARTED|Overall Study||18
8514082|NCT00422162|20985063|P2|NOT COMPLETED|Overall Study||30
8514083|NCT00422162|20985064|P1|NOT COMPLETED|Overall Study||24
8514084|NCT00422162|20985063|P2|COMPLETED|Overall Study||142
8514085|NCT00422162|20985064|P1|COMPLETED|Overall Study||143
8514086|NCT00422162|20985063|P2|Received Treatment|Overall Study||171
8514087|NCT00422162|20985064|P1|Received Treatment|Overall Study||167
8514088|NCT00422162|20985063|P2|STARTED|Overall Study||172
8514089|NCT00422162|20985064|P1|STARTED|Overall Study||167
8514090|NCT00422097|20985124|P8|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514091|NCT00422097|20985125|P7|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514092|NCT00422097|20985126|P6|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514093|NCT00422097|20985127|P5|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514094|NCT00422097|20985128|P4|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514095|NCT00422097|20985129|P3|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514096|NCT00422097|20985130|P2|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514097|NCT00422097|20985131|P1|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
8514098|NCT00422097|20985124|P8|COMPLETED|Ixabepilone With Famotidine or Food||7
8514099|NCT00422097|20985125|P7|COMPLETED|Ixabepilone With Famotidine or Food||8
8514100|NCT00422097|20985126|P6|COMPLETED|Ixabepilone With Famotidine or Food||0
8514101|NCT00422097|20985127|P5|COMPLETED|Ixabepilone With Famotidine or Food||0
8514102|NCT00422097|20985128|P4|COMPLETED|Ixabepilone With Famotidine or Food||0
8514103|NCT00422097|20985129|P3|COMPLETED|Ixabepilone With Famotidine or Food||0
8514104|NCT00422097|20985130|P2|COMPLETED|Ixabepilone With Famotidine or Food||0
8514105|NCT00422097|20985131|P1|COMPLETED|Ixabepilone With Famotidine or Food||0
8514106|NCT00422097|20985124|P8|STARTED|Ixabepilone With Famotidine or Food||7
8514107|NCT00422097|20985125|P7|STARTED|Ixabepilone With Famotidine or Food||8
8514108|NCT00422097|20985126|P6|STARTED|Ixabepilone With Famotidine or Food||0
8514109|NCT00422097|20985127|P5|STARTED|Ixabepilone With Famotidine or Food||0
8514110|NCT00422097|20985128|P4|STARTED|Ixabepilone With Famotidine or Food||0
8514111|NCT00422097|20985129|P3|STARTED|Ixabepilone With Famotidine or Food||0
8514112|NCT00422097|20985130|P2|STARTED|Ixabepilone With Famotidine or Food||0
8514113|NCT00422097|20985131|P1|STARTED|Ixabepilone With Famotidine or Food||0
8514114|NCT00422097|20985124|P8|NOT COMPLETED|Dose Level 6||0
8514115|NCT00422097|20985125|P7|NOT COMPLETED|Dose Level 6||0
8514116|NCT00422097|20985126|P6|NOT COMPLETED|Dose Level 6||0
8514117|NCT00422097|20985127|P5|NOT COMPLETED|Dose Level 6||0
8514118|NCT00422097|20985128|P4|NOT COMPLETED|Dose Level 6||0
8514119|NCT00422097|20985129|P3|NOT COMPLETED|Dose Level 6||0
8514120|NCT00422097|20985130|P2|NOT COMPLETED|Dose Level 6||0
8514121|NCT00422097|20985131|P1|NOT COMPLETED|Dose Level 6||0
8514122|NCT00422097|20985124|P8|COMPLETED|Dose Level 6||0
8514123|NCT00422097|20985125|P7|COMPLETED|Dose Level 6||0
8514124|NCT00422097|20985126|P6|COMPLETED|Dose Level 6||6
8514125|NCT00422097|20985127|P5|COMPLETED|Dose Level 6||0
8514126|NCT00422097|20985128|P4|COMPLETED|Dose Level 6||0
8514127|NCT00422097|20985129|P3|COMPLETED|Dose Level 6||0
8514128|NCT00422097|20985130|P2|COMPLETED|Dose Level 6||0
8514129|NCT00422097|20985131|P1|COMPLETED|Dose Level 6||0
8514130|NCT00422097|20985124|P8|STARTED|Dose Level 6||0
8514131|NCT00422097|20985125|P7|STARTED|Dose Level 6||0
8514132|NCT00422097|20985126|P6|STARTED|Dose Level 6||6
8514133|NCT00422097|20985127|P5|STARTED|Dose Level 6||0
8514134|NCT00422097|20985128|P4|STARTED|Dose Level 6||0
8514135|NCT00422097|20985129|P3|STARTED|Dose Level 6||0
8514136|NCT00422097|20985130|P2|STARTED|Dose Level 6||0
8514137|NCT00422097|20985131|P1|STARTED|Dose Level 6||0
8514138|NCT00422097|20985124|P8|NOT COMPLETED|Dose Level 5||0
8514139|NCT00422097|20985125|P7|NOT COMPLETED|Dose Level 5||0
8514140|NCT00422097|20985126|P6|NOT COMPLETED|Dose Level 5||0
8514141|NCT00422097|20985127|P5|NOT COMPLETED|Dose Level 5||0
8514142|NCT00422097|20985128|P4|NOT COMPLETED|Dose Level 5||0
8514143|NCT00422097|20985129|P3|NOT COMPLETED|Dose Level 5||0
8514144|NCT00422097|20985130|P2|NOT COMPLETED|Dose Level 5||0
8514145|NCT00422097|20985131|P1|NOT COMPLETED|Dose Level 5||0
8514146|NCT00422097|20985124|P8|COMPLETED|Dose Level 5||0
8514147|NCT00422097|20985125|P7|COMPLETED|Dose Level 5||0
8514148|NCT00422097|20985126|P6|COMPLETED|Dose Level 5||0
8514149|NCT00422097|20985127|P5|COMPLETED|Dose Level 5||23
8514150|NCT00422097|20985128|P4|COMPLETED|Dose Level 5||0
8514151|NCT00422097|20985129|P3|COMPLETED|Dose Level 5||0
8514152|NCT00422097|20985130|P2|COMPLETED|Dose Level 5||0
8514153|NCT00422097|20985131|P1|COMPLETED|Dose Level 5||0
8514154|NCT00422097|20985124|P8|STARTED|Dose Level 5||0
8514155|NCT00422097|20985125|P7|STARTED|Dose Level 5||0
8514156|NCT00422097|20985126|P6|STARTED|Dose Level 5||0
8514157|NCT00422097|20985127|P5|STARTED|Dose Level 5||23
8514158|NCT00422097|20985128|P4|STARTED|Dose Level 5||0
8514159|NCT00422097|20985129|P3|STARTED|Dose Level 5||0
8514160|NCT00422097|20985130|P2|STARTED|Dose Level 5||0
8514161|NCT00422097|20985131|P1|STARTED|Dose Level 5||0
8514162|NCT00422097|20985124|P8|NOT COMPLETED|Dose Level 4||0
8514163|NCT00422097|20985125|P7|NOT COMPLETED|Dose Level 4||0
8514164|NCT00422097|20985126|P6|NOT COMPLETED|Dose Level 4||0
8514165|NCT00422097|20985127|P5|NOT COMPLETED|Dose Level 4||0
8514166|NCT00422097|20985128|P4|NOT COMPLETED|Dose Level 4||0
8514167|NCT00422097|20985129|P3|NOT COMPLETED|Dose Level 4||0
8514168|NCT00422097|20985130|P2|NOT COMPLETED|Dose Level 4||0
8514169|NCT00422097|20985131|P1|NOT COMPLETED|Dose Level 4||0
8514170|NCT00422097|20985124|P8|COMPLETED|Dose Level 4||0
8514171|NCT00422097|20985125|P7|COMPLETED|Dose Level 4||0
8514172|NCT00422097|20985126|P6|COMPLETED|Dose Level 4||0
8514173|NCT00422097|20985127|P5|COMPLETED|Dose Level 4||0
8514174|NCT00422097|20985128|P4|COMPLETED|Dose Level 4||3
8514175|NCT00422097|20985129|P3|COMPLETED|Dose Level 4||0
8514176|NCT00422097|20985130|P2|COMPLETED|Dose Level 4||0
8514177|NCT00422097|20985131|P1|COMPLETED|Dose Level 4||0
8514178|NCT00422097|20985124|P8|STARTED|Dose Level 4||0
8514179|NCT00422097|20985125|P7|STARTED|Dose Level 4||0
8514180|NCT00422097|20985126|P6|STARTED|Dose Level 4||0
8514181|NCT00422097|20985127|P5|STARTED|Dose Level 4||0
8514182|NCT00422097|20985128|P4|STARTED|Dose Level 4||3
8514183|NCT00422097|20985129|P3|STARTED|Dose Level 4||0
8514184|NCT00422097|20985130|P2|STARTED|Dose Level 4||0
8514185|NCT00422097|20985131|P1|STARTED|Dose Level 4||0
8514186|NCT00422097|20985124|P8|NOT COMPLETED|Dose Level 3||0
8514187|NCT00422097|20985125|P7|NOT COMPLETED|Dose Level 3||0
8514188|NCT00422097|20985126|P6|NOT COMPLETED|Dose Level 3||0
8514189|NCT00422097|20985127|P5|NOT COMPLETED|Dose Level 3||0
8514190|NCT00422097|20985128|P4|NOT COMPLETED|Dose Level 3||0
8514191|NCT00422097|20985129|P3|NOT COMPLETED|Dose Level 3||0
8514192|NCT00422097|20985130|P2|NOT COMPLETED|Dose Level 3||0
8514193|NCT00422097|20985131|P1|NOT COMPLETED|Dose Level 3||0
8514194|NCT00422097|20985124|P8|COMPLETED|Dose Level 3||0
8514195|NCT00422097|20985125|P7|COMPLETED|Dose Level 3||0
8514196|NCT00422097|20985126|P6|COMPLETED|Dose Level 3||0
8514197|NCT00422097|20985127|P5|COMPLETED|Dose Level 3||0
8514198|NCT00422097|20985128|P4|COMPLETED|Dose Level 3||0
8514200|NCT00422097|20985130|P2|COMPLETED|Dose Level 3||0
8514201|NCT00422097|20985131|P1|COMPLETED|Dose Level 3||0
8514202|NCT00422097|20985124|P8|STARTED|Dose Level 3||0
8514203|NCT00422097|20985125|P7|STARTED|Dose Level 3||0
8514204|NCT00422097|20985126|P6|STARTED|Dose Level 3||0
8514205|NCT00422097|20985127|P5|STARTED|Dose Level 3||0
8514206|NCT00422097|20985128|P4|STARTED|Dose Level 3||0
8514207|NCT00422097|20985129|P3|STARTED|Dose Level 3||3
8514208|NCT00422097|20985130|P2|STARTED|Dose Level 3||0
8514209|NCT00422097|20985131|P1|STARTED|Dose Level 3||0
8514210|NCT00422097|20985124|P8|NOT COMPLETED|Dose Level 2||0
8514211|NCT00422097|20985125|P7|NOT COMPLETED|Dose Level 2||0
8514212|NCT00422097|20985126|P6|NOT COMPLETED|Dose Level 2||0
8514213|NCT00422097|20985127|P5|NOT COMPLETED|Dose Level 2||0
8514214|NCT00422097|20985128|P4|NOT COMPLETED|Dose Level 2||0
8514215|NCT00422097|20985129|P3|NOT COMPLETED|Dose Level 2||0
8514216|NCT00422097|20985130|P2|NOT COMPLETED|Dose Level 2||1
8514217|NCT00422097|20985131|P1|NOT COMPLETED|Dose Level 2||0
8514218|NCT00422097|20985124|P8|COMPLETED|Dose Level 2||0
8514219|NCT00422097|20985125|P7|COMPLETED|Dose Level 2||0
8514220|NCT00422097|20985126|P6|COMPLETED|Dose Level 2||0
8514221|NCT00422097|20985127|P5|COMPLETED|Dose Level 2||0
8514222|NCT00422097|20985128|P4|COMPLETED|Dose Level 2||0
8514223|NCT00422097|20985129|P3|COMPLETED|Dose Level 2||0
8514224|NCT00422097|20985130|P2|COMPLETED|Dose Level 2||5
8514225|NCT00422097|20985131|P1|COMPLETED|Dose Level 2||0
8514226|NCT00422097|20985124|P8|STARTED|Dose Level 2||0
8514227|NCT00422097|20985125|P7|STARTED|Dose Level 2||0
8514228|NCT00422097|20985126|P6|STARTED|Dose Level 2||0
8514229|NCT00422097|20985127|P5|STARTED|Dose Level 2||0
8514230|NCT00422097|20985128|P4|STARTED|Dose Level 2||0
8514231|NCT00422097|20985129|P3|STARTED|Dose Level 2||0
8514232|NCT00422097|20985130|P2|STARTED|Dose Level 2||6
8514233|NCT00422097|20985131|P1|STARTED|Dose Level 2||0
8514234|NCT00422097|20985124|P8|NOT COMPLETED|Dose Level 1||0
8514235|NCT00422097|20985125|P7|NOT COMPLETED|Dose Level 1||0
8514236|NCT00422097|20985126|P6|NOT COMPLETED|Dose Level 1||0
8514237|NCT00422097|20985127|P5|NOT COMPLETED|Dose Level 1||0
8514238|NCT00422097|20985128|P4|NOT COMPLETED|Dose Level 1||0
8514239|NCT00422097|20985129|P3|NOT COMPLETED|Dose Level 1||0
8514240|NCT00422097|20985130|P2|NOT COMPLETED|Dose Level 1||0
8514241|NCT00422097|20985131|P1|NOT COMPLETED|Dose Level 1||0
8514242|NCT00422097|20985124|P8|COMPLETED|Dose Level 1||0
8514243|NCT00422097|20985125|P7|COMPLETED|Dose Level 1||0
8514244|NCT00422097|20985126|P6|COMPLETED|Dose Level 1||0
8514245|NCT00422097|20985127|P5|COMPLETED|Dose Level 1||0
8514246|NCT00422097|20985128|P4|COMPLETED|Dose Level 1||0
8514247|NCT00422097|20985129|P3|COMPLETED|Dose Level 1||0
8514248|NCT00422097|20985130|P2|COMPLETED|Dose Level 1||0
8514249|NCT00422097|20985131|P1|COMPLETED|Dose Level 1||3
8514250|NCT00422097|20985124|P8|STARTED|Dose Level 1||0
8514251|NCT00422097|20985125|P7|STARTED|Dose Level 1||0
8514252|NCT00422097|20985126|P6|STARTED|Dose Level 1||0
8514253|NCT00422097|20985127|P5|STARTED|Dose Level 1||0
8514254|NCT00422097|20985128|P4|STARTED|Dose Level 1||0
8514255|NCT00422097|20985129|P3|STARTED|Dose Level 1||0
8514256|NCT00422097|20985130|P2|STARTED|Dose Level 1||0
8514257|NCT00422097|20985131|P1|STARTED|Dose Level 1||3
8514258|NCT00422058|20985196|P6|NOT COMPLETED|Open-Label Extension, Week 20-104||34
8514259|NCT00422058|20985197|P5|NOT COMPLETED|Open-Label Extension, Week 20-104||35
8514260|NCT00422058|20985198|P4|NOT COMPLETED|Open-Label Extension, Week 20-104||28
8514261|NCT00422058|20985199|P3|NOT COMPLETED|Open-Label Extension, Week 20-104||36
8514262|NCT00422058|20985200|P2|NOT COMPLETED|Open-Label Extension, Week 20-104||39
8514263|NCT00422058|20985201|P1|NOT COMPLETED|Open-Label Extension, Week 20-104||32
8514264|NCT00422058|20985196|P6|COMPLETED|Open-Label Extension, Week 20-104||45
8514265|NCT00422058|20985197|P5|COMPLETED|Open-Label Extension, Week 20-104||47
8514266|NCT00422058|20985198|P4|COMPLETED|Open-Label Extension, Week 20-104||45
8514267|NCT00422058|20985199|P3|COMPLETED|Open-Label Extension, Week 20-104||38
8514268|NCT00422058|20985200|P2|COMPLETED|Open-Label Extension, Week 20-104||46
8514269|NCT00422058|20985201|P1|COMPLETED|Open-Label Extension, Week 20-104||47
8514270|NCT00422058|20985196|P6|Enrolled in Extension|Open-Label Extension, Week 20-104||67
8514271|NCT00422058|20985197|P5|Enrolled in Extension|Open-Label Extension, Week 20-104||72
8514272|NCT00422058|20985198|P4|Enrolled in Extension|Open-Label Extension, Week 20-104||65
8514273|NCT00422058|20985199|P3|Enrolled in Extension|Open-Label Extension, Week 20-104||59
8514274|NCT00422058|20985200|P2|Enrolled in Extension|Open-Label Extension, Week 20-104||68
8514275|NCT00422058|20985201|P1|Enrolled in Extension|Open-Label Extension, Week 20-104||67
8514276|NCT00422058|20985196|P6|STARTED|Open-Label Extension, Week 20-104||79
8514277|NCT00422058|20985197|P5|STARTED|Open-Label Extension, Week 20-104||82
8514278|NCT00422058|20985198|P4|STARTED|Open-Label Extension, Week 20-104||73
8514279|NCT00422058|20985199|P3|STARTED|Open-Label Extension, Week 20-104||74
8514280|NCT00422058|20985200|P2|STARTED|Open-Label Extension, Week 20-104||85
8514281|NCT00422058|20985201|P1|STARTED|Open-Label Extension, Week 20-104||79
8514282|NCT00422058|20985196|P6|NOT COMPLETED|Double-Blind, Week 0-20||16
8514283|NCT00422058|20985197|P5|NOT COMPLETED|Double-Blind, Week 0-20||11
8514284|NCT00422058|20985198|P4|NOT COMPLETED|Double-Blind, Week 0-20||20
8514285|NCT00422058|20985199|P3|NOT COMPLETED|Double-Blind, Week 0-20||16
8514286|NCT00422058|20985200|P2|NOT COMPLETED|Double-Blind, Week 0-20||10
8514287|NCT00422058|20985201|P1|NOT COMPLETED|Double-Blind, Week 0-20||19
8514288|NCT00422058|20985196|P6|COMPLETED|Double-Blind, Week 0-20||79
8514289|NCT00422058|20985197|P5|COMPLETED|Double-Blind, Week 0-20||82
8514290|NCT00422058|20985198|P4|COMPLETED|Double-Blind, Week 0-20||73
8514291|NCT00422058|20985199|P3|COMPLETED|Double-Blind, Week 0-20||74
8514292|NCT00422058|20985200|P2|COMPLETED|Double-Blind, Week 0-20||85
8514293|NCT00422058|20985201|P1|COMPLETED|Double-Blind, Week 0-20||79
8514294|NCT00422058|20985196|P6|STARTED|Double-Blind, Week 0-20||95
8514295|NCT00422058|20985197|P5|STARTED|Double-Blind, Week 0-20||93
8514296|NCT00422058|20985198|P4|STARTED|Double-Blind, Week 0-20||93
8514297|NCT00422058|20985199|P3|STARTED|Double-Blind, Week 0-20||90
8514298|NCT00422058|20985200|P2|STARTED|Double-Blind, Week 0-20||95
8514299|NCT00422058|20985201|P1|STARTED|Double-Blind, Week 0-20||98
8514300|NCT00422032|20985331|P2|NOT COMPLETED|Overall Study||0
8514301|NCT00422032|20985332|P1|NOT COMPLETED|Overall Study||0
8514302|NCT00422032|20985331|P2|COMPLETED|Overall Study||21
8514303|NCT00422032|20985332|P1|COMPLETED|Overall Study||37
8514304|NCT00422032|20985331|P2|STARTED|Overall Study||21
8514305|NCT00422032|20985332|P1|STARTED|Overall Study||37
8514318|NCT00421954|20985375|P1|NOT COMPLETED|Overall Study||0
8514319|NCT00421954|20985375|P1|COMPLETED|Overall Study||0
8514320|NCT00421954|20985375|P1|STARTED|Overall Study||0
8514321|NCT00421928|20985382|P3|NOT COMPLETED|Overall Study||134
8514322|NCT00421928|20985383|P2|NOT COMPLETED|Overall Study||224
8514323|NCT00421928|20985384|P1|NOT COMPLETED|Overall Study||163
8514324|NCT00421928|20985382|P3|COMPLETED|Overall Study||203
8514325|NCT00421928|20985383|P2|COMPLETED|Overall Study||118
8514326|NCT00421928|20985384|P1|COMPLETED|Overall Study||181
8514327|NCT00421928|20985382|P3|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
8514328|NCT00421928|20985383|P2|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
8514329|NCT00421928|20985384|P1|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
8514330|NCT00421889|20985419|P9|NOT COMPLETED|Overall Study||11
8514331|NCT00421889|20985420|P8|NOT COMPLETED|Overall Study||2
8514332|NCT00421889|20985421|P7|NOT COMPLETED|Overall Study||4
8514333|NCT00421889|20985422|P6|NOT COMPLETED|Overall Study||35
8514334|NCT00421889|20985423|P5|NOT COMPLETED|Overall Study||6
8514335|NCT00421889|20985424|P4|NOT COMPLETED|Overall Study||4
8514336|NCT00421889|20985425|P3|NOT COMPLETED|Overall Study||3
8514337|NCT00421889|20985426|P2|NOT COMPLETED|Overall Study||5
8514338|NCT00421889|20985427|P1|NOT COMPLETED|Overall Study||5
8514339|NCT00421889|20985419|P9|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
8514340|NCT00421889|20985420|P8|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
8514341|NCT00421889|20985421|P7|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
8514342|NCT00421889|20985422|P6|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
8514343|NCT00421889|20985423|P5|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
8514344|NCT00421889|20985424|P4|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
8514345|NCT00421889|20985425|P3|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
8514346|NCT00421889|20985426|P2|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
8514347|NCT00421889|20985427|P1|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
8514348|NCT00421889|20985419|P9|STARTED|Overall Study||15
8514349|NCT00421889|20985420|P8|STARTED|Overall Study||3
8514350|NCT00421889|20985421|P7|STARTED|Overall Study||4
8514351|NCT00421889|20985422|P6|STARTED|Overall Study||35
8514352|NCT00421889|20985423|P5|STARTED|Overall Study||6
8514353|NCT00421889|20985424|P4|STARTED|Overall Study||4
8514354|NCT00421889|20985425|P3|STARTED|Overall Study||3
8514355|NCT00421889|20985426|P2|STARTED|Overall Study||5
8514356|NCT00421889|20985427|P1|STARTED|Overall Study||5
8514357|NCT00421733|20985472|P3|NOT COMPLETED|Overall Study||20
8514358|NCT00421733|20985473|P2|NOT COMPLETED|Overall Study||26
8514359|NCT00421733|20985474|P1|NOT COMPLETED|Overall Study||15
8514360|NCT00421733|20985472|P3|COMPLETED|Overall Study||73
8514361|NCT00421733|20985473|P2|COMPLETED|Overall Study||69
8514362|NCT00421733|20985474|P1|COMPLETED|Overall Study||78
8514363|NCT00421733|20985472|P3|STARTED|Overall Study||93
8514364|NCT00421733|20985473|P2|STARTED|Overall Study||95
8514365|NCT00421733|20985474|P1|STARTED|Overall Study||93
8514366|NCT00421707|20985494|P2|NOT COMPLETED|Period 3:Treatment Period 2||3
8514367|NCT00421707|20985495|P1|NOT COMPLETED|Period 3:Treatment Period 2||2
8514368|NCT00421707|20985494|P2|COMPLETED|Period 3:Treatment Period 2||49
8514369|NCT00421707|20985495|P1|COMPLETED|Period 3:Treatment Period 2||53
8514370|NCT00421707|20985494|P2|STARTED|Period 3:Treatment Period 2||52
8514371|NCT00421707|20985495|P1|STARTED|Period 3:Treatment Period 2||55
8514372|NCT00421707|20985494|P2|NOT COMPLETED|Period 2: Washout||4
8514373|NCT00421707|20985495|P1|NOT COMPLETED|Period 2: Washout||1
8514374|NCT00421707|20985494|P2|COMPLETED|Period 2: Washout||52
8514375|NCT00421707|20985495|P1|COMPLETED|Period 2: Washout||55
8514376|NCT00421707|20985494|P2|STARTED|Period 2: Washout||56
8514377|NCT00421707|20985495|P1|STARTED|Period 2: Washout||56
8514378|NCT00421707|20985494|P2|NOT COMPLETED|Period 1: Treatment Period 1||9
8514379|NCT00421707|20985495|P1|NOT COMPLETED|Period 1: Treatment Period 1||11
8514380|NCT00421707|20985494|P2|COMPLETED|Period 1: Treatment Period 1||56
8514381|NCT00421707|20985495|P1|COMPLETED|Period 1: Treatment Period 1||56
8514382|NCT00421707|20985494|P2|STARTED|Period 1: Treatment Period 1||65
8514383|NCT00421707|20985495|P1|STARTED|Period 1: Treatment Period 1||67
8514384|NCT00421603|20985537|P2|NOT COMPLETED|Overall Study||12
8514385|NCT00421603|20985538|P1|NOT COMPLETED|Overall Study||11
8514386|NCT00421603|20985537|P2|COMPLETED|Overall Study|Completed all 14 week sof trial|30
8514387|NCT00421603|20985538|P1|COMPLETED|Overall Study|Completed all 14 week sof trial|28
8514388|NCT00421603|20985537|P2|STARTED|Overall Study||42
8514389|NCT00421603|20985538|P1|STARTED|Overall Study||39
8514390|NCT00421408|20985546|P2|NOT COMPLETED|Overall Study||45
8514391|NCT00421408|20985547|P1|NOT COMPLETED|Overall Study||42
8514392|NCT00421408|20985546|P2|COMPLETED|Overall Study||61
8514393|NCT00421408|20985547|P1|COMPLETED|Overall Study||60
8514394|NCT00421408|20985546|P2|STARTED|Overall Study||106
8514395|NCT00421408|20985547|P1|STARTED|Overall Study||102
8514396|NCT00421343|20985565|P1|NOT COMPLETED|Overall Study||6
8514397|NCT00421343|20985565|P1|COMPLETED|Overall Study||23
8514398|NCT00421343|20985565|P1|STARTED|Overall Study||29
8514399|NCT00421174|20985571|P2|NOT COMPLETED|Overall Study||1
8514400|NCT00421174|20985572|P1|NOT COMPLETED|Overall Study||2
8514401|NCT00421174|20985571|P2|COMPLETED|Overall Study||18
8514402|NCT00421174|20985572|P1|COMPLETED|Overall Study||16
8514403|NCT00421174|20985571|P2|STARTED|Overall Study||19
8514404|NCT00421174|20985572|P1|STARTED|Overall Study||18
8514405|NCT00421148|20985620|P20|NOT COMPLETED|Overall Study||0
8514406|NCT00421148|20985621|P19|NOT COMPLETED|Overall Study||1
8514407|NCT00421148|20985622|P18|NOT COMPLETED|Overall Study||2
8514408|NCT00421148|20985623|P17|NOT COMPLETED|Overall Study||0
8514409|NCT00421148|20985624|P16|NOT COMPLETED|Overall Study||0
8514410|NCT00421148|20985625|P15|NOT COMPLETED|Overall Study||0
8514411|NCT00421148|20985626|P14|NOT COMPLETED|Overall Study||0
8514412|NCT00421148|20985627|P13|NOT COMPLETED|Overall Study||0
8514413|NCT00421148|20985628|P12|NOT COMPLETED|Overall Study||0
8514414|NCT00421148|20985629|P11|NOT COMPLETED|Overall Study||0
8514415|NCT00421148|20985630|P10|NOT COMPLETED|Overall Study||0
8514416|NCT00421148|20985631|P9|NOT COMPLETED|Overall Study||0
8514417|NCT00421148|20985632|P8|NOT COMPLETED|Overall Study||0
8514418|NCT00421148|20985633|P7|NOT COMPLETED|Overall Study||0
8514419|NCT00421148|20985634|P6|NOT COMPLETED|Overall Study||1
8514420|NCT00421148|20985635|P5|NOT COMPLETED|Overall Study||0
8514421|NCT00421148|20985636|P4|NOT COMPLETED|Overall Study||0
8514422|NCT00421148|20985637|P3|NOT COMPLETED|Overall Study||0
8514423|NCT00421148|20985638|P2|NOT COMPLETED|Overall Study||0
8514424|NCT00421148|20985639|P1|NOT COMPLETED|Overall Study||0
8514425|NCT00421148|20985620|P20|COMPLETED|Overall Study||6
8514426|NCT00421148|20985621|P19|COMPLETED|Overall Study||5
8514427|NCT00421148|20985622|P18|COMPLETED|Overall Study||4
8514428|NCT00421148|20985623|P17|COMPLETED|Overall Study||6
8514429|NCT00421148|20985624|P16|COMPLETED|Overall Study||6
8514430|NCT00421148|20985625|P15|COMPLETED|Overall Study||6
8514431|NCT00421148|20985626|P14|COMPLETED|Overall Study||6
8514432|NCT00421148|20985627|P13|COMPLETED|Overall Study||6
8514433|NCT00421148|20985628|P12|COMPLETED|Overall Study||6
8514434|NCT00421148|20985629|P11|COMPLETED|Overall Study||6
8514435|NCT00421148|20985630|P10|COMPLETED|Overall Study||5
8514436|NCT00421148|20985631|P9|COMPLETED|Overall Study||5
8514437|NCT00421148|20985632|P8|COMPLETED|Overall Study||5
8514438|NCT00421148|20985633|P7|COMPLETED|Overall Study||6
8514439|NCT00421148|20985634|P6|COMPLETED|Overall Study||4
8514440|NCT00421148|20985635|P5|COMPLETED|Overall Study||1
8514441|NCT00421148|20985636|P4|COMPLETED|Overall Study||1
8514442|NCT00421148|20985637|P3|COMPLETED|Overall Study||2
8514443|NCT00421148|20985638|P2|COMPLETED|Overall Study||2
8514444|NCT00421148|20985639|P1|COMPLETED|Overall Study||2
8514445|NCT00421148|20985620|P20|Treated|Overall Study||6
8514446|NCT00421148|20985621|P19|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
8514447|NCT00421148|20985622|P18|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
8514448|NCT00421148|20985623|P17|Treated|Overall Study||6
8514449|NCT00421148|20985624|P16|Treated|Overall Study||6
8514450|NCT00421148|20985625|P15|Treated|Overall Study||6
8514451|NCT00421148|20985626|P14|Treated|Overall Study||6
8514452|NCT00421148|20985627|P13|Treated|Overall Study||6
8514453|NCT00421148|20985628|P12|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6
8514454|NCT00421148|20985629|P11|Treated|Overall Study||6
8514455|NCT00421148|20985630|P10|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5
8514456|NCT00421148|20985631|P9|Treated|Overall Study||5
8514457|NCT00421148|20985632|P8|Treated|Overall Study||5
8514458|NCT00421148|20985633|P7|Treated|Overall Study||6
8514459|NCT00421148|20985634|P6|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4
8514460|NCT00421148|20985635|P5|Treated|Overall Study||1
8514461|NCT00421148|20985636|P4|Treated|Overall Study||1
8514462|NCT00421148|20985637|P3|Treated|Overall Study||2
8514463|NCT00421148|20985638|P2|Treated|Overall Study||2
8514464|NCT00421148|20985639|P1|Treated|Overall Study||2
8514465|NCT00421148|20985620|P20|STARTED|Overall Study||6
8514466|NCT00421148|20985621|P19|STARTED|Overall Study||6
8514467|NCT00421148|20985622|P18|STARTED|Overall Study||6
8514468|NCT00421148|20985623|P17|STARTED|Overall Study||6
8514469|NCT00421148|20985624|P16|STARTED|Overall Study||6
8514470|NCT00421148|20985625|P15|STARTED|Overall Study||6
8514471|NCT00421148|20985626|P14|STARTED|Overall Study||6
8514472|NCT00421148|20985627|P13|STARTED|Overall Study||6
8514473|NCT00421148|20985628|P12|STARTED|Overall Study||6
8514474|NCT00421148|20985629|P11|STARTED|Overall Study||6
8514475|NCT00421148|20985630|P10|STARTED|Overall Study||5
8514476|NCT00421148|20985631|P9|STARTED|Overall Study||5
8514477|NCT00421148|20985632|P8|STARTED|Overall Study||5
8514478|NCT00421148|20985633|P7|STARTED|Overall Study||6
8514479|NCT00421148|20985634|P6|STARTED|Overall Study||5
8514480|NCT00421148|20985635|P5|STARTED|Overall Study||1
8514481|NCT00421148|20985636|P4|STARTED|Overall Study||1
8514482|NCT00421148|20985637|P3|STARTED|Overall Study||2
8514483|NCT00421148|20985638|P2|STARTED|Overall Study||2
8514484|NCT00421148|20985639|P1|STARTED|Overall Study||2
8514485|NCT00420992|20985723|P2|NOT COMPLETED|Maintenance Phase||75
8514486|NCT00420992|20985724|P1|NOT COMPLETED|Maintenance Phase||61
8514487|NCT00420992|20985723|P2|COMPLETED|Maintenance Phase||98
8514488|NCT00420992|20985724|P1|COMPLETED|Maintenance Phase||110
8514489|NCT00420992|20985723|P2|STARTED|Maintenance Phase||173
8514490|NCT00420992|20985724|P1|STARTED|Maintenance Phase||171
8514491|NCT00420992|20985723|P2|NOT COMPLETED|Titration Phase||0
8514492|NCT00420992|20985724|P1|NOT COMPLETED|Titration Phase||203
8514493|NCT00420992|20985723|P2|COMPLETED|Titration Phase||0
8514494|NCT00420992|20985724|P1|COMPLETED|Titration Phase||344
8514495|NCT00420992|20985723|P2|STARTED|Titration Phase||0
8514496|NCT00420992|20985724|P1|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
8514497|NCT00420927|20985738|P7|NOT COMPLETED|Period 2||53
8514498|NCT00420927|20985739|P6|NOT COMPLETED|Period 2||15
8514499|NCT00420927|20985740|P5|NOT COMPLETED|Period 2||43
8514500|NCT00420927|20985741|P4|NOT COMPLETED|Period 2||10
8514501|NCT00420927|20985742|P3|NOT COMPLETED|Period 2||13
8514502|NCT00420927|20985743|P2|NOT COMPLETED|Period 2||0
8514503|NCT00420927|20985744|P1|NOT COMPLETED|Period 2||0
8514504|NCT00420927|20985738|P7|COMPLETED|Period 2||295
8514505|NCT00420927|20985739|P6|COMPLETED|Period 2||97
8514506|NCT00420927|20985740|P5|COMPLETED|Period 2||216
8514507|NCT00420927|20985741|P4|COMPLETED|Period 2||95
8514508|NCT00420927|20985742|P3|COMPLETED|Period 2||89
8514509|NCT00420927|20985743|P2|COMPLETED|Period 2||0
8514510|NCT00420927|20985744|P1|COMPLETED|Period 2||0
8514511|NCT00420927|20985738|P7|STARTED|Period 2||348
8514512|NCT00420927|20985739|P6|STARTED|Period 2||112
8514513|NCT00420927|20985740|P5|STARTED|Period 2||259
8514514|NCT00420927|20985741|P4|STARTED|Period 2||105
8514515|NCT00420927|20985742|P3|STARTED|Period 2||102
8514516|NCT00420927|20985743|P2|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
8514517|NCT00420927|20985744|P1|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
8514518|NCT00420927|20985738|P7|NOT COMPLETED|Period 1||0
8514519|NCT00420927|20985739|P6|NOT COMPLETED|Period 1||0
8514520|NCT00420927|20985740|P5|NOT COMPLETED|Period 1||0
8514521|NCT00420927|20985741|P4|NOT COMPLETED|Period 1||0
8514522|NCT00420927|20985742|P3|NOT COMPLETED|Period 1||0
8514523|NCT00420927|20985743|P2|NOT COMPLETED|Period 1||57
8514524|NCT00420927|20985744|P1|NOT COMPLETED|Period 1||49
8514525|NCT00420927|20985738|P7|COMPLETED|Period 1||0
8514526|NCT00420927|20985739|P6|COMPLETED|Period 1||0
8514527|NCT00420927|20985740|P5|COMPLETED|Period 1||0
8514528|NCT00420927|20985741|P4|COMPLETED|Period 1||0
8514529|NCT00420927|20985742|P3|COMPLETED|Period 1||0
8514530|NCT00420927|20985743|P2|COMPLETED|Period 1||460
8514531|NCT00420927|20985744|P1|COMPLETED|Period 1||466
8514532|NCT00420927|20985738|P7|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8514533|NCT00420927|20985739|P6|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8514534|NCT00420927|20985740|P5|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8514535|NCT00420927|20985741|P4|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8514536|NCT00420927|20985742|P3|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
8514537|NCT00420927|20985743|P2|STARTED|Period 1||517
8514538|NCT00420927|20985744|P1|STARTED|Period 1||515
8514539|NCT00420849|20985848|P1|NOT COMPLETED|Overall Study||331
8514540|NCT00420849|20985848|P1|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
8514541|NCT00420849|20985848|P1|STARTED|Overall Study||587
8514542|NCT00420784|20985917|P4|NOT COMPLETED|Overall Study||78
8514543|NCT00420784|20985918|P3|NOT COMPLETED|Overall Study||53
8514544|NCT00420784|20985919|P2|NOT COMPLETED|Overall Study||58
8514545|NCT00420784|20985920|P1|NOT COMPLETED|Overall Study||29
8514546|NCT00420784|20985917|P4|COMPLETED|Overall Study||36
8514547|NCT00420784|20985918|P3|COMPLETED|Overall Study||58
8514548|NCT00420784|20985919|P2|COMPLETED|Overall Study||55
8514549|NCT00420784|20985920|P1|COMPLETED|Overall Study||86
8514550|NCT00420784|20985917|P4|STARTED|Overall Study||114
8514551|NCT00420784|20985918|P3|STARTED|Overall Study||111
8514552|NCT00420784|20985919|P2|STARTED|Overall Study||113
8514553|NCT00420784|20985920|P1|STARTED|Overall Study||115
8514554|NCT00420771|20985949|P2|NOT COMPLETED|Overall Study||4
8514555|NCT00420771|20985950|P1|NOT COMPLETED|Overall Study||3
8514556|NCT00420771|20985949|P2|COMPLETED|Overall Study||7
8514557|NCT00420771|20985950|P1|COMPLETED|Overall Study||5
8514558|NCT00420771|20985949|P2|STARTED|Overall Study||11
8514559|NCT00420771|20985950|P1|STARTED|Overall Study||8
8514560|NCT00420745|20985958|P2|NOT COMPLETED|Overall Study||6
8514561|NCT00420745|20985959|P1|NOT COMPLETED|Overall Study||15
8514562|NCT00420745|20985958|P2|COMPLETED|Overall Study||333
8514563|NCT00420745|20985959|P1|COMPLETED|Overall Study||655
8514564|NCT00420745|20985958|P2|STARTED|Overall Study||339
8514565|NCT00420745|20985959|P1|STARTED|Overall Study||670
8514566|NCT00420641|20985978|P3|NOT COMPLETED|Overall Study||44
8514567|NCT00420641|20985979|P2|NOT COMPLETED|Overall Study||72
8514568|NCT00420641|20985980|P1|NOT COMPLETED|Overall Study||45
8514569|NCT00420641|20985978|P3|COMPLETED|Overall Study||128
8514570|NCT00420641|20985979|P2|COMPLETED|Overall Study||100
8514571|NCT00420641|20985980|P1|COMPLETED|Overall Study||115
8514572|NCT00420641|20985978|P3|STARTED|Overall Study||172
8514573|NCT00420641|20985979|P2|STARTED|Overall Study||172
8514574|NCT00420641|20985980|P1|STARTED|Overall Study||160
8514575|NCT00420628|20986056|P2|NOT COMPLETED|Overall Study||4
8514576|NCT00420628|20986057|P1|NOT COMPLETED|Overall Study||9
8514577|NCT00420628|20986056|P2|COMPLETED|Overall Study||32
8514578|NCT00420628|20986057|P1|COMPLETED|Overall Study||63
8514579|NCT00420628|20986056|P2|STARTED|Overall Study||36
8514580|NCT00420628|20986057|P1|STARTED|Overall Study||72
8514581|NCT00420511|20986073|P2|NOT COMPLETED|Overall Study||1
8514582|NCT00420511|20986074|P1|NOT COMPLETED|Overall Study||2
8514583|NCT00420511|20986073|P2|COMPLETED|Overall Study||10
8514584|NCT00420511|20986074|P1|COMPLETED|Overall Study||8
8514585|NCT00420511|20986073|P2|STARTED|Overall Study||11
8514586|NCT00420511|20986074|P1|STARTED|Overall Study||10
8514587|NCT00420459|20986084|P1|NOT COMPLETED|Overall Study||0
8514588|NCT00420459|20986084|P1|COMPLETED|Overall Study||12
8514589|NCT00420459|20986084|P1|STARTED|Overall Study||12
8514590|NCT00420420|20986095|P2|NOT COMPLETED|Overall Study||4
8514591|NCT00420420|20986096|P1|NOT COMPLETED|Overall Study||8
8514592|NCT00420420|20986095|P2|COMPLETED|Overall Study||67
8514593|NCT00420420|20986096|P1|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
8514594|NCT00420420|20986095|P2|STARTED|Overall Study|Number of patients randomized.|71
8514595|NCT00420420|20986096|P1|STARTED|Overall Study|Number of patients randomized.|73
8514596|NCT00420407|20986114|P2|NOT COMPLETED|Overall Study||6
8514597|NCT00420407|20986115|P1|NOT COMPLETED|Overall Study||4
8514598|NCT00420407|20986114|P2|COMPLETED|Overall Study||34
8514599|NCT00420407|20986115|P1|COMPLETED|Overall Study||37
8514600|NCT00420407|20986114|P2|STARTED|Overall Study||40
8514601|NCT00420407|20986115|P1|STARTED|Overall Study||41
8514602|NCT00420381|20986122|P1|NOT COMPLETED|Overall Study||1
8514603|NCT00420381|20986122|P1|COMPLETED|Overall Study||27
8514604|NCT00420381|20986122|P1|Received at Least One Dose of Study Drug|Overall Study||27
8514605|NCT00420381|20986122|P1|STARTED|Overall Study||28
8514606|NCT00420342|20986134|P3|NOT COMPLETED|Overall Study||1
8514607|NCT00420342|20986135|P2|NOT COMPLETED|Overall Study||2
8514608|NCT00420342|20986136|P1|NOT COMPLETED|Overall Study||1
8514609|NCT00420342|20986134|P3|COMPLETED|Overall Study||28
8514610|NCT00420342|20986135|P2|COMPLETED|Overall Study||31
8514611|NCT00420342|20986136|P1|COMPLETED|Overall Study||29
8514612|NCT00420342|20986134|P3|Received Treatment|Overall Study||29
8514613|NCT00420342|20986135|P2|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
8514614|NCT00420342|20986136|P1|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
8514615|NCT00420342|20986134|P3|STARTED|Overall Study||29
8514616|NCT00420342|20986135|P2|STARTED|Overall Study||33
8514617|NCT00420342|20986136|P1|STARTED|Overall Study||30
8514618|NCT00420316|20986179|P2|NOT COMPLETED|Overall Study||9
8514619|NCT00420316|20986180|P1|NOT COMPLETED|Overall Study||12
8514620|NCT00420316|20986179|P2|COMPLETED|Overall Study||522
8514621|NCT00420316|20986180|P1|COMPLETED|Overall Study||1070
8514622|NCT00420316|20986179|P2|STARTED|Overall Study||531
8514623|NCT00420316|20986180|P1|STARTED|Overall Study||1082
8514624|NCT00420303|20986204|P2|NOT COMPLETED|Overall Study||4
8514625|NCT00420303|20986205|P1|NOT COMPLETED|Overall Study||1
8514626|NCT00420303|20986204|P2|COMPLETED|Overall Study||8
8514627|NCT00420303|20986205|P1|COMPLETED|Overall Study||11
8514628|NCT00420303|20986204|P2|STARTED|Overall Study||12
8514629|NCT00420303|20986205|P1|STARTED|Overall Study||12
8514630|NCT00420290|20986217|P2|NOT COMPLETED|Overall Study||4
8514631|NCT00420290|20986218|P1|NOT COMPLETED|Overall Study||4
8514632|NCT00420290|20986217|P2|COMPLETED|Overall Study||7
8514633|NCT00420290|20986218|P1|COMPLETED|Overall Study||7
8514634|NCT00420290|20986217|P2|STARTED|Overall Study||11
8514635|NCT00420290|20986218|P1|STARTED|Overall Study||11
8514636|NCT00420238|20986234|P2|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
8514637|NCT00420238|20986235|P1|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
8514638|NCT00420238|20986234|P2|COMPLETED|12 Week Open-Label Treatment Period 2||38
8514639|NCT00420238|20986235|P1|COMPLETED|12 Week Open-Label Treatment Period 2||36
8514640|NCT00420238|20986234|P2|STARTED|12 Week Open-Label Treatment Period 2||39
8514641|NCT00420238|20986235|P1|STARTED|12 Week Open-Label Treatment Period 2||38
8514642|NCT00420238|20986234|P2|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
8514643|NCT00420238|20986235|P1|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
8514644|NCT00420238|20986234|P2|COMPLETED|12 Week Double-Blind Treatment Period 1||39
8514645|NCT00420238|20986235|P1|COMPLETED|12 Week Double-Blind Treatment Period 1||38
8514646|NCT00420238|20986234|P2|STARTED|12 Week Double-Blind Treatment Period 1||43
8514647|NCT00420238|20986235|P1|STARTED|12 Week Double-Blind Treatment Period 1||39
8514648|NCT00420212|20986374|P3|NOT COMPLETED|Overall Study||96
8514649|NCT00420212|20986375|P2|NOT COMPLETED|Overall Study||95
8514650|NCT00420212|20986376|P1|NOT COMPLETED|Overall Study||91
8514651|NCT00420212|20986374|P3|COMPLETED|Overall Study||320
8514652|NCT00420212|20986375|P2|COMPLETED|Overall Study||315
8514653|NCT00420212|20986376|P1|COMPLETED|Overall Study||317
8514654|NCT00420212|20986374|P3|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
8514655|NCT00420212|20986375|P2|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
8514656|NCT00420212|20986376|P1|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
8514657|NCT00420199|20986402|P2|NOT COMPLETED|Overall Study||0
8514658|NCT00420199|20986403|P1|NOT COMPLETED|Overall Study||1
8514659|NCT00420199|20986402|P2|COMPLETED|Overall Study||23
8514660|NCT00420199|20986403|P1|COMPLETED|Overall Study||26
8514661|NCT00420199|20986402|P2|STARTED|Overall Study||23
8514662|NCT00420199|20986403|P1|STARTED|Overall Study||27
8514663|NCT00420147|20986458|P2|NOT COMPLETED|Overall Study||0
8514664|NCT00420147|20986459|P1|NOT COMPLETED|Overall Study||0
8514665|NCT00420147|20986458|P2|COMPLETED|Overall Study||19
8514666|NCT00420147|20986459|P1|COMPLETED|Overall Study||19
8514667|NCT00420147|20986458|P2|STARTED|Overall Study||19
8514668|NCT00420147|20986459|P1|STARTED|Overall Study||19
8514669|NCT00420095|20986469|P2|NOT COMPLETED|Overall Study||1
8514670|NCT00420095|20986470|P1|NOT COMPLETED|Overall Study||3
8514671|NCT00420095|20986469|P2|COMPLETED|Overall Study||59
8514672|NCT00420095|20986470|P1|COMPLETED|Overall Study||54
8514673|NCT00420095|20986469|P2|STARTED|Overall Study||60
8514674|NCT00420095|20986470|P1|STARTED|Overall Study||57
8514675|NCT00420056|20986488|P1|NOT COMPLETED|Overall Study||17
8514676|NCT00420056|20986488|P1|COMPLETED|Overall Study||0
8514677|NCT00420056|20986488|P1|STARTED|Overall Study||17
8514678|NCT00420017|20986512|P2|NOT COMPLETED|Overall Study||0
8514679|NCT00420017|20986513|P1|NOT COMPLETED|Overall Study||2
8514680|NCT00420017|20986512|P2|COMPLETED|Overall Study||40
8514681|NCT00420017|20986513|P1|COMPLETED|Overall Study|40 completed analysis|38
8514682|NCT00420017|20986512|P2|STARTED|Overall Study||40
8514683|NCT00420017|20986513|P1|STARTED|Overall Study||40
8514684|NCT00420004|20986528|P3|NOT COMPLETED|Overall Study||32
8514685|NCT00420004|20986529|P2|NOT COMPLETED|Overall Study||71
8514686|NCT00420004|20986530|P1|NOT COMPLETED|Overall Study||129
8514687|NCT00420004|20986528|P3|COMPLETED|Overall Study||30
8514688|NCT00420004|20986529|P2|COMPLETED|Overall Study||67
8514689|NCT00420004|20986530|P1|COMPLETED|Overall Study||140
8514690|NCT00420004|20986528|P3|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
8514691|NCT00420004|20986529|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
8514692|NCT00420004|20986530|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
8514693|NCT00420004|20986528|P3|STARTED|Overall Study||62
8514694|NCT00420004|20986529|P2|STARTED|Overall Study||138
8514695|NCT00420004|20986530|P1|STARTED|Overall Study||269
8514696|NCT00419952|20986595|P2|NOT COMPLETED|Overall Study||125
8514697|NCT00419952|20986596|P1|NOT COMPLETED|Overall Study||149
8514698|NCT00419952|20986595|P2|COMPLETED|Overall Study||240
8514699|NCT00419952|20986596|P1|COMPLETED|Overall Study||228
8514700|NCT00419952|20986595|P2|STARTED|Overall Study||365
8514701|NCT00419952|20986596|P1|STARTED|Overall Study||377
8514702|NCT00419926|20986630|P2|NOT COMPLETED|Overall Study||10
8514703|NCT00419926|20986631|P1|NOT COMPLETED|Overall Study||14
8514704|NCT00419926|20986630|P2|COMPLETED|Overall Study||148
8514705|NCT00419926|20986631|P1|COMPLETED|Overall Study||141
8514706|NCT00419926|20986630|P2|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
8514707|NCT00419926|20986631|P1|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
8514708|NCT00419770|20986647|P2|NOT COMPLETED|Overall Study||1
8514709|NCT00419770|20986648|P1|NOT COMPLETED|Overall Study||5
8514710|NCT00419770|20986647|P2|COMPLETED|Overall Study||8
8514711|NCT00419770|20986648|P1|COMPLETED|Overall Study||6
8514712|NCT00419770|20986647|P2|STARTED|Overall Study||9
8514713|NCT00419770|20986648|P1|STARTED|Overall Study||11
8514714|NCT00419757|20986656|P2|NOT COMPLETED|Overall Study||21
8514715|NCT00419757|20986657|P1|NOT COMPLETED|Overall Study||18
8514716|NCT00419757|20986656|P2|COMPLETED|Overall Study|Randomized patients|102
8514717|NCT00419757|20986657|P1|COMPLETED|Overall Study|Randomized patients|109
8514718|NCT00419757|20986656|P2|STARTED|Overall Study|Randomized patients|123
8514719|NCT00419757|20986657|P1|STARTED|Overall Study|Randomized patients|127
8514720|NCT00419744|20986696|P3|NOT COMPLETED|Overall Study||133
8514721|NCT00419744|20986697|P2|NOT COMPLETED|Overall Study||118
8514722|NCT00419744|20986698|P1|NOT COMPLETED|Overall Study||117
8514723|NCT00419744|20986696|P3|COMPLETED|Overall Study||271
8514724|NCT00419744|20986697|P2|COMPLETED|Overall Study||290
8514725|NCT00419744|20986698|P1|COMPLETED|Overall Study||290
8514726|NCT00419744|20986696|P3|STARTED|Overall Study||404
8514727|NCT00419744|20986697|P2|STARTED|Overall Study||408
8514728|NCT00419744|20986698|P1|STARTED|Overall Study||407
8514732|NCT00419562|20986741|P2|NOT COMPLETED|Overall Study||31
8514733|NCT00419562|20986742|P1|NOT COMPLETED|Overall Study||33
8514734|NCT00419562|20986741|P2|COMPLETED|Overall Study||246
8514735|NCT00419562|20986742|P1|COMPLETED|Overall Study||250
8514736|NCT00419562|20986741|P2|STARTED|Overall Study||277
8514737|NCT00419562|20986742|P1|STARTED|Overall Study||283
8514738|NCT00419445|20986755|P3|NOT COMPLETED|Overall Study||1
8514739|NCT00419445|20986756|P2|NOT COMPLETED|Overall Study||2
8514740|NCT00419445|20986757|P1|NOT COMPLETED|Overall Study||1
8514741|NCT00419445|20986755|P3|COMPLETED|Overall Study||7
8514742|NCT00419445|20986756|P2|COMPLETED|Overall Study||14
8514743|NCT00419445|20986757|P1|COMPLETED|Overall Study||7
8514744|NCT00419445|20986755|P3|STARTED|Overall Study||8
8514745|NCT00419445|20986756|P2|STARTED|Overall Study||16
8514746|NCT00419445|20986757|P1|STARTED|Overall Study||8
8514747|NCT00419393|20986765|P1|NOT COMPLETED|Overall Study||24
8514748|NCT00419393|20986765|P1|COMPLETED|Overall Study||166
8514749|NCT00419393|20986765|P1|STARTED|Overall Study|One subject did not receive medication|190
8514750|NCT00419380|20986775|P2|NOT COMPLETED|Overall Study||10
8514751|NCT00419380|20986776|P1|NOT COMPLETED|Overall Study||1
8514752|NCT00419380|20986775|P2|COMPLETED|Overall Study||12
8514753|NCT00419380|20986776|P1|COMPLETED|Overall Study||18
8514754|NCT00419380|20986775|P2|STARTED|Overall Study||22
8514755|NCT00419380|20986776|P1|STARTED|Overall Study||19
8514756|NCT00419341|20986784|P1|NOT COMPLETED|Efficacy Period||10
8514757|NCT00419341|20986784|P1|COMPLETED|Efficacy Period||28
8514758|NCT00419341|20986784|P1|STARTED|Efficacy Period||38
8514759|NCT00419341|20986784|P1|NOT COMPLETED|Wash in/Wash Out Period||11
8514760|NCT00419341|20986784|P1|COMPLETED|Wash in/Wash Out Period||38
8514761|NCT00419341|20986784|P1|STARTED|Wash in/Wash Out Period||49
8514762|NCT00419315|20986807|P2|NOT COMPLETED|Overall Study||0
8514763|NCT00419315|20986808|P1|NOT COMPLETED|Overall Study||0
8514764|NCT00419315|20986807|P2|COMPLETED|Overall Study||78
8514765|NCT00419315|20986808|P1|COMPLETED|Overall Study||85
8514766|NCT00419315|20986807|P2|STARTED|Overall Study||78
8514767|NCT00419315|20986808|P1|STARTED|Overall Study||85
8514768|NCT00419263|20986819|P3|NOT COMPLETED|Overall Study||3
8514769|NCT00419263|20986820|P2|NOT COMPLETED|Overall Study||2
8514770|NCT00419263|20986821|P1|NOT COMPLETED|Overall Study||3
8514771|NCT00419263|20986819|P3|COMPLETED|Overall Study||112
8514772|NCT00419263|20986820|P2|COMPLETED|Overall Study||112
8514773|NCT00419263|20986821|P1|COMPLETED|Overall Study||112
8514774|NCT00419263|20986819|P3|STARTED|Overall Study||115
8514775|NCT00419263|20986820|P2|STARTED|Overall Study||114
8514776|NCT00419263|20986821|P1|STARTED|Overall Study||115
8514777|NCT00419159|20986850|P2|NOT COMPLETED|Overall Study||100
8514778|NCT00419159|20986851|P1|NOT COMPLETED|Overall Study||99
8514779|NCT00419159|20986850|P2|COMPLETED|Overall Study||0
8514780|NCT00419159|20986851|P1|COMPLETED|Overall Study||0
8514781|NCT00419159|20986850|P2|STARTED|Overall Study||100
8514782|NCT00419159|20986851|P1|STARTED|Overall Study|Full Analysis Set|99
8514783|NCT00419120|20986881|P1|NOT COMPLETED|Long Term Follow up Period||10
8514784|NCT00419120|20986881|P1|COMPLETED|Long Term Follow up Period||0
8514785|NCT00419120|20986881|P1|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
8514786|NCT00419120|20986881|P1|NOT COMPLETED|Primary Study Period||0
8514787|NCT00419120|20986881|P1|COMPLETED|Primary Study Period||10
8514788|NCT00419120|20986881|P1|STARTED|Primary Study Period||10
8514789|NCT00419094|20986888|P2|NOT COMPLETED|Overall Study||30
8514790|NCT00419094|20986889|P1|NOT COMPLETED|Overall Study||7
8514791|NCT00419094|20986888|P2|COMPLETED|Overall Study||141
8514792|NCT00419094|20986889|P1|COMPLETED|Overall Study||50
8514793|NCT00419094|20986888|P2|STARTED|Overall Study||171
8514794|NCT00419094|20986889|P1|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
8514795|NCT00419003|20986903|P2|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
8514796|NCT00419003|20986904|P1|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
8514797|NCT00419003|20986903|P2|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
8514798|NCT00419003|20986904|P1|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
8514799|NCT00419003|20986903|P2|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|8
8514800|NCT00419003|20986904|P1|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|6
8514801|NCT00419003|20986903|P2|NOT COMPLETED|Phase I, Ketamine Infusion||6
8514802|NCT00419003|20986904|P1|NOT COMPLETED|Phase I, Ketamine Infusion||6
8514803|NCT00419003|20986903|P2|COMPLETED|Phase I, Ketamine Infusion||7
8514804|NCT00419003|20986904|P1|COMPLETED|Phase I, Ketamine Infusion||7
8514805|NCT00419003|20986903|P2|STARTED|Phase I, Ketamine Infusion||13
8514806|NCT00419003|20986904|P1|STARTED|Phase I, Ketamine Infusion||13
8514807|NCT00418977|20986915|P2|NOT COMPLETED|Overall Study||3
8514808|NCT00418977|20986916|P1|NOT COMPLETED|Overall Study||3
8514809|NCT00418977|20986915|P2|COMPLETED|Overall Study||13
8514810|NCT00418977|20986916|P1|COMPLETED|Overall Study||40
8514811|NCT00418977|20986915|P2|STARTED|Overall Study||16
8514812|NCT00418977|20986916|P1|STARTED|Overall Study||43
8514813|NCT00418964|20986933|P3|NOT COMPLETED|Overall Study||6
8514814|NCT00418964|20986934|P2|NOT COMPLETED|Overall Study||3
8514815|NCT00418964|20986935|P1|NOT COMPLETED|Overall Study||1
8514816|NCT00418964|20986933|P3|COMPLETED|Overall Study||14
8514817|NCT00418964|20986934|P2|COMPLETED|Overall Study||17
8514818|NCT00418964|20986935|P1|COMPLETED|Overall Study||21
8514819|NCT00418964|20986933|P3|STARTED|Overall Study||20
8514820|NCT00418964|20986934|P2|STARTED|Overall Study||20
8514821|NCT00418964|20986935|P1|STARTED|Overall Study||22
8514822|NCT00418951|20986946|P3|NOT COMPLETED|Overall Study||0
8514823|NCT00418951|20986947|P2|NOT COMPLETED|Overall Study||0
8514824|NCT00418951|20986948|P1|NOT COMPLETED|Overall Study||0
8514825|NCT00418951|20986946|P3|COMPLETED|Overall Study||40
8514826|NCT00418951|20986947|P2|COMPLETED|Overall Study||33
8514827|NCT00418951|20986948|P1|COMPLETED|Overall Study||39
8514828|NCT00418951|20986946|P3|STARTED|Overall Study||40
8514829|NCT00418951|20986947|P2|STARTED|Overall Study||33
8514830|NCT00418951|20986948|P1|STARTED|Overall Study||39
8514831|NCT00418938|20986958|P2|NOT COMPLETED|Overall Study||23
8514832|NCT00418938|20986959|P1|NOT COMPLETED|Overall Study||24
8514833|NCT00418938|20986958|P2|COMPLETED|Overall Study||108
8514834|NCT00418938|20986959|P1|COMPLETED|Overall Study||109
8514835|NCT00418938|20986958|P2|STARTED|Overall Study||131
8514836|NCT00418938|20986959|P1|STARTED|Overall Study||133
8514837|NCT00418886|20986979|P2|NOT COMPLETED|Overall Study||255
8514838|NCT00418886|20986980|P1|NOT COMPLETED|Overall Study||226
8514839|NCT00418886|20986979|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
8514840|NCT00418886|20986980|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
8514841|NCT00418886|20986979|P2|STARTED|Overall Study|randomised patients|278
8514842|NCT00418886|20986980|P1|STARTED|Overall Study|randomised patients|256
8514843|NCT00418834|20987006|P2|NOT COMPLETED|Overall Study||20
8514844|NCT00418834|20987007|P1|NOT COMPLETED|Overall Study||23
8514845|NCT00418834|20987006|P2|COMPLETED|Overall Study||507
8514846|NCT00418834|20987007|P1|COMPLETED|Overall Study||503
8514847|NCT00418834|20987006|P2|STARTED|Overall Study||527
8514848|NCT00418834|20987007|P1|STARTED|Overall Study||526
8514849|NCT00418717|20987067|P1|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
8514850|NCT00418717|20987067|P1|COMPLETED|Treatment Period B - Weeks 5-12||39
8514851|NCT00418717|20987067|P1|STARTED|Treatment Period B - Weeks 5-12||41
8514852|NCT00418717|20987067|P1|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
8514853|NCT00418717|20987067|P1|COMPLETED|Treatment Period A - Weeks 1-4||41
8514854|NCT00418717|20987067|P1|STARTED|Treatment Period A - Weeks 1-4||42
8514855|NCT00418691|20987075|P3|NOT COMPLETED|Overall Study||5
8514856|NCT00418691|20987076|P2|NOT COMPLETED|Overall Study||2
8514857|NCT00418691|20987077|P1|NOT COMPLETED|Overall Study||2
8514858|NCT00418691|20987075|P3|COMPLETED|Overall Study||5
8514859|NCT00418691|20987076|P2|COMPLETED|Overall Study||10
8514860|NCT00418691|20987077|P1|COMPLETED|Overall Study||9
8514861|NCT00418691|20987075|P3|STARTED|Overall Study||10
8514862|NCT00418691|20987076|P2|STARTED|Overall Study||12
8514863|NCT00418691|20987077|P1|STARTED|Overall Study||11
8514864|NCT00418665|20987088|P3|NOT COMPLETED|Treatment Extension||2
8514865|NCT00418665|20987089|P2|NOT COMPLETED|Treatment Extension||4
8514866|NCT00418665|20987090|P1|NOT COMPLETED|Treatment Extension||6
8514867|NCT00418665|20987088|P3|COMPLETED|Treatment Extension||7
8514868|NCT00418665|20987089|P2|COMPLETED|Treatment Extension||4
8514869|NCT00418665|20987090|P1|COMPLETED|Treatment Extension||1
8514870|NCT00418665|20987088|P3|STARTED|Treatment Extension||9
8514871|NCT00418665|20987089|P2|STARTED|Treatment Extension||8
8514872|NCT00418665|20987090|P1|STARTED|Treatment Extension||7
8514873|NCT00418665|20987088|P3|NOT COMPLETED|Treatment Period||4
8514874|NCT00418665|20987089|P2|NOT COMPLETED|Treatment Period||6
8514875|NCT00418665|20987090|P1|NOT COMPLETED|Treatment Period||5
8514876|NCT00418665|20987088|P3|COMPLETED|Treatment Period||9
8514877|NCT00418665|20987089|P2|COMPLETED|Treatment Period||8
8514878|NCT00418665|20987090|P1|COMPLETED|Treatment Period||7
8514879|NCT00418665|20987088|P3|Received Study Medication|Treatment Period||13
8514880|NCT00418665|20987089|P2|Received Study Medication|Treatment Period||13
8514881|NCT00418665|20987090|P1|Received Study Medication|Treatment Period||11
8514882|NCT00418665|20987088|P3|STARTED|Treatment Period||13
8514883|NCT00418665|20987089|P2|STARTED|Treatment Period||14
8514884|NCT00418665|20987090|P1|STARTED|Treatment Period||12
8514885|NCT00418574|20987109|P2|NOT COMPLETED|Overall Study||23
8514886|NCT00418574|20987110|P1|NOT COMPLETED|Overall Study||48
8514887|NCT00418574|20987109|P2|COMPLETED|Overall Study||272
8514888|NCT00418574|20987110|P1|COMPLETED|Overall Study||545
8514889|NCT00418574|20987109|P2|TREATED|Overall Study||294
8514890|NCT00418574|20987110|P1|TREATED|Overall Study||592
8514891|NCT00418574|20987109|P2|STARTED|Overall Study||295
8514892|NCT00418574|20987110|P1|STARTED|Overall Study||593
8514902|NCT00418522|20987196|P2|NOT COMPLETED|Overall Study||42
8514903|NCT00418522|20987197|P1|NOT COMPLETED|Overall Study||83
8514904|NCT00418522|20987196|P2|COMPLETED|Overall Study||152
8514905|NCT00418522|20987197|P1|COMPLETED|Overall Study||136
8514906|NCT00418522|20987196|P2|Received Treatment|Overall Study||190
8514907|NCT00418522|20987197|P1|Received Treatment|Overall Study||212
8514908|NCT00418522|20987196|P2|STARTED|Overall Study||194
8514909|NCT00418522|20987197|P1|STARTED|Overall Study||219
8514910|NCT00418457|20987243|P2|NOT COMPLETED|Overall Study||0
8514911|NCT00418457|20987244|P1|NOT COMPLETED|Overall Study||0
8514912|NCT00418457|20987243|P2|COMPLETED|Overall Study||1043
8514913|NCT00418457|20987244|P1|COMPLETED|Overall Study||1065
8514914|NCT00418457|20987243|P2|STARTED|Overall Study||1043
8514915|NCT00418457|20987244|P1|STARTED|Overall Study||1065
8514916|NCT00418379|20987261|P3|NOT COMPLETED|Year 5||3
8514917|NCT00418379|20987262|P2|NOT COMPLETED|Year 5||5
8514918|NCT00418379|20987263|P1|NOT COMPLETED|Year 5||2
8514919|NCT00418379|20987261|P3|COMPLETED|Year 5||131
8514920|NCT00418379|20987262|P2|COMPLETED|Year 5||115
8514921|NCT00418379|20987263|P1|COMPLETED|Year 5||126
8514922|NCT00418379|20987261|P3|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
8514923|NCT00418379|20987262|P2|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
8514924|NCT00418379|20987263|P1|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
8514925|NCT00418379|20987261|P3|NOT COMPLETED|Year 4||2
8514926|NCT00418379|20987262|P2|NOT COMPLETED|Year 4||5
8514927|NCT00418379|20987263|P1|NOT COMPLETED|Year 4||3
8514928|NCT00418379|20987261|P3|COMPLETED|Year 4||154
8514929|NCT00418379|20987262|P2|COMPLETED|Year 4||136
8514930|NCT00418379|20987263|P1|COMPLETED|Year 4||142
8514931|NCT00418379|20987261|P3|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
8514932|NCT00418379|20987262|P2|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
8514933|NCT00418379|20987263|P1|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
8514934|NCT00418379|20987261|P3|NOT COMPLETED|Year 3||3
8514935|NCT00418379|20987262|P2|NOT COMPLETED|Year 3||2
8514936|NCT00418379|20987263|P1|NOT COMPLETED|Year 3||3
8514937|NCT00418379|20987261|P3|COMPLETED|Year 3||163
8514938|NCT00418379|20987262|P2|COMPLETED|Year 3||146
8514939|NCT00418379|20987263|P1|COMPLETED|Year 3||148
8514940|NCT00418379|20987261|P3|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
8514941|NCT00418379|20987262|P2|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
8514942|NCT00418379|20987263|P1|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
8514943|NCT00418379|20987261|P3|NOT COMPLETED|Year 2||10
8514944|NCT00418379|20987262|P2|NOT COMPLETED|Year 2||4
8514945|NCT00418379|20987263|P1|NOT COMPLETED|Year 2||8
8514946|NCT00418379|20987261|P3|COMPLETED|Year 2||172
8514947|NCT00418379|20987262|P2|COMPLETED|Year 2||155
8514948|NCT00418379|20987263|P1|COMPLETED|Year 2||159
8514949|NCT00418379|20987261|P3|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
8514950|NCT00418379|20987262|P2|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
8514951|NCT00418379|20987263|P1|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
8514952|NCT00418379|20987261|P3|NOT COMPLETED|Year 1||15
8514953|NCT00418379|20987262|P2|NOT COMPLETED|Year 1||28
8514954|NCT00418379|20987263|P1|NOT COMPLETED|Year 1||18
8514955|NCT00418379|20987261|P3|COMPLETED|Year 1||204
8514956|NCT00418379|20987262|P2|COMPLETED|Year 1||179
8514957|NCT00418379|20987263|P1|COMPLETED|Year 1||189
8514958|NCT00418379|20987261|P3|STARTED|Year 1||219
8514959|NCT00418379|20987262|P2|STARTED|Year 1||207
8514960|NCT00418379|20987263|P1|STARTED|Year 1||207
8514961|NCT00418314|20987273|P2|NOT COMPLETED|Overall Study||2
8514962|NCT00418314|20987274|P1|NOT COMPLETED|Overall Study||1
8514963|NCT00418314|20987273|P2|COMPLETED|Overall Study||828
8514964|NCT00418314|20987274|P1|COMPLETED|Overall Study||816
8514965|NCT00418314|20987273|P2|STARTED|Overall Study||830
8514966|NCT00418314|20987274|P1|STARTED|Overall Study||817
8514967|NCT00418262|20987284|P1|NOT COMPLETED|Visits 8 Thru 10||5
8514968|NCT00418262|20987284|P1|COMPLETED|Visits 8 Thru 10||11
8514969|NCT00418262|20987284|P1|STARTED|Visits 8 Thru 10||16
8514970|NCT00418262|20987284|P1|NOT COMPLETED|Visits 5 Thru 8||9
8514971|NCT00418262|20987284|P1|COMPLETED|Visits 5 Thru 8||16
8514972|NCT00418262|20987284|P1|STARTED|Visits 5 Thru 8||25
8514973|NCT00418262|20987284|P1|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
8514974|NCT00418262|20987284|P1|COMPLETED|Visits 1 (Baseline) Thru 5||25
8514975|NCT00418262|20987284|P1|STARTED|Visits 1 (Baseline) Thru 5||27
8514976|NCT00418184|20987304|P2|NOT COMPLETED|Open-label Phase||5
8514977|NCT00418184|20987305|P1|NOT COMPLETED|Open-label Phase||5
8514978|NCT00418184|20987304|P2|COMPLETED|Open-label Phase|5 dropped out|43
8514979|NCT00418184|20987305|P1|COMPLETED|Open-label Phase|5 dropped out|97
8514980|NCT00418184|20987304|P2|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
8514981|NCT00418184|20987305|P1|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
8514982|NCT00418184|20987304|P2|NOT COMPLETED|Double-blind Phase||11
8514983|NCT00418184|20987305|P1|NOT COMPLETED|Double-blind Phase||27
8514984|NCT00418184|20987304|P2|COMPLETED|Double-blind Phase||52
8514985|NCT00418184|20987305|P1|COMPLETED|Double-blind Phase||110
8514986|NCT00418184|20987304|P2|STARTED|Double-blind Phase||63
8514987|NCT00418184|20987305|P1|STARTED|Double-blind Phase||137
8514988|NCT00418145|20987313|P1|NOT COMPLETED|Overall Study||6
8514989|NCT00418145|20987313|P1|COMPLETED|Overall Study||10
8514990|NCT00418145|20987313|P1|STARTED|Overall Study||16
8514991|NCT00418093|20987325|P1|NOT COMPLETED|Overall Study||0
8514992|NCT00418093|20987325|P1|COMPLETED|Overall Study||19
8514993|NCT00418093|20987325|P1|Completed Study|Overall Study||19
8514994|NCT00418093|20987325|P1|STARTED|Overall Study||19
8514995|NCT00418028|20987334|P2|NOT COMPLETED|Overall Study||1
8514996|NCT00418028|20987335|P1|NOT COMPLETED|Overall Study||2
8514997|NCT00418028|20987334|P2|COMPLETED|Overall Study||97
8514998|NCT00418028|20987335|P1|COMPLETED|Overall Study||95
8514999|NCT00418028|20987334|P2|STARTED|Overall Study||98
8515000|NCT00418028|20987335|P1|STARTED|Overall Study||97
8515001|NCT00418015|20987357|P4|NOT COMPLETED|Overall Study||0
8515002|NCT00418015|20987358|P3|NOT COMPLETED|Overall Study||0
8515003|NCT00418015|20987359|P2|NOT COMPLETED|Overall Study||0
8515004|NCT00418015|20987360|P1|NOT COMPLETED|Overall Study||0
8515005|NCT00418015|20987357|P4|COMPLETED|Overall Study||25
8515006|NCT00418015|20987358|P3|COMPLETED|Overall Study||78
8515007|NCT00418015|20987359|P2|COMPLETED|Overall Study||46
8515008|NCT00418015|20987360|P1|COMPLETED|Overall Study||144
8515009|NCT00418015|20987357|P4|STARTED|Overall Study||25
8515010|NCT00418015|20987358|P3|STARTED|Overall Study||78
8515011|NCT00418015|20987359|P2|STARTED|Overall Study||46
8515012|NCT00418015|20987360|P1|STARTED|Overall Study||144
8515013|NCT00417989|20987388|P2|NOT COMPLETED|Overall Study||22
8515014|NCT00417989|20987389|P1|NOT COMPLETED|Overall Study||20
8515015|NCT00417989|20987388|P2|COMPLETED|Overall Study||219
8515016|NCT00417989|20987389|P1|COMPLETED|Overall Study||224
8515017|NCT00417989|20987388|P2|STARTED|Overall Study||241
8515018|NCT00417989|20987389|P1|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
8515019|NCT00417976|20987411|P1|NOT COMPLETED|Overall Study||3
8515020|NCT00417976|20987411|P1|COMPLETED|Overall Study||39
8515021|NCT00417976|20987411|P1|STARTED|Overall Study||42
8515022|NCT00417963|20987416|P1|NOT COMPLETED|Overall Study||41
8515023|NCT00417963|20987416|P1|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
8515024|NCT00417963|20987416|P1|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
8515025|NCT00417885|20987433|P1|NOT COMPLETED|Overall Study||6
8515026|NCT00417885|20987433|P1|COMPLETED|Overall Study||0
8515027|NCT00417885|20987433|P1|STARTED|Overall Study||6
8515028|NCT00417859|20987444|P2|NOT COMPLETED|Overall Study||1
8515029|NCT00417859|20987445|P1|NOT COMPLETED|Overall Study||0
8515030|NCT00417859|20987444|P2|COMPLETED|Overall Study||29
8515031|NCT00417859|20987445|P1|COMPLETED|Overall Study||26
8515032|NCT00417859|20987444|P2|STARTED|Overall Study||30
8515033|NCT00417859|20987445|P1|STARTED|Overall Study||26
8515034|NCT00417612|20987459|P2|NOT COMPLETED|Overall Study||3
8515035|NCT00417612|20987460|P1|NOT COMPLETED|Overall Study||3
8515036|NCT00417612|20987459|P2|COMPLETED|Overall Study||8
8515037|NCT00417612|20987460|P1|COMPLETED|Overall Study||19
8515038|NCT00417612|20987459|P2|STARTED|Overall Study||11
8515039|NCT00417612|20987460|P1|STARTED|Overall Study||22
8515040|NCT00417482|20987486|P3|NOT COMPLETED|Phase B 2nd 16 Weeks||3
8515041|NCT00417482|20987487|P2|NOT COMPLETED|Phase B 2nd 16 Weeks||13
8515042|NCT00417482|20987488|P1|NOT COMPLETED|Phase B 2nd 16 Weeks||3
8515043|NCT00417482|20987486|P3|COMPLETED|Phase B 2nd 16 Weeks||10
8515044|NCT00417482|20987487|P2|COMPLETED|Phase B 2nd 16 Weeks||14
8515045|NCT00417482|20987488|P1|COMPLETED|Phase B 2nd 16 Weeks||10
8515046|NCT00417482|20987486|P3|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
8515047|NCT00417482|20987487|P2|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
8515048|NCT00417482|20987488|P1|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
8515049|NCT00417482|20987486|P3|NOT COMPLETED|Phase B 1st 16 Weeks||27
8515050|NCT00417482|20987487|P2|NOT COMPLETED|Phase B 1st 16 Weeks||11
8515051|NCT00417482|20987488|P1|NOT COMPLETED|Phase B 1st 16 Weeks||19
8515052|NCT00417482|20987486|P3|COMPLETED|Phase B 1st 16 Weeks||13
8515053|NCT00417482|20987487|P2|COMPLETED|Phase B 1st 16 Weeks||27
8515054|NCT00417482|20987488|P1|COMPLETED|Phase B 1st 16 Weeks||13
8515055|NCT00417482|20987486|P3|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
8515056|NCT00417482|20987487|P2|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
8515057|NCT00417482|20987488|P1|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
8515058|NCT00417417|20987514|P2|NOT COMPLETED|Overall Study||0
8515059|NCT00417417|20987515|P1|NOT COMPLETED|Overall Study||0
8515060|NCT00417417|20987514|P2|COMPLETED|Overall Study||6
8515061|NCT00417417|20987515|P1|COMPLETED|Overall Study||4
8515062|NCT00417417|20987514|P2|STARTED|Overall Study||6
8515063|NCT00417417|20987515|P1|STARTED|Overall Study||4
8515064|NCT00417274|20987523|P1|NOT COMPLETED|Overall Study||0
8515065|NCT00417274|20987523|P1|COMPLETED|Overall Study||31
8515066|NCT00417274|20987523|P1|STARTED|Overall Study||31
8515067|NCT00417248|20987527|P1|NOT COMPLETED|Overall Study||8
8515068|NCT00417248|20987527|P1|COMPLETED|Overall Study||0
8515069|NCT00417248|20987527|P1|STARTED|Overall Study||8
8515070|NCT00417170|20987534|P2|NOT COMPLETED|Overall Study||3
8515071|NCT00417170|20987535|P1|NOT COMPLETED|Overall Study||2
8515072|NCT00417170|20987534|P2|COMPLETED|Overall Study||22
8515073|NCT00417170|20987535|P1|COMPLETED|Overall Study||21
8515074|NCT00417170|20987534|P2|Pharmacodynamics Population|Overall Study||23
8515075|NCT00417170|20987535|P1|Pharmacodynamics Population|Overall Study||21
8515076|NCT00417170|20987534|P2|STARTED|Overall Study||25
8515077|NCT00417170|20987535|P1|STARTED|Overall Study|"Started indicates Safety population."|23
8515078|NCT00417079|20987551|P2|NOT COMPLETED|Overall Study||273
8515079|NCT00417079|20987552|P1|NOT COMPLETED|Overall Study||331
8515080|NCT00417079|20987551|P2|COMPLETED|Overall Study|Randomized patients|105
8515081|NCT00417079|20987552|P1|COMPLETED|Overall Study|Randomized patients|46
8515082|NCT00417079|20987551|P2|STARTED|Overall Study|Randomized patients|378
8515083|NCT00417079|20987552|P1|STARTED|Overall Study|Randomized patients|377
8515084|NCT00417027|20987575|P3|NOT COMPLETED|Overall Study||5
8515085|NCT00417027|20987576|P2|NOT COMPLETED|Overall Study||5
8515086|NCT00417027|20987577|P1|NOT COMPLETED|Overall Study||0
8515087|NCT00417027|20987575|P3|COMPLETED|Overall Study||54
8515088|NCT00417027|20987576|P2|COMPLETED|Overall Study||60
8515089|NCT00417027|20987577|P1|COMPLETED|Overall Study||66
8515090|NCT00417027|20987575|P3|STARTED|Overall Study||59
8515091|NCT00417027|20987576|P2|STARTED|Overall Study||65
8515092|NCT00417027|20987577|P1|STARTED|Overall Study||66
8515093|NCT00416949|20987603|P1|NOT COMPLETED|Overall Study||5
8515094|NCT00416949|20987603|P1|COMPLETED|Overall Study||4
8515095|NCT00416949|20987603|P1|STARTED|Overall Study||9
8515096|NCT00416884|20987607|P1|NOT COMPLETED|Overall Study||1
8515097|NCT00416884|20987607|P1|COMPLETED|Overall Study||0
8515098|NCT00416884|20987607|P1|STARTED|Overall Study||1
8515099|NCT00416793|20987611|P1|NOT COMPLETED|Overall Study||0
8515100|NCT00416793|20987611|P1|COMPLETED|Overall Study||9
8515101|NCT00416793|20987611|P1|STARTED|Overall Study||9
8515102|NCT00416715|20987616|P1|NOT COMPLETED|Overall Study||15
8515103|NCT00416715|20987616|P1|COMPLETED|Overall Study||85
8515104|NCT00416715|20987616|P1|STARTED|Overall Study||100
8515105|NCT00416624|20987627|P4|NOT COMPLETED|Overall Study||17
8515106|NCT00416624|20987628|P3|NOT COMPLETED|Overall Study||18
8515107|NCT00416624|20987629|P2|NOT COMPLETED|Overall Study||27
8515108|NCT00416624|20987630|P1|NOT COMPLETED|Overall Study||22
8515109|NCT00416624|20987627|P4|COMPLETED|Overall Study||40
8515110|NCT00416624|20987628|P3|COMPLETED|Overall Study||40
8515111|NCT00416624|20987629|P2|COMPLETED|Overall Study||33
8515112|NCT00416624|20987630|P1|COMPLETED|Overall Study||39
8515113|NCT00416624|20987627|P4|STARTED|Overall Study||57
8515114|NCT00416624|20987628|P3|STARTED|Overall Study||58
8515115|NCT00416624|20987629|P2|STARTED|Overall Study||60
8515116|NCT00416624|20987630|P1|STARTED|Overall Study||61
8515117|NCT00416598|20987684|P1|NOT COMPLETED|Decitabine Maintenance||72
8515118|NCT00416598|20987684|P1|COMPLETED|Decitabine Maintenance||62
8515119|NCT00416598|20987684|P1|STARTED|Decitabine Maintenance||134
8515120|NCT00416598|20987684|P1|NOT COMPLETED|Induction & Intensification||412
8515121|NCT00416598|20987684|P1|COMPLETED|Induction & Intensification||134
8515122|NCT00416598|20987684|P1|STARTED|Induction & Intensification||546
8515123|NCT00416572|20987692|P3|NOT COMPLETED|Overall Study||8
8515124|NCT00416572|20987693|P2|NOT COMPLETED|Overall Study||7
8515125|NCT00416572|20987694|P1|NOT COMPLETED|Overall Study||13
8515126|NCT00416572|20987692|P3|COMPLETED|Overall Study||76
8515127|NCT00416572|20987693|P2|COMPLETED|Overall Study||78
8515128|NCT00416572|20987694|P1|COMPLETED|Overall Study||70
8515129|NCT00416572|20987692|P3|STARTED|Overall Study||84
8515130|NCT00416572|20987693|P2|STARTED|Overall Study||85
8515131|NCT00416572|20987694|P1|STARTED|Overall Study||83
8515132|NCT00416520|20987710|P4|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
8515133|NCT00416520|20987711|P3|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
8515134|NCT00416520|20987712|P2|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
8515135|NCT00416520|20987713|P1|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
8515136|NCT00416520|20987710|P4|COMPLETED|Placebo-controlled Withdrawal Period||49
8515137|NCT00416520|20987711|P3|COMPLETED|Placebo-controlled Withdrawal Period||49
8515138|NCT00416520|20987712|P2|COMPLETED|Placebo-controlled Withdrawal Period||0
8515139|NCT00416520|20987713|P1|COMPLETED|Placebo-controlled Withdrawal Period||0
8515140|NCT00416520|20987710|P4|STARTED|Placebo-controlled Withdrawal Period||54
8515141|NCT00416520|20987711|P3|STARTED|Placebo-controlled Withdrawal Period||50
8515142|NCT00416520|20987712|P2|STARTED|Placebo-controlled Withdrawal Period||0
8515143|NCT00416520|20987713|P1|STARTED|Placebo-controlled Withdrawal Period||0
8515144|NCT00416520|20987710|P4|NOT COMPLETED|Open-label Period||0
8515145|NCT00416520|20987711|P3|NOT COMPLETED|Open-label Period||0
8515146|NCT00416520|20987712|P2|NOT COMPLETED|Open-label Period||32
8515147|NCT00416520|20987713|P1|NOT COMPLETED|Open-label Period||60
8515148|NCT00416520|20987710|P4|COMPLETED|Open-label Period||0
8515149|NCT00416520|20987711|P3|COMPLETED|Open-label Period||0
8515150|NCT00416520|20987712|P2|COMPLETED|Open-label Period||139
8515151|NCT00416520|20987713|P1|COMPLETED|Open-label Period||105
8515152|NCT00416520|20987710|P4|STARTED|Open-label Period||0
8515153|NCT00416520|20987711|P3|STARTED|Open-label Period||0
8515154|NCT00416520|20987712|P2|STARTED|Open-label Period||171
8515155|NCT00416520|20987713|P1|STARTED|Open-label Period||165
8515156|NCT00416494|20987725|P2|NOT COMPLETED|Overall Study||0
8515157|NCT00416494|20987726|P1|NOT COMPLETED|Overall Study||0
8515158|NCT00416494|20987725|P2|COMPLETED|Overall Study||31
8515159|NCT00416494|20987726|P1|COMPLETED|Overall Study||19
8515160|NCT00416494|20987725|P2|STARTED|Overall Study||31
8515161|NCT00416494|20987726|P1|STARTED|Overall Study||19
8515162|NCT00416455|20987742|P2|NOT COMPLETED|Overall Study||8
8515163|NCT00416455|20987743|P1|NOT COMPLETED|Overall Study||16
8515164|NCT00416455|20987742|P2|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
8515165|NCT00416455|20987743|P1|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
8515166|NCT00416455|20987742|P2|STARTED|Overall Study|This is a diagnostic imaging study.|215
8515167|NCT00416455|20987743|P1|STARTED|Overall Study|This is a diagnostic imaging study.|169
8515168|NCT00416312|20987778|P1|NOT COMPLETED|Overall Study||2
8515169|NCT00416312|20987778|P1|COMPLETED|Overall Study||7
8515170|NCT00416312|20987778|P1|Patient-specific Dosimetry|Overall Study||9
8515171|NCT00416312|20987778|P1|Conventional Dosimetry|Overall Study||9
8515172|NCT00416312|20987778|P1|STARTED|Overall Study||9
8515173|NCT00416195|20987784|P2|NOT COMPLETED|Overall Study||4
8515174|NCT00416195|20987785|P1|NOT COMPLETED|Overall Study||2
8515175|NCT00416195|20987784|P2|COMPLETED|Overall Study||34
8515176|NCT00416195|20987785|P1|COMPLETED|Overall Study||8
8515177|NCT00416195|20987784|P2|STARTED|Overall Study||38
8515178|NCT00416195|20987785|P1|STARTED|Overall Study||10
8515179|NCT00416182|20987795|P2|NOT COMPLETED|Overall Study||2
8515180|NCT00416182|20987796|P1|NOT COMPLETED|Overall Study||3
8515181|NCT00416182|20987795|P2|COMPLETED|Overall Study||6
8515182|NCT00416182|20987796|P1|COMPLETED|Overall Study||5
8515183|NCT00416182|20987795|P2|STARTED|Overall Study||8
8515184|NCT00416182|20987796|P1|STARTED|Overall Study||8
8515185|NCT00416078|20987810|P2|NOT COMPLETED|Overall Study||8
8515186|NCT00416078|20987811|P1|NOT COMPLETED|Overall Study||11
8515187|NCT00416078|20987810|P2|COMPLETED|Overall Study||16
8515188|NCT00416078|20987811|P1|COMPLETED|Overall Study||18
8515189|NCT00416078|20987810|P2|STARTED|Overall Study||24
8515190|NCT00416078|20987811|P1|STARTED|Overall Study||29
8515191|NCT00415909|20987827|P1|NOT COMPLETED|Overall Study||3
8515192|NCT00415909|20987827|P1|COMPLETED|Overall Study||0
8515193|NCT00415909|20987827|P1|STARTED|Overall Study||3
8515194|NCT00415870|20987833|P2|NOT COMPLETED|Overall Study||7
8515195|NCT00415870|20987834|P1|NOT COMPLETED|Overall Study||6
8515196|NCT00415870|20987833|P2|COMPLETED|Overall Study||26
8515197|NCT00415870|20987834|P1|COMPLETED|Overall Study||26
8515198|NCT00415870|20987833|P2|STARTED|Overall Study||33
8515199|NCT00415870|20987834|P1|STARTED|Overall Study||32
8515200|NCT00415857|20987846|P2|NOT COMPLETED|Overall Study||0
8515201|NCT00415857|20987847|P1|NOT COMPLETED|Overall Study||0
8515202|NCT00415857|20987846|P2|COMPLETED|Overall Study||3
8515203|NCT00415857|20987847|P1|COMPLETED|Overall Study||2
8515204|NCT00415857|20987846|P2|STARTED|Overall Study||3
8515205|NCT00415857|20987847|P1|STARTED|Overall Study||2
8515206|NCT00415636|20987861|P6|NOT COMPLETED|Overall Study||2
8515207|NCT00415636|20987862|P5|NOT COMPLETED|Overall Study||2
8515208|NCT00415636|20987863|P4|NOT COMPLETED|Overall Study||6
8515209|NCT00415636|20987864|P3|NOT COMPLETED|Overall Study||1
8515210|NCT00415636|20987865|P2|NOT COMPLETED|Overall Study||0
8515211|NCT00415636|20987866|P1|NOT COMPLETED|Overall Study||1
8515212|NCT00415636|20987861|P6|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
8515213|NCT00415636|20987862|P5|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
8515214|NCT00415636|20987863|P4|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
8515215|NCT00415636|20987864|P3|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
8515216|NCT00415636|20987865|P2|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
8515217|NCT00415636|20987866|P1|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
8515218|NCT00415636|20987861|P6|STARTED|Overall Study||3
8515219|NCT00415636|20987862|P5|STARTED|Overall Study||6
8515220|NCT00415636|20987863|P4|STARTED|Overall Study||13
8515221|NCT00415636|20987864|P3|STARTED|Overall Study||3
8515222|NCT00415636|20987865|P2|STARTED|Overall Study||3
8515223|NCT00415636|20987866|P1|STARTED|Overall Study||3
8515230|NCT00415610|20987928|P3|NOT COMPLETED|Overall Study||5
8515231|NCT00415610|20987929|P2|NOT COMPLETED|Overall Study||2
8515232|NCT00415610|20987930|P1|NOT COMPLETED|Overall Study||3
8515233|NCT00415610|20987928|P3|COMPLETED|Overall Study||17
8515234|NCT00415610|20987929|P2|COMPLETED|Overall Study||18
8515235|NCT00415610|20987930|P1|COMPLETED|Overall Study||15
8515236|NCT00415610|20987928|P3|STARTED|Overall Study||22
8515237|NCT00415610|20987929|P2|STARTED|Overall Study||20
8515238|NCT00415610|20987930|P1|STARTED|Overall Study||18
8515239|NCT00415597|20987950|P1|NOT COMPLETED|Treatment||305
8515240|NCT00415597|20987950|P1|COMPLETED|Treatment||160
8515241|NCT00415597|20987950|P1|STARTED|Treatment||465
8515242|NCT00415597|20987950|P1|NOT COMPLETED|Enrollment||2
8515243|NCT00415597|20987950|P1|COMPLETED|Enrollment||465
8515244|NCT00415597|20987950|P1|STARTED|Enrollment||467
8515245|NCT00415532|20987958|P2|NOT COMPLETED|Safety Follow Up Period||12
8515246|NCT00415532|20987959|P1|NOT COMPLETED|Safety Follow Up Period||9
8515247|NCT00415532|20987958|P2|COMPLETED|Safety Follow Up Period||18
8515248|NCT00415532|20987959|P1|COMPLETED|Safety Follow Up Period||34
8515249|NCT00415532|20987958|P2|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
8515250|NCT00415532|20987959|P1|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
8515251|NCT00415532|20987958|P2|NOT COMPLETED|Treatment Period||15
8515252|NCT00415532|20987959|P1|NOT COMPLETED|Treatment Period||17
8515253|NCT00415532|20987958|P2|COMPLETED|Treatment Period||142
8515254|NCT00415532|20987959|P1|COMPLETED|Treatment Period||60
8515255|NCT00415532|20987958|P2|Switched to Romiplostim Group|Treatment Period||0
8515256|NCT00415532|20987959|P1|Switched to Romiplostim Group|Treatment Period||2
8515257|NCT00415532|20987958|P2|Received Treatment|Treatment Period||154
8515258|NCT00415532|20987959|P1|Received Treatment|Treatment Period||75
8515259|NCT00415532|20987958|P2|STARTED|Treatment Period||157
8515260|NCT00415532|20987959|P1|STARTED|Treatment Period||77
8515261|NCT00415519|20987981|P2|NOT COMPLETED|Overall Study||0
8515262|NCT00415519|20987982|P1|NOT COMPLETED|Overall Study||4
8515263|NCT00415519|20987981|P2|COMPLETED|Overall Study||12
8515264|NCT00415519|20987982|P1|COMPLETED|Overall Study||9
8515265|NCT00415519|20987981|P2|STARTED|Overall Study||12
8515266|NCT00415519|20987982|P1|STARTED|Overall Study||13
8515267|NCT00415506|20988002|P2|NOT COMPLETED|Overall Study||1
8515268|NCT00415506|20988003|P1|NOT COMPLETED|Overall Study||3
8515269|NCT00415506|20988002|P2|COMPLETED|Overall Study||9
8515270|NCT00415506|20988003|P1|COMPLETED|Overall Study||9
8515271|NCT00415506|20988002|P2|STARTED|Overall Study||10
8515272|NCT00415506|20988003|P1|STARTED|Overall Study||12
8515273|NCT00415493|20988013|P2|NOT COMPLETED|Overall Study||0
8515274|NCT00415493|20988014|P1|NOT COMPLETED|Overall Study||0
8515275|NCT00415493|20988013|P2|COMPLETED|Overall Study||12
8515276|NCT00415493|20988014|P1|COMPLETED|Overall Study||12
8515277|NCT00415493|20988013|P2|STARTED|Overall Study||12
8515278|NCT00415493|20988014|P1|STARTED|Overall Study||12
8515279|NCT00415363|20988022|P2|NOT COMPLETED|Overall Study||54
8515280|NCT00415363|20988023|P1|NOT COMPLETED|Overall Study||55
8515281|NCT00415363|20988022|P2|COMPLETED|Overall Study||0
8515282|NCT00415363|20988023|P1|COMPLETED|Overall Study||0
8515283|NCT00415363|20988022|P2|Safety Population|Overall Study||53
8515284|NCT00415363|20988023|P1|Safety Population|Overall Study||54
8515285|NCT00415363|20988022|P2|STARTED|Overall Study||54
8515286|NCT00415363|20988023|P1|STARTED|Overall Study||55
8515287|NCT00415194|20988053|P2|NOT COMPLETED|Overall Study||342
8515288|NCT00415194|20988054|P1|NOT COMPLETED|Overall Study||328
8515289|NCT00415194|20988053|P2|COMPLETED|Overall Study||55
8515290|NCT00415194|20988054|P1|COMPLETED|Overall Study||70
8515291|NCT00415194|20988053|P2|Received at Least 1 Dose of Study Drug|Overall Study||385
8515292|NCT00415194|20988054|P1|Received at Least 1 Dose of Study Drug|Overall Study||392
8515293|NCT00415194|20988053|P2|STARTED|Overall Study||397
8515294|NCT00415194|20988054|P1|STARTED|Overall Study||398
8515295|NCT00415168|20988070|P1|NOT COMPLETED|Overall Study||52
8515296|NCT00415168|20988070|P1|COMPLETED|Overall Study||1
8515297|NCT00415168|20988070|P1|Completed Treatment|Overall Study||15
8515298|NCT00415168|20988070|P1|STARTED|Overall Study||53
8515299|NCT00415051|20988080|P1|NOT COMPLETED|Overall Study||1
8515300|NCT00415051|20988080|P1|COMPLETED|Overall Study||19
8515301|NCT00415051|20988080|P1|STARTED|Overall Study||20
8515302|NCT00414973|20988091|P4|NOT COMPLETED|Overall Study||0
8515303|NCT00414973|20988092|P3|NOT COMPLETED|Overall Study||3
8515304|NCT00414973|20988093|P2|NOT COMPLETED|Overall Study||10
8515305|NCT00414973|20988094|P1|NOT COMPLETED|Overall Study||28
8515306|NCT00414973|20988091|P4|COMPLETED|Overall Study||11
8515307|NCT00414973|20988092|P3|COMPLETED|Overall Study||21
8515308|NCT00414973|20988093|P2|COMPLETED|Overall Study||99
8515309|NCT00414973|20988094|P1|COMPLETED|Overall Study||190
8515310|NCT00414973|20988091|P4|STARTED|Overall Study||11
8515311|NCT00414973|20988092|P3|STARTED|Overall Study||24
8515312|NCT00414973|20988093|P2|STARTED|Overall Study||109
8515313|NCT00414973|20988094|P1|STARTED|Overall Study||218
8515314|NCT00414960|20988114|P2|NOT COMPLETED|Overall Study||1
8515315|NCT00414960|20988115|P1|NOT COMPLETED|Overall Study||7
8515316|NCT00414960|20988114|P2|COMPLETED|Overall Study||14
8515317|NCT00414960|20988115|P1|COMPLETED|Overall Study||18
8515318|NCT00414960|20988114|P2|Received at Least One Dose of Study Drug|Overall Study||15
8515319|NCT00414960|20988115|P1|Received at Least One Dose of Study Drug|Overall Study||24
8515320|NCT00414960|20988114|P2|STARTED|Overall Study||15
8515321|NCT00414960|20988115|P1|STARTED|Overall Study||25
8515322|NCT00414908|20988125|P2|NOT COMPLETED|Overall Study||1
8515323|NCT00414908|20988126|P1|NOT COMPLETED|Overall Study||1
8515324|NCT00414908|20988125|P2|COMPLETED|Overall Study||28
8515325|NCT00414908|20988126|P1|COMPLETED|Overall Study||24
8515326|NCT00414908|20988125|P2|STARTED|Overall Study||29
8515327|NCT00414908|20988126|P1|STARTED|Overall Study||25
8515328|NCT00414817|20988150|P2|NOT COMPLETED|Overall Study||3016
8515329|NCT00414817|20988151|P1|NOT COMPLETED|Overall Study||3130
8515330|NCT00414817|20988150|P2|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
8515331|NCT00414817|20988151|P1|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
8515332|NCT00414817|20988150|P2|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
8515333|NCT00414817|20988151|P1|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
8515334|NCT00414817|20988150|P2|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
8515335|NCT00414817|20988151|P1|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
8515336|NCT00414817|20988150|P2|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
8515337|NCT00414817|20988151|P1|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
8515338|NCT00414817|20988150|P2|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
8515339|NCT00414817|20988151|P1|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
8515340|NCT00414817|20988150|P2|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
8515341|NCT00414817|20988151|P1|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
8515342|NCT00414817|20988150|P2|STARTED|Overall Study||7031
8515343|NCT00414817|20988151|P1|STARTED|Overall Study||7033
8515344|NCT00414726|20988163|P2|NOT COMPLETED|Overall Study||1
8515345|NCT00414726|20988164|P1|NOT COMPLETED|Overall Study||0
8515346|NCT00414726|20988163|P2|COMPLETED|Overall Study||41
8515347|NCT00414726|20988164|P1|COMPLETED|Overall Study||43
8515348|NCT00414726|20988163|P2|STARTED|Overall Study||42
8515349|NCT00414726|20988164|P1|STARTED|Overall Study||43
8515350|NCT00414700|20988174|P2|NOT COMPLETED|Overall Study||3
8515351|NCT00414700|20988175|P1|NOT COMPLETED|Overall Study||6
8515352|NCT00414700|20988174|P2|COMPLETED|Overall Study||58
8515353|NCT00414700|20988175|P1|COMPLETED|Overall Study||51
8515354|NCT00414700|20988174|P2|STARTED|Overall Study||61
8515355|NCT00414700|20988175|P1|STARTED|Overall Study||57
8515356|NCT00414661|20988199|P4|NOT COMPLETED|Overall Study||3
8515357|NCT00414661|20988200|P3|NOT COMPLETED|Overall Study||2
8515358|NCT00414661|20988201|P2|NOT COMPLETED|Overall Study||14
8515359|NCT00414661|20988202|P1|NOT COMPLETED|Overall Study||14
8515360|NCT00414661|20988199|P4|COMPLETED|Overall Study||0
8515361|NCT00414661|20988200|P3|COMPLETED|Overall Study||20
8515362|NCT00414661|20988201|P2|COMPLETED|Overall Study||75
8515363|NCT00414661|20988202|P1|COMPLETED|Overall Study||34
8515364|NCT00414661|20988199|P4|STARTED|Overall Study||3
8515365|NCT00414661|20988200|P3|STARTED|Overall Study||22
8515366|NCT00414661|20988201|P2|STARTED|Overall Study||89
8515367|NCT00414661|20988202|P1|STARTED|Overall Study||48
8515368|NCT00414635|20988226|P2|NOT COMPLETED|Overall Study||2
8515369|NCT00414635|20988227|P1|NOT COMPLETED|Overall Study||5
8515370|NCT00414635|20988226|P2|COMPLETED|Overall Study||28
8515371|NCT00414635|20988227|P1|COMPLETED|Overall Study||25
8515372|NCT00414635|20988226|P2|STARTED|Overall Study||30
8515373|NCT00414635|20988227|P1|STARTED|Overall Study||30
8515374|NCT00414609|20988247|P3|NOT COMPLETED|Extension Study||57
8515375|NCT00414609|20988248|P2|NOT COMPLETED|Extension Study||0
8515376|NCT00414609|20988249|P1|NOT COMPLETED|Extension Study||0
8515377|NCT00414609|20988247|P3|COMPLETED|Extension Study||365
8515378|NCT00414609|20988248|P2|COMPLETED|Extension Study||0
8515379|NCT00414609|20988249|P1|COMPLETED|Extension Study||0
8515380|NCT00414609|20988247|P3|Echocardiogram (ECHO) Analysis Set|Extension Study||400
8515381|NCT00414609|20988248|P2|Echocardiogram (ECHO) Analysis Set|Extension Study||0
8515382|NCT00414609|20988249|P1|Echocardiogram (ECHO) Analysis Set|Extension Study||0
8515383|NCT00414609|20988247|P3|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
8515384|NCT00414609|20988248|P2|STARTED|Extension Study||0
8515385|NCT00414609|20988249|P1|STARTED|Extension Study||0
8515386|NCT00414609|20988247|P3|NOT COMPLETED|Core Study||0
8515387|NCT00414609|20988248|P2|NOT COMPLETED|Core Study||45
8515388|NCT00414609|20988249|P1|NOT COMPLETED|Core Study||34
8515389|NCT00414609|20988247|P3|COMPLETED|Core Study||0
8515390|NCT00414609|20988248|P2|COMPLETED|Core Study||378
8515391|NCT00414609|20988249|P1|COMPLETED|Core Study||363
8515392|NCT00414609|20988247|P3|Echocardiogram Evaluable Set|Core Study||0
8515393|NCT00414609|20988248|P2|Echocardiogram Evaluable Set|Core Study||343
8515394|NCT00414609|20988249|P1|Echocardiogram Evaluable Set|Core Study||330
8515395|NCT00414609|20988247|P3|Received Study Drug|Core Study||0
8515396|NCT00414609|20988248|P2|Received Study Drug|Core Study||422
8515397|NCT00414609|20988249|P1|Received Study Drug|Core Study||397
8515398|NCT00414609|20988247|P3|STARTED|Core Study||0
8515399|NCT00414609|20988248|P2|STARTED|Core Study||423
8515400|NCT00414609|20988249|P1|STARTED|Core Study||397
8515401|NCT00414596|20988272|P1|NOT COMPLETED|Overall Study||2
8515402|NCT00414596|20988272|P1|COMPLETED|Overall Study|April 2007|18
8515403|NCT00414596|20988272|P1|STARTED|Overall Study|December 2006|20
8515404|NCT00414544|20988281|P1|NOT COMPLETED|Overall Study||14
8515405|NCT00414544|20988281|P1|COMPLETED|Overall Study||131
8515406|NCT00414544|20988281|P1|STARTED|Overall Study||145
8515407|NCT00414518|20988289|P2|NOT COMPLETED|Overall Study||0
8515408|NCT00414518|20988290|P1|NOT COMPLETED|Overall Study||0
8515409|NCT00414518|20988289|P2|COMPLETED|Overall Study||9
8515410|NCT00414518|20988290|P1|COMPLETED|Overall Study||7
8515411|NCT00414518|20988289|P2|STARTED|Overall Study||9
8515412|NCT00414518|20988290|P1|STARTED|Overall Study||7
8515413|NCT00414466|20988304|P4|NOT COMPLETED|Overall Study||1
8515414|NCT00414466|20988305|P3|NOT COMPLETED|Overall Study||1
8515415|NCT00414466|20988306|P2|NOT COMPLETED|Overall Study||0
8515416|NCT00414466|20988307|P1|NOT COMPLETED|Overall Study||2
8515417|NCT00414466|20988304|P4|COMPLETED|Overall Study||42
8515418|NCT00414466|20988305|P3|COMPLETED|Overall Study||40
8515419|NCT00414466|20988306|P2|COMPLETED|Overall Study||42
8515420|NCT00414466|20988307|P1|COMPLETED|Overall Study||42
8515421|NCT00414466|20988304|P4|STARTED|Overall Study||43
8515422|NCT00414466|20988305|P3|STARTED|Overall Study||41
8515423|NCT00414466|20988306|P2|STARTED|Overall Study||42
8515424|NCT00414466|20988307|P1|STARTED|Overall Study||44
8515425|NCT00414453|20988325|P1|NOT COMPLETED|Overall Study||16
8515426|NCT00414453|20988325|P1|COMPLETED|Overall Study||3
8515427|NCT00414453|20988325|P1|STARTED|Overall Study||19
8515428|NCT00414440|20988373|P2|NOT COMPLETED|Extension Period||140
8515429|NCT00414440|20988374|P1|NOT COMPLETED|Extension Period||150
8515430|NCT00414440|20988373|P2|COMPLETED|Extension Period|Extension|77
8515431|NCT00414440|20988374|P1|COMPLETED|Extension Period|Extension|64
8515432|NCT00414440|20988373|P2|STARTED|Extension Period|Extension|217
8515433|NCT00414440|20988374|P1|STARTED|Extension Period|Extension|214
8515434|NCT00414440|20988373|P2|NOT COMPLETED|Core Period||32
8515435|NCT00414440|20988374|P1|NOT COMPLETED|Core Period||70
8515436|NCT00414440|20988373|P2|COMPLETED|Core Period|Core period|185
8515437|NCT00414440|20988374|P1|COMPLETED|Core Period|Core period|144
8515438|NCT00414440|20988373|P2|STARTED|Core Period|Core period|217
8515439|NCT00414440|20988374|P1|STARTED|Core Period|Core period|214
8515440|NCT00414388|20988388|P1|NOT COMPLETED|Overall Study||1
8515441|NCT00414388|20988388|P1|COMPLETED|Overall Study||21
8515442|NCT00414388|20988388|P1|STARTED|Overall Study||22
8515443|NCT00414310|20988396|P2|NOT COMPLETED|Overall Study||0
8515444|NCT00414310|20988397|P1|NOT COMPLETED|Overall Study||1
8515445|NCT00414310|20988396|P2|COMPLETED|Overall Study||79
8515446|NCT00414310|20988397|P1|COMPLETED|Overall Study||70
8515447|NCT00414310|20988396|P2|STARTED|Overall Study||79
8515448|NCT00414310|20988397|P1|STARTED|Overall Study||71
8515449|NCT00414271|20988407|P1|NOT COMPLETED|Overall Study||0
8515450|NCT00414271|20988407|P1|COMPLETED|Overall Study||18
8515451|NCT00414271|20988407|P1|STARTED|Overall Study||18
8515452|NCT00414206|20988418|P3|NOT COMPLETED|Overall Study||55
8515453|NCT00414206|20988419|P2|NOT COMPLETED|Overall Study||56
8515454|NCT00414206|20988420|P1|NOT COMPLETED|Overall Study||58
8515455|NCT00414206|20988418|P3|COMPLETED|Overall Study||59
8515456|NCT00414206|20988419|P2|COMPLETED|Overall Study||58
8515457|NCT00414206|20988420|P1|COMPLETED|Overall Study||57
8515458|NCT00414206|20988418|P3|STARTED|Overall Study||114
8515459|NCT00414206|20988419|P2|STARTED|Overall Study||114
8515460|NCT00414206|20988420|P1|STARTED|Overall Study||115
8515461|NCT00414167|20988430|P2|NOT COMPLETED|Overall Study||3
8515462|NCT00414167|20988431|P1|NOT COMPLETED|Overall Study||4
8515463|NCT00414167|20988430|P2|COMPLETED|Overall Study||27
8515464|NCT00414167|20988431|P1|COMPLETED|Overall Study||27
8515465|NCT00414167|20988430|P2|STARTED|Overall Study||30
8515466|NCT00414167|20988431|P1|STARTED|Overall Study||31
8515467|NCT00414076|20988441|P2|NOT COMPLETED|Overall Study||5
8515468|NCT00414076|20988442|P1|NOT COMPLETED|Overall Study||3
8515469|NCT00414076|20988441|P2|COMPLETED|Overall Study||0
8515470|NCT00414076|20988442|P1|COMPLETED|Overall Study||1
8515471|NCT00414076|20988441|P2|STARTED|Overall Study||5
8515472|NCT00414076|20988442|P1|STARTED|Overall Study||4
8515473|NCT00414050|20988452|P4|NOT COMPLETED|Overall Study||8
8515474|NCT00414050|20988453|P3|NOT COMPLETED|Overall Study||6
8515475|NCT00414050|20988454|P2|NOT COMPLETED|Overall Study||8
8515476|NCT00414050|20988455|P1|NOT COMPLETED|Overall Study||9
8515477|NCT00414050|20988452|P4|COMPLETED|Overall Study||423
8515478|NCT00414050|20988453|P3|COMPLETED|Overall Study||423
8515479|NCT00414050|20988454|P2|COMPLETED|Overall Study||419
8515480|NCT00414050|20988455|P1|COMPLETED|Overall Study||422
8515481|NCT00414050|20988452|P4|Received Vaccination 3|Overall Study||424
8515482|NCT00414050|20988453|P3|Received Vaccination 3|Overall Study||425
8515483|NCT00414050|20988454|P2|Received Vaccination 3|Overall Study||419
8515484|NCT00414050|20988455|P1|Received Vaccination 3|Overall Study||424
8515485|NCT00414050|20988452|P4|Received Vaccination 2|Overall Study||425
8515486|NCT00414050|20988453|P3|Received Vaccination 2|Overall Study||425
8515487|NCT00414050|20988454|P2|Received Vaccination 2|Overall Study||421
8515488|NCT00414050|20988455|P1|Received Vaccination 2|Overall Study||425
8515489|NCT00414050|20988452|P4|Received Vaccination 1|Overall Study||431
8515490|NCT00414050|20988453|P3|Received Vaccination 1|Overall Study||429
8515491|NCT00414050|20988454|P2|Received Vaccination 1|Overall Study||426
8515492|NCT00414050|20988455|P1|Received Vaccination 1|Overall Study||431
8515493|NCT00414050|20988452|P4|STARTED|Overall Study||431
8515494|NCT00414050|20988453|P3|STARTED|Overall Study||429
8515495|NCT00414050|20988454|P2|STARTED|Overall Study||427
8515496|NCT00414050|20988455|P1|STARTED|Overall Study||431
8515497|NCT00414011|20988469|P1|NOT COMPLETED|Overall Study||5
8515498|NCT00414011|20988469|P1|COMPLETED|Overall Study||35
8515499|NCT00414011|20988469|P1|STARTED|Overall Study||40
8515500|NCT00413972|20988478|P4|NOT COMPLETED|Overall Study||3
8515501|NCT00413972|20988479|P3|NOT COMPLETED|Overall Study||10
8515502|NCT00413972|20988480|P2|NOT COMPLETED|Overall Study||8
8515503|NCT00413972|20988481|P1|NOT COMPLETED|Overall Study||7
8515504|NCT00413972|20988478|P4|COMPLETED|Overall Study||95
8515505|NCT00413972|20988479|P3|COMPLETED|Overall Study||88
8515506|NCT00413972|20988480|P2|COMPLETED|Overall Study||90
8515507|NCT00413972|20988481|P1|COMPLETED|Overall Study||91
8515508|NCT00413972|20988478|P4|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
8515509|NCT00413972|20988479|P3|STARTED|Overall Study||98
8515510|NCT00413972|20988480|P2|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
8515511|NCT00413972|20988481|P1|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
8515512|NCT00413959|20988491|P1|NOT COMPLETED|Overall Study||1
8515513|NCT00413959|20988491|P1|COMPLETED|Overall Study||11
8515514|NCT00413959|20988491|P1|STARTED|Overall Study||12
8515515|NCT00413920|20988498|P2|NOT COMPLETED|Overall Study||28
8515516|NCT00413920|20988499|P1|NOT COMPLETED|Overall Study||28
8515517|NCT00413920|20988498|P2|COMPLETED|Overall Study||82
8515518|NCT00413920|20988499|P1|COMPLETED|Overall Study||84
8515519|NCT00413920|20988498|P2|STARTED|Overall Study||110
8515520|NCT00413920|20988499|P1|STARTED|Overall Study||112
8515521|NCT00413894|20988514|P1|NOT COMPLETED|Overall Study||80
8515522|NCT00413894|20988514|P1|COMPLETED|Overall Study||344
8515523|NCT00413894|20988514|P1|STARTED|Overall Study||424
8515524|NCT00413777|20988531|P2|NOT COMPLETED|Extension Period||0
8515525|NCT00413777|20988532|P1|NOT COMPLETED|Extension Period||0
8515526|NCT00413777|20988531|P2|COMPLETED|Extension Period||18
8515527|NCT00413777|20988532|P1|COMPLETED|Extension Period||17
8515528|NCT00413777|20988531|P2|STARTED|Extension Period||18
8515529|NCT00413777|20988532|P1|STARTED|Extension Period||17
8515530|NCT00413777|20988531|P2|NOT COMPLETED|Fixed-dose Period||3
8515531|NCT00413777|20988532|P1|NOT COMPLETED|Fixed-dose Period||4
8515532|NCT00413777|20988531|P2|COMPLETED|Fixed-dose Period||21
8515533|NCT00413777|20988532|P1|COMPLETED|Fixed-dose Period||18
8515534|NCT00413777|20988531|P2|STARTED|Fixed-dose Period||24
8515535|NCT00413777|20988532|P1|STARTED|Fixed-dose Period||22
8515536|NCT00413699|20988580|P3|NOT COMPLETED|Extension Period||5
8515537|NCT00413699|20988581|P2|NOT COMPLETED|Extension Period||0
8515538|NCT00413699|20988582|P1|NOT COMPLETED|Extension Period||0
8515539|NCT00413699|20988580|P3|COMPLETED|Extension Period||43
8515540|NCT00413699|20988581|P2|COMPLETED|Extension Period||0
8515541|NCT00413699|20988582|P1|COMPLETED|Extension Period||0
8515542|NCT00413699|20988580|P3|STARTED|Extension Period||48
8515543|NCT00413699|20988581|P2|STARTED|Extension Period||0
8515544|NCT00413699|20988582|P1|STARTED|Extension Period||0
8515545|NCT00413699|20988580|P3|NOT COMPLETED|Initial Period||0
8515546|NCT00413699|20988581|P2|NOT COMPLETED|Initial Period||1705
8515547|NCT00413699|20988582|P1|NOT COMPLETED|Initial Period||639
8515548|NCT00413699|20988580|P3|COMPLETED|Initial Period||0
8515549|NCT00413699|20988581|P2|COMPLETED|Initial Period||1653
8515550|NCT00413699|20988582|P1|COMPLETED|Initial Period||484
8515551|NCT00413699|20988580|P3|STARTED|Initial Period||0
8515552|NCT00413699|20988581|P2|STARTED|Initial Period||3358
8515553|NCT00413699|20988582|P1|STARTED|Initial Period||1123
8515554|NCT00413660|20988664|P11|NOT COMPLETED|Post Week 12||1
8515555|NCT00413660|20988665|P10|NOT COMPLETED|Post Week 12||1
8515556|NCT00413660|20988666|P9|NOT COMPLETED|Post Week 12||0
8515557|NCT00413660|20988667|P8|NOT COMPLETED|Post Week 12||0
8515558|NCT00413660|20988668|P7|NOT COMPLETED|Post Week 12||3
8515559|NCT00413660|20988669|P6|NOT COMPLETED|Post Week 12||3
8515560|NCT00413660|20988670|P5|NOT COMPLETED|Post Week 12||6
8515561|NCT00413660|20988671|P4|NOT COMPLETED|Post Week 12||1
8515562|NCT00413660|20988672|P3|NOT COMPLETED|Post Week 12||8
8515563|NCT00413660|20988673|P2|NOT COMPLETED|Post Week 12||4
8515564|NCT00413660|20988674|P1|NOT COMPLETED|Post Week 12||3
8515565|NCT00413660|20988664|P11|COMPLETED|Post Week 12||17
8515566|NCT00413660|20988665|P10|COMPLETED|Post Week 12||12
8515567|NCT00413660|20988666|P9|COMPLETED|Post Week 12||13
8515568|NCT00413660|20988667|P8|COMPLETED|Post Week 12||21
8515569|NCT00413660|20988668|P7|COMPLETED|Post Week 12||37
8515570|NCT00413660|20988669|P6|COMPLETED|Post Week 12||54
8515571|NCT00413660|20988670|P5|COMPLETED|Post Week 12||60
8515572|NCT00413660|20988671|P4|COMPLETED|Post Week 12||66
8515573|NCT00413660|20988672|P3|COMPLETED|Post Week 12||56
8515574|NCT00413660|20988673|P2|COMPLETED|Post Week 12||44
8515575|NCT00413660|20988674|P1|COMPLETED|Post Week 12||40
8515576|NCT00413660|20988664|P11|STARTED|Post Week 12||18
8515577|NCT00413660|20988665|P10|STARTED|Post Week 12||13
8515578|NCT00413660|20988666|P9|STARTED|Post Week 12||13
8515579|NCT00413660|20988667|P8|STARTED|Post Week 12||21
8515580|NCT00413660|20988668|P7|STARTED|Post Week 12||40
8515581|NCT00413660|20988669|P6|STARTED|Post Week 12||57
8515582|NCT00413660|20988670|P5|STARTED|Post Week 12||66
8515583|NCT00413660|20988671|P4|STARTED|Post Week 12||67
8515584|NCT00413660|20988672|P3|STARTED|Post Week 12||64
8515585|NCT00413660|20988673|P2|STARTED|Post Week 12||48
8515586|NCT00413660|20988674|P1|STARTED|Post Week 12||43
8515587|NCT00413660|20988664|P11|NOT COMPLETED|Up To Week 12||0
8515588|NCT00413660|20988665|P10|NOT COMPLETED|Up To Week 12||0
8515589|NCT00413660|20988666|P9|NOT COMPLETED|Up To Week 12||0
8515590|NCT00413660|20988667|P8|NOT COMPLETED|Up To Week 12||0
8515591|NCT00413660|20988668|P7|NOT COMPLETED|Up To Week 12||11
8515592|NCT00413660|20988669|P6|NOT COMPLETED|Up To Week 12||10
8515593|NCT00413660|20988670|P5|NOT COMPLETED|Up To Week 12||9
8515594|NCT00413660|20988671|P4|NOT COMPLETED|Up To Week 12||8
8515595|NCT00413660|20988672|P3|NOT COMPLETED|Up To Week 12||7
8515596|NCT00413660|20988673|P2|NOT COMPLETED|Up To Week 12||7
8515597|NCT00413660|20988674|P1|NOT COMPLETED|Up To Week 12||7
8515598|NCT00413660|20988664|P11|COMPLETED|Up To Week 12||0
8515599|NCT00413660|20988665|P10|COMPLETED|Up To Week 12||0
8515600|NCT00413660|20988666|P9|COMPLETED|Up To Week 12||0
8515601|NCT00413660|20988667|P8|COMPLETED|Up To Week 12||0
8515602|NCT00413660|20988668|P7|COMPLETED|Up To Week 12||58
8515603|NCT00413660|20988669|P6|COMPLETED|Up To Week 12||70
8515604|NCT00413660|20988670|P5|COMPLETED|Up To Week 12||66
8515605|NCT00413660|20988671|P4|COMPLETED|Up To Week 12||67
8515606|NCT00413660|20988672|P3|COMPLETED|Up To Week 12||64
8515607|NCT00413660|20988673|P2|COMPLETED|Up To Week 12||61
8515608|NCT00413660|20988674|P1|COMPLETED|Up To Week 12||64
8515609|NCT00413660|20988664|P11|Treated|Up To Week 12||0
8515610|NCT00413660|20988665|P10|Treated|Up To Week 12||0
8515611|NCT00413660|20988666|P9|Treated|Up To Week 12||0
8515612|NCT00413660|20988667|P8|Treated|Up To Week 12||0
8515613|NCT00413660|20988668|P7|Treated|Up To Week 12||69
8515614|NCT00413660|20988669|P6|Treated|Up To Week 12||80
8515615|NCT00413660|20988670|P5|Treated|Up To Week 12||75
8515616|NCT00413660|20988671|P4|Treated|Up To Week 12||74
8515617|NCT00413660|20988672|P3|Treated|Up To Week 12||71
8515618|NCT00413660|20988673|P2|Treated|Up To Week 12||68
8515619|NCT00413660|20988674|P1|Treated|Up To Week 12||70
8515620|NCT00413660|20988664|P11|STARTED|Up To Week 12||0
8515621|NCT00413660|20988665|P10|STARTED|Up To Week 12||0
8515622|NCT00413660|20988666|P9|STARTED|Up To Week 12||0
8515623|NCT00413660|20988667|P8|STARTED|Up To Week 12||0
8515624|NCT00413660|20988668|P7|STARTED|Up To Week 12||69
8515625|NCT00413660|20988669|P6|STARTED|Up To Week 12||80
8515626|NCT00413660|20988670|P5|STARTED|Up To Week 12||75
8515627|NCT00413660|20988671|P4|STARTED|Up To Week 12||75
8515628|NCT00413660|20988672|P3|STARTED|Up To Week 12||71
8515629|NCT00413660|20988673|P2|STARTED|Up To Week 12||68
8515630|NCT00413660|20988674|P1|STARTED|Up To Week 12||71
8515637|NCT00413582|20989061|P2|NOT COMPLETED|Overall Study||0
8515638|NCT00413582|20989062|P1|NOT COMPLETED|Overall Study||0
8515639|NCT00413582|20989061|P2|COMPLETED|Overall Study|all enrolled completed|55
8515640|NCT00413582|20989062|P1|COMPLETED|Overall Study|all enrolled completed|55
8515641|NCT00413582|20989061|P2|Completion of Study|Overall Study|all enrolled completed|55
8515642|NCT00413582|20989062|P1|Completion of Study|Overall Study|all enrolled completed|55
8515643|NCT00413582|20989061|P2|STARTED|Overall Study|all enrolled completed|55
8515644|NCT00413582|20989062|P1|STARTED|Overall Study|all enrolled completed|55
8515645|NCT00413478|20989070|P1|NOT COMPLETED|Overall Study||0
8515646|NCT00413478|20989070|P1|COMPLETED|Overall Study||9
8515647|NCT00413478|20989070|P1|STARTED|Overall Study||9
8515648|NCT00413413|20989077|P3|NOT COMPLETED|Double-Blind||18
8515649|NCT00413413|20989078|P2|NOT COMPLETED|Double-Blind||14
8515650|NCT00413413|20989079|P1|NOT COMPLETED|Double-Blind||15
8515651|NCT00413413|20989077|P3|COMPLETED|Double-Blind||285
8515652|NCT00413413|20989078|P2|COMPLETED|Double-Blind||293
8515653|NCT00413413|20989079|P1|COMPLETED|Double-Blind||293
8515654|NCT00413413|20989077|P3|STARTED|Double-Blind||303
8515655|NCT00413413|20989078|P2|STARTED|Double-Blind||307
8515656|NCT00413413|20989079|P1|STARTED|Double-Blind||308
8515657|NCT00413413|20989077|P3|NOT COMPLETED|Single-Blind||0
8515658|NCT00413413|20989078|P2|NOT COMPLETED|Single-Blind||216
8515659|NCT00413413|20989079|P1|NOT COMPLETED|Single-Blind||0
8515660|NCT00413413|20989077|P3|COMPLETED|Single-Blind||0
8515661|NCT00413413|20989078|P2|COMPLETED|Single-Blind||918
8515662|NCT00413413|20989079|P1|COMPLETED|Single-Blind||0
8515663|NCT00413413|20989077|P3|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
8515664|NCT00413413|20989078|P2|STARTED|Single-Blind||1134
8515665|NCT00413413|20989079|P1|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
8515666|NCT00413400|20989101|P2|NOT COMPLETED|Overall Study||4
8515667|NCT00413400|20989102|P1|NOT COMPLETED|Overall Study||2
8515668|NCT00413400|20989101|P2|COMPLETED|Overall Study||12
8515669|NCT00413400|20989102|P1|COMPLETED|Overall Study||22
8515670|NCT00413400|20989101|P2|3 Month Visit|Overall Study||12
8515671|NCT00413400|20989102|P1|3 Month Visit|Overall Study||22
8515672|NCT00413400|20989101|P2|STARTED|Overall Study||16
8515673|NCT00413400|20989102|P1|STARTED|Overall Study||24
8515674|NCT00413374|20989132|P2|NOT COMPLETED|Overall Study||0
8515675|NCT00413374|20989133|P1|NOT COMPLETED|Overall Study||6
8515676|NCT00413374|20989132|P2|COMPLETED|Overall Study||80
8515677|NCT00413374|20989133|P1|COMPLETED|Overall Study||34
8515678|NCT00413374|20989132|P2|STARTED|Overall Study||80
8515679|NCT00413374|20989133|P1|STARTED|Overall Study||40
8515680|NCT00413335|20989145|P2|NOT COMPLETED|Overall Study||0
8515681|NCT00413335|20989146|P1|NOT COMPLETED|Overall Study||0
8515682|NCT00413335|20989145|P2|COMPLETED|Overall Study||9
8515683|NCT00413335|20989146|P1|COMPLETED|Overall Study||12
8515684|NCT00413335|20989145|P2|STARTED|Overall Study||9
8515685|NCT00413335|20989146|P1|STARTED|Overall Study||12
8515686|NCT00413283|20989164|P4|NOT COMPLETED|Overall Study||4
8515687|NCT00413283|20989165|P3|NOT COMPLETED|Overall Study||2
8515688|NCT00413283|20989166|P2|NOT COMPLETED|Overall Study||3
8515689|NCT00413283|20989167|P1|NOT COMPLETED|Overall Study||1
8515690|NCT00413283|20989164|P4|COMPLETED|Overall Study||13
8515691|NCT00413283|20989165|P3|COMPLETED|Overall Study||16
8515692|NCT00413283|20989166|P2|COMPLETED|Overall Study||13
8515693|NCT00413283|20989167|P1|COMPLETED|Overall Study||11
8515694|NCT00413283|20989164|P4|Received Study Drug|Overall Study||16
8515695|NCT00413283|20989165|P3|Received Study Drug|Overall Study||18
8515696|NCT00413283|20989166|P2|Received Study Drug|Overall Study||16
8515697|NCT00413283|20989167|P1|Received Study Drug|Overall Study||12
8515698|NCT00413283|20989164|P4|STARTED|Overall Study||17
8515699|NCT00413283|20989165|P3|STARTED|Overall Study||18
8515700|NCT00413283|20989166|P2|STARTED|Overall Study||16
8515701|NCT00413283|20989167|P1|STARTED|Overall Study||12
8515702|NCT00413244|20989199|P2|NOT COMPLETED|Overall Study||1
8515703|NCT00413244|20989200|P1|NOT COMPLETED|Overall Study||10
8515704|NCT00413244|20989199|P2|COMPLETED|Overall Study||19
8515705|NCT00413244|20989200|P1|COMPLETED|Overall Study||21
8515706|NCT00413244|20989199|P2|STARTED|Overall Study||20
8515707|NCT00413244|20989200|P1|STARTED|Overall Study||31
8515708|NCT00413231|20989228|P1|NOT COMPLETED|365-day to 60-month Post Treatment||46
8515709|NCT00413231|20989228|P1|COMPLETED|365-day to 60-month Post Treatment||93
8515710|NCT00413231|20989228|P1|STARTED|365-day to 60-month Post Treatment||139
8515711|NCT00413231|20989228|P1|NOT COMPLETED|30-day to 365-day Post Treatment||13
8515712|NCT00413231|20989228|P1|COMPLETED|30-day to 365-day Post Treatment||139
8515713|NCT00413231|20989228|P1|STARTED|30-day to 365-day Post Treatment||152
8515714|NCT00413231|20989228|P1|NOT COMPLETED|0 to 30-day Post Treatment||8
8515715|NCT00413231|20989228|P1|COMPLETED|0 to 30-day Post Treatment||152
8515716|NCT00413231|20989228|P1|STARTED|0 to 30-day Post Treatment||160
8515717|NCT00413218|20989260|P2|NOT COMPLETED|Overall Study||96
8515718|NCT00413218|20989261|P1|NOT COMPLETED|Overall Study||103
8515719|NCT00413218|20989260|P2|COMPLETED|Overall Study||131
8515720|NCT00413218|20989261|P1|COMPLETED|Overall Study||120
8515721|NCT00413218|20989260|P2|Intent to Treat Population (ITT)|Overall Study||219
8515722|NCT00413218|20989261|P1|Intent to Treat Population (ITT)|Overall Study||221
8515723|NCT00413218|20989260|P2|STARTED|Overall Study||227
8515724|NCT00413218|20989261|P1|STARTED|Overall Study||223
8515725|NCT00413192|20989287|P4|NOT COMPLETED|Overall Study||32
8515726|NCT00413192|20989288|P3|NOT COMPLETED|Overall Study||19
8515727|NCT00413192|20989289|P2|NOT COMPLETED|Overall Study||40
8515728|NCT00413192|20989290|P1|NOT COMPLETED|Overall Study||37
8515729|NCT00413192|20989287|P4|COMPLETED|Overall Study||0
8515730|NCT00413192|20989288|P3|COMPLETED|Overall Study||0
8515731|NCT00413192|20989289|P2|COMPLETED|Overall Study||0
8515732|NCT00413192|20989290|P1|COMPLETED|Overall Study||0
8515733|NCT00413192|20989287|P4|STARTED|Overall Study||32
8515734|NCT00413192|20989288|P3|STARTED|Overall Study||19
8515735|NCT00413192|20989289|P2|STARTED|Overall Study||40
8515736|NCT00413192|20989290|P1|STARTED|Overall Study||37
8515737|NCT00413166|20989331|P3|NOT COMPLETED|Overall Study||0
8515738|NCT00413166|20989332|P2|NOT COMPLETED|Overall Study||0
8515739|NCT00413166|20989333|P1|NOT COMPLETED|Overall Study||0
8515740|NCT00413166|20989331|P3|COMPLETED|Overall Study||16
8515741|NCT00413166|20989332|P2|COMPLETED|Overall Study||5
8515742|NCT00413166|20989333|P1|COMPLETED|Overall Study||57
8515743|NCT00413166|20989331|P3|STARTED|Overall Study||16
8515744|NCT00413166|20989332|P2|STARTED|Overall Study||5
8515745|NCT00413166|20989333|P1|STARTED|Overall Study||57
8515746|NCT00413153|20989343|P2|NOT COMPLETED|Overall Study||1
8515747|NCT00413153|20989344|P1|NOT COMPLETED|Overall Study||2
8515748|NCT00413153|20989343|P2|COMPLETED|Overall Study||7
8515749|NCT00413153|20989344|P1|COMPLETED|Overall Study||5
8515750|NCT00413153|20989343|P2|STARTED|Overall Study||8
8515751|NCT00413153|20989344|P1|STARTED|Overall Study||7
8515752|NCT00413062|20989368|P2|NOT COMPLETED|Overall Study||210
8515753|NCT00413062|20989369|P1|NOT COMPLETED|Overall Study||678
8515754|NCT00413062|20989368|P2|COMPLETED|Overall Study||344
8515755|NCT00413062|20989369|P1|COMPLETED|Overall Study||988
8515756|NCT00413062|20989368|P2|STARTED|Overall Study||554
8515757|NCT00413062|20989369|P1|STARTED|Overall Study||1666
8515758|NCT00413049|20989395|P2|NOT COMPLETED|Overall Study||18
8515759|NCT00413049|20989396|P1|NOT COMPLETED|Overall Study||24
8515760|NCT00413049|20989395|P2|COMPLETED|Overall Study||331
8515761|NCT00413049|20989396|P1|COMPLETED|Overall Study||325
8515762|NCT00413049|20989395|P2|STARTED|Overall Study||349
8515763|NCT00413049|20989396|P1|STARTED|Overall Study||349
8515764|NCT00413036|20989412|P1|NOT COMPLETED|Overall Study||217
8515765|NCT00413036|20989412|P1|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
8515766|NCT00413036|20989412|P1|STARTED|Overall Study||217
8515773|NCT00412984|20989445|P2|NOT COMPLETED|Overall Study||2493
8515774|NCT00412984|20989446|P1|NOT COMPLETED|Overall Study||2310
8515775|NCT00412984|20989445|P2|COMPLETED|Overall Study||6588
8515776|NCT00412984|20989446|P1|COMPLETED|Overall Study||6810
8515777|NCT00412984|20989445|P2|STARTED|Overall Study|Randomized participants|9081
8515778|NCT00412984|20989446|P1|STARTED|Overall Study|Randomized participants|9120
8515779|NCT00412971|20989490|P2|NOT COMPLETED|Overall Study||10
8515780|NCT00412971|20989491|P1|NOT COMPLETED|Overall Study||30
8515781|NCT00412971|20989490|P2|COMPLETED|Overall Study||108
8515782|NCT00412971|20989491|P1|COMPLETED|Overall Study||85
8515783|NCT00412971|20989490|P2|STARTED|Overall Study||118
8515784|NCT00412971|20989491|P1|STARTED|Overall Study||115
8515785|NCT00412958|20989504|P4|NOT COMPLETED|Overall Study||1
8515786|NCT00412958|20989505|P3|NOT COMPLETED|Overall Study||0
8515787|NCT00412958|20989506|P2|NOT COMPLETED|Overall Study||4
8515788|NCT00412958|20989507|P1|NOT COMPLETED|Overall Study||3
8515789|NCT00412958|20989504|P4|COMPLETED|Overall Study||30
8515790|NCT00412958|20989505|P3|COMPLETED|Overall Study||32
8515791|NCT00412958|20989506|P2|COMPLETED|Overall Study||29
8515792|NCT00412958|20989507|P1|COMPLETED|Overall Study||26
8515793|NCT00412958|20989504|P4|STARTED|Overall Study||31
8515794|NCT00412958|20989505|P3|STARTED|Overall Study||32
8515795|NCT00412958|20989506|P2|STARTED|Overall Study||33
8515796|NCT00412958|20989507|P1|STARTED|Overall Study||29
8515797|NCT00412932|20989517|P1|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
8515798|NCT00412932|20989517|P1|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
8515799|NCT00412932|20989517|P1|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
8515800|NCT00412932|20989517|P1|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
8515801|NCT00412932|20989517|P1|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
8515802|NCT00412932|20989517|P1|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
8515803|NCT00412932|20989517|P1|NOT COMPLETED|Olmesartan 40 mg||8
8515804|NCT00412932|20989517|P1|COMPLETED|Olmesartan 40 mg||161
8515805|NCT00412932|20989517|P1|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
8515806|NCT00412932|20989517|P1|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
8515807|NCT00412932|20989517|P1|COMPLETED|Olmesartan (Olm) 20 mg||171
8515808|NCT00412932|20989517|P1|STARTED|Olmesartan (Olm) 20 mg||178
8515809|NCT00412893|20989528|P2|NOT COMPLETED|Overall Study||144
8515810|NCT00412893|20989529|P1|NOT COMPLETED|Overall Study||145
8515811|NCT00412893|20989528|P2|COMPLETED|Overall Study|Defined as completed treatment|120
8515812|NCT00412893|20989529|P1|COMPLETED|Overall Study|Defined as completed treatment|118
8515813|NCT00412893|20989528|P2|Received Treatment|Overall Study||258
8515814|NCT00412893|20989529|P1|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
8515815|NCT00412893|20989528|P2|STARTED|Overall Study||264
8515816|NCT00412893|20989529|P1|STARTED|Overall Study||263
8515817|NCT00412867|20989555|P1|NOT COMPLETED|Overall Study||0
8515818|NCT00412867|20989555|P1|COMPLETED|Overall Study||58
8515819|NCT00412867|20989555|P1|STARTED|Overall Study||58
8515820|NCT00412854|20989567|P2|NOT COMPLETED|Overall Study||16
8515821|NCT00412854|20989568|P1|NOT COMPLETED|Overall Study||14
8515822|NCT00412854|20989567|P2|COMPLETED|Overall Study||314
8515823|NCT00412854|20989568|P1|COMPLETED|Overall Study||316
8515824|NCT00412854|20989567|P2|STARTED|Overall Study||330
8515825|NCT00412854|20989568|P1|STARTED|Overall Study||330
8515826|NCT00412841|20989596|P2|NOT COMPLETED|Overall Study||5
8515827|NCT00412841|20989597|P1|NOT COMPLETED|Overall Study||10
8515828|NCT00412841|20989596|P2|COMPLETED|Overall Study||16
8515829|NCT00412841|20989597|P1|COMPLETED|Overall Study||12
8515830|NCT00412841|20989596|P2|STARTED|Overall Study||21
8515831|NCT00412841|20989597|P1|STARTED|Overall Study||22
8515832|NCT00412750|20989612|P3|NOT COMPLETED|Overall Study||23
8515833|NCT00412750|20989613|P2|NOT COMPLETED|Overall Study||21
8515834|NCT00412750|20989614|P1|NOT COMPLETED|Overall Study||31
8515835|NCT00412750|20989612|P3|COMPLETED|Overall Study||31
8515836|NCT00412750|20989613|P2|COMPLETED|Overall Study||34
8515837|NCT00412750|20989614|P1|COMPLETED|Overall Study||19
8515838|NCT00412750|20989612|P3|STARTED|Overall Study||54
8515839|NCT00412750|20989613|P2|STARTED|Overall Study||55
8515840|NCT00412750|20989614|P1|STARTED|Overall Study||50
8515841|NCT00412737|20989639|P2|NOT COMPLETED|Overall Study||6
8515842|NCT00412737|20989640|P1|NOT COMPLETED|Overall Study||16
8515843|NCT00412737|20989639|P2|COMPLETED|Overall Study||232
8515844|NCT00412737|20989640|P1|COMPLETED|Overall Study||221
8515845|NCT00412737|20989639|P2|STARTED|Overall Study||238
8515846|NCT00412737|20989640|P1|STARTED|Overall Study||237
8515847|NCT00412607|20989658|P1|NOT COMPLETED|Overall Study||104
8515848|NCT00412607|20989658|P1|COMPLETED|Overall Study||145
8515849|NCT00412607|20989658|P1|Started Study Catheter|Overall Study||233
8515850|NCT00412607|20989658|P1|STARTED|Overall Study||249
8515851|NCT00412542|20989671|P2|NOT COMPLETED|Overall Study||3
8515852|NCT00412542|20989672|P1|NOT COMPLETED|Overall Study||0
8515853|NCT00412542|20989671|P2|COMPLETED|Overall Study||42
8515854|NCT00412542|20989672|P1|COMPLETED|Overall Study||33
8515855|NCT00412542|20989671|P2|STARTED|Overall Study||45
8515856|NCT00412542|20989672|P1|STARTED|Overall Study||33
8515857|NCT00412529|20989678|P2|NOT COMPLETED|Overall Study||0
8515858|NCT00412529|20989679|P1|NOT COMPLETED|Overall Study||0
8515859|NCT00412529|20989678|P2|COMPLETED|Overall Study||21
8515860|NCT00412529|20989679|P1|COMPLETED|Overall Study||23
8515861|NCT00412529|20989678|P2|STARTED|Overall Study||21
8515862|NCT00412529|20989679|P1|STARTED|Overall Study||23
8515863|NCT00412516|20989702|P3|NOT COMPLETED|Overall Study||0
8515864|NCT00412516|20989703|P2|NOT COMPLETED|Overall Study||0
8515865|NCT00412516|20989704|P1|NOT COMPLETED|Overall Study||0
8515866|NCT00412516|20989702|P3|COMPLETED|Overall Study||214
8515867|NCT00412516|20989703|P2|COMPLETED|Overall Study||212
8515868|NCT00412516|20989704|P1|COMPLETED|Overall Study||93
8515869|NCT00412516|20989702|P3|STARTED|Overall Study||214
8515870|NCT00412516|20989703|P2|STARTED|Overall Study||212
8515871|NCT00412516|20989704|P1|STARTED|Overall Study||93
8515872|NCT00412464|20989721|P1|NOT COMPLETED|Overall Study||0
8515873|NCT00412464|20989721|P1|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
8515874|NCT00412464|20989721|P1|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
8515875|NCT00412451|20989733|P4|NOT COMPLETED|Overall Study||2
8515876|NCT00412451|20989734|P3|NOT COMPLETED|Overall Study||1
8515877|NCT00412451|20989735|P2|NOT COMPLETED|Overall Study||0
8515878|NCT00412451|20989736|P1|NOT COMPLETED|Overall Study||0
8515879|NCT00412451|20989733|P4|COMPLETED|Overall Study||11
8515880|NCT00412451|20989734|P3|COMPLETED|Overall Study||14
8515881|NCT00412451|20989735|P2|COMPLETED|Overall Study||15
8515882|NCT00412451|20989736|P1|COMPLETED|Overall Study||8
8515883|NCT00412451|20989733|P4|STARTED|Overall Study||13
8515884|NCT00412451|20989734|P3|STARTED|Overall Study||15
8515885|NCT00412451|20989735|P2|STARTED|Overall Study||15
8515886|NCT00412451|20989736|P1|STARTED|Overall Study||8
8515887|NCT00412425|20989748|P2|NOT COMPLETED|Overall Study||0
8515888|NCT00412425|20989749|P1|NOT COMPLETED|Overall Study||0
8515889|NCT00412425|20989748|P2|COMPLETED|Overall Study||15
8515890|NCT00412425|20989749|P1|COMPLETED|Overall Study||15
8515891|NCT00412425|20989748|P2|STARTED|Overall Study||15
8515892|NCT00412425|20989749|P1|STARTED|Overall Study||15
8515893|NCT00412373|20989757|P2|NOT COMPLETED|Overall Study||77
8515894|NCT00412373|20989758|P1|NOT COMPLETED|Overall Study||41
8515895|NCT00412373|20989757|P2|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
8515896|NCT00412373|20989758|P1|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
8515897|NCT00412373|20989757|P2|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
8515898|NCT00412373|20989758|P1|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
8515899|NCT00412360|20989800|P2|NOT COMPLETED|Overall Study||3
8515900|NCT00412360|20989801|P1|NOT COMPLETED|Overall Study||1
8515901|NCT00412360|20989800|P2|COMPLETED|Overall Study||108
8515902|NCT00412360|20989801|P1|COMPLETED|Overall Study||112
8515903|NCT00412360|20989800|P2|STARTED|Overall Study||111
8515904|NCT00412360|20989801|P1|STARTED|Overall Study||113
8515905|NCT00412243|20989825|P1|NOT COMPLETED|Overall Study||0
8515906|NCT00412243|20989825|P1|COMPLETED|Overall Study||50
8515907|NCT00412243|20989825|P1|STARTED|Overall Study||50
8515908|NCT00412217|20989831|P2|NOT COMPLETED|Overall Study||48
8515909|NCT00412217|20989832|P1|NOT COMPLETED|Overall Study||46
8515910|NCT00412217|20989831|P2|COMPLETED|Overall Study||0
8515911|NCT00412217|20989832|P1|COMPLETED|Overall Study||0
8515912|NCT00412217|20989831|P2|STARTED|Overall Study||48
8515913|NCT00412217|20989832|P1|STARTED|Overall Study||46
8515922|NCT00412087|20989901|P2|NOT COMPLETED|Overall Study||65
8515923|NCT00412087|20989902|P1|NOT COMPLETED|Overall Study||62
8515924|NCT00412087|20989901|P2|COMPLETED|Overall Study||66
8515925|NCT00412087|20989902|P1|COMPLETED|Overall Study||72
8515926|NCT00412087|20989901|P2|STARTED|Overall Study||131
8515927|NCT00412087|20989902|P1|STARTED|Overall Study||134
8515928|NCT00412074|20989913|P3|NOT COMPLETED|Overall Study||67
8515929|NCT00412074|20989914|P2|NOT COMPLETED|Overall Study||22
8515930|NCT00412074|20989915|P1|NOT COMPLETED|Overall Study||77
8515931|NCT00412074|20989913|P3|COMPLETED|Overall Study||128
8515932|NCT00412074|20989914|P2|COMPLETED|Overall Study||44
8515933|NCT00412074|20989915|P1|COMPLETED|Overall Study||122
8515934|NCT00412074|20989913|P3|STARTED|Overall Study||195
8515935|NCT00412074|20989914|P2|STARTED|Overall Study||66
8515936|NCT00412074|20989915|P1|STARTED|Overall Study||199
8515937|NCT00412061|20989931|P2|NOT COMPLETED|Open Label Phase||170
8515938|NCT00412061|20989932|P1|NOT COMPLETED|Open Label Phase||0
8515939|NCT00412061|20989931|P2|COMPLETED|Open Label Phase||0
8515940|NCT00412061|20989932|P1|COMPLETED|Open Label Phase||0
8515941|NCT00412061|20989931|P2|STARTED|Open Label Phase||170
8515942|NCT00412061|20989932|P1|STARTED|Open Label Phase||0
8515943|NCT00412061|20989931|P2|NOT COMPLETED|Double Blind Phase||213
8515944|NCT00412061|20989932|P1|NOT COMPLETED|Double Blind Phase||216
8515945|NCT00412061|20989931|P2|COMPLETED|Double Blind Phase||0
8515946|NCT00412061|20989932|P1|COMPLETED|Double Blind Phase||0
8515947|NCT00412061|20989931|P2|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
8515948|NCT00412061|20989932|P1|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
8515949|NCT00412061|20989931|P2|STARTED|Double Blind Phase||213
8515950|NCT00412061|20989932|P1|STARTED|Double Blind Phase||216
8515951|NCT00411788|20989950|P1|NOT COMPLETED|Overall Study||2
8515952|NCT00411788|20989950|P1|COMPLETED|Overall Study||9
8515953|NCT00411788|20989950|P1|STARTED|Overall Study||11
8515954|NCT00411762|20989959|P1|NOT COMPLETED|Overall Study||5
8515955|NCT00411762|20989959|P1|COMPLETED|Overall Study||20
8515956|NCT00411762|20989959|P1|STARTED|Overall Study||25
8515957|NCT00411749|20989966|P2|NOT COMPLETED|Overall Study||0
8515958|NCT00411749|20989967|P1|NOT COMPLETED|Overall Study||0
8515959|NCT00411749|20989966|P2|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
8515960|NCT00411749|20989967|P1|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
8515961|NCT00411749|20989966|P2|Vaccinated|Overall Study||25
8515962|NCT00411749|20989967|P1|Vaccinated|Overall Study||82
8515963|NCT00411749|20989966|P2|STARTED|Overall Study||25
8515964|NCT00411749|20989967|P1|STARTED|Overall Study||82
8515965|NCT00411671|20989983|P1|NOT COMPLETED|Overall Study||20
8515966|NCT00411671|20989983|P1|COMPLETED|Overall Study||85
8515967|NCT00411671|20989983|P1|STARTED|Overall Study||105
8515974|NCT00411632|20990016|P1|NOT COMPLETED|Overall Study||1
8515975|NCT00411632|20990016|P1|COMPLETED|Overall Study||36
8515976|NCT00411632|20990016|P1|STARTED|Overall Study||37
8515977|NCT00411619|20990020|P1|NOT COMPLETED|Overall Study||6
8515978|NCT00411619|20990020|P1|COMPLETED|Overall Study||22
8515979|NCT00411619|20990020|P1|STARTED|Overall Study||28
8515980|NCT00411554|20990027|P2|NOT COMPLETED|Overall Study||9
8515981|NCT00411554|20990028|P1|NOT COMPLETED|Overall Study||8
8515982|NCT00411554|20990027|P2|COMPLETED|Overall Study||147
8515983|NCT00411554|20990028|P1|COMPLETED|Overall Study||155
8515984|NCT00411554|20990027|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
8515985|NCT00411554|20990028|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
8515986|NCT00411463|20990040|P2|NOT COMPLETED|Overall Study||3
8515987|NCT00411463|20990041|P1|NOT COMPLETED|Overall Study||3
8515988|NCT00411463|20990040|P2|COMPLETED|Overall Study||8
8515989|NCT00411463|20990041|P1|COMPLETED|Overall Study||11
8515990|NCT00411463|20990040|P2|STARTED|Overall Study||11
8515991|NCT00411463|20990041|P1|STARTED|Overall Study||14
8515992|NCT00411450|20990054|P1|NOT COMPLETED|Overall Study||3
8515993|NCT00411450|20990054|P1|COMPLETED|Overall Study|Ended second-line treatment|113
8515994|NCT00411450|20990054|P1|Received Treatment|Overall Study||115
8515995|NCT00411450|20990054|P1|STARTED|Overall Study||116
8515996|NCT00411411|20990082|P2|NOT COMPLETED|Overall Study||0
8515997|NCT00411411|20990083|P1|NOT COMPLETED|Overall Study||0
8515998|NCT00411411|20990082|P2|COMPLETED|Overall Study||25
8515999|NCT00411411|20990083|P1|COMPLETED|Overall Study||24
8516000|NCT00411411|20990082|P2|STARTED|Overall Study||25
8516001|NCT00411411|20990083|P1|STARTED|Overall Study||24
8516002|NCT00411398|20990091|P1|NOT COMPLETED|Overall Study||5
8516003|NCT00411398|20990091|P1|COMPLETED|Overall Study||10
8516004|NCT00411398|20990091|P1|STARTED|Overall Study||15
8516005|NCT00411216|20990097|P2|NOT COMPLETED|Overall Study||2
8516006|NCT00411216|20990098|P1|NOT COMPLETED|Overall Study||0
8516007|NCT00411216|20990097|P2|COMPLETED|Overall Study||8
8516008|NCT00411216|20990098|P1|COMPLETED|Overall Study||13
8516009|NCT00411216|20990097|P2|STARTED|Overall Study||10
8516010|NCT00411216|20990098|P1|STARTED|Overall Study||13
8516011|NCT00411151|20990104|P1|NOT COMPLETED|Overall Study||47
8516012|NCT00411151|20990104|P1|COMPLETED|Overall Study||5
8516013|NCT00411151|20990104|P1|STARTED|Overall Study||52
8516014|NCT00411086|20990114|P1|NOT COMPLETED|Overall Study||0
8516015|NCT00411086|20990114|P1|COMPLETED|Overall Study||52
8516016|NCT00411086|20990114|P1|STARTED|Overall Study||52
8516017|NCT00410904|20990122|P2|NOT COMPLETED|Overall Study||0
8516018|NCT00410904|20990123|P1|NOT COMPLETED|Overall Study||0
8516019|NCT00410904|20990122|P2|COMPLETED|Overall Study||20
8516020|NCT00410904|20990123|P1|COMPLETED|Overall Study||40
8516021|NCT00410904|20990122|P2|STARTED|Overall Study||20
8516022|NCT00410904|20990123|P1|STARTED|Overall Study||40
8516023|NCT00410891|20990131|P1|NOT COMPLETED|Overall Study||0
8516024|NCT00410891|20990131|P1|COMPLETED|Overall Study||129
8516025|NCT00410891|20990131|P1|STARTED|Overall Study||129
8516026|NCT00410826|20990137|P2|NOT COMPLETED|Overall Study||4
8516027|NCT00410826|20990138|P1|NOT COMPLETED|Overall Study||9
8516028|NCT00410826|20990137|P2|COMPLETED|Overall Study||95
8516029|NCT00410826|20990138|P1|COMPLETED|Overall Study||96
8516030|NCT00410826|20990137|P2|STARTED|Overall Study||99
8516031|NCT00410826|20990138|P1|STARTED|Overall Study||105
8516032|NCT00410813|20990148|P2|NOT COMPLETED|Overall Study||42
8516033|NCT00410813|20990149|P1|NOT COMPLETED|Overall Study||43
8516034|NCT00410813|20990148|P2|COMPLETED|Overall Study||0
8516035|NCT00410813|20990149|P1|COMPLETED|Overall Study|Patients treated until progression.|0
8516036|NCT00410813|20990148|P2|Eligible|Overall Study||38
8516037|NCT00410813|20990149|P1|Eligible|Overall Study||41
8516038|NCT00410813|20990148|P2|STARTED|Overall Study||42
8516039|NCT00410813|20990149|P1|STARTED|Overall Study||43
8516040|NCT00410761|20990186|P2|NOT COMPLETED|Overall Study||72
8516041|NCT00410761|20990187|P1|NOT COMPLETED|Overall Study||120
8516042|NCT00410761|20990186|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
8516043|NCT00410761|20990187|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
8516044|NCT00410761|20990186|P2|STARTED|Overall Study|randomised patients|100
8516045|NCT00410761|20990187|P1|STARTED|Overall Study|randomised patients|231
8516046|NCT00410605|20990207|P1|NOT COMPLETED|Overall Study||25
8516047|NCT00410605|20990207|P1|COMPLETED|Overall Study||14
8516048|NCT00410605|20990207|P1|STARTED|Overall Study||39
8516049|NCT00410514|20990219|P3|NOT COMPLETED|Overall Study||7
8516050|NCT00410514|20990220|P2|NOT COMPLETED|Overall Study||3
8516051|NCT00410514|20990221|P1|NOT COMPLETED|Overall Study||2
8516052|NCT00410514|20990219|P3|COMPLETED|Overall Study||58
8516053|NCT00410514|20990220|P2|COMPLETED|Overall Study||67
8516054|NCT00410514|20990221|P1|COMPLETED|Overall Study||63
8516055|NCT00410514|20990219|P3|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
8516056|NCT00410514|20990220|P2|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
8516057|NCT00410514|20990221|P1|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
8516058|NCT00410514|20990219|P3|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
8516059|NCT00410514|20990220|P2|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
8516060|NCT00410514|20990221|P1|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
8516061|NCT00410514|20990219|P3|STARTED|Overall Study||65
8516062|NCT00410514|20990220|P2|STARTED|Overall Study||70
8516063|NCT00410514|20990221|P1|STARTED|Overall Study||65
8516064|NCT00410488|20990282|P2|NOT COMPLETED|Overall Study||0
8516065|NCT00410488|20990283|P1|NOT COMPLETED|Overall Study||0
8516066|NCT00410488|20990282|P2|COMPLETED|Overall Study||34
8516067|NCT00410488|20990283|P1|COMPLETED|Overall Study||16
8516068|NCT00410488|20990282|P2|STARTED|Overall Study||34
8516069|NCT00410488|20990283|P1|STARTED|Overall Study||16
8516070|NCT00410423|20990288|P4|NOT COMPLETED|Phase 2||0
8516071|NCT00410423|20990289|P3|NOT COMPLETED|Phase 2||0
8516072|NCT00410423|20990290|P2|NOT COMPLETED|Phase 2||0
8516073|NCT00410423|20990291|P1|NOT COMPLETED|Phase 2||0
8516074|NCT00410423|20990288|P4|COMPLETED|Phase 2||44
8516075|NCT00410423|20990289|P3|COMPLETED|Phase 2||0
8516076|NCT00410423|20990290|P2|COMPLETED|Phase 2||0
8516077|NCT00410423|20990291|P1|COMPLETED|Phase 2||0
8516078|NCT00410423|20990288|P4|STARTED|Phase 2||44
8516079|NCT00410423|20990289|P3|STARTED|Phase 2||0
8516080|NCT00410423|20990290|P2|STARTED|Phase 2||0
8516081|NCT00410423|20990291|P1|STARTED|Phase 2||0
8516082|NCT00410423|20990288|P4|NOT COMPLETED|Phase 1 - Dose Level 3||0
8516083|NCT00410423|20990289|P3|NOT COMPLETED|Phase 1 - Dose Level 3||0
8516084|NCT00410423|20990290|P2|NOT COMPLETED|Phase 1 - Dose Level 3||0
8516085|NCT00410423|20990291|P1|NOT COMPLETED|Phase 1 - Dose Level 3||0
8516086|NCT00410423|20990288|P4|COMPLETED|Phase 1 - Dose Level 3||0
8516087|NCT00410423|20990289|P3|COMPLETED|Phase 1 - Dose Level 3||3
8516088|NCT00410423|20990290|P2|COMPLETED|Phase 1 - Dose Level 3||0
8516089|NCT00410423|20990291|P1|COMPLETED|Phase 1 - Dose Level 3||0
8516090|NCT00410423|20990288|P4|STARTED|Phase 1 - Dose Level 3||0
8516091|NCT00410423|20990289|P3|STARTED|Phase 1 - Dose Level 3||3
8516092|NCT00410423|20990290|P2|STARTED|Phase 1 - Dose Level 3||0
8516093|NCT00410423|20990291|P1|STARTED|Phase 1 - Dose Level 3||0
8516094|NCT00410423|20990288|P4|NOT COMPLETED|Phase 1 - Dose Level 2||0
8516095|NCT00410423|20990289|P3|NOT COMPLETED|Phase 1 - Dose Level 2||0
8516096|NCT00410423|20990290|P2|NOT COMPLETED|Phase 1 - Dose Level 2||0
8516097|NCT00410423|20990291|P1|NOT COMPLETED|Phase 1 - Dose Level 2||0
8516098|NCT00410423|20990288|P4|COMPLETED|Phase 1 - Dose Level 2||0
8516099|NCT00410423|20990289|P3|COMPLETED|Phase 1 - Dose Level 2||0
8516100|NCT00410423|20990290|P2|COMPLETED|Phase 1 - Dose Level 2||5
8516101|NCT00410423|20990291|P1|COMPLETED|Phase 1 - Dose Level 2||0
8516102|NCT00410423|20990288|P4|STARTED|Phase 1 - Dose Level 2||0
8516103|NCT00410423|20990289|P3|STARTED|Phase 1 - Dose Level 2||0
8516104|NCT00410423|20990290|P2|STARTED|Phase 1 - Dose Level 2||5
8516105|NCT00410423|20990291|P1|STARTED|Phase 1 - Dose Level 2||0
8516106|NCT00410423|20990288|P4|NOT COMPLETED|Phase 1 - Dose Level 1||0
8516107|NCT00410423|20990289|P3|NOT COMPLETED|Phase 1 - Dose Level 1||0
8516108|NCT00410423|20990290|P2|NOT COMPLETED|Phase 1 - Dose Level 1||0
8516109|NCT00410423|20990291|P1|NOT COMPLETED|Phase 1 - Dose Level 1||0
8516110|NCT00410423|20990288|P4|COMPLETED|Phase 1 - Dose Level 1||0
8516111|NCT00410423|20990289|P3|COMPLETED|Phase 1 - Dose Level 1||0
8516112|NCT00410423|20990290|P2|COMPLETED|Phase 1 - Dose Level 1||0
8516113|NCT00410423|20990291|P1|COMPLETED|Phase 1 - Dose Level 1||3
8516114|NCT00410423|20990288|P4|STARTED|Phase 1 - Dose Level 1||0
8516115|NCT00410423|20990289|P3|STARTED|Phase 1 - Dose Level 1||0
8516116|NCT00410423|20990290|P2|STARTED|Phase 1 - Dose Level 1||0
8516117|NCT00410423|20990291|P1|STARTED|Phase 1 - Dose Level 1||3
8516118|NCT00410410|20990304|P9|NOT COMPLETED|Open-Label Period (OL)||349
8516119|NCT00410410|20990305|P8|NOT COMPLETED|Open-Label Period (OL)||0
8516120|NCT00410410|20990306|P7|NOT COMPLETED|Open-Label Period (OL)||0
8516121|NCT00410410|20990307|P6|NOT COMPLETED|Open-Label Period (OL)||0
8516122|NCT00410410|20990308|P5|NOT COMPLETED|Open-Label Period (OL)||0
8516123|NCT00410410|20990309|P4|NOT COMPLETED|Open-Label Period (OL)||0
8516124|NCT00410410|20990310|P3|NOT COMPLETED|Open-Label Period (OL)||0
8516125|NCT00410410|20990311|P2|NOT COMPLETED|Open-Label Period (OL)||0
8516126|NCT00410410|20990312|P1|NOT COMPLETED|Open-Label Period (OL)||0
8516127|NCT00410410|20990304|P9|COMPLETED|Open-Label Period (OL)||0
8516128|NCT00410410|20990305|P8|COMPLETED|Open-Label Period (OL)||0
8516129|NCT00410410|20990306|P7|COMPLETED|Open-Label Period (OL)||0
8516130|NCT00410410|20990307|P6|COMPLETED|Open-Label Period (OL)||0
8516131|NCT00410410|20990308|P5|COMPLETED|Open-Label Period (OL)||0
8516132|NCT00410410|20990309|P4|COMPLETED|Open-Label Period (OL)||0
8516133|NCT00410410|20990310|P3|COMPLETED|Open-Label Period (OL)||0
8516134|NCT00410410|20990311|P2|COMPLETED|Open-Label Period (OL)||0
8516135|NCT00410410|20990312|P1|COMPLETED|Open-Label Period (OL)||0
8516136|NCT00410410|20990304|P9|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
8516137|NCT00410410|20990305|P8|STARTED|Open-Label Period (OL)||0
8516138|NCT00410410|20990306|P7|STARTED|Open-Label Period (OL)||0
8516139|NCT00410410|20990307|P6|STARTED|Open-Label Period (OL)||0
8516140|NCT00410410|20990308|P5|STARTED|Open-Label Period (OL)||0
8516141|NCT00410410|20990309|P4|STARTED|Open-Label Period (OL)||0
8516142|NCT00410410|20990310|P3|STARTED|Open-Label Period (OL)||0
8516143|NCT00410410|20990311|P2|STARTED|Open-Label Period (OL)||0
8516144|NCT00410410|20990312|P1|STARTED|Open-Label Period (OL)||0
8516145|NCT00410410|20990304|P9|NOT COMPLETED|Maintenance Period (MP)||0
8516146|NCT00410410|20990305|P8|NOT COMPLETED|Maintenance Period (MP)||55
8516147|NCT00410410|20990306|P7|NOT COMPLETED|Maintenance Period (MP)||50
8516148|NCT00410410|20990307|P6|NOT COMPLETED|Maintenance Period (MP)||0
8516149|NCT00410410|20990308|P5|NOT COMPLETED|Maintenance Period (MP)||0
8516150|NCT00410410|20990309|P4|NOT COMPLETED|Maintenance Period (MP)||0
8516151|NCT00410410|20990310|P3|NOT COMPLETED|Maintenance Period (MP)||0
8516152|NCT00410410|20990311|P2|NOT COMPLETED|Maintenance Period (MP)||0
8516153|NCT00410410|20990312|P1|NOT COMPLETED|Maintenance Period (MP)||0
8516154|NCT00410410|20990304|P9|COMPLETED|Maintenance Period (MP)||0
8516155|NCT00410410|20990305|P8|COMPLETED|Maintenance Period (MP)||11
8516156|NCT00410410|20990306|P7|COMPLETED|Maintenance Period (MP)||15
8516157|NCT00410410|20990307|P6|COMPLETED|Maintenance Period (MP)||0
8516158|NCT00410410|20990308|P5|COMPLETED|Maintenance Period (MP)||0
8516159|NCT00410410|20990309|P4|COMPLETED|Maintenance Period (MP)||0
8516160|NCT00410410|20990310|P3|COMPLETED|Maintenance Period (MP)||0
8516161|NCT00410410|20990311|P2|COMPLETED|Maintenance Period (MP)||0
8516162|NCT00410410|20990312|P1|COMPLETED|Maintenance Period (MP)||0
8516163|NCT00410410|20990304|P9|STARTED|Maintenance Period (MP)||0
8516164|NCT00410410|20990305|P8|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
8516165|NCT00410410|20990306|P7|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
8516166|NCT00410410|20990307|P6|STARTED|Maintenance Period (MP)||0
8516167|NCT00410410|20990308|P5|STARTED|Maintenance Period (MP)||0
8516168|NCT00410410|20990309|P4|STARTED|Maintenance Period (MP)||0
8516169|NCT00410410|20990310|P3|STARTED|Maintenance Period (MP)||0
8516170|NCT00410410|20990311|P2|STARTED|Maintenance Period (MP)||0
8516171|NCT00410410|20990312|P1|STARTED|Maintenance Period (MP)||0
8516172|NCT00410410|20990304|P9|NOT COMPLETED|Induction Period (IP)||0
8516173|NCT00410410|20990305|P8|NOT COMPLETED|Induction Period (IP)||0
8516174|NCT00410410|20990306|P7|NOT COMPLETED|Induction Period (IP)||0
8516175|NCT00410410|20990307|P6|NOT COMPLETED|Induction Period (IP)||29
8516176|NCT00410410|20990308|P5|NOT COMPLETED|Induction Period (IP)||32
8516177|NCT00410410|20990309|P4|NOT COMPLETED|Induction Period (IP)||20
8516178|NCT00410410|20990310|P3|NOT COMPLETED|Induction Period (IP)||17
8516179|NCT00410410|20990311|P2|NOT COMPLETED|Induction Period (IP)||35
8516180|NCT00410410|20990312|P1|NOT COMPLETED|Induction Period (IP)||35
8516181|NCT00410410|20990304|P9|COMPLETED|Induction Period (IP)||0
8516182|NCT00410410|20990305|P8|COMPLETED|Induction Period (IP)||0
8516183|NCT00410410|20990306|P7|COMPLETED|Induction Period (IP)||0
8516184|NCT00410410|20990307|P6|COMPLETED|Induction Period (IP)||21
8516185|NCT00410410|20990308|P5|COMPLETED|Induction Period (IP)||19
8516186|NCT00410410|20990309|P4|COMPLETED|Induction Period (IP)||120
8516187|NCT00410410|20990310|P3|COMPLETED|Induction Period (IP)||53
8516188|NCT00410410|20990311|P2|COMPLETED|Induction Period (IP)||104
8516189|NCT00410410|20990312|P1|COMPLETED|Induction Period (IP)||106
8516190|NCT00410410|20990304|P9|STARTED|Induction Period (IP)||0
8516191|NCT00410410|20990305|P8|STARTED|Induction Period (IP)||0
8516192|NCT00410410|20990306|P7|STARTED|Induction Period (IP)||0
8516193|NCT00410410|20990307|P6|STARTED|Induction Period (IP)||50
8516194|NCT00410410|20990308|P5|STARTED|Induction Period (IP)||51
8516195|NCT00410410|20990309|P4|STARTED|Induction Period (IP)||140
8516196|NCT00410410|20990310|P3|STARTED|Induction Period (IP)||70
8516197|NCT00410410|20990311|P2|STARTED|Induction Period (IP)||139
8516198|NCT00410410|20990312|P1|STARTED|Induction Period (IP)||141
8516199|NCT00410384|20990473|P3|NOT COMPLETED|Overall Study||82
8516200|NCT00410384|20990474|P2|NOT COMPLETED|Overall Study||72
8516201|NCT00410384|20990475|P1|NOT COMPLETED|Overall Study||89
8516202|NCT00410384|20990473|P3|COMPLETED|Overall Study||191
8516203|NCT00410384|20990474|P2|COMPLETED|Overall Study||199
8516204|NCT00410384|20990475|P1|COMPLETED|Overall Study||186
8516205|NCT00410384|20990473|P3|STARTED|Overall Study||273
8516206|NCT00410384|20990474|P2|STARTED|Overall Study||271
8516207|NCT00410384|20990475|P1|STARTED|Overall Study||275
8516208|NCT00410280|20990503|P2|NOT COMPLETED|Overall Study||0
8516209|NCT00410280|20990504|P1|NOT COMPLETED|Overall Study||0
8516210|NCT00410280|20990503|P2|COMPLETED|Overall Study||13
8516211|NCT00410280|20990504|P1|COMPLETED|Overall Study||14
8516212|NCT00410280|20990503|P2|STARTED|Overall Study||13
8516213|NCT00410280|20990504|P1|STARTED|Overall Study||14
8516214|NCT00410202|20990548|P3|NOT COMPLETED|Off-treatment Follow up||12
8516215|NCT00410202|20990549|P2|NOT COMPLETED|Off-treatment Follow up||8
8516216|NCT00410202|20990550|P1|NOT COMPLETED|Off-treatment Follow up||14
8516217|NCT00410202|20990548|P3|COMPLETED|Off-treatment Follow up||2
8516218|NCT00410202|20990549|P2|COMPLETED|Off-treatment Follow up||0
8516219|NCT00410202|20990550|P1|COMPLETED|Off-treatment Follow up||1
8516220|NCT00410202|20990548|P3|STARTED|Off-treatment Follow up||14
8516221|NCT00410202|20990549|P2|STARTED|Off-treatment Follow up||8
8516222|NCT00410202|20990550|P1|STARTED|Off-treatment Follow up||15
8516223|NCT00410202|20990548|P3|NOT COMPLETED|On-Treatment||71
8516224|NCT00410202|20990549|P2|NOT COMPLETED|On-Treatment||79
8516225|NCT00410202|20990550|P1|NOT COMPLETED|On-Treatment||75
8516226|NCT00410202|20990548|P3|COMPLETED|On-Treatment|Completed the 100 week dosing|66
8516227|NCT00410202|20990549|P2|COMPLETED|On-Treatment|Completed the 100 week dosing|61
8516228|NCT00410202|20990550|P1|COMPLETED|On-Treatment|Completed the 100 week dosing|63
8516229|NCT00410202|20990548|P3|Discontinued at or After Week 48 Visit|On-Treatment||3
8516230|NCT00410202|20990549|P2|Discontinued at or After Week 48 Visit|On-Treatment||6
8516231|NCT00410202|20990550|P1|Discontinued at or After Week 48 Visit|On-Treatment||2
8516232|NCT00410202|20990548|P3|Discontinued Prior to Week 48 Visit|On-Treatment||2
8516233|NCT00410202|20990549|P2|Discontinued Prior to Week 48 Visit|On-Treatment||2
8516234|NCT00410202|20990550|P1|Discontinued Prior to Week 48 Visit|On-Treatment||4
8516235|NCT00410202|20990548|P3|STARTED|On-Treatment||137
8516236|NCT00410202|20990549|P2|STARTED|On-Treatment||140
8516237|NCT00410202|20990550|P1|STARTED|On-Treatment||138
8516238|NCT00410189|20990630|P1|NOT COMPLETED|Overall Study||0
8516239|NCT00410189|20990630|P1|COMPLETED|Overall Study||54
8516240|NCT00410189|20990630|P1|STARTED|Overall Study||54
8516241|NCT00410163|20990637|P2|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
8516242|NCT00410163|20990638|P1|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
8516243|NCT00410163|20990637|P2|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
8516244|NCT00410163|20990638|P1|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
8516245|NCT00410163|20990637|P2|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
8516324|NCT00409773|20990871|P4|STARTED|Overall Study||228
8516325|NCT00409773|20990872|P3|STARTED|Overall Study||229
8516246|NCT00410163|20990638|P1|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
8516247|NCT00410163|20990637|P2|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
8516248|NCT00410163|20990638|P1|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
8516249|NCT00410163|20990637|P2|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
8516250|NCT00410163|20990638|P1|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
8516251|NCT00410163|20990637|P2|STARTED|Treatment and Follow-up Phase (2 Years)||30
8516252|NCT00410163|20990638|P1|STARTED|Treatment and Follow-up Phase (2 Years)||31
8516253|NCT00410150|20990682|P2|NOT COMPLETED|Overall Study||3
8516254|NCT00410150|20990683|P1|NOT COMPLETED|Overall Study||2
8516255|NCT00410150|20990682|P2|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
8516256|NCT00410150|20990683|P1|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
8516257|NCT00410150|20990682|P2|STARTED|Overall Study||20
8516258|NCT00410150|20990683|P1|STARTED|Overall Study||22
8516259|NCT00410124|20990691|P2|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
8516260|NCT00410124|20990692|P1|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
8516261|NCT00410124|20990691|P2|COMPLETED|Extension Phase - Open Label (45 Months)||0
8516262|NCT00410124|20990692|P1|COMPLETED|Extension Phase - Open Label (45 Months)||0
8516263|NCT00410124|20990691|P2|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
8516264|NCT00410124|20990692|P1|STARTED|Extension Phase - Open Label (45 Months)||67
8516265|NCT00410124|20990691|P2|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
8516266|NCT00410124|20990692|P1|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
8516267|NCT00410124|20990691|P2|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
8516268|NCT00410124|20990692|P1|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
8516269|NCT00410124|20990691|P2|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
8516270|NCT00410124|20990692|P1|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
8516271|NCT00410124|20990691|P2|Ongoing|Core Phase Double Blind (15 Months)||4
8516272|NCT00410124|20990692|P1|Ongoing|Core Phase Double Blind (15 Months)||13
8516273|NCT00410124|20990691|P2|STARTED|Core Phase Double Blind (15 Months)||139
8516274|NCT00410124|20990692|P1|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
8516275|NCT00410072|20990723|P2|NOT COMPLETED|After Week 48 to Week 96||11
8516276|NCT00410072|20990724|P1|NOT COMPLETED|After Week 48 to Week 96||6
8516277|NCT00410072|20990723|P2|COMPLETED|After Week 48 to Week 96||174
8516278|NCT00410072|20990724|P1|COMPLETED|After Week 48 to Week 96||170
8516279|NCT00410072|20990723|P2|STARTED|After Week 48 to Week 96||185
8516280|NCT00410072|20990724|P1|STARTED|After Week 48 to Week 96||176
8516281|NCT00410072|20990723|P2|NOT COMPLETED|Day 1 to Week 48||12
8516282|NCT00410072|20990724|P1|NOT COMPLETED|Day 1 to Week 48||6
8516283|NCT00410072|20990723|P2|COMPLETED|Day 1 to Week 48||185
8516284|NCT00410072|20990724|P1|COMPLETED|Day 1 to Week 48||176
8516285|NCT00410072|20990723|P2|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
8516286|NCT00410072|20990724|P1|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
8516287|NCT00410059|20990760|P1|NOT COMPLETED|Overall Study||0
8516288|NCT00410059|20990760|P1|COMPLETED|Overall Study||59
8516289|NCT00410059|20990760|P1|STARTED|Overall Study||59
8516290|NCT00410046|20990764|P1|NOT COMPLETED|Overall Study||5
8516291|NCT00410046|20990764|P1|COMPLETED|Overall Study||79
8516292|NCT00410046|20990764|P1|STARTED|Overall Study||84
8516293|NCT00409838|20990795|P2|NOT COMPLETED|Long-term Extension Period||0
8516294|NCT00409838|20990796|P1|NOT COMPLETED|Long-term Extension Period||18
8516295|NCT00409838|20990795|P2|COMPLETED|Long-term Extension Period||0
8516296|NCT00409838|20990796|P1|COMPLETED|Long-term Extension Period||87
8516297|NCT00409838|20990795|P2|STARTED|Long-term Extension Period||0
8516298|NCT00409838|20990796|P1|STARTED|Long-term Extension Period||105
8516299|NCT00409838|20990795|P2|NOT COMPLETED|Short-term Period||5
8516300|NCT00409838|20990796|P1|NOT COMPLETED|Short-term Period||3
8516301|NCT00409838|20990795|P2|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
8516302|NCT00409838|20990796|P1|COMPLETED|Short-term Period||53
8516303|NCT00409838|20990795|P2|Treated (Baseline) Population|Short-term Period||57
8516304|NCT00409838|20990796|P1|Treated (Baseline) Population|Short-term Period||55
8516305|NCT00409838|20990795|P2|STARTED|Short-term Period|Randomized|57
8516306|NCT00409838|20990796|P1|STARTED|Short-term Period|Randomized|56
8516307|NCT00409825|20990857|P1|NOT COMPLETED|Overall Study||0
8516308|NCT00409825|20990857|P1|COMPLETED|Overall Study||61
8516309|NCT00409825|20990857|P1|STARTED|Overall Study||61
8516310|NCT00409786|20990861|P1|NOT COMPLETED|Overall Study||3
8516311|NCT00409786|20990861|P1|COMPLETED|Overall Study||47
8516312|NCT00409786|20990861|P1|STARTED|Overall Study||50
8516313|NCT00409773|20990870|P5|NOT COMPLETED|Overall Study||10
8516314|NCT00409773|20990871|P4|NOT COMPLETED|Overall Study||12
8516315|NCT00409773|20990872|P3|NOT COMPLETED|Overall Study||9
8516316|NCT00409773|20990873|P2|NOT COMPLETED|Overall Study||7
8516317|NCT00409773|20990874|P1|NOT COMPLETED|Overall Study||9
8516318|NCT00409773|20990870|P5|COMPLETED|Overall Study||218
8516319|NCT00409773|20990871|P4|COMPLETED|Overall Study||216
8516320|NCT00409773|20990872|P3|COMPLETED|Overall Study||220
8516321|NCT00409773|20990873|P2|COMPLETED|Overall Study||222
8516322|NCT00409773|20990874|P1|COMPLETED|Overall Study||220
8516323|NCT00409773|20990870|P5|STARTED|Overall Study||228
8516326|NCT00409773|20990873|P2|STARTED|Overall Study||229
8516327|NCT00409773|20990874|P1|STARTED|Overall Study||229
8516328|NCT00409747|20990956|P1|NOT COMPLETED|Overall Study||1
8516329|NCT00409747|20990956|P1|COMPLETED|Overall Study||10
8516330|NCT00409747|20990956|P1|STARTED|Overall Study||11
8516331|NCT00409708|20990963|P2|NOT COMPLETED|Washout||10
8516332|NCT00409708|20990964|P1|NOT COMPLETED|Washout||21
8516333|NCT00409708|20990963|P2|COMPLETED|Washout||29
8516334|NCT00409708|20990964|P1|COMPLETED|Washout||17
8516335|NCT00409708|20990963|P2|STARTED|Washout||39
8516336|NCT00409708|20990964|P1|STARTED|Washout||38
8516337|NCT00409708|20990963|P2|NOT COMPLETED|Treatment||17
8516338|NCT00409708|20990964|P1|NOT COMPLETED|Treatment||15
8516339|NCT00409708|20990963|P2|COMPLETED|Treatment||39
8516340|NCT00409708|20990964|P1|COMPLETED|Treatment||38
8516341|NCT00409708|20990963|P2|STARTED|Treatment||56
8516342|NCT00409708|20990964|P1|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
8516343|NCT00409682|20990985|P3|NOT COMPLETED|EOW Double-blind Maintenance Period||27
8516344|NCT00409682|20990986|P2|NOT COMPLETED|EOW Double-blind Maintenance Period||37
8516345|NCT00409682|20990987|P1|NOT COMPLETED|EOW Double-blind Maintenance Period||0
8516346|NCT00409682|20990985|P3|COMPLETED|EOW Double-blind Maintenance Period||66
8516347|NCT00409682|20990986|P2|COMPLETED|EOW Double-blind Maintenance Period||58
8516348|NCT00409682|20990987|P1|COMPLETED|EOW Double-blind Maintenance Period||0
8516349|NCT00409682|20990985|P3|STARTED|EOW Double-blind Maintenance Period||93
8516350|NCT00409682|20990986|P2|STARTED|EOW Double-blind Maintenance Period||95
8516351|NCT00409682|20990987|P1|STARTED|EOW Double-blind Maintenance Period||0
8516352|NCT00409682|20990985|P3|NOT COMPLETED|Open-label Induction Period||0
8516353|NCT00409682|20990986|P2|NOT COMPLETED|Open-label Induction Period||0
8516354|NCT00409682|20990987|P1|NOT COMPLETED|Open-label Induction Period||4
8516355|NCT00409682|20990985|P3|COMPLETED|Open-label Induction Period||0
8516356|NCT00409682|20990986|P2|COMPLETED|Open-label Induction Period||0
8516357|NCT00409682|20990987|P1|COMPLETED|Open-label Induction Period||188
8516358|NCT00409682|20990985|P3|STARTED|Open-label Induction Period||0
8516359|NCT00409682|20990986|P2|STARTED|Open-label Induction Period||0
8516360|NCT00409682|20990987|P1|STARTED|Open-label Induction Period||192
8516361|NCT00409617|20991004|P1|NOT COMPLETED|Overall Study||160
8516362|NCT00409617|20991004|P1|COMPLETED|Overall Study||785
8516363|NCT00409617|20991004|P1|STARTED|Overall Study||945
8516364|NCT00409578|20991020|P4|NOT COMPLETED|Overall Study||67
8516365|NCT00409578|20991021|P3|NOT COMPLETED|Overall Study||54
8516366|NCT00409578|20991022|P2|NOT COMPLETED|Overall Study||70
8516367|NCT00409578|20991023|P1|NOT COMPLETED|Overall Study||52
8516368|NCT00409578|20991020|P4|COMPLETED|Overall Study||214
8516369|NCT00409578|20991021|P3|COMPLETED|Overall Study||215
8516370|NCT00409578|20991022|P2|COMPLETED|Overall Study||201
8516371|NCT00409578|20991023|P1|COMPLETED|Overall Study||228
8516372|NCT00409578|20991020|P4|STARTED|Overall Study||281
8516373|NCT00409578|20991021|P3|STARTED|Overall Study||269
8516374|NCT00409578|20991022|P2|STARTED|Overall Study||271
8516375|NCT00409578|20991023|P1|STARTED|Overall Study||280
8516376|NCT00409565|20991045|P1|NOT COMPLETED|Overall Study||1
8516377|NCT00409565|20991045|P1|COMPLETED|Overall Study||45
8516378|NCT00409565|20991045|P1|Overall Response Rate|Overall Study||7
8516379|NCT00409565|20991045|P1|STARTED|Overall Study||46
8516380|NCT00409539|20991058|P5|NOT COMPLETED|Overall Study||25
8516381|NCT00409539|20991059|P4|NOT COMPLETED|Overall Study||12
8516382|NCT00409539|20991060|P3|NOT COMPLETED|Overall Study||14
8516383|NCT00409539|20991061|P2|NOT COMPLETED|Overall Study||11
8516384|NCT00409539|20991062|P1|NOT COMPLETED|Overall Study||11
8516385|NCT00409539|20991058|P5|COMPLETED|Overall Study||85
8516386|NCT00409539|20991059|P4|COMPLETED|Overall Study||97
8516387|NCT00409539|20991060|P3|COMPLETED|Overall Study||95
8516388|NCT00409539|20991061|P2|COMPLETED|Overall Study||100
8516389|NCT00409539|20991062|P1|COMPLETED|Overall Study||100
8516390|NCT00409539|20991058|P5|STARTED|Overall Study||110
8516391|NCT00409539|20991059|P4|STARTED|Overall Study||109
8516392|NCT00409539|20991060|P3|STARTED|Overall Study||109
8516393|NCT00409539|20991061|P2|STARTED|Overall Study||111
8516394|NCT00409539|20991062|P1|STARTED|Overall Study||111
8516395|NCT00409409|20991081|P2|NOT COMPLETED|Overall Study||4
8516396|NCT00409409|20991082|P1|NOT COMPLETED|Overall Study||8
8516397|NCT00409409|20991081|P2|COMPLETED|Overall Study||135
8516398|NCT00409409|20991082|P1|COMPLETED|Overall Study||131
8516399|NCT00409409|20991081|P2|STARTED|Overall Study||139
8516400|NCT00409409|20991082|P1|STARTED|Overall Study||139
8516401|NCT00409344|20991090|P2|NOT COMPLETED|Overall Study||0
8516402|NCT00409344|20991091|P1|NOT COMPLETED|Overall Study||0
8516403|NCT00409344|20991090|P2|COMPLETED|Overall Study|No participants were enrolled to completion|0
8516404|NCT00409344|20991091|P1|COMPLETED|Overall Study|No participants were enrolled to completion|0
8516405|NCT00409344|20991090|P2|STARTED|Overall Study|No participants enrolled|0
8516406|NCT00409344|20991091|P1|STARTED|Overall Study|No participants enrolled|0
8516407|NCT00409331|20991109|P1|NOT COMPLETED|Overall Study||1
8516408|NCT00409331|20991109|P1|COMPLETED|Overall Study||0
8516409|NCT00409331|20991109|P1|STARTED|Overall Study||1
8516410|NCT00409292|20991113|P1|NOT COMPLETED|Overall Study||0
8516411|NCT00409292|20991113|P1|COMPLETED|Overall Study||33
8516412|NCT00409292|20991113|P1|STARTED|Overall Study||33
8516413|NCT00409240|20991122|P2|NOT COMPLETED|Overall Study||1
8516414|NCT00409240|20991123|P1|NOT COMPLETED|Overall Study||3
8516415|NCT00409240|20991122|P2|COMPLETED|Overall Study||49
8516416|NCT00409240|20991123|P1|COMPLETED|Overall Study||50
8516417|NCT00409240|20991122|P2|STARTED|Overall Study||50
8516418|NCT00409240|20991123|P1|STARTED|Overall Study||53
8516419|NCT00409188|20991131|P2|NOT COMPLETED|Overall Study||175
8516420|NCT00409188|20991132|P1|NOT COMPLETED|Overall Study||383
8516421|NCT00409188|20991131|P2|COMPLETED|Overall Study||332
8516422|NCT00409188|20991132|P1|COMPLETED|Overall Study||623
8516423|NCT00409188|20991131|P2|STARTED|Overall Study||507
8516424|NCT00409188|20991132|P1|STARTED|Overall Study||1006
8516425|NCT00409175|20991148|P2|NOT COMPLETED|Overall Study||19
8516426|NCT00409175|20991149|P1|NOT COMPLETED|Overall Study||18
8516427|NCT00409175|20991148|P2|COMPLETED|Overall Study||44
8516428|NCT00409175|20991149|P1|COMPLETED|Overall Study||47
8516429|NCT00409175|20991148|P2|STARTED|Overall Study||63
8516430|NCT00409175|20991149|P1|STARTED|Overall Study||65
8516431|NCT00409006|20991175|P2|NOT COMPLETED|Overall Study||12
8516432|NCT00409006|20991176|P1|NOT COMPLETED|Overall Study||20
8516433|NCT00409006|20991175|P2|COMPLETED|Overall Study||19
8516434|NCT00409006|20991176|P1|COMPLETED|Overall Study||19
8516435|NCT00409006|20991175|P2|STARTED|Overall Study||31
8516436|NCT00409006|20991176|P1|STARTED|Overall Study||39
8516437|NCT00408993|20991192|P2|NOT COMPLETED|Overall Study||17
8516438|NCT00408993|20991193|P1|NOT COMPLETED|Overall Study||19
8516439|NCT00408993|20991192|P2|COMPLETED|Overall Study||92
8516440|NCT00408993|20991193|P1|COMPLETED|Overall Study||87
8516441|NCT00408993|20991192|P2|STARTED|Overall Study||109
8516442|NCT00408993|20991193|P1|STARTED|Overall Study||106
8516443|NCT00408928|20991225|P1|NOT COMPLETED|Overall Study||3
8516444|NCT00408928|20991225|P1|COMPLETED|Overall Study||8
8516445|NCT00408928|20991225|P1|STARTED|Overall Study||11
8516446|NCT00408902|20991230|P1|NOT COMPLETED|Overall Study||10
8516447|NCT00408902|20991230|P1|COMPLETED|Overall Study||0
8516448|NCT00408902|20991230|P1|STARTED|Overall Study||10
8516449|NCT00408876|20991240|P4|NOT COMPLETED|Overall Study||35
8516450|NCT00408876|20991241|P3|NOT COMPLETED|Overall Study||50
8516451|NCT00408876|20991242|P2|NOT COMPLETED|Overall Study||36
8516452|NCT00408876|20991243|P1|NOT COMPLETED|Overall Study||16
8516453|NCT00408876|20991240|P4|COMPLETED|Overall Study||82
8516454|NCT00408876|20991241|P3|COMPLETED|Overall Study||62
8516455|NCT00408876|20991242|P2|COMPLETED|Overall Study||80
8516456|NCT00408876|20991243|P1|COMPLETED|Overall Study||43
8516457|NCT00408876|20991240|P4|STARTED|Overall Study||117
8516458|NCT00408876|20991241|P3|STARTED|Overall Study||112
8516459|NCT00408876|20991242|P2|STARTED|Overall Study||116
8516460|NCT00408876|20991243|P1|STARTED|Overall Study||59
8516461|NCT00408694|20991493|P1|NOT COMPLETED|Overall Study||2
8516462|NCT00408694|20991493|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
8516463|NCT00408694|20991493|P1|STARTED|Overall Study||46
8516464|NCT00408681|20991505|P1|NOT COMPLETED|Overall Study||9
8516465|NCT00408681|20991505|P1|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
8516466|NCT00408681|20991505|P1|STARTED|Overall Study||20
8516467|NCT00408629|20991524|P2|NOT COMPLETED|Overall Study||125
8516468|NCT00408629|20991525|P1|NOT COMPLETED|Overall Study||97
8516469|NCT00408629|20991524|P2|COMPLETED|Overall Study||135
8516470|NCT00408629|20991525|P1|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
8516471|NCT00408629|20991524|P2|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
8516472|NCT00408629|20991525|P1|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
8516473|NCT00408603|20991567|P3|NOT COMPLETED|Overall Study||40
8516474|NCT00408603|20991568|P2|NOT COMPLETED|Overall Study||2
8516475|NCT00408603|20991569|P1|NOT COMPLETED|Overall Study||4
8516476|NCT00408603|20991567|P3|COMPLETED|Overall Study||35
8516477|NCT00408603|20991568|P2|COMPLETED|Overall Study||37
8516478|NCT00408603|20991569|P1|COMPLETED|Overall Study||65
8516479|NCT00408603|20991567|P3|STARTED|Overall Study||75
8516480|NCT00408603|20991568|P2|STARTED|Overall Study||39
8516481|NCT00408603|20991569|P1|STARTED|Overall Study||69
8516482|NCT00408590|20991585|P9|NOT COMPLETED|Overall Study||0
8516483|NCT00408590|20991586|P8|NOT COMPLETED|Overall Study||0
8516484|NCT00408590|20991587|P7|NOT COMPLETED|Overall Study||0
8516485|NCT00408590|20991588|P6|NOT COMPLETED|Overall Study||0
8516486|NCT00408590|20991589|P5|NOT COMPLETED|Overall Study||0
8516487|NCT00408590|20991590|P4|NOT COMPLETED|Overall Study||0
8516488|NCT00408590|20991591|P3|NOT COMPLETED|Overall Study||0
8516489|NCT00408590|20991592|P2|NOT COMPLETED|Overall Study||0
8516490|NCT00408590|20991593|P1|NOT COMPLETED|Overall Study||0
8516491|NCT00408590|20991585|P9|COMPLETED|Overall Study||13
8516492|NCT00408590|20991586|P8|COMPLETED|Overall Study||3
8516493|NCT00408590|20991587|P7|COMPLETED|Overall Study||3
8516494|NCT00408590|20991588|P6|COMPLETED|Overall Study||3
8516495|NCT00408590|20991589|P5|COMPLETED|Overall Study||3
8516496|NCT00408590|20991590|P4|COMPLETED|Overall Study||3
8516497|NCT00408590|20991591|P3|COMPLETED|Overall Study||3
8516498|NCT00408590|20991592|P2|COMPLETED|Overall Study||3
8516499|NCT00408590|20991593|P1|COMPLETED|Overall Study||3
8516500|NCT00408590|20991585|P9|STARTED|Overall Study||13
8516501|NCT00408590|20991586|P8|STARTED|Overall Study||3
8516502|NCT00408590|20991587|P7|STARTED|Overall Study||3
8516503|NCT00408590|20991588|P6|STARTED|Overall Study||3
8516504|NCT00408590|20991589|P5|STARTED|Overall Study||3
8516505|NCT00408590|20991590|P4|STARTED|Overall Study||3
8516506|NCT00408590|20991591|P3|STARTED|Overall Study||3
8516507|NCT00408590|20991592|P2|STARTED|Overall Study||3
8516508|NCT00408590|20991593|P1|STARTED|Overall Study||3
8516509|NCT00408564|20991612|P1|NOT COMPLETED|Overall Study||0
8516510|NCT00408564|20991612|P1|COMPLETED|Overall Study||39
8516511|NCT00408564|20991612|P1|STARTED|Overall Study||39
8516512|NCT00408499|20991621|P5|NOT COMPLETED|Phase II- MTD Expansion||20
8516513|NCT00408499|20991622|P4|NOT COMPLETED|Phase II- MTD Expansion||0
8516514|NCT00408499|20991623|P3|NOT COMPLETED|Phase II- MTD Expansion||0
8516515|NCT00408499|20991624|P2|NOT COMPLETED|Phase II- MTD Expansion||0
8516516|NCT00408499|20991625|P1|NOT COMPLETED|Phase II- MTD Expansion||0
8516517|NCT00408499|20991621|P5|COMPLETED|Phase II- MTD Expansion||24
8516518|NCT00408499|20991622|P4|COMPLETED|Phase II- MTD Expansion||0
8516519|NCT00408499|20991623|P3|COMPLETED|Phase II- MTD Expansion||0
8516520|NCT00408499|20991624|P2|COMPLETED|Phase II- MTD Expansion||0
8516521|NCT00408499|20991625|P1|COMPLETED|Phase II- MTD Expansion||0
8516522|NCT00408499|20991621|P5|STARTED|Phase II- MTD Expansion||44
8516523|NCT00408499|20991622|P4|STARTED|Phase II- MTD Expansion||0
8516524|NCT00408499|20991623|P3|STARTED|Phase II- MTD Expansion||0
8516525|NCT00408499|20991624|P2|STARTED|Phase II- MTD Expansion||0
8516526|NCT00408499|20991625|P1|STARTED|Phase II- MTD Expansion||0
8516527|NCT00408499|20991621|P5|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
8516528|NCT00408499|20991622|P4|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
8516529|NCT00408499|20991623|P3|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
8516530|NCT00408499|20991624|P2|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
8516531|NCT00408499|20991625|P1|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
8516532|NCT00408499|20991621|P5|COMPLETED|Phase 1: Dose Levels 1-4||0
8516533|NCT00408499|20991622|P4|COMPLETED|Phase 1: Dose Levels 1-4||6
8516534|NCT00408499|20991623|P3|COMPLETED|Phase 1: Dose Levels 1-4||2
8516535|NCT00408499|20991624|P2|COMPLETED|Phase 1: Dose Levels 1-4||5
8516536|NCT00408499|20991625|P1|COMPLETED|Phase 1: Dose Levels 1-4||2
8516537|NCT00408499|20991621|P5|STARTED|Phase 1: Dose Levels 1-4||0
8516538|NCT00408499|20991622|P4|STARTED|Phase 1: Dose Levels 1-4||6
8516539|NCT00408499|20991623|P3|STARTED|Phase 1: Dose Levels 1-4||3
8516540|NCT00408499|20991624|P2|STARTED|Phase 1: Dose Levels 1-4||7
8516541|NCT00408499|20991625|P1|STARTED|Phase 1: Dose Levels 1-4||4
8516542|NCT00408460|20991634|P1|NOT COMPLETED|Overall Study||0
8516543|NCT00408460|20991634|P1|COMPLETED|Overall Study||34
8516544|NCT00408460|20991634|P1|STARTED|Overall Study||34
8516545|NCT00408434|20991647|P7|NOT COMPLETED|Overall Study||4
8516546|NCT00408434|20991648|P6|NOT COMPLETED|Overall Study||3
8516547|NCT00408434|20991649|P5|NOT COMPLETED|Overall Study||6
8516548|NCT00408434|20991650|P4|NOT COMPLETED|Overall Study||3
8516549|NCT00408434|20991651|P3|NOT COMPLETED|Overall Study||6
8516550|NCT00408434|20991652|P2|NOT COMPLETED|Overall Study||3
8516551|NCT00408434|20991653|P1|NOT COMPLETED|Overall Study||6
8516552|NCT00408434|20991647|P7|COMPLETED|Overall Study||0
8516553|NCT00408434|20991648|P6|COMPLETED|Overall Study||0
8516554|NCT00408434|20991649|P5|COMPLETED|Overall Study||0
8516555|NCT00408434|20991650|P4|COMPLETED|Overall Study||0
8516556|NCT00408434|20991651|P3|COMPLETED|Overall Study||0
8516557|NCT00408434|20991652|P2|COMPLETED|Overall Study||0
8516558|NCT00408434|20991653|P1|COMPLETED|Overall Study||0
8516559|NCT00408434|20991647|P7|STARTED|Overall Study||4
8516560|NCT00408434|20991648|P6|STARTED|Overall Study||3
8516561|NCT00408434|20991649|P5|STARTED|Overall Study||6
8516562|NCT00408434|20991650|P4|STARTED|Overall Study||3
8516563|NCT00408434|20991651|P3|STARTED|Overall Study||6
8516564|NCT00408434|20991652|P2|STARTED|Overall Study||3
8516565|NCT00408434|20991653|P1|STARTED|Overall Study||6
8516566|NCT00408421|20991700|P3|NOT COMPLETED|Treatment Re-Randomization||5
8516567|NCT00408421|20991701|P2|NOT COMPLETED|Treatment Re-Randomization||7
8516568|NCT00408421|20991702|P1|NOT COMPLETED|Treatment Re-Randomization||7
8516569|NCT00408421|20991700|P3|COMPLETED|Treatment Re-Randomization||38
8516570|NCT00408421|20991701|P2|COMPLETED|Treatment Re-Randomization||39
8516571|NCT00408421|20991702|P1|COMPLETED|Treatment Re-Randomization||96
8516572|NCT00408421|20991700|P3|STARTED|Treatment Re-Randomization||43
8516573|NCT00408421|20991701|P2|STARTED|Treatment Re-Randomization||46
8516574|NCT00408421|20991702|P1|STARTED|Treatment Re-Randomization||103
8516575|NCT00408421|20991700|P3|NOT COMPLETED|Treatment Initial Randomization||0
8516576|NCT00408421|20991701|P2|NOT COMPLETED|Treatment Initial Randomization||22
8516577|NCT00408421|20991702|P1|NOT COMPLETED|Treatment Initial Randomization||17
8516578|NCT00408421|20991700|P3|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
8516579|NCT00408421|20991701|P2|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
8516580|NCT00408421|20991702|P1|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
8516581|NCT00408421|20991700|P3|STARTED|Treatment Initial Randomization||0
8516582|NCT00408421|20991701|P2|STARTED|Treatment Initial Randomization||111
8516583|NCT00408421|20991702|P1|STARTED|Treatment Initial Randomization||120
8516584|NCT00408408|20991782|P6|NOT COMPLETED|Overall Study||3
8516585|NCT00408408|20991783|P5|NOT COMPLETED|Overall Study||5
8516586|NCT00408408|20991784|P4|NOT COMPLETED|Overall Study||7
8516587|NCT00408408|20991785|P3|NOT COMPLETED|Overall Study||0
8516588|NCT00408408|20991786|P2|NOT COMPLETED|Overall Study||3
8516589|NCT00408408|20991787|P1|NOT COMPLETED|Overall Study||2
8516590|NCT00408408|20991782|P6|COMPLETED|Overall Study||201
8516591|NCT00408408|20991783|P5|COMPLETED|Overall Study||192
8516592|NCT00408408|20991784|P4|COMPLETED|Overall Study||194
8516593|NCT00408408|20991785|P3|COMPLETED|Overall Study||204
8516594|NCT00408408|20991786|P2|COMPLETED|Overall Study||196
8516595|NCT00408408|20991787|P1|COMPLETED|Overall Study||199
8516596|NCT00408408|20991782|P6|STARTED|Overall Study||204
8516597|NCT00408408|20991783|P5|STARTED|Overall Study||197
8516598|NCT00408408|20991784|P4|STARTED|Overall Study||201
8516599|NCT00408408|20991785|P3|STARTED|Overall Study||204
8516600|NCT00408408|20991786|P2|STARTED|Overall Study||199
8516601|NCT00408408|20991787|P1|STARTED|Overall Study||201
8516602|NCT00408317|20991849|P2|NOT COMPLETED|Second Intervention Period||2
8516603|NCT00408317|20991850|P1|NOT COMPLETED|Second Intervention Period||2
8516604|NCT00408317|20991849|P2|COMPLETED|Second Intervention Period||14
8516605|NCT00408317|20991850|P1|COMPLETED|Second Intervention Period||12
8516606|NCT00408317|20991849|P2|STARTED|Second Intervention Period||16
8516607|NCT00408317|20991850|P1|STARTED|Second Intervention Period||14
8516608|NCT00408317|20991849|P2|NOT COMPLETED|First Intervention Period||1
8516609|NCT00408317|20991850|P1|NOT COMPLETED|First Intervention Period||0
8516610|NCT00408317|20991849|P2|COMPLETED|First Intervention Period||16
8516611|NCT00408317|20991850|P1|COMPLETED|First Intervention Period||14
8516612|NCT00408317|20991849|P2|STARTED|First Intervention Period||17
8516613|NCT00408317|20991850|P1|STARTED|First Intervention Period||14
8516614|NCT00408200|20991864|P2|NOT COMPLETED|Overall Study||0
8516615|NCT00408200|20991865|P1|NOT COMPLETED|Overall Study||0
8516616|NCT00408200|20991864|P2|COMPLETED|Overall Study||53
8516617|NCT00408200|20991865|P1|COMPLETED|Overall Study||57
8516618|NCT00408200|20991864|P2|STARTED|Overall Study||53
8516619|NCT00408200|20991865|P1|STARTED|Overall Study||57
8516620|NCT00408070|20991873|P1|NOT COMPLETED|Overall Study||0
8516621|NCT00408070|20991873|P1|COMPLETED|Overall Study||5
8516622|NCT00408070|20991873|P1|STARTED|Overall Study||5
8516735|NCT00407966|20991920|P1|NOT COMPLETED|Overall Study||0
8516736|NCT00407966|20991920|P1|COMPLETED|Overall Study||45
8516737|NCT00407966|20991920|P1|CR|Overall Study||30
8516738|NCT00407966|20991920|P1|STARTED|Overall Study||45
8516739|NCT00407888|20991924|P1|NOT COMPLETED|Overall Study||0
8516740|NCT00407888|20991924|P1|COMPLETED|Overall Study||60
8516741|NCT00407888|20991924|P1|STARTED|Overall Study||60
8516742|NCT00407797|20991932|P1|NOT COMPLETED|Overall Study||18
8516743|NCT00407797|20991932|P1|COMPLETED|Overall Study||118
8516744|NCT00407797|20991932|P1|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
8516745|NCT00407797|20991932|P1|STARTED|Overall Study||136
8516746|NCT00407758|20991947|P1|NOT COMPLETED|Overall Study||1
8516747|NCT00407758|20991947|P1|COMPLETED|Overall Study||27
8516748|NCT00407758|20991947|P1|STARTED|Overall Study||28
8516749|NCT00407745|20991960|P2|NOT COMPLETED|Overall Study||17
8516750|NCT00407745|20991961|P1|NOT COMPLETED|Overall Study||19
8516751|NCT00407745|20991960|P2|COMPLETED|Overall Study||91
8516752|NCT00407745|20991961|P1|COMPLETED|Overall Study||93
8516753|NCT00407745|20991960|P2|Treated|Overall Study||107
8516754|NCT00407745|20991961|P1|Treated|Overall Study||112
8516755|NCT00407745|20991960|P2|STARTED|Overall Study||108
8516756|NCT00407745|20991961|P1|STARTED|Overall Study||112
8516757|NCT00407654|20992033|P1|NOT COMPLETED|Overall Study||0
8516758|NCT00407654|20992033|P1|COMPLETED|Overall Study||75
8516759|NCT00407654|20992033|P1|STARTED|Overall Study||75
8516760|NCT00407563|20992047|P1|NOT COMPLETED|Overall Study||1
8516761|NCT00407563|20992047|P1|COMPLETED|Overall Study|One patient remains on study treatment.|47
8516762|NCT00407563|20992047|P1|STARTED|Overall Study||48
8516763|NCT00407550|20992057|P2|NOT COMPLETED|Overall Study||4
8516764|NCT00407550|20992058|P1|NOT COMPLETED|Overall Study||3
8516765|NCT00407550|20992057|P2|COMPLETED|Overall Study||5
8516766|NCT00407550|20992058|P1|COMPLETED|Overall Study||7
8516767|NCT00407550|20992057|P2|STARTED|Overall Study||9
8516768|NCT00407550|20992058|P1|STARTED|Overall Study||10
8516772|NCT00407485|20992084|P1|NOT COMPLETED|Overall Study||0
8516773|NCT00407485|20992084|P1|COMPLETED|Overall Study||22
8516774|NCT00407485|20992084|P1|STARTED|Overall Study||22
8516775|NCT00407420|20992091|P2|NOT COMPLETED|Overall Study||6
8516776|NCT00407420|20992092|P1|NOT COMPLETED|Overall Study||9
8516777|NCT00407420|20992091|P2|COMPLETED|Overall Study||46
8516778|NCT00407420|20992092|P1|COMPLETED|Overall Study||45
8516779|NCT00407420|20992091|P2|STARTED|Overall Study||52
8516780|NCT00407420|20992092|P1|STARTED|Overall Study||54
8516781|NCT00407381|20992107|P3|NOT COMPLETED|Overall Study||2
8516782|NCT00407381|20992108|P2|NOT COMPLETED|Overall Study||4
8516783|NCT00407381|20992109|P1|NOT COMPLETED|Overall Study||3
8516784|NCT00407381|20992107|P3|COMPLETED|Overall Study||40
8516785|NCT00407381|20992108|P2|COMPLETED|Overall Study||38
8516786|NCT00407381|20992109|P1|COMPLETED|Overall Study||39
8516787|NCT00407381|20992107|P3|STARTED|Overall Study||42
8516788|NCT00407381|20992108|P2|STARTED|Overall Study||42
8516789|NCT00407381|20992109|P1|STARTED|Overall Study||42
8516790|NCT00407355|20992119|P2|NOT COMPLETED|Overall Study||11
8516791|NCT00407355|20992120|P1|NOT COMPLETED|Overall Study||10
8516792|NCT00407355|20992119|P2|COMPLETED|Overall Study||9
8516793|NCT00407355|20992120|P1|COMPLETED|Overall Study||10
8516794|NCT00407355|20992119|P2|STARTED|Overall Study||20
8516795|NCT00407355|20992120|P1|STARTED|Overall Study||20
8516796|NCT00407030|20992131|P3|NOT COMPLETED|Extension Period - up to 68 Weeks||0
8516797|NCT00407030|20992132|P2|NOT COMPLETED|Extension Period - up to 68 Weeks||29
8516798|NCT00407030|20992133|P1|NOT COMPLETED|Extension Period - up to 68 Weeks||27
8516799|NCT00407030|20992131|P3|COMPLETED|Extension Period - up to 68 Weeks||0
8516800|NCT00407030|20992132|P2|COMPLETED|Extension Period - up to 68 Weeks||74
8516801|NCT00407030|20992133|P1|COMPLETED|Extension Period - up to 68 Weeks||84
8516802|NCT00407030|20992131|P3|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
8516803|NCT00407030|20992132|P2|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
8516804|NCT00407030|20992133|P1|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
8516805|NCT00407030|20992131|P3|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
8516806|NCT00407030|20992132|P2|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
8516807|NCT00407030|20992133|P1|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
8516808|NCT00407030|20992131|P3|COMPLETED|Main Period - 8 to 20 Weeks||68
8516809|NCT00407030|20992132|P2|COMPLETED|Main Period - 8 to 20 Weeks||75
8516810|NCT00407030|20992133|P1|COMPLETED|Main Period - 8 to 20 Weeks||76
8516811|NCT00407030|20992131|P3|STARTED|Main Period - 8 to 20 Weeks||74
8516812|NCT00407030|20992132|P2|STARTED|Main Period - 8 to 20 Weeks||78
8516813|NCT00407030|20992133|P1|STARTED|Main Period - 8 to 20 Weeks||81
8516814|NCT00406848|20992161|P2|NOT COMPLETED|Overall Study||54
8516815|NCT00406848|20992162|P1|NOT COMPLETED|Overall Study||93
8516816|NCT00406848|20992161|P2|COMPLETED|Overall Study||67
8516817|NCT00406848|20992162|P1|COMPLETED|Overall Study||156
8516818|NCT00406848|20992161|P2|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
8516819|NCT00406848|20992162|P1|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
8516820|NCT00406783|20992226|P2|NOT COMPLETED|Overall Study||15
8516821|NCT00406783|20992227|P1|NOT COMPLETED|Overall Study||14
8516822|NCT00406783|20992226|P2|COMPLETED|Overall Study||256
8516823|NCT00406783|20992227|P1|COMPLETED|Overall Study||262
8516824|NCT00406783|20992226|P2|STARTED|Overall Study||271
8516825|NCT00406783|20992227|P1|STARTED|Overall Study||276
8516826|NCT00406718|20992242|P3|NOT COMPLETED|Overall Study||8
8516827|NCT00406718|20992243|P2|NOT COMPLETED|Overall Study||14
8516828|NCT00406718|20992244|P1|NOT COMPLETED|Overall Study||4
8516829|NCT00406718|20992242|P3|COMPLETED|Overall Study||39
8516830|NCT00406718|20992243|P2|COMPLETED|Overall Study||34
8516831|NCT00406718|20992244|P1|COMPLETED|Overall Study||43
8516832|NCT00406718|20992242|P3|STARTED|Overall Study||47
8516833|NCT00406718|20992243|P2|STARTED|Overall Study||48
8516834|NCT00406718|20992244|P1|STARTED|Overall Study||47
8516835|NCT00406692|20992258|P1|NOT COMPLETED|Overall Study||7
8516836|NCT00406692|20992258|P1|COMPLETED|Overall Study||9
8516837|NCT00406692|20992258|P1|STARTED|Overall Study||16
8516838|NCT00406653|20992268|P7|NOT COMPLETED|Open-Label Period||324
8516839|NCT00406653|20992269|P6|NOT COMPLETED|Open-Label Period||0
8516840|NCT00406653|20992270|P5|NOT COMPLETED|Open-Label Period||0
8516841|NCT00406653|20992271|P4|NOT COMPLETED|Open-Label Period||0
8516842|NCT00406653|20992272|P3|NOT COMPLETED|Open-Label Period||0
8516843|NCT00406653|20992273|P2|NOT COMPLETED|Open-Label Period||0
8516844|NCT00406653|20992274|P1|NOT COMPLETED|Open-Label Period||0
8516845|NCT00406653|20992268|P7|COMPLETED|Open-Label Period||0
8516846|NCT00406653|20992269|P6|COMPLETED|Open-Label Period||0
8516847|NCT00406653|20992270|P5|COMPLETED|Open-Label Period||0
8516848|NCT00406653|20992271|P4|COMPLETED|Open-Label Period||0
8516849|NCT00406653|20992272|P3|COMPLETED|Open-Label Period||0
8516850|NCT00406653|20992273|P2|COMPLETED|Open-Label Period||0
8516851|NCT00406653|20992274|P1|COMPLETED|Open-Label Period||0
8516852|NCT00406653|20992268|P7|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
8516853|NCT00406653|20992269|P6|STARTED|Open-Label Period||0
8516854|NCT00406653|20992270|P5|STARTED|Open-Label Period||0
8516855|NCT00406653|20992271|P4|STARTED|Open-Label Period||0
8516856|NCT00406653|20992272|P3|STARTED|Open-Label Period||0
8516857|NCT00406653|20992273|P2|STARTED|Open-Label Period||0
8516858|NCT00406653|20992274|P1|STARTED|Open-Label Period||0
8516859|NCT00406653|20992268|P7|NOT COMPLETED|Maintenance Period||0
8516860|NCT00406653|20992269|P6|NOT COMPLETED|Maintenance Period||36
8516861|NCT00406653|20992270|P5|NOT COMPLETED|Maintenance Period||30
8516862|NCT00406653|20992271|P4|NOT COMPLETED|Maintenance Period||0
8516863|NCT00406653|20992272|P3|NOT COMPLETED|Maintenance Period||0
8516864|NCT00406653|20992273|P2|NOT COMPLETED|Maintenance Period||0
8516865|NCT00406653|20992274|P1|NOT COMPLETED|Maintenance Period||0
8516866|NCT00406653|20992268|P7|COMPLETED|Maintenance Period||0
8516867|NCT00406653|20992269|P6|COMPLETED|Maintenance Period||10
8516868|NCT00406653|20992270|P5|COMPLETED|Maintenance Period||14
8516869|NCT00406653|20992271|P4|COMPLETED|Maintenance Period||0
8516870|NCT00406653|20992272|P3|COMPLETED|Maintenance Period||0
8516871|NCT00406653|20992273|P2|COMPLETED|Maintenance Period||0
8516872|NCT00406653|20992274|P1|COMPLETED|Maintenance Period||0
8516873|NCT00406653|20992268|P7|STARTED|Maintenance Period||0
8516874|NCT00406653|20992269|P6|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
8516875|NCT00406653|20992270|P5|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
8516876|NCT00406653|20992271|P4|STARTED|Maintenance Period||0
8516877|NCT00406653|20992272|P3|STARTED|Maintenance Period||0
8516878|NCT00406653|20992273|P2|STARTED|Maintenance Period||0
8516879|NCT00406653|20992274|P1|STARTED|Maintenance Period||0
8516880|NCT00406653|20992268|P7|NOT COMPLETED|Induction Period||0
8516881|NCT00406653|20992269|P6|NOT COMPLETED|Induction Period||0
8516882|NCT00406653|20992270|P5|NOT COMPLETED|Induction Period||0
8516883|NCT00406653|20992271|P4|NOT COMPLETED|Induction Period||26
8516884|NCT00406653|20992272|P3|NOT COMPLETED|Induction Period||18
8516885|NCT00406653|20992273|P2|NOT COMPLETED|Induction Period||34
8516886|NCT00406653|20992274|P1|NOT COMPLETED|Induction Period||15
8516887|NCT00406653|20992268|P7|COMPLETED|Induction Period||0
8516888|NCT00406653|20992269|P6|COMPLETED|Induction Period||0
8516889|NCT00406653|20992270|P5|COMPLETED|Induction Period||0
8516890|NCT00406653|20992271|P4|COMPLETED|Induction Period||102
8516891|NCT00406653|20992272|P3|COMPLETED|Induction Period||112
8516892|NCT00406653|20992273|P2|COMPLETED|Induction Period||94
8516893|NCT00406653|20992274|P1|COMPLETED|Induction Period||50
8516894|NCT00406653|20992268|P7|STARTED|Induction Period||0
8516895|NCT00406653|20992269|P6|STARTED|Induction Period||0
8516896|NCT00406653|20992270|P5|STARTED|Induction Period||0
8516897|NCT00406653|20992271|P4|STARTED|Induction Period||128
8516898|NCT00406653|20992272|P3|STARTED|Induction Period||130
8516899|NCT00406653|20992273|P2|STARTED|Induction Period||128
8516900|NCT00406653|20992274|P1|STARTED|Induction Period||65
8516901|NCT00406640|20992355|P2|NOT COMPLETED|OL Extension Phase for Non-Responders||24
8516902|NCT00406640|20992356|P1|NOT COMPLETED|OL Extension Phase for Non-Responders||22
8516903|NCT00406640|20992355|P2|COMPLETED|OL Extension Phase for Non-Responders||36
8516904|NCT00406640|20992356|P1|COMPLETED|OL Extension Phase for Non-Responders||47
8516905|NCT00406640|20992355|P2|STARTED|OL Extension Phase for Non-Responders||60
8516906|NCT00406640|20992356|P1|STARTED|OL Extension Phase for Non-Responders||69
8516907|NCT00406640|20992355|P2|NOT COMPLETED|DB Continuation Phase for Responders||37
8516908|NCT00406640|20992356|P1|NOT COMPLETED|DB Continuation Phase for Responders||33
8516909|NCT00406640|20992355|P2|COMPLETED|DB Continuation Phase for Responders||151
8516910|NCT00406640|20992356|P1|COMPLETED|DB Continuation Phase for Responders||139
8516911|NCT00406640|20992355|P2|STARTED|DB Continuation Phase for Responders||188
8516912|NCT00406640|20992356|P1|STARTED|DB Continuation Phase for Responders||172
8516913|NCT00406640|20992355|P2|NOT COMPLETED|Acute Phase||43
8516914|NCT00406640|20992356|P1|NOT COMPLETED|Acute Phase||51
8516915|NCT00406640|20992355|P2|COMPLETED|Acute Phase||256
8516916|NCT00406640|20992356|P1|COMPLETED|Acute Phase||245
8516917|NCT00406640|20992355|P2|STARTED|Acute Phase||299
8516918|NCT00406640|20992356|P1|STARTED|Acute Phase||296
8516919|NCT00406419|20992389|P3|NOT COMPLETED|Overall Study||347
8516920|NCT00406419|20992390|P2|NOT COMPLETED|Overall Study||344
8516921|NCT00406419|20992391|P1|NOT COMPLETED|Overall Study||324
8516922|NCT00406419|20992389|P3|COMPLETED|Overall Study||0
8516923|NCT00406419|20992390|P2|COMPLETED|Overall Study||0
8516924|NCT00406419|20992391|P1|COMPLETED|Overall Study||0
8516925|NCT00406419|20992389|P3|STARTED|Overall Study||347
8516926|NCT00406419|20992390|P2|STARTED|Overall Study||344
8516927|NCT00406419|20992391|P1|STARTED|Overall Study||324
8516928|NCT00406393|20992476|P2|NOT COMPLETED|Overall Study||1
8516929|NCT00406393|20992477|P1|NOT COMPLETED|Overall Study||2
8516930|NCT00406393|20992476|P2|COMPLETED|Overall Study||152
8516931|NCT00406393|20992477|P1|COMPLETED|Overall Study||149
8516932|NCT00406393|20992476|P2|STARTED|Overall Study||153
8516933|NCT00406393|20992477|P1|STARTED|Overall Study||151
8516934|NCT00406367|20992507|P2|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
8516935|NCT00406367|20992508|P1|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
8516936|NCT00406367|20992507|P2|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
8516937|NCT00406367|20992508|P1|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
8516938|NCT00406367|20992507|P2|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
8516939|NCT00406367|20992508|P1|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
8516940|NCT00406367|20992507|P2|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
8516941|NCT00406367|20992508|P1|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
8516942|NCT00406367|20992507|P2|COMPLETED|Main Period - 6 to 20 Weeks||32
8516943|NCT00406367|20992508|P1|COMPLETED|Main Period - 6 to 20 Weeks||70
8516944|NCT00406367|20992507|P2|STARTED|Main Period - 6 to 20 Weeks||34
8516945|NCT00406367|20992508|P1|STARTED|Main Period - 6 to 20 Weeks||75
8516946|NCT00406354|20992523|P3|NOT COMPLETED|All Randomized and Treated Patients||22
8516947|NCT00406354|20992524|P2|NOT COMPLETED|All Randomized and Treated Patients||13
8516948|NCT00406354|20992525|P1|NOT COMPLETED|All Randomized and Treated Patients||16
8516949|NCT00406354|20992523|P3|COMPLETED|All Randomized and Treated Patients||37
8516950|NCT00406354|20992524|P2|COMPLETED|All Randomized and Treated Patients||48
8516951|NCT00406354|20992525|P1|COMPLETED|All Randomized and Treated Patients||44
8516952|NCT00406354|20992523|P3|STARTED|All Randomized and Treated Patients||59
8516953|NCT00406354|20992524|P2|STARTED|All Randomized and Treated Patients||61
8516954|NCT00406354|20992525|P1|STARTED|All Randomized and Treated Patients||60
8516955|NCT00406354|20992523|P3|NOT COMPLETED|All Randomized Patients||1
8516956|NCT00406354|20992524|P2|NOT COMPLETED|All Randomized Patients||0
8516957|NCT00406354|20992525|P1|NOT COMPLETED|All Randomized Patients||0
8516958|NCT00406354|20992523|P3|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
8516959|NCT00406354|20992524|P2|COMPLETED|All Randomized Patients||61
8516960|NCT00406354|20992525|P1|COMPLETED|All Randomized Patients||60
8516961|NCT00406354|20992523|P3|STARTED|All Randomized Patients||60
8516962|NCT00406354|20992524|P2|STARTED|All Randomized Patients||61
8516963|NCT00406354|20992525|P1|STARTED|All Randomized Patients||60
8516967|NCT00406276|20992614|P1|NOT COMPLETED|Overall Study||4
8516968|NCT00406276|20992614|P1|COMPLETED|Overall Study||24
8516969|NCT00406276|20992614|P1|STARTED|Overall Study||28
8516970|NCT00406133|20992623|P4|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
8516971|NCT00406133|20992624|P3|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
8516972|NCT00406133|20992625|P2|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
8516973|NCT00406133|20992626|P1|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
8516974|NCT00406133|20992623|P4|COMPLETED|Phase 2 (Second 26 Week Period)||60
8516975|NCT00406133|20992624|P3|COMPLETED|Phase 2 (Second 26 Week Period)||67
8516976|NCT00406133|20992625|P2|COMPLETED|Phase 2 (Second 26 Week Period)||152
8516977|NCT00406133|20992626|P1|COMPLETED|Phase 2 (Second 26 Week Period)||157
8516978|NCT00406133|20992623|P4|STARTED|Phase 2 (Second 26 Week Period)||60
8516979|NCT00406133|20992624|P3|STARTED|Phase 2 (Second 26 Week Period)||67
8516980|NCT00406133|20992625|P2|STARTED|Phase 2 (Second 26 Week Period)||155
8516981|NCT00406133|20992626|P1|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
8516982|NCT00406133|20992623|P4|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
8516983|NCT00406133|20992624|P3|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
8516984|NCT00406133|20992625|P2|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
8516985|NCT00406133|20992626|P1|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
8516986|NCT00406133|20992623|P4|COMPLETED|Phase 1 (First 26 Week Period)||60
8516987|NCT00406133|20992624|P3|COMPLETED|Phase 1 (First 26 Week Period)||67
8516988|NCT00406133|20992625|P2|COMPLETED|Phase 1 (First 26 Week Period)||155
8516989|NCT00406133|20992626|P1|COMPLETED|Phase 1 (First 26 Week Period)||162
8516990|NCT00406133|20992623|P4|STARTED|Phase 1 (First 26 Week Period)||62
8516991|NCT00406133|20992624|P3|STARTED|Phase 1 (First 26 Week Period)||67
8516992|NCT00406133|20992625|P2|STARTED|Phase 1 (First 26 Week Period)||157
8516993|NCT00406133|20992626|P1|STARTED|Phase 1 (First 26 Week Period)||165
8516994|NCT00406107|20992690|P2|NOT COMPLETED|Overall Study||1
8516995|NCT00406107|20992691|P1|NOT COMPLETED|Overall Study||1
8516996|NCT00406107|20992690|P2|COMPLETED|Overall Study||4
8516997|NCT00406107|20992691|P1|COMPLETED|Overall Study||14
8516998|NCT00406107|20992690|P2|STARTED|Overall Study||5
8516999|NCT00406107|20992691|P1|STARTED|Overall Study||15
8517000|NCT00406029|20992706|P5|NOT COMPLETED|Overall Study||8
8517001|NCT00406029|20992707|P4|NOT COMPLETED|Overall Study||17
8517002|NCT00406029|20992708|P3|NOT COMPLETED|Overall Study||10
8517003|NCT00406029|20992709|P2|NOT COMPLETED|Overall Study||8
8517004|NCT00406029|20992710|P1|NOT COMPLETED|Overall Study||16
8517005|NCT00406029|20992706|P5|COMPLETED|Overall Study||41
8517006|NCT00406029|20992707|P4|COMPLETED|Overall Study||40
8517007|NCT00406029|20992708|P3|COMPLETED|Overall Study||39
8517008|NCT00406029|20992709|P2|COMPLETED|Overall Study||41
8517009|NCT00406029|20992710|P1|COMPLETED|Overall Study||33
8517010|NCT00406029|20992706|P5|Treated|Overall Study||47
8517011|NCT00406029|20992707|P4|Treated|Overall Study||54
8517012|NCT00406029|20992708|P3|Treated|Overall Study||47
8517013|NCT00406029|20992709|P2|Treated|Overall Study||49
8517014|NCT00406029|20992710|P1|Treated|Overall Study||49
8517015|NCT00406029|20992706|P5|STARTED|Overall Study||49
8517016|NCT00406029|20992707|P4|STARTED|Overall Study||57
8517017|NCT00406029|20992708|P3|STARTED|Overall Study||49
8517018|NCT00406029|20992709|P2|STARTED|Overall Study||49
8517019|NCT00406029|20992710|P1|STARTED|Overall Study||49
8517020|NCT00405964|20992814|P2|NOT COMPLETED|Overall Study||95
8517021|NCT00405964|20992815|P1|NOT COMPLETED|Overall Study||59
8517022|NCT00405964|20992814|P2|COMPLETED|Overall Study||261
8517023|NCT00405964|20992815|P1|COMPLETED|Overall Study||301
8517024|NCT00405964|20992814|P2|STARTED|Overall Study||356
8517025|NCT00405964|20992815|P1|STARTED|Overall Study||360
8517026|NCT00405938|20992827|P2|NOT COMPLETED|Overall Study||0
8517027|NCT00405938|20992828|P1|NOT COMPLETED|Overall Study||0
8517028|NCT00405938|20992827|P2|COMPLETED|Overall Study||41
8517029|NCT00405938|20992828|P1|COMPLETED|Overall Study||38
8517030|NCT00405938|20992827|P2|STARTED|Overall Study||41
8517031|NCT00405938|20992828|P1|STARTED|Overall Study||38
8517032|NCT00405912|20992837|P3|NOT COMPLETED|Overall Study||16
8517033|NCT00405912|20992838|P2|NOT COMPLETED|Overall Study||19
8517034|NCT00405912|20992839|P1|NOT COMPLETED|Overall Study||16
8517035|NCT00405912|20992837|P3|COMPLETED|Overall Study||23
8517036|NCT00405912|20992838|P2|COMPLETED|Overall Study||21
8517037|NCT00405912|20992839|P1|COMPLETED|Overall Study||23
8517038|NCT00405912|20992837|P3|STARTED|Overall Study||39
8517039|NCT00405912|20992838|P2|STARTED|Overall Study||40
8517040|NCT00405912|20992839|P1|STARTED|Overall Study||39
8517041|NCT00405821|20992852|P2|NOT COMPLETED|Overall Study||22
8517042|NCT00405821|20992853|P1|NOT COMPLETED|Overall Study||22
8517043|NCT00405821|20992852|P2|COMPLETED|Overall Study||198
8517044|NCT00405821|20992853|P1|COMPLETED|Overall Study||198
8517045|NCT00405821|20992852|P2|STARTED|Overall Study||220
8517046|NCT00405821|20992853|P1|STARTED|Overall Study||220
8517047|NCT00405756|20992866|P3|NOT COMPLETED|Follow-up||88
8517048|NCT00405756|20992867|P2|NOT COMPLETED|Follow-up||90
8517049|NCT00405756|20992868|P1|NOT COMPLETED|Follow-up||75
8517050|NCT00405756|20992866|P3|COMPLETED|Follow-up||0
8517051|NCT00405756|20992867|P2|COMPLETED|Follow-up||0
8517052|NCT00405756|20992868|P1|COMPLETED|Follow-up||0
8517053|NCT00405756|20992866|P3|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
8517054|NCT00405756|20992867|P2|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
8517055|NCT00405756|20992868|P1|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
8517056|NCT00405756|20992866|P3|NOT COMPLETED|Open-label Extension||72
8517057|NCT00405756|20992867|P2|NOT COMPLETED|Open-label Extension||47
8517058|NCT00405756|20992868|P1|NOT COMPLETED|Open-label Extension||19
8517059|NCT00405756|20992866|P3|COMPLETED|Open-label Extension||0
8517060|NCT00405756|20992867|P2|COMPLETED|Open-label Extension||0
8517061|NCT00405756|20992868|P1|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
8517062|NCT00405756|20992866|P3|STARTED|Open-label Extension||72
8517063|NCT00405756|20992867|P2|STARTED|Open-label Extension||47
8517064|NCT00405756|20992868|P1|STARTED|Open-label Extension||19
8517065|NCT00405756|20992866|P3|NOT COMPLETED|Double-blind Treatment||154
8517066|NCT00405756|20992867|P2|NOT COMPLETED|Double-blind Treatment||153
8517067|NCT00405756|20992868|P1|NOT COMPLETED|Double-blind Treatment||152
8517068|NCT00405756|20992866|P3|COMPLETED|Double-blind Treatment||0
8517069|NCT00405756|20992867|P2|COMPLETED|Double-blind Treatment||0
8517070|NCT00405756|20992868|P1|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
8517071|NCT00405756|20992866|P3|Safety Population|Double-blind Treatment||153
8517072|NCT00405756|20992867|P2|Safety Population|Double-blind Treatment||152
8517073|NCT00405756|20992868|P1|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
8517074|NCT00405756|20992866|P3|STARTED|Double-blind Treatment||154
8517075|NCT00405756|20992867|P2|STARTED|Double-blind Treatment||153
8517076|NCT00405756|20992868|P1|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
8517077|NCT00405704|20992958|P2|NOT COMPLETED|Overall Study||46
8517078|NCT00405704|20992959|P1|NOT COMPLETED|Overall Study||41
8517079|NCT00405704|20992958|P2|COMPLETED|Overall Study||259
8517080|NCT00405704|20992959|P1|COMPLETED|Overall Study||261
8517081|NCT00405704|20992958|P2|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
8517082|NCT00405704|20992959|P1|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
8517083|NCT00405704|20992958|P2|Recurrent UTI With E. Coli|Overall Study||57
8517084|NCT00405704|20992959|P1|Recurrent UTI With E. Coli|Overall Study||30
8517085|NCT00405704|20992958|P2|Outcome Stool Assessed|Overall Study||210
8517086|NCT00405704|20992959|P1|Outcome Stool Assessed|Overall Study||203
8517087|NCT00405704|20992958|P2|Completed Assessments for New Scarring|Overall Study||227
8517088|NCT00405704|20992959|P1|Completed Assessments for New Scarring|Overall Study||220
8517089|NCT00405704|20992958|P2|Completed Outcome Renal Scan|Overall Study||235
8517090|NCT00405704|20992959|P1|Completed Outcome Renal Scan|Overall Study||227
8517091|NCT00405704|20992958|P2|STARTED|Overall Study||305
8517092|NCT00405704|20992959|P1|STARTED|Overall Study||302
8517093|NCT00405652|20992979|P1|NOT COMPLETED|Overall Study||4
8517094|NCT00405652|20992979|P1|COMPLETED|Overall Study||30
8517095|NCT00405652|20992979|P1|STARTED|Overall Study||34
8517096|NCT00405639|20992986|P2|NOT COMPLETED|Overall Study||0
8517097|NCT00405639|20992987|P1|NOT COMPLETED|Overall Study||3
8517098|NCT00405639|20992986|P2|COMPLETED|Overall Study||12
8517099|NCT00405639|20992987|P1|COMPLETED|Overall Study||22
8517100|NCT00405639|20992986|P2|STARTED|Overall Study||12
8517101|NCT00405639|20992987|P1|STARTED|Overall Study||25
8517102|NCT00405587|20993003|P4|NOT COMPLETED|Overall Study||20
8517103|NCT00405587|20993004|P3|NOT COMPLETED|Overall Study||22
8517104|NCT00405587|20993005|P2|NOT COMPLETED|Overall Study||28
8517105|NCT00405587|20993006|P1|NOT COMPLETED|Overall Study||26
8517106|NCT00405587|20993003|P4|COMPLETED|Overall Study||1
8517107|NCT00405587|20993004|P3|COMPLETED|Overall Study||10
8517108|NCT00405587|20993005|P2|COMPLETED|Overall Study||2
8517109|NCT00405587|20993006|P1|COMPLETED|Overall Study||0
8517110|NCT00405587|20993003|P4|STARTED|Overall Study||21
8517111|NCT00405587|20993004|P3|STARTED|Overall Study||32
8517112|NCT00405587|20993005|P2|STARTED|Overall Study||30
8517113|NCT00405587|20993006|P1|STARTED|Overall Study||26
8517114|NCT00405548|20993124|P2|NOT COMPLETED|Overall Study||1
8517115|NCT00405548|20993125|P1|NOT COMPLETED|Overall Study||4
8517116|NCT00405548|20993124|P2|COMPLETED|Overall Study||12
8517117|NCT00405548|20993125|P1|COMPLETED|Overall Study||24
8517118|NCT00405548|20993124|P2|STARTED|Overall Study||13
8517119|NCT00405548|20993125|P1|STARTED|Overall Study||28
8517120|NCT00405522|20993139|P2|NOT COMPLETED|Overall Study||0
8517121|NCT00405522|20993140|P1|NOT COMPLETED|Overall Study||0
8517122|NCT00405522|20993139|P2|COMPLETED|Overall Study||17
8517123|NCT00405522|20993140|P1|COMPLETED|Overall Study||17
8517124|NCT00405522|20993139|P2|STARTED|Overall Study||17
8517125|NCT00405522|20993140|P1|STARTED|Overall Study||17
8517126|NCT00405509|20993152|P2|NOT COMPLETED|Overall Study||0
8517127|NCT00405509|20993153|P1|NOT COMPLETED|Overall Study||0
8517128|NCT00405509|20993152|P2|COMPLETED|Overall Study||22
8517129|NCT00405509|20993153|P1|COMPLETED|Overall Study||11
8517130|NCT00405509|20993152|P2|STARTED|Overall Study||22
8517131|NCT00405509|20993153|P1|STARTED|Overall Study||11
8517132|NCT00405392|20993169|P2|NOT COMPLETED|Overall Study||27
8517133|NCT00405392|20993170|P1|NOT COMPLETED|Overall Study||30
8517134|NCT00405392|20993169|P2|COMPLETED|Overall Study||155
8517135|NCT00405392|20993170|P1|COMPLETED|Overall Study||153
8517136|NCT00405392|20993169|P2|STARTED|Overall Study||182
8517137|NCT00405392|20993170|P1|STARTED|Overall Study||183
8517138|NCT00405353|20993180|P1|NOT COMPLETED|Overall Study||0
8517139|NCT00405353|20993180|P1|COMPLETED|Overall Study||10
8517140|NCT00405353|20993180|P1|STARTED|Overall Study||10
8517141|NCT00405288|20993186|P2|NOT COMPLETED|Overall Study||0
8517142|NCT00405288|20993187|P1|NOT COMPLETED|Overall Study||0
8517143|NCT00405288|20993186|P2|COMPLETED|Overall Study||204
8517144|NCT00405288|20993187|P1|COMPLETED|Overall Study||204
8517145|NCT00405288|20993186|P2|STARTED|Overall Study||204
8517146|NCT00405288|20993187|P1|STARTED|Overall Study||204
8517147|NCT00405275|20993217|P2|NOT COMPLETED|Overall Study||19
8517148|NCT00405275|20993218|P1|NOT COMPLETED|Overall Study||23
8517149|NCT00405275|20993217|P2|COMPLETED|Overall Study||156
8517150|NCT00405275|20993218|P1|COMPLETED|Overall Study||155
8517151|NCT00405275|20993217|P2|24 Week (Switch)|Overall Study||44
8517152|NCT00405275|20993218|P1|24 Week (Switch)|Overall Study||44
8517153|NCT00405275|20993217|P2|24 Week (no Switch)|Overall Study||121
8517154|NCT00405275|20993218|P1|24 Week (no Switch)|Overall Study||119
8517155|NCT00405275|20993217|P2|24 Weeks (Total)|Overall Study||165
8517156|NCT00405275|20993218|P1|24 Weeks (Total)|Overall Study||163
8517157|NCT00405275|20993217|P2|STARTED|Overall Study||175
8517158|NCT00405275|20993218|P1|STARTED|Overall Study||178
8517159|NCT00405067|20993227|P3|NOT COMPLETED|Overall Study||5
8517160|NCT00405067|20993228|P2|NOT COMPLETED|Overall Study||9
8517161|NCT00405067|20993229|P1|NOT COMPLETED|Overall Study||4
8517162|NCT00405067|20993227|P3|COMPLETED|Overall Study||24
8517163|NCT00405067|20993228|P2|COMPLETED|Overall Study||19
8517164|NCT00405067|20993229|P1|COMPLETED|Overall Study||24
8517165|NCT00405067|20993227|P3|STARTED|Overall Study||29
8517166|NCT00405067|20993228|P2|STARTED|Overall Study||28
8517167|NCT00405067|20993229|P1|STARTED|Overall Study||28
8517168|NCT00404924|20993266|P2|NOT COMPLETED|Overall Study||306
8517169|NCT00404924|20993267|P1|NOT COMPLETED|Overall Study||603
8517170|NCT00404924|20993266|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
8517171|NCT00404924|20993267|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
8517172|NCT00404924|20993266|P2|STARTED|Overall Study|randomised patients|307
8517173|NCT00404924|20993267|P1|STARTED|Overall Study|randomised patients|617
8517174|NCT00404820|20993285|P2|NOT COMPLETED|Overall Study||24
8517175|NCT00404820|20993286|P1|NOT COMPLETED|Overall Study||19
8517176|NCT00404820|20993285|P2|COMPLETED|Overall Study||172
8517177|NCT00404820|20993286|P1|COMPLETED|Overall Study||389
8517178|NCT00404820|20993285|P2|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
8517179|NCT00404820|20993286|P1|Started Treatment|Overall Study||408
8517180|NCT00404820|20993285|P2|STARTED|Overall Study||196
8517181|NCT00404820|20993286|P1|STARTED|Overall Study||408
8517182|NCT00404768|20993308|P4|NOT COMPLETED|Part C||14
8517183|NCT00404768|20993309|P3|NOT COMPLETED|Part C||8
8517184|NCT00404768|20993310|P2|NOT COMPLETED|Part C||0
8517185|NCT00404768|20993311|P1|NOT COMPLETED|Part C||0
8517186|NCT00404768|20993308|P4|COMPLETED|Part C||20
8517187|NCT00404768|20993309|P3|COMPLETED|Part C||22
8517188|NCT00404768|20993310|P2|COMPLETED|Part C||0
8517189|NCT00404768|20993311|P1|COMPLETED|Part C||0
8517190|NCT00404768|20993308|P4|STARTED|Part C||34
8517191|NCT00404768|20993309|P3|STARTED|Part C||30
8517192|NCT00404768|20993310|P2|STARTED|Part C||0
8517193|NCT00404768|20993311|P1|STARTED|Part C||0
8517194|NCT00404768|20993308|P4|NOT COMPLETED|Part A and B||0
8517195|NCT00404768|20993309|P3|NOT COMPLETED|Part A and B||0
8517196|NCT00404768|20993310|P2|NOT COMPLETED|Part A and B||1
8517197|NCT00404768|20993311|P1|NOT COMPLETED|Part A and B||1
8517198|NCT00404768|20993308|P4|COMPLETED|Part A and B||0
8517199|NCT00404768|20993309|P3|COMPLETED|Part A and B||0
8517200|NCT00404768|20993310|P2|COMPLETED|Part A and B||8
8517201|NCT00404768|20993311|P1|COMPLETED|Part A and B||19
8517202|NCT00404768|20993308|P4|STARTED|Part A and B||0
8517203|NCT00404768|20993309|P3|STARTED|Part A and B||0
8517204|NCT00404768|20993310|P2|STARTED|Part A and B||9
8517205|NCT00404768|20993311|P1|STARTED|Part A and B||20
8517206|NCT00404755|20993372|P1|NOT COMPLETED|Phase III (Imipramine)||0
8517207|NCT00404755|20993372|P1|COMPLETED|Phase III (Imipramine)||3
8517208|NCT00404755|20993372|P1|STARTED|Phase III (Imipramine)||3
8517209|NCT00404755|20993372|P1|NOT COMPLETED|Phase II (Escitalopram)||2
8517210|NCT00404755|20993372|P1|COMPLETED|Phase II (Escitalopram)||9
8517211|NCT00404755|20993372|P1|STARTED|Phase II (Escitalopram)||11
8517212|NCT00404755|20993372|P1|NOT COMPLETED|Phase I (Bupropion)||4
8517213|NCT00404755|20993372|P1|COMPLETED|Phase I (Bupropion)||13
8517214|NCT00404755|20993372|P1|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
8517215|NCT00404651|20993387|P4|NOT COMPLETED|Overall Study||21
8517216|NCT00404651|20993388|P3|NOT COMPLETED|Overall Study||45
8517217|NCT00404651|20993389|P2|NOT COMPLETED|Overall Study||28
8517218|NCT00404651|20993390|P1|NOT COMPLETED|Overall Study||39
8517219|NCT00404651|20993387|P4|COMPLETED|Overall Study||146
8517220|NCT00404651|20993388|P3|COMPLETED|Overall Study||294
8517221|NCT00404651|20993389|P2|COMPLETED|Overall Study||315
8517222|NCT00404651|20993390|P1|COMPLETED|Overall Study||301
8517223|NCT00404651|20993387|P4|STARTED|Overall Study||167
8517224|NCT00404651|20993388|P3|STARTED|Overall Study||339
8517225|NCT00404651|20993389|P2|STARTED|Overall Study||343
8517226|NCT00404651|20993390|P1|STARTED|Overall Study||340
8517227|NCT00404547|20993418|P2|NOT COMPLETED|Overall Study||25
8517228|NCT00404547|20993419|P1|NOT COMPLETED|Overall Study||90
8517229|NCT00404547|20993418|P2|COMPLETED|Overall Study||334
8517230|NCT00404547|20993419|P1|COMPLETED|Overall Study||672
8517231|NCT00404547|20993418|P2|STARTED|Overall Study||359
8517232|NCT00404547|20993419|P1|STARTED|Overall Study||762
8517233|NCT00404495|20993429|P2|NOT COMPLETED|Overall Study||11
8517234|NCT00404495|20993430|P1|NOT COMPLETED|Overall Study||44
8517235|NCT00404495|20993429|P2|COMPLETED|Overall Study||6
8517236|NCT00404495|20993430|P1|COMPLETED|Overall Study||22
8517237|NCT00404495|20993429|P2|STARTED|Overall Study||17
8517238|NCT00404495|20993430|P1|STARTED|Overall Study||66
8517239|NCT00404352|20993449|P9|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
8517240|NCT00404352|20993450|P8|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
8517241|NCT00404352|20993451|P7|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
8517242|NCT00404352|20993452|P6|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8517243|NCT00404352|20993453|P5|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8517244|NCT00404352|20993454|P4|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8517245|NCT00404352|20993455|P3|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8517246|NCT00404352|20993456|P2|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8517247|NCT00404352|20993457|P1|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
8517248|NCT00404352|20993449|P9|COMPLETED|Open Label Extension (up to 36 Months)||9
8517249|NCT00404352|20993450|P8|COMPLETED|Open Label Extension (up to 36 Months)||4
8517250|NCT00404352|20993451|P7|COMPLETED|Open Label Extension (up to 36 Months)||3
8517251|NCT00404352|20993452|P6|COMPLETED|Open Label Extension (up to 36 Months)||0
8517252|NCT00404352|20993453|P5|COMPLETED|Open Label Extension (up to 36 Months)||0
8517253|NCT00404352|20993454|P4|COMPLETED|Open Label Extension (up to 36 Months)||0
8517254|NCT00404352|20993455|P3|COMPLETED|Open Label Extension (up to 36 Months)||0
8517255|NCT00404352|20993456|P2|COMPLETED|Open Label Extension (up to 36 Months)||0
8517256|NCT00404352|20993457|P1|COMPLETED|Open Label Extension (up to 36 Months)||0
8517257|NCT00404352|20993449|P9|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
8517258|NCT00404352|20993450|P8|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
8517259|NCT00404352|20993451|P7|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
8517260|NCT00404352|20993452|P6|STARTED|Open Label Extension (up to 36 Months)||0
8517261|NCT00404352|20993453|P5|STARTED|Open Label Extension (up to 36 Months)||0
8517262|NCT00404352|20993454|P4|STARTED|Open Label Extension (up to 36 Months)||0
8517263|NCT00404352|20993455|P3|STARTED|Open Label Extension (up to 36 Months)||0
8517264|NCT00404352|20993456|P2|STARTED|Open Label Extension (up to 36 Months)||0
8517265|NCT00404352|20993457|P1|STARTED|Open Label Extension (up to 36 Months)||0
8517266|NCT00404352|20993449|P9|NOT COMPLETED|Open Label (up to 24 Month)||0
8517267|NCT00404352|20993450|P8|NOT COMPLETED|Open Label (up to 24 Month)||0
8517268|NCT00404352|20993451|P7|NOT COMPLETED|Open Label (up to 24 Month)||0
8517269|NCT00404352|20993452|P6|NOT COMPLETED|Open Label (up to 24 Month)||7
8517270|NCT00404352|20993453|P5|NOT COMPLETED|Open Label (up to 24 Month)||2
8517271|NCT00404352|20993454|P4|NOT COMPLETED|Open Label (up to 24 Month)||3
8517272|NCT00404352|20993455|P3|NOT COMPLETED|Open Label (up to 24 Month)||0
8517273|NCT00404352|20993456|P2|NOT COMPLETED|Open Label (up to 24 Month)||0
8517274|NCT00404352|20993457|P1|NOT COMPLETED|Open Label (up to 24 Month)||0
8517275|NCT00404352|20993449|P9|COMPLETED|Open Label (up to 24 Month)||0
8517276|NCT00404352|20993450|P8|COMPLETED|Open Label (up to 24 Month)||0
8517277|NCT00404352|20993451|P7|COMPLETED|Open Label (up to 24 Month)||0
8517278|NCT00404352|20993452|P6|COMPLETED|Open Label (up to 24 Month)||52
8517279|NCT00404352|20993453|P5|COMPLETED|Open Label (up to 24 Month)||28
8517280|NCT00404352|20993454|P4|COMPLETED|Open Label (up to 24 Month)||28
8517281|NCT00404352|20993455|P3|COMPLETED|Open Label (up to 24 Month)||0
8517282|NCT00404352|20993456|P2|COMPLETED|Open Label (up to 24 Month)||0
8517283|NCT00404352|20993457|P1|COMPLETED|Open Label (up to 24 Month)||0
8517284|NCT00404352|20993449|P9|STARTED|Open Label (up to 24 Month)||0
8517285|NCT00404352|20993450|P8|STARTED|Open Label (up to 24 Month)||0
8517286|NCT00404352|20993451|P7|STARTED|Open Label (up to 24 Month)||0
8517287|NCT00404352|20993452|P6|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
8517288|NCT00404352|20993453|P5|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
8517289|NCT00404352|20993454|P4|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
8517290|NCT00404352|20993455|P3|STARTED|Open Label (up to 24 Month)||0
8517291|NCT00404352|20993456|P2|STARTED|Open Label (up to 24 Month)||0
8517292|NCT00404352|20993457|P1|STARTED|Open Label (up to 24 Month)||0
8517293|NCT00404352|20993449|P9|NOT COMPLETED|Double Blind (up to 24 Month)||0
8517294|NCT00404352|20993450|P8|NOT COMPLETED|Double Blind (up to 24 Month)||0
8517295|NCT00404352|20993451|P7|NOT COMPLETED|Double Blind (up to 24 Month)||0
8517296|NCT00404352|20993452|P6|NOT COMPLETED|Double Blind (up to 24 Month)||0
8517297|NCT00404352|20993453|P5|NOT COMPLETED|Double Blind (up to 24 Month)||0
8517298|NCT00404352|20993454|P4|NOT COMPLETED|Double Blind (up to 24 Month)||0
8517299|NCT00404352|20993455|P3|NOT COMPLETED|Double Blind (up to 24 Month)||79
8517300|NCT00404352|20993456|P2|NOT COMPLETED|Double Blind (up to 24 Month)||47
8517301|NCT00404352|20993457|P1|NOT COMPLETED|Double Blind (up to 24 Month)||52
8517302|NCT00404352|20993449|P9|COMPLETED|Double Blind (up to 24 Month)||0
8517303|NCT00404352|20993450|P8|COMPLETED|Double Blind (up to 24 Month)||0
8517304|NCT00404352|20993451|P7|COMPLETED|Double Blind (up to 24 Month)||0
8517305|NCT00404352|20993452|P6|COMPLETED|Double Blind (up to 24 Month)||0
8517306|NCT00404352|20993453|P5|COMPLETED|Double Blind (up to 24 Month)||0
8517307|NCT00404352|20993454|P4|COMPLETED|Double Blind (up to 24 Month)||0
8517308|NCT00404352|20993455|P3|COMPLETED|Double Blind (up to 24 Month)||92
8517309|NCT00404352|20993456|P2|COMPLETED|Double Blind (up to 24 Month)||128
8517310|NCT00404352|20993457|P1|COMPLETED|Double Blind (up to 24 Month)||119
8517311|NCT00404352|20993449|P9|Treated|Double Blind (up to 24 Month)||0
8517312|NCT00404352|20993450|P8|Treated|Double Blind (up to 24 Month)||0
8517313|NCT00404352|20993451|P7|Treated|Double Blind (up to 24 Month)||0
8517314|NCT00404352|20993452|P6|Treated|Double Blind (up to 24 Month)||0
8517315|NCT00404352|20993453|P5|Treated|Double Blind (up to 24 Month)||0
8517316|NCT00404352|20993454|P4|Treated|Double Blind (up to 24 Month)||0
8517317|NCT00404352|20993455|P3|Treated|Double Blind (up to 24 Month)||171
8517318|NCT00404352|20993456|P2|Treated|Double Blind (up to 24 Month)||173
8517319|NCT00404352|20993457|P1|Treated|Double Blind (up to 24 Month)||171
8517320|NCT00404352|20993449|P9|STARTED|Double Blind (up to 24 Month)||0
8517321|NCT00404352|20993450|P8|STARTED|Double Blind (up to 24 Month)||0
8517322|NCT00404352|20993451|P7|STARTED|Double Blind (up to 24 Month)||0
8517323|NCT00404352|20993452|P6|STARTED|Double Blind (up to 24 Month)||0
8517324|NCT00404352|20993453|P5|STARTED|Double Blind (up to 24 Month)||0
8517325|NCT00404352|20993454|P4|STARTED|Double Blind (up to 24 Month)||0
8517326|NCT00404352|20993455|P3|STARTED|Double Blind (up to 24 Month)||171
8517327|NCT00404352|20993456|P2|STARTED|Double Blind (up to 24 Month)||175
8517328|NCT00404352|20993457|P1|STARTED|Double Blind (up to 24 Month)||171
8517329|NCT00404248|20993492|P9|NOT COMPLETED|Overall Study||0
8517330|NCT00404248|20993493|P8|NOT COMPLETED|Overall Study||0
8517331|NCT00404248|20993494|P7|NOT COMPLETED|Overall Study||0
8517332|NCT00404248|20993495|P6|NOT COMPLETED|Overall Study||0
8517333|NCT00404248|20993496|P5|NOT COMPLETED|Overall Study||0
8517334|NCT00404248|20993497|P4|NOT COMPLETED|Overall Study||0
8517335|NCT00404248|20993498|P3|NOT COMPLETED|Overall Study||0
8517336|NCT00404248|20993499|P2|NOT COMPLETED|Overall Study||1
8517337|NCT00404248|20993500|P1|NOT COMPLETED|Overall Study||0
8517338|NCT00404248|20993492|P9|COMPLETED|Overall Study||3
8517339|NCT00404248|20993493|P8|COMPLETED|Overall Study||6
8517340|NCT00404248|20993494|P7|COMPLETED|Overall Study||6
8517341|NCT00404248|20993495|P6|COMPLETED|Overall Study||3
8517342|NCT00404248|20993496|P5|COMPLETED|Overall Study||3
8517343|NCT00404248|20993497|P4|COMPLETED|Overall Study||2
8517344|NCT00404248|20993498|P3|COMPLETED|Overall Study||5
8517345|NCT00404248|20993499|P2|COMPLETED|Overall Study||3
8517346|NCT00404248|20993500|P1|COMPLETED|Overall Study||3
8517347|NCT00404248|20993492|P9|STARTED|Overall Study||3
8517348|NCT00404248|20993493|P8|STARTED|Overall Study||6
8517349|NCT00404248|20993494|P7|STARTED|Overall Study||6
8517350|NCT00404248|20993495|P6|STARTED|Overall Study||3
8517351|NCT00404248|20993496|P5|STARTED|Overall Study||3
8517352|NCT00404248|20993497|P4|STARTED|Overall Study||2
8517353|NCT00404248|20993498|P3|STARTED|Overall Study||5
8517354|NCT00404248|20993499|P2|STARTED|Overall Study||4
8517355|NCT00404248|20993500|P1|STARTED|Overall Study||3
8517356|NCT00404235|20993533|P2|NOT COMPLETED|Overall Study||2
8517357|NCT00404235|20993534|P1|NOT COMPLETED|Overall Study||1
8517358|NCT00404235|20993533|P2|COMPLETED|Overall Study||39
8517359|NCT00404235|20993534|P1|COMPLETED|Overall Study||34
8517360|NCT00404235|20993533|P2|STARTED|Overall Study||41
8517361|NCT00404235|20993534|P1|STARTED|Overall Study||35
8517362|NCT00404092|20993552|P4|NOT COMPLETED|Overall Study||0
8517363|NCT00404092|20993553|P3|NOT COMPLETED|Overall Study||1
8517364|NCT00404092|20993554|P2|NOT COMPLETED|Overall Study||0
8517365|NCT00404092|20993555|P1|NOT COMPLETED|Overall Study||1
8517366|NCT00404092|20993552|P4|COMPLETED|Overall Study||20
8517367|NCT00404092|20993553|P3|COMPLETED|Overall Study||8
8517368|NCT00404092|20993554|P2|COMPLETED|Overall Study||8
8517369|NCT00404092|20993555|P1|COMPLETED|Overall Study||8
8517370|NCT00404092|20993552|P4|STARTED|Overall Study||20
8517371|NCT00404092|20993553|P3|STARTED|Overall Study||9
8517372|NCT00404092|20993554|P2|STARTED|Overall Study||8
8517373|NCT00404092|20993555|P1|STARTED|Overall Study||9
8517374|NCT00404079|20993571|P2|NOT COMPLETED|Overall Study||20
8517375|NCT00404079|20993572|P1|NOT COMPLETED|Overall Study||22
8517376|NCT00404079|20993571|P2|COMPLETED|Overall Study||105
8517377|NCT00404079|20993572|P1|COMPLETED|Overall Study||103
8517378|NCT00404079|20993571|P2|STARTED|Overall Study||125
8517379|NCT00404079|20993572|P1|STARTED|Overall Study||125
8517380|NCT00404066|20993578|P1|NOT COMPLETED|Overall Study||3
8517381|NCT00404066|20993578|P1|COMPLETED|Overall Study||18
8517382|NCT00404066|20993578|P1|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
8517383|NCT00403845|20993583|P4|NOT COMPLETED|Treatment Period 4||0
8517384|NCT00403845|20993584|P3|NOT COMPLETED|Treatment Period 4||0
8517385|NCT00403845|20993585|P2|NOT COMPLETED|Treatment Period 4||0
8517386|NCT00403845|20993586|P1|NOT COMPLETED|Treatment Period 4||0
8517387|NCT00403845|20993583|P4|COMPLETED|Treatment Period 4||11
8517388|NCT00403845|20993584|P3|COMPLETED|Treatment Period 4||11
8517389|NCT00403845|20993585|P2|COMPLETED|Treatment Period 4||13
8517390|NCT00403845|20993586|P1|COMPLETED|Treatment Period 4||10
8517391|NCT00403845|20993583|P4|STARTED|Treatment Period 4||11
8517392|NCT00403845|20993584|P3|STARTED|Treatment Period 4||11
8517393|NCT00403845|20993585|P2|STARTED|Treatment Period 4||13
8517394|NCT00403845|20993586|P1|STARTED|Treatment Period 4||10
8517395|NCT00403845|20993583|P4|NOT COMPLETED|Treatment Period 3||2
8517396|NCT00403845|20993584|P3|NOT COMPLETED|Treatment Period 3||0
8517397|NCT00403845|20993585|P2|NOT COMPLETED|Treatment Period 3||0
8517398|NCT00403845|20993586|P1|NOT COMPLETED|Treatment Period 3||0
8517399|NCT00403845|20993583|P4|COMPLETED|Treatment Period 3||11
8517400|NCT00403845|20993584|P3|COMPLETED|Treatment Period 3||11
8517401|NCT00403845|20993585|P2|COMPLETED|Treatment Period 3||13
8517402|NCT00403845|20993586|P1|COMPLETED|Treatment Period 3||10
8517403|NCT00403845|20993583|P4|STARTED|Treatment Period 3||13
8517404|NCT00403845|20993584|P3|STARTED|Treatment Period 3||11
8517405|NCT00403845|20993585|P2|STARTED|Treatment Period 3||13
8517406|NCT00403845|20993586|P1|STARTED|Treatment Period 3||10
8517407|NCT00403845|20993583|P4|NOT COMPLETED|Treatment Period 2||0
8517408|NCT00403845|20993584|P3|NOT COMPLETED|Treatment Period 2||0
8517409|NCT00403845|20993585|P2|NOT COMPLETED|Treatment Period 2||0
8517410|NCT00403845|20993586|P1|NOT COMPLETED|Treatment Period 2||1
8517411|NCT00403845|20993583|P4|COMPLETED|Treatment Period 2||13
8517412|NCT00403845|20993584|P3|COMPLETED|Treatment Period 2||11
8517413|NCT00403845|20993585|P2|COMPLETED|Treatment Period 2||13
8517414|NCT00403845|20993586|P1|COMPLETED|Treatment Period 2||10
8517415|NCT00403845|20993583|P4|STARTED|Treatment Period 2||13
8517416|NCT00403845|20993584|P3|STARTED|Treatment Period 2||11
8517417|NCT00403845|20993585|P2|STARTED|Treatment Period 2||13
8517418|NCT00403845|20993586|P1|STARTED|Treatment Period 2||11
8517419|NCT00403845|20993583|P4|NOT COMPLETED|Treatment Period 1||1
8517420|NCT00403845|20993584|P3|NOT COMPLETED|Treatment Period 1||0
8517421|NCT00403845|20993585|P2|NOT COMPLETED|Treatment Period 1||0
8517422|NCT00403845|20993586|P1|NOT COMPLETED|Treatment Period 1||1
8517423|NCT00403845|20993583|P4|COMPLETED|Treatment Period 1||13
8517424|NCT00403845|20993584|P3|COMPLETED|Treatment Period 1||11
8517425|NCT00403845|20993585|P2|COMPLETED|Treatment Period 1||13
8517426|NCT00403845|20993586|P1|COMPLETED|Treatment Period 1||11
8517427|NCT00403845|20993583|P4|STARTED|Treatment Period 1||14
8517428|NCT00403845|20993584|P3|STARTED|Treatment Period 1||11
8517429|NCT00403845|20993585|P2|STARTED|Treatment Period 1||13
8517430|NCT00403845|20993586|P1|STARTED|Treatment Period 1||12
8517431|NCT00403767|20993610|P2|NOT COMPLETED|Overall Study||2468
8517432|NCT00403767|20993611|P1|NOT COMPLETED|Overall Study||2520
8517433|NCT00403767|20993610|P2|COMPLETED|Overall Study||4657
8517434|NCT00403767|20993611|P1|COMPLETED|Overall Study||4591
8517435|NCT00403767|20993610|P2|STARTED|Overall Study||7125
8517436|NCT00403767|20993611|P1|STARTED|Overall Study||7111
8517437|NCT00403754|20993635|P4|NOT COMPLETED|Open Label: Salmeterol||0
8517438|NCT00403754|20993636|P3|NOT COMPLETED|Open Label: Salmeterol||0
8517439|NCT00403754|20993637|P2|NOT COMPLETED|Open Label: Salmeterol||0
8517440|NCT00403754|20993638|P1|NOT COMPLETED|Open Label: Salmeterol||0
8517441|NCT00403754|20993635|P4|COMPLETED|Open Label: Salmeterol||11
8517442|NCT00403754|20993636|P3|COMPLETED|Open Label: Salmeterol||8
8517443|NCT00403754|20993637|P2|COMPLETED|Open Label: Salmeterol||9
8517444|NCT00403754|20993638|P1|COMPLETED|Open Label: Salmeterol||11
8517445|NCT00403754|20993635|P4|STARTED|Open Label: Salmeterol||11
8517446|NCT00403754|20993636|P3|STARTED|Open Label: Salmeterol||8
8517447|NCT00403754|20993637|P2|STARTED|Open Label: Salmeterol||9
8517448|NCT00403754|20993638|P1|STARTED|Open Label: Salmeterol||11
8517449|NCT00403754|20993635|P4|NOT COMPLETED|Core Treatment Period 4||0
8517450|NCT00403754|20993636|P3|NOT COMPLETED|Core Treatment Period 4||0
8517451|NCT00403754|20993637|P2|NOT COMPLETED|Core Treatment Period 4||0
8517452|NCT00403754|20993638|P1|NOT COMPLETED|Core Treatment Period 4||0
8517453|NCT00403754|20993635|P4|COMPLETED|Core Treatment Period 4||11
8517454|NCT00403754|20993636|P3|COMPLETED|Core Treatment Period 4||8
8517455|NCT00403754|20993637|P2|COMPLETED|Core Treatment Period 4||9
8517456|NCT00403754|20993638|P1|COMPLETED|Core Treatment Period 4||11
8517457|NCT00403754|20993635|P4|STARTED|Core Treatment Period 4||11
8517458|NCT00403754|20993636|P3|STARTED|Core Treatment Period 4||8
8517459|NCT00403754|20993637|P2|STARTED|Core Treatment Period 4||9
8517460|NCT00403754|20993638|P1|STARTED|Core Treatment Period 4||11
8517461|NCT00403754|20993635|P4|NOT COMPLETED|Core Treatment Period 3||0
8517462|NCT00403754|20993636|P3|NOT COMPLETED|Core Treatment Period 3||0
8517463|NCT00403754|20993637|P2|NOT COMPLETED|Core Treatment Period 3||0
8517464|NCT00403754|20993638|P1|NOT COMPLETED|Core Treatment Period 3||0
8517465|NCT00403754|20993635|P4|COMPLETED|Core Treatment Period 3||11
8517466|NCT00403754|20993636|P3|COMPLETED|Core Treatment Period 3||8
8517467|NCT00403754|20993637|P2|COMPLETED|Core Treatment Period 3||9
8517468|NCT00403754|20993638|P1|COMPLETED|Core Treatment Period 3||11
8517469|NCT00403754|20993635|P4|STARTED|Core Treatment Period 3||11
8517470|NCT00403754|20993636|P3|STARTED|Core Treatment Period 3||8
8517471|NCT00403754|20993637|P2|STARTED|Core Treatment Period 3||9
8517472|NCT00403754|20993638|P1|STARTED|Core Treatment Period 3||11
8517473|NCT00403754|20993635|P4|NOT COMPLETED|Core Treatment Period 2||0
8517474|NCT00403754|20993636|P3|NOT COMPLETED|Core Treatment Period 2||1
8517475|NCT00403754|20993637|P2|NOT COMPLETED|Core Treatment Period 2||0
8517476|NCT00403754|20993638|P1|NOT COMPLETED|Core Treatment Period 2||0
8517477|NCT00403754|20993635|P4|COMPLETED|Core Treatment Period 2||11
8517478|NCT00403754|20993636|P3|COMPLETED|Core Treatment Period 2||8
8517479|NCT00403754|20993637|P2|COMPLETED|Core Treatment Period 2||9
8517480|NCT00403754|20993638|P1|COMPLETED|Core Treatment Period 2||11
8517481|NCT00403754|20993635|P4|STARTED|Core Treatment Period 2||11
8517482|NCT00403754|20993636|P3|STARTED|Core Treatment Period 2||9
8517483|NCT00403754|20993637|P2|STARTED|Core Treatment Period 2||9
8517484|NCT00403754|20993638|P1|STARTED|Core Treatment Period 2||11
8517485|NCT00403754|20993635|P4|NOT COMPLETED|Core Treatment Period 1||0
8517486|NCT00403754|20993636|P3|NOT COMPLETED|Core Treatment Period 1||0
8517487|NCT00403754|20993637|P2|NOT COMPLETED|Core Treatment Period 1||1
8517488|NCT00403754|20993638|P1|NOT COMPLETED|Core Treatment Period 1||0
8517489|NCT00403754|20993635|P4|COMPLETED|Core Treatment Period 1||11
8517490|NCT00403754|20993636|P3|COMPLETED|Core Treatment Period 1||9
8517491|NCT00403754|20993637|P2|COMPLETED|Core Treatment Period 1||9
8517492|NCT00403754|20993638|P1|COMPLETED|Core Treatment Period 1||11
8517493|NCT00403754|20993635|P4|STARTED|Core Treatment Period 1||11
8517494|NCT00403754|20993636|P3|STARTED|Core Treatment Period 1||9
8517495|NCT00403754|20993637|P2|STARTED|Core Treatment Period 1||10
8517496|NCT00403754|20993638|P1|STARTED|Core Treatment Period 1||11
8517497|NCT00403585|20993665|P1|NOT COMPLETED|Open-Label Phase; Extension Study||6
8517498|NCT00403585|20993665|P1|COMPLETED|Open-Label Phase; Extension Study||74
8517499|NCT00403585|20993665|P1|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
8517500|NCT00403585|20993665|P1|NOT COMPLETED|Initial Treatment Phase||2
8517501|NCT00403585|20993665|P1|COMPLETED|Initial Treatment Phase||102
8517502|NCT00403585|20993665|P1|STARTED|Initial Treatment Phase||104
8517503|NCT00403546|20993676|P3|NOT COMPLETED|Randomized Trial||16
8517504|NCT00403546|20993677|P2|NOT COMPLETED|Randomized Trial||17
8517505|NCT00403546|20993678|P1|NOT COMPLETED|Randomized Trial||0
8517506|NCT00403546|20993676|P3|COMPLETED|Randomized Trial||21
8517507|NCT00403546|20993677|P2|COMPLETED|Randomized Trial||21
8517508|NCT00403546|20993678|P1|COMPLETED|Randomized Trial||0
8517509|NCT00403546|20993676|P3|STARTED|Randomized Trial||37
8517510|NCT00403546|20993677|P2|STARTED|Randomized Trial||38
8517511|NCT00403546|20993678|P1|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
8517512|NCT00403546|20993676|P3|NOT COMPLETED|Screening Phase||0
8517513|NCT00403546|20993677|P2|NOT COMPLETED|Screening Phase||0
8517514|NCT00403546|20993678|P1|NOT COMPLETED|Screening Phase||28
8517515|NCT00403546|20993676|P3|COMPLETED|Screening Phase||0
8517516|NCT00403546|20993677|P2|COMPLETED|Screening Phase||0
8517517|NCT00403546|20993678|P1|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
8517518|NCT00403546|20993676|P3|STARTED|Screening Phase||0
8517519|NCT00403546|20993677|P2|STARTED|Screening Phase||0
8517520|NCT00403546|20993678|P1|STARTED|Screening Phase||103
8517521|NCT00403546|20993676|P3|NOT COMPLETED|Signed Informed Consent/Open-Label||0
8517522|NCT00403546|20993677|P2|NOT COMPLETED|Signed Informed Consent/Open-Label||0
8517523|NCT00403546|20993678|P1|NOT COMPLETED|Signed Informed Consent/Open-Label||28
8517524|NCT00403546|20993676|P3|COMPLETED|Signed Informed Consent/Open-Label||0
8517525|NCT00403546|20993677|P2|COMPLETED|Signed Informed Consent/Open-Label||0
8517526|NCT00403546|20993678|P1|COMPLETED|Signed Informed Consent/Open-Label||103
8517527|NCT00403546|20993676|P3|STARTED|Signed Informed Consent/Open-Label||0
8517528|NCT00403546|20993677|P2|STARTED|Signed Informed Consent/Open-Label||0
8517529|NCT00403546|20993678|P1|STARTED|Signed Informed Consent/Open-Label||131
8517530|NCT00403494|20993720|P2|NOT COMPLETED|Overall Study||14
8517531|NCT00403494|20993721|P1|NOT COMPLETED|Overall Study||15
8517532|NCT00403494|20993720|P2|COMPLETED|Overall Study||80
8517533|NCT00403494|20993721|P1|COMPLETED|Overall Study||81
8517534|NCT00403494|20993720|P2|Safety Population|Overall Study||91
8517535|NCT00403494|20993721|P1|Safety Population|Overall Study||97
8517536|NCT00403494|20993720|P2|Per-protocol|Overall Study||69
8517537|NCT00403494|20993721|P1|Per-protocol|Overall Study||69
8517538|NCT00403494|20993720|P2|Intent to Treat|Overall Study||83
8517539|NCT00403494|20993721|P1|Intent to Treat|Overall Study||87
8517540|NCT00403494|20993720|P2|STARTED|Overall Study||94
8517541|NCT00403494|20993721|P1|STARTED|Overall Study||96
8517542|NCT00403481|20993733|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
8517543|NCT00403481|20993733|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
8517544|NCT00403481|20993733|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
8517545|NCT00403481|20993733|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
8517546|NCT00403481|20993733|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
8517547|NCT00403481|20993733|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
8517548|NCT00403481|20993733|P1|NOT COMPLETED|Olm 40 mg||5
8517549|NCT00403481|20993733|P1|COMPLETED|Olm 40 mg||177
8517550|NCT00403481|20993733|P1|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
8517551|NCT00403481|20993733|P1|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
8517552|NCT00403481|20993733|P1|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
8517553|NCT00403481|20993733|P1|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
8517554|NCT00403455|20993748|P1|NOT COMPLETED|Overall Study||1
8517555|NCT00403455|20993748|P1|COMPLETED|Overall Study||37
8517556|NCT00403455|20993748|P1|STARTED|Overall Study||38
8517557|NCT00403403|20993754|P2|NOT COMPLETED|Overall Study||0
8517558|NCT00403403|20993755|P1|NOT COMPLETED|Overall Study||0
8517559|NCT00403403|20993754|P2|COMPLETED|Overall Study||52
8517560|NCT00403403|20993755|P1|COMPLETED|Overall Study||50
8517561|NCT00403403|20993754|P2|Safety-Evaluable Patients|Overall Study||51
8517562|NCT00403403|20993755|P1|Safety-Evaluable Patients|Overall Study||47
8517563|NCT00403403|20993754|P2|STARTED|Overall Study||52
8517564|NCT00403403|20993755|P1|STARTED|Overall Study||50
8517565|NCT00403390|20993771|P2|NOT COMPLETED|Overall Study||0
8517566|NCT00403390|20993772|P1|NOT COMPLETED|Overall Study||3
8517567|NCT00403390|20993771|P2|COMPLETED|Overall Study||18
8517568|NCT00403390|20993772|P1|COMPLETED|Overall Study||13
8517569|NCT00403390|20993771|P2|STARTED|Overall Study||18
8517570|NCT00403390|20993772|P1|STARTED|Overall Study||16
8517571|NCT00403273|20993780|P2|NOT COMPLETED|Overall Study||4
8517572|NCT00403273|20993781|P1|NOT COMPLETED|Overall Study||3
8517573|NCT00403273|20993780|P2|COMPLETED|Overall Study||25
8517574|NCT00403273|20993781|P1|COMPLETED|Overall Study||22
8517575|NCT00403273|20993780|P2|STARTED|Overall Study||29
8517576|NCT00403273|20993781|P1|STARTED|Overall Study||25
8517577|NCT00403234|20993823|P4|NOT COMPLETED|Overall Study||0
8517578|NCT00403234|20993824|P3|NOT COMPLETED|Overall Study||1
8517579|NCT00403234|20993825|P2|NOT COMPLETED|Overall Study||1
8517580|NCT00403234|20993826|P1|NOT COMPLETED|Overall Study||1
8517581|NCT00403234|20993823|P4|COMPLETED|Overall Study||2
8517582|NCT00403234|20993824|P3|COMPLETED|Overall Study||2
8517583|NCT00403234|20993825|P2|COMPLETED|Overall Study||2
8517584|NCT00403234|20993826|P1|COMPLETED|Overall Study||1
8517585|NCT00403234|20993823|P4|STARTED|Overall Study||2
8517586|NCT00403234|20993824|P3|STARTED|Overall Study||3
8517587|NCT00403234|20993825|P2|STARTED|Overall Study||3
8517588|NCT00403234|20993826|P1|STARTED|Overall Study||2
8517589|NCT00403130|20993836|P1|NOT COMPLETED|Survival Follow-up up to 6 Years||10
8517590|NCT00403130|20993836|P1|COMPLETED|Survival Follow-up up to 6 Years||16
8517591|NCT00403130|20993836|P1|STARTED|Survival Follow-up up to 6 Years||26
8517592|NCT00403130|20993836|P1|NOT COMPLETED|2 Years From Start of Treatment||5
8517593|NCT00403130|20993836|P1|COMPLETED|2 Years From Start of Treatment||26
8517594|NCT00403130|20993836|P1|STARTED|2 Years From Start of Treatment||31
8517595|NCT00403117|20993843|P1|NOT COMPLETED|Overall Study||20
8517596|NCT00403117|20993843|P1|COMPLETED|Overall Study||29
8517597|NCT00403117|20993843|P1|STARTED|Overall Study||49
8517610|NCT00402896|20994054|P1|NOT COMPLETED|Overall Study||0
8517611|NCT00402896|20994054|P1|COMPLETED|Overall Study||20
8517612|NCT00402896|20994054|P1|STARTED|Overall Study||20
8517613|NCT00402883|20994058|P1|NOT COMPLETED|Maintenance Therapy||0
8517614|NCT00402883|20994058|P1|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
8517615|NCT00402883|20994058|P1|STARTED|Maintenance Therapy||5
8517616|NCT00402883|20994058|P1|NOT COMPLETED|Consolidation Therapy||0
8517617|NCT00402883|20994058|P1|COMPLETED|Consolidation Therapy||5
8517618|NCT00402883|20994058|P1|STARTED|Consolidation Therapy||5
8517619|NCT00402883|20994058|P1|NOT COMPLETED|Induction Therapy||0
8517620|NCT00402883|20994058|P1|COMPLETED|Induction Therapy||5
8517621|NCT00402883|20994058|P1|STARTED|Induction Therapy||5
8517622|NCT00402831|20994064|P2|NOT COMPLETED|Overall Study||3
8517623|NCT00402831|20994065|P1|NOT COMPLETED|Overall Study||1
8517624|NCT00402831|20994064|P2|COMPLETED|Overall Study||200
8517625|NCT00402831|20994065|P1|COMPLETED|Overall Study||201
8517626|NCT00402831|20994064|P2|ProQuad® Dose 1 (Day 30)|Overall Study||203
8517627|NCT00402831|20994065|P1|ProQuad® Dose 1 (Day 30)|Overall Study||202
8517628|NCT00402831|20994064|P2|ProQuad® Dose 1 (Day 1)|Overall Study||203
8517629|NCT00402831|20994065|P1|ProQuad® Dose 1 (Day 1)|Overall Study||202
8517630|NCT00402831|20994064|P2|STARTED|Overall Study||203
8517631|NCT00402831|20994065|P1|STARTED|Overall Study||202
8517632|NCT00402779|20994099|P2|NOT COMPLETED|Overall Study||76
8517633|NCT00402779|20994100|P1|NOT COMPLETED|Overall Study||77
8517634|NCT00402779|20994099|P2|COMPLETED|Overall Study||75
8517635|NCT00402779|20994100|P1|COMPLETED|Overall Study||75
8517636|NCT00402779|20994099|P2|STARTED|Overall Study||151
8517637|NCT00402779|20994100|P1|STARTED|Overall Study||152
8517638|NCT00402740|20994106|P1|NOT COMPLETED|Overall Study||80
8517639|NCT00402740|20994106|P1|COMPLETED|Overall Study||242
8517640|NCT00402740|20994106|P1|STARTED|Overall Study||322
8517641|NCT00402727|20994118|P2|NOT COMPLETED|Overall Study||34
8517642|NCT00402727|20994119|P1|NOT COMPLETED|Overall Study||42
8517643|NCT00402727|20994118|P2|COMPLETED|Overall Study||347
8517644|NCT00402727|20994119|P1|COMPLETED|Overall Study||390
8517645|NCT00402727|20994118|P2|Achieving Test Of Cure (TOC)|Overall Study||347
8517646|NCT00402727|20994119|P1|Achieving Test Of Cure (TOC)|Overall Study||390
8517647|NCT00402727|20994118|P2|Achieving End Of Treatment (EOT)|Overall Study||355
8517648|NCT00402727|20994119|P1|Achieving End Of Treatment (EOT)|Overall Study||408
8517649|NCT00402727|20994118|P2|STARTED|Overall Study||381
8517650|NCT00402727|20994119|P1|STARTED|Overall Study||432
8517651|NCT00402714|20994149|P2|NOT COMPLETED|Overall Study||0
8517652|NCT00402714|20994150|P1|NOT COMPLETED|Overall Study||0
8517653|NCT00402714|20994149|P2|COMPLETED|Overall Study||11
8517654|NCT00402714|20994150|P1|COMPLETED|Overall Study||3
8517655|NCT00402714|20994149|P2|STARTED|Overall Study||11
8517656|NCT00402714|20994150|P1|STARTED|Overall Study||3
8517657|NCT00402688|20994161|P3|NOT COMPLETED|Overall Study||15
8517658|NCT00402688|20994162|P2|NOT COMPLETED|Overall Study||16
8517659|NCT00402688|20994163|P1|NOT COMPLETED|Overall Study||21
8517660|NCT00402688|20994161|P3|COMPLETED|Overall Study||65
8517661|NCT00402688|20994162|P2|COMPLETED|Overall Study||65
8517662|NCT00402688|20994163|P1|COMPLETED|Overall Study||60
8517663|NCT00402688|20994161|P3|STARTED|Overall Study||80
8517664|NCT00402688|20994162|P2|STARTED|Overall Study||81
8517665|NCT00402688|20994163|P1|STARTED|Overall Study||81
8517666|NCT00402649|20994186|P1|NOT COMPLETED|Overall Study||2
8517667|NCT00402649|20994186|P1|COMPLETED|Overall Study||33
8517668|NCT00402649|20994186|P1|STARTED|Overall Study||35
8517669|NCT00402597|20994201|P5|NOT COMPLETED|Overall Study||124
8517670|NCT00402597|20994202|P4|NOT COMPLETED|Overall Study||74
8517671|NCT00402597|20994203|P3|NOT COMPLETED|Overall Study||212
8517672|NCT00402597|20994204|P2|NOT COMPLETED|Overall Study||46
8517673|NCT00402597|20994205|P1|NOT COMPLETED|Overall Study||191
8517674|NCT00402597|20994201|P5|COMPLETED|Overall Study||479
8517675|NCT00402597|20994202|P4|COMPLETED|Overall Study||279
8517676|NCT00402597|20994203|P3|COMPLETED|Overall Study||834
8517677|NCT00402597|20994204|P2|COMPLETED|Overall Study||261
8517678|NCT00402597|20994205|P1|COMPLETED|Overall Study||962
8517679|NCT00402597|20994201|P5|STARTED|Overall Study||603
8517680|NCT00402597|20994202|P4|STARTED|Overall Study||353
8517681|NCT00402597|20994203|P3|STARTED|Overall Study||1046
8517682|NCT00402597|20994204|P2|STARTED|Overall Study||307
8517683|NCT00402597|20994205|P1|STARTED|Overall Study||1153
8517684|NCT00402363|20994246|P4|NOT COMPLETED|Overall Study||10
8517685|NCT00402363|20994247|P3|NOT COMPLETED|Overall Study||6
8517686|NCT00402363|20994248|P2|NOT COMPLETED|Overall Study||30
8517687|NCT00402363|20994249|P1|NOT COMPLETED|Overall Study||33
8517688|NCT00402363|20994246|P4|COMPLETED|Overall Study||45
8517689|NCT00402363|20994247|P3|COMPLETED|Overall Study||60
8517690|NCT00402363|20994248|P2|COMPLETED|Overall Study||246
8517691|NCT00402363|20994249|P1|COMPLETED|Overall Study||233
8517692|NCT00402363|20994246|P4|STARTED|Overall Study||55
8517693|NCT00402363|20994247|P3|STARTED|Overall Study||66
8517694|NCT00402363|20994248|P2|STARTED|Overall Study||276
8517695|NCT00402363|20994249|P1|STARTED|Overall Study||266
8517696|NCT00402337|20994312|P5|NOT COMPLETED|Overall Study||8
8517697|NCT00402337|20994313|P4|NOT COMPLETED|Overall Study||12
8517698|NCT00402337|20994314|P3|NOT COMPLETED|Overall Study||4
8517699|NCT00402337|20994315|P2|NOT COMPLETED|Overall Study||6
8517700|NCT00402337|20994316|P1|NOT COMPLETED|Overall Study||5
8517701|NCT00402337|20994312|P5|COMPLETED|Overall Study||61
8517702|NCT00402337|20994313|P4|COMPLETED|Overall Study||51
8517703|NCT00402337|20994314|P3|COMPLETED|Overall Study||58
8517704|NCT00402337|20994315|P2|COMPLETED|Overall Study||51
8517705|NCT00402337|20994316|P1|COMPLETED|Overall Study||54
8517706|NCT00402337|20994312|P5|STARTED|Overall Study||69
8517707|NCT00402337|20994313|P4|STARTED|Overall Study||63
8517708|NCT00402337|20994314|P3|STARTED|Overall Study||62
8517709|NCT00402337|20994315|P2|STARTED|Overall Study||57
8517710|NCT00402337|20994316|P1|STARTED|Overall Study||59
8517711|NCT00402324|20994355|P2|NOT COMPLETED|Overall Study||41
8517712|NCT00402324|20994356|P1|NOT COMPLETED|Overall Study||43
8517713|NCT00402324|20994355|P2|COMPLETED|Overall Study||60
8517714|NCT00402324|20994356|P1|COMPLETED|Overall Study||58
8517715|NCT00402324|20994355|P2|STARTED|Overall Study||101
8517716|NCT00402324|20994356|P1|STARTED|Overall Study||101
8517717|NCT00402285|20994389|P3|NOT COMPLETED|Overall Study||2
8517718|NCT00402285|20994390|P2|NOT COMPLETED|Overall Study||6
8517719|NCT00402285|20994391|P1|NOT COMPLETED|Overall Study||7
8517720|NCT00402285|20994389|P3|COMPLETED|Overall Study||26
8517721|NCT00402285|20994390|P2|COMPLETED|Overall Study||21
8517722|NCT00402285|20994391|P1|COMPLETED|Overall Study||22
8517723|NCT00402285|20994389|P3|STARTED|Overall Study||28
8517724|NCT00402285|20994390|P2|STARTED|Overall Study||27
8517725|NCT00402285|20994391|P1|STARTED|Overall Study||29
8517726|NCT00402246|20994399|P2|NOT COMPLETED|Overall Study||234
8517727|NCT00402246|20994400|P1|NOT COMPLETED|Overall Study||220
8517728|NCT00402246|20994399|P2|COMPLETED|Overall Study||749
8517729|NCT00402246|20994400|P1|COMPLETED|Overall Study||794
8517730|NCT00402246|20994399|P2|STARTED|Overall Study||983
8517731|NCT00402246|20994400|P1|STARTED|Overall Study||1014
8517732|NCT00402233|20994434|P4|NOT COMPLETED|Overall Study||11
8517733|NCT00402233|20994435|P3|NOT COMPLETED|Overall Study||11
8517734|NCT00402233|20994436|P2|NOT COMPLETED|Overall Study||10
8517735|NCT00402233|20994437|P1|NOT COMPLETED|Overall Study||5
8517736|NCT00402233|20994434|P4|COMPLETED|Overall Study||62
8517737|NCT00402233|20994435|P3|COMPLETED|Overall Study||70
8517738|NCT00402233|20994436|P2|COMPLETED|Overall Study||70
8517739|NCT00402233|20994437|P1|COMPLETED|Overall Study||72
8517740|NCT00402233|20994434|P4|STARTED|Overall Study||73
8517741|NCT00402233|20994435|P3|STARTED|Overall Study||81
8517742|NCT00402233|20994436|P2|STARTED|Overall Study||80
8517743|NCT00402233|20994437|P1|STARTED|Overall Study||77
8517744|NCT00402194|20994461|P2|NOT COMPLETED|Overall Study||0
8517745|NCT00402194|20994462|P1|NOT COMPLETED|Overall Study||0
8517746|NCT00402194|20994461|P2|COMPLETED|Overall Study||8
8517747|NCT00402194|20994462|P1|COMPLETED|Overall Study||9
8517748|NCT00402194|20994461|P2|STARTED|Overall Study||8
8517749|NCT00402194|20994462|P1|STARTED|Overall Study||9
8517750|NCT00402168|20994472|P2|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
8517751|NCT00402168|20994473|P1|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
8517752|NCT00402168|20994472|P2|COMPLETED|Switched From CNI to Belatacept in LT||0
8517753|NCT00402168|20994473|P1|COMPLETED|Switched From CNI to Belatacept in LT||32
8517754|NCT00402168|20994472|P2|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
8517755|NCT00402168|20994473|P1|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
8517756|NCT00402168|20994472|P2|NOT COMPLETED|Long Term (LT)||17
8517757|NCT00402168|20994473|P1|NOT COMPLETED|Long Term (LT)||11
8517758|NCT00402168|20994472|P2|COMPLETED|Long Term (LT)||64
8517759|NCT00402168|20994473|P1|COMPLETED|Long Term (LT)||70
8517760|NCT00402168|20994472|P2|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
8517761|NCT00402168|20994473|P1|STARTED|Long Term (LT)||81
8517762|NCT00402168|20994472|P2|NOT COMPLETED|Treatment (up to 12 Months)||2
8517763|NCT00402168|20994473|P1|NOT COMPLETED|Treatment (up to 12 Months)||2
8517764|NCT00402168|20994472|P2|COMPLETED|Treatment (up to 12 Months)||86
8517765|NCT00402168|20994473|P1|COMPLETED|Treatment (up to 12 Months)||81
8517766|NCT00402168|20994472|P2|STARTED|Treatment (up to 12 Months)||88
8517767|NCT00402168|20994473|P1|STARTED|Treatment (up to 12 Months)||83
8517768|NCT00402168|20994472|P2|NOT COMPLETED|Randomized||1
8517769|NCT00402168|20994473|P1|NOT COMPLETED|Randomized||1
8517770|NCT00402168|20994472|P2|COMPLETED|Randomized||88
8517771|NCT00402168|20994473|P1|COMPLETED|Randomized||83
8517772|NCT00402168|20994472|P2|STARTED|Randomized||89
8517773|NCT00402168|20994473|P1|STARTED|Randomized||84
8517774|NCT00402116|20994531|P3|NOT COMPLETED|Overall Study||55
8517775|NCT00402116|20994532|P2|NOT COMPLETED|Overall Study||6
8517776|NCT00402116|20994533|P1|NOT COMPLETED|Overall Study||3
8517777|NCT00402116|20994531|P3|COMPLETED|Overall Study||5
8517778|NCT00402116|20994532|P2|COMPLETED|Overall Study||0
8517779|NCT00402116|20994533|P1|COMPLETED|Overall Study||3
8517780|NCT00402116|20994531|P3|STARTED|Overall Study||60
8517781|NCT00402116|20994532|P2|STARTED|Overall Study||6
8517782|NCT00402116|20994533|P1|STARTED|Overall Study||6
8517783|NCT00402103|20994563|P2|NOT COMPLETED|Overall Study||13
8517784|NCT00402103|20994564|P1|NOT COMPLETED|Overall Study||91
8517785|NCT00402103|20994563|P2|COMPLETED|Overall Study||73
8517786|NCT00402103|20994564|P1|COMPLETED|Overall Study||379
8517787|NCT00402103|20994563|P2|STARTED|Overall Study||86
8517788|NCT00402103|20994564|P1|STARTED|Overall Study||470
8517789|NCT00402051|20994580|P2|NOT COMPLETED|Overall Study||35
8517790|NCT00402051|20994581|P1|NOT COMPLETED|Overall Study||38
8517791|NCT00402051|20994580|P2|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
8517792|NCT00402051|20994581|P1|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
8517793|NCT00402051|20994580|P2|Received Treatment|Overall Study||65
8517794|NCT00402051|20994581|P1|Received Treatment|Overall Study||65
8517795|NCT00402051|20994580|P2|STARTED|Overall Study||67
8517796|NCT00402051|20994581|P1|STARTED|Overall Study||66
8517797|NCT00402025|20994598|P3|NOT COMPLETED|Overall Study||10
8517798|NCT00402025|20994599|P2|NOT COMPLETED|Overall Study||3
8517799|NCT00402025|20994600|P1|NOT COMPLETED|Overall Study||2
8517800|NCT00402025|20994598|P3|COMPLETED|Overall Study||0
8517801|NCT00402025|20994599|P2|COMPLETED|Overall Study||1
8517802|NCT00402025|20994600|P1|COMPLETED|Overall Study||1
8517803|NCT00402025|20994598|P3|STARTED|Overall Study||10
8517804|NCT00402025|20994599|P2|STARTED|Overall Study||4
8517805|NCT00402025|20994600|P1|STARTED|Overall Study||3
8517806|NCT00401973|20994626|P3|NOT COMPLETED|Overall Study||23
8517807|NCT00401973|20994627|P2|NOT COMPLETED|Overall Study||26
8517808|NCT00401973|20994628|P1|NOT COMPLETED|Overall Study||11
8517809|NCT00401973|20994626|P3|COMPLETED|Overall Study||50
8517810|NCT00401973|20994627|P2|COMPLETED|Overall Study||50
8517811|NCT00401973|20994628|P1|COMPLETED|Overall Study||39
8517812|NCT00401973|20994626|P3|STARTED|Overall Study||73
8517813|NCT00401973|20994627|P2|STARTED|Overall Study||76
8517814|NCT00401973|20994628|P1|STARTED|Overall Study||50
8517815|NCT00401960|20994667|P2|NOT COMPLETED|Overall Study||0
8517816|NCT00401960|20994668|P1|NOT COMPLETED|Overall Study||5
8517817|NCT00401960|20994667|P2|COMPLETED|Overall Study||1
8517818|NCT00401960|20994668|P1|COMPLETED|Overall Study||0
8517819|NCT00401960|20994667|P2|STARTED|Overall Study||1
8517820|NCT00401960|20994668|P1|STARTED|Overall Study||5
8517821|NCT00401882|20994678|P2|NOT COMPLETED|Overall Study||0
8517822|NCT00401882|20994679|P1|NOT COMPLETED|Overall Study||0
8517823|NCT00401882|20994678|P2|COMPLETED|Overall Study||5
8517824|NCT00401882|20994679|P1|COMPLETED|Overall Study||2
8517825|NCT00401882|20994678|P2|STARTED|Overall Study||5
8517826|NCT00401882|20994679|P1|STARTED|Overall Study||2
8517827|NCT00401843|20994698|P3|NOT COMPLETED|Overall Study||142
8517828|NCT00401843|20994699|P2|NOT COMPLETED|Overall Study||144
8517829|NCT00401843|20994700|P1|NOT COMPLETED|Overall Study||21
8517830|NCT00401843|20994698|P3|COMPLETED|Overall Study||0
8517831|NCT00401843|20994699|P2|COMPLETED|Overall Study||0
8517832|NCT00401843|20994700|P1|COMPLETED|Overall Study||0
8517833|NCT00401843|20994698|P3|Treated|Overall Study||139
8517834|NCT00401843|20994699|P2|Treated|Overall Study||142
8517835|NCT00401843|20994700|P1|Treated|Overall Study||21
8517836|NCT00401843|20994698|P3|STARTED|Overall Study||142
8517837|NCT00401843|20994699|P2|STARTED|Overall Study||144
8517838|NCT00401843|20994700|P1|STARTED|Overall Study||21
8517839|NCT00401830|20994718|P2|NOT COMPLETED|Overall Study||32
8517840|NCT00401830|20994719|P1|NOT COMPLETED|Overall Study||31
8517841|NCT00401830|20994718|P2|COMPLETED|Overall Study||46
8517842|NCT00401830|20994719|P1|COMPLETED|Overall Study||50
8517843|NCT00401830|20994718|P2|STARTED|Overall Study||78
8517844|NCT00401830|20994719|P1|STARTED|Overall Study||81
8517845|NCT00401817|20994751|P1|NOT COMPLETED|Overall Study||0
8517846|NCT00401817|20994751|P1|COMPLETED|Overall Study||11
8517847|NCT00401817|20994751|P1|STARTED|Overall Study||11
8517848|NCT00401778|20994761|P3|NOT COMPLETED|Overall Study||1
8517849|NCT00401778|20994762|P2|NOT COMPLETED|Overall Study||1
8517850|NCT00401778|20994763|P1|NOT COMPLETED|Overall Study||1
8517851|NCT00401778|20994761|P3|COMPLETED|Overall Study||10
8517852|NCT00401778|20994762|P2|COMPLETED|Overall Study||11
8517853|NCT00401778|20994763|P1|COMPLETED|Overall Study||9
8517854|NCT00401778|20994761|P3|STARTED|Overall Study||11
8517855|NCT00401778|20994762|P2|STARTED|Overall Study||12
8517856|NCT00401778|20994763|P1|STARTED|Overall Study||10
8517857|NCT00401752|20994777|P2|NOT COMPLETED|Overall Study||18
8517858|NCT00401752|20994778|P1|NOT COMPLETED|Overall Study||10
8517859|NCT00401752|20994777|P2|COMPLETED|Overall Study||94
8517860|NCT00401752|20994778|P1|COMPLETED|Overall Study||97
8517861|NCT00401752|20994777|P2|Patients Included in Per-Protocol Popula|Overall Study||99
8517862|NCT00401752|20994778|P1|Patients Included in Per-Protocol Popula|Overall Study||100
8517863|NCT00401752|20994777|P2|Patients Included in Safety Population|Overall Study||110
8517864|NCT00401752|20994778|P1|Patients Included in Safety Population|Overall Study||107
8517865|NCT00401752|20994777|P2|Patients Included in ITT Population|Overall Study||111
8517866|NCT00401752|20994778|P1|Patients Included in ITT Population|Overall Study||106
8517867|NCT00401752|20994777|P2|Number of Patients Received Treatment|Overall Study||111
8517868|NCT00401752|20994778|P1|Number of Patients Received Treatment|Overall Study||107
8517869|NCT00401752|20994777|P2|STARTED|Overall Study||112
8517870|NCT00401752|20994778|P1|STARTED|Overall Study||107
8517871|NCT00401726|20994796|P2|NOT COMPLETED|Overall Study||112
8517872|NCT00401726|20994797|P1|NOT COMPLETED|Overall Study||97
8517873|NCT00401726|20994796|P2|COMPLETED|Overall Study||156
8517874|NCT00401726|20994797|P1|COMPLETED|Overall Study||172
8517875|NCT00401726|20994796|P2|STARTED|Overall Study||268
8517876|NCT00401726|20994797|P1|STARTED|Overall Study||269
8517877|NCT00401622|20994819|P2|NOT COMPLETED|Overall Study||43
8517878|NCT00401622|20994820|P1|NOT COMPLETED|Overall Study||34
8517879|NCT00401622|20994819|P2|COMPLETED|Overall Study||117
8517880|NCT00401622|20994820|P1|COMPLETED|Overall Study||126
8517881|NCT00401622|20994819|P2|STARTED|Overall Study||160
8517882|NCT00401622|20994820|P1|STARTED|Overall Study||160
8517883|NCT00401544|20994832|P4|NOT COMPLETED|Overall Study||16
8517884|NCT00401544|20994833|P3|NOT COMPLETED|Overall Study||12
8517885|NCT00401544|20994834|P2|NOT COMPLETED|Overall Study||18
8517886|NCT00401544|20994835|P1|NOT COMPLETED|Overall Study||18
8517887|NCT00401544|20994832|P4|COMPLETED|Overall Study||44
8517888|NCT00401544|20994833|P3|COMPLETED|Overall Study||48
8517889|NCT00401544|20994834|P2|COMPLETED|Overall Study||44
8517890|NCT00401544|20994835|P1|COMPLETED|Overall Study||38
8517891|NCT00401544|20994832|P4|STARTED|Overall Study|Randomized and treated|60
8517892|NCT00401544|20994833|P3|STARTED|Overall Study|Randomized and treated|60
8517893|NCT00401544|20994834|P2|STARTED|Overall Study|Randomized and treated|62
8517894|NCT00401544|20994835|P1|STARTED|Overall Study|Randomized and treated|56
8517895|NCT00401531|20994875|P2|NOT COMPLETED|Overall Study||10
8517896|NCT00401531|20994876|P1|NOT COMPLETED|Overall Study||9
8517897|NCT00401531|20994875|P2|COMPLETED|Overall Study||196
8517898|NCT00401531|20994876|P1|COMPLETED|Overall Study||197
8517899|NCT00401531|20994875|P2|STARTED|Overall Study||206
8517900|NCT00401531|20994876|P1|STARTED|Overall Study||206
8517901|NCT00401518|20994895|P3|NOT COMPLETED|Overall Study||23
8517902|NCT00401518|20994896|P2|NOT COMPLETED|Overall Study||37
8517903|NCT00401518|20994897|P1|NOT COMPLETED|Overall Study||6
8517904|NCT00401518|20994895|P3|COMPLETED|Overall Study||94
8517905|NCT00401518|20994896|P2|COMPLETED|Overall Study||190
8517906|NCT00401518|20994897|P1|COMPLETED|Overall Study||40
8517907|NCT00401518|20994895|P3|STARTED|Overall Study||117
8517908|NCT00401518|20994896|P2|STARTED|Overall Study||227
8517909|NCT00401518|20994897|P1|STARTED|Overall Study||46
8517910|NCT00401414|20994926|P3|NOT COMPLETED|Overall Study||0
8517911|NCT00401414|20994927|P2|NOT COMPLETED|Overall Study||0
8517912|NCT00401414|20994928|P1|NOT COMPLETED|Overall Study||0
8517913|NCT00401414|20994926|P3|COMPLETED|Overall Study||79
8517914|NCT00401414|20994927|P2|COMPLETED|Overall Study||147
8517915|NCT00401414|20994928|P1|COMPLETED|Overall Study||118
8517916|NCT00401414|20994926|P3|STARTED|Overall Study||79
8517917|NCT00401414|20994927|P2|STARTED|Overall Study||147
8517918|NCT00401414|20994928|P1|STARTED|Overall Study||118
8517919|NCT00401401|20994952|P4|NOT COMPLETED|Overall Study||3
8517920|NCT00401401|20994953|P3|NOT COMPLETED|Overall Study||1
8517921|NCT00401401|20994954|P2|NOT COMPLETED|Overall Study||0
8517922|NCT00401401|20994955|P1|NOT COMPLETED|Overall Study||0
8517923|NCT00401401|20994952|P4|COMPLETED|Overall Study||9
8517924|NCT00401401|20994953|P3|COMPLETED|Overall Study||5
8517925|NCT00401401|20994954|P2|COMPLETED|Overall Study||6
8517926|NCT00401401|20994955|P1|COMPLETED|Overall Study||6
8517927|NCT00401401|20994952|P4|STARTED|Overall Study||12
8517928|NCT00401401|20994953|P3|STARTED|Overall Study||6
8517929|NCT00401401|20994954|P2|STARTED|Overall Study||6
8517930|NCT00401401|20994955|P1|STARTED|Overall Study||6
8517931|NCT00401375|20994980|P3|NOT COMPLETED|Overall Study||25
8517932|NCT00401375|20994981|P2|NOT COMPLETED|Overall Study||25
8517933|NCT00401375|20994982|P1|NOT COMPLETED|Overall Study||22
8517934|NCT00401375|20994980|P3|COMPLETED|Overall Study||149
8517935|NCT00401375|20994981|P2|COMPLETED|Overall Study||151
8517936|NCT00401375|20994982|P1|COMPLETED|Overall Study||152
8517937|NCT00401375|20994980|P3|Received at Least 1 Dose of Study Drug|Overall Study||171
8517938|NCT00401375|20994981|P2|Received at Least 1 Dose of Study Drug|Overall Study||173
8517939|NCT00401375|20994982|P1|Received at Least 1 Dose of Study Drug|Overall Study||171
8517940|NCT00401375|20994980|P3|STARTED|Overall Study||174
8517941|NCT00401375|20994981|P2|STARTED|Overall Study||176
8517942|NCT00401375|20994982|P1|STARTED|Overall Study||174
8517943|NCT00401258|20994999|P1|NOT COMPLETED|Overall Study||7
8517944|NCT00401258|20994999|P1|COMPLETED|Overall Study||8
8517945|NCT00401258|20994999|P1|STARTED|Overall Study||15
8517946|NCT00401245|20995014|P8|NOT COMPLETED|Double Blind Tapering Phase||7
8517947|NCT00401245|20995015|P7|NOT COMPLETED|Double Blind Tapering Phase||7
8517948|NCT00401245|20995016|P6|NOT COMPLETED|Double Blind Tapering Phase||4
8517949|NCT00401245|20995017|P5|NOT COMPLETED|Double Blind Tapering Phase||4
8517950|NCT00401245|20995018|P4|NOT COMPLETED|Double Blind Tapering Phase||0
8517951|NCT00401245|20995019|P3|NOT COMPLETED|Double Blind Tapering Phase||0
8517952|NCT00401245|20995020|P2|NOT COMPLETED|Double Blind Tapering Phase||0
8517953|NCT00401245|20995021|P1|NOT COMPLETED|Double Blind Tapering Phase||0
8517954|NCT00401245|20995014|P8|COMPLETED|Double Blind Tapering Phase||95
8517955|NCT00401245|20995015|P7|COMPLETED|Double Blind Tapering Phase||80
8517956|NCT00401245|20995016|P6|COMPLETED|Double Blind Tapering Phase||90
8517957|NCT00401245|20995017|P5|COMPLETED|Double Blind Tapering Phase||97
8517958|NCT00401245|20995018|P4|COMPLETED|Double Blind Tapering Phase||0
8517959|NCT00401245|20995019|P3|COMPLETED|Double Blind Tapering Phase||0
8517960|NCT00401245|20995020|P2|COMPLETED|Double Blind Tapering Phase||0
8517961|NCT00401245|20995021|P1|COMPLETED|Double Blind Tapering Phase||0
8517962|NCT00401245|20995014|P8|STARTED|Double Blind Tapering Phase||102
8517963|NCT00401245|20995015|P7|STARTED|Double Blind Tapering Phase||87
8517964|NCT00401245|20995016|P6|STARTED|Double Blind Tapering Phase||94
8517965|NCT00401245|20995017|P5|STARTED|Double Blind Tapering Phase||101
8517966|NCT00401245|20995018|P4|STARTED|Double Blind Tapering Phase||0
8517967|NCT00401245|20995019|P3|STARTED|Double Blind Tapering Phase||0
8517968|NCT00401245|20995020|P2|STARTED|Double Blind Tapering Phase||0
8517969|NCT00401245|20995021|P1|STARTED|Double Blind Tapering Phase||0
8517970|NCT00401245|20995014|P8|NOT COMPLETED|Open Label Phase||0
8517971|NCT00401245|20995015|P7|NOT COMPLETED|Open Label Phase||0
8517972|NCT00401245|20995016|P6|NOT COMPLETED|Open Label Phase||0
8517973|NCT00401245|20995017|P5|NOT COMPLETED|Open Label Phase||0
8517974|NCT00401245|20995018|P4|NOT COMPLETED|Open Label Phase||21
8517975|NCT00401245|20995019|P3|NOT COMPLETED|Open Label Phase||23
8517976|NCT00401245|20995020|P2|NOT COMPLETED|Open Label Phase||35
8517977|NCT00401245|20995021|P1|NOT COMPLETED|Open Label Phase||21
8517978|NCT00401245|20995014|P8|COMPLETED|Open Label Phase||0
8517979|NCT00401245|20995015|P7|COMPLETED|Open Label Phase||0
8517980|NCT00401245|20995016|P6|COMPLETED|Open Label Phase||0
8517981|NCT00401245|20995017|P5|COMPLETED|Open Label Phase||0
8517982|NCT00401245|20995018|P4|COMPLETED|Open Label Phase||84
8517983|NCT00401245|20995019|P3|COMPLETED|Open Label Phase||95
8517984|NCT00401245|20995020|P2|COMPLETED|Open Label Phase||81
8517985|NCT00401245|20995021|P1|COMPLETED|Open Label Phase||101
8517986|NCT00401245|20995014|P8|STARTED|Open Label Phase||0
8517987|NCT00401245|20995015|P7|STARTED|Open Label Phase||0
8517988|NCT00401245|20995016|P6|STARTED|Open Label Phase||0
8517989|NCT00401245|20995017|P5|STARTED|Open Label Phase||0
8517990|NCT00401245|20995018|P4|STARTED|Open Label Phase||105
8517991|NCT00401245|20995019|P3|STARTED|Open Label Phase||118
8517992|NCT00401245|20995020|P2|STARTED|Open Label Phase||116
8517993|NCT00401245|20995021|P1|STARTED|Open Label Phase||122
8517994|NCT00401245|20995014|P8|NOT COMPLETED|Between Titration and Open Label Phase||0
8517995|NCT00401245|20995015|P7|NOT COMPLETED|Between Titration and Open Label Phase||0
8517996|NCT00401245|20995016|P6|NOT COMPLETED|Between Titration and Open Label Phase||0
8517997|NCT00401245|20995017|P5|NOT COMPLETED|Between Titration and Open Label Phase||0
8517998|NCT00401245|20995018|P4|NOT COMPLETED|Between Titration and Open Label Phase||2
8517999|NCT00401245|20995019|P3|NOT COMPLETED|Between Titration and Open Label Phase||0
8518000|NCT00401245|20995020|P2|NOT COMPLETED|Between Titration and Open Label Phase||2
8518001|NCT00401245|20995021|P1|NOT COMPLETED|Between Titration and Open Label Phase||0
8518002|NCT00401245|20995014|P8|COMPLETED|Between Titration and Open Label Phase||0
8518003|NCT00401245|20995015|P7|COMPLETED|Between Titration and Open Label Phase||0
8518004|NCT00401245|20995016|P6|COMPLETED|Between Titration and Open Label Phase||0
8518005|NCT00401245|20995017|P5|COMPLETED|Between Titration and Open Label Phase||0
8518006|NCT00401245|20995018|P4|COMPLETED|Between Titration and Open Label Phase||105
8518007|NCT00401245|20995019|P3|COMPLETED|Between Titration and Open Label Phase||118
8518008|NCT00401245|20995020|P2|COMPLETED|Between Titration and Open Label Phase||116
8518009|NCT00401245|20995021|P1|COMPLETED|Between Titration and Open Label Phase||122
8518010|NCT00401245|20995014|P8|STARTED|Between Titration and Open Label Phase||0
8518011|NCT00401245|20995015|P7|STARTED|Between Titration and Open Label Phase||0
8518012|NCT00401245|20995016|P6|STARTED|Between Titration and Open Label Phase||0
8518013|NCT00401245|20995017|P5|STARTED|Between Titration and Open Label Phase||0
8518014|NCT00401245|20995018|P4|STARTED|Between Titration and Open Label Phase||107
8518015|NCT00401245|20995019|P3|STARTED|Between Titration and Open Label Phase||118
8518016|NCT00401245|20995020|P2|STARTED|Between Titration and Open Label Phase||118
8518017|NCT00401245|20995021|P1|STARTED|Between Titration and Open Label Phase||122
8518018|NCT00401245|20995014|P8|NOT COMPLETED|Double Blind Titration Phase||0
8518019|NCT00401245|20995015|P7|NOT COMPLETED|Double Blind Titration Phase||0
8518020|NCT00401245|20995016|P6|NOT COMPLETED|Double Blind Titration Phase||0
8518021|NCT00401245|20995017|P5|NOT COMPLETED|Double Blind Titration Phase||0
8518022|NCT00401245|20995018|P4|NOT COMPLETED|Double Blind Titration Phase||15
8518023|NCT00401245|20995019|P3|NOT COMPLETED|Double Blind Titration Phase||6
8518024|NCT00401245|20995020|P2|NOT COMPLETED|Double Blind Titration Phase||3
8518025|NCT00401245|20995021|P1|NOT COMPLETED|Double Blind Titration Phase||4
8518026|NCT00401245|20995014|P8|COMPLETED|Double Blind Titration Phase||0
8518027|NCT00401245|20995015|P7|COMPLETED|Double Blind Titration Phase||0
8518028|NCT00401245|20995016|P6|COMPLETED|Double Blind Titration Phase||0
8518029|NCT00401245|20995017|P5|COMPLETED|Double Blind Titration Phase||0
8518030|NCT00401245|20995018|P4|COMPLETED|Double Blind Titration Phase||107
8518031|NCT00401245|20995019|P3|COMPLETED|Double Blind Titration Phase||118
8518032|NCT00401245|20995020|P2|COMPLETED|Double Blind Titration Phase||118
8518033|NCT00401245|20995021|P1|COMPLETED|Double Blind Titration Phase||122
8518034|NCT00401245|20995014|P8|STARTED|Double Blind Titration Phase||0
8518035|NCT00401245|20995015|P7|STARTED|Double Blind Titration Phase||0
8518036|NCT00401245|20995016|P6|STARTED|Double Blind Titration Phase||0
8518037|NCT00401245|20995017|P5|STARTED|Double Blind Titration Phase||0
8518038|NCT00401245|20995018|P4|STARTED|Double Blind Titration Phase||122
8518039|NCT00401245|20995019|P3|STARTED|Double Blind Titration Phase||124
8518040|NCT00401245|20995020|P2|STARTED|Double Blind Titration Phase||121
8518041|NCT00401245|20995021|P1|STARTED|Double Blind Titration Phase||126
8518042|NCT00401193|20995089|P3|NOT COMPLETED|Overall Study||6
8518043|NCT00401193|20995090|P2|NOT COMPLETED|Overall Study||11
8518044|NCT00401193|20995091|P1|NOT COMPLETED|Overall Study||15
8518045|NCT00401193|20995089|P3|COMPLETED|Overall Study||63
8518046|NCT00401193|20995090|P2|COMPLETED|Overall Study||106
8518047|NCT00401193|20995091|P1|COMPLETED|Overall Study||103
8518048|NCT00401193|20995089|P3|Modified Intent to Treat Population|Overall Study||67
8518049|NCT00401193|20995090|P2|Modified Intent to Treat Population|Overall Study||115
8518050|NCT00401193|20995091|P1|Modified Intent to Treat Population|Overall Study||112
8518051|NCT00401193|20995089|P3|Intent to Treat Population|Overall Study||67
8518052|NCT00401193|20995090|P2|Intent to Treat Population|Overall Study||115
8518053|NCT00401193|20995091|P1|Intent to Treat Population|Overall Study||115
8518054|NCT00401193|20995089|P3|STARTED|Overall Study||69
8518055|NCT00401193|20995090|P2|STARTED|Overall Study||117
8518056|NCT00401193|20995091|P1|STARTED|Overall Study||118
8518057|NCT00401102|20995105|P1|NOT COMPLETED|Overall Study||7
8518058|NCT00401102|20995105|P1|COMPLETED|Overall Study||5
8518059|NCT00401102|20995105|P1|STARTED|Overall Study||12
8518060|NCT00400985|20995109|P1|NOT COMPLETED|Overall Study||52
8518061|NCT00400985|20995109|P1|COMPLETED|Overall Study||449
8518062|NCT00400985|20995109|P1|STARTED|Overall Study||501
8518063|NCT00400946|20995118|P5|NOT COMPLETED|Overall Study||38
8518064|NCT00400946|20995119|P4|NOT COMPLETED|Overall Study||47
8518065|NCT00400946|20995120|P3|NOT COMPLETED|Overall Study||2
8518066|NCT00400946|20995121|P2|NOT COMPLETED|Overall Study||11
8518067|NCT00400946|20995122|P1|NOT COMPLETED|Overall Study||14
8518068|NCT00400946|20995118|P5|COMPLETED|Overall Study||206
8518069|NCT00400946|20995119|P4|COMPLETED|Overall Study||4
8518070|NCT00400946|20995120|P3|COMPLETED|Overall Study||40
8518071|NCT00400946|20995121|P2|COMPLETED|Overall Study||221
8518072|NCT00400946|20995122|P1|COMPLETED|Overall Study||217
8518073|NCT00400946|20995118|P5|Eligible and Treated|Overall Study||243
8518074|NCT00400946|20995119|P4|Eligible and Treated|Overall Study||46
8518075|NCT00400946|20995120|P3|Eligible and Treated|Overall Study||42
8518076|NCT00400946|20995121|P2|Eligible and Treated|Overall Study||232
8518077|NCT00400946|20995122|P1|Eligible and Treated|Overall Study||231
8518078|NCT00400946|20995118|P5|Evaluable for Day 32 MRD|Overall Study||168
8518079|NCT00400946|20995119|P4|Evaluable for Day 32 MRD|Overall Study||12
8518080|NCT00400946|20995120|P3|Evaluable for Day 32 MRD|Overall Study||33
8518081|NCT00400946|20995121|P2|Evaluable for Day 32 MRD|Overall Study||167
8518082|NCT00400946|20995122|P1|Evaluable for Day 32 MRD|Overall Study||166
8518083|NCT00400946|20995118|P5|Evaluable for Day 18 Marrow Morphology|Overall Study||152
8518084|NCT00400946|20995119|P4|Evaluable for Day 18 Marrow Morphology|Overall Study||13
8518085|NCT00400946|20995120|P3|Evaluable for Day 18 Marrow Morphology|Overall Study||19
8518086|NCT00400946|20995121|P2|Evaluable for Day 18 Marrow Morphology|Overall Study||161
8518087|NCT00400946|20995122|P1|Evaluable for Day 18 Marrow Morphology|Overall Study||158
8518088|NCT00400946|20995118|P5|Evaluable for CNS Directed-Treatment|Overall Study||227
8518089|NCT00400946|20995119|P4|Evaluable for CNS Directed-Treatment|Overall Study||21
8518090|NCT00400946|20995120|P3|Evaluable for CNS Directed-Treatment|Overall Study||42
8518091|NCT00400946|20995121|P2|Evaluable for CNS Directed-Treatment|Overall Study||232
8518092|NCT00400946|20995122|P1|Evaluable for CNS Directed-Treatment|Overall Study||231
8518093|NCT00400946|20995118|P5|STARTED|Overall Study||244
8518094|NCT00400946|20995119|P4|STARTED|Overall Study||51
8518095|NCT00400946|20995120|P3|STARTED|Overall Study||42
8518096|NCT00400946|20995121|P2|STARTED|Overall Study||232
8518097|NCT00400946|20995122|P1|STARTED|Overall Study||231
8518098|NCT00400881|20995150|P2|NOT COMPLETED|Overall Study||0
8518099|NCT00400881|20995151|P1|NOT COMPLETED|Overall Study||0
8518100|NCT00400881|20995150|P2|COMPLETED|Overall Study||60
8518101|NCT00400881|20995151|P1|COMPLETED|Overall Study||62
8518102|NCT00400881|20995150|P2|STARTED|Overall Study||60
8518103|NCT00400881|20995151|P1|STARTED|Overall Study||62
8518104|NCT00400829|20995159|P1|NOT COMPLETED|Overall Study||0
8518105|NCT00400829|20995159|P1|COMPLETED|Overall Study||66
8518106|NCT00400829|20995159|P1|STARTED|Overall Study||66
8518107|NCT00400803|20995165|P1|NOT COMPLETED|Overall Study||0
8518108|NCT00400803|20995165|P1|COMPLETED|Overall Study||35
8518109|NCT00400803|20995165|P1|STARTED|Overall Study||35
8518110|NCT00400764|20995181|P5|NOT COMPLETED|Phase II||11
8518111|NCT00400764|20995182|P4|NOT COMPLETED|Phase II||26
8518112|NCT00400764|20995183|P3|NOT COMPLETED|Phase II||23
8518113|NCT00400764|20995184|P2|NOT COMPLETED|Phase II||0
8518114|NCT00400764|20995185|P1|NOT COMPLETED|Phase II||0
8518115|NCT00400764|20995181|P5|COMPLETED|Phase II||0
8518116|NCT00400764|20995182|P4|COMPLETED|Phase II||0
8518117|NCT00400764|20995183|P3|COMPLETED|Phase II||0
8518118|NCT00400764|20995184|P2|COMPLETED|Phase II||0
8518119|NCT00400764|20995185|P1|COMPLETED|Phase II||0
8518120|NCT00400764|20995181|P5|Treated|Phase II||11
8518121|NCT00400764|20995182|P4|Treated|Phase II||26
8518122|NCT00400764|20995183|P3|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
8518123|NCT00400764|20995184|P2|Treated|Phase II||0
8518124|NCT00400764|20995185|P1|Treated|Phase II||0
8518125|NCT00400764|20995181|P5|STARTED|Phase II||11
8518126|NCT00400764|20995182|P4|STARTED|Phase II||26
8518127|NCT00400764|20995183|P3|STARTED|Phase II||23
8518128|NCT00400764|20995184|P2|STARTED|Phase II||0
8518129|NCT00400764|20995185|P1|STARTED|Phase II||0
8518130|NCT00400764|20995181|P5|NOT COMPLETED|Phase Ib||0
8518131|NCT00400764|20995182|P4|NOT COMPLETED|Phase Ib||0
8518132|NCT00400764|20995183|P3|NOT COMPLETED|Phase Ib||0
8518133|NCT00400764|20995184|P2|NOT COMPLETED|Phase Ib||4
8518134|NCT00400764|20995185|P1|NOT COMPLETED|Phase Ib||6
8518135|NCT00400764|20995181|P5|COMPLETED|Phase Ib||0
8518136|NCT00400764|20995182|P4|COMPLETED|Phase Ib||0
8518137|NCT00400764|20995183|P3|COMPLETED|Phase Ib||0
8518138|NCT00400764|20995184|P2|COMPLETED|Phase Ib||2
8518139|NCT00400764|20995185|P1|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
8518140|NCT00400764|20995181|P5|Treated|Phase Ib||0
8518141|NCT00400764|20995182|P4|Treated|Phase Ib||0
8518142|NCT00400764|20995183|P3|Treated|Phase Ib||0
8518143|NCT00400764|20995184|P2|Treated|Phase Ib||6
8518144|NCT00400764|20995185|P1|Treated|Phase Ib||6
8518145|NCT00400764|20995181|P5|STARTED|Phase Ib||0
8518146|NCT00400764|20995182|P4|STARTED|Phase Ib||0
8518147|NCT00400764|20995183|P3|STARTED|Phase Ib||0
8518148|NCT00400764|20995184|P2|STARTED|Phase Ib||6
8518149|NCT00400764|20995185|P1|STARTED|Phase Ib||6
8518150|NCT00400712|20995238|P2|NOT COMPLETED|Overall Study||16
8518151|NCT00400712|20995239|P1|NOT COMPLETED|Overall Study||17
8518152|NCT00400712|20995238|P2|COMPLETED|Overall Study||35
8518153|NCT00400712|20995239|P1|COMPLETED|Overall Study||35
8518154|NCT00400712|20995238|P2|STARTED|Overall Study||51
8518155|NCT00400712|20995239|P1|STARTED|Overall Study||52
8518156|NCT00400686|20995257|P1|NOT COMPLETED|Overall Study||0
8518157|NCT00400686|20995257|P1|COMPLETED|Overall Study||31
8518158|NCT00400686|20995257|P1|STARTED|Overall Study||31
8518159|NCT00400634|20995265|P2|NOT COMPLETED|Overall Study||1
8518160|NCT00400634|20995266|P1|NOT COMPLETED|Overall Study||4
8518161|NCT00400634|20995265|P2|COMPLETED|Overall Study||19
8518162|NCT00400634|20995266|P1|COMPLETED|Overall Study||34
8518163|NCT00400634|20995265|P2|STARTED|Overall Study||20
8518164|NCT00400634|20995266|P1|STARTED|Overall Study||38
8518165|NCT00400569|20995274|P1|NOT COMPLETED|Overall Study||1
8518166|NCT00400569|20995274|P1|COMPLETED|Overall Study||47
8518167|NCT00400569|20995274|P1|STARTED|Overall Study||48
8518168|NCT00400517|20995285|P1|NOT COMPLETED|Overall Study||2
8518169|NCT00400517|20995285|P1|COMPLETED|Overall Study||26
8518170|NCT00400517|20995285|P1|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
8518171|NCT00400439|20995294|P2|NOT COMPLETED|Overall Study||2
8518172|NCT00400439|20995295|P1|NOT COMPLETED|Overall Study||5
8518173|NCT00400439|20995294|P2|COMPLETED|Overall Study||23
8518174|NCT00400439|20995295|P1|COMPLETED|Overall Study||47
8518175|NCT00400439|20995294|P2|STARTED|Overall Study||25
8518176|NCT00400439|20995295|P1|STARTED|Overall Study||52
8518177|NCT00400400|20995305|P2|NOT COMPLETED|Overall Study||15
8518178|NCT00400400|20995306|P1|NOT COMPLETED|Overall Study||14
8518179|NCT00400400|20995305|P2|COMPLETED|Overall Study||185
8518180|NCT00400400|20995306|P1|COMPLETED|Overall Study||186
8518181|NCT00400400|20995305|P2|Intent-to-Treat Population|Overall Study||197
8518182|NCT00400400|20995306|P1|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
8518183|NCT00400400|20995305|P2|STARTED|Overall Study||200
8518184|NCT00400400|20995306|P1|STARTED|Overall Study||200
8518185|NCT00400205|20995324|P1|NOT COMPLETED|Overall Study||5
8518186|NCT00400205|20995324|P1|COMPLETED|Overall Study||9
8518187|NCT00400205|20995324|P1|STARTED|Overall Study||14
8518188|NCT00400179|20995331|P2|NOT COMPLETED|Overall Study||18
8518189|NCT00400179|20995332|P1|NOT COMPLETED|Overall Study||6
8518190|NCT00400179|20995331|P2|COMPLETED|Overall Study||508
8518191|NCT00400179|20995332|P1|COMPLETED|Overall Study|Received Treatment|521
8518192|NCT00400179|20995331|P2|STARTED|Overall Study||526
8518193|NCT00400179|20995332|P1|STARTED|Overall Study|Signed informed consent form and randomized|527
8518194|NCT00400153|20995349|P3|NOT COMPLETED|Overall Study||61
8518195|NCT00400153|20995350|P2|NOT COMPLETED|Overall Study||55
8518196|NCT00400153|20995351|P1|NOT COMPLETED|Overall Study||48
8518197|NCT00400153|20995349|P3|COMPLETED|Overall Study||422
8518198|NCT00400153|20995350|P2|COMPLETED|Overall Study||436
8518199|NCT00400153|20995351|P1|COMPLETED|Overall Study||438
8518200|NCT00400153|20995349|P3|STARTED|Overall Study||483
8518201|NCT00400153|20995350|P2|STARTED|Overall Study||491
8518202|NCT00400153|20995351|P1|STARTED|Overall Study||486
8518203|NCT00399893|20995598|P2|NOT COMPLETED|Overall Study||0
8518204|NCT00399893|20995599|P1|NOT COMPLETED|Overall Study||1
8518205|NCT00399893|20995598|P2|COMPLETED|Overall Study||3
8518206|NCT00399893|20995599|P1|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
8518207|NCT00399893|20995598|P2|STARTED|Overall Study||3
8518208|NCT00399893|20995599|P1|STARTED|Overall Study||2
8518209|NCT00399880|20995627|P2|NOT COMPLETED|Overall Study||0
8518210|NCT00399880|20995628|P1|NOT COMPLETED|Overall Study||0
8518211|NCT00399880|20995627|P2|COMPLETED|Overall Study||65
8518212|NCT00399880|20995628|P1|COMPLETED|Overall Study||65
8518213|NCT00399880|20995627|P2|STARTED|Overall Study||65
8518214|NCT00399880|20995628|P1|STARTED|Overall Study||65
8518215|NCT00399841|20995636|P3|NOT COMPLETED|Overall Study||0
8518216|NCT00399841|20995637|P2|NOT COMPLETED|Overall Study||0
8518217|NCT00399841|20995638|P1|NOT COMPLETED|Overall Study||12
8518218|NCT00399841|20995636|P3|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518219|NCT00399841|20995637|P2|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518220|NCT00399841|20995638|P1|COMPLETED|Overall Study||1
8518221|NCT00399841|20995636|P3|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518222|NCT00399841|20995637|P2|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518223|NCT00399841|20995638|P1|12-week|Overall Study||2
8518224|NCT00399841|20995636|P3|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518225|NCT00399841|20995637|P2|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518226|NCT00399841|20995638|P1|Permanent Implant|Overall Study||6
8518227|NCT00399841|20995636|P3|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518228|NCT00399841|20995637|P2|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
8518229|NCT00399841|20995638|P1|STARTED|Overall Study||13
8518230|NCT00399802|20995645|P2|NOT COMPLETED|Overall Study||3
8518231|NCT00399802|20995646|P1|NOT COMPLETED|Overall Study||0
8518232|NCT00399802|20995645|P2|COMPLETED|Overall Study||26
8518233|NCT00399802|20995646|P1|COMPLETED|Overall Study||14
8518234|NCT00399802|20995645|P2|STARTED|Overall Study||29
8518235|NCT00399802|20995646|P1|STARTED|Overall Study||14
8518236|NCT00399763|20995660|P2|NOT COMPLETED|Overall Study||3
8518237|NCT00399763|20995661|P1|NOT COMPLETED|Overall Study||2
8518238|NCT00399763|20995660|P2|COMPLETED|Overall Study||32
8518239|NCT00399763|20995661|P1|COMPLETED|Overall Study||33
8518240|NCT00399763|20995660|P2|STARTED|Overall Study||35
8518241|NCT00399763|20995661|P1|STARTED|Overall Study||35
8518242|NCT00399568|20995673|P2|NOT COMPLETED|Overall Study||9
8518243|NCT00399568|20995674|P1|NOT COMPLETED|Overall Study||12
8518244|NCT00399568|20995673|P2|COMPLETED|Overall Study||156
8518245|NCT00399568|20995674|P1|COMPLETED|Overall Study||154
8518246|NCT00399568|20995673|P2|STARTED|Overall Study||165
8518247|NCT00399568|20995674|P1|STARTED|Overall Study||166
8518248|NCT00399542|20995688|P2|NOT COMPLETED|Overall Study||43
8518249|NCT00399542|20995689|P1|NOT COMPLETED|Overall Study||84
8518250|NCT00399542|20995688|P2|COMPLETED|Overall Study||151
8518251|NCT00399542|20995689|P1|COMPLETED|Overall Study||303
8518252|NCT00399542|20995688|P2|STARTED|Overall Study||194
8518253|NCT00399542|20995689|P1|STARTED|Overall Study||387
8518254|NCT00399529|20995751|P1|NOT COMPLETED|Overall Study||2
8518255|NCT00399529|20995751|P1|COMPLETED|Overall Study||20
8518256|NCT00399529|20995751|P1|STARTED|Overall Study||22
8518257|NCT00399516|20995757|P1|NOT COMPLETED|Overall Study||2
8518258|NCT00399516|20995757|P1|COMPLETED|Overall Study||19
8518259|NCT00399516|20995757|P1|STARTED|Overall Study||21
8518260|NCT00399360|20995765|P4|NOT COMPLETED|Overall Study||6
8518261|NCT00399360|20995766|P3|NOT COMPLETED|Overall Study||3
8518262|NCT00399360|20995767|P2|NOT COMPLETED|Overall Study||3
8518263|NCT00399360|20995768|P1|NOT COMPLETED|Overall Study||2
8518264|NCT00399360|20995765|P4|COMPLETED|Overall Study||9
8518265|NCT00399360|20995766|P3|COMPLETED|Overall Study||10
8518266|NCT00399360|20995767|P2|COMPLETED|Overall Study||8
8518267|NCT00399360|20995768|P1|COMPLETED|Overall Study||9
8518268|NCT00399360|20995765|P4|STARTED|Overall Study||15
8518269|NCT00399360|20995766|P3|STARTED|Overall Study||13
8518270|NCT00399360|20995767|P2|STARTED|Overall Study||11
8518271|NCT00399360|20995768|P1|STARTED|Overall Study||11
8518281|NCT00399035|20995839|P3|NOT COMPLETED|Overall Study||252
8518282|NCT00399035|20995840|P2|NOT COMPLETED|Overall Study||158
8518283|NCT00399035|20995841|P1|NOT COMPLETED|Overall Study||313
8518284|NCT00399035|20995839|P3|COMPLETED|Overall Study||106
8518285|NCT00399035|20995840|P2|COMPLETED|Overall Study||58
8518286|NCT00399035|20995841|P1|COMPLETED|Overall Study||189
8518287|NCT00399035|20995839|P3|STARTED|Overall Study||358
8518288|NCT00399035|20995840|P2|STARTED|Overall Study||216
8518289|NCT00399035|20995841|P1|STARTED|Overall Study||502
8518290|NCT00398983|20995862|P2|NOT COMPLETED|Overall Study||0
8518291|NCT00398983|20995863|P1|NOT COMPLETED|Overall Study||0
8518292|NCT00398983|20995862|P2|COMPLETED|Overall Study||25
8518293|NCT00398983|20995863|P1|COMPLETED|Overall Study||20
8518294|NCT00398983|20995862|P2|STARTED|Overall Study||25
8518295|NCT00398983|20995863|P1|STARTED|Overall Study||20
8518296|NCT00398918|20995869|P1|NOT COMPLETED|Overall Study||0
8518297|NCT00398918|20995869|P1|COMPLETED|Overall Study||10
8518298|NCT00398918|20995869|P1|STARTED|Overall Study||10
8518299|NCT00398866|20995877|P3|NOT COMPLETED|Overall Study||8
8518300|NCT00398866|20995878|P2|NOT COMPLETED|Overall Study||8
8518301|NCT00398866|20995879|P1|NOT COMPLETED|Overall Study||14
8518302|NCT00398866|20995877|P3|COMPLETED|Overall Study||58
8518303|NCT00398866|20995878|P2|COMPLETED|Overall Study||60
8518304|NCT00398866|20995879|P1|COMPLETED|Overall Study||52
8518305|NCT00398866|20995877|P3|STARTED|Overall Study||66
8518306|NCT00398866|20995878|P2|STARTED|Overall Study||68
8518307|NCT00398866|20995879|P1|STARTED|Overall Study||66
8518308|NCT00398632|20995890|P1|NOT COMPLETED|Overall Study||2
8518309|NCT00398632|20995890|P1|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
8518310|NCT00398632|20995890|P1|STARTED|Overall Study||6
8518311|NCT00398567|20995898|P3|NOT COMPLETED|Overall Study||34
8518312|NCT00398567|20995899|P2|NOT COMPLETED|Overall Study||4
8518313|NCT00398567|20995900|P1|NOT COMPLETED|Overall Study||4
8518314|NCT00398567|20995898|P3|COMPLETED|Overall Study||3
8518315|NCT00398567|20995899|P2|COMPLETED|Overall Study||0
8518316|NCT00398567|20995900|P1|COMPLETED|Overall Study||0
8518317|NCT00398567|20995898|P3|STARTED|Overall Study||37
8518318|NCT00398567|20995899|P2|STARTED|Overall Study||4
8518319|NCT00398567|20995900|P1|STARTED|Overall Study||4
8518320|NCT00398476|20995912|P2|NOT COMPLETED|Treatment Period 2||0
8518321|NCT00398476|20995913|P1|NOT COMPLETED|Treatment Period 2||0
8518322|NCT00398476|20995912|P2|COMPLETED|Treatment Period 2||64
8518323|NCT00398476|20995913|P1|COMPLETED|Treatment Period 2||63
8518324|NCT00398476|20995912|P2|STARTED|Treatment Period 2||64
8518325|NCT00398476|20995913|P1|STARTED|Treatment Period 2||63
8518326|NCT00398476|20995912|P2|NOT COMPLETED|Washout Period (20 Minutes)||0
8518327|NCT00398476|20995913|P1|NOT COMPLETED|Washout Period (20 Minutes)||0
8518328|NCT00398476|20995912|P2|COMPLETED|Washout Period (20 Minutes)||64
8518329|NCT00398476|20995913|P1|COMPLETED|Washout Period (20 Minutes)||63
8518330|NCT00398476|20995912|P2|STARTED|Washout Period (20 Minutes)||64
8518331|NCT00398476|20995913|P1|STARTED|Washout Period (20 Minutes)||63
8518332|NCT00398476|20995912|P2|NOT COMPLETED|Treatment Period 1||0
8518333|NCT00398476|20995913|P1|NOT COMPLETED|Treatment Period 1||0
8518334|NCT00398476|20995912|P2|COMPLETED|Treatment Period 1||64
8518335|NCT00398476|20995913|P1|COMPLETED|Treatment Period 1||63
8518336|NCT00398476|20995912|P2|STARTED|Treatment Period 1||64
8518337|NCT00398476|20995913|P1|STARTED|Treatment Period 1||63
8518338|NCT00398411|20995954|P2|NOT COMPLETED|Overall Study||1
8518339|NCT00398411|20995955|P1|NOT COMPLETED|Overall Study||0
8518340|NCT00398411|20995954|P2|COMPLETED|Overall Study||31
8518341|NCT00398411|20995955|P1|COMPLETED|Overall Study||34
8518342|NCT00398411|20995954|P2|STARTED|Overall Study||32
8518343|NCT00398411|20995955|P1|STARTED|Overall Study||34
8518344|NCT00398398|20995971|P1|NOT COMPLETED|Overall Study||0
8518345|NCT00398398|20995971|P1|COMPLETED|Overall Study||44
8518346|NCT00398398|20995971|P1|STARTED|Overall Study||44
8518347|NCT00398320|20995978|P1|NOT COMPLETED|Overall Study||6
8518348|NCT00398320|20995978|P1|COMPLETED|Overall Study||34
8518349|NCT00398320|20995978|P1|STARTED|Overall Study||40
8518350|NCT00398216|20995991|P5|NOT COMPLETED|Overall Study||15
8518351|NCT00398216|20995992|P4|NOT COMPLETED|Overall Study||22
8518352|NCT00398216|20995993|P3|NOT COMPLETED|Overall Study||21
8518353|NCT00398216|20995994|P2|NOT COMPLETED|Overall Study||19
8518354|NCT00398216|20995995|P1|NOT COMPLETED|Overall Study||11
8518355|NCT00398216|20995991|P5|COMPLETED|Overall Study||157
8518356|NCT00398216|20995992|P4|COMPLETED|Overall Study||155
8518357|NCT00398216|20995993|P3|COMPLETED|Overall Study||164
8518358|NCT00398216|20995994|P2|COMPLETED|Overall Study||151
8518359|NCT00398216|20995995|P1|COMPLETED|Overall Study||181
8518360|NCT00398216|20995991|P5|STARTED|Overall Study||172
8518361|NCT00398216|20995992|P4|STARTED|Overall Study||177
8518362|NCT00398216|20995993|P3|STARTED|Overall Study||185
8518363|NCT00398216|20995994|P2|STARTED|Overall Study||170
8518364|NCT00398216|20995995|P1|STARTED|Overall Study||192
8518365|NCT00398138|20996022|P1|NOT COMPLETED|Overall Study||2
8518366|NCT00398138|20996022|P1|COMPLETED|Overall Study||10
8518367|NCT00398138|20996022|P1|STARTED|Overall Study||12
8518368|NCT00398112|20996027|P1|NOT COMPLETED|Overall Study||18
8518369|NCT00398112|20996027|P1|COMPLETED|Overall Study||0
8518370|NCT00398112|20996027|P1|STARTED|Overall Study||18
8518371|NCT00398086|20996038|P3|NOT COMPLETED|Overall Study||2
8518372|NCT00398086|20996039|P2|NOT COMPLETED|Overall Study||23
8518373|NCT00398086|20996040|P1|NOT COMPLETED|Overall Study||9
8518374|NCT00398086|20996038|P3|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
8518375|NCT00398086|20996039|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
8518376|NCT00398086|20996040|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
8518377|NCT00398086|20996038|P3|Phase 1, Dose Escalation Population|Overall Study||3
8518378|NCT00398086|20996039|P2|Phase 1, Dose Escalation Population|Overall Study||7
8518379|NCT00398086|20996040|P1|Phase 1, Dose Escalation Population|Overall Study||20
8518380|NCT00398086|20996038|P3|STARTED|Overall Study||3
8518381|NCT00398086|20996039|P2|STARTED|Overall Study||44
8518382|NCT00398086|20996040|P1|STARTED|Overall Study||20
8518383|NCT00398073|20996074|P2|NOT COMPLETED|Overall Study||0
8518384|NCT00398073|20996075|P1|NOT COMPLETED|Overall Study||1
8518385|NCT00398073|20996074|P2|COMPLETED|Overall Study||17
8518386|NCT00398073|20996075|P1|COMPLETED|Overall Study||17
8518387|NCT00398073|20996074|P2|STARTED|Overall Study||17
8518388|NCT00398073|20996075|P1|STARTED|Overall Study||18
8518389|NCT00398047|20996085|P1|NOT COMPLETED|Overall Study||3
8518390|NCT00398047|20996085|P1|COMPLETED|Overall Study|all three patients progressed before completing|0
8518391|NCT00398047|20996085|P1|STARTED|Overall Study||3
8518392|NCT00397982|20996095|P1|NOT COMPLETED|Overall Study||4
8518393|NCT00397982|20996095|P1|COMPLETED|Overall Study||13
8518394|NCT00397982|20996095|P1|STARTED|Overall Study||17
8518395|NCT00397943|20996109|P5|NOT COMPLETED|Overall Study||0
8518396|NCT00397943|20996110|P4|NOT COMPLETED|Overall Study||0
8518397|NCT00397943|20996111|P3|NOT COMPLETED|Overall Study||0
8518398|NCT00397943|20996112|P2|NOT COMPLETED|Overall Study||9
8518399|NCT00397943|20996113|P1|NOT COMPLETED|Overall Study||12
8518400|NCT00397943|20996109|P5|COMPLETED|Overall Study||10
8518401|NCT00397943|20996110|P4|COMPLETED|Overall Study||10
8518402|NCT00397943|20996111|P3|COMPLETED|Overall Study||10
8518403|NCT00397943|20996112|P2|COMPLETED|Overall Study||31
8518404|NCT00397943|20996113|P1|COMPLETED|Overall Study||28
8518405|NCT00397943|20996109|P5|STARTED|Overall Study||10
8518406|NCT00397943|20996110|P4|STARTED|Overall Study||10
8518407|NCT00397943|20996111|P3|STARTED|Overall Study||10
8518408|NCT00397943|20996112|P2|STARTED|Overall Study||40
8518409|NCT00397943|20996113|P1|STARTED|Overall Study||40
8518410|NCT00397930|20996269|P2|NOT COMPLETED|Overall Study||51
8518411|NCT00397930|20996270|P1|NOT COMPLETED|Overall Study||38
8518412|NCT00397930|20996269|P2|COMPLETED|Overall Study||153
8518413|NCT00397930|20996270|P1|COMPLETED|Overall Study||168
8518414|NCT00397930|20996269|P2|STARTED|Overall Study||204
8518415|NCT00397930|20996270|P1|STARTED|Overall Study||206
8518416|NCT00397904|20996276|P1|NOT COMPLETED|Overall Study||0
8518417|NCT00397904|20996276|P1|COMPLETED|Overall Study||16
8518418|NCT00397904|20996276|P1|STARTED|Overall Study||16
8518419|NCT00397891|20996285|P5|NOT COMPLETED|Overall Study||1
8518420|NCT00397891|20996286|P4|NOT COMPLETED|Overall Study||0
8518421|NCT00397891|20996287|P3|NOT COMPLETED|Overall Study||0
8518422|NCT00397891|20996288|P2|NOT COMPLETED|Overall Study||0
8518423|NCT00397891|20996289|P1|NOT COMPLETED|Overall Study||1
8518424|NCT00397891|20996285|P5|COMPLETED|Overall Study||7
8518425|NCT00397891|20996286|P4|COMPLETED|Overall Study||6
8518426|NCT00397891|20996287|P3|COMPLETED|Overall Study||6
8518427|NCT00397891|20996288|P2|COMPLETED|Overall Study||6
8518428|NCT00397891|20996289|P1|COMPLETED|Overall Study||5
8518429|NCT00397891|20996285|P5|STARTED|Overall Study||8
8518430|NCT00397891|20996286|P4|STARTED|Overall Study||6
8518431|NCT00397891|20996287|P3|STARTED|Overall Study||6
8518432|NCT00397891|20996288|P2|STARTED|Overall Study||6
8518433|NCT00397891|20996289|P1|STARTED|Overall Study||6
8518434|NCT00397878|20996387|P1|NOT COMPLETED|Overall Study||0
8518435|NCT00397878|20996387|P1|COMPLETED|Overall Study||10
8518436|NCT00397878|20996387|P1|STARTED|Overall Study||10
8518437|NCT00397839|20996396|P2|NOT COMPLETED|Overall Study||18
8518438|NCT00397839|20996397|P1|NOT COMPLETED|Overall Study||7
8518439|NCT00397839|20996396|P2|COMPLETED|Overall Study||69
8518440|NCT00397839|20996397|P1|COMPLETED|Overall Study||41
8518441|NCT00397839|20996396|P2|STARTED|Overall Study||87
8518442|NCT00397839|20996397|P1|STARTED|Overall Study||48
8518443|NCT00397813|20996417|P6|NOT COMPLETED|Overall Study||0
8518444|NCT00397813|20996418|P5|NOT COMPLETED|Overall Study||0
8518445|NCT00397813|20996419|P4|NOT COMPLETED|Overall Study||0
8518446|NCT00397813|20996420|P3|NOT COMPLETED|Overall Study||0
8518447|NCT00397813|20996421|P2|NOT COMPLETED|Overall Study||0
8518448|NCT00397813|20996422|P1|NOT COMPLETED|Overall Study||0
8518449|NCT00397813|20996417|P6|COMPLETED|Overall Study||24
8518450|NCT00397813|20996418|P5|COMPLETED|Overall Study||5
8518451|NCT00397813|20996419|P4|COMPLETED|Overall Study||12
8518452|NCT00397813|20996420|P3|COMPLETED|Overall Study||0
8518453|NCT00397813|20996421|P2|COMPLETED|Overall Study||0
8518454|NCT00397813|20996422|P1|COMPLETED|Overall Study||36
8518455|NCT00397813|20996417|P6|STARTED|Overall Study||24
8518456|NCT00397813|20996418|P5|STARTED|Overall Study||5
8518457|NCT00397813|20996419|P4|STARTED|Overall Study||12
8518458|NCT00397813|20996420|P3|STARTED|Overall Study||0
8518459|NCT00397813|20996421|P2|STARTED|Overall Study||0
8518460|NCT00397813|20996422|P1|STARTED|Overall Study||36
8518461|NCT00397631|20996462|P2|NOT COMPLETED|Overall Study||44
8518462|NCT00397631|20996463|P1|NOT COMPLETED|Overall Study||30
8518463|NCT00397631|20996462|P2|COMPLETED|Overall Study||215
8518464|NCT00397631|20996463|P1|COMPLETED|Overall Study||231
8518465|NCT00397631|20996462|P2|STARTED|Overall Study||259
8518466|NCT00397631|20996463|P1|STARTED|Overall Study|Randomization ratio was 1:1|261
8518467|NCT00397579|20996473|P1|NOT COMPLETED|Overall Study||0
8518468|NCT00397579|20996473|P1|COMPLETED|Overall Study||11
8518469|NCT00397579|20996473|P1|STARTED|Overall Study||11
8518470|NCT00397540|20996479|P2|NOT COMPLETED|Overall Study||0
8518471|NCT00397540|20996480|P1|NOT COMPLETED|Overall Study||1
8518472|NCT00397540|20996479|P2|COMPLETED|Overall Study||85
8518473|NCT00397540|20996480|P1|COMPLETED|Overall Study||59
8518474|NCT00397540|20996479|P2|STARTED|Overall Study||85
8518475|NCT00397540|20996480|P1|STARTED|Overall Study||60
8518476|NCT00397514|20996488|P1|NOT COMPLETED|Overall Study||9
8518477|NCT00397514|20996488|P1|COMPLETED|Overall Study||25
8518478|NCT00397514|20996488|P1|STARTED|Overall Study||34
8518479|NCT00397488|20996498|P1|NOT COMPLETED|Overall Study||7
8518480|NCT00397488|20996498|P1|COMPLETED|Overall Study||71
8518481|NCT00397488|20996498|P1|STARTED|Overall Study||78
8518482|NCT00397462|20996505|P3|NOT COMPLETED|Overall Study||0
8518483|NCT00397462|20996506|P2|NOT COMPLETED|Overall Study||0
8518484|NCT00397462|20996507|P1|NOT COMPLETED|Overall Study||0
8518485|NCT00397462|20996505|P3|COMPLETED|Overall Study||15
8518486|NCT00397462|20996506|P2|COMPLETED|Overall Study||13
8518487|NCT00397462|20996507|P1|COMPLETED|Overall Study||16
8518488|NCT00397462|20996505|P3|STARTED|Overall Study||15
8518489|NCT00397462|20996506|P2|STARTED|Overall Study||13
8518490|NCT00397462|20996507|P1|STARTED|Overall Study||16
8518491|NCT00397254|20996518|P2|NOT COMPLETED|Overall Study||2
8518492|NCT00397254|20996519|P1|NOT COMPLETED|Overall Study||2
8518493|NCT00397254|20996518|P2|COMPLETED|Overall Study||74
8518494|NCT00397254|20996519|P1|COMPLETED|Overall Study||77
8518495|NCT00397254|20996518|P2|STARTED|Overall Study||76
8518496|NCT00397254|20996519|P1|STARTED|Overall Study||79
8518497|NCT00397215|20996541|P4|NOT COMPLETED|Month 24 (Day 720)||0
8518498|NCT00397215|20996542|P3|NOT COMPLETED|Month 24 (Day 720)||0
8518499|NCT00397215|20996543|P2|NOT COMPLETED|Month 24 (Day 720)||0
8518500|NCT00397215|20996544|P1|NOT COMPLETED|Month 24 (Day 720)||0
8518501|NCT00397215|20996541|P4|COMPLETED|Month 24 (Day 720)||36
8518502|NCT00397215|20996542|P3|COMPLETED|Month 24 (Day 720)||117
8518503|NCT00397215|20996543|P2|COMPLETED|Month 24 (Day 720)||45
8518504|NCT00397215|20996544|P1|COMPLETED|Month 24 (Day 720)||122
8518505|NCT00397215|20996541|P4|STARTED|Month 24 (Day 720)||36
8518506|NCT00397215|20996542|P3|STARTED|Month 24 (Day 720)||117
8518507|NCT00397215|20996543|P2|STARTED|Month 24 (Day 720)||45
8518508|NCT00397215|20996544|P1|STARTED|Month 24 (Day 720)||122
8518509|NCT00397215|20996541|P4|NOT COMPLETED|Month 12 (Day 360)||0
8518510|NCT00397215|20996542|P3|NOT COMPLETED|Month 12 (Day 360)||0
8518511|NCT00397215|20996543|P2|NOT COMPLETED|Month 12 (Day 360)||0
8518512|NCT00397215|20996544|P1|NOT COMPLETED|Month 12 (Day 360)||0
8518513|NCT00397215|20996541|P4|COMPLETED|Month 12 (Day 360)||42
8518514|NCT00397215|20996542|P3|COMPLETED|Month 12 (Day 360)||125
8518515|NCT00397215|20996543|P2|COMPLETED|Month 12 (Day 360)||48
8518516|NCT00397215|20996544|P1|COMPLETED|Month 12 (Day 360)||130
8518517|NCT00397215|20996541|P4|STARTED|Month 12 (Day 360)||42
8518518|NCT00397215|20996542|P3|STARTED|Month 12 (Day 360)||125
8518519|NCT00397215|20996543|P2|STARTED|Month 12 (Day 360)||48
8518520|NCT00397215|20996544|P1|STARTED|Month 12 (Day 360)||130
8518521|NCT00397215|20996541|P4|NOT COMPLETED|Month 6 (Day 180)||0
8518522|NCT00397215|20996542|P3|NOT COMPLETED|Month 6 (Day 180)||5
8518523|NCT00397215|20996543|P2|NOT COMPLETED|Month 6 (Day 180)||3
8518524|NCT00397215|20996544|P1|NOT COMPLETED|Month 6 (Day 180)||2
8518525|NCT00397215|20996541|P4|COMPLETED|Month 6 (Day 180)||51
8518526|NCT00397215|20996542|P3|COMPLETED|Month 6 (Day 180)||153
8518527|NCT00397215|20996543|P2|COMPLETED|Month 6 (Day 180)||55
8518528|NCT00397215|20996544|P1|COMPLETED|Month 6 (Day 180)||162
8518529|NCT00397215|20996541|P4|STARTED|Month 6 (Day 180)||51
8518530|NCT00397215|20996542|P3|STARTED|Month 6 (Day 180)||158
8518531|NCT00397215|20996543|P2|STARTED|Month 6 (Day 180)||58
8518532|NCT00397215|20996544|P1|STARTED|Month 6 (Day 180)||164
8518533|NCT00397215|20996541|P4|NOT COMPLETED|Month 0 (Day 0)||4
8518534|NCT00397215|20996542|P3|NOT COMPLETED|Month 0 (Day 0)||6
8518535|NCT00397215|20996543|P2|NOT COMPLETED|Month 0 (Day 0)||5
8518536|NCT00397215|20996544|P1|NOT COMPLETED|Month 0 (Day 0)||7
8518537|NCT00397215|20996541|P4|COMPLETED|Month 0 (Day 0)||48
8518538|NCT00397215|20996542|P3|COMPLETED|Month 0 (Day 0)||153
8518539|NCT00397215|20996543|P2|COMPLETED|Month 0 (Day 0)||56
8518540|NCT00397215|20996544|P1|COMPLETED|Month 0 (Day 0)||158
8518541|NCT00397215|20996541|P4|STARTED|Month 0 (Day 0)||52
8518542|NCT00397215|20996542|P3|STARTED|Month 0 (Day 0)||159
8518543|NCT00397215|20996543|P2|STARTED|Month 0 (Day 0)||61
8518544|NCT00397215|20996544|P1|STARTED|Month 0 (Day 0)||165
8518545|NCT00397189|20996680|P2|NOT COMPLETED|Extension Period||43
8518546|NCT00397189|20996681|P1|NOT COMPLETED|Extension Period||113
8518547|NCT00397189|20996680|P2|COMPLETED|Extension Period||134
8518548|NCT00397189|20996681|P1|COMPLETED|Extension Period||421
8518549|NCT00397189|20996680|P2|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
8518550|NCT00397189|20996681|P1|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
8518551|NCT00397189|20996680|P2|NOT COMPLETED|3 Weeks Period||22
8518552|NCT00397189|20996681|P1|NOT COMPLETED|3 Weeks Period||21
8518553|NCT00397189|20996680|P2|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
8518554|NCT00397189|20996681|P1|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
8518555|NCT00397189|20996680|P2|STARTED|3 Weeks Period||395
8518556|NCT00397189|20996681|P1|STARTED|3 Weeks Period||394
8518557|NCT00397150|20996691|P2|NOT COMPLETED|Overall Study||145
8518558|NCT00397150|20996692|P1|NOT COMPLETED|Overall Study||135
8518559|NCT00397150|20996691|P2|COMPLETED|Overall Study||1111
8518560|NCT00397150|20996692|P1|COMPLETED|Overall Study||1188
8518561|NCT00397150|20996691|P2|STARTED|Overall Study||1256
8518562|NCT00397150|20996692|P1|STARTED|Overall Study||1323
8518563|NCT00397046|20996708|P4|NOT COMPLETED|Overall Study||5
8518564|NCT00397046|20996709|P3|NOT COMPLETED|Overall Study||10
8518565|NCT00397046|20996710|P2|NOT COMPLETED|Overall Study||3
8518566|NCT00397046|20996711|P1|NOT COMPLETED|Overall Study||3
8518567|NCT00397046|20996708|P4|COMPLETED|Overall Study||0
8518568|NCT00397046|20996709|P3|COMPLETED|Overall Study||0
8518569|NCT00397046|20996710|P2|COMPLETED|Overall Study||0
8518570|NCT00397046|20996711|P1|COMPLETED|Overall Study||0
8518571|NCT00397046|20996708|P4|STARTED|Overall Study||5
8518572|NCT00397046|20996709|P3|STARTED|Overall Study||10
8518573|NCT00397046|20996710|P2|STARTED|Overall Study||3
8518574|NCT00397046|20996711|P1|STARTED|Overall Study||3
8518575|NCT00397033|20996733|P3|NOT COMPLETED|Overall Study||23
8518576|NCT00397033|20996734|P2|NOT COMPLETED|Overall Study||37
8518577|NCT00397033|20996735|P1|NOT COMPLETED|Overall Study||44
8518578|NCT00397033|20996733|P3|COMPLETED|Overall Study||77
8518579|NCT00397033|20996734|P2|COMPLETED|Overall Study||72
8518580|NCT00397033|20996735|P1|COMPLETED|Overall Study||63
8518581|NCT00397033|20996733|P3|ITT Population|Overall Study||98
8518582|NCT00397033|20996734|P2|ITT Population|Overall Study||105
8518583|NCT00397033|20996735|P1|ITT Population|Overall Study||107
8518584|NCT00397033|20996733|P3|Safety Population: >= 1 Dose of Drug|Overall Study||98
8518585|NCT00397033|20996734|P2|Safety Population: >= 1 Dose of Drug|Overall Study||108
8518586|NCT00397033|20996735|P1|Safety Population: >= 1 Dose of Drug|Overall Study||107
8518587|NCT00397033|20996733|P3|STARTED|Overall Study||100
8518588|NCT00397033|20996734|P2|STARTED|Overall Study||109
8518589|NCT00397033|20996735|P1|STARTED|Overall Study||107
8518590|NCT00397020|20996796|P2|NOT COMPLETED|Overall Study||1
8518591|NCT00397020|20996797|P1|NOT COMPLETED|Overall Study||1
8518592|NCT00397020|20996796|P2|COMPLETED|Overall Study||15
8518593|NCT00397020|20996797|P1|COMPLETED|Overall Study||13
8518594|NCT00397020|20996796|P2|STARTED|Overall Study||16
8518595|NCT00397020|20996797|P1|STARTED|Overall Study||14
8518596|NCT00396981|20996805|P2|NOT COMPLETED|Overall Study||9
8518597|NCT00396981|20996806|P1|NOT COMPLETED|Overall Study||15
8518598|NCT00396981|20996805|P2|COMPLETED|Overall Study||306
8518599|NCT00396981|20996806|P1|COMPLETED|Overall Study||296
8518600|NCT00396981|20996805|P2|STARTED|Overall Study||315
8518601|NCT00396981|20996806|P1|STARTED|Overall Study||311
8518602|NCT00396877|20996826|P2|NOT COMPLETED|Overall Study||8
8518603|NCT00396877|20996827|P1|NOT COMPLETED|Overall Study||6
8518604|NCT00396877|20996826|P2|COMPLETED|Overall Study|Completed follow-up|459
8518605|NCT00396877|20996827|P1|COMPLETED|Overall Study|Completed follow-up|433
8518606|NCT00396877|20996826|P2|Completed Treatment|Overall Study||352
8518607|NCT00396877|20996827|P1|Completed Treatment|Overall Study||356
8518608|NCT00396877|20996826|P2|Treated|Overall Study||464
8518609|NCT00396877|20996827|P1|Treated|Overall Study||436
8518610|NCT00396877|20996826|P2|STARTED|Overall Study|Randomized|467
8518611|NCT00396877|20996827|P1|STARTED|Overall Study|Randomized|439
8518612|NCT00396812|20996837|P1|NOT COMPLETED|Overall Study||1
8518613|NCT00396812|20996837|P1|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
8518614|NCT00396812|20996837|P1|STARTED|Overall Study||4
8518615|NCT00396656|20996849|P2|NOT COMPLETED|Second Treatment Period||1
8518616|NCT00396656|20996850|P1|NOT COMPLETED|Second Treatment Period||0
8518617|NCT00396656|20996849|P2|COMPLETED|Second Treatment Period||12
8518618|NCT00396656|20996850|P1|COMPLETED|Second Treatment Period||15
8518619|NCT00396656|20996849|P2|STARTED|Second Treatment Period||13
8518620|NCT00396656|20996850|P1|STARTED|Second Treatment Period||15
8518621|NCT00396656|20996849|P2|NOT COMPLETED|First Treatment Period||2
8518622|NCT00396656|20996850|P1|NOT COMPLETED|First Treatment Period||0
8518623|NCT00396656|20996849|P2|COMPLETED|First Treatment Period||13
8518624|NCT00396656|20996850|P1|COMPLETED|First Treatment Period||15
8518625|NCT00396656|20996849|P2|STARTED|First Treatment Period||15
8518626|NCT00396656|20996850|P1|STARTED|First Treatment Period||15
8518627|NCT00396630|20996868|P2|NOT COMPLETED|Overall Study||5
8518628|NCT00396630|20996869|P1|NOT COMPLETED|Overall Study||5
8518629|NCT00396630|20996868|P2|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
8518630|NCT00396630|20996869|P1|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
8518631|NCT00396630|20996868|P2|STARTED|Overall Study||100
8518632|NCT00396630|20996869|P1|STARTED|Overall Study||100
8518633|NCT00396591|20996889|P1|NOT COMPLETED|Overall Study||16
8518634|NCT00396591|20996889|P1|COMPLETED|Overall Study||0
8518635|NCT00396591|20996889|P1|STARTED|Overall Study||16
8518636|NCT00396565|20996902|P3|NOT COMPLETED|Overall Study||17
8518637|NCT00396565|20996903|P2|NOT COMPLETED|Overall Study||91
8518638|NCT00396565|20996904|P1|NOT COMPLETED|Overall Study||48
8518639|NCT00396565|20996902|P3|COMPLETED|Overall Study||30
8518640|NCT00396565|20996903|P2|COMPLETED|Overall Study||47
8518641|NCT00396565|20996904|P1|COMPLETED|Overall Study||88
8518642|NCT00396565|20996902|P3|STARTED|Overall Study||47
8518643|NCT00396565|20996903|P2|STARTED|Overall Study||138
8518644|NCT00396565|20996904|P1|STARTED|Overall Study||136
8518645|NCT00396409|20996929|P2|NOT COMPLETED|Period 2 - 2008||2
8518646|NCT00396409|20996930|P1|NOT COMPLETED|Period 2 - 2008||7
8518647|NCT00396409|20996929|P2|COMPLETED|Period 2 - 2008||53
8518648|NCT00396409|20996930|P1|COMPLETED|Period 2 - 2008||52
8518649|NCT00396409|20996929|P2|STARTED|Period 2 - 2008||55
8518650|NCT00396409|20996930|P1|STARTED|Period 2 - 2008||59
8518651|NCT00396409|20996929|P2|NOT COMPLETED|Between Period 1 and Period 2||2
8518652|NCT00396409|20996930|P1|NOT COMPLETED|Between Period 1 and Period 2||3
8518653|NCT00396409|20996929|P2|COMPLETED|Between Period 1 and Period 2||55
8518654|NCT00396409|20996930|P1|COMPLETED|Between Period 1 and Period 2||59
8518655|NCT00396409|20996929|P2|STARTED|Between Period 1 and Period 2||57
8518656|NCT00396409|20996930|P1|STARTED|Between Period 1 and Period 2||62
8518657|NCT00396409|20996929|P2|NOT COMPLETED|Period 1 - 2007||6
8518658|NCT00396409|20996930|P1|NOT COMPLETED|Period 1 - 2007||3
8518659|NCT00396409|20996929|P2|COMPLETED|Period 1 - 2007||57
8518660|NCT00396409|20996930|P1|COMPLETED|Period 1 - 2007||62
8518661|NCT00396409|20996929|P2|STARTED|Period 1 - 2007||63
8518662|NCT00396409|20996930|P1|STARTED|Period 1 - 2007||65
8518663|NCT00396383|20996960|P1|NOT COMPLETED|Overall Study||3
8518664|NCT00396383|20996960|P1|COMPLETED|Overall Study||6
8518665|NCT00396383|20996960|P1|STARTED|Overall Study||9
8518666|NCT00396331|20996973|P1|NOT COMPLETED|Overall Study||32
8518667|NCT00396331|20996973|P1|COMPLETED|Overall Study||68
8518668|NCT00396331|20996973|P1|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
8518669|NCT00396331|20996973|P1|Number of Participants Treated|Overall Study||100
8518670|NCT00396331|20996973|P1|STARTED|Overall Study||100
8518671|NCT00396318|20997026|P1|NOT COMPLETED|7-Day Post-Treatment Contact||1
8518672|NCT00396318|20997026|P1|COMPLETED|7-Day Post-Treatment Contact||240
8518673|NCT00396318|20997026|P1|STARTED|7-Day Post-Treatment Contact||241
8518674|NCT00396318|20997026|P1|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
8518675|NCT00396318|20997026|P1|COMPLETED|48- to 96-Hour Follow-Up Period||241
8518676|NCT00396318|20997026|P1|STARTED|48- to 96-Hour Follow-Up Period||246
8518677|NCT00396318|20997026|P1|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
8518678|NCT00396318|20997026|P1|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
8518679|NCT00396318|20997026|P1|STARTED|At Least One Dose of Tenecteplase (MITT)||246
8518680|NCT00396292|20997039|P2|NOT COMPLETED|Overall Study||16
8518681|NCT00396292|20997040|P1|NOT COMPLETED|Overall Study||9
8518682|NCT00396292|20997039|P2|COMPLETED|Overall Study||162
8518683|NCT00396292|20997040|P1|COMPLETED|Overall Study||165
8518684|NCT00396292|20997039|P2|STARTED|Overall Study||178
8518685|NCT00396292|20997040|P1|STARTED|Overall Study||174
8518686|NCT00396279|20997046|P1|NOT COMPLETED|Overall Study||30
8518687|NCT00396279|20997046|P1|COMPLETED|Overall Study|Defined as participants with a complete resection|7
8518688|NCT00396279|20997046|P1|STARTED|Overall Study||37
8518689|NCT00396266|20997057|P2|NOT COMPLETED|Overall Study||0
8518690|NCT00396266|20997058|P1|NOT COMPLETED|Overall Study||0
8518691|NCT00396266|20997057|P2|COMPLETED|Overall Study||14
8518692|NCT00396266|20997058|P1|COMPLETED|Overall Study||8
8518693|NCT00396266|20997057|P2|STARTED|Overall Study||14
8518694|NCT00396266|20997058|P1|STARTED|Overall Study||8
8518695|NCT00396253|20997079|P1|NOT COMPLETED|Overall Study||13
8518696|NCT00396253|20997079|P1|COMPLETED|Overall Study||210
8518697|NCT00396253|20997079|P1|STARTED|Overall Study||223
8518698|NCT00396201|20997091|P1|NOT COMPLETED|Follow-up Period||0
8518699|NCT00396201|20997091|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
8518700|NCT00396201|20997091|P1|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
8518701|NCT00396201|20997091|P1|NOT COMPLETED|Treatment Period||0
8518702|NCT00396201|20997091|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
8518703|NCT00396201|20997091|P1|STARTED|Treatment Period||22
8518704|NCT00396162|20997110|P2|NOT COMPLETED|Overall Study||3
8518705|NCT00396162|20997111|P1|NOT COMPLETED|Overall Study||2
8518706|NCT00396162|20997110|P2|COMPLETED|Overall Study||35
8518707|NCT00396162|20997111|P1|COMPLETED|Overall Study||37
8518708|NCT00396162|20997110|P2|STARTED|Overall Study||38
8518709|NCT00396162|20997111|P1|STARTED|Overall Study||39
8518710|NCT00396136|20997123|P1|NOT COMPLETED|Overall Study||125
8518711|NCT00396136|20997123|P1|COMPLETED|Overall Study||96
8518712|NCT00396136|20997123|P1|STARTED|Overall Study||221
8518713|NCT00396097|20997130|P2|NOT COMPLETED|Overall Study||46
8518714|NCT00396097|20997131|P1|NOT COMPLETED|Overall Study||26
8518715|NCT00396097|20997130|P2|COMPLETED|Overall Study||156
8518716|NCT00396097|20997131|P1|COMPLETED|Overall Study||88
8518717|NCT00396097|20997130|P2|STARTED|Overall Study||202
8518718|NCT00396097|20997131|P1|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
8518719|NCT00396084|20997159|P6|NOT COMPLETED|Overall Study||2
8518720|NCT00396084|20997160|P5|NOT COMPLETED|Overall Study||1
8518721|NCT00396084|20997161|P4|NOT COMPLETED|Overall Study||1
8518722|NCT00396084|20997162|P3|NOT COMPLETED|Overall Study||0
8518723|NCT00396084|20997163|P2|NOT COMPLETED|Overall Study||0
8518724|NCT00396084|20997164|P1|NOT COMPLETED|Overall Study||0
8518725|NCT00396084|20997159|P6|COMPLETED|Overall Study||18
8518726|NCT00396084|20997160|P5|COMPLETED|Overall Study||9
8518727|NCT00396084|20997161|P4|COMPLETED|Overall Study||9
8518728|NCT00396084|20997162|P3|COMPLETED|Overall Study||10
8518729|NCT00396084|20997163|P2|COMPLETED|Overall Study||10
8518730|NCT00396084|20997164|P1|COMPLETED|Overall Study||10
8518731|NCT00396084|20997159|P6|STARTED|Overall Study||20
8518732|NCT00396084|20997160|P5|STARTED|Overall Study||10
8518733|NCT00396084|20997161|P4|STARTED|Overall Study||10
8518734|NCT00396084|20997162|P3|STARTED|Overall Study||10
8518735|NCT00396084|20997163|P2|STARTED|Overall Study||10
8518736|NCT00396084|20997164|P1|STARTED|Overall Study||10
8518737|NCT00396032|20997239|P2|NOT COMPLETED|Overall Study||5
8518738|NCT00396032|20997240|P1|NOT COMPLETED|Overall Study||4
8518739|NCT00396032|20997239|P2|COMPLETED|Overall Study||71
8518740|NCT00396032|20997240|P1|COMPLETED|Overall Study||70
8518741|NCT00396032|20997239|P2|STARTED|Overall Study||76
8518742|NCT00396032|20997240|P1|STARTED|Overall Study||74
8518743|NCT00396019|20997257|P3|NOT COMPLETED|Overall Study||1
8518744|NCT00396019|20997258|P2|NOT COMPLETED|Overall Study||3
8518745|NCT00396019|20997259|P1|NOT COMPLETED|Overall Study||0
8518746|NCT00396019|20997257|P3|COMPLETED|Overall Study||29
8518747|NCT00396019|20997258|P2|COMPLETED|Overall Study||26
8518748|NCT00396019|20997259|P1|COMPLETED|Overall Study||27
8518749|NCT00396019|20997257|P3|STARTED|Overall Study||30
8518750|NCT00396019|20997258|P2|STARTED|Overall Study||29
8518751|NCT00396019|20997259|P1|STARTED|Overall Study||27
8518755|NCT00395993|20997286|P2|NOT COMPLETED|Overall Study||19
8518756|NCT00395993|20997287|P1|NOT COMPLETED|Overall Study||35
8518757|NCT00395993|20997286|P2|COMPLETED|Overall Study||212
8518758|NCT00395993|20997287|P1|COMPLETED|Overall Study||211
8518759|NCT00395993|20997286|P2|STARTED|Overall Study||231
8518760|NCT00395993|20997287|P1|STARTED|Overall Study||246
8518761|NCT00395967|20997293|P1|NOT COMPLETED|Follow-up Period||2
8518762|NCT00395967|20997293|P1|COMPLETED|Follow-up Period||3
8518763|NCT00395967|20997293|P1|STARTED|Follow-up Period|Participants who had transplants.|5
8518764|NCT00395967|20997293|P1|NOT COMPLETED|Treatment Period||1
8518765|NCT00395967|20997293|P1|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
8518766|NCT00395967|20997293|P1|STARTED|Treatment Period||5
8518767|NCT00395876|20997304|P2|NOT COMPLETED|Overall Study||0
8518768|NCT00395876|20997305|P1|NOT COMPLETED|Overall Study||3
8518769|NCT00395876|20997304|P2|COMPLETED|Overall Study||50
8518770|NCT00395876|20997305|P1|COMPLETED|Overall Study||47
8518771|NCT00395876|20997304|P2|STARTED|Overall Study||50
8518772|NCT00395876|20997305|P1|STARTED|Overall Study||50
8518773|NCT00395863|20997333|P2|NOT COMPLETED|Overall Study||3
8518774|NCT00395863|20997334|P1|NOT COMPLETED|Overall Study||2
8518775|NCT00395863|20997333|P2|COMPLETED|Overall Study||20
8518776|NCT00395863|20997334|P1|COMPLETED|Overall Study||21
8518777|NCT00395863|20997333|P2|STARTED|Overall Study||23
8518778|NCT00395863|20997334|P1|STARTED|Overall Study||23
8518779|NCT00395850|20997369|P4|NOT COMPLETED|Disulfiram/Placebo Treatment||13
8518780|NCT00395850|20997370|P3|NOT COMPLETED|Disulfiram/Placebo Treatment||19
8518781|NCT00395850|20997371|P2|NOT COMPLETED|Disulfiram/Placebo Treatment||14
8518782|NCT00395850|20997372|P1|NOT COMPLETED|Disulfiram/Placebo Treatment||9
8518783|NCT00395850|20997369|P4|COMPLETED|Disulfiram/Placebo Treatment||8
8518784|NCT00395850|20997370|P3|COMPLETED|Disulfiram/Placebo Treatment||5
8518785|NCT00395850|20997371|P2|COMPLETED|Disulfiram/Placebo Treatment||9
8518786|NCT00395850|20997372|P1|COMPLETED|Disulfiram/Placebo Treatment||11
8518787|NCT00395850|20997369|P4|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
8518788|NCT00395850|20997370|P3|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
8518789|NCT00395850|20997371|P2|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
8518790|NCT00395850|20997372|P1|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
8518791|NCT00395850|20997369|P4|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
8518792|NCT00395850|20997370|P3|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
8518793|NCT00395850|20997371|P2|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
8518794|NCT00395850|20997372|P1|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
8518795|NCT00395850|20997369|P4|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
8518796|NCT00395850|20997370|P3|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
8518797|NCT00395850|20997371|P2|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
8518798|NCT00395850|20997372|P1|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
8518799|NCT00395850|20997369|P4|STARTED|Randomization to Disulfiram/ Pre-admin||25
8518800|NCT00395850|20997370|P3|STARTED|Randomization to Disulfiram/ Pre-admin||30
8518801|NCT00395850|20997371|P2|STARTED|Randomization to Disulfiram/ Pre-admin||25
8518802|NCT00395850|20997372|P1|STARTED|Randomization to Disulfiram/ Pre-admin||27
8518803|NCT00395850|20997369|P4|NOT COMPLETED|Pre-randomization Baseline/Induction||0
8518804|NCT00395850|20997370|P3|NOT COMPLETED|Pre-randomization Baseline/Induction||0
8518805|NCT00395850|20997371|P2|NOT COMPLETED|Pre-randomization Baseline/Induction||0
8518806|NCT00395850|20997372|P1|NOT COMPLETED|Pre-randomization Baseline/Induction||11
8518807|NCT00395850|20997369|P4|COMPLETED|Pre-randomization Baseline/Induction||0
8518808|NCT00395850|20997370|P3|COMPLETED|Pre-randomization Baseline/Induction||0
8518809|NCT00395850|20997371|P2|COMPLETED|Pre-randomization Baseline/Induction||0
8518810|NCT00395850|20997372|P1|COMPLETED|Pre-randomization Baseline/Induction||107
8518811|NCT00395850|20997369|P4|STARTED|Pre-randomization Baseline/Induction||0
8518812|NCT00395850|20997370|P3|STARTED|Pre-randomization Baseline/Induction||0
8518813|NCT00395850|20997371|P2|STARTED|Pre-randomization Baseline/Induction||0
8518814|NCT00395850|20997372|P1|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
8518815|NCT00395746|20997389|P3|NOT COMPLETED|Overall Study||22
8518816|NCT00395746|20997390|P2|NOT COMPLETED|Overall Study||4
8518817|NCT00395746|20997391|P1|NOT COMPLETED|Overall Study||10
8518818|NCT00395746|20997389|P3|COMPLETED|Overall Study|Completed 52 weeks treatment|66
8518819|NCT00395746|20997390|P2|COMPLETED|Overall Study|Completed 52 weeks treatment|84
8518820|NCT00395746|20997391|P1|COMPLETED|Overall Study|Completed 52 weeks treatment|78
8518821|NCT00395746|20997389|P3|STARTED|Overall Study|Exposed to study drug|88
8518822|NCT00395746|20997390|P2|STARTED|Overall Study|Exposed to study drug|88
8518823|NCT00395746|20997391|P1|STARTED|Overall Study|Exposed to study drug|88
8518824|NCT00395733|20997437|P2|NOT COMPLETED|Period 2||5
8518825|NCT00395733|20997438|P1|NOT COMPLETED|Period 2||2
8518826|NCT00395733|20997437|P2|COMPLETED|Period 2||37
8518827|NCT00395733|20997438|P1|COMPLETED|Period 2||39
8518828|NCT00395733|20997437|P2|STARTED|Period 2||42
8518829|NCT00395733|20997438|P1|STARTED|Period 2||41
8518830|NCT00395733|20997437|P2|NOT COMPLETED|Period 1||0
8518831|NCT00395733|20997438|P1|NOT COMPLETED|Period 1||0
8518832|NCT00395733|20997437|P2|COMPLETED|Period 1||42
8518833|NCT00395733|20997438|P1|COMPLETED|Period 1||41
8518834|NCT00395733|20997437|P2|STARTED|Period 1||42
8518835|NCT00395733|20997438|P1|STARTED|Period 1||41
8518836|NCT00395694|20997462|P2|NOT COMPLETED|Continuation Phase||13
8518837|NCT00395694|20997463|P1|NOT COMPLETED|Continuation Phase||15
8518838|NCT00395694|20997462|P2|COMPLETED|Continuation Phase||35
8518839|NCT00395694|20997463|P1|COMPLETED|Continuation Phase||34
8518840|NCT00395694|20997462|P2|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
8518841|NCT00395694|20997463|P1|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
8518842|NCT00395694|20997462|P2|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
8518843|NCT00395694|20997463|P1|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
8518844|NCT00395694|20997462|P2|COMPLETED|Escalation Phase + Maintenance Phase||49
8518845|NCT00395694|20997463|P1|COMPLETED|Escalation Phase + Maintenance Phase||50
8518846|NCT00395694|20997462|P2|STARTED|Escalation Phase + Maintenance Phase||51
8518847|NCT00395694|20997463|P1|STARTED|Escalation Phase + Maintenance Phase||51
8518848|NCT00395642|20997494|P1|NOT COMPLETED|Overall Study||13
8518849|NCT00395642|20997494|P1|COMPLETED|Overall Study||53
8518850|NCT00395642|20997494|P1|STARTED|Overall Study||66
8518851|NCT00395629|20997501|P3|NOT COMPLETED|Extension Study||3
8518852|NCT00395629|20997502|P2|NOT COMPLETED|Extension Study||0
8518853|NCT00395629|20997503|P1|NOT COMPLETED|Extension Study||0
8518854|NCT00395629|20997501|P3|COMPLETED|Extension Study||8
8518855|NCT00395629|20997502|P2|COMPLETED|Extension Study||6
8518856|NCT00395629|20997503|P1|COMPLETED|Extension Study||9
8518857|NCT00395629|20997501|P3|STARTED|Extension Study||11
8518858|NCT00395629|20997502|P2|STARTED|Extension Study||6
8518859|NCT00395629|20997503|P1|STARTED|Extension Study||9
8518860|NCT00395629|20997501|P3|NOT COMPLETED|Core Study||7
8518861|NCT00395629|20997502|P2|NOT COMPLETED|Core Study||4
8518862|NCT00395629|20997503|P1|NOT COMPLETED|Core Study||1
8518863|NCT00395629|20997501|P3|COMPLETED|Core Study||16
8518864|NCT00395629|20997502|P2|COMPLETED|Core Study||11
8518865|NCT00395629|20997503|P1|COMPLETED|Core Study||10
8518866|NCT00395629|20997501|P3|STARTED|Core Study||23
8518867|NCT00395629|20997502|P2|STARTED|Core Study||15
8518868|NCT00395629|20997503|P1|STARTED|Core Study||11
8518869|NCT00395538|20997520|P3|NOT COMPLETED|Overall Study||23
8518870|NCT00395538|20997521|P2|NOT COMPLETED|Overall Study||13
8518871|NCT00395538|20997522|P1|NOT COMPLETED|Overall Study||3
8518872|NCT00395538|20997520|P3|COMPLETED|Overall Study||0
8518873|NCT00395538|20997521|P2|COMPLETED|Overall Study||2
8518874|NCT00395538|20997522|P1|COMPLETED|Overall Study||5
8518875|NCT00395538|20997520|P3|Completed Bone Biopsy Year 4|Overall Study||1
8518876|NCT00395538|20997521|P2|Completed Bone Biopsy Year 4|Overall Study||1
8518877|NCT00395538|20997522|P1|Completed Bone Biopsy Year 4|Overall Study||0
8518878|NCT00395538|20997520|P3|Completed Bone Biopsy Year 2|Overall Study||3
8518879|NCT00395538|20997521|P2|Completed Bone Biopsy Year 2|Overall Study||2
8518880|NCT00395538|20997522|P1|Completed Bone Biopsy Year 2|Overall Study||0
8518881|NCT00395538|20997520|P3|Completed Bone Biopsy Year 1|Overall Study||4
8518882|NCT00395538|20997521|P2|Completed Bone Biopsy Year 1|Overall Study||1
8518883|NCT00395538|20997522|P1|Completed Bone Biopsy Year 1|Overall Study||0
8518884|NCT00395538|20997520|P3|Randomized to Bone Biospy Year 4|Overall Study||8
8518885|NCT00395538|20997521|P2|Randomized to Bone Biospy Year 4|Overall Study||2
8518886|NCT00395538|20997522|P1|Randomized to Bone Biospy Year 4|Overall Study||0
8518887|NCT00395538|20997520|P3|Randomized to Bone Biopsy Year 2|Overall Study||6
8518888|NCT00395538|20997521|P2|Randomized to Bone Biopsy Year 2|Overall Study||2
8518889|NCT00395538|20997522|P1|Randomized to Bone Biopsy Year 2|Overall Study||0
8518890|NCT00395538|20997520|P3|Randomized to Bone Biopsy Year 1|Overall Study||5
8518891|NCT00395538|20997521|P2|Randomized to Bone Biopsy Year 1|Overall Study||1
8518892|NCT00395538|20997522|P1|Randomized to Bone Biopsy Year 1|Overall Study||0
8518893|NCT00395538|20997520|P3|Received HPTH on New Protocol|Overall Study||19
8518894|NCT00395538|20997521|P2|Received HPTH on New Protocol|Overall Study||5
8518895|NCT00395538|20997522|P1|Received HPTH on New Protocol|Overall Study||7
8518896|NCT00395538|20997520|P3|Signed Consent to the New Protocol|Overall Study||23
8518897|NCT00395538|20997521|P2|Signed Consent to the New Protocol|Overall Study||5
8518898|NCT00395538|20997522|P1|Signed Consent to the New Protocol|Overall Study||7
8518899|NCT00395538|20997520|P3|STARTED|Overall Study||23
8518900|NCT00395538|20997521|P2|STARTED|Overall Study||15
8518901|NCT00395538|20997522|P1|STARTED|Overall Study||8
8518902|NCT00395512|20997595|P4|NOT COMPLETED|Overall Study||38
8518903|NCT00395512|20997596|P3|NOT COMPLETED|Overall Study||28
8518904|NCT00395512|20997597|P2|NOT COMPLETED|Overall Study||37
8518905|NCT00395512|20997598|P1|NOT COMPLETED|Overall Study||38
8518906|NCT00395512|20997595|P4|COMPLETED|Overall Study||126
8518907|NCT00395512|20997596|P3|COMPLETED|Overall Study||136
8518908|NCT00395512|20997597|P2|COMPLETED|Overall Study||126
8518909|NCT00395512|20997598|P1|COMPLETED|Overall Study||126
8518910|NCT00395512|20997595|P4|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
8518911|NCT00395512|20997596|P3|Safety Set|Overall Study||164
8518912|NCT00395512|20997597|P2|Safety Set|Overall Study||163
8518913|NCT00395512|20997598|P1|Safety Set|Overall Study||164
8518914|NCT00395512|20997595|P4|STARTED|Overall Study||164
8518915|NCT00395512|20997596|P3|STARTED|Overall Study||164
8518916|NCT00395512|20997597|P2|STARTED|Overall Study||163
8518917|NCT00395512|20997598|P1|STARTED|Overall Study||164
8518918|NCT00395486|20997770|P2|NOT COMPLETED|Overall Study||5
8518919|NCT00395486|20997771|P1|NOT COMPLETED|Overall Study||6
8518920|NCT00395486|20997770|P2|COMPLETED|Overall Study|Completed subjects|121
8518921|NCT00395486|20997771|P1|COMPLETED|Overall Study|Completed subjects|126
8518922|NCT00395486|20997770|P2|STARTED|Overall Study|Randomized subjects|126
8518923|NCT00395486|20997771|P1|STARTED|Overall Study|Randomized subjects|132
8518924|NCT00395460|20997801|P2|NOT COMPLETED|Overall Study||0
8518925|NCT00395460|20997802|P1|NOT COMPLETED|Overall Study||1
8518926|NCT00395460|20997801|P2|COMPLETED|Overall Study||75
8518927|NCT00395460|20997802|P1|COMPLETED|Overall Study||71
8518928|NCT00395460|20997801|P2|Received Treatment|Overall Study||75
8518929|NCT00395460|20997802|P1|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
8518930|NCT00395460|20997801|P2|STARTED|Overall Study||75
8518931|NCT00395460|20997802|P1|STARTED|Overall Study||72
8518932|NCT00395447|20997826|P2|NOT COMPLETED|Overall Study||111
8518933|NCT00395447|20997827|P1|NOT COMPLETED|Overall Study||121
8518934|NCT00395447|20997826|P2|COMPLETED|Overall Study||602
8518935|NCT00395447|20997827|P1|COMPLETED|Overall Study||910
8518936|NCT00395447|20997826|P2|STARTED|Overall Study||713
8518937|NCT00395447|20997827|P1|STARTED|Overall Study||1031
8518938|NCT00395343|20997835|P2|NOT COMPLETED|Overall Study||36
8518939|NCT00395343|20997836|P1|NOT COMPLETED|Overall Study||41
8518940|NCT00395343|20997835|P2|COMPLETED|Overall Study||283
8518941|NCT00395343|20997836|P1|COMPLETED|Overall Study||281
8518942|NCT00395343|20997835|P2|STARTED|Overall Study||319
8518943|NCT00395343|20997836|P1|STARTED|Overall Study||322
8518944|NCT00395304|20997854|P6|NOT COMPLETED|Treatment Period 3||1
8518945|NCT00395304|20997855|P5|NOT COMPLETED|Treatment Period 3||0
8518946|NCT00395304|20997856|P4|NOT COMPLETED|Treatment Period 3||2
8518947|NCT00395304|20997857|P3|NOT COMPLETED|Treatment Period 3||0
8518948|NCT00395304|20997858|P2|NOT COMPLETED|Treatment Period 3||2
8518949|NCT00395304|20997859|P1|NOT COMPLETED|Treatment Period 3||1
8518950|NCT00395304|20997854|P6|COMPLETED|Treatment Period 3||27
8518951|NCT00395304|20997855|P5|COMPLETED|Treatment Period 3||27
8518952|NCT00395304|20997856|P4|COMPLETED|Treatment Period 3||25
8518953|NCT00395304|20997857|P3|COMPLETED|Treatment Period 3||29
8518954|NCT00395304|20997858|P2|COMPLETED|Treatment Period 3||20
8518955|NCT00395304|20997859|P1|COMPLETED|Treatment Period 3||29
8518956|NCT00395304|20997854|P6|STARTED|Treatment Period 3||28
8518957|NCT00395304|20997855|P5|STARTED|Treatment Period 3||27
8518958|NCT00395304|20997856|P4|STARTED|Treatment Period 3||27
8518959|NCT00395304|20997857|P3|STARTED|Treatment Period 3||29
8518960|NCT00395304|20997858|P2|STARTED|Treatment Period 3||22
8518961|NCT00395304|20997859|P1|STARTED|Treatment Period 3||30
8518962|NCT00395304|20997854|P6|NOT COMPLETED|Treatment Period 2||2
8518963|NCT00395304|20997855|P5|NOT COMPLETED|Treatment Period 2||0
8518964|NCT00395304|20997856|P4|NOT COMPLETED|Treatment Period 2||1
8518965|NCT00395304|20997857|P3|NOT COMPLETED|Treatment Period 2||1
8518966|NCT00395304|20997858|P2|NOT COMPLETED|Treatment Period 2||4
8518967|NCT00395304|20997859|P1|NOT COMPLETED|Treatment Period 2||0
8518968|NCT00395304|20997854|P6|COMPLETED|Treatment Period 2||28
8518969|NCT00395304|20997855|P5|COMPLETED|Treatment Period 2||27
8518970|NCT00395304|20997856|P4|COMPLETED|Treatment Period 2||27
8518971|NCT00395304|20997857|P3|COMPLETED|Treatment Period 2||29
8518972|NCT00395304|20997858|P2|COMPLETED|Treatment Period 2||22
8518973|NCT00395304|20997859|P1|COMPLETED|Treatment Period 2||30
8518974|NCT00395304|20997854|P6|STARTED|Treatment Period 2||30
8518975|NCT00395304|20997855|P5|STARTED|Treatment Period 2||27
8518976|NCT00395304|20997856|P4|STARTED|Treatment Period 2||28
8518977|NCT00395304|20997857|P3|STARTED|Treatment Period 2||30
8518978|NCT00395304|20997858|P2|STARTED|Treatment Period 2||26
8518979|NCT00395304|20997859|P1|STARTED|Treatment Period 2||30
8518980|NCT00395304|20997854|P6|NOT COMPLETED|Treatment Period 1||2
8518981|NCT00395304|20997855|P5|NOT COMPLETED|Treatment Period 1||1
8518982|NCT00395304|20997856|P4|NOT COMPLETED|Treatment Period 1||3
8518983|NCT00395304|20997857|P3|NOT COMPLETED|Treatment Period 1||0
8518984|NCT00395304|20997858|P2|NOT COMPLETED|Treatment Period 1||4
8518985|NCT00395304|20997859|P1|NOT COMPLETED|Treatment Period 1||1
8518986|NCT00395304|20997854|P6|COMPLETED|Treatment Period 1||30
8518987|NCT00395304|20997855|P5|COMPLETED|Treatment Period 1||27
8518988|NCT00395304|20997856|P4|COMPLETED|Treatment Period 1||28
8518989|NCT00395304|20997857|P3|COMPLETED|Treatment Period 1||30
8518990|NCT00395304|20997858|P2|COMPLETED|Treatment Period 1||26
8518991|NCT00395304|20997859|P1|COMPLETED|Treatment Period 1||30
8518992|NCT00395304|20997854|P6|STARTED|Treatment Period 1||32
8518993|NCT00395304|20997855|P5|STARTED|Treatment Period 1||28
8518994|NCT00395304|20997856|P4|STARTED|Treatment Period 1||31
8518995|NCT00395304|20997857|P3|STARTED|Treatment Period 1||30
8518996|NCT00395304|20997858|P2|STARTED|Treatment Period 1||30
8518997|NCT00395304|20997859|P1|STARTED|Treatment Period 1||31
8518998|NCT00395291|20997902|P2|NOT COMPLETED|Second Intervention||0
8518999|NCT00395291|20997903|P1|NOT COMPLETED|Second Intervention||0
8519000|NCT00395291|20997902|P2|COMPLETED|Second Intervention||9
8519001|NCT00395291|20997903|P1|COMPLETED|Second Intervention||13
8519002|NCT00395291|20997902|P2|STARTED|Second Intervention||9
8519003|NCT00395291|20997903|P1|STARTED|Second Intervention||13
8519004|NCT00395291|20997902|P2|NOT COMPLETED|Washout Period for 30 Days||0
8519005|NCT00395291|20997903|P1|NOT COMPLETED|Washout Period for 30 Days||2
8519006|NCT00395291|20997902|P2|COMPLETED|Washout Period for 30 Days||9
8519007|NCT00395291|20997903|P1|COMPLETED|Washout Period for 30 Days||13
8519008|NCT00395291|20997902|P2|STARTED|Washout Period for 30 Days||9
8519009|NCT00395291|20997903|P1|STARTED|Washout Period for 30 Days||15
8519010|NCT00395291|20997902|P2|NOT COMPLETED|First Intervention||0
8519011|NCT00395291|20997903|P1|NOT COMPLETED|First Intervention||2
8519012|NCT00395291|20997902|P2|COMPLETED|First Intervention||9
8519013|NCT00395291|20997903|P1|COMPLETED|First Intervention||15
8519014|NCT00395291|20997902|P2|STARTED|First Intervention||9
8519015|NCT00395291|20997903|P1|STARTED|First Intervention||17
8519016|NCT00395226|20997935|P2|NOT COMPLETED|Overall Study||5
8519017|NCT00395226|20997936|P1|NOT COMPLETED|Overall Study||4
8519018|NCT00395226|20997935|P2|COMPLETED|Overall Study||22
8519019|NCT00395226|20997936|P1|COMPLETED|Overall Study||22
8519020|NCT00395226|20997935|P2|STARTED|Overall Study||27
8519021|NCT00395226|20997936|P1|STARTED|Overall Study||26
8519022|NCT00395161|20997944|P2|NOT COMPLETED|Overall Study||0
8519023|NCT00395161|20997945|P1|NOT COMPLETED|Overall Study||0
8519024|NCT00395161|20997944|P2|COMPLETED|Overall Study||144
8519025|NCT00395161|20997945|P1|COMPLETED|Overall Study||149
8519026|NCT00395161|20997944|P2|STARTED|Overall Study||144
8519027|NCT00395161|20997945|P1|STARTED|Overall Study||149
8519028|NCT00395135|20997961|P5|NOT COMPLETED|Year 2||190
8519029|NCT00395135|20997962|P4|NOT COMPLETED|Year 2||88
8519030|NCT00395135|20997963|P3|NOT COMPLETED|Year 2||147
8519031|NCT00395135|20997964|P2|NOT COMPLETED|Year 2||0
8519032|NCT00395135|20997965|P1|NOT COMPLETED|Year 2||0
8519033|NCT00395135|20997961|P5|COMPLETED|Year 2||507
8519034|NCT00395135|20997962|P4|COMPLETED|Year 2||195
8519035|NCT00395135|20997963|P3|COMPLETED|Year 2||426
8519036|NCT00395135|20997964|P2|COMPLETED|Year 2||0
8519037|NCT00395135|20997965|P1|COMPLETED|Year 2||0
8519038|NCT00395135|20997961|P5|STARTED|Year 2||697
8519039|NCT00395135|20997962|P4|STARTED|Year 2||283
8519040|NCT00395135|20997963|P3|STARTED|Year 2||573
8519041|NCT00395135|20997964|P2|STARTED|Year 2||0
8519042|NCT00395135|20997965|P1|STARTED|Year 2||0
8519043|NCT00395135|20997961|P5|NOT COMPLETED|Year 1||0
8519044|NCT00395135|20997962|P4|NOT COMPLETED|Year 1||0
8519045|NCT00395135|20997963|P3|NOT COMPLETED|Year 1||0
8519046|NCT00395135|20997964|P2|NOT COMPLETED|Year 1||871
8519047|NCT00395135|20997965|P1|NOT COMPLETED|Year 1||712
8519048|NCT00395135|20997961|P5|COMPLETED|Year 1||0
8519049|NCT00395135|20997962|P4|COMPLETED|Year 1||0
8519050|NCT00395135|20997963|P3|COMPLETED|Year 1||0
8519051|NCT00395135|20997964|P2|COMPLETED|Year 1||716
8519052|NCT00395135|20997965|P1|COMPLETED|Year 1||883
8519053|NCT00395135|20997961|P5|STARTED|Year 1||0
8519054|NCT00395135|20997962|P4|STARTED|Year 1||0
8519055|NCT00395135|20997963|P3|STARTED|Year 1||0
8519056|NCT00395135|20997964|P2|STARTED|Year 1||1587
8519057|NCT00395135|20997965|P1|STARTED|Year 1||1595
8519058|NCT00395083|20997983|P2|NOT COMPLETED|Overall Study||8
8519059|NCT00395083|20997984|P1|NOT COMPLETED|Overall Study||10
8519060|NCT00395083|20997983|P2|COMPLETED|Overall Study||201
8519061|NCT00395083|20997984|P1|COMPLETED|Overall Study||207
8519062|NCT00395083|20997983|P2|STARTED|Overall Study||209
8519063|NCT00395083|20997984|P1|STARTED|Overall Study||217
8519064|NCT00395057|20998000|P4|NOT COMPLETED|Overall Study||33
8519065|NCT00395057|20998001|P3|NOT COMPLETED|Overall Study||33
8519066|NCT00395057|20998002|P2|NOT COMPLETED|Overall Study||34
8519067|NCT00395057|20998003|P1|NOT COMPLETED|Overall Study||32
8519068|NCT00395057|20998000|P4|COMPLETED|Overall Study||1
8519069|NCT00395057|20998001|P3|COMPLETED|Overall Study||2
8519070|NCT00395057|20998002|P2|COMPLETED|Overall Study||1
8519071|NCT00395057|20998003|P1|COMPLETED|Overall Study||2
8519072|NCT00395057|20998000|P4|STARTED|Overall Study||34
8519073|NCT00395057|20998001|P3|STARTED|Overall Study||35
8519074|NCT00395057|20998002|P2|STARTED|Overall Study||35
8519075|NCT00395057|20998003|P1|STARTED|Overall Study||34
8519076|NCT00395044|20998031|P2|NOT COMPLETED|Overall Study||14
8519077|NCT00395044|20998032|P1|NOT COMPLETED|Overall Study||18
8519078|NCT00395044|20998031|P2|COMPLETED|Overall Study||11
8519079|NCT00395044|20998032|P1|COMPLETED|Overall Study||7
8519080|NCT00395044|20998031|P2|STARTED|Overall Study||25
8519081|NCT00395044|20998032|P1|STARTED|Overall Study||25
8519082|NCT00395018|20998050|P1|NOT COMPLETED|Off-Treatment Follow-up||4
8519083|NCT00395018|20998050|P1|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
8519084|NCT00395018|20998050|P1|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
8519085|NCT00395018|20998050|P1|NOT COMPLETED|On-Treatment||10
8519086|NCT00395018|20998050|P1|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
8519087|NCT00395018|20998050|P1|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
8519088|NCT00395018|20998050|P1|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
8519089|NCT00395018|20998050|P1|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
8519090|NCT00394953|20998071|P2|NOT COMPLETED|Second Treatment Period||74
8519091|NCT00394953|20998072|P1|NOT COMPLETED|Second Treatment Period||29
8519092|NCT00394953|20998071|P2|COMPLETED|Second Treatment Period||148
8519093|NCT00394953|20998072|P1|COMPLETED|Second Treatment Period||187
8519094|NCT00394953|20998071|P2|STARTED|Second Treatment Period||222
8519095|NCT00394953|20998072|P1|STARTED|Second Treatment Period||216
8519096|NCT00394953|20998071|P2|NOT COMPLETED|First Treatment Period||22
8519097|NCT00394953|20998072|P1|NOT COMPLETED|First Treatment Period||29
8519098|NCT00394953|20998071|P2|COMPLETED|First Treatment Period||222
8519099|NCT00394953|20998072|P1|COMPLETED|First Treatment Period||216
8519100|NCT00394953|20998071|P2|STARTED|First Treatment Period||244
8519101|NCT00394953|20998072|P1|STARTED|First Treatment Period||245
8519102|NCT00394914|20998090|P3|NOT COMPLETED|Treatment Period||6
8519103|NCT00394914|20998091|P2|NOT COMPLETED|Treatment Period||10
8519104|NCT00394914|20998092|P1|NOT COMPLETED|Treatment Period||0
8519105|NCT00394914|20998090|P3|COMPLETED|Treatment Period||151
8519106|NCT00394914|20998091|P2|COMPLETED|Treatment Period||144
8519107|NCT00394914|20998092|P1|COMPLETED|Treatment Period||0
8519108|NCT00394914|20998090|P3|STARTED|Treatment Period||157
8519109|NCT00394914|20998091|P2|STARTED|Treatment Period||154
8519110|NCT00394914|20998092|P1|STARTED|Treatment Period||0
8519111|NCT00394914|20998090|P3|NOT COMPLETED|Pre-exposure Period||0
8519112|NCT00394914|20998091|P2|NOT COMPLETED|Pre-exposure Period||0
8519113|NCT00394914|20998092|P1|NOT COMPLETED|Pre-exposure Period||0
8519114|NCT00394914|20998090|P3|COMPLETED|Pre-exposure Period||0
8519115|NCT00394914|20998091|P2|COMPLETED|Pre-exposure Period||0
8519116|NCT00394914|20998092|P1|COMPLETED|Pre-exposure Period||311
8519117|NCT00394914|20998090|P3|STARTED|Pre-exposure Period||0
8519118|NCT00394914|20998091|P2|STARTED|Pre-exposure Period||0
8519119|NCT00394914|20998092|P1|STARTED|Pre-exposure Period||311
8519120|NCT00394914|20998090|P3|NOT COMPLETED|Screening Period||0
8519121|NCT00394914|20998091|P2|NOT COMPLETED|Screening Period||0
8519122|NCT00394914|20998092|P1|NOT COMPLETED|Screening Period||0
8519123|NCT00394914|20998090|P3|COMPLETED|Screening Period||0
8519124|NCT00394914|20998091|P2|COMPLETED|Screening Period||0
8519125|NCT00394914|20998092|P1|COMPLETED|Screening Period||311
8519126|NCT00394914|20998090|P3|STARTED|Screening Period||0
8519127|NCT00394914|20998091|P2|STARTED|Screening Period||0
8519128|NCT00394914|20998092|P1|STARTED|Screening Period||311
8519153|NCT00394888|20998351|P3|NOT COMPLETED|Overall Study||0
8519154|NCT00394888|20998352|P2|NOT COMPLETED|Overall Study||0
8519155|NCT00394888|20998353|P1|NOT COMPLETED|Overall Study||0
8519156|NCT00394888|20998351|P3|COMPLETED|Overall Study||201
8519157|NCT00394888|20998352|P2|COMPLETED|Overall Study||48
8519158|NCT00394888|20998353|P1|COMPLETED|Overall Study||108
8519159|NCT00394888|20998351|P3|STARTED|Overall Study||201
8519160|NCT00394888|20998352|P2|STARTED|Overall Study||48
8519161|NCT00394888|20998353|P1|STARTED|Overall Study||108
8519162|NCT00394836|20998366|P2|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
8519163|NCT00394836|20998367|P1|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
8519164|NCT00394836|20998366|P2|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
8519165|NCT00394836|20998367|P1|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
8519166|NCT00394836|20998366|P2|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
8519167|NCT00394836|20998367|P1|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
8519168|NCT00394836|20998366|P2|NOT COMPLETED|Teatment or Follow-up Phase||78
8519169|NCT00394836|20998367|P1|NOT COMPLETED|Teatment or Follow-up Phase||28
8519170|NCT00394836|20998366|P2|COMPLETED|Teatment or Follow-up Phase||8
8519171|NCT00394836|20998367|P1|COMPLETED|Teatment or Follow-up Phase||2
8519172|NCT00394836|20998366|P2|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
8519173|NCT00394836|20998367|P1|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
8519174|NCT00394836|20998366|P2|STARTED|Teatment or Follow-up Phase||86
8519175|NCT00394836|20998367|P1|STARTED|Teatment or Follow-up Phase||30
8519176|NCT00394771|20998413|P4|NOT COMPLETED|Overall Study||39
8519177|NCT00394771|20998414|P3|NOT COMPLETED|Overall Study||47
8519178|NCT00394771|20998415|P2|NOT COMPLETED|Overall Study||34
8519179|NCT00394771|20998416|P1|NOT COMPLETED|Overall Study||41
8519180|NCT00394771|20998413|P4|COMPLETED|Overall Study||109
8519181|NCT00394771|20998414|P3|COMPLETED|Overall Study||96
8519182|NCT00394771|20998415|P2|COMPLETED|Overall Study||102
8519183|NCT00394771|20998416|P1|COMPLETED|Overall Study||99
8519184|NCT00394771|20998413|P4|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
8519185|NCT00394771|20998414|P3|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
8519186|NCT00394771|20998415|P2|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
8519187|NCT00394771|20998416|P1|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
8519188|NCT00394771|20998413|P4|STARTED|Overall Study|Safety population of treated participants|148
8519189|NCT00394771|20998414|P3|STARTED|Overall Study|Safety population of treated participants|143
8519190|NCT00394771|20998415|P2|STARTED|Overall Study|Safety population of treated participants|136
8519191|NCT00394771|20998416|P1|STARTED|Overall Study|Safety population of treated participants|140
8519192|NCT00394706|20998486|P8|NOT COMPLETED|Overall Study||0
8519193|NCT00394706|20998487|P7|NOT COMPLETED|Overall Study||3
8519194|NCT00394706|20998488|P6|NOT COMPLETED|Overall Study||7
8519195|NCT00394706|20998489|P5|NOT COMPLETED|Overall Study||2
8519196|NCT00394706|20998490|P4|NOT COMPLETED|Overall Study||1
8519197|NCT00394706|20998491|P3|NOT COMPLETED|Overall Study||9
8519198|NCT00394706|20998492|P2|NOT COMPLETED|Overall Study||2
8519199|NCT00394706|20998493|P1|NOT COMPLETED|Overall Study||4
8519200|NCT00394706|20998486|P8|COMPLETED|Overall Study||851
8519201|NCT00394706|20998487|P7|COMPLETED|Overall Study||926
8519202|NCT00394706|20998488|P6|COMPLETED|Overall Study||1377
8519203|NCT00394706|20998489|P5|COMPLETED|Overall Study||1634
8519204|NCT00394706|20998490|P4|COMPLETED|Overall Study||1632
8519205|NCT00394706|20998491|P3|COMPLETED|Overall Study||1615
8519206|NCT00394706|20998492|P2|COMPLETED|Overall Study||1860
8519207|NCT00394706|20998493|P1|COMPLETED|Overall Study||1815
8519208|NCT00394706|20998486|P8|STARTED|Overall Study||851
8519209|NCT00394706|20998487|P7|STARTED|Overall Study||929
8519210|NCT00394706|20998488|P6|STARTED|Overall Study||1384
8519211|NCT00394706|20998489|P5|STARTED|Overall Study||1636
8519212|NCT00394706|20998490|P4|STARTED|Overall Study||1633
8519213|NCT00394706|20998491|P3|STARTED|Overall Study||1624
8519214|NCT00394706|20998492|P2|STARTED|Overall Study||1862
8519215|NCT00394706|20998493|P1|STARTED|Overall Study||1819
8519216|NCT00394654|20998525|P2|NOT COMPLETED|Overall Study||0
8519217|NCT00394654|20998526|P1|NOT COMPLETED|Overall Study||2
8519218|NCT00394654|20998525|P2|COMPLETED|Overall Study||15
8519219|NCT00394654|20998526|P1|COMPLETED|Overall Study||13
8519220|NCT00394654|20998525|P2|STARTED|Overall Study||15
8519221|NCT00394654|20998526|P1|STARTED|Overall Study||15
8519222|NCT00394589|20998591|P3|NOT COMPLETED|Overall Study||7
8519223|NCT00394589|20998592|P2|NOT COMPLETED|Overall Study||3
8519224|NCT00394589|20998593|P1|NOT COMPLETED|Overall Study||8
8519225|NCT00394589|20998591|P3|COMPLETED|Overall Study||11
8519226|NCT00394589|20998592|P2|COMPLETED|Overall Study||8
8519227|NCT00394589|20998593|P1|COMPLETED|Overall Study||6
8519228|NCT00394589|20998591|P3|STARTED|Overall Study||18
8519229|NCT00394589|20998592|P2|STARTED|Overall Study||11
8519230|NCT00394589|20998593|P1|STARTED|Overall Study||14
8519231|NCT00394524|20998603|P2|NOT COMPLETED|Overall Study||4
8519232|NCT00394524|20998604|P1|NOT COMPLETED|Overall Study||3
8519233|NCT00394524|20998603|P2|COMPLETED|Overall Study||76
8519234|NCT00394524|20998604|P1|COMPLETED|Overall Study||77
8519235|NCT00394524|20998603|P2|STARTED|Overall Study||80
8519236|NCT00394524|20998604|P1|STARTED|Overall Study||80
8519237|NCT00394472|20998618|P2|NOT COMPLETED|Overall Study||11
8519238|NCT00394472|20998619|P1|NOT COMPLETED|Overall Study||9
8519239|NCT00394472|20998618|P2|COMPLETED|Overall Study||111
8519240|NCT00394472|20998619|P1|COMPLETED|Overall Study||113
8519241|NCT00394472|20998618|P2|STARTED|Overall Study||122
8519242|NCT00394472|20998619|P1|STARTED|Overall Study||122
8519243|NCT00394433|20998627|P1|NOT COMPLETED|Overall Study||3
8519244|NCT00394433|20998627|P1|COMPLETED|Overall Study||35
8519245|NCT00394433|20998627|P1|Evaluable and Treated|Overall Study||35
8519246|NCT00394433|20998627|P1|STARTED|Overall Study||38
8519247|NCT00394355|20998638|P4|NOT COMPLETED|Overall Study||31
8519248|NCT00394355|20998639|P3|NOT COMPLETED|Overall Study||38
8519249|NCT00394355|20998640|P2|NOT COMPLETED|Overall Study||34
8519250|NCT00394355|20998641|P1|NOT COMPLETED|Overall Study||35
8519251|NCT00394355|20998638|P4|COMPLETED|Overall Study||111
8519252|NCT00394355|20998639|P3|COMPLETED|Overall Study||109
8519253|NCT00394355|20998640|P2|COMPLETED|Overall Study||103
8519254|NCT00394355|20998641|P1|COMPLETED|Overall Study||105
8519255|NCT00394355|20998638|P4|STARTED|Overall Study||142
8519256|NCT00394355|20998639|P3|STARTED|Overall Study||147
8519257|NCT00394355|20998640|P2|STARTED|Overall Study||137
8519258|NCT00394355|20998641|P1|STARTED|Overall Study||140
8519259|NCT00394329|20998667|P4|NOT COMPLETED|Overall Study||24
8519260|NCT00394329|20998668|P3|NOT COMPLETED|Overall Study||13
8519261|NCT00394329|20998669|P2|NOT COMPLETED|Overall Study||9
8519262|NCT00394329|20998670|P1|NOT COMPLETED|Overall Study||8
8519263|NCT00394329|20998667|P4|COMPLETED|Overall Study||50
8519264|NCT00394329|20998668|P3|COMPLETED|Overall Study||58
8519265|NCT00394329|20998669|P2|COMPLETED|Overall Study||63
8519266|NCT00394329|20998670|P1|COMPLETED|Overall Study||63
8519267|NCT00394329|20998667|P4|STARTED|Overall Study||74
8519268|NCT00394329|20998668|P3|STARTED|Overall Study||71
8519269|NCT00394329|20998669|P2|STARTED|Overall Study||72
8519270|NCT00394329|20998670|P1|STARTED|Overall Study||71
8519271|NCT00394277|20998720|P4|NOT COMPLETED|Overall Study||125
8519272|NCT00394277|20998721|P3|NOT COMPLETED|Overall Study||120
8519273|NCT00394277|20998722|P2|NOT COMPLETED|Overall Study||60
8519274|NCT00394277|20998723|P1|NOT COMPLETED|Overall Study||58
8519275|NCT00394277|20998720|P4|COMPLETED|Overall Study||266
8519276|NCT00394277|20998721|P3|COMPLETED|Overall Study||273
8519277|NCT00394277|20998722|P2|COMPLETED|Overall Study||136
8519278|NCT00394277|20998723|P1|COMPLETED|Overall Study||137
8519279|NCT00394277|20998720|P4|STARTED|Overall Study||391
8519280|NCT00394277|20998721|P3|STARTED|Overall Study||393
8519281|NCT00394277|20998722|P2|STARTED|Overall Study||196
8519282|NCT00394277|20998723|P1|STARTED|Overall Study||195
8519283|NCT00394251|20998747|P2|NOT COMPLETED|Overall Study||38
8519284|NCT00394251|20998748|P1|NOT COMPLETED|Overall Study||37
8519285|NCT00394251|20998747|P2|COMPLETED|Overall Study||61
8519286|NCT00394251|20998748|P1|COMPLETED|Overall Study||61
8519287|NCT00394251|20998747|P2|At Least One Dose of Taxane|Overall Study||93
8519288|NCT00394251|20998748|P1|At Least One Dose of Taxane|Overall Study||93
8519289|NCT00394251|20998747|P2|STARTED|Overall Study||99
8519290|NCT00394251|20998748|P1|STARTED|Overall Study||98
8519291|NCT00394212|20998776|P2|NOT COMPLETED|Overall Study||1
8519292|NCT00394212|20998777|P1|NOT COMPLETED|Overall Study||7
8519293|NCT00394212|20998776|P2|COMPLETED|Overall Study||26
8519294|NCT00394212|20998777|P1|COMPLETED|Overall Study||43
8519295|NCT00394212|20998776|P2|6 Month Follow-up|Overall Study||26
8519296|NCT00394212|20998777|P1|6 Month Follow-up|Overall Study||43
8519297|NCT00394212|20998776|P2|3 Month Follow-up|Overall Study||26
8519298|NCT00394212|20998777|P1|3 Month Follow-up|Overall Study||45
8519299|NCT00394212|20998776|P2|6 Week Follow-up|Overall Study||26
8519300|NCT00394212|20998777|P1|6 Week Follow-up|Overall Study||45
8519301|NCT00394212|20998776|P2|STARTED|Overall Study||27
8519302|NCT00394212|20998777|P1|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
8519303|NCT00394095|20998791|P2|NOT COMPLETED|Overall Study||0
8519304|NCT00394095|20998792|P1|NOT COMPLETED|Overall Study||1
8519305|NCT00394095|20998791|P2|COMPLETED|Overall Study||14
8519306|NCT00394095|20998792|P1|COMPLETED|Overall Study||16
8519307|NCT00394095|20998791|P2|Screened|Overall Study||14
8519308|NCT00394095|20998792|P1|Screened|Overall Study||17
8519309|NCT00394095|20998791|P2|STARTED|Overall Study||14
8519310|NCT00394095|20998792|P1|STARTED|Overall Study||17
8519311|NCT00394082|20998800|P1|NOT COMPLETED|Overall Study||26
8519312|NCT00394082|20998800|P1|COMPLETED|Overall Study|Treatment completed upon disease progression|24
8519313|NCT00394082|20998800|P1|At Least One Response Assessment|Overall Study||43
8519314|NCT00394082|20998800|P1|STARTED|Overall Study||50
8519315|NCT00393978|20998811|P2|NOT COMPLETED|Overall Study||20
8519316|NCT00393978|20998812|P1|NOT COMPLETED|Overall Study||16
8519317|NCT00393978|20998811|P2|COMPLETED|Overall Study||18
8519318|NCT00393978|20998812|P1|COMPLETED|Overall Study||21
8519319|NCT00393978|20998811|P2|STARTED|Overall Study||38
8519320|NCT00393978|20998812|P1|STARTED|Overall Study||37
8519321|NCT00393939|20998822|P2|NOT COMPLETED|Overall Study||297
8519322|NCT00393939|20998823|P1|NOT COMPLETED|Overall Study||296
8519323|NCT00393939|20998822|P2|COMPLETED|Overall Study||0
8519324|NCT00393939|20998823|P1|COMPLETED|Overall Study||0
8519325|NCT00393939|20998822|P2|Treated|Overall Study||293
8519326|NCT00393939|20998823|P1|Treated|Overall Study||295
8519327|NCT00393939|20998822|P2|STARTED|Overall Study||297
8519328|NCT00393939|20998823|P1|STARTED|Overall Study||296
8519329|NCT00393913|20998841|P1|NOT COMPLETED|CPAP Withdrawal||0
8519330|NCT00393913|20998841|P1|COMPLETED|CPAP Withdrawal||42
8519331|NCT00393913|20998841|P1|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
8519332|NCT00393913|20998841|P1|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
8519333|NCT00393913|20998841|P1|NOT COMPLETED|CPAP||7
8519334|NCT00393913|20998841|P1|COMPLETED|CPAP||93
8519335|NCT00393913|20998841|P1|STARTED|CPAP|Excludes normal volunteers without OSA|100
8519336|NCT00393913|20998841|P1|NOT COMPLETED|Initial Assessment||37
8519337|NCT00393913|20998841|P1|COMPLETED|Initial Assessment||107
8519338|NCT00393913|20998841|P1|STARTED|Initial Assessment||144
8519339|NCT00393887|20998849|P2|NOT COMPLETED|Overall Study||9
8519340|NCT00393887|20998850|P1|NOT COMPLETED|Overall Study||16
8519341|NCT00393887|20998849|P2|COMPLETED|Overall Study||41
8519342|NCT00393887|20998850|P1|COMPLETED|Overall Study||34
8519343|NCT00393887|20998849|P2|1 Year|Overall Study||50
8519344|NCT00393887|20998850|P1|1 Year|Overall Study||45
8519345|NCT00393887|20998849|P2|STARTED|Overall Study||50
8519346|NCT00393887|20998850|P1|STARTED|Overall Study||50
8519347|NCT00393874|20998859|P3|NOT COMPLETED|Overall Study||2
8519348|NCT00393874|20998860|P2|NOT COMPLETED|Overall Study||4
8519349|NCT00393874|20998861|P1|NOT COMPLETED|Overall Study||3
8519350|NCT00393874|20998859|P3|COMPLETED|Overall Study||13
8519351|NCT00393874|20998860|P2|COMPLETED|Overall Study||13
8519352|NCT00393874|20998861|P1|COMPLETED|Overall Study||15
8519353|NCT00393874|20998859|P3|STARTED|Overall Study||15
8519354|NCT00393874|20998860|P2|STARTED|Overall Study||17
8519355|NCT00393874|20998861|P1|STARTED|Overall Study||18
8519356|NCT00393861|20998878|P1|NOT COMPLETED|Overall Study||26
8519357|NCT00393861|20998878|P1|COMPLETED|Overall Study||3
8519358|NCT00393861|20998878|P1|STARTED|Overall Study||29
8519359|NCT00393848|20998889|P4|NOT COMPLETED|Overall Study||1
8519360|NCT00393848|20998890|P3|NOT COMPLETED|Overall Study||2
8519361|NCT00393848|20998891|P2|NOT COMPLETED|Overall Study||0
8519362|NCT00393848|20998892|P1|NOT COMPLETED|Overall Study||0
8519363|NCT00393848|20998889|P4|COMPLETED|Overall Study||8
8519364|NCT00393848|20998890|P3|COMPLETED|Overall Study||4
8519365|NCT00393848|20998891|P2|COMPLETED|Overall Study||9
8519366|NCT00393848|20998892|P1|COMPLETED|Overall Study||16
8519367|NCT00393848|20998889|P4|STARTED|Overall Study||9
8519368|NCT00393848|20998890|P3|STARTED|Overall Study||6
8519369|NCT00393848|20998891|P2|STARTED|Overall Study||9
8519370|NCT00393848|20998892|P1|STARTED|Overall Study||16
8519371|NCT00393796|20998906|P2|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
8519372|NCT00393796|20998907|P1|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
8519373|NCT00393796|20998906|P2|COMPLETED|Open Label Period - Placebo to SUTENT||16
8519374|NCT00393796|20998907|P1|COMPLETED|Open Label Period - Placebo to SUTENT||0
8519375|NCT00393796|20998906|P2|STARTED|Open Label Period - Placebo to SUTENT||16
8519376|NCT00393796|20998907|P1|STARTED|Open Label Period - Placebo to SUTENT||0
8519377|NCT00393796|20998906|P2|NOT COMPLETED|Double Blind Period||0
8519378|NCT00393796|20998907|P1|NOT COMPLETED|Double Blind Period||0
8519379|NCT00393796|20998906|P2|COMPLETED|Double Blind Period||28
8519380|NCT00393796|20998907|P1|COMPLETED|Double Blind Period||26
8519381|NCT00393796|20998906|P2|STARTED|Double Blind Period||28
8519382|NCT00393796|20998907|P1|STARTED|Double Blind Period||26
8519383|NCT00393718|20998915|P2|NOT COMPLETED|Overall Study||22
8519384|NCT00393718|20998916|P1|NOT COMPLETED|Overall Study||43
8519385|NCT00393718|20998915|P2|COMPLETED|Overall Study||110
8519386|NCT00393718|20998916|P1|COMPLETED|Overall Study||225
8519387|NCT00393718|20998915|P2|STARTED|Overall Study||132
8519388|NCT00393718|20998916|P1|STARTED|Overall Study||268
8519389|NCT00393705|20998948|P2|NOT COMPLETED|Overall Study||23
8519390|NCT00393705|20998949|P1|NOT COMPLETED|Overall Study||23
8519391|NCT00393705|20998948|P2|COMPLETED|Overall Study||128
8519392|NCT00393705|20998949|P1|COMPLETED|Overall Study||128
8519393|NCT00393705|20998948|P2|Received at Least One Dose of Study Drug|Overall Study||139
8519394|NCT00393705|20998949|P1|Received at Least One Dose of Study Drug|Overall Study||139
8519395|NCT00393705|20998948|P2|STARTED|Overall Study||151
8519396|NCT00393705|20998949|P1|STARTED|Overall Study||151
8519397|NCT00393523|20998978|P5|NOT COMPLETED|Overall Study||1
8519398|NCT00393523|20998979|P4|NOT COMPLETED|Overall Study||6
8519399|NCT00393523|20998980|P3|NOT COMPLETED|Overall Study||4
8519400|NCT00393523|20998981|P2|NOT COMPLETED|Overall Study||9
8519401|NCT00393523|20998982|P1|NOT COMPLETED|Overall Study||12
8519402|NCT00393523|20998978|P5|COMPLETED|Overall Study||19
8519403|NCT00393523|20998979|P4|COMPLETED|Overall Study||348
8519404|NCT00393523|20998980|P3|COMPLETED|Overall Study||349
8519405|NCT00393523|20998981|P2|COMPLETED|Overall Study||366
8519406|NCT00393523|20998982|P1|COMPLETED|Overall Study||364
8519407|NCT00393523|20998978|P5|Vaccination Visit 1|Overall Study||20
8519408|NCT00393523|20998979|P4|Vaccination Visit 1|Overall Study||352
8519409|NCT00393523|20998980|P3|Vaccination Visit 1|Overall Study||349
8519410|NCT00393523|20998981|P2|Vaccination Visit 1|Overall Study||375
8519411|NCT00393523|20998982|P1|Vaccination Visit 1|Overall Study||374
8519412|NCT00393523|20998978|P5|STARTED|Overall Study||20
8519413|NCT00393523|20998979|P4|STARTED|Overall Study||354
8519414|NCT00393523|20998980|P3|STARTED|Overall Study||353
8519415|NCT00393523|20998981|P2|STARTED|Overall Study||375
8519416|NCT00393523|20998982|P1|STARTED|Overall Study||376
8519417|NCT00393510|20998999|P2|NOT COMPLETED|Overall Study||9
8519418|NCT00393510|20999000|P1|NOT COMPLETED|Overall Study||3
8519419|NCT00393510|20998999|P2|COMPLETED|Overall Study||31
8519420|NCT00393510|20999000|P1|COMPLETED|Overall Study||37
8519421|NCT00393510|20998999|P2|STARTED|Overall Study||40
8519422|NCT00393510|20999000|P1|STARTED|Overall Study||40
8519423|NCT00393484|20999012|P2|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
8519424|NCT00393484|20999013|P1|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
8519425|NCT00393484|20999012|P2|COMPLETED|Open-label Period (Weeks 96 to 240)||21
8519426|NCT00393484|20999013|P1|COMPLETED|Open-label Period (Weeks 96 to 240)||40
8519427|NCT00393484|20999012|P2|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
8519428|NCT00393484|20999013|P1|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
8519429|NCT00393484|20999012|P2|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
8519430|NCT00393484|20999013|P1|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
8519431|NCT00393484|20999012|P2|STARTED|Open-label Period (Weeks 96 to 240)||44
8519432|NCT00393484|20999013|P1|STARTED|Open-label Period (Weeks 96 to 240)||48
8519433|NCT00393484|20999012|P2|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
8519434|NCT00393484|20999013|P1|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
8519435|NCT00393484|20999012|P2|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
8519436|NCT00393484|20999013|P1|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
8519437|NCT00393484|20999012|P2|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
8519438|NCT00393484|20999013|P1|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
8519439|NCT00393484|20999012|P2|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
8519440|NCT00393484|20999013|P1|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
8519441|NCT00393458|20999049|P4|NOT COMPLETED|Overall Study||137
8519442|NCT00393458|20999050|P3|NOT COMPLETED|Overall Study||112
8519443|NCT00393458|20999051|P2|NOT COMPLETED|Overall Study||102
8519444|NCT00393458|20999052|P1|NOT COMPLETED|Overall Study||99
8519445|NCT00393458|20999049|P4|COMPLETED|Overall Study||295
8519446|NCT00393458|20999050|P3|COMPLETED|Overall Study||323
8519447|NCT00393458|20999051|P2|COMPLETED|Overall Study||326
8519448|NCT00393458|20999052|P1|COMPLETED|Overall Study||338
8519449|NCT00393458|20999049|P4|Exposed to Study Medication or Placebo|Overall Study||432
8519450|NCT00393458|20999050|P3|Exposed to Study Medication or Placebo|Overall Study||434
8519451|NCT00393458|20999051|P2|Exposed to Study Medication or Placebo|Overall Study||425
8519452|NCT00393458|20999052|P1|Exposed to Study Medication or Placebo|Overall Study||437
8519453|NCT00393458|20999049|P4|STARTED|Overall Study||432
8519454|NCT00393458|20999050|P3|STARTED|Overall Study||435
8519455|NCT00393458|20999051|P2|STARTED|Overall Study||428
8519456|NCT00393458|20999052|P1|STARTED|Overall Study||437
8519457|NCT00393380|20999066|P1|NOT COMPLETED|Overall Study||0
8519458|NCT00393380|20999066|P1|COMPLETED|Overall Study||13
8519459|NCT00393380|20999066|P1|STARTED|Overall Study||13
8519460|NCT00393367|20999079|P2|NOT COMPLETED|Overall Study||7
8519461|NCT00393367|20999080|P1|NOT COMPLETED|Overall Study||2
8519462|NCT00393367|20999079|P2|COMPLETED|Overall Study||81
8519463|NCT00393367|20999080|P1|COMPLETED|Overall Study||89
8519464|NCT00393367|20999079|P2|STARTED|Overall Study||88
8519465|NCT00393367|20999080|P1|STARTED|Overall Study||91
8519466|NCT00393094|20999108|P1|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
8519467|NCT00393094|20999108|P1|COMPLETED|Disease Progression After Trtmt: Onstudy||29
8519468|NCT00393094|20999108|P1|STARTED|Disease Progression After Trtmt: Onstudy||30
8519469|NCT00393094|20999108|P1|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
8519470|NCT00393094|20999108|P1|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
8519471|NCT00393094|20999108|P1|STARTED|Period1Bevacizumab & Irinotecan Patients||31
8519472|NCT00393068|20999115|P1|NOT COMPLETED|Overall Study||18
8519473|NCT00393068|20999115|P1|COMPLETED|Overall Study||44
8519474|NCT00393068|20999115|P1|STARTED|Overall Study||62
8519475|NCT00393042|20999119|P2|NOT COMPLETED|Second Intervetion||8
8519476|NCT00393042|20999120|P1|NOT COMPLETED|Second Intervetion||2
8519477|NCT00393042|20999119|P2|COMPLETED|Second Intervetion||19
8519478|NCT00393042|20999120|P1|COMPLETED|Second Intervetion||24
8519479|NCT00393042|20999119|P2|Completed 25/30 mg Dosage|Second Intervetion||20
8519480|NCT00393042|20999120|P1|Completed 25/30 mg Dosage|Second Intervetion||24
8519481|NCT00393042|20999119|P2|Completed the 20mg Dosage|Second Intervetion||21
8519482|NCT00393042|20999120|P1|Completed the 20mg Dosage|Second Intervetion||24
8519483|NCT00393042|20999119|P2|Completed 10 mg Dosage|Second Intervetion||24
8519484|NCT00393042|20999120|P1|Completed 10 mg Dosage|Second Intervetion||26
8519485|NCT00393042|20999119|P2|Completed Placebo Dosage|Second Intervetion||21
8519486|NCT00393042|20999120|P1|Completed Placebo Dosage|Second Intervetion||25
8519487|NCT00393042|20999119|P2|STARTED|Second Intervetion||27
8519488|NCT00393042|20999120|P1|STARTED|Second Intervetion||26
8519489|NCT00393042|20999119|P2|NOT COMPLETED|First Intervention||6
8519490|NCT00393042|20999120|P1|NOT COMPLETED|First Intervention||5
8519491|NCT00393042|20999119|P2|COMPLETED|First Intervention||27
8519492|NCT00393042|20999120|P1|COMPLETED|First Intervention||26
8519493|NCT00393042|20999119|P2|Completed 25/30mg Dosage|First Intervention||27
8519494|NCT00393042|20999120|P1|Completed 25/30mg Dosage|First Intervention||27
8519495|NCT00393042|20999119|P2|Completed 20 mg Dosage|First Intervention||28
8519496|NCT00393042|20999120|P1|Completed 20 mg Dosage|First Intervention||26
8519497|NCT00393042|20999119|P2|Completed 10mg Dosage|First Intervention||29
8519498|NCT00393042|20999120|P1|Completed 10mg Dosage|First Intervention||29
8519499|NCT00393042|20999119|P2|Completed the Placebo Dosage|First Intervention||29
8519500|NCT00393042|20999120|P1|Completed the Placebo Dosage|First Intervention||27
8519501|NCT00393042|20999119|P2|STARTED|First Intervention||33
8519502|NCT00393042|20999120|P1|STARTED|First Intervention||31
8519503|NCT00393029|20999192|P2|NOT COMPLETED|Overall Study||1
8519504|NCT00393029|20999193|P1|NOT COMPLETED|Overall Study||0
8519505|NCT00393029|20999192|P2|COMPLETED|Overall Study||9
8519506|NCT00393029|20999193|P1|COMPLETED|Overall Study||2
8519507|NCT00393029|20999192|P2|STARTED|Overall Study||10
8519508|NCT00393029|20999193|P1|STARTED|Overall Study||2
8519509|NCT00392990|20999204|P2|NOT COMPLETED|Follow up for 2 Years||0
8519510|NCT00392990|20999205|P1|NOT COMPLETED|Follow up for 2 Years||4
8519511|NCT00392990|20999204|P2|COMPLETED|Follow up for 2 Years||5
8519512|NCT00392990|20999205|P1|COMPLETED|Follow up for 2 Years||16
8519513|NCT00392990|20999204|P2|STARTED|Follow up for 2 Years||5
8519514|NCT00392990|20999205|P1|STARTED|Follow up for 2 Years||20
8519515|NCT00392990|20999204|P2|NOT COMPLETED|Treatment on Study||1
8519516|NCT00392990|20999205|P1|NOT COMPLETED|Treatment on Study||3
8519517|NCT00392990|20999204|P2|COMPLETED|Treatment on Study||4
8519518|NCT00392990|20999205|P1|COMPLETED|Treatment on Study||17
8519519|NCT00392990|20999204|P2|STARTED|Treatment on Study||5
8519520|NCT00392990|20999205|P1|STARTED|Treatment on Study||20
8519521|NCT00392951|20999217|P1|NOT COMPLETED|Overall Study||0
8519522|NCT00392951|20999217|P1|COMPLETED|Overall Study||30
8519523|NCT00392951|20999217|P1|STARTED|Overall Study||30
8519524|NCT00392925|20999229|P4|NOT COMPLETED|Randomization to Treatment Group Period||18
8519525|NCT00392925|20999230|P3|NOT COMPLETED|Randomization to Treatment Group Period||19
8519526|NCT00392925|20999231|P2|NOT COMPLETED|Randomization to Treatment Group Period||8
8519527|NCT00392925|20999232|P1|NOT COMPLETED|Randomization to Treatment Group Period||0
8519528|NCT00392925|20999229|P4|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
8519529|NCT00392925|20999230|P3|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
8519530|NCT00392925|20999231|P2|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
8519531|NCT00392925|20999232|P1|COMPLETED|Randomization to Treatment Group Period||0
8519532|NCT00392925|20999229|P4|STARTED|Randomization to Treatment Group Period||56
8519533|NCT00392925|20999230|P3|STARTED|Randomization to Treatment Group Period||56
8519534|NCT00392925|20999231|P2|STARTED|Randomization to Treatment Group Period||27
8519535|NCT00392925|20999232|P1|STARTED|Randomization to Treatment Group Period||0
8519536|NCT00392925|20999229|P4|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8519537|NCT00392925|20999230|P3|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8519538|NCT00392925|20999231|P2|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8519539|NCT00392925|20999232|P1|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
8519540|NCT00392925|20999229|P4|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8519541|NCT00392925|20999230|P3|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8519542|NCT00392925|20999231|P2|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
8519543|NCT00392925|20999232|P1|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
8519544|NCT00392925|20999229|P4|STARTED|4 Week Lead-In Period - Non-Randomized||0
8519545|NCT00392925|20999230|P3|STARTED|4 Week Lead-In Period - Non-Randomized||0
8519546|NCT00392925|20999231|P2|STARTED|4 Week Lead-In Period - Non-Randomized||0
8519547|NCT00392925|20999232|P1|STARTED|4 Week Lead-In Period - Non-Randomized||177
8519548|NCT00392860|20999320|P3|NOT COMPLETED|Overall Study||0
8519549|NCT00392860|20999321|P2|NOT COMPLETED|Overall Study||0
8519550|NCT00392860|20999322|P1|NOT COMPLETED|Overall Study||0
8519551|NCT00392860|20999320|P3|COMPLETED|Overall Study||1
8519552|NCT00392860|20999321|P2|COMPLETED|Overall Study||0
8519553|NCT00392860|20999322|P1|COMPLETED|Overall Study||3
8519554|NCT00392860|20999320|P3|STARTED|Overall Study||1
8519555|NCT00392860|20999321|P2|STARTED|Overall Study||0
8519556|NCT00392860|20999322|P1|STARTED|Overall Study||3
8519557|NCT00392834|20999330|P2|NOT COMPLETED|Overall Study||0
8519558|NCT00392834|20999331|P1|NOT COMPLETED|Overall Study||0
8519559|NCT00392834|20999330|P2|COMPLETED|Overall Study||32
8519560|NCT00392834|20999331|P1|COMPLETED|Overall Study||2
8519561|NCT00392834|20999330|P2|STARTED|Overall Study||32
8519562|NCT00392834|20999331|P1|STARTED|Overall Study||2
8519563|NCT00392821|20999337|P1|NOT COMPLETED|Overall Study||19
8519564|NCT00392821|20999337|P1|COMPLETED|Overall Study||59
8519565|NCT00392821|20999337|P1|STARTED|Overall Study||78
8519566|NCT00392808|20999346|P4|NOT COMPLETED|Overall Study||4
8519567|NCT00392808|20999347|P3|NOT COMPLETED|Overall Study||2
8519568|NCT00392808|20999348|P2|NOT COMPLETED|Overall Study||3
8519569|NCT00392808|20999349|P1|NOT COMPLETED|Overall Study||6
8519570|NCT00392808|20999346|P4|COMPLETED|Overall Study||100
8519571|NCT00392808|20999347|P3|COMPLETED|Overall Study||107
8519572|NCT00392808|20999348|P2|COMPLETED|Overall Study||86
8519573|NCT00392808|20999349|P1|COMPLETED|Overall Study||81
8519574|NCT00392808|20999346|P4|STARTED|Overall Study||104
8519575|NCT00392808|20999347|P3|STARTED|Overall Study||109
8519576|NCT00392808|20999348|P2|STARTED|Overall Study||89
8519577|NCT00392808|20999349|P1|STARTED|Overall Study||87
8519578|NCT00392782|20999363|P1|NOT COMPLETED|Overall Study||0
8519579|NCT00392782|20999363|P1|COMPLETED|Overall Study||24
8519580|NCT00392782|20999363|P1|STARTED|Overall Study||24
8519581|NCT00392769|20999373|P1|NOT COMPLETED|Overall Study||10
8519582|NCT00392769|20999373|P1|COMPLETED|Overall Study||23
8519583|NCT00392769|20999373|P1|STARTED|Overall Study||33
8519584|NCT00392704|20999377|P1|NOT COMPLETED|Combined Modality Therapy||5
8519585|NCT00392704|20999377|P1|COMPLETED|Combined Modality Therapy||49
8519586|NCT00392704|20999377|P1|STARTED|Combined Modality Therapy||54
8519587|NCT00392704|20999377|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||6
8519588|NCT00392704|20999377|P1|COMPLETED|Neoadjuvant Chemotherapy||54
8519589|NCT00392704|20999377|P1|STARTED|Neoadjuvant Chemotherapy||60
8519590|NCT00392678|20999386|P4|NOT COMPLETED|Overall Study||1
8519591|NCT00392678|20999387|P3|NOT COMPLETED|Overall Study||2
8519592|NCT00392678|20999388|P2|NOT COMPLETED|Overall Study||1
8519593|NCT00392678|20999389|P1|NOT COMPLETED|Overall Study||0
8519594|NCT00392678|20999386|P4|COMPLETED|Overall Study||26
8519595|NCT00392678|20999387|P3|COMPLETED|Overall Study||25
8519596|NCT00392678|20999388|P2|COMPLETED|Overall Study||26
8519597|NCT00392678|20999389|P1|COMPLETED|Overall Study||27
8519598|NCT00392678|20999386|P4|STARTED|Overall Study||27
8519599|NCT00392678|20999387|P3|STARTED|Overall Study||27
8519600|NCT00392678|20999388|P2|STARTED|Overall Study||27
8519601|NCT00392678|20999389|P1|STARTED|Overall Study||27
8519602|NCT00392665|20999425|P2|NOT COMPLETED|Overall Study||15
8519603|NCT00392665|20999426|P1|NOT COMPLETED|Overall Study||17
8519604|NCT00392665|20999425|P2|COMPLETED|Overall Study||3
8519605|NCT00392665|20999426|P1|COMPLETED|Overall Study||1
8519606|NCT00392665|20999425|P2|STARTED|Overall Study||18
8519607|NCT00392665|20999426|P1|STARTED|Overall Study||18
8519608|NCT00392496|20999438|P1|NOT COMPLETED|Overall Study||0
8519609|NCT00392496|20999438|P1|COMPLETED|Overall Study||19
8519610|NCT00392496|20999438|P1|STARTED|Overall Study||19
8519611|NCT00392444|20999442|P1|NOT COMPLETED|Overall Study||0
8519612|NCT00392444|20999442|P1|COMPLETED|Overall Study||39
8519613|NCT00392444|20999442|P1|STARTED|Overall Study||39
8519614|NCT00392392|20999446|P1|NOT COMPLETED|Overall Study||20
8519615|NCT00392392|20999446|P1|COMPLETED|Overall Study||9
8519616|NCT00392392|20999446|P1|STARTED|Overall Study||29
8519617|NCT00392379|20999452|P2|NOT COMPLETED|Overall Study||38
8519618|NCT00392379|20999453|P1|NOT COMPLETED|Overall Study||22
8519619|NCT00392379|20999452|P2|COMPLETED|Overall Study|Medication period|96
8519620|NCT00392379|20999453|P1|COMPLETED|Overall Study|Medication period|114
8519621|NCT00392379|20999452|P2|STARTED|Overall Study|Medication period|134
8519622|NCT00392379|20999453|P1|STARTED|Overall Study|Medication period|136
8519623|NCT00392327|20999471|P8|NOT COMPLETED|Overall Study||11
8519624|NCT00392327|20999472|P7|NOT COMPLETED|Overall Study||9
8519625|NCT00392327|20999473|P6|NOT COMPLETED|Overall Study||5
8519626|NCT00392327|20999474|P5|NOT COMPLETED|Overall Study||3
8519627|NCT00392327|20999475|P4|NOT COMPLETED|Overall Study||16
8519628|NCT00392327|20999476|P3|NOT COMPLETED|Overall Study||20
8519629|NCT00392327|20999477|P2|NOT COMPLETED|Overall Study||19
8519630|NCT00392327|20999478|P1|NOT COMPLETED|Overall Study||15
8519631|NCT00392327|20999471|P8|COMPLETED|Overall Study||11
8519632|NCT00392327|20999472|P7|COMPLETED|Overall Study||12
8519633|NCT00392327|20999473|P6|COMPLETED|Overall Study||14
8519634|NCT00392327|20999474|P5|COMPLETED|Overall Study||20
8519635|NCT00392327|20999475|P4|COMPLETED|Overall Study||42
8519636|NCT00392327|20999476|P3|COMPLETED|Overall Study||36
8519637|NCT00392327|20999477|P2|COMPLETED|Overall Study||74
8519638|NCT00392327|20999478|P1|COMPLETED|Overall Study||72
8519639|NCT00392327|20999471|P8|STARTED|Overall Study||22
8519640|NCT00392327|20999472|P7|STARTED|Overall Study||21
8519641|NCT00392327|20999473|P6|STARTED|Overall Study||19
8519642|NCT00392327|20999474|P5|STARTED|Overall Study||23
8519643|NCT00392327|20999475|P4|STARTED|Overall Study||58
8519644|NCT00392327|20999476|P3|STARTED|Overall Study||56
8519645|NCT00392327|20999477|P2|STARTED|Overall Study||93
8519646|NCT00392327|20999478|P1|STARTED|Overall Study||87
8519647|NCT00392288|20999547|P3|NOT COMPLETED|Overall Study||17
8519648|NCT00392288|20999548|P2|NOT COMPLETED|Overall Study||22
8519649|NCT00392288|20999549|P1|NOT COMPLETED|Overall Study||32
8519650|NCT00392288|20999547|P3|COMPLETED|Overall Study|ITT set = 172 patients|159
8519651|NCT00392288|20999548|P2|COMPLETED|Overall Study|ITT set = 166 patients|155
8519652|NCT00392288|20999549|P1|COMPLETED|Overall Study|ITT set = 163 patients|143
8519653|NCT00392288|20999547|P3|Treatment Period|Overall Study||175
8519654|NCT00392288|20999548|P2|Treatment Period|Overall Study||174
8519655|NCT00392288|20999549|P1|Treatment Period|Overall Study||172
8519656|NCT00392288|20999547|P3|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
8519657|NCT00392288|20999548|P2|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
8519658|NCT00392288|20999549|P1|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
8519659|NCT00392236|20999565|P2|NOT COMPLETED|Overall Study||6
8519660|NCT00392236|20999566|P1|NOT COMPLETED|Overall Study||12
8519661|NCT00392236|20999565|P2|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
8519662|NCT00392236|20999566|P1|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
8519663|NCT00392236|20999565|P2|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
8519664|NCT00392236|20999566|P1|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
8519665|NCT00392223|20999574|P2|NOT COMPLETED|Overall Study||13
8519666|NCT00392223|20999575|P1|NOT COMPLETED|Overall Study||9
8519667|NCT00392223|20999574|P2|COMPLETED|Overall Study||47
8519668|NCT00392223|20999575|P1|COMPLETED|Overall Study||49
8519669|NCT00392223|20999574|P2|STARTED|Overall Study||60
8519670|NCT00392223|20999575|P1|STARTED|Overall Study||58
8519671|NCT00392210|20999593|P2|NOT COMPLETED|Second Voiding Trial||0
8519672|NCT00392210|20999594|P1|NOT COMPLETED|Second Voiding Trial||0
8519673|NCT00392210|20999593|P2|COMPLETED|Second Voiding Trial||31
8519674|NCT00392210|20999594|P1|COMPLETED|Second Voiding Trial||34
8519675|NCT00392210|20999593|P2|STARTED|Second Voiding Trial||31
8519676|NCT00392210|20999594|P1|STARTED|Second Voiding Trial||34
8519677|NCT00392210|20999593|P2|NOT COMPLETED|First Voiding Trial||2
8519678|NCT00392210|20999594|P1|NOT COMPLETED|First Voiding Trial||2
8519679|NCT00392210|20999593|P2|COMPLETED|First Voiding Trial||31
8519680|NCT00392210|20999594|P1|COMPLETED|First Voiding Trial||34
8519681|NCT00392210|20999593|P2|STARTED|First Voiding Trial||33
8519682|NCT00392210|20999594|P1|STARTED|First Voiding Trial||36
8519683|NCT00392197|20999602|P2|NOT COMPLETED|Overall Study||30
8519684|NCT00392197|20999603|P1|NOT COMPLETED|Overall Study||21
8519685|NCT00392197|20999602|P2|COMPLETED|Overall Study||33
8519686|NCT00392197|20999603|P1|COMPLETED|Overall Study||27
8519687|NCT00392197|20999602|P2|STARTED|Overall Study||63
8519688|NCT00392197|20999603|P1|STARTED|Overall Study||48
8519689|NCT00392171|20999611|P1|NOT COMPLETED|Overall Study||105
8519690|NCT00392171|20999611|P1|COMPLETED|Overall Study||15
8519691|NCT00392171|20999611|P1|STARTED|Overall Study||120
8519692|NCT00392054|20999617|P2|NOT COMPLETED|Overall Study||0
8519693|NCT00392054|20999618|P1|NOT COMPLETED|Overall Study||0
8519694|NCT00392054|20999617|P2|COMPLETED|Overall Study||61
8519695|NCT00392054|20999618|P1|COMPLETED|Overall Study||66
8519696|NCT00392054|20999617|P2|Received Allocated Intervention|Overall Study||60
8519697|NCT00392054|20999618|P1|Received Allocated Intervention|Overall Study||65
8519698|NCT00392054|20999617|P2|STARTED|Overall Study|All participants randomized are included in final analysis|61
8519699|NCT00392054|20999618|P1|STARTED|Overall Study|All participants randomized are included in final analysis|66
8519700|NCT00392041|20999640|P2|NOT COMPLETED|Weeks 5 - 12||5
8519701|NCT00392041|20999641|P1|NOT COMPLETED|Weeks 5 - 12||4
8519702|NCT00392041|20999640|P2|COMPLETED|Weeks 5 - 12||9
8519703|NCT00392041|20999641|P1|COMPLETED|Weeks 5 - 12||7
8519704|NCT00392041|20999640|P2|STARTED|Weeks 5 - 12||14
8519705|NCT00392041|20999641|P1|STARTED|Weeks 5 - 12||11
8519706|NCT00392041|20999640|P2|NOT COMPLETED|First 4 Weeks||3
8519707|NCT00392041|20999641|P1|NOT COMPLETED|First 4 Weeks||8
8519708|NCT00392041|20999640|P2|COMPLETED|First 4 Weeks||14
8519709|NCT00392041|20999641|P1|COMPLETED|First 4 Weeks||11
8519710|NCT00392041|20999640|P2|STARTED|First 4 Weeks||17
8519711|NCT00392041|20999641|P1|STARTED|First 4 Weeks||19
8519712|NCT00391989|20999655|P1|NOT COMPLETED|Overall Study||2
8519713|NCT00391989|20999655|P1|COMPLETED|Overall Study||53
8519714|NCT00391989|20999655|P1|STARTED|Overall Study||55
8519715|NCT00391976|20999662|P3|NOT COMPLETED|Overall Study||35
8519716|NCT00391976|20999663|P2|NOT COMPLETED|Overall Study||25
8519717|NCT00391976|20999664|P1|NOT COMPLETED|Overall Study||27
8519718|NCT00391976|20999662|P3|COMPLETED|Overall Study||0
8519719|NCT00391976|20999663|P2|COMPLETED|Overall Study||18
8519720|NCT00391976|20999664|P1|COMPLETED|Overall Study||18
8519721|NCT00391976|20999662|P3|Safety Population|Overall Study||35
8519722|NCT00391976|20999663|P2|Safety Population|Overall Study||43
8519723|NCT00391976|20999664|P1|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
8519724|NCT00391976|20999662|P3|Randomized|Overall Study||0
8519725|NCT00391976|20999663|P2|Randomized|Overall Study||43
8519726|NCT00391976|20999664|P1|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
8519727|NCT00391976|20999662|P3|STARTED|Overall Study||35
8519728|NCT00391976|20999663|P2|STARTED|Overall Study||43
8519729|NCT00391976|20999664|P1|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
8519730|NCT00391898|20999688|P2|NOT COMPLETED|Overall Study||10
8519731|NCT00391898|20999689|P1|NOT COMPLETED|Overall Study||11
8519732|NCT00391898|20999688|P2|COMPLETED|Overall Study||39
8519733|NCT00391898|20999689|P1|COMPLETED|Overall Study||35
8519734|NCT00391898|20999688|P2|STARTED|Overall Study||49
8519735|NCT00391898|20999689|P1|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
8519736|NCT00391872|20999709|P2|NOT COMPLETED|Overall Study||255
8519737|NCT00391872|20999710|P1|NOT COMPLETED|Overall Study||307
8519738|NCT00391872|20999709|P2|COMPLETED|Overall Study||9036
8519739|NCT00391872|20999710|P1|COMPLETED|Overall Study||9026
8519740|NCT00391872|20999709|P2|STARTED|Overall Study||9291
8519741|NCT00391872|20999710|P1|STARTED|Overall Study||9333
8519742|NCT00391846|20999748|P2|NOT COMPLETED|Overall Study||7
8519743|NCT00391846|20999749|P1|NOT COMPLETED|Overall Study||8
8519744|NCT00391846|20999748|P2|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
8519745|NCT00391846|20999749|P1|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
8519746|NCT00391846|20999748|P2|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
8519747|NCT00391846|20999749|P1|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
8519748|NCT00391807|20999769|P1|NOT COMPLETED|Overall Study||715
8519749|NCT00391807|20999769|P1|COMPLETED|Overall Study||968
8519750|NCT00391807|20999769|P1|STARTED|Overall Study||1683
8519751|NCT00391768|20999796|P7|NOT COMPLETED|Overall Study||4
8519752|NCT00391768|20999797|P6|NOT COMPLETED|Overall Study||3
8519753|NCT00391768|20999798|P5|NOT COMPLETED|Overall Study||2
8519754|NCT00391768|20999799|P4|NOT COMPLETED|Overall Study||1
8519755|NCT00391768|20999800|P3|NOT COMPLETED|Overall Study||1
8519756|NCT00391768|20999801|P2|NOT COMPLETED|Overall Study||0
8519757|NCT00391768|20999802|P1|NOT COMPLETED|Overall Study||0
8519758|NCT00391768|20999796|P7|COMPLETED|Overall Study||19
8519759|NCT00391768|20999797|P6|COMPLETED|Overall Study||7
8519760|NCT00391768|20999798|P5|COMPLETED|Overall Study||22
8519761|NCT00391768|20999799|P4|COMPLETED|Overall Study||7
8519762|NCT00391768|20999800|P3|COMPLETED|Overall Study||6
8519763|NCT00391768|20999801|P2|COMPLETED|Overall Study||3
8519764|NCT00391768|20999802|P1|COMPLETED|Overall Study||12
8519765|NCT00391768|20999796|P7|STARTED|Overall Study||23
8519766|NCT00391768|20999797|P6|STARTED|Overall Study||10
8519767|NCT00391768|20999798|P5|STARTED|Overall Study||24
8519768|NCT00391768|20999799|P4|STARTED|Overall Study||8
8519769|NCT00391768|20999800|P3|STARTED|Overall Study||7
8519770|NCT00391768|20999801|P2|STARTED|Overall Study||3
8519771|NCT00391768|20999802|P1|STARTED|Overall Study||12
8519772|NCT00391716|20999870|P3|NOT COMPLETED|Overall Study||19
8519773|NCT00391716|20999871|P2|NOT COMPLETED|Overall Study||19
8519774|NCT00391716|20999872|P1|NOT COMPLETED|Overall Study||27
8519775|NCT00391716|20999870|P3|COMPLETED|Overall Study||30
8519776|NCT00391716|20999871|P2|COMPLETED|Overall Study||28
8519777|NCT00391716|20999872|P1|COMPLETED|Overall Study||27
8519778|NCT00391716|20999870|P3|STARTED|Overall Study||49
8519779|NCT00391716|20999871|P2|STARTED|Overall Study||47
8519780|NCT00391716|20999872|P1|STARTED|Overall Study||54
8519793|NCT00391599|20999931|P2|NOT COMPLETED|Overall Study||0
8519794|NCT00391599|20999932|P1|NOT COMPLETED|Overall Study||0
8519795|NCT00391599|20999931|P2|COMPLETED|Overall Study||65
8519796|NCT00391599|20999932|P1|COMPLETED|Overall Study||65
8519797|NCT00391599|20999931|P2|STARTED|Overall Study||65
8519798|NCT00391599|20999932|P1|STARTED|Overall Study||65
8519799|NCT00391586|20999942|P1|NOT COMPLETED|Overall Study||24
8519800|NCT00391586|20999942|P1|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
8519801|NCT00391586|20999942|P1|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
8519802|NCT00391586|20999942|P1|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
8519803|NCT00391586|20999942|P1|STARTED|Overall Study||45
8519804|NCT00391469|20999951|P2|NOT COMPLETED|Overall Study||0
8519805|NCT00391469|20999952|P1|NOT COMPLETED|Overall Study||0
8519806|NCT00391469|20999951|P2|COMPLETED|Overall Study||671
8519807|NCT00391469|20999952|P1|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
8519808|NCT00391469|20999951|P2|STARTED|Overall Study||671
8519809|NCT00391469|20999952|P1|STARTED|Overall Study||688
8519810|NCT00391443|20999966|P2|NOT COMPLETED|Overall Study||0
8519811|NCT00391443|20999967|P1|NOT COMPLETED|Overall Study||0
8519812|NCT00391443|20999966|P2|COMPLETED|Overall Study||407
8519813|NCT00391443|20999967|P1|COMPLETED|Overall Study||209
8519814|NCT00391443|20999966|P2|STARTED|Overall Study||407
8519815|NCT00391443|20999967|P1|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
8519816|NCT00391391|20999979|P4|NOT COMPLETED|Overall Study||19
8519817|NCT00391391|20999980|P3|NOT COMPLETED|Overall Study||23
8519818|NCT00391391|20999981|P2|NOT COMPLETED|Overall Study||10
8519819|NCT00391391|20999982|P1|NOT COMPLETED|Overall Study||9
8519820|NCT00391391|20999979|P4|COMPLETED|Overall Study||145
8519821|NCT00391391|20999980|P3|COMPLETED|Overall Study||138
8519822|NCT00391391|20999981|P2|COMPLETED|Overall Study||87
8519823|NCT00391391|20999982|P1|COMPLETED|Overall Study||89
8519824|NCT00391391|20999979|P4|STARTED|Overall Study|1 participant was not vaccinated.|164
8519825|NCT00391391|20999980|P3|STARTED|Overall Study|1 participant was not vaccinated.|161
8519826|NCT00391391|20999981|P2|STARTED|Overall Study||97
8519827|NCT00391391|20999982|P1|STARTED|Overall Study|1 participant was not vaccinated.|98
8519834|NCT00391274|21000027|P2|NOT COMPLETED|Overall Study||57
8519835|NCT00391274|21000028|P1|NOT COMPLETED|Overall Study||61
8519836|NCT00391274|21000027|P2|COMPLETED|Overall Study||47
8519837|NCT00391274|21000028|P1|COMPLETED|Overall Study||46
8519838|NCT00391274|21000027|P2|Received at Least One Dose of Study Drug|Overall Study||102
8519839|NCT00391274|21000028|P1|Received at Least One Dose of Study Drug|Overall Study||106
8519840|NCT00391274|21000027|P2|STARTED|Overall Study||104
8519841|NCT00391274|21000028|P1|STARTED|Overall Study||107
8519842|NCT00391222|21000047|P4|NOT COMPLETED|Period III (Double-Blind Treatment)||0
8519843|NCT00391222|21000048|P3|NOT COMPLETED|Period III (Double-Blind Treatment)||23
8519844|NCT00391222|21000049|P2|NOT COMPLETED|Period III (Double-Blind Treatment)||22
8519845|NCT00391222|21000050|P1|NOT COMPLETED|Period III (Double-Blind Treatment)||28
8519846|NCT00391222|21000047|P4|COMPLETED|Period III (Double-Blind Treatment)||0
8519847|NCT00391222|21000048|P3|COMPLETED|Period III (Double-Blind Treatment)||108
8519848|NCT00391222|21000049|P2|COMPLETED|Period III (Double-Blind Treatment)||113
8519849|NCT00391222|21000050|P1|COMPLETED|Period III (Double-Blind Treatment)||104
8519850|NCT00391222|21000047|P4|STARTED|Period III (Double-Blind Treatment)||0
8519851|NCT00391222|21000048|P3|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
8519852|NCT00391222|21000049|P2|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
8519853|NCT00391222|21000050|P1|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
8519854|NCT00391222|21000047|P4|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
8519855|NCT00391222|21000048|P3|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
8519856|NCT00391222|21000049|P2|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
8519857|NCT00391222|21000050|P1|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
8519858|NCT00391222|21000047|P4|COMPLETED|Period II (Open-label Risperidone LAI)||398
8519859|NCT00391222|21000048|P3|COMPLETED|Period II (Open-label Risperidone LAI)||0
8519860|NCT00391222|21000049|P2|COMPLETED|Period II (Open-label Risperidone LAI)||0
8519861|NCT00391222|21000050|P1|COMPLETED|Period II (Open-label Risperidone LAI)||0
8519862|NCT00391222|21000047|P4|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
8519863|NCT00391222|21000048|P3|STARTED|Period II (Open-label Risperidone LAI)||0
8519864|NCT00391222|21000049|P2|STARTED|Period II (Open-label Risperidone LAI)||0
8519865|NCT00391222|21000050|P1|STARTED|Period II (Open-label Risperidone LAI)||0
8519866|NCT00391118|21000077|P3|NOT COMPLETED|Overall Study||58
8519867|NCT00391118|21000078|P2|NOT COMPLETED|Overall Study||55
8519868|NCT00391118|21000079|P1|NOT COMPLETED|Overall Study||11
8519869|NCT00391118|21000077|P3|COMPLETED|Overall Study||15
8519870|NCT00391118|21000078|P2|COMPLETED|Overall Study||14
8519871|NCT00391118|21000079|P1|COMPLETED|Overall Study||0
8519872|NCT00391118|21000077|P3|Received ≥1 Dose of Assigned Study Drug|Overall Study||72
8519873|NCT00391118|21000078|P2|Received ≥1 Dose of Assigned Study Drug|Overall Study||67
8519874|NCT00391118|21000079|P1|Received ≥1 Dose of Assigned Study Drug|Overall Study||11
8519875|NCT00391118|21000077|P3|STARTED|Overall Study||73
8519876|NCT00391118|21000078|P2|STARTED|Overall Study||69
8519877|NCT00391118|21000079|P1|STARTED|Overall Study||11
8519878|NCT00391092|21000105|P2|NOT COMPLETED|Overall Study||216
8519879|NCT00391092|21000106|P1|NOT COMPLETED|Overall Study||208
8519880|NCT00391092|21000105|P2|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
8519881|NCT00391092|21000106|P1|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
8519882|NCT00391092|21000105|P2|Received Treatment|Overall Study||215
8519883|NCT00391092|21000106|P1|Received Treatment|Overall Study||206
8519884|NCT00391092|21000105|P2|STARTED|Overall Study||216
8519885|NCT00391092|21000106|P1|STARTED|Overall Study||208
8519886|NCT00391079|21000126|P2|NOT COMPLETED|Overall Study||16
8519887|NCT00391079|21000127|P1|NOT COMPLETED|Overall Study||26
8519888|NCT00391079|21000126|P2|COMPLETED|Overall Study||156
8519889|NCT00391079|21000127|P1|COMPLETED|Overall Study||141
8519890|NCT00391079|21000126|P2|STARTED|Overall Study||172
8519891|NCT00391079|21000127|P1|STARTED|Overall Study||167
8519892|NCT00391053|21000149|P4|NOT COMPLETED|Overall Study||10
8519893|NCT00391053|21000150|P3|NOT COMPLETED|Overall Study||2
8519894|NCT00391053|21000151|P2|NOT COMPLETED|Overall Study||1
8519895|NCT00391053|21000152|P1|NOT COMPLETED|Overall Study||9
8519896|NCT00391053|21000149|P4|COMPLETED|Overall Study||1252
8519897|NCT00391053|21000150|P3|COMPLETED|Overall Study||868
8519898|NCT00391053|21000151|P2|COMPLETED|Overall Study||847
8519899|NCT00391053|21000152|P1|COMPLETED|Overall Study||848
8519900|NCT00391053|21000149|P4|STARTED|Overall Study||1262
8519901|NCT00391053|21000150|P3|STARTED|Overall Study||870
8519902|NCT00391053|21000151|P2|STARTED|Overall Study||848
8519903|NCT00391053|21000152|P1|STARTED|Overall Study||857
8519904|NCT00391027|21000176|P2|NOT COMPLETED|Overall Study||12
8519905|NCT00391027|21000177|P1|NOT COMPLETED|Overall Study||25
8519906|NCT00391027|21000176|P2|COMPLETED|Overall Study||110
8519907|NCT00391027|21000177|P1|COMPLETED|Overall Study||110
8519908|NCT00391027|21000176|P2|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
8519909|NCT00391027|21000177|P1|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
8519910|NCT00390949|21000217|P2|NOT COMPLETED|Overall Study||2128
8519911|NCT00390949|21000218|P1|NOT COMPLETED|Overall Study||2098
8519912|NCT00390949|21000217|P2|COMPLETED|Overall Study||2664
8519913|NCT00390949|21000218|P1|COMPLETED|Overall Study||2564
8519914|NCT00390949|21000217|P2|STARTED|Overall Study||4792
8519915|NCT00390949|21000218|P1|STARTED|Overall Study||4662
8519916|NCT00390910|21000227|P3|NOT COMPLETED|Overall Study||10
8519917|NCT00390910|21000228|P2|NOT COMPLETED|Overall Study||4
8519918|NCT00390910|21000229|P1|NOT COMPLETED|Overall Study||2
8519919|NCT00390910|21000227|P3|COMPLETED|Overall Study||139
8519920|NCT00390910|21000228|P2|COMPLETED|Overall Study||83
8519921|NCT00390910|21000229|P1|COMPLETED|Overall Study||48
8519922|NCT00390910|21000227|P3|STARTED|Overall Study||149
8519923|NCT00390910|21000228|P2|STARTED|Overall Study||87
8519924|NCT00390910|21000229|P1|STARTED|Overall Study||50
8519925|NCT00390884|21000317|P2|NOT COMPLETED|Overall Study||2
8519926|NCT00390884|21000318|P1|NOT COMPLETED|Overall Study||2
8519927|NCT00390884|21000317|P2|COMPLETED|Overall Study||55
8519928|NCT00390884|21000318|P1|COMPLETED|Overall Study||114
8519929|NCT00390884|21000317|P2|STARTED|Overall Study||57
8519930|NCT00390884|21000318|P1|STARTED|Overall Study||116
8519931|NCT00390858|21000330|P2|NOT COMPLETED|Overall Study||7
8519932|NCT00390858|21000331|P1|NOT COMPLETED|Overall Study||9
8520021|NCT00390364|21000621|P1|STARTED|Overall Study||1
8519933|NCT00390858|21000330|P2|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
8519934|NCT00390858|21000331|P1|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
8519935|NCT00390858|21000330|P2|Completed Core & Entered Extension Study|Overall Study||20
8519936|NCT00390858|21000331|P1|Completed Core & Entered Extension Study|Overall Study||19
8519937|NCT00390858|21000330|P2|STARTED|Overall Study|20 Participants started the Core Study|20
8519938|NCT00390858|21000331|P1|STARTED|Overall Study|20 participants started the Core Study|20
8519939|NCT00390806|21000345|P2|NOT COMPLETED|Overall Study||32
8519940|NCT00390806|21000346|P1|NOT COMPLETED|Overall Study||30
8519941|NCT00390806|21000345|P2|COMPLETED|Overall Study||204
8519942|NCT00390806|21000346|P1|COMPLETED|Overall Study||206
8519943|NCT00390806|21000345|P2|Ongoing|Overall Study||2
8519944|NCT00390806|21000346|P1|Ongoing|Overall Study||4
8519945|NCT00390806|21000345|P2|STARTED|Overall Study||236
8519946|NCT00390806|21000346|P1|STARTED|Overall Study||236
8519947|NCT00390780|21000414|P2|NOT COMPLETED|Overall Study||27
8519948|NCT00390780|21000415|P1|NOT COMPLETED|Overall Study||23
8519949|NCT00390780|21000414|P2|COMPLETED|Overall Study||260
8519950|NCT00390780|21000415|P1|COMPLETED|Overall Study||268
8519951|NCT00390780|21000414|P2|Treatment|Overall Study||287
8519952|NCT00390780|21000415|P1|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
8519953|NCT00390780|21000414|P2|STARTED|Overall Study||287
8519954|NCT00390780|21000415|P1|STARTED|Overall Study||291
8519955|NCT00390689|21000448|P3|NOT COMPLETED|Overall Study||3
8519956|NCT00390689|21000449|P2|NOT COMPLETED|Overall Study||5
8519957|NCT00390689|21000450|P1|NOT COMPLETED|Overall Study||5
8519958|NCT00390689|21000448|P3|COMPLETED|Overall Study||50
8519959|NCT00390689|21000449|P2|COMPLETED|Overall Study||48
8519960|NCT00390689|21000450|P1|COMPLETED|Overall Study||43
8519961|NCT00390689|21000448|P3|STARTED|Overall Study||53
8519962|NCT00390689|21000449|P2|STARTED|Overall Study||53
8519963|NCT00390689|21000450|P1|STARTED|Overall Study||48
8519964|NCT00390611|21000510|P2|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
8519965|NCT00390611|21000511|P1|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
8519966|NCT00390611|21000510|P2|COMPLETED|Maintenance Sorafenib to Month 12||0
8519967|NCT00390611|21000511|P1|COMPLETED|Maintenance Sorafenib to Month 12||13
8519968|NCT00390611|21000510|P2|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
8519969|NCT00390611|21000511|P1|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
8519970|NCT00390611|21000510|P2|NOT COMPLETED|6 Cycles of Study Treatment||5
8519971|NCT00390611|21000511|P1|NOT COMPLETED|6 Cycles of Study Treatment||9
8519972|NCT00390611|21000510|P2|COMPLETED|6 Cycles of Study Treatment||37
8519973|NCT00390611|21000511|P1|COMPLETED|6 Cycles of Study Treatment||34
8519974|NCT00390611|21000510|P2|STARTED|6 Cycles of Study Treatment||42
8519975|NCT00390611|21000511|P1|STARTED|6 Cycles of Study Treatment||43
8519976|NCT00390572|21000525|P2|NOT COMPLETED|Overall Study||5
8519977|NCT00390572|21000526|P1|NOT COMPLETED|Overall Study||8
8519978|NCT00390572|21000525|P2|COMPLETED|Overall Study||64
8519979|NCT00390572|21000526|P1|COMPLETED|Overall Study||60
8519980|NCT00390572|21000525|P2|STARTED|Overall Study||69
8519981|NCT00390572|21000526|P1|STARTED|Overall Study||68
8519982|NCT00390559|21000540|P1|NOT COMPLETED|Overall Study||44
8519983|NCT00390559|21000540|P1|COMPLETED|Overall Study||80
8519984|NCT00390559|21000540|P1|ActiveP/PlaceboC|Overall Study||90
8519985|NCT00390559|21000540|P1|PlaceboP/PlaceboC|Overall Study||93
8519986|NCT00390559|21000540|P1|ActiveP/ActiveC|Overall Study||87
8519987|NCT00390559|21000540|P1|Received PlaceboP/Active C|Overall Study||93
8519988|NCT00390559|21000540|P1|STARTED|Overall Study||124
8519989|NCT00390546|21000552|P2|NOT COMPLETED|Overall Study||5
8519990|NCT00390546|21000553|P1|NOT COMPLETED|Overall Study||6
8519991|NCT00390546|21000552|P2|COMPLETED|Overall Study||34
8519992|NCT00390546|21000553|P1|COMPLETED|Overall Study||27
8519993|NCT00390546|21000552|P2|STARTED|Overall Study||39
8519994|NCT00390546|21000553|P1|STARTED|Overall Study||33
8519995|NCT00390468|21000563|P1|NOT COMPLETED|Overall Study||3
8519996|NCT00390468|21000563|P1|COMPLETED|Overall Study||15
8519997|NCT00390468|21000563|P1|STARTED|Overall Study||18
8519998|NCT00390455|21000569|P2|NOT COMPLETED|Overall Study||23
8519999|NCT00390455|21000570|P1|NOT COMPLETED|Overall Study||32
8520000|NCT00390455|21000569|P2|COMPLETED|Overall Study||124
8520001|NCT00390455|21000570|P1|COMPLETED|Overall Study||116
8520002|NCT00390455|21000569|P2|STARTED|Overall Study||147
8520003|NCT00390455|21000570|P1|STARTED|Overall Study||148
8520004|NCT00390429|21000591|P4|NOT COMPLETED|Overall Study||0
8520005|NCT00390429|21000592|P3|NOT COMPLETED|Overall Study||0
8520006|NCT00390429|21000593|P2|NOT COMPLETED|Overall Study||0
8520007|NCT00390429|21000594|P1|NOT COMPLETED|Overall Study||0
8520008|NCT00390429|21000591|P4|COMPLETED|Overall Study||39
8520009|NCT00390429|21000592|P3|COMPLETED|Overall Study||25
8520010|NCT00390429|21000593|P2|COMPLETED|Overall Study||12
8520011|NCT00390429|21000594|P1|COMPLETED|Overall Study||5
8520012|NCT00390429|21000591|P4|STARTED|Overall Study||39
8520013|NCT00390429|21000592|P3|STARTED|Overall Study||25
8520014|NCT00390429|21000593|P2|STARTED|Overall Study||12
8520015|NCT00390429|21000594|P1|STARTED|Overall Study||5
8520016|NCT00390416|21000615|P1|NOT COMPLETED|Overall Study||4
8520017|NCT00390416|21000615|P1|COMPLETED|Overall Study||44
8520018|NCT00390416|21000615|P1|STARTED|Overall Study||48
8520019|NCT00390364|21000621|P1|NOT COMPLETED|Overall Study||0
8520020|NCT00390364|21000621|P1|COMPLETED|Overall Study||1
8520028|NCT00390299|21000653|P5|NOT COMPLETED|Overall Study||0
8520029|NCT00390299|21000654|P4|NOT COMPLETED|Overall Study||0
8520030|NCT00390299|21000655|P3|NOT COMPLETED|Overall Study||0
8520031|NCT00390299|21000656|P2|NOT COMPLETED|Overall Study||0
8520032|NCT00390299|21000657|P1|NOT COMPLETED|Overall Study||1
8520033|NCT00390299|21000653|P5|COMPLETED|Overall Study||10
8520034|NCT00390299|21000654|P4|COMPLETED|Overall Study||3
8520035|NCT00390299|21000655|P3|COMPLETED|Overall Study||3
8520036|NCT00390299|21000656|P2|COMPLETED|Overall Study||3
8520037|NCT00390299|21000657|P1|COMPLETED|Overall Study||3
8520038|NCT00390299|21000653|P5|STARTED|Overall Study||10
8520039|NCT00390299|21000654|P4|STARTED|Overall Study||3
8520040|NCT00390299|21000655|P3|STARTED|Overall Study||3
8520041|NCT00390299|21000656|P2|STARTED|Overall Study||3
8520042|NCT00390299|21000657|P1|STARTED|Overall Study||4
8520043|NCT00390234|21000677|P1|NOT COMPLETED|Overall Study||0
8520044|NCT00390234|21000677|P1|COMPLETED|Overall Study||63
8520045|NCT00390234|21000677|P1|STARTED|Overall Study||63
8520046|NCT00390221|21000688|P3|NOT COMPLETED|Overall Study||15
8520047|NCT00390221|21000689|P2|NOT COMPLETED|Overall Study||20
8520048|NCT00390221|21000690|P1|NOT COMPLETED|Overall Study||18
8520049|NCT00390221|21000688|P3|COMPLETED|Overall Study||194
8520050|NCT00390221|21000689|P2|COMPLETED|Overall Study||188
8520051|NCT00390221|21000690|P1|COMPLETED|Overall Study||186
8520052|NCT00390221|21000688|P3|STARTED|Overall Study||209
8520053|NCT00390221|21000689|P2|STARTED|Overall Study||208
8520054|NCT00390221|21000690|P1|STARTED|Overall Study||204
8520055|NCT00390182|21000711|P1|NOT COMPLETED|Overall Study||5
8520056|NCT00390182|21000711|P1|COMPLETED|Overall Study||33
8520057|NCT00390182|21000711|P1|STARTED|Overall Study||38
8520058|NCT00390013|21000720|P4|NOT COMPLETED|Phase 2 Second Treatment||0
8520059|NCT00390013|21000721|P3|NOT COMPLETED|Phase 2 Second Treatment||0
8520060|NCT00390013|21000722|P2|NOT COMPLETED|Phase 2 Second Treatment||0
8520061|NCT00390013|21000723|P1|NOT COMPLETED|Phase 2 Second Treatment||0
8520062|NCT00390013|21000720|P4|COMPLETED|Phase 2 Second Treatment||0
8520063|NCT00390013|21000721|P3|COMPLETED|Phase 2 Second Treatment||0
8520064|NCT00390013|21000722|P2|COMPLETED|Phase 2 Second Treatment||1
8520065|NCT00390013|21000723|P1|COMPLETED|Phase 2 Second Treatment||2
8520066|NCT00390013|21000720|P4|STARTED|Phase 2 Second Treatment||0
8520067|NCT00390013|21000721|P3|STARTED|Phase 2 Second Treatment||0
8520068|NCT00390013|21000722|P2|STARTED|Phase 2 Second Treatment||1
8520069|NCT00390013|21000723|P1|STARTED|Phase 2 Second Treatment||2
8520070|NCT00390013|21000720|P4|NOT COMPLETED|Phase 2 First Treatment||0
8520071|NCT00390013|21000721|P3|NOT COMPLETED|Phase 2 First Treatment||0
8520072|NCT00390013|21000722|P2|NOT COMPLETED|Phase 2 First Treatment||1
8520073|NCT00390013|21000723|P1|NOT COMPLETED|Phase 2 First Treatment||1
8520074|NCT00390013|21000720|P4|COMPLETED|Phase 2 First Treatment||0
8520075|NCT00390013|21000721|P3|COMPLETED|Phase 2 First Treatment||0
8520076|NCT00390013|21000722|P2|COMPLETED|Phase 2 First Treatment||1
8520077|NCT00390013|21000723|P1|COMPLETED|Phase 2 First Treatment||2
8520078|NCT00390013|21000720|P4|STARTED|Phase 2 First Treatment||0
8520079|NCT00390013|21000721|P3|STARTED|Phase 2 First Treatment||0
8520080|NCT00390013|21000722|P2|STARTED|Phase 2 First Treatment||2
8520081|NCT00390013|21000723|P1|STARTED|Phase 2 First Treatment||3
8520082|NCT00390013|21000720|P4|NOT COMPLETED|Phase 1||1
8520083|NCT00390013|21000721|P3|NOT COMPLETED|Phase 1||0
8520084|NCT00390013|21000722|P2|NOT COMPLETED|Phase 1||0
8520085|NCT00390013|21000723|P1|NOT COMPLETED|Phase 1||0
8520086|NCT00390013|21000720|P4|COMPLETED|Phase 1||1
8520087|NCT00390013|21000721|P3|COMPLETED|Phase 1||2
8520088|NCT00390013|21000722|P2|COMPLETED|Phase 1||0
8520089|NCT00390013|21000723|P1|COMPLETED|Phase 1||0
8520090|NCT00390013|21000720|P4|STARTED|Phase 1||2
8520091|NCT00390013|21000721|P3|STARTED|Phase 1||2
8520092|NCT00390013|21000722|P2|STARTED|Phase 1||0
8520093|NCT00390013|21000723|P1|STARTED|Phase 1||0
8520094|NCT00389974|21000729|P1|NOT COMPLETED|Overall Study||0
8520095|NCT00389974|21000729|P1|COMPLETED|Overall Study||19
8520096|NCT00389974|21000729|P1|STARTED|Overall Study||19
8520097|NCT00389857|21000735|P2|NOT COMPLETED|Overall Study||0
8520098|NCT00389857|21000736|P1|NOT COMPLETED|Overall Study||0
8520099|NCT00389857|21000735|P2|COMPLETED|Overall Study||17
8520100|NCT00389857|21000736|P1|COMPLETED|Overall Study||14
8520101|NCT00389857|21000735|P2|STARTED|Overall Study||17
8520102|NCT00389857|21000736|P1|STARTED|Overall Study||14
8520103|NCT00389831|21000748|P2|NOT COMPLETED|Overall Study||7
8520104|NCT00389831|21000749|P1|NOT COMPLETED|Overall Study||0
8520105|NCT00389831|21000748|P2|COMPLETED|Overall Study||27
8520106|NCT00389831|21000749|P1|COMPLETED|Overall Study||10
8520107|NCT00389831|21000748|P2|STARTED|Overall Study||34
8520108|NCT00389831|21000749|P1|STARTED|Overall Study||10
8520109|NCT00389818|21000775|P1|NOT COMPLETED|Overall Study||3
8520110|NCT00389818|21000775|P1|COMPLETED|Overall Study||40
8520111|NCT00389818|21000775|P1|STARTED|Overall Study||43
8520112|NCT00389805|21000781|P2|NOT COMPLETED|Phase II||0
8520113|NCT00389805|21000782|P1|NOT COMPLETED|Phase II||0
8520114|NCT00389805|21000781|P2|COMPLETED|Phase II||0
8520115|NCT00389805|21000782|P1|COMPLETED|Phase II||0
8520116|NCT00389805|21000781|P2|STARTED|Phase II|The Phase II study was not conducted.|0
8520117|NCT00389805|21000782|P1|STARTED|Phase II|The Phase II study was not conducted.|0
8520118|NCT00389805|21000781|P2|NOT COMPLETED|Phase I||0
8520119|NCT00389805|21000782|P1|NOT COMPLETED|Phase I||0
8520120|NCT00389805|21000781|P2|COMPLETED|Phase I||12
8520121|NCT00389805|21000782|P1|COMPLETED|Phase I||15
8520122|NCT00389805|21000781|P2|STARTED|Phase I||12
8520123|NCT00389805|21000782|P1|STARTED|Phase I||15
8520124|NCT00389597|21000812|P4|NOT COMPLETED|Overall Study||6
8520125|NCT00389597|21000813|P3|NOT COMPLETED|Overall Study||4
8520126|NCT00389597|21000814|P2|NOT COMPLETED|Overall Study||6
8520127|NCT00389597|21000815|P1|NOT COMPLETED|Overall Study||8
8520128|NCT00389597|21000812|P4|COMPLETED|Overall Study||99
8520129|NCT00389597|21000813|P3|COMPLETED|Overall Study||221
8520130|NCT00389597|21000814|P2|COMPLETED|Overall Study||75
8520131|NCT00389597|21000815|P1|COMPLETED|Overall Study||156
8520132|NCT00389597|21000812|P4|24 mo|Overall Study||99
8520133|NCT00389597|21000813|P3|24 mo|Overall Study||221
8520134|NCT00389597|21000814|P2|24 mo|Overall Study||75
8520135|NCT00389597|21000815|P1|24 mo|Overall Study||156
8520136|NCT00389597|21000812|P4|STARTED|Overall Study||105
8520137|NCT00389597|21000813|P3|STARTED|Overall Study||225
8520138|NCT00389597|21000814|P2|STARTED|Overall Study||81
8520139|NCT00389597|21000815|P1|STARTED|Overall Study||164
8520140|NCT00389532|21000827|P2|NOT COMPLETED|Overall Study||0
8520141|NCT00389532|21000828|P1|NOT COMPLETED|Overall Study||0
8520142|NCT00389532|21000827|P2|COMPLETED|Overall Study||56
8520143|NCT00389532|21000828|P1|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
8520144|NCT00389532|21000827|P2|STARTED|Overall Study||56
8520145|NCT00389532|21000828|P1|STARTED|Overall Study||60
8520146|NCT00389519|21000840|P4|NOT COMPLETED|Treated||4
8520147|NCT00389519|21000841|P3|NOT COMPLETED|Treated||0
8520148|NCT00389519|21000842|P2|NOT COMPLETED|Treated||1
8520149|NCT00389519|21000843|P1|NOT COMPLETED|Treated||2
8520150|NCT00389519|21000840|P4|COMPLETED|Treated||76
8520151|NCT00389519|21000841|P3|COMPLETED|Treated||40
8520152|NCT00389519|21000842|P2|COMPLETED|Treated||40
8520153|NCT00389519|21000843|P1|COMPLETED|Treated||79
8520154|NCT00389519|21000840|P4|STARTED|Treated||80
8520155|NCT00389519|21000841|P3|STARTED|Treated||40
8520156|NCT00389519|21000842|P2|STARTED|Treated||41
8520157|NCT00389519|21000843|P1|STARTED|Treated||81
8520158|NCT00389519|21000840|P4|NOT COMPLETED|Randomized||0
8520159|NCT00389519|21000841|P3|NOT COMPLETED|Randomized||0
8520160|NCT00389519|21000842|P2|NOT COMPLETED|Randomized||0
8520161|NCT00389519|21000843|P1|NOT COMPLETED|Randomized||2
8520162|NCT00389519|21000840|P4|COMPLETED|Randomized||80
8520163|NCT00389519|21000841|P3|COMPLETED|Randomized||40
8520164|NCT00389519|21000842|P2|COMPLETED|Randomized||41
8520165|NCT00389519|21000843|P1|COMPLETED|Randomized||81
8520166|NCT00389519|21000840|P4|STARTED|Randomized||80
8520167|NCT00389519|21000841|P3|STARTED|Randomized||40
8520168|NCT00389519|21000842|P2|STARTED|Randomized||41
8520169|NCT00389519|21000843|P1|STARTED|Randomized||83
8520170|NCT00389519|21000840|P4|NOT COMPLETED|Placebo Run-In||0
8520171|NCT00389519|21000841|P3|NOT COMPLETED|Placebo Run-In||0
8520172|NCT00389519|21000842|P2|NOT COMPLETED|Placebo Run-In||0
8520173|NCT00389519|21000843|P1|NOT COMPLETED|Placebo Run-In||178
8520174|NCT00389519|21000840|P4|COMPLETED|Placebo Run-In||0
8520175|NCT00389519|21000841|P3|COMPLETED|Placebo Run-In||0
8520176|NCT00389519|21000842|P2|COMPLETED|Placebo Run-In||0
8520177|NCT00389519|21000843|P1|COMPLETED|Placebo Run-In||244
8520178|NCT00389519|21000840|P4|STARTED|Placebo Run-In||0
8520179|NCT00389519|21000841|P3|STARTED|Placebo Run-In||0
8520180|NCT00389519|21000842|P2|STARTED|Placebo Run-In||0
8520181|NCT00389519|21000843|P1|STARTED|Placebo Run-In||422
8520182|NCT00389493|21000872|P3|NOT COMPLETED|Overall Study||3
8520183|NCT00389493|21000873|P2|NOT COMPLETED|Overall Study||8
8520184|NCT00389493|21000874|P1|NOT COMPLETED|Overall Study||3
8520185|NCT00389493|21000872|P3|COMPLETED|Overall Study||17
8520186|NCT00389493|21000873|P2|COMPLETED|Overall Study||32
8520187|NCT00389493|21000874|P1|COMPLETED|Overall Study||37
8520188|NCT00389493|21000872|P3|STARTED|Overall Study||20
8520189|NCT00389493|21000873|P2|STARTED|Overall Study||40
8520190|NCT00389493|21000874|P1|STARTED|Overall Study||40
8520191|NCT00389467|21000898|P4|NOT COMPLETED|Overall Study||0
8520192|NCT00389467|21000899|P3|NOT COMPLETED|Overall Study||0
8520193|NCT00389467|21000900|P2|NOT COMPLETED|Overall Study||0
8520194|NCT00389467|21000901|P1|NOT COMPLETED|Overall Study||0
8520195|NCT00389467|21000898|P4|COMPLETED|Overall Study||20
8520196|NCT00389467|21000899|P3|COMPLETED|Overall Study||30
8520197|NCT00389467|21000900|P2|COMPLETED|Overall Study||34
8520198|NCT00389467|21000901|P1|COMPLETED|Overall Study||34
8520199|NCT00389467|21000898|P4|STARTED|Overall Study||20
8520200|NCT00389467|21000899|P3|STARTED|Overall Study||30
8520201|NCT00389467|21000900|P2|STARTED|Overall Study||34
8520202|NCT00389467|21000901|P1|STARTED|Overall Study||34
8520203|NCT00389441|21000920|P1|NOT COMPLETED|Overall Study||52
8520204|NCT00389441|21000920|P1|COMPLETED|Overall Study||0
8520205|NCT00389441|21000920|P1|STARTED|Overall Study||52
8520206|NCT00389324|21000929|P1|NOT COMPLETED|Subcutaneous Phase||7
8520207|NCT00389324|21000929|P1|COMPLETED|Subcutaneous Phase||25
8520208|NCT00389324|21000929|P1|STARTED|Subcutaneous Phase||32
8520209|NCT00389324|21000929|P1|NOT COMPLETED|Intravenous Phase||0
8520210|NCT00389324|21000929|P1|COMPLETED|Intravenous Phase||32
8520296|NCT00388414|21001228|P2|STARTED|Second Intervention (8 Weeks)||7
8520211|NCT00389324|21000929|P1|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
8520212|NCT00389324|21000929|P1|NOT COMPLETED|Run-In Phase||3
8520213|NCT00389324|21000929|P1|COMPLETED|Run-In Phase||18
8520214|NCT00389324|21000929|P1|STARTED|Run-In Phase||21
8520215|NCT00389207|21000939|P3|NOT COMPLETED|Overall Study||41
8520216|NCT00389207|21000940|P2|NOT COMPLETED|Overall Study||72
8520217|NCT00389207|21000941|P1|NOT COMPLETED|Overall Study||63
8520218|NCT00389207|21000939|P3|COMPLETED|Overall Study||152
8520219|NCT00389207|21000940|P2|COMPLETED|Overall Study||116
8520220|NCT00389207|21000941|P1|COMPLETED|Overall Study||125
8520221|NCT00389207|21000939|P3|STARTED|Overall Study||193
8520222|NCT00389207|21000940|P2|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
8520223|NCT00389207|21000941|P1|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
8520224|NCT00389168|21001045|P2|NOT COMPLETED|Overall Study||5
8520225|NCT00389168|21001046|P1|NOT COMPLETED|Overall Study||9
8520226|NCT00389168|21001045|P2|COMPLETED|Overall Study||53
8520227|NCT00389168|21001046|P1|COMPLETED|Overall Study||47
8520228|NCT00389168|21001045|P2|STARTED|Overall Study||58
8520229|NCT00389168|21001046|P1|STARTED|Overall Study||56
8520230|NCT00389064|21001064|P2|NOT COMPLETED|Overall Study||59
8520231|NCT00389064|21001065|P1|NOT COMPLETED|Overall Study||45
8520232|NCT00389064|21001064|P2|COMPLETED|Overall Study||168
8520233|NCT00389064|21001065|P1|COMPLETED|Overall Study||178
8520234|NCT00389064|21001064|P2|STARTED|Overall Study||227
8520235|NCT00389064|21001065|P1|STARTED|Overall Study||223
8520236|NCT00388973|21001093|P2|NOT COMPLETED|Overall Study||58
8520237|NCT00388973|21001094|P1|NOT COMPLETED|Overall Study||56
8520238|NCT00388973|21001093|P2|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
8520239|NCT00388973|21001094|P1|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
8520240|NCT00388973|21001093|P2|Completed Study|Overall Study||114
8520241|NCT00388973|21001094|P1|Completed Study|Overall Study||110
8520242|NCT00388973|21001093|P2|STARTED|Overall Study|Randomized|172
8520243|NCT00388973|21001094|P1|STARTED|Overall Study|Randomized|166
8520244|NCT00388947|21001114|P1|NOT COMPLETED|Overall Study||47
8520245|NCT00388947|21001114|P1|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
8520246|NCT00388947|21001114|P1|STARTED|Overall Study||1590
8520247|NCT00388804|21001121|P2|NOT COMPLETED|Overall Study||0
8520248|NCT00388804|21001122|P1|NOT COMPLETED|Overall Study||0
8520249|NCT00388804|21001121|P2|COMPLETED|Overall Study||21
8520250|NCT00388804|21001122|P1|COMPLETED|Overall Study||17
8520251|NCT00388804|21001121|P2|STARTED|Overall Study||21
8520252|NCT00388804|21001122|P1|STARTED|Overall Study||17
8520253|NCT00388726|21001130|P2|NOT COMPLETED|Overall Study||244
8520254|NCT00388726|21001131|P1|NOT COMPLETED|Overall Study||484
8520255|NCT00388726|21001130|P2|COMPLETED|Overall Study||10
8520256|NCT00388726|21001131|P1|COMPLETED|Overall Study||24
8520257|NCT00388726|21001130|P2|STARTED|Overall Study||254
8520258|NCT00388726|21001131|P1|STARTED|Overall Study||508
8520259|NCT00388674|21001147|P2|NOT COMPLETED|End of Study||2169
8520260|NCT00388674|21001148|P1|NOT COMPLETED|End of Study||1734
8520261|NCT00388674|21001147|P2|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|3993
8520262|NCT00388674|21001148|P1|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|4482
8520263|NCT00388674|21001147|P2|STARTED|End of Study||6162
8520264|NCT00388674|21001148|P1|STARTED|End of Study||6216
8520265|NCT00388674|21001147|P2|NOT COMPLETED|Initial Treatment||2586
8520266|NCT00388674|21001148|P1|NOT COMPLETED|Initial Treatment||1828
8520267|NCT00388674|21001147|P2|COMPLETED|Initial Treatment|"Completed=discontinued initial treatment reason of successful treatment or end of study"|3576
8520268|NCT00388674|21001148|P1|COMPLETED|Initial Treatment|Completed=Reason of 'successful treatment', 'other: successful treatment' or 'other: end of study'|4388
8520269|NCT00388674|21001147|P2|STARTED|Initial Treatment||6162
8520270|NCT00388674|21001148|P1|STARTED|Initial Treatment||6216
8520271|NCT00388583|21001166|P2|NOT COMPLETED|Overall Study||4
8520272|NCT00388583|21001167|P1|NOT COMPLETED|Overall Study||6
8520273|NCT00388583|21001166|P2|COMPLETED|Overall Study||406
8520274|NCT00388583|21001167|P1|COMPLETED|Overall Study||401
8520275|NCT00388583|21001166|P2|STARTED|Overall Study||410
8520276|NCT00388583|21001167|P1|STARTED|Overall Study||407
8520277|NCT00388505|21001181|P2|NOT COMPLETED|Overall Study||38
8520278|NCT00388505|21001182|P1|NOT COMPLETED|Overall Study||83
8520279|NCT00388505|21001181|P2|COMPLETED|Overall Study||171
8520280|NCT00388505|21001182|P1|COMPLETED|Overall Study||225
8520281|NCT00388505|21001181|P2|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
8520282|NCT00388505|21001182|P1|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
8520283|NCT00388453|21001207|P3|NOT COMPLETED|Overall Study||0
8520284|NCT00388453|21001208|P2|NOT COMPLETED|Overall Study||0
8520285|NCT00388453|21001209|P1|NOT COMPLETED|Overall Study||0
8520286|NCT00388453|21001207|P3|COMPLETED|Overall Study||10
8520287|NCT00388453|21001208|P2|COMPLETED|Overall Study||17
8520288|NCT00388453|21001209|P1|COMPLETED|Overall Study||20
8520289|NCT00388453|21001207|P3|STARTED|Overall Study||10
8520290|NCT00388453|21001208|P2|STARTED|Overall Study||17
8520291|NCT00388453|21001209|P1|STARTED|Overall Study||20
8520292|NCT00388414|21001228|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
8520293|NCT00388414|21001229|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
8520294|NCT00388414|21001228|P2|COMPLETED|Second Intervention (8 Weeks)||7
8520295|NCT00388414|21001229|P1|COMPLETED|Second Intervention (8 Weeks)||7
8520297|NCT00388414|21001229|P1|STARTED|Second Intervention (8 Weeks)||7
8520298|NCT00388414|21001228|P2|NOT COMPLETED|Washout (1 Week)||0
8520299|NCT00388414|21001229|P1|NOT COMPLETED|Washout (1 Week)||0
8520300|NCT00388414|21001228|P2|COMPLETED|Washout (1 Week)||7
8520301|NCT00388414|21001229|P1|COMPLETED|Washout (1 Week)||7
8520302|NCT00388414|21001228|P2|STARTED|Washout (1 Week)||7
8520303|NCT00388414|21001229|P1|STARTED|Washout (1 Week)||7
8520304|NCT00388414|21001228|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
8520305|NCT00388414|21001229|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
8520306|NCT00388414|21001228|P2|COMPLETED|First Intervention (8 Weeks)||7
8520307|NCT00388414|21001229|P1|COMPLETED|First Intervention (8 Weeks)||7
8520308|NCT00388414|21001228|P2|STARTED|First Intervention (8 Weeks)||7
8520309|NCT00388414|21001229|P1|STARTED|First Intervention (8 Weeks)||7
8520310|NCT00388362|21001237|P1|NOT COMPLETED|Remained on Study Median of 514 Days||2
8520311|NCT00388362|21001237|P1|COMPLETED|Remained on Study Median of 514 Days||21
8520312|NCT00388362|21001237|P1|STARTED|Remained on Study Median of 514 Days||23
8520313|NCT00388362|21001237|P1|NOT COMPLETED|Enrolled||13
8520314|NCT00388362|21001237|P1|COMPLETED|Enrolled||23
8520315|NCT00388362|21001237|P1|STARTED|Enrolled||36
8520316|NCT00388349|21001242|P2|NOT COMPLETED|Phase 2 Dose Expansion||0
8520317|NCT00388349|21001243|P1|NOT COMPLETED|Phase 2 Dose Expansion||0
8520318|NCT00388349|21001242|P2|COMPLETED|Phase 2 Dose Expansion||0
8520319|NCT00388349|21001243|P1|COMPLETED|Phase 2 Dose Expansion||139
8520320|NCT00388349|21001242|P2|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
8520321|NCT00388349|21001243|P1|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
8520322|NCT00388349|21001242|P2|NOT COMPLETED|Phase I Dose Escalation||3
8520323|NCT00388349|21001243|P1|NOT COMPLETED|Phase I Dose Escalation||0
8520324|NCT00388349|21001242|P2|COMPLETED|Phase I Dose Escalation||1
8520325|NCT00388349|21001243|P1|COMPLETED|Phase I Dose Escalation||3
8520326|NCT00388349|21001242|P2|STARTED|Phase I Dose Escalation||4
8520327|NCT00388349|21001243|P1|STARTED|Phase I Dose Escalation||3
8520328|NCT00388297|21001256|P4|NOT COMPLETED|Overall Study||8
8520329|NCT00388297|21001257|P3|NOT COMPLETED|Overall Study||11
8520330|NCT00388297|21001258|P2|NOT COMPLETED|Overall Study||12
8520331|NCT00388297|21001259|P1|NOT COMPLETED|Overall Study||16
8520332|NCT00388297|21001256|P4|COMPLETED|Overall Study||253
8520333|NCT00388297|21001257|P3|COMPLETED|Overall Study||254
8520334|NCT00388297|21001258|P2|COMPLETED|Overall Study||326
8520335|NCT00388297|21001259|P1|COMPLETED|Overall Study||323
8520336|NCT00388297|21001256|P4|STARTED|Overall Study||261
8520337|NCT00388297|21001257|P3|STARTED|Overall Study||265
8520338|NCT00388297|21001258|P2|STARTED|Overall Study||338
8520339|NCT00388297|21001259|P1|STARTED|Overall Study||339
8520340|NCT00388154|21001369|P1|NOT COMPLETED|Overall Study||1
8520341|NCT00388154|21001369|P1|COMPLETED|Overall Study||20
8520342|NCT00388154|21001369|P1|STARTED|Overall Study||21
8520343|NCT00388037|21001374|P1|NOT COMPLETED|Overall Study||1
8520344|NCT00388037|21001374|P1|COMPLETED|Overall Study||30
8520345|NCT00388037|21001374|P1|STARTED|Overall Study||31
8520346|NCT00387959|21001378|P1|NOT COMPLETED|Overall Study||1
8520347|NCT00387959|21001378|P1|COMPLETED|Overall Study||16
8520348|NCT00387959|21001378|P1|STARTED|Overall Study||17
8520349|NCT00387894|21001382|P1|NOT COMPLETED|Overall Study||1
8520350|NCT00387894|21001382|P1|COMPLETED|Overall Study||5
8520351|NCT00387894|21001382|P1|STARTED|Overall Study||6
8520352|NCT00387881|21001389|P2|NOT COMPLETED|Overall Study||102
8520353|NCT00387881|21001390|P1|NOT COMPLETED|Overall Study||89
8520354|NCT00387881|21001389|P2|COMPLETED|Overall Study||243
8520355|NCT00387881|21001390|P1|COMPLETED|Overall Study||245
8520356|NCT00387881|21001389|P2|STARTED|Overall Study||345
8520357|NCT00387881|21001390|P1|STARTED|Overall Study||334
8520358|NCT00387829|21001414|P2|NOT COMPLETED|Intent-to-treat Population||30
8520359|NCT00387829|21001415|P1|NOT COMPLETED|Intent-to-treat Population||38
8520360|NCT00387829|21001414|P2|COMPLETED|Intent-to-treat Population||136
8520361|NCT00387829|21001415|P1|COMPLETED|Intent-to-treat Population||139
8520362|NCT00387829|21001414|P2|STARTED|Intent-to-treat Population||166
8520363|NCT00387829|21001415|P1|STARTED|Intent-to-treat Population||177
8520364|NCT00387829|21001414|P2|NOT COMPLETED|Safety Population||33
8520365|NCT00387829|21001415|P1|NOT COMPLETED|Safety Population||39
8520366|NCT00387829|21001414|P2|COMPLETED|Safety Population||136
8520367|NCT00387829|21001415|P1|COMPLETED|Safety Population||139
8520368|NCT00387829|21001414|P2|STARTED|Safety Population||169
8520369|NCT00387829|21001415|P1|STARTED|Safety Population||178
8520370|NCT00387790|21001423|P1|NOT COMPLETED|Overall Study||14
8520371|NCT00387790|21001423|P1|COMPLETED|Overall Study||50
8520372|NCT00387790|21001423|P1|STARTED|Overall Study||64
8520373|NCT00387764|21001429|P1|NOT COMPLETED|Overall Study||31
8520374|NCT00387764|21001429|P1|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
8520375|NCT00387764|21001429|P1|STARTED|Overall Study||80
8520376|NCT00387751|21001447|P1|NOT COMPLETED|Overall Study||0
8520377|NCT00387751|21001447|P1|COMPLETED|Overall Study||14
8520378|NCT00387751|21001447|P1|STARTED|Overall Study||14
8520379|NCT00387725|21001457|P4|NOT COMPLETED|Overall Study||2
8520380|NCT00387725|21001458|P3|NOT COMPLETED|Overall Study||2
8520381|NCT00387725|21001459|P2|NOT COMPLETED|Overall Study||1
8520382|NCT00387725|21001460|P1|NOT COMPLETED|Overall Study||1
8520383|NCT00387725|21001457|P4|COMPLETED|Overall Study||43
8520384|NCT00387725|21001458|P3|COMPLETED|Overall Study||43
8520385|NCT00387725|21001459|P2|COMPLETED|Overall Study||15
8520386|NCT00387725|21001460|P1|COMPLETED|Overall Study||20
8520387|NCT00387725|21001457|P4|STARTED|Overall Study||45
8520388|NCT00387725|21001458|P3|STARTED|Overall Study||45
8520389|NCT00387725|21001459|P2|STARTED|Overall Study||16
8520390|NCT00387725|21001460|P1|STARTED|Overall Study||21
8520391|NCT00387712|21001480|P2|NOT COMPLETED|Overall Study||36
8520392|NCT00387712|21001481|P1|NOT COMPLETED|Overall Study||29
8520393|NCT00387712|21001480|P2|COMPLETED|Overall Study||16
8520394|NCT00387712|21001481|P1|COMPLETED|Overall Study||18
8520395|NCT00387712|21001480|P2|STARTED|Overall Study||52
8520396|NCT00387712|21001481|P1|STARTED|Overall Study||47
8520397|NCT00387673|21001491|P3|NOT COMPLETED|Overall Study||0
8520398|NCT00387673|21001492|P2|NOT COMPLETED|Overall Study||0
8520399|NCT00387673|21001493|P1|NOT COMPLETED|Overall Study||0
8520400|NCT00387673|21001491|P3|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
8520401|NCT00387673|21001492|P2|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
8520402|NCT00387673|21001493|P1|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
8520403|NCT00387673|21001491|P3|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
8520404|NCT00387673|21001492|P2|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
8520405|NCT00387673|21001493|P1|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
8520406|NCT00387660|21001501|P2|NOT COMPLETED|Overall Study||0
8520407|NCT00387660|21001502|P1|NOT COMPLETED|Overall Study||0
8520408|NCT00387660|21001501|P2|COMPLETED|Overall Study||40
8520409|NCT00387660|21001502|P1|COMPLETED|Overall Study||40
8520410|NCT00387660|21001501|P2|STARTED|Overall Study||40
8520411|NCT00387660|21001502|P1|STARTED|Overall Study||40
8520412|NCT00387647|21001512|P1|NOT COMPLETED|Overall Study||18
8520413|NCT00387647|21001512|P1|COMPLETED|Overall Study||6
8520414|NCT00387647|21001512|P1|STARTED|Overall Study||24
8520415|NCT00387621|21001521|P2|NOT COMPLETED|Second Intervention||0
8520416|NCT00387621|21001522|P1|NOT COMPLETED|Second Intervention||0
8520417|NCT00387621|21001521|P2|COMPLETED|Second Intervention||29
8520418|NCT00387621|21001522|P1|COMPLETED|Second Intervention||29
8520419|NCT00387621|21001521|P2|STARTED|Second Intervention||29
8520420|NCT00387621|21001522|P1|STARTED|Second Intervention||29
8520421|NCT00387621|21001521|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8520422|NCT00387621|21001522|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8520423|NCT00387621|21001521|P2|COMPLETED|Washout Period of 2 Weeks||29
8520424|NCT00387621|21001522|P1|COMPLETED|Washout Period of 2 Weeks||29
8520425|NCT00387621|21001521|P2|STARTED|Washout Period of 2 Weeks||29
8520426|NCT00387621|21001522|P1|STARTED|Washout Period of 2 Weeks||29
8520427|NCT00387621|21001521|P2|NOT COMPLETED|First Intervention||0
8520428|NCT00387621|21001522|P1|NOT COMPLETED|First Intervention||0
8520429|NCT00387621|21001521|P2|COMPLETED|First Intervention||29
8520430|NCT00387621|21001522|P1|COMPLETED|First Intervention||29
8520431|NCT00387621|21001521|P2|STARTED|First Intervention||29
8520432|NCT00387621|21001522|P1|STARTED|First Intervention||29
8520433|NCT00387465|21001555|P3|NOT COMPLETED|Overall Study||0
8520434|NCT00387465|21001556|P2|NOT COMPLETED|Overall Study||1
8520435|NCT00387465|21001557|P1|NOT COMPLETED|Overall Study||0
8520436|NCT00387465|21001555|P3|COMPLETED|Overall Study||35
8520437|NCT00387465|21001556|P2|COMPLETED|Overall Study||6
8520438|NCT00387465|21001557|P1|COMPLETED|Overall Study||3
8520439|NCT00387465|21001555|P3|STARTED|Overall Study||35
8520440|NCT00387465|21001556|P2|STARTED|Overall Study||7
8520441|NCT00387465|21001557|P1|STARTED|Overall Study||3
8520442|NCT00387426|21001574|P1|NOT COMPLETED|Overall Study||14
8520443|NCT00387426|21001574|P1|COMPLETED|Overall Study||0
8520444|NCT00387426|21001574|P1|STARTED|Overall Study||14
8520445|NCT00387348|21001581|P3|NOT COMPLETED|Overall Study||4
8520446|NCT00387348|21001582|P2|NOT COMPLETED|Overall Study||3
8520447|NCT00387348|21001583|P1|NOT COMPLETED|Overall Study||3
8520448|NCT00387348|21001581|P3|COMPLETED|Overall Study||7
8520449|NCT00387348|21001582|P2|COMPLETED|Overall Study||2
8520450|NCT00387348|21001583|P1|COMPLETED|Overall Study||5
8520451|NCT00387348|21001581|P3|STARTED|Overall Study||11
8520452|NCT00387348|21001582|P2|STARTED|Overall Study||5
8520453|NCT00387348|21001583|P1|STARTED|Overall Study||8
8520454|NCT00387335|21001599|P2|NOT COMPLETED|Overall Study||0
8520455|NCT00387335|21001600|P1|NOT COMPLETED|Overall Study||0
8520456|NCT00387335|21001599|P2|COMPLETED|Overall Study||7
8520457|NCT00387335|21001600|P1|COMPLETED|Overall Study||15
8520458|NCT00387335|21001599|P2|STARTED|Overall Study||7
8520459|NCT00387335|21001600|P1|STARTED|Overall Study||15
8520460|NCT00387244|21001612|P1|NOT COMPLETED|Overall Study||7
8520461|NCT00387244|21001612|P1|COMPLETED|Overall Study||0
8520462|NCT00387244|21001612|P1|End of Trial|Overall Study||0
8520463|NCT00387244|21001612|P1|STARTED|Overall Study||7
8520464|NCT00387153|21001616|P1|NOT COMPLETED|Overall Study||8
8520465|NCT00387153|21001616|P1|COMPLETED|Overall Study||0
8520466|NCT00387153|21001616|P1|STARTED|Overall Study||8
8520467|NCT00387127|21001622|P2|NOT COMPLETED|Overall Study||34
8520468|NCT00387127|21001623|P1|NOT COMPLETED|Overall Study||33
8520469|NCT00387127|21001622|P2|COMPLETED|Overall Study||0
8520470|NCT00387127|21001623|P1|COMPLETED|Overall Study||0
8520471|NCT00387127|21001622|P2|STARTED|Overall Study||34
8520472|NCT00387127|21001623|P1|STARTED|Overall Study||33
8520473|NCT00387088|21001665|P2|NOT COMPLETED|Overall Study||373
8520474|NCT00387088|21001666|P1|NOT COMPLETED|Overall Study||318
8520475|NCT00387088|21001665|P2|COMPLETED|Overall Study||1629
8520476|NCT00387088|21001666|P1|COMPLETED|Overall Study||1671
8520477|NCT00387088|21001665|P2|STARTED|Overall Study||2002
8520478|NCT00387088|21001666|P1|STARTED|Overall Study||1989
8520479|NCT00387036|21001710|P2|NOT COMPLETED|2-Week Crossover Second Intervention||0
8520480|NCT00387036|21001711|P1|NOT COMPLETED|2-Week Crossover Second Intervention||0
8520481|NCT00387036|21001710|P2|COMPLETED|2-Week Crossover Second Intervention||6
8520482|NCT00387036|21001711|P1|COMPLETED|2-Week Crossover Second Intervention||6
8520483|NCT00387036|21001710|P2|STARTED|2-Week Crossover Second Intervention||6
8520484|NCT00387036|21001711|P1|STARTED|2-Week Crossover Second Intervention||6
8520485|NCT00387036|21001710|P2|NOT COMPLETED|2-Week Placebo Washout||0
8520486|NCT00387036|21001711|P1|NOT COMPLETED|2-Week Placebo Washout||0
8520487|NCT00387036|21001710|P2|COMPLETED|2-Week Placebo Washout||6
8520488|NCT00387036|21001711|P1|COMPLETED|2-Week Placebo Washout||6
8520489|NCT00387036|21001710|P2|STARTED|2-Week Placebo Washout||6
8520490|NCT00387036|21001711|P1|STARTED|2-Week Placebo Washout||6
8520491|NCT00387036|21001710|P2|NOT COMPLETED|2-Week First Intervention||0
8520492|NCT00387036|21001711|P1|NOT COMPLETED|2-Week First Intervention||0
8520493|NCT00387036|21001710|P2|COMPLETED|2-Week First Intervention||6
8520494|NCT00387036|21001711|P1|COMPLETED|2-Week First Intervention||6
8520495|NCT00387036|21001710|P2|STARTED|2-Week First Intervention||6
8520496|NCT00387036|21001711|P1|STARTED|2-Week First Intervention||6
8520497|NCT00387023|21001719|P1|NOT COMPLETED|Overall Study||0
8520498|NCT00387023|21001719|P1|COMPLETED|Overall Study||12
8520499|NCT00387023|21001719|P1|STARTED|Overall Study||12
8520500|NCT00387010|21001723|P1|NOT COMPLETED|Treatment Period||11
8520501|NCT00387010|21001723|P1|COMPLETED|Treatment Period||169
8520502|NCT00387010|21001723|P1|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
8520503|NCT00387010|21001723|P1|STARTED|Treatment Period||180
8520504|NCT00387010|21001723|P1|NOT COMPLETED|Dose Titration Period||38
8520505|NCT00387010|21001723|P1|COMPLETED|Dose Titration Period||180
8520506|NCT00387010|21001723|P1|STARTED|Dose Titration Period||218
8520507|NCT00386880|21001744|P2|NOT COMPLETED|Overall Study||0
8520508|NCT00386880|21001745|P1|NOT COMPLETED|Overall Study||0
8520509|NCT00386880|21001744|P2|COMPLETED|Overall Study||8
8520510|NCT00386880|21001745|P1|COMPLETED|Overall Study||30
8520511|NCT00386880|21001744|P2|STARTED|Overall Study||8
8520512|NCT00386880|21001745|P1|STARTED|Overall Study||30
8520513|NCT00386776|21001750|P1|NOT COMPLETED|Overall Study||8
8520514|NCT00386776|21001750|P1|COMPLETED|Overall Study||32
8520515|NCT00386776|21001750|P1|STARTED|Overall Study||40
8520516|NCT00386724|21001760|P1|NOT COMPLETED|Overall Study||5
8520517|NCT00386724|21001760|P1|COMPLETED|Overall Study||3
8520518|NCT00386724|21001760|P1|3 Months Post-activation|Overall Study||4
8520519|NCT00386724|21001760|P1|STARTED|Overall Study||8
8520520|NCT00386607|21001764|P2|NOT COMPLETED|Extension||17
8520521|NCT00386607|21001765|P1|NOT COMPLETED|Extension||0
8520522|NCT00386607|21001764|P2|COMPLETED|Extension||145
8520523|NCT00386607|21001765|P1|COMPLETED|Extension||0
8520524|NCT00386607|21001764|P2|STARTED|Extension||162
8520525|NCT00386607|21001765|P1|STARTED|Extension||0
8520526|NCT00386607|21001764|P2|NOT COMPLETED|Core||0
8520527|NCT00386607|21001765|P1|NOT COMPLETED|Core||115
8520528|NCT00386607|21001764|P2|COMPLETED|Core||0
8520529|NCT00386607|21001765|P1|COMPLETED|Core||486
8520530|NCT00386607|21001764|P2|STARTED|Core||0
8520531|NCT00386607|21001765|P1|STARTED|Core||601
8520532|NCT00386477|21001783|P2|NOT COMPLETED|Overall Study||0
8520533|NCT00386477|21001784|P1|NOT COMPLETED|Overall Study||0
8520534|NCT00386477|21001783|P2|COMPLETED|Overall Study||145
8520535|NCT00386477|21001784|P1|COMPLETED|Overall Study||155
8520536|NCT00386477|21001783|P2|STARTED|Overall Study||145
8520537|NCT00386477|21001784|P1|STARTED|Overall Study||155
8520538|NCT00386425|21001793|P3|NOT COMPLETED|Overall Study||0
8520539|NCT00386425|21001794|P2|NOT COMPLETED|Overall Study||1
8520540|NCT00386425|21001795|P1|NOT COMPLETED|Overall Study||3
8520541|NCT00386425|21001793|P3|COMPLETED|Overall Study||53
8520542|NCT00386425|21001794|P2|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
8520543|NCT00386425|21001795|P1|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
8520544|NCT00386425|21001793|P3|Received Study Drug|Overall Study||53
8520545|NCT00386425|21001794|P2|Received Study Drug|Overall Study||206
8520546|NCT00386425|21001795|P1|Received Study Drug|Overall Study||227
8520547|NCT00386425|21001793|P3|STARTED|Overall Study||53
8520548|NCT00386425|21001794|P2|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
8520549|NCT00386425|21001795|P1|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
8520550|NCT00386360|21001821|P2|NOT COMPLETED|Overall Study||17
8520551|NCT00386360|21001822|P1|NOT COMPLETED|Overall Study||9
8520552|NCT00386360|21001821|P2|COMPLETED|Overall Study||95
8520553|NCT00386360|21001822|P1|COMPLETED|Overall Study||40
8520554|NCT00386360|21001821|P2|Primary Efficacy|Overall Study||77
8520555|NCT00386360|21001822|P1|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
8520556|NCT00386360|21001821|P2|Intent to Treat Population (ITT)|Overall Study||110
8520557|NCT00386360|21001822|P1|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
8520558|NCT00386360|21001821|P2|STARTED|Overall Study||112
8520559|NCT00386360|21001822|P1|STARTED|Overall Study||49
8520560|NCT00386334|21001856|P2|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
8520561|NCT00386334|21001857|P1|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
8520562|NCT00386334|21001856|P2|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
8520563|NCT00386334|21001857|P1|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
8520564|NCT00386334|21001856|P2|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
8520565|NCT00386334|21001857|P1|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
8520566|NCT00386334|21001856|P2|NOT COMPLETED|Double Blind Period||47
8520567|NCT00386334|21001857|P1|NOT COMPLETED|Double Blind Period||46
8520568|NCT00386334|21001856|P2|COMPLETED|Double Blind Period||147
8520569|NCT00386334|21001857|P1|COMPLETED|Double Blind Period||148
8520570|NCT00386334|21001856|P2|STARTED|Double Blind Period||194
8520571|NCT00386334|21001857|P1|STARTED|Double Blind Period||194
8520572|NCT00386308|21002001|P2|NOT COMPLETED|Overall Study||19
8520573|NCT00386308|21002002|P1|NOT COMPLETED|Overall Study||29
8520574|NCT00386308|21002001|P2|COMPLETED|Overall Study||54
8520575|NCT00386308|21002002|P1|COMPLETED|Overall Study||94
8520576|NCT00386308|21002001|P2|Modified Intent to Treat Population|Overall Study||72
8520577|NCT00386308|21002002|P1|Modified Intent to Treat Population|Overall Study||115
8520578|NCT00386308|21002001|P2|Intent to Treat Population|Overall Study||72
8520579|NCT00386308|21002002|P1|Intent to Treat Population|Overall Study||117
8520580|NCT00386308|21002001|P2|STARTED|Overall Study||73
8520581|NCT00386308|21002002|P1|STARTED|Overall Study||123
8520582|NCT00386256|21002018|P4|NOT COMPLETED|Overall Study||0
8520583|NCT00386256|21002019|P3|NOT COMPLETED|Overall Study||0
8520584|NCT00386256|21002020|P2|NOT COMPLETED|Overall Study||0
8520585|NCT00386256|21002021|P1|NOT COMPLETED|Overall Study||0
8520586|NCT00386256|21002018|P4|COMPLETED|Overall Study||3
8520587|NCT00386256|21002019|P3|COMPLETED|Overall Study||4
8520588|NCT00386256|21002020|P2|COMPLETED|Overall Study||15
8520589|NCT00386256|21002021|P1|COMPLETED|Overall Study||16
8520590|NCT00386256|21002018|P4|STARTED|Overall Study||3
8520591|NCT00386256|21002019|P3|STARTED|Overall Study||4
8520592|NCT00386256|21002020|P2|STARTED|Overall Study||15
8520593|NCT00386256|21002021|P1|STARTED|Overall Study||16
8520594|NCT00386243|21002037|P2|NOT COMPLETED|Overall Study||13
8520595|NCT00386243|21002038|P1|NOT COMPLETED|Overall Study||7
8520596|NCT00386243|21002037|P2|COMPLETED|Overall Study||108
8520597|NCT00386243|21002038|P1|COMPLETED|Overall Study||114
8520598|NCT00386243|21002037|P2|STARTED|Overall Study||121
8520599|NCT00386243|21002038|P1|STARTED|Overall Study||121
8520600|NCT00386152|21002059|P3|NOT COMPLETED|Overall Study||33
8520601|NCT00386152|21002060|P2|NOT COMPLETED|Overall Study||40
8520602|NCT00386152|21002061|P1|NOT COMPLETED|Overall Study||44
8520603|NCT00386152|21002059|P3|COMPLETED|Overall Study||42
8520604|NCT00386152|21002060|P2|COMPLETED|Overall Study||37
8520605|NCT00386152|21002061|P1|COMPLETED|Overall Study||31
8520606|NCT00386152|21002059|P3|STARTED|Overall Study|number of subjects treated|75
8520607|NCT00386152|21002060|P2|STARTED|Overall Study|number of subjects treated|77
8520608|NCT00386152|21002061|P1|STARTED|Overall Study|number of subjects treated|75
8520609|NCT00386100|21002080|P2|NOT COMPLETED|Overall Study||131
8520610|NCT00386100|21002081|P1|NOT COMPLETED|Overall Study||154
8520611|NCT00386100|21002080|P2|COMPLETED|Overall Study||217
8520612|NCT00386100|21002081|P1|COMPLETED|Overall Study||186
8520613|NCT00386100|21002080|P2|STARTED|Overall Study||348
8520614|NCT00386100|21002081|P1|STARTED|Overall Study||340
8520615|NCT00386022|21002145|P2|NOT COMPLETED|Plus Estrogen||1
8520616|NCT00386022|21002146|P1|NOT COMPLETED|Plus Estrogen||2
8520617|NCT00386022|21002145|P2|COMPLETED|Plus Estrogen||8
8520618|NCT00386022|21002146|P1|COMPLETED|Plus Estrogen||8
8520619|NCT00386022|21002145|P2|All Doses GnRH|Plus Estrogen||8
8520620|NCT00386022|21002146|P1|All Doses GnRH|Plus Estrogen||8
8520621|NCT00386022|21002145|P2|Estrogen Patch|Plus Estrogen||9
8520622|NCT00386022|21002146|P1|Estrogen Patch|Plus Estrogen||8
8520623|NCT00386022|21002145|P2|STARTED|Plus Estrogen||9
8520624|NCT00386022|21002146|P1|STARTED|Plus Estrogen||10
8520625|NCT00386022|21002145|P2|NOT COMPLETED|Baseline||0
8520626|NCT00386022|21002146|P1|NOT COMPLETED|Baseline||0
8520627|NCT00386022|21002145|P2|COMPLETED|Baseline||9
8520628|NCT00386022|21002146|P1|COMPLETED|Baseline||10
8520629|NCT00386022|21002145|P2|All Doses of GnRH|Baseline||9
8520630|NCT00386022|21002146|P1|All Doses of GnRH|Baseline||10
8520631|NCT00386022|21002145|P2|STARTED|Baseline||9
8520632|NCT00386022|21002146|P1|STARTED|Baseline||10
8520633|NCT00386009|21002156|P2|NOT COMPLETED|Overall Study||10
8520634|NCT00386009|21002157|P1|NOT COMPLETED|Overall Study||9
8520635|NCT00386009|21002156|P2|COMPLETED|Overall Study||89
8520636|NCT00386009|21002157|P1|COMPLETED|Overall Study||92
8520637|NCT00386009|21002156|P2|STARTED|Overall Study||99
8520638|NCT00386009|21002157|P1|STARTED|Overall Study||101
8520639|NCT00385996|21002195|P1|NOT COMPLETED|Overall Study||0
8520640|NCT00385996|21002195|P1|COMPLETED|Overall Study||22
8520641|NCT00385996|21002195|P1|STARTED|Overall Study||22
8520642|NCT00385944|21002204|P3|NOT COMPLETED|2nd Maintenance Dose Period||0
8520643|NCT00385944|21002205|P2|NOT COMPLETED|2nd Maintenance Dose Period||3
8520644|NCT00385944|21002206|P1|NOT COMPLETED|2nd Maintenance Dose Period||2
8520645|NCT00385944|21002204|P3|COMPLETED|2nd Maintenance Dose Period||0
8520646|NCT00385944|21002205|P2|COMPLETED|2nd Maintenance Dose Period||19
8520647|NCT00385944|21002206|P1|COMPLETED|2nd Maintenance Dose Period||22
8520648|NCT00385944|21002204|P3|STARTED|2nd Maintenance Dose Period||0
8520649|NCT00385944|21002205|P2|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
8520650|NCT00385944|21002206|P1|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
8520651|NCT00385944|21002204|P3|NOT COMPLETED|1st Maintenance Dose Period||0
8520652|NCT00385944|21002205|P2|NOT COMPLETED|1st Maintenance Dose Period||1
8520653|NCT00385944|21002206|P1|NOT COMPLETED|1st Maintenance Dose Period||4
8520654|NCT00385944|21002204|P3|COMPLETED|1st Maintenance Dose Period||0
8520655|NCT00385944|21002205|P2|COMPLETED|1st Maintenance Dose Period||24
8520656|NCT00385944|21002206|P1|COMPLETED|1st Maintenance Dose Period||25
8520657|NCT00385944|21002204|P3|STARTED|1st Maintenance Dose Period||0
8520658|NCT00385944|21002205|P2|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
8520659|NCT00385944|21002206|P1|STARTED|1st Maintenance Dose Period||29
8520660|NCT00385944|21002204|P3|NOT COMPLETED|Loading Dose||0
8520661|NCT00385944|21002205|P2|NOT COMPLETED|Loading Dose||0
8520662|NCT00385944|21002206|P1|NOT COMPLETED|Loading Dose||0
8520663|NCT00385944|21002204|P3|COMPLETED|Loading Dose||56
8520664|NCT00385944|21002205|P2|COMPLETED|Loading Dose||0
8520665|NCT00385944|21002206|P1|COMPLETED|Loading Dose||0
8520666|NCT00385944|21002204|P3|STARTED|Loading Dose||56
8520667|NCT00385944|21002205|P2|STARTED|Loading Dose||0
8520668|NCT00385944|21002206|P1|STARTED|Loading Dose||0
8520669|NCT00385918|21002249|P3|NOT COMPLETED|Intervention Phase After Randomization||0
8520670|NCT00385918|21002250|P2|NOT COMPLETED|Intervention Phase After Randomization||0
8520671|NCT00385918|21002251|P1|NOT COMPLETED|Intervention Phase After Randomization||3
8520672|NCT00385918|21002249|P3|COMPLETED|Intervention Phase After Randomization||0
8520673|NCT00385918|21002250|P2|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
8520674|NCT00385918|21002251|P1|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
8520675|NCT00385918|21002249|P3|STARTED|Intervention Phase After Randomization||0
8520676|NCT00385918|21002250|P2|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
8520677|NCT00385918|21002251|P1|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
8520678|NCT00385918|21002249|P3|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
8520679|NCT00385918|21002250|P2|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
8520680|NCT00385918|21002251|P1|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
8520681|NCT00385918|21002249|P3|COMPLETED|Feasibility & Baseline Measurement Phase||21
8520682|NCT00385918|21002250|P2|COMPLETED|Feasibility & Baseline Measurement Phase||0
8520683|NCT00385918|21002251|P1|COMPLETED|Feasibility & Baseline Measurement Phase||0
8520684|NCT00385918|21002249|P3|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
8520685|NCT00385918|21002250|P2|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
8520686|NCT00385918|21002251|P1|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
8520687|NCT00385918|21002249|P3|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
8520688|NCT00385918|21002250|P2|Number Eligible|Feasibility & Baseline Measurement Phase||0
8520689|NCT00385918|21002251|P1|Number Eligible|Feasibility & Baseline Measurement Phase||0
8520690|NCT00385918|21002249|P3|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
8520691|NCT00385918|21002250|P2|STARTED|Feasibility & Baseline Measurement Phase||0
8520692|NCT00385918|21002251|P1|STARTED|Feasibility & Baseline Measurement Phase||0
8520693|NCT00385840|21002275|P2|NOT COMPLETED|Overall Study||14
8520694|NCT00385840|21002276|P1|NOT COMPLETED|Overall Study||4
8520695|NCT00385840|21002275|P2|COMPLETED|Overall Study||531
8520696|NCT00385840|21002276|P1|COMPLETED|Overall Study||129
8520697|NCT00385840|21002275|P2|STARTED|Overall Study||545
8520698|NCT00385840|21002276|P1|STARTED|Overall Study||133
8520699|NCT00385827|21002299|P3|NOT COMPLETED|Part 2||48
8520700|NCT00385827|21002300|P2|NOT COMPLETED|Part 2||33
8520701|NCT00385827|21002301|P1|NOT COMPLETED|Part 2||0
8520702|NCT00385827|21002299|P3|COMPLETED|Part 2||0
8520703|NCT00385827|21002300|P2|COMPLETED|Part 2||16
8520704|NCT00385827|21002301|P1|COMPLETED|Part 2||0
8520705|NCT00385827|21002299|P3|Treated|Part 2||46
8520706|NCT00385827|21002300|P2|Treated|Part 2||47
8520707|NCT00385827|21002301|P1|Treated|Part 2||0
8520708|NCT00385827|21002299|P3|STARTED|Part 2||48
8520709|NCT00385827|21002300|P2|STARTED|Part 2||49
8520710|NCT00385827|21002301|P1|STARTED|Part 2||0
8520711|NCT00385827|21002299|P3|NOT COMPLETED|Part 1||0
8520712|NCT00385827|21002300|P2|NOT COMPLETED|Part 1||0
8520713|NCT00385827|21002301|P1|NOT COMPLETED|Part 1||9
8520714|NCT00385827|21002299|P3|COMPLETED|Part 1||0
8520715|NCT00385827|21002300|P2|COMPLETED|Part 1||0
8520716|NCT00385827|21002301|P1|COMPLETED|Part 1||0
8520717|NCT00385827|21002299|P3|Treated|Part 1||0
8520718|NCT00385827|21002300|P2|Treated|Part 1||0
8520719|NCT00385827|21002301|P1|Treated|Part 1||9
8520720|NCT00385827|21002299|P3|STARTED|Part 1||0
8520721|NCT00385827|21002300|P2|STARTED|Part 1||0
8520722|NCT00385827|21002301|P1|STARTED|Part 1||9
8520723|NCT00385801|21002323|P2|NOT COMPLETED|Overall Study||8
8520724|NCT00385801|21002324|P1|NOT COMPLETED|Overall Study||9
8520725|NCT00385801|21002323|P2|COMPLETED|Overall Study||8
8520726|NCT00385801|21002324|P1|COMPLETED|Overall Study||6
8520727|NCT00385801|21002323|P2|STARTED|Overall Study||16
8520728|NCT00385801|21002324|P1|STARTED|Overall Study||15
8520729|NCT00385788|21002338|P2|NOT COMPLETED|Overall Study||0
8520730|NCT00385788|21002339|P1|NOT COMPLETED|Overall Study||0
8520731|NCT00385788|21002338|P2|COMPLETED|Overall Study||40
8520732|NCT00385788|21002339|P1|COMPLETED|Overall Study||12
8520733|NCT00385788|21002338|P2|STARTED|Overall Study||40
8520734|NCT00385788|21002339|P1|STARTED|Overall Study||12
8520735|NCT00385762|21002345|P1|NOT COMPLETED|Overall Study||2
8520736|NCT00385762|21002345|P1|COMPLETED|Overall Study||33
8520737|NCT00385762|21002345|P1|STARTED|Overall Study||35
8520738|NCT00385736|21002355|P3|NOT COMPLETED|Safety Analysis Set||80
8520739|NCT00385736|21002356|P2|NOT COMPLETED|Safety Analysis Set||44
8520740|NCT00385736|21002357|P1|NOT COMPLETED|Safety Analysis Set||70
8520741|NCT00385736|21002355|P3|COMPLETED|Safety Analysis Set||143
8520742|NCT00385736|21002356|P2|COMPLETED|Safety Analysis Set||86
8520743|NCT00385736|21002357|P1|COMPLETED|Safety Analysis Set||153
8520744|NCT00385736|21002355|P3|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
8520745|NCT00385736|21002356|P2|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
8520746|NCT00385736|21002357|P1|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
8520747|NCT00385736|21002355|P3|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
8520748|NCT00385736|21002356|P2|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
8520749|NCT00385736|21002357|P1|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
8520750|NCT00385736|21002355|P3|COMPLETED|Efficacy Analysis Set - Maintenance||143
8520751|NCT00385736|21002356|P2|COMPLETED|Efficacy Analysis Set - Maintenance||86
8520752|NCT00385736|21002357|P1|COMPLETED|Efficacy Analysis Set - Maintenance||153
8520753|NCT00385736|21002355|P3|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
8520754|NCT00385736|21002356|P2|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
8520755|NCT00385736|21002357|P1|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
8520756|NCT00385736|21002355|P3|NOT COMPLETED|Efficacy Analysis Set - Induction||9
8520757|NCT00385736|21002356|P2|NOT COMPLETED|Efficacy Analysis Set - Induction||12
8520758|NCT00385736|21002357|P1|NOT COMPLETED|Efficacy Analysis Set - Induction||9
8520759|NCT00385736|21002355|P3|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
8520760|NCT00385736|21002356|P2|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
8520761|NCT00385736|21002357|P1|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
8520762|NCT00385736|21002355|P3|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
8520763|NCT00385736|21002356|P2|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
8520764|NCT00385736|21002357|P1|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
8520765|NCT00385723|21002402|P3|NOT COMPLETED|Overall Study||2
8520766|NCT00385723|21002403|P2|NOT COMPLETED|Overall Study||1
8520767|NCT00385723|21002404|P1|NOT COMPLETED|Overall Study||2
8520768|NCT00385723|21002402|P3|COMPLETED|Overall Study||44
8520769|NCT00385723|21002403|P2|COMPLETED|Overall Study||45
8520770|NCT00385723|21002404|P1|COMPLETED|Overall Study||44
8520771|NCT00385723|21002402|P3|STARTED|Overall Study||46
8520772|NCT00385723|21002403|P2|STARTED|Overall Study||46
8520773|NCT00385723|21002404|P1|STARTED|Overall Study||46
8520774|NCT00385684|21002418|P2|NOT COMPLETED|PHASE B||0
8520775|NCT00385684|21002419|P1|NOT COMPLETED|PHASE B||0
8520776|NCT00385684|21002418|P2|COMPLETED|PHASE B||3
8520777|NCT00385684|21002419|P1|COMPLETED|PHASE B||5
8520778|NCT00385684|21002418|P2|STARTED|PHASE B||3
8520779|NCT00385684|21002419|P1|STARTED|PHASE B||5
8520780|NCT00385684|21002418|P2|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
8520781|NCT00385684|21002419|P1|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
8520782|NCT00385684|21002418|P2|COMPLETED|SECOND INTERVENTION OF PHASE A||3
8520783|NCT00385684|21002419|P1|COMPLETED|SECOND INTERVENTION OF PHASE A||5
8520784|NCT00385684|21002418|P2|STARTED|SECOND INTERVENTION OF PHASE A||5
8520785|NCT00385684|21002419|P1|STARTED|SECOND INTERVENTION OF PHASE A||5
8520786|NCT00385684|21002418|P2|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
8520787|NCT00385684|21002419|P1|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
8520788|NCT00385684|21002418|P2|COMPLETED|FIRST INTERVENTION OF PHASE A||5
8520789|NCT00385684|21002419|P1|COMPLETED|FIRST INTERVENTION OF PHASE A||5
8520790|NCT00385684|21002418|P2|STARTED|FIRST INTERVENTION OF PHASE A||5
8520791|NCT00385684|21002419|P1|STARTED|FIRST INTERVENTION OF PHASE A||6
8520792|NCT00385671|21002428|P3|NOT COMPLETED|Overall Study||36
8520793|NCT00385671|21002429|P2|NOT COMPLETED|Overall Study||51
8520794|NCT00385671|21002430|P1|NOT COMPLETED|Overall Study||38
8520795|NCT00385671|21002428|P3|COMPLETED|Overall Study||99
8520796|NCT00385671|21002429|P2|COMPLETED|Overall Study||87
8520797|NCT00385671|21002430|P1|COMPLETED|Overall Study||96
8520798|NCT00385671|21002428|P3|STARTED|Overall Study||135
8520799|NCT00385671|21002429|P2|STARTED|Overall Study||138
8520800|NCT00385671|21002430|P1|STARTED|Overall Study||134
8520801|NCT00385593|21002586|P2|NOT COMPLETED|Overall Study||37
8520802|NCT00385593|21002587|P1|NOT COMPLETED|Overall Study||58
8520803|NCT00385593|21002586|P2|COMPLETED|Overall Study||289
8520804|NCT00385593|21002587|P1|COMPLETED|Overall Study||270
8520805|NCT00385593|21002586|P2|STARTED|Overall Study||326
8520806|NCT00385593|21002587|P1|STARTED|Overall Study||328
8520807|NCT00385580|21002605|P2|NOT COMPLETED|Overall Study||0
8520808|NCT00385580|21002606|P1|NOT COMPLETED|Overall Study||0
8520809|NCT00385580|21002605|P2|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
8520810|NCT00385580|21002606|P1|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
8520811|NCT00385580|21002605|P2|STARTED|Overall Study|Number of participants treated.|47
8520812|NCT00385580|21002606|P1|STARTED|Overall Study|Number of participants treated.|48
8520813|NCT00385541|21002697|P2|NOT COMPLETED|Overall Study||1
8520814|NCT00385541|21002698|P1|NOT COMPLETED|Overall Study||0
8520815|NCT00385541|21002697|P2|COMPLETED|Overall Study||24
8520816|NCT00385541|21002698|P1|COMPLETED|Overall Study||25
8520817|NCT00385541|21002697|P2|STARTED|Overall Study||25
8520818|NCT00385541|21002698|P1|STARTED|Overall Study||25
8520819|NCT00385515|21002714|P2|NOT COMPLETED|Overall Study||3
8520820|NCT00385515|21002715|P1|NOT COMPLETED|Overall Study||4
8520821|NCT00385515|21002714|P2|COMPLETED|Overall Study||21
8520822|NCT00385515|21002715|P1|COMPLETED|Overall Study||53
8520823|NCT00385515|21002714|P2|STARTED|Overall Study||24
8520824|NCT00385515|21002715|P1|STARTED|Overall Study||57
8520825|NCT00385268|21002723|P2|NOT COMPLETED|Overall Study||8
8520826|NCT00385268|21002724|P1|NOT COMPLETED|Overall Study||16
8520827|NCT00385268|21002723|P2|COMPLETED|Overall Study||18
8520828|NCT00385268|21002724|P1|COMPLETED|Overall Study||18
8520829|NCT00385268|21002723|P2|STARTED|Overall Study||26
8520830|NCT00385268|21002724|P1|STARTED|Overall Study||34
8520831|NCT00385255|21002732|P2|NOT COMPLETED|Overall Study||73
8520832|NCT00385255|21002733|P1|NOT COMPLETED|Overall Study||21
8520833|NCT00385255|21002732|P2|COMPLETED|Overall Study||785
8520834|NCT00385255|21002733|P1|COMPLETED|Overall Study||839
8520835|NCT00385255|21002732|P2|19-64 Years of Age (YOA) Cohort|Overall Study||749
8520836|NCT00385255|21002733|P1|19-64 Years of Age (YOA) Cohort|Overall Study||748
8520837|NCT00385255|21002732|P2|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
8520838|NCT00385255|21002733|P1|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
8520839|NCT00385255|21002732|P2|STARTED|Overall Study||858
8520840|NCT00385255|21002733|P1|STARTED|Overall Study||860
8520841|NCT00385216|21002797|P2|NOT COMPLETED|Second Intervention||0
8520842|NCT00385216|21002798|P1|NOT COMPLETED|Second Intervention||0
8520843|NCT00385216|21002797|P2|COMPLETED|Second Intervention||9
8520844|NCT00385216|21002798|P1|COMPLETED|Second Intervention||11
8520845|NCT00385216|21002797|P2|STARTED|Second Intervention||9
8520846|NCT00385216|21002798|P1|STARTED|Second Intervention||11
8520847|NCT00385216|21002797|P2|NOT COMPLETED|First Intervention||0
8520848|NCT00385216|21002798|P1|NOT COMPLETED|First Intervention||0
8520849|NCT00385216|21002797|P2|COMPLETED|First Intervention||9
8520850|NCT00385216|21002798|P1|COMPLETED|First Intervention||11
8520851|NCT00385216|21002797|P2|STARTED|First Intervention||9
8520852|NCT00385216|21002798|P1|STARTED|First Intervention||11
8520853|NCT00385203|21002812|P2|NOT COMPLETED|Overall Study||7
8520854|NCT00385203|21002813|P1|NOT COMPLETED|Overall Study||26
8520855|NCT00385203|21002812|P2|COMPLETED|Overall Study||3
8520856|NCT00385203|21002813|P1|COMPLETED|Overall Study||0
8520857|NCT00385203|21002812|P2|STARTED|Overall Study||10
8520858|NCT00385203|21002813|P1|STARTED|Overall Study||26
8520859|NCT00385138|21002833|P2|NOT COMPLETED|Overall Study||28
8520860|NCT00385138|21002834|P1|NOT COMPLETED|Overall Study||30
8520861|NCT00385138|21002833|P2|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
8520862|NCT00385138|21002834|P1|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
8520863|NCT00385138|21002833|P2|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
8520864|NCT00385138|21002834|P1|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
8520865|NCT00385138|21002833|P2|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
8520866|NCT00385138|21002834|P1|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
8520867|NCT00385138|21002833|P2|Intent-to-treat (ITT)|Overall Study||2669
8520868|NCT00385138|21002834|P1|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
8520869|NCT00385138|21002833|P2|STARTED|Overall Study||2669
8520870|NCT00385138|21002834|P1|STARTED|Overall Study||2695
8520871|NCT00385008|21002880|P2|NOT COMPLETED|Overall Study||0
8520872|NCT00385008|21002881|P1|NOT COMPLETED|Overall Study||0
8520873|NCT00385008|21002880|P2|COMPLETED|Overall Study||10
8520874|NCT00385008|21002881|P1|COMPLETED|Overall Study||10
8520875|NCT00385008|21002880|P2|In Presence of Migraine|Overall Study||5
8520876|NCT00385008|21002881|P1|In Presence of Migraine|Overall Study||5
8520877|NCT00385008|21002880|P2|In Absence of Migraine|Overall Study||10
8520878|NCT00385008|21002881|P1|In Absence of Migraine|Overall Study||10
8520879|NCT00385008|21002880|P2|STARTED|Overall Study||10
8520880|NCT00385008|21002881|P1|STARTED|Overall Study||10
8520881|NCT00384956|21002901|P1|NOT COMPLETED|Overall Study||3
8520882|NCT00384956|21002901|P1|COMPLETED|Overall Study||22
8520883|NCT00384956|21002901|P1|STARTED|Overall Study||25
8520884|NCT00384930|21002918|P5|NOT COMPLETED|Overall Study||47
8520885|NCT00384930|21002919|P4|NOT COMPLETED|Overall Study||41
8520886|NCT00384930|21002920|P3|NOT COMPLETED|Overall Study||30
8520887|NCT00384930|21002921|P2|NOT COMPLETED|Overall Study||27
8520888|NCT00384930|21002922|P1|NOT COMPLETED|Overall Study||27
8520889|NCT00384930|21002918|P5|COMPLETED|Overall Study||162
8520890|NCT00384930|21002919|P4|COMPLETED|Overall Study||175
8520891|NCT00384930|21002920|P3|COMPLETED|Overall Study||182
8520892|NCT00384930|21002921|P2|COMPLETED|Overall Study||182
8520893|NCT00384930|21002922|P1|COMPLETED|Overall Study||185
8520894|NCT00384930|21002918|P5|Received Double-Blind Study Drug|Overall Study||209
8520895|NCT00384930|21002919|P4|Received Double-Blind Study Drug|Overall Study||216
8520896|NCT00384930|21002920|P3|Received Double-Blind Study Drug|Overall Study||212
8520897|NCT00384930|21002921|P2|Received Double-Blind Study Drug|Overall Study||208
8520898|NCT00384930|21002922|P1|Received Double-Blind Study Drug|Overall Study||211
8520899|NCT00384930|21002918|P5|STARTED|Overall Study||209
8520900|NCT00384930|21002919|P4|STARTED|Overall Study||216
8520901|NCT00384930|21002920|P3|STARTED|Overall Study||212
8520902|NCT00384930|21002921|P2|STARTED|Overall Study||209
8520903|NCT00384930|21002922|P1|STARTED|Overall Study||212
8520904|NCT00384865|21002980|P4|NOT COMPLETED|Overall Study||0
8520905|NCT00384865|21002981|P3|NOT COMPLETED|Overall Study||0
8520906|NCT00384865|21002982|P2|NOT COMPLETED|Overall Study||0
8520907|NCT00384865|21002983|P1|NOT COMPLETED|Overall Study||0
8520908|NCT00384865|21002980|P4|COMPLETED|Overall Study||16
8520909|NCT00384865|21002981|P3|COMPLETED|Overall Study||16
8520910|NCT00384865|21002982|P2|COMPLETED|Overall Study||16
8520911|NCT00384865|21002983|P1|COMPLETED|Overall Study||16
8520912|NCT00384865|21002980|P4|Completed Six Month Assessment|Overall Study||11
8520913|NCT00384865|21002981|P3|Completed Six Month Assessment|Overall Study||15
8520914|NCT00384865|21002982|P2|Completed Six Month Assessment|Overall Study||12
8520915|NCT00384865|21002983|P1|Completed Six Month Assessment|Overall Study||11
8520916|NCT00384865|21002980|P4|STARTED|Overall Study||16
8520917|NCT00384865|21002981|P3|STARTED|Overall Study||16
8520918|NCT00384865|21002982|P2|STARTED|Overall Study||16
8520919|NCT00384865|21002983|P1|STARTED|Overall Study||16
8520920|NCT00384839|21003001|P1|NOT COMPLETED|Overall Study||8
8520921|NCT00384839|21003001|P1|COMPLETED|Overall Study||28
8520922|NCT00384839|21003001|P1|STARTED|Overall Study||36
8520923|NCT00384813|21003012|P2|NOT COMPLETED|Overall Study||0
8520924|NCT00384813|21003013|P1|NOT COMPLETED|Overall Study||2
8520925|NCT00384813|21003012|P2|COMPLETED|Overall Study||20
8520926|NCT00384813|21003013|P1|COMPLETED|Overall Study||21
8520927|NCT00384813|21003012|P2|STARTED|Overall Study||20
8520928|NCT00384813|21003013|P1|STARTED|Overall Study||23
8520929|NCT00384774|21003026|P7|NOT COMPLETED|Overall Study||0
8520930|NCT00384774|21003027|P6|NOT COMPLETED|Overall Study||0
8520931|NCT00384774|21003028|P5|NOT COMPLETED|Overall Study||0
8520932|NCT00384774|21003029|P4|NOT COMPLETED|Overall Study||0
8520933|NCT00384774|21003030|P3|NOT COMPLETED|Overall Study||0
8520934|NCT00384774|21003031|P2|NOT COMPLETED|Overall Study||0
8520935|NCT00384774|21003032|P1|NOT COMPLETED|Overall Study||0
8520936|NCT00384774|21003026|P7|COMPLETED|Overall Study||4
8520937|NCT00384774|21003027|P6|COMPLETED|Overall Study||16
8520938|NCT00384774|21003028|P5|COMPLETED|Overall Study||28
8520939|NCT00384774|21003029|P4|COMPLETED|Overall Study||24
8520940|NCT00384774|21003030|P3|COMPLETED|Overall Study||12
8520941|NCT00384774|21003031|P2|COMPLETED|Overall Study||4
8520942|NCT00384774|21003032|P1|COMPLETED|Overall Study||42
8520943|NCT00384774|21003026|P7|Received at Least 1 Dose of Study Drug|Overall Study||4
8520944|NCT00384774|21003027|P6|Received at Least 1 Dose of Study Drug|Overall Study||16
8520945|NCT00384774|21003028|P5|Received at Least 1 Dose of Study Drug|Overall Study||28
8520946|NCT00384774|21003029|P4|Received at Least 1 Dose of Study Drug|Overall Study||24
8520947|NCT00384774|21003030|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
8520948|NCT00384774|21003031|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
8520949|NCT00384774|21003032|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
8520950|NCT00384774|21003026|P7|STARTED|Overall Study||4
8520951|NCT00384774|21003027|P6|STARTED|Overall Study||16
8520952|NCT00384774|21003028|P5|STARTED|Overall Study||28
8520953|NCT00384774|21003029|P4|STARTED|Overall Study||24
8520954|NCT00384774|21003030|P3|STARTED|Overall Study||12
8520955|NCT00384774|21003031|P2|STARTED|Overall Study||4
8520956|NCT00384774|21003032|P1|STARTED|Overall Study||42
8520957|NCT00384748|21003106|P2|NOT COMPLETED|Overall Study||0
8520958|NCT00384748|21003107|P1|NOT COMPLETED|Overall Study||0
8520959|NCT00384748|21003106|P2|COMPLETED|Overall Study||23
8520960|NCT00384748|21003107|P1|COMPLETED|Overall Study||25
8520961|NCT00384748|21003106|P2|STARTED|Overall Study||23
8520962|NCT00384748|21003107|P1|STARTED|Overall Study||25
8520963|NCT00384670|21003113|P1|NOT COMPLETED|Overall Study||0
8520964|NCT00384670|21003113|P1|COMPLETED|Overall Study||7
8520965|NCT00384670|21003113|P1|STARTED|Overall Study||7
8520966|NCT00384449|21003123|P1|NOT COMPLETED|Overall Study||0
8520967|NCT00384449|21003123|P1|COMPLETED|Overall Study||1
8520968|NCT00384449|21003123|P1|STARTED|Overall Study||1
8520969|NCT00384397|21003134|P3|NOT COMPLETED|Overall Study||33
8520970|NCT00384397|21003135|P2|NOT COMPLETED|Overall Study||46
8520971|NCT00384397|21003136|P1|NOT COMPLETED|Overall Study||32
8520972|NCT00384397|21003134|P3|COMPLETED|Overall Study||385
8520973|NCT00384397|21003135|P2|COMPLETED|Overall Study||247
8520974|NCT00384397|21003136|P1|COMPLETED|Overall Study||375
8520975|NCT00384397|21003134|P3|STARTED|Overall Study||418
8520976|NCT00384397|21003135|P2|STARTED|Overall Study||293
8520977|NCT00384397|21003136|P1|STARTED|Overall Study||407
8520978|NCT00384332|21003155|P2|NOT COMPLETED|Overall Study||0
8520979|NCT00384332|21003156|P1|NOT COMPLETED|Overall Study||4
8520980|NCT00384332|21003155|P2|COMPLETED|Overall Study||10
8520981|NCT00384332|21003156|P1|COMPLETED|Overall Study||9
8520982|NCT00384332|21003155|P2|STARTED|Overall Study||10
8520983|NCT00384332|21003156|P1|STARTED|Overall Study||13
8520984|NCT00384293|21003166|P3|NOT COMPLETED|Post-randomization Period||219
8520985|NCT00384293|21003167|P2|NOT COMPLETED|Post-randomization Period||214
8520986|NCT00384293|21003168|P1|NOT COMPLETED|Post-randomization Period||0
8520987|NCT00384293|21003166|P3|COMPLETED|Post-randomization Period||0
8520988|NCT00384293|21003167|P2|COMPLETED|Post-randomization Period||0
8520989|NCT00384293|21003168|P1|COMPLETED|Post-randomization Period||0
8520990|NCT00384293|21003166|P3|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
8520991|NCT00384293|21003167|P2|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
8520992|NCT00384293|21003168|P1|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
8520993|NCT00384293|21003166|P3|STARTED|Post-randomization Period||219
8520994|NCT00384293|21003167|P2|STARTED|Post-randomization Period||214
8520995|NCT00384293|21003168|P1|STARTED|Post-randomization Period||0
8520996|NCT00384293|21003166|P3|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
8520997|NCT00384293|21003167|P2|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
8520998|NCT00384293|21003168|P1|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
8520999|NCT00384293|21003166|P3|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
8521000|NCT00384293|21003167|P2|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
8521001|NCT00384293|21003168|P1|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
8521002|NCT00384293|21003166|P3|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
8521003|NCT00384293|21003167|P2|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
8521004|NCT00384293|21003168|P1|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
8521005|NCT00384293|21003166|P3|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
8521006|NCT00384293|21003167|P2|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
8521007|NCT00384293|21003168|P1|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
8521008|NCT00384293|21003166|P3|STARTED|MK0524A Active Run-In, Pre-randomization||0
8521009|NCT00384293|21003167|P2|STARTED|MK0524A Active Run-In, Pre-randomization||0
8521010|NCT00384293|21003168|P1|STARTED|MK0524A Active Run-In, Pre-randomization||937
8521011|NCT00384241|21003181|P2|NOT COMPLETED|Overall Study||0
8521012|NCT00384241|21003182|P1|NOT COMPLETED|Overall Study||0
8521013|NCT00384241|21003181|P2|COMPLETED|Overall Study||599
8521014|NCT00384241|21003182|P1|COMPLETED|Overall Study||500
8521015|NCT00384241|21003181|P2|STARTED|Overall Study||599
8521016|NCT00384241|21003182|P1|STARTED|Overall Study||500
8521017|NCT00384189|21003192|P4|NOT COMPLETED|Overall Study||40
8521018|NCT00384189|21003193|P3|NOT COMPLETED|Overall Study||58
8521019|NCT00384189|21003194|P2|NOT COMPLETED|Overall Study||57
8521020|NCT00384189|21003195|P1|NOT COMPLETED|Overall Study||50
8521021|NCT00384189|21003192|P4|COMPLETED|Overall Study||110
8521022|NCT00384189|21003193|P3|COMPLETED|Overall Study||255
8521023|NCT00384189|21003194|P2|COMPLETED|Overall Study||255
8521024|NCT00384189|21003195|P1|COMPLETED|Overall Study||255
8521025|NCT00384189|21003192|P4|Actual Treatment Received|Overall Study||146
8521026|NCT00384189|21003193|P3|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
8521027|NCT00384189|21003194|P2|Actual Treatment Received|Overall Study||312
8521028|NCT00384189|21003195|P1|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
8521029|NCT00384189|21003192|P4|Randomized, Not Treated|Overall Study||4
8521030|NCT00384189|21003193|P3|Randomized, Not Treated|Overall Study||2
8521031|NCT00384189|21003194|P2|Randomized, Not Treated|Overall Study||0
8521032|NCT00384189|21003195|P1|Randomized, Not Treated|Overall Study||1
8521033|NCT00384189|21003192|P4|STARTED|Overall Study||150
8521034|NCT00384189|21003193|P3|STARTED|Overall Study||313
8521035|NCT00384189|21003194|P2|STARTED|Overall Study||312
8521036|NCT00384189|21003195|P1|STARTED|Overall Study||305
8521037|NCT00384176|21003256|P3|NOT COMPLETED|Overall Study||132
8521038|NCT00384176|21003257|P2|NOT COMPLETED|Overall Study||319
8521039|NCT00384176|21003258|P1|NOT COMPLETED|Overall Study||312
8521040|NCT00384176|21003256|P3|COMPLETED|Overall Study||60
8521041|NCT00384176|21003257|P2|COMPLETED|Overall Study||394
8521042|NCT00384176|21003258|P1|COMPLETED|Overall Study||397
8521043|NCT00384176|21003256|P3|STARTED|Overall Study||192
8521044|NCT00384176|21003257|P2|STARTED|Overall Study||713
8521045|NCT00384176|21003258|P1|STARTED|Overall Study||709
8521046|NCT00384085|21003284|P3|NOT COMPLETED|Overall Study||56
8521047|NCT00384085|21003285|P2|NOT COMPLETED|Overall Study||46
8521048|NCT00384085|21003286|P1|NOT COMPLETED|Overall Study||39
8521049|NCT00384085|21003284|P3|COMPLETED|Overall Study|Based on the entire ITT population|141
8521050|NCT00384085|21003285|P2|COMPLETED|Overall Study|Based on the entire ITT population|150
8521051|NCT00384085|21003286|P1|COMPLETED|Overall Study|Based on the entire ITT population|156
8521052|NCT00384085|21003284|P3|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
8521053|NCT00384085|21003285|P2|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
8521054|NCT00384085|21003286|P1|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
8521055|NCT00384085|21003284|P3|Treated (Safety Population)|Overall Study||194
8521056|NCT00384085|21003285|P2|Treated (Safety Population)|Overall Study||194
8521057|NCT00384085|21003286|P1|Treated (Safety Population)|Overall Study||194
8521058|NCT00384085|21003284|P3|Intent-To-Treat (ITT)|Overall Study||197
8521059|NCT00384085|21003285|P2|Intent-To-Treat (ITT)|Overall Study||196
8521060|NCT00384085|21003286|P1|Intent-To-Treat (ITT)|Overall Study||195
8521061|NCT00384085|21003284|P3|STARTED|Overall Study|Randomized|197
8521062|NCT00384085|21003285|P2|STARTED|Overall Study|Randomized|196
8521063|NCT00384085|21003286|P1|STARTED|Overall Study|Randomized|195
8521064|NCT00384059|21003312|P2|NOT COMPLETED|Toddler Dose||2
8521065|NCT00384059|21003313|P1|NOT COMPLETED|Toddler Dose||1
8521066|NCT00384059|21003312|P2|COMPLETED|Toddler Dose||120
8521067|NCT00384059|21003313|P1|COMPLETED|Toddler Dose||130
8521068|NCT00384059|21003312|P2|STARTED|Toddler Dose||122
8521069|NCT00384059|21003313|P1|STARTED|Toddler Dose||131
8521070|NCT00384059|21003312|P2|NOT COMPLETED|After Infant Series||10
8521071|NCT00384059|21003313|P1|NOT COMPLETED|After Infant Series||4
8521072|NCT00384059|21003312|P2|COMPLETED|After Infant Series||122
8521073|NCT00384059|21003313|P1|COMPLETED|After Infant Series||131
8521074|NCT00384059|21003312|P2|STARTED|After Infant Series||132
8521075|NCT00384059|21003313|P1|STARTED|After Infant Series||135
8521076|NCT00384059|21003312|P2|NOT COMPLETED|Infant Series||13
8521077|NCT00384059|21003313|P1|NOT COMPLETED|Infant Series||6
8521078|NCT00384059|21003312|P2|COMPLETED|Infant Series||132
8521079|NCT00384059|21003313|P1|COMPLETED|Infant Series||135
8521080|NCT00384059|21003312|P2|Vaccinated Dose 2|Infant Series||135
8521081|NCT00384059|21003313|P1|Vaccinated Dose 2|Infant Series||136
8521082|NCT00384059|21003312|P2|Vaccinated Dose 1|Infant Series||139
8521083|NCT00384059|21003313|P1|Vaccinated Dose 1|Infant Series||139
8521084|NCT00384059|21003312|P2|STARTED|Infant Series||145
8521085|NCT00384059|21003313|P1|STARTED|Infant Series||141
8521086|NCT00384033|21003363|P4|NOT COMPLETED|Overall Study||40
8521087|NCT00384033|21003364|P3|NOT COMPLETED|Overall Study||43
8521088|NCT00384033|21003365|P2|NOT COMPLETED|Overall Study||35
8521089|NCT00384033|21003366|P1|NOT COMPLETED|Overall Study||41
8521090|NCT00384033|21003363|P4|COMPLETED|Overall Study||119
8521091|NCT00384033|21003364|P3|COMPLETED|Overall Study||117
8521092|NCT00384033|21003365|P2|COMPLETED|Overall Study||120
8521093|NCT00384033|21003366|P1|COMPLETED|Overall Study||123
8521094|NCT00384033|21003363|P4|Treated|Overall Study||157
8521095|NCT00384033|21003364|P3|Treated|Overall Study||150
8521096|NCT00384033|21003365|P2|Treated|Overall Study||148
8521097|NCT00384033|21003366|P1|Treated|Overall Study||161
8521098|NCT00384033|21003363|P4|STARTED|Overall Study||159
8521099|NCT00384033|21003364|P3|STARTED|Overall Study||160
8521100|NCT00384033|21003365|P2|STARTED|Overall Study||155
8521101|NCT00384033|21003366|P1|STARTED|Overall Study||164
8521102|NCT00383942|21003410|P2|NOT COMPLETED|Overall Study||0
8521103|NCT00383942|21003411|P1|NOT COMPLETED|Overall Study||0
8521104|NCT00383942|21003410|P2|COMPLETED|Overall Study||40
8521105|NCT00383942|21003411|P1|COMPLETED|Overall Study||40
8521106|NCT00383942|21003410|P2|STARTED|Overall Study||40
8521107|NCT00383942|21003411|P1|STARTED|Overall Study||40
8521108|NCT00383786|21003419|P2|NOT COMPLETED|Overall Study||12
8521109|NCT00383786|21003420|P1|NOT COMPLETED|Overall Study||4
8521110|NCT00383786|21003419|P2|COMPLETED|Overall Study||13
8521111|NCT00383786|21003420|P1|COMPLETED|Overall Study||18
8521112|NCT00383786|21003419|P2|STARTED|Overall Study||25
8521113|NCT00383786|21003420|P1|STARTED|Overall Study||22
8521114|NCT00383760|21003426|P1|NOT COMPLETED|Overall Study||0
8521115|NCT00383760|21003426|P1|COMPLETED|Overall Study||15
8521116|NCT00383760|21003426|P1|STARTED|Overall Study||15
8521117|NCT00383747|21003442|P4|NOT COMPLETED|Visit 2||0
8521118|NCT00383747|21003443|P3|NOT COMPLETED|Visit 2||0
8521119|NCT00383747|21003444|P2|NOT COMPLETED|Visit 2||0
8521120|NCT00383747|21003445|P1|NOT COMPLETED|Visit 2||0
8521121|NCT00383747|21003442|P4|COMPLETED|Visit 2||16
8521122|NCT00383747|21003443|P3|COMPLETED|Visit 2||16
8521123|NCT00383747|21003444|P2|COMPLETED|Visit 2||14
8521124|NCT00383747|21003445|P1|COMPLETED|Visit 2||14
8521125|NCT00383747|21003442|P4|STARTED|Visit 2||16
8521126|NCT00383747|21003443|P3|STARTED|Visit 2||16
8521127|NCT00383747|21003444|P2|STARTED|Visit 2||14
8521128|NCT00383747|21003445|P1|STARTED|Visit 2||14
8521129|NCT00383747|21003442|P4|NOT COMPLETED|Visit 1||0
8521130|NCT00383747|21003443|P3|NOT COMPLETED|Visit 1||0
8521131|NCT00383747|21003444|P2|NOT COMPLETED|Visit 1||0
8521132|NCT00383747|21003445|P1|NOT COMPLETED|Visit 1||0
8521133|NCT00383747|21003442|P4|COMPLETED|Visit 1||16
8521134|NCT00383747|21003443|P3|COMPLETED|Visit 1||16
8521135|NCT00383747|21003444|P2|COMPLETED|Visit 1||14
8521136|NCT00383747|21003445|P1|COMPLETED|Visit 1||14
8521137|NCT00383747|21003442|P4|STARTED|Visit 1||16
8521138|NCT00383747|21003443|P3|STARTED|Visit 1||16
8521139|NCT00383747|21003444|P2|STARTED|Visit 1||14
8521140|NCT00383747|21003445|P1|STARTED|Visit 1||14
8521141|NCT00383721|21003470|P5|NOT COMPLETED|26-Week Treatment Safety Extension||0
8521142|NCT00383721|21003471|P4|NOT COMPLETED|26-Week Treatment Safety Extension||17
8521143|NCT00383721|21003472|P3|NOT COMPLETED|26-Week Treatment Safety Extension||23
8521144|NCT00383721|21003473|P2|NOT COMPLETED|26-Week Treatment Safety Extension||17
8521145|NCT00383721|21003474|P1|NOT COMPLETED|26-Week Treatment Safety Extension||19
8521146|NCT00383721|21003470|P5|COMPLETED|26-Week Treatment Safety Extension||8
8521147|NCT00383721|21003471|P4|COMPLETED|26-Week Treatment Safety Extension||131
8521148|NCT00383721|21003472|P3|COMPLETED|26-Week Treatment Safety Extension||126
8521149|NCT00383721|21003473|P2|COMPLETED|26-Week Treatment Safety Extension||136
8521150|NCT00383721|21003474|P1|COMPLETED|26-Week Treatment Safety Extension||126
8521151|NCT00383721|21003470|P5|STARTED|26-Week Treatment Safety Extension||8
8521152|NCT00383721|21003471|P4|STARTED|26-Week Treatment Safety Extension||148
8521153|NCT00383721|21003472|P3|STARTED|26-Week Treatment Safety Extension||149
8521154|NCT00383721|21003473|P2|STARTED|26-Week Treatment Safety Extension||153
8521155|NCT00383721|21003474|P1|STARTED|26-Week Treatment Safety Extension||145
8521156|NCT00383721|21003470|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
8521157|NCT00383721|21003471|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
8521158|NCT00383721|21003472|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
8521159|NCT00383721|21003473|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
8521160|NCT00383721|21003474|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
8521161|NCT00383721|21003470|P5|COMPLETED|26-Week Double-Blind Treatment Period||169
8521162|NCT00383721|21003471|P4|COMPLETED|26-Week Double-Blind Treatment Period||193
8521163|NCT00383721|21003472|P3|COMPLETED|26-Week Double-Blind Treatment Period||202
8521164|NCT00383721|21003473|P2|COMPLETED|26-Week Double-Blind Treatment Period||202
8521165|NCT00383721|21003474|P1|COMPLETED|26-Week Double-Blind Treatment Period|"1 participant listed as ongoing since the participant status could not be formally confirmed."|190
8521166|NCT00383721|21003470|P5|STARTED|26-Week Double-Blind Treatment Period||236
8521167|NCT00383721|21003471|P4|STARTED|26-Week Double-Blind Treatment Period||243
8521168|NCT00383721|21003472|P3|STARTED|26-Week Double-Blind Treatment Period||253
8521169|NCT00383721|21003473|P2|STARTED|26-Week Double-Blind Treatment Period||239
8521170|NCT00383721|21003474|P1|STARTED|26-Week Double-Blind Treatment Period||225
8521171|NCT00383708|21003511|P1|NOT COMPLETED|Co-administration Period||5
8521172|NCT00383708|21003511|P1|COMPLETED|Co-administration Period||52
8521173|NCT00383708|21003511|P1|STARTED|Co-administration Period||57
8521174|NCT00383708|21003511|P1|NOT COMPLETED|Run-in Period||7
8521175|NCT00383708|21003511|P1|COMPLETED|Run-in Period||85
8521176|NCT00383708|21003511|P1|STARTED|Run-in Period||92
8521177|NCT00383708|21003511|P1|NOT COMPLETED|Enrolment Through Start Treatment||33
8521178|NCT00383708|21003511|P1|COMPLETED|Enrolment Through Start Treatment||92
8521179|NCT00383708|21003511|P1|STARTED|Enrolment Through Start Treatment||125
8521180|NCT00383643|21003548|P3|NOT COMPLETED|Overall Study||1
8521181|NCT00383643|21003549|P2|NOT COMPLETED|Overall Study||1
8521182|NCT00383643|21003550|P1|NOT COMPLETED|Overall Study||1
8521183|NCT00383643|21003548|P3|COMPLETED|Overall Study||13
8521184|NCT00383643|21003549|P2|COMPLETED|Overall Study||15
8521185|NCT00383643|21003550|P1|COMPLETED|Overall Study||17
8521186|NCT00383643|21003548|P3|STARTED|Overall Study||14
8521187|NCT00383643|21003549|P2|STARTED|Overall Study||16
8521188|NCT00383643|21003550|P1|STARTED|Overall Study||18
8521189|NCT00383630|21003570|P1|NOT COMPLETED|Overall Study||0
8521190|NCT00383630|21003570|P1|COMPLETED|Overall Study||1
8521191|NCT00383630|21003570|P1|STARTED|Overall Study||1
8521192|NCT00383565|21003576|P1|NOT COMPLETED|Overall Study||0
8521193|NCT00383565|21003576|P1|COMPLETED|Overall Study||9
8521194|NCT00383565|21003576|P1|STARTED|Overall Study||9
8521195|NCT00383552|21003586|P4|NOT COMPLETED|Overall Study||72
8521196|NCT00383552|21003587|P3|NOT COMPLETED|Overall Study||61
8521197|NCT00383552|21003588|P2|NOT COMPLETED|Overall Study||41
8521198|NCT00383552|21003589|P1|NOT COMPLETED|Overall Study||36
8521199|NCT00383552|21003586|P4|COMPLETED|Overall Study||116
8521200|NCT00383552|21003587|P3|COMPLETED|Overall Study||127
8521201|NCT00383552|21003588|P2|COMPLETED|Overall Study||147
8521202|NCT00383552|21003589|P1|COMPLETED|Overall Study||146
8521203|NCT00383552|21003586|P4|STARTED|Overall Study||188
8521204|NCT00383552|21003587|P3|STARTED|Overall Study||188
8521205|NCT00383552|21003588|P2|STARTED|Overall Study||188
8521206|NCT00383552|21003589|P1|STARTED|Overall Study||182
8521207|NCT00383500|21003631|P3|NOT COMPLETED|Overall Study||2
8521208|NCT00383500|21003632|P2|NOT COMPLETED|Overall Study||3
8521209|NCT00383500|21003633|P1|NOT COMPLETED|Overall Study||8
8521210|NCT00383500|21003631|P3|COMPLETED|Overall Study||22
8521211|NCT00383500|21003632|P2|COMPLETED|Overall Study||21
8521212|NCT00383500|21003633|P1|COMPLETED|Overall Study||19
8521213|NCT00383500|21003631|P3|STARTED|Overall Study||24
8521214|NCT00383500|21003632|P2|STARTED|Overall Study||24
8521215|NCT00383500|21003633|P1|STARTED|Overall Study||27
8521216|NCT00383448|21003644|P1|NOT COMPLETED|Overall Study||0
8521217|NCT00383448|21003644|P1|COMPLETED|Overall Study||38
8521218|NCT00383448|21003644|P1|STARTED|Overall Study||38
8521219|NCT00383435|21003657|P5|NOT COMPLETED|26-Week Treatment Safety Extension||3
8521220|NCT00383435|21003658|P4|NOT COMPLETED|26-Week Treatment Safety Extension||15
8521221|NCT00383435|21003659|P3|NOT COMPLETED|26-Week Treatment Safety Extension||16
8521222|NCT00383435|21003660|P2|NOT COMPLETED|26-Week Treatment Safety Extension||9
8521223|NCT00383435|21003661|P1|NOT COMPLETED|26-Week Treatment Safety Extension||14
8521224|NCT00383435|21003657|P5|COMPLETED|26-Week Treatment Safety Extension||10
8521225|NCT00383435|21003658|P4|COMPLETED|26-Week Treatment Safety Extension||116
8521226|NCT00383435|21003659|P3|COMPLETED|26-Week Treatment Safety Extension||108
8521227|NCT00383435|21003660|P2|COMPLETED|26-Week Treatment Safety Extension||121
8521228|NCT00383435|21003661|P1|COMPLETED|26-Week Treatment Safety Extension||117
8521229|NCT00383435|21003657|P5|STARTED|26-Week Treatment Safety Extension||13
8521230|NCT00383435|21003658|P4|STARTED|26-Week Treatment Safety Extension||131
8521231|NCT00383435|21003659|P3|STARTED|26-Week Treatment Safety Extension||124
8521232|NCT00383435|21003660|P2|STARTED|26-Week Treatment Safety Extension||130
8521233|NCT00383435|21003661|P1|STARTED|26-Week Treatment Safety Extension||131
8521234|NCT00383435|21003657|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
8521235|NCT00383435|21003658|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
8521236|NCT00383435|21003659|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
8521237|NCT00383435|21003660|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
8521238|NCT00383435|21003661|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
8521239|NCT00383435|21003657|P5|COMPLETED|26-Week Double-Blind Treatment Period||159
8521240|NCT00383435|21003658|P4|COMPLETED|26-Week Double-Blind Treatment Period||172
8521241|NCT00383435|21003659|P3|COMPLETED|26-Week Double-Blind Treatment Period||164
8521242|NCT00383435|21003660|P2|COMPLETED|26-Week Double-Blind Treatment Period||169
8521333|NCT00382993|21003956|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
8521243|NCT00383435|21003661|P1|COMPLETED|26-Week Double-Blind Treatment Period||176
8521244|NCT00383435|21003657|P5|STARTED|26-Week Double-Blind Treatment Period||212
8521245|NCT00383435|21003658|P4|STARTED|26-Week Double-Blind Treatment Period||209
8521246|NCT00383435|21003659|P3|STARTED|26-Week Double-Blind Treatment Period||210
8521247|NCT00383435|21003660|P2|STARTED|26-Week Double-Blind Treatment Period||207
8521248|NCT00383435|21003661|P1|STARTED|26-Week Double-Blind Treatment Period||217
8521249|NCT00383331|21003700|P2|NOT COMPLETED|Overall Study||1
8521250|NCT00383331|21003701|P1|NOT COMPLETED|Overall Study||0
8521251|NCT00383331|21003700|P2|COMPLETED|Overall Study||8
8521252|NCT00383331|21003701|P1|COMPLETED|Overall Study||10
8521253|NCT00383331|21003700|P2|STARTED|Overall Study||9
8521254|NCT00383331|21003701|P1|STARTED|Overall Study||10
8521255|NCT00383292|21003720|P3|NOT COMPLETED|Overall Study||8
8521256|NCT00383292|21003721|P2|NOT COMPLETED|Overall Study||6
8521257|NCT00383292|21003722|P1|NOT COMPLETED|Overall Study||15
8521258|NCT00383292|21003720|P3|COMPLETED|Overall Study||22
8521259|NCT00383292|21003721|P2|COMPLETED|Overall Study||26
8521260|NCT00383292|21003722|P1|COMPLETED|Overall Study||53
8521261|NCT00383292|21003720|P3|Received at Least One Dose of Study Drug|Overall Study||30
8521262|NCT00383292|21003721|P2|Received at Least One Dose of Study Drug|Overall Study||32
8521263|NCT00383292|21003722|P1|Received at Least One Dose of Study Drug|Overall Study||68
8521264|NCT00383292|21003720|P3|STARTED|Overall Study||30
8521265|NCT00383292|21003721|P2|STARTED|Overall Study||32
8521266|NCT00383292|21003722|P1|STARTED|Overall Study||68
8521267|NCT00383266|21003750|P1|NOT COMPLETED|Overall Study||0
8521268|NCT00383266|21003750|P1|COMPLETED|Overall Study||9
8521269|NCT00383266|21003750|P1|STARTED|Overall Study||9
8521270|NCT00383240|21003763|P4|NOT COMPLETED|Overall Study||77
8521271|NCT00383240|21003764|P3|NOT COMPLETED|Overall Study||85
8521272|NCT00383240|21003765|P2|NOT COMPLETED|Overall Study||33
8521273|NCT00383240|21003766|P1|NOT COMPLETED|Overall Study||35
8521274|NCT00383240|21003763|P4|COMPLETED|Overall Study||119
8521275|NCT00383240|21003764|P3|COMPLETED|Overall Study||117
8521276|NCT00383240|21003765|P2|COMPLETED|Overall Study||159
8521277|NCT00383240|21003766|P1|COMPLETED|Overall Study||156
8521278|NCT00383240|21003763|P4|STARTED|Overall Study||196
8521279|NCT00383240|21003764|P3|STARTED|Overall Study||202
8521280|NCT00383240|21003765|P2|STARTED|Overall Study||192
8521281|NCT00383240|21003766|P1|STARTED|Overall Study||191
8521282|NCT00383162|21003797|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
8521283|NCT00383162|21003798|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
8521284|NCT00383162|21003797|P2|COMPLETED|Migraine Attack 2 (Period 2)||66
8521285|NCT00383162|21003798|P1|COMPLETED|Migraine Attack 2 (Period 2)||65
8521286|NCT00383162|21003797|P2|STARTED|Migraine Attack 2 (Period 2)||73
8521287|NCT00383162|21003798|P1|STARTED|Migraine Attack 2 (Period 2)||67
8521288|NCT00383162|21003797|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
8521289|NCT00383162|21003798|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
8521290|NCT00383162|21003797|P2|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
8521291|NCT00383162|21003798|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
8521292|NCT00383162|21003797|P2|STARTED|Migraine Attack 1 (Period 1)||86
8521293|NCT00383162|21003798|P1|STARTED|Migraine Attack 1 (Period 1)||87
8521294|NCT00383149|21003840|P1|NOT COMPLETED|Overall Study||54
8521295|NCT00383149|21003840|P1|COMPLETED|Overall Study||0
8521296|NCT00383149|21003840|P1|STARTED|Overall Study||54
8521297|NCT00383123|21003859|P2|NOT COMPLETED|Overall Study||86
8521298|NCT00383123|21003860|P1|NOT COMPLETED|Overall Study||111
8521299|NCT00383123|21003859|P2|COMPLETED|Overall Study||1124
8521300|NCT00383123|21003860|P1|COMPLETED|Overall Study||2004
8521301|NCT00383123|21003859|P2|STARTED|Overall Study||1210
8521302|NCT00383123|21003860|P1|STARTED|Overall Study||2115
8521303|NCT00383110|21003882|P2|NOT COMPLETED|Overall Study||0
8521304|NCT00383110|21003883|P1|NOT COMPLETED|Overall Study||0
8521305|NCT00383110|21003882|P2|COMPLETED|Overall Study||150
8521306|NCT00383110|21003883|P1|COMPLETED|Overall Study||150
8521307|NCT00383110|21003882|P2|STARTED|Overall Study||150
8521308|NCT00383110|21003883|P1|STARTED|Overall Study||150
8521309|NCT00383084|21003901|P2|NOT COMPLETED|Overall Study||10
8521310|NCT00383084|21003902|P1|NOT COMPLETED|Overall Study||12
8521311|NCT00383084|21003901|P2|COMPLETED|Overall Study||28
8521312|NCT00383084|21003902|P1|COMPLETED|Overall Study||34
8521313|NCT00383084|21003901|P2|STARTED|Overall Study||38
8521314|NCT00383084|21003902|P1|STARTED|Overall Study||46
8521315|NCT00383071|21003918|P4|NOT COMPLETED|Overall Study||3
8521316|NCT00383071|21003919|P3|NOT COMPLETED|Overall Study||7
8521317|NCT00383071|21003920|P2|NOT COMPLETED|Overall Study||4
8521318|NCT00383071|21003921|P1|NOT COMPLETED|Overall Study||0
8521319|NCT00383071|21003918|P4|COMPLETED|Overall Study||22
8521320|NCT00383071|21003919|P3|COMPLETED|Overall Study||44
8521321|NCT00383071|21003920|P2|COMPLETED|Overall Study||21
8521322|NCT00383071|21003921|P1|COMPLETED|Overall Study||25
8521323|NCT00383071|21003918|P4|STARTED|Overall Study||25
8521324|NCT00383071|21003919|P3|STARTED|Overall Study||51
8521325|NCT00383071|21003920|P2|STARTED|Overall Study||25
8521326|NCT00383071|21003921|P1|STARTED|Overall Study||25
8521327|NCT00383019|21003933|P2|NOT COMPLETED|Overall Study||2
8521328|NCT00383019|21003934|P1|NOT COMPLETED|Overall Study||5
8521329|NCT00383019|21003933|P2|COMPLETED|Overall Study||143
8521330|NCT00383019|21003934|P1|COMPLETED|Overall Study||139
8521331|NCT00383019|21003933|P2|STARTED|Overall Study||145
8521332|NCT00383019|21003934|P1|STARTED|Overall Study||144
8521334|NCT00382993|21003957|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
8521335|NCT00382993|21003956|P2|COMPLETED|Migraine Attack 2 (Period 2)||63
8521336|NCT00382993|21003957|P1|COMPLETED|Migraine Attack 2 (Period 2)||68
8521337|NCT00382993|21003956|P2|STARTED|Migraine Attack 2 (Period 2)||67
8521338|NCT00382993|21003957|P1|STARTED|Migraine Attack 2 (Period 2)||70
8521339|NCT00382993|21003956|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
8521340|NCT00382993|21003957|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
8521341|NCT00382993|21003956|P2|COMPLETED|Migraine Attack 1 (Period 1)||67
8521342|NCT00382993|21003957|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
8521343|NCT00382993|21003956|P2|STARTED|Migraine Attack 1 (Period 1)||85
8521344|NCT00382993|21003957|P1|STARTED|Migraine Attack 1 (Period 1)||84
8521345|NCT00382967|21004001|P2|NOT COMPLETED|Overall Study||1
8521346|NCT00382967|21004002|P1|NOT COMPLETED|Overall Study||1
8521347|NCT00382967|21004001|P2|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
8521348|NCT00382967|21004002|P1|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
8521349|NCT00382967|21004001|P2|STARTED|Overall Study||138
8521350|NCT00382967|21004002|P1|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
8521351|NCT00382928|21004012|P2|NOT COMPLETED|Overall Study||0
8521352|NCT00382928|21004013|P1|NOT COMPLETED|Overall Study||0
8521353|NCT00382928|21004012|P2|COMPLETED|Overall Study||95
8521354|NCT00382928|21004013|P1|COMPLETED|Overall Study||97
8521355|NCT00382928|21004012|P2|STARTED|Overall Study||95
8521356|NCT00382928|21004013|P1|STARTED|Overall Study||97
8521357|NCT00382863|21004027|P2|NOT COMPLETED|Overall Study||36
8521358|NCT00382863|21004028|P1|NOT COMPLETED|Overall Study||15
8521359|NCT00382863|21004027|P2|COMPLETED|Overall Study||78
8521360|NCT00382863|21004028|P1|COMPLETED|Overall Study||81
8521361|NCT00382863|21004027|P2|STARTED|Overall Study||114
8521362|NCT00382863|21004028|P1|STARTED|Overall Study||96
8521363|NCT00382824|21004084|P2|NOT COMPLETED|Overall Study||13
8521364|NCT00382824|21004085|P1|NOT COMPLETED|Overall Study||12
8521365|NCT00382824|21004084|P2|COMPLETED|Overall Study||16
8521366|NCT00382824|21004085|P1|COMPLETED|Overall Study||20
8521367|NCT00382824|21004084|P2|STARTED|Overall Study||29
8521368|NCT00382824|21004085|P1|STARTED|Overall Study||32
8521369|NCT00382785|21004101|P2|NOT COMPLETED|Overall Study||0
8521370|NCT00382785|21004102|P1|NOT COMPLETED|Overall Study||0
8521371|NCT00382785|21004101|P2|COMPLETED|Overall Study||26
8521372|NCT00382785|21004102|P1|COMPLETED|Overall Study||25
8521373|NCT00382785|21004101|P2|STARTED|Overall Study||26
8521374|NCT00382785|21004102|P1|STARTED|Overall Study||25
8521375|NCT00382733|21004112|P5|NOT COMPLETED|Overall Study||0
8521376|NCT00382733|21004113|P4|NOT COMPLETED|Overall Study||0
8521377|NCT00382733|21004114|P3|NOT COMPLETED|Overall Study||0
8521378|NCT00382733|21004115|P2|NOT COMPLETED|Overall Study||1
8521379|NCT00382733|21004116|P1|NOT COMPLETED|Overall Study||0
8521380|NCT00382733|21004112|P5|COMPLETED|Overall Study||2
8521381|NCT00382733|21004113|P4|COMPLETED|Overall Study||14
8521382|NCT00382733|21004114|P3|COMPLETED|Overall Study||3
8521383|NCT00382733|21004115|P2|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
8521384|NCT00382733|21004116|P1|COMPLETED|Overall Study||3
8521385|NCT00382733|21004112|P5|STARTED|Overall Study||2
8521386|NCT00382733|21004113|P4|STARTED|Overall Study||14
8521387|NCT00382733|21004114|P3|STARTED|Overall Study||3
8521388|NCT00382733|21004115|P2|STARTED|Overall Study||4
8521389|NCT00382733|21004116|P1|STARTED|Overall Study||3
8521390|NCT00382720|21004137|P3|NOT COMPLETED|Overall Study||86
8521391|NCT00382720|21004138|P2|NOT COMPLETED|Overall Study||89
8521392|NCT00382720|21004139|P1|NOT COMPLETED|Overall Study||79
8521393|NCT00382720|21004137|P3|COMPLETED|Overall Study||0
8521394|NCT00382720|21004138|P2|COMPLETED|Overall Study||0
8521395|NCT00382720|21004139|P1|COMPLETED|Overall Study||0
8521396|NCT00382720|21004137|P3|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
8521397|NCT00382720|21004138|P2|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
8521398|NCT00382720|21004139|P1|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
8521399|NCT00382720|21004137|P3|Administered Optimal Dose (Parts I & II)|Overall Study||82
8521400|NCT00382720|21004138|P2|Administered Optimal Dose (Parts I & II)|Overall Study||88
8521401|NCT00382720|21004139|P1|Administered Optimal Dose (Parts I & II)|Overall Study||78
8521402|NCT00382720|21004137|P3|Administered Non-Optimal Dose (Part I)|Overall Study||0
8521403|NCT00382720|21004138|P2|Administered Non-Optimal Dose (Part I)|Overall Study||11
8521404|NCT00382720|21004139|P1|Administered Non-Optimal Dose (Part I)|Overall Study||10
8521405|NCT00382720|21004137|P3|STARTED|Overall Study||86
8521406|NCT00382720|21004138|P2|STARTED|Overall Study||89
8521407|NCT00382720|21004139|P1|STARTED|Overall Study||79
8521408|NCT00382590|21004155|P2|NOT COMPLETED|Overall Study||0
8521409|NCT00382590|21004156|P1|NOT COMPLETED|Overall Study||0
8521410|NCT00382590|21004155|P2|COMPLETED|Overall Study||6
8521411|NCT00382590|21004156|P1|COMPLETED|Overall Study||4
8521412|NCT00382590|21004155|P2|STARTED|Overall Study||6
8521413|NCT00382590|21004156|P1|STARTED|Overall Study||4
8521414|NCT00382408|21004164|P2|NOT COMPLETED|Overall Study||54
8521415|NCT00382408|21004165|P1|NOT COMPLETED|Overall Study||144
8521416|NCT00382408|21004164|P2|COMPLETED|Overall Study||955
8521417|NCT00382408|21004165|P1|COMPLETED|Overall Study||2887
8521418|NCT00382408|21004164|P2|STARTED|Overall Study||1009
8521419|NCT00382408|21004165|P1|STARTED|Overall Study||3031
8521420|NCT00382291|21004192|P3|NOT COMPLETED|Overall Study||8
8521421|NCT00382291|21004193|P2|NOT COMPLETED|Overall Study||7
8521422|NCT00382291|21004194|P1|NOT COMPLETED|Overall Study||4
8521423|NCT00382291|21004192|P3|COMPLETED|Overall Study||13
8521424|NCT00382291|21004193|P2|COMPLETED|Overall Study||10
8521425|NCT00382291|21004194|P1|COMPLETED|Overall Study||14
8521426|NCT00382291|21004192|P3|STARTED|Overall Study||21
8521427|NCT00382291|21004193|P2|STARTED|Overall Study||17
8521428|NCT00382291|21004194|P1|STARTED|Overall Study||18
8521429|NCT00382265|21004207|P2|NOT COMPLETED|Overall Study||6
8521430|NCT00382265|21004208|P1|NOT COMPLETED|Overall Study||9
8521431|NCT00382265|21004207|P2|COMPLETED|Overall Study||239
8521432|NCT00382265|21004208|P1|COMPLETED|Overall Study||258
8521433|NCT00382265|21004207|P2|STARTED|Overall Study||245
8521434|NCT00382265|21004208|P1|STARTED|Overall Study||267
8521435|NCT00382174|21004226|P3|NOT COMPLETED|Overall Study||21
8521436|NCT00382174|21004227|P2|NOT COMPLETED|Overall Study||17
8521437|NCT00382174|21004228|P1|NOT COMPLETED|Overall Study||4
8521438|NCT00382174|21004226|P3|COMPLETED|Overall Study||51
8521439|NCT00382174|21004227|P2|COMPLETED|Overall Study||37
8521440|NCT00382174|21004228|P1|COMPLETED|Overall Study||14
8521441|NCT00382174|21004226|P3|STARTED|Overall Study||72
8521442|NCT00382174|21004227|P2|STARTED|Overall Study||54
8521443|NCT00382174|21004228|P1|STARTED|Overall Study||18
8521444|NCT00382148|21004241|P2|NOT COMPLETED|Overall Study||0
8521445|NCT00382148|21004242|P1|NOT COMPLETED|Overall Study||1
8521446|NCT00382148|21004241|P2|COMPLETED|Overall Study||7
8521447|NCT00382148|21004242|P1|COMPLETED|Overall Study||3
8521448|NCT00382148|21004241|P2|STARTED|Overall Study||7
8521449|NCT00382148|21004242|P1|STARTED|Overall Study||4
8521450|NCT00382109|21004256|P2|NOT COMPLETED|Overall Study||4
8521451|NCT00382109|21004257|P1|NOT COMPLETED|Overall Study||12
8521452|NCT00382109|21004256|P2|COMPLETED|Overall Study||66
8521453|NCT00382109|21004257|P1|COMPLETED|Overall Study||64
8521454|NCT00382109|21004256|P2|STARTED|Overall Study||70
8521455|NCT00382109|21004257|P1|STARTED|Overall Study||76
8521456|NCT00382031|21004279|P2|NOT COMPLETED|Overall Study||0
8521457|NCT00382031|21004280|P1|NOT COMPLETED|Overall Study||0
8521458|NCT00382031|21004279|P2|COMPLETED|Overall Study||95
8521459|NCT00382031|21004280|P1|COMPLETED|Overall Study||191
8521460|NCT00382031|21004279|P2|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
8521461|NCT00382031|21004280|P1|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
8521462|NCT00382018|21004296|P4|NOT COMPLETED|Overall Study||59
8521463|NCT00382018|21004297|P3|NOT COMPLETED|Overall Study||64
8521464|NCT00382018|21004298|P2|NOT COMPLETED|Overall Study||165
8521465|NCT00382018|21004299|P1|NOT COMPLETED|Overall Study||0
8521466|NCT00382018|21004296|P4|COMPLETED|Overall Study||0
8521467|NCT00382018|21004297|P3|COMPLETED|Overall Study||0
8521468|NCT00382018|21004298|P2|COMPLETED|Overall Study||0
8521469|NCT00382018|21004299|P1|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
8521470|NCT00382018|21004296|P4|STARTED|Overall Study||59
8521471|NCT00382018|21004297|P3|STARTED|Overall Study||64
8521472|NCT00382018|21004298|P2|STARTED|Overall Study||165
8521473|NCT00382018|21004299|P1|STARTED|Overall Study||276
8521474|NCT00381966|21004317|P1|NOT COMPLETED|Overall Study||0
8521475|NCT00381966|21004317|P1|COMPLETED|Overall Study||5
8521476|NCT00381966|21004317|P1|STARTED|Overall Study||5
8521477|NCT00381888|21004322|P1|NOT COMPLETED|Overall Study||17
8521478|NCT00381888|21004322|P1|COMPLETED|Overall Study||27
8521479|NCT00381888|21004322|P1|STARTED|Overall Study||44
8521480|NCT00381862|21004327|P1|NOT COMPLETED|Overall Study||10
8521481|NCT00381862|21004327|P1|COMPLETED|Overall Study||44
8521482|NCT00381862|21004327|P1|STARTED|Overall Study||54
8521483|NCT00381849|21004333|P2|NOT COMPLETED|Open-label||0
8521484|NCT00381849|21004334|P1|NOT COMPLETED|Open-label||0
8521485|NCT00381849|21004333|P2|COMPLETED|Open-label||9
8521486|NCT00381849|21004334|P1|COMPLETED|Open-label||10
8521487|NCT00381849|21004333|P2|STARTED|Open-label||9
8521488|NCT00381849|21004334|P1|STARTED|Open-label||10
8521489|NCT00381849|21004333|P2|NOT COMPLETED|Second Intervention||0
8521490|NCT00381849|21004334|P1|NOT COMPLETED|Second Intervention||0
8521491|NCT00381849|21004333|P2|COMPLETED|Second Intervention||9
8521492|NCT00381849|21004334|P1|COMPLETED|Second Intervention||10
8521493|NCT00381849|21004333|P2|STARTED|Second Intervention||9
8521494|NCT00381849|21004334|P1|STARTED|Second Intervention||10
8521495|NCT00381849|21004333|P2|NOT COMPLETED|Wash Out||1
8521496|NCT00381849|21004334|P1|NOT COMPLETED|Wash Out||0
8521497|NCT00381849|21004333|P2|COMPLETED|Wash Out||9
8521498|NCT00381849|21004334|P1|COMPLETED|Wash Out||10
8521499|NCT00381849|21004333|P2|STARTED|Wash Out||10
8521500|NCT00381849|21004334|P1|STARTED|Wash Out||10
8521501|NCT00381849|21004333|P2|NOT COMPLETED|First Intervention||0
8521502|NCT00381849|21004334|P1|NOT COMPLETED|First Intervention||0
8521503|NCT00381849|21004333|P2|COMPLETED|First Intervention||10
8521504|NCT00381849|21004334|P1|COMPLETED|First Intervention||10
8521505|NCT00381849|21004333|P2|STARTED|First Intervention||10
8521506|NCT00381849|21004334|P1|STARTED|First Intervention||10
8521507|NCT00381810|21004352|P1|NOT COMPLETED|B Cell Follow-up||7
8521508|NCT00381810|21004352|P1|COMPLETED|B Cell Follow-up||0
8521509|NCT00381810|21004352|P1|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
8521510|NCT00381810|21004352|P1|NOT COMPLETED|Treatment and Safety Follow-up||15
8521511|NCT00381810|21004352|P1|COMPLETED|Treatment and Safety Follow-up||16
8521512|NCT00381810|21004352|P1|STARTED|Treatment and Safety Follow-up||31
8521513|NCT00381797|21004361|P5|NOT COMPLETED|Overall Study||2
8521514|NCT00381797|21004362|P4|NOT COMPLETED|Overall Study||1
8521515|NCT00381797|21004363|P3|NOT COMPLETED|Overall Study||0
8521516|NCT00381797|21004364|P2|NOT COMPLETED|Overall Study||1
8521517|NCT00381797|21004365|P1|NOT COMPLETED|Overall Study||1
8521518|NCT00381797|21004361|P5|COMPLETED|Overall Study||35
8521519|NCT00381797|21004362|P4|COMPLETED|Overall Study||14
8521520|NCT00381797|21004363|P3|COMPLETED|Overall Study||10
8521521|NCT00381797|21004364|P2|COMPLETED|Overall Study||16
8521522|NCT00381797|21004365|P1|COMPLETED|Overall Study||17
8521523|NCT00381797|21004361|P5|STARTED|Overall Study||37
8521524|NCT00381797|21004362|P4|STARTED|Overall Study||15
8521525|NCT00381797|21004363|P3|STARTED|Overall Study||10
8521526|NCT00381797|21004364|P2|STARTED|Overall Study||17
8521527|NCT00381797|21004365|P1|STARTED|Overall Study||18
8521528|NCT00381706|21004440|P3|NOT COMPLETED|Overall Study||1
8521529|NCT00381706|21004441|P2|NOT COMPLETED|Overall Study||2
8521530|NCT00381706|21004442|P1|NOT COMPLETED|Overall Study||7
8521531|NCT00381706|21004440|P3|COMPLETED|Overall Study||79
8521532|NCT00381706|21004441|P2|COMPLETED|Overall Study||81
8521533|NCT00381706|21004442|P1|COMPLETED|Overall Study||75
8521534|NCT00381706|21004440|P3|STARTED|Overall Study||80
8521535|NCT00381706|21004441|P2|STARTED|Overall Study||83
8521536|NCT00381706|21004442|P1|STARTED|Overall Study||82
8521537|NCT00381693|21004465|P1|NOT COMPLETED|Overall Study||8
8521538|NCT00381693|21004465|P1|COMPLETED|Overall Study||2
8521539|NCT00381693|21004465|P1|STARTED|Overall Study||10
8521540|NCT00381680|21004474|P2|NOT COMPLETED|Overall Study||50
8521541|NCT00381680|21004475|P1|NOT COMPLETED|Overall Study||125
8521542|NCT00381680|21004474|P2|COMPLETED|Overall Study||19
8521543|NCT00381680|21004475|P1|COMPLETED|Overall Study||81
8521544|NCT00381680|21004474|P2|STARTED|Overall Study||69
8521545|NCT00381680|21004475|P1|STARTED|Overall Study||206
8521552|NCT00381628|21004509|P4|NOT COMPLETED|Overall Study||0
8521553|NCT00381628|21004510|P3|NOT COMPLETED|Overall Study||0
8521554|NCT00381628|21004511|P2|NOT COMPLETED|Overall Study||0
8521555|NCT00381628|21004512|P1|NOT COMPLETED|Overall Study||0
8521556|NCT00381628|21004509|P4|COMPLETED|Overall Study||14
8521557|NCT00381628|21004510|P3|COMPLETED|Overall Study||0
8521558|NCT00381628|21004511|P2|COMPLETED|Overall Study||27
8521559|NCT00381628|21004512|P1|COMPLETED|Overall Study||18
8521560|NCT00381628|21004509|P4|STARTED|Overall Study||14
8521561|NCT00381628|21004510|P3|STARTED|Overall Study||0
8521562|NCT00381628|21004511|P2|STARTED|Overall Study||27
8521563|NCT00381628|21004512|P1|STARTED|Overall Study||18
8521564|NCT00381615|21004526|P4|NOT COMPLETED|Overall Study||2
8521565|NCT00381615|21004527|P3|NOT COMPLETED|Overall Study||1
8521566|NCT00381615|21004528|P2|NOT COMPLETED|Overall Study||5
8521567|NCT00381615|21004529|P1|NOT COMPLETED|Overall Study||4
8521568|NCT00381615|21004526|P4|COMPLETED|Overall Study||22
8521569|NCT00381615|21004527|P3|COMPLETED|Overall Study||24
8521570|NCT00381615|21004528|P2|COMPLETED|Overall Study||45
8521571|NCT00381615|21004529|P1|COMPLETED|Overall Study||44
8521572|NCT00381615|21004526|P4|STARTED|Overall Study||24
8521573|NCT00381615|21004527|P3|STARTED|Overall Study||25
8521574|NCT00381615|21004528|P2|STARTED|Overall Study||50
8521575|NCT00381615|21004529|P1|STARTED|Overall Study||48
8521576|NCT00381563|21004581|P2|NOT COMPLETED|Overall Study||6
8521577|NCT00381563|21004582|P1|NOT COMPLETED|Overall Study||7
8521578|NCT00381563|21004581|P2|COMPLETED|Overall Study||33
8521579|NCT00381563|21004582|P1|COMPLETED|Overall Study||34
8521580|NCT00381563|21004581|P2|STARTED|Overall Study||39
8521581|NCT00381563|21004582|P1|STARTED|Overall Study||41
8521582|NCT00381550|21004589|P1|NOT COMPLETED|Overall Study||0
8521583|NCT00381550|21004589|P1|COMPLETED|Overall Study||35
8521584|NCT00381550|21004589|P1|STARTED|Overall Study||35
8521585|NCT00381485|21004597|P4|NOT COMPLETED|Double-Blind Treatment Period||33
8521586|NCT00381485|21004598|P3|NOT COMPLETED|Double-Blind Treatment Period||25
8521587|NCT00381485|21004599|P2|NOT COMPLETED|Double-Blind Treatment Period||27
8521588|NCT00381485|21004600|P1|NOT COMPLETED|Double-Blind Treatment Period||0
8521589|NCT00381485|21004597|P4|COMPLETED|Double-Blind Treatment Period||207
8521590|NCT00381485|21004598|P3|COMPLETED|Double-Blind Treatment Period||208
8521591|NCT00381485|21004599|P2|COMPLETED|Double-Blind Treatment Period||228
8521592|NCT00381485|21004600|P1|COMPLETED|Double-Blind Treatment Period||0
8521593|NCT00381485|21004597|P4|STARTED|Double-Blind Treatment Period||240
8521594|NCT00381485|21004598|P3|STARTED|Double-Blind Treatment Period||233
8521595|NCT00381485|21004599|P2|STARTED|Double-Blind Treatment Period||255
8521596|NCT00381485|21004600|P1|STARTED|Double-Blind Treatment Period||0
8521597|NCT00381485|21004597|P4|NOT COMPLETED|Open-Label Run-In Period||0
8521598|NCT00381485|21004598|P3|NOT COMPLETED|Open-Label Run-In Period||0
8521599|NCT00381485|21004599|P2|NOT COMPLETED|Open-Label Run-In Period||0
8521600|NCT00381485|21004600|P1|NOT COMPLETED|Open-Label Run-In Period||106
8521601|NCT00381485|21004597|P4|COMPLETED|Open-Label Run-In Period||0
8521602|NCT00381485|21004598|P3|COMPLETED|Open-Label Run-In Period||0
8521603|NCT00381485|21004599|P2|COMPLETED|Open-Label Run-In Period||0
8521604|NCT00381485|21004600|P1|COMPLETED|Open-Label Run-In Period||728
8521605|NCT00381485|21004597|P4|STARTED|Open-Label Run-In Period||0
8521606|NCT00381485|21004598|P3|STARTED|Open-Label Run-In Period||0
8521607|NCT00381485|21004599|P2|STARTED|Open-Label Run-In Period||0
8521608|NCT00381485|21004600|P1|STARTED|Open-Label Run-In Period||834
8521609|NCT00381381|21004618|P1|NOT COMPLETED|Overall Study||64
8521610|NCT00381381|21004618|P1|COMPLETED|Overall Study||135
8521611|NCT00381381|21004618|P1|STARTED|Overall Study||199
8521612|NCT00381303|21004627|P2|NOT COMPLETED|Overall Study||33
8521613|NCT00381303|21004628|P1|NOT COMPLETED|Overall Study||94
8521614|NCT00381303|21004627|P2|COMPLETED|Overall Study||109
8521615|NCT00381303|21004628|P1|COMPLETED|Overall Study||193
8521616|NCT00381303|21004627|P2|STARTED|Overall Study||142
8521617|NCT00381303|21004628|P1|STARTED|Overall Study||287
8521618|NCT00381238|21004688|P1|NOT COMPLETED|Overall Study||12
8521619|NCT00381238|21004688|P1|COMPLETED|Overall Study||21
8521620|NCT00381238|21004688|P1|STARTED|Overall Study||33
8521621|NCT00381095|21004704|P2|NOT COMPLETED|Overall Study||21
8521622|NCT00381095|21004705|P1|NOT COMPLETED|Overall Study||13
8521623|NCT00381095|21004704|P2|COMPLETED|Overall Study||59
8521624|NCT00381095|21004705|P1|COMPLETED|Overall Study||59
8521625|NCT00381095|21004704|P2|STARTED|Overall Study||80
8521626|NCT00381095|21004705|P1|STARTED|Overall Study||72
8521627|NCT00381043|21004737|P2|NOT COMPLETED|Overall Study||8
8521628|NCT00381043|21004738|P1|NOT COMPLETED|Overall Study||12
8521629|NCT00381043|21004737|P2|COMPLETED|Overall Study||41
8521630|NCT00381043|21004738|P1|COMPLETED|Overall Study||39
8521631|NCT00381043|21004737|P2|STARTED|Overall Study||49
8521632|NCT00381043|21004738|P1|STARTED|Overall Study||51
8521633|NCT00381004|21004756|P1|NOT COMPLETED|Overall Study||0
8521634|NCT00381004|21004756|P1|COMPLETED|Overall Study||60
8521635|NCT00381004|21004756|P1|STARTED|Overall Study||60
8521636|NCT00380978|21004764|P2|NOT COMPLETED|Overall Study||10
8521637|NCT00380978|21004765|P1|NOT COMPLETED|Overall Study||2
8521638|NCT00380978|21004764|P2|COMPLETED|Overall Study||400
8521639|NCT00380978|21004765|P1|COMPLETED|Overall Study||406
8521640|NCT00380978|21004764|P2|STARTED|Overall Study||410
8521641|NCT00380978|21004765|P1|STARTED|Overall Study||408
8521648|NCT00380861|21004806|P2|NOT COMPLETED|Overall Study||17
8521649|NCT00380861|21004807|P1|NOT COMPLETED|Overall Study||18
8521650|NCT00380861|21004806|P2|COMPLETED|Overall Study||74
8521651|NCT00380861|21004807|P1|COMPLETED|Overall Study||75
8521652|NCT00380861|21004806|P2|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
8521653|NCT00380861|21004807|P1|STARTED|Overall Study||93
8521654|NCT00380744|21004820|P7|NOT COMPLETED|Overall Study||1
8521655|NCT00380744|21004821|P6|NOT COMPLETED|Overall Study||0
8521656|NCT00380744|21004822|P5|NOT COMPLETED|Overall Study||0
8521657|NCT00380744|21004823|P4|NOT COMPLETED|Overall Study||0
8521658|NCT00380744|21004824|P3|NOT COMPLETED|Overall Study||0
8521659|NCT00380744|21004825|P2|NOT COMPLETED|Overall Study||0
8521660|NCT00380744|21004826|P1|NOT COMPLETED|Overall Study||1
8521661|NCT00380744|21004820|P7|COMPLETED|Overall Study||24
8521662|NCT00380744|21004821|P6|COMPLETED|Overall Study||25
8521663|NCT00380744|21004822|P5|COMPLETED|Overall Study||23
8521664|NCT00380744|21004823|P4|COMPLETED|Overall Study||4
8521665|NCT00380744|21004824|P3|COMPLETED|Overall Study||20
8521666|NCT00380744|21004825|P2|COMPLETED|Overall Study||4
8521667|NCT00380744|21004826|P1|COMPLETED|Overall Study||19
8521668|NCT00380744|21004820|P7|Received at Least 1 Dose of Study Drug|Overall Study||25
8521669|NCT00380744|21004821|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
8521670|NCT00380744|21004822|P5|Received at Least 1 Dose of Study Drug|Overall Study||23
8521671|NCT00380744|21004823|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
8521672|NCT00380744|21004824|P3|Received at Least 1 Dose of Study Drug|Overall Study||20
8521673|NCT00380744|21004825|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
8521674|NCT00380744|21004826|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
8521675|NCT00380744|21004820|P7|STARTED|Overall Study||25
8521676|NCT00380744|21004821|P6|STARTED|Overall Study||25
8521677|NCT00380744|21004822|P5|STARTED|Overall Study||23
8521678|NCT00380744|21004823|P4|STARTED|Overall Study||4
8521679|NCT00380744|21004824|P3|STARTED|Overall Study||20
8521680|NCT00380744|21004825|P2|STARTED|Overall Study||4
8521681|NCT00380744|21004826|P1|STARTED|Overall Study||20
8521682|NCT00380718|21004876|P1|NOT COMPLETED|Overall Study||18
8521683|NCT00380718|21004876|P1|COMPLETED|Overall Study||15
8521684|NCT00380718|21004876|P1|Received Escalated Dose in Cycle 2|Overall Study||25
8521685|NCT00380718|21004876|P1|Received at Least One Dose of Study Drug|Overall Study||33
8521686|NCT00380718|21004876|P1|STARTED|Overall Study||33
8521687|NCT00380692|21004888|P2|NOT COMPLETED|Study Period III - Open Label||12
8521688|NCT00380692|21004889|P1|NOT COMPLETED|Study Period III - Open Label||6
8521689|NCT00380692|21004888|P2|COMPLETED|Study Period III - Open Label||34
8521690|NCT00380692|21004889|P1|COMPLETED|Study Period III - Open Label||36
8521691|NCT00380692|21004888|P2|STARTED|Study Period III - Open Label||46
8521692|NCT00380692|21004889|P1|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
8521693|NCT00380692|21004888|P2|NOT COMPLETED|Study Period II - Double Blind||3
8521694|NCT00380692|21004889|P1|NOT COMPLETED|Study Period II - Double Blind||5
8521695|NCT00380692|21004888|P2|COMPLETED|Study Period II - Double Blind||46
8521696|NCT00380692|21004889|P1|COMPLETED|Study Period II - Double Blind||43
8521697|NCT00380692|21004888|P2|STARTED|Study Period II - Double Blind||49
8521698|NCT00380692|21004889|P1|STARTED|Study Period II - Double Blind||48
8521699|NCT00380588|21004937|P2|NOT COMPLETED|Overall Study||40
8521700|NCT00380588|21004938|P1|NOT COMPLETED|Overall Study||39
8521701|NCT00380588|21004937|P2|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
8521702|NCT00380588|21004938|P1|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
8521703|NCT00380588|21004937|P2|Received at Least One Dose of Study Drug|Overall Study||42
8521704|NCT00380588|21004938|P1|Received at Least One Dose of Study Drug|Overall Study||41
8521705|NCT00380588|21004937|P2|STARTED|Overall Study||42
8521706|NCT00380588|21004938|P1|STARTED|Overall Study||42
8521707|NCT00380393|21004952|P2|NOT COMPLETED|Month 14||56
8521708|NCT00380393|21004953|P1|NOT COMPLETED|Month 14||57
8521709|NCT00380393|21004952|P2|COMPLETED|Month 14||391
8521710|NCT00380393|21004953|P1|COMPLETED|Month 14||390
8521711|NCT00380393|21004952|P2|STARTED|Month 14||447
8521712|NCT00380393|21004953|P1|STARTED|Month 14||447
8521713|NCT00380393|21004952|P2|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
8521714|NCT00380393|21004953|P1|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
8521715|NCT00380393|21004952|P2|COMPLETED|Month 8 (Cross-sectional Visit)||407
8521716|NCT00380393|21004953|P1|COMPLETED|Month 8 (Cross-sectional Visit)||398
8521717|NCT00380393|21004952|P2|STARTED|Month 8 (Cross-sectional Visit)||447
8521718|NCT00380393|21004953|P1|STARTED|Month 8 (Cross-sectional Visit)||447
8521719|NCT00380367|21005001|P1|NOT COMPLETED|Overall Study||2
8521720|NCT00380367|21005001|P1|COMPLETED|Overall Study||108
8521721|NCT00380367|21005001|P1|STARTED|Overall Study||110
8521722|NCT00380250|21005008|P2|NOT COMPLETED|Overall Study||55
8521723|NCT00380250|21005009|P1|NOT COMPLETED|Overall Study||99
8521724|NCT00380250|21005008|P2|COMPLETED|Overall Study||139
8521725|NCT00380250|21005009|P1|COMPLETED|Overall Study||297
8521726|NCT00380250|21005008|P2|STARTED|Overall Study||194
8521727|NCT00380250|21005009|P1|STARTED|Overall Study||396
8521728|NCT00380081|21005077|P6|NOT COMPLETED|Overall Study||1
8521729|NCT00380081|21005078|P5|NOT COMPLETED|Overall Study||1
8521730|NCT00380081|21005079|P4|NOT COMPLETED|Overall Study||0
8521731|NCT00380081|21005080|P3|NOT COMPLETED|Overall Study||0
8521732|NCT00380081|21005081|P2|NOT COMPLETED|Overall Study||0
8521733|NCT00380081|21005082|P1|NOT COMPLETED|Overall Study||0
8521734|NCT00380081|21005077|P6|COMPLETED|Overall Study||13
8521735|NCT00380081|21005078|P5|COMPLETED|Overall Study||12
8521736|NCT00380081|21005079|P4|COMPLETED|Overall Study||15
8521737|NCT00380081|21005080|P3|COMPLETED|Overall Study||13
8521738|NCT00380081|21005081|P2|COMPLETED|Overall Study||13
8521739|NCT00380081|21005082|P1|COMPLETED|Overall Study||14
8521740|NCT00380081|21005077|P6|STARTED|Overall Study||14
8521741|NCT00380081|21005078|P5|STARTED|Overall Study||13
8521742|NCT00380081|21005079|P4|STARTED|Overall Study||15
8521743|NCT00380081|21005080|P3|STARTED|Overall Study||13
8521744|NCT00380081|21005081|P2|STARTED|Overall Study||13
8521745|NCT00380081|21005082|P1|STARTED|Overall Study||14
8521746|NCT00380068|21005132|P1|NOT COMPLETED|Overall Study||69
8521747|NCT00380068|21005132|P1|COMPLETED|Overall Study||155
8521748|NCT00380068|21005132|P1|STARTED|Overall Study||224
8521749|NCT00380029|21005152|P1|NOT COMPLETED|Overall Study||0
8521750|NCT00380029|21005152|P1|COMPLETED|Overall Study||20
8521751|NCT00380029|21005152|P1|STARTED|Overall Study||20
8521752|NCT00379912|21005164|P2|NOT COMPLETED|Overall Study||0
8521753|NCT00379912|21005165|P1|NOT COMPLETED|Overall Study||1
8521754|NCT00379912|21005164|P2|COMPLETED|Overall Study||8
8521755|NCT00379912|21005165|P1|COMPLETED|Overall Study||6
8521756|NCT00379912|21005164|P2|STARTED|Overall Study||8
8521757|NCT00379912|21005165|P1|STARTED|Overall Study||7
8521758|NCT00379899|21005187|P2|NOT COMPLETED|Overall Study||40
8521759|NCT00379899|21005188|P1|NOT COMPLETED|Overall Study||40
8521760|NCT00379899|21005187|P2|COMPLETED|Overall Study||140
8521761|NCT00379899|21005188|P1|COMPLETED|Overall Study||140
8521762|NCT00379899|21005187|P2|STARTED|Overall Study||180
8521763|NCT00379899|21005188|P1|STARTED|Overall Study||180
8521764|NCT00379834|21005216|P1|NOT COMPLETED|Overall Study||2
8521765|NCT00379834|21005216|P1|COMPLETED|Overall Study||8
8521766|NCT00379834|21005216|P1|STARTED|Overall Study||10
8521767|NCT00379821|21005224|P4|NOT COMPLETED|Overall Study||79
8521768|NCT00379821|21005225|P3|NOT COMPLETED|Overall Study||67
8521769|NCT00379821|21005226|P2|NOT COMPLETED|Overall Study||89
8521770|NCT00379821|21005227|P1|NOT COMPLETED|Overall Study||73
8521771|NCT00379821|21005224|P4|COMPLETED|Overall Study||81
8521772|NCT00379821|21005225|P3|COMPLETED|Overall Study||93
8521773|NCT00379821|21005226|P2|COMPLETED|Overall Study||71
8521774|NCT00379821|21005227|P1|COMPLETED|Overall Study||87
8521775|NCT00379821|21005224|P4|STARTED|Overall Study||160
8521776|NCT00379821|21005225|P3|STARTED|Overall Study||160
8521777|NCT00379821|21005226|P2|STARTED|Overall Study||160
8521778|NCT00379821|21005227|P1|STARTED|Overall Study||160
8521779|NCT00379808|21005368|P2|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
8521780|NCT00379808|21005369|P1|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
8521781|NCT00379808|21005368|P2|COMPLETED|Intervention Period 2 (4 Weeks)||10
8521782|NCT00379808|21005369|P1|COMPLETED|Intervention Period 2 (4 Weeks)||11
8521783|NCT00379808|21005368|P2|STARTED|Intervention Period 2 (4 Weeks)||11
8521784|NCT00379808|21005369|P1|STARTED|Intervention Period 2 (4 Weeks)||11
8521952|NCT00378898|21005818|P2|COMPLETED|Overall Study||11
8521785|NCT00379808|21005368|P2|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
8521786|NCT00379808|21005369|P1|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
8521787|NCT00379808|21005368|P2|COMPLETED|Intervention Period 1 (4 Weeks)||11
8521788|NCT00379808|21005369|P1|COMPLETED|Intervention Period 1 (4 Weeks)||11
8521789|NCT00379808|21005368|P2|STARTED|Intervention Period 1 (4 Weeks)||11
8521790|NCT00379808|21005369|P1|STARTED|Intervention Period 1 (4 Weeks)||11
8521791|NCT00379795|21005390|P5|NOT COMPLETED|Overall Study||49
8521792|NCT00379795|21005391|P4|NOT COMPLETED|Overall Study||68
8521793|NCT00379795|21005392|P3|NOT COMPLETED|Overall Study||93
8521794|NCT00379795|21005393|P2|NOT COMPLETED|Overall Study||51
8521795|NCT00379795|21005394|P1|NOT COMPLETED|Overall Study||476
8521796|NCT00379795|21005390|P5|COMPLETED|Overall Study||14
8521797|NCT00379795|21005391|P4|COMPLETED|Overall Study||6
8521798|NCT00379795|21005392|P3|COMPLETED|Overall Study||23
8521799|NCT00379795|21005393|P2|COMPLETED|Overall Study||23
8521800|NCT00379795|21005394|P1|COMPLETED|Overall Study||50
8521801|NCT00379795|21005390|P5|Received Ranibizumab in Extension Study|Overall Study||0
8521802|NCT00379795|21005391|P4|Received Ranibizumab in Extension Study|Overall Study||55
8521803|NCT00379795|21005392|P3|Received Ranibizumab in Extension Study|Overall Study||113
8521804|NCT00379795|21005393|P2|Received Ranibizumab in Extension Study|Overall Study||41
8521805|NCT00379795|21005394|P1|Received Ranibizumab in Extension Study|Overall Study||377
8521806|NCT00379795|21005390|P5|STARTED|Overall Study||63
8521807|NCT00379795|21005391|P4|STARTED|Overall Study||74
8521808|NCT00379795|21005392|P3|STARTED|Overall Study||116
8521809|NCT00379795|21005393|P2|STARTED|Overall Study||74
8521810|NCT00379795|21005394|P1|STARTED|Overall Study||526
8521811|NCT00379769|21005424|P6|NOT COMPLETED|Observational Follow-up||148
8521812|NCT00379769|21005425|P5|NOT COMPLETED|Observational Follow-up||149
8521813|NCT00379769|21005426|P4|NOT COMPLETED|Observational Follow-up||0
8521814|NCT00379769|21005427|P3|NOT COMPLETED|Observational Follow-up||0
8521815|NCT00379769|21005428|P2|NOT COMPLETED|Observational Follow-up||0
8521816|NCT00379769|21005429|P1|NOT COMPLETED|Observational Follow-up||0
8521817|NCT00379769|21005424|P6|COMPLETED|Observational Follow-up||1102
8521818|NCT00379769|21005425|P5|COMPLETED|Observational Follow-up||1131
8521819|NCT00379769|21005426|P4|COMPLETED|Observational Follow-up||0
8521820|NCT00379769|21005427|P3|COMPLETED|Observational Follow-up||0
8521821|NCT00379769|21005428|P2|COMPLETED|Observational Follow-up||0
8521822|NCT00379769|21005429|P1|COMPLETED|Observational Follow-up||0
8521823|NCT00379769|21005424|P6|STARTED|Observational Follow-up|"647 from SU in Addition to Background MET arm; 603 from MET in Addition to Background SU arm."|1250
8521824|NCT00379769|21005425|P5|STARTED|Observational Follow-up|"665 from RSG in Addition to Background MET arm; 615 from RGS in Addition to Background SU arm."|1280
8521825|NCT00379769|21005426|P4|STARTED|Observational Follow-up||0
8521826|NCT00379769|21005427|P3|STARTED|Observational Follow-up||0
8521827|NCT00379769|21005428|P2|STARTED|Observational Follow-up||0
8521828|NCT00379769|21005429|P1|STARTED|Observational Follow-up||0
8521829|NCT00379769|21005424|P6|NOT COMPLETED|Main Study||0
8521830|NCT00379769|21005425|P5|NOT COMPLETED|Main Study||0
8521831|NCT00379769|21005426|P4|NOT COMPLETED|Main Study||230
8521832|NCT00379769|21005427|P3|NOT COMPLETED|Main Study||207
8521833|NCT00379769|21005428|P2|NOT COMPLETED|Main Study||199
8521834|NCT00379769|21005429|P1|NOT COMPLETED|Main Study||178
8521835|NCT00379769|21005424|P6|COMPLETED|Main Study||0
8521836|NCT00379769|21005425|P5|COMPLETED|Main Study||0
8521837|NCT00379769|21005426|P4|COMPLETED|Main Study||892
8521838|NCT00379769|21005427|P3|COMPLETED|Main Study||896
8521839|NCT00379769|21005428|P2|COMPLETED|Main Study||906
8521840|NCT00379769|21005429|P1|COMPLETED|Main Study||939
8521841|NCT00379769|21005424|P6|STARTED|Main Study||0
8521842|NCT00379769|21005425|P5|STARTED|Main Study||0
8521843|NCT00379769|21005426|P4|STARTED|Main Study||1122
8521844|NCT00379769|21005427|P3|STARTED|Main Study||1103
8521845|NCT00379769|21005428|P2|STARTED|Main Study||1105
8521846|NCT00379769|21005429|P1|STARTED|Main Study||1117
8521847|NCT00379639|21005588|P5|NOT COMPLETED|Overall Study||6
8521848|NCT00379639|21005589|P4|NOT COMPLETED|Overall Study||6
8521849|NCT00379639|21005590|P3|NOT COMPLETED|Overall Study||9
8521850|NCT00379639|21005591|P2|NOT COMPLETED|Overall Study||5
8521851|NCT00379639|21005592|P1|NOT COMPLETED|Overall Study||3
8521852|NCT00379639|21005588|P5|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
8521853|NCT00379639|21005589|P4|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
8521854|NCT00379639|21005590|P3|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
8521855|NCT00379639|21005591|P2|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
8521856|NCT00379639|21005592|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
8521857|NCT00379639|21005588|P5|Completed 6 Cycles of Therapy|Overall Study||0
8521858|NCT00379639|21005589|P4|Completed 6 Cycles of Therapy|Overall Study||0
8521859|NCT00379639|21005590|P3|Completed 6 Cycles of Therapy|Overall Study||1
8521860|NCT00379639|21005591|P2|Completed 6 Cycles of Therapy|Overall Study||2
8521861|NCT00379639|21005592|P1|Completed 6 Cycles of Therapy|Overall Study||4
8521862|NCT00379639|21005588|P5|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
8521863|NCT00379639|21005589|P4|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
8521864|NCT00379639|21005590|P3|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
8521953|NCT00378898|21005819|P1|COMPLETED|Overall Study||11
8521865|NCT00379639|21005591|P2|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
8521866|NCT00379639|21005592|P1|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
8521867|NCT00379639|21005588|P5|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
8521868|NCT00379639|21005589|P4|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
8521869|NCT00379639|21005590|P3|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
8521870|NCT00379639|21005591|P2|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
8521871|NCT00379639|21005592|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
8521872|NCT00379587|21005614|P1|NOT COMPLETED|Overall Study||2
8521873|NCT00379587|21005614|P1|COMPLETED|Overall Study||63
8521874|NCT00379587|21005614|P1|STARTED|Overall Study||65
8521875|NCT00379574|21005621|P1|NOT COMPLETED|Overall Study||0
8521876|NCT00379574|21005621|P1|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
8521877|NCT00379574|21005621|P1|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
8521878|NCT00379353|21005628|P2|NOT COMPLETED|Overall Study||6
8521879|NCT00379353|21005629|P1|NOT COMPLETED|Overall Study||11
8521880|NCT00379353|21005628|P2|COMPLETED|Overall Study||9
8521881|NCT00379353|21005629|P1|COMPLETED|Overall Study||5
8521882|NCT00379353|21005628|P2|STARTED|Overall Study||15
8521883|NCT00379353|21005629|P1|STARTED|Overall Study||16
8521899|NCT00379288|21005685|P4|NOT COMPLETED|Overall Study||8
8521900|NCT00379288|21005686|P3|NOT COMPLETED|Overall Study||10
8521901|NCT00379288|21005687|P2|NOT COMPLETED|Overall Study||22
8521902|NCT00379288|21005688|P1|NOT COMPLETED|Overall Study||19
8521903|NCT00379288|21005685|P4|COMPLETED|Overall Study||57
8521904|NCT00379288|21005686|P3|COMPLETED|Overall Study||58
8521905|NCT00379288|21005687|P2|COMPLETED|Overall Study||108
8521906|NCT00379288|21005688|P1|COMPLETED|Overall Study||122
8521907|NCT00379288|21005685|P4|STARTED|Overall Study||65
8521908|NCT00379288|21005686|P3|STARTED|Overall Study||68
8521909|NCT00379288|21005687|P2|STARTED|Overall Study||130
8521910|NCT00379288|21005688|P1|STARTED|Overall Study||141
8521911|NCT00379236|21005700|P3|NOT COMPLETED|Open-label Extension||55
8521912|NCT00379236|21005701|P2|NOT COMPLETED|Open-label Extension||0
8521913|NCT00379236|21005702|P1|NOT COMPLETED|Open-label Extension||0
8521914|NCT00379236|21005700|P3|COMPLETED|Open-label Extension||378
8521915|NCT00379236|21005701|P2|COMPLETED|Open-label Extension||0
8521916|NCT00379236|21005702|P1|COMPLETED|Open-label Extension||0
8521917|NCT00379236|21005700|P3|STARTED|Open-label Extension||433
8521918|NCT00379236|21005701|P2|STARTED|Open-label Extension||0
8521919|NCT00379236|21005702|P1|STARTED|Open-label Extension||0
8521920|NCT00379236|21005700|P3|NOT COMPLETED|Double-blind||0
8521921|NCT00379236|21005701|P2|NOT COMPLETED|Double-blind||36
8521922|NCT00379236|21005702|P1|NOT COMPLETED|Double-blind||36
8521923|NCT00379236|21005700|P3|COMPLETED|Double-blind||0
8521924|NCT00379236|21005701|P2|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
8521925|NCT00379236|21005702|P1|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
8521926|NCT00379236|21005700|P3|STARTED|Double-blind||0
8521927|NCT00379236|21005701|P2|STARTED|Double-blind||295
8521928|NCT00379236|21005702|P1|STARTED|Double-blind||293
8521929|NCT00379210|21005747|P2|NOT COMPLETED|Overall Study||7
8521930|NCT00379210|21005748|P1|NOT COMPLETED|Overall Study||10
8521931|NCT00379210|21005747|P2|COMPLETED|Overall Study||23
8521932|NCT00379210|21005748|P1|COMPLETED|Overall Study||20
8521933|NCT00379210|21005747|P2|STARTED|Overall Study||30
8521934|NCT00379210|21005748|P1|STARTED|Overall Study||30
8521935|NCT00379197|21005754|P1|NOT COMPLETED|Overall Study||5
8521936|NCT00379197|21005754|P1|COMPLETED|Overall Study||8
8521937|NCT00379197|21005754|P1|STARTED|Overall Study||13
8521938|NCT00379145|21005759|P1|NOT COMPLETED|Overall Study||0
8521939|NCT00379145|21005759|P1|COMPLETED|Overall Study||20
8521940|NCT00379145|21005759|P1|STARTED|Overall Study||20
8521941|NCT00379080|21005771|P3|NOT COMPLETED|Overall Study||0
8521942|NCT00379080|21005772|P2|NOT COMPLETED|Overall Study||4
8521943|NCT00379080|21005773|P1|NOT COMPLETED|Overall Study||0
8521944|NCT00379080|21005771|P3|COMPLETED|Overall Study||31
8521945|NCT00379080|21005772|P2|COMPLETED|Overall Study||15
8521946|NCT00379080|21005773|P1|COMPLETED|Overall Study||6
8521947|NCT00379080|21005771|P3|STARTED|Overall Study||31
8521948|NCT00379080|21005772|P2|STARTED|Overall Study||19
8521949|NCT00379080|21005773|P1|STARTED|Overall Study||6
8521950|NCT00378898|21005818|P2|NOT COMPLETED|Overall Study||6
8521951|NCT00378898|21005819|P1|NOT COMPLETED|Overall Study||11
8521954|NCT00378898|21005818|P2|STARTED|Overall Study||17
8521955|NCT00378898|21005819|P1|STARTED|Overall Study||22
8521956|NCT00378703|21005831|P4|NOT COMPLETED|Overall Study||91
8521957|NCT00378703|21005832|P3|NOT COMPLETED|Overall Study||90
8521958|NCT00378703|21005833|P2|NOT COMPLETED|Overall Study||91
8521959|NCT00378703|21005834|P1|NOT COMPLETED|Overall Study||89
8521960|NCT00378703|21005831|P4|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
8521961|NCT00378703|21005832|P3|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
8521962|NCT00378703|21005833|P2|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
8521963|NCT00378703|21005834|P1|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
8521964|NCT00378703|21005831|P4|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
8521965|NCT00378703|21005832|P3|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
8521966|NCT00378703|21005833|P2|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
8521967|NCT00378703|21005834|P1|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
8521968|NCT00378703|21005831|P4|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
8521969|NCT00378703|21005832|P3|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
8521970|NCT00378703|21005833|P2|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
8521971|NCT00378703|21005834|P1|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
8521972|NCT00378703|21005831|P4|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
8521973|NCT00378703|21005832|P3|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
8521974|NCT00378703|21005833|P2|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
8521975|NCT00378703|21005834|P1|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
8521976|NCT00378599|21005856|P1|NOT COMPLETED|Overall Study||52
8521977|NCT00378599|21005856|P1|COMPLETED|Overall Study||73
8521978|NCT00378599|21005856|P1|STARTED|Overall Study||125
8521979|NCT00378573|21005860|P1|NOT COMPLETED|Follow-up||14
8521980|NCT00378573|21005860|P1|COMPLETED|Follow-up||3
8521981|NCT00378573|21005860|P1|STARTED|Follow-up||17
8521982|NCT00378573|21005860|P1|NOT COMPLETED|Treatment Period||17
8521983|NCT00378573|21005860|P1|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
8521984|NCT00378573|21005860|P1|STARTED|Treatment Period||17
8521985|NCT00378560|21005868|P2|NOT COMPLETED|Overall Study||58
8521986|NCT00378560|21005869|P1|NOT COMPLETED|Overall Study||56
8521987|NCT00378560|21005868|P2|COMPLETED|Overall Study||454
8521988|NCT00378560|21005869|P1|COMPLETED|Overall Study||453
8521989|NCT00378560|21005868|P2|Vaccinated|Overall Study||512
8521990|NCT00378560|21005869|P1|Vaccinated|Overall Study||509
8521991|NCT00378560|21005868|P2|STARTED|Overall Study||512
8521992|NCT00378560|21005869|P1|STARTED|Overall Study||509
8522006|NCT00378378|21005909|P3|NOT COMPLETED|Overall Study||2
8522007|NCT00378378|21005910|P2|NOT COMPLETED|Overall Study||1
8522008|NCT00378378|21005911|P1|NOT COMPLETED|Overall Study||0
8522009|NCT00378378|21005909|P3|COMPLETED|Overall Study||24
8522010|NCT00378378|21005910|P2|COMPLETED|Overall Study||49
8522011|NCT00378378|21005911|P1|COMPLETED|Overall Study||51
8522012|NCT00378378|21005909|P3|STARTED|Overall Study||26
8522013|NCT00378378|21005910|P2|STARTED|Overall Study||50
8522014|NCT00378378|21005911|P1|STARTED|Overall Study||51
8522015|NCT00378352|21005924|P6|NOT COMPLETED|Efficacy Phase||7
8522016|NCT00378352|21005925|P5|NOT COMPLETED|Efficacy Phase||11
8522017|NCT00378352|21005926|P4|NOT COMPLETED|Efficacy Phase||0
8522018|NCT00378352|21005927|P3|NOT COMPLETED|Efficacy Phase||0
8522019|NCT00378352|21005928|P2|NOT COMPLETED|Efficacy Phase||0
8522020|NCT00378352|21005929|P1|NOT COMPLETED|Efficacy Phase||0
8522021|NCT00378352|21005924|P6|COMPLETED|Efficacy Phase||59
8522022|NCT00378352|21005925|P5|COMPLETED|Efficacy Phase||54
8522023|NCT00378352|21005926|P4|COMPLETED|Efficacy Phase||0
8522024|NCT00378352|21005927|P3|COMPLETED|Efficacy Phase||0
8522025|NCT00378352|21005928|P2|COMPLETED|Efficacy Phase||0
8522026|NCT00378352|21005929|P1|COMPLETED|Efficacy Phase||0
8522027|NCT00378352|21005924|P6|Safety Analysis|Efficacy Phase||64
8522028|NCT00378352|21005925|P5|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
8522029|NCT00378352|21005926|P4|Safety Analysis|Efficacy Phase||0
8522030|NCT00378352|21005927|P3|Safety Analysis|Efficacy Phase||0
8522031|NCT00378352|21005928|P2|Safety Analysis|Efficacy Phase||0
8522032|NCT00378352|21005929|P1|Safety Analysis|Efficacy Phase||0
8522033|NCT00378352|21005924|P6|STARTED|Efficacy Phase||66
8522034|NCT00378352|21005925|P5|STARTED|Efficacy Phase||65
8522035|NCT00378352|21005926|P4|STARTED|Efficacy Phase||0
8522036|NCT00378352|21005927|P3|STARTED|Efficacy Phase||0
8522037|NCT00378352|21005928|P2|STARTED|Efficacy Phase||0
8522038|NCT00378352|21005929|P1|STARTED|Efficacy Phase||0
8522039|NCT00378352|21005924|P6|NOT COMPLETED|Dose Escalation 60,000 Units||0
8522040|NCT00378352|21005925|P5|NOT COMPLETED|Dose Escalation 60,000 Units||0
8522041|NCT00378352|21005926|P4|NOT COMPLETED|Dose Escalation 60,000 Units||1
8522042|NCT00378352|21005927|P3|NOT COMPLETED|Dose Escalation 60,000 Units||3
8522043|NCT00378352|21005928|P2|NOT COMPLETED|Dose Escalation 60,000 Units||0
8522044|NCT00378352|21005929|P1|NOT COMPLETED|Dose Escalation 60,000 Units||0
8522045|NCT00378352|21005924|P6|COMPLETED|Dose Escalation 60,000 Units||0
8522046|NCT00378352|21005925|P5|COMPLETED|Dose Escalation 60,000 Units||0
8522047|NCT00378352|21005926|P4|COMPLETED|Dose Escalation 60,000 Units||10
8522048|NCT00378352|21005927|P3|COMPLETED|Dose Escalation 60,000 Units||17
8522049|NCT00378352|21005928|P2|COMPLETED|Dose Escalation 60,000 Units||0
8522050|NCT00378352|21005929|P1|COMPLETED|Dose Escalation 60,000 Units||0
8522051|NCT00378352|21005924|P6|Safety Analysis|Dose Escalation 60,000 Units||0
8522052|NCT00378352|21005925|P5|Safety Analysis|Dose Escalation 60,000 Units||0
8522053|NCT00378352|21005926|P4|Safety Analysis|Dose Escalation 60,000 Units||11
8522054|NCT00378352|21005927|P3|Safety Analysis|Dose Escalation 60,000 Units||19
8522055|NCT00378352|21005928|P2|Safety Analysis|Dose Escalation 60,000 Units||0
8522056|NCT00378352|21005929|P1|Safety Analysis|Dose Escalation 60,000 Units||0
8522057|NCT00378352|21005924|P6|STARTED|Dose Escalation 60,000 Units||0
8522058|NCT00378352|21005925|P5|STARTED|Dose Escalation 60,000 Units||0
8522059|NCT00378352|21005926|P4|STARTED|Dose Escalation 60,000 Units||11
8522060|NCT00378352|21005927|P3|STARTED|Dose Escalation 60,000 Units||20
8522061|NCT00378352|21005928|P2|STARTED|Dose Escalation 60,000 Units||0
8522062|NCT00378352|21005929|P1|STARTED|Dose Escalation 60,000 Units||0
8522063|NCT00378352|21005924|P6|NOT COMPLETED|Dose Escalation 30,000 Units||0
8522064|NCT00378352|21005925|P5|NOT COMPLETED|Dose Escalation 30,000 Units||0
8522065|NCT00378352|21005926|P4|NOT COMPLETED|Dose Escalation 30,000 Units||2
8522066|NCT00378352|21005927|P3|NOT COMPLETED|Dose Escalation 30,000 Units||0
8522067|NCT00378352|21005928|P2|NOT COMPLETED|Dose Escalation 30,000 Units||3
8522068|NCT00378352|21005929|P1|NOT COMPLETED|Dose Escalation 30,000 Units||0
8522069|NCT00378352|21005924|P6|COMPLETED|Dose Escalation 30,000 Units||0
8522070|NCT00378352|21005925|P5|COMPLETED|Dose Escalation 30,000 Units||0
8522071|NCT00378352|21005926|P4|COMPLETED|Dose Escalation 30,000 Units||9
8522072|NCT00378352|21005927|P3|COMPLETED|Dose Escalation 30,000 Units||0
8522073|NCT00378352|21005928|P2|COMPLETED|Dose Escalation 30,000 Units||16
8522074|NCT00378352|21005929|P1|COMPLETED|Dose Escalation 30,000 Units||0
8522075|NCT00378352|21005924|P6|Safety Analysis|Dose Escalation 30,000 Units||0
8522076|NCT00378352|21005925|P5|Safety Analysis|Dose Escalation 30,000 Units||0
8522077|NCT00378352|21005926|P4|Safety Analysis|Dose Escalation 30,000 Units||11
8522078|NCT00378352|21005927|P3|Safety Analysis|Dose Escalation 30,000 Units||0
8522079|NCT00378352|21005928|P2|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
8522080|NCT00378352|21005929|P1|Safety Analysis|Dose Escalation 30,000 Units||0
8522081|NCT00378352|21005924|P6|STARTED|Dose Escalation 30,000 Units||0
8522082|NCT00378352|21005925|P5|STARTED|Dose Escalation 30,000 Units||0
8522083|NCT00378352|21005926|P4|STARTED|Dose Escalation 30,000 Units||11
8522084|NCT00378352|21005927|P3|STARTED|Dose Escalation 30,000 Units||0
8522085|NCT00378352|21005928|P2|STARTED|Dose Escalation 30,000 Units||19
8522086|NCT00378352|21005929|P1|STARTED|Dose Escalation 30,000 Units||0
8522087|NCT00378352|21005924|P6|NOT COMPLETED|Dose Escalation 15,000 Units||0
8522088|NCT00378352|21005925|P5|NOT COMPLETED|Dose Escalation 15,000 Units||0
8522089|NCT00378352|21005926|P4|NOT COMPLETED|Dose Escalation 15,000 Units||1
8522090|NCT00378352|21005927|P3|NOT COMPLETED|Dose Escalation 15,000 Units||0
8522091|NCT00378352|21005928|P2|NOT COMPLETED|Dose Escalation 15,000 Units||0
8522092|NCT00378352|21005929|P1|NOT COMPLETED|Dose Escalation 15,000 Units||5
8522093|NCT00378352|21005924|P6|COMPLETED|Dose Escalation 15,000 Units||0
8522094|NCT00378352|21005925|P5|COMPLETED|Dose Escalation 15,000 Units||0
8522095|NCT00378352|21005926|P4|COMPLETED|Dose Escalation 15,000 Units||10
8522096|NCT00378352|21005927|P3|COMPLETED|Dose Escalation 15,000 Units||0
8522097|NCT00378352|21005928|P2|COMPLETED|Dose Escalation 15,000 Units||0
8522098|NCT00378352|21005929|P1|COMPLETED|Dose Escalation 15,000 Units||15
8522099|NCT00378352|21005924|P6|Safety Analysis|Dose Escalation 15,000 Units||0
8522100|NCT00378352|21005925|P5|Safety Analysis|Dose Escalation 15,000 Units||0
8522101|NCT00378352|21005926|P4|Safety Analysis|Dose Escalation 15,000 Units||11
8522102|NCT00378352|21005927|P3|Safety Analysis|Dose Escalation 15,000 Units||0
8522103|NCT00378352|21005928|P2|Safety Analysis|Dose Escalation 15,000 Units||0
8522104|NCT00378352|21005929|P1|Safety Analysis|Dose Escalation 15,000 Units||19
8522105|NCT00378352|21005924|P6|STARTED|Dose Escalation 15,000 Units||0
8522106|NCT00378352|21005925|P5|STARTED|Dose Escalation 15,000 Units||0
8522107|NCT00378352|21005926|P4|STARTED|Dose Escalation 15,000 Units||11
8522108|NCT00378352|21005927|P3|STARTED|Dose Escalation 15,000 Units||0
8522109|NCT00378352|21005928|P2|STARTED|Dose Escalation 15,000 Units||0
8522110|NCT00378352|21005929|P1|STARTED|Dose Escalation 15,000 Units||20
8522111|NCT00378326|21005951|P1|NOT COMPLETED|Overall Study||0
8522112|NCT00378326|21005951|P1|COMPLETED|Overall Study||26
8522113|NCT00378326|21005951|P1|STARTED|Overall Study||26
8522114|NCT00378209|21005957|P1|NOT COMPLETED|Overall Study||22
8522199|NCT00377637|21006172|P1|COMPLETED|Maintenance Phase||0
8522200|NCT00377637|21006169|P4|STARTED|Maintenance Phase||111
8522115|NCT00378209|21005957|P1|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
8522116|NCT00378209|21005957|P1|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
8522123|NCT00378079|21005980|P3|NOT COMPLETED|Overall Study||0
8522124|NCT00378079|21005981|P2|NOT COMPLETED|Overall Study||1
8522125|NCT00378079|21005982|P1|NOT COMPLETED|Overall Study||6
8522126|NCT00378079|21005980|P3|COMPLETED|Overall Study||71
8522127|NCT00378079|21005981|P2|COMPLETED|Overall Study||69
8522128|NCT00378079|21005982|P1|COMPLETED|Overall Study||64
8522129|NCT00378079|21005980|P3|STARTED|Overall Study||71
8522130|NCT00378079|21005981|P2|STARTED|Overall Study||70
8522131|NCT00378079|21005982|P1|STARTED|Overall Study||70
8522132|NCT00378014|21006004|P2|NOT COMPLETED|Extension (Month 12 to Month 59)||14
8522133|NCT00378014|21006005|P1|NOT COMPLETED|Extension (Month 12 to Month 59)||14
8522134|NCT00378014|21006004|P2|COMPLETED|Extension (Month 12 to Month 59)||26
8522135|NCT00378014|21006005|P1|COMPLETED|Extension (Month 12 to Month 59)||27
8522136|NCT00378014|21006004|P2|STARTED|Extension (Month 12 to Month 59)||40
8522137|NCT00378014|21006005|P1|STARTED|Extension (Month 12 to Month 59)||41
8522138|NCT00378014|21006004|P2|NOT COMPLETED|Core (Randomization to Month 11)||12
8522139|NCT00378014|21006005|P1|NOT COMPLETED|Core (Randomization to Month 11)||14
8522140|NCT00378014|21006004|P2|COMPLETED|Core (Randomization to Month 11)||90
8522141|NCT00378014|21006005|P1|COMPLETED|Core (Randomization to Month 11)||87
8522142|NCT00378014|21006004|P2|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
8522143|NCT00378014|21006005|P1|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
8522144|NCT00378014|21006004|P2|STARTED|Core (Randomization to Month 11)||102
8522145|NCT00378014|21006005|P1|STARTED|Core (Randomization to Month 11)||101
8522146|NCT00377962|21006031|P2|NOT COMPLETED|Extension Study: 12-24 Months||4
8522147|NCT00377962|21006032|P1|NOT COMPLETED|Extension Study: 12-24 Months||10
8522148|NCT00377962|21006031|P2|COMPLETED|Extension Study: 12-24 Months||123
8522149|NCT00377962|21006032|P1|COMPLETED|Extension Study: 12-24 Months||98
8522150|NCT00377962|21006031|P2|STARTED|Extension Study: 12-24 Months||127
8522151|NCT00377962|21006032|P1|STARTED|Extension Study: 12-24 Months||108
8522152|NCT00377962|21006031|P2|NOT COMPLETED|Core Study: 0-12 Months||9
8522153|NCT00377962|21006032|P1|NOT COMPLETED|Core Study: 0-12 Months||28
8522154|NCT00377962|21006031|P2|COMPLETED|Core Study: 0-12 Months||133
8522155|NCT00377962|21006032|P1|COMPLETED|Core Study: 0-12 Months||112
8522156|NCT00377962|21006031|P2|STARTED|Core Study: 0-12 Months||142
8522157|NCT00377962|21006032|P1|STARTED|Core Study: 0-12 Months||140
8522158|NCT00377858|21006068|P2|NOT COMPLETED|Overall Study||27
8522159|NCT00377858|21006069|P1|NOT COMPLETED|Overall Study||31
8522160|NCT00377858|21006068|P2|COMPLETED|Overall Study||215
8522161|NCT00377858|21006069|P1|COMPLETED|Overall Study||211
8522162|NCT00377858|21006068|P2|Had at Least One Post-Baseline Value|Overall Study||240
8522163|NCT00377858|21006069|P1|Had at Least One Post-Baseline Value|Overall Study||239
8522164|NCT00377858|21006068|P2|STARTED|Overall Study||242
8522165|NCT00377858|21006069|P1|STARTED|Overall Study||242
8522166|NCT00377832|21006099|P2|NOT COMPLETED|Overall Study||0
8522167|NCT00377832|21006100|P1|NOT COMPLETED|Overall Study||0
8522168|NCT00377832|21006099|P2|COMPLETED|Overall Study||6
8522169|NCT00377832|21006100|P1|COMPLETED|Overall Study||7
8522170|NCT00377832|21006099|P2|STARTED|Overall Study||6
8522171|NCT00377832|21006100|P1|STARTED|Overall Study||7
8522172|NCT00377819|21006122|P2|NOT COMPLETED|Overall Study||10
8522173|NCT00377819|21006123|P1|NOT COMPLETED|Overall Study||13
8522174|NCT00377819|21006122|P2|COMPLETED|Overall Study||243
8522175|NCT00377819|21006123|P1|COMPLETED|Overall Study||238
8522176|NCT00377819|21006122|P2|Received Study Medication|Overall Study||253
8522177|NCT00377819|21006123|P1|Received Study Medication|Overall Study||249
8522178|NCT00377819|21006122|P2|STARTED|Overall Study||253
8522179|NCT00377819|21006123|P1|STARTED|Overall Study||251
8522180|NCT00377741|21006135|P2|NOT COMPLETED|Overall Study||0
8522181|NCT00377741|21006136|P1|NOT COMPLETED|Overall Study||0
8522182|NCT00377741|21006135|P2|COMPLETED|Overall Study||15
8522183|NCT00377741|21006136|P1|COMPLETED|Overall Study||16
8522184|NCT00377741|21006135|P2|STARTED|Overall Study||15
8522185|NCT00377741|21006136|P1|STARTED|Overall Study||16
8522186|NCT00377676|21006152|P2|NOT COMPLETED|Overall Study||322
8522187|NCT00377676|21006153|P1|NOT COMPLETED|Overall Study||961
8522188|NCT00377676|21006152|P2|COMPLETED|Overall Study||694
8522189|NCT00377676|21006153|P1|COMPLETED|Overall Study||1093
8522190|NCT00377676|21006152|P2|STARTED|Overall Study||1016
8522191|NCT00377676|21006153|P1|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
8522192|NCT00377637|21006169|P4|NOT COMPLETED|Maintenance Phase||57
8522193|NCT00377637|21006170|P3|NOT COMPLETED|Maintenance Phase||43
8522194|NCT00377637|21006171|P2|NOT COMPLETED|Maintenance Phase||0
8522195|NCT00377637|21006172|P1|NOT COMPLETED|Maintenance Phase||0
8522196|NCT00377637|21006169|P4|COMPLETED|Maintenance Phase||54
8522197|NCT00377637|21006170|P3|COMPLETED|Maintenance Phase||73
8522198|NCT00377637|21006171|P2|COMPLETED|Maintenance Phase||0
8522201|NCT00377637|21006170|P3|STARTED|Maintenance Phase||116
8522202|NCT00377637|21006171|P2|STARTED|Maintenance Phase||0
8522203|NCT00377637|21006172|P1|STARTED|Maintenance Phase||0
8522204|NCT00377637|21006169|P4|NOT COMPLETED|Induction Phase||0
8522205|NCT00377637|21006170|P3|NOT COMPLETED|Induction Phase||0
8522206|NCT00377637|21006171|P2|NOT COMPLETED|Induction Phase||35
8522207|NCT00377637|21006172|P1|NOT COMPLETED|Induction Phase||29
8522208|NCT00377637|21006169|P4|COMPLETED|Induction Phase||0
8522209|NCT00377637|21006170|P3|COMPLETED|Induction Phase||0
8522210|NCT00377637|21006171|P2|COMPLETED|Induction Phase||150
8522211|NCT00377637|21006172|P1|COMPLETED|Induction Phase||156
8522212|NCT00377637|21006169|P4|Safety Population|Induction Phase||0
8522213|NCT00377637|21006170|P3|Safety Population|Induction Phase||0
8522214|NCT00377637|21006171|P2|Safety Population|Induction Phase||184
8522215|NCT00377637|21006172|P1|Safety Population|Induction Phase||180
8522216|NCT00377637|21006169|P4|STARTED|Induction Phase||0
8522217|NCT00377637|21006170|P3|STARTED|Induction Phase||0
8522218|NCT00377637|21006171|P2|STARTED|Induction Phase|Intent-To-Treat|185
8522219|NCT00377637|21006172|P1|STARTED|Induction Phase|Intent-To-Treat|185
8522220|NCT00377611|21006208|P2|NOT COMPLETED|Overall Study||33
8522221|NCT00377611|21006209|P1|NOT COMPLETED|Overall Study||22
8522222|NCT00377611|21006208|P2|COMPLETED|Overall Study||1974
8522223|NCT00377611|21006209|P1|COMPLETED|Overall Study||1025
8522224|NCT00377611|21006208|P2|STARTED|Overall Study||2007
8522225|NCT00377611|21006209|P1|STARTED|Overall Study||1047
8522226|NCT00377572|21006272|P2|NOT COMPLETED|Overall Study||54
8522227|NCT00377572|21006273|P1|NOT COMPLETED|Overall Study||53
8522228|NCT00377572|21006272|P2|COMPLETED|Overall Study||157
8522229|NCT00377572|21006273|P1|COMPLETED|Overall Study||155
8522230|NCT00377572|21006272|P2|STARTED|Overall Study||211
8522231|NCT00377572|21006273|P1|STARTED|Overall Study||208
8522232|NCT00377520|21006311|P1|NOT COMPLETED|Overall Study||1
8522233|NCT00377520|21006311|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
8522234|NCT00377520|21006311|P1|STARTED|Overall Study||27
8522235|NCT00377455|21006316|P1|NOT COMPLETED|Overall Study||1
8522236|NCT00377455|21006316|P1|COMPLETED|Overall Study||4
8522237|NCT00377455|21006316|P1|STARTED|Overall Study||5
8522238|NCT00377429|21006324|P1|NOT COMPLETED|Overall Study||15
8522239|NCT00377429|21006324|P1|COMPLETED|Overall Study|Completed main study|32
8522240|NCT00377429|21006324|P1|STARTED|Overall Study|Treated|47
8522241|NCT00377403|21006335|P2|NOT COMPLETED|Overall Study||7
8522242|NCT00377403|21006336|P1|NOT COMPLETED|Overall Study||4
8522243|NCT00377403|21006335|P2|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
8522244|NCT00377403|21006336|P1|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
8522245|NCT00377403|21006335|P2|Day 28 Assessment|Overall Study||77
8522246|NCT00377403|21006336|P1|Day 28 Assessment|Overall Study||82
8522247|NCT00377403|21006335|P2|Day 10 Assessment|Overall Study||71
8522248|NCT00377403|21006336|P1|Day 10 Assessment|Overall Study||81
8522249|NCT00377403|21006335|P2|Day 7 Assessment|Overall Study||75
8522250|NCT00377403|21006336|P1|Day 7 Assessment|Overall Study||80
8522251|NCT00377403|21006335|P2|Day -3 Assessment|Overall Study||74
8522252|NCT00377403|21006336|P1|Day -3 Assessment|Overall Study||81
8522253|NCT00377403|21006335|P2|STARTED|Overall Study||81
8522254|NCT00377403|21006336|P1|STARTED|Overall Study||85
8522255|NCT00377364|21006344|P2|NOT COMPLETED|Overall Study||0
8522256|NCT00377364|21006345|P1|NOT COMPLETED|Overall Study||2
8522257|NCT00377364|21006344|P2|COMPLETED|Overall Study||14
8522258|NCT00377364|21006345|P1|COMPLETED|Overall Study||14
8522259|NCT00377364|21006344|P2|STARTED|Overall Study||14
8522260|NCT00377364|21006345|P1|STARTED|Overall Study||16
8522261|NCT00377312|21006371|P2|NOT COMPLETED|Overall Study||1
8522262|NCT00377312|21006372|P1|NOT COMPLETED|Overall Study||1
8522263|NCT00377312|21006371|P2|COMPLETED|Overall Study||4
8522264|NCT00377312|21006372|P1|COMPLETED|Overall Study||5
8522265|NCT00377312|21006371|P2|STARTED|Overall Study||5
8522266|NCT00377312|21006372|P1|STARTED|Overall Study||6
8522267|NCT00377299|21006404|P2|NOT COMPLETED|Overall Study||24
8522268|NCT00377299|21006405|P1|NOT COMPLETED|Overall Study||19
8522269|NCT00377299|21006404|P2|COMPLETED|Overall Study||4
8522270|NCT00377299|21006405|P1|COMPLETED|Overall Study||13
8522271|NCT00377299|21006404|P2|STARTED|Overall Study||28
8522272|NCT00377299|21006405|P1|STARTED|Overall Study||32
8522273|NCT00377260|21006421|P2|NOT COMPLETED|Overall Study||5
8522274|NCT00377260|21006422|P1|NOT COMPLETED|Overall Study||2
8522275|NCT00377260|21006421|P2|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
8522276|NCT00377260|21006422|P1|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
8522277|NCT00377260|21006421|P2|STARTED|Overall Study||147
8522278|NCT00377260|21006422|P1|STARTED|Overall Study||144
8522279|NCT00377234|21006476|P2|NOT COMPLETED|Overall Study||31
8522280|NCT00377234|21006477|P1|NOT COMPLETED|Overall Study||34
8522281|NCT00377234|21006476|P2|COMPLETED|Overall Study||145
8522282|NCT00377234|21006477|P1|COMPLETED|Overall Study||146
8522283|NCT00377234|21006476|P2|Safety Analysis Set: Risedronate|Overall Study||174
8522284|NCT00377234|21006477|P1|Safety Analysis Set: Risedronate|Overall Study||153
8522285|NCT00377234|21006476|P2|Safety Analysis Set: Ibandronate|Overall Study||150
8522286|NCT00377234|21006477|P1|Safety Analysis Set: Ibandronate|Overall Study||177
8522287|NCT00377234|21006476|P2|Safety Analysis Set: Period 2|Overall Study||150
8522288|NCT00377234|21006477|P1|Safety Analysis Set: Period 2|Overall Study||153
8522289|NCT00377234|21006476|P2|Safety Analysis Set: Period 1|Overall Study||174
8522290|NCT00377234|21006477|P1|Safety Analysis Set: Period 1|Overall Study||177
8522291|NCT00377234|21006476|P2|Received Treatment|Overall Study||174
8522292|NCT00377234|21006477|P1|Received Treatment|Overall Study||177
8522293|NCT00377234|21006476|P2|Did Not Receive Study Treatment|Overall Study||2
8522294|NCT00377234|21006477|P1|Did Not Receive Study Treatment|Overall Study||3
8522295|NCT00377234|21006476|P2|Randomized|Overall Study||176
8522296|NCT00377234|21006477|P1|Randomized|Overall Study||180
8522297|NCT00377234|21006476|P2|STARTED|Overall Study||176
8522298|NCT00377234|21006477|P1|STARTED|Overall Study||180
8522299|NCT00377156|21006495|P2|NOT COMPLETED|Overall Study||54
8522300|NCT00377156|21006496|P1|NOT COMPLETED|Overall Study||48
8522301|NCT00377156|21006495|P2|COMPLETED|Overall Study||48
8522302|NCT00377156|21006496|P1|COMPLETED|Overall Study||63
8522303|NCT00377156|21006495|P2|STARTED|Overall Study||102
8522304|NCT00377156|21006496|P1|STARTED|Overall Study||111
8522305|NCT00376961|21006510|P2|NOT COMPLETED|Maintenance||23
8522306|NCT00376961|21006511|P1|NOT COMPLETED|Maintenance||0
8522307|NCT00376961|21006510|P2|COMPLETED|Maintenance||27
8522308|NCT00376961|21006511|P1|COMPLETED|Maintenance||0
8522309|NCT00376961|21006510|P2|Eligible|Maintenance||47
8522310|NCT00376961|21006511|P1|Eligible|Maintenance||0
8522311|NCT00376961|21006510|P2|STARTED|Maintenance||50
8522312|NCT00376961|21006511|P1|STARTED|Maintenance||0
8522313|NCT00376961|21006510|P2|NOT COMPLETED|Initial Registration||0
8522314|NCT00376961|21006511|P1|NOT COMPLETED|Initial Registration||7
8522315|NCT00376961|21006510|P2|COMPLETED|Initial Registration||0
8522316|NCT00376961|21006511|P1|COMPLETED|Initial Registration||61
8522317|NCT00376961|21006510|P2|Eligible|Initial Registration||0
8522318|NCT00376961|21006511|P1|Eligible|Initial Registration||65
8522319|NCT00376961|21006510|P2|STARTED|Initial Registration||0
8522320|NCT00376961|21006511|P1|STARTED|Initial Registration||68
8522324|NCT00376935|21006529|P4|NOT COMPLETED|Overall Study||0
8522325|NCT00376935|21006530|P3|NOT COMPLETED|Overall Study||0
8522326|NCT00376935|21006531|P2|NOT COMPLETED|Overall Study||0
8522327|NCT00376935|21006532|P1|NOT COMPLETED|Overall Study||0
8522328|NCT00376935|21006529|P4|COMPLETED|Overall Study||24
8522329|NCT00376935|21006530|P3|COMPLETED|Overall Study||25
8522330|NCT00376935|21006531|P2|COMPLETED|Overall Study||25
8522331|NCT00376935|21006532|P1|COMPLETED|Overall Study||25
8522332|NCT00376935|21006529|P4|STARTED|Overall Study||24
8522333|NCT00376935|21006530|P3|STARTED|Overall Study||25
8522334|NCT00376935|21006531|P2|STARTED|Overall Study||25
8522335|NCT00376935|21006532|P1|STARTED|Overall Study||25
8522336|NCT00376805|21006570|P1|NOT COMPLETED|Overall Study||0
8522337|NCT00376805|21006570|P1|COMPLETED|Overall Study||6
8522338|NCT00376805|21006570|P1|STARTED|Overall Study||6
8522339|NCT00376688|21006577|P1|NOT COMPLETED|Overall Study||4
8522340|NCT00376688|21006577|P1|COMPLETED|Overall Study||27
8522341|NCT00376688|21006577|P1|STARTED|Overall Study||31
8522342|NCT00376675|21006583|P2|NOT COMPLETED|Overall Study||14
8522343|NCT00376675|21006584|P1|NOT COMPLETED|Overall Study||20
8522344|NCT00376675|21006583|P2|COMPLETED|Overall Study||56
8522345|NCT00376675|21006584|P1|COMPLETED|Overall Study||49
8522346|NCT00376675|21006583|P2|STARTED|Overall Study||70
8522347|NCT00376675|21006584|P1|STARTED|Overall Study||69
8522348|NCT00376597|21006608|P2|NOT COMPLETED|Overall Study||3
8522349|NCT00376597|21006609|P1|NOT COMPLETED|Overall Study||11
8522350|NCT00376597|21006608|P2|COMPLETED|Overall Study||312
8522351|NCT00376597|21006609|P1|COMPLETED|Overall Study||242
8522352|NCT00376597|21006608|P2|STARTED|Overall Study||315
8522353|NCT00376597|21006609|P1|STARTED|Overall Study||253
8522354|NCT00376558|21006623|P2|NOT COMPLETED|Overall Study||0
8522355|NCT00376558|21006624|P1|NOT COMPLETED|Overall Study||0
8522356|NCT00376558|21006623|P2|COMPLETED|Overall Study||25
8522357|NCT00376558|21006624|P1|COMPLETED|Overall Study||25
8522358|NCT00376558|21006623|P2|STARTED|Overall Study||25
8522359|NCT00376558|21006624|P1|STARTED|Overall Study||25
8522360|NCT00376532|21006633|P2|NOT COMPLETED|Overall Study||6
8522361|NCT00376532|21006634|P1|NOT COMPLETED|Overall Study||6
8522362|NCT00376532|21006633|P2|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
8522363|NCT00376532|21006634|P1|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
8522364|NCT00376532|21006633|P2|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
8522365|NCT00376532|21006634|P1|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
8522366|NCT00376506|21006644|P2|NOT COMPLETED|Overall Study||2
8522367|NCT00376506|21006645|P1|NOT COMPLETED|Overall Study||0
8522368|NCT00376506|21006644|P2|COMPLETED|Overall Study||4
8522369|NCT00376506|21006645|P1|COMPLETED|Overall Study||4
8522370|NCT00376506|21006644|P2|STARTED|Overall Study||6
8522371|NCT00376506|21006645|P1|STARTED|Overall Study||4
8522372|NCT00376363|21006663|P2|NOT COMPLETED|Overall Study||46
8522373|NCT00376363|21006664|P1|NOT COMPLETED|Overall Study||56
8522374|NCT00376363|21006663|P2|COMPLETED|Overall Study||87
8522375|NCT00376363|21006664|P1|COMPLETED|Overall Study||87
8522376|NCT00376363|21006663|P2|STARTED|Overall Study||133
8522377|NCT00376363|21006664|P1|STARTED|Overall Study||143
8522378|NCT00376259|21006676|P2|NOT COMPLETED|Overall Study||21
8522379|NCT00376259|21006677|P1|NOT COMPLETED|Overall Study||22
8522380|NCT00376259|21006676|P2|COMPLETED|Overall Study||0
8522381|NCT00376259|21006677|P1|COMPLETED|Overall Study||0
8522382|NCT00376259|21006676|P2|Received Study Drug|Overall Study||21
8522383|NCT00376259|21006677|P1|Received Study Drug|Overall Study||21
8522384|NCT00376259|21006676|P2|STARTED|Overall Study||21
8522385|NCT00376259|21006677|P1|STARTED|Overall Study||22
8522386|NCT00376246|21006689|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8522387|NCT00376246|21006690|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8522388|NCT00376246|21006689|P2|COMPLETED|Second Intervention (2 Weeks)||12
8522389|NCT00376246|21006690|P1|COMPLETED|Second Intervention (2 Weeks)||10
8522390|NCT00376246|21006689|P2|STARTED|Second Intervention (2 Weeks)||12
8522391|NCT00376246|21006690|P1|STARTED|Second Intervention (2 Weeks)||10
8522392|NCT00376246|21006689|P2|NOT COMPLETED|Washout (2 Weeks)||0
8522393|NCT00376246|21006690|P1|NOT COMPLETED|Washout (2 Weeks)||0
8522394|NCT00376246|21006689|P2|COMPLETED|Washout (2 Weeks)||12
8522395|NCT00376246|21006690|P1|COMPLETED|Washout (2 Weeks)||10
8522396|NCT00376246|21006689|P2|STARTED|Washout (2 Weeks)||12
8522397|NCT00376246|21006690|P1|STARTED|Washout (2 Weeks)||10
8522398|NCT00376246|21006689|P2|NOT COMPLETED|First Intervention (2 Weeks)||2
8522399|NCT00376246|21006690|P1|NOT COMPLETED|First Intervention (2 Weeks)||4
8522400|NCT00376246|21006689|P2|COMPLETED|First Intervention (2 Weeks)||12
8522401|NCT00376246|21006690|P1|COMPLETED|First Intervention (2 Weeks)||10
8522402|NCT00376246|21006689|P2|STARTED|First Intervention (2 Weeks)||14
8522403|NCT00376246|21006690|P1|STARTED|First Intervention (2 Weeks)||14
8522404|NCT00376220|21006700|P2|NOT COMPLETED|Overall Study||12
8522405|NCT00376220|21006701|P1|NOT COMPLETED|Overall Study||10
8522406|NCT00376220|21006700|P2|COMPLETED|Overall Study||35
8522407|NCT00376220|21006701|P1|COMPLETED|Overall Study||37
8522408|NCT00376220|21006700|P2|STARTED|Overall Study||47
8522409|NCT00376220|21006701|P1|STARTED|Overall Study||47
8522410|NCT00376168|21006709|P2|NOT COMPLETED|Overall Study||1
8522411|NCT00376168|21006710|P1|NOT COMPLETED|Overall Study||2
8522412|NCT00376168|21006709|P2|COMPLETED|Overall Study||15
8522413|NCT00376168|21006710|P1|COMPLETED|Overall Study||14
8522414|NCT00376168|21006709|P2|STARTED|Overall Study|One patient randomized but not treated|16
8522415|NCT00376168|21006710|P1|STARTED|Overall Study||16
8522416|NCT00375999|21006724|P1|NOT COMPLETED|Overall Study||2
8522417|NCT00375999|21006724|P1|COMPLETED|Overall Study||32
8522418|NCT00375999|21006724|P1|STARTED|Overall Study||34
8522419|NCT00375973|21006730|P2|NOT COMPLETED|Overall Study||2
8522420|NCT00375973|21006731|P1|NOT COMPLETED|Overall Study||10
8522421|NCT00375973|21006730|P2|COMPLETED|Overall Study||28
8522422|NCT00375973|21006731|P1|COMPLETED|Overall Study||20
8522423|NCT00375973|21006730|P2|STARTED|Overall Study||30
8522424|NCT00375973|21006731|P1|STARTED|Overall Study||30
8522425|NCT00375934|21006751|P2|NOT COMPLETED|Overall Study||6
8522426|NCT00375934|21006752|P1|NOT COMPLETED|Overall Study||3
8522427|NCT00375934|21006751|P2|COMPLETED|Overall Study||95
8522428|NCT00375934|21006752|P1|COMPLETED|Overall Study||96
8522429|NCT00375934|21006751|P2|STARTED|Overall Study||101
8522430|NCT00375934|21006752|P1|STARTED|Overall Study||99
8522431|NCT00375830|21006781|P3|NOT COMPLETED|Overall Study||0
8522432|NCT00375830|21006782|P2|NOT COMPLETED|Overall Study||0
8522433|NCT00375830|21006783|P1|NOT COMPLETED|Overall Study||0
8522434|NCT00375830|21006781|P3|COMPLETED|Overall Study||74
8522435|NCT00375830|21006782|P2|COMPLETED|Overall Study||30
8522436|NCT00375830|21006783|P1|COMPLETED|Overall Study||10
8522437|NCT00375830|21006781|P3|STARTED|Overall Study||74
8522438|NCT00375830|21006782|P2|STARTED|Overall Study||30
8522439|NCT00375830|21006783|P1|STARTED|Overall Study||10
8522440|NCT00375752|21006810|P2|NOT COMPLETED|Overall Study||15
8522441|NCT00375752|21006811|P1|NOT COMPLETED|Overall Study||12
8522442|NCT00375752|21006810|P2|COMPLETED|Overall Study||74
8522443|NCT00375752|21006811|P1|COMPLETED|Overall Study||67
8522444|NCT00375752|21006810|P2|STARTED|Overall Study||89
8522445|NCT00375752|21006811|P1|STARTED|Overall Study||79
8522446|NCT00375713|21006827|P2|NOT COMPLETED|Overall Study||23
8522447|NCT00375713|21006828|P1|NOT COMPLETED|Overall Study||20
8522448|NCT00375713|21006827|P2|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
8522449|NCT00375713|21006828|P1|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
8522450|NCT00375713|21006827|P2|STARTED|Overall Study|Randomized population (N=234).|234
8522451|NCT00375713|21006828|P1|STARTED|Overall Study|Randomized population (N=232).|232
8522452|NCT00375674|21006842|P2|NOT COMPLETED|Overall Study||141
8522453|NCT00375674|21006843|P1|NOT COMPLETED|Overall Study||144
8522454|NCT00375674|21006842|P2|COMPLETED|Overall Study||165
8522455|NCT00375674|21006843|P1|COMPLETED|Overall Study||165
8522456|NCT00375674|21006842|P2|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
8522457|NCT00375674|21006843|P1|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
8522458|NCT00375674|21006842|P2|Intent-to-Treat Population|Overall Study||306
8522459|NCT00375674|21006843|P1|Intent-to-Treat Population|Overall Study||309
8522460|NCT00375674|21006842|P2|STARTED|Overall Study||306
8522461|NCT00375674|21006843|P1|STARTED|Overall Study||309
8522462|NCT00375609|21006872|P3|NOT COMPLETED|Overall Study||1
8522463|NCT00375609|21006873|P2|NOT COMPLETED|Overall Study||7
8522464|NCT00375609|21006874|P1|NOT COMPLETED|Overall Study||4
8522465|NCT00375609|21006872|P3|COMPLETED|Overall Study||42
8522466|NCT00375609|21006873|P2|COMPLETED|Overall Study||77
8522467|NCT00375609|21006874|P1|COMPLETED|Overall Study||84
8522468|NCT00375609|21006872|P3|STARTED|Overall Study||43
8522469|NCT00375609|21006873|P2|STARTED|Overall Study||84
8522470|NCT00375609|21006874|P1|STARTED|Overall Study||88
8522471|NCT00375518|21006890|P2|NOT COMPLETED|Overall Study||17
8522472|NCT00375518|21006891|P1|NOT COMPLETED|Overall Study||8
8522473|NCT00375518|21006890|P2|COMPLETED|Overall Study||65
8522474|NCT00375518|21006891|P1|COMPLETED|Overall Study||72
8522475|NCT00375518|21006890|P2|STARTED|Overall Study||82
8522476|NCT00375518|21006891|P1|STARTED|Overall Study||80
8522477|NCT00375505|21006899|P2|NOT COMPLETED|Overall Study||2
8522478|NCT00375505|21006900|P1|NOT COMPLETED|Overall Study||1
8522479|NCT00375505|21006899|P2|COMPLETED|Overall Study||32
8522480|NCT00375505|21006900|P1|COMPLETED|Overall Study||35
8522481|NCT00375505|21006899|P2|STARTED|Overall Study||34
8522482|NCT00375505|21006900|P1|STARTED|Overall Study||36
8522483|NCT00375492|21006944|P2|NOT COMPLETED|Overall Study||26
8522484|NCT00375492|21006945|P1|NOT COMPLETED|Overall Study||26
8522485|NCT00375492|21006944|P2|COMPLETED|Overall Study||72
8522486|NCT00375492|21006945|P1|COMPLETED|Overall Study||70
8522487|NCT00375492|21006944|P2|STARTED|Overall Study||98
8522488|NCT00375492|21006945|P1|STARTED|Overall Study||96
8522489|NCT00375427|21006975|P2|NOT COMPLETED|Overall Study||74
8522490|NCT00375427|21006976|P1|NOT COMPLETED|Overall Study||60
8522491|NCT00375427|21006975|P2|COMPLETED|Overall Study||142
8522492|NCT00375427|21006976|P1|COMPLETED|Overall Study||149
8522493|NCT00375427|21006975|P2|STARTED|Overall Study||216
8522494|NCT00375427|21006976|P1|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
8522495|NCT00375219|21007001|P3|NOT COMPLETED|Overall Study||21
8522496|NCT00375219|21007002|P2|NOT COMPLETED|Overall Study||20
8522497|NCT00375219|21007003|P1|NOT COMPLETED|Overall Study||59
8522498|NCT00375219|21007001|P3|COMPLETED|Overall Study||0
8522499|NCT00375219|21007002|P2|COMPLETED|Overall Study||0
8522500|NCT00375219|21007003|P1|COMPLETED|Overall Study||3
8522501|NCT00375219|21007001|P3|STARTED|Overall Study||21
8522502|NCT00375219|21007002|P2|STARTED|Overall Study||20
8522503|NCT00375219|21007003|P1|STARTED|Overall Study||62
8522504|NCT00375167|21007071|P2|NOT COMPLETED|Overall Study||0
8522505|NCT00375167|21007072|P1|NOT COMPLETED|Overall Study||0
8522506|NCT00375167|21007071|P2|COMPLETED|Overall Study||17
8522507|NCT00375167|21007072|P1|COMPLETED|Overall Study||16
8522508|NCT00375167|21007071|P2|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17
8522509|NCT00375167|21007072|P1|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16
8522510|NCT00374907|21007086|P2|NOT COMPLETED|116-Week Short-term + Long-term Period||14
8522511|NCT00374907|21007087|P1|NOT COMPLETED|116-Week Short-term + Long-term Period||13
8522512|NCT00374907|21007086|P2|COMPLETED|116-Week Short-term + Long-term Period||2
8522513|NCT00374907|21007087|P1|COMPLETED|116-Week Short-term + Long-term Period||7
8522514|NCT00374907|21007086|P2|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
8522515|NCT00374907|21007087|P1|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
8522516|NCT00374907|21007086|P2|STARTED|116-Week Short-term + Long-term Period||16
8522517|NCT00374907|21007087|P1|STARTED|116-Week Short-term + Long-term Period||20
8522518|NCT00374907|21007086|P2|NOT COMPLETED|12-Week Short-term Period||1
8522519|NCT00374907|21007087|P1|NOT COMPLETED|12-Week Short-term Period||3
8522520|NCT00374907|21007086|P2|COMPLETED|12-Week Short-term Period||15
8522521|NCT00374907|21007087|P1|COMPLETED|12-Week Short-term Period||17
8522522|NCT00374907|21007086|P2|STARTED|12-Week Short-term Period||16
8522523|NCT00374907|21007087|P1|STARTED|12-Week Short-term Period||20
8522524|NCT00374868|21007099|P1|NOT COMPLETED|Overall Study||36
8522525|NCT00374868|21007099|P1|COMPLETED|Overall Study||2
8522526|NCT00374868|21007099|P1|STARTED|Overall Study||38
8522527|NCT00374842|21007113|P3|NOT COMPLETED|Overall Study||0
8522528|NCT00374842|21007114|P2|NOT COMPLETED|Overall Study||0
8522529|NCT00374842|21007115|P1|NOT COMPLETED|Overall Study||0
8522530|NCT00374842|21007113|P3|COMPLETED|Overall Study||100
8522531|NCT00374842|21007114|P2|COMPLETED|Overall Study||100
8522532|NCT00374842|21007115|P1|COMPLETED|Overall Study||100
8522533|NCT00374842|21007113|P3|STARTED|Overall Study||100
8522534|NCT00374842|21007114|P2|STARTED|Overall Study||100
8522535|NCT00374842|21007115|P1|STARTED|Overall Study||100
8522536|NCT00374803|21007146|P2|NOT COMPLETED|Overall Study||0
8522537|NCT00374803|21007147|P1|NOT COMPLETED|Overall Study||0
8522538|NCT00374803|21007146|P2|COMPLETED|Overall Study||23
8522539|NCT00374803|21007147|P1|COMPLETED|Overall Study||22
8522540|NCT00374803|21007146|P2|STARTED|Overall Study||23
8522541|NCT00374803|21007147|P1|STARTED|Overall Study||22
8522542|NCT00374556|21007163|P2|NOT COMPLETED|Overall Study||1
8522543|NCT00374556|21007164|P1|NOT COMPLETED|Overall Study||1
8522544|NCT00374556|21007163|P2|COMPLETED|Overall Study||15
8522545|NCT00374556|21007164|P1|COMPLETED|Overall Study||13
8522546|NCT00374556|21007163|P2|STARTED|Overall Study||16
8522547|NCT00374556|21007164|P1|STARTED|Overall Study||14
8522548|NCT00374543|21007216|P2|NOT COMPLETED|Overall Study||0
8522549|NCT00374543|21007217|P1|NOT COMPLETED|Overall Study||0
8522550|NCT00374543|21007216|P2|COMPLETED|Overall Study||1
8522551|NCT00374543|21007217|P1|COMPLETED|Overall Study||2
8522552|NCT00374543|21007216|P2|STARTED|Overall Study||1
8522553|NCT00374543|21007217|P1|STARTED|Overall Study||2
8522554|NCT00374452|21007225|P2|NOT COMPLETED|Overall Study||5
8522555|NCT00374452|21007226|P1|NOT COMPLETED|Overall Study||5
8522556|NCT00374452|21007225|P2|COMPLETED|Overall Study||43
8522557|NCT00374452|21007226|P1|COMPLETED|Overall Study||29
8522558|NCT00374452|21007225|P2|Intervention Started|Overall Study||46
8522559|NCT00374452|21007226|P1|Intervention Started|Overall Study||30
8522560|NCT00374452|21007225|P2|STARTED|Overall Study||48
8522561|NCT00374452|21007226|P1|STARTED|Overall Study||34
8522562|NCT00374335|21007232|P1|NOT COMPLETED|Overall Study||0
8522563|NCT00374335|21007232|P1|COMPLETED|Overall Study||261
8522564|NCT00374335|21007232|P1|STARTED|Overall Study||261
8522565|NCT00374322|21007239|P2|NOT COMPLETED|Overall Study||1304
8522566|NCT00374322|21007240|P1|NOT COMPLETED|Overall Study||1257
8522567|NCT00374322|21007239|P2|COMPLETED|Overall Study||278
8522568|NCT00374322|21007240|P1|COMPLETED|Overall Study||322
8522569|NCT00374322|21007239|P2|Received >=1 Dose of Study Treatment|Overall Study||1576
8522570|NCT00374322|21007240|P1|Received >=1 Dose of Study Treatment|Overall Study||1571
8522571|NCT00374322|21007239|P2|STARTED|Overall Study||1582
8522572|NCT00374322|21007240|P1|STARTED|Overall Study||1579
8522573|NCT00374244|21007278|P2|NOT COMPLETED|Overall Study||0
8522574|NCT00374244|21007279|P1|NOT COMPLETED|Overall Study||0
8522575|NCT00374244|21007278|P2|COMPLETED|Overall Study||14
8522576|NCT00374244|21007279|P1|COMPLETED|Overall Study||14
8522577|NCT00374244|21007278|P2|STARTED|Overall Study||14
8522578|NCT00374244|21007279|P1|STARTED|Overall Study||14
8522579|NCT00374231|21007325|P1|NOT COMPLETED|Overall Study||0
8522580|NCT00374231|21007325|P1|COMPLETED|Overall Study||40
8522581|NCT00374231|21007325|P1|STARTED|Overall Study||40
8522582|NCT00374140|21007331|P1|NOT COMPLETED|Overall Study||2
8522583|NCT00374140|21007331|P1|COMPLETED|Overall Study||38
8522584|NCT00374140|21007331|P1|STARTED|Overall Study||40
8522585|NCT00374127|21007338|P1|NOT COMPLETED|Overall Study||11
8522586|NCT00374127|21007338|P1|COMPLETED|Overall Study||24
8522587|NCT00374127|21007338|P1|STARTED|Overall Study||35
8522588|NCT00374088|21007374|P2|NOT COMPLETED|Overall Study||1
8522589|NCT00374088|21007375|P1|NOT COMPLETED|Overall Study||1
8522590|NCT00374088|21007374|P2|COMPLETED|Overall Study||10
8522591|NCT00374088|21007375|P1|COMPLETED|Overall Study||9
8522592|NCT00374088|21007374|P2|STARTED|Overall Study||11
8522593|NCT00374088|21007375|P1|STARTED|Overall Study||10
8522594|NCT00373958|21007387|P2|NOT COMPLETED|Toddler Dose||38
8522595|NCT00373958|21007388|P1|NOT COMPLETED|Toddler Dose||30
8522596|NCT00373958|21007387|P2|COMPLETED|Toddler Dose||252
8522597|NCT00373958|21007388|P1|COMPLETED|Toddler Dose||264
8522598|NCT00373958|21007387|P2|Vaccinated Toddler Dose|Toddler Dose||265
8522599|NCT00373958|21007388|P1|Vaccinated Toddler Dose|Toddler Dose||272
8522600|NCT00373958|21007387|P2|Withdrawn After Infant Series|Toddler Dose||25
8522601|NCT00373958|21007388|P1|Withdrawn After Infant Series|Toddler Dose||22
8522602|NCT00373958|21007387|P2|STARTED|Toddler Dose||290
8522603|NCT00373958|21007388|P1|STARTED|Toddler Dose||294
8522604|NCT00373958|21007387|P2|NOT COMPLETED|Infant Series||42
8522605|NCT00373958|21007388|P1|NOT COMPLETED|Infant Series||40
8522606|NCT00373958|21007387|P2|COMPLETED|Infant Series||290
8522607|NCT00373958|21007388|P1|COMPLETED|Infant Series||294
8522608|NCT00373958|21007387|P2|Vaccinated Dose 3|Infant Series||300
8522609|NCT00373958|21007388|P1|Vaccinated Dose 3|Infant Series||298
8522610|NCT00373958|21007387|P2|Vaccinated Dose 2|Infant Series||305
8522611|NCT00373958|21007388|P1|Vaccinated Dose 2|Infant Series||309
8522612|NCT00373958|21007387|P2|Vaccinated Dose 1|Infant Series||331
8522613|NCT00373958|21007388|P1|Vaccinated Dose 1|Infant Series||332
8522614|NCT00373958|21007387|P2|STARTED|Infant Series||332
8522615|NCT00373958|21007388|P1|STARTED|Infant Series|One participant was prerandomized but not consented.|334
8522616|NCT00373880|21007436|P1|NOT COMPLETED|Overall Study||18
8522617|NCT00373880|21007436|P1|COMPLETED|Overall Study||8
8522618|NCT00373880|21007436|P1|STARTED|Overall Study||26
8522619|NCT00373698|21007466|P2|NOT COMPLETED|Overall Study||0
8522620|NCT00373698|21007467|P1|NOT COMPLETED|Overall Study||11
8522621|NCT00373698|21007466|P2|COMPLETED|Overall Study||99
8522622|NCT00373698|21007467|P1|COMPLETED|Overall Study||85
8522623|NCT00373698|21007466|P2|STARTED|Overall Study||99
8522624|NCT00373698|21007467|P1|STARTED|Overall Study||96
8522633|NCT00373529|21007516|P1|NOT COMPLETED|Overall Study||108
8522634|NCT00373529|21007516|P1|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
8522635|NCT00373529|21007516|P1|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
8522636|NCT00373529|21007516|P1|STARTED|Overall Study||116
8522637|NCT00373490|21007528|P2|NOT COMPLETED|Overall Study||6
8522638|NCT00373490|21007529|P1|NOT COMPLETED|Overall Study||9
8522639|NCT00373490|21007528|P2|COMPLETED|Overall Study||0
8522640|NCT00373490|21007529|P1|COMPLETED|Overall Study||1
8522641|NCT00373490|21007528|P2|STARTED|Overall Study||6
8522642|NCT00373490|21007529|P1|STARTED|Overall Study||10
8522643|NCT00373425|21007552|P5|NOT COMPLETED|Overall Study||72
8522644|NCT00373425|21007553|P4|NOT COMPLETED|Overall Study||11
8522645|NCT00373425|21007554|P3|NOT COMPLETED|Overall Study||134
8522646|NCT00373425|21007555|P2|NOT COMPLETED|Overall Study||153
8522647|NCT00373425|21007556|P1|NOT COMPLETED|Overall Study||370
8522648|NCT00373425|21007552|P5|COMPLETED|Overall Study|Completed 2 years of study treatment|60
8522649|NCT00373425|21007553|P4|COMPLETED|Overall Study|Completed 2 years of study treatment|0
8522650|NCT00373425|21007554|P3|COMPLETED|Overall Study|Completed 2 years of study treatment|0
8522651|NCT00373425|21007555|P2|COMPLETED|Overall Study|Completed 2 years of study treatment|197
8522652|NCT00373425|21007556|P1|COMPLETED|Overall Study|Completed 2 years of study treatment|253
8522653|NCT00373425|21007552|P5|Received Treatment|Overall Study||132
8522654|NCT00373425|21007553|P4|Received Treatment|Overall Study||7
8522655|NCT00373425|21007554|P3|Received Treatment|Overall Study||134
8522656|NCT00373425|21007555|P2|Received Treatment|Overall Study||342
8522657|NCT00373425|21007556|P1|Received Treatment|Overall Study||612
8522658|NCT00373425|21007552|P5|STARTED|Overall Study||132
8522659|NCT00373425|21007553|P4|STARTED|Overall Study||11
8522660|NCT00373425|21007554|P3|STARTED|Overall Study||134
8522661|NCT00373425|21007555|P2|STARTED|Overall Study||350
8522662|NCT00373425|21007556|P1|STARTED|Overall Study||623
8522663|NCT00373399|21007581|P6|NOT COMPLETED|Overall Study||0
8522664|NCT00373399|21007582|P5|NOT COMPLETED|Overall Study||0
8522665|NCT00373399|21007583|P4|NOT COMPLETED|Overall Study||0
8522666|NCT00373399|21007584|P3|NOT COMPLETED|Overall Study||0
8522667|NCT00373399|21007585|P2|NOT COMPLETED|Overall Study||0
8522668|NCT00373399|21007586|P1|NOT COMPLETED|Overall Study||0
8522669|NCT00373399|21007581|P6|COMPLETED|Overall Study||7
8522670|NCT00373399|21007582|P5|COMPLETED|Overall Study||7
8522671|NCT00373399|21007583|P4|COMPLETED|Overall Study||6
8522672|NCT00373399|21007584|P3|COMPLETED|Overall Study||4
8522673|NCT00373399|21007585|P2|COMPLETED|Overall Study||7
8522674|NCT00373399|21007586|P1|COMPLETED|Overall Study||5
8522675|NCT00373399|21007581|P6|STARTED|Overall Study||7
8522676|NCT00373399|21007582|P5|STARTED|Overall Study||7
8522677|NCT00373399|21007583|P4|STARTED|Overall Study||6
8522678|NCT00373399|21007584|P3|STARTED|Overall Study||4
8522679|NCT00373399|21007585|P2|STARTED|Overall Study||7
8522680|NCT00373399|21007586|P1|STARTED|Overall Study||5
8522681|NCT00373386|21007594|P1|NOT COMPLETED|Overall Study||0
8522682|NCT00373386|21007594|P1|COMPLETED|Overall Study||9
8522683|NCT00373386|21007594|P1|STARTED|Overall Study||9
8522684|NCT00373360|21007604|P1|NOT COMPLETED|Overall Study||0
8522685|NCT00373360|21007604|P1|COMPLETED|Overall Study||10
8522686|NCT00373360|21007604|P1|STARTED|Overall Study||10
8522687|NCT00373334|21007635|P3|NOT COMPLETED|Overall Study||13
8522688|NCT00373334|21007636|P2|NOT COMPLETED|Overall Study||18
8522689|NCT00373334|21007637|P1|NOT COMPLETED|Overall Study||10
8522690|NCT00373334|21007635|P3|COMPLETED|Overall Study||32
8522691|NCT00373334|21007636|P2|COMPLETED|Overall Study||32
8522692|NCT00373334|21007637|P1|COMPLETED|Overall Study||33
8522693|NCT00373334|21007635|P3|STARTED|Overall Study||45
8522694|NCT00373334|21007636|P2|STARTED|Overall Study||50
8522695|NCT00373334|21007637|P1|STARTED|Overall Study||43
8522696|NCT00373295|21007651|P6|NOT COMPLETED|Intervention 3 (8 Days)||0
8522697|NCT00373295|21007652|P5|NOT COMPLETED|Intervention 3 (8 Days)||0
8522698|NCT00373295|21007653|P4|NOT COMPLETED|Intervention 3 (8 Days)||0
8522699|NCT00373295|21007654|P3|NOT COMPLETED|Intervention 3 (8 Days)||0
8522700|NCT00373295|21007655|P2|NOT COMPLETED|Intervention 3 (8 Days)||0
8522701|NCT00373295|21007656|P1|NOT COMPLETED|Intervention 3 (8 Days)||0
8522702|NCT00373295|21007651|P6|COMPLETED|Intervention 3 (8 Days)||2
8522703|NCT00373295|21007652|P5|COMPLETED|Intervention 3 (8 Days)||2
8522704|NCT00373295|21007653|P4|COMPLETED|Intervention 3 (8 Days)||2
8522705|NCT00373295|21007654|P3|COMPLETED|Intervention 3 (8 Days)||1
8522706|NCT00373295|21007655|P2|COMPLETED|Intervention 3 (8 Days)||1
8522707|NCT00373295|21007656|P1|COMPLETED|Intervention 3 (8 Days)||2
8522708|NCT00373295|21007651|P6|STARTED|Intervention 3 (8 Days)||2
8522709|NCT00373295|21007652|P5|STARTED|Intervention 3 (8 Days)||2
8522710|NCT00373295|21007653|P4|STARTED|Intervention 3 (8 Days)||2
8522711|NCT00373295|21007654|P3|STARTED|Intervention 3 (8 Days)||1
8522712|NCT00373295|21007655|P2|STARTED|Intervention 3 (8 Days)||1
8522713|NCT00373295|21007656|P1|STARTED|Intervention 3 (8 Days)||2
8522714|NCT00373295|21007651|P6|NOT COMPLETED|Intervention 2 (8 Days)||0
8522715|NCT00373295|21007652|P5|NOT COMPLETED|Intervention 2 (8 Days)||0
8522716|NCT00373295|21007653|P4|NOT COMPLETED|Intervention 2 (8 Days)||0
8522717|NCT00373295|21007654|P3|NOT COMPLETED|Intervention 2 (8 Days)||0
8522718|NCT00373295|21007655|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
8522719|NCT00373295|21007656|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
8522720|NCT00373295|21007651|P6|COMPLETED|Intervention 2 (8 Days)||2
8522721|NCT00373295|21007652|P5|COMPLETED|Intervention 2 (8 Days)||2
8522722|NCT00373295|21007653|P4|COMPLETED|Intervention 2 (8 Days)||2
8522723|NCT00373295|21007654|P3|COMPLETED|Intervention 2 (8 Days)||1
8522724|NCT00373295|21007655|P2|COMPLETED|Intervention 2 (8 Days)||1
8522725|NCT00373295|21007656|P1|COMPLETED|Intervention 2 (8 Days)||2
8522726|NCT00373295|21007651|P6|STARTED|Intervention 2 (8 Days)||2
8522727|NCT00373295|21007652|P5|STARTED|Intervention 2 (8 Days)||2
8522728|NCT00373295|21007653|P4|STARTED|Intervention 2 (8 Days)||2
8522729|NCT00373295|21007654|P3|STARTED|Intervention 2 (8 Days)||1
8522730|NCT00373295|21007655|P2|STARTED|Intervention 2 (8 Days)||1
8522731|NCT00373295|21007656|P1|STARTED|Intervention 2 (8 Days)||2
8522732|NCT00373295|21007651|P6|NOT COMPLETED|Intervention 1 (8 Days)||0
8522733|NCT00373295|21007652|P5|NOT COMPLETED|Intervention 1 (8 Days)||1
8522734|NCT00373295|21007653|P4|NOT COMPLETED|Intervention 1 (8 Days)||0
8522735|NCT00373295|21007654|P3|NOT COMPLETED|Intervention 1 (8 Days)||0
8522736|NCT00373295|21007655|P2|NOT COMPLETED|Intervention 1 (8 Days)||2
8522737|NCT00373295|21007656|P1|NOT COMPLETED|Intervention 1 (8 Days)||0
8522738|NCT00373295|21007651|P6|COMPLETED|Intervention 1 (8 Days)||2
8522739|NCT00373295|21007652|P5|COMPLETED|Intervention 1 (8 Days)||2
8522740|NCT00373295|21007653|P4|COMPLETED|Intervention 1 (8 Days)||2
8522741|NCT00373295|21007654|P3|COMPLETED|Intervention 1 (8 Days)||1
8522742|NCT00373295|21007655|P2|COMPLETED|Intervention 1 (8 Days)||1
8522743|NCT00373295|21007656|P1|COMPLETED|Intervention 1 (8 Days)||2
8522744|NCT00373295|21007651|P6|STARTED|Intervention 1 (8 Days)||2
8522745|NCT00373295|21007652|P5|STARTED|Intervention 1 (8 Days)||3
8522746|NCT00373295|21007653|P4|STARTED|Intervention 1 (8 Days)||2
8522747|NCT00373295|21007654|P3|STARTED|Intervention 1 (8 Days)||1
8522748|NCT00373295|21007655|P2|STARTED|Intervention 1 (8 Days)||3
8522749|NCT00373295|21007656|P1|STARTED|Intervention 1 (8 Days)||2
8522750|NCT00373269|21007666|P2|NOT COMPLETED|Overall Study||0
8522751|NCT00373269|21007667|P1|NOT COMPLETED|Overall Study||0
8522752|NCT00373269|21007666|P2|COMPLETED|Overall Study||10
8522753|NCT00373269|21007667|P1|COMPLETED|Overall Study||11
8522754|NCT00373269|21007666|P2|STARTED|Overall Study||10
8522755|NCT00373269|21007667|P1|STARTED|Overall Study||11
8522756|NCT00373256|21007677|P2|NOT COMPLETED|Overall Study||247
8522757|NCT00373256|21007678|P1|NOT COMPLETED|Overall Study||241
8522758|NCT00373256|21007677|P2|COMPLETED|Overall Study||0
8522759|NCT00373256|21007678|P1|COMPLETED|Overall Study||0
8522760|NCT00373256|21007677|P2|Treated|Overall Study||236
8522761|NCT00373256|21007678|P1|Treated|Overall Study||235
8522762|NCT00373256|21007677|P2|STARTED|Overall Study||247
8522763|NCT00373256|21007678|P1|STARTED|Overall Study||241
8522764|NCT00373113|21007704|P2|NOT COMPLETED|Overall Study||244
8522765|NCT00373113|21007705|P1|NOT COMPLETED|Overall Study||238
8522766|NCT00373113|21007704|P2|COMPLETED|Overall Study||0
8522767|NCT00373113|21007705|P1|COMPLETED|Overall Study||0
8522768|NCT00373113|21007704|P2|Received Treatment|Overall Study||240
8522769|NCT00373113|21007705|P1|Received Treatment|Overall Study||238
8522770|NCT00373113|21007704|P2|STARTED|Overall Study||244
8522771|NCT00373113|21007705|P1|STARTED|Overall Study||238
8522772|NCT00372996|21007727|P4|NOT COMPLETED|Overall Study||20
8522773|NCT00372996|21007728|P3|NOT COMPLETED|Overall Study||28
8522774|NCT00372996|21007729|P2|NOT COMPLETED|Overall Study||14
8522775|NCT00372996|21007730|P1|NOT COMPLETED|Overall Study||37
8522776|NCT00372996|21007727|P4|COMPLETED|Overall Study||23
8522777|NCT00372996|21007728|P3|COMPLETED|Overall Study||33
8522778|NCT00372996|21007729|P2|COMPLETED|Overall Study||22
8522779|NCT00372996|21007730|P1|COMPLETED|Overall Study||42
8522780|NCT00372996|21007727|P4|STARTED|Overall Study||43
8522781|NCT00372996|21007728|P3|STARTED|Overall Study||61
8522782|NCT00372996|21007729|P2|STARTED|Overall Study||36
8522783|NCT00372996|21007730|P1|STARTED|Overall Study||79
8522784|NCT00372970|21007756|P2|NOT COMPLETED|Overall Study||0
8522785|NCT00372970|21007757|P1|NOT COMPLETED|Overall Study||0
8522786|NCT00372970|21007756|P2|COMPLETED|Overall Study||16
8522787|NCT00372970|21007757|P1|COMPLETED|Overall Study||16
8522788|NCT00372970|21007756|P2|STARTED|Overall Study||16
8522789|NCT00372970|21007757|P1|STARTED|Overall Study||16
8522790|NCT00372957|21007766|P3|NOT COMPLETED|Overall Study||0
8522791|NCT00372957|21007767|P2|NOT COMPLETED|Overall Study||0
8522792|NCT00372957|21007768|P1|NOT COMPLETED|Overall Study||0
8522793|NCT00372957|21007766|P3|COMPLETED|Overall Study||10
8522794|NCT00372957|21007767|P2|COMPLETED|Overall Study||10
8522795|NCT00372957|21007768|P1|COMPLETED|Overall Study||10
8522796|NCT00372957|21007766|P3|STARTED|Overall Study||10
8522797|NCT00372957|21007767|P2|STARTED|Overall Study||10
8522798|NCT00372957|21007768|P1|STARTED|Overall Study||10
8522799|NCT00372905|21007815|P4|NOT COMPLETED|Follow up Until Relapse or Progression||3
8522800|NCT00372905|21007816|P3|NOT COMPLETED|Follow up Until Relapse or Progression||0
8522801|NCT00372905|21007817|P2|NOT COMPLETED|Follow up Until Relapse or Progression||1
8522802|NCT00372905|21007818|P1|NOT COMPLETED|Follow up Until Relapse or Progression||0
8522803|NCT00372905|21007815|P4|COMPLETED|Follow up Until Relapse or Progression||5
8522804|NCT00372905|21007816|P3|COMPLETED|Follow up Until Relapse or Progression||3
8522805|NCT00372905|21007817|P2|COMPLETED|Follow up Until Relapse or Progression||2
8522806|NCT00372905|21007818|P1|COMPLETED|Follow up Until Relapse or Progression||3
8522807|NCT00372905|21007815|P4|STARTED|Follow up Until Relapse or Progression||8
8522808|NCT00372905|21007816|P3|STARTED|Follow up Until Relapse or Progression||3
8522809|NCT00372905|21007817|P2|STARTED|Follow up Until Relapse or Progression||3
8522810|NCT00372905|21007818|P1|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
8522811|NCT00372905|21007815|P4|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
8522812|NCT00372905|21007816|P3|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8522813|NCT00372905|21007817|P2|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8522814|NCT00372905|21007818|P1|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8522815|NCT00372905|21007815|P4|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
8522816|NCT00372905|21007816|P3|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8522817|NCT00372905|21007817|P2|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8522818|NCT00372905|21007818|P1|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
8522819|NCT00372905|21007815|P4|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
8522820|NCT00372905|21007816|P3|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
8522821|NCT00372905|21007817|P2|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
8522822|NCT00372905|21007818|P1|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
8522823|NCT00372905|21007815|P4|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
8522824|NCT00372905|21007816|P3|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
8522825|NCT00372905|21007817|P2|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
8522826|NCT00372905|21007818|P1|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
8522827|NCT00372905|21007815|P4|Registration|Expansion Phase at Dose 1.3mg/m2||8
8522828|NCT00372905|21007816|P3|Registration|Expansion Phase at Dose 1.3mg/m2||0
8522829|NCT00372905|21007817|P2|Registration|Expansion Phase at Dose 1.3mg/m2||0
8522830|NCT00372905|21007818|P1|Registration|Expansion Phase at Dose 1.3mg/m2||0
8522831|NCT00372905|21007815|P4|STARTED|Expansion Phase at Dose 1.3mg/m2||8
8522832|NCT00372905|21007816|P3|STARTED|Expansion Phase at Dose 1.3mg/m2||0
8522833|NCT00372905|21007817|P2|STARTED|Expansion Phase at Dose 1.3mg/m2||0
8522834|NCT00372905|21007818|P1|STARTED|Expansion Phase at Dose 1.3mg/m2||0
8522835|NCT00372905|21007815|P4|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8522836|NCT00372905|21007816|P3|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
8522837|NCT00372905|21007817|P2|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8522838|NCT00372905|21007818|P1|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8522839|NCT00372905|21007815|P4|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8522840|NCT00372905|21007816|P3|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
8522841|NCT00372905|21007817|P2|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8522842|NCT00372905|21007818|P1|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
8522843|NCT00372905|21007815|P4|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
8522844|NCT00372905|21007816|P3|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
8522845|NCT00372905|21007817|P2|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
8522846|NCT00372905|21007818|P1|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
8522847|NCT00372905|21007815|P4|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
8522848|NCT00372905|21007816|P3|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
8522849|NCT00372905|21007817|P2|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
8522850|NCT00372905|21007818|P1|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
8522851|NCT00372905|21007815|P4|Registered|Cohort 3: Dose Level 1.6mg/m2||0
8522852|NCT00372905|21007816|P3|Registered|Cohort 3: Dose Level 1.6mg/m2||4
8522853|NCT00372905|21007817|P2|Registered|Cohort 3: Dose Level 1.6mg/m2||0
8522854|NCT00372905|21007818|P1|Registered|Cohort 3: Dose Level 1.6mg/m2||0
8522855|NCT00372905|21007815|P4|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
8522856|NCT00372905|21007816|P3|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
8522857|NCT00372905|21007817|P2|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
8522858|NCT00372905|21007818|P1|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
8522859|NCT00372905|21007815|P4|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8522860|NCT00372905|21007816|P3|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8522861|NCT00372905|21007817|P2|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8522862|NCT00372905|21007818|P1|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8522863|NCT00372905|21007815|P4|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8522864|NCT00372905|21007816|P3|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8522865|NCT00372905|21007817|P2|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
8522866|NCT00372905|21007818|P1|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
8522867|NCT00372905|21007815|P4|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
8522868|NCT00372905|21007816|P3|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
8522869|NCT00372905|21007817|P2|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
8522870|NCT00372905|21007818|P1|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
8522871|NCT00372905|21007815|P4|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
8522872|NCT00372905|21007816|P3|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
8522873|NCT00372905|21007817|P2|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
8522874|NCT00372905|21007818|P1|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
8522875|NCT00372905|21007815|P4|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
8522876|NCT00372905|21007816|P3|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
8522877|NCT00372905|21007817|P2|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
8522878|NCT00372905|21007818|P1|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
8522879|NCT00372905|21007815|P4|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
8522880|NCT00372905|21007816|P3|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
8522881|NCT00372905|21007817|P2|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
8522882|NCT00372905|21007818|P1|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
8522883|NCT00372905|21007815|P4|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8522884|NCT00372905|21007816|P3|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8522885|NCT00372905|21007817|P2|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8522886|NCT00372905|21007818|P1|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
8522887|NCT00372905|21007815|P4|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8522888|NCT00372905|21007816|P3|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8522889|NCT00372905|21007817|P2|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
8522890|NCT00372905|21007818|P1|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
8522891|NCT00372905|21007815|P4|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
8522892|NCT00372905|21007816|P3|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
8522893|NCT00372905|21007817|P2|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
8522894|NCT00372905|21007818|P1|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
8522895|NCT00372905|21007815|P4|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
8522896|NCT00372905|21007816|P3|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
8522897|NCT00372905|21007817|P2|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
8522898|NCT00372905|21007818|P1|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
8522899|NCT00372905|21007815|P4|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
8522900|NCT00372905|21007816|P3|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
8522901|NCT00372905|21007817|P2|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
8522902|NCT00372905|21007818|P1|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
8522903|NCT00372905|21007815|P4|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
8522904|NCT00372905|21007816|P3|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
8522905|NCT00372905|21007817|P2|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
8522906|NCT00372905|21007818|P1|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
8522907|NCT00372775|21007830|P1|NOT COMPLETED|Overall Study||63
8522908|NCT00372775|21007830|P1|COMPLETED|Overall Study||3
8522909|NCT00372775|21007830|P1|Received Treatment|Overall Study||64
8522910|NCT00372775|21007830|P1|STARTED|Overall Study||66
8522911|NCT00372697|21007852|P2|NOT COMPLETED|Overall Study||1
8522912|NCT00372697|21007853|P1|NOT COMPLETED|Overall Study||1
8522913|NCT00372697|21007852|P2|COMPLETED|Overall Study||11
8522914|NCT00372697|21007853|P1|COMPLETED|Overall Study||15
8522915|NCT00372697|21007852|P2|STARTED|Overall Study||12
8522916|NCT00372697|21007853|P1|STARTED|Overall Study||16
8522917|NCT00372619|21007878|P7|NOT COMPLETED|Overall Study||0
8522918|NCT00372619|21007879|P6|NOT COMPLETED|Overall Study||3
8522919|NCT00372619|21007880|P5|NOT COMPLETED|Overall Study||0
8522920|NCT00372619|21007881|P4|NOT COMPLETED|Overall Study||0
8522921|NCT00372619|21007882|P3|NOT COMPLETED|Overall Study||0
8522922|NCT00372619|21007883|P2|NOT COMPLETED|Overall Study||0
8522923|NCT00372619|21007884|P1|NOT COMPLETED|Overall Study||0
8522924|NCT00372619|21007878|P7|COMPLETED|Overall Study||2
8522925|NCT00372619|21007879|P6|COMPLETED|Overall Study||39
8522926|NCT00372619|21007880|P5|COMPLETED|Overall Study||7
8522927|NCT00372619|21007881|P4|COMPLETED|Overall Study||10
8522928|NCT00372619|21007882|P3|COMPLETED|Overall Study||3
8522929|NCT00372619|21007883|P2|COMPLETED|Overall Study||2
8522930|NCT00372619|21007884|P1|COMPLETED|Overall Study||8
8522931|NCT00372619|21007878|P7|STARTED|Overall Study||2
8522932|NCT00372619|21007879|P6|STARTED|Overall Study||42
8522933|NCT00372619|21007880|P5|STARTED|Overall Study||7
8522934|NCT00372619|21007881|P4|STARTED|Overall Study||10
8522935|NCT00372619|21007882|P3|STARTED|Overall Study||3
8522936|NCT00372619|21007883|P2|STARTED|Overall Study||2
8522937|NCT00372619|21007884|P1|STARTED|Overall Study||8
8522947|NCT00372567|21007948|P3|NOT COMPLETED|Phase 3 Study||12
8522948|NCT00372567|21007949|P2|NOT COMPLETED|Phase 3 Study||26
8522949|NCT00372567|21007950|P1|NOT COMPLETED|Phase 3 Study||31
8522950|NCT00372567|21007948|P3|COMPLETED|Phase 3 Study||0
8522951|NCT00372567|21007949|P2|COMPLETED|Phase 3 Study||0
8522952|NCT00372567|21007950|P1|COMPLETED|Phase 3 Study||0
8522953|NCT00372567|21007948|P3|Received Treatment|Phase 3 Study||12
8522954|NCT00372567|21007949|P2|Received Treatment|Phase 3 Study||25
8522955|NCT00372567|21007950|P1|Received Treatment|Phase 3 Study||31
8522956|NCT00372567|21007948|P3|STARTED|Phase 3 Study||12
8522957|NCT00372567|21007949|P2|STARTED|Phase 3 Study||26
8522958|NCT00372567|21007950|P1|STARTED|Phase 3 Study||31
8522959|NCT00372567|21007948|P3|NOT COMPLETED|Phase 1 Sub-study||0
8522960|NCT00372567|21007949|P2|NOT COMPLETED|Phase 1 Sub-study||0
8522961|NCT00372567|21007950|P1|NOT COMPLETED|Phase 1 Sub-study||0
8522962|NCT00372567|21007948|P3|COMPLETED|Phase 1 Sub-study||12
8522963|NCT00372567|21007949|P2|COMPLETED|Phase 1 Sub-study||0
8522964|NCT00372567|21007950|P1|COMPLETED|Phase 1 Sub-study||0
8522965|NCT00372567|21007948|P3|STARTED|Phase 1 Sub-study||12
8522966|NCT00372567|21007949|P2|STARTED|Phase 1 Sub-study||0
8522967|NCT00372567|21007950|P1|STARTED|Phase 1 Sub-study||0
8522968|NCT00372528|21007978|P1|NOT COMPLETED|Overall Study||21
8522969|NCT00372528|21007978|P1|COMPLETED|Overall Study||0
8522970|NCT00372528|21007978|P1|STARTED|Overall Study||21
8522971|NCT00372489|21007983|P1|NOT COMPLETED|Overall Study||79
8522972|NCT00372489|21007983|P1|COMPLETED|Overall Study||2
8522973|NCT00372489|21007983|P1|STARTED|Overall Study||81
8522974|NCT00372424|21007987|P1|NOT COMPLETED|Overall Study||26
8522975|NCT00372424|21007987|P1|COMPLETED|Overall Study||0
8522976|NCT00372424|21007987|P1|Treated|Overall Study||25
8522977|NCT00372424|21007987|P1|STARTED|Overall Study||26
8522978|NCT00372411|21008001|P3|NOT COMPLETED|Overall Study||3
8522979|NCT00372411|21008002|P2|NOT COMPLETED|Overall Study||8
8522980|NCT00372411|21008003|P1|NOT COMPLETED|Overall Study||5
8522981|NCT00372411|21008001|P3|COMPLETED|Overall Study||25
8522982|NCT00372411|21008002|P2|COMPLETED|Overall Study||42
8522983|NCT00372411|21008003|P1|COMPLETED|Overall Study||44
8522984|NCT00372411|21008001|P3|STARTED|Overall Study||28
8522985|NCT00372411|21008002|P2|STARTED|Overall Study||50
8522986|NCT00372411|21008003|P1|STARTED|Overall Study||49
8522987|NCT00372385|21008027|P4|NOT COMPLETED|Overall Study||8
8522988|NCT00372385|21008028|P3|NOT COMPLETED|Overall Study||10
8522989|NCT00372385|21008029|P2|NOT COMPLETED|Overall Study||20
8522990|NCT00372385|21008030|P1|NOT COMPLETED|Overall Study||33
8522991|NCT00372385|21008027|P4|COMPLETED|Overall Study||70
8522992|NCT00372385|21008028|P3|COMPLETED|Overall Study||72
8522993|NCT00372385|21008029|P2|COMPLETED|Overall Study||61
8522994|NCT00372385|21008030|P1|COMPLETED|Overall Study||49
8522995|NCT00372385|21008027|P4|STARTED|Overall Study||78
8522996|NCT00372385|21008028|P3|STARTED|Overall Study||82
8522997|NCT00372385|21008029|P2|STARTED|Overall Study||81
8522998|NCT00372385|21008030|P1|STARTED|Overall Study||82
8522999|NCT00372255|21008059|P2|NOT COMPLETED|Overall Study||1
8523000|NCT00372255|21008060|P1|NOT COMPLETED|Overall Study||2
8523001|NCT00372255|21008059|P2|COMPLETED|Overall Study||113
8523002|NCT00372255|21008060|P1|COMPLETED|Overall Study||108
8523003|NCT00372255|21008059|P2|STARTED|Overall Study||114
8523004|NCT00372255|21008060|P1|STARTED|Overall Study||110
8523005|NCT00372229|21008082|P2|NOT COMPLETED|Follow-Up Phase||52
8523006|NCT00372229|21008083|P1|NOT COMPLETED|Follow-Up Phase||46
8523007|NCT00372229|21008082|P2|COMPLETED|Follow-Up Phase||70
8523008|NCT00372229|21008083|P1|COMPLETED|Follow-Up Phase||71
8523009|NCT00372229|21008082|P2|STARTED|Follow-Up Phase||122
8523010|NCT00372229|21008083|P1|STARTED|Follow-Up Phase||117
8523011|NCT00372229|21008082|P2|NOT COMPLETED|Study Phase||29
8523012|NCT00372229|21008083|P1|NOT COMPLETED|Study Phase||31
8523013|NCT00372229|21008082|P2|COMPLETED|Study Phase||122
8523014|NCT00372229|21008083|P1|COMPLETED|Study Phase||117
8523015|NCT00372229|21008082|P2|STARTED|Study Phase||151
8523016|NCT00372229|21008083|P1|STARTED|Study Phase||148
8523017|NCT00372190|21008173|P2|NOT COMPLETED|Overall Study||1
8523018|NCT00372190|21008174|P1|NOT COMPLETED|Overall Study||3
8523019|NCT00372190|21008173|P2|COMPLETED|Overall Study||96
8523020|NCT00372190|21008174|P1|COMPLETED|Overall Study||90
8523021|NCT00372190|21008173|P2|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
8523022|NCT00372190|21008174|P1|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
8523023|NCT00372112|21008190|P4|NOT COMPLETED|Overall Study||4
8523024|NCT00372112|21008191|P3|NOT COMPLETED|Overall Study||4
8523025|NCT00372112|21008192|P2|NOT COMPLETED|Overall Study||1
8523026|NCT00372112|21008193|P1|NOT COMPLETED|Overall Study||1
8523027|NCT00372112|21008190|P4|COMPLETED|Overall Study||14
8523028|NCT00372112|21008191|P3|COMPLETED|Overall Study||13
8523029|NCT00372112|21008192|P2|COMPLETED|Overall Study||15
8523030|NCT00372112|21008193|P1|COMPLETED|Overall Study||16
8523031|NCT00372112|21008190|P4|STARTED|Overall Study||18
8523032|NCT00372112|21008191|P3|STARTED|Overall Study||17
8523033|NCT00372112|21008192|P2|STARTED|Overall Study||16
8523034|NCT00372112|21008193|P1|STARTED|Overall Study||17
8523035|NCT00372060|21008324|P2|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
8523036|NCT00372060|21008325|P1|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
8523037|NCT00372060|21008324|P2|COMPLETED|Period II - Open-label (Weeks 12-52)||59
8523038|NCT00372060|21008325|P1|COMPLETED|Period II - Open-label (Weeks 12-52)||49
8523039|NCT00372060|21008324|P2|STARTED|Period II - Open-label (Weeks 12-52)||67
8523040|NCT00372060|21008325|P1|STARTED|Period II - Open-label (Weeks 12-52)||63
8523041|NCT00372060|21008324|P2|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
8523042|NCT00372060|21008325|P1|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
8523043|NCT00372060|21008324|P2|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
8523044|NCT00372060|21008325|P1|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
8523045|NCT00372060|21008324|P2|STARTED|Period I - Double-blind (Weeks 0-12)||68
8523046|NCT00372060|21008325|P1|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
8523047|NCT00371865|21008340|P2|NOT COMPLETED|Overall Study||14
8523048|NCT00371865|21008341|P1|NOT COMPLETED|Overall Study||15
8523049|NCT00371865|21008340|P2|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
8523050|NCT00371865|21008341|P1|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
8523051|NCT00371865|21008340|P2|STARTED|Overall Study||57
8523052|NCT00371865|21008341|P1|STARTED|Overall Study||57
8523053|NCT00371839|21008358|P3|NOT COMPLETED|Overall Study||2
8523054|NCT00371839|21008359|P2|NOT COMPLETED|Overall Study||7
8523055|NCT00371839|21008360|P1|NOT COMPLETED|Overall Study||17
8523056|NCT00371839|21008358|P3|COMPLETED|Overall Study||7
8523057|NCT00371839|21008359|P2|COMPLETED|Overall Study||13
8523058|NCT00371839|21008360|P1|COMPLETED|Overall Study||32
8523059|NCT00371839|21008358|P3|STARTED|Overall Study||9
8523060|NCT00371839|21008359|P2|STARTED|Overall Study||20
8523061|NCT00371839|21008360|P1|STARTED|Overall Study||49
8523062|NCT00371826|21008369|P3|NOT COMPLETED|Extension Phase (24 Months)||2
8523063|NCT00371826|21008370|P2|NOT COMPLETED|Extension Phase (24 Months)||10
8523064|NCT00371826|21008371|P1|NOT COMPLETED|Extension Phase (24 Months)||5
8523065|NCT00371826|21008369|P3|COMPLETED|Extension Phase (24 Months)||3
8523066|NCT00371826|21008370|P2|COMPLETED|Extension Phase (24 Months)||29
8523067|NCT00371826|21008371|P1|COMPLETED|Extension Phase (24 Months)||18
8523068|NCT00371826|21008369|P3|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
8523069|NCT00371826|21008370|P2|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
8523070|NCT00371826|21008371|P1|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
8523071|NCT00371826|21008369|P3|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
8523072|NCT00371826|21008370|P2|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
8523073|NCT00371826|21008371|P1|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
8523074|NCT00371826|21008369|P3|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
8523075|NCT00371826|21008370|P2|STARTED|Extension Phase (24 Months)||39
8523076|NCT00371826|21008371|P1|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
8523077|NCT00371826|21008369|P3|NOT COMPLETED|Core Phase (12 Months)||24
8523078|NCT00371826|21008370|P2|NOT COMPLETED|Core Phase (12 Months)||8
8523079|NCT00371826|21008371|P1|NOT COMPLETED|Core Phase (12 Months)||24
8523080|NCT00371826|21008369|P3|COMPLETED|Core Phase (12 Months)||6
8523081|NCT00371826|21008370|P2|COMPLETED|Core Phase (12 Months)||39
8523082|NCT00371826|21008371|P1|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
8523083|NCT00371826|21008369|P3|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
8523084|NCT00371826|21008370|P2|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
8523085|NCT00371826|21008371|P1|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
8523086|NCT00371826|21008369|P3|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
8523087|NCT00371826|21008370|P2|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
8523088|NCT00371826|21008371|P1|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
8523089|NCT00371826|21008369|P3|STARTED|Core Phase (12 Months)||30
8523090|NCT00371826|21008370|P2|STARTED|Core Phase (12 Months)||47
8523091|NCT00371826|21008371|P1|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
8523092|NCT00371787|21008495|P2|NOT COMPLETED|Overall Study||1
8523093|NCT00371787|21008496|P1|NOT COMPLETED|Overall Study||3
8523094|NCT00371787|21008495|P2|COMPLETED|Overall Study||11
8523095|NCT00371787|21008496|P1|COMPLETED|Overall Study||23
8523096|NCT00371787|21008495|P2|STARTED|Overall Study||12
8523097|NCT00371787|21008496|P1|STARTED|Overall Study||26
8523098|NCT00371761|21008510|P2|NOT COMPLETED|Overall Study||10
8523099|NCT00371761|21008511|P1|NOT COMPLETED|Overall Study||8
8523100|NCT00371761|21008510|P2|COMPLETED|Overall Study||2
8523101|NCT00371761|21008511|P1|COMPLETED|Overall Study||5
8523102|NCT00371761|21008510|P2|STARTED|Overall Study||12
8523103|NCT00371761|21008511|P1|STARTED|Overall Study||13
8523104|NCT00371683|21008519|P2|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
8523105|NCT00371683|21008520|P1|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
8523106|NCT00371683|21008519|P2|COMPLETED|Follow-Up Period - Randomized Patients||1461
8523107|NCT00371683|21008520|P1|COMPLETED|Follow-Up Period - Randomized Patients||1492
8523108|NCT00371683|21008519|P2|STARTED|Follow-Up Period - Randomized Patients||1533
8523109|NCT00371683|21008520|P1|STARTED|Follow-Up Period - Randomized Patients||1553
8523110|NCT00371683|21008519|P2|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
8523111|NCT00371683|21008520|P1|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
8523112|NCT00371683|21008519|P2|COMPLETED|DB Treatment Period-Randomized Patients||1489
8523113|NCT00371683|21008520|P1|COMPLETED|DB Treatment Period-Randomized Patients||1509
8523114|NCT00371683|21008519|P2|STARTED|DB Treatment Period-Randomized Patients||1596
8523115|NCT00371683|21008520|P1|STARTED|DB Treatment Period-Randomized Patients||1599
8523116|NCT00371644|21008574|P2|NOT COMPLETED|Overall Study||13
8523117|NCT00371644|21008575|P1|NOT COMPLETED|Overall Study||28
8523118|NCT00371644|21008574|P2|COMPLETED|Overall Study||44
8523119|NCT00371644|21008575|P1|COMPLETED|Overall Study||44
8523120|NCT00371644|21008574|P2|STARTED|Overall Study||57
8523121|NCT00371644|21008575|P1|STARTED|Overall Study||72
8523122|NCT00371631|21008581|P1|NOT COMPLETED|Overall Study||0
8523123|NCT00371631|21008581|P1|COMPLETED|Overall Study||13
8523124|NCT00371631|21008581|P1|STARTED|Overall Study||13
8523125|NCT00371566|21008588|P2|NOT COMPLETED|Follow Up Phase||7
8523126|NCT00371566|21008589|P1|NOT COMPLETED|Follow Up Phase||3
8523127|NCT00371566|21008588|P2|COMPLETED|Follow Up Phase||58
8523128|NCT00371566|21008589|P1|COMPLETED|Follow Up Phase||28
8523129|NCT00371566|21008588|P2|STARTED|Follow Up Phase||65
8523130|NCT00371566|21008589|P1|STARTED|Follow Up Phase||31
8523131|NCT00371566|21008588|P2|NOT COMPLETED|Chemoradiation Phase||3
8523132|NCT00371566|21008589|P1|NOT COMPLETED|Chemoradiation Phase||5
8523133|NCT00371566|21008588|P2|COMPLETED|Chemoradiation Phase||65
8523134|NCT00371566|21008589|P1|COMPLETED|Chemoradiation Phase||31
8523135|NCT00371566|21008588|P2|STARTED|Chemoradiation Phase||68
8523136|NCT00371566|21008589|P1|STARTED|Chemoradiation Phase||36
8523137|NCT00371566|21008588|P2|NOT COMPLETED|Treatment Phase||3
8523138|NCT00371566|21008589|P1|NOT COMPLETED|Treatment Phase||0
8523139|NCT00371566|21008588|P2|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
8523140|NCT00371566|21008589|P1|COMPLETED|Treatment Phase||36
8523141|NCT00371566|21008588|P2|STARTED|Treatment Phase||71
8523142|NCT00371566|21008589|P1|STARTED|Treatment Phase||36
8523143|NCT00371540|21008661|P2|NOT COMPLETED|Overall Study||9
8523144|NCT00371540|21008662|P1|NOT COMPLETED|Overall Study||10
8523145|NCT00371540|21008661|P2|COMPLETED|Overall Study||87
8523146|NCT00371540|21008662|P1|COMPLETED|Overall Study||102
8523147|NCT00371540|21008661|P2|STARTED|Overall Study||96
8523148|NCT00371540|21008662|P1|STARTED|Overall Study||112
8523149|NCT00371462|21008674|P2|NOT COMPLETED|Overall Study||8
8523150|NCT00371462|21008675|P1|NOT COMPLETED|Overall Study||8
8523151|NCT00371462|21008674|P2|COMPLETED|Overall Study||27
8523152|NCT00371462|21008675|P1|COMPLETED|Overall Study||27
8523153|NCT00371462|21008674|P2|STARTED|Overall Study||35
8523154|NCT00371462|21008675|P1|STARTED|Overall Study||35
8523155|NCT00371449|21008681|P1|NOT COMPLETED|Overall Study||0
8523156|NCT00371449|21008681|P1|COMPLETED|Overall Study||120
8523157|NCT00371449|21008681|P1|STARTED|Overall Study||120
8523158|NCT00371436|21008692|P2|NOT COMPLETED|Overall Study||21
8523159|NCT00371436|21008693|P1|NOT COMPLETED|Overall Study||34
8523160|NCT00371436|21008692|P2|COMPLETED|Overall Study||68
8523161|NCT00371436|21008693|P1|COMPLETED|Overall Study||58
8523162|NCT00371436|21008692|P2|STARTED|Overall Study||89
8523163|NCT00371436|21008693|P1|STARTED|Overall Study||92
8523164|NCT00371397|21008699|P12|NOT COMPLETED|Session 3||0
8523165|NCT00371397|21008700|P11|NOT COMPLETED|Session 3||0
8523166|NCT00371397|21008701|P10|NOT COMPLETED|Session 3||0
8523167|NCT00371397|21008702|P9|NOT COMPLETED|Session 3||0
8523168|NCT00371397|21008703|P8|NOT COMPLETED|Session 3||0
8523169|NCT00371397|21008704|P7|NOT COMPLETED|Session 3||0
8523170|NCT00371397|21008705|P6|NOT COMPLETED|Session 3||0
8523171|NCT00371397|21008706|P5|NOT COMPLETED|Session 3||0
8523172|NCT00371397|21008707|P4|NOT COMPLETED|Session 3||0
8523173|NCT00371397|21008708|P3|NOT COMPLETED|Session 3||0
8523174|NCT00371397|21008709|P2|NOT COMPLETED|Session 3||0
8523175|NCT00371397|21008710|P1|NOT COMPLETED|Session 3||0
8523176|NCT00371397|21008699|P12|COMPLETED|Session 3||2
8523177|NCT00371397|21008700|P11|COMPLETED|Session 3||4
8523178|NCT00371397|21008701|P10|COMPLETED|Session 3||5
8523179|NCT00371397|21008702|P9|COMPLETED|Session 3||6
8523180|NCT00371397|21008703|P8|COMPLETED|Session 3||4
8523181|NCT00371397|21008704|P7|COMPLETED|Session 3||4
8523182|NCT00371397|21008705|P6|COMPLETED|Session 3||4
8523183|NCT00371397|21008706|P5|COMPLETED|Session 3||3
8523184|NCT00371397|21008707|P4|COMPLETED|Session 3||2
8523185|NCT00371397|21008708|P3|COMPLETED|Session 3||5
8523186|NCT00371397|21008709|P2|COMPLETED|Session 3||7
8523187|NCT00371397|21008710|P1|COMPLETED|Session 3||4
8523188|NCT00371397|21008699|P12|STARTED|Session 3||2
8523189|NCT00371397|21008700|P11|STARTED|Session 3||4
8523190|NCT00371397|21008701|P10|STARTED|Session 3||5
8523191|NCT00371397|21008702|P9|STARTED|Session 3||6
8523192|NCT00371397|21008703|P8|STARTED|Session 3||4
8523193|NCT00371397|21008704|P7|STARTED|Session 3||4
8523194|NCT00371397|21008705|P6|STARTED|Session 3||4
8523195|NCT00371397|21008706|P5|STARTED|Session 3||3
8523196|NCT00371397|21008707|P4|STARTED|Session 3||2
8523197|NCT00371397|21008708|P3|STARTED|Session 3||5
8523198|NCT00371397|21008709|P2|STARTED|Session 3||7
8523199|NCT00371397|21008710|P1|STARTED|Session 3||4
8523200|NCT00371397|21008699|P12|NOT COMPLETED|Session 2||0
8523201|NCT00371397|21008700|P11|NOT COMPLETED|Session 2||0
8523202|NCT00371397|21008701|P10|NOT COMPLETED|Session 2||0
8523203|NCT00371397|21008702|P9|NOT COMPLETED|Session 2||0
8523204|NCT00371397|21008703|P8|NOT COMPLETED|Session 2||0
8523205|NCT00371397|21008704|P7|NOT COMPLETED|Session 2||0
8523206|NCT00371397|21008705|P6|NOT COMPLETED|Session 2||0
8523207|NCT00371397|21008706|P5|NOT COMPLETED|Session 2||0
8523208|NCT00371397|21008707|P4|NOT COMPLETED|Session 2||0
8523209|NCT00371397|21008708|P3|NOT COMPLETED|Session 2||0
8523210|NCT00371397|21008709|P2|NOT COMPLETED|Session 2||0
8523211|NCT00371397|21008710|P1|NOT COMPLETED|Session 2||0
8523212|NCT00371397|21008699|P12|COMPLETED|Session 2||2
8523213|NCT00371397|21008700|P11|COMPLETED|Session 2||4
8523214|NCT00371397|21008701|P10|COMPLETED|Session 2||5
8523215|NCT00371397|21008702|P9|COMPLETED|Session 2||6
8523216|NCT00371397|21008703|P8|COMPLETED|Session 2||4
8523217|NCT00371397|21008704|P7|COMPLETED|Session 2||4
8523218|NCT00371397|21008705|P6|COMPLETED|Session 2||4
8523219|NCT00371397|21008706|P5|COMPLETED|Session 2||3
8523220|NCT00371397|21008707|P4|COMPLETED|Session 2||2
8523221|NCT00371397|21008708|P3|COMPLETED|Session 2||5
8523222|NCT00371397|21008709|P2|COMPLETED|Session 2||7
8523223|NCT00371397|21008710|P1|COMPLETED|Session 2||4
8523224|NCT00371397|21008699|P12|STARTED|Session 2||2
8523225|NCT00371397|21008700|P11|STARTED|Session 2||4
8523226|NCT00371397|21008701|P10|STARTED|Session 2||5
8523227|NCT00371397|21008702|P9|STARTED|Session 2||6
8523228|NCT00371397|21008703|P8|STARTED|Session 2||4
8523229|NCT00371397|21008704|P7|STARTED|Session 2||4
8523230|NCT00371397|21008705|P6|STARTED|Session 2||4
8523231|NCT00371397|21008706|P5|STARTED|Session 2||3
8523232|NCT00371397|21008707|P4|STARTED|Session 2||2
8523233|NCT00371397|21008708|P3|STARTED|Session 2||5
8523234|NCT00371397|21008709|P2|STARTED|Session 2||7
8523235|NCT00371397|21008710|P1|STARTED|Session 2||4
8523236|NCT00371397|21008699|P12|NOT COMPLETED|Session 1||0
8523237|NCT00371397|21008700|P11|NOT COMPLETED|Session 1||0
8523238|NCT00371397|21008701|P10|NOT COMPLETED|Session 1||0
8523239|NCT00371397|21008702|P9|NOT COMPLETED|Session 1||0
8523240|NCT00371397|21008703|P8|NOT COMPLETED|Session 1||1
8523241|NCT00371397|21008704|P7|NOT COMPLETED|Session 1||0
8523242|NCT00371397|21008705|P6|NOT COMPLETED|Session 1||0
8523243|NCT00371397|21008706|P5|NOT COMPLETED|Session 1||0
8523244|NCT00371397|21008707|P4|NOT COMPLETED|Session 1||0
8523245|NCT00371397|21008708|P3|NOT COMPLETED|Session 1||0
8523246|NCT00371397|21008709|P2|NOT COMPLETED|Session 1||0
8523247|NCT00371397|21008710|P1|NOT COMPLETED|Session 1||1
8523248|NCT00371397|21008699|P12|COMPLETED|Session 1||2
8523249|NCT00371397|21008700|P11|COMPLETED|Session 1||4
8523250|NCT00371397|21008701|P10|COMPLETED|Session 1||5
8523251|NCT00371397|21008702|P9|COMPLETED|Session 1||6
8523252|NCT00371397|21008703|P8|COMPLETED|Session 1||4
8523253|NCT00371397|21008704|P7|COMPLETED|Session 1||4
8523254|NCT00371397|21008705|P6|COMPLETED|Session 1||4
8523255|NCT00371397|21008706|P5|COMPLETED|Session 1||3
8523256|NCT00371397|21008707|P4|COMPLETED|Session 1||2
8523257|NCT00371397|21008708|P3|COMPLETED|Session 1||5
8523258|NCT00371397|21008709|P2|COMPLETED|Session 1||7
8523259|NCT00371397|21008710|P1|COMPLETED|Session 1||4
8523260|NCT00371397|21008699|P12|STARTED|Session 1||2
8523261|NCT00371397|21008700|P11|STARTED|Session 1||4
8523262|NCT00371397|21008701|P10|STARTED|Session 1||5
8523263|NCT00371397|21008702|P9|STARTED|Session 1||6
8523264|NCT00371397|21008703|P8|STARTED|Session 1||5
8523265|NCT00371397|21008704|P7|STARTED|Session 1||4
8523266|NCT00371397|21008705|P6|STARTED|Session 1||4
8523267|NCT00371397|21008706|P5|STARTED|Session 1||3
8523268|NCT00371397|21008707|P4|STARTED|Session 1||2
8523269|NCT00371397|21008708|P3|STARTED|Session 1||5
8523270|NCT00371397|21008709|P2|STARTED|Session 1||7
8523271|NCT00371397|21008710|P1|STARTED|Session 1||5
8523272|NCT00371345|21008718|P2|NOT COMPLETED|Overall Study||46
8523273|NCT00371345|21008719|P1|NOT COMPLETED|Overall Study||24
8523274|NCT00371345|21008718|P2|COMPLETED|Overall Study||0
8523275|NCT00371345|21008719|P1|COMPLETED|Overall Study||0
8523276|NCT00371345|21008718|P2|STARTED|Overall Study||46
8523277|NCT00371345|21008719|P1|STARTED|Overall Study||24
8523278|NCT00371293|21008779|P3|NOT COMPLETED|Overall Study||16
8523279|NCT00371293|21008780|P2|NOT COMPLETED|Overall Study||19
8523280|NCT00371293|21008781|P1|NOT COMPLETED|Overall Study||10
8523281|NCT00371293|21008779|P3|COMPLETED|Overall Study||46
8523282|NCT00371293|21008780|P2|COMPLETED|Overall Study||42
8523283|NCT00371293|21008781|P1|COMPLETED|Overall Study||48
8523284|NCT00371293|21008779|P3|STARTED|Overall Study||62
8523285|NCT00371293|21008780|P2|STARTED|Overall Study||61
8523286|NCT00371293|21008781|P1|STARTED|Overall Study||58
8523287|NCT00371267|21008803|P2|NOT COMPLETED|Overall Study||18
8523288|NCT00371267|21008804|P1|NOT COMPLETED|Overall Study||9
8523289|NCT00371267|21008803|P2|COMPLETED|Overall Study||32
8523290|NCT00371267|21008804|P1|COMPLETED|Overall Study||39
8523291|NCT00371267|21008803|P2|STARTED|Overall Study||50
8523292|NCT00371267|21008804|P1|STARTED|Overall Study||48
8523293|NCT00371254|21008820|P2|NOT COMPLETED|Overall Study||21
8523294|NCT00371254|21008821|P1|NOT COMPLETED|Overall Study||23
8523295|NCT00371254|21008820|P2|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
8523296|NCT00371254|21008821|P1|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
8523297|NCT00371254|21008820|P2|STARTED|Overall Study|Number of participants treated|21
8523298|NCT00371254|21008821|P1|STARTED|Overall Study|Number of participants treated|23
8523299|NCT00371176|21008873|P2|NOT COMPLETED|Overall Study||8
8523300|NCT00371176|21008874|P1|NOT COMPLETED|Overall Study||5
8523301|NCT00371176|21008873|P2|COMPLETED|Overall Study||5
8523302|NCT00371176|21008874|P1|COMPLETED|Overall Study||8
8523303|NCT00371176|21008873|P2|Completed Treatment|Overall Study||9
8523304|NCT00371176|21008874|P1|Completed Treatment|Overall Study||10
8523305|NCT00371176|21008873|P2|STARTED|Overall Study||13
8523306|NCT00371176|21008874|P1|STARTED|Overall Study||13
8523307|NCT00371150|21008904|P2|NOT COMPLETED|Overall Study||2
8523308|NCT00371150|21008905|P1|NOT COMPLETED|Overall Study||3
8523309|NCT00371150|21008904|P2|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|4
8523310|NCT00371150|21008905|P1|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|37
8523311|NCT00371150|21008904|P2|Discontinued at or After Week 48 Visit|Overall Study||1
8523312|NCT00371150|21008905|P1|Discontinued at or After Week 48 Visit|Overall Study||2
8523313|NCT00371150|21008904|P2|Discontinued Prior to Week 48 Visit|Overall Study||1
8523314|NCT00371150|21008905|P1|Discontinued Prior to Week 48 Visit|Overall Study||1
8523315|NCT00371150|21008904|P2|STARTED|Overall Study||6
8523316|NCT00371150|21008905|P1|STARTED|Overall Study||40
8523317|NCT00371137|21008940|P3|NOT COMPLETED|Overall Study||79
8523318|NCT00371137|21008941|P2|NOT COMPLETED|Overall Study||63
8523319|NCT00371137|21008942|P1|NOT COMPLETED|Overall Study||72
8523320|NCT00371137|21008940|P3|COMPLETED|Overall Study||104
8523321|NCT00371137|21008941|P2|COMPLETED|Overall Study||119
8523322|NCT00371137|21008942|P1|COMPLETED|Overall Study||111
8523323|NCT00371137|21008940|P3|Treated|Overall Study||182
8523324|NCT00371137|21008941|P2|Treated|Overall Study||182
8523325|NCT00371137|21008942|P1|Treated|Overall Study||183
8523326|NCT00371137|21008940|P3|STARTED|Overall Study||183
8523327|NCT00371137|21008941|P2|STARTED|Overall Study||182
8523328|NCT00371137|21008942|P1|STARTED|Overall Study||183
8523329|NCT00370994|21008952|P2|NOT COMPLETED|Overall Study||0
8523330|NCT00370994|21008953|P1|NOT COMPLETED|Overall Study||0
8523331|NCT00370994|21008952|P2|COMPLETED|Overall Study||60
8523332|NCT00370994|21008953|P1|COMPLETED|Overall Study||60
8523333|NCT00370994|21008952|P2|STARTED|Overall Study||60
8523334|NCT00370994|21008953|P1|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
8523335|NCT00370838|21008963|P2|NOT COMPLETED|Taper||0
8523336|NCT00370838|21008964|P1|NOT COMPLETED|Taper||0
8523337|NCT00370838|21008963|P2|COMPLETED|Taper||3
8523338|NCT00370838|21008964|P1|COMPLETED|Taper||7
8523339|NCT00370838|21008963|P2|STARTED|Taper||3
8523340|NCT00370838|21008964|P1|STARTED|Taper||7
8523341|NCT00370838|21008963|P2|NOT COMPLETED|Period 2 (Days 65-107)||0
8523342|NCT00370838|21008964|P1|NOT COMPLETED|Period 2 (Days 65-107)||0
8523343|NCT00370838|21008963|P2|COMPLETED|Period 2 (Days 65-107)||3
8523344|NCT00370838|21008964|P1|COMPLETED|Period 2 (Days 65-107)||7
8523345|NCT00370838|21008963|P2|STARTED|Period 2 (Days 65-107)||3
8523346|NCT00370838|21008964|P1|STARTED|Period 2 (Days 65-107)||7
8523347|NCT00370838|21008963|P2|NOT COMPLETED|Washout (Days 51-64)||0
8523348|NCT00370838|21008964|P1|NOT COMPLETED|Washout (Days 51-64)||0
8523349|NCT00370838|21008963|P2|COMPLETED|Washout (Days 51-64)||3
8523350|NCT00370838|21008964|P1|COMPLETED|Washout (Days 51-64)||7
8523351|NCT00370838|21008963|P2|STARTED|Washout (Days 51-64)||3
8523352|NCT00370838|21008964|P1|STARTED|Washout (Days 51-64)||7
8523353|NCT00370838|21008963|P2|NOT COMPLETED|Period 1 (Days 8-50)||0
8523354|NCT00370838|21008964|P1|NOT COMPLETED|Period 1 (Days 8-50)||0
8523355|NCT00370838|21008963|P2|COMPLETED|Period 1 (Days 8-50)||3
8523356|NCT00370838|21008964|P1|COMPLETED|Period 1 (Days 8-50)||7
8523357|NCT00370838|21008963|P2|STARTED|Period 1 (Days 8-50)||3
8523358|NCT00370838|21008964|P1|STARTED|Period 1 (Days 8-50)||7
8523359|NCT00370695|21008982|P1|NOT COMPLETED|Overall Study||15
8523360|NCT00370695|21008982|P1|COMPLETED|Overall Study||0
8523361|NCT00370695|21008982|P1|12 Weeks Post-activation|Overall Study||2
8523362|NCT00370695|21008982|P1|STARTED|Overall Study||15
8523363|NCT00370682|21008989|P3|NOT COMPLETED|Overall Study||1
8523364|NCT00370682|21008990|P2|NOT COMPLETED|Overall Study||3
8523365|NCT00370682|21008991|P1|NOT COMPLETED|Overall Study||0
8523366|NCT00370682|21008989|P3|COMPLETED|Overall Study||39
8523367|NCT00370682|21008990|P2|COMPLETED|Overall Study||37
8523368|NCT00370682|21008991|P1|COMPLETED|Overall Study||40
8523369|NCT00370682|21008989|P3|STARTED|Overall Study||40
8523370|NCT00370682|21008990|P2|STARTED|Overall Study||40
8523371|NCT00370682|21008991|P1|STARTED|Overall Study||40
8523372|NCT00370552|21009033|P3|NOT COMPLETED|Overall Study||32
8523373|NCT00370552|21009034|P2|NOT COMPLETED|Overall Study||45
8523374|NCT00370552|21009035|P1|NOT COMPLETED|Overall Study||46
8523375|NCT00370552|21009033|P3|COMPLETED|Overall Study||0
8523376|NCT00370552|21009034|P2|COMPLETED|Overall Study||0
8523377|NCT00370552|21009035|P1|COMPLETED|Overall Study||0
8523378|NCT00370552|21009033|P3|STARTED|Overall Study|Randomized|32
8523379|NCT00370552|21009034|P2|STARTED|Overall Study|Randomized|45
8523380|NCT00370552|21009035|P1|STARTED|Overall Study|Randomized|46
8523381|NCT00370396|21009076|P3|NOT COMPLETED|Overall Study||1
8523382|NCT00370396|21009077|P2|NOT COMPLETED|Overall Study||1
8523383|NCT00370396|21009078|P1|NOT COMPLETED|Overall Study||11
8523384|NCT00370396|21009076|P3|COMPLETED|Overall Study||282
8523385|NCT00370396|21009077|P2|COMPLETED|Overall Study||91
8523386|NCT00370396|21009078|P1|COMPLETED|Overall Study||726
8523387|NCT00370396|21009076|P3|STARTED|Overall Study||283
8523388|NCT00370396|21009077|P2|STARTED|Overall Study||92
8523389|NCT00370396|21009078|P1|STARTED|Overall Study||737
8523390|NCT00370331|21009132|P2|NOT COMPLETED|Overall Study||23
8523391|NCT00370331|21009133|P1|NOT COMPLETED|Overall Study||7
8523392|NCT00370331|21009132|P2|COMPLETED|Overall Study||112
8523393|NCT00370331|21009133|P1|COMPLETED|Overall Study||55
8523394|NCT00370331|21009132|P2|STARTED|Overall Study||135
8523395|NCT00370331|21009133|P1|STARTED|Overall Study||62
8523396|NCT00370292|21009159|P1|NOT COMPLETED|Overall Study||13
8523397|NCT00370292|21009159|P1|COMPLETED|Overall Study||6
8523398|NCT00370292|21009159|P1|STARTED|Overall Study||19
8523399|NCT00370149|21009172|P2|NOT COMPLETED|Overall Study||19
8523400|NCT00370149|21009173|P1|NOT COMPLETED|Overall Study||19
8523401|NCT00370149|21009172|P2|COMPLETED|Overall Study||142
8523402|NCT00370149|21009173|P1|COMPLETED|Overall Study||146
8523403|NCT00370149|21009172|P2|STARTED|Overall Study||161
8523404|NCT00370149|21009173|P1|STARTED|Overall Study||165
8523405|NCT00370071|21009183|P1|NOT COMPLETED|Overall Study||2
8523406|NCT00370071|21009183|P1|COMPLETED|Overall Study||37
8523407|NCT00370071|21009183|P1|STARTED|Overall Study||39
8523408|NCT00370032|21009200|P2|NOT COMPLETED|Follow-up Period||0
8523409|NCT00370032|21009201|P1|NOT COMPLETED|Follow-up Period||1
8523410|NCT00370032|21009200|P2|COMPLETED|Follow-up Period||22
8523411|NCT00370032|21009201|P1|COMPLETED|Follow-up Period||22
8523412|NCT00370032|21009200|P2|STARTED|Follow-up Period||22
8523413|NCT00370032|21009201|P1|STARTED|Follow-up Period||23
8523414|NCT00370032|21009200|P2|NOT COMPLETED|Treatment Period 2||0
8523415|NCT00370032|21009201|P1|NOT COMPLETED|Treatment Period 2||0
8523416|NCT00370032|21009200|P2|COMPLETED|Treatment Period 2||22
8523417|NCT00370032|21009201|P1|COMPLETED|Treatment Period 2||23
8523418|NCT00370032|21009200|P2|STARTED|Treatment Period 2||22
8523419|NCT00370032|21009201|P1|STARTED|Treatment Period 2||23
8523420|NCT00370032|21009200|P2|NOT COMPLETED|Washout Period||2
8523421|NCT00370032|21009201|P1|NOT COMPLETED|Washout Period||1
8523422|NCT00370032|21009200|P2|COMPLETED|Washout Period||22
8523423|NCT00370032|21009201|P1|COMPLETED|Washout Period||23
8523424|NCT00370032|21009200|P2|STARTED|Washout Period||24
8523425|NCT00370032|21009201|P1|STARTED|Washout Period||24
8523426|NCT00370032|21009200|P2|NOT COMPLETED|Treatment Period 1||1
8523427|NCT00370032|21009201|P1|NOT COMPLETED|Treatment Period 1||0
8523428|NCT00370032|21009200|P2|COMPLETED|Treatment Period 1||24
8523429|NCT00370032|21009201|P1|COMPLETED|Treatment Period 1||24
8523430|NCT00370032|21009200|P2|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
8523431|NCT00370032|21009201|P1|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
8523432|NCT00369967|21009221|P2|NOT COMPLETED|Overall Study||12
8523433|NCT00369967|21009222|P1|NOT COMPLETED|Overall Study||23
8523434|NCT00369967|21009221|P2|COMPLETED|Overall Study||5
8523435|NCT00369967|21009222|P1|COMPLETED|Overall Study||8
8523436|NCT00369967|21009221|P2|STARTED|Overall Study||17
8523437|NCT00369967|21009222|P1|STARTED|Overall Study||31
8523438|NCT00369941|21009240|P2|NOT COMPLETED|Overall Study||100
8523439|NCT00369941|21009241|P1|NOT COMPLETED|Overall Study||72
8523440|NCT00369941|21009240|P2|COMPLETED|Overall Study||184
8523441|NCT00369941|21009241|P1|COMPLETED|Overall Study||210
8523442|NCT00369941|21009240|P2|Treated|Overall Study||282
8523443|NCT00369941|21009241|P1|Treated|Overall Study||281
8523444|NCT00369941|21009240|P2|STARTED|Overall Study||284
8523445|NCT00369941|21009241|P1|STARTED|Overall Study||282
8523446|NCT00369928|21009394|P3|NOT COMPLETED|Overall Study||20
8523447|NCT00369928|21009395|P2|NOT COMPLETED|Overall Study||16
8523448|NCT00369928|21009396|P1|NOT COMPLETED|Overall Study||8
8523449|NCT00369928|21009394|P3|COMPLETED|Overall Study||66
8523450|NCT00369928|21009395|P2|COMPLETED|Overall Study||69
8523451|NCT00369928|21009396|P1|COMPLETED|Overall Study||77
8523452|NCT00369928|21009394|P3|STARTED|Overall Study||86
8523453|NCT00369928|21009395|P2|STARTED|Overall Study||85
8523454|NCT00369928|21009396|P1|STARTED|Overall Study||85
8523455|NCT00369915|21009406|P2|NOT COMPLETED|Overall Study||3
8523456|NCT00369915|21009407|P1|NOT COMPLETED|Overall Study||6
8523457|NCT00369915|21009406|P2|COMPLETED|Overall Study||4
8523458|NCT00369915|21009407|P1|COMPLETED|Overall Study||4
8523459|NCT00369915|21009406|P2|STARTED|Overall Study||7
8523460|NCT00369915|21009407|P1|STARTED|Overall Study||10
8523461|NCT00369824|21009421|P6|NOT COMPLETED|Overall Study||11
8523462|NCT00369824|21009422|P5|NOT COMPLETED|Overall Study||18
8523463|NCT00369824|21009423|P4|NOT COMPLETED|Overall Study||15
8523464|NCT00369824|21009424|P3|NOT COMPLETED|Overall Study||12
8523465|NCT00369824|21009425|P2|NOT COMPLETED|Overall Study||19
8523466|NCT00369824|21009426|P1|NOT COMPLETED|Overall Study||15
8523467|NCT00369824|21009421|P6|COMPLETED|Overall Study||204
8523468|NCT00369824|21009422|P5|COMPLETED|Overall Study||196
8523469|NCT00369824|21009423|P4|COMPLETED|Overall Study||199
8523470|NCT00369824|21009424|P3|COMPLETED|Overall Study||202
8523471|NCT00369824|21009425|P2|COMPLETED|Overall Study||195
8523472|NCT00369824|21009426|P1|COMPLETED|Overall Study||197
8523473|NCT00369824|21009421|P6|STARTED|Overall Study||215
8523474|NCT00369824|21009422|P5|STARTED|Overall Study||214
8523475|NCT00369824|21009423|P4|STARTED|Overall Study||214
8523476|NCT00369824|21009424|P3|STARTED|Overall Study||214
8523477|NCT00369824|21009425|P2|STARTED|Overall Study||214
8523478|NCT00369824|21009426|P1|STARTED|Overall Study||212
8523479|NCT00369785|21009526|P2|NOT COMPLETED|Overall Study||25
8523480|NCT00369785|21009527|P1|NOT COMPLETED|Overall Study||27
8523481|NCT00369785|21009526|P2|COMPLETED|Overall Study||74
8523482|NCT00369785|21009527|P1|COMPLETED|Overall Study||72
8523483|NCT00369785|21009526|P2|STARTED|Overall Study||99
8523484|NCT00369785|21009527|P1|STARTED|Overall Study||99
8523485|NCT00369746|21009537|P2|NOT COMPLETED|Overall Study||0
8523486|NCT00369746|21009538|P1|NOT COMPLETED|Overall Study||0
8523487|NCT00369746|21009537|P2|COMPLETED|Overall Study||536
8523488|NCT00369746|21009538|P1|COMPLETED|Overall Study||138
8523489|NCT00369746|21009537|P2|STARTED|Overall Study||536
8523490|NCT00369746|21009538|P1|STARTED|Overall Study||138
8523491|NCT00369707|21009548|P1|NOT COMPLETED|Follow up for 2 Years After Treatment||3
8523492|NCT00369707|21009548|P1|COMPLETED|Follow up for 2 Years After Treatment||38
8523493|NCT00369707|21009548|P1|STARTED|Follow up for 2 Years After Treatment||41
8523494|NCT00369707|21009548|P1|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
8523495|NCT00369707|21009548|P1|COMPLETED|Maintenance Period (up to 4 Cycles)||27
8523496|NCT00369707|21009548|P1|STARTED|Maintenance Period (up to 4 Cycles)||35
8523497|NCT00369707|21009548|P1|NOT COMPLETED|Induction Part B (2 Cycles)||7
8523498|NCT00369707|21009548|P1|COMPLETED|Induction Part B (2 Cycles)||35
8523499|NCT00369707|21009548|P1|STARTED|Induction Part B (2 Cycles)||42
8523500|NCT00369707|21009548|P1|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
8523501|NCT00369707|21009548|P1|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
8523502|NCT00369707|21009548|P1|STARTED|Induction Part A (1 Cycle -35 Days)||42
8523503|NCT00369681|21009561|P1|NOT COMPLETED|Overall Study||1
8523504|NCT00369681|21009561|P1|COMPLETED|Overall Study||49
8523505|NCT00369681|21009561|P1|STARTED|Overall Study||50
8523506|NCT00369668|21009571|P3|NOT COMPLETED|Overall Study||7
8523507|NCT00369668|21009572|P2|NOT COMPLETED|Overall Study||5
8523508|NCT00369668|21009573|P1|NOT COMPLETED|Overall Study||4
8523509|NCT00369668|21009571|P3|COMPLETED|Overall Study||3
8523510|NCT00369668|21009572|P2|COMPLETED|Overall Study||5
8523511|NCT00369668|21009573|P1|COMPLETED|Overall Study||6
8523512|NCT00369668|21009571|P3|STARTED|Overall Study||10
8523513|NCT00369668|21009572|P2|STARTED|Overall Study||10
8523514|NCT00369668|21009573|P1|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
8523515|NCT00369655|21009587|P1|NOT COMPLETED|Overall Study||2
8523516|NCT00369655|21009587|P1|COMPLETED|Overall Study||19
8523517|NCT00369655|21009587|P1|STARTED|Overall Study||21
8523518|NCT00369629|21009596|P4|NOT COMPLETED|Follow up for 1 Year||0
8523519|NCT00369629|21009597|P3|NOT COMPLETED|Follow up for 1 Year||3
8523520|NCT00369629|21009598|P2|NOT COMPLETED|Follow up for 1 Year||2
8523521|NCT00369629|21009599|P1|NOT COMPLETED|Follow up for 1 Year||2
8523522|NCT00369629|21009596|P4|COMPLETED|Follow up for 1 Year||0
8523523|NCT00369629|21009597|P3|COMPLETED|Follow up for 1 Year||2
8523524|NCT00369629|21009598|P2|COMPLETED|Follow up for 1 Year||1
8523525|NCT00369629|21009599|P1|COMPLETED|Follow up for 1 Year||4
8523526|NCT00369629|21009596|P4|STARTED|Follow up for 1 Year||0
8523527|NCT00369629|21009597|P3|STARTED|Follow up for 1 Year||5
8523528|NCT00369629|21009598|P2|STARTED|Follow up for 1 Year||3
8523529|NCT00369629|21009599|P1|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
8523530|NCT00369629|21009596|P4|NOT COMPLETED|Completed 4 More Cycles||0
8523531|NCT00369629|21009597|P3|NOT COMPLETED|Completed 4 More Cycles||2
8523532|NCT00369629|21009598|P2|NOT COMPLETED|Completed 4 More Cycles||2
8523533|NCT00369629|21009599|P1|NOT COMPLETED|Completed 4 More Cycles||4
8523534|NCT00369629|21009596|P4|COMPLETED|Completed 4 More Cycles||0
8523535|NCT00369629|21009597|P3|COMPLETED|Completed 4 More Cycles||0
8523536|NCT00369629|21009598|P2|COMPLETED|Completed 4 More Cycles||0
8523537|NCT00369629|21009599|P1|COMPLETED|Completed 4 More Cycles||0
8523538|NCT00369629|21009596|P4|STARTED|Completed 4 More Cycles||0
8523539|NCT00369629|21009597|P3|STARTED|Completed 4 More Cycles||2
8523540|NCT00369629|21009598|P2|STARTED|Completed 4 More Cycles||2
8523541|NCT00369629|21009599|P1|STARTED|Completed 4 More Cycles||4
8523542|NCT00369629|21009596|P4|NOT COMPLETED|Moved on to 4 More Cycles||0
8523543|NCT00369629|21009597|P3|NOT COMPLETED|Moved on to 4 More Cycles||1
8523544|NCT00369629|21009598|P2|NOT COMPLETED|Moved on to 4 More Cycles||0
8523545|NCT00369629|21009599|P1|NOT COMPLETED|Moved on to 4 More Cycles||0
8523546|NCT00369629|21009596|P4|COMPLETED|Moved on to 4 More Cycles||0
8523547|NCT00369629|21009597|P3|COMPLETED|Moved on to 4 More Cycles||2
8523548|NCT00369629|21009598|P2|COMPLETED|Moved on to 4 More Cycles||2
8523549|NCT00369629|21009599|P1|COMPLETED|Moved on to 4 More Cycles||4
8523550|NCT00369629|21009596|P4|STARTED|Moved on to 4 More Cycles||0
8523551|NCT00369629|21009597|P3|STARTED|Moved on to 4 More Cycles||3
8523552|NCT00369629|21009598|P2|STARTED|Moved on to 4 More Cycles||2
8523553|NCT00369629|21009599|P1|STARTED|Moved on to 4 More Cycles||4
8523554|NCT00369629|21009596|P4|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
8523555|NCT00369629|21009597|P3|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
8523556|NCT00369629|21009598|P2|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
8523557|NCT00369629|21009599|P1|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
8523558|NCT00369629|21009596|P4|COMPLETED|Treated 2 Cycles/Reached First Response||0
8523559|NCT00369629|21009597|P3|COMPLETED|Treated 2 Cycles/Reached First Response||3
8523560|NCT00369629|21009598|P2|COMPLETED|Treated 2 Cycles/Reached First Response||2
8523561|NCT00369629|21009599|P1|COMPLETED|Treated 2 Cycles/Reached First Response||4
8523562|NCT00369629|21009596|P4|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
8523563|NCT00369629|21009597|P3|STARTED|Treated 2 Cycles/Reached First Response||5
8523564|NCT00369629|21009598|P2|STARTED|Treated 2 Cycles/Reached First Response||3
8523565|NCT00369629|21009599|P1|STARTED|Treated 2 Cycles/Reached First Response||6
8523566|NCT00369590|21009611|P2|NOT COMPLETED|Overall Study||0
8523567|NCT00369590|21009612|P1|NOT COMPLETED|Overall Study||0
8523568|NCT00369590|21009611|P2|COMPLETED|Overall Study||42
8523569|NCT00369590|21009612|P1|COMPLETED|Overall Study||16
8523570|NCT00369590|21009611|P2|STARTED|Overall Study||42
8523571|NCT00369590|21009612|P1|STARTED|Overall Study||16
8523572|NCT00369577|21009630|P3|NOT COMPLETED|Overall Study||1
8523573|NCT00369577|21009631|P2|NOT COMPLETED|Overall Study||0
8523574|NCT00369577|21009632|P1|NOT COMPLETED|Overall Study||0
8523575|NCT00369577|21009630|P3|COMPLETED|Overall Study||40
8523576|NCT00369577|21009631|P2|COMPLETED|Overall Study||45
8523577|NCT00369577|21009632|P1|COMPLETED|Overall Study||43
8523578|NCT00369577|21009630|P3|STARTED|Overall Study||41
8523579|NCT00369577|21009631|P2|STARTED|Overall Study||45
8523580|NCT00369577|21009632|P1|STARTED|Overall Study||43
8523587|NCT00369512|21009658|P1|NOT COMPLETED|Overall Study||0
8523588|NCT00369512|21009658|P1|COMPLETED|Overall Study||15
8523589|NCT00369512|21009658|P1|STARTED|Overall Study||15
8523590|NCT00369486|21009669|P5|NOT COMPLETED|34-Week Visit||3
8523591|NCT00369486|21009670|P4|NOT COMPLETED|34-Week Visit||3
8523592|NCT00369486|21009671|P3|NOT COMPLETED|34-Week Visit||1
8523593|NCT00369486|21009672|P2|NOT COMPLETED|34-Week Visit||1
8523594|NCT00369486|21009673|P1|NOT COMPLETED|34-Week Visit||0
8523595|NCT00369486|21009669|P5|COMPLETED|34-Week Visit|Number of eyes|22
8523596|NCT00369486|21009670|P4|COMPLETED|34-Week Visit|Number of eyes|19
8523597|NCT00369486|21009671|P3|COMPLETED|34-Week Visit|Number of eyes|22
8523598|NCT00369486|21009672|P2|COMPLETED|34-Week Visit|Number of eyes|20
8523599|NCT00369486|21009673|P1|COMPLETED|34-Week Visit|Number of eyes|38
8523600|NCT00369486|21009669|P5|STARTED|34-Week Visit|Number of eyes that|25
8523601|NCT00369486|21009670|P4|STARTED|34-Week Visit|Number of eyes|22
8523602|NCT00369486|21009671|P3|STARTED|34-Week Visit|Number of eyes|23
8523603|NCT00369486|21009672|P2|STARTED|34-Week Visit|Number of eyes|21
8523604|NCT00369486|21009673|P1|STARTED|34-Week Visit|Number of eyes|38
8523605|NCT00369486|21009669|P5|NOT COMPLETED|17-Week Visit||1
8523606|NCT00369486|21009670|P4|NOT COMPLETED|17-Week Visit||1
8523607|NCT00369486|21009671|P3|NOT COMPLETED|17-Week Visit||1
8523608|NCT00369486|21009672|P2|NOT COMPLETED|17-Week Visit||0
8523609|NCT00369486|21009673|P1|NOT COMPLETED|17-Week Visit||0
8523610|NCT00369486|21009669|P5|COMPLETED|17-Week Visit|Number of eyes|24
8523611|NCT00369486|21009670|P4|COMPLETED|17-Week Visit|Number of eyes|21
8523612|NCT00369486|21009671|P3|COMPLETED|17-Week Visit|Number of eyes|22
8523613|NCT00369486|21009672|P2|COMPLETED|17-Week Visit|Number of eyes|21
8523614|NCT00369486|21009673|P1|COMPLETED|17-Week Visit|Number of eyes|38
8523615|NCT00369486|21009669|P5|STARTED|17-Week Visit|Number of eyes|25
8523616|NCT00369486|21009670|P4|STARTED|17-Week Visit|Number of eyes|22
8523617|NCT00369486|21009671|P3|STARTED|17-Week Visit|Number of eyes|23
8523618|NCT00369486|21009672|P2|STARTED|17-Week Visit|Number of eyes|21
8523619|NCT00369486|21009673|P1|STARTED|17-Week Visit|Number of eyes|38
8523620|NCT00369486|21009669|P5|NOT COMPLETED|8-Week Visit||1
8523621|NCT00369486|21009670|P4|NOT COMPLETED|8-Week Visit||1
8523622|NCT00369486|21009671|P3|NOT COMPLETED|8-Week Visit||0
8523623|NCT00369486|21009672|P2|NOT COMPLETED|8-Week Visit||1
8523624|NCT00369486|21009673|P1|NOT COMPLETED|8-Week Visit||0
8523625|NCT00369486|21009669|P5|COMPLETED|8-Week Visit|Number of eyes|24
8523626|NCT00369486|21009670|P4|COMPLETED|8-Week Visit|Number of eyes|21
8523627|NCT00369486|21009671|P3|COMPLETED|8-Week Visit|Number of eyes|22
8523628|NCT00369486|21009672|P2|COMPLETED|8-Week Visit|Number of eyes|20
8523629|NCT00369486|21009673|P1|COMPLETED|8-Week Visit|Number of eyes|38
8523630|NCT00369486|21009669|P5|STARTED|8-Week Visit|Number of eyes|25
8523631|NCT00369486|21009670|P4|STARTED|8-Week Visit|Number of eyes|22
8523632|NCT00369486|21009671|P3|STARTED|8-Week Visit|Number of eyes|22
8523633|NCT00369486|21009672|P2|STARTED|8-Week Visit|Number of eyes|21
8523634|NCT00369486|21009673|P1|STARTED|8-Week Visit|Number of eyes|38
8523635|NCT00369486|21009669|P5|NOT COMPLETED|4-Week Visit||1
8523636|NCT00369486|21009670|P4|NOT COMPLETED|4-Week Visit||2
8523637|NCT00369486|21009671|P3|NOT COMPLETED|4-Week Visit||1
8523638|NCT00369486|21009672|P2|NOT COMPLETED|4-Week Visit||2
8523639|NCT00369486|21009673|P1|NOT COMPLETED|4-Week Visit||2
8523640|NCT00369486|21009669|P5|COMPLETED|4-Week Visit|Number of eyes|24
8523641|NCT00369486|21009670|P4|COMPLETED|4-Week Visit|Number of eyes|20
8523642|NCT00369486|21009671|P3|COMPLETED|4-Week Visit|Number of eyes|22
8523643|NCT00369486|21009672|P2|COMPLETED|4-Week Visit|Number of eyes;|19
8523644|NCT00369486|21009673|P1|COMPLETED|4-Week Visit|Number of eyes|36
8523645|NCT00369486|21009669|P5|STARTED|4-Week Visit|Number of eyes|25
8523646|NCT00369486|21009670|P4|STARTED|4-Week Visit|Number of eyes|22
8523647|NCT00369486|21009671|P3|STARTED|4-Week Visit|Number of eyes|23
8523648|NCT00369486|21009672|P2|STARTED|4-Week Visit|Number of eyes|21
8523649|NCT00369486|21009673|P1|STARTED|4-Week Visit|Number of eyes|38
8523650|NCT00369382|21009712|P2|NOT COMPLETED|Overall Study||3
8523651|NCT00369382|21009713|P1|NOT COMPLETED|Overall Study||10
8523652|NCT00369382|21009712|P2|COMPLETED|Overall Study||54
8523653|NCT00369382|21009713|P1|COMPLETED|Overall Study||49
8523654|NCT00369382|21009712|P2|Completed Assigned Treatment Regimen|Overall Study||33
8523655|NCT00369382|21009713|P1|Completed Assigned Treatment Regimen|Overall Study||48
8523656|NCT00369382|21009712|P2|Received Treatment|Overall Study||57
8523657|NCT00369382|21009713|P1|Received Treatment|Overall Study||57
8523658|NCT00369382|21009712|P2|STARTED|Overall Study||57
8523659|NCT00369382|21009713|P1|STARTED|Overall Study||59
8523660|NCT00369343|21009746|P2|NOT COMPLETED|Open-label Phase||30
8523661|NCT00369343|21009747|P1|NOT COMPLETED|Open-label Phase||57
8523662|NCT00369343|21009746|P2|COMPLETED|Open-label Phase||79
8523663|NCT00369343|21009747|P1|COMPLETED|Open-label Phase||155
8523664|NCT00369343|21009746|P2|STARTED|Open-label Phase||109
8523665|NCT00369343|21009747|P1|STARTED|Open-label Phase||212
8523666|NCT00369343|21009746|P2|NOT COMPLETED|Double-blind Phase||16
8523667|NCT00369343|21009747|P1|NOT COMPLETED|Double-blind Phase||44
8523668|NCT00369343|21009746|P2|COMPLETED|Double-blind Phase||109
8523669|NCT00369343|21009747|P1|COMPLETED|Double-blind Phase||212
8523670|NCT00369343|21009746|P2|STARTED|Double-blind Phase||125
8523671|NCT00369343|21009747|P1|STARTED|Double-blind Phase||256
8523675|NCT00369278|21009796|P2|NOT COMPLETED|Overall Study||21
8523676|NCT00369278|21009797|P1|NOT COMPLETED|Overall Study||24
8523677|NCT00369278|21009796|P2|COMPLETED|Overall Study||44
8523678|NCT00369278|21009797|P1|COMPLETED|Overall Study||39
8523679|NCT00369278|21009796|P2|STARTED|Overall Study||65
8523680|NCT00369278|21009797|P1|STARTED|Overall Study||63
8523681|NCT00369265|21009813|P2|NOT COMPLETED|Overall Study||7
8523682|NCT00369265|21009814|P1|NOT COMPLETED|Overall Study||4
8523683|NCT00369265|21009813|P2|COMPLETED|Overall Study||0
8523684|NCT00369265|21009814|P1|COMPLETED|Overall Study||0
8523685|NCT00369265|21009813|P2|STARTED|Overall Study||7
8523686|NCT00369265|21009814|P1|STARTED|Overall Study||4
8523687|NCT00369226|21009822|P2|NOT COMPLETED|Phase II (45 Days)||0
8523688|NCT00369226|21009823|P1|NOT COMPLETED|Phase II (45 Days)||0
8523689|NCT00369226|21009822|P2|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
8523690|NCT00369226|21009823|P1|COMPLETED|Phase II (45 Days)||0
8523691|NCT00369226|21009822|P2|STARTED|Phase II (45 Days)||32
8523692|NCT00369226|21009823|P1|STARTED|Phase II (45 Days)||0
8523693|NCT00369226|21009822|P2|NOT COMPLETED|Phase I (45 Days)||0
8523694|NCT00369226|21009823|P1|NOT COMPLETED|Phase I (45 Days)||0
8523695|NCT00369226|21009822|P2|COMPLETED|Phase I (45 Days)||0
8523696|NCT00369226|21009823|P1|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
8523697|NCT00369226|21009822|P2|STARTED|Phase I (45 Days)||0
8523698|NCT00369226|21009823|P1|STARTED|Phase I (45 Days)||13
8523699|NCT00369161|21009835|P2|NOT COMPLETED|Overall Study||24
8523700|NCT00369161|21009836|P1|NOT COMPLETED|Overall Study||27
8523701|NCT00369161|21009835|P2|COMPLETED|Overall Study||95
8523702|NCT00369161|21009836|P1|COMPLETED|Overall Study||82
8523703|NCT00369161|21009835|P2|Intention to Treat (ITT)|Overall Study||117
8523704|NCT00369161|21009836|P1|Intention to Treat (ITT)|Overall Study||107
8523705|NCT00369161|21009835|P2|STARTED|Overall Study||119
8523706|NCT00369161|21009836|P1|STARTED|Overall Study|"Started indicates randomized and safety population."|109
8523707|NCT00369122|21009846|P1|NOT COMPLETED|Overall Study||11
8523708|NCT00369122|21009846|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
8523709|NCT00369122|21009846|P1|STARTED|Overall Study||60
8523710|NCT00368992|21009853|P1|NOT COMPLETED|Overall Study||110
8523711|NCT00368992|21009853|P1|COMPLETED|Overall Study||0
8523712|NCT00368992|21009853|P1|STARTED|Overall Study||110
8523713|NCT00368979|21009862|P2|NOT COMPLETED|Overall Study||30
8523714|NCT00368979|21009863|P1|NOT COMPLETED|Overall Study||25
8523715|NCT00368979|21009862|P2|COMPLETED|Overall Study||163
8523716|NCT00368979|21009863|P1|COMPLETED|Overall Study||160
8523717|NCT00368979|21009862|P2|STARTED|Overall Study||193
8523718|NCT00368979|21009863|P1|STARTED|Overall Study||185
8523719|NCT00368966|21009879|P2|NOT COMPLETED|Toddler Dose||3
8523720|NCT00368966|21009880|P1|NOT COMPLETED|Toddler Dose||1
8523721|NCT00368966|21009879|P2|COMPLETED|Toddler Dose||286
8523722|NCT00368966|21009880|P1|COMPLETED|Toddler Dose||292
8523723|NCT00368966|21009879|P2|STARTED|Toddler Dose||289
8523724|NCT00368966|21009880|P1|STARTED|Toddler Dose||293
8523725|NCT00368966|21009879|P2|NOT COMPLETED|After Infant||5
8523726|NCT00368966|21009880|P1|NOT COMPLETED|After Infant||6
8523727|NCT00368966|21009879|P2|COMPLETED|After Infant||289
8523728|NCT00368966|21009880|P1|COMPLETED|After Infant||293
8523729|NCT00368966|21009879|P2|STARTED|After Infant||294
8523730|NCT00368966|21009880|P1|STARTED|After Infant||299
8523731|NCT00368966|21009879|P2|NOT COMPLETED|Infant Series||10
8523732|NCT00368966|21009880|P1|NOT COMPLETED|Infant Series||16
8523733|NCT00368966|21009879|P2|COMPLETED|Infant Series||294
8523734|NCT00368966|21009880|P1|COMPLETED|Infant Series||299
8523735|NCT00368966|21009879|P2|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
8523736|NCT00368966|21009880|P1|Vaccinated Dose 3|Infant Series||301
8523737|NCT00368966|21009879|P2|Vaccinated Dose 2|Infant Series||298
8523738|NCT00368966|21009880|P1|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
8523739|NCT00368966|21009879|P2|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
8523740|NCT00368966|21009880|P1|Vaccinated Dose 1|Infant Series||314
8523741|NCT00368966|21009879|P2|STARTED|Infant Series||304
8523742|NCT00368966|21009880|P1|STARTED|Infant Series||315
8523743|NCT00368940|21009936|P2|NOT COMPLETED|Completed 12-wk Treatment||5
8523744|NCT00368940|21009937|P1|NOT COMPLETED|Completed 12-wk Treatment||6
8523745|NCT00368940|21009936|P2|COMPLETED|Completed 12-wk Treatment||32
8523746|NCT00368940|21009937|P1|COMPLETED|Completed 12-wk Treatment||31
8523747|NCT00368940|21009936|P2|STARTED|Completed 12-wk Treatment||37
8523748|NCT00368940|21009937|P1|STARTED|Completed 12-wk Treatment||37
8523749|NCT00368940|21009936|P2|NOT COMPLETED|Intention-to-Treat||0
8523750|NCT00368940|21009937|P1|NOT COMPLETED|Intention-to-Treat||0
8523751|NCT00368940|21009936|P2|COMPLETED|Intention-to-Treat||37
8523752|NCT00368940|21009937|P1|COMPLETED|Intention-to-Treat||37
8523753|NCT00368940|21009936|P2|STARTED|Intention-to-Treat||37
8523754|NCT00368940|21009937|P1|STARTED|Intention-to-Treat||37
8523755|NCT00368927|21009951|P2|NOT COMPLETED|Overall Study||3
8523756|NCT00368927|21009952|P1|NOT COMPLETED|Overall Study||5
8523757|NCT00368927|21009951|P2|COMPLETED|Overall Study||27
8523758|NCT00368927|21009952|P1|COMPLETED|Overall Study||26
8523759|NCT00368927|21009951|P2|STARTED|Overall Study||30
8523760|NCT00368927|21009952|P1|STARTED|Overall Study||31
8523761|NCT00368875|21009960|P2|NOT COMPLETED|Overall Study||48
8523762|NCT00368875|21009961|P1|NOT COMPLETED|Overall Study||6
8523763|NCT00368875|21009960|P2|COMPLETED|Overall Study||0
8523764|NCT00368875|21009961|P1|COMPLETED|Overall Study||0
8523765|NCT00368875|21009960|P2|STARTED|Overall Study||48
8523766|NCT00368875|21009961|P1|STARTED|Overall Study||6
8523767|NCT00368849|21009969|P2|NOT COMPLETED|Overall Study||2
8523768|NCT00368849|21009970|P1|NOT COMPLETED|Overall Study||0
8523769|NCT00368849|21009969|P2|COMPLETED|Overall Study||8
8523770|NCT00368849|21009970|P1|COMPLETED|Overall Study||10
8523771|NCT00368849|21009969|P2|STARTED|Overall Study||10
8523772|NCT00368849|21009970|P1|STARTED|Overall Study||10
8523785|NCT00368654|21010021|P4|NOT COMPLETED|Overall Study||3
8523786|NCT00368654|21010022|P3|NOT COMPLETED|Overall Study||3
8523787|NCT00368654|21010023|P2|NOT COMPLETED|Overall Study||3
8523788|NCT00368654|21010024|P1|NOT COMPLETED|Overall Study||3
8523789|NCT00368654|21010021|P4|COMPLETED|Overall Study||0
8523790|NCT00368654|21010022|P3|COMPLETED|Overall Study||0
8523791|NCT00368654|21010023|P2|COMPLETED|Overall Study||0
8523792|NCT00368654|21010024|P1|COMPLETED|Overall Study||0
8523793|NCT00368654|21010021|P4|STARTED|Overall Study||3
8523794|NCT00368654|21010022|P3|STARTED|Overall Study||3
8523795|NCT00368654|21010023|P2|STARTED|Overall Study||3
8523796|NCT00368654|21010024|P1|STARTED|Overall Study||3
8523797|NCT00368641|21010040|P2|NOT COMPLETED|Overall Study||6
8523798|NCT00368641|21010041|P1|NOT COMPLETED|Overall Study||6
8523799|NCT00368641|21010040|P2|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
8523800|NCT00368641|21010041|P1|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
8523801|NCT00368641|21010040|P2|STARTED|Overall Study||6
8523802|NCT00368641|21010041|P1|STARTED|Overall Study||6
8523803|NCT00368550|21010049|P2|NOT COMPLETED|Overall Study||23
8523804|NCT00368550|21010050|P1|NOT COMPLETED|Overall Study||28
8523805|NCT00368550|21010049|P2|COMPLETED|Overall Study||48
8523806|NCT00368550|21010050|P1|COMPLETED|Overall Study||35
8523807|NCT00368550|21010049|P2|STARTED|Overall Study||71
8523808|NCT00368550|21010050|P1|STARTED|Overall Study||63
8523809|NCT00368537|21010062|P2|NOT COMPLETED|Baseline Participants||24
8523810|NCT00368537|21010063|P1|NOT COMPLETED|Baseline Participants||24
8523811|NCT00368537|21010062|P2|COMPLETED|Baseline Participants||239
8523812|NCT00368537|21010063|P1|COMPLETED|Baseline Participants||244
8523813|NCT00368537|21010062|P2|STARTED|Baseline Participants||263
8523814|NCT00368537|21010063|P1|STARTED|Baseline Participants||268
8523815|NCT00368537|21010062|P2|NOT COMPLETED|Randomization||6
8523816|NCT00368537|21010063|P1|NOT COMPLETED|Randomization||13
8523817|NCT00368537|21010062|P2|COMPLETED|Randomization||263
8523818|NCT00368537|21010063|P1|COMPLETED|Randomization||268
8523819|NCT00368537|21010062|P2|STARTED|Randomization||269
8523820|NCT00368537|21010063|P1|STARTED|Randomization||281
8523821|NCT00368472|21010077|P1|NOT COMPLETED|Overall Study||105
8523822|NCT00368472|21010077|P1|COMPLETED|Overall Study||33
8523823|NCT00368472|21010077|P1|STARTED|Overall Study||138
8523824|NCT00368459|21010085|P2|NOT COMPLETED|Overall Study||1
8523825|NCT00368459|21010086|P1|NOT COMPLETED|Overall Study||2
8523826|NCT00368459|21010085|P2|COMPLETED|Overall Study||20
8523827|NCT00368459|21010086|P1|COMPLETED|Overall Study||19
8523828|NCT00368459|21010085|P2|STARTED|Overall Study||21
8523829|NCT00368459|21010086|P1|STARTED|Overall Study||21
8523830|NCT00368355|21010112|P2|NOT COMPLETED|Overall Study||17
8523831|NCT00368355|21010113|P1|NOT COMPLETED|Overall Study||11
8523832|NCT00368355|21010112|P2|COMPLETED|Overall Study||11
8523833|NCT00368355|21010113|P1|COMPLETED|Overall Study||7
8523834|NCT00368355|21010112|P2|STARTED|Overall Study||28
8523835|NCT00368355|21010113|P1|STARTED|Overall Study||18
8523836|NCT00368316|21010129|P2|NOT COMPLETED|Overall Study||46
8523837|NCT00368316|21010130|P1|NOT COMPLETED|Overall Study||42
8523838|NCT00368316|21010129|P2|COMPLETED|Overall Study||1319
8523839|NCT00368316|21010130|P1|COMPLETED|Overall Study||1392
8523840|NCT00368316|21010129|P2|STARTED|Overall Study||1365
8523841|NCT00368316|21010130|P1|STARTED|Overall Study||1434
8523842|NCT00368290|21010142|P2|NOT COMPLETED|Overall Study||10
8523843|NCT00368290|21010143|P1|NOT COMPLETED|Overall Study||13
8523844|NCT00368290|21010142|P2|COMPLETED|Overall Study||37
8523845|NCT00368290|21010143|P1|COMPLETED|Overall Study||34
8523846|NCT00368290|21010142|P2|STARTED|Overall Study||47
8523847|NCT00368290|21010143|P1|STARTED|Overall Study||47
8523848|NCT00368277|21010153|P2|NOT COMPLETED|Overall Study||108
8523849|NCT00368277|21010154|P1|NOT COMPLETED|Overall Study||113
8523850|NCT00368277|21010153|P2|COMPLETED|Overall Study||336
8523851|NCT00368277|21010154|P1|COMPLETED|Overall Study||344
8523852|NCT00368277|21010153|P2|STARTED|Overall Study||444
8523853|NCT00368277|21010154|P1|STARTED|Overall Study||457
8523854|NCT00368251|21010169|P3|NOT COMPLETED|Overall Study||1
8523855|NCT00368251|21010170|P2|NOT COMPLETED|Overall Study||0
8523856|NCT00368251|21010171|P1|NOT COMPLETED|Overall Study||1
8523857|NCT00368251|21010169|P3|COMPLETED|Overall Study||17
8523858|NCT00368251|21010170|P2|COMPLETED|Overall Study||20
8523859|NCT00368251|21010171|P1|COMPLETED|Overall Study||17
8523860|NCT00368251|21010169|P3|STARTED|Overall Study||18
8523861|NCT00368251|21010170|P2|STARTED|Overall Study||20
8523862|NCT00368251|21010171|P1|STARTED|Overall Study||18
8523863|NCT00368108|21010194|P3|NOT COMPLETED|Overall Study||68
8523864|NCT00368108|21010195|P2|NOT COMPLETED|Overall Study||53
8523865|NCT00368108|21010196|P1|NOT COMPLETED|Overall Study||64
8523866|NCT00368108|21010194|P3|COMPLETED|Overall Study||182
8523867|NCT00368108|21010195|P2|COMPLETED|Overall Study||198
8523868|NCT00368108|21010196|P1|COMPLETED|Overall Study||187
8523869|NCT00368108|21010194|P3|STARTED|Overall Study||250
8523870|NCT00368108|21010195|P2|STARTED|Overall Study||251
8523871|NCT00368108|21010196|P1|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
8523872|NCT00368069|21010215|P2|NOT COMPLETED|Overall Study||7
8523873|NCT00368069|21010216|P1|NOT COMPLETED|Overall Study||8
8523874|NCT00368069|21010215|P2|COMPLETED|Overall Study||72
8523875|NCT00368069|21010216|P1|COMPLETED|Overall Study||71
8523876|NCT00368069|21010215|P2|STARTED|Overall Study||79
8523877|NCT00368069|21010216|P1|STARTED|Overall Study||79
8523878|NCT00367991|21010234|P2|NOT COMPLETED|Overall Study||2
8523879|NCT00367991|21010235|P1|NOT COMPLETED|Overall Study||2
8523880|NCT00367991|21010234|P2|COMPLETED|Overall Study||13
8523881|NCT00367991|21010235|P1|COMPLETED|Overall Study||27
8523882|NCT00367991|21010234|P2|STARTED|Overall Study||15
8523883|NCT00367991|21010235|P1|STARTED|Overall Study||29
8523890|NCT00367770|21010280|P1|NOT COMPLETED|Overall Study||2
8523891|NCT00367770|21010280|P1|COMPLETED|Overall Study||35
8523892|NCT00367770|21010280|P1|STARTED|Overall Study||37
8523893|NCT00367744|21010288|P2|NOT COMPLETED|Overall Study||5
8523894|NCT00367744|21010289|P1|NOT COMPLETED|Overall Study||4
8523895|NCT00367744|21010288|P2|COMPLETED|Overall Study||32
8523896|NCT00367744|21010289|P1|COMPLETED|Overall Study||30
8523897|NCT00367744|21010288|P2|STARTED|Overall Study||37
8523898|NCT00367744|21010289|P1|STARTED|Overall Study||34
8523899|NCT00367679|21010297|P1|NOT COMPLETED|Overall Study||0
8523900|NCT00367679|21010297|P1|COMPLETED|Overall Study||35
8523901|NCT00367679|21010297|P1|STARTED|Overall Study||35
8523902|NCT00367640|21010318|P4|NOT COMPLETED|Overall Study||10
8523903|NCT00367640|21010319|P3|NOT COMPLETED|Overall Study||19
8523904|NCT00367640|21010320|P2|NOT COMPLETED|Overall Study||22
8523905|NCT00367640|21010321|P1|NOT COMPLETED|Overall Study||18
8523906|NCT00367640|21010318|P4|COMPLETED|Overall Study||146
8523907|NCT00367640|21010319|P3|COMPLETED|Overall Study||141
8523908|NCT00367640|21010320|P2|COMPLETED|Overall Study||133
8523909|NCT00367640|21010321|P1|COMPLETED|Overall Study||139
8523910|NCT00367640|21010318|P4|STARTED|Overall Study||156
8523911|NCT00367640|21010319|P3|STARTED|Overall Study||160
8523912|NCT00367640|21010320|P2|STARTED|Overall Study||155
8523913|NCT00367640|21010321|P1|STARTED|Overall Study||157
8523914|NCT00367601|21010331|P1|NOT COMPLETED|Overall Study||0
8523915|NCT00367601|21010331|P1|COMPLETED|Overall Study||25
8523916|NCT00367601|21010331|P1|STARTED|Overall Study||25
8523917|NCT00367484|21010337|P1|NOT COMPLETED|Overall Study||17
8523918|NCT00367484|21010337|P1|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
8523919|NCT00367484|21010337|P1|STARTED|Overall Study||460
8523920|NCT00367458|21010343|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
8523921|NCT00367458|21010344|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
8523922|NCT00367458|21010343|P2|COMPLETED|Second Intervention - 8 Weeks||12
8523923|NCT00367458|21010344|P1|COMPLETED|Second Intervention - 8 Weeks||10
8523924|NCT00367458|21010343|P2|STARTED|Second Intervention - 8 Weeks||12
8523925|NCT00367458|21010344|P1|STARTED|Second Intervention - 8 Weeks||10
8523926|NCT00367458|21010343|P2|NOT COMPLETED|Washout Period - 4-6 Weeks||0
8523927|NCT00367458|21010344|P1|NOT COMPLETED|Washout Period - 4-6 Weeks||0
8523928|NCT00367458|21010343|P2|COMPLETED|Washout Period - 4-6 Weeks||12
8523929|NCT00367458|21010344|P1|COMPLETED|Washout Period - 4-6 Weeks||10
8523930|NCT00367458|21010343|P2|STARTED|Washout Period - 4-6 Weeks||12
8523931|NCT00367458|21010344|P1|STARTED|Washout Period - 4-6 Weeks||10
8523932|NCT00367458|21010343|P2|NOT COMPLETED|First Intervention - 8 Weeks||0
8523933|NCT00367458|21010344|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
8523934|NCT00367458|21010343|P2|COMPLETED|First Intervention - 8 Weeks||12
8523935|NCT00367458|21010344|P1|COMPLETED|First Intervention - 8 Weeks||10
8523936|NCT00367458|21010343|P2|STARTED|First Intervention - 8 Weeks||12
8523937|NCT00367458|21010344|P1|STARTED|First Intervention - 8 Weeks||12
8523938|NCT00367432|21010358|P2|NOT COMPLETED|Second Period (up to 54 Months)||16
8523939|NCT00367432|21010359|P1|NOT COMPLETED|Second Period (up to 54 Months)||87
8523940|NCT00367432|21010358|P2|COMPLETED|Second Period (up to 54 Months)||69
8523941|NCT00367432|21010359|P1|COMPLETED|Second Period (up to 54 Months)||188
8523942|NCT00367432|21010358|P2|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
8523943|NCT00367432|21010359|P1|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
8523944|NCT00367432|21010358|P2|NOT COMPLETED|First Period (16 Weeks)||0
8523945|NCT00367432|21010359|P1|NOT COMPLETED|First Period (16 Weeks)||38
8523946|NCT00367432|21010358|P2|COMPLETED|First Period (16 Weeks)||0
8523947|NCT00367432|21010359|P1|COMPLETED|First Period (16 Weeks)||275
8523948|NCT00367432|21010358|P2|STARTED|First Period (16 Weeks)||0
8523949|NCT00367432|21010359|P1|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
8523959|NCT00367341|21010386|P2|NOT COMPLETED|Overall Study||0
8523960|NCT00367341|21010387|P1|NOT COMPLETED|Overall Study||2
8523961|NCT00367341|21010386|P2|COMPLETED|Overall Study||40
8523962|NCT00367341|21010387|P1|COMPLETED|Overall Study||40
8523963|NCT00367341|21010386|P2|STARTED|Overall Study||40
8523964|NCT00367341|21010387|P1|STARTED|Overall Study||42
8523965|NCT00367237|21010397|P2|NOT COMPLETED|Overall Study||11
8523966|NCT00367237|21010398|P1|NOT COMPLETED|Overall Study||10
8523967|NCT00367237|21010397|P2|COMPLETED|Overall Study||47
8523968|NCT00367237|21010398|P1|COMPLETED|Overall Study||47
8523969|NCT00367237|21010397|P2|STARTED|Overall Study|Number of subjects randomized|58
8523970|NCT00367237|21010398|P1|STARTED|Overall Study|Number of subjects randomized|57
8523971|NCT00367133|21010407|P3|NOT COMPLETED|3 Years||18
8523972|NCT00367133|21010408|P2|NOT COMPLETED|3 Years||23
8523973|NCT00367133|21010409|P1|NOT COMPLETED|3 Years||28
8523974|NCT00367133|21010407|P3|COMPLETED|3 Years||98
8523975|NCT00367133|21010408|P2|COMPLETED|3 Years||93
8523976|NCT00367133|21010409|P1|COMPLETED|3 Years||115
8523977|NCT00367133|21010407|P3|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
8523978|NCT00367133|21010408|P2|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
8523979|NCT00367133|21010409|P1|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
8523980|NCT00367133|21010407|P3|NOT COMPLETED|2 Years||49
8523981|NCT00367133|21010408|P2|NOT COMPLETED|2 Years||36
8523982|NCT00367133|21010409|P1|NOT COMPLETED|2 Years||58
8523983|NCT00367133|21010407|P3|COMPLETED|2 Years||205
8523984|NCT00367133|21010408|P2|COMPLETED|2 Years||220
8523985|NCT00367133|21010409|P1|COMPLETED|2 Years||272
8523986|NCT00367133|21010407|P3|STARTED|2 Years|Number of Eyes|254
8523987|NCT00367133|21010408|P2|STARTED|2 Years|Number of Eyes|256
8523988|NCT00367133|21010409|P1|STARTED|2 Years|Number of Eyes|330
8523989|NCT00367055|21010461|P2|NOT COMPLETED|Overall Study||11
8523990|NCT00367055|21010462|P1|NOT COMPLETED|Overall Study||11
8523991|NCT00367055|21010461|P2|COMPLETED|Overall Study||30
8523992|NCT00367055|21010462|P1|COMPLETED|Overall Study||32
8523993|NCT00367055|21010461|P2|STARTED|Overall Study||41
8523994|NCT00367055|21010462|P1|STARTED|Overall Study||43
8523998|NCT00366899|21010482|P2|NOT COMPLETED|Toddler Dose||1
8523999|NCT00366899|21010483|P1|NOT COMPLETED|Toddler Dose||2
8524000|NCT00366899|21010482|P2|COMPLETED|Toddler Dose||281
8524001|NCT00366899|21010483|P1|COMPLETED|Toddler Dose||285
8524002|NCT00366899|21010482|P2|STARTED|Toddler Dose||282
8524003|NCT00366899|21010483|P1|STARTED|Toddler Dose||287
8524004|NCT00366899|21010482|P2|NOT COMPLETED|After Infant Series||9
8524005|NCT00366899|21010483|P1|NOT COMPLETED|After Infant Series||7
8524006|NCT00366899|21010482|P2|COMPLETED|After Infant Series||282
8524007|NCT00366899|21010483|P1|COMPLETED|After Infant Series||287
8524008|NCT00366899|21010482|P2|STARTED|After Infant Series||291
8524009|NCT00366899|21010483|P1|STARTED|After Infant Series||294
8524010|NCT00366899|21010482|P2|NOT COMPLETED|Infant Series||12
8524011|NCT00366899|21010483|P1|NOT COMPLETED|Infant Series||9
8524012|NCT00366899|21010482|P2|COMPLETED|Infant Series||291
8524013|NCT00366899|21010483|P1|COMPLETED|Infant Series||294
8524014|NCT00366899|21010482|P2|Vaccinated Dose 2|Infant Series||293
8524015|NCT00366899|21010483|P1|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
8524016|NCT00366899|21010482|P2|Vaccinated Dose 1|Infant Series||302
8524017|NCT00366899|21010483|P1|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
8524018|NCT00366899|21010482|P2|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
8524019|NCT00366899|21010483|P1|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
8524020|NCT00366678|21010543|P3|NOT COMPLETED|Toddler Dose||0
8524021|NCT00366678|21010544|P2|NOT COMPLETED|Toddler Dose||1
8524022|NCT00366678|21010545|P1|NOT COMPLETED|Toddler Dose||5
8524023|NCT00366678|21010543|P3|COMPLETED|Toddler Dose||137
8524024|NCT00366678|21010544|P2|COMPLETED|Toddler Dose||151
8524025|NCT00366678|21010545|P1|COMPLETED|Toddler Dose||268
8524026|NCT00366678|21010543|P3|STARTED|Toddler Dose||137
8524027|NCT00366678|21010544|P2|STARTED|Toddler Dose||152
8524028|NCT00366678|21010545|P1|STARTED|Toddler Dose||273
8524029|NCT00366678|21010543|P3|NOT COMPLETED|After Infant||0
8524030|NCT00366678|21010544|P2|NOT COMPLETED|After Infant||10
8524031|NCT00366678|21010545|P1|NOT COMPLETED|After Infant||17
8524032|NCT00366678|21010543|P3|COMPLETED|After Infant||0
8524033|NCT00366678|21010544|P2|COMPLETED|After Infant||289
8524034|NCT00366678|21010545|P1|COMPLETED|After Infant||273
8524035|NCT00366678|21010543|P3|STARTED|After Infant||0
8524036|NCT00366678|21010544|P2|STARTED|After Infant||299
8524037|NCT00366678|21010545|P1|STARTED|After Infant||290
8524038|NCT00366678|21010543|P3|NOT COMPLETED|Infant Series||0
8524039|NCT00366678|21010544|P2|NOT COMPLETED|Infant Series||10
8524040|NCT00366678|21010545|P1|NOT COMPLETED|Infant Series||14
8524041|NCT00366678|21010543|P3|COMPLETED|Infant Series||0
8524042|NCT00366678|21010544|P2|COMPLETED|Infant Series||299
8524043|NCT00366678|21010545|P1|COMPLETED|Infant Series||290
8524044|NCT00366678|21010543|P3|Vaccinated Dose 3|Infant Series||0
8524045|NCT00366678|21010544|P2|Vaccinated Dose 3|Infant Series||302
8524046|NCT00366678|21010545|P1|Vaccinated Dose 3|Infant Series||291
8524047|NCT00366678|21010543|P3|Vaccinated Dose 2|Infant Series||0
8524048|NCT00366678|21010544|P2|Vaccinated Dose 2|Infant Series||304
8524049|NCT00366678|21010545|P1|Vaccinated Dose 2|Infant Series||295
8524050|NCT00366678|21010543|P3|Vaccinated Dose 1|Infant Series||0
8524051|NCT00366678|21010544|P2|Vaccinated Dose 1|Infant Series||309
8524052|NCT00366678|21010545|P1|Vaccinated Dose 1|Infant Series||302
8524053|NCT00366678|21010543|P3|STARTED|Infant Series||0
8524054|NCT00366678|21010544|P2|STARTED|Infant Series||309
8524055|NCT00366678|21010545|P1|STARTED|Infant Series||304
8524056|NCT00366626|21010612|P2|NOT COMPLETED|Overall Study||0
8524057|NCT00366626|21010613|P1|NOT COMPLETED|Overall Study||0
8524058|NCT00366626|21010612|P2|COMPLETED|Overall Study||45
8524059|NCT00366626|21010613|P1|COMPLETED|Overall Study||38
8524060|NCT00366626|21010612|P2|STARTED|Overall Study||45
8524061|NCT00366626|21010613|P1|STARTED|Overall Study||38
8524062|NCT00366548|21010627|P2|NOT COMPLETED|Toddler Dose||0
8524063|NCT00366548|21010628|P1|NOT COMPLETED|Toddler Dose||0
8524064|NCT00366548|21010627|P2|COMPLETED|Toddler Dose||244
8524065|NCT00366548|21010628|P1|COMPLETED|Toddler Dose||240
8524066|NCT00366548|21010627|P2|STARTED|Toddler Dose||244
8524067|NCT00366548|21010628|P1|STARTED|Toddler Dose||240
8524068|NCT00366548|21010627|P2|NOT COMPLETED|After Infant Series||1
8524069|NCT00366548|21010628|P1|NOT COMPLETED|After Infant Series||6
8524070|NCT00366548|21010627|P2|COMPLETED|After Infant Series||244
8524071|NCT00366548|21010628|P1|COMPLETED|After Infant Series||240
8524072|NCT00366548|21010627|P2|STARTED|After Infant Series||245
8524073|NCT00366548|21010628|P1|STARTED|After Infant Series||246
8524074|NCT00366548|21010627|P2|NOT COMPLETED|Infant Series||5
8524075|NCT00366548|21010628|P1|NOT COMPLETED|Infant Series||4
8524076|NCT00366548|21010627|P2|COMPLETED|Infant Series||245
8524077|NCT00366548|21010628|P1|COMPLETED|Infant Series||246
8524078|NCT00366548|21010627|P2|Vaccinated Dose 3|Infant Series||247
8524079|NCT00366548|21010628|P1|Vaccinated Dose 3|Infant Series||246
8524080|NCT00366548|21010627|P2|Vaccinated Dose 2|Infant Series||249
8524081|NCT00366548|21010628|P1|Vaccinated Dose 2|Infant Series||246
8524082|NCT00366548|21010627|P2|Vaccinated Dose 1|Infant Series||250
8524083|NCT00366548|21010628|P1|Vaccinated Dose 1|Infant Series||250
8524084|NCT00366548|21010627|P2|STARTED|Infant Series||250
8524085|NCT00366548|21010628|P1|STARTED|Infant Series||250
8524086|NCT00366535|21010664|P2|NOT COMPLETED|Second Phase: 12 Weeks||3
8524087|NCT00366535|21010665|P1|NOT COMPLETED|Second Phase: 12 Weeks||3
8524088|NCT00366535|21010664|P2|COMPLETED|Second Phase: 12 Weeks||18
8524089|NCT00366535|21010665|P1|COMPLETED|Second Phase: 12 Weeks||21
8524090|NCT00366535|21010664|P2|STARTED|Second Phase: 12 Weeks||21
8524091|NCT00366535|21010665|P1|STARTED|Second Phase: 12 Weeks||24
8524092|NCT00366535|21010664|P2|NOT COMPLETED|Washout Period (at Least a Week)||0
8524093|NCT00366535|21010665|P1|NOT COMPLETED|Washout Period (at Least a Week)||0
8524094|NCT00366535|21010664|P2|COMPLETED|Washout Period (at Least a Week)||21
8524095|NCT00366535|21010665|P1|COMPLETED|Washout Period (at Least a Week)||24
8524096|NCT00366535|21010664|P2|STARTED|Washout Period (at Least a Week)||21
8524097|NCT00366535|21010665|P1|STARTED|Washout Period (at Least a Week)||24
8524098|NCT00366535|21010664|P2|NOT COMPLETED|First Phase: 12 Weeks||8
8524099|NCT00366535|21010665|P1|NOT COMPLETED|First Phase: 12 Weeks||3
8524100|NCT00366535|21010664|P2|COMPLETED|First Phase: 12 Weeks||21
8524101|NCT00366535|21010665|P1|COMPLETED|First Phase: 12 Weeks||24
8524102|NCT00366535|21010664|P2|STARTED|First Phase: 12 Weeks||29
8524103|NCT00366535|21010665|P1|STARTED|First Phase: 12 Weeks||27
8524104|NCT00366457|21010679|P1|NOT COMPLETED|Overall Study||2
8524105|NCT00366457|21010679|P1|COMPLETED|Overall Study||30
8524106|NCT00366457|21010679|P1|STARTED|Overall Study||32
8524107|NCT00366444|21010688|P2|NOT COMPLETED|Overall Study||2
8524108|NCT00366444|21010689|P1|NOT COMPLETED|Overall Study||1
8524109|NCT00366444|21010688|P2|COMPLETED|Overall Study||97
8524110|NCT00366444|21010689|P1|COMPLETED|Overall Study||101
8524111|NCT00366444|21010688|P2|STARTED|Overall Study||99
8524112|NCT00366444|21010689|P1|STARTED|Overall Study||102
8524113|NCT00366340|21010717|P2|NOT COMPLETED|Toddler Dose||1
8524114|NCT00366340|21010718|P1|NOT COMPLETED|Toddler Dose||1
8524115|NCT00366340|21010717|P2|COMPLETED|Toddler Dose||286
8524116|NCT00366340|21010718|P1|COMPLETED|Toddler Dose||289
8524117|NCT00366340|21010717|P2|STARTED|Toddler Dose||287
8524118|NCT00366340|21010718|P1|STARTED|Toddler Dose||290
8524119|NCT00366340|21010717|P2|NOT COMPLETED|After the Infant Series||6
8524120|NCT00366340|21010718|P1|NOT COMPLETED|After the Infant Series||3
8524121|NCT00366340|21010717|P2|COMPLETED|After the Infant Series||287
8524122|NCT00366340|21010718|P1|COMPLETED|After the Infant Series||290
8524123|NCT00366340|21010717|P2|STARTED|After the Infant Series||293
8524124|NCT00366340|21010718|P1|STARTED|After the Infant Series||293
8524125|NCT00366340|21010717|P2|NOT COMPLETED|Infant Series||10
8524126|NCT00366340|21010718|P1|NOT COMPLETED|Infant Series||8
8524127|NCT00366340|21010717|P2|COMPLETED|Infant Series||293
8524128|NCT00366340|21010718|P1|COMPLETED|Infant Series||293
8524129|NCT00366340|21010717|P2|Vaccinated Dose 3|Infant Series||293
8524130|NCT00366340|21010718|P1|Vaccinated Dose 3|Infant Series||294
8524131|NCT00366340|21010717|P2|Vaccinated Dose 2|Infant Series||297
8524132|NCT00366340|21010718|P1|Vaccinated Dose 2|Infant Series||296
8524133|NCT00366340|21010717|P2|Vaccinated Dose 1|Infant Series||303
8524134|NCT00366340|21010718|P1|Vaccinated Dose 1|Infant Series||300
8524135|NCT00366340|21010717|P2|STARTED|Infant Series||303
8524136|NCT00366340|21010718|P1|STARTED|Infant Series||301
8524137|NCT00366301|21010776|P4|NOT COMPLETED|Overall Study||8
8524138|NCT00366301|21010777|P3|NOT COMPLETED|Overall Study||4
8524139|NCT00366301|21010778|P2|NOT COMPLETED|Overall Study||6
8524140|NCT00366301|21010779|P1|NOT COMPLETED|Overall Study||8
8524141|NCT00366301|21010776|P4|COMPLETED|Overall Study||116
8524142|NCT00366301|21010777|P3|COMPLETED|Overall Study||122
8524143|NCT00366301|21010778|P2|COMPLETED|Overall Study||120
8524144|NCT00366301|21010779|P1|COMPLETED|Overall Study||116
8524145|NCT00366301|21010776|P4|Either 6W or 14W CRP Obtained|Overall Study||119
8524146|NCT00366301|21010777|P3|Either 6W or 14W CRP Obtained|Overall Study||124
8524147|NCT00366301|21010778|P2|Either 6W or 14W CRP Obtained|Overall Study||124
8524148|NCT00366301|21010779|P1|Either 6W or 14W CRP Obtained|Overall Study||120
8524149|NCT00366301|21010776|P4|STARTED|Overall Study||124
8524150|NCT00366301|21010777|P3|STARTED|Overall Study||126
8524151|NCT00366301|21010778|P2|STARTED|Overall Study||126
8524152|NCT00366301|21010779|P1|STARTED|Overall Study||124
8524153|NCT00366275|21010789|P1|NOT COMPLETED|Overall Study||6
8524154|NCT00366275|21010789|P1|COMPLETED|Overall Study||58
8524155|NCT00366275|21010789|P1|STARTED|Overall Study||64
8524156|NCT00366249|21010795|P2|NOT COMPLETED|Overall Study||78
8524157|NCT00366249|21010796|P1|NOT COMPLETED|Overall Study||131
8524158|NCT00366249|21010795|P2|COMPLETED|Overall Study||430
8524159|NCT00366249|21010796|P1|COMPLETED|Overall Study||422
8524160|NCT00366249|21010795|P2|STARTED|Overall Study||508
8524161|NCT00366249|21010796|P1|STARTED|Overall Study||553
8524162|NCT00366106|21010810|P1|NOT COMPLETED|Overall Study||0
8524163|NCT00366106|21010810|P1|COMPLETED|Overall Study||32
8524164|NCT00366106|21010810|P1|STARTED|Overall Study||32
8524165|NCT00366028|21010819|P2|NOT COMPLETED|Overall Study||0
8524166|NCT00366028|21010820|P1|NOT COMPLETED|Overall Study||0
8524167|NCT00366028|21010819|P2|COMPLETED|Overall Study||735
8524168|NCT00366028|21010820|P1|COMPLETED|Overall Study||889
8524169|NCT00366028|21010819|P2|STARTED|Overall Study||735
8524170|NCT00366028|21010820|P1|STARTED|Overall Study||889
8524171|NCT00365989|21010828|P1|NOT COMPLETED|Overall Study||2
8524172|NCT00365989|21010828|P1|COMPLETED|Overall Study||48
8524173|NCT00365989|21010828|P1|STARTED|Overall Study||50
8524174|NCT00365976|21010836|P2|NOT COMPLETED|Overall Study||5
8524175|NCT00365976|21010837|P1|NOT COMPLETED|Overall Study||1
8524176|NCT00365976|21010836|P2|COMPLETED|Overall Study||20
8524177|NCT00365976|21010837|P1|COMPLETED|Overall Study||32
8524178|NCT00365976|21010836|P2|STARTED|Overall Study||25
8524179|NCT00365976|21010837|P1|STARTED|Overall Study||33
8524180|NCT00365872|21010868|P3|NOT COMPLETED|Overall Study||0
8524181|NCT00365872|21010869|P2|NOT COMPLETED|Overall Study||0
8524182|NCT00365872|21010870|P1|NOT COMPLETED|Overall Study||0
8524183|NCT00365872|21010868|P3|COMPLETED|Overall Study||6
8524184|NCT00365872|21010869|P2|COMPLETED|Overall Study||6
8524185|NCT00365872|21010870|P1|COMPLETED|Overall Study||5
8524186|NCT00365872|21010868|P3|STARTED|Overall Study||6
8524187|NCT00365872|21010869|P2|STARTED|Overall Study||6
8524188|NCT00365872|21010870|P1|STARTED|Overall Study||5
8524189|NCT00365859|21010883|P4|NOT COMPLETED|Overall Study||131
8524190|NCT00365859|21010884|P3|NOT COMPLETED|Overall Study||67
8524191|NCT00365859|21010885|P2|NOT COMPLETED|Overall Study||33
8524192|NCT00365859|21010886|P1|NOT COMPLETED|Overall Study||31
8524193|NCT00365859|21010883|P4|COMPLETED|Overall Study||199
8524194|NCT00365859|21010884|P3|COMPLETED|Overall Study||107
8524195|NCT00365859|21010885|P2|COMPLETED|Overall Study||37
8524196|NCT00365859|21010886|P1|COMPLETED|Overall Study||55
8524197|NCT00365859|21010883|P4|Efficacy Population|Overall Study||322
8524198|NCT00365859|21010884|P3|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
8524199|NCT00365859|21010885|P2|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
8524200|NCT00365859|21010886|P1|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
8524201|NCT00365859|21010883|P4|Safety Population|Overall Study||330
8524202|NCT00365859|21010884|P3|Safety Population|Overall Study||174
8524203|NCT00365859|21010885|P2|Safety Population|Overall Study||70
8524204|NCT00365859|21010886|P1|Safety Population|Overall Study||86
8524205|NCT00365859|21010883|P4|STARTED|Overall Study||330
8524206|NCT00365859|21010884|P3|STARTED|Overall Study||174
8524207|NCT00365859|21010885|P2|STARTED|Overall Study||70
8524208|NCT00365859|21010886|P1|STARTED|Overall Study||86
8524209|NCT00365846|21010975|P1|NOT COMPLETED|Overall Study||1
8524210|NCT00365846|21010975|P1|COMPLETED|Overall Study||28
8524211|NCT00365846|21010975|P1|STARTED|Overall Study||29
8524212|NCT00365794|21010984|P1|NOT COMPLETED|Overall Study||2
8524213|NCT00365794|21010984|P1|COMPLETED|Overall Study||20
8524214|NCT00365794|21010984|P1|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22
8524215|NCT00365768|21010999|P2|NOT COMPLETED|Overall Study||0
8524216|NCT00365768|21011000|P1|NOT COMPLETED|Overall Study||0
8524217|NCT00365768|21010999|P2|COMPLETED|Overall Study||25
8524218|NCT00365768|21011000|P1|COMPLETED|Overall Study||24
8524219|NCT00365768|21010999|P2|STARTED|Overall Study||25
8524220|NCT00365768|21011000|P1|STARTED|Overall Study||24
8524221|NCT00365716|21011013|P7|NOT COMPLETED|Extension 2||10
8524222|NCT00365716|21011014|P6|NOT COMPLETED|Extension 2||0
8524223|NCT00365716|21011015|P5|NOT COMPLETED|Extension 2||0
8524224|NCT00365716|21011016|P4|NOT COMPLETED|Extension 2||0
8524225|NCT00365716|21011017|P3|NOT COMPLETED|Extension 2||0
8524226|NCT00365716|21011018|P2|NOT COMPLETED|Extension 2||0
8524227|NCT00365716|21011019|P1|NOT COMPLETED|Extension 2||0
8524228|NCT00365716|21011013|P7|COMPLETED|Extension 2||7
8524229|NCT00365716|21011014|P6|COMPLETED|Extension 2||0
8524230|NCT00365716|21011015|P5|COMPLETED|Extension 2||0
8524231|NCT00365716|21011016|P4|COMPLETED|Extension 2||0
8524232|NCT00365716|21011017|P3|COMPLETED|Extension 2||0
8524233|NCT00365716|21011018|P2|COMPLETED|Extension 2||0
8524234|NCT00365716|21011019|P1|COMPLETED|Extension 2||0
8524235|NCT00365716|21011013|P7|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
8524236|NCT00365716|21011014|P6|STARTED|Extension 2||0
8524237|NCT00365716|21011015|P5|STARTED|Extension 2||0
8524238|NCT00365716|21011016|P4|STARTED|Extension 2||0
8524239|NCT00365716|21011017|P3|STARTED|Extension 2||0
8524240|NCT00365716|21011018|P2|STARTED|Extension 2||0
8524241|NCT00365716|21011019|P1|STARTED|Extension 2||0
8524242|NCT00365716|21011013|P7|NOT COMPLETED|Extension 1||0
8524243|NCT00365716|21011014|P6|NOT COMPLETED|Extension 1||22
8524244|NCT00365716|21011015|P5|NOT COMPLETED|Extension 1||0
8524245|NCT00365716|21011016|P4|NOT COMPLETED|Extension 1||0
8524246|NCT00365716|21011017|P3|NOT COMPLETED|Extension 1||0
8524247|NCT00365716|21011018|P2|NOT COMPLETED|Extension 1||0
8524248|NCT00365716|21011019|P1|NOT COMPLETED|Extension 1||0
8524249|NCT00365716|21011013|P7|COMPLETED|Extension 1||0
8524250|NCT00365716|21011014|P6|COMPLETED|Extension 1||219
8524251|NCT00365716|21011015|P5|COMPLETED|Extension 1||0
8524252|NCT00365716|21011016|P4|COMPLETED|Extension 1||0
8524253|NCT00365716|21011017|P3|COMPLETED|Extension 1||0
8524254|NCT00365716|21011018|P2|COMPLETED|Extension 1||0
8524255|NCT00365716|21011019|P1|COMPLETED|Extension 1||0
8524256|NCT00365716|21011013|P7|STARTED|Extension 1||0
8524257|NCT00365716|21011014|P6|STARTED|Extension 1||241
8524258|NCT00365716|21011015|P5|STARTED|Extension 1||0
8524259|NCT00365716|21011016|P4|STARTED|Extension 1||0
8524260|NCT00365716|21011017|P3|STARTED|Extension 1||0
8524261|NCT00365716|21011018|P2|STARTED|Extension 1||0
8524262|NCT00365716|21011019|P1|STARTED|Extension 1||0
8524263|NCT00365716|21011013|P7|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
8524264|NCT00365716|21011014|P6|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
8524265|NCT00365716|21011015|P5|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
8524266|NCT00365716|21011016|P4|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
8524267|NCT00365716|21011017|P3|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
8524268|NCT00365716|21011018|P2|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
8524269|NCT00365716|21011019|P1|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
8524270|NCT00365716|21011013|P7|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
8524271|NCT00365716|21011014|P6|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
8524272|NCT00365716|21011015|P5|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
8524273|NCT00365716|21011016|P4|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
8524274|NCT00365716|21011017|P3|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
8524275|NCT00365716|21011018|P2|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
8524276|NCT00365716|21011019|P1|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
8524277|NCT00365716|21011013|P7|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
8524278|NCT00365716|21011014|P6|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
8524279|NCT00365716|21011015|P5|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
8524280|NCT00365716|21011016|P4|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
8524281|NCT00365716|21011017|P3|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
8524282|NCT00365716|21011018|P2|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
8524283|NCT00365716|21011019|P1|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
8524284|NCT00365716|21011013|P7|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
8524285|NCT00365716|21011014|P6|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
8524286|NCT00365716|21011015|P5|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
8524287|NCT00365716|21011016|P4|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
8524288|NCT00365716|21011017|P3|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
8524289|NCT00365716|21011018|P2|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
8524290|NCT00365716|21011019|P1|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
8524291|NCT00365716|21011013|P7|COMPLETED|Base Study (Day 1 to Month 7)||0
8524292|NCT00365716|21011014|P6|COMPLETED|Base Study (Day 1 to Month 7)||0
8524293|NCT00365716|21011015|P5|COMPLETED|Base Study (Day 1 to Month 7)||139
8524294|NCT00365716|21011016|P4|COMPLETED|Base Study (Day 1 to Month 7)||136
8524295|NCT00365716|21011017|P3|COMPLETED|Base Study (Day 1 to Month 7)||271
8524296|NCT00365716|21011018|P2|COMPLETED|Base Study (Day 1 to Month 7)||260
8524297|NCT00365716|21011019|P1|COMPLETED|Base Study (Day 1 to Month 7)||269
8524298|NCT00365716|21011013|P7|STARTED|Base Study (Day 1 to Month 7)||0
8524299|NCT00365716|21011014|P6|STARTED|Base Study (Day 1 to Month 7)||0
8524300|NCT00365716|21011015|P5|STARTED|Base Study (Day 1 to Month 7)||146
8524301|NCT00365716|21011016|P4|STARTED|Base Study (Day 1 to Month 7)||146
8524302|NCT00365716|21011017|P3|STARTED|Base Study (Day 1 to Month 7)||292
8524303|NCT00365716|21011018|P2|STARTED|Base Study (Day 1 to Month 7)||284
8524304|NCT00365716|21011019|P1|STARTED|Base Study (Day 1 to Month 7)||290
8524305|NCT00365599|21011034|P1|NOT COMPLETED|Overall Study||0
8524306|NCT00365599|21011034|P1|COMPLETED|Overall Study||43
8524307|NCT00365599|21011034|P1|STARTED|Overall Study||43
8524308|NCT00365547|21011040|P1|NOT COMPLETED|Overall Study||3
8524309|NCT00365547|21011040|P1|COMPLETED|Overall Study||43
8524310|NCT00365547|21011040|P1|STARTED|Overall Study||46
8524311|NCT00365508|21011050|P2|NOT COMPLETED|Overall Study||154
8524312|NCT00365508|21011051|P1|NOT COMPLETED|Overall Study||139
8524313|NCT00365508|21011050|P2|COMPLETED|Overall Study||167
8524314|NCT00365508|21011051|P1|COMPLETED|Overall Study||182
8524315|NCT00365508|21011050|P2|STARTED|Overall Study||321
8524316|NCT00365508|21011051|P1|STARTED|Overall Study||321
8524317|NCT00365456|21011059|P2|NOT COMPLETED|Trial Period III (12 Months)||5
8524318|NCT00365456|21011060|P1|NOT COMPLETED|Trial Period III (12 Months)||18
8524319|NCT00365456|21011059|P2|COMPLETED|Trial Period III (12 Months)||127
8524320|NCT00365456|21011060|P1|COMPLETED|Trial Period III (12 Months)||118
8524321|NCT00365456|21011059|P2|STARTED|Trial Period III (12 Months)||132
8524322|NCT00365456|21011060|P1|STARTED|Trial Period III (12 Months)||136
8524323|NCT00365456|21011059|P2|NOT COMPLETED|Trial Period II (12 Months)||14
8524324|NCT00365456|21011060|P1|NOT COMPLETED|Trial Period II (12 Months)||0
8524325|NCT00365456|21011059|P2|COMPLETED|Trial Period II (12 Months)||268
8524326|NCT00365456|21011060|P1|COMPLETED|Trial Period II (12 Months)||0
8524327|NCT00365456|21011059|P2|STARTED|Trial Period II (12 Months)||282
8524328|NCT00365456|21011060|P1|STARTED|Trial Period II (12 Months)||0
8524329|NCT00365456|21011059|P2|NOT COMPLETED|Trial Period I (12 Months)||0
8524330|NCT00365456|21011060|P1|NOT COMPLETED|Trial Period I (12 Months)||125
8524331|NCT00365456|21011059|P2|COMPLETED|Trial Period I (12 Months)||0
8524332|NCT00365456|21011060|P1|COMPLETED|Trial Period I (12 Months)||282
8524333|NCT00365456|21011059|P2|STARTED|Trial Period I (12 Months)||0
8524334|NCT00365456|21011060|P1|STARTED|Trial Period I (12 Months)||407
8524338|NCT00365391|21011077|P1|NOT COMPLETED|Overall Study||0
8524339|NCT00365391|21011077|P1|COMPLETED|Overall Study||27
8524340|NCT00365391|21011077|P1|STARTED|Overall Study||27
8524341|NCT00365378|21011087|P3|NOT COMPLETED|Extension||197
8524342|NCT00365378|21011088|P2|NOT COMPLETED|Extension||0
8524343|NCT00365378|21011089|P1|NOT COMPLETED|Extension||0
8524344|NCT00365378|21011087|P3|COMPLETED|Extension||203
8524345|NCT00365378|21011088|P2|COMPLETED|Extension||0
8524346|NCT00365378|21011089|P1|COMPLETED|Extension||0
8524347|NCT00365378|21011087|P3|STARTED|Extension||400
8524348|NCT00365378|21011088|P2|STARTED|Extension||0
8524349|NCT00365378|21011089|P1|STARTED|Extension||0
8524350|NCT00365378|21011087|P3|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
8524351|NCT00365378|21011088|P2|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
8524352|NCT00365378|21011089|P1|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
8524353|NCT00365378|21011087|P3|COMPLETED|Follow-up (Month 7 Though Month 48)||0
8524354|NCT00365378|21011088|P2|COMPLETED|Follow-up (Month 7 Though Month 48)||836
8524355|NCT00365378|21011089|P1|COMPLETED|Follow-up (Month 7 Though Month 48)||835
8524356|NCT00365378|21011087|P3|STARTED|Follow-up (Month 7 Though Month 48)||0
8524357|NCT00365378|21011088|P2|STARTED|Follow-up (Month 7 Though Month 48)||1038
8524358|NCT00365378|21011089|P1|STARTED|Follow-up (Month 7 Though Month 48)||993
8524359|NCT00365378|21011087|P3|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
8524360|NCT00365378|21011088|P2|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
8524361|NCT00365378|21011089|P1|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
8524362|NCT00365378|21011087|P3|COMPLETED|Vaccination (Day 1 to Month 7)||0
8524363|NCT00365378|21011088|P2|COMPLETED|Vaccination (Day 1 to Month 7)||1038
8524364|NCT00365378|21011089|P1|COMPLETED|Vaccination (Day 1 to Month 7)||993
8524365|NCT00365378|21011087|P3|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
8524366|NCT00365378|21011088|P2|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
8524367|NCT00365378|21011089|P1|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
8524368|NCT00365378|21011087|P3|STARTED|Vaccination (Day 1 to Month 7)||0
8524369|NCT00365378|21011088|P2|STARTED|Vaccination (Day 1 to Month 7)||1205
8524370|NCT00365378|21011089|P1|STARTED|Vaccination (Day 1 to Month 7)||1204
8524371|NCT00365365|21011103|P3|NOT COMPLETED|Overall Study||15
8524372|NCT00365365|21011104|P2|NOT COMPLETED|Overall Study||36
8524373|NCT00365365|21011105|P1|NOT COMPLETED|Overall Study||34
8524374|NCT00365365|21011103|P3|COMPLETED|Overall Study||44
8524375|NCT00365365|21011104|P2|COMPLETED|Overall Study||41
8524376|NCT00365365|21011105|P1|COMPLETED|Overall Study||44
8524377|NCT00365365|21011103|P3|COMPLETED TREATMENT|Overall Study||45
8524378|NCT00365365|21011104|P2|COMPLETED TREATMENT|Overall Study||36
8524379|NCT00365365|21011105|P1|COMPLETED TREATMENT|Overall Study||38
8524380|NCT00365365|21011103|P3|TREATED (SAFETY POPULATION)|Overall Study||59
8524381|NCT00365365|21011104|P2|TREATED (SAFETY POPULATION)|Overall Study||75
8524382|NCT00365365|21011105|P1|TREATED (SAFETY POPULATION)|Overall Study||78
8524383|NCT00365365|21011103|P3|STARTED|Overall Study||59
8524384|NCT00365365|21011104|P2|STARTED|Overall Study||77
8524385|NCT00365365|21011105|P1|STARTED|Overall Study||78
8524386|NCT00365352|21011122|P3|NOT COMPLETED|Overall Study||15
8524387|NCT00365352|21011123|P2|NOT COMPLETED|Overall Study||11
8524388|NCT00365352|21011124|P1|NOT COMPLETED|Overall Study||20
8524389|NCT00365352|21011122|P3|COMPLETED|Overall Study||98
8524390|NCT00365352|21011123|P2|COMPLETED|Overall Study||104
8524391|NCT00365352|21011124|P1|COMPLETED|Overall Study||77
8524392|NCT00365352|21011122|P3|Modified Intent-to-Treat Population|Overall Study||111
8524393|NCT00365352|21011123|P2|Modified Intent-to-Treat Population|Overall Study||114
8524394|NCT00365352|21011124|P1|Modified Intent-to-Treat Population|Overall Study||96
8524395|NCT00365352|21011122|P3|Safety Population|Overall Study||111
8524396|NCT00365352|21011123|P2|Safety Population|Overall Study||115
8524397|NCT00365352|21011124|P1|Safety Population|Overall Study||96
8524398|NCT00365352|21011122|P3|STARTED|Overall Study||113
8524399|NCT00365352|21011123|P2|STARTED|Overall Study||115
8524400|NCT00365352|21011124|P1|STARTED|Overall Study||97
8524401|NCT00365300|21011208|P2|NOT COMPLETED|Double-blind Phase||9
8524402|NCT00365300|21011209|P1|NOT COMPLETED|Double-blind Phase||11
8524403|NCT00365300|21011208|P2|COMPLETED|Double-blind Phase||45
8524404|NCT00365300|21011209|P1|COMPLETED|Double-blind Phase||43
8524405|NCT00365300|21011208|P2|STARTED|Double-blind Phase||54
8524406|NCT00365300|21011209|P1|STARTED|Double-blind Phase||54
8524407|NCT00365300|21011208|P2|NOT COMPLETED|Open-label Phase||0
8524408|NCT00365300|21011209|P1|NOT COMPLETED|Open-label Phase||22
8524409|NCT00365300|21011208|P2|COMPLETED|Open-label Phase||0
8524410|NCT00365300|21011209|P1|COMPLETED|Open-label Phase||107
8524411|NCT00365300|21011208|P2|STARTED|Open-label Phase||0
8524412|NCT00365300|21011209|P1|STARTED|Open-label Phase||129
8524413|NCT00365274|21011218|P1|NOT COMPLETED|Overall Study||0
8524414|NCT00365274|21011218|P1|COMPLETED|Overall Study||6
8524415|NCT00365274|21011218|P1|STARTED|Overall Study||6
8524416|NCT00365261|21011224|P2|NOT COMPLETED|Overall Study||3
8524417|NCT00365261|21011225|P1|NOT COMPLETED|Overall Study||3
8524418|NCT00365261|21011224|P2|COMPLETED|Overall Study||19
8524419|NCT00365261|21011225|P1|COMPLETED|Overall Study||20
8524420|NCT00365261|21011224|P2|STARTED|Overall Study||22
8524421|NCT00365261|21011225|P1|STARTED|Overall Study||23
8524422|NCT00365209|21011235|P1|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
8524423|NCT00365209|21011235|P1|COMPLETED|Stage 2: Receiving 4g Curcumin||19
8524424|NCT00365209|21011235|P1|STARTED|Stage 2: Receiving 4g Curcumin||21
8524425|NCT00365209|21011235|P1|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
8524426|NCT00365209|21011235|P1|COMPLETED|Stage 1: Receiving 2g Curcumin||21
8524427|NCT00365209|21011235|P1|STARTED|Stage 1: Receiving 2g Curcumin||23
8524428|NCT00365144|21011264|P1|NOT COMPLETED|Overall Study||0
8524429|NCT00365144|21011264|P1|COMPLETED|Overall Study||36
8524430|NCT00365144|21011264|P1|STARTED|Overall Study||36
8524431|NCT00365105|21011274|P2|NOT COMPLETED|Overall Study||8
8524432|NCT00365105|21011275|P1|NOT COMPLETED|Overall Study||5
8524433|NCT00365105|21011274|P2|COMPLETED|Overall Study||124
8524434|NCT00365105|21011275|P1|COMPLETED|Overall Study||124
8524435|NCT00365105|21011274|P2|Eligible With Adverse Event Data|Overall Study||124
8524436|NCT00365105|21011275|P1|Eligible With Adverse Event Data|Overall Study||123
8524437|NCT00365105|21011274|P2|Eligible|Overall Study||124
8524438|NCT00365105|21011275|P1|Eligible|Overall Study||124
8524439|NCT00365105|21011274|P2|STARTED|Overall Study||132
8524440|NCT00365105|21011275|P1|STARTED|Overall Study||129
8524441|NCT00365053|21011291|P1|NOT COMPLETED|Overall Study||0
8524442|NCT00365053|21011291|P1|COMPLETED|Overall Study||13
8524443|NCT00365053|21011291|P1|STARTED|Overall Study||13
8524444|NCT00364949|21011302|P2|NOT COMPLETED|Overall Study||0
8524445|NCT00364949|21011303|P1|NOT COMPLETED|Overall Study||0
8524446|NCT00364949|21011302|P2|COMPLETED|Overall Study||39
8524447|NCT00364949|21011303|P1|COMPLETED|Overall Study||31
8524448|NCT00364949|21011302|P2|STARTED|Overall Study||39
8524449|NCT00364949|21011303|P1|STARTED|Overall Study||31
8524450|NCT00364923|21011321|P1|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
8524451|NCT00364923|21011321|P1|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
8524452|NCT00364923|21011321|P1|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
8524453|NCT00364923|21011321|P1|NOT COMPLETED|Treatment With Pralatrexate||4
8524454|NCT00364923|21011321|P1|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
8524455|NCT00364923|21011321|P1|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
8524456|NCT00364858|21011330|P2|NOT COMPLETED|Overall Study||22
8524457|NCT00364858|21011331|P1|NOT COMPLETED|Overall Study||7
8524458|NCT00364858|21011330|P2|COMPLETED|Overall Study||40
8524459|NCT00364858|21011331|P1|COMPLETED|Overall Study||26
8524460|NCT00364858|21011330|P2|STARTED|Overall Study||62
8524461|NCT00364858|21011331|P1|STARTED|Overall Study||33
8524462|NCT00364845|21011346|P2|NOT COMPLETED|Overall Study||11
8524463|NCT00364845|21011347|P1|NOT COMPLETED|Overall Study||11
8524464|NCT00364845|21011346|P2|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
8524465|NCT00364845|21011347|P1|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
8524466|NCT00364845|21011346|P2|STARTED|Overall Study||23
8524467|NCT00364845|21011347|P1|STARTED|Overall Study||28
8524468|NCT00364832|21011368|P12|NOT COMPLETED|Extension Year 2||3
8524469|NCT00364832|21011369|P11|NOT COMPLETED|Extension Year 2||5
8524470|NCT00364832|21011370|P10|NOT COMPLETED|Extension Year 2||5
8524471|NCT00364832|21011371|P9|NOT COMPLETED|Extension Year 2||0
8524472|NCT00364832|21011372|P8|NOT COMPLETED|Extension Year 2||0
8524473|NCT00364832|21011373|P7|NOT COMPLETED|Extension Year 2||0
8524474|NCT00364832|21011374|P6|NOT COMPLETED|Extension Year 2||0
8524475|NCT00364832|21011375|P5|NOT COMPLETED|Extension Year 2||0
8524476|NCT00364832|21011376|P4|NOT COMPLETED|Extension Year 2||0
8524477|NCT00364832|21011377|P3|NOT COMPLETED|Extension Year 2||0
8524478|NCT00364832|21011378|P2|NOT COMPLETED|Extension Year 2||0
8524479|NCT00364832|21011379|P1|NOT COMPLETED|Extension Year 2||0
8524480|NCT00364832|21011368|P12|COMPLETED|Extension Year 2||11
8524481|NCT00364832|21011369|P11|COMPLETED|Extension Year 2||9
8524482|NCT00364832|21011370|P10|COMPLETED|Extension Year 2||9
8524483|NCT00364832|21011371|P9|COMPLETED|Extension Year 2||0
8524484|NCT00364832|21011372|P8|COMPLETED|Extension Year 2||0
8524485|NCT00364832|21011373|P7|COMPLETED|Extension Year 2||0
8524486|NCT00364832|21011374|P6|COMPLETED|Extension Year 2||0
8524487|NCT00364832|21011375|P5|COMPLETED|Extension Year 2||0
8524488|NCT00364832|21011376|P4|COMPLETED|Extension Year 2||0
8524489|NCT00364832|21011377|P3|COMPLETED|Extension Year 2||0
8524490|NCT00364832|21011378|P2|COMPLETED|Extension Year 2||0
8524491|NCT00364832|21011379|P1|COMPLETED|Extension Year 2||0
8524492|NCT00364832|21011368|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
8524493|NCT00364832|21011369|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
8524494|NCT00364832|21011370|P10|STARTED|Extension Year 2||14
8524495|NCT00364832|21011371|P9|STARTED|Extension Year 2||0
8524496|NCT00364832|21011372|P8|STARTED|Extension Year 2||0
8524497|NCT00364832|21011373|P7|STARTED|Extension Year 2||0
8524498|NCT00364832|21011374|P6|STARTED|Extension Year 2||0
8524499|NCT00364832|21011375|P5|STARTED|Extension Year 2||0
8524500|NCT00364832|21011376|P4|STARTED|Extension Year 2||0
8524501|NCT00364832|21011377|P3|STARTED|Extension Year 2||0
8524502|NCT00364832|21011378|P2|STARTED|Extension Year 2||0
8524503|NCT00364832|21011379|P1|STARTED|Extension Year 2||0
8524504|NCT00364832|21011368|P12|NOT COMPLETED|Extension Year 1||10
8524505|NCT00364832|21011369|P11|NOT COMPLETED|Extension Year 1||2
8524506|NCT00364832|21011370|P10|NOT COMPLETED|Extension Year 1||4
8524507|NCT00364832|21011371|P9|NOT COMPLETED|Extension Year 1||0
8524508|NCT00364832|21011372|P8|NOT COMPLETED|Extension Year 1||0
8524509|NCT00364832|21011373|P7|NOT COMPLETED|Extension Year 1||0
8524510|NCT00364832|21011374|P6|NOT COMPLETED|Extension Year 1||0
8524511|NCT00364832|21011375|P5|NOT COMPLETED|Extension Year 1||0
8524512|NCT00364832|21011376|P4|NOT COMPLETED|Extension Year 1||0
8524513|NCT00364832|21011377|P3|NOT COMPLETED|Extension Year 1||0
8524514|NCT00364832|21011378|P2|NOT COMPLETED|Extension Year 1||0
8524515|NCT00364832|21011379|P1|NOT COMPLETED|Extension Year 1||0
8524516|NCT00364832|21011368|P12|COMPLETED|Extension Year 1||17
8524517|NCT00364832|21011369|P11|COMPLETED|Extension Year 1||15
8524518|NCT00364832|21011370|P10|COMPLETED|Extension Year 1||14
8524519|NCT00364832|21011371|P9|COMPLETED|Extension Year 1||0
8524520|NCT00364832|21011372|P8|COMPLETED|Extension Year 1||0
8524521|NCT00364832|21011373|P7|COMPLETED|Extension Year 1||0
8524522|NCT00364832|21011374|P6|COMPLETED|Extension Year 1||0
8524523|NCT00364832|21011375|P5|COMPLETED|Extension Year 1||0
8524524|NCT00364832|21011376|P4|COMPLETED|Extension Year 1||0
8524525|NCT00364832|21011377|P3|COMPLETED|Extension Year 1||0
8524526|NCT00364832|21011378|P2|COMPLETED|Extension Year 1||0
8524527|NCT00364832|21011379|P1|COMPLETED|Extension Year 1||0
8524528|NCT00364832|21011368|P12|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
8524529|NCT00364832|21011369|P11|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
8524530|NCT00364832|21011370|P10|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
8524531|NCT00364832|21011371|P9|STARTED|Extension Year 1||0
8524532|NCT00364832|21011372|P8|STARTED|Extension Year 1||0
8524533|NCT00364832|21011373|P7|STARTED|Extension Year 1||0
8524534|NCT00364832|21011374|P6|STARTED|Extension Year 1||0
8524535|NCT00364832|21011375|P5|STARTED|Extension Year 1||0
8524536|NCT00364832|21011376|P4|STARTED|Extension Year 1||0
8524537|NCT00364832|21011377|P3|STARTED|Extension Year 1||0
8524538|NCT00364832|21011378|P2|STARTED|Extension Year 1||0
8524539|NCT00364832|21011379|P1|STARTED|Extension Year 1||0
8524540|NCT00364832|21011368|P12|NOT COMPLETED|Core Period||0
8524541|NCT00364832|21011369|P11|NOT COMPLETED|Core Period||0
8524542|NCT00364832|21011370|P10|NOT COMPLETED|Core Period||0
8524543|NCT00364832|21011371|P9|NOT COMPLETED|Core Period||0
8524544|NCT00364832|21011372|P8|NOT COMPLETED|Core Period||1
8524545|NCT00364832|21011373|P7|NOT COMPLETED|Core Period||4
8524546|NCT00364832|21011374|P6|NOT COMPLETED|Core Period||0
8524547|NCT00364832|21011375|P5|NOT COMPLETED|Core Period||0
8524548|NCT00364832|21011376|P4|NOT COMPLETED|Core Period||1
8524549|NCT00364832|21011377|P3|NOT COMPLETED|Core Period||1
8524550|NCT00364832|21011378|P2|NOT COMPLETED|Core Period||2
8524551|NCT00364832|21011379|P1|NOT COMPLETED|Core Period||2
8524552|NCT00364832|21011368|P12|COMPLETED|Core Period||0
8524553|NCT00364832|21011369|P11|COMPLETED|Core Period||0
8524554|NCT00364832|21011370|P10|COMPLETED|Core Period||0
8524555|NCT00364832|21011371|P9|COMPLETED|Core Period||16
8524556|NCT00364832|21011372|P8|COMPLETED|Core Period||14
8524557|NCT00364832|21011373|P7|COMPLETED|Core Period||12
8524558|NCT00364832|21011374|P6|COMPLETED|Core Period||12
8524559|NCT00364832|21011375|P5|COMPLETED|Core Period||16
8524560|NCT00364832|21011376|P4|COMPLETED|Core Period||15
8524561|NCT00364832|21011377|P3|COMPLETED|Core Period||14
8524562|NCT00364832|21011378|P2|COMPLETED|Core Period||13
8524563|NCT00364832|21011379|P1|COMPLETED|Core Period||14
8524564|NCT00364832|21011368|P12|STARTED|Core Period||0
8524565|NCT00364832|21011369|P11|STARTED|Core Period||0
8524566|NCT00364832|21011370|P10|STARTED|Core Period||0
8524567|NCT00364832|21011371|P9|STARTED|Core Period||16
8524568|NCT00364832|21011372|P8|STARTED|Core Period||15
8524569|NCT00364832|21011373|P7|STARTED|Core Period||16
8524570|NCT00364832|21011374|P6|STARTED|Core Period||12
8524571|NCT00364832|21011375|P5|STARTED|Core Period||16
8524572|NCT00364832|21011376|P4|STARTED|Core Period||16
8524573|NCT00364832|21011377|P3|STARTED|Core Period||15
8524574|NCT00364832|21011378|P2|STARTED|Core Period||15
8524575|NCT00364832|21011379|P1|STARTED|Core Period||16
8524576|NCT00364819|21011432|P1|NOT COMPLETED|Overall Study||0
8524577|NCT00364819|21011432|P1|COMPLETED|Overall Study||6
8524578|NCT00364819|21011432|P1|STARTED|Overall Study||6
8524579|NCT00364793|21011444|P4|NOT COMPLETED|Overall Study||3
8524580|NCT00364793|21011445|P3|NOT COMPLETED|Overall Study||4
8524581|NCT00364793|21011446|P2|NOT COMPLETED|Overall Study||5
8524582|NCT00364793|21011447|P1|NOT COMPLETED|Overall Study||8
8524583|NCT00364793|21011444|P4|COMPLETED|Overall Study||5
8524584|NCT00364793|21011445|P3|COMPLETED|Overall Study||0
8524585|NCT00364793|21011446|P2|COMPLETED|Overall Study||5
8524586|NCT00364793|21011447|P1|COMPLETED|Overall Study||7
8524587|NCT00364793|21011444|P4|STARTED|Overall Study||8
8524588|NCT00364793|21011445|P3|STARTED|Overall Study||4
8524589|NCT00364793|21011446|P2|STARTED|Overall Study||10
8524590|NCT00364793|21011447|P1|STARTED|Overall Study||15
8524591|NCT00364689|21011584|P1|NOT COMPLETED|Overall Study||1
8524592|NCT00364689|21011584|P1|COMPLETED|Overall Study||12
8524593|NCT00364689|21011584|P1|STARTED|Overall Study||13
8524594|NCT00364611|21011604|P2|NOT COMPLETED|Overall Study||21
8524595|NCT00364611|21011605|P1|NOT COMPLETED|Overall Study||51
8524596|NCT00364611|21011604|P2|COMPLETED|Overall Study||0
8524597|NCT00364611|21011605|P1|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
8524598|NCT00364611|21011604|P2|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
8524599|NCT00364611|21011605|P1|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
8524600|NCT00364611|21011604|P2|STARTED|Overall Study||21
8524601|NCT00364611|21011605|P1|STARTED|Overall Study||52
8524602|NCT00364533|21011628|P5|NOT COMPLETED|Overall Study||51
8524603|NCT00364533|21011629|P4|NOT COMPLETED|Overall Study||31
8524604|NCT00364533|21011630|P3|NOT COMPLETED|Overall Study||45
8524605|NCT00364533|21011631|P2|NOT COMPLETED|Overall Study||40
8524606|NCT00364533|21011632|P1|NOT COMPLETED|Overall Study||42
8524607|NCT00364533|21011628|P5|COMPLETED|Overall Study||24
8524608|NCT00364533|21011629|P4|COMPLETED|Overall Study||36
8524609|NCT00364533|21011630|P3|COMPLETED|Overall Study||30
8524610|NCT00364533|21011631|P2|COMPLETED|Overall Study||31
8524611|NCT00364533|21011632|P1|COMPLETED|Overall Study||35
8524612|NCT00364533|21011628|P5|STARTED|Overall Study||75
8524613|NCT00364533|21011629|P4|STARTED|Overall Study||67
8524614|NCT00364533|21011630|P3|STARTED|Overall Study||75
8524615|NCT00364533|21011631|P2|STARTED|Overall Study||71
8524616|NCT00364533|21011632|P1|STARTED|Overall Study||77
8524617|NCT00364377|21011656|P2|NOT COMPLETED|Overall Study||0
8524618|NCT00364377|21011657|P1|NOT COMPLETED|Overall Study||0
8524619|NCT00364377|21011656|P2|COMPLETED|Overall Study||11
8524620|NCT00364377|21011657|P1|COMPLETED|Overall Study||11
8524621|NCT00364377|21011656|P2|STARTED|Overall Study||11
8524622|NCT00364377|21011657|P1|STARTED|Overall Study||11
8524623|NCT00364351|21011665|P2|NOT COMPLETED|Overall Study||583
8524624|NCT00364351|21011666|P1|NOT COMPLETED|Overall Study||592
8524625|NCT00364351|21011665|P2|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
8524626|NCT00364351|21011666|P1|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
8524627|NCT00364351|21011665|P2|STARTED|Overall Study|randomised patients|617
8524628|NCT00364351|21011666|P1|STARTED|Overall Study|randomised patients|623
8524629|NCT00364286|21011684|P1|NOT COMPLETED|Overall Study||3
8524630|NCT00364286|21011684|P1|COMPLETED|Overall Study||14
8524631|NCT00364286|21011684|P1|STARTED|Overall Study||17
8524632|NCT00364182|21011691|P3|NOT COMPLETED|Fourth Intervention||0
8524633|NCT00364182|21011692|P2|NOT COMPLETED|Fourth Intervention||0
8524634|NCT00364182|21011693|P1|NOT COMPLETED|Fourth Intervention||0
8524635|NCT00364182|21011691|P3|COMPLETED|Fourth Intervention||22
8524636|NCT00364182|21011692|P2|COMPLETED|Fourth Intervention||19
8524637|NCT00364182|21011693|P1|COMPLETED|Fourth Intervention||0
8524638|NCT00364182|21011691|P3|STARTED|Fourth Intervention||22
8524639|NCT00364182|21011692|P2|STARTED|Fourth Intervention||19
8524640|NCT00364182|21011693|P1|STARTED|Fourth Intervention||0
8524641|NCT00364182|21011691|P3|NOT COMPLETED|Third Intervention||1
8524642|NCT00364182|21011692|P2|NOT COMPLETED|Third Intervention||1
8524643|NCT00364182|21011693|P1|NOT COMPLETED|Third Intervention||0
8524644|NCT00364182|21011691|P3|COMPLETED|Third Intervention||22
8524645|NCT00364182|21011692|P2|COMPLETED|Third Intervention||19
8524646|NCT00364182|21011693|P1|COMPLETED|Third Intervention||0
8524647|NCT00364182|21011691|P3|STARTED|Third Intervention||23
8524648|NCT00364182|21011692|P2|STARTED|Third Intervention||20
8524649|NCT00364182|21011693|P1|STARTED|Third Intervention||0
8524650|NCT00364182|21011691|P3|NOT COMPLETED|Second Intervention||2
8524651|NCT00364182|21011692|P2|NOT COMPLETED|Second Intervention||2
8524652|NCT00364182|21011693|P1|NOT COMPLETED|Second Intervention||0
8524653|NCT00364182|21011691|P3|COMPLETED|Second Intervention||23
8524654|NCT00364182|21011692|P2|COMPLETED|Second Intervention||20
8524655|NCT00364182|21011693|P1|COMPLETED|Second Intervention||0
8524656|NCT00364182|21011691|P3|Randomized|Second Intervention||25
8524657|NCT00364182|21011692|P2|Randomized|Second Intervention||22
8524658|NCT00364182|21011693|P1|Randomized|Second Intervention||0
8524659|NCT00364182|21011691|P3|STARTED|Second Intervention||25
8524660|NCT00364182|21011692|P2|STARTED|Second Intervention||22
8524661|NCT00364182|21011693|P1|STARTED|Second Intervention||0
8524662|NCT00364182|21011691|P3|NOT COMPLETED|First Intervention||0
8524663|NCT00364182|21011692|P2|NOT COMPLETED|First Intervention||0
8524664|NCT00364182|21011693|P1|NOT COMPLETED|First Intervention||3
8524665|NCT00364182|21011691|P3|COMPLETED|First Intervention||25
8524666|NCT00364182|21011692|P2|COMPLETED|First Intervention||22
8524667|NCT00364182|21011693|P1|COMPLETED|First Intervention||0
8524668|NCT00364182|21011691|P3|STARTED|First Intervention||25
8524669|NCT00364182|21011692|P2|STARTED|First Intervention||22
8524670|NCT00364182|21011693|P1|STARTED|First Intervention||3
8524671|NCT00364156|21011727|P2|NOT COMPLETED|Overall Study||81
8524672|NCT00364156|21011728|P1|NOT COMPLETED|Overall Study||79
8524673|NCT00364156|21011727|P2|COMPLETED|Overall Study||205
8524674|NCT00364156|21011728|P1|COMPLETED|Overall Study||203
8524675|NCT00364156|21011727|P2|STARTED|Overall Study||286
8524676|NCT00364156|21011728|P1|STARTED|Overall Study||282
8524677|NCT00364130|21011736|P2|NOT COMPLETED|Post Intervention Follow-up Period||11
8524678|NCT00364130|21011737|P1|NOT COMPLETED|Post Intervention Follow-up Period||5
8524679|NCT00364130|21011736|P2|COMPLETED|Post Intervention Follow-up Period||50
8524680|NCT00364130|21011737|P1|COMPLETED|Post Intervention Follow-up Period||55
8524681|NCT00364130|21011736|P2|STARTED|Post Intervention Follow-up Period||61
8524682|NCT00364130|21011737|P1|STARTED|Post Intervention Follow-up Period||60
8524683|NCT00364130|21011736|P2|NOT COMPLETED|Intervention Period||8
8524684|NCT00364130|21011737|P1|NOT COMPLETED|Intervention Period||9
8524685|NCT00364130|21011736|P2|COMPLETED|Intervention Period||61
8524686|NCT00364130|21011737|P1|COMPLETED|Intervention Period||60
8524687|NCT00364130|21011736|P2|STARTED|Intervention Period||69
8524688|NCT00364130|21011737|P1|STARTED|Intervention Period||69
8524689|NCT00364013|21011759|P2|NOT COMPLETED|Overall Study||95
8524690|NCT00364013|21011760|P1|NOT COMPLETED|Overall Study||101
8524691|NCT00364013|21011759|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
8524692|NCT00364013|21011760|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
8524693|NCT00364013|21011759|P2|Received Study Drug|Overall Study||583
8524694|NCT00364013|21011760|P1|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
8524695|NCT00364013|21011759|P2|STARTED|Overall Study||590
8524696|NCT00364013|21011760|P1|STARTED|Overall Study||593
8524697|NCT00363896|21011788|P2|NOT COMPLETED|Overall Study||47
8524698|NCT00363896|21011789|P1|NOT COMPLETED|Overall Study||89
8524699|NCT00363896|21011788|P2|COMPLETED|Overall Study||169
8524700|NCT00363896|21011789|P1|COMPLETED|Overall Study||538
8524701|NCT00363896|21011788|P2|STARTED|Overall Study||216
8524702|NCT00363896|21011789|P1|STARTED|Overall Study||627
8524703|NCT00363883|21011801|P1|NOT COMPLETED|Overall Study||0
8524704|NCT00363883|21011801|P1|COMPLETED|Overall Study||14
8524705|NCT00363883|21011801|P1|STARTED|Overall Study||14
8524706|NCT00363805|21011810|P3|NOT COMPLETED|Overall Study||3
8524707|NCT00363805|21011811|P2|NOT COMPLETED|Overall Study||6
8524708|NCT00363805|21011812|P1|NOT COMPLETED|Overall Study||4
8524709|NCT00363805|21011810|P3|COMPLETED|Overall Study||70
8524710|NCT00363805|21011811|P2|COMPLETED|Overall Study||57
8524711|NCT00363805|21011812|P1|COMPLETED|Overall Study||38
8524712|NCT00363805|21011810|P3|STARTED|Overall Study||73
8524713|NCT00363805|21011811|P2|STARTED|Overall Study||63
8524714|NCT00363805|21011812|P1|STARTED|Overall Study||42
8524715|NCT00363779|21011823|P1|NOT COMPLETED|Overall Study||0
8524716|NCT00363779|21011823|P1|COMPLETED|Overall Study||5
8524717|NCT00363779|21011823|P1|STARTED|Overall Study||5
8524718|NCT00363766|21011830|P2|NOT COMPLETED|Overall Study||20
8524719|NCT00363766|21011831|P1|NOT COMPLETED|Overall Study||32
8524720|NCT00363766|21011830|P2|COMPLETED|Overall Study||0
8524721|NCT00363766|21011831|P1|COMPLETED|Overall Study||0
8524722|NCT00363766|21011830|P2|STARTED|Overall Study||20
8524723|NCT00363766|21011831|P1|STARTED|Overall Study||32
8524724|NCT00363675|21011851|P1|NOT COMPLETED|Overall Study||0
8524725|NCT00363675|21011851|P1|COMPLETED|Overall Study||3
8524726|NCT00363675|21011851|P1|Completed Testing|Overall Study||3
8524727|NCT00363675|21011851|P1|STARTED|Overall Study||3
8524728|NCT00363649|21011860|P2|NOT COMPLETED|Overall Study||1
8524729|NCT00363649|21011861|P1|NOT COMPLETED|Overall Study||7
8524730|NCT00363649|21011860|P2|COMPLETED|Overall Study||15
8524731|NCT00363649|21011861|P1|COMPLETED|Overall Study||11
8524732|NCT00363649|21011860|P2|Did Not Cross Over|Overall Study||3
8524733|NCT00363649|21011861|P1|Did Not Cross Over|Overall Study||2
8524734|NCT00363649|21011860|P2|Crossed Over to Arm A|Overall Study||12
8524735|NCT00363649|21011861|P1|Crossed Over to Arm A|Overall Study||0
8524736|NCT00363649|21011860|P2|Crossed Over to Arm B|Overall Study||0
8524737|NCT00363649|21011861|P1|Crossed Over to Arm B|Overall Study||9
8524738|NCT00363649|21011860|P2|STARTED|Overall Study||16
8524739|NCT00363649|21011861|P1|STARTED|Overall Study||18
8524740|NCT00363545|21011877|P2|NOT COMPLETED|Overall Study||57
8524741|NCT00363545|21011878|P1|NOT COMPLETED|Overall Study||44
8524742|NCT00363545|21011877|P2|COMPLETED|Overall Study||581
8524743|NCT00363545|21011878|P1|COMPLETED|Overall Study||592
8524744|NCT00363545|21011877|P2|STARTED|Overall Study||638
8524745|NCT00363545|21011878|P1|STARTED|Overall Study||636
8524746|NCT00363480|21011896|P1|NOT COMPLETED|Overall Study||17
8524747|NCT00363480|21011896|P1|COMPLETED|Overall Study||204
8524748|NCT00363480|21011896|P1|STARTED|Overall Study||221
8524749|NCT00363467|21011916|P1|NOT COMPLETED|Overall Study||1
8524750|NCT00363467|21011916|P1|COMPLETED|Overall Study||2
8524751|NCT00363467|21011916|P1|STARTED|Overall Study||3
8524752|NCT00363415|21011926|P2|NOT COMPLETED|Overall Study||249
8524753|NCT00363415|21011927|P1|NOT COMPLETED|Overall Study||361
8524754|NCT00363415|21011926|P2|COMPLETED|Overall Study||206
8524755|NCT00363415|21011927|P1|COMPLETED|Overall Study||92
8524756|NCT00363415|21011926|P2|Received at Least One Dose of Study Drug|Overall Study||447
8524757|NCT00363415|21011927|P1|Received at Least One Dose of Study Drug|Overall Study||433
8524758|NCT00363415|21011926|P2|STARTED|Overall Study||455
8524759|NCT00363415|21011927|P1|STARTED|Overall Study||453
8524760|NCT00363311|21011945|P2|NOT COMPLETED|Overall Study||45
8524761|NCT00363311|21011946|P1|NOT COMPLETED|Overall Study||76
8524762|NCT00363311|21011945|P2|COMPLETED|Overall Study||102
8524763|NCT00363311|21011946|P1|COMPLETED|Overall Study||79
8524764|NCT00363311|21011945|P2|STARTED|Overall Study||147
8524765|NCT00363311|21011946|P1|STARTED|Overall Study||155
8524766|NCT00363298|21012012|P2|NOT COMPLETED|4-week Study Continuation Phase||0
8524767|NCT00363298|21012013|P1|NOT COMPLETED|4-week Study Continuation Phase||1
8524768|NCT00363298|21012012|P2|COMPLETED|4-week Study Continuation Phase||7
8524769|NCT00363298|21012013|P1|COMPLETED|4-week Study Continuation Phase||5
8524770|NCT00363298|21012012|P2|STARTED|4-week Study Continuation Phase||7
8524771|NCT00363298|21012013|P1|STARTED|4-week Study Continuation Phase||6
8524772|NCT00363298|21012012|P2|NOT COMPLETED|First Study Week||5
8524773|NCT00363298|21012013|P1|NOT COMPLETED|First Study Week||6
8524774|NCT00363298|21012012|P2|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
8524775|NCT00363298|21012013|P1|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
8524776|NCT00363298|21012012|P2|STARTED|First Study Week||12
8524777|NCT00363298|21012013|P1|STARTED|First Study Week||12
8524778|NCT00363246|21012021|P1|NOT COMPLETED|Overall Study||97
8524779|NCT00363246|21012021|P1|COMPLETED|Overall Study||669
8524780|NCT00363246|21012021|P1|STARTED|Overall Study||766
8524781|NCT00363168|21012028|P2|NOT COMPLETED|Overall Study||0
8524782|NCT00363168|21012029|P1|NOT COMPLETED|Overall Study||0
8524783|NCT00363168|21012028|P2|COMPLETED|Overall Study||2
8524784|NCT00363168|21012029|P1|COMPLETED|Overall Study||5
8524785|NCT00363168|21012028|P2|STARTED|Overall Study||2
8524786|NCT00363168|21012029|P1|STARTED|Overall Study||5
8524787|NCT00363142|21012039|P2|NOT COMPLETED|Overall Study||3
8524788|NCT00363142|21012040|P1|NOT COMPLETED|Overall Study||7
8524789|NCT00363142|21012039|P2|COMPLETED|Overall Study||66
8524790|NCT00363142|21012040|P1|COMPLETED|Overall Study||133
8524791|NCT00363142|21012039|P2|STARTED|Overall Study||69
8524792|NCT00363142|21012040|P1|STARTED|Overall Study||140
8524793|NCT00363129|21012069|P2|NOT COMPLETED|Overall Study||33
8524794|NCT00363129|21012070|P1|NOT COMPLETED|Overall Study||29
8524795|NCT00363129|21012069|P2|COMPLETED|Overall Study||60
8524796|NCT00363129|21012070|P1|COMPLETED|Overall Study||67
8524797|NCT00363129|21012069|P2|STARTED|Overall Study||93
8524798|NCT00363129|21012070|P1|STARTED|Overall Study||96
8524799|NCT00363077|21012086|P2|NOT COMPLETED|Overall Study||0
8524800|NCT00363077|21012087|P1|NOT COMPLETED|Overall Study||0
8524801|NCT00363077|21012086|P2|COMPLETED|Overall Study||75
8524802|NCT00363077|21012087|P1|COMPLETED|Overall Study||75
8524803|NCT00363077|21012086|P2|STARTED|Overall Study||75
8524804|NCT00363077|21012087|P1|STARTED|Overall Study||75
8524805|NCT00363051|21012113|P2|NOT COMPLETED|Overall Study||22
8524806|NCT00363051|21012114|P1|NOT COMPLETED|Overall Study||38
8524807|NCT00363051|21012113|P2|COMPLETED|Overall Study||23
8524808|NCT00363051|21012114|P1|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
8524809|NCT00363051|21012113|P2|STARTED|Overall Study||45
8524810|NCT00363051|21012114|P1|STARTED|Overall Study||115
8524811|NCT00363038|21012131|P1|NOT COMPLETED|Overall Study||0
8524812|NCT00363038|21012131|P1|COMPLETED|Overall Study||16
8524813|NCT00363038|21012131|P1|STARTED|Overall Study||16
8524814|NCT00362882|21012137|P2|NOT COMPLETED|Overall Study||0
8524815|NCT00362882|21012138|P1|NOT COMPLETED|Overall Study||0
8524816|NCT00362882|21012137|P2|COMPLETED|Overall Study||41
8524817|NCT00362882|21012138|P1|COMPLETED|Overall Study||40
8524818|NCT00362882|21012137|P2|STARTED|Overall Study||41
8524819|NCT00362882|21012138|P1|STARTED|Overall Study||40
8524820|NCT00362817|21012150|P1|NOT COMPLETED|Overall Study||0
8524821|NCT00362817|21012150|P1|COMPLETED|Overall Study||17
8524822|NCT00362817|21012150|P1|STARTED|Overall Study||17
8524823|NCT00362648|21012163|P4|NOT COMPLETED|Overall Study||11
8524824|NCT00362648|21012164|P3|NOT COMPLETED|Overall Study||9
8524825|NCT00362648|21012165|P2|NOT COMPLETED|Overall Study||134
8524826|NCT00362648|21012166|P1|NOT COMPLETED|Overall Study||126
8524827|NCT00362648|21012163|P4|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
8524828|NCT00362648|21012164|P3|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
8524829|NCT00362648|21012165|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
8524830|NCT00362648|21012166|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
8524831|NCT00362648|21012163|P4|Vaccinated at Visit 3|Overall Study||1007
8524832|NCT00362648|21012164|P3|Vaccinated at Visit 3|Overall Study||1009
8524833|NCT00362648|21012165|P2|Vaccinated at Visit 3|Overall Study||2612
8524834|NCT00362648|21012166|P1|Vaccinated at Visit 3|Overall Study||2613
8524835|NCT00362648|21012163|P4|Vaccinated at Visit 2|Overall Study||1009
8524836|NCT00362648|21012164|P3|Vaccinated at Visit 2|Overall Study||1013
8524837|NCT00362648|21012165|P2|Vaccinated at Visit 2|Overall Study||2666
8524838|NCT00362648|21012166|P1|Vaccinated at Visit 2|Overall Study||2657
8524839|NCT00362648|21012163|P4|Vaccinated at Visit 1|Overall Study||1018
8524840|NCT00362648|21012164|P3|Vaccinated at Visit 1|Overall Study||1018
8524841|NCT00362648|21012165|P2|Vaccinated at Visit 1|Overall Study||2735
8524842|NCT00362648|21012166|P1|Vaccinated at Visit 1|Overall Study||2733
8524843|NCT00362648|21012163|P4|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
8524844|NCT00362648|21012164|P3|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
8524845|NCT00362648|21012165|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
8524846|NCT00362648|21012166|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
8524847|NCT00362609|21012184|P2|NOT COMPLETED|Overall Study||2
8524848|NCT00362609|21012185|P1|NOT COMPLETED|Overall Study||0
8524849|NCT00362609|21012184|P2|COMPLETED|Overall Study||38
8524850|NCT00362609|21012185|P1|COMPLETED|Overall Study||19
8524851|NCT00362609|21012184|P2|STARTED|Overall Study||40
8524852|NCT00362609|21012185|P1|STARTED|Overall Study||19
8524853|NCT00362466|21012199|P2|NOT COMPLETED|Overall Study||0
8524854|NCT00362466|21012200|P1|NOT COMPLETED|Overall Study||0
8524855|NCT00362466|21012199|P2|COMPLETED|Overall Study||1
8524856|NCT00362466|21012200|P1|COMPLETED|Overall Study||2
8524857|NCT00362466|21012199|P2|STARTED|Overall Study||1
8524858|NCT00362466|21012200|P1|STARTED|Overall Study||2
8524859|NCT00362453|21012222|P2|NOT COMPLETED|Overall Study||0
8524860|NCT00362453|21012223|P1|NOT COMPLETED|Overall Study||0
8524861|NCT00362453|21012222|P2|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
8524862|NCT00362453|21012223|P1|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
8524863|NCT00362453|21012222|P2|STARTED|Overall Study||20
8524864|NCT00362453|21012223|P1|STARTED|Overall Study||20
8524865|NCT00362440|21012255|P2|NOT COMPLETED|Overall Study||1
8524866|NCT00362440|21012256|P1|NOT COMPLETED|Overall Study||2
8524867|NCT00362440|21012255|P2|COMPLETED|Overall Study||3
8524868|NCT00362440|21012256|P1|COMPLETED|Overall Study||3
8524869|NCT00362440|21012255|P2|STARTED|Overall Study||4
8524870|NCT00362440|21012256|P1|STARTED|Overall Study||5
8524871|NCT00362414|21012266|P1|NOT COMPLETED|Overall Study||3
8524872|NCT00362414|21012266|P1|COMPLETED|Overall Study||12
8524873|NCT00362414|21012266|P1|STARTED|Overall Study||15
8524874|NCT00362401|21012286|P3|NOT COMPLETED|Overall Study||0
8524875|NCT00362401|21012287|P2|NOT COMPLETED|Overall Study||0
8524876|NCT00362401|21012288|P1|NOT COMPLETED|Overall Study||0
8524877|NCT00362401|21012286|P3|COMPLETED|Overall Study||40
8524878|NCT00362401|21012287|P2|COMPLETED|Overall Study||29
8524879|NCT00362401|21012288|P1|COMPLETED|Overall Study||15
8524880|NCT00362401|21012286|P3|STARTED|Overall Study||40
8524881|NCT00362401|21012287|P2|STARTED|Overall Study||29
8524882|NCT00362401|21012288|P1|STARTED|Overall Study||15
8524883|NCT00362375|21012295|P2|NOT COMPLETED|Overall Study||35
8524884|NCT00362375|21012296|P1|NOT COMPLETED|Overall Study||40
8524885|NCT00362375|21012295|P2|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
8524886|NCT00362375|21012296|P1|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
8524887|NCT00362375|21012295|P2|STARTED|Overall Study|Number eligible and randomized|152
8524888|NCT00362375|21012296|P1|STARTED|Overall Study|Number eligible and randomized|161
8524889|NCT00362336|21012313|P3|NOT COMPLETED|Overall Study||3
8524890|NCT00362336|21012314|P2|NOT COMPLETED|Overall Study||7
8524891|NCT00362336|21012315|P1|NOT COMPLETED|Overall Study||10
8524892|NCT00362336|21012313|P3|COMPLETED|Overall Study||134
8524893|NCT00362336|21012314|P2|COMPLETED|Overall Study||235
8524894|NCT00362336|21012315|P1|COMPLETED|Overall Study||233
8524895|NCT00362336|21012313|P3|STARTED|Overall Study||137
8524896|NCT00362336|21012314|P2|STARTED|Overall Study||242
8524897|NCT00362336|21012315|P1|STARTED|Overall Study||243
8524898|NCT00362297|21012343|P2|NOT COMPLETED|Treatment 2||0
8524899|NCT00362297|21012344|P1|NOT COMPLETED|Treatment 2||0
8524900|NCT00362297|21012343|P2|COMPLETED|Treatment 2||11
8524901|NCT00362297|21012344|P1|COMPLETED|Treatment 2||16
8524902|NCT00362297|21012343|P2|STARTED|Treatment 2||11
8524903|NCT00362297|21012344|P1|STARTED|Treatment 2||16
8524904|NCT00362297|21012343|P2|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||4
8524905|NCT00362297|21012344|P1|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||0
8524906|NCT00362297|21012343|P2|COMPLETED|Treatment 1 (Initial Drug Assignment)||11
8524907|NCT00362297|21012344|P1|COMPLETED|Treatment 1 (Initial Drug Assignment)||16
8524908|NCT00362297|21012343|P2|STARTED|Treatment 1 (Initial Drug Assignment)||15
8524909|NCT00362297|21012344|P1|STARTED|Treatment 1 (Initial Drug Assignment)||16
8524910|NCT00362232|21012352|P2|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
8524911|NCT00362232|21012353|P1|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
8524912|NCT00362232|21012352|P2|COMPLETED|Follow-up (30 (+ 5) Days)||1416
8524913|NCT00362232|21012353|P1|COMPLETED|Follow-up (30 (+ 5) Days)||1433
8524914|NCT00362232|21012352|P2|STARTED|Follow-up (30 (+ 5) Days)||1455
8524915|NCT00362232|21012353|P1|STARTED|Follow-up (30 (+ 5) Days)||1471
8524916|NCT00362232|21012352|P2|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
8524917|NCT00362232|21012353|P1|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
8524918|NCT00362232|21012352|P2|COMPLETED|Treatment (12 +/- 2 Days)||1413
8524919|NCT00362232|21012353|P1|COMPLETED|Treatment (12 +/- 2 Days)||1425
8524920|NCT00362232|21012352|P2|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
8524921|NCT00362232|21012353|P1|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
8524922|NCT00362232|21012352|P2|STARTED|Treatment (12 +/- 2 Days)||1564
8524923|NCT00362232|21012353|P1|STARTED|Treatment (12 +/- 2 Days)||1584
8524924|NCT00362180|21012398|P9|NOT COMPLETED|20 Week Safety Follow-up||0
8524925|NCT00362180|21012399|P8|NOT COMPLETED|20 Week Safety Follow-up||0
8524926|NCT00362180|21012400|P7|NOT COMPLETED|20 Week Safety Follow-up||0
8524927|NCT00362180|21012401|P6|NOT COMPLETED|20 Week Safety Follow-up||0
8524928|NCT00362180|21012402|P5|NOT COMPLETED|20 Week Safety Follow-up||0
8524929|NCT00362180|21012403|P4|NOT COMPLETED|20 Week Safety Follow-up||0
8524930|NCT00362180|21012404|P3|NOT COMPLETED|20 Week Safety Follow-up||0
8524931|NCT00362180|21012405|P2|NOT COMPLETED|20 Week Safety Follow-up||0
8524932|NCT00362180|21012406|P1|NOT COMPLETED|20 Week Safety Follow-up||0
8524933|NCT00362180|21012398|P9|COMPLETED|20 Week Safety Follow-up||1
8524934|NCT00362180|21012399|P8|COMPLETED|20 Week Safety Follow-up||3
8524935|NCT00362180|21012400|P7|COMPLETED|20 Week Safety Follow-up||0
8524936|NCT00362180|21012401|P6|COMPLETED|20 Week Safety Follow-up||9
8524937|NCT00362180|21012402|P5|COMPLETED|20 Week Safety Follow-up||11
8524938|NCT00362180|21012403|P4|COMPLETED|20 Week Safety Follow-up||0
8524939|NCT00362180|21012404|P3|COMPLETED|20 Week Safety Follow-up||1
8524940|NCT00362180|21012405|P2|COMPLETED|20 Week Safety Follow-up||2
8524941|NCT00362180|21012406|P1|COMPLETED|20 Week Safety Follow-up||3
8524942|NCT00362180|21012398|P9|STARTED|20 Week Safety Follow-up||1
8524943|NCT00362180|21012399|P8|STARTED|20 Week Safety Follow-up||3
8524944|NCT00362180|21012400|P7|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
8524945|NCT00362180|21012401|P6|STARTED|20 Week Safety Follow-up||9
8524946|NCT00362180|21012402|P5|STARTED|20 Week Safety Follow-up||11
8524947|NCT00362180|21012403|P4|STARTED|20 Week Safety Follow-up||0
8524948|NCT00362180|21012404|P3|STARTED|20 Week Safety Follow-up||1
8524949|NCT00362180|21012405|P2|STARTED|20 Week Safety Follow-up||2
8524950|NCT00362180|21012406|P1|STARTED|20 Week Safety Follow-up||3
8524951|NCT00362180|21012398|P9|NOT COMPLETED|Treated Period||0
8524952|NCT00362180|21012399|P8|NOT COMPLETED|Treated Period||1
8524953|NCT00362180|21012400|P7|NOT COMPLETED|Treated Period||0
8524954|NCT00362180|21012401|P6|NOT COMPLETED|Treated Period||1
8524955|NCT00362180|21012402|P5|NOT COMPLETED|Treated Period||0
8524956|NCT00362180|21012403|P4|NOT COMPLETED|Treated Period||0
8524957|NCT00362180|21012404|P3|NOT COMPLETED|Treated Period||0
8524958|NCT00362180|21012405|P2|NOT COMPLETED|Treated Period||0
8524959|NCT00362180|21012406|P1|NOT COMPLETED|Treated Period||1
8524960|NCT00362180|21012398|P9|COMPLETED|Treated Period||1
8524961|NCT00362180|21012399|P8|COMPLETED|Treated Period||2
8524962|NCT00362180|21012400|P7|COMPLETED|Treated Period||6
8524963|NCT00362180|21012401|P6|COMPLETED|Treated Period||9
8524964|NCT00362180|21012402|P5|COMPLETED|Treated Period||11
8524965|NCT00362180|21012403|P4|COMPLETED|Treated Period||0
8524966|NCT00362180|21012404|P3|COMPLETED|Treated Period||1
8524967|NCT00362180|21012405|P2|COMPLETED|Treated Period||2
8524968|NCT00362180|21012406|P1|COMPLETED|Treated Period||3
8524969|NCT00362180|21012398|P9|STARTED|Treated Period||1
8524970|NCT00362180|21012399|P8|STARTED|Treated Period||3
8524971|NCT00362180|21012400|P7|STARTED|Treated Period||6
8524972|NCT00362180|21012401|P6|STARTED|Treated Period||10
8524973|NCT00362180|21012402|P5|STARTED|Treated Period||11
8524974|NCT00362180|21012403|P4|STARTED|Treated Period||0
8524975|NCT00362180|21012404|P3|STARTED|Treated Period||1
8524976|NCT00362180|21012405|P2|STARTED|Treated Period||2
8524977|NCT00362180|21012406|P1|STARTED|Treated Period||4
8524978|NCT00362128|21012467|P1|NOT COMPLETED|Overall Study||0
8524979|NCT00362128|21012467|P1|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
8524980|NCT00362128|21012467|P1|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
8524981|NCT00362115|21012478|P7|NOT COMPLETED|Overall Study||12
8524982|NCT00362115|21012479|P6|NOT COMPLETED|Overall Study||7
8524983|NCT00362115|21012480|P5|NOT COMPLETED|Overall Study||7
8524984|NCT00362115|21012481|P4|NOT COMPLETED|Overall Study||4
8524985|NCT00362115|21012482|P3|NOT COMPLETED|Overall Study||7
8524986|NCT00362115|21012483|P2|NOT COMPLETED|Overall Study||6
8524987|NCT00362115|21012484|P1|NOT COMPLETED|Overall Study||2
8524988|NCT00362115|21012478|P7|COMPLETED|Overall Study||52
8524989|NCT00362115|21012479|P6|COMPLETED|Overall Study||57
8524990|NCT00362115|21012480|P5|COMPLETED|Overall Study||57
8524991|NCT00362115|21012481|P4|COMPLETED|Overall Study||59
8524992|NCT00362115|21012482|P3|COMPLETED|Overall Study||57
8524993|NCT00362115|21012483|P2|COMPLETED|Overall Study||59
8524994|NCT00362115|21012484|P1|COMPLETED|Overall Study||63
8524995|NCT00362115|21012478|P7|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
8524996|NCT00362115|21012479|P6|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
8524997|NCT00362115|21012480|P5|STARTED|Overall Study||64
8524998|NCT00362115|21012481|P4|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
8524999|NCT00362115|21012482|P3|STARTED|Overall Study||64
8525000|NCT00362115|21012483|P2|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
8525001|NCT00362115|21012484|P1|STARTED|Overall Study||65
8525002|NCT00361972|21012635|P2|NOT COMPLETED|Overall Study||0
8525003|NCT00361972|21012636|P1|NOT COMPLETED|Overall Study||0
8525004|NCT00361972|21012635|P2|COMPLETED|Overall Study||9
8525005|NCT00361972|21012636|P1|COMPLETED|Overall Study||8
8525006|NCT00361972|21012635|P2|STARTED|Overall Study||9
8525007|NCT00361972|21012636|P1|STARTED|Overall Study||8
8525008|NCT00361712|21012646|P2|NOT COMPLETED|Overall Study||0
8525009|NCT00361712|21012647|P1|NOT COMPLETED|Overall Study||0
8525010|NCT00361712|21012646|P2|COMPLETED|Overall Study||21
8525011|NCT00361712|21012647|P1|COMPLETED|Overall Study||20
8525012|NCT00361712|21012646|P2|STARTED|Overall Study||21
8525013|NCT00361712|21012647|P1|STARTED|Overall Study||20
8525014|NCT00361634|21012657|P1|NOT COMPLETED|Overall Study||2
8525015|NCT00361634|21012657|P1|COMPLETED|Overall Study||12
8525016|NCT00361634|21012657|P1|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
8525017|NCT00361634|21012657|P1|STARTED|Overall Study||14
8525018|NCT00361595|21012675|P1|NOT COMPLETED|Overall Study||0
8525019|NCT00361595|21012675|P1|COMPLETED|Overall Study||35
8525020|NCT00361595|21012675|P1|STARTED|Overall Study||35
8525021|NCT00361569|21012686|P4|NOT COMPLETED|Overall Study||21
8525022|NCT00361569|21012687|P3|NOT COMPLETED|Overall Study||18
8525023|NCT00361569|21012688|P2|NOT COMPLETED|Overall Study||11
8525024|NCT00361569|21012689|P1|NOT COMPLETED|Overall Study||12
8525025|NCT00361569|21012686|P4|COMPLETED|Overall Study||135
8525026|NCT00361569|21012687|P3|COMPLETED|Overall Study||137
8525027|NCT00361569|21012688|P2|COMPLETED|Overall Study||150
8525028|NCT00361569|21012689|P1|COMPLETED|Overall Study||138
8525029|NCT00361569|21012686|P4|STARTED|Overall Study||156
8525030|NCT00361569|21012687|P3|STARTED|Overall Study||155
8525031|NCT00361569|21012688|P2|STARTED|Overall Study||161
8525032|NCT00361569|21012689|P1|STARTED|Overall Study||150
8525033|NCT00361504|21012713|P2|NOT COMPLETED|Overall Study||145
8525034|NCT00361504|21012714|P1|NOT COMPLETED|Overall Study||481
8525035|NCT00361504|21012713|P2|COMPLETED|Overall Study||78
8525036|NCT00361504|21012714|P1|COMPLETED|Overall Study||413
8525037|NCT00361504|21012713|P2|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
8525038|NCT00361504|21012714|P1|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
8525039|NCT00361439|21012724|P2|NOT COMPLETED|Overall Study||0
8525040|NCT00361439|21012725|P1|NOT COMPLETED|Overall Study||0
8525041|NCT00361439|21012724|P2|COMPLETED|Overall Study||9
8525042|NCT00361439|21012725|P1|COMPLETED|Overall Study||8
8525043|NCT00361439|21012724|P2|STARTED|Overall Study||9
8525044|NCT00361439|21012725|P1|STARTED|Overall Study||8
8525045|NCT00361374|21012740|P3|NOT COMPLETED|Overall Study||12
8525046|NCT00361374|21012741|P2|NOT COMPLETED|Overall Study||15
8525047|NCT00361374|21012742|P1|NOT COMPLETED|Overall Study||15
8525048|NCT00361374|21012740|P3|COMPLETED|Overall Study||53
8525049|NCT00361374|21012741|P2|COMPLETED|Overall Study||50
8525050|NCT00361374|21012742|P1|COMPLETED|Overall Study||51
8525051|NCT00361374|21012740|P3|STARTED|Overall Study||65
8525052|NCT00361374|21012741|P2|STARTED|Overall Study||65
8525053|NCT00361374|21012742|P1|STARTED|Overall Study||66
8525054|NCT00361335|21012755|P7|NOT COMPLETED|SC Period: Week E0 to Week E24||9
8525055|NCT00361335|21012756|P6|NOT COMPLETED|SC Period: Week E0 to Week E24||1
8525056|NCT00361335|21012757|P5|NOT COMPLETED|SC Period: Week E0 to Week E24||0
8525057|NCT00361335|21012758|P4|NOT COMPLETED|SC Period: Week E0 to Week E24||4
8525058|NCT00361335|21012759|P3|NOT COMPLETED|SC Period: Week E0 to Week E24||5
8525059|NCT00361335|21012760|P2|NOT COMPLETED|SC Period: Week E0 to Week E24||3
8525060|NCT00361335|21012761|P1|NOT COMPLETED|SC Period: Week E0 to Week E24||2
8525061|NCT00361335|21012755|P7|COMPLETED|SC Period: Week E0 to Week E24||164
8525062|NCT00361335|21012756|P6|COMPLETED|SC Period: Week E0 to Week E24||23
8525063|NCT00361335|21012757|P5|COMPLETED|SC Period: Week E0 to Week E24||3
8525064|NCT00361335|21012758|P4|COMPLETED|SC Period: Week E0 to Week E24||59
8525065|NCT00361335|21012759|P3|COMPLETED|SC Period: Week E0 to Week E24||99
8525066|NCT00361335|21012760|P2|COMPLETED|SC Period: Week E0 to Week E24||56
8525067|NCT00361335|21012761|P1|COMPLETED|SC Period: Week E0 to Week E24||80
8525068|NCT00361335|21012755|P7|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
8525069|NCT00361335|21012756|P6|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
8525070|NCT00361335|21012757|P5|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
8525071|NCT00361335|21012758|P4|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
8525072|NCT00361335|21012759|P3|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
8525073|NCT00361335|21012760|P2|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
8525074|NCT00361335|21012761|P1|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
8525075|NCT00361335|21012755|P7|NOT COMPLETED|IV Period: Baseline to E0||0
8525076|NCT00361335|21012756|P6|NOT COMPLETED|IV Period: Baseline to E0||0
8525077|NCT00361335|21012757|P5|NOT COMPLETED|IV Period: Baseline to E0||24
8525078|NCT00361335|21012758|P4|NOT COMPLETED|IV Period: Baseline to E0||27
8525079|NCT00361335|21012759|P3|NOT COMPLETED|IV Period: Baseline to E0||21
8525080|NCT00361335|21012760|P2|NOT COMPLETED|IV Period: Baseline to E0||29
8525081|NCT00361335|21012761|P1|NOT COMPLETED|IV Period: Baseline to E0||20
8525082|NCT00361335|21012755|P7|COMPLETED|IV Period: Baseline to E0||0
8525083|NCT00361335|21012756|P6|COMPLETED|IV Period: Baseline to E0||0
8525084|NCT00361335|21012757|P5|COMPLETED|IV Period: Baseline to E0||105
8525085|NCT00361335|21012758|P4|COMPLETED|IV Period: Baseline to E0||102
8525086|NCT00361335|21012759|P3|COMPLETED|IV Period: Baseline to E0||107
8525087|NCT00361335|21012760|P2|COMPLETED|IV Period: Baseline to E0||99
8525088|NCT00361335|21012761|P1|COMPLETED|IV Period: Baseline to E0||109
8525089|NCT00361335|21012755|P7|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
8525090|NCT00361335|21012756|P6|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
8525091|NCT00361335|21012757|P5|STARTED|IV Period: Baseline to E0||129
8525092|NCT00361335|21012758|P4|STARTED|IV Period: Baseline to E0||129
8525093|NCT00361335|21012759|P3|STARTED|IV Period: Baseline to E0||128
8525094|NCT00361335|21012760|P2|STARTED|IV Period: Baseline to E0||128
8525095|NCT00361335|21012761|P1|STARTED|IV Period: Baseline to E0||129
8525096|NCT00361296|21012805|P1|NOT COMPLETED|Overall Study||3
8525097|NCT00361296|21012805|P1|COMPLETED|Overall Study||2
8525098|NCT00361296|21012805|P1|STARTED|Overall Study||5
8525099|NCT00361283|21012812|P1|NOT COMPLETED|Overall Study||27
8525100|NCT00361283|21012812|P1|COMPLETED|Overall Study||81
8525101|NCT00361283|21012812|P1|STARTED|Overall Study||108
8525102|NCT00361270|21012820|P4|NOT COMPLETED|Overall Study||13
8525103|NCT00361270|21012821|P3|NOT COMPLETED|Overall Study||10
8525104|NCT00361270|21012822|P2|NOT COMPLETED|Overall Study||14
8525105|NCT00361270|21012823|P1|NOT COMPLETED|Overall Study||24
8525106|NCT00361270|21012820|P4|COMPLETED|Overall Study||25
8525107|NCT00361270|21012821|P3|COMPLETED|Overall Study||25
8525108|NCT00361270|21012822|P2|COMPLETED|Overall Study||25
8525109|NCT00361270|21012823|P1|COMPLETED|Overall Study||25
8525110|NCT00361270|21012820|P4|STARTED|Overall Study||38
8525111|NCT00361270|21012821|P3|STARTED|Overall Study||35
8525112|NCT00361270|21012822|P2|STARTED|Overall Study||39
8525113|NCT00361270|21012823|P1|STARTED|Overall Study||49
8525114|NCT00361257|21012843|P2|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
8525115|NCT00361257|21012844|P1|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
8525116|NCT00361257|21012843|P2|COMPLETED|Step 2: Minocycline(Open Label) for All||19
8525117|NCT00361257|21012844|P1|COMPLETED|Step 2: Minocycline(Open Label) for All||13
8525118|NCT00361257|21012843|P2|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
8525209|NCT00360490|21013188|P2|STARTED|Overall Study||83
8525119|NCT00361257|21012844|P1|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
8525120|NCT00361257|21012843|P2|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
8525121|NCT00361257|21012844|P1|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
8525122|NCT00361257|21012843|P2|COMPLETED|Step 1: Minocycline vs. Placebo||43
8525123|NCT00361257|21012844|P1|COMPLETED|Step 1: Minocycline vs. Placebo||40
8525124|NCT00361257|21012843|P2|STARTED|Step 1: Minocycline vs. Placebo||55
8525125|NCT00361257|21012844|P1|STARTED|Step 1: Minocycline vs. Placebo||52
8525126|NCT00361231|21012896|P1|NOT COMPLETED|Overall Study||34
8525127|NCT00361231|21012896|P1|COMPLETED|Overall Study||1
8525128|NCT00361231|21012896|P1|STARTED|Overall Study||35
8525129|NCT00361218|21012901|P1|NOT COMPLETED|Overall Study||23
8525130|NCT00361218|21012901|P1|COMPLETED|Overall Study||30
8525131|NCT00361218|21012901|P1|Completed Baseline Assessment|Overall Study||47
8525132|NCT00361218|21012901|P1|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
8525133|NCT00361140|21012909|P3|NOT COMPLETED|Overall Study||0
8525134|NCT00361140|21012910|P2|NOT COMPLETED|Overall Study||0
8525135|NCT00361140|21012911|P1|NOT COMPLETED|Overall Study||0
8525136|NCT00361140|21012909|P3|COMPLETED|Overall Study||3
8525137|NCT00361140|21012910|P2|COMPLETED|Overall Study||29
8525138|NCT00361140|21012911|P1|COMPLETED|Overall Study||40
8525139|NCT00361140|21012909|P3|STARTED|Overall Study||3
8525140|NCT00361140|21012910|P2|STARTED|Overall Study||29
8525141|NCT00361140|21012911|P1|STARTED|Overall Study||40
8525142|NCT00360971|21012924|P2|NOT COMPLETED|Overall Study||0
8525143|NCT00360971|21012925|P1|NOT COMPLETED|Overall Study||0
8525144|NCT00360971|21012924|P2|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
8525145|NCT00360971|21012925|P1|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
8525146|NCT00360971|21012924|P2|STARTED|Overall Study||11
8525147|NCT00360971|21012925|P1|STARTED|Overall Study||10
8525148|NCT00360828|21012941|P1|NOT COMPLETED|Overall Study||1
8525149|NCT00360828|21012941|P1|COMPLETED|Overall Study||9
8525150|NCT00360828|21012941|P1|STARTED|Overall Study||10
8525151|NCT00360724|21012951|P2|NOT COMPLETED|Overall Study||4
8525152|NCT00360724|21012952|P1|NOT COMPLETED|Overall Study||4
8525153|NCT00360724|21012951|P2|COMPLETED|Overall Study||28
8525154|NCT00360724|21012952|P1|COMPLETED|Overall Study||29
8525155|NCT00360724|21012951|P2|STARTED|Overall Study||32
8525156|NCT00360724|21012952|P1|STARTED|Overall Study||33
8525157|NCT00360698|21012980|P2|NOT COMPLETED|Treatment Period||1
8525158|NCT00360698|21012981|P1|NOT COMPLETED|Treatment Period||1
8525159|NCT00360698|21012980|P2|COMPLETED|Treatment Period||56
8525160|NCT00360698|21012981|P1|COMPLETED|Treatment Period||48
8525161|NCT00360698|21012980|P2|STARTED|Treatment Period||57
8525162|NCT00360698|21012981|P1|STARTED|Treatment Period||49
8525163|NCT00360698|21012980|P2|NOT COMPLETED|Run-In||10
8525164|NCT00360698|21012981|P1|NOT COMPLETED|Run-In||0
8525165|NCT00360698|21012980|P2|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
8525166|NCT00360698|21012981|P1|COMPLETED|Run-In||0
8525167|NCT00360698|21012980|P2|STARTED|Run-In||135
8525168|NCT00360698|21012981|P1|STARTED|Run-In||0
8525169|NCT00360685|21013009|P2|NOT COMPLETED|Overall Study||0
8525170|NCT00360685|21013010|P1|NOT COMPLETED|Overall Study||0
8525171|NCT00360685|21013009|P2|COMPLETED|Overall Study||42
8525172|NCT00360685|21013010|P1|COMPLETED|Overall Study||47
8525173|NCT00360685|21013009|P2|STARTED|Overall Study||42
8525174|NCT00360685|21013010|P1|STARTED|Overall Study||47
8525175|NCT00360672|21013020|P1|NOT COMPLETED|Overall Study||0
8525176|NCT00360672|21013020|P1|COMPLETED|Overall Study||27
8525177|NCT00360672|21013020|P1|STARTED|Overall Study||27
8525178|NCT00360568|21013026|P2|NOT COMPLETED|Overall Study||5
8525179|NCT00360568|21013027|P1|NOT COMPLETED|Overall Study||2
8525180|NCT00360568|21013026|P2|COMPLETED|Overall Study||24
8525181|NCT00360568|21013027|P1|COMPLETED|Overall Study||31
8525182|NCT00360568|21013026|P2|STARTED|Overall Study||29
8525183|NCT00360568|21013027|P1|STARTED|Overall Study||33
8525184|NCT00360555|21013138|P4|NOT COMPLETED|Overall Study||112
8525185|NCT00360555|21013139|P3|NOT COMPLETED|Overall Study||145
8525186|NCT00360555|21013140|P2|NOT COMPLETED|Overall Study||134
8525187|NCT00360555|21013141|P1|NOT COMPLETED|Overall Study||122
8525188|NCT00360555|21013138|P4|COMPLETED|Overall Study||287
8525189|NCT00360555|21013139|P3|COMPLETED|Overall Study||251
8525190|NCT00360555|21013140|P2|COMPLETED|Overall Study||259
8525191|NCT00360555|21013141|P1|COMPLETED|Overall Study||274
8525192|NCT00360555|21013138|P4|STARTED|Overall Study||399
8525193|NCT00360555|21013139|P3|STARTED|Overall Study||396
8525194|NCT00360555|21013140|P2|STARTED|Overall Study||393
8525195|NCT00360555|21013141|P1|STARTED|Overall Study||396
8525196|NCT00360529|21013158|P3|NOT COMPLETED|Overall Study||91
8525197|NCT00360529|21013159|P2|NOT COMPLETED|Overall Study||65
8525198|NCT00360529|21013160|P1|NOT COMPLETED|Overall Study||61
8525199|NCT00360529|21013158|P3|COMPLETED|Overall Study||199
8525200|NCT00360529|21013159|P2|COMPLETED|Overall Study||230
8525201|NCT00360529|21013160|P1|COMPLETED|Overall Study||234
8525202|NCT00360529|21013158|P3|STARTED|Overall Study||290
8525203|NCT00360529|21013159|P2|STARTED|Overall Study||295
8525204|NCT00360529|21013160|P1|STARTED|Overall Study||295
8525205|NCT00360490|21013188|P2|NOT COMPLETED|Overall Study||11
8525206|NCT00360490|21013189|P1|NOT COMPLETED|Overall Study||9
8525207|NCT00360490|21013188|P2|COMPLETED|Overall Study||72
8525208|NCT00360490|21013189|P1|COMPLETED|Overall Study||73
8525210|NCT00360490|21013189|P1|STARTED|Overall Study||82
8525211|NCT00360412|21013224|P2|NOT COMPLETED|Overall Study||662
8525212|NCT00360412|21013225|P1|NOT COMPLETED|Overall Study||333
8525213|NCT00360412|21013224|P2|COMPLETED|Overall Study||2
8525214|NCT00360412|21013225|P1|COMPLETED|Overall Study||0
8525215|NCT00360412|21013224|P2|STARTED|Overall Study||664
8525216|NCT00360412|21013225|P1|STARTED|Overall Study||333
8525217|NCT00360399|21013240|P3|NOT COMPLETED|Overall Study||46
8525218|NCT00360399|21013241|P2|NOT COMPLETED|Overall Study||36
8525219|NCT00360399|21013242|P1|NOT COMPLETED|Overall Study||28
8525220|NCT00360399|21013240|P3|COMPLETED|Overall Study||69
8525221|NCT00360399|21013241|P2|COMPLETED|Overall Study||79
8525222|NCT00360399|21013242|P1|COMPLETED|Overall Study||86
8525223|NCT00360399|21013240|P3|Had Post-randomization Assessment|Overall Study||105
8525224|NCT00360399|21013241|P2|Had Post-randomization Assessment|Overall Study||106
8525225|NCT00360399|21013242|P1|Had Post-randomization Assessment|Overall Study||105
8525226|NCT00360399|21013240|P3|STARTED|Overall Study||115
8525227|NCT00360399|21013241|P2|STARTED|Overall Study||115
8525228|NCT00360399|21013242|P1|STARTED|Overall Study||114
8525229|NCT00360360|21013265|P1|NOT COMPLETED|Overall Study||6
8525230|NCT00360360|21013265|P1|COMPLETED|Overall Study||54
8525231|NCT00360360|21013265|P1|STARTED|Overall Study||60
8525232|NCT00360334|21013272|P2|NOT COMPLETED|Overall Study||13
8525233|NCT00360334|21013273|P1|NOT COMPLETED|Overall Study||19
8525234|NCT00360334|21013272|P2|COMPLETED|Overall Study||104
8525235|NCT00360334|21013273|P1|COMPLETED|Overall Study||99
8525236|NCT00360334|21013272|P2|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
8525237|NCT00360334|21013273|P1|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
8525238|NCT00360334|21013272|P2|STARTED|Overall Study||117
8525239|NCT00360334|21013273|P1|STARTED|Overall Study||118
8525240|NCT00360308|21013336|P3|NOT COMPLETED|Overall Study||88
8525241|NCT00360308|21013337|P2|NOT COMPLETED|Overall Study||79
8525242|NCT00360308|21013338|P1|NOT COMPLETED|Overall Study||76
8525243|NCT00360308|21013336|P3|COMPLETED|Overall Study||154
8525244|NCT00360308|21013337|P2|COMPLETED|Overall Study||155
8525245|NCT00360308|21013338|P1|COMPLETED|Overall Study||171
8525246|NCT00360308|21013336|P3|STARTED|Overall Study||242
8525247|NCT00360308|21013337|P2|STARTED|Overall Study||234
8525248|NCT00360308|21013338|P1|STARTED|Overall Study||247
8525249|NCT00360282|21013355|P4|NOT COMPLETED|Second Intervention||0
8525250|NCT00360282|21013356|P3|NOT COMPLETED|Second Intervention||0
8525251|NCT00360282|21013357|P2|NOT COMPLETED|Second Intervention||1
8525252|NCT00360282|21013358|P1|NOT COMPLETED|Second Intervention||0
8525253|NCT00360282|21013355|P4|COMPLETED|Second Intervention||6
8525254|NCT00360282|21013356|P3|COMPLETED|Second Intervention||6
8525255|NCT00360282|21013357|P2|COMPLETED|Second Intervention||7
8525256|NCT00360282|21013358|P1|COMPLETED|Second Intervention||6
8525257|NCT00360282|21013355|P4|STARTED|Second Intervention||6
8525258|NCT00360282|21013356|P3|STARTED|Second Intervention||6
8525259|NCT00360282|21013357|P2|STARTED|Second Intervention||8
8525260|NCT00360282|21013358|P1|STARTED|Second Intervention||6
8525261|NCT00360282|21013355|P4|NOT COMPLETED|Washout 1-3 Weeks||0
8525262|NCT00360282|21013356|P3|NOT COMPLETED|Washout 1-3 Weeks||1
8525263|NCT00360282|21013357|P2|NOT COMPLETED|Washout 1-3 Weeks||0
8525264|NCT00360282|21013358|P1|NOT COMPLETED|Washout 1-3 Weeks||0
8525265|NCT00360282|21013355|P4|COMPLETED|Washout 1-3 Weeks||6
8525266|NCT00360282|21013356|P3|COMPLETED|Washout 1-3 Weeks||6
8525267|NCT00360282|21013357|P2|COMPLETED|Washout 1-3 Weeks||8
8525268|NCT00360282|21013358|P1|COMPLETED|Washout 1-3 Weeks||6
8525269|NCT00360282|21013355|P4|STARTED|Washout 1-3 Weeks||6
8525270|NCT00360282|21013356|P3|STARTED|Washout 1-3 Weeks||7
8525271|NCT00360282|21013357|P2|STARTED|Washout 1-3 Weeks||8
8525272|NCT00360282|21013358|P1|STARTED|Washout 1-3 Weeks||6
8525273|NCT00360282|21013355|P4|NOT COMPLETED|First Intervention||0
8525274|NCT00360282|21013356|P3|NOT COMPLETED|First Intervention||0
8525275|NCT00360282|21013357|P2|NOT COMPLETED|First Intervention||0
8525276|NCT00360282|21013358|P1|NOT COMPLETED|First Intervention||0
8525277|NCT00360282|21013355|P4|COMPLETED|First Intervention||6
8525278|NCT00360282|21013356|P3|COMPLETED|First Intervention||7
8525279|NCT00360282|21013357|P2|COMPLETED|First Intervention||8
8525280|NCT00360282|21013358|P1|COMPLETED|First Intervention||6
8525281|NCT00360282|21013355|P4|STARTED|First Intervention||6
8525282|NCT00360282|21013356|P3|STARTED|First Intervention||7
8525283|NCT00360282|21013357|P2|STARTED|First Intervention||8
8525284|NCT00360282|21013358|P1|STARTED|First Intervention||6
8525285|NCT00360269|21013370|P2|NOT COMPLETED|Overall Study||12
8525286|NCT00360269|21013371|P1|NOT COMPLETED|Overall Study||10
8525287|NCT00360269|21013370|P2|COMPLETED|Overall Study||7
8525288|NCT00360269|21013371|P1|COMPLETED|Overall Study||9
8525289|NCT00360269|21013370|P2|STARTED|Overall Study||19
8525290|NCT00360269|21013371|P1|STARTED|Overall Study||19
8525291|NCT00360243|21013389|P4|NOT COMPLETED|Overall Study||125
8525292|NCT00360243|21013390|P3|NOT COMPLETED|Overall Study||156
8525293|NCT00360243|21013391|P2|NOT COMPLETED|Overall Study||120
8525294|NCT00360243|21013392|P1|NOT COMPLETED|Overall Study||102
8525295|NCT00360243|21013389|P4|COMPLETED|Overall Study||224
8525296|NCT00360243|21013390|P3|COMPLETED|Overall Study||180
8525297|NCT00360243|21013391|P2|COMPLETED|Overall Study||243
8525298|NCT00360243|21013392|P1|COMPLETED|Overall Study||235
8525299|NCT00360243|21013389|P4|STARTED|Overall Study||349
8525300|NCT00360243|21013390|P3|STARTED|Overall Study||336
8525301|NCT00360243|21013391|P2|STARTED|Overall Study||363
8525302|NCT00360243|21013392|P1|STARTED|Overall Study||337
8525303|NCT00360230|21013413|P7|NOT COMPLETED|Overall Study||2
8525304|NCT00360230|21013414|P6|NOT COMPLETED|Overall Study||4
8525305|NCT00360230|21013415|P5|NOT COMPLETED|Overall Study||5
8525306|NCT00360230|21013416|P4|NOT COMPLETED|Overall Study||2
8525307|NCT00360230|21013417|P3|NOT COMPLETED|Overall Study||3
8525308|NCT00360230|21013418|P2|NOT COMPLETED|Overall Study||3
8525309|NCT00360230|21013419|P1|NOT COMPLETED|Overall Study||6
8525310|NCT00360230|21013413|P7|COMPLETED|Overall Study||43
8525311|NCT00360230|21013414|P6|COMPLETED|Overall Study||86
8525312|NCT00360230|21013415|P5|COMPLETED|Overall Study||85
8525313|NCT00360230|21013416|P4|COMPLETED|Overall Study||88
8525314|NCT00360230|21013417|P3|COMPLETED|Overall Study||42
8525315|NCT00360230|21013418|P2|COMPLETED|Overall Study||87
8525316|NCT00360230|21013419|P1|COMPLETED|Overall Study||84
8525317|NCT00360230|21013413|P7|STARTED|Overall Study||45
8525318|NCT00360230|21013414|P6|STARTED|Overall Study||90
8525319|NCT00360230|21013415|P5|STARTED|Overall Study||90
8525320|NCT00360230|21013416|P4|STARTED|Overall Study||90
8525321|NCT00360230|21013417|P3|STARTED|Overall Study||45
8525322|NCT00360230|21013418|P2|STARTED|Overall Study||90
8525323|NCT00360230|21013419|P1|STARTED|Overall Study||90
8525324|NCT00360126|21013470|P1|NOT COMPLETED|Overall Study||0
8525325|NCT00360126|21013470|P1|COMPLETED|Overall Study||11
8525326|NCT00360126|21013470|P1|STARTED|Overall Study||11
8525327|NCT00360009|21013477|P3|NOT COMPLETED|Overall Study||3
8525328|NCT00360009|21013478|P2|NOT COMPLETED|Overall Study||4
8525329|NCT00360009|21013479|P1|NOT COMPLETED|Overall Study||0
8525330|NCT00360009|21013477|P3|COMPLETED|Overall Study||23
8525331|NCT00360009|21013478|P2|COMPLETED|Overall Study||22
8525332|NCT00360009|21013479|P1|COMPLETED|Overall Study||10
8525333|NCT00360009|21013477|P3|STARTED|Overall Study||26
8525334|NCT00360009|21013478|P2|STARTED|Overall Study||26
8525335|NCT00360009|21013479|P1|STARTED|Overall Study||10
8525336|NCT00359983|21013520|P3|NOT COMPLETED|Year 5 Persistence Follow-up||0
8525337|NCT00359983|21013521|P2|NOT COMPLETED|Year 5 Persistence Follow-up||0
8525338|NCT00359983|21013522|P1|NOT COMPLETED|Year 5 Persistence Follow-up||0
8525339|NCT00359983|21013520|P3|COMPLETED|Year 5 Persistence Follow-up||42
8525340|NCT00359983|21013521|P2|COMPLETED|Year 5 Persistence Follow-up||44
8525341|NCT00359983|21013522|P1|COMPLETED|Year 5 Persistence Follow-up||95
8525342|NCT00359983|21013520|P3|STARTED|Year 5 Persistence Follow-up||42
8525343|NCT00359983|21013521|P2|STARTED|Year 5 Persistence Follow-up||44
8525344|NCT00359983|21013522|P1|STARTED|Year 5 Persistence Follow-up||95
8525345|NCT00359983|21013520|P3|NOT COMPLETED|Year 3 Persistence Follow-up||0
8525346|NCT00359983|21013521|P2|NOT COMPLETED|Year 3 Persistence Follow-up||0
8525347|NCT00359983|21013522|P1|NOT COMPLETED|Year 3 Persistence Follow-up||0
8525348|NCT00359983|21013520|P3|COMPLETED|Year 3 Persistence Follow-up||51
8525349|NCT00359983|21013521|P2|COMPLETED|Year 3 Persistence Follow-up||47
8525350|NCT00359983|21013522|P1|COMPLETED|Year 3 Persistence Follow-up||103
8525351|NCT00359983|21013520|P3|STARTED|Year 3 Persistence Follow-up||51
8525352|NCT00359983|21013521|P2|STARTED|Year 3 Persistence Follow-up||47
8525353|NCT00359983|21013522|P1|STARTED|Year 3 Persistence Follow-up||103
8525354|NCT00359983|21013520|P3|NOT COMPLETED|Year 1 Persistence Follow-up||0
8525355|NCT00359983|21013521|P2|NOT COMPLETED|Year 1 Persistence Follow-up||0
8525356|NCT00359983|21013522|P1|NOT COMPLETED|Year 1 Persistence Follow-up||0
8525357|NCT00359983|21013520|P3|COMPLETED|Year 1 Persistence Follow-up||62
8525358|NCT00359983|21013521|P2|COMPLETED|Year 1 Persistence Follow-up||70
8525359|NCT00359983|21013522|P1|COMPLETED|Year 1 Persistence Follow-up||138
8525360|NCT00359983|21013520|P3|STARTED|Year 1 Persistence Follow-up||62
8525361|NCT00359983|21013521|P2|STARTED|Year 1 Persistence Follow-up||70
8525362|NCT00359983|21013522|P1|STARTED|Year 1 Persistence Follow-up||138
8525363|NCT00359944|21013557|P3|NOT COMPLETED|Overall Study||19
8525364|NCT00359944|21013558|P2|NOT COMPLETED|Overall Study||19
8525365|NCT00359944|21013559|P1|NOT COMPLETED|Overall Study||16
8525366|NCT00359944|21013557|P3|COMPLETED|Overall Study||38
8525367|NCT00359944|21013558|P2|COMPLETED|Overall Study||28
8525368|NCT00359944|21013559|P1|COMPLETED|Overall Study||34
8525369|NCT00359944|21013557|P3|STARTED|Overall Study||57
8525370|NCT00359944|21013558|P2|STARTED|Overall Study||47
8525371|NCT00359944|21013559|P1|STARTED|Overall Study||50
8525372|NCT00359801|21013575|P2|NOT COMPLETED|Overall Study||220
8525373|NCT00359801|21013576|P1|NOT COMPLETED|Overall Study||305
8525374|NCT00359801|21013575|P2|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
8525375|NCT00359801|21013576|P1|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
8525376|NCT00359801|21013575|P2|STARTED|Overall Study||989
8525377|NCT00359801|21013576|P1|STARTED|Overall Study||987
8525378|NCT00359788|21013610|P2|NOT COMPLETED|Overall Study||17
8525379|NCT00359788|21013611|P1|NOT COMPLETED|Overall Study||23
8525380|NCT00359788|21013610|P2|COMPLETED|Overall Study||159
8525381|NCT00359788|21013611|P1|COMPLETED|Overall Study||150
8525382|NCT00359788|21013610|P2|STARTED|Overall Study||176
8525383|NCT00359788|21013611|P1|STARTED|Overall Study||173
8525384|NCT00359762|21013845|P5|NOT COMPLETED|Period I||0
8525385|NCT00359762|21013846|P4|NOT COMPLETED|Period I||0
8525386|NCT00359762|21013847|P3|NOT COMPLETED|Period I||0
8525387|NCT00359762|21013848|P2|NOT COMPLETED|Period I||0
8525388|NCT00359762|21013849|P1|NOT COMPLETED|Period I||0
8525389|NCT00359762|21013845|P5|COMPLETED|Period I||0
8525390|NCT00359762|21013846|P4|COMPLETED|Period I||0
8525391|NCT00359762|21013847|P3|COMPLETED|Period I||0
8525392|NCT00359762|21013848|P2|COMPLETED|Period I||0
8525393|NCT00359762|21013849|P1|COMPLETED|Period I||0
8525394|NCT00359762|21013845|P5|STARTED|Period I||0
8525395|NCT00359762|21013846|P4|STARTED|Period I||0
8525396|NCT00359762|21013847|P3|STARTED|Period I||0
8525397|NCT00359762|21013848|P2|STARTED|Period I||0
8525398|NCT00359762|21013849|P1|STARTED|Period I||0
8525399|NCT00359762|21013845|P5|NOT COMPLETED|Period III||0
8525400|NCT00359762|21013846|P4|NOT COMPLETED|Period III||65
8525401|NCT00359762|21013847|P3|NOT COMPLETED|Period III||30
8525402|NCT00359762|21013848|P2|NOT COMPLETED|Period III||29
8525403|NCT00359762|21013849|P1|NOT COMPLETED|Period III||0
8525404|NCT00359762|21013845|P5|COMPLETED|Period III||0
8525405|NCT00359762|21013846|P4|COMPLETED|Period III||101
8525406|NCT00359762|21013847|P3|COMPLETED|Period III||47
8525407|NCT00359762|21013848|P2|COMPLETED|Period III||48
8525408|NCT00359762|21013849|P1|COMPLETED|Period III||0
8525409|NCT00359762|21013845|P5|Extension ITT Efficacy Population|Period III||0
8525410|NCT00359762|21013846|P4|Extension ITT Efficacy Population|Period III||164
8525411|NCT00359762|21013847|P3|Extension ITT Efficacy Population|Period III||75
8525412|NCT00359762|21013848|P2|Extension ITT Efficacy Population|Period III||73
8525413|NCT00359762|21013849|P1|Extension ITT Efficacy Population|Period III||0
8525414|NCT00359762|21013845|P5|Extension ITT Safety Population|Period III||0
8525415|NCT00359762|21013846|P4|Extension ITT Safety Population|Period III||166
8525416|NCT00359762|21013847|P3|Extension ITT Safety Population|Period III||76
8525417|NCT00359762|21013848|P2|Extension ITT Safety Population|Period III||74
8525418|NCT00359762|21013849|P1|Extension ITT Safety Population|Period III||0
8525419|NCT00359762|21013845|P5|STARTED|Period III||0
8525420|NCT00359762|21013846|P4|STARTED|Period III||166
8525421|NCT00359762|21013847|P3|STARTED|Period III||77
8525422|NCT00359762|21013848|P2|STARTED|Period III||77
8525423|NCT00359762|21013849|P1|STARTED|Period III||0
8525424|NCT00359762|21013845|P5|NOT COMPLETED|Period II||174
8525425|NCT00359762|21013846|P4|NOT COMPLETED|Period II||0
8525426|NCT00359762|21013847|P3|NOT COMPLETED|Period II||0
8525427|NCT00359762|21013848|P2|NOT COMPLETED|Period II||0
8525428|NCT00359762|21013849|P1|NOT COMPLETED|Period II||128
8525429|NCT00359762|21013845|P5|COMPLETED|Period II||341
8525430|NCT00359762|21013846|P4|COMPLETED|Period II||0
8525431|NCT00359762|21013847|P3|COMPLETED|Period II||0
8525432|NCT00359762|21013848|P2|COMPLETED|Period II||0
8525433|NCT00359762|21013849|P1|COMPLETED|Period II||386
8525434|NCT00359762|21013845|P5|Without Treatment Failure|Period II||138
8525435|NCT00359762|21013846|P4|Without Treatment Failure|Period II||0
8525436|NCT00359762|21013847|P3|Without Treatment Failure|Period II||0
8525437|NCT00359762|21013848|P2|Without Treatment Failure|Period II||0
8525438|NCT00359762|21013849|P1|Without Treatment Failure|Period II||124
8525439|NCT00359762|21013845|P5|Met Primary Endpoint|Period II||203
8525440|NCT00359762|21013846|P4|Met Primary Endpoint|Period II||0
8525441|NCT00359762|21013847|P3|Met Primary Endpoint|Period II||0
8525442|NCT00359762|21013848|P2|Met Primary Endpoint|Period II||0
8525443|NCT00359762|21013849|P1|Met Primary Endpoint|Period II||262
8525444|NCT00359762|21013845|P5|ITT Efficacy Population|Period II||490
8525445|NCT00359762|21013846|P4|ITT Efficacy Population|Period II||0
8525446|NCT00359762|21013847|P3|ITT Efficacy Population|Period II||0
8525447|NCT00359762|21013848|P2|ITT Efficacy Population|Period II||0
8525448|NCT00359762|21013849|P1|ITT Efficacy Population|Period II||487
8525449|NCT00359762|21013845|P5|Intent to Treat (ITT) Safety Population|Period II||511
8525450|NCT00359762|21013846|P4|Intent to Treat (ITT) Safety Population|Period II||0
8525451|NCT00359762|21013847|P3|Intent to Treat (ITT) Safety Population|Period II||0
8525452|NCT00359762|21013848|P2|Intent to Treat (ITT) Safety Population|Period II||0
8525453|NCT00359762|21013849|P1|Intent to Treat (ITT) Safety Population|Period II||508
8525454|NCT00359762|21013845|P5|STARTED|Period II||515
8525455|NCT00359762|21013846|P4|STARTED|Period II||0
8525456|NCT00359762|21013847|P3|STARTED|Period II||0
8525457|NCT00359762|21013848|P2|STARTED|Period II||0
8525458|NCT00359762|21013849|P1|STARTED|Period II||514
8525459|NCT00359736|21013912|P2|NOT COMPLETED|Overall Study||0
8525460|NCT00359736|21013913|P1|NOT COMPLETED|Overall Study||0
8525461|NCT00359736|21013912|P2|COMPLETED|Overall Study||15
8525462|NCT00359736|21013913|P1|COMPLETED|Overall Study||14
8525463|NCT00359736|21013912|P2|STARTED|Overall Study||15
8525464|NCT00359736|21013913|P1|STARTED|Overall Study||14
8525465|NCT00359632|21013923|P2|NOT COMPLETED|Overall Study||0
8525466|NCT00359632|21013924|P1|NOT COMPLETED|Overall Study||4
8525467|NCT00359632|21013923|P2|COMPLETED|Overall Study||9
8525468|NCT00359632|21013924|P1|COMPLETED|Overall Study||20
8525469|NCT00359632|21013923|P2|STARTED|Overall Study||9
8525470|NCT00359632|21013924|P1|STARTED|Overall Study||24
8525471|NCT00359619|21013938|P7|NOT COMPLETED|Overall Study||4
8525472|NCT00359619|21013939|P6|NOT COMPLETED|Overall Study||5
8525473|NCT00359619|21013940|P5|NOT COMPLETED|Overall Study||3
8525474|NCT00359619|21013941|P4|NOT COMPLETED|Overall Study||3
8525475|NCT00359619|21013942|P3|NOT COMPLETED|Overall Study||7
8525476|NCT00359619|21013943|P2|NOT COMPLETED|Overall Study||5
8525477|NCT00359619|21013944|P1|NOT COMPLETED|Overall Study||8
8525478|NCT00359619|21013938|P7|COMPLETED|Overall Study||46
8525479|NCT00359619|21013939|P6|COMPLETED|Overall Study||45
8525480|NCT00359619|21013940|P5|COMPLETED|Overall Study||45
8525481|NCT00359619|21013941|P4|COMPLETED|Overall Study||45
8525482|NCT00359619|21013942|P3|COMPLETED|Overall Study||42
8525483|NCT00359619|21013943|P2|COMPLETED|Overall Study||45
8525484|NCT00359619|21013944|P1|COMPLETED|Overall Study||80
8525485|NCT00359619|21013938|P7|STARTED|Overall Study||50
8525486|NCT00359619|21013939|P6|STARTED|Overall Study||50
8525487|NCT00359619|21013940|P5|STARTED|Overall Study||48
8525488|NCT00359619|21013941|P4|STARTED|Overall Study||48
8525489|NCT00359619|21013942|P3|STARTED|Overall Study||49
8525490|NCT00359619|21013943|P2|STARTED|Overall Study||50
8525491|NCT00359619|21013944|P1|STARTED|Overall Study||88
8525492|NCT00359424|21014074|P2|NOT COMPLETED|Overall Study||67
8525493|NCT00359424|21014075|P1|NOT COMPLETED|Overall Study||130
8525494|NCT00359424|21014074|P2|COMPLETED|Overall Study||155
8525495|NCT00359424|21014075|P1|COMPLETED|Overall Study||304
8525496|NCT00359424|21014074|P2|270 Day Follow up|Overall Study||159
8525497|NCT00359424|21014075|P1|270 Day Follow up|Overall Study||313
8525498|NCT00359424|21014074|P2|180 Day Follow up|Overall Study||167
8525499|NCT00359424|21014075|P1|180 Day Follow up|Overall Study||325
8525500|NCT00359424|21014074|P2|90 Day Follow up|Overall Study||172
8525501|NCT00359424|21014075|P1|90 Day Follow up|Overall Study||343
8525502|NCT00359424|21014074|P2|STARTED|Overall Study||222
8525503|NCT00359424|21014075|P1|STARTED|Overall Study||434
8525504|NCT00359281|21014114|P9|NOT COMPLETED|Overall Study||0
8525505|NCT00359281|21014115|P8|NOT COMPLETED|Overall Study||0
8525506|NCT00359281|21014116|P7|NOT COMPLETED|Overall Study||2
8525507|NCT00359281|21014117|P6|NOT COMPLETED|Overall Study||0
8525508|NCT00359281|21014118|P5|NOT COMPLETED|Overall Study||0
8525509|NCT00359281|21014119|P4|NOT COMPLETED|Overall Study||0
8525510|NCT00359281|21014120|P3|NOT COMPLETED|Overall Study||0
8525511|NCT00359281|21014121|P2|NOT COMPLETED|Overall Study||0
8525512|NCT00359281|21014122|P1|NOT COMPLETED|Overall Study||1
8525513|NCT00359281|21014114|P9|COMPLETED|Overall Study||20
8525514|NCT00359281|21014115|P8|COMPLETED|Overall Study||15
8525515|NCT00359281|21014116|P7|COMPLETED|Overall Study||16
8525516|NCT00359281|21014117|P6|COMPLETED|Overall Study||15
8525517|NCT00359281|21014118|P5|COMPLETED|Overall Study||10
8525518|NCT00359281|21014119|P4|COMPLETED|Overall Study||10
8525519|NCT00359281|21014120|P3|COMPLETED|Overall Study||10
8525520|NCT00359281|21014121|P2|COMPLETED|Overall Study||15
8525521|NCT00359281|21014122|P1|COMPLETED|Overall Study||15
8525522|NCT00359281|21014114|P9|STARTED|Overall Study||20
8525523|NCT00359281|21014115|P8|STARTED|Overall Study||15
8525524|NCT00359281|21014116|P7|STARTED|Overall Study||18
8525525|NCT00359281|21014117|P6|STARTED|Overall Study||15
8525526|NCT00359281|21014118|P5|STARTED|Overall Study||10
8525527|NCT00359281|21014119|P4|STARTED|Overall Study||10
8525528|NCT00359281|21014120|P3|STARTED|Overall Study||10
8525529|NCT00359281|21014121|P2|STARTED|Overall Study||15
8525530|NCT00359281|21014122|P1|STARTED|Overall Study||16
8525531|NCT00359216|21014154|P2|NOT COMPLETED|Overall Study||1
8525532|NCT00359216|21014155|P1|NOT COMPLETED|Overall Study||0
8525533|NCT00359216|21014154|P2|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
8525534|NCT00359216|21014155|P1|COMPLETED|Overall Study||20
8525535|NCT00359216|21014154|P2|STARTED|Overall Study||10
8525536|NCT00359216|21014155|P1|STARTED|Overall Study||20
8525537|NCT00359203|21014163|P2|NOT COMPLETED|Overall Study||0
8525538|NCT00359203|21014164|P1|NOT COMPLETED|Overall Study||0
8525539|NCT00359203|21014163|P2|COMPLETED|Overall Study||38
8525540|NCT00359203|21014164|P1|COMPLETED|Overall Study||39
8525541|NCT00359203|21014163|P2|STARTED|Overall Study||38
8525542|NCT00359203|21014164|P1|STARTED|Overall Study||39
8525543|NCT00359138|21014173|P3|NOT COMPLETED|Overall Study||0
8525544|NCT00359138|21014174|P2|NOT COMPLETED|Overall Study||0
8525545|NCT00359138|21014175|P1|NOT COMPLETED|Overall Study||0
8525546|NCT00359138|21014173|P3|COMPLETED|Overall Study||12
8525547|NCT00359138|21014174|P2|COMPLETED|Overall Study||12
8525548|NCT00359138|21014175|P1|COMPLETED|Overall Study||12
8525549|NCT00359138|21014173|P3|STARTED|Overall Study||12
8525550|NCT00359138|21014174|P2|STARTED|Overall Study||12
8525551|NCT00359138|21014175|P1|STARTED|Overall Study||12
8525552|NCT00359073|21014185|P2|NOT COMPLETED|Overall Study||2
8525553|NCT00359073|21014186|P1|NOT COMPLETED|Overall Study||4
8525554|NCT00359073|21014185|P2|COMPLETED|Overall Study||11
8525555|NCT00359073|21014186|P1|COMPLETED|Overall Study||8
8525556|NCT00359073|21014185|P2|STARTED|Overall Study||13
8525557|NCT00359073|21014186|P1|STARTED|Overall Study||12
8525558|NCT00359021|21014198|P2|NOT COMPLETED|Overall Study||52
8525559|NCT00359021|21014199|P1|NOT COMPLETED|Overall Study||81
8525560|NCT00359021|21014198|P2|COMPLETED|Overall Study||195
8525561|NCT00359021|21014199|P1|COMPLETED|Overall Study||175
8525562|NCT00359021|21014198|P2|STARTED|Overall Study||247
8525563|NCT00359021|21014199|P1|STARTED|Overall Study||256
8525564|NCT00358956|21014211|P1|NOT COMPLETED|Overall Study||8
8525565|NCT00358956|21014211|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
8525566|NCT00358956|21014211|P1|STARTED|Overall Study||19
8525567|NCT00358917|21014223|P2|NOT COMPLETED|Overall Study||69
8525568|NCT00358917|21014224|P1|NOT COMPLETED|Overall Study||66
8525569|NCT00358917|21014223|P2|COMPLETED|Overall Study||230
8525570|NCT00358917|21014224|P1|COMPLETED|Overall Study||234
8525571|NCT00358917|21014223|P2|STARTED|Overall Study||299
8525572|NCT00358917|21014224|P1|STARTED|Overall Study||300
8525573|NCT00358826|21014242|P8|NOT COMPLETED|MDCT Substudy||0
8525574|NCT00358826|21014243|P7|NOT COMPLETED|MDCT Substudy||0
8525575|NCT00358826|21014244|P6|NOT COMPLETED|MDCT Substudy||2
8525576|NCT00358826|21014245|P5|NOT COMPLETED|MDCT Substudy||1
8525577|NCT00358826|21014246|P4|NOT COMPLETED|MDCT Substudy||0
8525578|NCT00358826|21014247|P3|NOT COMPLETED|MDCT Substudy||0
8525579|NCT00358826|21014248|P2|NOT COMPLETED|MDCT Substudy||0
8525580|NCT00358826|21014249|P1|NOT COMPLETED|MDCT Substudy||0
8525581|NCT00358826|21014242|P8|COMPLETED|MDCT Substudy||27
8525582|NCT00358826|21014243|P7|COMPLETED|MDCT Substudy||19
8525583|NCT00358826|21014244|P6|COMPLETED|MDCT Substudy||20
8525584|NCT00358826|21014245|P5|COMPLETED|MDCT Substudy||24
8525585|NCT00358826|21014246|P4|COMPLETED|MDCT Substudy||0
8525586|NCT00358826|21014247|P3|COMPLETED|MDCT Substudy||0
8525587|NCT00358826|21014248|P2|COMPLETED|MDCT Substudy||0
8525588|NCT00358826|21014249|P1|COMPLETED|MDCT Substudy||0
8525589|NCT00358826|21014242|P8|STARTED|MDCT Substudy||27
8525590|NCT00358826|21014243|P7|STARTED|MDCT Substudy||19
8525591|NCT00358826|21014244|P6|STARTED|MDCT Substudy||22
8525592|NCT00358826|21014245|P5|STARTED|MDCT Substudy||25
8525593|NCT00358826|21014246|P4|STARTED|MDCT Substudy||0
8525594|NCT00358826|21014247|P3|STARTED|MDCT Substudy||0
8525595|NCT00358826|21014248|P2|STARTED|MDCT Substudy||0
8525596|NCT00358826|21014249|P1|STARTED|MDCT Substudy||0
8525597|NCT00358826|21014242|P8|NOT COMPLETED|Core Study||0
8525598|NCT00358826|21014243|P7|NOT COMPLETED|Core Study||0
8525599|NCT00358826|21014244|P6|NOT COMPLETED|Core Study||0
8525600|NCT00358826|21014245|P5|NOT COMPLETED|Core Study||0
8525601|NCT00358826|21014246|P4|NOT COMPLETED|Core Study||2
8525602|NCT00358826|21014247|P3|NOT COMPLETED|Core Study||2
8525603|NCT00358826|21014248|P2|NOT COMPLETED|Core Study||5
8525604|NCT00358826|21014249|P1|NOT COMPLETED|Core Study||3
8525605|NCT00358826|21014242|P8|COMPLETED|Core Study||0
8525606|NCT00358826|21014243|P7|COMPLETED|Core Study||0
8525607|NCT00358826|21014244|P6|COMPLETED|Core Study||0
8525608|NCT00358826|21014245|P5|COMPLETED|Core Study||0
8525609|NCT00358826|21014246|P4|COMPLETED|Core Study||50
8525610|NCT00358826|21014247|P3|COMPLETED|Core Study||42
8525611|NCT00358826|21014248|P2|COMPLETED|Core Study||41
8525612|NCT00358826|21014249|P1|COMPLETED|Core Study||46
8525613|NCT00358826|21014242|P8|STARTED|Core Study||0
8525614|NCT00358826|21014243|P7|STARTED|Core Study||0
8525615|NCT00358826|21014244|P6|STARTED|Core Study||0
8525616|NCT00358826|21014245|P5|STARTED|Core Study||0
8525617|NCT00358826|21014246|P4|STARTED|Core Study||52
8525618|NCT00358826|21014247|P3|STARTED|Core Study||44
8525619|NCT00358826|21014248|P2|STARTED|Core Study||46
8525620|NCT00358826|21014249|P1|STARTED|Core Study||49
8525621|NCT00358735|21014285|P2|NOT COMPLETED|Overall Study||17
8525622|NCT00358735|21014286|P1|NOT COMPLETED|Overall Study||8
8525623|NCT00358735|21014285|P2|COMPLETED|Overall Study|Efficacy|190
8525624|NCT00358735|21014286|P1|COMPLETED|Overall Study|Efficacy|196
8525625|NCT00358735|21014285|P2|Not Completed Safety|Overall Study||13
8525626|NCT00358735|21014286|P1|Not Completed Safety|Overall Study||6
8525627|NCT00358735|21014285|P2|Completed Safety|Overall Study||194
8525628|NCT00358735|21014286|P1|Completed Safety|Overall Study||198
8525629|NCT00358735|21014285|P2|STARTED|Overall Study||207
8525630|NCT00358735|21014286|P1|STARTED|Overall Study||204
8525631|NCT00358670|21014316|P2|NOT COMPLETED|Overall Study||219
8525632|NCT00358670|21014317|P1|NOT COMPLETED|Overall Study||222
8525633|NCT00358670|21014316|P2|COMPLETED|Overall Study||0
8525634|NCT00358670|21014317|P1|COMPLETED|Overall Study||0
8525635|NCT00358670|21014316|P2|STARTED|Overall Study||219
8525636|NCT00358670|21014317|P1|STARTED|Overall Study||222
8525637|NCT00358657|21014331|P1|NOT COMPLETED|Overall Study||0
8525638|NCT00358657|21014331|P1|COMPLETED|Overall Study||14
8525639|NCT00358657|21014331|P1|STARTED|Overall Study||14
8525640|NCT00358644|21014343|P1|NOT COMPLETED|Overall Study||50
8525641|NCT00358644|21014343|P1|COMPLETED|Overall Study||5
8525642|NCT00358644|21014343|P1|STARTED|Overall Study||55
8525643|NCT00358579|21014349|P2|NOT COMPLETED|Overall Study||0
8525644|NCT00358579|21014350|P1|NOT COMPLETED|Overall Study||0
8525645|NCT00358579|21014349|P2|COMPLETED|Overall Study||374
8525646|NCT00358579|21014350|P1|COMPLETED|Overall Study||353
8525647|NCT00358579|21014349|P2|STARTED|Overall Study||374
8525648|NCT00358579|21014350|P1|STARTED|Overall Study||353
8525649|NCT00358527|21014366|P2|NOT COMPLETED|Overall Study||3
8525650|NCT00358527|21014367|P1|NOT COMPLETED|Overall Study||13
8525651|NCT00358527|21014366|P2|COMPLETED|Overall Study||131
8525652|NCT00358527|21014367|P1|COMPLETED|Overall Study||254
8525653|NCT00358527|21014366|P2|STARTED|Overall Study||134
8525654|NCT00358527|21014367|P1|STARTED|Overall Study||267
8525655|NCT00358501|21014377|P2|NOT COMPLETED|Overall Study||0
8525656|NCT00358501|21014378|P1|NOT COMPLETED|Overall Study||0
8525657|NCT00358501|21014377|P2|COMPLETED|Overall Study||32
8525658|NCT00358501|21014378|P1|COMPLETED|Overall Study||102
8525659|NCT00358501|21014377|P2|STARTED|Overall Study||32
8525660|NCT00358501|21014378|P1|STARTED|Overall Study||102
8525661|NCT00358462|21014393|P2|NOT COMPLETED|Overall Study||64
8525662|NCT00358462|21014394|P1|NOT COMPLETED|Overall Study||59
8525663|NCT00358462|21014393|P2|COMPLETED|Overall Study||238
8525664|NCT00358462|21014394|P1|COMPLETED|Overall Study||245
8525665|NCT00358462|21014393|P2|STARTED|Overall Study||302
8525666|NCT00358462|21014394|P1|STARTED|Overall Study||304
8525667|NCT00358449|21014417|P3|NOT COMPLETED|Overall Study||2
8525668|NCT00358449|21014418|P2|NOT COMPLETED|Overall Study||1
8525669|NCT00358449|21014419|P1|NOT COMPLETED|Overall Study||4
8525670|NCT00358449|21014417|P3|COMPLETED|Overall Study||18
8525671|NCT00358449|21014418|P2|COMPLETED|Overall Study||19
8525672|NCT00358449|21014419|P1|COMPLETED|Overall Study||15
8525673|NCT00358449|21014417|P3|STARTED|Overall Study||20
8525674|NCT00358449|21014418|P2|STARTED|Overall Study||20
8525675|NCT00358449|21014419|P1|STARTED|Overall Study||19
8525676|NCT00358436|21014522|P2|NOT COMPLETED|Overall Study||86
8525677|NCT00358436|21014523|P1|NOT COMPLETED|Overall Study||154
8525678|NCT00358436|21014522|P2|COMPLETED|Overall Study||118
8525679|NCT00358436|21014523|P1|COMPLETED|Overall Study||446
8525680|NCT00358436|21014522|P2|STARTED|Overall Study||204
8525681|NCT00358436|21014523|P1|STARTED|Overall Study||600
8525682|NCT00358332|21014539|P4|NOT COMPLETED|Overall Study||0
8525683|NCT00358332|21014540|P3|NOT COMPLETED|Overall Study||1
8525684|NCT00358332|21014541|P2|NOT COMPLETED|Overall Study||3
8525685|NCT00358332|21014542|P1|NOT COMPLETED|Overall Study||0
8525686|NCT00358332|21014539|P4|COMPLETED|Overall Study||25
8525687|NCT00358332|21014540|P3|COMPLETED|Overall Study||29
8525688|NCT00358332|21014541|P2|COMPLETED|Overall Study||27
8525689|NCT00358332|21014542|P1|COMPLETED|Overall Study||15
8525690|NCT00358332|21014539|P4|STARTED|Overall Study||25
8525691|NCT00358332|21014540|P3|STARTED|Overall Study||30
8525692|NCT00358332|21014541|P2|STARTED|Overall Study||30
8525693|NCT00358332|21014542|P1|STARTED|Overall Study||15
8525694|NCT00358215|21014594|P2|NOT COMPLETED|Overall Study||652
8525695|NCT00358215|21014595|P1|NOT COMPLETED|Overall Study||679
8525696|NCT00358215|21014594|P2|COMPLETED|Overall Study|Participants who completed investigational product|484
8525697|NCT00358215|21014595|P1|COMPLETED|Overall Study|Participants who completed investigational product|463
8525698|NCT00358215|21014594|P2|Received Investigational Product|Overall Study||1133
8525699|NCT00358215|21014595|P1|Received Investigational Product|Overall Study||1140
8525700|NCT00358215|21014594|P2|STARTED|Overall Study||1136
8525701|NCT00358215|21014595|P1|STARTED|Overall Study||1142
8525702|NCT00358150|21014609|P1|NOT COMPLETED|Overall Study||7
8525703|NCT00358150|21014609|P1|COMPLETED|Overall Study||19
8525704|NCT00358150|21014609|P1|STARTED|Overall Study||26
8525705|NCT00358007|21014631|P1|NOT COMPLETED|Overall Study||2
8525706|NCT00358007|21014631|P1|COMPLETED|Overall Study||28
8525707|NCT00358007|21014631|P1|STARTED|Overall Study||30
8525708|NCT00357994|21014638|P2|NOT COMPLETED|Overall Study||3
8525709|NCT00357994|21014639|P1|NOT COMPLETED|Overall Study||2
8525710|NCT00357994|21014638|P2|COMPLETED|Overall Study||31
8525711|NCT00357994|21014639|P1|COMPLETED|Overall Study||35
8525712|NCT00357994|21014638|P2|STARTED|Overall Study||34
8525713|NCT00357994|21014639|P1|STARTED|Overall Study||37
8525714|NCT00357968|21014693|P2|NOT COMPLETED|Crossover Maintenance Dose Phase||0
8525715|NCT00357968|21014694|P1|NOT COMPLETED|Crossover Maintenance Dose Phase||0
8525716|NCT00357968|21014693|P2|COMPLETED|Crossover Maintenance Dose Phase||55
8525717|NCT00357968|21014694|P1|COMPLETED|Crossover Maintenance Dose Phase||54
8525718|NCT00357968|21014693|P2|STARTED|Crossover Maintenance Dose Phase||55
8525719|NCT00357968|21014694|P1|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
8525720|NCT00357968|21014693|P2|NOT COMPLETED|First Maintenance Dose Phase||44
8525721|NCT00357968|21014694|P1|NOT COMPLETED|First Maintenance Dose Phase||48
8525722|NCT00357968|21014693|P2|COMPLETED|First Maintenance Dose Phase||55
8525723|NCT00357968|21014694|P1|COMPLETED|First Maintenance Dose Phase||54
8525724|NCT00357968|21014693|P2|Started Maintenance Dose|First Maintenance Dose Phase||55
8525725|NCT00357968|21014694|P1|Started Maintenance Dose|First Maintenance Dose Phase||55
8525726|NCT00357968|21014693|P2|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
8525727|NCT00357968|21014694|P1|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
8525728|NCT00357968|21014693|P2|Received Loading Dose|First Maintenance Dose Phase||99
8525729|NCT00357968|21014694|P1|Received Loading Dose|First Maintenance Dose Phase||102
8525730|NCT00357968|21014693|P2|STARTED|First Maintenance Dose Phase||99
8525731|NCT00357968|21014694|P1|STARTED|First Maintenance Dose Phase||102
8525732|NCT00357955|21014738|P2|NOT COMPLETED|Overall Study||3
8525733|NCT00357955|21014739|P1|NOT COMPLETED|Overall Study||6
8525734|NCT00357955|21014738|P2|COMPLETED|Overall Study||51
8525735|NCT00357955|21014739|P1|COMPLETED|Overall Study||58
8525736|NCT00357955|21014738|P2|STARTED|Overall Study||54
8525737|NCT00357955|21014739|P1|STARTED|Overall Study||64
8525738|NCT00357903|21014747|P2|NOT COMPLETED|Overall Study||43
8525739|NCT00357903|21014748|P1|NOT COMPLETED|Overall Study||363
8525740|NCT00357903|21014747|P2|COMPLETED|Overall Study||15
8525741|NCT00357903|21014748|P1|COMPLETED|Overall Study||218
8525742|NCT00357903|21014747|P2|STARTED|Overall Study||58
8525743|NCT00357903|21014748|P1|STARTED|Overall Study||581
8525744|NCT00357877|21014788|P2|NOT COMPLETED|Overall Study||30
8525745|NCT00357877|21014789|P1|NOT COMPLETED|Overall Study||26
8525746|NCT00357877|21014788|P2|COMPLETED|Overall Study||460
8525747|NCT00357877|21014789|P1|COMPLETED|Overall Study||467
8525748|NCT00357877|21014788|P2|STARTED|Overall Study||490
8525749|NCT00357877|21014789|P1|STARTED|Overall Study||493
8525750|NCT00357760|21014803|P2|NOT COMPLETED|Overall Study||35
8525751|NCT00357760|21014804|P1|NOT COMPLETED|Overall Study||59
8525752|NCT00357760|21014803|P2|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
8525753|NCT00357760|21014804|P1|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
8525754|NCT00357760|21014803|P2|Patients Who Undergo Dose Escalation|Overall Study||16
8525755|NCT00357760|21014804|P1|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
8525756|NCT00357760|21014803|P2|Eligible and Treated Patients|Overall Study||32
8525757|NCT00357760|21014804|P1|Eligible and Treated Patients|Overall Study||57
8525758|NCT00357760|21014803|P2|Patients Who Started Treatment|Overall Study||34
8525759|NCT00357760|21014804|P1|Patients Who Started Treatment|Overall Study||57
8525760|NCT00357760|21014803|P2|STARTED|Overall Study||35
8525761|NCT00357760|21014804|P1|STARTED|Overall Study||59
8525762|NCT00357734|21014814|P1|NOT COMPLETED|Overall Study||4
8525763|NCT00357734|21014814|P1|COMPLETED|Overall Study||10
8525764|NCT00357734|21014814|P1|Patient Received 500 mg of ZD1839|Overall Study||1
8525765|NCT00357734|21014814|P1|Patients Received 250 mg of ZD1839|Overall Study||13
8525766|NCT00357734|21014814|P1|STARTED|Overall Study||14
8525773|NCT00357552|21014877|P1|NOT COMPLETED|Weeks 24 to 104||5
8525774|NCT00357552|21014877|P1|COMPLETED|Weeks 24 to 104||117
8525775|NCT00357552|21014877|P1|STARTED|Weeks 24 to 104||122
8525776|NCT00357552|21014877|P1|NOT COMPLETED|Weeks 0 to 24||1
8525777|NCT00357552|21014877|P1|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
8525778|NCT00357552|21014877|P1|STARTED|Weeks 0 to 24||123
8525779|NCT00357552|21014877|P1|NOT COMPLETED|Screening||84
8525780|NCT00357552|21014877|P1|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
8525781|NCT00357552|21014877|P1|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
8525782|NCT00357500|21014892|P1|NOT COMPLETED|Overall Study||77
8525783|NCT00357500|21014892|P1|COMPLETED|Overall Study||24
8525784|NCT00357500|21014892|P1|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
8525785|NCT00357500|21014892|P1|STARTED|Overall Study||101
8525786|NCT00357396|21014901|P2|NOT COMPLETED|Overall Study||0
8525787|NCT00357396|21014902|P1|NOT COMPLETED|Overall Study||1
8525788|NCT00357396|21014901|P2|COMPLETED|Overall Study||4
8525789|NCT00357396|21014902|P1|COMPLETED|Overall Study||5
8525790|NCT00357396|21014901|P2|STARTED|Overall Study||4
8525791|NCT00357396|21014902|P1|STARTED|Overall Study||6
8525792|NCT00357370|21014910|P3|NOT COMPLETED|Cohort 2||2
8525793|NCT00357370|21014911|P2|NOT COMPLETED|Cohort 2||7
8525794|NCT00357370|21014912|P1|NOT COMPLETED|Cohort 2||2
8525795|NCT00357370|21014910|P3|COMPLETED|Cohort 2||22
8525796|NCT00357370|21014911|P2|COMPLETED|Cohort 2||16
8525797|NCT00357370|21014912|P1|COMPLETED|Cohort 2||22
8525798|NCT00357370|21014910|P3|STARTED|Cohort 2||24
8525799|NCT00357370|21014911|P2|STARTED|Cohort 2||23
8525800|NCT00357370|21014912|P1|STARTED|Cohort 2||24
8525801|NCT00357370|21014910|P3|NOT COMPLETED|Cohort 1||0
8525802|NCT00357370|21014911|P2|NOT COMPLETED|Cohort 1||0
8525803|NCT00357370|21014912|P1|NOT COMPLETED|Cohort 1||0
8525804|NCT00357370|21014910|P3|COMPLETED|Cohort 1||0
8525805|NCT00357370|21014911|P2|COMPLETED|Cohort 1||0
8525806|NCT00357370|21014912|P1|COMPLETED|Cohort 1||4
8525807|NCT00357370|21014910|P3|STARTED|Cohort 1||0
8525808|NCT00357370|21014911|P2|STARTED|Cohort 1||0
8525809|NCT00357370|21014912|P1|STARTED|Cohort 1||4
8525810|NCT00357331|21014937|P2|NOT COMPLETED|Overall Study||0
8525811|NCT00357331|21014938|P1|NOT COMPLETED|Overall Study||0
8525812|NCT00357331|21014937|P2|COMPLETED|Overall Study||41
8525813|NCT00357331|21014938|P1|COMPLETED|Overall Study||42
8525814|NCT00357331|21014937|P2|STARTED|Overall Study||41
8525815|NCT00357331|21014938|P1|STARTED|Overall Study||42
8525816|NCT00357214|21014952|P4|NOT COMPLETED|Overall Study||1
8525817|NCT00357214|21014953|P3|NOT COMPLETED|Overall Study||0
8525818|NCT00357214|21014954|P2|NOT COMPLETED|Overall Study||4
8525819|NCT00357214|21014955|P1|NOT COMPLETED|Overall Study||4
8525820|NCT00357214|21014952|P4|COMPLETED|Overall Study||42
8525821|NCT00357214|21014953|P3|COMPLETED|Overall Study||42
8525822|NCT00357214|21014954|P2|COMPLETED|Overall Study||39
8525823|NCT00357214|21014955|P1|COMPLETED|Overall Study||39
8525824|NCT00357214|21014952|P4|STARTED|Overall Study||43
8525825|NCT00357214|21014953|P3|STARTED|Overall Study||42
8525826|NCT00357214|21014954|P2|STARTED|Overall Study||43
8525827|NCT00357214|21014955|P1|STARTED|Overall Study||43
8525828|NCT00357162|21014965|P1|NOT COMPLETED|Overall Study||0
8525829|NCT00357162|21014965|P1|COMPLETED|Overall Study||21
8525830|NCT00357162|21014965|P1|STARTED|Overall Study||21
8525831|NCT00357110|21014975|P2|NOT COMPLETED|Overall Study||5
8525832|NCT00357110|21014976|P1|NOT COMPLETED|Overall Study||5
8525833|NCT00357110|21014975|P2|COMPLETED|Overall Study||2
8525834|NCT00357110|21014976|P1|COMPLETED|Overall Study||1
8525835|NCT00357110|21014975|P2|STARTED|Overall Study||7
8525836|NCT00357110|21014976|P1|STARTED|Overall Study||6
8525837|NCT00357097|21014984|P2|NOT COMPLETED|Overall Study||29
8525838|NCT00357097|21014985|P1|NOT COMPLETED|Overall Study||54
8525839|NCT00357097|21014984|P2|COMPLETED|Overall Study||38
8525840|NCT00357097|21014985|P1|COMPLETED|Overall Study||145
8525841|NCT00357097|21014984|P2|STARTED|Overall Study||67
8525842|NCT00357097|21014985|P1|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
8525843|NCT00357032|21015029|P1|NOT COMPLETED|Overall Study||0
8525844|NCT00357032|21015029|P1|COMPLETED|Overall Study||12
8525845|NCT00357032|21015029|P1|STARTED|Overall Study||12
8525846|NCT00357006|21015039|P3|NOT COMPLETED|Overall Study||3
8525847|NCT00357006|21015040|P2|NOT COMPLETED|Overall Study||5
8525848|NCT00357006|21015041|P1|NOT COMPLETED|Overall Study||2
8525849|NCT00357006|21015039|P3|COMPLETED|Overall Study||59
8525850|NCT00357006|21015040|P2|COMPLETED|Overall Study||51
8525851|NCT00357006|21015041|P1|COMPLETED|Overall Study||60
8525852|NCT00357006|21015039|P3|STARTED|Overall Study||62
8525853|NCT00357006|21015040|P2|STARTED|Overall Study||56
8525854|NCT00357006|21015041|P1|STARTED|Overall Study||62
8525855|NCT00356993|21015049|P1|NOT COMPLETED|Overall Study||3921
8525856|NCT00356993|21015049|P1|COMPLETED|Overall Study||2088
8525857|NCT00356993|21015049|P1|STARTED|Overall Study||6009
8525858|NCT00356915|21015056|P3|NOT COMPLETED|Overall Study||42
8525859|NCT00356915|21015057|P2|NOT COMPLETED|Overall Study||94
8525860|NCT00356915|21015058|P1|NOT COMPLETED|Overall Study||76
8525861|NCT00356915|21015056|P3|COMPLETED|Overall Study||156
8525862|NCT00356915|21015057|P2|COMPLETED|Overall Study||496
8525863|NCT00356915|21015058|P1|COMPLETED|Overall Study||517
8525864|NCT00356915|21015056|P3|STARTED|Overall Study||198
8525865|NCT00356915|21015057|P2|STARTED|Overall Study||590
8525866|NCT00356915|21015058|P1|STARTED|Overall Study||593
8525867|NCT00356889|21015075|P1|NOT COMPLETED|Overall Study||3
8525868|NCT00356889|21015075|P1|COMPLETED|Overall Study||53
8525869|NCT00356889|21015075|P1|STARTED|Overall Study||56
8525870|NCT00356863|21015084|P2|NOT COMPLETED|Overall Study||75
8525871|NCT00356863|21015085|P1|NOT COMPLETED|Overall Study||92
8525872|NCT00356863|21015084|P2|COMPLETED|Overall Study||445
8525873|NCT00356863|21015085|P1|COMPLETED|Overall Study||412
8525874|NCT00356863|21015084|P2|STARTED|Overall Study||520
8525875|NCT00356863|21015085|P1|STARTED|Overall Study||504
8525876|NCT00356811|21015111|P1|NOT COMPLETED|Overall Study||49
8525877|NCT00356811|21015111|P1|COMPLETED|Overall Study||8
8525878|NCT00356811|21015111|P1|STARTED|Overall Study||57
8525879|NCT00356759|21015126|P2|NOT COMPLETED|Overall Study||10
8525880|NCT00356759|21015127|P1|NOT COMPLETED|Overall Study||14
8525881|NCT00356759|21015126|P2|COMPLETED|Overall Study||114
8525882|NCT00356759|21015127|P1|COMPLETED|Overall Study||112
8525883|NCT00356759|21015126|P2|STARTED|Overall Study||124
8525884|NCT00356759|21015127|P1|STARTED|Overall Study||126
8525885|NCT00356603|21015145|P2|NOT COMPLETED|Overall Study||3
8525886|NCT00356603|21015146|P1|NOT COMPLETED|Overall Study||6
8525887|NCT00356603|21015145|P2|COMPLETED|Overall Study||33
8525888|NCT00356603|21015146|P1|COMPLETED|Overall Study||33
8525889|NCT00356603|21015145|P2|STARTED|Overall Study||36
8525890|NCT00356603|21015146|P1|STARTED|Overall Study||39
8525891|NCT00356590|21015160|P1|NOT COMPLETED|Overall Study||274
8525892|NCT00356590|21015160|P1|COMPLETED|Overall Study||194
8525893|NCT00356590|21015160|P1|STARTED|Overall Study||468
8525894|NCT00356525|21015196|P4|NOT COMPLETED|Overall Study||9
8525895|NCT00356525|21015197|P3|NOT COMPLETED|Overall Study||7
8525896|NCT00356525|21015198|P2|NOT COMPLETED|Overall Study||11
8525897|NCT00356525|21015199|P1|NOT COMPLETED|Overall Study||14
8525898|NCT00356525|21015196|P4|COMPLETED|Overall Study||0
8525899|NCT00356525|21015197|P3|COMPLETED|Overall Study||0
8525900|NCT00356525|21015198|P2|COMPLETED|Overall Study||0
8525901|NCT00356525|21015199|P1|COMPLETED|Overall Study||0
8525902|NCT00356525|21015196|P4|STARTED|Overall Study||9
8525903|NCT00356525|21015197|P3|STARTED|Overall Study||7
8525904|NCT00356525|21015198|P2|STARTED|Overall Study||11
8525905|NCT00356525|21015199|P1|STARTED|Overall Study||14
8525906|NCT00356434|21015227|P2|NOT COMPLETED|Overall Study||0
8525907|NCT00356434|21015228|P1|NOT COMPLETED|Overall Study||0
8525908|NCT00356434|21015227|P2|COMPLETED|Overall Study||7
8525909|NCT00356434|21015228|P1|COMPLETED|Overall Study||4
8525910|NCT00356434|21015227|P2|STARTED|Overall Study||7
8525911|NCT00356434|21015228|P1|STARTED|Overall Study||4
8525912|NCT00356421|21015240|P2|NOT COMPLETED|Overall Study||17
8525913|NCT00356421|21015241|P1|NOT COMPLETED|Overall Study||32
8525914|NCT00356421|21015240|P2|COMPLETED|Overall Study||3
8525915|NCT00356421|21015241|P1|COMPLETED|Overall Study||6
8525916|NCT00356421|21015240|P2|STARTED|Overall Study||20
8525917|NCT00356421|21015241|P1|STARTED|Overall Study||38
8525918|NCT00356408|21015281|P1|NOT COMPLETED|Overall Study||60
8525919|NCT00356408|21015281|P1|COMPLETED|Overall Study||43
8525920|NCT00356408|21015281|P1|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
8525921|NCT00356369|21015298|P2|NOT COMPLETED|Year 5||0
8525922|NCT00356369|21015299|P1|NOT COMPLETED|Year 5||0
8525923|NCT00356369|21015298|P2|COMPLETED|Year 5||105
8525924|NCT00356369|21015299|P1|COMPLETED|Year 5||299
8525925|NCT00356369|21015298|P2|STARTED|Year 5||105
8525926|NCT00356369|21015299|P1|STARTED|Year 5||299
8525927|NCT00356369|21015298|P2|NOT COMPLETED|Year 4||0
8525928|NCT00356369|21015299|P1|NOT COMPLETED|Year 4||0
8525929|NCT00356369|21015298|P2|COMPLETED|Year 4||109
8525930|NCT00356369|21015299|P1|COMPLETED|Year 4||317
8525931|NCT00356369|21015298|P2|STARTED|Year 4||109
8525932|NCT00356369|21015299|P1|STARTED|Year 4||317
8525933|NCT00356369|21015298|P2|NOT COMPLETED|Year 3||0
8525934|NCT00356369|21015299|P1|NOT COMPLETED|Year 3||0
8525935|NCT00356369|21015298|P2|COMPLETED|Year 3||116
8525936|NCT00356369|21015299|P1|COMPLETED|Year 3||344
8525937|NCT00356369|21015298|P2|STARTED|Year 3||116
8525938|NCT00356369|21015299|P1|STARTED|Year 3||344
8525939|NCT00356369|21015298|P2|NOT COMPLETED|Year 2||0
8525940|NCT00356369|21015299|P1|NOT COMPLETED|Year 2||0
8525941|NCT00356369|21015298|P2|COMPLETED|Year 2||117
8525942|NCT00356369|21015299|P1|COMPLETED|Year 2||354
8525943|NCT00356369|21015298|P2|STARTED|Year 2||117
8525944|NCT00356369|21015299|P1|STARTED|Year 2||354
8525945|NCT00356369|21015298|P2|NOT COMPLETED|Year 1||0
8525946|NCT00356369|21015299|P1|NOT COMPLETED|Year 1||0
8525947|NCT00356369|21015298|P2|COMPLETED|Year 1||121
8525948|NCT00356369|21015299|P1|COMPLETED|Year 1||364
8525949|NCT00356369|21015298|P2|STARTED|Year 1||121
8525950|NCT00356369|21015299|P1|STARTED|Year 1||364
8525951|NCT00356369|21015298|P2|NOT COMPLETED|Active Phase||1
8525952|NCT00356369|21015299|P1|NOT COMPLETED|Active Phase||2
8525953|NCT00356369|21015298|P2|COMPLETED|Active Phase||125
8525954|NCT00356369|21015299|P1|COMPLETED|Active Phase||372
8525955|NCT00356369|21015298|P2|STARTED|Active Phase||126
8525956|NCT00356369|21015299|P1|STARTED|Active Phase||374
8525957|NCT00356304|21015369|P2|NOT COMPLETED|Overall Study||4
8525958|NCT00356304|21015370|P1|NOT COMPLETED|Overall Study||2
8525959|NCT00356304|21015369|P2|COMPLETED|Overall Study||20
8525960|NCT00356304|21015370|P1|COMPLETED|Overall Study||24
8525961|NCT00356304|21015369|P2|STARTED|Overall Study||24
8525962|NCT00356304|21015370|P1|STARTED|Overall Study||26
8525963|NCT00356278|21015381|P3|NOT COMPLETED|Overall Study||19
8525964|NCT00356278|21015382|P2|NOT COMPLETED|Overall Study||15
8525965|NCT00356278|21015383|P1|NOT COMPLETED|Overall Study||25
8525966|NCT00356278|21015381|P3|COMPLETED|Overall Study||34
8525967|NCT00356278|21015382|P2|COMPLETED|Overall Study||35
8525968|NCT00356278|21015383|P1|COMPLETED|Overall Study||28
8525969|NCT00356278|21015381|P3|STARTED|Overall Study||53
8525970|NCT00356278|21015382|P2|STARTED|Overall Study||50
8525971|NCT00356278|21015383|P1|STARTED|Overall Study||53
8525972|NCT00356265|21015421|P3|NOT COMPLETED|Overall Study||1
8525973|NCT00356265|21015422|P2|NOT COMPLETED|Overall Study||0
8525974|NCT00356265|21015423|P1|NOT COMPLETED|Overall Study||0
8525975|NCT00356265|21015421|P3|COMPLETED|Overall Study||5
8525976|NCT00356265|21015422|P2|COMPLETED|Overall Study||2
8525977|NCT00356265|21015423|P1|COMPLETED|Overall Study||7
8525978|NCT00356265|21015421|P3|STARTED|Overall Study||6
8525979|NCT00356265|21015422|P2|STARTED|Overall Study||2
8525980|NCT00356265|21015423|P1|STARTED|Overall Study||7
8525981|NCT00356200|21015435|P2|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
8525982|NCT00356200|21015436|P1|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
8525983|NCT00356200|21015435|P2|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
8525984|NCT00356200|21015436|P1|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
8525985|NCT00356200|21015435|P2|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
8525986|NCT00356200|21015436|P1|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
8525987|NCT00356200|21015435|P2|NOT COMPLETED|Cohort 1: 10 ug/ml||0
8525988|NCT00356200|21015436|P1|NOT COMPLETED|Cohort 1: 10 ug/ml||1
8525989|NCT00356200|21015435|P2|COMPLETED|Cohort 1: 10 ug/ml||0
8525990|NCT00356200|21015436|P1|COMPLETED|Cohort 1: 10 ug/ml||4
8525991|NCT00356200|21015435|P2|STARTED|Cohort 1: 10 ug/ml||0
8525992|NCT00356200|21015436|P1|STARTED|Cohort 1: 10 ug/ml||5
8525993|NCT00356187|21015450|P2|NOT COMPLETED|Overall Study||0
8525994|NCT00356187|21015451|P1|NOT COMPLETED|Overall Study||0
8525995|NCT00356187|21015450|P2|COMPLETED|Overall Study||0
8525996|NCT00356187|21015451|P1|COMPLETED|Overall Study||0
8525997|NCT00356187|21015450|P2|STARTED|Overall Study||0
8525998|NCT00356187|21015451|P1|STARTED|Overall Study||0
8525999|NCT00356148|21015465|P2|NOT COMPLETED|Overall Study||1
8526000|NCT00356148|21015466|P1|NOT COMPLETED|Overall Study||2
8526001|NCT00356148|21015465|P2|COMPLETED|Overall Study||182
8526002|NCT00356148|21015466|P1|COMPLETED|Overall Study||187
8526003|NCT00356148|21015465|P2|STARTED|Overall Study||183
8526004|NCT00356148|21015466|P1|STARTED|Overall Study||189
8526005|NCT00356135|21015477|P3|NOT COMPLETED|Overall Study||5
8526006|NCT00356135|21015478|P2|NOT COMPLETED|Overall Study||2
8526007|NCT00356135|21015479|P1|NOT COMPLETED|Overall Study||4
8526008|NCT00356135|21015477|P3|COMPLETED|Overall Study||39
8526009|NCT00356135|21015478|P2|COMPLETED|Overall Study||46
8526010|NCT00356135|21015479|P1|COMPLETED|Overall Study||43
8526011|NCT00356135|21015477|P3|STARTED|Overall Study||44
8526012|NCT00356135|21015478|P2|STARTED|Overall Study||48
8526013|NCT00356135|21015479|P1|STARTED|Overall Study||47
8526014|NCT00356122|21015501|P1|NOT COMPLETED|FOLLOW-UP||41
8526015|NCT00356122|21015501|P1|COMPLETED|FOLLOW-UP||12
8526016|NCT00356122|21015501|P1|STARTED|FOLLOW-UP||53
8526017|NCT00356122|21015501|P1|NOT COMPLETED|TREATMENT||45
8526018|NCT00356122|21015501|P1|COMPLETED|TREATMENT||8
8526019|NCT00356122|21015501|P1|STARTED|TREATMENT||53
8526020|NCT00356057|21015512|P3|NOT COMPLETED|Overall Study||12
8526021|NCT00356057|21015513|P2|NOT COMPLETED|Overall Study||14
8526022|NCT00356057|21015514|P1|NOT COMPLETED|Overall Study||13
8526023|NCT00356057|21015512|P3|COMPLETED|Overall Study||22
8526024|NCT00356057|21015513|P2|COMPLETED|Overall Study||47
8526025|NCT00356057|21015514|P1|COMPLETED|Overall Study||45
8526026|NCT00356057|21015512|P3|IMPLANTED|Overall Study||25
8526027|NCT00356057|21015513|P2|IMPLANTED|Overall Study||52
8526028|NCT00356057|21015514|P1|IMPLANTED|Overall Study||49
8526029|NCT00356057|21015512|P3|STARTED|Overall Study||34
8526030|NCT00356057|21015513|P2|STARTED|Overall Study||61
8526031|NCT00356057|21015514|P1|STARTED|Overall Study||58
8526032|NCT00356031|21015552|P1|NOT COMPLETED|Overall Study||0
8526033|NCT00356031|21015552|P1|COMPLETED|Overall Study||20
8526034|NCT00356031|21015552|P1|STARTED|Overall Study||20
8526035|NCT00355914|21015563|P2|NOT COMPLETED|Overall Study||0
8526036|NCT00355914|21015564|P1|NOT COMPLETED|Overall Study||0
8526037|NCT00355914|21015563|P2|COMPLETED|Overall Study||60
8526038|NCT00355914|21015564|P1|COMPLETED|Overall Study||60
8526039|NCT00355914|21015563|P2|STARTED|Overall Study||60
8526040|NCT00355914|21015564|P1|STARTED|Overall Study||60
8526041|NCT00355797|21015575|P3|NOT COMPLETED|Overall Study||142
8526042|NCT00355797|21015576|P2|NOT COMPLETED|Overall Study||148
8526043|NCT00355797|21015577|P1|NOT COMPLETED|Overall Study||240
8526044|NCT00355797|21015575|P3|COMPLETED|Overall Study||239
8526045|NCT00355797|21015576|P2|COMPLETED|Overall Study||221
8526046|NCT00355797|21015577|P1|COMPLETED|Overall Study||501
8526047|NCT00355797|21015575|P3|STARTED|Overall Study||381
8526048|NCT00355797|21015576|P2|STARTED|Overall Study||369
8526049|NCT00355797|21015577|P1|STARTED|Overall Study||741
8526050|NCT00355784|21015609|P3|NOT COMPLETED|Overall Study||2
8526051|NCT00355784|21015610|P2|NOT COMPLETED|Overall Study||0
8526052|NCT00355784|21015611|P1|NOT COMPLETED|Overall Study||0
8526053|NCT00355784|21015609|P3|COMPLETED|Overall Study||5
8526054|NCT00355784|21015610|P2|COMPLETED|Overall Study||8
8526055|NCT00355784|21015611|P1|COMPLETED|Overall Study||9
8526056|NCT00355784|21015609|P3|STARTED|Overall Study||7
8526057|NCT00355784|21015610|P2|STARTED|Overall Study||8
8526058|NCT00355784|21015611|P1|STARTED|Overall Study||9
8526059|NCT00355706|21015645|P2|NOT COMPLETED|Overall Study||0
8526060|NCT00355706|21015646|P1|NOT COMPLETED|Overall Study||0
8526061|NCT00355706|21015645|P2|COMPLETED|Overall Study||50
8526062|NCT00355706|21015646|P1|COMPLETED|Overall Study||50
8526063|NCT00355706|21015645|P2|STARTED|Overall Study||50
8526064|NCT00355706|21015646|P1|STARTED|Overall Study||50
8526065|NCT00355615|21015660|P5|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
8526066|NCT00355615|21015661|P4|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
8526067|NCT00355615|21015662|P3|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
8526068|NCT00355615|21015663|P2|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
8526069|NCT00355615|21015664|P1|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
8526070|NCT00355615|21015660|P5|COMPLETED|40-week Rosuvastatin Open Label Period||164
8526071|NCT00355615|21015661|P4|COMPLETED|40-week Rosuvastatin Open Label Period||0
8526072|NCT00355615|21015662|P3|COMPLETED|40-week Rosuvastatin Open Label Period||0
8526073|NCT00355615|21015663|P2|COMPLETED|40-week Rosuvastatin Open Label Period||0
8526074|NCT00355615|21015664|P1|COMPLETED|40-week Rosuvastatin Open Label Period||0
8526075|NCT00355615|21015660|P5|STARTED|40-week Rosuvastatin Open Label Period||173
8526076|NCT00355615|21015661|P4|STARTED|40-week Rosuvastatin Open Label Period||0
8526077|NCT00355615|21015662|P3|STARTED|40-week Rosuvastatin Open Label Period||0
8526078|NCT00355615|21015663|P2|STARTED|40-week Rosuvastatin Open Label Period||0
8526079|NCT00355615|21015664|P1|STARTED|40-week Rosuvastatin Open Label Period||0
8526080|NCT00355615|21015660|P5|NOT COMPLETED|Randomized Double Blind Period||0
8526081|NCT00355615|21015661|P4|NOT COMPLETED|Randomized Double Blind Period||1
8526082|NCT00355615|21015662|P3|NOT COMPLETED|Randomized Double Blind Period||1
8526083|NCT00355615|21015663|P2|NOT COMPLETED|Randomized Double Blind Period||0
8526084|NCT00355615|21015664|P1|NOT COMPLETED|Randomized Double Blind Period||1
8526085|NCT00355615|21015660|P5|COMPLETED|Randomized Double Blind Period||0
8526086|NCT00355615|21015661|P4|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
8526087|NCT00355615|21015662|P3|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
8526088|NCT00355615|21015663|P2|COMPLETED|Randomized Double Blind Period||44
8526089|NCT00355615|21015664|P1|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
8526090|NCT00355615|21015660|P5|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
8526091|NCT00355615|21015661|P4|STARTED|Randomized Double Blind Period||46
8526092|NCT00355615|21015662|P3|STARTED|Randomized Double Blind Period||45
8526093|NCT00355615|21015663|P2|STARTED|Randomized Double Blind Period||44
8526094|NCT00355615|21015664|P1|STARTED|Randomized Double Blind Period||42
8526095|NCT00355472|21015723|P1|NOT COMPLETED|Overall Study||1
8526096|NCT00355472|21015723|P1|COMPLETED|Overall Study||15
8526097|NCT00355472|21015723|P1|STARTED|Overall Study||16
8526098|NCT00355394|21015750|P2|NOT COMPLETED|Overall Study||0
8526099|NCT00355394|21015751|P1|NOT COMPLETED|Overall Study||0
8526100|NCT00355394|21015750|P2|COMPLETED|Overall Study||16
8526101|NCT00355394|21015751|P1|COMPLETED|Overall Study||15
8526102|NCT00355394|21015750|P2|STARTED|Overall Study||16
8526103|NCT00355394|21015751|P1|STARTED|Overall Study||15
8526104|NCT00355368|21015769|P2|NOT COMPLETED|Overall Study||9
8526105|NCT00355368|21015770|P1|NOT COMPLETED|Overall Study||10
8526106|NCT00355368|21015769|P2|COMPLETED|Overall Study||201
8526107|NCT00355368|21015770|P1|COMPLETED|Overall Study||200
8526108|NCT00355368|21015769|P2|STARTED|Overall Study||210
8526109|NCT00355368|21015770|P1|STARTED|Overall Study||210
8526110|NCT00355342|21015784|P2|NOT COMPLETED|Overall Study||36
8526111|NCT00355342|21015785|P1|NOT COMPLETED|Overall Study||39
8526112|NCT00355342|21015784|P2|COMPLETED|Overall Study||56
8526113|NCT00355342|21015785|P1|COMPLETED|Overall Study||55
8526114|NCT00355342|21015784|P2|STARTED|Overall Study||92
8526115|NCT00355342|21015785|P1|STARTED|Overall Study||94
8526116|NCT00355264|21015793|P1|NOT COMPLETED|Extension (Variable Duration)||2
8526117|NCT00355264|21015793|P1|COMPLETED|Extension (Variable Duration)||10
8526118|NCT00355264|21015793|P1|STARTED|Extension (Variable Duration)||12
8526119|NCT00355264|21015793|P1|NOT COMPLETED|Part 3 (7 Weeks of Extension)||0
8526120|NCT00355264|21015793|P1|COMPLETED|Part 3 (7 Weeks of Extension)||2
8526121|NCT00355264|21015793|P1|STARTED|Part 3 (7 Weeks of Extension)||2
8526122|NCT00355264|21015793|P1|NOT COMPLETED|Part 2 (8 Weeks)||0
8526123|NCT00355264|21015793|P1|COMPLETED|Part 2 (8 Weeks)||12
8526124|NCT00355264|21015793|P1|STARTED|Part 2 (8 Weeks)||12
8526125|NCT00355264|21015793|P1|NOT COMPLETED|Part 1 (2 Weeks)||0
8526126|NCT00355264|21015793|P1|COMPLETED|Part 1 (2 Weeks)||12
8526127|NCT00355264|21015793|P1|STARTED|Part 1 (2 Weeks)||12
8526128|NCT00355199|21015804|P2|NOT COMPLETED|Overall Study||4
8526129|NCT00355199|21015805|P1|NOT COMPLETED|Overall Study||7
8526130|NCT00355199|21015804|P2|COMPLETED|Overall Study||122
8526131|NCT00355199|21015805|P1|COMPLETED|Overall Study||113
8526132|NCT00355199|21015804|P2|STARTED|Overall Study||126
8526133|NCT00355199|21015805|P1|STARTED|Overall Study||120
8526134|NCT00355147|21015821|P2|NOT COMPLETED|Overall Study||20
8526135|NCT00355147|21015822|P1|NOT COMPLETED|Overall Study||18
8526136|NCT00355147|21015821|P2|COMPLETED|Overall Study||67
8526137|NCT00355147|21015822|P1|COMPLETED|Overall Study||69
8526138|NCT00355147|21015821|P2|STARTED|Overall Study||87
8526139|NCT00355147|21015822|P1|STARTED|Overall Study||87
8526140|NCT00355134|21015841|P5|NOT COMPLETED|Extension Phase||19
8526141|NCT00355134|21015842|P4|NOT COMPLETED|Extension Phase||16
8526142|NCT00355134|21015843|P3|NOT COMPLETED|Extension Phase||0
8526143|NCT00355134|21015844|P2|NOT COMPLETED|Extension Phase||37
8526144|NCT00355134|21015845|P1|NOT COMPLETED|Extension Phase||31
8526145|NCT00355134|21015841|P5|COMPLETED|Extension Phase||88
8526146|NCT00355134|21015842|P4|COMPLETED|Extension Phase||89
8526147|NCT00355134|21015843|P3|COMPLETED|Extension Phase||0
8526148|NCT00355134|21015844|P2|COMPLETED|Extension Phase||180
8526149|NCT00355134|21015845|P1|COMPLETED|Extension Phase||172
8526150|NCT00355134|21015841|P5|STARTED|Extension Phase||107
8526151|NCT00355134|21015842|P4|STARTED|Extension Phase||105
8526152|NCT00355134|21015843|P3|STARTED|Extension Phase||0
8526153|NCT00355134|21015844|P2|STARTED|Extension Phase||217
8526154|NCT00355134|21015845|P1|STARTED|Extension Phase||203
8526155|NCT00355134|21015841|P5|NOT COMPLETED|Core Phase||0
8526156|NCT00355134|21015842|P4|NOT COMPLETED|Core Phase||0
8526157|NCT00355134|21015843|P3|NOT COMPLETED|Core Phase||100
8526158|NCT00355134|21015844|P2|NOT COMPLETED|Core Phase||86
8526159|NCT00355134|21015845|P1|NOT COMPLETED|Core Phase||119
8526160|NCT00355134|21015841|P5|COMPLETED|Core Phase||0
8526161|NCT00355134|21015842|P4|COMPLETED|Core Phase||0
8526162|NCT00355134|21015843|P3|COMPLETED|Core Phase||255
8526163|NCT00355134|21015844|P2|COMPLETED|Core Phase||272
8526164|NCT00355134|21015845|P1|COMPLETED|Core Phase||251
8526165|NCT00355134|21015841|P5|STARTED|Core Phase||0
8526166|NCT00355134|21015842|P4|STARTED|Core Phase||0
8526167|NCT00355134|21015843|P3|STARTED|Core Phase||355
8526168|NCT00355134|21015844|P2|STARTED|Core Phase||358
8526169|NCT00355134|21015845|P1|STARTED|Core Phase||370
8526170|NCT00355121|21015888|P3|NOT COMPLETED|Overall Study||5
8526171|NCT00355121|21015889|P2|NOT COMPLETED|Overall Study||29
8526172|NCT00355121|21015890|P1|NOT COMPLETED|Overall Study||21
8526173|NCT00355121|21015888|P3|COMPLETED|Overall Study||170
8526174|NCT00355121|21015889|P2|COMPLETED|Overall Study||324
8526175|NCT00355121|21015890|P1|COMPLETED|Overall Study||332
8526176|NCT00355121|21015888|P3|STARTED|Overall Study||175
8526177|NCT00355121|21015889|P2|STARTED|Overall Study||353
8526178|NCT00355121|21015890|P1|STARTED|Overall Study||353
8526179|NCT00355082|21015921|P3|NOT COMPLETED|Continuation Phase||3
8526180|NCT00355082|21015922|P2|NOT COMPLETED|Continuation Phase||0
8526181|NCT00355082|21015923|P1|NOT COMPLETED|Continuation Phase||24
8526182|NCT00355082|21015921|P3|COMPLETED|Continuation Phase||8
8526183|NCT00355082|21015922|P2|COMPLETED|Continuation Phase||0
8526184|NCT00355082|21015923|P1|COMPLETED|Continuation Phase||160
8526185|NCT00355082|21015921|P3|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
8526186|NCT00355082|21015922|P2|STARTED|Continuation Phase||0
8526187|NCT00355082|21015923|P1|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
8526188|NCT00355082|21015921|P3|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
8526189|NCT00355082|21015922|P2|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
8526190|NCT00355082|21015923|P1|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
8526191|NCT00355082|21015921|P3|COMPLETED|Double-Blind (DB) Treatment Phase||0
8526192|NCT00355082|21015922|P2|COMPLETED|Double-Blind (DB) Treatment Phase||79
8526193|NCT00355082|21015923|P1|COMPLETED|Double-Blind (DB) Treatment Phase||94
8526194|NCT00355082|21015921|P3|STARTED|Double-Blind (DB) Treatment Phase||0
8526195|NCT00355082|21015922|P2|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
8526196|NCT00355082|21015923|P1|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
8526197|NCT00355056|21015945|P2|NOT COMPLETED|Optional Patent Foramen Ovale Closure||3
8526198|NCT00355056|21015946|P1|NOT COMPLETED|Optional Patent Foramen Ovale Closure||0
8526199|NCT00355056|21015945|P2|COMPLETED|Optional Patent Foramen Ovale Closure||84
8526200|NCT00355056|21015946|P1|COMPLETED|Optional Patent Foramen Ovale Closure||0
8526201|NCT00355056|21015945|P2|STARTED|Optional Patent Foramen Ovale Closure|Participants who completed Sham Procedure randomization Arm were eligible. 87/103 consented.|87
8526202|NCT00355056|21015946|P1|STARTED|Optional Patent Foramen Ovale Closure|A sham procedure was not part of this period.|0
8526203|NCT00355056|21015945|P2|NOT COMPLETED|Randomization Period||6
8526204|NCT00355056|21015946|P1|NOT COMPLETED|Randomization Period||4
8526205|NCT00355056|21015945|P2|COMPLETED|Randomization Period||117
8526206|NCT00355056|21015946|P1|COMPLETED|Randomization Period||103
8526207|NCT00355056|21015945|P2|STARTED|Randomization Period||123
8526208|NCT00355056|21015946|P1|STARTED|Randomization Period||107
8526209|NCT00355030|21015976|P2|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
8526210|NCT00355030|21015977|P1|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
8526211|NCT00355030|21015976|P2|COMPLETED|Study Period 2 Long Term Follow-Up||17
8526212|NCT00355030|21015977|P1|COMPLETED|Study Period 2 Long Term Follow-Up||19
8526213|NCT00355030|21015976|P2|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
8526214|NCT00355030|21015977|P1|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
8526215|NCT00355030|21015976|P2|NOT COMPLETED|Study Period 1 Treatment||44
8526216|NCT00355030|21015977|P1|NOT COMPLETED|Study Period 1 Treatment||45
8526217|NCT00355030|21015976|P2|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
8526218|NCT00355030|21015977|P1|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
8526219|NCT00355030|21015976|P2|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
8526220|NCT00355030|21015977|P1|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
8526221|NCT00355030|21015976|P2|STARTED|Study Period 1 Treatment||45
8526222|NCT00355030|21015977|P1|STARTED|Study Period 1 Treatment||46
8526223|NCT00354978|21015999|P1|NOT COMPLETED|Overall Study||0
8526224|NCT00354978|21015999|P1|COMPLETED|Overall Study||43
8526225|NCT00354978|21015999|P1|STARTED|Overall Study||43
8526226|NCT00354913|21016003|P1|NOT COMPLETED|Overall Study||0
8526227|NCT00354913|21016003|P1|COMPLETED|Overall Study||21
8526228|NCT00354913|21016003|P1|STARTED|Overall Study||21
8526229|NCT00354887|21016010|P1|NOT COMPLETED|Overall Study||1
8526230|NCT00354887|21016010|P1|COMPLETED|Overall Study||29
8526231|NCT00354887|21016010|P1|STARTED|Overall Study||30
8526232|NCT00354835|21016016|P2|NOT COMPLETED|Overall Study||61
8526233|NCT00354835|21016017|P1|NOT COMPLETED|Overall Study||52
8526234|NCT00354835|21016016|P2|COMPLETED|Overall Study||181
8526235|NCT00354835|21016017|P1|COMPLETED|Overall Study||187
8526236|NCT00354835|21016016|P2|STARTED|Overall Study||242
8526237|NCT00354835|21016017|P1|STARTED|Overall Study||239
8526238|NCT00354770|21016049|P2|NOT COMPLETED|Overall Study||3
8526239|NCT00354770|21016050|P1|NOT COMPLETED|Overall Study||3
8526240|NCT00354770|21016049|P2|COMPLETED|Overall Study||22
8526241|NCT00354770|21016050|P1|COMPLETED|Overall Study||22
8526242|NCT00354770|21016049|P2|STARTED|Overall Study||25
8526243|NCT00354770|21016050|P1|STARTED|Overall Study||25
8526244|NCT00354744|21016056|P1|NOT COMPLETED|Overall Study||42
8526245|NCT00354744|21016056|P1|COMPLETED|Overall Study||67
8526246|NCT00354744|21016056|P1|STARTED|Overall Study||109
8526247|NCT00354679|21016062|P1|NOT COMPLETED|Overall Study||1
8526248|NCT00354679|21016062|P1|COMPLETED|Overall Study||33
8526249|NCT00354679|21016062|P1|STARTED|Overall Study||34
8526250|NCT00354640|21016066|P1|NOT COMPLETED|Overall Study||0
8526251|NCT00354640|21016066|P1|COMPLETED|Overall Study||11
8526252|NCT00354640|21016066|P1|STARTED|Overall Study||11
8526253|NCT00354614|21016071|P1|NOT COMPLETED|Overall Study||28
8526254|NCT00354614|21016071|P1|COMPLETED|Overall Study||53
8526255|NCT00354614|21016071|P1|STARTED|Overall Study||81
8526256|NCT00354601|21016075|P1|NOT COMPLETED|Overall Study||2
8526257|NCT00354601|21016075|P1|COMPLETED|Overall Study||0
8526258|NCT00354601|21016075|P1|STARTED|Overall Study||2
8526259|NCT00354484|21016084|P2|NOT COMPLETED|Overall Study||3
8526260|NCT00354484|21016085|P1|NOT COMPLETED|Overall Study||4
8526261|NCT00354484|21016084|P2|COMPLETED|Overall Study||144
8526262|NCT00354484|21016085|P1|COMPLETED|Overall Study||138
8526263|NCT00354484|21016084|P2|STARTED|Overall Study||147
8526264|NCT00354484|21016085|P1|STARTED|Overall Study||142
8526265|NCT00354432|21016095|P4|NOT COMPLETED|Overall Study||10
8526266|NCT00354432|21016096|P3|NOT COMPLETED|Overall Study||10
8526267|NCT00354432|21016097|P2|NOT COMPLETED|Overall Study||8
8526268|NCT00354432|21016098|P1|NOT COMPLETED|Overall Study||6
8526269|NCT00354432|21016095|P4|COMPLETED|Overall Study||20
8526270|NCT00354432|21016096|P3|COMPLETED|Overall Study||20
8526271|NCT00354432|21016097|P2|COMPLETED|Overall Study||22
8526272|NCT00354432|21016098|P1|COMPLETED|Overall Study||24
8526273|NCT00354432|21016095|P4|STARTED|Overall Study||30
8526274|NCT00354432|21016096|P3|STARTED|Overall Study||30
8526275|NCT00354432|21016097|P2|STARTED|Overall Study||30
8526276|NCT00354432|21016098|P1|STARTED|Overall Study||30
8526277|NCT00354341|21016114|P2|NOT COMPLETED|Overall Study||7
8526278|NCT00354341|21016115|P1|NOT COMPLETED|Overall Study||3
8526279|NCT00354341|21016114|P2|COMPLETED|Overall Study||75
8526280|NCT00354341|21016115|P1|COMPLETED|Overall Study||85
8526281|NCT00354341|21016114|P2|STARTED|Overall Study||82
8526282|NCT00354341|21016115|P1|STARTED|Overall Study||88
8526283|NCT00354224|21016131|P1|NOT COMPLETED|Overall Study||0
8526284|NCT00354224|21016131|P1|COMPLETED|Overall Study||10
8526285|NCT00354224|21016131|P1|STARTED|Overall Study||10
8526286|NCT00354172|21016137|P1|NOT COMPLETED|Overall Study||1
8526287|NCT00354172|21016137|P1|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
8526288|NCT00354172|21016137|P1|STARTED|Overall Study||16
8526289|NCT00354159|21016157|P2|NOT COMPLETED|Long-term Follow-up||176
8526290|NCT00354159|21016158|P1|NOT COMPLETED|Long-term Follow-up||180
8526291|NCT00354159|21016157|P2|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
8526292|NCT00354159|21016158|P1|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
8526293|NCT00354159|21016157|P2|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
8526294|NCT00354159|21016158|P1|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
8526295|NCT00354159|21016157|P2|NOT COMPLETED|Randomized Study Period||22
8526296|NCT00354159|21016158|P1|NOT COMPLETED|Randomized Study Period||22
8526297|NCT00354159|21016157|P2|COMPLETED|Randomized Study Period||176
8526298|NCT00354159|21016158|P1|COMPLETED|Randomized Study Period||180
8526299|NCT00354159|21016157|P2|STARTED|Randomized Study Period||198
8526300|NCT00354159|21016158|P1|STARTED|Randomized Study Period||202
8526301|NCT00354107|21016201|P1|NOT COMPLETED|Overall Study||5
8526302|NCT00354107|21016201|P1|COMPLETED|Overall Study||0
8526303|NCT00354107|21016201|P1|STARTED|Overall Study||5
8526304|NCT00354029|21016211|P2|NOT COMPLETED|Overall Study||2
8526305|NCT00354029|21016212|P1|NOT COMPLETED|Overall Study||4
8526306|NCT00354029|21016211|P2|COMPLETED|Overall Study||38
8526307|NCT00354029|21016212|P1|COMPLETED|Overall Study||39
8526308|NCT00354029|21016211|P2|STARTED|Overall Study||40
8526309|NCT00354029|21016212|P1|STARTED|Overall Study||43
8526310|NCT00353977|21016218|P1|NOT COMPLETED|Overall Study||0
8526311|NCT00353977|21016218|P1|COMPLETED|Overall Study||38
8526312|NCT00353977|21016218|P1|STARTED|Overall Study||38
8526313|NCT00353873|21016224|P2|NOT COMPLETED|Overall Study||3
8526314|NCT00353873|21016225|P1|NOT COMPLETED|Overall Study||6
8526315|NCT00353873|21016224|P2|COMPLETED|Overall Study||147
8526316|NCT00353873|21016225|P1|COMPLETED|Overall Study||147
8526317|NCT00353873|21016224|P2|STARTED|Overall Study||150
8526318|NCT00353873|21016225|P1|STARTED|Overall Study||153
8526319|NCT00353834|21016239|P2|NOT COMPLETED|Overall Study||0
8526320|NCT00353834|21016240|P1|NOT COMPLETED|Overall Study||0
8526321|NCT00353834|21016239|P2|COMPLETED|Overall Study||27
8526322|NCT00353834|21016240|P1|COMPLETED|Overall Study||26
8526323|NCT00353834|21016239|P2|STARTED|Overall Study||27
8526324|NCT00353834|21016240|P1|STARTED|Overall Study||26
8526325|NCT00353795|21016248|P1|NOT COMPLETED|Overall Study||0
8526326|NCT00353795|21016248|P1|COMPLETED|Overall Study||179
8526327|NCT00353795|21016248|P1|STARTED|Overall Study||179
8526328|NCT00353704|21016254|P2|NOT COMPLETED|Overall Study||1
8526329|NCT00353704|21016255|P1|NOT COMPLETED|Overall Study||3
8526330|NCT00353704|21016254|P2|COMPLETED|Overall Study||24
8526331|NCT00353704|21016255|P1|COMPLETED|Overall Study||22
8526332|NCT00353704|21016254|P2|STARTED|Overall Study||25
8526333|NCT00353704|21016255|P1|STARTED|Overall Study||25
8526334|NCT00353652|21016265|P8|NOT COMPLETED|Third Intervention - 3 Months||0
8526335|NCT00353652|21016266|P7|NOT COMPLETED|Third Intervention - 3 Months||0
8526336|NCT00353652|21016267|P6|NOT COMPLETED|Third Intervention - 3 Months||0
8526337|NCT00353652|21016268|P5|NOT COMPLETED|Third Intervention - 3 Months||0
8526338|NCT00353652|21016269|P4|NOT COMPLETED|Third Intervention - 3 Months||1
8526339|NCT00353652|21016270|P3|NOT COMPLETED|Third Intervention - 3 Months||0
8526340|NCT00353652|21016271|P2|NOT COMPLETED|Third Intervention - 3 Months||0
8526341|NCT00353652|21016272|P1|NOT COMPLETED|Third Intervention - 3 Months||0
8526342|NCT00353652|21016265|P8|COMPLETED|Third Intervention - 3 Months||0
8526343|NCT00353652|21016266|P7|COMPLETED|Third Intervention - 3 Months||1
8526344|NCT00353652|21016267|P6|COMPLETED|Third Intervention - 3 Months||0
8526345|NCT00353652|21016268|P5|COMPLETED|Third Intervention - 3 Months||3
8526346|NCT00353652|21016269|P4|COMPLETED|Third Intervention - 3 Months||6
8526347|NCT00353652|21016270|P3|COMPLETED|Third Intervention - 3 Months||6
8526348|NCT00353652|21016271|P2|COMPLETED|Third Intervention - 3 Months||0
8526349|NCT00353652|21016272|P1|COMPLETED|Third Intervention - 3 Months||0
8526350|NCT00353652|21016265|P8|STARTED|Third Intervention - 3 Months||0
8526351|NCT00353652|21016266|P7|STARTED|Third Intervention - 3 Months||1
8526352|NCT00353652|21016267|P6|STARTED|Third Intervention - 3 Months||0
8526353|NCT00353652|21016268|P5|STARTED|Third Intervention - 3 Months||3
8526354|NCT00353652|21016269|P4|STARTED|Third Intervention - 3 Months||7
8526355|NCT00353652|21016270|P3|STARTED|Third Intervention - 3 Months||6
8526356|NCT00353652|21016271|P2|STARTED|Third Intervention - 3 Months||0
8526357|NCT00353652|21016272|P1|STARTED|Third Intervention - 3 Months||0
8526358|NCT00353652|21016265|P8|NOT COMPLETED|Second Intervention - 3 Months||0
8526359|NCT00353652|21016266|P7|NOT COMPLETED|Second Intervention - 3 Months||0
8526360|NCT00353652|21016267|P6|NOT COMPLETED|Second Intervention - 3 Months||0
8526361|NCT00353652|21016268|P5|NOT COMPLETED|Second Intervention - 3 Months||0
8526362|NCT00353652|21016269|P4|NOT COMPLETED|Second Intervention - 3 Months||0
8526363|NCT00353652|21016270|P3|NOT COMPLETED|Second Intervention - 3 Months||0
8526364|NCT00353652|21016271|P2|NOT COMPLETED|Second Intervention - 3 Months||0
8526365|NCT00353652|21016272|P1|NOT COMPLETED|Second Intervention - 3 Months||0
8526366|NCT00353652|21016265|P8|COMPLETED|Second Intervention - 3 Months||0
8526367|NCT00353652|21016266|P7|COMPLETED|Second Intervention - 3 Months||1
8526368|NCT00353652|21016267|P6|COMPLETED|Second Intervention - 3 Months||0
8526369|NCT00353652|21016268|P5|COMPLETED|Second Intervention - 3 Months||3
8526370|NCT00353652|21016269|P4|COMPLETED|Second Intervention - 3 Months||7
8526371|NCT00353652|21016270|P3|COMPLETED|Second Intervention - 3 Months||6
8526372|NCT00353652|21016271|P2|COMPLETED|Second Intervention - 3 Months||11
8526373|NCT00353652|21016272|P1|COMPLETED|Second Intervention - 3 Months||12
8526374|NCT00353652|21016265|P8|STARTED|Second Intervention - 3 Months||0
8526375|NCT00353652|21016266|P7|STARTED|Second Intervention - 3 Months||1
8526376|NCT00353652|21016267|P6|STARTED|Second Intervention - 3 Months||0
8526377|NCT00353652|21016268|P5|STARTED|Second Intervention - 3 Months||3
8526378|NCT00353652|21016269|P4|STARTED|Second Intervention - 3 Months||7
8526379|NCT00353652|21016270|P3|STARTED|Second Intervention - 3 Months||6
8526380|NCT00353652|21016271|P2|STARTED|Second Intervention - 3 Months||11
8526381|NCT00353652|21016272|P1|STARTED|Second Intervention - 3 Months||12
8526382|NCT00353652|21016265|P8|NOT COMPLETED|First Intervention - 3 Months||0
8526383|NCT00353652|21016266|P7|NOT COMPLETED|First Intervention - 3 Months||0
8526384|NCT00353652|21016267|P6|NOT COMPLETED|First Intervention - 3 Months||0
8526385|NCT00353652|21016268|P5|NOT COMPLETED|First Intervention - 3 Months||0
8526386|NCT00353652|21016269|P4|NOT COMPLETED|First Intervention - 3 Months||0
8526387|NCT00353652|21016270|P3|NOT COMPLETED|First Intervention - 3 Months||0
8526388|NCT00353652|21016271|P2|NOT COMPLETED|First Intervention - 3 Months||4
8526389|NCT00353652|21016272|P1|NOT COMPLETED|First Intervention - 3 Months||3
8526390|NCT00353652|21016265|P8|COMPLETED|First Intervention - 3 Months||0
8526391|NCT00353652|21016266|P7|COMPLETED|First Intervention - 3 Months||1
8526392|NCT00353652|21016267|P6|COMPLETED|First Intervention - 3 Months||0
8526393|NCT00353652|21016268|P5|COMPLETED|First Intervention - 3 Months||3
8526394|NCT00353652|21016269|P4|COMPLETED|First Intervention - 3 Months||7
8526395|NCT00353652|21016270|P3|COMPLETED|First Intervention - 3 Months||6
8526396|NCT00353652|21016271|P2|COMPLETED|First Intervention - 3 Months||11
8526397|NCT00353652|21016272|P1|COMPLETED|First Intervention - 3 Months||12
8526398|NCT00353652|21016265|P8|STARTED|First Intervention - 3 Months||0
8526399|NCT00353652|21016266|P7|STARTED|First Intervention - 3 Months||1
8526400|NCT00353652|21016267|P6|STARTED|First Intervention - 3 Months||0
8526401|NCT00353652|21016268|P5|STARTED|First Intervention - 3 Months||3
8526402|NCT00353652|21016269|P4|STARTED|First Intervention - 3 Months||7
8526403|NCT00353652|21016270|P3|STARTED|First Intervention - 3 Months||6
8526404|NCT00353652|21016271|P2|STARTED|First Intervention - 3 Months||15
8526405|NCT00353652|21016272|P1|STARTED|First Intervention - 3 Months||15
8526406|NCT00353522|21016306|P2|NOT COMPLETED|Overall Study||9
8526407|NCT00353522|21016307|P1|NOT COMPLETED|Overall Study||15
8526408|NCT00353522|21016306|P2|COMPLETED|Overall Study||37
8526409|NCT00353522|21016307|P1|COMPLETED|Overall Study||74
8526410|NCT00353522|21016306|P2|STARTED|Overall Study||46
8526411|NCT00353522|21016307|P1|STARTED|Overall Study||89
8526412|NCT00353496|21016325|P2|NOT COMPLETED|Overall Study||17
8526413|NCT00353496|21016326|P1|NOT COMPLETED|Overall Study||16
8526414|NCT00353496|21016325|P2|COMPLETED|Overall Study||86
8526415|NCT00353496|21016326|P1|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
8526416|NCT00353496|21016325|P2|STARTED|Overall Study||103
8526417|NCT00353496|21016326|P1|STARTED|Overall Study||101
8526418|NCT00353431|21016343|P2|NOT COMPLETED|Overall Study||0
8526419|NCT00353431|21016344|P1|NOT COMPLETED|Overall Study||0
8526420|NCT00353431|21016343|P2|COMPLETED|Overall Study||67
8526421|NCT00353431|21016344|P1|COMPLETED|Overall Study||63
8526422|NCT00353431|21016343|P2|STARTED|Overall Study||67
8526423|NCT00353431|21016344|P1|STARTED|Overall Study||63
8526424|NCT00353418|21016360|P2|NOT COMPLETED|Overall Study||158
8526425|NCT00353418|21016361|P1|NOT COMPLETED|Overall Study||83
8526426|NCT00353418|21016360|P2|COMPLETED|Overall Study||119
8526427|NCT00353418|21016361|P1|COMPLETED|Overall Study||55
8526428|NCT00353418|21016360|P2|STARTED|Overall Study||277
8526429|NCT00353418|21016361|P1|STARTED|Overall Study||138
8526433|NCT00353301|21016386|P1|NOT COMPLETED|Overall Study||0
8526434|NCT00353301|21016386|P1|COMPLETED|Overall Study||25
8526435|NCT00353301|21016386|P1|STARTED|Overall Study||25
8526436|NCT00353275|21016393|P2|NOT COMPLETED|Overall Study||0
8526437|NCT00353275|21016394|P1|NOT COMPLETED|Overall Study||0
8526438|NCT00353275|21016393|P2|COMPLETED|Overall Study||3
8526439|NCT00353275|21016394|P1|COMPLETED|Overall Study||2
8526440|NCT00353275|21016393|P2|STARTED|Overall Study||3
8526441|NCT00353275|21016394|P1|STARTED|Overall Study||2
8526442|NCT00353262|21016406|P1|NOT COMPLETED|Overall Study||29
8526443|NCT00353262|21016406|P1|COMPLETED|Overall Study||7
8526444|NCT00353262|21016406|P1|STARTED|Overall Study||36
8526445|NCT00353119|21016425|P2|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
8526446|NCT00353119|21016426|P1|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
8526447|NCT00353119|21016425|P2|COMPLETED|Second Intervention Week 12 to Week 28||10
8526448|NCT00353119|21016426|P1|COMPLETED|Second Intervention Week 12 to Week 28||5
8526449|NCT00353119|21016425|P2|STARTED|Second Intervention Week 12 to Week 28||10
8526450|NCT00353119|21016426|P1|STARTED|Second Intervention Week 12 to Week 28||5
8526451|NCT00353119|21016425|P2|NOT COMPLETED|First Intervention Day 0 to Week 12||0
8526452|NCT00353119|21016426|P1|NOT COMPLETED|First Intervention Day 0 to Week 12||0
8526453|NCT00353119|21016425|P2|COMPLETED|First Intervention Day 0 to Week 12||10
8526454|NCT00353119|21016426|P1|COMPLETED|First Intervention Day 0 to Week 12||5
8526455|NCT00353119|21016425|P2|STARTED|First Intervention Day 0 to Week 12||10
8526456|NCT00353119|21016426|P1|STARTED|First Intervention Day 0 to Week 12||5
8526457|NCT00352911|21016438|P2|NOT COMPLETED|300mg Twice Daily (14 Days)||0
8526458|NCT00352911|21016439|P1|NOT COMPLETED|300mg Twice Daily (14 Days)||1
8526459|NCT00352911|21016438|P2|COMPLETED|300mg Twice Daily (14 Days)||3
8526460|NCT00352911|21016439|P1|COMPLETED|300mg Twice Daily (14 Days)||15
8526461|NCT00352911|21016438|P2|STARTED|300mg Twice Daily (14 Days)||3
8526462|NCT00352911|21016439|P1|STARTED|300mg Twice Daily (14 Days)||16
8526463|NCT00352911|21016438|P2|NOT COMPLETED|150mg Twice Daily (14 Days)||0
8526464|NCT00352911|21016439|P1|NOT COMPLETED|150mg Twice Daily (14 Days)||0
8526465|NCT00352911|21016438|P2|COMPLETED|150mg Twice Daily (14 Days)||3
8526466|NCT00352911|21016439|P1|COMPLETED|150mg Twice Daily (14 Days)||16
8526467|NCT00352911|21016438|P2|STARTED|150mg Twice Daily (14 Days)||3
8526468|NCT00352911|21016439|P1|STARTED|150mg Twice Daily (14 Days)||16
8526469|NCT00352885|21016447|P2|NOT COMPLETED|Overall Study||7
8526470|NCT00352885|21016448|P1|NOT COMPLETED|Overall Study||6
8526471|NCT00352885|21016447|P2|COMPLETED|Overall Study||4
8526472|NCT00352885|21016448|P1|COMPLETED|Overall Study||3
8526473|NCT00352885|21016447|P2|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
8526474|NCT00352885|21016448|P1|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
8526475|NCT00352885|21016447|P2|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
8526476|NCT00352885|21016448|P1|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
8526477|NCT00352885|21016447|P2|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
8526478|NCT00352885|21016448|P1|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
8526479|NCT00352885|21016447|P2|STARTED|Overall Study||11
8526480|NCT00352885|21016448|P1|STARTED|Overall Study||9
8526481|NCT00352846|21016466|P2|NOT COMPLETED|Overall Study||13
8526482|NCT00352846|21016467|P1|NOT COMPLETED|Overall Study||8
8526483|NCT00352846|21016466|P2|COMPLETED|Overall Study||24
8526484|NCT00352846|21016467|P1|COMPLETED|Overall Study||29
8526485|NCT00352846|21016466|P2|STARTED|Overall Study||37
8526486|NCT00352846|21016467|P1|STARTED|Overall Study||37
8526487|NCT00352794|21016473|P1|NOT COMPLETED|Overall Study||0
8526488|NCT00352794|21016473|P1|COMPLETED|Overall Study||40
8526489|NCT00352794|21016473|P1|STARTED|Overall Study||40
8526490|NCT00352781|21016477|P1|NOT COMPLETED|Overall Study||883
8526491|NCT00352781|21016477|P1|COMPLETED|Overall Study||884
8526492|NCT00352781|21016477|P1|STARTED|Overall Study||1767
8526493|NCT00352755|21016482|P1|NOT COMPLETED|Overall Study||2
8526494|NCT00352755|21016482|P1|COMPLETED|Overall Study||16
8526495|NCT00352755|21016482|P1|STARTED|Overall Study||18
8526496|NCT00352690|21016492|P2|NOT COMPLETED|Overall Study||0
8526497|NCT00352690|21016493|P1|NOT COMPLETED|Overall Study||2
8526498|NCT00352690|21016492|P2|COMPLETED|Overall Study||0
8526499|NCT00352690|21016493|P1|COMPLETED|Overall Study||8
8526500|NCT00352690|21016492|P2|STARTED|Overall Study||0
8526501|NCT00352690|21016493|P1|STARTED|Overall Study||10
8526502|NCT00352664|21016513|P2|NOT COMPLETED|Overall Study||0
8526503|NCT00352664|21016514|P1|NOT COMPLETED|Overall Study||7
8526504|NCT00352664|21016513|P2|COMPLETED|Overall Study||0
8526505|NCT00352664|21016514|P1|COMPLETED|Overall Study||20
8526506|NCT00352664|21016513|P2|STARTED|Overall Study||0
8526507|NCT00352664|21016514|P1|STARTED|Overall Study||27
8526508|NCT00352612|21016522|P2|NOT COMPLETED|Overall Study||0
8526509|NCT00352612|21016523|P1|NOT COMPLETED|Overall Study||0
8526510|NCT00352612|21016522|P2|COMPLETED|Overall Study||100
8526511|NCT00352612|21016523|P1|COMPLETED|Overall Study||100
8526512|NCT00352612|21016522|P2|STARTED|Overall Study||100
8526513|NCT00352612|21016523|P1|STARTED|Overall Study||100
8526514|NCT00352534|21016531|P7|NOT COMPLETED|Final Risk Group Assignment||39
8526515|NCT00352534|21016532|P6|NOT COMPLETED|Final Risk Group Assignment||45
8526516|NCT00352534|21016533|P5|NOT COMPLETED|Final Risk Group Assignment||1
8526517|NCT00352534|21016534|P4|NOT COMPLETED|Final Risk Group Assignment||3
8526518|NCT00352534|21016535|P3|NOT COMPLETED|Final Risk Group Assignment||3
8526519|NCT00352534|21016536|P2|NOT COMPLETED|Final Risk Group Assignment||0
8526520|NCT00352534|21016537|P1|NOT COMPLETED|Final Risk Group Assignment||0
8526521|NCT00352534|21016531|P7|COMPLETED|Final Risk Group Assignment||1
8526522|NCT00352534|21016532|P6|COMPLETED|Final Risk Group Assignment||503
8526523|NCT00352534|21016533|P5|COMPLETED|Final Risk Group Assignment||31
8526524|NCT00352534|21016534|P4|COMPLETED|Final Risk Group Assignment||49
8526525|NCT00352534|21016535|P3|COMPLETED|Final Risk Group Assignment||116
8526526|NCT00352534|21016536|P2|COMPLETED|Final Risk Group Assignment||0
8526527|NCT00352534|21016537|P1|COMPLETED|Final Risk Group Assignment||0
8526528|NCT00352534|21016531|P7|STARTED|Final Risk Group Assignment||40
8526529|NCT00352534|21016532|P6|STARTED|Final Risk Group Assignment||548
8526530|NCT00352534|21016533|P5|STARTED|Final Risk Group Assignment||32
8526531|NCT00352534|21016534|P4|STARTED|Final Risk Group Assignment||52
8526532|NCT00352534|21016535|P3|STARTED|Final Risk Group Assignment||119
8526533|NCT00352534|21016536|P2|STARTED|Final Risk Group Assignment||0
8526534|NCT00352534|21016537|P1|STARTED|Final Risk Group Assignment||0
8526535|NCT00352534|21016531|P7|NOT COMPLETED|Initial Staging||0
8526536|NCT00352534|21016532|P6|NOT COMPLETED|Initial Staging||0
8526537|NCT00352534|21016533|P5|NOT COMPLETED|Initial Staging||0
8526538|NCT00352534|21016534|P4|NOT COMPLETED|Initial Staging||0
8526539|NCT00352534|21016535|P3|NOT COMPLETED|Initial Staging||0
8526540|NCT00352534|21016536|P2|NOT COMPLETED|Initial Staging||9
8526541|NCT00352534|21016537|P1|NOT COMPLETED|Initial Staging||8
8526542|NCT00352534|21016531|P7|COMPLETED|Initial Staging||0
8526543|NCT00352534|21016532|P6|COMPLETED|Initial Staging||0
8526544|NCT00352534|21016533|P5|COMPLETED|Initial Staging||0
8526545|NCT00352534|21016534|P4|COMPLETED|Initial Staging||0
8526546|NCT00352534|21016535|P3|COMPLETED|Initial Staging||0
8526547|NCT00352534|21016536|P2|COMPLETED|Initial Staging||588
8526548|NCT00352534|21016537|P1|COMPLETED|Initial Staging||203
8526549|NCT00352534|21016531|P7|STARTED|Initial Staging||0
8526550|NCT00352534|21016532|P6|STARTED|Initial Staging||0
8526551|NCT00352534|21016533|P5|STARTED|Initial Staging||0
8526552|NCT00352534|21016534|P4|STARTED|Initial Staging||0
8526553|NCT00352534|21016535|P3|STARTED|Initial Staging||0
8526554|NCT00352534|21016536|P2|STARTED|Initial Staging||597
8526555|NCT00352534|21016537|P1|STARTED|Initial Staging||211
8526556|NCT00352417|21016554|P2|NOT COMPLETED|Overall Study||5
8526557|NCT00352417|21016555|P1|NOT COMPLETED|Overall Study||5
8526558|NCT00352417|21016554|P2|COMPLETED|Overall Study||21
8526559|NCT00352417|21016555|P1|COMPLETED|Overall Study||19
8526560|NCT00352417|21016554|P2|STARTED|Overall Study||26
8526561|NCT00352417|21016555|P1|STARTED|Overall Study||24
8526562|NCT00352365|21016569|P1|NOT COMPLETED|Maintenance Therapy||12
8526563|NCT00352365|21016569|P1|COMPLETED|Maintenance Therapy||0
8526564|NCT00352365|21016569|P1|Eligible and Began Protocol Therapy|Maintenance Therapy||8
8526565|NCT00352365|21016569|P1|STARTED|Maintenance Therapy||12
8526566|NCT00352365|21016569|P1|NOT COMPLETED|Induction Therapy||27
8526567|NCT00352365|21016569|P1|COMPLETED|Induction Therapy||14
8526568|NCT00352365|21016569|P1|Eligible and Began Protocol Therapy|Induction Therapy||37
8526569|NCT00352365|21016569|P1|Eligible|Induction Therapy||38
8526570|NCT00352365|21016569|P1|STARTED|Induction Therapy||41
8526571|NCT00352118|21016579|P1|NOT COMPLETED|Overall Study||4
8526572|NCT00352118|21016579|P1|COMPLETED|Overall Study||0
8526573|NCT00352118|21016579|P1|STARTED|Overall Study||4
8526574|NCT00352105|21016589|P1|NOT COMPLETED|Overall Study||40
8526575|NCT00352105|21016589|P1|COMPLETED|Overall Study||20
8526576|NCT00352105|21016589|P1|STARTED|Overall Study||60
8526577|NCT00352053|21016600|P2|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
8526578|NCT00352053|21016601|P1|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
8526579|NCT00352053|21016600|P2|COMPLETED|Third Extension Phase (Weeks 240-294)||2
8526580|NCT00352053|21016601|P1|COMPLETED|Third Extension Phase (Weeks 240-294)||0
8526581|NCT00352053|21016600|P2|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
8526582|NCT00352053|21016601|P1|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
8526583|NCT00352053|21016600|P2|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
8526584|NCT00352053|21016601|P1|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
8526585|NCT00352053|21016600|P2|COMPLETED|Second Extension Phase (Weeks 144-240)||9
8526586|NCT00352053|21016601|P1|COMPLETED|Second Extension Phase (Weeks 144-240)||4
8526587|NCT00352053|21016600|P2|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
8526588|NCT00352053|21016601|P1|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
8526589|NCT00352053|21016600|P2|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
8526590|NCT00352053|21016601|P1|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
8526591|NCT00352053|21016600|P2|COMPLETED|First Extension Phase (Weeks 48-144)||19
8526592|NCT00352053|21016601|P1|COMPLETED|First Extension Phase (Weeks 48-144)||12
8526593|NCT00352053|21016600|P2|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
8526594|NCT00352053|21016601|P1|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
8526595|NCT00352053|21016600|P2|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
8526596|NCT00352053|21016601|P1|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
8526597|NCT00352053|21016600|P2|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
8526598|NCT00352053|21016601|P1|COMPLETED|Double-Blind Phase (Through Week 48)||27
8526599|NCT00352053|21016600|P2|STARTED|Double-Blind Phase (Through Week 48)||42
8526600|NCT00352053|21016601|P1|STARTED|Double-Blind Phase (Through Week 48)||45
8526604|NCT00352001|21017037|P1|NOT COMPLETED|Overall Study||0
8526605|NCT00352001|21017037|P1|COMPLETED|Overall Study||37
8526606|NCT00352001|21017037|P1|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
8526607|NCT00352001|21017037|P1|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
8526608|NCT00352001|21017037|P1|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
8526609|NCT00352001|21017037|P1|STARTED|Overall Study||37
8526610|NCT00351936|21017048|P1|NOT COMPLETED|Overall Study||0
8526611|NCT00351936|21017048|P1|COMPLETED|Overall Study||15
8526612|NCT00351936|21017048|P1|STARTED|Overall Study||15
8526613|NCT00351819|21017067|P2|NOT COMPLETED|Overall Study||12
8526614|NCT00351819|21017068|P1|NOT COMPLETED|Overall Study||7
8526615|NCT00351819|21017067|P2|COMPLETED|Overall Study||29
8526616|NCT00351819|21017068|P1|COMPLETED|Overall Study||36
8526617|NCT00351819|21017067|P2|STARTED|Overall Study||41
8526618|NCT00351819|21017068|P1|STARTED|Overall Study||43
8526619|NCT00351741|21017118|P2|NOT COMPLETED|Overall Study||0
8526620|NCT00351741|21017119|P1|NOT COMPLETED|Overall Study||0
8526621|NCT00351741|21017118|P2|COMPLETED|Overall Study||31
8526622|NCT00351741|21017119|P1|COMPLETED|Overall Study||31
8526623|NCT00351741|21017118|P2|STARTED|Overall Study||31
8526624|NCT00351741|21017119|P1|STARTED|Overall Study||31
8526625|NCT00351533|21017139|P2|NOT COMPLETED|Overall Study||5
8526626|NCT00351533|21017140|P1|NOT COMPLETED|Overall Study||2
8526627|NCT00351533|21017139|P2|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
8526628|NCT00351533|21017140|P1|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
8526629|NCT00351533|21017139|P2|STARTED|Overall Study||49
8526630|NCT00351533|21017140|P1|STARTED|Overall Study||41
8526631|NCT00351468|21017200|P1|NOT COMPLETED|Overall Study||167
8526632|NCT00351468|21017200|P1|COMPLETED|Overall Study||135
8526633|NCT00351468|21017200|P1|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
8526634|NCT00351468|21017200|P1|Subjects From TRA108057 Repeat|Overall Study||43
8526635|NCT00351468|21017200|P1|Subjects From TRA102537 Raise|Overall Study||146
8526636|NCT00351468|21017200|P1|Subjects From TRA100773B|Overall Study||61
8526637|NCT00351468|21017200|P1|Subjects From TRA100773A|Overall Study||51
8526638|NCT00351468|21017200|P1|STARTED|Overall Study||302
8526639|NCT00351416|21017217|P2|NOT COMPLETED|Overall Study||0
8526640|NCT00351416|21017218|P1|NOT COMPLETED|Overall Study||0
8526641|NCT00351416|21017217|P2|COMPLETED|Overall Study||9
8526642|NCT00351416|21017218|P1|COMPLETED|Overall Study||6
8526643|NCT00351416|21017217|P2|STARTED|Overall Study||9
8526644|NCT00351416|21017218|P1|STARTED|Overall Study||6
8526645|NCT00351377|21017224|P1|NOT COMPLETED|Overall Study||7
8526646|NCT00351377|21017224|P1|COMPLETED|Overall Study||104
8526647|NCT00351377|21017224|P1|STARTED|Overall Study||111
8526648|NCT00351351|21017238|P2|NOT COMPLETED|Overall Study||4
8526649|NCT00351351|21017239|P1|NOT COMPLETED|Overall Study||9
8526650|NCT00351351|21017238|P2|COMPLETED|Overall Study||32
8526651|NCT00351351|21017239|P1|COMPLETED|Overall Study||25
8526652|NCT00351351|21017238|P2|STARTED|Overall Study||36
8526653|NCT00351351|21017239|P1|STARTED|Overall Study||34
8526654|NCT00351299|21017247|P2|NOT COMPLETED|Overall Study||0
8526655|NCT00351299|21017248|P1|NOT COMPLETED|Overall Study||0
8526656|NCT00351299|21017247|P2|COMPLETED|Overall Study||28
8526657|NCT00351299|21017248|P1|COMPLETED|Overall Study||25
8526658|NCT00351299|21017247|P2|STARTED|Overall Study||28
8526659|NCT00351299|21017248|P1|STARTED|Overall Study||25
8526660|NCT00351273|21017265|P3|NOT COMPLETED|Overall Study||5
8526661|NCT00351273|21017266|P2|NOT COMPLETED|Overall Study||2
8526662|NCT00351273|21017267|P1|NOT COMPLETED|Overall Study||1
8526663|NCT00351273|21017265|P3|COMPLETED|Overall Study||10
8526664|NCT00351273|21017266|P2|COMPLETED|Overall Study||10
8526665|NCT00351273|21017267|P1|COMPLETED|Overall Study||14
8526666|NCT00351273|21017265|P3|STARTED|Overall Study||15
8526667|NCT00351273|21017266|P2|STARTED|Overall Study||12
8526668|NCT00351273|21017267|P1|STARTED|Overall Study||15
8526669|NCT00351039|21017290|P1|NOT COMPLETED|Overall Study||0
8526670|NCT00351039|21017290|P1|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
8526671|NCT00351039|21017290|P1|STARTED|Overall Study||8
8526672|NCT00351000|21017299|P1|NOT COMPLETED|Overall Study||3
8526673|NCT00351000|21017299|P1|COMPLETED|Overall Study||21
8526674|NCT00351000|21017299|P1|STARTED|Overall Study||24
8526675|NCT00350870|21017310|P4|NOT COMPLETED|Overall Study||15
8526676|NCT00350870|21017311|P3|NOT COMPLETED|Overall Study||16
8526677|NCT00350870|21017312|P2|NOT COMPLETED|Overall Study||17
8526678|NCT00350870|21017313|P1|NOT COMPLETED|Overall Study||22
8526679|NCT00350870|21017310|P4|COMPLETED|Overall Study||7
8526680|NCT00350870|21017311|P3|COMPLETED|Overall Study||6
8526681|NCT00350870|21017312|P2|COMPLETED|Overall Study||11
8526682|NCT00350870|21017313|P1|COMPLETED|Overall Study||5
8526683|NCT00350870|21017310|P4|Had at Least 1 Day of Med|Overall Study||19
8526684|NCT00350870|21017311|P3|Had at Least 1 Day of Med|Overall Study||18
8526685|NCT00350870|21017312|P2|Had at Least 1 Day of Med|Overall Study||24
8526686|NCT00350870|21017313|P1|Had at Least 1 Day of Med|Overall Study||19
8526687|NCT00350870|21017310|P4|STARTED|Overall Study||22
8526688|NCT00350870|21017311|P3|STARTED|Overall Study||22
8526689|NCT00350870|21017312|P2|STARTED|Overall Study||28
8526690|NCT00350870|21017313|P1|STARTED|Overall Study||27
8526691|NCT00350844|21017327|P1|NOT COMPLETED|Overall Study||1
8526692|NCT00350844|21017327|P1|COMPLETED|Overall Study||5
8526693|NCT00350844|21017327|P1|STARTED|Overall Study||6
8526694|NCT00350792|21017331|P1|NOT COMPLETED|Overall Study||33
8526695|NCT00350792|21017331|P1|COMPLETED|Overall Study||29
8526696|NCT00350792|21017331|P1|STARTED|Overall Study||62
8526697|NCT00350779|21017341|P2|NOT COMPLETED|Overall Study||21
8526698|NCT00350779|21017342|P1|NOT COMPLETED|Overall Study||22
8526699|NCT00350779|21017341|P2|COMPLETED|Overall Study||71
8526700|NCT00350779|21017342|P1|COMPLETED|Overall Study||148
8526701|NCT00350779|21017341|P2|STARTED|Overall Study||92
8526702|NCT00350779|21017342|P1|STARTED|Overall Study||170
8526703|NCT00350727|21017363|P3|NOT COMPLETED|Phase II||22
8526704|NCT00350727|21017364|P2|NOT COMPLETED|Phase II||19
8526705|NCT00350727|21017365|P1|NOT COMPLETED|Phase II||0
8526706|NCT00350727|21017363|P3|COMPLETED|Phase II||0
8526707|NCT00350727|21017364|P2|COMPLETED|Phase II||0
8526708|NCT00350727|21017365|P1|COMPLETED|Phase II||0
8526709|NCT00350727|21017363|P3|STARTED|Phase II||22
8526710|NCT00350727|21017364|P2|STARTED|Phase II||19
8526711|NCT00350727|21017365|P1|STARTED|Phase II||0
8526712|NCT00350727|21017363|P3|NOT COMPLETED|Phase I: Dose Escalation||0
8526713|NCT00350727|21017364|P2|NOT COMPLETED|Phase I: Dose Escalation||0
8526714|NCT00350727|21017365|P1|NOT COMPLETED|Phase I: Dose Escalation||34
8526715|NCT00350727|21017363|P3|COMPLETED|Phase I: Dose Escalation||0
8526716|NCT00350727|21017364|P2|COMPLETED|Phase I: Dose Escalation||0
8526717|NCT00350727|21017365|P1|COMPLETED|Phase I: Dose Escalation||0
8526718|NCT00350727|21017363|P3|STARTED|Phase I: Dose Escalation||0
8526719|NCT00350727|21017364|P2|STARTED|Phase I: Dose Escalation||0
8526720|NCT00350727|21017365|P1|STARTED|Phase I: Dose Escalation||34
8526721|NCT00350636|21017509|P2|NOT COMPLETED|Overall Study||45
8526722|NCT00350636|21017510|P1|NOT COMPLETED|Overall Study||43
8526723|NCT00350636|21017509|P2|COMPLETED|Overall Study||355
8526724|NCT00350636|21017510|P1|COMPLETED|Overall Study||346
8526725|NCT00350636|21017509|P2|STARTED|Overall Study||400
8526726|NCT00350636|21017510|P1|STARTED|Overall Study||389
8526727|NCT00350623|21017529|P3|NOT COMPLETED|Overall Study||6
8526728|NCT00350623|21017530|P2|NOT COMPLETED|Overall Study||4
8526729|NCT00350623|21017531|P1|NOT COMPLETED|Overall Study||8
8526730|NCT00350623|21017529|P3|COMPLETED|Overall Study||62
8526731|NCT00350623|21017530|P2|COMPLETED|Overall Study||67
8526732|NCT00350623|21017531|P1|COMPLETED|Overall Study||63
8526733|NCT00350623|21017529|P3|STARTED|Overall Study||68
8526734|NCT00350623|21017530|P2|STARTED|Overall Study||71
8526735|NCT00350623|21017531|P1|STARTED|Overall Study||71
8526736|NCT00350545|21017539|P1|NOT COMPLETED|Overall Study||2
8526737|NCT00350545|21017539|P1|COMPLETED|Overall Study||35
8526738|NCT00350545|21017539|P1|STARTED|Overall Study||37
8526739|NCT00350532|21017549|P2|NOT COMPLETED|Overall Study||0
8526740|NCT00350532|21017550|P1|NOT COMPLETED|Overall Study||0
8526741|NCT00350532|21017549|P2|COMPLETED|Overall Study||19
8526742|NCT00350532|21017550|P1|COMPLETED|Overall Study||24
8526743|NCT00350532|21017549|P2|STARTED|Overall Study||19
8526744|NCT00350532|21017550|P1|STARTED|Overall Study||24
8526745|NCT00350519|21017558|P2|NOT COMPLETED|Overall Study||6
8526746|NCT00350519|21017559|P1|NOT COMPLETED|Overall Study||4
8526747|NCT00350519|21017558|P2|COMPLETED|Overall Study||13
8526748|NCT00350519|21017559|P1|COMPLETED|Overall Study||14
8526749|NCT00350519|21017558|P2|STARTED|Overall Study||19
8526750|NCT00350519|21017559|P1|STARTED|Overall Study||18
8526751|NCT00350402|21017573|P2|NOT COMPLETED|Overall Study||1
8526752|NCT00350402|21017574|P1|NOT COMPLETED|Overall Study||1
8526753|NCT00350402|21017573|P2|COMPLETED|Overall Study||20
8526754|NCT00350402|21017574|P1|COMPLETED|Overall Study||20
8526755|NCT00350402|21017573|P2|STARTED|Overall Study||21
8526756|NCT00350402|21017574|P1|STARTED|Overall Study||21
8526757|NCT00350363|21017586|P1|NOT COMPLETED|Overall Study||0
8526758|NCT00350363|21017586|P1|COMPLETED|Overall Study||60
8526759|NCT00350363|21017586|P1|STARTED|Overall Study||60
8526772|NCT00350272|21017647|P2|NOT COMPLETED|Open-Label 84 Week Treatment||8
8526773|NCT00350272|21017648|P1|NOT COMPLETED|Open-Label 84 Week Treatment||9
8526774|NCT00350272|21017647|P2|COMPLETED|Open-Label 84 Week Treatment||27
8526775|NCT00350272|21017648|P1|COMPLETED|Open-Label 84 Week Treatment||21
8526776|NCT00350272|21017647|P2|STARTED|Open-Label 84 Week Treatment||35
8526777|NCT00350272|21017648|P1|STARTED|Open-Label 84 Week Treatment||30
8526778|NCT00350272|21017647|P2|NOT COMPLETED|Blinded 12 Week Treatment||2
8526779|NCT00350272|21017648|P1|NOT COMPLETED|Blinded 12 Week Treatment||9
8526780|NCT00350272|21017647|P2|COMPLETED|Blinded 12 Week Treatment||35
8526781|NCT00350272|21017648|P1|COMPLETED|Blinded 12 Week Treatment||30
8526782|NCT00350272|21017647|P2|STARTED|Blinded 12 Week Treatment||37
8526783|NCT00350272|21017648|P1|STARTED|Blinded 12 Week Treatment||39
8526784|NCT00350220|21017658|P2|NOT COMPLETED|Overall Study||0
8526785|NCT00350220|21017659|P1|NOT COMPLETED|Overall Study||0
8526786|NCT00350220|21017658|P2|COMPLETED|Overall Study||30
8526787|NCT00350220|21017659|P1|COMPLETED|Overall Study||30
8526788|NCT00350220|21017658|P2|STARTED|Overall Study||30
8526789|NCT00350220|21017659|P1|STARTED|Overall Study||30
8526790|NCT00350207|21017670|P3|NOT COMPLETED|Overall Study||7
8526791|NCT00350207|21017671|P2|NOT COMPLETED|Overall Study||6
8526792|NCT00350207|21017672|P1|NOT COMPLETED|Overall Study||8
8526793|NCT00350207|21017670|P3|COMPLETED|Overall Study||119
8526794|NCT00350207|21017671|P2|COMPLETED|Overall Study||128
8526795|NCT00350207|21017672|P1|COMPLETED|Overall Study||120
8526796|NCT00350207|21017670|P3|STARTED|Overall Study||126
8526797|NCT00350207|21017671|P2|STARTED|Overall Study||134
8526798|NCT00350207|21017672|P1|STARTED|Overall Study||128
8526799|NCT00350142|21017866|P1|NOT COMPLETED|Overall Study||0
8526800|NCT00350142|21017866|P1|COMPLETED|Overall Study||20
8526801|NCT00350142|21017866|P1|STARTED|Overall Study||20
8526802|NCT00350025|21017873|P2|NOT COMPLETED|Overall Study||2
8526803|NCT00350025|21017874|P1|NOT COMPLETED|Overall Study||0
8526804|NCT00350025|21017873|P2|COMPLETED|Overall Study||28
8526805|NCT00350025|21017874|P1|COMPLETED|Overall Study||11
8526806|NCT00350025|21017873|P2|STARTED|Overall Study||30
8526807|NCT00350025|21017874|P1|STARTED|Overall Study||11
8526808|NCT00349973|21017884|P2|NOT COMPLETED|Overall Study||3
8526809|NCT00349973|21017885|P1|NOT COMPLETED|Overall Study||4
8526810|NCT00349973|21017884|P2|COMPLETED|Overall Study||5
8526811|NCT00349973|21017885|P1|COMPLETED|Overall Study||8
8526812|NCT00349973|21017884|P2|STARTED|Overall Study||8
8526813|NCT00349973|21017885|P1|STARTED|Overall Study||12
8526814|NCT00349921|21017899|P4|NOT COMPLETED|Second Spinal Injection||0
8526815|NCT00349921|21017900|P3|NOT COMPLETED|Second Spinal Injection||0
8526816|NCT00349921|21017901|P2|NOT COMPLETED|Second Spinal Injection||0
8526817|NCT00349921|21017902|P1|NOT COMPLETED|Second Spinal Injection||0
8526818|NCT00349921|21017899|P4|COMPLETED|Second Spinal Injection||1
8526819|NCT00349921|21017900|P3|COMPLETED|Second Spinal Injection||0
8526820|NCT00349921|21017901|P2|COMPLETED|Second Spinal Injection||10
8526821|NCT00349921|21017902|P1|COMPLETED|Second Spinal Injection||9
8526822|NCT00349921|21017899|P4|STARTED|Second Spinal Injection||1
8526823|NCT00349921|21017900|P3|STARTED|Second Spinal Injection||0
8526824|NCT00349921|21017901|P2|STARTED|Second Spinal Injection||10
8526825|NCT00349921|21017902|P1|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
8526826|NCT00349921|21017899|P4|NOT COMPLETED|First Spinal Injection||0
8526827|NCT00349921|21017900|P3|NOT COMPLETED|First Spinal Injection||1
8526828|NCT00349921|21017901|P2|NOT COMPLETED|First Spinal Injection||0
8526829|NCT00349921|21017902|P1|NOT COMPLETED|First Spinal Injection||1
8526830|NCT00349921|21017899|P4|COMPLETED|First Spinal Injection||1
8526831|NCT00349921|21017900|P3|COMPLETED|First Spinal Injection||0
8526832|NCT00349921|21017901|P2|COMPLETED|First Spinal Injection||10
8526833|NCT00349921|21017902|P1|COMPLETED|First Spinal Injection||9
8526834|NCT00349921|21017899|P4|STARTED|First Spinal Injection||1
8526835|NCT00349921|21017900|P3|STARTED|First Spinal Injection||1
8526836|NCT00349921|21017901|P2|STARTED|First Spinal Injection||10
8526837|NCT00349921|21017902|P1|STARTED|First Spinal Injection||10
8526838|NCT00349908|21017913|P2|NOT COMPLETED|Overall Study||4
8526839|NCT00349908|21017914|P1|NOT COMPLETED|Overall Study||0
8526840|NCT00349908|21017913|P2|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
8526841|NCT00349908|21017914|P1|COMPLETED|Overall Study||10
8526842|NCT00349908|21017913|P2|STARTED|Overall Study||10
8526843|NCT00349908|21017914|P1|STARTED|Overall Study||10
8526844|NCT00349778|21017932|P1|NOT COMPLETED|Overall Study||0
8526845|NCT00349778|21017932|P1|COMPLETED|Overall Study||102
8526846|NCT00349778|21017932|P1|STARTED|Overall Study||102
8526847|NCT00349752|21017940|P2|NOT COMPLETED|Overall Study||64
8526848|NCT00349752|21017941|P1|NOT COMPLETED|Overall Study||59
8526849|NCT00349752|21017940|P2|COMPLETED|Overall Study||23
8526850|NCT00349752|21017941|P1|COMPLETED|Overall Study||28
8526851|NCT00349752|21017940|P2|STARTED|Overall Study||87
8526852|NCT00349752|21017941|P1|STARTED|Overall Study||87
8526853|NCT00349713|21017970|P3|NOT COMPLETED|Overall Study||0
8526854|NCT00349713|21017971|P2|NOT COMPLETED|Overall Study||0
8526855|NCT00349713|21017972|P1|NOT COMPLETED|Overall Study||0
8526856|NCT00349713|21017970|P3|COMPLETED|Overall Study||20
8526857|NCT00349713|21017971|P2|COMPLETED|Overall Study||20
8526858|NCT00349713|21017972|P1|COMPLETED|Overall Study||20
8526859|NCT00349713|21017970|P3|STARTED|Overall Study||20
8526860|NCT00349713|21017971|P2|STARTED|Overall Study||20
8526861|NCT00349713|21017972|P1|STARTED|Overall Study||20
8526862|NCT00349622|21017994|P2|NOT COMPLETED|Overall Study||96
8526863|NCT00349622|21017995|P1|NOT COMPLETED|Overall Study||178
8526864|NCT00349622|21017994|P2|COMPLETED|Overall Study||77
8526865|NCT00349622|21017995|P1|COMPLETED|Overall Study||162
8526866|NCT00349622|21017994|P2|STARTED|Overall Study||173
8526867|NCT00349622|21017995|P1|STARTED|Overall Study||340
8526868|NCT00349466|21018013|P2|NOT COMPLETED|Overall Study||3
8526869|NCT00349466|21018014|P1|NOT COMPLETED|Overall Study||9
8526870|NCT00349466|21018013|P2|COMPLETED|Overall Study||35
8526871|NCT00349466|21018014|P1|COMPLETED|Overall Study||33
8526872|NCT00349466|21018013|P2|STARTED|Overall Study||38
8526873|NCT00349466|21018014|P1|STARTED|Overall Study||42
8526874|NCT00349388|21018022|P2|NOT COMPLETED|Overall Study||0
8526875|NCT00349388|21018023|P1|NOT COMPLETED|Overall Study||0
8526876|NCT00349388|21018022|P2|COMPLETED|Overall Study||1
8526877|NCT00349388|21018023|P1|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
8526878|NCT00349388|21018022|P2|STARTED|Overall Study||1
8526879|NCT00349388|21018023|P1|STARTED|Overall Study|no patients enrolled|0
8526880|NCT00349349|21018034|P3|NOT COMPLETED|Overall Study||6
8526881|NCT00349349|21018035|P2|NOT COMPLETED|Overall Study||62
8526882|NCT00349349|21018036|P1|NOT COMPLETED|Overall Study||53
8526883|NCT00349349|21018034|P3|COMPLETED|Overall Study||10
8526884|NCT00349349|21018035|P2|COMPLETED|Overall Study||50
8526885|NCT00349349|21018036|P1|COMPLETED|Overall Study||42
8526886|NCT00349349|21018034|P3|STARTED|Overall Study||16
8526887|NCT00349349|21018035|P2|STARTED|Overall Study||112
8526888|NCT00349349|21018036|P1|STARTED|Overall Study||95
8526889|NCT00349336|21018102|P2|NOT COMPLETED|Overall Study||14
8526890|NCT00349336|21018103|P1|NOT COMPLETED|Overall Study||13
8526891|NCT00349336|21018102|P2|COMPLETED|Overall Study||18
8526892|NCT00349336|21018103|P1|COMPLETED|Overall Study||19
8526893|NCT00349336|21018102|P2|STARTED|Overall Study||32
8526894|NCT00349336|21018103|P1|STARTED|Overall Study||32
8526895|NCT00348933|21018125|P1|NOT COMPLETED|Overall Study||25
8526896|NCT00348933|21018125|P1|COMPLETED|Overall Study||65
8526897|NCT00348933|21018125|P1|STARTED|Overall Study||90
8526898|NCT00348881|21018133|P2|NOT COMPLETED|Overall Study||12
8526899|NCT00348881|21018134|P1|NOT COMPLETED|Overall Study||17
8526900|NCT00348881|21018133|P2|COMPLETED|Overall Study||697
8526901|NCT00348881|21018134|P1|COMPLETED|Overall Study||1407
8526902|NCT00348881|21018133|P2|STARTED|Overall Study||709
8526903|NCT00348881|21018134|P1|STARTED|Overall Study||1424
8526904|NCT00348816|21018146|P1|NOT COMPLETED|Overall Study||1
8526905|NCT00348816|21018146|P1|COMPLETED|Overall Study||19
8526906|NCT00348816|21018146|P1|STARTED|Overall Study||20
8526907|NCT00348790|21018153|P1|NOT COMPLETED|Completed Treatment||25
8526908|NCT00348790|21018153|P1|COMPLETED|Completed Treatment||0
8526909|NCT00348790|21018153|P1|STARTED|Completed Treatment||25
8526910|NCT00348790|21018153|P1|NOT COMPLETED|Began Treatment||0
8526911|NCT00348790|21018153|P1|COMPLETED|Began Treatment||25
8526912|NCT00348790|21018153|P1|STARTED|Began Treatment||25
8526913|NCT00348686|21018165|P1|NOT COMPLETED|Overall Study||66
8526914|NCT00348686|21018165|P1|COMPLETED|Overall Study||249
8526915|NCT00348686|21018165|P1|STARTED|Overall Study||315
8526916|NCT00348673|21018182|P9|NOT COMPLETED|Stage 2||0
8526917|NCT00348673|21018183|P8|NOT COMPLETED|Stage 2||0
8526918|NCT00348673|21018184|P7|NOT COMPLETED|Stage 2||0
8526919|NCT00348673|21018185|P6|NOT COMPLETED|Stage 2||0
8526920|NCT00348673|21018186|P5|NOT COMPLETED|Stage 2||0
8526921|NCT00348673|21018187|P4|NOT COMPLETED|Stage 2||0
8526922|NCT00348673|21018188|P3|NOT COMPLETED|Stage 2||0
8526923|NCT00348673|21018189|P2|NOT COMPLETED|Stage 2||0
8526924|NCT00348673|21018190|P1|NOT COMPLETED|Stage 2||0
8526925|NCT00348673|21018182|P9|COMPLETED|Stage 2||2
8526926|NCT00348673|21018183|P8|COMPLETED|Stage 2||6
8526927|NCT00348673|21018184|P7|COMPLETED|Stage 2||6
8526928|NCT00348673|21018185|P6|COMPLETED|Stage 2||6
8526929|NCT00348673|21018186|P5|COMPLETED|Stage 2||0
8526930|NCT00348673|21018187|P4|COMPLETED|Stage 2||0
8526931|NCT00348673|21018188|P3|COMPLETED|Stage 2||0
8526932|NCT00348673|21018189|P2|COMPLETED|Stage 2||0
8526933|NCT00348673|21018190|P1|COMPLETED|Stage 2||0
8526934|NCT00348673|21018182|P9|STARTED|Stage 2||2
8526935|NCT00348673|21018183|P8|STARTED|Stage 2||6
8526936|NCT00348673|21018184|P7|STARTED|Stage 2||6
8526937|NCT00348673|21018185|P6|STARTED|Stage 2||6
8526938|NCT00348673|21018186|P5|STARTED|Stage 2||0
8526939|NCT00348673|21018187|P4|STARTED|Stage 2||0
8526940|NCT00348673|21018188|P3|STARTED|Stage 2||0
8526941|NCT00348673|21018189|P2|STARTED|Stage 2||0
8526942|NCT00348673|21018190|P1|STARTED|Stage 2||0
8526943|NCT00348673|21018182|P9|NOT COMPLETED|Stage 1||0
8526944|NCT00348673|21018183|P8|NOT COMPLETED|Stage 1||0
8526945|NCT00348673|21018184|P7|NOT COMPLETED|Stage 1||0
8526946|NCT00348673|21018185|P6|NOT COMPLETED|Stage 1||0
8526947|NCT00348673|21018186|P5|NOT COMPLETED|Stage 1||0
8526948|NCT00348673|21018187|P4|NOT COMPLETED|Stage 1||0
8526949|NCT00348673|21018188|P3|NOT COMPLETED|Stage 1||1
8526950|NCT00348673|21018189|P2|NOT COMPLETED|Stage 1||0
8526951|NCT00348673|21018190|P1|NOT COMPLETED|Stage 1||0
8526952|NCT00348673|21018182|P9|COMPLETED|Stage 1||0
8526953|NCT00348673|21018183|P8|COMPLETED|Stage 1||0
8526954|NCT00348673|21018184|P7|COMPLETED|Stage 1||0
8526955|NCT00348673|21018185|P6|COMPLETED|Stage 1||0
8526956|NCT00348673|21018186|P5|COMPLETED|Stage 1||4
8526957|NCT00348673|21018187|P4|COMPLETED|Stage 1||6
8526958|NCT00348673|21018188|P3|COMPLETED|Stage 1||6
8526959|NCT00348673|21018189|P2|COMPLETED|Stage 1||6
8526960|NCT00348673|21018190|P1|COMPLETED|Stage 1||6
8526961|NCT00348673|21018182|P9|Treated|Stage 1||0
8526962|NCT00348673|21018183|P8|Treated|Stage 1||0
8526963|NCT00348673|21018184|P7|Treated|Stage 1||0
8526964|NCT00348673|21018185|P6|Treated|Stage 1||0
8526965|NCT00348673|21018186|P5|Treated|Stage 1||4
8526966|NCT00348673|21018187|P4|Treated|Stage 1||6
8526967|NCT00348673|21018188|P3|Treated|Stage 1||6
8526968|NCT00348673|21018189|P2|Treated|Stage 1||6
8526969|NCT00348673|21018190|P1|Treated|Stage 1||6
8526970|NCT00348673|21018182|P9|STARTED|Stage 1||0
8526971|NCT00348673|21018183|P8|STARTED|Stage 1||0
8526972|NCT00348673|21018184|P7|STARTED|Stage 1||0
8526973|NCT00348673|21018185|P6|STARTED|Stage 1||0
8526974|NCT00348673|21018186|P5|STARTED|Stage 1||4
8526975|NCT00348673|21018187|P4|STARTED|Stage 1||6
8526976|NCT00348673|21018188|P3|STARTED|Stage 1||7
8526977|NCT00348673|21018189|P2|STARTED|Stage 1||6
8526978|NCT00348673|21018190|P1|STARTED|Stage 1||6
8526979|NCT00348595|21018239|P2|NOT COMPLETED|Overall Study||8
8526980|NCT00348595|21018240|P1|NOT COMPLETED|Overall Study||5
8526981|NCT00348595|21018239|P2|COMPLETED|Overall Study||26
8526982|NCT00348595|21018240|P1|COMPLETED|Overall Study||21
8526983|NCT00348595|21018239|P2|STARTED|Overall Study||34
8526984|NCT00348595|21018240|P1|STARTED|Overall Study||26
8526985|NCT00348556|21018252|P1|NOT COMPLETED|Overall Study||1
8526986|NCT00348556|21018252|P1|COMPLETED|Overall Study||3
8526987|NCT00348556|21018252|P1|STARTED|Overall Study||4
8526988|NCT00348374|21018259|P2|NOT COMPLETED|Overall Study||32
8526989|NCT00348374|21018260|P1|NOT COMPLETED|Overall Study||19
8526990|NCT00348374|21018259|P2|COMPLETED|Overall Study||71
8526991|NCT00348374|21018260|P1|COMPLETED|Overall Study||69
8526992|NCT00348374|21018259|P2|Received Study Treatment|Overall Study||96
8526993|NCT00348374|21018260|P1|Received Study Treatment|Overall Study||88
8526994|NCT00348374|21018259|P2|STARTED|Overall Study||103
8526995|NCT00348374|21018260|P1|STARTED|Overall Study||88
8526996|NCT00348348|21018307|P2|NOT COMPLETED|Overall Study||27
8526997|NCT00348348|21018308|P1|NOT COMPLETED|Overall Study||25
8526998|NCT00348348|21018307|P2|COMPLETED|Overall Study||555
8526999|NCT00348348|21018308|P1|COMPLETED|Overall Study||554
8527000|NCT00348348|21018307|P2|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
8527001|NCT00348348|21018308|P1|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
8527002|NCT00348309|21018323|P3|NOT COMPLETED|Overall Study||143
8527003|NCT00348309|21018324|P2|NOT COMPLETED|Overall Study||98
8527004|NCT00348309|21018325|P1|NOT COMPLETED|Overall Study||134
8527005|NCT00348309|21018323|P3|COMPLETED|Overall Study||346
8527006|NCT00348309|21018324|P2|COMPLETED|Overall Study||396
8527007|NCT00348309|21018325|P1|COMPLETED|Overall Study||362
8527008|NCT00348309|21018323|P3|STARTED|Overall Study||489
8527009|NCT00348309|21018324|P2|STARTED|Overall Study||494
8527010|NCT00348309|21018325|P1|STARTED|Overall Study||496
8527011|NCT00348283|21018398|P2|NOT COMPLETED|Open Label||34
8527012|NCT00348283|21018399|P1|NOT COMPLETED|Open Label||0
8527013|NCT00348283|21018398|P2|COMPLETED|Open Label||66
8527014|NCT00348283|21018399|P1|COMPLETED|Open Label||0
8527015|NCT00348283|21018398|P2|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
8527016|NCT00348283|21018399|P1|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
8527017|NCT00348283|21018398|P2|NOT COMPLETED|Double Blind||10
8527018|NCT00348283|21018399|P1|NOT COMPLETED|Double Blind||5
8527019|NCT00348283|21018398|P2|COMPLETED|Double Blind||54
8527020|NCT00348283|21018399|P1|COMPLETED|Double Blind||60
8527021|NCT00348283|21018398|P2|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
8527022|NCT00348283|21018399|P1|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
8527023|NCT00348283|21018398|P2|NOT COMPLETED|Induction||6
8527024|NCT00348283|21018399|P1|NOT COMPLETED|Induction||0
8527025|NCT00348283|21018398|P2|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
8527026|NCT00348283|21018399|P1|COMPLETED|Induction||0
8527027|NCT00348283|21018398|P2|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
8527028|NCT00348283|21018399|P1|STARTED|Induction||0
8527029|NCT00348205|21018415|P1|NOT COMPLETED|Overall Study||2
8527030|NCT00348205|21018415|P1|COMPLETED|Overall Study||78
8527031|NCT00348205|21018415|P1|STARTED|Overall Study||80
8527032|NCT00348140|21018428|P3|NOT COMPLETED|Overall Study||163
8527033|NCT00348140|21018429|P2|NOT COMPLETED|Overall Study||139
8527034|NCT00348140|21018430|P1|NOT COMPLETED|Overall Study||126
8527035|NCT00348140|21018428|P3|COMPLETED|Overall Study||328
8527036|NCT00348140|21018429|P2|COMPLETED|Overall Study||351
8527037|NCT00348140|21018430|P1|COMPLETED|Overall Study||361
8527038|NCT00348140|21018428|P3|STARTED|Overall Study||491
8527039|NCT00348140|21018429|P2|STARTED|Overall Study||490
8527040|NCT00348140|21018430|P1|STARTED|Overall Study||487
8527041|NCT00347958|21018528|P1|NOT COMPLETED|Overall Study||4
8527042|NCT00347958|21018528|P1|COMPLETED|Overall Study||540
8527043|NCT00347958|21018528|P1|STARTED|Overall Study||544
8527044|NCT00347932|21018537|P2|NOT COMPLETED|Overall Study||52
8527045|NCT00347932|21018538|P1|NOT COMPLETED|Overall Study||31
8527046|NCT00347932|21018537|P2|COMPLETED|Overall Study||430
8527047|NCT00347932|21018538|P1|COMPLETED|Overall Study||444
8527048|NCT00347932|21018537|P2|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
8527049|NCT00347932|21018538|P1|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
8527050|NCT00347919|21018553|P3|NOT COMPLETED|Overall Study||38
8527051|NCT00347919|21018554|P2|NOT COMPLETED|Overall Study||76
8527052|NCT00347919|21018555|P1|NOT COMPLETED|Overall Study||71
8527053|NCT00347919|21018553|P3|COMPLETED|Overall Study||2
8527054|NCT00347919|21018554|P2|COMPLETED|Overall Study||0
8527055|NCT00347919|21018555|P1|COMPLETED|Overall Study||2
8527056|NCT00347919|21018553|P3|STARTED|Overall Study|Safety Population|40
8527057|NCT00347919|21018554|P2|STARTED|Overall Study|Safety Population|76
8527058|NCT00347919|21018555|P1|STARTED|Overall Study|Safety Population|73
8527059|NCT00347776|21018578|P3|NOT COMPLETED|12 Month Follow-up||19
8527060|NCT00347776|21018579|P2|NOT COMPLETED|12 Month Follow-up||16
8527061|NCT00347776|21018580|P1|NOT COMPLETED|12 Month Follow-up||23
8527062|NCT00347776|21018578|P3|COMPLETED|12 Month Follow-up||436
8527063|NCT00347776|21018579|P2|COMPLETED|12 Month Follow-up||446
8527064|NCT00347776|21018580|P1|COMPLETED|12 Month Follow-up||425
8527065|NCT00347776|21018578|P3|STARTED|12 Month Follow-up||455
8527066|NCT00347776|21018579|P2|STARTED|12 Month Follow-up||462
8527067|NCT00347776|21018580|P1|STARTED|12 Month Follow-up||448
8527068|NCT00347776|21018578|P3|NOT COMPLETED|6 Month Follow-up||18
8527069|NCT00347776|21018579|P2|NOT COMPLETED|6 Month Follow-up||13
8527070|NCT00347776|21018580|P1|NOT COMPLETED|6 Month Follow-up||22
8527071|NCT00347776|21018578|P3|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
8527072|NCT00347776|21018579|P2|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
8527073|NCT00347776|21018580|P1|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
8527074|NCT00347776|21018578|P3|STARTED|6 Month Follow-up||473
8527075|NCT00347776|21018579|P2|STARTED|6 Month Follow-up||475
8527076|NCT00347776|21018580|P1|STARTED|6 Month Follow-up||470
8527077|NCT00347776|21018578|P3|NOT COMPLETED|1.5 Month Follow-up||12
8527078|NCT00347776|21018579|P2|NOT COMPLETED|1.5 Month Follow-up||8
8527079|NCT00347776|21018580|P1|NOT COMPLETED|1.5 Month Follow-up||14
8527080|NCT00347776|21018578|P3|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
8527081|NCT00347776|21018579|P2|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
8527082|NCT00347776|21018580|P1|COMPLETED|1.5 Month Follow-up||470
8527083|NCT00347776|21018578|P3|STARTED|1.5 Month Follow-up||485
8527084|NCT00347776|21018579|P2|STARTED|1.5 Month Follow-up||483
8527085|NCT00347776|21018580|P1|STARTED|1.5 Month Follow-up||484
8527086|NCT00347438|21018592|P1|NOT COMPLETED|Overall Study||2
8527087|NCT00347438|21018592|P1|COMPLETED|Overall Study||16
8527088|NCT00347438|21018592|P1|STARTED|Overall Study||18
8527089|NCT00347360|21018614|P15|NOT COMPLETED|Overall Study||4
8527090|NCT00347360|21018615|P14|NOT COMPLETED|Overall Study||8
8527091|NCT00347360|21018616|P13|NOT COMPLETED|Overall Study||10
8527092|NCT00347360|21018617|P12|NOT COMPLETED|Overall Study||6
8527093|NCT00347360|21018618|P11|NOT COMPLETED|Overall Study||5
8527094|NCT00347360|21018619|P10|NOT COMPLETED|Overall Study||9
8527095|NCT00347360|21018620|P9|NOT COMPLETED|Overall Study||6
8527096|NCT00347360|21018621|P8|NOT COMPLETED|Overall Study||3
8527097|NCT00347360|21018622|P7|NOT COMPLETED|Overall Study||7
8527098|NCT00347360|21018623|P6|NOT COMPLETED|Overall Study||8
8527099|NCT00347360|21018624|P5|NOT COMPLETED|Overall Study||5
8527100|NCT00347360|21018625|P4|NOT COMPLETED|Overall Study||13
8527101|NCT00347360|21018626|P3|NOT COMPLETED|Overall Study||6
8527102|NCT00347360|21018627|P2|NOT COMPLETED|Overall Study||8
8527103|NCT00347360|21018628|P1|NOT COMPLETED|Overall Study||5
8527104|NCT00347360|21018614|P15|COMPLETED|Overall Study||39
8527105|NCT00347360|21018615|P14|COMPLETED|Overall Study||36
8527106|NCT00347360|21018616|P13|COMPLETED|Overall Study||34
8527107|NCT00347360|21018617|P12|COMPLETED|Overall Study||37
8527108|NCT00347360|21018618|P11|COMPLETED|Overall Study||39
8527109|NCT00347360|21018619|P10|COMPLETED|Overall Study||35
8527110|NCT00347360|21018620|P9|COMPLETED|Overall Study||38
8527111|NCT00347360|21018621|P8|COMPLETED|Overall Study||40
8527112|NCT00347360|21018622|P7|COMPLETED|Overall Study||37
8527113|NCT00347360|21018623|P6|COMPLETED|Overall Study||36
8527114|NCT00347360|21018624|P5|COMPLETED|Overall Study||39
8527115|NCT00347360|21018625|P4|COMPLETED|Overall Study||30
8527116|NCT00347360|21018626|P3|COMPLETED|Overall Study||37
8527117|NCT00347360|21018627|P2|COMPLETED|Overall Study||35
8527118|NCT00347360|21018628|P1|COMPLETED|Overall Study||39
8527119|NCT00347360|21018614|P15|STARTED|Overall Study||43
8527120|NCT00347360|21018615|P14|STARTED|Overall Study||44
8527121|NCT00347360|21018616|P13|STARTED|Overall Study||44
8527122|NCT00347360|21018617|P12|STARTED|Overall Study||43
8527123|NCT00347360|21018618|P11|STARTED|Overall Study||44
8527124|NCT00347360|21018619|P10|STARTED|Overall Study||44
8527125|NCT00347360|21018620|P9|STARTED|Overall Study||44
8527126|NCT00347360|21018621|P8|STARTED|Overall Study||43
8527127|NCT00347360|21018622|P7|STARTED|Overall Study||44
8527128|NCT00347360|21018623|P6|STARTED|Overall Study||44
8527129|NCT00347360|21018624|P5|STARTED|Overall Study||44
8527130|NCT00347360|21018625|P4|STARTED|Overall Study||43
8527131|NCT00347360|21018626|P3|STARTED|Overall Study||43
8527132|NCT00347360|21018627|P2|STARTED|Overall Study||43
8527133|NCT00347360|21018628|P1|STARTED|Overall Study||44
8527134|NCT00347308|21018810|P1|NOT COMPLETED|Overall Study||0
8527135|NCT00347308|21018810|P1|COMPLETED|Overall Study||40
8527136|NCT00347308|21018810|P1|STARTED|Overall Study||40
8527137|NCT00347269|21018816|P2|NOT COMPLETED|Overall Study||106
8527138|NCT00347269|21018817|P1|NOT COMPLETED|Overall Study||94
8527139|NCT00347269|21018816|P2|COMPLETED|Overall Study||395
8527140|NCT00347269|21018817|P1|COMPLETED|Overall Study||409
8527141|NCT00347269|21018816|P2|STARTED|Overall Study||501
8527142|NCT00347269|21018817|P1|STARTED|Overall Study||503
8527143|NCT00347022|21018825|P2|NOT COMPLETED|Overall Study||5
8527144|NCT00347022|21018826|P1|NOT COMPLETED|Overall Study||12
8527145|NCT00347022|21018825|P2|COMPLETED|Overall Study||66
8527146|NCT00347022|21018826|P1|COMPLETED|Overall Study||62
8527147|NCT00347022|21018825|P2|STARTED|Overall Study||71
8527148|NCT00347022|21018826|P1|STARTED|Overall Study||74
8527149|NCT00347009|21018832|P1|NOT COMPLETED|Overall Study||27
8527150|NCT00347009|21018832|P1|COMPLETED|Overall Study||128
8527151|NCT00347009|21018832|P1|STARTED|Overall Study||155
8527152|NCT00346905|21018849|P1|NOT COMPLETED|Overall Study||4
8527153|NCT00346905|21018849|P1|COMPLETED|Overall Study||12
8527154|NCT00346905|21018849|P1|STARTED|Overall Study||16
8527155|NCT00346775|21018853|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
8527156|NCT00346775|21018854|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
8527157|NCT00346775|21018853|P2|COMPLETED|Period 3: Intervention Period 2||45
8527158|NCT00346775|21018854|P1|COMPLETED|Period 3: Intervention Period 2||44
8527159|NCT00346775|21018853|P2|STARTED|Period 3: Intervention Period 2||45
8527160|NCT00346775|21018854|P1|STARTED|Period 3: Intervention Period 2||44
8527161|NCT00346775|21018853|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8527162|NCT00346775|21018854|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8527163|NCT00346775|21018853|P2|COMPLETED|Period 2: Washout Period (7 Days)||45
8527164|NCT00346775|21018854|P1|COMPLETED|Period 2: Washout Period (7 Days)||44
8527165|NCT00346775|21018853|P2|STARTED|Period 2: Washout Period (7 Days)||45
8527166|NCT00346775|21018854|P1|STARTED|Period 2: Washout Period (7 Days)||44
8527167|NCT00346775|21018853|P2|NOT COMPLETED|Period 1: Intervention Period 1||3
8527168|NCT00346775|21018854|P1|NOT COMPLETED|Period 1: Intervention Period 1||5
8527169|NCT00346775|21018853|P2|COMPLETED|Period 1: Intervention Period 1||45
8527170|NCT00346775|21018854|P1|COMPLETED|Period 1: Intervention Period 1||44
8527171|NCT00346775|21018853|P2|STARTED|Period 1: Intervention Period 1||48
8527172|NCT00346775|21018854|P1|STARTED|Period 1: Intervention Period 1||49
8527173|NCT00346697|21018866|P2|NOT COMPLETED|Overall Study||1
8527174|NCT00346697|21018867|P1|NOT COMPLETED|Overall Study||0
8527175|NCT00346697|21018866|P2|COMPLETED|Overall Study||23
8527176|NCT00346697|21018867|P1|COMPLETED|Overall Study||24
8527177|NCT00346697|21018866|P2|STARTED|Overall Study||24
8527178|NCT00346697|21018867|P1|STARTED|Overall Study||24
8527179|NCT00346632|21018903|P10|NOT COMPLETED|Overall Study||3
8527180|NCT00346632|21018904|P9|NOT COMPLETED|Overall Study||4
8527181|NCT00346632|21018905|P8|NOT COMPLETED|Overall Study||4
8527182|NCT00346632|21018906|P7|NOT COMPLETED|Overall Study||5
8527183|NCT00346632|21018907|P6|NOT COMPLETED|Overall Study||2
8527184|NCT00346632|21018908|P5|NOT COMPLETED|Overall Study||4
8527185|NCT00346632|21018909|P4|NOT COMPLETED|Overall Study||3
8527186|NCT00346632|21018910|P3|NOT COMPLETED|Overall Study||6
8527187|NCT00346632|21018911|P2|NOT COMPLETED|Overall Study||3
8527188|NCT00346632|21018912|P1|NOT COMPLETED|Overall Study||3
8527189|NCT00346632|21018903|P10|COMPLETED|Overall Study||0
8527190|NCT00346632|21018904|P9|COMPLETED|Overall Study||0
8527191|NCT00346632|21018905|P8|COMPLETED|Overall Study||0
8527192|NCT00346632|21018906|P7|COMPLETED|Overall Study||0
8527193|NCT00346632|21018907|P6|COMPLETED|Overall Study||0
8527194|NCT00346632|21018908|P5|COMPLETED|Overall Study||0
8527195|NCT00346632|21018909|P4|COMPLETED|Overall Study||0
8527196|NCT00346632|21018910|P3|COMPLETED|Overall Study||0
8527197|NCT00346632|21018911|P2|COMPLETED|Overall Study||0
8527198|NCT00346632|21018912|P1|COMPLETED|Overall Study||0
8527199|NCT00346632|21018903|P10|STARTED|Overall Study||3
8527200|NCT00346632|21018904|P9|STARTED|Overall Study||4
8527201|NCT00346632|21018905|P8|STARTED|Overall Study||4
8527202|NCT00346632|21018906|P7|STARTED|Overall Study||5
8527203|NCT00346632|21018907|P6|STARTED|Overall Study||2
8527204|NCT00346632|21018908|P5|STARTED|Overall Study||4
8527205|NCT00346632|21018909|P4|STARTED|Overall Study||3
8527206|NCT00346632|21018910|P3|STARTED|Overall Study||6
8527207|NCT00346632|21018911|P2|STARTED|Overall Study||3
8527208|NCT00346632|21018912|P1|STARTED|Overall Study||3
8527209|NCT00346476|21019055|P1|NOT COMPLETED|Overall Study||0
8527210|NCT00346476|21019055|P1|COMPLETED|Overall Study||1250
8527211|NCT00346476|21019055|P1|STARTED|Overall Study||1250
8527212|NCT00346398|21019062|P2|NOT COMPLETED|Overall Study||2
8527213|NCT00346398|21019063|P1|NOT COMPLETED|Overall Study||3
8527214|NCT00346398|21019062|P2|COMPLETED|Overall Study||24
8527215|NCT00346398|21019063|P1|COMPLETED|Overall Study||22
8527216|NCT00346398|21019062|P2|STARTED|Overall Study||26
8527217|NCT00346398|21019063|P1|STARTED|Overall Study||25
8527218|NCT00346333|21019075|P2|NOT COMPLETED|Overall Study||8
8527219|NCT00346333|21019076|P1|NOT COMPLETED|Overall Study||5
8527220|NCT00346333|21019075|P2|COMPLETED|Overall Study||111
8527221|NCT00346333|21019076|P1|COMPLETED|Overall Study||116
8527222|NCT00346333|21019075|P2|STARTED|Overall Study||119
8527223|NCT00346333|21019076|P1|STARTED|Overall Study||121
8527224|NCT00346268|21019092|P2|NOT COMPLETED|Overall Study||3
8527225|NCT00346268|21019093|P1|NOT COMPLETED|Overall Study||2
8527226|NCT00346268|21019092|P2|COMPLETED|Overall Study||50
8527227|NCT00346268|21019093|P1|COMPLETED|Overall Study||50
8527228|NCT00346268|21019092|P2|STARTED|Overall Study||53
8527229|NCT00346268|21019093|P1|STARTED|Overall Study||52
8527251|NCT00346151|21019189|P1|NOT COMPLETED|Overall Study||3
8527252|NCT00346151|21019189|P1|COMPLETED|Overall Study||2
8527253|NCT00346151|21019189|P1|STARTED|Overall Study||5
8527254|NCT00346073|21019209|P2|NOT COMPLETED|Overall Study||24
8527255|NCT00346073|21019210|P1|NOT COMPLETED|Overall Study||41
8527256|NCT00346073|21019209|P2|COMPLETED|Overall Study||738
8527257|NCT00346073|21019210|P1|COMPLETED|Overall Study||1481
8527258|NCT00346073|21019209|P2|STARTED|Overall Study||762
8527259|NCT00346073|21019210|P1|STARTED|Overall Study||1522
8527260|NCT00346034|21019244|P1|NOT COMPLETED|Overall Study||57
8527261|NCT00346034|21019244|P1|COMPLETED|Overall Study||300
8527262|NCT00346034|21019244|P1|STARTED|Overall Study||357
8527263|NCT00345969|21019251|P2|NOT COMPLETED|Overall Study||2
8527264|NCT00345969|21019252|P1|NOT COMPLETED|Overall Study||1
8527265|NCT00345969|21019251|P2|COMPLETED|Overall Study||11
8527266|NCT00345969|21019252|P1|COMPLETED|Overall Study||11
8527267|NCT00345969|21019251|P2|STARTED|Overall Study||13
8527268|NCT00345969|21019252|P1|STARTED|Overall Study||12
8527269|NCT00345878|21019284|P2|NOT COMPLETED|Overall Study||1
8527270|NCT00345878|21019285|P1|NOT COMPLETED|Overall Study||4
8527271|NCT00345878|21019284|P2|COMPLETED|Overall Study||135
8527272|NCT00345878|21019285|P1|COMPLETED|Overall Study||131
8527273|NCT00345878|21019284|P2|STARTED|Overall Study||136
8527274|NCT00345878|21019285|P1|STARTED|Overall Study||135
8527275|NCT00345865|21019306|P5|NOT COMPLETED|Overall Study||0
8527276|NCT00345865|21019307|P4|NOT COMPLETED|Overall Study||0
8527277|NCT00345865|21019308|P3|NOT COMPLETED|Overall Study||0
8527278|NCT00345865|21019309|P2|NOT COMPLETED|Overall Study||0
8527279|NCT00345865|21019310|P1|NOT COMPLETED|Overall Study||0
8527280|NCT00345865|21019306|P5|COMPLETED|Overall Study||146
8527281|NCT00345865|21019307|P4|COMPLETED|Overall Study||5
8527282|NCT00345865|21019308|P3|COMPLETED|Overall Study||2
8527283|NCT00345865|21019309|P2|COMPLETED|Overall Study||149
8527284|NCT00345865|21019310|P1|COMPLETED|Overall Study||171
8527285|NCT00345865|21019306|P5|STARTED|Overall Study||146
8527286|NCT00345865|21019307|P4|STARTED|Overall Study||5
8527287|NCT00345865|21019308|P3|STARTED|Overall Study||2
8527288|NCT00345865|21019309|P2|STARTED|Overall Study||149
8527289|NCT00345865|21019310|P1|STARTED|Overall Study||171
8527290|NCT00345839|21019344|P2|NOT COMPLETED|Overall Study||159
8527291|NCT00345839|21019345|P1|NOT COMPLETED|Overall Study||149
8527384|NCT00345358|21019518|P3|NOT COMPLETED|Primary Vaccination Phase||8
8527292|NCT00345839|21019344|P2|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
8527293|NCT00345839|21019345|P1|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
8527294|NCT00345839|21019344|P2|STARTED|Overall Study|Randomized to placebo|1935
8527295|NCT00345839|21019345|P1|STARTED|Overall Study|Randomized to cinacalcet|1948
8527296|NCT00345683|21019371|P2|NOT COMPLETED|Overall Study||9
8527297|NCT00345683|21019372|P1|NOT COMPLETED|Overall Study||25
8527298|NCT00345683|21019371|P2|COMPLETED|Overall Study||1001
8527299|NCT00345683|21019372|P1|COMPLETED|Overall Study||2985
8527300|NCT00345683|21019371|P2|STARTED|Overall Study||1010
8527301|NCT00345683|21019372|P1|STARTED|Overall Study||3010
8527302|NCT00345631|21019395|P3|NOT COMPLETED|Overall Study||6
8527303|NCT00345631|21019396|P2|NOT COMPLETED|Overall Study||8
8527304|NCT00345631|21019397|P1|NOT COMPLETED|Overall Study||4
8527305|NCT00345631|21019395|P3|COMPLETED|Overall Study||128
8527306|NCT00345631|21019396|P2|COMPLETED|Overall Study||259
8527307|NCT00345631|21019397|P1|COMPLETED|Overall Study||83
8527308|NCT00345631|21019395|P3|STARTED|Overall Study||134
8527309|NCT00345631|21019396|P2|STARTED|Overall Study||267
8527310|NCT00345631|21019397|P1|STARTED|Overall Study||87
8527311|NCT00345605|21019429|P2|NOT COMPLETED|Arm 2, Opposite Treatment||0
8527312|NCT00345605|21019430|P1|NOT COMPLETED|Arm 2, Opposite Treatment||1
8527313|NCT00345605|21019429|P2|COMPLETED|Arm 2, Opposite Treatment||6
8527314|NCT00345605|21019430|P1|COMPLETED|Arm 2, Opposite Treatment||5
8527315|NCT00345605|21019429|P2|STARTED|Arm 2, Opposite Treatment||6
8527316|NCT00345605|21019430|P1|STARTED|Arm 2, Opposite Treatment||6
8527317|NCT00345605|21019429|P2|NOT COMPLETED|Crossover Wash-out||0
8527318|NCT00345605|21019430|P1|NOT COMPLETED|Crossover Wash-out||0
8527319|NCT00345605|21019429|P2|COMPLETED|Crossover Wash-out||6
8527320|NCT00345605|21019430|P1|COMPLETED|Crossover Wash-out||6
8527321|NCT00345605|21019429|P2|STARTED|Crossover Wash-out||6
8527322|NCT00345605|21019430|P1|STARTED|Crossover Wash-out||6
8527323|NCT00345605|21019429|P2|NOT COMPLETED|Interval||0
8527324|NCT00345605|21019430|P1|NOT COMPLETED|Interval||0
8527325|NCT00345605|21019429|P2|COMPLETED|Interval||6
8527326|NCT00345605|21019430|P1|COMPLETED|Interval||6
8527327|NCT00345605|21019429|P2|STARTED|Interval||6
8527328|NCT00345605|21019430|P1|STARTED|Interval||6
8527329|NCT00345605|21019429|P2|NOT COMPLETED|Arm 1||1
8527330|NCT00345605|21019430|P1|NOT COMPLETED|Arm 1||0
8527331|NCT00345605|21019429|P2|COMPLETED|Arm 1||5
8527332|NCT00345605|21019430|P1|COMPLETED|Arm 1||6
8527333|NCT00345605|21019429|P2|STARTED|Arm 1||6
8527334|NCT00345605|21019430|P1|STARTED|Arm 1||6
8527335|NCT00345605|21019429|P2|NOT COMPLETED|Initial Washout||0
8527336|NCT00345605|21019430|P1|NOT COMPLETED|Initial Washout||0
8527337|NCT00345605|21019429|P2|COMPLETED|Initial Washout||6
8527338|NCT00345605|21019430|P1|COMPLETED|Initial Washout||6
8527339|NCT00345605|21019429|P2|STARTED|Initial Washout||6
8527340|NCT00345605|21019430|P1|STARTED|Initial Washout||6
8527341|NCT00345592|21019450|P2|NOT COMPLETED|Overall Study||24
8527342|NCT00345592|21019451|P1|NOT COMPLETED|Overall Study||25
8527343|NCT00345592|21019450|P2|COMPLETED|Overall Study||173
8527344|NCT00345592|21019451|P1|COMPLETED|Overall Study||174
8527345|NCT00345592|21019450|P2|STARTED|Overall Study||197
8527346|NCT00345592|21019451|P1|STARTED|Overall Study||199
8527347|NCT00345579|21019459|P2|NOT COMPLETED|Overall Study||65
8527348|NCT00345579|21019460|P1|NOT COMPLETED|Overall Study||164
8527349|NCT00345579|21019459|P2|COMPLETED|Overall Study||1048
8527350|NCT00345579|21019460|P1|COMPLETED|Overall Study||3114
8527351|NCT00345579|21019459|P2|STARTED|Overall Study||1113
8527352|NCT00345579|21019460|P1|STARTED|Overall Study||3278
8527353|NCT00345540|21019480|P1|NOT COMPLETED|Overall Study||1
8527354|NCT00345540|21019480|P1|COMPLETED|Overall Study||15
8527355|NCT00345540|21019480|P1|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
8527356|NCT00345397|21019486|P1|NOT COMPLETED|Overall Study||1
8527357|NCT00345397|21019486|P1|COMPLETED|Overall Study||6
8527358|NCT00345397|21019486|P1|STARTED|Overall Study||7
8527359|NCT00345384|21019493|P2|NOT COMPLETED|Overall Study||0
8527360|NCT00345384|21019494|P1|NOT COMPLETED|Overall Study||0
8527361|NCT00345384|21019493|P2|COMPLETED|Overall Study||19
8527362|NCT00345384|21019494|P1|COMPLETED|Overall Study||19
8527363|NCT00345384|21019493|P2|STARTED|Overall Study||19
8527364|NCT00345384|21019494|P1|STARTED|Overall Study||19
8527365|NCT00345371|21019504|P2|NOT COMPLETED|Overall Study||33
8527366|NCT00345371|21019505|P1|NOT COMPLETED|Overall Study||30
8527367|NCT00345371|21019504|P2|COMPLETED|Overall Study||38
8527368|NCT00345371|21019505|P1|COMPLETED|Overall Study||39
8527369|NCT00345371|21019504|P2|STARTED|Overall Study||71
8527370|NCT00345371|21019505|P1|STARTED|Overall Study||69
8527371|NCT00345358|21019517|P4|NOT COMPLETED|Booster Vaccination Phase||0
8527372|NCT00345358|21019518|P3|NOT COMPLETED|Booster Vaccination Phase||0
8527373|NCT00345358|21019519|P2|NOT COMPLETED|Booster Vaccination Phase||0
8527374|NCT00345358|21019520|P1|NOT COMPLETED|Booster Vaccination Phase||4
8527375|NCT00345358|21019517|P4|COMPLETED|Booster Vaccination Phase||0
8527376|NCT00345358|21019518|P3|COMPLETED|Booster Vaccination Phase||0
8527377|NCT00345358|21019519|P2|COMPLETED|Booster Vaccination Phase||145
8527378|NCT00345358|21019520|P1|COMPLETED|Booster Vaccination Phase||141
8527379|NCT00345358|21019517|P4|STARTED|Booster Vaccination Phase||0
8527380|NCT00345358|21019518|P3|STARTED|Booster Vaccination Phase||0
8527381|NCT00345358|21019519|P2|STARTED|Booster Vaccination Phase||145
8527382|NCT00345358|21019520|P1|STARTED|Booster Vaccination Phase||145
8527383|NCT00345358|21019517|P4|NOT COMPLETED|Primary Vaccination Phase||2
8527385|NCT00345358|21019519|P2|NOT COMPLETED|Primary Vaccination Phase||4
8527386|NCT00345358|21019520|P1|NOT COMPLETED|Primary Vaccination Phase||5
8527387|NCT00345358|21019517|P4|COMPLETED|Primary Vaccination Phase||148
8527388|NCT00345358|21019518|P3|COMPLETED|Primary Vaccination Phase||142
8527389|NCT00345358|21019519|P2|COMPLETED|Primary Vaccination Phase||146
8527390|NCT00345358|21019520|P1|COMPLETED|Primary Vaccination Phase||145
8527391|NCT00345358|21019517|P4|STARTED|Primary Vaccination Phase||150
8527392|NCT00345358|21019518|P3|STARTED|Primary Vaccination Phase||150
8527393|NCT00345358|21019519|P2|STARTED|Primary Vaccination Phase||150
8527394|NCT00345358|21019520|P1|STARTED|Primary Vaccination Phase||150
8527398|NCT00345332|21019601|P2|NOT COMPLETED|Overall Study||0
8527399|NCT00345332|21019602|P1|NOT COMPLETED|Overall Study||0
8527400|NCT00345332|21019601|P2|COMPLETED|Overall Study||20
8527401|NCT00345332|21019602|P1|COMPLETED|Overall Study||11
8527402|NCT00345332|21019601|P2|STARTED|Overall Study||20
8527403|NCT00345332|21019602|P1|STARTED|Overall Study||11
8527404|NCT00345293|21019610|P2|NOT COMPLETED|Overall Study||0
8527405|NCT00345293|21019611|P1|NOT COMPLETED|Overall Study||2
8527406|NCT00345293|21019610|P2|COMPLETED|Overall Study||3
8527407|NCT00345293|21019611|P1|COMPLETED|Overall Study||8
8527408|NCT00345293|21019610|P2|STARTED|Overall Study||3
8527409|NCT00345293|21019611|P1|STARTED|Overall Study||10
8527410|NCT00345254|21019620|P2|NOT COMPLETED|Overall Study||0
8527411|NCT00345254|21019621|P1|NOT COMPLETED|Overall Study||0
8527412|NCT00345254|21019620|P2|COMPLETED|Overall Study||30
8527413|NCT00345254|21019621|P1|COMPLETED|Overall Study||30
8527414|NCT00345254|21019620|P2|STARTED|Overall Study||30
8527415|NCT00345254|21019621|P1|STARTED|Overall Study||30
8527416|NCT00345176|21019631|P4|NOT COMPLETED|Overall Study||10
8527417|NCT00345176|21019632|P3|NOT COMPLETED|Overall Study||6
8527418|NCT00345176|21019633|P2|NOT COMPLETED|Overall Study||6
8527419|NCT00345176|21019634|P1|NOT COMPLETED|Overall Study||5
8527420|NCT00345176|21019631|P4|COMPLETED|Overall Study||1069
8527421|NCT00345176|21019632|P3|COMPLETED|Overall Study||1062
8527422|NCT00345176|21019633|P2|COMPLETED|Overall Study||1038
8527423|NCT00345176|21019634|P1|COMPLETED|Overall Study||1007
8527424|NCT00345176|21019631|P4|STARTED|Overall Study||1079
8527425|NCT00345176|21019632|P3|STARTED|Overall Study||1068
8527426|NCT00345176|21019633|P2|STARTED|Overall Study||1044
8527427|NCT00345176|21019634|P1|STARTED|Overall Study||1012
8527428|NCT00345046|21019657|P3|NOT COMPLETED|Overall Study||2
8527429|NCT00345046|21019658|P2|NOT COMPLETED|Overall Study||1
8527430|NCT00345046|21019659|P1|NOT COMPLETED|Overall Study||1
8527431|NCT00345046|21019657|P3|COMPLETED|Overall Study||14
8527432|NCT00345046|21019658|P2|COMPLETED|Overall Study||21
8527433|NCT00345046|21019659|P1|COMPLETED|Overall Study||17
8527434|NCT00345046|21019657|P3|STARTED|Overall Study||16
8527435|NCT00345046|21019658|P2|STARTED|Overall Study||22
8527436|NCT00345046|21019659|P1|STARTED|Overall Study||18
8527437|NCT00345033|21019669|P2|NOT COMPLETED|Overall Study||4
8527438|NCT00345033|21019670|P1|NOT COMPLETED|Overall Study||4
8527439|NCT00345033|21019669|P2|COMPLETED|Overall Study||14
8527440|NCT00345033|21019670|P1|COMPLETED|Overall Study||16
8527441|NCT00345033|21019669|P2|STARTED|Overall Study||18
8527442|NCT00345033|21019670|P1|STARTED|Overall Study||20
8527443|NCT00344968|21019689|P3|NOT COMPLETED|Overall Study||116
8527444|NCT00344968|21019690|P2|NOT COMPLETED|Overall Study||102
8527445|NCT00344968|21019691|P1|NOT COMPLETED|Overall Study||59
8527446|NCT00344968|21019689|P3|COMPLETED|Overall Study||279
8527447|NCT00344968|21019690|P2|COMPLETED|Overall Study||274
8527448|NCT00344968|21019691|P1|COMPLETED|Overall Study||126
8527449|NCT00344968|21019689|P3|STARTED|Overall Study||395
8527450|NCT00344968|21019690|P2|STARTED|Overall Study||376
8527451|NCT00344968|21019691|P1|STARTED|Overall Study||185
8527452|NCT00344773|21019702|P1|NOT COMPLETED|Overall Study||21
8527453|NCT00344773|21019702|P1|COMPLETED|Overall Study||25
8527454|NCT00344773|21019702|P1|STARTED|Overall Study||46
8527455|NCT00344682|21019710|P2|NOT COMPLETED|Overall Study||1
8527456|NCT00344682|21019711|P1|NOT COMPLETED|Overall Study||4
8527457|NCT00344682|21019710|P2|COMPLETED|Overall Study||14
8527458|NCT00344682|21019711|P1|COMPLETED|Overall Study||12
8527459|NCT00344682|21019710|P2|STARTED|Overall Study||15
8527460|NCT00344682|21019711|P1|STARTED|Overall Study||16
8527461|NCT00344500|21019725|P3|NOT COMPLETED|Overall Study||2
8527462|NCT00344500|21019726|P2|NOT COMPLETED|Overall Study||35
8527463|NCT00344500|21019727|P1|NOT COMPLETED|Overall Study||23
8527464|NCT00344500|21019725|P3|COMPLETED|Overall Study||12
8527465|NCT00344500|21019726|P2|COMPLETED|Overall Study||25
8527466|NCT00344500|21019727|P1|COMPLETED|Overall Study||25
8527467|NCT00344500|21019725|P3|STARTED|Overall Study||14
8527468|NCT00344500|21019726|P2|STARTED|Overall Study||60
8527469|NCT00344500|21019727|P1|STARTED|Overall Study||48
8527470|NCT00344487|21019738|P1|NOT COMPLETED|Overall Study||1
8527471|NCT00344487|21019738|P1|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
8527472|NCT00344487|21019738|P1|STARTED|Overall Study||3
8527473|NCT00344461|21019742|P1|NOT COMPLETED|Overall Study||21
8527474|NCT00344461|21019742|P1|COMPLETED|Overall Study||33
8527475|NCT00344461|21019742|P1|STARTED|Overall Study||54
8527476|NCT00344448|21019753|P2|NOT COMPLETED|Open Label||1
8527477|NCT00344448|21019754|P1|NOT COMPLETED|Open Label||2
8527478|NCT00344448|21019753|P2|COMPLETED|Open Label||2
8527479|NCT00344448|21019754|P1|COMPLETED|Open Label||2
8527480|NCT00344448|21019753|P2|STARTED|Open Label||3
8527481|NCT00344448|21019754|P1|STARTED|Open Label||4
8527482|NCT00344448|21019753|P2|NOT COMPLETED|Double Blind, Placebo Controlled||0
8527483|NCT00344448|21019754|P1|NOT COMPLETED|Double Blind, Placebo Controlled||2
8527484|NCT00344448|21019753|P2|COMPLETED|Double Blind, Placebo Controlled||3
8527485|NCT00344448|21019754|P1|COMPLETED|Double Blind, Placebo Controlled||4
8527486|NCT00344448|21019753|P2|STARTED|Double Blind, Placebo Controlled||3
8527487|NCT00344448|21019754|P1|STARTED|Double Blind, Placebo Controlled||6
8527488|NCT00344448|21019753|P2|NOT COMPLETED|Screening||1
8527489|NCT00344448|21019754|P1|NOT COMPLETED|Screening||0
8527490|NCT00344448|21019753|P2|COMPLETED|Screening||3
8527491|NCT00344448|21019754|P1|COMPLETED|Screening||6
8527492|NCT00344448|21019753|P2|STARTED|Screening||4
8527493|NCT00344448|21019754|P1|STARTED|Screening|No randomization during the screening phase|6
8527494|NCT00344370|21019762|P2|NOT COMPLETED|Overall Study||3
8527495|NCT00344370|21019763|P1|NOT COMPLETED|Overall Study||15
8527496|NCT00344370|21019762|P2|COMPLETED|Overall Study||68
8527497|NCT00344370|21019763|P1|COMPLETED|Overall Study||128
8527498|NCT00344370|21019762|P2|STARTED|Overall Study||71
8527499|NCT00344370|21019763|P1|STARTED|Overall Study||143
8527500|NCT00344318|21019775|P4|NOT COMPLETED|Overall Study||3
8527501|NCT00344318|21019776|P3|NOT COMPLETED|Overall Study||1
8527502|NCT00344318|21019777|P2|NOT COMPLETED|Overall Study||5
8527503|NCT00344318|21019778|P1|NOT COMPLETED|Overall Study||4
8527504|NCT00344318|21019775|P4|COMPLETED|Overall Study||100
8527505|NCT00344318|21019776|P3|COMPLETED|Overall Study||99
8527506|NCT00344318|21019777|P2|COMPLETED|Overall Study||298
8527507|NCT00344318|21019778|P1|COMPLETED|Overall Study||296
8527508|NCT00344318|21019775|P4|STARTED|Overall Study||103
8527509|NCT00344318|21019776|P3|STARTED|Overall Study||100
8527510|NCT00344318|21019777|P2|STARTED|Overall Study||303
8527511|NCT00344318|21019778|P1|STARTED|Overall Study||300
8527512|NCT00344305|21019900|P2|NOT COMPLETED|Overall Study||1
8527513|NCT00344305|21019901|P1|NOT COMPLETED|Overall Study||2
8527514|NCT00344305|21019900|P2|COMPLETED|Overall Study||99
8527515|NCT00344305|21019901|P1|COMPLETED|Overall Study||98
8527516|NCT00344305|21019900|P2|STARTED|Overall Study||100
8527517|NCT00344305|21019901|P1|STARTED|Overall Study||100
8527518|NCT00344175|21019938|P2|NOT COMPLETED|Overall Study||10
8527519|NCT00344175|21019939|P1|NOT COMPLETED|Overall Study||12
8527520|NCT00344175|21019938|P2|COMPLETED|Overall Study||47
8527521|NCT00344175|21019939|P1|COMPLETED|Overall Study||109
8527522|NCT00344175|21019938|P2|STARTED|Overall Study||57
8527523|NCT00344175|21019939|P1|STARTED|Overall Study||121
8527524|NCT00344032|21019951|P2|NOT COMPLETED|Overall Study||10
8527525|NCT00344032|21019952|P1|NOT COMPLETED|Overall Study||14
8527526|NCT00344032|21019951|P2|COMPLETED|Overall Study||168
8527527|NCT00344032|21019952|P1|COMPLETED|Overall Study||162
8527528|NCT00344032|21019951|P2|STARTED|Overall Study||178
8527529|NCT00344032|21019952|P1|STARTED|Overall Study||176
8527530|NCT00344019|21019971|P3|NOT COMPLETED|Overall Study||74
8527531|NCT00344019|21019972|P2|NOT COMPLETED|Overall Study||0
8527532|NCT00344019|21019973|P1|NOT COMPLETED|Overall Study||0
8527533|NCT00344019|21019971|P3|COMPLETED|Overall Study||0
8527534|NCT00344019|21019972|P2|COMPLETED|Overall Study||11
8527535|NCT00344019|21019973|P1|COMPLETED|Overall Study||12
8527536|NCT00344019|21019971|P3|STARTED|Overall Study||74
8527537|NCT00344019|21019972|P2|STARTED|Overall Study||11
8527538|NCT00344019|21019973|P1|STARTED|Overall Study||12
8527539|NCT00343915|21019991|P2|NOT COMPLETED|Month 66 Follow-up||0
8527540|NCT00343915|21019992|P1|NOT COMPLETED|Month 66 Follow-up||0
8527541|NCT00343915|21019991|P2|COMPLETED|Month 66 Follow-up||76
8527542|NCT00343915|21019992|P1|COMPLETED|Month 66 Follow-up||158
8527543|NCT00343915|21019991|P2|STARTED|Month 66 Follow-up||76
8527544|NCT00343915|21019992|P1|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
8527545|NCT00343915|21019991|P2|NOT COMPLETED|Month 54 Follow-up||0
8527546|NCT00343915|21019992|P1|NOT COMPLETED|Month 54 Follow-up||0
8527547|NCT00343915|21019991|P2|COMPLETED|Month 54 Follow-up||79
8527548|NCT00343915|21019992|P1|COMPLETED|Month 54 Follow-up||166
8527549|NCT00343915|21019991|P2|STARTED|Month 54 Follow-up||79
8527550|NCT00343915|21019992|P1|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
8527551|NCT00343915|21019991|P2|NOT COMPLETED|Month 42 Follow-up||0
8527552|NCT00343915|21019992|P1|NOT COMPLETED|Month 42 Follow-up||0
8527553|NCT00343915|21019991|P2|COMPLETED|Month 42 Follow-up||84
8527554|NCT00343915|21019992|P1|COMPLETED|Month 42 Follow-up||174
8527555|NCT00343915|21019991|P2|STARTED|Month 42 Follow-up||84
8527556|NCT00343915|21019992|P1|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
8527557|NCT00343915|21019991|P2|NOT COMPLETED|Month 30 Follow-up||0
8527558|NCT00343915|21019992|P1|NOT COMPLETED|Month 30 Follow-up||0
8527559|NCT00343915|21019991|P2|COMPLETED|Month 30 Follow-up||88
8527560|NCT00343915|21019992|P1|COMPLETED|Month 30 Follow-up||179
8527561|NCT00343915|21019991|P2|STARTED|Month 30 Follow-up||88
8527562|NCT00343915|21019992|P1|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
8527563|NCT00343915|21019991|P2|NOT COMPLETED|Primary Study||3
8527564|NCT00343915|21019992|P1|NOT COMPLETED|Primary Study||4
8527565|NCT00343915|21019991|P2|COMPLETED|Primary Study||123
8527566|NCT00343915|21019992|P1|COMPLETED|Primary Study||254
8527567|NCT00343915|21019991|P2|STARTED|Primary Study||126
8527568|NCT00343915|21019992|P1|STARTED|Primary Study||258
8527569|NCT00343889|21020018|P2|NOT COMPLETED|Overall Study||1
8527570|NCT00343889|21020019|P1|NOT COMPLETED|Overall Study||3
8527571|NCT00343889|21020018|P2|COMPLETED|Overall Study||188
8527572|NCT00343889|21020019|P1|COMPLETED|Overall Study||187
8527573|NCT00343889|21020018|P2|STARTED|Overall Study||189
8527574|NCT00343889|21020019|P1|STARTED|Overall Study||190
8527575|NCT00343863|21020037|P2|NOT COMPLETED|Overall Study||0
8527576|NCT00343863|21020038|P1|NOT COMPLETED|Overall Study||0
8527577|NCT00343863|21020037|P2|COMPLETED|Overall Study||34
8527578|NCT00343863|21020038|P1|COMPLETED|Overall Study||7
8527579|NCT00343863|21020037|P2|STARTED|Overall Study||34
8527580|NCT00343863|21020038|P1|STARTED|Overall Study||7
8527581|NCT00343785|21020060|P1|NOT COMPLETED|Overall Study||0
8527582|NCT00343785|21020060|P1|COMPLETED|Overall Study||21
8527583|NCT00343785|21020060|P1|STARTED|Overall Study||21
8527584|NCT00343564|21020077|P11|NOT COMPLETED|Overall Study||0
8527585|NCT00343564|21020078|P10|NOT COMPLETED|Overall Study||0
8527586|NCT00343564|21020079|P9|NOT COMPLETED|Overall Study||0
8527587|NCT00343564|21020080|P8|NOT COMPLETED|Overall Study||0
8527588|NCT00343564|21020081|P7|NOT COMPLETED|Overall Study||0
8527589|NCT00343564|21020082|P6|NOT COMPLETED|Overall Study||0
8527590|NCT00343564|21020083|P5|NOT COMPLETED|Overall Study||0
8527591|NCT00343564|21020084|P4|NOT COMPLETED|Overall Study||0
8527592|NCT00343564|21020085|P3|NOT COMPLETED|Overall Study||0
8527593|NCT00343564|21020086|P2|NOT COMPLETED|Overall Study||0
8527594|NCT00343564|21020087|P1|NOT COMPLETED|Overall Study||0
8527595|NCT00343564|21020077|P11|COMPLETED|Overall Study||8
8527596|NCT00343564|21020078|P10|COMPLETED|Overall Study||8
8527597|NCT00343564|21020079|P9|COMPLETED|Overall Study||3
8527598|NCT00343564|21020080|P8|COMPLETED|Overall Study||3
8527599|NCT00343564|21020081|P7|COMPLETED|Overall Study||4
8527600|NCT00343564|21020082|P6|COMPLETED|Overall Study||9
8527601|NCT00343564|21020083|P5|COMPLETED|Overall Study||10
8527602|NCT00343564|21020084|P4|COMPLETED|Overall Study||7
8527603|NCT00343564|21020085|P3|COMPLETED|Overall Study||3
8527604|NCT00343564|21020086|P2|COMPLETED|Overall Study||7
8527605|NCT00343564|21020087|P1|COMPLETED|Overall Study||6
8527606|NCT00343564|21020077|P11|STARTED|Overall Study||8
8527607|NCT00343564|21020078|P10|STARTED|Overall Study||8
8527608|NCT00343564|21020079|P9|STARTED|Overall Study||3
8527609|NCT00343564|21020080|P8|STARTED|Overall Study||3
8527610|NCT00343564|21020081|P7|STARTED|Overall Study||4
8527611|NCT00343564|21020082|P6|STARTED|Overall Study||9
8527612|NCT00343564|21020083|P5|STARTED|Overall Study||10
8527613|NCT00343564|21020084|P4|STARTED|Overall Study||7
8527614|NCT00343564|21020085|P3|STARTED|Overall Study||3
8527615|NCT00343564|21020086|P2|STARTED|Overall Study||7
8527616|NCT00343564|21020087|P1|STARTED|Overall Study||6
8527617|NCT00343512|21020183|P1|NOT COMPLETED|Overall Study||2
8527618|NCT00343512|21020183|P1|COMPLETED|Overall Study||32
8527619|NCT00343512|21020183|P1|STARTED|Overall Study||34
8527620|NCT00343460|21020195|P3|NOT COMPLETED|Cycle 2 - 4||0
8527621|NCT00343460|21020196|P2|NOT COMPLETED|Cycle 2 - 4||50
8527622|NCT00343460|21020197|P1|NOT COMPLETED|Cycle 2 - 4||56
8527623|NCT00343460|21020195|P3|COMPLETED|Cycle 2 - 4||0
8527624|NCT00343460|21020196|P2|COMPLETED|Cycle 2 - 4||515
8527625|NCT00343460|21020197|P1|COMPLETED|Cycle 2 - 4||528
8527626|NCT00343460|21020195|P3|STARTED|Cycle 2 - 4||0
8527627|NCT00343460|21020196|P2|STARTED|Cycle 2 - 4||565
8527628|NCT00343460|21020197|P1|STARTED|Cycle 2 - 4||584
8527629|NCT00343460|21020195|P3|NOT COMPLETED|Cycle 1||18
8527630|NCT00343460|21020196|P2|NOT COMPLETED|Cycle 1||22
8527631|NCT00343460|21020197|P1|NOT COMPLETED|Cycle 1||22
8527632|NCT00343460|21020195|P3|COMPLETED|Cycle 1||454
8527633|NCT00343460|21020196|P2|COMPLETED|Cycle 1||459
8527634|NCT00343460|21020197|P1|COMPLETED|Cycle 1||453
8527635|NCT00343460|21020195|P3|STARTED|Cycle 1||472
8527636|NCT00343460|21020196|P2|STARTED|Cycle 1||481
8527637|NCT00343460|21020197|P1|STARTED|Cycle 1||475
8527638|NCT00343382|21020271|P3|NOT COMPLETED|Overall Study||17
8527639|NCT00343382|21020272|P2|NOT COMPLETED|Overall Study||14
8527640|NCT00343382|21020273|P1|NOT COMPLETED|Overall Study||4
8527641|NCT00343382|21020271|P3|COMPLETED|Overall Study||49
8527642|NCT00343382|21020272|P2|COMPLETED|Overall Study||51
8527643|NCT00343382|21020273|P1|COMPLETED|Overall Study||60
8527644|NCT00343382|21020271|P3|STARTED|Overall Study||66
8527645|NCT00343382|21020272|P2|STARTED|Overall Study||65
8527646|NCT00343382|21020273|P1|STARTED|Overall Study||64
8527647|NCT00343291|21020292|P2|NOT COMPLETED|Overall Study||56
8527648|NCT00343291|21020293|P1|NOT COMPLETED|Overall Study||57
8527649|NCT00343291|21020292|P2|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
8527650|NCT00343291|21020293|P1|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
8527651|NCT00343291|21020292|P2|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
8527652|NCT00343291|21020293|P1|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
8527653|NCT00343291|21020292|P2|STARTED|Overall Study||61
8527654|NCT00343291|21020293|P1|STARTED|Overall Study||60
8527655|NCT00343252|21020309|P2|NOT COMPLETED|18 Months (All Treated Participants)||81
8527656|NCT00343252|21020310|P1|NOT COMPLETED|18 Months (All Treated Participants)||101
8527657|NCT00343252|21020309|P2|COMPLETED|18 Months (All Treated Participants)||269
8527658|NCT00343252|21020310|P1|COMPLETED|18 Months (All Treated Participants)||259
8527659|NCT00343252|21020309|P2|STARTED|18 Months (All Treated Participants)||350
8527660|NCT00343252|21020310|P1|STARTED|18 Months (All Treated Participants)||360
8527661|NCT00343252|21020309|P2|NOT COMPLETED|12 Months (All Treated Participants)||69
8527662|NCT00343252|21020310|P1|NOT COMPLETED|12 Months (All Treated Participants)||86
8527663|NCT00343252|21020309|P2|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
8527664|NCT00343252|21020310|P1|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
8527665|NCT00343252|21020309|P2|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
8527666|NCT00343252|21020310|P1|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
8527667|NCT00343252|21020309|P2|NOT COMPLETED|6 Months (All Treated Participants)||44
8527668|NCT00343252|21020310|P1|NOT COMPLETED|6 Months (All Treated Participants)||56
8527669|NCT00343252|21020309|P2|COMPLETED|6 Months (All Treated Participants)||306
8527670|NCT00343252|21020310|P1|COMPLETED|6 Months (All Treated Participants)||304
8527671|NCT00343252|21020309|P2|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
8527672|NCT00343252|21020310|P1|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
8527673|NCT00343252|21020309|P2|NOT COMPLETED|All Randomized Participants||82
8527674|NCT00343252|21020310|P1|NOT COMPLETED|All Randomized Participants||102
8527675|NCT00343252|21020309|P2|COMPLETED|All Randomized Participants||269
8527676|NCT00343252|21020310|P1|COMPLETED|All Randomized Participants||259
8527677|NCT00343252|21020309|P2|STARTED|All Randomized Participants||351
8527678|NCT00343252|21020310|P1|STARTED|All Randomized Participants||361
8527679|NCT00343083|21020356|P1|NOT COMPLETED|Overall Study||21
8527680|NCT00343083|21020356|P1|COMPLETED|Overall Study||22
8527681|NCT00343083|21020356|P1|STARTED|Overall Study||43
8527682|NCT00343044|21020365|P1|NOT COMPLETED|Overall Study||0
8527683|NCT00343044|21020365|P1|COMPLETED|Overall Study||40
8527684|NCT00343044|21020365|P1|STARTED|Overall Study||40
8527685|NCT00342628|21020375|P3|NOT COMPLETED|Overall Study||19
8527686|NCT00342628|21020376|P2|NOT COMPLETED|Overall Study||21
8527687|NCT00342628|21020377|P1|NOT COMPLETED|Overall Study||20
8527688|NCT00342628|21020375|P3|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
8527689|NCT00342628|21020376|P2|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
8527690|NCT00342628|21020377|P1|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
8527691|NCT00342628|21020375|P3|STARTED|Overall Study||100
8527692|NCT00342628|21020376|P2|STARTED|Overall Study||101
8527693|NCT00342628|21020377|P1|STARTED|Overall Study||100
8527694|NCT00342563|21020398|P4|NOT COMPLETED|Overall Study||6
8527695|NCT00342563|21020399|P3|NOT COMPLETED|Overall Study||14
8527696|NCT00342563|21020400|P2|NOT COMPLETED|Overall Study||8
8527697|NCT00342563|21020401|P1|NOT COMPLETED|Overall Study||6
8527698|NCT00342563|21020398|P4|COMPLETED|Overall Study||22
8527699|NCT00342563|21020399|P3|COMPLETED|Overall Study||26
8527700|NCT00342563|21020400|P2|COMPLETED|Overall Study||19
8527701|NCT00342563|21020401|P1|COMPLETED|Overall Study||35
8527702|NCT00342563|21020398|P4|STARTED|Overall Study||28
8527703|NCT00342563|21020399|P3|STARTED|Overall Study||40
8527704|NCT00342563|21020400|P2|STARTED|Overall Study||27
8527705|NCT00342563|21020401|P1|STARTED|Overall Study||41
8527706|NCT00342355|21020421|P4|NOT COMPLETED|Overall Study||0
8527707|NCT00342355|21020422|P3|NOT COMPLETED|Overall Study||0
8527708|NCT00342355|21020423|P2|NOT COMPLETED|Overall Study||0
8527709|NCT00342355|21020424|P1|NOT COMPLETED|Overall Study||0
8527710|NCT00342355|21020421|P4|COMPLETED|Overall Study||443
8527711|NCT00342355|21020422|P3|COMPLETED|Overall Study||444
8527712|NCT00342355|21020423|P2|COMPLETED|Overall Study||440
8527713|NCT00342355|21020424|P1|COMPLETED|Overall Study||444
8527714|NCT00342355|21020421|P4|STARTED|Overall Study||443
8527715|NCT00342355|21020422|P3|STARTED|Overall Study||444
8527716|NCT00342355|21020423|P2|STARTED|Overall Study||440
8527717|NCT00342355|21020424|P1|STARTED|Overall Study||444
8527718|NCT00340834|21020443|P5|NOT COMPLETED|Extension Phase of Study||44
8527719|NCT00340834|21020444|P4|NOT COMPLETED|Extension Phase of Study||53
8527720|NCT00340834|21020445|P3|NOT COMPLETED|Extension Phase of Study||0
8527721|NCT00340834|21020446|P2|NOT COMPLETED|Extension Phase of Study||76
8527722|NCT00340834|21020447|P1|NOT COMPLETED|Extension Phase of Study||85
8527723|NCT00340834|21020443|P5|COMPLETED|Extension Phase of Study||123
8527724|NCT00340834|21020444|P4|COMPLETED|Extension Phase of Study||123
8527725|NCT00340834|21020445|P3|COMPLETED|Extension Phase of Study||0
8527726|NCT00340834|21020446|P2|COMPLETED|Extension Phase of Study||281
8527727|NCT00340834|21020447|P1|COMPLETED|Extension Phase of Study||245
8527728|NCT00340834|21020443|P5|Received Study Drug|Extension Phase of Study||167
8527729|NCT00340834|21020444|P4|Received Study Drug|Extension Phase of Study||174
8527730|NCT00340834|21020445|P3|Received Study Drug|Extension Phase of Study||0
8527731|NCT00340834|21020446|P2|Received Study Drug|Extension Phase of Study||356
8527732|NCT00340834|21020447|P1|Received Study Drug|Extension Phase of Study||330
8527733|NCT00340834|21020443|P5|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
8527734|NCT00340834|21020444|P4|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
8527735|NCT00340834|21020445|P3|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
8527736|NCT00340834|21020446|P2|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
8527737|NCT00340834|21020447|P1|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
8527738|NCT00340834|21020443|P5|NOT COMPLETED|Core Phase of Study||0
8527739|NCT00340834|21020444|P4|NOT COMPLETED|Core Phase of Study||0
8527740|NCT00340834|21020445|P3|NOT COMPLETED|Core Phase of Study||49
8527741|NCT00340834|21020446|P2|NOT COMPLETED|Core Phase of Study||33
8527742|NCT00340834|21020447|P1|NOT COMPLETED|Core Phase of Study||57
8527743|NCT00340834|21020443|P5|COMPLETED|Core Phase of Study||0
8527744|NCT00340834|21020444|P4|COMPLETED|Core Phase of Study||0
8527745|NCT00340834|21020445|P3|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
8527746|NCT00340834|21020446|P2|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
8527747|NCT00340834|21020447|P1|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
8527748|NCT00340834|21020443|P5|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
8527749|NCT00340834|21020444|P4|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
8527750|NCT00340834|21020445|P3|STARTED|Core Phase of Study||435
8527751|NCT00340834|21020446|P2|STARTED|Core Phase of Study||431
8527752|NCT00340834|21020447|P1|STARTED|Core Phase of Study||426
8527753|NCT00340704|21020481|P9|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
8527754|NCT00340704|21020482|P8|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
8527755|NCT00340704|21020483|P7|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
8527756|NCT00340704|21020484|P6|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
8527757|NCT00340704|21020485|P5|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
8527758|NCT00340704|21020486|P4|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
8527759|NCT00340704|21020487|P3|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8527760|NCT00340704|21020488|P2|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8527761|NCT00340704|21020489|P1|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8527762|NCT00340704|21020481|P9|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8527763|NCT00340704|21020482|P8|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
8527764|NCT00340704|21020483|P7|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
8527765|NCT00340704|21020484|P6|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
8527766|NCT00340704|21020485|P5|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
8527767|NCT00340704|21020486|P4|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
8527768|NCT00340704|21020487|P3|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8527769|NCT00340704|21020488|P2|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8527770|NCT00340704|21020489|P1|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
8527771|NCT00340704|21020481|P9|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8527772|NCT00340704|21020482|P8|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8527773|NCT00340704|21020483|P7|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8527774|NCT00340704|21020484|P6|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
8527775|NCT00340704|21020485|P5|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
8527776|NCT00340704|21020486|P4|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
8527777|NCT00340704|21020487|P3|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8527778|NCT00340704|21020488|P2|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8527779|NCT00340704|21020489|P1|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
8527780|NCT00340704|21020481|P9|STARTED|Group D- Denovo & 527.51 Rollover Study||29
8527781|NCT00340704|21020482|P8|STARTED|Group D- Denovo & 527.51 Rollover Study||13
8527782|NCT00340704|21020483|P7|STARTED|Group D- Denovo & 527.51 Rollover Study||54
8527783|NCT00340704|21020484|P6|STARTED|Group D- Denovo & 527.51 Rollover Study||37
8527784|NCT00340704|21020485|P5|STARTED|Group D- Denovo & 527.51 Rollover Study||21
8527785|NCT00340704|21020486|P4|STARTED|Group D- Denovo & 527.51 Rollover Study||29
8527786|NCT00340704|21020487|P3|STARTED|Group D- Denovo & 527.51 Rollover Study||0
8527787|NCT00340704|21020488|P2|STARTED|Group D- Denovo & 527.51 Rollover Study||0
8527788|NCT00340704|21020489|P1|STARTED|Group D- Denovo & 527.51 Rollover Study||0
8527789|NCT00340704|21020481|P9|NOT COMPLETED|PK Study||0
8527790|NCT00340704|21020482|P8|NOT COMPLETED|PK Study||0
8527791|NCT00340704|21020483|P7|NOT COMPLETED|PK Study||0
8527792|NCT00340704|21020484|P6|NOT COMPLETED|PK Study||0
8527793|NCT00340704|21020485|P5|NOT COMPLETED|PK Study||0
8527794|NCT00340704|21020486|P4|NOT COMPLETED|PK Study||0
8527795|NCT00340704|21020487|P3|NOT COMPLETED|PK Study||1
8527796|NCT00340704|21020488|P2|NOT COMPLETED|PK Study||1
8527797|NCT00340704|21020489|P1|NOT COMPLETED|PK Study||0
8527798|NCT00340704|21020481|P9|COMPLETED|PK Study||0
8527799|NCT00340704|21020482|P8|COMPLETED|PK Study||0
8527800|NCT00340704|21020483|P7|COMPLETED|PK Study||0
8527801|NCT00340704|21020484|P6|COMPLETED|PK Study||0
8527802|NCT00340704|21020485|P5|COMPLETED|PK Study||0
8527803|NCT00340704|21020486|P4|COMPLETED|PK Study||0
8527804|NCT00340704|21020487|P3|COMPLETED|PK Study||10
8527805|NCT00340704|21020488|P2|COMPLETED|PK Study||9
8527806|NCT00340704|21020489|P1|COMPLETED|PK Study||10
8527807|NCT00340704|21020481|P9|STARTED|PK Study||0
8527808|NCT00340704|21020482|P8|STARTED|PK Study||0
8527809|NCT00340704|21020483|P7|STARTED|PK Study||0
8527810|NCT00340704|21020484|P6|STARTED|PK Study||0
8527811|NCT00340704|21020485|P5|STARTED|PK Study||0
8527812|NCT00340704|21020486|P4|STARTED|PK Study||0
8527813|NCT00340704|21020487|P3|STARTED|PK Study||11
8527814|NCT00340704|21020488|P2|STARTED|PK Study||10
8527815|NCT00340704|21020489|P1|STARTED|PK Study||10
8527828|NCT00340379|21020612|P2|NOT COMPLETED|Overall Study||9
8527829|NCT00340379|21020613|P1|NOT COMPLETED|Overall Study||8
8527830|NCT00340379|21020612|P2|COMPLETED|Overall Study||28
8527831|NCT00340379|21020613|P1|COMPLETED|Overall Study||27
8527832|NCT00340379|21020612|P2|STARTED|Overall Study||37
8527833|NCT00340379|21020613|P1|STARTED|Overall Study||35
8527834|NCT00339833|21020625|P2|NOT COMPLETED|Overall Study||8
8527835|NCT00339833|21020626|P1|NOT COMPLETED|Overall Study||6
8527836|NCT00339833|21020625|P2|COMPLETED|Overall Study||18
8527837|NCT00339833|21020626|P1|COMPLETED|Overall Study||22
8527838|NCT00339833|21020625|P2|STARTED|Overall Study||26
8527839|NCT00339833|21020626|P1|STARTED|Overall Study||28
8527840|NCT00339183|21020636|P2|NOT COMPLETED|Overall Study||105
8527841|NCT00339183|21020637|P1|NOT COMPLETED|Overall Study||121
8527842|NCT00339183|21020636|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
8527843|NCT00339183|21020637|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
8527844|NCT00339183|21020636|P2|Received Study Drug|Overall Study||593
8527845|NCT00339183|21020637|P1|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
8527846|NCT00339183|21020636|P2|STARTED|Overall Study||595
8527847|NCT00339183|21020637|P1|STARTED|Overall Study||591
8527848|NCT00339144|21020666|P3|NOT COMPLETED|Overall Study||4
8527849|NCT00339144|21020667|P2|NOT COMPLETED|Overall Study||3
8527850|NCT00339144|21020668|P1|NOT COMPLETED|Overall Study||9
8527851|NCT00339144|21020666|P3|COMPLETED|Overall Study||0
8527852|NCT00339144|21020667|P2|COMPLETED|Overall Study||0
8527853|NCT00339144|21020668|P1|COMPLETED|Overall Study||0
8527854|NCT00339144|21020666|P3|STARTED|Overall Study|Number of participants enrolled and treated|4
8527855|NCT00339144|21020667|P2|STARTED|Overall Study|Number of participants enrolled and treated|3
8527856|NCT00339144|21020668|P1|STARTED|Overall Study|Number of participants enrolled and treated|9
8527857|NCT00339079|21020754|P4|NOT COMPLETED|Overall Study||24
8527858|NCT00339079|21020755|P3|NOT COMPLETED|Overall Study||18
8527859|NCT00339079|21020756|P2|NOT COMPLETED|Overall Study||23
8527860|NCT00339079|21020757|P1|NOT COMPLETED|Overall Study||33
8527861|NCT00339079|21020754|P4|COMPLETED|Overall Study||29
8527862|NCT00339079|21020755|P3|COMPLETED|Overall Study||27
8527863|NCT00339079|21020756|P2|COMPLETED|Overall Study||21
8527864|NCT00339079|21020757|P1|COMPLETED|Overall Study||20
8527865|NCT00339079|21020754|P4|STARTED|Overall Study||53
8527866|NCT00339079|21020755|P3|STARTED|Overall Study||45
8527867|NCT00339079|21020756|P2|STARTED|Overall Study||44
8527868|NCT00339079|21020757|P1|STARTED|Overall Study||53
8527869|NCT00339040|21020773|P2|NOT COMPLETED|Stage II||2
8527870|NCT00339040|21020774|P1|NOT COMPLETED|Stage II||10
8527871|NCT00339040|21020773|P2|COMPLETED|Stage II||27
8527872|NCT00339040|21020774|P1|COMPLETED|Stage II||84
8527873|NCT00339040|21020773|P2|Vaccination 6 at Week 120|Stage II||27
8527874|NCT00339040|21020774|P1|Vaccination 6 at Week 120|Stage II||0
8527875|NCT00339040|21020773|P2|Vaccination 5 at Week 104|Stage II||28
8527876|NCT00339040|21020774|P1|Vaccination 5 at Week 104|Stage II||0
8527877|NCT00339040|21020773|P2|Vaccination 4 at Week 96|Stage II||29
8527878|NCT00339040|21020774|P1|Vaccination 4 at Week 96|Stage II||84
8527879|NCT00339040|21020773|P2|STARTED|Stage II||29
8527880|NCT00339040|21020774|P1|STARTED|Stage II||94
8527881|NCT00339040|21020773|P2|NOT COMPLETED|Stage I||1
8527882|NCT00339040|21020774|P1|NOT COMPLETED|Stage I||2
8527883|NCT00339040|21020773|P2|COMPLETED|Stage I||29
8527884|NCT00339040|21020774|P1|COMPLETED|Stage I||94
8527885|NCT00339040|21020773|P2|Vaccination 3 at Week 24|Stage I||30
8527886|NCT00339040|21020774|P1|Vaccination 3 at Week 24|Stage I||94
8527887|NCT00339040|21020773|P2|Vaccination 2 at Week 8|Stage I||30
8527888|NCT00339040|21020774|P1|Vaccination 2 at Week 8|Stage I||95
8527889|NCT00339040|21020773|P2|Vaccination 1 at Week 0|Stage I||30
8527890|NCT00339040|21020774|P1|Vaccination 1 at Week 0|Stage I||96
8527891|NCT00339040|21020773|P2|STARTED|Stage I||30
8527892|NCT00339040|21020774|P1|STARTED|Stage I||96
8527893|NCT00338988|21020792|P1|NOT COMPLETED|Overall Study||1
8527894|NCT00338988|21020792|P1|COMPLETED|Overall Study||43
8527895|NCT00338988|21020792|P1|STARTED|Overall Study||44
8527896|NCT00338962|21020801|P4|NOT COMPLETED|Overall Study||3
8527897|NCT00338962|21020802|P3|NOT COMPLETED|Overall Study||6
8527898|NCT00338962|21020803|P2|NOT COMPLETED|Overall Study||4
8527899|NCT00338962|21020804|P1|NOT COMPLETED|Overall Study||8
8527900|NCT00338962|21020801|P4|COMPLETED|Overall Study||21
8527901|NCT00338962|21020802|P3|COMPLETED|Overall Study||16
8527902|NCT00338962|21020803|P2|COMPLETED|Overall Study||16
8527903|NCT00338962|21020804|P1|COMPLETED|Overall Study||14
8527904|NCT00338962|21020801|P4|STARTED|Overall Study||24
8527905|NCT00338962|21020802|P3|STARTED|Overall Study||22
8527906|NCT00338962|21020803|P2|STARTED|Overall Study||20
8527907|NCT00338962|21020804|P1|STARTED|Overall Study||22
8527908|NCT00338949|21020828|P2|NOT COMPLETED|Randomization||5
8527909|NCT00338949|21020829|P1|NOT COMPLETED|Randomization||1
8528004|NCT00337727|21021081|P1|COMPLETED|Overall Study||412
8527910|NCT00338949|21020828|P2|COMPLETED|Randomization|"Reasons for drop out:
~2- insomnia 2- symptom exacerbation
~1- akathisia"|25
8527911|NCT00338949|21020829|P1|COMPLETED|Randomization|1 subject withdrew after relapse and hospitalization|24
8527912|NCT00338949|21020828|P2|STARTED|Randomization||30
8527913|NCT00338949|21020829|P1|STARTED|Randomization||25
8527914|NCT00338949|21020828|P2|NOT COMPLETED|Subject Screening||11
8527915|NCT00338949|21020829|P1|NOT COMPLETED|Subject Screening||11
8527916|NCT00338949|21020828|P2|COMPLETED|Subject Screening||30
8527917|NCT00338949|21020829|P1|COMPLETED|Subject Screening||25
8527918|NCT00338949|21020828|P2|STARTED|Subject Screening||41
8527919|NCT00338949|21020829|P1|STARTED|Subject Screening||36
8527920|NCT00338884|21020837|P1|NOT COMPLETED|Overall Study||78
8527921|NCT00338884|21020837|P1|COMPLETED|Overall Study||42
8527922|NCT00338884|21020837|P1|Received Treatment|Overall Study||119
8527923|NCT00338884|21020837|P1|STARTED|Overall Study||120
8527924|NCT00338806|21020871|P2|NOT COMPLETED|Follow-up||3
8527925|NCT00338806|21020872|P1|NOT COMPLETED|Follow-up||1
8527926|NCT00338806|21020871|P2|COMPLETED|Follow-up||1
8527927|NCT00338806|21020872|P1|COMPLETED|Follow-up||1
8527928|NCT00338806|21020871|P2|STARTED|Follow-up||4
8527929|NCT00338806|21020872|P1|STARTED|Follow-up||2
8527930|NCT00338806|21020871|P2|NOT COMPLETED|Acute Phase||1
8527931|NCT00338806|21020872|P1|NOT COMPLETED|Acute Phase||0
8527932|NCT00338806|21020871|P2|COMPLETED|Acute Phase||4
8527933|NCT00338806|21020872|P1|COMPLETED|Acute Phase||2
8527934|NCT00338806|21020871|P2|STARTED|Acute Phase||5
8527935|NCT00338806|21020872|P1|STARTED|Acute Phase||2
8527936|NCT00338741|21020934|P2|NOT COMPLETED|Overall Study||0
8527937|NCT00338741|21020935|P1|NOT COMPLETED|Overall Study||2
8527938|NCT00338741|21020934|P2|COMPLETED|Overall Study||2
8527939|NCT00338741|21020935|P1|COMPLETED|Overall Study||32
8527940|NCT00338741|21020934|P2|STARTED|Overall Study||2
8527941|NCT00338741|21020935|P1|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
8527942|NCT00338728|21020943|P1|NOT COMPLETED|Overall Study||14
8527943|NCT00338728|21020943|P1|COMPLETED|Overall Study||45
8527944|NCT00338728|21020943|P1|STARTED|Overall Study||59
8527945|NCT00338598|21020950|P2|NOT COMPLETED|Overall Study||2
8527946|NCT00338598|21020951|P1|NOT COMPLETED|Overall Study||0
8527947|NCT00338598|21020950|P2|COMPLETED|Overall Study||8
8527948|NCT00338598|21020951|P1|COMPLETED|Overall Study||10
8527949|NCT00338598|21020950|P2|STARTED|Overall Study||10
8527950|NCT00338598|21020951|P1|STARTED|Overall Study||10
8527951|NCT00338455|21020971|P2|NOT COMPLETED|Overall Study||1
8527952|NCT00338455|21020972|P1|NOT COMPLETED|Overall Study||3
8527953|NCT00338455|21020971|P2|COMPLETED|Overall Study||6
8527954|NCT00338455|21020972|P1|COMPLETED|Overall Study||6
8527955|NCT00338455|21020971|P2|Administered Study Drug|Overall Study||7
8527956|NCT00338455|21020972|P1|Administered Study Drug|Overall Study||8
8527957|NCT00338455|21020971|P2|STARTED|Overall Study||7
8527958|NCT00338455|21020972|P1|STARTED|Overall Study||9
8527959|NCT00338286|21020986|P2|NOT COMPLETED|Overall Study||213
8527960|NCT00338286|21020987|P1|NOT COMPLETED|Overall Study||233
8527961|NCT00338286|21020986|P2|COMPLETED|Overall Study||837
8527962|NCT00338286|21020987|P1|COMPLETED|Overall Study||815
8527963|NCT00338286|21020986|P2|STARTED|Overall Study||1050
8527964|NCT00338286|21020987|P1|STARTED|Overall Study||1048
8527965|NCT00338104|21021004|P3|NOT COMPLETED|Overall Study||3
8527966|NCT00338104|21021005|P2|NOT COMPLETED|Overall Study||1
8527967|NCT00338104|21021006|P1|NOT COMPLETED|Overall Study||2
8527968|NCT00338104|21021004|P3|COMPLETED|Overall Study||22
8527969|NCT00338104|21021005|P2|COMPLETED|Overall Study||24
8527970|NCT00338104|21021006|P1|COMPLETED|Overall Study||23
8527971|NCT00338104|21021004|P3|STARTED|Overall Study||25
8527972|NCT00338104|21021005|P2|STARTED|Overall Study||25
8527973|NCT00338104|21021006|P1|STARTED|Overall Study||25
8527974|NCT00338039|21021017|P1|NOT COMPLETED|Overall Study||0
8527975|NCT00338039|21021017|P1|COMPLETED|Overall Study||69
8527976|NCT00338039|21021017|P1|STARTED|Overall Study||69
8527977|NCT00337987|21021022|P1|NOT COMPLETED|Overall Study||0
8527978|NCT00337987|21021022|P1|COMPLETED|Overall Study||49
8527979|NCT00337987|21021022|P1|STARTED|Overall Study||49
8527980|NCT00337935|21021029|P2|NOT COMPLETED|Overall Study||27
8527981|NCT00337935|21021030|P1|NOT COMPLETED|Overall Study||10
8527982|NCT00337935|21021029|P2|COMPLETED|Overall Study||91
8527983|NCT00337935|21021030|P1|COMPLETED|Overall Study||29
8527984|NCT00337935|21021029|P2|STARTED|Overall Study||118
8527985|NCT00337935|21021030|P1|STARTED|Overall Study||39
8527986|NCT00337818|21021043|P3|NOT COMPLETED|Overall Study||107
8527987|NCT00337818|21021044|P2|NOT COMPLETED|Overall Study||91
8527988|NCT00337818|21021045|P1|NOT COMPLETED|Overall Study||289
8527989|NCT00337818|21021043|P3|COMPLETED|Overall Study||51
8527990|NCT00337818|21021044|P2|COMPLETED|Overall Study||63
8527991|NCT00337818|21021045|P1|COMPLETED|Overall Study||169
8527992|NCT00337818|21021043|P3|STARTED|Overall Study||158
8527993|NCT00337818|21021044|P2|STARTED|Overall Study||154
8527994|NCT00337818|21021045|P1|STARTED|Overall Study||458
8527995|NCT00337779|21021067|P2|NOT COMPLETED|Overall Study||79
8527996|NCT00337779|21021068|P1|NOT COMPLETED|Overall Study||52
8527997|NCT00337779|21021067|P2|COMPLETED|Overall Study||490
8527998|NCT00337779|21021068|P1|COMPLETED|Overall Study||534
8527999|NCT00337779|21021067|P2|STARTED|Overall Study||569
8528000|NCT00337779|21021068|P1|STARTED|Overall Study||586
8528001|NCT00337727|21021080|P2|NOT COMPLETED|Overall Study||12
8528002|NCT00337727|21021081|P1|NOT COMPLETED|Overall Study||18
8528003|NCT00337727|21021080|P2|COMPLETED|Overall Study||406
8528005|NCT00337727|21021080|P2|STARTED|Overall Study||418
8528006|NCT00337727|21021081|P1|STARTED|Overall Study||430
8528007|NCT00337675|21021092|P3|NOT COMPLETED|Overall Study||99
8528008|NCT00337675|21021093|P2|NOT COMPLETED|Overall Study||103
8528009|NCT00337675|21021094|P1|NOT COMPLETED|Overall Study||97
8528010|NCT00337675|21021092|P3|COMPLETED|Overall Study||492
8528011|NCT00337675|21021093|P2|COMPLETED|Overall Study||488
8528012|NCT00337675|21021094|P1|COMPLETED|Overall Study||492
8528013|NCT00337675|21021092|P3|STARTED|Overall Study||591
8528014|NCT00337675|21021093|P2|STARTED|Overall Study||591
8528015|NCT00337675|21021094|P1|STARTED|Overall Study||589
8528016|NCT00337662|21021111|P4|NOT COMPLETED|Study Period III||0
8528017|NCT00337662|21021112|P3|NOT COMPLETED|Study Period III||44
8528018|NCT00337662|21021113|P2|NOT COMPLETED|Study Period III||58
8528019|NCT00337662|21021114|P1|NOT COMPLETED|Study Period III||60
8528020|NCT00337662|21021111|P4|COMPLETED|Study Period III||0
8528021|NCT00337662|21021112|P3|COMPLETED|Study Period III||100
8528022|NCT00337662|21021113|P2|COMPLETED|Study Period III||134
8528023|NCT00337662|21021114|P1|COMPLETED|Study Period III||126
8528024|NCT00337662|21021111|P4|STARTED|Study Period III||0
8528025|NCT00337662|21021112|P3|STARTED|Study Period III||144
8528026|NCT00337662|21021113|P2|STARTED|Study Period III||192
8528027|NCT00337662|21021114|P1|STARTED|Study Period III||186
8528028|NCT00337662|21021111|P4|NOT COMPLETED|Study Period II||106
8528029|NCT00337662|21021112|P3|NOT COMPLETED|Study Period II||0
8528030|NCT00337662|21021113|P2|NOT COMPLETED|Study Period II||0
8528031|NCT00337662|21021114|P1|NOT COMPLETED|Study Period II||0
8528032|NCT00337662|21021111|P4|COMPLETED|Study Period II||522
8528033|NCT00337662|21021112|P3|COMPLETED|Study Period II||0
8528034|NCT00337662|21021113|P2|COMPLETED|Study Period II||0
8528035|NCT00337662|21021114|P1|COMPLETED|Study Period II||0
8528036|NCT00337662|21021111|P4|STARTED|Study Period II||628
8528037|NCT00337662|21021112|P3|STARTED|Study Period II||0
8528038|NCT00337662|21021113|P2|STARTED|Study Period II||0
8528039|NCT00337662|21021114|P1|STARTED|Study Period II||0
8528040|NCT00337610|21021168|P2|NOT COMPLETED|Overall Study||14
8528041|NCT00337610|21021169|P1|NOT COMPLETED|Overall Study||17
8528042|NCT00337610|21021168|P2|COMPLETED|Overall Study||80
8528043|NCT00337610|21021169|P1|COMPLETED|Overall Study||79
8528044|NCT00337610|21021168|P2|Completed Week 18|Overall Study||82
8528045|NCT00337610|21021169|P1|Completed Week 18|Overall Study||89
8528046|NCT00337610|21021168|P2|STARTED|Overall Study||94
8528047|NCT00337610|21021169|P1|STARTED|Overall Study||96
8528048|NCT00337571|21021185|P4|NOT COMPLETED|Overall Study||7
8528049|NCT00337571|21021186|P3|NOT COMPLETED|Overall Study||10
8528050|NCT00337571|21021187|P2|NOT COMPLETED|Overall Study||9
8528051|NCT00337571|21021188|P1|NOT COMPLETED|Overall Study||14
8528052|NCT00337571|21021185|P4|COMPLETED|Overall Study||47
8528053|NCT00337571|21021186|P3|COMPLETED|Overall Study||49
8528054|NCT00337571|21021187|P2|COMPLETED|Overall Study||44
8528055|NCT00337571|21021188|P1|COMPLETED|Overall Study||38
8528056|NCT00337571|21021185|P4|STARTED|Overall Study||54
8528057|NCT00337571|21021186|P3|STARTED|Overall Study||59
8528058|NCT00337571|21021187|P2|STARTED|Overall Study||53
8528059|NCT00337571|21021188|P1|STARTED|Overall Study||52
8528060|NCT00337467|21021226|P1|NOT COMPLETED|Overall Study||10
8528061|NCT00337467|21021226|P1|COMPLETED|Overall Study||51
8528062|NCT00337467|21021226|P1|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
8528063|NCT00337467|21021226|P1|STARTED|Overall Study||61
8528064|NCT00337428|21021245|P2|NOT COMPLETED|Overall Study||3
8528065|NCT00337428|21021246|P1|NOT COMPLETED|Overall Study||4
8528066|NCT00337428|21021245|P2|COMPLETED|Overall Study||421
8528067|NCT00337428|21021246|P1|COMPLETED|Overall Study||415
8528068|NCT00337428|21021245|P2|STARTED|Overall Study||424
8528069|NCT00337428|21021246|P1|STARTED|Overall Study||419
8528070|NCT00337350|21021286|P2|NOT COMPLETED|Overall Study||1
8528071|NCT00337350|21021287|P1|NOT COMPLETED|Overall Study||1
8528072|NCT00337350|21021286|P2|COMPLETED|Overall Study||10
8528073|NCT00337350|21021287|P1|COMPLETED|Overall Study||8
8528074|NCT00337350|21021286|P2|STARTED|Overall Study||11
8528075|NCT00337350|21021287|P1|STARTED|Overall Study||9
8528076|NCT00337285|21021297|P1|NOT COMPLETED|Overall Study||158
8528077|NCT00337285|21021297|P1|COMPLETED|Overall Study||191
8528078|NCT00337285|21021297|P1|STARTED|Overall Study||349
8528079|NCT00337272|21021305|P2|NOT COMPLETED|Withdrawal Period||1
8528080|NCT00337272|21021306|P1|NOT COMPLETED|Withdrawal Period||0
8528081|NCT00337272|21021305|P2|COMPLETED|Withdrawal Period||6
8528082|NCT00337272|21021306|P1|COMPLETED|Withdrawal Period||6
8528083|NCT00337272|21021305|P2|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
8528084|NCT00337272|21021306|P1|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
8528085|NCT00337272|21021305|P2|NOT COMPLETED|Treatment Period||2
8528086|NCT00337272|21021306|P1|NOT COMPLETED|Treatment Period||1
8528087|NCT00337272|21021305|P2|COMPLETED|Treatment Period||7
8528088|NCT00337272|21021306|P1|COMPLETED|Treatment Period||6
8528089|NCT00337272|21021305|P2|Randomization|Treatment Period||9
8528090|NCT00337272|21021306|P1|Randomization|Treatment Period||7
8528091|NCT00337272|21021305|P2|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
8528092|NCT00337272|21021306|P1|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
8528093|NCT00337272|21021305|P2|NOT COMPLETED|Screening Period (Pre-randomization)||0
8528094|NCT00337272|21021306|P1|NOT COMPLETED|Screening Period (Pre-randomization)||6
8528095|NCT00337272|21021305|P2|COMPLETED|Screening Period (Pre-randomization)||0
8528096|NCT00337272|21021306|P1|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
8528097|NCT00337272|21021305|P2|STARTED|Screening Period (Pre-randomization)||0
8528098|NCT00337272|21021306|P1|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
8528099|NCT00337207|21021326|P1|NOT COMPLETED|Overall Study||3
8528100|NCT00337207|21021326|P1|COMPLETED|Overall Study||52
8528101|NCT00337207|21021326|P1|STARTED|Overall Study||55
8528102|NCT00337194|21021334|P2|NOT COMPLETED|Overall Study||4
8528103|NCT00337194|21021335|P1|NOT COMPLETED|Overall Study||12
8528104|NCT00337194|21021334|P2|COMPLETED|Overall Study||3
8528105|NCT00337194|21021335|P1|COMPLETED|Overall Study||11
8528106|NCT00337194|21021334|P2|STARTED|Overall Study||7
8528107|NCT00337194|21021335|P1|STARTED|Overall Study||23
8528108|NCT00337181|21021352|P2|NOT COMPLETED|Overall Study||0
8528109|NCT00337181|21021353|P1|NOT COMPLETED|Overall Study||0
8528110|NCT00337181|21021352|P2|COMPLETED|Overall Study||65
8528111|NCT00337181|21021353|P1|COMPLETED|Overall Study||49
8528112|NCT00337181|21021352|P2|STARTED|Overall Study||65
8528113|NCT00337181|21021353|P1|STARTED|Overall Study||49
8528114|NCT00337168|21021359|P1|NOT COMPLETED|Overall Study||8
8528115|NCT00337168|21021359|P1|COMPLETED|Overall Study||29
8528116|NCT00337168|21021359|P1|Eligible and Treated|Overall Study||36
8528117|NCT00337168|21021359|P1|Eligible|Overall Study||37
8528118|NCT00337168|21021359|P1|STARTED|Overall Study||37
8528119|NCT00337129|21021366|P1|NOT COMPLETED|Overall Study||40
8528120|NCT00337129|21021366|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
8528121|NCT00337129|21021366|P1|STARTED|Overall Study||40
8528122|NCT00337103|21021375|P2|NOT COMPLETED|Overall Study||548
8528123|NCT00337103|21021376|P1|NOT COMPLETED|Overall Study||554
8528124|NCT00337103|21021375|P2|COMPLETED|Overall Study||0
8528125|NCT00337103|21021376|P1|COMPLETED|Overall Study||0
8528126|NCT00337103|21021375|P2|Treated (Safety Population)|Overall Study||546
8528127|NCT00337103|21021376|P1|Treated (Safety Population)|Overall Study||544
8528128|NCT00337103|21021375|P2|STARTED|Overall Study||548
8528129|NCT00337103|21021376|P1|STARTED|Overall Study||554
8528130|NCT00337077|21021410|P3|NOT COMPLETED|Overall Study||25
8528131|NCT00337077|21021411|P2|NOT COMPLETED|Overall Study||53
8528132|NCT00337077|21021412|P1|NOT COMPLETED|Overall Study||43
8528133|NCT00337077|21021410|P3|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
8528134|NCT00337077|21021411|P2|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
8528135|NCT00337077|21021412|P1|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
8528136|NCT00337077|21021410|P3|Patients With Measurable Disease|Overall Study||13
8528137|NCT00337077|21021411|P2|Patients With Measurable Disease|Overall Study||38
8528138|NCT00337077|21021412|P1|Patients With Measurable Disease|Overall Study||26
8528139|NCT00337077|21021410|P3|Eligible and Treated|Overall Study||24
8528140|NCT00337077|21021411|P2|Eligible and Treated|Overall Study||51
8528141|NCT00337077|21021412|P1|Eligible and Treated|Overall Study||41
8528142|NCT00337077|21021410|P3|Toxicity Assessed|Overall Study||25
8528143|NCT00337077|21021411|P2|Toxicity Assessed|Overall Study||51
8528144|NCT00337077|21021412|P1|Toxicity Assessed|Overall Study||42
8528145|NCT00337077|21021410|P3|Treated|Overall Study||25
8528146|NCT00337077|21021411|P2|Treated|Overall Study||52
8528147|NCT00337077|21021412|P1|Treated|Overall Study||42
8528148|NCT00337077|21021410|P3|STARTED|Overall Study||25
8528149|NCT00337077|21021411|P2|STARTED|Overall Study||53
8528150|NCT00337077|21021412|P1|STARTED|Overall Study||43
8528151|NCT00336973|21021421|P1|NOT COMPLETED|Overall Study||33
8528152|NCT00336973|21021421|P1|COMPLETED|Overall Study||33
8528153|NCT00336973|21021421|P1|STARTED|Overall Study||66
8528154|NCT00336895|21021427|P1|NOT COMPLETED|Overall Study||4
8528155|NCT00336895|21021427|P1|COMPLETED|Overall Study||26
8528156|NCT00336895|21021427|P1|STARTED|Overall Study||30
8528157|NCT00336856|21021433|P1|NOT COMPLETED|Overall Study||4
8528158|NCT00336856|21021433|P1|COMPLETED|Overall Study||31
8528159|NCT00336856|21021433|P1|STARTED|Overall Study|Number of patients consented and registered for the study|35
8528160|NCT00336817|21021441|P2|NOT COMPLETED|Overall Study||2
8528161|NCT00336817|21021442|P1|NOT COMPLETED|Overall Study||1
8528162|NCT00336817|21021441|P2|COMPLETED|Overall Study||13
8528163|NCT00336817|21021442|P1|COMPLETED|Overall Study||14
8528164|NCT00336817|21021441|P2|STARTED|Overall Study||15
8528165|NCT00336817|21021442|P1|STARTED|Overall Study||15
8528166|NCT00336700|21021472|P1|NOT COMPLETED|Overall Study||0
8528167|NCT00336700|21021472|P1|COMPLETED|Overall Study||25
8528168|NCT00336700|21021472|P1|STARTED|Overall Study||25
8528169|NCT00336583|21021481|P1|NOT COMPLETED|Overall Study||2
8528170|NCT00336583|21021481|P1|COMPLETED|Overall Study||25
8528171|NCT00336583|21021481|P1|STARTED|Overall Study||27
8528172|NCT00336544|21021488|P2|NOT COMPLETED|Overall Study||22
8528173|NCT00336544|21021489|P1|NOT COMPLETED|Overall Study||19
8528174|NCT00336544|21021488|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
8528175|NCT00336544|21021489|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
8528176|NCT00336544|21021488|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|260
8528177|NCT00336544|21021489|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|261
8528178|NCT00336505|21021503|P2|NOT COMPLETED|Overall Study||27
8528179|NCT00336505|21021504|P1|NOT COMPLETED|Overall Study||37
8528180|NCT00336505|21021503|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
8528181|NCT00336505|21021504|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
8528182|NCT00336505|21021503|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|291
8528183|NCT00336505|21021504|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|291
8528184|NCT00336492|21021519|P3|NOT COMPLETED|Overall Study||11
8528185|NCT00336492|21021520|P2|NOT COMPLETED|Overall Study||4
8528186|NCT00336492|21021521|P1|NOT COMPLETED|Overall Study||15
8528187|NCT00336492|21021519|P3|COMPLETED|Overall Study||12
8528188|NCT00336492|21021520|P2|COMPLETED|Overall Study||18
8528189|NCT00336492|21021521|P1|COMPLETED|Overall Study||0
8528190|NCT00336492|21021519|P3|STARTED|Overall Study||23
8528191|NCT00336492|21021520|P2|STARTED|Overall Study||22
8528192|NCT00336492|21021521|P1|STARTED|Overall Study||15
8528193|NCT00336479|21021533|P4|NOT COMPLETED|Overall Study||4
8528194|NCT00336479|21021534|P3|NOT COMPLETED|Overall Study||26
8528195|NCT00336479|21021535|P2|NOT COMPLETED|Overall Study||25
8528196|NCT00336479|21021536|P1|NOT COMPLETED|Overall Study||37
8528197|NCT00336479|21021533|P4|COMPLETED|Overall Study||13
8528198|NCT00336479|21021534|P3|COMPLETED|Overall Study||53
8528199|NCT00336479|21021535|P2|COMPLETED|Overall Study||54
8528200|NCT00336479|21021536|P1|COMPLETED|Overall Study||38
8528201|NCT00336479|21021533|P4|STARTED|Overall Study||17
8528202|NCT00336479|21021534|P3|STARTED|Overall Study||79
8528203|NCT00336479|21021535|P2|STARTED|Overall Study||79
8528204|NCT00336479|21021536|P1|STARTED|Overall Study||75
8528205|NCT00336323|21021564|P5|NOT COMPLETED|Overall Study||3
8528206|NCT00336323|21021565|P4|NOT COMPLETED|Overall Study||0
8528207|NCT00336323|21021566|P3|NOT COMPLETED|Overall Study||1
8528208|NCT00336323|21021567|P2|NOT COMPLETED|Overall Study||1
8528209|NCT00336323|21021568|P1|NOT COMPLETED|Overall Study||0
8528210|NCT00336323|21021564|P5|COMPLETED|Overall Study||19
8528211|NCT00336323|21021565|P4|COMPLETED|Overall Study||22
8528212|NCT00336323|21021566|P3|COMPLETED|Overall Study||23
8528213|NCT00336323|21021567|P2|COMPLETED|Overall Study||21
8528214|NCT00336323|21021568|P1|COMPLETED|Overall Study||19
8528215|NCT00336323|21021564|P5|24 Week Visit|Overall Study||19
8528216|NCT00336323|21021565|P4|24 Week Visit|Overall Study||22
8528217|NCT00336323|21021566|P3|24 Week Visit|Overall Study|1 patient was dropped from the study|22
8528218|NCT00336323|21021567|P2|24 Week Visit|Overall Study|1 patient was dropped from the study|20
8528219|NCT00336323|21021568|P1|24 Week Visit|Overall Study||18
8528220|NCT00336323|21021564|P5|18 Week Visit|Overall Study|1 patient was dropped from the study|18
8528221|NCT00336323|21021565|P4|18 Week Visit|Overall Study||21
8528222|NCT00336323|21021566|P3|18 Week Visit|Overall Study||23
8528223|NCT00336323|21021567|P2|18 Week Visit|Overall Study||22
8528224|NCT00336323|21021568|P1|18 Week Visit|Overall Study||19
8528225|NCT00336323|21021564|P5|12 Week Visit|Overall Study|1 patient was dropped from study|20
8528226|NCT00336323|21021565|P4|12 Week Visit|Overall Study||22
8528227|NCT00336323|21021566|P3|12 Week Visit|Overall Study||24
8528228|NCT00336323|21021567|P2|12 Week Visit|Overall Study||21
8528229|NCT00336323|21021568|P1|12 Week Visit|Overall Study||19
8528230|NCT00336323|21021564|P5|9 Week Visit|Overall Study||19
8528231|NCT00336323|21021565|P4|9 Week Visit|Overall Study||21
8528232|NCT00336323|21021566|P3|9 Week Visit|Overall Study||23
8528233|NCT00336323|21021567|P2|9 Week Visit|Overall Study||21
8528234|NCT00336323|21021568|P1|9 Week Visit|Overall Study||18
8528235|NCT00336323|21021564|P5|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
8528236|NCT00336323|21021565|P4|6 Week Visit|Overall Study||22
8528237|NCT00336323|21021566|P3|6 Week Visit|Overall Study||24
8528238|NCT00336323|21021567|P2|6 Week Visit|Overall Study||22
8528239|NCT00336323|21021568|P1|6 Week Visit|Overall Study||18
8528240|NCT00336323|21021564|P5|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
8528241|NCT00336323|21021565|P4|3 Week Visit|Overall Study||22
8528242|NCT00336323|21021566|P3|3 Week Visit|Overall Study||24
8528243|NCT00336323|21021567|P2|3 Week Visit|Overall Study||21
8528244|NCT00336323|21021568|P1|3 Week Visit|Overall Study||18
8528245|NCT00336323|21021564|P5|STARTED|Overall Study||22
8528246|NCT00336323|21021565|P4|STARTED|Overall Study||22
8528247|NCT00336323|21021566|P3|STARTED|Overall Study||24
8528248|NCT00336323|21021567|P2|STARTED|Overall Study||22
8528249|NCT00336323|21021568|P1|STARTED|Overall Study||19
8528250|NCT00336284|21021625|P2|NOT COMPLETED|Overall Study||151
8528251|NCT00336284|21021626|P1|NOT COMPLETED|Overall Study||236
8528252|NCT00336284|21021625|P2|COMPLETED|Overall Study||322
8528253|NCT00336284|21021626|P1|COMPLETED|Overall Study||741
8528254|NCT00336284|21021625|P2|STARTED|Overall Study||473
8528255|NCT00336284|21021626|P1|STARTED|Overall Study||977
8528256|NCT00336232|21021638|P1|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
8528257|NCT00336232|21021638|P1|COMPLETED|High Vitamin K (500mcg Daily)||42
8528258|NCT00336232|21021638|P1|STARTED|High Vitamin K (500mcg Daily)||42
8528259|NCT00336232|21021638|P1|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
8528260|NCT00336232|21021638|P1|COMPLETED|Low Vitamin K (10mcg Daily)||42
8528261|NCT00336232|21021638|P1|STARTED|Low Vitamin K (10mcg Daily)||42
8528262|NCT00336232|21021638|P1|NOT COMPLETED|Baseline (200mcg Daily)||17
8528263|NCT00336232|21021638|P1|COMPLETED|Baseline (200mcg Daily)||42
8528264|NCT00336232|21021638|P1|STARTED|Baseline (200mcg Daily)||59
8528271|NCT00335972|21021681|P2|NOT COMPLETED|Overall Study||3
8528272|NCT00335972|21021682|P1|NOT COMPLETED|Overall Study||0
8528273|NCT00335972|21021681|P2|COMPLETED|Overall Study||68
8528274|NCT00335972|21021682|P1|COMPLETED|Overall Study||71
8528275|NCT00335972|21021681|P2|STARTED|Overall Study||71
8528276|NCT00335972|21021682|P1|STARTED|Overall Study||71
8528277|NCT00335959|21021692|P1|NOT COMPLETED|Overall Study||3
8528278|NCT00335959|21021692|P1|COMPLETED|Overall Study||4
8528279|NCT00335959|21021692|P1|Eligible and Began Protocol Therapy|Overall Study||6
8528280|NCT00335959|21021692|P1|Eligible|Overall Study||6
8528281|NCT00335959|21021692|P1|STARTED|Overall Study||7
8528287|NCT00335777|21021711|P1|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
8528288|NCT00335777|21021711|P1|COMPLETED|Treated 2 Headaches Per Protocol||22
8528289|NCT00335777|21021711|P1|STARTED|Treated 2 Headaches Per Protocol||35
8528290|NCT00335777|21021711|P1|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
8528291|NCT00335777|21021711|P1|COMPLETED|Enrolled and Dispensed Study Medication||35
8528292|NCT00335777|21021711|P1|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
8528293|NCT00335764|21021721|P5|NOT COMPLETED|Overall Study||1
8528294|NCT00335764|21021722|P4|NOT COMPLETED|Overall Study||0
8528295|NCT00335764|21021723|P3|NOT COMPLETED|Overall Study||0
8528296|NCT00335764|21021724|P2|NOT COMPLETED|Overall Study||0
8528297|NCT00335764|21021725|P1|NOT COMPLETED|Overall Study||1
8528298|NCT00335764|21021721|P5|COMPLETED|Overall Study||18
8528299|NCT00335764|21021722|P4|COMPLETED|Overall Study||19
8528300|NCT00335764|21021723|P3|COMPLETED|Overall Study||24
8528301|NCT00335764|21021724|P2|COMPLETED|Overall Study||13
8528302|NCT00335764|21021725|P1|COMPLETED|Overall Study||16
8528303|NCT00335764|21021721|P5|STARTED|Overall Study||19
8528304|NCT00335764|21021722|P4|STARTED|Overall Study||19
8528305|NCT00335764|21021723|P3|STARTED|Overall Study||24
8528306|NCT00335764|21021724|P2|STARTED|Overall Study||13
8528307|NCT00335764|21021725|P1|STARTED|Overall Study||17
8528314|NCT00335725|21021792|P2|NOT COMPLETED|Overall Study||5
8528315|NCT00335725|21021793|P1|NOT COMPLETED|Overall Study||4
8528316|NCT00335725|21021792|P2|COMPLETED|Overall Study||71
8528317|NCT00335725|21021793|P1|COMPLETED|Overall Study||71
8528318|NCT00335725|21021792|P2|STARTED|Overall Study||76
8528319|NCT00335725|21021793|P1|STARTED|Overall Study||75
8528320|NCT00335556|21021807|P6|NOT COMPLETED|Overall Study||1
8528321|NCT00335556|21021808|P5|NOT COMPLETED|Overall Study||1
8528322|NCT00335556|21021809|P4|NOT COMPLETED|Overall Study||5
8528323|NCT00335556|21021810|P3|NOT COMPLETED|Overall Study||5
8528324|NCT00335556|21021811|P2|NOT COMPLETED|Overall Study||34
8528325|NCT00335556|21021812|P1|NOT COMPLETED|Overall Study||2
8528326|NCT00335556|21021807|P6|COMPLETED|Overall Study||29
8528327|NCT00335556|21021808|P5|COMPLETED|Overall Study||77
8528328|NCT00335556|21021809|P4|COMPLETED|Overall Study||5
8528329|NCT00335556|21021810|P3|COMPLETED|Overall Study||2
8528330|NCT00335556|21021811|P2|COMPLETED|Overall Study||64
8528331|NCT00335556|21021812|P1|COMPLETED|Overall Study||66
8528332|NCT00335556|21021807|P6|STARTED|Overall Study||30
8528333|NCT00335556|21021808|P5|STARTED|Overall Study||78
8528334|NCT00335556|21021809|P4|STARTED|Overall Study||10
8528335|NCT00335556|21021810|P3|STARTED|Overall Study||7
8528336|NCT00335556|21021811|P2|STARTED|Overall Study||98
8528337|NCT00335556|21021812|P1|STARTED|Overall Study||68
8528338|NCT00335517|21021833|P1|NOT COMPLETED|Overall Study||2
8528339|NCT00335517|21021833|P1|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
8528340|NCT00335517|21021833|P1|STARTED|Overall Study||100
8528341|NCT00335504|21021841|P4|NOT COMPLETED|Overall Study||0
8528342|NCT00335504|21021842|P3|NOT COMPLETED|Overall Study||0
8528343|NCT00335504|21021843|P2|NOT COMPLETED|Overall Study||0
8528344|NCT00335504|21021844|P1|NOT COMPLETED|Overall Study||0
8528345|NCT00335504|21021841|P4|COMPLETED|Overall Study||22
8528346|NCT00335504|21021842|P3|COMPLETED|Overall Study||20
8528347|NCT00335504|21021843|P2|COMPLETED|Overall Study||21
8528348|NCT00335504|21021844|P1|COMPLETED|Overall Study||22
8528349|NCT00335504|21021841|P4|STARTED|Overall Study||22
8528350|NCT00335504|21021842|P3|STARTED|Overall Study||20
8528351|NCT00335504|21021843|P2|STARTED|Overall Study||21
8528352|NCT00335504|21021844|P1|STARTED|Overall Study||22
8528353|NCT00335478|21021866|P1|NOT COMPLETED|Overall Study||24
8528354|NCT00335478|21021866|P1|COMPLETED|Overall Study||30
8528355|NCT00335478|21021866|P1|STARTED|Overall Study||54
8528356|NCT00335452|21021874|P4|NOT COMPLETED|Overall Study||131
8528357|NCT00335452|21021875|P3|NOT COMPLETED|Overall Study||159
8528358|NCT00335452|21021876|P2|NOT COMPLETED|Overall Study||147
8528359|NCT00335452|21021877|P1|NOT COMPLETED|Overall Study||158
8528360|NCT00335452|21021874|P4|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
8528361|NCT00335452|21021875|P3|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
8528362|NCT00335452|21021876|P2|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
8528363|NCT00335452|21021877|P1|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
8528364|NCT00335452|21021874|P4|TREATED WITH ASA|Overall Study||6247
8528365|NCT00335452|21021875|P3|TREATED WITH ASA|Overall Study||6261
8528366|NCT00335452|21021876|P2|TREATED WITH ASA|Overall Study||6251
8528367|NCT00335452|21021877|P1|TREATED WITH ASA|Overall Study||6302
8528368|NCT00335452|21021874|P4|TREATED WITH CLOPIDOGREL|Overall Study||6217
8528369|NCT00335452|21021875|P3|TREATED WITH CLOPIDOGREL|Overall Study||6228
8528370|NCT00335452|21021876|P2|TREATED WITH CLOPIDOGREL|Overall Study||6218
8528371|NCT00335452|21021877|P1|TREATED WITH CLOPIDOGREL|Overall Study||6271
8528372|NCT00335452|21021874|P4|STARTED|Overall Study|Randomized|6253
8528373|NCT00335452|21021875|P3|STARTED|Overall Study|Randomized|6267
8528374|NCT00335452|21021876|P2|STARTED|Overall Study|Randomized|6254
8528375|NCT00335452|21021877|P1|STARTED|Overall Study|Randomized|6312
8528376|NCT00335322|21021902|P3|NOT COMPLETED|Overall Study||2
8528377|NCT00335322|21021903|P2|NOT COMPLETED|Overall Study||2
8528378|NCT00335322|21021904|P1|NOT COMPLETED|Overall Study||1
8528379|NCT00335322|21021902|P3|COMPLETED|Overall Study||103
8528380|NCT00335322|21021903|P2|COMPLETED|Overall Study||105
8528381|NCT00335322|21021904|P1|COMPLETED|Overall Study||114
8528382|NCT00335322|21021902|P3|STARTED|Overall Study||105
8528383|NCT00335322|21021903|P2|STARTED|Overall Study||107
8528384|NCT00335322|21021904|P1|STARTED|Overall Study||115
8528385|NCT00335283|21021917|P2|NOT COMPLETED|Overall Study||5
8528386|NCT00335283|21021918|P1|NOT COMPLETED|Overall Study||6
8528387|NCT00335283|21021917|P2|COMPLETED|Overall Study||34
8528388|NCT00335283|21021918|P1|COMPLETED|Overall Study||30
8528389|NCT00335283|21021917|P2|STARTED|Overall Study||39
8528390|NCT00335283|21021918|P1|STARTED|Overall Study||36
8528391|NCT00335257|21021933|P3|NOT COMPLETED|Overall Study||0
8528392|NCT00335257|21021934|P2|NOT COMPLETED|Overall Study||0
8528393|NCT00335257|21021935|P1|NOT COMPLETED|Overall Study||0
8528394|NCT00335257|21021933|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
8528395|NCT00335257|21021934|P2|COMPLETED|Overall Study||9377
8528396|NCT00335257|21021935|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
8528397|NCT00335257|21021933|P3|STARTED|Overall Study||60190
8528398|NCT00335257|21021934|P2|STARTED|Overall Study||9377
8528399|NCT00335257|21021935|P1|STARTED|Overall Study||15542
8528400|NCT00335153|21021952|P1|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
8528401|NCT00335153|21021952|P1|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
8528402|NCT00335153|21021952|P1|STARTED|Post-PEG-J Long-Term Treatment Period||324
8528403|NCT00335153|21021952|P1|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
8528404|NCT00335153|21021952|P1|COMPLETED|Nasojejunal (NJ) Test Period||324
8528405|NCT00335153|21021952|P1|STARTED|Nasojejunal (NJ) Test Period||354
8528406|NCT00335140|21021989|P1|NOT COMPLETED|Overall Study||1
8528407|NCT00335140|21021989|P1|COMPLETED|Overall Study||25
8528408|NCT00335140|21021989|P1|Treated|Overall Study||25
8528409|NCT00335140|21021989|P1|Eligible|Overall Study||25
8528410|NCT00335140|21021989|P1|STARTED|Overall Study||26
8528417|NCT00334893|21022010|P2|NOT COMPLETED|Overall Study||0
8528418|NCT00334893|21022011|P1|NOT COMPLETED|Overall Study||1
8528419|NCT00334893|21022010|P2|COMPLETED|Overall Study||37
8528420|NCT00334893|21022011|P1|COMPLETED|Overall Study||36
8528421|NCT00334893|21022010|P2|STARTED|Overall Study||37
8528422|NCT00334893|21022011|P1|STARTED|Overall Study||37
8528429|NCT00334802|21022036|P2|NOT COMPLETED|Overall Study||40
8528430|NCT00334802|21022037|P1|NOT COMPLETED|Overall Study||6
8528431|NCT00334802|21022036|P2|COMPLETED|Overall Study||16
8528432|NCT00334802|21022037|P1|COMPLETED|Overall Study||0
8528433|NCT00334802|21022036|P2|STARTED|Overall Study||56
8528434|NCT00334802|21022037|P1|STARTED|Overall Study||6
8528435|NCT00334737|21022057|P3|NOT COMPLETED|Follow up Phase||6
8528436|NCT00334737|21022058|P2|NOT COMPLETED|Follow up Phase||3
8528437|NCT00334737|21022059|P1|NOT COMPLETED|Follow up Phase||5
8528438|NCT00334737|21022057|P3|COMPLETED|Follow up Phase||24
8528439|NCT00334737|21022058|P2|COMPLETED|Follow up Phase||29
8528440|NCT00334737|21022059|P1|COMPLETED|Follow up Phase||27
8528441|NCT00334737|21022057|P3|STARTED|Follow up Phase||30
8528442|NCT00334737|21022058|P2|STARTED|Follow up Phase||32
8528443|NCT00334737|21022059|P1|STARTED|Follow up Phase||32
8528444|NCT00334737|21022057|P3|NOT COMPLETED|Hospital Phase||4
8528445|NCT00334737|21022058|P2|NOT COMPLETED|Hospital Phase||2
8528446|NCT00334737|21022059|P1|NOT COMPLETED|Hospital Phase||2
8528447|NCT00334737|21022057|P3|COMPLETED|Hospital Phase||30
8528448|NCT00334737|21022058|P2|COMPLETED|Hospital Phase||32
8528449|NCT00334737|21022059|P1|COMPLETED|Hospital Phase||32
8528450|NCT00334737|21022057|P3|STARTED|Hospital Phase||34
8528451|NCT00334737|21022058|P2|STARTED|Hospital Phase||34
8528452|NCT00334737|21022059|P1|STARTED|Hospital Phase||34
8528453|NCT00334633|21022094|P3|NOT COMPLETED|Overall Study||82
8528454|NCT00334633|21022095|P2|NOT COMPLETED|Overall Study||82
8528455|NCT00334633|21022096|P1|NOT COMPLETED|Overall Study||80
8528456|NCT00334633|21022094|P3|COMPLETED|Overall Study||114
8528457|NCT00334633|21022095|P2|COMPLETED|Overall Study||118
8528458|NCT00334633|21022096|P1|COMPLETED|Overall Study||117
8528459|NCT00334633|21022094|P3|STARTED|Overall Study||196
8528460|NCT00334633|21022095|P2|STARTED|Overall Study||200
8528461|NCT00334633|21022096|P1|STARTED|Overall Study||197
8528462|NCT00334542|21022107|P1|NOT COMPLETED|Overall Study||5
8528463|NCT00334542|21022107|P1|COMPLETED|Overall Study||45
8528464|NCT00334542|21022107|P1|STARTED|Overall Study||50
8528465|NCT00334295|21022114|P1|NOT COMPLETED|Overall Study||5
8528466|NCT00334295|21022114|P1|COMPLETED|Overall Study||30
8528467|NCT00334295|21022114|P1|STARTED|Overall Study||35
8528468|NCT00334282|21022124|P2|NOT COMPLETED|Overall Study||108
8528469|NCT00334282|21022125|P1|NOT COMPLETED|Overall Study||222
8528470|NCT00334282|21022124|P2|COMPLETED|Overall Study||37
8528471|NCT00334282|21022125|P1|COMPLETED|Overall Study||68
8528472|NCT00334282|21022124|P2|STARTED|Overall Study||145
8528473|NCT00334282|21022125|P1|STARTED|Overall Study||290
8528474|NCT00334204|21022148|P1|NOT COMPLETED|Overall Study||2
8528475|NCT00334204|21022148|P1|COMPLETED|Overall Study||56
8528476|NCT00334204|21022148|P1|STARTED|Overall Study||58
8528477|NCT00334113|21022156|P2|NOT COMPLETED|Overall Study||3
8528478|NCT00334113|21022157|P1|NOT COMPLETED|Overall Study||2
8528479|NCT00334113|21022156|P2|COMPLETED|Overall Study||31
8528480|NCT00334113|21022157|P1|COMPLETED|Overall Study||30
8528481|NCT00334113|21022156|P2|STARTED|Overall Study||34
8528482|NCT00334113|21022157|P1|STARTED|Overall Study||32
8528483|NCT00334074|21022163|P1|NOT COMPLETED|Overall Study||0
8528484|NCT00334074|21022163|P1|COMPLETED|Overall Study||30
8528485|NCT00334074|21022163|P1|STARTED|Overall Study||30
8528486|NCT00334061|21022168|P1|NOT COMPLETED|Overall Study||0
8528487|NCT00334061|21022168|P1|COMPLETED|Overall Study|November 2007|125
8528488|NCT00334061|21022168|P1|STARTED|Overall Study|June 2006|125
8528489|NCT00333983|21022180|P3|NOT COMPLETED|Overall Study||2
8528490|NCT00333983|21022181|P2|NOT COMPLETED|Overall Study||5
8528491|NCT00333983|21022182|P1|NOT COMPLETED|Overall Study||3
8528492|NCT00333983|21022180|P3|COMPLETED|Overall Study||19
8528493|NCT00333983|21022181|P2|COMPLETED|Overall Study||16
8528494|NCT00333983|21022182|P1|COMPLETED|Overall Study||17
8528495|NCT00333983|21022180|P3|STARTED|Overall Study||21
8528496|NCT00333983|21022181|P2|STARTED|Overall Study||21
8528497|NCT00333983|21022182|P1|STARTED|Overall Study||20
8528498|NCT00333970|21022192|P2|NOT COMPLETED|Overall Study||7
8528499|NCT00333970|21022193|P1|NOT COMPLETED|Overall Study||13
8528500|NCT00333970|21022192|P2|COMPLETED|Overall Study||18
8528501|NCT00333970|21022193|P1|COMPLETED|Overall Study||37
8528502|NCT00333970|21022192|P2|STARTED|Overall Study||25
8528503|NCT00333970|21022193|P1|STARTED|Overall Study||50
8528504|NCT00333879|21022199|P1|NOT COMPLETED|Overall Study||0
8528505|NCT00333879|21022199|P1|COMPLETED|Overall Study||4
8528506|NCT00333879|21022199|P1|STARTED|Overall Study||4
8528523|NCT00333840|21022271|P4|NOT COMPLETED|Second-line Treatment Period||188
8528524|NCT00333840|21022272|P3|NOT COMPLETED|Second-line Treatment Period||14
8528525|NCT00333840|21022273|P2|NOT COMPLETED|Second-line Treatment Period||0
8528526|NCT00333840|21022274|P1|NOT COMPLETED|Second-line Treatment Period||0
8528527|NCT00333840|21022271|P4|COMPLETED|Second-line Treatment Period||175
8528528|NCT00333840|21022272|P3|COMPLETED|Second-line Treatment Period||0
8528529|NCT00333840|21022273|P2|COMPLETED|Second-line Treatment Period||0
8528530|NCT00333840|21022274|P1|COMPLETED|Second-line Treatment Period||0
8528531|NCT00333840|21022271|P4|STARTED|Second-line Treatment Period||363
8528532|NCT00333840|21022272|P3|STARTED|Second-line Treatment Period||14
8528533|NCT00333840|21022273|P2|STARTED|Second-line Treatment Period||0
8528534|NCT00333840|21022274|P1|STARTED|Second-line Treatment Period||0
8528535|NCT00333840|21022271|P4|NOT COMPLETED|First-line Treatment Period||0
8528536|NCT00333840|21022272|P3|NOT COMPLETED|First-line Treatment Period||0
8528537|NCT00333840|21022273|P2|NOT COMPLETED|First-line Treatment Period||546
8528538|NCT00333840|21022274|P1|NOT COMPLETED|First-line Treatment Period||286
8528539|NCT00333840|21022271|P4|COMPLETED|First-line Treatment Period||0
8528540|NCT00333840|21022272|P3|COMPLETED|First-line Treatment Period||0
8528541|NCT00333840|21022273|P2|COMPLETED|First-line Treatment Period||7
8528542|NCT00333840|21022274|P1|COMPLETED|First-line Treatment Period||267
8528543|NCT00333840|21022271|P4|Safety Population; Received Study Drug|First-line Treatment Period||0
8528544|NCT00333840|21022272|P3|Safety Population; Received Study Drug|First-line Treatment Period||0
8528545|NCT00333840|21022273|P2|Safety Population; Received Study Drug|First-line Treatment Period||533
8528546|NCT00333840|21022274|P1|Safety Population; Received Study Drug|First-line Treatment Period||551
8528547|NCT00333840|21022271|P4|STARTED|First-line Treatment Period||0
8528548|NCT00333840|21022272|P3|STARTED|First-line Treatment Period||0
8528549|NCT00333840|21022273|P2|STARTED|First-line Treatment Period||553
8528550|NCT00333840|21022274|P1|STARTED|First-line Treatment Period||553
8528551|NCT00333814|21022302|P3|NOT COMPLETED|Overall Study||5
8528552|NCT00333814|21022303|P2|NOT COMPLETED|Overall Study||4
8528553|NCT00333814|21022304|P1|NOT COMPLETED|Overall Study||3
8528554|NCT00333814|21022302|P3|COMPLETED|Overall Study||71
8528555|NCT00333814|21022303|P2|COMPLETED|Overall Study||73
8528556|NCT00333814|21022304|P1|COMPLETED|Overall Study||73
8528557|NCT00333814|21022302|P3|STARTED|Overall Study||76
8528558|NCT00333814|21022303|P2|STARTED|Overall Study||77
8528559|NCT00333814|21022304|P1|STARTED|Overall Study||76
8528560|NCT00333801|21022320|P2|NOT COMPLETED|Overall Study||6
8528561|NCT00333801|21022321|P1|NOT COMPLETED|Overall Study||8
8528562|NCT00333801|21022320|P2|COMPLETED|Overall Study||36
8528563|NCT00333801|21022321|P1|COMPLETED|Overall Study||35
8528564|NCT00333801|21022320|P2|STARTED|Overall Study||42
8528565|NCT00333801|21022321|P1|STARTED|Overall Study||43
8528566|NCT00333788|21022339|P1|NOT COMPLETED|Overall Study||162
8528567|NCT00333788|21022339|P1|COMPLETED|Overall Study||71
8528568|NCT00333788|21022339|P1|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
8528569|NCT00333775|21022369|P3|NOT COMPLETED|Overall Study||247
8528570|NCT00333775|21022370|P2|NOT COMPLETED|Overall Study||248
8528571|NCT00333775|21022371|P1|NOT COMPLETED|Overall Study||241
8528572|NCT00333775|21022369|P3|COMPLETED|Overall Study||0
8528573|NCT00333775|21022370|P2|COMPLETED|Overall Study||0
8528574|NCT00333775|21022371|P1|COMPLETED|Overall Study||0
8528575|NCT00333775|21022369|P3|Received Treatment|Overall Study||245
8528576|NCT00333775|21022370|P2|Received Treatment|Overall Study||247
8528577|NCT00333775|21022371|P1|Received Treatment|Overall Study||238
8528578|NCT00333775|21022369|P3|STARTED|Overall Study||247
8528579|NCT00333775|21022370|P2|STARTED|Overall Study||248
8528580|NCT00333775|21022371|P1|STARTED|Overall Study||241
8528581|NCT00333762|21022391|P1|NOT COMPLETED|Overall Study||4
8528582|NCT00333762|21022391|P1|COMPLETED|Overall Study||0
8528583|NCT00333762|21022391|P1|STARTED|Overall Study||4
8528584|NCT00333710|21022398|P3|NOT COMPLETED|Overall Study||1
8528585|NCT00333710|21022399|P2|NOT COMPLETED|Overall Study||4
8528586|NCT00333710|21022400|P1|NOT COMPLETED|Overall Study||11
8528587|NCT00333710|21022398|P3|COMPLETED|Overall Study||15
8528588|NCT00333710|21022399|P2|COMPLETED|Overall Study||14
8528589|NCT00333710|21022400|P1|COMPLETED|Overall Study||8
8528590|NCT00333710|21022398|P3|STARTED|Overall Study||16
8528591|NCT00333710|21022399|P2|STARTED|Overall Study||18
8528592|NCT00333710|21022400|P1|STARTED|Overall Study||19
8528593|NCT00333619|21022410|P2|NOT COMPLETED|Overall Study||10
8528594|NCT00333619|21022411|P1|NOT COMPLETED|Overall Study||21
8528595|NCT00333619|21022410|P2|COMPLETED|Overall Study||99
8528596|NCT00333619|21022411|P1|COMPLETED|Overall Study||89
8528597|NCT00333619|21022410|P2|3-month Follow-up|Overall Study||105
8528598|NCT00333619|21022411|P1|3-month Follow-up|Overall Study||101
8528599|NCT00333619|21022410|P2|Post-treatment|Overall Study||109
8528600|NCT00333619|21022411|P1|Post-treatment|Overall Study||109
8528601|NCT00333619|21022410|P2|STARTED|Overall Study||109
8528602|NCT00333619|21022411|P1|STARTED|Overall Study||110
8528603|NCT00333606|21022421|P2|NOT COMPLETED|Overall Study||0
8528604|NCT00333606|21022422|P1|NOT COMPLETED|Overall Study||0
8528605|NCT00333606|21022421|P2|COMPLETED|Overall Study||30
8528606|NCT00333606|21022422|P1|COMPLETED|Overall Study||30
8528607|NCT00333606|21022421|P2|STARTED|Overall Study||30
8528608|NCT00333606|21022422|P1|STARTED|Overall Study||30
8528609|NCT00333437|21022430|P1|NOT COMPLETED|Overall Study||0
8528610|NCT00333437|21022430|P1|COMPLETED|Overall Study||7
8528611|NCT00333437|21022430|P1|STARTED|Overall Study||7
8528612|NCT00333359|21022440|P2|NOT COMPLETED|Overall Study||122
8528613|NCT00333359|21022441|P1|NOT COMPLETED|Overall Study||73
8528614|NCT00333359|21022440|P2|COMPLETED|Overall Study||260
8528615|NCT00333359|21022441|P1|COMPLETED|Overall Study||126
8528616|NCT00333359|21022440|P2|STARTED|Overall Study||382
8528617|NCT00333359|21022441|P1|STARTED|Overall Study||199
8528618|NCT00333229|21022484|P2|NOT COMPLETED|Overall Study||1
8528619|NCT00333229|21022485|P1|NOT COMPLETED|Overall Study||0
8528620|NCT00333229|21022484|P2|COMPLETED|Overall Study||4
8528621|NCT00333229|21022485|P1|COMPLETED|Overall Study||6
8528622|NCT00333229|21022484|P2|STARTED|Overall Study||5
8528623|NCT00333229|21022485|P1|STARTED|Overall Study||6
8528624|NCT00333177|21022503|P4|NOT COMPLETED|Overall Study||2
8528625|NCT00333177|21022504|P3|NOT COMPLETED|Overall Study||1
8528626|NCT00333177|21022505|P2|NOT COMPLETED|Overall Study||1
8528627|NCT00333177|21022506|P1|NOT COMPLETED|Overall Study||0
8528628|NCT00333177|21022503|P4|COMPLETED|Overall Study||12
8528629|NCT00333177|21022504|P3|COMPLETED|Overall Study||16
8528630|NCT00333177|21022505|P2|COMPLETED|Overall Study||16
8528631|NCT00333177|21022506|P1|COMPLETED|Overall Study||12
8528632|NCT00333177|21022503|P4|Received Intervention|Overall Study||12
8528633|NCT00333177|21022504|P3|Received Intervention|Overall Study||16
8528634|NCT00333177|21022505|P2|Received Intervention|Overall Study||16
8528635|NCT00333177|21022506|P1|Received Intervention|Overall Study||12
8528636|NCT00333177|21022503|P4|STARTED|Overall Study||14
8528637|NCT00333177|21022504|P3|STARTED|Overall Study||17
8528638|NCT00333177|21022505|P2|STARTED|Overall Study||17
8528639|NCT00333177|21022506|P1|STARTED|Overall Study||12
8528640|NCT00333138|21022555|P3|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
8528641|NCT00333138|21022556|P2|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
8528642|NCT00333138|21022557|P1|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
8528643|NCT00333138|21022555|P3|COMPLETED|Extension Study (Month6 to End of Study)||37
8528644|NCT00333138|21022556|P2|COMPLETED|Extension Study (Month6 to End of Study)||45
8528645|NCT00333138|21022557|P1|COMPLETED|Extension Study (Month6 to End of Study)||40
8528646|NCT00333138|21022555|P3|STARTED|Extension Study (Month6 to End of Study)||80
8528647|NCT00333138|21022556|P2|STARTED|Extension Study (Month6 to End of Study)||87
8528648|NCT00333138|21022557|P1|STARTED|Extension Study (Month6 to End of Study)||83
8528649|NCT00333138|21022555|P3|NOT COMPLETED|Core Study (6 Months)||12
8528650|NCT00333138|21022556|P2|NOT COMPLETED|Core Study (6 Months)||6
8528651|NCT00333138|21022557|P1|NOT COMPLETED|Core Study (6 Months)||7
8528652|NCT00333138|21022555|P3|COMPLETED|Core Study (6 Months)||82
8528653|NCT00333138|21022556|P2|COMPLETED|Core Study (6 Months)||88
8528654|NCT00333138|21022557|P1|COMPLETED|Core Study (6 Months)||86
8528655|NCT00333138|21022555|P3|STARTED|Core Study (6 Months)||94
8528656|NCT00333138|21022556|P2|STARTED|Core Study (6 Months)||94
8528657|NCT00333138|21022557|P1|STARTED|Core Study (6 Months)||93
8528658|NCT00332839|21022596|P2|NOT COMPLETED|Follow-up (Months 12 - 60)||3
8528659|NCT00332839|21022597|P1|NOT COMPLETED|Follow-up (Months 12 - 60)||4
8528660|NCT00332839|21022596|P2|COMPLETED|Follow-up (Months 12 - 60)||31
8528661|NCT00332839|21022597|P1|COMPLETED|Follow-up (Months 12 - 60)||29
8528662|NCT00332839|21022596|P2|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
8528663|NCT00332839|21022597|P1|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
8528664|NCT00332839|21022596|P2|NOT COMPLETED|Core (Months 0 - 12)||18
8528665|NCT00332839|21022597|P1|NOT COMPLETED|Core (Months 0 - 12)||10
8528666|NCT00332839|21022596|P2|COMPLETED|Core (Months 0 - 12)||28
8528667|NCT00332839|21022597|P1|COMPLETED|Core (Months 0 - 12)||37
8528668|NCT00332839|21022596|P2|Safety Set|Core (Months 0 - 12)||46
8528669|NCT00332839|21022597|P1|Safety Set|Core (Months 0 - 12)||47
8528670|NCT00332839|21022596|P2|STARTED|Core (Months 0 - 12)||46
8528671|NCT00332839|21022597|P1|STARTED|Core (Months 0 - 12)||47
8528672|NCT00332722|21022617|P2|NOT COMPLETED|Overall Study||0
8528673|NCT00332722|21022618|P1|NOT COMPLETED|Overall Study||0
8528674|NCT00332722|21022617|P2|COMPLETED|Overall Study||60
8528675|NCT00332722|21022618|P1|COMPLETED|Overall Study||60
8528676|NCT00332722|21022617|P2|STARTED|Overall Study||60
8528677|NCT00332722|21022618|P1|STARTED|Overall Study||60
8528678|NCT00332709|21022628|P2|NOT COMPLETED|Overall Study||20
8528679|NCT00332709|21022629|P1|NOT COMPLETED|Overall Study||16
8528680|NCT00332709|21022628|P2|COMPLETED|Overall Study||21
8528681|NCT00332709|21022629|P1|COMPLETED|Overall Study||24
8528682|NCT00332709|21022628|P2|STARTED|Overall Study||41
8528683|NCT00332709|21022629|P1|STARTED|Overall Study||40
8528684|NCT00332696|21022653|P2|NOT COMPLETED|Overall Study||30
8528685|NCT00332696|21022654|P1|NOT COMPLETED|Overall Study||30
8528686|NCT00332696|21022653|P2|COMPLETED|Overall Study||2
8528687|NCT00332696|21022654|P1|COMPLETED|Overall Study|Completed Month 3 Visit|2
8528688|NCT00332696|21022653|P2|Completed Day 14 Visit|Overall Study||15
8528689|NCT00332696|21022654|P1|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
8528690|NCT00332696|21022653|P2|STARTED|Overall Study||32
8528691|NCT00332696|21022654|P1|STARTED|Overall Study||32
8528692|NCT00332644|21022686|P6|NOT COMPLETED|Overall Study||15
8528693|NCT00332644|21022687|P5|NOT COMPLETED|Overall Study||12
8528694|NCT00332644|21022688|P4|NOT COMPLETED|Overall Study||20
8528695|NCT00332644|21022689|P3|NOT COMPLETED|Overall Study||9
8528696|NCT00332644|21022690|P2|NOT COMPLETED|Overall Study||22
8528697|NCT00332644|21022691|P1|NOT COMPLETED|Overall Study||12
8528698|NCT00332644|21022686|P6|COMPLETED|Overall Study||174
8528699|NCT00332644|21022687|P5|COMPLETED|Overall Study||250
8528700|NCT00332644|21022688|P4|COMPLETED|Overall Study||244
8528701|NCT00332644|21022689|P3|COMPLETED|Overall Study||258
8528702|NCT00332644|21022690|P2|COMPLETED|Overall Study||238
8528703|NCT00332644|21022691|P1|COMPLETED|Overall Study||250
8528704|NCT00332644|21022686|P6|STARTED|Overall Study||189
8528705|NCT00332644|21022687|P5|STARTED|Overall Study||262
8528706|NCT00332644|21022688|P4|STARTED|Overall Study||264
8528707|NCT00332644|21022689|P3|STARTED|Overall Study||267
8528708|NCT00332644|21022690|P2|STARTED|Overall Study||260
8528709|NCT00332644|21022691|P1|STARTED|Overall Study||262
8528710|NCT00332605|21022708|P3|NOT COMPLETED|Overall Study||8
8528711|NCT00332605|21022709|P2|NOT COMPLETED|Overall Study||2
8528712|NCT00332605|21022710|P1|NOT COMPLETED|Overall Study||2
8528713|NCT00332605|21022708|P3|COMPLETED|Overall Study||9
8528714|NCT00332605|21022709|P2|COMPLETED|Overall Study||12
8528715|NCT00332605|21022710|P1|COMPLETED|Overall Study||12
8528716|NCT00332605|21022708|P3|STARTED|Overall Study||17
8528717|NCT00332605|21022709|P2|STARTED|Overall Study||14
8528718|NCT00332605|21022710|P1|STARTED|Overall Study||14
8528719|NCT00332579|21022720|P2|NOT COMPLETED|Overall Study||1
8528720|NCT00332579|21022721|P1|NOT COMPLETED|Overall Study||1
8528721|NCT00332579|21022720|P2|COMPLETED|Overall Study||12
8528722|NCT00332579|21022721|P1|COMPLETED|Overall Study||11
8528723|NCT00332579|21022720|P2|STARTED|Overall Study||13
8528724|NCT00332579|21022721|P1|STARTED|Overall Study||12
8528725|NCT00332488|21022730|P3|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||21
8528726|NCT00332488|21022731|P2|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
8528727|NCT00332488|21022732|P1|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
8528728|NCT00332488|21022730|P3|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||233
8528729|NCT00332488|21022731|P2|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||70
8528730|NCT00332488|21022732|P1|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||27
8528731|NCT00332488|21022730|P3|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
8528732|NCT00332488|21022731|P2|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
8528733|NCT00332488|21022732|P1|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
8528734|NCT00332488|21022730|P3|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
8528735|NCT00332488|21022731|P2|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
8528736|NCT00332488|21022732|P1|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
8528737|NCT00332488|21022730|P3|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
8528738|NCT00332488|21022731|P2|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
8528739|NCT00332488|21022732|P1|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
8528740|NCT00332488|21022730|P3|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
8528741|NCT00332488|21022731|P2|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
8528742|NCT00332488|21022732|P1|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
8528743|NCT00332462|21022744|P1|NOT COMPLETED|Overall Study||16
8528744|NCT00332462|21022744|P1|COMPLETED|Overall Study||18
8528745|NCT00332462|21022744|P1|Patients Treated With Sandimmun® Optoral|Overall Study||29
8528746|NCT00332462|21022744|P1|Patients Treated With Sandimmun® i.v.|Overall Study||34
8528747|NCT00332462|21022744|P1|STARTED|Overall Study|Safety and Intention to treat population.|34
8528748|NCT00332332|21022751|P1|NOT COMPLETED|Overall Study||68
8528749|NCT00332332|21022751|P1|COMPLETED|Overall Study||178
8528750|NCT00332332|21022751|P1|Received Study Medication|Overall Study||230
8528751|NCT00332332|21022751|P1|STARTED|Overall Study||246
8528752|NCT00332241|21022760|P2|NOT COMPLETED|Overall Study||8
8528753|NCT00332241|21022761|P1|NOT COMPLETED|Overall Study||15
8528754|NCT00332241|21022760|P2|COMPLETED|Overall Study||39
8528755|NCT00332241|21022761|P1|COMPLETED|Overall Study||36
8528756|NCT00332241|21022760|P2|STARTED|Overall Study||47
8528757|NCT00332241|21022761|P1|STARTED|Overall Study||51
8528758|NCT00332202|21022783|P2|NOT COMPLETED|Overall Study||125
8528759|NCT00332202|21022784|P1|NOT COMPLETED|Overall Study||241
8528760|NCT00332202|21022783|P2|COMPLETED|Overall Study||129
8528761|NCT00332202|21022784|P1|COMPLETED|Overall Study||263
8528762|NCT00332202|21022783|P2|Received At Least One Dose of Study Drug|Overall Study||249
8528763|NCT00332202|21022784|P1|Received At Least One Dose of Study Drug|Overall Study||493
8528764|NCT00332202|21022783|P2|STARTED|Overall Study||254
8528765|NCT00332202|21022784|P1|STARTED|Overall Study||504
8528766|NCT00332189|21022813|P1|NOT COMPLETED|Overall Study||21
8528767|NCT00332189|21022813|P1|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
8528768|NCT00332189|21022813|P1|STARTED|Overall Study||111
8528769|NCT00332163|21022820|P2|NOT COMPLETED|Overall Study||0
8528770|NCT00332163|21022821|P1|NOT COMPLETED|Overall Study||0
8528771|NCT00332163|21022820|P2|COMPLETED|Overall Study||47
8528772|NCT00332163|21022821|P1|COMPLETED|Overall Study||48
8528773|NCT00332163|21022820|P2|Received Treatment|Overall Study||47
8528774|NCT00332163|21022821|P1|Received Treatment|Overall Study||48
8528775|NCT00332163|21022820|P2|STARTED|Overall Study||47
8528776|NCT00332163|21022821|P1|STARTED|Overall Study||48
8528777|NCT00331864|21022855|P2|NOT COMPLETED|Overall Study||4
8528778|NCT00331864|21022856|P1|NOT COMPLETED|Overall Study||58
8528779|NCT00331864|21022855|P2|COMPLETED|Overall Study||14
8528780|NCT00331864|21022856|P1|COMPLETED|Overall Study||455
8528781|NCT00331864|21022855|P2|STARTED|Overall Study||18
8528782|NCT00331864|21022856|P1|STARTED|Overall Study||513
8528783|NCT00331799|21022875|P1|NOT COMPLETED|Overall Study||3
8528784|NCT00331799|21022875|P1|COMPLETED|Overall Study||15
8528785|NCT00331799|21022875|P1|STARTED|Overall Study||18
8528786|NCT00331773|21022881|P2|NOT COMPLETED|Overall Study||7
8528787|NCT00331773|21022882|P1|NOT COMPLETED|Overall Study||16
8528788|NCT00331773|21022881|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
8528789|NCT00331773|21022882|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
8528790|NCT00331773|21022881|P2|STARTED|Overall Study||557
8528791|NCT00331773|21022882|P1|STARTED|Overall Study||558
8528792|NCT00331760|21022912|P2|NOT COMPLETED|Overall Study||8
8528793|NCT00331760|21022913|P1|NOT COMPLETED|Overall Study||15
8528794|NCT00331760|21022912|P2|COMPLETED|Overall Study||40
8528795|NCT00331760|21022913|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
8528796|NCT00331760|21022912|P2|STARTED|Overall Study||48
8528797|NCT00331760|21022913|P1|STARTED|Overall Study||58
8528798|NCT00331682|21022934|P1|NOT COMPLETED|Overall Study||1
8528799|NCT00331682|21022934|P1|COMPLETED|Overall Study||9
8528800|NCT00331682|21022934|P1|STARTED|Overall Study||10
8528801|NCT00331630|21022940|P1|NOT COMPLETED|Follow up for 5 Years||29
8528802|NCT00331630|21022940|P1|COMPLETED|Follow up for 5 Years||0
8528889|NCT00331344|21022992|P1|STARTED|Phase I||3
8528803|NCT00331630|21022940|P1|STARTED|Follow up for 5 Years|One patient did not enter follow up as was lost to follow up|29
8528804|NCT00331630|21022940|P1|NOT COMPLETED|Evaluated for and Completed SOC Surgery||2
8528805|NCT00331630|21022940|P1|COMPLETED|Evaluated for and Completed SOC Surgery||28
8528806|NCT00331630|21022940|P1|STARTED|Evaluated for and Completed SOC Surgery||30
8528807|NCT00331630|21022940|P1|NOT COMPLETED|Treatment on Study||0
8528808|NCT00331630|21022940|P1|COMPLETED|Treatment on Study||30
8528809|NCT00331630|21022940|P1|Completed 4 Cycles|Treatment on Study||30
8528810|NCT00331630|21022940|P1|Completed 1st Cycle|Treatment on Study||30
8528811|NCT00331630|21022940|P1|STARTED|Treatment on Study||30
8528812|NCT00331552|21022952|P2|NOT COMPLETED|Period 3: Phase II||0
8528813|NCT00331552|21022953|P1|NOT COMPLETED|Period 3: Phase II||2
8528814|NCT00331552|21022952|P2|COMPLETED|Period 3: Phase II||0
8528815|NCT00331552|21022953|P1|COMPLETED|Period 3: Phase II||22
8528816|NCT00331552|21022952|P2|STARTED|Period 3: Phase II||0
8528817|NCT00331552|21022953|P1|STARTED|Period 3: Phase II||24
8528818|NCT00331552|21022952|P2|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
8528819|NCT00331552|21022953|P1|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
8528820|NCT00331552|21022952|P2|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
8528821|NCT00331552|21022953|P1|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
8528822|NCT00331552|21022952|P2|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
8528823|NCT00331552|21022953|P1|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
8528824|NCT00331552|21022952|P2|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
8528825|NCT00331552|21022953|P1|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
8528826|NCT00331552|21022952|P2|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
8528827|NCT00331552|21022953|P1|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
8528828|NCT00331552|21022952|P2|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
8528829|NCT00331552|21022953|P1|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
8528830|NCT00331422|21022967|P1|NOT COMPLETED|Overall Study||5
8528831|NCT00331422|21022967|P1|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
8528832|NCT00331422|21022967|P1|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
8528833|NCT00331409|21022976|P1|NOT COMPLETED|Overall Study||4
8528834|NCT00331409|21022976|P1|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
8528835|NCT00331409|21022976|P1|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
8528836|NCT00331344|21022984|P9|NOT COMPLETED|Phase II||4
8528837|NCT00331344|21022985|P8|NOT COMPLETED|Phase II||0
8528838|NCT00331344|21022986|P7|NOT COMPLETED|Phase II||0
8528839|NCT00331344|21022987|P6|NOT COMPLETED|Phase II||0
8528840|NCT00331344|21022988|P5|NOT COMPLETED|Phase II||0
8528841|NCT00331344|21022989|P4|NOT COMPLETED|Phase II||0
8528842|NCT00331344|21022990|P3|NOT COMPLETED|Phase II||0
8528843|NCT00331344|21022991|P2|NOT COMPLETED|Phase II||0
8528844|NCT00331344|21022992|P1|NOT COMPLETED|Phase II||0
8528845|NCT00331344|21022984|P9|COMPLETED|Phase II||48
8528846|NCT00331344|21022985|P8|COMPLETED|Phase II||6
8528847|NCT00331344|21022986|P7|COMPLETED|Phase II||0
8528848|NCT00331344|21022987|P6|COMPLETED|Phase II||0
8528849|NCT00331344|21022988|P5|COMPLETED|Phase II||0
8528850|NCT00331344|21022989|P4|COMPLETED|Phase II||0
8528851|NCT00331344|21022990|P3|COMPLETED|Phase II||0
8528852|NCT00331344|21022991|P2|COMPLETED|Phase II||0
8528853|NCT00331344|21022992|P1|COMPLETED|Phase II||0
8528854|NCT00331344|21022984|P9|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
8528855|NCT00331344|21022985|P8|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
8528856|NCT00331344|21022986|P7|STARTED|Phase II||0
8528857|NCT00331344|21022987|P6|STARTED|Phase II||0
8528858|NCT00331344|21022988|P5|STARTED|Phase II||0
8528859|NCT00331344|21022989|P4|STARTED|Phase II||0
8528860|NCT00331344|21022990|P3|STARTED|Phase II||0
8528861|NCT00331344|21022991|P2|STARTED|Phase II||0
8528862|NCT00331344|21022992|P1|STARTED|Phase II||0
8528863|NCT00331344|21022984|P9|NOT COMPLETED|Phase I||0
8528864|NCT00331344|21022985|P8|NOT COMPLETED|Phase I||1
8528865|NCT00331344|21022986|P7|NOT COMPLETED|Phase I||0
8528866|NCT00331344|21022987|P6|NOT COMPLETED|Phase I||2
8528867|NCT00331344|21022988|P5|NOT COMPLETED|Phase I||2
8528868|NCT00331344|21022989|P4|NOT COMPLETED|Phase I||1
8528869|NCT00331344|21022990|P3|NOT COMPLETED|Phase I||0
8528870|NCT00331344|21022991|P2|NOT COMPLETED|Phase I||0
8528871|NCT00331344|21022992|P1|NOT COMPLETED|Phase I||0
8528872|NCT00331344|21022984|P9|COMPLETED|Phase I||0
8528873|NCT00331344|21022985|P8|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
8528874|NCT00331344|21022986|P7|COMPLETED|Phase I||4
8528875|NCT00331344|21022987|P6|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
8528876|NCT00331344|21022988|P5|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
8528877|NCT00331344|21022989|P4|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
8528878|NCT00331344|21022990|P3|COMPLETED|Phase I||3
8528879|NCT00331344|21022991|P2|COMPLETED|Phase I||3
8528880|NCT00331344|21022992|P1|COMPLETED|Phase I||3
8528881|NCT00331344|21022984|P9|STARTED|Phase I||0
8528882|NCT00331344|21022985|P8|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
8528883|NCT00331344|21022986|P7|STARTED|Phase I||4
8528884|NCT00331344|21022987|P6|STARTED|Phase I||5
8528885|NCT00331344|21022988|P5|STARTED|Phase I||6
8528886|NCT00331344|21022989|P4|STARTED|Phase I||6
8528887|NCT00331344|21022990|P3|STARTED|Phase I||3
8528888|NCT00331344|21022991|P2|STARTED|Phase I||3
8528890|NCT00331162|21023008|P2|NOT COMPLETED|Overall Study||0
8528891|NCT00331162|21023009|P1|NOT COMPLETED|Overall Study||0
8528892|NCT00331162|21023008|P2|COMPLETED|Overall Study||109
8528893|NCT00331162|21023009|P1|COMPLETED|Overall Study||113
8528894|NCT00331162|21023008|P2|STARTED|Overall Study||109
8528895|NCT00331162|21023009|P1|STARTED|Overall Study||113
8528896|NCT00331006|21023029|P1|NOT COMPLETED|Follow-Up Phase II||3
8528897|NCT00331006|21023029|P1|COMPLETED|Follow-Up Phase II||11
8528898|NCT00331006|21023029|P1|STARTED|Follow-Up Phase II||14
8528899|NCT00331006|21023029|P1|NOT COMPLETED|Follow-Up Phase I||1
8528900|NCT00331006|21023029|P1|COMPLETED|Follow-Up Phase I||14
8528901|NCT00331006|21023029|P1|STARTED|Follow-Up Phase I||15
8528902|NCT00331006|21023029|P1|NOT COMPLETED|Treatment Phase||1
8528903|NCT00331006|21023029|P1|COMPLETED|Treatment Phase||15
8528904|NCT00331006|21023029|P1|STARTED|Treatment Phase||16
8528905|NCT00331006|21023029|P1|NOT COMPLETED|Screening Phase||7
8528906|NCT00331006|21023029|P1|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
8528907|NCT00331006|21023029|P1|STARTED|Screening Phase||23
8528908|NCT00330967|21023042|P2|NOT COMPLETED|Overall Study||14
8528909|NCT00330967|21023043|P1|NOT COMPLETED|Overall Study||0
8528910|NCT00330967|21023042|P2|COMPLETED|Overall Study||11
8528911|NCT00330967|21023043|P1|COMPLETED|Overall Study||0
8528912|NCT00330967|21023042|P2|STARTED|Overall Study||25
8528913|NCT00330967|21023043|P1|STARTED|Overall Study||0
8528914|NCT00330928|21023054|P1|NOT COMPLETED|Overall Study||17
8528915|NCT00330928|21023054|P1|COMPLETED|Overall Study||89
8528916|NCT00330928|21023054|P1|1 Year Phone Contact|Overall Study||89
8528917|NCT00330928|21023054|P1|7 Day Phone Contact|Overall Study||99
8528918|NCT00330928|21023054|P1|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
8528919|NCT00330915|21023059|P1|NOT COMPLETED|Overall Study||0
8528920|NCT00330915|21023059|P1|COMPLETED|Overall Study||37
8528921|NCT00330915|21023059|P1|STARTED|Overall Study||37
8528922|NCT00330876|21023066|P2|NOT COMPLETED|Overall Study||13
8528923|NCT00330876|21023067|P1|NOT COMPLETED|Overall Study||71
8528924|NCT00330876|21023066|P2|COMPLETED|Overall Study||77
8528925|NCT00330876|21023067|P1|COMPLETED|Overall Study||378
8528926|NCT00330876|21023066|P2|STARTED|Overall Study||90
8528927|NCT00330876|21023067|P1|STARTED|Overall Study||449
8528928|NCT00330863|21023077|P2|NOT COMPLETED|Overall Study||80
8528929|NCT00330863|21023078|P1|NOT COMPLETED|Overall Study||81
8528930|NCT00330863|21023077|P2|COMPLETED|Overall Study||72
8528931|NCT00330863|21023078|P1|COMPLETED|Overall Study||72
8528932|NCT00330863|21023077|P2|STARTED|Overall Study||152
8528933|NCT00330863|21023078|P1|STARTED|Overall Study||153
8528934|NCT00330759|21023096|P2|NOT COMPLETED|Overall Study||706
8528935|NCT00330759|21023097|P1|NOT COMPLETED|Overall Study||712
8528936|NCT00330759|21023096|P2|COMPLETED|Overall Study||180
8528937|NCT00330759|21023097|P1|COMPLETED|Overall Study||178
8528938|NCT00330759|21023096|P2|Received Investigational Product|Overall Study||878
8528939|NCT00330759|21023097|P1|Received Investigational Product|Overall Study||878
8528940|NCT00330759|21023096|P2|STARTED|Overall Study||886
8528941|NCT00330759|21023097|P1|STARTED|Overall Study||890
8528942|NCT00330733|21023109|P2|NOT COMPLETED|Overall Study||5
8528943|NCT00330733|21023110|P1|NOT COMPLETED|Overall Study||7
8528944|NCT00330733|21023109|P2|COMPLETED|Overall Study||29
8528945|NCT00330733|21023110|P1|COMPLETED|Overall Study||30
8528946|NCT00330733|21023109|P2|Received Study Medication|Overall Study||34
8528947|NCT00330733|21023110|P1|Received Study Medication|Overall Study||36
8528948|NCT00330733|21023109|P2|STARTED|Overall Study||34
8528949|NCT00330733|21023110|P1|STARTED|Overall Study||37
8528950|NCT00330681|21023130|P2|NOT COMPLETED|Overall Study||14
8528951|NCT00330681|21023131|P1|NOT COMPLETED|Overall Study||9
8528952|NCT00330681|21023130|P2|COMPLETED|Overall Study||90
8528953|NCT00330681|21023131|P1|COMPLETED|Overall Study||93
8528954|NCT00330681|21023130|P2|STARTED|Overall Study||104
8528955|NCT00330681|21023131|P1|STARTED|Overall Study||102
8528956|NCT00330668|21023153|P1|NOT COMPLETED|QD Dosing Period||78
8528957|NCT00330668|21023153|P1|COMPLETED|QD Dosing Period||0
8528958|NCT00330668|21023153|P1|STARTED|QD Dosing Period||78
8528959|NCT00330668|21023153|P1|NOT COMPLETED|BID Dosing Period||36
8528960|NCT00330668|21023153|P1|COMPLETED|BID Dosing Period||78
8528961|NCT00330668|21023153|P1|STARTED|BID Dosing Period||114
8528962|NCT00330616|21023161|P1|NOT COMPLETED|Overall Study||21
8528963|NCT00330616|21023161|P1|COMPLETED|Overall Study||14
8528964|NCT00330616|21023161|P1|STARTED|Overall Study||35
8528965|NCT00330564|21023180|P1|NOT COMPLETED|Overall Study||0
8528966|NCT00330564|21023180|P1|COMPLETED|Overall Study||15
8528967|NCT00330564|21023180|P1|STARTED|Overall Study||15
8528968|NCT00330551|21023187|P2|NOT COMPLETED|Overall Study||16
8528969|NCT00330551|21023188|P1|NOT COMPLETED|Overall Study||10
8528970|NCT00330551|21023187|P2|COMPLETED|Overall Study||27
8528971|NCT00330551|21023188|P1|COMPLETED|Overall Study||30
8528972|NCT00330551|21023187|P2|STARTED|Overall Study||43
8528973|NCT00330551|21023188|P1|STARTED|Overall Study||40
8528974|NCT00330460|21023212|P2|NOT COMPLETED|Overall Study||33
8528975|NCT00330460|21023213|P1|NOT COMPLETED|Overall Study||42
8528976|NCT00330460|21023212|P2|COMPLETED|Overall Study||561
8528977|NCT00330460|21023213|P1|COMPLETED|Overall Study||553
8528978|NCT00330460|21023212|P2|STARTED|Overall Study||594
8528979|NCT00330460|21023213|P1|STARTED|Overall Study||595
8528980|NCT00330421|21023227|P2|NOT COMPLETED|Overall Study||0
8528981|NCT00330421|21023228|P1|NOT COMPLETED|Overall Study||0
8528982|NCT00330421|21023227|P2|COMPLETED|Overall Study||0
8528983|NCT00330421|21023228|P1|COMPLETED|Overall Study||15
8528984|NCT00330421|21023227|P2|STARTED|Overall Study||0
8528985|NCT00330421|21023228|P1|STARTED|Overall Study||15
8528986|NCT00330382|21023234|P2|NOT COMPLETED|Overall Study||17
8528987|NCT00330382|21023235|P1|NOT COMPLETED|Overall Study||24
8528988|NCT00330382|21023234|P2|COMPLETED|Overall Study||48
8528989|NCT00330382|21023235|P1|COMPLETED|Overall Study||43
8528990|NCT00330382|21023234|P2|STARTED|Overall Study||65
8528991|NCT00330382|21023235|P1|STARTED|Overall Study||67
8528992|NCT00330343|21023256|P1|NOT COMPLETED|Overall Study||5
8528993|NCT00330343|21023256|P1|COMPLETED|Overall Study||59
8528994|NCT00330343|21023256|P1|STARTED|Overall Study||64
8528995|NCT00330187|21023264|P4|NOT COMPLETED|Overall Study||14
8528996|NCT00330187|21023265|P3|NOT COMPLETED|Overall Study||18
8528997|NCT00330187|21023266|P2|NOT COMPLETED|Overall Study||18
8528998|NCT00330187|21023267|P1|NOT COMPLETED|Overall Study||20
8528999|NCT00330187|21023264|P4|COMPLETED|Overall Study||18
8529000|NCT00330187|21023265|P3|COMPLETED|Overall Study||11
8529001|NCT00330187|21023266|P2|COMPLETED|Overall Study||18
8529002|NCT00330187|21023267|P1|COMPLETED|Overall Study||17
8529003|NCT00330187|21023264|P4|STARTED|Overall Study||32
8529004|NCT00330187|21023265|P3|STARTED|Overall Study||29
8529005|NCT00330187|21023266|P2|STARTED|Overall Study||36
8529006|NCT00330187|21023267|P1|STARTED|Overall Study||37
8529007|NCT00330174|21023279|P2|NOT COMPLETED|Overall Study||19
8529008|NCT00330174|21023280|P1|NOT COMPLETED|Overall Study||22
8529009|NCT00330174|21023279|P2|COMPLETED|Overall Study||26
8529010|NCT00330174|21023280|P1|COMPLETED|Overall Study||23
8529011|NCT00330174|21023279|P2|STARTED|Overall Study||45
8529012|NCT00330174|21023280|P1|STARTED|Overall Study||45
8529013|NCT00330161|21023292|P1|NOT COMPLETED|Overall Study||0
8529014|NCT00330161|21023292|P1|COMPLETED|Overall Study||29
8529015|NCT00330161|21023292|P1|STARTED|Overall Study||29
8529016|NCT00329901|21023304|P3|NOT COMPLETED|Overall Study||4
8529017|NCT00329901|21023305|P2|NOT COMPLETED|Overall Study||5
8529018|NCT00329901|21023306|P1|NOT COMPLETED|Overall Study||9
8529019|NCT00329901|21023304|P3|COMPLETED|Overall Study||353
8529020|NCT00329901|21023305|P2|COMPLETED|Overall Study||349
8529021|NCT00329901|21023306|P1|COMPLETED|Overall Study||352
8529022|NCT00329901|21023304|P3|STARTED|Overall Study||357
8529023|NCT00329901|21023305|P2|STARTED|Overall Study||354
8529024|NCT00329901|21023306|P1|STARTED|Overall Study||361
8529025|NCT00329849|21023336|P2|NOT COMPLETED|Overall Study||4
8529026|NCT00329849|21023337|P1|NOT COMPLETED|Overall Study||6
8529027|NCT00329849|21023336|P2|COMPLETED|Overall Study||546
8529028|NCT00329849|21023337|P1|COMPLETED|Overall Study||944
8529029|NCT00329849|21023336|P2|STARTED|Overall Study||550
8529030|NCT00329849|21023337|P1|STARTED|Overall Study||950
8529031|NCT00329836|21023357|P1|NOT COMPLETED|Overall Study||0
8529032|NCT00329836|21023357|P1|COMPLETED|Overall Study||41
8529033|NCT00329836|21023357|P1|STARTED|Overall Study||41
8529034|NCT00329797|21023363|P2|NOT COMPLETED|Overall Study||6
8529035|NCT00329797|21023364|P1|NOT COMPLETED|Overall Study||7
8529036|NCT00329797|21023363|P2|COMPLETED|Overall Study||46
8529037|NCT00329797|21023364|P1|COMPLETED|Overall Study||50
8529038|NCT00329797|21023363|P2|STARTED|Overall Study||52
8529039|NCT00329797|21023364|P1|STARTED|Overall Study||57
8529040|NCT00329784|21023380|P4|NOT COMPLETED|Overall Study||0
8529041|NCT00329784|21023381|P3|NOT COMPLETED|Overall Study||0
8529042|NCT00329784|21023382|P2|NOT COMPLETED|Overall Study||5
8529043|NCT00329784|21023383|P1|NOT COMPLETED|Overall Study||5
8529044|NCT00329784|21023380|P4|COMPLETED|Overall Study||47
8529045|NCT00329784|21023381|P3|COMPLETED|Overall Study||51
8529046|NCT00329784|21023382|P2|COMPLETED|Overall Study||267
8529047|NCT00329784|21023383|P1|COMPLETED|Overall Study||265
8529048|NCT00329784|21023380|P4|STARTED|Overall Study||47
8529049|NCT00329784|21023381|P3|STARTED|Overall Study||51
8529050|NCT00329784|21023382|P2|STARTED|Overall Study||272
8529051|NCT00329784|21023383|P1|STARTED|Overall Study||270
8529052|NCT00329771|21023405|P1|NOT COMPLETED|Overall Study||3
8529053|NCT00329771|21023405|P1|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
8529054|NCT00329771|21023405|P1|STARTED|Overall Study||28
8529055|NCT00329745|21023411|P2|NOT COMPLETED|Overall Study||102
8529056|NCT00329745|21023412|P1|NOT COMPLETED|Overall Study||87
8529057|NCT00329745|21023411|P2|COMPLETED|Overall Study||4226
8529058|NCT00329745|21023412|P1|COMPLETED|Overall Study||4272
8529059|NCT00329745|21023411|P2|STARTED|Overall Study||4328
8529060|NCT00329745|21023412|P1|STARTED|Overall Study||4359
8529061|NCT00329732|21023422|P2|NOT COMPLETED|Overall Study||0
8529062|NCT00329732|21023423|P1|NOT COMPLETED|Overall Study||0
8529063|NCT00329732|21023422|P2|COMPLETED|Overall Study||0
8529064|NCT00329732|21023423|P1|COMPLETED|Overall Study||2
8529065|NCT00329732|21023422|P2|STARTED|Overall Study||0
8529066|NCT00329732|21023423|P1|STARTED|Overall Study||2
8529067|NCT00329719|21023432|P4|NOT COMPLETED|Overall Study||1
8529068|NCT00329719|21023433|P3|NOT COMPLETED|Overall Study||0
8529069|NCT00329719|21023434|P2|NOT COMPLETED|Overall Study||0
8529070|NCT00329719|21023435|P1|NOT COMPLETED|Overall Study||0
8529071|NCT00329719|21023432|P4|COMPLETED|Overall Study||44
8529072|NCT00329719|21023433|P3|COMPLETED|Overall Study||9
8529073|NCT00329719|21023434|P2|COMPLETED|Overall Study||49
8529074|NCT00329719|21023435|P1|COMPLETED|Overall Study||12
8529075|NCT00329719|21023432|P4|STARTED|Overall Study||45
8529076|NCT00329719|21023433|P3|STARTED|Overall Study||9
8529077|NCT00329719|21023434|P2|STARTED|Overall Study||49
8529078|NCT00329719|21023435|P1|STARTED|Overall Study||12
8529079|NCT00329641|21023457|P1|NOT COMPLETED|Overall Study||6
8529080|NCT00329641|21023457|P1|COMPLETED|Overall Study||19
8529081|NCT00329641|21023457|P1|Eligible and Received Treatment|Overall Study||24
8529082|NCT00329641|21023457|P1|Eligible|Overall Study||25
8529083|NCT00329641|21023457|P1|STARTED|Overall Study||25
8529084|NCT00329602|21023466|P3|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
8529085|NCT00329602|21023467|P2|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
8529086|NCT00329602|21023468|P1|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
8529087|NCT00329602|21023466|P3|COMPLETED|40-Week Open-Label Treatment Phase||233
8529088|NCT00329602|21023467|P2|COMPLETED|40-Week Open-Label Treatment Phase||0
8529089|NCT00329602|21023468|P1|COMPLETED|40-Week Open-Label Treatment Phase||0
8529090|NCT00329602|21023466|P3|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
8529091|NCT00329602|21023467|P2|STARTED|40-Week Open-Label Treatment Phase||0
8529092|NCT00329602|21023468|P1|STARTED|40-Week Open-Label Treatment Phase||0
8529093|NCT00329602|21023466|P3|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
8529094|NCT00329602|21023467|P2|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
8529095|NCT00329602|21023468|P1|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
8529096|NCT00329602|21023466|P3|COMPLETED|26-Week Double-Blind Treatment Phase||0
8529097|NCT00329602|21023467|P2|COMPLETED|26-Week Double-Blind Treatment Phase||98
8529098|NCT00329602|21023468|P1|COMPLETED|26-Week Double-Blind Treatment Phase||88
8529099|NCT00329602|21023466|P3|STARTED|26-Week Double-Blind Treatment Phase||0
8529100|NCT00329602|21023467|P2|STARTED|26-Week Double-Blind Treatment Phase||197
8529101|NCT00329602|21023468|P1|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
8529102|NCT00329550|21023506|P3|NOT COMPLETED|Overall Study||4
8529103|NCT00329550|21023507|P2|NOT COMPLETED|Overall Study||4
8529104|NCT00329550|21023508|P1|NOT COMPLETED|Overall Study||4
8529105|NCT00329550|21023506|P3|COMPLETED|Overall Study||12
8529106|NCT00329550|21023507|P2|COMPLETED|Overall Study||11
8529107|NCT00329550|21023508|P1|COMPLETED|Overall Study||5
8529108|NCT00329550|21023506|P3|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
8529109|NCT00329550|21023507|P2|STARTED|Overall Study||15
8529110|NCT00329550|21023508|P1|STARTED|Overall Study||9
8529111|NCT00329524|21023755|P1|NOT COMPLETED|Overall Study||0
8529112|NCT00329524|21023755|P1|COMPLETED|Overall Study||5
8529113|NCT00329524|21023755|P1|STARTED|Overall Study||5
8529114|NCT00329433|21023763|P2|NOT COMPLETED|Overall Study||0
8529115|NCT00329433|21023764|P1|NOT COMPLETED|Overall Study||0
8529116|NCT00329433|21023763|P2|COMPLETED|Overall Study||59
8529117|NCT00329433|21023764|P1|COMPLETED|Overall Study||61
8529118|NCT00329433|21023763|P2|STARTED|Overall Study||59
8529119|NCT00329433|21023764|P1|STARTED|Overall Study||61
8529120|NCT00329420|21023777|P3|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
8529121|NCT00329420|21023778|P2|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
8529122|NCT00329420|21023779|P1|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
8529123|NCT00329420|21023777|P3|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
8529124|NCT00329420|21023778|P2|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
8529125|NCT00329420|21023779|P1|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
8529126|NCT00329420|21023777|P3|STARTED|4-weekly Dosing Phase (Responders Only)||7
8529127|NCT00329420|21023778|P2|STARTED|4-weekly Dosing Phase (Responders Only)||7
8529128|NCT00329420|21023779|P1|STARTED|4-weekly Dosing Phase (Responders Only)||12
8529129|NCT00329420|21023777|P3|NOT COMPLETED|Re-induction Phase||8
8529130|NCT00329420|21023778|P2|NOT COMPLETED|Re-induction Phase||6
8529131|NCT00329420|21023779|P1|NOT COMPLETED|Re-induction Phase||6
8529132|NCT00329420|21023777|P3|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
8529133|NCT00329420|21023778|P2|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
8529134|NCT00329420|21023779|P1|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
8529135|NCT00329420|21023777|P3|STARTED|Re-induction Phase||15
8529136|NCT00329420|21023778|P2|STARTED|Re-induction Phase||13
8529137|NCT00329420|21023779|P1|STARTED|Re-induction Phase||18
8529138|NCT00329407|21024158|P1|NOT COMPLETED|Overall Study||1
8529139|NCT00329407|21024158|P1|COMPLETED|Overall Study||9
8529140|NCT00329407|21024158|P1|STARTED|Overall Study||10
8529141|NCT00329303|21024165|P2|NOT COMPLETED|Overall Study||2
8529142|NCT00329303|21024166|P1|NOT COMPLETED|Overall Study||2
8529143|NCT00329303|21024165|P2|COMPLETED|Overall Study||35
8529144|NCT00329303|21024166|P1|COMPLETED|Overall Study||32
8529145|NCT00329303|21024165|P2|STARTED|Overall Study||37
8529146|NCT00329303|21024166|P1|STARTED|Overall Study||34
8529147|NCT00329238|21024328|P2|NOT COMPLETED|Overall Study||281
8529148|NCT00329238|21024329|P1|NOT COMPLETED|Overall Study||276
8529149|NCT00329238|21024328|P2|COMPLETED|Overall Study||1145
8529150|NCT00329238|21024329|P1|COMPLETED|Overall Study||1154
8529151|NCT00329238|21024328|P2|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
8529152|NCT00329238|21024329|P1|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
8529153|NCT00329160|21024365|P1|NOT COMPLETED|Overall Study||88
8529154|NCT00329160|21024365|P1|COMPLETED|Overall Study||126
8529155|NCT00329160|21024365|P1|Treatment Period|Overall Study||214
8529156|NCT00329160|21024365|P1|Observation Period|Overall Study||214
8529157|NCT00329160|21024365|P1|STARTED|Overall Study||214
8529164|NCT00329030|21024383|P2|NOT COMPLETED|Overall Study||6
8529165|NCT00329030|21024384|P1|NOT COMPLETED|Overall Study||8
8529166|NCT00329030|21024383|P2|COMPLETED|Overall Study||107
8529167|NCT00329030|21024384|P1|COMPLETED|Overall Study||103
8529168|NCT00329030|21024383|P2|STARTED|Overall Study||113
8529169|NCT00329030|21024384|P1|STARTED|Overall Study||111
8529170|NCT00328926|21024415|P3|NOT COMPLETED|Overall Study||2
8529171|NCT00328926|21024416|P2|NOT COMPLETED|Overall Study||3
8529172|NCT00328926|21024417|P1|NOT COMPLETED|Overall Study||2
8529173|NCT00328926|21024415|P3|COMPLETED|Overall Study||1
8529174|NCT00328926|21024416|P2|COMPLETED|Overall Study||0
8529175|NCT00328926|21024417|P1|COMPLETED|Overall Study||3
8529176|NCT00328926|21024415|P3|STARTED|Overall Study||3
8529177|NCT00328926|21024416|P2|STARTED|Overall Study||3
8529178|NCT00328926|21024417|P1|STARTED|Overall Study||5
8529179|NCT00328861|21024433|P2|NOT COMPLETED|Overall Study||0
8529180|NCT00328861|21024434|P1|NOT COMPLETED|Overall Study||0
8529181|NCT00328861|21024433|P2|COMPLETED|Overall Study||1
8529182|NCT00328861|21024434|P1|COMPLETED|Overall Study||7
8529183|NCT00328861|21024433|P2|STARTED|Overall Study||1
8529184|NCT00328861|21024434|P1|STARTED|Overall Study||7
8529185|NCT00328783|21024442|P1|NOT COMPLETED|Overall Study||26
8529186|NCT00328783|21024442|P1|COMPLETED|Overall Study||86
8529187|NCT00328783|21024442|P1|STARTED|Overall Study||112
8529188|NCT00328770|21024450|P1|NOT COMPLETED|Overall Study||0
8529189|NCT00328770|21024450|P1|COMPLETED|Overall Study||70
8529190|NCT00328770|21024450|P1|STARTED|Overall Study||70
8529191|NCT00328627|21024468|P12|NOT COMPLETED|Overall Study||16
8529192|NCT00328627|21024469|P11|NOT COMPLETED|Overall Study||18
8529193|NCT00328627|21024470|P10|NOT COMPLETED|Overall Study||32
8529194|NCT00328627|21024471|P9|NOT COMPLETED|Overall Study||17
8529195|NCT00328627|21024472|P8|NOT COMPLETED|Overall Study||14
8529196|NCT00328627|21024473|P7|NOT COMPLETED|Overall Study||35
8529197|NCT00328627|21024474|P6|NOT COMPLETED|Overall Study||20
8529198|NCT00328627|21024475|P5|NOT COMPLETED|Overall Study||15
8529199|NCT00328627|21024476|P4|NOT COMPLETED|Overall Study||37
8529200|NCT00328627|21024477|P3|NOT COMPLETED|Overall Study||28
8529201|NCT00328627|21024478|P2|NOT COMPLETED|Overall Study||31
8529202|NCT00328627|21024479|P1|NOT COMPLETED|Overall Study||59
8529203|NCT00328627|21024468|P12|COMPLETED|Overall Study||114
8529204|NCT00328627|21024469|P11|COMPLETED|Overall Study||112
8529205|NCT00328627|21024470|P10|COMPLETED|Overall Study||97
8529206|NCT00328627|21024471|P9|COMPLETED|Overall Study||113
8529207|NCT00328627|21024472|P8|COMPLETED|Overall Study||116
8529208|NCT00328627|21024473|P7|COMPLETED|Overall Study||94
8529209|NCT00328627|21024474|P6|COMPLETED|Overall Study||110
8529210|NCT00328627|21024475|P5|COMPLETED|Overall Study||115
8529211|NCT00328627|21024476|P4|COMPLETED|Overall Study||93
8529212|NCT00328627|21024477|P3|COMPLETED|Overall Study||101
8529213|NCT00328627|21024478|P2|COMPLETED|Overall Study||97
8529214|NCT00328627|21024479|P1|COMPLETED|Overall Study||70
8529215|NCT00328627|21024468|P12|Safety Set|Overall Study||130
8529216|NCT00328627|21024469|P11|Safety Set|Overall Study||130
8529217|NCT00328627|21024470|P10|Safety Set|Overall Study||129
8529218|NCT00328627|21024471|P9|Safety Set|Overall Study||130
8529219|NCT00328627|21024472|P8|Safety Set|Overall Study||130
8529220|NCT00328627|21024473|P7|Safety Set|Overall Study||129
8529221|NCT00328627|21024474|P6|Safety Set|Overall Study||130
8529222|NCT00328627|21024475|P5|Safety Set|Overall Study||130
8529223|NCT00328627|21024476|P4|Safety Set|Overall Study||129
8529224|NCT00328627|21024477|P3|Safety Set|Overall Study||129
8529225|NCT00328627|21024478|P2|Safety Set|Overall Study||128
8529226|NCT00328627|21024479|P1|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
8529227|NCT00328627|21024468|P12|STARTED|Overall Study||130
8529228|NCT00328627|21024469|P11|STARTED|Overall Study||130
8529229|NCT00328627|21024470|P10|STARTED|Overall Study||129
8529230|NCT00328627|21024471|P9|STARTED|Overall Study||130
8529231|NCT00328627|21024472|P8|STARTED|Overall Study||130
8529232|NCT00328627|21024473|P7|STARTED|Overall Study||129
8529233|NCT00328627|21024474|P6|STARTED|Overall Study||130
8529234|NCT00328627|21024475|P5|STARTED|Overall Study||130
8529235|NCT00328627|21024476|P4|STARTED|Overall Study||130
8529236|NCT00328627|21024477|P3|STARTED|Overall Study||129
8529237|NCT00328627|21024478|P2|STARTED|Overall Study||128
8529238|NCT00328627|21024479|P1|STARTED|Overall Study||129
8529239|NCT00328614|21026002|P6|NOT COMPLETED|Overall Study||1
8529240|NCT00328614|21026003|P5|NOT COMPLETED|Overall Study||1
8529241|NCT00328614|21026004|P4|NOT COMPLETED|Overall Study||1
8529242|NCT00328614|21026005|P3|NOT COMPLETED|Overall Study||0
8529243|NCT00328614|21026006|P2|NOT COMPLETED|Overall Study||0
8529244|NCT00328614|21026007|P1|NOT COMPLETED|Overall Study||0
8529245|NCT00328614|21026002|P6|COMPLETED|Overall Study||5
8529246|NCT00328614|21026003|P5|COMPLETED|Overall Study||5
8529247|NCT00328614|21026004|P4|COMPLETED|Overall Study||5
8529248|NCT00328614|21026005|P3|COMPLETED|Overall Study||6
8529249|NCT00328614|21026006|P2|COMPLETED|Overall Study||4
8529250|NCT00328614|21026007|P1|COMPLETED|Overall Study||4
8529251|NCT00328614|21026002|P6|STARTED|Overall Study||6
8529252|NCT00328614|21026003|P5|STARTED|Overall Study||6
8529253|NCT00328614|21026004|P4|STARTED|Overall Study||6
8529254|NCT00328614|21026005|P3|STARTED|Overall Study||6
8529255|NCT00328614|21026006|P2|STARTED|Overall Study||4
8529256|NCT00328614|21026007|P1|STARTED|Overall Study||4
8529257|NCT00328562|21026016|P1|NOT COMPLETED|Overall Study||1
8529258|NCT00328562|21026016|P1|COMPLETED|Overall Study||12
8529259|NCT00328562|21026016|P1|STARTED|Overall Study||13
8529260|NCT00328510|21026025|P2|NOT COMPLETED|Overall Study||4
8529261|NCT00328510|21026026|P1|NOT COMPLETED|Overall Study||10
8529262|NCT00328510|21026025|P2|COMPLETED|Overall Study||37
8529263|NCT00328510|21026026|P1|COMPLETED|Overall Study||32
8529264|NCT00328510|21026025|P2|STARTED|Overall Study||41
8529265|NCT00328510|21026026|P1|STARTED|Overall Study||42
8529266|NCT00328263|21026034|P2|NOT COMPLETED|Overall Study||4
8529267|NCT00328263|21026035|P1|NOT COMPLETED|Overall Study||3
8529268|NCT00328263|21026034|P2|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
8529269|NCT00328263|21026035|P1|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
8529270|NCT00328263|21026034|P2|STARTED|Overall Study||221
8529271|NCT00328263|21026035|P1|STARTED|Overall Study||216
8529272|NCT00328198|21026041|P1|NOT COMPLETED|Follow-up||35
8529273|NCT00328198|21026041|P1|COMPLETED|Follow-up||43
8529274|NCT00328198|21026041|P1|STARTED|Follow-up|Eight participants did not enter Follow-up|78
8529275|NCT00328198|21026041|P1|NOT COMPLETED|Treatment||38
8529276|NCT00328198|21026041|P1|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
8529277|NCT00328198|21026041|P1|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
8529278|NCT00328172|21026056|P5|NOT COMPLETED|Overall Study||5
8529279|NCT00328172|21026057|P4|NOT COMPLETED|Overall Study||13
8529280|NCT00328172|21026058|P3|NOT COMPLETED|Overall Study||10
8529281|NCT00328172|21026059|P2|NOT COMPLETED|Overall Study||14
8529282|NCT00328172|21026060|P1|NOT COMPLETED|Overall Study||22
8529283|NCT00328172|21026056|P5|COMPLETED|Overall Study||60
8529284|NCT00328172|21026057|P4|COMPLETED|Overall Study||42
8529285|NCT00328172|21026058|P3|COMPLETED|Overall Study||47
8529286|NCT00328172|21026059|P2|COMPLETED|Overall Study||44
8529287|NCT00328172|21026060|P1|COMPLETED|Overall Study||45
8529288|NCT00328172|21026056|P5|STARTED|Overall Study||65
8529289|NCT00328172|21026057|P4|STARTED|Overall Study||55
8529290|NCT00328172|21026058|P3|STARTED|Overall Study||57
8529291|NCT00328172|21026059|P2|STARTED|Overall Study||58
8529292|NCT00328172|21026060|P1|STARTED|Overall Study||67
8529293|NCT00328094|21026084|P2|NOT COMPLETED|Overall Study||3
8529294|NCT00328094|21026085|P1|NOT COMPLETED|Overall Study||3
8529295|NCT00328094|21026084|P2|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
8529296|NCT00328094|21026085|P1|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
8529297|NCT00328094|21026084|P2|STARTED|Overall Study||125
8529298|NCT00328094|21026085|P1|STARTED|Overall Study||117
8529299|NCT00328042|21026095|P2|NOT COMPLETED|Overall Study||2
8529300|NCT00328042|21026096|P1|NOT COMPLETED|Overall Study||0
8529301|NCT00328042|21026095|P2|COMPLETED|Overall Study||63
8529302|NCT00328042|21026096|P1|COMPLETED|Overall Study||69
8529303|NCT00328042|21026095|P2|STARTED|Overall Study||65
8529304|NCT00328042|21026096|P1|STARTED|Overall Study||69
8529305|NCT00328016|21026106|P2|NOT COMPLETED|Overall Study||0
8529306|NCT00328016|21026107|P1|NOT COMPLETED|Overall Study||0
8529307|NCT00328016|21026106|P2|COMPLETED|Overall Study||21
8529308|NCT00328016|21026107|P1|COMPLETED|Overall Study||23
8529309|NCT00328016|21026106|P2|STARTED|Overall Study||21
8529310|NCT00328016|21026107|P1|STARTED|Overall Study||23
8529311|NCT00327717|21026119|P2|NOT COMPLETED|Overall Study||14
8529312|NCT00327717|21026120|P1|NOT COMPLETED|Overall Study||9
8529313|NCT00327717|21026119|P2|COMPLETED|Overall Study||106
8529314|NCT00327717|21026120|P1|COMPLETED|Overall Study||111
8529315|NCT00327717|21026119|P2|STARTED|Overall Study||120
8529316|NCT00327717|21026120|P1|STARTED|Overall Study||120
8529317|NCT00327470|21026146|P2|NOT COMPLETED|Overall Study||63
8529318|NCT00327470|21026147|P1|NOT COMPLETED|Overall Study||29
8529319|NCT00327470|21026146|P2|COMPLETED|Overall Study||118
8529320|NCT00327470|21026147|P1|COMPLETED|Overall Study||78
8529321|NCT00327470|21026146|P2|Treated|Overall Study||179
8529322|NCT00327470|21026147|P1|Treated|Overall Study||107
8529323|NCT00327470|21026146|P2|STARTED|Overall Study||181
8529324|NCT00327470|21026147|P1|STARTED|Overall Study||107
8529325|NCT00327444|21026167|P2|NOT COMPLETED|Open Label Treatment (OL) Period||10
8529326|NCT00327444|21026168|P1|NOT COMPLETED|Open Label Treatment (OL) Period||11
8529327|NCT00327444|21026167|P2|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
8529328|NCT00327444|21026168|P1|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
8529329|NCT00327444|21026167|P2|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
8529330|NCT00327444|21026168|P1|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
8529331|NCT00327444|21026167|P2|STARTED|Open Label Treatment (OL) Period||10
8529332|NCT00327444|21026168|P1|STARTED|Open Label Treatment (OL) Period||11
8529333|NCT00327444|21026167|P2|NOT COMPLETED|Double Blind Treatment (DB) Period||29
8529334|NCT00327444|21026168|P1|NOT COMPLETED|Double Blind Treatment (DB) Period||26
8529335|NCT00327444|21026167|P2|COMPLETED|Double Blind Treatment (DB) Period||0
8529336|NCT00327444|21026168|P1|COMPLETED|Double Blind Treatment (DB) Period||0
8529337|NCT00327444|21026167|P2|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
8529338|NCT00327444|21026168|P1|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
8529339|NCT00327444|21026167|P2|STARTED|Double Blind Treatment (DB) Period||29
8529340|NCT00327444|21026168|P1|STARTED|Double Blind Treatment (DB) Period||26
8529341|NCT00327392|21026180|P1|NOT COMPLETED|Overall Study||0
8529342|NCT00327392|21026180|P1|COMPLETED|Overall Study||123
8529343|NCT00327392|21026180|P1|STARTED|Overall Study||123
8529344|NCT00327340|21026186|P2|NOT COMPLETED|Overall Study||30
8529345|NCT00327340|21026187|P1|NOT COMPLETED|Overall Study||15
8529346|NCT00327340|21026186|P2|COMPLETED|Overall Study||16
8529347|NCT00327340|21026187|P1|COMPLETED|Overall Study||8
8529348|NCT00327340|21026186|P2|STARTED|Overall Study||46
8529349|NCT00327340|21026187|P1|STARTED|Overall Study||23
8529350|NCT00327171|21026201|P2|NOT COMPLETED|Overall Study||109
8529351|NCT00327171|21026202|P1|NOT COMPLETED|Overall Study||108
8529352|NCT00327171|21026201|P2|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
8529353|NCT00327171|21026202|P1|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
8529354|NCT00327171|21026201|P2|STARTED|Overall Study||109
8529355|NCT00327171|21026202|P1|STARTED|Overall Study||109
8529356|NCT00327015|21026234|P4|NOT COMPLETED|Overall Study||109
8529357|NCT00327015|21026235|P3|NOT COMPLETED|Overall Study||126
8529358|NCT00327015|21026236|P2|NOT COMPLETED|Overall Study||92
8529359|NCT00327015|21026237|P1|NOT COMPLETED|Overall Study||91
8529360|NCT00327015|21026234|P4|COMPLETED|Overall Study||219
8529361|NCT00327015|21026235|P3|COMPLETED|Overall Study||209
8529362|NCT00327015|21026236|P2|COMPLETED|Overall Study||231
8529363|NCT00327015|21026237|P1|COMPLETED|Overall Study||229
8529364|NCT00327015|21026234|P4|Completed Study Without Being Rescued|Overall Study||144
8529365|NCT00327015|21026235|P3|Completed Study Without Being Rescued|Overall Study||113
8529366|NCT00327015|21026236|P2|Completed Study Without Being Rescued|Overall Study||177
8529367|NCT00327015|21026237|P1|Completed Study Without Being Rescued|Overall Study||179
8529368|NCT00327015|21026234|P4|STARTED|Overall Study||328
8529369|NCT00327015|21026235|P3|STARTED|Overall Study||335
8529370|NCT00327015|21026236|P2|STARTED|Overall Study||323
8529371|NCT00327015|21026237|P1|STARTED|Overall Study||320
8529372|NCT00326963|21026279|P1|NOT COMPLETED|Overall Study||33
8529373|NCT00326963|21026279|P1|COMPLETED|Overall Study||107
8529374|NCT00326963|21026279|P1|STARTED|Overall Study||140
8529375|NCT00326950|21026299|P1|NOT COMPLETED|Overall Study||1
8529376|NCT00326950|21026299|P1|COMPLETED|Overall Study||14
8529377|NCT00326950|21026299|P1|STARTED|Overall Study||15
8529378|NCT00326924|21026306|P2|NOT COMPLETED|Overall Study||1
8529379|NCT00326924|21026307|P1|NOT COMPLETED|Overall Study||1
8529380|NCT00326924|21026306|P2|COMPLETED|Overall Study||188
8529381|NCT00326924|21026307|P1|COMPLETED|Overall Study||187
8529382|NCT00326924|21026306|P2|STARTED|Overall Study||189
8529383|NCT00326924|21026307|P1|STARTED|Overall Study||188
8529384|NCT00326911|21026321|P2|NOT COMPLETED|Overall Study||2
8529385|NCT00326911|21026322|P1|NOT COMPLETED|Overall Study||1
8529386|NCT00326911|21026321|P2|COMPLETED|Overall Study|This number reflects all treated patients.|29
8529387|NCT00326911|21026322|P1|COMPLETED|Overall Study|This number reflects all treated patients.|29
8529388|NCT00326911|21026321|P2|STARTED|Overall Study|This number reflects all randomized patients.|31
8529389|NCT00326911|21026322|P1|STARTED|Overall Study|This number reflects all randomized patients.|30
8529390|NCT00326898|21026375|P3|NOT COMPLETED|Overall Study||203
8529391|NCT00326898|21026376|P2|NOT COMPLETED|Overall Study||343
8529392|NCT00326898|21026377|P1|NOT COMPLETED|Overall Study||351
8529393|NCT00326898|21026375|P3|COMPLETED|Overall Study||444
8529394|NCT00326898|21026376|P2|COMPLETED|Overall Study||306
8529395|NCT00326898|21026377|P1|COMPLETED|Overall Study||296
8529396|NCT00326898|21026375|P3|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
8529397|NCT00326898|21026376|P2|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
8529398|NCT00326898|21026377|P1|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
8529399|NCT00326898|21026375|P3|Patients With Clear Cell Histology|Overall Study||540
8529400|NCT00326898|21026376|P2|Patients With Clear Cell Histology|Overall Study||540
8529401|NCT00326898|21026377|P1|Patients With Clear Cell Histology|Overall Study||542
8529402|NCT00326898|21026375|P3|Patients With Toxicity Data|Overall Study||626
8529403|NCT00326898|21026376|P2|Patients With Toxicity Data|Overall Study||628
8529404|NCT00326898|21026377|P1|Patients With Toxicity Data|Overall Study||625
8529405|NCT00326898|21026375|P3|STARTED|Overall Study||647
8529406|NCT00326898|21026376|P2|STARTED|Overall Study||649
8529407|NCT00326898|21026377|P1|STARTED|Overall Study||647
8529408|NCT00326885|21026394|P1|NOT COMPLETED|Overall Study||7
8529409|NCT00326885|21026394|P1|COMPLETED|Overall Study||25
8529410|NCT00326885|21026394|P1|STARTED|Overall Study||32
8529411|NCT00326872|21026403|P1|NOT COMPLETED|Overall Study||0
8529412|NCT00326872|21026403|P1|COMPLETED|Overall Study||26
8529413|NCT00326872|21026403|P1|STARTED|Overall Study||26
8529414|NCT00326781|21026414|P2|NOT COMPLETED|Overall Study||32
8529415|NCT00326781|21026415|P1|NOT COMPLETED|Overall Study||42
8529416|NCT00326781|21026414|P2|COMPLETED|Overall Study||298
8529417|NCT00326781|21026415|P1|COMPLETED|Overall Study||302
8529418|NCT00326781|21026414|P2|STARTED|Overall Study||330
8529419|NCT00326781|21026415|P1|STARTED|Overall Study||344
8529420|NCT00326716|21026425|P4|NOT COMPLETED|Infants||0
8529421|NCT00326716|21026426|P3|NOT COMPLETED|Infants||0
8529422|NCT00326716|21026427|P2|NOT COMPLETED|Infants||0
8529423|NCT00326716|21026428|P1|NOT COMPLETED|Infants||0
8529424|NCT00326716|21026425|P4|COMPLETED|Infants||20
8529425|NCT00326716|21026426|P3|COMPLETED|Infants||20
8529426|NCT00326716|21026427|P2|COMPLETED|Infants||0
8529427|NCT00326716|21026428|P1|COMPLETED|Infants||0
8529428|NCT00326716|21026425|P4|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
8529429|NCT00326716|21026426|P3|STARTED|Infants|All infants were followed.|20
8529430|NCT00326716|21026427|P2|STARTED|Infants||0
8529431|NCT00326716|21026428|P1|STARTED|Infants||0
8529432|NCT00326716|21026425|P4|NOT COMPLETED|Pre-Natal Mothers||0
8529433|NCT00326716|21026426|P3|NOT COMPLETED|Pre-Natal Mothers||0
8529434|NCT00326716|21026427|P2|NOT COMPLETED|Pre-Natal Mothers||2
8529435|NCT00326716|21026428|P1|NOT COMPLETED|Pre-Natal Mothers||1
8529436|NCT00326716|21026425|P4|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
8529437|NCT00326716|21026426|P3|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
8529438|NCT00326716|21026427|P2|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
8529439|NCT00326716|21026428|P1|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
8529440|NCT00326716|21026425|P4|STARTED|Pre-Natal Mothers||0
8529441|NCT00326716|21026426|P3|STARTED|Pre-Natal Mothers||0
8529442|NCT00326716|21026427|P2|STARTED|Pre-Natal Mothers||21
8529443|NCT00326716|21026428|P1|STARTED|Pre-Natal Mothers||20
8529444|NCT00326612|21026500|P2|NOT COMPLETED|Overall Study||137
8529445|NCT00326612|21026501|P1|NOT COMPLETED|Overall Study||129
8529446|NCT00326612|21026500|P2|COMPLETED|Overall Study||42
8529447|NCT00326612|21026501|P1|COMPLETED|Overall Study||50
8529448|NCT00326612|21026500|P2|STARTED|Overall Study||179
8529449|NCT00326612|21026501|P1|STARTED|Overall Study||179
8529450|NCT00326599|21026523|P4|NOT COMPLETED|Overall Study||19
8529451|NCT00326599|21026524|P3|NOT COMPLETED|Overall Study||53
8529452|NCT00326599|21026525|P2|NOT COMPLETED|Overall Study||1
8529453|NCT00326599|21026526|P1|NOT COMPLETED|Overall Study||6
8529454|NCT00326599|21026523|P4|COMPLETED|Overall Study||10
8529455|NCT00326599|21026524|P3|COMPLETED|Overall Study||5
8529456|NCT00326599|21026525|P2|COMPLETED|Overall Study||2
8529457|NCT00326599|21026526|P1|COMPLETED|Overall Study||0
8529458|NCT00326599|21026523|P4|STARTED|Overall Study||29
8529459|NCT00326599|21026524|P3|STARTED|Overall Study||58
8529460|NCT00326599|21026525|P2|STARTED|Overall Study||3
8529461|NCT00326599|21026526|P1|STARTED|Overall Study||6
8529462|NCT00326495|21026545|P1|NOT COMPLETED|Overall Study||5
8529463|NCT00326495|21026545|P1|COMPLETED|Overall Study||46
8529464|NCT00326495|21026545|P1|STARTED|Overall Study||51
8529465|NCT00326417|21026552|P4|NOT COMPLETED|Overall Study||3
8529466|NCT00326417|21026553|P3|NOT COMPLETED|Overall Study||1
8529467|NCT00326417|21026554|P2|NOT COMPLETED|Overall Study||0
8529468|NCT00326417|21026555|P1|NOT COMPLETED|Overall Study||14
8529469|NCT00326417|21026552|P4|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
8529470|NCT00326417|21026553|P3|COMPLETED|Overall Study||38
8529471|NCT00326417|21026554|P2|COMPLETED|Overall Study||41
8529472|NCT00326417|21026555|P1|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
8529473|NCT00326417|21026552|P4|Phase II|Overall Study||0
8529474|NCT00326417|21026553|P3|Phase II|Overall Study||33
8529475|NCT00326417|21026554|P2|Phase II|Overall Study||35
8529476|NCT00326417|21026555|P1|Phase II|Overall Study||8
8529477|NCT00326417|21026552|P4|Phase I|Overall Study||3
8529478|NCT00326417|21026553|P3|Phase I|Overall Study||6
8529479|NCT00326417|21026554|P2|Phase I|Overall Study||6
8529480|NCT00326417|21026555|P1|Phase I|Overall Study||6
8529481|NCT00326417|21026552|P4|STARTED|Overall Study||3
8529482|NCT00326417|21026553|P3|STARTED|Overall Study||39
8529483|NCT00326417|21026554|P2|STARTED|Overall Study||41
8529484|NCT00326417|21026555|P1|STARTED|Overall Study||14
8529485|NCT00326209|21026571|P1|NOT COMPLETED|Overall Study||282
8529486|NCT00326209|21026571|P1|COMPLETED|Overall Study||111
8529487|NCT00326209|21026571|P1|Safety Population|Overall Study||388
8529488|NCT00326209|21026571|P1|STARTED|Overall Study||393
8529489|NCT00326196|21026580|P2|NOT COMPLETED|Overall Study||0
8529490|NCT00326196|21026581|P1|NOT COMPLETED|Overall Study||0
8529491|NCT00326196|21026580|P2|COMPLETED|Overall Study||97
8529492|NCT00326196|21026581|P1|COMPLETED|Overall Study||101
8529493|NCT00326196|21026580|P2|STARTED|Overall Study||97
8529494|NCT00326196|21026581|P1|STARTED|Overall Study||101
8529495|NCT00326183|21026589|P2|NOT COMPLETED|Overall Study||83
8529496|NCT00326183|21026590|P1|NOT COMPLETED|Overall Study||200
8529497|NCT00326183|21026589|P2|COMPLETED|Overall Study||264
8529498|NCT00326183|21026590|P1|COMPLETED|Overall Study||1253
8529499|NCT00326183|21026589|P2|Postvaccination 2 Post-safety Follow-up|Overall Study||271
8529500|NCT00326183|21026590|P1|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
8529501|NCT00326183|21026589|P2|Vaccination 2 + Safety Follow-up|Overall Study||292
8529502|NCT00326183|21026590|P1|Vaccination 2 + Safety Follow-up|Overall Study||1301
8529503|NCT00326183|21026589|P2|Postvaccination 1 Post-safety Follow-up|Overall Study||325
8529504|NCT00326183|21026590|P1|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
8529505|NCT00326183|21026589|P2|Vaccination 1 + Safety Follow-up|Overall Study||347
8529506|NCT00326183|21026590|P1|Vaccination 1 + Safety Follow-up|Overall Study||1453
8529507|NCT00326183|21026589|P2|STARTED|Overall Study||347
8529508|NCT00326183|21026590|P1|STARTED|Overall Study||1453
8529509|NCT00326170|21026616|P1|NOT COMPLETED|Overall Study||0
8529510|NCT00326170|21026616|P1|COMPLETED|Overall Study||34
8529511|NCT00326170|21026616|P1|STARTED|Overall Study||34
8529512|NCT00326118|21026622|P2|NOT COMPLETED|Year 5 Follow up||0
8529513|NCT00326118|21026623|P1|NOT COMPLETED|Year 5 Follow up||0
8529514|NCT00326118|21026622|P2|COMPLETED|Year 5 Follow up||78
8529515|NCT00326118|21026623|P1|COMPLETED|Year 5 Follow up||217
8529516|NCT00326118|21026622|P2|STARTED|Year 5 Follow up||78
8529517|NCT00326118|21026623|P1|STARTED|Year 5 Follow up||217
8529518|NCT00326118|21026622|P2|NOT COMPLETED|Year 4 Follow-up||0
8529519|NCT00326118|21026623|P1|NOT COMPLETED|Year 4 Follow-up||0
8529520|NCT00326118|21026622|P2|COMPLETED|Year 4 Follow-up||80
8529521|NCT00326118|21026623|P1|COMPLETED|Year 4 Follow-up||228
8529522|NCT00326118|21026622|P2|STARTED|Year 4 Follow-up||80
8529523|NCT00326118|21026623|P1|STARTED|Year 4 Follow-up||228
8529524|NCT00326118|21026622|P2|NOT COMPLETED|Year 3 Follow-up||0
8529525|NCT00326118|21026623|P1|NOT COMPLETED|Year 3 Follow-up||0
8529526|NCT00326118|21026622|P2|COMPLETED|Year 3 Follow-up||89
8529527|NCT00326118|21026623|P1|COMPLETED|Year 3 Follow-up||256
8529528|NCT00326118|21026622|P2|STARTED|Year 3 Follow-up||89
8529529|NCT00326118|21026623|P1|STARTED|Year 3 Follow-up||256
8529530|NCT00326118|21026622|P2|NOT COMPLETED|Year 2 Follow-up||0
8529531|NCT00326118|21026623|P1|NOT COMPLETED|Year 2 Follow-up||0
8529532|NCT00326118|21026622|P2|COMPLETED|Year 2 Follow-up||92
8529533|NCT00326118|21026623|P1|COMPLETED|Year 2 Follow-up||270
8529534|NCT00326118|21026622|P2|STARTED|Year 2 Follow-up||92
8529535|NCT00326118|21026623|P1|STARTED|Year 2 Follow-up||270
8529536|NCT00326118|21026622|P2|NOT COMPLETED|Year 1 Follow-up||0
8529537|NCT00326118|21026623|P1|NOT COMPLETED|Year 1 Follow-up||0
8529538|NCT00326118|21026622|P2|COMPLETED|Year 1 Follow-up||100
8529539|NCT00326118|21026623|P1|COMPLETED|Year 1 Follow-up||295
8529540|NCT00326118|21026622|P2|STARTED|Year 1 Follow-up||100
8529541|NCT00326118|21026623|P1|STARTED|Year 1 Follow-up||295
8529542|NCT00326118|21026622|P2|NOT COMPLETED|Active Phase||1
8529543|NCT00326118|21026623|P1|NOT COMPLETED|Active Phase||4
8529544|NCT00326118|21026622|P2|COMPLETED|Active Phase||108
8529545|NCT00326118|21026623|P1|COMPLETED|Active Phase||320
8529546|NCT00326118|21026622|P2|STARTED|Active Phase||109
8529547|NCT00326118|21026623|P1|STARTED|Active Phase||324
8529548|NCT00326001|21026659|P2|NOT COMPLETED|Overall Study||8
8529549|NCT00326001|21026660|P1|NOT COMPLETED|Overall Study||7
8529550|NCT00326001|21026659|P2|COMPLETED|Overall Study||219
8529551|NCT00326001|21026660|P1|COMPLETED|Overall Study||229
8529552|NCT00326001|21026659|P2|STARTED|Overall Study||227
8529553|NCT00326001|21026660|P1|STARTED|Overall Study||236
8529554|NCT00325897|21026674|P2|NOT COMPLETED|Overall Study||13
8529555|NCT00325897|21026675|P1|NOT COMPLETED|Overall Study||12
8529556|NCT00325897|21026674|P2|COMPLETED|Overall Study||559
8529557|NCT00325897|21026675|P1|COMPLETED|Overall Study||558
8529558|NCT00325897|21026674|P2|STARTED|Overall Study||572
8529559|NCT00325897|21026675|P1|STARTED|Overall Study||570
8529560|NCT00325819|21026695|P2|NOT COMPLETED|Overall Study||13
8529561|NCT00325819|21026696|P1|NOT COMPLETED|Overall Study||9
8529562|NCT00325819|21026695|P2|COMPLETED|Overall Study||176
8529563|NCT00325819|21026696|P1|COMPLETED|Overall Study||176
8529564|NCT00325819|21026695|P2|STARTED|Overall Study||189
8529565|NCT00325819|21026696|P1|STARTED|Overall Study||185
8529566|NCT00325780|21026716|P1|NOT COMPLETED|Overall Study||155
8529567|NCT00325780|21026716|P1|COMPLETED|Overall Study||1200
8529568|NCT00325780|21026716|P1|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
8529569|NCT00325780|21026716|P1|STARTED|Overall Study||1355
8529570|NCT00325754|21026723|P2|NOT COMPLETED|Overall Study||1
8529571|NCT00325754|21026724|P1|NOT COMPLETED|Overall Study||4
8529572|NCT00325754|21026723|P2|COMPLETED|Overall Study||10
8529573|NCT00325754|21026724|P1|COMPLETED|Overall Study||7
8529574|NCT00325754|21026723|P2|STARTED|Overall Study||11
8529575|NCT00325754|21026724|P1|STARTED|Overall Study||11
8529576|NCT00325598|21026740|P2|NOT COMPLETED|Overall Study||0
8529577|NCT00325598|21026741|P1|NOT COMPLETED|Overall Study||0
8529578|NCT00325598|21026740|P2|COMPLETED|Overall Study||50
8529579|NCT00325598|21026741|P1|COMPLETED|Overall Study||50
8529580|NCT00325598|21026740|P2|STARTED|Overall Study||50
8529581|NCT00325598|21026741|P1|STARTED|Overall Study||50
8529582|NCT00325572|21026767|P2|NOT COMPLETED|PHASE ii||0
8529583|NCT00325572|21026768|P1|NOT COMPLETED|PHASE ii||0
8529584|NCT00325572|21026767|P2|COMPLETED|PHASE ii||0
8529585|NCT00325572|21026768|P1|COMPLETED|PHASE ii||0
8529586|NCT00325572|21026767|P2|STARTED|PHASE ii||0
8529587|NCT00325572|21026768|P1|STARTED|PHASE ii||0
8529588|NCT00325572|21026767|P2|NOT COMPLETED|PHASE I||0
8529589|NCT00325572|21026768|P1|NOT COMPLETED|PHASE I||0
8529590|NCT00325572|21026767|P2|COMPLETED|PHASE I||44
8529591|NCT00325572|21026768|P1|COMPLETED|PHASE I||45
8529592|NCT00325572|21026767|P2|STARTED|PHASE I||44
8529593|NCT00325572|21026768|P1|STARTED|PHASE I||45
8529594|NCT00325468|21026779|P5|NOT COMPLETED|Overall Study||8
8529595|NCT00325468|21026780|P4|NOT COMPLETED|Overall Study||34
8529596|NCT00325468|21026781|P3|NOT COMPLETED|Overall Study||4
8529597|NCT00325468|21026782|P2|NOT COMPLETED|Overall Study||5
8529598|NCT00325468|21026783|P1|NOT COMPLETED|Overall Study||11
8529599|NCT00325468|21026779|P5|COMPLETED|Overall Study||14
8529600|NCT00325468|21026780|P4|COMPLETED|Overall Study||90
8529601|NCT00325468|21026781|P3|COMPLETED|Overall Study||10
8529602|NCT00325468|21026782|P2|COMPLETED|Overall Study||12
8529603|NCT00325468|21026783|P1|COMPLETED|Overall Study||12
8529604|NCT00325468|21026779|P5|STARTED|Overall Study||22
8529605|NCT00325468|21026780|P4|STARTED|Overall Study||124
8529606|NCT00325468|21026781|P3|STARTED|Overall Study||14
8529607|NCT00325468|21026782|P2|STARTED|Overall Study||17
8529608|NCT00325468|21026783|P1|STARTED|Overall Study||23
8529609|NCT00325442|21026818|P2|NOT COMPLETED|Overall Study||21
8529610|NCT00325442|21026819|P1|NOT COMPLETED|Overall Study||9
8529611|NCT00325442|21026818|P2|COMPLETED|Overall Study||153
8529612|NCT00325442|21026819|P1|COMPLETED|Overall Study||167
8529613|NCT00325442|21026818|P2|STARTED|Overall Study||174
8529614|NCT00325442|21026819|P1|STARTED|Overall Study||176
8529615|NCT00325416|21026866|P2|NOT COMPLETED|Phase II: Treatment at MTD||2
8529616|NCT00325416|21026867|P1|NOT COMPLETED|Phase II: Treatment at MTD||0
8529617|NCT00325416|21026866|P2|COMPLETED|Phase II: Treatment at MTD||40
8529618|NCT00325416|21026867|P1|COMPLETED|Phase II: Treatment at MTD||78
8529619|NCT00325416|21026866|P2|Enrolled During Phase II|Phase II: Treatment at MTD||8
8529620|NCT00325416|21026867|P1|Enrolled During Phase II|Phase II: Treatment at MTD||40
8529621|NCT00325416|21026866|P2|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
8529622|NCT00325416|21026867|P1|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
8529623|NCT00325416|21026866|P2|STARTED|Phase II: Treatment at MTD||42
8529624|NCT00325416|21026867|P1|STARTED|Phase II: Treatment at MTD||78
8529625|NCT00325416|21026866|P2|NOT COMPLETED|Phase I: Dose Escalation||16
8529626|NCT00325416|21026867|P1|NOT COMPLETED|Phase I: Dose Escalation||22
8529627|NCT00325416|21026866|P2|COMPLETED|Phase I: Dose Escalation||44
8529628|NCT00325416|21026867|P1|COMPLETED|Phase I: Dose Escalation||48
8529629|NCT00325416|21026866|P2|STARTED|Phase I: Dose Escalation||60
8529630|NCT00325416|21026867|P1|STARTED|Phase I: Dose Escalation||70
8529631|NCT00325403|21026881|P2|NOT COMPLETED|Overall Study||51
8529632|NCT00325403|21026882|P1|NOT COMPLETED|Overall Study||18
8529633|NCT00325403|21026881|P2|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
8529634|NCT00325403|21026882|P1|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
8529635|NCT00325403|21026881|P2|STARTED|Overall Study||233
8529636|NCT00325403|21026882|P1|STARTED|Overall Study||116
8529637|NCT00325234|21026920|P2|NOT COMPLETED|Overall Study||66
8529638|NCT00325234|21026921|P1|NOT COMPLETED|Overall Study||69
8529639|NCT00325234|21026920|P2|COMPLETED|Overall Study||0
8529640|NCT00325234|21026921|P1|COMPLETED|Overall Study||0
8529641|NCT00325234|21026920|P2|Received At Least 1 Dose of Study Drug|Overall Study||66
8529642|NCT00325234|21026921|P1|Received At Least 1 Dose of Study Drug|Overall Study||65
8529643|NCT00325234|21026920|P2|STARTED|Overall Study||66
8529644|NCT00325234|21026921|P1|STARTED|Overall Study||69
8529645|NCT00325195|21026940|P3|NOT COMPLETED|Received Intervention: ITT Population||4
8529646|NCT00325195|21026941|P2|NOT COMPLETED|Received Intervention: ITT Population||25
8529647|NCT00325195|21026942|P1|NOT COMPLETED|Received Intervention: ITT Population||26
8529648|NCT00325195|21026940|P3|COMPLETED|Received Intervention: ITT Population||39
8529649|NCT00325195|21026941|P2|COMPLETED|Received Intervention: ITT Population||59
8529650|NCT00325195|21026942|P1|COMPLETED|Received Intervention: ITT Population||59
8529651|NCT00325195|21026940|P3|STARTED|Received Intervention: ITT Population||43
8529652|NCT00325195|21026941|P2|STARTED|Received Intervention: ITT Population||84
8529653|NCT00325195|21026942|P1|STARTED|Received Intervention: ITT Population||85
8529654|NCT00325195|21026940|P3|NOT COMPLETED|Randomized||3
8529655|NCT00325195|21026941|P2|NOT COMPLETED|Randomized||5
8529656|NCT00325195|21026942|P1|NOT COMPLETED|Randomized||5
8529657|NCT00325195|21026940|P3|COMPLETED|Randomized||43
8529658|NCT00325195|21026941|P2|COMPLETED|Randomized||84
8529659|NCT00325195|21026942|P1|COMPLETED|Randomized||85
8529660|NCT00325195|21026940|P3|STARTED|Randomized||46
8529661|NCT00325195|21026941|P2|STARTED|Randomized||89
8529662|NCT00325195|21026942|P1|STARTED|Randomized||90
8529663|NCT00325156|21026965|P1|NOT COMPLETED|Overall Study||112
8529664|NCT00325156|21026965|P1|COMPLETED|Overall Study||2478
8529665|NCT00325156|21026965|P1|STARTED|Overall Study||2590
8529666|NCT00325143|21026972|P1|NOT COMPLETED|Overall Study||26
8529667|NCT00325143|21026972|P1|COMPLETED|Overall Study||676
8529668|NCT00325143|21026972|P1|STARTED|Overall Study||702
8529669|NCT00325130|21026982|P2|NOT COMPLETED|Overall Study||30
8529670|NCT00325130|21026983|P1|NOT COMPLETED|Overall Study||19
8529671|NCT00325130|21026982|P2|COMPLETED|Overall Study||494
8529672|NCT00325130|21026983|P1|COMPLETED|Overall Study||499
8529673|NCT00325130|21026982|P2|STARTED|Overall Study||524
8529674|NCT00325130|21026983|P1|STARTED|Overall Study||518
8529675|NCT00325078|21027026|P3|NOT COMPLETED|Overall Study||2
8529676|NCT00325078|21027027|P2|NOT COMPLETED|Overall Study||5
8529677|NCT00325078|21027028|P1|NOT COMPLETED|Overall Study||5
8529678|NCT00325078|21027026|P3|COMPLETED|Overall Study||23
8529679|NCT00325078|21027027|P2|COMPLETED|Overall Study||2
8529680|NCT00325078|21027028|P1|COMPLETED|Overall Study||3
8529681|NCT00325078|21027026|P3|STARTED|Overall Study||25
8529682|NCT00325078|21027027|P2|STARTED|Overall Study||7
8529683|NCT00325078|21027028|P1|STARTED|Overall Study||8
8529684|NCT00325039|21027040|P2|NOT COMPLETED|Overall Study||14
8529685|NCT00325039|21027041|P1|NOT COMPLETED|Overall Study||18
8529686|NCT00325039|21027040|P2|COMPLETED|Overall Study||285
8529687|NCT00325039|21027041|P1|COMPLETED|Overall Study||280
8529688|NCT00325039|21027040|P2|STARTED|Overall Study||299
8529689|NCT00325039|21027041|P1|STARTED|Overall Study||298
8529690|NCT00324987|21027057|P2|NOT COMPLETED|Overall Study||6
8529691|NCT00324987|21027058|P1|NOT COMPLETED|Overall Study||6
8529692|NCT00324987|21027057|P2|COMPLETED|Overall Study|Patients were to be treated until progression|0
8529693|NCT00324987|21027058|P1|COMPLETED|Overall Study|Patients were to be treated until progression|0
8529694|NCT00324987|21027057|P2|STARTED|Overall Study||6
8529695|NCT00324987|21027058|P1|STARTED|Overall Study||6
8529696|NCT00324961|21027072|P1|NOT COMPLETED|Overall Study||43
8529697|NCT00324961|21027072|P1|COMPLETED|Overall Study||490
8529698|NCT00324961|21027072|P1|STARTED|Overall Study||533
8529699|NCT00324896|21027087|P2|NOT COMPLETED|Overall Study||8
8529700|NCT00324896|21027088|P1|NOT COMPLETED|Overall Study||3
8529701|NCT00324896|21027087|P2|COMPLETED|Overall Study||7
8529702|NCT00324896|21027088|P1|COMPLETED|Overall Study||12
8529703|NCT00324896|21027087|P2|STARTED|Overall Study||15
8529704|NCT00324896|21027088|P1|STARTED|Overall Study||15
8529705|NCT00324870|21027096|P1|NOT COMPLETED|Overall Study||0
8529706|NCT00324870|21027096|P1|COMPLETED|Overall Study||37
8529707|NCT00324870|21027096|P1|STARTED|Overall Study||37
8529708|NCT00324857|21027104|P4|NOT COMPLETED|Overall Study||5
8529709|NCT00324857|21027105|P3|NOT COMPLETED|Overall Study||7
8529710|NCT00324857|21027106|P2|NOT COMPLETED|Overall Study||6
8529711|NCT00324857|21027107|P1|NOT COMPLETED|Overall Study||6
8529712|NCT00324857|21027104|P4|COMPLETED|Overall Study||158
8529713|NCT00324857|21027105|P3|COMPLETED|Overall Study||158
8529714|NCT00324857|21027106|P2|COMPLETED|Overall Study||162
8529715|NCT00324857|21027107|P1|COMPLETED|Overall Study||161
8529716|NCT00324857|21027104|P4|STARTED|Overall Study||163
8529717|NCT00324857|21027105|P3|STARTED|Overall Study||165
8529718|NCT00324857|21027106|P2|STARTED|Overall Study||168
8529719|NCT00324857|21027107|P1|STARTED|Overall Study||167
8529728|NCT00324753|21027138|P2|NOT COMPLETED|Overall Study||0
8529729|NCT00324753|21027139|P1|NOT COMPLETED|Overall Study||0
8529730|NCT00324753|21027138|P2|COMPLETED|Overall Study||264
8529731|NCT00324753|21027139|P1|COMPLETED|Overall Study||190
8529732|NCT00324753|21027138|P2|STARTED|Overall Study||264
8529733|NCT00324753|21027139|P1|STARTED|Overall Study||190
8529743|NCT00324701|21027160|P2|NOT COMPLETED|Overall Study||17
8529744|NCT00324701|21027161|P1|NOT COMPLETED|Overall Study||20
8529745|NCT00324701|21027160|P2|COMPLETED|Overall Study||104
8529746|NCT00324701|21027161|P1|COMPLETED|Overall Study||100
8529747|NCT00324701|21027160|P2|Week 8 Assessment|Overall Study||107
8529748|NCT00324701|21027161|P1|Week 8 Assessment|Overall Study||108
8529749|NCT00324701|21027160|P2|STARTED|Overall Study||121
8529750|NCT00324701|21027161|P1|STARTED|Overall Study||120
8529751|NCT00324675|21027171|P2|NOT COMPLETED|Overall Study||0
8529752|NCT00324675|21027172|P1|NOT COMPLETED|Overall Study||1
8529753|NCT00324675|21027171|P2|COMPLETED|Overall Study||14
8529754|NCT00324675|21027172|P1|COMPLETED|Overall Study||13
8529755|NCT00324675|21027171|P2|STARTED|Overall Study||14
8529756|NCT00324675|21027172|P1|STARTED|Overall Study||14
8529757|NCT00324649|21027180|P2|NOT COMPLETED|Overall Study||5
8529758|NCT00324649|21027181|P1|NOT COMPLETED|Overall Study||2
8529759|NCT00324649|21027180|P2|COMPLETED|Overall Study||36
8529760|NCT00324649|21027181|P1|COMPLETED|Overall Study||37
8529761|NCT00324649|21027180|P2|STARTED|Overall Study||41
8529762|NCT00324649|21027181|P1|STARTED|Overall Study||39
8529763|NCT00324415|21027221|P1|NOT COMPLETED|Overall Study||0
8529764|NCT00324415|21027221|P1|COMPLETED|Overall Study||45
8529765|NCT00324415|21027221|P1|STARTED|Overall Study||45
8529766|NCT00324350|21027236|P2|NOT COMPLETED|Overall Study||0
8529767|NCT00324350|21027237|P1|NOT COMPLETED|Overall Study||0
8529768|NCT00324350|21027236|P2|COMPLETED|Overall Study||3632
8529769|NCT00324350|21027237|P1|COMPLETED|Overall Study||3655
8529770|NCT00324350|21027236|P2|Falls Follow-Up|Overall Study||3418
8529771|NCT00324350|21027237|P1|Falls Follow-Up|Overall Study||3364
8529772|NCT00324350|21027236|P2|Non-Vertebral Fracture Follow-Up|Overall Study||3632
8529773|NCT00324350|21027237|P1|Non-Vertebral Fracture Follow-Up|Overall Study||3655
8529774|NCT00324350|21027236|P2|STARTED|Overall Study||3632
8529775|NCT00324350|21027237|P1|STARTED|Overall Study||3655
8529776|NCT00324272|21027251|P4|NOT COMPLETED|Overall Study||0
8529777|NCT00324272|21027252|P3|NOT COMPLETED|Overall Study||0
8529778|NCT00324272|21027253|P2|NOT COMPLETED|Overall Study||0
8529779|NCT00324272|21027254|P1|NOT COMPLETED|Overall Study||0
8529780|NCT00324272|21027251|P4|COMPLETED|Overall Study||18
8529781|NCT00324272|21027252|P3|COMPLETED|Overall Study||18
8529782|NCT00324272|21027253|P2|COMPLETED|Overall Study||20
8529783|NCT00324272|21027254|P1|COMPLETED|Overall Study||18
8529784|NCT00324272|21027251|P4|STARTED|Overall Study||18
8529785|NCT00324272|21027252|P3|STARTED|Overall Study||18
8529786|NCT00324272|21027253|P2|STARTED|Overall Study||20
8529787|NCT00324272|21027254|P1|STARTED|Overall Study||18
8529788|NCT00324259|21027290|P2|NOT COMPLETED|Overall Study||0
8529789|NCT00324259|21027291|P1|NOT COMPLETED|Overall Study||0
8529790|NCT00324259|21027290|P2|COMPLETED|Overall Study||32
8529791|NCT00324259|21027291|P1|COMPLETED|Overall Study||34
8529792|NCT00324259|21027290|P2|STARTED|Overall Study||32
8529793|NCT00324259|21027291|P1|STARTED|Overall Study||34
8529794|NCT00324233|21027312|P2|NOT COMPLETED|Second Period||7
8529795|NCT00324233|21027313|P1|NOT COMPLETED|Second Period||5
8529796|NCT00324233|21027312|P2|COMPLETED|Second Period||11
8529797|NCT00324233|21027313|P1|COMPLETED|Second Period||12
8529798|NCT00324233|21027312|P2|STARTED|Second Period||18
8529799|NCT00324233|21027313|P1|STARTED|Second Period||17
8529800|NCT00324233|21027312|P2|NOT COMPLETED|First Period||0
8529801|NCT00324233|21027313|P1|NOT COMPLETED|First Period||1
8529802|NCT00324233|21027312|P2|COMPLETED|First Period||18
8529803|NCT00324233|21027313|P1|COMPLETED|First Period||17
8529804|NCT00324233|21027312|P2|STARTED|First Period||18
8529805|NCT00324233|21027313|P1|STARTED|First Period||18
8529806|NCT00324168|21027321|P2|NOT COMPLETED|Overall Study||30
8529807|NCT00324168|21027322|P1|NOT COMPLETED|Overall Study||28
8529808|NCT00324168|21027321|P2|COMPLETED|Overall Study||220
8529809|NCT00324168|21027322|P1|COMPLETED|Overall Study||222
8529810|NCT00324168|21027321|P2|STARTED|Overall Study||250
8529811|NCT00324168|21027322|P1|STARTED|Overall Study||250
8529812|NCT00324155|21027350|P2|NOT COMPLETED|Follow-up Phase||6
8529813|NCT00324155|21027351|P1|NOT COMPLETED|Follow-up Phase||11
8529814|NCT00324155|21027350|P2|COMPLETED|Follow-up Phase||245
8529815|NCT00324155|21027351|P1|COMPLETED|Follow-up Phase||236
8529816|NCT00324155|21027350|P2|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
8529817|NCT00324155|21027351|P1|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
8529818|NCT00324155|21027350|P2|NOT COMPLETED|Received Treatment in Maintenance Phase||47
8529819|NCT00324155|21027351|P1|NOT COMPLETED|Received Treatment in Maintenance Phase||32
8529820|NCT00324155|21027350|P2|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
8529821|NCT00324155|21027351|P1|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
8529822|NCT00324155|21027350|P2|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
8529823|NCT00324155|21027351|P1|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
8529824|NCT00324155|21027350|P2|NOT COMPLETED|Received Treatment in Induction Phase||197
8529825|NCT00324155|21027351|P1|NOT COMPLETED|Received Treatment in Induction Phase||202
8529826|NCT00324155|21027350|P2|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
8529827|NCT00324155|21027351|P1|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
8529828|NCT00324155|21027350|P2|STARTED|Received Treatment in Induction Phase||251
8529829|NCT00324155|21027351|P1|STARTED|Received Treatment in Induction Phase||247
8529830|NCT00324155|21027350|P2|NOT COMPLETED|Enrolled and Randomized||1
8529831|NCT00324155|21027351|P1|NOT COMPLETED|Enrolled and Randomized||3
8529832|NCT00324155|21027350|P2|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
8529833|NCT00324155|21027351|P1|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
8529834|NCT00324155|21027350|P2|STARTED|Enrolled and Randomized||252
8529835|NCT00324155|21027351|P1|STARTED|Enrolled and Randomized||250
8529836|NCT00324116|21027381|P1|NOT COMPLETED|Overall Study||32
8529837|NCT00324116|21027381|P1|COMPLETED|Overall Study||49
8529838|NCT00324116|21027381|P1|STARTED|Overall Study|subjects received treatment|81
8529839|NCT00324038|21027393|P2|NOT COMPLETED|Overall Study||51
8529840|NCT00324038|21027394|P1|NOT COMPLETED|Overall Study||49
8529841|NCT00324038|21027393|P2|COMPLETED|Overall Study||58
8529842|NCT00324038|21027394|P1|COMPLETED|Overall Study||61
8529843|NCT00324038|21027393|P2|STARTED|Overall Study||109
8529844|NCT00324038|21027394|P1|STARTED|Overall Study||110
8529845|NCT00323882|21027405|P5|NOT COMPLETED|Overall Study||32
8529846|NCT00323882|21027406|P4|NOT COMPLETED|Overall Study||7
8529847|NCT00323882|21027407|P3|NOT COMPLETED|Overall Study||13
8529848|NCT00323882|21027408|P2|NOT COMPLETED|Overall Study||6
8529849|NCT00323882|21027409|P1|NOT COMPLETED|Overall Study||8
8529850|NCT00323882|21027405|P5|COMPLETED|Overall Study||2
8529851|NCT00323882|21027406|P4|COMPLETED|Overall Study||0
8529852|NCT00323882|21027407|P3|COMPLETED|Overall Study||3
8529853|NCT00323882|21027408|P2|COMPLETED|Overall Study||0
8529854|NCT00323882|21027409|P1|COMPLETED|Overall Study||0
8529855|NCT00323882|21027405|P5|STARTED|Overall Study||34
8529856|NCT00323882|21027406|P4|STARTED|Overall Study||7
8529857|NCT00323882|21027407|P3|STARTED|Overall Study||16
8529858|NCT00323882|21027408|P2|STARTED|Overall Study||6
8529859|NCT00323882|21027409|P1|STARTED|Overall Study||8
8529860|NCT00323869|21027480|P1|NOT COMPLETED|Overall Study||1
8529861|NCT00323869|21027480|P1|COMPLETED|Overall Study||47
8529862|NCT00323869|21027480|P1|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
8529863|NCT00323869|21027480|P1|STARTED|Overall Study|Enrollment|48
8529864|NCT00323739|21027492|P1|NOT COMPLETED|Overall Study||0
8529865|NCT00323739|21027492|P1|COMPLETED|Overall Study||80
8529866|NCT00323739|21027492|P1|STARTED|Overall Study||80
8529867|NCT00323635|21027499|P2|NOT COMPLETED|Overall Study||0
8529868|NCT00323635|21027500|P1|NOT COMPLETED|Overall Study||0
8529869|NCT00323635|21027499|P2|COMPLETED|Overall Study||9
8529870|NCT00323635|21027500|P1|COMPLETED|Overall Study||10
8529871|NCT00323635|21027499|P2|STARTED|Overall Study||9
8529872|NCT00323635|21027500|P1|STARTED|Overall Study||10
8529873|NCT00323622|21027536|P8|NOT COMPLETED|Overall Study||15
8529874|NCT00323622|21027537|P7|NOT COMPLETED|Overall Study||5
8529875|NCT00323622|21027538|P6|NOT COMPLETED|Overall Study||74
8529876|NCT00323622|21027539|P5|NOT COMPLETED|Overall Study||39
8529877|NCT00323622|21027540|P4|NOT COMPLETED|Overall Study||12
8529878|NCT00323622|21027541|P3|NOT COMPLETED|Overall Study||4
8529879|NCT00323622|21027542|P2|NOT COMPLETED|Overall Study||92
8529880|NCT00323622|21027543|P1|NOT COMPLETED|Overall Study||31
8529881|NCT00323622|21027536|P8|COMPLETED|Overall Study||125
8529882|NCT00323622|21027537|P7|COMPLETED|Overall Study||38
8529883|NCT00323622|21027538|P6|COMPLETED|Overall Study||454
8529884|NCT00323622|21027539|P5|COMPLETED|Overall Study||120
8529885|NCT00323622|21027540|P4|COMPLETED|Overall Study||122
8529886|NCT00323622|21027541|P3|COMPLETED|Overall Study||38
8529887|NCT00323622|21027542|P2|COMPLETED|Overall Study||423
8529888|NCT00323622|21027543|P1|COMPLETED|Overall Study||145
8529889|NCT00323622|21027536|P8|STARTED|Overall Study||140
8529890|NCT00323622|21027537|P7|STARTED|Overall Study||43
8529891|NCT00323622|21027538|P6|STARTED|Overall Study||528
8529892|NCT00323622|21027539|P5|STARTED|Overall Study||159
8529893|NCT00323622|21027540|P4|STARTED|Overall Study||134
8529894|NCT00323622|21027541|P3|STARTED|Overall Study||42
8529895|NCT00323622|21027542|P2|STARTED|Overall Study||515
8529896|NCT00323622|21027543|P1|STARTED|Overall Study||176
8529897|NCT00323609|21027585|P4|NOT COMPLETED|Overall Study||15
8529898|NCT00323609|21027586|P3|NOT COMPLETED|Overall Study||8
8529899|NCT00323609|21027587|P2|NOT COMPLETED|Overall Study||99
8529900|NCT00323609|21027588|P1|NOT COMPLETED|Overall Study||91
8529901|NCT00323609|21027585|P4|COMPLETED|Overall Study||0
8529902|NCT00323609|21027586|P3|COMPLETED|Overall Study||0
8529903|NCT00323609|21027587|P2|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
8529904|NCT00323609|21027588|P1|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
8529905|NCT00323609|21027585|P4|STARTED|Overall Study||15
8529906|NCT00323609|21027586|P3|STARTED|Overall Study||8
8529907|NCT00323609|21027587|P2|STARTED|Overall Study||190
8529908|NCT00323609|21027588|P1|STARTED|Overall Study||191
8529909|NCT00323557|21027624|P2|NOT COMPLETED|Overall Study||0
8529910|NCT00323557|21027625|P1|NOT COMPLETED|Overall Study||1
8529911|NCT00323557|21027624|P2|COMPLETED|Overall Study||7
8529912|NCT00323557|21027625|P1|COMPLETED|Overall Study||24
8529913|NCT00323557|21027624|P2|STARTED|Overall Study||7
8529914|NCT00323557|21027625|P1|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
8529915|NCT00323492|21027634|P3|NOT COMPLETED|Study Phase 2||1
8529916|NCT00323492|21027635|P2|NOT COMPLETED|Study Phase 2||1
8529917|NCT00323492|21027636|P1|NOT COMPLETED|Study Phase 2||4
8529918|NCT00323492|21027634|P3|COMPLETED|Study Phase 2||24
8529919|NCT00323492|21027635|P2|COMPLETED|Study Phase 2||17
8529920|NCT00323492|21027636|P1|COMPLETED|Study Phase 2||40
8529921|NCT00323492|21027634|P3|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
8529922|NCT00323492|21027635|P2|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
8529923|NCT00323492|21027636|P1|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
8529924|NCT00323492|21027634|P3|NOT COMPLETED|Study Phase 1||0
8529925|NCT00323492|21027635|P2|NOT COMPLETED|Study Phase 1||0
8529926|NCT00323492|21027636|P1|NOT COMPLETED|Study Phase 1||2
8529927|NCT00323492|21027634|P3|COMPLETED|Study Phase 1||0
8529928|NCT00323492|21027635|P2|COMPLETED|Study Phase 1||45
8529929|NCT00323492|21027636|P1|COMPLETED|Study Phase 1||45
8529930|NCT00323492|21027634|P3|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
8529931|NCT00323492|21027635|P2|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
8529932|NCT00323492|21027636|P1|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
8529933|NCT00323492|21027634|P3|STARTED|Study Phase 1|Not applicable to Phase 1.|0
8529934|NCT00323492|21027635|P2|STARTED|Study Phase 1||45
8529935|NCT00323492|21027636|P1|STARTED|Study Phase 1||47
8529936|NCT00323479|21027667|P1|NOT COMPLETED|Overall Study||8
8529937|NCT00323479|21027667|P1|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
8529938|NCT00323479|21027667|P1|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
8529939|NCT00323479|21027667|P1|STARTED|Overall Study||114
8529940|NCT00323453|21027678|P2|NOT COMPLETED|Overall Study||0
8529941|NCT00323453|21027679|P1|NOT COMPLETED|Overall Study||0
8529942|NCT00323453|21027678|P2|COMPLETED|Overall Study||48
8529943|NCT00323453|21027679|P1|COMPLETED|Overall Study||61
8529944|NCT00323453|21027678|P2|STARTED|Overall Study||48
8529945|NCT00323453|21027679|P1|STARTED|Overall Study||61
8529946|NCT00323427|21027687|P2|NOT COMPLETED|Overall Study||23
8529947|NCT00323427|21027688|P1|NOT COMPLETED|Overall Study||31
8529948|NCT00323427|21027687|P2|COMPLETED|Overall Study||43
8529949|NCT00323427|21027688|P1|COMPLETED|Overall Study||38
8529950|NCT00323427|21027687|P2|STARTED|Overall Study||66
8529951|NCT00323427|21027688|P1|STARTED|Overall Study||69
8529952|NCT00323414|21027700|P2|NOT COMPLETED|Overall Study||1
8529953|NCT00323414|21027701|P1|NOT COMPLETED|Overall Study||0
8529954|NCT00323414|21027700|P2|COMPLETED|Overall Study||18
8529955|NCT00323414|21027701|P1|COMPLETED|Overall Study||18
8529956|NCT00323414|21027700|P2|STARTED|Overall Study||19
8529957|NCT00323414|21027701|P1|STARTED|Overall Study||18
8529958|NCT00323362|21027717|P1|NOT COMPLETED|Overall Study||0
8529959|NCT00323362|21027717|P1|COMPLETED|Overall Study||17
8529960|NCT00323362|21027717|P1|STARTED|Overall Study||17
8529961|NCT00323310|21027723|P1|NOT COMPLETED|Overall Study||3
8529962|NCT00323310|21027723|P1|COMPLETED|Overall Study||89
8529963|NCT00323310|21027723|P1|STARTED|Overall Study||92
8529976|NCT00323284|21027757|P2|NOT COMPLETED|24 Months Follow-up||22
8529977|NCT00323284|21027758|P1|NOT COMPLETED|24 Months Follow-up||18
8529978|NCT00323284|21027757|P2|COMPLETED|24 Months Follow-up||101
8529979|NCT00323284|21027758|P1|COMPLETED|24 Months Follow-up||98
8529980|NCT00323284|21027757|P2|STARTED|24 Months Follow-up||123
8529981|NCT00323284|21027758|P1|STARTED|24 Months Follow-up||116
8529982|NCT00323284|21027757|P2|NOT COMPLETED|12 Months Follow-up||9
8529983|NCT00323284|21027758|P1|NOT COMPLETED|12 Months Follow-up||5
8529984|NCT00323284|21027757|P2|COMPLETED|12 Months Follow-up||114
8529985|NCT00323284|21027758|P1|COMPLETED|12 Months Follow-up||111
8529986|NCT00323284|21027757|P2|STARTED|12 Months Follow-up||123
8529987|NCT00323284|21027758|P1|STARTED|12 Months Follow-up||116
8529988|NCT00323271|21027768|P2|NOT COMPLETED|Overall Study||3
8529989|NCT00323271|21027769|P1|NOT COMPLETED|Overall Study||2
8529990|NCT00323271|21027768|P2|COMPLETED|Overall Study||9
8529991|NCT00323271|21027769|P1|COMPLETED|Overall Study||11
8529992|NCT00323271|21027768|P2|STARTED|Overall Study||12
8529993|NCT00323271|21027769|P1|STARTED|Overall Study||13
8529994|NCT00323258|21027779|P2|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
8529995|NCT00323258|21027780|P1|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
8529996|NCT00323258|21027779|P2|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
8529997|NCT00323258|21027780|P1|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
8529998|NCT00323258|21027779|P2|STARTED|Secondary Outcome (6 Mon Refill Records)||72
8529999|NCT00323258|21027780|P1|STARTED|Secondary Outcome (6 Mon Refill Records)||71
8530000|NCT00323258|21027779|P2|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
8530001|NCT00323258|21027780|P1|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
8530002|NCT00323258|21027779|P2|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
8530003|NCT00323258|21027780|P1|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
8530004|NCT00323258|21027779|P2|STARTED|Primary Outcome (Phone Call at 6 Months)||72
8530005|NCT00323258|21027780|P1|STARTED|Primary Outcome (Phone Call at 6 Months)||71
8530006|NCT00323193|21027796|P2|NOT COMPLETED|Overall Study||15
8530007|NCT00323193|21027797|P1|NOT COMPLETED|Overall Study||23
8530008|NCT00323193|21027796|P2|COMPLETED|Overall Study||41
8530009|NCT00323193|21027797|P1|COMPLETED|Overall Study||30
8530010|NCT00323193|21027796|P2|STARTED|Overall Study||56
8530011|NCT00323193|21027797|P1|STARTED|Overall Study||53
8530012|NCT00323115|21027805|P1|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
8530013|NCT00323115|21027805|P1|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
8530014|NCT00323115|21027805|P1|STARTED|Adjuvant Therapy & Survival Follow-Up||10
8530015|NCT00323115|21027805|P1|NOT COMPLETED|Vaccine Administration||1
8530016|NCT00323115|21027805|P1|COMPLETED|Vaccine Administration||10
8530017|NCT00323115|21027805|P1|STARTED|Vaccine Administration||11
8530018|NCT00323063|21027832|P2|NOT COMPLETED|Overall Study||0
8530019|NCT00323063|21027833|P1|NOT COMPLETED|Overall Study||2
8530020|NCT00323063|21027832|P2|COMPLETED|Overall Study||23
8530021|NCT00323063|21027833|P1|COMPLETED|Overall Study||24
8530022|NCT00323063|21027832|P2|STARTED|Overall Study||23
8530023|NCT00323063|21027833|P1|STARTED|Overall Study||26
8530024|NCT00323037|21027845|P2|NOT COMPLETED|Overall Study||27
8530025|NCT00323037|21027846|P1|NOT COMPLETED|Overall Study||33
8530026|NCT00323037|21027845|P2|COMPLETED|Overall Study||126
8530027|NCT00323037|21027846|P1|COMPLETED|Overall Study||132
8530028|NCT00323037|21027845|P2|STARTED|Overall Study|Number randomized|153
8530029|NCT00323037|21027846|P1|STARTED|Overall Study|Number randomized|165
8530030|NCT00322881|21027850|P1|NOT COMPLETED|Overall Study||5
8530031|NCT00322881|21027850|P1|COMPLETED|Overall Study||7
8530032|NCT00322881|21027850|P1|STARTED|Overall Study||12
8530033|NCT00322868|21027854|P1|NOT COMPLETED|Overall Study||1
8530034|NCT00322868|21027854|P1|COMPLETED|Overall Study||20
8530035|NCT00322868|21027854|P1|STARTED|Overall Study||21
8530036|NCT00322855|21027873|P1|NOT COMPLETED|Overall Study||0
8530037|NCT00322855|21027873|P1|COMPLETED|Overall Study||1
8530038|NCT00322855|21027873|P1|STARTED|Overall Study||1
8530039|NCT00322842|21027879|P2|NOT COMPLETED|Overall Study||2
8530040|NCT00322842|21027880|P1|NOT COMPLETED|Overall Study||2
8530041|NCT00322842|21027879|P2|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
8530042|NCT00322842|21027880|P1|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
8530043|NCT00322842|21027879|P2|STARTED|Overall Study||31
8530044|NCT00322842|21027880|P1|STARTED|Overall Study||4
8530045|NCT00322777|21027907|P2|NOT COMPLETED|Overall Study||0
8530046|NCT00322777|21027908|P1|NOT COMPLETED|Overall Study||0
8530047|NCT00322777|21027907|P2|COMPLETED|Overall Study||45
8530048|NCT00322777|21027908|P1|COMPLETED|Overall Study||39
8530049|NCT00322777|21027907|P2|Data Collection at Week 24|Overall Study||45
8530050|NCT00322777|21027908|P1|Data Collection at Week 24|Overall Study||39
8530051|NCT00322777|21027907|P2|Data Collection at Week 16|Overall Study||45
8530052|NCT00322777|21027908|P1|Data Collection at Week 16|Overall Study||39
8530053|NCT00322777|21027907|P2|Data Collection at Week 8|Overall Study||45
8530054|NCT00322777|21027908|P1|Data Collection at Week 8|Overall Study||39
8530055|NCT00322777|21027907|P2|"Data Collection at BASELINE|"|Overall Study||45
8530056|NCT00322777|21027908|P1|"Data Collection at BASELINE|"|Overall Study||39
8530057|NCT00322777|21027907|P2|STARTED|Overall Study||45
8530058|NCT00322777|21027908|P1|STARTED|Overall Study||39
8530059|NCT00322712|21027918|P1|NOT COMPLETED|Overall Study||1
8530060|NCT00322712|21027918|P1|COMPLETED|Overall Study||11
8530061|NCT00322712|21027918|P1|STARTED|Overall Study||12
8530062|NCT00322621|21027922|P3|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
8530063|NCT00322621|21027923|P2|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
8530064|NCT00322621|21027924|P1|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
8530065|NCT00322621|21027922|P3|COMPLETED|Period III - Maintenance / Rescue Phase||33
8530066|NCT00322621|21027923|P2|COMPLETED|Period III - Maintenance / Rescue Phase||86
8530067|NCT00322621|21027924|P1|COMPLETED|Period III - Maintenance / Rescue Phase||0
8530068|NCT00322621|21027922|P3|STARTED|Period III - Maintenance / Rescue Phase||69
8530069|NCT00322621|21027923|P2|STARTED|Period III - Maintenance / Rescue Phase||115
8530070|NCT00322621|21027924|P1|STARTED|Period III - Maintenance / Rescue Phase||0
8530071|NCT00322621|21027922|P3|NOT COMPLETED|Period II - Acute Therapy Phase||0
8530072|NCT00322621|21027923|P2|NOT COMPLETED|Period II - Acute Therapy Phase||0
8530073|NCT00322621|21027924|P1|NOT COMPLETED|Period II - Acute Therapy Phase||32
8530074|NCT00322621|21027922|P3|COMPLETED|Period II - Acute Therapy Phase||0
8530075|NCT00322621|21027923|P2|COMPLETED|Period II - Acute Therapy Phase||0
8530076|NCT00322621|21027924|P1|COMPLETED|Period II - Acute Therapy Phase||184
8530077|NCT00322621|21027922|P3|STARTED|Period II - Acute Therapy Phase||0
8530078|NCT00322621|21027923|P2|STARTED|Period II - Acute Therapy Phase||0
8530079|NCT00322621|21027924|P1|STARTED|Period II - Acute Therapy Phase||216
8530080|NCT00322556|21027976|P1|NOT COMPLETED|Overall Study||12
8530081|NCT00322556|21027976|P1|COMPLETED|Overall Study||43
8530082|NCT00322556|21027976|P1|STARTED|Overall Study||55
8530083|NCT00322491|21027992|P2|NOT COMPLETED|Overall Study||2
8530084|NCT00322491|21027993|P1|NOT COMPLETED|Overall Study||2
8530085|NCT00322491|21027992|P2|COMPLETED|Overall Study||24
8530086|NCT00322491|21027993|P1|COMPLETED|Overall Study||21
8530087|NCT00322491|21027992|P2|STARTED|Overall Study||26
8530088|NCT00322491|21027993|P1|STARTED|Overall Study||23
8530089|NCT00322465|21028019|P4|NOT COMPLETED|Overall Study||26
8530090|NCT00322465|21028020|P3|NOT COMPLETED|Overall Study||26
8530091|NCT00322465|21028021|P2|NOT COMPLETED|Overall Study||24
8530092|NCT00322465|21028022|P1|NOT COMPLETED|Overall Study||20
8530093|NCT00322465|21028019|P4|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
8530094|NCT00322465|21028020|P3|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
8530095|NCT00322465|21028021|P2|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
8530096|NCT00322465|21028022|P1|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
8530097|NCT00322465|21028019|P4|STARTED|Overall Study|Randomized|79
8530098|NCT00322465|21028020|P3|STARTED|Overall Study|Randomized|77
8530099|NCT00322465|21028021|P2|STARTED|Overall Study|Randomized|73
8530100|NCT00322465|21028022|P1|STARTED|Overall Study|Randomized|76
8530101|NCT00322452|21028083|P2|NOT COMPLETED|Overall Study||276
8530102|NCT00322452|21028084|P1|NOT COMPLETED|Overall Study||247
8530103|NCT00322452|21028083|P2|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
8530104|NCT00322452|21028084|P1|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
8530105|NCT00322452|21028083|P2|STARTED|Overall Study|Number of patients randomized|608
8530106|NCT00322452|21028084|P1|STARTED|Overall Study|Number of patients randomized|609
8530107|NCT00322439|21028120|P1|NOT COMPLETED|Overall Study||1056
8530108|NCT00322439|21028120|P1|COMPLETED|Overall Study||1455
8530109|NCT00322439|21028120|P1|Received at Least 1 Dose of Etanercept|Overall Study||2510
8530110|NCT00322439|21028120|P1|STARTED|Overall Study||2511
8530111|NCT00322387|21028135|P2|NOT COMPLETED|Follow-up Period||3
8530112|NCT00322387|21028136|P1|NOT COMPLETED|Follow-up Period||2
8530113|NCT00322387|21028135|P2|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
8530114|NCT00322387|21028136|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
8530115|NCT00322387|21028135|P2|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
8530116|NCT00322387|21028136|P1|STARTED|Follow-up Period|Participants who had transplants|14
8530117|NCT00322387|21028135|P2|NOT COMPLETED|Treatment Period||1
8530118|NCT00322387|21028136|P1|NOT COMPLETED|Treatment Period||0
8530119|NCT00322387|21028135|P2|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
8530120|NCT00322387|21028136|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
8530121|NCT00322387|21028135|P2|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
8530122|NCT00322387|21028136|P1|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
8530123|NCT00322374|21028170|P4|NOT COMPLETED|Second Escalation||0
8530124|NCT00322374|21028171|P3|NOT COMPLETED|Second Escalation||6
8530125|NCT00322374|21028172|P2|NOT COMPLETED|Second Escalation||0
8530126|NCT00322374|21028173|P1|NOT COMPLETED|Second Escalation||0
8530127|NCT00322374|21028170|P4|COMPLETED|Second Escalation||0
8530128|NCT00322374|21028171|P3|COMPLETED|Second Escalation||0
8530129|NCT00322374|21028172|P2|COMPLETED|Second Escalation||0
8530130|NCT00322374|21028173|P1|COMPLETED|Second Escalation||0
8530131|NCT00322374|21028170|P4|STARTED|Second Escalation||0
8530132|NCT00322374|21028171|P3|STARTED|Second Escalation||6
8530133|NCT00322374|21028172|P2|STARTED|Second Escalation||0
8530134|NCT00322374|21028173|P1|STARTED|Second Escalation||0
8530135|NCT00322374|21028170|P4|NOT COMPLETED|First Escalation||0
8530136|NCT00322374|21028171|P3|NOT COMPLETED|First Escalation||0
8530137|NCT00322374|21028172|P2|NOT COMPLETED|First Escalation||30
8530138|NCT00322374|21028173|P1|NOT COMPLETED|First Escalation||0
8530139|NCT00322374|21028170|P4|COMPLETED|First Escalation||0
8530140|NCT00322374|21028171|P3|COMPLETED|First Escalation||0
8530141|NCT00322374|21028172|P2|COMPLETED|First Escalation||0
8530142|NCT00322374|21028173|P1|COMPLETED|First Escalation||0
8530143|NCT00322374|21028170|P4|STARTED|First Escalation||0
8530144|NCT00322374|21028171|P3|STARTED|First Escalation||0
8530145|NCT00322374|21028172|P2|STARTED|First Escalation||30
8530146|NCT00322374|21028173|P1|STARTED|First Escalation||0
8530147|NCT00322374|21028170|P4|NOT COMPLETED|Starting Dose||0
8530148|NCT00322374|21028171|P3|NOT COMPLETED|Starting Dose||0
8530149|NCT00322374|21028172|P2|NOT COMPLETED|Starting Dose||0
8530150|NCT00322374|21028173|P1|NOT COMPLETED|Starting Dose||6
8530151|NCT00322374|21028170|P4|COMPLETED|Starting Dose||0
8530152|NCT00322374|21028171|P3|COMPLETED|Starting Dose||0
8530153|NCT00322374|21028172|P2|COMPLETED|Starting Dose||0
8530154|NCT00322374|21028173|P1|COMPLETED|Starting Dose||0
8530155|NCT00322374|21028170|P4|STARTED|Starting Dose||0
8530156|NCT00322374|21028171|P3|STARTED|Starting Dose||0
8530157|NCT00322374|21028172|P2|STARTED|Starting Dose||0
8530158|NCT00322374|21028173|P1|STARTED|Starting Dose||6
8530159|NCT00322374|21028170|P4|NOT COMPLETED|Enrollment||0
8530160|NCT00322374|21028171|P3|NOT COMPLETED|Enrollment||0
8530161|NCT00322374|21028172|P2|NOT COMPLETED|Enrollment||0
8530162|NCT00322374|21028173|P1|NOT COMPLETED|Enrollment||0
8530163|NCT00322374|21028170|P4|COMPLETED|Enrollment||42
8530164|NCT00322374|21028171|P3|COMPLETED|Enrollment||0
8530165|NCT00322374|21028172|P2|COMPLETED|Enrollment||0
8530166|NCT00322374|21028173|P1|COMPLETED|Enrollment||0
8530167|NCT00322374|21028170|P4|STARTED|Enrollment||42
8530168|NCT00322374|21028171|P3|STARTED|Enrollment||0
8530169|NCT00322374|21028172|P2|STARTED|Enrollment||0
8530170|NCT00322374|21028173|P1|STARTED|Enrollment||0
8530171|NCT00322348|21028223|P2|NOT COMPLETED|Overall Study||33
8530172|NCT00322348|21028224|P1|NOT COMPLETED|Overall Study||37
8530173|NCT00322348|21028223|P2|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
8530174|NCT00322348|21028224|P1|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
8530175|NCT00322348|21028223|P2|Received Study Treatment|Overall Study||48
8530176|NCT00322348|21028224|P1|Received Study Treatment|Overall Study||50
8530177|NCT00322348|21028223|P2|STARTED|Overall Study||49
8530178|NCT00322348|21028224|P1|STARTED|Overall Study||49
8530179|NCT00322335|21028243|P3|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
8530180|NCT00322335|21028244|P2|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
8530181|NCT00322335|21028245|P1|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
8530182|NCT00322335|21028243|P3|COMPLETED|Subjects 66 Months After Booster Dose||53
8530183|NCT00322335|21028244|P2|COMPLETED|Subjects 66 Months After Booster Dose||104
8530184|NCT00322335|21028245|P1|COMPLETED|Subjects 66 Months After Booster Dose||48
8530185|NCT00322335|21028243|P3|STARTED|Subjects 66 Months After Booster Dose||53
8530186|NCT00322335|21028244|P2|STARTED|Subjects 66 Months After Booster Dose||104
8530187|NCT00322335|21028245|P1|STARTED|Subjects 66 Months After Booster Dose||48
8530188|NCT00322335|21028243|P3|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
8530189|NCT00322335|21028244|P2|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
8530190|NCT00322335|21028245|P1|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
8530191|NCT00322335|21028243|P3|COMPLETED|Subjects 54 Months After Booster Dose||56
8530192|NCT00322335|21028244|P2|COMPLETED|Subjects 54 Months After Booster Dose||108
8530193|NCT00322335|21028245|P1|COMPLETED|Subjects 54 Months After Booster Dose||50
8530194|NCT00322335|21028243|P3|STARTED|Subjects 54 Months After Booster Dose||56
8530195|NCT00322335|21028244|P2|STARTED|Subjects 54 Months After Booster Dose||108
8530196|NCT00322335|21028245|P1|STARTED|Subjects 54 Months After Booster Dose||50
8530197|NCT00322335|21028243|P3|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
8530198|NCT00322335|21028244|P2|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
8530199|NCT00322335|21028245|P1|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
8530200|NCT00322335|21028243|P3|COMPLETED|Subjects 42 Months After Booster Dose||56
8530201|NCT00322335|21028244|P2|COMPLETED|Subjects 42 Months After Booster Dose||113
8530202|NCT00322335|21028245|P1|COMPLETED|Subjects 42 Months After Booster Dose||51
8530203|NCT00322335|21028243|P3|STARTED|Subjects 42 Months After Booster Dose||56
8530204|NCT00322335|21028244|P2|STARTED|Subjects 42 Months After Booster Dose||113
8530205|NCT00322335|21028245|P1|STARTED|Subjects 42 Months After Booster Dose||51
8530206|NCT00322335|21028243|P3|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
8530207|NCT00322335|21028244|P2|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
8530208|NCT00322335|21028245|P1|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
8530209|NCT00322335|21028243|P3|COMPLETED|Subjects 30 Months After Booster Dose||57
8530210|NCT00322335|21028244|P2|COMPLETED|Subjects 30 Months After Booster Dose||119
8530211|NCT00322335|21028245|P1|COMPLETED|Subjects 30 Months After Booster Dose||54
8530212|NCT00322335|21028243|P3|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
8530213|NCT00322335|21028244|P2|STARTED|Subjects 30 Months After Booster Dose||119
8530214|NCT00322335|21028245|P1|STARTED|Subjects 30 Months After Booster Dose||54
8530215|NCT00322335|21028243|P3|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
8530216|NCT00322335|21028244|P2|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
8530217|NCT00322335|21028245|P1|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
8530218|NCT00322335|21028243|P3|COMPLETED|Subjects 18 Months After Booster Dose||3
8530219|NCT00322335|21028244|P2|COMPLETED|Subjects 18 Months After Booster Dose||123
8530220|NCT00322335|21028245|P1|COMPLETED|Subjects 18 Months After Booster Dose||58
8530221|NCT00322335|21028243|P3|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
8530222|NCT00322335|21028244|P2|STARTED|Subjects 18 Months After Booster Dose||123
8530223|NCT00322335|21028245|P1|STARTED|Subjects 18 Months After Booster Dose||58
8530224|NCT00322309|21028285|P2|NOT COMPLETED|Overall Study||4
8530225|NCT00322309|21028286|P1|NOT COMPLETED|Overall Study||2
8530226|NCT00322309|21028285|P2|COMPLETED|Overall Study||9
8530227|NCT00322309|21028286|P1|COMPLETED|Overall Study||9
8530228|NCT00322309|21028285|P2|STARTED|Overall Study||13
8530229|NCT00322309|21028286|P1|STARTED|Overall Study||11
8530230|NCT00322231|21028302|P2|NOT COMPLETED|Period 2||0
8530231|NCT00322231|21028303|P1|NOT COMPLETED|Period 2||0
8530232|NCT00322231|21028302|P2|COMPLETED|Period 2||49
8530233|NCT00322231|21028303|P1|COMPLETED|Period 2||51
8530234|NCT00322231|21028302|P2|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
8530235|NCT00322231|21028303|P1|STARTED|Period 2||51
8530236|NCT00322231|21028302|P2|NOT COMPLETED|Period 1||0
8530237|NCT00322231|21028303|P1|NOT COMPLETED|Period 1||0
8530238|NCT00322231|21028302|P2|COMPLETED|Period 1||50
8530239|NCT00322231|21028303|P1|COMPLETED|Period 1||51
8530240|NCT00322231|21028302|P2|STARTED|Period 1||50
8530241|NCT00322231|21028303|P1|STARTED|Period 1||51
8530242|NCT00322153|21028315|P2|NOT COMPLETED|Overall Study||69
8530243|NCT00322153|21028316|P1|NOT COMPLETED|Overall Study||63
8530244|NCT00322153|21028315|P2|COMPLETED|Overall Study||273
8530245|NCT00322153|21028316|P1|COMPLETED|Overall Study||272
8530246|NCT00322153|21028315|P2|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
8530247|NCT00322153|21028316|P1|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
8530248|NCT00322153|21028315|P2|STARTED|Overall Study|Randomized to Memantine ER|342
8530249|NCT00322153|21028316|P1|STARTED|Overall Study|Randomized to placebo|335
8530250|NCT00322101|21028328|P2|NOT COMPLETED|Overall Study||0
8530251|NCT00322101|21028329|P1|NOT COMPLETED|Overall Study||0
8530252|NCT00322101|21028328|P2|COMPLETED|Overall Study||11
8530253|NCT00322101|21028329|P1|COMPLETED|Overall Study||14
8530254|NCT00322101|21028328|P2|STARTED|Overall Study||11
8530255|NCT00322101|21028329|P1|STARTED|Overall Study||14
8530256|NCT00322049|21028349|P4|NOT COMPLETED|Overall Study||1
8530257|NCT00322049|21028350|P3|NOT COMPLETED|Overall Study||0
8530258|NCT00322049|21028351|P2|NOT COMPLETED|Overall Study||1
8530259|NCT00322049|21028352|P1|NOT COMPLETED|Overall Study||0
8530260|NCT00322049|21028349|P4|COMPLETED|Overall Study||16
8530261|NCT00322049|21028350|P3|COMPLETED|Overall Study||20
8530262|NCT00322049|21028351|P2|COMPLETED|Overall Study||9
8530263|NCT00322049|21028352|P1|COMPLETED|Overall Study||4
8530264|NCT00322049|21028349|P4|STARTED|Overall Study||17
8530265|NCT00322049|21028350|P3|STARTED|Overall Study||20
8530266|NCT00322049|21028351|P2|STARTED|Overall Study||10
8530267|NCT00322049|21028352|P1|STARTED|Overall Study||4
8530268|NCT00322023|21028385|P3|NOT COMPLETED|Overall Study||6
8530269|NCT00322023|21028386|P2|NOT COMPLETED|Overall Study||2
8530270|NCT00322023|21028387|P1|NOT COMPLETED|Overall Study||0
8530271|NCT00322023|21028385|P3|COMPLETED|Overall Study||16
8530272|NCT00322023|21028386|P2|COMPLETED|Overall Study||19
8530273|NCT00322023|21028387|P1|COMPLETED|Overall Study||12
8530274|NCT00322023|21028385|P3|STARTED|Overall Study||22
8530275|NCT00322023|21028386|P2|STARTED|Overall Study||21
8530276|NCT00322023|21028387|P1|STARTED|Overall Study||12
8530277|NCT00321984|21028404|P3|NOT COMPLETED|Overall Study||26
8530278|NCT00321984|21028405|P2|NOT COMPLETED|Overall Study||21
8530279|NCT00321984|21028406|P1|NOT COMPLETED|Overall Study||27
8530280|NCT00321984|21028404|P3|COMPLETED|Overall Study||289
8530281|NCT00321984|21028405|P2|COMPLETED|Overall Study||294
8530282|NCT00321984|21028406|P1|COMPLETED|Overall Study||290
8530283|NCT00321984|21028404|P3|STARTED|Overall Study||315
8530284|NCT00321984|21028405|P2|STARTED|Overall Study||315
8530285|NCT00321984|21028406|P1|STARTED|Overall Study||317
8530286|NCT00321971|21028425|P2|NOT COMPLETED|Overall Study||11
8530287|NCT00321971|21028426|P1|NOT COMPLETED|Overall Study||8
8530288|NCT00321971|21028425|P2|COMPLETED|Overall Study||26
8530289|NCT00321971|21028426|P1|COMPLETED|Overall Study||28
8530290|NCT00321971|21028425|P2|STARTED|Overall Study||37
8530291|NCT00321971|21028426|P1|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
8530292|NCT00321932|21028434|P2|NOT COMPLETED|Overall Study||21
8530293|NCT00321932|21028435|P1|NOT COMPLETED|Overall Study||10
8530294|NCT00321932|21028434|P2|COMPLETED|Overall Study||11
8530295|NCT00321932|21028435|P1|COMPLETED|Overall Study||19
8530296|NCT00321932|21028434|P2|STARTED|Overall Study||32
8530297|NCT00321932|21028435|P1|STARTED|Overall Study||29
8530298|NCT00321919|21028459|P2|NOT COMPLETED|Overall Study||52
8530299|NCT00321919|21028460|P1|NOT COMPLETED|Overall Study||75
8530300|NCT00321919|21028459|P2|COMPLETED|Overall Study||250
8530301|NCT00321919|21028460|P1|COMPLETED|Overall Study||226
8530302|NCT00321919|21028459|P2|STARTED|Overall Study||302
8530303|NCT00321919|21028460|P1|STARTED|Overall Study||301
8530304|NCT00321906|21028502|P2|NOT COMPLETED|Overall Study||56
8530305|NCT00321906|21028503|P1|NOT COMPLETED|Overall Study||46
8530306|NCT00321906|21028502|P2|COMPLETED|Overall Study||31
8530307|NCT00321906|21028503|P1|COMPLETED|Overall Study||48
8530308|NCT00321906|21028502|P2|STARTED|Overall Study||87
8530309|NCT00321906|21028503|P1|STARTED|Overall Study||94
8530310|NCT00321893|21028525|P2|NOT COMPLETED|Overall Study||14
8530311|NCT00321893|21028526|P1|NOT COMPLETED|Overall Study||24
8530312|NCT00321893|21028525|P2|COMPLETED|Overall Study||87
8530313|NCT00321893|21028526|P1|COMPLETED|Overall Study||77
8530314|NCT00321893|21028525|P2|STARTED|Overall Study||101
8530315|NCT00321893|21028526|P1|STARTED|Overall Study||101
8530316|NCT00321854|21028540|P2|NOT COMPLETED|Overall Study||82
8530317|NCT00321854|21028541|P1|NOT COMPLETED|Overall Study||63
8530318|NCT00321854|21028540|P2|COMPLETED|Overall Study||192
8530319|NCT00321854|21028541|P1|COMPLETED|Overall Study||198
8530320|NCT00321854|21028540|P2|STARTED|Overall Study||274
8530321|NCT00321854|21028541|P1|STARTED|Overall Study||261
8530322|NCT00321828|21028659|P1|NOT COMPLETED|Overall Study||4
8530323|NCT00321828|21028659|P1|COMPLETED|Overall Study||86
8530324|NCT00321828|21028659|P1|STARTED|Overall Study||90
8530325|NCT00321789|21028665|P2|NOT COMPLETED|Overall Study||16
8530326|NCT00321789|21028666|P1|NOT COMPLETED|Overall Study||15
8530327|NCT00321789|21028665|P2|COMPLETED|Overall Study||112
8530328|NCT00321789|21028666|P1|COMPLETED|Overall Study||112
8530329|NCT00321789|21028665|P2|STARTED|Overall Study||128
8530330|NCT00321789|21028666|P1|STARTED|Overall Study||127
8530331|NCT00321763|21028698|P4|NOT COMPLETED|Overall Study||5
8530332|NCT00321763|21028699|P3|NOT COMPLETED|Overall Study||6
8530333|NCT00321763|21028700|P2|NOT COMPLETED|Overall Study||2
8530334|NCT00321763|21028701|P1|NOT COMPLETED|Overall Study||6
8530335|NCT00321763|21028698|P4|COMPLETED|Overall Study||565
8530336|NCT00321763|21028699|P3|COMPLETED|Overall Study||848
8530337|NCT00321763|21028700|P2|COMPLETED|Overall Study||848
8530338|NCT00321763|21028701|P1|COMPLETED|Overall Study||844
8530339|NCT00321763|21028698|P4|STARTED|Overall Study||570
8530340|NCT00321763|21028699|P3|STARTED|Overall Study||854
8530341|NCT00321763|21028700|P2|STARTED|Overall Study||850
8530342|NCT00321763|21028701|P1|STARTED|Overall Study||850
8530343|NCT00321737|21028761|P3|NOT COMPLETED|Overall Study||54
8530344|NCT00321737|21028762|P2|NOT COMPLETED|Overall Study||48
8530345|NCT00321737|21028763|P1|NOT COMPLETED|Overall Study||122
8530346|NCT00321737|21028761|P3|COMPLETED|Overall Study||104
8530347|NCT00321737|21028762|P2|COMPLETED|Overall Study||92
8530348|NCT00321737|21028763|P1|COMPLETED|Overall Study||25
8530349|NCT00321737|21028761|P3|STARTED|Overall Study||158
8530350|NCT00321737|21028762|P2|STARTED|Overall Study||140
8530351|NCT00321737|21028763|P1|STARTED|Overall Study||147
8530352|NCT00321711|21028791|P5|NOT COMPLETED|Part B||5
8530353|NCT00321711|21028792|P4|NOT COMPLETED|Part B||6
8530354|NCT00321711|21028793|P3|NOT COMPLETED|Part B||0
8530355|NCT00321711|21028794|P2|NOT COMPLETED|Part B||0
8530356|NCT00321711|21028795|P1|NOT COMPLETED|Part B||0
8530357|NCT00321711|21028791|P5|COMPLETED|Part B||10
8530358|NCT00321711|21028792|P4|COMPLETED|Part B||8
8530359|NCT00321711|21028793|P3|COMPLETED|Part B||0
8530360|NCT00321711|21028794|P2|COMPLETED|Part B||0
8530361|NCT00321711|21028795|P1|COMPLETED|Part B||0
8530362|NCT00321711|21028791|P5|STARTED|Part B||15
8530363|NCT00321711|21028792|P4|STARTED|Part B||14
8530364|NCT00321711|21028793|P3|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
8530365|NCT00321711|21028794|P2|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
8530366|NCT00321711|21028795|P1|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
8530367|NCT00321711|21028791|P5|NOT COMPLETED|Part A||0
8530368|NCT00321711|21028792|P4|NOT COMPLETED|Part A||0
8530369|NCT00321711|21028793|P3|NOT COMPLETED|Part A||11
8530370|NCT00321711|21028794|P2|NOT COMPLETED|Part A||10
8530371|NCT00321711|21028795|P1|NOT COMPLETED|Part A||5
8530372|NCT00321711|21028791|P5|COMPLETED|Part A||0
8530373|NCT00321711|21028792|P4|COMPLETED|Part A||0
8530374|NCT00321711|21028793|P3|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
8530375|NCT00321711|21028794|P2|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
8530376|NCT00321711|21028795|P1|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
8530377|NCT00321711|21028791|P5|STARTED|Part A||0
8530378|NCT00321711|21028792|P4|STARTED|Part A||0
8530379|NCT00321711|21028793|P3|STARTED|Part A||14
8530380|NCT00321711|21028794|P2|STARTED|Part A||13
8530381|NCT00321711|21028795|P1|STARTED|Part A||13
8530382|NCT00321698|21028827|P5|NOT COMPLETED|Phase II, MTD Dose||0
8530383|NCT00321698|21028828|P4|NOT COMPLETED|Phase II, MTD Dose||0
8530384|NCT00321698|21028829|P3|NOT COMPLETED|Phase II, MTD Dose||0
8530385|NCT00321698|21028830|P2|NOT COMPLETED|Phase II, MTD Dose||0
8530386|NCT00321698|21028831|P1|NOT COMPLETED|Phase II, MTD Dose||0
8530387|NCT00321698|21028827|P5|COMPLETED|Phase II, MTD Dose||13
8530388|NCT00321698|21028828|P4|COMPLETED|Phase II, MTD Dose||0
8530389|NCT00321698|21028829|P3|COMPLETED|Phase II, MTD Dose||0
8530390|NCT00321698|21028830|P2|COMPLETED|Phase II, MTD Dose||0
8530391|NCT00321698|21028831|P1|COMPLETED|Phase II, MTD Dose||0
8530392|NCT00321698|21028827|P5|STARTED|Phase II, MTD Dose|+1 screen failure|13
8530393|NCT00321698|21028828|P4|STARTED|Phase II, MTD Dose||0
8530394|NCT00321698|21028829|P3|STARTED|Phase II, MTD Dose||0
8530395|NCT00321698|21028830|P2|STARTED|Phase II, MTD Dose||0
8530396|NCT00321698|21028831|P1|STARTED|Phase II, MTD Dose||0
8530397|NCT00321698|21028827|P5|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
8530398|NCT00321698|21028828|P4|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
8530399|NCT00321698|21028829|P3|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
8530400|NCT00321698|21028830|P2|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
8530401|NCT00321698|21028831|P1|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
8530402|NCT00321698|21028827|P5|COMPLETED|Phase I, Rad Only & Dose 1-3||0
8530403|NCT00321698|21028828|P4|COMPLETED|Phase I, Rad Only & Dose 1-3||3
8530404|NCT00321698|21028829|P3|COMPLETED|Phase I, Rad Only & Dose 1-3||3
8530405|NCT00321698|21028830|P2|COMPLETED|Phase I, Rad Only & Dose 1-3||3
8530406|NCT00321698|21028831|P1|COMPLETED|Phase I, Rad Only & Dose 1-3||3
8530407|NCT00321698|21028827|P5|STARTED|Phase I, Rad Only & Dose 1-3||0
8530408|NCT00321698|21028828|P4|STARTED|Phase I, Rad Only & Dose 1-3||3
8530409|NCT00321698|21028829|P3|STARTED|Phase I, Rad Only & Dose 1-3||3
8530410|NCT00321698|21028830|P2|STARTED|Phase I, Rad Only & Dose 1-3||3
8530411|NCT00321698|21028831|P1|STARTED|Phase I, Rad Only & Dose 1-3||3
8530412|NCT00321685|21028845|P1|NOT COMPLETED|Overall Study||39
8530413|NCT00321685|21028845|P1|COMPLETED|Overall Study||18
8530414|NCT00321685|21028845|P1|Eligible and Treated|Overall Study||53
8530415|NCT00321685|21028845|P1|Started Protocol Therapy|Overall Study||55
8530416|NCT00321685|21028845|P1|Eligible|Overall Study||55
8530417|NCT00321685|21028845|P1|STARTED|Overall Study||57
8530418|NCT00321672|21028857|P4|NOT COMPLETED|Overall Study||2
8530419|NCT00321672|21028858|P3|NOT COMPLETED|Overall Study||11
8530420|NCT00321672|21028859|P2|NOT COMPLETED|Overall Study||8
8530421|NCT00321672|21028860|P1|NOT COMPLETED|Overall Study||12
8530422|NCT00321672|21028857|P4|COMPLETED|Overall Study||71
8530423|NCT00321672|21028858|P3|COMPLETED|Overall Study||156
8530424|NCT00321672|21028859|P2|COMPLETED|Overall Study||81
8530425|NCT00321672|21028860|P1|COMPLETED|Overall Study||153
8530426|NCT00321672|21028857|P4|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
8530427|NCT00321672|21028858|P3|STARTED|Overall Study||167
8530428|NCT00321672|21028859|P2|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
8530429|NCT00321672|21028860|P1|STARTED|Overall Study||165
8530430|NCT00321646|21028886|P1|NOT COMPLETED|Prostatectomy||0
8530431|NCT00321646|21028886|P1|COMPLETED|Prostatectomy||37
8530432|NCT00321646|21028886|P1|STARTED|Prostatectomy||37
8530433|NCT00321646|21028886|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||4
8530434|NCT00321646|21028886|P1|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
8530435|NCT00321646|21028886|P1|STARTED|Neoadjuvant Chemotherapy||42
8530436|NCT00321620|21028893|P2|NOT COMPLETED|Overall Study||722
8530437|NCT00321620|21028894|P1|NOT COMPLETED|Overall Study||743
8530438|NCT00321620|21028893|P2|COMPLETED|Overall Study||228
8530439|NCT00321620|21028894|P1|COMPLETED|Overall Study||208
8530440|NCT00321620|21028893|P2|Received Investigational Product|Overall Study||942
8530441|NCT00321620|21028894|P1|Received Investigational Product|Overall Study||946
8530442|NCT00321620|21028893|P2|STARTED|Overall Study||950
8530443|NCT00321620|21028894|P1|STARTED|Overall Study||951
8530444|NCT00321594|21028906|P5|NOT COMPLETED|Phase II, MTD Dose||0
8530445|NCT00321594|21028907|P4|NOT COMPLETED|Phase II, MTD Dose||0
8530446|NCT00321594|21028908|P3|NOT COMPLETED|Phase II, MTD Dose||0
8530447|NCT00321594|21028909|P2|NOT COMPLETED|Phase II, MTD Dose||0
8530448|NCT00321594|21028910|P1|NOT COMPLETED|Phase II, MTD Dose||0
8530449|NCT00321594|21028906|P5|COMPLETED|Phase II, MTD Dose||36
8530450|NCT00321594|21028907|P4|COMPLETED|Phase II, MTD Dose||6
8530451|NCT00321594|21028908|P3|COMPLETED|Phase II, MTD Dose||0
8530452|NCT00321594|21028909|P2|COMPLETED|Phase II, MTD Dose||0
8530453|NCT00321594|21028910|P1|COMPLETED|Phase II, MTD Dose||0
8530454|NCT00321594|21028906|P5|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
8530455|NCT00321594|21028907|P4|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
8530456|NCT00321594|21028908|P3|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
8530457|NCT00321594|21028909|P2|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
8530458|NCT00321594|21028910|P1|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
8530459|NCT00321594|21028906|P5|NOT COMPLETED|Phase I, Level 1-4||0
8530460|NCT00321594|21028907|P4|NOT COMPLETED|Phase I, Level 1-4||0
8530461|NCT00321594|21028908|P3|NOT COMPLETED|Phase I, Level 1-4||0
8530462|NCT00321594|21028909|P2|NOT COMPLETED|Phase I, Level 1-4||0
8530463|NCT00321594|21028910|P1|NOT COMPLETED|Phase I, Level 1-4||0
8530464|NCT00321594|21028906|P5|COMPLETED|Phase I, Level 1-4||0
8530465|NCT00321594|21028907|P4|COMPLETED|Phase I, Level 1-4||6
8530466|NCT00321594|21028908|P3|COMPLETED|Phase I, Level 1-4||6
8530467|NCT00321594|21028909|P2|COMPLETED|Phase I, Level 1-4||3
8530468|NCT00321594|21028910|P1|COMPLETED|Phase I, Level 1-4||3
8530469|NCT00321594|21028906|P5|STARTED|Phase I, Level 1-4||0
8530470|NCT00321594|21028907|P4|STARTED|Phase I, Level 1-4||6
8530471|NCT00321594|21028908|P3|STARTED|Phase I, Level 1-4||6
8530472|NCT00321594|21028909|P2|STARTED|Phase I, Level 1-4||3
8530473|NCT00321594|21028910|P1|STARTED|Phase I, Level 1-4||3
8530477|NCT00321464|21028930|P2|NOT COMPLETED|Overall Study||558
8530478|NCT00321464|21028931|P1|NOT COMPLETED|Overall Study||559
8530479|NCT00321464|21028930|P2|COMPLETED|Overall Study||468
8530480|NCT00321464|21028931|P1|COMPLETED|Overall Study||461
8530481|NCT00321464|21028930|P2|Received Investigational Product|Overall Study||1019
8530482|NCT00321464|21028931|P1|Received Investigational Product|Overall Study||1014
8530483|NCT00321464|21028930|P2|STARTED|Overall Study||1026
8530484|NCT00321464|21028931|P1|STARTED|Overall Study||1020
8530485|NCT00321373|21028944|P3|NOT COMPLETED|Overall Study||3
8530486|NCT00321373|21028945|P2|NOT COMPLETED|Overall Study||0
8530487|NCT00321373|21028946|P1|NOT COMPLETED|Overall Study||2
8530488|NCT00321373|21028944|P3|COMPLETED|Overall Study||404
8530489|NCT00321373|21028945|P2|COMPLETED|Overall Study||406
8530490|NCT00321373|21028946|P1|COMPLETED|Overall Study||405
8530491|NCT00321373|21028944|P3|STARTED|Overall Study||407
8530492|NCT00321373|21028945|P2|STARTED|Overall Study||406
8530493|NCT00321373|21028946|P1|STARTED|Overall Study||407
8530494|NCT00321321|21028969|P1|NOT COMPLETED|Overall Study||0
8530495|NCT00321321|21028969|P1|COMPLETED|Overall Study||12
8530496|NCT00321321|21028969|P1|STARTED|Overall Study||12
8530497|NCT00321269|21028975|P2|NOT COMPLETED|Overall Study||6
8530498|NCT00321269|21028976|P1|NOT COMPLETED|Overall Study||8
8530499|NCT00321269|21028975|P2|COMPLETED|Overall Study||68
8530500|NCT00321269|21028976|P1|COMPLETED|Overall Study||66
8530501|NCT00321269|21028975|P2|STARTED|Overall Study||74
8530502|NCT00321269|21028976|P1|STARTED|Overall Study||74
8530503|NCT00321048|21028986|P2|NOT COMPLETED|Overall Study||8
8530504|NCT00321048|21028987|P1|NOT COMPLETED|Overall Study||6
8530505|NCT00321048|21028986|P2|COMPLETED|Overall Study||21
8530506|NCT00321048|21028987|P1|COMPLETED|Overall Study||22
8530507|NCT00321048|21028986|P2|STARTED|Overall Study||29
8530508|NCT00321048|21028987|P1|STARTED|Overall Study||28
8530509|NCT00320801|21028995|P4|NOT COMPLETED|Extension Phase||48
8530510|NCT00320801|21028996|P3|NOT COMPLETED|Extension Phase||0
8530511|NCT00320801|21028997|P2|NOT COMPLETED|Extension Phase||0
8530512|NCT00320801|21028998|P1|NOT COMPLETED|Extension Phase||0
8530513|NCT00320801|21028995|P4|COMPLETED|Extension Phase||7
8530514|NCT00320801|21028996|P3|COMPLETED|Extension Phase||0
8530515|NCT00320801|21028997|P2|COMPLETED|Extension Phase||0
8530516|NCT00320801|21028998|P1|COMPLETED|Extension Phase||0
8530517|NCT00320801|21028995|P4|STARTED|Extension Phase||55
8530518|NCT00320801|21028996|P3|STARTED|Extension Phase||0
8530519|NCT00320801|21028997|P2|STARTED|Extension Phase||0
8530520|NCT00320801|21028998|P1|STARTED|Extension Phase||0
8530521|NCT00320801|21028995|P4|NOT COMPLETED|Double-blind Phase||0
8530522|NCT00320801|21028996|P3|NOT COMPLETED|Double-blind Phase||14
8530523|NCT00320801|21028997|P2|NOT COMPLETED|Double-blind Phase||11
8530524|NCT00320801|21028998|P1|NOT COMPLETED|Double-blind Phase||0
8530525|NCT00320801|21028995|P4|COMPLETED|Double-blind Phase||0
8530526|NCT00320801|21028996|P3|COMPLETED|Double-blind Phase||35
8530527|NCT00320801|21028997|P2|COMPLETED|Double-blind Phase||36
8530528|NCT00320801|21028998|P1|COMPLETED|Double-blind Phase||0
8530529|NCT00320801|21028995|P4|STARTED|Double-blind Phase||0
8530530|NCT00320801|21028996|P3|STARTED|Double-blind Phase||49
8530531|NCT00320801|21028997|P2|STARTED|Double-blind Phase||47
8530532|NCT00320801|21028998|P1|STARTED|Double-blind Phase||0
8530533|NCT00320801|21028995|P4|NOT COMPLETED|Open-label Run-in Period||0
8530534|NCT00320801|21028996|P3|NOT COMPLETED|Open-label Run-in Period||0
8530535|NCT00320801|21028997|P2|NOT COMPLETED|Open-label Run-in Period||0
8530536|NCT00320801|21028998|P1|NOT COMPLETED|Open-label Run-in Period||92
8530537|NCT00320801|21028995|P4|COMPLETED|Open-label Run-in Period||0
8530538|NCT00320801|21028996|P3|COMPLETED|Open-label Run-in Period||0
8530539|NCT00320801|21028997|P2|COMPLETED|Open-label Run-in Period||0
8530540|NCT00320801|21028998|P1|COMPLETED|Open-label Run-in Period||96
8530541|NCT00320801|21028995|P4|STARTED|Open-label Run-in Period||0
8530542|NCT00320801|21028996|P3|STARTED|Open-label Run-in Period||0
8530543|NCT00320801|21028997|P2|STARTED|Open-label Run-in Period||0
8530544|NCT00320801|21028998|P1|STARTED|Open-label Run-in Period||188
8530545|NCT00320788|21029013|P5|NOT COMPLETED|Overall Study||5
8530546|NCT00320788|21029014|P4|NOT COMPLETED|Overall Study||5
8530547|NCT00320788|21029015|P3|NOT COMPLETED|Overall Study||3
8530548|NCT00320788|21029016|P2|NOT COMPLETED|Overall Study||6
8530549|NCT00320788|21029017|P1|NOT COMPLETED|Overall Study||6
8530550|NCT00320788|21029013|P5|COMPLETED|Overall Study||26
8530551|NCT00320788|21029014|P4|COMPLETED|Overall Study||27
8530552|NCT00320788|21029015|P3|COMPLETED|Overall Study||29
8530553|NCT00320788|21029016|P2|COMPLETED|Overall Study||26
8530554|NCT00320788|21029017|P1|COMPLETED|Overall Study||26
8530555|NCT00320788|21029013|P5|Participants Received Treatment (SAF)|Overall Study||31
8530556|NCT00320788|21029014|P4|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
8530557|NCT00320788|21029015|P3|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
8530558|NCT00320788|21029016|P2|Participants Received Treatment (SAF)|Overall Study||32
8530559|NCT00320788|21029017|P1|Participants Received Treatment (SAF)|Overall Study||32
8530560|NCT00320788|21029013|P5|STARTED|Overall Study||31
8530561|NCT00320788|21029014|P4|STARTED|Overall Study|Participants Randomized|32
8530562|NCT00320788|21029015|P3|STARTED|Overall Study||32
8530563|NCT00320788|21029016|P2|STARTED|Overall Study||32
8530564|NCT00320788|21029017|P1|STARTED|Overall Study||32
8530565|NCT00320749|21029060|P3|NOT COMPLETED|Overall Study||9
8530566|NCT00320749|21029061|P2|NOT COMPLETED|Overall Study||2
8530567|NCT00320749|21029062|P1|NOT COMPLETED|Overall Study||0
8530568|NCT00320749|21029060|P3|COMPLETED|Overall Study||1
8530569|NCT00320749|21029061|P2|COMPLETED|Overall Study||6
8530570|NCT00320749|21029062|P1|COMPLETED|Overall Study||3
8530571|NCT00320749|21029060|P3|STARTED|Overall Study||10
8530572|NCT00320749|21029061|P2|STARTED|Overall Study||8
8530573|NCT00320749|21029062|P1|STARTED|Overall Study||3
8530574|NCT00320710|21029071|P3|NOT COMPLETED|Overall Study||5
8530575|NCT00320710|21029072|P2|NOT COMPLETED|Overall Study||76
8530576|NCT00320710|21029073|P1|NOT COMPLETED|Overall Study||94
8530577|NCT00320710|21029071|P3|COMPLETED|Overall Study||8
8530578|NCT00320710|21029072|P2|COMPLETED|Overall Study||127
8530579|NCT00320710|21029073|P1|COMPLETED|Overall Study||106
8530580|NCT00320710|21029071|P3|Treated (Safety Set)|Overall Study||13
8530581|NCT00320710|21029072|P2|Treated (Safety Set)|Overall Study||202
8530582|NCT00320710|21029073|P1|Treated (Safety Set)|Overall Study||198
8530583|NCT00320710|21029071|P3|STARTED|Overall Study||13
8530584|NCT00320710|21029072|P2|STARTED|Overall Study||203
8530585|NCT00320710|21029073|P1|STARTED|Overall Study||200
8530586|NCT00320671|21029096|P2|NOT COMPLETED|Overall Study||38
8530587|NCT00320671|21029097|P1|NOT COMPLETED|Overall Study||33
8530588|NCT00320671|21029096|P2|COMPLETED|Overall Study||58
8530589|NCT00320671|21029097|P1|COMPLETED|Overall Study||69
8530590|NCT00320671|21029096|P2|STARTED|Overall Study||96
8530591|NCT00320671|21029097|P1|STARTED|Overall Study||102
8530592|NCT00320606|21029103|P1|NOT COMPLETED|Overall Study||3
8530593|NCT00320606|21029103|P1|COMPLETED|Overall Study||17
8530594|NCT00320606|21029103|P1|STARTED|Overall Study||20
8530595|NCT00320593|21029119|P2|NOT COMPLETED|Overall Study||1
8530596|NCT00320593|21029120|P1|NOT COMPLETED|Overall Study||7
8530597|NCT00320593|21029119|P2|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
8530598|NCT00320593|21029120|P1|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
8530599|NCT00320593|21029119|P2|STARTED|Overall Study||59
8530600|NCT00320593|21029120|P1|STARTED|Overall Study||59
8530601|NCT00320541|21029144|P2|NOT COMPLETED|Overall Study||57
8530602|NCT00320541|21029145|P1|NOT COMPLETED|Overall Study||50
8530603|NCT00320541|21029144|P2|COMPLETED|Overall Study||36
8530604|NCT00320541|21029145|P1|COMPLETED|Overall Study||44
8530605|NCT00320541|21029144|P2|STARTED|Overall Study||93
8530606|NCT00320541|21029145|P1|STARTED|Overall Study||94
8530607|NCT00320528|21029172|P3|NOT COMPLETED|Study Period III||106
8530608|NCT00320528|21029173|P2|NOT COMPLETED|Study Period III||31
8530609|NCT00320528|21029174|P1|NOT COMPLETED|Study Period III||87
8530610|NCT00320528|21029172|P3|COMPLETED|Study Period III||2
8530611|NCT00320528|21029173|P2|COMPLETED|Study Period III||0
8530612|NCT00320528|21029174|P1|COMPLETED|Study Period III||0
8530613|NCT00320528|21029172|P3|STARTED|Study Period III||108
8530614|NCT00320528|21029173|P2|STARTED|Study Period III||31
8530615|NCT00320528|21029174|P1|STARTED|Study Period III||87
8530616|NCT00320528|21029172|P3|NOT COMPLETED|Study Period II||22
8530617|NCT00320528|21029173|P2|NOT COMPLETED|Study Period II||10
8530618|NCT00320528|21029174|P1|NOT COMPLETED|Study Period II||11
8530619|NCT00320528|21029172|P3|COMPLETED|Study Period II||108
8530620|NCT00320528|21029173|P2|COMPLETED|Study Period II||31
8530621|NCT00320528|21029174|P1|COMPLETED|Study Period II||87
8530622|NCT00320528|21029172|P3|Received at Least One Dose of Study Drug|Study Period II||128
8530623|NCT00320528|21029173|P2|Received at Least One Dose of Study Drug|Study Period II||38
8530624|NCT00320528|21029174|P1|Received at Least One Dose of Study Drug|Study Period II||97
8530625|NCT00320528|21029172|P3|STARTED|Study Period II||130
8530626|NCT00320528|21029173|P2|STARTED|Study Period II||41
8530627|NCT00320528|21029174|P1|STARTED|Study Period II||98
8530628|NCT00320515|21029209|P1|NOT COMPLETED|Overall Study||49
8530629|NCT00320515|21029209|P1|COMPLETED|Overall Study||20
8530630|NCT00320515|21029209|P1|STARTED|Overall Study||69
8530631|NCT00320489|21029218|P2|NOT COMPLETED|Overall Study||136
8530632|NCT00320489|21029219|P1|NOT COMPLETED|Overall Study||145
8530633|NCT00320489|21029218|P2|COMPLETED|Overall Study||124
8530634|NCT00320489|21029219|P1|COMPLETED|Overall Study||119
8530635|NCT00320489|21029218|P2|STARTED|Overall Study||260
8530636|NCT00320489|21029219|P1|STARTED|Overall Study||264
8530637|NCT00320424|21029275|P1|NOT COMPLETED|Overall Study||6
8530638|NCT00320424|21029275|P1|COMPLETED|Overall Study||42
8530639|NCT00320424|21029275|P1|STARTED|Overall Study||48
8530640|NCT00320411|21029289|P1|NOT COMPLETED|Overall Study||4
8530641|NCT00320411|21029289|P1|COMPLETED|Overall Study||58
8530642|NCT00320411|21029289|P1|STARTED|Overall Study||62
8530643|NCT00320398|21029312|P2|NOT COMPLETED|Overall Study||4
8530644|NCT00320398|21029313|P1|NOT COMPLETED|Overall Study||2
8530645|NCT00320398|21029312|P2|COMPLETED|Overall Study||52
8530646|NCT00320398|21029313|P1|COMPLETED|Overall Study||56
8530647|NCT00320398|21029312|P2|STARTED|Overall Study||56
8530648|NCT00320398|21029313|P1|STARTED|Overall Study||58
8530649|NCT00320385|21029341|P2|NOT COMPLETED|Overall Study||22
8530650|NCT00320385|21029342|P1|NOT COMPLETED|Overall Study||18
8530651|NCT00320385|21029341|P2|COMPLETED|Overall Study||126
8530652|NCT00320385|21029342|P1|COMPLETED|Overall Study||130
8530653|NCT00320385|21029341|P2|STARTED|Overall Study||148
8530654|NCT00320385|21029342|P1|STARTED|Overall Study||148
8530655|NCT00320372|21029365|P2|NOT COMPLETED|Overall Study||163
8530656|NCT00320372|21029366|P1|NOT COMPLETED|Overall Study||195
8530657|NCT00320372|21029365|P2|COMPLETED|Overall Study||138
8530658|NCT00320372|21029366|P1|COMPLETED|Overall Study||299
8530659|NCT00320372|21029365|P2|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
8530660|NCT00320372|21029366|P1|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
8530661|NCT00320372|21029365|P2|VNS Therapy D-23 Original|Overall Study||0
8530662|NCT00320372|21029366|P1|VNS Therapy D-23 Original|Overall Study||335
8530663|NCT00320372|21029365|P2|STARTED|Overall Study||301
8530664|NCT00320372|21029366|P1|STARTED|Overall Study||494
8530665|NCT00320281|21029393|P2|NOT COMPLETED|Overall Study||0
8530666|NCT00320281|21029394|P1|NOT COMPLETED|Overall Study||0
8530667|NCT00320281|21029393|P2|COMPLETED|Overall Study||9
8530668|NCT00320281|21029394|P1|COMPLETED|Overall Study||10
8530669|NCT00320281|21029393|P2|STARTED|Overall Study||9
8530670|NCT00320281|21029394|P1|STARTED|Overall Study||10
8530671|NCT00320255|21029408|P6|NOT COMPLETED|Overall Study||0
8530672|NCT00320255|21029409|P5|NOT COMPLETED|Overall Study||0
8530673|NCT00320255|21029410|P4|NOT COMPLETED|Overall Study||8
8530674|NCT00320255|21029411|P3|NOT COMPLETED|Overall Study||6
8530675|NCT00320255|21029412|P2|NOT COMPLETED|Overall Study||7
8530676|NCT00320255|21029413|P1|NOT COMPLETED|Overall Study||11
8530677|NCT00320255|21029408|P6|COMPLETED|Overall Study||3
8530678|NCT00320255|21029409|P5|COMPLETED|Overall Study||2
8530679|NCT00320255|21029410|P4|COMPLETED|Overall Study||25
8530680|NCT00320255|21029411|P3|COMPLETED|Overall Study||24
8530681|NCT00320255|21029412|P2|COMPLETED|Overall Study||25
8530682|NCT00320255|21029413|P1|COMPLETED|Overall Study||19
8530683|NCT00320255|21029408|P6|Received Treatment|Overall Study||3
8530684|NCT00320255|21029409|P5|Received Treatment|Overall Study||2
8530685|NCT00320255|21029410|P4|Received Treatment|Overall Study||32
8530686|NCT00320255|21029411|P3|Received Treatment|Overall Study||29
8530687|NCT00320255|21029412|P2|Received Treatment|Overall Study||32
8530688|NCT00320255|21029413|P1|Received Treatment|Overall Study||29
8530689|NCT00320255|21029408|P6|STARTED|Overall Study||3
8530690|NCT00320255|21029409|P5|STARTED|Overall Study||2
8530691|NCT00320255|21029410|P4|STARTED|Overall Study||33
8530692|NCT00320255|21029411|P3|STARTED|Overall Study||30
8530693|NCT00320255|21029412|P2|STARTED|Overall Study||32
8530694|NCT00320255|21029413|P1|STARTED|Overall Study||30
8530695|NCT00320242|21029493|P2|NOT COMPLETED|Overall Study||4
8530696|NCT00320242|21029494|P1|NOT COMPLETED|Overall Study||2
8530697|NCT00320242|21029493|P2|COMPLETED|Overall Study||12
8530698|NCT00320242|21029494|P1|COMPLETED|Overall Study||14
8530699|NCT00320242|21029493|P2|STARTED|Overall Study||16
8530700|NCT00320242|21029494|P1|STARTED|Overall Study||16
8530701|NCT00320216|21029506|P5|NOT COMPLETED|Overall Study||6
8530702|NCT00320216|21029507|P4|NOT COMPLETED|Overall Study||3
8530703|NCT00320216|21029508|P3|NOT COMPLETED|Overall Study||6
8530704|NCT00320216|21029509|P2|NOT COMPLETED|Overall Study||10
8530705|NCT00320216|21029510|P1|NOT COMPLETED|Overall Study||16
8530706|NCT00320216|21029506|P5|COMPLETED|Overall Study||58
8530707|NCT00320216|21029507|P4|COMPLETED|Overall Study||61
8530708|NCT00320216|21029508|P3|COMPLETED|Overall Study||58
8530709|NCT00320216|21029509|P2|COMPLETED|Overall Study||54
8530710|NCT00320216|21029510|P1|COMPLETED|Overall Study||48
8530711|NCT00320216|21029506|P5|STARTED|Overall Study||64
8530712|NCT00320216|21029507|P4|STARTED|Overall Study||64
8530713|NCT00320216|21029508|P3|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
8530714|NCT00320216|21029509|P2|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
8530715|NCT00320216|21029510|P1|STARTED|Overall Study||64
8530716|NCT00320190|21029544|P2|NOT COMPLETED|Long-term (12-month) Extension||2
8530717|NCT00320190|21029545|P1|NOT COMPLETED|Long-term (12-month) Extension||9
8530718|NCT00320190|21029544|P2|COMPLETED|Long-term (12-month) Extension||1
8530719|NCT00320190|21029545|P1|COMPLETED|Long-term (12-month) Extension||2
8530720|NCT00320190|21029544|P2|STARTED|Long-term (12-month) Extension||3
8530721|NCT00320190|21029545|P1|STARTED|Long-term (12-month) Extension||11
8530722|NCT00320190|21029544|P2|NOT COMPLETED|First 12 Months||10
8530723|NCT00320190|21029545|P1|NOT COMPLETED|First 12 Months||8
8530724|NCT00320190|21029544|P2|COMPLETED|First 12 Months||3
8530725|NCT00320190|21029545|P1|COMPLETED|First 12 Months||11
8530726|NCT00320190|21029544|P2|STARTED|First 12 Months||13
8530727|NCT00320190|21029545|P1|STARTED|First 12 Months||19
8530728|NCT00320112|21029565|P2|NOT COMPLETED|Overall Study||5
8530729|NCT00320112|21029566|P1|NOT COMPLETED|Overall Study||8
8530730|NCT00320112|21029565|P2|COMPLETED|Overall Study||114
8530731|NCT00320112|21029566|P1|COMPLETED|Overall Study||117
8530732|NCT00320112|21029565|P2|STARTED|Overall Study||119
8530733|NCT00320112|21029566|P1|STARTED|Overall Study||125
8530734|NCT00319982|21029580|P2|NOT COMPLETED|Overall Study||0
8530735|NCT00319982|21029581|P1|NOT COMPLETED|Overall Study||1
8530736|NCT00319982|21029580|P2|COMPLETED|Overall Study||20
8530737|NCT00319982|21029581|P1|COMPLETED|Overall Study||18
8530738|NCT00319982|21029580|P2|STARTED|Overall Study||20
8530739|NCT00319982|21029581|P1|STARTED|Overall Study||19
8530740|NCT00319956|21029601|P2|NOT COMPLETED|Overall Study||24
8530741|NCT00319956|21029602|P1|NOT COMPLETED|Overall Study||20
8530742|NCT00319956|21029601|P2|COMPLETED|Overall Study||85
8530743|NCT00319956|21029602|P1|COMPLETED|Overall Study||91
8530744|NCT00319956|21029601|P2|STARTED|Overall Study||109
8530745|NCT00319956|21029602|P1|STARTED|Overall Study||111
8530746|NCT00319839|21029614|P1|NOT COMPLETED|Overall Study||6
8530747|NCT00319839|21029614|P1|COMPLETED|Overall Study||1
8530748|NCT00319839|21029614|P1|STARTED|Overall Study||7
8530749|NCT00319748|21029620|P1|NOT COMPLETED|Overall Study||0
8530750|NCT00319748|21029620|P1|COMPLETED|Overall Study||13
8530751|NCT00319748|21029620|P1|STARTED|Overall Study||13
8530752|NCT00319735|21029630|P1|NOT COMPLETED|Overall Study||2
8530753|NCT00319735|21029630|P1|COMPLETED|Overall Study||39
8530754|NCT00319735|21029630|P1|STARTED|Overall Study||41
8530755|NCT00319696|21029643|P1|NOT COMPLETED|Overall Study||60
8530756|NCT00319696|21029643|P1|COMPLETED|Overall Study||56
8530757|NCT00319696|21029643|P1|STARTED|Overall Study||116
8530758|NCT00319644|21029669|P2|NOT COMPLETED|Overall Study||0
8530759|NCT00319644|21029670|P1|NOT COMPLETED|Overall Study||0
8530760|NCT00319644|21029669|P2|COMPLETED|Overall Study||16
8530761|NCT00319644|21029670|P1|COMPLETED|Overall Study||21
8530762|NCT00319644|21029669|P2|STARTED|Overall Study||16
8530763|NCT00319644|21029670|P1|STARTED|Overall Study||21
8530764|NCT00319592|21029680|P2|NOT COMPLETED|Overall Study||1
8530765|NCT00319592|21029681|P1|NOT COMPLETED|Overall Study||1
8530766|NCT00319592|21029680|P2|COMPLETED|Overall Study||29
8530767|NCT00319592|21029681|P1|COMPLETED|Overall Study||29
8530768|NCT00319592|21029680|P2|STARTED|Overall Study||30
8530769|NCT00319592|21029681|P1|STARTED|Overall Study||30
8530770|NCT00319553|21029697|P2|NOT COMPLETED|Overall Study||4
8530771|NCT00319553|21029698|P1|NOT COMPLETED|Overall Study||4
8530772|NCT00319553|21029697|P2|COMPLETED|Overall Study||317
8530773|NCT00319553|21029698|P1|COMPLETED|Overall Study||319
8530774|NCT00319553|21029697|P2|STARTED|Overall Study||321
8530775|NCT00319553|21029698|P1|STARTED|Overall Study||323
8530776|NCT00319501|21029712|P2|NOT COMPLETED|Open-label Extension Period||0
8530777|NCT00319501|21029713|P1|NOT COMPLETED|Open-label Extension Period||51
8530778|NCT00319501|21029712|P2|COMPLETED|Open-label Extension Period||0
8530779|NCT00319501|21029713|P1|COMPLETED|Open-label Extension Period||0
8530780|NCT00319501|21029712|P2|Received Treatment|Open-label Extension Period||0
8530781|NCT00319501|21029713|P1|Received Treatment|Open-label Extension Period||33
8530782|NCT00319501|21029712|P2|STARTED|Open-label Extension Period||0
8530783|NCT00319501|21029713|P1|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
8530784|NCT00319501|21029712|P2|NOT COMPLETED|Open-label Period||0
8530785|NCT00319501|21029713|P1|NOT COMPLETED|Open-label Period||116
8530786|NCT00319501|21029712|P2|COMPLETED|Open-label Period||0
8530787|NCT00319501|21029713|P1|COMPLETED|Open-label Period|Competed=continuing treatment|45
8530788|NCT00319501|21029712|P2|Received Treatment|Open-label Period||0
8530789|NCT00319501|21029713|P1|Received Treatment|Open-label Period||128
8530790|NCT00319501|21029712|P2|STARTED|Open-label Period||0
8530791|NCT00319501|21029713|P1|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
8530792|NCT00319501|21029712|P2|NOT COMPLETED|Double-blind Period||32
8530793|NCT00319501|21029713|P1|NOT COMPLETED|Double-blind Period||43
8530794|NCT00319501|21029712|P2|COMPLETED|Double-blind Period||78
8530795|NCT00319501|21029713|P1|COMPLETED|Double-blind Period||81
8530796|NCT00319501|21029712|P2|Received Treatment|Double-blind Period||81
8530797|NCT00319501|21029713|P1|Received Treatment|Double-blind Period||82
8530798|NCT00319501|21029712|P2|STARTED|Double-blind Period|Randomized participants|110
8530799|NCT00319501|21029713|P1|STARTED|Double-blind Period|Randomized participants|124
8530800|NCT00319449|21029739|P2|NOT COMPLETED|Overall Study||0
8530801|NCT00319449|21029740|P1|NOT COMPLETED|Overall Study||2
8530802|NCT00319449|21029739|P2|COMPLETED|Overall Study||12
8530803|NCT00319449|21029740|P1|COMPLETED|Overall Study||8
8530804|NCT00319449|21029739|P2|STARTED|Overall Study||12
8530805|NCT00319449|21029740|P1|STARTED|Overall Study||10
8530806|NCT00319436|21029752|P2|NOT COMPLETED|Overall Study||7
8530807|NCT00319436|21029753|P1|NOT COMPLETED|Overall Study||6
8530808|NCT00319436|21029752|P2|COMPLETED|Overall Study||17
8530809|NCT00319436|21029753|P1|COMPLETED|Overall Study||17
8530810|NCT00319436|21029752|P2|STARTED|Overall Study||24
8530811|NCT00319436|21029753|P1|STARTED|Overall Study||23
8530812|NCT00319254|21029771|P1|NOT COMPLETED|Overall Study||54
8530813|NCT00319254|21029771|P1|COMPLETED|Overall Study||21
8530814|NCT00319254|21029771|P1|Treated|Overall Study||73
8530815|NCT00319254|21029771|P1|STARTED|Overall Study||75
8530816|NCT00319111|21029784|P1|NOT COMPLETED|Overall Study||47
8530817|NCT00319111|21029784|P1|COMPLETED|Overall Study||104
8530818|NCT00319111|21029784|P1|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
8530819|NCT00319098|21029798|P2|NOT COMPLETED|Overall Study||32
8530820|NCT00319098|21029799|P1|NOT COMPLETED|Overall Study||135
8530821|NCT00319098|21029798|P2|COMPLETED|Overall Study||1237
8530822|NCT00319098|21029799|P1|COMPLETED|Overall Study||3667
8530823|NCT00319098|21029798|P2|STARTED|Overall Study||1269
8530824|NCT00319098|21029799|P1|STARTED|Overall Study||3802
8530825|NCT00319046|21029857|P1|NOT COMPLETED|Overall Study||8
8530826|NCT00319046|21029857|P1|COMPLETED|Overall Study||34
8530827|NCT00319046|21029857|P1|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
8530828|NCT00319020|21029866|P2|NOT COMPLETED|Overall Study||13
8530829|NCT00319020|21029867|P1|NOT COMPLETED|Overall Study||7
8530830|NCT00319020|21029866|P2|COMPLETED|Overall Study||8
8530831|NCT00319020|21029867|P1|COMPLETED|Overall Study||8
8530832|NCT00319020|21029866|P2|Enrollment in FUTURE 2 (F-2)|Overall Study||20
8530833|NCT00319020|21029867|P1|Enrollment in FUTURE 2 (F-2)|Overall Study||13
8530834|NCT00319020|21029866|P2|STARTED|Overall Study||21
8530835|NCT00319020|21029867|P1|STARTED|Overall Study||15
8530836|NCT00318929|21029896|P1|NOT COMPLETED|Overall Study||0
8530837|NCT00318929|21029896|P1|COMPLETED|Overall Study||14
8530838|NCT00318929|21029896|P1|STARTED|Overall Study||14
8530839|NCT00318812|21029905|P2|NOT COMPLETED|Overall Study||0
8530840|NCT00318812|21029906|P1|NOT COMPLETED|Overall Study||0
8530841|NCT00318812|21029905|P2|COMPLETED|Overall Study||22
8530842|NCT00318812|21029906|P1|COMPLETED|Overall Study||18
8530843|NCT00318812|21029905|P2|STARTED|Overall Study||22
8530844|NCT00318812|21029906|P1|STARTED|Overall Study||18
8530845|NCT00318708|21029918|P2|NOT COMPLETED|Overall Study||5
8530846|NCT00318708|21029919|P1|NOT COMPLETED|Overall Study||8
8530847|NCT00318708|21029918|P2|COMPLETED|Overall Study||40
8530848|NCT00318708|21029919|P1|COMPLETED|Overall Study||39
8530849|NCT00318708|21029918|P2|8-week Milestone|Overall Study||42
8530850|NCT00318708|21029919|P1|8-week Milestone|Overall Study||42
8530851|NCT00318708|21029918|P2|STARTED|Overall Study||45
8530852|NCT00318708|21029919|P1|STARTED|Overall Study||47
8530853|NCT00318656|21029939|P2|NOT COMPLETED|Overall Study||2
8530854|NCT00318656|21029940|P1|NOT COMPLETED|Overall Study||0
8530855|NCT00318656|21029939|P2|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
8530856|NCT00318656|21029940|P1|COMPLETED|Overall Study||12
8530857|NCT00318656|21029939|P2|STARTED|Overall Study||11
8530858|NCT00318656|21029940|P1|STARTED|Overall Study||12
8530865|NCT00318565|21029997|P1|NOT COMPLETED|Overall Study||24
8530866|NCT00318565|21029997|P1|COMPLETED|Overall Study||267
8530867|NCT00318565|21029997|P1|STARTED|Overall Study||291
8530868|NCT00318474|21030004|P2|NOT COMPLETED|Overall Study||17
8530869|NCT00318474|21030005|P1|NOT COMPLETED|Overall Study||18
8530870|NCT00318474|21030004|P2|COMPLETED|Overall Study||10
8530871|NCT00318474|21030005|P1|COMPLETED|Overall Study||7
8530872|NCT00318474|21030004|P2|STARTED|Overall Study||27
8530873|NCT00318474|21030005|P1|STARTED|Overall Study||25
8530874|NCT00318461|21030016|P5|NOT COMPLETED|Open-Label Extension, 18 Months||97
8530875|NCT00318461|21030017|P4|NOT COMPLETED|Open-Label Extension, 18 Months||43
8530876|NCT00318461|21030018|P3|NOT COMPLETED|Open-Label Extension, 18 Months||73
8530877|NCT00318461|21030019|P2|NOT COMPLETED|Open-Label Extension, 18 Months||60
8530878|NCT00318461|21030020|P1|NOT COMPLETED|Open-Label Extension, 18 Months||78
8530879|NCT00318461|21030016|P5|COMPLETED|Open-Label Extension, 18 Months||113
8530880|NCT00318461|21030017|P4|COMPLETED|Open-Label Extension, 18 Months||31
8530881|NCT00318461|21030018|P3|COMPLETED|Open-Label Extension, 18 Months||118
8530882|NCT00318461|21030019|P2|COMPLETED|Open-Label Extension, 18 Months||137
8530883|NCT00318461|21030020|P1|COMPLETED|Open-Label Extension, 18 Months||130
8530884|NCT00318461|21030016|P5|STARTED|Open-Label Extension, 18 Months||210
8530885|NCT00318461|21030017|P4|STARTED|Open-Label Extension, 18 Months||74
8530886|NCT00318461|21030018|P3|STARTED|Open-Label Extension, 18 Months||191
8530887|NCT00318461|21030019|P2|STARTED|Open-Label Extension, 18 Months||197
8530888|NCT00318461|21030020|P1|STARTED|Open-Label Extension, 18 Months||208
8530889|NCT00318461|21030016|P5|NOT COMPLETED|Double-Blind, 6 Months||34
8530890|NCT00318461|21030017|P4|NOT COMPLETED|Double-Blind, 6 Months||48
8530891|NCT00318461|21030018|P3|NOT COMPLETED|Double-Blind, 6 Months||51
8530892|NCT00318461|21030019|P2|NOT COMPLETED|Double-Blind, 6 Months||44
8530893|NCT00318461|21030020|P1|NOT COMPLETED|Double-Blind, 6 Months||34
8530894|NCT00318461|21030016|P5|COMPLETED|Double-Blind, 6 Months||210
8530895|NCT00318461|21030017|P4|COMPLETED|Double-Blind, 6 Months||74
8530896|NCT00318461|21030018|P3|COMPLETED|Double-Blind, 6 Months||191
8530897|NCT00318461|21030019|P2|COMPLETED|Double-Blind, 6 Months||197
8530898|NCT00318461|21030020|P1|COMPLETED|Double-Blind, 6 Months||208
8530899|NCT00318461|21030016|P5|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
8530900|NCT00318461|21030017|P4|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
8530901|NCT00318461|21030018|P3|Exposed to Study Drug|Double-Blind, 6 Months||242
8530902|NCT00318461|21030019|P2|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
8530903|NCT00318461|21030020|P1|Exposed to Study Drug|Double-Blind, 6 Months||242
8530904|NCT00318461|21030016|P5|STARTED|Double-Blind, 6 Months|Randomised|244
8530905|NCT00318461|21030017|P4|STARTED|Double-Blind, 6 Months|Randomised|122
8530906|NCT00318461|21030018|P3|STARTED|Double-Blind, 6 Months|Randomised|242
8530907|NCT00318461|21030019|P2|STARTED|Double-Blind, 6 Months|Randomised|241
8530908|NCT00318461|21030020|P1|STARTED|Double-Blind, 6 Months|Randomised|242
8530909|NCT00318409|21030099|P2|NOT COMPLETED|Overall Study||1
8530910|NCT00318409|21030100|P1|NOT COMPLETED|Overall Study||2
8530911|NCT00318409|21030099|P2|COMPLETED|Overall Study||9
8530912|NCT00318409|21030100|P1|COMPLETED|Overall Study||18
8530913|NCT00318409|21030099|P2|STARTED|Overall Study||10
8530914|NCT00318409|21030100|P1|STARTED|Overall Study||20
8530915|NCT00318370|21030119|P3|NOT COMPLETED|Period 3||33
8530916|NCT00318370|21030120|P2|NOT COMPLETED|Period 3||0
8530917|NCT00318370|21030121|P1|NOT COMPLETED|Period 3||0
8530918|NCT00318370|21030119|P3|COMPLETED|Period 3||3
8530919|NCT00318370|21030120|P2|COMPLETED|Period 3||0
8530920|NCT00318370|21030121|P1|COMPLETED|Period 3||0
8530921|NCT00318370|21030119|P3|STARTED|Period 3||36
8530922|NCT00318370|21030120|P2|STARTED|Period 3||0
8530923|NCT00318370|21030121|P1|STARTED|Period 3||0
8530924|NCT00318370|21030119|P3|NOT COMPLETED|Period 2||0
8530925|NCT00318370|21030120|P2|NOT COMPLETED|Period 2||11
8530926|NCT00318370|21030121|P1|NOT COMPLETED|Period 2||0
8530927|NCT00318370|21030119|P3|COMPLETED|Period 2||0
8530928|NCT00318370|21030120|P2|COMPLETED|Period 2||36
8530929|NCT00318370|21030121|P1|COMPLETED|Period 2||0
8530930|NCT00318370|21030119|P3|STARTED|Period 2||0
8530931|NCT00318370|21030120|P2|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
8530932|NCT00318370|21030121|P1|STARTED|Period 2||0
8530933|NCT00318370|21030119|P3|NOT COMPLETED|Period 1||0
8530934|NCT00318370|21030120|P2|NOT COMPLETED|Period 1||0
8530935|NCT00318370|21030121|P1|NOT COMPLETED|Period 1||7
8530936|NCT00318370|21030119|P3|COMPLETED|Period 1||0
8530937|NCT00318370|21030120|P2|COMPLETED|Period 1||0
8530938|NCT00318370|21030121|P1|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
8530939|NCT00318370|21030119|P3|STARTED|Period 1||0
8530940|NCT00318370|21030120|P2|STARTED|Period 1||0
8530941|NCT00318370|21030121|P1|STARTED|Period 1||28
8530942|NCT00318357|21030133|P2|NOT COMPLETED|Overall Study||32
8530943|NCT00318357|21030134|P1|NOT COMPLETED|Overall Study||39
8530944|NCT00318357|21030133|P2|COMPLETED|Overall Study||104
8530945|NCT00318357|21030134|P1|COMPLETED|Overall Study||134
8530946|NCT00318357|21030133|P2|STARTED|Overall Study||136
8530947|NCT00318357|21030134|P1|STARTED|Overall Study||173
8530948|NCT00318292|21030142|P2|NOT COMPLETED|Overall Study||0
8530949|NCT00318292|21030143|P1|NOT COMPLETED|Overall Study||0
8530950|NCT00318292|21030142|P2|COMPLETED|Overall Study||45
8530951|NCT00318292|21030143|P1|COMPLETED|Overall Study||45
8530952|NCT00318292|21030142|P2|STARTED|Overall Study||45
8530953|NCT00318292|21030143|P1|STARTED|Overall Study||45
8530954|NCT00318149|21030155|P6|NOT COMPLETED|Overall Study||2
8530955|NCT00318149|21030156|P5|NOT COMPLETED|Overall Study||0
8530956|NCT00318149|21030157|P4|NOT COMPLETED|Overall Study||0
8530957|NCT00318149|21030158|P3|NOT COMPLETED|Overall Study||0
8530958|NCT00318149|21030159|P2|NOT COMPLETED|Overall Study||0
8530959|NCT00318149|21030160|P1|NOT COMPLETED|Overall Study||0
8530960|NCT00318149|21030155|P6|COMPLETED|Overall Study||73
8530961|NCT00318149|21030156|P5|COMPLETED|Overall Study||75
8530962|NCT00318149|21030157|P4|COMPLETED|Overall Study||75
8530963|NCT00318149|21030158|P3|COMPLETED|Overall Study||75
8530964|NCT00318149|21030159|P2|COMPLETED|Overall Study||50
8530965|NCT00318149|21030160|P1|COMPLETED|Overall Study||75
8530966|NCT00318149|21030155|P6|STARTED|Overall Study||75
8530967|NCT00318149|21030156|P5|STARTED|Overall Study||75
8530968|NCT00318149|21030157|P4|STARTED|Overall Study||75
8530969|NCT00318149|21030158|P3|STARTED|Overall Study||75
8530970|NCT00318149|21030159|P2|STARTED|Overall Study||50
8530971|NCT00318149|21030160|P1|STARTED|Overall Study||75
8530972|NCT00318136|21030246|P1|NOT COMPLETED|Overall Study||45
8530973|NCT00318136|21030246|P1|COMPLETED|Overall Study||2
8530974|NCT00318136|21030246|P1|STARTED|Overall Study||47
8530975|NCT00317941|21030255|P3|NOT COMPLETED|Overall Study||8
8530976|NCT00317941|21030256|P2|NOT COMPLETED|Overall Study||5
8530977|NCT00317941|21030257|P1|NOT COMPLETED|Overall Study||7
8530978|NCT00317941|21030255|P3|COMPLETED|Overall Study||60
8530979|NCT00317941|21030256|P2|COMPLETED|Overall Study||74
8530980|NCT00317941|21030257|P1|COMPLETED|Overall Study||66
8530981|NCT00317941|21030255|P3|Fulfilled Requirements PP Population|Overall Study||63
8530982|NCT00317941|21030256|P2|Fulfilled Requirements PP Population|Overall Study||76
8530983|NCT00317941|21030257|P1|Fulfilled Requirements PP Population|Overall Study||66
8530984|NCT00317941|21030255|P3|Fulfilled Requirement Safety Population|Overall Study||65
8530985|NCT00317941|21030256|P2|Fulfilled Requirement Safety Population|Overall Study||77
8530986|NCT00317941|21030257|P1|Fulfilled Requirement Safety Population|Overall Study||73
8530987|NCT00317941|21030255|P3|Participants Received Treatment|Overall Study||68
8530988|NCT00317941|21030256|P2|Participants Received Treatment|Overall Study||79
8530989|NCT00317941|21030257|P1|Participants Received Treatment|Overall Study||73
8530990|NCT00317941|21030255|P3|STARTED|Overall Study||68
8530991|NCT00317941|21030256|P2|STARTED|Overall Study||79
8530992|NCT00317941|21030257|P1|STARTED|Overall Study||73
8530993|NCT00317720|21030298|P2|NOT COMPLETED|Overall Study||0
8530994|NCT00317720|21030299|P1|NOT COMPLETED|Overall Study||0
8530995|NCT00317720|21030298|P2|COMPLETED|Overall Study||7
8530996|NCT00317720|21030299|P1|COMPLETED|Overall Study||40
8530997|NCT00317720|21030298|P2|STARTED|Overall Study||7
8530998|NCT00317720|21030299|P1|STARTED|Overall Study||40
8530999|NCT00317642|21030306|P2|NOT COMPLETED|Overall Study||135
8531000|NCT00317642|21030307|P1|NOT COMPLETED|Overall Study||122
8531001|NCT00317642|21030306|P2|COMPLETED|Overall Study|achieved remission and completed consolidation|28
8531002|NCT00317642|21030307|P1|COMPLETED|Overall Study|achieved remission and completed consolidation|41
8531003|NCT00317642|21030306|P2|Received >= 1 Study Drug (Safety Set)|Overall Study||155
8531004|NCT00317642|21030307|P1|Received >= 1 Study Drug (Safety Set)|Overall Study||161
8531005|NCT00317642|21030306|P2|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
8531006|NCT00317642|21030307|P1|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
8531007|NCT00317642|21030306|P2|STARTED|Overall Study||163
8531008|NCT00317642|21030307|P1|STARTED|Overall Study||163
8531009|NCT00317473|21030386|P6|NOT COMPLETED|Overall Study||3
8531010|NCT00317473|21030387|P5|NOT COMPLETED|Overall Study||8
8531011|NCT00317473|21030388|P4|NOT COMPLETED|Overall Study||2
8531012|NCT00317473|21030389|P3|NOT COMPLETED|Overall Study||3
8531013|NCT00317473|21030390|P2|NOT COMPLETED|Overall Study||3
8531014|NCT00317473|21030391|P1|NOT COMPLETED|Overall Study||4
8531015|NCT00317473|21030386|P6|COMPLETED|Overall Study||12
8531016|NCT00317473|21030387|P5|COMPLETED|Overall Study||22
8531017|NCT00317473|21030388|P4|COMPLETED|Overall Study||13
8531018|NCT00317473|21030389|P3|COMPLETED|Overall Study||27
8531019|NCT00317473|21030390|P2|COMPLETED|Overall Study||12
8531020|NCT00317473|21030391|P1|COMPLETED|Overall Study||26
8531021|NCT00317473|21030386|P6|STARTED|Overall Study||15
8531022|NCT00317473|21030387|P5|STARTED|Overall Study||30
8531023|NCT00317473|21030388|P4|STARTED|Overall Study||15
8531024|NCT00317473|21030389|P3|STARTED|Overall Study||30
8531025|NCT00317473|21030390|P2|STARTED|Overall Study||15
8531026|NCT00317473|21030391|P1|STARTED|Overall Study||30
8531027|NCT00317239|21030417|P2|NOT COMPLETED|Overall Study||19
8531028|NCT00317239|21030418|P1|NOT COMPLETED|Overall Study||13
8531029|NCT00317239|21030417|P2|COMPLETED|Overall Study||84
8531030|NCT00317239|21030418|P1|COMPLETED|Overall Study||134
8531031|NCT00317239|21030417|P2|STARTED|Overall Study||103
8531032|NCT00317239|21030418|P1|STARTED|Overall Study||147
8531033|NCT00317226|21030424|P1|NOT COMPLETED|Overall Study||23
8531034|NCT00317226|21030424|P1|COMPLETED|Overall Study||104
8531035|NCT00317226|21030424|P1|STARTED|Overall Study||127
8531036|NCT00317109|21030430|P2|NOT COMPLETED|Overall Study||0
8531037|NCT00317109|21030431|P1|NOT COMPLETED|Overall Study||3
8531038|NCT00317109|21030430|P2|COMPLETED|Overall Study||84
8531039|NCT00317109|21030431|P1|COMPLETED|Overall Study||81
8531040|NCT00317109|21030430|P2|STARTED|Overall Study||84
8531041|NCT00317109|21030431|P1|STARTED|Overall Study||84
8531042|NCT00317044|21030468|P3|NOT COMPLETED|Overall Study||45
8531043|NCT00317044|21030469|P2|NOT COMPLETED|Overall Study||40
8531044|NCT00317044|21030470|P1|NOT COMPLETED|Overall Study||48
8531045|NCT00317044|21030468|P3|COMPLETED|Overall Study||283
8531046|NCT00317044|21030469|P2|COMPLETED|Overall Study||273
8531047|NCT00317044|21030470|P1|COMPLETED|Overall Study||272
8531048|NCT00317044|21030468|P3|STARTED|Overall Study||328
8531049|NCT00317044|21030469|P2|STARTED|Overall Study||313
8531050|NCT00317044|21030470|P1|STARTED|Overall Study||320
8531051|NCT00316914|21030516|P2|NOT COMPLETED|Overall Study||36
8531052|NCT00316914|21030517|P1|NOT COMPLETED|Overall Study||33
8531053|NCT00316914|21030516|P2|COMPLETED|Overall Study||16
8531054|NCT00316914|21030517|P1|COMPLETED|Overall Study||17
8531055|NCT00316914|21030516|P2|STARTED|Overall Study||52
8531056|NCT00316914|21030517|P1|STARTED|Overall Study||50
8531057|NCT00316888|21030547|P2|NOT COMPLETED|Overall Study||8
8531058|NCT00316888|21030548|P1|NOT COMPLETED|Overall Study||6
8531059|NCT00316888|21030547|P2|COMPLETED|Overall Study||27
8531060|NCT00316888|21030548|P1|COMPLETED|Overall Study||22
8531061|NCT00316888|21030547|P2|Started Chemo+Radiation+Cetuximab|Overall Study||34
8531062|NCT00316888|21030548|P1|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
8531063|NCT00316888|21030547|P2|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
8531064|NCT00316888|21030548|P1|Started Induction Chemotherapy|Overall Study||28
8531065|NCT00316888|21030547|P2|Treated|Overall Study||34
8531066|NCT00316888|21030548|P1|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
8531067|NCT00316888|21030547|P2|Eligible|Overall Study||35
8531068|NCT00316888|21030548|P1|Eligible|Overall Study||28
8531069|NCT00316888|21030547|P2|STARTED|Overall Study||35
8531070|NCT00316888|21030548|P1|STARTED|Overall Study||28
8531071|NCT00316862|21030562|P1|NOT COMPLETED|Overall Study||0
8531072|NCT00316862|21030562|P1|COMPLETED|Overall Study||82
8531073|NCT00316862|21030562|P1|STARTED|Overall Study||82
8531074|NCT00316719|21030570|P2|NOT COMPLETED|Overall Study||6
8531075|NCT00316719|21030571|P1|NOT COMPLETED|Overall Study||2
8531076|NCT00316719|21030570|P2|COMPLETED|Overall Study||47
8531077|NCT00316719|21030571|P1|COMPLETED|Overall Study||50
8531078|NCT00316719|21030570|P2|STARTED|Overall Study||53
8531079|NCT00316719|21030571|P1|STARTED|Overall Study||52
8531080|NCT00316706|21030597|P2|NOT COMPLETED|Overall Study||48
8531081|NCT00316706|21030598|P1|NOT COMPLETED|Overall Study||38
8531082|NCT00316706|21030597|P2|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
8531083|NCT00316706|21030598|P1|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
8531084|NCT00316706|21030597|P2|STARTED|Overall Study||619
8531085|NCT00316706|21030598|P1|STARTED|Overall Study||626
8531086|NCT00316693|21030614|P2|NOT COMPLETED|Overall Study||85
8531087|NCT00316693|21030615|P1|NOT COMPLETED|Overall Study||77
8531088|NCT00316693|21030614|P2|COMPLETED|Overall Study||436
8531089|NCT00316693|21030615|P1|COMPLETED|Overall Study||442
8531090|NCT00316693|21030614|P2|STARTED|Overall Study||521
8531091|NCT00316693|21030615|P1|STARTED|Overall Study||519
8531092|NCT00316602|21030657|P2|NOT COMPLETED|Overall Study||25
8531093|NCT00316602|21030658|P1|NOT COMPLETED|Overall Study||10
8531094|NCT00316602|21030657|P2|COMPLETED|Overall Study||325
8531095|NCT00316602|21030658|P1|COMPLETED|Overall Study||272
8531096|NCT00316602|21030657|P2|STARTED|Overall Study||350
8531097|NCT00316602|21030658|P1|STARTED|Overall Study||282
8531098|NCT00316589|21030690|P4|NOT COMPLETED|Overall Study||5
8531099|NCT00316589|21030691|P3|NOT COMPLETED|Overall Study||1
8531100|NCT00316589|21030692|P2|NOT COMPLETED|Overall Study||24
8531101|NCT00316589|21030693|P1|NOT COMPLETED|Overall Study||1
8531102|NCT00316589|21030690|P4|COMPLETED|Overall Study||127
8531103|NCT00316589|21030691|P3|COMPLETED|Overall Study||8
8531104|NCT00316589|21030692|P2|COMPLETED|Overall Study||328
8531105|NCT00316589|21030693|P1|COMPLETED|Overall Study||87
8531106|NCT00316589|21030690|P4|STARTED|Overall Study||132
8531107|NCT00316589|21030691|P3|STARTED|Overall Study||9
8531108|NCT00316589|21030692|P2|STARTED|Overall Study||352
8531109|NCT00316589|21030693|P1|STARTED|Overall Study||88
8531110|NCT00316524|21030761|P4|NOT COMPLETED|Overall Study||0
8531111|NCT00316524|21030762|P3|NOT COMPLETED|Overall Study||6
8531112|NCT00316524|21030763|P2|NOT COMPLETED|Overall Study||8
8531113|NCT00316524|21030764|P1|NOT COMPLETED|Overall Study||8
8531114|NCT00316524|21030761|P4|COMPLETED|Overall Study||200
8531115|NCT00316524|21030762|P3|COMPLETED|Overall Study||175
8531116|NCT00316524|21030763|P2|COMPLETED|Overall Study||173
8531117|NCT00316524|21030764|P1|COMPLETED|Overall Study||175
8531118|NCT00316524|21030761|P4|STARTED|Overall Study||200
8531119|NCT00316524|21030762|P3|STARTED|Overall Study||181
8531120|NCT00316524|21030763|P2|STARTED|Overall Study||181
8531121|NCT00316524|21030764|P1|STARTED|Overall Study||183
8531122|NCT00316355|21030816|P2|NOT COMPLETED|Overall Study||7
8531123|NCT00316355|21030817|P1|NOT COMPLETED|Overall Study||5
8531124|NCT00316355|21030816|P2|COMPLETED|Overall Study||12
8531125|NCT00316355|21030817|P1|COMPLETED|Overall Study||10
8531126|NCT00316355|21030816|P2|Started Treatment|Overall Study||18
8531127|NCT00316355|21030817|P1|Started Treatment|Overall Study||12
8531128|NCT00316355|21030816|P2|STARTED|Overall Study||19
8531129|NCT00316355|21030817|P1|STARTED|Overall Study||15
8531130|NCT00316303|21030827|P2|NOT COMPLETED|Overall Study||16
8531131|NCT00316303|21030828|P1|NOT COMPLETED|Overall Study||11
8531132|NCT00316303|21030827|P2|COMPLETED|Overall Study||102
8531133|NCT00316303|21030828|P1|COMPLETED|Overall Study||107
8531134|NCT00316303|21030827|P2|STARTED|Overall Study||118
8531135|NCT00316303|21030828|P1|STARTED|Overall Study||118
8531136|NCT00316277|21030844|P2|NOT COMPLETED|Phase 2 (24 Weeks)||19
8531137|NCT00316277|21030845|P1|NOT COMPLETED|Phase 2 (24 Weeks)||19
8531138|NCT00316277|21030844|P2|COMPLETED|Phase 2 (24 Weeks)||161
8531139|NCT00316277|21030845|P1|COMPLETED|Phase 2 (24 Weeks)||161
8531140|NCT00316277|21030844|P2|STARTED|Phase 2 (24 Weeks)||180
8531141|NCT00316277|21030845|P1|STARTED|Phase 2 (24 Weeks)||180
8531142|NCT00316277|21030844|P2|NOT COMPLETED|Phase 1 (12 Weeks)||300
8531143|NCT00316277|21030845|P1|NOT COMPLETED|Phase 1 (12 Weeks)||310
8531144|NCT00316277|21030844|P2|COMPLETED|Phase 1 (12 Weeks)||24
8531145|NCT00316277|21030845|P1|COMPLETED|Phase 1 (12 Weeks)||19
8531146|NCT00316277|21030844|P2|STARTED|Phase 1 (12 Weeks)||324
8531147|NCT00316277|21030845|P1|STARTED|Phase 1 (12 Weeks)||329
8531148|NCT00316264|21030866|P3|NOT COMPLETED|Overall Study||6
8531149|NCT00316264|21030867|P2|NOT COMPLETED|Overall Study||7
8531150|NCT00316264|21030868|P1|NOT COMPLETED|Overall Study||6
8531151|NCT00316264|21030866|P3|COMPLETED|Overall Study||87
8531152|NCT00316264|21030867|P2|COMPLETED|Overall Study||77
8531153|NCT00316264|21030868|P1|COMPLETED|Overall Study||77
8531154|NCT00316264|21030866|P3|STARTED|Overall Study||93
8531155|NCT00316264|21030867|P2|STARTED|Overall Study||84
8531156|NCT00316264|21030868|P1|STARTED|Overall Study||83
8531157|NCT00316225|21030936|P1|NOT COMPLETED|Overall Study||25
8531158|NCT00316225|21030936|P1|COMPLETED|Overall Study||6
8531159|NCT00316225|21030936|P1|STARTED|Overall Study||31
8531160|NCT00316199|21030945|P1|NOT COMPLETED|Overall Study||12
8531161|NCT00316199|21030945|P1|COMPLETED|Overall Study||48
8531162|NCT00316199|21030945|P1|STARTED|Overall Study||60
8531163|NCT00316186|21030953|P1|NOT COMPLETED|Overall Study||12
8531164|NCT00316186|21030953|P1|COMPLETED|Overall Study||21
8531165|NCT00316186|21030953|P1|STARTED|Overall Study||33
8531166|NCT00316173|21030967|P2|NOT COMPLETED|Treatment Phase||42
8531167|NCT00316173|21030968|P1|NOT COMPLETED|Treatment Phase||0
8531168|NCT00316173|21030967|P2|COMPLETED|Treatment Phase||13
8531169|NCT00316173|21030968|P1|COMPLETED|Treatment Phase||0
8531170|NCT00316173|21030967|P2|STARTED|Treatment Phase||55
8531171|NCT00316173|21030968|P1|STARTED|Treatment Phase||0
8531172|NCT00316173|21030967|P2|NOT COMPLETED|Run-in Phase||0
8531173|NCT00316173|21030968|P1|NOT COMPLETED|Run-in Phase||7
8531174|NCT00316173|21030967|P2|COMPLETED|Run-in Phase||0
8531175|NCT00316173|21030968|P1|COMPLETED|Run-in Phase||15
8531176|NCT00316173|21030967|P2|STARTED|Run-in Phase||0
8531177|NCT00316173|21030968|P1|STARTED|Run-in Phase||22
8531178|NCT00316121|21030981|P2|NOT COMPLETED|Overall Study||9
8531179|NCT00316121|21030982|P1|NOT COMPLETED|Overall Study||22
8531180|NCT00316121|21030981|P2|COMPLETED|Overall Study||37
8531181|NCT00316121|21030982|P1|COMPLETED|Overall Study||70
8531182|NCT00316121|21030981|P2|STARTED|Overall Study||46
8531183|NCT00316121|21030982|P1|STARTED|Overall Study||92
8531184|NCT00316082|21030993|P5|NOT COMPLETED|Overall Study||26
8531185|NCT00316082|21030994|P4|NOT COMPLETED|Overall Study||26
8531186|NCT00316082|21030995|P3|NOT COMPLETED|Overall Study||27
8531187|NCT00316082|21030996|P2|NOT COMPLETED|Overall Study||22
8531188|NCT00316082|21030997|P1|NOT COMPLETED|Overall Study||33
8531189|NCT00316082|21030993|P5|COMPLETED|Overall Study||48
8531190|NCT00316082|21030994|P4|COMPLETED|Overall Study||46
8531191|NCT00316082|21030995|P3|COMPLETED|Overall Study||44
8531192|NCT00316082|21030996|P2|COMPLETED|Overall Study||52
8531193|NCT00316082|21030997|P1|COMPLETED|Overall Study||41
8531194|NCT00316082|21030993|P5|Completed Study Without Being Rescued|Overall Study||31
8531195|NCT00316082|21030994|P4|Completed Study Without Being Rescued|Overall Study||27
8531196|NCT00316082|21030995|P3|Completed Study Without Being Rescued|Overall Study||29
8531197|NCT00316082|21030996|P2|Completed Study Without Being Rescued|Overall Study||35
8531198|NCT00316082|21030997|P1|Completed Study Without Being Rescued|Overall Study||25
8531199|NCT00316082|21030993|P5|STARTED|Overall Study||74
8531200|NCT00316082|21030994|P4|STARTED|Overall Study||72
8531201|NCT00316082|21030995|P3|STARTED|Overall Study||71
8531202|NCT00316082|21030996|P2|STARTED|Overall Study||74
8531203|NCT00316082|21030997|P1|STARTED|Overall Study||74
8531204|NCT00316017|21031028|P3|NOT COMPLETED|Overall Study||19
8531205|NCT00316017|21031029|P2|NOT COMPLETED|Overall Study||13
8531206|NCT00316017|21031030|P1|NOT COMPLETED|Overall Study||11
8531207|NCT00316017|21031028|P3|COMPLETED|Overall Study||376
8531208|NCT00316017|21031029|P2|COMPLETED|Overall Study||256
8531209|NCT00316017|21031030|P1|COMPLETED|Overall Study||220
8531210|NCT00316017|21031028|P3|STARTED|Overall Study|19 of 19 not complete due to BONG|395
8531211|NCT00316017|21031029|P2|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
8531212|NCT00316017|21031030|P1|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
8531213|NCT00316004|21031104|P3|NOT COMPLETED|Overall Study||21
8531214|NCT00316004|21031105|P2|NOT COMPLETED|Overall Study||14
8531215|NCT00316004|21031106|P1|NOT COMPLETED|Overall Study||14
8531216|NCT00316004|21031104|P3|COMPLETED|Overall Study||582
8531217|NCT00316004|21031105|P2|COMPLETED|Overall Study||341
8531218|NCT00316004|21031106|P1|COMPLETED|Overall Study||359
8531219|NCT00316004|21031104|P3|STARTED|Overall Study||603
8531220|NCT00316004|21031105|P2|STARTED|Overall Study||355
8531221|NCT00316004|21031106|P1|STARTED|Overall Study||373
8531222|NCT00315939|21031161|P2|NOT COMPLETED|Admission 3 (3 Months)||2
8531223|NCT00315939|21031162|P1|NOT COMPLETED|Admission 3 (3 Months)||4
8531224|NCT00315939|21031161|P2|COMPLETED|Admission 3 (3 Months)||49
8531225|NCT00315939|21031162|P1|COMPLETED|Admission 3 (3 Months)||48
8531226|NCT00315939|21031161|P2|STARTED|Admission 3 (3 Months)||51
8531227|NCT00315939|21031162|P1|STARTED|Admission 3 (3 Months)||52
8531228|NCT00315939|21031161|P2|NOT COMPLETED|Admission 2 (3 Months)||4
8531229|NCT00315939|21031162|P1|NOT COMPLETED|Admission 2 (3 Months)||4
8531230|NCT00315939|21031161|P2|COMPLETED|Admission 2 (3 Months)||51
8531231|NCT00315939|21031162|P1|COMPLETED|Admission 2 (3 Months)||52
8531232|NCT00315939|21031161|P2|STARTED|Admission 2 (3 Months)||55
8531233|NCT00315939|21031162|P1|STARTED|Admission 2 (3 Months)||56
8531234|NCT00315939|21031161|P2|NOT COMPLETED|Admission 1 (3 Months)||6
8531235|NCT00315939|21031162|P1|NOT COMPLETED|Admission 1 (3 Months)||3
8531236|NCT00315939|21031161|P2|COMPLETED|Admission 1 (3 Months)||55
8531237|NCT00315939|21031162|P1|COMPLETED|Admission 1 (3 Months)||56
8531238|NCT00315939|21031161|P2|STARTED|Admission 1 (3 Months)||61
8531239|NCT00315939|21031162|P1|STARTED|Admission 1 (3 Months)||59
8531240|NCT00315822|21031170|P2|NOT COMPLETED|Overall Study||0
8531241|NCT00315822|21031171|P1|NOT COMPLETED|Overall Study||0
8531242|NCT00315822|21031170|P2|COMPLETED|Overall Study||202
8531243|NCT00315822|21031171|P1|COMPLETED|Overall Study||198
8531244|NCT00315822|21031170|P2|STARTED|Overall Study||202
8531245|NCT00315822|21031171|P1|STARTED|Overall Study||198
8531246|NCT00315731|21031177|P1|NOT COMPLETED|Overall Study||6
8531247|NCT00315731|21031177|P1|COMPLETED|Overall Study||9
8531248|NCT00315731|21031177|P1|STARTED|Overall Study||15
8531249|NCT00315705|21031205|P1|NOT COMPLETED|Phase 2||25
8531250|NCT00315705|21031205|P1|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
8531251|NCT00315705|21031205|P1|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
8531252|NCT00315705|21031205|P1|NOT COMPLETED|Phase 1||25
8531253|NCT00315705|21031205|P1|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
8531254|NCT00315705|21031205|P1|STARTED|Phase 1||25
8531255|NCT00315627|21031242|P1|NOT COMPLETED|Overall Study||0
8531256|NCT00315627|21031242|P1|COMPLETED|Overall Study||3
8531257|NCT00315627|21031242|P1|STARTED|Overall Study||3
8531258|NCT00315614|21031250|P1|NOT COMPLETED|Overall Study||0
8531259|NCT00315614|21031250|P1|COMPLETED|Overall Study||3
8531260|NCT00315614|21031250|P1|STARTED|Overall Study||3
8531261|NCT00315588|21031257|P1|NOT COMPLETED|Overall Study||0
8531262|NCT00315588|21031257|P1|COMPLETED|Overall Study||7
8531263|NCT00315588|21031257|P1|STARTED|Overall Study||7
8531264|NCT00315458|21031266|P4|NOT COMPLETED|Overall Study||29
8531265|NCT00315458|21031267|P3|NOT COMPLETED|Overall Study||52
8531266|NCT00315458|21031268|P2|NOT COMPLETED|Overall Study||12
8531267|NCT00315458|21031269|P1|NOT COMPLETED|Overall Study||3
8531268|NCT00315458|21031266|P4|COMPLETED|Overall Study||10
8531269|NCT00315458|21031267|P3|COMPLETED|Overall Study||107
8531270|NCT00315458|21031268|P2|COMPLETED|Overall Study||44
8531271|NCT00315458|21031269|P1|COMPLETED|Overall Study||48
8531272|NCT00315458|21031266|P4|STARTED|Overall Study||39
8531273|NCT00315458|21031267|P3|STARTED|Overall Study||159
8531274|NCT00315458|21031268|P2|STARTED|Overall Study||56
8531275|NCT00315458|21031269|P1|STARTED|Overall Study||51
8531276|NCT00315445|21031282|P3|NOT COMPLETED|Overall Study||24
8531277|NCT00315445|21031283|P2|NOT COMPLETED|Overall Study||16
8531278|NCT00315445|21031284|P1|NOT COMPLETED|Overall Study||27
8531279|NCT00315445|21031282|P3|COMPLETED|Overall Study||22
8531280|NCT00315445|21031283|P2|COMPLETED|Overall Study||27
8531281|NCT00315445|21031284|P1|COMPLETED|Overall Study||18
8531282|NCT00315445|21031282|P3|STARTED|Overall Study||46
8531283|NCT00315445|21031283|P2|STARTED|Overall Study||43
8531284|NCT00315445|21031284|P1|STARTED|Overall Study||45
8531285|NCT00315341|21031357|P2|NOT COMPLETED|Overall Study||138
8531286|NCT00315341|21031358|P1|NOT COMPLETED|Overall Study||400
8531287|NCT00315341|21031357|P2|COMPLETED|Overall Study||391
8531288|NCT00315341|21031358|P1|COMPLETED|Overall Study||340
8531289|NCT00315341|21031357|P2|STARTED|Overall Study||529
8531290|NCT00315341|21031358|P1|STARTED|Overall Study||740
8531291|NCT00315328|21031368|P4|NOT COMPLETED|Overall Study||2
8531292|NCT00315328|21031369|P3|NOT COMPLETED|Overall Study||5
8531293|NCT00315328|21031370|P2|NOT COMPLETED|Overall Study||7
8531294|NCT00315328|21031371|P1|NOT COMPLETED|Overall Study||14
8531295|NCT00315328|21031368|P4|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
8531296|NCT00315328|21031369|P3|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
8531297|NCT00315328|21031370|P2|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
8531298|NCT00315328|21031371|P1|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
8531299|NCT00315328|21031368|P4|5 Week Visit|Overall Study||19
8531300|NCT00315328|21031369|P3|5 Week Visit|Overall Study||17
8531301|NCT00315328|21031370|P2|5 Week Visit|Overall Study||89
8531302|NCT00315328|21031371|P1|5 Week Visit|Overall Study||91
8531303|NCT00315328|21031368|P4|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
8531304|NCT00315328|21031369|P3|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
8531305|NCT00315328|21031370|P2|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
8531306|NCT00315328|21031371|P1|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
8531307|NCT00315302|21031441|P4|NOT COMPLETED|Overall Study||3
8531308|NCT00315302|21031442|P3|NOT COMPLETED|Overall Study||2
8531309|NCT00315302|21031443|P2|NOT COMPLETED|Overall Study||2
8531310|NCT00315302|21031444|P1|NOT COMPLETED|Overall Study||6
8531311|NCT00315302|21031441|P4|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
8531312|NCT00315302|21031442|P3|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
8531313|NCT00315302|21031443|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
8531314|NCT00315302|21031444|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
8531315|NCT00315302|21031441|P4|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
8531316|NCT00315302|21031442|P3|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
8531317|NCT00315302|21031443|P2|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
8531318|NCT00315302|21031444|P1|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
8531319|NCT00315302|21031441|P4|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
8531320|NCT00315302|21031442|P3|18 Week Primary Outcome Visit|Overall Study||24
8531321|NCT00315302|21031443|P2|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
8531322|NCT00315302|21031444|P1|18 Week Primary Outcome Visit|Overall Study||84
8531323|NCT00315302|21031441|P4|10 Week Visit|Overall Study||29
8531324|NCT00315302|21031442|P3|10 Week Visit|Overall Study||24
8531325|NCT00315302|21031443|P2|10 Week Visit|Overall Study||85
8531326|NCT00315302|21031444|P1|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
8531327|NCT00315302|21031441|P4|5 Week Visit|Overall Study||30
8531328|NCT00315302|21031442|P3|5 Week Visit|Overall Study||26
8531329|NCT00315302|21031443|P2|5 Week Visit|Overall Study||86
8531330|NCT00315302|21031444|P1|5 Week Visit|Overall Study||85
8531331|NCT00315302|21031441|P4|STARTED|Overall Study||34
8531332|NCT00315302|21031442|P3|STARTED|Overall Study||26
8531333|NCT00315302|21031443|P2|STARTED|Overall Study||90
8531334|NCT00315302|21031444|P1|STARTED|Overall Study||90
8531335|NCT00315146|21031490|P4|NOT COMPLETED|Overall Study||0
8531336|NCT00315146|21031491|P3|NOT COMPLETED|Overall Study||2
8531337|NCT00315146|21031492|P2|NOT COMPLETED|Overall Study||3
8531338|NCT00315146|21031493|P1|NOT COMPLETED|Overall Study||2
8531339|NCT00315146|21031490|P4|COMPLETED|Overall Study||22
8531340|NCT00315146|21031491|P3|COMPLETED|Overall Study||20
8531341|NCT00315146|21031492|P2|COMPLETED|Overall Study||19
8531342|NCT00315146|21031493|P1|COMPLETED|Overall Study||20
8531343|NCT00315146|21031490|P4|STARTED|Overall Study||22
8531344|NCT00315146|21031491|P3|STARTED|Overall Study||22
8531345|NCT00315146|21031492|P2|STARTED|Overall Study||22
8531346|NCT00315146|21031493|P1|STARTED|Overall Study||22
8531347|NCT00315120|21031511|P4|NOT COMPLETED|Overall Study||0
8531348|NCT00315120|21031512|P3|NOT COMPLETED|Overall Study||0
8531349|NCT00315120|21031513|P2|NOT COMPLETED|Overall Study||0
8531350|NCT00315120|21031514|P1|NOT COMPLETED|Overall Study||0
8531351|NCT00315120|21031511|P4|COMPLETED|Overall Study||107
8531352|NCT00315120|21031512|P3|COMPLETED|Overall Study||115
8531353|NCT00315120|21031513|P2|COMPLETED|Overall Study||118
8531354|NCT00315120|21031514|P1|COMPLETED|Overall Study||115
8531355|NCT00315120|21031511|P4|STARTED|Overall Study||107
8531356|NCT00315120|21031512|P3|STARTED|Overall Study||115
8531357|NCT00315120|21031513|P2|STARTED|Overall Study||118
8531358|NCT00315120|21031514|P1|STARTED|Overall Study||115
8531359|NCT00315055|21031574|P2|NOT COMPLETED|Overall Study||5
8531360|NCT00315055|21031575|P1|NOT COMPLETED|Overall Study||3
8531361|NCT00315055|21031574|P2|COMPLETED|Overall Study||150
8531362|NCT00315055|21031575|P1|COMPLETED|Overall Study||152
8531363|NCT00315055|21031574|P2|STARTED|Overall Study||155
8531364|NCT00315055|21031575|P1|STARTED|Overall Study||155
8531365|NCT00314951|21031593|P2|NOT COMPLETED|Follow-up||34
8531366|NCT00314951|21031594|P1|NOT COMPLETED|Follow-up||44
8531367|NCT00314951|21031593|P2|COMPLETED|Follow-up||255
8531368|NCT00314951|21031594|P1|COMPLETED|Follow-up||263
8531369|NCT00314951|21031593|P2|STARTED|Follow-up||289
8531370|NCT00314951|21031594|P1|STARTED|Follow-up||307
8531371|NCT00314951|21031593|P2|NOT COMPLETED|Treatment||11
8531372|NCT00314951|21031594|P1|NOT COMPLETED|Treatment||16
8531373|NCT00314951|21031593|P2|COMPLETED|Treatment||289
8531374|NCT00314951|21031594|P1|COMPLETED|Treatment||307
8531375|NCT00314951|21031593|P2|STARTED|Treatment||300
8531376|NCT00314951|21031594|P1|STARTED|Treatment||323
8531377|NCT00314951|21031593|P2|NOT COMPLETED|Enrollment||6
8531378|NCT00314951|21031594|P1|NOT COMPLETED|Enrollment||0
8531379|NCT00314951|21031593|P2|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
8531380|NCT00314951|21031594|P1|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
8531381|NCT00314951|21031593|P2|STARTED|Enrollment||306
8531382|NCT00314951|21031594|P1|STARTED|Enrollment||323
8531383|NCT00314808|21031604|P1|NOT COMPLETED|Overall Study||8
8531384|NCT00314808|21031604|P1|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
8531385|NCT00314808|21031604|P1|STARTED|Overall Study||33
8531386|NCT00314795|21031612|P1|NOT COMPLETED|Overall Study||20
8531387|NCT00314795|21031612|P1|COMPLETED|Overall Study||2
8531388|NCT00314795|21031612|P1|STARTED|Overall Study||22
8531389|NCT00314574|21031622|P2|NOT COMPLETED|Overall Study||83
8531390|NCT00314574|21031623|P1|NOT COMPLETED|Overall Study||94
8531391|NCT00314574|21031622|P2|COMPLETED|Overall Study||344
8531392|NCT00314574|21031623|P1|COMPLETED|Overall Study||329
8531393|NCT00314574|21031622|P2|Safety Population|Overall Study||428
8531394|NCT00314574|21031623|P1|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
8531395|NCT00314574|21031622|P2|Received at Least One Dose of Study Drug|Overall Study||427
8531396|NCT00314574|21031623|P1|Received at Least One Dose of Study Drug|Overall Study||421
8531397|NCT00314574|21031622|P2|STARTED|Overall Study||427
8531398|NCT00314574|21031623|P1|STARTED|Overall Study||423
8531405|NCT00314353|21031670|P2|NOT COMPLETED|Follow-up||0
8531406|NCT00314353|21031671|P1|NOT COMPLETED|Follow-up||0
8531407|NCT00314353|21031670|P2|COMPLETED|Follow-up||0
8531408|NCT00314353|21031671|P1|COMPLETED|Follow-up||3
8531409|NCT00314353|21031670|P2|STARTED|Follow-up||0
8531410|NCT00314353|21031671|P1|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
8531411|NCT00314353|21031670|P2|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
8531412|NCT00314353|21031671|P1|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
8531413|NCT00314353|21031670|P2|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
8531414|NCT00314353|21031671|P1|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
8531415|NCT00314353|21031670|P2|STARTED|Protocol Therapy (8 Cycles)||3
8531416|NCT00314353|21031671|P1|STARTED|Protocol Therapy (8 Cycles)||4
8531417|NCT00314340|21031685|P1|NOT COMPLETED|Overall Study||1
8531418|NCT00314340|21031685|P1|COMPLETED|Overall Study||11
8531419|NCT00314340|21031685|P1|Placebo|Overall Study||12
8531420|NCT00314340|21031685|P1|Hydrocodone Plus APAP|Overall Study||12
8531421|NCT00314340|21031685|P1|ER Morphine|Overall Study||11
8531422|NCT00314340|21031685|P1|STARTED|Overall Study||12
8531423|NCT00314327|21031691|P1|NOT COMPLETED|Overall Study||1
8531424|NCT00314327|21031691|P1|COMPLETED|Overall Study||0
8531425|NCT00314327|21031691|P1|STARTED|Overall Study||1
8531426|NCT00314262|21031696|P1|NOT COMPLETED|Overall Study||5
8531427|NCT00314262|21031696|P1|COMPLETED|Overall Study||7
8531428|NCT00314262|21031696|P1|STARTED|Overall Study||12
8531429|NCT00314249|21031704|P2|NOT COMPLETED|Overall Study||163
8531430|NCT00314249|21031705|P1|NOT COMPLETED|Overall Study||152
8531431|NCT00314249|21031704|P2|COMPLETED|Overall Study||353
8531432|NCT00314249|21031705|P1|COMPLETED|Overall Study||357
8531433|NCT00314249|21031704|P2|STARTED|Overall Study||516
8531434|NCT00314249|21031705|P1|STARTED|Overall Study||509
8531435|NCT00314236|21031723|P2|NOT COMPLETED|Overall Study||2
8531436|NCT00314236|21031724|P1|NOT COMPLETED|Overall Study||0
8531437|NCT00314236|21031723|P2|COMPLETED|Overall Study||37
8531438|NCT00314236|21031724|P1|COMPLETED|Overall Study||41
8531439|NCT00314236|21031723|P2|STARTED|Overall Study||39
8531440|NCT00314236|21031724|P1|STARTED|Overall Study||41
8531441|NCT00314145|21031738|P2|NOT COMPLETED|Overall Study||29
8531442|NCT00314145|21031739|P1|NOT COMPLETED|Overall Study||21
8531443|NCT00314145|21031738|P2|COMPLETED|Overall Study||381
8531444|NCT00314145|21031739|P1|COMPLETED|Overall Study||389
8531445|NCT00314145|21031738|P2|STARTED|Overall Study||410
8531446|NCT00314145|21031739|P1|STARTED|Overall Study||410
8531447|NCT00314132|21031753|P2|NOT COMPLETED|Overall Study||18
8531448|NCT00314132|21031754|P1|NOT COMPLETED|Overall Study||8
8531449|NCT00314132|21031753|P2|COMPLETED|Overall Study||1583
8531450|NCT00314132|21031754|P1|COMPLETED|Overall Study||395
8531451|NCT00314132|21031753|P2|STARTED|Overall Study||1601
8531452|NCT00314132|21031754|P1|STARTED|Overall Study||403
8531453|NCT00314106|21031764|P2|NOT COMPLETED|Overall Study||0
8531454|NCT00314106|21031765|P1|NOT COMPLETED|Overall Study||0
8531455|NCT00314106|21031764|P2|COMPLETED|Overall Study||8
8531456|NCT00314106|21031765|P1|COMPLETED|Overall Study||18
8531457|NCT00314106|21031764|P2|STARTED|Overall Study||8
8531458|NCT00314106|21031765|P1|STARTED|Overall Study||18
8531459|NCT00314093|21031773|P1|NOT COMPLETED|Overall Study||0
8531460|NCT00314093|21031773|P1|COMPLETED|Overall Study||0
8531461|NCT00314093|21031773|P1|STARTED|Overall Study||0
8531462|NCT00313911|21031781|P2|NOT COMPLETED|Overall Study||41
8531463|NCT00313911|21031782|P1|NOT COMPLETED|Overall Study||94
8531464|NCT00313911|21031781|P2|COMPLETED|Overall Study||670
8531465|NCT00313911|21031782|P1|COMPLETED|Overall Study||1328
8531466|NCT00313911|21031781|P2|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
8531467|NCT00313911|21031782|P1|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
8531468|NCT00313846|21031796|P2|NOT COMPLETED|Overall Study||11
8531469|NCT00313846|21031797|P1|NOT COMPLETED|Overall Study||5
8531470|NCT00313846|21031796|P2|COMPLETED|Overall Study||153
8531471|NCT00313846|21031797|P1|COMPLETED|Overall Study||157
8531472|NCT00313846|21031796|P2|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
8531473|NCT00313846|21031797|P1|STARTED|Overall Study||162
8531486|NCT00313781|21031847|P3|NOT COMPLETED|After Crossover||27
8531487|NCT00313781|21031848|P2|NOT COMPLETED|After Crossover||0
8531488|NCT00313781|21031849|P1|NOT COMPLETED|After Crossover||0
8531489|NCT00313781|21031847|P3|COMPLETED|After Crossover||10
8531490|NCT00313781|21031848|P2|COMPLETED|After Crossover||0
8531491|NCT00313781|21031849|P1|COMPLETED|After Crossover||0
8531492|NCT00313781|21031847|P3|STARTED|After Crossover||37
8531493|NCT00313781|21031848|P2|STARTED|After Crossover||0
8531494|NCT00313781|21031849|P1|STARTED|After Crossover||0
8531495|NCT00313781|21031847|P3|NOT COMPLETED|Before Crossover||0
8531496|NCT00313781|21031848|P2|NOT COMPLETED|Before Crossover||79
8531497|NCT00313781|21031849|P1|NOT COMPLETED|Before Crossover||75
8531498|NCT00313781|21031847|P3|COMPLETED|Before Crossover||0
8531499|NCT00313781|21031848|P2|COMPLETED|Before Crossover||23
8531500|NCT00313781|21031849|P1|COMPLETED|Before Crossover||27
8531501|NCT00313781|21031847|P3|Treated|Before Crossover||0
8531502|NCT00313781|21031848|P2|Treated|Before Crossover||102
8531503|NCT00313781|21031849|P1|Treated|Before Crossover||97
8531504|NCT00313781|21031847|P3|STARTED|Before Crossover||0
8531505|NCT00313781|21031848|P2|STARTED|Before Crossover||102
8531506|NCT00313781|21031849|P1|STARTED|Before Crossover||102
8531507|NCT00313729|21031883|P1|NOT COMPLETED|Overall Study||0
8531508|NCT00313729|21031883|P1|COMPLETED|Overall Study||120
8531509|NCT00313729|21031883|P1|STARTED|Overall Study||120
8531510|NCT00313716|21031895|P6|NOT COMPLETED|Overall Study||13
8531511|NCT00313716|21031896|P5|NOT COMPLETED|Overall Study||6
8531512|NCT00313716|21031897|P4|NOT COMPLETED|Overall Study||4
8531513|NCT00313716|21031898|P3|NOT COMPLETED|Overall Study||12
8531514|NCT00313716|21031899|P2|NOT COMPLETED|Overall Study||8
8531515|NCT00313716|21031900|P1|NOT COMPLETED|Overall Study||5
8531516|NCT00313716|21031895|P6|COMPLETED|Overall Study||35
8531517|NCT00313716|21031896|P5|COMPLETED|Overall Study||27
8531518|NCT00313716|21031897|P4|COMPLETED|Overall Study||16
8531519|NCT00313716|21031898|P3|COMPLETED|Overall Study||38
8531520|NCT00313716|21031899|P2|COMPLETED|Overall Study||23
8531521|NCT00313716|21031900|P1|COMPLETED|Overall Study||13
8531522|NCT00313716|21031895|P6|STARTED|Overall Study||48
8531523|NCT00313716|21031896|P5|STARTED|Overall Study||33
8531524|NCT00313716|21031897|P4|STARTED|Overall Study||20
8531525|NCT00313716|21031898|P3|STARTED|Overall Study||50
8531526|NCT00313716|21031899|P2|STARTED|Overall Study||31
8531527|NCT00313716|21031900|P1|STARTED|Overall Study||18
8531528|NCT00313703|21031927|P4|NOT COMPLETED|Overall Study||12
8531529|NCT00313703|21031928|P3|NOT COMPLETED|Overall Study||5
8531530|NCT00313703|21031929|P2|NOT COMPLETED|Overall Study||2
8531531|NCT00313703|21031930|P1|NOT COMPLETED|Overall Study||11
8531532|NCT00313703|21031927|P4|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
8531533|NCT00313703|21031928|P3|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
8531534|NCT00313703|21031929|P2|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
8531535|NCT00313703|21031930|P1|COMPLETED|Overall Study|Some subjects lost to follow-up|175
8531536|NCT00313703|21031927|P4|STARTED|Overall Study||12
8531537|NCT00313703|21031928|P3|STARTED|Overall Study||77
8531538|NCT00313703|21031929|P2|STARTED|Overall Study||34
8531539|NCT00313703|21031930|P1|STARTED|Overall Study||186
8531540|NCT00313612|21031946|P2|NOT COMPLETED|Overall Study||1
8531541|NCT00313612|21031947|P1|NOT COMPLETED|Overall Study||0
8531542|NCT00313612|21031946|P2|COMPLETED|Overall Study||19
8531543|NCT00313612|21031947|P1|COMPLETED|Overall Study||19
8531544|NCT00313612|21031946|P2|STARTED|Overall Study||20
8531545|NCT00313612|21031947|P1|STARTED|Overall Study||19
8531546|NCT00313586|21031959|P4|NOT COMPLETED|Overall Study||23
8531547|NCT00313586|21031960|P3|NOT COMPLETED|Overall Study||24
8531548|NCT00313586|21031961|P2|NOT COMPLETED|Overall Study||70
8531549|NCT00313586|21031962|P1|NOT COMPLETED|Overall Study||70
8531550|NCT00313586|21031959|P4|COMPLETED|Overall Study||0
8531551|NCT00313586|21031960|P3|COMPLETED|Overall Study||0
8531552|NCT00313586|21031961|P2|COMPLETED|Overall Study||5
8531553|NCT00313586|21031962|P1|COMPLETED|Overall Study||5
8531554|NCT00313586|21031959|P4|Treated|Overall Study||23
8531555|NCT00313586|21031960|P3|Treated|Overall Study||24
8531556|NCT00313586|21031961|P2|Treated|Overall Study||75
8531557|NCT00313586|21031962|P1|Treated|Overall Study||74
8531558|NCT00313586|21031959|P4|STARTED|Overall Study||23
8531559|NCT00313586|21031960|P3|STARTED|Overall Study||24
8531560|NCT00313586|21031961|P2|STARTED|Overall Study||75
8531561|NCT00313586|21031962|P1|STARTED|Overall Study||75
8531562|NCT00313560|21031970|P1|NOT COMPLETED|Overall Study||0
8531563|NCT00313560|21031970|P1|COMPLETED|Overall Study||48
8531564|NCT00313560|21031970|P1|STARTED|Overall Study||48
8531565|NCT00313443|21031979|P1|NOT COMPLETED|Overall Study||0
8531566|NCT00313443|21031979|P1|COMPLETED|Overall Study||30
8531567|NCT00313443|21031979|P1|STARTED|Overall Study||30
8531568|NCT00313313|21031990|P3|NOT COMPLETED|Overall Study||82
8531569|NCT00313313|21031991|P2|NOT COMPLETED|Overall Study||66
8531570|NCT00313313|21031992|P1|NOT COMPLETED|Overall Study||63
8531571|NCT00313313|21031990|P3|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
8531572|NCT00313313|21031991|P2|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
8531573|NCT00313313|21031992|P1|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
8531574|NCT00313313|21031990|P3|STARTED|Overall Study||267
8531575|NCT00313313|21031991|P2|STARTED|Overall Study||253
8531576|NCT00313313|21031992|P1|STARTED|Overall Study||248
8531577|NCT00313300|21032014|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
8531578|NCT00313300|21032015|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
8531579|NCT00313300|21032016|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
8531580|NCT00313300|21032017|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
8531581|NCT00313300|21032018|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
8531582|NCT00313300|21032014|P5|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
8531583|NCT00313300|21032015|P4|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
8531584|NCT00313300|21032016|P3|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
8531585|NCT00313300|21032017|P2|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
8531586|NCT00313300|21032018|P1|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
8531587|NCT00313300|21032014|P5|STARTED|Follow-Up(30days)-Randomized Phase B||201
8531588|NCT00313300|21032015|P4|STARTED|Follow-Up(30days)-Randomized Phase B||222
8531589|NCT00313300|21032016|P3|STARTED|Follow-Up(30days)-Randomized Phase B||119
8531590|NCT00313300|21032017|P2|STARTED|Follow-Up(30days)-Randomized Phase B||123
8531591|NCT00313300|21032018|P1|STARTED|Follow-Up(30days)-Randomized Phase B||383
8531592|NCT00313300|21032014|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
8531593|NCT00313300|21032015|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
8531594|NCT00313300|21032016|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
8531595|NCT00313300|21032017|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
8531596|NCT00313300|21032018|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
8531597|NCT00313300|21032014|P5|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
8531598|NCT00313300|21032015|P4|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
8531599|NCT00313300|21032016|P3|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
8531600|NCT00313300|21032017|P2|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
8531601|NCT00313300|21032018|P1|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
8531602|NCT00313300|21032014|P5|STARTED|Follow-Up(30days)-Randomized Phase A||0
8531603|NCT00313300|21032015|P4|STARTED|Follow-Up(30days)-Randomized Phase A||0
8531604|NCT00313300|21032016|P3|STARTED|Follow-Up(30days)-Randomized Phase A||174
8531605|NCT00313300|21032017|P2|STARTED|Follow-Up(30days)-Randomized Phase A||162
8531606|NCT00313300|21032018|P1|STARTED|Follow-Up(30days)-Randomized Phase A||163
8531607|NCT00313300|21032014|P5|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
8531608|NCT00313300|21032015|P4|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
8531609|NCT00313300|21032016|P3|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
8531610|NCT00313300|21032017|P2|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
8531611|NCT00313300|21032018|P1|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
8531612|NCT00313300|21032014|P5|COMPLETED|Randomized in Phase B (26 Weeks)||13
8531613|NCT00313300|21032015|P4|COMPLETED|Randomized in Phase B (26 Weeks)||15
8531614|NCT00313300|21032016|P3|COMPLETED|Randomized in Phase B (26 Weeks)||94
8531615|NCT00313300|21032017|P2|COMPLETED|Randomized in Phase B (26 Weeks)||105
8531616|NCT00313300|21032018|P1|COMPLETED|Randomized in Phase B (26 Weeks)||333
8531617|NCT00313300|21032014|P5|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
8531618|NCT00313300|21032015|P4|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
8531619|NCT00313300|21032016|P3|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
8531620|NCT00313300|21032017|P2|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
8531621|NCT00313300|21032018|P1|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
8531622|NCT00313300|21032014|P5|STARTED|Randomized in Phase B (26 Weeks)||221
8531623|NCT00313300|21032015|P4|STARTED|Randomized in Phase B (26 Weeks)||248
8531624|NCT00313300|21032016|P3|STARTED|Randomized in Phase B (26 Weeks)||134
8531625|NCT00313300|21032017|P2|STARTED|Randomized in Phase B (26 Weeks)||138
8531626|NCT00313300|21032018|P1|STARTED|Randomized in Phase B (26 Weeks)||427
8531627|NCT00313300|21032014|P5|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
8531628|NCT00313300|21032015|P4|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
8531629|NCT00313300|21032016|P3|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
8531630|NCT00313300|21032017|P2|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
8531631|NCT00313300|21032018|P1|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
8531632|NCT00313300|21032014|P5|COMPLETED|Randomized in Phase A (26 Weeks)||0
8531633|NCT00313300|21032015|P4|COMPLETED|Randomized in Phase A (26 Weeks)||0
8531634|NCT00313300|21032016|P3|COMPLETED|Randomized in Phase A (26 Weeks)||149
8531635|NCT00313300|21032017|P2|COMPLETED|Randomized in Phase A (26 Weeks)||140
8531636|NCT00313300|21032018|P1|COMPLETED|Randomized in Phase A (26 Weeks)||130
8531637|NCT00313300|21032014|P5|STARTED|Randomized in Phase A (26 Weeks)||0
8531638|NCT00313300|21032015|P4|STARTED|Randomized in Phase A (26 Weeks)||0
8531639|NCT00313300|21032016|P3|STARTED|Randomized in Phase A (26 Weeks)||184
8531640|NCT00313300|21032017|P2|STARTED|Randomized in Phase A (26 Weeks)||179
8531641|NCT00313300|21032018|P1|STARTED|Randomized in Phase A (26 Weeks)||184
8531642|NCT00313209|21032070|P2|NOT COMPLETED|Overall Study||82
8531643|NCT00313209|21032071|P1|NOT COMPLETED|Overall Study||107
8531644|NCT00313209|21032070|P2|COMPLETED|Overall Study||385
8531645|NCT00313209|21032071|P1|COMPLETED|Overall Study||359
8531646|NCT00313209|21032070|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
8531647|NCT00313209|21032071|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
8531648|NCT00313170|21032088|P3|NOT COMPLETED|Overall Study||32
8531649|NCT00313170|21032089|P2|NOT COMPLETED|Overall Study||34
8531650|NCT00313170|21032090|P1|NOT COMPLETED|Overall Study||36
8531651|NCT00313170|21032088|P3|COMPLETED|Overall Study||14
8531652|NCT00313170|21032089|P2|COMPLETED|Overall Study||17
8531653|NCT00313170|21032090|P1|COMPLETED|Overall Study||11
8531654|NCT00313170|21032088|P3|STARTED|Overall Study||46
8531655|NCT00313170|21032089|P2|STARTED|Overall Study||51
8531656|NCT00313170|21032090|P1|STARTED|Overall Study||47
8531660|NCT00313014|21032196|P3|NOT COMPLETED|Overall Study||61
8531661|NCT00313014|21032197|P2|NOT COMPLETED|Overall Study||73
8531662|NCT00313014|21032198|P1|NOT COMPLETED|Overall Study||93
8531663|NCT00313014|21032196|P3|COMPLETED|Overall Study||159
8531664|NCT00313014|21032197|P2|COMPLETED|Overall Study||146
8531665|NCT00313014|21032198|P1|COMPLETED|Overall Study||128
8531666|NCT00313014|21032196|P3|STARTED|Overall Study||220
8531667|NCT00313014|21032197|P2|STARTED|Overall Study||219
8531668|NCT00313014|21032198|P1|STARTED|Overall Study||221
8531669|NCT00312923|21032218|P2|NOT COMPLETED|Overall Study||6
8531670|NCT00312923|21032219|P1|NOT COMPLETED|Overall Study||9
8531671|NCT00312923|21032218|P2|COMPLETED|Overall Study||20
8531672|NCT00312923|21032219|P1|COMPLETED|Overall Study||19
8531673|NCT00312923|21032218|P2|STARTED|Overall Study||26
8531674|NCT00312923|21032219|P1|STARTED|Overall Study||28
8531675|NCT00312897|21032229|P2|NOT COMPLETED|Overall Study||6
8531676|NCT00312897|21032230|P1|NOT COMPLETED|Overall Study||6
8531677|NCT00312897|21032229|P2|COMPLETED|Overall Study||18
8531678|NCT00312897|21032230|P1|COMPLETED|Overall Study||21
8531679|NCT00312897|21032229|P2|STARTED|Overall Study||24
8531680|NCT00312897|21032230|P1|STARTED|Overall Study||27
8531681|NCT00312884|21032240|P2|NOT COMPLETED|Overall Study||12
8531682|NCT00312884|21032241|P1|NOT COMPLETED|Overall Study||17
8531683|NCT00312884|21032240|P2|COMPLETED|Overall Study||79
8531684|NCT00312884|21032241|P1|COMPLETED|Overall Study||74
8531685|NCT00312884|21032240|P2|STARTED|Overall Study||91
8531686|NCT00312884|21032241|P1|STARTED|Overall Study||91
8531687|NCT00312858|21032255|P2|NOT COMPLETED|Overall Study||93
8531688|NCT00312858|21032256|P1|NOT COMPLETED|Overall Study||68
8531689|NCT00312858|21032255|P2|COMPLETED|Overall Study||230
8531690|NCT00312858|21032256|P1|COMPLETED|Overall Study||262
8531691|NCT00312858|21032255|P2|Visit 4|Overall Study||240
8531692|NCT00312858|21032256|P1|Visit 4|Overall Study||262
8531693|NCT00312858|21032255|P2|Visit 3|Overall Study||261
8531694|NCT00312858|21032256|P1|Visit 3|Overall Study||273
8531695|NCT00312858|21032255|P2|Visit 2|Overall Study||294
8531696|NCT00312858|21032256|P1|Visit 2|Overall Study||305
8531697|NCT00312858|21032255|P2|Visit 1|Overall Study||323
8531698|NCT00312858|21032256|P1|Visit 1|Overall Study||330
8531699|NCT00312858|21032255|P2|STARTED|Overall Study||323
8531700|NCT00312858|21032256|P1|STARTED|Overall Study||330
8531701|NCT00312845|21032310|P2|NOT COMPLETED|Overall Study||95
8531702|NCT00312845|21032311|P1|NOT COMPLETED|Overall Study||99
8531703|NCT00312845|21032310|P2|COMPLETED|Overall Study||245
8531704|NCT00312845|21032311|P1|COMPLETED|Overall Study||237
8531705|NCT00312845|21032310|P2|STARTED|Overall Study||340
8531706|NCT00312845|21032311|P1|STARTED|Overall Study||336
8531707|NCT00312728|21032319|P1|NOT COMPLETED|Overall Study||110
8531708|NCT00312728|21032319|P1|COMPLETED|Overall Study||5
8531709|NCT00312728|21032319|P1|STARTED|Overall Study||115
8531710|NCT00312702|21032331|P3|NOT COMPLETED|Challenge Phase||0
8531711|NCT00312702|21032332|P2|NOT COMPLETED|Challenge Phase||0
8531712|NCT00312702|21032333|P1|NOT COMPLETED|Challenge Phase||0
8531713|NCT00312702|21032331|P3|COMPLETED|Challenge Phase||1
8531714|NCT00312702|21032332|P2|COMPLETED|Challenge Phase||12
8531715|NCT00312702|21032333|P1|COMPLETED|Challenge Phase||0
8531716|NCT00312702|21032331|P3|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
8531717|NCT00312702|21032332|P2|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
8531891|NCT00310856|21032754|P2|NOT COMPLETED|Overall Study||5
8531718|NCT00312702|21032333|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
8531719|NCT00312702|21032331|P3|NOT COMPLETED|Immunization Phase||0
8531720|NCT00312702|21032332|P2|NOT COMPLETED|Immunization Phase||1
8531721|NCT00312702|21032333|P1|NOT COMPLETED|Immunization Phase||0
8531722|NCT00312702|21032331|P3|COMPLETED|Immunization Phase||0
8531723|NCT00312702|21032332|P2|COMPLETED|Immunization Phase||12
8531724|NCT00312702|21032333|P1|COMPLETED|Immunization Phase||5
8531725|NCT00312702|21032331|P3|STARTED|Immunization Phase||0
8531726|NCT00312702|21032332|P2|STARTED|Immunization Phase||13
8531727|NCT00312702|21032333|P1|STARTED|Immunization Phase||5
8531728|NCT00312663|21032346|P3|NOT COMPLETED|Challenge Phase||0
8531729|NCT00312663|21032347|P2|NOT COMPLETED|Challenge Phase||0
8531730|NCT00312663|21032348|P1|NOT COMPLETED|Challenge Phase||0
8531731|NCT00312663|21032346|P3|COMPLETED|Challenge Phase||6
8531732|NCT00312663|21032347|P2|COMPLETED|Challenge Phase||10
8531733|NCT00312663|21032348|P1|COMPLETED|Challenge Phase||0
8531734|NCT00312663|21032346|P3|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
8531735|NCT00312663|21032347|P2|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
8531736|NCT00312663|21032348|P1|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
8531737|NCT00312663|21032346|P3|NOT COMPLETED|Immunization Phase||0
8531738|NCT00312663|21032347|P2|NOT COMPLETED|Immunization Phase||1
8531739|NCT00312663|21032348|P1|NOT COMPLETED|Immunization Phase||0
8531740|NCT00312663|21032346|P3|COMPLETED|Immunization Phase||0
8531741|NCT00312663|21032347|P2|COMPLETED|Immunization Phase||12
8531742|NCT00312663|21032348|P1|COMPLETED|Immunization Phase||5
8531743|NCT00312663|21032346|P3|STARTED|Immunization Phase||0
8531744|NCT00312663|21032347|P2|STARTED|Immunization Phase||13
8531745|NCT00312663|21032348|P1|STARTED|Immunization Phase||5
8531746|NCT00312572|21032361|P2|NOT COMPLETED|Overall Study||21
8531747|NCT00312572|21032362|P1|NOT COMPLETED|Overall Study||16
8531748|NCT00312572|21032361|P2|COMPLETED|Overall Study||82
8531749|NCT00312572|21032362|P1|COMPLETED|Overall Study||85
8531750|NCT00312572|21032361|P2|STARTED|Overall Study||103
8531751|NCT00312572|21032362|P1|STARTED|Overall Study||101
8531764|NCT00312377|21032409|P2|NOT COMPLETED|Overall Study||668
8531765|NCT00312377|21032410|P1|NOT COMPLETED|Overall Study||644
8531766|NCT00312377|21032409|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
8531767|NCT00312377|21032410|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
8531768|NCT00312377|21032409|P2|STARTED|Overall Study|randomised patients|697
8531769|NCT00312377|21032410|P1|STARTED|Overall Study|randomised patients|694
8531770|NCT00312338|21032434|P2|NOT COMPLETED|Overall Study||3
8531771|NCT00312338|21032435|P1|NOT COMPLETED|Overall Study||22
8531772|NCT00312338|21032434|P2|COMPLETED|Overall Study||54
8531773|NCT00312338|21032435|P1|COMPLETED|Overall Study||83
8531774|NCT00312338|21032434|P2|STARTED|Overall Study||57
8531775|NCT00312338|21032435|P1|STARTED|Overall Study||105
8531776|NCT00312221|21032448|P4|NOT COMPLETED|Double-blind Phase||70
8531777|NCT00312221|21032449|P3|NOT COMPLETED|Double-blind Phase||72
8531778|NCT00312221|21032450|P2|NOT COMPLETED|Double-blind Phase||59
8531779|NCT00312221|21032451|P1|NOT COMPLETED|Double-blind Phase||0
8531780|NCT00312221|21032448|P4|COMPLETED|Double-blind Phase||63
8531781|NCT00312221|21032449|P3|COMPLETED|Double-blind Phase||77
8531782|NCT00312221|21032450|P2|COMPLETED|Double-blind Phase||77
8531783|NCT00312221|21032451|P1|COMPLETED|Double-blind Phase||0
8531784|NCT00312221|21032448|P4|STARTED|Double-blind Phase||133
8531785|NCT00312221|21032449|P3|STARTED|Double-blind Phase||149
8531786|NCT00312221|21032450|P2|STARTED|Double-blind Phase||136
8531787|NCT00312221|21032451|P1|STARTED|Double-blind Phase||0
8531788|NCT00312221|21032448|P4|NOT COMPLETED|Open-label Run-in Period||0
8531789|NCT00312221|21032449|P3|NOT COMPLETED|Open-label Run-in Period||0
8531790|NCT00312221|21032450|P2|NOT COMPLETED|Open-label Run-in Period||0
8531791|NCT00312221|21032451|P1|NOT COMPLETED|Open-label Run-in Period||234
8531792|NCT00312221|21032448|P4|COMPLETED|Open-label Run-in Period||0
8531793|NCT00312221|21032449|P3|COMPLETED|Open-label Run-in Period||0
8531794|NCT00312221|21032450|P2|COMPLETED|Open-label Run-in Period||0
8531795|NCT00312221|21032451|P1|COMPLETED|Open-label Run-in Period||418
8531796|NCT00312221|21032448|P4|STARTED|Open-label Run-in Period||0
8531797|NCT00312221|21032449|P3|STARTED|Open-label Run-in Period||0
8531798|NCT00312221|21032450|P2|STARTED|Open-label Run-in Period||0
8531799|NCT00312221|21032451|P1|STARTED|Open-label Run-in Period||652
8531800|NCT00312208|21032471|P2|NOT COMPLETED|Overall Study||123
8531801|NCT00312208|21032472|P1|NOT COMPLETED|Overall Study||172
8531802|NCT00312208|21032471|P2|COMPLETED|Overall Study||1526
8531803|NCT00312208|21032472|P1|COMPLETED|Overall Study||1477
8531804|NCT00312208|21032471|P2|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
8531805|NCT00312208|21032472|P1|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
8531806|NCT00312195|21032482|P2|NOT COMPLETED|Overall Study||6
8531807|NCT00312195|21032483|P1|NOT COMPLETED|Overall Study||6
8531808|NCT00312195|21032482|P2|COMPLETED|Overall Study||123
8531809|NCT00312195|21032483|P1|COMPLETED|Overall Study||132
8531810|NCT00312195|21032482|P2|STARTED|Overall Study||129
8531811|NCT00312195|21032483|P1|STARTED|Overall Study||138
8531812|NCT00311766|21032499|P2|NOT COMPLETED|Overall Study||5
8531813|NCT00311766|21032500|P1|NOT COMPLETED|Overall Study||0
8531814|NCT00311766|21032499|P2|COMPLETED|Overall Study||17
8531815|NCT00311766|21032500|P1|COMPLETED|Overall Study||8
8531816|NCT00311766|21032499|P2|STARTED|Overall Study||22
8531817|NCT00311766|21032500|P1|STARTED|Overall Study||8
8531818|NCT00311623|21032511|P3|NOT COMPLETED|Overall Study||2
8531819|NCT00311623|21032512|P2|NOT COMPLETED|Overall Study||0
8531820|NCT00311623|21032513|P1|NOT COMPLETED|Overall Study||0
8531821|NCT00311623|21032511|P3|COMPLETED|Overall Study||0
8531822|NCT00311623|21032512|P2|COMPLETED|Overall Study||20
8531823|NCT00311623|21032513|P1|COMPLETED|Overall Study||10
8531824|NCT00311623|21032511|P3|STARTED|Overall Study||2
8531825|NCT00311623|21032512|P2|STARTED|Overall Study||20
8531826|NCT00311623|21032513|P1|STARTED|Overall Study||10
8531827|NCT00311584|21032555|P2|NOT COMPLETED|Overall Study||23
8531828|NCT00311584|21032556|P1|NOT COMPLETED|Overall Study||20
8531829|NCT00311584|21032555|P2|COMPLETED|Overall Study||7
8531830|NCT00311584|21032556|P1|COMPLETED|Overall Study||9
8531831|NCT00311584|21032555|P2|STARTED|Overall Study||30
8531832|NCT00311584|21032556|P1|STARTED|Overall Study||29
8531833|NCT00311402|21032564|P2|NOT COMPLETED|Overall Study||177
8531834|NCT00311402|21032565|P1|NOT COMPLETED|Overall Study||210
8531835|NCT00311402|21032564|P2|COMPLETED|Overall Study||462
8531836|NCT00311402|21032565|P1|COMPLETED|Overall Study||445
8531837|NCT00311402|21032564|P2|STARTED|Overall Study||639
8531838|NCT00311402|21032565|P1|STARTED|Overall Study||655
8531839|NCT00311376|21032592|P3|NOT COMPLETED|Treatment Cycle 2||0
8531840|NCT00311376|21032593|P2|NOT COMPLETED|Treatment Cycle 2||13
8531841|NCT00311376|21032594|P1|NOT COMPLETED|Treatment Cycle 2||9
8531842|NCT00311376|21032592|P3|COMPLETED|Treatment Cycle 2||0
8531843|NCT00311376|21032593|P2|COMPLETED|Treatment Cycle 2||112
8531844|NCT00311376|21032594|P1|COMPLETED|Treatment Cycle 2||106
8531845|NCT00311376|21032592|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
8531846|NCT00311376|21032593|P2|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
8531847|NCT00311376|21032594|P1|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
8531848|NCT00311376|21032592|P3|NOT COMPLETED|Treatment Cycle 1||17
8531849|NCT00311376|21032593|P2|NOT COMPLETED|Treatment Cycle 1||17
8531850|NCT00311376|21032594|P1|NOT COMPLETED|Treatment Cycle 1||27
8531851|NCT00311376|21032592|P3|COMPLETED|Treatment Cycle 1||132
8531852|NCT00311376|21032593|P2|COMPLETED|Treatment Cycle 1||118
8531853|NCT00311376|21032594|P1|COMPLETED|Treatment Cycle 1||105
8531854|NCT00311376|21032592|P3|STARTED|Treatment Cycle 1||149
8531855|NCT00311376|21032593|P2|STARTED|Treatment Cycle 1||135
8531856|NCT00311376|21032594|P1|STARTED|Treatment Cycle 1||132
8531857|NCT00311363|21032614|P3|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
8531858|NCT00311363|21032615|P2|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
8531859|NCT00311363|21032616|P1|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
8531860|NCT00311363|21032614|P3|COMPLETED|12-Week Double-Blind Treatment Period||84
8531861|NCT00311363|21032615|P2|COMPLETED|12-Week Double-Blind Treatment Period||84
8531862|NCT00311363|21032616|P1|COMPLETED|12-Week Double-Blind Treatment Period||0
8531863|NCT00311363|21032614|P3|STARTED|12-Week Double-Blind Treatment Period||96
8531864|NCT00311363|21032615|P2|STARTED|12-Week Double-Blind Treatment Period||98
8531865|NCT00311363|21032616|P1|STARTED|12-Week Double-Blind Treatment Period||0
8531866|NCT00311363|21032614|P3|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
8531867|NCT00311363|21032615|P2|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
8531868|NCT00311363|21032616|P1|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
8531869|NCT00311363|21032614|P3|COMPLETED|24-Week Single-Blind Treatment Period||0
8531870|NCT00311363|21032615|P2|COMPLETED|24-Week Single-Blind Treatment Period||0
8531871|NCT00311363|21032616|P1|COMPLETED|24-Week Single-Blind Treatment Period||221
8531872|NCT00311363|21032614|P3|STARTED|24-Week Single-Blind Treatment Period||0
8531873|NCT00311363|21032615|P2|STARTED|24-Week Single-Blind Treatment Period||0
8531874|NCT00311363|21032616|P1|STARTED|24-Week Single-Blind Treatment Period||327
8531875|NCT00311311|21032676|P2|NOT COMPLETED|Overall Study||9
8531876|NCT00311311|21032677|P1|NOT COMPLETED|Overall Study||8
8531877|NCT00311311|21032676|P2|COMPLETED|Overall Study||26
8531878|NCT00311311|21032677|P1|COMPLETED|Overall Study||29
8531879|NCT00311311|21032676|P2|STARTED|Overall Study||35
8531880|NCT00311311|21032677|P1|STARTED|Overall Study||37
8531881|NCT00311246|21032727|P1|NOT COMPLETED|Overall Study||0
8531882|NCT00311246|21032727|P1|COMPLETED|Overall Study||11
8531883|NCT00311246|21032727|P1|STARTED|Overall Study||11
8531884|NCT00311181|21032735|P1|NOT COMPLETED|Overall Study||96
8531885|NCT00311181|21032735|P1|COMPLETED|Overall Study||121
8531886|NCT00311181|21032735|P1|STARTED|Overall Study||217
8531887|NCT00311155|21032741|P1|NOT COMPLETED|Overall Study||93
8531888|NCT00311155|21032741|P1|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
8531889|NCT00311155|21032741|P1|STARTED|Overall Study||694
8531890|NCT00310856|21032753|P3|NOT COMPLETED|Overall Study||8
8531892|NCT00310856|21032755|P1|NOT COMPLETED|Overall Study||5
8531893|NCT00310856|21032753|P3|COMPLETED|Overall Study||42
8531894|NCT00310856|21032754|P2|COMPLETED|Overall Study||56
8531895|NCT00310856|21032755|P1|COMPLETED|Overall Study||59
8531896|NCT00310856|21032753|P3|STARTED|Overall Study||50
8531897|NCT00310856|21032754|P2|STARTED|Overall Study||61
8531898|NCT00310856|21032755|P1|STARTED|Overall Study||64
8531899|NCT00310817|21032779|P4|NOT COMPLETED|Overall Study||8
8531900|NCT00310817|21032780|P3|NOT COMPLETED|Overall Study||8
8531901|NCT00310817|21032781|P2|NOT COMPLETED|Overall Study||8
8531902|NCT00310817|21032782|P1|NOT COMPLETED|Overall Study||11
8531903|NCT00310817|21032779|P4|COMPLETED|Overall Study||74
8531904|NCT00310817|21032780|P3|COMPLETED|Overall Study||120
8531905|NCT00310817|21032781|P2|COMPLETED|Overall Study||198
8531906|NCT00310817|21032782|P1|COMPLETED|Overall Study||196
8531907|NCT00310817|21032779|P4|STARTED|Overall Study||82
8531908|NCT00310817|21032780|P3|STARTED|Overall Study||128
8531909|NCT00310817|21032781|P2|STARTED|Overall Study||206
8531910|NCT00310817|21032782|P1|STARTED|Overall Study||207
8531911|NCT00310804|21032870|P2|NOT COMPLETED|Overall Study||0
8531912|NCT00310804|21032871|P1|NOT COMPLETED|Overall Study||5
8531913|NCT00310804|21032870|P2|COMPLETED|Overall Study||171
8531914|NCT00310804|21032871|P1|COMPLETED|Overall Study||1024
8531915|NCT00310804|21032870|P2|STARTED|Overall Study||171
8531916|NCT00310804|21032871|P1|STARTED|Overall Study||1029
8531917|NCT00310791|21032906|P2|NOT COMPLETED|Overall Study||10
8531918|NCT00310791|21032907|P1|NOT COMPLETED|Overall Study||10
8531919|NCT00310791|21032906|P2|COMPLETED|Overall Study||30
8531920|NCT00310791|21032907|P1|COMPLETED|Overall Study||30
8531921|NCT00310791|21032906|P2|STARTED|Overall Study||40
8531922|NCT00310791|21032907|P1|STARTED|Overall Study||40
8531923|NCT00310466|21032915|P2|NOT COMPLETED|Overall Study||12
8531924|NCT00310466|21032916|P1|NOT COMPLETED|Overall Study||18
8531925|NCT00310466|21032915|P2|COMPLETED|Overall Study||101
8531926|NCT00310466|21032916|P1|COMPLETED|Overall Study||95
8531927|NCT00310466|21032915|P2|STARTED|Overall Study||113
8531928|NCT00310466|21032916|P1|STARTED|Overall Study||113
8531929|NCT00310440|21032930|P2|NOT COMPLETED|Overall Study||13
8531930|NCT00310440|21032931|P1|NOT COMPLETED|Overall Study||26
8531931|NCT00310440|21032930|P2|COMPLETED|Overall Study||141
8531932|NCT00310440|21032931|P1|COMPLETED|Overall Study||139
8531933|NCT00310440|21032930|P2|STARTED|Overall Study||154
8531934|NCT00310440|21032931|P1|STARTED|Overall Study||165
8531935|NCT00310427|21032957|P2|NOT COMPLETED|Overall Study||1
8531936|NCT00310427|21032958|P1|NOT COMPLETED|Overall Study||2
8531937|NCT00310427|21032957|P2|COMPLETED|Overall Study||25
8531938|NCT00310427|21032958|P1|COMPLETED|Overall Study||25
8531939|NCT00310427|21032957|P2|STARTED|Overall Study||26
8531940|NCT00310427|21032958|P1|STARTED|Overall Study||27
8531941|NCT00310401|21032980|P2|NOT COMPLETED|Overall Study||0
8531942|NCT00310401|21032981|P1|NOT COMPLETED|Overall Study||0
8531943|NCT00310401|21032980|P2|COMPLETED|Overall Study||246
8531944|NCT00310401|21032981|P1|COMPLETED|Overall Study||260
8531945|NCT00310401|21032980|P2|STARTED|Overall Study||246
8531946|NCT00310401|21032981|P1|STARTED|Overall Study||260
8531947|NCT00310388|21032995|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||13
8531948|NCT00310388|21032996|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
8531949|NCT00310388|21032995|P2|COMPLETED|Safety Follow-up Continuation Phase||13
8531950|NCT00310388|21032996|P1|COMPLETED|Safety Follow-up Continuation Phase||0
8531951|NCT00310388|21032995|P2|STARTED|Safety Follow-up Continuation Phase||26
8531952|NCT00310388|21032996|P1|STARTED|Safety Follow-up Continuation Phase||0
8531953|NCT00310388|21032995|P2|NOT COMPLETED|Primary Reporting Phase||0
8531954|NCT00310388|21032996|P1|NOT COMPLETED|Primary Reporting Phase||346
8531955|NCT00310388|21032995|P2|COMPLETED|Primary Reporting Phase||0
8531956|NCT00310388|21032996|P1|COMPLETED|Primary Reporting Phase||30
8531957|NCT00310388|21032995|P2|STARTED|Primary Reporting Phase||0
8531958|NCT00310388|21032996|P1|STARTED|Primary Reporting Phase||376
8531959|NCT00310375|21033038|P3|NOT COMPLETED|Safety Follow-up Continuation Phase||1
8531960|NCT00310375|21033039|P2|NOT COMPLETED|Safety Follow-up Continuation Phase||0
8531961|NCT00310375|21033040|P1|NOT COMPLETED|Safety Follow-up Continuation Phase||0
8531962|NCT00310375|21033038|P3|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
8531963|NCT00310375|21033039|P2|COMPLETED|Safety Follow-up Continuation Phase||0
8531964|NCT00310375|21033040|P1|COMPLETED|Safety Follow-up Continuation Phase||0
8531965|NCT00310375|21033038|P3|STARTED|Safety Follow-up Continuation Phase||19
8531966|NCT00310375|21033039|P2|STARTED|Safety Follow-up Continuation Phase||0
8531967|NCT00310375|21033040|P1|STARTED|Safety Follow-up Continuation Phase||0
8531968|NCT00310375|21033038|P3|NOT COMPLETED|Primary Reporting Phase||0
8531969|NCT00310375|21033039|P2|NOT COMPLETED|Primary Reporting Phase||68
8531970|NCT00310375|21033040|P1|NOT COMPLETED|Primary Reporting Phase||91
8531971|NCT00310375|21033038|P3|COMPLETED|Primary Reporting Phase||0
8531972|NCT00310375|21033039|P2|COMPLETED|Primary Reporting Phase||11
8531973|NCT00310375|21033040|P1|COMPLETED|Primary Reporting Phase||11
8531974|NCT00310375|21033038|P3|STARTED|Primary Reporting Phase||0
8531975|NCT00310375|21033039|P2|STARTED|Primary Reporting Phase||79
8531976|NCT00310375|21033040|P1|STARTED|Primary Reporting Phase||102
8531977|NCT00310362|21033085|P3|NOT COMPLETED|Overall Study||0
8531978|NCT00310362|21033086|P2|NOT COMPLETED|Overall Study||0
8531979|NCT00310362|21033087|P1|NOT COMPLETED|Overall Study||0
8531980|NCT00310362|21033085|P3|COMPLETED|Overall Study||1206
8531981|NCT00310362|21033086|P2|COMPLETED|Overall Study||1205
8531982|NCT00310362|21033087|P1|COMPLETED|Overall Study||1199
8531983|NCT00310362|21033085|P3|STARTED|Overall Study||1206
8531984|NCT00310362|21033086|P2|STARTED|Overall Study||1205
8531985|NCT00310362|21033087|P1|STARTED|Overall Study||1199
8531986|NCT00310310|21033106|P2|NOT COMPLETED|Overall Study||20
8531987|NCT00310310|21033107|P1|NOT COMPLETED|Overall Study||30
8531988|NCT00310310|21033106|P2|COMPLETED|Overall Study||100
8531989|NCT00310310|21033107|P1|COMPLETED|Overall Study||90
8531990|NCT00310310|21033106|P2|STARTED|Overall Study||120
8531991|NCT00310310|21033107|P1|STARTED|Overall Study||120
8532016|NCT00310076|21033168|P1|NOT COMPLETED|Overall Study||3
8532017|NCT00310076|21033168|P1|COMPLETED|Overall Study||26
8532018|NCT00310076|21033168|P1|STARTED|Overall Study||29
8532019|NCT00310050|21033174|P1|NOT COMPLETED|Overall Study||1
8532020|NCT00310050|21033174|P1|COMPLETED|Overall Study||3
8532021|NCT00310050|21033174|P1|STARTED|Overall Study||4
8532028|NCT00309985|21033200|P2|NOT COMPLETED|Overall Study||1
8532029|NCT00309985|21033201|P1|NOT COMPLETED|Overall Study||62
8532030|NCT00309985|21033200|P2|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
8532031|NCT00309985|21033201|P1|COMPLETED|Overall Study||335
8532032|NCT00309985|21033200|P2|Both Baseline and 3-month FACT-P Evals|Overall Study||299
8532033|NCT00309985|21033201|P1|Both Baseline and 3-month FACT-P Evals|Overall Study||334
8532034|NCT00309985|21033200|P2|Toxicity Analysis|Overall Study||392
8532035|NCT00309985|21033201|P1|Toxicity Analysis|Overall Study||390
8532036|NCT00309985|21033200|P2|STARTED|Overall Study||393
8532037|NCT00309985|21033201|P1|STARTED|Overall Study||397
8532038|NCT00309959|21033217|P1|NOT COMPLETED|Overall Study||2
8532039|NCT00309959|21033217|P1|COMPLETED|Overall Study||35
8532040|NCT00309959|21033217|P1|STARTED|Overall Study||37
8532041|NCT00309946|21033226|P1|NOT COMPLETED|Overall Study||1
8532042|NCT00309946|21033226|P1|COMPLETED|Overall Study||50
8532043|NCT00309946|21033226|P1|STARTED|Overall Study||51
8532044|NCT00309907|21033232|P1|NOT COMPLETED|Overall Study||20
8532045|NCT00309907|21033232|P1|COMPLETED|Overall Study||19
8532046|NCT00309907|21033232|P1|STARTED|Overall Study||39
8532047|NCT00309842|21033241|P1|NOT COMPLETED|Overall Study||1
8532048|NCT00309842|21033241|P1|COMPLETED|Overall Study||212
8532049|NCT00309842|21033241|P1|STARTED|Overall Study||213
8532050|NCT00309777|21033259|P4|NOT COMPLETED|Overall Study||4
8532051|NCT00309777|21033260|P3|NOT COMPLETED|Overall Study||19
8532052|NCT00309777|21033261|P2|NOT COMPLETED|Overall Study||9
8532053|NCT00309777|21033262|P1|NOT COMPLETED|Overall Study||23
8532054|NCT00309777|21033259|P4|COMPLETED|Overall Study||107
8532055|NCT00309777|21033260|P3|COMPLETED|Overall Study||304
8532056|NCT00309777|21033261|P2|COMPLETED|Overall Study||99
8532057|NCT00309777|21033262|P1|COMPLETED|Overall Study||292
8532058|NCT00309777|21033259|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
8532059|NCT00309777|21033260|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
8532060|NCT00309777|21033261|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
8532061|NCT00309777|21033262|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
8532062|NCT00309777|21033259|P4|STARTED|Overall Study||111
8532063|NCT00309777|21033260|P3|STARTED|Overall Study||323
8532064|NCT00309777|21033261|P2|STARTED|Overall Study||108
8532065|NCT00309777|21033262|P1|STARTED|Overall Study||315
8532066|NCT00309751|21033278|P2|NOT COMPLETED|Overall Study||15
8532067|NCT00309751|21033279|P1|NOT COMPLETED|Overall Study||31
8532068|NCT00309751|21033278|P2|COMPLETED|Overall Study||124
8532069|NCT00309751|21033279|P1|COMPLETED|Overall Study||248
8532070|NCT00309751|21033278|P2|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
8532071|NCT00309751|21033279|P1|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
8532072|NCT00309751|21033278|P2|STARTED|Overall Study||139
8532073|NCT00309751|21033279|P1|STARTED|Overall Study||279
8532074|NCT00309738|21033289|P2|NOT COMPLETED|Overall Study||12
8532075|NCT00309738|21033290|P1|NOT COMPLETED|Overall Study||13
8532076|NCT00309738|21033289|P2|COMPLETED|Overall Study||107
8532077|NCT00309738|21033290|P1|COMPLETED|Overall Study||223
8532078|NCT00309738|21033289|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
8532079|NCT00309738|21033290|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
8532080|NCT00309738|21033289|P2|STARTED|Overall Study||119
8532081|NCT00309738|21033290|P1|STARTED|Overall Study||236
8532082|NCT00309608|21033303|P5|NOT COMPLETED|Overall Study||4
8532083|NCT00309608|21033304|P4|NOT COMPLETED|Overall Study||6
8532084|NCT00309608|21033305|P3|NOT COMPLETED|Overall Study||10
8532085|NCT00309608|21033306|P2|NOT COMPLETED|Overall Study||13
8532086|NCT00309608|21033307|P1|NOT COMPLETED|Overall Study||14
8532087|NCT00309608|21033303|P5|COMPLETED|Overall Study||61
8532088|NCT00309608|21033304|P4|COMPLETED|Overall Study||60
8532089|NCT00309608|21033305|P3|COMPLETED|Overall Study||56
8532090|NCT00309608|21033306|P2|COMPLETED|Overall Study||52
8532091|NCT00309608|21033307|P1|COMPLETED|Overall Study||57
8532092|NCT00309608|21033303|P5|STARTED|Overall Study||65
8532093|NCT00309608|21033304|P4|STARTED|Overall Study||66
8532094|NCT00309608|21033305|P3|STARTED|Overall Study||66
8532095|NCT00309608|21033306|P2|STARTED|Overall Study||65
8532096|NCT00309608|21033307|P1|STARTED|Overall Study||71
8532097|NCT00309465|21033334|P6|NOT COMPLETED|Overall Study||0
8532098|NCT00309465|21033335|P5|NOT COMPLETED|Overall Study||0
8532099|NCT00309465|21033336|P4|NOT COMPLETED|Overall Study||1
8532100|NCT00309465|21033337|P3|NOT COMPLETED|Overall Study||0
8532101|NCT00309465|21033338|P2|NOT COMPLETED|Overall Study||0
8532102|NCT00309465|21033339|P1|NOT COMPLETED|Overall Study||0
8532103|NCT00309465|21033334|P6|COMPLETED|Overall Study||76
8532104|NCT00309465|21033335|P5|COMPLETED|Overall Study||76
8532105|NCT00309465|21033336|P4|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
8532106|NCT00309465|21033337|P3|COMPLETED|Overall Study||58
8532107|NCT00309465|21033338|P2|COMPLETED|Overall Study||58
8532108|NCT00309465|21033339|P1|COMPLETED|Overall Study||58
8532109|NCT00309465|21033334|P6|STARTED|Overall Study||76
8532110|NCT00309465|21033335|P5|STARTED|Overall Study||76
8532111|NCT00309465|21033336|P4|STARTED|Overall Study||76
8532112|NCT00309465|21033337|P3|STARTED|Overall Study||58
8532113|NCT00309465|21033338|P2|STARTED|Overall Study||58
8532114|NCT00309465|21033339|P1|STARTED|Overall Study||58
8532115|NCT00309452|21033355|P2|NOT COMPLETED|Overall Study||0
8532116|NCT00309452|21033356|P1|NOT COMPLETED|Overall Study||3
8532117|NCT00309452|21033355|P2|COMPLETED|Overall Study||60
8532118|NCT00309452|21033356|P1|COMPLETED|Overall Study||57
8532119|NCT00309452|21033355|P2|STARTED|Overall Study||60
8532120|NCT00309452|21033356|P1|STARTED|Overall Study||60
8532121|NCT00309387|21033384|P2|NOT COMPLETED|Overall Study||159
8532122|NCT00309387|21033385|P1|NOT COMPLETED|Overall Study||142
8532123|NCT00309387|21033384|P2|COMPLETED|Overall Study||351
8532124|NCT00309387|21033385|P1|COMPLETED|Overall Study||368
8532125|NCT00309387|21033384|P2|STARTED|Overall Study||510
8532126|NCT00309387|21033385|P1|STARTED|Overall Study||510
8532127|NCT00309244|21033403|P2|NOT COMPLETED|Overall Study||97
8532128|NCT00309244|21033404|P1|NOT COMPLETED|Overall Study||118
8532129|NCT00309244|21033403|P2|COMPLETED|Overall Study||246
8532130|NCT00309244|21033404|P1|COMPLETED|Overall Study||216
8532131|NCT00309244|21033403|P2|STARTED|Overall Study||343
8532132|NCT00309244|21033404|P1|STARTED|Overall Study||334
8532133|NCT00309166|21033426|P2|NOT COMPLETED|Overall Study||3
8532134|NCT00309166|21033427|P1|NOT COMPLETED|Overall Study||5
8532135|NCT00309166|21033426|P2|COMPLETED|Overall Study||86
8532136|NCT00309166|21033427|P1|COMPLETED|Overall Study||176
8532137|NCT00309166|21033426|P2|STARTED|Overall Study||89
8532138|NCT00309166|21033427|P1|STARTED|Overall Study||181
8532139|NCT00309140|21033453|P1|NOT COMPLETED|Overall Study||0
8532140|NCT00309140|21033453|P1|COMPLETED|Overall Study||23
8532141|NCT00309140|21033453|P1|Received at Least 1 Dose of Study Drug|Overall Study||23
8532142|NCT00309140|21033453|P1|STARTED|Overall Study||23
8532143|NCT00308997|21033461|P2|NOT COMPLETED|Overall Study||1
8532144|NCT00308997|21033462|P1|NOT COMPLETED|Overall Study||1
8532145|NCT00308997|21033461|P2|COMPLETED|Overall Study||28
8532146|NCT00308997|21033462|P1|COMPLETED|Overall Study||55
8532147|NCT00308997|21033461|P2|STARTED|Overall Study||29
8532148|NCT00308997|21033462|P1|STARTED|Overall Study||56
8532149|NCT00308737|21033481|P3|NOT COMPLETED|Overall Study||37
8532150|NCT00308737|21033482|P2|NOT COMPLETED|Overall Study||289
8532151|NCT00308737|21033483|P1|NOT COMPLETED|Overall Study||463
8532152|NCT00308737|21033481|P3|COMPLETED|Overall Study||127
8532153|NCT00308737|21033482|P2|COMPLETED|Overall Study||662
8532154|NCT00308737|21033483|P1|COMPLETED|Overall Study||475
8532155|NCT00308737|21033481|P3|STARTED|Overall Study||164
8532156|NCT00308737|21033482|P2|STARTED|Overall Study||951
8532157|NCT00308737|21033483|P1|STARTED|Overall Study||938
8532158|NCT00308711|21033523|P3|NOT COMPLETED|Overall Study||5
8532159|NCT00308711|21033524|P2|NOT COMPLETED|Overall Study||4
8532160|NCT00308711|21033525|P1|NOT COMPLETED|Overall Study||2
8532161|NCT00308711|21033523|P3|COMPLETED|Overall Study||431
8532162|NCT00308711|21033524|P2|COMPLETED|Overall Study||440
8532163|NCT00308711|21033525|P1|COMPLETED|Overall Study||426
8532164|NCT00308711|21033523|P3|STARTED|Overall Study||436
8532165|NCT00308711|21033524|P2|STARTED|Overall Study||444
8532166|NCT00308711|21033525|P1|STARTED|Overall Study||428
8532167|NCT00308620|21033560|P3|NOT COMPLETED|Overall Study||1
8532168|NCT00308620|21033561|P2|NOT COMPLETED|Overall Study||1
8532169|NCT00308620|21033562|P1|NOT COMPLETED|Overall Study||1
8532170|NCT00308620|21033560|P3|COMPLETED|Overall Study||5
8532171|NCT00308620|21033561|P2|COMPLETED|Overall Study||3
8532172|NCT00308620|21033562|P1|COMPLETED|Overall Study||2
8532173|NCT00308620|21033560|P3|STARTED|Overall Study||6
8532174|NCT00308620|21033561|P2|STARTED|Overall Study||4
8532175|NCT00308620|21033562|P1|STARTED|Overall Study||3
8532176|NCT00308581|21033571|P3|NOT COMPLETED|Randomized Maintenance Phase||0
8532177|NCT00308581|21033572|P2|NOT COMPLETED|Randomized Maintenance Phase||103
8532178|NCT00308581|21033573|P1|NOT COMPLETED|Randomized Maintenance Phase||105
8532179|NCT00308581|21033571|P3|COMPLETED|Randomized Maintenance Phase||0
8532180|NCT00308581|21033572|P2|COMPLETED|Randomized Maintenance Phase||83
8532181|NCT00308581|21033573|P1|COMPLETED|Randomized Maintenance Phase||82
8532182|NCT00308581|21033571|P3|STARTED|Randomized Maintenance Phase||0
8532183|NCT00308581|21033572|P2|STARTED|Randomized Maintenance Phase||186
8532184|NCT00308581|21033573|P1|STARTED|Randomized Maintenance Phase||187
8532185|NCT00308581|21033571|P3|NOT COMPLETED|Induction Phase||166
8532186|NCT00308581|21033572|P2|NOT COMPLETED|Induction Phase||0
8532187|NCT00308581|21033573|P1|NOT COMPLETED|Induction Phase||0
8532188|NCT00308581|21033571|P3|COMPLETED|Induction Phase||373
8532189|NCT00308581|21033572|P2|COMPLETED|Induction Phase|Not applicable in this period|0
8532190|NCT00308581|21033573|P1|COMPLETED|Induction Phase|Not applicable in this period|0
8532191|NCT00308581|21033571|P3|STARTED|Induction Phase||539
8532192|NCT00308581|21033572|P2|STARTED|Induction Phase|Not applicable in this period|0
8532193|NCT00308581|21033573|P1|STARTED|Induction Phase|Not applicable in this period|0
8532194|NCT00308555|21033699|P2|NOT COMPLETED|Overall Study||0
8532195|NCT00308555|21033700|P1|NOT COMPLETED|Overall Study||3
8532196|NCT00308555|21033699|P2|COMPLETED|Overall Study||11
8532197|NCT00308555|21033700|P1|COMPLETED|Overall Study||10
8532198|NCT00308555|21033699|P2|STARTED|Overall Study||11
8532199|NCT00308555|21033700|P1|STARTED|Overall Study||13
8532200|NCT00308516|21033708|P2|NOT COMPLETED|Overall Study||21
8532201|NCT00308516|21033709|P1|NOT COMPLETED|Overall Study||29
8532202|NCT00308516|21033708|P2|COMPLETED|Overall Study||10
8532203|NCT00308516|21033709|P1|COMPLETED|Overall Study||6
8532204|NCT00308516|21033708|P2|STARTED|Overall Study||31
8532205|NCT00308516|21033709|P1|STARTED|Overall Study||35
8532206|NCT00308308|21033717|P2|NOT COMPLETED|Overall Study||68
8532207|NCT00308308|21033718|P1|NOT COMPLETED|Overall Study||103
8532208|NCT00308308|21033717|P2|COMPLETED|Overall Study||220
8532209|NCT00308308|21033718|P1|COMPLETED|Overall Study||198
8532210|NCT00308308|21033717|P2|STARTED|Overall Study||288
8532211|NCT00308308|21033718|P1|STARTED|Overall Study||301
8532212|NCT00308282|21033742|P4|NOT COMPLETED|Overall Study||2
8532213|NCT00308282|21033743|P3|NOT COMPLETED|Overall Study||1
8532214|NCT00308282|21033744|P2|NOT COMPLETED|Overall Study||4
8532215|NCT00308282|21033745|P1|NOT COMPLETED|Overall Study||3
8532216|NCT00308282|21033742|P4|COMPLETED|Overall Study||32
8532217|NCT00308282|21033743|P3|COMPLETED|Overall Study||33
8532218|NCT00308282|21033744|P2|COMPLETED|Overall Study||30
8532219|NCT00308282|21033745|P1|COMPLETED|Overall Study||31
8532220|NCT00308282|21033742|P4|Received at Least One Dose of Study Drug|Overall Study||34
8532221|NCT00308282|21033743|P3|Received at Least One Dose of Study Drug|Overall Study||34
8532222|NCT00308282|21033744|P2|Received at Least One Dose of Study Drug|Overall Study||34
8532223|NCT00308282|21033745|P1|Received at Least One Dose of Study Drug|Overall Study||34
8532224|NCT00308282|21033742|P4|STARTED|Overall Study||34
8532225|NCT00308282|21033743|P3|STARTED|Overall Study||34
8532226|NCT00308282|21033744|P2|STARTED|Overall Study||34
8532227|NCT00308282|21033745|P1|STARTED|Overall Study||34
8532228|NCT00308230|21033785|P3|NOT COMPLETED|Overall Study||0
8532229|NCT00308230|21033786|P2|NOT COMPLETED|Overall Study||0
8532230|NCT00308230|21033787|P1|NOT COMPLETED|Overall Study||0
8532231|NCT00308230|21033785|P3|COMPLETED|Overall Study||20
8532232|NCT00308230|21033786|P2|COMPLETED|Overall Study||8
8532233|NCT00308230|21033787|P1|COMPLETED|Overall Study||6
8532234|NCT00308230|21033785|P3|STARTED|Overall Study||20
8532235|NCT00308230|21033786|P2|STARTED|Overall Study||8
8532236|NCT00308230|21033787|P1|STARTED|Overall Study||6
8532237|NCT00308139|21033797|P2|NOT COMPLETED|Overall Study||87
8532238|NCT00308139|21033798|P1|NOT COMPLETED|Overall Study||94
8532239|NCT00308139|21033797|P2|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
8532240|NCT00308139|21033798|P1|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
8532241|NCT00308139|21033797|P2|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
8532242|NCT00308139|21033798|P1|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
8532243|NCT00308139|21033797|P2|Evaluable Meal Tolerance Cohort|Overall Study||24
8532244|NCT00308139|21033798|P1|Evaluable Meal Tolerance Cohort|Overall Study||27
8532245|NCT00308139|21033797|P2|Pharmacokinetics Population|Overall Study||0
8532246|NCT00308139|21033798|P1|Pharmacokinetics Population|Overall Study||129
8532247|NCT00308139|21033797|P2|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
8532248|NCT00308139|21033798|P1|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
8532249|NCT00308139|21033797|P2|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
8532413|NCT00307125|21034293|P1|COMPLETED|Pilot Phase||0
8532250|NCT00308139|21033798|P1|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
8532251|NCT00308139|21033797|P2|STARTED|Overall Study||151
8532252|NCT00308139|21033798|P1|STARTED|Overall Study||152
8532253|NCT00308113|21033872|P4|NOT COMPLETED|Overall Study||1
8532254|NCT00308113|21033873|P3|NOT COMPLETED|Overall Study||0
8532255|NCT00308113|21033874|P2|NOT COMPLETED|Overall Study||0
8532256|NCT00308113|21033875|P1|NOT COMPLETED|Overall Study||0
8532257|NCT00308113|21033872|P4|COMPLETED|Overall Study||1
8532258|NCT00308113|21033873|P3|COMPLETED|Overall Study||1
8532259|NCT00308113|21033874|P2|COMPLETED|Overall Study||0
8532260|NCT00308113|21033875|P1|COMPLETED|Overall Study||0
8532261|NCT00308113|21033872|P4|STARTED|Overall Study||2
8532262|NCT00308113|21033873|P3|STARTED|Overall Study||1
8532263|NCT00308113|21033874|P2|STARTED|Overall Study||0
8532264|NCT00308113|21033875|P1|STARTED|Overall Study||0
8532265|NCT00308087|21033895|P2|NOT COMPLETED|Overall Study||37
8532266|NCT00308087|21033896|P1|NOT COMPLETED|Overall Study||36
8532267|NCT00308087|21033895|P2|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
8532268|NCT00308087|21033896|P1|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
8532269|NCT00308087|21033895|P2|STARTED|Overall Study||38
8532270|NCT00308087|21033896|P1|STARTED|Overall Study||37
8532271|NCT00308074|21033912|P1|NOT COMPLETED|Overall Study||1
8532272|NCT00308074|21033912|P1|COMPLETED|Overall Study||13
8532273|NCT00308074|21033912|P1|STARTED|Overall Study||14
8532274|NCT00308061|21033921|P2|NOT COMPLETED|Overall Study||0
8532275|NCT00308061|21033922|P1|NOT COMPLETED|Overall Study||0
8532276|NCT00308061|21033921|P2|COMPLETED|Overall Study||20
8532277|NCT00308061|21033922|P1|COMPLETED|Overall Study||20
8532278|NCT00308061|21033921|P2|STARTED|Overall Study||20
8532279|NCT00308061|21033922|P1|STARTED|Overall Study||20
8532280|NCT00307931|21033929|P1|NOT COMPLETED|Overall Study||1
8532281|NCT00307931|21033929|P1|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
8532282|NCT00307931|21033929|P1|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
8532283|NCT00307801|21033946|P2|NOT COMPLETED|Overall Study||17
8532284|NCT00307801|21033947|P1|NOT COMPLETED|Overall Study||32
8532285|NCT00307801|21033946|P2|COMPLETED|Overall Study||65
8532286|NCT00307801|21033947|P1|COMPLETED|Overall Study||117
8532287|NCT00307801|21033946|P2|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
8532288|NCT00307801|21033947|P1|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
8532289|NCT00307801|21033946|P2|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
8532290|NCT00307801|21033947|P1|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
8532291|NCT00307801|21033946|P2|Cycle 1, Visit 5, Baseline|Overall Study||81
8532292|NCT00307801|21033947|P1|Cycle 1, Visit 5, Baseline|Overall Study||145
8532293|NCT00307801|21033946|P2|Subjects Received Treatment|Overall Study||81
8532294|NCT00307801|21033947|P1|Subjects Received Treatment|Overall Study||145
8532295|NCT00307801|21033946|P2|STARTED|Overall Study||82
8532296|NCT00307801|21033947|P1|STARTED|Overall Study||149
8532297|NCT00307736|21034059|P4|NOT COMPLETED|Overall Study||3
8532298|NCT00307736|21034060|P3|NOT COMPLETED|Overall Study||3
8532299|NCT00307736|21034061|P2|NOT COMPLETED|Overall Study||0
8532300|NCT00307736|21034062|P1|NOT COMPLETED|Overall Study||0
8532301|NCT00307736|21034059|P4|COMPLETED|Overall Study||20
8532302|NCT00307736|21034060|P3|COMPLETED|Overall Study||0
8532303|NCT00307736|21034061|P2|COMPLETED|Overall Study||3
8532304|NCT00307736|21034062|P1|COMPLETED|Overall Study||3
8532305|NCT00307736|21034059|P4|STARTED|Overall Study||23
8532306|NCT00307736|21034060|P3|STARTED|Overall Study||3
8532307|NCT00307736|21034061|P2|STARTED|Overall Study||3
8532308|NCT00307736|21034062|P1|STARTED|Overall Study||3
8532309|NCT00307684|21034073|P3|NOT COMPLETED|Double Blind Phase||0
8532310|NCT00307684|21034074|P2|NOT COMPLETED|Double Blind Phase||5
8532311|NCT00307684|21034075|P1|NOT COMPLETED|Double Blind Phase||2
8532312|NCT00307684|21034073|P3|COMPLETED|Double Blind Phase||0
8532313|NCT00307684|21034074|P2|COMPLETED|Double Blind Phase||17
8532314|NCT00307684|21034075|P1|COMPLETED|Double Blind Phase||21
8532315|NCT00307684|21034073|P3|STARTED|Double Blind Phase||0
8532316|NCT00307684|21034074|P2|STARTED|Double Blind Phase||22
8532317|NCT00307684|21034075|P1|STARTED|Double Blind Phase||23
8532318|NCT00307684|21034073|P3|NOT COMPLETED|Open Label Phase||56
8532319|NCT00307684|21034074|P2|NOT COMPLETED|Open Label Phase||0
8532320|NCT00307684|21034075|P1|NOT COMPLETED|Open Label Phase||0
8532321|NCT00307684|21034073|P3|COMPLETED|Open Label Phase||99
8532322|NCT00307684|21034074|P2|COMPLETED|Open Label Phase||0
8532323|NCT00307684|21034075|P1|COMPLETED|Open Label Phase||0
8532324|NCT00307684|21034073|P3|STARTED|Open Label Phase|1 screening failure|155
8532325|NCT00307684|21034074|P2|STARTED|Open Label Phase||0
8532326|NCT00307684|21034075|P1|STARTED|Open Label Phase||0
8532327|NCT00307489|21034103|P2|NOT COMPLETED|Week 48 Through Week 168||6
8532328|NCT00307489|21034104|P1|NOT COMPLETED|Week 48 Through Week 168||6
8532329|NCT00307489|21034103|P2|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
8532330|NCT00307489|21034104|P1|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
8532331|NCT00307489|21034103|P2|STARTED|Week 48 Through Week 168||50
8532332|NCT00307489|21034104|P1|STARTED|Week 48 Through Week 168||52
8532333|NCT00307489|21034103|P2|NOT COMPLETED|Baseline Through Week 48||2
8532334|NCT00307489|21034104|P1|NOT COMPLETED|Baseline Through Week 48||1
8532335|NCT00307489|21034103|P2|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
8532336|NCT00307489|21034104|P1|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
8532337|NCT00307489|21034103|P2|STARTED|Baseline Through Week 48||52
8532338|NCT00307489|21034104|P1|STARTED|Baseline Through Week 48||53
8532339|NCT00307437|21034149|P7|NOT COMPLETED|After Controlled Period||113
8532340|NCT00307437|21034150|P6|NOT COMPLETED|After Controlled Period||122
8532341|NCT00307437|21034151|P5|NOT COMPLETED|After Controlled Period||55
8532342|NCT00307437|21034152|P4|NOT COMPLETED|After Controlled Period||58
8532343|NCT00307437|21034153|P3|NOT COMPLETED|After Controlled Period||0
8532344|NCT00307437|21034154|P2|NOT COMPLETED|After Controlled Period||0
8532345|NCT00307437|21034155|P1|NOT COMPLETED|After Controlled Period||0
8532346|NCT00307437|21034149|P7|COMPLETED|After Controlled Period||289
8532347|NCT00307437|21034150|P6|COMPLETED|After Controlled Period||281
8532348|NCT00307437|21034151|P5|COMPLETED|After Controlled Period||140
8532349|NCT00307437|21034152|P4|COMPLETED|After Controlled Period||139
8532350|NCT00307437|21034153|P3|COMPLETED|After Controlled Period||0
8532351|NCT00307437|21034154|P2|COMPLETED|After Controlled Period||0
8532352|NCT00307437|21034155|P1|COMPLETED|After Controlled Period||0
8532353|NCT00307437|21034149|P7|STARTED|After Controlled Period||402
8532354|NCT00307437|21034150|P6|STARTED|After Controlled Period||403
8532355|NCT00307437|21034151|P5|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
8532356|NCT00307437|21034152|P4|STARTED|After Controlled Period||197
8532357|NCT00307437|21034153|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8532358|NCT00307437|21034154|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8532359|NCT00307437|21034155|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
8532360|NCT00307437|21034149|P7|NOT COMPLETED|Controlled Period||0
8532361|NCT00307437|21034150|P6|NOT COMPLETED|Controlled Period||0
8532362|NCT00307437|21034151|P5|NOT COMPLETED|Controlled Period||0
8532363|NCT00307437|21034152|P4|NOT COMPLETED|Controlled Period||0
8532364|NCT00307437|21034153|P3|NOT COMPLETED|Controlled Period||9
8532365|NCT00307437|21034154|P2|NOT COMPLETED|Controlled Period||6
8532366|NCT00307437|21034155|P1|NOT COMPLETED|Controlled Period||16
8532367|NCT00307437|21034149|P7|COMPLETED|Controlled Period||0
8532368|NCT00307437|21034150|P6|COMPLETED|Controlled Period||0
8532369|NCT00307437|21034151|P5|COMPLETED|Controlled Period||0
8532370|NCT00307437|21034152|P4|COMPLETED|Controlled Period||0
8532371|NCT00307437|21034153|P3|COMPLETED|Controlled Period||402
8532372|NCT00307437|21034154|P2|COMPLETED|Controlled Period||403
8532373|NCT00307437|21034155|P1|COMPLETED|Controlled Period||394
8532374|NCT00307437|21034149|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8532375|NCT00307437|21034150|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8532376|NCT00307437|21034151|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8532377|NCT00307437|21034152|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
8532378|NCT00307437|21034153|P3|STARTED|Controlled Period||411
8532379|NCT00307437|21034154|P2|STARTED|Controlled Period||409
8532380|NCT00307437|21034155|P1|STARTED|Controlled Period||410
8532381|NCT00307333|21034181|P2|NOT COMPLETED|Overall Study||3
8532382|NCT00307333|21034182|P1|NOT COMPLETED|Overall Study||11
8532383|NCT00307333|21034181|P2|COMPLETED|Overall Study||1489
8532384|NCT00307333|21034182|P1|COMPLETED|Overall Study||1500
8532385|NCT00307333|21034181|P2|STARTED|Overall Study||1492
8532386|NCT00307333|21034182|P1|STARTED|Overall Study||1511
8532387|NCT00307294|21034194|P1|NOT COMPLETED|Overall Study||1
8532388|NCT00307294|21034194|P1|COMPLETED|Overall Study||39
8532389|NCT00307294|21034194|P1|STARTED|Overall Study||40
8532390|NCT00307164|21034203|P2|NOT COMPLETED|Overall Study||14
8532391|NCT00307164|21034204|P1|NOT COMPLETED|Overall Study||15
8532392|NCT00307164|21034203|P2|COMPLETED|Overall Study||68
8532393|NCT00307164|21034204|P1|COMPLETED|Overall Study||68
8532394|NCT00307164|21034203|P2|STARTED|Overall Study||82
8532395|NCT00307164|21034204|P1|STARTED|Overall Study||83
8532396|NCT00307151|21034244|P4|NOT COMPLETED|Overall Study||11
8532397|NCT00307151|21034245|P3|NOT COMPLETED|Overall Study||20
8532398|NCT00307151|21034246|P2|NOT COMPLETED|Overall Study||7
8532399|NCT00307151|21034247|P1|NOT COMPLETED|Overall Study||11
8532400|NCT00307151|21034244|P4|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
8532401|NCT00307151|21034245|P3|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
8532402|NCT00307151|21034246|P2|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
8532403|NCT00307151|21034247|P1|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
8532404|NCT00307151|21034244|P4|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
8532405|NCT00307151|21034245|P3|STARTED|Overall Study||147
8532406|NCT00307151|21034246|P2|STARTED|Overall Study||82
8532407|NCT00307151|21034247|P1|STARTED|Overall Study||82
8532408|NCT00307125|21034291|P3|NOT COMPLETED|Pilot Phase||1
8532409|NCT00307125|21034292|P2|NOT COMPLETED|Pilot Phase||2
8532410|NCT00307125|21034293|P1|NOT COMPLETED|Pilot Phase||0
8532411|NCT00307125|21034291|P3|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
8532412|NCT00307125|21034292|P2|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
8532414|NCT00307125|21034291|P3|STARTED|Pilot Phase||7
8532415|NCT00307125|21034292|P2|STARTED|Pilot Phase||15
8532416|NCT00307125|21034293|P1|STARTED|Pilot Phase||0
8532417|NCT00307125|21034291|P3|NOT COMPLETED|Screening Phase||0
8532418|NCT00307125|21034292|P2|NOT COMPLETED|Screening Phase||0
8532419|NCT00307125|21034293|P1|NOT COMPLETED|Screening Phase||454
8532420|NCT00307125|21034291|P3|COMPLETED|Screening Phase||0
8532421|NCT00307125|21034292|P2|COMPLETED|Screening Phase||0
8532422|NCT00307125|21034293|P1|COMPLETED|Screening Phase||303
8532423|NCT00307125|21034291|P3|STARTED|Screening Phase||0
8532424|NCT00307125|21034292|P2|STARTED|Screening Phase||0
8532425|NCT00307125|21034293|P1|STARTED|Screening Phase||757
8532426|NCT00307086|21034315|P1|NOT COMPLETED|Overall Study||5
8532427|NCT00307086|21034315|P1|COMPLETED|Overall Study||25
8532428|NCT00307086|21034315|P1|STARTED|Overall Study||30
8532429|NCT00307047|21034321|P2|NOT COMPLETED|Overall Study||49
8532430|NCT00307047|21034322|P1|NOT COMPLETED|Overall Study||69
8532431|NCT00307047|21034321|P2|COMPLETED|Overall Study||1180
8532432|NCT00307047|21034322|P1|COMPLETED|Overall Study||2389
8532433|NCT00307047|21034321|P2|STARTED|Overall Study||1229
8532434|NCT00307047|21034322|P1|STARTED|Overall Study||2458
8532435|NCT00307034|21034460|P2|NOT COMPLETED|Overall Study||7
8532436|NCT00307034|21034461|P1|NOT COMPLETED|Overall Study||2
8532437|NCT00307034|21034460|P2|COMPLETED|Overall Study||169
8532438|NCT00307034|21034461|P1|COMPLETED|Overall Study||173
8532439|NCT00307034|21034460|P2|STARTED|Overall Study||176
8532440|NCT00307034|21034461|P1|STARTED|Overall Study||175
8532441|NCT00306995|21034506|P7|NOT COMPLETED|Study Part II for Subset 2||0
8532442|NCT00306995|21034507|P6|NOT COMPLETED|Study Part II for Subset 2||0
8532443|NCT00306995|21034508|P5|NOT COMPLETED|Study Part II for Subset 2||0
8532444|NCT00306995|21034509|P4|NOT COMPLETED|Study Part II for Subset 2||0
8532445|NCT00306995|21034510|P3|NOT COMPLETED|Study Part II for Subset 2||0
8532446|NCT00306995|21034511|P2|NOT COMPLETED|Study Part II for Subset 2||1
8532447|NCT00306995|21034512|P1|NOT COMPLETED|Study Part II for Subset 2||0
8532448|NCT00306995|21034506|P7|COMPLETED|Study Part II for Subset 2||24
8532449|NCT00306995|21034507|P6|COMPLETED|Study Part II for Subset 2||26
8532450|NCT00306995|21034508|P5|COMPLETED|Study Part II for Subset 2||23
8532451|NCT00306995|21034509|P4|COMPLETED|Study Part II for Subset 2||22
8532452|NCT00306995|21034510|P3|COMPLETED|Study Part II for Subset 2||23
8532453|NCT00306995|21034511|P2|COMPLETED|Study Part II for Subset 2||23
8532454|NCT00306995|21034512|P1|COMPLETED|Study Part II for Subset 2||23
8532455|NCT00306995|21034506|P7|STARTED|Study Part II for Subset 2||24
8532456|NCT00306995|21034507|P6|STARTED|Study Part II for Subset 2||26
8532457|NCT00306995|21034508|P5|STARTED|Study Part II for Subset 2||23
8532458|NCT00306995|21034509|P4|STARTED|Study Part II for Subset 2||22
8532459|NCT00306995|21034510|P3|STARTED|Study Part II for Subset 2||23
8532460|NCT00306995|21034511|P2|STARTED|Study Part II for Subset 2||24
8532461|NCT00306995|21034512|P1|STARTED|Study Part II for Subset 2||23
8532462|NCT00306995|21034506|P7|NOT COMPLETED|Study Part II for Subset 1||0
8532463|NCT00306995|21034507|P6|NOT COMPLETED|Study Part II for Subset 1||0
8532464|NCT00306995|21034508|P5|NOT COMPLETED|Study Part II for Subset 1||0
8532465|NCT00306995|21034509|P4|NOT COMPLETED|Study Part II for Subset 1||0
8532466|NCT00306995|21034510|P3|NOT COMPLETED|Study Part II for Subset 1||0
8532467|NCT00306995|21034511|P2|NOT COMPLETED|Study Part II for Subset 1||0
8532468|NCT00306995|21034512|P1|NOT COMPLETED|Study Part II for Subset 1||0
8532469|NCT00306995|21034506|P7|COMPLETED|Study Part II for Subset 1||23
8532470|NCT00306995|21034507|P6|COMPLETED|Study Part II for Subset 1||26
8532471|NCT00306995|21034508|P5|COMPLETED|Study Part II for Subset 1||27
8532472|NCT00306995|21034509|P4|COMPLETED|Study Part II for Subset 1||27
8532473|NCT00306995|21034510|P3|COMPLETED|Study Part II for Subset 1||27
8532474|NCT00306995|21034511|P2|COMPLETED|Study Part II for Subset 1||26
8532475|NCT00306995|21034512|P1|COMPLETED|Study Part II for Subset 1||27
8532476|NCT00306995|21034506|P7|STARTED|Study Part II for Subset 1||23
8532477|NCT00306995|21034507|P6|STARTED|Study Part II for Subset 1||26
8532478|NCT00306995|21034508|P5|STARTED|Study Part II for Subset 1||27
8532479|NCT00306995|21034509|P4|STARTED|Study Part II for Subset 1||27
8532480|NCT00306995|21034510|P3|STARTED|Study Part II for Subset 1||27
8532481|NCT00306995|21034511|P2|STARTED|Study Part II for Subset 1||26
8532482|NCT00306995|21034512|P1|STARTED|Study Part II for Subset 1||27
8532483|NCT00306995|21034506|P7|NOT COMPLETED|Study Part I||1
8532484|NCT00306995|21034507|P6|NOT COMPLETED|Study Part I||0
8532485|NCT00306995|21034508|P5|NOT COMPLETED|Study Part I||0
8532486|NCT00306995|21034509|P4|NOT COMPLETED|Study Part I||0
8532487|NCT00306995|21034510|P3|NOT COMPLETED|Study Part I||0
8532488|NCT00306995|21034511|P2|NOT COMPLETED|Study Part I||0
8532489|NCT00306995|21034512|P1|NOT COMPLETED|Study Part I||0
8532490|NCT00306995|21034506|P7|COMPLETED|Study Part I||54
8532491|NCT00306995|21034507|P6|COMPLETED|Study Part I||55
8532492|NCT00306995|21034508|P5|COMPLETED|Study Part I||55
8532493|NCT00306995|21034509|P4|COMPLETED|Study Part I||55
8532494|NCT00306995|21034510|P3|COMPLETED|Study Part I||55
8532495|NCT00306995|21034511|P2|COMPLETED|Study Part I||55
8532496|NCT00306995|21034512|P1|COMPLETED|Study Part I||55
8532497|NCT00306995|21034506|P7|STARTED|Study Part I||55
8532498|NCT00306995|21034507|P6|STARTED|Study Part I||55
8532499|NCT00306995|21034508|P5|STARTED|Study Part I||55
8532500|NCT00306995|21034509|P4|STARTED|Study Part I||55
8532501|NCT00306995|21034510|P3|STARTED|Study Part I||55
8532502|NCT00306995|21034511|P2|STARTED|Study Part I||55
8532503|NCT00306995|21034512|P1|STARTED|Study Part I||55
8532504|NCT00306917|21034894|P2|NOT COMPLETED|Overall Study||109
8532505|NCT00306917|21034895|P1|NOT COMPLETED|Overall Study||108
8532506|NCT00306917|21034894|P2|COMPLETED|Overall Study||15
8532507|NCT00306917|21034895|P1|COMPLETED|Overall Study||13
8532508|NCT00306917|21034894|P2|60 Month Follow up|Overall Study||15
8532509|NCT00306917|21034895|P1|60 Month Follow up|Overall Study||13
8532510|NCT00306917|21034894|P2|48 Month Follow up|Overall Study||22
8532511|NCT00306917|21034895|P1|48 Month Follow up|Overall Study||29
8532512|NCT00306917|21034894|P2|36 Month Follow up|Overall Study||42
8532513|NCT00306917|21034895|P1|36 Month Follow up|Overall Study||56
8532514|NCT00306917|21034894|P2|24 Month Follow up|Overall Study||71
8532515|NCT00306917|21034895|P1|24 Month Follow up|Overall Study||60
8532516|NCT00306917|21034894|P2|12 Month Follow|Overall Study||94
8532517|NCT00306917|21034895|P1|12 Month Follow|Overall Study||86
8532518|NCT00306917|21034894|P2|Postoperative to 6 Month Follow up|Overall Study||100
8532519|NCT00306917|21034895|P1|Postoperative to 6 Month Follow up|Overall Study||93
8532520|NCT00306917|21034894|P2|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
8532521|NCT00306917|21034895|P1|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
8532522|NCT00306891|21034905|P4|NOT COMPLETED|Part B||17
8532523|NCT00306891|21034906|P3|NOT COMPLETED|Part B||11
8532524|NCT00306891|21034907|P2|NOT COMPLETED|Part B||0
8532525|NCT00306891|21034908|P1|NOT COMPLETED|Part B||0
8532526|NCT00306891|21034905|P4|COMPLETED|Part B||14
8532527|NCT00306891|21034906|P3|COMPLETED|Part B||5
8532528|NCT00306891|21034907|P2|COMPLETED|Part B||0
8532529|NCT00306891|21034908|P1|COMPLETED|Part B||0
8532530|NCT00306891|21034905|P4|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
8532531|NCT00306891|21034906|P3|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
8532532|NCT00306891|21034907|P2|STARTED|Part B||0
8532533|NCT00306891|21034908|P1|STARTED|Part B||0
8532534|NCT00306891|21034905|P4|NOT COMPLETED|Part A||0
8532535|NCT00306891|21034906|P3|NOT COMPLETED|Part A||0
8532536|NCT00306891|21034907|P2|NOT COMPLETED|Part A||6
8532537|NCT00306891|21034908|P1|NOT COMPLETED|Part A||5
8532538|NCT00306891|21034905|P4|COMPLETED|Part A||0
8532539|NCT00306891|21034906|P3|COMPLETED|Part A||0
8532540|NCT00306891|21034907|P2|COMPLETED|Part A||16
8532541|NCT00306891|21034908|P1|COMPLETED|Part A||18
8532542|NCT00306891|21034905|P4|STARTED|Part A||0
8532543|NCT00306891|21034906|P3|STARTED|Part A||0
8532544|NCT00306891|21034907|P2|STARTED|Part A||22
8532545|NCT00306891|21034908|P1|STARTED|Part A||23
8532546|NCT00306852|21034931|P2|NOT COMPLETED|Overall Study||38
8532547|NCT00306852|21034932|P1|NOT COMPLETED|Overall Study||29
8532548|NCT00306852|21034931|P2|COMPLETED|Overall Study||69
8532549|NCT00306852|21034932|P1|COMPLETED|Overall Study||76
8532550|NCT00306852|21034931|P2|STARTED|Overall Study||107
8532551|NCT00306852|21034932|P1|STARTED|Overall Study||105
8532552|NCT00306787|21034950|P2|NOT COMPLETED|Overall Study||241
8532553|NCT00306787|21034951|P1|NOT COMPLETED|Overall Study||234
8532554|NCT00306787|21034950|P2|COMPLETED|Overall Study||359
8532555|NCT00306787|21034951|P1|COMPLETED|Overall Study||345
8532556|NCT00306787|21034950|P2|Intent to Treat (ITT) Population|Overall Study||381
8532557|NCT00306787|21034951|P1|Intent to Treat (ITT) Population|Overall Study||370
8532558|NCT00306787|21034950|P2|Received Study Drug (Safety Population)|Overall Study||385
8532559|NCT00306787|21034951|P1|Received Study Drug (Safety Population)|Overall Study||371
8532560|NCT00306787|21034950|P2|STARTED|Overall Study||600
8532561|NCT00306787|21034951|P1|STARTED|Overall Study||579
8532562|NCT00306670|21034969|P2|NOT COMPLETED|Overall Study||2
8532563|NCT00306670|21034970|P1|NOT COMPLETED|Overall Study||0
8532564|NCT00306670|21034969|P2|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
8532565|NCT00306670|21034970|P1|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
8532566|NCT00306670|21034969|P2|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
8532567|NCT00306670|21034970|P1|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
8532568|NCT00306592|21034976|P2|NOT COMPLETED|Overall Study||58
8532569|NCT00306592|21034977|P1|NOT COMPLETED|Overall Study||31
8532570|NCT00306592|21034976|P2|COMPLETED|Overall Study||632
8532571|NCT00306592|21034977|P1|COMPLETED|Overall Study||373
8532572|NCT00306592|21034976|P2|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
8532573|NCT00306592|21034977|P1|Entered 101-MS-321 Extension Study|Overall Study||22
8532574|NCT00306592|21034976|P2|Completed at 48 Weeks|Overall Study||632
8532575|NCT00306592|21034977|P1|Completed at 48 Weeks|Overall Study||81
8532576|NCT00306592|21034976|P2|Completed Between 24 and 48 Weeks|Overall Study||0
8532577|NCT00306592|21034977|P1|Completed Between 24 and 48 Weeks|Overall Study||85
8532578|NCT00306592|21034976|P2|Completed at 24 Weeks|Overall Study||0
8532579|NCT00306592|21034977|P1|Completed at 24 Weeks|Overall Study||207
8532580|NCT00306592|21034976|P2|STARTED|Overall Study||690
8532581|NCT00306592|21034977|P1|STARTED|Overall Study||404
8532582|NCT00306527|21034987|P4|NOT COMPLETED|Overall Study||6
8532583|NCT00306527|21034988|P3|NOT COMPLETED|Overall Study||5
8532584|NCT00306527|21034989|P2|NOT COMPLETED|Overall Study||7
8532585|NCT00306527|21034990|P1|NOT COMPLETED|Overall Study||6
8532586|NCT00306527|21034987|P4|COMPLETED|Overall Study||590
8532587|NCT00306527|21034988|P3|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567
8532588|NCT00306527|21034989|P2|COMPLETED|Overall Study||527
8532589|NCT00306527|21034990|P1|COMPLETED|Overall Study||527
8532590|NCT00306527|21034987|P4|STARTED|Overall Study||596
8532591|NCT00306527|21034988|P3|STARTED|Overall Study||572
8532592|NCT00306527|21034989|P2|STARTED|Overall Study||534
8532593|NCT00306527|21034990|P1|STARTED|Overall Study||533
8532594|NCT00306488|21035044|P1|NOT COMPLETED|Overall Study||1
8532595|NCT00306488|21035044|P1|COMPLETED|Overall Study||10
8532596|NCT00306488|21035044|P1|STARTED|Overall Study||11
8532597|NCT00306384|21035062|P3|NOT COMPLETED|Overall Study||277
8532598|NCT00306384|21035063|P2|NOT COMPLETED|Overall Study||508
8532599|NCT00306384|21035064|P1|NOT COMPLETED|Overall Study||542
8532600|NCT00306384|21035062|P3|COMPLETED|Overall Study||251
8532601|NCT00306384|21035063|P2|COMPLETED|Overall Study||891
8532602|NCT00306384|21035064|P1|COMPLETED|Overall Study||854
8532603|NCT00306384|21035062|P3|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
8532604|NCT00306384|21035063|P2|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
8532605|NCT00306384|21035064|P1|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
8532606|NCT00306384|21035062|P3|STARTED|Overall Study||528
8532607|NCT00306384|21035063|P2|STARTED|Overall Study||1399
8532608|NCT00306384|21035064|P1|STARTED|Overall Study||1396
8532609|NCT00306293|21035096|P2|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
8532610|NCT00306293|21035097|P1|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
8532611|NCT00306293|21035096|P2|COMPLETED|Period 2 (Day 67 to Day 126 )||26
8532612|NCT00306293|21035097|P1|COMPLETED|Period 2 (Day 67 to Day 126 )||24
8532613|NCT00306293|21035096|P2|STARTED|Period 2 (Day 67 to Day 126 )||27
8532614|NCT00306293|21035097|P1|STARTED|Period 2 (Day 67 to Day 126 )||27
8532615|NCT00306293|21035096|P2|NOT COMPLETED|Washout (Day 61 to Day 66)||0
8532616|NCT00306293|21035097|P1|NOT COMPLETED|Washout (Day 61 to Day 66)||0
8532617|NCT00306293|21035096|P2|COMPLETED|Washout (Day 61 to Day 66)||27
8532618|NCT00306293|21035097|P1|COMPLETED|Washout (Day 61 to Day 66)||27
8532619|NCT00306293|21035096|P2|STARTED|Washout (Day 61 to Day 66)||27
8532620|NCT00306293|21035097|P1|STARTED|Washout (Day 61 to Day 66)||27
8532621|NCT00306293|21035096|P2|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
8532622|NCT00306293|21035097|P1|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
8532623|NCT00306293|21035096|P2|COMPLETED|Period 1 (Day 1 to Day 60)||27
8532624|NCT00306293|21035097|P1|COMPLETED|Period 1 (Day 1 to Day 60)||27
8532625|NCT00306293|21035096|P2|STARTED|Period 1 (Day 1 to Day 60)||35
8532626|NCT00306293|21035097|P1|STARTED|Period 1 (Day 1 to Day 60)||35
8532636|NCT00306189|21035280|P4|NOT COMPLETED|Overall Study||5
8532637|NCT00306189|21035281|P3|NOT COMPLETED|Overall Study||11
8532638|NCT00306189|21035282|P2|NOT COMPLETED|Overall Study||6
8532639|NCT00306189|21035283|P1|NOT COMPLETED|Overall Study||9
8532640|NCT00306189|21035280|P4|COMPLETED|Overall Study||52
8532641|NCT00306189|21035281|P3|COMPLETED|Overall Study||45
8532642|NCT00306189|21035282|P2|COMPLETED|Overall Study||50
8532643|NCT00306189|21035283|P1|COMPLETED|Overall Study||48
8532644|NCT00306189|21035280|P4|STARTED|Overall Study||57
8532645|NCT00306189|21035281|P3|STARTED|Overall Study||56
8532646|NCT00306189|21035282|P2|STARTED|Overall Study||56
8532647|NCT00306189|21035283|P1|STARTED|Overall Study||57
8532648|NCT00306163|21035295|P2|NOT COMPLETED|Overall Study||0
8532649|NCT00306163|21035296|P1|NOT COMPLETED|Overall Study||0
8532650|NCT00306163|21035295|P2|COMPLETED|Overall Study||18
8532651|NCT00306163|21035296|P1|COMPLETED|Overall Study||19
8532652|NCT00306163|21035295|P2|STARTED|Overall Study||18
8532653|NCT00306163|21035296|P1|STARTED|Overall Study||19
8532654|NCT00305942|21035302|P1|NOT COMPLETED|Overall Study||38
8532655|NCT00305942|21035302|P1|COMPLETED|Overall Study||23
8532656|NCT00305942|21035302|P1|STARTED|Overall Study||61
8532657|NCT00305877|21035310|P2|NOT COMPLETED|Overall Study||34
8532658|NCT00305877|21035311|P1|NOT COMPLETED|Overall Study||24
8532659|NCT00305877|21035310|P2|COMPLETED|Overall Study||34
8532660|NCT00305877|21035311|P1|COMPLETED|Overall Study||45
8532661|NCT00305877|21035310|P2|Included in Efficacy Analysis|Overall Study||62
8532662|NCT00305877|21035311|P1|Included in Efficacy Analysis|Overall Study||65
8532663|NCT00305877|21035310|P2|Eligible|Overall Study||66
8532664|NCT00305877|21035311|P1|Eligible|Overall Study||66
8532665|NCT00305877|21035310|P2|Treated|Overall Study||63
8532666|NCT00305877|21035311|P1|Treated|Overall Study||67
8532667|NCT00305877|21035310|P2|STARTED|Overall Study||68
8532668|NCT00305877|21035311|P1|STARTED|Overall Study||69
8532669|NCT00305864|21035325|P4|NOT COMPLETED|Overall Study||13
8532670|NCT00305864|21035326|P3|NOT COMPLETED|Overall Study||1
8532671|NCT00305864|21035327|P2|NOT COMPLETED|Overall Study||1
8532672|NCT00305864|21035328|P1|NOT COMPLETED|Overall Study||0
8532673|NCT00305864|21035325|P4|COMPLETED|Overall Study||81
8532674|NCT00305864|21035326|P3|COMPLETED|Overall Study||6
8532675|NCT00305864|21035327|P2|COMPLETED|Overall Study||9
8532676|NCT00305864|21035328|P1|COMPLETED|Overall Study||7
8532677|NCT00305864|21035325|P4|STARTED|Overall Study||94
8532678|NCT00305864|21035326|P3|STARTED|Overall Study||7
8532679|NCT00305864|21035327|P2|STARTED|Overall Study||10
8532680|NCT00305864|21035328|P1|STARTED|Overall Study||7
8532681|NCT00305773|21035341|P2|NOT COMPLETED|Overall Study||18
8532682|NCT00305773|21035342|P1|NOT COMPLETED|Overall Study||14
8532683|NCT00305773|21035341|P2|COMPLETED|Overall Study||4
8532684|NCT00305773|21035342|P1|COMPLETED|Overall Study||1
8532685|NCT00305773|21035341|P2|STARTED|Overall Study||22
8532686|NCT00305773|21035342|P1|STARTED|Overall Study||15
8532687|NCT00305760|21035356|P1|NOT COMPLETED|Overall Study||47
8532688|NCT00305760|21035356|P1|COMPLETED|Overall Study||13
8532689|NCT00305760|21035356|P1|STARTED|Overall Study||60
8532690|NCT00305695|21035362|P2|NOT COMPLETED|Overall Study||27
8532691|NCT00305695|21035363|P1|NOT COMPLETED|Overall Study||41
8532692|NCT00305695|21035362|P2|COMPLETED|Overall Study||52
8532693|NCT00305695|21035363|P1|COMPLETED|Overall Study||40
8532694|NCT00305695|21035362|P2|STARTED|Overall Study||79
8532695|NCT00305695|21035363|P1|STARTED|Overall Study||81
8532696|NCT00305682|21035381|P6|NOT COMPLETED|Overall Study||0
8532697|NCT00305682|21035382|P5|NOT COMPLETED|Overall Study||0
8532698|NCT00305682|21035383|P4|NOT COMPLETED|Overall Study||0
8532699|NCT00305682|21035384|P3|NOT COMPLETED|Overall Study||0
8532700|NCT00305682|21035385|P2|NOT COMPLETED|Overall Study||0
8532701|NCT00305682|21035386|P1|NOT COMPLETED|Overall Study||0
8532702|NCT00305682|21035381|P6|COMPLETED|Overall Study||35
8532703|NCT00305682|21035382|P5|COMPLETED|Overall Study||39
8532704|NCT00305682|21035383|P4|COMPLETED|Overall Study||34
8532705|NCT00305682|21035384|P3|COMPLETED|Overall Study||7
8532706|NCT00305682|21035385|P2|COMPLETED|Overall Study||71
8532707|NCT00305682|21035386|P1|COMPLETED|Overall Study||98
8532708|NCT00305682|21035381|P6|STARTED|Overall Study||35
8532709|NCT00305682|21035382|P5|STARTED|Overall Study||39
8532710|NCT00305682|21035383|P4|STARTED|Overall Study||34
8532711|NCT00305682|21035384|P3|STARTED|Overall Study||7
8532712|NCT00305682|21035385|P2|STARTED|Overall Study||71
8532713|NCT00305682|21035386|P1|STARTED|Overall Study||98
8532714|NCT00305643|21035486|P2|NOT COMPLETED|Overall Study||0
8532715|NCT00305643|21035487|P1|NOT COMPLETED|Overall Study||0
8532716|NCT00305643|21035486|P2|COMPLETED|Overall Study||5
8532717|NCT00305643|21035487|P1|COMPLETED|Overall Study||6
8532718|NCT00305643|21035486|P2|STARTED|Overall Study||5
8532719|NCT00305643|21035487|P1|STARTED|Overall Study||6
8532720|NCT00305604|21035497|P2|NOT COMPLETED|Overall Study||47
8532721|NCT00305604|21035498|P1|NOT COMPLETED|Overall Study||32
8532722|NCT00305604|21035497|P2|COMPLETED|Overall Study||57
8532723|NCT00305604|21035498|P1|COMPLETED|Overall Study||70
8532724|NCT00305604|21035497|P2|STARTED|Overall Study||104
8532725|NCT00305604|21035498|P1|STARTED|Overall Study||102
8532726|NCT00305578|21035512|P2|NOT COMPLETED|Overall Study||2
8532727|NCT00305578|21035513|P1|NOT COMPLETED|Overall Study||3
8532728|NCT00305578|21035512|P2|COMPLETED|Overall Study||12
8532729|NCT00305578|21035513|P1|COMPLETED|Overall Study||12
8532730|NCT00305578|21035512|P2|STARTED|Overall Study||14
8532731|NCT00305578|21035513|P1|STARTED|Overall Study||15
8532732|NCT00305565|21035522|P3|NOT COMPLETED|Overall Study (ITT Population)||5
8532733|NCT00305565|21035523|P2|NOT COMPLETED|Overall Study (ITT Population)||11
8532734|NCT00305565|21035524|P1|NOT COMPLETED|Overall Study (ITT Population)||13
8532735|NCT00305565|21035522|P3|COMPLETED|Overall Study (ITT Population)||102
8532736|NCT00305565|21035523|P2|COMPLETED|Overall Study (ITT Population)||90
8532737|NCT00305565|21035524|P1|COMPLETED|Overall Study (ITT Population)||89
8532738|NCT00305565|21035522|P3|STARTED|Overall Study (ITT Population)||107
8532739|NCT00305565|21035523|P2|STARTED|Overall Study (ITT Population)||101
8532740|NCT00305565|21035524|P1|STARTED|Overall Study (ITT Population)||102
8532741|NCT00305565|21035522|P3|NOT COMPLETED|Overall Study (Safety Population)||7
8532742|NCT00305565|21035523|P2|NOT COMPLETED|Overall Study (Safety Population)||12
8532743|NCT00305565|21035524|P1|NOT COMPLETED|Overall Study (Safety Population)||14
8532744|NCT00305565|21035522|P3|COMPLETED|Overall Study (Safety Population)||106
8532745|NCT00305565|21035523|P2|COMPLETED|Overall Study (Safety Population)||95
8532746|NCT00305565|21035524|P1|COMPLETED|Overall Study (Safety Population)||97
8532747|NCT00305565|21035522|P3|STARTED|Overall Study (Safety Population)||113
8532748|NCT00305565|21035523|P2|STARTED|Overall Study (Safety Population)||107
8532749|NCT00305565|21035524|P1|STARTED|Overall Study (Safety Population)||111
8532750|NCT00305448|21035642|P3|NOT COMPLETED|Overall Study||33
8532751|NCT00305448|21035643|P2|NOT COMPLETED|Overall Study||34
8532752|NCT00305448|21035644|P1|NOT COMPLETED|Overall Study||31
8532753|NCT00305448|21035642|P3|COMPLETED|Overall Study||14
8532754|NCT00305448|21035643|P2|COMPLETED|Overall Study||17
8532755|NCT00305448|21035644|P1|COMPLETED|Overall Study||14
8532756|NCT00305448|21035642|P3|STARTED|Overall Study||47
8532757|NCT00305448|21035643|P2|STARTED|Overall Study||51
8532758|NCT00305448|21035644|P1|STARTED|Overall Study||45
8532759|NCT00305344|21035660|P1|NOT COMPLETED|Overall Study||0
8532760|NCT00305344|21035660|P1|COMPLETED|Overall Study||23
8532761|NCT00305344|21035660|P1|STARTED|Overall Study||23
8532762|NCT00305253|21035666|P2|NOT COMPLETED|Overall Study||1
8532763|NCT00305253|21035667|P1|NOT COMPLETED|Overall Study||0
8532764|NCT00305253|21035666|P2|COMPLETED|Overall Study||558
8532765|NCT00305253|21035667|P1|COMPLETED|Overall Study||432
8532766|NCT00305253|21035666|P2|STARTED|Overall Study||559
8532767|NCT00305253|21035667|P1|STARTED|Overall Study||432
8532768|NCT00305227|21035679|P2|NOT COMPLETED|Overall Study||6
8532769|NCT00305227|21035680|P1|NOT COMPLETED|Overall Study||7
8532770|NCT00305227|21035679|P2|COMPLETED|Overall Study|with at least 8 weeks of observation|44
8532771|NCT00305227|21035680|P1|COMPLETED|Overall Study|with at least 8 weeks of observation|43
8532772|NCT00305227|21035679|P2|STARTED|Overall Study||50
8532773|NCT00305227|21035680|P1|STARTED|Overall Study||50
8532774|NCT00305162|21035688|P2|NOT COMPLETED|1 Year Follow-up Period||65
8532775|NCT00305162|21035689|P1|NOT COMPLETED|1 Year Follow-up Period||55
8532776|NCT00305162|21035688|P2|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
8532777|NCT00305162|21035689|P1|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
8532778|NCT00305162|21035688|P2|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
8532779|NCT00305162|21035689|P1|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
8532780|NCT00305162|21035688|P2|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
8532781|NCT00305162|21035689|P1|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
8532782|NCT00305162|21035688|P2|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
8532783|NCT00305162|21035689|P1|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
8532784|NCT00305162|21035688|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
8532785|NCT00305162|21035689|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
8532786|NCT00305162|21035688|P2|STARTED|1 Year Follow-up Period||4447
8532787|NCT00305162|21035689|P1|STARTED|1 Year Follow-up Period||4435
8532788|NCT00305162|21035688|P2|NOT COMPLETED|30-day Follow-up Period||63
8532789|NCT00305162|21035689|P1|NOT COMPLETED|30-day Follow-up Period||62
8532790|NCT00305162|21035688|P2|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
8532791|NCT00305162|21035689|P1|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
8532792|NCT00305162|21035688|P2|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
8532793|NCT00305162|21035689|P1|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
8532794|NCT00305162|21035688|P2|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
8532795|NCT00305162|21035689|P1|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
8532796|NCT00305162|21035688|P2|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
8532797|NCT00305162|21035689|P1|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
8532798|NCT00305162|21035688|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
8532799|NCT00305162|21035689|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
8532800|NCT00305162|21035688|P2|STARTED|30-day Follow-up Period||4447
8532801|NCT00305162|21035689|P1|STARTED|30-day Follow-up Period||4435
8532802|NCT00305162|21035688|P2|NOT COMPLETED|48 Hour Follow-up Period||16
8532803|NCT00305162|21035689|P1|NOT COMPLETED|48 Hour Follow-up Period||20
8532804|NCT00305162|21035688|P2|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
8532805|NCT00305162|21035689|P1|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
8532806|NCT00305162|21035688|P2|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
8532807|NCT00305162|21035689|P1|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
8532808|NCT00305162|21035688|P2|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
8532809|NCT00305162|21035689|P1|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
8532810|NCT00305162|21035688|P2|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
8532811|NCT00305162|21035689|P1|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
8532812|NCT00305162|21035688|P2|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
8532813|NCT00305162|21035689|P1|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
8532814|NCT00305162|21035688|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
8532815|NCT00305162|21035689|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
8532816|NCT00305162|21035688|P2|STARTED|48 Hour Follow-up Period||4447
8532817|NCT00305162|21035689|P1|STARTED|48 Hour Follow-up Period||4435
8532818|NCT00305110|21035727|P1|NOT COMPLETED|Overall Study||29
8532819|NCT00305110|21035727|P1|COMPLETED|Overall Study||269
8532820|NCT00305110|21035727|P1|All Necessary Data Collected|Overall Study||269
8532821|NCT00305110|21035727|P1|STARTED|Overall Study||298
8532822|NCT00305084|21035741|P5|NOT COMPLETED|Overall Study||0
8532823|NCT00305084|21035742|P4|NOT COMPLETED|Overall Study||0
8532824|NCT00305084|21035743|P3|NOT COMPLETED|Overall Study||0
8532825|NCT00305084|21035744|P2|NOT COMPLETED|Overall Study||0
8532826|NCT00305084|21035745|P1|NOT COMPLETED|Overall Study||0
8532827|NCT00305084|21035741|P5|COMPLETED|Overall Study||3
8532828|NCT00305084|21035742|P4|COMPLETED|Overall Study||3
8532829|NCT00305084|21035743|P3|COMPLETED|Overall Study||3
8532830|NCT00305084|21035744|P2|COMPLETED|Overall Study||3
8532831|NCT00305084|21035745|P1|COMPLETED|Overall Study||3
8532832|NCT00305084|21035741|P5|STARTED|Overall Study||3
8532833|NCT00305084|21035742|P4|STARTED|Overall Study||3
8532834|NCT00305084|21035743|P3|STARTED|Overall Study||3
8532835|NCT00305084|21035744|P2|STARTED|Overall Study||3
8532836|NCT00305084|21035745|P1|STARTED|Overall Study||3
8532837|NCT00305058|21035800|P2|NOT COMPLETED|Overall Study||4
8532838|NCT00305058|21035801|P1|NOT COMPLETED|Overall Study||7
8532839|NCT00305058|21035800|P2|COMPLETED|Overall Study||93
8532840|NCT00305058|21035801|P1|COMPLETED|Overall Study||90
8532841|NCT00305058|21035800|P2|Data Collection Forms Filed for Analysis|Overall Study||93
8532842|NCT00305058|21035801|P1|Data Collection Forms Filed for Analysis|Overall Study||90
8532843|NCT00305058|21035800|P2|All Outcome Data Collected|Overall Study||95
8532844|NCT00305058|21035801|P1|All Outcome Data Collected|Overall Study||93
8532845|NCT00305058|21035800|P2|Inclusion/Exclusion Verification|Overall Study||97
8532846|NCT00305058|21035801|P1|Inclusion/Exclusion Verification|Overall Study||96
8532847|NCT00305058|21035800|P2|STARTED|Overall Study||97
8532848|NCT00305058|21035801|P1|STARTED|Overall Study||97
8532849|NCT00304954|21035817|P4|NOT COMPLETED|Overall Study||0
8532850|NCT00304954|21035818|P3|NOT COMPLETED|Overall Study||1
8532851|NCT00304954|21035819|P2|NOT COMPLETED|Overall Study||0
8532852|NCT00304954|21035820|P1|NOT COMPLETED|Overall Study||1
8532853|NCT00304954|21035817|P4|COMPLETED|Overall Study||3
8532854|NCT00304954|21035818|P3|COMPLETED|Overall Study||2
8532855|NCT00304954|21035819|P2|COMPLETED|Overall Study||3
8532856|NCT00304954|21035820|P1|COMPLETED|Overall Study||3
8532857|NCT00304954|21035817|P4|STARTED|Overall Study||3
8532858|NCT00304954|21035818|P3|STARTED|Overall Study||3
8532859|NCT00304954|21035819|P2|STARTED|Overall Study||3
8532860|NCT00304954|21035820|P1|STARTED|Overall Study||4
8532861|NCT00304915|21035840|P2|NOT COMPLETED|Overall Study||16
8532862|NCT00304915|21035841|P1|NOT COMPLETED|Overall Study||18
8532863|NCT00304915|21035840|P2|COMPLETED|Overall Study||110
8532864|NCT00304915|21035841|P1|COMPLETED|Overall Study||105
8532865|NCT00304915|21035840|P2|STARTED|Overall Study||126
8532866|NCT00304915|21035841|P1|STARTED|Overall Study||123
8532867|NCT00304746|21035849|P2|NOT COMPLETED|Overall Study||0
8532868|NCT00304746|21035850|P1|NOT COMPLETED|Overall Study||0
8532869|NCT00304746|21035849|P2|COMPLETED|Overall Study||50
8532870|NCT00304746|21035850|P1|COMPLETED|Overall Study||50
8532871|NCT00304746|21035849|P2|STARTED|Overall Study||50
8532872|NCT00304746|21035850|P1|STARTED|Overall Study||50
8532873|NCT00304707|21035860|P2|NOT COMPLETED|Overall Study||6
8532874|NCT00304707|21035861|P1|NOT COMPLETED|Overall Study||7
8532875|NCT00304707|21035860|P2|COMPLETED|Overall Study||64
8532876|NCT00304707|21035861|P1|COMPLETED|Overall Study||66
8532877|NCT00304707|21035860|P2|STARTED|Overall Study||70
8532878|NCT00304707|21035861|P1|STARTED|Overall Study||73
8532879|NCT00304512|21035870|P3|NOT COMPLETED|Extension Period||0
8532880|NCT00304512|21035871|P2|NOT COMPLETED|Extension Period||0
8532881|NCT00304512|21035872|P1|NOT COMPLETED|Extension Period||0
8532882|NCT00304512|21035870|P3|COMPLETED|Extension Period||3
8532883|NCT00304512|21035871|P2|COMPLETED|Extension Period||4
8532884|NCT00304512|21035872|P1|COMPLETED|Extension Period||2
8532885|NCT00304512|21035870|P3|STARTED|Extension Period||3
8532886|NCT00304512|21035871|P2|STARTED|Extension Period||4
8532887|NCT00304512|21035872|P1|STARTED|Extension Period||2
8532888|NCT00304512|21035870|P3|NOT COMPLETED|Treatment Period||0
8532889|NCT00304512|21035871|P2|NOT COMPLETED|Treatment Period||0
8532890|NCT00304512|21035872|P1|NOT COMPLETED|Treatment Period||0
8532891|NCT00304512|21035870|P3|COMPLETED|Treatment Period||3
8532892|NCT00304512|21035871|P2|COMPLETED|Treatment Period||4
8532893|NCT00304512|21035872|P1|COMPLETED|Treatment Period||2
8532894|NCT00304512|21035870|P3|Pharmacodynamic (PD) Population|Treatment Period||3
8532895|NCT00304512|21035871|P2|Pharmacodynamic (PD) Population|Treatment Period||4
8532896|NCT00304512|21035872|P1|Pharmacodynamic (PD) Population|Treatment Period||2
8532897|NCT00304512|21035870|P3|Pharmacokinetic (PK) Population|Treatment Period||3
8532898|NCT00304512|21035871|P2|Pharmacokinetic (PK) Population|Treatment Period||4
8532899|NCT00304512|21035872|P1|Pharmacokinetic (PK) Population|Treatment Period||2
8532900|NCT00304512|21035870|P3|Safety Population|Treatment Period||3
8532901|NCT00304512|21035871|P2|Safety Population|Treatment Period||4
8532902|NCT00304512|21035872|P1|Safety Population|Treatment Period||2
8532903|NCT00304512|21035870|P3|STARTED|Treatment Period||3
8532904|NCT00304512|21035871|P2|STARTED|Treatment Period||4
8532905|NCT00304512|21035872|P1|STARTED|Treatment Period||2
8532906|NCT00304356|21035886|P1|NOT COMPLETED|Nitazoxanide||5
8532907|NCT00304356|21035886|P1|COMPLETED|Nitazoxanide||22
8532908|NCT00304356|21035886|P1|STARTED|Nitazoxanide||27
8532909|NCT00304356|21035886|P1|NOT COMPLETED|Nitazoxanide||5
8532910|NCT00304356|21035886|P1|COMPLETED|Nitazoxanide||22
8532911|NCT00304356|21035886|P1|STARTED|Nitazoxanide||27
8532912|NCT00304278|21035890|P1|NOT COMPLETED|Overall Study||2
8532913|NCT00304278|21035890|P1|COMPLETED|Overall Study||19
8532914|NCT00304278|21035890|P1|STARTED|Overall Study||21
8532915|NCT00304265|21035897|P2|NOT COMPLETED|Overall Study||0
8532916|NCT00304265|21035898|P1|NOT COMPLETED|Overall Study||0
8532917|NCT00304265|21035897|P2|COMPLETED|Overall Study||98
8532918|NCT00304265|21035898|P1|COMPLETED|Overall Study||117
8532919|NCT00304265|21035897|P2|STARTED|Overall Study||98
8532920|NCT00304265|21035898|P1|STARTED|Overall Study||117
8532921|NCT00304187|21035906|P2|NOT COMPLETED|Overall Study||1
8532922|NCT00304187|21035907|P1|NOT COMPLETED|Overall Study||2
8532923|NCT00304187|21035906|P2|COMPLETED|Overall Study||13
8532924|NCT00304187|21035907|P1|COMPLETED|Overall Study||13
8532925|NCT00304187|21035906|P2|STARTED|Overall Study||14
8532926|NCT00304187|21035907|P1|STARTED|Overall Study||15
8532927|NCT00304161|21035917|P2|NOT COMPLETED|Overall Study||6
8532928|NCT00304161|21035918|P1|NOT COMPLETED|Overall Study||6
8532929|NCT00304161|21035917|P2|COMPLETED|Overall Study||21
8532930|NCT00304161|21035918|P1|COMPLETED|Overall Study||22
8532931|NCT00304161|21035917|P2|STARTED|Overall Study||27
8532932|NCT00304161|21035918|P1|STARTED|Overall Study||28
8532933|NCT00304096|21035928|P2|NOT COMPLETED|Overall Study||0
8532934|NCT00304096|21035929|P1|NOT COMPLETED|Overall Study||0
8532935|NCT00304096|21035928|P2|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
8532936|NCT00304096|21035929|P1|COMPLETED|Overall Study||6
8532937|NCT00304096|21035928|P2|STARTED|Overall Study||5
8532938|NCT00304096|21035929|P1|STARTED|Overall Study||6
8532939|NCT00304083|21035939|P2|NOT COMPLETED|Overall Study||8
8532940|NCT00304083|21035940|P1|NOT COMPLETED|Overall Study||22
8532941|NCT00304083|21035939|P2|COMPLETED|Overall Study||6
8532942|NCT00304083|21035940|P1|COMPLETED|Overall Study||12
8532943|NCT00304083|21035939|P2|Patients Had Neither RT or Surgery|Overall Study||1
8532944|NCT00304083|21035940|P1|Patients Had Neither RT or Surgery|Overall Study||6
8532945|NCT00304083|21035939|P2|Patients Treated With RT Only|Overall Study||2
8532946|NCT00304083|21035940|P1|Patients Treated With RT Only|Overall Study||4
8532947|NCT00304083|21035939|P2|Patients Treated With Surgery and RT|Overall Study||1
8532948|NCT00304083|21035940|P1|Patients Treated With Surgery and RT|Overall Study||5
8532949|NCT00304083|21035939|P2|Patients Treated With Surgery|Overall Study||3
8532950|NCT00304083|21035940|P1|Patients Treated With Surgery|Overall Study||7
8532951|NCT00304083|21035939|P2|Completed 4 Cycles|Overall Study||7
8532952|NCT00304083|21035940|P1|Completed 4 Cycles|Overall Study||22
8532953|NCT00304083|21035939|P2|STARTED|Overall Study||14
8532954|NCT00304083|21035940|P1|STARTED|Overall Study||34
8532964|NCT00304031|21035976|P3|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
8532965|NCT00304031|21035977|P2|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
8532966|NCT00304031|21035978|P1|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
8532967|NCT00304031|21035976|P3|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|420
8532968|NCT00304031|21035977|P2|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|411
8532969|NCT00304031|21035978|P1|COMPLETED|Randomization to Adjuvant TMZ Arm||0
8532970|NCT00304031|21035976|P3|Quality of Life Population|Randomization to Adjuvant TMZ Arm||95
8532971|NCT00304031|21035977|P2|Quality of Life Population|Randomization to Adjuvant TMZ Arm||96
8532972|NCT00304031|21035978|P1|Quality of Life Population|Randomization to Adjuvant TMZ Arm||0
8532973|NCT00304031|21035976|P3|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
8532974|NCT00304031|21035977|P2|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
8532975|NCT00304031|21035978|P1|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
8532976|NCT00304031|21035976|P3|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||262
8532977|NCT00304031|21035977|P2|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||254
8532978|NCT00304031|21035978|P1|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
8532979|NCT00304031|21035976|P3|Eligible Population|Randomization to Adjuvant TMZ Arm||420
8532980|NCT00304031|21035977|P2|Eligible Population|Randomization to Adjuvant TMZ Arm||411
8532981|NCT00304031|21035978|P1|Eligible Population|Randomization to Adjuvant TMZ Arm||0
8532982|NCT00304031|21035976|P3|STARTED|Randomization to Adjuvant TMZ Arm||422
8532983|NCT00304031|21035977|P2|STARTED|Randomization to Adjuvant TMZ Arm||411
8532984|NCT00304031|21035978|P1|STARTED|Randomization to Adjuvant TMZ Arm||0
8532985|NCT00304031|21035976|P3|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
8532986|NCT00304031|21035977|P2|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
8532987|NCT00304031|21035978|P1|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||292
8532988|NCT00304031|21035976|P3|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
8532989|NCT00304031|21035977|P2|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
8532990|NCT00304031|21035978|P1|COMPLETED|Concomitant RT+TMZ (Pre-randomization)|These participants completed concomitant treatment and met requirements for randomization.|833
8532991|NCT00304031|21035976|P3|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
8532992|NCT00304031|21035977|P2|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
8532993|NCT00304031|21035978|P1|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||1120
8532994|NCT00304031|21035976|P3|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
8532995|NCT00304031|21035977|P2|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
8532996|NCT00304031|21035978|P1|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||1125
8533084|NCT00303472|21036240|P3|STARTED|Treatment Extension (Optional)||11
8532997|NCT00304031|21035976|P3|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
8532998|NCT00304031|21035977|P2|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
8532999|NCT00304031|21035978|P1|STARTED|Concomitant RT+TMZ (Pre-randomization)|All participants registered to concomitant treatment; randomized after completing this treatment.|1125
8533000|NCT00303979|21036031|P3|NOT COMPLETED|Overall Study||0
8533001|NCT00303979|21036032|P2|NOT COMPLETED|Overall Study||0
8533002|NCT00303979|21036033|P1|NOT COMPLETED|Overall Study||7572
8533003|NCT00303979|21036031|P3|COMPLETED|Overall Study|at 18 months|9641
8533004|NCT00303979|21036032|P2|COMPLETED|Overall Study|at 6 months|9992
8533005|NCT00303979|21036033|P1|COMPLETED|Overall Study|at 24 Months|7605
8533006|NCT00303979|21036031|P3|STARTED|Overall Study|at 18 months|9641
8533007|NCT00303979|21036032|P2|STARTED|Overall Study|at 6 months|9992
8533008|NCT00303979|21036033|P1|STARTED|Overall Study|at baseline|15177
8533009|NCT00303966|21036051|P1|NOT COMPLETED|Overall Study||0
8533010|NCT00303966|21036051|P1|COMPLETED|Overall Study||5
8533011|NCT00303966|21036051|P1|STARTED|Overall Study||5
8533012|NCT00303953|21036060|P1|NOT COMPLETED|Overall Study||19
8533013|NCT00303953|21036060|P1|COMPLETED|Overall Study||3
8533014|NCT00303953|21036060|P1|Eligible and Treated|Overall Study||20
8533015|NCT00303953|21036060|P1|Eligible|Overall Study||21
8533016|NCT00303953|21036060|P1|STARTED|Overall Study||22
8533017|NCT00303901|21036066|P1|NOT COMPLETED|Overall Study||0
8533018|NCT00303901|21036066|P1|COMPLETED|Overall Study||40
8533019|NCT00303901|21036066|P1|STARTED|Overall Study||40
8533020|NCT00303862|21036072|P1|NOT COMPLETED|Overall Study||0
8533021|NCT00303862|21036072|P1|COMPLETED|Overall Study||10
8533022|NCT00303862|21036072|P1|STARTED|Overall Study||10
8533023|NCT00303823|21036081|P2|NOT COMPLETED|Overall Study||10
8533024|NCT00303823|21036082|P1|NOT COMPLETED|Overall Study||15
8533025|NCT00303823|21036081|P2|COMPLETED|Overall Study||38
8533026|NCT00303823|21036082|P1|COMPLETED|Overall Study||35
8533027|NCT00303823|21036081|P2|STARTED|Overall Study||48
8533028|NCT00303823|21036082|P1|STARTED|Overall Study||50
8533029|NCT00303719|21036096|P2|NOT COMPLETED|Overall Study||37
8533030|NCT00303719|21036097|P1|NOT COMPLETED|Overall Study||0
8533031|NCT00303719|21036096|P2|COMPLETED|Overall Study||292
8533032|NCT00303719|21036097|P1|COMPLETED|Overall Study||13
8533033|NCT00303719|21036096|P2|STARTED|Overall Study||329
8533034|NCT00303719|21036097|P1|STARTED|Overall Study||13
8533035|NCT00303667|21036113|P2|NOT COMPLETED|Overall Study||4
8533036|NCT00303667|21036114|P1|NOT COMPLETED|Overall Study||0
8533037|NCT00303667|21036113|P2|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
8533038|NCT00303667|21036114|P1|COMPLETED|Overall Study||8
8533039|NCT00303667|21036113|P2|STARTED|Overall Study||39
8533040|NCT00303667|21036114|P1|STARTED|Overall Study||8
8533041|NCT00303628|21036138|P2|NOT COMPLETED|Overall Study||73
8533042|NCT00303628|21036139|P1|NOT COMPLETED|Overall Study||50
8533043|NCT00303628|21036138|P2|COMPLETED|Overall Study||106
8533044|NCT00303628|21036139|P1|COMPLETED|Overall Study||126
8533045|NCT00303628|21036138|P2|Treated|Overall Study||174
8533046|NCT00303628|21036139|P1|Treated|Overall Study||173
8533047|NCT00303628|21036138|P2|Eligible|Overall Study||177
8533048|NCT00303628|21036139|P1|Eligible|Overall Study||171
8533049|NCT00303628|21036138|P2|STARTED|Overall Study||179
8533050|NCT00303628|21036139|P1|STARTED|Overall Study||176
8533051|NCT00303602|21036157|P2|NOT COMPLETED|Overall Study||15
8533052|NCT00303602|21036158|P1|NOT COMPLETED|Overall Study||19
8533053|NCT00303602|21036157|P2|COMPLETED|Overall Study||50
8533054|NCT00303602|21036158|P1|COMPLETED|Overall Study||65
8533055|NCT00303602|21036157|P2|STARTED|Overall Study||65
8533056|NCT00303602|21036158|P1|STARTED|Overall Study||84
8533057|NCT00303511|21036198|P1|NOT COMPLETED|Overall Study||0
8533058|NCT00303511|21036198|P1|COMPLETED|Overall Study||10
8533059|NCT00303511|21036198|P1|STARTED|Overall Study||10
8533060|NCT00303485|21036204|P2|NOT COMPLETED|Overall Study||2
8533061|NCT00303485|21036205|P1|NOT COMPLETED|Overall Study||1
8533062|NCT00303485|21036204|P2|COMPLETED|Overall Study||15
8533063|NCT00303485|21036205|P1|COMPLETED|Overall Study||48
8533064|NCT00303485|21036204|P2|STARTED|Overall Study||17
8533065|NCT00303485|21036205|P1|STARTED|Overall Study||49
8533066|NCT00303472|21036236|P7|NOT COMPLETED|Treatment Extension (Optional)||0
8533067|NCT00303472|21036237|P6|NOT COMPLETED|Treatment Extension (Optional)||1
8533068|NCT00303472|21036238|P5|NOT COMPLETED|Treatment Extension (Optional)||4
8533069|NCT00303472|21036239|P4|NOT COMPLETED|Treatment Extension (Optional)||8
8533070|NCT00303472|21036240|P3|NOT COMPLETED|Treatment Extension (Optional)||9
8533071|NCT00303472|21036241|P2|NOT COMPLETED|Treatment Extension (Optional)||6
8533072|NCT00303472|21036242|P1|NOT COMPLETED|Treatment Extension (Optional)||5
8533073|NCT00303472|21036236|P7|COMPLETED|Treatment Extension (Optional)||1
8533074|NCT00303472|21036237|P6|COMPLETED|Treatment Extension (Optional)||4
8533075|NCT00303472|21036238|P5|COMPLETED|Treatment Extension (Optional)||1
8533076|NCT00303472|21036239|P4|COMPLETED|Treatment Extension (Optional)||5
8533077|NCT00303472|21036240|P3|COMPLETED|Treatment Extension (Optional)||2
8533078|NCT00303472|21036241|P2|COMPLETED|Treatment Extension (Optional)||5
8533079|NCT00303472|21036242|P1|COMPLETED|Treatment Extension (Optional)||1
8533080|NCT00303472|21036236|P7|STARTED|Treatment Extension (Optional)||1
8533081|NCT00303472|21036237|P6|STARTED|Treatment Extension (Optional)||5
8533082|NCT00303472|21036238|P5|STARTED|Treatment Extension (Optional)||5
8533083|NCT00303472|21036239|P4|STARTED|Treatment Extension (Optional)||13
8533085|NCT00303472|21036241|P2|STARTED|Treatment Extension (Optional)||11
8533086|NCT00303472|21036242|P1|STARTED|Treatment Extension (Optional)||6
8533087|NCT00303472|21036236|P7|NOT COMPLETED|Treatment Period||2
8533088|NCT00303472|21036237|P6|NOT COMPLETED|Treatment Period||1
8533089|NCT00303472|21036238|P5|NOT COMPLETED|Treatment Period||3
8533090|NCT00303472|21036239|P4|NOT COMPLETED|Treatment Period||2
8533091|NCT00303472|21036240|P3|NOT COMPLETED|Treatment Period||0
8533092|NCT00303472|21036241|P2|NOT COMPLETED|Treatment Period||0
8533093|NCT00303472|21036242|P1|NOT COMPLETED|Treatment Period||0
8533094|NCT00303472|21036236|P7|COMPLETED|Treatment Period||3
8533095|NCT00303472|21036237|P6|COMPLETED|Treatment Period||11
8533096|NCT00303472|21036238|P5|COMPLETED|Treatment Period||8
8533097|NCT00303472|21036239|P4|COMPLETED|Treatment Period||14
8533098|NCT00303472|21036240|P3|COMPLETED|Treatment Period||11
8533099|NCT00303472|21036241|P2|COMPLETED|Treatment Period||11
8533100|NCT00303472|21036242|P1|COMPLETED|Treatment Period||6
8533101|NCT00303472|21036236|P7|STARTED|Treatment Period||5
8533102|NCT00303472|21036237|P6|STARTED|Treatment Period||12
8533103|NCT00303472|21036238|P5|STARTED|Treatment Period||11
8533104|NCT00303472|21036239|P4|STARTED|Treatment Period||16
8533105|NCT00303472|21036240|P3|STARTED|Treatment Period||11
8533106|NCT00303472|21036241|P2|STARTED|Treatment Period||11
8533107|NCT00303472|21036242|P1|STARTED|Treatment Period||6
8533108|NCT00303459|21036302|P2|NOT COMPLETED|Overall Study||89
8533109|NCT00303459|21036303|P1|NOT COMPLETED|Overall Study||83
8533110|NCT00303459|21036302|P2|COMPLETED|Overall Study||86
8533111|NCT00303459|21036303|P1|COMPLETED|Overall Study||76
8533112|NCT00303459|21036302|P2|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
8533113|NCT00303459|21036303|P1|STARTED|Overall Study||159
8533114|NCT00303446|21036329|P2|NOT COMPLETED|Overall Study||4
8533115|NCT00303446|21036330|P1|NOT COMPLETED|Overall Study||2
8533116|NCT00303446|21036329|P2|COMPLETED|Overall Study||21
8533117|NCT00303446|21036330|P1|COMPLETED|Overall Study||23
8533118|NCT00303446|21036329|P2|STARTED|Overall Study||25
8533119|NCT00303446|21036330|P1|STARTED|Overall Study||25
8533120|NCT00303329|21036366|P2|NOT COMPLETED|Overall Study||62
8533121|NCT00303329|21036367|P1|NOT COMPLETED|Overall Study||35
8533122|NCT00303329|21036366|P2|COMPLETED|Overall Study||37
8533123|NCT00303329|21036367|P1|COMPLETED|Overall Study||50
8533124|NCT00303329|21036366|P2|STARTED|Overall Study||99
8533125|NCT00303329|21036367|P1|STARTED|Overall Study||85
8533126|NCT00303316|21036381|P2|NOT COMPLETED|Overall Study||3
8533127|NCT00303316|21036382|P1|NOT COMPLETED|Overall Study||2
8533128|NCT00303316|21036381|P2|COMPLETED|Overall Study||223
8533129|NCT00303316|21036382|P1|COMPLETED|Overall Study||230
8533130|NCT00303316|21036381|P2|STARTED|Overall Study||226
8533131|NCT00303316|21036382|P1|STARTED|Overall Study||232
8533132|NCT00303186|21036394|P1|NOT COMPLETED|Overall Study||52
8533133|NCT00303186|21036394|P1|COMPLETED|Overall Study||55
8533134|NCT00303186|21036394|P1|STARTED|Overall Study||107
8533135|NCT00303108|21036428|P3|NOT COMPLETED|Overall Study||16
8533136|NCT00303108|21036429|P2|NOT COMPLETED|Overall Study||9
8533137|NCT00303108|21036430|P1|NOT COMPLETED|Overall Study||12
8533138|NCT00303108|21036428|P3|COMPLETED|Overall Study||31
8533139|NCT00303108|21036429|P2|COMPLETED|Overall Study||37
8533140|NCT00303108|21036430|P1|COMPLETED|Overall Study||31
8533141|NCT00303108|21036428|P3|STARTED|Overall Study||47
8533142|NCT00303108|21036429|P2|STARTED|Overall Study||46
8533143|NCT00303108|21036430|P1|STARTED|Overall Study||43
8533144|NCT00303069|21036450|P4|NOT COMPLETED|Overall Study||2
8533145|NCT00303069|21036451|P3|NOT COMPLETED|Overall Study||1
8533146|NCT00303069|21036452|P2|NOT COMPLETED|Overall Study||0
8533147|NCT00303069|21036453|P1|NOT COMPLETED|Overall Study||2
8533148|NCT00303069|21036450|P4|COMPLETED|Overall Study||29
8533149|NCT00303069|21036451|P3|COMPLETED|Overall Study||33
8533150|NCT00303069|21036452|P2|COMPLETED|Overall Study||28
8533151|NCT00303069|21036453|P1|COMPLETED|Overall Study||29
8533152|NCT00303069|21036450|P4|STARTED|Overall Study||31
8533153|NCT00303069|21036451|P3|STARTED|Overall Study||34
8533154|NCT00303069|21036452|P2|STARTED|Overall Study||28
8533155|NCT00303069|21036453|P1|STARTED|Overall Study||31
8533156|NCT00302952|21036473|P2|NOT COMPLETED|Overall Study||5
8533157|NCT00302952|21036474|P1|NOT COMPLETED|Overall Study||3
8533158|NCT00302952|21036473|P2|COMPLETED|Overall Study||25
8533159|NCT00302952|21036474|P1|COMPLETED|Overall Study||31
8533160|NCT00302952|21036473|P2|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
8533161|NCT00302952|21036474|P1|Completed Intent-to-Treat (ITT)|Overall Study||34
8533162|NCT00302952|21036473|P2|Started Intent-to-Treat (ITT)|Overall Study||30
8533163|NCT00302952|21036474|P1|Started Intent-to-Treat (ITT)|Overall Study||34
8533164|NCT00302952|21036473|P2|STARTED|Overall Study||30
8533165|NCT00302952|21036474|P1|STARTED|Overall Study||34
8533166|NCT00302848|21036511|P3|NOT COMPLETED|Overall Study||579
8533167|NCT00302848|21036512|P2|NOT COMPLETED|Overall Study||419
8533168|NCT00302848|21036513|P1|NOT COMPLETED|Overall Study||401
8533169|NCT00302848|21036511|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
8533170|NCT00302848|21036512|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
8533171|NCT00302848|21036513|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
8533172|NCT00302848|21036511|P3|STARTED|Overall Study||26341
8533173|NCT00302848|21036512|P2|STARTED|Overall Study||15428
8533174|NCT00302848|21036513|P1|STARTED|Overall Study||16534
8533175|NCT00302731|21036524|P4|NOT COMPLETED|Overall Study||0
8533176|NCT00302731|21036525|P3|NOT COMPLETED|Overall Study||3
8533177|NCT00302731|21036526|P2|NOT COMPLETED|Overall Study||5
8533178|NCT00302731|21036527|P1|NOT COMPLETED|Overall Study||4
8533179|NCT00302731|21036524|P4|COMPLETED|Overall Study||4
8533180|NCT00302731|21036525|P3|COMPLETED|Overall Study||2
8533181|NCT00302731|21036526|P2|COMPLETED|Overall Study||1
8533182|NCT00302731|21036527|P1|COMPLETED|Overall Study||2
8533183|NCT00302731|21036524|P4|STARTED|Overall Study||4
8533184|NCT00302731|21036525|P3|STARTED|Overall Study||5
8533185|NCT00302731|21036526|P2|STARTED|Overall Study||6
8533186|NCT00302731|21036527|P1|STARTED|Overall Study||6
8533187|NCT00302718|21036553|P4|NOT COMPLETED|Overall Study||2
8533188|NCT00302718|21036554|P3|NOT COMPLETED|Overall Study||2
8533189|NCT00302718|21036555|P2|NOT COMPLETED|Overall Study||1
8533190|NCT00302718|21036556|P1|NOT COMPLETED|Overall Study||1
8533191|NCT00302718|21036553|P4|COMPLETED|Overall Study||19
8533192|NCT00302718|21036554|P3|COMPLETED|Overall Study||19
8533193|NCT00302718|21036555|P2|COMPLETED|Overall Study||20
8533194|NCT00302718|21036556|P1|COMPLETED|Overall Study||19
8533195|NCT00302718|21036553|P4|STARTED|Overall Study||21
8533196|NCT00302718|21036554|P3|STARTED|Overall Study||21
8533197|NCT00302718|21036555|P2|STARTED|Overall Study||21
8533198|NCT00302718|21036556|P1|STARTED|Overall Study||20
8533199|NCT00302458|21036622|P1|NOT COMPLETED|Overall Study||3
8533200|NCT00302458|21036622|P1|COMPLETED|Overall Study||26
8533201|NCT00302458|21036622|P1|STARTED|Overall Study||29
8533202|NCT00302328|21036633|P3|NOT COMPLETED|Overall Study||0
8533203|NCT00302328|21036634|P2|NOT COMPLETED|Overall Study||1
8533204|NCT00302328|21036635|P1|NOT COMPLETED|Overall Study||0
8533205|NCT00302328|21036633|P3|COMPLETED|Overall Study||18
8533206|NCT00302328|21036634|P2|COMPLETED|Overall Study|developed cancer during the study|34
8533207|NCT00302328|21036635|P1|COMPLETED|Overall Study||25
8533208|NCT00302328|21036633|P3|STARTED|Overall Study||18
8533209|NCT00302328|21036634|P2|STARTED|Overall Study||35
8533210|NCT00302328|21036635|P1|STARTED|Overall Study||25
8533211|NCT00302211|21036652|P5|NOT COMPLETED|Open Label-Patients From Double-Blind||8
8533212|NCT00302211|21036653|P4|NOT COMPLETED|Open Label-Patients From Double-Blind||8
8533213|NCT00302211|21036654|P3|NOT COMPLETED|Open Label-Patients From Double-Blind||0
8533214|NCT00302211|21036655|P2|NOT COMPLETED|Open Label-Patients From Double-Blind||0
8533215|NCT00302211|21036656|P1|NOT COMPLETED|Open Label-Patients From Double-Blind||0
8533216|NCT00302211|21036652|P5|COMPLETED|Open Label-Patients From Double-Blind||24
8533217|NCT00302211|21036653|P4|COMPLETED|Open Label-Patients From Double-Blind||18
8533218|NCT00302211|21036654|P3|COMPLETED|Open Label-Patients From Double-Blind||0
8533219|NCT00302211|21036655|P2|COMPLETED|Open Label-Patients From Double-Blind||0
8533220|NCT00302211|21036656|P1|COMPLETED|Open Label-Patients From Double-Blind||0
8533221|NCT00302211|21036652|P5|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
8533222|NCT00302211|21036653|P4|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
8533223|NCT00302211|21036654|P3|STARTED|Open Label-Patients From Double-Blind||0
8533224|NCT00302211|21036655|P2|STARTED|Open Label-Patients From Double-Blind||0
8533225|NCT00302211|21036656|P1|STARTED|Open Label-Patients From Double-Blind||0
8533226|NCT00302211|21036652|P5|NOT COMPLETED|Double Blind Period (New Patients)||0
8533227|NCT00302211|21036653|P4|NOT COMPLETED|Double Blind Period (New Patients)||0
8533228|NCT00302211|21036654|P3|NOT COMPLETED|Double Blind Period (New Patients)||4
8533229|NCT00302211|21036655|P2|NOT COMPLETED|Double Blind Period (New Patients)||2
8533230|NCT00302211|21036656|P1|NOT COMPLETED|Double Blind Period (New Patients)||3
8533231|NCT00302211|21036652|P5|COMPLETED|Double Blind Period (New Patients)||0
8533232|NCT00302211|21036653|P4|COMPLETED|Double Blind Period (New Patients)||0
8533233|NCT00302211|21036654|P3|COMPLETED|Double Blind Period (New Patients)||10
8533234|NCT00302211|21036655|P2|COMPLETED|Double Blind Period (New Patients)||25
8533235|NCT00302211|21036656|P1|COMPLETED|Double Blind Period (New Patients)||23
8533236|NCT00302211|21036652|P5|STARTED|Double Blind Period (New Patients)||0
8533237|NCT00302211|21036653|P4|STARTED|Double Blind Period (New Patients)||0
8533238|NCT00302211|21036654|P3|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14
8533239|NCT00302211|21036655|P2|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27
8533240|NCT00302211|21036656|P1|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26
8533241|NCT00302159|21036682|P1|NOT COMPLETED|Overall Study||2
8533242|NCT00302159|21036682|P1|COMPLETED|Overall Study||41
8533243|NCT00302159|21036682|P1|STARTED|Overall Study||43
8533244|NCT00302133|21036693|P2|NOT COMPLETED|Overall Study||4
8533245|NCT00302133|21036694|P1|NOT COMPLETED|Overall Study||4
8533246|NCT00302133|21036693|P2|COMPLETED|Overall Study||5
8533247|NCT00302133|21036694|P1|COMPLETED|Overall Study||5
8533248|NCT00302133|21036693|P2|STARTED|Overall Study||9
8533249|NCT00302133|21036694|P1|STARTED|Overall Study||9
8533250|NCT00302107|21036704|P2|NOT COMPLETED|Overall Study||9
8533251|NCT00302107|21036705|P1|NOT COMPLETED|Overall Study||8
8533252|NCT00302107|21036704|P2|COMPLETED|Overall Study||30
8533253|NCT00302107|21036705|P1|COMPLETED|Overall Study||31
8533254|NCT00302107|21036704|P2|STARTED|Overall Study||39
8533255|NCT00302107|21036705|P1|STARTED|Overall Study||39
8533256|NCT00302081|21036714|P3|NOT COMPLETED|Overall Study||52
8533257|NCT00302081|21036715|P2|NOT COMPLETED|Overall Study||43
8533258|NCT00302081|21036716|P1|NOT COMPLETED|Overall Study||56
8533259|NCT00302081|21036714|P3|COMPLETED|Overall Study||178
8533260|NCT00302081|21036715|P2|COMPLETED|Overall Study||186
8533261|NCT00302081|21036716|P1|COMPLETED|Overall Study||181
8533262|NCT00302081|21036714|P3|STARTED|Overall Study||230
8533263|NCT00302081|21036715|P2|STARTED|Overall Study||229
8533264|NCT00302081|21036716|P1|STARTED|Overall Study||237
8533265|NCT00302068|21036727|P3|NOT COMPLETED|Overall Study||1
8533266|NCT00302068|21036728|P2|NOT COMPLETED|Overall Study||4
8533267|NCT00302068|21036729|P1|NOT COMPLETED|Overall Study||1
8533268|NCT00302068|21036727|P3|COMPLETED|Overall Study||23
8533269|NCT00302068|21036728|P2|COMPLETED|Overall Study||36
8533270|NCT00302068|21036729|P1|COMPLETED|Overall Study||36
8533271|NCT00302068|21036727|P3|STARTED|Overall Study||24
8533272|NCT00302068|21036728|P2|STARTED|Overall Study||40
8533273|NCT00302068|21036729|P1|STARTED|Overall Study||37
8533274|NCT00302055|21036757|P2|NOT COMPLETED|Overall Study||13
8533275|NCT00302055|21036758|P1|NOT COMPLETED|Overall Study||9
8533276|NCT00302055|21036757|P2|COMPLETED|Overall Study||36
8533277|NCT00302055|21036758|P1|COMPLETED|Overall Study||14
8533278|NCT00302055|21036757|P2|STARTED|Overall Study||49
8533279|NCT00302055|21036758|P1|STARTED|Overall Study||23
8533280|NCT00302042|21036766|P2|NOT COMPLETED|Overall Study||8
8533281|NCT00302042|21036767|P1|NOT COMPLETED|Overall Study||7
8533282|NCT00302042|21036766|P2|COMPLETED|Overall Study||38
8533283|NCT00302042|21036767|P1|COMPLETED|Overall Study||39
8533284|NCT00302042|21036766|P2|STARTED|Overall Study||46
8533285|NCT00302042|21036767|P1|STARTED|Overall Study||46
8533289|NCT00301964|21036780|P1|NOT COMPLETED|Overall Study||4
8533290|NCT00301964|21036780|P1|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
8533291|NCT00301964|21036780|P1|STARTED|Overall Study||56
8533292|NCT00301873|21036795|P1|NOT COMPLETED|Overall Study||0
8533293|NCT00301873|21036795|P1|COMPLETED|Overall Study||59
8533294|NCT00301873|21036795|P1|STARTED|Overall Study||59
8533295|NCT00301834|21036801|P1|NOT COMPLETED|Overall Study||1
8533296|NCT00301834|21036801|P1|COMPLETED|Overall Study||34
8533297|NCT00301834|21036801|P1|STARTED|Overall Study||35
8533298|NCT00301821|21036810|P1|NOT COMPLETED|Overall Study||26
8533299|NCT00301821|21036810|P1|COMPLETED|Overall Study||81
8533300|NCT00301821|21036810|P1|STARTED|Overall Study||107
8533301|NCT00301808|21036817|P1|NOT COMPLETED|Overall Study||12
8533302|NCT00301808|21036817|P1|COMPLETED|Overall Study||17
8533303|NCT00301808|21036817|P1|STARTED|Overall Study||29
8533304|NCT00301756|21036824|P1|NOT COMPLETED|Overall Study||0
8533305|NCT00301756|21036824|P1|COMPLETED|Overall Study||32
8533306|NCT00301756|21036824|P1|STARTED|Overall Study||32
8533307|NCT00301418|21036836|P1|NOT COMPLETED|Overall Study||0
8533308|NCT00301418|21036836|P1|COMPLETED|Overall Study||11
8533309|NCT00301418|21036836|P1|STARTED|Overall Study||11
8533310|NCT00301366|21036842|P1|NOT COMPLETED|Overall Study||1
8533311|NCT00301366|21036842|P1|COMPLETED|Overall Study||37
8533312|NCT00301366|21036842|P1|STARTED|Overall Study||38
8533325|NCT00301080|21037007|P5|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533326|NCT00301080|21037008|P4|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533327|NCT00301080|21037009|P3|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533328|NCT00301080|21037010|P2|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533329|NCT00301080|21037011|P1|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533330|NCT00301080|21037007|P5|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533331|NCT00301080|21037008|P4|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533332|NCT00301080|21037009|P3|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533333|NCT00301080|21037010|P2|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533334|NCT00301080|21037011|P1|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
8533335|NCT00301080|21037007|P5|STARTED|Revised Version (3 Arms & 12 Weeks)||0
8533336|NCT00301080|21037008|P4|STARTED|Revised Version (3 Arms & 12 Weeks)||0
8533337|NCT00301080|21037009|P3|STARTED|Revised Version (3 Arms & 12 Weeks)||0
8533338|NCT00301080|21037010|P2|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
8533339|NCT00301080|21037011|P1|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
8533340|NCT00301080|21037007|P5|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
8533341|NCT00301080|21037008|P4|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
8533342|NCT00301080|21037009|P3|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
8533343|NCT00301080|21037010|P2|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
8533344|NCT00301080|21037011|P1|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
8533345|NCT00301080|21037007|P5|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
8533346|NCT00301080|21037008|P4|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
8533347|NCT00301080|21037009|P3|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
8533348|NCT00301080|21037010|P2|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
8533349|NCT00301080|21037011|P1|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
8533350|NCT00301080|21037007|P5|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
8533351|NCT00301080|21037008|P4|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
8533352|NCT00301080|21037009|P3|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
8533353|NCT00301080|21037010|P2|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
8533354|NCT00301080|21037011|P1|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
8533355|NCT00301080|21037007|P5|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
8533356|NCT00301080|21037008|P4|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
8533357|NCT00301080|21037009|P3|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
8533358|NCT00301080|21037010|P2|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
8533359|NCT00301080|21037011|P1|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
8533360|NCT00301080|21037007|P5|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
8533361|NCT00301080|21037008|P4|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
8533362|NCT00301080|21037009|P3|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
8533363|NCT00301080|21037010|P2|STARTED|Original Version (2 Arms & 4 Weeks)||3
8533364|NCT00301080|21037011|P1|STARTED|Original Version (2 Arms & 4 Weeks)||4
8533365|NCT00301067|21037040|P4|NOT COMPLETED|Follow up Until Death||1
8533366|NCT00301067|21037041|P3|NOT COMPLETED|Follow up Until Death||0
8533367|NCT00301067|21037042|P2|NOT COMPLETED|Follow up Until Death||0
8533368|NCT00301067|21037043|P1|NOT COMPLETED|Follow up Until Death||1
8533369|NCT00301067|21037040|P4|COMPLETED|Follow up Until Death||2
8533370|NCT00301067|21037041|P3|COMPLETED|Follow up Until Death||3
8533371|NCT00301067|21037042|P2|COMPLETED|Follow up Until Death||3
8533372|NCT00301067|21037043|P1|COMPLETED|Follow up Until Death||3
8533373|NCT00301067|21037040|P4|STARTED|Follow up Until Death||3
8533374|NCT00301067|21037041|P3|STARTED|Follow up Until Death||3
8533375|NCT00301067|21037042|P2|STARTED|Follow up Until Death||3
8533376|NCT00301067|21037043|P1|STARTED|Follow up Until Death||4
8533377|NCT00301067|21037040|P4|NOT COMPLETED|Completed 12 Cycles of Treatment||2
8533378|NCT00301067|21037041|P3|NOT COMPLETED|Completed 12 Cycles of Treatment||0
8533379|NCT00301067|21037042|P2|NOT COMPLETED|Completed 12 Cycles of Treatment||1
8533380|NCT00301067|21037043|P1|NOT COMPLETED|Completed 12 Cycles of Treatment||0
8533381|NCT00301067|21037040|P4|COMPLETED|Completed 12 Cycles of Treatment||0
8533382|NCT00301067|21037041|P3|COMPLETED|Completed 12 Cycles of Treatment||0
8533383|NCT00301067|21037042|P2|COMPLETED|Completed 12 Cycles of Treatment||0
8533384|NCT00301067|21037043|P1|COMPLETED|Completed 12 Cycles of Treatment||0
8533385|NCT00301067|21037040|P4|STARTED|Completed 12 Cycles of Treatment||2
8533386|NCT00301067|21037041|P3|STARTED|Completed 12 Cycles of Treatment||0
8533387|NCT00301067|21037042|P2|STARTED|Completed 12 Cycles of Treatment||1
8533388|NCT00301067|21037043|P1|STARTED|Completed 12 Cycles of Treatment||0
8533389|NCT00301067|21037040|P4|NOT COMPLETED|Completed 4 Cycles of Treatment||5
8533390|NCT00301067|21037041|P3|NOT COMPLETED|Completed 4 Cycles of Treatment||2
8533391|NCT00301067|21037042|P2|NOT COMPLETED|Completed 4 Cycles of Treatment||1
8533392|NCT00301067|21037043|P1|NOT COMPLETED|Completed 4 Cycles of Treatment||1
8533393|NCT00301067|21037040|P4|COMPLETED|Completed 4 Cycles of Treatment||2
8533394|NCT00301067|21037041|P3|COMPLETED|Completed 4 Cycles of Treatment||0
8533395|NCT00301067|21037042|P2|COMPLETED|Completed 4 Cycles of Treatment||1
8533396|NCT00301067|21037043|P1|COMPLETED|Completed 4 Cycles of Treatment||0
8533397|NCT00301067|21037040|P4|STARTED|Completed 4 Cycles of Treatment||7
8533398|NCT00301067|21037041|P3|STARTED|Completed 4 Cycles of Treatment||2
8533399|NCT00301067|21037042|P2|STARTED|Completed 4 Cycles of Treatment||2
8533400|NCT00301067|21037043|P1|STARTED|Completed 4 Cycles of Treatment||1
8533401|NCT00301067|21037040|P4|NOT COMPLETED|Reached 1st Response/2 Cycles||2
8533402|NCT00301067|21037041|P3|NOT COMPLETED|Reached 1st Response/2 Cycles||1
8533403|NCT00301067|21037042|P2|NOT COMPLETED|Reached 1st Response/2 Cycles||1
8533404|NCT00301067|21037043|P1|NOT COMPLETED|Reached 1st Response/2 Cycles||2
8533405|NCT00301067|21037040|P4|COMPLETED|Reached 1st Response/2 Cycles||7
8533406|NCT00301067|21037041|P3|COMPLETED|Reached 1st Response/2 Cycles||2
8533407|NCT00301067|21037042|P2|COMPLETED|Reached 1st Response/2 Cycles||2
8533408|NCT00301067|21037043|P1|COMPLETED|Reached 1st Response/2 Cycles||1
8533409|NCT00301067|21037040|P4|STARTED|Reached 1st Response/2 Cycles||9
8533410|NCT00301067|21037041|P3|STARTED|Reached 1st Response/2 Cycles||3
8533411|NCT00301067|21037042|P2|STARTED|Reached 1st Response/2 Cycles||3
8533412|NCT00301067|21037043|P1|STARTED|Reached 1st Response/2 Cycles||3
8533413|NCT00301067|21037040|P4|NOT COMPLETED|Completed DLT Period/1st Cycle||1
8533414|NCT00301067|21037041|P3|NOT COMPLETED|Completed DLT Period/1st Cycle||0
8533415|NCT00301067|21037042|P2|NOT COMPLETED|Completed DLT Period/1st Cycle||0
8533416|NCT00301067|21037043|P1|NOT COMPLETED|Completed DLT Period/1st Cycle||1
8533417|NCT00301067|21037040|P4|COMPLETED|Completed DLT Period/1st Cycle||9
8533418|NCT00301067|21037041|P3|COMPLETED|Completed DLT Period/1st Cycle||3
8533419|NCT00301067|21037042|P2|COMPLETED|Completed DLT Period/1st Cycle||3
8533420|NCT00301067|21037043|P1|COMPLETED|Completed DLT Period/1st Cycle||3
8533512|NCT00300456|21037289|P5|COMPLETED|Overall Study||99
8533421|NCT00301067|21037040|P4|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
8533422|NCT00301067|21037041|P3|STARTED|Completed DLT Period/1st Cycle||3
8533423|NCT00301067|21037042|P2|STARTED|Completed DLT Period/1st Cycle||3
8533424|NCT00301067|21037043|P1|STARTED|Completed DLT Period/1st Cycle||4
8533425|NCT00301028|21037062|P1|NOT COMPLETED|Overall Study||0
8533426|NCT00301028|21037062|P1|COMPLETED|Overall Study||47
8533427|NCT00301028|21037062|P1|STARTED|Overall Study||47
8533428|NCT00300885|21037068|P2|NOT COMPLETED|Follow-up||195
8533429|NCT00300885|21037069|P1|NOT COMPLETED|Follow-up||178
8533430|NCT00300885|21037068|P2|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
8533431|NCT00300885|21037069|P1|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
8533432|NCT00300885|21037068|P2|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
8533433|NCT00300885|21037069|P1|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
8533434|NCT00300885|21037068|P2|NOT COMPLETED|Treatment||374
8533435|NCT00300885|21037069|P1|NOT COMPLETED|Treatment||373
8533436|NCT00300885|21037068|P2|COMPLETED|Treatment||88
8533437|NCT00300885|21037069|P1|COMPLETED|Treatment||91
8533438|NCT00300885|21037068|P2|Received Treatment|Treatment||459
8533439|NCT00300885|21037069|P1|Received Treatment|Treatment||463
8533440|NCT00300885|21037068|P2|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
8533441|NCT00300885|21037069|P1|STARTED|Treatment||464
8533442|NCT00300781|21037087|P2|NOT COMPLETED|Overall Study||62
8533443|NCT00300781|21037088|P1|NOT COMPLETED|Overall Study||63
8533444|NCT00300781|21037087|P2|COMPLETED|Overall Study||8
8533445|NCT00300781|21037088|P1|COMPLETED|Overall Study||3
8533446|NCT00300781|21037087|P2|STARTED|Overall Study||70
8533447|NCT00300781|21037088|P1|STARTED|Overall Study||66
8533448|NCT00300755|21037103|P3|NOT COMPLETED|Overall Study||2
8533449|NCT00300755|21037104|P2|NOT COMPLETED|Overall Study||4
8533450|NCT00300755|21037105|P1|NOT COMPLETED|Overall Study||1
8533451|NCT00300755|21037103|P3|COMPLETED|Overall Study||19
8533452|NCT00300755|21037104|P2|COMPLETED|Overall Study||17
8533453|NCT00300755|21037105|P1|COMPLETED|Overall Study||17
8533454|NCT00300755|21037103|P3|STARTED|Overall Study||21
8533455|NCT00300755|21037104|P2|STARTED|Overall Study||21
8533456|NCT00300755|21037105|P1|STARTED|Overall Study||18
8533457|NCT00300742|21037122|P1|NOT COMPLETED|Overall Study||2
8533458|NCT00300742|21037122|P1|COMPLETED|Overall Study||3
8533459|NCT00300742|21037122|P1|STARTED|Overall Study||5
8533460|NCT00300677|21037130|P1|NOT COMPLETED|Overall Study||0
8533461|NCT00300677|21037130|P1|COMPLETED|Overall Study||12
8533462|NCT00300677|21037130|P1|STARTED|Overall Study||12
8533463|NCT00300495|21037139|P2|NOT COMPLETED|Overall Study||1
8533464|NCT00300495|21037140|P1|NOT COMPLETED|Overall Study||4
8533465|NCT00300495|21037139|P2|COMPLETED|Overall Study||8
8533466|NCT00300495|21037140|P1|COMPLETED|Overall Study||6
8533467|NCT00300495|21037139|P2|STARTED|Overall Study||9
8533468|NCT00300495|21037140|P1|STARTED|Overall Study||10
8533469|NCT00300482|21037154|P6|NOT COMPLETED|Overall Study||16
8533470|NCT00300482|21037155|P5|NOT COMPLETED|Overall Study||23
8533471|NCT00300482|21037156|P4|NOT COMPLETED|Overall Study||24
8533472|NCT00300482|21037157|P3|NOT COMPLETED|Overall Study||51
8533473|NCT00300482|21037158|P2|NOT COMPLETED|Overall Study||41
8533474|NCT00300482|21037159|P1|NOT COMPLETED|Overall Study||41
8533475|NCT00300482|21037154|P6|COMPLETED|Overall Study||115
8533476|NCT00300482|21037155|P5|COMPLETED|Overall Study||243
8533477|NCT00300482|21037156|P4|COMPLETED|Overall Study||237
8533478|NCT00300482|21037157|P3|COMPLETED|Overall Study||208
8533479|NCT00300482|21037158|P2|COMPLETED|Overall Study||220
8533480|NCT00300482|21037159|P1|COMPLETED|Overall Study||220
8533481|NCT00300482|21037154|P6|STARTED|Overall Study||131
8533482|NCT00300482|21037155|P5|STARTED|Overall Study||266
8533483|NCT00300482|21037156|P4|STARTED|Overall Study||261
8533484|NCT00300482|21037157|P3|STARTED|Overall Study||259
8533485|NCT00300482|21037158|P2|STARTED|Overall Study||261
8533486|NCT00300482|21037159|P1|STARTED|Overall Study|"For all arms, started means treated."|261
8533487|NCT00300469|21037221|P6|NOT COMPLETED|Overall Study||9
8533488|NCT00300469|21037222|P5|NOT COMPLETED|Overall Study||14
8533489|NCT00300469|21037223|P4|NOT COMPLETED|Overall Study||9
8533490|NCT00300469|21037224|P3|NOT COMPLETED|Overall Study||17
8533491|NCT00300469|21037225|P2|NOT COMPLETED|Overall Study||21
8533492|NCT00300469|21037226|P1|NOT COMPLETED|Overall Study||21
8533493|NCT00300469|21037221|P6|COMPLETED|Overall Study||46
8533494|NCT00300469|21037222|P5|COMPLETED|Overall Study||95
8533495|NCT00300469|21037223|P4|COMPLETED|Overall Study||104
8533496|NCT00300469|21037224|P3|COMPLETED|Overall Study||95
8533497|NCT00300469|21037225|P2|COMPLETED|Overall Study||89
8533498|NCT00300469|21037226|P1|COMPLETED|Overall Study||89
8533499|NCT00300469|21037221|P6|STARTED|Overall Study||55
8533500|NCT00300469|21037222|P5|STARTED|Overall Study||109
8533501|NCT00300469|21037223|P4|STARTED|Overall Study||113
8533502|NCT00300469|21037224|P3|STARTED|Overall Study||112
8533503|NCT00300469|21037225|P2|STARTED|Overall Study||110
8533504|NCT00300469|21037226|P1|STARTED|Overall Study|"For all arms, started means treated."|110
8533505|NCT00300456|21037288|P6|NOT COMPLETED|Overall Study||11
8533506|NCT00300456|21037289|P5|NOT COMPLETED|Overall Study||17
8533507|NCT00300456|21037290|P4|NOT COMPLETED|Overall Study||14
8533508|NCT00300456|21037291|P3|NOT COMPLETED|Overall Study||21
8533509|NCT00300456|21037292|P2|NOT COMPLETED|Overall Study||16
8533510|NCT00300456|21037293|P1|NOT COMPLETED|Overall Study||16
8533511|NCT00300456|21037288|P6|COMPLETED|Overall Study||48
8533513|NCT00300456|21037290|P4|COMPLETED|Overall Study||105
8533514|NCT00300456|21037291|P3|COMPLETED|Overall Study||98
8533515|NCT00300456|21037292|P2|COMPLETED|Overall Study||102
8533516|NCT00300456|21037293|P1|COMPLETED|Overall Study||103
8533517|NCT00300456|21037288|P6|STARTED|Overall Study||59
8533518|NCT00300456|21037289|P5|STARTED|Overall Study||116
8533519|NCT00300456|21037290|P4|STARTED|Overall Study||119
8533520|NCT00300456|21037291|P3|STARTED|Overall Study||119
8533521|NCT00300456|21037292|P2|STARTED|Overall Study||118
8533522|NCT00300456|21037293|P1|STARTED|Overall Study|"For all arms, started means treated."|119
8533523|NCT00300430|21037352|P3|NOT COMPLETED|Overall Study||151
8533524|NCT00300430|21037353|P2|NOT COMPLETED|Overall Study||169
8533525|NCT00300430|21037354|P1|NOT COMPLETED|Overall Study||367
8533526|NCT00300430|21037352|P3|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
8533527|NCT00300430|21037353|P2|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
8533528|NCT00300430|21037354|P1|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
8533529|NCT00300430|21037352|P3|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
8533530|NCT00300430|21037353|P2|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
8533531|NCT00300430|21037354|P1|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
8533532|NCT00300391|21037388|P2|NOT COMPLETED|Overall Study||0
8533533|NCT00300391|21037389|P1|NOT COMPLETED|Overall Study||0
8533534|NCT00300391|21037388|P2|COMPLETED|Overall Study||14
8533535|NCT00300391|21037389|P1|COMPLETED|Overall Study||16
8533536|NCT00300391|21037388|P2|STARTED|Overall Study||14
8533537|NCT00300391|21037389|P1|STARTED|Overall Study||16
8533538|NCT00300365|21037407|P2|NOT COMPLETED|Overall Study||2
8533539|NCT00300365|21037408|P1|NOT COMPLETED|Overall Study||4
8533540|NCT00300365|21037407|P2|COMPLETED|Overall Study||38
8533541|NCT00300365|21037408|P1|COMPLETED|Overall Study||34
8533542|NCT00300365|21037407|P2|STARTED|Overall Study||40
8533543|NCT00300365|21037408|P1|STARTED|Overall Study||38
8533544|NCT00300274|21037417|P3|NOT COMPLETED|Overall Study||45
8533545|NCT00300274|21037418|P2|NOT COMPLETED|Overall Study||27
8533546|NCT00300274|21037419|P1|NOT COMPLETED|Overall Study||46
8533547|NCT00300274|21037417|P3|COMPLETED|Overall Study||226
8533548|NCT00300274|21037418|P2|COMPLETED|Overall Study||141
8533549|NCT00300274|21037419|P1|COMPLETED|Overall Study||236
8533550|NCT00300274|21037417|P3|Completed 12 Month|Overall Study||248
8533551|NCT00300274|21037418|P2|Completed 12 Month|Overall Study||149
8533552|NCT00300274|21037419|P1|Completed 12 Month|Overall Study||250
8533553|NCT00300274|21037417|P3|STARTED|Overall Study||271
8533554|NCT00300274|21037418|P2|STARTED|Overall Study||168
8533555|NCT00300274|21037419|P1|STARTED|Overall Study||282
8533556|NCT00300235|21037459|P5|NOT COMPLETED|Overall Study||0
8533557|NCT00300235|21037460|P4|NOT COMPLETED|Overall Study||0
8533558|NCT00300235|21037461|P3|NOT COMPLETED|Overall Study||0
8533559|NCT00300235|21037462|P2|NOT COMPLETED|Overall Study||0
8533560|NCT00300235|21037463|P1|NOT COMPLETED|Overall Study||0
8533561|NCT00300235|21037459|P5|COMPLETED|Overall Study||251
8533562|NCT00300235|21037460|P4|COMPLETED|Overall Study||362
8533563|NCT00300235|21037461|P3|COMPLETED|Overall Study||398
8533564|NCT00300235|21037462|P2|COMPLETED|Overall Study||240
8533565|NCT00300235|21037463|P1|COMPLETED|Overall Study||208
8533566|NCT00300235|21037459|P5|STARTED|Overall Study||251
8533567|NCT00300235|21037460|P4|STARTED|Overall Study||362
8533568|NCT00300235|21037461|P3|STARTED|Overall Study||398
8533569|NCT00300235|21037462|P2|STARTED|Overall Study||240
8533570|NCT00300235|21037463|P1|STARTED|Overall Study||208
8533571|NCT00300053|21037478|P3|NOT COMPLETED|Overall Study||6
8533572|NCT00300053|21037479|P2|NOT COMPLETED|Overall Study||3
8533573|NCT00300053|21037480|P1|NOT COMPLETED|Overall Study||2
8533574|NCT00300053|21037478|P3|COMPLETED|Overall Study||50
8533575|NCT00300053|21037479|P2|COMPLETED|Overall Study||53
8533576|NCT00300053|21037480|P1|COMPLETED|Overall Study||53
8533577|NCT00300053|21037478|P3|6-Month Evaluation|Overall Study||53
8533578|NCT00300053|21037479|P2|6-Month Evaluation|Overall Study||55
8533579|NCT00300053|21037480|P1|6-Month Evaluation|Overall Study||54
8533580|NCT00300053|21037478|P3|3-Month Evaluation|Overall Study||54
8533581|NCT00300053|21037479|P2|3-Month Evaluation|Overall Study||56
8533582|NCT00300053|21037480|P1|3-Month Evaluation|Overall Study||55
8533583|NCT00300053|21037478|P3|STARTED|Overall Study|started = randomized and treated/injected|56
8533584|NCT00300053|21037479|P2|STARTED|Overall Study|started = randomized and treated/injected|56
8533585|NCT00300053|21037480|P1|STARTED|Overall Study|started = randomized and treated/injected|55
8533586|NCT00299988|21037506|P2|NOT COMPLETED|Overall Study||0
8533587|NCT00299988|21037507|P1|NOT COMPLETED|Overall Study||0
8533588|NCT00299988|21037506|P2|COMPLETED|Overall Study||8
8533589|NCT00299988|21037507|P1|COMPLETED|Overall Study||16
8533590|NCT00299988|21037506|P2|STARTED|Overall Study||8
8533591|NCT00299988|21037507|P1|STARTED|Overall Study||16
8533592|NCT00299975|21037518|P3|NOT COMPLETED|Overall Study||8
8533593|NCT00299975|21037519|P2|NOT COMPLETED|Overall Study||1
8533594|NCT00299975|21037520|P1|NOT COMPLETED|Overall Study||3
8533595|NCT00299975|21037518|P3|COMPLETED|Overall Study||25
8533596|NCT00299975|21037519|P2|COMPLETED|Overall Study||31
8533597|NCT00299975|21037520|P1|COMPLETED|Overall Study||29
8533598|NCT00299975|21037518|P3|Received Allocated Intervention|Overall Study||32
8533599|NCT00299975|21037519|P2|Received Allocated Intervention|Overall Study||32
8533600|NCT00299975|21037520|P1|Received Allocated Intervention|Overall Study||32
8533601|NCT00299975|21037518|P3|STARTED|Overall Study||33
8533602|NCT00299975|21037519|P2|STARTED|Overall Study||32
8533603|NCT00299975|21037520|P1|STARTED|Overall Study||32
8533604|NCT00299741|21037570|P1|NOT COMPLETED|Overall Study||0
8533605|NCT00299741|21037570|P1|COMPLETED|Overall Study||36
8533606|NCT00299741|21037570|P1|STARTED|Overall Study||36
8533607|NCT00299702|21037577|P2|NOT COMPLETED|Overall Study||50
8533608|NCT00299702|21037578|P1|NOT COMPLETED|Overall Study||53
8533609|NCT00299702|21037577|P2|COMPLETED|Overall Study||126
8533610|NCT00299702|21037578|P1|COMPLETED|Overall Study||126
8533611|NCT00299702|21037577|P2|STARTED|Overall Study||176
8533612|NCT00299702|21037578|P1|STARTED|Overall Study||179
8533613|NCT00299689|21037586|P1|NOT COMPLETED|Overall Study||0
8533614|NCT00299689|21037586|P1|COMPLETED|Overall Study||69
8533615|NCT00299689|21037586|P1|STARTED|Overall Study||69
8533616|NCT00299546|21037593|P3|NOT COMPLETED|Overall Study||86
8533617|NCT00299546|21037594|P2|NOT COMPLETED|Overall Study||92
8533618|NCT00299546|21037595|P1|NOT COMPLETED|Overall Study||100
8533619|NCT00299546|21037593|P3|COMPLETED|Overall Study||67
8533620|NCT00299546|21037594|P2|COMPLETED|Overall Study||61
8533621|NCT00299546|21037595|P1|COMPLETED|Overall Study||55
8533622|NCT00299546|21037593|P3|STARTED|Overall Study||153
8533623|NCT00299546|21037594|P2|STARTED|Overall Study||153
8533624|NCT00299546|21037595|P1|STARTED|Overall Study||155
8533625|NCT00299494|21037626|P6|NOT COMPLETED|Overall Study||26
8533626|NCT00299494|21037627|P5|NOT COMPLETED|Overall Study||27
8533627|NCT00299494|21037628|P4|NOT COMPLETED|Overall Study||10
8533628|NCT00299494|21037629|P3|NOT COMPLETED|Overall Study||4
8533629|NCT00299494|21037630|P2|NOT COMPLETED|Overall Study||1
8533630|NCT00299494|21037631|P1|NOT COMPLETED|Overall Study||3
8533631|NCT00299494|21037626|P6|COMPLETED|Overall Study||4
8533632|NCT00299494|21037627|P5|COMPLETED|Overall Study||13
8533633|NCT00299494|21037628|P4|COMPLETED|Overall Study||24
8533634|NCT00299494|21037629|P3|COMPLETED|Overall Study||3
8533635|NCT00299494|21037630|P2|COMPLETED|Overall Study||2
8533636|NCT00299494|21037631|P1|COMPLETED|Overall Study||2
8533637|NCT00299494|21037626|P6|STARTED|Overall Study||30
8533638|NCT00299494|21037627|P5|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
8533639|NCT00299494|21037628|P4|STARTED|Overall Study||34
8533640|NCT00299494|21037629|P3|STARTED|Overall Study||7
8533641|NCT00299494|21037630|P2|STARTED|Overall Study||3
8533642|NCT00299494|21037631|P1|STARTED|Overall Study||5
8533643|NCT00299416|21037734|P1|NOT COMPLETED|Overall Study||0
8533644|NCT00299416|21037734|P1|COMPLETED|Overall Study||30
8533645|NCT00299416|21037734|P1|STARTED|Overall Study||30
8533646|NCT00299221|21037742|P2|NOT COMPLETED|Overall Study||0
8533647|NCT00299221|21037743|P1|NOT COMPLETED|Overall Study||0
8533648|NCT00299221|21037742|P2|COMPLETED|Overall Study||71
8533649|NCT00299221|21037743|P1|COMPLETED|Overall Study||79
8533650|NCT00299221|21037742|P2|STARTED|Overall Study||71
8533651|NCT00299221|21037743|P1|STARTED|Overall Study||79
8533652|NCT00299195|21037759|P2|NOT COMPLETED|Overall Study||0
8533653|NCT00299195|21037760|P1|NOT COMPLETED|Overall Study||0
8533654|NCT00299195|21037759|P2|COMPLETED|Overall Study||33
8533655|NCT00299195|21037760|P1|COMPLETED|Overall Study||30
8533656|NCT00299195|21037759|P2|STARTED|Overall Study||33
8533657|NCT00299195|21037760|P1|STARTED|Overall Study||30
8533658|NCT00299156|21037777|P3|NOT COMPLETED|Period 2 (Randomized)||0
8533659|NCT00299156|21037778|P2|NOT COMPLETED|Period 2 (Randomized)||1
8533660|NCT00299156|21037779|P1|NOT COMPLETED|Period 2 (Randomized)||0
8533661|NCT00299156|21037777|P3|COMPLETED|Period 2 (Randomized)||16
8533662|NCT00299156|21037778|P2|COMPLETED|Period 2 (Randomized)||16
8533663|NCT00299156|21037779|P1|COMPLETED|Period 2 (Randomized)||0
8533664|NCT00299156|21037777|P3|STARTED|Period 2 (Randomized)||16
8533665|NCT00299156|21037778|P2|STARTED|Period 2 (Randomized)||17
8533666|NCT00299156|21037779|P1|STARTED|Period 2 (Randomized)||0
8533667|NCT00299156|21037777|P3|NOT COMPLETED|Period 1 (Non-Randomized)||0
8533668|NCT00299156|21037778|P2|NOT COMPLETED|Period 1 (Non-Randomized)||0
8533669|NCT00299156|21037779|P1|NOT COMPLETED|Period 1 (Non-Randomized)||0
8533670|NCT00299156|21037777|P3|COMPLETED|Period 1 (Non-Randomized)||0
8533671|NCT00299156|21037778|P2|COMPLETED|Period 1 (Non-Randomized)||0
8533672|NCT00299156|21037779|P1|COMPLETED|Period 1 (Non-Randomized)||32
8533673|NCT00299156|21037777|P3|STARTED|Period 1 (Non-Randomized)||0
8533674|NCT00299156|21037778|P2|STARTED|Period 1 (Non-Randomized)||0
8533675|NCT00299156|21037779|P1|STARTED|Period 1 (Non-Randomized)||32
8533676|NCT00299130|21037790|P3|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
8533677|NCT00299130|21037791|P2|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
8533678|NCT00299130|21037792|P1|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
8533679|NCT00299130|21037790|P3|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
8533680|NCT00299130|21037791|P2|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
8533681|NCT00299130|21037792|P1|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
8533682|NCT00299130|21037790|P3|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
8533683|NCT00299130|21037791|P2|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
8533684|NCT00299130|21037792|P1|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
8533685|NCT00299130|21037790|P3|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
8533686|NCT00299130|21037791|P2|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
8533687|NCT00299130|21037792|P1|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
8533688|NCT00299130|21037790|P3|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
8533689|NCT00299130|21037791|P2|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
8533690|NCT00299130|21037792|P1|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
8533691|NCT00299130|21037790|P3|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
8533692|NCT00299130|21037791|P2|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
8533693|NCT00299130|21037792|P1|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
8533694|NCT00299130|21037790|P3|NOT COMPLETED|Treatment Period (up to 5 Years)||50
8533695|NCT00299130|21037791|P2|NOT COMPLETED|Treatment Period (up to 5 Years)||43
8533696|NCT00299130|21037792|P1|NOT COMPLETED|Treatment Period (up to 5 Years)||53
8533697|NCT00299130|21037790|P3|COMPLETED|Treatment Period (up to 5 Years)||121
8533698|NCT00299130|21037791|P2|COMPLETED|Treatment Period (up to 5 Years)||125
8533699|NCT00299130|21037792|P1|COMPLETED|Treatment Period (up to 5 Years)||119
8533700|NCT00299130|21037790|P3|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
8533701|NCT00299130|21037791|P2|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
8533702|NCT00299130|21037792|P1|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
8533703|NCT00299130|21037790|P3|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
8533704|NCT00299130|21037791|P2|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
8533705|NCT00299130|21037792|P1|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
8533706|NCT00299130|21037790|P3|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
8533707|NCT00299130|21037791|P2|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
8533708|NCT00299130|21037792|P1|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
8533709|NCT00299130|21037790|P3|Treated|Treatment Period (up to 5 Years)||170
8533710|NCT00299130|21037791|P2|Treated|Treatment Period (up to 5 Years)||167
8533711|NCT00299130|21037792|P1|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
8533712|NCT00299130|21037790|P3|STARTED|Treatment Period (up to 5 Years)||171
8533713|NCT00299130|21037791|P2|STARTED|Treatment Period (up to 5 Years)||168
8533714|NCT00299130|21037792|P1|STARTED|Treatment Period (up to 5 Years)||172
8533715|NCT00299104|21037897|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
8533716|NCT00299104|21037898|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
8533717|NCT00299104|21037899|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
8533718|NCT00299104|21037897|P3|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
8533719|NCT00299104|21037898|P2|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
8533720|NCT00299104|21037899|P1|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
8533721|NCT00299104|21037897|P3|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
8533722|NCT00299104|21037898|P2|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
8533723|NCT00299104|21037899|P1|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
8533724|NCT00299104|21037897|P3|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
8533725|NCT00299104|21037898|P2|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
8533726|NCT00299104|21037899|P1|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
8533727|NCT00299104|21037897|P3|COMPLETED|Safety Follow-Up (SFU) Period||176
8533728|NCT00299104|21037898|P2|COMPLETED|Safety Follow-Up (SFU) Period||171
8533729|NCT00299104|21037899|P1|COMPLETED|Safety Follow-Up (SFU) Period||129
8533730|NCT00299104|21037897|P3|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
8533731|NCT00299104|21037898|P2|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
8533732|NCT00299104|21037899|P1|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
8533733|NCT00299104|21037897|P3|NOT COMPLETED|Treatment Period||172
8533734|NCT00299104|21037898|P2|NOT COMPLETED|Treatment Period||175
8533735|NCT00299104|21037899|P1|NOT COMPLETED|Treatment Period||189
8533736|NCT00299104|21037897|P3|COMPLETED|Treatment Period||80
8533737|NCT00299104|21037898|P2|COMPLETED|Treatment Period||77
8533738|NCT00299104|21037899|P1|COMPLETED|Treatment Period|Completed Week 152|62
8533739|NCT00299104|21037897|P3|Completed Week 104|Treatment Period||216
8533740|NCT00299104|21037898|P2|Completed Week 104|Treatment Period||213
8533741|NCT00299104|21037899|P1|Completed Week 104|Treatment Period||178
8533742|NCT00299104|21037897|P3|Completed Week 52|Treatment Period||232
8533743|NCT00299104|21037898|P2|Completed Week 52|Treatment Period||227
8533744|NCT00299104|21037899|P1|Completed Week 52|Treatment Period||213
8533745|NCT00299104|21037897|P3|Completed Week 24|Treatment Period||241
8533746|NCT00299104|21037898|P2|Completed Week 24|Treatment Period||240
8533747|NCT00299104|21037899|P1|Completed Week 24|Treatment Period||227
8533748|NCT00299104|21037897|P3|Safety/ITT: Received Study Drug|Treatment Period||250
8533749|NCT00299104|21037898|P2|Safety/ITT: Received Study Drug|Treatment Period||249
8533750|NCT00299104|21037899|P1|Safety/ITT: Received Study Drug|Treatment Period||249
8533751|NCT00299104|21037897|P3|STARTED|Treatment Period||252
8533752|NCT00299104|21037898|P2|STARTED|Treatment Period||252
8533753|NCT00299104|21037899|P1|STARTED|Treatment Period||251
8533754|NCT00299000|21037996|P2|NOT COMPLETED|Overall Study||0
8533755|NCT00299000|21037997|P1|NOT COMPLETED|Overall Study||0
8533756|NCT00299000|21037996|P2|COMPLETED|Overall Study||2
8533757|NCT00299000|21037997|P1|COMPLETED|Overall Study||2
8533758|NCT00299000|21037996|P2|STARTED|Overall Study||2
8533759|NCT00299000|21037997|P1|STARTED|Overall Study||2
8533760|NCT00298896|21038009|P1|NOT COMPLETED|Overall Study||50
8533761|NCT00298896|21038009|P1|COMPLETED|Overall Study||5
8533762|NCT00298896|21038009|P1|STARTED|Overall Study||55
8533763|NCT00298831|21038014|P1|NOT COMPLETED|Overall Study||32
8533764|NCT00298831|21038014|P1|COMPLETED|Overall Study||192
8533765|NCT00298831|21038014|P1|Treated|Overall Study||197
8533766|NCT00298831|21038014|P1|STARTED|Overall Study||224
8533767|NCT00298766|21038023|P1|NOT COMPLETED|Overall Study||46
8533768|NCT00298766|21038023|P1|COMPLETED|Overall Study||24
8533769|NCT00298766|21038023|P1|STARTED|Overall Study||70
8533770|NCT00298740|21038032|P1|NOT COMPLETED|Overall Study||9
8533771|NCT00298740|21038032|P1|COMPLETED|Overall Study||3
8533772|NCT00298740|21038032|P1|STARTED|Overall Study||12
8533773|NCT00298610|21038036|P1|NOT COMPLETED|Overall Study||0
8533774|NCT00298610|21038036|P1|COMPLETED|Overall Study||30
8533775|NCT00298610|21038036|P1|STARTED|Overall Study||30
8533776|NCT00298558|21038050|P4|NOT COMPLETED|10th Annual (A10)||163
8533777|NCT00298558|21038051|P3|NOT COMPLETED|10th Annual (A10)||171
8533778|NCT00298558|21038052|P2|NOT COMPLETED|10th Annual (A10)||153
8533779|NCT00298558|21038053|P1|NOT COMPLETED|10th Annual (A10)||172
8533780|NCT00298558|21038050|P4|COMPLETED|10th Annual (A10)||285
8533781|NCT00298558|21038051|P3|COMPLETED|10th Annual (A10)||319
8533782|NCT00298558|21038052|P2|COMPLETED|10th Annual (A10)||316
8533783|NCT00298558|21038053|P1|COMPLETED|10th Annual (A10)||300
8533784|NCT00298558|21038050|P4|STARTED|10th Annual (A10)||448
8533785|NCT00298558|21038051|P3|STARTED|10th Annual (A10)||490
8533786|NCT00298558|21038052|P2|STARTED|10th Annual (A10)||469
8533787|NCT00298558|21038053|P1|STARTED|10th Annual (A10)||472
8533788|NCT00298558|21038050|P4|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
8533789|NCT00298558|21038051|P3|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
8533790|NCT00298558|21038052|P2|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
8533791|NCT00298558|21038053|P1|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
8533792|NCT00298558|21038050|P4|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
8533793|NCT00298558|21038051|P3|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
8533794|NCT00298558|21038052|P2|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
8533795|NCT00298558|21038053|P1|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
8533796|NCT00298558|21038050|P4|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
8533797|NCT00298558|21038051|P3|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
8533798|NCT00298558|21038052|P2|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
8533799|NCT00298558|21038053|P1|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
8533800|NCT00298558|21038050|P4|NOT COMPLETED|3rd Annual Booster||0
8533801|NCT00298558|21038051|P3|NOT COMPLETED|3rd Annual Booster||140
8533802|NCT00298558|21038052|P2|NOT COMPLETED|3rd Annual Booster||128
8533803|NCT00298558|21038053|P1|NOT COMPLETED|3rd Annual Booster||122
8533804|NCT00298558|21038050|P4|COMPLETED|3rd Annual Booster||0
8533805|NCT00298558|21038051|P3|COMPLETED|3rd Annual Booster||230
8533806|NCT00298558|21038052|P2|COMPLETED|3rd Annual Booster||243
8533807|NCT00298558|21038053|P1|COMPLETED|3rd Annual Booster||250
8533808|NCT00298558|21038050|P4|STARTED|3rd Annual Booster||0
8533809|NCT00298558|21038051|P3|STARTED|3rd Annual Booster||370
8533810|NCT00298558|21038052|P2|STARTED|3rd Annual Booster||371
8533811|NCT00298558|21038053|P1|STARTED|3rd Annual Booster||372
8533812|NCT00298558|21038050|P4|NOT COMPLETED|2nd Annual (A2)||32
8533813|NCT00298558|21038051|P3|NOT COMPLETED|2nd Annual (A2)||27
8533814|NCT00298558|21038052|P2|NOT COMPLETED|2nd Annual (A2)||11
8533815|NCT00298558|21038053|P1|NOT COMPLETED|2nd Annual (A2)||22
8533816|NCT00298558|21038050|P4|COMPLETED|2nd Annual (A2)||552
8533817|NCT00298558|21038051|P3|COMPLETED|2nd Annual (A2)||574
8533818|NCT00298558|21038052|P2|COMPLETED|2nd Annual (A2)||555
8533819|NCT00298558|21038053|P1|COMPLETED|2nd Annual (A2)||563
8533820|NCT00298558|21038050|P4|STARTED|2nd Annual (A2)||584
8533821|NCT00298558|21038051|P3|STARTED|2nd Annual (A2)||601
8533822|NCT00298558|21038052|P2|STARTED|2nd Annual (A2)||566
8533823|NCT00298558|21038053|P1|STARTED|2nd Annual (A2)||585
8533824|NCT00298558|21038050|P4|NOT COMPLETED|1st Annual (A1)||55
8533825|NCT00298558|21038051|P3|NOT COMPLETED|1st Annual (A1)||52
8533826|NCT00298558|21038052|P2|NOT COMPLETED|1st Annual (A1)||63
8533827|NCT00298558|21038053|P1|NOT COMPLETED|1st Annual (A1)||55
8533828|NCT00298558|21038050|P4|COMPLETED|1st Annual (A1)||584
8533829|NCT00298558|21038051|P3|COMPLETED|1st Annual (A1)||601
8533830|NCT00298558|21038052|P2|COMPLETED|1st Annual (A1)||566
8533831|NCT00298558|21038053|P1|COMPLETED|1st Annual (A1)||585
8533832|NCT00298558|21038050|P4|STARTED|1st Annual (A1)||639
8533833|NCT00298558|21038051|P3|STARTED|1st Annual (A1)||653
8533834|NCT00298558|21038052|P2|STARTED|1st Annual (A1)||629
8533835|NCT00298558|21038053|P1|STARTED|1st Annual (A1)||640
8533836|NCT00298558|21038050|P4|NOT COMPLETED|Booster||0
8533837|NCT00298558|21038051|P3|NOT COMPLETED|Booster||75
8533838|NCT00298558|21038052|P2|NOT COMPLETED|Booster||70
8533839|NCT00298558|21038053|P1|NOT COMPLETED|Booster||89
8533840|NCT00298558|21038050|P4|COMPLETED|Booster||0
8533841|NCT00298558|21038051|P3|COMPLETED|Booster||295
8533842|NCT00298558|21038052|P2|COMPLETED|Booster||301
8533843|NCT00298558|21038053|P1|COMPLETED|Booster||283
8533844|NCT00298558|21038050|P4|STARTED|Booster||0
8533845|NCT00298558|21038051|P3|STARTED|Booster||370
8533846|NCT00298558|21038052|P2|STARTED|Booster||371
8533847|NCT00298558|21038053|P1|STARTED|Booster||372
8533848|NCT00298558|21038050|P4|NOT COMPLETED|Immediate Post Test||65
8533849|NCT00298558|21038051|P3|NOT COMPLETED|Immediate Post Test||59
8533850|NCT00298558|21038052|P2|NOT COMPLETED|Immediate Post Test||76
8533851|NCT00298558|21038053|P1|NOT COMPLETED|Immediate Post Test||71
8533852|NCT00298558|21038050|P4|COMPLETED|Immediate Post Test||639
8533853|NCT00298558|21038051|P3|COMPLETED|Immediate Post Test||653
8533854|NCT00298558|21038052|P2|COMPLETED|Immediate Post Test||629
8533855|NCT00298558|21038053|P1|COMPLETED|Immediate Post Test||640
8533856|NCT00298558|21038050|P4|STARTED|Immediate Post Test||704
8533857|NCT00298558|21038051|P3|STARTED|Immediate Post Test||712
8533858|NCT00298558|21038052|P2|STARTED|Immediate Post Test||705
8533859|NCT00298558|21038053|P1|STARTED|Immediate Post Test||711
8533860|NCT00298558|21038050|P4|NOT COMPLETED|Intervention||419
8533861|NCT00298558|21038051|P3|NOT COMPLETED|Intervention||75
8533862|NCT00298558|21038052|P2|NOT COMPLETED|Intervention||78
8533863|NCT00298558|21038053|P1|NOT COMPLETED|Intervention||91
8533864|NCT00298558|21038050|P4|COMPLETED|Intervention||285
8533865|NCT00298558|21038051|P3|COMPLETED|Intervention||637
8533866|NCT00298558|21038052|P2|COMPLETED|Intervention||627
8533867|NCT00298558|21038053|P1|COMPLETED|Intervention||620
8533868|NCT00298558|21038050|P4|STARTED|Intervention||704
8533869|NCT00298558|21038051|P3|STARTED|Intervention||712
8533870|NCT00298558|21038052|P2|STARTED|Intervention||705
8533871|NCT00298558|21038053|P1|STARTED|Intervention||711
8533872|NCT00298558|21038050|P4|NOT COMPLETED|Baseline||0
8533873|NCT00298558|21038051|P3|NOT COMPLETED|Baseline||0
8533874|NCT00298558|21038052|P2|NOT COMPLETED|Baseline||0
8533875|NCT00298558|21038053|P1|NOT COMPLETED|Baseline||0
8533876|NCT00298558|21038050|P4|COMPLETED|Baseline||704
8533877|NCT00298558|21038051|P3|COMPLETED|Baseline||712
8533878|NCT00298558|21038052|P2|COMPLETED|Baseline||705
8533879|NCT00298558|21038053|P1|COMPLETED|Baseline||711
8533880|NCT00298558|21038050|P4|STARTED|Baseline||704
8533881|NCT00298558|21038051|P3|STARTED|Baseline||712
8533882|NCT00298558|21038052|P2|STARTED|Baseline||705
8533883|NCT00298558|21038053|P1|STARTED|Baseline||711
8533884|NCT00298389|21038086|P3|NOT COMPLETED|Overall Study||0
8533885|NCT00298389|21038087|P2|NOT COMPLETED|Overall Study||0
8533886|NCT00298389|21038088|P1|NOT COMPLETED|Overall Study||0
8533887|NCT00298389|21038086|P3|COMPLETED|Overall Study||19
8533888|NCT00298389|21038087|P2|COMPLETED|Overall Study||17
8533889|NCT00298389|21038088|P1|COMPLETED|Overall Study||20
8533890|NCT00298389|21038086|P3|STARTED|Overall Study||19
8533891|NCT00298389|21038087|P2|STARTED|Overall Study||17
8533892|NCT00298389|21038088|P1|STARTED|Overall Study||20
8533893|NCT00298363|21038102|P3|NOT COMPLETED|Overall Study||6
8533894|NCT00298363|21038103|P2|NOT COMPLETED|Overall Study||8
8533895|NCT00298363|21038104|P1|NOT COMPLETED|Overall Study||17
8533896|NCT00298363|21038102|P3|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
8533897|NCT00298363|21038103|P2|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
8533898|NCT00298363|21038104|P1|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
8533899|NCT00298363|21038102|P3|STARTED|Overall Study||22
8533900|NCT00298363|21038103|P2|STARTED|Overall Study||45
8533901|NCT00298363|21038104|P1|STARTED|Overall Study||45
8533902|NCT00298272|21038262|P2|NOT COMPLETED|Safety Follow-up Phase||4
8533903|NCT00298272|21038263|P1|NOT COMPLETED|Safety Follow-up Phase||4
8533904|NCT00298272|21038262|P2|COMPLETED|Safety Follow-up Phase||13
8533905|NCT00298272|21038263|P1|COMPLETED|Safety Follow-up Phase||18
8533906|NCT00298272|21038262|P2|STARTED|Safety Follow-up Phase||17
8533907|NCT00298272|21038263|P1|STARTED|Safety Follow-up Phase||22
8533908|NCT00298272|21038262|P2|NOT COMPLETED|Open Label Retreatment Phase||4
8533909|NCT00298272|21038263|P1|NOT COMPLETED|Open Label Retreatment Phase||9
8533910|NCT00298272|21038262|P2|COMPLETED|Open Label Retreatment Phase||12
8533911|NCT00298272|21038263|P1|COMPLETED|Open Label Retreatment Phase||13
8533912|NCT00298272|21038262|P2|Completed to Week 56|Open Label Retreatment Phase||12
8533913|NCT00298272|21038263|P1|Completed to Week 56|Open Label Retreatment Phase||13
8533914|NCT00298272|21038262|P2|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
8533915|NCT00298272|21038263|P1|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
8533916|NCT00298272|21038262|P2|STARTED|Open Label Retreatment Phase||16
8533917|NCT00298272|21038263|P1|STARTED|Open Label Retreatment Phase||22
8533918|NCT00298272|21038262|P2|NOT COMPLETED|Double-blind Phase||0
8533919|NCT00298272|21038263|P1|NOT COMPLETED|Double-blind Phase||8
8533920|NCT00298272|21038262|P2|COMPLETED|Double-blind Phase||18
8533921|NCT00298272|21038263|P1|COMPLETED|Double-blind Phase||28
8533922|NCT00298272|21038262|P2|Completed to Week 56|Double-blind Phase||3
8533923|NCT00298272|21038263|P1|Completed to Week 56|Double-blind Phase||8
8533924|NCT00298272|21038262|P2|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
8533925|NCT00298272|21038263|P1|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
8533926|NCT00298272|21038262|P2|Safety Population|Double-blind Phase||18
8533927|NCT00298272|21038263|P1|Safety Population|Double-blind Phase|received treatment|33
8533928|NCT00298272|21038262|P2|STARTED|Double-blind Phase||18
8533929|NCT00298272|21038263|P1|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
8533930|NCT00298233|21038286|P4|NOT COMPLETED|Overall Study||0
8533931|NCT00298233|21038287|P3|NOT COMPLETED|Overall Study||0
8533932|NCT00298233|21038288|P2|NOT COMPLETED|Overall Study||0
8533933|NCT00298233|21038289|P1|NOT COMPLETED|Overall Study||0
8533934|NCT00298233|21038286|P4|COMPLETED|Overall Study||124
8533935|NCT00298233|21038287|P3|COMPLETED|Overall Study||122
8533936|NCT00298233|21038288|P2|COMPLETED|Overall Study||41
8533937|NCT00298233|21038289|P1|COMPLETED|Overall Study||39
8533938|NCT00298233|21038286|P4|STARTED|Overall Study||124
8533939|NCT00298233|21038287|P3|STARTED|Overall Study||122
8533940|NCT00298233|21038288|P2|STARTED|Overall Study||41
8533941|NCT00298233|21038289|P1|STARTED|Overall Study||39
8533942|NCT00298155|21038308|P3|NOT COMPLETED|Overall Study||0
8533943|NCT00298155|21038309|P2|NOT COMPLETED|Overall Study||0
8533944|NCT00298155|21038310|P1|NOT COMPLETED|Overall Study||0
8533945|NCT00298155|21038308|P3|COMPLETED|Overall Study||13
8533946|NCT00298155|21038309|P2|COMPLETED|Overall Study||10
8533947|NCT00298155|21038310|P1|COMPLETED|Overall Study||12
8533948|NCT00298155|21038308|P3|STARTED|Overall Study||13
8533949|NCT00298155|21038309|P2|STARTED|Overall Study||10
8533950|NCT00298155|21038310|P1|STARTED|Overall Study||12
8533951|NCT00298090|21038321|P1|NOT COMPLETED|Overall Study||18
8533952|NCT00298090|21038321|P1|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
8533953|NCT00298090|21038321|P1|STARTED|Overall Study||47
8533954|NCT00298038|21038327|P2|NOT COMPLETED|Overall Study||93
8533955|NCT00298038|21038328|P1|NOT COMPLETED|Overall Study||52
8533956|NCT00298038|21038327|P2|COMPLETED|Overall Study||66
8533957|NCT00298038|21038328|P1|COMPLETED|Overall Study||88
8533958|NCT00298038|21038327|P2|Received At Least 1 Dose Of Study Drug|Overall Study||159
8533959|NCT00298038|21038328|P1|Received At Least 1 Dose Of Study Drug|Overall Study||140
8533960|NCT00298038|21038327|P2|STARTED|Overall Study||159
8533961|NCT00298038|21038328|P1|STARTED|Overall Study||140
8533962|NCT00297830|21038347|P3|NOT COMPLETED|12 Month Visit||0
8533963|NCT00297830|21038348|P2|NOT COMPLETED|12 Month Visit||6
8533964|NCT00297830|21038349|P1|NOT COMPLETED|12 Month Visit||1
8533965|NCT00297830|21038347|P3|COMPLETED|12 Month Visit||24
8533966|NCT00297830|21038348|P2|COMPLETED|12 Month Visit||35
8533967|NCT00297830|21038349|P1|COMPLETED|12 Month Visit||37
8533968|NCT00297830|21038347|P3|STARTED|12 Month Visit||24
8533969|NCT00297830|21038348|P2|STARTED|12 Month Visit||41
8533970|NCT00297830|21038349|P1|STARTED|12 Month Visit||38
8533971|NCT00297830|21038347|P3|NOT COMPLETED|6 Month Visit||3
8533972|NCT00297830|21038348|P2|NOT COMPLETED|6 Month Visit||2
8533973|NCT00297830|21038349|P1|NOT COMPLETED|6 Month Visit||3
8533974|NCT00297830|21038347|P3|COMPLETED|6 Month Visit||24
8533975|NCT00297830|21038348|P2|COMPLETED|6 Month Visit||41
8533976|NCT00297830|21038349|P1|COMPLETED|6 Month Visit||38
8533977|NCT00297830|21038347|P3|STARTED|6 Month Visit||27
8533978|NCT00297830|21038348|P2|STARTED|6 Month Visit||43
8533979|NCT00297830|21038349|P1|STARTED|6 Month Visit||41
8533980|NCT00297830|21038347|P3|NOT COMPLETED|Baseline||0
8533981|NCT00297830|21038348|P2|NOT COMPLETED|Baseline||0
8533982|NCT00297830|21038349|P1|NOT COMPLETED|Baseline||0
8533983|NCT00297830|21038347|P3|COMPLETED|Baseline||27
8533984|NCT00297830|21038348|P2|COMPLETED|Baseline||43
8533985|NCT00297830|21038349|P1|COMPLETED|Baseline||41
8533986|NCT00297830|21038347|P3|STARTED|Baseline||27
8533987|NCT00297830|21038348|P2|STARTED|Baseline||43
8533988|NCT00297830|21038349|P1|STARTED|Baseline||41
8533989|NCT00297778|21038368|P2|NOT COMPLETED|Overall Study||20
8533990|NCT00297778|21038369|P1|NOT COMPLETED|Overall Study||19
8533991|NCT00297778|21038368|P2|COMPLETED|Overall Study||124
8533992|NCT00297778|21038369|P1|COMPLETED|Overall Study||133
8533993|NCT00297778|21038368|P2|STARTED|Overall Study||144
8533994|NCT00297778|21038369|P1|STARTED|Overall Study||152
8533995|NCT00297648|21038403|P1|NOT COMPLETED|Overall Study||36
8533996|NCT00297648|21038403|P1|COMPLETED|Overall Study||53
8533997|NCT00297648|21038403|P1|STARTED|Overall Study||89
8533998|NCT00297596|21038442|P1|NOT COMPLETED|Overall Study||0
8533999|NCT00297596|21038442|P1|COMPLETED|Overall Study||25
8534000|NCT00297596|21038442|P1|STARTED|Overall Study||25
8534001|NCT00297492|21038449|P3|NOT COMPLETED|6 Month Follow-up||27
8534002|NCT00297492|21038450|P2|NOT COMPLETED|6 Month Follow-up||49
8534003|NCT00297492|21038451|P1|NOT COMPLETED|6 Month Follow-up||63
8534004|NCT00297492|21038449|P3|COMPLETED|6 Month Follow-up||118
8534005|NCT00297492|21038450|P2|COMPLETED|6 Month Follow-up||237
8534006|NCT00297492|21038451|P1|COMPLETED|6 Month Follow-up||227
8534007|NCT00297492|21038449|P3|STARTED|6 Month Follow-up||145
8534008|NCT00297492|21038450|P2|STARTED|6 Month Follow-up||286
8534009|NCT00297492|21038451|P1|STARTED|6 Month Follow-up||290
8534010|NCT00297492|21038449|P3|NOT COMPLETED|Set Quit Date||5
8534011|NCT00297492|21038450|P2|NOT COMPLETED|Set Quit Date||13
8534012|NCT00297492|21038451|P1|NOT COMPLETED|Set Quit Date||7
8534013|NCT00297492|21038449|P3|COMPLETED|Set Quit Date||145
8534014|NCT00297492|21038450|P2|COMPLETED|Set Quit Date||286
8534015|NCT00297492|21038451|P1|COMPLETED|Set Quit Date||290
8534016|NCT00297492|21038449|P3|STARTED|Set Quit Date||150
8534017|NCT00297492|21038450|P2|STARTED|Set Quit Date||299
8534018|NCT00297492|21038451|P1|STARTED|Set Quit Date||297
8534019|NCT00297479|21038462|P3|NOT COMPLETED|Overall Study||51
8534020|NCT00297479|21038463|P2|NOT COMPLETED|Overall Study||54
8534021|NCT00297479|21038464|P1|NOT COMPLETED|Overall Study||37
8534022|NCT00297479|21038462|P3|COMPLETED|Overall Study||103
8534023|NCT00297479|21038463|P2|COMPLETED|Overall Study||101
8534024|NCT00297479|21038464|P1|COMPLETED|Overall Study||66
8534025|NCT00297479|21038462|P3|26- Week Follow Up|Overall Study||103
8534026|NCT00297479|21038463|P2|26- Week Follow Up|Overall Study||101
8534027|NCT00297479|21038464|P1|26- Week Follow Up|Overall Study||66
8534028|NCT00297479|21038462|P3|4-Week Follow Up|Overall Study||128
8534029|NCT00297479|21038463|P2|4-Week Follow Up|Overall Study||132
8534030|NCT00297479|21038464|P1|4-Week Follow Up|Overall Study||78
8534031|NCT00297479|21038462|P3|STARTED|Overall Study||154
8534032|NCT00297479|21038463|P2|STARTED|Overall Study||155
8534033|NCT00297479|21038464|P1|STARTED|Overall Study||103
8534034|NCT00297427|21038483|P2|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
8534035|NCT00297427|21038484|P1|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
8534036|NCT00297427|21038483|P2|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
8534196|NCT00296504|21038713|P5|COMPLETED|Interim Analysis||36
8534037|NCT00297427|21038484|P1|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
8534038|NCT00297427|21038483|P2|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
8534039|NCT00297427|21038484|P1|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
8534040|NCT00297427|21038483|P2|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
8534041|NCT00297427|21038484|P1|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
8534042|NCT00297427|21038483|P2|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
8534043|NCT00297427|21038484|P1|COMPLETED|Phase 2: Optional Crossover for Sham||38
8534044|NCT00297427|21038483|P2|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
8534045|NCT00297427|21038484|P1|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
8534046|NCT00297427|21038483|P2|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
8534047|NCT00297427|21038484|P1|STARTED|Phase 2: Optional Crossover for Sham||54
8534048|NCT00297427|21038483|P2|NOT COMPLETED|Phase 1: Initial Intervention||9
8534049|NCT00297427|21038484|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
8534050|NCT00297427|21038483|P2|COMPLETED|Phase 1: Initial Intervention||54
8534051|NCT00297427|21038484|P1|COMPLETED|Phase 1: Initial Intervention||56
8534052|NCT00297427|21038483|P2|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
8534053|NCT00297427|21038484|P1|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
8534054|NCT00297258|21038525|P1|NOT COMPLETED|Overall Study||142
8534055|NCT00297258|21038525|P1|COMPLETED|Overall Study||0
8534056|NCT00297258|21038525|P1|STARTED|Overall Study||142
8534057|NCT00297232|21038544|P1|NOT COMPLETED|Overall Study||605
8534058|NCT00297232|21038544|P1|COMPLETED|Overall Study||489
8534059|NCT00297232|21038544|P1|STARTED|Overall Study||1094
8534060|NCT00297167|21038550|P3|NOT COMPLETED|Open-label Dose Normalization Period 2||0
8534061|NCT00297167|21038551|P2|NOT COMPLETED|Open-label Dose Normalization Period 2||0
8534062|NCT00297167|21038552|P1|NOT COMPLETED|Open-label Dose Normalization Period 2||0
8534063|NCT00297167|21038550|P3|COMPLETED|Open-label Dose Normalization Period 2||31
8534064|NCT00297167|21038551|P2|COMPLETED|Open-label Dose Normalization Period 2||0
8534065|NCT00297167|21038552|P1|COMPLETED|Open-label Dose Normalization Period 2||0
8534066|NCT00297167|21038550|P3|STARTED|Open-label Dose Normalization Period 2||31
8534067|NCT00297167|21038551|P2|STARTED|Open-label Dose Normalization Period 2||0
8534068|NCT00297167|21038552|P1|STARTED|Open-label Dose Normalization Period 2||0
8534069|NCT00297167|21038550|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
8534070|NCT00297167|21038551|P2|NOT COMPLETED|Second Double-blind Intervention Period||0
8534071|NCT00297167|21038552|P1|NOT COMPLETED|Second Double-blind Intervention Period||1
8534072|NCT00297167|21038550|P3|COMPLETED|Second Double-blind Intervention Period||0
8534073|NCT00297167|21038551|P2|COMPLETED|Second Double-blind Intervention Period||15
8534074|NCT00297167|21038552|P1|COMPLETED|Second Double-blind Intervention Period||16
8534075|NCT00297167|21038550|P3|STARTED|Second Double-blind Intervention Period||0
8534076|NCT00297167|21038551|P2|STARTED|Second Double-blind Intervention Period||15
8534077|NCT00297167|21038552|P1|STARTED|Second Double-blind Intervention Period||17
8534078|NCT00297167|21038550|P3|NOT COMPLETED|Open-label Dose Normalization Period 1||1
8534079|NCT00297167|21038551|P2|NOT COMPLETED|Open-label Dose Normalization Period 1||0
8534080|NCT00297167|21038552|P1|NOT COMPLETED|Open-label Dose Normalization Period 1||0
8534081|NCT00297167|21038550|P3|COMPLETED|Open-label Dose Normalization Period 1||32
8534082|NCT00297167|21038551|P2|COMPLETED|Open-label Dose Normalization Period 1||0
8534083|NCT00297167|21038552|P1|COMPLETED|Open-label Dose Normalization Period 1||0
8534084|NCT00297167|21038550|P3|STARTED|Open-label Dose Normalization Period 1||33
8534085|NCT00297167|21038551|P2|STARTED|Open-label Dose Normalization Period 1||0
8534086|NCT00297167|21038552|P1|STARTED|Open-label Dose Normalization Period 1||0
8534087|NCT00297167|21038550|P3|NOT COMPLETED|First Double-blind Intervention Period||0
8534088|NCT00297167|21038551|P2|NOT COMPLETED|First Double-blind Intervention Period||0
8534089|NCT00297167|21038552|P1|NOT COMPLETED|First Double-blind Intervention Period||0
8534090|NCT00297167|21038550|P3|COMPLETED|First Double-blind Intervention Period||0
8534091|NCT00297167|21038551|P2|COMPLETED|First Double-blind Intervention Period||16
8534092|NCT00297167|21038552|P1|COMPLETED|First Double-blind Intervention Period||17
8534093|NCT00297167|21038550|P3|STARTED|First Double-blind Intervention Period||0
8534094|NCT00297167|21038551|P2|STARTED|First Double-blind Intervention Period||16
8534095|NCT00297167|21038552|P1|STARTED|First Double-blind Intervention Period||17
8534096|NCT00297115|21038578|P2|NOT COMPLETED|Overall Study||246
8534097|NCT00297115|21038579|P1|NOT COMPLETED|Overall Study||245
8534098|NCT00297115|21038578|P2|COMPLETED|Overall Study||550
8534099|NCT00297115|21038579|P1|COMPLETED|Overall Study||527
8534100|NCT00297115|21038578|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
8534101|NCT00297115|21038579|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
8534102|NCT00297102|21038597|P2|NOT COMPLETED|Overall Study||233
8534103|NCT00297102|21038598|P1|NOT COMPLETED|Overall Study||263
8534104|NCT00297102|21038597|P2|COMPLETED|Overall Study||525
8534105|NCT00297102|21038598|P1|COMPLETED|Overall Study||502
8534106|NCT00297102|21038597|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
8534107|NCT00297102|21038598|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
8534108|NCT00297037|21038616|P2|NOT COMPLETED|Overall Study||0
8534109|NCT00297037|21038617|P1|NOT COMPLETED|Overall Study||2
8534110|NCT00297037|21038616|P2|COMPLETED|Overall Study||11
8534111|NCT00297037|21038617|P1|COMPLETED|Overall Study||8
8534112|NCT00297037|21038616|P2|STARTED|Overall Study||11
8534113|NCT00297037|21038617|P1|STARTED|Overall Study||10
8534114|NCT00296816|21038629|P1|NOT COMPLETED|Overall Study||74
8534115|NCT00296816|21038629|P1|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
8534116|NCT00296816|21038629|P1|STARTED|Overall Study||132
8534117|NCT00296725|21038641|P1|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1
8534118|NCT00296725|21038641|P1|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7
8534119|NCT00296725|21038641|P1|STARTED|Phase 2: Imipramine (1-6 Weeks)||8
8534120|NCT00296725|21038641|P1|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5
8534121|NCT00296725|21038641|P1|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12
8534122|NCT00296725|21038641|P1|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17
8534123|NCT00296647|21038654|P5|NOT COMPLETED|Overall Study||20
8534124|NCT00296647|21038655|P4|NOT COMPLETED|Overall Study||17
8534125|NCT00296647|21038656|P3|NOT COMPLETED|Overall Study||34
8534126|NCT00296647|21038657|P2|NOT COMPLETED|Overall Study||28
8534127|NCT00296647|21038658|P1|NOT COMPLETED|Overall Study||32
8534128|NCT00296647|21038654|P5|COMPLETED|Overall Study||248
8534129|NCT00296647|21038655|P4|COMPLETED|Overall Study||262
8534130|NCT00296647|21038656|P3|COMPLETED|Overall Study||222
8534131|NCT00296647|21038657|P2|COMPLETED|Overall Study||233
8534132|NCT00296647|21038658|P1|COMPLETED|Overall Study||250
8534133|NCT00296647|21038654|P5|STARTED|Overall Study||268
8534134|NCT00296647|21038655|P4|STARTED|Overall Study||279
8534135|NCT00296647|21038656|P3|STARTED|Overall Study||256
8534136|NCT00296647|21038657|P2|STARTED|Overall Study||261
8534137|NCT00296647|21038658|P1|STARTED|Overall Study||282
8534138|NCT00296517|21038672|P2|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
8534139|NCT00296517|21038673|P1|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
8534140|NCT00296517|21038672|P2|COMPLETED|Dose Level 3 - Weeks 3-12||99
8534141|NCT00296517|21038673|P1|COMPLETED|Dose Level 3 - Weeks 3-12||112
8534142|NCT00296517|21038672|P2|STARTED|Dose Level 3 - Weeks 3-12||161
8534143|NCT00296517|21038673|P1|STARTED|Dose Level 3 - Weeks 3-12||157
8534144|NCT00296517|21038672|P2|NOT COMPLETED|Dose Level 2 - Week 2||5
8534145|NCT00296517|21038673|P1|NOT COMPLETED|Dose Level 2 - Week 2||2
8534146|NCT00296517|21038672|P2|COMPLETED|Dose Level 2 - Week 2||161
8534147|NCT00296517|21038673|P1|COMPLETED|Dose Level 2 - Week 2||157
8534148|NCT00296517|21038672|P2|STARTED|Dose Level 2 - Week 2||166
8534149|NCT00296517|21038673|P1|STARTED|Dose Level 2 - Week 2||159
8534150|NCT00296517|21038672|P2|NOT COMPLETED|Dose Level 1 - Week 1||0
8534151|NCT00296517|21038673|P1|NOT COMPLETED|Dose Level 1 - Week 1||0
8534152|NCT00296517|21038672|P2|COMPLETED|Dose Level 1 - Week 1||166
8534153|NCT00296517|21038673|P1|COMPLETED|Dose Level 1 - Week 1||159
8534154|NCT00296517|21038672|P2|STARTED|Dose Level 1 - Week 1||166
8534155|NCT00296517|21038673|P1|STARTED|Dose Level 1 - Week 1||159
8534156|NCT00296504|21038709|P9|NOT COMPLETED|Final Analysis||21
8534157|NCT00296504|21038710|P8|NOT COMPLETED|Final Analysis||0
8534158|NCT00296504|21038711|P7|NOT COMPLETED|Final Analysis||0
8534159|NCT00296504|21038712|P6|NOT COMPLETED|Final Analysis||0
8534160|NCT00296504|21038713|P5|NOT COMPLETED|Final Analysis||0
8534161|NCT00296504|21038714|P4|NOT COMPLETED|Final Analysis||0
8534162|NCT00296504|21038715|P3|NOT COMPLETED|Final Analysis||0
8534163|NCT00296504|21038716|P2|NOT COMPLETED|Final Analysis||0
8534164|NCT00296504|21038717|P1|NOT COMPLETED|Final Analysis||0
8534165|NCT00296504|21038709|P9|COMPLETED|Final Analysis||90
8534166|NCT00296504|21038710|P8|COMPLETED|Final Analysis||0
8534167|NCT00296504|21038711|P7|COMPLETED|Final Analysis||0
8534168|NCT00296504|21038712|P6|COMPLETED|Final Analysis||0
8534169|NCT00296504|21038713|P5|COMPLETED|Final Analysis||0
8534170|NCT00296504|21038714|P4|COMPLETED|Final Analysis||0
8534171|NCT00296504|21038715|P3|COMPLETED|Final Analysis||0
8534172|NCT00296504|21038716|P2|COMPLETED|Final Analysis||0
8534173|NCT00296504|21038717|P1|COMPLETED|Final Analysis||0
8534174|NCT00296504|21038709|P9|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
8534175|NCT00296504|21038710|P8|STARTED|Final Analysis||0
8534176|NCT00296504|21038711|P7|STARTED|Final Analysis||0
8534177|NCT00296504|21038712|P6|STARTED|Final Analysis||0
8534178|NCT00296504|21038713|P5|STARTED|Final Analysis||0
8534179|NCT00296504|21038714|P4|STARTED|Final Analysis||0
8534180|NCT00296504|21038715|P3|STARTED|Final Analysis||0
8534181|NCT00296504|21038716|P2|STARTED|Final Analysis||0
8534182|NCT00296504|21038717|P1|STARTED|Final Analysis||0
8534183|NCT00296504|21038709|P9|NOT COMPLETED|Interim Analysis||0
8534184|NCT00296504|21038710|P8|NOT COMPLETED|Interim Analysis||49
8534185|NCT00296504|21038711|P7|NOT COMPLETED|Interim Analysis||74
8534186|NCT00296504|21038712|P6|NOT COMPLETED|Interim Analysis||37
8534187|NCT00296504|21038713|P5|NOT COMPLETED|Interim Analysis||37
8534188|NCT00296504|21038714|P4|NOT COMPLETED|Interim Analysis||43
8534189|NCT00296504|21038715|P3|NOT COMPLETED|Interim Analysis||105
8534190|NCT00296504|21038716|P2|NOT COMPLETED|Interim Analysis||18
8534191|NCT00296504|21038717|P1|NOT COMPLETED|Interim Analysis||76
8534192|NCT00296504|21038709|P9|COMPLETED|Interim Analysis||0
8534193|NCT00296504|21038710|P8|COMPLETED|Interim Analysis||37
8534194|NCT00296504|21038711|P7|COMPLETED|Interim Analysis||30
8534195|NCT00296504|21038712|P6|COMPLETED|Interim Analysis||41
8534197|NCT00296504|21038714|P4|COMPLETED|Interim Analysis||11
8534198|NCT00296504|21038715|P3|COMPLETED|Interim Analysis||116
8534199|NCT00296504|21038716|P2|COMPLETED|Interim Analysis||0
8534200|NCT00296504|21038717|P1|COMPLETED|Interim Analysis||43
8534201|NCT00296504|21038709|P9|Ongoing|Interim Analysis||0
8534202|NCT00296504|21038710|P8|Ongoing|Interim Analysis||1
8534203|NCT00296504|21038711|P7|Ongoing|Interim Analysis||30
8534204|NCT00296504|21038712|P6|Ongoing|Interim Analysis||0
8534205|NCT00296504|21038713|P5|Ongoing|Interim Analysis||0
8534206|NCT00296504|21038714|P4|Ongoing|Interim Analysis||22
8534207|NCT00296504|21038715|P3|Ongoing|Interim Analysis||16
8534208|NCT00296504|21038716|P2|Ongoing|Interim Analysis||12
8534209|NCT00296504|21038717|P1|Ongoing|Interim Analysis||32
8534210|NCT00296504|21038709|P9|STARTED|Interim Analysis||0
8534211|NCT00296504|21038710|P8|STARTED|Interim Analysis||86
8534212|NCT00296504|21038711|P7|STARTED|Interim Analysis||104
8534213|NCT00296504|21038712|P6|STARTED|Interim Analysis||78
8534214|NCT00296504|21038713|P5|STARTED|Interim Analysis||73
8534215|NCT00296504|21038714|P4|STARTED|Interim Analysis||54
8534216|NCT00296504|21038715|P3|STARTED|Interim Analysis||221
8534217|NCT00296504|21038716|P2|STARTED|Interim Analysis||18
8534218|NCT00296504|21038717|P1|STARTED|Interim Analysis||119
8534219|NCT00296491|21038810|P4|NOT COMPLETED|Overall Study||43
8534220|NCT00296491|21038811|P3|NOT COMPLETED|Overall Study||43
8534221|NCT00296491|21038812|P2|NOT COMPLETED|Overall Study||53
8534222|NCT00296491|21038813|P1|NOT COMPLETED|Overall Study||42
8534223|NCT00296491|21038810|P4|COMPLETED|Overall Study||138
8534224|NCT00296491|21038811|P3|COMPLETED|Overall Study||137
8534225|NCT00296491|21038812|P2|COMPLETED|Overall Study||129
8534226|NCT00296491|21038813|P1|COMPLETED|Overall Study||140
8534227|NCT00296491|21038810|P4|STARTED|Overall Study||181
8534228|NCT00296491|21038811|P3|STARTED|Overall Study||180
8534229|NCT00296491|21038812|P2|STARTED|Overall Study||182
8534230|NCT00296491|21038813|P1|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
8534231|NCT00296400|21038842|P3|NOT COMPLETED|Overall Study||13
8534232|NCT00296400|21038843|P2|NOT COMPLETED|Overall Study||18
8534233|NCT00296400|21038844|P1|NOT COMPLETED|Overall Study||17
8534234|NCT00296400|21038842|P3|COMPLETED|Overall Study||67
8534235|NCT00296400|21038843|P2|COMPLETED|Overall Study||69
8534236|NCT00296400|21038844|P1|COMPLETED|Overall Study||53
8534237|NCT00296400|21038842|P3|STARTED|Overall Study||80
8534238|NCT00296400|21038843|P2|STARTED|Overall Study||87
8534239|NCT00296400|21038844|P1|STARTED|Overall Study||70
8534240|NCT00296374|21039068|P3|NOT COMPLETED|Overall Study||29
8534241|NCT00296374|21039069|P2|NOT COMPLETED|Overall Study||23
8534242|NCT00296374|21039070|P1|NOT COMPLETED|Overall Study||25
8534243|NCT00296374|21039068|P3|COMPLETED|Overall Study||82
8534244|NCT00296374|21039069|P2|COMPLETED|Overall Study||101
8534245|NCT00296374|21039070|P1|COMPLETED|Overall Study||93
8534246|NCT00296374|21039068|P3|STARTED|Overall Study||111
8534247|NCT00296374|21039069|P2|STARTED|Overall Study||124
8534248|NCT00296374|21039070|P1|STARTED|Overall Study||118
8534249|NCT00296335|21039293|P2|NOT COMPLETED|Overall Study||122
8534250|NCT00296335|21039294|P1|NOT COMPLETED|Overall Study||30
8534251|NCT00296335|21039293|P2|COMPLETED|Overall Study||309
8534252|NCT00296335|21039294|P1|COMPLETED|Overall Study||394
8534253|NCT00296335|21039293|P2|STARTED|Overall Study||431
8534254|NCT00296335|21039294|P1|STARTED|Overall Study||424
8534255|NCT00296322|21039306|P2|NOT COMPLETED|Overall Study||79
8534256|NCT00296322|21039307|P1|NOT COMPLETED|Overall Study||21
8534257|NCT00296322|21039306|P2|COMPLETED|Overall Study||184
8534258|NCT00296322|21039307|P1|COMPLETED|Overall Study||237
8534259|NCT00296322|21039306|P2|STARTED|Overall Study||263
8534260|NCT00296322|21039307|P1|STARTED|Overall Study||258
8534261|NCT00296296|21039319|P2|NOT COMPLETED|Overall Study||13
8534262|NCT00296296|21039320|P1|NOT COMPLETED|Overall Study||2
8534263|NCT00296296|21039319|P2|COMPLETED|Overall Study||5
8534264|NCT00296296|21039320|P1|COMPLETED|Overall Study||9
8534265|NCT00296296|21039319|P2|STARTED|Overall Study||18
8534266|NCT00296296|21039320|P1|STARTED|Overall Study||11
8534267|NCT00296244|21039334|P2|NOT COMPLETED|Overall Study||1
8534268|NCT00296244|21039335|P1|NOT COMPLETED|Overall Study||0
8534269|NCT00296244|21039334|P2|COMPLETED|Overall Study||19
8534270|NCT00296244|21039335|P1|COMPLETED|Overall Study||20
8534271|NCT00296244|21039334|P2|STARTED|Overall Study||20
8534272|NCT00296244|21039335|P1|STARTED|Overall Study||20
8534273|NCT00296231|21039351|P1|NOT COMPLETED|Overall Study||0
8534274|NCT00296231|21039351|P1|COMPLETED|Overall Study||14
8534275|NCT00296231|21039351|P1|STARTED|Overall Study||14
8534276|NCT00296192|21039361|P5|NOT COMPLETED|Overall Study||0
8534277|NCT00296192|21039362|P4|NOT COMPLETED|Overall Study||0
8534278|NCT00296192|21039363|P3|NOT COMPLETED|Overall Study||0
8534279|NCT00296192|21039364|P2|NOT COMPLETED|Overall Study||0
8534280|NCT00296192|21039365|P1|NOT COMPLETED|Overall Study||0
8534281|NCT00296192|21039361|P5|COMPLETED|Overall Study||16
8534282|NCT00296192|21039362|P4|COMPLETED|Overall Study||17
8534283|NCT00296192|21039363|P3|COMPLETED|Overall Study||16
8534284|NCT00296192|21039364|P2|COMPLETED|Overall Study||16
8534285|NCT00296192|21039365|P1|COMPLETED|Overall Study||17
8534286|NCT00296192|21039361|P5|STARTED|Overall Study||16
8534287|NCT00296192|21039362|P4|STARTED|Overall Study||17
8534288|NCT00296192|21039363|P3|STARTED|Overall Study||16
8534289|NCT00296192|21039364|P2|STARTED|Overall Study||16
8534290|NCT00296192|21039365|P1|STARTED|Overall Study||17
8534291|NCT00296140|21039399|P2|NOT COMPLETED|Overall Study||0
8534292|NCT00296140|21039400|P1|NOT COMPLETED|Overall Study||3
8534293|NCT00296140|21039399|P2|COMPLETED|Overall Study||33
8534294|NCT00296140|21039400|P1|COMPLETED|Overall Study||30
8534295|NCT00296140|21039399|P2|STARTED|Overall Study||33
8534296|NCT00296140|21039400|P1|STARTED|Overall Study||33
8534297|NCT00296036|21039412|P6|NOT COMPLETED|Overall Study||4
8534298|NCT00296036|21039413|P5|NOT COMPLETED|Overall Study||2
8534299|NCT00296036|21039414|P4|NOT COMPLETED|Overall Study||1
8534300|NCT00296036|21039415|P3|NOT COMPLETED|Overall Study||2
8534301|NCT00296036|21039416|P2|NOT COMPLETED|Overall Study||0
8534302|NCT00296036|21039417|P1|NOT COMPLETED|Overall Study||1
8534303|NCT00296036|21039412|P6|COMPLETED|Overall Study||28
8534304|NCT00296036|21039413|P5|COMPLETED|Overall Study||31
8534305|NCT00296036|21039414|P4|COMPLETED|Overall Study||16
8534306|NCT00296036|21039415|P3|COMPLETED|Overall Study||16
8534307|NCT00296036|21039416|P2|COMPLETED|Overall Study||18
8534308|NCT00296036|21039417|P1|COMPLETED|Overall Study||18
8534309|NCT00296036|21039412|P6|STARTED|Overall Study||32
8534310|NCT00296036|21039413|P5|STARTED|Overall Study||33
8534311|NCT00296036|21039414|P4|STARTED|Overall Study||17
8534312|NCT00296036|21039415|P3|STARTED|Overall Study||18
8534313|NCT00296036|21039416|P2|STARTED|Overall Study||18
8534314|NCT00296036|21039417|P1|STARTED|Overall Study||19
8534315|NCT00295932|21039454|P11|NOT COMPLETED|Overall Study||1
8534316|NCT00295932|21039455|P10|NOT COMPLETED|Overall Study||0
8534317|NCT00295932|21039456|P9|NOT COMPLETED|Overall Study||0
8534318|NCT00295932|21039457|P8|NOT COMPLETED|Overall Study||0
8534319|NCT00295932|21039458|P7|NOT COMPLETED|Overall Study||0
8534320|NCT00295932|21039459|P6|NOT COMPLETED|Overall Study||0
8534321|NCT00295932|21039460|P5|NOT COMPLETED|Overall Study||0
8534322|NCT00295932|21039461|P4|NOT COMPLETED|Overall Study||0
8534323|NCT00295932|21039462|P3|NOT COMPLETED|Overall Study||0
8534324|NCT00295932|21039463|P2|NOT COMPLETED|Overall Study||0
8534325|NCT00295932|21039464|P1|NOT COMPLETED|Overall Study||0
8534326|NCT00295932|21039454|P11|COMPLETED|Overall Study||12
8534327|NCT00295932|21039455|P10|COMPLETED|Overall Study||12
8534328|NCT00295932|21039456|P9|COMPLETED|Overall Study||10
8534329|NCT00295932|21039457|P8|COMPLETED|Overall Study||4
8534330|NCT00295932|21039458|P7|COMPLETED|Overall Study||3
8534331|NCT00295932|21039459|P6|COMPLETED|Overall Study||18
8534332|NCT00295932|21039460|P5|COMPLETED|Overall Study||2
8534333|NCT00295932|21039461|P4|COMPLETED|Overall Study||4
8534334|NCT00295932|21039462|P3|COMPLETED|Overall Study||3
8534335|NCT00295932|21039463|P2|COMPLETED|Overall Study||6
8534336|NCT00295932|21039464|P1|COMPLETED|Overall Study||4
8534337|NCT00295932|21039454|P11|STARTED|Overall Study||13
8534338|NCT00295932|21039455|P10|STARTED|Overall Study||12
8534339|NCT00295932|21039456|P9|STARTED|Overall Study||10
8534340|NCT00295932|21039457|P8|STARTED|Overall Study||4
8534341|NCT00295932|21039458|P7|STARTED|Overall Study||3
8534342|NCT00295932|21039459|P6|STARTED|Overall Study||18
8534343|NCT00295932|21039460|P5|STARTED|Overall Study||2
8534344|NCT00295932|21039461|P4|STARTED|Overall Study||4
8534345|NCT00295932|21039462|P3|STARTED|Overall Study||3
8534346|NCT00295932|21039463|P2|STARTED|Overall Study||6
8534347|NCT00295932|21039464|P1|STARTED|Overall Study||4
8534348|NCT00295880|21039498|P1|NOT COMPLETED|Overall Study||2
8534349|NCT00295880|21039498|P1|COMPLETED|Overall Study||10
8534350|NCT00295880|21039498|P1|STARTED|Overall Study||12
8534351|NCT00295867|21039509|P1|NOT COMPLETED|Overall Study||11
8534352|NCT00295867|21039509|P1|COMPLETED|Overall Study||34
8534353|NCT00295867|21039509|P1|STARTED|Overall Study||45
8534354|NCT00295854|21039518|P3|NOT COMPLETED|Overall Study||15
8534355|NCT00295854|21039519|P2|NOT COMPLETED|Overall Study||21
8534356|NCT00295854|21039520|P1|NOT COMPLETED|Overall Study||18
8534357|NCT00295854|21039518|P3|COMPLETED|Overall Study||87
8534358|NCT00295854|21039519|P2|COMPLETED|Overall Study||87
8534359|NCT00295854|21039520|P1|COMPLETED|Overall Study||77
8534360|NCT00295854|21039518|P3|ITT Population (N=296)|Overall Study||99
8534361|NCT00295854|21039519|P2|ITT Population (N=296)|Overall Study||105
8534362|NCT00295854|21039520|P1|ITT Population (N=296)|Overall Study||92
8534363|NCT00295854|21039518|P3|Safety Population (N=304)|Overall Study||101
8534364|NCT00295854|21039519|P2|Safety Population (N=304)|Overall Study||108
8534365|NCT00295854|21039520|P1|Safety Population (N=304)|Overall Study||95
8534366|NCT00295854|21039518|P3|STARTED|Overall Study||102
8534367|NCT00295854|21039519|P2|STARTED|Overall Study||108
8534368|NCT00295854|21039520|P1|STARTED|Overall Study||95
8534369|NCT00295750|21039534|P3|NOT COMPLETED|Overall Study||32
8534370|NCT00295750|21039535|P2|NOT COMPLETED|Overall Study||41
8534371|NCT00295750|21039536|P1|NOT COMPLETED|Overall Study||43
8534372|NCT00295750|21039534|P3|COMPLETED|Overall Study||172
8534373|NCT00295750|21039535|P2|COMPLETED|Overall Study||169
8534374|NCT00295750|21039536|P1|COMPLETED|Overall Study||163
8534375|NCT00295750|21039534|P3|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
8534376|NCT00295750|21039535|P2|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
8534377|NCT00295750|21039536|P1|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
8534378|NCT00295750|21039534|P3|STARTED|Overall Study|randomized|204
8534379|NCT00295750|21039535|P2|STARTED|Overall Study|randomized|210
8534380|NCT00295750|21039536|P1|STARTED|Overall Study|randomized|206
8534381|NCT00295633|21039571|P3|NOT COMPLETED|Overall Study||76
8534382|NCT00295633|21039572|P2|NOT COMPLETED|Overall Study||67
8534383|NCT00295633|21039573|P1|NOT COMPLETED|Overall Study||62
8534384|NCT00295633|21039571|P3|COMPLETED|Overall Study||108
8534385|NCT00295633|21039572|P2|COMPLETED|Overall Study||119
8534386|NCT00295633|21039573|P1|COMPLETED|Overall Study||133
8534387|NCT00295633|21039571|P3|Completed Study Without Being Rescued|Overall Study||51
8534388|NCT00295633|21039572|P2|Completed Study Without Being Rescued|Overall Study||82
8534389|NCT00295633|21039573|P1|Completed Study Without Being Rescued|Overall Study||88
8534390|NCT00295633|21039571|P3|STARTED|Overall Study||184
8534391|NCT00295633|21039572|P2|STARTED|Overall Study||186
8534392|NCT00295633|21039573|P1|STARTED|Overall Study||195
8534393|NCT00295620|21039592|P2|NOT COMPLETED|Overall Study||896
8534394|NCT00295620|21039593|P1|NOT COMPLETED|Overall Study||872
8534395|NCT00295620|21039592|P2|COMPLETED|Overall Study||842
8534396|NCT00295620|21039593|P1|COMPLETED|Overall Study||860
8534397|NCT00295620|21039592|P2|Safety Analysis Set|Overall Study||1710
8534398|NCT00295620|21039593|P1|Safety Analysis Set|Overall Study||1705
8534399|NCT00295620|21039592|P2|STARTED|Overall Study||1738
8534400|NCT00295620|21039593|P1|STARTED|Overall Study||1732
8534401|NCT00295503|21039607|P1|NOT COMPLETED|Overall Study||0
8534402|NCT00295503|21039607|P1|COMPLETED|Overall Study||53
8534403|NCT00295503|21039607|P1|STARTED|Overall Study||53
8534404|NCT00295490|21039617|P4|NOT COMPLETED|Overall Study||5
8534405|NCT00295490|21039618|P3|NOT COMPLETED|Overall Study||4
8534406|NCT00295490|21039619|P2|NOT COMPLETED|Overall Study||4
8534407|NCT00295490|21039620|P1|NOT COMPLETED|Overall Study||1
8534408|NCT00295490|21039617|P4|COMPLETED|Overall Study||12
8534409|NCT00295490|21039618|P3|COMPLETED|Overall Study||12
8534410|NCT00295490|21039619|P2|COMPLETED|Overall Study||15
8534411|NCT00295490|21039620|P1|COMPLETED|Overall Study||14
8534412|NCT00295490|21039617|P4|STARTED|Overall Study||17
8534413|NCT00295490|21039618|P3|STARTED|Overall Study||16
8534414|NCT00295490|21039619|P2|STARTED|Overall Study||19
8534415|NCT00295490|21039620|P1|STARTED|Overall Study||15
8534416|NCT00295061|21039660|P2|NOT COMPLETED|Overall Study||0
8534417|NCT00295061|21039661|P1|NOT COMPLETED|Overall Study||0
8534418|NCT00295061|21039660|P2|COMPLETED|Overall Study||12
8534419|NCT00295061|21039661|P1|COMPLETED|Overall Study||12
8534420|NCT00295061|21039660|P2|STARTED|Overall Study||12
8534421|NCT00295061|21039661|P1|STARTED|Overall Study||12
8534422|NCT00295022|21039670|P3|NOT COMPLETED|Overall Study||5
8534423|NCT00295022|21039671|P2|NOT COMPLETED|Overall Study||1
8534424|NCT00295022|21039672|P1|NOT COMPLETED|Overall Study||1
8534425|NCT00295022|21039670|P3|COMPLETED|Overall Study||151
8534426|NCT00295022|21039671|P2|COMPLETED|Overall Study||156
8534427|NCT00295022|21039672|P1|COMPLETED|Overall Study||104
8534428|NCT00295022|21039670|P3|STARTED|Overall Study||156
8534429|NCT00295022|21039671|P2|STARTED|Overall Study||157
8534430|NCT00295022|21039672|P1|STARTED|Overall Study||105
8534431|NCT00295009|21039761|P6|NOT COMPLETED|Overall Study||269
8534432|NCT00295009|21039762|P5|NOT COMPLETED|Overall Study||58
8534433|NCT00295009|21039763|P4|NOT COMPLETED|Overall Study||25
8534434|NCT00295009|21039764|P3|NOT COMPLETED|Overall Study||12
8534435|NCT00295009|21039765|P2|NOT COMPLETED|Overall Study||49
8534436|NCT00295009|21039766|P1|NOT COMPLETED|Overall Study||41
8534437|NCT00295009|21039761|P6|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
8534438|NCT00295009|21039762|P5|COMPLETED|Overall Study|Completed 60 month visit|116
8534439|NCT00295009|21039763|P4|COMPLETED|Overall Study|Completed 60 month visit|57
8534440|NCT00295009|21039764|P3|COMPLETED|Overall Study|Completed 60 month visit|39
8534441|NCT00295009|21039765|P2|COMPLETED|Overall Study|Completed 60 month visit|134
8534442|NCT00295009|21039766|P1|COMPLETED|Overall Study|Completed 60 month visit|52
8534443|NCT00295009|21039761|P6|Completed 24 Month Analysis|Overall Study||198
8534444|NCT00295009|21039762|P5|Completed 24 Month Analysis|Overall Study||133
8534445|NCT00295009|21039763|P4|Completed 24 Month Analysis|Overall Study||60
8534446|NCT00295009|21039764|P3|Completed 24 Month Analysis|Overall Study||45
8534447|NCT00295009|21039765|P2|Completed 24 Month Analysis|Overall Study||148
8534448|NCT00295009|21039766|P1|Completed 24 Month Analysis|Overall Study||71
8534449|NCT00295009|21039761|P6|Treated|Overall Study||259
8534450|NCT00295009|21039762|P5|Treated|Overall Study||165
8534451|NCT00295009|21039763|P4|Treated|Overall Study||72
8534452|NCT00295009|21039764|P3|Treated|Overall Study||50
8534453|NCT00295009|21039765|P2|Treated|Overall Study||162
8534454|NCT00295009|21039766|P1|Treated|Overall Study||80
8534455|NCT00295009|21039761|P6|STARTED|Overall Study||269
8534456|NCT00295009|21039762|P5|STARTED|Overall Study||174
8534457|NCT00295009|21039763|P4|STARTED|Overall Study||82
8534458|NCT00295009|21039764|P3|STARTED|Overall Study||51
8534459|NCT00295009|21039765|P2|STARTED|Overall Study||183
8534460|NCT00295009|21039766|P1|STARTED|Overall Study||93
8534461|NCT00294762|21039788|P2|NOT COMPLETED|Overall Study||3
8534462|NCT00294762|21039789|P1|NOT COMPLETED|Overall Study||3
8534463|NCT00294762|21039788|P2|COMPLETED|Overall Study||68
8534464|NCT00294762|21039789|P1|COMPLETED|Overall Study||69
8534465|NCT00294762|21039788|P2|STARTED|Overall Study||71
8534466|NCT00294762|21039789|P1|STARTED|Overall Study||72
8534467|NCT00294723|21039808|P3|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
8534468|NCT00294723|21039809|P2|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
8534469|NCT00294723|21039810|P1|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
8534470|NCT00294723|21039808|P3|COMPLETED|Additional Open-Label Extension 91 Weeks||8
8534471|NCT00294723|21039809|P2|COMPLETED|Additional Open-Label Extension 91 Weeks||32
8534472|NCT00294723|21039810|P1|COMPLETED|Additional Open-Label Extension 91 Weeks||34
8534473|NCT00294723|21039808|P3|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
8534555|NCT00294398|21040067|P2|COMPLETED|Overall Study||48
8534474|NCT00294723|21039809|P2|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
8534475|NCT00294723|21039810|P1|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
8534476|NCT00294723|21039808|P3|NOT COMPLETED|Open-Label Extension 52 Weeks||40
8534477|NCT00294723|21039809|P2|NOT COMPLETED|Open-Label Extension 52 Weeks||39
8534478|NCT00294723|21039810|P1|NOT COMPLETED|Open-Label Extension 52 Weeks||40
8534479|NCT00294723|21039808|P3|COMPLETED|Open-Label Extension 52 Weeks||97
8534480|NCT00294723|21039809|P2|COMPLETED|Open-Label Extension 52 Weeks||110
8534481|NCT00294723|21039810|P1|COMPLETED|Open-Label Extension 52 Weeks||114
8534482|NCT00294723|21039808|P3|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
8534483|NCT00294723|21039809|P2|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
8534484|NCT00294723|21039810|P1|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
8534485|NCT00294723|21039808|P3|NOT COMPLETED|Double-Blind Period 52 Weeks||96
8534486|NCT00294723|21039809|P2|NOT COMPLETED|Double-Blind Period 52 Weeks||89
8534487|NCT00294723|21039810|P1|NOT COMPLETED|Double-Blind Period 52 Weeks||74
8534488|NCT00294723|21039808|P3|COMPLETED|Double-Blind Period 52 Weeks||152
8534489|NCT00294723|21039809|P2|COMPLETED|Double-Blind Period 52 Weeks||162
8534490|NCT00294723|21039810|P1|COMPLETED|Double-Blind Period 52 Weeks||173
8534491|NCT00294723|21039808|P3|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
8534492|NCT00294723|21039809|P2|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
8534493|NCT00294723|21039810|P1|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
8534494|NCT00294723|21039808|P3|STARTED|Double-Blind Period 52 Weeks|Randomised|248
8534495|NCT00294723|21039809|P2|STARTED|Double-Blind Period 52 Weeks|Randomised|251
8534496|NCT00294723|21039810|P1|STARTED|Double-Blind Period 52 Weeks|Randomised|247
8534497|NCT00294684|21039871|P2|NOT COMPLETED|Overall Study||8
8534498|NCT00294684|21039872|P1|NOT COMPLETED|Overall Study||5
8534499|NCT00294684|21039871|P2|COMPLETED|Overall Study||62
8534500|NCT00294684|21039872|P1|COMPLETED|Overall Study||65
8534501|NCT00294684|21039871|P2|STARTED|Overall Study||70
8534502|NCT00294684|21039872|P1|STARTED|Overall Study||70
8534503|NCT00294671|21039912|P2|NOT COMPLETED|Overall Study||40
8534504|NCT00294671|21039913|P1|NOT COMPLETED|Overall Study||27
8534505|NCT00294671|21039912|P2|COMPLETED|Overall Study||26
8534506|NCT00294671|21039913|P1|COMPLETED|Overall Study||37
8534507|NCT00294671|21039912|P2|STARTED|Overall Study||66
8534508|NCT00294671|21039913|P1|STARTED|Overall Study||64
8534509|NCT00294658|21039929|P2|NOT COMPLETED|Overall Study||9
8534510|NCT00294658|21039930|P1|NOT COMPLETED|Overall Study||6
8534511|NCT00294658|21039929|P2|COMPLETED|Overall Study||51
8534512|NCT00294658|21039930|P1|COMPLETED|Overall Study||60
8534513|NCT00294658|21039929|P2|STARTED|Overall Study||60
8534514|NCT00294658|21039930|P1|STARTED|Overall Study||66
8534515|NCT00294645|21039994|P2|NOT COMPLETED|Overall Study||92
8534516|NCT00294645|21039995|P1|NOT COMPLETED|Overall Study||48
8534517|NCT00294645|21039994|P2|COMPLETED|Overall Study||510
8534518|NCT00294645|21039995|P1|COMPLETED|Overall Study||247
8534519|NCT00294645|21039994|P2|STARTED|Overall Study||602
8534520|NCT00294645|21039995|P1|STARTED|Overall Study||295
8534521|NCT00294632|21040029|P2|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
8534522|NCT00294632|21040030|P1|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
8534523|NCT00294632|21040029|P2|COMPLETED|Phase II: 20 mg Lenalidomide||38
8534524|NCT00294632|21040030|P1|COMPLETED|Phase II: 20 mg Lenalidomide||6
8534525|NCT00294632|21040029|P2|STARTED|Phase II: 20 mg Lenalidomide||38
8534526|NCT00294632|21040030|P1|STARTED|Phase II: 20 mg Lenalidomide||6
8534527|NCT00294632|21040029|P2|NOT COMPLETED|Phase I Dose Escalation Period||0
8534528|NCT00294632|21040030|P1|NOT COMPLETED|Phase I Dose Escalation Period||0
8534529|NCT00294632|21040029|P2|COMPLETED|Phase I Dose Escalation Period||0
8534530|NCT00294632|21040030|P1|COMPLETED|Phase I Dose Escalation Period||14
8534531|NCT00294632|21040029|P2|Cohort 4: 25 mg|Phase I Dose Escalation Period||0
8534532|NCT00294632|21040030|P1|Cohort 4: 25 mg|Phase I Dose Escalation Period||2
8534533|NCT00294632|21040029|P2|Cohort 3: 20 mg|Phase I Dose Escalation Period||0
8534534|NCT00294632|21040030|P1|Cohort 3: 20 mg|Phase I Dose Escalation Period||6
8534535|NCT00294632|21040029|P2|Cohort 2: 15 mg|Phase I Dose Escalation Period||0
8534536|NCT00294632|21040030|P1|Cohort 2: 15 mg|Phase I Dose Escalation Period||3
8534537|NCT00294632|21040029|P2|Cohort 1: 10 mg|Phase I Dose Escalation Period||0
8534538|NCT00294632|21040030|P1|Cohort 1: 10 mg|Phase I Dose Escalation Period||3
8534539|NCT00294632|21040029|P2|STARTED|Phase I Dose Escalation Period||0
8534540|NCT00294632|21040030|P1|STARTED|Phase I Dose Escalation Period||14
8534541|NCT00294554|21040039|P2|NOT COMPLETED|Overall Study||2
8534542|NCT00294554|21040040|P1|NOT COMPLETED|Overall Study||0
8534543|NCT00294554|21040039|P2|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit
~1 S withdrawn @ 13 wks b/o extreme agitation"|8
8534544|NCT00294554|21040040|P1|COMPLETED|Overall Study||10
8534545|NCT00294554|21040039|P2|STARTED|Overall Study||10
8534546|NCT00294554|21040040|P1|STARTED|Overall Study||10
8534547|NCT00294515|21040050|P2|NOT COMPLETED|Overall Study||28
8534548|NCT00294515|21040051|P1|NOT COMPLETED|Overall Study||34
8534549|NCT00294515|21040050|P2|COMPLETED|Overall Study||132
8534550|NCT00294515|21040051|P1|COMPLETED|Overall Study||132
8534551|NCT00294515|21040050|P2|STARTED|Overall Study|Randomized|160
8534552|NCT00294515|21040051|P1|STARTED|Overall Study|Randomized|166
8534553|NCT00294398|21040067|P2|NOT COMPLETED|Overall Study||26
8534554|NCT00294398|21040068|P1|NOT COMPLETED|Overall Study||21
8534556|NCT00294398|21040068|P1|COMPLETED|Overall Study||57
8534557|NCT00294398|21040067|P2|STARTED|Overall Study||74
8534558|NCT00294398|21040068|P1|STARTED|Overall Study||78
8534559|NCT00294060|21040076|P1|NOT COMPLETED|Overall Study||1173
8534560|NCT00294060|21040076|P1|COMPLETED|Overall Study||840
8534561|NCT00294060|21040076|P1|STARTED|Overall Study||2013
8534562|NCT00294047|21040084|P2|NOT COMPLETED|Month 84||989
8534563|NCT00294047|21040085|P1|NOT COMPLETED|Month 84||973
8534564|NCT00294047|21040084|P2|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
8534565|NCT00294047|21040085|P1|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
8534566|NCT00294047|21040084|P2|STARTED|Month 84||2870
8534567|NCT00294047|21040085|P1|STARTED|Month 84||2877
8534568|NCT00294047|21040084|P2|NOT COMPLETED|Month 48||433
8534569|NCT00294047|21040085|P1|NOT COMPLETED|Month 48||425
8534570|NCT00294047|21040084|P2|COMPLETED|Month 48||2438
8534571|NCT00294047|21040085|P1|COMPLETED|Month 48||2456
8534572|NCT00294047|21040084|P2|Participated up to Month 48|Month 48||2281
8534573|NCT00294047|21040085|P1|Participated up to Month 48|Month 48||2305
8534574|NCT00294047|21040084|P2|STARTED|Month 48||2871
8534575|NCT00294047|21040085|P1|STARTED|Month 48||2881
8534576|NCT00293813|21040190|P3|NOT COMPLETED|Overall Study||8
8534577|NCT00293813|21040191|P2|NOT COMPLETED|Overall Study||9
8534578|NCT00293813|21040192|P1|NOT COMPLETED|Overall Study||13
8534579|NCT00293813|21040190|P3|COMPLETED|Overall Study||74
8534580|NCT00293813|21040191|P2|COMPLETED|Overall Study||74
8534581|NCT00293813|21040192|P1|COMPLETED|Overall Study||69
8534582|NCT00293813|21040190|P3|STARTED|Overall Study||82
8534583|NCT00293813|21040191|P2|STARTED|Overall Study||83
8534584|NCT00293813|21040192|P1|STARTED|Overall Study||82
8534585|NCT00293722|21040203|P1|NOT COMPLETED|Overall Study||427
8534586|NCT00293722|21040203|P1|COMPLETED|Overall Study||864
8534587|NCT00293722|21040203|P1|STARTED|Overall Study||1291
8534588|NCT00293709|21040217|P1|NOT COMPLETED|Overall Study||47
8534589|NCT00293709|21040217|P1|COMPLETED|Overall Study||102
8534590|NCT00293709|21040217|P1|STARTED|Overall Study||149
8534591|NCT00293579|21040231|P1|NOT COMPLETED|Overall Study||1
8534592|NCT00293579|21040231|P1|COMPLETED|Overall Study||4
8534593|NCT00293579|21040231|P1|STARTED|Overall Study||5
8534594|NCT00293540|21040240|P2|NOT COMPLETED|Overall Study||8
8534595|NCT00293540|21040241|P1|NOT COMPLETED|Overall Study||7
8534596|NCT00293540|21040240|P2|COMPLETED|Overall Study||119
8534597|NCT00293540|21040241|P1|COMPLETED|Overall Study||115
8534598|NCT00293540|21040240|P2|STARTED|Overall Study||127
8534599|NCT00293540|21040241|P1|STARTED|Overall Study||122
8534609|NCT00293397|21040271|P1|NOT COMPLETED|Overall Study||2
8534610|NCT00293397|21040271|P1|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
8534611|NCT00293397|21040271|P1|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
8534612|NCT00293397|21040271|P1|STARTED|Overall Study||20
8534613|NCT00293384|21040281|P1|NOT COMPLETED|Overall Study||5
8534614|NCT00293384|21040281|P1|COMPLETED|Overall Study||35
8534615|NCT00293384|21040281|P1|STARTED|Overall Study||40
8534616|NCT00293293|21040290|P2|NOT COMPLETED|Overall Study||2
8534617|NCT00293293|21040291|P1|NOT COMPLETED|Overall Study||2
8534618|NCT00293293|21040290|P2|COMPLETED|Overall Study||21
8534619|NCT00293293|21040291|P1|COMPLETED|Overall Study||18
8534620|NCT00293293|21040290|P2|STARTED|Overall Study||23
8534621|NCT00293293|21040291|P1|STARTED|Overall Study||20
8534622|NCT00293267|21040319|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
8534623|NCT00293267|21040320|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
8534624|NCT00293267|21040319|P2|COMPLETED|Open-Label Post Virologic Failure Phase||29
8534625|NCT00293267|21040320|P1|COMPLETED|Open-Label Post Virologic Failure Phase||15
8534626|NCT00293267|21040319|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
8534627|NCT00293267|21040320|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
8534628|NCT00293267|21040319|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||2
8534629|NCT00293267|21040320|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||20
8534630|NCT00293267|21040319|P2|COMPLETED|Extension - Open-Label Week 157-240||26
8534631|NCT00293267|21040320|P1|COMPLETED|Extension - Open-Label Week 157-240||111
8534632|NCT00293267|21040319|P2|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
8534633|NCT00293267|21040320|P1|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
8534634|NCT00293267|21040319|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
8534635|NCT00293267|21040320|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
8534636|NCT00293267|21040319|P2|COMPLETED|Extension - Double-Blind Week 49-156||35
8534637|NCT00293267|21040320|P1|COMPLETED|Extension - Double-Blind Week 49-156||139
8534638|NCT00293267|21040319|P2|STARTED|Extension - Double-Blind Week 49-156||50
8534639|NCT00293267|21040320|P1|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
8534640|NCT00293267|21040319|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
8534641|NCT00293267|21040320|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
8534642|NCT00293267|21040319|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||50
8534643|NCT00293267|21040320|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||193
8534644|NCT00293267|21040319|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
8534645|NCT00293267|21040320|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
8534646|NCT00293267|21040319|P2|Treated|Primary Study - Double-Blind Week 0-48||118
8534647|NCT00293267|21040320|P1|Treated|Primary Study - Double-Blind Week 0-48||232
8534648|NCT00293267|21040319|P2|STARTED|Primary Study - Double-Blind Week 0-48||118
8534649|NCT00293267|21040320|P1|STARTED|Primary Study - Double-Blind Week 0-48||234
8534650|NCT00293254|21040360|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
8534651|NCT00293254|21040361|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
8534652|NCT00293254|21040360|P2|COMPLETED|Open-Label Post Virologic Failure Phase||37
8534653|NCT00293254|21040361|P1|COMPLETED|Open-Label Post Virologic Failure Phase||19
8534654|NCT00293254|21040360|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
8534655|NCT00293254|21040361|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
8534656|NCT00293254|21040360|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||1
8534657|NCT00293254|21040361|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||10
8534658|NCT00293254|21040360|P2|COMPLETED|Extension - Open-Label Week 157-240||18
8534659|NCT00293254|21040361|P1|COMPLETED|Extension - Open-Label Week 157-240||110
8534660|NCT00293254|21040360|P2|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
8534661|NCT00293254|21040361|P1|STARTED|Extension - Open-Label Week 157-240||120
8534662|NCT00293254|21040360|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
8534663|NCT00293254|21040361|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
8534664|NCT00293254|21040360|P2|COMPLETED|Extension - Double-Blind Week 49-156||25
8534665|NCT00293254|21040361|P1|COMPLETED|Extension - Double-Blind Week 49-156||120
8534666|NCT00293254|21040360|P2|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
8534667|NCT00293254|21040361|P1|STARTED|Extension - Double-Blind Week 49-156||177
8534668|NCT00293254|21040360|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
8534669|NCT00293254|21040361|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
8534670|NCT00293254|21040360|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||55
8534671|NCT00293254|21040361|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||177
8534672|NCT00293254|21040360|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
8534673|NCT00293254|21040361|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
8534674|NCT00293254|21040360|P2|Treated|Primary Study - Double-Blind Week 0-48||119
8534675|NCT00293254|21040361|P1|Treated|Primary Study - Double-Blind Week 0-48||230
8534676|NCT00293254|21040360|P2|STARTED|Primary Study - Double-Blind Week 0-48||119
8534677|NCT00293254|21040361|P1|STARTED|Primary Study - Double-Blind Week 0-48||232
8534678|NCT00293241|21040401|P2|NOT COMPLETED|Overall Study||41
8534679|NCT00293241|21040402|P1|NOT COMPLETED|Overall Study||36
8534680|NCT00293241|21040401|P2|COMPLETED|Overall Study||265
8534681|NCT00293241|21040402|P1|COMPLETED|Overall Study||263
8534682|NCT00293241|21040401|P2|STARTED|Overall Study||306
8534683|NCT00293241|21040402|P1|STARTED|Overall Study||299
8534684|NCT00293215|21040446|P2|NOT COMPLETED|Overall Study||3
8534685|NCT00293215|21040447|P1|NOT COMPLETED|Overall Study||5
8534686|NCT00293215|21040446|P2|COMPLETED|Overall Study||0
8534687|NCT00293215|21040447|P1|COMPLETED|Overall Study||1
8534688|NCT00293215|21040446|P2|STARTED|Overall Study||3
8534689|NCT00293215|21040447|P1|STARTED|Overall Study||6
8534690|NCT00293059|21040469|P2|NOT COMPLETED|Overall Study||19
8534691|NCT00293059|21040470|P1|NOT COMPLETED|Overall Study||35
8534692|NCT00293059|21040469|P2|COMPLETED|Overall Study||51
8534693|NCT00293059|21040470|P1|COMPLETED|Overall Study||85
8534694|NCT00293059|21040469|P2|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
8534695|NCT00293059|21040470|P1|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
8534696|NCT00293059|21040469|P2|Cycle 3/Treatment Day 84|Overall Study||55
8534697|NCT00293059|21040470|P1|Cycle 3/Treatment Day 84|Overall Study||100
8534698|NCT00293059|21040469|P2|Cycle 1/Treatment Day 28|Overall Study||64
8534699|NCT00293059|21040470|P1|Cycle 1/Treatment Day 28|Overall Study||115
8534700|NCT00293059|21040469|P2|Subjects Received Treatment|Overall Study||66
8534701|NCT00293059|21040470|P1|Subjects Received Treatment|Overall Study||119
8534702|NCT00293059|21040469|P2|STARTED|Overall Study||70
8534703|NCT00293059|21040470|P1|STARTED|Overall Study||120
8534704|NCT00293033|21040582|P1|NOT COMPLETED|Double-blind Treatment Period||12
8534705|NCT00293033|21040582|P1|COMPLETED|Double-blind Treatment Period||70
8534706|NCT00293033|21040582|P1|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82
8534707|NCT00293033|21040582|P1|NOT COMPLETED|Open-label Titration Period||69
8534708|NCT00293033|21040582|P1|COMPLETED|Open-label Titration Period||82
8534709|NCT00293033|21040582|P1|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151
8534710|NCT00293020|21040685|P1|NOT COMPLETED|Overall Study||162
8534711|NCT00293020|21040685|P1|COMPLETED|Overall Study||82
8534712|NCT00293020|21040685|P1|STARTED|Overall Study||244
8534713|NCT00292981|21040689|P1|NOT COMPLETED|Overall Study||39
8534714|NCT00292981|21040689|P1|COMPLETED|Overall Study||18
8534715|NCT00292981|21040689|P1|STARTED|Overall Study||57
8534716|NCT00292942|21040700|P4|NOT COMPLETED|Overall Study||1
8534717|NCT00292942|21040701|P3|NOT COMPLETED|Overall Study||1
8534718|NCT00292942|21040702|P2|NOT COMPLETED|Overall Study||0
8534719|NCT00292942|21040703|P1|NOT COMPLETED|Overall Study||0
8534720|NCT00292942|21040700|P4|COMPLETED|Overall Study||6
8534721|NCT00292942|21040701|P3|COMPLETED|Overall Study||6
8534722|NCT00292942|21040702|P2|COMPLETED|Overall Study||6
8534723|NCT00292942|21040703|P1|COMPLETED|Overall Study||6
8534724|NCT00292942|21040700|P4|STARTED|Overall Study||7
8534725|NCT00292942|21040701|P3|STARTED|Overall Study||7
8534726|NCT00292942|21040702|P2|STARTED|Overall Study||6
8534727|NCT00292942|21040703|P1|STARTED|Overall Study||6
8534728|NCT00292591|21040737|P3|NOT COMPLETED|Overall Study||58
8534729|NCT00292591|21040738|P2|NOT COMPLETED|Overall Study||56
8534730|NCT00292591|21040739|P1|NOT COMPLETED|Overall Study||64
8534731|NCT00292591|21040737|P3|COMPLETED|Overall Study||110
8534732|NCT00292591|21040738|P2|COMPLETED|Overall Study||111
8534733|NCT00292591|21040739|P1|COMPLETED|Overall Study||102
8534734|NCT00292591|21040737|P3|STARTED|Overall Study||168
8534735|NCT00292591|21040738|P2|STARTED|Overall Study||167
8534736|NCT00292591|21040739|P1|STARTED|Overall Study||166
8534737|NCT00292461|21040749|P2|NOT COMPLETED|Overall Study||6
8534738|NCT00292461|21040750|P1|NOT COMPLETED|Overall Study||10
8534739|NCT00292461|21040749|P2|COMPLETED|Overall Study||24
8534740|NCT00292461|21040750|P1|COMPLETED|Overall Study||24
8534741|NCT00292461|21040749|P2|STARTED|Overall Study||30
8534742|NCT00292461|21040750|P1|STARTED|Overall Study||34
8534743|NCT00292370|21040765|P3|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
8534744|NCT00292370|21040766|P2|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
8534745|NCT00292370|21040767|P1|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
8534746|NCT00292370|21040765|P3|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
8534747|NCT00292370|21040766|P2|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
8534748|NCT00292370|21040767|P1|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
8534749|NCT00292370|21040765|P3|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
8534750|NCT00292370|21040766|P2|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
8534751|NCT00292370|21040767|P1|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I
~28 Excluded Ph II:
~20 responded
~7 declined
~1 medical
~50 to Arm 2 & 3"|0
8534752|NCT00292370|21040765|P3|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
8534753|NCT00292370|21040766|P2|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
8534754|NCT00292370|21040767|P1|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
8534755|NCT00292370|21040765|P3|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
8534756|NCT00292370|21040766|P2|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
8534757|NCT00292370|21040767|P1|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
8534758|NCT00292370|21040765|P3|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
8534759|NCT00292370|21040766|P2|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
8534760|NCT00292370|21040767|P1|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
8534761|NCT00292318|21040792|P2|NOT COMPLETED|Overall Study||1
8534762|NCT00292318|21040793|P1|NOT COMPLETED|Overall Study||2
8534763|NCT00292318|21040792|P2|COMPLETED|Overall Study||2
8534764|NCT00292318|21040793|P1|COMPLETED|Overall Study||2
8534765|NCT00292318|21040792|P2|STARTED|Overall Study||3
8534766|NCT00292318|21040793|P1|STARTED|Overall Study||4
8534767|NCT00292227|21040803|P3|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
8534768|NCT00292227|21040804|P2|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
8534769|NCT00292227|21040805|P1|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
8534770|NCT00292227|21040803|P3|COMPLETED|Cross-over Period 2 (Day 39)||30
8534771|NCT00292227|21040804|P2|COMPLETED|Cross-over Period 2 (Day 39)||31
8534772|NCT00292227|21040805|P1|COMPLETED|Cross-over Period 2 (Day 39)||65
8534773|NCT00292227|21040803|P3|STARTED|Cross-over Period 2 (Day 39)||30
8534774|NCT00292227|21040804|P2|STARTED|Cross-over Period 2 (Day 39)||31
8534775|NCT00292227|21040805|P1|STARTED|Cross-over Period 2 (Day 39)||65
8534776|NCT00292227|21040803|P3|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
8534777|NCT00292227|21040804|P2|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
8534778|NCT00292227|21040805|P1|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
8534779|NCT00292227|21040803|P3|COMPLETED|Cross-over Period 1 (Day 32)||30
8534780|NCT00292227|21040804|P2|COMPLETED|Cross-over Period 1 (Day 32)||31
8534781|NCT00292227|21040805|P1|COMPLETED|Cross-over Period 1 (Day 32)||65
8534782|NCT00292227|21040803|P3|STARTED|Cross-over Period 1 (Day 32)||30
8534783|NCT00292227|21040804|P2|STARTED|Cross-over Period 1 (Day 32)||31
8534784|NCT00292227|21040805|P1|STARTED|Cross-over Period 1 (Day 32)||65
8534785|NCT00292227|21040803|P3|NOT COMPLETED|Patch Period||3
8534786|NCT00292227|21040804|P2|NOT COMPLETED|Patch Period||0
8534787|NCT00292227|21040805|P1|NOT COMPLETED|Patch Period||1
8534788|NCT00292227|21040803|P3|COMPLETED|Patch Period||30
8534789|NCT00292227|21040804|P2|COMPLETED|Patch Period||31
8534790|NCT00292227|21040805|P1|COMPLETED|Patch Period||65
8534791|NCT00292227|21040803|P3|STARTED|Patch Period||33
8534792|NCT00292227|21040804|P2|STARTED|Patch Period||31
8534793|NCT00292227|21040805|P1|STARTED|Patch Period||66
8534815|NCT00292162|21040950|P2|NOT COMPLETED|Overall Study||2
8534816|NCT00292162|21040951|P1|NOT COMPLETED|Overall Study||1
8534817|NCT00292162|21040950|P2|COMPLETED|Overall Study||20
8534818|NCT00292162|21040951|P1|COMPLETED|Overall Study||18
8534819|NCT00292162|21040950|P2|STARTED|Overall Study||22
8534820|NCT00292162|21040951|P1|STARTED|Overall Study||19
8534821|NCT00292045|21040967|P1|NOT COMPLETED|Extended Treatment Beyond Week 13||0
8534822|NCT00292045|21040967|P1|COMPLETED|Extended Treatment Beyond Week 13||10
8534823|NCT00292045|21040967|P1|STARTED|Extended Treatment Beyond Week 13||10
8534824|NCT00292045|21040967|P1|NOT COMPLETED|Core Study (Through Week 13)||2
8534825|NCT00292045|21040967|P1|COMPLETED|Core Study (Through Week 13)||13
8534826|NCT00292045|21040967|P1|STARTED|Core Study (Through Week 13)||15
8534827|NCT00291876|21040974|P1|NOT COMPLETED|Month 246||0
8534828|NCT00291876|21040974|P1|COMPLETED|Month 246||116
8534829|NCT00291876|21040974|P1|STARTED|Month 246||116
8534830|NCT00291876|21040974|P1|NOT COMPLETED|Month 234||0
8534831|NCT00291876|21040974|P1|COMPLETED|Month 234||110
8534832|NCT00291876|21040974|P1|STARTED|Month 234||110
8534833|NCT00291876|21040974|P1|NOT COMPLETED|Month 222||0
8534834|NCT00291876|21040974|P1|COMPLETED|Month 222||114
8534835|NCT00291876|21040974|P1|STARTED|Month 222||114
8534836|NCT00291876|21040974|P1|NOT COMPLETED|Month 210||0
8534837|NCT00291876|21040974|P1|COMPLETED|Month 210||124
8534838|NCT00291876|21040974|P1|STARTED|Month 210||124
8534839|NCT00291876|21040974|P1|NOT COMPLETED|Month 198||0
8534840|NCT00291876|21040974|P1|COMPLETED|Month 198||135
8534841|NCT00291876|21040974|P1|STARTED|Month 198||135
8534842|NCT00291876|21040974|P1|NOT COMPLETED|Month 186||0
8534843|NCT00291876|21040974|P1|COMPLETED|Month 186||129
8534844|NCT00291876|21040974|P1|STARTED|Month 186||129
8534845|NCT00291876|21040974|P1|NOT COMPLETED|Month 174||0
8534846|NCT00291876|21040974|P1|COMPLETED|Month 174||127
8534847|NCT00291876|21040974|P1|STARTED|Month 174||127
8534848|NCT00291876|21040974|P1|NOT COMPLETED|Month 162||0
8534849|NCT00291876|21040974|P1|COMPLETED|Month 162||127
8534850|NCT00291876|21040974|P1|STARTED|Month 162||127
8534851|NCT00291876|21040974|P1|NOT COMPLETED|Month 150||0
8534852|NCT00291876|21040974|P1|COMPLETED|Month 150||117
8534853|NCT00291876|21040974|P1|STARTED|Month 150||117
8534854|NCT00291876|21040974|P1|NOT COMPLETED|Month 138||0
8534855|NCT00291876|21040974|P1|COMPLETED|Month 138||107
8534856|NCT00291876|21040974|P1|STARTED|Month 138||107
8534857|NCT00291694|21040988|P2|NOT COMPLETED|Overall Study||5
8534858|NCT00291694|21040989|P1|NOT COMPLETED|Overall Study||3
8534859|NCT00291694|21040988|P2|COMPLETED|Overall Study||43
8534860|NCT00291694|21040989|P1|COMPLETED|Overall Study||21
8534861|NCT00291694|21040988|P2|STARTED|Overall Study||48
8534862|NCT00291694|21040989|P1|STARTED|Overall Study||24
8534863|NCT00291668|21041006|P3|NOT COMPLETED|Overall Study||1
8534864|NCT00291668|21041007|P2|NOT COMPLETED|Overall Study||1
8534865|NCT00291668|21041008|P1|NOT COMPLETED|Overall Study||4
8534866|NCT00291668|21041006|P3|COMPLETED|Overall Study||31
8534867|NCT00291668|21041007|P2|COMPLETED|Overall Study||29
8534868|NCT00291668|21041008|P1|COMPLETED|Overall Study||28
8534869|NCT00291668|21041006|P3|STARTED|Overall Study||32
8534870|NCT00291668|21041007|P2|STARTED|Overall Study||30
8534871|NCT00291668|21041008|P1|STARTED|Overall Study||32
8534872|NCT00291655|21041094|P1|NOT COMPLETED|Overall Study||15
8534873|NCT00291655|21041094|P1|COMPLETED|Overall Study||115
8534874|NCT00291655|21041094|P1|STARTED|Overall Study||130
8534875|NCT00291642|21041104|P5|NOT COMPLETED|Overall Study||1
8534876|NCT00291642|21041105|P4|NOT COMPLETED|Overall Study||0
8534877|NCT00291642|21041106|P3|NOT COMPLETED|Overall Study||2
8534878|NCT00291642|21041107|P2|NOT COMPLETED|Overall Study||0
8534879|NCT00291642|21041108|P1|NOT COMPLETED|Overall Study||2
8534880|NCT00291642|21041104|P5|COMPLETED|Overall Study||118
8534881|NCT00291642|21041105|P4|COMPLETED|Overall Study||119
8534882|NCT00291642|21041106|P3|COMPLETED|Overall Study||117
8534883|NCT00291642|21041107|P2|COMPLETED|Overall Study||116
8534884|NCT00291642|21041108|P1|COMPLETED|Overall Study||76
8534885|NCT00291642|21041104|P5|STARTED|Overall Study||119
8534886|NCT00291642|21041105|P4|STARTED|Overall Study||119
8534887|NCT00291642|21041106|P3|STARTED|Overall Study||119
8534888|NCT00291642|21041107|P2|STARTED|Overall Study||116
8534889|NCT00291642|21041108|P1|STARTED|Overall Study||78
8534890|NCT00291577|21041160|P1|NOT COMPLETED|Overall Study||21
8534891|NCT00291577|21041160|P1|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
8534892|NCT00291577|21041160|P1|STARTED|Overall Study||22
8534893|NCT00291551|21041179|P1|NOT COMPLETED|Overall Study||13
8534894|NCT00291551|21041179|P1|COMPLETED|Overall Study||26
8534895|NCT00291551|21041179|P1|STARTED|Overall Study||39
8534896|NCT00291343|21041196|P2|NOT COMPLETED|Overall Study||0
8534897|NCT00291343|21041197|P1|NOT COMPLETED|Overall Study||0
8534898|NCT00291343|21041196|P2|COMPLETED|Overall Study||93
8534899|NCT00291343|21041197|P1|COMPLETED|Overall Study||203
8534900|NCT00291343|21041196|P2|STARTED|Overall Study||93
8534901|NCT00291343|21041197|P1|STARTED|Overall Study||203
8534902|NCT00291330|21041227|P2|NOT COMPLETED|Overall Study||97
8534903|NCT00291330|21041228|P1|NOT COMPLETED|Overall Study||101
8534904|NCT00291330|21041227|P2|COMPLETED|Overall Study|Completed planned observation time|1169
8534905|NCT00291330|21041228|P1|COMPLETED|Overall Study|Completed planned observation time|1172
8534906|NCT00291330|21041227|P2|STARTED|Overall Study|Started Treatment|1266
8534907|NCT00291330|21041228|P1|STARTED|Overall Study|Started Treatment|1273
8534908|NCT00291317|21041250|P1|NOT COMPLETED|Overall Study||0
8534909|NCT00291317|21041250|P1|COMPLETED|Overall Study||6
8534910|NCT00291317|21041250|P1|STARTED|Overall Study||6
8534911|NCT00291226|21041257|P2|NOT COMPLETED|Overall Study||1
8534912|NCT00291226|21041258|P1|NOT COMPLETED|Overall Study||1
8534913|NCT00291226|21041257|P2|COMPLETED|Overall Study||3
8534914|NCT00291226|21041258|P1|COMPLETED|Overall Study||3
8534915|NCT00291226|21041257|P2|STARTED|Overall Study||4
8534916|NCT00291226|21041258|P1|STARTED|Overall Study||4
8534917|NCT00291187|21041270|P4|NOT COMPLETED|Overall Study||0
8534918|NCT00291187|21041271|P3|NOT COMPLETED|Overall Study||1
8534919|NCT00291187|21041272|P2|NOT COMPLETED|Overall Study||0
8534920|NCT00291187|21041273|P1|NOT COMPLETED|Overall Study||0
8534921|NCT00291187|21041270|P4|COMPLETED|Overall Study||106
8534922|NCT00291187|21041271|P3|COMPLETED|Overall Study||102
8534923|NCT00291187|21041272|P2|COMPLETED|Overall Study||100
8534924|NCT00291187|21041273|P1|COMPLETED|Overall Study||103
8534925|NCT00291187|21041270|P4|STARTED|Overall Study||106
8534926|NCT00291187|21041271|P3|STARTED|Overall Study||103
8534927|NCT00291187|21041272|P2|STARTED|Overall Study||100
8534928|NCT00291187|21041273|P1|STARTED|Overall Study||103
8534929|NCT00291161|21041299|P4|NOT COMPLETED|Overall Study||65
8534930|NCT00291161|21041300|P3|NOT COMPLETED|Overall Study||93
8534931|NCT00291161|21041301|P2|NOT COMPLETED|Overall Study||58
8534932|NCT00291161|21041302|P1|NOT COMPLETED|Overall Study||81
8534933|NCT00291161|21041299|P4|COMPLETED|Overall Study||122
8534934|NCT00291161|21041300|P3|COMPLETED|Overall Study||206
8534935|NCT00291161|21041301|P2|COMPLETED|Overall Study||134
8534936|NCT00291161|21041302|P1|COMPLETED|Overall Study||235
8534937|NCT00291161|21041299|P4|STARTED|Overall Study||187
8534938|NCT00291161|21041300|P3|STARTED|Overall Study||299
8534939|NCT00291161|21041301|P2|STARTED|Overall Study||192
8534940|NCT00291161|21041302|P1|STARTED|Overall Study||316
8534941|NCT00291135|21041310|P1|NOT COMPLETED|Overall Study||0
8534942|NCT00291135|21041310|P1|COMPLETED|Overall Study||42
8534943|NCT00291135|21041310|P1|STARTED|Overall Study||42
8534944|NCT00291018|21041317|P3|NOT COMPLETED|Overall Study||43
8534945|NCT00291018|21041318|P2|NOT COMPLETED|Overall Study||42
8534946|NCT00291018|21041319|P1|NOT COMPLETED|Overall Study||25
8534947|NCT00291018|21041317|P3|COMPLETED|Overall Study|Evaluated at 84 Months|93
8534948|NCT00291018|21041318|P2|COMPLETED|Overall Study|Evaluated at 84 Months|64
8534949|NCT00291018|21041319|P1|COMPLETED|Overall Study|Evaluated at 84 Months|78
8534950|NCT00291018|21041317|P3|Evaluated at 24 Months|Overall Study||105
8534951|NCT00291018|21041318|P2|Evaluated at 24 Months|Overall Study||92
8534952|NCT00291018|21041319|P1|Evaluated at 24 Months|Overall Study||99
8534953|NCT00291018|21041317|P3|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
8534954|NCT00291018|21041318|P2|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
8534955|NCT00291018|21041319|P1|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
8534956|NCT00290888|21041359|P2|NOT COMPLETED|Overall Study||1
8534957|NCT00290888|21041360|P1|NOT COMPLETED|Overall Study||3
8534958|NCT00290888|21041359|P2|COMPLETED|Overall Study||44
8534959|NCT00290888|21041360|P1|COMPLETED|Overall Study||38
8534960|NCT00290888|21041359|P2|STARTED|Overall Study||45
8534961|NCT00290888|21041360|P1|STARTED|Overall Study||41
8534962|NCT00290810|21041368|P1|NOT COMPLETED|Overall Study||0
8534963|NCT00290810|21041368|P1|COMPLETED|Overall Study||12
8534964|NCT00290810|21041368|P1|STARTED|Overall Study||12
8534965|NCT00290771|21041377|P2|NOT COMPLETED|Overall Study||97
8534966|NCT00290771|21041378|P1|NOT COMPLETED|Overall Study||127
8534967|NCT00290771|21041377|P2|COMPLETED|Overall Study||3
8534968|NCT00290771|21041378|P1|COMPLETED|Overall Study||4
8534969|NCT00290771|21041377|P2|STARTED|Overall Study||100
8534970|NCT00290771|21041378|P1|STARTED|Overall Study||131
8534971|NCT00290758|21041402|P2|NOT COMPLETED|Post Intervention rFNA||5
8534972|NCT00290758|21041403|P1|NOT COMPLETED|Post Intervention rFNA||6
8534973|NCT00290758|21041402|P2|COMPLETED|Post Intervention rFNA||49
8534974|NCT00290758|21041403|P1|COMPLETED|Post Intervention rFNA||49
8534975|NCT00290758|21041402|P2|STARTED|Post Intervention rFNA||54
8534976|NCT00290758|21041403|P1|STARTED|Post Intervention rFNA||55
8534977|NCT00290758|21041402|P2|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
8534978|NCT00290758|21041403|P1|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
8534979|NCT00290758|21041402|P2|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
8534980|NCT00290758|21041403|P1|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
8534981|NCT00290758|21041402|P2|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
8534982|NCT00290758|21041403|P1|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
8534983|NCT00290758|21041402|P2|Treatment|Pre-Intervention rFNA Through Follow-Up||64
8534984|NCT00290758|21041403|P1|Treatment|Pre-Intervention rFNA Through Follow-Up||61
8534985|NCT00290758|21041402|P2|Randomization|Pre-Intervention rFNA Through Follow-Up||62
8534986|NCT00290758|21041403|P1|Randomization|Pre-Intervention rFNA Through Follow-Up||62
8534987|NCT00290758|21041402|P2|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
8534988|NCT00290758|21041403|P1|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
8534989|NCT00290758|21041402|P2|STARTED|Pre-Intervention rFNA Through Follow-Up||64
8534990|NCT00290758|21041403|P1|STARTED|Pre-Intervention rFNA Through Follow-Up||62
8534991|NCT00290745|21041423|P1|NOT COMPLETED|Overall Study||12
8534992|NCT00290745|21041423|P1|COMPLETED|Overall Study||67
8534993|NCT00290745|21041423|P1|STARTED|Overall Study||79
8534994|NCT00290732|21041437|P5|NOT COMPLETED|Overall Study||0
8534995|NCT00290732|21041438|P4|NOT COMPLETED|Overall Study||0
8534996|NCT00290732|21041439|P3|NOT COMPLETED|Overall Study||1
8534997|NCT00290732|21041440|P2|NOT COMPLETED|Overall Study||1
8534998|NCT00290732|21041441|P1|NOT COMPLETED|Overall Study||0
8534999|NCT00290732|21041437|P5|COMPLETED|Overall Study||3
8535000|NCT00290732|21041438|P4|COMPLETED|Overall Study||6
8535001|NCT00290732|21041439|P3|COMPLETED|Overall Study||3
8535002|NCT00290732|21041440|P2|COMPLETED|Overall Study||3
8535003|NCT00290732|21041441|P1|COMPLETED|Overall Study||3
8535004|NCT00290732|21041437|P5|STARTED|Overall Study||3
8535005|NCT00290732|21041438|P4|STARTED|Overall Study||6
8535006|NCT00290732|21041439|P3|STARTED|Overall Study||4
8535007|NCT00290732|21041440|P2|STARTED|Overall Study||4
8535008|NCT00290732|21041441|P1|STARTED|Overall Study||3
8535009|NCT00290706|21041463|P4|NOT COMPLETED|Overall Study||12
8535010|NCT00290706|21041464|P3|NOT COMPLETED|Overall Study||6
8535011|NCT00290706|21041465|P2|NOT COMPLETED|Overall Study||6
8535012|NCT00290706|21041466|P1|NOT COMPLETED|Overall Study||5
8535013|NCT00290706|21041463|P4|COMPLETED|Overall Study||2
8535014|NCT00290706|21041464|P3|COMPLETED|Overall Study||1
8535015|NCT00290706|21041465|P2|COMPLETED|Overall Study||0
8535016|NCT00290706|21041466|P1|COMPLETED|Overall Study||0
8535017|NCT00290706|21041463|P4|Reached 1st Response/Cycle 3|Overall Study||2
8535018|NCT00290706|21041464|P3|Reached 1st Response/Cycle 3|Overall Study||1
8535019|NCT00290706|21041465|P2|Reached 1st Response/Cycle 3|Overall Study||0
8535020|NCT00290706|21041466|P1|Reached 1st Response/Cycle 3|Overall Study||0
8535021|NCT00290706|21041463|P4|Attempted1st Cycle|Overall Study||14
8535022|NCT00290706|21041464|P3|Attempted1st Cycle|Overall Study||7
8535023|NCT00290706|21041465|P2|Attempted1st Cycle|Overall Study||6
8535024|NCT00290706|21041466|P1|Attempted1st Cycle|Overall Study||5
8535025|NCT00290706|21041463|P4|STARTED|Overall Study||14
8535026|NCT00290706|21041464|P3|STARTED|Overall Study||7
8535027|NCT00290706|21041465|P2|STARTED|Overall Study||6
8535028|NCT00290706|21041466|P1|STARTED|Overall Study||5
8535029|NCT00290693|21041485|P1|NOT COMPLETED|Overall Study||2
8535030|NCT00290693|21041485|P1|COMPLETED|Overall Study||43
8535031|NCT00290693|21041485|P1|STARTED|Overall Study||45
8535032|NCT00290654|21041493|P1|NOT COMPLETED|Overall Study||0
8535033|NCT00290654|21041493|P1|COMPLETED|Overall Study||41
8535034|NCT00290654|21041493|P1|STARTED|Overall Study||41
8535035|NCT00290615|21041504|P1|NOT COMPLETED|Overall Study||0
8535036|NCT00290615|21041504|P1|COMPLETED|Overall Study||30
8535037|NCT00290615|21041504|P1|STARTED|Overall Study||30
8535038|NCT00290589|21041513|P2|NOT COMPLETED|Overall Study||2
8535039|NCT00290589|21041514|P1|NOT COMPLETED|Overall Study||2
8535040|NCT00290589|21041513|P2|COMPLETED|Overall Study||41
8535041|NCT00290589|21041514|P1|COMPLETED|Overall Study||37
8535042|NCT00290589|21041513|P2|STARTED|Overall Study||43
8535043|NCT00290589|21041514|P1|STARTED|Overall Study||39
8535044|NCT00290537|21041524|P2|NOT COMPLETED|Overall Study||0
8535045|NCT00290537|21041525|P1|NOT COMPLETED|Overall Study||0
8535046|NCT00290537|21041524|P2|COMPLETED|Overall Study||0
8535047|NCT00290537|21041525|P1|COMPLETED|Overall Study||4
8535048|NCT00290537|21041524|P2|STARTED|Overall Study||0
8535049|NCT00290537|21041525|P1|STARTED|Overall Study||4
8535050|NCT00290498|21041532|P2|NOT COMPLETED|Overall Study||0
8535051|NCT00290498|21041533|P1|NOT COMPLETED|Overall Study||8
8535052|NCT00290498|21041532|P2|COMPLETED|Overall Study||10
8535053|NCT00290498|21041533|P1|COMPLETED|Overall Study||41
8535054|NCT00290498|21041532|P2|STARTED|Overall Study||10
8535055|NCT00290498|21041533|P1|STARTED|Overall Study||49
8535056|NCT00290472|21041544|P3|NOT COMPLETED|Overall Study||0
8535057|NCT00290472|21041545|P2|NOT COMPLETED|Overall Study||0
8535058|NCT00290472|21041546|P1|NOT COMPLETED|Overall Study||0
8535059|NCT00290472|21041544|P3|COMPLETED|Overall Study||18
8535060|NCT00290472|21041545|P2|COMPLETED|Overall Study||39
8535061|NCT00290472|21041546|P1|COMPLETED|Overall Study||32
8535062|NCT00290472|21041544|P3|STARTED|Overall Study||18
8535063|NCT00290472|21041545|P2|STARTED|Overall Study||39
8535064|NCT00290472|21041546|P1|STARTED|Overall Study||32
8535065|NCT00290433|21041558|P1|NOT COMPLETED|Overall Study||36
8535066|NCT00290433|21041558|P1|COMPLETED|Overall Study||17
8535067|NCT00290433|21041558|P1|STARTED|Overall Study||53
8535068|NCT00290407|21041562|P1|NOT COMPLETED|Overall Study||2
8535069|NCT00290407|21041562|P1|COMPLETED|Overall Study||0
8535070|NCT00290407|21041562|P1|STARTED|Overall Study||2
8535071|NCT00290355|21041569|P2|NOT COMPLETED|Overall Study||5
8535072|NCT00290355|21041570|P1|NOT COMPLETED|Overall Study||17
8535073|NCT00290355|21041569|P2|COMPLETED|Overall Study||55
8535074|NCT00290355|21041570|P1|COMPLETED|Overall Study||105
8535075|NCT00290355|21041569|P2|STARTED|Overall Study||60
8535076|NCT00290355|21041570|P1|STARTED|Overall Study||122
8535077|NCT00290342|21041614|P2|NOT COMPLETED|Overall Study||5
8535078|NCT00290342|21041615|P1|NOT COMPLETED|Overall Study||7
8535079|NCT00290342|21041614|P2|COMPLETED|Overall Study||223
8535080|NCT00290342|21041615|P1|COMPLETED|Overall Study||217
8535081|NCT00290342|21041614|P2|STARTED|Overall Study||228
8535082|NCT00290342|21041615|P1|STARTED|Overall Study||224
8535083|NCT00290329|21041646|P3|NOT COMPLETED|Overall Study||0
8535084|NCT00290329|21041647|P2|NOT COMPLETED|Overall Study||0
8535085|NCT00290329|21041648|P1|NOT COMPLETED|Overall Study||0
8535086|NCT00290329|21041646|P3|COMPLETED|Overall Study||61
8535087|NCT00290329|21041647|P2|COMPLETED|Overall Study||86
8535088|NCT00290329|21041648|P1|COMPLETED|Overall Study||102
8535089|NCT00290329|21041646|P3|STARTED|Overall Study||61
8535090|NCT00290329|21041647|P2|STARTED|Overall Study||86
8535091|NCT00290329|21041648|P1|STARTED|Overall Study||102
8535092|NCT00290290|21041670|P2|NOT COMPLETED|Overall Study||18
8535093|NCT00290290|21041671|P1|NOT COMPLETED|Overall Study||18
8535094|NCT00290290|21041670|P2|COMPLETED|Overall Study||391
8535095|NCT00290290|21041671|P1|COMPLETED|Overall Study||422
8535096|NCT00290290|21041670|P2|STARTED|Overall Study||409
8535097|NCT00290290|21041671|P1|STARTED|Overall Study||440
8535098|NCT00290251|21041677|P3|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
8535099|NCT00290251|21041678|P2|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
8535100|NCT00290251|21041679|P1|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
8535101|NCT00290251|21041677|P3|COMPLETED|Elective Extension (to 12 Months no Rx)||5
8535102|NCT00290251|21041678|P2|COMPLETED|Elective Extension (to 12 Months no Rx)||3
8535103|NCT00290251|21041679|P1|COMPLETED|Elective Extension (to 12 Months no Rx)||5
8535104|NCT00290251|21041677|P3|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
8535105|NCT00290251|21041678|P2|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
8535106|NCT00290251|21041679|P1|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
8535107|NCT00290251|21041677|P3|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
8535108|NCT00290251|21041678|P2|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
8535109|NCT00290251|21041679|P1|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
8535110|NCT00290251|21041677|P3|COMPLETED|Treatment 2 (Months 4 - 6)||0
8535111|NCT00290251|21041678|P2|COMPLETED|Treatment 2 (Months 4 - 6)||5
8535112|NCT00290251|21041679|P1|COMPLETED|Treatment 2 (Months 4 - 6)||6
8535113|NCT00290251|21041677|P3|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
8535114|NCT00290251|21041678|P2|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
8535115|NCT00290251|21041679|P1|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
8535116|NCT00290251|21041677|P3|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
8535117|NCT00290251|21041678|P2|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
8535118|NCT00290251|21041679|P1|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
8535119|NCT00290251|21041677|P3|COMPLETED|Treatment 1 (Months 1 - 3)||12
8535120|NCT00290251|21041678|P2|COMPLETED|Treatment 1 (Months 1 - 3)||13
8535121|NCT00290251|21041679|P1|COMPLETED|Treatment 1 (Months 1 - 3)||13
8535122|NCT00290251|21041677|P3|STARTED|Treatment 1 (Months 1 - 3)||14
8535123|NCT00290251|21041678|P2|STARTED|Treatment 1 (Months 1 - 3)||14
8535124|NCT00290251|21041679|P1|STARTED|Treatment 1 (Months 1 - 3)||14
8535125|NCT00290238|21041691|P2|NOT COMPLETED|Overall Study||41
8535126|NCT00290238|21041692|P1|NOT COMPLETED|Overall Study||42
8535127|NCT00290238|21041691|P2|COMPLETED|Overall Study||24
8535128|NCT00290238|21041692|P1|COMPLETED|Overall Study||15
8535129|NCT00290238|21041691|P2|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
8535130|NCT00290238|21041692|P1|STARTED|Overall Study||57
8535131|NCT00290199|21041702|P2|NOT COMPLETED|Overall Study||0
8535132|NCT00290199|21041703|P1|NOT COMPLETED|Overall Study||0
8535133|NCT00290199|21041702|P2|COMPLETED|Overall Study||82
8535134|NCT00290199|21041703|P1|COMPLETED|Overall Study||87
8535135|NCT00290199|21041702|P2|STARTED|Overall Study||82
8535136|NCT00290199|21041703|P1|STARTED|Overall Study||87
8535137|NCT00290186|21041717|P2|NOT COMPLETED|Overall Study||5
8535138|NCT00290186|21041718|P1|NOT COMPLETED|Overall Study||5
8535139|NCT00290186|21041717|P2|COMPLETED|Overall Study||19
8535140|NCT00290186|21041718|P1|COMPLETED|Overall Study||20
8535141|NCT00290186|21041717|P2|Completed 6-month Followup Assessments|Overall Study||19
8535142|NCT00290186|21041718|P1|Completed 6-month Followup Assessments|Overall Study||20
8535143|NCT00290186|21041717|P2|Completed 3-month Followup Assessments|Overall Study||21
8535144|NCT00290186|21041718|P1|Completed 3-month Followup Assessments|Overall Study||20
8535145|NCT00290186|21041717|P2|Completed Post-treatment Assessments|Overall Study||22
8535146|NCT00290186|21041718|P1|Completed Post-treatment Assessments|Overall Study||24
8535147|NCT00290186|21041717|P2|Completed 8 Weeks of Treatment|Overall Study||22
8535148|NCT00290186|21041718|P1|Completed 8 Weeks of Treatment|Overall Study||24
8535149|NCT00290186|21041717|P2|Completed Baseline Assessments|Overall Study||24
8535150|NCT00290186|21041718|P1|Completed Baseline Assessments|Overall Study||25
8535151|NCT00290186|21041717|P2|STARTED|Overall Study||24
8535152|NCT00290186|21041718|P1|STARTED|Overall Study||25
8535153|NCT00290147|21041758|P2|NOT COMPLETED|Overall Study||0
8535154|NCT00290147|21041759|P1|NOT COMPLETED|Overall Study||0
8535155|NCT00290147|21041758|P2|COMPLETED|Overall Study||12
8535156|NCT00290147|21041759|P1|COMPLETED|Overall Study||10
8535157|NCT00290147|21041758|P2|STARTED|Overall Study||12
8535158|NCT00290147|21041759|P1|STARTED|Overall Study||10
8535159|NCT00289991|21041769|P2|NOT COMPLETED|Overall Study||80
8535160|NCT00289991|21041770|P1|NOT COMPLETED|Overall Study||58
8535161|NCT00289991|21041769|P2|COMPLETED|Overall Study||175
8535162|NCT00289991|21041770|P1|COMPLETED|Overall Study||176
8535163|NCT00289991|21041769|P2|STARTED|Overall Study||255
8535164|NCT00289991|21041770|P1|STARTED|Overall Study||234
8535165|NCT00289978|21041795|P3|NOT COMPLETED|Overall Study||86
8535166|NCT00289978|21041796|P2|NOT COMPLETED|Overall Study||56
8535167|NCT00289978|21041797|P1|NOT COMPLETED|Overall Study||97
8535168|NCT00289978|21041795|P3|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
8535169|NCT00289978|21041796|P2|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
8535170|NCT00289978|21041797|P1|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
8535171|NCT00289978|21041795|P3|STARTED|Overall Study||418
8535172|NCT00289978|21041796|P2|STARTED|Overall Study||425
8535173|NCT00289978|21041797|P1|STARTED|Overall Study||429
8535174|NCT00289913|21041816|P5|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8535175|NCT00289913|21041817|P4|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8535176|NCT00289913|21041818|P3|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8535177|NCT00289913|21041819|P2|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8535178|NCT00289913|21041820|P1|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
8535179|NCT00289913|21041816|P5|COMPLETED|Visit 4 (Stage I and Stage II)||597
8535180|NCT00289913|21041817|P4|COMPLETED|Visit 4 (Stage I and Stage II)||131
8535181|NCT00289913|21041818|P3|COMPLETED|Visit 4 (Stage I and Stage II)||138
8535182|NCT00289913|21041819|P2|COMPLETED|Visit 4 (Stage I and Stage II)||106
8535183|NCT00289913|21041820|P1|COMPLETED|Visit 4 (Stage I and Stage II)||122
8535184|NCT00289913|21041816|P5|STARTED|Visit 4 (Stage I and Stage II)||597
8535185|NCT00289913|21041817|P4|STARTED|Visit 4 (Stage I and Stage II)||131
8535186|NCT00289913|21041818|P3|STARTED|Visit 4 (Stage I and Stage II)||138
8535187|NCT00289913|21041819|P2|STARTED|Visit 4 (Stage I and Stage II)||106
8535188|NCT00289913|21041820|P1|STARTED|Visit 4 (Stage I and Stage II)||122
8535189|NCT00289913|21041816|P5|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
8535190|NCT00289913|21041817|P4|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
8535191|NCT00289913|21041818|P3|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
8535192|NCT00289913|21041819|P2|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
8535193|NCT00289913|21041820|P1|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
8535194|NCT00289913|21041816|P5|COMPLETED|Visit 3 (Stage I and Stage II)||597
8535195|NCT00289913|21041817|P4|COMPLETED|Visit 3 (Stage I and Stage II)||131
8535196|NCT00289913|21041818|P3|COMPLETED|Visit 3 (Stage I and Stage II)||138
8535197|NCT00289913|21041819|P2|COMPLETED|Visit 3 (Stage I and Stage II)||106
8535198|NCT00289913|21041820|P1|COMPLETED|Visit 3 (Stage I and Stage II)||122
8535199|NCT00289913|21041816|P5|STARTED|Visit 3 (Stage I and Stage II)||605
8535200|NCT00289913|21041817|P4|STARTED|Visit 3 (Stage I and Stage II)||135
8535201|NCT00289913|21041818|P3|STARTED|Visit 3 (Stage I and Stage II)||140
8535202|NCT00289913|21041819|P2|STARTED|Visit 3 (Stage I and Stage II)||114
8535203|NCT00289913|21041820|P1|STARTED|Visit 3 (Stage I and Stage II)||131
8535204|NCT00289913|21041816|P5|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
8535205|NCT00289913|21041817|P4|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
8535206|NCT00289913|21041818|P3|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
8535207|NCT00289913|21041819|P2|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
8535208|NCT00289913|21041820|P1|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
8535209|NCT00289913|21041816|P5|COMPLETED|Visit 2 (Stage I and Stage II)||605
8535210|NCT00289913|21041817|P4|COMPLETED|Visit 2 (Stage I and Stage II)||135
8535211|NCT00289913|21041818|P3|COMPLETED|Visit 2 (Stage I and Stage II)||140
8535212|NCT00289913|21041819|P2|COMPLETED|Visit 2 (Stage I and Stage II)||114
8535213|NCT00289913|21041820|P1|COMPLETED|Visit 2 (Stage I and Stage II)||131
8535214|NCT00289913|21041816|P5|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
8535215|NCT00289913|21041817|P4|STARTED|Visit 2 (Stage I and Stage II)||141
8535216|NCT00289913|21041818|P3|STARTED|Visit 2 (Stage I and Stage II)||150
8535217|NCT00289913|21041819|P2|STARTED|Visit 2 (Stage I and Stage II)||135
8535218|NCT00289913|21041820|P1|STARTED|Visit 2 (Stage I and Stage II)||146
8535219|NCT00289913|21041816|P5|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
8535220|NCT00289913|21041817|P4|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
8535221|NCT00289913|21041818|P3|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
8535222|NCT00289913|21041819|P2|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
8535223|NCT00289913|21041820|P1|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
8535224|NCT00289913|21041816|P5|COMPLETED|Visit 1 (Stage I and Stage II)||645
8535225|NCT00289913|21041817|P4|COMPLETED|Visit 1 (Stage I and Stage II)||141
8535226|NCT00289913|21041818|P3|COMPLETED|Visit 1 (Stage I and Stage II)||150
8535227|NCT00289913|21041819|P2|COMPLETED|Visit 1 (Stage I and Stage II)||135
8535228|NCT00289913|21041820|P1|COMPLETED|Visit 1 (Stage I and Stage II)||146
8535229|NCT00289913|21041816|P5|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
8535230|NCT00289913|21041817|P4|STARTED|Visit 1 (Stage I and Stage II)||152
8535231|NCT00289913|21041818|P3|STARTED|Visit 1 (Stage I and Stage II)||159
8535232|NCT00289913|21041819|P2|STARTED|Visit 1 (Stage I and Stage II)||151
8535233|NCT00289913|21041820|P1|STARTED|Visit 1 (Stage I and Stage II)||155
8535234|NCT00289900|21041851|P6|NOT COMPLETED|Overall Study||61
8535235|NCT00289900|21041852|P5|NOT COMPLETED|Overall Study||45
8535236|NCT00289900|21041853|P4|NOT COMPLETED|Overall Study||59
8535237|NCT00289900|21041854|P3|NOT COMPLETED|Overall Study||33
8535238|NCT00289900|21041855|P2|NOT COMPLETED|Overall Study||120
8535239|NCT00289900|21041856|P1|NOT COMPLETED|Overall Study||68
8535240|NCT00289900|21041851|P6|COMPLETED|Overall Study||372
8535241|NCT00289900|21041852|P5|COMPLETED|Overall Study||392
8535242|NCT00289900|21041853|P4|COMPLETED|Overall Study||380
8535243|NCT00289900|21041854|P3|COMPLETED|Overall Study||265
8535244|NCT00289900|21041855|P2|COMPLETED|Overall Study||316
8535245|NCT00289900|21041856|P1|COMPLETED|Overall Study||229
8535246|NCT00289900|21041851|P6|Treated|Overall Study||433
8535247|NCT00289900|21041852|P5|Treated|Overall Study||437
8535248|NCT00289900|21041853|P4|Treated|Overall Study||439
8535249|NCT00289900|21041854|P3|Treated|Overall Study||298
8535250|NCT00289900|21041855|P2|Treated|Overall Study||435
8535251|NCT00289900|21041856|P1|Treated|Overall Study||297
8535252|NCT00289900|21041851|P6|STARTED|Overall Study||433
8535253|NCT00289900|21041852|P5|STARTED|Overall Study||437
8535254|NCT00289900|21041853|P4|STARTED|Overall Study||439
8535255|NCT00289900|21041854|P3|STARTED|Overall Study||298
8535256|NCT00289900|21041855|P2|STARTED|Overall Study||436
8535257|NCT00289900|21041856|P1|STARTED|Overall Study||297
8535258|NCT00289887|21041960|P2|NOT COMPLETED|Overall Study||29
8535259|NCT00289887|21041961|P1|NOT COMPLETED|Overall Study||22
8535260|NCT00289887|21041960|P2|COMPLETED|Overall Study||105
8535261|NCT00289887|21041961|P1|COMPLETED|Overall Study||105
8535262|NCT00289887|21041960|P2|STARTED|Overall Study||134
8535263|NCT00289887|21041961|P1|STARTED|Overall Study||127
8535264|NCT00289874|21041979|P2|NOT COMPLETED|Overall Study||8
8535265|NCT00289874|21041980|P1|NOT COMPLETED|Overall Study||6
8535266|NCT00289874|21041979|P2|COMPLETED|Overall Study||210
8535267|NCT00289874|21041980|P1|COMPLETED|Overall Study||197
8535268|NCT00289874|21041979|P2|STARTED|Overall Study||218
8535269|NCT00289874|21041980|P1|STARTED|Overall Study||203
8535270|NCT00289848|21041990|P2|NOT COMPLETED|Overall Study||45
8535271|NCT00289848|21041991|P1|NOT COMPLETED|Overall Study||46
8535272|NCT00289848|21041990|P2|COMPLETED|Overall Study||133
8535273|NCT00289848|21041991|P1|COMPLETED|Overall Study||306
8535274|NCT00289848|21041990|P2|STARTED|Overall Study||178
8535275|NCT00289848|21041991|P1|STARTED|Overall Study||352
8535276|NCT00289783|21042003|P2|NOT COMPLETED|Fourth Dose Phase||24
8535277|NCT00289783|21042004|P1|NOT COMPLETED|Fourth Dose Phase||87
8535278|NCT00289783|21042003|P2|COMPLETED|Fourth Dose Phase||899
8535279|NCT00289783|21042004|P1|COMPLETED|Fourth Dose Phase||2682
8535280|NCT00289783|21042003|P2|STARTED|Fourth Dose Phase||923
8535281|NCT00289783|21042004|P1|STARTED|Fourth Dose Phase||2769
8535282|NCT00289783|21042003|P2|NOT COMPLETED|Primary Phase||83
8535283|NCT00289783|21042004|P1|NOT COMPLETED|Primary Phase||248
8535284|NCT00289783|21042003|P2|COMPLETED|Primary Phase||961
8535285|NCT00289783|21042004|P1|COMPLETED|Primary Phase||2888
8535286|NCT00289783|21042003|P2|STARTED|Primary Phase||1044
8535287|NCT00289783|21042004|P1|STARTED|Primary Phase||3136
8535288|NCT00289770|21042182|P1|NOT COMPLETED|Year 15||1
8535289|NCT00289770|21042182|P1|COMPLETED|Year 15||49
8535290|NCT00289770|21042182|P1|STARTED|Year 15||50
8535291|NCT00289770|21042182|P1|NOT COMPLETED|Year 14||0
8535292|NCT00289770|21042182|P1|COMPLETED|Year 14||43
8535293|NCT00289770|21042182|P1|STARTED|Year 14||43
8535294|NCT00289770|21042182|P1|NOT COMPLETED|Year 13||0
8535295|NCT00289770|21042182|P1|COMPLETED|Year 13||37
8535296|NCT00289770|21042182|P1|STARTED|Year 13||37
8535297|NCT00289770|21042182|P1|NOT COMPLETED|Year 12||0
8535298|NCT00289770|21042182|P1|COMPLETED|Year 12||40
8535299|NCT00289770|21042182|P1|STARTED|Year 12||40
8535300|NCT00289770|21042182|P1|NOT COMPLETED|Year 11||0
8535301|NCT00289770|21042182|P1|COMPLETED|Year 11||37
8535302|NCT00289770|21042182|P1|STARTED|Year 11||37
8535303|NCT00289757|21042194|P1|NOT COMPLETED|Overall Study||0
8535304|NCT00289757|21042194|P1|COMPLETED|Overall Study||78
8535305|NCT00289757|21042194|P1|STARTED|Overall Study||78
8535306|NCT00289744|21042205|P3|NOT COMPLETED|Additional Dose Phase||0
8535307|NCT00289744|21042206|P2|NOT COMPLETED|Additional Dose Phase||0
8535308|NCT00289744|21042207|P1|NOT COMPLETED|Additional Dose Phase||0
8535309|NCT00289744|21042205|P3|COMPLETED|Additional Dose Phase||6
8535310|NCT00289744|21042206|P2|COMPLETED|Additional Dose Phase||19
8535311|NCT00289744|21042207|P1|COMPLETED|Additional Dose Phase||0
8535312|NCT00289744|21042205|P3|STARTED|Additional Dose Phase||6
8535313|NCT00289744|21042206|P2|STARTED|Additional Dose Phase||19
8535314|NCT00289744|21042207|P1|STARTED|Additional Dose Phase||0
8535315|NCT00289744|21042205|P3|NOT COMPLETED|Year 10 Long-term Follow-up||0
8535316|NCT00289744|21042206|P2|NOT COMPLETED|Year 10 Long-term Follow-up||0
8535317|NCT00289744|21042207|P1|NOT COMPLETED|Year 10 Long-term Follow-up||0
8535318|NCT00289744|21042205|P3|COMPLETED|Year 10 Long-term Follow-up||0
8535319|NCT00289744|21042206|P2|COMPLETED|Year 10 Long-term Follow-up||0
8535320|NCT00289744|21042207|P1|COMPLETED|Year 10 Long-term Follow-up||171
8535321|NCT00289744|21042205|P3|STARTED|Year 10 Long-term Follow-up||0
8535322|NCT00289744|21042206|P2|STARTED|Year 10 Long-term Follow-up||0
8535323|NCT00289744|21042207|P1|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
8535324|NCT00289744|21042205|P3|NOT COMPLETED|Year 9 Long-term Follow-up||0
8535325|NCT00289744|21042206|P2|NOT COMPLETED|Year 9 Long-term Follow-up||0
8535326|NCT00289744|21042207|P1|NOT COMPLETED|Year 9 Long-term Follow-up||0
8535327|NCT00289744|21042205|P3|COMPLETED|Year 9 Long-term Follow-up||0
8535328|NCT00289744|21042206|P2|COMPLETED|Year 9 Long-term Follow-up||0
8535329|NCT00289744|21042207|P1|COMPLETED|Year 9 Long-term Follow-up||173
8535330|NCT00289744|21042205|P3|STARTED|Year 9 Long-term Follow-up||0
8535331|NCT00289744|21042206|P2|STARTED|Year 9 Long-term Follow-up||0
8535332|NCT00289744|21042207|P1|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
8535333|NCT00289744|21042205|P3|NOT COMPLETED|Year 8 Long-term Follow-up||0
8535334|NCT00289744|21042206|P2|NOT COMPLETED|Year 8 Long-term Follow-up||0
8535335|NCT00289744|21042207|P1|NOT COMPLETED|Year 8 Long-term Follow-up||0
8535336|NCT00289744|21042205|P3|COMPLETED|Year 8 Long-term Follow-up||0
8535337|NCT00289744|21042206|P2|COMPLETED|Year 8 Long-term Follow-up||0
8535338|NCT00289744|21042207|P1|COMPLETED|Year 8 Long-term Follow-up||174
8535339|NCT00289744|21042205|P3|STARTED|Year 8 Long-term Follow-up||0
8535340|NCT00289744|21042206|P2|STARTED|Year 8 Long-term Follow-up||0
8535341|NCT00289744|21042207|P1|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
8535342|NCT00289744|21042205|P3|NOT COMPLETED|Year 7 Long-term Follow-up||0
8535343|NCT00289744|21042206|P2|NOT COMPLETED|Year 7 Long-term Follow-up||0
8535344|NCT00289744|21042207|P1|NOT COMPLETED|Year 7 Long-term Follow-up||0
8535345|NCT00289744|21042205|P3|COMPLETED|Year 7 Long-term Follow-up||0
8535346|NCT00289744|21042206|P2|COMPLETED|Year 7 Long-term Follow-up||0
8535347|NCT00289744|21042207|P1|COMPLETED|Year 7 Long-term Follow-up||175
8535348|NCT00289744|21042205|P3|STARTED|Year 7 Long-term Follow-up||0
8535349|NCT00289744|21042206|P2|STARTED|Year 7 Long-term Follow-up||0
8535350|NCT00289744|21042207|P1|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
8535351|NCT00289744|21042205|P3|NOT COMPLETED|Year 6 Long-term Follow-up||0
8535352|NCT00289744|21042206|P2|NOT COMPLETED|Year 6 Long-term Follow-up||0
8535353|NCT00289744|21042207|P1|NOT COMPLETED|Year 6 Long-term Follow-up||0
8535354|NCT00289744|21042205|P3|COMPLETED|Year 6 Long-term Follow-up||0
8535355|NCT00289744|21042206|P2|COMPLETED|Year 6 Long-term Follow-up||0
8535356|NCT00289744|21042207|P1|COMPLETED|Year 6 Long-term Follow-up||178
8535357|NCT00289744|21042205|P3|STARTED|Year 6 Long-term Follow-up||0
8535358|NCT00289744|21042206|P2|STARTED|Year 6 Long-term Follow-up||0
8535359|NCT00289744|21042207|P1|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
8535360|NCT00289731|21042228|P3|NOT COMPLETED|Overall Study||2
8535361|NCT00289731|21042229|P2|NOT COMPLETED|Overall Study||2
8535362|NCT00289731|21042230|P1|NOT COMPLETED|Overall Study||2
8535363|NCT00289731|21042228|P3|COMPLETED|Overall Study||195
8535364|NCT00289731|21042229|P2|COMPLETED|Overall Study||198
8535365|NCT00289731|21042230|P1|COMPLETED|Overall Study||197
8535366|NCT00289731|21042228|P3|STARTED|Overall Study||197
8535367|NCT00289731|21042229|P2|STARTED|Overall Study||200
8535368|NCT00289731|21042230|P1|STARTED|Overall Study||199
8535369|NCT00289718|21042322|P1|NOT COMPLETED|Overall Study||0
8535370|NCT00289718|21042322|P1|COMPLETED|Overall Study||51
8535371|NCT00289718|21042322|P1|STARTED|Overall Study||51
8535372|NCT00289653|21042337|P1|NOT COMPLETED|Overall Study||11
8535373|NCT00289653|21042337|P1|COMPLETED|Overall Study||12
8535374|NCT00289653|21042337|P1|STARTED|Overall Study||23
8535402|NCT00289471|21042383|P1|NOT COMPLETED|Overall Study||0
8535403|NCT00289471|21042383|P1|COMPLETED|Overall Study||630
8535404|NCT00289471|21042383|P1|STARTED|Overall Study||630
8535405|NCT00289458|21042390|P3|NOT COMPLETED|Overall Study||6
8535406|NCT00289458|21042391|P2|NOT COMPLETED|Overall Study||6
8535407|NCT00289458|21042392|P1|NOT COMPLETED|Overall Study||6
8535408|NCT00289458|21042390|P3|COMPLETED|Overall Study||22
8535409|NCT00289458|21042391|P2|COMPLETED|Overall Study||20
8535410|NCT00289458|21042392|P1|COMPLETED|Overall Study||19
8535411|NCT00289458|21042390|P3|STARTED|Overall Study||28
8535412|NCT00289458|21042391|P2|STARTED|Overall Study||26
8535413|NCT00289458|21042392|P1|STARTED|Overall Study||25
8535414|NCT00289341|21042417|P2|NOT COMPLETED|Overall Study||0
8535415|NCT00289341|21042418|P1|NOT COMPLETED|Overall Study||0
8535416|NCT00289341|21042417|P2|COMPLETED|Overall Study||12
8535417|NCT00289341|21042418|P1|COMPLETED|Overall Study||12
8535418|NCT00289341|21042417|P2|STARTED|Overall Study||12
8535419|NCT00289341|21042418|P1|STARTED|Overall Study||12
8535420|NCT00289315|21042431|P3|NOT COMPLETED|Overall Study||140
8535421|NCT00289315|21042432|P2|NOT COMPLETED|Overall Study||122
8535422|NCT00289315|21042433|P1|NOT COMPLETED|Overall Study||101
8535423|NCT00289315|21042431|P3|COMPLETED|Overall Study||447
8535424|NCT00289315|21042432|P2|COMPLETED|Overall Study||638
8535425|NCT00289315|21042433|P1|COMPLETED|Overall Study||612
8535426|NCT00289315|21042431|P3|STARTED|Overall Study||587
8535427|NCT00289315|21042432|P2|STARTED|Overall Study||760
8535428|NCT00289315|21042433|P1|STARTED|Overall Study||713
8535429|NCT00289289|21042453|P3|NOT COMPLETED|Overall Study||49
8535430|NCT00289289|21042454|P2|NOT COMPLETED|Overall Study||10
8535431|NCT00289289|21042455|P1|NOT COMPLETED|Overall Study||19
8535432|NCT00289289|21042453|P3|COMPLETED|Overall Study||95
8535433|NCT00289289|21042454|P2|COMPLETED|Overall Study||114
8535434|NCT00289289|21042455|P1|COMPLETED|Overall Study||113
8535435|NCT00289289|21042453|P3|STARTED|Overall Study||144
8535436|NCT00289289|21042454|P2|STARTED|Overall Study||124
8535437|NCT00289289|21042455|P1|STARTED|Overall Study||132
8535438|NCT00289276|21042470|P2|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
8535439|NCT00289276|21042471|P1|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
8535440|NCT00289276|21042470|P2|COMPLETED|Second Part of FAST Study (Expansion)||106
8535441|NCT00289276|21042471|P1|COMPLETED|Second Part of FAST Study (Expansion)||0
8535442|NCT00289276|21042470|P2|STARTED|Second Part of FAST Study (Expansion)||109
8535443|NCT00289276|21042471|P1|STARTED|Second Part of FAST Study (Expansion)||0
8535444|NCT00289276|21042470|P2|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
8535445|NCT00289276|21042471|P1|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
8535446|NCT00289276|21042470|P2|COMPLETED|First Part of FAST Study (Pivotal)||0
8535447|NCT00289276|21042471|P1|COMPLETED|First Part of FAST Study (Pivotal)||47
8535448|NCT00289276|21042470|P2|STARTED|First Part of FAST Study (Pivotal)||0
8535449|NCT00289276|21042471|P1|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
8535459|NCT00289198|21042506|P2|NOT COMPLETED|Overall Study||30
8535460|NCT00289198|21042507|P1|NOT COMPLETED|Overall Study||31
8535461|NCT00289198|21042506|P2|COMPLETED|Overall Study||121
8535462|NCT00289198|21042507|P1|COMPLETED|Overall Study||120
8535463|NCT00289198|21042506|P2|STARTED|Overall Study||151
8535464|NCT00289198|21042507|P1|STARTED|Overall Study||151
8535465|NCT00289185|21042557|P2|NOT COMPLETED|Overall Study||26
8535466|NCT00289185|21042558|P1|NOT COMPLETED|Overall Study||28
8535467|NCT00289185|21042557|P2|COMPLETED|Overall Study||144
8535468|NCT00289185|21042558|P1|COMPLETED|Overall Study||142
8535469|NCT00289185|21042557|P2|STARTED|Overall Study||170
8535470|NCT00289185|21042558|P1|STARTED|Overall Study||170
8535471|NCT00289133|21042605|P2|NOT COMPLETED|Overall Study||298
8535472|NCT00289133|21042606|P1|NOT COMPLETED|Overall Study||272
8535473|NCT00289133|21042605|P2|COMPLETED|Overall Study||179
8535474|NCT00289133|21042606|P1|COMPLETED|Overall Study||189
8535475|NCT00289133|21042605|P2|STARTED|Overall Study||477
8535476|NCT00289133|21042606|P1|STARTED|Overall Study||461
8535477|NCT00289120|21042628|P1|NOT COMPLETED|Overall Study||0
8535478|NCT00289120|21042628|P1|COMPLETED|Overall Study||13
8535479|NCT00289120|21042628|P1|STARTED|Overall Study||13
8535480|NCT00289107|21042646|P2|NOT COMPLETED|Overall Study||44
8535481|NCT00289107|21042647|P1|NOT COMPLETED|Overall Study||53
8535482|NCT00289107|21042646|P2|COMPLETED|Overall Study||28
8535483|NCT00289107|21042647|P1|COMPLETED|Overall Study||24
8535484|NCT00289107|21042646|P2|STARTED|Overall Study||72
8535485|NCT00289107|21042647|P1|STARTED|Overall Study||77
8535486|NCT00289094|21042655|P2|NOT COMPLETED|Overall Study||47
8535487|NCT00289094|21042656|P1|NOT COMPLETED|Overall Study||47
8535488|NCT00289094|21042655|P2|COMPLETED|Overall Study||2
8535489|NCT00289094|21042656|P1|COMPLETED|Overall Study||3
8535490|NCT00289094|21042655|P2|STARTED|Overall Study||49
8535491|NCT00289094|21042656|P1|STARTED|Overall Study||50
8535492|NCT00289016|21042662|P1|NOT COMPLETED|Overall Study||37
8535493|NCT00289016|21042662|P1|COMPLETED|Overall Study||13
8535494|NCT00289016|21042662|P1|STARTED|Overall Study||50
8535495|NCT00288912|21042674|P3|NOT COMPLETED|Overall Study||28
8535496|NCT00288912|21042675|P2|NOT COMPLETED|Overall Study||17
8535497|NCT00288912|21042676|P1|NOT COMPLETED|Overall Study||17
8535498|NCT00288912|21042674|P3|COMPLETED|Overall Study||146
8535499|NCT00288912|21042675|P2|COMPLETED|Overall Study||157
8535500|NCT00288912|21042676|P1|COMPLETED|Overall Study||158
8535501|NCT00288912|21042674|P3|STARTED|Overall Study||174
8535502|NCT00288912|21042675|P2|STARTED|Overall Study||174
8535503|NCT00288912|21042676|P1|STARTED|Overall Study||175
8535504|NCT00288886|21042695|P2|NOT COMPLETED|Overall Study||11
8535505|NCT00288886|21042696|P1|NOT COMPLETED|Overall Study||11
8535506|NCT00288886|21042695|P2|COMPLETED|Overall Study||81
8535507|NCT00288886|21042696|P1|COMPLETED|Overall Study||80
8535508|NCT00288886|21042695|P2|12-month Follow Up|Overall Study||81
8535509|NCT00288886|21042696|P1|12-month Follow Up|Overall Study||80
8535510|NCT00288886|21042695|P2|6-month Follow Up|Overall Study||84
8535511|NCT00288886|21042696|P1|6-month Follow Up|Overall Study||85
8535512|NCT00288886|21042695|P2|3-month Follow Up|Overall Study||85
8535513|NCT00288886|21042696|P1|3-month Follow Up|Overall Study||82
8535514|NCT00288886|21042695|P2|STARTED|Overall Study||92
8535515|NCT00288886|21042696|P1|STARTED|Overall Study||91
8535516|NCT00288860|21042716|P2|NOT COMPLETED|Overall Study||97
8535517|NCT00288860|21042717|P1|NOT COMPLETED|Overall Study||102
8535518|NCT00288860|21042716|P2|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
8535519|NCT00288860|21042717|P1|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
8535520|NCT00288860|21042716|P2|Completed 12 Month fu Survey|Overall Study||281
8535521|NCT00288860|21042717|P1|Completed 12 Month fu Survey|Overall Study||257
8535522|NCT00288860|21042716|P2|Completed 4 Month fu Survey|Overall Study||299
8535523|NCT00288860|21042717|P1|Completed 4 Month fu Survey|Overall Study||275
8535524|NCT00288860|21042716|P2|Completed Intake Survey|Overall Study||417
8535525|NCT00288860|21042717|P1|Completed Intake Survey|Overall Study||408
8535526|NCT00288860|21042716|P2|STARTED|Overall Study||425
8535527|NCT00288860|21042717|P1|STARTED|Overall Study||412
8535528|NCT00288704|21042730|P3|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
8535529|NCT00288704|21042731|P2|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
8535530|NCT00288704|21042732|P1|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
8535531|NCT00288704|21042730|P3|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
8535532|NCT00288704|21042731|P2|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
8535533|NCT00288704|21042732|P1|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
8535534|NCT00288704|21042730|P3|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
8535535|NCT00288704|21042731|P2|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
8535536|NCT00288704|21042732|P1|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
8535537|NCT00288704|21042730|P3|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
8535538|NCT00288704|21042731|P2|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
8535539|NCT00288704|21042732|P1|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
8535540|NCT00288704|21042730|P3|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
8535541|NCT00288704|21042731|P2|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
8535542|NCT00288704|21042732|P1|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
8535543|NCT00288704|21042730|P3|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
8535544|NCT00288704|21042731|P2|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
8535545|NCT00288704|21042732|P1|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
8535546|NCT00288704|21042730|P3|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
8535547|NCT00288704|21042731|P2|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
8535548|NCT00288704|21042732|P1|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
8535549|NCT00288704|21042730|P3|COMPLETED|Part A, Double Blind, Weeks 1-6||0
8535550|NCT00288704|21042731|P2|COMPLETED|Part A, Double Blind, Weeks 1-6||22
8535551|NCT00288704|21042732|P1|COMPLETED|Part A, Double Blind, Weeks 1-6||24
8535552|NCT00288704|21042730|P3|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
8535553|NCT00288704|21042731|P2|STARTED|Part A, Double Blind, Weeks 1-6||23
8535554|NCT00288704|21042732|P1|STARTED|Part A, Double Blind, Weeks 1-6||24
8535555|NCT00288639|21042759|P1|NOT COMPLETED|Overall Study||12
8535556|NCT00288639|21042759|P1|COMPLETED|Overall Study||86
8535557|NCT00288639|21042759|P1|STARTED|Overall Study||98
8535558|NCT00288626|21042776|P1|NOT COMPLETED|Overall Study||7
8535559|NCT00288626|21042776|P1|COMPLETED|Overall Study||17
8535560|NCT00288626|21042776|P1|STARTED|Overall Study||24
8535561|NCT00288600|21042801|P2|NOT COMPLETED|Overall Study||0
8535562|NCT00288600|21042802|P1|NOT COMPLETED|Overall Study||0
8535563|NCT00288600|21042801|P2|COMPLETED|Overall Study||46
8535564|NCT00288600|21042802|P1|COMPLETED|Overall Study||46
8535565|NCT00288600|21042801|P2|STARTED|Overall Study||46
8535566|NCT00288600|21042802|P1|STARTED|Overall Study||46
8535567|NCT00288587|21042810|P2|NOT COMPLETED|Overall Study||10
8535568|NCT00288587|21042811|P1|NOT COMPLETED|Overall Study||5
8535569|NCT00288587|21042810|P2|COMPLETED|Overall Study||7
8535570|NCT00288587|21042811|P1|COMPLETED|Overall Study||14
8535571|NCT00288587|21042810|P2|STARTED|Overall Study||17
8535572|NCT00288587|21042811|P1|STARTED|Overall Study||19
8535573|NCT00288574|21042827|P2|NOT COMPLETED|Overall Study||0
8535574|NCT00288574|21042828|P1|NOT COMPLETED|Overall Study||0
8535575|NCT00288574|21042827|P2|COMPLETED|Overall Study||44
8535576|NCT00288574|21042828|P1|COMPLETED|Overall Study||49
8535577|NCT00288574|21042827|P2|STARTED|Overall Study||44
8535578|NCT00288574|21042828|P1|STARTED|Overall Study||49
8535579|NCT00288509|21042854|P1|NOT COMPLETED|Treatment Cycle 4||8
8535580|NCT00288509|21042854|P1|COMPLETED|Treatment Cycle 4||80
8535581|NCT00288509|21042854|P1|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
8535582|NCT00288509|21042854|P1|NOT COMPLETED|Treatment Cycle 3||5
8535583|NCT00288509|21042854|P1|COMPLETED|Treatment Cycle 3||91
8535584|NCT00288509|21042854|P1|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
8535585|NCT00288509|21042854|P1|NOT COMPLETED|Treatment Cycle 2||3
8535586|NCT00288509|21042854|P1|COMPLETED|Treatment Cycle 2||97
8535587|NCT00288509|21042854|P1|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
8535588|NCT00288509|21042854|P1|NOT COMPLETED|Treatment Cycle 1||6
8535589|NCT00288509|21042854|P1|COMPLETED|Treatment Cycle 1||102
8535590|NCT00288509|21042854|P1|STARTED|Treatment Cycle 1||108
8535591|NCT00288366|21042863|P2|NOT COMPLETED|Overall Study||0
8535592|NCT00288366|21042864|P1|NOT COMPLETED|Overall Study||0
8535593|NCT00288366|21042863|P2|COMPLETED|Overall Study||26
8535594|NCT00288366|21042864|P1|COMPLETED|Overall Study||23
8535595|NCT00288366|21042863|P2|STARTED|Overall Study||26
8535596|NCT00288366|21042864|P1|STARTED|Overall Study||23
8535603|NCT00288067|21042889|P1|NOT COMPLETED|Overall Study||0
8535604|NCT00288067|21042889|P1|COMPLETED|Overall Study||32
8535605|NCT00288067|21042889|P1|STARTED|Overall Study||32
8535606|NCT00288054|21042895|P1|NOT COMPLETED|Overall Study||24
8535607|NCT00288054|21042895|P1|COMPLETED|Overall Study||0
8535608|NCT00288054|21042895|P1|STARTED|Overall Study||24
8535609|NCT00288015|21042903|P1|NOT COMPLETED|Follow up for Survival x 2 Years||26
8535610|NCT00288015|21042903|P1|COMPLETED|Follow up for Survival x 2 Years||3
8535611|NCT00288015|21042903|P1|STARTED|Follow up for Survival x 2 Years||29
8535612|NCT00288015|21042903|P1|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
8535613|NCT00288015|21042903|P1|COMPLETED|Continued Bevacizumab Cycle 3+||19
8535614|NCT00288015|21042903|P1|STARTED|Continued Bevacizumab Cycle 3+||26
8535615|NCT00288015|21042903|P1|NOT COMPLETED|First Response Assessment||4
8535616|NCT00288015|21042903|P1|COMPLETED|First Response Assessment||26
8535617|NCT00288015|21042903|P1|STARTED|First Response Assessment||30
8535618|NCT00288015|21042903|P1|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
8535619|NCT00288015|21042903|P1|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
8535620|NCT00288015|21042903|P1|STARTED|Bevacizumab Treatment Cycles 1-2||32
8535621|NCT00288015|21042903|P1|NOT COMPLETED|Registered to Study||0
8535622|NCT00288015|21042903|P1|COMPLETED|Registered to Study||32
8535623|NCT00288015|21042903|P1|STARTED|Registered to Study||32
8535624|NCT00287989|21042915|P3|NOT COMPLETED|Overall Study||0
8535625|NCT00287989|21042916|P2|NOT COMPLETED|Overall Study||0
8535626|NCT00287989|21042917|P1|NOT COMPLETED|Overall Study||0
8535627|NCT00287989|21042915|P3|COMPLETED|Overall Study||29
8535628|NCT00287989|21042916|P2|COMPLETED|Overall Study||29
8535629|NCT00287989|21042917|P1|COMPLETED|Overall Study||28
8535630|NCT00287989|21042915|P3|STARTED|Overall Study||29
8535631|NCT00287989|21042916|P2|STARTED|Overall Study||29
8535632|NCT00287989|21042917|P1|STARTED|Overall Study||28
8535633|NCT00287872|21042928|P1|NOT COMPLETED|Overall Study||0
8535634|NCT00287872|21042928|P1|COMPLETED|Overall Study||30
8535635|NCT00287872|21042928|P1|STARTED|Overall Study||30
8535636|NCT00287729|21042938|P2|NOT COMPLETED|Overall Study||31
8535637|NCT00287729|21042939|P1|NOT COMPLETED|Overall Study||34
8535638|NCT00287729|21042938|P2|COMPLETED|Overall Study||142
8535639|NCT00287729|21042939|P1|COMPLETED|Overall Study||137
8535640|NCT00287729|21042938|P2|STARTED|Overall Study||173
8535641|NCT00287729|21042939|P1|STARTED|Overall Study||171
8535642|NCT00287716|21042962|P3|NOT COMPLETED|Overall Study||31
8535643|NCT00287716|21042963|P2|NOT COMPLETED|Overall Study||17
8535644|NCT00287716|21042964|P1|NOT COMPLETED|Overall Study||38
8535645|NCT00287716|21042962|P3|COMPLETED|Overall Study||143
8535646|NCT00287716|21042963|P2|COMPLETED|Overall Study||70
8535647|NCT00287716|21042964|P1|COMPLETED|Overall Study||136
8535648|NCT00287716|21042962|P3|STARTED|Overall Study||174
8535649|NCT00287716|21042963|P2|STARTED|Overall Study||87
8535650|NCT00287716|21042964|P1|STARTED|Overall Study||174
8535651|NCT00287690|21042995|P2|NOT COMPLETED|Overall Study||26
8535652|NCT00287690|21042996|P1|NOT COMPLETED|Overall Study||20
8535653|NCT00287690|21042995|P2|COMPLETED|Overall Study||12
8535654|NCT00287690|21042996|P1|COMPLETED|Overall Study||13
8535655|NCT00287690|21042995|P2|STARTED|Overall Study||38
8535656|NCT00287690|21042996|P1|STARTED|Overall Study||33
8535657|NCT00287586|21043008|P2|NOT COMPLETED|Overall Study||52
8535658|NCT00287586|21043009|P1|NOT COMPLETED|Overall Study||45
8535659|NCT00287586|21043008|P2|COMPLETED|Overall Study||100
8535660|NCT00287586|21043009|P1|COMPLETED|Overall Study||111
8535661|NCT00287586|21043008|P2|Intent-to-treat: Received Study Drug|Overall Study||151
8535662|NCT00287586|21043009|P1|Intent-to-treat: Received Study Drug|Overall Study||155
8535663|NCT00287586|21043008|P2|STARTED|Overall Study||152
8535664|NCT00287586|21043009|P1|STARTED|Overall Study||156
8535665|NCT00287469|21043047|P2|NOT COMPLETED|Overall Study||214
8535666|NCT00287469|21043048|P1|NOT COMPLETED|Overall Study||220
8535667|NCT00287469|21043047|P2|COMPLETED|Overall Study||786
8535668|NCT00287469|21043048|P1|COMPLETED|Overall Study||780
8535669|NCT00287469|21043047|P2|STARTED|Overall Study||1000
8535670|NCT00287469|21043048|P1|STARTED|Overall Study||1000
8535671|NCT00287365|21043058|P1|NOT COMPLETED|Overall Study||13
8535672|NCT00287365|21043058|P1|COMPLETED|Overall Study||12
8535673|NCT00287365|21043058|P1|STARTED|Overall Study||25
8535674|NCT00287339|21043069|P2|NOT COMPLETED|Overall Study||0
8535675|NCT00287339|21043070|P1|NOT COMPLETED|Overall Study||0
8535676|NCT00287339|21043069|P2|COMPLETED|Overall Study||18
8535677|NCT00287339|21043070|P1|COMPLETED|Overall Study||22
8535678|NCT00287339|21043069|P2|STARTED|Overall Study||18
8535679|NCT00287339|21043070|P1|STARTED|Overall Study||22
8535680|NCT00287287|21043076|P1|NOT COMPLETED|Overall Study||0
8535681|NCT00287287|21043076|P1|COMPLETED|Overall Study||25
8535682|NCT00287287|21043076|P1|STARTED|Overall Study||25
8535683|NCT00287222|21043080|P1|NOT COMPLETED|Overall Study||0
8535684|NCT00287222|21043080|P1|COMPLETED|Overall Study||21
8535685|NCT00287222|21043080|P1|STARTED|Overall Study||21
8535686|NCT00287118|21043084|P1|NOT COMPLETED|Overall Study||52
8535687|NCT00287118|21043084|P1|COMPLETED|Overall Study||137
8535688|NCT00287118|21043084|P1|STARTED|Overall Study||189
8535689|NCT00287079|21043090|P2|NOT COMPLETED|Overall Study||1
8535690|NCT00287079|21043091|P1|NOT COMPLETED|Overall Study||22
8535691|NCT00287079|21043090|P2|COMPLETED|Overall Study||2
8535692|NCT00287079|21043091|P1|COMPLETED|Overall Study||10
8535693|NCT00287079|21043090|P2|STARTED|Overall Study||3
8535694|NCT00287079|21043091|P1|STARTED|Overall Study||32
8535695|NCT00287053|21043103|P2|NOT COMPLETED|Overall Study||1
8535696|NCT00287053|21043104|P1|NOT COMPLETED|Overall Study||4
8535697|NCT00287053|21043103|P2|COMPLETED|Overall Study||26
8535698|NCT00287053|21043104|P1|COMPLETED|Overall Study||26
8535699|NCT00287053|21043103|P2|STARTED|Overall Study||27
8535700|NCT00287053|21043104|P1|STARTED|Overall Study||30
8535701|NCT00286949|21043110|P1|NOT COMPLETED|Overall Study||0
8535702|NCT00286949|21043110|P1|COMPLETED|Overall Study||12
8535703|NCT00286949|21043110|P1|STARTED|Overall Study||12
8535704|NCT00286754|21043119|P3|NOT COMPLETED|Overall Study||10
8535705|NCT00286754|21043120|P2|NOT COMPLETED|Overall Study||18
8535706|NCT00286754|21043121|P1|NOT COMPLETED|Overall Study||20
8535707|NCT00286754|21043119|P3|COMPLETED|Overall Study||170
8535708|NCT00286754|21043120|P2|COMPLETED|Overall Study||159
8535709|NCT00286754|21043121|P1|COMPLETED|Overall Study||156
8535710|NCT00286754|21043119|P3|STARTED|Overall Study||180
8535711|NCT00286754|21043120|P2|STARTED|Overall Study||177
8535712|NCT00286754|21043121|P1|STARTED|Overall Study||176
8535713|NCT00286741|21043155|P2|NOT COMPLETED|Overall Study||17
8535714|NCT00286741|21043156|P1|NOT COMPLETED|Overall Study||11
8535715|NCT00286741|21043155|P2|COMPLETED|Overall Study||89
8535716|NCT00286741|21043156|P1|COMPLETED|Overall Study||122
8535717|NCT00286741|21043155|P2|STARTED|Overall Study||106
8535718|NCT00286741|21043156|P1|STARTED|Overall Study||133
8535719|NCT00286728|21043168|P2|NOT COMPLETED|Overall Study||29
8535720|NCT00286728|21043169|P1|NOT COMPLETED|Overall Study||36
8535721|NCT00286728|21043168|P2|COMPLETED|Overall Study||116
8535722|NCT00286728|21043169|P1|COMPLETED|Overall Study||106
8535723|NCT00286728|21043168|P2|STARTED|Overall Study||145
8535724|NCT00286728|21043169|P1|STARTED|Overall Study||142
8535725|NCT00286494|21043180|P3|NOT COMPLETED|Overall Study||39
8535726|NCT00286494|21043181|P2|NOT COMPLETED|Overall Study||44
8535727|NCT00286494|21043182|P1|NOT COMPLETED|Overall Study||26
8535728|NCT00286494|21043180|P3|COMPLETED|Overall Study||160
8535729|NCT00286494|21043181|P2|COMPLETED|Overall Study||153
8535730|NCT00286494|21043182|P1|COMPLETED|Overall Study||71
8535731|NCT00286494|21043180|P3|STARTED|Overall Study||199
8535732|NCT00286494|21043181|P2|STARTED|Overall Study||197
8535733|NCT00286494|21043182|P1|STARTED|Overall Study||97
8535734|NCT00286468|21043343|P3|NOT COMPLETED|Overall Study||50
8535735|NCT00286468|21043344|P2|NOT COMPLETED|Overall Study||50
8535736|NCT00286468|21043345|P1|NOT COMPLETED|Overall Study||37
8535737|NCT00286468|21043343|P3|COMPLETED|Overall Study||148
8535738|NCT00286468|21043344|P2|COMPLETED|Overall Study||153
8535739|NCT00286468|21043345|P1|COMPLETED|Overall Study||62
8535740|NCT00286468|21043343|P3|STARTED|Overall Study||198
8535741|NCT00286468|21043344|P2|STARTED|Overall Study||203
8535742|NCT00286468|21043345|P1|STARTED|Overall Study||99
8535743|NCT00286455|21043506|P3|NOT COMPLETED|Overall Study||24
8535744|NCT00286455|21043507|P2|NOT COMPLETED|Overall Study||28
8535745|NCT00286455|21043508|P1|NOT COMPLETED|Overall Study||25
8535746|NCT00286455|21043506|P3|COMPLETED|Overall Study||107
8535747|NCT00286455|21043507|P2|COMPLETED|Overall Study||105
8535748|NCT00286455|21043508|P1|COMPLETED|Overall Study||40
8535749|NCT00286455|21043506|P3|STARTED|Overall Study||131
8535750|NCT00286455|21043507|P2|STARTED|Overall Study||133
8535751|NCT00286455|21043508|P1|STARTED|Overall Study||65
8535752|NCT00286442|21043687|P3|NOT COMPLETED|Overall Study||32
8535753|NCT00286442|21043688|P2|NOT COMPLETED|Overall Study||45
8535754|NCT00286442|21043689|P1|NOT COMPLETED|Overall Study||37
8535755|NCT00286442|21043687|P3|COMPLETED|Overall Study||72
8535756|NCT00286442|21043688|P2|COMPLETED|Overall Study||165
8535757|NCT00286442|21043689|P1|COMPLETED|Overall Study||176
8535758|NCT00286442|21043687|P3|STARTED|Overall Study||104
8535759|NCT00286442|21043688|P2|STARTED|Overall Study||210
8535760|NCT00286442|21043689|P1|STARTED|Overall Study||213
8535761|NCT00286429|21043850|P3|NOT COMPLETED|Overall Study||52
8535762|NCT00286429|21043851|P2|NOT COMPLETED|Overall Study||48
8535763|NCT00286429|21043852|P1|NOT COMPLETED|Overall Study||75
8535764|NCT00286429|21043850|P3|COMPLETED|Overall Study||77
8535765|NCT00286429|21043851|P2|COMPLETED|Overall Study||83
8535766|NCT00286429|21043852|P1|COMPLETED|Overall Study||55
8535767|NCT00286429|21043850|P3|STARTED|Overall Study||129
8535768|NCT00286429|21043851|P2|STARTED|Overall Study||131
8535769|NCT00286429|21043852|P1|STARTED|Overall Study||130
8535770|NCT00286325|21043956|P1|NOT COMPLETED|Overall Study||0
8535771|NCT00286325|21043956|P1|COMPLETED|Overall Study||8
8535772|NCT00286325|21043956|P1|STARTED|Overall Study||8
8535773|NCT00286221|21043968|P4|NOT COMPLETED|Overall Study||6
8535774|NCT00286221|21043969|P3|NOT COMPLETED|Overall Study||9
8535775|NCT00286221|21043970|P2|NOT COMPLETED|Overall Study||5
8535776|NCT00286221|21043971|P1|NOT COMPLETED|Overall Study||10
8535777|NCT00286221|21043968|P4|COMPLETED|Overall Study||34
8535778|NCT00286221|21043969|P3|COMPLETED|Overall Study||31
8535779|NCT00286221|21043970|P2|COMPLETED|Overall Study||35
8535780|NCT00286221|21043971|P1|COMPLETED|Overall Study||29
8535781|NCT00286221|21043968|P4|STARTED|Overall Study||40
8535782|NCT00286221|21043969|P3|STARTED|Overall Study||40
8535783|NCT00286221|21043970|P2|STARTED|Overall Study||40
8535784|NCT00286221|21043971|P1|STARTED|Overall Study||39
8535785|NCT00286182|21043987|P2|NOT COMPLETED|Overall Study||3
8535786|NCT00286182|21043988|P1|NOT COMPLETED|Overall Study||5
8535787|NCT00286182|21043987|P2|COMPLETED|Overall Study||25
8535788|NCT00286182|21043988|P1|COMPLETED|Overall Study||23
8535789|NCT00286182|21043987|P2|STARTED|Overall Study||28
8535790|NCT00286182|21043988|P1|STARTED|Overall Study||28
8535791|NCT00286156|21043997|P3|NOT COMPLETED|Overall Study||1
8535792|NCT00286156|21043998|P2|NOT COMPLETED|Overall Study||1
8535793|NCT00286156|21043999|P1|NOT COMPLETED|Overall Study||2
8535794|NCT00286156|21043997|P3|COMPLETED|Overall Study||9
8535795|NCT00286156|21043998|P2|COMPLETED|Overall Study||9
8535796|NCT00286156|21043999|P1|COMPLETED|Overall Study||8
8535797|NCT00286156|21043997|P3|STARTED|Overall Study||10
8535798|NCT00286156|21043998|P2|STARTED|Overall Study||10
8535799|NCT00286156|21043999|P1|STARTED|Overall Study||10
8535800|NCT00286091|21044012|P2|NOT COMPLETED|Open-label Treatment Phase||71
8535801|NCT00286091|21044013|P1|NOT COMPLETED|Open-label Treatment Phase||77
8535802|NCT00286091|21044012|P2|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
8535803|NCT00286091|21044013|P1|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
8535804|NCT00286091|21044012|P2|Received Treatment|Open-label Treatment Phase||101
8535805|NCT00286091|21044013|P1|Received Treatment|Open-label Treatment Phase||109
8535806|NCT00286091|21044012|P2|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
8535807|NCT00286091|21044013|P1|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
8535808|NCT00286091|21044012|P2|NOT COMPLETED|Double-blind Treatment Phase||593
8535809|NCT00286091|21044013|P1|NOT COMPLETED|Double-blind Treatment Phase||584
8535810|NCT00286091|21044012|P2|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
8535811|NCT00286091|21044013|P1|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
8535812|NCT00286091|21044012|P2|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
8535813|NCT00286091|21044013|P1|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
8535814|NCT00286091|21044012|P2|Received Treatment|Double-blind Treatment Phase||716
8535815|NCT00286091|21044013|P1|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
8535816|NCT00286091|21044012|P2|STARTED|Double-blind Treatment Phase||716
8535817|NCT00286091|21044013|P1|STARTED|Double-blind Treatment Phase||716
8535818|NCT00286078|21044027|P2|NOT COMPLETED|Overall Study||34
8535819|NCT00286078|21044028|P1|NOT COMPLETED|Overall Study||32
8535820|NCT00286078|21044027|P2|COMPLETED|Overall Study||34
8535821|NCT00286078|21044028|P1|COMPLETED|Overall Study||40
8535822|NCT00286078|21044027|P2|12 Weeks|Overall Study||62
8535823|NCT00286078|21044028|P1|12 Weeks|Overall Study||63
8535824|NCT00286078|21044027|P2|STARTED|Overall Study||68
8535825|NCT00286078|21044028|P1|STARTED|Overall Study||72
8535826|NCT00285857|21044036|P1|NOT COMPLETED|Overall Study||4
8535827|NCT00285857|21044036|P1|COMPLETED|Overall Study||26
8535828|NCT00285857|21044036|P1|STARTED|Overall Study||30
8535829|NCT00285818|21044049|P2|NOT COMPLETED|Overall Study||2
8535830|NCT00285818|21044050|P1|NOT COMPLETED|Overall Study||4
8535831|NCT00285818|21044049|P2|COMPLETED|Overall Study||3
8535832|NCT00285818|21044050|P1|COMPLETED|Overall Study||2
8535833|NCT00285818|21044049|P2|STARTED|Overall Study||5
8535834|NCT00285818|21044050|P1|STARTED|Overall Study||6
8535835|NCT00285779|21044058|P2|NOT COMPLETED|Follow-up Period (wk 24-32)||0
8535836|NCT00285779|21044059|P1|NOT COMPLETED|Follow-up Period (wk 24-32)||1
8535837|NCT00285779|21044058|P2|COMPLETED|Follow-up Period (wk 24-32)||10
8535838|NCT00285779|21044059|P1|COMPLETED|Follow-up Period (wk 24-32)||8
8535839|NCT00285779|21044058|P2|STARTED|Follow-up Period (wk 24-32)||10
8535840|NCT00285779|21044059|P1|STARTED|Follow-up Period (wk 24-32)||9
8535841|NCT00285779|21044058|P2|NOT COMPLETED|Open Label Period (wk 12-24)||2
8535842|NCT00285779|21044059|P1|NOT COMPLETED|Open Label Period (wk 12-24)||2
8535843|NCT00285779|21044058|P2|COMPLETED|Open Label Period (wk 12-24)||10
8535844|NCT00285779|21044059|P1|COMPLETED|Open Label Period (wk 12-24)||9
8535845|NCT00285779|21044058|P2|STARTED|Open Label Period (wk 12-24)||12
8535846|NCT00285779|21044059|P1|STARTED|Open Label Period (wk 12-24)||11
8535847|NCT00285779|21044058|P2|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
8535848|NCT00285779|21044059|P1|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
8535849|NCT00285779|21044058|P2|COMPLETED|Placebo-controlled Period (wk 1-12)||12
8535850|NCT00285779|21044059|P1|COMPLETED|Placebo-controlled Period (wk 1-12)||11
8535851|NCT00285779|21044058|P2|STARTED|Placebo-controlled Period (wk 1-12)||13
8535852|NCT00285779|21044059|P1|STARTED|Placebo-controlled Period (wk 1-12)||14
8535853|NCT00285649|21044095|P3|NOT COMPLETED|Overall Study||6
8535854|NCT00285649|21044096|P2|NOT COMPLETED|Overall Study||6
8535855|NCT00285649|21044097|P1|NOT COMPLETED|Overall Study||9
8535856|NCT00285649|21044095|P3|COMPLETED|Overall Study||42
8535857|NCT00285649|21044096|P2|COMPLETED|Overall Study||66
8535858|NCT00285649|21044097|P1|COMPLETED|Overall Study||63
8535859|NCT00285649|21044095|P3|STARTED|Overall Study||48
8535860|NCT00285649|21044096|P2|STARTED|Overall Study||72
8535861|NCT00285649|21044097|P1|STARTED|Overall Study||72
8535862|NCT00285584|21044107|P2|NOT COMPLETED|Month 9||3
8535863|NCT00285584|21044108|P1|NOT COMPLETED|Month 9||1
8535864|NCT00285584|21044107|P2|COMPLETED|Month 9||14
8535865|NCT00285584|21044108|P1|COMPLETED|Month 9||15
8535866|NCT00285584|21044107|P2|STARTED|Month 9||17
8535867|NCT00285584|21044108|P1|STARTED|Month 9||16
8535868|NCT00285584|21044107|P2|NOT COMPLETED|Month 6||1
8535869|NCT00285584|21044108|P1|NOT COMPLETED|Month 6||0
8535870|NCT00285584|21044107|P2|COMPLETED|Month 6||17
8535871|NCT00285584|21044108|P1|COMPLETED|Month 6||16
8535872|NCT00285584|21044107|P2|STARTED|Month 6||18
8535873|NCT00285584|21044108|P1|STARTED|Month 6||16
8535874|NCT00285584|21044107|P2|NOT COMPLETED|Month 3||3
8535875|NCT00285584|21044108|P1|NOT COMPLETED|Month 3||4
8535876|NCT00285584|21044107|P2|COMPLETED|Month 3||18
8535877|NCT00285584|21044108|P1|COMPLETED|Month 3||16
8535878|NCT00285584|21044107|P2|STARTED|Month 3||21
8535879|NCT00285584|21044108|P1|STARTED|Month 3||20
8535880|NCT00285584|21044107|P2|NOT COMPLETED|Enrollment (Month 0)||0
8535881|NCT00285584|21044108|P1|NOT COMPLETED|Enrollment (Month 0)||0
8535882|NCT00285584|21044107|P2|COMPLETED|Enrollment (Month 0)||21
8535883|NCT00285584|21044108|P1|COMPLETED|Enrollment (Month 0)||20
8535884|NCT00285584|21044107|P2|STARTED|Enrollment (Month 0)||21
8535885|NCT00285584|21044108|P1|STARTED|Enrollment (Month 0)||20
8535886|NCT00285467|21044122|P2|NOT COMPLETED|Overall Study||0
8535887|NCT00285467|21044123|P1|NOT COMPLETED|Overall Study||0
8535888|NCT00285467|21044122|P2|COMPLETED|Overall Study||22
8535889|NCT00285467|21044123|P1|COMPLETED|Overall Study||25
8535890|NCT00285467|21044122|P2|STARTED|Overall Study||22
8535891|NCT00285467|21044123|P1|STARTED|Overall Study||25
8535892|NCT00285246|21044131|P1|NOT COMPLETED|Overall Study||48
8535893|NCT00285246|21044131|P1|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
8535894|NCT00285246|21044131|P1|STARTED|Overall Study||838
8535895|NCT00285207|21044140|P2|NOT COMPLETED|Overall Study||6
8535896|NCT00285207|21044141|P1|NOT COMPLETED|Overall Study||9
8535897|NCT00285207|21044140|P2|COMPLETED|Overall Study||71
8535898|NCT00285207|21044141|P1|COMPLETED|Overall Study||61
8535899|NCT00285207|21044140|P2|Treated|Overall Study||75
8535900|NCT00285207|21044141|P1|Treated|Overall Study||63
8535901|NCT00285207|21044140|P2|STARTED|Overall Study||77
8535902|NCT00285207|21044141|P1|STARTED|Overall Study||70
8535903|NCT00285012|21044149|P2|NOT COMPLETED|Received Study Tx||94
8535904|NCT00285012|21044150|P1|NOT COMPLETED|Received Study Tx||72
8535905|NCT00285012|21044149|P2|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
8535906|NCT00285012|21044150|P1|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
8535907|NCT00285012|21044149|P2|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
8535908|NCT00285012|21044150|P1|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
8535909|NCT00285012|21044149|P2|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
8535910|NCT00285012|21044150|P1|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
8535911|NCT00285012|21044149|P2|STARTED|Received Study Tx||251
8535912|NCT00285012|21044150|P1|STARTED|Received Study Tx||248
8535913|NCT00285012|21044149|P2|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
8535914|NCT00285012|21044150|P1|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
8535915|NCT00285012|21044149|P2|COMPLETED|Assigned to Study Treatment (Tx)||251
8535916|NCT00285012|21044150|P1|COMPLETED|Assigned to Study Treatment (Tx)||248
8535917|NCT00285012|21044149|P2|STARTED|Assigned to Study Treatment (Tx)||254
8535918|NCT00285012|21044150|P1|STARTED|Assigned to Study Treatment (Tx)||250
8535919|NCT00284934|21044176|P2|NOT COMPLETED|Overall Study||3
8535920|NCT00284934|21044177|P1|NOT COMPLETED|Overall Study||4
8535921|NCT00284934|21044176|P2|COMPLETED|Overall Study||43
8535922|NCT00284934|21044177|P1|COMPLETED|Overall Study||44
8535923|NCT00284934|21044176|P2|Intent-to-treat Population (ITT)|Overall Study||45
8535924|NCT00284934|21044177|P1|Intent-to-treat Population (ITT)|Overall Study||47
8535925|NCT00284934|21044176|P2|STARTED|Overall Study||46
8535926|NCT00284934|21044177|P1|STARTED|Overall Study||48
8535927|NCT00284856|21044192|P3|NOT COMPLETED|Overall Study||60
8535928|NCT00284856|21044193|P2|NOT COMPLETED|Overall Study||50
8535929|NCT00284856|21044194|P1|NOT COMPLETED|Overall Study||51
8535930|NCT00284856|21044192|P3|COMPLETED|Overall Study||276
8535931|NCT00284856|21044193|P2|COMPLETED|Overall Study||286
8535932|NCT00284856|21044194|P1|COMPLETED|Overall Study||296
8535933|NCT00284856|21044192|P3|STARTED|Overall Study||336
8535934|NCT00284856|21044193|P2|STARTED|Overall Study||336
8535935|NCT00284856|21044194|P1|STARTED|Overall Study||347
8535936|NCT00284739|21044210|P2|NOT COMPLETED|Overall Study||0
8535937|NCT00284739|21044211|P1|NOT COMPLETED|Overall Study||0
8535938|NCT00284739|21044210|P2|COMPLETED|Overall Study||9
8535939|NCT00284739|21044211|P1|COMPLETED|Overall Study||11
8535940|NCT00284739|21044210|P2|STARTED|Overall Study||9
8535941|NCT00284739|21044211|P1|STARTED|Overall Study||11
8535942|NCT00284557|21044223|P2|NOT COMPLETED|Overall Study||13
8535943|NCT00284557|21044224|P1|NOT COMPLETED|Overall Study||9
8535944|NCT00284557|21044223|P2|COMPLETED|Overall Study||50
8535945|NCT00284557|21044224|P1|COMPLETED|Overall Study||58
8535946|NCT00284557|21044223|P2|STARTED|Overall Study||63
8535947|NCT00284557|21044224|P1|STARTED|Overall Study||67
8535948|NCT00284518|21044236|P4|NOT COMPLETED|Overall Study||33
8535949|NCT00284518|21044237|P3|NOT COMPLETED|Overall Study||28
8535950|NCT00284518|21044238|P2|NOT COMPLETED|Overall Study||28
8535951|NCT00284518|21044239|P1|NOT COMPLETED|Overall Study||26
8535952|NCT00284518|21044236|P4|COMPLETED|Overall Study||61
8535953|NCT00284518|21044237|P3|COMPLETED|Overall Study||67
8535954|NCT00284518|21044238|P2|COMPLETED|Overall Study||66
8535955|NCT00284518|21044239|P1|COMPLETED|Overall Study||71
8535956|NCT00284518|21044236|P4|STARTED|Overall Study||94
8535957|NCT00284518|21044237|P3|STARTED|Overall Study||95
8535958|NCT00284518|21044238|P2|STARTED|Overall Study||94
8535959|NCT00284518|21044239|P1|STARTED|Overall Study||97
8535960|NCT00284180|21044279|P2|NOT COMPLETED|Overall Study||4
8535961|NCT00284180|21044280|P1|NOT COMPLETED|Overall Study||0
8535962|NCT00284180|21044279|P2|COMPLETED|Overall Study||17
8535963|NCT00284180|21044280|P1|COMPLETED|Overall Study||11
8535964|NCT00284180|21044279|P2|STARTED|Overall Study||21
8535965|NCT00284180|21044280|P1|STARTED|Overall Study||11
8535966|NCT00284154|21044286|P1|NOT COMPLETED|Overall Study||42
8535967|NCT00284154|21044286|P1|COMPLETED|Overall Study||9
8535968|NCT00284154|21044286|P1|STARTED|Overall Study||51
8535969|NCT00284141|21044293|P1|NOT COMPLETED|Overall Study||98
8535970|NCT00284141|21044293|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
8535971|NCT00284141|21044293|P1|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
8535972|NCT00284141|21044293|P1|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
8535973|NCT00284141|21044293|P1|STARTED|Overall Study||98
8535974|NCT00284089|21044316|P4|NOT COMPLETED|Extension Phase||12
8535975|NCT00284089|21044317|P3|NOT COMPLETED|Extension Phase||6
8535976|NCT00284089|21044318|P2|NOT COMPLETED|Extension Phase||0
8535977|NCT00284089|21044319|P1|NOT COMPLETED|Extension Phase||2
8535978|NCT00284089|21044316|P4|COMPLETED|Extension Phase||21
8535979|NCT00284089|21044317|P3|COMPLETED|Extension Phase||22
8535980|NCT00284089|21044318|P2|COMPLETED|Extension Phase||6
8535981|NCT00284089|21044319|P1|COMPLETED|Extension Phase||1
8535982|NCT00284089|21044316|P4|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
8535983|NCT00284089|21044317|P3|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
8535984|NCT00284089|21044318|P2|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
8535985|NCT00284089|21044319|P1|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
8535986|NCT00284089|21044316|P4|NOT COMPLETED|Multiple Dose Phase||4
8535987|NCT00284089|21044317|P3|NOT COMPLETED|Multiple Dose Phase||4
8535988|NCT00284089|21044318|P2|NOT COMPLETED|Multiple Dose Phase||0
8535989|NCT00284089|21044319|P1|NOT COMPLETED|Multiple Dose Phase||1
8535990|NCT00284089|21044316|P4|COMPLETED|Multiple Dose Phase||37
8535991|NCT00284089|21044317|P3|COMPLETED|Multiple Dose Phase||31
8535992|NCT00284089|21044318|P2|COMPLETED|Multiple Dose Phase||6
8535993|NCT00284089|21044319|P1|COMPLETED|Multiple Dose Phase||4
8535994|NCT00284089|21044316|P4|STARTED|Multiple Dose Phase||41
8535995|NCT00284089|21044317|P3|STARTED|Multiple Dose Phase||35
8535996|NCT00284089|21044318|P2|STARTED|Multiple Dose Phase||6
8535997|NCT00284089|21044319|P1|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
8535998|NCT00284089|21044316|P4|NOT COMPLETED|Single Dose Phase||0
8535999|NCT00284089|21044317|P3|NOT COMPLETED|Single Dose Phase||0
8536000|NCT00284089|21044318|P2|NOT COMPLETED|Single Dose Phase||0
8536001|NCT00284089|21044319|P1|NOT COMPLETED|Single Dose Phase||0
8536002|NCT00284089|21044316|P4|COMPLETED|Single Dose Phase||0
8536003|NCT00284089|21044317|P3|COMPLETED|Single Dose Phase||0
8536004|NCT00284089|21044318|P2|COMPLETED|Single Dose Phase||6
8536005|NCT00284089|21044319|P1|COMPLETED|Single Dose Phase||6
8536006|NCT00284089|21044316|P4|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
8536007|NCT00284089|21044317|P3|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
8536008|NCT00284089|21044318|P2|STARTED|Single Dose Phase||6
8536009|NCT00284089|21044319|P1|STARTED|Single Dose Phase||6
8536010|NCT00284050|21044348|P3|NOT COMPLETED|Overall Study||9
8536011|NCT00284050|21044349|P2|NOT COMPLETED|Overall Study||5
8536012|NCT00284050|21044350|P1|NOT COMPLETED|Overall Study||5
8536013|NCT00284050|21044348|P3|COMPLETED|Overall Study||40
8536014|NCT00284050|21044349|P2|COMPLETED|Overall Study||46
8536015|NCT00284050|21044350|P1|COMPLETED|Overall Study||46
8536016|NCT00284050|21044348|P3|STARTED|Overall Study||49
8536017|NCT00284050|21044349|P2|STARTED|Overall Study||51
8536018|NCT00284050|21044350|P1|STARTED|Overall Study||51
8536019|NCT00283959|21044364|P1|NOT COMPLETED|Extension Period||1
8536020|NCT00283959|21044364|P1|COMPLETED|Extension Period||3
8536021|NCT00283959|21044364|P1|STARTED|Extension Period||4
8536022|NCT00283959|21044364|P1|NOT COMPLETED|Treatment Period||0
8536023|NCT00283959|21044364|P1|COMPLETED|Treatment Period||4
8536024|NCT00283959|21044364|P1|Pharmacodynamics (PD) Population|Treatment Period||4
8536025|NCT00283959|21044364|P1|Safety Population|Treatment Period||4
8536026|NCT00283959|21044364|P1|STARTED|Treatment Period||4
8536027|NCT00283933|21044369|P1|NOT COMPLETED|Extension Period||0
8536028|NCT00283933|21044369|P1|COMPLETED|Extension Period||5
8536029|NCT00283933|21044369|P1|STARTED|Extension Period||5
8536030|NCT00283933|21044369|P1|NOT COMPLETED|Treatment Period||0
8536031|NCT00283933|21044369|P1|COMPLETED|Treatment Period||5
8536032|NCT00283933|21044369|P1|Pharmacodynamic (PD) Population|Treatment Period||5
8536033|NCT00283933|21044369|P1|Safety Population|Treatment Period||5
8536034|NCT00283933|21044369|P1|STARTED|Treatment Period||5
8536035|NCT00283868|21044376|P2|NOT COMPLETED|Overall Study||8
8536036|NCT00283868|21044377|P1|NOT COMPLETED|Overall Study||7
8536037|NCT00283868|21044376|P2|COMPLETED|Overall Study||103
8536038|NCT00283868|21044377|P1|COMPLETED|Overall Study||104
8536039|NCT00283868|21044376|P2|STARTED|Overall Study||111
8536040|NCT00283868|21044377|P1|STARTED|Overall Study||111
8536041|NCT00283842|21044394|P5|NOT COMPLETED|Overall Study||15
8536042|NCT00283842|21044395|P4|NOT COMPLETED|Overall Study||27
8536043|NCT00283842|21044396|P3|NOT COMPLETED|Overall Study||31
8536044|NCT00283842|21044397|P2|NOT COMPLETED|Overall Study||18
8536045|NCT00283842|21044398|P1|NOT COMPLETED|Overall Study||12
8536046|NCT00283842|21044394|P5|COMPLETED|Overall Study||75
8536047|NCT00283842|21044395|P4|COMPLETED|Overall Study||42
8536048|NCT00283842|21044396|P3|COMPLETED|Overall Study||68
8536049|NCT00283842|21044397|P2|COMPLETED|Overall Study||69
8536050|NCT00283842|21044398|P1|COMPLETED|Overall Study||51
8536051|NCT00283842|21044394|P5|STARTED|Overall Study||90
8536052|NCT00283842|21044395|P4|STARTED|Overall Study||69
8536053|NCT00283842|21044396|P3|STARTED|Overall Study||99
8536054|NCT00283842|21044397|P2|STARTED|Overall Study||87
8536055|NCT00283842|21044398|P1|STARTED|Overall Study||63
8536056|NCT00283816|21044417|P2|NOT COMPLETED|Overall Study||2
8536057|NCT00283816|21044418|P1|NOT COMPLETED|Overall Study||2
8536058|NCT00283816|21044417|P2|COMPLETED|Overall Study||16
8536059|NCT00283816|21044418|P1|COMPLETED|Overall Study||16
8536060|NCT00283816|21044417|P2|STARTED|Overall Study||18
8536061|NCT00283816|21044418|P1|STARTED|Overall Study||18
8536062|NCT00283803|21044430|P1|NOT COMPLETED|Overall Study||13
8536063|NCT00283803|21044430|P1|COMPLETED|Overall Study||19
8536064|NCT00283803|21044430|P1|STARTED|Overall Study||32
8536065|NCT00283712|21044438|P2|NOT COMPLETED|Overall Study||1
8536066|NCT00283712|21044439|P1|NOT COMPLETED|Overall Study||0
8536067|NCT00283712|21044438|P2|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
8536068|NCT00283712|21044439|P1|COMPLETED|Overall Study||10
8536069|NCT00283712|21044438|P2|Per-Protocol Sample|Overall Study||7
8536070|NCT00283712|21044439|P1|Per-Protocol Sample|Overall Study||6
8536071|NCT00283712|21044438|P2|Safety Sample|Overall Study||10
8536072|NCT00283712|21044439|P1|Safety Sample|Overall Study||10
8536073|NCT00283712|21044438|P2|Intent-to-treat Sample|Overall Study||10
8536074|NCT00283712|21044439|P1|Intent-to-treat Sample|Overall Study||10
8536075|NCT00283712|21044438|P2|STARTED|Overall Study||10
8536076|NCT00283712|21044439|P1|STARTED|Overall Study||10
8536077|NCT00283686|21044477|P4|NOT COMPLETED|Overall Study||32
8536078|NCT00283686|21044478|P3|NOT COMPLETED|Overall Study||33
8536079|NCT00283686|21044479|P2|NOT COMPLETED|Overall Study||41
8536080|NCT00283686|21044480|P1|NOT COMPLETED|Overall Study||29
8536081|NCT00283686|21044477|P4|COMPLETED|Overall Study||109
8536082|NCT00283686|21044478|P3|COMPLETED|Overall Study||111
8536083|NCT00283686|21044479|P2|COMPLETED|Overall Study||92
8536084|NCT00283686|21044480|P1|COMPLETED|Overall Study||111
8536085|NCT00283686|21044477|P4|STARTED|Overall Study||141
8536086|NCT00283686|21044478|P3|STARTED|Overall Study||144
8536087|NCT00283686|21044479|P2|STARTED|Overall Study||133
8536088|NCT00283686|21044480|P1|STARTED|Overall Study||140
8536089|NCT00283595|21044524|P2|NOT COMPLETED|Overall Study||2
8536090|NCT00283595|21044525|P1|NOT COMPLETED|Overall Study||1
8536091|NCT00283595|21044524|P2|COMPLETED|Overall Study||9
8536092|NCT00283595|21044525|P1|COMPLETED|Overall Study||9
8536093|NCT00283595|21044524|P2|STARTED|Overall Study||11
8536094|NCT00283595|21044525|P1|STARTED|Overall Study||10
8536095|NCT00283504|21044535|P2|NOT COMPLETED|Overall Study||0
8536096|NCT00283504|21044536|P1|NOT COMPLETED|Overall Study||0
8536097|NCT00283504|21044535|P2|COMPLETED|Overall Study||6
8536098|NCT00283504|21044536|P1|COMPLETED|Overall Study||7
8536099|NCT00283504|21044535|P2|STARTED|Overall Study||6
8536100|NCT00283504|21044536|P1|STARTED|Overall Study||7
8536101|NCT00283439|21044550|P4|NOT COMPLETED|Overall Study||9
8536102|NCT00283439|21044551|P3|NOT COMPLETED|Overall Study||11
8536103|NCT00283439|21044552|P2|NOT COMPLETED|Overall Study||11
8536104|NCT00283439|21044553|P1|NOT COMPLETED|Overall Study||8
8536105|NCT00283439|21044550|P4|COMPLETED|Overall Study||0
8536106|NCT00283439|21044551|P3|COMPLETED|Overall Study||0
8536107|NCT00283439|21044552|P2|COMPLETED|Overall Study||0
8536108|NCT00283439|21044553|P1|COMPLETED|Overall Study||0
8536109|NCT00283439|21044550|P4|STARTED|Overall Study||9
8536110|NCT00283439|21044551|P3|STARTED|Overall Study||11
8536111|NCT00283439|21044552|P2|STARTED|Overall Study||11
8536112|NCT00283439|21044553|P1|STARTED|Overall Study||8
8536113|NCT00283400|21044579|P4|NOT COMPLETED|Overall Study||0
8536114|NCT00283400|21044580|P3|NOT COMPLETED|Overall Study||1
8536115|NCT00283400|21044581|P2|NOT COMPLETED|Overall Study||1
8536116|NCT00283400|21044582|P1|NOT COMPLETED|Overall Study||2
8536117|NCT00283400|21044579|P4|COMPLETED|Overall Study||0
8536118|NCT00283400|21044580|P3|COMPLETED|Overall Study||6
8536119|NCT00283400|21044581|P2|COMPLETED|Overall Study||19
8536120|NCT00283400|21044582|P1|COMPLETED|Overall Study||18
8536121|NCT00283400|21044579|P4|STARTED|Overall Study||0
8536122|NCT00283400|21044580|P3|STARTED|Overall Study||7
8536123|NCT00283400|21044581|P2|STARTED|Overall Study||20
8536124|NCT00283400|21044582|P1|STARTED|Overall Study||20
8536125|NCT00283387|21044600|P2|NOT COMPLETED|Second Intervention||0
8536126|NCT00283387|21044601|P1|NOT COMPLETED|Second Intervention||0
8536127|NCT00283387|21044600|P2|COMPLETED|Second Intervention||5
8536128|NCT00283387|21044601|P1|COMPLETED|Second Intervention||5
8536129|NCT00283387|21044600|P2|STARTED|Second Intervention||5
8536130|NCT00283387|21044601|P1|STARTED|Second Intervention||5
8536131|NCT00283387|21044600|P2|NOT COMPLETED|Washout Period of 2 Months||0
8536132|NCT00283387|21044601|P1|NOT COMPLETED|Washout Period of 2 Months||0
8536133|NCT00283387|21044600|P2|COMPLETED|Washout Period of 2 Months||5
8536134|NCT00283387|21044601|P1|COMPLETED|Washout Period of 2 Months||5
8536135|NCT00283387|21044600|P2|STARTED|Washout Period of 2 Months||5
8536136|NCT00283387|21044601|P1|STARTED|Washout Period of 2 Months||5
8536137|NCT00283387|21044600|P2|NOT COMPLETED|First Intervention||2
8536138|NCT00283387|21044601|P1|NOT COMPLETED|First Intervention||1
8536139|NCT00283387|21044600|P2|COMPLETED|First Intervention||5
8536140|NCT00283387|21044601|P1|COMPLETED|First Intervention||5
8536141|NCT00283387|21044600|P2|STARTED|First Intervention||7
8536142|NCT00283387|21044601|P1|STARTED|First Intervention||6
8536143|NCT00283296|21044607|P1|NOT COMPLETED|Overall Study||5
8536144|NCT00283296|21044607|P1|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
8536145|NCT00283296|21044607|P1|STARTED|Overall Study||14
8536158|NCT00283244|21044638|P3|NOT COMPLETED|Overall Study||51
8536159|NCT00283244|21044639|P2|NOT COMPLETED|Overall Study||51
8536160|NCT00283244|21044640|P1|NOT COMPLETED|Overall Study||18
8536161|NCT00283244|21044638|P3|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
8536162|NCT00283244|21044639|P2|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
8536163|NCT00283244|21044640|P1|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
8536164|NCT00283244|21044638|P3|STARTED|Overall Study||51
8536165|NCT00283244|21044639|P2|STARTED|Overall Study||51
8536166|NCT00283244|21044640|P1|STARTED|Overall Study||44
8536167|NCT00283075|21044660|P2|NOT COMPLETED|Overall Study||0
8536168|NCT00283075|21044661|P1|NOT COMPLETED|Overall Study||0
8536169|NCT00283075|21044660|P2|COMPLETED|Overall Study||6
8536170|NCT00283075|21044661|P1|COMPLETED|Overall Study||25
8536171|NCT00283075|21044660|P2|STARTED|Overall Study||6
8536172|NCT00283075|21044661|P1|STARTED|Overall Study||25
8536173|NCT00283062|21044676|P4|NOT COMPLETED|Overall Study||49
8536174|NCT00283062|21044677|P3|NOT COMPLETED|Overall Study||41
8536175|NCT00283062|21044678|P2|NOT COMPLETED|Overall Study||7
8536176|NCT00283062|21044679|P1|NOT COMPLETED|Overall Study||12
8536177|NCT00283062|21044676|P4|COMPLETED|Overall Study||13
8536178|NCT00283062|21044677|P3|COMPLETED|Overall Study||15
8536179|NCT00283062|21044678|P2|COMPLETED|Overall Study||48
8536180|NCT00283062|21044679|P1|COMPLETED|Overall Study||43
8536181|NCT00283062|21044676|P4|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
8536182|NCT00283062|21044677|P3|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
8536183|NCT00283062|21044678|P2|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
8536184|NCT00283062|21044679|P1|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
8536185|NCT00283062|21044676|P4|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
8536186|NCT00283062|21044677|P3|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
8536187|NCT00283062|21044678|P2|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
8536188|NCT00283062|21044679|P1|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
8536189|NCT00283062|21044676|P4|ADMINISTERED STUDY TREATMENT|Overall Study||17
8536190|NCT00283062|21044677|P3|ADMINISTERED STUDY TREATMENT|Overall Study||20
8536191|NCT00283062|21044678|P2|ADMINISTERED STUDY TREATMENT|Overall Study||51
8536192|NCT00283062|21044679|P1|ADMINISTERED STUDY TREATMENT|Overall Study||50
8536193|NCT00283062|21044676|P4|STARTED|Overall Study||62
8536194|NCT00283062|21044677|P3|STARTED|Overall Study||56
8536195|NCT00283062|21044678|P2|STARTED|Overall Study||55
8536196|NCT00283062|21044679|P1|STARTED|Overall Study||55
8536197|NCT00283049|21044712|P3|NOT COMPLETED|Overall Study||54
8536198|NCT00283049|21044713|P2|NOT COMPLETED|Overall Study||45
8536199|NCT00283049|21044714|P1|NOT COMPLETED|Overall Study||58
8536200|NCT00283049|21044712|P3|COMPLETED|Overall Study||76
8536201|NCT00283049|21044713|P2|COMPLETED|Overall Study||83
8536202|NCT00283049|21044714|P1|COMPLETED|Overall Study||70
8536203|NCT00283049|21044712|P3|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
8536204|NCT00283049|21044713|P2|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
8536205|NCT00283049|21044714|P1|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
8536206|NCT00282984|21044742|P2|NOT COMPLETED|Overall Study||61
8536207|NCT00282984|21044743|P1|NOT COMPLETED|Overall Study||51
8536208|NCT00282984|21044742|P2|COMPLETED|Overall Study||289
8536209|NCT00282984|21044743|P1|COMPLETED|Overall Study||302
8536210|NCT00282984|21044742|P2|STARTED|Overall Study||350
8536211|NCT00282984|21044743|P1|STARTED|Overall Study||353
8536212|NCT00282971|21044769|P2|NOT COMPLETED|Overall Study||22
8536213|NCT00282971|21044770|P1|NOT COMPLETED|Overall Study||34
8536214|NCT00282971|21044769|P2|COMPLETED|Overall Study||149
8536215|NCT00282971|21044770|P1|COMPLETED|Overall Study||146
8536216|NCT00282971|21044769|P2|STARTED|Overall Study||171
8536217|NCT00282971|21044770|P1|STARTED|Overall Study||180
8536218|NCT00282919|21044780|P1|NOT COMPLETED|Overall Study||7
8536219|NCT00282919|21044780|P1|COMPLETED|Overall Study||103
8536220|NCT00282919|21044780|P1|STARTED|Overall Study||110
8536221|NCT00282867|21044795|P3|NOT COMPLETED|Overall Study||0
8536222|NCT00282867|21044796|P2|NOT COMPLETED|Overall Study||1
8536223|NCT00282867|21044797|P1|NOT COMPLETED|Overall Study||1
8536224|NCT00282867|21044795|P3|COMPLETED|Overall Study||25
8536225|NCT00282867|21044796|P2|COMPLETED|Overall Study||24
8536226|NCT00282867|21044797|P1|COMPLETED|Overall Study||23
8536227|NCT00282867|21044795|P3|STARTED|Overall Study||25
8536228|NCT00282867|21044796|P2|STARTED|Overall Study||25
8536229|NCT00282867|21044797|P1|STARTED|Overall Study||24
8536230|NCT00282841|21044811|P1|NOT COMPLETED|Overall Study||0
8536231|NCT00282841|21044811|P1|COMPLETED|Overall Study||61
8536232|NCT00282841|21044811|P1|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61
8536233|NCT00282828|21044819|P3|NOT COMPLETED|Overall Study||9
8536234|NCT00282828|21044820|P2|NOT COMPLETED|Overall Study||12
8536235|NCT00282828|21044821|P1|NOT COMPLETED|Overall Study||6
8536236|NCT00282828|21044819|P3|COMPLETED|Overall Study||50
8536237|NCT00282828|21044820|P2|COMPLETED|Overall Study||47
8536238|NCT00282828|21044821|P1|COMPLETED|Overall Study||57
8536239|NCT00282828|21044819|P3|STARTED|Overall Study||59
8536240|NCT00282828|21044820|P2|STARTED|Overall Study||59
8536241|NCT00282828|21044821|P1|STARTED|Overall Study||63
8536242|NCT00282815|21044834|P2|NOT COMPLETED|Overall Study||6
8536243|NCT00282815|21044835|P1|NOT COMPLETED|Overall Study||7
8536244|NCT00282815|21044834|P2|COMPLETED|Overall Study||11
8536245|NCT00282815|21044835|P1|COMPLETED|Overall Study||8
8536246|NCT00282815|21044834|P2|STARTED|Overall Study||17
8536247|NCT00282815|21044835|P1|STARTED|Overall Study||15
8536248|NCT00282672|21044848|P4|NOT COMPLETED|5 Year: Follow up||5
8536249|NCT00282672|21044849|P3|NOT COMPLETED|5 Year: Follow up||0
8536250|NCT00282672|21044850|P2|NOT COMPLETED|5 Year: Follow up||5
8536251|NCT00282672|21044851|P1|NOT COMPLETED|5 Year: Follow up||1
8536252|NCT00282672|21044848|P4|COMPLETED|5 Year: Follow up||20
8536253|NCT00282672|21044849|P3|COMPLETED|5 Year: Follow up||12
8536254|NCT00282672|21044850|P2|COMPLETED|5 Year: Follow up||27
8536255|NCT00282672|21044851|P1|COMPLETED|5 Year: Follow up||14
8536256|NCT00282672|21044848|P4|STARTED|5 Year: Follow up|11 withdrew|25
8536257|NCT00282672|21044849|P3|STARTED|5 Year: Follow up|3 withdrew|12
8536258|NCT00282672|21044850|P2|STARTED|5 Year: Follow up|7 withdrew|32
8536259|NCT00282672|21044851|P1|STARTED|5 Year: Follow up|1 withdrew|15
8536260|NCT00282672|21044848|P4|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
8536261|NCT00282672|21044849|P3|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
8536262|NCT00282672|21044850|P2|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
8536263|NCT00282672|21044851|P1|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
8536264|NCT00282672|21044848|P4|COMPLETED|2 Year: Sham Crossed Over to RFA||36
8536265|NCT00282672|21044849|P3|COMPLETED|2 Year: Sham Crossed Over to RFA||15
8536266|NCT00282672|21044850|P2|COMPLETED|2 Year: Sham Crossed Over to RFA||39
8536267|NCT00282672|21044851|P1|COMPLETED|2 Year: Sham Crossed Over to RFA||16
8536268|NCT00282672|21044848|P4|STARTED|2 Year: Sham Crossed Over to RFA||38
8536269|NCT00282672|21044849|P3|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
8536270|NCT00282672|21044850|P2|STARTED|2 Year: Sham Crossed Over to RFA||40
8536271|NCT00282672|21044851|P1|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
8536272|NCT00282672|21044848|P4|NOT COMPLETED|1 Year||4
8536273|NCT00282672|21044849|P3|NOT COMPLETED|1 Year||1
8536274|NCT00282672|21044850|P2|NOT COMPLETED|1 Year||2
8536275|NCT00282672|21044851|P1|NOT COMPLETED|1 Year||3
8536276|NCT00282672|21044848|P4|COMPLETED|1 Year||38
8536277|NCT00282672|21044849|P3|COMPLETED|1 Year||20
8536278|NCT00282672|21044850|P2|COMPLETED|1 Year||40
8536279|NCT00282672|21044851|P1|COMPLETED|1 Year||19
8536280|NCT00282672|21044848|P4|STARTED|1 Year||42
8536281|NCT00282672|21044849|P3|STARTED|1 Year||21
8536282|NCT00282672|21044850|P2|STARTED|1 Year||42
8536283|NCT00282672|21044851|P1|STARTED|1 Year||22
8536284|NCT00282568|21044899|P1|NOT COMPLETED|Extended Treatment Period||24
8536285|NCT00282568|21044899|P1|COMPLETED|Extended Treatment Period||42
8536286|NCT00282568|21044899|P1|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
8536287|NCT00282568|21044899|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||3
8536288|NCT00282568|21044899|P1|COMPLETED|Pharmacokinetic Treatment Period||67
8536289|NCT00282568|21044899|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
8536290|NCT00282568|21044899|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||68
8536291|NCT00282568|21044899|P1|STARTED|Pharmacokinetic Treatment Period||70
8536298|NCT00282438|21044976|P2|NOT COMPLETED|Overall Study||1
8536299|NCT00282438|21044977|P1|NOT COMPLETED|Overall Study||1
8536300|NCT00282438|21044976|P2|COMPLETED|Overall Study||0
8536301|NCT00282438|21044977|P1|COMPLETED|Overall Study||0
8536302|NCT00282438|21044976|P2|STARTED|Overall Study||1
8536303|NCT00282438|21044977|P1|STARTED|Overall Study||1
8536304|NCT00282412|21044987|P1|NOT COMPLETED|Overall Study||2
8536305|NCT00282412|21044987|P1|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
8536306|NCT00282412|21044987|P1|STARTED|Overall Study||4
8536307|NCT00282347|21044993|P2|NOT COMPLETED|B Cell Follow-up Period||0
8536308|NCT00282347|21044994|P1|NOT COMPLETED|B Cell Follow-up Period||5
8536309|NCT00282347|21044993|P2|COMPLETED|B Cell Follow-up Period||4
8536310|NCT00282347|21044994|P1|COMPLETED|B Cell Follow-up Period||15
8536311|NCT00282347|21044993|P2|STARTED|B Cell Follow-up Period||4
8536312|NCT00282347|21044994|P1|STARTED|B Cell Follow-up Period||20
8536313|NCT00282347|21044993|P2|NOT COMPLETED|Safety Follow-up Period||6
8536314|NCT00282347|21044994|P1|NOT COMPLETED|Safety Follow-up Period||3
8536315|NCT00282347|21044993|P2|COMPLETED|Safety Follow-up Period||57
8536316|NCT00282347|21044994|P1|COMPLETED|Safety Follow-up Period||64
8536317|NCT00282347|21044993|P2|STARTED|Safety Follow-up Period||63
8536318|NCT00282347|21044994|P1|STARTED|Safety Follow-up Period||67
8536319|NCT00282347|21044993|P2|NOT COMPLETED|Treatment Period||9
8536320|NCT00282347|21044994|P1|NOT COMPLETED|Treatment Period||5
8536321|NCT00282347|21044993|P2|COMPLETED|Treatment Period||63
8536322|NCT00282347|21044994|P1|COMPLETED|Treatment Period||67
8536323|NCT00282347|21044993|P2|STARTED|Treatment Period||72
8536324|NCT00282347|21044994|P1|STARTED|Treatment Period||72
8536325|NCT00282334|21045020|P2|NOT COMPLETED|Overall Study||5
8536326|NCT00282334|21045021|P1|NOT COMPLETED|Overall Study||8
8536327|NCT00282334|21045020|P2|COMPLETED|Overall Study||118
8536328|NCT00282334|21045021|P1|COMPLETED|Overall Study||105
8536329|NCT00282334|21045020|P2|STARTED|Overall Study||123
8536330|NCT00282334|21045021|P1|STARTED|Overall Study||113
8536331|NCT00282308|21045029|P3|NOT COMPLETED|Safety Follow-up Period||19
8536332|NCT00282308|21045030|P2|NOT COMPLETED|Safety Follow-up Period||0
8536333|NCT00282308|21045031|P1|NOT COMPLETED|Safety Follow-up Period||0
8536334|NCT00282308|21045029|P3|COMPLETED|Safety Follow-up Period||81
8536335|NCT00282308|21045030|P2|COMPLETED|Safety Follow-up Period||0
8536336|NCT00282308|21045031|P1|COMPLETED|Safety Follow-up Period||0
8536337|NCT00282308|21045029|P3|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
8536338|NCT00282308|21045030|P2|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
8536339|NCT00282308|21045031|P1|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
8536340|NCT00282308|21045029|P3|NOT COMPLETED|Optional Extension Re-treatment Period||6
8536341|NCT00282308|21045030|P2|NOT COMPLETED|Optional Extension Re-treatment Period||0
8536342|NCT00282308|21045031|P1|NOT COMPLETED|Optional Extension Re-treatment Period||0
8536343|NCT00282308|21045029|P3|COMPLETED|Optional Extension Re-treatment Period||72
8536344|NCT00282308|21045030|P2|COMPLETED|Optional Extension Re-treatment Period||0
8536345|NCT00282308|21045031|P1|COMPLETED|Optional Extension Re-treatment Period||0
8536346|NCT00282308|21045029|P3|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
8536347|NCT00282308|21045030|P2|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
8536348|NCT00282308|21045031|P1|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
8536349|NCT00282308|21045029|P3|NOT COMPLETED|Treatment Period||0
8536350|NCT00282308|21045030|P2|NOT COMPLETED|Treatment Period||6
8536351|NCT00282308|21045031|P1|NOT COMPLETED|Treatment Period||4
8536352|NCT00282308|21045029|P3|COMPLETED|Treatment Period||0
8536353|NCT00282308|21045030|P2|COMPLETED|Treatment Period||28
8536354|NCT00282308|21045031|P1|COMPLETED|Treatment Period||65
8536355|NCT00282308|21045029|P3|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
8536356|NCT00282308|21045030|P2|STARTED|Treatment Period||34
8536357|NCT00282308|21045031|P1|STARTED|Treatment Period||69
8536358|NCT00282295|21045061|P3|NOT COMPLETED|Overall Study||8
8536359|NCT00282295|21045062|P2|NOT COMPLETED|Overall Study||17
8536360|NCT00282295|21045063|P1|NOT COMPLETED|Overall Study||3
8536361|NCT00282295|21045061|P3|COMPLETED|Overall Study||441
8536362|NCT00282295|21045062|P2|COMPLETED|Overall Study||429
8536363|NCT00282295|21045063|P1|COMPLETED|Overall Study||443
8536364|NCT00282295|21045061|P3|STARTED|Overall Study||449
8536365|NCT00282295|21045062|P2|STARTED|Overall Study||446
8536366|NCT00282295|21045063|P1|STARTED|Overall Study||446
8536367|NCT00282282|21045112|P1|NOT COMPLETED|Overall Study||0
8536368|NCT00282282|21045112|P1|COMPLETED|Overall Study||29
8536369|NCT00282282|21045112|P1|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
8536370|NCT00282256|21045118|P1|NOT COMPLETED|Extension Treatment Period||2
8536371|NCT00282256|21045118|P1|COMPLETED|Extension Treatment Period||16
8536372|NCT00282256|21045118|P1|STARTED|Extension Treatment Period||18
8536373|NCT00282256|21045118|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||1
8536374|NCT00282256|21045118|P1|COMPLETED|Pharmacokinetic Treatment Period||18
8536375|NCT00282256|21045118|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
8536376|NCT00282256|21045118|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||19
8536377|NCT00282256|21045118|P1|STARTED|Pharmacokinetic Treatment Period||19
8536378|NCT00282243|21045139|P1|NOT COMPLETED|Extension Treatment Period||22
8536379|NCT00282243|21045139|P1|COMPLETED|Extension Treatment Period||43
8536380|NCT00282243|21045139|P1|STARTED|Extension Treatment Period||65
8536381|NCT00282243|21045139|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||5
8536382|NCT00282243|21045139|P1|COMPLETED|Pharmacokinetic Treatment Period||65
8536383|NCT00282243|21045139|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
8536384|NCT00282243|21045139|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||70
8536385|NCT00282243|21045139|P1|STARTED|Pharmacokinetic Treatment Period||70
8536386|NCT00282152|21045165|P2|NOT COMPLETED|Overall Study||0
8536387|NCT00282152|21045166|P1|NOT COMPLETED|Overall Study||1
8536388|NCT00282152|21045165|P2|COMPLETED|Overall Study||15
8536389|NCT00282152|21045166|P1|COMPLETED|Overall Study||14
8536390|NCT00282152|21045165|P2|STARTED|Overall Study||15
8536391|NCT00282152|21045166|P1|STARTED|Overall Study||15
8536392|NCT00282113|21045187|P3|NOT COMPLETED|Overall Study||0
8536393|NCT00282113|21045188|P2|NOT COMPLETED|Overall Study||0
8536394|NCT00282113|21045189|P1|NOT COMPLETED|Overall Study||1
8536395|NCT00282113|21045187|P3|COMPLETED|Overall Study||29
8536396|NCT00282113|21045188|P2|COMPLETED|Overall Study||30
8536397|NCT00282113|21045189|P1|COMPLETED|Overall Study||30
8536398|NCT00282113|21045187|P3|STARTED|Overall Study||29
8536399|NCT00282113|21045188|P2|STARTED|Overall Study||30
8536400|NCT00282113|21045189|P1|STARTED|Overall Study||31
8536401|NCT00282087|21045203|P1|NOT COMPLETED|Overall Study||1
8536402|NCT00282087|21045203|P1|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
8536403|NCT00282087|21045203|P1|STARTED|Overall Study||47
8536404|NCT00282048|21045216|P1|NOT COMPLETED|Overall Study||62
8536405|NCT00282048|21045216|P1|COMPLETED|Overall Study||0
8536406|NCT00282048|21045216|P1|STARTED|Overall Study||62
8536407|NCT00281957|21045230|P2|NOT COMPLETED|Overall Study||42
8536408|NCT00281957|21045231|P1|NOT COMPLETED|Overall Study||67
8536409|NCT00281957|21045230|P2|COMPLETED|Overall Study||0
8536410|NCT00281957|21045231|P1|COMPLETED|Overall Study||0
8536411|NCT00281957|21045230|P2|Eligible and Received Treatment|Overall Study||39
8536412|NCT00281957|21045231|P1|Eligible and Received Treatment|Overall Study||63
8536413|NCT00281957|21045230|P2|Eligible|Overall Study||40
8536414|NCT00281957|21045231|P1|Eligible|Overall Study||66
8536415|NCT00281957|21045230|P2|STARTED|Overall Study||42
8536416|NCT00281957|21045231|P1|STARTED|Overall Study||67
8536417|NCT00281918|21045245|P2|NOT COMPLETED|Overall Study||108
8536418|NCT00281918|21045246|P1|NOT COMPLETED|Overall Study||142
8536419|NCT00281918|21045245|P2|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
8536420|NCT00281918|21045246|P1|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
8536421|NCT00281918|21045245|P2|Safety Population; Received Study Drug|Overall Study||402
8536422|NCT00281918|21045246|P1|Safety Population; Received Study Drug|Overall Study||398
8536423|NCT00281918|21045245|P2|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
8536424|NCT00281918|21045246|P1|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
8536425|NCT00281879|21045280|P8|NOT COMPLETED|Overall Study||1
8536426|NCT00281879|21045281|P7|NOT COMPLETED|Overall Study||0
8536427|NCT00281879|21045282|P6|NOT COMPLETED|Overall Study||9
8536428|NCT00281879|21045283|P5|NOT COMPLETED|Overall Study||6
8536429|NCT00281879|21045284|P4|NOT COMPLETED|Overall Study||0
8536430|NCT00281879|21045285|P3|NOT COMPLETED|Overall Study||20
8536431|NCT00281879|21045286|P2|NOT COMPLETED|Overall Study||36
8536432|NCT00281879|21045287|P1|NOT COMPLETED|Overall Study||128
8536433|NCT00281879|21045280|P8|COMPLETED|Overall Study||0
8536434|NCT00281879|21045281|P7|COMPLETED|Overall Study||0
8536435|NCT00281879|21045282|P6|COMPLETED|Overall Study||0
8536436|NCT00281879|21045283|P5|COMPLETED|Overall Study||0
8536437|NCT00281879|21045284|P4|COMPLETED|Overall Study||0
8536438|NCT00281879|21045285|P3|COMPLETED|Overall Study||0
8536439|NCT00281879|21045286|P2|COMPLETED|Overall Study||0
8536440|NCT00281879|21045287|P1|COMPLETED|Overall Study||0
8536441|NCT00281879|21045280|P8|STARTED|Overall Study||1
8536442|NCT00281879|21045281|P7|STARTED|Overall Study||0
8536443|NCT00281879|21045282|P6|STARTED|Overall Study||9
8536444|NCT00281879|21045283|P5|STARTED|Overall Study||6
8536445|NCT00281879|21045284|P4|STARTED|Overall Study||0
8536446|NCT00281879|21045285|P3|STARTED|Overall Study||20
8536447|NCT00281879|21045286|P2|STARTED|Overall Study||36
8536448|NCT00281879|21045287|P1|STARTED|Overall Study||128
8536449|NCT00281840|21045305|P1|NOT COMPLETED|Overall Study||25
8536450|NCT00281840|21045305|P1|COMPLETED|Overall Study||5
8536451|NCT00281840|21045305|P1|STARTED|Overall Study||30
8536452|NCT00281827|21045310|P1|NOT COMPLETED|Overall Study||0
8536453|NCT00281827|21045310|P1|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
8536454|NCT00281827|21045310|P1|STARTED|Overall Study||22
8536455|NCT00281697|21045321|P2|NOT COMPLETED|Overall Study||197
8536456|NCT00281697|21045322|P1|NOT COMPLETED|Overall Study||401
8536457|NCT00281697|21045321|P2|COMPLETED|Overall Study||28
8536458|NCT00281697|21045322|P1|COMPLETED|Overall Study||58
8536459|NCT00281697|21045321|P2|STARTED|Overall Study||225
8536460|NCT00281697|21045322|P1|STARTED|Overall Study||459
8536461|NCT00281684|21045342|P4|NOT COMPLETED|Overall Study||0
8536462|NCT00281684|21045343|P3|NOT COMPLETED|Overall Study||1
8536463|NCT00281684|21045344|P2|NOT COMPLETED|Overall Study||0
8536464|NCT00281684|21045345|P1|NOT COMPLETED|Overall Study||1
8536465|NCT00281684|21045342|P4|COMPLETED|Overall Study||38
8536466|NCT00281684|21045343|P3|COMPLETED|Overall Study||33
8536467|NCT00281684|21045344|P2|COMPLETED|Overall Study||36
8536468|NCT00281684|21045345|P1|COMPLETED|Overall Study||36
8536469|NCT00281684|21045342|P4|STARTED|Overall Study||38
8536470|NCT00281684|21045343|P3|STARTED|Overall Study||34
8536471|NCT00281684|21045344|P2|STARTED|Overall Study||36
8536472|NCT00281684|21045345|P1|STARTED|Overall Study||37
8536473|NCT00281671|21045417|P2|NOT COMPLETED|Overall Study||0
8536474|NCT00281671|21045418|P1|NOT COMPLETED|Overall Study||0
8536475|NCT00281671|21045417|P2|COMPLETED|Overall Study||4
8536476|NCT00281671|21045418|P1|COMPLETED|Overall Study||5
8536477|NCT00281671|21045417|P2|STARTED|Overall Study||4
8536478|NCT00281671|21045418|P1|STARTED|Overall Study||5
8536497|NCT00281632|21045451|P1|NOT COMPLETED|Overall Study||36
8536498|NCT00281632|21045451|P1|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
8536499|NCT00281632|21045451|P1|STARTED|Overall Study||36
8536500|NCT00281580|21045493|P16|NOT COMPLETED|Overall Study||13
8536501|NCT00281580|21045494|P15|NOT COMPLETED|Overall Study||7
8536502|NCT00281580|21045495|P14|NOT COMPLETED|Overall Study||7
8536503|NCT00281580|21045496|P13|NOT COMPLETED|Overall Study||13
8536504|NCT00281580|21045497|P12|NOT COMPLETED|Overall Study||10
8536505|NCT00281580|21045498|P11|NOT COMPLETED|Overall Study||4
8536506|NCT00281580|21045499|P10|NOT COMPLETED|Overall Study||12
8536507|NCT00281580|21045500|P9|NOT COMPLETED|Overall Study||8
8536508|NCT00281580|21045501|P8|NOT COMPLETED|Overall Study||1
8536509|NCT00281580|21045502|P7|NOT COMPLETED|Overall Study||5
8536510|NCT00281580|21045503|P6|NOT COMPLETED|Overall Study||3
8536511|NCT00281580|21045504|P5|NOT COMPLETED|Overall Study||4
8536512|NCT00281580|21045505|P4|NOT COMPLETED|Overall Study||17
8536513|NCT00281580|21045506|P3|NOT COMPLETED|Overall Study||5
8536514|NCT00281580|21045507|P2|NOT COMPLETED|Overall Study||1
8536515|NCT00281580|21045508|P1|NOT COMPLETED|Overall Study||7
8536516|NCT00281580|21045493|P16|COMPLETED|Overall Study||116
8536517|NCT00281580|21045494|P15|COMPLETED|Overall Study||133
8536518|NCT00281580|21045495|P14|COMPLETED|Overall Study||43
8536519|NCT00281580|21045496|P13|COMPLETED|Overall Study||129
8536520|NCT00281580|21045497|P12|COMPLETED|Overall Study||136
8536521|NCT00281580|21045498|P11|COMPLETED|Overall Study||44
8536522|NCT00281580|21045499|P10|COMPLETED|Overall Study||117
8536523|NCT00281580|21045500|P9|COMPLETED|Overall Study||135
8536524|NCT00281580|21045501|P8|COMPLETED|Overall Study||46
8536525|NCT00281580|21045502|P7|COMPLETED|Overall Study||39
8536526|NCT00281580|21045503|P6|COMPLETED|Overall Study||43
8536527|NCT00281580|21045504|P5|COMPLETED|Overall Study||40
8536528|NCT00281580|21045505|P4|COMPLETED|Overall Study||118
8536529|NCT00281580|21045506|P3|COMPLETED|Overall Study||125
8536530|NCT00281580|21045507|P2|COMPLETED|Overall Study||41
8536531|NCT00281580|21045508|P1|COMPLETED|Overall Study||39
8536532|NCT00281580|21045493|P16|STARTED|Overall Study||129
8536533|NCT00281580|21045494|P15|STARTED|Overall Study||140
8536534|NCT00281580|21045495|P14|STARTED|Overall Study||50
8536535|NCT00281580|21045496|P13|STARTED|Overall Study||142
8536536|NCT00281580|21045497|P12|STARTED|Overall Study||146
8536537|NCT00281580|21045498|P11|STARTED|Overall Study||48
8536538|NCT00281580|21045499|P10|STARTED|Overall Study||129
8536539|NCT00281580|21045500|P9|STARTED|Overall Study||143
8536540|NCT00281580|21045501|P8|STARTED|Overall Study||47
8536541|NCT00281580|21045502|P7|STARTED|Overall Study||44
8536542|NCT00281580|21045503|P6|STARTED|Overall Study||46
8536543|NCT00281580|21045504|P5|STARTED|Overall Study||44
8536544|NCT00281580|21045505|P4|STARTED|Overall Study||135
8536545|NCT00281580|21045506|P3|STARTED|Overall Study||130
8536546|NCT00281580|21045507|P2|STARTED|Overall Study||42
8536547|NCT00281580|21045508|P1|STARTED|Overall Study||46
8536548|NCT00281528|21045855|P3|NOT COMPLETED|Overall Study||79
8536549|NCT00281528|21045856|P2|NOT COMPLETED|Overall Study||54
8536550|NCT00281528|21045857|P1|NOT COMPLETED|Overall Study||75
8536551|NCT00281528|21045855|P3|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
8536552|NCT00281528|21045856|P2|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
8536553|NCT00281528|21045857|P1|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
8536554|NCT00281528|21045855|P3|STARTED|Overall Study||79
8536555|NCT00281528|21045856|P2|STARTED|Overall Study||54
8536556|NCT00281528|21045857|P1|STARTED|Overall Study||75
8536557|NCT00281463|21045901|P1|NOT COMPLETED|Overall Study||0
8536558|NCT00281463|21045901|P1|COMPLETED|Overall Study||45
8536559|NCT00281463|21045901|P1|STARTED|Overall Study||45
8536560|NCT00281320|21045908|P2|NOT COMPLETED|Overall Study||21
8536561|NCT00281320|21045909|P1|NOT COMPLETED|Overall Study||25
8536562|NCT00281320|21045908|P2|COMPLETED|Overall Study||40
8536563|NCT00281320|21045909|P1|COMPLETED|Overall Study||36
8536564|NCT00281320|21045908|P2|STARTED|Overall Study||61
8536565|NCT00281320|21045909|P1|STARTED|Overall Study||61
8536566|NCT00281099|21045931|P2|NOT COMPLETED|Overall Study||222
8536567|NCT00281099|21045932|P1|NOT COMPLETED|Overall Study||205
8536568|NCT00281099|21045931|P2|COMPLETED|Overall Study||296
8536569|NCT00281099|21045932|P1|COMPLETED|Overall Study||308
8536570|NCT00281099|21045931|P2|STARTED|Overall Study||518
8536571|NCT00281099|21045932|P1|STARTED|Overall Study||513
8536572|NCT00281021|21045973|P1|NOT COMPLETED|Overall Study||2
8536573|NCT00281021|21045973|P1|COMPLETED|Overall Study||24
8536574|NCT00281021|21045973|P1|STARTED|Overall Study||26
8536575|NCT00280917|21045981|P4|NOT COMPLETED|Overall Study||2
8536576|NCT00280917|21045982|P3|NOT COMPLETED|Overall Study||6
8536577|NCT00280917|21045983|P2|NOT COMPLETED|Overall Study||6
8536578|NCT00280917|21045984|P1|NOT COMPLETED|Overall Study||2
8536579|NCT00280917|21045981|P4|COMPLETED|Overall Study||61
8536580|NCT00280917|21045982|P3|COMPLETED|Overall Study||57
8536581|NCT00280917|21045983|P2|COMPLETED|Overall Study||57
8536582|NCT00280917|21045984|P1|COMPLETED|Overall Study||63
8536583|NCT00280917|21045981|P4|STARTED|Overall Study||63
8536584|NCT00280917|21045982|P3|STARTED|Overall Study||63
8536585|NCT00280917|21045983|P2|STARTED|Overall Study||63
8536586|NCT00280917|21045984|P1|STARTED|Overall Study||65
8536587|NCT00280904|21045994|P1|NOT COMPLETED|Overall Study||0
8536588|NCT00280904|21045994|P1|COMPLETED|Overall Study||433
8536589|NCT00280904|21045994|P1|STARTED|Overall Study||433
8536590|NCT00280826|21045999|P1|NOT COMPLETED|Overall Study||0
8536591|NCT00280826|21045999|P1|COMPLETED|Overall Study||6
8536592|NCT00280826|21045999|P1|STARTED|Overall Study||6
8536593|NCT00280748|21046007|P1|NOT COMPLETED|Overall Study||4
8536594|NCT00280748|21046007|P1|COMPLETED|Overall Study||6
8536595|NCT00280748|21046007|P1|STARTED|Overall Study||10
8536596|NCT00280735|21046017|P1|NOT COMPLETED|Overall Study||18
8536597|NCT00280735|21046017|P1|COMPLETED|Overall Study||57
8536598|NCT00280735|21046017|P1|Received Adequate Exposure|Overall Study||57
8536599|NCT00280735|21046017|P1|Received Treatment|Overall Study||72
8536600|NCT00280735|21046017|P1|STARTED|Overall Study||75
8536601|NCT00280683|21046029|P2|NOT COMPLETED|Overall Study||3
8536602|NCT00280683|21046030|P1|NOT COMPLETED|Overall Study||2
8536603|NCT00280683|21046029|P2|COMPLETED|Overall Study||7
8536604|NCT00280683|21046030|P1|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
8536605|NCT00280683|21046029|P2|STARTED|Overall Study||10
8536606|NCT00280683|21046030|P1|STARTED|Overall Study||10
8536625|NCT00280397|21046067|P1|NOT COMPLETED|Overall Study||1
8536626|NCT00280397|21046067|P1|COMPLETED|Overall Study||26
8536627|NCT00280397|21046067|P1|STARTED|Overall Study||27
8536628|NCT00280384|21046082|P8|NOT COMPLETED|Overall Study||0
8536629|NCT00280384|21046083|P7|NOT COMPLETED|Overall Study||0
8536630|NCT00280384|21046084|P6|NOT COMPLETED|Overall Study||0
8536631|NCT00280384|21046085|P5|NOT COMPLETED|Overall Study||0
8536632|NCT00280384|21046086|P4|NOT COMPLETED|Overall Study||0
8536633|NCT00280384|21046087|P3|NOT COMPLETED|Overall Study||0
8536634|NCT00280384|21046088|P2|NOT COMPLETED|Overall Study||0
8536635|NCT00280384|21046089|P1|NOT COMPLETED|Overall Study||0
8536636|NCT00280384|21046082|P8|COMPLETED|Overall Study||6
8536637|NCT00280384|21046083|P7|COMPLETED|Overall Study||6
8536638|NCT00280384|21046084|P6|COMPLETED|Overall Study||6
8536639|NCT00280384|21046085|P5|COMPLETED|Overall Study||6
8536640|NCT00280384|21046086|P4|COMPLETED|Overall Study||6
8536641|NCT00280384|21046087|P3|COMPLETED|Overall Study||6
8536642|NCT00280384|21046088|P2|COMPLETED|Overall Study||6
8536643|NCT00280384|21046089|P1|COMPLETED|Overall Study||6
8536644|NCT00280384|21046082|P8|STARTED|Overall Study||6
8536645|NCT00280384|21046083|P7|STARTED|Overall Study||6
8536646|NCT00280384|21046084|P6|STARTED|Overall Study||6
8536647|NCT00280384|21046085|P5|STARTED|Overall Study||6
8536648|NCT00280384|21046086|P4|STARTED|Overall Study||6
8536649|NCT00280384|21046087|P3|STARTED|Overall Study||6
8536650|NCT00280384|21046088|P2|STARTED|Overall Study||6
8536651|NCT00280384|21046089|P1|STARTED|Overall Study||6
8536652|NCT00280293|21046133|P2|NOT COMPLETED|Overall Study||23
8536653|NCT00280293|21046134|P1|NOT COMPLETED|Overall Study||26
8536654|NCT00280293|21046133|P2|COMPLETED|Overall Study||34
8536655|NCT00280293|21046134|P1|COMPLETED|Overall Study||29
8536656|NCT00280293|21046133|P2|STARTED|Overall Study||57
8536657|NCT00280293|21046134|P1|STARTED|Overall Study||55
8536658|NCT00280241|21046146|P1|NOT COMPLETED|Overall Study||10
8536659|NCT00280241|21046146|P1|COMPLETED|Overall Study||55
8536660|NCT00280241|21046146|P1|STARTED|Overall Study||65
8536661|NCT00280150|21046157|P4|NOT COMPLETED|Overall Study||10
8536662|NCT00280150|21046158|P3|NOT COMPLETED|Overall Study||5
8536663|NCT00280150|21046159|P2|NOT COMPLETED|Overall Study||1
8536664|NCT00280150|21046160|P1|NOT COMPLETED|Overall Study||3
8536665|NCT00280150|21046157|P4|COMPLETED|Overall Study||20
8536666|NCT00280150|21046158|P3|COMPLETED|Overall Study||1
8536667|NCT00280150|21046159|P2|COMPLETED|Overall Study||4
8536668|NCT00280150|21046160|P1|COMPLETED|Overall Study||2
8536669|NCT00280150|21046157|P4|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
8536670|NCT00280150|21046158|P3|Consolidation Therapy|Overall Study||3
8536671|NCT00280150|21046159|P2|Consolidation Therapy|Overall Study||5
8536672|NCT00280150|21046160|P1|Consolidation Therapy|Overall Study||2
8536673|NCT00280150|21046157|P4|Cohort Induction|Overall Study||30
8536674|NCT00280150|21046158|P3|Cohort Induction|Overall Study||6
8536675|NCT00280150|21046159|P2|Cohort Induction|Overall Study||5
8536676|NCT00280150|21046160|P1|Cohort Induction|Overall Study||5
8536677|NCT00280150|21046157|P4|STARTED|Overall Study||30
8536678|NCT00280150|21046158|P3|STARTED|Overall Study||6
8536679|NCT00280150|21046159|P2|STARTED|Overall Study||5
8536680|NCT00280150|21046160|P1|STARTED|Overall Study||5
8536681|NCT00279955|21046176|P3|NOT COMPLETED|Overall Study||0
8536682|NCT00279955|21046177|P2|NOT COMPLETED|Overall Study||0
8536683|NCT00279955|21046178|P1|NOT COMPLETED|Overall Study||0
8536684|NCT00279955|21046176|P3|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
8536685|NCT00279955|21046177|P2|COMPLETED|Overall Study||486
8536686|NCT00279955|21046178|P1|COMPLETED|Overall Study||157
8536687|NCT00279955|21046176|P3|STARTED|Overall Study||358
8536688|NCT00279955|21046177|P2|STARTED|Overall Study||486
8536689|NCT00279955|21046178|P1|STARTED|Overall Study||157
8536690|NCT00279916|21046191|P2|NOT COMPLETED|Overall Study||5
8536691|NCT00279916|21046192|P1|NOT COMPLETED|Overall Study||7
8536692|NCT00279916|21046191|P2|COMPLETED|Overall Study||41
8536693|NCT00279916|21046192|P1|COMPLETED|Overall Study||38
8536694|NCT00279916|21046191|P2|STARTED|Overall Study||46
8536695|NCT00279916|21046192|P1|STARTED|Overall Study||45
8536696|NCT00279812|21046218|P6|NOT COMPLETED|Overall Study||1
8536697|NCT00279812|21046219|P5|NOT COMPLETED|Overall Study||3
8536698|NCT00279812|21046220|P4|NOT COMPLETED|Overall Study||0
8536699|NCT00279812|21046221|P3|NOT COMPLETED|Overall Study||3
8536700|NCT00279812|21046222|P2|NOT COMPLETED|Overall Study||6
8536701|NCT00279812|21046223|P1|NOT COMPLETED|Overall Study||1
8536702|NCT00279812|21046218|P6|COMPLETED|Overall Study||18
8536703|NCT00279812|21046219|P5|COMPLETED|Overall Study||17
8536704|NCT00279812|21046220|P4|COMPLETED|Overall Study||23
8536705|NCT00279812|21046221|P3|COMPLETED|Overall Study||21
8536706|NCT00279812|21046222|P2|COMPLETED|Overall Study||20
8536707|NCT00279812|21046223|P1|COMPLETED|Overall Study||20
8536708|NCT00279812|21046218|P6|STARTED|Overall Study||19
8536709|NCT00279812|21046219|P5|STARTED|Overall Study||20
8536710|NCT00279812|21046220|P4|STARTED|Overall Study||23
8536711|NCT00279812|21046221|P3|STARTED|Overall Study||24
8536712|NCT00279812|21046222|P2|STARTED|Overall Study||26
8536713|NCT00279812|21046223|P1|STARTED|Overall Study||21
8536714|NCT00279708|21046251|P2|NOT COMPLETED|Overall Study||4
8536715|NCT00279708|21046252|P1|NOT COMPLETED|Overall Study||3
8536716|NCT00279708|21046251|P2|COMPLETED|Overall Study||24
8536717|NCT00279708|21046252|P1|COMPLETED|Overall Study||24
8536718|NCT00279708|21046251|P2|STARTED|Overall Study||28
8536719|NCT00279708|21046252|P1|STARTED|Overall Study|"Started meaning randomized"|27
8536720|NCT00279591|21046260|P2|NOT COMPLETED|Overall Study||0
8536721|NCT00279591|21046261|P1|NOT COMPLETED|Overall Study||0
8536722|NCT00279591|21046260|P2|COMPLETED|Overall Study||46
8536723|NCT00279591|21046261|P1|COMPLETED|Overall Study||48
8536724|NCT00279591|21046260|P2|STARTED|Overall Study||46
8536725|NCT00279591|21046261|P1|STARTED|Overall Study||48
8536726|NCT00279500|21046275|P1|NOT COMPLETED|Overall Study||0
8536727|NCT00279500|21046275|P1|COMPLETED|Overall Study|6 patients treated|6
8536728|NCT00279500|21046275|P1|STARTED|Overall Study|6 patients treated|6
8536729|NCT00279409|21046281|P2|NOT COMPLETED|Overall Study||0
8536730|NCT00279409|21046282|P1|NOT COMPLETED|Overall Study||0
8536731|NCT00279409|21046281|P2|COMPLETED|Overall Study||0
8536732|NCT00279409|21046282|P1|COMPLETED|Overall Study||0
8536733|NCT00279409|21046281|P2|STARTED|Overall Study||0
8536734|NCT00279409|21046282|P1|STARTED|Overall Study||0
8536735|NCT00279305|21046290|P2|NOT COMPLETED|Overall Study||1
8536736|NCT00279305|21046291|P1|NOT COMPLETED|Overall Study||8
8536737|NCT00279305|21046290|P2|COMPLETED|Overall Study||29
8536738|NCT00279305|21046291|P1|COMPLETED|Overall Study||49
8536739|NCT00279305|21046290|P2|STARTED|Overall Study||30
8536740|NCT00279305|21046291|P1|STARTED|Overall Study||57
8536741|NCT00279214|21046299|P2|NOT COMPLETED|Overall Study||2
8536742|NCT00279214|21046300|P1|NOT COMPLETED|Overall Study||3
8536743|NCT00279214|21046299|P2|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
8536744|NCT00279214|21046300|P1|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
8536745|NCT00279214|21046299|P2|STARTED|Overall Study||21
8536746|NCT00279214|21046300|P1|STARTED|Overall Study||22
8536747|NCT00279201|21046330|P6|NOT COMPLETED|Intensification Addendum||37
8536748|NCT00279201|21046331|P5|NOT COMPLETED|Intensification Addendum||29
8536749|NCT00279201|21046332|P4|NOT COMPLETED|Intensification Addendum||28
8536750|NCT00279201|21046333|P3|NOT COMPLETED|Intensification Addendum||23
8536751|NCT00279201|21046334|P2|NOT COMPLETED|Intensification Addendum||0
8536752|NCT00279201|21046335|P1|NOT COMPLETED|Intensification Addendum||0
8536753|NCT00279201|21046330|P6|COMPLETED|Intensification Addendum||162
8536754|NCT00279201|21046331|P5|COMPLETED|Intensification Addendum||142
8536755|NCT00279201|21046332|P4|COMPLETED|Intensification Addendum||172
8536756|NCT00279201|21046333|P3|COMPLETED|Intensification Addendum||151
8536757|NCT00279201|21046334|P2|COMPLETED|Intensification Addendum||0
8536758|NCT00279201|21046335|P1|COMPLETED|Intensification Addendum||0
8536759|NCT00279201|21046330|P6|STARTED|Intensification Addendum||199
8536760|NCT00279201|21046331|P5|STARTED|Intensification Addendum||171
8536761|NCT00279201|21046332|P4|STARTED|Intensification Addendum||200
8536762|NCT00279201|21046333|P3|STARTED|Intensification Addendum||174
8536763|NCT00279201|21046334|P2|STARTED|Intensification Addendum||0
8536764|NCT00279201|21046335|P1|STARTED|Intensification Addendum||0
8536765|NCT00279201|21046330|P6|NOT COMPLETED|Maintenance||0
8536766|NCT00279201|21046331|P5|NOT COMPLETED|Maintenance||0
8536767|NCT00279201|21046332|P4|NOT COMPLETED|Maintenance||0
8536768|NCT00279201|21046333|P3|NOT COMPLETED|Maintenance||0
8536769|NCT00279201|21046334|P2|NOT COMPLETED|Maintenance||234
8536770|NCT00279201|21046335|P1|NOT COMPLETED|Maintenance||231
8536771|NCT00279201|21046330|P6|COMPLETED|Maintenance||0
8536772|NCT00279201|21046331|P5|COMPLETED|Maintenance||0
8536773|NCT00279201|21046332|P4|COMPLETED|Maintenance||0
8536774|NCT00279201|21046333|P3|COMPLETED|Maintenance||0
8536775|NCT00279201|21046334|P2|COMPLETED|Maintenance||239
8536776|NCT00279201|21046335|P1|COMPLETED|Maintenance||188
8536777|NCT00279201|21046330|P6|STARTED|Maintenance||0
8536778|NCT00279201|21046331|P5|STARTED|Maintenance||0
8536779|NCT00279201|21046332|P4|STARTED|Maintenance||0
8536780|NCT00279201|21046333|P3|STARTED|Maintenance||0
8536781|NCT00279201|21046334|P2|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
8536782|NCT00279201|21046335|P1|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
8536783|NCT00279201|21046330|P6|NOT COMPLETED|Initiation||0
8536784|NCT00279201|21046331|P5|NOT COMPLETED|Initiation||0
8536785|NCT00279201|21046332|P4|NOT COMPLETED|Initiation||0
8536786|NCT00279201|21046333|P3|NOT COMPLETED|Initiation||0
8536787|NCT00279201|21046334|P2|NOT COMPLETED|Initiation||145
8536788|NCT00279201|21046335|P1|NOT COMPLETED|Initiation||128
8536789|NCT00279201|21046330|P6|COMPLETED|Initiation||0
8536790|NCT00279201|21046331|P5|COMPLETED|Initiation||0
8536791|NCT00279201|21046332|P4|COMPLETED|Initiation||0
8536792|NCT00279201|21046333|P3|COMPLETED|Initiation||0
8536793|NCT00279201|21046334|P2|COMPLETED|Initiation||900
8536794|NCT00279201|21046335|P1|COMPLETED|Initiation||918
8536795|NCT00279201|21046330|P6|STARTED|Initiation||0
8536796|NCT00279201|21046331|P5|STARTED|Initiation||0
8536797|NCT00279201|21046332|P4|STARTED|Initiation||0
8536798|NCT00279201|21046333|P3|STARTED|Initiation||0
8536799|NCT00279201|21046334|P2|STARTED|Initiation||1045
8536800|NCT00279201|21046335|P1|STARTED|Initiation||1046
8536801|NCT00278993|21046479|P1|NOT COMPLETED|Overall Study||107
8536802|NCT00278993|21046479|P1|COMPLETED|Overall Study||1
8536803|NCT00278993|21046479|P1|STARTED|Overall Study||108
8536804|NCT00278954|21046487|P1|NOT COMPLETED|Overall Study||5
8536805|NCT00278954|21046487|P1|COMPLETED|Overall Study||45
8536806|NCT00278954|21046487|P1|STARTED|Overall Study||50
8536810|NCT00278889|21046531|P3|NOT COMPLETED|Overall Study||20
8536811|NCT00278889|21046532|P2|NOT COMPLETED|Overall Study||27
8536812|NCT00278889|21046533|P1|NOT COMPLETED|Overall Study||25
8536813|NCT00278889|21046531|P3|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
8536814|NCT00278889|21046532|P2|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
8536815|NCT00278889|21046533|P1|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
8536816|NCT00278889|21046531|P3|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
8536817|NCT00278889|21046532|P2|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
8536818|NCT00278889|21046533|P1|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
8536819|NCT00278889|21046531|P3|STARTED|Overall Study|Randomised|68
8536820|NCT00278889|21046532|P2|STARTED|Overall Study|Randomised|74
8536821|NCT00278889|21046533|P1|STARTED|Overall Study|Randomised|73
8536822|NCT00278876|21046559|P1|NOT COMPLETED|Overall Study||9
8536823|NCT00278876|21046559|P1|COMPLETED|Overall Study||38
8536824|NCT00278876|21046559|P1|STARTED|Overall Study||47
8536825|NCT00278863|21046567|P2|NOT COMPLETED|Overall Study||2
8536826|NCT00278863|21046568|P1|NOT COMPLETED|Overall Study||5
8536827|NCT00278863|21046567|P2|COMPLETED|Overall Study||45
8536828|NCT00278863|21046568|P1|COMPLETED|Overall Study||44
8536829|NCT00278863|21046567|P2|STARTED|Overall Study||47
8536830|NCT00278863|21046568|P1|STARTED|Overall Study||49
8536831|NCT00278655|21046576|P1|NOT COMPLETED|Overall Study||0
8536832|NCT00278655|21046576|P1|COMPLETED|Overall Study||21
8536833|NCT00278655|21046576|P1|STARTED|Overall Study||21
8536834|NCT00278629|21046581|P1|NOT COMPLETED|Overall Study||14
8536835|NCT00278629|21046581|P1|COMPLETED|Overall Study||66
8536836|NCT00278629|21046581|P1|STARTED|Overall Study||80
8536837|NCT00278564|21046588|P1|NOT COMPLETED|Overall Study||4
8536838|NCT00278564|21046588|P1|COMPLETED|Overall Study||3
8536839|NCT00278564|21046588|P1|STARTED|Overall Study||7
8536840|NCT00278538|21046592|P1|NOT COMPLETED|Overall Study||2
8536841|NCT00278538|21046592|P1|COMPLETED|Overall Study||30
8536842|NCT00278538|21046592|P1|STARTED|Overall Study||32
8536843|NCT00278525|21046598|P2|NOT COMPLETED|Overall Study||0
8536844|NCT00278525|21046599|P1|NOT COMPLETED|Overall Study||0
8536845|NCT00278525|21046598|P2|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
8536846|NCT00278525|21046599|P1|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
8536847|NCT00278525|21046598|P2|STARTED|Overall Study||10
8536848|NCT00278525|21046599|P1|STARTED|Overall Study||9
8536849|NCT00278512|21046609|P2|NOT COMPLETED|Overall Study||0
8536850|NCT00278512|21046610|P1|NOT COMPLETED|Overall Study||1
8536851|NCT00278512|21046609|P2|COMPLETED|Overall Study||0
8536852|NCT00278512|21046610|P1|COMPLETED|Overall Study||6
8536853|NCT00278512|21046609|P2|STARTED|Overall Study||0
8536854|NCT00278512|21046610|P1|STARTED|Overall Study||7
8536855|NCT00278473|21046618|P2|NOT COMPLETED|Overall Study||3
8536856|NCT00278473|21046619|P1|NOT COMPLETED|Overall Study||4
8536857|NCT00278473|21046618|P2|COMPLETED|Overall Study||40
8536858|NCT00278473|21046619|P1|COMPLETED|Overall Study||41
8536859|NCT00278473|21046618|P2|STARTED|Overall Study||43
8536860|NCT00278473|21046619|P1|STARTED|Overall Study||45
8536861|NCT00278395|21046635|P1|NOT COMPLETED|Overall Study||3
8536862|NCT00278395|21046635|P1|COMPLETED|Overall Study||11
8536863|NCT00278395|21046635|P1|STARTED|Overall Study||14
8536864|NCT00278343|21046642|P1|NOT COMPLETED|Overall Study||0
8536865|NCT00278343|21046642|P1|COMPLETED|Overall Study||74
8536866|NCT00278343|21046642|P1|STARTED|Overall Study||74
8536867|NCT00278200|21046653|P2|NOT COMPLETED|Overall Study||4
8536868|NCT00278200|21046654|P1|NOT COMPLETED|Overall Study||1
8536869|NCT00278200|21046653|P2|COMPLETED|Overall Study||8
8536870|NCT00278200|21046654|P1|COMPLETED|Overall Study||1
8536871|NCT00278200|21046653|P2|STARTED|Overall Study||12
8536872|NCT00278200|21046654|P1|STARTED|Overall Study||2
8536873|NCT00278161|21046663|P1|NOT COMPLETED|Overall Study||11
8536874|NCT00278161|21046663|P1|COMPLETED|Overall Study||70
8536875|NCT00278161|21046663|P1|STARTED|Overall Study||81
8536876|NCT00278148|21046669|P3|NOT COMPLETED|Phase II - Expansion Phase||6
8536877|NCT00278148|21046670|P2|NOT COMPLETED|Phase II - Expansion Phase||0
8536878|NCT00278148|21046671|P1|NOT COMPLETED|Phase II - Expansion Phase||0
8536879|NCT00278148|21046669|P3|COMPLETED|Phase II - Expansion Phase||20
8536880|NCT00278148|21046670|P2|COMPLETED|Phase II - Expansion Phase||0
8536881|NCT00278148|21046671|P1|COMPLETED|Phase II - Expansion Phase||0
8536882|NCT00278148|21046669|P3|STARTED|Phase II - Expansion Phase|Includes the 3 participants from phase I|26
8536883|NCT00278148|21046670|P2|STARTED|Phase II - Expansion Phase||0
8536884|NCT00278148|21046671|P1|STARTED|Phase II - Expansion Phase||0
8536885|NCT00278148|21046669|P3|NOT COMPLETED|Phase I - Dose Escalation||0
8536886|NCT00278148|21046670|P2|NOT COMPLETED|Phase I - Dose Escalation||0
8536887|NCT00278148|21046671|P1|NOT COMPLETED|Phase I - Dose Escalation||0
8536888|NCT00278148|21046669|P3|COMPLETED|Phase I - Dose Escalation||3
8536889|NCT00278148|21046670|P2|COMPLETED|Phase I - Dose Escalation||2
8536890|NCT00278148|21046671|P1|COMPLETED|Phase I - Dose Escalation||4
8536891|NCT00278148|21046669|P3|STARTED|Phase I - Dose Escalation||3
8536892|NCT00278148|21046670|P2|STARTED|Phase I - Dose Escalation||2
8536893|NCT00278148|21046671|P1|STARTED|Phase I - Dose Escalation||4
8536894|NCT00278109|21046683|P1|NOT COMPLETED|Overall Study||4
8536895|NCT00278109|21046683|P1|COMPLETED|Overall Study||21
8536896|NCT00278109|21046683|P1|Completed 3 Cycles of Chemotherapy|Overall Study||25
8536897|NCT00278109|21046683|P1|STARTED|Overall Study||25
8536898|NCT00277524|21046687|P4|NOT COMPLETED|Overall Study||0
8536899|NCT00277524|21046688|P3|NOT COMPLETED|Overall Study||0
8536900|NCT00277524|21046689|P2|NOT COMPLETED|Overall Study||0
8536901|NCT00277524|21046690|P1|NOT COMPLETED|Overall Study||0
8536902|NCT00277524|21046687|P4|COMPLETED|Overall Study||850
8536903|NCT00277524|21046688|P3|COMPLETED|Overall Study||1088
8536904|NCT00277524|21046689|P2|COMPLETED|Overall Study||324
8536905|NCT00277524|21046690|P1|COMPLETED|Overall Study||621
8536906|NCT00277524|21046687|P4|STARTED|Overall Study||850
8536907|NCT00277524|21046688|P3|STARTED|Overall Study||1088
8536908|NCT00277524|21046689|P2|STARTED|Overall Study||324
8536909|NCT00277524|21046690|P1|STARTED|Overall Study||621
8536910|NCT00277446|21046708|P1|NOT COMPLETED|Overall Study||0
8536911|NCT00277446|21046708|P1|COMPLETED|Overall Study||13
8536912|NCT00277446|21046708|P1|STARTED|Overall Study||13
8536913|NCT00277394|21046716|P2|NOT COMPLETED|Overall Study||24
8536914|NCT00277394|21046717|P1|NOT COMPLETED|Overall Study||37
8536915|NCT00277394|21046716|P2|COMPLETED|Overall Study||246
8536916|NCT00277394|21046717|P1|COMPLETED|Overall Study||232
8536917|NCT00277394|21046716|P2|STARTED|Overall Study||270
8536918|NCT00277394|21046717|P1|STARTED|Overall Study||269
8536919|NCT00277355|21046729|P2|NOT COMPLETED|Overall Study||5
8536920|NCT00277355|21046730|P1|NOT COMPLETED|Overall Study||14
8536921|NCT00277355|21046729|P2|COMPLETED|Overall Study||22
8536922|NCT00277355|21046730|P1|COMPLETED|Overall Study||73
8536923|NCT00277355|21046729|P2|STARTED|Overall Study||27
8536924|NCT00277355|21046730|P1|STARTED|Overall Study||87
8536925|NCT00277212|21046738|P3|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
8536926|NCT00277212|21046739|P2|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
8536927|NCT00277212|21046740|P1|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
8536928|NCT00277212|21046738|P3|COMPLETED|Phase 2 - Double-Blind Treatment||65
8536929|NCT00277212|21046739|P2|COMPLETED|Phase 2 - Double-Blind Treatment||53
8536930|NCT00277212|21046740|P1|COMPLETED|Phase 2 - Double-Blind Treatment||0
8536931|NCT00277212|21046738|P3|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
8536932|NCT00277212|21046739|P2|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
8536933|NCT00277212|21046740|P1|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
8536934|NCT00277212|21046738|P3|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
8536935|NCT00277212|21046739|P2|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
8536936|NCT00277212|21046740|P1|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
8536937|NCT00277212|21046738|P3|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
8536938|NCT00277212|21046739|P2|STARTED|Phase 2 - Double-Blind Treatment||173
8536939|NCT00277212|21046740|P1|STARTED|Phase 2 - Double-Blind Treatment||0
8536940|NCT00277212|21046738|P3|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
8536941|NCT00277212|21046739|P2|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
8536942|NCT00277212|21046740|P1|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
8536943|NCT00277212|21046738|P3|COMPLETED|Phase 1 - Single-Blind Treatment||0
8536944|NCT00277212|21046739|P2|COMPLETED|Phase 1 - Single-Blind Treatment||0
8536945|NCT00277212|21046740|P1|COMPLETED|Phase 1 - Single-Blind Treatment||352
8536946|NCT00277212|21046738|P3|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
8536947|NCT00277212|21046739|P2|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
8536948|NCT00277212|21046740|P1|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
8536949|NCT00277212|21046738|P3|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
8536950|NCT00277212|21046739|P2|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
8536951|NCT00277212|21046740|P1|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
8536952|NCT00277212|21046738|P3|STARTED|Phase 1 - Single-Blind Treatment||0
8536953|NCT00277212|21046739|P2|STARTED|Phase 1 - Single-Blind Treatment||0
8536954|NCT00277212|21046740|P1|STARTED|Phase 1 - Single-Blind Treatment||787
8536955|NCT00277095|21046778|P1|NOT COMPLETED|Overall Study||21
8536956|NCT00277095|21046778|P1|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
8536957|NCT00277095|21046778|P1|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
8536958|NCT00276861|21046782|P1|NOT COMPLETED|Overall Study||0
8536959|NCT00276861|21046782|P1|COMPLETED|Overall Study||10
8536960|NCT00276861|21046782|P1|STARTED|Overall Study||10
8536961|NCT00276744|21046787|P1|NOT COMPLETED|PART B||0
8536962|NCT00276744|21046787|P1|COMPLETED|PART B||0
8536963|NCT00276744|21046787|P1|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
8536964|NCT00276744|21046787|P1|NOT COMPLETED|PART A||98
8536965|NCT00276744|21046787|P1|COMPLETED|PART A||142
8536966|NCT00276744|21046787|P1|STARTED|PART A||240
8536967|NCT00276614|21046791|P1|NOT COMPLETED|Overall Study||3
8536968|NCT00276614|21046791|P1|COMPLETED|Overall Study||1
8536969|NCT00276614|21046791|P1|STARTED|Overall Study||4
8536970|NCT00276549|21046795|P1|NOT COMPLETED|Overall Study||0
8536971|NCT00276549|21046795|P1|COMPLETED|Overall Study||35
8536972|NCT00276549|21046795|P1|STARTED|Overall Study||35
8536973|NCT00276484|21046802|P2|NOT COMPLETED|Overall Study||13
8536974|NCT00276484|21046803|P1|NOT COMPLETED|Overall Study||9
8536975|NCT00276484|21046802|P2|COMPLETED|Overall Study||278
8536976|NCT00276484|21046803|P1|COMPLETED|Overall Study||279
8536977|NCT00276484|21046802|P2|STARTED|Overall Study||291
8536978|NCT00276484|21046803|P1|STARTED|Overall Study||288
8536979|NCT00276458|21046835|P2|NOT COMPLETED|Overall Study||7
8536980|NCT00276458|21046836|P1|NOT COMPLETED|Overall Study||6
8536981|NCT00276458|21046835|P2|COMPLETED|Overall Study||91
8536982|NCT00276458|21046836|P1|COMPLETED|Overall Study||92
8536983|NCT00276458|21046835|P2|STARTED|Overall Study||98
8536984|NCT00276458|21046836|P1|STARTED|Overall Study||98
8536985|NCT00276419|21046870|P2|NOT COMPLETED|Second Intervention||0
8536986|NCT00276419|21046871|P1|NOT COMPLETED|Second Intervention||0
8536987|NCT00276419|21046870|P2|COMPLETED|Second Intervention||8
8536988|NCT00276419|21046871|P1|COMPLETED|Second Intervention||7
8536989|NCT00276419|21046870|P2|STARTED|Second Intervention||8
8536990|NCT00276419|21046871|P1|STARTED|Second Intervention||7
8536991|NCT00276419|21046870|P2|NOT COMPLETED|Wash-out Phase||0
8536992|NCT00276419|21046871|P1|NOT COMPLETED|Wash-out Phase||0
8536993|NCT00276419|21046870|P2|COMPLETED|Wash-out Phase||8
8536994|NCT00276419|21046871|P1|COMPLETED|Wash-out Phase||7
8536995|NCT00276419|21046870|P2|STARTED|Wash-out Phase||8
8536996|NCT00276419|21046871|P1|STARTED|Wash-out Phase||7
8536997|NCT00276419|21046870|P2|NOT COMPLETED|First Intervention||2
8536998|NCT00276419|21046871|P1|NOT COMPLETED|First Intervention||1
8536999|NCT00276419|21046870|P2|COMPLETED|First Intervention||8
8537000|NCT00276419|21046871|P1|COMPLETED|First Intervention||7
8537001|NCT00276419|21046870|P2|STARTED|First Intervention||10
8537002|NCT00276419|21046871|P1|STARTED|First Intervention||8
8537003|NCT00276406|21046883|P2|NOT COMPLETED|Overall Study||0
8537004|NCT00276406|21046884|P1|NOT COMPLETED|Overall Study||0
8537005|NCT00276406|21046883|P2|COMPLETED|Overall Study||14
8537006|NCT00276406|21046884|P1|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
8537007|NCT00276406|21046883|P2|STARTED|Overall Study||14
8537008|NCT00276406|21046884|P1|STARTED|Overall Study||16
8537009|NCT00276380|21046914|P2|NOT COMPLETED|Overall Study||14
8537010|NCT00276380|21046915|P1|NOT COMPLETED|Overall Study||14
8537011|NCT00276380|21046914|P2|COMPLETED|Overall Study||88
8537012|NCT00276380|21046915|P1|COMPLETED|Overall Study||88
8537013|NCT00276380|21046914|P2|STARTED|Overall Study||102
8537014|NCT00276380|21046915|P1|STARTED|Overall Study||102
8537015|NCT00276250|21046936|P3|NOT COMPLETED|Overall Study||0
8537016|NCT00276250|21046937|P2|NOT COMPLETED|Overall Study||0
8537017|NCT00276250|21046938|P1|NOT COMPLETED|Overall Study||0
8537018|NCT00276250|21046936|P3|COMPLETED|Overall Study||0
8537019|NCT00276250|21046937|P2|COMPLETED|Overall Study||1
8537020|NCT00276250|21046938|P1|COMPLETED|Overall Study||4
8537021|NCT00276250|21046936|P3|STARTED|Overall Study||0
8537022|NCT00276250|21046937|P2|STARTED|Overall Study||1
8537023|NCT00276250|21046938|P1|STARTED|Overall Study||4
8537024|NCT00276159|21046970|P1|NOT COMPLETED|Overall Study||6
8537025|NCT00276159|21046970|P1|COMPLETED|Overall Study||0
8537026|NCT00276159|21046970|P1|STARTED|Overall Study||6
8537027|NCT00276094|21046980|P3|NOT COMPLETED|Overall Study||38
8537028|NCT00276094|21046981|P2|NOT COMPLETED|Overall Study||42
8537029|NCT00276094|21046982|P1|NOT COMPLETED|Overall Study||57
8537030|NCT00276094|21046980|P3|COMPLETED|Overall Study||230
8537031|NCT00276094|21046981|P2|COMPLETED|Overall Study||234
8537032|NCT00276094|21046982|P1|COMPLETED|Overall Study||225
8537033|NCT00276094|21046980|P3|STARTED|Overall Study||268
8537034|NCT00276094|21046981|P2|STARTED|Overall Study||276
8537035|NCT00276094|21046982|P1|STARTED|Overall Study||282
8537036|NCT00276016|21047035|P6|NOT COMPLETED|Intervention 3||0
8537037|NCT00276016|21047036|P5|NOT COMPLETED|Intervention 3||0
8537038|NCT00276016|21047037|P4|NOT COMPLETED|Intervention 3||0
8537039|NCT00276016|21047038|P3|NOT COMPLETED|Intervention 3||0
8537040|NCT00276016|21047039|P2|NOT COMPLETED|Intervention 3||0
8537041|NCT00276016|21047040|P1|NOT COMPLETED|Intervention 3||0
8537042|NCT00276016|21047035|P6|COMPLETED|Intervention 3||6
8537043|NCT00276016|21047036|P5|COMPLETED|Intervention 3||6
8537044|NCT00276016|21047037|P4|COMPLETED|Intervention 3||6
8537045|NCT00276016|21047038|P3|COMPLETED|Intervention 3||7
8537046|NCT00276016|21047039|P2|COMPLETED|Intervention 3||6
8537047|NCT00276016|21047040|P1|COMPLETED|Intervention 3||7
8537048|NCT00276016|21047035|P6|STARTED|Intervention 3||6
8537049|NCT00276016|21047036|P5|STARTED|Intervention 3||6
8537050|NCT00276016|21047037|P4|STARTED|Intervention 3||6
8537051|NCT00276016|21047038|P3|STARTED|Intervention 3||7
8537052|NCT00276016|21047039|P2|STARTED|Intervention 3||6
8537053|NCT00276016|21047040|P1|STARTED|Intervention 3||7
8537054|NCT00276016|21047035|P6|NOT COMPLETED|Wash Out 2||0
8537055|NCT00276016|21047036|P5|NOT COMPLETED|Wash Out 2||0
8537056|NCT00276016|21047037|P4|NOT COMPLETED|Wash Out 2||0
8537057|NCT00276016|21047038|P3|NOT COMPLETED|Wash Out 2||0
8537058|NCT00276016|21047039|P2|NOT COMPLETED|Wash Out 2||0
8537059|NCT00276016|21047040|P1|NOT COMPLETED|Wash Out 2||0
8537060|NCT00276016|21047035|P6|COMPLETED|Wash Out 2||6
8537061|NCT00276016|21047036|P5|COMPLETED|Wash Out 2||6
8537062|NCT00276016|21047037|P4|COMPLETED|Wash Out 2||6
8537063|NCT00276016|21047038|P3|COMPLETED|Wash Out 2||7
8537064|NCT00276016|21047039|P2|COMPLETED|Wash Out 2||6
8537065|NCT00276016|21047040|P1|COMPLETED|Wash Out 2||7
8537066|NCT00276016|21047035|P6|STARTED|Wash Out 2||6
8537067|NCT00276016|21047036|P5|STARTED|Wash Out 2||6
8537068|NCT00276016|21047037|P4|STARTED|Wash Out 2||6
8537069|NCT00276016|21047038|P3|STARTED|Wash Out 2||7
8537070|NCT00276016|21047039|P2|STARTED|Wash Out 2||6
8537071|NCT00276016|21047040|P1|STARTED|Wash Out 2||7
8537072|NCT00276016|21047035|P6|NOT COMPLETED|Intervention 2||0
8537073|NCT00276016|21047036|P5|NOT COMPLETED|Intervention 2||0
8537074|NCT00276016|21047037|P4|NOT COMPLETED|Intervention 2||0
8537075|NCT00276016|21047038|P3|NOT COMPLETED|Intervention 2||0
8537076|NCT00276016|21047039|P2|NOT COMPLETED|Intervention 2||0
8537077|NCT00276016|21047040|P1|NOT COMPLETED|Intervention 2||0
8537078|NCT00276016|21047035|P6|COMPLETED|Intervention 2||6
8537079|NCT00276016|21047036|P5|COMPLETED|Intervention 2||6
8537080|NCT00276016|21047037|P4|COMPLETED|Intervention 2||6
8537081|NCT00276016|21047038|P3|COMPLETED|Intervention 2||7
8537082|NCT00276016|21047039|P2|COMPLETED|Intervention 2||6
8537083|NCT00276016|21047040|P1|COMPLETED|Intervention 2||7
8537084|NCT00276016|21047035|P6|STARTED|Intervention 2||6
8537085|NCT00276016|21047036|P5|STARTED|Intervention 2||6
8537086|NCT00276016|21047037|P4|STARTED|Intervention 2||6
8537087|NCT00276016|21047038|P3|STARTED|Intervention 2||7
8537088|NCT00276016|21047039|P2|STARTED|Intervention 2||6
8537089|NCT00276016|21047040|P1|STARTED|Intervention 2||7
8537090|NCT00276016|21047035|P6|NOT COMPLETED|Wash Out 1||0
8537091|NCT00276016|21047036|P5|NOT COMPLETED|Wash Out 1||0
8537092|NCT00276016|21047037|P4|NOT COMPLETED|Wash Out 1||0
8537093|NCT00276016|21047038|P3|NOT COMPLETED|Wash Out 1||0
8537094|NCT00276016|21047039|P2|NOT COMPLETED|Wash Out 1||0
8537095|NCT00276016|21047040|P1|NOT COMPLETED|Wash Out 1||0
8537096|NCT00276016|21047035|P6|COMPLETED|Wash Out 1||6
8537097|NCT00276016|21047036|P5|COMPLETED|Wash Out 1||6
8537098|NCT00276016|21047037|P4|COMPLETED|Wash Out 1||6
8537099|NCT00276016|21047038|P3|COMPLETED|Wash Out 1||7
8537100|NCT00276016|21047039|P2|COMPLETED|Wash Out 1||6
8537101|NCT00276016|21047040|P1|COMPLETED|Wash Out 1||7
8537102|NCT00276016|21047035|P6|STARTED|Wash Out 1||6
8537103|NCT00276016|21047036|P5|STARTED|Wash Out 1||6
8537104|NCT00276016|21047037|P4|STARTED|Wash Out 1||6
8537105|NCT00276016|21047038|P3|STARTED|Wash Out 1||7
8537106|NCT00276016|21047039|P2|STARTED|Wash Out 1||6
8537107|NCT00276016|21047040|P1|STARTED|Wash Out 1||7
8537108|NCT00276016|21047035|P6|NOT COMPLETED|Intervention 1||0
8537109|NCT00276016|21047036|P5|NOT COMPLETED|Intervention 1||0
8537110|NCT00276016|21047037|P4|NOT COMPLETED|Intervention 1||0
8537111|NCT00276016|21047038|P3|NOT COMPLETED|Intervention 1||0
8537112|NCT00276016|21047039|P2|NOT COMPLETED|Intervention 1||1
8537113|NCT00276016|21047040|P1|NOT COMPLETED|Intervention 1||0
8537114|NCT00276016|21047035|P6|COMPLETED|Intervention 1||6
8537115|NCT00276016|21047036|P5|COMPLETED|Intervention 1||6
8537116|NCT00276016|21047037|P4|COMPLETED|Intervention 1||6
8537117|NCT00276016|21047038|P3|COMPLETED|Intervention 1||7
8537118|NCT00276016|21047039|P2|COMPLETED|Intervention 1||6
8537119|NCT00276016|21047040|P1|COMPLETED|Intervention 1||7
8537120|NCT00276016|21047035|P6|STARTED|Intervention 1||6
8537121|NCT00276016|21047036|P5|STARTED|Intervention 1||6
8537122|NCT00276016|21047037|P4|STARTED|Intervention 1||6
8537123|NCT00276016|21047038|P3|STARTED|Intervention 1||7
8537124|NCT00276016|21047039|P2|STARTED|Intervention 1||7
8537125|NCT00276016|21047040|P1|STARTED|Intervention 1||7
8537126|NCT00275834|21047052|P3|NOT COMPLETED|Overall Study||1
8537127|NCT00275834|21047053|P2|NOT COMPLETED|Overall Study||3
8537128|NCT00275834|21047054|P1|NOT COMPLETED|Overall Study||3
8537129|NCT00275834|21047052|P3|COMPLETED|Overall Study||74
8537130|NCT00275834|21047053|P2|COMPLETED|Overall Study||73
8537131|NCT00275834|21047054|P1|COMPLETED|Overall Study||71
8537132|NCT00275834|21047052|P3|Completed Study While on Study Drug|Overall Study||62
8537133|NCT00275834|21047053|P2|Completed Study While on Study Drug|Overall Study||51
8537134|NCT00275834|21047054|P1|Completed Study While on Study Drug|Overall Study||54
8537135|NCT00275834|21047052|P3|STARTED|Overall Study||75
8537136|NCT00275834|21047053|P2|STARTED|Overall Study||76
8537137|NCT00275834|21047054|P1|STARTED|Overall Study||74
8537138|NCT00275821|21047086|P3|NOT COMPLETED|Overall Study||12
8537139|NCT00275821|21047087|P2|NOT COMPLETED|Overall Study||23
8537140|NCT00275821|21047088|P1|NOT COMPLETED|Overall Study||14
8537141|NCT00275821|21047086|P3|COMPLETED|Overall Study||103
8537142|NCT00275821|21047087|P2|COMPLETED|Overall Study||95
8537143|NCT00275821|21047088|P1|COMPLETED|Overall Study||106
8537144|NCT00275821|21047086|P3|STARTED|Overall Study||115
8537145|NCT00275821|21047087|P2|STARTED|Overall Study||118
8537146|NCT00275821|21047088|P1|STARTED|Overall Study||120
8537147|NCT00275561|21047107|P2|NOT COMPLETED|Overall Study||6
8537148|NCT00275561|21047108|P1|NOT COMPLETED|Overall Study||2
8537149|NCT00275561|21047107|P2|COMPLETED|Overall Study||15
8537150|NCT00275561|21047108|P1|COMPLETED|Overall Study||19
8537151|NCT00275561|21047107|P2|STARTED|Overall Study||21
8537152|NCT00275561|21047108|P1|STARTED|Overall Study||21
8537153|NCT00275509|21047120|P2|NOT COMPLETED|Overall Study||1
8537154|NCT00275509|21047121|P1|NOT COMPLETED|Overall Study||0
8537155|NCT00275509|21047120|P2|COMPLETED|Overall Study||25
8537156|NCT00275509|21047121|P1|COMPLETED|Overall Study||30
8537157|NCT00275509|21047120|P2|STARTED|Overall Study||26
8537158|NCT00275509|21047121|P1|STARTED|Overall Study||30
8537159|NCT00275392|21047133|P2|NOT COMPLETED|Overall Study||2
8537160|NCT00275392|21047134|P1|NOT COMPLETED|Overall Study||0
8537161|NCT00275392|21047133|P2|COMPLETED|Overall Study||17
8537162|NCT00275392|21047134|P1|COMPLETED|Overall Study||20
8537163|NCT00275392|21047133|P2|STARTED|Overall Study||19
8537164|NCT00275392|21047134|P1|STARTED|Overall Study||20
8537165|NCT00275340|21047144|P2|NOT COMPLETED|Overall Study||4
8537166|NCT00275340|21047145|P1|NOT COMPLETED|Overall Study||2
8537167|NCT00275340|21047144|P2|COMPLETED|Overall Study||45
8537168|NCT00275340|21047145|P1|COMPLETED|Overall Study||50
8537169|NCT00275340|21047144|P2|STARTED|Overall Study||49
8537170|NCT00275340|21047145|P1|STARTED|Overall Study||52
8537171|NCT00275301|21047149|P1|NOT COMPLETED|Overall Study||5
8537172|NCT00275301|21047149|P1|COMPLETED|Overall Study||14
8537173|NCT00275301|21047149|P1|STARTED|Overall Study||19
8537174|NCT00275275|21047156|P3|NOT COMPLETED|Overall Study||6
8537175|NCT00275275|21047157|P2|NOT COMPLETED|Overall Study||2
8537176|NCT00275275|21047158|P1|NOT COMPLETED|Overall Study||6
8537177|NCT00275275|21047156|P3|COMPLETED|Overall Study||15
8537178|NCT00275275|21047157|P2|COMPLETED|Overall Study||18
8537179|NCT00275275|21047158|P1|COMPLETED|Overall Study||14
8537180|NCT00275275|21047156|P3|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
8537181|NCT00275275|21047157|P2|STARTED|Overall Study||20
8537182|NCT00275275|21047158|P1|STARTED|Overall Study||20
8537183|NCT00275262|21047168|P2|NOT COMPLETED|Overall Study||9
8537184|NCT00275262|21047169|P1|NOT COMPLETED|Overall Study||6
8537185|NCT00275262|21047168|P2|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
8537186|NCT00275262|21047169|P1|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
8537187|NCT00275262|21047168|P2|STARTED|Overall Study||13
8537188|NCT00275262|21047169|P1|STARTED|Overall Study||12
8537189|NCT00275028|21047183|P1|NOT COMPLETED|Overall Study||47
8537190|NCT00275028|21047183|P1|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
8537191|NCT00275028|21047183|P1|STARTED|Overall Study||47
8537192|NCT00275002|21047190|P2|NOT COMPLETED|Overall Study||16
8537193|NCT00275002|21047191|P1|NOT COMPLETED|Overall Study||22
8537194|NCT00275002|21047190|P2|COMPLETED|Overall Study||0
8537195|NCT00275002|21047191|P1|COMPLETED|Overall Study||3
8537196|NCT00275002|21047190|P2|STARTED|Overall Study||16
8537197|NCT00275002|21047191|P1|STARTED|Overall Study||25
8537201|NCT00274924|21047211|P3|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
8537202|NCT00274924|21047212|P2|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
8537203|NCT00274924|21047213|P1|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
8537204|NCT00274924|21047211|P3|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
8537205|NCT00274924|21047212|P2|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
8537206|NCT00274924|21047213|P1|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
8537207|NCT00274924|21047211|P3|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
8537208|NCT00274924|21047212|P2|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
8537209|NCT00274924|21047213|P1|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
8537210|NCT00274924|21047211|P3|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
8537211|NCT00274924|21047212|P2|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
8537212|NCT00274924|21047213|P1|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
8537213|NCT00274924|21047211|P3|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
8537214|NCT00274924|21047212|P2|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
8537215|NCT00274924|21047213|P1|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
8537216|NCT00274924|21047211|P3|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
8537217|NCT00274924|21047212|P2|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
8537218|NCT00274924|21047213|P1|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
8537219|NCT00274924|21047211|P3|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
8537220|NCT00274924|21047212|P2|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
8537221|NCT00274924|21047213|P1|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
8537222|NCT00274924|21047211|P3|Treated|Step 1 (R-CHOP X 3 Cycles)||5
8537223|NCT00274924|21047212|P2|Treated|Step 1 (R-CHOP X 3 Cycles)||77
8537224|NCT00274924|21047213|P1|Treated|Step 1 (R-CHOP X 3 Cycles)||17
8537225|NCT00274924|21047211|P3|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
8537226|NCT00274924|21047212|P2|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
8537227|NCT00274924|21047213|P1|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
8537228|NCT00274846|21047222|P1|NOT COMPLETED|Overall Study||1
8537229|NCT00274846|21047222|P1|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
8537230|NCT00274846|21047222|P1|STARTED|Overall Study||21
8537231|NCT00274781|21047230|P1|NOT COMPLETED|Overall Study||0
8537232|NCT00274781|21047230|P1|COMPLETED|Overall Study||30
8537233|NCT00274781|21047230|P1|STARTED|Overall Study||30
8537234|NCT00274768|21047236|P1|NOT COMPLETED|Overall Study||0
8537235|NCT00274768|21047236|P1|COMPLETED|Overall Study||26
8537236|NCT00274768|21047236|P1|STARTED|Overall Study||26
8537237|NCT00274742|21047251|P6|NOT COMPLETED|Overall Study||3
8537238|NCT00274742|21047252|P5|NOT COMPLETED|Overall Study||16
8537239|NCT00274742|21047253|P4|NOT COMPLETED|Overall Study||5
8537240|NCT00274742|21047254|P3|NOT COMPLETED|Overall Study||2
8537241|NCT00274742|21047255|P2|NOT COMPLETED|Overall Study||8
8537242|NCT00274742|21047256|P1|NOT COMPLETED|Overall Study||0
8537243|NCT00274742|21047251|P6|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
8537244|NCT00274742|21047252|P5|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
8537245|NCT00274742|21047253|P4|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
8537246|NCT00274742|21047254|P3|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
8537247|NCT00274742|21047255|P2|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
8537248|NCT00274742|21047256|P1|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
8537249|NCT00274742|21047251|P6|STARTED|Overall Study||4
8537250|NCT00274742|21047252|P5|STARTED|Overall Study||32
8537251|NCT00274742|21047253|P4|STARTED|Overall Study||9
8537252|NCT00274742|21047254|P3|STARTED|Overall Study||6
8537253|NCT00274742|21047255|P2|STARTED|Overall Study||13
8537254|NCT00274742|21047256|P1|STARTED|Overall Study||12
8537255|NCT00274716|21047294|P6|NOT COMPLETED|Phase B||1
8537256|NCT00274716|21047295|P5|NOT COMPLETED|Phase B||0
8537257|NCT00274716|21047296|P4|NOT COMPLETED|Phase B||1
8537258|NCT00274716|21047297|P3|NOT COMPLETED|Phase B||3
8537259|NCT00274716|21047298|P2|NOT COMPLETED|Phase B||4
8537260|NCT00274716|21047299|P1|NOT COMPLETED|Phase B||1
8537261|NCT00274716|21047294|P6|COMPLETED|Phase B||14
8537262|NCT00274716|21047295|P5|COMPLETED|Phase B||16
8537263|NCT00274716|21047296|P4|COMPLETED|Phase B||41
8537264|NCT00274716|21047297|P3|COMPLETED|Phase B||41
8537265|NCT00274716|21047298|P2|COMPLETED|Phase B||40
8537266|NCT00274716|21047299|P1|COMPLETED|Phase B||42
8537267|NCT00274716|21047294|P6|STARTED|Phase B||15
8537268|NCT00274716|21047295|P5|STARTED|Phase B||16
8537269|NCT00274716|21047296|P4|STARTED|Phase B||42
8537270|NCT00274716|21047297|P3|STARTED|Phase B||44
8537271|NCT00274716|21047298|P2|STARTED|Phase B||44
8537272|NCT00274716|21047299|P1|STARTED|Phase B||43
8537273|NCT00274716|21047294|P6|NOT COMPLETED|Phase A||4
8537274|NCT00274716|21047295|P5|NOT COMPLETED|Phase A||3
8537275|NCT00274716|21047296|P4|NOT COMPLETED|Phase A||9
8537276|NCT00274716|21047297|P3|NOT COMPLETED|Phase A||8
8537277|NCT00274716|21047298|P2|NOT COMPLETED|Phase A||10
8537278|NCT00274716|21047299|P1|NOT COMPLETED|Phase A||11
8537279|NCT00274716|21047294|P6|COMPLETED|Phase A||15
8537280|NCT00274716|21047295|P5|COMPLETED|Phase A||16
8537281|NCT00274716|21047296|P4|COMPLETED|Phase A||42
8537282|NCT00274716|21047297|P3|COMPLETED|Phase A||44
8537283|NCT00274716|21047298|P2|COMPLETED|Phase A||44
8537284|NCT00274716|21047299|P1|COMPLETED|Phase A||43
8537285|NCT00274716|21047294|P6|STARTED|Phase A||19
8537286|NCT00274716|21047295|P5|STARTED|Phase A||19
8537287|NCT00274716|21047296|P4|STARTED|Phase A||51
8537288|NCT00274716|21047297|P3|STARTED|Phase A||52
8537289|NCT00274716|21047298|P2|STARTED|Phase A||54
8537290|NCT00274716|21047299|P1|STARTED|Phase A||54
8537291|NCT00274651|21047361|P2|NOT COMPLETED|Overall Study||20
8537292|NCT00274651|21047362|P1|NOT COMPLETED|Overall Study||28
8537293|NCT00274651|21047361|P2|COMPLETED|Overall Study||4
8537294|NCT00274651|21047362|P1|COMPLETED|Overall Study||1
8537295|NCT00274651|21047361|P2|STARTED|Overall Study||24
8537296|NCT00274651|21047362|P1|STARTED|Overall Study||29
8537297|NCT00274625|21047377|P2|NOT COMPLETED|Overall Study||62
8537298|NCT00274625|21047378|P1|NOT COMPLETED|Overall Study||60
8537299|NCT00274625|21047377|P2|COMPLETED|Overall Study||141
8537300|NCT00274625|21047378|P1|COMPLETED|Overall Study||139
8537301|NCT00274625|21047377|P2|STARTED|Overall Study||203
8537302|NCT00274625|21047378|P1|STARTED|Overall Study||199
8537303|NCT00274469|21047386|P2|NOT COMPLETED|Overall Study||93
8537304|NCT00274469|21047387|P1|NOT COMPLETED|Overall Study||79
8537305|NCT00274469|21047386|P2|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10
8537306|NCT00274469|21047387|P1|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23
8537307|NCT00274469|21047386|P2|STARTED|Overall Study|Number of patients randomized|103
8537308|NCT00274469|21047387|P1|STARTED|Overall Study|Number of patients randomized|102
8537309|NCT00274456|21047407|P4|NOT COMPLETED|Overall Study||45
8537310|NCT00274456|21047408|P3|NOT COMPLETED|Overall Study||35
8537311|NCT00274456|21047409|P2|NOT COMPLETED|Overall Study||27
8537312|NCT00274456|21047410|P1|NOT COMPLETED|Overall Study||37
8537313|NCT00274456|21047407|P4|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
8537314|NCT00274456|21047408|P3|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
8537315|NCT00274456|21047409|P2|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
8537316|NCT00274456|21047410|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
8537317|NCT00274456|21047407|P4|At Least One Response Assessment|Overall Study||70
8537318|NCT00274456|21047408|P3|At Least One Response Assessment|Overall Study||73
8537319|NCT00274456|21047409|P2|At Least One Response Assessment|Overall Study||76
8537320|NCT00274456|21047410|P1|At Least One Response Assessment|Overall Study||73
8537321|NCT00274456|21047407|P4|STARTED|Overall Study||74
8537322|NCT00274456|21047408|P3|STARTED|Overall Study||74
8537323|NCT00274456|21047409|P2|STARTED|Overall Study||76
8537324|NCT00274456|21047410|P1|STARTED|Overall Study||76
8537325|NCT00274287|21047452|P1|NOT COMPLETED|Overall Study||2
8537326|NCT00274287|21047452|P1|COMPLETED|Overall Study||13
8537327|NCT00274287|21047452|P1|STARTED|Overall Study||15
8537328|NCT00274261|21047462|P2|NOT COMPLETED|Overall Study||337
8537329|NCT00274261|21047463|P1|NOT COMPLETED|Overall Study||489
8537330|NCT00274261|21047462|P2|COMPLETED|Overall Study||296
8537331|NCT00274261|21047463|P1|COMPLETED|Overall Study||443
8537332|NCT00274261|21047462|P2|STARTED|Overall Study||633
8537333|NCT00274261|21047463|P1|STARTED|Overall Study||932
8537334|NCT00273910|21047477|P6|NOT COMPLETED|Overall Study||0
8537335|NCT00273910|21047478|P5|NOT COMPLETED|Overall Study||0
8537336|NCT00273910|21047479|P4|NOT COMPLETED|Overall Study||0
8537337|NCT00273910|21047480|P3|NOT COMPLETED|Overall Study||0
8537338|NCT00273910|21047481|P2|NOT COMPLETED|Overall Study||0
8537339|NCT00273910|21047482|P1|NOT COMPLETED|Overall Study||0
8537340|NCT00273910|21047477|P6|COMPLETED|Overall Study||14
8537341|NCT00273910|21047478|P5|COMPLETED|Overall Study||15
8537342|NCT00273910|21047479|P4|COMPLETED|Overall Study||19
8537343|NCT00273910|21047480|P3|COMPLETED|Overall Study||18
8537344|NCT00273910|21047481|P2|COMPLETED|Overall Study||19
8537345|NCT00273910|21047482|P1|COMPLETED|Overall Study||19
8537346|NCT00273910|21047477|P6|STARTED|Overall Study||14
8537347|NCT00273910|21047478|P5|STARTED|Overall Study||15
8537348|NCT00273910|21047479|P4|STARTED|Overall Study||19
8537349|NCT00273910|21047480|P3|STARTED|Overall Study||18
8537350|NCT00273910|21047481|P2|STARTED|Overall Study||19
8537351|NCT00273910|21047482|P1|STARTED|Overall Study||19
8537352|NCT00273858|21047502|P1|NOT COMPLETED|Overall Study||537
8537353|NCT00273858|21047502|P1|COMPLETED|Overall Study||343
8537354|NCT00273858|21047502|P1|STARTED|Overall Study||880
8537355|NCT00273793|21047517|P6|NOT COMPLETED|Overall Study||0
8537356|NCT00273793|21047518|P5|NOT COMPLETED|Overall Study||0
8537357|NCT00273793|21047519|P4|NOT COMPLETED|Overall Study||0
8537358|NCT00273793|21047520|P3|NOT COMPLETED|Overall Study||0
8537359|NCT00273793|21047521|P2|NOT COMPLETED|Overall Study||0
8537360|NCT00273793|21047522|P1|NOT COMPLETED|Overall Study||0
8537361|NCT00273793|21047517|P6|COMPLETED|Overall Study||29
8537362|NCT00273793|21047518|P5|COMPLETED|Overall Study||58
8537363|NCT00273793|21047519|P4|COMPLETED|Overall Study||60
8537364|NCT00273793|21047520|P3|COMPLETED|Overall Study||18
8537365|NCT00273793|21047521|P2|COMPLETED|Overall Study||38
8537366|NCT00273793|21047522|P1|COMPLETED|Overall Study||36
8537367|NCT00273793|21047517|P6|STARTED|Overall Study||29
8537368|NCT00273793|21047518|P5|STARTED|Overall Study||58
8537369|NCT00273793|21047519|P4|STARTED|Overall Study||60
8537370|NCT00273793|21047520|P3|STARTED|Overall Study||18
8537371|NCT00273793|21047521|P2|STARTED|Overall Study||38
8537372|NCT00273793|21047522|P1|STARTED|Overall Study||36
8537373|NCT00273754|21047544|P2|NOT COMPLETED|Overall Study||0
8537374|NCT00273754|21047545|P1|NOT COMPLETED|Overall Study||0
8537375|NCT00273754|21047544|P2|COMPLETED|Overall Study||36
8537376|NCT00273754|21047545|P1|COMPLETED|Overall Study||36
8537377|NCT00273754|21047544|P2|STARTED|Overall Study||36
8537378|NCT00273754|21047545|P1|STARTED|Overall Study||36
8537379|NCT00273364|21047563|P2|NOT COMPLETED|Overall Study||0
8537380|NCT00273364|21047564|P1|NOT COMPLETED|Overall Study||0
8537381|NCT00273364|21047563|P2|COMPLETED|Overall Study||55
8537382|NCT00273364|21047564|P1|COMPLETED|Overall Study||55
8537383|NCT00273364|21047563|P2|STARTED|Overall Study||55
8537384|NCT00273364|21047564|P1|STARTED|Overall Study||55
8537385|NCT00273182|21047570|P1|NOT COMPLETED|Overall Study||985
8537386|NCT00273182|21047570|P1|COMPLETED|Overall Study||1014
8537387|NCT00273182|21047570|P1|STARTED|Overall Study||1999
8537388|NCT00273052|21047580|P2|NOT COMPLETED|Overall Study||88
8537389|NCT00273052|21047581|P1|NOT COMPLETED|Overall Study||69
8537390|NCT00273052|21047580|P2|COMPLETED|Overall Study||190
8537391|NCT00273052|21047581|P1|COMPLETED|Overall Study||221
8537392|NCT00273052|21047580|P2|STARTED|Overall Study||278
8537393|NCT00273052|21047581|P1|STARTED|Overall Study||290
8537394|NCT00272987|21047616|P3|NOT COMPLETED|Overall Study||11
8537395|NCT00272987|21047617|P2|NOT COMPLETED|Overall Study||4
8537396|NCT00272987|21047618|P1|NOT COMPLETED|Overall Study||9
8537397|NCT00272987|21047616|P3|COMPLETED|Overall Study||9
8537398|NCT00272987|21047617|P2|COMPLETED|Overall Study||10
8537399|NCT00272987|21047618|P1|COMPLETED|Overall Study||20
8537400|NCT00272987|21047616|P3|STARTED|Overall Study||20
8537401|NCT00272987|21047617|P2|STARTED|Overall Study||14
8537402|NCT00272987|21047618|P1|STARTED|Overall Study||29
8537403|NCT00272961|21047688|P5|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
8537404|NCT00272961|21047689|P4|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
8537405|NCT00272961|21047690|P3|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
8537406|NCT00272961|21047691|P2|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
8537407|NCT00272961|21047692|P1|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
8537408|NCT00272961|21047688|P5|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
8537409|NCT00272961|21047689|P4|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
8537410|NCT00272961|21047690|P3|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
8537411|NCT00272961|21047691|P2|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
8537412|NCT00272961|21047692|P1|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
8537413|NCT00272961|21047688|P5|STARTED|Treatment Phase: Week 3 Up to Week 12||10
8537414|NCT00272961|21047689|P4|STARTED|Treatment Phase: Week 3 Up to Week 12||10
8537415|NCT00272961|21047690|P3|STARTED|Treatment Phase: Week 3 Up to Week 12||11
8537416|NCT00272961|21047691|P2|STARTED|Treatment Phase: Week 3 Up to Week 12||8
8537417|NCT00272961|21047692|P1|STARTED|Treatment Phase: Week 3 Up to Week 12||10
8537418|NCT00272961|21047688|P5|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537419|NCT00272961|21047689|P4|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537420|NCT00272961|21047690|P3|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537421|NCT00272961|21047691|P2|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537422|NCT00272961|21047692|P1|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
8537423|NCT00272961|21047688|P5|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537424|NCT00272961|21047689|P4|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537425|NCT00272961|21047690|P3|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537426|NCT00272961|21047691|P2|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
8537427|NCT00272961|21047692|P1|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
8537428|NCT00272961|21047688|P5|STARTED|Placebo Run-in Phase: Up to Week 2||0
8537429|NCT00272961|21047689|P4|STARTED|Placebo Run-in Phase: Up to Week 2||0
8537430|NCT00272961|21047690|P3|STARTED|Placebo Run-in Phase: Up to Week 2||0
8537431|NCT00272961|21047691|P2|STARTED|Placebo Run-in Phase: Up to Week 2||0
8537432|NCT00272961|21047692|P1|STARTED|Placebo Run-in Phase: Up to Week 2||60
8537433|NCT00272844|21047749|P1|NOT COMPLETED|Overall Study||5
8537434|NCT00272844|21047749|P1|COMPLETED|Overall Study||18
8537435|NCT00272844|21047749|P1|STARTED|Overall Study||23
8537436|NCT00272792|21047757|P2|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
8537437|NCT00272792|21047758|P1|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
8537438|NCT00272792|21047757|P2|COMPLETED|Part 2: Blinded, Placebo Control Period||9
8537439|NCT00272792|21047758|P1|COMPLETED|Part 2: Blinded, Placebo Control Period||32
8537440|NCT00272792|21047757|P2|STARTED|Part 2: Blinded, Placebo Control Period||12
8537441|NCT00272792|21047758|P1|STARTED|Part 2: Blinded, Placebo Control Period||33
8537442|NCT00272792|21047757|P2|NOT COMPLETED|Part 1: Responsiveness||0
8537443|NCT00272792|21047758|P1|NOT COMPLETED|Part 1: Responsiveness||1
8537444|NCT00272792|21047757|P2|COMPLETED|Part 1: Responsiveness||0
8537445|NCT00272792|21047758|P1|COMPLETED|Part 1: Responsiveness||89
8537446|NCT00272792|21047757|P2|STARTED|Part 1: Responsiveness||0
8537447|NCT00272792|21047758|P1|STARTED|Part 1: Responsiveness||90
8537448|NCT00272779|21047768|P2|NOT COMPLETED|Baseline Through Week 96||136
8537449|NCT00272779|21047769|P1|NOT COMPLETED|Baseline Through Week 96||139
8537450|NCT00272779|21047768|P2|COMPLETED|Baseline Through Week 96||307
8537451|NCT00272779|21047769|P1|COMPLETED|Baseline Through Week 96||301
8537452|NCT00272779|21047768|P2|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
8537453|NCT00272779|21047769|P1|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
8537454|NCT00272779|21047768|P2|STARTED|Baseline Through Week 96|Number randomized to LPV|443
8537455|NCT00272779|21047769|P1|STARTED|Baseline Through Week 96|Number randomized to ATV|440
8537456|NCT00272779|21047768|P2|NOT COMPLETED|Baseline Through Week 48||443
8537457|NCT00272779|21047769|P1|NOT COMPLETED|Baseline Through Week 48||440
8537458|NCT00272779|21047768|P2|COMPLETED|Baseline Through Week 48||0
8537459|NCT00272779|21047769|P1|COMPLETED|Baseline Through Week 48||0
8537460|NCT00272779|21047768|P2|STILL ON TREATMENT|Baseline Through Week 48||368
8537461|NCT00272779|21047769|P1|STILL ON TREATMENT|Baseline Through Week 48||385
8537462|NCT00272779|21047768|P2|Discontinued on or After Week 48|Baseline Through Week 48||14
8537463|NCT00272779|21047769|P1|Discontinued on or After Week 48|Baseline Through Week 48||14
8537464|NCT00272779|21047768|P2|Discontinued Before Week 48|Baseline Through Week 48||58
8537465|NCT00272779|21047769|P1|Discontinued Before Week 48|Baseline Through Week 48||39
8537466|NCT00272779|21047768|P2|TREATED AS RANDOMIZED|Baseline Through Week 48||440
8537467|NCT00272779|21047769|P1|TREATED AS RANDOMIZED|Baseline Through Week 48||438
8537468|NCT00272779|21047768|P2|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
8537469|NCT00272779|21047769|P1|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
8537470|NCT00272779|21047768|P2|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
8537471|NCT00272779|21047769|P1|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
8537472|NCT00272337|21047953|P5|NOT COMPLETED|Overall Study||0
8537473|NCT00272337|21047954|P4|NOT COMPLETED|Overall Study||0
8537474|NCT00272337|21047955|P3|NOT COMPLETED|Overall Study||0
8537475|NCT00272337|21047956|P2|NOT COMPLETED|Overall Study||0
8537476|NCT00272337|21047957|P1|NOT COMPLETED|Overall Study||0
8537477|NCT00272337|21047953|P5|COMPLETED|Overall Study||8
8537478|NCT00272337|21047954|P4|COMPLETED|Overall Study||7
8537479|NCT00272337|21047955|P3|COMPLETED|Overall Study||7
8537480|NCT00272337|21047956|P2|COMPLETED|Overall Study||7
8537481|NCT00272337|21047957|P1|COMPLETED|Overall Study||8
8537482|NCT00272337|21047953|P5|STARTED|Overall Study||8
8537483|NCT00272337|21047954|P4|STARTED|Overall Study||7
8537484|NCT00272337|21047955|P3|STARTED|Overall Study||7
8537485|NCT00272337|21047956|P2|STARTED|Overall Study||7
8537486|NCT00272337|21047957|P1|STARTED|Overall Study||8
8537487|NCT00272311|21047984|P5|NOT COMPLETED|Overall Study||0
8537488|NCT00272311|21047985|P4|NOT COMPLETED|Overall Study||0
8537489|NCT00272311|21047986|P3|NOT COMPLETED|Overall Study||0
8537490|NCT00272311|21047987|P2|NOT COMPLETED|Overall Study||0
8537491|NCT00272311|21047988|P1|NOT COMPLETED|Overall Study||0
8537492|NCT00272311|21047984|P5|COMPLETED|Overall Study||14
8537493|NCT00272311|21047985|P4|COMPLETED|Overall Study||14
8537494|NCT00272311|21047986|P3|COMPLETED|Overall Study||14
8537495|NCT00272311|21047987|P2|COMPLETED|Overall Study||14
8537496|NCT00272311|21047988|P1|COMPLETED|Overall Study||14
8537497|NCT00272311|21047984|P5|STARTED|Overall Study||14
8537498|NCT00272311|21047985|P4|STARTED|Overall Study||14
8537499|NCT00272311|21047986|P3|STARTED|Overall Study||14
8537500|NCT00272311|21047987|P2|STARTED|Overall Study||14
8537501|NCT00272311|21047988|P1|STARTED|Overall Study||14
8537502|NCT00272168|21048012|P2|NOT COMPLETED|Overall Study||10
8537503|NCT00272168|21048013|P1|NOT COMPLETED|Overall Study||10
8537504|NCT00272168|21048012|P2|COMPLETED|Overall Study||31
8537505|NCT00272168|21048013|P1|COMPLETED|Overall Study||37
8537506|NCT00272168|21048012|P2|STARTED|Overall Study||41
8537507|NCT00272168|21048013|P1|STARTED|Overall Study||47
8537508|NCT00272038|21048029|P1|NOT COMPLETED|Overall Study||7
8537509|NCT00272038|21048029|P1|COMPLETED|Overall Study||22
8537510|NCT00272038|21048029|P1|STARTED|Overall Study||29
8537511|NCT00271947|21048035|P1|NOT COMPLETED|Overall Study||1
8537512|NCT00271947|21048035|P1|COMPLETED|Overall Study||0
8537513|NCT00271947|21048035|P1|STARTED|Overall Study||1
8537514|NCT00271856|21048041|P2|NOT COMPLETED|Overall Study||18
8537515|NCT00271856|21048042|P1|NOT COMPLETED|Overall Study||11
8537516|NCT00271856|21048041|P2|COMPLETED|Overall Study||70
8537517|NCT00271856|21048042|P1|COMPLETED|Overall Study||78
8537518|NCT00271856|21048041|P2|STARTED|Overall Study||88
8537519|NCT00271856|21048042|P1|STARTED|Overall Study||89
8537520|NCT00271817|21048061|P3|NOT COMPLETED|Part 2||84
8537521|NCT00271817|21048062|P2|NOT COMPLETED|Part 2||32
8537522|NCT00271817|21048063|P1|NOT COMPLETED|Part 2||0
8537523|NCT00271817|21048061|P3|COMPLETED|Part 2||401
8537524|NCT00271817|21048062|P2|COMPLETED|Part 2||234
8537525|NCT00271817|21048063|P1|COMPLETED|Part 2||0
8537526|NCT00271817|21048061|P3|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
8537527|NCT00271817|21048062|P2|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
8537528|NCT00271817|21048063|P1|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
8537529|NCT00271817|21048061|P3|NOT COMPLETED|Part 1||285
8537530|NCT00271817|21048062|P2|NOT COMPLETED|Part 1||59
8537531|NCT00271817|21048063|P1|NOT COMPLETED|Part 1||106
8537532|NCT00271817|21048061|P3|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
8537533|NCT00271817|21048062|P2|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
8537534|NCT00271817|21048063|P1|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
8537535|NCT00271817|21048061|P3|STARTED|Part 1||676
8537536|NCT00271817|21048062|P2|STARTED|Part 1||272
8537537|NCT00271817|21048063|P1|STARTED|Part 1||272
8537538|NCT00271739|21048092|P2|NOT COMPLETED|Overall Study||105
8537539|NCT00271739|21048093|P1|NOT COMPLETED|Overall Study||115
8537540|NCT00271739|21048092|P2|COMPLETED|Overall Study||716
8537541|NCT00271739|21048093|P1|COMPLETED|Overall Study||729
8537542|NCT00271739|21048092|P2|STARTED|Overall Study||821
8537543|NCT00271739|21048093|P1|STARTED|Overall Study||844
8537544|NCT00271609|21048105|P2|NOT COMPLETED|Overall Study||3
8537545|NCT00271609|21048106|P1|NOT COMPLETED|Overall Study||13
8537546|NCT00271609|21048105|P2|COMPLETED|Overall Study||29
8537547|NCT00271609|21048106|P1|COMPLETED|Overall Study||43
8537548|NCT00271609|21048105|P2|STARTED|Overall Study||32
8537549|NCT00271609|21048106|P1|STARTED|Overall Study||56
8537550|NCT00271596|21048116|P2|NOT COMPLETED|Overall Study||1
8537551|NCT00271596|21048117|P1|NOT COMPLETED|Overall Study||1
8537552|NCT00271596|21048116|P2|COMPLETED|Overall Study||15
8537553|NCT00271596|21048117|P1|COMPLETED|Overall Study||16
8537554|NCT00271596|21048116|P2|STARTED|Overall Study||16
8537555|NCT00271596|21048117|P1|STARTED|Overall Study||17
8537556|NCT00271570|21048143|P2|NOT COMPLETED|Overall Study||0
8537557|NCT00271570|21048144|P1|NOT COMPLETED|Overall Study||0
8537558|NCT00271570|21048143|P2|COMPLETED|Overall Study||12
8537559|NCT00271570|21048144|P1|COMPLETED|Overall Study||12
8537560|NCT00271570|21048143|P2|STARTED|Overall Study||12
8537561|NCT00271570|21048144|P1|STARTED|Overall Study||12
8537562|NCT00271544|21048152|P1|NOT COMPLETED|Overall Study||20
8537563|NCT00271544|21048152|P1|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
8537564|NCT00271544|21048152|P1|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
8537565|NCT00271544|21048152|P1|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
8537566|NCT00271544|21048152|P1|STARTED|Overall Study|Total number of subjects enrolled.|190
8537567|NCT00271505|21048173|P1|NOT COMPLETED|Overall Study||5
8537568|NCT00271505|21048173|P1|COMPLETED|Overall Study||38
8537569|NCT00271505|21048173|P1|STARTED|Overall Study||43
8537570|NCT00271375|21048182|P3|NOT COMPLETED|Overall Study||0
8537571|NCT00271375|21048183|P2|NOT COMPLETED|Overall Study||0
8537572|NCT00271375|21048184|P1|NOT COMPLETED|Overall Study||0
8537573|NCT00271375|21048182|P3|COMPLETED|Overall Study||57
8537574|NCT00271375|21048183|P2|COMPLETED|Overall Study||83
8537575|NCT00271375|21048184|P1|COMPLETED|Overall Study||114
8537576|NCT00271375|21048182|P3|STARTED|Overall Study||57
8537577|NCT00271375|21048183|P2|STARTED|Overall Study||83
8537578|NCT00271375|21048184|P1|STARTED|Overall Study||114
8537579|NCT00271219|21048222|P2|NOT COMPLETED|Overall Study||28
8537580|NCT00271219|21048223|P1|NOT COMPLETED|Overall Study||16
8537581|NCT00271219|21048222|P2|COMPLETED|Overall Study||58
8537582|NCT00271219|21048223|P1|COMPLETED|Overall Study||73
8537583|NCT00271219|21048222|P2|STARTED|Overall Study||86
8537584|NCT00271219|21048223|P1|STARTED|Overall Study||89
8537585|NCT00271154|21048249|P2|NOT COMPLETED|Overall Study||0
8537586|NCT00271154|21048250|P1|NOT COMPLETED|Overall Study||0
8537587|NCT00271154|21048249|P2|COMPLETED|Overall Study||419
8537588|NCT00271154|21048250|P1|COMPLETED|Overall Study||191
8537589|NCT00271154|21048249|P2|STARTED|Overall Study||419
8537590|NCT00271154|21048250|P1|STARTED|Overall Study||191
8537591|NCT00271102|21048261|P2|NOT COMPLETED|Overall Study||5
8537592|NCT00271102|21048262|P1|NOT COMPLETED|Overall Study||5
8537593|NCT00271102|21048261|P2|COMPLETED|Overall Study||30
8537594|NCT00271102|21048262|P1|COMPLETED|Overall Study||30
8537595|NCT00271102|21048261|P2|STARTED|Overall Study||35
8537596|NCT00271102|21048262|P1|STARTED|Overall Study||35
8537597|NCT00271024|21048272|P4|NOT COMPLETED|Overall Study||24
8537598|NCT00271024|21048273|P3|NOT COMPLETED|Overall Study||23
8537599|NCT00271024|21048274|P2|NOT COMPLETED|Overall Study||26
8537600|NCT00271024|21048275|P1|NOT COMPLETED|Overall Study||22
8537601|NCT00271024|21048272|P4|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
8537602|NCT00271024|21048273|P3|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
8537603|NCT00271024|21048274|P2|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
8537604|NCT00271024|21048275|P1|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
8537694|NCT00270231|21048524|P2|COMPLETED|Second Intervention||30
8537605|NCT00271024|21048272|P4|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
8537606|NCT00271024|21048273|P3|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
8537607|NCT00271024|21048274|P2|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
8537608|NCT00271024|21048275|P1|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
8537609|NCT00271024|21048272|P4|STARTED|Overall Study||88
8537610|NCT00271024|21048273|P3|STARTED|Overall Study||88
8537611|NCT00271024|21048274|P2|STARTED|Overall Study||77
8537612|NCT00271024|21048275|P1|STARTED|Overall Study||80
8537613|NCT00271011|21048317|P1|NOT COMPLETED|Overall Study||0
8537614|NCT00271011|21048317|P1|COMPLETED|Overall Study||13
8537615|NCT00271011|21048317|P1|STARTED|Overall Study||13
8537616|NCT00270998|21048325|P3|NOT COMPLETED|12 Month Follow-up||21
8537617|NCT00270998|21048326|P2|NOT COMPLETED|12 Month Follow-up||25
8537618|NCT00270998|21048327|P1|NOT COMPLETED|12 Month Follow-up||14
8537619|NCT00270998|21048325|P3|COMPLETED|12 Month Follow-up||111
8537620|NCT00270998|21048326|P2|COMPLETED|12 Month Follow-up||99
8537621|NCT00270998|21048327|P1|COMPLETED|12 Month Follow-up||96
8537622|NCT00270998|21048325|P3|STARTED|12 Month Follow-up||132
8537623|NCT00270998|21048326|P2|STARTED|12 Month Follow-up||124
8537624|NCT00270998|21048327|P1|STARTED|12 Month Follow-up||110
8537625|NCT00270998|21048325|P3|NOT COMPLETED|3 Month Follow-up||18
8537626|NCT00270998|21048326|P2|NOT COMPLETED|3 Month Follow-up||22
8537627|NCT00270998|21048327|P1|NOT COMPLETED|3 Month Follow-up||39
8537628|NCT00270998|21048325|P3|COMPLETED|3 Month Follow-up||132
8537629|NCT00270998|21048326|P2|COMPLETED|3 Month Follow-up||124
8537630|NCT00270998|21048327|P1|COMPLETED|3 Month Follow-up||110
8537631|NCT00270998|21048325|P3|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
8537632|NCT00270998|21048326|P2|STARTED|3 Month Follow-up||146
8537633|NCT00270998|21048327|P1|STARTED|3 Month Follow-up||149
8537634|NCT00270894|21048356|P1|NOT COMPLETED|Overall Study||2
8537635|NCT00270894|21048356|P1|COMPLETED|Overall Study||28
8537636|NCT00270894|21048356|P1|STARTED|Overall Study||30
8537637|NCT00270855|21048368|P2|NOT COMPLETED|Overall Study||8
8537638|NCT00270855|21048369|P1|NOT COMPLETED|Overall Study||8
8537639|NCT00270855|21048368|P2|COMPLETED|Overall Study||6
8537640|NCT00270855|21048369|P1|COMPLETED|Overall Study||7
8537641|NCT00270855|21048368|P2|STARTED|Overall Study||14
8537642|NCT00270855|21048369|P1|STARTED|Overall Study||15
8537643|NCT00270842|21048428|P3|NOT COMPLETED|Overall Study||16
8537644|NCT00270842|21048429|P2|NOT COMPLETED|Overall Study||16
8537645|NCT00270842|21048430|P1|NOT COMPLETED|Overall Study||15
8537646|NCT00270842|21048428|P3|COMPLETED|Overall Study||18
8537647|NCT00270842|21048429|P2|COMPLETED|Overall Study||18
8537648|NCT00270842|21048430|P1|COMPLETED|Overall Study||18
8537649|NCT00270842|21048428|P3|STARTED|Overall Study||34
8537650|NCT00270842|21048429|P2|STARTED|Overall Study||34
8537651|NCT00270842|21048430|P1|STARTED|Overall Study||33
8537652|NCT00270790|21048441|P1|NOT COMPLETED|Overall Study||5
8537653|NCT00270790|21048441|P1|COMPLETED|Overall Study||16
8537654|NCT00270790|21048441|P1|STARTED|Overall Study||21
8537655|NCT00270634|21048450|P4|NOT COMPLETED|Overall Study||5
8537656|NCT00270634|21048451|P3|NOT COMPLETED|Overall Study||22
8537657|NCT00270634|21048452|P2|NOT COMPLETED|Overall Study||13
8537658|NCT00270634|21048453|P1|NOT COMPLETED|Overall Study||17
8537659|NCT00270634|21048450|P4|COMPLETED|Overall Study||81
8537660|NCT00270634|21048451|P3|COMPLETED|Overall Study||62
8537661|NCT00270634|21048452|P2|COMPLETED|Overall Study||64
8537662|NCT00270634|21048453|P1|COMPLETED|Overall Study||70
8537663|NCT00270634|21048450|P4|STARTED|Overall Study||86
8537664|NCT00270634|21048451|P3|STARTED|Overall Study||84
8537665|NCT00270634|21048452|P2|STARTED|Overall Study||77
8537666|NCT00270634|21048453|P1|STARTED|Overall Study||87
8537667|NCT00270296|21048490|P3|NOT COMPLETED|Overall Study||61
8537668|NCT00270296|21048491|P2|NOT COMPLETED|Overall Study||90
8537669|NCT00270296|21048492|P1|NOT COMPLETED|Overall Study||99
8537670|NCT00270296|21048490|P3|COMPLETED|Overall Study||109
8537671|NCT00270296|21048491|P2|COMPLETED|Overall Study||185
8537672|NCT00270296|21048492|P1|COMPLETED|Overall Study||186
8537673|NCT00270296|21048490|P3|STARTED|Overall Study||170
8537674|NCT00270296|21048491|P2|STARTED|Overall Study||275
8537675|NCT00270296|21048492|P1|STARTED|Overall Study||285
8537676|NCT00270257|21048505|P2|NOT COMPLETED|Overall Study||424
8537677|NCT00270257|21048506|P1|NOT COMPLETED|Overall Study||412
8537678|NCT00270257|21048505|P2|COMPLETED|Overall Study||204
8537679|NCT00270257|21048506|P1|COMPLETED|Overall Study||211
8537680|NCT00270257|21048505|P2|Visit 104|Overall Study||204
8537681|NCT00270257|21048506|P1|Visit 104|Overall Study||211
8537682|NCT00270257|21048505|P2|Week 78|Overall Study||285
8537683|NCT00270257|21048506|P1|Week 78|Overall Study||283
8537684|NCT00270257|21048505|P2|Week 52|Overall Study||340
8537685|NCT00270257|21048506|P1|Week 52|Overall Study||362
8537686|NCT00270257|21048505|P2|Week 26|Overall Study||440
8537687|NCT00270257|21048506|P1|Week 26|Overall Study||460
8537688|NCT00270257|21048505|P2|Week 8|Overall Study||443
8537689|NCT00270257|21048506|P1|Week 8|Overall Study||510
8537690|NCT00270257|21048505|P2|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
8537691|NCT00270257|21048506|P1|STARTED|Overall Study||623
8537692|NCT00270231|21048524|P2|NOT COMPLETED|Second Intervention||1
8537693|NCT00270231|21048525|P1|NOT COMPLETED|Second Intervention||0
8537695|NCT00270231|21048525|P1|COMPLETED|Second Intervention||30
8537696|NCT00270231|21048524|P2|STARTED|Second Intervention||31
8537697|NCT00270231|21048525|P1|STARTED|Second Intervention||30
8537698|NCT00270231|21048524|P2|NOT COMPLETED|Washout Period||0
8537699|NCT00270231|21048525|P1|NOT COMPLETED|Washout Period||1
8537700|NCT00270231|21048524|P2|COMPLETED|Washout Period||31
8537701|NCT00270231|21048525|P1|COMPLETED|Washout Period||30
8537702|NCT00270231|21048524|P2|STARTED|Washout Period||31
8537703|NCT00270231|21048525|P1|STARTED|Washout Period||31
8537704|NCT00270231|21048524|P2|NOT COMPLETED|First Intervention||1
8537705|NCT00270231|21048525|P1|NOT COMPLETED|First Intervention||1
8537706|NCT00270231|21048524|P2|COMPLETED|First Intervention||31
8537707|NCT00270231|21048525|P1|COMPLETED|First Intervention||31
8537708|NCT00270231|21048524|P2|STARTED|First Intervention||32
8537709|NCT00270231|21048525|P1|STARTED|First Intervention||32
8537710|NCT00270205|21048535|P4|NOT COMPLETED|Overall Study||1
8537711|NCT00270205|21048536|P3|NOT COMPLETED|Overall Study||0
8537712|NCT00270205|21048537|P2|NOT COMPLETED|Overall Study||0
8537713|NCT00270205|21048538|P1|NOT COMPLETED|Overall Study||1
8537714|NCT00270205|21048535|P4|COMPLETED|Overall Study||6
8537715|NCT00270205|21048536|P3|COMPLETED|Overall Study||6
8537716|NCT00270205|21048537|P2|COMPLETED|Overall Study||6
8537717|NCT00270205|21048538|P1|COMPLETED|Overall Study||5
8537718|NCT00270205|21048535|P4|STARTED|Overall Study||7
8537719|NCT00270205|21048536|P3|STARTED|Overall Study||6
8537720|NCT00270205|21048537|P2|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
8537721|NCT00270205|21048538|P1|STARTED|Overall Study||6
8537722|NCT00269919|21048656|P1|NOT COMPLETED|Overall Study||27
8537723|NCT00269919|21048656|P1|COMPLETED|Overall Study||13
8537724|NCT00269919|21048656|P1|Treated|Overall Study||39
8537725|NCT00269919|21048656|P1|STARTED|Overall Study||40
8537726|NCT00269633|21048675|P2|NOT COMPLETED|Overall Study||0
8537727|NCT00269633|21048676|P1|NOT COMPLETED|Overall Study||1
8537728|NCT00269633|21048675|P2|COMPLETED|Overall Study||5
8537729|NCT00269633|21048676|P1|COMPLETED|Overall Study||3
8537730|NCT00269633|21048675|P2|STARTED|Overall Study||5
8537731|NCT00269633|21048676|P1|STARTED|Overall Study||4
8537732|NCT00269477|21048686|P4|NOT COMPLETED|Overall Study||0
8537733|NCT00269477|21048687|P3|NOT COMPLETED|Overall Study||1
8537734|NCT00269477|21048688|P2|NOT COMPLETED|Overall Study||6
8537735|NCT00269477|21048689|P1|NOT COMPLETED|Overall Study||5
8537736|NCT00269477|21048686|P4|COMPLETED|Overall Study||60
8537737|NCT00269477|21048687|P3|COMPLETED|Overall Study||57
8537738|NCT00269477|21048688|P2|COMPLETED|Overall Study||12
8537739|NCT00269477|21048689|P1|COMPLETED|Overall Study||4
8537740|NCT00269477|21048686|P4|STARTED|Overall Study||60
8537741|NCT00269477|21048687|P3|STARTED|Overall Study||58
8537742|NCT00269477|21048688|P2|STARTED|Overall Study||18
8537743|NCT00269477|21048689|P1|STARTED|Overall Study||9
8537744|NCT00269399|21048705|P2|NOT COMPLETED|Overall Study||27
8537745|NCT00269399|21048706|P1|NOT COMPLETED|Overall Study||41
8537746|NCT00269399|21048705|P2|COMPLETED|Overall Study||91
8537747|NCT00269399|21048706|P1|COMPLETED|Overall Study||78
8537748|NCT00269399|21048705|P2|STARTED|Overall Study||118
8537749|NCT00269399|21048706|P1|STARTED|Overall Study||119
8537750|NCT00269152|21048716|P2|NOT COMPLETED|Overall Study||10
8537751|NCT00269152|21048717|P1|NOT COMPLETED|Overall Study||18
8537752|NCT00269152|21048716|P2|COMPLETED|Overall Study||49
8537753|NCT00269152|21048717|P1|COMPLETED|Overall Study||45
8537754|NCT00269152|21048716|P2|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
8537755|NCT00269152|21048717|P1|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
8537756|NCT00269113|21048733|P2|NOT COMPLETED|Overall Study||37
8537757|NCT00269113|21048734|P1|NOT COMPLETED|Overall Study||74
8537758|NCT00269113|21048733|P2|COMPLETED|Overall Study||146
8537759|NCT00269113|21048734|P1|COMPLETED|Overall Study||103
8537760|NCT00269113|21048733|P2|STARTED|Overall Study||183
8537761|NCT00269113|21048734|P1|STARTED|Overall Study||177
8537762|NCT00269087|21048752|P1|NOT COMPLETED|Overall Study||34
8537763|NCT00269087|21048752|P1|COMPLETED|Overall Study||88
8537764|NCT00269087|21048752|P1|STARTED|Overall Study||122
8537765|NCT00268996|21048782|P2|NOT COMPLETED|Overall Study||20
8537766|NCT00268996|21048783|P1|NOT COMPLETED|Overall Study||21
8537767|NCT00268996|21048782|P2|COMPLETED|Overall Study||152
8537768|NCT00268996|21048783|P1|COMPLETED|Overall Study||130
8537769|NCT00268996|21048782|P2|STARTED|Overall Study||172
8537770|NCT00268996|21048783|P1|STARTED|Overall Study||151
8537771|NCT00268983|21048827|P2|NOT COMPLETED|Overall Study||0
8537772|NCT00268983|21048828|P1|NOT COMPLETED|Overall Study||3
8537773|NCT00268983|21048827|P2|COMPLETED|Overall Study||8
8537774|NCT00268983|21048828|P1|COMPLETED|Overall Study||3
8537775|NCT00268983|21048827|P2|STARTED|Overall Study||8
8537776|NCT00268983|21048828|P1|STARTED|Overall Study||6
8537777|NCT00268905|21048871|P3|NOT COMPLETED|Overall Study||12
8537778|NCT00268905|21048872|P2|NOT COMPLETED|Overall Study||9
8537779|NCT00268905|21048873|P1|NOT COMPLETED|Overall Study||43
8537780|NCT00268905|21048871|P3|COMPLETED|Overall Study||0
8537781|NCT00268905|21048872|P2|COMPLETED|Overall Study||0
8537782|NCT00268905|21048873|P1|COMPLETED|Overall Study||0
8537783|NCT00268905|21048871|P3|STARTED|Overall Study||12
8537784|NCT00268905|21048872|P2|STARTED|Overall Study||9
8537785|NCT00268905|21048873|P1|STARTED|Overall Study||43
8537786|NCT00268892|21048890|P3|NOT COMPLETED|Overall Study||39
8537787|NCT00268892|21048891|P2|NOT COMPLETED|Overall Study||42
8537788|NCT00268892|21048892|P1|NOT COMPLETED|Overall Study||39
8537789|NCT00268892|21048890|P3|COMPLETED|Overall Study||54
8537790|NCT00268892|21048891|P2|COMPLETED|Overall Study||53
8537791|NCT00268892|21048892|P1|COMPLETED|Overall Study||51
8537792|NCT00268892|21048890|P3|Switched to Higher Dose|Overall Study||76
8537793|NCT00268892|21048891|P2|Switched to Higher Dose|Overall Study||68
8537794|NCT00268892|21048892|P1|Switched to Higher Dose|Overall Study||59
8537795|NCT00268892|21048890|P3|STARTED|Overall Study||93
8537796|NCT00268892|21048891|P2|STARTED|Overall Study||95
8537797|NCT00268892|21048892|P1|STARTED|Overall Study||90
8537798|NCT00268762|21048903|P1|NOT COMPLETED|Overall Study||0
8537799|NCT00268762|21048903|P1|COMPLETED|Overall Study||65
8537800|NCT00268762|21048903|P1|STARTED|Overall Study||65
8537801|NCT00268463|21048911|P2|NOT COMPLETED|Overall Study||12
8537802|NCT00268463|21048912|P1|NOT COMPLETED|Overall Study||10
8537803|NCT00268463|21048911|P2|COMPLETED|Overall Study||0
8537804|NCT00268463|21048912|P1|COMPLETED|Overall Study||0
8537805|NCT00268463|21048911|P2|STARTED|Overall Study||12
8537806|NCT00268463|21048912|P1|STARTED|Overall Study||10
8537807|NCT00268450|21048918|P1|NOT COMPLETED|Overall Study||0
8537808|NCT00268450|21048918|P1|COMPLETED|Overall Study||21
8537809|NCT00268450|21048918|P1|STARTED|Overall Study||21
8537810|NCT00268437|21048928|P1|NOT COMPLETED|Overall Study||1
8537811|NCT00268437|21048928|P1|COMPLETED|Overall Study||26
8537812|NCT00268437|21048928|P1|STARTED|Overall Study||27
8537813|NCT00268346|21048935|P2|NOT COMPLETED|Overall Study||3
8537814|NCT00268346|21048936|P1|NOT COMPLETED|Overall Study||0
8537815|NCT00268346|21048935|P2|COMPLETED|Overall Study||37
8537816|NCT00268346|21048936|P1|COMPLETED|Overall Study||18
8537817|NCT00268346|21048935|P2|Started Treatment|Overall Study||40
8537818|NCT00268346|21048936|P1|Started Treatment|Overall Study||18
8537819|NCT00268346|21048935|P2|STARTED|Overall Study||40
8537820|NCT00268346|21048936|P1|STARTED|Overall Study||18
8537821|NCT00268242|21048942|P1|NOT COMPLETED|Overall Study||1
8537822|NCT00268242|21048942|P1|COMPLETED|Overall Study||23
8537823|NCT00268242|21048942|P1|STARTED|Overall Study||24
8537824|NCT00268203|21048951|P1|NOT COMPLETED|Overall Study||647
8537825|NCT00268203|21048951|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
8537826|NCT00268203|21048951|P1|Completed 2 Years of Follow-up|Overall Study||62
8537827|NCT00268203|21048951|P1|STARTED|Overall Study||765
8537828|NCT00267969|21048965|P7|NOT COMPLETED|After Controlled Period||72
8537829|NCT00267969|21048966|P6|NOT COMPLETED|After Controlled Period||82
8537830|NCT00267969|21048967|P5|NOT COMPLETED|After Controlled Period||35
8537831|NCT00267969|21048968|P4|NOT COMPLETED|After Controlled Period||36
8537832|NCT00267969|21048969|P3|NOT COMPLETED|After Controlled Period||0
8537833|NCT00267969|21048970|P2|NOT COMPLETED|After Controlled Period||0
8537834|NCT00267969|21048971|P1|NOT COMPLETED|After Controlled Period||0
8537835|NCT00267969|21048965|P7|COMPLETED|After Controlled Period||173
8537836|NCT00267969|21048966|P6|COMPLETED|After Controlled Period||172
8537837|NCT00267969|21048967|P5|COMPLETED|After Controlled Period||85
8537838|NCT00267969|21048968|P4|COMPLETED|After Controlled Period||87
8537839|NCT00267969|21048969|P3|COMPLETED|After Controlled Period||0
8537840|NCT00267969|21048970|P2|COMPLETED|After Controlled Period||0
8537841|NCT00267969|21048971|P1|COMPLETED|After Controlled Period||0
8537842|NCT00267969|21048965|P7|STARTED|After Controlled Period||245
8537843|NCT00267969|21048966|P6|STARTED|After Controlled Period||254
8537844|NCT00267969|21048967|P5|STARTED|After Controlled Period||120
8537845|NCT00267969|21048968|P4|STARTED|After Controlled Period||123
8537846|NCT00267969|21048969|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8537847|NCT00267969|21048970|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8537848|NCT00267969|21048971|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8537849|NCT00267969|21048965|P7|NOT COMPLETED|Controlled Period||0
8537850|NCT00267969|21048966|P6|NOT COMPLETED|Controlled Period||0
8537851|NCT00267969|21048967|P5|NOT COMPLETED|Controlled Period||0
8537852|NCT00267969|21048968|P4|NOT COMPLETED|Controlled Period||0
8537853|NCT00267969|21048969|P3|NOT COMPLETED|Controlled Period||11
8537854|NCT00267969|21048970|P2|NOT COMPLETED|Controlled Period||1
8537855|NCT00267969|21048971|P1|NOT COMPLETED|Controlled Period||12
8537856|NCT00267969|21048965|P7|COMPLETED|Controlled Period||0
8537857|NCT00267969|21048966|P6|COMPLETED|Controlled Period||0
8537858|NCT00267969|21048967|P5|COMPLETED|Controlled Period||0
8537859|NCT00267969|21048968|P4|COMPLETED|Controlled Period||0
8537860|NCT00267969|21048969|P3|COMPLETED|Controlled Period||245
8537861|NCT00267969|21048970|P2|COMPLETED|Controlled Period||254
8537862|NCT00267969|21048971|P1|COMPLETED|Controlled Period||243
8537863|NCT00267969|21048965|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8537864|NCT00267969|21048966|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8537865|NCT00267969|21048967|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8537866|NCT00267969|21048968|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8537867|NCT00267969|21048969|P3|STARTED|Controlled Period|Number of patients randomized|256
8537868|NCT00267969|21048970|P2|STARTED|Controlled Period|Number of patients randomized|255
8537869|NCT00267969|21048971|P1|STARTED|Controlled Period|Number of patients randomized|255
8537870|NCT00267956|21048997|P4|NOT COMPLETED|After Controlled Period||2
8537871|NCT00267956|21048998|P3|NOT COMPLETED|After Controlled Period||5
8537872|NCT00267956|21048999|P2|NOT COMPLETED|After Controlled Period||0
8537873|NCT00267956|21049000|P1|NOT COMPLETED|After Controlled Period||0
8537874|NCT00267956|21048997|P4|COMPLETED|After Controlled Period||70
8537875|NCT00267956|21048998|P3|COMPLETED|After Controlled Period||52
8537876|NCT00267956|21048999|P2|COMPLETED|After Controlled Period||0
8537877|NCT00267956|21049000|P1|COMPLETED|After Controlled Period||0
8537878|NCT00267956|21048997|P4|STARTED|After Controlled Period||72
8537879|NCT00267956|21048998|P3|STARTED|After Controlled Period||57
8537880|NCT00267956|21048999|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8537881|NCT00267956|21049000|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
8537882|NCT00267956|21048997|P4|NOT COMPLETED|Controlled Period||0
8537883|NCT00267956|21048998|P3|NOT COMPLETED|Controlled Period||0
8537884|NCT00267956|21048999|P2|NOT COMPLETED|Controlled Period||4
8537885|NCT00267956|21049000|P1|NOT COMPLETED|Controlled Period||13
8537886|NCT00267956|21048997|P4|COMPLETED|Controlled Period||0
8537887|NCT00267956|21048998|P3|COMPLETED|Controlled Period||0
8537888|NCT00267956|21048999|P2|COMPLETED|Controlled Period||72
8537889|NCT00267956|21049000|P1|COMPLETED|Controlled Period||57
8537890|NCT00267956|21048997|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8537891|NCT00267956|21048998|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
8537892|NCT00267956|21048999|P2|STARTED|Controlled Period||76
8537893|NCT00267956|21049000|P1|STARTED|Controlled Period||70
8537894|NCT00267865|21049018|P1|NOT COMPLETED|Consolidation Treatment||0
8537895|NCT00267865|21049018|P1|COMPLETED|Consolidation Treatment||5
8537896|NCT00267865|21049018|P1|STARTED|Consolidation Treatment||5
8537897|NCT00267865|21049018|P1|NOT COMPLETED|Induction Treatment||3
8537898|NCT00267865|21049018|P1|COMPLETED|Induction Treatment||9
8537899|NCT00267865|21049018|P1|STARTED|Induction Treatment||12
8537900|NCT00267774|21049029|P2|NOT COMPLETED|Overall Study||0
8537901|NCT00267774|21049030|P1|NOT COMPLETED|Overall Study||0
8537902|NCT00267774|21049029|P2|COMPLETED|Overall Study||496
8537903|NCT00267774|21049030|P1|COMPLETED|Overall Study||509
8537904|NCT00267774|21049029|P2|STARTED|Overall Study||496
8537905|NCT00267774|21049030|P1|STARTED|Overall Study||509
8537906|NCT00267748|21049041|P3|NOT COMPLETED|Randomized Period||132
8537907|NCT00267748|21049042|P2|NOT COMPLETED|Randomized Period||127
8537908|NCT00267748|21049043|P1|NOT COMPLETED|Randomized Period||0
8537909|NCT00267748|21049041|P3|COMPLETED|Randomized Period||14
8537910|NCT00267748|21049042|P2|COMPLETED|Randomized Period||19
8537911|NCT00267748|21049043|P1|COMPLETED|Randomized Period||0
8537912|NCT00267748|21049041|P3|Treated|Randomized Period||143
8537913|NCT00267748|21049042|P2|Treated|Randomized Period||146
8537914|NCT00267748|21049043|P1|Treated|Randomized Period||0
8537915|NCT00267748|21049041|P3|STARTED|Randomized Period||146
8537916|NCT00267748|21049042|P2|STARTED|Randomized Period||146
8537917|NCT00267748|21049043|P1|STARTED|Randomized Period||0
8537918|NCT00267748|21049041|P3|NOT COMPLETED|Non-randomized Period||0
8537919|NCT00267748|21049042|P2|NOT COMPLETED|Non-randomized Period||0
8537920|NCT00267748|21049043|P1|NOT COMPLETED|Non-randomized Period||23
8537921|NCT00267748|21049041|P3|COMPLETED|Non-randomized Period||0
8537922|NCT00267748|21049042|P2|COMPLETED|Non-randomized Period||0
8537923|NCT00267748|21049043|P1|COMPLETED|Non-randomized Period||2
8537924|NCT00267748|21049041|P3|STARTED|Non-randomized Period||0
8537925|NCT00267748|21049042|P2|STARTED|Non-randomized Period||0
8537926|NCT00267748|21049043|P1|STARTED|Non-randomized Period||25
8537927|NCT00267696|21049060|P1|NOT COMPLETED|Overall Study||0
8537928|NCT00267696|21049060|P1|COMPLETED|Overall Study||45
8537929|NCT00267696|21049060|P1|STARTED|Overall Study||45
8537930|NCT00267670|21049067|P2|NOT COMPLETED|Overall Study||0
8537931|NCT00267670|21049068|P1|NOT COMPLETED|Overall Study||4
8537932|NCT00267670|21049067|P2|COMPLETED|Overall Study||7
8537933|NCT00267670|21049068|P1|COMPLETED|Overall Study||15
8537934|NCT00267670|21049067|P2|STARTED|Overall Study||7
8537935|NCT00267670|21049068|P1|STARTED|Overall Study||19
8537936|NCT00267644|21049082|P2|NOT COMPLETED|Overall Study||0
8537937|NCT00267644|21049083|P1|NOT COMPLETED|Overall Study||0
8537938|NCT00267644|21049082|P2|COMPLETED|Overall Study||63
8537939|NCT00267644|21049083|P1|COMPLETED|Overall Study||13
8537940|NCT00267644|21049082|P2|STARTED|Overall Study||63
8537941|NCT00267644|21049083|P1|STARTED|Overall Study||13
8537942|NCT00267631|21049093|P2|NOT COMPLETED|Overall Study||0
8537943|NCT00267631|21049094|P1|NOT COMPLETED|Overall Study||0
8537944|NCT00267631|21049093|P2|COMPLETED|Overall Study||3031
8537945|NCT00267631|21049094|P1|COMPLETED|Overall Study||2361
8537946|NCT00267631|21049093|P2|STARTED|Overall Study||3031
8537947|NCT00267631|21049094|P1|STARTED|Overall Study||2361
8537948|NCT00267488|21049100|P1|NOT COMPLETED|Overall Study||11
8537949|NCT00267488|21049100|P1|COMPLETED|Overall Study||26
8537950|NCT00267488|21049100|P1|STARTED|Overall Study||37
8537951|NCT00267293|21049112|P3|NOT COMPLETED|Overall Study||0
8537952|NCT00267293|21049113|P2|NOT COMPLETED|Overall Study||0
8537953|NCT00267293|21049114|P1|NOT COMPLETED|Overall Study||0
8537954|NCT00267293|21049112|P3|COMPLETED|Overall Study||20
8537955|NCT00267293|21049113|P2|COMPLETED|Overall Study||20
8537956|NCT00267293|21049114|P1|COMPLETED|Overall Study||20
8537957|NCT00267293|21049112|P3|STARTED|Overall Study||20
8537958|NCT00267293|21049113|P2|STARTED|Overall Study||20
8537959|NCT00267293|21049114|P1|STARTED|Overall Study||20
8537960|NCT00267202|21049124|P2|NOT COMPLETED|Overall Study||34
8537961|NCT00267202|21049125|P1|NOT COMPLETED|Overall Study||53
8537962|NCT00267202|21049124|P2|COMPLETED|Overall Study||105
8537963|NCT00267202|21049125|P1|COMPLETED|Overall Study||83
8537964|NCT00267202|21049124|P2|STARTED|Overall Study||139
8537965|NCT00267202|21049125|P1|STARTED|Overall Study||136
8537966|NCT00267189|21049146|P2|NOT COMPLETED|Overall Study||1
8537967|NCT00267189|21049147|P1|NOT COMPLETED|Overall Study||5
8537968|NCT00267189|21049146|P2|COMPLETED|Overall Study||72
8537969|NCT00267189|21049147|P1|COMPLETED|Overall Study|"Completed indicates completed study."|67
8537970|NCT00267189|21049146|P2|Completed Study Medication|Overall Study||72
8537971|NCT00267189|21049147|P1|Completed Study Medication|Overall Study||54
8537972|NCT00267189|21049146|P2|STARTED|Overall Study||73
8537973|NCT00267189|21049147|P1|STARTED|Overall Study|Intention to treat (ITT) population.|72
8537974|NCT00267150|21049157|P1|NOT COMPLETED|Overall Study||1
8537975|NCT00267150|21049157|P1|COMPLETED|Overall Study||30
8537976|NCT00267150|21049157|P1|STARTED|Overall Study||31
8537977|NCT00267111|21049164|P2|NOT COMPLETED|Overall Study||0
8537978|NCT00267111|21049165|P1|NOT COMPLETED|Overall Study||0
8537979|NCT00267111|21049164|P2|COMPLETED|Overall Study||55
8537980|NCT00267111|21049165|P1|COMPLETED|Overall Study||55
8537981|NCT00267111|21049164|P2|STARTED|Overall Study||55
8537982|NCT00267111|21049165|P1|STARTED|Overall Study||55
8537983|NCT00267098|21049181|P8|NOT COMPLETED|Overall Study||15
8537984|NCT00267098|21049182|P7|NOT COMPLETED|Overall Study||46
8537985|NCT00267098|21049183|P6|NOT COMPLETED|Overall Study||40
8537986|NCT00267098|21049184|P5|NOT COMPLETED|Overall Study||37
8537987|NCT00267098|21049185|P4|NOT COMPLETED|Overall Study||106
8537988|NCT00267098|21049186|P3|NOT COMPLETED|Overall Study||94
8537989|NCT00267098|21049187|P2|NOT COMPLETED|Overall Study||51
8537990|NCT00267098|21049188|P1|NOT COMPLETED|Overall Study||109
8537991|NCT00267098|21049181|P8|COMPLETED|Overall Study||5
8537992|NCT00267098|21049182|P7|COMPLETED|Overall Study||55
8537993|NCT00267098|21049183|P6|COMPLETED|Overall Study||66
8537994|NCT00267098|21049184|P5|COMPLETED|Overall Study||10
8537995|NCT00267098|21049185|P4|COMPLETED|Overall Study||135
8537996|NCT00267098|21049186|P3|COMPLETED|Overall Study||149
8537997|NCT00267098|21049187|P2|COMPLETED|Overall Study||0
8537998|NCT00267098|21049188|P1|COMPLETED|Overall Study||0
8537999|NCT00267098|21049181|P8|STARTED|Overall Study||20
8538000|NCT00267098|21049182|P7|STARTED|Overall Study||101
8538001|NCT00267098|21049183|P6|STARTED|Overall Study||106
8538002|NCT00267098|21049184|P5|STARTED|Overall Study||47
8538003|NCT00267098|21049185|P4|STARTED|Overall Study||241
8538004|NCT00267098|21049186|P3|STARTED|Overall Study||243
8538005|NCT00267098|21049187|P2|STARTED|Overall Study||51
8538006|NCT00267098|21049188|P1|STARTED|Overall Study||109
8538007|NCT00267085|21049321|P1|NOT COMPLETED|Overall Study||0
8538008|NCT00267085|21049321|P1|COMPLETED|Overall Study||10
8538009|NCT00267085|21049321|P1|STARTED|Overall Study||10
8538010|NCT00267059|21049325|P1|NOT COMPLETED|Overall Study||0
8538011|NCT00267059|21049325|P1|COMPLETED|Overall Study||44
8538012|NCT00267059|21049325|P1|STARTED|Overall Study||44
8538013|NCT00267046|21049331|P2|NOT COMPLETED|Overall Study||11
8538014|NCT00267046|21049332|P1|NOT COMPLETED|Overall Study||12
8538015|NCT00267046|21049331|P2|COMPLETED|Overall Study||5
8538016|NCT00267046|21049332|P1|COMPLETED|Overall Study||20
8538017|NCT00267046|21049331|P2|STARTED|Overall Study||16
8538018|NCT00267046|21049332|P1|STARTED|Overall Study||32
8538019|NCT00267020|21049342|P2|NOT COMPLETED|Overall Study||43
8538020|NCT00267020|21049343|P1|NOT COMPLETED|Overall Study||86
8538021|NCT00267020|21049342|P2|COMPLETED|Overall Study||1
8538022|NCT00267020|21049343|P1|COMPLETED|Overall Study||0
8538023|NCT00267020|21049342|P2|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|38
8538024|NCT00267020|21049343|P1|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|81
8538025|NCT00267020|21049342|P2|Received at Least 1 Dose|Overall Study||39
8538026|NCT00267020|21049343|P1|Received at Least 1 Dose|Overall Study||82
8538027|NCT00267020|21049342|P2|STARTED|Overall Study||44
8538028|NCT00267020|21049343|P1|STARTED|Overall Study||86
8538029|NCT00267007|21049365|P2|NOT COMPLETED|Overall Study||1
8538030|NCT00267007|21049366|P1|NOT COMPLETED|Overall Study||8
8538031|NCT00267007|21049365|P2|COMPLETED|Overall Study||10
8538032|NCT00267007|21049366|P1|COMPLETED|Overall Study||11
8538033|NCT00267007|21049365|P2|STARTED|Overall Study||11
8538034|NCT00267007|21049366|P1|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
8538035|NCT00266877|21049377|P3|NOT COMPLETED|Overall Study||28
8538036|NCT00266877|21049378|P2|NOT COMPLETED|Overall Study||48
8538037|NCT00266877|21049379|P1|NOT COMPLETED|Overall Study||91
8538038|NCT00266877|21049377|P3|COMPLETED|Overall Study||0
8538039|NCT00266877|21049378|P2|COMPLETED|Overall Study||0
8538040|NCT00266877|21049379|P1|COMPLETED|Overall Study||0
8538041|NCT00266877|21049377|P3|STARTED|Overall Study||28
8538042|NCT00266877|21049378|P2|STARTED|Overall Study||48
8538043|NCT00266877|21049379|P1|STARTED|Overall Study||91
8538044|NCT00266864|21049398|P2|NOT COMPLETED|Overall Study||2
8538045|NCT00266864|21049399|P1|NOT COMPLETED|Overall Study||5
8538046|NCT00266864|21049398|P2|COMPLETED|Overall Study||11
8538047|NCT00266864|21049399|P1|COMPLETED|Overall Study||13
8538048|NCT00266864|21049398|P2|STARTED|Overall Study||13
8538049|NCT00266864|21049399|P1|STARTED|Overall Study||18
8538050|NCT00266851|21049409|P3|NOT COMPLETED|Overall Study||0
8538051|NCT00266851|21049410|P2|NOT COMPLETED|Overall Study||0
8538052|NCT00266851|21049411|P1|NOT COMPLETED|Overall Study||0
8538053|NCT00266851|21049409|P3|COMPLETED|Overall Study||22
8538054|NCT00266851|21049410|P2|COMPLETED|Overall Study||38
8538055|NCT00266851|21049411|P1|COMPLETED|Overall Study||37
8538056|NCT00266851|21049409|P3|Completed 12 Month Follow up|Overall Study||13
8538057|NCT00266851|21049410|P2|Completed 12 Month Follow up|Overall Study||19
8538058|NCT00266851|21049411|P1|Completed 12 Month Follow up|Overall Study||25
8538059|NCT00266851|21049409|P3|Completed 9 Month Follow up|Overall Study||15
8538060|NCT00266851|21049410|P2|Completed 9 Month Follow up|Overall Study||23
8538061|NCT00266851|21049411|P1|Completed 9 Month Follow up|Overall Study||22
8538062|NCT00266851|21049409|P3|Completed 6 Month Follow up|Overall Study||17
8538063|NCT00266851|21049410|P2|Completed 6 Month Follow up|Overall Study||22
8538064|NCT00266851|21049411|P1|Completed 6 Month Follow up|Overall Study||27
8538065|NCT00266851|21049409|P3|Completed 3 Month Follow up|Overall Study||15
8538066|NCT00266851|21049410|P2|Completed 3 Month Follow up|Overall Study||22
8538067|NCT00266851|21049411|P1|Completed 3 Month Follow up|Overall Study||26
8538068|NCT00266851|21049409|P3|STARTED|Overall Study||22
8538069|NCT00266851|21049410|P2|STARTED|Overall Study||38
8538070|NCT00266851|21049411|P1|STARTED|Overall Study||37
8538071|NCT00266825|21049430|P2|NOT COMPLETED|Completed Follow-Up||24
8538072|NCT00266825|21049431|P1|NOT COMPLETED|Completed Follow-Up||25
8538073|NCT00266825|21049430|P2|COMPLETED|Completed Follow-Up||154
8538074|NCT00266825|21049431|P1|COMPLETED|Completed Follow-Up||147
8538075|NCT00266825|21049430|P2|STARTED|Completed Follow-Up||178
8538076|NCT00266825|21049431|P1|STARTED|Completed Follow-Up||172
8538077|NCT00266825|21049430|P2|NOT COMPLETED|Enrolled and Allocated Intervention||0
8538078|NCT00266825|21049431|P1|NOT COMPLETED|Enrolled and Allocated Intervention||0
8538079|NCT00266825|21049430|P2|COMPLETED|Enrolled and Allocated Intervention||178
8538080|NCT00266825|21049431|P1|COMPLETED|Enrolled and Allocated Intervention||172
8538081|NCT00266825|21049430|P2|STARTED|Enrolled and Allocated Intervention||178
8538082|NCT00266825|21049431|P1|STARTED|Enrolled and Allocated Intervention||172
8538083|NCT00266812|21049457|P2|NOT COMPLETED|Overall Study||11
8538084|NCT00266812|21049458|P1|NOT COMPLETED|Overall Study||21
8538085|NCT00266812|21049457|P2|COMPLETED|Overall Study||2
8538086|NCT00266812|21049458|P1|COMPLETED|Overall Study||1
8538087|NCT00266812|21049457|P2|STARTED|Overall Study||13
8538088|NCT00266812|21049458|P1|STARTED|Overall Study||22
8538089|NCT00266799|21049466|P2|NOT COMPLETED|Overall Study||34
8538090|NCT00266799|21049467|P1|NOT COMPLETED|Overall Study||36
8538091|NCT00266799|21049466|P2|COMPLETED|Overall Study||68
8538092|NCT00266799|21049467|P1|COMPLETED|Overall Study||62
8538093|NCT00266799|21049466|P2|STARTED|Overall Study||102
8538094|NCT00266799|21049467|P1|STARTED|Overall Study||98
8538095|NCT00266708|21049483|P2|NOT COMPLETED|Overall Study||9
8538096|NCT00266708|21049484|P1|NOT COMPLETED|Overall Study||4
8538097|NCT00266708|21049483|P2|COMPLETED|Overall Study||13
8538098|NCT00266708|21049484|P1|COMPLETED|Overall Study||16
8538099|NCT00266708|21049483|P2|STARTED|Overall Study||22
8538100|NCT00266708|21049484|P1|STARTED|Overall Study||20
8538101|NCT00266695|21049524|P1|NOT COMPLETED|Overall Study||29
8538102|NCT00266695|21049524|P1|COMPLETED|Overall Study||174
8538103|NCT00266695|21049524|P1|STARTED|Overall Study||203
8538104|NCT00266656|21049536|P2|NOT COMPLETED|Overall Study||13
8538105|NCT00266656|21049537|P1|NOT COMPLETED|Overall Study||14
8538106|NCT00266656|21049536|P2|COMPLETED|Overall Study||20
8538107|NCT00266656|21049537|P1|COMPLETED|Overall Study||22
8538108|NCT00266656|21049536|P2|STARTED|Overall Study||33
8538109|NCT00266656|21049537|P1|STARTED|Overall Study||36
8538110|NCT00266630|21049561|P2|NOT COMPLETED|Overall Study||28
8538111|NCT00266630|21049562|P1|NOT COMPLETED|Overall Study||42
8538112|NCT00266630|21049561|P2|COMPLETED|Overall Study||11
8538113|NCT00266630|21049562|P1|COMPLETED|Overall Study||58
8538114|NCT00266630|21049561|P2|STARTED|Overall Study||39
8538115|NCT00266630|21049562|P1|STARTED|Overall Study||100
8538116|NCT00266409|21049604|P4|NOT COMPLETED|Overall Study||22
8538117|NCT00266409|21049605|P3|NOT COMPLETED|Overall Study||17
8538118|NCT00266409|21049606|P2|NOT COMPLETED|Overall Study||46
8538119|NCT00266409|21049607|P1|NOT COMPLETED|Overall Study||45
8538120|NCT00266409|21049604|P4|COMPLETED|Overall Study||49
8538121|NCT00266409|21049605|P3|COMPLETED|Overall Study||55
8538122|NCT00266409|21049606|P2|COMPLETED|Overall Study||92
8538123|NCT00266409|21049607|P1|COMPLETED|Overall Study||92
8538124|NCT00266409|21049604|P4|STARTED|Overall Study||71
8538125|NCT00266409|21049605|P3|STARTED|Overall Study||72
8538126|NCT00266409|21049606|P2|STARTED|Overall Study||138
8538127|NCT00266409|21049607|P1|STARTED|Overall Study||137
8538128|NCT00266279|21049889|P1|NOT COMPLETED|Overall Study||2
8538129|NCT00266279|21049889|P1|COMPLETED|Overall Study||15
8538130|NCT00266279|21049889|P1|STARTED|Overall Study||17
8538131|NCT00266227|21049896|P3|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
8538132|NCT00266227|21049897|P2|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
8538133|NCT00266227|21049898|P1|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
8538134|NCT00266227|21049896|P3|COMPLETED|Retreatment: Week 48 to Week 72||0
8538135|NCT00266227|21049897|P2|COMPLETED|Retreatment: Week 48 to Week 72||92
8538136|NCT00266227|21049898|P1|COMPLETED|Retreatment: Week 48 to Week 72||227
8538137|NCT00266227|21049896|P3|STARTED|Retreatment: Week 48 to Week 72||0
8538138|NCT00266227|21049897|P2|STARTED|Retreatment: Week 48 to Week 72||134
8538139|NCT00266227|21049898|P1|STARTED|Retreatment: Week 48 to Week 72||291
8538140|NCT00266227|21049896|P3|NOT COMPLETED|Retreatment: Up to Week 48||0
8538141|NCT00266227|21049897|P2|NOT COMPLETED|Retreatment: Up to Week 48||23
8538142|NCT00266227|21049898|P1|NOT COMPLETED|Retreatment: Up to Week 48||27
8538143|NCT00266227|21049896|P3|COMPLETED|Retreatment: Up to Week 48||0
8538144|NCT00266227|21049897|P2|COMPLETED|Retreatment: Up to Week 48||134
8538145|NCT00266227|21049898|P1|COMPLETED|Retreatment: Up to Week 48||291
8538146|NCT00266227|21049896|P3|STARTED|Retreatment: Up to Week 48||0
8538147|NCT00266227|21049897|P2|STARTED|Retreatment: Up to Week 48||157
8538148|NCT00266227|21049898|P1|STARTED|Retreatment: Up to Week 48||318
8538149|NCT00266227|21049896|P3|NOT COMPLETED|Initial Treatment||77
8538150|NCT00266227|21049897|P2|NOT COMPLETED|Initial Treatment||0
8538151|NCT00266227|21049898|P1|NOT COMPLETED|Initial Treatment||0
8538152|NCT00266227|21049896|P3|COMPLETED|Initial Treatment||482
8538153|NCT00266227|21049897|P2|COMPLETED|Initial Treatment||0
8538154|NCT00266227|21049898|P1|COMPLETED|Initial Treatment||0
8538155|NCT00266227|21049896|P3|STARTED|Initial Treatment||559
8538156|NCT00266227|21049897|P2|STARTED|Initial Treatment||0
8538157|NCT00266227|21049898|P1|STARTED|Initial Treatment||0
8538158|NCT00266110|21049943|P1|NOT COMPLETED|Overall Study||7
8538159|NCT00266110|21049943|P1|COMPLETED|Overall Study||10
8538160|NCT00266110|21049943|P1|STARTED|Overall Study||17
8538161|NCT00266032|21049952|P3|NOT COMPLETED|Open-label Safety Extension||25
8538162|NCT00266032|21049953|P2|NOT COMPLETED|Open-label Safety Extension||14
8538163|NCT00266032|21049954|P1|NOT COMPLETED|Open-label Safety Extension||41
8538164|NCT00266032|21049952|P3|COMPLETED|Open-label Safety Extension||140
8538165|NCT00266032|21049953|P2|COMPLETED|Open-label Safety Extension||115
8538166|NCT00266032|21049954|P1|COMPLETED|Open-label Safety Extension||448
8538167|NCT00266032|21049952|P3|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
8538168|NCT00266032|21049953|P2|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
8538169|NCT00266032|21049954|P1|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
8538170|NCT00266032|21049952|P3|NOT COMPLETED|Treatment||47
8538171|NCT00266032|21049953|P2|NOT COMPLETED|Treatment||64
8538172|NCT00266032|21049954|P1|NOT COMPLETED|Treatment||111
8538173|NCT00266032|21049952|P3|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
8538174|NCT00266032|21049953|P2|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
8538175|NCT00266032|21049954|P1|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
8538176|NCT00266032|21049952|P3|Patients Treated and in FAS|Treatment|FAS|216
8538177|NCT00266032|21049953|P2|Patients Treated and in FAS|Treatment|FAS|209
8538178|NCT00266032|21049954|P1|Patients Treated and in FAS|Treatment|FAS|642
8538179|NCT00266032|21049952|P3|Patients Treated|Treatment||229
8538180|NCT00266032|21049953|P2|Patients Treated|Treatment||221
8538181|NCT00266032|21049954|P1|Patients Treated|Treatment||684
8538182|NCT00266032|21049952|P3|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
8538183|NCT00266032|21049953|P2|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
8538184|NCT00266032|21049954|P1|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
8538185|NCT00265980|21049982|P1|NOT COMPLETED|Overall Study||0
8538186|NCT00265980|21049982|P1|COMPLETED|Overall Study||22
8538187|NCT00265980|21049982|P1|Weight -10% Leptin|Overall Study||22
8538188|NCT00265980|21049982|P1|Weight -10% Placebo|Overall Study||22
8538189|NCT00265980|21049982|P1|Weight Initial|Overall Study||22
8538190|NCT00265980|21049982|P1|STARTED|Overall Study||22
8538191|NCT00265941|21049989|P2|NOT COMPLETED|Overall Study||26
8538192|NCT00265941|21049990|P1|NOT COMPLETED|Overall Study||23
8538193|NCT00265941|21049989|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
8538194|NCT00265941|21049990|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
8538195|NCT00265941|21049989|P2|STARTED|Overall Study||470
8538196|NCT00265941|21049990|P1|STARTED|Overall Study||470
8538197|NCT00265889|21050022|P1|NOT COMPLETED|Overall Study||5
8538198|NCT00265889|21050022|P1|COMPLETED|Overall Study||37
8538199|NCT00265889|21050022|P1|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
8538200|NCT00265889|21050022|P1|Cycle 1: 1st Regimen/Transplant|Overall Study||37
8538201|NCT00265889|21050022|P1|STARTED|Overall Study||42
8538202|NCT00265850|21050031|P3|NOT COMPLETED|Overall Study||0
8538203|NCT00265850|21050032|P2|NOT COMPLETED|Overall Study||0
8538204|NCT00265850|21050033|P1|NOT COMPLETED|Overall Study||0
8538205|NCT00265850|21050031|P3|COMPLETED|Overall Study||533
8538206|NCT00265850|21050032|P2|COMPLETED|Overall Study||902
8538207|NCT00265850|21050033|P1|COMPLETED|Overall Study||899
8538208|NCT00265850|21050031|P3|STARTED|Overall Study||533
8538209|NCT00265850|21050032|P2|STARTED|Overall Study||902
8538210|NCT00265850|21050033|P1|STARTED|Overall Study||899
8538214|NCT00265785|21050049|P1|NOT COMPLETED|Overall Study||27
8538215|NCT00265785|21050049|P1|COMPLETED|Overall Study||0
8538216|NCT00265785|21050049|P1|Eligible and Began Protocol Treatment|Overall Study||24
8538217|NCT00265785|21050049|P1|Eligible|Overall Study||26
8538218|NCT00265785|21050049|P1|STARTED|Overall Study||27
8538219|NCT00265759|21050062|P4|NOT COMPLETED|Overall Study||9
8538220|NCT00265759|21050063|P3|NOT COMPLETED|Overall Study||2
8538221|NCT00265759|21050064|P2|NOT COMPLETED|Overall Study||1
8538222|NCT00265759|21050065|P1|NOT COMPLETED|Overall Study||0
8538223|NCT00265759|21050062|P4|COMPLETED|Overall Study||236
8538224|NCT00265759|21050063|P3|COMPLETED|Overall Study||123
8538225|NCT00265759|21050064|P2|COMPLETED|Overall Study||127
8538226|NCT00265759|21050065|P1|COMPLETED|Overall Study||124
8538227|NCT00265759|21050062|P4|STARTED|Overall Study||245
8538228|NCT00265759|21050063|P3|STARTED|Overall Study||125
8538229|NCT00265759|21050064|P2|STARTED|Overall Study||128
8538230|NCT00265759|21050065|P1|STARTED|Overall Study||124
8538231|NCT00265616|21050096|P2|NOT COMPLETED|Overall Study||0
8538232|NCT00265616|21050097|P1|NOT COMPLETED|Overall Study||0
8538233|NCT00265616|21050096|P2|COMPLETED|Overall Study||9
8538234|NCT00265616|21050097|P1|COMPLETED|Overall Study||14
8538235|NCT00265616|21050096|P2|STARTED|Overall Study||9
8538236|NCT00265616|21050097|P1|STARTED|Overall Study||14
8538237|NCT00265564|21050115|P2|NOT COMPLETED|Overall Study||9
8538238|NCT00265564|21050116|P1|NOT COMPLETED|Overall Study||10
8538239|NCT00265564|21050115|P2|COMPLETED|Overall Study||49
8538240|NCT00265564|21050116|P1|COMPLETED|Overall Study||49
8538241|NCT00265564|21050115|P2|STARTED|Overall Study||58
8538242|NCT00265564|21050116|P1|STARTED|Overall Study||59
8538243|NCT00265538|21050128|P4|NOT COMPLETED|Overall Study||19
8538244|NCT00265538|21050129|P3|NOT COMPLETED|Overall Study||11
8538245|NCT00265538|21050130|P2|NOT COMPLETED|Overall Study||9
8538246|NCT00265538|21050131|P1|NOT COMPLETED|Overall Study||10
8538247|NCT00265538|21050128|P4|COMPLETED|Overall Study||267
8538248|NCT00265538|21050129|P3|COMPLETED|Overall Study||171
8538249|NCT00265538|21050130|P2|COMPLETED|Overall Study||161
8538250|NCT00265538|21050131|P1|COMPLETED|Overall Study||186
8538251|NCT00265538|21050128|P4|STARTED|Overall Study||286
8538252|NCT00265538|21050129|P3|STARTED|Overall Study||182
8538253|NCT00265538|21050130|P2|STARTED|Overall Study||170
8538254|NCT00265538|21050131|P1|STARTED|Overall Study||196
8538255|NCT00265512|21050145|P2|NOT COMPLETED|Overall Study||95
8538256|NCT00265512|21050146|P1|NOT COMPLETED|Overall Study||45
8538257|NCT00265512|21050145|P2|COMPLETED|Overall Study||359
8538258|NCT00265512|21050146|P1|COMPLETED|Overall Study||168
8538259|NCT00265512|21050145|P2|STARTED|Overall Study||454
8538260|NCT00265512|21050146|P1|STARTED|Overall Study||213
8538261|NCT00265473|21050156|P1|NOT COMPLETED|Overall Study||0
8538262|NCT00265473|21050156|P1|COMPLETED|Overall Study||5
8538263|NCT00265473|21050156|P1|STARTED|Overall Study||5
8538264|NCT00265395|21050166|P2|NOT COMPLETED|Overall Study||17
8538265|NCT00265395|21050167|P1|NOT COMPLETED|Overall Study||8
8538266|NCT00265395|21050166|P2|COMPLETED|Overall Study||56
8538267|NCT00265395|21050167|P1|COMPLETED|Overall Study||78
8538268|NCT00265395|21050166|P2|STARTED|Overall Study||73
8538269|NCT00265395|21050167|P1|STARTED|Overall Study||86
8538273|NCT00265343|21050192|P2|NOT COMPLETED|Overall Study||19
8538274|NCT00265343|21050193|P1|NOT COMPLETED|Overall Study||21
8538275|NCT00265343|21050192|P2|COMPLETED|Overall Study||153
8538276|NCT00265343|21050193|P1|COMPLETED|Overall Study||113
8538277|NCT00265343|21050192|P2|STARTED|Overall Study||172
8538278|NCT00265343|21050193|P1|STARTED|Overall Study||134
8538282|NCT00265317|21050227|P4|NOT COMPLETED|Phase 2||65
8538283|NCT00265317|21050228|P3|NOT COMPLETED|Phase 2||64
8538284|NCT00265317|21050229|P2|NOT COMPLETED|Phase 2||0
8538285|NCT00265317|21050230|P1|NOT COMPLETED|Phase 2||0
8538286|NCT00265317|21050227|P4|COMPLETED|Phase 2||2
8538287|NCT00265317|21050228|P3|COMPLETED|Phase 2||1
8538288|NCT00265317|21050229|P2|COMPLETED|Phase 2||0
8538289|NCT00265317|21050230|P1|COMPLETED|Phase 2||0
8538290|NCT00265317|21050227|P4|STARTED|Phase 2||67
8538291|NCT00265317|21050228|P3|STARTED|Phase 2||65
8538292|NCT00265317|21050229|P2|STARTED|Phase 2||0
8538293|NCT00265317|21050230|P1|STARTED|Phase 2||0
8538294|NCT00265317|21050227|P4|NOT COMPLETED|Lead-In||0
8538295|NCT00265317|21050228|P3|NOT COMPLETED|Lead-In||0
8538296|NCT00265317|21050229|P2|NOT COMPLETED|Lead-In||17
8538297|NCT00265317|21050230|P1|NOT COMPLETED|Lead-In||12
8538298|NCT00265317|21050227|P4|COMPLETED|Lead-In||0
8538299|NCT00265317|21050228|P3|COMPLETED|Lead-In||0
8538300|NCT00265317|21050229|P2|COMPLETED|Lead-In||0
8538301|NCT00265317|21050230|P1|COMPLETED|Lead-In||1
8538302|NCT00265317|21050227|P4|STARTED|Lead-In||0
8538303|NCT00265317|21050228|P3|STARTED|Lead-In||0
8538304|NCT00265317|21050229|P2|STARTED|Lead-In||17
8538305|NCT00265317|21050230|P1|STARTED|Lead-In||13
8538306|NCT00265239|21050345|P2|NOT COMPLETED|Overall Study||1
8538307|NCT00265239|21050346|P1|NOT COMPLETED|Overall Study||2
8538308|NCT00265239|21050345|P2|COMPLETED|Overall Study||51
8538309|NCT00265239|21050346|P1|COMPLETED|Overall Study||50
8538310|NCT00265239|21050345|P2|STARTED|Overall Study||52
8538311|NCT00265239|21050346|P1|STARTED|Overall Study||52
8538312|NCT00265200|21050358|P1|NOT COMPLETED|Overall Study||4
8538313|NCT00265200|21050358|P1|COMPLETED|Overall Study||24
8538314|NCT00265200|21050358|P1|STARTED|Overall Study||28
8538315|NCT00265148|21050364|P2|NOT COMPLETED|Overall Study||9
8538316|NCT00265148|21050365|P1|NOT COMPLETED|Overall Study||9
8538317|NCT00265148|21050364|P2|COMPLETED|Overall Study||31
8538318|NCT00265148|21050365|P1|COMPLETED|Overall Study||31
8538319|NCT00265148|21050364|P2|STARTED|Overall Study||40
8538320|NCT00265148|21050365|P1|STARTED|Overall Study||40
8538321|NCT00265122|21050429|P6|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
8538322|NCT00265122|21050430|P5|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
8538323|NCT00265122|21050431|P4|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
8538324|NCT00265122|21050432|P3|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
8538325|NCT00265122|21050433|P2|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
8538326|NCT00265122|21050434|P1|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
8538327|NCT00265122|21050429|P6|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
8538328|NCT00265122|21050430|P5|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
8538329|NCT00265122|21050431|P4|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
8538330|NCT00265122|21050432|P3|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
8538331|NCT00265122|21050433|P2|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
8538332|NCT00265122|21050434|P1|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
8538333|NCT00265122|21050429|P6|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
8538334|NCT00265122|21050430|P5|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
8538335|NCT00265122|21050431|P4|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
8538336|NCT00265122|21050432|P3|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
8538337|NCT00265122|21050433|P2|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
8538338|NCT00265122|21050434|P1|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
8538339|NCT00265122|21050429|P6|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
8538340|NCT00265122|21050430|P5|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
8538341|NCT00265122|21050431|P4|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
8538342|NCT00265122|21050432|P3|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
8538343|NCT00265122|21050433|P2|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
8538344|NCT00265122|21050434|P1|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
8538345|NCT00265122|21050429|P6|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
8538346|NCT00265122|21050430|P5|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
8538347|NCT00265122|21050431|P4|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
8538348|NCT00265122|21050432|P3|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
8538349|NCT00265122|21050433|P2|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
8538350|NCT00265122|21050434|P1|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
8538351|NCT00265122|21050429|P6|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
8538352|NCT00265122|21050430|P5|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
8538353|NCT00265122|21050431|P4|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
8538354|NCT00265122|21050432|P3|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
8538355|NCT00265122|21050433|P2|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
8538356|NCT00265122|21050434|P1|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
8538357|NCT00265109|21050456|P1|NOT COMPLETED|Overall Study||6
8538358|NCT00265109|21050456|P1|COMPLETED|Overall Study||11
8538359|NCT00265109|21050456|P1|STARTED|Overall Study||17
8538360|NCT00265096|21050475|P3|NOT COMPLETED|Overall Study||39
8538361|NCT00265096|21050476|P2|NOT COMPLETED|Overall Study||51
8538362|NCT00265096|21050477|P1|NOT COMPLETED|Overall Study||36
8538363|NCT00265096|21050475|P3|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
8538364|NCT00265096|21050476|P2|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
8538365|NCT00265096|21050477|P1|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
8538366|NCT00265096|21050475|P3|STARTED|Overall Study||146
8538367|NCT00265096|21050476|P2|STARTED|Overall Study||146
8538368|NCT00265096|21050477|P1|STARTED|Overall Study||113
8538369|NCT00265083|21050509|P3|NOT COMPLETED|Overall Study||42
8538370|NCT00265083|21050510|P2|NOT COMPLETED|Overall Study||42
8538371|NCT00265083|21050511|P1|NOT COMPLETED|Overall Study||17
8538372|NCT00265083|21050509|P3|COMPLETED|Overall Study||98
8538373|NCT00265083|21050510|P2|COMPLETED|Overall Study|One patient did not receive study agent.|96
8538374|NCT00265083|21050511|P1|COMPLETED|Overall Study||61
8538375|NCT00265083|21050509|P3|STARTED|Overall Study||140
8538376|NCT00265083|21050510|P2|STARTED|Overall Study|One patient did not receive study agent.|138
8538377|NCT00265083|21050511|P1|STARTED|Overall Study||78
8538378|NCT00264875|21050532|P1|NOT COMPLETED|Overall Study||30
8538379|NCT00264875|21050532|P1|COMPLETED|Overall Study||190
8538380|NCT00264875|21050532|P1|STARTED|Overall Study||220
8538381|NCT00264849|21050538|P2|NOT COMPLETED|Overall Study||25
8538382|NCT00264849|21050539|P1|NOT COMPLETED|Overall Study||22
8538383|NCT00264849|21050538|P2|COMPLETED|Overall Study||106
8538384|NCT00264849|21050539|P1|COMPLETED|Overall Study||253
8538385|NCT00264849|21050538|P2|STARTED|Overall Study||131
8538386|NCT00264849|21050539|P1|STARTED|Overall Study||275
8538387|NCT00264810|21050573|P2|NOT COMPLETED|Open Label Evaluation Period||6
8538388|NCT00264810|21050574|P1|NOT COMPLETED|Open Label Evaluation Period||6
8538389|NCT00264810|21050573|P2|COMPLETED|Open Label Evaluation Period||86
8538390|NCT00264810|21050574|P1|COMPLETED|Open Label Evaluation Period||89
8538391|NCT00264810|21050573|P2|1-year Post-implant|Open Label Evaluation Period||90
8538392|NCT00264810|21050574|P1|1-year Post-implant|Open Label Evaluation Period||92
8538393|NCT00264810|21050573|P2|STARTED|Open Label Evaluation Period||92
8538394|NCT00264810|21050574|P1|STARTED|Open Label Evaluation Period||95
8538395|NCT00264810|21050573|P2|NOT COMPLETED|Blinded Evaluation Period||1
8538396|NCT00264810|21050574|P1|NOT COMPLETED|Blinded Evaluation Period||1
8538397|NCT00264810|21050573|P2|COMPLETED|Blinded Evaluation Period||92
8538398|NCT00264810|21050574|P1|COMPLETED|Blinded Evaluation Period||95
8538399|NCT00264810|21050573|P2|STARTED|Blinded Evaluation Period||93
8538400|NCT00264810|21050574|P1|STARTED|Blinded Evaluation Period||96
8538401|NCT00264810|21050573|P2|NOT COMPLETED|Stimulation Optimization Period||1
8538402|NCT00264810|21050574|P1|NOT COMPLETED|Stimulation Optimization Period||1
8538403|NCT00264810|21050573|P2|COMPLETED|Stimulation Optimization Period||93
8538404|NCT00264810|21050574|P1|COMPLETED|Stimulation Optimization Period||96
8538405|NCT00264810|21050573|P2|STARTED|Stimulation Optimization Period||94
8538406|NCT00264810|21050574|P1|STARTED|Stimulation Optimization Period||97
8538407|NCT00264810|21050573|P2|NOT COMPLETED|Post-Operative Stabilization Period||0
8538408|NCT00264810|21050574|P1|NOT COMPLETED|Post-Operative Stabilization Period||0
8538409|NCT00264810|21050573|P2|COMPLETED|Post-Operative Stabilization Period||94
8538410|NCT00264810|21050574|P1|COMPLETED|Post-Operative Stabilization Period||97
8538411|NCT00264810|21050573|P2|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
8538412|NCT00264810|21050574|P1|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
8538413|NCT00264810|21050573|P2|NOT COMPLETED|Baseline||26
8538414|NCT00264810|21050574|P1|NOT COMPLETED|Baseline||23
8538415|NCT00264810|21050573|P2|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
8538416|NCT00264810|21050574|P1|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
8538417|NCT00264810|21050573|P2|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
8538418|NCT00264810|21050574|P1|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
8538419|NCT00264797|21050584|P2|NOT COMPLETED|Overall Study||43
8538420|NCT00264797|21050585|P1|NOT COMPLETED|Overall Study||33
8538421|NCT00264797|21050584|P2|COMPLETED|Overall Study||109
8538422|NCT00264797|21050585|P1|COMPLETED|Overall Study||118
8538423|NCT00264797|21050584|P2|STARTED|Overall Study||152
8538424|NCT00264797|21050585|P1|STARTED|Overall Study||151
8538425|NCT00264641|21050599|P2|NOT COMPLETED|Overall Study||0
8538426|NCT00264641|21050600|P1|NOT COMPLETED|Overall Study||0
8538427|NCT00264641|21050599|P2|COMPLETED|Overall Study||10
8538428|NCT00264641|21050600|P1|COMPLETED|Overall Study||10
8538429|NCT00264641|21050599|P2|Initiation of the Study|Overall Study||10
8538430|NCT00264641|21050600|P1|Initiation of the Study|Overall Study||10
8538431|NCT00264641|21050599|P2|STARTED|Overall Study||10
8538432|NCT00264641|21050600|P1|STARTED|Overall Study||10
8538433|NCT00264576|21050607|P2|NOT COMPLETED|Overall Study||1
8538434|NCT00264576|21050608|P1|NOT COMPLETED|Overall Study||1
8538435|NCT00264576|21050607|P2|COMPLETED|Overall Study||304
8538436|NCT00264576|21050608|P1|COMPLETED|Overall Study||307
8538437|NCT00264576|21050607|P2|STARTED|Overall Study||305
8538438|NCT00264576|21050608|P1|STARTED|Overall Study||308
8538439|NCT00264550|21050632|P4|NOT COMPLETED|Overall Study||30
8538440|NCT00264550|21050633|P3|NOT COMPLETED|Overall Study||17
8538441|NCT00264550|21050634|P2|NOT COMPLETED|Overall Study||41
8538442|NCT00264550|21050635|P1|NOT COMPLETED|Overall Study||43
8538443|NCT00264550|21050632|P4|COMPLETED|Overall Study||59
8538444|NCT00264550|21050633|P3|COMPLETED|Overall Study||72
8538445|NCT00264550|21050634|P2|COMPLETED|Overall Study||92
8538446|NCT00264550|21050635|P1|COMPLETED|Overall Study||90
8538447|NCT00264550|21050632|P4|STARTED|Overall Study||89
8538448|NCT00264550|21050633|P3|STARTED|Overall Study||89
8538449|NCT00264550|21050634|P2|STARTED|Overall Study||133
8538450|NCT00264550|21050635|P1|STARTED|Overall Study||133
8538451|NCT00264537|21050674|P4|NOT COMPLETED|Overall Study||60
8538452|NCT00264537|21050675|P3|NOT COMPLETED|Overall Study||50
8538453|NCT00264537|21050676|P2|NOT COMPLETED|Overall Study||58
8538454|NCT00264537|21050677|P1|NOT COMPLETED|Overall Study||50
8538455|NCT00264537|21050674|P4|COMPLETED|Overall Study||99
8538456|NCT00264537|21050675|P3|COMPLETED|Overall Study||109
8538457|NCT00264537|21050676|P2|COMPLETED|Overall Study||101
8538458|NCT00264537|21050677|P1|COMPLETED|Overall Study||110
8538459|NCT00264537|21050674|P4|STARTED|Overall Study||159
8538460|NCT00264537|21050675|P3|STARTED|Overall Study||159
8538461|NCT00264537|21050676|P2|STARTED|Overall Study||159
8538462|NCT00264537|21050677|P1|STARTED|Overall Study||160
8538463|NCT00264498|21050709|P2|NOT COMPLETED|Crossover Treatment||9
8538464|NCT00264498|21050710|P1|NOT COMPLETED|Crossover Treatment||6
8538465|NCT00264498|21050709|P2|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8538466|NCT00264498|21050710|P1|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8538467|NCT00264498|21050709|P2|STARTED|Crossover Treatment||9
8538468|NCT00264498|21050710|P1|STARTED|Crossover Treatment||6
8538469|NCT00264498|21050709|P2|NOT COMPLETED|Randomized Treatment||18
8538470|NCT00264498|21050710|P1|NOT COMPLETED|Randomized Treatment||17
8538471|NCT00264498|21050709|P2|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8538472|NCT00264498|21050710|P1|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
8538473|NCT00264498|21050709|P2|STARTED|Randomized Treatment||18
8538474|NCT00264498|21050710|P1|STARTED|Randomized Treatment||17
8538475|NCT00264381|21050718|P2|NOT COMPLETED|Overall Study||0
8538476|NCT00264381|21050719|P1|NOT COMPLETED|Overall Study||0
8538477|NCT00264381|21050718|P2|COMPLETED|Overall Study||37
8538478|NCT00264381|21050719|P1|COMPLETED|Overall Study||35
8538479|NCT00264381|21050718|P2|STARTED|Overall Study||37
8538480|NCT00264381|21050719|P1|STARTED|Overall Study||35
8538481|NCT00264303|21050733|P2|NOT COMPLETED|Overall Study||29
8538482|NCT00264303|21050734|P1|NOT COMPLETED|Overall Study||25
8538483|NCT00264303|21050733|P2|COMPLETED|Overall Study||419
8538484|NCT00264303|21050734|P1|COMPLETED|Overall Study||413
8538485|NCT00264303|21050733|P2|STARTED|Overall Study||448
8538486|NCT00264303|21050734|P1|STARTED|Overall Study||438
8538487|NCT00264290|21050752|P2|NOT COMPLETED|Observation (4 Weeks)||0
8538488|NCT00264290|21050753|P1|NOT COMPLETED|Observation (4 Weeks)||0
8538489|NCT00264290|21050752|P2|COMPLETED|Observation (4 Weeks)||14
8538490|NCT00264290|21050753|P1|COMPLETED|Observation (4 Weeks)||15
8538491|NCT00264290|21050752|P2|STARTED|Observation (4 Weeks)||14
8538492|NCT00264290|21050753|P1|STARTED|Observation (4 Weeks)||15
8538493|NCT00264290|21050752|P2|NOT COMPLETED|Intervention (8 Weeks)||0
8538494|NCT00264290|21050753|P1|NOT COMPLETED|Intervention (8 Weeks)||1
8538495|NCT00264290|21050752|P2|COMPLETED|Intervention (8 Weeks)||14
8538496|NCT00264290|21050753|P1|COMPLETED|Intervention (8 Weeks)||15
8538497|NCT00264290|21050752|P2|STARTED|Intervention (8 Weeks)||14
8538498|NCT00264290|21050753|P1|STARTED|Intervention (8 Weeks)||16
8538499|NCT00264238|21050769|P1|NOT COMPLETED|Overall Study||1
8538500|NCT00264238|21050769|P1|COMPLETED|Overall Study||14
8538501|NCT00264238|21050769|P1|STARTED|Overall Study||15
8538502|NCT00264147|21050781|P6|NOT COMPLETED|Treatment II Period||33
8538503|NCT00264147|21050782|P5|NOT COMPLETED|Treatment II Period||33
8538504|NCT00264147|21050783|P4|NOT COMPLETED|Treatment II Period||0
8538505|NCT00264147|21050784|P3|NOT COMPLETED|Treatment II Period||0
8538506|NCT00264147|21050785|P2|NOT COMPLETED|Treatment II Period||0
8538507|NCT00264147|21050786|P1|NOT COMPLETED|Treatment II Period||0
8538508|NCT00264147|21050781|P6|COMPLETED|Treatment II Period||116
8538509|NCT00264147|21050782|P5|COMPLETED|Treatment II Period||147
8538510|NCT00264147|21050783|P4|COMPLETED|Treatment II Period||0
8538511|NCT00264147|21050784|P3|COMPLETED|Treatment II Period||0
8538512|NCT00264147|21050785|P2|COMPLETED|Treatment II Period||0
8538513|NCT00264147|21050786|P1|COMPLETED|Treatment II Period||0
8538514|NCT00264147|21050781|P6|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
8538515|NCT00264147|21050782|P5|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
8538516|NCT00264147|21050783|P4|STARTED|Treatment II Period||0
8538517|NCT00264147|21050784|P3|STARTED|Treatment II Period||0
8538518|NCT00264147|21050785|P2|STARTED|Treatment II Period||0
8538519|NCT00264147|21050786|P1|STARTED|Treatment II Period||0
8538520|NCT00264147|21050781|P6|NOT COMPLETED|Treatment I Period||0
8538521|NCT00264147|21050782|P5|NOT COMPLETED|Treatment I Period||56
8538522|NCT00264147|21050783|P4|NOT COMPLETED|Treatment I Period||72
8538523|NCT00264147|21050784|P3|NOT COMPLETED|Treatment I Period||77
8538524|NCT00264147|21050785|P2|NOT COMPLETED|Treatment I Period||83
8538525|NCT00264147|21050786|P1|NOT COMPLETED|Treatment I Period||98
8538526|NCT00264147|21050781|P6|COMPLETED|Treatment I Period||0
8538527|NCT00264147|21050782|P5|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
8538528|NCT00264147|21050783|P4|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
8538529|NCT00264147|21050784|P3|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
8538530|NCT00264147|21050785|P2|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
8538531|NCT00264147|21050786|P1|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
8538532|NCT00264147|21050781|P6|STARTED|Treatment I Period||0
8538533|NCT00264147|21050782|P5|STARTED|Treatment I Period||155
8538534|NCT00264147|21050783|P4|STARTED|Treatment I Period||140
8538535|NCT00264147|21050784|P3|STARTED|Treatment I Period||151
8538536|NCT00264147|21050785|P2|STARTED|Treatment I Period||154
8538537|NCT00264147|21050786|P1|STARTED|Treatment I Period||161
8538538|NCT00264004|21050829|P4|NOT COMPLETED|Overall Study||15
8538539|NCT00264004|21050830|P3|NOT COMPLETED|Overall Study||14
8538540|NCT00264004|21050831|P2|NOT COMPLETED|Overall Study||11
8538541|NCT00264004|21050832|P1|NOT COMPLETED|Overall Study||17
8538542|NCT00264004|21050829|P4|COMPLETED|Overall Study|Completed 12 weeks treatment|19
8538543|NCT00264004|21050830|P3|COMPLETED|Overall Study|Completed 12 weeks treatment|16
8538544|NCT00264004|21050831|P2|COMPLETED|Overall Study|Completed 12 weeks treatment|21
8538545|NCT00264004|21050832|P1|COMPLETED|Overall Study|Completed 12 weeks treatment|13
8538546|NCT00264004|21050829|P4|STARTED|Overall Study|Randomised|34
8538547|NCT00264004|21050830|P3|STARTED|Overall Study|Randomised|30
8538548|NCT00264004|21050831|P2|STARTED|Overall Study|Randomised|32
8538549|NCT00264004|21050832|P1|STARTED|Overall Study|Randomised|30
8538550|NCT00263887|21050860|P2|NOT COMPLETED|Overall Study||7
8538551|NCT00263887|21050861|P1|NOT COMPLETED|Overall Study||3
8538552|NCT00263887|21050860|P2|COMPLETED|Overall Study||32
8538553|NCT00263887|21050861|P1|COMPLETED|Overall Study||35
8538554|NCT00263887|21050860|P2|STARTED|Overall Study||39
8538555|NCT00263887|21050861|P1|STARTED|Overall Study||38
8538556|NCT00263757|21050869|P2|NOT COMPLETED|Overall Study||8
8538557|NCT00263757|21050870|P1|NOT COMPLETED|Overall Study||8
8538558|NCT00263757|21050869|P2|COMPLETED|Overall Study||5
8538559|NCT00263757|21050870|P1|COMPLETED|Overall Study||4
8538560|NCT00263757|21050869|P2|STARTED|Overall Study||13
8538561|NCT00263757|21050870|P1|STARTED|Overall Study||12
8538562|NCT00263666|21050882|P2|NOT COMPLETED|Overall Study||11
8538563|NCT00263666|21050883|P1|NOT COMPLETED|Overall Study||7
8538564|NCT00263666|21050882|P2|COMPLETED|Overall Study||39
8538565|NCT00263666|21050883|P1|COMPLETED|Overall Study||43
8538566|NCT00263666|21050882|P2|STARTED|Overall Study||50
8538567|NCT00263666|21050883|P1|STARTED|Overall Study||50
8538568|NCT00263588|21050936|P2|NOT COMPLETED|Overall Study||132
8538569|NCT00263588|21050937|P1|NOT COMPLETED|Overall Study||81
8538570|NCT00263588|21050936|P2|COMPLETED|Overall Study||15
8538571|NCT00263588|21050937|P1|COMPLETED|Overall Study||14
8538572|NCT00263588|21050936|P2|STARTED|Overall Study||147
8538573|NCT00263588|21050937|P1|STARTED|Overall Study||95
8538574|NCT00263575|21050960|P1|NOT COMPLETED|Maintence Period||77
8538575|NCT00263575|21050960|P1|COMPLETED|Maintence Period||19
8538576|NCT00263575|21050960|P1|STARTED|Maintence Period||96
8538577|NCT00263575|21050960|P1|NOT COMPLETED|Titration Period||43
8538578|NCT00263575|21050960|P1|COMPLETED|Titration Period||96
8538579|NCT00263575|21050960|P1|STARTED|Titration Period||139
8538580|NCT00263562|21050968|P2|NOT COMPLETED|Overall Study||0
8538581|NCT00263562|21050969|P1|NOT COMPLETED|Overall Study||3
8538582|NCT00263562|21050968|P2|COMPLETED|Overall Study||9
8538583|NCT00263562|21050969|P1|COMPLETED|Overall Study||6
8538584|NCT00263562|21050968|P2|STARTED|Overall Study||9
8538585|NCT00263562|21050969|P1|STARTED|Overall Study||9
8538586|NCT00263328|21050986|P3|NOT COMPLETED|Overall Study||7
8538587|NCT00263328|21050987|P2|NOT COMPLETED|Overall Study||2
8538588|NCT00263328|21050988|P1|NOT COMPLETED|Overall Study||8
8538589|NCT00263328|21050986|P3|COMPLETED|Overall Study||6
8538590|NCT00263328|21050987|P2|COMPLETED|Overall Study||12
8538591|NCT00263328|21050988|P1|COMPLETED|Overall Study||10
8538592|NCT00263328|21050986|P3|STARTED|Overall Study||13
8538593|NCT00263328|21050987|P2|STARTED|Overall Study||14
8538594|NCT00263328|21050988|P1|STARTED|Overall Study||18
8538595|NCT00263211|21051146|P2|NOT COMPLETED|Overall Study||1
8538596|NCT00263211|21051147|P1|NOT COMPLETED|Overall Study||5
8538597|NCT00263211|21051146|P2|COMPLETED|Overall Study||23
8538598|NCT00263211|21051147|P1|COMPLETED|Overall Study||19
8538599|NCT00263211|21051146|P2|STARTED|Overall Study||24
8538600|NCT00263211|21051147|P1|STARTED|Overall Study||24
8538601|NCT00262964|21051165|P4|NOT COMPLETED|Overall Study||0
8538602|NCT00262964|21051166|P3|NOT COMPLETED|Overall Study||0
8538603|NCT00262964|21051167|P2|NOT COMPLETED|Overall Study||0
8538604|NCT00262964|21051168|P1|NOT COMPLETED|Overall Study||0
8538605|NCT00262964|21051165|P4|COMPLETED|Overall Study||12
8538606|NCT00262964|21051166|P3|COMPLETED|Overall Study||17
8538607|NCT00262964|21051167|P2|COMPLETED|Overall Study||11
8538608|NCT00262964|21051168|P1|COMPLETED|Overall Study||11
8538609|NCT00262964|21051165|P4|STARTED|Overall Study||12
8538610|NCT00262964|21051166|P3|STARTED|Overall Study||17
8538611|NCT00262964|21051167|P2|STARTED|Overall Study||11
8538612|NCT00262964|21051168|P1|STARTED|Overall Study||11
8538613|NCT00262951|21051198|P1|NOT COMPLETED|Overall Study||16
8538614|NCT00262951|21051198|P1|COMPLETED|Overall Study||7
8538615|NCT00262951|21051198|P1|STARTED|Overall Study||23
8538616|NCT00262925|21051203|P1|NOT COMPLETED|Overall Study||11
8538617|NCT00262925|21051203|P1|COMPLETED|Overall Study||1
8538618|NCT00262925|21051203|P1|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
8538619|NCT00262873|21051209|P1|NOT COMPLETED|Overall Study||8
8538620|NCT00262873|21051209|P1|COMPLETED|Overall Study||0
8538621|NCT00262873|21051209|P1|STARTED|Overall Study||8
8538622|NCT00262860|21051220|P1|NOT COMPLETED|Overall Study||2
8538623|NCT00262860|21051220|P1|COMPLETED|Overall Study||16
8538624|NCT00262860|21051220|P1|STARTED|Overall Study||18
8538625|NCT00262847|21051229|P3|NOT COMPLETED|Overall Study||396
8538626|NCT00262847|21051230|P2|NOT COMPLETED|Overall Study||513
8538627|NCT00262847|21051231|P1|NOT COMPLETED|Overall Study||518
8538628|NCT00262847|21051229|P3|COMPLETED|Overall Study||227
8538629|NCT00262847|21051230|P2|COMPLETED|Overall Study||112
8538630|NCT00262847|21051231|P1|COMPLETED|Overall Study||107
8538631|NCT00262847|21051229|P3|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
8538632|NCT00262847|21051230|P2|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
8538633|NCT00262847|21051231|P1|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
8538634|NCT00262834|21051250|P2|NOT COMPLETED|Overall Study||4
8538635|NCT00262834|21051251|P1|NOT COMPLETED|Overall Study||1
8538636|NCT00262834|21051250|P2|COMPLETED|Overall Study||25
8538637|NCT00262834|21051251|P1|COMPLETED|Overall Study||24
8538638|NCT00262834|21051250|P2|STARTED|Overall Study||29
8538639|NCT00262834|21051251|P1|STARTED|Overall Study||25
8538640|NCT00262821|21051264|P2|NOT COMPLETED|Overall Study||19
8538641|NCT00262821|21051265|P1|NOT COMPLETED|Overall Study||4
8538642|NCT00262821|21051264|P2|COMPLETED|Overall Study||185
8538643|NCT00262821|21051265|P1|COMPLETED|Overall Study||194
8538644|NCT00262821|21051264|P2|STARTED|Overall Study||204
8538645|NCT00262821|21051265|P1|STARTED|Overall Study||198
8538646|NCT00262743|21051277|P2|NOT COMPLETED|Overall Study||12
8538647|NCT00262743|21051278|P1|NOT COMPLETED|Overall Study||0
8538648|NCT00262743|21051277|P2|COMPLETED|Overall Study||30
8538649|NCT00262743|21051278|P1|COMPLETED|Overall Study||27
8538650|NCT00262743|21051277|P2|STARTED|Overall Study||42
8538651|NCT00262743|21051278|P1|STARTED|Overall Study||27
8538652|NCT00262730|21051285|P1|NOT COMPLETED|Overall Study||0
8538653|NCT00262730|21051285|P1|COMPLETED|Overall Study||97
8538654|NCT00262730|21051285|P1|STARTED|Overall Study||97
8538655|NCT00262639|21051293|P4|NOT COMPLETED|Overall Study||0
8538656|NCT00262639|21051294|P3|NOT COMPLETED|Overall Study||0
8538657|NCT00262639|21051295|P2|NOT COMPLETED|Overall Study||0
8538658|NCT00262639|21051296|P1|NOT COMPLETED|Overall Study||0
8538659|NCT00262639|21051293|P4|COMPLETED|Overall Study||7
8538660|NCT00262639|21051294|P3|COMPLETED|Overall Study||9
8538661|NCT00262639|21051295|P2|COMPLETED|Overall Study||26
8538662|NCT00262639|21051296|P1|COMPLETED|Overall Study||18
8538663|NCT00262639|21051293|P4|STARTED|Overall Study||7
8538664|NCT00262639|21051294|P3|STARTED|Overall Study||9
8538665|NCT00262639|21051295|P2|STARTED|Overall Study||26
8538666|NCT00262639|21051296|P1|STARTED|Overall Study||18
8538667|NCT00262600|21051313|P3|NOT COMPLETED|Overall Study||266
8538668|NCT00262600|21051314|P2|NOT COMPLETED|Overall Study||252
8538669|NCT00262600|21051315|P1|NOT COMPLETED|Overall Study||235
8538670|NCT00262600|21051313|P3|COMPLETED|Overall Study||5756
8538671|NCT00262600|21051314|P2|COMPLETED|Overall Study||5824
8538672|NCT00262600|21051315|P1|COMPLETED|Overall Study||5780
8538673|NCT00262600|21051313|P3|STARTED|Overall Study||6022
8538674|NCT00262600|21051314|P2|STARTED|Overall Study||6076
8538675|NCT00262600|21051315|P1|STARTED|Overall Study||6015
8538676|NCT00262522|21051342|P4|NOT COMPLETED|Study Start Through 96 Weeks||0
8538677|NCT00262522|21051343|P3|NOT COMPLETED|Study Start Through 96 Weeks||77
8538678|NCT00262522|21051344|P2|NOT COMPLETED|Study Start Through 96 Weeks||0
8538679|NCT00262522|21051345|P1|NOT COMPLETED|Study Start Through 96 Weeks||77
8538680|NCT00262522|21051342|P4|COMPLETED|Study Start Through 96 Weeks||0
8538681|NCT00262522|21051343|P3|COMPLETED|Study Start Through 96 Weeks||254
8538682|NCT00262522|21051344|P2|COMPLETED|Study Start Through 96 Weeks||0
8538683|NCT00262522|21051345|P1|COMPLETED|Study Start Through 96 Weeks||256
8538684|NCT00262522|21051342|P4|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
8538685|NCT00262522|21051343|P3|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
8538686|NCT00262522|21051344|P2|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
8538687|NCT00262522|21051345|P1|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
8538688|NCT00262522|21051342|P4|NOT COMPLETED|Study Start Through 48 Weeks||0
8538689|NCT00262522|21051343|P3|NOT COMPLETED|Study Start Through 48 Weeks||55
8538690|NCT00262522|21051344|P2|NOT COMPLETED|Study Start Through 48 Weeks||0
8538691|NCT00262522|21051345|P1|NOT COMPLETED|Study Start Through 48 Weeks||49
8538692|NCT00262522|21051342|P4|COMPLETED|Study Start Through 48 Weeks||0
8538693|NCT00262522|21051343|P3|COMPLETED|Study Start Through 48 Weeks||276
8538694|NCT00262522|21051344|P2|COMPLETED|Study Start Through 48 Weeks||0
8538695|NCT00262522|21051345|P1|COMPLETED|Study Start Through 48 Weeks||284
8538696|NCT00262522|21051342|P4|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
8538697|NCT00262522|21051343|P3|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
8538698|NCT00262522|21051344|P2|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
8538699|NCT00262522|21051345|P1|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
8538700|NCT00262522|21051342|P4|NOT COMPLETED|Study Start Through 8 Weeks||5
8538701|NCT00262522|21051343|P3|NOT COMPLETED|Study Start Through 8 Weeks||11
8538702|NCT00262522|21051344|P2|NOT COMPLETED|Study Start Through 8 Weeks||5
8538703|NCT00262522|21051345|P1|NOT COMPLETED|Study Start Through 8 Weeks||4
8538704|NCT00262522|21051342|P4|COMPLETED|Study Start Through 8 Weeks||160
8538705|NCT00262522|21051343|P3|COMPLETED|Study Start Through 8 Weeks||155
8538706|NCT00262522|21051344|P2|COMPLETED|Study Start Through 8 Weeks||161
8538707|NCT00262522|21051345|P1|COMPLETED|Study Start Through 8 Weeks||163
8538708|NCT00262522|21051342|P4|STARTED|Study Start Through 8 Weeks||165
8538709|NCT00262522|21051343|P3|STARTED|Study Start Through 8 Weeks||166
8538710|NCT00262522|21051344|P2|STARTED|Study Start Through 8 Weeks||166
8538711|NCT00262522|21051345|P1|STARTED|Study Start Through 8 Weeks||167
8538712|NCT00262509|21051367|P2|NOT COMPLETED|Overall Study||0
8538713|NCT00262509|21051368|P1|NOT COMPLETED|Overall Study||0
8538714|NCT00262509|21051367|P2|COMPLETED|Overall Study||9
8538715|NCT00262509|21051368|P1|COMPLETED|Overall Study||8
8538716|NCT00262509|21051367|P2|STARTED|Overall Study||9
8538717|NCT00262509|21051368|P1|STARTED|Overall Study||8
8538718|NCT00262314|21051374|P1|NOT COMPLETED|Overall Study||337
8538719|NCT00262314|21051374|P1|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
8538720|NCT00262314|21051374|P1|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
8538721|NCT00262301|21051392|P3|NOT COMPLETED|Open-label Phase||0
8538722|NCT00262301|21051393|P2|NOT COMPLETED|Open-label Phase||0
8538723|NCT00262301|21051394|P1|NOT COMPLETED|Open-label Phase||0
8538724|NCT00262301|21051392|P3|COMPLETED|Open-label Phase||57
8538725|NCT00262301|21051393|P2|COMPLETED|Open-label Phase||0
8538726|NCT00262301|21051394|P1|COMPLETED|Open-label Phase||0
8538727|NCT00262301|21051392|P3|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
8538728|NCT00262301|21051393|P2|STARTED|Open-label Phase||0
8538729|NCT00262301|21051394|P1|STARTED|Open-label Phase||0
8538730|NCT00262301|21051392|P3|NOT COMPLETED|Double-blind Phase||0
8538731|NCT00262301|21051393|P2|NOT COMPLETED|Double-blind Phase||1
8538732|NCT00262301|21051394|P1|NOT COMPLETED|Double-blind Phase||1
8538733|NCT00262301|21051392|P3|COMPLETED|Double-blind Phase||0
8538734|NCT00262301|21051393|P2|COMPLETED|Double-blind Phase||15
8538735|NCT00262301|21051394|P1|COMPLETED|Double-blind Phase||15
8538736|NCT00262301|21051392|P3|STARTED|Double-blind Phase||0
8538737|NCT00262301|21051393|P2|STARTED|Double-blind Phase||16
8538738|NCT00262301|21051394|P1|STARTED|Double-blind Phase||16
8538739|NCT00262223|21051407|P2|NOT COMPLETED|12-month Post-treatment Follow-up||7
8538740|NCT00262223|21051408|P1|NOT COMPLETED|12-month Post-treatment Follow-up||7
8538741|NCT00262223|21051407|P2|COMPLETED|12-month Post-treatment Follow-up||22
8538742|NCT00262223|21051408|P1|COMPLETED|12-month Post-treatment Follow-up||21
8538743|NCT00262223|21051407|P2|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
8538744|NCT00262223|21051408|P1|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
8538745|NCT00262223|21051407|P2|NOT COMPLETED|6-month Post-treatment Follow-up||1
8538746|NCT00262223|21051408|P1|NOT COMPLETED|6-month Post-treatment Follow-up||6
8538747|NCT00262223|21051407|P2|COMPLETED|6-month Post-treatment Follow-up||28
8538748|NCT00262223|21051408|P1|COMPLETED|6-month Post-treatment Follow-up||22
8538749|NCT00262223|21051407|P2|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
8538750|NCT00262223|21051408|P1|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
8538751|NCT00262223|21051407|P2|NOT COMPLETED|1-week Post-treatment Follow-up||4
8538752|NCT00262223|21051408|P1|NOT COMPLETED|1-week Post-treatment Follow-up||4
8538753|NCT00262223|21051407|P2|COMPLETED|1-week Post-treatment Follow-up||25
8538754|NCT00262223|21051408|P1|COMPLETED|1-week Post-treatment Follow-up||24
8538755|NCT00262223|21051407|P2|STARTED|1-week Post-treatment Follow-up||29
8538756|NCT00262223|21051408|P1|STARTED|1-week Post-treatment Follow-up||28
8538757|NCT00262223|21051407|P2|NOT COMPLETED|Treatment Phase||8
8538758|NCT00262223|21051408|P1|NOT COMPLETED|Treatment Phase||4
8538759|NCT00262223|21051407|P2|COMPLETED|Treatment Phase||29
8538760|NCT00262223|21051408|P1|COMPLETED|Treatment Phase||28
8538761|NCT00262223|21051407|P2|STARTED|Treatment Phase||37
8538762|NCT00262223|21051408|P1|STARTED|Treatment Phase||32
8538763|NCT00262119|21051419|P3|NOT COMPLETED|Overall Study||58
8538764|NCT00262119|21051420|P2|NOT COMPLETED|Overall Study||70
8538765|NCT00262119|21051421|P1|NOT COMPLETED|Overall Study||58
8538766|NCT00262119|21051419|P3|COMPLETED|Overall Study||325
8538767|NCT00262119|21051420|P2|COMPLETED|Overall Study||328
8538768|NCT00262119|21051421|P1|COMPLETED|Overall Study||327
8538769|NCT00262119|21051419|P3|STARTED|Overall Study||383
8538770|NCT00262119|21051420|P2|STARTED|Overall Study||398
8538771|NCT00262119|21051421|P1|STARTED|Overall Study||385
8538790|NCT00262067|21051463|P4|NOT COMPLETED|Overall Study||113
8538791|NCT00262067|21051464|P3|NOT COMPLETED|Overall Study||216
8538792|NCT00262067|21051465|P2|NOT COMPLETED|Overall Study||100
8538793|NCT00262067|21051466|P1|NOT COMPLETED|Overall Study||219
8538794|NCT00262067|21051463|P4|COMPLETED|Overall Study||93
8538795|NCT00262067|21051464|P3|COMPLETED|Overall Study||193
8538796|NCT00262067|21051465|P2|COMPLETED|Overall Study||107
8538797|NCT00262067|21051466|P1|COMPLETED|Overall Study||196
8538798|NCT00262067|21051463|P4|STARTED|Overall Study||206
8538799|NCT00262067|21051464|P3|STARTED|Overall Study||409
8538800|NCT00262067|21051465|P2|STARTED|Overall Study||207
8538801|NCT00262067|21051466|P1|STARTED|Overall Study||415
8538802|NCT00262041|21051500|P3|NOT COMPLETED|Overall Study||6
8538803|NCT00262041|21051501|P2|NOT COMPLETED|Overall Study||4
8538804|NCT00262041|21051502|P1|NOT COMPLETED|Overall Study||2
8538805|NCT00262041|21051500|P3|COMPLETED|Overall Study||203
8538806|NCT00262041|21051501|P2|COMPLETED|Overall Study||147
8538807|NCT00262041|21051502|P1|COMPLETED|Overall Study||162
8538808|NCT00262041|21051500|P3|STARTED|Overall Study||209
8538809|NCT00262041|21051501|P2|STARTED|Overall Study||151
8538810|NCT00262041|21051502|P1|STARTED|Overall Study||164
8538811|NCT00262028|21051531|P9|NOT COMPLETED|Overall Study||19
8538812|NCT00262028|21051532|P8|NOT COMPLETED|Overall Study||18
8538813|NCT00262028|21051533|P7|NOT COMPLETED|Overall Study||12
8538814|NCT00262028|21051534|P6|NOT COMPLETED|Overall Study||13
8538815|NCT00262028|21051535|P5|NOT COMPLETED|Overall Study||12
8538816|NCT00262028|21051536|P4|NOT COMPLETED|Overall Study||23
8538817|NCT00262028|21051537|P3|NOT COMPLETED|Overall Study||20
8538818|NCT00262028|21051538|P2|NOT COMPLETED|Overall Study||27
8538819|NCT00262028|21051539|P1|NOT COMPLETED|Overall Study||24
8538820|NCT00262028|21051531|P9|COMPLETED|Overall Study||81
8538821|NCT00262028|21051532|P8|COMPLETED|Overall Study||55
8538822|NCT00262028|21051533|P7|COMPLETED|Overall Study||59
8538823|NCT00262028|21051534|P6|COMPLETED|Overall Study||60
8538824|NCT00262028|21051535|P5|COMPLETED|Overall Study||62
8538825|NCT00262028|21051536|P4|COMPLETED|Overall Study||134
8538826|NCT00262028|21051537|P3|COMPLETED|Overall Study||137
8538827|NCT00262028|21051538|P2|COMPLETED|Overall Study||126
8538828|NCT00262028|21051539|P1|COMPLETED|Overall Study||128
8538829|NCT00262028|21051531|P9|STARTED|Overall Study||100
8538830|NCT00262028|21051532|P8|STARTED|Overall Study||73
8538831|NCT00262028|21051533|P7|STARTED|Overall Study||71
8538832|NCT00262028|21051534|P6|STARTED|Overall Study||73
8538833|NCT00262028|21051535|P5|STARTED|Overall Study||74
8538834|NCT00262028|21051536|P4|STARTED|Overall Study||157
8538835|NCT00262028|21051537|P3|STARTED|Overall Study||157
8538836|NCT00262028|21051538|P2|STARTED|Overall Study||153
8538837|NCT00262028|21051539|P1|STARTED|Overall Study||152
8538838|NCT00262002|21051601|P7|NOT COMPLETED|Overall Study||6
8538839|NCT00262002|21051602|P6|NOT COMPLETED|Overall Study||7
8538840|NCT00262002|21051603|P5|NOT COMPLETED|Overall Study||7
8538841|NCT00262002|21051604|P4|NOT COMPLETED|Overall Study||5
8538842|NCT00262002|21051605|P3|NOT COMPLETED|Overall Study||0
8538843|NCT00262002|21051606|P2|NOT COMPLETED|Overall Study||6
8538844|NCT00262002|21051607|P1|NOT COMPLETED|Overall Study||11
8538845|NCT00262002|21051601|P7|COMPLETED|Overall Study||84
8538846|NCT00262002|21051602|P6|COMPLETED|Overall Study||83
8538847|NCT00262002|21051603|P5|COMPLETED|Overall Study||91
8538848|NCT00262002|21051604|P4|COMPLETED|Overall Study||93
8538849|NCT00262002|21051605|P3|COMPLETED|Overall Study||45
8538850|NCT00262002|21051606|P2|COMPLETED|Overall Study||84
8538851|NCT00262002|21051607|P1|COMPLETED|Overall Study||79
8538852|NCT00262002|21051601|P7|STARTED|Overall Study||90
8538853|NCT00262002|21051602|P6|STARTED|Overall Study||90
8538854|NCT00262002|21051603|P5|STARTED|Overall Study||98
8538855|NCT00262002|21051604|P4|STARTED|Overall Study||98
8538856|NCT00262002|21051605|P3|STARTED|Overall Study||45
8538857|NCT00262002|21051606|P2|STARTED|Overall Study||90
8538858|NCT00262002|21051607|P1|STARTED|Overall Study||90
8538859|NCT00261950|21051700|P1|NOT COMPLETED|Overall Study||26
8538860|NCT00261950|21051700|P1|COMPLETED|Overall Study||84
8538861|NCT00261950|21051700|P1|STARTED|Overall Study||110
8538862|NCT00261846|21051725|P12|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
8538863|NCT00261846|21051726|P11|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
8538864|NCT00261846|21051727|P10|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
8538865|NCT00261846|21051728|P9|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
8538866|NCT00261846|21051729|P8|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
8538867|NCT00261846|21051730|P7|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
8538868|NCT00261846|21051731|P6|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
8538869|NCT00261846|21051732|P5|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
8538870|NCT00261846|21051733|P4|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
8538871|NCT00261846|21051734|P3|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
8538872|NCT00261846|21051735|P2|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
8538873|NCT00261846|21051736|P1|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
8538874|NCT00261846|21051725|P12|COMPLETED|Period 2: Part 2 (Efficacy)||1
8538875|NCT00261846|21051726|P11|COMPLETED|Period 2: Part 2 (Efficacy)||15
8538876|NCT00261846|21051727|P10|COMPLETED|Period 2: Part 2 (Efficacy)||30
8538877|NCT00261846|21051728|P9|COMPLETED|Period 2: Part 2 (Efficacy)||12
8538878|NCT00261846|21051729|P8|COMPLETED|Period 2: Part 2 (Efficacy)||21
8538879|NCT00261846|21051730|P7|COMPLETED|Period 2: Part 2 (Efficacy)||16
8538880|NCT00261846|21051731|P6|COMPLETED|Period 2: Part 2 (Efficacy)||3
8538881|NCT00261846|21051732|P5|COMPLETED|Period 2: Part 2 (Efficacy)||39
8538882|NCT00261846|21051733|P4|COMPLETED|Period 2: Part 2 (Efficacy)||60
8538883|NCT00261846|21051734|P3|COMPLETED|Period 2: Part 2 (Efficacy)||0
8538884|NCT00261846|21051735|P2|COMPLETED|Period 2: Part 2 (Efficacy)||0
8538885|NCT00261846|21051736|P1|COMPLETED|Period 2: Part 2 (Efficacy)||0
8538886|NCT00261846|21051725|P12|STARTED|Period 2: Part 2 (Efficacy)||24
8538887|NCT00261846|21051726|P11|STARTED|Period 2: Part 2 (Efficacy)||64
8538888|NCT00261846|21051727|P10|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
8538889|NCT00261846|21051728|P9|STARTED|Period 2: Part 2 (Efficacy)||26
8538890|NCT00261846|21051729|P8|STARTED|Period 2: Part 2 (Efficacy)||50
8538891|NCT00261846|21051730|P7|STARTED|Period 2: Part 2 (Efficacy)||38
8538892|NCT00261846|21051731|P6|STARTED|Period 2: Part 2 (Efficacy)||5
8538893|NCT00261846|21051732|P5|STARTED|Period 2: Part 2 (Efficacy)||89
8538894|NCT00261846|21051733|P4|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
8538895|NCT00261846|21051734|P3|STARTED|Period 2: Part 2 (Efficacy)||0
8538896|NCT00261846|21051735|P2|STARTED|Period 2: Part 2 (Efficacy)||0
8538897|NCT00261846|21051736|P1|STARTED|Period 2: Part 2 (Efficacy)||0
8538898|NCT00261846|21051725|P12|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538899|NCT00261846|21051726|P11|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538900|NCT00261846|21051727|P10|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538901|NCT00261846|21051728|P9|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538902|NCT00261846|21051729|P8|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538903|NCT00261846|21051730|P7|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538904|NCT00261846|21051731|P6|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538905|NCT00261846|21051732|P5|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538906|NCT00261846|21051733|P4|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538907|NCT00261846|21051734|P3|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
8538908|NCT00261846|21051735|P2|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
8538909|NCT00261846|21051736|P1|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
8538910|NCT00261846|21051725|P12|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538911|NCT00261846|21051726|P11|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538912|NCT00261846|21051727|P10|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538913|NCT00261846|21051728|P9|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538914|NCT00261846|21051729|P8|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538915|NCT00261846|21051730|P7|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538916|NCT00261846|21051731|P6|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538917|NCT00261846|21051732|P5|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538918|NCT00261846|21051733|P4|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538919|NCT00261846|21051734|P3|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538920|NCT00261846|21051735|P2|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538921|NCT00261846|21051736|P1|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
8538922|NCT00261846|21051725|P12|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538923|NCT00261846|21051726|P11|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538924|NCT00261846|21051727|P10|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538925|NCT00261846|21051728|P9|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538926|NCT00261846|21051729|P8|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538927|NCT00261846|21051730|P7|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538928|NCT00261846|21051731|P6|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538929|NCT00261846|21051732|P5|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538930|NCT00261846|21051733|P4|STARTED|Period 1: Part 1 (Dose Escalation)||0
8538931|NCT00261846|21051734|P3|STARTED|Period 1: Part 1 (Dose Escalation)||12
8538932|NCT00261846|21051735|P2|STARTED|Period 1: Part 1 (Dose Escalation)||3
8538933|NCT00261846|21051736|P1|STARTED|Period 1: Part 1 (Dose Escalation)||3
8538934|NCT00261833|21051995|P2|NOT COMPLETED|Overall Study||18
8538935|NCT00261833|21051996|P1|NOT COMPLETED|Overall Study||9
8538936|NCT00261833|21051995|P2|COMPLETED|Overall Study||69
8538937|NCT00261833|21051996|P1|COMPLETED|Overall Study||84
8538938|NCT00261833|21051995|P2|STARTED|Overall Study||87
8538939|NCT00261833|21051996|P1|STARTED|Overall Study||93
8538940|NCT00261716|21052030|P2|NOT COMPLETED|Overall Study||10
8538941|NCT00261716|21052031|P1|NOT COMPLETED|Overall Study||6
8538942|NCT00261716|21052030|P2|COMPLETED|Overall Study||11
8538943|NCT00261716|21052031|P1|COMPLETED|Overall Study||11
8538944|NCT00261716|21052030|P2|STARTED|Overall Study||21
8538945|NCT00261716|21052031|P1|STARTED|Overall Study||17
8538946|NCT00261495|21052051|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
8538947|NCT00261495|21052052|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
8538948|NCT00261495|21052051|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||47
8538949|NCT00261495|21052052|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||50
8538950|NCT00261495|21052051|P2|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
8538951|NCT00261495|21052052|P1|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
8538952|NCT00261495|21052051|P2|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
8538953|NCT00261495|21052052|P1|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
8538954|NCT00261495|21052051|P2|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
8538955|NCT00261495|21052052|P1|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
8538956|NCT00261495|21052051|P2|STARTED|Maintenance Phase (Weeks 4 to 24)||185
8538957|NCT00261495|21052052|P1|STARTED|Maintenance Phase (Weeks 4 to 24)||206
8538958|NCT00261495|21052051|P2|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
8538959|NCT00261495|21052052|P1|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
8538960|NCT00261495|21052051|P2|COMPLETED|Titration Phase (Weeks 0 to 4)||185
8538961|NCT00261495|21052052|P1|COMPLETED|Titration Phase (Weeks 0 to 4)||206
8538962|NCT00261495|21052051|P2|STARTED|Titration Phase (Weeks 0 to 4)||250
8538963|NCT00261495|21052052|P1|STARTED|Titration Phase (Weeks 0 to 4)||254
8538964|NCT00261443|21052216|P3|NOT COMPLETED|4: Extension Phase||2
8538965|NCT00261443|21052217|P2|NOT COMPLETED|4: Extension Phase||3
8538966|NCT00261443|21052218|P1|NOT COMPLETED|4: Extension Phase||0
8538967|NCT00261443|21052216|P3|COMPLETED|4: Extension Phase||21
8538968|NCT00261443|21052217|P2|COMPLETED|4: Extension Phase||16
8538969|NCT00261443|21052218|P1|COMPLETED|4: Extension Phase||0
8538970|NCT00261443|21052216|P3|STARTED|4: Extension Phase||23
8538971|NCT00261443|21052217|P2|STARTED|4: Extension Phase||19
8538972|NCT00261443|21052218|P1|STARTED|4: Extension Phase||0
8538973|NCT00261443|21052216|P3|NOT COMPLETED|3: Assessment of Relapse||65
8538974|NCT00261443|21052217|P2|NOT COMPLETED|3: Assessment of Relapse||80
8538975|NCT00261443|21052218|P1|NOT COMPLETED|3: Assessment of Relapse||0
8538976|NCT00261443|21052216|P3|COMPLETED|3: Assessment of Relapse||103
8538977|NCT00261443|21052217|P2|COMPLETED|3: Assessment of Relapse||89
8538978|NCT00261443|21052218|P1|COMPLETED|3: Assessment of Relapse||0
8538979|NCT00261443|21052216|P3|STARTED|3: Assessment of Relapse||168
8538980|NCT00261443|21052217|P2|STARTED|3: Assessment of Relapse||169
8538981|NCT00261443|21052218|P1|STARTED|3: Assessment of Relapse||0
8538982|NCT00261443|21052216|P3|NOT COMPLETED|2: Stability & Maintenance of Stability||0
8538983|NCT00261443|21052217|P2|NOT COMPLETED|2: Stability & Maintenance of Stability||0
8538984|NCT00261443|21052218|P1|NOT COMPLETED|2: Stability & Maintenance of Stability||340
8538985|NCT00261443|21052216|P3|COMPLETED|2: Stability & Maintenance of Stability||0
8538986|NCT00261443|21052217|P2|COMPLETED|2: Stability & Maintenance of Stability||0
8538987|NCT00261443|21052218|P1|COMPLETED|2: Stability & Maintenance of Stability||346
8538988|NCT00261443|21052216|P3|STARTED|2: Stability & Maintenance of Stability||0
8538989|NCT00261443|21052217|P2|STARTED|2: Stability & Maintenance of Stability||0
8538990|NCT00261443|21052218|P1|STARTED|2: Stability & Maintenance of Stability||686
8538991|NCT00261443|21052216|P3|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
8538992|NCT00261443|21052217|P2|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
8538993|NCT00261443|21052218|P1|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
8538994|NCT00261443|21052216|P3|COMPLETED|1: Confirmation of Partial Nonresponse||0
8538995|NCT00261443|21052217|P2|COMPLETED|1: Confirmation of Partial Nonresponse||0
8538996|NCT00261443|21052218|P1|COMPLETED|1: Confirmation of Partial Nonresponse||686
8538997|NCT00261443|21052216|P3|STARTED|1: Confirmation of Partial Nonresponse||0
8538998|NCT00261443|21052217|P2|STARTED|1: Confirmation of Partial Nonresponse||0
8538999|NCT00261443|21052218|P1|STARTED|1: Confirmation of Partial Nonresponse||1270
8539000|NCT00261040|21052475|P2|NOT COMPLETED|Overall Study||0
8539001|NCT00261040|21052476|P1|NOT COMPLETED|Overall Study||1
8539002|NCT00261040|21052475|P2|COMPLETED|Overall Study||20
8539003|NCT00261040|21052476|P1|COMPLETED|Overall Study||19
8539004|NCT00261040|21052475|P2|STARTED|Overall Study||20
8539005|NCT00261040|21052476|P1|STARTED|Overall Study||20
8539006|NCT00260962|21052492|P2|NOT COMPLETED|Overall Study||2
8539007|NCT00260962|21052493|P1|NOT COMPLETED|Overall Study||4
8539008|NCT00260962|21052492|P2|COMPLETED|Overall Study||14
8539009|NCT00260962|21052493|P1|COMPLETED|Overall Study||14
8539010|NCT00260962|21052492|P2|STARTED|Overall Study||16
8539011|NCT00260962|21052493|P1|STARTED|Overall Study||18
8539012|NCT00260832|21052503|P2|NOT COMPLETED|Overall Study||211
8539013|NCT00260832|21052504|P1|NOT COMPLETED|Overall Study||228
8539014|NCT00260832|21052503|P2|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
8539015|NCT00260832|21052504|P1|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
8539016|NCT00260832|21052503|P2|STARTED|Overall Study||242
8539017|NCT00260832|21052504|P1|STARTED|Overall Study||243
8539018|NCT00260689|21052515|P3|NOT COMPLETED|Overall Study||15
8539019|NCT00260689|21052516|P2|NOT COMPLETED|Overall Study||49
8539020|NCT00260689|21052517|P1|NOT COMPLETED|Overall Study||41
8539021|NCT00260689|21052515|P3|COMPLETED|Overall Study||1
8539022|NCT00260689|21052516|P2|COMPLETED|Overall Study||11
8539023|NCT00260689|21052517|P1|COMPLETED|Overall Study||19
8539024|NCT00260689|21052515|P3|STARTED|Overall Study||16
8539025|NCT00260689|21052516|P2|STARTED|Overall Study||60
8539026|NCT00260689|21052517|P1|STARTED|Overall Study||60
8539027|NCT00260533|21052533|P2|NOT COMPLETED|Overall Study||3
8539028|NCT00260533|21052534|P1|NOT COMPLETED|Overall Study||3
8539029|NCT00260533|21052533|P2|COMPLETED|Overall Study||10
8539030|NCT00260533|21052534|P1|COMPLETED|Overall Study||11
8539031|NCT00260533|21052533|P2|STARTED|Overall Study||13
8539032|NCT00260533|21052534|P1|STARTED|Overall Study||14
8539033|NCT00260429|21052542|P2|NOT COMPLETED|Overall Study||0
8539034|NCT00260429|21052543|P1|NOT COMPLETED|Overall Study||2
8539035|NCT00260429|21052542|P2|COMPLETED|Overall Study||12
8539036|NCT00260429|21052543|P1|COMPLETED|Overall Study||21
8539037|NCT00260429|21052542|P2|STARTED|Overall Study||12
8539038|NCT00260429|21052543|P1|STARTED|Overall Study||23
8539039|NCT00260208|21052551|P2|NOT COMPLETED|Overall Study||34
8539040|NCT00260208|21052552|P1|NOT COMPLETED|Overall Study||47
8539041|NCT00260208|21052551|P2|COMPLETED|Overall Study||138
8539042|NCT00260208|21052552|P1|COMPLETED|Overall Study||137
8539043|NCT00260208|21052551|P2|Modified ITT|Overall Study||96
8539044|NCT00260208|21052552|P1|Modified ITT|Overall Study||101
8539045|NCT00260208|21052551|P2|Intent to Treat (ITT) Population|Overall Study||169
8539046|NCT00260208|21052552|P1|Intent to Treat (ITT) Population|Overall Study||182
8539047|NCT00260208|21052551|P2|STARTED|Overall Study||172
8539048|NCT00260208|21052552|P1|STARTED|Overall Study|"Started indicates safety population."|184
8539049|NCT00260195|21052582|P2|NOT COMPLETED|Overall Study||0
8539050|NCT00260195|21052583|P1|NOT COMPLETED|Overall Study||0
8539051|NCT00260195|21052582|P2|COMPLETED|Overall Study||37
8539052|NCT00260195|21052583|P1|COMPLETED|Overall Study||39
8539053|NCT00260195|21052582|P2|STARTED|Overall Study||37
8539054|NCT00260195|21052583|P1|STARTED|Overall Study||39
8539055|NCT00260065|21052595|P1|NOT COMPLETED|Overall Study||93
8539056|NCT00260065|21052595|P1|COMPLETED|Overall Study||6
8539057|NCT00260065|21052595|P1|STARTED|Overall Study||99
8539058|NCT00259857|21052602|P2|NOT COMPLETED|24 Months Treatment||3
8539059|NCT00259857|21052603|P1|NOT COMPLETED|24 Months Treatment||0
8539060|NCT00259857|21052602|P2|COMPLETED|24 Months Treatment||6
8539061|NCT00259857|21052603|P1|COMPLETED|24 Months Treatment||10
8539062|NCT00259857|21052602|P2|STARTED|24 Months Treatment||9
8539063|NCT00259857|21052603|P1|STARTED|24 Months Treatment||10
8539064|NCT00259857|21052602|P2|NOT COMPLETED|12 Months Treatment||2
8539065|NCT00259857|21052603|P1|NOT COMPLETED|12 Months Treatment||1
8539066|NCT00259857|21052602|P2|COMPLETED|12 Months Treatment||9
8539067|NCT00259857|21052603|P1|COMPLETED|12 Months Treatment||10
8539068|NCT00259857|21052602|P2|STARTED|12 Months Treatment||11
8539069|NCT00259857|21052603|P1|STARTED|12 Months Treatment||11
8539070|NCT00259740|21052621|P2|NOT COMPLETED|Overall Study||53
8539071|NCT00259740|21052622|P1|NOT COMPLETED|Overall Study||43
8539072|NCT00259740|21052621|P2|COMPLETED|Overall Study||0
8539073|NCT00259740|21052622|P1|COMPLETED|Overall Study||0
8539074|NCT00259740|21052621|P2|Received Study Medication|Overall Study||53
8539075|NCT00259740|21052622|P1|Received Study Medication|Overall Study||42
8539076|NCT00259740|21052621|P2|STARTED|Overall Study||53
8539077|NCT00259740|21052622|P1|STARTED|Overall Study||43
8539078|NCT00259649|21052632|P1|NOT COMPLETED|Overall Study||10
8539079|NCT00259649|21052632|P1|COMPLETED|Overall Study||61
8539080|NCT00259649|21052632|P1|STARTED|Overall Study||71
8539081|NCT00259610|21052640|P4|NOT COMPLETED|Overall Study||43
8539082|NCT00259610|21052641|P3|NOT COMPLETED|Overall Study||73
8539083|NCT00259610|21052642|P2|NOT COMPLETED|Overall Study||46
8539084|NCT00259610|21052643|P1|NOT COMPLETED|Overall Study||76
8539085|NCT00259610|21052640|P4|COMPLETED|Overall Study||81
8539086|NCT00259610|21052641|P3|COMPLETED|Overall Study||182
8539087|NCT00259610|21052642|P2|COMPLETED|Overall Study||86
8539088|NCT00259610|21052643|P1|COMPLETED|Overall Study||168
8539089|NCT00259610|21052640|P4|STARTED|Overall Study||124
8539090|NCT00259610|21052641|P3|STARTED|Overall Study||255
8539091|NCT00259610|21052642|P2|STARTED|Overall Study||132
8539092|NCT00259610|21052643|P1|STARTED|Overall Study||244
8539093|NCT00259298|21052657|P1|NOT COMPLETED|Overall Study||3
8539094|NCT00259298|21052657|P1|COMPLETED|Overall Study||9
8539095|NCT00259298|21052657|P1|Received at Least 1 Dose of Study Drug|Overall Study||10
8539096|NCT00259298|21052657|P1|STARTED|Overall Study||12
8539097|NCT00259285|21052665|P1|NOT COMPLETED|Overall Study||0
8539098|NCT00259285|21052665|P1|COMPLETED|Overall Study||10
8539099|NCT00259285|21052665|P1|STARTED|Overall Study||10
8539100|NCT00259272|21052675|P4|NOT COMPLETED|Overall Study||21
8539101|NCT00259272|21052676|P3|NOT COMPLETED|Overall Study||5
8539102|NCT00259272|21052677|P2|NOT COMPLETED|Overall Study||7
8539103|NCT00259272|21052678|P1|NOT COMPLETED|Overall Study||15
8539104|NCT00259272|21052675|P4|COMPLETED|Overall Study||27
8539105|NCT00259272|21052676|P3|COMPLETED|Overall Study||21
8539106|NCT00259272|21052677|P2|COMPLETED|Overall Study||24
8539107|NCT00259272|21052678|P1|COMPLETED|Overall Study||21
8539108|NCT00259272|21052675|P4|STARTED|Overall Study||48
8539109|NCT00259272|21052676|P3|STARTED|Overall Study||26
8539110|NCT00259272|21052677|P2|STARTED|Overall Study||31
8539111|NCT00259272|21052678|P1|STARTED|Overall Study||36
8539112|NCT00259090|21052756|P3|NOT COMPLETED|Overall Study||0
8539113|NCT00259090|21052757|P2|NOT COMPLETED|Overall Study||0
8539114|NCT00259090|21052758|P1|NOT COMPLETED|Overall Study||0
8539115|NCT00259090|21052756|P3|COMPLETED|Overall Study||37
8539116|NCT00259090|21052757|P2|COMPLETED|Overall Study||31
8539117|NCT00259090|21052758|P1|COMPLETED|Overall Study||35
8539118|NCT00259090|21052756|P3|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
8539119|NCT00259090|21052757|P2|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
8539120|NCT00259090|21052758|P1|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
8539121|NCT00259012|21052774|P2|NOT COMPLETED|Overall Study||4
8539122|NCT00259012|21052775|P1|NOT COMPLETED|Overall Study||2
8539123|NCT00259012|21052774|P2|COMPLETED|Overall Study||30
8539124|NCT00259012|21052775|P1|COMPLETED|Overall Study||31
8539125|NCT00259012|21052774|P2|STARTED|Overall Study||34
8539126|NCT00259012|21052775|P1|STARTED|Overall Study||33
8539127|NCT00258960|21052807|P1|NOT COMPLETED|Overall Study||17
8539128|NCT00258960|21052807|P1|COMPLETED|Overall Study||32
8539129|NCT00258960|21052807|P1|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49
8539130|NCT00258908|21052815|P1|NOT COMPLETED|Overall Study||0
8539131|NCT00258908|21052815|P1|COMPLETED|Overall Study||112
8539132|NCT00258908|21052815|P1|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
8539133|NCT00258895|21052823|P2|NOT COMPLETED|Overall Study||3
8539134|NCT00258895|21052824|P1|NOT COMPLETED|Overall Study||10
8539135|NCT00258895|21052823|P2|COMPLETED|Overall Study||159
8539136|NCT00258895|21052824|P1|COMPLETED|Overall Study||477
8539137|NCT00258895|21052823|P2|STARTED|Overall Study||162
8539138|NCT00258895|21052824|P1|STARTED|Overall Study||487
8539139|NCT00258882|21052840|P2|NOT COMPLETED|Pregnancy Surveillance||0
8539140|NCT00258882|21052841|P1|NOT COMPLETED|Pregnancy Surveillance||0
8539141|NCT00258882|21052840|P2|COMPLETED|Pregnancy Surveillance||675
8539142|NCT00258882|21052841|P1|COMPLETED|Pregnancy Surveillance||225
8539143|NCT00258882|21052840|P2|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
8539144|NCT00258882|21052841|P1|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
8539145|NCT00258882|21052840|P2|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
8539146|NCT00258882|21052841|P1|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
8539147|NCT00258882|21052840|P2|COMPLETED|Adacel Recipients-Risk Interval Method||0
8539148|NCT00258882|21052841|P1|COMPLETED|Adacel Recipients-Risk Interval Method||124139
8539149|NCT00258882|21052840|P2|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
8539150|NCT00258882|21052841|P1|STARTED|Adacel Recipients-Risk Interval Method||124139
8539151|NCT00258882|21052840|P2|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
8539152|NCT00258882|21052841|P1|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
8539153|NCT00258882|21052840|P2|COMPLETED|Adacel Recipients Historic Cohort Method||203154
8539154|NCT00258882|21052841|P1|COMPLETED|Adacel Recipients Historic Cohort Method||124139
8539155|NCT00258882|21052840|P2|STARTED|Adacel Recipients Historic Cohort Method||203154
8539156|NCT00258882|21052841|P1|STARTED|Adacel Recipients Historic Cohort Method||124139
8539157|NCT00258856|21052860|P4|NOT COMPLETED|Overall Study||1
8539158|NCT00258856|21052861|P3|NOT COMPLETED|Overall Study||2
8539159|NCT00258856|21052862|P2|NOT COMPLETED|Overall Study||0
8539160|NCT00258856|21052863|P1|NOT COMPLETED|Overall Study||3
8539161|NCT00258856|21052860|P4|COMPLETED|Overall Study||58
8539162|NCT00258856|21052861|P3|COMPLETED|Overall Study||56
8539163|NCT00258856|21052862|P2|COMPLETED|Overall Study||58
8539164|NCT00258856|21052863|P1|COMPLETED|Overall Study||56
8539165|NCT00258856|21052860|P4|STARTED|Overall Study||59
8539166|NCT00258856|21052861|P3|STARTED|Overall Study||58
8539167|NCT00258856|21052862|P2|STARTED|Overall Study||58
8539168|NCT00258856|21052863|P1|STARTED|Overall Study||59
8539169|NCT00258830|21052875|P2|NOT COMPLETED|Overall Study||0
8539170|NCT00258830|21052876|P1|NOT COMPLETED|Overall Study||0
8539171|NCT00258830|21052875|P2|COMPLETED|Overall Study||60
8539172|NCT00258830|21052876|P1|COMPLETED|Overall Study||60
8539173|NCT00258830|21052875|P2|STARTED|Overall Study||60
8539174|NCT00258830|21052876|P1|STARTED|Overall Study||60
8539175|NCT00258817|21052890|P2|NOT COMPLETED|Overall Study||0
8539176|NCT00258817|21052891|P1|NOT COMPLETED|Overall Study||0
8539177|NCT00258817|21052890|P2|COMPLETED|Overall Study||15
8539178|NCT00258817|21052891|P1|COMPLETED|Overall Study||15
8539179|NCT00258817|21052890|P2|STARTED|Overall Study||15
8539180|NCT00258817|21052891|P1|STARTED|Overall Study||15
8539181|NCT00258674|21052904|P3|NOT COMPLETED|Overall Study||34
8539182|NCT00258674|21052905|P2|NOT COMPLETED|Overall Study||53
8539183|NCT00258674|21052906|P1|NOT COMPLETED|Overall Study||32
8539184|NCT00258674|21052904|P3|COMPLETED|Overall Study||568
8539185|NCT00258674|21052905|P2|COMPLETED|Overall Study||758
8539186|NCT00258674|21052906|P1|COMPLETED|Overall Study||565
8539187|NCT00258674|21052904|P3|STARTED|Overall Study||602
8539188|NCT00258674|21052905|P2|STARTED|Overall Study||811
8539189|NCT00258674|21052906|P1|STARTED|Overall Study||597
8539190|NCT00258440|21052965|P3|NOT COMPLETED|Overall Study||1
8539191|NCT00258440|21052966|P2|NOT COMPLETED|Overall Study||0
8539192|NCT00258440|21052967|P1|NOT COMPLETED|Overall Study||0
8539193|NCT00258440|21052965|P3|COMPLETED|Overall Study||5
8539194|NCT00258440|21052966|P2|COMPLETED|Overall Study||0
8539195|NCT00258440|21052967|P1|COMPLETED|Overall Study||1
8539196|NCT00258440|21052965|P3|STARTED|Overall Study||6
8539197|NCT00258440|21052966|P2|STARTED|Overall Study||0
8539198|NCT00258440|21052967|P1|STARTED|Overall Study||1
8539199|NCT00258362|21052978|P1|NOT COMPLETED|Overall Study||0
8539200|NCT00258362|21052978|P1|COMPLETED|Overall Study||41
8539201|NCT00258362|21052978|P1|STARTED|Overall Study||41
8539202|NCT00258349|21052983|P1|NOT COMPLETED|Overall Study||0
8539203|NCT00258349|21052983|P1|COMPLETED|Overall Study||16
8539204|NCT00258349|21052983|P1|HER2-positive by Central Review|Overall Study||10
8539205|NCT00258349|21052983|P1|STARTED|Overall Study||16
8539206|NCT00258310|21052990|P1|NOT COMPLETED|Overall Study||0
8539207|NCT00258310|21052990|P1|COMPLETED|Overall Study||35
8539208|NCT00258310|21052990|P1|STARTED|Overall Study||35
8539209|NCT00258206|21052994|P1|NOT COMPLETED|Overall Study||0
8539210|NCT00258206|21052994|P1|COMPLETED|Overall Study||21
8539211|NCT00258206|21052994|P1|STARTED|Overall Study||21
8539212|NCT00258180|21052998|P1|NOT COMPLETED|Overall Study||0
8539213|NCT00258180|21052998|P1|COMPLETED|Overall Study||2
8539214|NCT00258180|21052998|P1|STARTED|Overall Study||2
8539215|NCT00258154|21053005|P2|NOT COMPLETED|Overall Study||7
8539216|NCT00258154|21053006|P1|NOT COMPLETED|Overall Study||9
8539217|NCT00258154|21053005|P2|COMPLETED|Overall Study|Subjects who completed the study.|195
8539218|NCT00258154|21053006|P1|COMPLETED|Overall Study|Subjects who completed the study.|192
8539219|NCT00258154|21053005|P2|Vaccinated at Visit 3|Overall Study||197
8539220|NCT00258154|21053006|P1|Vaccinated at Visit 3|Overall Study||195
8539221|NCT00258154|21053005|P2|Vaccinated at Visit 2|Overall Study||198
8539222|NCT00258154|21053006|P1|Vaccinated at Visit 2|Overall Study||198
8539223|NCT00258154|21053005|P2|Vaccinated at Visit 1|Overall Study||202
8539224|NCT00258154|21053006|P1|Vaccinated at Visit 1|Overall Study||201
8539225|NCT00258154|21053005|P2|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
8539226|NCT00258154|21053006|P1|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
8539227|NCT00258128|21053076|P2|NOT COMPLETED|Overall Study||0
8539228|NCT00258128|21053077|P1|NOT COMPLETED|Overall Study||0
8539229|NCT00258128|21053076|P2|COMPLETED|Overall Study||9
8539230|NCT00258128|21053077|P1|COMPLETED|Overall Study||8
8539231|NCT00258128|21053076|P2|STARTED|Overall Study||9
8539232|NCT00258128|21053077|P1|STARTED|Overall Study||8
8539233|NCT00258011|21053085|P1|NOT COMPLETED|Overall Study||0
8539234|NCT00258011|21053085|P1|COMPLETED|Overall Study||3
8539235|NCT00258011|21053085|P1|STARTED|Overall Study||3
8539236|NCT00257933|21053092|P2|NOT COMPLETED|Overall Study||0
8539237|NCT00257933|21053093|P1|NOT COMPLETED|Overall Study||0
8539238|NCT00257933|21053092|P2|COMPLETED|Overall Study||78
8539239|NCT00257933|21053093|P1|COMPLETED|Overall Study||74
8539240|NCT00257933|21053092|P2|STARTED|Overall Study||78
8539241|NCT00257933|21053093|P1|STARTED|Overall Study||74
8539242|NCT00257920|21053101|P2|NOT COMPLETED|Period: Second Intervention||1
8539243|NCT00257920|21053102|P1|NOT COMPLETED|Period: Second Intervention||2
8539244|NCT00257920|21053101|P2|COMPLETED|Period: Second Intervention||18
8539245|NCT00257920|21053102|P1|COMPLETED|Period: Second Intervention||19
8539246|NCT00257920|21053101|P2|STARTED|Period: Second Intervention||19
8539247|NCT00257920|21053102|P1|STARTED|Period: Second Intervention||21
8539248|NCT00257920|21053101|P2|NOT COMPLETED|Period: Washout Period of Two Weeks||1
8539249|NCT00257920|21053102|P1|NOT COMPLETED|Period: Washout Period of Two Weeks||0
8539250|NCT00257920|21053101|P2|COMPLETED|Period: Washout Period of Two Weeks||19
8539251|NCT00257920|21053102|P1|COMPLETED|Period: Washout Period of Two Weeks||21
8539252|NCT00257920|21053101|P2|STARTED|Period: Washout Period of Two Weeks||20
8539253|NCT00257920|21053102|P1|STARTED|Period: Washout Period of Two Weeks||21
8539254|NCT00257920|21053101|P2|NOT COMPLETED|Period: First Intervention||0
8539255|NCT00257920|21053102|P1|NOT COMPLETED|Period: First Intervention||0
8539256|NCT00257920|21053101|P2|COMPLETED|Period: First Intervention||20
8539257|NCT00257920|21053102|P1|COMPLETED|Period: First Intervention||21
8539258|NCT00257920|21053101|P2|STARTED|Period: First Intervention||20
8539259|NCT00257920|21053102|P1|STARTED|Period: First Intervention||21
8539260|NCT00257894|21053112|P2|NOT COMPLETED|Overall Study||5
8539261|NCT00257894|21053113|P1|NOT COMPLETED|Overall Study||4
8539262|NCT00257894|21053112|P2|COMPLETED|Overall Study||15
8539263|NCT00257894|21053113|P1|COMPLETED|Overall Study||17
8539264|NCT00257894|21053112|P2|STARTED|Overall Study||20
8539265|NCT00257894|21053113|P1|STARTED|Overall Study||21
8539266|NCT00257725|21053125|P1|NOT COMPLETED|Overall Study||3
8539267|NCT00257725|21053125|P1|COMPLETED|Overall Study||8
8539268|NCT00257725|21053125|P1|STARTED|Overall Study||11
8539269|NCT00257686|21053137|P6|NOT COMPLETED|Overall Study||9
8539270|NCT00257686|21053138|P5|NOT COMPLETED|Overall Study||22
8539271|NCT00257686|21053139|P4|NOT COMPLETED|Overall Study||11
8539272|NCT00257686|21053140|P3|NOT COMPLETED|Overall Study||18
8539273|NCT00257686|21053141|P2|NOT COMPLETED|Overall Study||19
8539274|NCT00257686|21053142|P1|NOT COMPLETED|Overall Study||21
8539275|NCT00257686|21053137|P6|COMPLETED|Overall Study||95
8539276|NCT00257686|21053138|P5|COMPLETED|Overall Study||194
8539277|NCT00257686|21053139|P4|COMPLETED|Overall Study||88
8539278|NCT00257686|21053140|P3|COMPLETED|Overall Study||208
8539279|NCT00257686|21053141|P2|COMPLETED|Overall Study||89
8539280|NCT00257686|21053142|P1|COMPLETED|Overall Study||188
8539281|NCT00257686|21053137|P6|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
8539282|NCT00257686|21053138|P5|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
8539283|NCT00257686|21053139|P4|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
8539284|NCT00257686|21053140|P3|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
8539285|NCT00257686|21053141|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
8539286|NCT00257686|21053142|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
8539287|NCT00257686|21053137|P6|STARTED|Overall Study||104
8539288|NCT00257686|21053138|P5|STARTED|Overall Study||216
8539289|NCT00257686|21053139|P4|STARTED|Overall Study||99
8539290|NCT00257686|21053140|P3|STARTED|Overall Study||226
8539291|NCT00257686|21053141|P2|STARTED|Overall Study||108
8539292|NCT00257686|21053142|P1|STARTED|Overall Study||209
8539293|NCT00257660|21053164|P2|NOT COMPLETED|Overall Study||23
8539294|NCT00257660|21053165|P1|NOT COMPLETED|Overall Study||10
8539295|NCT00257660|21053164|P2|COMPLETED|Overall Study||38
8539296|NCT00257660|21053165|P1|COMPLETED|Overall Study||45
8539297|NCT00257660|21053164|P2|STARTED|Overall Study||61
8539298|NCT00257660|21053165|P1|STARTED|Overall Study||55
8539299|NCT00257608|21053195|P3|NOT COMPLETED|Post Chemotherapy Phase||244
8539300|NCT00257608|21053196|P2|NOT COMPLETED|Post Chemotherapy Phase||264
8539301|NCT00257608|21053197|P1|NOT COMPLETED|Post Chemotherapy Phase||0
8539302|NCT00257608|21053195|P3|COMPLETED|Post Chemotherapy Phase||126
8539303|NCT00257608|21053196|P2|COMPLETED|Post Chemotherapy Phase||109
8539304|NCT00257608|21053197|P1|COMPLETED|Post Chemotherapy Phase||0
8539305|NCT00257608|21053195|P3|STARTED|Post Chemotherapy Phase||370
8539306|NCT00257608|21053196|P2|STARTED|Post Chemotherapy Phase||373
8539307|NCT00257608|21053197|P1|STARTED|Post Chemotherapy Phase||0
8539308|NCT00257608|21053195|P3|NOT COMPLETED|Chemotherapy Phase||0
8539309|NCT00257608|21053196|P2|NOT COMPLETED|Chemotherapy Phase||0
8539310|NCT00257608|21053197|P1|NOT COMPLETED|Chemotherapy Phase||376
8539311|NCT00257608|21053195|P3|COMPLETED|Chemotherapy Phase||0
8539312|NCT00257608|21053196|P2|COMPLETED|Chemotherapy Phase||0
8539313|NCT00257608|21053197|P1|COMPLETED|Chemotherapy Phase||769
8539314|NCT00257608|21053195|P3|STARTED|Chemotherapy Phase||0
8539315|NCT00257608|21053196|P2|STARTED|Chemotherapy Phase||0
8539316|NCT00257608|21053197|P1|STARTED|Chemotherapy Phase||1145
8539317|NCT00257556|21053223|P2|NOT COMPLETED|Overall Study||10
8539318|NCT00257556|21053224|P1|NOT COMPLETED|Overall Study||14
8539319|NCT00257556|21053223|P2|COMPLETED|Overall Study||32
8539320|NCT00257556|21053224|P1|COMPLETED|Overall Study||24
8539321|NCT00257556|21053223|P2|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
8539322|NCT00257556|21053224|P1|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
8539323|NCT00257556|21053223|P2|STARTED|Overall Study||42
8539324|NCT00257556|21053224|P1|STARTED|Overall Study||38
8539325|NCT00257322|21053250|P1|NOT COMPLETED|Overall Study||4
8539326|NCT00257322|21053250|P1|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
8539327|NCT00257322|21053250|P1|STARTED|Overall Study|20 subjects accrued.|20
8539328|NCT00257309|21053257|P2|NOT COMPLETED|Overall Study||2
8539329|NCT00257309|21053258|P1|NOT COMPLETED|Overall Study||2
8539330|NCT00257309|21053257|P2|COMPLETED|Overall Study||130
8539331|NCT00257309|21053258|P1|COMPLETED|Overall Study||132
8539332|NCT00257309|21053257|P2|STARTED|Overall Study||132
8539333|NCT00257309|21053258|P1|STARTED|Overall Study||134
8539350|NCT00257010|21053326|P1|NOT COMPLETED|Overall Study||128
8539351|NCT00257010|21053326|P1|COMPLETED|Overall Study||319
8539352|NCT00257010|21053326|P1|STARTED|Overall Study||447
8539353|NCT00256997|21053337|P2|NOT COMPLETED|Overall Study||55
8539354|NCT00256997|21053338|P1|NOT COMPLETED|Overall Study||48
8539355|NCT00256997|21053337|P2|COMPLETED|Overall Study||31
8539356|NCT00256997|21053338|P1|COMPLETED|Overall Study||33
8539357|NCT00256997|21053337|P2|Treated|Overall Study||86
8539358|NCT00256997|21053338|P1|Treated|Overall Study||79
8539359|NCT00256997|21053337|P2|STARTED|Overall Study||86
8539360|NCT00256997|21053338|P1|STARTED|Overall Study||81
8539361|NCT00256984|21053362|P1|NOT COMPLETED|Overall Study||16
8539362|NCT00256984|21053362|P1|COMPLETED|Overall Study||59
8539363|NCT00256984|21053362|P1|STARTED|Overall Study||75
8539364|NCT00256867|21053380|P8|NOT COMPLETED|Overall Study||11
8539365|NCT00256867|21053381|P7|NOT COMPLETED|Overall Study||5
8539366|NCT00256867|21053382|P6|NOT COMPLETED|Overall Study||6
8539367|NCT00256867|21053383|P5|NOT COMPLETED|Overall Study||7
8539368|NCT00256867|21053384|P4|NOT COMPLETED|Overall Study||6
8539369|NCT00256867|21053385|P3|NOT COMPLETED|Overall Study||5
8539370|NCT00256867|21053386|P2|NOT COMPLETED|Overall Study||5
8539371|NCT00256867|21053387|P1|NOT COMPLETED|Overall Study||2
8539372|NCT00256867|21053380|P8|COMPLETED|Overall Study||36
8539373|NCT00256867|21053381|P7|COMPLETED|Overall Study||41
8539374|NCT00256867|21053382|P6|COMPLETED|Overall Study||40
8539375|NCT00256867|21053383|P5|COMPLETED|Overall Study||41
8539376|NCT00256867|21053384|P4|COMPLETED|Overall Study||40
8539377|NCT00256867|21053385|P3|COMPLETED|Overall Study||40
8539378|NCT00256867|21053386|P2|COMPLETED|Overall Study||39
8539379|NCT00256867|21053387|P1|COMPLETED|Overall Study||45
8539380|NCT00256867|21053380|P8|STARTED|Overall Study||47
8539381|NCT00256867|21053381|P7|STARTED|Overall Study||46
8539382|NCT00256867|21053382|P6|STARTED|Overall Study||46
8539383|NCT00256867|21053383|P5|STARTED|Overall Study||48
8539384|NCT00256867|21053384|P4|STARTED|Overall Study||46
8539385|NCT00256867|21053385|P3|STARTED|Overall Study||45
8539386|NCT00256867|21053386|P2|STARTED|Overall Study||44
8539387|NCT00256867|21053387|P1|STARTED|Overall Study||47
8539388|NCT00256854|21053477|P6|NOT COMPLETED|Overall Study||1
8539389|NCT00256854|21053478|P5|NOT COMPLETED|Overall Study||1
8539390|NCT00256854|21053479|P4|NOT COMPLETED|Overall Study||3
8539391|NCT00256854|21053480|P3|NOT COMPLETED|Overall Study||3
8539392|NCT00256854|21053481|P2|NOT COMPLETED|Overall Study||4
8539393|NCT00256854|21053482|P1|NOT COMPLETED|Overall Study||3
8539394|NCT00256854|21053477|P6|COMPLETED|Overall Study||13
8539395|NCT00256854|21053478|P5|COMPLETED|Overall Study||15
8539396|NCT00256854|21053479|P4|COMPLETED|Overall Study||24
8539397|NCT00256854|21053480|P3|COMPLETED|Overall Study||23
8539398|NCT00256854|21053481|P2|COMPLETED|Overall Study||22
8539399|NCT00256854|21053482|P1|COMPLETED|Overall Study||23
8539400|NCT00256854|21053477|P6|STARTED|Overall Study||14
8539401|NCT00256854|21053478|P5|STARTED|Overall Study||16
8539402|NCT00256854|21053479|P4|STARTED|Overall Study||27
8539403|NCT00256854|21053480|P3|STARTED|Overall Study||26
8539404|NCT00256854|21053481|P2|STARTED|Overall Study||26
8539405|NCT00256854|21053482|P1|STARTED|Overall Study||26
8539406|NCT00256750|21053541|P3|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
8539407|NCT00256750|21053542|P2|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
8539408|NCT00256750|21053543|P1|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
8539409|NCT00256750|21053541|P3|COMPLETED|Long Term Extension (LTE; 84 Months)||127
8539410|NCT00256750|21053542|P2|COMPLETED|Long Term Extension (LTE; 84 Months)||136
8539411|NCT00256750|21053543|P1|COMPLETED|Long Term Extension (LTE; 84 Months)||89
8539412|NCT00256750|21053541|P3|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
8539413|NCT00256750|21053542|P2|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
8539414|NCT00256750|21053543|P1|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
8539415|NCT00256750|21053541|P3|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
8539416|NCT00256750|21053542|P2|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
8539417|NCT00256750|21053543|P1|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
8539418|NCT00256750|21053541|P3|COMPLETED|Post-Transplant Treated (36 Months)||158
8539419|NCT00256750|21053542|P2|COMPLETED|Post-Transplant Treated (36 Months)||170
8539420|NCT00256750|21053543|P1|COMPLETED|Post-Transplant Treated (36 Months)||143
8539421|NCT00256750|21053541|P3|STARTED|Post-Transplant Treated (36 Months)||164
8539422|NCT00256750|21053542|P2|STARTED|Post-Transplant Treated (36 Months)||176
8539423|NCT00256750|21053543|P1|STARTED|Post-Transplant Treated (36 Months)||153
8539424|NCT00256750|21053541|P3|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
8539425|NCT00256750|21053542|P2|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
8539426|NCT00256750|21053543|P1|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
8539427|NCT00256750|21053541|P3|COMPLETED|Post-Transplant Treated (24 Months)||164
8539428|NCT00256750|21053542|P2|COMPLETED|Post-Transplant Treated (24 Months)||176
8539429|NCT00256750|21053543|P1|COMPLETED|Post-Transplant Treated (24 Months)||153
8539430|NCT00256750|21053541|P3|STARTED|Post-Transplant Treated (24 Months)||173
8539431|NCT00256750|21053542|P2|STARTED|Post-Transplant Treated (24 Months)||183
8539432|NCT00256750|21053543|P1|STARTED|Post-Transplant Treated (24 Months)||174
8539433|NCT00256750|21053541|P3|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
8539434|NCT00256750|21053542|P2|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
8539435|NCT00256750|21053543|P1|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
8539436|NCT00256750|21053541|P3|COMPLETED|Post-Transplant Treated (12 Months)||173
8539437|NCT00256750|21053542|P2|COMPLETED|Post-Transplant Treated (12 Months)||183
8539438|NCT00256750|21053543|P1|COMPLETED|Post-Transplant Treated (12 Months)||174
8539439|NCT00256750|21053541|P3|STARTED|Post-Transplant Treated (12 Months)||219
8539440|NCT00256750|21053542|P2|STARTED|Post-Transplant Treated (12 Months)||226
8539441|NCT00256750|21053543|P1|STARTED|Post-Transplant Treated (12 Months)||215
8539442|NCT00256750|21053541|P3|NOT COMPLETED|Transplanted Pre-Treatment||0
8539443|NCT00256750|21053542|P2|NOT COMPLETED|Transplanted Pre-Treatment||0
8539444|NCT00256750|21053543|P1|NOT COMPLETED|Transplanted Pre-Treatment||6
8539445|NCT00256750|21053541|P3|COMPLETED|Transplanted Pre-Treatment||219
8539446|NCT00256750|21053542|P2|COMPLETED|Transplanted Pre-Treatment||226
8539447|NCT00256750|21053543|P1|COMPLETED|Transplanted Pre-Treatment||215
8539448|NCT00256750|21053541|P3|STARTED|Transplanted Pre-Treatment||219
8539449|NCT00256750|21053542|P2|STARTED|Transplanted Pre-Treatment||226
8539450|NCT00256750|21053543|P1|STARTED|Transplanted Pre-Treatment||221
8539451|NCT00256724|21053679|P2|NOT COMPLETED|Overall Study||8
8539452|NCT00256724|21053680|P1|NOT COMPLETED|Overall Study||5
8539453|NCT00256724|21053679|P2|COMPLETED|Overall Study||16
8539454|NCT00256724|21053680|P1|COMPLETED|Overall Study||18
8539455|NCT00256724|21053679|P2|STARTED|Overall Study||24
8539456|NCT00256724|21053680|P1|STARTED|Overall Study||23
8539457|NCT00256698|21053690|P2|NOT COMPLETED|Overall Study||172
8539458|NCT00256698|21053691|P1|NOT COMPLETED|Overall Study||167
8539459|NCT00256698|21053690|P2|COMPLETED|Overall Study||84
8539460|NCT00256698|21053691|P1|COMPLETED|Overall Study||91
8539461|NCT00256698|21053690|P2|STARTED|Overall Study||256
8539462|NCT00256698|21053691|P1|STARTED|Overall Study||258
8539463|NCT00256451|21053709|P4|NOT COMPLETED|Session4||0
8539464|NCT00256451|21053710|P3|NOT COMPLETED|Session4||0
8539465|NCT00256451|21053711|P2|NOT COMPLETED|Session4||0
8539466|NCT00256451|21053712|P1|NOT COMPLETED|Session4||0
8539467|NCT00256451|21053709|P4|COMPLETED|Session4||8
8539468|NCT00256451|21053710|P3|COMPLETED|Session4||10
8539469|NCT00256451|21053711|P2|COMPLETED|Session4||8
8539470|NCT00256451|21053712|P1|COMPLETED|Session4||9
8539471|NCT00256451|21053709|P4|STARTED|Session4||8
8539472|NCT00256451|21053710|P3|STARTED|Session4||10
8539473|NCT00256451|21053711|P2|STARTED|Session4||8
8539474|NCT00256451|21053712|P1|STARTED|Session4||9
8539475|NCT00256451|21053709|P4|NOT COMPLETED|Session3||0
8539476|NCT00256451|21053710|P3|NOT COMPLETED|Session3||0
8539477|NCT00256451|21053711|P2|NOT COMPLETED|Session3||0
8539478|NCT00256451|21053712|P1|NOT COMPLETED|Session3||0
8539479|NCT00256451|21053709|P4|COMPLETED|Session3||9
8539480|NCT00256451|21053710|P3|COMPLETED|Session3||10
8539481|NCT00256451|21053711|P2|COMPLETED|Session3||9
8539482|NCT00256451|21053712|P1|COMPLETED|Session3||9
8539483|NCT00256451|21053709|P4|STARTED|Session3||9
8539484|NCT00256451|21053710|P3|STARTED|Session3||10
8539485|NCT00256451|21053711|P2|STARTED|Session3||9
8539486|NCT00256451|21053712|P1|STARTED|Session3||9
8539487|NCT00256451|21053709|P4|NOT COMPLETED|Session2||0
8539488|NCT00256451|21053710|P3|NOT COMPLETED|Session2||0
8539489|NCT00256451|21053711|P2|NOT COMPLETED|Session2||0
8539490|NCT00256451|21053712|P1|NOT COMPLETED|Session2||0
8539491|NCT00256451|21053709|P4|COMPLETED|Session2||10
8539492|NCT00256451|21053710|P3|COMPLETED|Session2||10
8539493|NCT00256451|21053711|P2|COMPLETED|Session2||11
8539494|NCT00256451|21053712|P1|COMPLETED|Session2||9
8539495|NCT00256451|21053709|P4|STARTED|Session2||10
8539496|NCT00256451|21053710|P3|STARTED|Session2||10
8539497|NCT00256451|21053711|P2|STARTED|Session2||11
8539498|NCT00256451|21053712|P1|STARTED|Session2||9
8539499|NCT00256451|21053709|P4|NOT COMPLETED|Session1||0
8539500|NCT00256451|21053710|P3|NOT COMPLETED|Session1||0
8539501|NCT00256451|21053711|P2|NOT COMPLETED|Session1||0
8539502|NCT00256451|21053712|P1|NOT COMPLETED|Session1||0
8539503|NCT00256451|21053709|P4|COMPLETED|Session1||11
8539504|NCT00256451|21053710|P3|COMPLETED|Session1||11
8539505|NCT00256451|21053711|P2|COMPLETED|Session1||11
8539506|NCT00256451|21053712|P1|COMPLETED|Session1||10
8539507|NCT00256451|21053709|P4|STARTED|Session1||11
8539508|NCT00256451|21053710|P3|STARTED|Session1||11
8539509|NCT00256451|21053711|P2|STARTED|Session1||11
8539510|NCT00256451|21053712|P1|STARTED|Session1||10
8539511|NCT00256308|21053738|P1|NOT COMPLETED|Overall Study||2
8539512|NCT00256308|21053738|P1|COMPLETED|Overall Study||4
8539513|NCT00256308|21053738|P1|STARTED|Overall Study||6
8539514|NCT00256295|21053746|P1|NOT COMPLETED|Overall Study||4
8539515|NCT00256295|21053746|P1|COMPLETED|Overall Study||3
8539516|NCT00256295|21053746|P1|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
8539517|NCT00256282|21053752|P1|NOT COMPLETED|Overall Study||16
8539518|NCT00256282|21053752|P1|COMPLETED|Overall Study||36
8539519|NCT00256282|21053752|P1|STARTED|Overall Study||52
8539520|NCT00256243|21053757|P1|NOT COMPLETED|Overall Study||10
8539521|NCT00256243|21053757|P1|COMPLETED|Overall Study||38
8539522|NCT00256243|21053757|P1|STARTED|Overall Study||48
8539523|NCT00256204|21053766|P4|NOT COMPLETED|Overall Study||49
8539524|NCT00256204|21053767|P3|NOT COMPLETED|Overall Study||54
8539525|NCT00256204|21053768|P2|NOT COMPLETED|Overall Study||50
8539526|NCT00256204|21053769|P1|NOT COMPLETED|Overall Study||67
8539527|NCT00256204|21053766|P4|COMPLETED|Overall Study||244
8539528|NCT00256204|21053767|P3|COMPLETED|Overall Study||241
8539529|NCT00256204|21053768|P2|COMPLETED|Overall Study||238
8539530|NCT00256204|21053769|P1|COMPLETED|Overall Study||231
8539531|NCT00256204|21053766|P4|STARTED|Overall Study||293
8539532|NCT00256204|21053767|P3|STARTED|Overall Study||295
8539533|NCT00256204|21053768|P2|STARTED|Overall Study||288
8539534|NCT00256204|21053769|P1|STARTED|Overall Study||298
8539535|NCT00256126|21053784|P2|NOT COMPLETED|Overall Study||2
8539536|NCT00256126|21053785|P1|NOT COMPLETED|Overall Study||2
8539537|NCT00256126|21053784|P2|COMPLETED|Overall Study||167
8539538|NCT00256126|21053785|P1|COMPLETED|Overall Study||147
8539539|NCT00256126|21053784|P2|STARTED|Overall Study||169
8539540|NCT00256126|21053785|P1|STARTED|Overall Study||149
8539541|NCT00255970|21053803|P2|NOT COMPLETED|Overall Study||0
8539542|NCT00255970|21053804|P1|NOT COMPLETED|Overall Study||0
8539543|NCT00255970|21053803|P2|COMPLETED|Overall Study||19
8539544|NCT00255970|21053804|P1|COMPLETED|Overall Study||21
8539545|NCT00255970|21053803|P2|Final Visit Week 24|Overall Study||19
8539546|NCT00255970|21053804|P1|Final Visit Week 24|Overall Study||21
8539547|NCT00255970|21053803|P2|Screening Visit|Overall Study||19
8539548|NCT00255970|21053804|P1|Screening Visit|Overall Study||21
8539549|NCT00255970|21053803|P2|STARTED|Overall Study||19
8539550|NCT00255970|21053804|P1|STARTED|Overall Study||21
8539551|NCT00255944|21053824|P2|NOT COMPLETED|Overall Study||834
8539552|NCT00255944|21053825|P1|NOT COMPLETED|Overall Study||797
8539553|NCT00255944|21053824|P2|COMPLETED|Overall Study||477
8539554|NCT00255944|21053825|P1|COMPLETED|Overall Study||514
8539555|NCT00255944|21053824|P2|STARTED|Overall Study||1311
8539556|NCT00255944|21053825|P1|STARTED|Overall Study||1311
8539557|NCT00255840|21053833|P2|NOT COMPLETED|Overall Study||70
8539558|NCT00255840|21053834|P1|NOT COMPLETED|Overall Study||63
8539559|NCT00255840|21053833|P2|COMPLETED|Overall Study||334
8539560|NCT00255840|21053834|P1|COMPLETED|Overall Study||345
8539561|NCT00255840|21053833|P2|STARTED|Overall Study||404
8539562|NCT00255840|21053834|P1|STARTED|Overall Study||408
8539563|NCT00255801|21053840|P1|NOT COMPLETED|Overall Study||0
8539564|NCT00255801|21053840|P1|COMPLETED|Overall Study||37
8539565|NCT00255801|21053840|P1|STARTED|Overall Study||37
8539566|NCT00255723|21053847|P2|NOT COMPLETED|Overall Study||2
8539567|NCT00255723|21053848|P1|NOT COMPLETED|Overall Study||2
8539568|NCT00255723|21053847|P2|COMPLETED|Overall Study||39
8539569|NCT00255723|21053848|P1|COMPLETED|Overall Study||54
8539570|NCT00255723|21053847|P2|STARTED|Overall Study||41
8539571|NCT00255723|21053848|P1|STARTED|Overall Study||56
8539572|NCT00255684|21053854|P1|NOT COMPLETED|Overall Study||0
8539573|NCT00255684|21053854|P1|COMPLETED|Overall Study||16
8539574|NCT00255684|21053854|P1|STARTED|Overall Study||16
8539575|NCT00255346|21053864|P5|NOT COMPLETED|Overall Study||0
8539576|NCT00255346|21053865|P4|NOT COMPLETED|Overall Study||0
8539577|NCT00255346|21053866|P3|NOT COMPLETED|Overall Study||0
8539578|NCT00255346|21053867|P2|NOT COMPLETED|Overall Study||0
8539579|NCT00255346|21053868|P1|NOT COMPLETED|Overall Study||1
8539580|NCT00255346|21053864|P5|COMPLETED|Overall Study||33
8539581|NCT00255346|21053865|P4|COMPLETED|Overall Study||11
8539582|NCT00255346|21053866|P3|COMPLETED|Overall Study||8
8539583|NCT00255346|21053867|P2|COMPLETED|Overall Study||6
8539584|NCT00255346|21053868|P1|COMPLETED|Overall Study||9
8539585|NCT00255346|21053864|P5|STARTED|Overall Study||33
8539586|NCT00255346|21053865|P4|STARTED|Overall Study||11
8539587|NCT00255346|21053866|P3|STARTED|Overall Study||8
8539588|NCT00255346|21053867|P2|STARTED|Overall Study||6
8539589|NCT00255346|21053868|P1|STARTED|Overall Study||10
8539590|NCT00255190|21053883|P2|NOT COMPLETED|Overall Study||157
8539591|NCT00255190|21053884|P1|NOT COMPLETED|Overall Study||50
8539592|NCT00255190|21053883|P2|COMPLETED|Overall Study||281
8539593|NCT00255190|21053884|P1|COMPLETED|Overall Study||103
8539594|NCT00255190|21053883|P2|STARTED|Overall Study||438
8539595|NCT00255190|21053884|P1|STARTED|Overall Study||153
8539596|NCT00255177|21053952|P4|NOT COMPLETED|Overall Study||2
8539597|NCT00255177|21053953|P3|NOT COMPLETED|Overall Study||1
8539598|NCT00255177|21053954|P2|NOT COMPLETED|Overall Study||1
8539599|NCT00255177|21053955|P1|NOT COMPLETED|Overall Study||2
8539600|NCT00255177|21053952|P4|COMPLETED|Overall Study||4
8539601|NCT00255177|21053953|P3|COMPLETED|Overall Study||12
8539602|NCT00255177|21053954|P2|COMPLETED|Overall Study||13
8539603|NCT00255177|21053955|P1|COMPLETED|Overall Study||9
8539604|NCT00255177|21053952|P4|STARTED|Overall Study||6
8539605|NCT00255177|21053953|P3|STARTED|Overall Study||13
8539606|NCT00255177|21053954|P2|STARTED|Overall Study||14
8539607|NCT00255177|21053955|P1|STARTED|Overall Study||11
8539608|NCT00255164|21053968|P3|NOT COMPLETED|Overall Study||49
8539609|NCT00255164|21053969|P2|NOT COMPLETED|Overall Study||49
8539610|NCT00255164|21053970|P1|NOT COMPLETED|Overall Study||123
8539611|NCT00255164|21053968|P3|COMPLETED|Overall Study||103
8539612|NCT00255164|21053969|P2|COMPLETED|Overall Study||110
8539613|NCT00255164|21053970|P1|COMPLETED|Overall Study||17
8539614|NCT00255164|21053968|P3|STARTED|Overall Study||152
8539615|NCT00255164|21053969|P2|STARTED|Overall Study||159
8539616|NCT00255164|21053970|P1|STARTED|Overall Study||140
8539617|NCT00255151|21053996|P3|NOT COMPLETED|Overall Study||49
8539618|NCT00255151|21053997|P2|NOT COMPLETED|Overall Study||49
8539619|NCT00255151|21053998|P1|NOT COMPLETED|Overall Study||123
8539620|NCT00255151|21053996|P3|COMPLETED|Overall Study||103
8539621|NCT00255151|21053997|P2|COMPLETED|Overall Study||110
8539622|NCT00255151|21053998|P1|COMPLETED|Overall Study||17
8539623|NCT00255151|21053996|P3|STARTED|Overall Study||152
8539624|NCT00255151|21053997|P2|STARTED|Overall Study||159
8539625|NCT00255151|21053998|P1|STARTED|Overall Study||140
8539626|NCT00255125|21054023|P2|NOT COMPLETED|Overall Study||0
8539627|NCT00255125|21054024|P1|NOT COMPLETED|Overall Study||0
8539628|NCT00255125|21054023|P2|COMPLETED|Overall Study||44
8539629|NCT00255125|21054024|P1|COMPLETED|Overall Study||42
8539630|NCT00255125|21054023|P2|STARTED|Overall Study||44
8539631|NCT00255125|21054024|P1|STARTED|Overall Study||42
8539632|NCT00255086|21054036|P2|NOT COMPLETED|Overall Study||2
8539633|NCT00255086|21054037|P1|NOT COMPLETED|Overall Study||2
8539634|NCT00255086|21054036|P2|COMPLETED|Overall Study||6
8539635|NCT00255086|21054037|P1|COMPLETED|Overall Study||7
8539636|NCT00255086|21054036|P2|STARTED|Overall Study||8
8539637|NCT00255086|21054037|P1|STARTED|Overall Study||9
8539638|NCT00255047|21054049|P4|NOT COMPLETED|Overall Study||46
8539639|NCT00255047|21054050|P3|NOT COMPLETED|Overall Study||50
8539640|NCT00255047|21054051|P2|NOT COMPLETED|Overall Study||48
8539641|NCT00255047|21054052|P1|NOT COMPLETED|Overall Study||48
8539642|NCT00255047|21054049|P4|COMPLETED|Overall Study||502
8539643|NCT00255047|21054050|P3|COMPLETED|Overall Study||496
8539644|NCT00255047|21054051|P2|COMPLETED|Overall Study||487
8539645|NCT00255047|21054052|P1|COMPLETED|Overall Study||490
8539646|NCT00255047|21054049|P4|STARTED|Overall Study||548
8539647|NCT00255047|21054050|P3|STARTED|Overall Study||546
8539648|NCT00255047|21054051|P2|STARTED|Overall Study||535
8539649|NCT00255047|21054052|P1|STARTED|Overall Study||538
8539650|NCT00255034|21054076|P2|NOT COMPLETED|Overall Study||38
8539651|NCT00255034|21054077|P1|NOT COMPLETED|Overall Study||15
8539652|NCT00255034|21054076|P2|COMPLETED|Overall Study||26
8539653|NCT00255034|21054077|P1|COMPLETED|Overall Study||64
8539654|NCT00255034|21054076|P2|STARTED|Overall Study||64
8539655|NCT00255034|21054077|P1|STARTED|Overall Study||79
8539656|NCT00255008|21054087|P4|NOT COMPLETED|Overall Study||22
8539657|NCT00255008|21054088|P3|NOT COMPLETED|Overall Study||16
8539658|NCT00255008|21054089|P2|NOT COMPLETED|Overall Study||9
8539659|NCT00255008|21054090|P1|NOT COMPLETED|Overall Study||32
8539660|NCT00255008|21054087|P4|COMPLETED|Overall Study||12
8539661|NCT00255008|21054088|P3|COMPLETED|Overall Study||17
8539662|NCT00255008|21054089|P2|COMPLETED|Overall Study||0
8539663|NCT00255008|21054090|P1|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
8539664|NCT00255008|21054087|P4|STARTED|Overall Study||34
8539665|NCT00255008|21054088|P3|STARTED|Overall Study||33
8539666|NCT00255008|21054089|P2|STARTED|Overall Study||9
8539667|NCT00255008|21054090|P1|STARTED|Overall Study||45
8539668|NCT00254995|21054102|P2|NOT COMPLETED|Overall Study||0
8539669|NCT00254995|21054103|P1|NOT COMPLETED|Overall Study||0
8539670|NCT00254995|21054102|P2|COMPLETED|Overall Study||31065
8539671|NCT00254995|21054103|P1|COMPLETED|Overall Study||31561
8539672|NCT00254995|21054102|P2|STARTED|Overall Study||31065
8539673|NCT00254995|21054103|P1|STARTED|Overall Study||31561
8539674|NCT00254982|21054126|P2|NOT COMPLETED|Overall Study||31
8539675|NCT00254982|21054127|P1|NOT COMPLETED|Overall Study||36
8539676|NCT00254982|21054126|P2|COMPLETED|Overall Study||265
8539677|NCT00254982|21054127|P1|COMPLETED|Overall Study||261
8539678|NCT00254982|21054126|P2|STARTED|Overall Study||296
8539679|NCT00254982|21054127|P1|STARTED|Overall Study||297
8539680|NCT00254592|21054133|P1|NOT COMPLETED|Overall Study||2
8539681|NCT00254592|21054133|P1|COMPLETED|Overall Study||41
8539682|NCT00254592|21054133|P1|STARTED|Overall Study||43
8539683|NCT00254566|21054139|P2|NOT COMPLETED|Overall Study||26
8539684|NCT00254566|21054140|P1|NOT COMPLETED|Overall Study||31
8539685|NCT00254566|21054139|P2|COMPLETED|Overall Study||172
8539686|NCT00254566|21054140|P1|COMPLETED|Overall Study||167
8539687|NCT00254566|21054139|P2|STARTED|Overall Study||198
8539688|NCT00254566|21054140|P1|STARTED|Overall Study||198
8539689|NCT00254540|21054164|P2|NOT COMPLETED|Overall Study||22
8539690|NCT00254540|21054165|P1|NOT COMPLETED|Overall Study||19
8539691|NCT00254540|21054164|P2|COMPLETED|Overall Study||4
8539692|NCT00254540|21054165|P1|COMPLETED|Overall Study||6
8539693|NCT00254540|21054164|P2|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
8539694|NCT00254540|21054165|P1|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
8539695|NCT00254501|21054194|P2|NOT COMPLETED|Overall Study||1
8539696|NCT00254501|21054195|P1|NOT COMPLETED|Overall Study||1
8539697|NCT00254501|21054194|P2|COMPLETED|Overall Study||36
8539698|NCT00254501|21054195|P1|COMPLETED|Overall Study||31
8539699|NCT00254501|21054194|P2|STARTED|Overall Study||37
8539700|NCT00254501|21054195|P1|STARTED|Overall Study||32
8539701|NCT00254488|21054209|P2|NOT COMPLETED|Overall Study||49
8539702|NCT00254488|21054210|P1|NOT COMPLETED|Overall Study||57
8539703|NCT00254488|21054209|P2|COMPLETED|Overall Study||63
8539704|NCT00254488|21054210|P1|COMPLETED|Overall Study||55
8539705|NCT00254488|21054209|P2|STARTED|Overall Study||112
8539706|NCT00254488|21054210|P1|STARTED|Overall Study||112
8539707|NCT00254462|21054220|P2|NOT COMPLETED|Overall Study||10
8539708|NCT00254462|21054221|P1|NOT COMPLETED|Overall Study||8
8539709|NCT00254462|21054220|P2|COMPLETED|Overall Study||39
8539710|NCT00254462|21054221|P1|COMPLETED|Overall Study||36
8539711|NCT00254462|21054220|P2|STARTED|Overall Study||49
8539712|NCT00254462|21054221|P1|STARTED|Overall Study||44
8539713|NCT00254410|21054229|P1|NOT COMPLETED|Overall Study||0
8539714|NCT00254410|21054229|P1|COMPLETED|Overall Study||30
8539715|NCT00254410|21054229|P1|STARTED|Overall Study||30
8539716|NCT00254397|21054240|P4|NOT COMPLETED|Overall Study||25
8539717|NCT00254397|21054241|P3|NOT COMPLETED|Overall Study||19
8539718|NCT00254397|21054242|P2|NOT COMPLETED|Overall Study||1
8539719|NCT00254397|21054243|P1|NOT COMPLETED|Overall Study||6
8539720|NCT00254397|21054240|P4|COMPLETED|Overall Study||20
8539721|NCT00254397|21054241|P3|COMPLETED|Overall Study||18
8539722|NCT00254397|21054242|P2|COMPLETED|Overall Study||5
8539723|NCT00254397|21054243|P1|COMPLETED|Overall Study||4
8539724|NCT00254397|21054240|P4|STARTED|Overall Study||45
8539725|NCT00254397|21054241|P3|STARTED|Overall Study||37
8539726|NCT00254397|21054242|P2|STARTED|Overall Study||6
8539727|NCT00254397|21054243|P1|STARTED|Overall Study||10
8539728|NCT00254293|21054267|P7|NOT COMPLETED|LTE Open Label Fixed Dosing||13
8539729|NCT00254293|21054268|P6|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8539730|NCT00254293|21054269|P5|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8539731|NCT00254293|21054270|P4|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8539732|NCT00254293|21054271|P3|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8539733|NCT00254293|21054272|P2|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8539734|NCT00254293|21054273|P1|NOT COMPLETED|LTE Open Label Fixed Dosing||0
8539735|NCT00254293|21054267|P7|COMPLETED|LTE Open Label Fixed Dosing||35
8539736|NCT00254293|21054268|P6|COMPLETED|LTE Open Label Fixed Dosing||0
8539737|NCT00254293|21054269|P5|COMPLETED|LTE Open Label Fixed Dosing||0
8539738|NCT00254293|21054270|P4|COMPLETED|LTE Open Label Fixed Dosing||0
8539739|NCT00254293|21054271|P3|COMPLETED|LTE Open Label Fixed Dosing||0
8539740|NCT00254293|21054272|P2|COMPLETED|LTE Open Label Fixed Dosing||0
8539741|NCT00254293|21054273|P1|COMPLETED|LTE Open Label Fixed Dosing||0
8539742|NCT00254293|21054267|P7|STARTED|LTE Open Label Fixed Dosing||48
8539743|NCT00254293|21054268|P6|STARTED|LTE Open Label Fixed Dosing||0
8539744|NCT00254293|21054269|P5|STARTED|LTE Open Label Fixed Dosing||0
8539745|NCT00254293|21054270|P4|STARTED|LTE Open Label Fixed Dosing||0
8539746|NCT00254293|21054271|P3|STARTED|LTE Open Label Fixed Dosing||0
8539747|NCT00254293|21054272|P2|STARTED|LTE Open Label Fixed Dosing||0
8539748|NCT00254293|21054273|P1|STARTED|LTE Open Label Fixed Dosing||0
8539749|NCT00254293|21054267|P7|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
8539750|NCT00254293|21054268|P6|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
8539751|NCT00254293|21054269|P5|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
8539752|NCT00254293|21054270|P4|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
8539753|NCT00254293|21054271|P3|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
8539754|NCT00254293|21054272|P2|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
8539755|NCT00254293|21054273|P1|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
8539756|NCT00254293|21054267|P7|COMPLETED|LTE Open Label Variable SC Dosing||0
8539757|NCT00254293|21054268|P6|COMPLETED|LTE Open Label Variable SC Dosing||0
8539758|NCT00254293|21054269|P5|COMPLETED|LTE Open Label Variable SC Dosing||8
8539759|NCT00254293|21054270|P4|COMPLETED|LTE Open Label Variable SC Dosing||0
8539760|NCT00254293|21054271|P3|COMPLETED|LTE Open Label Variable SC Dosing||32
8539761|NCT00254293|21054272|P2|COMPLETED|LTE Open Label Variable SC Dosing||0
8539762|NCT00254293|21054273|P1|COMPLETED|LTE Open Label Variable SC Dosing||8
8539763|NCT00254293|21054267|P7|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
8539764|NCT00254293|21054268|P6|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
8539765|NCT00254293|21054269|P5|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
8539766|NCT00254293|21054270|P4|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
8539767|NCT00254293|21054271|P3|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
8539768|NCT00254293|21054272|P2|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
8539769|NCT00254293|21054273|P1|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
8539770|NCT00254293|21054267|P7|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
8539771|NCT00254293|21054268|P6|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
8539772|NCT00254293|21054269|P5|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
8539773|NCT00254293|21054270|P4|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
8539774|NCT00254293|21054271|P3|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
8539775|NCT00254293|21054272|P2|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
8539776|NCT00254293|21054273|P1|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
8539777|NCT00254293|21054267|P7|COMPLETED|Short Term (12 Week) Randomized Dosing||0
8539778|NCT00254293|21054268|P6|COMPLETED|Short Term (12 Week) Randomized Dosing||17
8539779|NCT00254293|21054269|P5|COMPLETED|Short Term (12 Week) Randomized Dosing||5
8539780|NCT00254293|21054270|P4|COMPLETED|Short Term (12 Week) Randomized Dosing||5
8539781|NCT00254293|21054271|P3|COMPLETED|Short Term (12 Week) Randomized Dosing||26
8539782|NCT00254293|21054272|P2|COMPLETED|Short Term (12 Week) Randomized Dosing||3
8539783|NCT00254293|21054273|P1|COMPLETED|Short Term (12 Week) Randomized Dosing||7
8539784|NCT00254293|21054267|P7|STARTED|Short Term (12 Week) Randomized Dosing||0
8539785|NCT00254293|21054268|P6|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
8539786|NCT00254293|21054269|P5|STARTED|Short Term (12 Week) Randomized Dosing||5
8539787|NCT00254293|21054270|P4|STARTED|Short Term (12 Week) Randomized Dosing||6
8539788|NCT00254293|21054271|P3|STARTED|Short Term (12 Week) Randomized Dosing||29
8539789|NCT00254293|21054272|P2|STARTED|Short Term (12 Week) Randomized Dosing||4
8539790|NCT00254293|21054273|P1|STARTED|Short Term (12 Week) Randomized Dosing||7
8539791|NCT00254163|21054356|P2|NOT COMPLETED|Overall Study||46
8539792|NCT00254163|21054357|P1|NOT COMPLETED|Overall Study||45
8539793|NCT00254163|21054356|P2|COMPLETED|Overall Study||46
8539794|NCT00254163|21054357|P1|COMPLETED|Overall Study||47
8539795|NCT00254163|21054356|P2|STARTED|Overall Study||92
8539796|NCT00254163|21054357|P1|STARTED|Overall Study||92
8539797|NCT00254072|21054381|P2|NOT COMPLETED|Overall Study||0
8539798|NCT00254072|21054382|P1|NOT COMPLETED|Overall Study||0
8539799|NCT00254072|21054381|P2|COMPLETED|Overall Study||175
8539800|NCT00254072|21054382|P1|COMPLETED|Overall Study||180
8539801|NCT00254072|21054381|P2|STARTED|Overall Study||175
8539802|NCT00254072|21054382|P1|STARTED|Overall Study||180
8539803|NCT00253981|21054390|P2|NOT COMPLETED|Overall Study||0
8539804|NCT00253981|21054391|P1|NOT COMPLETED|Overall Study||0
8539805|NCT00253981|21054390|P2|COMPLETED|Overall Study||14
8539806|NCT00253981|21054391|P1|COMPLETED|Overall Study||16
8539807|NCT00253981|21054390|P2|STARTED|Overall Study||14
8539808|NCT00253981|21054391|P1|STARTED|Overall Study||16
8539809|NCT00253890|21054399|P2|NOT COMPLETED|Overall Study||7
8539810|NCT00253890|21054400|P1|NOT COMPLETED|Overall Study||7
8539811|NCT00253890|21054399|P2|COMPLETED|Overall Study||61
8539812|NCT00253890|21054400|P1|COMPLETED|Overall Study||62
8539813|NCT00253890|21054399|P2|STARTED|Overall Study||68
8539814|NCT00253890|21054400|P1|STARTED|Overall Study||69
8539815|NCT00253747|21054408|P2|NOT COMPLETED|Overall Study||27
8539816|NCT00253747|21054409|P1|NOT COMPLETED|Overall Study||24
8539817|NCT00253747|21054408|P2|COMPLETED|Overall Study||101
8539818|NCT00253747|21054409|P1|COMPLETED|Overall Study||103
8539819|NCT00253747|21054408|P2|STARTED|Overall Study||128
8539820|NCT00253747|21054409|P1|STARTED|Overall Study||127
8539821|NCT00253708|21054430|P3|NOT COMPLETED|Overall Study||1
8539822|NCT00253708|21054431|P2|NOT COMPLETED|Overall Study||0
8539823|NCT00253708|21054432|P1|NOT COMPLETED|Overall Study||0
8539824|NCT00253708|21054430|P3|COMPLETED|Overall Study||8
8539825|NCT00253708|21054431|P2|COMPLETED|Overall Study||10
8539826|NCT00253708|21054432|P1|COMPLETED|Overall Study||20
8539827|NCT00253708|21054430|P3|STARTED|Overall Study||9
8539828|NCT00253708|21054431|P2|STARTED|Overall Study||10
8539829|NCT00253708|21054432|P1|STARTED|Overall Study||20
8539830|NCT00253643|21054462|P4|NOT COMPLETED|Overall Study||3
8539831|NCT00253643|21054463|P3|NOT COMPLETED|Overall Study||1
8539832|NCT00253643|21054464|P2|NOT COMPLETED|Overall Study||0
8539833|NCT00253643|21054465|P1|NOT COMPLETED|Overall Study||0
8539834|NCT00253643|21054462|P4|COMPLETED|Overall Study||28
8539835|NCT00253643|21054463|P3|COMPLETED|Overall Study||28
8539836|NCT00253643|21054464|P2|COMPLETED|Overall Study||15
8539837|NCT00253643|21054465|P1|COMPLETED|Overall Study||14
8539838|NCT00253643|21054462|P4|STARTED|Overall Study||31
8539839|NCT00253643|21054463|P3|STARTED|Overall Study||29
8539840|NCT00253643|21054464|P2|STARTED|Overall Study||15
8539841|NCT00253643|21054465|P1|STARTED|Overall Study||14
8539842|NCT00253630|21054479|P1|NOT COMPLETED|Overall Study||2
8539843|NCT00253630|21054479|P1|COMPLETED|Overall Study||35
8539844|NCT00253630|21054479|P1|STARTED|Overall Study||37
8539845|NCT00253513|21054488|P1|NOT COMPLETED|Overall Study||0
8539846|NCT00253513|21054488|P1|COMPLETED|Overall Study||60
8539847|NCT00253513|21054488|P1|STARTED|Overall Study||60
8539848|NCT00253448|21054495|P1|NOT COMPLETED|Overall Study||1
8539849|NCT00253448|21054495|P1|COMPLETED|Overall Study||34
8539850|NCT00253448|21054495|P1|STARTED|Overall Study||35
8539851|NCT00253435|21054501|P2|NOT COMPLETED|Overall Study||0
8539852|NCT00253435|21054502|P1|NOT COMPLETED|Overall Study||0
8539853|NCT00253435|21054501|P2|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
8539854|NCT00253435|21054502|P1|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
8539855|NCT00253435|21054501|P2|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
8539856|NCT00253435|21054502|P1|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
8539857|NCT00253435|21054501|P2|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
8539858|NCT00253435|21054502|P1|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
8539859|NCT00253435|21054501|P2|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
8539860|NCT00253435|21054502|P1|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
8539861|NCT00253435|21054501|P2|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
8539862|NCT00253435|21054502|P1|STARTED|Overall Study|Total number is 42|42
8539863|NCT00253370|21054514|P1|NOT COMPLETED|Overall Study||43
8539864|NCT00253370|21054514|P1|COMPLETED|Overall Study||1
8539865|NCT00253370|21054514|P1|STARTED|Overall Study||44
8539866|NCT00253019|21054523|P3|NOT COMPLETED|Overall Study||18
8539867|NCT00253019|21054524|P2|NOT COMPLETED|Overall Study||31
8539868|NCT00253019|21054525|P1|NOT COMPLETED|Overall Study||29
8539869|NCT00253019|21054523|P3|COMPLETED|Overall Study||83
8539870|NCT00253019|21054524|P2|COMPLETED|Overall Study||78
8539871|NCT00253019|21054525|P1|COMPLETED|Overall Study||82
8539872|NCT00253019|21054523|P3|STARTED|Overall Study||101
8539873|NCT00253019|21054524|P2|STARTED|Overall Study||109
8539874|NCT00253019|21054525|P1|STARTED|Overall Study||111
8539875|NCT00252967|21054535|P2|NOT COMPLETED|Overall Study||0
8539876|NCT00252967|21054536|P1|NOT COMPLETED|Overall Study||0
8539877|NCT00252967|21054535|P2|COMPLETED|Overall Study||33
8539878|NCT00252967|21054536|P1|COMPLETED|Overall Study||31
8539879|NCT00252967|21054535|P2|STARTED|Overall Study||33
8539880|NCT00252967|21054536|P1|STARTED|Overall Study||31
8539881|NCT00252733|21054560|P2|NOT COMPLETED|Overall Study||92
8539882|NCT00252733|21054561|P1|NOT COMPLETED|Overall Study||106
8539883|NCT00252733|21054560|P2|COMPLETED|Overall Study||618
8539884|NCT00252733|21054561|P1|COMPLETED|Overall Study||605
8539885|NCT00252733|21054560|P2|STARTED|Overall Study||710
8539886|NCT00252733|21054561|P1|STARTED|Overall Study||711
8539887|NCT00252720|21054571|P2|NOT COMPLETED|Overall Study||165
8539888|NCT00252720|21054572|P1|NOT COMPLETED|Overall Study||132
8539889|NCT00252720|21054571|P2|COMPLETED|Overall Study||789
8539890|NCT00252720|21054572|P1|COMPLETED|Overall Study||819
8539891|NCT00252720|21054571|P2|STARTED|Overall Study||954
8539892|NCT00252720|21054572|P1|STARTED|Overall Study||951
8539893|NCT00252694|21054586|P2|NOT COMPLETED|Overall Study||154
8539894|NCT00252694|21054587|P1|NOT COMPLETED|Overall Study||144
8539895|NCT00252694|21054586|P2|COMPLETED|Overall Study||800
8539896|NCT00252694|21054587|P1|COMPLETED|Overall Study||807
8539897|NCT00252694|21054586|P2|STARTED|Overall Study||954
8539898|NCT00252694|21054587|P1|STARTED|Overall Study||951
8539899|NCT00252629|21054602|P3|NOT COMPLETED|Overall Study||0
8539900|NCT00252629|21054603|P2|NOT COMPLETED|Overall Study||0
8539901|NCT00252629|21054604|P1|NOT COMPLETED|Overall Study||1
8539902|NCT00252629|21054602|P3|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
8539903|NCT00252629|21054603|P2|COMPLETED|Overall Study||9
8539904|NCT00252629|21054604|P1|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
8539905|NCT00252629|21054602|P3|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
8539906|NCT00252629|21054603|P2|STARTED|Overall Study||9
8539907|NCT00252629|21054604|P1|STARTED|Overall Study||9
8539908|NCT00252590|21054620|P3|NOT COMPLETED|Overall Study||3
8539909|NCT00252590|21054621|P2|NOT COMPLETED|Overall Study||2
8539910|NCT00252590|21054622|P1|NOT COMPLETED|Overall Study||2
8539911|NCT00252590|21054620|P3|COMPLETED|Overall Study||31
8539912|NCT00252590|21054621|P2|COMPLETED|Overall Study||28
8539913|NCT00252590|21054622|P1|COMPLETED|Overall Study||33
8539914|NCT00252590|21054620|P3|STARTED|Overall Study||34
8539915|NCT00252590|21054621|P2|STARTED|Overall Study||30
8539916|NCT00252590|21054622|P1|STARTED|Overall Study||35
8539917|NCT00252577|21054633|P1|NOT COMPLETED|Overall Study||20
8539918|NCT00252577|21054633|P1|COMPLETED|Overall Study||110
8539919|NCT00252577|21054633|P1|STARTED|Overall Study||130
8539920|NCT00252564|21054639|P2|NOT COMPLETED|Overall Study||44
8539921|NCT00252564|21054640|P1|NOT COMPLETED|Overall Study||39
8539922|NCT00252564|21054639|P2|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
8539923|NCT00252564|21054640|P1|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
8539924|NCT00252564|21054639|P2|STARTED|Overall Study|From randomization|123
8539925|NCT00252564|21054640|P1|STARTED|Overall Study|From randomization|124
8539926|NCT00252538|21054652|P2|NOT COMPLETED|Overall Study||0
8539927|NCT00252538|21054653|P1|NOT COMPLETED|Overall Study||0
8539928|NCT00252538|21054652|P2|COMPLETED|Overall Study||114
8539929|NCT00252538|21054653|P1|COMPLETED|Overall Study||19
8539930|NCT00252538|21054652|P2|STARTED|Overall Study||114
8539931|NCT00252538|21054653|P1|STARTED|Overall Study||19
8539932|NCT00252512|21054660|P2|NOT COMPLETED|12 Month Follow up||1
8539933|NCT00252512|21054661|P1|NOT COMPLETED|12 Month Follow up||9
8539934|NCT00252512|21054660|P2|COMPLETED|12 Month Follow up||121
8539935|NCT00252512|21054661|P1|COMPLETED|12 Month Follow up||123
8539936|NCT00252512|21054660|P2|STARTED|12 Month Follow up||122
8539937|NCT00252512|21054661|P1|STARTED|12 Month Follow up||132
8539938|NCT00252512|21054660|P2|NOT COMPLETED|Six Month Follow up||12
8539939|NCT00252512|21054661|P1|NOT COMPLETED|Six Month Follow up||4
8539940|NCT00252512|21054660|P2|COMPLETED|Six Month Follow up||122
8539941|NCT00252512|21054661|P1|COMPLETED|Six Month Follow up||132
8539942|NCT00252512|21054660|P2|STARTED|Six Month Follow up||134
8539943|NCT00252512|21054661|P1|STARTED|Six Month Follow up||136
8539944|NCT00252512|21054660|P2|NOT COMPLETED|Intervention||31
8539945|NCT00252512|21054661|P1|NOT COMPLETED|Intervention||29
8539946|NCT00252512|21054660|P2|COMPLETED|Intervention||134
8539947|NCT00252512|21054661|P1|COMPLETED|Intervention||136
8539948|NCT00252512|21054660|P2|STARTED|Intervention||165
8539949|NCT00252512|21054661|P1|STARTED|Intervention||165
8539950|NCT00252499|21054680|P3|NOT COMPLETED|Overall Study||0
8539951|NCT00252499|21054681|P2|NOT COMPLETED|Overall Study||0
8539952|NCT00252499|21054682|P1|NOT COMPLETED|Overall Study||1
8539953|NCT00252499|21054680|P3|COMPLETED|Overall Study||6
8539954|NCT00252499|21054681|P2|COMPLETED|Overall Study||2
8539955|NCT00252499|21054682|P1|COMPLETED|Overall Study||4
8539956|NCT00252499|21054680|P3|STARTED|Overall Study||6
8539957|NCT00252499|21054681|P2|STARTED|Overall Study||2
8539958|NCT00252499|21054682|P1|STARTED|Overall Study||5
8539959|NCT00252382|21054705|P1|NOT COMPLETED|Overall Study||26
8539960|NCT00252382|21054705|P1|COMPLETED|Overall Study||5
8539961|NCT00252382|21054705|P1|STARTED|Overall Study||31
8539962|NCT00252239|21054714|P4|NOT COMPLETED|Overall Study||1
8539963|NCT00252239|21054715|P3|NOT COMPLETED|Overall Study||2
8539964|NCT00252239|21054716|P2|NOT COMPLETED|Overall Study||0
8539965|NCT00252239|21054717|P1|NOT COMPLETED|Overall Study||1
8539966|NCT00252239|21054714|P4|COMPLETED|Overall Study||30
8539967|NCT00252239|21054715|P3|COMPLETED|Overall Study||17
8539968|NCT00252239|21054716|P2|COMPLETED|Overall Study||31
8539969|NCT00252239|21054717|P1|COMPLETED|Overall Study||30
8539970|NCT00252239|21054714|P4|STARTED|Overall Study||31
8539971|NCT00252239|21054715|P3|STARTED|Overall Study||19
8539972|NCT00252239|21054716|P2|STARTED|Overall Study||31
8539973|NCT00252239|21054717|P1|STARTED|Overall Study||31
8539974|NCT00252187|21054729|P2|NOT COMPLETED|Overall Study||1
8539975|NCT00252187|21054730|P1|NOT COMPLETED|Overall Study||4
8539976|NCT00252187|21054729|P2|COMPLETED|Overall Study||20
8539977|NCT00252187|21054730|P1|COMPLETED|Overall Study||20
8539978|NCT00252187|21054729|P2|STARTED|Overall Study||21
8539979|NCT00252187|21054730|P1|STARTED|Overall Study||24
8539980|NCT00252174|21054753|P3|NOT COMPLETED|Overall Study||0
8539981|NCT00252174|21054754|P2|NOT COMPLETED|Overall Study||1
8539982|NCT00252174|21054755|P1|NOT COMPLETED|Overall Study||0
8539983|NCT00252174|21054753|P3|COMPLETED|Overall Study||0
8539984|NCT00252174|21054754|P2|COMPLETED|Overall Study||1
8539985|NCT00252174|21054755|P1|COMPLETED|Overall Study||0
8539986|NCT00252174|21054753|P3|STARTED|Overall Study|No subjects entered Stage 2|0
8539987|NCT00252174|21054754|P2|STARTED|Overall Study|2 subjects entered the control arm in total|2
8539988|NCT00252174|21054755|P1|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
8539989|NCT00252057|21054795|P2|NOT COMPLETED|Overall Study||8
8539990|NCT00252057|21054796|P1|NOT COMPLETED|Overall Study||3
8539991|NCT00252057|21054795|P2|COMPLETED|Overall Study||368
8539992|NCT00252057|21054796|P1|COMPLETED|Overall Study||370
8539993|NCT00252057|21054795|P2|STARTED|Overall Study||376
8539994|NCT00252057|21054796|P1|STARTED|Overall Study||373
8539995|NCT00251979|21054804|P2|NOT COMPLETED|Overall Study||40
8539996|NCT00251979|21054805|P1|NOT COMPLETED|Overall Study||38
8539997|NCT00251979|21054804|P2|COMPLETED|Overall Study||349
8539998|NCT00251979|21054805|P1|COMPLETED|Overall Study||337
8539999|NCT00251979|21054804|P2|STARTED|Overall Study|ITT population|389
8540000|NCT00251979|21054805|P1|STARTED|Overall Study|ITT population|375
8540001|NCT00251927|21054837|P2|NOT COMPLETED|Overall Study||74
8540002|NCT00251927|21054838|P1|NOT COMPLETED|Overall Study||108
8540003|NCT00251927|21054837|P2|COMPLETED|Overall Study|Completed 5 year visit|192
8540004|NCT00251927|21054838|P1|COMPLETED|Overall Study|Completed 5 year visit|180
8540005|NCT00251927|21054837|P2|STARTED|Overall Study|Randomised|266
8540006|NCT00251927|21054838|P1|STARTED|Overall Study|Randomised|288
8540007|NCT00251862|21054868|P3|NOT COMPLETED|Overall Study||0
8540008|NCT00251862|21054869|P2|NOT COMPLETED|Overall Study||0
8540009|NCT00251862|21054870|P1|NOT COMPLETED|Overall Study||0
8540010|NCT00251862|21054868|P3|COMPLETED|Overall Study||276
8540011|NCT00251862|21054869|P2|COMPLETED|Overall Study||269
8540012|NCT00251862|21054870|P1|COMPLETED|Overall Study||280
8540013|NCT00251862|21054868|P3|STARTED|Overall Study||276
8540014|NCT00251862|21054869|P2|STARTED|Overall Study||269
8540015|NCT00251862|21054870|P1|STARTED|Overall Study||280
8540016|NCT00251758|21054890|P3|NOT COMPLETED|Overall Study||27
8540017|NCT00251758|21054891|P2|NOT COMPLETED|Overall Study||27
8540018|NCT00251758|21054892|P1|NOT COMPLETED|Overall Study||28
8540019|NCT00251758|21054890|P3|COMPLETED|Overall Study||277
8540020|NCT00251758|21054891|P2|COMPLETED|Overall Study||285
8540021|NCT00251758|21054892|P1|COMPLETED|Overall Study||264
8540022|NCT00251758|21054890|P3|STARTED|Overall Study||304
8540023|NCT00251758|21054891|P2|STARTED|Overall Study||312
8540024|NCT00251758|21054892|P1|STARTED|Overall Study||292
8540025|NCT00251745|21054912|P3|NOT COMPLETED|Overall Study||27
8540026|NCT00251745|21054913|P2|NOT COMPLETED|Overall Study||27
8540027|NCT00251745|21054914|P1|NOT COMPLETED|Overall Study||28
8540028|NCT00251745|21054912|P3|COMPLETED|Overall Study||277
8540029|NCT00251745|21054913|P2|COMPLETED|Overall Study||285
8540030|NCT00251745|21054914|P1|COMPLETED|Overall Study||264
8540031|NCT00251745|21054912|P3|STARTED|Overall Study||304
8540032|NCT00251745|21054913|P2|STARTED|Overall Study||312
8540033|NCT00251745|21054914|P1|STARTED|Overall Study||292
8540034|NCT00251719|21054934|P3|NOT COMPLETED|Overall Study||30
8540035|NCT00251719|21054935|P2|NOT COMPLETED|Overall Study||45
8540036|NCT00251719|21054936|P1|NOT COMPLETED|Overall Study||53
8540037|NCT00251719|21054934|P3|COMPLETED|Overall Study||643
8540038|NCT00251719|21054935|P2|COMPLETED|Overall Study||642
8540039|NCT00251719|21054936|P1|COMPLETED|Overall Study||641
8540040|NCT00251719|21054934|P3|STARTED|Overall Study||673
8540041|NCT00251719|21054935|P2|STARTED|Overall Study||687
8540042|NCT00251719|21054936|P1|STARTED|Overall Study||694
8540043|NCT00251693|21054962|P3|NOT COMPLETED|Overall Study||46
8540044|NCT00251693|21054963|P2|NOT COMPLETED|Overall Study||44
8540045|NCT00251693|21054964|P1|NOT COMPLETED|Overall Study||51
8540046|NCT00251693|21054962|P3|COMPLETED|Overall Study||644
8540047|NCT00251693|21054963|P2|COMPLETED|Overall Study||624
8540048|NCT00251693|21054964|P1|COMPLETED|Overall Study||629
8540049|NCT00251693|21054962|P3|STARTED|Overall Study||690
8540050|NCT00251693|21054963|P2|STARTED|Overall Study||668
8540051|NCT00251693|21054964|P1|STARTED|Overall Study||680
8540052|NCT00251641|21054989|P2|NOT COMPLETED|Overall Study||88
8540053|NCT00251641|21054990|P1|NOT COMPLETED|Overall Study||112
8540054|NCT00251641|21054989|P2|COMPLETED|Overall Study||127
8540055|NCT00251641|21054990|P1|COMPLETED|Overall Study||541
8540056|NCT00251641|21054989|P2|STARTED|Overall Study||215
8540057|NCT00251641|21054990|P1|STARTED|Overall Study||653
8540058|NCT00251589|21055008|P4|NOT COMPLETED|Overall Study||2
8540059|NCT00251589|21055009|P3|NOT COMPLETED|Overall Study||2
8540060|NCT00251589|21055010|P2|NOT COMPLETED|Overall Study||3
8540061|NCT00251589|21055011|P1|NOT COMPLETED|Overall Study||15
8540062|NCT00251589|21055008|P4|COMPLETED|Overall Study||0
8540063|NCT00251589|21055009|P3|COMPLETED|Overall Study||0
8540064|NCT00251589|21055010|P2|COMPLETED|Overall Study||0
8540065|NCT00251589|21055011|P1|COMPLETED|Overall Study||1
8540066|NCT00251589|21055008|P4|STARTED|Overall Study||2
8540067|NCT00251589|21055009|P3|STARTED|Overall Study||2
8540068|NCT00251589|21055010|P2|STARTED|Overall Study||3
8540069|NCT00251589|21055011|P1|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
8540070|NCT00251316|21055048|P2|NOT COMPLETED|Overall Study||3
8540071|NCT00251316|21055049|P1|NOT COMPLETED|Overall Study||2
8540072|NCT00251316|21055048|P2|COMPLETED|Overall Study||14
8540073|NCT00251316|21055049|P1|COMPLETED|Overall Study||15
8540074|NCT00251316|21055048|P2|STARTED|Overall Study||17
8540075|NCT00251316|21055049|P1|STARTED|Overall Study||17
8540076|NCT00251303|21055057|P2|NOT COMPLETED|Overall Study||1
8540077|NCT00251303|21055058|P1|NOT COMPLETED|Overall Study||8
8540078|NCT00251303|21055057|P2|COMPLETED|Overall Study||29
8540079|NCT00251303|21055058|P1|COMPLETED|Overall Study||22
8540080|NCT00251303|21055057|P2|STARTED|Overall Study||30
8540081|NCT00251303|21055058|P1|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
8540082|NCT00251238|21055068|P2|NOT COMPLETED|Overall Study||0
8540083|NCT00251238|21055069|P1|NOT COMPLETED|Overall Study||0
8540084|NCT00251238|21055068|P2|COMPLETED|Overall Study||20
8540085|NCT00251238|21055069|P1|COMPLETED|Overall Study||21
8540086|NCT00251238|21055068|P2|STARTED|Overall Study||20
8540087|NCT00251238|21055069|P1|STARTED|Overall Study||21
8540088|NCT00251225|21055079|P1|NOT COMPLETED|Overall Study||0
8540089|NCT00251225|21055079|P1|COMPLETED|Overall Study||49
8540090|NCT00251225|21055079|P1|STARTED|Overall Study||49
8540091|NCT00251004|21055088|P3|NOT COMPLETED|Overall Study||31
8540092|NCT00251004|21055089|P2|NOT COMPLETED|Overall Study||41
8540093|NCT00251004|21055090|P1|NOT COMPLETED|Overall Study||45
8540094|NCT00251004|21055088|P3|COMPLETED|Overall Study||246
8540095|NCT00251004|21055089|P2|COMPLETED|Overall Study||238
8540096|NCT00251004|21055090|P1|COMPLETED|Overall Study||232
8540097|NCT00251004|21055088|P3|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
8540098|NCT00251004|21055089|P2|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
8540099|NCT00251004|21055090|P1|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
8540100|NCT00251004|21055088|P3|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
8540101|NCT00251004|21055089|P2|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
8540102|NCT00251004|21055090|P1|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
8540103|NCT00251004|21055088|P3|STARTED|Overall Study||277
8540104|NCT00251004|21055089|P2|STARTED|Overall Study||279
8540105|NCT00251004|21055090|P1|STARTED|Overall Study||277
8540106|NCT00250926|21055107|P1|NOT COMPLETED|Overall Study||0
8540107|NCT00250926|21055107|P1|COMPLETED|Overall Study||23
8540108|NCT00250926|21055107|P1|STARTED|Overall Study||23
8540109|NCT00250835|21055114|P1|NOT COMPLETED|Overall Study||1
8540110|NCT00250835|21055114|P1|COMPLETED|Overall Study||37
8540111|NCT00250835|21055114|P1|STARTED|Overall Study||38
8540112|NCT00250718|21055123|P1|NOT COMPLETED|Overall Study||3
8540113|NCT00250718|21055123|P1|COMPLETED|Overall Study||14
8540114|NCT00250718|21055123|P1|Received Treatment|Overall Study||16
8540115|NCT00250718|21055123|P1|STARTED|Overall Study||17
8540116|NCT00250705|21055128|P1|NOT COMPLETED|Overall Study||2
8540117|NCT00250705|21055128|P1|COMPLETED|Overall Study||10
8540118|NCT00250705|21055128|P1|STARTED|Overall Study||12
8540119|NCT00250679|21055139|P3|NOT COMPLETED|Overall Study||44
8540120|NCT00250679|21055140|P2|NOT COMPLETED|Overall Study||49
8540121|NCT00250679|21055141|P1|NOT COMPLETED|Overall Study||39
8540122|NCT00250679|21055139|P3|COMPLETED|Overall Study||103
8540123|NCT00250679|21055140|P2|COMPLETED|Overall Study||100
8540124|NCT00250679|21055141|P1|COMPLETED|Overall Study||108
8540125|NCT00250679|21055139|P3|STARTED|Overall Study||147
8540126|NCT00250679|21055140|P2|STARTED|Overall Study||149
8540127|NCT00250679|21055141|P1|STARTED|Overall Study||147
8540128|NCT00250588|21055242|P3|NOT COMPLETED|Overall Study||13
8540129|NCT00250588|21055243|P2|NOT COMPLETED|Overall Study||19
8540130|NCT00250588|21055244|P1|NOT COMPLETED|Overall Study||9
8540131|NCT00250588|21055242|P3|COMPLETED|Overall Study||74
8540132|NCT00250588|21055243|P2|COMPLETED|Overall Study||65
8540133|NCT00250588|21055244|P1|COMPLETED|Overall Study||72
8540134|NCT00250588|21055242|P3|STARTED|Overall Study||87
8540135|NCT00250588|21055243|P2|STARTED|Overall Study||84
8540136|NCT00250588|21055244|P1|STARTED|Overall Study||81
8540137|NCT00250497|21055260|P2|NOT COMPLETED|Overall Study||15
8540138|NCT00250497|21055261|P1|NOT COMPLETED|Overall Study||5
8540139|NCT00250497|21055260|P2|COMPLETED|Overall Study||159
8540140|NCT00250497|21055261|P1|COMPLETED|Overall Study||177
8540141|NCT00250497|21055260|P2|STARTED|Overall Study||174
8540142|NCT00250497|21055261|P1|STARTED|Overall Study||182
8540143|NCT00250484|21055279|P2|NOT COMPLETED|Overall Study||0
8540144|NCT00250484|21055280|P1|NOT COMPLETED|Overall Study||0
8540145|NCT00250484|21055279|P2|COMPLETED|Overall Study||8
8540146|NCT00250484|21055280|P1|COMPLETED|Overall Study||9
8540147|NCT00250484|21055279|P2|STARTED|Overall Study||8
8540148|NCT00250484|21055280|P1|STARTED|Overall Study||9
8540149|NCT00250458|21055292|P2|NOT COMPLETED|Overall Study||17
8540150|NCT00250458|21055293|P1|NOT COMPLETED|Overall Study||32
8540151|NCT00250458|21055292|P2|COMPLETED|Overall Study||97
8540152|NCT00250458|21055293|P1|COMPLETED|Overall Study||200
8540153|NCT00250458|21055292|P2|STARTED|Overall Study||114
8540154|NCT00250458|21055293|P1|STARTED|Overall Study||232
8540155|NCT00250432|21055303|P2|NOT COMPLETED|Overall Study||47
8540156|NCT00250432|21055304|P1|NOT COMPLETED|Overall Study||45
8540157|NCT00250432|21055303|P2|COMPLETED|Overall Study||53
8540158|NCT00250432|21055304|P1|COMPLETED|Overall Study||59
8540159|NCT00250432|21055303|P2|STARTED|Overall Study||100
8540160|NCT00250432|21055304|P1|STARTED|Overall Study||104
8540161|NCT00250276|21055316|P4|NOT COMPLETED|Overall Study||19
8540162|NCT00250276|21055317|P3|NOT COMPLETED|Overall Study||19
8540163|NCT00250276|21055318|P2|NOT COMPLETED|Overall Study||21
8540164|NCT00250276|21055319|P1|NOT COMPLETED|Overall Study||17
8540165|NCT00250276|21055316|P4|COMPLETED|Overall Study||181
8540166|NCT00250276|21055317|P3|COMPLETED|Overall Study||182
8540167|NCT00250276|21055318|P2|COMPLETED|Overall Study||177
8540168|NCT00250276|21055319|P1|COMPLETED|Overall Study||182
8540169|NCT00250276|21055316|P4|STARTED|Overall Study||200
8540170|NCT00250276|21055317|P3|STARTED|Overall Study||201
8540171|NCT00250276|21055318|P2|STARTED|Overall Study||198
8540172|NCT00250276|21055319|P1|STARTED|Overall Study||199
8540173|NCT00249873|21055399|P2|NOT COMPLETED|Overall Study||1254
8540174|NCT00249873|21055400|P1|NOT COMPLETED|Overall Study||1330
8540175|NCT00249873|21055399|P2|COMPLETED|Overall Study|started and completed study drug|2528
8540176|NCT00249873|21055400|P1|COMPLETED|Overall Study|started and completed study drug|2442
8540177|NCT00249873|21055399|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
8540178|NCT00249873|21055400|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
8540179|NCT00249834|21055420|P8|NOT COMPLETED|Overall Study||0
8540180|NCT00249834|21055421|P7|NOT COMPLETED|Overall Study||1
8540181|NCT00249834|21055422|P6|NOT COMPLETED|Overall Study||2
8540182|NCT00249834|21055423|P5|NOT COMPLETED|Overall Study||5
8540183|NCT00249834|21055424|P4|NOT COMPLETED|Overall Study||8
8540184|NCT00249834|21055425|P3|NOT COMPLETED|Overall Study||14
8540185|NCT00249834|21055426|P2|NOT COMPLETED|Overall Study||19
8540186|NCT00249834|21055427|P1|NOT COMPLETED|Overall Study||1
8540187|NCT00249834|21055420|P8|COMPLETED|Overall Study||2
8540188|NCT00249834|21055421|P7|COMPLETED|Overall Study||1
8540189|NCT00249834|21055422|P6|COMPLETED|Overall Study||8
8540190|NCT00249834|21055423|P5|COMPLETED|Overall Study||19
8540191|NCT00249834|21055424|P4|COMPLETED|Overall Study||26
8540192|NCT00249834|21055425|P3|COMPLETED|Overall Study||31
8540193|NCT00249834|21055426|P2|COMPLETED|Overall Study||29
8540194|NCT00249834|21055427|P1|COMPLETED|Overall Study||0
8540195|NCT00249834|21055420|P8|STARTED|Overall Study||2
8540196|NCT00249834|21055421|P7|STARTED|Overall Study||2
8540197|NCT00249834|21055422|P6|STARTED|Overall Study||10
8540198|NCT00249834|21055423|P5|STARTED|Overall Study||24
8540199|NCT00249834|21055424|P4|STARTED|Overall Study||34
8540200|NCT00249834|21055425|P3|STARTED|Overall Study||45
8540201|NCT00249834|21055426|P2|STARTED|Overall Study||48
8540202|NCT00249834|21055427|P1|STARTED|Overall Study||1
8540203|NCT00249821|21055476|P2|NOT COMPLETED|Overall Study||1
8540204|NCT00249821|21055477|P1|NOT COMPLETED|Overall Study||0
8540205|NCT00249821|21055476|P2|COMPLETED|Overall Study||11
8540206|NCT00249821|21055477|P1|COMPLETED|Overall Study||10
8540207|NCT00249821|21055476|P2|STARTED|Overall Study||12
8540208|NCT00249821|21055477|P1|STARTED|Overall Study||10
8540209|NCT00249808|21055497|P1|NOT COMPLETED|Overall Study||182
8540210|NCT00249808|21055497|P1|COMPLETED|Overall Study||1084
8540211|NCT00249808|21055497|P1|STARTED|Overall Study||1266
8540212|NCT00249795|21055505|P2|NOT COMPLETED|Overall Study||1390
8540213|NCT00249795|21055506|P1|NOT COMPLETED|Overall Study||1394
8540214|NCT00249795|21055505|P2|COMPLETED|Overall Study|started and completed study drug|3108
8540215|NCT00249795|21055506|P1|COMPLETED|Overall Study|started and completed study drug|3124
8540216|NCT00249795|21055505|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
8540217|NCT00249795|21055506|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
8540218|NCT00249769|21055527|P3|NOT COMPLETED|Overall Study||28
8540219|NCT00249769|21055528|P2|NOT COMPLETED|Overall Study||15
8540220|NCT00249769|21055529|P1|NOT COMPLETED|Overall Study||2
8540221|NCT00249769|21055527|P3|COMPLETED|Overall Study||222
8540222|NCT00249769|21055528|P2|COMPLETED|Overall Study||235
8540223|NCT00249769|21055529|P1|COMPLETED|Overall Study||98
8540224|NCT00249769|21055527|P3|Received Measles Vaccine|Overall Study||235
8540225|NCT00249769|21055528|P2|Received Measles Vaccine|Overall Study||236
8540226|NCT00249769|21055529|P1|Received Measles Vaccine|Overall Study||97
8540227|NCT00249769|21055527|P3|Received LJEV|Overall Study||224
8540228|NCT00249769|21055528|P2|Received LJEV|Overall Study||236
8540229|NCT00249769|21055529|P1|Received LJEV|Overall Study||100
8540230|NCT00249769|21055527|P3|STARTED|Overall Study||250
8540231|NCT00249769|21055528|P2|STARTED|Overall Study||250
8540232|NCT00249769|21055529|P1|STARTED|Overall Study||100
8540233|NCT00249613|21055557|P2|NOT COMPLETED|12 Month Follow-up||15
8540234|NCT00249613|21055558|P1|NOT COMPLETED|12 Month Follow-up||17
8540235|NCT00249613|21055557|P2|COMPLETED|12 Month Follow-up||124
8540236|NCT00249613|21055558|P1|COMPLETED|12 Month Follow-up||135
8540237|NCT00249613|21055557|P2|STARTED|12 Month Follow-up||139
8540238|NCT00249613|21055558|P1|STARTED|12 Month Follow-up||152
8540239|NCT00249613|21055557|P2|NOT COMPLETED|Baseline||0
8540240|NCT00249613|21055558|P1|NOT COMPLETED|Baseline||0
8540241|NCT00249613|21055557|P2|COMPLETED|Baseline||139
8540242|NCT00249613|21055558|P1|COMPLETED|Baseline||152
8540243|NCT00249613|21055557|P2|STARTED|Baseline||139
8540244|NCT00249613|21055558|P1|STARTED|Baseline||152
8540245|NCT00249496|21055569|P2|NOT COMPLETED|Overall Study||1
8540246|NCT00249496|21055570|P1|NOT COMPLETED|Overall Study||0
8540247|NCT00249496|21055569|P2|COMPLETED|Overall Study||26
8540248|NCT00249496|21055570|P1|COMPLETED|Overall Study||24
8540249|NCT00249496|21055569|P2|STARTED|Overall Study||27
8540250|NCT00249496|21055570|P1|STARTED|Overall Study||24
8540251|NCT00249470|21055586|P2|NOT COMPLETED|Overall Study||0
8540252|NCT00249470|21055587|P1|NOT COMPLETED|Overall Study||0
8540253|NCT00249470|21055586|P2|COMPLETED|Overall Study||28
8540254|NCT00249470|21055587|P1|COMPLETED|Overall Study||28
8540255|NCT00249470|21055586|P2|STARTED|Overall Study||28
8540256|NCT00249470|21055587|P1|STARTED|Overall Study||28
8540257|NCT00249444|21055599|P2|NOT COMPLETED|Overall Study||15
8540258|NCT00249444|21055600|P1|NOT COMPLETED|Overall Study||12
8540259|NCT00249444|21055599|P2|COMPLETED|Overall Study||29
8540260|NCT00249444|21055600|P1|COMPLETED|Overall Study||30
8540261|NCT00249444|21055599|P2|STARTED|Overall Study||44
8540262|NCT00249444|21055600|P1|STARTED|Overall Study||42
8540263|NCT00249379|21055610|P2|NOT COMPLETED|Overall Study||8
8540264|NCT00249379|21055611|P1|NOT COMPLETED|Overall Study||8
8540265|NCT00249379|21055610|P2|COMPLETED|Overall Study||4
8540266|NCT00249379|21055611|P1|COMPLETED|Overall Study||6
8540267|NCT00249379|21055610|P2|STARTED|Overall Study||12
8540268|NCT00249379|21055611|P1|STARTED|Overall Study||14
8540269|NCT00249288|21055625|P2|NOT COMPLETED|Overall Study||5
8540270|NCT00249288|21055626|P1|NOT COMPLETED|Overall Study||5
8540271|NCT00249288|21055625|P2|COMPLETED|Overall Study||14
8540272|NCT00249288|21055626|P1|COMPLETED|Overall Study||14
8540273|NCT00249288|21055625|P2|Initiated Treatment|Overall Study||15
8540274|NCT00249288|21055626|P1|Initiated Treatment|Overall Study||17
8540275|NCT00249288|21055625|P2|STARTED|Overall Study||19
8540276|NCT00249288|21055626|P1|STARTED|Overall Study||19
8540277|NCT00249249|21055661|P4|NOT COMPLETED|Overall Study||3
8540278|NCT00249249|21055662|P3|NOT COMPLETED|Overall Study||15
8540279|NCT00249249|21055663|P2|NOT COMPLETED|Overall Study||5
8540280|NCT00249249|21055664|P1|NOT COMPLETED|Overall Study||20
8540281|NCT00249249|21055661|P4|COMPLETED|Overall Study||100
8540282|NCT00249249|21055662|P3|COMPLETED|Overall Study||288
8540283|NCT00249249|21055663|P2|COMPLETED|Overall Study||98
8540284|NCT00249249|21055664|P1|COMPLETED|Overall Study||301
8540285|NCT00249249|21055661|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
8540286|NCT00249249|21055662|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
8540287|NCT00249249|21055663|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
8540288|NCT00249249|21055664|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
8540289|NCT00249249|21055661|P4|STARTED|Overall Study||103
8540290|NCT00249249|21055662|P3|STARTED|Overall Study||303
8540291|NCT00249249|21055663|P2|STARTED|Overall Study||103
8540292|NCT00249249|21055664|P1|STARTED|Overall Study||321
8540293|NCT00249002|21055718|P1|NOT COMPLETED|Overall Study||7
8540294|NCT00249002|21055718|P1|COMPLETED|Overall Study||2
8540295|NCT00249002|21055718|P1|STARTED|Overall Study||9
8540296|NCT00248833|21055737|P3|NOT COMPLETED|Overall Study||2
8540297|NCT00248833|21055738|P2|NOT COMPLETED|Overall Study||3
8540298|NCT00248833|21055739|P1|NOT COMPLETED|Overall Study||3
8540299|NCT00248833|21055737|P3|COMPLETED|Overall Study||9
8540300|NCT00248833|21055738|P2|COMPLETED|Overall Study||8
8540301|NCT00248833|21055739|P1|COMPLETED|Overall Study||9
8540302|NCT00248833|21055737|P3|STARTED|Overall Study||11
8540303|NCT00248833|21055738|P2|STARTED|Overall Study||11
8540304|NCT00248833|21055739|P1|STARTED|Overall Study||12
8540305|NCT00248807|21055757|P2|NOT COMPLETED|Overall Study||0
8540306|NCT00248807|21055758|P1|NOT COMPLETED|Overall Study||0
8540307|NCT00248807|21055757|P2|COMPLETED|Overall Study||11
8540308|NCT00248807|21055758|P1|COMPLETED|Overall Study||19
8540309|NCT00248807|21055757|P2|STARTED|Overall Study||11
8540310|NCT00248807|21055758|P1|STARTED|Overall Study||19
8540311|NCT00248794|21055775|P3|NOT COMPLETED|Overall Study||3
8540312|NCT00248794|21055776|P2|NOT COMPLETED|Overall Study||8
8540313|NCT00248794|21055777|P1|NOT COMPLETED|Overall Study||6
8540314|NCT00248794|21055775|P3|COMPLETED|Overall Study||7
8540315|NCT00248794|21055776|P2|COMPLETED|Overall Study||16
8540316|NCT00248794|21055777|P1|COMPLETED|Overall Study||19
8540317|NCT00248794|21055775|P3|STARTED|Overall Study||10
8540318|NCT00248794|21055776|P2|STARTED|Overall Study||24
8540319|NCT00248794|21055777|P1|STARTED|Overall Study||25
8540320|NCT00248781|21055799|P2|NOT COMPLETED|Overall Study||4
8540321|NCT00248781|21055800|P1|NOT COMPLETED|Overall Study||10
8540322|NCT00248781|21055799|P2|COMPLETED|Overall Study||47
8540323|NCT00248781|21055800|P1|COMPLETED|Overall Study||42
8540324|NCT00248781|21055799|P2|STARTED|Overall Study||51
8540325|NCT00248781|21055800|P1|STARTED|Overall Study||52
8540326|NCT00248651|21055827|P3|NOT COMPLETED|Overall Study||32
8540327|NCT00248651|21055828|P2|NOT COMPLETED|Overall Study||40
8540328|NCT00248651|21055829|P1|NOT COMPLETED|Overall Study||28
8540329|NCT00248651|21055827|P3|COMPLETED|Overall Study||65
8540330|NCT00248651|21055828|P2|COMPLETED|Overall Study||58
8540331|NCT00248651|21055829|P1|COMPLETED|Overall Study||69
8540332|NCT00248651|21055827|P3|Completed 12 Weeks of Treatment|Overall Study||75
8540333|NCT00248651|21055828|P2|Completed 12 Weeks of Treatment|Overall Study||66
8540334|NCT00248651|21055829|P1|Completed 12 Weeks of Treatment|Overall Study||78
8540335|NCT00248651|21055827|P3|STARTED|Overall Study||97
8540336|NCT00248651|21055828|P2|STARTED|Overall Study||98
8540337|NCT00248651|21055829|P1|STARTED|Overall Study||97
8540338|NCT00248638|21055848|P2|NOT COMPLETED|Overall Study||0
8540339|NCT00248638|21055849|P1|NOT COMPLETED|Overall Study||0
8540340|NCT00248638|21055848|P2|COMPLETED|Overall Study||75
8540341|NCT00248638|21055849|P1|COMPLETED|Overall Study||75
8540342|NCT00248638|21055848|P2|STARTED|Overall Study||75
8540343|NCT00248638|21055849|P1|STARTED|Overall Study||75
8540344|NCT00248625|21055865|P2|NOT COMPLETED|Overall Study||2
8540345|NCT00248625|21055866|P1|NOT COMPLETED|Overall Study||0
8540346|NCT00248625|21055865|P2|COMPLETED|Overall Study||90
8540347|NCT00248625|21055866|P1|COMPLETED|Overall Study||92
8540348|NCT00248625|21055865|P2|STARTED|Overall Study||92
8540349|NCT00248625|21055866|P1|STARTED|Overall Study||92
8540350|NCT00248612|21055890|P4|NOT COMPLETED|Overall Study||0
8540351|NCT00248612|21055891|P3|NOT COMPLETED|Overall Study||0
8540352|NCT00248612|21055892|P2|NOT COMPLETED|Overall Study||0
8540353|NCT00248612|21055893|P1|NOT COMPLETED|Overall Study||0
8540354|NCT00248612|21055890|P4|COMPLETED|Overall Study||22
8540355|NCT00248612|21055891|P3|COMPLETED|Overall Study||14
8540356|NCT00248612|21055892|P2|COMPLETED|Overall Study||21
8540357|NCT00248612|21055893|P1|COMPLETED|Overall Study||24
8540358|NCT00248612|21055890|P4|STARTED|Overall Study||22
8540359|NCT00248612|21055891|P3|STARTED|Overall Study||14
8540360|NCT00248612|21055892|P2|STARTED|Overall Study||21
8540361|NCT00248612|21055893|P1|STARTED|Overall Study||24
8540362|NCT00248560|21055935|P1|NOT COMPLETED|Overall Study||0
8540363|NCT00248560|21055935|P1|COMPLETED|Overall Study||36
8540364|NCT00248560|21055935|P1|STARTED|Overall Study||36
8540365|NCT00248547|21055944|P2|NOT COMPLETED|Overall Study||0
8540366|NCT00248547|21055945|P1|NOT COMPLETED|Overall Study||0
8540367|NCT00248547|21055944|P2|COMPLETED|Overall Study||20
8540368|NCT00248547|21055945|P1|COMPLETED|Overall Study||20
8540369|NCT00248547|21055944|P2|STARTED|Overall Study||20
8540370|NCT00248547|21055945|P1|STARTED|Overall Study||20
8540371|NCT00248534|21055951|P1|NOT COMPLETED|Overall Study||0
8540372|NCT00248534|21055951|P1|COMPLETED|Overall Study||16
8540373|NCT00248534|21055951|P1|STARTED|Overall Study||16
8540374|NCT00248495|21055958|P1|NOT COMPLETED|Overall Study||1
8540375|NCT00248495|21055958|P1|COMPLETED|Overall Study||37
8540376|NCT00248495|21055958|P1|STARTED|Overall Study||38
8540377|NCT00248287|21055969|P2|NOT COMPLETED|Overall Study||19
8540378|NCT00248287|21055970|P1|NOT COMPLETED|Overall Study||24
8540379|NCT00248287|21055969|P2|COMPLETED|Overall Study||60
8540380|NCT00248287|21055970|P1|COMPLETED|Overall Study||51
8540381|NCT00248287|21055969|P2|STARTED|Overall Study||79
8540382|NCT00248287|21055970|P1|STARTED|Overall Study||75
8540383|NCT00248170|21055984|P2|NOT COMPLETED|Overall Study||808
8540384|NCT00248170|21055985|P1|NOT COMPLETED|Overall Study||761
8540385|NCT00248170|21055984|P2|COMPLETED|Overall Study||1286
8540386|NCT00248170|21055985|P1|COMPLETED|Overall Study||1317
8540387|NCT00248170|21055984|P2|Safety Set|Overall Study||2062
8540388|NCT00248170|21055985|P1|Safety Set|Overall Study||2049
8540389|NCT00248170|21055984|P2|Intent-to-treat (ITT)|Overall Study||2075
8540390|NCT00248170|21055985|P1|Intent-to-treat (ITT)|Overall Study||2061
8540391|NCT00248170|21055984|P2|STARTED|Overall Study||2094
8540392|NCT00248170|21055985|P1|STARTED|Overall Study||2078
8540393|NCT00248040|21056008|P3|NOT COMPLETED|Overall Study||4
8540394|NCT00248040|21056009|P2|NOT COMPLETED|Overall Study||1
8540395|NCT00248040|21056010|P1|NOT COMPLETED|Overall Study||3
8540396|NCT00248040|21056008|P3|COMPLETED|Overall Study||22
8540397|NCT00248040|21056009|P2|COMPLETED|Overall Study||22
8540398|NCT00248040|21056010|P1|COMPLETED|Overall Study||22
8540399|NCT00248040|21056008|P3|STARTED|Overall Study||26
8540400|NCT00248040|21056009|P2|STARTED|Overall Study||23
8540401|NCT00248040|21056010|P1|STARTED|Overall Study||25
8540402|NCT00247962|21056059|P2|NOT COMPLETED|Overall Study||19
8540403|NCT00247962|21056060|P1|NOT COMPLETED|Overall Study||26
8540404|NCT00247962|21056059|P2|COMPLETED|Overall Study||168
8540405|NCT00247962|21056060|P1|COMPLETED|Overall Study||353
8540406|NCT00247962|21056059|P2|STARTED|Overall Study||187
8540407|NCT00247962|21056060|P1|STARTED|Overall Study||379
8540408|NCT00247728|21056071|P3|NOT COMPLETED|Overall Study||14
8540409|NCT00247728|21056072|P2|NOT COMPLETED|Overall Study||6
8540410|NCT00247728|21056073|P1|NOT COMPLETED|Overall Study||3
8540411|NCT00247728|21056071|P3|COMPLETED|Overall Study||43
8540412|NCT00247728|21056072|P2|COMPLETED|Overall Study||51
8540413|NCT00247728|21056073|P1|COMPLETED|Overall Study||55
8540414|NCT00247728|21056071|P3|STARTED|Overall Study||57
8540415|NCT00247728|21056072|P2|STARTED|Overall Study||57
8540416|NCT00247728|21056073|P1|STARTED|Overall Study||58
8540417|NCT00247676|21056087|P1|NOT COMPLETED|Overall Study||36
8540418|NCT00247676|21056087|P1|COMPLETED|Overall Study||1
8540419|NCT00247676|21056087|P1|STARTED|Overall Study||37
8540420|NCT00247624|21056117|P2|NOT COMPLETED|Overall Study||4
8540421|NCT00247624|21056118|P1|NOT COMPLETED|Overall Study||5
8540422|NCT00247624|21056117|P2|COMPLETED|Overall Study||26
8540423|NCT00247624|21056118|P1|COMPLETED|Overall Study||25
8540424|NCT00247624|21056117|P2|STARTED|Overall Study||30
8540425|NCT00247624|21056118|P1|STARTED|Overall Study||30
8540426|NCT00247611|21056132|P2|NOT COMPLETED|On Protocol Sample||125
8540427|NCT00247611|21056133|P1|NOT COMPLETED|On Protocol Sample||111
8540428|NCT00247611|21056132|P2|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
8540429|NCT00247611|21056133|P1|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
8540430|NCT00247611|21056132|P2|STARTED|On Protocol Sample|ITT sample participants|277
8540431|NCT00247611|21056133|P1|STARTED|On Protocol Sample|ITT sample participants|287
8540432|NCT00247611|21056132|P2|NOT COMPLETED|Intention to Treat Sample||13
8540433|NCT00247611|21056133|P1|NOT COMPLETED|Intention to Treat Sample||17
8540434|NCT00247611|21056132|P2|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
8540435|NCT00247611|21056133|P1|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
8540436|NCT00247611|21056132|P2|STARTED|Intention to Treat Sample|Participants randomized|290
8540437|NCT00247611|21056133|P1|STARTED|Intention to Treat Sample|Participants randomized|304
8540438|NCT00247611|21056132|P2|NOT COMPLETED|Baselined||13
8540439|NCT00247611|21056133|P1|NOT COMPLETED|Baselined||17
8540440|NCT00247611|21056132|P2|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
8540441|NCT00247611|21056133|P1|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
8540442|NCT00247611|21056132|P2|STARTED|Baselined|Participants randomized|290
8540443|NCT00247611|21056133|P1|STARTED|Baselined|Participants randomized|304
8540444|NCT00247416|21056151|P2|NOT COMPLETED|Overall Study||2
8540445|NCT00247416|21056152|P1|NOT COMPLETED|Overall Study||1
8540446|NCT00247416|21056151|P2|COMPLETED|Overall Study||31
8540447|NCT00247416|21056152|P1|COMPLETED|Overall Study||25
8540448|NCT00247416|21056151|P2|STARTED|Overall Study||33
8540449|NCT00247416|21056152|P1|STARTED|Overall Study||26
8540450|NCT00247377|21056166|P2|NOT COMPLETED|Overall Study||0
8540451|NCT00247377|21056167|P1|NOT COMPLETED|Overall Study||0
8540452|NCT00247377|21056166|P2|COMPLETED|Overall Study||86
8540453|NCT00247377|21056167|P1|COMPLETED|Overall Study||111
8540454|NCT00247377|21056166|P2|STARTED|Overall Study||86
8540455|NCT00247377|21056167|P1|STARTED|Overall Study||111
8540456|NCT00247273|21056193|P2|NOT COMPLETED|Overall Study||137
8540457|NCT00247273|21056194|P1|NOT COMPLETED|Overall Study||146
8540458|NCT00247273|21056193|P2|COMPLETED|Overall Study||513
8540459|NCT00247273|21056194|P1|COMPLETED|Overall Study||498
8540460|NCT00247273|21056193|P2|Intent to Treat Population|Overall Study||650
8540461|NCT00247273|21056194|P1|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
8540462|NCT00247273|21056193|P2|STARTED|Overall Study||650
8540463|NCT00247273|21056194|P1|STARTED|Overall Study||644
8540464|NCT00246805|21056240|P2|NOT COMPLETED|Phase 2||0
8540465|NCT00246805|21056241|P1|NOT COMPLETED|Phase 2||0
8540466|NCT00246805|21056240|P2|COMPLETED|Phase 2||33
8540467|NCT00246805|21056241|P1|COMPLETED|Phase 2||33
8540468|NCT00246805|21056240|P2|STARTED|Phase 2||33
8540469|NCT00246805|21056241|P1|STARTED|Phase 2||33
8540470|NCT00246805|21056240|P2|NOT COMPLETED|Phase 1||0
8540471|NCT00246805|21056241|P1|NOT COMPLETED|Phase 1||1
8540472|NCT00246805|21056240|P2|COMPLETED|Phase 1||33
8540473|NCT00246805|21056241|P1|COMPLETED|Phase 1||33
8540474|NCT00246805|21056240|P2|STARTED|Phase 1||33
8540475|NCT00246805|21056241|P1|STARTED|Phase 1||34
8540476|NCT00246753|21056247|P1|NOT COMPLETED|Overall Study||8
8540477|NCT00246753|21056247|P1|COMPLETED|Overall Study||21
8540478|NCT00246753|21056247|P1|STARTED|Overall Study||29
8540479|NCT00246740|21056255|P2|NOT COMPLETED|Experimental Phase||0
8540480|NCT00246740|21056256|P1|NOT COMPLETED|Experimental Phase||0
8540481|NCT00246740|21056255|P2|COMPLETED|Experimental Phase||20
8540482|NCT00246740|21056256|P1|COMPLETED|Experimental Phase||22
8540483|NCT00246740|21056255|P2|STARTED|Experimental Phase||20
8540484|NCT00246740|21056256|P1|STARTED|Experimental Phase||22
8540485|NCT00246740|21056255|P2|NOT COMPLETED|Initial Enrollment||8
8540486|NCT00246740|21056256|P1|NOT COMPLETED|Initial Enrollment||6
8540487|NCT00246740|21056255|P2|COMPLETED|Initial Enrollment||20
8540488|NCT00246740|21056256|P1|COMPLETED|Initial Enrollment||22
8540489|NCT00246740|21056255|P2|STARTED|Initial Enrollment||28
8540490|NCT00246740|21056256|P1|STARTED|Initial Enrollment||28
8540491|NCT00246571|21056280|P2|NOT COMPLETED|Overall Study||104
8540492|NCT00246571|21056281|P1|NOT COMPLETED|Overall Study||113
8540493|NCT00246571|21056280|P2|COMPLETED|Overall Study||0
8540494|NCT00246571|21056281|P1|COMPLETED|Overall Study||0
8540495|NCT00246571|21056280|P2|Randomized But Not Treated|Overall Study||1
8540496|NCT00246571|21056281|P1|Randomized But Not Treated|Overall Study||3
8540497|NCT00246571|21056280|P2|STARTED|Overall Study||104
8540498|NCT00246571|21056281|P1|STARTED|Overall Study||113
8540499|NCT00246519|21056321|P2|NOT COMPLETED|Overall Study||64
8540500|NCT00246519|21056322|P1|NOT COMPLETED|Overall Study||56
8540501|NCT00246519|21056321|P2|COMPLETED|Overall Study||382
8540502|NCT00246519|21056322|P1|COMPLETED|Overall Study||386
8540503|NCT00246519|21056321|P2|STARTED|Overall Study||446
8540504|NCT00246519|21056322|P1|STARTED|Overall Study||442
8540505|NCT00246441|21056330|P2|NOT COMPLETED|Overall Study||0
8540506|NCT00246441|21056331|P1|NOT COMPLETED|Overall Study||1
8540507|NCT00246441|21056330|P2|COMPLETED|Overall Study||22
8540508|NCT00246441|21056331|P1|COMPLETED|Overall Study||19
8540509|NCT00246441|21056330|P2|STARTED|Overall Study||22
8540510|NCT00246441|21056331|P1|STARTED|Overall Study||20
8540511|NCT00246376|21056346|P5|NOT COMPLETED|Overall Study||17
8540512|NCT00246376|21056347|P4|NOT COMPLETED|Overall Study||26
8540513|NCT00246376|21056348|P3|NOT COMPLETED|Overall Study||16
8540514|NCT00246376|21056349|P2|NOT COMPLETED|Overall Study||19
8540515|NCT00246376|21056350|P1|NOT COMPLETED|Overall Study||15
8540516|NCT00246376|21056346|P5|COMPLETED|Overall Study||28
8540517|NCT00246376|21056347|P4|COMPLETED|Overall Study||21
8540518|NCT00246376|21056348|P3|COMPLETED|Overall Study||29
8540519|NCT00246376|21056349|P2|COMPLETED|Overall Study||24
8540520|NCT00246376|21056350|P1|COMPLETED|Overall Study||26
8540521|NCT00246376|21056346|P5|After Dietary run-in at Two Weeks|Overall Study||42
8540522|NCT00246376|21056347|P4|After Dietary run-in at Two Weeks|Overall Study||40
8540523|NCT00246376|21056348|P3|After Dietary run-in at Two Weeks|Overall Study||41
8540524|NCT00246376|21056349|P2|After Dietary run-in at Two Weeks|Overall Study||38
8540525|NCT00246376|21056350|P1|After Dietary run-in at Two Weeks|Overall Study||30
8540526|NCT00246376|21056346|P5|STARTED|Overall Study||45
8540527|NCT00246376|21056347|P4|STARTED|Overall Study||47
8540528|NCT00246376|21056348|P3|STARTED|Overall Study||45
8540529|NCT00246376|21056349|P2|STARTED|Overall Study||43
8540530|NCT00246376|21056350|P1|STARTED|Overall Study||41
8540531|NCT00246337|21056401|P9|NOT COMPLETED|Overall Study||11
8540532|NCT00246337|21056402|P8|NOT COMPLETED|Overall Study||13
8540533|NCT00246337|21056403|P7|NOT COMPLETED|Overall Study||9
8540534|NCT00246337|21056404|P6|NOT COMPLETED|Overall Study||15
8540535|NCT00246337|21056405|P5|NOT COMPLETED|Overall Study||4
8540536|NCT00246337|21056406|P4|NOT COMPLETED|Overall Study||1
8540537|NCT00246337|21056407|P3|NOT COMPLETED|Overall Study||3
8540538|NCT00246337|21056408|P2|NOT COMPLETED|Overall Study||2
8540539|NCT00246337|21056409|P1|NOT COMPLETED|Overall Study||32
8540540|NCT00246337|21056401|P9|COMPLETED|Overall Study||34
8540541|NCT00246337|21056402|P8|COMPLETED|Overall Study||40
8540542|NCT00246337|21056403|P7|COMPLETED|Overall Study||45
8540543|NCT00246337|21056404|P6|COMPLETED|Overall Study||39
8540544|NCT00246337|21056405|P5|COMPLETED|Overall Study||12
8540545|NCT00246337|21056406|P4|COMPLETED|Overall Study||16
8540546|NCT00246337|21056407|P3|COMPLETED|Overall Study||15
8540547|NCT00246337|21056408|P2|COMPLETED|Overall Study||14
8540548|NCT00246337|21056409|P1|COMPLETED|Overall Study||115
8540549|NCT00246337|21056401|P9|Completed Period (Both Doses)|Overall Study||15
8540550|NCT00246337|21056402|P8|Completed Period (Both Doses)|Overall Study||13
8540551|NCT00246337|21056403|P7|Completed Period (Both Doses)|Overall Study||16
8540552|NCT00246337|21056404|P6|Completed Period (Both Doses)|Overall Study||10
8540553|NCT00246337|21056405|P5|Completed Period (Both Doses)|Overall Study||4
8540554|NCT00246337|21056406|P4|Completed Period (Both Doses)|Overall Study||11
8540555|NCT00246337|21056407|P3|Completed Period (Both Doses)|Overall Study||6
8540556|NCT00246337|21056408|P2|Completed Period (Both Doses)|Overall Study||10
8540557|NCT00246337|21056409|P1|Completed Period (Both Doses)|Overall Study||69
8540558|NCT00246337|21056401|P9|Completed Period (Initial Dose)|Overall Study||19
8540559|NCT00246337|21056402|P8|Completed Period (Initial Dose)|Overall Study||27
8540560|NCT00246337|21056403|P7|Completed Period (Initial Dose)|Overall Study||29
8540561|NCT00246337|21056404|P6|Completed Period (Initial Dose)|Overall Study||29
8540562|NCT00246337|21056405|P5|Completed Period (Initial Dose)|Overall Study||8
8540563|NCT00246337|21056406|P4|Completed Period (Initial Dose)|Overall Study||5
8540564|NCT00246337|21056407|P3|Completed Period (Initial Dose)|Overall Study||9
8540565|NCT00246337|21056408|P2|Completed Period (Initial Dose)|Overall Study||4
8540566|NCT00246337|21056409|P1|Completed Period (Initial Dose)|Overall Study||46
8540567|NCT00246337|21056401|P9|STARTED|Overall Study||45
8540568|NCT00246337|21056402|P8|STARTED|Overall Study||53
8540569|NCT00246337|21056403|P7|STARTED|Overall Study||54
8540570|NCT00246337|21056404|P6|STARTED|Overall Study||54
8540571|NCT00246337|21056405|P5|STARTED|Overall Study||16
8540572|NCT00246337|21056406|P4|STARTED|Overall Study||17
8540573|NCT00246337|21056407|P3|STARTED|Overall Study||18
8540574|NCT00246337|21056408|P2|STARTED|Overall Study||16
8540575|NCT00246337|21056409|P1|STARTED|Overall Study||147
8540576|NCT00246324|21056456|P1|NOT COMPLETED|Overall Study||1
8540577|NCT00246324|21056456|P1|COMPLETED|Overall Study||15
8540578|NCT00246324|21056456|P1|STARTED|Overall Study||16
8540579|NCT00246259|21056463|P2|NOT COMPLETED|Overall Study||26
8540580|NCT00246259|21056464|P1|NOT COMPLETED|Overall Study||28
8540581|NCT00246259|21056463|P2|COMPLETED|Overall Study||15
8540582|NCT00246259|21056464|P1|COMPLETED|Overall Study||16
8540583|NCT00246259|21056463|P2|Eligible for Intent-to-treat (ITT)|Overall Study||35
8540584|NCT00246259|21056464|P1|Eligible for Intent-to-treat (ITT)|Overall Study||42
8540585|NCT00246259|21056463|P2|STARTED|Overall Study||41
8540586|NCT00246259|21056464|P1|STARTED|Overall Study||44
8540587|NCT00246090|21056498|P1|NOT COMPLETED|Overall Study||295
8540588|NCT00246090|21056498|P1|COMPLETED|Overall Study||3
8540589|NCT00246090|21056498|P1|STARTED|Overall Study||298
8540590|NCT00246025|21056507|P4|NOT COMPLETED|Overall Study||13
8540591|NCT00246025|21056508|P3|NOT COMPLETED|Overall Study||10
8540592|NCT00246025|21056509|P2|NOT COMPLETED|Overall Study||9
8540593|NCT00246025|21056510|P1|NOT COMPLETED|Overall Study||10
8540594|NCT00246025|21056507|P4|COMPLETED|Overall Study||116
8540595|NCT00246025|21056508|P3|COMPLETED|Overall Study||116
8540596|NCT00246025|21056509|P2|COMPLETED|Overall Study||124
8540597|NCT00246025|21056510|P1|COMPLETED|Overall Study||114
8540598|NCT00246025|21056507|P4|STARTED|Overall Study||129
8540599|NCT00246025|21056508|P3|STARTED|Overall Study||126
8540600|NCT00246025|21056509|P2|STARTED|Overall Study||133
8540601|NCT00246025|21056510|P1|STARTED|Overall Study||124
8540602|NCT00246012|21056569|P9|NOT COMPLETED|Overall Study||28
8540603|NCT00246012|21056570|P8|NOT COMPLETED|Overall Study||28
8540604|NCT00246012|21056571|P7|NOT COMPLETED|Overall Study||31
8540605|NCT00246012|21056572|P6|NOT COMPLETED|Overall Study||28
8540606|NCT00246012|21056573|P5|NOT COMPLETED|Overall Study||3
8540607|NCT00246012|21056574|P4|NOT COMPLETED|Overall Study||3
8540608|NCT00246012|21056575|P3|NOT COMPLETED|Overall Study||2
8540609|NCT00246012|21056576|P2|NOT COMPLETED|Overall Study||1
8540610|NCT00246012|21056577|P1|NOT COMPLETED|Overall Study||3
8540611|NCT00246012|21056569|P9|COMPLETED|Overall Study||4
8540612|NCT00246012|21056570|P8|COMPLETED|Overall Study||5
8540613|NCT00246012|21056571|P7|COMPLETED|Overall Study||1
8540614|NCT00246012|21056572|P6|COMPLETED|Overall Study||4
8540615|NCT00246012|21056573|P5|COMPLETED|Overall Study||0
8540616|NCT00246012|21056574|P4|COMPLETED|Overall Study||0
8540617|NCT00246012|21056575|P3|COMPLETED|Overall Study||1
8540618|NCT00246012|21056576|P2|COMPLETED|Overall Study||2
8540619|NCT00246012|21056577|P1|COMPLETED|Overall Study||0
8540620|NCT00246012|21056569|P9|Treated|Overall Study||32
8540621|NCT00246012|21056570|P8|Treated|Overall Study||33
8540622|NCT00246012|21056571|P7|Treated|Overall Study||31
8540623|NCT00246012|21056572|P6|Treated|Overall Study||31
8540624|NCT00246012|21056573|P5|Treated|Overall Study||3
8540625|NCT00246012|21056574|P4|Treated|Overall Study||3
8540626|NCT00246012|21056575|P3|Treated|Overall Study||3
8540627|NCT00246012|21056576|P2|Treated|Overall Study||3
8540628|NCT00246012|21056577|P1|Treated|Overall Study||3
8540629|NCT00246012|21056569|P9|STARTED|Overall Study||32
8540630|NCT00246012|21056570|P8|STARTED|Overall Study||33
8540631|NCT00246012|21056571|P7|STARTED|Overall Study||32
8540632|NCT00246012|21056572|P6|STARTED|Overall Study||32
8540633|NCT00246012|21056573|P5|STARTED|Overall Study||3
8540634|NCT00246012|21056574|P4|STARTED|Overall Study||3
8540635|NCT00246012|21056575|P3|STARTED|Overall Study||3
8540636|NCT00246012|21056576|P2|STARTED|Overall Study||3
8540637|NCT00246012|21056577|P1|STARTED|Overall Study||3
8540638|NCT00245960|21056672|P2|NOT COMPLETED|Overall Study||28
8540639|NCT00245960|21056673|P1|NOT COMPLETED|Overall Study||29
8540640|NCT00245960|21056672|P2|COMPLETED|Overall Study||345
8540641|NCT00245960|21056673|P1|COMPLETED|Overall Study||350
8540642|NCT00245960|21056672|P2|STARTED|Overall Study||373
8540643|NCT00245960|21056673|P1|STARTED|Overall Study||379
8540644|NCT00245856|21056681|P2|NOT COMPLETED|Period Two||1
8540645|NCT00245856|21056682|P1|NOT COMPLETED|Period Two||0
8540646|NCT00245856|21056681|P2|COMPLETED|Period Two||38
8540647|NCT00245856|21056682|P1|COMPLETED|Period Two||0
8540648|NCT00245856|21056681|P2|STARTED|Period Two||39
8540649|NCT00245856|21056682|P1|STARTED|Period Two||0
8540650|NCT00245856|21056681|P2|NOT COMPLETED|Period One||0
8540651|NCT00245856|21056682|P1|NOT COMPLETED|Period One||0
8540652|NCT00245856|21056681|P2|COMPLETED|Period One||0
8540653|NCT00245856|21056682|P1|COMPLETED|Period One||28
8540654|NCT00245856|21056681|P2|STARTED|Period One||0
8540655|NCT00245856|21056682|P1|STARTED|Period One||28
8540656|NCT00245765|21056692|P3|NOT COMPLETED|Overall Study||8
8540657|NCT00245765|21056693|P2|NOT COMPLETED|Overall Study||14
8540658|NCT00245765|21056694|P1|NOT COMPLETED|Overall Study||32
8540659|NCT00245765|21056692|P3|COMPLETED|Overall Study||50
8540660|NCT00245765|21056693|P2|COMPLETED|Overall Study||45
8540661|NCT00245765|21056694|P1|COMPLETED|Overall Study||27
8540662|NCT00245765|21056692|P3|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57
8540663|NCT00245765|21056693|P2|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60
8540664|NCT00245765|21056694|P1|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58
8540665|NCT00245765|21056692|P3|STARTED|Overall Study||58
8540666|NCT00245765|21056693|P2|STARTED|Overall Study||59
8540667|NCT00245765|21056694|P1|STARTED|Overall Study||59
8540668|NCT00245635|21056734|P2|NOT COMPLETED|Overall Study||0
8540669|NCT00245635|21056735|P1|NOT COMPLETED|Overall Study||0
8540670|NCT00245635|21056734|P2|COMPLETED|Overall Study||18
8540671|NCT00245635|21056735|P1|COMPLETED|Overall Study||25
8540672|NCT00245635|21056734|P2|STARTED|Overall Study||18
8540673|NCT00245635|21056735|P1|STARTED|Overall Study||25
8540674|NCT00245583|21056743|P2|NOT COMPLETED|Overall Study||9
8540675|NCT00245583|21056744|P1|NOT COMPLETED|Overall Study||6
8540676|NCT00245583|21056743|P2|COMPLETED|Overall Study||13
8540677|NCT00245583|21056744|P1|COMPLETED|Overall Study||14
8540678|NCT00245583|21056743|P2|STARTED|Overall Study||22
8540679|NCT00245583|21056744|P1|STARTED|Overall Study||20
8540680|NCT00245570|21056764|P6|NOT COMPLETED|Treatment Period IV||0
8540681|NCT00245570|21056765|P5|NOT COMPLETED|Treatment Period IV||0
8540682|NCT00245570|21056766|P4|NOT COMPLETED|Treatment Period IV||0
8540683|NCT00245570|21056767|P3|NOT COMPLETED|Treatment Period IV||0
8540684|NCT00245570|21056768|P2|NOT COMPLETED|Treatment Period IV||0
8540685|NCT00245570|21056769|P1|NOT COMPLETED|Treatment Period IV||0
8540686|NCT00245570|21056764|P6|COMPLETED|Treatment Period IV||8
8540687|NCT00245570|21056765|P5|COMPLETED|Treatment Period IV||8
8540688|NCT00245570|21056766|P4|COMPLETED|Treatment Period IV||8
8540689|NCT00245570|21056767|P3|COMPLETED|Treatment Period IV||8
8540690|NCT00245570|21056768|P2|COMPLETED|Treatment Period IV||7
8540691|NCT00245570|21056769|P1|COMPLETED|Treatment Period IV||7
8540692|NCT00245570|21056764|P6|STARTED|Treatment Period IV||8
8540693|NCT00245570|21056765|P5|STARTED|Treatment Period IV||8
8540694|NCT00245570|21056766|P4|STARTED|Treatment Period IV||8
8540695|NCT00245570|21056767|P3|STARTED|Treatment Period IV||8
8540696|NCT00245570|21056768|P2|STARTED|Treatment Period IV||7
8540697|NCT00245570|21056769|P1|STARTED|Treatment Period IV||7
8540698|NCT00245570|21056764|P6|NOT COMPLETED|Washout Between Periods III and IV||0
8540699|NCT00245570|21056765|P5|NOT COMPLETED|Washout Between Periods III and IV||0
8540700|NCT00245570|21056766|P4|NOT COMPLETED|Washout Between Periods III and IV||0
8540701|NCT00245570|21056767|P3|NOT COMPLETED|Washout Between Periods III and IV||0
8540702|NCT00245570|21056768|P2|NOT COMPLETED|Washout Between Periods III and IV||1
8540703|NCT00245570|21056769|P1|NOT COMPLETED|Washout Between Periods III and IV||0
8540704|NCT00245570|21056764|P6|COMPLETED|Washout Between Periods III and IV||8
8540705|NCT00245570|21056765|P5|COMPLETED|Washout Between Periods III and IV||8
8540706|NCT00245570|21056766|P4|COMPLETED|Washout Between Periods III and IV||8
8540707|NCT00245570|21056767|P3|COMPLETED|Washout Between Periods III and IV||8
8540708|NCT00245570|21056768|P2|COMPLETED|Washout Between Periods III and IV||7
8540709|NCT00245570|21056769|P1|COMPLETED|Washout Between Periods III and IV||7
8540710|NCT00245570|21056764|P6|STARTED|Washout Between Periods III and IV||8
8540711|NCT00245570|21056765|P5|STARTED|Washout Between Periods III and IV||8
8540712|NCT00245570|21056766|P4|STARTED|Washout Between Periods III and IV||8
8540713|NCT00245570|21056767|P3|STARTED|Washout Between Periods III and IV||8
8540714|NCT00245570|21056768|P2|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
8540715|NCT00245570|21056769|P1|STARTED|Washout Between Periods III and IV||7
8540716|NCT00245570|21056764|P6|NOT COMPLETED|Treatment Period III||0
8540717|NCT00245570|21056765|P5|NOT COMPLETED|Treatment Period III||0
8540718|NCT00245570|21056766|P4|NOT COMPLETED|Treatment Period III||0
8540719|NCT00245570|21056767|P3|NOT COMPLETED|Treatment Period III||0
8540720|NCT00245570|21056768|P2|NOT COMPLETED|Treatment Period III||0
8540721|NCT00245570|21056769|P1|NOT COMPLETED|Treatment Period III||0
8540722|NCT00245570|21056764|P6|COMPLETED|Treatment Period III||8
8540723|NCT00245570|21056765|P5|COMPLETED|Treatment Period III||8
8540724|NCT00245570|21056766|P4|COMPLETED|Treatment Period III||8
8540725|NCT00245570|21056767|P3|COMPLETED|Treatment Period III||8
8540726|NCT00245570|21056768|P2|COMPLETED|Treatment Period III||8
8540727|NCT00245570|21056769|P1|COMPLETED|Treatment Period III||7
8540728|NCT00245570|21056764|P6|STARTED|Treatment Period III||8
8540729|NCT00245570|21056765|P5|STARTED|Treatment Period III||8
8540730|NCT00245570|21056766|P4|STARTED|Treatment Period III||8
8540731|NCT00245570|21056767|P3|STARTED|Treatment Period III||8
8540732|NCT00245570|21056768|P2|STARTED|Treatment Period III||8
8540733|NCT00245570|21056769|P1|STARTED|Treatment Period III||7
8540734|NCT00245570|21056764|P6|NOT COMPLETED|Washout Between Periods II and III||0
8540735|NCT00245570|21056765|P5|NOT COMPLETED|Washout Between Periods II and III||0
8540736|NCT00245570|21056766|P4|NOT COMPLETED|Washout Between Periods II and III||0
8540737|NCT00245570|21056767|P3|NOT COMPLETED|Washout Between Periods II and III||0
8540738|NCT00245570|21056768|P2|NOT COMPLETED|Washout Between Periods II and III||0
8540739|NCT00245570|21056769|P1|NOT COMPLETED|Washout Between Periods II and III||0
8540740|NCT00245570|21056764|P6|COMPLETED|Washout Between Periods II and III||8
8540741|NCT00245570|21056765|P5|COMPLETED|Washout Between Periods II and III||8
8540742|NCT00245570|21056766|P4|COMPLETED|Washout Between Periods II and III||8
8540743|NCT00245570|21056767|P3|COMPLETED|Washout Between Periods II and III||8
8540744|NCT00245570|21056768|P2|COMPLETED|Washout Between Periods II and III||8
8540745|NCT00245570|21056769|P1|COMPLETED|Washout Between Periods II and III||7
8540746|NCT00245570|21056764|P6|STARTED|Washout Between Periods II and III||8
8540747|NCT00245570|21056765|P5|STARTED|Washout Between Periods II and III||8
8540748|NCT00245570|21056766|P4|STARTED|Washout Between Periods II and III||8
8540749|NCT00245570|21056767|P3|STARTED|Washout Between Periods II and III||8
8540750|NCT00245570|21056768|P2|STARTED|Washout Between Periods II and III||8
8540751|NCT00245570|21056769|P1|STARTED|Washout Between Periods II and III||7
8540752|NCT00245570|21056764|P6|NOT COMPLETED|Treatment Period II||0
8540753|NCT00245570|21056765|P5|NOT COMPLETED|Treatment Period II||0
8540754|NCT00245570|21056766|P4|NOT COMPLETED|Treatment Period II||0
8540755|NCT00245570|21056767|P3|NOT COMPLETED|Treatment Period II||0
8540756|NCT00245570|21056768|P2|NOT COMPLETED|Treatment Period II||0
8540757|NCT00245570|21056769|P1|NOT COMPLETED|Treatment Period II||0
8540758|NCT00245570|21056764|P6|COMPLETED|Treatment Period II||8
8540759|NCT00245570|21056765|P5|COMPLETED|Treatment Period II||8
8540760|NCT00245570|21056766|P4|COMPLETED|Treatment Period II||8
8540761|NCT00245570|21056767|P3|COMPLETED|Treatment Period II||8
8540762|NCT00245570|21056768|P2|COMPLETED|Treatment Period II||8
8540763|NCT00245570|21056769|P1|COMPLETED|Treatment Period II||7
8540764|NCT00245570|21056764|P6|STARTED|Treatment Period II||8
8540765|NCT00245570|21056765|P5|STARTED|Treatment Period II||8
8540766|NCT00245570|21056766|P4|STARTED|Treatment Period II||8
8540767|NCT00245570|21056767|P3|STARTED|Treatment Period II||8
8540768|NCT00245570|21056768|P2|STARTED|Treatment Period II||8
8540769|NCT00245570|21056769|P1|STARTED|Treatment Period II||7
8540770|NCT00245557|21056815|P2|NOT COMPLETED|Overall Study||16
8540771|NCT00245557|21056816|P1|NOT COMPLETED|Overall Study||6
8540772|NCT00245557|21056815|P2|COMPLETED|Overall Study||10
8540773|NCT00245557|21056816|P1|COMPLETED|Overall Study||11
8540774|NCT00245557|21056815|P2|STARTED|Overall Study||26
8540775|NCT00245557|21056816|P1|STARTED|Overall Study||17
8540776|NCT00245518|21056829|P2|NOT COMPLETED|Overall Study||0
8540777|NCT00245518|21056830|P1|NOT COMPLETED|Overall Study||0
8540778|NCT00245518|21056829|P2|COMPLETED|Overall Study||16
8540779|NCT00245518|21056830|P1|COMPLETED|Overall Study||17
8540780|NCT00245518|21056829|P2|STARTED|Overall Study||16
8540781|NCT00245518|21056830|P1|STARTED|Overall Study||17
8540782|NCT00245466|21056903|P3|NOT COMPLETED|Overall Study||37
8540783|NCT00245466|21056904|P2|NOT COMPLETED|Overall Study||44
8540784|NCT00245466|21056905|P1|NOT COMPLETED|Overall Study||36
8540785|NCT00245466|21056903|P3|COMPLETED|Overall Study||3
8540786|NCT00245466|21056904|P2|COMPLETED|Overall Study||2
8540787|NCT00245466|21056905|P1|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
8540788|NCT00245466|21056903|P3|Started FE200486 CS02A|Overall Study||26
8540789|NCT00245466|21056904|P2|Started FE200486 CS02A|Overall Study||30
8540790|NCT00245466|21056905|P1|Started FE200486 CS02A|Overall Study||32
8540791|NCT00245466|21056903|P3|STARTED|Overall Study||40
8540792|NCT00245466|21056904|P2|STARTED|Overall Study||46
8540793|NCT00245466|21056905|P1|STARTED|Overall Study||43
8540794|NCT00245219|21056922|P3|NOT COMPLETED|Overall Study||2
8540795|NCT00245219|21056923|P2|NOT COMPLETED|Overall Study||6
8540796|NCT00245219|21056924|P1|NOT COMPLETED|Overall Study||6
8540797|NCT00245219|21056922|P3|COMPLETED|Overall Study||58
8540798|NCT00245219|21056923|P2|COMPLETED|Overall Study||88
8540799|NCT00245219|21056924|P1|COMPLETED|Overall Study||85
8540800|NCT00245219|21056922|P3|STARTED|Overall Study||60
8540801|NCT00245219|21056923|P2|STARTED|Overall Study||94
8540802|NCT00245219|21056924|P1|STARTED|Overall Study||91
8540803|NCT00245128|21056938|P1|NOT COMPLETED|Overall Study||10
8540804|NCT00245128|21056938|P1|COMPLETED|Overall Study||0
8540805|NCT00245128|21056938|P1|STARTED|Overall Study||10
8540806|NCT00245102|21056948|P6|NOT COMPLETED|Overall Study||4
8540807|NCT00245102|21056949|P5|NOT COMPLETED|Overall Study||0
8540808|NCT00245102|21056950|P4|NOT COMPLETED|Overall Study||3
8540809|NCT00245102|21056951|P3|NOT COMPLETED|Overall Study||7
8540810|NCT00245102|21056952|P2|NOT COMPLETED|Overall Study||4
8540811|NCT00245102|21056953|P1|NOT COMPLETED|Overall Study||7
8540812|NCT00245102|21056948|P6|COMPLETED|Overall Study||19
8540813|NCT00245102|21056949|P5|COMPLETED|Overall Study||5
8540814|NCT00245102|21056950|P4|COMPLETED|Overall Study||10
8540815|NCT00245102|21056951|P3|COMPLETED|Overall Study||39
8540816|NCT00245102|21056952|P2|COMPLETED|Overall Study||12
8540817|NCT00245102|21056953|P1|COMPLETED|Overall Study||37
8540818|NCT00245102|21056948|P6|STARTED|Overall Study||23
8540819|NCT00245102|21056949|P5|STARTED|Overall Study||5
8540820|NCT00245102|21056950|P4|STARTED|Overall Study||13
8540821|NCT00245102|21056951|P3|STARTED|Overall Study||46
8540822|NCT00245102|21056952|P2|STARTED|Overall Study||16
8540823|NCT00245102|21056953|P1|STARTED|Overall Study||44
8540824|NCT00245063|21056969|P2|NOT COMPLETED|Overall Study||5
8540825|NCT00245063|21056970|P1|NOT COMPLETED|Overall Study||7
8540826|NCT00245063|21056969|P2|COMPLETED|Overall Study||8
8540827|NCT00245063|21056970|P1|COMPLETED|Overall Study||5
8540828|NCT00245063|21056969|P2|STARTED|Overall Study||13
8540829|NCT00245063|21056970|P1|STARTED|Overall Study||12
8540830|NCT00245050|21056978|P2|NOT COMPLETED|Overall Study||2
8540831|NCT00245050|21056979|P1|NOT COMPLETED|Overall Study||3
8540832|NCT00245050|21056978|P2|COMPLETED|Overall Study||14
8540833|NCT00245050|21056979|P1|COMPLETED|Overall Study||15
8540834|NCT00245050|21056978|P2|STARTED|Overall Study||16
8540835|NCT00245050|21056979|P1|STARTED|Overall Study||18
8540836|NCT00245037|21056987|P1|NOT COMPLETED|Overall Study||17
8540837|NCT00245037|21056987|P1|COMPLETED|Overall Study|17 participants died from infectious complications.|130
8540838|NCT00245037|21056987|P1|STARTED|Overall Study||147
8540839|NCT00245011|21056997|P1|NOT COMPLETED|Overall Study||1
8540840|NCT00245011|21056997|P1|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
8540841|NCT00245011|21056997|P1|STARTED|Overall Study||11
8540842|NCT00244985|21057006|P1|NOT COMPLETED|Overall Study||0
8540843|NCT00244985|21057006|P1|COMPLETED|Overall Study||42
8540844|NCT00244985|21057006|P1|STARTED|Overall Study||42
8540848|NCT00244881|21057018|P1|NOT COMPLETED|Overall Study||3
8540849|NCT00244881|21057018|P1|COMPLETED|Overall Study||23
8540850|NCT00244881|21057018|P1|STARTED|Overall Study||26
8540851|NCT00244855|21057026|P2|NOT COMPLETED|Overall Study||1
8540852|NCT00244855|21057027|P1|NOT COMPLETED|Overall Study||0
8540853|NCT00244855|21057026|P2|COMPLETED|Overall Study||24
8540854|NCT00244855|21057027|P1|COMPLETED|Overall Study||7
8540855|NCT00244855|21057026|P2|STARTED|Overall Study||25
8540856|NCT00244855|21057027|P1|STARTED|Overall Study||7
8540857|NCT00244764|21057035|P1|NOT COMPLETED|Overall Study||96
8540858|NCT00244764|21057035|P1|COMPLETED|Overall Study||129
8540859|NCT00244764|21057035|P1|STARTED|Overall Study||225
8540860|NCT00244751|21057045|P3|NOT COMPLETED|Overall Study||10
8540861|NCT00244751|21057046|P2|NOT COMPLETED|Overall Study||15
8540862|NCT00244751|21057047|P1|NOT COMPLETED|Overall Study||16
8540863|NCT00244751|21057045|P3|COMPLETED|Overall Study||78
8540864|NCT00244751|21057046|P2|COMPLETED|Overall Study||74
8540865|NCT00244751|21057047|P1|COMPLETED|Overall Study||72
8540866|NCT00244751|21057045|P3|STARTED|Overall Study||88
8540867|NCT00244751|21057046|P2|STARTED|Overall Study||89
8540868|NCT00244751|21057047|P1|STARTED|Overall Study||88
8540869|NCT00244725|21057148|P4|NOT COMPLETED|Overall Study||21
8540870|NCT00244725|21057149|P3|NOT COMPLETED|Overall Study||24
8540871|NCT00244725|21057150|P2|NOT COMPLETED|Overall Study||19
8540872|NCT00244725|21057151|P1|NOT COMPLETED|Overall Study||23
8540873|NCT00244725|21057148|P4|COMPLETED|Overall Study||216
8540874|NCT00244725|21057149|P3|COMPLETED|Overall Study||215
8540875|NCT00244725|21057150|P2|COMPLETED|Overall Study||226
8540876|NCT00244725|21057151|P1|COMPLETED|Overall Study||214
8540877|NCT00244725|21057148|P4|STARTED|Overall Study||237
8540878|NCT00244725|21057149|P3|STARTED|Overall Study||239
8540879|NCT00244725|21057150|P2|STARTED|Overall Study||245
8540880|NCT00244725|21057151|P1|STARTED|Overall Study||237
8540881|NCT00244712|21057207|P2|NOT COMPLETED|Overall Study||124
8540882|NCT00244712|21057208|P1|NOT COMPLETED|Overall Study||109
8540883|NCT00244712|21057207|P2|COMPLETED|Overall Study||221
8540884|NCT00244712|21057208|P1|COMPLETED|Overall Study||234
8540885|NCT00244712|21057207|P2|STARTED|Overall Study||345
8540886|NCT00244712|21057208|P1|STARTED|Overall Study||343
8540887|NCT00244621|21057243|P3|NOT COMPLETED|Open-label Treatment Period||2
8540888|NCT00244621|21057244|P2|NOT COMPLETED|Open-label Treatment Period||1
8540889|NCT00244621|21057245|P1|NOT COMPLETED|Open-label Treatment Period||1
8540890|NCT00244621|21057243|P3|COMPLETED|Open-label Treatment Period||28
8540891|NCT00244621|21057244|P2|COMPLETED|Open-label Treatment Period||28
8540892|NCT00244621|21057245|P1|COMPLETED|Open-label Treatment Period||25
8540893|NCT00244621|21057243|P3|STARTED|Open-label Treatment Period||30
8540894|NCT00244621|21057244|P2|STARTED|Open-label Treatment Period||29
8540895|NCT00244621|21057245|P1|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
8540896|NCT00244621|21057243|P3|NOT COMPLETED|Double-blind Treatment Period||2
8540897|NCT00244621|21057244|P2|NOT COMPLETED|Double-blind Treatment Period||3
8540898|NCT00244621|21057245|P1|NOT COMPLETED|Double-blind Treatment Period||2
8540899|NCT00244621|21057243|P3|COMPLETED|Double-blind Treatment Period||30
8540900|NCT00244621|21057244|P2|COMPLETED|Double-blind Treatment Period||29
8540901|NCT00244621|21057245|P1|COMPLETED|Double-blind Treatment Period||27
8540902|NCT00244621|21057243|P3|STARTED|Double-blind Treatment Period||32
8540903|NCT00244621|21057244|P2|STARTED|Double-blind Treatment Period||32
8540904|NCT00244621|21057245|P1|STARTED|Double-blind Treatment Period||29
8540905|NCT00244374|21057262|P5|NOT COMPLETED|Vaccine Adherence Cohort||0
8540906|NCT00244374|21057263|P4|NOT COMPLETED|Vaccine Adherence Cohort||0
8540907|NCT00244374|21057264|P3|NOT COMPLETED|Vaccine Adherence Cohort||0
8540908|NCT00244374|21057265|P2|NOT COMPLETED|Vaccine Adherence Cohort||0
8540909|NCT00244374|21057266|P1|NOT COMPLETED|Vaccine Adherence Cohort||0
8540910|NCT00244374|21057262|P5|COMPLETED|Vaccine Adherence Cohort||41
8540911|NCT00244374|21057263|P4|COMPLETED|Vaccine Adherence Cohort||36
8540912|NCT00244374|21057264|P3|COMPLETED|Vaccine Adherence Cohort||43
8540913|NCT00244374|21057265|P2|COMPLETED|Vaccine Adherence Cohort||47
8540914|NCT00244374|21057266|P1|COMPLETED|Vaccine Adherence Cohort||0
8540915|NCT00244374|21057262|P5|STARTED|Vaccine Adherence Cohort||41
8540916|NCT00244374|21057263|P4|STARTED|Vaccine Adherence Cohort||36
8540917|NCT00244374|21057264|P3|STARTED|Vaccine Adherence Cohort||43
8540918|NCT00244374|21057265|P2|STARTED|Vaccine Adherence Cohort||47
8540919|NCT00244374|21057266|P1|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
8540920|NCT00244374|21057262|P5|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540921|NCT00244374|21057263|P4|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540922|NCT00244374|21057264|P3|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540923|NCT00244374|21057265|P2|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540924|NCT00244374|21057266|P1|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
8540925|NCT00244374|21057262|P5|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540926|NCT00244374|21057263|P4|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540927|NCT00244374|21057264|P3|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540928|NCT00244374|21057265|P2|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
8540929|NCT00244374|21057266|P1|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
8540930|NCT00244374|21057262|P5|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
8540931|NCT00244374|21057263|P4|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
8540932|NCT00244374|21057264|P3|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
8540933|NCT00244374|21057265|P2|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
8540934|NCT00244374|21057266|P1|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
8540935|NCT00244374|21057262|P5|STARTED|Evaluation for Vaccine Adherence Cohort||0
8540936|NCT00244374|21057263|P4|STARTED|Evaluation for Vaccine Adherence Cohort||0
8540937|NCT00244374|21057264|P3|STARTED|Evaluation for Vaccine Adherence Cohort||0
8540938|NCT00244374|21057265|P2|STARTED|Evaluation for Vaccine Adherence Cohort||0
8540939|NCT00244374|21057266|P1|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
8540940|NCT00244374|21057262|P5|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
8540941|NCT00244374|21057263|P4|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
8540942|NCT00244374|21057264|P3|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
8540943|NCT00244374|21057265|P2|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
8540944|NCT00244374|21057266|P1|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
8540945|NCT00244374|21057262|P5|COMPLETED|Pre-Randomization Cross-sectional Study||0
8540946|NCT00244374|21057263|P4|COMPLETED|Pre-Randomization Cross-sectional Study||0
8540947|NCT00244374|21057264|P3|COMPLETED|Pre-Randomization Cross-sectional Study||0
8540948|NCT00244374|21057265|P2|COMPLETED|Pre-Randomization Cross-sectional Study||0
8540949|NCT00244374|21057266|P1|COMPLETED|Pre-Randomization Cross-sectional Study||409
8540950|NCT00244374|21057262|P5|STARTED|Pre-Randomization Cross-sectional Study||0
8540951|NCT00244374|21057263|P4|STARTED|Pre-Randomization Cross-sectional Study||0
8540952|NCT00244374|21057264|P3|STARTED|Pre-Randomization Cross-sectional Study||0
8540953|NCT00244374|21057265|P2|STARTED|Pre-Randomization Cross-sectional Study||0
8540954|NCT00244374|21057266|P1|STARTED|Pre-Randomization Cross-sectional Study||546
8540955|NCT00244140|21057284|P2|NOT COMPLETED|Overall Study||0
8540956|NCT00244140|21057285|P1|NOT COMPLETED|Overall Study||0
8540957|NCT00244140|21057284|P2|COMPLETED|Overall Study||22
8540958|NCT00244140|21057285|P1|COMPLETED|Overall Study||412
8540959|NCT00244140|21057284|P2|STARTED|Overall Study||22
8540960|NCT00244140|21057285|P1|STARTED|Overall Study||412
8540961|NCT00244101|21057300|P3|NOT COMPLETED|Overall Study||0
8540962|NCT00244101|21057301|P2|NOT COMPLETED|Overall Study||0
8540963|NCT00244101|21057302|P1|NOT COMPLETED|Overall Study||0
8540964|NCT00244101|21057300|P3|COMPLETED|Overall Study||216
8540965|NCT00244101|21057301|P2|COMPLETED|Overall Study||223
8540966|NCT00244101|21057302|P1|COMPLETED|Overall Study||209
8540967|NCT00244101|21057300|P3|STARTED|Overall Study||216
8540968|NCT00244101|21057301|P2|STARTED|Overall Study||223
8540969|NCT00244101|21057302|P1|STARTED|Overall Study||209
8540970|NCT00244010|21057312|P2|NOT COMPLETED|Overall Study||0
8540971|NCT00244010|21057313|P1|NOT COMPLETED|Overall Study||0
8540972|NCT00244010|21057312|P2|COMPLETED|Overall Study||2
8540973|NCT00244010|21057313|P1|COMPLETED|Overall Study||2
8540974|NCT00244010|21057312|P2|STARTED|Overall Study||2
8540975|NCT00244010|21057313|P1|STARTED|Overall Study||2
8540976|NCT00243932|21057322|P3|NOT COMPLETED|Stage 2: Efficacy||0
8540977|NCT00243932|21057323|P2|NOT COMPLETED|Stage 2: Efficacy||0
8540978|NCT00243932|21057324|P1|NOT COMPLETED|Stage 2: Efficacy||0
8540979|NCT00243932|21057322|P3|COMPLETED|Stage 2: Efficacy||0
8540980|NCT00243932|21057323|P2|COMPLETED|Stage 2: Efficacy||40
8540981|NCT00243932|21057324|P1|COMPLETED|Stage 2: Efficacy||40
8540982|NCT00243932|21057322|P3|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
8540983|NCT00243932|21057323|P2|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
8540984|NCT00243932|21057324|P1|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
8540985|NCT00243932|21057322|P3|NOT COMPLETED|Stage 1: Dose Selection||0
8540986|NCT00243932|21057323|P2|NOT COMPLETED|Stage 1: Dose Selection||0
8540987|NCT00243932|21057324|P1|NOT COMPLETED|Stage 1: Dose Selection||2
8540988|NCT00243932|21057322|P3|COMPLETED|Stage 1: Dose Selection||35
8540989|NCT00243932|21057323|P2|COMPLETED|Stage 1: Dose Selection||35
8540990|NCT00243932|21057324|P1|COMPLETED|Stage 1: Dose Selection||33
8540991|NCT00243932|21057322|P3|STARTED|Stage 1: Dose Selection||35
8540992|NCT00243932|21057323|P2|STARTED|Stage 1: Dose Selection||35
8540993|NCT00243932|21057324|P1|STARTED|Stage 1: Dose Selection||35
8540994|NCT00243919|21057335|P3|NOT COMPLETED|Overall Study||11
8540995|NCT00243919|21057336|P2|NOT COMPLETED|Overall Study||18
8540996|NCT00243919|21057337|P1|NOT COMPLETED|Overall Study||17
8540997|NCT00243919|21057335|P3|COMPLETED|Overall Study||115
8540998|NCT00243919|21057336|P2|COMPLETED|Overall Study||125
8540999|NCT00243919|21057337|P1|COMPLETED|Overall Study||122
8541000|NCT00243919|21057335|P3|STARTED|Overall Study||126
8541001|NCT00243919|21057336|P2|STARTED|Overall Study||143
8541002|NCT00243919|21057337|P1|STARTED|Overall Study||139
8541003|NCT00243841|21057381|P6|NOT COMPLETED|Overall Study||2
8541004|NCT00243841|21057382|P5|NOT COMPLETED|Overall Study||0
8541005|NCT00243841|21057383|P4|NOT COMPLETED|Overall Study||0
8541006|NCT00243841|21057384|P3|NOT COMPLETED|Overall Study||1
8541007|NCT00243841|21057385|P2|NOT COMPLETED|Overall Study||0
8541008|NCT00243841|21057386|P1|NOT COMPLETED|Overall Study||0
8541009|NCT00243841|21057381|P6|COMPLETED|Overall Study||19
8541010|NCT00243841|21057382|P5|COMPLETED|Overall Study||39
8541011|NCT00243841|21057383|P4|COMPLETED|Overall Study||3
8541012|NCT00243841|21057384|P3|COMPLETED|Overall Study||4
8541013|NCT00243841|21057385|P2|COMPLETED|Overall Study||6
8541014|NCT00243841|21057386|P1|COMPLETED|Overall Study||3
8541015|NCT00243841|21057381|P6|STARTED|Overall Study||21
8541016|NCT00243841|21057382|P5|STARTED|Overall Study||39
8541017|NCT00243841|21057383|P4|STARTED|Overall Study||3
8541018|NCT00243841|21057384|P3|STARTED|Overall Study||5
8541019|NCT00243841|21057385|P2|STARTED|Overall Study||6
8541020|NCT00243841|21057386|P1|STARTED|Overall Study||3
8541021|NCT00243659|21057408|P2|NOT COMPLETED|Overall Study||3
8541022|NCT00243659|21057409|P1|NOT COMPLETED|Overall Study||2
8541023|NCT00243659|21057408|P2|COMPLETED|Overall Study||5
8541024|NCT00243659|21057409|P1|COMPLETED|Overall Study||20
8541025|NCT00243659|21057408|P2|STARTED|Overall Study||8
8541026|NCT00243659|21057409|P1|STARTED|Overall Study||22
8541027|NCT00243503|21057417|P1|NOT COMPLETED|Overall Study||58
8541028|NCT00243503|21057417|P1|COMPLETED|Overall Study||2
8541029|NCT00243503|21057417|P1|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
8541030|NCT00243412|21057434|P2|NOT COMPLETED|Overall Study||11
8541031|NCT00243412|21057435|P1|NOT COMPLETED|Overall Study||10
8541032|NCT00243412|21057434|P2|COMPLETED|Overall Study|Completed Week 104|10
8541033|NCT00243412|21057435|P1|COMPLETED|Overall Study|Completed Week 104|11
8541034|NCT00243412|21057434|P2|Safety Evaluable|Overall Study||20
8541035|NCT00243412|21057435|P1|Safety Evaluable|Overall Study||21
8541036|NCT00243412|21057434|P2|STARTED|Overall Study|Intent to treat|21
8541037|NCT00243412|21057435|P1|STARTED|Overall Study|Intent to treat|21
8541065|NCT00243347|21057528|P1|NOT COMPLETED|Overall Study||19
8541066|NCT00243347|21057528|P1|COMPLETED|Overall Study|Completed study|0
8541067|NCT00243347|21057528|P1|STARTED|Overall Study|Treated|19
8541068|NCT00243269|21057537|P4|NOT COMPLETED|Overall Study||4
8541069|NCT00243269|21057538|P3|NOT COMPLETED|Overall Study||1
8541070|NCT00243269|21057539|P2|NOT COMPLETED|Overall Study||1
8541071|NCT00243269|21057540|P1|NOT COMPLETED|Overall Study||3
8541072|NCT00243269|21057537|P4|COMPLETED|Overall Study||25
8541073|NCT00243269|21057538|P3|COMPLETED|Overall Study||11
8541074|NCT00243269|21057539|P2|COMPLETED|Overall Study||10
8541075|NCT00243269|21057540|P1|COMPLETED|Overall Study||28
8541076|NCT00243269|21057537|P4|STARTED|Overall Study||29
8541077|NCT00243269|21057538|P3|STARTED|Overall Study||12
8541078|NCT00243269|21057539|P2|STARTED|Overall Study||11
8541079|NCT00243269|21057540|P1|STARTED|Overall Study||31
8541080|NCT00243243|21057556|P2|NOT COMPLETED|Overall Study||0
8541081|NCT00243243|21057557|P1|NOT COMPLETED|Overall Study||0
8541082|NCT00243243|21057556|P2|COMPLETED|Overall Study||10
8541083|NCT00243243|21057557|P1|COMPLETED|Overall Study||10
8541084|NCT00243243|21057556|P2|STARTED|Overall Study||10
8541085|NCT00243243|21057557|P1|STARTED|Overall Study||10
8541086|NCT00243191|21057563|P1|NOT COMPLETED|Overall Study||0
8541087|NCT00243191|21057563|P1|COMPLETED|Overall Study||18
8541088|NCT00243191|21057563|P1|STARTED|Overall Study||18
8541089|NCT00243152|21057567|P2|NOT COMPLETED|Overall Study||0
8541090|NCT00243152|21057568|P1|NOT COMPLETED|Overall Study||0
8541091|NCT00243152|21057567|P2|COMPLETED|Overall Study||3
8541092|NCT00243152|21057568|P1|COMPLETED|Overall Study||3
8541093|NCT00243152|21057567|P2|Scan 2: Placebo or Drug|Overall Study||3
8541094|NCT00243152|21057568|P1|Scan 2: Placebo or Drug|Overall Study||3
8541095|NCT00243152|21057567|P2|Scan 1: Drug or Placebo|Overall Study||3
8541096|NCT00243152|21057568|P1|Scan 1: Drug or Placebo|Overall Study||3
8541097|NCT00243152|21057567|P2|STARTED|Overall Study||3
8541098|NCT00243152|21057568|P1|STARTED|Overall Study||3
8541099|NCT00243074|21057575|P1|NOT COMPLETED|Overall Study||54
8541100|NCT00243074|21057575|P1|COMPLETED|Overall Study||0
8541101|NCT00243074|21057575|P1|STARTED|Overall Study||54
8541102|NCT00243061|21057585|P1|NOT COMPLETED|Overall Study||0
8541103|NCT00243061|21057585|P1|COMPLETED|Overall Study||24
8541104|NCT00243061|21057585|P1|STARTED|Overall Study||24
8541105|NCT00243022|21057601|P2|NOT COMPLETED|Overall Study||1
8541106|NCT00243022|21057602|P1|NOT COMPLETED|Overall Study||2
8541107|NCT00243022|21057601|P2|COMPLETED|Overall Study||4
8541108|NCT00243022|21057602|P1|COMPLETED|Overall Study||5
8541109|NCT00243022|21057601|P2|STARTED|Overall Study||5
8541110|NCT00243022|21057602|P1|STARTED|Overall Study||7
8541111|NCT00242710|21057626|P4|NOT COMPLETED|Study Extension (up to Year 2)||10
8541112|NCT00242710|21057627|P3|NOT COMPLETED|Study Extension (up to Year 2)||15
8541113|NCT00242710|21057628|P2|NOT COMPLETED|Study Extension (up to Year 2)||29
8541114|NCT00242710|21057629|P1|NOT COMPLETED|Study Extension (up to Year 2)||27
8541115|NCT00242710|21057626|P4|COMPLETED|Study Extension (up to Year 2)||84
8541116|NCT00242710|21057627|P3|COMPLETED|Study Extension (up to Year 2)||69
8541117|NCT00242710|21057628|P2|COMPLETED|Study Extension (up to Year 2)||148
8541118|NCT00242710|21057629|P1|COMPLETED|Study Extension (up to Year 2)||141
8541119|NCT00242710|21057626|P4|STARTED|Study Extension (up to Year 2)||94
8541120|NCT00242710|21057627|P3|STARTED|Study Extension (up to Year 2)||84
8541121|NCT00242710|21057628|P2|STARTED|Study Extension (up to Year 2)||177
8541122|NCT00242710|21057629|P1|STARTED|Study Extension (up to Year 2)||168
8541123|NCT00242710|21057626|P4|NOT COMPLETED|Period Between Core Study and Extension||49
8541124|NCT00242710|21057627|P3|NOT COMPLETED|Period Between Core Study and Extension||48
8541125|NCT00242710|21057628|P2|NOT COMPLETED|Period Between Core Study and Extension||112
8541126|NCT00242710|21057629|P1|NOT COMPLETED|Period Between Core Study and Extension||119
8541127|NCT00242710|21057626|P4|COMPLETED|Period Between Core Study and Extension||94
8541128|NCT00242710|21057627|P3|COMPLETED|Period Between Core Study and Extension||84
8541129|NCT00242710|21057628|P2|COMPLETED|Period Between Core Study and Extension||177
8541130|NCT00242710|21057629|P1|COMPLETED|Period Between Core Study and Extension||168
8541131|NCT00242710|21057626|P4|STARTED|Period Between Core Study and Extension||143
8541132|NCT00242710|21057627|P3|STARTED|Period Between Core Study and Extension||132
8541133|NCT00242710|21057628|P2|STARTED|Period Between Core Study and Extension||289
8541134|NCT00242710|21057629|P1|STARTED|Period Between Core Study and Extension||287
8541135|NCT00242710|21057626|P4|NOT COMPLETED|Core Study (up to Year 1)||31
8541136|NCT00242710|21057627|P3|NOT COMPLETED|Core Study (up to Year 1)||51
8541137|NCT00242710|21057628|P2|NOT COMPLETED|Core Study (up to Year 1)||64
8541138|NCT00242710|21057629|P1|NOT COMPLETED|Core Study (up to Year 1)||86
8541139|NCT00242710|21057626|P4|COMPLETED|Core Study (up to Year 1)||143
8541140|NCT00242710|21057627|P3|COMPLETED|Core Study (up to Year 1)||132
8541141|NCT00242710|21057628|P2|COMPLETED|Core Study (up to Year 1)||289
8541142|NCT00242710|21057629|P1|COMPLETED|Core Study (up to Year 1)||287
8541143|NCT00242710|21057626|P4|Treated|Core Study (up to Year 1)||172
8541144|NCT00242710|21057627|P3|Treated|Core Study (up to Year 1)||179
8541145|NCT00242710|21057628|P2|Treated|Core Study (up to Year 1)||349
8541146|NCT00242710|21057629|P1|Treated|Core Study (up to Year 1)||361
8541147|NCT00242710|21057626|P4|STARTED|Core Study (up to Year 1)||174
8541148|NCT00242710|21057627|P3|STARTED|Core Study (up to Year 1)||183
8541149|NCT00242710|21057628|P2|STARTED|Core Study (up to Year 1)||353
8541150|NCT00242710|21057629|P1|STARTED|Core Study (up to Year 1)||373
8541151|NCT00242684|21057679|P1|NOT COMPLETED|Overall Study||0
8541152|NCT00242684|21057679|P1|COMPLETED|Overall Study||446
8541153|NCT00242684|21057679|P1|STARTED|Overall Study||446
8541154|NCT00242658|21057686|P2|NOT COMPLETED|Overall Study||19
8541155|NCT00242658|21057687|P1|NOT COMPLETED|Overall Study||22
8541156|NCT00242658|21057686|P2|COMPLETED|Overall Study||188
8541157|NCT00242658|21057687|P1|COMPLETED|Overall Study||165
8541158|NCT00242658|21057686|P2|STARTED|Overall Study||207
8541159|NCT00242658|21057687|P1|STARTED|Overall Study||187
8541160|NCT00242632|21057697|P2|NOT COMPLETED|Overall Study||0
8541161|NCT00242632|21057698|P1|NOT COMPLETED|Overall Study||0
8541162|NCT00242632|21057697|P2|COMPLETED|Overall Study||11
8541163|NCT00242632|21057698|P1|COMPLETED|Overall Study||11
8541164|NCT00242632|21057697|P2|STARTED|Overall Study||11
8541165|NCT00242632|21057698|P1|STARTED|Overall Study||11
8541166|NCT00242619|21057706|P2|NOT COMPLETED|Overall Study||0
8541167|NCT00242619|21057707|P1|NOT COMPLETED|Overall Study||0
8541168|NCT00242619|21057706|P2|COMPLETED|Overall Study||4
8541169|NCT00242619|21057707|P1|COMPLETED|Overall Study||8
8541170|NCT00242619|21057706|P2|STARTED|Overall Study||4
8541171|NCT00242619|21057707|P1|STARTED|Overall Study||8
8541172|NCT00242580|21057718|P3|NOT COMPLETED|Overall Study||14
8541173|NCT00242580|21057719|P2|NOT COMPLETED|Overall Study||12
8541174|NCT00242580|21057720|P1|NOT COMPLETED|Overall Study||10
8541175|NCT00242580|21057718|P3|COMPLETED|Overall Study||24
8541176|NCT00242580|21057719|P2|COMPLETED|Overall Study||29
8541177|NCT00242580|21057720|P1|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
8541178|NCT00242580|21057718|P3|STARTED|Overall Study||38
8541179|NCT00242580|21057719|P2|STARTED|Overall Study||41
8541180|NCT00242580|21057720|P1|STARTED|Overall Study||32
8541181|NCT00242567|21057745|P2|NOT COMPLETED|Overall Study||140
8541182|NCT00242567|21057746|P1|NOT COMPLETED|Overall Study||166
8541183|NCT00242567|21057745|P2|COMPLETED|Overall Study||123
8541184|NCT00242567|21057746|P1|COMPLETED|Overall Study||93
8541185|NCT00242567|21057745|P2|Never Received Study Drug|Overall Study||191
8541186|NCT00242567|21057746|P1|Never Received Study Drug|Overall Study||0
8541187|NCT00242567|21057745|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
8541188|NCT00242567|21057746|P1|Received at Least 1 Dose of Study Drug|Overall Study||259
8541189|NCT00242567|21057745|P2|STARTED|Overall Study||263
8541190|NCT00242567|21057746|P1|STARTED|Overall Study||259
8541191|NCT00242502|21057762|P1|NOT COMPLETED|Overall Study||0
8541192|NCT00242502|21057762|P1|COMPLETED|Overall Study||59
8541193|NCT00242502|21057762|P1|STARTED|Overall Study||59
8541206|NCT00242216|21057793|P2|NOT COMPLETED|Overall Study||22
8541207|NCT00242216|21057794|P1|NOT COMPLETED|Overall Study||18
8541208|NCT00242216|21057793|P2|COMPLETED|Overall Study||15
8541209|NCT00242216|21057794|P1|COMPLETED|Overall Study||21
8541210|NCT00242216|21057793|P2|STARTED|Overall Study||37
8541211|NCT00242216|21057794|P1|STARTED|Overall Study||39
8541212|NCT00241969|21057804|P2|NOT COMPLETED|Overall Study||0
8541213|NCT00241969|21057805|P1|NOT COMPLETED|Overall Study||0
8541214|NCT00241969|21057804|P2|COMPLETED|Overall Study||42
8541215|NCT00241969|21057805|P1|COMPLETED|Overall Study||36
8541216|NCT00241969|21057804|P2|STARTED|Overall Study||42
8541217|NCT00241969|21057805|P1|STARTED|Overall Study||36
8541218|NCT00241904|21057817|P2|NOT COMPLETED|Overall Study||24
8541219|NCT00241904|21057818|P1|NOT COMPLETED|Overall Study||34
8541220|NCT00241904|21057817|P2|COMPLETED|Overall Study||240
8541221|NCT00241904|21057818|P1|COMPLETED|Overall Study||227
8541222|NCT00241904|21057817|P2|STARTED|Overall Study||264
8541223|NCT00241904|21057818|P1|STARTED|Overall Study||261
8541224|NCT00241839|21057832|P2|NOT COMPLETED|Overall Study||18
8541225|NCT00241839|21057833|P1|NOT COMPLETED|Overall Study||19
8541226|NCT00241839|21057832|P2|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
8541227|NCT00241839|21057833|P1|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
8541228|NCT00241839|21057832|P2|STARTED|Overall Study||71
8541229|NCT00241839|21057833|P1|STARTED|Overall Study||71
8541230|NCT00241644|21057849|P4|NOT COMPLETED|Second Efficacy Period (Year 2)||118
8541231|NCT00241644|21057850|P3|NOT COMPLETED|Second Efficacy Period (Year 2)||64
8541232|NCT00241644|21057851|P2|NOT COMPLETED|Second Efficacy Period (Year 2)||57
8541233|NCT00241644|21057852|P1|NOT COMPLETED|Second Efficacy Period (Year 2)||61
8541234|NCT00241644|21057849|P4|COMPLETED|Second Efficacy Period (Year 2)||1407
8541235|NCT00241644|21057850|P3|COMPLETED|Second Efficacy Period (Year 2)||682
8541236|NCT00241644|21057851|P2|COMPLETED|Second Efficacy Period (Year 2)||697
8541237|NCT00241644|21057852|P1|COMPLETED|Second Efficacy Period (Year 2)||710
8541238|NCT00241644|21057849|P4|STARTED|Second Efficacy Period (Year 2)||1525
8541239|NCT00241644|21057850|P3|STARTED|Second Efficacy Period (Year 2)||746
8541240|NCT00241644|21057851|P2|STARTED|Second Efficacy Period (Year 2)||754
8541241|NCT00241644|21057852|P1|STARTED|Second Efficacy Period (Year 2)||771
8541242|NCT00241644|21057849|P4|NOT COMPLETED|First Efficacy Period (Year 1)||495
8541243|NCT00241644|21057850|P3|NOT COMPLETED|First Efficacy Period (Year 1)||249
8541244|NCT00241644|21057851|P2|NOT COMPLETED|First Efficacy Period (Year 1)||268
8541245|NCT00241644|21057852|P1|NOT COMPLETED|First Efficacy Period (Year 1)||227
8541246|NCT00241644|21057849|P4|COMPLETED|First Efficacy Period (Year 1)||2803
8541247|NCT00241644|21057850|P3|COMPLETED|First Efficacy Period (Year 1)||1392
8541248|NCT00241644|21057851|P2|COMPLETED|First Efficacy Period (Year 1)||1383
8541249|NCT00241644|21057852|P1|COMPLETED|First Efficacy Period (Year 1)||1420
8541250|NCT00241644|21057849|P4|STARTED|First Efficacy Period (Year 1)||3298
8541251|NCT00241644|21057850|P3|STARTED|First Efficacy Period (Year 1)||1641
8541252|NCT00241644|21057851|P2|STARTED|First Efficacy Period (Year 1)||1651
8541253|NCT00241644|21057852|P1|STARTED|First Efficacy Period (Year 1)||1647
8541254|NCT00241631|21057936|P2|NOT COMPLETED|Phase 2 (4 Weeks)||0
8541255|NCT00241631|21057937|P1|NOT COMPLETED|Phase 2 (4 Weeks)||0
8541256|NCT00241631|21057936|P2|COMPLETED|Phase 2 (4 Weeks)||16
8541257|NCT00241631|21057937|P1|COMPLETED|Phase 2 (4 Weeks)||14
8541258|NCT00241631|21057936|P2|STARTED|Phase 2 (4 Weeks)||16
8541259|NCT00241631|21057937|P1|STARTED|Phase 2 (4 Weeks)||14
8541260|NCT00241631|21057936|P2|NOT COMPLETED|Wash Out (2 Weeks)||0
8541261|NCT00241631|21057937|P1|NOT COMPLETED|Wash Out (2 Weeks)||0
8541262|NCT00241631|21057936|P2|COMPLETED|Wash Out (2 Weeks)||16
8541263|NCT00241631|21057937|P1|COMPLETED|Wash Out (2 Weeks)||14
8541264|NCT00241631|21057936|P2|STARTED|Wash Out (2 Weeks)||16
8541265|NCT00241631|21057937|P1|STARTED|Wash Out (2 Weeks)||14
8541266|NCT00241631|21057936|P2|NOT COMPLETED|Phase 1 (4 Weeks)||5
8541267|NCT00241631|21057937|P1|NOT COMPLETED|Phase 1 (4 Weeks)||8
8541268|NCT00241631|21057936|P2|COMPLETED|Phase 1 (4 Weeks)||16
8541269|NCT00241631|21057937|P1|COMPLETED|Phase 1 (4 Weeks)||14
8541270|NCT00241631|21057936|P2|STARTED|Phase 1 (4 Weeks)||21
8541271|NCT00241631|21057937|P1|STARTED|Phase 1 (4 Weeks)||22
8541272|NCT00241631|21057936|P2|NOT COMPLETED|Run in (2 Weeks)||3
8541273|NCT00241631|21057937|P1|NOT COMPLETED|Run in (2 Weeks)||3
8541274|NCT00241631|21057936|P2|COMPLETED|Run in (2 Weeks)||21
8541275|NCT00241631|21057937|P1|COMPLETED|Run in (2 Weeks)||22
8541276|NCT00241631|21057936|P2|STARTED|Run in (2 Weeks)||24
8541277|NCT00241631|21057937|P1|STARTED|Run in (2 Weeks)||25
8541278|NCT00241358|21057950|P3|NOT COMPLETED|Overall Study||1
8541279|NCT00241358|21057951|P2|NOT COMPLETED|Overall Study||1
8541280|NCT00241358|21057952|P1|NOT COMPLETED|Overall Study||0
8541281|NCT00241358|21057950|P3|COMPLETED|Overall Study||20
8541282|NCT00241358|21057951|P2|COMPLETED|Overall Study||45
8541283|NCT00241358|21057952|P1|COMPLETED|Overall Study||25
8541284|NCT00241358|21057950|P3|STARTED|Overall Study||21
8541285|NCT00241358|21057951|P2|STARTED|Overall Study||46
8541286|NCT00241358|21057952|P1|STARTED|Overall Study||25
8541287|NCT00241280|21057985|P2|NOT COMPLETED|Overall Study||68
8541288|NCT00241280|21057986|P1|NOT COMPLETED|Overall Study||48
8541289|NCT00241280|21057985|P2|COMPLETED|Overall Study||186
8541290|NCT00241280|21057986|P1|COMPLETED|Overall Study||199
8541291|NCT00241280|21057985|P2|STARTED|Overall Study||254
8541292|NCT00241280|21057986|P1|STARTED|Overall Study||247
8541293|NCT00241176|21057994|P1|NOT COMPLETED|Overall Study||0
8541294|NCT00241176|21057994|P1|COMPLETED|Overall Study||11
8541295|NCT00241176|21057994|P1|STARTED|Overall Study||11
8541296|NCT00240994|21058001|P1|NOT COMPLETED|Overall Study||3
8541297|NCT00240994|21058001|P1|COMPLETED|Overall Study||32
8541298|NCT00240994|21058001|P1|STARTED|Overall Study||35
8541299|NCT00240981|21058007|P2|NOT COMPLETED|Overall Study||33
8541300|NCT00240981|21058008|P1|NOT COMPLETED|Overall Study||38
8541301|NCT00240981|21058007|P2|COMPLETED|Overall Study||70
8541302|NCT00240981|21058008|P1|COMPLETED|Overall Study||68
8541303|NCT00240981|21058007|P2|Intent to Treat Sample|Overall Study||83
8541304|NCT00240981|21058008|P1|Intent to Treat Sample|Overall Study||82
8541305|NCT00240981|21058007|P2|STARTED|Overall Study||103
8541306|NCT00240981|21058008|P1|STARTED|Overall Study||106
8541307|NCT00240539|21058036|P4|NOT COMPLETED|Overall Study||0
8541308|NCT00240539|21058037|P3|NOT COMPLETED|Overall Study||0
8541309|NCT00240539|21058038|P2|NOT COMPLETED|Overall Study||0
8541310|NCT00240539|21058039|P1|NOT COMPLETED|Overall Study||0
8541311|NCT00240539|21058036|P4|COMPLETED|Overall Study||1
8541312|NCT00240539|21058037|P3|COMPLETED|Overall Study||31
8541313|NCT00240539|21058038|P2|COMPLETED|Overall Study||2
8541314|NCT00240539|21058039|P1|COMPLETED|Overall Study||2
8541315|NCT00240539|21058036|P4|STARTED|Overall Study||1
8541316|NCT00240539|21058037|P3|STARTED|Overall Study||31
8541317|NCT00240539|21058038|P2|STARTED|Overall Study||2
8541318|NCT00240539|21058039|P1|STARTED|Overall Study||2
8541319|NCT00240526|21058061|P4|NOT COMPLETED|Year 20||0
8541320|NCT00240526|21058062|P3|NOT COMPLETED|Year 20||0
8541321|NCT00240526|21058063|P2|NOT COMPLETED|Year 20||0
8541322|NCT00240526|21058064|P1|NOT COMPLETED|Year 20||0
8541323|NCT00240526|21058061|P4|COMPLETED|Year 20||20
8541324|NCT00240526|21058062|P3|COMPLETED|Year 20||13
8541325|NCT00240526|21058063|P2|COMPLETED|Year 20||17
8541326|NCT00240526|21058064|P1|COMPLETED|Year 20||19
8541327|NCT00240526|21058061|P4|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
8541328|NCT00240526|21058062|P3|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
8541329|NCT00240526|21058063|P2|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
8541330|NCT00240526|21058064|P1|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
8541331|NCT00240526|21058061|P4|NOT COMPLETED|Year 19||0
8541332|NCT00240526|21058062|P3|NOT COMPLETED|Year 19||0
8541333|NCT00240526|21058063|P2|NOT COMPLETED|Year 19||0
8541334|NCT00240526|21058064|P1|NOT COMPLETED|Year 19||0
8541335|NCT00240526|21058061|P4|COMPLETED|Year 19||18
8541336|NCT00240526|21058062|P3|COMPLETED|Year 19||12
8541337|NCT00240526|21058063|P2|COMPLETED|Year 19||16
8541338|NCT00240526|21058064|P1|COMPLETED|Year 19||17
8541339|NCT00240526|21058061|P4|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
8541340|NCT00240526|21058062|P3|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
8541341|NCT00240526|21058063|P2|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
8541342|NCT00240526|21058064|P1|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
8541343|NCT00240526|21058061|P4|NOT COMPLETED|Year 18||0
8541344|NCT00240526|21058062|P3|NOT COMPLETED|Year 18||0
8541345|NCT00240526|21058063|P2|NOT COMPLETED|Year 18||0
8541346|NCT00240526|21058064|P1|NOT COMPLETED|Year 18||0
8541347|NCT00240526|21058061|P4|COMPLETED|Year 18||20
8541348|NCT00240526|21058062|P3|COMPLETED|Year 18||14
8541349|NCT00240526|21058063|P2|COMPLETED|Year 18||17
8541350|NCT00240526|21058064|P1|COMPLETED|Year 18||16
8541351|NCT00240526|21058061|P4|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
8541352|NCT00240526|21058062|P3|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
8541353|NCT00240526|21058063|P2|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
8541354|NCT00240526|21058064|P1|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
8541355|NCT00240526|21058061|P4|NOT COMPLETED|Year 17||0
8541356|NCT00240526|21058062|P3|NOT COMPLETED|Year 17||0
8541357|NCT00240526|21058063|P2|NOT COMPLETED|Year 17||0
8541358|NCT00240526|21058064|P1|NOT COMPLETED|Year 17||0
8541359|NCT00240526|21058061|P4|COMPLETED|Year 17||20
8541360|NCT00240526|21058062|P3|COMPLETED|Year 17||13
8541361|NCT00240526|21058063|P2|COMPLETED|Year 17||17
8541362|NCT00240526|21058064|P1|COMPLETED|Year 17||19
8541363|NCT00240526|21058061|P4|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
8541364|NCT00240526|21058062|P3|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
8541365|NCT00240526|21058063|P2|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
8541366|NCT00240526|21058064|P1|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
8541367|NCT00240526|21058061|P4|NOT COMPLETED|Year 16||0
8541368|NCT00240526|21058062|P3|NOT COMPLETED|Year 16||0
8541369|NCT00240526|21058063|P2|NOT COMPLETED|Year 16||0
8541370|NCT00240526|21058064|P1|NOT COMPLETED|Year 16||0
8541371|NCT00240526|21058061|P4|COMPLETED|Year 16||22
8541372|NCT00240526|21058062|P3|COMPLETED|Year 16||16
8541373|NCT00240526|21058063|P2|COMPLETED|Year 16||19
8541374|NCT00240526|21058064|P1|COMPLETED|Year 16||17
8541375|NCT00240526|21058061|P4|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
8541463|NCT00239681|21058254|P1|NOT COMPLETED|Overall Study||693
8541376|NCT00240526|21058062|P3|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
8541377|NCT00240526|21058063|P2|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
8541378|NCT00240526|21058064|P1|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
8541379|NCT00240526|21058061|P4|NOT COMPLETED|Year 15||0
8541380|NCT00240526|21058062|P3|NOT COMPLETED|Year 15||0
8541381|NCT00240526|21058063|P2|NOT COMPLETED|Year 15||0
8541382|NCT00240526|21058064|P1|NOT COMPLETED|Year 15||0
8541383|NCT00240526|21058061|P4|COMPLETED|Year 15||21
8541384|NCT00240526|21058062|P3|COMPLETED|Year 15||14
8541385|NCT00240526|21058063|P2|COMPLETED|Year 15||19
8541386|NCT00240526|21058064|P1|COMPLETED|Year 15||19
8541387|NCT00240526|21058061|P4|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
8541388|NCT00240526|21058062|P3|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
8541389|NCT00240526|21058063|P2|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
8541390|NCT00240526|21058064|P1|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
8541391|NCT00240500|21058100|P6|NOT COMPLETED|Overall Study||1
8541392|NCT00240500|21058101|P5|NOT COMPLETED|Overall Study||3
8541393|NCT00240500|21058102|P4|NOT COMPLETED|Overall Study||4
8541394|NCT00240500|21058103|P3|NOT COMPLETED|Overall Study||3
8541395|NCT00240500|21058104|P2|NOT COMPLETED|Overall Study||3
8541396|NCT00240500|21058105|P1|NOT COMPLETED|Overall Study||1
8541397|NCT00240500|21058100|P6|COMPLETED|Overall Study||2
8541398|NCT00240500|21058101|P5|COMPLETED|Overall Study||26
8541399|NCT00240500|21058102|P4|COMPLETED|Overall Study||19
8541400|NCT00240500|21058103|P3|COMPLETED|Overall Study||14
8541401|NCT00240500|21058104|P2|COMPLETED|Overall Study||17
8541402|NCT00240500|21058105|P1|COMPLETED|Overall Study||16
8541403|NCT00240500|21058100|P6|STARTED|Overall Study||3
8541404|NCT00240500|21058101|P5|STARTED|Overall Study||29
8541405|NCT00240500|21058102|P4|STARTED|Overall Study||23
8541406|NCT00240500|21058103|P3|STARTED|Overall Study||17
8541407|NCT00240500|21058104|P2|STARTED|Overall Study||20
8541408|NCT00240500|21058105|P1|STARTED|Overall Study||17
8541409|NCT00240487|21058127|P2|NOT COMPLETED|Overall Study||0
8541410|NCT00240487|21058128|P1|NOT COMPLETED|Overall Study||0
8541411|NCT00240487|21058127|P2|COMPLETED|Overall Study||28
8541412|NCT00240487|21058128|P1|COMPLETED|Overall Study||24
8541413|NCT00240487|21058127|P2|STARTED|Overall Study||28
8541414|NCT00240487|21058128|P1|STARTED|Overall Study||24
8541415|NCT00240331|21058136|P2|NOT COMPLETED|Overall Study||134
8541416|NCT00240331|21058137|P1|NOT COMPLETED|Overall Study||126
8541417|NCT00240331|21058136|P2|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
8541418|NCT00240331|21058137|P1|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
8541419|NCT00240331|21058136|P2|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
8541420|NCT00240331|21058137|P1|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
8541421|NCT00240227|21058155|P1|NOT COMPLETED|Overall Study||0
8541422|NCT00240227|21058155|P1|COMPLETED|Overall Study||8
8541423|NCT00240227|21058155|P1|STARTED|Overall Study||8
8541424|NCT00240162|21058171|P1|NOT COMPLETED|Overall Study||0
8541425|NCT00240162|21058171|P1|COMPLETED|Overall Study||21
8541426|NCT00240162|21058171|P1|STARTED|Overall Study||21
8541427|NCT00240110|21058180|P2|NOT COMPLETED|Overall Study||7
8541428|NCT00240110|21058181|P1|NOT COMPLETED|Overall Study||6
8541429|NCT00240110|21058180|P2|COMPLETED|Overall Study||6
8541430|NCT00240110|21058181|P1|COMPLETED|Overall Study||7
8541431|NCT00240110|21058180|P2|STARTED|Overall Study||13
8541432|NCT00240110|21058181|P1|STARTED|Overall Study||13
8541433|NCT00240097|21058189|P1|NOT COMPLETED|Part II||23
8541434|NCT00240097|21058189|P1|COMPLETED|Part II||3
8541435|NCT00240097|21058189|P1|STARTED|Part II||26
8541436|NCT00240097|21058189|P1|NOT COMPLETED|Part I||4
8541437|NCT00240097|21058189|P1|COMPLETED|Part I||26
8541438|NCT00240097|21058189|P1|STARTED|Part I||30
8541439|NCT00240071|21058199|P1|NOT COMPLETED|Overall Study||3
8541440|NCT00240071|21058199|P1|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
8541441|NCT00240071|21058199|P1|STARTED|Overall Study||30
8541442|NCT00239928|21058204|P1|NOT COMPLETED|Overall Study||10
8541443|NCT00239928|21058204|P1|COMPLETED|Overall Study||51
8541444|NCT00239928|21058204|P1|STARTED|Overall Study||61
8541445|NCT00239837|21058216|P2|NOT COMPLETED|Overall Study||7
8541446|NCT00239837|21058217|P1|NOT COMPLETED|Overall Study||3
8541447|NCT00239837|21058216|P2|COMPLETED|Overall Study|3-year follow-up|45
8541448|NCT00239837|21058217|P1|COMPLETED|Overall Study|3-year follow-up|45
8541449|NCT00239837|21058216|P2|6 Months|Overall Study||50
8541450|NCT00239837|21058217|P1|6 Months|Overall Study||48
8541451|NCT00239837|21058216|P2|STARTED|Overall Study||52
8541452|NCT00239837|21058217|P1|STARTED|Overall Study||48
8541453|NCT00239733|21058237|P1|NOT COMPLETED|Overall Study||0
8541454|NCT00239733|21058237|P1|COMPLETED|Overall Study||6
8541455|NCT00239733|21058237|P1|STARTED|Overall Study||6
8541456|NCT00239720|21058244|P2|NOT COMPLETED|Overall Study||1
8541457|NCT00239720|21058245|P1|NOT COMPLETED|Overall Study||1
8541458|NCT00239720|21058244|P2|COMPLETED|Overall Study|One participant lost to follow-up|0
8541459|NCT00239720|21058245|P1|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
8541460|NCT00239720|21058244|P2|STARTED|Overall Study||1
8541461|NCT00239720|21058245|P1|STARTED|Overall Study||3
8541462|NCT00239681|21058253|P2|NOT COMPLETED|Overall Study||715
8541464|NCT00239681|21058253|P2|COMPLETED|Overall Study||8186
8541465|NCT00239681|21058254|P1|COMPLETED|Overall Study||8208
8541466|NCT00239681|21058253|P2|Randomized and Treated (Safety Pop)|Overall Study||8864
8541467|NCT00239681|21058254|P1|Randomized and Treated (Safety Pop)|Overall Study||8869
8541468|NCT00239681|21058253|P2|STARTED|Overall Study||8901
8541469|NCT00239681|21058254|P1|STARTED|Overall Study||8901
8541470|NCT00239642|21058273|P3|NOT COMPLETED|Overall Study||2
8541471|NCT00239642|21058274|P2|NOT COMPLETED|Overall Study||0
8541472|NCT00239642|21058275|P1|NOT COMPLETED|Overall Study||2
8541473|NCT00239642|21058273|P3|COMPLETED|Overall Study||47
8541474|NCT00239642|21058274|P2|COMPLETED|Overall Study||47
8541475|NCT00239642|21058275|P1|COMPLETED|Overall Study||47
8541476|NCT00239642|21058273|P3|STARTED|Overall Study||49
8541477|NCT00239642|21058274|P2|STARTED|Overall Study||47
8541478|NCT00239642|21058275|P1|STARTED|Overall Study||49
8541479|NCT00239590|21058307|P2|NOT COMPLETED|Completed Study Protocol||2
8541480|NCT00239590|21058308|P1|NOT COMPLETED|Completed Study Protocol||1
8541481|NCT00239590|21058307|P2|COMPLETED|Completed Study Protocol||10
8541482|NCT00239590|21058308|P1|COMPLETED|Completed Study Protocol||13
8541483|NCT00239590|21058307|P2|STARTED|Completed Study Protocol||12
8541484|NCT00239590|21058308|P1|STARTED|Completed Study Protocol||14
8541485|NCT00239590|21058307|P2|NOT COMPLETED|Started Intervention After Randomization||0
8541486|NCT00239590|21058308|P1|NOT COMPLETED|Started Intervention After Randomization||0
8541487|NCT00239590|21058307|P2|COMPLETED|Started Intervention After Randomization||12
8541488|NCT00239590|21058308|P1|COMPLETED|Started Intervention After Randomization||14
8541489|NCT00239590|21058307|P2|STARTED|Started Intervention After Randomization||12
8541490|NCT00239590|21058308|P1|STARTED|Started Intervention After Randomization||14
8541491|NCT00239590|21058307|P2|NOT COMPLETED|Randomized||2
8541492|NCT00239590|21058308|P1|NOT COMPLETED|Randomized||0
8541493|NCT00239590|21058307|P2|COMPLETED|Randomized||12
8541494|NCT00239590|21058308|P1|COMPLETED|Randomized||14
8541495|NCT00239590|21058307|P2|STARTED|Randomized||14
8541496|NCT00239590|21058308|P1|STARTED|Randomized||14
8541497|NCT00239577|21058320|P4|NOT COMPLETED|Booster Phase||0
8541498|NCT00239577|21058321|P3|NOT COMPLETED|Booster Phase||0
8541499|NCT00239577|21058322|P2|NOT COMPLETED|Booster Phase||0
8541500|NCT00239577|21058323|P1|NOT COMPLETED|Booster Phase||0
8541501|NCT00239577|21058320|P4|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
8541502|NCT00239577|21058321|P3|COMPLETED|Booster Phase||12
8541503|NCT00239577|21058322|P2|COMPLETED|Booster Phase||9
8541504|NCT00239577|21058323|P1|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
8541505|NCT00239577|21058320|P4|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
8541506|NCT00239577|21058321|P3|STARTED|Booster Phase||12
8541507|NCT00239577|21058322|P2|STARTED|Booster Phase||9
8541508|NCT00239577|21058323|P1|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
8541509|NCT00239577|21058320|P4|NOT COMPLETED|Primary Phase||0
8541510|NCT00239577|21058321|P3|NOT COMPLETED|Primary Phase||3
8541511|NCT00239577|21058322|P2|NOT COMPLETED|Primary Phase||3
8541512|NCT00239577|21058323|P1|NOT COMPLETED|Primary Phase||5
8541513|NCT00239577|21058320|P4|COMPLETED|Primary Phase||21
8541514|NCT00239577|21058321|P3|COMPLETED|Primary Phase||18
8541515|NCT00239577|21058322|P2|COMPLETED|Primary Phase||19
8541516|NCT00239577|21058323|P1|COMPLETED|Primary Phase||17
8541517|NCT00239577|21058320|P4|STARTED|Primary Phase||21
8541518|NCT00239577|21058321|P3|STARTED|Primary Phase||21
8541519|NCT00239577|21058322|P2|STARTED|Primary Phase||22
8541520|NCT00239577|21058323|P1|STARTED|Primary Phase||22
8541521|NCT00239356|21058427|P2|NOT COMPLETED|Overall Study||9
8541522|NCT00239356|21058428|P1|NOT COMPLETED|Overall Study||39
8541523|NCT00239356|21058427|P2|COMPLETED|Overall Study||11
8541524|NCT00239356|21058428|P1|COMPLETED|Overall Study||58
8541525|NCT00239356|21058427|P2|STARTED|Overall Study||20
8541526|NCT00239356|21058428|P1|STARTED|Overall Study||97
8541527|NCT00239226|21058450|P4|NOT COMPLETED|Overall Study||3
8541528|NCT00239226|21058451|P3|NOT COMPLETED|Overall Study||1
8541529|NCT00239226|21058452|P2|NOT COMPLETED|Overall Study||0
8541530|NCT00239226|21058453|P1|NOT COMPLETED|Overall Study||1
8541531|NCT00239226|21058450|P4|COMPLETED|Overall Study||14
8541532|NCT00239226|21058451|P3|COMPLETED|Overall Study||36
8541533|NCT00239226|21058452|P2|COMPLETED|Overall Study||18
8541534|NCT00239226|21058453|P1|COMPLETED|Overall Study||29
8541535|NCT00239226|21058450|P4|STARTED|Overall Study||17
8541536|NCT00239226|21058451|P3|STARTED|Overall Study||37
8541537|NCT00239226|21058452|P2|STARTED|Overall Study||18
8541538|NCT00239226|21058453|P1|STARTED|Overall Study||30
8541539|NCT00239005|21058465|P2|NOT COMPLETED|Overall Study||12
8541540|NCT00239005|21058466|P1|NOT COMPLETED|Overall Study||12
8541541|NCT00239005|21058465|P2|COMPLETED|Overall Study||53
8541542|NCT00239005|21058466|P1|COMPLETED|Overall Study||57
8541543|NCT00239005|21058465|P2|Intention-to-treat Population (ITT)|Overall Study||61
8541544|NCT00239005|21058466|P1|Intention-to-treat Population (ITT)|Overall Study||68
8541545|NCT00239005|21058465|P2|STARTED|Overall Study||65
8541546|NCT00239005|21058466|P1|STARTED|Overall Study||69
8541547|NCT00238615|21058476|P1|NOT COMPLETED|Overall Study||0
8541548|NCT00238615|21058476|P1|COMPLETED|Overall Study||13
8541549|NCT00238615|21058476|P1|STARTED|Overall Study||13
8541550|NCT00238433|21058482|P1|NOT COMPLETED|Overall Study||3
8541551|NCT00238433|21058482|P1|COMPLETED|Overall Study||34
8541552|NCT00238433|21058482|P1|STARTED|Overall Study||37
8541559|NCT00238355|21058500|P1|NOT COMPLETED|Overall Study||3
8541560|NCT00238355|21058500|P1|COMPLETED|Overall Study||10
8541561|NCT00238355|21058500|P1|STARTED|Overall Study||13
8541562|NCT00238303|21058507|P3|NOT COMPLETED|Overall Study||9
8541563|NCT00238303|21058508|P2|NOT COMPLETED|Overall Study||2
8541564|NCT00238303|21058509|P1|NOT COMPLETED|Overall Study||15
8541565|NCT00238303|21058507|P3|COMPLETED|Overall Study||11
8541566|NCT00238303|21058508|P2|COMPLETED|Overall Study||13
8541567|NCT00238303|21058509|P1|COMPLETED|Overall Study||53
8541568|NCT00238303|21058507|P3|STARTED|Overall Study||20
8541569|NCT00238303|21058508|P2|STARTED|Overall Study||15
8541570|NCT00238303|21058509|P1|STARTED|Overall Study||68
8541571|NCT00238264|21058526|P1|NOT COMPLETED|Overall Study||36
8541572|NCT00238264|21058526|P1|COMPLETED|Overall Study||56
8541573|NCT00238264|21058526|P1|STARTED|Overall Study||92
8541574|NCT00238238|21058539|P3|NOT COMPLETED|Overall Study||0
8541575|NCT00238238|21058540|P2|NOT COMPLETED|Overall Study||3
8541576|NCT00238238|21058541|P1|NOT COMPLETED|Overall Study||0
8541577|NCT00238238|21058539|P3|COMPLETED|Overall Study||46
8541578|NCT00238238|21058540|P2|COMPLETED|Overall Study||45
8541579|NCT00238238|21058541|P1|COMPLETED|Overall Study||3
8541580|NCT00238238|21058539|P3|STARTED|Overall Study||46
8541581|NCT00238238|21058540|P2|STARTED|Overall Study||48
8541582|NCT00238238|21058541|P1|STARTED|Overall Study||3
8541583|NCT00238121|21058554|P2|NOT COMPLETED|Overall Study||2
8541584|NCT00238121|21058555|P1|NOT COMPLETED|Overall Study||3
8541585|NCT00238121|21058554|P2|COMPLETED|Overall Study||14
8541586|NCT00238121|21058555|P1|COMPLETED|Overall Study||37
8541587|NCT00238121|21058554|P2|STARTED|Overall Study||16
8541588|NCT00238121|21058555|P1|STARTED|Overall Study||40
8541589|NCT00238108|21058568|P2|NOT COMPLETED|Overall Study||0
8541590|NCT00238108|21058569|P1|NOT COMPLETED|Overall Study||0
8541591|NCT00238108|21058568|P2|COMPLETED|Overall Study||8
8541592|NCT00238108|21058569|P1|COMPLETED|Overall Study||8
8541593|NCT00238108|21058568|P2|STARTED|Overall Study||8
8541594|NCT00238108|21058569|P1|STARTED|Overall Study||8
8541595|NCT00237809|21058581|P4|NOT COMPLETED|Overall Study||9
8541596|NCT00237809|21058582|P3|NOT COMPLETED|Overall Study||9
8541597|NCT00237809|21058583|P2|NOT COMPLETED|Overall Study||10
8541598|NCT00237809|21058584|P1|NOT COMPLETED|Overall Study||11
8541599|NCT00237809|21058581|P4|COMPLETED|Overall Study||17
8541600|NCT00237809|21058582|P3|COMPLETED|Overall Study||15
8541601|NCT00237809|21058583|P2|COMPLETED|Overall Study||17
8541602|NCT00237809|21058584|P1|COMPLETED|Overall Study||16
8541603|NCT00237809|21058581|P4|STARTED|Overall Study||26
8541604|NCT00237809|21058582|P3|STARTED|Overall Study||24
8541605|NCT00237809|21058583|P2|STARTED|Overall Study||27
8541606|NCT00237809|21058584|P1|STARTED|Overall Study||27
8541607|NCT00237796|21058620|P2|NOT COMPLETED|Overall Study||5
8541608|NCT00237796|21058621|P1|NOT COMPLETED|Overall Study||10
8541609|NCT00237796|21058620|P2|COMPLETED|Overall Study||33
8541610|NCT00237796|21058621|P1|COMPLETED|Overall Study||31
8541611|NCT00237796|21058620|P2|STARTED|Overall Study||38
8541612|NCT00237796|21058621|P1|STARTED|Overall Study||41
8541613|NCT00237770|21058641|P2|NOT COMPLETED|Overall Study||0
8541614|NCT00237770|21058642|P1|NOT COMPLETED|Overall Study||0
8541615|NCT00237770|21058641|P2|COMPLETED|Overall Study||7
8541616|NCT00237770|21058642|P1|COMPLETED|Overall Study||9
8541617|NCT00237770|21058641|P2|STARTED|Overall Study||7
8541618|NCT00237770|21058642|P1|STARTED|Overall Study||9
8541619|NCT00237744|21058655|P3|NOT COMPLETED|Overall Study||0
8541620|NCT00237744|21058656|P2|NOT COMPLETED|Overall Study||1
8541621|NCT00237744|21058657|P1|NOT COMPLETED|Overall Study||3
8541622|NCT00237744|21058655|P3|COMPLETED|Overall Study||18
8541623|NCT00237744|21058656|P2|COMPLETED|Overall Study||10
8541624|NCT00237744|21058657|P1|COMPLETED|Overall Study||8
8541625|NCT00237744|21058655|P3|STARTED|Overall Study||18
8541626|NCT00237744|21058656|P2|STARTED|Overall Study||11
8541627|NCT00237744|21058657|P1|STARTED|Overall Study||11
8541628|NCT00237718|21058670|P2|NOT COMPLETED|Overall Study||41
8541629|NCT00237718|21058671|P1|NOT COMPLETED|Overall Study||46
8541630|NCT00237718|21058670|P2|COMPLETED|Overall Study||124
8541631|NCT00237718|21058671|P1|COMPLETED|Overall Study||114
8541632|NCT00237718|21058670|P2|STARTED|Overall Study||165
8541633|NCT00237718|21058671|P1|STARTED|Overall Study||160
8541634|NCT00237692|21058683|P4|NOT COMPLETED|Overall Study||19
8541635|NCT00237692|21058684|P3|NOT COMPLETED|Overall Study||22
8541636|NCT00237692|21058685|P2|NOT COMPLETED|Overall Study||14
8541637|NCT00237692|21058686|P1|NOT COMPLETED|Overall Study||18
8541638|NCT00237692|21058683|P4|COMPLETED|Overall Study||128
8541639|NCT00237692|21058684|P3|COMPLETED|Overall Study||127
8541640|NCT00237692|21058685|P2|COMPLETED|Overall Study||134
8541641|NCT00237692|21058686|P1|COMPLETED|Overall Study||129
8541642|NCT00237692|21058683|P4|18 Month f/u|Overall Study||122
8541643|NCT00237692|21058684|P3|18 Month f/u|Overall Study||126
8541644|NCT00237692|21058685|P2|18 Month f/u|Overall Study||131
8541645|NCT00237692|21058686|P1|18 Month f/u|Overall Study||124
8541646|NCT00237692|21058683|P4|12 Month f/u|Overall Study||127
8541647|NCT00237692|21058684|P3|12 Month f/u|Overall Study||132
8541648|NCT00237692|21058685|P2|12 Month f/u|Overall Study||127
8541649|NCT00237692|21058686|P1|12 Month f/u|Overall Study||137
8541650|NCT00237692|21058683|P4|6 Month f/u|Overall Study||134
8541651|NCT00237692|21058684|P3|6 Month f/u|Overall Study||135
8541652|NCT00237692|21058685|P2|6 Month f/u|Overall Study||134
8541653|NCT00237692|21058686|P1|6 Month f/u|Overall Study||132
8541654|NCT00237692|21058683|P4|STARTED|Overall Study||147
8541655|NCT00237692|21058684|P3|STARTED|Overall Study||149
8541656|NCT00237692|21058685|P2|STARTED|Overall Study||148
8541657|NCT00237692|21058686|P1|STARTED|Overall Study||147
8541658|NCT00237666|21058716|P1|NOT COMPLETED|Overall Study||6
8541659|NCT00237666|21058716|P1|COMPLETED|Overall Study||24
8541660|NCT00237666|21058716|P1|STARTED|Overall Study||30
8541661|NCT00237458|21058726|P1|NOT COMPLETED|Overall Study||3
8541662|NCT00237458|21058726|P1|COMPLETED|Overall Study||4
8541663|NCT00237458|21058726|P1|STARTED|Overall Study||7
8541664|NCT00237185|21058744|P2|NOT COMPLETED|Extension||19
8541665|NCT00237185|21058745|P1|NOT COMPLETED|Extension||16
8541666|NCT00237185|21058744|P2|COMPLETED|Extension||13
8541667|NCT00237185|21058745|P1|COMPLETED|Extension||8
8541668|NCT00237185|21058744|P2|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
8541669|NCT00237185|21058745|P1|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
8541670|NCT00237185|21058744|P2|NOT COMPLETED|Core||37
8541671|NCT00237185|21058745|P1|NOT COMPLETED|Core||44
8541672|NCT00237185|21058744|P2|COMPLETED|Core||37
8541673|NCT00237185|21058745|P1|COMPLETED|Core||30
8541674|NCT00237185|21058744|P2|Treated Participants|Core||74
8541675|NCT00237185|21058745|P1|Treated Participants|Core||73
8541676|NCT00237185|21058744|P2|STARTED|Core||74
8541677|NCT00237185|21058745|P1|STARTED|Core||74
8541678|NCT00237042|21058776|P3|NOT COMPLETED|Long Term (12 Month) Follow up||9
8541679|NCT00237042|21058777|P2|NOT COMPLETED|Long Term (12 Month) Follow up||9
8541680|NCT00237042|21058778|P1|NOT COMPLETED|Long Term (12 Month) Follow up||11
8541681|NCT00237042|21058776|P3|COMPLETED|Long Term (12 Month) Follow up||48
8541682|NCT00237042|21058777|P2|COMPLETED|Long Term (12 Month) Follow up||46
8541683|NCT00237042|21058778|P1|COMPLETED|Long Term (12 Month) Follow up||48
8541684|NCT00237042|21058776|P3|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
8541685|NCT00237042|21058777|P2|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
8541686|NCT00237042|21058778|P1|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
8541687|NCT00237042|21058776|P3|NOT COMPLETED|Short Term (6 Month) Follow up||11
8541688|NCT00237042|21058777|P2|NOT COMPLETED|Short Term (6 Month) Follow up||8
8541689|NCT00237042|21058778|P1|NOT COMPLETED|Short Term (6 Month) Follow up||9
8541690|NCT00237042|21058776|P3|COMPLETED|Short Term (6 Month) Follow up||46
8541691|NCT00237042|21058777|P2|COMPLETED|Short Term (6 Month) Follow up||47
8541692|NCT00237042|21058778|P1|COMPLETED|Short Term (6 Month) Follow up||50
8541693|NCT00237042|21058776|P3|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
8541694|NCT00237042|21058777|P2|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
8541695|NCT00237042|21058778|P1|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
8541696|NCT00237042|21058776|P3|NOT COMPLETED|Treatment||38
8541697|NCT00237042|21058777|P2|NOT COMPLETED|Treatment||7
8541698|NCT00237042|21058778|P1|NOT COMPLETED|Treatment||6
8541699|NCT00237042|21058776|P3|COMPLETED|Treatment||36
8541700|NCT00237042|21058777|P2|COMPLETED|Treatment||50
8541701|NCT00237042|21058778|P1|COMPLETED|Treatment||54
8541702|NCT00237042|21058776|P3|STARTED|Treatment||74
8541703|NCT00237042|21058777|P2|STARTED|Treatment||57
8541704|NCT00237042|21058778|P1|STARTED|Treatment||60
8541705|NCT00236977|21058797|P2|NOT COMPLETED|Overall Study||19
8541706|NCT00236977|21058798|P1|NOT COMPLETED|Overall Study||21
8541707|NCT00236977|21058797|P2|COMPLETED|Overall Study||72
8541708|NCT00236977|21058798|P1|COMPLETED|Overall Study||70
8541709|NCT00236977|21058797|P2|STARTED|Overall Study||91
8541710|NCT00236977|21058798|P1|STARTED|Overall Study||91
8541711|NCT00236951|21058820|P4|NOT COMPLETED|Overall Study||31
8541712|NCT00236951|21058821|P3|NOT COMPLETED|Overall Study||19
8541713|NCT00236951|21058822|P2|NOT COMPLETED|Overall Study||31
8541714|NCT00236951|21058823|P1|NOT COMPLETED|Overall Study||26
8541715|NCT00236951|21058820|P4|COMPLETED|Overall Study||17
8541716|NCT00236951|21058821|P3|COMPLETED|Overall Study||21
8541717|NCT00236951|21058822|P2|COMPLETED|Overall Study||46
8541718|NCT00236951|21058823|P1|COMPLETED|Overall Study||33
8541719|NCT00236951|21058820|P4|STARTED|Overall Study||48
8541720|NCT00236951|21058821|P3|STARTED|Overall Study||40
8541721|NCT00236951|21058822|P2|STARTED|Overall Study||77
8541722|NCT00236951|21058823|P1|STARTED|Overall Study||59
8541729|NCT00236899|21058852|P4|NOT COMPLETED|Overall Study||40
8541730|NCT00236899|21058853|P3|NOT COMPLETED|Overall Study||44
8541731|NCT00236899|21058854|P2|NOT COMPLETED|Overall Study||40
8541732|NCT00236899|21058855|P1|NOT COMPLETED|Overall Study||42
8541733|NCT00236899|21058852|P4|COMPLETED|Overall Study||19
8541734|NCT00236899|21058853|P3|COMPLETED|Overall Study||14
8541735|NCT00236899|21058854|P2|COMPLETED|Overall Study||24
8541736|NCT00236899|21058855|P1|COMPLETED|Overall Study||18
8541737|NCT00236899|21058852|P4|STARTED|Overall Study||59
8541738|NCT00236899|21058853|P3|STARTED|Overall Study||58
8541739|NCT00236899|21058854|P2|STARTED|Overall Study||64
8541740|NCT00236899|21058855|P1|STARTED|Overall Study||60
8541741|NCT00236197|21058887|P2|NOT COMPLETED|Overall Study||14
8541742|NCT00236197|21058888|P1|NOT COMPLETED|Overall Study||5
8541743|NCT00236197|21058887|P2|COMPLETED|Overall Study||293
8541744|NCT00236197|21058888|P1|COMPLETED|Overall Study||307
8541745|NCT00236197|21058887|P2|STARTED|Overall Study||307
8541746|NCT00236197|21058888|P1|STARTED|Overall Study||312
8541747|NCT00236184|21058896|P2|NOT COMPLETED|Overall Study||11
8541748|NCT00236184|21058897|P1|NOT COMPLETED|Overall Study||18
8541749|NCT00236184|21058896|P2|COMPLETED|Overall Study||308
8541750|NCT00236184|21058897|P1|COMPLETED|Overall Study||292
8541751|NCT00236184|21058896|P2|STARTED|Overall Study||319
8541752|NCT00236184|21058897|P1|STARTED|Overall Study||310
8541753|NCT00236080|21058908|P5|NOT COMPLETED|Overall Study||1
8541754|NCT00236080|21058909|P4|NOT COMPLETED|Overall Study||2
8541755|NCT00236080|21058910|P3|NOT COMPLETED|Overall Study||5
8541756|NCT00236080|21058911|P2|NOT COMPLETED|Overall Study||1
8541757|NCT00236080|21058912|P1|NOT COMPLETED|Overall Study||2
8541758|NCT00236080|21058908|P5|COMPLETED|Overall Study||26
8541759|NCT00236080|21058909|P4|COMPLETED|Overall Study||23
8541760|NCT00236080|21058910|P3|COMPLETED|Overall Study||22
8541761|NCT00236080|21058911|P2|COMPLETED|Overall Study||27
8541762|NCT00236080|21058912|P1|COMPLETED|Overall Study||27
8541763|NCT00236080|21058908|P5|STARTED|Overall Study||27
8541764|NCT00236080|21058909|P4|STARTED|Overall Study||25
8541765|NCT00236080|21058910|P3|STARTED|Overall Study||27
8541766|NCT00236080|21058911|P2|STARTED|Overall Study||28
8541767|NCT00236080|21058912|P1|STARTED|Overall Study||29
8541768|NCT00235989|21058933|P6|NOT COMPLETED|Extension Treatment Period (ET)||0
8541769|NCT00235989|21058934|P5|NOT COMPLETED|Extension Treatment Period (ET)||0
8541770|NCT00235989|21058935|P4|NOT COMPLETED|Extension Treatment Period (ET)||6
8541771|NCT00235989|21058936|P3|NOT COMPLETED|Extension Treatment Period (ET)||5
8541772|NCT00235989|21058937|P2|NOT COMPLETED|Extension Treatment Period (ET)||4
8541773|NCT00235989|21058938|P1|NOT COMPLETED|Extension Treatment Period (ET)||8
8541774|NCT00235989|21058933|P6|COMPLETED|Extension Treatment Period (ET)||0
8541775|NCT00235989|21058934|P5|COMPLETED|Extension Treatment Period (ET)||0
8541776|NCT00235989|21058935|P4|COMPLETED|Extension Treatment Period (ET)||14
8541777|NCT00235989|21058936|P3|COMPLETED|Extension Treatment Period (ET)||14
8541778|NCT00235989|21058937|P2|COMPLETED|Extension Treatment Period (ET)||2
8541779|NCT00235989|21058938|P1|COMPLETED|Extension Treatment Period (ET)||8
8541780|NCT00235989|21058933|P6|STARTED|Extension Treatment Period (ET)||0
8541781|NCT00235989|21058934|P5|STARTED|Extension Treatment Period (ET)||0
8541782|NCT00235989|21058935|P4|STARTED|Extension Treatment Period (ET)||20
8541783|NCT00235989|21058936|P3|STARTED|Extension Treatment Period (ET)||19
8541784|NCT00235989|21058937|P2|STARTED|Extension Treatment Period (ET)||6
8541785|NCT00235989|21058938|P1|STARTED|Extension Treatment Period (ET)||16
8541786|NCT00235989|21058933|P6|NOT COMPLETED|Core Treatment Period (CT)||2
8541787|NCT00235989|21058934|P5|NOT COMPLETED|Core Treatment Period (CT)||0
8541788|NCT00235989|21058935|P4|NOT COMPLETED|Core Treatment Period (CT)||0
8541789|NCT00235989|21058936|P3|NOT COMPLETED|Core Treatment Period (CT)||0
8541790|NCT00235989|21058937|P2|NOT COMPLETED|Core Treatment Period (CT)||0
8541791|NCT00235989|21058938|P1|NOT COMPLETED|Core Treatment Period (CT)||0
8541792|NCT00235989|21058933|P6|COMPLETED|Core Treatment Period (CT)||25
8541793|NCT00235989|21058934|P5|COMPLETED|Core Treatment Period (CT)||36
8541794|NCT00235989|21058935|P4|COMPLETED|Core Treatment Period (CT)||0
8541795|NCT00235989|21058936|P3|COMPLETED|Core Treatment Period (CT)||0
8541796|NCT00235989|21058937|P2|COMPLETED|Core Treatment Period (CT)||0
8541797|NCT00235989|21058938|P1|COMPLETED|Core Treatment Period (CT)||0
8541798|NCT00235989|21058933|P6|STARTED|Core Treatment Period (CT)||27
8541799|NCT00235989|21058934|P5|STARTED|Core Treatment Period (CT)||36
8541800|NCT00235989|21058935|P4|STARTED|Core Treatment Period (CT)||0
8541801|NCT00235989|21058936|P3|STARTED|Core Treatment Period (CT)||0
8541802|NCT00235989|21058937|P2|STARTED|Core Treatment Period (CT)||0
8541803|NCT00235989|21058938|P1|STARTED|Core Treatment Period (CT)||0
8541804|NCT00235872|21058952|P1|NOT COMPLETED|Overall Study||147
8541805|NCT00235872|21058952|P1|COMPLETED|Overall Study||162
8541806|NCT00235872|21058952|P1|STARTED|Overall Study||309
8541807|NCT00235833|21058967|P1|NOT COMPLETED|Overall Study||16
8541808|NCT00235833|21058967|P1|COMPLETED|Overall Study||9
8541809|NCT00235833|21058967|P1|STARTED|Overall Study||25
8541810|NCT00235755|21058983|P3|NOT COMPLETED|12-Week Maintenance Phase||31
8541811|NCT00235755|21058984|P2|NOT COMPLETED|12-Week Maintenance Phase||27
8541812|NCT00235755|21058985|P1|NOT COMPLETED|12-Week Maintenance Phase||16
8541813|NCT00235755|21058983|P3|COMPLETED|12-Week Maintenance Phase||122
8541814|NCT00235755|21058984|P2|COMPLETED|12-Week Maintenance Phase||135
8541815|NCT00235755|21058985|P1|COMPLETED|12-Week Maintenance Phase||152
8541816|NCT00235755|21058983|P3|STARTED|12-Week Maintenance Phase||153
8541817|NCT00235755|21058984|P2|STARTED|12-Week Maintenance Phase||162
8541818|NCT00235755|21058985|P1|STARTED|12-Week Maintenance Phase||168
8541819|NCT00235755|21058983|P3|NOT COMPLETED|4-Week Titration Phase||26
8541820|NCT00235755|21058984|P2|NOT COMPLETED|4-Week Titration Phase||19
8541821|NCT00235755|21058985|P1|NOT COMPLETED|4-Week Titration Phase||11
8541822|NCT00235755|21058983|P3|COMPLETED|4-Week Titration Phase||153
8541823|NCT00235755|21058984|P2|COMPLETED|4-Week Titration Phase||162
8541824|NCT00235755|21058985|P1|COMPLETED|4-Week Titration Phase||168
8541825|NCT00235755|21058983|P3|STARTED|4-Week Titration Phase||179
8541826|NCT00235755|21058984|P2|STARTED|4-Week Titration Phase||181
8541827|NCT00235755|21058985|P1|STARTED|4-Week Titration Phase||179
8541828|NCT00235716|21059063|P4|NOT COMPLETED|Overall Study||62
8541829|NCT00235716|21059064|P3|NOT COMPLETED|Overall Study||65
8541830|NCT00235716|21059065|P2|NOT COMPLETED|Overall Study||67
8541831|NCT00235716|21059066|P1|NOT COMPLETED|Overall Study||62
8541832|NCT00235716|21059063|P4|COMPLETED|Overall Study||90
8541833|NCT00235716|21059064|P3|COMPLETED|Overall Study||89
8541834|NCT00235716|21059065|P2|COMPLETED|Overall Study||88
8541835|NCT00235716|21059066|P1|COMPLETED|Overall Study||90
8541836|NCT00235716|21059063|P4|STARTED|Overall Study||152
8541837|NCT00235716|21059064|P3|STARTED|Overall Study||154
8541838|NCT00235716|21059065|P2|STARTED|Overall Study||155
8541839|NCT00235716|21059066|P1|STARTED|Overall Study||152
8541840|NCT00235573|21059100|P1|NOT COMPLETED|Overall Study||0
8541841|NCT00235573|21059100|P1|COMPLETED|Overall Study||21
8541842|NCT00235573|21059100|P1|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
8541843|NCT00235547|21059106|P2|NOT COMPLETED|6 Month Follow-up Survey||68
8541844|NCT00235547|21059107|P1|NOT COMPLETED|6 Month Follow-up Survey||71
8541845|NCT00235547|21059106|P2|COMPLETED|6 Month Follow-up Survey||76
8541846|NCT00235547|21059107|P1|COMPLETED|6 Month Follow-up Survey||83
8541847|NCT00235547|21059106|P2|STARTED|6 Month Follow-up Survey||144
8541848|NCT00235547|21059107|P1|STARTED|6 Month Follow-up Survey||154
8541849|NCT00235547|21059106|P2|NOT COMPLETED|2 Month Follow-up Survey||40
8541850|NCT00235547|21059107|P1|NOT COMPLETED|2 Month Follow-up Survey||46
8541851|NCT00235547|21059106|P2|COMPLETED|2 Month Follow-up Survey||104
8541852|NCT00235547|21059107|P1|COMPLETED|2 Month Follow-up Survey||108
8541853|NCT00235547|21059106|P2|STARTED|2 Month Follow-up Survey||144
8541854|NCT00235547|21059107|P1|STARTED|2 Month Follow-up Survey||154
8541855|NCT00235495|21059117|P2|NOT COMPLETED|Overall Study||68
8541856|NCT00235495|21059118|P1|NOT COMPLETED|Overall Study||68
8541857|NCT00235495|21059117|P2|COMPLETED|Overall Study||351
8541858|NCT00235495|21059118|P1|COMPLETED|Overall Study||354
8541859|NCT00235495|21059117|P2|STARTED|Overall Study||419
8541860|NCT00235495|21059118|P1|STARTED|Overall Study||422
8541861|NCT00235456|21059168|P2|NOT COMPLETED|Overall Study||7
8541862|NCT00235456|21059169|P1|NOT COMPLETED|Overall Study||2
8541863|NCT00235456|21059168|P2|COMPLETED|Overall Study||143
8541864|NCT00235456|21059169|P1|COMPLETED|Overall Study||148
8541865|NCT00235456|21059168|P2|STARTED|Overall Study||150
8541866|NCT00235456|21059169|P1|STARTED|Overall Study||150
8541867|NCT00235443|21059191|P6|NOT COMPLETED|Overall Study||45
8541868|NCT00235443|21059192|P5|NOT COMPLETED|Overall Study||30
8541869|NCT00235443|21059193|P4|NOT COMPLETED|Overall Study||97
8541870|NCT00235443|21059194|P3|NOT COMPLETED|Overall Study||62
8541871|NCT00235443|21059195|P2|NOT COMPLETED|Overall Study||38
8541872|NCT00235443|21059196|P1|NOT COMPLETED|Overall Study||8
8541873|NCT00235443|21059191|P6|COMPLETED|Overall Study||9
8541874|NCT00235443|21059192|P5|COMPLETED|Overall Study||9
8541875|NCT00235443|21059193|P4|COMPLETED|Overall Study||108
8541876|NCT00235443|21059194|P3|COMPLETED|Overall Study||23
8541877|NCT00235443|21059195|P2|COMPLETED|Overall Study||19
8541878|NCT00235443|21059196|P1|COMPLETED|Overall Study||3
8541879|NCT00235443|21059191|P6|STARTED|Overall Study||54
8541880|NCT00235443|21059192|P5|STARTED|Overall Study||39
8541881|NCT00235443|21059193|P4|STARTED|Overall Study||205
8541882|NCT00235443|21059194|P3|STARTED|Overall Study||85
8541883|NCT00235443|21059195|P2|STARTED|Overall Study||57
8541884|NCT00235443|21059196|P1|STARTED|Overall Study||11
8541885|NCT00235391|21059337|P6|NOT COMPLETED|Overall Study||4
8541886|NCT00235391|21059338|P5|NOT COMPLETED|Overall Study||12
8541887|NCT00235391|21059339|P4|NOT COMPLETED|Overall Study||220
8541888|NCT00235391|21059340|P3|NOT COMPLETED|Overall Study||24
8541889|NCT00235391|21059341|P2|NOT COMPLETED|Overall Study||18
8541890|NCT00235391|21059342|P1|NOT COMPLETED|Overall Study||12
8541891|NCT00235391|21059337|P6|COMPLETED|Overall Study||3
8541892|NCT00235391|21059338|P5|COMPLETED|Overall Study||31
8541893|NCT00235391|21059339|P4|COMPLETED|Overall Study||944
8541894|NCT00235391|21059340|P3|COMPLETED|Overall Study||148
8541895|NCT00235391|21059341|P2|COMPLETED|Overall Study||182
8541896|NCT00235391|21059342|P1|COMPLETED|Overall Study||85
8541897|NCT00235391|21059337|P6|Deferasirox Treatment|Overall Study||7
8541898|NCT00235391|21059338|P5|Deferasirox Treatment|Overall Study||43
8541899|NCT00235391|21059339|P4|Deferasirox Treatment|Overall Study||1164
8541900|NCT00235391|21059340|P3|Deferasirox Treatment|Overall Study||172
8541901|NCT00235391|21059341|P2|Deferasirox Treatment|Overall Study||200
8541902|NCT00235391|21059342|P1|Deferasirox Treatment|Overall Study||97
8541903|NCT00235391|21059337|P6|STARTED|Overall Study||7
8541904|NCT00235391|21059338|P5|STARTED|Overall Study||43
8541905|NCT00235391|21059339|P4|STARTED|Overall Study||1164
8541906|NCT00235391|21059340|P3|STARTED|Overall Study||172
8541907|NCT00235391|21059341|P2|STARTED|Overall Study||200
8541908|NCT00235391|21059342|P1|STARTED|Overall Study||97
8541909|NCT00235326|21059359|P2|NOT COMPLETED|Overall Study||1400
8541910|NCT00235326|21059360|P1|NOT COMPLETED|Overall Study||746
8541911|NCT00235326|21059359|P2|COMPLETED|Overall Study||1586
8541912|NCT00235326|21059360|P1|COMPLETED|Overall Study||829
8541913|NCT00235326|21059359|P2|STARTED|Overall Study||2986
8541914|NCT00235326|21059360|P1|STARTED|Overall Study||1575
8541915|NCT00234884|21059364|P1|NOT COMPLETED|Overall Study||1630
8541916|NCT00234884|21059364|P1|COMPLETED|Overall Study||1805
8541917|NCT00234884|21059364|P1|STARTED|Overall Study||3435
8541918|NCT00234832|21059374|P2|NOT COMPLETED|Overall Study||996
8541919|NCT00234832|21059375|P1|NOT COMPLETED|Overall Study||1016
8541920|NCT00234832|21059374|P2|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
8541921|NCT00234832|21059375|P1|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
8541922|NCT00234832|21059374|P2|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
8541923|NCT00234832|21059375|P1|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
8541924|NCT00234533|21059400|P1|NOT COMPLETED|Overall Study||11
8541925|NCT00234533|21059400|P1|COMPLETED|Overall Study||240
8541926|NCT00234533|21059400|P1|STARTED|Overall Study||251
8541927|NCT00234494|21059419|P1|NOT COMPLETED|Overall Study||2
8541928|NCT00234494|21059419|P1|COMPLETED|Overall Study||43
8541929|NCT00234494|21059419|P1|STARTED|Overall Study||45
8541930|NCT00234286|21059426|P1|NOT COMPLETED|Overall Study||0
8541931|NCT00234286|21059426|P1|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
8541932|NCT00234286|21059426|P1|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
8541933|NCT00234104|21059465|P4|NOT COMPLETED|Overall Study||8
8541934|NCT00234104|21059466|P3|NOT COMPLETED|Overall Study||5
8541935|NCT00234104|21059467|P2|NOT COMPLETED|Overall Study||1
8541936|NCT00234104|21059468|P1|NOT COMPLETED|Overall Study||4
8541937|NCT00234104|21059465|P4|COMPLETED|Overall Study||21
8541938|NCT00234104|21059466|P3|COMPLETED|Overall Study||29
8541939|NCT00234104|21059467|P2|COMPLETED|Overall Study||28
8541940|NCT00234104|21059468|P1|COMPLETED|Overall Study||26
8541941|NCT00234104|21059465|P4|STARTED|Overall Study||29
8541942|NCT00234104|21059466|P3|STARTED|Overall Study||34
8541943|NCT00234104|21059467|P2|STARTED|Overall Study||29
8541944|NCT00234104|21059468|P1|STARTED|Overall Study||30
8541945|NCT00234078|21059482|P4|NOT COMPLETED|Overall Study||4
8541946|NCT00234078|21059483|P3|NOT COMPLETED|Overall Study||10
8541947|NCT00234078|21059484|P2|NOT COMPLETED|Overall Study||9
8541948|NCT00234078|21059485|P1|NOT COMPLETED|Overall Study||6
8541949|NCT00234078|21059482|P4|COMPLETED|Overall Study||68
8541950|NCT00234078|21059483|P3|COMPLETED|Overall Study||64
8541951|NCT00234078|21059484|P2|COMPLETED|Overall Study||63
8541952|NCT00234078|21059485|P1|COMPLETED|Overall Study||66
8541953|NCT00234078|21059482|P4|STARTED|Overall Study||72
8541954|NCT00234078|21059483|P3|STARTED|Overall Study||74
8541955|NCT00234078|21059484|P2|STARTED|Overall Study||72
8541956|NCT00234078|21059485|P1|STARTED|Overall Study||72
8541957|NCT00234065|21059509|P2|NOT COMPLETED|Overall Study||356
8541958|NCT00234065|21059510|P1|NOT COMPLETED|Overall Study||475
8541959|NCT00234065|21059509|P2|COMPLETED|Overall Study||1004
8541960|NCT00234065|21059510|P1|COMPLETED|Overall Study||881
8541961|NCT00234065|21059509|P2|STARTED|Overall Study||1360
8541962|NCT00234065|21059510|P1|STARTED|Overall Study||1356
8541963|NCT00234052|21059526|P1|NOT COMPLETED|Follow-up for 5 Years||49
8541964|NCT00234052|21059526|P1|COMPLETED|Follow-up for 5 Years||1
8541965|NCT00234052|21059526|P1|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50
8541966|NCT00234052|21059526|P1|NOT COMPLETED|Treatment||21
8541967|NCT00234052|21059526|P1|COMPLETED|Treatment||30
8541968|NCT00234052|21059526|P1|Went Into Maintenance Phase|Treatment||30
8541969|NCT00234052|21059526|P1|Completed 6 Cycles|Treatment||33
8541970|NCT00234052|21059526|P1|Started Treatment|Treatment||50
8541971|NCT00234052|21059526|P1|STARTED|Treatment||51
8541972|NCT00234039|21059536|P1|NOT COMPLETED|Overall Study||50
8541973|NCT00234039|21059536|P1|COMPLETED|Overall Study||8
8541974|NCT00234039|21059536|P1|Eligible and Began Protocol Therapy|Overall Study||47
8541975|NCT00234039|21059536|P1|Eligible|Overall Study||49
8541976|NCT00234039|21059536|P1|STARTED|Overall Study||58
8541977|NCT00233987|21059543|P1|NOT COMPLETED|Overall Study||15
8541978|NCT00233987|21059543|P1|COMPLETED|Overall Study||83
8541979|NCT00233987|21059543|P1|Eligible and Treated|Overall Study||92
8541980|NCT00233987|21059543|P1|Eligible|Overall Study||94
8541981|NCT00233987|21059543|P1|STARTED|Overall Study||98
8541982|NCT00233948|21059552|P6|NOT COMPLETED|Overall Study||0
8541983|NCT00233948|21059553|P5|NOT COMPLETED|Overall Study||0
8541984|NCT00233948|21059554|P4|NOT COMPLETED|Overall Study||0
8541985|NCT00233948|21059555|P3|NOT COMPLETED|Overall Study||0
8541986|NCT00233948|21059556|P2|NOT COMPLETED|Overall Study||0
8541987|NCT00233948|21059557|P1|NOT COMPLETED|Overall Study||1
8541988|NCT00233948|21059552|P6|COMPLETED|Overall Study||12
8541989|NCT00233948|21059553|P5|COMPLETED|Overall Study||4
8541990|NCT00233948|21059554|P4|COMPLETED|Overall Study||3
8541991|NCT00233948|21059555|P3|COMPLETED|Overall Study||3
8541992|NCT00233948|21059556|P2|COMPLETED|Overall Study||3
8541993|NCT00233948|21059557|P1|COMPLETED|Overall Study||3
8541994|NCT00233948|21059552|P6|STARTED|Overall Study||12
8541995|NCT00233948|21059553|P5|STARTED|Overall Study||4
8541996|NCT00233948|21059554|P4|STARTED|Overall Study||3
8541997|NCT00233948|21059555|P3|STARTED|Overall Study||3
8541998|NCT00233948|21059556|P2|STARTED|Overall Study||3
8541999|NCT00233948|21059557|P1|STARTED|Overall Study||4
8542000|NCT00233519|21059574|P2|NOT COMPLETED|Overall Study||1
8542001|NCT00233519|21059575|P1|NOT COMPLETED|Overall Study||1
8542002|NCT00233519|21059574|P2|COMPLETED|Overall Study||9
8542003|NCT00233519|21059575|P1|COMPLETED|Overall Study||6
8542004|NCT00233519|21059574|P2|STARTED|Overall Study||10
8542005|NCT00233519|21059575|P1|STARTED|Overall Study||7
8542006|NCT00233480|21059583|P2|NOT COMPLETED|Overall Study||1
8542007|NCT00233480|21059584|P1|NOT COMPLETED|Overall Study||0
8542008|NCT00233480|21059583|P2|COMPLETED|Overall Study||12
8542009|NCT00233480|21059584|P1|COMPLETED|Overall Study||14
8542010|NCT00233480|21059583|P2|STARTED|Overall Study||13
8542011|NCT00233480|21059584|P1|STARTED|Overall Study||14
8542012|NCT00233454|21059600|P1|NOT COMPLETED|Overall Study||6
8542013|NCT00233454|21059600|P1|COMPLETED|Overall Study||20
8542014|NCT00233454|21059600|P1|2 Months (for Response Rate)|Overall Study||26
8542015|NCT00233454|21059600|P1|STARTED|Overall Study||26
8542016|NCT00233402|21059608|P2|NOT COMPLETED|Overall Study||124
8542017|NCT00233402|21059609|P1|NOT COMPLETED|Overall Study||104
8542018|NCT00233402|21059608|P2|COMPLETED|Overall Study||271
8542019|NCT00233402|21059609|P1|COMPLETED|Overall Study||280
8542020|NCT00233402|21059608|P2|STARTED|Overall Study||395
8542021|NCT00233402|21059609|P1|STARTED|Overall Study||384
8542022|NCT00233324|21059624|P4|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
8542023|NCT00233324|21059625|P3|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
8542024|NCT00233324|21059626|P2|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
8542025|NCT00233324|21059627|P1|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
8542026|NCT00233324|21059624|P4|COMPLETED|Follow up at 18-22 Months Corrected Age||269
8542027|NCT00233324|21059625|P3|COMPLETED|Follow up at 18-22 Months Corrected Age||256
8542028|NCT00233324|21059626|P2|COMPLETED|Follow up at 18-22 Months Corrected Age||261
8542029|NCT00233324|21059627|P1|COMPLETED|Follow up at 18-22 Months Corrected Age||237
8542030|NCT00233324|21059624|P4|STARTED|Follow up at 18-22 Months Corrected Age||280
8542031|NCT00233324|21059625|P3|STARTED|Follow up at 18-22 Months Corrected Age||274
8542032|NCT00233324|21059626|P2|STARTED|Follow up at 18-22 Months Corrected Age||275
8542033|NCT00233324|21059627|P1|STARTED|Follow up at 18-22 Months Corrected Age||250
8542034|NCT00233324|21059624|P4|NOT COMPLETED|Main Study||47
8542035|NCT00233324|21059625|P3|NOT COMPLETED|Main Study||62
8542036|NCT00233324|21059626|P2|NOT COMPLETED|Main Study||60
8542037|NCT00233324|21059627|P1|NOT COMPLETED|Main Study||68
8542038|NCT00233324|21059624|P4|COMPLETED|Main Study||280
8542039|NCT00233324|21059625|P3|COMPLETED|Main Study||274
8542040|NCT00233324|21059626|P2|COMPLETED|Main Study||275
8542041|NCT00233324|21059627|P1|COMPLETED|Main Study||250
8542042|NCT00233324|21059624|P4|STARTED|Main Study||327
8542043|NCT00233324|21059625|P3|STARTED|Main Study||336
8542044|NCT00233324|21059626|P2|STARTED|Main Study||335
8542045|NCT00233324|21059627|P1|STARTED|Main Study||318
8542046|NCT00233103|21059711|P2|NOT COMPLETED|Overall Study||6
8542047|NCT00233103|21059712|P1|NOT COMPLETED|Overall Study||5
8542048|NCT00233103|21059711|P2|COMPLETED|Overall Study||19
8542049|NCT00233103|21059712|P1|COMPLETED|Overall Study||22
8542050|NCT00233103|21059711|P2|STARTED|Overall Study||25
8542051|NCT00233103|21059712|P1|STARTED|Overall Study||27
8542052|NCT00233090|21059726|P2|NOT COMPLETED|Overall Study||0
8542053|NCT00233090|21059727|P1|NOT COMPLETED|Overall Study||0
8542054|NCT00233090|21059726|P2|COMPLETED|Overall Study||9
8542055|NCT00233090|21059727|P1|COMPLETED|Overall Study||12
8542056|NCT00233090|21059726|P2|STARTED|Overall Study||9
8542057|NCT00233090|21059727|P1|STARTED|Overall Study||12
8542058|NCT00233064|21059749|P2|NOT COMPLETED|Overall Study||12
8542059|NCT00233064|21059750|P1|NOT COMPLETED|Overall Study||14
8542060|NCT00233064|21059749|P2|COMPLETED|Overall Study||190
8542061|NCT00233064|21059750|P1|COMPLETED|Overall Study||197
8542062|NCT00233064|21059749|P2|STARTED|Overall Study||202
8542063|NCT00233064|21059750|P1|STARTED|Overall Study||211
8542064|NCT00232739|21059757|P1|NOT COMPLETED|Overall Study||9
8542065|NCT00232739|21059757|P1|COMPLETED|Overall Study||91
8542066|NCT00232739|21059757|P1|STARTED|Overall Study||100
8542067|NCT00232596|21059776|P2|NOT COMPLETED|12-Week Maintenance Phase||28
8542068|NCT00232596|21059777|P1|NOT COMPLETED|12-Week Maintenance Phase||12
8542069|NCT00232596|21059776|P2|COMPLETED|12-Week Maintenance Phase||97
8542070|NCT00232596|21059777|P1|COMPLETED|12-Week Maintenance Phase|"One participant withdrew after being considered a completer and is listed as an early withdraw."|126
8542071|NCT00232596|21059776|P2|STARTED|12-Week Maintenance Phase||125
8542072|NCT00232596|21059777|P1|STARTED|12-Week Maintenance Phase||138
8542073|NCT00232596|21059776|P2|NOT COMPLETED|6-Week Titration Phase||29
8542074|NCT00232596|21059777|P1|NOT COMPLETED|6-Week Titration Phase||14
8542075|NCT00232596|21059776|P2|COMPLETED|6-Week Titration Phase||125
8542076|NCT00232596|21059777|P1|COMPLETED|6-Week Titration Phase||138
8542077|NCT00232596|21059776|P2|STARTED|6-Week Titration Phase||154
8542078|NCT00232596|21059777|P1|STARTED|6-Week Titration Phase||152
8542079|NCT00232583|21059829|P2|NOT COMPLETED|Overall Study||13
8542080|NCT00232583|21059830|P1|NOT COMPLETED|Overall Study||10
8542081|NCT00232583|21059829|P2|COMPLETED|Overall Study||16
8542082|NCT00232583|21059830|P1|COMPLETED|Overall Study||19
8542083|NCT00232583|21059829|P2|STARTED|Overall Study||29
8542084|NCT00232583|21059830|P1|STARTED|Overall Study||29
8542085|NCT00232557|21059868|P2|NOT COMPLETED|Overall Study||5
8542086|NCT00232557|21059869|P1|NOT COMPLETED|Overall Study||3
8542087|NCT00232557|21059868|P2|COMPLETED|Overall Study||60
8542088|NCT00232557|21059869|P1|COMPLETED|Overall Study||68
8542089|NCT00232557|21059868|P2|STARTED|Overall Study||65
8542090|NCT00232557|21059869|P1|STARTED|Overall Study||71
8542091|NCT00232544|21059879|P2|NOT COMPLETED|Overall Study||15
8542092|NCT00232544|21059880|P1|NOT COMPLETED|Overall Study||20
8542093|NCT00232544|21059879|P2|COMPLETED|Overall Study||111
8542094|NCT00232544|21059880|P1|COMPLETED|Overall Study||104
8542095|NCT00232544|21059879|P2|STARTED|Overall Study||126
8542096|NCT00232544|21059880|P1|STARTED|Overall Study||124
8542097|NCT00232505|21059890|P2|NOT COMPLETED|Overall Study||11
8542098|NCT00232505|21059891|P1|NOT COMPLETED|Overall Study||5
8542099|NCT00232505|21059890|P2|COMPLETED|Overall Study||60
8542100|NCT00232505|21059891|P1|COMPLETED|Overall Study||26
8542101|NCT00232505|21059890|P2|Off Protocol|Overall Study||0
8542102|NCT00232505|21059891|P1|Off Protocol|Overall Study||5
8542103|NCT00232505|21059890|P2|Early Progressors|Overall Study||5
8542104|NCT00232505|21059891|P1|Early Progressors|Overall Study||2
8542105|NCT00232505|21059890|P2|Not Evaluable|Overall Study||6
8542106|NCT00232505|21059891|P1|Not Evaluable|Overall Study||0
8542107|NCT00232505|21059890|P2|STARTED|Overall Study||71
8542108|NCT00232505|21059891|P1|STARTED|Overall Study||31
8542109|NCT00232479|21059904|P1|NOT COMPLETED|Overall Study||0
8542110|NCT00232479|21059904|P1|COMPLETED|Overall Study||44
8542111|NCT00232479|21059904|P1|STARTED|Overall Study||44
8542112|NCT00232180|21059911|P3|NOT COMPLETED|Open Label Phase||148
8542113|NCT00232180|21059912|P2|NOT COMPLETED|Open Label Phase||0
8542114|NCT00232180|21059913|P1|NOT COMPLETED|Open Label Phase||0
8542115|NCT00232180|21059911|P3|COMPLETED|Open Label Phase||1098
8542116|NCT00232180|21059912|P2|COMPLETED|Open Label Phase||0
8542117|NCT00232180|21059913|P1|COMPLETED|Open Label Phase||0
8542118|NCT00232180|21059911|P3|Treated|Open Label Phase||1245
8542119|NCT00232180|21059912|P2|Treated|Open Label Phase||0
8542120|NCT00232180|21059913|P1|Treated|Open Label Phase||0
8542121|NCT00232180|21059911|P3|STARTED|Open Label Phase||1246
8542122|NCT00232180|21059912|P2|STARTED|Open Label Phase||0
8542123|NCT00232180|21059913|P1|STARTED|Open Label Phase||0
8542124|NCT00232180|21059911|P3|NOT COMPLETED|Double-blind (DB) Phase||0
8542125|NCT00232180|21059912|P2|NOT COMPLETED|Double-blind (DB) Phase||605
8542126|NCT00232180|21059913|P1|NOT COMPLETED|Double-blind (DB) Phase||541
8542127|NCT00232180|21059911|P3|COMPLETED|Double-blind (DB) Phase||0
8542128|NCT00232180|21059912|P2|COMPLETED|Double-blind (DB) Phase||771
8542129|NCT00232180|21059913|P1|COMPLETED|Double-blind (DB) Phase||826
8542130|NCT00232180|21059911|P3|Treated|Double-blind (DB) Phase||0
8542131|NCT00232180|21059912|P2|Treated|Double-blind (DB) Phase||1372
8542132|NCT00232180|21059913|P1|Treated|Double-blind (DB) Phase||1364
8542133|NCT00232180|21059911|P3|STARTED|Double-blind (DB) Phase||0
8542134|NCT00232180|21059912|P2|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
8542135|NCT00232180|21059913|P1|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
8542142|NCT00231894|21060029|P2|NOT COMPLETED|Overall Study||1
8542143|NCT00231894|21060030|P1|NOT COMPLETED|Overall Study||1
8542144|NCT00231894|21060029|P2|COMPLETED|Overall Study||24
8542145|NCT00231894|21060030|P1|COMPLETED|Overall Study||30
8542146|NCT00231894|21060029|P2|STARTED|Overall Study||25
8542147|NCT00231894|21060030|P1|STARTED|Overall Study||31
8542148|NCT00231868|21060052|P1|NOT COMPLETED|Overall Study||16
8542149|NCT00231868|21060052|P1|COMPLETED|Overall Study||65
8542150|NCT00231868|21060052|P1|STARTED|Overall Study||81
8542151|NCT00231842|21060056|P1|NOT COMPLETED|Overall Study||11
8542152|NCT00231842|21060056|P1|COMPLETED|Overall Study||19
8542153|NCT00231842|21060056|P1|Completed Full Prescribed Therapy|Overall Study||19
8542154|NCT00231842|21060056|P1|Completed Prescribed RT|Overall Study||27
8542155|NCT00231842|21060056|P1|Completed First 3 Cycles|Overall Study||27
8542156|NCT00231842|21060056|P1|Initiated Therapy|Overall Study||27
8542157|NCT00231842|21060056|P1|STARTED|Overall Study||30
8542158|NCT00231816|21060063|P2|NOT COMPLETED|Overall Study||12
8542159|NCT00231816|21060064|P1|NOT COMPLETED|Overall Study||16
8542160|NCT00231816|21060063|P2|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
8542161|NCT00231816|21060064|P1|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
8542162|NCT00231816|21060063|P2|Vaccinated at Visit 2|Overall Study||371
8542163|NCT00231816|21060064|P1|Vaccinated at Visit 2|Overall Study||369
8542164|NCT00231816|21060063|P2|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
8542165|NCT00231816|21060064|P1|Vaccinated at Visit 1|Overall Study||382
8542166|NCT00231816|21060063|P2|STARTED|Overall Study||381
8542167|NCT00231816|21060064|P1|STARTED|Overall Study||382
8542168|NCT00231777|21060079|P2|NOT COMPLETED|Overall Study||2
8542169|NCT00231777|21060080|P1|NOT COMPLETED|Overall Study||6
8542170|NCT00231777|21060079|P2|COMPLETED|Overall Study||44
8542171|NCT00231777|21060080|P1|COMPLETED|Overall Study||164
8542172|NCT00231777|21060079|P2|STARTED|Overall Study||46
8542173|NCT00231777|21060080|P1|STARTED|Overall Study||170
8542174|NCT00231478|21060094|P2|NOT COMPLETED|Overall Study||6
8542175|NCT00231478|21060095|P1|NOT COMPLETED|Overall Study||8
8542176|NCT00231478|21060094|P2|COMPLETED|Overall Study||78
8542177|NCT00231478|21060095|P1|COMPLETED|Overall Study||79
8542178|NCT00231478|21060094|P2|STARTED|Overall Study||84
8542179|NCT00231478|21060095|P1|STARTED|Overall Study||87
8542180|NCT00231465|21060107|P1|NOT COMPLETED|Overall Study||2
8542181|NCT00231465|21060107|P1|COMPLETED|Overall Study||42
8542182|NCT00231465|21060107|P1|STARTED|Overall Study||44
8542183|NCT00231413|21060120|P7|NOT COMPLETED|Overall Study||4
8542184|NCT00231413|21060121|P6|NOT COMPLETED|Overall Study||5
8542185|NCT00231413|21060122|P5|NOT COMPLETED|Overall Study||3
8542186|NCT00231413|21060123|P4|NOT COMPLETED|Overall Study||3
8542187|NCT00231413|21060124|P3|NOT COMPLETED|Overall Study||7
8542188|NCT00231413|21060125|P2|NOT COMPLETED|Overall Study||5
8542189|NCT00231413|21060126|P1|NOT COMPLETED|Overall Study||8
8542190|NCT00231413|21060120|P7|COMPLETED|Overall Study||46
8542191|NCT00231413|21060121|P6|COMPLETED|Overall Study||45
8542192|NCT00231413|21060122|P5|COMPLETED|Overall Study||45
8542193|NCT00231413|21060123|P4|COMPLETED|Overall Study||45
8542194|NCT00231413|21060124|P3|COMPLETED|Overall Study||42
8542195|NCT00231413|21060125|P2|COMPLETED|Overall Study||45
8542196|NCT00231413|21060126|P1|COMPLETED|Overall Study||80
8542197|NCT00231413|21060120|P7|STARTED|Overall Study||50
8542198|NCT00231413|21060121|P6|STARTED|Overall Study||50
8542199|NCT00231413|21060122|P5|STARTED|Overall Study||48
8542200|NCT00231413|21060123|P4|STARTED|Overall Study||48
8542201|NCT00231413|21060124|P3|STARTED|Overall Study||49
8542202|NCT00231413|21060125|P2|STARTED|Overall Study||50
8542203|NCT00231413|21060126|P1|STARTED|Overall Study||88
8542204|NCT00231309|21060282|P1|NOT COMPLETED|Overall Study||0
8542205|NCT00231309|21060282|P1|COMPLETED|Overall Study||10
8542206|NCT00231309|21060282|P1|STARTED|Overall Study||10
8542207|NCT00231283|21060287|P1|NOT COMPLETED|Overall Study||5
8542208|NCT00231283|21060287|P1|COMPLETED|Overall Study||95
8542209|NCT00231283|21060287|P1|STARTED|Overall Study||100
8542210|NCT00231179|21060296|P2|NOT COMPLETED|Overall Study||24
8542211|NCT00231179|21060297|P1|NOT COMPLETED|Overall Study||24
8542212|NCT00231179|21060296|P2|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
8542213|NCT00231179|21060297|P1|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
8542214|NCT00231179|21060296|P2|STARTED|Overall Study||150
8542215|NCT00231179|21060297|P1|STARTED|Overall Study||152
8542216|NCT00231153|21060313|P2|NOT COMPLETED|Overall Study||188
8542217|NCT00231153|21060314|P1|NOT COMPLETED|Overall Study||217
8542218|NCT00231153|21060313|P2|COMPLETED|Overall Study||720
8542219|NCT00231153|21060314|P1|COMPLETED|Overall Study||690
8542220|NCT00231153|21060313|P2|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
8542221|NCT00231153|21060314|P1|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
8542222|NCT00231114|21060324|P2|NOT COMPLETED|Post-Treatment Period||1
8542223|NCT00231114|21060325|P1|NOT COMPLETED|Post-Treatment Period||8
8542224|NCT00231114|21060324|P2|COMPLETED|Post-Treatment Period||97
8542225|NCT00231114|21060325|P1|COMPLETED|Post-Treatment Period||181
8542226|NCT00231114|21060324|P2|STARTED|Post-Treatment Period||98
8542227|NCT00231114|21060325|P1|STARTED|Post-Treatment Period||189
8542228|NCT00231114|21060324|P2|NOT COMPLETED|Treatment Period||0
8542229|NCT00231114|21060325|P1|NOT COMPLETED|Treatment Period||1
8542230|NCT00231114|21060324|P2|COMPLETED|Treatment Period||98
8542231|NCT00231114|21060325|P1|COMPLETED|Treatment Period||189
8542232|NCT00231114|21060324|P2|STARTED|Treatment Period||98
8542233|NCT00231114|21060325|P1|STARTED|Treatment Period||190
8542234|NCT00231114|21060324|P2|NOT COMPLETED|Randomized||3
8542235|NCT00231114|21060325|P1|NOT COMPLETED|Randomized||6
8542236|NCT00231114|21060324|P2|COMPLETED|Randomized||98
8542237|NCT00231114|21060325|P1|COMPLETED|Randomized||190
8542238|NCT00231114|21060324|P2|STARTED|Randomized||101
8542239|NCT00231114|21060325|P1|STARTED|Randomized||196
8542240|NCT00231062|21060361|P1|NOT COMPLETED|Overall Study||6
8542241|NCT00231062|21060361|P1|COMPLETED|Overall Study||109
8542242|NCT00231062|21060361|P1|STARTED|Overall Study||115
8542243|NCT00230971|21060369|P2|NOT COMPLETED|Baseline Participants||19
8542244|NCT00230971|21060370|P1|NOT COMPLETED|Baseline Participants||22
8542245|NCT00230971|21060369|P2|COMPLETED|Baseline Participants||216
8542246|NCT00230971|21060370|P1|COMPLETED|Baseline Participants||210
8542247|NCT00230971|21060369|P2|STARTED|Baseline Participants||235
8542248|NCT00230971|21060370|P1|STARTED|Baseline Participants||232
8542249|NCT00230971|21060369|P2|NOT COMPLETED|Randomization||3
8542250|NCT00230971|21060370|P1|NOT COMPLETED|Randomization||3
8542251|NCT00230971|21060369|P2|COMPLETED|Randomization||235
8542252|NCT00230971|21060370|P1|COMPLETED|Randomization||232
8542253|NCT00230971|21060369|P2|STARTED|Randomization||238
8542254|NCT00230971|21060370|P1|STARTED|Randomization||235
8542255|NCT00230802|21060384|P2|NOT COMPLETED|Overall Study||0
8542256|NCT00230802|21060385|P1|NOT COMPLETED|Overall Study||0
8542257|NCT00230802|21060384|P2|COMPLETED|Overall Study||23
8542258|NCT00230802|21060385|P1|COMPLETED|Overall Study||25
8542259|NCT00230802|21060384|P2|STARTED|Overall Study||23
8542260|NCT00230802|21060385|P1|STARTED|Overall Study||25
8542261|NCT00230737|21060398|P3|NOT COMPLETED|Overall Study||0
8542262|NCT00230737|21060399|P2|NOT COMPLETED|Overall Study||0
8542263|NCT00230737|21060400|P1|NOT COMPLETED|Overall Study||0
8542264|NCT00230737|21060398|P3|COMPLETED|Overall Study||8
8542265|NCT00230737|21060399|P2|COMPLETED|Overall Study||10
8542266|NCT00230737|21060400|P1|COMPLETED|Overall Study||9
8542267|NCT00230737|21060398|P3|STARTED|Overall Study||8
8542268|NCT00230737|21060399|P2|STARTED|Overall Study||10
8542269|NCT00230737|21060400|P1|STARTED|Overall Study||9
8542270|NCT00230282|21060408|P1|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
8542271|NCT00230282|21060408|P1|COMPLETED|Maintanence Therapy With Alemtuzumab||17
8542272|NCT00230282|21060408|P1|STARTED|Maintanence Therapy With Alemtuzumab||17
8542273|NCT00230282|21060408|P1|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
8542274|NCT00230282|21060408|P1|COMPLETED|Fludarabine + Cyclophosphamide||17
8542275|NCT00230282|21060408|P1|STARTED|Fludarabine + Cyclophosphamide||25
8542276|NCT00230178|21060416|P3|NOT COMPLETED|Overall Study||7
8542277|NCT00230178|21060417|P2|NOT COMPLETED|Overall Study||7
8542278|NCT00230178|21060418|P1|NOT COMPLETED|Overall Study||4
8542279|NCT00230178|21060416|P3|COMPLETED|Overall Study||86
8542280|NCT00230178|21060417|P2|COMPLETED|Overall Study||86
8542281|NCT00230178|21060418|P1|COMPLETED|Overall Study||90
8542282|NCT00230178|21060416|P3|Treated|Overall Study||91
8542283|NCT00230178|21060417|P2|Treated|Overall Study||92
8542284|NCT00230178|21060418|P1|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
8542285|NCT00230178|21060416|P3|STARTED|Overall Study||93
8542286|NCT00230178|21060417|P2|STARTED|Overall Study||93
8542287|NCT00230178|21060418|P1|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
8542288|NCT00230126|21060434|P2|NOT COMPLETED|Overall Study||1
8542289|NCT00230126|21060435|P1|NOT COMPLETED|Overall Study||2
8542290|NCT00230126|21060434|P2|COMPLETED|Overall Study||27
8542291|NCT00230126|21060435|P1|COMPLETED|Overall Study||28
8542292|NCT00230126|21060434|P2|STARTED|Overall Study||28
8542293|NCT00230126|21060435|P1|STARTED|Overall Study||30
8542294|NCT00230100|21060447|P2|NOT COMPLETED|Overall Study||0
8542295|NCT00230100|21060448|P1|NOT COMPLETED|Overall Study||0
8542296|NCT00230100|21060447|P2|COMPLETED|Overall Study||17
8542297|NCT00230100|21060448|P1|COMPLETED|Overall Study||29
8542298|NCT00230100|21060447|P2|STARTED|Overall Study||17
8542299|NCT00230100|21060448|P1|STARTED|Overall Study||29
8542300|NCT00230048|21060470|P2|NOT COMPLETED|Overall Study||18
8542301|NCT00230048|21060471|P1|NOT COMPLETED|Overall Study||13
8542302|NCT00230048|21060470|P2|COMPLETED|Overall Study||37
8542303|NCT00230048|21060471|P1|COMPLETED|Overall Study||39
8542304|NCT00230048|21060470|P2|Completed Intervention/Control Session|Overall Study||55
8542305|NCT00230048|21060471|P1|Completed Intervention/Control Session|Overall Study||52
8542306|NCT00230048|21060470|P2|STARTED|Overall Study||55
8542307|NCT00230048|21060471|P1|STARTED|Overall Study||52
8542308|NCT00230022|21060481|P2|NOT COMPLETED|Overall Study||0
8542309|NCT00230022|21060482|P1|NOT COMPLETED|Overall Study||0
8542310|NCT00230022|21060481|P2|COMPLETED|Overall Study||15
8542311|NCT00230022|21060482|P1|COMPLETED|Overall Study||15
8542312|NCT00230022|21060481|P2|STARTED|Overall Study||15
8542313|NCT00230022|21060482|P1|STARTED|Overall Study||15
8542314|NCT00230009|21060490|P2|NOT COMPLETED|Follow-up||26
8542315|NCT00230009|21060491|P1|NOT COMPLETED|Follow-up||31
8542316|NCT00230009|21060490|P2|COMPLETED|Follow-up||24
8542317|NCT00230009|21060491|P1|COMPLETED|Follow-up||19
8542318|NCT00230009|21060490|P2|STARTED|Follow-up||50
8542319|NCT00230009|21060491|P1|STARTED|Follow-up||50
8542320|NCT00230009|21060490|P2|NOT COMPLETED|Single Session Intervention/Control||0
8542321|NCT00230009|21060491|P1|NOT COMPLETED|Single Session Intervention/Control||0
8542322|NCT00230009|21060490|P2|COMPLETED|Single Session Intervention/Control||50
8542323|NCT00230009|21060491|P1|COMPLETED|Single Session Intervention/Control||50
8542324|NCT00230009|21060490|P2|STARTED|Single Session Intervention/Control||50
8542325|NCT00230009|21060491|P1|STARTED|Single Session Intervention/Control||50
8542326|NCT00229970|21060508|P3|NOT COMPLETED|Overall Study||0
8542327|NCT00229970|21060509|P2|NOT COMPLETED|Overall Study||0
8542328|NCT00229970|21060510|P1|NOT COMPLETED|Overall Study||0
8542329|NCT00229970|21060508|P3|COMPLETED|Overall Study||75
8542330|NCT00229970|21060509|P2|COMPLETED|Overall Study||72
8542331|NCT00229970|21060510|P1|COMPLETED|Overall Study||78
8542332|NCT00229970|21060508|P3|STARTED|Overall Study||75
8542333|NCT00229970|21060509|P2|STARTED|Overall Study||72
8542334|NCT00229970|21060510|P1|STARTED|Overall Study||78
8542335|NCT00229957|21060520|P2|NOT COMPLETED|Overall Study||12
8542336|NCT00229957|21060521|P1|NOT COMPLETED|Overall Study||20
8542337|NCT00229957|21060520|P2|COMPLETED|Overall Study||139
8542338|NCT00229957|21060521|P1|COMPLETED|Overall Study||132
8542339|NCT00229957|21060520|P2|STARTED|Overall Study||151
8542340|NCT00229957|21060521|P1|STARTED|Overall Study||152
8542341|NCT00229931|21060529|P2|NOT COMPLETED|Overall Study||2
8542342|NCT00229931|21060530|P1|NOT COMPLETED|Overall Study||4
8542343|NCT00229931|21060529|P2|COMPLETED|Overall Study||3
8542344|NCT00229931|21060530|P1|COMPLETED|Overall Study||2
8542345|NCT00229931|21060529|P2|STARTED|Overall Study||5
8542346|NCT00229931|21060530|P1|STARTED|Overall Study||6
8542347|NCT00229723|21060545|P7|NOT COMPLETED|Maintenance Phase||10
8542348|NCT00229723|21060546|P6|NOT COMPLETED|Maintenance Phase||19
8542349|NCT00229723|21060547|P5|NOT COMPLETED|Maintenance Phase||15
8542350|NCT00229723|21060548|P4|NOT COMPLETED|Maintenance Phase||17
8542351|NCT00229723|21060549|P3|NOT COMPLETED|Maintenance Phase||9
8542352|NCT00229723|21060550|P2|NOT COMPLETED|Maintenance Phase||14
8542353|NCT00229723|21060551|P1|NOT COMPLETED|Maintenance Phase||25
8542354|NCT00229723|21060545|P7|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
8542355|NCT00229723|21060546|P6|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
8542356|NCT00229723|21060547|P5|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
8542357|NCT00229723|21060548|P4|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
8542358|NCT00229723|21060549|P3|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
8542359|NCT00229723|21060550|P2|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
8542360|NCT00229723|21060551|P1|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
8542361|NCT00229723|21060545|P7|STARTED|Maintenance Phase||19
8542362|NCT00229723|21060546|P6|STARTED|Maintenance Phase||31
8542363|NCT00229723|21060547|P5|STARTED|Maintenance Phase||22
8542364|NCT00229723|21060548|P4|STARTED|Maintenance Phase||26
8542365|NCT00229723|21060549|P3|STARTED|Maintenance Phase||25
8542366|NCT00229723|21060550|P2|STARTED|Maintenance Phase||19
8542367|NCT00229723|21060551|P1|STARTED|Maintenance Phase||50
8542368|NCT00229723|21060545|P7|NOT COMPLETED|Concomitant Phase||3
8542369|NCT00229723|21060546|P6|NOT COMPLETED|Concomitant Phase||3
8542370|NCT00229723|21060547|P5|NOT COMPLETED|Concomitant Phase||2
8542371|NCT00229723|21060548|P4|NOT COMPLETED|Concomitant Phase||5
8542372|NCT00229723|21060549|P3|NOT COMPLETED|Concomitant Phase||6
8542373|NCT00229723|21060550|P2|NOT COMPLETED|Concomitant Phase||5
8542374|NCT00229723|21060551|P1|NOT COMPLETED|Concomitant Phase||10
8542375|NCT00229723|21060545|P7|COMPLETED|Concomitant Phase||19
8542376|NCT00229723|21060546|P6|COMPLETED|Concomitant Phase||31
8542377|NCT00229723|21060547|P5|COMPLETED|Concomitant Phase||22
8542378|NCT00229723|21060548|P4|COMPLETED|Concomitant Phase||26
8542379|NCT00229723|21060549|P3|COMPLETED|Concomitant Phase||25
8542380|NCT00229723|21060550|P2|COMPLETED|Concomitant Phase||19
8542381|NCT00229723|21060551|P1|COMPLETED|Concomitant Phase||50
8542382|NCT00229723|21060545|P7|STARTED|Concomitant Phase|Received randomized treatment|22
8542383|NCT00229723|21060546|P6|STARTED|Concomitant Phase|Received randomized treatment|34
8542384|NCT00229723|21060547|P5|STARTED|Concomitant Phase|Received randomized treatment|24
8542385|NCT00229723|21060548|P4|STARTED|Concomitant Phase|Received randomized treatment|31
8542386|NCT00229723|21060549|P3|STARTED|Concomitant Phase|Received randomized treatment|31
8542387|NCT00229723|21060550|P2|STARTED|Concomitant Phase|Received randomized treatment|24
8542388|NCT00229723|21060551|P1|STARTED|Concomitant Phase|Received randomized treatment|60
8542389|NCT00229658|21060604|P2|NOT COMPLETED|Overall Study||167
8542390|NCT00229658|21060605|P1|NOT COMPLETED|Overall Study||225
8542391|NCT00229658|21060604|P2|COMPLETED|Overall Study||364
8542392|NCT00229658|21060605|P1|COMPLETED|Overall Study||541
8542393|NCT00229658|21060604|P2|STARTED|Overall Study||531
8542394|NCT00229658|21060605|P1|STARTED|Overall Study||766
8542395|NCT00229619|21060633|P1|NOT COMPLETED|Overall Study||0
8542396|NCT00229619|21060633|P1|COMPLETED|Overall Study||11
8542397|NCT00229619|21060633|P1|STARTED|Overall Study||11
8542398|NCT00229203|21060641|P2|NOT COMPLETED|Overall Study||19
8542399|NCT00229203|21060642|P1|NOT COMPLETED|Overall Study||32
8542400|NCT00229203|21060641|P2|COMPLETED|Overall Study||0
8542401|NCT00229203|21060642|P1|COMPLETED|Overall Study||0
8542402|NCT00229203|21060641|P2|STARTED|Overall Study||19
8542403|NCT00229203|21060642|P1|STARTED|Overall Study||32
8542404|NCT00228943|21060654|P1|NOT COMPLETED|Week 2||1
8542405|NCT00228943|21060654|P1|COMPLETED|Week 2||27
8542406|NCT00228943|21060654|P1|STARTED|Week 2||28
8542407|NCT00228943|21060654|P1|NOT COMPLETED|Week 1||0
8542408|NCT00228943|21060654|P1|COMPLETED|Week 1||28
8542409|NCT00228943|21060654|P1|STARTED|Week 1||28
8542410|NCT00228917|21060670|P8|NOT COMPLETED|Overall Study||0
8542411|NCT00228917|21060671|P7|NOT COMPLETED|Overall Study||0
8542412|NCT00228917|21060672|P6|NOT COMPLETED|Overall Study||2
8542413|NCT00228917|21060673|P5|NOT COMPLETED|Overall Study||0
8542414|NCT00228917|21060674|P4|NOT COMPLETED|Overall Study||0
8542415|NCT00228917|21060675|P3|NOT COMPLETED|Overall Study||0
8542416|NCT00228917|21060676|P2|NOT COMPLETED|Overall Study||0
8542417|NCT00228917|21060677|P1|NOT COMPLETED|Overall Study||0
8542418|NCT00228917|21060670|P8|COMPLETED|Overall Study||33
8542419|NCT00228917|21060671|P7|COMPLETED|Overall Study||69
8542420|NCT00228917|21060672|P6|COMPLETED|Overall Study||102
8542421|NCT00228917|21060673|P5|COMPLETED|Overall Study||205
8542422|NCT00228917|21060674|P4|COMPLETED|Overall Study||33
8542423|NCT00228917|21060675|P3|COMPLETED|Overall Study||65
8542424|NCT00228917|21060676|P2|COMPLETED|Overall Study||96
8542425|NCT00228917|21060677|P1|COMPLETED|Overall Study||193
8542426|NCT00228917|21060670|P8|STARTED|Overall Study||33
8542427|NCT00228917|21060671|P7|STARTED|Overall Study||69
8542428|NCT00228917|21060672|P6|STARTED|Overall Study||104
8542429|NCT00228917|21060673|P5|STARTED|Overall Study||205
8542430|NCT00228917|21060674|P4|STARTED|Overall Study||33
8542431|NCT00228917|21060675|P3|STARTED|Overall Study||65
8542432|NCT00228917|21060676|P2|STARTED|Overall Study||96
8542433|NCT00228917|21060677|P1|STARTED|Overall Study||193
8542434|NCT00228813|21060723|P1|NOT COMPLETED|Overall Study||4
8542435|NCT00228813|21060723|P1|COMPLETED|Overall Study||4
8542436|NCT00228813|21060723|P1|STARTED|Overall Study||8
8542437|NCT00228566|21060729|P1|NOT COMPLETED|Overall Study||71
8542438|NCT00228566|21060729|P1|COMPLETED|Overall Study||176
8542439|NCT00228566|21060729|P1|STARTED|Overall Study||247
8542440|NCT00228553|21060733|P1|NOT COMPLETED|Overall Study||430
8542441|NCT00228553|21060733|P1|COMPLETED|Overall Study||313
8542442|NCT00228553|21060733|P1|STARTED|Overall Study||743
8542443|NCT00228384|21060739|P2|NOT COMPLETED|Overall Study||29
8542444|NCT00228384|21060740|P1|NOT COMPLETED|Overall Study||29
8542445|NCT00228384|21060739|P2|COMPLETED|Overall Study||47
8542446|NCT00228384|21060740|P1|COMPLETED|Overall Study||43
8542447|NCT00228384|21060739|P2|Three Year Follow-up (Final)|Overall Study||47
8542448|NCT00228384|21060740|P1|Three Year Follow-up (Final)|Overall Study||43
8542449|NCT00228384|21060739|P2|30-Day Follow-up (Safety Outcome)|Overall Study||72
8542450|NCT00228384|21060740|P1|30-Day Follow-up (Safety Outcome)|Overall Study||69
8542451|NCT00228384|21060739|P2|Baseline|Overall Study||76
8542452|NCT00228384|21060740|P1|Baseline|Overall Study||72
8542453|NCT00228384|21060739|P2|STARTED|Overall Study||76
8542454|NCT00228384|21060740|P1|STARTED|Overall Study||72
8542455|NCT00227994|21060780|P2|NOT COMPLETED|Overall Study||7
8542456|NCT00227994|21060781|P1|NOT COMPLETED|Overall Study||7
8542457|NCT00227994|21060780|P2|COMPLETED|Overall Study||13
8542458|NCT00227994|21060781|P1|COMPLETED|Overall Study||13
8542459|NCT00227994|21060780|P2|STARTED|Overall Study||20
8542460|NCT00227994|21060781|P1|STARTED|Overall Study||20
8542461|NCT00227903|21060791|P2|NOT COMPLETED|Overall Study||10
8542462|NCT00227903|21060792|P1|NOT COMPLETED|Overall Study||5
8542463|NCT00227903|21060791|P2|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
8542464|NCT00227903|21060792|P1|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
8542465|NCT00227903|21060791|P2|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
8542466|NCT00227903|21060792|P1|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
8542467|NCT00227903|21060791|P2|STARTED|Overall Study||92
8542468|NCT00227903|21060792|P1|STARTED|Overall Study||91
8542469|NCT00227877|21060856|P4|NOT COMPLETED|12-months Follow-up||26
8542470|NCT00227877|21060857|P3|NOT COMPLETED|12-months Follow-up||31
8542471|NCT00227877|21060858|P2|NOT COMPLETED|12-months Follow-up||263
8542472|NCT00227877|21060859|P1|NOT COMPLETED|12-months Follow-up||310
8542473|NCT00227877|21060856|P4|COMPLETED|12-months Follow-up||266
8542474|NCT00227877|21060857|P3|COMPLETED|12-months Follow-up||266
8542475|NCT00227877|21060858|P2|COMPLETED|12-months Follow-up||765
8542476|NCT00227877|21060859|P1|COMPLETED|12-months Follow-up||758
8542477|NCT00227877|21060856|P4|STARTED|12-months Follow-up||292
8542478|NCT00227877|21060857|P3|STARTED|12-months Follow-up||297
8542479|NCT00227877|21060858|P2|STARTED|12-months Follow-up||1028
8542480|NCT00227877|21060859|P1|STARTED|12-months Follow-up||1068
8542481|NCT00227877|21060856|P4|NOT COMPLETED|3-months Follow-up||21
8542482|NCT00227877|21060857|P3|NOT COMPLETED|3-months Follow-up||52
8542483|NCT00227877|21060858|P2|NOT COMPLETED|3-months Follow-up||267
8542484|NCT00227877|21060859|P1|NOT COMPLETED|3-months Follow-up||313
8542485|NCT00227877|21060856|P4|COMPLETED|3-months Follow-up||271
8542486|NCT00227877|21060857|P3|COMPLETED|3-months Follow-up||245
8542487|NCT00227877|21060858|P2|COMPLETED|3-months Follow-up||761
8542488|NCT00227877|21060859|P1|COMPLETED|3-months Follow-up||755
8542489|NCT00227877|21060856|P4|STARTED|3-months Follow-up||292
8542490|NCT00227877|21060857|P3|STARTED|3-months Follow-up||297
8542491|NCT00227877|21060858|P2|STARTED|3-months Follow-up||1028
8542492|NCT00227877|21060859|P1|STARTED|3-months Follow-up||1068
8542493|NCT00227877|21060856|P4|NOT COMPLETED|Post-visit Checklist||0
8542494|NCT00227877|21060857|P3|NOT COMPLETED|Post-visit Checklist||1
8542495|NCT00227877|21060858|P2|NOT COMPLETED|Post-visit Checklist||13
8542496|NCT00227877|21060859|P1|NOT COMPLETED|Post-visit Checklist||24
8542497|NCT00227877|21060856|P4|COMPLETED|Post-visit Checklist||292
8542498|NCT00227877|21060857|P3|COMPLETED|Post-visit Checklist||296
8542499|NCT00227877|21060858|P2|COMPLETED|Post-visit Checklist||1015
8542500|NCT00227877|21060859|P1|COMPLETED|Post-visit Checklist||1044
8542501|NCT00227877|21060856|P4|STARTED|Post-visit Checklist||292
8542502|NCT00227877|21060857|P3|STARTED|Post-visit Checklist||297
8542503|NCT00227877|21060858|P2|STARTED|Post-visit Checklist||1028
8542504|NCT00227877|21060859|P1|STARTED|Post-visit Checklist||1068
8542505|NCT00227877|21060856|P4|NOT COMPLETED|Pre-visit Assessment||0
8542506|NCT00227877|21060857|P3|NOT COMPLETED|Pre-visit Assessment||0
8542507|NCT00227877|21060858|P2|NOT COMPLETED|Pre-visit Assessment||3
8542508|NCT00227877|21060859|P1|NOT COMPLETED|Pre-visit Assessment||7
8542509|NCT00227877|21060856|P4|COMPLETED|Pre-visit Assessment|Final analysis sample|292
8542510|NCT00227877|21060857|P3|COMPLETED|Pre-visit Assessment|Final analysis sample|297
8542511|NCT00227877|21060858|P2|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
8542512|NCT00227877|21060859|P1|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
8542513|NCT00227877|21060856|P4|STARTED|Pre-visit Assessment||292
8542514|NCT00227877|21060857|P3|STARTED|Pre-visit Assessment||297
8542515|NCT00227877|21060858|P2|STARTED|Pre-visit Assessment||1031
8542516|NCT00227877|21060859|P1|STARTED|Pre-visit Assessment||1075
8542517|NCT00227760|21060889|P1|NOT COMPLETED|Overall Study||0
8542518|NCT00227760|21060889|P1|COMPLETED|Overall Study||44
8542519|NCT00227760|21060889|P1|STARTED|Overall Study||44
8542520|NCT00227721|21060895|P1|NOT COMPLETED|Overall Study||1
8542521|NCT00227721|21060895|P1|COMPLETED|Overall Study||29
8542522|NCT00227721|21060895|P1|STARTED|Overall Study||30
8542523|NCT00227617|21060900|P3|NOT COMPLETED|Stage 2||0
8542524|NCT00227617|21060901|P2|NOT COMPLETED|Stage 2||0
8542525|NCT00227617|21060902|P1|NOT COMPLETED|Stage 2||0
8542526|NCT00227617|21060900|P3|COMPLETED|Stage 2||0
8542527|NCT00227617|21060901|P2|COMPLETED|Stage 2||0
8542528|NCT00227617|21060902|P1|COMPLETED|Stage 2||0
8542529|NCT00227617|21060900|P3|STARTED|Stage 2||0
8542530|NCT00227617|21060901|P2|STARTED|Stage 2||0
8542531|NCT00227617|21060902|P1|STARTED|Stage 2||0
8542532|NCT00227617|21060900|P3|NOT COMPLETED|Stage 1||0
8542533|NCT00227617|21060901|P2|NOT COMPLETED|Stage 1||0
8542534|NCT00227617|21060902|P1|NOT COMPLETED|Stage 1||0
8542535|NCT00227617|21060900|P3|COMPLETED|Stage 1||2
8542536|NCT00227617|21060901|P2|COMPLETED|Stage 1||12
8542537|NCT00227617|21060902|P1|COMPLETED|Stage 1||22
8542538|NCT00227617|21060900|P3|STARTED|Stage 1||2
8542539|NCT00227617|21060901|P2|STARTED|Stage 1||12
8542540|NCT00227617|21060902|P1|STARTED|Stage 1||22
8542541|NCT00227591|21060918|P1|NOT COMPLETED|Overall Study||1
8542542|NCT00227591|21060918|P1|COMPLETED|Overall Study||47
8542543|NCT00227591|21060918|P1|Began Treatment|Overall Study||47
8542544|NCT00227591|21060918|P1|STARTED|Overall Study|48 pts registered to the study|48
8542545|NCT00227539|21060922|P1|NOT COMPLETED|Overall Study||1
8542546|NCT00227539|21060922|P1|COMPLETED|Overall Study||24
8542547|NCT00227539|21060922|P1|STARTED|Overall Study||25
8542548|NCT00227370|21060930|P2|NOT COMPLETED|Overall Study||24
8542549|NCT00227370|21060931|P1|NOT COMPLETED|Overall Study||21
8542550|NCT00227370|21060930|P2|COMPLETED|Overall Study||46
8542551|NCT00227370|21060931|P1|COMPLETED|Overall Study||45
8542552|NCT00227370|21060930|P2|STARTED|Overall Study|Treatment Group|70
8542553|NCT00227370|21060931|P1|STARTED|Overall Study|Placebo Group|66
8542554|NCT00227344|21060951|P2|NOT COMPLETED|Overall Study||5
8542555|NCT00227344|21060952|P1|NOT COMPLETED|Overall Study||12
8542556|NCT00227344|21060951|P2|COMPLETED|Overall Study||37
8542557|NCT00227344|21060952|P1|COMPLETED|Overall Study||75
8542558|NCT00227344|21060951|P2|STARTED|Overall Study||42
8542559|NCT00227344|21060952|P1|STARTED|Overall Study||87
8542560|NCT00227305|21060972|P1|NOT COMPLETED|Overall Study||144
8542561|NCT00227305|21060972|P1|COMPLETED|Overall Study|Completed 26 weeks|237
8542562|NCT00227305|21060972|P1|Drug Received|Overall Study|safety population|380
8542563|NCT00227305|21060972|P1|STARTED|Overall Study|enrolled|381
8542564|NCT00227266|21060989|P3|NOT COMPLETED|Overall Study||4
8542565|NCT00227266|21060990|P2|NOT COMPLETED|Overall Study||0
8542566|NCT00227266|21060991|P1|NOT COMPLETED|Overall Study||1
8542567|NCT00227266|21060989|P3|COMPLETED|Overall Study||29
8542568|NCT00227266|21060990|P2|COMPLETED|Overall Study||30
8542569|NCT00227266|21060991|P1|COMPLETED|Overall Study||30
8542570|NCT00227266|21060989|P3|STARTED|Overall Study||33
8542571|NCT00227266|21060990|P2|STARTED|Overall Study||30
8542572|NCT00227266|21060991|P1|STARTED|Overall Study||31
8542573|NCT00227019|21061011|P1|NOT COMPLETED|Overall Study||0
8542574|NCT00227019|21061011|P1|COMPLETED|Overall Study||16
8542575|NCT00227019|21061011|P1|STARTED|Overall Study||16
8542576|NCT00226941|21061021|P4|NOT COMPLETED|Overall Study||2
8542577|NCT00226941|21061022|P3|NOT COMPLETED|Overall Study||0
8542578|NCT00226941|21061023|P2|NOT COMPLETED|Overall Study||0
8542579|NCT00226941|21061024|P1|NOT COMPLETED|Overall Study||0
8542580|NCT00226941|21061021|P4|COMPLETED|Overall Study||5
8542581|NCT00226941|21061022|P3|COMPLETED|Overall Study||4
8542582|NCT00226941|21061023|P2|COMPLETED|Overall Study||6
8542583|NCT00226941|21061024|P1|COMPLETED|Overall Study||6
8542584|NCT00226941|21061021|P4|STARTED|Overall Study||7
8542585|NCT00226941|21061022|P3|STARTED|Overall Study||4
8542586|NCT00226941|21061023|P2|STARTED|Overall Study||6
8542587|NCT00226941|21061024|P1|STARTED|Overall Study||6
8542588|NCT00226811|21061058|P1|NOT COMPLETED|Overall Study||76
8542589|NCT00226811|21061058|P1|COMPLETED|Overall Study||2
8542590|NCT00226811|21061058|P1|STARTED|Overall Study||78
8542591|NCT00226655|21061068|P1|NOT COMPLETED|Overall Study||79
8542592|NCT00226655|21061068|P1|COMPLETED|Overall Study||33
8542593|NCT00226655|21061068|P1|STARTED|Overall Study||112
8542594|NCT00226590|21061072|P1|NOT COMPLETED|Overall Study||0
8542595|NCT00226590|21061072|P1|COMPLETED|Overall Study||39
8542596|NCT00226590|21061072|P1|STARTED|Overall Study||39
8542597|NCT00226577|21061079|P1|NOT COMPLETED|Overall Study||0
8542598|NCT00226577|21061079|P1|COMPLETED|Overall Study||52
8542599|NCT00226577|21061079|P1|STARTED|Overall Study||52
8542600|NCT00226499|21061090|P3|NOT COMPLETED|Overall Study||359
8542601|NCT00226499|21061091|P2|NOT COMPLETED|Overall Study||1072
8542602|NCT00226499|21061092|P1|NOT COMPLETED|Overall Study||1074
8542603|NCT00226499|21061090|P3|COMPLETED|Overall Study||468
8542604|NCT00226499|21061091|P2|COMPLETED|Overall Study||1415
8542605|NCT00226499|21061092|P1|COMPLETED|Overall Study||1415
8542606|NCT00226499|21061090|P3|STARTED|Overall Study||827
8542607|NCT00226499|21061091|P2|STARTED|Overall Study||2487
8542608|NCT00226499|21061092|P1|STARTED|Overall Study||2489
8542609|NCT00226239|21061207|P1|NOT COMPLETED|Maintenance Cetuximab||14
8542610|NCT00226239|21061207|P1|COMPLETED|Maintenance Cetuximab||17
8542611|NCT00226239|21061207|P1|STARTED|Maintenance Cetuximab||31
8542612|NCT00226239|21061207|P1|NOT COMPLETED|XPE, Definitive Therapy||4
8542613|NCT00226239|21061207|P1|COMPLETED|XPE, Definitive Therapy||33
8542614|NCT00226239|21061207|P1|STARTED|XPE, Definitive Therapy||37
8542615|NCT00226239|21061207|P1|NOT COMPLETED|TPE, Induction Therapy||2
8542616|NCT00226239|21061207|P1|COMPLETED|TPE, Induction Therapy||37
8542617|NCT00226239|21061207|P1|STARTED|TPE, Induction Therapy||39
8542618|NCT00225784|21061216|P1|NOT COMPLETED|Overall Study||4
8542619|NCT00225784|21061216|P1|COMPLETED|Overall Study||33
8542620|NCT00225784|21061216|P1|STARTED|Overall Study||37
8542621|NCT00225758|21061227|P1|NOT COMPLETED|Overall Study||4
8542622|NCT00225758|21061227|P1|COMPLETED|Overall Study||23
8542623|NCT00225758|21061227|P1|STARTED|Overall Study||27
8542624|NCT00225732|21061237|P2|NOT COMPLETED|Overall Study||0
8542625|NCT00225732|21061238|P1|NOT COMPLETED|Overall Study||0
8542626|NCT00225732|21061237|P2|COMPLETED|Overall Study||166
8542627|NCT00225732|21061238|P1|COMPLETED|Overall Study||153
8542628|NCT00225732|21061237|P2|STARTED|Overall Study||166
8542629|NCT00225732|21061238|P1|STARTED|Overall Study||153
8542630|NCT00225498|21061244|P1|NOT COMPLETED|Overall Study||0
8542631|NCT00225498|21061244|P1|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
8542632|NCT00225498|21061244|P1|STARTED|Overall Study||10
8542633|NCT00225420|21061248|P3|NOT COMPLETED|Overall Study||0
8542634|NCT00225420|21061249|P2|NOT COMPLETED|Overall Study||0
8542635|NCT00225420|21061250|P1|NOT COMPLETED|Overall Study||0
8542636|NCT00225420|21061248|P3|COMPLETED|Overall Study||3
8542637|NCT00225420|21061249|P2|COMPLETED|Overall Study||6
8542638|NCT00225420|21061250|P1|COMPLETED|Overall Study||9
8542639|NCT00225420|21061248|P3|STARTED|Overall Study||3
8542640|NCT00225420|21061249|P2|STARTED|Overall Study||6
8542641|NCT00225420|21061250|P1|STARTED|Overall Study||9
8542642|NCT00225277|21061259|P2|NOT COMPLETED|Overall Study||95
8542643|NCT00225277|21061260|P1|NOT COMPLETED|Overall Study||97
8542644|NCT00225277|21061259|P2|COMPLETED|Overall Study||178
8542645|NCT00225277|21061260|P1|COMPLETED|Overall Study||177
8542646|NCT00225277|21061259|P2|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
8542647|NCT00225277|21061260|P1|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
8542648|NCT00225251|21061278|P2|NOT COMPLETED|Overall Study||1
8542649|NCT00225251|21061279|P1|NOT COMPLETED|Overall Study||1
8542650|NCT00225251|21061278|P2|COMPLETED|Overall Study||6
8542651|NCT00225251|21061279|P1|COMPLETED|Overall Study||10
8542652|NCT00225251|21061278|P2|STARTED|Overall Study||7
8542653|NCT00225251|21061279|P1|STARTED|Overall Study||11
8542654|NCT00225212|21061293|P1|NOT COMPLETED|Overall Study||6
8542655|NCT00225212|21061293|P1|COMPLETED|Overall Study||29
8542656|NCT00225212|21061293|P1|STARTED|Overall Study||35
8542657|NCT00225147|21061302|P4|NOT COMPLETED|Open-label Phase||10
8542658|NCT00225147|21061303|P3|NOT COMPLETED|Open-label Phase||0
8542659|NCT00225147|21061304|P2|NOT COMPLETED|Open-label Phase||0
8542660|NCT00225147|21061305|P1|NOT COMPLETED|Open-label Phase||0
8542661|NCT00225147|21061302|P4|COMPLETED|Open-label Phase||52
8542662|NCT00225147|21061303|P3|COMPLETED|Open-label Phase||0
8542663|NCT00225147|21061304|P2|COMPLETED|Open-label Phase||0
8542664|NCT00225147|21061305|P1|COMPLETED|Open-label Phase||0
8542665|NCT00225147|21061302|P4|STARTED|Open-label Phase||62
8542666|NCT00225147|21061303|P3|STARTED|Open-label Phase||0
8542667|NCT00225147|21061304|P2|STARTED|Open-label Phase||0
8542668|NCT00225147|21061305|P1|STARTED|Open-label Phase||0
8542669|NCT00225147|21061302|P4|NOT COMPLETED|Double-blind Phase||0
8542670|NCT00225147|21061303|P3|NOT COMPLETED|Double-blind Phase||0
8542671|NCT00225147|21061304|P2|NOT COMPLETED|Double-blind Phase||0
8542672|NCT00225147|21061305|P1|NOT COMPLETED|Double-blind Phase||0
8542673|NCT00225147|21061302|P4|COMPLETED|Double-blind Phase||0
8542674|NCT00225147|21061303|P3|COMPLETED|Double-blind Phase||13
8542675|NCT00225147|21061304|P2|COMPLETED|Double-blind Phase||12
8542676|NCT00225147|21061305|P1|COMPLETED|Double-blind Phase||13
8542677|NCT00225147|21061302|P4|STARTED|Double-blind Phase||0
8542678|NCT00225147|21061303|P3|STARTED|Double-blind Phase||13
8542679|NCT00225147|21061304|P2|STARTED|Double-blind Phase||12
8542680|NCT00225147|21061305|P1|STARTED|Double-blind Phase||13
8542681|NCT00225017|21061321|P2|NOT COMPLETED|Overall Study||1
8542682|NCT00225017|21061322|P1|NOT COMPLETED|Overall Study||0
8542683|NCT00225017|21061321|P2|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
8542684|NCT00225017|21061322|P1|COMPLETED|Overall Study||26
8542685|NCT00225017|21061321|P2|STARTED|Overall Study||24
8542686|NCT00225017|21061322|P1|STARTED|Overall Study||26
8542687|NCT00224952|21061335|P3|NOT COMPLETED|Overall Study||0
8542688|NCT00224952|21061336|P2|NOT COMPLETED|Overall Study||0
8542689|NCT00224952|21061337|P1|NOT COMPLETED|Overall Study||0
8542690|NCT00224952|21061335|P3|COMPLETED|Overall Study||134
8542691|NCT00224952|21061336|P2|COMPLETED|Overall Study||87
8542692|NCT00224952|21061337|P1|COMPLETED|Overall Study||53
8542693|NCT00224952|21061335|P3|STARTED|Overall Study||134
8542694|NCT00224952|21061336|P2|STARTED|Overall Study||87
8542695|NCT00224952|21061337|P1|STARTED|Overall Study||53
8542696|NCT00224874|21061352|P4|NOT COMPLETED|Overall Study||0
8542697|NCT00224874|21061353|P3|NOT COMPLETED|Overall Study||1
8542698|NCT00224874|21061354|P2|NOT COMPLETED|Overall Study||0
8542699|NCT00224874|21061355|P1|NOT COMPLETED|Overall Study||0
8542700|NCT00224874|21061352|P4|COMPLETED|Overall Study||42
8542701|NCT00224874|21061353|P3|COMPLETED|Overall Study||46
8542702|NCT00224874|21061354|P2|COMPLETED|Overall Study||45
8542703|NCT00224874|21061355|P1|COMPLETED|Overall Study||46
8542704|NCT00224874|21061352|P4|STARTED|Overall Study||42
8542705|NCT00224874|21061353|P3|STARTED|Overall Study||47
8542706|NCT00224874|21061354|P2|STARTED|Overall Study||45
8542707|NCT00224874|21061355|P1|STARTED|Overall Study||46
8542708|NCT00224770|21061400|P3|NOT COMPLETED|Overall Study||0
8542709|NCT00224770|21061401|P2|NOT COMPLETED|Overall Study||2
8542710|NCT00224770|21061402|P1|NOT COMPLETED|Overall Study||4
8542711|NCT00224770|21061400|P3|COMPLETED|Overall Study||14
8542712|NCT00224770|21061401|P2|COMPLETED|Overall Study||52
8542713|NCT00224770|21061402|P1|COMPLETED|Overall Study||38
8542714|NCT00224770|21061400|P3|STARTED|Overall Study||14
8542715|NCT00224770|21061401|P2|STARTED|Overall Study||54
8542716|NCT00224770|21061402|P1|STARTED|Overall Study||42
8542717|NCT00224484|21061437|P3|NOT COMPLETED|Overall Study||62
8542718|NCT00224484|21061438|P2|NOT COMPLETED|Overall Study||65
8542719|NCT00224484|21061439|P1|NOT COMPLETED|Overall Study||146
8542720|NCT00224484|21061437|P3|COMPLETED|Overall Study||1425
8542721|NCT00224484|21061438|P2|COMPLETED|Overall Study||1426
8542722|NCT00224484|21061439|P1|COMPLETED|Overall Study||2831
8542723|NCT00224484|21061437|P3|STARTED|Overall Study||1487
8542724|NCT00224484|21061438|P2|STARTED|Overall Study||1491
8542725|NCT00224484|21061439|P1|STARTED|Overall Study||2977
8542726|NCT00224289|21061498|P1|NOT COMPLETED|Overall Study||0
8542727|NCT00224289|21061498|P1|COMPLETED|Overall Study||17
8542728|NCT00224289|21061498|P1|STARTED|Overall Study||17
8542729|NCT00224133|21061503|P1|NOT COMPLETED|Overall Study||226
8542730|NCT00224133|21061503|P1|COMPLETED|Overall Study||435
8542731|NCT00224133|21061503|P1|STARTED|Overall Study||661
8542732|NCT00224120|21061509|P2|NOT COMPLETED|Overall Study||24
8542733|NCT00224120|21061510|P1|NOT COMPLETED|Overall Study||22
8542734|NCT00224120|21061509|P2|COMPLETED|Overall Study||205
8542735|NCT00224120|21061510|P1|COMPLETED|Overall Study||211
8542736|NCT00224120|21061509|P2|STARTED|Overall Study||229
8542737|NCT00224120|21061510|P1|STARTED|Overall Study||233
8542738|NCT00224107|21061520|P2|NOT COMPLETED|Overall Study||14
8542739|NCT00224107|21061521|P1|NOT COMPLETED|Overall Study||31
8542740|NCT00224107|21061520|P2|COMPLETED|Overall Study||214
8542741|NCT00224107|21061521|P1|COMPLETED|Overall Study||202
8542742|NCT00224107|21061520|P2|STARTED|Overall Study||228
8542743|NCT00224107|21061521|P1|STARTED|Overall Study||233
8542744|NCT00224055|21061531|P2|NOT COMPLETED|Overall Study||14
8542745|NCT00224055|21061532|P1|NOT COMPLETED|Overall Study||15
8542746|NCT00224055|21061531|P2|COMPLETED|Overall Study||31
8542747|NCT00224055|21061532|P1|COMPLETED|Overall Study||29
8542748|NCT00224055|21061531|P2|STARTED|Overall Study||45
8542749|NCT00224055|21061532|P1|STARTED|Overall Study||44
8542750|NCT00224042|21061542|P2|NOT COMPLETED|Overall Study||6
8542751|NCT00224042|21061543|P1|NOT COMPLETED|Overall Study||6
8542752|NCT00224042|21061542|P2|COMPLETED|Overall Study||20
8542753|NCT00224042|21061543|P1|COMPLETED|Overall Study||20
8542754|NCT00224042|21061542|P2|STARTED|Overall Study||26
8542755|NCT00224042|21061543|P1|STARTED|Overall Study||26
8542756|NCT00224029|21061555|P1|NOT COMPLETED|Overall Study||6
8542757|NCT00224029|21061555|P1|COMPLETED|Overall Study||18
8542758|NCT00224029|21061555|P1|STARTED|Overall Study||24
8542759|NCT00224016|21061561|P2|NOT COMPLETED|Follow-Up Period||0
8542760|NCT00224016|21061562|P1|NOT COMPLETED|Follow-Up Period||0
8542761|NCT00224016|21061561|P2|COMPLETED|Follow-Up Period||0
8542762|NCT00224016|21061562|P1|COMPLETED|Follow-Up Period||35
8542763|NCT00224016|21061561|P2|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
8542764|NCT00224016|21061562|P1|STARTED|Follow-Up Period||35
8542765|NCT00224016|21061561|P2|NOT COMPLETED|Maintenance Period||1
8542766|NCT00224016|21061562|P1|NOT COMPLETED|Maintenance Period||2
8542767|NCT00224016|21061561|P2|COMPLETED|Maintenance Period||14
8542768|NCT00224016|21061562|P1|COMPLETED|Maintenance Period||36
8542769|NCT00224016|21061561|P2|STARTED|Maintenance Period||15
8542770|NCT00224016|21061562|P1|STARTED|Maintenance Period||38
8542771|NCT00224016|21061561|P2|NOT COMPLETED|Titration Period||1
8542772|NCT00224016|21061562|P1|NOT COMPLETED|Titration Period||1
8542773|NCT00224016|21061561|P2|COMPLETED|Titration Period||15
8542774|NCT00224016|21061562|P1|COMPLETED|Titration Period||38
8542775|NCT00224016|21061561|P2|STARTED|Titration Period||16
8542776|NCT00224016|21061562|P1|STARTED|Titration Period||39
8542777|NCT00224003|21061570|P1|NOT COMPLETED|Overall Study||7
8542778|NCT00224003|21061570|P1|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
8542779|NCT00224003|21061570|P1|STARTED|Overall Study|First patient in: April 2, 2003|23
8542786|NCT00223977|21061602|P3|NOT COMPLETED|Overall Study||3
8542787|NCT00223977|21061603|P2|NOT COMPLETED|Overall Study||11
8542788|NCT00223977|21061604|P1|NOT COMPLETED|Overall Study||9
8542789|NCT00223977|21061602|P3|COMPLETED|Overall Study||39
8542790|NCT00223977|21061603|P2|COMPLETED|Overall Study||47
8542791|NCT00223977|21061604|P1|COMPLETED|Overall Study||37
8542792|NCT00223977|21061602|P3|STARTED|Overall Study||42
8542793|NCT00223977|21061603|P2|STARTED|Overall Study||58
8542794|NCT00223977|21061604|P1|STARTED|Overall Study||46
8542795|NCT00223821|21061626|P2|NOT COMPLETED|Overall Study||10
8542796|NCT00223821|21061627|P1|NOT COMPLETED|Overall Study||4
8542797|NCT00223821|21061626|P2|COMPLETED|Overall Study||22
8542798|NCT00223821|21061627|P1|COMPLETED|Overall Study||28
8542799|NCT00223821|21061626|P2|Completed 6-month Follow-up|Overall Study||25
8542800|NCT00223821|21061627|P1|Completed 6-month Follow-up|Overall Study||28
8542801|NCT00223821|21061626|P2|Completed Post-treatment Assessment|Overall Study||27
8542802|NCT00223821|21061627|P1|Completed Post-treatment Assessment|Overall Study||31
8542803|NCT00223821|21061626|P2|Completed Therapy|Overall Study||28
8542804|NCT00223821|21061627|P1|Completed Therapy|Overall Study||31
8542805|NCT00223821|21061626|P2|STARTED|Overall Study||32
8542806|NCT00223821|21061627|P1|STARTED|Overall Study||32
8542807|NCT00223808|21061638|P3|NOT COMPLETED|Overall Study||5
8542808|NCT00223808|21061639|P2|NOT COMPLETED|Overall Study||5
8542809|NCT00223808|21061640|P1|NOT COMPLETED|Overall Study||3
8542810|NCT00223808|21061638|P3|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
8542811|NCT00223808|21061639|P2|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
8542812|NCT00223808|21061640|P1|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
8542813|NCT00223808|21061638|P3|STARTED|Overall Study||23
8542814|NCT00223808|21061639|P2|STARTED|Overall Study||22
8542815|NCT00223808|21061640|P1|STARTED|Overall Study||22
8542816|NCT00223795|21061657|P2|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
8542817|NCT00223795|21061658|P1|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
8542818|NCT00223795|21061657|P2|COMPLETED|Second Intervention - All Use Canes 4 mo||17
8542819|NCT00223795|21061658|P1|COMPLETED|Second Intervention - All Use Canes 4 mo||18
8542820|NCT00223795|21061657|P2|STARTED|Second Intervention - All Use Canes 4 mo||18
8542821|NCT00223795|21061658|P1|STARTED|Second Intervention - All Use Canes 4 mo||19
8542822|NCT00223795|21061657|P2|NOT COMPLETED|First Intervention - Eight Weeks||9
8542823|NCT00223795|21061658|P1|NOT COMPLETED|First Intervention - Eight Weeks||7
8542824|NCT00223795|21061657|P2|COMPLETED|First Intervention - Eight Weeks||18
8542825|NCT00223795|21061658|P1|COMPLETED|First Intervention - Eight Weeks||19
8542826|NCT00223795|21061657|P2|STARTED|First Intervention - Eight Weeks||27
8542827|NCT00223795|21061658|P1|STARTED|First Intervention - Eight Weeks||26
8542828|NCT00223704|21061668|P3|NOT COMPLETED|Overall Study||0
8542829|NCT00223704|21061669|P2|NOT COMPLETED|Overall Study||0
8542830|NCT00223704|21061670|P1|NOT COMPLETED|Overall Study||0
8542831|NCT00223704|21061668|P3|COMPLETED|Overall Study||40
8542832|NCT00223704|21061669|P2|COMPLETED|Overall Study||37
8542833|NCT00223704|21061670|P1|COMPLETED|Overall Study||38
8542834|NCT00223704|21061668|P3|STARTED|Overall Study||40
8542835|NCT00223704|21061669|P2|STARTED|Overall Study||37
8542836|NCT00223704|21061670|P1|STARTED|Overall Study||38
8542837|NCT00223678|21061692|P2|NOT COMPLETED|Overall Study||0
8542838|NCT00223678|21061693|P1|NOT COMPLETED|Overall Study||0
8542839|NCT00223678|21061692|P2|COMPLETED|Overall Study||7
8542840|NCT00223678|21061693|P1|COMPLETED|Overall Study||13
8542841|NCT00223678|21061692|P2|STARTED|Overall Study||7
8542842|NCT00223678|21061693|P1|STARTED|Overall Study||13
8542843|NCT00223665|21061699|P1|NOT COMPLETED|Overall Study||0
8542844|NCT00223665|21061699|P1|COMPLETED|Overall Study||102
8542845|NCT00223665|21061699|P1|STARTED|Overall Study||102
8542846|NCT00223652|21061719|P2|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
8542847|NCT00223652|21061720|P1|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
8542848|NCT00223652|21061719|P2|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
8542849|NCT00223652|21061720|P1|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
8542850|NCT00223652|21061719|P2|STARTED|T-CBT and TAU 6 Month Follow-up||41
8542851|NCT00223652|21061720|P1|STARTED|T-CBT and TAU 6 Month Follow-up||40
8542852|NCT00223652|21061719|P2|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
8542853|NCT00223652|21061720|P1|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
8542854|NCT00223652|21061719|P2|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
8542855|NCT00223652|21061720|P1|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
8542856|NCT00223652|21061719|P2|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
8542857|NCT00223652|21061720|P1|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
8542858|NCT00223652|21061719|P2|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
8542859|NCT00223652|21061720|P1|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
8542860|NCT00223652|21061719|P2|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
8542861|NCT00223652|21061720|P1|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
8542862|NCT00223652|21061719|P2|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
8542863|NCT00223652|21061720|P1|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
8542864|NCT00223496|21061736|P1|NOT COMPLETED|Overall Study||22
8542865|NCT00223496|21061736|P1|COMPLETED|Overall Study||10
8542866|NCT00223496|21061736|P1|STARTED|Overall Study|32 people consented, 19 were baselined|32
8542867|NCT00223262|21061742|P2|NOT COMPLETED|Overall Study||1
8542868|NCT00223262|21061743|P1|NOT COMPLETED|Overall Study||8
8542869|NCT00223262|21061742|P2|COMPLETED|Overall Study||11
8542870|NCT00223262|21061743|P1|COMPLETED|Overall Study||8
8542871|NCT00223262|21061742|P2|STARTED|Overall Study||12
8542872|NCT00223262|21061743|P1|STARTED|Overall Study||16
8542873|NCT00223236|21061751|P2|NOT COMPLETED|Overall Study||14
8542874|NCT00223236|21061752|P1|NOT COMPLETED|Overall Study||7
8542875|NCT00223236|21061751|P2|COMPLETED|Overall Study|4 completed 12 week trial.|4
8542876|NCT00223236|21061752|P1|COMPLETED|Overall Study|9 completed 12 week trial.|9
8542877|NCT00223236|21061751|P2|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
8542878|NCT00223236|21061752|P1|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
8542879|NCT00223080|21061766|P2|NOT COMPLETED|Overall Study||797
8542880|NCT00223080|21061767|P1|NOT COMPLETED|Overall Study||796
8542881|NCT00223080|21061766|P2|COMPLETED|Overall Study||7401
8542882|NCT00223080|21061767|P1|COMPLETED|Overall Study||7401
8542883|NCT00223080|21061766|P2|STARTED|Overall Study||8198
8542884|NCT00223080|21061767|P1|STARTED|Overall Study||8197
8542885|NCT00222729|21061785|P1|NOT COMPLETED|Overall Study||3
8542886|NCT00222729|21061785|P1|COMPLETED|Overall Study||37
8542887|NCT00222729|21061785|P1|STARTED|Overall Study||40
8542888|NCT00222131|21061794|P2|NOT COMPLETED|Overall Study||0
8542889|NCT00222131|21061795|P1|NOT COMPLETED|Overall Study||0
8542890|NCT00222131|21061794|P2|COMPLETED|Overall Study||35
8542891|NCT00222131|21061795|P1|COMPLETED|Overall Study||38
8542892|NCT00222131|21061794|P2|STARTED|Overall Study||35
8542893|NCT00222131|21061795|P1|STARTED|Overall Study||38
8542894|NCT00222105|21061803|P1|NOT COMPLETED|Overall Study||14
8542895|NCT00222105|21061803|P1|COMPLETED|Overall Study||11
8542896|NCT00222105|21061803|P1|STARTED|Overall Study||25
8542897|NCT00221403|21061811|P3|NOT COMPLETED|Overall Study||0
8542898|NCT00221403|21061812|P2|NOT COMPLETED|Overall Study||5
8542899|NCT00221403|21061813|P1|NOT COMPLETED|Overall Study||2
8542900|NCT00221403|21061811|P3|COMPLETED|Overall Study||7
8542901|NCT00221403|21061812|P2|COMPLETED|Overall Study||16
8542902|NCT00221403|21061813|P1|COMPLETED|Overall Study||16
8542903|NCT00221403|21061811|P3|STARTED|Overall Study||7
8542904|NCT00221403|21061812|P2|STARTED|Overall Study||21
8542905|NCT00221403|21061813|P1|STARTED|Overall Study||18
8542906|NCT00221338|21061823|P2|NOT COMPLETED|Overall Study||29
8542907|NCT00221338|21061824|P1|NOT COMPLETED|Overall Study||24
8542908|NCT00221338|21061823|P2|COMPLETED|Overall Study||347
8542909|NCT00221338|21061824|P1|COMPLETED|Overall Study||350
8542910|NCT00221338|21061823|P2|STARTED|Overall Study||376
8542911|NCT00221338|21061824|P1|STARTED|Overall Study||374
8542912|NCT00221299|21061843|P4|NOT COMPLETED|Overall Study||1
8542913|NCT00221299|21061844|P3|NOT COMPLETED|Overall Study||0
8542914|NCT00221299|21061845|P2|NOT COMPLETED|Overall Study||2
8542915|NCT00221299|21061846|P1|NOT COMPLETED|Overall Study||1
8542916|NCT00221299|21061843|P4|COMPLETED|Overall Study||10
8542917|NCT00221299|21061844|P3|COMPLETED|Overall Study||14
8542918|NCT00221299|21061845|P2|COMPLETED|Overall Study||11
8542919|NCT00221299|21061846|P1|COMPLETED|Overall Study||10
8542920|NCT00221299|21061843|P4|STARTED|Overall Study||11
8542921|NCT00221299|21061844|P3|STARTED|Overall Study||14
8542922|NCT00221299|21061845|P2|STARTED|Overall Study||13
8542923|NCT00221299|21061846|P1|STARTED|Overall Study||11
8542924|NCT00221195|21061856|P2|NOT COMPLETED|Therapy 2 (Months 10-15)||0
8542925|NCT00221195|21061857|P1|NOT COMPLETED|Therapy 2 (Months 10-15)||2
8542926|NCT00221195|21061856|P2|COMPLETED|Therapy 2 (Months 10-15)||14
8542927|NCT00221195|21061857|P1|COMPLETED|Therapy 2 (Months 10-15)||12
8542928|NCT00221195|21061856|P2|STARTED|Therapy 2 (Months 10-15)||14
8542929|NCT00221195|21061857|P1|STARTED|Therapy 2 (Months 10-15)||14
8542930|NCT00221195|21061856|P2|NOT COMPLETED|Washout Period (Months 7-9)||1
8542931|NCT00221195|21061857|P1|NOT COMPLETED|Washout Period (Months 7-9)||0
8542932|NCT00221195|21061856|P2|COMPLETED|Washout Period (Months 7-9)||14
8542933|NCT00221195|21061857|P1|COMPLETED|Washout Period (Months 7-9)||14
8542934|NCT00221195|21061856|P2|STARTED|Washout Period (Months 7-9)||15
8542935|NCT00221195|21061857|P1|STARTED|Washout Period (Months 7-9)||14
8542936|NCT00221195|21061856|P2|NOT COMPLETED|Therapy 1 (Months 1-6)||2
8542937|NCT00221195|21061857|P1|NOT COMPLETED|Therapy 1 (Months 1-6)||3
8542938|NCT00221195|21061856|P2|COMPLETED|Therapy 1 (Months 1-6)||15
8542939|NCT00221195|21061857|P1|COMPLETED|Therapy 1 (Months 1-6)||14
8542940|NCT00221195|21061856|P2|STARTED|Therapy 1 (Months 1-6)||17
8542941|NCT00221195|21061857|P1|STARTED|Therapy 1 (Months 1-6)||17
8542942|NCT00221117|21061866|P2|NOT COMPLETED|Overall Study||0
8542943|NCT00221117|21061867|P1|NOT COMPLETED|Overall Study||0
8542944|NCT00221117|21061866|P2|COMPLETED|Overall Study||9
8542945|NCT00221117|21061867|P1|COMPLETED|Overall Study||12
8542946|NCT00221117|21061866|P2|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
8542947|NCT00221117|21061867|P1|STARTED|Overall Study||12
8542948|NCT00221104|21061879|P2|NOT COMPLETED|Overall Study||76
8542949|NCT00221104|21061880|P1|NOT COMPLETED|Overall Study||83
8542950|NCT00221104|21061879|P2|COMPLETED|Overall Study||709
8542951|NCT00221104|21061880|P1|COMPLETED|Overall Study||710
8542952|NCT00221104|21061879|P2|STARTED|Overall Study||785
8542953|NCT00221104|21061880|P1|STARTED|Overall Study||793
8542954|NCT00220961|21061896|P2|NOT COMPLETED|Overall Study||90
8542955|NCT00220961|21061897|P1|NOT COMPLETED|Overall Study||71
8542956|NCT00220961|21061896|P2|COMPLETED|Overall Study||213
8542957|NCT00220961|21061897|P1|COMPLETED|Overall Study||228
8542958|NCT00220961|21061896|P2|STARTED|Overall Study||303
8542959|NCT00220961|21061897|P1|STARTED|Overall Study||299
8542960|NCT00220805|21061913|P2|NOT COMPLETED|Overall Study||11
8542961|NCT00220805|21061914|P1|NOT COMPLETED|Overall Study||8
8542962|NCT00220805|21061913|P2|COMPLETED|Overall Study||16
8542963|NCT00220805|21061914|P1|COMPLETED|Overall Study||22
8542964|NCT00220805|21061913|P2|STARTED|Overall Study||27
8542965|NCT00220805|21061914|P1|STARTED|Overall Study||30
8542966|NCT00220779|21061935|P3|NOT COMPLETED|Overall Study||4
8542967|NCT00220779|21061936|P2|NOT COMPLETED|Overall Study||4
8542968|NCT00220779|21061937|P1|NOT COMPLETED|Overall Study||7
8542969|NCT00220779|21061935|P3|COMPLETED|Overall Study||37
8542970|NCT00220779|21061936|P2|COMPLETED|Overall Study||38
8542971|NCT00220779|21061937|P1|COMPLETED|Overall Study||38
8542972|NCT00220779|21061935|P3|STARTED|Overall Study||41
8542973|NCT00220779|21061936|P2|STARTED|Overall Study||42
8542974|NCT00220779|21061937|P1|STARTED|Overall Study||45
8542975|NCT00220740|21061947|P2|NOT COMPLETED|Withdrawal Period||15
8542976|NCT00220740|21061948|P1|NOT COMPLETED|Withdrawal Period||6
8542977|NCT00220740|21061947|P2|COMPLETED|Withdrawal Period||16
8542978|NCT00220740|21061948|P1|COMPLETED|Withdrawal Period||37
8542979|NCT00220740|21061947|P2|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
8542980|NCT00220740|21061948|P1|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
8542981|NCT00220740|21061947|P2|NOT COMPLETED|Rescue Treatment||18
8542982|NCT00220740|21061948|P1|NOT COMPLETED|Rescue Treatment||19
8542983|NCT00220740|21061947|P2|COMPLETED|Rescue Treatment||5
8542984|NCT00220740|21061948|P1|COMPLETED|Rescue Treatment||26
8542985|NCT00220740|21061947|P2|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
8542986|NCT00220740|21061948|P1|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
8542987|NCT00220740|21061947|P2|NOT COMPLETED|Efficacy Period||46
8542988|NCT00220740|21061948|P1|NOT COMPLETED|Efficacy Period||26
8542989|NCT00220740|21061947|P2|COMPLETED|Efficacy Period||12
8542990|NCT00220740|21061948|P1|COMPLETED|Efficacy Period||33
8542991|NCT00220740|21061947|P2|STARTED|Efficacy Period||58
8542992|NCT00220740|21061948|P1|STARTED|Efficacy Period||59
8542993|NCT00220727|21061962|P2|NOT COMPLETED|Second Infusion (Week <6)||0
8542994|NCT00220727|21061963|P1|NOT COMPLETED|Second Infusion (Week <6)||1
8542995|NCT00220727|21061962|P2|COMPLETED|Second Infusion (Week <6)||4
8542996|NCT00220727|21061963|P1|COMPLETED|Second Infusion (Week <6)||3
8542997|NCT00220727|21061962|P2|STARTED|Second Infusion (Week <6)||4
8542998|NCT00220727|21061963|P1|STARTED|Second Infusion (Week <6)||4
8542999|NCT00220727|21061962|P2|NOT COMPLETED|First Infusion (Week 0)||0
8543000|NCT00220727|21061963|P1|NOT COMPLETED|First Infusion (Week 0)||0
8543001|NCT00220727|21061962|P2|COMPLETED|First Infusion (Week 0)||4
8543002|NCT00220727|21061963|P1|COMPLETED|First Infusion (Week 0)||4
8543003|NCT00220727|21061962|P2|STARTED|First Infusion (Week 0)||4
8543004|NCT00220727|21061963|P1|STARTED|First Infusion (Week 0)||4
8543005|NCT00220701|21061979|P2|NOT COMPLETED|Overall Study||4
8543006|NCT00220701|21061980|P1|NOT COMPLETED|Overall Study||5
8543007|NCT00220701|21061979|P2|COMPLETED|Overall Study||13
8543008|NCT00220701|21061980|P1|COMPLETED|Overall Study||12
8543009|NCT00220701|21061979|P2|STARTED|Overall Study||17
8543010|NCT00220701|21061980|P1|STARTED|Overall Study||17
8543011|NCT00220636|21061996|P1|NOT COMPLETED|Overall Study||4
8543012|NCT00220636|21061996|P1|COMPLETED|Overall Study||11
8543013|NCT00220636|21061996|P1|STARTED|Overall Study||15
8543014|NCT00219557|21062006|P3|NOT COMPLETED|Phase 2||33
8543015|NCT00219557|21062007|P2|NOT COMPLETED|Phase 2||69
8543016|NCT00219557|21062008|P1|NOT COMPLETED|Phase 2||0
8543017|NCT00219557|21062006|P3|COMPLETED|Phase 2||1
8543018|NCT00219557|21062007|P2|COMPLETED|Phase 2||0
8543019|NCT00219557|21062008|P1|COMPLETED|Phase 2||0
8543020|NCT00219557|21062006|P3|Treated|Phase 2||31
8543021|NCT00219557|21062007|P2|Treated|Phase 2||68
8543022|NCT00219557|21062008|P1|Treated|Phase 2||0
8543023|NCT00219557|21062006|P3|STARTED|Phase 2||34
8543024|NCT00219557|21062007|P2|STARTED|Phase 2||69
8543025|NCT00219557|21062008|P1|STARTED|Phase 2||0
8543026|NCT00219557|21062006|P3|NOT COMPLETED|Phase 1||0
8543027|NCT00219557|21062007|P2|NOT COMPLETED|Phase 1||0
8543028|NCT00219557|21062008|P1|NOT COMPLETED|Phase 1||7
8543029|NCT00219557|21062006|P3|COMPLETED|Phase 1||0
8543030|NCT00219557|21062007|P2|COMPLETED|Phase 1||0
8543031|NCT00219557|21062008|P1|COMPLETED|Phase 1||1
8543032|NCT00219557|21062006|P3|STARTED|Phase 1||0
8543033|NCT00219557|21062007|P2|STARTED|Phase 1||0
8543034|NCT00219557|21062008|P1|STARTED|Phase 1||8
8543035|NCT00219544|21062036|P2|NOT COMPLETED|Double Blind Treatment Period||0
8543036|NCT00219544|21062037|P1|NOT COMPLETED|Double Blind Treatment Period||0
8543037|NCT00219544|21062036|P2|COMPLETED|Double Blind Treatment Period||77
8543038|NCT00219544|21062037|P1|COMPLETED|Double Blind Treatment Period||80
8543039|NCT00219544|21062036|P2|STARTED|Double Blind Treatment Period||77
8543040|NCT00219544|21062037|P1|STARTED|Double Blind Treatment Period||80
8543041|NCT00219544|21062036|P2|NOT COMPLETED|Single Blind Treatment Period||0
8543042|NCT00219544|21062037|P1|NOT COMPLETED|Single Blind Treatment Period||22
8543043|NCT00219544|21062036|P2|COMPLETED|Single Blind Treatment Period||0
8543044|NCT00219544|21062037|P1|COMPLETED|Single Blind Treatment Period||234
8543045|NCT00219544|21062036|P2|STARTED|Single Blind Treatment Period||0
8543046|NCT00219544|21062037|P1|STARTED|Single Blind Treatment Period||256
8543047|NCT00219349|21062075|P1|NOT COMPLETED|Escitalopram Phase||3
8543048|NCT00219349|21062075|P1|COMPLETED|Escitalopram Phase||4
8543049|NCT00219349|21062075|P1|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
8543050|NCT00219349|21062075|P1|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
8543051|NCT00219349|21062075|P1|COMPLETED|Cognitive Behavioral Therapy Phase||15
8543052|NCT00219349|21062075|P1|STARTED|Cognitive Behavioral Therapy Phase||25
8543053|NCT00219284|21062088|P2|NOT COMPLETED|Extension Phase - 8 Weeks||7
8543054|NCT00219284|21062089|P1|NOT COMPLETED|Extension Phase - 8 Weeks||2
8543055|NCT00219284|21062088|P2|COMPLETED|Extension Phase - 8 Weeks||99
8543056|NCT00219284|21062089|P1|COMPLETED|Extension Phase - 8 Weeks||112
8543057|NCT00219284|21062088|P2|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
8543058|NCT00219284|21062089|P1|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
8543059|NCT00219284|21062088|P2|NOT COMPLETED|Treatment Phase - 16 Weeks||51
8543060|NCT00219284|21062089|P1|NOT COMPLETED|Treatment Phase - 16 Weeks||44
8543061|NCT00219284|21062088|P2|COMPLETED|Treatment Phase - 16 Weeks||128
8543062|NCT00219284|21062089|P1|COMPLETED|Treatment Phase - 16 Weeks||136
8543063|NCT00219284|21062088|P2|STARTED|Treatment Phase - 16 Weeks||179
8543064|NCT00219284|21062089|P1|STARTED|Treatment Phase - 16 Weeks||180
8543065|NCT00219141|21062114|P3|NOT COMPLETED|Overall Study||12
8543066|NCT00219141|21062115|P2|NOT COMPLETED|Overall Study||21
8543067|NCT00219141|21062116|P1|NOT COMPLETED|Overall Study||14
8543068|NCT00219141|21062114|P3|COMPLETED|Overall Study||142
8543069|NCT00219141|21062115|P2|COMPLETED|Overall Study||131
8543070|NCT00219141|21062116|P1|COMPLETED|Overall Study||140
8543071|NCT00219141|21062114|P3|STARTED|Overall Study||154
8543072|NCT00219141|21062115|P2|STARTED|Overall Study||152
8543073|NCT00219141|21062116|P1|STARTED|Overall Study||154
8543074|NCT00218634|21062162|P2|NOT COMPLETED|Overall Study||15
8543075|NCT00218634|21062163|P1|NOT COMPLETED|Overall Study||8
8543076|NCT00218634|21062162|P2|COMPLETED|Overall Study||30
8543077|NCT00218634|21062163|P1|COMPLETED|Overall Study||36
8543078|NCT00218634|21062162|P2|STARTED|Overall Study||45
8543079|NCT00218634|21062163|P1|STARTED|Overall Study||44
8543080|NCT00218543|21062183|P1|NOT COMPLETED|Overall Study||15
8543081|NCT00218543|21062183|P1|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
8543082|NCT00218543|21062183|P1|STARTED|Overall Study||20
8543083|NCT00218491|21062191|P3|NOT COMPLETED|Overall Study||0
8543084|NCT00218491|21062192|P2|NOT COMPLETED|Overall Study||0
8543085|NCT00218491|21062193|P1|NOT COMPLETED|Overall Study||0
8543086|NCT00218491|21062191|P3|COMPLETED|Overall Study||38
8543087|NCT00218491|21062192|P2|COMPLETED|Overall Study||33
8543088|NCT00218491|21062193|P1|COMPLETED|Overall Study||40
8543089|NCT00218491|21062191|P3|STARTED|Overall Study||38
8543090|NCT00218491|21062192|P2|STARTED|Overall Study||33
8543091|NCT00218491|21062193|P1|STARTED|Overall Study||40
8543092|NCT00218465|21062203|P2|NOT COMPLETED|Overall Study||18
8543093|NCT00218465|21062204|P1|NOT COMPLETED|Overall Study||17
8543094|NCT00218465|21062203|P2|COMPLETED|Overall Study||30
8543095|NCT00218465|21062204|P1|COMPLETED|Overall Study||33
8543096|NCT00218465|21062203|P2|STARTED|Overall Study||48
8543097|NCT00218465|21062204|P1|STARTED|Overall Study||50
8543098|NCT00218439|21062216|P2|NOT COMPLETED|Second Intervention (4 Weeks)||5
8543099|NCT00218439|21062217|P1|NOT COMPLETED|Second Intervention (4 Weeks)||7
8543100|NCT00218439|21062216|P2|COMPLETED|Second Intervention (4 Weeks)||30
8543101|NCT00218439|21062217|P1|COMPLETED|Second Intervention (4 Weeks)||33
8543102|NCT00218439|21062216|P2|STARTED|Second Intervention (4 Weeks)||35
8543103|NCT00218439|21062217|P1|STARTED|Second Intervention (4 Weeks)||40
8543104|NCT00218439|21062216|P2|NOT COMPLETED|First Intervention (4 Weeks)||12
8543105|NCT00218439|21062217|P1|NOT COMPLETED|First Intervention (4 Weeks)||18
8543106|NCT00218439|21062216|P2|COMPLETED|First Intervention (4 Weeks)||35
8543107|NCT00218439|21062217|P1|COMPLETED|First Intervention (4 Weeks)||40
8543108|NCT00218439|21062216|P2|STARTED|First Intervention (4 Weeks)||47
8543109|NCT00218439|21062217|P1|STARTED|First Intervention (4 Weeks)||58
8543110|NCT00218426|21062234|P3|NOT COMPLETED|Overall Study||91
8543111|NCT00218426|21062235|P2|NOT COMPLETED|Overall Study||86
8543112|NCT00218426|21062236|P1|NOT COMPLETED|Overall Study||48
8543113|NCT00218426|21062234|P3|COMPLETED|Overall Study||11
8543114|NCT00218426|21062235|P2|COMPLETED|Overall Study||16
8543115|NCT00218426|21062236|P1|COMPLETED|Overall Study||54
8543116|NCT00218426|21062234|P3|STARTED|Overall Study||102
8543117|NCT00218426|21062235|P2|STARTED|Overall Study||102
8543118|NCT00218426|21062236|P1|STARTED|Overall Study||102
8543119|NCT00218387|21062277|P3|NOT COMPLETED|Overall Study||23
8543120|NCT00218387|21062278|P2|NOT COMPLETED|Overall Study||18
8543121|NCT00218387|21062279|P1|NOT COMPLETED|Overall Study||15
8543122|NCT00218387|21062277|P3|COMPLETED|Overall Study||17
8543123|NCT00218387|21062278|P2|COMPLETED|Overall Study||25
8543124|NCT00218387|21062279|P1|COMPLETED|Overall Study||25
8543125|NCT00218387|21062277|P3|STARTED|Overall Study||40
8543126|NCT00218387|21062278|P2|STARTED|Overall Study||43
8543127|NCT00218387|21062279|P1|STARTED|Overall Study||40
8543128|NCT00218335|21062294|P4|NOT COMPLETED|Overall Study||36
8543129|NCT00218335|21062295|P3|NOT COMPLETED|Overall Study||54
8543130|NCT00218335|21062296|P2|NOT COMPLETED|Overall Study||3
8543131|NCT00218335|21062297|P1|NOT COMPLETED|Overall Study||6
8543132|NCT00218335|21062294|P4|COMPLETED|Overall Study||388
8543133|NCT00218335|21062295|P3|COMPLETED|Overall Study||319
8543134|NCT00218335|21062296|P2|COMPLETED|Overall Study||110
8543135|NCT00218335|21062297|P1|COMPLETED|Overall Study||108
8543136|NCT00218335|21062294|P4|18 Month Follow-up|Overall Study||368
8543137|NCT00218335|21062295|P3|18 Month Follow-up|Overall Study||296
8543138|NCT00218335|21062296|P2|18 Month Follow-up|Overall Study||108
8543139|NCT00218335|21062297|P1|18 Month Follow-up|Overall Study||101
8543140|NCT00218335|21062294|P4|12 Month Follow-up|Overall Study||303
8543141|NCT00218335|21062295|P3|12 Month Follow-up|Overall Study||244
8543142|NCT00218335|21062296|P2|12 Month Follow-up|Overall Study||102
8543143|NCT00218335|21062297|P1|12 Month Follow-up|Overall Study||95
8543144|NCT00218335|21062294|P4|6 Month Follow-up|Overall Study||301
8543145|NCT00218335|21062295|P3|6 Month Follow-up|Overall Study||219
8543146|NCT00218335|21062296|P2|6 Month Follow-up|Overall Study||99
8543147|NCT00218335|21062297|P1|6 Month Follow-up|Overall Study||103
8543148|NCT00218335|21062294|P4|STARTED|Overall Study||424
8543149|NCT00218335|21062295|P3|STARTED|Overall Study||373
8543150|NCT00218335|21062296|P2|STARTED|Overall Study||113
8543151|NCT00218335|21062297|P1|STARTED|Overall Study||114
8543152|NCT00218296|21062361|P2|NOT COMPLETED|Overall Study||121
8543153|NCT00218296|21062362|P1|NOT COMPLETED|Overall Study||111
8543154|NCT00218296|21062361|P2|COMPLETED|Overall Study||48
8543155|NCT00218296|21062362|P1|COMPLETED|Overall Study||52
8543156|NCT00218296|21062361|P2|Attended Visti|Overall Study||102
8543157|NCT00218296|21062362|P1|Attended Visti|Overall Study||97
8543158|NCT00218296|21062361|P2|STARTED|Overall Study||169
8543159|NCT00218296|21062362|P1|STARTED|Overall Study||163
8543160|NCT00218257|21062378|P2|NOT COMPLETED|Intervention 2||0
8543161|NCT00218257|21062379|P1|NOT COMPLETED|Intervention 2||0
8543162|NCT00218257|21062378|P2|COMPLETED|Intervention 2||19
8543163|NCT00218257|21062379|P1|COMPLETED|Intervention 2||19
8543164|NCT00218257|21062378|P2|STARTED|Intervention 2||19
8543165|NCT00218257|21062379|P1|STARTED|Intervention 2||19
8543166|NCT00218257|21062378|P2|NOT COMPLETED|Period Between Visit 1 and 2||3
8543167|NCT00218257|21062379|P1|NOT COMPLETED|Period Between Visit 1 and 2||4
8543168|NCT00218257|21062378|P2|COMPLETED|Period Between Visit 1 and 2||19
8543169|NCT00218257|21062379|P1|COMPLETED|Period Between Visit 1 and 2||19
8543170|NCT00218257|21062378|P2|STARTED|Period Between Visit 1 and 2||22
8543171|NCT00218257|21062379|P1|STARTED|Period Between Visit 1 and 2||23
8543172|NCT00218257|21062378|P2|NOT COMPLETED|Intervention 1||0
8543173|NCT00218257|21062379|P1|NOT COMPLETED|Intervention 1||0
8543174|NCT00218257|21062378|P2|COMPLETED|Intervention 1||22
8543175|NCT00218257|21062379|P1|COMPLETED|Intervention 1||23
8543176|NCT00218257|21062378|P2|STARTED|Intervention 1||22
8543177|NCT00218257|21062379|P1|STARTED|Intervention 1||23
8543178|NCT00218062|21062397|P4|NOT COMPLETED|Overall Study||13
8543179|NCT00218062|21062398|P3|NOT COMPLETED|Overall Study||12
8543180|NCT00218062|21062399|P2|NOT COMPLETED|Overall Study||16
8543181|NCT00218062|21062400|P1|NOT COMPLETED|Overall Study||15
8543182|NCT00218062|21062397|P4|COMPLETED|Overall Study||3
8543183|NCT00218062|21062398|P3|COMPLETED|Overall Study||3
8543184|NCT00218062|21062399|P2|COMPLETED|Overall Study||4
8543185|NCT00218062|21062400|P1|COMPLETED|Overall Study||7
8543186|NCT00218062|21062397|P4|Received First Dose of Study Medication|Overall Study||12
8543187|NCT00218062|21062398|P3|Received First Dose of Study Medication|Overall Study||10
8543188|NCT00218062|21062399|P2|Received First Dose of Study Medication|Overall Study||11
8543189|NCT00218062|21062400|P1|Received First Dose of Study Medication|Overall Study||16
8543190|NCT00218062|21062397|P4|STARTED|Overall Study||16
8543191|NCT00218062|21062398|P3|STARTED|Overall Study||15
8543192|NCT00218062|21062399|P2|STARTED|Overall Study||20
8543193|NCT00218062|21062400|P1|STARTED|Overall Study||22
8543194|NCT00218036|21062431|P5|NOT COMPLETED|Overall Study||6
8543195|NCT00218036|21062432|P4|NOT COMPLETED|Overall Study||6
8543196|NCT00218036|21062433|P3|NOT COMPLETED|Overall Study||8
8543197|NCT00218036|21062434|P2|NOT COMPLETED|Overall Study||3
8543198|NCT00218036|21062435|P1|NOT COMPLETED|Overall Study||5
8543199|NCT00218036|21062431|P5|COMPLETED|Overall Study||3
8543200|NCT00218036|21062432|P4|COMPLETED|Overall Study||6
8543201|NCT00218036|21062433|P3|COMPLETED|Overall Study||5
8543202|NCT00218036|21062434|P2|COMPLETED|Overall Study||3
8543203|NCT00218036|21062435|P1|COMPLETED|Overall Study||6
8543204|NCT00218036|21062431|P5|STARTED|Overall Study||9
8543205|NCT00218036|21062432|P4|STARTED|Overall Study||12
8543206|NCT00218036|21062433|P3|STARTED|Overall Study||13
8543207|NCT00218036|21062434|P2|STARTED|Overall Study||6
8543208|NCT00218036|21062435|P1|STARTED|Overall Study||11
8543209|NCT00218023|21062461|P4|NOT COMPLETED|Overall Study||7
8543210|NCT00218023|21062462|P3|NOT COMPLETED|Overall Study||10
8543211|NCT00218023|21062463|P2|NOT COMPLETED|Overall Study||15
8543212|NCT00218023|21062464|P1|NOT COMPLETED|Overall Study||13
8543213|NCT00218023|21062461|P4|COMPLETED|Overall Study||11
8543214|NCT00218023|21062462|P3|COMPLETED|Overall Study||6
8543215|NCT00218023|21062463|P2|COMPLETED|Overall Study||10
8543216|NCT00218023|21062464|P1|COMPLETED|Overall Study||9
8543217|NCT00218023|21062461|P4|Received Drug or Placebo in Phase II|Overall Study||18
8543218|NCT00218023|21062462|P3|Received Drug or Placebo in Phase II|Overall Study||15
8543219|NCT00218023|21062463|P2|Received Drug or Placebo in Phase II|Overall Study||24
8543220|NCT00218023|21062464|P1|Received Drug or Placebo in Phase II|Overall Study||18
8543221|NCT00218023|21062461|P4|STARTED|Overall Study||18
8543222|NCT00218023|21062462|P3|STARTED|Overall Study||16
8543223|NCT00218023|21062463|P2|STARTED|Overall Study||25
8543224|NCT00218023|21062464|P1|STARTED|Overall Study||22
8543225|NCT00217971|21062480|P2|NOT COMPLETED|Overall Study||33
8543226|NCT00217971|21062481|P1|NOT COMPLETED|Overall Study||24
8543227|NCT00217971|21062480|P2|COMPLETED|Overall Study||44
8543228|NCT00217971|21062481|P1|COMPLETED|Overall Study||55
8543229|NCT00217971|21062480|P2|STARTED|Overall Study||77
8543230|NCT00217971|21062481|P1|STARTED|Overall Study||79
8543231|NCT00217724|21062487|P2|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
8543232|NCT00217724|21062488|P1|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
8543233|NCT00217724|21062487|P2|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
8543234|NCT00217724|21062488|P1|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
8543235|NCT00217724|21062487|P2|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
8543236|NCT00217724|21062488|P1|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
8543237|NCT00217724|21062487|P2|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
8543238|NCT00217724|21062488|P1|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
8543239|NCT00217724|21062487|P2|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
8543240|NCT00217724|21062488|P1|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
8543241|NCT00217724|21062487|P2|STARTED|Course 1, (Glutamine/Placebo Arms)||10
8543242|NCT00217724|21062488|P1|STARTED|Course 1, (Glutamine/Placebo Arms)||8
8543243|NCT00217672|21062496|P2|NOT COMPLETED|Follow-up||0
8543244|NCT00217672|21062497|P1|NOT COMPLETED|Follow-up||5
8543245|NCT00217672|21062496|P2|COMPLETED|Follow-up||0
8543246|NCT00217672|21062497|P1|COMPLETED|Follow-up||69
8543247|NCT00217672|21062496|P2|STARTED|Follow-up||0
8543248|NCT00217672|21062497|P1|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
8543249|NCT00217672|21062496|P2|NOT COMPLETED|Treatment||7
8543250|NCT00217672|21062497|P1|NOT COMPLETED|Treatment||67
8543251|NCT00217672|21062496|P2|COMPLETED|Treatment||0
8543252|NCT00217672|21062497|P1|COMPLETED|Treatment||0
8543253|NCT00217672|21062496|P2|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
8543254|NCT00217672|21062497|P1|STARTED|Treatment||67
8543255|NCT00217672|21062496|P2|NOT COMPLETED|Allocation||0
8543256|NCT00217672|21062497|P1|NOT COMPLETED|Allocation||2
8543257|NCT00217672|21062496|P2|COMPLETED|Allocation||7
8543258|NCT00217672|21062497|P1|COMPLETED|Allocation||67
8543259|NCT00217672|21062496|P2|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
8543260|NCT00217672|21062497|P1|STARTED|Allocation||69
8543261|NCT00217620|21062503|P1|NOT COMPLETED|Overall Study||51
8543262|NCT00217620|21062503|P1|COMPLETED|Overall Study||0
8543263|NCT00217620|21062503|P1|Eligible and Began Protocol Therapy|Overall Study||37
8543264|NCT00217620|21062503|P1|Eligible|Overall Study||38
8543265|NCT00217620|21062503|P1|STARTED|Overall Study||51
8543266|NCT00217594|21062514|P1|NOT COMPLETED|Overall Study||0
8543267|NCT00217594|21062514|P1|COMPLETED|Overall Study||31
8543268|NCT00217594|21062514|P1|STARTED|Overall Study||31
8543269|NCT00217581|21062518|P1|NOT COMPLETED|Overall Study||1
8543270|NCT00217581|21062518|P1|COMPLETED|Overall Study||38
8543271|NCT00217581|21062518|P1|STARTED|Overall Study||39
8543272|NCT00217490|21062530|P4|NOT COMPLETED|Overall Study||23
8543273|NCT00217490|21062531|P3|NOT COMPLETED|Overall Study||24
8543274|NCT00217490|21062532|P2|NOT COMPLETED|Overall Study||25
8543275|NCT00217490|21062533|P1|NOT COMPLETED|Overall Study||17
8543276|NCT00217490|21062530|P4|COMPLETED|Overall Study||130
8543277|NCT00217490|21062531|P3|COMPLETED|Overall Study||131
8543278|NCT00217490|21062532|P2|COMPLETED|Overall Study||128
8543279|NCT00217490|21062533|P1|COMPLETED|Overall Study||137
8543280|NCT00217490|21062530|P4|STARTED|Overall Study||153
8543281|NCT00217490|21062531|P3|STARTED|Overall Study||155
8543282|NCT00217490|21062532|P2|STARTED|Overall Study||153
8543283|NCT00217490|21062533|P1|STARTED|Overall Study||154
8543284|NCT00217464|21062547|P1|NOT COMPLETED|Overall Study||17
8543285|NCT00217464|21062547|P1|COMPLETED|Overall Study||0
8543286|NCT00217464|21062547|P1|STARTED|Overall Study||17
8543287|NCT00217438|21062554|P2|NOT COMPLETED|Overall Study||1
8543288|NCT00217438|21062555|P1|NOT COMPLETED|Overall Study||0
8543289|NCT00217438|21062554|P2|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
8543290|NCT00217438|21062555|P1|COMPLETED|Overall Study||66
8543291|NCT00217438|21062554|P2|STARTED|Overall Study||64
8543292|NCT00217438|21062555|P1|STARTED|Overall Study||66
8543293|NCT00217425|21062563|P1|NOT COMPLETED|Overall Study||37
8543294|NCT00217425|21062563|P1|COMPLETED|Overall Study||9
8543295|NCT00217425|21062563|P1|Eligible and Treated|Overall Study||39
8543296|NCT00217425|21062563|P1|Treated|Overall Study||44
8543297|NCT00217425|21062563|P1|STARTED|Overall Study||46
8543298|NCT00217399|21062569|P1|NOT COMPLETED|Overall Study||0
8543299|NCT00217399|21062569|P1|COMPLETED|Overall Study||35
8543300|NCT00217399|21062569|P1|STARTED|Overall Study||35
8543301|NCT00217087|21062577|P2|NOT COMPLETED|Overall Study||20
8543302|NCT00217087|21062578|P1|NOT COMPLETED|Overall Study||11
8543303|NCT00217087|21062577|P2|COMPLETED|Overall Study||17
8543304|NCT00217087|21062578|P1|COMPLETED|Overall Study||25
8543305|NCT00217087|21062577|P2|STARTED|Overall Study||37
8543306|NCT00217087|21062578|P1|STARTED|Overall Study||36
8543307|NCT00217022|21062592|P2|NOT COMPLETED|Overall Study||1
8543308|NCT00217022|21062593|P1|NOT COMPLETED|Overall Study||1
8543309|NCT00217022|21062592|P2|COMPLETED|Overall Study||3
8543310|NCT00217022|21062593|P1|COMPLETED|Overall Study||11
8543311|NCT00217022|21062592|P2|STARTED|Overall Study||4
8543312|NCT00217022|21062593|P1|STARTED|Overall Study||12
8543313|NCT00216736|21062603|P2|NOT COMPLETED|Overall Study||1
8543314|NCT00216736|21062604|P1|NOT COMPLETED|Overall Study||1
8543315|NCT00216736|21062603|P2|COMPLETED|Overall Study||30
8543316|NCT00216736|21062604|P1|COMPLETED|Overall Study||31
8543317|NCT00216736|21062603|P2|STARTED|Overall Study||31
8543318|NCT00216736|21062604|P1|STARTED|Overall Study||32
8543319|NCT00216671|21062618|P2|NOT COMPLETED|Overall Study||50
8543320|NCT00216671|21062619|P1|NOT COMPLETED|Overall Study||35
8543321|NCT00216671|21062618|P2|COMPLETED|Overall Study||60
8543322|NCT00216671|21062619|P1|COMPLETED|Overall Study||75
8543323|NCT00216671|21062618|P2|STARTED|Overall Study||110
8543324|NCT00216671|21062619|P1|STARTED|Overall Study||110
8543325|NCT00216476|21062637|P3|NOT COMPLETED|Overall Study||17
8543326|NCT00216476|21062638|P2|NOT COMPLETED|Overall Study||107
8543327|NCT00216476|21062639|P1|NOT COMPLETED|Overall Study||105
8543328|NCT00216476|21062637|P3|COMPLETED|Overall Study||28
8543329|NCT00216476|21062638|P2|COMPLETED|Overall Study||230
8543330|NCT00216476|21062639|P1|COMPLETED|Overall Study||224
8543331|NCT00216476|21062637|P3|STARTED|Overall Study||45
8543332|NCT00216476|21062638|P2|STARTED|Overall Study||337
8543333|NCT00216476|21062639|P1|STARTED|Overall Study||329
8543334|NCT00216320|21062659|P3|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
8543335|NCT00216320|21062660|P2|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
8543336|NCT00216320|21062661|P1|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
8543337|NCT00216320|21062659|P3|COMPLETED|Phase 2 (Weeks 6 -12)||24
8543338|NCT00216320|21062660|P2|COMPLETED|Phase 2 (Weeks 6 -12)||31
8543339|NCT00216320|21062661|P1|COMPLETED|Phase 2 (Weeks 6 -12)||38
8543340|NCT00216320|21062659|P3|STARTED|Phase 2 (Weeks 6 -12)||25
8543341|NCT00216320|21062660|P2|STARTED|Phase 2 (Weeks 6 -12)||35
8543342|NCT00216320|21062661|P1|STARTED|Phase 2 (Weeks 6 -12)||43
8543343|NCT00216320|21062659|P3|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
8543344|NCT00216320|21062660|P2|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
8543345|NCT00216320|21062661|P1|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
8543346|NCT00216320|21062659|P3|COMPLETED|Phase 1 (Weeks 0 - 6)||25
8543347|NCT00216320|21062660|P2|COMPLETED|Phase 1 (Weeks 0 - 6)||35
8543348|NCT00216320|21062661|P1|COMPLETED|Phase 1 (Weeks 0 - 6)||43
8543349|NCT00216320|21062659|P3|STARTED|Phase 1 (Weeks 0 - 6)||30
8543350|NCT00216320|21062660|P2|STARTED|Phase 1 (Weeks 0 - 6)||39
8543351|NCT00216320|21062661|P1|STARTED|Phase 1 (Weeks 0 - 6)||43
8543352|NCT00216203|21062676|P1|NOT COMPLETED|Overall Study||2
8543353|NCT00216203|21062676|P1|COMPLETED|Overall Study||34
8543354|NCT00216203|21062676|P1|STARTED|Overall Study||36
8543355|NCT00216125|21062684|P3|NOT COMPLETED|Randomization Phase||8
8543356|NCT00216125|21062685|P2|NOT COMPLETED|Randomization Phase||11
8543357|NCT00216125|21062686|P1|NOT COMPLETED|Randomization Phase||0
8543358|NCT00216125|21062684|P3|COMPLETED|Randomization Phase||74
8543359|NCT00216125|21062685|P2|COMPLETED|Randomization Phase||73
8543360|NCT00216125|21062686|P1|COMPLETED|Randomization Phase||0
8543361|NCT00216125|21062684|P3|DSMB Cohort for Futility|Randomization Phase||74
8543362|NCT00216125|21062685|P2|DSMB Cohort for Futility|Randomization Phase||73
8543363|NCT00216125|21062686|P1|DSMB Cohort for Futility|Randomization Phase||0
8543364|NCT00216125|21062684|P3|STARTED|Randomization Phase||82
8543365|NCT00216125|21062685|P2|STARTED|Randomization Phase||84
8543366|NCT00216125|21062686|P1|STARTED|Randomization Phase||0
8543367|NCT00216125|21062684|P3|NOT COMPLETED|Pre-Randomization Phase||0
8543368|NCT00216125|21062685|P2|NOT COMPLETED|Pre-Randomization Phase||0
8543369|NCT00216125|21062686|P1|NOT COMPLETED|Pre-Randomization Phase||77
8543370|NCT00216125|21062684|P3|COMPLETED|Pre-Randomization Phase||0
8543371|NCT00216125|21062685|P2|COMPLETED|Pre-Randomization Phase||0
8543372|NCT00216125|21062686|P1|COMPLETED|Pre-Randomization Phase||166
8543373|NCT00216125|21062684|P3|DSMB Cohort for Futility|Pre-Randomization Phase||0
8543374|NCT00216125|21062685|P2|DSMB Cohort for Futility|Pre-Randomization Phase||0
8543375|NCT00216125|21062686|P1|DSMB Cohort for Futility|Pre-Randomization Phase||203
8543376|NCT00216125|21062684|P3|STARTED|Pre-Randomization Phase||0
8543377|NCT00216125|21062685|P2|STARTED|Pre-Randomization Phase||0
8543378|NCT00216125|21062686|P1|STARTED|Pre-Randomization Phase||243
8543379|NCT00216099|21062695|P1|NOT COMPLETED|Overall Study||1
8543380|NCT00216099|21062695|P1|COMPLETED|Overall Study||48
8543381|NCT00216099|21062695|P1|Response Analysis|Overall Study||48
8543382|NCT00216099|21062695|P1|Toxicity Analysis|Overall Study||49
8543383|NCT00216099|21062695|P1|STARTED|Overall Study||49
8543384|NCT00216086|21062706|P1|NOT COMPLETED|Overall Study||4
8543385|NCT00216086|21062706|P1|COMPLETED|Overall Study||18
8543386|NCT00216086|21062706|P1|STARTED|Overall Study||22
8543387|NCT00216060|21062715|P2|NOT COMPLETED|Overall Study||0
8543388|NCT00216060|21062716|P1|NOT COMPLETED|Overall Study||0
8543389|NCT00216060|21062715|P2|COMPLETED|Overall Study||31
8543390|NCT00216060|21062716|P1|COMPLETED|Overall Study||32
8543391|NCT00216060|21062715|P2|STARTED|Overall Study||31
8543392|NCT00216060|21062716|P1|STARTED|Overall Study||32
8543393|NCT00215943|21062738|P2|NOT COMPLETED|Overall Study||14
8543394|NCT00215943|21062739|P1|NOT COMPLETED|Overall Study||9
8543395|NCT00215943|21062738|P2|COMPLETED|Overall Study||23
8543396|NCT00215943|21062739|P1|COMPLETED|Overall Study||27
8543397|NCT00215943|21062738|P2|STARTED|Overall Study||37
8543398|NCT00215943|21062739|P1|STARTED|Overall Study||36
8543399|NCT00215930|21062751|P1|NOT COMPLETED|Overall Study||0
8543400|NCT00215930|21062751|P1|COMPLETED|Overall Study||53
8543401|NCT00215930|21062751|P1|STARTED|Overall Study||53
8543402|NCT00215787|21062757|P1|NOT COMPLETED|Overall Study||0
8543403|NCT00215787|21062757|P1|COMPLETED|Overall Study||20
8543404|NCT00215787|21062757|P1|STARTED|Overall Study||20
8543405|NCT00215683|21062764|P3|NOT COMPLETED|Overall Study||32
8543406|NCT00215683|21062765|P2|NOT COMPLETED|Overall Study||26
8543407|NCT00215683|21062766|P1|NOT COMPLETED|Overall Study||29
8543408|NCT00215683|21062764|P3|COMPLETED|Overall Study||12
8543409|NCT00215683|21062765|P2|COMPLETED|Overall Study||22
8543410|NCT00215683|21062766|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
8543411|NCT00215683|21062764|P3|Switched to 160 mg|Overall Study||36
8543412|NCT00215683|21062765|P2|Switched to 160 mg|Overall Study||41
8543413|NCT00215683|21062766|P1|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
8543414|NCT00215683|21062764|P3|STARTED|Overall Study||44
8543415|NCT00215683|21062765|P2|STARTED|Overall Study||48
8543416|NCT00215683|21062766|P1|STARTED|Overall Study|Safety analysis set|45
8543417|NCT00215657|21062785|P8|NOT COMPLETED|Overall Study||16
8543418|NCT00215657|21062786|P7|NOT COMPLETED|Overall Study||23
8543419|NCT00215657|21062787|P6|NOT COMPLETED|Overall Study||20
8543420|NCT00215657|21062788|P5|NOT COMPLETED|Overall Study||23
8543421|NCT00215657|21062789|P4|NOT COMPLETED|Overall Study||18
8543422|NCT00215657|21062790|P3|NOT COMPLETED|Overall Study||11
8543423|NCT00215657|21062791|P2|NOT COMPLETED|Overall Study||11
8543424|NCT00215657|21062792|P1|NOT COMPLETED|Overall Study||22
8543425|NCT00215657|21062785|P8|COMPLETED|Overall Study||11
8543426|NCT00215657|21062786|P7|COMPLETED|Overall Study||4
8543427|NCT00215657|21062787|P6|COMPLETED|Overall Study||4
8543428|NCT00215657|21062788|P5|COMPLETED|Overall Study||4
8543429|NCT00215657|21062789|P4|COMPLETED|Overall Study||6
8543430|NCT00215657|21062790|P3|COMPLETED|Overall Study||2
8543431|NCT00215657|21062791|P2|COMPLETED|Overall Study||1
8543432|NCT00215657|21062792|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
8543433|NCT00215657|21062785|P8|Started FE200486 CS07A|Overall Study||23
8543434|NCT00215657|21062786|P7|Started FE200486 CS07A|Overall Study||14
8543435|NCT00215657|21062787|P6|Started FE200486 CS07A|Overall Study||20
8543436|NCT00215657|21062788|P5|Started FE200486 CS07A|Overall Study||17
8543437|NCT00215657|21062789|P4|Started FE200486 CS07A|Overall Study||24
8543438|NCT00215657|21062790|P3|Started FE200486 CS07A|Overall Study||7
8543439|NCT00215657|21062791|P2|Started FE200486 CS07A|Overall Study||6
8543440|NCT00215657|21062792|P1|Started FE200486 CS07A|Overall Study||20
8543441|NCT00215657|21062785|P8|Intention-to-treat Population|Overall Study||27
8543442|NCT00215657|21062786|P7|Intention-to-treat Population|Overall Study||24
8543443|NCT00215657|21062787|P6|Intention-to-treat Population|Overall Study||24
8543444|NCT00215657|21062788|P5|Intention-to-treat Population|Overall Study||24
8543445|NCT00215657|21062789|P4|Intention-to-treat Population|Overall Study||24
8543446|NCT00215657|21062790|P3|Intention-to-treat Population|Overall Study||12
8543447|NCT00215657|21062791|P2|Intention-to-treat Population|Overall Study||12
8543448|NCT00215657|21062792|P1|Intention-to-treat Population|Overall Study||25
8543449|NCT00215657|21062785|P8|STARTED|Overall Study||27
8543450|NCT00215657|21062786|P7|STARTED|Overall Study||27
8543451|NCT00215657|21062787|P6|STARTED|Overall Study||24
8543452|NCT00215657|21062788|P5|STARTED|Overall Study||27
8543453|NCT00215657|21062789|P4|STARTED|Overall Study||24
8543454|NCT00215657|21062790|P3|STARTED|Overall Study||13
8543455|NCT00215657|21062791|P2|STARTED|Overall Study||12
8543456|NCT00215657|21062792|P1|STARTED|Overall Study||26
8543457|NCT00215644|21062820|P2|NOT COMPLETED|Overall Study||36
8543458|NCT00215644|21062821|P1|NOT COMPLETED|Overall Study||36
8543459|NCT00215644|21062820|P2|COMPLETED|Overall Study||0
8543460|NCT00215644|21062821|P1|COMPLETED|Overall Study||0
8543461|NCT00215644|21062820|P2|Treated|Overall Study||36
8543462|NCT00215644|21062821|P1|Treated|Overall Study||35
8543463|NCT00215644|21062820|P2|STARTED|Overall Study||36
8543464|NCT00215644|21062821|P1|STARTED|Overall Study||36
8543465|NCT00215553|21062848|P7|NOT COMPLETED|Overall Study||0
8543466|NCT00215553|21062849|P6|NOT COMPLETED|Overall Study||6
8543467|NCT00215553|21062850|P5|NOT COMPLETED|Overall Study||2
8543468|NCT00215553|21062851|P4|NOT COMPLETED|Overall Study||1
8543469|NCT00215553|21062852|P3|NOT COMPLETED|Overall Study||2
8543470|NCT00215553|21062853|P2|NOT COMPLETED|Overall Study||1
8543471|NCT00215553|21062854|P1|NOT COMPLETED|Overall Study||0
8543472|NCT00215553|21062848|P7|COMPLETED|Overall Study||36
8543473|NCT00215553|21062849|P6|COMPLETED|Overall Study||32
8543474|NCT00215553|21062850|P5|COMPLETED|Overall Study||26
8543475|NCT00215553|21062851|P4|COMPLETED|Overall Study||4
8543476|NCT00215553|21062852|P3|COMPLETED|Overall Study||4
8543477|NCT00215553|21062853|P2|COMPLETED|Overall Study||5
8543478|NCT00215553|21062854|P1|COMPLETED|Overall Study||5
8543479|NCT00215553|21062848|P7|STARTED|Overall Study||36
8543480|NCT00215553|21062849|P6|STARTED|Overall Study||38
8543481|NCT00215553|21062850|P5|STARTED|Overall Study||28
8543482|NCT00215553|21062851|P4|STARTED|Overall Study||5
8543483|NCT00215553|21062852|P3|STARTED|Overall Study||6
8543484|NCT00215553|21062853|P2|STARTED|Overall Study||6
8543485|NCT00215553|21062854|P1|STARTED|Overall Study||5
8543486|NCT00215540|21062887|P3|NOT COMPLETED|Overall Study||0
8543487|NCT00215540|21062888|P2|NOT COMPLETED|Overall Study||0
8543488|NCT00215540|21062889|P1|NOT COMPLETED|Overall Study||1
8543489|NCT00215540|21062887|P3|COMPLETED|Overall Study||44
8543490|NCT00215540|21062888|P2|COMPLETED|Overall Study||47
8543491|NCT00215540|21062889|P1|COMPLETED|Overall Study||44
8543492|NCT00215540|21062887|P3|STARTED|Overall Study||44
8543493|NCT00215540|21062888|P2|STARTED|Overall Study||47
8543494|NCT00215540|21062889|P1|STARTED|Overall Study||45
8543495|NCT00215150|21062924|P1|NOT COMPLETED|Randomization Phase Placebo||1
8543496|NCT00215150|21062924|P1|COMPLETED|Randomization Phase Placebo||10
8543497|NCT00215150|21062924|P1|STARTED|Randomization Phase Placebo||11
8543498|NCT00215150|21062924|P1|NOT COMPLETED|Randomization Phase Ziprasidone||3
8543499|NCT00215150|21062924|P1|COMPLETED|Randomization Phase Ziprasidone||7
8543500|NCT00215150|21062924|P1|STARTED|Randomization Phase Ziprasidone||10
8543501|NCT00215150|21062924|P1|NOT COMPLETED|Open Label Phase||30
8543502|NCT00215150|21062924|P1|COMPLETED|Open Label Phase||21
8543503|NCT00215150|21062924|P1|STARTED|Open Label Phase|Number of subjects consented|51
8543504|NCT00215137|21062932|P3|NOT COMPLETED|Randomization Period||0
8543505|NCT00215137|21062933|P2|NOT COMPLETED|Randomization Period||2
8543506|NCT00215137|21062934|P1|NOT COMPLETED|Randomization Period||0
8543507|NCT00215137|21062932|P3|COMPLETED|Randomization Period||5
8543508|NCT00215137|21062933|P2|COMPLETED|Randomization Period||5
8543509|NCT00215137|21062934|P1|COMPLETED|Randomization Period||0
8543510|NCT00215137|21062932|P3|STARTED|Randomization Period||5
8543511|NCT00215137|21062933|P2|STARTED|Randomization Period||7
8543512|NCT00215137|21062934|P1|STARTED|Randomization Period||0
8543513|NCT00215137|21062932|P3|NOT COMPLETED|Open Label Escitalopram||0
8543514|NCT00215137|21062933|P2|NOT COMPLETED|Open Label Escitalopram||0
8543515|NCT00215137|21062934|P1|NOT COMPLETED|Open Label Escitalopram||1
8543516|NCT00215137|21062932|P3|COMPLETED|Open Label Escitalopram||0
8543517|NCT00215137|21062933|P2|COMPLETED|Open Label Escitalopram||0
8543518|NCT00215137|21062934|P1|COMPLETED|Open Label Escitalopram||13
8543519|NCT00215137|21062932|P3|STARTED|Open Label Escitalopram||0
8543520|NCT00215137|21062933|P2|STARTED|Open Label Escitalopram||0
8543521|NCT00215137|21062934|P1|STARTED|Open Label Escitalopram||14
8543522|NCT00214903|21062946|P4|NOT COMPLETED|Overall Study||0
8543523|NCT00214903|21062947|P3|NOT COMPLETED|Overall Study||0
8543524|NCT00214903|21062948|P2|NOT COMPLETED|Overall Study||0
8543525|NCT00214903|21062949|P1|NOT COMPLETED|Overall Study||0
8543526|NCT00214903|21062946|P4|COMPLETED|Overall Study||3057
8543527|NCT00214903|21062947|P3|COMPLETED|Overall Study||4113
8543528|NCT00214903|21062948|P2|COMPLETED|Overall Study||13384
8543529|NCT00214903|21062949|P1|COMPLETED|Overall Study||10043
8543530|NCT00214903|21062946|P4|STARTED|Overall Study||3057
8543531|NCT00214903|21062947|P3|STARTED|Overall Study||4113
8543532|NCT00214903|21062948|P2|STARTED|Overall Study||13384
8543533|NCT00214903|21062949|P1|STARTED|Overall Study||10043
8543534|NCT00214786|21062963|P1|NOT COMPLETED|Overall Study||3
8543535|NCT00214786|21062963|P1|COMPLETED|Overall Study||1
8543536|NCT00214786|21062963|P1|STARTED|Overall Study||4
8543561|NCT00214526|21063005|P2|NOT COMPLETED|Post-Treatment Period||0
8543562|NCT00214526|21063006|P1|NOT COMPLETED|Post-Treatment Period||1
8543563|NCT00214526|21063005|P2|COMPLETED|Post-Treatment Period||49
8543564|NCT00214526|21063006|P1|COMPLETED|Post-Treatment Period||52
8543565|NCT00214526|21063005|P2|STARTED|Post-Treatment Period||49
8543566|NCT00214526|21063006|P1|STARTED|Post-Treatment Period||53
8543567|NCT00214526|21063005|P2|NOT COMPLETED|Treatment Period||5
8543568|NCT00214526|21063006|P1|NOT COMPLETED|Treatment Period||2
8543569|NCT00214526|21063005|P2|COMPLETED|Treatment Period||49
8543570|NCT00214526|21063006|P1|COMPLETED|Treatment Period||53
8543571|NCT00214526|21063005|P2|STARTED|Treatment Period||54
8543572|NCT00214526|21063006|P1|STARTED|Treatment Period||55
8543573|NCT00214526|21063005|P2|NOT COMPLETED|Randomized||2
8543574|NCT00214526|21063006|P1|NOT COMPLETED|Randomized||1
8543575|NCT00214526|21063005|P2|COMPLETED|Randomized||54
8543576|NCT00214526|21063006|P1|COMPLETED|Randomized||55
8543577|NCT00214526|21063005|P2|STARTED|Randomized||56
8543578|NCT00214526|21063006|P1|STARTED|Randomized||56
8543579|NCT00214500|21063032|P1|NOT COMPLETED|Extension Period||2
8543580|NCT00214500|21063032|P1|COMPLETED|Extension Period||6
8543581|NCT00214500|21063032|P1|STARTED|Extension Period||8
8543582|NCT00214500|21063032|P1|NOT COMPLETED|Treatment Period||1
8543583|NCT00214500|21063032|P1|COMPLETED|Treatment Period||8
8543584|NCT00214500|21063032|P1|Pharmacodynamic (PD) Population|Treatment Period||9
8543585|NCT00214500|21063032|P1|Pharmacokinetic (PK) Population|Treatment Period||9
8543586|NCT00214500|21063032|P1|Safety Population|Treatment Period||9
8543587|NCT00214500|21063032|P1|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
8543588|NCT00214487|21063042|P2|NOT COMPLETED|Overall Study||3
8543589|NCT00214487|21063043|P1|NOT COMPLETED|Overall Study||5
8543590|NCT00214487|21063042|P2|COMPLETED|Overall Study||40
8543591|NCT00214487|21063043|P1|COMPLETED|Overall Study||38
8543592|NCT00214487|21063042|P2|STARTED|Overall Study||43
8543593|NCT00214487|21063043|P1|STARTED|Overall Study||43
8543594|NCT00214461|21063053|P4|NOT COMPLETED|Overall Study||1
8543595|NCT00214461|21063054|P3|NOT COMPLETED|Overall Study||2
8543596|NCT00214461|21063055|P2|NOT COMPLETED|Overall Study||0
8543597|NCT00214461|21063056|P1|NOT COMPLETED|Overall Study||0
8543598|NCT00214461|21063053|P4|COMPLETED|Overall Study||11
8543599|NCT00214461|21063054|P3|COMPLETED|Overall Study||10
8543600|NCT00214461|21063055|P2|COMPLETED|Overall Study||12
8543601|NCT00214461|21063056|P1|COMPLETED|Overall Study||12
8543602|NCT00214461|21063053|P4|STARTED|Overall Study||12
8543603|NCT00214461|21063054|P3|STARTED|Overall Study||12
8543604|NCT00214461|21063055|P2|STARTED|Overall Study||12
8543605|NCT00214461|21063056|P1|STARTED|Overall Study||12
8543606|NCT00214422|21063073|P3|NOT COMPLETED|Overall Study||1
8543607|NCT00214422|21063074|P2|NOT COMPLETED|Overall Study||1
8543608|NCT00214422|21063075|P1|NOT COMPLETED|Overall Study||5
8543609|NCT00214422|21063073|P3|COMPLETED|Overall Study||3
8543610|NCT00214422|21063074|P2|COMPLETED|Overall Study||2
8543611|NCT00214422|21063075|P1|COMPLETED|Overall Study||7
8543612|NCT00214422|21063073|P3|STARTED|Overall Study||4
8543613|NCT00214422|21063074|P2|STARTED|Overall Study||3
8543614|NCT00214422|21063075|P1|STARTED|Overall Study||12
8543615|NCT00214383|21063098|P2|NOT COMPLETED|Overall Study||26
8543616|NCT00214383|21063099|P1|NOT COMPLETED|Overall Study||16
8543617|NCT00214383|21063098|P2|COMPLETED|Overall Study||127
8543618|NCT00214383|21063099|P1|COMPLETED|Overall Study||132
8543619|NCT00214383|21063098|P2|STARTED|Overall Study||153
8543620|NCT00214383|21063099|P1|STARTED|Overall Study||148
8543621|NCT00214201|21063111|P2|NOT COMPLETED|Overall Study||2
8543622|NCT00214201|21063112|P1|NOT COMPLETED|Overall Study||2
8543623|NCT00214201|21063111|P2|COMPLETED|Overall Study||18
8543624|NCT00214201|21063112|P1|COMPLETED|Overall Study||18
8543625|NCT00214201|21063111|P2|STARTED|Overall Study||20
8543626|NCT00214201|21063112|P1|STARTED|Overall Study||20
8543627|NCT00214149|21063122|P1|NOT COMPLETED|Overall Study||127
8543720|NCT00213135|21063242|P1|STARTED|Overall Study||456
8543628|NCT00214149|21063122|P1|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
8543629|NCT00214149|21063122|P1|STARTED|Overall Study||127
8543633|NCT00214097|21063135|P3|NOT COMPLETED|Overall Study||0
8543634|NCT00214097|21063136|P2|NOT COMPLETED|Overall Study||0
8543635|NCT00214097|21063137|P1|NOT COMPLETED|Overall Study||0
8543636|NCT00214097|21063135|P3|COMPLETED|Overall Study||135
8543637|NCT00214097|21063136|P2|COMPLETED|Overall Study||111
8543638|NCT00214097|21063137|P1|COMPLETED|Overall Study||101
8543639|NCT00214097|21063135|P3|STARTED|Overall Study||135
8543640|NCT00214097|21063136|P2|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111
8543641|NCT00214097|21063137|P1|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101
8543642|NCT00214045|21063165|P2|NOT COMPLETED|Overall Study||0
8543643|NCT00214045|21063166|P1|NOT COMPLETED|Overall Study||0
8543644|NCT00214045|21063165|P2|COMPLETED|Overall Study||18
8543645|NCT00214045|21063166|P1|COMPLETED|Overall Study||18
8543646|NCT00214045|21063165|P2|STARTED|Overall Study||18
8543647|NCT00214045|21063166|P1|STARTED|Overall Study||18
8543648|NCT00214019|21063172|P1|NOT COMPLETED|Overall Study||30
8543649|NCT00214019|21063172|P1|COMPLETED|Overall Study||6
8543650|NCT00214019|21063172|P1|Fluticason/Salmeterol Arm|Overall Study||6
8543651|NCT00214019|21063172|P1|Fluticasone/Placebo Arm|Overall Study||6
8543652|NCT00214019|21063172|P1|Placebo/Salmeterol Arm|Overall Study||6
8543653|NCT00214019|21063172|P1|Placebo/Placebo Arm|Overall Study||6
8543654|NCT00214019|21063172|P1|STARTED|Overall Study||36
8543655|NCT00213980|21063181|P2|NOT COMPLETED|Overall Study||7
8543656|NCT00213980|21063182|P1|NOT COMPLETED|Overall Study||6
8543657|NCT00213980|21063181|P2|COMPLETED|Overall Study||29
8543658|NCT00213980|21063182|P1|COMPLETED|Overall Study||26
8543659|NCT00213980|21063181|P2|STARTED|Overall Study||36
8543660|NCT00213980|21063182|P1|STARTED|Overall Study||32
8543661|NCT00213239|21063196|P2|NOT COMPLETED|Overall Study||0
8543662|NCT00213239|21063197|P1|NOT COMPLETED|Overall Study||0
8543663|NCT00213239|21063196|P2|COMPLETED|Overall Study||32
8543664|NCT00213239|21063197|P1|COMPLETED|Overall Study||32
8543665|NCT00213239|21063196|P2|STARTED|Overall Study||32
8543666|NCT00213239|21063197|P1|STARTED|Overall Study||32
8543667|NCT00213148|21063209|P5|NOT COMPLETED|Cycle 3 (1 Month)||1
8543668|NCT00213148|21063210|P4|NOT COMPLETED|Cycle 3 (1 Month)||1
8543669|NCT00213148|21063211|P3|NOT COMPLETED|Cycle 3 (1 Month)||1
8543670|NCT00213148|21063212|P2|NOT COMPLETED|Cycle 3 (1 Month)||2
8543671|NCT00213148|21063213|P1|NOT COMPLETED|Cycle 3 (1 Month)||0
8543672|NCT00213148|21063209|P5|COMPLETED|Cycle 3 (1 Month)||21
8543673|NCT00213148|21063210|P4|COMPLETED|Cycle 3 (1 Month)||23
8543674|NCT00213148|21063211|P3|COMPLETED|Cycle 3 (1 Month)||25
8543675|NCT00213148|21063212|P2|COMPLETED|Cycle 3 (1 Month)||8
8543676|NCT00213148|21063213|P1|COMPLETED|Cycle 3 (1 Month)||23
8543677|NCT00213148|21063209|P5|STARTED|Cycle 3 (1 Month)||22
8543678|NCT00213148|21063210|P4|STARTED|Cycle 3 (1 Month)||24
8543679|NCT00213148|21063211|P3|STARTED|Cycle 3 (1 Month)||26
8543680|NCT00213148|21063212|P2|STARTED|Cycle 3 (1 Month)||10
8543681|NCT00213148|21063213|P1|STARTED|Cycle 3 (1 Month)||23
8543682|NCT00213148|21063209|P5|NOT COMPLETED|Cycle 2 (1 Month)||30
8543683|NCT00213148|21063210|P4|NOT COMPLETED|Cycle 2 (1 Month)||19
8543684|NCT00213148|21063211|P3|NOT COMPLETED|Cycle 2 (1 Month)||14
8543685|NCT00213148|21063212|P2|NOT COMPLETED|Cycle 2 (1 Month)||6
8543686|NCT00213148|21063213|P1|NOT COMPLETED|Cycle 2 (1 Month)||14
8543687|NCT00213148|21063209|P5|COMPLETED|Cycle 2 (1 Month)||11
8543688|NCT00213148|21063210|P4|COMPLETED|Cycle 2 (1 Month)||33
8543689|NCT00213148|21063211|P3|COMPLETED|Cycle 2 (1 Month)||28
8543690|NCT00213148|21063212|P2|COMPLETED|Cycle 2 (1 Month)||4
8543691|NCT00213148|21063213|P1|COMPLETED|Cycle 2 (1 Month)||29
8543692|NCT00213148|21063209|P5|STARTED|Cycle 2 (1 Month)||41
8543693|NCT00213148|21063210|P4|STARTED|Cycle 2 (1 Month)||52
8543694|NCT00213148|21063211|P3|STARTED|Cycle 2 (1 Month)||42
8543695|NCT00213148|21063212|P2|STARTED|Cycle 2 (1 Month)||10
8543696|NCT00213148|21063213|P1|STARTED|Cycle 2 (1 Month)||43
8543697|NCT00213148|21063209|P5|NOT COMPLETED|Cycle 1 (1 Month)||22
8543698|NCT00213148|21063210|P4|NOT COMPLETED|Cycle 1 (1 Month)||18
8543699|NCT00213148|21063211|P3|NOT COMPLETED|Cycle 1 (1 Month)||19
8543700|NCT00213148|21063212|P2|NOT COMPLETED|Cycle 1 (1 Month)||0
8543701|NCT00213148|21063213|P1|NOT COMPLETED|Cycle 1 (1 Month)||24
8543702|NCT00213148|21063209|P5|COMPLETED|Cycle 1 (1 Month)||17
8543703|NCT00213148|21063210|P4|COMPLETED|Cycle 1 (1 Month)||58
8543704|NCT00213148|21063211|P3|COMPLETED|Cycle 1 (1 Month)||60
8543705|NCT00213148|21063212|P2|COMPLETED|Cycle 1 (1 Month)||0
8543706|NCT00213148|21063213|P1|COMPLETED|Cycle 1 (1 Month)||53
8543707|NCT00213148|21063209|P5|STARTED|Cycle 1 (1 Month)||39
8543708|NCT00213148|21063210|P4|STARTED|Cycle 1 (1 Month)||76
8543709|NCT00213148|21063211|P3|STARTED|Cycle 1 (1 Month)||79
8543710|NCT00213148|21063212|P2|STARTED|Cycle 1 (1 Month)||0
8543711|NCT00213148|21063213|P1|STARTED|Cycle 1 (1 Month)||77
8543712|NCT00213135|21063240|P3|NOT COMPLETED|Overall Study||57
8543713|NCT00213135|21063241|P2|NOT COMPLETED|Overall Study||35
8543714|NCT00213135|21063242|P1|NOT COMPLETED|Overall Study||50
8543715|NCT00213135|21063240|P3|COMPLETED|Overall Study||380
8543716|NCT00213135|21063241|P2|COMPLETED|Overall Study||398
8543717|NCT00213135|21063242|P1|COMPLETED|Overall Study||406
8543718|NCT00213135|21063240|P3|STARTED|Overall Study||437
8543719|NCT00213135|21063241|P2|STARTED|Overall Study||433
8543721|NCT00212888|21063262|P3|NOT COMPLETED|Overall Study||1
8543722|NCT00212888|21063263|P2|NOT COMPLETED|Overall Study||0
8543723|NCT00212888|21063264|P1|NOT COMPLETED|Overall Study||3
8543724|NCT00212888|21063262|P3|COMPLETED|Overall Study||14
8543725|NCT00212888|21063263|P2|COMPLETED|Overall Study||18
8543726|NCT00212888|21063264|P1|COMPLETED|Overall Study||16
8543727|NCT00212888|21063262|P3|STARTED|Overall Study||15
8543728|NCT00212888|21063263|P2|STARTED|Overall Study||18
8543729|NCT00212888|21063264|P1|STARTED|Overall Study||19
8543730|NCT00212758|21063285|P2|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
8543731|NCT00212758|21063286|P1|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
8543732|NCT00212758|21063285|P2|COMPLETED|Standard Therapy of GH (12 Months)||8
8543733|NCT00212758|21063286|P1|COMPLETED|Standard Therapy of GH (12 Months)||6
8543734|NCT00212758|21063285|P2|STARTED|Standard Therapy of GH (12 Months)||9
8543735|NCT00212758|21063286|P1|STARTED|Standard Therapy of GH (12 Months)||8
8543736|NCT00212758|21063285|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8543737|NCT00212758|21063286|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8543738|NCT00212758|21063285|P2|COMPLETED|Second Intervention (7 Days)||9
8543739|NCT00212758|21063286|P1|COMPLETED|Second Intervention (7 Days)||8
8543740|NCT00212758|21063285|P2|STARTED|Second Intervention (7 Days)||9
8543741|NCT00212758|21063286|P1|STARTED|Second Intervention (7 Days)||8
8543742|NCT00212758|21063285|P2|NOT COMPLETED|Wash Out Period (2 Weeks)||0
8543743|NCT00212758|21063286|P1|NOT COMPLETED|Wash Out Period (2 Weeks)||0
8543744|NCT00212758|21063285|P2|COMPLETED|Wash Out Period (2 Weeks)||9
8543745|NCT00212758|21063286|P1|COMPLETED|Wash Out Period (2 Weeks)||8
8543746|NCT00212758|21063285|P2|STARTED|Wash Out Period (2 Weeks)||9
8543747|NCT00212758|21063286|P1|STARTED|Wash Out Period (2 Weeks)||8
8543748|NCT00212758|21063285|P2|NOT COMPLETED|First Intervention (7 Days)||0
8543749|NCT00212758|21063286|P1|NOT COMPLETED|First Intervention (7 Days)||0
8543750|NCT00212758|21063285|P2|COMPLETED|First Intervention (7 Days)||9
8543751|NCT00212758|21063286|P1|COMPLETED|First Intervention (7 Days)||8
8543752|NCT00212758|21063285|P2|STARTED|First Intervention (7 Days)||9
8543753|NCT00212758|21063286|P1|STARTED|First Intervention (7 Days)||8
8543754|NCT00212446|21063292|P1|NOT COMPLETED|Overall Study||0
8543755|NCT00212446|21063292|P1|COMPLETED|Overall Study||8
8543756|NCT00212446|21063292|P1|STARTED|Overall Study||8
8543757|NCT00212355|21063302|P1|NOT COMPLETED|Overall Study||3
8543758|NCT00212355|21063302|P1|COMPLETED|Overall Study||34
8543759|NCT00212355|21063302|P1|STARTED|Overall Study||37
8543760|NCT00212264|21063309|P3|NOT COMPLETED|Overall Study||4
8543761|NCT00212264|21063310|P2|NOT COMPLETED|Overall Study||16
8543762|NCT00212264|21063311|P1|NOT COMPLETED|Overall Study||12
8543763|NCT00212264|21063309|P3|COMPLETED|Overall Study||64
8543764|NCT00212264|21063310|P2|COMPLETED|Overall Study||54
8543765|NCT00212264|21063311|P1|COMPLETED|Overall Study||58
8543766|NCT00212264|21063309|P3|STARTED|Overall Study||68
8543767|NCT00212264|21063310|P2|STARTED|Overall Study||70
8543768|NCT00212264|21063311|P1|STARTED|Overall Study||70
8543789|NCT00211887|21063345|P3|NOT COMPLETED|Overall Study||36
8543790|NCT00211887|21063346|P2|NOT COMPLETED|Overall Study||56
8543791|NCT00211887|21063347|P1|NOT COMPLETED|Overall Study||102
8543792|NCT00211887|21063345|P3|COMPLETED|Overall Study||223
8543793|NCT00211887|21063346|P2|COMPLETED|Overall Study||194
8543794|NCT00211887|21063347|P1|COMPLETED|Overall Study||397
8543795|NCT00211887|21063345|P3|STARTED|Overall Study||259
8543796|NCT00211887|21063346|P2|STARTED|Overall Study||250
8543797|NCT00211887|21063347|P1|STARTED|Overall Study||499
8543798|NCT00211809|21063364|P1|NOT COMPLETED|Overall Study||6
8543799|NCT00211809|21063364|P1|COMPLETED|Overall Study||11
8543800|NCT00211809|21063364|P1|STARTED|Overall Study||17
8543801|NCT00211757|21063380|P2|NOT COMPLETED|Overall Study||2
8543802|NCT00211757|21063381|P1|NOT COMPLETED|Overall Study||1
8543803|NCT00211757|21063380|P2|COMPLETED|Overall Study||14
8543804|NCT00211757|21063381|P1|COMPLETED|Overall Study||10
8543805|NCT00211757|21063380|P2|STARTED|Overall Study||16
8543806|NCT00211757|21063381|P1|STARTED|Overall Study||11
8543807|NCT00211692|21063391|P2|NOT COMPLETED|Overall Study||0
8543808|NCT00211692|21063392|P1|NOT COMPLETED|Overall Study||0
8543809|NCT00211692|21063391|P2|COMPLETED|Overall Study||31
8543810|NCT00211692|21063392|P1|COMPLETED|Overall Study||33
8543811|NCT00211692|21063391|P2|STARTED|Overall Study||31
8543812|NCT00211692|21063392|P1|STARTED|Overall Study||33
8543813|NCT00211536|21063402|P2|NOT COMPLETED|Overall Study||7
8543814|NCT00211536|21063403|P1|NOT COMPLETED|Overall Study||4
8543815|NCT00211536|21063402|P2|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
8543816|NCT00211536|21063403|P1|COMPLETED|Overall Study||49
8543817|NCT00211536|21063402|P2|As Treated Data Analysis Set|Overall Study||48
8543818|NCT00211536|21063403|P1|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
8543819|NCT00211536|21063402|P2|STARTED|Overall Study||54
8543820|NCT00211536|21063403|P1|STARTED|Overall Study||53
8543821|NCT00211510|21063419|P2|NOT COMPLETED|Overall Study||2
8543822|NCT00211510|21063420|P1|NOT COMPLETED|Overall Study||6
8543823|NCT00211510|21063419|P2|COMPLETED|Overall Study||72
8543824|NCT00211510|21063420|P1|COMPLETED|Overall Study||66
8543825|NCT00211510|21063419|P2|STARTED|Overall Study||74
8543826|NCT00211510|21063420|P1|STARTED|Overall Study||72
8543827|NCT00211237|21063438|P3|NOT COMPLETED|12 Months||6
8543828|NCT00211237|21063439|P2|NOT COMPLETED|12 Months||2
8543829|NCT00211237|21063440|P1|NOT COMPLETED|12 Months||9
8543830|NCT00211237|21063438|P3|COMPLETED|12 Months||28
8543831|NCT00211237|21063439|P2|COMPLETED|12 Months||6
8543832|NCT00211237|21063440|P1|COMPLETED|12 Months||40
8543833|NCT00211237|21063438|P3|STARTED|12 Months||34
8543834|NCT00211237|21063439|P2|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
8543835|NCT00211237|21063440|P1|STARTED|12 Months||49
8543836|NCT00211237|21063438|P3|NOT COMPLETED|6 Months||3
8543837|NCT00211237|21063439|P2|NOT COMPLETED|6 Months||2
8543838|NCT00211237|21063440|P1|NOT COMPLETED|6 Months||8
8543839|NCT00211237|21063438|P3|COMPLETED|6 Months||33
8543840|NCT00211237|21063439|P2|COMPLETED|6 Months||9
8543841|NCT00211237|21063440|P1|COMPLETED|6 Months||49
8543842|NCT00211237|21063438|P3|STARTED|6 Months||36
8543843|NCT00211237|21063439|P2|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
8543844|NCT00211237|21063440|P1|STARTED|6 Months||57
8543845|NCT00211237|21063438|P3|NOT COMPLETED|3 Months||1
8543846|NCT00211237|21063439|P2|NOT COMPLETED|3 Months||4
8543847|NCT00211237|21063440|P1|NOT COMPLETED|3 Months||8
8543848|NCT00211237|21063438|P3|COMPLETED|3 Months||33
8543849|NCT00211237|21063439|P2|COMPLETED|3 Months||14
8543850|NCT00211237|21063440|P1|COMPLETED|3 Months||57
8543851|NCT00211237|21063438|P3|STARTED|3 Months||34
8543852|NCT00211237|21063439|P2|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
8543853|NCT00211237|21063440|P1|STARTED|3 Months||65
8543854|NCT00211237|21063438|P3|NOT COMPLETED|1 Month||0
8543855|NCT00211237|21063439|P2|NOT COMPLETED|1 Month||9
8543856|NCT00211237|21063440|P1|NOT COMPLETED|1 Month||3
8543857|NCT00211237|21063438|P3|COMPLETED|1 Month||0
8543858|NCT00211237|21063439|P2|COMPLETED|1 Month||52
8543859|NCT00211237|21063440|P1|COMPLETED|1 Month||65
8543860|NCT00211237|21063438|P3|STARTED|1 Month||0
8543861|NCT00211237|21063439|P2|STARTED|1 Month||61
8543862|NCT00211237|21063440|P1|STARTED|1 Month||68
8543863|NCT00211237|21063438|P3|NOT COMPLETED|Baseline||0
8543864|NCT00211237|21063439|P2|NOT COMPLETED|Baseline||3
8543865|NCT00211237|21063440|P1|NOT COMPLETED|Baseline||2
8543866|NCT00211237|21063438|P3|COMPLETED|Baseline||0
8543867|NCT00211237|21063439|P2|COMPLETED|Baseline||61
8543868|NCT00211237|21063440|P1|COMPLETED|Baseline||68
8543869|NCT00211237|21063438|P3|STARTED|Baseline||0
8543870|NCT00211237|21063439|P2|STARTED|Baseline||64
8543871|NCT00211237|21063440|P1|STARTED|Baseline||70
8543872|NCT00211185|21063530|P1|NOT COMPLETED|Overall Study||20
8543873|NCT00211185|21063530|P1|COMPLETED|Overall Study||29
8543874|NCT00211185|21063530|P1|STARTED|Overall Study||49
8543875|NCT00211172|21063544|P2|NOT COMPLETED|Overall Study||32
8543876|NCT00211172|21063545|P1|NOT COMPLETED|Overall Study||39
8543877|NCT00211172|21063544|P2|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
8543878|NCT00211172|21063545|P1|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
8543879|NCT00211172|21063544|P2|STARTED|Overall Study||458
8543880|NCT00211172|21063545|P1|STARTED|Overall Study||449
8543881|NCT00211081|21063551|P1|NOT COMPLETED|Overall Study||2
8543882|NCT00211081|21063551|P1|COMPLETED|Overall Study||10
8543883|NCT00211081|21063551|P1|STARTED|Overall Study||12
8543884|NCT00210639|21063563|P2|NOT COMPLETED|Overall Study||42
8543885|NCT00210639|21063564|P1|NOT COMPLETED|Overall Study||63
8543886|NCT00210639|21063563|P2|COMPLETED|Overall Study||41
8543887|NCT00210639|21063564|P1|COMPLETED|Overall Study||61
8543888|NCT00210639|21063563|P2|STARTED|Overall Study||83
8543889|NCT00210639|21063564|P1|STARTED|Overall Study||124
8543890|NCT00210626|21063572|P2|NOT COMPLETED|Overall Study||45
8543891|NCT00210626|21063573|P1|NOT COMPLETED|Overall Study||48
8543892|NCT00210626|21063572|P2|COMPLETED|Overall Study||50
8543893|NCT00210626|21063573|P1|COMPLETED|Overall Study||49
8543894|NCT00210626|21063572|P2|STARTED|Overall Study||95
8543895|NCT00210626|21063573|P1|STARTED|Overall Study||97
8543896|NCT00210470|21063581|P1|NOT COMPLETED|Overall Study||0
8543897|NCT00210470|21063581|P1|COMPLETED|Overall Study||27
8543898|NCT00210470|21063581|P1|STARTED|Overall Study||27
8543899|NCT00210353|21063596|P3|NOT COMPLETED|Overall Study||26
8543900|NCT00210353|21063597|P2|NOT COMPLETED|Overall Study||45
8543901|NCT00210353|21063598|P1|NOT COMPLETED|Overall Study||38
8543902|NCT00210353|21063596|P3|COMPLETED|Overall Study||125
8543903|NCT00210353|21063597|P2|COMPLETED|Overall Study||107
8543904|NCT00210353|21063598|P1|COMPLETED|Overall Study||113
8543905|NCT00210353|21063596|P3|STARTED|Overall Study||151
8543906|NCT00210353|21063597|P2|STARTED|Overall Study||152
8543907|NCT00210353|21063598|P1|STARTED|Overall Study||151
8543908|NCT00209560|21063620|P2|NOT COMPLETED|Overall Study||0
8543909|NCT00209560|21063621|P1|NOT COMPLETED|Overall Study||1
8543910|NCT00209560|21063620|P2|COMPLETED|Overall Study||42
8543911|NCT00209560|21063621|P1|COMPLETED|Overall Study||120
8543912|NCT00209560|21063620|P2|STARTED|Overall Study||42
8543913|NCT00209560|21063621|P1|STARTED|Overall Study||121
8543914|NCT00209417|21063631|P2|NOT COMPLETED|Overall Study||0
8543915|NCT00209417|21063632|P1|NOT COMPLETED|Overall Study||0
8543916|NCT00209417|21063631|P2|COMPLETED|Overall Study||327
8543917|NCT00209417|21063632|P1|COMPLETED|Overall Study||321
8543918|NCT00209417|21063631|P2|STARTED|Overall Study||327
8543919|NCT00209417|21063632|P1|STARTED|Overall Study||321
8543920|NCT00209339|21063640|P1|NOT COMPLETED|At 5 Years Follow-up||8
8543921|NCT00209339|21063640|P1|COMPLETED|At 5 Years Follow-up||15
8543922|NCT00209339|21063640|P1|STARTED|At 5 Years Follow-up||23
8543923|NCT00209339|21063640|P1|NOT COMPLETED|At 4 Years Follow-up||5
8543924|NCT00209339|21063640|P1|COMPLETED|At 4 Years Follow-up||23
8543925|NCT00209339|21063640|P1|STARTED|At 4 Years Follow-up||28
8543926|NCT00209339|21063640|P1|NOT COMPLETED|At 3 Years Follow-up||1
8543927|NCT00209339|21063640|P1|COMPLETED|At 3 Years Follow-up||28
8543928|NCT00209339|21063640|P1|STARTED|At 3 Years Follow-up||29
8543929|NCT00209339|21063640|P1|NOT COMPLETED|At 24 Months Follow-up||11
8543930|NCT00209339|21063640|P1|COMPLETED|At 24 Months Follow-up||29
8543931|NCT00209339|21063640|P1|STARTED|At 24 Months Follow-up||40
8543932|NCT00209339|21063640|P1|NOT COMPLETED|At 12 Months Follow-up||15
8543933|NCT00209339|21063640|P1|COMPLETED|At 12 Months Follow-up||40
8543934|NCT00209339|21063640|P1|STARTED|At 12 Months Follow-up||55
8543935|NCT00209274|21063724|P2|NOT COMPLETED|Overall Study||47
8543936|NCT00209274|21063725|P1|NOT COMPLETED|Overall Study||71
8543937|NCT00209274|21063724|P2|COMPLETED|Overall Study||48
8543938|NCT00209274|21063725|P1|COMPLETED|Overall Study||113
8543939|NCT00209274|21063724|P2|STARTED|Overall Study||95
8543940|NCT00209274|21063725|P1|STARTED|Overall Study||184
8543941|NCT00209170|21064045|P2|NOT COMPLETED|Overall Study||3
8543942|NCT00209170|21064046|P1|NOT COMPLETED|Overall Study||2
8543943|NCT00209170|21064045|P2|COMPLETED|Overall Study||4
8543944|NCT00209170|21064046|P1|COMPLETED|Overall Study||5
8543945|NCT00209170|21064045|P2|STARTED|Overall Study||7
8543946|NCT00209170|21064046|P1|STARTED|Overall Study||7
8543947|NCT00209131|21064054|P2|NOT COMPLETED|Overall Study||11
8543948|NCT00209131|21064055|P1|NOT COMPLETED|Overall Study||15
8543949|NCT00209131|21064054|P2|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
8543950|NCT00209131|21064055|P1|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
8543951|NCT00209131|21064054|P2|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
8543952|NCT00209131|21064055|P1|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
8543953|NCT00209092|21064065|P2|NOT COMPLETED|Overall Study||2
8543954|NCT00209092|21064066|P1|NOT COMPLETED|Overall Study||8
8543955|NCT00209092|21064065|P2|COMPLETED|Overall Study||24
8543956|NCT00209092|21064066|P1|COMPLETED|Overall Study||17
8543957|NCT00209092|21064065|P2|STARTED|Overall Study||26
8543958|NCT00209092|21064066|P1|STARTED|Overall Study||25
8543959|NCT00209027|21064076|P2|NOT COMPLETED|Overall Study||0
8543960|NCT00209027|21064077|P1|NOT COMPLETED|Overall Study||10
8543961|NCT00209027|21064076|P2|COMPLETED|Overall Study||10
8543962|NCT00209027|21064077|P1|COMPLETED|Overall Study||0
8543963|NCT00209027|21064076|P2|STARTED|Overall Study||10
8543964|NCT00209027|21064077|P1|STARTED|Overall Study||10
8543965|NCT00208975|21064083|P1|NOT COMPLETED|Overall Study||0
8543966|NCT00208975|21064083|P1|COMPLETED|Overall Study||15
8543967|NCT00208975|21064083|P1|STARTED|Overall Study||15
8543968|NCT00208949|21064090|P2|NOT COMPLETED|Overall Study||0
8543969|NCT00208949|21064091|P1|NOT COMPLETED|Overall Study||0
8543970|NCT00208949|21064090|P2|COMPLETED|Overall Study||25
8543971|NCT00208949|21064091|P1|COMPLETED|Overall Study||25
8543972|NCT00208949|21064090|P2|STARTED|Overall Study||25
8543973|NCT00208949|21064091|P1|STARTED|Overall Study||25
8543974|NCT00208767|21064101|P2|NOT COMPLETED|Overall Study||7
8543975|NCT00208767|21064102|P1|NOT COMPLETED|Overall Study||27
8543976|NCT00208767|21064101|P2|COMPLETED|Overall Study||33
8543977|NCT00208767|21064102|P1|COMPLETED|Overall Study||53
8543978|NCT00208767|21064101|P2|STARTED|Overall Study||40
8543979|NCT00208767|21064102|P1|STARTED|Overall Study||80
8543980|NCT00208507|21064110|P2|NOT COMPLETED|Overall Study||8
8543981|NCT00208507|21064111|P1|NOT COMPLETED|Overall Study||14
8543982|NCT00208507|21064110|P2|COMPLETED|Overall Study||79
8543983|NCT00208507|21064111|P1|COMPLETED|Overall Study||163
8543984|NCT00208507|21064110|P2|STARTED|Overall Study||87
8543985|NCT00208507|21064111|P1|STARTED|Overall Study||177
8543986|NCT00208494|21064119|P2|NOT COMPLETED|Overall Study||34
8543987|NCT00208494|21064120|P1|NOT COMPLETED|Overall Study||30
8543988|NCT00208494|21064119|P2|COMPLETED|Overall Study||162
8543989|NCT00208494|21064120|P1|COMPLETED|Overall Study||164
8543990|NCT00208494|21064119|P2|STARTED|Overall Study||196
8543991|NCT00208494|21064120|P1|STARTED|Overall Study||194
8543992|NCT00208325|21064130|P4|NOT COMPLETED|Overall Study||14
8543993|NCT00208325|21064131|P3|NOT COMPLETED|Overall Study||14
8543994|NCT00208325|21064132|P2|NOT COMPLETED|Overall Study||54
8543995|NCT00208325|21064133|P1|NOT COMPLETED|Overall Study||51
8543996|NCT00208325|21064130|P4|COMPLETED|Overall Study||147
8543997|NCT00208325|21064131|P3|COMPLETED|Overall Study||156
8543998|NCT00208325|21064132|P2|COMPLETED|Overall Study||142
8543999|NCT00208325|21064133|P1|COMPLETED|Overall Study||142
8544000|NCT00208325|21064130|P4|STARTED|Overall Study||161
8544001|NCT00208325|21064131|P3|STARTED|Overall Study||170
8544002|NCT00208325|21064132|P2|STARTED|Overall Study||196
8544003|NCT00208325|21064133|P1|STARTED|Overall Study||193
8544004|NCT00208091|21064241|P1|NOT COMPLETED|Overall Study||0
8544005|NCT00208091|21064241|P1|COMPLETED|Overall Study||16
8544006|NCT00208091|21064241|P1|STARTED|Overall Study||16
8544007|NCT00208026|21064249|P1|NOT COMPLETED|Overall Study||0
8544008|NCT00208026|21064249|P1|COMPLETED|Overall Study||3
8544009|NCT00208026|21064249|P1|STARTED|Overall Study||3
8544010|NCT00207883|21064257|P2|NOT COMPLETED|Overall Study||0
8544011|NCT00207883|21064258|P1|NOT COMPLETED|Overall Study||0
8544012|NCT00207883|21064257|P2|COMPLETED|Overall Study||119
8544013|NCT00207883|21064258|P1|COMPLETED|Overall Study||93
8544014|NCT00207883|21064257|P2|STARTED|Overall Study||119
8544015|NCT00207883|21064258|P1|STARTED|Overall Study||93
8544016|NCT00207740|21064270|P4|NOT COMPLETED|Overall Study||43
8544017|NCT00207740|21064271|P3|NOT COMPLETED|Overall Study||40
8544018|NCT00207740|21064272|P2|NOT COMPLETED|Overall Study||41
8544019|NCT00207740|21064273|P1|NOT COMPLETED|Overall Study||29
8544020|NCT00207740|21064270|P4|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
8544021|NCT00207740|21064271|P3|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
8544022|NCT00207740|21064272|P2|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
8544023|NCT00207740|21064273|P1|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
8544024|NCT00207740|21064270|P4|STARTED|Overall Study||78
8544025|NCT00207740|21064271|P3|STARTED|Overall Study||76
8544026|NCT00207740|21064272|P2|STARTED|Overall Study||77
8544027|NCT00207740|21064273|P1|STARTED|Overall Study||78
8544028|NCT00207727|21064319|P5|NOT COMPLETED|Overall Study||34
8544029|NCT00207727|21064320|P4|NOT COMPLETED|Overall Study||37
8544030|NCT00207727|21064321|P3|NOT COMPLETED|Overall Study||41
8544031|NCT00207727|21064322|P2|NOT COMPLETED|Overall Study||42
8544032|NCT00207727|21064323|P1|NOT COMPLETED|Overall Study||38
8544033|NCT00207727|21064319|P5|COMPLETED|Overall Study||16
8544034|NCT00207727|21064320|P4|COMPLETED|Overall Study||13
8544035|NCT00207727|21064321|P3|COMPLETED|Overall Study||9
8544036|NCT00207727|21064322|P2|COMPLETED|Overall Study||8
8544037|NCT00207727|21064323|P1|COMPLETED|Overall Study||11
8544038|NCT00207727|21064319|P5|STARTED|Overall Study||50
8544039|NCT00207727|21064320|P4|STARTED|Overall Study||50
8544040|NCT00207727|21064321|P3|STARTED|Overall Study||50
8544041|NCT00207727|21064322|P2|STARTED|Overall Study||50
8544042|NCT00207727|21064323|P1|STARTED|Overall Study||49
8544043|NCT00207714|21064350|P5|NOT COMPLETED|Overall Study||5
8544044|NCT00207714|21064351|P4|NOT COMPLETED|Overall Study||8
8544045|NCT00207714|21064352|P3|NOT COMPLETED|Overall Study||10
8544046|NCT00207714|21064353|P2|NOT COMPLETED|Overall Study||7
8544047|NCT00207714|21064354|P1|NOT COMPLETED|Overall Study||14
8544048|NCT00207714|21064350|P5|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
8544049|NCT00207714|21064351|P4|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
8544050|NCT00207714|21064352|P3|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
8544051|NCT00207714|21064353|P2|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
8544052|NCT00207714|21064354|P1|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
8544053|NCT00207714|21064350|P5|STARTED|Overall Study||34
8544054|NCT00207714|21064351|P4|STARTED|Overall Study||34
8544055|NCT00207714|21064352|P3|STARTED|Overall Study||34
8544056|NCT00207714|21064353|P2|STARTED|Overall Study||35
8544057|NCT00207714|21064354|P1|STARTED|Overall Study||35
8544058|NCT00207142|21064376|P4|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
8544059|NCT00207142|21064377|P3|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
8544060|NCT00207142|21064378|P2|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
8544061|NCT00207142|21064379|P1|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
8544062|NCT00207142|21064376|P4|COMPLETED|Maintenance Phase/Rescue Phase||41
8544063|NCT00207142|21064377|P3|COMPLETED|Maintenance Phase/Rescue Phase||72
8544064|NCT00207142|21064378|P2|COMPLETED|Maintenance Phase/Rescue Phase||78
8544065|NCT00207142|21064379|P1|COMPLETED|Maintenance Phase/Rescue Phase||0
8544066|NCT00207142|21064376|P4|STARTED|Maintenance Phase/Rescue Phase||50
8544067|NCT00207142|21064377|P3|STARTED|Maintenance Phase/Rescue Phase||85
8544068|NCT00207142|21064378|P2|STARTED|Maintenance Phase/Rescue Phase||87
8544069|NCT00207142|21064379|P1|STARTED|Maintenance Phase/Rescue Phase||0
8544070|NCT00207142|21064376|P4|NOT COMPLETED|Induction Phase||0
8544071|NCT00207142|21064377|P3|NOT COMPLETED|Induction Phase||0
8544072|NCT00207142|21064378|P2|NOT COMPLETED|Induction Phase||0
8544073|NCT00207142|21064379|P1|NOT COMPLETED|Induction Phase||30
8544074|NCT00207142|21064376|P4|COMPLETED|Induction Phase||0
8544075|NCT00207142|21064377|P3|COMPLETED|Induction Phase||0
8544076|NCT00207142|21064378|P2|COMPLETED|Induction Phase||0
8544167|NCT00205777|21064632|P4|NOT COMPLETED|Study Extension II||149
8544077|NCT00207142|21064379|P1|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
8544078|NCT00207142|21064376|P4|STARTED|Induction Phase||0
8544079|NCT00207142|21064377|P3|STARTED|Induction Phase||0
8544080|NCT00207142|21064378|P2|STARTED|Induction Phase||0
8544081|NCT00207142|21064379|P1|STARTED|Induction Phase||252
8544082|NCT00207090|21064416|P1|NOT COMPLETED|Overall Study||7
8544083|NCT00207090|21064416|P1|COMPLETED|Overall Study||8
8544084|NCT00207090|21064416|P1|STARTED|Overall Study|Number of participants treated|15
8544085|NCT00206726|21064445|P1|NOT COMPLETED|Overall Study||51
8544086|NCT00206726|21064445|P1|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
8544087|NCT00206726|21064445|P1|4 Cycles Completed|Overall Study|per protocol population|41
8544088|NCT00206726|21064445|P1|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
8544089|NCT00206726|21064445|P1|STARTED|Overall Study||60
8544090|NCT00206518|21064456|P2|NOT COMPLETED|Overall Study||6
8544091|NCT00206518|21064457|P1|NOT COMPLETED|Overall Study||10
8544092|NCT00206518|21064456|P2|COMPLETED|Overall Study||78
8544093|NCT00206518|21064457|P1|COMPLETED|Overall Study||73
8544094|NCT00206518|21064456|P2|STARTED|Overall Study||84
8544095|NCT00206518|21064457|P1|STARTED|Overall Study||83
8544096|NCT00206440|21064469|P2|NOT COMPLETED|Overall Study||4
8544097|NCT00206440|21064470|P1|NOT COMPLETED|Overall Study||5
8544098|NCT00206440|21064469|P2|COMPLETED|Overall Study||18
8544099|NCT00206440|21064470|P1|COMPLETED|Overall Study||16
8544100|NCT00206440|21064469|P2|STARTED|Overall Study||22
8544101|NCT00206440|21064470|P1|STARTED|Overall Study||21
8544102|NCT00206427|21064476|P1|NOT COMPLETED|Overall Study||2
8544103|NCT00206427|21064476|P1|COMPLETED|Overall Study|Complete 6-week therapy|47
8544104|NCT00206427|21064476|P1|STARTED|Overall Study|Received First Dose|49
8544105|NCT00206375|21064483|P3|NOT COMPLETED|Overall Study||4
8544106|NCT00206375|21064484|P2|NOT COMPLETED|Overall Study||2
8544107|NCT00206375|21064485|P1|NOT COMPLETED|Overall Study||3
8544108|NCT00206375|21064483|P3|COMPLETED|Overall Study||3
8544109|NCT00206375|21064484|P2|COMPLETED|Overall Study||1
8544110|NCT00206375|21064485|P1|COMPLETED|Overall Study||3
8544111|NCT00206375|21064483|P3|STARTED|Overall Study||7
8544112|NCT00206375|21064484|P2|STARTED|Overall Study||3
8544113|NCT00206375|21064485|P1|STARTED|Overall Study||6
8544114|NCT00206336|21064499|P1|NOT COMPLETED|Overall Study||0
8544115|NCT00206336|21064499|P1|COMPLETED|Overall Study||20
8544116|NCT00206336|21064499|P1|STARTED|Overall Study||20
8544117|NCT00206323|21064505|P2|NOT COMPLETED|Overall Study||3
8544118|NCT00206323|21064506|P1|NOT COMPLETED|Overall Study||6
8544119|NCT00206323|21064505|P2|COMPLETED|Overall Study||12
8544120|NCT00206323|21064506|P1|COMPLETED|Overall Study||8
8544121|NCT00206323|21064505|P2|STARTED|Overall Study||15
8544122|NCT00206323|21064506|P1|STARTED|Overall Study||14
8544123|NCT00206102|21064514|P2|NOT COMPLETED|Overall Study||315
8544124|NCT00206102|21064515|P1|NOT COMPLETED|Overall Study||408
8544125|NCT00206102|21064514|P2|COMPLETED|Overall Study||187
8544126|NCT00206102|21064515|P1|COMPLETED|Overall Study||188
8544127|NCT00206102|21064514|P2|STARTED|Overall Study||502
8544128|NCT00206102|21064515|P1|STARTED|Overall Study||596
8544129|NCT00206076|21064551|P2|NOT COMPLETED|Overall Study||1
8544130|NCT00206076|21064552|P1|NOT COMPLETED|Overall Study||3
8544131|NCT00206076|21064551|P2|COMPLETED|Overall Study||9
8544132|NCT00206076|21064552|P1|COMPLETED|Overall Study||6
8544133|NCT00206076|21064551|P2|STARTED|Overall Study||10
8544134|NCT00206076|21064552|P1|STARTED|Overall Study||9
8544135|NCT00205881|21064562|P1|NOT COMPLETED|Overall Study||16
8544136|NCT00205881|21064562|P1|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
8544137|NCT00205881|21064562|P1|STARTED|Overall Study||32
8544138|NCT00205855|21064567|P1|NOT COMPLETED|Overall Study||21
8544139|NCT00205855|21064567|P1|COMPLETED|Overall Study||44
8544140|NCT00205855|21064567|P1|STARTED|Overall Study||65
8544141|NCT00205803|21064573|P2|NOT COMPLETED|Toddler Dose||3
8544142|NCT00205803|21064574|P1|NOT COMPLETED|Toddler Dose||2
8544143|NCT00205803|21064573|P2|COMPLETED|Toddler Dose||100
8544144|NCT00205803|21064574|P1|COMPLETED|Toddler Dose||84
8544145|NCT00205803|21064573|P2|STARTED|Toddler Dose||103
8544146|NCT00205803|21064574|P1|STARTED|Toddler Dose||86
8544147|NCT00205803|21064573|P2|NOT COMPLETED|After Infant Series||13
8544148|NCT00205803|21064574|P1|NOT COMPLETED|After Infant Series||18
8544149|NCT00205803|21064573|P2|COMPLETED|After Infant Series||103
8544150|NCT00205803|21064574|P1|COMPLETED|After Infant Series||86
8544151|NCT00205803|21064573|P2|STARTED|After Infant Series||116
8544152|NCT00205803|21064574|P1|STARTED|After Infant Series||104
8544153|NCT00205803|21064573|P2|NOT COMPLETED|Infant Series||11
8544154|NCT00205803|21064574|P1|NOT COMPLETED|Infant Series||18
8544155|NCT00205803|21064573|P2|COMPLETED|Infant Series||116
8544156|NCT00205803|21064574|P1|COMPLETED|Infant Series||104
8544157|NCT00205803|21064573|P2|Vaccinated Dose 3|Infant Series||118
8544158|NCT00205803|21064574|P1|Vaccinated Dose 3|Infant Series||110
8544159|NCT00205803|21064573|P2|Vaccinated Dose 2|Infant Series||122
8544160|NCT00205803|21064574|P1|Vaccinated Dose 2|Infant Series||115
8544161|NCT00205803|21064573|P2|Vaccinated Dose 1|Infant Series||126
8544162|NCT00205803|21064574|P1|Vaccinated Dose 1|Infant Series||121
8544163|NCT00205803|21064573|P2|STARTED|Infant Series||127
8544164|NCT00205803|21064574|P1|STARTED|Infant Series||122
8544165|NCT00205777|21064630|P6|NOT COMPLETED|Study Extension II||282
8544166|NCT00205777|21064631|P5|NOT COMPLETED|Study Extension II||0
8544168|NCT00205777|21064633|P3|NOT COMPLETED|Study Extension II||0
8544169|NCT00205777|21064634|P2|NOT COMPLETED|Study Extension II||0
8544170|NCT00205777|21064635|P1|NOT COMPLETED|Study Extension II||0
8544171|NCT00205777|21064630|P6|COMPLETED|Study Extension II||860
8544172|NCT00205777|21064631|P5|COMPLETED|Study Extension II||0
8544173|NCT00205777|21064632|P4|COMPLETED|Study Extension II||441
8544174|NCT00205777|21064633|P3|COMPLETED|Study Extension II||0
8544175|NCT00205777|21064634|P2|COMPLETED|Study Extension II||0
8544176|NCT00205777|21064635|P1|COMPLETED|Study Extension II||0
8544177|NCT00205777|21064630|P6|TREATED|Study Extension II||1011
8544178|NCT00205777|21064631|P5|TREATED|Study Extension II||0
8544179|NCT00205777|21064632|P4|TREATED|Study Extension II||519
8544180|NCT00205777|21064633|P3|TREATED|Study Extension II||0
8544181|NCT00205777|21064634|P2|TREATED|Study Extension II||0
8544182|NCT00205777|21064635|P1|TREATED|Study Extension II||0
8544183|NCT00205777|21064630|P6|STARTED|Study Extension II||1142
8544184|NCT00205777|21064631|P5|STARTED|Study Extension II||0
8544185|NCT00205777|21064632|P4|STARTED|Study Extension II||590
8544186|NCT00205777|21064633|P3|STARTED|Study Extension II||0
8544187|NCT00205777|21064634|P2|STARTED|Study Extension II||0
8544188|NCT00205777|21064635|P1|STARTED|Study Extension II||0
8544189|NCT00205777|21064630|P6|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
8544190|NCT00205777|21064631|P5|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
8544191|NCT00205777|21064632|P4|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
8544192|NCT00205777|21064633|P3|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
8544193|NCT00205777|21064634|P2|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
8544194|NCT00205777|21064635|P1|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
8544195|NCT00205777|21064630|P6|COMPLETED|Completed SE I, Entered Extension SE II||0
8544196|NCT00205777|21064631|P5|COMPLETED|Completed SE I, Entered Extension SE II||582
8544197|NCT00205777|21064632|P4|COMPLETED|Completed SE I, Entered Extension SE II||590
8544198|NCT00205777|21064633|P3|COMPLETED|Completed SE I, Entered Extension SE II||0
8544199|NCT00205777|21064634|P2|COMPLETED|Completed SE I, Entered Extension SE II||0
8544200|NCT00205777|21064635|P1|COMPLETED|Completed SE I, Entered Extension SE II||560
8544201|NCT00205777|21064630|P6|STARTED|Completed SE I, Entered Extension SE II||0
8544202|NCT00205777|21064631|P5|STARTED|Completed SE I, Entered Extension SE II||840
8544203|NCT00205777|21064632|P4|STARTED|Completed SE I, Entered Extension SE II||830
8544204|NCT00205777|21064633|P3|STARTED|Completed SE I, Entered Extension SE II||0
8544205|NCT00205777|21064634|P2|STARTED|Completed SE I, Entered Extension SE II||0
8544206|NCT00205777|21064635|P1|STARTED|Completed SE I, Entered Extension SE II||833
8544207|NCT00205777|21064630|P6|NOT COMPLETED|Study Extension I||0
8544208|NCT00205777|21064631|P5|NOT COMPLETED|Study Extension I||201
8544209|NCT00205777|21064632|P4|NOT COMPLETED|Study Extension I||228
8544210|NCT00205777|21064633|P3|NOT COMPLETED|Study Extension I||1070
8544211|NCT00205777|21064634|P2|NOT COMPLETED|Study Extension I||0
8544212|NCT00205777|21064635|P1|NOT COMPLETED|Study Extension I||214
8544213|NCT00205777|21064630|P6|COMPLETED|Study Extension I||0
8544214|NCT00205777|21064631|P5|COMPLETED|Study Extension I||840
8544215|NCT00205777|21064632|P4|COMPLETED|Study Extension I||830
8544216|NCT00205777|21064633|P3|COMPLETED|Study Extension I||0
8544217|NCT00205777|21064634|P2|COMPLETED|Study Extension I||0
8544218|NCT00205777|21064635|P1|COMPLETED|Study Extension I||833
8544219|NCT00205777|21064630|P6|STARTED|Study Extension I||0
8544220|NCT00205777|21064631|P5|STARTED|Study Extension I||1041
8544221|NCT00205777|21064632|P4|STARTED|Study Extension I||1058
8544222|NCT00205777|21064633|P3|STARTED|Study Extension I||1070
8544223|NCT00205777|21064634|P2|STARTED|Study Extension I||0
8544224|NCT00205777|21064635|P1|STARTED|Study Extension I||1047
8544225|NCT00205777|21064630|P6|NOT COMPLETED|Completed Core Study, Entered SE I||0
8544226|NCT00205777|21064631|P5|NOT COMPLETED|Completed Core Study, Entered SE I||0
8544227|NCT00205777|21064632|P4|NOT COMPLETED|Completed Core Study, Entered SE I||224
8544228|NCT00205777|21064633|P3|NOT COMPLETED|Completed Core Study, Entered SE I||207
8544229|NCT00205777|21064634|P2|NOT COMPLETED|Completed Core Study, Entered SE I||204
8544230|NCT00205777|21064635|P1|NOT COMPLETED|Completed Core Study, Entered SE I||232
8544231|NCT00205777|21064630|P6|COMPLETED|Completed Core Study, Entered SE I||0
8544232|NCT00205777|21064631|P5|COMPLETED|Completed Core Study, Entered SE I||0
8544233|NCT00205777|21064632|P4|COMPLETED|Completed Core Study, Entered SE I||1058
8544234|NCT00205777|21064633|P3|COMPLETED|Completed Core Study, Entered SE I||1070
8544235|NCT00205777|21064634|P2|COMPLETED|Completed Core Study, Entered SE I||1041
8544236|NCT00205777|21064635|P1|COMPLETED|Completed Core Study, Entered SE I||1047
8544237|NCT00205777|21064630|P6|STARTED|Completed Core Study, Entered SE I||0
8544238|NCT00205777|21064631|P5|STARTED|Completed Core Study, Entered SE I||0
8544239|NCT00205777|21064632|P4|STARTED|Completed Core Study, Entered SE I||1282
8544240|NCT00205777|21064633|P3|STARTED|Completed Core Study, Entered SE I||1277
8544241|NCT00205777|21064634|P2|STARTED|Completed Core Study, Entered SE I||1245
8544242|NCT00205777|21064635|P1|STARTED|Completed Core Study, Entered SE I||1279
8544243|NCT00205777|21064630|P6|NOT COMPLETED|Core Study (Up to 3 Years)||0
8544244|NCT00205777|21064631|P5|NOT COMPLETED|Core Study (Up to 3 Years)||0
8544245|NCT00205777|21064632|P4|NOT COMPLETED|Core Study (Up to 3 Years)||632
8544246|NCT00205777|21064633|P3|NOT COMPLETED|Core Study (Up to 3 Years)||607
8544247|NCT00205777|21064634|P2|NOT COMPLETED|Core Study (Up to 3 Years)||659
8544248|NCT00205777|21064635|P1|NOT COMPLETED|Core Study (Up to 3 Years)||628
8544249|NCT00205777|21064630|P6|COMPLETED|Core Study (Up to 3 Years)||0
8544250|NCT00205777|21064631|P5|COMPLETED|Core Study (Up to 3 Years)||0
8544251|NCT00205777|21064632|P4|COMPLETED|Core Study (Up to 3 Years)||1282
8544252|NCT00205777|21064633|P3|COMPLETED|Core Study (Up to 3 Years)||1277
8544253|NCT00205777|21064634|P2|COMPLETED|Core Study (Up to 3 Years)||1245
8544254|NCT00205777|21064635|P1|COMPLETED|Core Study (Up to 3 Years)||1279
8544255|NCT00205777|21064630|P6|TREATED|Core Study (Up to 3 Years)||0
8544256|NCT00205777|21064631|P5|TREATED|Core Study (Up to 3 Years)||0
8544257|NCT00205777|21064632|P4|TREATED|Core Study (Up to 3 Years)||1885
8544258|NCT00205777|21064633|P3|TREATED|Core Study (Up to 3 Years)||1849
8544259|NCT00205777|21064634|P2|TREATED|Core Study (Up to 3 Years)||1872
8544260|NCT00205777|21064635|P1|TREATED|Core Study (Up to 3 Years)||1886
8544261|NCT00205777|21064630|P6|STARTED|Core Study (Up to 3 Years)||0
8544262|NCT00205777|21064631|P5|STARTED|Core Study (Up to 3 Years)||0
8544263|NCT00205777|21064632|P4|STARTED|Core Study (Up to 3 Years)||1914
8544264|NCT00205777|21064633|P3|STARTED|Core Study (Up to 3 Years)||1884
8544265|NCT00205777|21064634|P2|STARTED|Core Study (Up to 3 Years)||1904
8544266|NCT00205777|21064635|P1|STARTED|Core Study (Up to 3 Years)||1907
8544267|NCT00205712|21064844|P2|NOT COMPLETED|Overall Study||1
8544268|NCT00205712|21064845|P1|NOT COMPLETED|Overall Study||0
8544269|NCT00205712|21064844|P2|COMPLETED|Overall Study||19
8544270|NCT00205712|21064845|P1|COMPLETED|Overall Study||20
8544271|NCT00205712|21064844|P2|STARTED|Overall Study||20
8544272|NCT00205712|21064845|P1|STARTED|Overall Study||20
8544273|NCT00205699|21064858|P3|NOT COMPLETED|Overall Study||6
8544274|NCT00205699|21064859|P2|NOT COMPLETED|Overall Study||6
8544275|NCT00205699|21064860|P1|NOT COMPLETED|Overall Study||3
8544276|NCT00205699|21064858|P3|COMPLETED|Overall Study||43
8544277|NCT00205699|21064859|P2|COMPLETED|Overall Study||40
8544278|NCT00205699|21064860|P1|COMPLETED|Overall Study||46
8544279|NCT00205699|21064858|P3|STARTED|Overall Study||49
8544280|NCT00205699|21064859|P2|STARTED|Overall Study||46
8544281|NCT00205699|21064860|P1|STARTED|Overall Study||49
8544282|NCT00205660|21064885|P2|NOT COMPLETED|Overall Study||2
8544283|NCT00205660|21064886|P1|NOT COMPLETED|Overall Study||2
8544284|NCT00205660|21064885|P2|COMPLETED|Overall Study||35
8544285|NCT00205660|21064886|P1|COMPLETED|Overall Study||12
8544286|NCT00205660|21064885|P2|STARTED|Overall Study||37
8544287|NCT00205660|21064886|P1|STARTED|Overall Study||14
8544288|NCT00205504|21064898|P2|NOT COMPLETED|Overall Study||0
8544289|NCT00205504|21064899|P1|NOT COMPLETED|Overall Study||7
8544290|NCT00205504|21064898|P2|COMPLETED|Overall Study||15
8544291|NCT00205504|21064899|P1|COMPLETED|Overall Study||14
8544292|NCT00205504|21064898|P2|STARTED|Overall Study||15
8544293|NCT00205504|21064899|P1|STARTED|Overall Study||21
8544294|NCT00205374|21064925|P2|NOT COMPLETED|Overall Study||0
8544295|NCT00205374|21064926|P1|NOT COMPLETED|Overall Study||0
8544296|NCT00205374|21064925|P2|COMPLETED|Overall Study||9
8544297|NCT00205374|21064926|P1|COMPLETED|Overall Study||10
8544298|NCT00205374|21064925|P2|STARTED|Overall Study||9
8544299|NCT00205374|21064926|P1|STARTED|Overall Study||10
8544300|NCT00205348|21064934|P1|NOT COMPLETED|Overall Study||30
8544301|NCT00205348|21064934|P1|COMPLETED|Overall Study||116
8544302|NCT00205348|21064934|P1|STARTED|Overall Study||146
8544303|NCT00205179|21064940|P2|NOT COMPLETED|Overall Study||4
8544304|NCT00205179|21064941|P1|NOT COMPLETED|Overall Study||2
8544305|NCT00205179|21064940|P2|COMPLETED|Overall Study||29
8544306|NCT00205179|21064941|P1|COMPLETED|Overall Study||30
8544307|NCT00205179|21064940|P2|STARTED|Overall Study||33
8544308|NCT00205179|21064941|P1|STARTED|Overall Study||32
8544309|NCT00205049|21065005|P2|NOT COMPLETED|Overall Study||0
8544310|NCT00205049|21065006|P1|NOT COMPLETED|Overall Study||0
8544311|NCT00205049|21065005|P2|COMPLETED|Overall Study||0
8544312|NCT00205049|21065006|P1|COMPLETED|Overall Study||0
8544313|NCT00205049|21065005|P2|STARTED|Overall Study||0
8544314|NCT00205049|21065006|P1|STARTED|Overall Study||0
8544315|NCT00204932|21065014|P2|NOT COMPLETED|Overall Study||6
8544316|NCT00204932|21065015|P1|NOT COMPLETED|Overall Study||2
8544317|NCT00204932|21065014|P2|COMPLETED|Overall Study||18
8544318|NCT00204932|21065015|P1|COMPLETED|Overall Study||22
8544319|NCT00204932|21065014|P2|STARTED|Overall Study||24
8544320|NCT00204932|21065015|P1|STARTED|Overall Study||24
8544321|NCT00204737|21065023|P2|NOT COMPLETED|Overall Study||0
8544322|NCT00204737|21065024|P1|NOT COMPLETED|Overall Study||0
8544323|NCT00204737|21065023|P2|COMPLETED|Overall Study||6
8544324|NCT00204737|21065024|P1|COMPLETED|Overall Study||6
8544325|NCT00204737|21065023|P2|STARTED|Overall Study||6
8544326|NCT00204737|21065024|P1|STARTED|Overall Study||6
8544327|NCT00204373|21065048|P1|NOT COMPLETED|Overall Study||0
8544328|NCT00204373|21065048|P1|COMPLETED|Overall Study||72
8544329|NCT00204373|21065048|P1|STARTED|Overall Study||72
8544330|NCT00203996|21065059|P10|NOT COMPLETED|Overall Study||1
8544331|NCT00203996|21065060|P9|NOT COMPLETED|Overall Study||0
8544332|NCT00203996|21065061|P8|NOT COMPLETED|Overall Study||2
8544333|NCT00203996|21065062|P7|NOT COMPLETED|Overall Study||0
8544334|NCT00203996|21065063|P6|NOT COMPLETED|Overall Study||0
8544335|NCT00203996|21065064|P5|NOT COMPLETED|Overall Study||1
8544336|NCT00203996|21065065|P4|NOT COMPLETED|Overall Study||10
8544337|NCT00203996|21065066|P3|NOT COMPLETED|Overall Study||0
8544338|NCT00203996|21065067|P2|NOT COMPLETED|Overall Study||0
8544339|NCT00203996|21065068|P1|NOT COMPLETED|Overall Study||0
8544340|NCT00203996|21065059|P10|COMPLETED|Overall Study||2
8544341|NCT00203996|21065060|P9|COMPLETED|Overall Study||2
8544342|NCT00203996|21065061|P8|COMPLETED|Overall Study||2
8544343|NCT00203996|21065062|P7|COMPLETED|Overall Study||2
8544344|NCT00203996|21065063|P6|COMPLETED|Overall Study||3
8544345|NCT00203996|21065064|P5|COMPLETED|Overall Study||3
8544346|NCT00203996|21065065|P4|COMPLETED|Overall Study||9
8544347|NCT00203996|21065066|P3|COMPLETED|Overall Study||0
8544348|NCT00203996|21065067|P2|COMPLETED|Overall Study||0
8544349|NCT00203996|21065068|P1|COMPLETED|Overall Study||0
8544350|NCT00203996|21065059|P10|Aim 3 Only: Third Intervention|Overall Study||2
8544351|NCT00203996|21065060|P9|Aim 3 Only: Third Intervention|Overall Study||2
8544352|NCT00203996|21065061|P8|Aim 3 Only: Third Intervention|Overall Study||2
8544353|NCT00203996|21065062|P7|Aim 3 Only: Third Intervention|Overall Study||2
8544354|NCT00203996|21065063|P6|Aim 3 Only: Third Intervention|Overall Study||3
8544355|NCT00203996|21065064|P5|Aim 3 Only: Third Intervention|Overall Study||0
8544356|NCT00203996|21065065|P4|Aim 3 Only: Third Intervention|Overall Study||0
8544357|NCT00203996|21065066|P3|Aim 3 Only: Third Intervention|Overall Study||0
8544358|NCT00203996|21065067|P2|Aim 3 Only: Third Intervention|Overall Study||0
8544359|NCT00203996|21065068|P1|Aim 3 Only: Third Intervention|Overall Study||0
8544360|NCT00203996|21065059|P10|Aim 3 Only: Second Washout|Overall Study||2
8544361|NCT00203996|21065060|P9|Aim 3 Only: Second Washout|Overall Study||2
8544362|NCT00203996|21065061|P8|Aim 3 Only: Second Washout|Overall Study||2
8544363|NCT00203996|21065062|P7|Aim 3 Only: Second Washout|Overall Study||2
8544364|NCT00203996|21065063|P6|Aim 3 Only: Second Washout|Overall Study||3
8544365|NCT00203996|21065064|P5|Aim 3 Only: Second Washout|Overall Study||0
8544366|NCT00203996|21065065|P4|Aim 3 Only: Second Washout|Overall Study||0
8544367|NCT00203996|21065066|P3|Aim 3 Only: Second Washout|Overall Study||0
8544368|NCT00203996|21065067|P2|Aim 3 Only: Second Washout|Overall Study||0
8544369|NCT00203996|21065068|P1|Aim 3 Only: Second Washout|Overall Study||0
8544370|NCT00203996|21065059|P10|Aim 3 Only: Second Intervention|Overall Study||2
8544371|NCT00203996|21065060|P9|Aim 3 Only: Second Intervention|Overall Study||2
8544372|NCT00203996|21065061|P8|Aim 3 Only: Second Intervention|Overall Study||2
8544373|NCT00203996|21065062|P7|Aim 3 Only: Second Intervention|Overall Study||2
8544374|NCT00203996|21065063|P6|Aim 3 Only: Second Intervention|Overall Study||3
8544375|NCT00203996|21065064|P5|Aim 3 Only: Second Intervention|Overall Study||0
8544376|NCT00203996|21065065|P4|Aim 3 Only: Second Intervention|Overall Study||0
8544377|NCT00203996|21065066|P3|Aim 3 Only: Second Intervention|Overall Study||0
8544378|NCT00203996|21065067|P2|Aim 3 Only: Second Intervention|Overall Study||0
8544379|NCT00203996|21065068|P1|Aim 3 Only: Second Intervention|Overall Study||0
8544380|NCT00203996|21065059|P10|Aim 3 Only: Washout|Overall Study||2
8544381|NCT00203996|21065060|P9|Aim 3 Only: Washout|Overall Study||2
8544382|NCT00203996|21065061|P8|Aim 3 Only: Washout|Overall Study||2
8544383|NCT00203996|21065062|P7|Aim 3 Only: Washout|Overall Study||2
8544384|NCT00203996|21065063|P6|Aim 3 Only: Washout|Overall Study||3
8544385|NCT00203996|21065064|P5|Aim 3 Only: Washout|Overall Study||0
8544386|NCT00203996|21065065|P4|Aim 3 Only: Washout|Overall Study||0
8544387|NCT00203996|21065066|P3|Aim 3 Only: Washout|Overall Study||0
8544388|NCT00203996|21065067|P2|Aim 3 Only: Washout|Overall Study||0
8544389|NCT00203996|21065068|P1|Aim 3 Only: Washout|Overall Study||0
8544390|NCT00203996|21065059|P10|Aim 3 Only: First Intervention|Overall Study||3
8544391|NCT00203996|21065060|P9|Aim 3 Only: First Intervention|Overall Study||2
8544392|NCT00203996|21065061|P8|Aim 3 Only: First Intervention|Overall Study||4
8544393|NCT00203996|21065062|P7|Aim 3 Only: First Intervention|Overall Study||2
8544394|NCT00203996|21065063|P6|Aim 3 Only: First Intervention|Overall Study||3
8544395|NCT00203996|21065064|P5|Aim 3 Only: First Intervention|Overall Study||0
8544396|NCT00203996|21065065|P4|Aim 3 Only: First Intervention|Overall Study||0
8544397|NCT00203996|21065066|P3|Aim 3 Only: First Intervention|Overall Study||0
8544398|NCT00203996|21065067|P2|Aim 3 Only: First Intervention|Overall Study||0
8544399|NCT00203996|21065068|P1|Aim 3 Only: First Intervention|Overall Study||0
8544400|NCT00203996|21065059|P10|STARTED|Overall Study||3
8544401|NCT00203996|21065060|P9|STARTED|Overall Study||2
8544402|NCT00203996|21065061|P8|STARTED|Overall Study||4
8544403|NCT00203996|21065062|P7|STARTED|Overall Study||2
8544404|NCT00203996|21065063|P6|STARTED|Overall Study||3
8544405|NCT00203996|21065064|P5|STARTED|Overall Study||4
8544406|NCT00203996|21065065|P4|STARTED|Overall Study||19
8544407|NCT00203996|21065066|P3|STARTED|Overall Study||0
8544408|NCT00203996|21065067|P2|STARTED|Overall Study||0
8544409|NCT00203996|21065068|P1|STARTED|Overall Study||0
8544410|NCT00203931|21065117|P2|NOT COMPLETED|Overall Study||5
8544411|NCT00203931|21065118|P1|NOT COMPLETED|Overall Study||7
8544412|NCT00203931|21065117|P2|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
8544413|NCT00203931|21065118|P1|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
8544414|NCT00203931|21065117|P2|STARTED|Overall Study||28
8544415|NCT00203931|21065118|P1|STARTED|Overall Study||27
8544416|NCT00203892|21065135|P3|NOT COMPLETED|Overall Study||0
8544417|NCT00203892|21065136|P2|NOT COMPLETED|Overall Study||2
8544418|NCT00203892|21065137|P1|NOT COMPLETED|Overall Study||2
8544419|NCT00203892|21065135|P3|COMPLETED|Overall Study||6
8544420|NCT00203892|21065136|P2|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
8544421|NCT00203892|21065137|P1|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
8544422|NCT00203892|21065135|P3|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
8544423|NCT00203892|21065136|P2|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
8544424|NCT00203892|21065137|P1|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
8544425|NCT00203892|21065135|P3|STARTED|Overall Study||6
8544426|NCT00203892|21065136|P2|STARTED|Overall Study||10
8544427|NCT00203892|21065137|P1|STARTED|Overall Study||7
8544428|NCT00203502|21065148|P1|NOT COMPLETED|Overall Study||1
8544429|NCT00203502|21065148|P1|COMPLETED|Overall Study||39
8544430|NCT00203502|21065148|P1|STARTED|Overall Study||40
8544431|NCT00203476|21065159|P3|NOT COMPLETED|Overall Study||0
8544432|NCT00203476|21065160|P2|NOT COMPLETED|Overall Study||1
8544433|NCT00203476|21065161|P1|NOT COMPLETED|Overall Study||1
8544434|NCT00203476|21065159|P3|COMPLETED|Overall Study||10
8544435|NCT00203476|21065160|P2|COMPLETED|Overall Study||9
8544436|NCT00203476|21065161|P1|COMPLETED|Overall Study||9
8544437|NCT00203476|21065159|P3|STARTED|Overall Study||10
8544438|NCT00203476|21065160|P2|STARTED|Overall Study||10
8544439|NCT00203476|21065161|P1|STARTED|Overall Study||10
8544440|NCT00203424|21065178|P1|NOT COMPLETED|Follow-up Period||6
8544441|NCT00203424|21065178|P1|COMPLETED|Follow-up Period||10
8544442|NCT00203424|21065178|P1|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
8544443|NCT00203424|21065178|P1|NOT COMPLETED|Treatment Period||11
8544444|NCT00203424|21065178|P1|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
8544445|NCT00203424|21065178|P1|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
8544446|NCT00203411|21065185|P1|NOT COMPLETED|Follow-up||4
8544447|NCT00203411|21065185|P1|COMPLETED|Follow-up||41
8544448|NCT00203411|21065185|P1|STARTED|Follow-up||45
8544449|NCT00203411|21065185|P1|NOT COMPLETED|Treatment Period||0
8544450|NCT00203411|21065185|P1|COMPLETED|Treatment Period||45
8544451|NCT00203411|21065185|P1|STARTED|Treatment Period||45
8544452|NCT00203307|21065194|P2|NOT COMPLETED|Second Intervention||0
8544453|NCT00203307|21065195|P1|NOT COMPLETED|Second Intervention||0
8544454|NCT00203307|21065194|P2|COMPLETED|Second Intervention||0
8544455|NCT00203307|21065195|P1|COMPLETED|Second Intervention||1
8544456|NCT00203307|21065194|P2|STARTED|Second Intervention||0
8544457|NCT00203307|21065195|P1|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
8544458|NCT00203307|21065194|P2|NOT COMPLETED|First Intervention||0
8544459|NCT00203307|21065195|P1|NOT COMPLETED|First Intervention||2
8544460|NCT00203307|21065194|P2|COMPLETED|First Intervention||0
8544461|NCT00203307|21065195|P1|COMPLETED|First Intervention||1
8544462|NCT00203307|21065194|P2|STARTED|First Intervention||0
8544463|NCT00203307|21065195|P1|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
8544464|NCT00203294|21065203|P2|NOT COMPLETED|Overall Study||13
8544465|NCT00203294|21065204|P1|NOT COMPLETED|Overall Study||8
8544466|NCT00203294|21065203|P2|COMPLETED|Overall Study||10
8544467|NCT00203294|21065204|P1|COMPLETED|Overall Study||14
8544468|NCT00203294|21065203|P2|STARTED|Overall Study||23
8544469|NCT00203294|21065204|P1|STARTED|Overall Study||22
8544470|NCT00203268|21065210|P1|NOT COMPLETED|Late Treatment||0
8544471|NCT00203268|21065210|P1|COMPLETED|Late Treatment||9
8544472|NCT00203268|21065210|P1|STARTED|Late Treatment||9
8544473|NCT00203268|21065210|P1|NOT COMPLETED|Early Treatment||4
8544474|NCT00203268|21065210|P1|COMPLETED|Early Treatment||9
8544475|NCT00203268|21065210|P1|STARTED|Early Treatment||13
8544476|NCT00203242|21065216|P1|NOT COMPLETED|Overall Study||1
8544477|NCT00203242|21065216|P1|COMPLETED|Overall Study||14
8544478|NCT00203242|21065216|P1|STARTED|Overall Study||15
8544479|NCT00203229|21065222|P2|NOT COMPLETED|Overall Study||3
8544480|NCT00203229|21065223|P1|NOT COMPLETED|Overall Study||3
8544481|NCT00203229|21065222|P2|COMPLETED|Overall Study||7
8544482|NCT00203229|21065223|P1|COMPLETED|Overall Study||7
8544483|NCT00203229|21065222|P2|STARTED|Overall Study||10
8544484|NCT00203229|21065223|P1|STARTED|Overall Study||10
8544485|NCT00203216|21065229|P1|NOT COMPLETED|Overall Study||4
8544486|NCT00203216|21065229|P1|COMPLETED|Overall Study||27
8544487|NCT00203216|21065229|P1|STARTED|Overall Study||31
8544488|NCT00203203|21065235|P2|NOT COMPLETED|Overall Study||0
8544489|NCT00203203|21065236|P1|NOT COMPLETED|Overall Study||1
8544490|NCT00203203|21065235|P2|COMPLETED|Overall Study||20
8544491|NCT00203203|21065236|P1|COMPLETED|Overall Study||9
8544492|NCT00203203|21065235|P2|STARTED|Overall Study||20
8544493|NCT00203203|21065236|P1|STARTED|Overall Study||10
8544494|NCT00203047|21065268|P2|NOT COMPLETED|Overall Study||203
8544495|NCT00203047|21065269|P1|NOT COMPLETED|Overall Study||191
8544496|NCT00203047|21065268|P2|COMPLETED|Overall Study||7
8544497|NCT00203047|21065269|P1|COMPLETED|Overall Study||13
8544498|NCT00203047|21065268|P2|In Database as of January 29, 2009|Overall Study||209
8544499|NCT00203047|21065269|P1|In Database as of January 29, 2009|Overall Study||199
8544500|NCT00203047|21065268|P2|STARTED|Overall Study||210
8544501|NCT00203047|21065269|P1|STARTED|Overall Study||204
8544502|NCT00203021|21065283|P2|NOT COMPLETED|Overall Study||77
8544503|NCT00203021|21065284|P1|NOT COMPLETED|Overall Study||79
8544504|NCT00203021|21065283|P2|COMPLETED|Overall Study||24
8544505|NCT00203021|21065284|P1|COMPLETED|Overall Study||28
8544506|NCT00203021|21065283|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
8544507|NCT00203021|21065284|P1|Received at Least 1 Dose of Study Drug|Overall Study||107
8544508|NCT00203021|21065283|P2|STARTED|Overall Study||101
8544509|NCT00203021|21065284|P1|STARTED|Overall Study||107
8544510|NCT00202930|21065292|P1|NOT COMPLETED|Overall Study||0
8544511|NCT00202930|21065292|P1|COMPLETED|Overall Study||4
8544512|NCT00202930|21065292|P1|STARTED|Overall Study||4
8544513|NCT00202878|21065302|P2|NOT COMPLETED|Overall Study||2217
8544514|NCT00202878|21065303|P1|NOT COMPLETED|Overall Study||2199
8544515|NCT00202878|21065302|P2|COMPLETED|Overall Study||6860
8544516|NCT00202878|21065303|P1|COMPLETED|Overall Study||6868
8544517|NCT00202878|21065302|P2|STARTED|Overall Study||9077
8544518|NCT00202878|21065303|P1|STARTED|Overall Study||9067
8544519|NCT00202839|21065317|P2|NOT COMPLETED|Overall Study||10
8544520|NCT00202839|21065318|P1|NOT COMPLETED|Overall Study||24
8544521|NCT00202839|21065317|P2|COMPLETED|Overall Study||72
8544522|NCT00202839|21065318|P1|COMPLETED|Overall Study||54
8544523|NCT00202839|21065317|P2|STARTED|Overall Study||82
8544524|NCT00202839|21065318|P1|STARTED|Overall Study||78
8544525|NCT00202722|21065326|P1|NOT COMPLETED|Overall Study||0
8544526|NCT00202722|21065326|P1|COMPLETED|Overall Study||41
8544527|NCT00202722|21065326|P1|STARTED|Overall Study||41
8544534|NCT00202449|21065361|P3|NOT COMPLETED|Overall Study||12
8544535|NCT00202449|21065362|P2|NOT COMPLETED|Overall Study||11
8544536|NCT00202449|21065363|P1|NOT COMPLETED|Overall Study||11
8544537|NCT00202449|21065361|P3|COMPLETED|Overall Study||9
8544538|NCT00202449|21065362|P2|COMPLETED|Overall Study||9
8544539|NCT00202449|21065363|P1|COMPLETED|Overall Study||7
8544540|NCT00202449|21065361|P3|STARTED|Overall Study||21
8544541|NCT00202449|21065362|P2|STARTED|Overall Study||20
8544542|NCT00202449|21065363|P1|STARTED|Overall Study||18
8544543|NCT00201877|21065377|P1|NOT COMPLETED|Overall Study||0
8544544|NCT00201877|21065377|P1|COMPLETED|Overall Study||25
8544545|NCT00201877|21065377|P1|STARTED|Overall Study||25
8544546|NCT00201864|21065384|P1|NOT COMPLETED|Overall Study||0
8544547|NCT00201864|21065384|P1|COMPLETED|Overall Study||40
8544548|NCT00201864|21065384|P1|STARTED|Overall Study||40
8544549|NCT00201851|21065395|P3|NOT COMPLETED|Overall Study||1
8544550|NCT00201851|21065396|P2|NOT COMPLETED|Overall Study||2
8544551|NCT00201851|21065397|P1|NOT COMPLETED|Overall Study||8
8544552|NCT00201851|21065395|P3|COMPLETED|Overall Study||230
8544553|NCT00201851|21065396|P2|COMPLETED|Overall Study||255
8544554|NCT00201851|21065397|P1|COMPLETED|Overall Study||244
8544555|NCT00201851|21065395|P3|STARTED|Overall Study||231
8544556|NCT00201851|21065396|P2|STARTED|Overall Study||257
8544557|NCT00201851|21065397|P1|STARTED|Overall Study||252
8544558|NCT00201838|21065407|P2|NOT COMPLETED|Overall Study||0
8544559|NCT00201838|21065408|P1|NOT COMPLETED|Overall Study||0
8544560|NCT00201838|21065407|P2|COMPLETED|Overall Study||8
8544561|NCT00201838|21065408|P1|COMPLETED|Overall Study||30
8544562|NCT00201838|21065407|P2|Treatment Cohort|Overall Study||8
8544563|NCT00201838|21065408|P1|Treatment Cohort|Overall Study||30
8544564|NCT00201838|21065407|P2|STARTED|Overall Study||8
8544565|NCT00201838|21065408|P1|STARTED|Overall Study||30
8544566|NCT00201825|21065422|P1|NOT COMPLETED|Overall Study||0
8544567|NCT00201825|21065422|P1|COMPLETED|Overall Study||29
8544568|NCT00201825|21065422|P1|STARTED|Overall Study||29
8544569|NCT00201773|21065429|P1|NOT COMPLETED|Overall Study||6
8544570|NCT00201773|21065429|P1|COMPLETED|Overall Study||16
8544571|NCT00201773|21065429|P1|Stopped Exemestane After 4 Weeks|Overall Study||1
8544572|NCT00201773|21065429|P1|Received All Exemestane Therapy|Overall Study||5
8544573|NCT00201773|21065429|P1|Completed 8 Weeks of Planned Therapy|Overall Study||16
8544574|NCT00201773|21065429|P1|STARTED|Overall Study||22
8544575|NCT00201760|21065438|P2|NOT COMPLETED|Overall Study||0
8544576|NCT00201760|21065439|P1|NOT COMPLETED|Overall Study||0
8544577|NCT00201760|21065438|P2|COMPLETED|Overall Study||5
8544578|NCT00201760|21065439|P1|COMPLETED|Overall Study||5
8544579|NCT00201760|21065438|P2|STARTED|Overall Study||5
8544580|NCT00201760|21065439|P1|STARTED|Overall Study||5
8544581|NCT00201734|21065451|P2|NOT COMPLETED|Overall Study||0
8544582|NCT00201734|21065452|P1|NOT COMPLETED|Overall Study||3
8544583|NCT00201734|21065451|P2|COMPLETED|Overall Study||25
8544584|NCT00201734|21065452|P1|COMPLETED|Overall Study||29
8544585|NCT00201734|21065451|P2|Patients Not Evaluable|Overall Study||0
8544586|NCT00201734|21065452|P1|Patients Not Evaluable|Overall Study||3
8544587|NCT00201734|21065451|P2|STARTED|Overall Study||25
8544588|NCT00201734|21065452|P1|STARTED|Overall Study||32
8544589|NCT00201643|21065469|P2|NOT COMPLETED|Overall Study||4
8544590|NCT00201643|21065470|P1|NOT COMPLETED|Overall Study||5
8544591|NCT00201643|21065469|P2|COMPLETED|Overall Study||210
8544592|NCT00201643|21065470|P1|COMPLETED|Overall Study||218
8544593|NCT00201643|21065469|P2|STARTED|Overall Study||214
8544594|NCT00201643|21065470|P1|STARTED|Overall Study||223
8544595|NCT00201448|21065494|P2|NOT COMPLETED|Overall Study||0
8544596|NCT00201448|21065495|P1|NOT COMPLETED|Overall Study||0
8544597|NCT00201448|21065494|P2|COMPLETED|Overall Study||40
8544598|NCT00201448|21065495|P1|COMPLETED|Overall Study||42
8544599|NCT00201448|21065494|P2|STARTED|Overall Study||40
8544600|NCT00201448|21065495|P1|STARTED|Overall Study||42
8544601|NCT00201409|21065505|P2|NOT COMPLETED|Overall Study||1
8544602|NCT00201409|21065506|P1|NOT COMPLETED|Overall Study||1
8544603|NCT00201409|21065505|P2|COMPLETED|Overall Study||66
8544604|NCT00201409|21065506|P1|COMPLETED|Overall Study||64
8544605|NCT00201409|21065505|P2|STARTED|Overall Study||67
8544606|NCT00201409|21065506|P1|STARTED|Overall Study||65
8544607|NCT00201240|21065516|P1|NOT COMPLETED|Overall Study||3
8544608|NCT00201240|21065516|P1|COMPLETED|Overall Study||44
8544609|NCT00201240|21065516|P1|STARTED|Overall Study||47
8544610|NCT00201201|21065534|P2|NOT COMPLETED|Overall Study||7
8544611|NCT00201201|21065535|P1|NOT COMPLETED|Overall Study||5
8544612|NCT00201201|21065534|P2|COMPLETED|Overall Study||66
8544613|NCT00201201|21065535|P1|COMPLETED|Overall Study||82
8544614|NCT00201201|21065534|P2|STARTED|Overall Study||73
8544615|NCT00201201|21065535|P1|STARTED|Overall Study||87
8544616|NCT00201123|21065554|P3|NOT COMPLETED|Overall Study||9
8544617|NCT00201123|21065555|P2|NOT COMPLETED|Overall Study||4
8544618|NCT00201123|21065556|P1|NOT COMPLETED|Overall Study||6
8544619|NCT00201123|21065554|P3|COMPLETED|Overall Study||23
8544620|NCT00201123|21065555|P2|COMPLETED|Overall Study||28
8544621|NCT00201123|21065556|P1|COMPLETED|Overall Study||26
8544622|NCT00201123|21065554|P3|Did Not Meet Continuation Criteria|Overall Study||5
8544623|NCT00201123|21065555|P2|Did Not Meet Continuation Criteria|Overall Study||0
8544624|NCT00201123|21065556|P1|Did Not Meet Continuation Criteria|Overall Study||2
8544625|NCT00201123|21065554|P3|STARTED|Overall Study||32
8544626|NCT00201123|21065555|P2|STARTED|Overall Study||32
8544627|NCT00201123|21065556|P1|STARTED|Overall Study||32
8544628|NCT00201006|21065573|P3|NOT COMPLETED|Overall Study||4
8544629|NCT00201006|21065574|P2|NOT COMPLETED|Overall Study||2
8544630|NCT00201006|21065575|P1|NOT COMPLETED|Overall Study||8
8544631|NCT00201006|21065573|P3|COMPLETED|Overall Study||75
8544632|NCT00201006|21065574|P2|COMPLETED|Overall Study||70
8544633|NCT00201006|21065575|P1|COMPLETED|Overall Study||75
8544634|NCT00201006|21065573|P3|STARTED|Overall Study||79
8544635|NCT00201006|21065574|P2|STARTED|Overall Study||72
8544636|NCT00201006|21065575|P1|STARTED|Overall Study||83
8544637|NCT00200967|21065585|P2|NOT COMPLETED|Run-out Period||0
8544638|NCT00200967|21065586|P1|NOT COMPLETED|Run-out Period||1
8544639|NCT00200967|21065585|P2|COMPLETED|Run-out Period||41
8544640|NCT00200967|21065586|P1|COMPLETED|Run-out Period||34
8544641|NCT00200967|21065585|P2|STARTED|Run-out Period||41
8544642|NCT00200967|21065586|P1|STARTED|Run-out Period||35
8544643|NCT00200967|21065585|P2|NOT COMPLETED|Second Treatment Period||2
8544644|NCT00200967|21065586|P1|NOT COMPLETED|Second Treatment Period||1
8544645|NCT00200967|21065585|P2|COMPLETED|Second Treatment Period||41
8544646|NCT00200967|21065586|P1|COMPLETED|Second Treatment Period||35
8544647|NCT00200967|21065585|P2|STARTED|Second Treatment Period||43
8544648|NCT00200967|21065586|P1|STARTED|Second Treatment Period||36
8544649|NCT00200967|21065585|P2|NOT COMPLETED|Wash-out Period||1
8544650|NCT00200967|21065586|P1|NOT COMPLETED|Wash-out Period||0
8544651|NCT00200967|21065585|P2|COMPLETED|Wash-out Period||43
8544652|NCT00200967|21065586|P1|COMPLETED|Wash-out Period||36
8544653|NCT00200967|21065585|P2|STARTED|Wash-out Period||44
8544654|NCT00200967|21065586|P1|STARTED|Wash-out Period||36
8544655|NCT00200967|21065585|P2|NOT COMPLETED|First Treatment Period||1
8544656|NCT00200967|21065586|P1|NOT COMPLETED|First Treatment Period||6
8544657|NCT00200967|21065585|P2|COMPLETED|First Treatment Period||44
8544658|NCT00200967|21065586|P1|COMPLETED|First Treatment Period||36
8544659|NCT00200967|21065585|P2|First Treatment Period|First Treatment Period||45
8544660|NCT00200967|21065586|P1|First Treatment Period|First Treatment Period||42
8544661|NCT00200967|21065585|P2|STARTED|First Treatment Period||45
8544662|NCT00200967|21065586|P1|STARTED|First Treatment Period||42
8544672|NCT00200850|21065636|P3|NOT COMPLETED|Overall Study||6
8544673|NCT00200850|21065637|P2|NOT COMPLETED|Overall Study||1
8544674|NCT00200850|21065638|P1|NOT COMPLETED|Overall Study||3
8544675|NCT00200850|21065636|P3|COMPLETED|Overall Study||5
8544676|NCT00200850|21065637|P2|COMPLETED|Overall Study||9
8544677|NCT00200850|21065638|P1|COMPLETED|Overall Study||7
8544678|NCT00200850|21065636|P3|STARTED|Overall Study||11
8544679|NCT00200850|21065637|P2|STARTED|Overall Study||10
8544680|NCT00200850|21065638|P1|STARTED|Overall Study||10
8544681|NCT00200785|21065648|P2|NOT COMPLETED|Second Intervention||0
8544682|NCT00200785|21065649|P1|NOT COMPLETED|Second Intervention||0
8544683|NCT00200785|21065648|P2|COMPLETED|Second Intervention||6
8544684|NCT00200785|21065649|P1|COMPLETED|Second Intervention||9
8544685|NCT00200785|21065648|P2|STARTED|Second Intervention||6
8544686|NCT00200785|21065649|P1|STARTED|Second Intervention||9
8544687|NCT00200785|21065648|P2|NOT COMPLETED|Washout Period of 1 Week||0
8544688|NCT00200785|21065649|P1|NOT COMPLETED|Washout Period of 1 Week||0
8544689|NCT00200785|21065648|P2|COMPLETED|Washout Period of 1 Week||6
8544690|NCT00200785|21065649|P1|COMPLETED|Washout Period of 1 Week||9
8544691|NCT00200785|21065648|P2|STARTED|Washout Period of 1 Week||6
8544692|NCT00200785|21065649|P1|STARTED|Washout Period of 1 Week||9
8544693|NCT00200785|21065648|P2|NOT COMPLETED|First Intervention||0
8544694|NCT00200785|21065649|P1|NOT COMPLETED|First Intervention||0
8544695|NCT00200785|21065648|P2|COMPLETED|First Intervention||6
8544696|NCT00200785|21065649|P1|COMPLETED|First Intervention||9
8544697|NCT00200785|21065648|P2|STARTED|First Intervention||6
8544698|NCT00200785|21065649|P1|STARTED|First Intervention||9
8544699|NCT00200356|21065659|P2|NOT COMPLETED|Overall Study||7
8544700|NCT00200356|21065660|P1|NOT COMPLETED|Overall Study||8
8544701|NCT00200356|21065659|P2|COMPLETED|Overall Study||195
8544702|NCT00200356|21065660|P1|COMPLETED|Overall Study||191
8544703|NCT00200356|21065659|P2|Safety Analysis Set|Overall Study||198
8544704|NCT00200356|21065660|P1|Safety Analysis Set|Overall Study||194
8544705|NCT00200356|21065659|P2|STARTED|Overall Study||202
8544706|NCT00200356|21065660|P1|STARTED|Overall Study||199
8544707|NCT00200343|21065687|P3|NOT COMPLETED|Overall Study||13
8544708|NCT00200343|21065688|P2|NOT COMPLETED|Overall Study||8
8544709|NCT00200343|21065689|P1|NOT COMPLETED|Overall Study||16
8544710|NCT00200343|21065687|P3|COMPLETED|Overall Study||184
8544711|NCT00200343|21065688|P2|COMPLETED|Overall Study||192
8544712|NCT00200343|21065689|P1|COMPLETED|Overall Study||183
8544713|NCT00200343|21065687|P3|STARTED|Overall Study||197
8544714|NCT00200343|21065688|P2|STARTED|Overall Study||200
8544715|NCT00200343|21065689|P1|STARTED|Overall Study||199
8544716|NCT00200161|21065714|P2|NOT COMPLETED|Overall Study||0
8544717|NCT00200161|21065715|P1|NOT COMPLETED|Overall Study||0
8544718|NCT00200161|21065714|P2|COMPLETED|Overall Study||42
8544719|NCT00200161|21065715|P1|COMPLETED|Overall Study||43
8544720|NCT00200161|21065714|P2|STARTED|Overall Study||42
8544721|NCT00200161|21065715|P1|STARTED|Overall Study||43
8544722|NCT00200057|21065727|P1|NOT COMPLETED|Overall Study||9
8544723|NCT00200057|21065727|P1|COMPLETED|Overall Study||111
8544724|NCT00200057|21065727|P1|12 Month Follow-up|Overall Study||111
8544725|NCT00200057|21065727|P1|6 Month Follow-up|Overall Study||114
8544726|NCT00200057|21065727|P1|3 Month Follow-up|Overall Study||116
8544727|NCT00200057|21065727|P1|1 Month Follow-up|Overall Study||117
8544728|NCT00200057|21065727|P1|STARTED|Overall Study||120
8544729|NCT00199914|21065739|P2|NOT COMPLETED|Overall Study||6
8544730|NCT00199914|21065740|P1|NOT COMPLETED|Overall Study||3
8544731|NCT00199914|21065739|P2|COMPLETED|Overall Study||54
8544732|NCT00199914|21065740|P1|COMPLETED|Overall Study||50
8544733|NCT00199914|21065739|P2|STARTED|Overall Study||60
8544734|NCT00199914|21065740|P1|STARTED|Overall Study||53
8544735|NCT00199875|21065751|P5|NOT COMPLETED|Overall Study||1
8544736|NCT00199875|21065752|P4|NOT COMPLETED|Overall Study||0
8544737|NCT00199875|21065753|P3|NOT COMPLETED|Overall Study||0
8544738|NCT00199875|21065754|P2|NOT COMPLETED|Overall Study||0
8544739|NCT00199875|21065755|P1|NOT COMPLETED|Overall Study||0
8544740|NCT00199875|21065751|P5|COMPLETED|Overall Study||2
8544741|NCT00199875|21065752|P4|COMPLETED|Overall Study||3
8544742|NCT00199875|21065753|P3|COMPLETED|Overall Study||6
8544743|NCT00199875|21065754|P2|COMPLETED|Overall Study||3
8544744|NCT00199875|21065755|P1|COMPLETED|Overall Study||3
8544745|NCT00199875|21065751|P5|STARTED|Overall Study||3
8544746|NCT00199875|21065752|P4|STARTED|Overall Study||3
8544747|NCT00199875|21065753|P3|STARTED|Overall Study||6
8544748|NCT00199875|21065754|P2|STARTED|Overall Study||3
8544749|NCT00199875|21065755|P1|STARTED|Overall Study||3
8544750|NCT00199381|21065777|P1|NOT COMPLETED|Overall Study||504
8544751|NCT00199381|21065777|P1|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
8544752|NCT00199381|21065777|P1|STARTED|Overall Study||504
8544753|NCT00198822|21065784|P3|NOT COMPLETED|Overall Study||21
8544754|NCT00198822|21065785|P2|NOT COMPLETED|Overall Study||20
8544755|NCT00198822|21065786|P1|NOT COMPLETED|Overall Study||14
8544756|NCT00198822|21065784|P3|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
8544757|NCT00198822|21065785|P2|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
8544758|NCT00198822|21065786|P1|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
8544759|NCT00198822|21065784|P3|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
8544760|NCT00198822|21065785|P2|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
8544761|NCT00198822|21065786|P1|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
8544762|NCT00198133|21065805|P2|NOT COMPLETED|Overall Study||8
8544763|NCT00198133|21065806|P1|NOT COMPLETED|Overall Study||5
8544764|NCT00198133|21065805|P2|COMPLETED|Overall Study||3
8544765|NCT00198133|21065806|P1|COMPLETED|Overall Study||11
8544766|NCT00198133|21065805|P2|STARTED|Overall Study||11
8544767|NCT00198133|21065806|P1|STARTED|Overall Study||16
8544768|NCT00198107|21065818|P3|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2
8544769|NCT00198107|21065819|P2|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
8544770|NCT00198107|21065820|P1|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
8544771|NCT00198107|21065818|P3|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8
8544772|NCT00198107|21065819|P2|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
8544773|NCT00198107|21065820|P1|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
8544774|NCT00198107|21065818|P3|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10
8544775|NCT00198107|21065819|P2|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
8544776|NCT00198107|21065820|P1|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
8544777|NCT00198107|21065818|P3|NOT COMPLETED|Double-Blind Period||0
8544778|NCT00198107|21065819|P2|NOT COMPLETED|Double-Blind Period||3
8544779|NCT00198107|21065820|P1|NOT COMPLETED|Double-Blind Period||6
8544780|NCT00198107|21065818|P3|COMPLETED|Double-Blind Period||0
8544781|NCT00198107|21065819|P2|COMPLETED|Double-Blind Period||37
8544782|NCT00198107|21065820|P1|COMPLETED|Double-Blind Period||35
8544783|NCT00198107|21065818|P3|1 or More Follow-up Visits|Double-Blind Period||0
8544784|NCT00198107|21065819|P2|1 or More Follow-up Visits|Double-Blind Period||38
8544785|NCT00198107|21065820|P1|1 or More Follow-up Visits|Double-Blind Period||40
8544786|NCT00198107|21065818|P3|STARTED|Double-Blind Period||0
8544787|NCT00198107|21065819|P2|STARTED|Double-Blind Period||40
8544788|NCT00198107|21065820|P1|STARTED|Double-Blind Period||41
8544789|NCT00198081|21065857|P2|NOT COMPLETED|Overall Study||0
8544790|NCT00198081|21065858|P1|NOT COMPLETED|Overall Study||1
8544791|NCT00198081|21065857|P2|COMPLETED|Overall Study|No enrollment on this arm.|0
8544792|NCT00198081|21065858|P1|COMPLETED|Overall Study||4
8544793|NCT00198081|21065857|P2|STARTED|Overall Study|No enrollment on this arm.|0
8544794|NCT00198081|21065858|P1|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
8544795|NCT00198042|21065884|P1|NOT COMPLETED|Overall Study||0
8544796|NCT00198042|21065884|P1|COMPLETED|Overall Study||18
8544797|NCT00198042|21065884|P1|STARTED|Overall Study||18
8544798|NCT00198029|21065888|P1|NOT COMPLETED|Overall Study||4
8544799|NCT00198029|21065888|P1|COMPLETED|Overall Study||28
8544800|NCT00198029|21065888|P1|STARTED|Overall Study||32
8544801|NCT00197496|21065895|P2|NOT COMPLETED|Follow-up||1
8544802|NCT00197496|21065896|P1|NOT COMPLETED|Follow-up||2
8544803|NCT00197496|21065895|P2|COMPLETED|Follow-up||4
8544804|NCT00197496|21065896|P1|COMPLETED|Follow-up||10
8544805|NCT00197496|21065895|P2|STARTED|Follow-up||5
8544806|NCT00197496|21065896|P1|STARTED|Follow-up||12
8544807|NCT00197496|21065895|P2|NOT COMPLETED|Baseline to Discharge||2
8544808|NCT00197496|21065896|P1|NOT COMPLETED|Baseline to Discharge||2
8544809|NCT00197496|21065895|P2|COMPLETED|Baseline to Discharge||5
8544810|NCT00197496|21065896|P1|COMPLETED|Baseline to Discharge||12
8544811|NCT00197496|21065895|P2|STARTED|Baseline to Discharge||7
8544812|NCT00197496|21065896|P1|STARTED|Baseline to Discharge||14
8544813|NCT00197392|21065911|P2|NOT COMPLETED|Overall Study||86
8544814|NCT00197392|21065912|P1|NOT COMPLETED|Overall Study||88
8544815|NCT00197392|21065911|P2|COMPLETED|Overall Study||134
8544816|NCT00197392|21065912|P1|COMPLETED|Overall Study||126
8544817|NCT00197392|21065911|P2|Per Protocol|Overall Study||134
8544818|NCT00197392|21065912|P1|Per Protocol|Overall Study||126
8544819|NCT00197392|21065911|P2|Evaluable|Overall Study||181
8544820|NCT00197392|21065912|P1|Evaluable|Overall Study||176
8544821|NCT00197392|21065911|P2|Modified Intent to Treat|Overall Study||210
8544822|NCT00197392|21065912|P1|Modified Intent to Treat|Overall Study||209
8544823|NCT00197392|21065911|P2|Safety Population|Overall Study||220
8544824|NCT00197392|21065912|P1|Safety Population|Overall Study||214
8544825|NCT00197392|21065911|P2|STARTED|Overall Study||220
8544826|NCT00197392|21065912|P1|STARTED|Overall Study||214
8544827|NCT00197236|21065944|P3|NOT COMPLETED|Overall Study||23
8544828|NCT00197236|21065945|P2|NOT COMPLETED|Overall Study||17
8544829|NCT00197236|21065946|P1|NOT COMPLETED|Overall Study||14
8544830|NCT00197236|21065944|P3|COMPLETED|Overall Study||109
8544831|NCT00197236|21065945|P2|COMPLETED|Overall Study||110
8544832|NCT00197236|21065946|P1|COMPLETED|Overall Study||121
8544833|NCT00197236|21065944|P3|STARTED|Overall Study||132
8544834|NCT00197236|21065945|P2|STARTED|Overall Study||127
8544835|NCT00197236|21065946|P1|STARTED|Overall Study||135
8544836|NCT00197184|21065995|P2|NOT COMPLETED|Overall Study||0
8544837|NCT00197184|21065996|P1|NOT COMPLETED|Overall Study||0
8544838|NCT00197184|21065995|P2|COMPLETED|Overall Study||137
8544839|NCT00197184|21065996|P1|COMPLETED|Overall Study||139
8544840|NCT00197184|21065995|P2|STARTED|Overall Study||137
8544841|NCT00197184|21065996|P1|STARTED|Overall Study||139
8544842|NCT00197145|21066020|P2|NOT COMPLETED|Period 2 : Open Label Phase||0
8544843|NCT00197145|21066021|P1|NOT COMPLETED|Period 2 : Open Label Phase||10
8544844|NCT00197145|21066020|P2|COMPLETED|Period 2 : Open Label Phase||0
8544845|NCT00197145|21066021|P1|COMPLETED|Period 2 : Open Label Phase||0
8544846|NCT00197145|21066020|P2|STARTED|Period 2 : Open Label Phase||0
8544847|NCT00197145|21066021|P1|STARTED|Period 2 : Open Label Phase||10
8544848|NCT00197145|21066020|P2|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
8544849|NCT00197145|21066021|P1|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
8544850|NCT00197145|21066020|P2|COMPLETED|Period 1: Randomized Treatment Phase||0
8544851|NCT00197145|21066021|P1|COMPLETED|Period 1: Randomized Treatment Phase||0
8544852|NCT00197145|21066020|P2|STARTED|Period 1: Randomized Treatment Phase||11
8544853|NCT00197145|21066021|P1|STARTED|Period 1: Randomized Treatment Phase||13
8544854|NCT00197119|21066079|P2|NOT COMPLETED|Year 10||0
8544855|NCT00197119|21066080|P1|NOT COMPLETED|Year 10||0
8544856|NCT00197119|21066079|P2|COMPLETED|Year 10||108
8544857|NCT00197119|21066080|P1|COMPLETED|Year 10||120
8544858|NCT00197119|21066079|P2|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
8544859|NCT00197119|21066080|P1|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
8544860|NCT00197119|21066079|P2|NOT COMPLETED|Year 9||0
8544861|NCT00197119|21066080|P1|NOT COMPLETED|Year 9||0
8544862|NCT00197119|21066079|P2|COMPLETED|Year 9||114
8544863|NCT00197119|21066080|P1|COMPLETED|Year 9||121
8544864|NCT00197119|21066079|P2|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
8544865|NCT00197119|21066080|P1|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
8544866|NCT00197119|21066079|P2|NOT COMPLETED|Year 8||0
8544867|NCT00197119|21066080|P1|NOT COMPLETED|Year 8||0
8544868|NCT00197119|21066079|P2|COMPLETED|Year 8||115
8544869|NCT00197119|21066080|P1|COMPLETED|Year 8||122
8544870|NCT00197119|21066079|P2|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
8544871|NCT00197119|21066080|P1|STARTED|Year 8||122
8544872|NCT00197119|21066079|P2|NOT COMPLETED|Year 7||0
8544873|NCT00197119|21066080|P1|NOT COMPLETED|Year 7||0
8544874|NCT00197119|21066079|P2|COMPLETED|Year 7||114
8544875|NCT00197119|21066080|P1|COMPLETED|Year 7||122
8544876|NCT00197119|21066079|P2|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
8544877|NCT00197119|21066080|P1|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
8544878|NCT00197119|21066079|P2|NOT COMPLETED|Year 6||0
8544879|NCT00197119|21066080|P1|NOT COMPLETED|Year 6||0
8544880|NCT00197119|21066079|P2|COMPLETED|Year 6||118
8544881|NCT00197119|21066080|P1|COMPLETED|Year 6||126
8544882|NCT00197119|21066079|P2|STARTED|Year 6||118
8544883|NCT00197119|21066080|P1|STARTED|Year 6||126
8544884|NCT00197106|21066092|P3|NOT COMPLETED|Overall Treatment Period||6
8544885|NCT00197106|21066093|P2|NOT COMPLETED|Overall Treatment Period||1
8544886|NCT00197106|21066094|P1|NOT COMPLETED|Overall Treatment Period||0
8544887|NCT00197106|21066092|P3|COMPLETED|Overall Treatment Period||74
8544888|NCT00197106|21066093|P2|COMPLETED|Overall Treatment Period||77
8544889|NCT00197106|21066094|P1|COMPLETED|Overall Treatment Period||0
8544890|NCT00197106|21066092|P3|STARTED|Overall Treatment Period||80
8544891|NCT00197106|21066093|P2|STARTED|Overall Treatment Period||78
8544892|NCT00197106|21066094|P1|STARTED|Overall Treatment Period||0
8544893|NCT00197106|21066092|P3|NOT COMPLETED|4-Week Run-In Period||0
8544894|NCT00197106|21066093|P2|NOT COMPLETED|4-Week Run-In Period||0
8544895|NCT00197106|21066094|P1|NOT COMPLETED|4-Week Run-In Period||99
8544896|NCT00197106|21066092|P3|COMPLETED|4-Week Run-In Period||0
8544897|NCT00197106|21066093|P2|COMPLETED|4-Week Run-In Period||0
8544898|NCT00197106|21066094|P1|COMPLETED|4-Week Run-In Period||158
8544899|NCT00197106|21066092|P3|STARTED|4-Week Run-In Period||0
8544900|NCT00197106|21066093|P2|STARTED|4-Week Run-In Period||0
8544901|NCT00197106|21066094|P1|STARTED|4-Week Run-In Period||257
8544911|NCT00197028|21066243|P2|NOT COMPLETED|Overall Study||21
8544912|NCT00197028|21066244|P1|NOT COMPLETED|Overall Study||16
8544913|NCT00197028|21066243|P2|COMPLETED|Overall Study||86
8544914|NCT00197028|21066244|P1|COMPLETED|Overall Study||91
8544915|NCT00197028|21066243|P2|STARTED|Overall Study||107
8544916|NCT00197028|21066244|P1|STARTED|Overall Study||107
8544917|NCT00197015|21066287|P3|NOT COMPLETED|Overall Study||77
8544918|NCT00197015|21066288|P2|NOT COMPLETED|Overall Study||89
8544919|NCT00197015|21066289|P1|NOT COMPLETED|Overall Study||50
8544920|NCT00197015|21066287|P3|COMPLETED|Overall Study||385
8544921|NCT00197015|21066288|P2|COMPLETED|Overall Study||366
8544922|NCT00197015|21066289|P1|COMPLETED|Overall Study||274
8544923|NCT00197015|21066287|P3|STARTED|Overall Study||462
8544924|NCT00197015|21066288|P2|STARTED|Overall Study||455
8544925|NCT00197015|21066289|P1|STARTED|Overall Study||324
8544926|NCT00197002|21066348|P3|NOT COMPLETED|Overall Study||17
8544927|NCT00197002|21066349|P2|NOT COMPLETED|Overall Study||18
8544928|NCT00197002|21066350|P1|NOT COMPLETED|Overall Study||22
8544929|NCT00197002|21066348|P3|COMPLETED|Overall Study||132
8544930|NCT00197002|21066349|P2|COMPLETED|Overall Study||119
8544931|NCT00197002|21066350|P1|COMPLETED|Overall Study||125
8544932|NCT00197002|21066348|P3|STARTED|Overall Study||149
8544933|NCT00197002|21066349|P2|STARTED|Overall Study||137
8544934|NCT00197002|21066350|P1|STARTED|Overall Study||147
8544935|NCT00196976|21066401|P14|NOT COMPLETED|Booster Study||0
8544936|NCT00196976|21066402|P13|NOT COMPLETED|Booster Study||0
8544937|NCT00196976|21066403|P12|NOT COMPLETED|Booster Study||2
8544938|NCT00196976|21066404|P11|NOT COMPLETED|Booster Study||2
8544939|NCT00196976|21066405|P10|NOT COMPLETED|Booster Study||0
8544940|NCT00196976|21066406|P9|NOT COMPLETED|Booster Study||0
8544941|NCT00196976|21066407|P8|NOT COMPLETED|Booster Study||0
8544942|NCT00196976|21066408|P7|NOT COMPLETED|Booster Study||0
8544943|NCT00196976|21066409|P6|NOT COMPLETED|Booster Study||0
8544944|NCT00196976|21066410|P5|NOT COMPLETED|Booster Study||0
8544945|NCT00196976|21066411|P4|NOT COMPLETED|Booster Study||0
8544946|NCT00196976|21066412|P3|NOT COMPLETED|Booster Study||0
8544947|NCT00196976|21066413|P2|NOT COMPLETED|Booster Study||0
8544948|NCT00196976|21066414|P1|NOT COMPLETED|Booster Study||0
8544949|NCT00196976|21066401|P14|COMPLETED|Booster Study||43
8544950|NCT00196976|21066402|P13|COMPLETED|Booster Study||45
8544951|NCT00196976|21066403|P12|COMPLETED|Booster Study||30
8544952|NCT00196976|21066404|P11|COMPLETED|Booster Study||31
8544953|NCT00196976|21066405|P10|COMPLETED|Booster Study||0
8544954|NCT00196976|21066406|P9|COMPLETED|Booster Study||0
8544955|NCT00196976|21066407|P8|COMPLETED|Booster Study||0
8544956|NCT00196976|21066408|P7|COMPLETED|Booster Study||0
8544957|NCT00196976|21066409|P6|COMPLETED|Booster Study||0
8544958|NCT00196976|21066410|P5|COMPLETED|Booster Study||0
8544959|NCT00196976|21066411|P4|COMPLETED|Booster Study||0
8544960|NCT00196976|21066412|P3|COMPLETED|Booster Study||0
8544961|NCT00196976|21066413|P2|COMPLETED|Booster Study||0
8544962|NCT00196976|21066414|P1|COMPLETED|Booster Study||0
8544963|NCT00196976|21066401|P14|STARTED|Booster Study||43
8544964|NCT00196976|21066402|P13|STARTED|Booster Study||45
8544965|NCT00196976|21066403|P12|STARTED|Booster Study||32
8544966|NCT00196976|21066404|P11|STARTED|Booster Study||33
8544967|NCT00196976|21066405|P10|STARTED|Booster Study||0
8544968|NCT00196976|21066406|P9|STARTED|Booster Study||0
8544969|NCT00196976|21066407|P8|STARTED|Booster Study||0
8544970|NCT00196976|21066408|P7|STARTED|Booster Study||0
8544971|NCT00196976|21066409|P6|STARTED|Booster Study||0
8544972|NCT00196976|21066410|P5|STARTED|Booster Study||0
8544973|NCT00196976|21066411|P4|STARTED|Booster Study||0
8544974|NCT00196976|21066412|P3|STARTED|Booster Study||0
8544975|NCT00196976|21066413|P2|STARTED|Booster Study||0
8544976|NCT00196976|21066414|P1|STARTED|Booster Study||0
8544977|NCT00196976|21066401|P14|NOT COMPLETED|Primary Study||0
8544978|NCT00196976|21066402|P13|NOT COMPLETED|Primary Study||0
8544979|NCT00196976|21066403|P12|NOT COMPLETED|Primary Study||0
8544980|NCT00196976|21066404|P11|NOT COMPLETED|Primary Study||0
8544981|NCT00196976|21066405|P10|NOT COMPLETED|Primary Study||1
8544982|NCT00196976|21066406|P9|NOT COMPLETED|Primary Study||0
8544983|NCT00196976|21066407|P8|NOT COMPLETED|Primary Study||3
8544984|NCT00196976|21066408|P7|NOT COMPLETED|Primary Study||0
8544985|NCT00196976|21066409|P6|NOT COMPLETED|Primary Study||2
8544986|NCT00196976|21066410|P5|NOT COMPLETED|Primary Study||3
8544987|NCT00196976|21066411|P4|NOT COMPLETED|Primary Study||1
8544988|NCT00196976|21066412|P3|NOT COMPLETED|Primary Study||4
8544989|NCT00196976|21066413|P2|NOT COMPLETED|Primary Study||1
8544990|NCT00196976|21066414|P1|NOT COMPLETED|Primary Study||1
8544991|NCT00196976|21066401|P14|COMPLETED|Primary Study||0
8544992|NCT00196976|21066402|P13|COMPLETED|Primary Study||0
8544993|NCT00196976|21066403|P12|COMPLETED|Primary Study||0
8544994|NCT00196976|21066404|P11|COMPLETED|Primary Study||0
8544995|NCT00196976|21066405|P10|COMPLETED|Primary Study||51
8544996|NCT00196976|21066406|P9|COMPLETED|Primary Study||52
8544997|NCT00196976|21066407|P8|COMPLETED|Primary Study||49
8544998|NCT00196976|21066408|P7|COMPLETED|Primary Study||50
8544999|NCT00196976|21066409|P6|COMPLETED|Primary Study||52
8545000|NCT00196976|21066410|P5|COMPLETED|Primary Study||37
8545001|NCT00196976|21066411|P4|COMPLETED|Primary Study||39
8545002|NCT00196976|21066412|P3|COMPLETED|Primary Study||37
8545003|NCT00196976|21066413|P2|COMPLETED|Primary Study||40
8545004|NCT00196976|21066414|P1|COMPLETED|Primary Study||38
8545005|NCT00196976|21066401|P14|STARTED|Primary Study||0
8545006|NCT00196976|21066402|P13|STARTED|Primary Study||0
8545007|NCT00196976|21066403|P12|STARTED|Primary Study||0
8545008|NCT00196976|21066404|P11|STARTED|Primary Study||0
8545009|NCT00196976|21066405|P10|STARTED|Primary Study||52
8545010|NCT00196976|21066406|P9|STARTED|Primary Study||52
8545011|NCT00196976|21066407|P8|STARTED|Primary Study||52
8545012|NCT00196976|21066408|P7|STARTED|Primary Study||50
8545013|NCT00196976|21066409|P6|STARTED|Primary Study||54
8545014|NCT00196976|21066410|P5|STARTED|Primary Study||40
8545015|NCT00196976|21066411|P4|STARTED|Primary Study||40
8545016|NCT00196976|21066412|P3|STARTED|Primary Study||41
8545017|NCT00196976|21066413|P2|STARTED|Primary Study||41
8545018|NCT00196976|21066414|P1|STARTED|Primary Study||39
8545019|NCT00196937|21066610|P3|NOT COMPLETED|Overall Study||7
8545020|NCT00196937|21066611|P2|NOT COMPLETED|Overall Study||5
8545021|NCT00196937|21066612|P1|NOT COMPLETED|Overall Study||9
8545022|NCT00196937|21066610|P3|COMPLETED|Overall Study||204
8545023|NCT00196937|21066611|P2|COMPLETED|Overall Study||221
8545024|NCT00196937|21066612|P1|COMPLETED|Overall Study||220
8545025|NCT00196937|21066610|P3|STARTED|Overall Study||211
8545026|NCT00196937|21066611|P2|STARTED|Overall Study||226
8545027|NCT00196937|21066612|P1|STARTED|Overall Study||229
8545028|NCT00196716|21066656|P1|NOT COMPLETED|0.3 mg/kg Period||0
8545029|NCT00196716|21066656|P1|COMPLETED|0.3 mg/kg Period||21
8545030|NCT00196716|21066656|P1|STARTED|0.3 mg/kg Period||21
8545031|NCT00196716|21066656|P1|NOT COMPLETED|1.0 mg/kg Period||0
8545032|NCT00196716|21066656|P1|COMPLETED|1.0 mg/kg Period||21
8545033|NCT00196716|21066656|P1|STARTED|1.0 mg/kg Period||21
8545034|NCT00196326|21066666|P1|NOT COMPLETED|Overall Study||986
8545035|NCT00196326|21066666|P1|COMPLETED|Overall Study||1249
8545036|NCT00196326|21066666|P1|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
8545037|NCT00196326|21066666|P1|Safety Population|Overall Study|Treated participants|2185
8545038|NCT00196326|21066666|P1|STARTED|Overall Study|Took at least one dose of study medication|2235
8545039|NCT00196313|21066674|P2|NOT COMPLETED|Overall Study||8
8545040|NCT00196313|21066675|P1|NOT COMPLETED|Overall Study||11
8545041|NCT00196313|21066674|P2|COMPLETED|Overall Study||40
8545042|NCT00196313|21066675|P1|COMPLETED|Overall Study||36
8545043|NCT00196313|21066674|P2|STARTED|Overall Study||48
8545044|NCT00196313|21066675|P1|STARTED|Overall Study||47
8545045|NCT00196196|21066689|P1|NOT COMPLETED|Overall Study||7
8545046|NCT00196196|21066689|P1|COMPLETED|Overall Study||267
8545047|NCT00196196|21066689|P1|STARTED|Overall Study||274
8545048|NCT00196105|21066697|P3|NOT COMPLETED|Overall Study||7
8545049|NCT00196105|21066698|P2|NOT COMPLETED|Overall Study||5
8545050|NCT00196105|21066699|P1|NOT COMPLETED|Overall Study||4
8545051|NCT00196105|21066697|P3|COMPLETED|Overall Study||82
8545052|NCT00196105|21066698|P2|COMPLETED|Overall Study||83
8545053|NCT00196105|21066699|P1|COMPLETED|Overall Study||60
8545054|NCT00196105|21066697|P3|STARTED|Overall Study||89
8545055|NCT00196105|21066698|P2|STARTED|Overall Study||88
8545056|NCT00196105|21066699|P1|STARTED|Overall Study||64
8545057|NCT00195819|21066719|P2|NOT COMPLETED|Open-label||20
8545058|NCT00195819|21066720|P1|NOT COMPLETED|Open-label||0
8545059|NCT00195819|21066719|P2|COMPLETED|Open-label||62
8545060|NCT00195819|21066720|P1|COMPLETED|Open-label||0
8545061|NCT00195819|21066719|P2|STARTED|Open-label||82
8545062|NCT00195819|21066720|P1|STARTED|Open-label||0
8545063|NCT00195819|21066719|P2|NOT COMPLETED|Double-Blind||0
8545064|NCT00195819|21066720|P1|NOT COMPLETED|Double-Blind||2
8545065|NCT00195819|21066719|P2|COMPLETED|Double-Blind||38
8545066|NCT00195819|21066720|P1|COMPLETED|Double-Blind||42
8545067|NCT00195819|21066719|P2|STARTED|Double-Blind||38
8545068|NCT00195819|21066720|P1|STARTED|Double-Blind||44
8545069|NCT00195715|21066770|P1|NOT COMPLETED|Overall Study||377
8545070|NCT00195715|21066770|P1|COMPLETED|Overall Study||400
8545071|NCT00195715|21066770|P1|STARTED|Overall Study||777
8545072|NCT00195702|21066801|P6|NOT COMPLETED|Open-label Extension Phase||78
8545073|NCT00195702|21066802|P5|NOT COMPLETED|Open-label Extension Phase||78
8545074|NCT00195702|21066803|P4|NOT COMPLETED|Open-label Extension Phase||99
8545075|NCT00195702|21066804|P3|NOT COMPLETED|Open-label Extension Phase||0
8545076|NCT00195702|21066805|P2|NOT COMPLETED|Open-label Extension Phase||0
8545077|NCT00195702|21066806|P1|NOT COMPLETED|Open-label Extension Phase||0
8545078|NCT00195702|21066801|P6|COMPLETED|Open-label Extension Phase||56
8545079|NCT00195702|21066802|P5|COMPLETED|Open-label Extension Phase||80
8545080|NCT00195702|21066803|P4|COMPLETED|Open-label Extension Phase||66
8545081|NCT00195702|21066804|P3|COMPLETED|Open-label Extension Phase||0
8545082|NCT00195702|21066805|P2|COMPLETED|Open-label Extension Phase||0
8545083|NCT00195702|21066806|P1|COMPLETED|Open-label Extension Phase||0
8545084|NCT00195702|21066801|P6|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
8545085|NCT00195702|21066802|P5|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
8545086|NCT00195702|21066803|P4|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
8545087|NCT00195702|21066804|P3|STARTED|Open-label Extension Phase||0
8545088|NCT00195702|21066805|P2|STARTED|Open-label Extension Phase||0
8545089|NCT00195702|21066806|P1|STARTED|Open-label Extension Phase||0
8545090|NCT00195702|21066801|P6|NOT COMPLETED|Double-blind Phase||0
8545091|NCT00195702|21066802|P5|NOT COMPLETED|Double-blind Phase||0
8545092|NCT00195702|21066803|P4|NOT COMPLETED|Double-blind Phase||0
8545093|NCT00195702|21066804|P3|NOT COMPLETED|Double-blind Phase||60
8545094|NCT00195702|21066805|P2|NOT COMPLETED|Double-blind Phase||48
8545095|NCT00195702|21066806|P1|NOT COMPLETED|Double-blind Phase||44
8545096|NCT00195702|21066801|P6|COMPLETED|Double-blind Phase||0
8545097|NCT00195702|21066802|P5|COMPLETED|Double-blind Phase||0
8545098|NCT00195702|21066803|P4|COMPLETED|Double-blind Phase||0
8545099|NCT00195702|21066804|P3|COMPLETED|Double-blind Phase||140
8545100|NCT00195702|21066805|P2|COMPLETED|Double-blind Phase||159
8545101|NCT00195702|21066806|P1|COMPLETED|Double-blind Phase||168
8545102|NCT00195702|21066801|P6|STARTED|Double-blind Phase||0
8545103|NCT00195702|21066802|P5|STARTED|Double-blind Phase||0
8545104|NCT00195702|21066803|P4|STARTED|Double-blind Phase||0
8545105|NCT00195702|21066804|P3|STARTED|Double-blind Phase||200
8545106|NCT00195702|21066805|P2|STARTED|Double-blind Phase||207
8545107|NCT00195702|21066806|P1|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
8545108|NCT00195676|21066870|P1|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
8545109|NCT00195676|21066870|P1|COMPLETED|Period R - Retreatment 16 Weeks||490
8545110|NCT00195676|21066870|P1|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
8545111|NCT00195676|21066870|P1|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
8545112|NCT00195676|21066870|P1|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
8545113|NCT00195676|21066870|P1|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
8545114|NCT00195676|21066870|P1|NOT COMPLETED|Period O - Open-label Treatment||606
8545115|NCT00195676|21066870|P1|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
8545116|NCT00195676|21066870|P1|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
8545117|NCT00195663|21066884|P3|NOT COMPLETED|Open-Label Extension Period||97
8545118|NCT00195663|21066885|P2|NOT COMPLETED|Open-Label Extension Period||74
8545119|NCT00195663|21066886|P1|NOT COMPLETED|Open-Label Extension Period||76
8545120|NCT00195663|21066884|P3|COMPLETED|Open-Label Extension Period||86
8545121|NCT00195663|21066885|P2|COMPLETED|Open-Label Extension Period||85
8545122|NCT00195663|21066886|P1|COMPLETED|Open-Label Extension Period||79
8545123|NCT00195663|21066884|P3|STARTED|Open-Label Extension Period||183
8545124|NCT00195663|21066885|P2|STARTED|Open-Label Extension Period||159
8545125|NCT00195663|21066886|P1|STARTED|Open-Label Extension Period||155
8545126|NCT00195663|21066884|P3|NOT COMPLETED|2-year Double-blind Treatment Period||72
8545127|NCT00195663|21066885|P2|NOT COMPLETED|2-year Double-blind Treatment Period||108
8545128|NCT00195663|21066886|P1|NOT COMPLETED|2-year Double-blind Treatment Period||93
8545129|NCT00195663|21066884|P3|COMPLETED|2-year Double-blind Treatment Period||196
8545130|NCT00195663|21066885|P2|COMPLETED|2-year Double-blind Treatment Period||166
8545131|NCT00195663|21066886|P1|COMPLETED|2-year Double-blind Treatment Period||164
8545132|NCT00195663|21066884|P3|STARTED|2-year Double-blind Treatment Period||268
8545133|NCT00195663|21066885|P2|STARTED|2-year Double-blind Treatment Period||274
8545134|NCT00195663|21066886|P1|STARTED|2-year Double-blind Treatment Period||257
8545135|NCT00195650|21066980|P1|NOT COMPLETED|Overall Study||525
8545136|NCT00195650|21066980|P1|COMPLETED|Overall Study||321
8545227|NCT00195260|21067118|P8|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545137|NCT00195650|21066980|P1|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
8545138|NCT00195624|21066996|P2|NOT COMPLETED|Overall Study||0
8545139|NCT00195624|21066997|P1|NOT COMPLETED|Overall Study||0
8545140|NCT00195624|21066996|P2|COMPLETED|Overall Study||42
8545141|NCT00195624|21066997|P1|COMPLETED|Overall Study||5
8545142|NCT00195624|21066996|P2|STARTED|Overall Study||42
8545143|NCT00195624|21066997|P1|STARTED|Overall Study||5
8545144|NCT00195507|21067005|P2|NOT COMPLETED|Overall Study||118
8545145|NCT00195507|21067006|P1|NOT COMPLETED|Overall Study||99
8545146|NCT00195507|21067005|P2|COMPLETED|Overall Study||245
8545147|NCT00195507|21067006|P1|COMPLETED|Overall Study||258
8545148|NCT00195507|21067005|P2|STARTED|Overall Study||363
8545149|NCT00195507|21067006|P1|STARTED|Overall Study||357
8545150|NCT00195494|21067020|P6|NOT COMPLETED|Year 2||0
8545151|NCT00195494|21067021|P5|NOT COMPLETED|Year 2||0
8545152|NCT00195494|21067022|P4|NOT COMPLETED|Year 2||23
8545153|NCT00195494|21067023|P3|NOT COMPLETED|Year 2||18
8545154|NCT00195494|21067024|P2|NOT COMPLETED|Year 2||16
8545155|NCT00195494|21067025|P1|NOT COMPLETED|Year 2||7
8545156|NCT00195494|21067020|P6|COMPLETED|Year 2||0
8545157|NCT00195494|21067021|P5|COMPLETED|Year 2||0
8545158|NCT00195494|21067022|P4|COMPLETED|Year 2||76
8545159|NCT00195494|21067023|P3|COMPLETED|Year 2||93
8545160|NCT00195494|21067024|P2|COMPLETED|Year 2||74
8545161|NCT00195494|21067025|P1|COMPLETED|Year 2||104
8545162|NCT00195494|21067020|P6|STARTED|Year 2||0
8545163|NCT00195494|21067021|P5|STARTED|Year 2||0
8545164|NCT00195494|21067022|P4|STARTED|Year 2||99
8545165|NCT00195494|21067023|P3|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
8545166|NCT00195494|21067024|P2|STARTED|Year 2||90
8545167|NCT00195494|21067025|P1|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
8545168|NCT00195494|21067020|P6|NOT COMPLETED|Year 1||53
8545169|NCT00195494|21067021|P5|NOT COMPLETED|Year 1||79
8545170|NCT00195494|21067022|P4|NOT COMPLETED|Year 1||0
8545171|NCT00195494|21067023|P3|NOT COMPLETED|Year 1||0
8545172|NCT00195494|21067024|P2|NOT COMPLETED|Year 1||0
8545173|NCT00195494|21067025|P1|NOT COMPLETED|Year 1||0
8545174|NCT00195494|21067020|P6|COMPLETED|Year 1||221
8545175|NCT00195494|21067021|P5|COMPLETED|Year 1||189
8545176|NCT00195494|21067022|P4|COMPLETED|Year 1||0
8545177|NCT00195494|21067023|P3|COMPLETED|Year 1||0
8545178|NCT00195494|21067024|P2|COMPLETED|Year 1||0
8545179|NCT00195494|21067025|P1|COMPLETED|Year 1||0
8545180|NCT00195494|21067020|P6|STARTED|Year 1||274
8545181|NCT00195494|21067021|P5|STARTED|Year 1||268
8545182|NCT00195494|21067022|P4|STARTED|Year 1||0
8545183|NCT00195494|21067023|P3|STARTED|Year 1||0
8545184|NCT00195494|21067024|P2|STARTED|Year 1||0
8545185|NCT00195494|21067025|P1|STARTED|Year 1||0
8545186|NCT00195442|21067043|P1|NOT COMPLETED|Overall Study||136
8545187|NCT00195442|21067043|P1|COMPLETED|Overall Study||152
8545188|NCT00195442|21067043|P1|STARTED|Overall Study||288
8545189|NCT00195429|21067062|P2|NOT COMPLETED|Overall Study||5
8545190|NCT00195429|21067063|P1|NOT COMPLETED|Overall Study||5
8545191|NCT00195429|21067062|P2|COMPLETED|Overall Study||18
8545192|NCT00195429|21067063|P1|COMPLETED|Overall Study||19
8545193|NCT00195429|21067062|P2|STARTED|Overall Study||23
8545194|NCT00195429|21067063|P1|STARTED|Overall Study||24
8545195|NCT00195403|21067071|P1|NOT COMPLETED|Overall Study||0
8545196|NCT00195403|21067071|P1|COMPLETED|Overall Study||1014
8545197|NCT00195403|21067071|P1|STARTED|Overall Study||1014
8545198|NCT00195351|21067079|P2|NOT COMPLETED|Overall Study||16
8545199|NCT00195351|21067080|P1|NOT COMPLETED|Overall Study||21
8545200|NCT00195351|21067079|P2|COMPLETED|Overall Study||215
8545201|NCT00195351|21067080|P1|COMPLETED|Overall Study||215
8545202|NCT00195351|21067079|P2|STARTED|Overall Study||231
8545203|NCT00195351|21067080|P1|STARTED|Overall Study||236
8545204|NCT00195338|21067090|P1|NOT COMPLETED|Overall Study||12
8545205|NCT00195338|21067090|P1|COMPLETED|Overall Study||13
8545206|NCT00195338|21067090|P1|STARTED|Overall Study||25
8545207|NCT00195273|21067100|P2|NOT COMPLETED|Overall Study||14
8545208|NCT00195273|21067101|P1|NOT COMPLETED|Overall Study||21
8545209|NCT00195273|21067100|P2|COMPLETED|Overall Study||16
8545210|NCT00195273|21067101|P1|COMPLETED|Overall Study||10
8545211|NCT00195273|21067100|P2|STARTED|Overall Study||30
8545212|NCT00195273|21067101|P1|STARTED|Overall Study||31
8545213|NCT00195260|21067115|P11|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
8545214|NCT00195260|21067116|P10|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
8545215|NCT00195260|21067117|P9|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
8545216|NCT00195260|21067118|P8|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545217|NCT00195260|21067119|P7|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545218|NCT00195260|21067120|P6|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545219|NCT00195260|21067121|P5|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545220|NCT00195260|21067122|P4|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545221|NCT00195260|21067123|P3|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545222|NCT00195260|21067124|P2|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545223|NCT00195260|21067125|P1|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545224|NCT00195260|21067115|P11|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
8545225|NCT00195260|21067116|P10|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545226|NCT00195260|21067117|P9|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
8545228|NCT00195260|21067119|P7|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545229|NCT00195260|21067120|P6|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545230|NCT00195260|21067121|P5|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545231|NCT00195260|21067122|P4|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545232|NCT00195260|21067123|P3|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545233|NCT00195260|21067124|P2|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545234|NCT00195260|21067125|P1|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545235|NCT00195260|21067115|P11|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
8545236|NCT00195260|21067116|P10|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
8545237|NCT00195260|21067117|P9|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
8545238|NCT00195260|21067118|P8|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545239|NCT00195260|21067119|P7|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545240|NCT00195260|21067120|P6|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545241|NCT00195260|21067121|P5|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545242|NCT00195260|21067122|P4|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545243|NCT00195260|21067123|P3|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545244|NCT00195260|21067124|P2|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545245|NCT00195260|21067125|P1|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
8545246|NCT00195260|21067115|P11|NOT COMPLETED|Part 1: Dose Escalation||0
8545247|NCT00195260|21067116|P10|NOT COMPLETED|Part 1: Dose Escalation||0
8545248|NCT00195260|21067117|P9|NOT COMPLETED|Part 1: Dose Escalation||0
8545249|NCT00195260|21067118|P8|NOT COMPLETED|Part 1: Dose Escalation||6
8545250|NCT00195260|21067119|P7|NOT COMPLETED|Part 1: Dose Escalation||10
8545251|NCT00195260|21067120|P6|NOT COMPLETED|Part 1: Dose Escalation||7
8545252|NCT00195260|21067121|P5|NOT COMPLETED|Part 1: Dose Escalation||7
8545253|NCT00195260|21067122|P4|NOT COMPLETED|Part 1: Dose Escalation||7
8545254|NCT00195260|21067123|P3|NOT COMPLETED|Part 1: Dose Escalation||6
8545255|NCT00195260|21067124|P2|NOT COMPLETED|Part 1: Dose Escalation||4
8545256|NCT00195260|21067125|P1|NOT COMPLETED|Part 1: Dose Escalation||4
8545257|NCT00195260|21067115|P11|COMPLETED|Part 1: Dose Escalation||0
8545258|NCT00195260|21067116|P10|COMPLETED|Part 1: Dose Escalation||0
8545259|NCT00195260|21067117|P9|COMPLETED|Part 1: Dose Escalation||0
8545260|NCT00195260|21067118|P8|COMPLETED|Part 1: Dose Escalation||0
8545261|NCT00195260|21067119|P7|COMPLETED|Part 1: Dose Escalation||0
8545262|NCT00195260|21067120|P6|COMPLETED|Part 1: Dose Escalation||0
8545263|NCT00195260|21067121|P5|COMPLETED|Part 1: Dose Escalation||0
8545264|NCT00195260|21067122|P4|COMPLETED|Part 1: Dose Escalation||0
8545265|NCT00195260|21067123|P3|COMPLETED|Part 1: Dose Escalation||0
8545266|NCT00195260|21067124|P2|COMPLETED|Part 1: Dose Escalation||0
8545267|NCT00195260|21067125|P1|COMPLETED|Part 1: Dose Escalation||0
8545268|NCT00195260|21067115|P11|STARTED|Part 1: Dose Escalation||0
8545269|NCT00195260|21067116|P10|STARTED|Part 1: Dose Escalation||0
8545270|NCT00195260|21067117|P9|STARTED|Part 1: Dose Escalation||0
8545271|NCT00195260|21067118|P8|STARTED|Part 1: Dose Escalation||6
8545272|NCT00195260|21067119|P7|STARTED|Part 1: Dose Escalation||10
8545273|NCT00195260|21067120|P6|STARTED|Part 1: Dose Escalation||7
8545274|NCT00195260|21067121|P5|STARTED|Part 1: Dose Escalation||7
8545275|NCT00195260|21067122|P4|STARTED|Part 1: Dose Escalation||7
8545276|NCT00195260|21067123|P3|STARTED|Part 1: Dose Escalation||6
8545277|NCT00195260|21067124|P2|STARTED|Part 1: Dose Escalation||4
8545278|NCT00195260|21067125|P1|STARTED|Part 1: Dose Escalation||4
8545279|NCT00195039|21067271|P1|NOT COMPLETED|Overall Study||0
8545280|NCT00195039|21067271|P1|COMPLETED|Overall Study||47
8545281|NCT00195039|21067271|P1|STARTED|Overall Study||47
8545282|NCT00195013|21067284|P2|NOT COMPLETED|Overall Study||1
8545283|NCT00195013|21067285|P1|NOT COMPLETED|Overall Study||2
8545284|NCT00195013|21067284|P2|COMPLETED|Overall Study||15
8545285|NCT00195013|21067285|P1|COMPLETED|Overall Study||12
8545286|NCT00195013|21067284|P2|STARTED|Overall Study||16
8545287|NCT00195013|21067285|P1|STARTED|Overall Study||14
8545288|NCT00194987|21067293|P2|NOT COMPLETED|Overall Study||3
8545289|NCT00194987|21067294|P1|NOT COMPLETED|Overall Study||0
8545290|NCT00194987|21067293|P2|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
8545291|NCT00194987|21067294|P1|COMPLETED|Overall Study||51
8545292|NCT00194987|21067293|P2|STARTED|Overall Study||51
8545293|NCT00194987|21067294|P1|STARTED|Overall Study||51
8545294|NCT00194896|21067310|P4|NOT COMPLETED|Overall Study||12
8545295|NCT00194896|21067311|P3|NOT COMPLETED|Overall Study||6
8545296|NCT00194896|21067312|P2|NOT COMPLETED|Overall Study||5
8545297|NCT00194896|21067313|P1|NOT COMPLETED|Overall Study||11
8545298|NCT00194896|21067310|P4|COMPLETED|Overall Study||9
8545299|NCT00194896|21067311|P3|COMPLETED|Overall Study||7
8545300|NCT00194896|21067312|P2|COMPLETED|Overall Study||10
8545301|NCT00194896|21067313|P1|COMPLETED|Overall Study||4
8545302|NCT00194896|21067310|P4|STARTED|Overall Study||21
8545303|NCT00194896|21067311|P3|STARTED|Overall Study||13
8545304|NCT00194896|21067312|P2|STARTED|Overall Study||15
8545305|NCT00194896|21067313|P1|STARTED|Overall Study||15
8545306|NCT00194792|21067327|P1|NOT COMPLETED|Overall Study||1
8545307|NCT00194792|21067327|P1|COMPLETED|Overall Study||27
8545308|NCT00194792|21067327|P1|STARTED|Overall Study||28
8545309|NCT00194779|21067337|P1|NOT COMPLETED|Overall Study||0
8545310|NCT00194779|21067337|P1|COMPLETED|Overall Study||50
8545311|NCT00194779|21067337|P1|STARTED|Overall Study||50
8545312|NCT00194675|21067351|P2|NOT COMPLETED|Overall Study||2
8545313|NCT00194675|21067352|P1|NOT COMPLETED|Overall Study||5
8545314|NCT00194675|21067351|P2|COMPLETED|Overall Study||24
8545315|NCT00194675|21067352|P1|COMPLETED|Overall Study||22
8545316|NCT00194675|21067351|P2|STARTED|Overall Study||26
8545317|NCT00194675|21067352|P1|STARTED|Overall Study||27
8545318|NCT00194610|21067370|P2|NOT COMPLETED|Overall Study||0
8545319|NCT00194610|21067371|P1|NOT COMPLETED|Overall Study||0
8545320|NCT00194610|21067370|P2|COMPLETED|Overall Study||9
8545321|NCT00194610|21067371|P1|COMPLETED|Overall Study||11
8545322|NCT00194610|21067370|P2|STARTED|Overall Study||9
8545323|NCT00194610|21067371|P1|STARTED|Overall Study||11
8545324|NCT00194532|21067379|P2|NOT COMPLETED|Overall Study||0
8545325|NCT00194532|21067380|P1|NOT COMPLETED|Overall Study||0
8545326|NCT00194532|21067379|P2|COMPLETED|Overall Study||150
8545327|NCT00194532|21067380|P1|COMPLETED|Overall Study||150
8545328|NCT00194532|21067379|P2|STARTED|Overall Study||150
8545329|NCT00194532|21067380|P1|STARTED|Overall Study||150
8545330|NCT00194129|21067390|P2|NOT COMPLETED|Overall Study||13
8545331|NCT00194129|21067391|P1|NOT COMPLETED|Overall Study||10
8545332|NCT00194129|21067390|P2|COMPLETED|Overall Study||3
8545333|NCT00194129|21067391|P1|COMPLETED|Overall Study||5
8545334|NCT00194129|21067390|P2|STARTED|Overall Study||16
8545335|NCT00194129|21067391|P1|STARTED|Overall Study||15
8545336|NCT00194116|21067406|P2|NOT COMPLETED|Overall Study||15
8545337|NCT00194116|21067407|P1|NOT COMPLETED|Overall Study||13
8545338|NCT00194116|21067406|P2|COMPLETED|Overall Study||13
8545339|NCT00194116|21067407|P1|COMPLETED|Overall Study||13
8545340|NCT00194116|21067406|P2|STARTED|Overall Study||28
8545341|NCT00194116|21067407|P1|STARTED|Overall Study||26
8545342|NCT00194077|21067427|P2|NOT COMPLETED|Overall Study||30
8545343|NCT00194077|21067428|P1|NOT COMPLETED|Overall Study||24
8545344|NCT00194077|21067427|P2|COMPLETED|Overall Study|"Lack of efficacy:
~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
8545345|NCT00194077|21067428|P1|COMPLETED|Overall Study|"Lack of efficacy:
~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
8545346|NCT00194077|21067427|P2|STARTED|Overall Study||30
8545347|NCT00194077|21067428|P1|STARTED|Overall Study||30
8545348|NCT00194025|21067434|P1|NOT COMPLETED|Overall Study||5
8545349|NCT00194025|21067434|P1|COMPLETED|Overall Study|5 participants withdrew prematurely|15
8545350|NCT00194025|21067434|P1|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
8545351|NCT00194012|21067449|P2|NOT COMPLETED|Open Label Extension (OLE)||6
8545352|NCT00194012|21067450|P1|NOT COMPLETED|Open Label Extension (OLE)||5
8545353|NCT00194012|21067449|P2|COMPLETED|Open Label Extension (OLE)||15
8545354|NCT00194012|21067450|P1|COMPLETED|Open Label Extension (OLE)||17
8545355|NCT00194012|21067449|P2|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
8545356|NCT00194012|21067450|P1|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
8545357|NCT00194012|21067449|P2|NOT COMPLETED|Randomized Phase||25
8545358|NCT00194012|21067450|P1|NOT COMPLETED|Randomized Phase||16
8545359|NCT00194012|21067449|P2|COMPLETED|Randomized Phase||6
8545360|NCT00194012|21067450|P1|COMPLETED|Randomized Phase||15
8545361|NCT00194012|21067449|P2|Received More Than One Dose|Randomized Phase||29
8545362|NCT00194012|21067450|P1|Received More Than One Dose|Randomized Phase||30
8545363|NCT00194012|21067449|P2|STARTED|Randomized Phase||31
8545364|NCT00194012|21067450|P1|STARTED|Randomized Phase||31
8545365|NCT00193609|21067486|P1|NOT COMPLETED|Overall Study||4
8545366|NCT00193609|21067486|P1|COMPLETED|Overall Study||44
8545367|NCT00193609|21067486|P1|STARTED|Overall Study||48
8545368|NCT00193596|21067493|P2|NOT COMPLETED|Overall Study||66
8545369|NCT00193596|21067494|P1|NOT COMPLETED|Overall Study||56
8545370|NCT00193596|21067493|P2|COMPLETED|Overall Study||39
8545371|NCT00193596|21067494|P1|COMPLETED|Overall Study||37
8545372|NCT00193596|21067493|P2|STARTED|Overall Study||105
8545373|NCT00193596|21067494|P1|STARTED|Overall Study||93
8545374|NCT00193492|21067504|P2|NOT COMPLETED|Overall Study||15
8545375|NCT00193492|21067505|P1|NOT COMPLETED|Overall Study||17
8545376|NCT00193492|21067504|P2|COMPLETED|Overall Study||14
8545377|NCT00193492|21067505|P1|COMPLETED|Overall Study||14
8545378|NCT00193492|21067504|P2|STARTED|Overall Study||29
8545379|NCT00193492|21067505|P1|STARTED|Overall Study||31
8545380|NCT00193479|21067513|P1|NOT COMPLETED|Maintenance Rituximab||0
8545381|NCT00193479|21067513|P1|COMPLETED|Maintenance Rituximab||44
8545382|NCT00193479|21067513|P1|STARTED|Maintenance Rituximab||44
8545383|NCT00193479|21067513|P1|NOT COMPLETED|Induction Chemotherapy||3
8545384|NCT00193479|21067513|P1|COMPLETED|Induction Chemotherapy||48
8545385|NCT00193479|21067513|P1|STARTED|Induction Chemotherapy||51
8545386|NCT00193453|21067517|P1|NOT COMPLETED|Overall Study||48
8545387|NCT00193453|21067517|P1|COMPLETED|Overall Study||21
8545388|NCT00193453|21067517|P1|STARTED|Overall Study||69
8545389|NCT00193427|21067523|P1|NOT COMPLETED|Overall Study||49
8545390|NCT00193427|21067523|P1|COMPLETED|Overall Study||26
8545391|NCT00193427|21067523|P1|STARTED|Overall Study||75
8545392|NCT00193414|21067530|P1|NOT COMPLETED|Overall Study||58
8545393|NCT00193414|21067530|P1|COMPLETED|Overall Study||14
8545394|NCT00193414|21067530|P1|STARTED|Overall Study||72
8545395|NCT00193375|21067536|P1|NOT COMPLETED|Overall Study||19
8545396|NCT00193375|21067536|P1|COMPLETED|Overall Study||41
8545397|NCT00193375|21067536|P1|STARTED|Overall Study||60
8545398|NCT00193258|21067542|P1|NOT COMPLETED|Overall Study||0
8545399|NCT00193258|21067542|P1|COMPLETED|Overall Study||94
8545400|NCT00193258|21067542|P1|STARTED|Overall Study||94
8545401|NCT00193219|21067548|P1|NOT COMPLETED|Overall Study||30
8545402|NCT00193219|21067548|P1|COMPLETED|Overall Study||6
8545403|NCT00193219|21067548|P1|STARTED|Overall Study||36
8545404|NCT00193206|21067554|P1|NOT COMPLETED|Postoperative Therapy||14
8545405|NCT00193206|21067554|P1|COMPLETED|Postoperative Therapy||102
8545406|NCT00193206|21067554|P1|STARTED|Postoperative Therapy||116
8545407|NCT00193206|21067554|P1|NOT COMPLETED|Surgery||0
8545408|NCT00193206|21067554|P1|COMPLETED|Surgery||116
8545409|NCT00193206|21067554|P1|STARTED|Surgery||116
8545410|NCT00193206|21067554|P1|NOT COMPLETED|Preoperative Therapy||7
8545411|NCT00193206|21067554|P1|COMPLETED|Preoperative Therapy||116
8545412|NCT00193206|21067554|P1|STARTED|Preoperative Therapy||123
8545413|NCT00193180|21067558|P1|NOT COMPLETED|Overall Study||10
8545414|NCT00193180|21067558|P1|COMPLETED|Overall Study||27
8545415|NCT00193180|21067558|P1|STARTED|Overall Study||37
8545416|NCT00193128|21067566|P2|NOT COMPLETED|Overall Study||10
8545417|NCT00193128|21067567|P1|NOT COMPLETED|Overall Study||0
8545418|NCT00193128|21067566|P2|COMPLETED|Overall Study||39
8545419|NCT00193128|21067567|P1|COMPLETED|Overall Study||10
8545420|NCT00193128|21067566|P2|STARTED|Overall Study||49
8545421|NCT00193128|21067567|P1|STARTED|Overall Study||10
8545422|NCT00193063|21067573|P1|NOT COMPLETED|Overall Study||4
8545423|NCT00193063|21067573|P1|COMPLETED|Overall Study||37
8545424|NCT00193063|21067573|P1|STARTED|Overall Study||41
8545425|NCT00193050|21067579|P1|NOT COMPLETED|Adjuvant||10
8545426|NCT00193050|21067579|P1|COMPLETED|Adjuvant||77
8545427|NCT00193050|21067579|P1|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
8545428|NCT00193050|21067579|P1|NOT COMPLETED|Surgery||0
8545429|NCT00193050|21067579|P1|COMPLETED|Surgery||103
8545430|NCT00193050|21067579|P1|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
8545431|NCT00193050|21067579|P1|NOT COMPLETED|Neoadjuvant Treatment||9
8545432|NCT00193050|21067579|P1|COMPLETED|Neoadjuvant Treatment||101
8545433|NCT00193050|21067579|P1|STARTED|Neoadjuvant Treatment||110
8545434|NCT00193037|21067585|P2|NOT COMPLETED|Crossover Treatment||0
8545435|NCT00193037|21067586|P1|NOT COMPLETED|Crossover Treatment||0
8545436|NCT00193037|21067585|P2|COMPLETED|Crossover Treatment||24
8545437|NCT00193037|21067586|P1|COMPLETED|Crossover Treatment||32
8545438|NCT00193037|21067585|P2|STARTED|Crossover Treatment||24
8545439|NCT00193037|21067586|P1|STARTED|Crossover Treatment||32
8545440|NCT00193037|21067585|P2|NOT COMPLETED|Randomized Treatment||28
8545441|NCT00193037|21067586|P1|NOT COMPLETED|Randomized Treatment||18
8545442|NCT00193037|21067585|P2|COMPLETED|Randomized Treatment||24
8545443|NCT00193037|21067586|P1|COMPLETED|Randomized Treatment||32
8545444|NCT00193037|21067585|P2|STARTED|Randomized Treatment||52
8545445|NCT00193037|21067586|P1|STARTED|Randomized Treatment||50
8545446|NCT00192647|21067596|P2|NOT COMPLETED|Overall Study||146
8545447|NCT00192647|21067597|P1|NOT COMPLETED|Overall Study||128
8545448|NCT00192647|21067596|P2|COMPLETED|Overall Study||302
8545449|NCT00192647|21067597|P1|COMPLETED|Overall Study||320
8545450|NCT00192647|21067596|P2|Treated|Overall Study||438
8545451|NCT00192647|21067597|P1|Treated|Overall Study||433
8545452|NCT00192647|21067596|P2|STARTED|Overall Study||448
8545453|NCT00192647|21067597|P1|STARTED|Overall Study||448
8545454|NCT00192296|21067617|P4|NOT COMPLETED|Overall Study||0
8545455|NCT00192296|21067618|P3|NOT COMPLETED|Overall Study||0
8545456|NCT00192296|21067619|P2|NOT COMPLETED|Overall Study||1
8545457|NCT00192296|21067620|P1|NOT COMPLETED|Overall Study||0
8545458|NCT00192296|21067617|P4|COMPLETED|Overall Study||6
8545459|NCT00192296|21067618|P3|COMPLETED|Overall Study||6
8545460|NCT00192296|21067619|P2|COMPLETED|Overall Study||5
8545461|NCT00192296|21067620|P1|COMPLETED|Overall Study||6
8545462|NCT00192296|21067617|P4|STARTED|Overall Study||6
8545463|NCT00192296|21067618|P3|STARTED|Overall Study||6
8545464|NCT00192296|21067619|P2|STARTED|Overall Study||6
8545465|NCT00192296|21067620|P1|STARTED|Overall Study||6
8545466|NCT00192114|21067674|P1|NOT COMPLETED|Overall Study||24
8545467|NCT00192114|21067674|P1|COMPLETED|Overall Study||4
8545468|NCT00192114|21067674|P1|Received at Least 1 Dose of Study Drug|Overall Study||28
8545469|NCT00192114|21067674|P1|STARTED|Overall Study||28
8545470|NCT00192075|21067691|P2|NOT COMPLETED|Overall Study||19
8545471|NCT00192075|21067692|P1|NOT COMPLETED|Overall Study||39
8545472|NCT00192075|21067691|P2|COMPLETED|Overall Study||23
8545473|NCT00192075|21067692|P1|COMPLETED|Overall Study||3
8545474|NCT00192075|21067691|P2|STARTED|Overall Study||42
8545475|NCT00192075|21067692|P1|STARTED|Overall Study||42
8545476|NCT00192036|21067717|P1|NOT COMPLETED|Overall Study||21
8545477|NCT00192036|21067717|P1|COMPLETED|Overall Study||28
8545478|NCT00192036|21067717|P1|STARTED|Overall Study||49
8545479|NCT00192023|21067727|P2|NOT COMPLETED|Period IV - Optional Open-Label||0
8545480|NCT00192023|21067728|P1|NOT COMPLETED|Period IV - Optional Open-Label||75
8545481|NCT00192023|21067727|P2|COMPLETED|Period IV - Optional Open-Label||0
8545482|NCT00192023|21067728|P1|COMPLETED|Period IV - Optional Open-Label||49
8545483|NCT00192023|21067727|P2|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
8545484|NCT00192023|21067728|P1|STARTED|Period IV - Optional Open-Label||124
8545485|NCT00192023|21067727|P2|NOT COMPLETED|Period III - Double-Blind||0
8545486|NCT00192023|21067728|P1|NOT COMPLETED|Period III - Double-Blind||7
8545487|NCT00192023|21067727|P2|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
8545488|NCT00192023|21067728|P1|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
8545489|NCT00192023|21067727|P2|STARTED|Period III - Double-Blind||32
8545490|NCT00192023|21067728|P1|STARTED|Period III - Double-Blind||107
8545491|NCT00191984|21067750|P1|NOT COMPLETED|Overall Study||39
8545492|NCT00191984|21067750|P1|COMPLETED|Overall Study||7
8545493|NCT00191984|21067750|P1|STARTED|Overall Study||46
8545494|NCT00191945|21067760|P2|NOT COMPLETED|Open-Label Treatment Extension||0
8545495|NCT00191945|21067761|P1|NOT COMPLETED|Open-Label Treatment Extension||0
8545496|NCT00191945|21067760|P2|COMPLETED|Open-Label Treatment Extension||48
8545497|NCT00191945|21067761|P1|COMPLETED|Open-Label Treatment Extension||94
8545498|NCT00191945|21067760|P2|STARTED|Open-Label Treatment Extension||48
8545499|NCT00191945|21067761|P1|STARTED|Open-Label Treatment Extension||94
8545500|NCT00191945|21067760|P2|NOT COMPLETED|Double-Blind Acute Treatment||3
8545501|NCT00191945|21067761|P1|NOT COMPLETED|Double-Blind Acute Treatment||6
8545502|NCT00191945|21067760|P2|COMPLETED|Double-Blind Acute Treatment||48
8545503|NCT00191945|21067761|P1|COMPLETED|Double-Blind Acute Treatment||94
8545504|NCT00191945|21067760|P2|STARTED|Double-Blind Acute Treatment||51
8545505|NCT00191945|21067761|P1|STARTED|Double-Blind Acute Treatment||100
8545506|NCT00191906|21067797|P4|NOT COMPLETED|Study Period III||0
8545507|NCT00191906|21067798|P3|NOT COMPLETED|Study Period III||0
8545508|NCT00191906|21067799|P2|NOT COMPLETED|Study Period III||4
8545509|NCT00191906|21067800|P1|NOT COMPLETED|Study Period III||5
8545510|NCT00191906|21067797|P4|COMPLETED|Study Period III||0
8545511|NCT00191906|21067798|P3|COMPLETED|Study Period III||0
8545512|NCT00191906|21067799|P2|COMPLETED|Study Period III||7
8545513|NCT00191906|21067800|P1|COMPLETED|Study Period III||9
8545514|NCT00191906|21067797|P4|STARTED|Study Period III||0
8545515|NCT00191906|21067798|P3|STARTED|Study Period III||0
8545516|NCT00191906|21067799|P2|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
8545517|NCT00191906|21067800|P1|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
8545518|NCT00191906|21067797|P4|NOT COMPLETED|Study Period II||0
8545519|NCT00191906|21067798|P3|NOT COMPLETED|Study Period II||1
8545520|NCT00191906|21067799|P2|NOT COMPLETED|Study Period II||5
8545521|NCT00191906|21067800|P1|NOT COMPLETED|Study Period II||0
8545522|NCT00191906|21067797|P4|COMPLETED|Study Period II||18
8545523|NCT00191906|21067798|P3|COMPLETED|Study Period II||26
8545524|NCT00191906|21067799|P2|COMPLETED|Study Period II||32
8545525|NCT00191906|21067800|P1|COMPLETED|Study Period II||39
8545526|NCT00191906|21067797|P4|STARTED|Study Period II||18
8545527|NCT00191906|21067798|P3|STARTED|Study Period II||27
8545528|NCT00191906|21067799|P2|STARTED|Study Period II||37
8545529|NCT00191906|21067800|P1|STARTED|Study Period II||39
8545530|NCT00191854|21067843|P3|NOT COMPLETED|Overall Study||39
8545531|NCT00191854|21067844|P2|NOT COMPLETED|Overall Study||30
8545532|NCT00191854|21067845|P1|NOT COMPLETED|Overall Study||37
8545533|NCT00191854|21067843|P3|COMPLETED|Overall Study||12
8545534|NCT00191854|21067844|P2|COMPLETED|Overall Study||17
8545535|NCT00191854|21067845|P1|COMPLETED|Overall Study||12
8545536|NCT00191854|21067843|P3|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
8545537|NCT00191854|21067844|P2|Received at Least One Dose of Study Drug|Overall Study||47
8545538|NCT00191854|21067845|P1|Received at Least One Dose of Study Drug|Overall Study||49
8545539|NCT00191854|21067843|P3|STARTED|Overall Study||51
8545540|NCT00191854|21067844|P2|STARTED|Overall Study||47
8545541|NCT00191854|21067845|P1|STARTED|Overall Study||49
8545542|NCT00191815|21067865|P1|NOT COMPLETED|Overall Study||40
8545543|NCT00191815|21067865|P1|COMPLETED|Overall Study||30
8545544|NCT00191815|21067865|P1|Treated|Overall Study||67
8545545|NCT00191815|21067865|P1|STARTED|Overall Study||70
8545546|NCT00191789|21067877|P1|NOT COMPLETED|Overall Study||25
8545547|NCT00191789|21067877|P1|COMPLETED|Overall Study||40
8545548|NCT00191789|21067877|P1|STARTED|Overall Study||65
8545549|NCT00191724|21067894|P5|NOT COMPLETED|Overall Study||3
8545550|NCT00191724|21067895|P4|NOT COMPLETED|Overall Study||3
8545551|NCT00191724|21067896|P3|NOT COMPLETED|Overall Study||1
8545552|NCT00191724|21067897|P2|NOT COMPLETED|Overall Study||1
8545553|NCT00191724|21067898|P1|NOT COMPLETED|Overall Study||1
8545554|NCT00191724|21067894|P5|COMPLETED|Overall Study||12
8545555|NCT00191724|21067895|P4|COMPLETED|Overall Study||5
8545556|NCT00191724|21067896|P3|COMPLETED|Overall Study||8
8545557|NCT00191724|21067897|P2|COMPLETED|Overall Study||8
8545558|NCT00191724|21067898|P1|COMPLETED|Overall Study||5
8545559|NCT00191724|21067894|P5|STARTED|Overall Study||15
8545560|NCT00191724|21067895|P4|STARTED|Overall Study||8
8545561|NCT00191724|21067896|P3|STARTED|Overall Study||9
8545562|NCT00191724|21067897|P2|STARTED|Overall Study||9
8545563|NCT00191724|21067898|P1|STARTED|Overall Study||6
8545564|NCT00191646|21067927|P2|NOT COMPLETED|Overall Study||153
8545565|NCT00191646|21067928|P1|NOT COMPLETED|Overall Study||171
8545566|NCT00191646|21067927|P2|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
8545567|NCT00191646|21067928|P1|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
8545568|NCT00191646|21067927|P2|Received Crossover Therapy|Overall Study||78
8545569|NCT00191646|21067928|P1|Received Crossover Therapy|Overall Study||77
8545570|NCT00191646|21067927|P2|Received Consolidation Therapy|Overall Study||183
8545571|NCT00191646|21067928|P1|Received Consolidation Therapy|Overall Study||169
8545572|NCT00191646|21067927|P2|Received Induction Therapy|Overall Study||409
8545573|NCT00191646|21067928|P1|Received Induction Therapy|Overall Study||411
8545574|NCT00191646|21067927|P2|STARTED|Overall Study||414
8545575|NCT00191646|21067928|P1|STARTED|Overall Study||417
8545576|NCT00191477|21067948|P2|NOT COMPLETED|Overall Study||129
8545577|NCT00191477|21067949|P1|NOT COMPLETED|Overall Study||138
8545578|NCT00191477|21067948|P2|COMPLETED|Overall Study||47
8545579|NCT00191477|21067949|P1|COMPLETED|Overall Study||41
8545580|NCT00191477|21067948|P2|Received Study Drug|Overall Study||162
8545581|NCT00191477|21067949|P1|Received Study Drug|Overall Study||166
8545582|NCT00191477|21067948|P2|STARTED|Overall Study||176
8545583|NCT00191477|21067949|P1|STARTED|Overall Study||179
8545584|NCT00191451|21067968|P3|NOT COMPLETED|Overall Study||14
8545585|NCT00191451|21067969|P2|NOT COMPLETED|Overall Study||14
8545586|NCT00191451|21067970|P1|NOT COMPLETED|Overall Study||7
8545587|NCT00191451|21067968|P3|COMPLETED|Overall Study||35
8545588|NCT00191451|21067969|P2|COMPLETED|Overall Study||37
8545589|NCT00191451|21067970|P1|COMPLETED|Overall Study||43
8545590|NCT00191451|21067968|P3|Received at Least One Dose of Study Drug|Overall Study||47
8545591|NCT00191451|21067969|P2|Received at Least One Dose of Study Drug|Overall Study||48
8545592|NCT00191451|21067970|P1|Received at Least One Dose of Study Drug|Overall Study||50
8545593|NCT00191451|21067968|P3|STARTED|Overall Study||49
8545594|NCT00191451|21067969|P2|STARTED|Overall Study||51
8545595|NCT00191451|21067970|P1|STARTED|Overall Study||50
8545596|NCT00191386|21067990|P1|NOT COMPLETED|Overall Study||160
8545597|NCT00191386|21067990|P1|COMPLETED|Overall Study||68
8545598|NCT00191386|21067990|P1|3 Years|Overall Study||65
8545599|NCT00191386|21067990|P1|2 Years|Overall Study||105
8545600|NCT00191386|21067990|P1|12 Months|Overall Study||149
8545601|NCT00191386|21067990|P1|6 Months|Overall Study||183
8545602|NCT00191386|21067990|P1|STARTED|Overall Study||228
8545603|NCT00191334|21067997|P1|NOT COMPLETED|Overall Study||17
8545604|NCT00191334|21067997|P1|COMPLETED|Overall Study||33
8545605|NCT00191334|21067997|P1|STARTED|Overall Study||50
8545606|NCT00191308|21068005|P1|NOT COMPLETED|Overall Study||1
8545607|NCT00191308|21068005|P1|COMPLETED|Overall Study||29
8545608|NCT00191308|21068005|P1|STARTED|Overall Study||30
8545609|NCT00191282|21068015|P2|NOT COMPLETED|Overall Study||212
8545610|NCT00191282|21068016|P1|NOT COMPLETED|Overall Study||220
8545611|NCT00191282|21068015|P2|COMPLETED|Overall Study||346
8545612|NCT00191282|21068016|P1|COMPLETED|Overall Study||338
8545613|NCT00191282|21068015|P2|STARTED|Overall Study||558
8545614|NCT00191282|21068016|P1|STARTED|Overall Study||558
8545615|NCT00191269|21068076|P2|NOT COMPLETED|Overall Study||58
8545616|NCT00191269|21068077|P1|NOT COMPLETED|Overall Study||6
8545617|NCT00191269|21068076|P2|COMPLETED|Overall Study||4
8545618|NCT00191269|21068077|P1|COMPLETED|Overall Study||0
8545619|NCT00191269|21068076|P2|STARTED|Overall Study||62
8545620|NCT00191269|21068077|P1|STARTED|Overall Study||6
8545621|NCT00191191|21068093|P2|NOT COMPLETED|Overall Study||112
8545622|NCT00191191|21068094|P1|NOT COMPLETED|Overall Study||114
8545623|NCT00191191|21068093|P2|COMPLETED|Overall Study||0
8545624|NCT00191191|21068094|P1|COMPLETED|Overall Study||0
8545625|NCT00191191|21068093|P2|Full Analysis Set Population|Overall Study||108
8545626|NCT00191191|21068094|P1|Full Analysis Set Population|Overall Study||108
8545627|NCT00191191|21068093|P2|Safety Analysis Population|Overall Study||111
8545628|NCT00191191|21068094|P1|Safety Analysis Population|Overall Study||114
8545629|NCT00191191|21068093|P2|STARTED|Overall Study||112
8545630|NCT00191191|21068094|P1|STARTED|Overall Study||114
8545631|NCT00191165|21068110|P2|NOT COMPLETED|Overall Study||2
8545632|NCT00191165|21068111|P1|NOT COMPLETED|Overall Study||2
8545633|NCT00191165|21068110|P2|COMPLETED|Overall Study||11
8545634|NCT00191165|21068111|P1|COMPLETED|Overall Study||12
8545635|NCT00191165|21068110|P2|STARTED|Overall Study||13
8545636|NCT00191165|21068111|P1|STARTED|Overall Study||14
8545637|NCT00191152|21068123|P2|NOT COMPLETED|Crossover Treatment||28
8545638|NCT00191152|21068124|P1|NOT COMPLETED|Crossover Treatment||27
8545639|NCT00191152|21068123|P2|COMPLETED|Crossover Treatment||53
8545640|NCT00191152|21068124|P1|COMPLETED|Crossover Treatment||50
8545641|NCT00191152|21068123|P2|Received Treatment|Crossover Treatment||80
8545642|NCT00191152|21068124|P1|Received Treatment|Crossover Treatment||76
8545643|NCT00191152|21068123|P2|STARTED|Crossover Treatment||81
8545644|NCT00191152|21068124|P1|STARTED|Crossover Treatment||77
8545645|NCT00191152|21068123|P2|NOT COMPLETED|Initial Treatment||153
8545646|NCT00191152|21068124|P1|NOT COMPLETED|Initial Treatment||141
8545647|NCT00191152|21068123|P2|COMPLETED|Initial Treatment||83
8545648|NCT00191152|21068124|P1|COMPLETED|Initial Treatment||98
8545649|NCT00191152|21068123|P2|Received Initial Treatment|Initial Treatment||227
8545650|NCT00191152|21068124|P1|Received Initial Treatment|Initial Treatment||236
8545651|NCT00191152|21068123|P2|STARTED|Initial Treatment||236
8545652|NCT00191152|21068124|P1|STARTED|Initial Treatment||239
8545653|NCT00191139|21068156|P2|NOT COMPLETED|Overall Study||12
8545654|NCT00191139|21068157|P1|NOT COMPLETED|Overall Study||5
8545655|NCT00191139|21068156|P2|COMPLETED|Overall Study||20
8545656|NCT00191139|21068157|P1|COMPLETED|Overall Study||27
8545657|NCT00191139|21068156|P2|STARTED|Overall Study||32
8545658|NCT00191139|21068157|P1|STARTED|Overall Study||32
8545659|NCT00191113|21068173|P2|NOT COMPLETED|Addendum 3||0
8545660|NCT00191113|21068174|P1|NOT COMPLETED|Addendum 3||0
8545661|NCT00191113|21068173|P2|COMPLETED|Addendum 3||37
8545662|NCT00191113|21068174|P1|COMPLETED|Addendum 3||20
8545663|NCT00191113|21068173|P2|STARTED|Addendum 3||37
8545664|NCT00191113|21068174|P1|STARTED|Addendum 3||20
8545665|NCT00191113|21068173|P2|NOT COMPLETED|Addendum 2||17
8545666|NCT00191113|21068174|P1|NOT COMPLETED|Addendum 2||10
8545667|NCT00191113|21068173|P2|COMPLETED|Addendum 2||31
8545668|NCT00191113|21068174|P1|COMPLETED|Addendum 2||18
8545669|NCT00191113|21068173|P2|STARTED|Addendum 2||48
8545670|NCT00191113|21068174|P1|STARTED|Addendum 2||28
8545671|NCT00191113|21068173|P2|NOT COMPLETED|Addendum 1||0
8545672|NCT00191113|21068174|P1|NOT COMPLETED|Addendum 1||0
8545673|NCT00191113|21068173|P2|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
8545674|NCT00191113|21068174|P1|COMPLETED|Addendum 1||2
8545675|NCT00191113|21068173|P2|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
8545676|NCT00191113|21068174|P1|STARTED|Addendum 1||2
8545677|NCT00191113|21068173|P2|NOT COMPLETED|Core Study||15
8545678|NCT00191113|21068174|P1|NOT COMPLETED|Core Study||35
8545679|NCT00191113|21068173|P2|COMPLETED|Core Study||61
8545680|NCT00191113|21068174|P1|COMPLETED|Core Study||43
8545681|NCT00191113|21068173|P2|STARTED|Core Study||76
8545682|NCT00191113|21068174|P1|STARTED|Core Study||78
8545683|NCT00191100|21068216|P2|NOT COMPLETED|Overall Study||12
8545684|NCT00191100|21068217|P1|NOT COMPLETED|Overall Study||42
8545685|NCT00191100|21068216|P2|COMPLETED|Overall Study||244
8545686|NCT00191100|21068217|P1|COMPLETED|Overall Study||217
8545687|NCT00191100|21068216|P2|STARTED|Overall Study||256
8545688|NCT00191100|21068217|P1|STARTED|Overall Study||259
8545689|NCT00190983|21068233|P1|NOT COMPLETED|Overall Study||2
8545690|NCT00190983|21068233|P1|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
8545691|NCT00190983|21068233|P1|STARTED|Overall Study||29
8545692|NCT00190775|21068242|P2|NOT COMPLETED|Overall Study||100
8545693|NCT00190775|21068243|P1|NOT COMPLETED|Overall Study||149
8545694|NCT00190775|21068242|P2|COMPLETED|Overall Study||134
8545695|NCT00190775|21068243|P1|COMPLETED|Overall Study||119
8545696|NCT00190775|21068242|P2|Received Study Drug|Overall Study||234
8545697|NCT00190775|21068243|P1|Received Study Drug|Overall Study||266
8545698|NCT00190775|21068242|P2|STARTED|Overall Study||234
8545699|NCT00190775|21068243|P1|STARTED|Overall Study||268
8545700|NCT00190749|21068314|P2|NOT COMPLETED|Overall Study||31
8545701|NCT00190749|21068315|P1|NOT COMPLETED|Overall Study||26
8545702|NCT00190749|21068314|P2|COMPLETED|Overall Study||31
8545703|NCT00190749|21068315|P1|COMPLETED|Overall Study||42
8545704|NCT00190749|21068314|P2|STARTED|Overall Study||62
8545705|NCT00190749|21068315|P1|STARTED|Overall Study||68
8545706|NCT00190684|21068379|P1|NOT COMPLETED|Overall Study||1489
8545707|NCT00190684|21068379|P1|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
8545708|NCT00190684|21068379|P1|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
8545709|NCT00190684|21068379|P1|STARTED|Overall Study||1553
8545710|NCT00190671|21068400|P2|NOT COMPLETED|Overall Study||42
8545711|NCT00190671|21068401|P1|NOT COMPLETED|Overall Study||27
8545712|NCT00190671|21068400|P2|COMPLETED|Overall Study||19
8545713|NCT00190671|21068401|P1|COMPLETED|Overall Study||15
8545714|NCT00190671|21068400|P2|STARTED|Overall Study||61
8545715|NCT00190671|21068401|P1|STARTED|Overall Study||42
8545716|NCT00189540|21068421|P2|NOT COMPLETED|Overall Study||1
8545717|NCT00189540|21068422|P1|NOT COMPLETED|Overall Study||7
8545718|NCT00189540|21068421|P2|COMPLETED|Overall Study||5
8545719|NCT00189540|21068422|P1|COMPLETED|Overall Study||14
8545720|NCT00189540|21068421|P2|STARTED|Overall Study||6
8545721|NCT00189540|21068422|P1|STARTED|Overall Study||21
8545722|NCT00189488|21068440|P2|NOT COMPLETED|Overall Study||22
8545723|NCT00189488|21068441|P1|NOT COMPLETED|Overall Study||15
8545724|NCT00189488|21068440|P2|COMPLETED|Overall Study||55
8545725|NCT00189488|21068441|P1|COMPLETED|Overall Study||63
8545726|NCT00189488|21068440|P2|Received Palifermin/Placebo|Overall Study||76
8545727|NCT00189488|21068441|P1|Received Palifermin/Placebo|Overall Study||75
8545728|NCT00189488|21068440|P2|STARTED|Overall Study||77
8545729|NCT00189488|21068441|P1|STARTED|Overall Study||78
8545730|NCT00189475|21068463|P2|NOT COMPLETED|Overall Study||0
8545731|NCT00189475|21068464|P1|NOT COMPLETED|Overall Study||0
8545732|NCT00189475|21068463|P2|COMPLETED|Overall Study||42
8545733|NCT00189475|21068464|P1|COMPLETED|Overall Study||42
8545734|NCT00189475|21068463|P2|STARTED|Overall Study||42
8545735|NCT00189475|21068464|P1|STARTED|Overall Study||42
8545736|NCT00189462|21068472|P2|NOT COMPLETED|Overall Study||21
8545737|NCT00189462|21068473|P1|NOT COMPLETED|Overall Study||23
8545738|NCT00189462|21068472|P2|COMPLETED|Overall Study||28
8545739|NCT00189462|21068473|P1|COMPLETED|Overall Study||27
8545740|NCT00189462|21068472|P2|STARTED|Overall Study||49
8545741|NCT00189462|21068473|P1|STARTED|Overall Study||50
8545748|NCT00189423|21068490|P2|NOT COMPLETED|Overall Study||766
8545749|NCT00189423|21068491|P1|NOT COMPLETED|Overall Study||765
8545750|NCT00189423|21068490|P2|COMPLETED|Overall Study||74
8545751|NCT00189423|21068491|P1|COMPLETED|Overall Study||48
8545752|NCT00189423|21068490|P2|STARTED|Overall Study||840
8545753|NCT00189423|21068491|P1|STARTED|Overall Study||813
8545754|NCT00189306|21068513|P1|NOT COMPLETED|Long-Term Follow-up||38
8545755|NCT00189306|21068513|P1|COMPLETED|Long-Term Follow-up||119
8545756|NCT00189306|21068513|P1|STARTED|Long-Term Follow-up||157
8545757|NCT00189306|21068513|P1|NOT COMPLETED|Posttreatment Period||12
8545758|NCT00189306|21068513|P1|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
8545759|NCT00189306|21068513|P1|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
8545760|NCT00189306|21068513|P1|NOT COMPLETED|Treatment Period||5
8545856|NCT00187200|21068709|P1|STARTED|Overall Study||49
8545761|NCT00189306|21068513|P1|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
8545762|NCT00189306|21068513|P1|STARTED|Treatment Period||169
8545763|NCT00189228|21068518|P1|NOT COMPLETED|Overall Study||0
8545764|NCT00189228|21068518|P1|COMPLETED|Overall Study||18
8545765|NCT00189228|21068518|P1|STARTED|Overall Study||18
8545766|NCT00189202|21068522|P1|NOT COMPLETED|Overall Study||5
8545767|NCT00189202|21068522|P1|COMPLETED|Overall Study||44
8545768|NCT00189202|21068522|P1|STARTED|Overall Study||49
8545769|NCT00189137|21068533|P2|NOT COMPLETED|Overall Study||0
8545770|NCT00189137|21068534|P1|NOT COMPLETED|Overall Study||0
8545771|NCT00189137|21068533|P2|COMPLETED|Overall Study||43
8545772|NCT00189137|21068534|P1|COMPLETED|Overall Study||37
8545773|NCT00189137|21068533|P2|STARTED|Overall Study||43
8545774|NCT00189137|21068534|P1|STARTED|Overall Study||37
8545775|NCT00189098|21068544|P2|NOT COMPLETED|Overall Study||6
8545776|NCT00189098|21068545|P1|NOT COMPLETED|Overall Study||5
8545777|NCT00189098|21068544|P2|COMPLETED|Overall Study||44
8545778|NCT00189098|21068545|P1|COMPLETED|Overall Study||46
8545779|NCT00189098|21068544|P2|STARTED|Overall Study||50
8545780|NCT00189098|21068545|P1|STARTED|Overall Study||51
8545781|NCT00187889|21068563|P2|NOT COMPLETED|Overall Study||4
8545782|NCT00187889|21068564|P1|NOT COMPLETED|Overall Study||6
8545783|NCT00187889|21068563|P2|COMPLETED|Overall Study||22
8545784|NCT00187889|21068564|P1|COMPLETED|Overall Study||19
8545785|NCT00187889|21068563|P2|STARTED|Overall Study||26
8545786|NCT00187889|21068564|P1|STARTED|Overall Study||25
8545787|NCT00187876|21068574|P2|NOT COMPLETED|Overall Study||0
8545788|NCT00187876|21068575|P1|NOT COMPLETED|Overall Study||0
8545789|NCT00187876|21068574|P2|COMPLETED|Overall Study||43
8545790|NCT00187876|21068575|P1|COMPLETED|Overall Study||24
8545791|NCT00187876|21068574|P2|STARTED|Overall Study||43
8545792|NCT00187876|21068575|P1|STARTED|Overall Study||24
8545793|NCT00187720|21068583|P2|NOT COMPLETED|Overall Study||0
8545794|NCT00187720|21068584|P1|NOT COMPLETED|Overall Study||0
8545795|NCT00187720|21068583|P2|COMPLETED|Overall Study||14
8545796|NCT00187720|21068584|P1|COMPLETED|Overall Study||9
8545797|NCT00187720|21068583|P2|STARTED|Overall Study||14
8545798|NCT00187720|21068584|P1|STARTED|Overall Study||9
8545799|NCT00187681|21068592|P2|NOT COMPLETED|Overall Study||0
8545800|NCT00187681|21068593|P1|NOT COMPLETED|Overall Study||0
8545801|NCT00187681|21068592|P2|COMPLETED|Overall Study||8
8545802|NCT00187681|21068593|P1|COMPLETED|Overall Study||12
8545803|NCT00187681|21068592|P2|STARTED|Overall Study||8
8545804|NCT00187681|21068593|P1|STARTED|Overall Study||12
8545805|NCT00187655|21068601|P1|NOT COMPLETED|Overall Study||0
8545806|NCT00187655|21068601|P1|COMPLETED|Overall Study||24
8545807|NCT00187655|21068601|P1|STARTED|Overall Study||24
8545808|NCT00187486|21068606|P1|NOT COMPLETED|Overall Study||1
8545809|NCT00187486|21068606|P1|COMPLETED|Overall Study||65
8545810|NCT00187486|21068606|P1|STARTED|Overall Study||66
8545811|NCT00187369|21068613|P2|NOT COMPLETED|Fetuses or Infants||30
8545812|NCT00187369|21068614|P1|NOT COMPLETED|Fetuses or Infants||12
8545813|NCT00187369|21068613|P2|COMPLETED|Fetuses or Infants||2782
8545814|NCT00187369|21068614|P1|COMPLETED|Fetuses or Infants||2783
8545815|NCT00187369|21068613|P2|Included in the Study|Fetuses or Infants||2786
8545816|NCT00187369|21068614|P1|Included in the Study|Fetuses or Infants||2785
8545817|NCT00187369|21068613|P2|STARTED|Fetuses or Infants||2812
8545818|NCT00187369|21068614|P1|STARTED|Fetuses or Infants||2795
8545819|NCT00187369|21068613|P2|NOT COMPLETED|Mothers||14
8545820|NCT00187369|21068614|P1|NOT COMPLETED|Mothers||6
8545821|NCT00187369|21068613|P2|COMPLETED|Mothers||1392
8545822|NCT00187369|21068614|P1|COMPLETED|Mothers||1392
8545823|NCT00187369|21068613|P2|Included in the Study|Mothers||1393
8545824|NCT00187369|21068614|P1|Included in the Study|Mothers||1393
8545825|NCT00187369|21068613|P2|STARTED|Mothers||1406
8545826|NCT00187369|21068614|P1|STARTED|Mothers||1398
8545827|NCT00187278|21068642|P2|NOT COMPLETED|Overall Study||13
8545828|NCT00187278|21068643|P1|NOT COMPLETED|Overall Study||10
8545829|NCT00187278|21068642|P2|COMPLETED|Overall Study||902
8545830|NCT00187278|21068643|P1|COMPLETED|Overall Study||908
8545831|NCT00187278|21068642|P2|STARTED|Overall Study||915
8545832|NCT00187278|21068643|P1|STARTED|Overall Study||918
8545851|NCT00187200|21068708|P2|NOT COMPLETED|Overall Study||18
8545852|NCT00187200|21068709|P1|NOT COMPLETED|Overall Study||18
8545853|NCT00187200|21068708|P2|COMPLETED|Overall Study||26
8545854|NCT00187200|21068709|P1|COMPLETED|Overall Study||31
8545855|NCT00187200|21068708|P2|STARTED|Overall Study||44
8545857|NCT00187135|21068727|P6|NOT COMPLETED|Visit Three||6
8545858|NCT00187135|21068728|P5|NOT COMPLETED|Visit Three||8
8545859|NCT00187135|21068729|P4|NOT COMPLETED|Visit Three||9
8545860|NCT00187135|21068730|P3|NOT COMPLETED|Visit Three||9
8545861|NCT00187135|21068731|P2|NOT COMPLETED|Visit Three||7
8545862|NCT00187135|21068732|P1|NOT COMPLETED|Visit Three||7
8545863|NCT00187135|21068727|P6|COMPLETED|Visit Three||12
8545864|NCT00187135|21068728|P5|COMPLETED|Visit Three||11
8545865|NCT00187135|21068729|P4|COMPLETED|Visit Three||9
8545866|NCT00187135|21068730|P3|COMPLETED|Visit Three||14
8545867|NCT00187135|21068731|P2|COMPLETED|Visit Three||17
8545868|NCT00187135|21068732|P1|COMPLETED|Visit Three||14
8545869|NCT00187135|21068727|P6|STARTED|Visit Three||18
8545870|NCT00187135|21068728|P5|STARTED|Visit Three||19
8545871|NCT00187135|21068729|P4|STARTED|Visit Three||18
8545872|NCT00187135|21068730|P3|STARTED|Visit Three||23
8545873|NCT00187135|21068731|P2|STARTED|Visit Three||24
8545874|NCT00187135|21068732|P1|STARTED|Visit Three||21
8545875|NCT00187135|21068727|P6|NOT COMPLETED|Visit Two||8
8545876|NCT00187135|21068728|P5|NOT COMPLETED|Visit Two||6
8545877|NCT00187135|21068729|P4|NOT COMPLETED|Visit Two||8
8545878|NCT00187135|21068730|P3|NOT COMPLETED|Visit Two||2
8545879|NCT00187135|21068731|P2|NOT COMPLETED|Visit Two||3
8545880|NCT00187135|21068732|P1|NOT COMPLETED|Visit Two||5
8545881|NCT00187135|21068727|P6|COMPLETED|Visit Two||18
8545882|NCT00187135|21068728|P5|COMPLETED|Visit Two||19
8545883|NCT00187135|21068729|P4|COMPLETED|Visit Two||18
8545884|NCT00187135|21068730|P3|COMPLETED|Visit Two||23
8545885|NCT00187135|21068731|P2|COMPLETED|Visit Two||24
8545886|NCT00187135|21068732|P1|COMPLETED|Visit Two||21
8545887|NCT00187135|21068727|P6|STARTED|Visit Two||26
8545888|NCT00187135|21068728|P5|STARTED|Visit Two||25
8545889|NCT00187135|21068729|P4|STARTED|Visit Two||26
8545890|NCT00187135|21068730|P3|STARTED|Visit Two||25
8545891|NCT00187135|21068731|P2|STARTED|Visit Two||27
8545892|NCT00187135|21068732|P1|STARTED|Visit Two||26
8545893|NCT00187135|21068727|P6|NOT COMPLETED|Visit One||2
8545894|NCT00187135|21068728|P5|NOT COMPLETED|Visit One||0
8545895|NCT00187135|21068729|P4|NOT COMPLETED|Visit One||0
8545896|NCT00187135|21068730|P3|NOT COMPLETED|Visit One||0
8545897|NCT00187135|21068731|P2|NOT COMPLETED|Visit One||1
8545898|NCT00187135|21068732|P1|NOT COMPLETED|Visit One||4
8545899|NCT00187135|21068727|P6|COMPLETED|Visit One||26
8545900|NCT00187135|21068728|P5|COMPLETED|Visit One||25
8545901|NCT00187135|21068729|P4|COMPLETED|Visit One||26
8545902|NCT00187135|21068730|P3|COMPLETED|Visit One||25
8545903|NCT00187135|21068731|P2|COMPLETED|Visit One||27
8545904|NCT00187135|21068732|P1|COMPLETED|Visit One||26
8545905|NCT00187135|21068727|P6|STARTED|Visit One||28
8545906|NCT00187135|21068728|P5|STARTED|Visit One||25
8545907|NCT00187135|21068729|P4|STARTED|Visit One||26
8545908|NCT00187135|21068730|P3|STARTED|Visit One||25
8545909|NCT00187135|21068731|P2|STARTED|Visit One||28
8545910|NCT00187135|21068732|P1|STARTED|Visit One||30
8545911|NCT00187096|21068755|P3|NOT COMPLETED|Overall Study||1
8545912|NCT00187096|21068756|P2|NOT COMPLETED|Overall Study||0
8545913|NCT00187096|21068757|P1|NOT COMPLETED|Overall Study||0
8545914|NCT00187096|21068755|P3|COMPLETED|Overall Study||11
8545915|NCT00187096|21068756|P2|COMPLETED|Overall Study||3
8545916|NCT00187096|21068757|P1|COMPLETED|Overall Study||10
8545917|NCT00187096|21068755|P3|STARTED|Overall Study||12
8545918|NCT00187096|21068756|P2|STARTED|Overall Study||3
8545919|NCT00187096|21068757|P1|STARTED|Overall Study||10
8545920|NCT00186901|21068795|P3|NOT COMPLETED|Overall Study||149
8545921|NCT00186901|21068796|P2|NOT COMPLETED|Overall Study||45
8545922|NCT00186901|21068797|P1|NOT COMPLETED|Overall Study||49
8545923|NCT00186901|21068795|P3|COMPLETED|Overall Study||0
8545924|NCT00186901|21068796|P2|COMPLETED|Overall Study||96
8545925|NCT00186901|21068797|P1|COMPLETED|Overall Study||85
8545926|NCT00186901|21068795|P3|24 Month Follow-up|Overall Study||0
8545927|NCT00186901|21068796|P2|24 Month Follow-up|Overall Study||107
8545928|NCT00186901|21068797|P1|24 Month Follow-up|Overall Study||106
8545929|NCT00186901|21068795|P3|12 Month Follow-up|Overall Study||0
8545930|NCT00186901|21068796|P2|12 Month Follow-up|Overall Study||122
8545931|NCT00186901|21068797|P1|12 Month Follow-up|Overall Study||117
8545932|NCT00186901|21068795|P3|Baseline|Overall Study||0
8545933|NCT00186901|21068796|P2|Baseline|Overall Study||141
8545934|NCT00186901|21068797|P1|Baseline|Overall Study||134
8545935|NCT00186901|21068795|P3|STARTED|Overall Study||149
8545936|NCT00186901|21068796|P2|STARTED|Overall Study||141
8545937|NCT00186901|21068797|P1|STARTED|Overall Study||134
8545950|NCT00186875|21068916|P2|NOT COMPLETED|Overall Study||0
8545951|NCT00186875|21068917|P1|NOT COMPLETED|Overall Study||0
8545952|NCT00186875|21068916|P2|COMPLETED|Overall Study||14
8545953|NCT00186875|21068917|P1|COMPLETED|Overall Study||26
8545954|NCT00186875|21068916|P2|STARTED|Overall Study||14
8545955|NCT00186875|21068917|P1|STARTED|Overall Study||26
8545956|NCT00186628|21068931|P1|NOT COMPLETED|Overall Study||3
8545957|NCT00186628|21068931|P1|COMPLETED|Overall Study||33
8545958|NCT00186628|21068931|P1|STARTED|Overall Study||36
8545959|NCT00186537|21068942|P3|NOT COMPLETED|Overall Study||3
8545960|NCT00186537|21068943|P2|NOT COMPLETED|Overall Study||0
8545961|NCT00186537|21068944|P1|NOT COMPLETED|Overall Study||7
8545962|NCT00186537|21068942|P3|COMPLETED|Overall Study||13
8545963|NCT00186537|21068943|P2|COMPLETED|Overall Study||12
8545964|NCT00186537|21068944|P1|COMPLETED|Overall Study||12
8545965|NCT00186537|21068942|P3|STARTED|Overall Study||16
8545966|NCT00186537|21068943|P2|STARTED|Overall Study||12
8545967|NCT00186537|21068944|P1|STARTED|Overall Study||19
8545968|NCT00186498|21068960|P2|NOT COMPLETED|Overall Study||2
8545969|NCT00186498|21068961|P1|NOT COMPLETED|Overall Study||2
8545970|NCT00186498|21068960|P2|COMPLETED|Overall Study||3
8545971|NCT00186498|21068961|P1|COMPLETED|Overall Study||4
8545972|NCT00186498|21068960|P2|STARTED|Overall Study||5
8545973|NCT00186498|21068961|P1|STARTED|Overall Study||6
8545974|NCT00186485|21068967|P1|NOT COMPLETED|Overall Study||3
8545975|NCT00186485|21068967|P1|COMPLETED|Overall Study||25
8545976|NCT00186485|21068967|P1|STARTED|Overall Study||28
8545977|NCT00186446|21068973|P1|NOT COMPLETED|Overall Study||9
8545978|NCT00186446|21068973|P1|COMPLETED|Overall Study||11
8545979|NCT00186446|21068973|P1|STARTED|Overall Study||20
8545980|NCT00186186|21068979|P1|NOT COMPLETED|Overall Study||8
8545981|NCT00186186|21068979|P1|COMPLETED|Overall Study||20
8545982|NCT00186186|21068979|P1|STARTED|Overall Study||28
8545983|NCT00186121|21068984|P1|NOT COMPLETED|Overall Study||3
8545984|NCT00186121|21068984|P1|COMPLETED|Overall Study||32
8545985|NCT00186121|21068984|P1|STARTED|Overall Study||35
8545986|NCT00186069|21068996|P2|NOT COMPLETED|Overall Study||0
8545987|NCT00186069|21068997|P1|NOT COMPLETED|Overall Study||0
8545988|NCT00186069|21068996|P2|COMPLETED|Overall Study||15
8545989|NCT00186069|21068997|P1|COMPLETED|Overall Study||15
8545990|NCT00186069|21068996|P2|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
8545991|NCT00186069|21068997|P1|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
8545992|NCT00186056|21069009|P2|NOT COMPLETED|Overall Study||1
8545993|NCT00186056|21069010|P1|NOT COMPLETED|Overall Study||2
8545994|NCT00186056|21069009|P2|COMPLETED|Overall Study||16
8545995|NCT00186056|21069010|P1|COMPLETED|Overall Study||12
8545996|NCT00186056|21069009|P2|STARTED|Overall Study||17
8545997|NCT00186056|21069010|P1|STARTED|Overall Study||14
8545998|NCT00186043|21069018|P2|NOT COMPLETED|Overall Study||13
8545999|NCT00186043|21069019|P1|NOT COMPLETED|Overall Study||15
8546000|NCT00186043|21069018|P2|COMPLETED|Overall Study||12
8546001|NCT00186043|21069019|P1|COMPLETED|Overall Study||15
8546002|NCT00186043|21069018|P2|STARTED|Overall Study||25
8546003|NCT00186043|21069019|P1|STARTED|Overall Study||30
8546004|NCT00186017|21069031|P2|NOT COMPLETED|Overall Study||3
8546005|NCT00186017|21069032|P1|NOT COMPLETED|Overall Study||2
8546006|NCT00186017|21069031|P2|COMPLETED|Overall Study||22
8546007|NCT00186017|21069032|P1|COMPLETED|Overall Study||23
8546008|NCT00186017|21069031|P2|STARTED|Overall Study||25
8546009|NCT00186017|21069032|P1|STARTED|Overall Study||25
8546010|NCT00185965|21069046|P2|NOT COMPLETED|Overall Study||1
8546011|NCT00185965|21069047|P1|NOT COMPLETED|Overall Study||0
8546012|NCT00185965|21069046|P2|COMPLETED|Overall Study||14
8546013|NCT00185965|21069047|P1|COMPLETED|Overall Study||15
8546014|NCT00185965|21069046|P2|STARTED|Overall Study||15
8546015|NCT00185965|21069047|P1|STARTED|Overall Study||15
8546016|NCT00185900|21069055|P2|NOT COMPLETED|Overall Study||0
8546017|NCT00185900|21069056|P1|NOT COMPLETED|Overall Study||0
8546018|NCT00185900|21069055|P2|COMPLETED|Overall Study||100
8546019|NCT00185900|21069056|P1|COMPLETED|Overall Study||92
8546020|NCT00185900|21069055|P2|STARTED|Overall Study||100
8546021|NCT00185900|21069056|P1|STARTED|Overall Study||92
8546022|NCT00185731|21069072|P1|NOT COMPLETED|Overall Study||2
8546023|NCT00185731|21069072|P1|COMPLETED|Overall Study||23
8546024|NCT00185731|21069072|P1|STARTED|Overall Study||25
8546025|NCT00185692|21069078|P1|NOT COMPLETED|Overall Study||16
8546026|NCT00185692|21069078|P1|COMPLETED|Overall Study||0
8546027|NCT00185692|21069078|P1|STARTED|Overall Study||16
8546028|NCT00185679|21069083|P1|NOT COMPLETED|Overall Study||0
8546029|NCT00185679|21069083|P1|COMPLETED|Overall Study||13
8546030|NCT00185679|21069083|P1|STARTED|Overall Study||13
8546036|NCT00185614|21069098|P1|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
8546037|NCT00185614|21069098|P1|COMPLETED|Allogenic HCT (Allo-HCT)||59
8546038|NCT00185614|21069098|P1|STARTED|Allogenic HCT (Allo-HCT)||59
8546039|NCT00185614|21069098|P1|NOT COMPLETED|Inter-treatment Period||4
8546040|NCT00185614|21069098|P1|COMPLETED|Inter-treatment Period||59
8546041|NCT00185614|21069098|P1|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
8546042|NCT00185614|21069098|P1|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
8546043|NCT00185614|21069098|P1|COMPLETED|Autologous HCT (Auto-HCT)||63
8546044|NCT00185614|21069098|P1|STARTED|Autologous HCT (Auto-HCT)||63
8546045|NCT00185588|21069110|P4|NOT COMPLETED|Overall Study||4
8546046|NCT00185588|21069111|P3|NOT COMPLETED|Overall Study||6
8546047|NCT00185588|21069112|P2|NOT COMPLETED|Overall Study||2
8546048|NCT00185588|21069113|P1|NOT COMPLETED|Overall Study||3
8546049|NCT00185588|21069110|P4|COMPLETED|Overall Study||13
8546050|NCT00185588|21069111|P3|COMPLETED|Overall Study||0
8546051|NCT00185588|21069112|P2|COMPLETED|Overall Study||2
8546052|NCT00185588|21069113|P1|COMPLETED|Overall Study||3
8546053|NCT00185588|21069110|P4|STARTED|Overall Study||17
8546054|NCT00185588|21069111|P3|STARTED|Overall Study||6
8546055|NCT00185588|21069112|P2|STARTED|Overall Study||4
8546056|NCT00185588|21069113|P1|STARTED|Overall Study||6
8546057|NCT00185458|21069127|P1|NOT COMPLETED|HRT Phase||27
8546058|NCT00185458|21069127|P1|COMPLETED|HRT Phase||141
8546059|NCT00185458|21069127|P1|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
8546060|NCT00185458|21069127|P1|NOT COMPLETED|Contraception Phase||58
8546061|NCT00185458|21069127|P1|COMPLETED|Contraception Phase||336
8546062|NCT00185458|21069127|P1|STARTED|Contraception Phase||394
8546063|NCT00185380|21069190|P3|NOT COMPLETED|Overall Study||74
8546064|NCT00185380|21069191|P2|NOT COMPLETED|Overall Study||72
8546065|NCT00185380|21069192|P1|NOT COMPLETED|Overall Study||66
8546066|NCT00185380|21069190|P3|COMPLETED|Overall Study||182
8546067|NCT00185380|21069191|P2|COMPLETED|Overall Study||174
8546068|NCT00185380|21069192|P1|COMPLETED|Overall Study||174
8546069|NCT00185380|21069190|P3|Subjects Received Treatment|Overall Study||254
8546070|NCT00185380|21069191|P2|Subjects Received Treatment|Overall Study||245
8546071|NCT00185380|21069192|P1|Subjects Received Treatment|Overall Study||239
8546072|NCT00185380|21069190|P3|STARTED|Overall Study||256
8546073|NCT00185380|21069191|P2|STARTED|Overall Study||246
8546074|NCT00185380|21069192|P1|STARTED|Overall Study||240
8546075|NCT00185211|21069220|P2|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
8546076|NCT00185211|21069221|P1|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
8546077|NCT00185211|21069220|P2|COMPLETED|Follow-up Study (91031 - This Study)||123
8546078|NCT00185211|21069221|P1|COMPLETED|Follow-up Study (91031 - This Study)||235
8546079|NCT00185211|21069220|P2|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
8546080|NCT00185211|21069221|P1|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
8546081|NCT00185211|21069220|P2|NOT COMPLETED|Placebo-controlled Study (92012)||10
8546082|NCT00185211|21069221|P1|NOT COMPLETED|Placebo-controlled Study (92012)||21
8546083|NCT00185211|21069220|P2|COMPLETED|Placebo-controlled Study (92012)||166
8546084|NCT00185211|21069221|P1|COMPLETED|Placebo-controlled Study (92012)||271
8546085|NCT00185211|21069220|P2|STARTED|Placebo-controlled Study (92012)||176
8546086|NCT00185211|21069221|P1|STARTED|Placebo-controlled Study (92012)||292
8546087|NCT00184717|21069249|P5|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
8546088|NCT00184717|21069250|P4|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
8546089|NCT00184717|21069251|P3|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
8546090|NCT00184717|21069252|P2|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
8546091|NCT00184717|21069253|P1|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
8546092|NCT00184717|21069249|P5|COMPLETED|Extension Period (GHLIQUID-1517)||5
8546093|NCT00184717|21069250|P4|COMPLETED|Extension Period (GHLIQUID-1517)||7
8546094|NCT00184717|21069251|P3|COMPLETED|Extension Period (GHLIQUID-1517)||0
8546095|NCT00184717|21069252|P2|COMPLETED|Extension Period (GHLIQUID-1517)||27
8546096|NCT00184717|21069253|P1|COMPLETED|Extension Period (GHLIQUID-1517)||23
8546097|NCT00184717|21069249|P5|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
8546098|NCT00184717|21069250|P4|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
8546099|NCT00184717|21069251|P3|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
8546100|NCT00184717|21069252|P2|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
8546101|NCT00184717|21069253|P1|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
8546102|NCT00184717|21069249|P5|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
8546103|NCT00184717|21069250|P4|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
8546104|NCT00184717|21069251|P3|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
8546105|NCT00184717|21069252|P2|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
8546106|NCT00184717|21069253|P1|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
8546107|NCT00184717|21069249|P5|COMPLETED|Main Period (GHLIQUID-1516)||0
8546108|NCT00184717|21069250|P4|COMPLETED|Main Period (GHLIQUID-1516)||0
8546109|NCT00184717|21069251|P3|COMPLETED|Main Period (GHLIQUID-1516)||20
8546110|NCT00184717|21069252|P2|COMPLETED|Main Period (GHLIQUID-1516)||36
8546111|NCT00184717|21069253|P1|COMPLETED|Main Period (GHLIQUID-1516)||36
8546112|NCT00184717|21069249|P5|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
8546113|NCT00184717|21069250|P4|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
8546114|NCT00184717|21069251|P3|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
8546115|NCT00184717|21069252|P2|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
8546116|NCT00184717|21069253|P1|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
8546117|NCT00184717|21069249|P5|STARTED|Main Period (GHLIQUID-1516)||0
8546118|NCT00184717|21069250|P4|STARTED|Main Period (GHLIQUID-1516)||0
8546119|NCT00184717|21069251|P3|STARTED|Main Period (GHLIQUID-1516)||21
8546120|NCT00184717|21069252|P2|STARTED|Main Period (GHLIQUID-1516)||38
8546121|NCT00184717|21069253|P1|STARTED|Main Period (GHLIQUID-1516)||39
8546122|NCT00184600|21069294|P3|NOT COMPLETED|Overall Study||34
8546123|NCT00184600|21069295|P2|NOT COMPLETED|Overall Study||51
8546124|NCT00184600|21069296|P1|NOT COMPLETED|Overall Study||45
8546125|NCT00184600|21069294|P3|COMPLETED|Overall Study||201
8546126|NCT00184600|21069295|P2|COMPLETED|Overall Study||188
8546127|NCT00184600|21069296|P1|COMPLETED|Overall Study||189
8546128|NCT00184600|21069294|P3|STARTED|Overall Study||235
8546129|NCT00184600|21069295|P2|STARTED|Overall Study||239
8546130|NCT00184600|21069296|P1|STARTED|Overall Study||234
8546131|NCT00184548|21069350|P4|NOT COMPLETED|Overall Study||7
8546132|NCT00184548|21069351|P3|NOT COMPLETED|Overall Study||3
8546133|NCT00184548|21069352|P2|NOT COMPLETED|Overall Study||13
8546134|NCT00184548|21069353|P1|NOT COMPLETED|Overall Study||8
8546135|NCT00184548|21069350|P4|COMPLETED|Overall Study||38
8546136|NCT00184548|21069351|P3|COMPLETED|Overall Study||44
8546137|NCT00184548|21069352|P2|COMPLETED|Overall Study||242
8546138|NCT00184548|21069353|P1|COMPLETED|Overall Study||218
8546139|NCT00184548|21069350|P4|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
8546140|NCT00184548|21069351|P3|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
8546141|NCT00184548|21069352|P2|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
8546142|NCT00184548|21069353|P1|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
8546143|NCT00184548|21069350|P4|STARTED|Overall Study||45
8546144|NCT00184548|21069351|P3|STARTED|Overall Study||47
8546145|NCT00184548|21069352|P2|STARTED|Overall Study||255
8546146|NCT00184548|21069353|P1|STARTED|Overall Study||226
8546147|NCT00184093|21069387|P1|NOT COMPLETED|Overall Study||9
8546148|NCT00184093|21069387|P1|COMPLETED|Overall Study||26
8546149|NCT00184093|21069387|P1|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
8546150|NCT00184054|21069392|P1|NOT COMPLETED|Overall Study||1
8546151|NCT00184054|21069392|P1|COMPLETED|Overall Study||10
8546152|NCT00184054|21069392|P1|STARTED|Overall Study||11
8546153|NCT00184028|21069397|P1|NOT COMPLETED|Overall Study||10
8546154|NCT00184028|21069397|P1|COMPLETED|Overall Study||2
8546155|NCT00184028|21069397|P1|STARTED|Overall Study||12
8546156|NCT00184002|21069402|P1|NOT COMPLETED|Overall Study||17
8546157|NCT00184002|21069402|P1|COMPLETED|Overall Study||51
8546158|NCT00184002|21069402|P1|STARTED|Overall Study||68
8546159|NCT00183963|21069411|P4|NOT COMPLETED|Overall Study||1
8546160|NCT00183963|21069412|P3|NOT COMPLETED|Overall Study||1
8546161|NCT00183963|21069413|P2|NOT COMPLETED|Overall Study||1
8546162|NCT00183963|21069414|P1|NOT COMPLETED|Overall Study||1
8546163|NCT00183963|21069411|P4|COMPLETED|Overall Study||0
8546164|NCT00183963|21069412|P3|COMPLETED|Overall Study||0
8546165|NCT00183963|21069413|P2|COMPLETED|Overall Study||0
8546166|NCT00183963|21069414|P1|COMPLETED|Overall Study||0
8546167|NCT00183963|21069411|P4|STARTED|Overall Study||1
8546168|NCT00183963|21069412|P3|STARTED|Overall Study||1
8546169|NCT00183963|21069413|P2|STARTED|Overall Study||1
8546170|NCT00183963|21069414|P1|STARTED|Overall Study||1
8546171|NCT00183872|21069428|P1|NOT COMPLETED|Overall Study||16
8546172|NCT00183872|21069428|P1|COMPLETED|Overall Study||24
8546173|NCT00183872|21069428|P1|STARTED|Overall Study||40
8546174|NCT00183794|21069433|P1|NOT COMPLETED|Overall Study||0
8546175|NCT00183794|21069433|P1|COMPLETED|Overall Study||20
8546176|NCT00183794|21069433|P1|STARTED|Overall Study||20
8546177|NCT00183729|21069440|P2|NOT COMPLETED|Overall Study||5
8546178|NCT00183729|21069441|P1|NOT COMPLETED|Overall Study||3
8546179|NCT00183729|21069440|P2|COMPLETED|Overall Study||13
8546180|NCT00183729|21069441|P1|COMPLETED|Overall Study||14
8546181|NCT00183729|21069440|P2|STARTED|Overall Study||18
8546182|NCT00183729|21069441|P1|STARTED|Overall Study||17
8546183|NCT00183677|21069451|P1|NOT COMPLETED|Overall Study||44
8546184|NCT00183677|21069451|P1|COMPLETED|Overall Study||53
8546185|NCT00183677|21069451|P1|STARTED|Overall Study||97
8546186|NCT00183625|21069457|P4|NOT COMPLETED|Overall Study||14
8546187|NCT00183625|21069458|P3|NOT COMPLETED|Overall Study||19
8546188|NCT00183625|21069459|P2|NOT COMPLETED|Overall Study||18
8546189|NCT00183625|21069460|P1|NOT COMPLETED|Overall Study||18
8546190|NCT00183625|21069457|P4|COMPLETED|Overall Study||10
8546191|NCT00183625|21069458|P3|COMPLETED|Overall Study||9
8546192|NCT00183625|21069459|P2|COMPLETED|Overall Study||10
8546193|NCT00183625|21069460|P1|COMPLETED|Overall Study||9
8546194|NCT00183625|21069457|P4|Obtained Employment|Overall Study||14
8546195|NCT00183625|21069458|P3|Obtained Employment|Overall Study||14
8546196|NCT00183625|21069459|P2|Obtained Employment|Overall Study||18
8546197|NCT00183625|21069460|P1|Obtained Employment|Overall Study||21
8546198|NCT00183625|21069457|P4|STARTED|Overall Study||24
8546199|NCT00183625|21069458|P3|STARTED|Overall Study||28
8546200|NCT00183625|21069459|P2|STARTED|Overall Study||28
8546201|NCT00183625|21069460|P1|STARTED|Overall Study||27
8546202|NCT00183469|21069470|P2|NOT COMPLETED|Overall Study||29
8546203|NCT00183469|21069471|P1|NOT COMPLETED|Overall Study||28
8546204|NCT00183469|21069470|P2|COMPLETED|Overall Study||16
8546205|NCT00183469|21069471|P1|COMPLETED|Overall Study||13
8546206|NCT00183469|21069470|P2|STARTED|Overall Study||45
8546207|NCT00183469|21069471|P1|STARTED|Overall Study||41
8546208|NCT00183456|21069481|P4|NOT COMPLETED|Overall Study||28
8546209|NCT00183456|21069482|P3|NOT COMPLETED|Overall Study||16
8546210|NCT00183456|21069483|P2|NOT COMPLETED|Overall Study||1
8546211|NCT00183456|21069484|P1|NOT COMPLETED|Overall Study||3
8546212|NCT00183456|21069481|P4|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
8546213|NCT00183456|21069482|P3|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
8546214|NCT00183456|21069483|P2|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
8546215|NCT00183456|21069484|P1|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
8546216|NCT00183456|21069481|P4|18 Month Follow-up|Overall Study||207
8546217|NCT00183456|21069482|P3|18 Month Follow-up|Overall Study||303
8546218|NCT00183456|21069483|P2|18 Month Follow-up|Overall Study||81
8546219|NCT00183456|21069484|P1|18 Month Follow-up|Overall Study||80
8546220|NCT00183456|21069481|P4|12 Month Follow-up|Overall Study||186
8546221|NCT00183456|21069482|P3|12 Month Follow-up|Overall Study||267
8546222|NCT00183456|21069483|P2|12 Month Follow-up|Overall Study||74
8546223|NCT00183456|21069484|P1|12 Month Follow-up|Overall Study||76
8546224|NCT00183456|21069481|P4|6 Month Follow-up|Overall Study||175
8546225|NCT00183456|21069482|P3|6 Month Follow-up|Overall Study||278
8546226|NCT00183456|21069483|P2|6 Month Follow-up|Overall Study||77
8546227|NCT00183456|21069484|P1|6 Month Follow-up|Overall Study||74
8546228|NCT00183456|21069481|P4|STARTED|Overall Study||248
8546229|NCT00183456|21069482|P3|STARTED|Overall Study||329
8546230|NCT00183456|21069483|P2|STARTED|Overall Study||84
8546231|NCT00183456|21069484|P1|STARTED|Overall Study||85
8546232|NCT00183443|21069533|P3|NOT COMPLETED|Overall Study||0
8546233|NCT00183443|21069534|P2|NOT COMPLETED|Overall Study||0
8546234|NCT00183443|21069535|P1|NOT COMPLETED|Overall Study||0
8546235|NCT00183443|21069533|P3|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
8546236|NCT00183443|21069534|P2|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
8546237|NCT00183443|21069535|P1|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
8546238|NCT00183443|21069533|P3|STARTED|Overall Study||25
8546239|NCT00183443|21069534|P2|STARTED|Overall Study||26
8546240|NCT00183443|21069535|P1|STARTED|Overall Study||24
8546241|NCT00183430|21069557|P2|NOT COMPLETED|Overall Study||0
8546242|NCT00183430|21069558|P1|NOT COMPLETED|Overall Study||6
8546243|NCT00183430|21069557|P2|COMPLETED|Overall Study||11
8546244|NCT00183430|21069558|P1|COMPLETED|Overall Study||3
8546245|NCT00183430|21069557|P2|STARTED|Overall Study||11
8546246|NCT00183430|21069558|P1|STARTED|Overall Study||9
8546247|NCT00183391|21069570|P2|NOT COMPLETED|Block 2 - 5 Weeks||2
8546248|NCT00183391|21069571|P1|NOT COMPLETED|Block 2 - 5 Weeks||4
8546249|NCT00183391|21069570|P2|COMPLETED|Block 2 - 5 Weeks||108
8546250|NCT00183391|21069571|P1|COMPLETED|Block 2 - 5 Weeks||91
8546251|NCT00183391|21069570|P2|STARTED|Block 2 - 5 Weeks||110
8546252|NCT00183391|21069571|P1|STARTED|Block 2 - 5 Weeks||95
8546253|NCT00183391|21069570|P2|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
8546254|NCT00183391|21069571|P1|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
8546255|NCT00183391|21069570|P2|COMPLETED|Crossover Placebo - 2 Weeks||110
8546256|NCT00183391|21069571|P1|COMPLETED|Crossover Placebo - 2 Weeks||95
8546257|NCT00183391|21069570|P2|STARTED|Crossover Placebo - 2 Weeks||110
8546258|NCT00183391|21069571|P1|STARTED|Crossover Placebo - 2 Weeks||95
8546259|NCT00183391|21069570|P2|NOT COMPLETED|Block 1 - 5 Weeks||14
8546260|NCT00183391|21069571|P1|NOT COMPLETED|Block 1 - 5 Weeks||13
8546261|NCT00183391|21069570|P2|COMPLETED|Block 1 - 5 Weeks||110
8546262|NCT00183391|21069571|P1|COMPLETED|Block 1 - 5 Weeks||95
8546263|NCT00183391|21069570|P2|STARTED|Block 1 - 5 Weeks||124
8546264|NCT00183391|21069571|P1|STARTED|Block 1 - 5 Weeks||108
8546265|NCT00183339|21069631|P2|NOT COMPLETED|Overall Study||4
8546266|NCT00183339|21069632|P1|NOT COMPLETED|Overall Study||6
8546267|NCT00183339|21069631|P2|COMPLETED|Overall Study||4
8546268|NCT00183339|21069632|P1|COMPLETED|Overall Study||4
8546269|NCT00183339|21069631|P2|STARTED|Overall Study||8
8546270|NCT00183339|21069632|P1|STARTED|Overall Study||10
8546271|NCT00183274|21069644|P6|NOT COMPLETED|Phase 3: Double-Blind||4
8546272|NCT00183274|21069645|P5|NOT COMPLETED|Phase 3: Double-Blind||20
8546273|NCT00183274|21069646|P4|NOT COMPLETED|Phase 3: Double-Blind||2
8546274|NCT00183274|21069647|P3|NOT COMPLETED|Phase 3: Double-Blind||0
8546275|NCT00183274|21069648|P2|NOT COMPLETED|Phase 3: Double-Blind||0
8546276|NCT00183274|21069649|P1|NOT COMPLETED|Phase 3: Double-Blind||0
8546277|NCT00183274|21069644|P6|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
8546278|NCT00183274|21069645|P5|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
8546279|NCT00183274|21069646|P4|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
8546280|NCT00183274|21069647|P3|COMPLETED|Phase 3: Double-Blind||0
8546281|NCT00183274|21069648|P2|COMPLETED|Phase 3: Double-Blind||0
8546282|NCT00183274|21069649|P1|COMPLETED|Phase 3: Double-Blind||0
8546283|NCT00183274|21069644|P6|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
8546284|NCT00183274|21069645|P5|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
8546285|NCT00183274|21069646|P4|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
8546286|NCT00183274|21069647|P3|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
8546287|NCT00183274|21069648|P2|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
8546288|NCT00183274|21069649|P1|STARTED|Phase 3: Double-Blind||0
8546289|NCT00183274|21069644|P6|NOT COMPLETED|Phase 2: Double-Blind||0
8546290|NCT00183274|21069645|P5|NOT COMPLETED|Phase 2: Double-Blind||0
8546291|NCT00183274|21069646|P4|NOT COMPLETED|Phase 2: Double-Blind||0
8546292|NCT00183274|21069647|P3|NOT COMPLETED|Phase 2: Double-Blind||43
8546293|NCT00183274|21069648|P2|NOT COMPLETED|Phase 2: Double-Blind||26
8546294|NCT00183274|21069649|P1|NOT COMPLETED|Phase 2: Double-Blind||0
8546295|NCT00183274|21069644|P6|COMPLETED|Phase 2: Double-Blind||0
8546296|NCT00183274|21069645|P5|COMPLETED|Phase 2: Double-Blind||0
8546297|NCT00183274|21069646|P4|COMPLETED|Phase 2: Double-Blind||0
8546298|NCT00183274|21069647|P3|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
8546299|NCT00183274|21069648|P2|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
8546300|NCT00183274|21069649|P1|COMPLETED|Phase 2: Double-Blind||0
8546301|NCT00183274|21069644|P6|STARTED|Phase 2: Double-Blind||0
8546302|NCT00183274|21069645|P5|STARTED|Phase 2: Double-Blind||0
8546303|NCT00183274|21069646|P4|STARTED|Phase 2: Double-Blind||0
8546304|NCT00183274|21069647|P3|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
8546305|NCT00183274|21069648|P2|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
8546306|NCT00183274|21069649|P1|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
8546307|NCT00183274|21069644|P6|NOT COMPLETED|Phase 1: Open-Label||0
8546308|NCT00183274|21069645|P5|NOT COMPLETED|Phase 1: Open-Label||0
8546309|NCT00183274|21069646|P4|NOT COMPLETED|Phase 1: Open-Label||0
8546310|NCT00183274|21069647|P3|NOT COMPLETED|Phase 1: Open-Label||0
8546311|NCT00183274|21069648|P2|NOT COMPLETED|Phase 1: Open-Label||0
8546312|NCT00183274|21069649|P1|NOT COMPLETED|Phase 1: Open-Label||110
8546313|NCT00183274|21069644|P6|COMPLETED|Phase 1: Open-Label||0
8546314|NCT00183274|21069645|P5|COMPLETED|Phase 1: Open-Label||0
8546315|NCT00183274|21069646|P4|COMPLETED|Phase 1: Open-Label||0
8546316|NCT00183274|21069647|P3|COMPLETED|Phase 1: Open-Label||0
8546317|NCT00183274|21069648|P2|COMPLETED|Phase 1: Open-Label||0
8546318|NCT00183274|21069649|P1|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
8546319|NCT00183274|21069644|P6|STARTED|Phase 1: Open-Label||0
8546320|NCT00183274|21069645|P5|STARTED|Phase 1: Open-Label||0
8546321|NCT00183274|21069646|P4|STARTED|Phase 1: Open-Label||0
8546322|NCT00183274|21069647|P3|STARTED|Phase 1: Open-Label||0
8546323|NCT00183274|21069648|P2|STARTED|Phase 1: Open-Label||0
8546324|NCT00183274|21069649|P1|STARTED|Phase 1: Open-Label||268
8546325|NCT00183248|21069666|P2|NOT COMPLETED|Overall Study||1
8546326|NCT00183248|21069667|P1|NOT COMPLETED|Overall Study||1
8546327|NCT00183248|21069666|P2|COMPLETED|Overall Study||4
8546328|NCT00183248|21069667|P1|COMPLETED|Overall Study||3
8546329|NCT00183248|21069666|P2|STARTED|Overall Study||5
8546330|NCT00183248|21069667|P1|STARTED|Overall Study||4
8546331|NCT00183196|21069688|P3|NOT COMPLETED|Overall Study||18
8546332|NCT00183196|21069689|P2|NOT COMPLETED|Overall Study||15
8546333|NCT00183196|21069690|P1|NOT COMPLETED|Overall Study||20
8546334|NCT00183196|21069688|P3|COMPLETED|Overall Study||32
8546335|NCT00183196|21069689|P2|COMPLETED|Overall Study||35
8546336|NCT00183196|21069690|P1|COMPLETED|Overall Study||30
8546337|NCT00183196|21069688|P3|STARTED|Overall Study|1 subject had no post-randomization data|50
8546338|NCT00183196|21069689|P2|STARTED|Overall Study|1 subject had no post-randomization data|50
8546339|NCT00183196|21069690|P1|STARTED|Overall Study|2 subjects had no post-randomization data|50
8546340|NCT00183170|21069700|P2|NOT COMPLETED|Second Intervention||2
8546341|NCT00183170|21069701|P1|NOT COMPLETED|Second Intervention||1
8546342|NCT00183170|21069700|P2|COMPLETED|Second Intervention||99
8546343|NCT00183170|21069701|P1|COMPLETED|Second Intervention||94
8546344|NCT00183170|21069700|P2|STARTED|Second Intervention||101
8546345|NCT00183170|21069701|P1|STARTED|Second Intervention||95
8546346|NCT00183170|21069700|P2|NOT COMPLETED|Washout 1 Week||8
8546347|NCT00183170|21069701|P1|NOT COMPLETED|Washout 1 Week||6
8546348|NCT00183170|21069700|P2|COMPLETED|Washout 1 Week||101
8546349|NCT00183170|21069701|P1|COMPLETED|Washout 1 Week||95
8546350|NCT00183170|21069700|P2|STARTED|Washout 1 Week||109
8546351|NCT00183170|21069701|P1|STARTED|Washout 1 Week||101
8546352|NCT00183170|21069700|P2|NOT COMPLETED|First Intervention||0
8546353|NCT00183170|21069701|P1|NOT COMPLETED|First Intervention||2
8546354|NCT00183170|21069700|P2|COMPLETED|First Intervention||109
8546355|NCT00183170|21069701|P1|COMPLETED|First Intervention||101
8546356|NCT00183170|21069700|P2|STARTED|First Intervention||109
8546357|NCT00183170|21069701|P1|STARTED|First Intervention||103
8546358|NCT00183092|21069717|P4|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
8546359|NCT00183092|21069718|P3|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
8546360|NCT00183092|21069719|P2|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
8546361|NCT00183092|21069720|P1|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
8546362|NCT00183092|21069717|P4|COMPLETED|Open-label Period (Month 2 Until Death)||0
8546363|NCT00183092|21069718|P3|COMPLETED|Open-label Period (Month 2 Until Death)||0
8546364|NCT00183092|21069719|P2|COMPLETED|Open-label Period (Month 2 Until Death)||0
8546365|NCT00183092|21069720|P1|COMPLETED|Open-label Period (Month 2 Until Death)||0
8546366|NCT00183092|21069717|P4|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
8546367|NCT00183092|21069718|P3|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
8546368|NCT00183092|21069719|P2|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
8546369|NCT00183092|21069720|P1|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
8546370|NCT00183092|21069717|P4|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
8546371|NCT00183092|21069718|P3|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
8546372|NCT00183092|21069719|P2|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
8546373|NCT00183092|21069720|P1|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
8546374|NCT00183092|21069717|P4|COMPLETED|Double-blind (Baseline - Month 2)||0
8546375|NCT00183092|21069718|P3|COMPLETED|Double-blind (Baseline - Month 2)||0
8546376|NCT00183092|21069719|P2|COMPLETED|Double-blind (Baseline - Month 2)||16
8546377|NCT00183092|21069720|P1|COMPLETED|Double-blind (Baseline - Month 2)||11
8546378|NCT00183092|21069717|P4|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
8546379|NCT00183092|21069718|P3|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
8546380|NCT00183092|21069719|P2|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
8546381|NCT00183092|21069720|P1|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
8546382|NCT00183092|21069717|P4|Alive at Month 2|Double-blind (Baseline - Month 2)||0
8546383|NCT00183092|21069718|P3|Alive at Month 2|Double-blind (Baseline - Month 2)||0
8546384|NCT00183092|21069719|P2|Alive at Month 2|Double-blind (Baseline - Month 2)||19
8546385|NCT00183092|21069720|P1|Alive at Month 2|Double-blind (Baseline - Month 2)||13
8546386|NCT00183092|21069717|P4|STARTED|Double-blind (Baseline - Month 2)||0
8546387|NCT00183092|21069718|P3|STARTED|Double-blind (Baseline - Month 2)||0
8546388|NCT00183092|21069719|P2|STARTED|Double-blind (Baseline - Month 2)||28
8546389|NCT00183092|21069720|P1|STARTED|Double-blind (Baseline - Month 2)||23
8546390|NCT00182793|21069741|P1|NOT COMPLETED|Overall Study||0
8546391|NCT00182793|21069741|P1|COMPLETED|Overall Study||32
8546392|NCT00182793|21069741|P1|STARTED|Overall Study||32
8546393|NCT00182767|21069746|P5|NOT COMPLETED|Overall Study||0
8546394|NCT00182767|21069747|P4|NOT COMPLETED|Overall Study||0
8546395|NCT00182767|21069748|P3|NOT COMPLETED|Overall Study||0
8546396|NCT00182767|21069749|P2|NOT COMPLETED|Overall Study||0
8546397|NCT00182767|21069750|P1|NOT COMPLETED|Overall Study||0
8546398|NCT00182767|21069746|P5|COMPLETED|Overall Study||24
8546399|NCT00182767|21069747|P4|COMPLETED|Overall Study||3
8546400|NCT00182767|21069748|P3|COMPLETED|Overall Study||6
8546401|NCT00182767|21069749|P2|COMPLETED|Overall Study||6
8546402|NCT00182767|21069750|P1|COMPLETED|Overall Study||6
8546403|NCT00182767|21069746|P5|STARTED|Overall Study||24
8546404|NCT00182767|21069747|P4|STARTED|Overall Study||3
8546405|NCT00182767|21069748|P3|STARTED|Overall Study||6
8546406|NCT00182767|21069749|P2|STARTED|Overall Study||6
8546407|NCT00182767|21069750|P1|STARTED|Overall Study||6
8546408|NCT00182754|21069767|P2|NOT COMPLETED|Overall Study||0
8546409|NCT00182754|21069768|P1|NOT COMPLETED|Overall Study||0
8546410|NCT00182754|21069767|P2|COMPLETED|Overall Study||17
8546411|NCT00182754|21069768|P1|COMPLETED|Overall Study||16
8546412|NCT00182754|21069767|P2|STARTED|Overall Study||17
8546413|NCT00182754|21069768|P1|STARTED|Overall Study||16
8546414|NCT00182728|21069778|P1|NOT COMPLETED|Overall Study||0
8546415|NCT00182728|21069778|P1|COMPLETED|Overall Study||71
8546416|NCT00182728|21069778|P1|STARTED|Overall Study||71
8546417|NCT00182689|21069790|P2|NOT COMPLETED|Overall Study||49
8546418|NCT00182689|21069791|P1|NOT COMPLETED|Overall Study||40
8546419|NCT00182689|21069790|P2|COMPLETED|Overall Study||0
8546420|NCT00182689|21069791|P1|COMPLETED|Overall Study||0
8546421|NCT00182689|21069790|P2|Eligible and Began Protocol Therapy|Overall Study||45
8546422|NCT00182689|21069791|P1|Eligible and Began Protocol Therapy|Overall Study||38
8546423|NCT00182689|21069790|P2|Eligible|Overall Study||45
8546424|NCT00182689|21069791|P1|Eligible|Overall Study||39
8546425|NCT00182689|21069790|P2|STARTED|Overall Study||49
8546426|NCT00182689|21069791|P1|STARTED|Overall Study||40
8546427|NCT00182637|21069801|P1|NOT COMPLETED|Overall Study||3
8546428|NCT00182637|21069801|P1|COMPLETED|Overall Study|off study date|2
8546429|NCT00182637|21069801|P1|STARTED|Overall Study|active/on treatment date|5
8546430|NCT00182325|21069809|P2|NOT COMPLETED|Overall Study||53
8546431|NCT00182325|21069810|P1|NOT COMPLETED|Overall Study||34
8546432|NCT00182325|21069809|P2|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43
8546433|NCT00182325|21069810|P1|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63
8546434|NCT00182325|21069809|P2|STARTED|Overall Study||96
8546435|NCT00182325|21069810|P1|STARTED|Overall Study||97
8546436|NCT00182091|21069838|P4|NOT COMPLETED|Overall Study||0
8546437|NCT00182091|21069839|P3|NOT COMPLETED|Overall Study||0
8546438|NCT00182091|21069840|P2|NOT COMPLETED|Overall Study||0
8546439|NCT00182091|21069841|P1|NOT COMPLETED|Overall Study||1
8546440|NCT00182091|21069838|P4|COMPLETED|Overall Study||20
8546441|NCT00182091|21069839|P3|COMPLETED|Overall Study||25
8546442|NCT00182091|21069840|P2|COMPLETED|Overall Study||15
8546443|NCT00182091|21069841|P1|COMPLETED|Overall Study||14
8546444|NCT00182091|21069838|P4|STARTED|Overall Study||20
8546445|NCT00182091|21069839|P3|STARTED|Overall Study||25
8546446|NCT00182091|21069840|P2|STARTED|Overall Study||15
8546447|NCT00182091|21069841|P1|STARTED|Overall Study||15
8546448|NCT00182078|21069857|P2|NOT COMPLETED|Overall Study||0
8546449|NCT00182078|21069858|P1|NOT COMPLETED|Overall Study||1
8546450|NCT00182078|21069857|P2|COMPLETED|Overall Study||17
8546451|NCT00182078|21069858|P1|COMPLETED|Overall Study||8
8546452|NCT00182078|21069857|P2|STARTED|Overall Study||17
8546453|NCT00182078|21069858|P1|STARTED|Overall Study||9
8546454|NCT00182000|21069870|P2|NOT COMPLETED|Overall Study||2
8546455|NCT00182000|21069871|P1|NOT COMPLETED|Overall Study||5
8546456|NCT00182000|21069870|P2|COMPLETED|Overall Study||13
8546457|NCT00182000|21069871|P1|COMPLETED|Overall Study||9
8546458|NCT00182000|21069870|P2|STARTED|Overall Study||15
8546459|NCT00182000|21069871|P1|STARTED|Overall Study||14
8546460|NCT00181961|21069879|P2|NOT COMPLETED|Overall Study||5
8546461|NCT00181961|21069880|P1|NOT COMPLETED|Overall Study||1
8546462|NCT00181961|21069879|P2|COMPLETED|Overall Study||4
8546463|NCT00181961|21069880|P1|COMPLETED|Overall Study||6
8546464|NCT00181961|21069879|P2|STARTED|Overall Study||9
8546465|NCT00181961|21069880|P1|STARTED|Overall Study||7
8546466|NCT00181883|21069886|P1|NOT COMPLETED|Overall Study||10
8546467|NCT00181883|21069886|P1|COMPLETED|Overall Study||20
8546468|NCT00181883|21069886|P1|STARTED|Overall Study||30
8546469|NCT00181844|21069890|P1|NOT COMPLETED|Exposed to Study Medication||17
8546470|NCT00181844|21069890|P1|COMPLETED|Exposed to Study Medication||22
8546471|NCT00181844|21069890|P1|STARTED|Exposed to Study Medication||39
8546472|NCT00181844|21069890|P1|NOT COMPLETED|Signed Consent||12
8546473|NCT00181844|21069890|P1|COMPLETED|Signed Consent||39
8546474|NCT00181844|21069890|P1|STARTED|Signed Consent||51
8546475|NCT00181766|21069894|P1|NOT COMPLETED|Overall Study||12
8546476|NCT00181766|21069894|P1|COMPLETED|Overall Study|Completed the trial.|33
8546477|NCT00181766|21069894|P1|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
8546478|NCT00181714|21069899|P1|NOT COMPLETED|Began Treatment With OROS-MPH||124
8546479|NCT00181714|21069899|P1|COMPLETED|Began Treatment With OROS-MPH||30
8546480|NCT00181714|21069899|P1|STARTED|Began Treatment With OROS-MPH||154
8546481|NCT00181714|21069899|P1|NOT COMPLETED|Signed Consent/Enrolled||49
8546482|NCT00181714|21069899|P1|COMPLETED|Signed Consent/Enrolled||154
8546483|NCT00181714|21069899|P1|STARTED|Signed Consent/Enrolled||203
8546484|NCT00181623|21069903|P1|NOT COMPLETED|Overall Study||1
8546485|NCT00181623|21069903|P1|COMPLETED|Overall Study||5
8546486|NCT00181623|21069903|P1|STARTED|Overall Study||6
8546487|NCT00181610|21069911|P3|NOT COMPLETED|Overall Study||0
8546488|NCT00181610|21069912|P2|NOT COMPLETED|Overall Study||1
8546489|NCT00181610|21069913|P1|NOT COMPLETED|Overall Study||0
8546490|NCT00181610|21069911|P3|COMPLETED|Overall Study||3
8546491|NCT00181610|21069912|P2|COMPLETED|Overall Study||3
8546492|NCT00181610|21069913|P1|COMPLETED|Overall Study||4
8546493|NCT00181610|21069911|P3|STARTED|Overall Study||3
8546494|NCT00181610|21069912|P2|STARTED|Overall Study||4
8546495|NCT00181610|21069913|P1|STARTED|Overall Study||4
8546496|NCT00181363|21069924|P1|NOT COMPLETED|Overall Study||0
8546497|NCT00181363|21069924|P1|COMPLETED|Overall Study||10
8546498|NCT00181363|21069924|P1|STARTED|Overall Study|10|10
8546499|NCT00181285|21069939|P2|NOT COMPLETED|Overall Study||0
8546500|NCT00181285|21069940|P1|NOT COMPLETED|Overall Study||0
8546501|NCT00181285|21069939|P2|COMPLETED|Overall Study||25
8546502|NCT00181285|21069940|P1|COMPLETED|Overall Study||27
8546503|NCT00181285|21069939|P2|STARTED|Overall Study||25
8546504|NCT00181285|21069940|P1|STARTED|Overall Study||27
8546505|NCT00181207|21069950|P2|NOT COMPLETED|Overall Study||0
8546506|NCT00181207|21069951|P1|NOT COMPLETED|Overall Study||0
8546507|NCT00181207|21069950|P2|COMPLETED|Overall Study||26
8546508|NCT00181207|21069951|P1|COMPLETED|Overall Study||24
8546509|NCT00181207|21069950|P2|STARTED|Overall Study||26
8546510|NCT00181207|21069951|P1|STARTED|Overall Study||24
8546511|NCT00181168|21069961|P2|NOT COMPLETED|Overall Study||0
8546512|NCT00181168|21069962|P1|NOT COMPLETED|Overall Study||0
8546513|NCT00181168|21069961|P2|COMPLETED|Overall Study||33
8546514|NCT00181168|21069962|P1|COMPLETED|Overall Study||30
8546515|NCT00181168|21069961|P2|STARTED|Overall Study||33
8546516|NCT00181168|21069962|P1|STARTED|Overall Study||30
8546517|NCT00181155|21069968|P2|NOT COMPLETED|Overall Study||0
8546518|NCT00181155|21069969|P1|NOT COMPLETED|Overall Study||2
8546519|NCT00181155|21069968|P2|COMPLETED|Overall Study||3
8546520|NCT00181155|21069969|P1|COMPLETED|Overall Study||13
8546521|NCT00181155|21069968|P2|STARTED|Overall Study||3
8546522|NCT00181155|21069969|P1|STARTED|Overall Study||15
8546523|NCT00180713|21069979|P2|NOT COMPLETED|Overall Study||3
8546524|NCT00180713|21069980|P1|NOT COMPLETED|Overall Study||5
8546525|NCT00180713|21069979|P2|COMPLETED|Overall Study||16
8546526|NCT00180713|21069980|P1|COMPLETED|Overall Study||18
8546527|NCT00180713|21069979|P2|STARTED|Overall Study||19
8546528|NCT00180713|21069980|P1|STARTED|Overall Study||23
8546529|NCT00180687|21069998|P4|NOT COMPLETED|Overall Study||0
8546530|NCT00180687|21069999|P3|NOT COMPLETED|Overall Study||0
8546531|NCT00180687|21070000|P2|NOT COMPLETED|Overall Study||0
8546532|NCT00180687|21070001|P1|NOT COMPLETED|Overall Study||0
8546533|NCT00180687|21069998|P4|COMPLETED|Overall Study||20
8546534|NCT00180687|21069999|P3|COMPLETED|Overall Study||20
8546535|NCT00180687|21070000|P2|COMPLETED|Overall Study||20
8546536|NCT00180687|21070001|P1|COMPLETED|Overall Study||20
8546537|NCT00180687|21069998|P4|STARTED|Overall Study||20
8546538|NCT00180687|21069999|P3|STARTED|Overall Study||20
8546539|NCT00180687|21070000|P2|STARTED|Overall Study||20
8546540|NCT00180687|21070001|P1|STARTED|Overall Study||20
8546541|NCT00180674|21070023|P1|NOT COMPLETED|Phase 2, Warfarin Treatment Period||1
8546542|NCT00180674|21070023|P1|COMPLETED|Phase 2, Warfarin Treatment Period||9
8546543|NCT00180674|21070023|P1|STARTED|Phase 2, Warfarin Treatment Period||10
8546544|NCT00180674|21070023|P1|NOT COMPLETED|Phase 1, Observation Period||4
8546545|NCT00180674|21070023|P1|COMPLETED|Phase 1, Observation Period||10
8546546|NCT00180674|21070023|P1|STARTED|Phase 1, Observation Period||14
8546547|NCT00180661|21070033|P2|NOT COMPLETED|Overall Study||0
8546548|NCT00180661|21070034|P1|NOT COMPLETED|Overall Study||0
8546549|NCT00180661|21070033|P2|COMPLETED|Overall Study||20
8546550|NCT00180661|21070034|P1|COMPLETED|Overall Study||19
8546551|NCT00180661|21070033|P2|STARTED|Overall Study||20
8546552|NCT00180661|21070034|P1|STARTED|Overall Study||19
8546553|NCT00180479|21070052|P2|NOT COMPLETED|Overall Study||13
8546554|NCT00180479|21070053|P1|NOT COMPLETED|Overall Study||16
8546555|NCT00180479|21070052|P2|COMPLETED|Overall Study||320
8546556|NCT00180479|21070053|P1|COMPLETED|Overall Study||653
8546557|NCT00180479|21070052|P2|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
8546558|NCT00180479|21070053|P1|STARTED|Overall Study||669
8546562|NCT00180271|21070154|P2|NOT COMPLETED|Overall Study||0
8546563|NCT00180271|21070155|P1|NOT COMPLETED|Overall Study||0
8546564|NCT00180271|21070154|P2|COMPLETED|Overall Study||731
8546565|NCT00180271|21070155|P1|COMPLETED|Overall Study||1089
8546566|NCT00180271|21070154|P2|STARTED|Overall Study||731
8546567|NCT00180271|21070155|P1|STARTED|Overall Study||1089
8546568|NCT00179998|21070165|P2|NOT COMPLETED|Crossover Period - 6 Months||2
8546569|NCT00179998|21070166|P1|NOT COMPLETED|Crossover Period - 6 Months||0
8546570|NCT00179998|21070165|P2|COMPLETED|Crossover Period - 6 Months||10
8546571|NCT00179998|21070166|P1|COMPLETED|Crossover Period - 6 Months||12
8546572|NCT00179998|21070165|P2|STARTED|Crossover Period - 6 Months||12
8546573|NCT00179998|21070166|P1|STARTED|Crossover Period - 6 Months||12
8546574|NCT00179998|21070165|P2|NOT COMPLETED|Initial Period - 6 Months||0
8546575|NCT00179998|21070166|P1|NOT COMPLETED|Initial Period - 6 Months||0
8546576|NCT00179998|21070165|P2|COMPLETED|Initial Period - 6 Months||12
8546577|NCT00179998|21070166|P1|COMPLETED|Initial Period - 6 Months||12
8546578|NCT00179998|21070165|P2|STARTED|Initial Period - 6 Months||12
8546579|NCT00179998|21070166|P1|STARTED|Initial Period - 6 Months||12
8546580|NCT00179959|21070178|P2|NOT COMPLETED|Overall Study||3
8546581|NCT00179959|21070179|P1|NOT COMPLETED|Overall Study||6
8546582|NCT00179959|21070178|P2|COMPLETED|Overall Study||13
8546583|NCT00179959|21070179|P1|COMPLETED|Overall Study||9
8546584|NCT00179959|21070178|P2|STARTED|Overall Study||16
8546585|NCT00179959|21070179|P1|STARTED|Overall Study||15
8546586|NCT00179673|21070185|P1|NOT COMPLETED|Overall Study||43
8546587|NCT00179673|21070185|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
8546588|NCT00179673|21070185|P1|Received Study Drug|Overall Study||43
8546589|NCT00179673|21070185|P1|STARTED|Overall Study||43
8546590|NCT00179660|21070193|P1|NOT COMPLETED|Overall Study||50
8546591|NCT00179660|21070193|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
8546592|NCT00179660|21070193|P1|Completed 12 Cycles of Treatment|Overall Study||12
8546593|NCT00179660|21070193|P1|Received Study Drug|Overall Study||49
8546594|NCT00179660|21070193|P1|STARTED|Overall Study||50
8546595|NCT00179647|21070202|P1|NOT COMPLETED|Overall Study||1913
8546596|NCT00179647|21070202|P1|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
8546597|NCT00179647|21070202|P1|STARTED|Overall Study||1913
8546598|NCT00179621|21070209|P4|NOT COMPLETED|Open-Label Period||43
8546599|NCT00179621|21070210|P3|NOT COMPLETED|Open-Label Period||28
8546600|NCT00179621|21070211|P2|NOT COMPLETED|Open-Label Period||28
8546601|NCT00179621|21070212|P1|NOT COMPLETED|Open-Label Period||0
8546602|NCT00179621|21070209|P4|COMPLETED|Open-Label Period||13
8546603|NCT00179621|21070210|P3|COMPLETED|Open-Label Period||19
8546604|NCT00179621|21070211|P2|COMPLETED|Open-Label Period||14
8546605|NCT00179621|21070212|P1|COMPLETED|Open-Label Period||0
8546606|NCT00179621|21070209|P4|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
8546607|NCT00179621|21070210|P3|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
8546608|NCT00179621|21070211|P2|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
8546609|NCT00179621|21070212|P1|STARTED|Open-Label Period||0
8546610|NCT00179621|21070209|P4|NOT COMPLETED|Double-Blind Period||0
8546611|NCT00179621|21070210|P3|NOT COMPLETED|Double-Blind Period||30
8546612|NCT00179621|21070211|P2|NOT COMPLETED|Double-Blind Period||46
8546613|NCT00179621|21070212|P1|NOT COMPLETED|Double-Blind Period||64
8546614|NCT00179621|21070209|P4|COMPLETED|Double-Blind Period||0
8546615|NCT00179621|21070210|P3|COMPLETED|Double-Blind Period||39
8546616|NCT00179621|21070211|P2|COMPLETED|Double-Blind Period||23
8546617|NCT00179621|21070212|P1|COMPLETED|Double-Blind Period||3
8546618|NCT00179621|21070209|P4|STARTED|Double-Blind Period||0
8546619|NCT00179621|21070210|P3|STARTED|Double-Blind Period||69
8546620|NCT00179621|21070211|P2|STARTED|Double-Blind Period||69
8546621|NCT00179621|21070212|P1|STARTED|Double-Blind Period||67
8546622|NCT00179517|21070265|P2|NOT COMPLETED|Overall Study||1
8546623|NCT00179517|21070266|P1|NOT COMPLETED|Overall Study||2
8546624|NCT00179517|21070265|P2|COMPLETED|Overall Study||19
8546625|NCT00179517|21070266|P1|COMPLETED|Overall Study||18
8546626|NCT00179517|21070265|P2|STARTED|Overall Study||20
8546627|NCT00179517|21070266|P1|STARTED|Overall Study||20
8546628|NCT00179478|21070290|P2|NOT COMPLETED|Overall Study||15
8546629|NCT00179478|21070291|P1|NOT COMPLETED|Overall Study||13
8546630|NCT00179478|21070290|P2|COMPLETED|Overall Study||59
8546631|NCT00179478|21070291|P1|COMPLETED|Overall Study||68
8546632|NCT00179478|21070290|P2|STARTED|Overall Study||74
8546633|NCT00179478|21070291|P1|STARTED|Overall Study||81
8546634|NCT00179413|21070304|P2|NOT COMPLETED|Overall Study||115
8546635|NCT00179413|21070305|P1|NOT COMPLETED|Overall Study||125
8546636|NCT00179413|21070304|P2|COMPLETED|Overall Study||152
8546637|NCT00179413|21070305|P1|COMPLETED|Overall Study||157
8546638|NCT00179413|21070304|P2|STARTED|Overall Study||267
8546639|NCT00179413|21070305|P1|STARTED|Overall Study||282
8546640|NCT00179309|21070317|P2|NOT COMPLETED|Crossover||0
8546641|NCT00179309|21070318|P1|NOT COMPLETED|Crossover||0
8546642|NCT00179309|21070317|P2|COMPLETED|Crossover||3
8546643|NCT00179309|21070318|P1|COMPLETED|Crossover||0
8546644|NCT00179309|21070317|P2|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
8546645|NCT00179309|21070318|P1|STARTED|Crossover||0
8546646|NCT00179309|21070317|P2|NOT COMPLETED|Treatment||5
8546647|NCT00179309|21070318|P1|NOT COMPLETED|Treatment||4
8546648|NCT00179309|21070317|P2|COMPLETED|Treatment||18
8546649|NCT00179309|21070318|P1|COMPLETED|Treatment||21
8546650|NCT00179309|21070317|P2|STARTED|Treatment||23
8546651|NCT00179309|21070318|P1|STARTED|Treatment||25
8546652|NCT00179127|21070328|P2|NOT COMPLETED|Overall Study||0
8546653|NCT00179127|21070329|P1|NOT COMPLETED|Overall Study||0
8546654|NCT00179127|21070328|P2|COMPLETED|Overall Study||0
8546655|NCT00179127|21070329|P1|COMPLETED|Overall Study||0
8546656|NCT00179127|21070328|P2|STARTED|Overall Study||0
8546657|NCT00179127|21070329|P1|STARTED|Overall Study||0
8546658|NCT00179010|21070341|P2|NOT COMPLETED|Overall Study||2
8546659|NCT00179010|21070342|P1|NOT COMPLETED|Overall Study||1
8546660|NCT00179010|21070341|P2|COMPLETED|Overall Study||5
8546661|NCT00179010|21070342|P1|COMPLETED|Overall Study||5
8546662|NCT00179010|21070341|P2|STARTED|Overall Study||7
8546663|NCT00179010|21070342|P1|STARTED|Overall Study||6
8546664|NCT00178919|21070352|P2|NOT COMPLETED|Overall Study||25
8546665|NCT00178919|21070353|P1|NOT COMPLETED|Overall Study||0
8546666|NCT00178919|21070352|P2|COMPLETED|Overall Study||68
8546667|NCT00178919|21070353|P1|COMPLETED|Overall Study||19
8546668|NCT00178919|21070352|P2|STARTED|Overall Study||93
8546669|NCT00178919|21070353|P1|STARTED|Overall Study||19
8546670|NCT00178841|21070361|P1|NOT COMPLETED|Overall Study||0
8546671|NCT00178841|21070361|P1|COMPLETED|Overall Study||4
8546672|NCT00178841|21070361|P1|STARTED|Overall Study||4
8546673|NCT00178711|21070369|P2|NOT COMPLETED|Overall Study||0
8546674|NCT00178711|21070370|P1|NOT COMPLETED|Overall Study||0
8546675|NCT00178711|21070369|P2|COMPLETED|Overall Study||45
8546676|NCT00178711|21070370|P1|COMPLETED|Overall Study||52
8546677|NCT00178711|21070369|P2|STARTED|Overall Study||45
8546678|NCT00178711|21070370|P1|STARTED|Overall Study||52
8546679|NCT00178685|21070381|P3|NOT COMPLETED|Overall Study||196
8546680|NCT00178685|21070382|P2|NOT COMPLETED|Overall Study||204
8546681|NCT00178685|21070383|P1|NOT COMPLETED|Overall Study||111
8546682|NCT00178685|21070381|P3|COMPLETED|Overall Study||128
8546683|NCT00178685|21070382|P2|COMPLETED|Overall Study||120
8546684|NCT00178685|21070383|P1|COMPLETED|Overall Study||61
8546685|NCT00178685|21070381|P3|STARTED|Overall Study||324
8546686|NCT00178685|21070382|P2|STARTED|Overall Study||324
8546687|NCT00178685|21070383|P1|STARTED|Overall Study||172
8546688|NCT00178646|21070397|P3|NOT COMPLETED|Overall Study||1
8546689|NCT00178646|21070398|P2|NOT COMPLETED|Overall Study||1
8546690|NCT00178646|21070399|P1|NOT COMPLETED|Overall Study||0
8546691|NCT00178646|21070397|P3|COMPLETED|Overall Study||10
8546692|NCT00178646|21070398|P2|COMPLETED|Overall Study||8
8546693|NCT00178646|21070399|P1|COMPLETED|Overall Study||12
8546694|NCT00178646|21070397|P3|STARTED|Overall Study||11
8546695|NCT00178646|21070398|P2|STARTED|Overall Study||9
8546696|NCT00178646|21070399|P1|STARTED|Overall Study||12
8546697|NCT00178633|21070425|P1|NOT COMPLETED|Overall Study||6
8546698|NCT00178633|21070425|P1|COMPLETED|Overall Study||37
8546699|NCT00178633|21070425|P1|STARTED|Overall Study||43
8546700|NCT00178503|21070433|P1|NOT COMPLETED|MPH Trial: High Dose||0
8546701|NCT00178503|21070433|P1|COMPLETED|MPH Trial: High Dose||24
8546702|NCT00178503|21070433|P1|STARTED|MPH Trial: High Dose||24
8546703|NCT00178503|21070433|P1|NOT COMPLETED|MPH Trial: Med Dose||0
8546704|NCT00178503|21070433|P1|COMPLETED|MPH Trial: Med Dose||24
8546705|NCT00178503|21070433|P1|STARTED|MPH Trial: Med Dose||24
8546706|NCT00178503|21070433|P1|NOT COMPLETED|MPH Trial: Low Dose||0
8546707|NCT00178503|21070433|P1|COMPLETED|MPH Trial: Low Dose||24
8546708|NCT00178503|21070433|P1|STARTED|MPH Trial: Low Dose||24
8546709|NCT00178503|21070433|P1|NOT COMPLETED|MPH Trial: Placebo||0
8546710|NCT00178503|21070433|P1|COMPLETED|MPH Trial: Placebo||24
8546711|NCT00178503|21070433|P1|STARTED|MPH Trial: Placebo||24
8546712|NCT00178477|21070451|P1|NOT COMPLETED|Overall Study||5
8546713|NCT00178477|21070451|P1|COMPLETED|Overall Study||5
8546714|NCT00178477|21070451|P1|STARTED|Overall Study||10
8546715|NCT00178464|21070455|P1|NOT COMPLETED|Overall Study||2
8546716|NCT00178464|21070455|P1|COMPLETED|Overall Study||9
8546717|NCT00178464|21070455|P1|STARTED|Overall Study||11
8546718|NCT00178399|21070460|P1|NOT COMPLETED|Overall Study||13
8546719|NCT00178399|21070460|P1|COMPLETED|Overall Study||115
8546720|NCT00178399|21070460|P1|STARTED|Overall Study||128
8546721|NCT00178256|21070467|P4|NOT COMPLETED|Overall Study||2
8546722|NCT00178256|21070468|P3|NOT COMPLETED|Overall Study||0
8546723|NCT00178256|21070469|P2|NOT COMPLETED|Overall Study||1
8546724|NCT00178256|21070470|P1|NOT COMPLETED|Overall Study||4
8546725|NCT00178256|21070467|P4|COMPLETED|Overall Study||16
8546726|NCT00178256|21070468|P3|COMPLETED|Overall Study||6
8546727|NCT00178256|21070469|P2|COMPLETED|Overall Study||6
8546728|NCT00178256|21070470|P1|COMPLETED|Overall Study||6
8546729|NCT00178256|21070467|P4|STARTED|Overall Study||18
8546730|NCT00178256|21070468|P3|STARTED|Overall Study||6
8546731|NCT00178256|21070469|P2|STARTED|Overall Study||7
8546732|NCT00178256|21070470|P1|STARTED|Overall Study||10
8546733|NCT00178191|21070480|P3|NOT COMPLETED|Overall Study||0
8546734|NCT00178191|21070481|P2|NOT COMPLETED|Overall Study||0
8546735|NCT00178191|21070482|P1|NOT COMPLETED|Overall Study||0
8546736|NCT00178191|21070480|P3|COMPLETED|Overall Study||7
8546737|NCT00178191|21070481|P2|COMPLETED|Overall Study||10
8546738|NCT00178191|21070482|P1|COMPLETED|Overall Study||11
8546739|NCT00178191|21070480|P3|STARTED|Overall Study||7
8546740|NCT00178191|21070481|P2|STARTED|Overall Study||10
8546741|NCT00178191|21070482|P1|STARTED|Overall Study||11
8546742|NCT00178178|21070494|P4|NOT COMPLETED|Overall Study||0
8546743|NCT00178178|21070495|P3|NOT COMPLETED|Overall Study||0
8546744|NCT00178178|21070496|P2|NOT COMPLETED|Overall Study||0
8546745|NCT00178178|21070497|P1|NOT COMPLETED|Overall Study||0
8546746|NCT00178178|21070494|P4|COMPLETED|Overall Study||24
8546747|NCT00178178|21070495|P3|COMPLETED|Overall Study||24
8546748|NCT00178178|21070496|P2|COMPLETED|Overall Study||24
8546749|NCT00178178|21070497|P1|COMPLETED|Overall Study||24
8546750|NCT00178178|21070494|P4|STARTED|Overall Study||24
8546751|NCT00178178|21070495|P3|STARTED|Overall Study||24
8546752|NCT00178178|21070496|P2|STARTED|Overall Study||24
8546753|NCT00178178|21070497|P1|STARTED|Overall Study||24
8546754|NCT00178126|21070509|P2|NOT COMPLETED|Overall Study||27
8546755|NCT00178126|21070510|P1|NOT COMPLETED|Overall Study||25
8546756|NCT00178126|21070509|P2|COMPLETED|Overall Study||86
8546757|NCT00178126|21070510|P1|COMPLETED|Overall Study||94
8546758|NCT00178126|21070509|P2|STARTED|Overall Study||113
8546759|NCT00178126|21070510|P1|STARTED|Overall Study||119
8546760|NCT00177970|21070518|P2|NOT COMPLETED|Overall Study||0
8546761|NCT00177970|21070519|P1|NOT COMPLETED|Overall Study||0
8546762|NCT00177970|21070518|P2|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
8546763|NCT00177970|21070519|P1|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
8546764|NCT00177970|21070518|P2|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
8546765|NCT00177970|21070519|P1|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
8546766|NCT00177866|21070541|P2|NOT COMPLETED|Overall Study||0
8546767|NCT00177866|21070542|P1|NOT COMPLETED|Overall Study||0
8546768|NCT00177866|21070541|P2|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
8546769|NCT00177866|21070542|P1|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
8546770|NCT00177866|21070541|P2|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
8546771|NCT00177866|21070542|P1|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
8546772|NCT00177671|21070552|P2|NOT COMPLETED|Overall Study||14
8546773|NCT00177671|21070553|P1|NOT COMPLETED|Overall Study||25
8546774|NCT00177671|21070552|P2|COMPLETED|Overall Study||49
8546775|NCT00177671|21070553|P1|COMPLETED|Overall Study||42
8546776|NCT00177671|21070552|P2|Month 24|Overall Study||49
8546777|NCT00177671|21070553|P1|Month 24|Overall Study||42
8546778|NCT00177671|21070552|P2|Month 12|Overall Study||57
8546779|NCT00177671|21070553|P1|Month 12|Overall Study||45
8546780|NCT00177671|21070552|P2|STARTED|Overall Study||63
8546781|NCT00177671|21070553|P1|STARTED|Overall Study||67
8546782|NCT00177307|21070565|P1|NOT COMPLETED|Overall Study||1
8546783|NCT00177307|21070565|P1|COMPLETED|Overall Study||39
8546784|NCT00177307|21070565|P1|STARTED|Overall Study||40
8546785|NCT00177294|21070574|P2|NOT COMPLETED|Overall Study||5
8546786|NCT00177294|21070575|P1|NOT COMPLETED|Overall Study||7
8546787|NCT00177294|21070574|P2|COMPLETED|Overall Study||59
8546788|NCT00177294|21070575|P1|COMPLETED|Overall Study||53
8546789|NCT00177294|21070574|P2|STARTED|Overall Study||64
8546790|NCT00177294|21070575|P1|STARTED|Overall Study||60
8546791|NCT00177255|21070581|P1|NOT COMPLETED|Overall Study||0
8546792|NCT00177255|21070581|P1|COMPLETED|Overall Study||39
8546793|NCT00177255|21070581|P1|STARTED|Overall Study||39
8546794|NCT00177216|21070589|P3|NOT COMPLETED|Overall Study||1
8546795|NCT00177216|21070590|P2|NOT COMPLETED|Overall Study||3
8546796|NCT00177216|21070591|P1|NOT COMPLETED|Overall Study||6
8546797|NCT00177216|21070589|P3|COMPLETED|Overall Study||19
8546798|NCT00177216|21070590|P2|COMPLETED|Overall Study||20
8546799|NCT00177216|21070591|P1|COMPLETED|Overall Study||20
8546800|NCT00177216|21070589|P3|STARTED|Overall Study||20
8546801|NCT00177216|21070590|P2|STARTED|Overall Study||23
8546802|NCT00177216|21070591|P1|STARTED|Overall Study||26
8546803|NCT00177164|21070607|P2|NOT COMPLETED|Overall Study||16
8546804|NCT00177164|21070608|P1|NOT COMPLETED|Overall Study||9
8546805|NCT00177164|21070607|P2|COMPLETED|Overall Study||9
8546806|NCT00177164|21070608|P1|COMPLETED|Overall Study||14
8546807|NCT00177164|21070607|P2|STARTED|Overall Study||25
8546808|NCT00177164|21070608|P1|STARTED|Overall Study||23
8546809|NCT00176930|21070628|P8|NOT COMPLETED|Overall Study||0
8546810|NCT00176930|21070629|P7|NOT COMPLETED|Overall Study||0
8546811|NCT00176930|21070630|P6|NOT COMPLETED|Overall Study||0
8546812|NCT00176930|21070631|P5|NOT COMPLETED|Overall Study||0
8546813|NCT00176930|21070632|P4|NOT COMPLETED|Overall Study||0
8546814|NCT00176930|21070633|P3|NOT COMPLETED|Overall Study||0
8546815|NCT00176930|21070634|P2|NOT COMPLETED|Overall Study||0
8546816|NCT00176930|21070635|P1|NOT COMPLETED|Overall Study||0
8546817|NCT00176930|21070628|P8|COMPLETED|Overall Study||2
8546818|NCT00176930|21070629|P7|COMPLETED|Overall Study||2
8546819|NCT00176930|21070630|P6|COMPLETED|Overall Study||85
8546820|NCT00176930|21070631|P5|COMPLETED|Overall Study||213
8546821|NCT00176930|21070632|P4|COMPLETED|Overall Study||1
8546822|NCT00176930|21070633|P3|COMPLETED|Overall Study||1
8546823|NCT00176930|21070634|P2|COMPLETED|Overall Study||13
8546824|NCT00176930|21070635|P1|COMPLETED|Overall Study||12
8546825|NCT00176930|21070628|P8|STARTED|Overall Study||2
8546826|NCT00176930|21070629|P7|STARTED|Overall Study||2
8546827|NCT00176930|21070630|P6|STARTED|Overall Study||85
8546828|NCT00176930|21070631|P5|STARTED|Overall Study||213
8546829|NCT00176930|21070632|P4|STARTED|Overall Study||1
8546830|NCT00176930|21070633|P3|STARTED|Overall Study||1
8546831|NCT00176930|21070634|P2|STARTED|Overall Study||13
8546832|NCT00176930|21070635|P1|STARTED|Overall Study||12
8546833|NCT00176917|21070725|P1|NOT COMPLETED|Overall Study||0
8546834|NCT00176917|21070725|P1|COMPLETED|Overall Study||41
8546835|NCT00176917|21070725|P1|STARTED|Overall Study||41
8546836|NCT00176904|21070732|P1|NOT COMPLETED|Overall Study||0
8546837|NCT00176904|21070732|P1|COMPLETED|Overall Study||135
8546838|NCT00176904|21070732|P1|STARTED|Overall Study||135
8546839|NCT00176891|21070740|P1|NOT COMPLETED|Overall Study||3
8546840|NCT00176891|21070740|P1|COMPLETED|Overall Study||22
8546841|NCT00176891|21070740|P1|STARTED|Overall Study||25
8546842|NCT00176878|21070751|P1|NOT COMPLETED|Overall Study||0
8546843|NCT00176878|21070751|P1|COMPLETED|Overall Study||10
8546844|NCT00176878|21070751|P1|STARTED|Overall Study||10
8546845|NCT00176865|21070763|P3|NOT COMPLETED|Overall Study||0
8546846|NCT00176865|21070764|P2|NOT COMPLETED|Overall Study||0
8546847|NCT00176865|21070765|P1|NOT COMPLETED|Overall Study||0
8546848|NCT00176865|21070763|P3|COMPLETED|Overall Study||6
8546849|NCT00176865|21070764|P2|COMPLETED|Overall Study||10
8546850|NCT00176865|21070765|P1|COMPLETED|Overall Study||3
8546851|NCT00176865|21070763|P3|STARTED|Overall Study||6
8546852|NCT00176865|21070764|P2|STARTED|Overall Study||10
8546853|NCT00176865|21070765|P1|STARTED|Overall Study||3
8546854|NCT00176852|21070803|P3|NOT COMPLETED|Overall Study||0
8546855|NCT00176852|21070804|P2|NOT COMPLETED|Overall Study||0
8546856|NCT00176852|21070805|P1|NOT COMPLETED|Overall Study||0
8546857|NCT00176852|21070803|P3|COMPLETED|Overall Study||14
8546858|NCT00176852|21070804|P2|COMPLETED|Overall Study||5
8546859|NCT00176852|21070805|P1|COMPLETED|Overall Study||3
8546860|NCT00176852|21070803|P3|STARTED|Overall Study||14
8546861|NCT00176852|21070804|P2|STARTED|Overall Study||5
8546862|NCT00176852|21070805|P1|STARTED|Overall Study||3
8546863|NCT00176839|21070861|P1|NOT COMPLETED|Overall Study||0
8546864|NCT00176839|21070861|P1|COMPLETED|Overall Study||11
8546865|NCT00176839|21070861|P1|STARTED|Overall Study||11
8546866|NCT00176826|21070870|P1|NOT COMPLETED|Overall Study||0
8546867|NCT00176826|21070870|P1|COMPLETED|Overall Study||22
8546868|NCT00176826|21070870|P1|STARTED|Overall Study||22
8546869|NCT00176800|21070880|P1|NOT COMPLETED|Overall Study||0
8546870|NCT00176800|21070880|P1|COMPLETED|Overall Study||69
8546871|NCT00176800|21070880|P1|STARTED|Overall Study||69
8546872|NCT00176644|21070886|P1|NOT COMPLETED|Overall Study||1
8546873|NCT00176644|21070886|P1|COMPLETED|Overall Study||22
8546874|NCT00176644|21070886|P1|STARTED|Overall Study||23
8546875|NCT00176631|21070894|P1|NOT COMPLETED|Overall Study||0
8546876|NCT00176631|21070894|P1|COMPLETED|Overall Study||10
8546877|NCT00176631|21070894|P1|STARTED|Overall Study||10
8546878|NCT00176605|21070899|P1|NOT COMPLETED|Overall Study||2
8546879|NCT00176605|21070899|P1|COMPLETED|Overall Study||13
8546880|NCT00176605|21070899|P1|STARTED|Overall Study||15
8546881|NCT00176501|21070904|P1|NOT COMPLETED|Overall Study||0
8546882|NCT00176501|21070904|P1|COMPLETED|Overall Study||3
8546883|NCT00176501|21070904|P1|STARTED|Overall Study||3
8546884|NCT00176488|21070910|P1|NOT COMPLETED|Overall Study||1
8546885|NCT00176488|21070910|P1|COMPLETED|Overall Study||30
8546886|NCT00176488|21070910|P1|STARTED|Overall Study||31
8546887|NCT00176462|21070918|P2|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
8546888|NCT00176462|21070919|P1|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
8546889|NCT00176462|21070918|P2|COMPLETED|Continuation -up to 30mos Post Remission||26
8546890|NCT00176462|21070919|P1|COMPLETED|Continuation -up to 30mos Post Remission||19
8546891|NCT00176462|21070918|P2|STARTED|Continuation -up to 30mos Post Remission||26
8546892|NCT00176462|21070919|P1|STARTED|Continuation -up to 30mos Post Remission||19
8546893|NCT00176462|21070918|P2|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
8546894|NCT00176462|21070919|P1|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
8546895|NCT00176462|21070918|P2|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
8546896|NCT00176462|21070919|P1|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
8546897|NCT00176462|21070918|P2|STARTED|Intensive Continuation (8X8-week Cycles)||29
8546898|NCT00176462|21070919|P1|STARTED|Intensive Continuation (8X8-week Cycles)||20
8546899|NCT00176462|21070918|P2|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
8546900|NCT00176462|21070919|P1|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
8546901|NCT00176462|21070918|P2|COMPLETED|Delayed Intensification (8 Weeks)||29
8546902|NCT00176462|21070919|P1|COMPLETED|Delayed Intensification (8 Weeks)||20
8546903|NCT00176462|21070918|P2|STARTED|Delayed Intensification (8 Weeks)||29
8546904|NCT00176462|21070919|P1|STARTED|Delayed Intensification (8 Weeks)||20
8546905|NCT00176462|21070918|P2|NOT COMPLETED|Consolidation (12 Weeks)||5
8546906|NCT00176462|21070919|P1|NOT COMPLETED|Consolidation (12 Weeks)||0
8546907|NCT00176462|21070918|P2|COMPLETED|Consolidation (12 Weeks)||29
8546908|NCT00176462|21070919|P1|COMPLETED|Consolidation (12 Weeks)||20
8546909|NCT00176462|21070918|P2|STARTED|Consolidation (12 Weeks)||34
8546910|NCT00176462|21070919|P1|STARTED|Consolidation (12 Weeks)||20
8546911|NCT00176462|21070918|P2|NOT COMPLETED|Induction (4 Weeks)||5
8546912|NCT00176462|21070919|P1|NOT COMPLETED|Induction (4 Weeks)||1
8546913|NCT00176462|21070918|P2|COMPLETED|Induction (4 Weeks)||34
8546914|NCT00176462|21070919|P1|COMPLETED|Induction (4 Weeks)||20
8546915|NCT00176462|21070918|P2|STARTED|Induction (4 Weeks)||39
8546916|NCT00176462|21070919|P1|STARTED|Induction (4 Weeks)||21
8546917|NCT00176436|21070928|P2|NOT COMPLETED|Overall Study||5
8546918|NCT00176436|21070929|P1|NOT COMPLETED|Overall Study||6
8546919|NCT00176436|21070928|P2|COMPLETED|Overall Study||12
8546920|NCT00176436|21070929|P1|COMPLETED|Overall Study||14
8546921|NCT00176436|21070928|P2|STARTED|Overall Study||17
8546922|NCT00176436|21070929|P1|STARTED|Overall Study||20
8546923|NCT00176423|21070937|P2|NOT COMPLETED|Overall Study||6
8546924|NCT00176423|21070938|P1|NOT COMPLETED|Overall Study||7
8546925|NCT00176423|21070937|P2|COMPLETED|Overall Study||38
8546926|NCT00176423|21070938|P1|COMPLETED|Overall Study||35
8546927|NCT00176423|21070937|P2|STARTED|Overall Study||44
8546928|NCT00176423|21070938|P1|STARTED|Overall Study||42
8546929|NCT00176306|21070950|P1|NOT COMPLETED|Overall Study||0
8546930|NCT00176306|21070950|P1|COMPLETED|Overall Study||15
8546931|NCT00176306|21070950|P1|STARTED|Overall Study||15
8546932|NCT00176254|21070954|P1|NOT COMPLETED|Overall Study||1
8546933|NCT00176254|21070954|P1|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
8546934|NCT00176254|21070954|P1|STARTED|Overall Study||40
8546935|NCT00176228|21070962|P1|NOT COMPLETED|Overall Study||2
8546936|NCT00176228|21070962|P1|COMPLETED|Overall Study|Study ended|46
8546937|NCT00176228|21070962|P1|STARTED|Overall Study|When study began|48
8546938|NCT00176202|21070969|P2|NOT COMPLETED|Overall Study||16
8546939|NCT00176202|21070970|P1|NOT COMPLETED|Overall Study||5
8546940|NCT00176202|21070969|P2|COMPLETED|Overall Study||17
8546941|NCT00176202|21070970|P1|COMPLETED|Overall Study||27
8546942|NCT00176202|21070969|P2|STARTED|Overall Study||33
8546943|NCT00176202|21070970|P1|STARTED|Overall Study||32
8546947|NCT00175877|21070991|P1|NOT COMPLETED|Overall Study||349
8546948|NCT00175877|21070991|P1|COMPLETED|Overall Study||497
8546949|NCT00175877|21070991|P1|STARTED|Overall Study||846
8546950|NCT00175825|21071026|P4|NOT COMPLETED|Overall Study||1
8546951|NCT00175825|21071027|P3|NOT COMPLETED|Overall Study||1
8546952|NCT00175825|21071028|P2|NOT COMPLETED|Overall Study||4
8546953|NCT00175825|21071029|P1|NOT COMPLETED|Overall Study||5
8546954|NCT00175825|21071026|P4|COMPLETED|Overall Study||51
8546955|NCT00175825|21071027|P3|COMPLETED|Overall Study||51
8546956|NCT00175825|21071028|P2|COMPLETED|Overall Study||46
8546957|NCT00175825|21071029|P1|COMPLETED|Overall Study||49
8546958|NCT00175825|21071026|P4|STARTED|Overall Study||52
8546959|NCT00175825|21071027|P3|STARTED|Overall Study||52
8546960|NCT00175825|21071028|P2|STARTED|Overall Study||50
8546961|NCT00175825|21071029|P1|STARTED|Overall Study||54
8546962|NCT00175019|21071082|P3|NOT COMPLETED|Overall Study||57
8546963|NCT00175019|21071083|P2|NOT COMPLETED|Overall Study||171
8546964|NCT00175019|21071084|P1|NOT COMPLETED|Overall Study||194
8546965|NCT00175019|21071082|P3|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
8546966|NCT00175019|21071083|P2|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
8546967|NCT00175019|21071084|P1|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
8546968|NCT00175019|21071082|P3|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
8546969|NCT00175019|21071083|P2|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
8546970|NCT00175019|21071084|P1|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
8546971|NCT00175006|21071128|P1|NOT COMPLETED|Overall Study||0
8546972|NCT00175006|21071128|P1|COMPLETED|Overall Study||13
8546973|NCT00175006|21071128|P1|STARTED|Overall Study||13
8546974|NCT00174967|21071137|P4|NOT COMPLETED|Overall Study||2
8546975|NCT00174967|21071138|P3|NOT COMPLETED|Overall Study||2
8546976|NCT00174967|21071139|P2|NOT COMPLETED|Overall Study||3
8546977|NCT00174967|21071140|P1|NOT COMPLETED|Overall Study||1
8546978|NCT00174967|21071137|P4|COMPLETED|Overall Study||36
8546979|NCT00174967|21071138|P3|COMPLETED|Overall Study||36
8546980|NCT00174967|21071139|P2|COMPLETED|Overall Study||37
8546981|NCT00174967|21071140|P1|COMPLETED|Overall Study||36
8546982|NCT00174967|21071137|P4|STARTED|Overall Study||38
8546983|NCT00174967|21071138|P3|STARTED|Overall Study||38
8546984|NCT00174967|21071139|P2|STARTED|Overall Study||40
8546985|NCT00174967|21071140|P1|STARTED|Overall Study||37
8546986|NCT00174954|21071186|P1|NOT COMPLETED|Overall Study||4
8546987|NCT00174954|21071186|P1|COMPLETED|Overall Study||28
8546988|NCT00174954|21071186|P1|STARTED|Overall Study||32
8546989|NCT00174941|21071194|P4|NOT COMPLETED|Overall Study||58
8546990|NCT00174941|21071195|P3|NOT COMPLETED|Overall Study||18
8546991|NCT00174941|21071196|P2|NOT COMPLETED|Overall Study||38
8546992|NCT00174941|21071197|P1|NOT COMPLETED|Overall Study||2
8546993|NCT00174941|21071194|P4|COMPLETED|Overall Study||58
8546994|NCT00174941|21071195|P3|COMPLETED|Overall Study||11
8546995|NCT00174941|21071196|P2|COMPLETED|Overall Study||41
8546996|NCT00174941|21071197|P1|COMPLETED|Overall Study||6
8546997|NCT00174941|21071194|P4|STARTED|Overall Study||116
8546998|NCT00174941|21071195|P3|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
8546999|NCT00174941|21071196|P2|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
8547000|NCT00174941|21071197|P1|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
8547001|NCT00174915|21071272|P5|NOT COMPLETED|Overall Study||33
8547002|NCT00174915|21071273|P4|NOT COMPLETED|Overall Study||57
8547003|NCT00174915|21071274|P3|NOT COMPLETED|Overall Study||48
8547004|NCT00174915|21071275|P2|NOT COMPLETED|Overall Study||69
8547005|NCT00174915|21071276|P1|NOT COMPLETED|Overall Study||93
8547006|NCT00174915|21071272|P5|COMPLETED|Overall Study||101
8547007|NCT00174915|21071273|P4|COMPLETED|Overall Study||211
8547008|NCT00174915|21071274|P3|COMPLETED|Overall Study||86
8547009|NCT00174915|21071275|P2|COMPLETED|Overall Study||200
8547010|NCT00174915|21071276|P1|COMPLETED|Overall Study||174
8547011|NCT00174915|21071272|P5|STARTED|Overall Study||134
8547012|NCT00174915|21071273|P4|STARTED|Overall Study||268
8547013|NCT00174915|21071274|P3|STARTED|Overall Study||134
8547014|NCT00174915|21071275|P2|STARTED|Overall Study||269
8547015|NCT00174915|21071276|P1|STARTED|Overall Study||267
8547016|NCT00174785|21071335|P2|NOT COMPLETED|Overall Study||716
8547017|NCT00174785|21071336|P1|NOT COMPLETED|Overall Study||696
8547018|NCT00174785|21071335|P2|COMPLETED|Overall Study|completed study drug|1611
8547019|NCT00174785|21071336|P1|COMPLETED|Overall Study|completed study drug|1605
8547020|NCT00174785|21071335|P2|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
8547021|NCT00174785|21071336|P1|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
8547022|NCT00174460|21071352|P2|NOT COMPLETED|Overall Study||1
8547023|NCT00174460|21071353|P1|NOT COMPLETED|Overall Study||0
8547024|NCT00174460|21071352|P2|COMPLETED|Overall Study||14
8547025|NCT00174460|21071353|P1|COMPLETED|Overall Study||18
8547026|NCT00174460|21071352|P2|Received Study Treatment|Overall Study||14
8547027|NCT00174460|21071353|P1|Received Study Treatment|Overall Study||18
8547028|NCT00174460|21071352|P2|STARTED|Overall Study||15
8547029|NCT00174460|21071353|P1|STARTED|Overall Study||18
8547033|NCT00174382|21071408|P1|NOT COMPLETED|Overall Study||33
8547034|NCT00174382|21071408|P1|COMPLETED|Overall Study||116
8547035|NCT00174382|21071408|P1|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
8547036|NCT00174291|21071427|P2|NOT COMPLETED|Overall Study||6
8547037|NCT00174291|21071428|P1|NOT COMPLETED|Overall Study||5
8547038|NCT00174291|21071427|P2|COMPLETED|Overall Study||4
8547039|NCT00174291|21071428|P1|COMPLETED|Overall Study||6
8547040|NCT00174291|21071427|P2|STARTED|Overall Study||10
8547041|NCT00174291|21071428|P1|STARTED|Overall Study||11
8547042|NCT00174265|21071458|P2|NOT COMPLETED|Overall Study||21
8547043|NCT00174265|21071459|P1|NOT COMPLETED|Overall Study||29
8547044|NCT00174265|21071458|P2|COMPLETED|Overall Study||89
8547045|NCT00174265|21071459|P1|COMPLETED|Overall Study||57
8547046|NCT00174265|21071458|P2|STARTED|Overall Study||110
8547047|NCT00174265|21071459|P1|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
8547048|NCT00174252|21071467|P1|NOT COMPLETED|Overall Study||2
8547049|NCT00174252|21071467|P1|COMPLETED|Overall Study||55
8547050|NCT00174252|21071467|P1|STARTED|Overall Study||57
8547051|NCT00174187|21071502|P3|NOT COMPLETED|Period 2 (After 3 Years)||8
8547052|NCT00174187|21071503|P2|NOT COMPLETED|Period 2 (After 3 Years)||0
8547053|NCT00174187|21071504|P1|NOT COMPLETED|Period 2 (After 3 Years)||0
8547054|NCT00174187|21071502|P3|COMPLETED|Period 2 (After 3 Years)||13
8547055|NCT00174187|21071503|P2|COMPLETED|Period 2 (After 3 Years)||0
8547056|NCT00174187|21071504|P1|COMPLETED|Period 2 (After 3 Years)||0
8547057|NCT00174187|21071502|P3|STARTED|Period 2 (After 3 Years)||21
8547058|NCT00174187|21071503|P2|STARTED|Period 2 (After 3 Years)||0
8547059|NCT00174187|21071504|P1|STARTED|Period 2 (After 3 Years)||0
8547060|NCT00174187|21071502|P3|NOT COMPLETED|Between Period 1 and Period 2||5
8547061|NCT00174187|21071503|P2|NOT COMPLETED|Between Period 1 and Period 2||0
8547062|NCT00174187|21071504|P1|NOT COMPLETED|Between Period 1 and Period 2||0
8547063|NCT00174187|21071502|P3|COMPLETED|Between Period 1 and Period 2||21
8547064|NCT00174187|21071503|P2|COMPLETED|Between Period 1 and Period 2||0
8547065|NCT00174187|21071504|P1|COMPLETED|Between Period 1 and Period 2||0
8547066|NCT00174187|21071502|P3|Consented|Between Period 1 and Period 2||24
8547067|NCT00174187|21071503|P2|Consented|Between Period 1 and Period 2||0
8547068|NCT00174187|21071504|P1|Consented|Between Period 1 and Period 2||0
8547069|NCT00174187|21071502|P3|STARTED|Between Period 1 and Period 2||26
8547070|NCT00174187|21071503|P2|STARTED|Between Period 1 and Period 2||0
8547071|NCT00174187|21071504|P1|STARTED|Between Period 1 and Period 2||0
8547072|NCT00174187|21071502|P3|NOT COMPLETED|Period 1 (up to 3 Years)||0
8547073|NCT00174187|21071503|P2|NOT COMPLETED|Period 1 (up to 3 Years)||4
8547074|NCT00174187|21071504|P1|NOT COMPLETED|Period 1 (up to 3 Years)||0
8547075|NCT00174187|21071502|P3|COMPLETED|Period 1 (up to 3 Years)||0
8547076|NCT00174187|21071503|P2|COMPLETED|Period 1 (up to 3 Years)||11
8547077|NCT00174187|21071504|P1|COMPLETED|Period 1 (up to 3 Years)||15
8547078|NCT00174187|21071502|P3|STARTED|Period 1 (up to 3 Years)||0
8547079|NCT00174187|21071503|P2|STARTED|Period 1 (up to 3 Years)||15
8547080|NCT00174187|21071504|P1|STARTED|Period 1 (up to 3 Years)||15
8547093|NCT00172042|21071588|P2|NOT COMPLETED|Overall Study||125
8547094|NCT00172042|21071589|P1|NOT COMPLETED|Overall Study||158
8547095|NCT00172042|21071588|P2|COMPLETED|Overall Study||86
8547096|NCT00172042|21071589|P1|COMPLETED|Overall Study||68
8547097|NCT00172042|21071588|P2|STARTED|Overall Study||211
8547098|NCT00172042|21071589|P1|STARTED|Overall Study||226
8547099|NCT00171925|21071611|P2|NOT COMPLETED|Overall Study||31
8547100|NCT00171925|21071612|P1|NOT COMPLETED|Overall Study||30
8547101|NCT00171925|21071611|P2|COMPLETED|Overall Study||40
8547102|NCT00171925|21071612|P1|COMPLETED|Overall Study||42
8547103|NCT00171925|21071611|P2|STARTED|Overall Study||71
8547104|NCT00171925|21071612|P1|STARTED|Overall Study||72
8547105|NCT00171873|21071624|P2|NOT COMPLETED|Overall Study||3
8547106|NCT00171873|21071625|P1|NOT COMPLETED|Overall Study||9
8547107|NCT00171873|21071624|P2|COMPLETED|Overall Study||40
8547108|NCT00171873|21071625|P1|COMPLETED|Overall Study||33
8547109|NCT00171873|21071624|P2|STARTED|Overall Study||43
8547110|NCT00171873|21071625|P1|STARTED|Overall Study||42
8547111|NCT00171834|21071638|P7|NOT COMPLETED|Overall Study||4
8547112|NCT00171834|21071639|P6|NOT COMPLETED|Overall Study||35
8547113|NCT00171834|21071640|P5|NOT COMPLETED|Overall Study||8
8547114|NCT00171834|21071641|P4|NOT COMPLETED|Overall Study||12
8547115|NCT00171834|21071642|P3|NOT COMPLETED|Overall Study||12
8547116|NCT00171834|21071643|P2|NOT COMPLETED|Overall Study||12
8547117|NCT00171834|21071644|P1|NOT COMPLETED|Overall Study||6
8547118|NCT00171834|21071638|P7|COMPLETED|Overall Study||0
8547119|NCT00171834|21071639|P6|COMPLETED|Overall Study||0
8547120|NCT00171834|21071640|P5|COMPLETED|Overall Study||0
8547121|NCT00171834|21071641|P4|COMPLETED|Overall Study||0
8547122|NCT00171834|21071642|P3|COMPLETED|Overall Study||0
8547123|NCT00171834|21071643|P2|COMPLETED|Overall Study||0
8547124|NCT00171834|21071644|P1|COMPLETED|Overall Study||0
8547125|NCT00171834|21071638|P7|Completed 6 Cycles of Treatment|Overall Study||0
8547126|NCT00171834|21071639|P6|Completed 6 Cycles of Treatment|Overall Study||1
8547127|NCT00171834|21071640|P5|Completed 6 Cycles of Treatment|Overall Study||2
8547128|NCT00171834|21071641|P4|Completed 6 Cycles of Treatment|Overall Study||0
8547129|NCT00171834|21071642|P3|Completed 6 Cycles of Treatment|Overall Study||1
8547130|NCT00171834|21071643|P2|Completed 6 Cycles of Treatment|Overall Study||0
8547131|NCT00171834|21071644|P1|Completed 6 Cycles of Treatment|Overall Study||0
8547132|NCT00171834|21071638|P7|STARTED|Overall Study||4
8547133|NCT00171834|21071639|P6|STARTED|Overall Study||35
8547134|NCT00171834|21071640|P5|STARTED|Overall Study||8
8547135|NCT00171834|21071641|P4|STARTED|Overall Study||12
8547136|NCT00171834|21071642|P3|STARTED|Overall Study||12
8547137|NCT00171834|21071643|P2|STARTED|Overall Study||12
8547138|NCT00171834|21071644|P1|STARTED|Overall Study||6
8547139|NCT00171704|21071684|P2|NOT COMPLETED|Overall Study||49
8547140|NCT00171704|21071685|P1|NOT COMPLETED|Overall Study||44
8547141|NCT00171704|21071684|P2|COMPLETED|Overall Study||81
8547142|NCT00171704|21071685|P1|COMPLETED|Overall Study||89
8547143|NCT00171704|21071684|P2|STARTED|Overall Study||130
8547144|NCT00171704|21071685|P1|STARTED|Overall Study||133
8547145|NCT00171340|21071707|P2|NOT COMPLETED|Overall Study||135
8547146|NCT00171340|21071708|P1|NOT COMPLETED|Overall Study||124
8547147|NCT00171340|21071707|P2|COMPLETED|Overall Study||398
8547148|NCT00171340|21071708|P1|COMPLETED|Overall Study||408
8547149|NCT00171340|21071707|P2|STARTED|Overall Study||533
8547150|NCT00171340|21071708|P1|STARTED|Overall Study||532
8547151|NCT00171314|21071724|P2|NOT COMPLETED|Overall Study||78
8547152|NCT00171314|21071725|P1|NOT COMPLETED|Overall Study||91
8547153|NCT00171314|21071724|P2|COMPLETED|Overall Study||186
8547154|NCT00171314|21071725|P1|COMPLETED|Overall Study||172
8547155|NCT00171314|21071724|P2|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
8547156|NCT00171314|21071725|P1|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
8547157|NCT00171314|21071724|P2|STARTED|Overall Study||264
8547158|NCT00171314|21071725|P1|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
8547159|NCT00171301|21071741|P2|NOT COMPLETED|Overall Study||9
8547160|NCT00171301|21071742|P1|NOT COMPLETED|Overall Study||8
8547161|NCT00171301|21071741|P2|COMPLETED|Overall Study||62
8547162|NCT00171301|21071742|P1|COMPLETED|Overall Study||154
8547163|NCT00171301|21071741|P2|Received Deferasirox|Overall Study||69
8547164|NCT00171301|21071742|P1|Received Deferasirox|Overall Study||162
8547165|NCT00171301|21071741|P2|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
8547166|NCT00171301|21071742|P1|STARTED|Overall Study||162
8547167|NCT00171210|21071755|P2|NOT COMPLETED|Overall Study||115
8547168|NCT00171210|21071756|P1|NOT COMPLETED|Overall Study||69
8547169|NCT00171210|21071755|P2|COMPLETED|Overall Study||181
8547170|NCT00171210|21071756|P1|COMPLETED|Overall Study||190
8547171|NCT00171210|21071755|P2|STARTED EXTENSION STUDY|Overall Study||247
8547172|NCT00171210|21071756|P1|STARTED EXTENSION STUDY|Overall Study||259
8547173|NCT00171210|21071755|P2|STARTED|Overall Study||296
8547174|NCT00171210|21071756|P1|STARTED|Overall Study||259
8547175|NCT00171054|21071786|P2|NOT COMPLETED|Overall Study||12
8547176|NCT00171054|21071787|P1|NOT COMPLETED|Overall Study||10
8547177|NCT00171054|21071786|P2|COMPLETED|Overall Study||50
8547178|NCT00171054|21071787|P1|COMPLETED|Overall Study||53
8547179|NCT00171054|21071786|P2|STARTED|Overall Study||62
8547180|NCT00171054|21071787|P1|STARTED|Overall Study||63
8547181|NCT00170950|21071819|P2|NOT COMPLETED|Overall Study||910
8547182|NCT00170950|21071820|P1|NOT COMPLETED|Overall Study||885
8547183|NCT00170950|21071819|P2|COMPLETED|Overall Study||4852
8547184|NCT00170950|21071820|P1|COMPLETED|Overall Study||4859
8547185|NCT00170950|21071819|P2|STARTED|Overall Study||5762
8547186|NCT00170950|21071820|P1|STARTED|Overall Study||5744
8547187|NCT00170846|21071833|P3|NOT COMPLETED|Overall Study||13
8547188|NCT00170846|21071834|P2|NOT COMPLETED|Overall Study||19
8547189|NCT00170846|21071835|P1|NOT COMPLETED|Overall Study||11
8547190|NCT00170846|21071833|P3|COMPLETED|Overall Study||131
8547191|NCT00170846|21071834|P2|COMPLETED|Overall Study||108
8547192|NCT00170846|21071835|P1|COMPLETED|Overall Study||112
8547193|NCT00170846|21071833|P3|STARTED|Overall Study||144
8547194|NCT00170846|21071834|P2|STARTED|Overall Study||127
8547195|NCT00170846|21071835|P1|STARTED|Overall Study||123
8547196|NCT00170625|21071849|P1|NOT COMPLETED|Overall Study||0
8547197|NCT00170625|21071849|P1|COMPLETED|Overall Study||26
8547198|NCT00170625|21071849|P1|STARTED|Overall Study||26
8547199|NCT00170157|21071854|P2|NOT COMPLETED|Treatment Period 2 Crossover||0
8547200|NCT00170157|21071855|P1|NOT COMPLETED|Treatment Period 2 Crossover||0
8547201|NCT00170157|21071854|P2|COMPLETED|Treatment Period 2 Crossover||41
8547202|NCT00170157|21071855|P1|COMPLETED|Treatment Period 2 Crossover||0
8547203|NCT00170157|21071854|P2|STARTED|Treatment Period 2 Crossover||41
8547204|NCT00170157|21071855|P1|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
8547205|NCT00170157|21071854|P2|NOT COMPLETED|Washout Period of 14 Days||17
8547206|NCT00170157|21071855|P1|NOT COMPLETED|Washout Period of 14 Days||0
8547207|NCT00170157|21071854|P2|COMPLETED|Washout Period of 14 Days||41
8547208|NCT00170157|21071855|P1|COMPLETED|Washout Period of 14 Days||0
8547209|NCT00170157|21071854|P2|STARTED|Washout Period of 14 Days||58
8547210|NCT00170157|21071855|P1|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
8547211|NCT00170157|21071854|P2|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
8547212|NCT00170157|21071855|P1|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
8547213|NCT00170157|21071854|P2|COMPLETED|Treatment Period 1 Initial Randomization||58
8547214|NCT00170157|21071855|P1|COMPLETED|Treatment Period 1 Initial Randomization||54
8547215|NCT00170157|21071854|P2|STARTED|Treatment Period 1 Initial Randomization||58
8547216|NCT00170157|21071855|P1|STARTED|Treatment Period 1 Initial Randomization||54
8547217|NCT00169442|21071867|P6|NOT COMPLETED|Overall Study||2
8547218|NCT00169442|21071868|P5|NOT COMPLETED|Overall Study||1
8547219|NCT00169442|21071869|P4|NOT COMPLETED|Overall Study||0
8547220|NCT00169442|21071870|P3|NOT COMPLETED|Overall Study||1
8547221|NCT00169442|21071871|P2|NOT COMPLETED|Overall Study||1
8547222|NCT00169442|21071872|P1|NOT COMPLETED|Overall Study||0
8547223|NCT00169442|21071867|P6|COMPLETED|Overall Study||41
8547224|NCT00169442|21071868|P5|COMPLETED|Overall Study||41
8547225|NCT00169442|21071869|P4|COMPLETED|Overall Study||250
8547226|NCT00169442|21071870|P3|COMPLETED|Overall Study||166
8547227|NCT00169442|21071871|P2|COMPLETED|Overall Study||123
8547228|NCT00169442|21071872|P1|COMPLETED|Overall Study||119
8547229|NCT00169442|21071867|P6|STARTED|Overall Study||43
8547230|NCT00169442|21071868|P5|STARTED|Overall Study||42
8547231|NCT00169442|21071869|P4|STARTED|Overall Study||250
8547232|NCT00169442|21071870|P3|STARTED|Overall Study||167
8547233|NCT00169442|21071871|P2|STARTED|Overall Study||124
8547234|NCT00169442|21071872|P1|STARTED|Overall Study||119
8547235|NCT00169104|21071981|P2|NOT COMPLETED|Overall Study||2
8547236|NCT00169104|21071982|P1|NOT COMPLETED|Overall Study||2
8547237|NCT00169104|21071981|P2|COMPLETED|Overall Study||8
8547238|NCT00169104|21071982|P1|COMPLETED|Overall Study||11
8547239|NCT00169104|21071981|P2|STARTED|Overall Study||10
8547240|NCT00169104|21071982|P1|STARTED|Overall Study||13
8547241|NCT00168844|21071996|P3|NOT COMPLETED|Overall Study||91
8547242|NCT00168844|21071997|P2|NOT COMPLETED|Overall Study||55
8547243|NCT00168844|21071998|P1|NOT COMPLETED|Overall Study||55
8547244|NCT00168844|21071996|P3|COMPLETED|Overall Study||228
8547245|NCT00168844|21071997|P2|COMPLETED|Overall Study||277
8547246|NCT00168844|21071998|P1|COMPLETED|Overall Study||277
8547247|NCT00168844|21071996|P3|STARTED|Overall Study||319
8547248|NCT00168844|21071997|P2|STARTED|Overall Study||332
8547249|NCT00168844|21071998|P1|STARTED|Overall Study||332
8547250|NCT00168831|21072180|P3|NOT COMPLETED|Overall Study||114
8547251|NCT00168831|21072181|P2|NOT COMPLETED|Overall Study||81
8547252|NCT00168831|21072182|P1|NOT COMPLETED|Overall Study||60
8547253|NCT00168831|21072180|P3|COMPLETED|Overall Study||220
8547254|NCT00168831|21072181|P2|COMPLETED|Overall Study||254
8547255|NCT00168831|21072182|P1|COMPLETED|Overall Study||278
8547256|NCT00168831|21072180|P3|STARTED|Overall Study||334
8547257|NCT00168831|21072181|P2|STARTED|Overall Study||335
8547258|NCT00168831|21072182|P1|STARTED|Overall Study||338
8547259|NCT00168818|21072364|P3|NOT COMPLETED|Treatment||133
8547260|NCT00168818|21072365|P2|NOT COMPLETED|Treatment||151
8547261|NCT00168818|21072366|P1|NOT COMPLETED|Treatment||133
8547262|NCT00168818|21072364|P3|COMPLETED|Treatment||1021
8547263|NCT00168818|21072365|P2|COMPLETED|Treatment||1012
8547264|NCT00168818|21072366|P1|COMPLETED|Treatment||1013
8547265|NCT00168818|21072364|P3|STARTED|Treatment||1154
8547266|NCT00168818|21072365|P2|STARTED|Treatment||1163
8547267|NCT00168818|21072366|P1|STARTED|Treatment||1146
8547268|NCT00168818|21072364|P3|NOT COMPLETED|Overall Study||124
8547269|NCT00168818|21072365|P2|NOT COMPLETED|Overall Study||109
8547270|NCT00168818|21072366|P1|NOT COMPLETED|Overall Study||117
8547271|NCT00168818|21072364|P3|COMPLETED|Overall Study||1030
8547272|NCT00168818|21072365|P2|COMPLETED|Overall Study||1054
8547273|NCT00168818|21072366|P1|COMPLETED|Overall Study||1029
8547274|NCT00168818|21072364|P3|STARTED|Overall Study||1154
8547275|NCT00168818|21072365|P2|STARTED|Overall Study||1163
8547276|NCT00168818|21072366|P1|STARTED|Overall Study||1146
8547277|NCT00168805|21072410|P3|NOT COMPLETED|Treatment||62
8547278|NCT00168805|21072411|P2|NOT COMPLETED|Treatment||56
8547279|NCT00168805|21072412|P1|NOT COMPLETED|Treatment||49
8547280|NCT00168805|21072410|P3|COMPLETED|Treatment||632
8547281|NCT00168805|21072411|P2|COMPLETED|Treatment||647
8547282|NCT00168805|21072412|P1|COMPLETED|Treatment||630
8547283|NCT00168805|21072410|P3|STARTED|Treatment||694
8547284|NCT00168805|21072411|P2|STARTED|Treatment||703
8547285|NCT00168805|21072412|P1|STARTED|Treatment||679
8547286|NCT00168805|21072410|P3|NOT COMPLETED|Overall Study||78
8547287|NCT00168805|21072411|P2|NOT COMPLETED|Overall Study||78
8547288|NCT00168805|21072412|P1|NOT COMPLETED|Overall Study||71
8547289|NCT00168805|21072410|P3|COMPLETED|Overall Study||616
8547290|NCT00168805|21072411|P2|COMPLETED|Overall Study||625
8547291|NCT00168805|21072412|P1|COMPLETED|Overall Study||608
8547292|NCT00168805|21072410|P3|STARTED|Overall Study||694
8547293|NCT00168805|21072411|P2|STARTED|Overall Study||703
8547294|NCT00168805|21072412|P1|STARTED|Overall Study||679
8547295|NCT00168454|21072459|P6|NOT COMPLETED|Overall Study||6
8547296|NCT00168454|21072460|P5|NOT COMPLETED|Overall Study||6
8547297|NCT00168454|21072461|P4|NOT COMPLETED|Overall Study||9
8547298|NCT00168454|21072462|P3|NOT COMPLETED|Overall Study||6
8547299|NCT00168454|21072463|P2|NOT COMPLETED|Overall Study||7
8547300|NCT00168454|21072464|P1|NOT COMPLETED|Overall Study||7
8547301|NCT00168454|21072459|P6|COMPLETED|Overall Study||50
8547302|NCT00168454|21072460|P5|COMPLETED|Overall Study||47
8547303|NCT00168454|21072461|P4|COMPLETED|Overall Study||40
8547304|NCT00168454|21072462|P3|COMPLETED|Overall Study||48
8547305|NCT00168454|21072463|P2|COMPLETED|Overall Study||50
8547306|NCT00168454|21072464|P1|COMPLETED|Overall Study||37
8547307|NCT00168454|21072459|P6|STARTED|Overall Study||56
8547308|NCT00168454|21072460|P5|STARTED|Overall Study||53
8547309|NCT00168454|21072461|P4|STARTED|Overall Study||49
8547310|NCT00168454|21072462|P3|STARTED|Overall Study||54
8547311|NCT00168454|21072463|P2|STARTED|Overall Study||57
8547312|NCT00168454|21072464|P1|STARTED|Overall Study||44
8547313|NCT00168428|21072510|P2|NOT COMPLETED|Open-Label Phase (OL)||68
8547314|NCT00168428|21072511|P1|NOT COMPLETED|Open-Label Phase (OL)||44
8547315|NCT00168428|21072510|P2|COMPLETED|Open-Label Phase (OL)||261
8547316|NCT00168428|21072511|P1|COMPLETED|Open-Label Phase (OL)||261
8547317|NCT00168428|21072510|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
8547318|NCT00168428|21072511|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
8547319|NCT00168428|21072510|P2|NOT COMPLETED|Double-Blind Phase (DB)||24
8547320|NCT00168428|21072511|P1|NOT COMPLETED|Double-Blind Phase (DB)||36
8547321|NCT00168428|21072510|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
8547322|NCT00168428|21072511|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
8547323|NCT00168428|21072510|P2|STARTED|Double-Blind Phase (DB)||358
8547324|NCT00168428|21072511|P1|STARTED|Double-Blind Phase (DB)||347
8547325|NCT00168389|21072530|P3|NOT COMPLETED|Overall Study||95
8547326|NCT00168389|21072531|P2|NOT COMPLETED|Overall Study||48
8547327|NCT00168389|21072532|P1|NOT COMPLETED|Overall Study||56
8547328|NCT00168389|21072530|P3|COMPLETED|Overall Study||70
8547329|NCT00168389|21072531|P2|COMPLETED|Overall Study||118
8547330|NCT00168389|21072532|P1|COMPLETED|Overall Study||107
8547331|NCT00168389|21072530|P3|STARTED|Overall Study||165
8547332|NCT00168389|21072531|P2|STARTED|Overall Study||166
8547333|NCT00168389|21072532|P1|STARTED|Overall Study||163
8547334|NCT00168337|21072561|P3|NOT COMPLETED|Overall Study||103
8547335|NCT00168337|21072562|P2|NOT COMPLETED|Overall Study||69
8547336|NCT00168337|21072563|P1|NOT COMPLETED|Overall Study||70
8547337|NCT00168337|21072561|P3|COMPLETED|Overall Study||82
8547338|NCT00168337|21072562|P2|COMPLETED|Overall Study||112
8547339|NCT00168337|21072563|P1|COMPLETED|Overall Study||118
8547340|NCT00168337|21072561|P3|STARTED|Overall Study||185
8547341|NCT00168337|21072562|P2|STARTED|Overall Study||181
8547342|NCT00168337|21072563|P1|STARTED|Overall Study||188
8547343|NCT00168324|21072592|P3|NOT COMPLETED|Open-Label Period||6
8547344|NCT00168324|21072593|P2|NOT COMPLETED|Open-Label Period||8
8547345|NCT00168324|21072594|P1|NOT COMPLETED|Open-Label Period||4
8547346|NCT00168324|21072592|P3|COMPLETED|Open-Label Period||152
8547347|NCT00168324|21072593|P2|COMPLETED|Open-Label Period||147
8547348|NCT00168324|21072594|P1|COMPLETED|Open-Label Period||160
8547349|NCT00168324|21072592|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
8547350|NCT00168324|21072593|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
8547351|NCT00168324|21072594|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
8547352|NCT00168324|21072592|P3|NOT COMPLETED|Double-Blind Period||13
8547353|NCT00168324|21072593|P2|NOT COMPLETED|Double-Blind Period||7
8547354|NCT00168324|21072594|P1|NOT COMPLETED|Double-Blind Period||12
8547355|NCT00168324|21072592|P3|COMPLETED|Double-Blind Period||189
8547356|NCT00168324|21072593|P2|COMPLETED|Double-Blind Period||189
8547357|NCT00168324|21072594|P1|COMPLETED|Double-Blind Period||189
8547358|NCT00168324|21072592|P3|STARTED|Double-Blind Period||202
8547359|NCT00168324|21072593|P2|STARTED|Double-Blind Period||196
8547360|NCT00168324|21072594|P1|STARTED|Double-Blind Period||201
8547361|NCT00168311|21072616|P2|NOT COMPLETED|Overall Study||2
8547362|NCT00168311|21072617|P1|NOT COMPLETED|Overall Study||0
8547363|NCT00168311|21072616|P2|COMPLETED|Overall Study||8
8547364|NCT00168311|21072617|P1|COMPLETED|Overall Study||12
8547365|NCT00168311|21072616|P2|STARTED|Overall Study||10
8547366|NCT00168311|21072617|P1|STARTED|Overall Study||12
8547367|NCT00168298|21072626|P3|NOT COMPLETED|Open-Label Period||8
8547368|NCT00168298|21072627|P2|NOT COMPLETED|Open-Label Period||5
8547369|NCT00168298|21072628|P1|NOT COMPLETED|Open-Label Period||7
8547370|NCT00168298|21072626|P3|COMPLETED|Open-Label Period||160
8547371|NCT00168298|21072627|P2|COMPLETED|Open-Label Period||168
8547372|NCT00168298|21072628|P1|COMPLETED|Open-Label Period||172
8547373|NCT00168298|21072626|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
8547374|NCT00168298|21072627|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
8547375|NCT00168298|21072628|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
8547376|NCT00168298|21072626|P3|NOT COMPLETED|Double-Blind Period||15
8547377|NCT00168298|21072627|P2|NOT COMPLETED|Double-Blind Period||12
8547378|NCT00168298|21072628|P1|NOT COMPLETED|Double-Blind Period||12
8547379|NCT00168298|21072626|P3|COMPLETED|Double-Blind Period||209
8547380|NCT00168298|21072627|P2|COMPLETED|Double-Blind Period||206
8547381|NCT00168298|21072628|P1|COMPLETED|Double-Blind Period||214
8547382|NCT00168298|21072626|P3|STARTED|Double-Blind Period||224
8547383|NCT00168298|21072627|P2|STARTED|Double-Blind Period||218
8547384|NCT00168298|21072628|P1|STARTED|Double-Blind Period||226
8547385|NCT00168103|21072648|P4|NOT COMPLETED|Overall Study||0
8547386|NCT00168103|21072649|P3|NOT COMPLETED|Overall Study||1
8547387|NCT00168103|21072650|P2|NOT COMPLETED|Overall Study||5
8547388|NCT00168103|21072651|P1|NOT COMPLETED|Overall Study||2
8547389|NCT00168103|21072648|P4|COMPLETED|Overall Study||1
8547390|NCT00168103|21072649|P3|COMPLETED|Overall Study||41
8547391|NCT00168103|21072650|P2|COMPLETED|Overall Study||38
8547392|NCT00168103|21072651|P1|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
8547393|NCT00168103|21072648|P4|STARTED|Overall Study||1
8547394|NCT00168103|21072649|P3|STARTED|Overall Study||42
8547395|NCT00168103|21072650|P2|STARTED|Overall Study||43
8547396|NCT00168103|21072651|P1|STARTED|Overall Study||40
8547397|NCT00168064|21072673|P2|NOT COMPLETED|Overall Study||44
8547398|NCT00168064|21072674|P1|NOT COMPLETED|Overall Study||49
8547399|NCT00168064|21072673|P2|COMPLETED|Overall Study||86
8547400|NCT00168064|21072674|P1|COMPLETED|Overall Study||81
8547401|NCT00168064|21072673|P2|STARTED|Overall Study|127 participants received AP formulation|130
8547402|NCT00168064|21072674|P1|STARTED|Overall Study|128 participants received PG formulation|130
8547403|NCT00168038|21072682|P1|NOT COMPLETED|Overall Study||2
8547404|NCT00168038|21072682|P1|COMPLETED|Overall Study||55
8547405|NCT00168038|21072682|P1|STARTED|Overall Study||57
8547406|NCT00167934|21072696|P2|NOT COMPLETED|Overall Study||0
8547407|NCT00167934|21072697|P1|NOT COMPLETED|Overall Study||0
8547408|NCT00167934|21072696|P2|COMPLETED|Overall Study||82
8547409|NCT00167934|21072697|P1|COMPLETED|Overall Study||82
8547410|NCT00167934|21072696|P2|STARTED|Overall Study||82
8547411|NCT00167934|21072697|P1|STARTED|Overall Study||82
8547412|NCT00167778|21072705|P1|NOT COMPLETED|Overall Study||1
8547413|NCT00167778|21072705|P1|COMPLETED|Overall Study||10
8547414|NCT00167778|21072705|P1|STARTED|Overall Study||11
8547415|NCT00167661|21072754|P1|NOT COMPLETED|Overall Study||0
8547416|NCT00167661|21072754|P1|COMPLETED|Overall Study||33
8547417|NCT00167661|21072754|P1|STARTED|Overall Study||33
8547418|NCT00167544|21072769|P2|NOT COMPLETED|Overall Study||0
8547419|NCT00167544|21072770|P1|NOT COMPLETED|Overall Study||1
8547420|NCT00167544|21072769|P2|COMPLETED|Overall Study||33
8547421|NCT00167544|21072770|P1|COMPLETED|Overall Study||30
8547422|NCT00167544|21072769|P2|STARTED|Overall Study||33
8547423|NCT00167544|21072770|P1|STARTED|Overall Study||31
8547424|NCT00167414|21072784|P1|NOT COMPLETED|Overall Study||10
8547425|NCT00167414|21072784|P1|COMPLETED|Overall Study||39
8547426|NCT00167414|21072784|P1|STARTED|Overall Study||49
8547427|NCT00167388|21072796|P4|NOT COMPLETED|Overall Study||0
8547428|NCT00167388|21072797|P3|NOT COMPLETED|Overall Study||0
8547429|NCT00167388|21072798|P2|NOT COMPLETED|Overall Study||0
8547430|NCT00167388|21072799|P1|NOT COMPLETED|Overall Study||0
8547431|NCT00167388|21072796|P4|COMPLETED|Overall Study||6
8547432|NCT00167388|21072797|P3|COMPLETED|Overall Study||6
8547433|NCT00167388|21072798|P2|COMPLETED|Overall Study||5
8547434|NCT00167388|21072799|P1|COMPLETED|Overall Study||5
8547435|NCT00167388|21072796|P4|Completed Doppler Study|Overall Study||6
8547436|NCT00167388|21072797|P3|Completed Doppler Study|Overall Study||6
8547437|NCT00167388|21072798|P2|Completed Doppler Study|Overall Study||5
8547438|NCT00167388|21072799|P1|Completed Doppler Study|Overall Study||5
8547439|NCT00167388|21072796|P4|STARTED|Overall Study||6
8547440|NCT00167388|21072797|P3|STARTED|Overall Study||6
8547441|NCT00167388|21072798|P2|STARTED|Overall Study||5
8547442|NCT00167388|21072799|P1|STARTED|Overall Study||5
8547443|NCT00167310|21072809|P2|NOT COMPLETED|Overall Study||10
8547444|NCT00167310|21072810|P1|NOT COMPLETED|Overall Study||8
8547445|NCT00167310|21072809|P2|COMPLETED|Overall Study||18
8547446|NCT00167310|21072810|P1|COMPLETED|Overall Study||21
8547447|NCT00167310|21072809|P2|STARTED|Overall Study||28
8547448|NCT00167310|21072810|P1|STARTED|Overall Study||29
8547449|NCT00167245|21072820|P2|NOT COMPLETED|Overall Study||41
8547450|NCT00167245|21072821|P1|NOT COMPLETED|Overall Study||29
8547451|NCT00167245|21072820|P2|COMPLETED|Overall Study||46
8547452|NCT00167245|21072821|P1|COMPLETED|Overall Study||54
8547453|NCT00167245|21072820|P2|STARTED|Overall Study||87
8547454|NCT00167245|21072821|P1|STARTED|Overall Study||83
8547455|NCT00167206|21072833|P1|NOT COMPLETED|Overall Study||0
8547456|NCT00167206|21072833|P1|COMPLETED|Overall Study||16
8547457|NCT00167206|21072833|P1|STARTED|Overall Study||16
8547458|NCT00167180|21072847|P2|NOT COMPLETED|Overall Study||0
8547459|NCT00167180|21072848|P1|NOT COMPLETED|Overall Study||0
8547460|NCT00167180|21072847|P2|COMPLETED|Overall Study||57
8547461|NCT00167180|21072848|P1|COMPLETED|Overall Study||0
8547462|NCT00167180|21072847|P2|STARTED|Overall Study||57
8547463|NCT00167180|21072848|P1|STARTED|Overall Study||0
8547464|NCT00167102|21072864|P2|NOT COMPLETED|Overall Study||0
8547465|NCT00167102|21072865|P1|NOT COMPLETED|Overall Study||0
8547466|NCT00167102|21072864|P2|COMPLETED|Overall Study||22
8547467|NCT00167102|21072865|P1|COMPLETED|Overall Study||23
8547468|NCT00167102|21072864|P2|STARTED|Overall Study||22
8547469|NCT00167102|21072865|P1|STARTED|Overall Study||23
8547470|NCT00166712|21072875|P2|NOT COMPLETED|Overall Study||5
8547471|NCT00166712|21072876|P1|NOT COMPLETED|Overall Study||2
8547472|NCT00166712|21072875|P2|COMPLETED|Overall Study|Completed study participation.|11
8547473|NCT00166712|21072876|P1|COMPLETED|Overall Study|Completed study participation.|22
8547474|NCT00166712|21072875|P2|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
8547475|NCT00166712|21072876|P1|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
8547476|NCT00166712|21072875|P2|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
8547477|NCT00166712|21072876|P1|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
8547478|NCT00166712|21072875|P2|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
8547479|NCT00166712|21072876|P1|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
8547480|NCT00166712|21072875|P2|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
8547481|NCT00166712|21072876|P1|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
8547482|NCT00166712|21072875|P2|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
8547483|NCT00166712|21072876|P1|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
8547484|NCT00166517|21072893|P2|NOT COMPLETED|Overall Study||2
8547485|NCT00166517|21072894|P1|NOT COMPLETED|Overall Study||5
8547486|NCT00166517|21072893|P2|COMPLETED|Overall Study||61
8547487|NCT00166517|21072894|P1|COMPLETED|Overall Study||110
8547488|NCT00166517|21072893|P2|Vaccinated at Visit 3|Overall Study||61
8547489|NCT00166517|21072894|P1|Vaccinated at Visit 3|Overall Study||110
8547490|NCT00166517|21072893|P2|Vaccinated at Visit 2|Overall Study||61
8547491|NCT00166517|21072894|P1|Vaccinated at Visit 2|Overall Study||112
8547492|NCT00166517|21072893|P2|Vaccinated at Visit 1|Overall Study||63
8547493|NCT00166517|21072894|P1|Vaccinated at Visit 1|Overall Study||115
8547494|NCT00166517|21072893|P2|STARTED|Overall Study||63
8547495|NCT00166517|21072894|P1|STARTED|Overall Study||115
8547496|NCT00166504|21072904|P2|NOT COMPLETED|Overall Study||4
8547497|NCT00166504|21072905|P1|NOT COMPLETED|Overall Study||5
8547498|NCT00166504|21072904|P2|COMPLETED|Overall Study||91
8547499|NCT00166504|21072905|P1|COMPLETED|Overall Study||103
8547500|NCT00166504|21072904|P2|STARTED|Overall Study||95
8547501|NCT00166504|21072905|P1|STARTED|Overall Study||108
8547502|NCT00166439|21072911|P1|NOT COMPLETED|Overall Study||5
8547503|NCT00166439|21072911|P1|COMPLETED|Overall Study||45
8547504|NCT00166439|21072911|P1|STARTED|Overall Study||50
8547505|NCT00166361|21072919|P2|NOT COMPLETED|Overall Study||0
8547506|NCT00166361|21072920|P1|NOT COMPLETED|Overall Study||0
8547507|NCT00166361|21072919|P2|COMPLETED|Overall Study||10
8547508|NCT00166361|21072920|P1|COMPLETED|Overall Study||14
8547509|NCT00166361|21072919|P2|STARTED|Overall Study||10
8547510|NCT00166361|21072920|P1|STARTED|Overall Study||14
8547511|NCT00166296|21072928|P2|NOT COMPLETED|Overall Study||9
8547512|NCT00166296|21072929|P1|NOT COMPLETED|Overall Study||7
8547513|NCT00166296|21072928|P2|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
8547514|NCT00166296|21072929|P1|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
8547515|NCT00166296|21072928|P2|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
8547516|NCT00166296|21072929|P1|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
8547517|NCT00166296|21072928|P2|STARTED|Overall Study|Randomized patients|66
8547518|NCT00166296|21072929|P1|STARTED|Overall Study|Randomized patients|67
8547519|NCT00166205|21072941|P1|NOT COMPLETED|Overall Study||48
8547520|NCT00166205|21072941|P1|COMPLETED|Overall Study||228
8547521|NCT00166205|21072941|P1|Intervention - SAGB Surgery|Overall Study||276
8547522|NCT00166205|21072941|P1|STARTED|Overall Study||276
8547523|NCT00166166|21072957|P2|NOT COMPLETED|Overall Study||0
8547524|NCT00166166|21072958|P1|NOT COMPLETED|Overall Study||0
8547525|NCT00166166|21072957|P2|COMPLETED|Overall Study||71
8547526|NCT00166166|21072958|P1|COMPLETED|Overall Study||103
8547527|NCT00166166|21072957|P2|STARTED|Overall Study||71
8547528|NCT00166166|21072958|P1|STARTED|Overall Study||103
8547529|NCT00166114|21072981|P2|NOT COMPLETED|Overall Study||6
8547530|NCT00166114|21072982|P1|NOT COMPLETED|Overall Study||14
8547531|NCT00166114|21072981|P2|COMPLETED|Overall Study||13
8547532|NCT00166114|21072982|P1|COMPLETED|Overall Study||7
8547533|NCT00166114|21072981|P2|STARTED|Overall Study||19
8547534|NCT00166114|21072982|P1|STARTED|Overall Study||21
8547535|NCT00166036|21072990|P2|NOT COMPLETED|Overall Study||0
8547536|NCT00166036|21072991|P1|NOT COMPLETED|Overall Study||0
8547537|NCT00166036|21072990|P2|COMPLETED|Overall Study||19
8547538|NCT00166036|21072991|P1|COMPLETED|Overall Study||17
8547539|NCT00166036|21072990|P2|STARTED|Overall Study||19
8547540|NCT00166036|21072991|P1|STARTED|Overall Study||17
8547541|NCT00165984|21072999|P1|NOT COMPLETED|Overall Study||15
8547542|NCT00165984|21072999|P1|COMPLETED|Overall Study||150
8547543|NCT00165984|21072999|P1|STARTED|Overall Study||165
8547544|NCT00165958|21073008|P2|NOT COMPLETED|Overall Study||2
8547545|NCT00165958|21073009|P1|NOT COMPLETED|Overall Study||1
8547546|NCT00165958|21073008|P2|COMPLETED|Overall Study||19
8547547|NCT00165958|21073009|P1|COMPLETED|Overall Study||18
8547548|NCT00165958|21073008|P2|STARTED|Overall Study||21
8547549|NCT00165958|21073009|P1|STARTED|Overall Study||19
8547550|NCT00165841|21073017|P2|NOT COMPLETED|Overall Study||62
8547551|NCT00165841|21073018|P1|NOT COMPLETED|Overall Study||30
8547552|NCT00165841|21073017|P2|COMPLETED|Overall Study||35
8547553|NCT00165841|21073018|P1|COMPLETED|Overall Study||73
8547554|NCT00165841|21073017|P2|STARTED|Overall Study||97
8547555|NCT00165841|21073018|P1|STARTED|Overall Study||103
8547556|NCT00165789|21073028|P4|NOT COMPLETED|Overall Study||14
8547557|NCT00165789|21073029|P3|NOT COMPLETED|Overall Study||1
8547558|NCT00165789|21073030|P2|NOT COMPLETED|Overall Study||4
8547559|NCT00165789|21073031|P1|NOT COMPLETED|Overall Study||0
8547560|NCT00165789|21073028|P4|COMPLETED|Overall Study||21
8547561|NCT00165789|21073029|P3|COMPLETED|Overall Study||11
8547562|NCT00165789|21073030|P2|COMPLETED|Overall Study||16
8547563|NCT00165789|21073031|P1|COMPLETED|Overall Study||8
8547564|NCT00165789|21073028|P4|STARTED|Overall Study||35
8547565|NCT00165789|21073029|P3|STARTED|Overall Study||12
8547566|NCT00165789|21073030|P2|STARTED|Overall Study||20
8547567|NCT00165789|21073031|P1|STARTED|Overall Study||8
8547568|NCT00165776|21073085|P4|NOT COMPLETED|Overall Study||2
8547569|NCT00165776|21073086|P3|NOT COMPLETED|Overall Study||2
8547570|NCT00165776|21073087|P2|NOT COMPLETED|Overall Study||1
8547571|NCT00165776|21073088|P1|NOT COMPLETED|Overall Study||4
8547572|NCT00165776|21073085|P4|COMPLETED|Overall Study||29
8547573|NCT00165776|21073086|P3|COMPLETED|Overall Study||31
8547574|NCT00165776|21073087|P2|COMPLETED|Overall Study||33
8547575|NCT00165776|21073088|P1|COMPLETED|Overall Study||31
8547576|NCT00165776|21073085|P4|STARTED|Overall Study||31
8547577|NCT00165776|21073086|P3|STARTED|Overall Study||33
8547578|NCT00165776|21073087|P2|STARTED|Overall Study||34
8547579|NCT00165776|21073088|P1|STARTED|Overall Study||35
8547580|NCT00165698|21073124|P2|NOT COMPLETED|Overall Study||15
8547581|NCT00165698|21073125|P1|NOT COMPLETED|Overall Study||8
8547582|NCT00165698|21073124|P2|COMPLETED|Overall Study||105
8547583|NCT00165698|21073125|P1|COMPLETED|Overall Study||112
8547584|NCT00165698|21073124|P2|STARTED|Overall Study||120
8547585|NCT00165698|21073125|P1|STARTED|Overall Study||120
8547586|NCT00165672|21073151|P2|NOT COMPLETED|Overall Study||1
8547587|NCT00165672|21073152|P1|NOT COMPLETED|Overall Study||0
8547588|NCT00165672|21073151|P2|COMPLETED|Overall Study||12
8547589|NCT00165672|21073152|P1|COMPLETED|Overall Study||13
8547590|NCT00165672|21073151|P2|STARTED|Overall Study||13
8547591|NCT00165672|21073152|P1|STARTED|Overall Study||13
8547592|NCT00165646|21073161|P3|NOT COMPLETED|Overall Study||4
8547593|NCT00165646|21073162|P2|NOT COMPLETED|Overall Study||5
8547594|NCT00165646|21073163|P1|NOT COMPLETED|Overall Study||5
8547595|NCT00165646|21073161|P3|COMPLETED|Overall Study||98
8547596|NCT00165646|21073162|P2|COMPLETED|Overall Study||88
8547597|NCT00165646|21073163|P1|COMPLETED|Overall Study||88
8547598|NCT00165646|21073161|P3|STARTED|Overall Study||102
8547599|NCT00165646|21073162|P2|STARTED|Overall Study||93
8547600|NCT00165646|21073163|P1|STARTED|Overall Study||93
8547601|NCT00165503|21073171|P1|NOT COMPLETED|Overall Study||16
8547602|NCT00165503|21073171|P1|COMPLETED|Overall Study||0
8547603|NCT00165503|21073171|P1|STARTED|Overall Study||16
8547604|NCT00163657|21073178|P3|NOT COMPLETED|Overall Study||37
8547605|NCT00163657|21073179|P2|NOT COMPLETED|Overall Study||23
8547606|NCT00163657|21073180|P1|NOT COMPLETED|Overall Study||20
8547607|NCT00163657|21073178|P3|COMPLETED|Overall Study||116
8547608|NCT00163657|21073179|P2|COMPLETED|Overall Study||56
8547609|NCT00163657|21073180|P1|COMPLETED|Overall Study||60
8547610|NCT00163657|21073178|P3|STARTED|Overall Study||153
8547611|NCT00163657|21073179|P2|STARTED|Overall Study||79
8547612|NCT00163657|21073180|P1|STARTED|Overall Study||80
8547613|NCT00163293|21073194|P3|NOT COMPLETED|Overall Study||19
8547614|NCT00163293|21073195|P2|NOT COMPLETED|Overall Study||7
8547615|NCT00163293|21073196|P1|NOT COMPLETED|Overall Study||13
8547616|NCT00163293|21073194|P3|COMPLETED|Overall Study||66
8547617|NCT00163293|21073195|P2|COMPLETED|Overall Study||69
8547618|NCT00163293|21073196|P1|COMPLETED|Overall Study||66
8547619|NCT00163293|21073194|P3|STARTED|Overall Study||85
8547620|NCT00163293|21073195|P2|STARTED|Overall Study||76
8547621|NCT00163293|21073196|P1|STARTED|Overall Study||79
8547622|NCT00163215|21073270|P1|NOT COMPLETED|Overall Study||15
8547623|NCT00163215|21073270|P1|COMPLETED|Overall Study||31
8547624|NCT00163215|21073270|P1|STARTED|Overall Study||46
8547625|NCT00163189|21073290|P1|NOT COMPLETED|Overall Study||63
8547626|NCT00163189|21073290|P1|COMPLETED|Overall Study||35
8547627|NCT00163189|21073290|P1|STARTED|Overall Study||98
8547628|NCT00163020|21073314|P2|NOT COMPLETED|Overall Study||2
8547629|NCT00163020|21073315|P1|NOT COMPLETED|Overall Study||0
8547630|NCT00163020|21073314|P2|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
8547631|NCT00163020|21073315|P1|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
8547632|NCT00163020|21073314|P2|STARTED|Overall Study|Twins = 80 Triplets = 25|105
8547633|NCT00163020|21073315|P1|STARTED|Overall Study|Twins = 160 Triplets = 56|216
8547634|NCT00162981|21073355|P2|NOT COMPLETED|Overall Study||6
8547635|NCT00162981|21073356|P1|NOT COMPLETED|Overall Study||4
8547636|NCT00162981|21073355|P2|COMPLETED|Overall Study||30
8547637|NCT00162981|21073356|P1|COMPLETED|Overall Study||28
8547638|NCT00162981|21073355|P2|STARTED|Overall Study||36
8547639|NCT00162981|21073356|P1|STARTED|Overall Study||32
8547640|NCT00162942|21073372|P2|NOT COMPLETED|Overall Study||52
8547641|NCT00162942|21073373|P1|NOT COMPLETED|Overall Study||106
8547642|NCT00162942|21073372|P2|COMPLETED|Overall Study||26
8547643|NCT00162942|21073373|P1|COMPLETED|Overall Study||51
8547644|NCT00162942|21073372|P2|Week 12|Overall Study||61
8547645|NCT00162942|21073373|P1|Week 12|Overall Study||127
8547646|NCT00162942|21073372|P2|STARTED|Overall Study||78
8547647|NCT00162942|21073373|P1|STARTED|Overall Study||157
8547648|NCT00162773|21073421|P1|NOT COMPLETED|Overall Study||22
8547649|NCT00162773|21073421|P1|COMPLETED|Overall Study||7
8547650|NCT00162773|21073421|P1|STARTED|Overall Study||29
8547657|NCT00162266|21073433|P4|NOT COMPLETED|Open-Label Period||137
8547658|NCT00162266|21073434|P3|NOT COMPLETED|Open-Label Period||0
8547659|NCT00162266|21073435|P2|NOT COMPLETED|Open-Label Period||0
8547660|NCT00162266|21073436|P1|NOT COMPLETED|Open-Label Period||0
8547661|NCT00162266|21073433|P4|COMPLETED|Open-Label Period||82
8547662|NCT00162266|21073434|P3|COMPLETED|Open-Label Period||0
8547663|NCT00162266|21073435|P2|COMPLETED|Open-Label Period||0
8547664|NCT00162266|21073436|P1|COMPLETED|Open-Label Period||0
8547665|NCT00162266|21073433|P4|STARTED|Open-Label Period||219
8547666|NCT00162266|21073434|P3|STARTED|Open-Label Period||0
8547667|NCT00162266|21073435|P2|STARTED|Open-Label Period||0
8547668|NCT00162266|21073436|P1|STARTED|Open-Label Period||0
8547669|NCT00162266|21073433|P4|NOT COMPLETED|Double-Blind Period||0
8547670|NCT00162266|21073434|P3|NOT COMPLETED|Double-Blind Period||48
8547671|NCT00162266|21073435|P2|NOT COMPLETED|Double-Blind Period||31
8547672|NCT00162266|21073436|P1|NOT COMPLETED|Double-Blind Period||25
8547673|NCT00162266|21073433|P4|COMPLETED|Double-Blind Period||0
8547674|NCT00162266|21073434|P3|COMPLETED|Double-Blind Period||71
8547675|NCT00162266|21073435|P2|COMPLETED|Double-Blind Period||74
8547676|NCT00162266|21073436|P1|COMPLETED|Double-Blind Period||90
8547677|NCT00162266|21073433|P4|Completed Day 1 to Day 181|Double-Blind Period||0
8547678|NCT00162266|21073434|P3|Completed Day 1 to Day 181|Double-Blind Period||78
8547679|NCT00162266|21073435|P2|Completed Day 1 to Day 181|Double-Blind Period||80
8547680|NCT00162266|21073436|P1|Completed Day 1 to Day 181|Double-Blind Period||98
8547681|NCT00162266|21073433|P4|STARTED|Double-Blind Period||0
8547682|NCT00162266|21073434|P3|STARTED|Double-Blind Period||119
8547683|NCT00162266|21073435|P2|STARTED|Double-Blind Period||105
8547684|NCT00162266|21073436|P1|STARTED|Double-Blind Period||115
8547685|NCT00162136|21073637|P1|NOT COMPLETED|Overall Study||35
8547686|NCT00162136|21073637|P1|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
8547687|NCT00162136|21073637|P1|STARTED|Overall Study||35
8547688|NCT00162123|21073669|P8|NOT COMPLETED|Overall Study||58
8547689|NCT00162123|21073670|P7|NOT COMPLETED|Overall Study||4
8547690|NCT00162123|21073671|P6|NOT COMPLETED|Overall Study||9
8547691|NCT00162123|21073672|P5|NOT COMPLETED|Overall Study||31
8547692|NCT00162123|21073673|P4|NOT COMPLETED|Overall Study||8
8547693|NCT00162123|21073674|P3|NOT COMPLETED|Overall Study||21
8547694|NCT00162123|21073675|P2|NOT COMPLETED|Overall Study||29
8547695|NCT00162123|21073676|P1|NOT COMPLETED|Overall Study||44
8547696|NCT00162123|21073669|P8|COMPLETED|Overall Study|Still on treatment|0
8547697|NCT00162123|21073670|P7|COMPLETED|Overall Study|Still on treatment|0
8547698|NCT00162123|21073671|P6|COMPLETED|Overall Study|Still on treatment|4
8547699|NCT00162123|21073672|P5|COMPLETED|Overall Study|Still on treatment|14
8547700|NCT00162123|21073673|P4|COMPLETED|Overall Study|Still on treatment|3
8547701|NCT00162123|21073674|P3|COMPLETED|Overall Study|Still on treatment|3
8547702|NCT00162123|21073675|P2|COMPLETED|Overall Study|Still on treatment|5
8547703|NCT00162123|21073676|P1|COMPLETED|Overall Study|Still on treatment|9
8547704|NCT00162123|21073669|P8|Received Treatment|Overall Study||0
8547705|NCT00162123|21073670|P7|Received Treatment|Overall Study||4
8547706|NCT00162123|21073671|P6|Received Treatment|Overall Study||12
8547707|NCT00162123|21073672|P5|Received Treatment|Overall Study||33
8547708|NCT00162123|21073673|P4|Received Treatment|Overall Study||11
8547709|NCT00162123|21073674|P3|Received Treatment|Overall Study||24
8547710|NCT00162123|21073675|P2|Received Treatment|Overall Study||34
8547711|NCT00162123|21073676|P1|Received Treatment|Overall Study||53
8547712|NCT00162123|21073669|P8|STARTED|Overall Study|Enrolled|58
8547713|NCT00162123|21073670|P7|STARTED|Overall Study|Enrolled|4
8547714|NCT00162123|21073671|P6|STARTED|Overall Study|Enrolled|13
8547715|NCT00162123|21073672|P5|STARTED|Overall Study|Enrolled|45
8547716|NCT00162123|21073673|P4|STARTED|Overall Study|Enrolled|11
8547717|NCT00162123|21073674|P3|STARTED|Overall Study|Enrolled|24
8547718|NCT00162123|21073675|P2|STARTED|Overall Study|Enrolled|34
8547719|NCT00162123|21073676|P1|STARTED|Overall Study|Enrolled|53
8547720|NCT00162097|21073709|P4|NOT COMPLETED|Overall Study||1
8547721|NCT00162097|21073710|P3|NOT COMPLETED|Overall Study||0
8547722|NCT00162097|21073711|P2|NOT COMPLETED|Overall Study||0
8547723|NCT00162097|21073712|P1|NOT COMPLETED|Overall Study||0
8547724|NCT00162097|21073709|P4|COMPLETED|Overall Study||6
8547725|NCT00162097|21073710|P3|COMPLETED|Overall Study||1
8547726|NCT00162097|21073711|P2|COMPLETED|Overall Study||2
8547727|NCT00162097|21073712|P1|COMPLETED|Overall Study||6
8547728|NCT00162097|21073709|P4|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
8547729|NCT00162097|21073710|P3|STARTED|Overall Study|Treated on Day 1|1
8547730|NCT00162097|21073711|P2|STARTED|Overall Study|Treated on Day 1|2
8547731|NCT00162097|21073712|P1|STARTED|Overall Study|Treated on Day 1|6
8547732|NCT00162032|21073774|P2|NOT COMPLETED|Overall Study||2
8547733|NCT00162032|21073775|P1|NOT COMPLETED|Overall Study||5
8547734|NCT00162032|21073774|P2|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
8547735|NCT00162032|21073775|P1|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
8547736|NCT00162032|21073774|P2|STARTED|Overall Study||116
8547737|NCT00162032|21073775|P1|STARTED|Overall Study||329
8547738|NCT00161616|21073796|P2|NOT COMPLETED|Overall Study||19
8547739|NCT00161616|21073797|P1|NOT COMPLETED|Overall Study||26
8547740|NCT00161616|21073796|P2|COMPLETED|Overall Study||119
8547741|NCT00161616|21073797|P1|COMPLETED|Overall Study||113
8547742|NCT00161616|21073796|P2|STARTED|Overall Study||138
8547743|NCT00161616|21073797|P1|STARTED|Overall Study||139
8547744|NCT00161473|21073807|P2|NOT COMPLETED|Overall Study||6
8547745|NCT00161473|21073808|P1|NOT COMPLETED|Overall Study||5
8547746|NCT00161473|21073807|P2|COMPLETED|Overall Study||6
8547747|NCT00161473|21073808|P1|COMPLETED|Overall Study||7
8547748|NCT00161473|21073807|P2|STARTED|Overall Study||12
8547749|NCT00161473|21073808|P1|STARTED|Overall Study||12
8547750|NCT00161382|21073822|P2|NOT COMPLETED|Overall Study||289
8547751|NCT00161382|21073823|P1|NOT COMPLETED|Overall Study||249
8547752|NCT00161382|21073822|P2|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
8547753|NCT00161382|21073823|P1|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
8547754|NCT00161382|21073822|P2|STARTED|Overall Study|Number of students allocated to comparison group|847
8547755|NCT00161382|21073823|P1|STARTED|Overall Study|Number of students allocated to intervention group|598
8547756|NCT00161213|21073829|P1|NOT COMPLETED|Overall Study||2
8547757|NCT00161213|21073829|P1|COMPLETED|Overall Study||42
8547758|NCT00161213|21073829|P1|STARTED|Overall Study||44
8547759|NCT00160706|21073836|P1|NOT COMPLETED|Overall Study||286
8547760|NCT00160706|21073836|P1|COMPLETED|Overall Study||24
8547761|NCT00160706|21073836|P1|STARTED|Overall Study||310
8547762|NCT00160693|21073848|P1|NOT COMPLETED|Overall Study||235
8547763|NCT00160693|21073848|P1|COMPLETED|Overall Study||167
8547764|NCT00160693|21073848|P1|STARTED|Overall Study||402
8547765|NCT00160680|21073867|P2|NOT COMPLETED|Overall Study||13
8547766|NCT00160680|21073868|P1|NOT COMPLETED|Overall Study||9
8547767|NCT00160680|21073867|P2|COMPLETED|Overall Study||18
8547768|NCT00160680|21073868|P1|COMPLETED|Overall Study||22
8547769|NCT00160680|21073867|P2|STARTED|Overall Study||31
8547770|NCT00160680|21073868|P1|STARTED|Overall Study||31
8547771|NCT00160667|21073903|P3|NOT COMPLETED|Overall Study||6
8547772|NCT00160667|21073904|P2|NOT COMPLETED|Overall Study||3
8547773|NCT00160667|21073905|P1|NOT COMPLETED|Overall Study||5
8547774|NCT00160667|21073903|P3|COMPLETED|Overall Study||45
8547775|NCT00160667|21073904|P2|COMPLETED|Overall Study||48
8547776|NCT00160667|21073905|P1|COMPLETED|Overall Study||45
8547777|NCT00160667|21073903|P3|STARTED|Overall Study||51
8547778|NCT00160667|21073904|P2|STARTED|Overall Study||51
8547779|NCT00160667|21073905|P1|STARTED|Overall Study||50
8547780|NCT00160654|21073952|P1|NOT COMPLETED|Overall Study||33
8547781|NCT00160654|21073952|P1|COMPLETED|Overall Study||218
8547782|NCT00160654|21073952|P1|STARTED|Overall Study||251
8547783|NCT00160641|21073962|P1|NOT COMPLETED|Overall Study||221
8547784|NCT00160641|21073962|P1|COMPLETED|Overall Study||346
8547785|NCT00160641|21073962|P1|STARTED|Overall Study||567
8547786|NCT00160615|21073995|P2|NOT COMPLETED|Overall Study||45
8547787|NCT00160615|21073996|P1|NOT COMPLETED|Overall Study||18
8547788|NCT00160615|21073995|P2|COMPLETED|Overall Study||56
8547789|NCT00160615|21073996|P1|COMPLETED|Overall Study||32
8547790|NCT00160615|21073995|P2|STARTED|Overall Study||101
8547791|NCT00160615|21073996|P1|STARTED|Overall Study||50
8547792|NCT00160563|21074019|P3|NOT COMPLETED|Overall Study||90
8547793|NCT00160563|21074020|P2|NOT COMPLETED|Overall Study||45
8547794|NCT00160563|21074021|P1|NOT COMPLETED|Overall Study||51
8547795|NCT00160563|21074019|P3|COMPLETED|Overall Study||11
8547796|NCT00160563|21074020|P2|COMPLETED|Overall Study||2
8547797|NCT00160563|21074021|P1|COMPLETED|Overall Study||8
8547798|NCT00160563|21074019|P3|STARTED|Overall Study||101
8547799|NCT00160563|21074020|P2|STARTED|Overall Study||47
8547800|NCT00160563|21074021|P1|STARTED|Overall Study||59
8547801|NCT00160524|21074033|P1|NOT COMPLETED|Overall Study||478
8547802|NCT00160524|21074033|P1|COMPLETED|Overall Study||117
8547803|NCT00160524|21074033|P1|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
8547804|NCT00160251|21074050|P8|NOT COMPLETED|Post-amendment 2||55
8547805|NCT00160251|21074051|P7|NOT COMPLETED|Post-amendment 2||0
8547806|NCT00160251|21074052|P6|NOT COMPLETED|Post-amendment 2||0
8547807|NCT00160251|21074053|P5|NOT COMPLETED|Post-amendment 2||0
8547808|NCT00160251|21074054|P4|NOT COMPLETED|Post-amendment 2||0
8547809|NCT00160251|21074055|P3|NOT COMPLETED|Post-amendment 2||0
8547810|NCT00160251|21074056|P2|NOT COMPLETED|Post-amendment 2||0
8547811|NCT00160251|21074057|P1|NOT COMPLETED|Post-amendment 2||0
8547812|NCT00160251|21074050|P8|COMPLETED|Post-amendment 2||88
8547813|NCT00160251|21074051|P7|COMPLETED|Post-amendment 2||0
8547814|NCT00160251|21074052|P6|COMPLETED|Post-amendment 2||0
8547815|NCT00160251|21074053|P5|COMPLETED|Post-amendment 2||0
8547816|NCT00160251|21074054|P4|COMPLETED|Post-amendment 2||0
8547817|NCT00160251|21074055|P3|COMPLETED|Post-amendment 2||0
8547818|NCT00160251|21074056|P2|COMPLETED|Post-amendment 2||0
8547819|NCT00160251|21074057|P1|COMPLETED|Post-amendment 2||0
8547820|NCT00160251|21074050|P8|STARTED|Post-amendment 2||143
8547821|NCT00160251|21074051|P7|STARTED|Post-amendment 2||0
8547822|NCT00160251|21074052|P6|STARTED|Post-amendment 2||0
8547823|NCT00160251|21074053|P5|STARTED|Post-amendment 2||0
8547824|NCT00160251|21074054|P4|STARTED|Post-amendment 2||0
8547825|NCT00160251|21074055|P3|STARTED|Post-amendment 2||0
8547826|NCT00160251|21074056|P2|STARTED|Post-amendment 2||0
8547827|NCT00160251|21074057|P1|STARTED|Post-amendment 2||0
8547828|NCT00160251|21074050|P8|NOT COMPLETED|Prior to Amendment 2||0
8547829|NCT00160251|21074051|P7|NOT COMPLETED|Prior to Amendment 2||4
8547830|NCT00160251|21074052|P6|NOT COMPLETED|Prior to Amendment 2||83
8547831|NCT00160251|21074053|P5|NOT COMPLETED|Prior to Amendment 2||28
8547832|NCT00160251|21074054|P4|NOT COMPLETED|Prior to Amendment 2||40
8547833|NCT00160251|21074055|P3|NOT COMPLETED|Prior to Amendment 2||44
8547834|NCT00160251|21074056|P2|NOT COMPLETED|Prior to Amendment 2||6
8547835|NCT00160251|21074057|P1|NOT COMPLETED|Prior to Amendment 2||9
8547836|NCT00160251|21074050|P8|COMPLETED|Prior to Amendment 2||0
8547837|NCT00160251|21074051|P7|COMPLETED|Prior to Amendment 2||61
8547838|NCT00160251|21074052|P6|COMPLETED|Prior to Amendment 2||14
8547839|NCT00160251|21074053|P5|COMPLETED|Prior to Amendment 2||21
8547840|NCT00160251|21074054|P4|COMPLETED|Prior to Amendment 2||9
8547841|NCT00160251|21074055|P3|COMPLETED|Prior to Amendment 2||4
8547842|NCT00160251|21074056|P2|COMPLETED|Prior to Amendment 2||28
8547843|NCT00160251|21074057|P1|COMPLETED|Prior to Amendment 2||6
8547844|NCT00160251|21074050|P8|STARTED|Prior to Amendment 2||0
8547845|NCT00160251|21074051|P7|STARTED|Prior to Amendment 2||65
8547846|NCT00160251|21074052|P6|STARTED|Prior to Amendment 2||97
8547847|NCT00160251|21074053|P5|STARTED|Prior to Amendment 2||49
8547848|NCT00160251|21074054|P4|STARTED|Prior to Amendment 2||49
8547849|NCT00160251|21074055|P3|STARTED|Prior to Amendment 2||48
8547850|NCT00160251|21074056|P2|STARTED|Prior to Amendment 2||34
8547851|NCT00160251|21074057|P1|STARTED|Prior to Amendment 2||15
8547852|NCT00160199|21074133|P2|NOT COMPLETED|Overall Study||37
8547853|NCT00160199|21074134|P1|NOT COMPLETED|Overall Study||24
8547854|NCT00160199|21074133|P2|COMPLETED|Overall Study||81
8547855|NCT00160199|21074134|P1|COMPLETED|Overall Study||98
8547856|NCT00160199|21074133|P2|STARTED|Overall Study||118
8547857|NCT00160199|21074134|P1|STARTED|Overall Study||122
8547858|NCT00159965|21074154|P2|NOT COMPLETED|Overall Study||5
8547859|NCT00159965|21074155|P1|NOT COMPLETED|Overall Study||7
8547860|NCT00159965|21074154|P2|COMPLETED|Overall Study||14
8547861|NCT00159965|21074155|P1|COMPLETED|Overall Study||12
8547862|NCT00159965|21074154|P2|STARTED|Overall Study||19
8547863|NCT00159965|21074155|P1|STARTED|Overall Study||19
8547920|NCT00159822|21074466|P1|NOT COMPLETED|Post-treatment Follow-up Period||3
8547921|NCT00159822|21074466|P1|COMPLETED|Post-treatment Follow-up Period||23
8547922|NCT00159822|21074466|P1|STARTED|Post-treatment Follow-up Period||26
8547923|NCT00159822|21074466|P1|NOT COMPLETED|Voriconazole Treatment Period||22
8547924|NCT00159822|21074466|P1|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
8547925|NCT00159822|21074466|P1|STARTED|Voriconazole Treatment Period||48
8547926|NCT00159783|21074484|P3|NOT COMPLETED|Overall Study||39
8547927|NCT00159783|21074485|P2|NOT COMPLETED|Overall Study||27
8547928|NCT00159783|21074486|P1|NOT COMPLETED|Overall Study||19
8547929|NCT00159783|21074484|P3|COMPLETED|Overall Study||68
8547930|NCT00159783|21074485|P2|COMPLETED|Overall Study||52
8547931|NCT00159783|21074486|P1|COMPLETED|Overall Study||13
8547932|NCT00159783|21074484|P3|STARTED|Overall Study||107
8547933|NCT00159783|21074485|P2|STARTED|Overall Study||79
8547934|NCT00159783|21074486|P1|STARTED|Overall Study||32
8547935|NCT00159432|21074516|P1|NOT COMPLETED|Overall Study||10
8547936|NCT00159432|21074516|P1|COMPLETED|Overall Study||53
8547937|NCT00159432|21074516|P1|STARTED|Overall Study||63
8547938|NCT00159419|21074523|P2|NOT COMPLETED|Overall Study||0
8547939|NCT00159419|21074524|P1|NOT COMPLETED|Overall Study||0
8547940|NCT00159419|21074523|P2|COMPLETED|Overall Study||9
8547941|NCT00159419|21074524|P1|COMPLETED|Overall Study||9
8547942|NCT00159419|21074523|P2|STARTED|Overall Study||9
8547943|NCT00159419|21074524|P1|STARTED|Overall Study||9
8547944|NCT00159263|21074530|P6|NOT COMPLETED|Sixth Intervention||0
8547945|NCT00159263|21074531|P5|NOT COMPLETED|Sixth Intervention||0
8547946|NCT00159263|21074532|P4|NOT COMPLETED|Sixth Intervention||0
8547947|NCT00159263|21074533|P3|NOT COMPLETED|Sixth Intervention||0
8547948|NCT00159263|21074534|P2|NOT COMPLETED|Sixth Intervention||0
8547949|NCT00159263|21074535|P1|NOT COMPLETED|Sixth Intervention||0
8547950|NCT00159263|21074530|P6|COMPLETED|Sixth Intervention||2
8547951|NCT00159263|21074531|P5|COMPLETED|Sixth Intervention||2
8547952|NCT00159263|21074532|P4|COMPLETED|Sixth Intervention||2
8547953|NCT00159263|21074533|P3|COMPLETED|Sixth Intervention||2
8547954|NCT00159263|21074534|P2|COMPLETED|Sixth Intervention||1
8547955|NCT00159263|21074535|P1|COMPLETED|Sixth Intervention||1
8547956|NCT00159263|21074530|P6|STARTED|Sixth Intervention||2
8547957|NCT00159263|21074531|P5|STARTED|Sixth Intervention||2
8547958|NCT00159263|21074532|P4|STARTED|Sixth Intervention||2
8547959|NCT00159263|21074533|P3|STARTED|Sixth Intervention||2
8547960|NCT00159263|21074534|P2|STARTED|Sixth Intervention||1
8547961|NCT00159263|21074535|P1|STARTED|Sixth Intervention||1
8547962|NCT00159263|21074530|P6|NOT COMPLETED|Washout||0
8547963|NCT00159263|21074531|P5|NOT COMPLETED|Washout||0
8547964|NCT00159263|21074532|P4|NOT COMPLETED|Washout||0
8547965|NCT00159263|21074533|P3|NOT COMPLETED|Washout||0
8547966|NCT00159263|21074534|P2|NOT COMPLETED|Washout||0
8547967|NCT00159263|21074535|P1|NOT COMPLETED|Washout||0
8547968|NCT00159263|21074530|P6|COMPLETED|Washout||2
8547969|NCT00159263|21074531|P5|COMPLETED|Washout||2
8547970|NCT00159263|21074532|P4|COMPLETED|Washout||2
8547971|NCT00159263|21074533|P3|COMPLETED|Washout||2
8547972|NCT00159263|21074534|P2|COMPLETED|Washout||1
8547973|NCT00159263|21074535|P1|COMPLETED|Washout||1
8547974|NCT00159263|21074530|P6|STARTED|Washout||2
8547975|NCT00159263|21074531|P5|STARTED|Washout||2
8547976|NCT00159263|21074532|P4|STARTED|Washout||2
8547977|NCT00159263|21074533|P3|STARTED|Washout||2
8547978|NCT00159263|21074534|P2|STARTED|Washout||1
8547979|NCT00159263|21074535|P1|STARTED|Washout||1
8547980|NCT00159263|21074530|P6|NOT COMPLETED|Fifth Intervention||0
8547981|NCT00159263|21074531|P5|NOT COMPLETED|Fifth Intervention||0
8547982|NCT00159263|21074532|P4|NOT COMPLETED|Fifth Intervention||0
8547983|NCT00159263|21074533|P3|NOT COMPLETED|Fifth Intervention||0
8547984|NCT00159263|21074534|P2|NOT COMPLETED|Fifth Intervention||0
8547985|NCT00159263|21074535|P1|NOT COMPLETED|Fifth Intervention||0
8547986|NCT00159263|21074530|P6|COMPLETED|Fifth Intervention||2
8547987|NCT00159263|21074531|P5|COMPLETED|Fifth Intervention||2
8547988|NCT00159263|21074532|P4|COMPLETED|Fifth Intervention||2
8547989|NCT00159263|21074533|P3|COMPLETED|Fifth Intervention||2
8547990|NCT00159263|21074534|P2|COMPLETED|Fifth Intervention||1
8547991|NCT00159263|21074535|P1|COMPLETED|Fifth Intervention||1
8547992|NCT00159263|21074530|P6|STARTED|Fifth Intervention||2
8547993|NCT00159263|21074531|P5|STARTED|Fifth Intervention||2
8547994|NCT00159263|21074532|P4|STARTED|Fifth Intervention||2
8547995|NCT00159263|21074533|P3|STARTED|Fifth Intervention||2
8547996|NCT00159263|21074534|P2|STARTED|Fifth Intervention||1
8547997|NCT00159263|21074535|P1|STARTED|Fifth Intervention||1
8547998|NCT00159263|21074530|P6|NOT COMPLETED|Washout||0
8547999|NCT00159263|21074531|P5|NOT COMPLETED|Washout||0
8548000|NCT00159263|21074532|P4|NOT COMPLETED|Washout||0
8548001|NCT00159263|21074533|P3|NOT COMPLETED|Washout||0
8548002|NCT00159263|21074534|P2|NOT COMPLETED|Washout||0
8548003|NCT00159263|21074535|P1|NOT COMPLETED|Washout||0
8548004|NCT00159263|21074530|P6|COMPLETED|Washout||2
8548005|NCT00159263|21074531|P5|COMPLETED|Washout||2
8548006|NCT00159263|21074532|P4|COMPLETED|Washout||2
8548007|NCT00159263|21074533|P3|COMPLETED|Washout||2
8548008|NCT00159263|21074534|P2|COMPLETED|Washout||1
8548009|NCT00159263|21074535|P1|COMPLETED|Washout||1
8548010|NCT00159263|21074530|P6|STARTED|Washout||2
8548011|NCT00159263|21074531|P5|STARTED|Washout||2
8548012|NCT00159263|21074532|P4|STARTED|Washout||2
8548013|NCT00159263|21074533|P3|STARTED|Washout||2
8548014|NCT00159263|21074534|P2|STARTED|Washout||1
8548015|NCT00159263|21074535|P1|STARTED|Washout||1
8548016|NCT00159263|21074530|P6|NOT COMPLETED|Fourth Intervention||0
8548017|NCT00159263|21074531|P5|NOT COMPLETED|Fourth Intervention||0
8548018|NCT00159263|21074532|P4|NOT COMPLETED|Fourth Intervention||0
8548019|NCT00159263|21074533|P3|NOT COMPLETED|Fourth Intervention||0
8548020|NCT00159263|21074534|P2|NOT COMPLETED|Fourth Intervention||0
8548021|NCT00159263|21074535|P1|NOT COMPLETED|Fourth Intervention||0
8548022|NCT00159263|21074530|P6|COMPLETED|Fourth Intervention||2
8548023|NCT00159263|21074531|P5|COMPLETED|Fourth Intervention||2
8548024|NCT00159263|21074532|P4|COMPLETED|Fourth Intervention||2
8548025|NCT00159263|21074533|P3|COMPLETED|Fourth Intervention||2
8548026|NCT00159263|21074534|P2|COMPLETED|Fourth Intervention||1
8548027|NCT00159263|21074535|P1|COMPLETED|Fourth Intervention||1
8548028|NCT00159263|21074530|P6|STARTED|Fourth Intervention||2
8548029|NCT00159263|21074531|P5|STARTED|Fourth Intervention||2
8548030|NCT00159263|21074532|P4|STARTED|Fourth Intervention||2
8548031|NCT00159263|21074533|P3|STARTED|Fourth Intervention||2
8548032|NCT00159263|21074534|P2|STARTED|Fourth Intervention||1
8548033|NCT00159263|21074535|P1|STARTED|Fourth Intervention||1
8548034|NCT00159263|21074530|P6|NOT COMPLETED|Washout||0
8548035|NCT00159263|21074531|P5|NOT COMPLETED|Washout||0
8548036|NCT00159263|21074532|P4|NOT COMPLETED|Washout||0
8548037|NCT00159263|21074533|P3|NOT COMPLETED|Washout||0
8548038|NCT00159263|21074534|P2|NOT COMPLETED|Washout||0
8548039|NCT00159263|21074535|P1|NOT COMPLETED|Washout||0
8548040|NCT00159263|21074530|P6|COMPLETED|Washout||2
8548041|NCT00159263|21074531|P5|COMPLETED|Washout||2
8548042|NCT00159263|21074532|P4|COMPLETED|Washout||2
8548043|NCT00159263|21074533|P3|COMPLETED|Washout||2
8548044|NCT00159263|21074534|P2|COMPLETED|Washout||1
8548045|NCT00159263|21074535|P1|COMPLETED|Washout||1
8548046|NCT00159263|21074530|P6|STARTED|Washout||2
8548047|NCT00159263|21074531|P5|STARTED|Washout||2
8548048|NCT00159263|21074532|P4|STARTED|Washout||2
8548049|NCT00159263|21074533|P3|STARTED|Washout||2
8548050|NCT00159263|21074534|P2|STARTED|Washout||1
8548051|NCT00159263|21074535|P1|STARTED|Washout||1
8548052|NCT00159263|21074530|P6|NOT COMPLETED|Third Intervention||0
8548053|NCT00159263|21074531|P5|NOT COMPLETED|Third Intervention||0
8548054|NCT00159263|21074532|P4|NOT COMPLETED|Third Intervention||0
8548055|NCT00159263|21074533|P3|NOT COMPLETED|Third Intervention||0
8548056|NCT00159263|21074534|P2|NOT COMPLETED|Third Intervention||0
8548057|NCT00159263|21074535|P1|NOT COMPLETED|Third Intervention||0
8548058|NCT00159263|21074530|P6|COMPLETED|Third Intervention||2
8548059|NCT00159263|21074531|P5|COMPLETED|Third Intervention||2
8548060|NCT00159263|21074532|P4|COMPLETED|Third Intervention||2
8548061|NCT00159263|21074533|P3|COMPLETED|Third Intervention||2
8548062|NCT00159263|21074534|P2|COMPLETED|Third Intervention||1
8548063|NCT00159263|21074535|P1|COMPLETED|Third Intervention||1
8548064|NCT00159263|21074530|P6|STARTED|Third Intervention||2
8548065|NCT00159263|21074531|P5|STARTED|Third Intervention||2
8548066|NCT00159263|21074532|P4|STARTED|Third Intervention||2
8548067|NCT00159263|21074533|P3|STARTED|Third Intervention||2
8548068|NCT00159263|21074534|P2|STARTED|Third Intervention||1
8548069|NCT00159263|21074535|P1|STARTED|Third Intervention||1
8548070|NCT00159263|21074530|P6|NOT COMPLETED|Washout||0
8548071|NCT00159263|21074531|P5|NOT COMPLETED|Washout||0
8548072|NCT00159263|21074532|P4|NOT COMPLETED|Washout||0
8548073|NCT00159263|21074533|P3|NOT COMPLETED|Washout||0
8548074|NCT00159263|21074534|P2|NOT COMPLETED|Washout||0
8548075|NCT00159263|21074535|P1|NOT COMPLETED|Washout||0
8548076|NCT00159263|21074530|P6|COMPLETED|Washout||2
8548077|NCT00159263|21074531|P5|COMPLETED|Washout||2
8548078|NCT00159263|21074532|P4|COMPLETED|Washout||2
8548079|NCT00159263|21074533|P3|COMPLETED|Washout||2
8548080|NCT00159263|21074534|P2|COMPLETED|Washout||1
8548081|NCT00159263|21074535|P1|COMPLETED|Washout||1
8548082|NCT00159263|21074530|P6|STARTED|Washout||2
8548083|NCT00159263|21074531|P5|STARTED|Washout||2
8548084|NCT00159263|21074532|P4|STARTED|Washout||2
8548085|NCT00159263|21074533|P3|STARTED|Washout||2
8548086|NCT00159263|21074534|P2|STARTED|Washout||1
8548087|NCT00159263|21074535|P1|STARTED|Washout||1
8548088|NCT00159263|21074530|P6|NOT COMPLETED|Second Intervention||0
8548089|NCT00159263|21074531|P5|NOT COMPLETED|Second Intervention||0
8548090|NCT00159263|21074532|P4|NOT COMPLETED|Second Intervention||0
8548091|NCT00159263|21074533|P3|NOT COMPLETED|Second Intervention||0
8548092|NCT00159263|21074534|P2|NOT COMPLETED|Second Intervention||0
8548093|NCT00159263|21074535|P1|NOT COMPLETED|Second Intervention||0
8548094|NCT00159263|21074530|P6|COMPLETED|Second Intervention||2
8548095|NCT00159263|21074531|P5|COMPLETED|Second Intervention||2
8548096|NCT00159263|21074532|P4|COMPLETED|Second Intervention||2
8548097|NCT00159263|21074533|P3|COMPLETED|Second Intervention||2
8548098|NCT00159263|21074534|P2|COMPLETED|Second Intervention||1
8548099|NCT00159263|21074535|P1|COMPLETED|Second Intervention||1
8548100|NCT00159263|21074530|P6|STARTED|Second Intervention||2
8548101|NCT00159263|21074531|P5|STARTED|Second Intervention||2
8548102|NCT00159263|21074532|P4|STARTED|Second Intervention||2
8548103|NCT00159263|21074533|P3|STARTED|Second Intervention||2
8548104|NCT00159263|21074534|P2|STARTED|Second Intervention||1
8548105|NCT00159263|21074535|P1|STARTED|Second Intervention||1
8548106|NCT00159263|21074530|P6|NOT COMPLETED|Washout||0
8548107|NCT00159263|21074531|P5|NOT COMPLETED|Washout||0
8548108|NCT00159263|21074532|P4|NOT COMPLETED|Washout||0
8548109|NCT00159263|21074533|P3|NOT COMPLETED|Washout||0
8548110|NCT00159263|21074534|P2|NOT COMPLETED|Washout||0
8548111|NCT00159263|21074535|P1|NOT COMPLETED|Washout||0
8548112|NCT00159263|21074530|P6|COMPLETED|Washout||2
8548113|NCT00159263|21074531|P5|COMPLETED|Washout||2
8548114|NCT00159263|21074532|P4|COMPLETED|Washout||2
8548115|NCT00159263|21074533|P3|COMPLETED|Washout||2
8548116|NCT00159263|21074534|P2|COMPLETED|Washout||1
8548117|NCT00159263|21074535|P1|COMPLETED|Washout||1
8548118|NCT00159263|21074530|P6|STARTED|Washout||2
8548119|NCT00159263|21074531|P5|STARTED|Washout||2
8548120|NCT00159263|21074532|P4|STARTED|Washout||2
8548121|NCT00159263|21074533|P3|STARTED|Washout||2
8548122|NCT00159263|21074534|P2|STARTED|Washout||1
8548123|NCT00159263|21074535|P1|STARTED|Washout||1
8548124|NCT00159263|21074530|P6|NOT COMPLETED|First Intervention||0
8548125|NCT00159263|21074531|P5|NOT COMPLETED|First Intervention||0
8548126|NCT00159263|21074532|P4|NOT COMPLETED|First Intervention||0
8548127|NCT00159263|21074533|P3|NOT COMPLETED|First Intervention||0
8548128|NCT00159263|21074534|P2|NOT COMPLETED|First Intervention||0
8548129|NCT00159263|21074535|P1|NOT COMPLETED|First Intervention||0
8548130|NCT00159263|21074530|P6|COMPLETED|First Intervention||2
8548131|NCT00159263|21074531|P5|COMPLETED|First Intervention||2
8548132|NCT00159263|21074532|P4|COMPLETED|First Intervention||2
8548133|NCT00159263|21074533|P3|COMPLETED|First Intervention||2
8548134|NCT00159263|21074534|P2|COMPLETED|First Intervention||1
8548135|NCT00159263|21074535|P1|COMPLETED|First Intervention||1
8548136|NCT00159263|21074530|P6|STARTED|First Intervention||2
8548137|NCT00159263|21074531|P5|STARTED|First Intervention||2
8548138|NCT00159263|21074532|P4|STARTED|First Intervention||2
8548139|NCT00159263|21074533|P3|STARTED|First Intervention||2
8548140|NCT00159263|21074534|P2|STARTED|First Intervention||1
8548141|NCT00159263|21074535|P1|STARTED|First Intervention||1
8548142|NCT00159250|21074563|P2|NOT COMPLETED|Overall Study||0
8548143|NCT00159250|21074564|P1|NOT COMPLETED|Overall Study||0
8548144|NCT00159250|21074563|P2|COMPLETED|Overall Study||5
8548145|NCT00159250|21074564|P1|COMPLETED|Overall Study||2
8548146|NCT00159250|21074563|P2|STARTED|Overall Study||5
8548147|NCT00159250|21074564|P1|STARTED|Overall Study||2
8548148|NCT00158925|21074580|P1|NOT COMPLETED|Overall Study||12
8548149|NCT00158925|21074580|P1|COMPLETED|Overall Study||84
8548150|NCT00158925|21074580|P1|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
8548151|NCT00158860|21074590|P2|NOT COMPLETED|Overall Study||71
8548152|NCT00158860|21074591|P1|NOT COMPLETED|Overall Study||35
8548153|NCT00158860|21074590|P2|COMPLETED|Overall Study||184
8548154|NCT00158860|21074591|P1|COMPLETED|Overall Study||93
8548155|NCT00158860|21074590|P2|STARTED|Overall Study||255
8548156|NCT00158860|21074591|P1|STARTED|Overall Study||128
8548157|NCT00158756|21074610|P5|NOT COMPLETED|Overall Study||3
8548158|NCT00158756|21074611|P4|NOT COMPLETED|Overall Study||1
8548159|NCT00158756|21074612|P3|NOT COMPLETED|Overall Study||8
8548160|NCT00158756|21074613|P2|NOT COMPLETED|Overall Study||0
8548161|NCT00158756|21074614|P1|NOT COMPLETED|Overall Study||5
8548162|NCT00158756|21074610|P5|COMPLETED|Overall Study||96
8548163|NCT00158756|21074611|P4|COMPLETED|Overall Study||22
8548164|NCT00158756|21074612|P3|COMPLETED|Overall Study||73
8548165|NCT00158756|21074613|P2|COMPLETED|Overall Study||25
8548166|NCT00158756|21074614|P1|COMPLETED|Overall Study||75
8548167|NCT00158756|21074610|P5|STARTED|Overall Study||99
8548168|NCT00158756|21074611|P4|STARTED|Overall Study||23
8548169|NCT00158756|21074612|P3|STARTED|Overall Study||81
8548170|NCT00158756|21074613|P2|STARTED|Overall Study||25
8548171|NCT00158756|21074614|P1|STARTED|Overall Study||80
8548172|NCT00158743|21074711|P2|NOT COMPLETED|Overall Study||7
8548173|NCT00158743|21074712|P1|NOT COMPLETED|Overall Study||9
8548174|NCT00158743|21074711|P2|COMPLETED|Overall Study||20
8548175|NCT00158743|21074712|P1|COMPLETED|Overall Study||15
8548176|NCT00158743|21074711|P2|STARTED|Overall Study||27
8548177|NCT00158743|21074712|P1|STARTED|Overall Study||24
8548178|NCT00158600|21074720|P2|NOT COMPLETED|Overall Study||4
8548179|NCT00158600|21074721|P1|NOT COMPLETED|Overall Study||5
8548180|NCT00158600|21074720|P2|COMPLETED|Overall Study||26
8548181|NCT00158600|21074721|P1|COMPLETED|Overall Study||55
8548182|NCT00158600|21074720|P2|STARTED|Overall Study||30
8548183|NCT00158600|21074721|P1|STARTED|Overall Study||60
8548184|NCT00158379|21074739|P1|NOT COMPLETED|Overall Study||0
8548185|NCT00158379|21074739|P1|COMPLETED|Overall Study||105
8548186|NCT00158379|21074739|P1|STARTED|Overall Study||105
8548187|NCT00158262|21074746|P2|NOT COMPLETED|Overall Study||1
8548188|NCT00158262|21074747|P1|NOT COMPLETED|Overall Study||1
8548189|NCT00158262|21074746|P2|COMPLETED|Overall Study||21
8548190|NCT00158262|21074747|P1|COMPLETED|Overall Study||20
8548191|NCT00158262|21074746|P2|STARTED|Overall Study||22
8548192|NCT00158262|21074747|P1|STARTED|Overall Study||21
8548193|NCT00158249|21074759|P2|NOT COMPLETED|Overall Study||0
8548194|NCT00158249|21074760|P1|NOT COMPLETED|Overall Study||2
8548195|NCT00158249|21074759|P2|COMPLETED|Overall Study||10
8548196|NCT00158249|21074760|P1|COMPLETED|Overall Study||9
8548197|NCT00158249|21074759|P2|STARTED|Overall Study||10
8548198|NCT00158249|21074760|P1|STARTED|Overall Study||11
8548199|NCT00158223|21074770|P2|NOT COMPLETED|Overall Study||3
8548200|NCT00158223|21074771|P1|NOT COMPLETED|Overall Study||5
8548201|NCT00158223|21074770|P2|COMPLETED|Overall Study||22
8548202|NCT00158223|21074771|P1|COMPLETED|Overall Study||23
8548203|NCT00158223|21074770|P2|STARTED|Overall Study||25
8548204|NCT00158223|21074771|P1|STARTED|Overall Study||28
8548205|NCT00158197|21074785|P4|NOT COMPLETED|Overall Study||0
8548206|NCT00158197|21074786|P3|NOT COMPLETED|Overall Study||0
8548207|NCT00158197|21074787|P2|NOT COMPLETED|Overall Study||0
8548208|NCT00158197|21074788|P1|NOT COMPLETED|Overall Study||0
8548209|NCT00158197|21074785|P4|COMPLETED|Overall Study||29
8548210|NCT00158197|21074786|P3|COMPLETED|Overall Study||28
8548211|NCT00158197|21074787|P2|COMPLETED|Overall Study||30
8548212|NCT00158197|21074788|P1|COMPLETED|Overall Study||32
8548213|NCT00158197|21074785|P4|STARTED|Overall Study||29
8548214|NCT00158197|21074786|P3|STARTED|Overall Study||28
8548215|NCT00158197|21074787|P2|STARTED|Overall Study||30
8548216|NCT00158197|21074788|P1|STARTED|Overall Study||32
8548217|NCT00158184|21074808|P2|NOT COMPLETED|Overall Study||2
8548218|NCT00158184|21074809|P1|NOT COMPLETED|Overall Study||6
8548219|NCT00158184|21074808|P2|COMPLETED|Overall Study||9
8548220|NCT00158184|21074809|P1|COMPLETED|Overall Study||10
8548221|NCT00158184|21074808|P2|STARTED|Overall Study||11
8548222|NCT00158184|21074809|P1|STARTED|Overall Study||16
8548223|NCT00158054|21074819|P2|NOT COMPLETED|Overall Study||3
8548224|NCT00158054|21074820|P1|NOT COMPLETED|Overall Study||10
8548225|NCT00158054|21074819|P2|COMPLETED|Overall Study||74
8548226|NCT00158054|21074820|P1|COMPLETED|Overall Study||70
8548227|NCT00158054|21074819|P2|STARTED|Overall Study||77
8548228|NCT00158054|21074820|P1|STARTED|Overall Study||80
8548229|NCT00157950|21074834|P2|NOT COMPLETED|Overall Study||0
8548230|NCT00157950|21074835|P1|NOT COMPLETED|Overall Study||1
8548231|NCT00157950|21074834|P2|COMPLETED|Overall Study||59
8548232|NCT00157950|21074835|P1|COMPLETED|Overall Study||116
8548233|NCT00157950|21074834|P2|Vaccinated at Dose 3|Overall Study||59
8548234|NCT00157950|21074835|P1|Vaccinated at Dose 3|Overall Study||116
8548235|NCT00157950|21074834|P2|Vaccinated at Dose 2|Overall Study||59
8548236|NCT00157950|21074835|P1|Vaccinated at Dose 2|Overall Study||117
8548237|NCT00157950|21074834|P2|Vaccinated at Dose 1|Overall Study||59
8548238|NCT00157950|21074835|P1|Vaccinated at Dose 1|Overall Study||117
8548239|NCT00157950|21074834|P2|STARTED|Overall Study||59
8548240|NCT00157950|21074835|P1|STARTED|Overall Study||117
8548241|NCT00157820|21074852|P3|NOT COMPLETED|2nd 8 Months||14
8548242|NCT00157820|21074853|P2|NOT COMPLETED|2nd 8 Months||13
8548243|NCT00157820|21074854|P1|NOT COMPLETED|2nd 8 Months||5
8548244|NCT00157820|21074852|P3|COMPLETED|2nd 8 Months||94
8548245|NCT00157820|21074853|P2|COMPLETED|2nd 8 Months||88
8548246|NCT00157820|21074854|P1|COMPLETED|2nd 8 Months||98
8548247|NCT00157820|21074852|P3|STARTED|2nd 8 Months||108
8548248|NCT00157820|21074853|P2|STARTED|2nd 8 Months||101
8548249|NCT00157820|21074854|P1|STARTED|2nd 8 Months||103
8548250|NCT00157820|21074852|P3|NOT COMPLETED|1 Month Wash Out Period||0
8548251|NCT00157820|21074853|P2|NOT COMPLETED|1 Month Wash Out Period||0
8548252|NCT00157820|21074854|P1|NOT COMPLETED|1 Month Wash Out Period||0
8548253|NCT00157820|21074852|P3|COMPLETED|1 Month Wash Out Period||108
8548254|NCT00157820|21074853|P2|COMPLETED|1 Month Wash Out Period||101
8548255|NCT00157820|21074854|P1|COMPLETED|1 Month Wash Out Period||103
8548256|NCT00157820|21074852|P3|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
8548257|NCT00157820|21074853|P2|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
8548258|NCT00157820|21074854|P1|STARTED|1 Month Wash Out Period||103
8548259|NCT00157820|21074852|P3|NOT COMPLETED|1st 8 Month||6
8548260|NCT00157820|21074853|P2|NOT COMPLETED|1st 8 Month||12
8548261|NCT00157820|21074854|P1|NOT COMPLETED|1st 8 Month||8
8548262|NCT00157820|21074852|P3|COMPLETED|1st 8 Month||106
8548263|NCT00157820|21074853|P2|COMPLETED|1st 8 Month||99
8548264|NCT00157820|21074854|P1|COMPLETED|1st 8 Month||103
8548265|NCT00157820|21074852|P3|STARTED|1st 8 Month||112
8548266|NCT00157820|21074853|P2|STARTED|1st 8 Month||111
8548267|NCT00157820|21074854|P1|STARTED|1st 8 Month||111
8548268|NCT00157820|21074852|P3|NOT COMPLETED|Randomized||8
8548269|NCT00157820|21074853|P2|NOT COMPLETED|Randomized||5
8548270|NCT00157820|21074854|P1|NOT COMPLETED|Randomized||7
8548271|NCT00157820|21074852|P3|COMPLETED|Randomized||112
8548272|NCT00157820|21074853|P2|COMPLETED|Randomized||111
8548273|NCT00157820|21074854|P1|COMPLETED|Randomized||111
8548274|NCT00157820|21074852|P3|STARTED|Randomized||120
8548275|NCT00157820|21074853|P2|STARTED|Randomized||116
8548276|NCT00157820|21074854|P1|STARTED|Randomized||118
8548277|NCT00157755|21074867|P6|NOT COMPLETED|Overall Study||5
8548278|NCT00157755|21074868|P5|NOT COMPLETED|Overall Study||2
8548279|NCT00157755|21074869|P4|NOT COMPLETED|Overall Study||4
8548280|NCT00157755|21074870|P3|NOT COMPLETED|Overall Study||7
8548281|NCT00157755|21074871|P2|NOT COMPLETED|Overall Study||4
8548282|NCT00157755|21074872|P1|NOT COMPLETED|Overall Study||2
8548283|NCT00157755|21074867|P6|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
8548284|NCT00157755|21074868|P5|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
8548285|NCT00157755|21074869|P4|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
8548286|NCT00157755|21074870|P3|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
8548287|NCT00157755|21074871|P2|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
8548288|NCT00157755|21074872|P1|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
8548289|NCT00157755|21074867|P6|STARTED|Overall Study||5
8548290|NCT00157755|21074868|P5|STARTED|Overall Study||12
8548291|NCT00157755|21074869|P4|STARTED|Overall Study||15
8548292|NCT00157755|21074870|P3|STARTED|Overall Study||10
8548293|NCT00157755|21074871|P2|STARTED|Overall Study||19
8548294|NCT00157755|21074872|P1|STARTED|Overall Study||26
8548295|NCT00157573|21074894|P2|NOT COMPLETED|Overall Study||0
8548296|NCT00157573|21074895|P1|NOT COMPLETED|Overall Study||0
8548297|NCT00157573|21074894|P2|COMPLETED|Overall Study||37
8548298|NCT00157573|21074895|P1|COMPLETED|Overall Study||35
8548299|NCT00157573|21074894|P2|STARTED|Overall Study||37
8548300|NCT00157573|21074895|P1|STARTED|Overall Study||35
8548301|NCT00157248|21074908|P4|NOT COMPLETED|Overall Study||47
8548302|NCT00157248|21074909|P3|NOT COMPLETED|Overall Study||21
8548303|NCT00157248|21074910|P2|NOT COMPLETED|Overall Study||37
8548304|NCT00157248|21074911|P1|NOT COMPLETED|Overall Study||48
8548305|NCT00157248|21074908|P4|COMPLETED|Overall Study||77
8548306|NCT00157248|21074909|P3|COMPLETED|Overall Study||29
8548307|NCT00157248|21074910|P2|COMPLETED|Overall Study||52
8548308|NCT00157248|21074911|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
8548309|NCT00157248|21074908|P4|STARTED|Overall Study||124
8548310|NCT00157248|21074909|P3|STARTED|Overall Study||50
8548311|NCT00157248|21074910|P2|STARTED|Overall Study||89
8548312|NCT00157248|21074911|P1|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
8548313|NCT00157209|21075017|P2|NOT COMPLETED|Overall Study||0
8548314|NCT00157209|21075018|P1|NOT COMPLETED|Overall Study||10
8548315|NCT00157209|21075017|P2|COMPLETED|Overall Study||83
8548316|NCT00157209|21075018|P1|COMPLETED|Overall Study||78
8548317|NCT00157209|21075017|P2|STARTED|Overall Study||83
8548318|NCT00157209|21075018|P1|STARTED|Overall Study||88
8548319|NCT00157196|21075032|P1|NOT COMPLETED|Overall Study||9
8548320|NCT00157196|21075032|P1|COMPLETED|Overall Study||13
8548321|NCT00157196|21075032|P1|STARTED|Overall Study||22
8548325|NCT00157014|21075065|P4|NOT COMPLETED|Overall Study||1
8548326|NCT00157014|21075066|P3|NOT COMPLETED|Overall Study||1
8548327|NCT00157014|21075067|P2|NOT COMPLETED|Overall Study||5
8548328|NCT00157014|21075068|P1|NOT COMPLETED|Overall Study||7
8548329|NCT00157014|21075065|P4|COMPLETED|Overall Study||5
8548330|NCT00157014|21075066|P3|COMPLETED|Overall Study||4
8548331|NCT00157014|21075067|P2|COMPLETED|Overall Study||41
8548332|NCT00157014|21075068|P1|COMPLETED|Overall Study||45
8548333|NCT00157014|21075065|P4|STARTED|Overall Study||6
8548334|NCT00157014|21075066|P3|STARTED|Overall Study||5
8548335|NCT00157014|21075067|P2|STARTED|Overall Study||46
8548336|NCT00157014|21075068|P1|STARTED|Overall Study||52
8548337|NCT00156936|21075148|P2|NOT COMPLETED|Overall Study||11
8548338|NCT00156936|21075149|P1|NOT COMPLETED|Overall Study||72
8548339|NCT00156936|21075148|P2|COMPLETED|Overall Study||5
8548340|NCT00156936|21075149|P1|COMPLETED|Overall Study||20
8548341|NCT00156936|21075148|P2|STARTED|Overall Study||16
8548342|NCT00156936|21075149|P1|STARTED|Overall Study||92
8548343|NCT00156923|21075157|P2|NOT COMPLETED|Overall Study||32
8548344|NCT00156923|21075158|P1|NOT COMPLETED|Overall Study||34
8548345|NCT00156923|21075157|P2|COMPLETED|Overall Study||20
8548346|NCT00156923|21075158|P1|COMPLETED|Overall Study||22
8548347|NCT00156923|21075157|P2|STARTED|Overall Study||52
8548348|NCT00156923|21075158|P1|STARTED|Overall Study||56
8548349|NCT00156910|21075166|P2|NOT COMPLETED|Open-Label Phase (OL)||55
8548350|NCT00156910|21075167|P1|NOT COMPLETED|Open-Label Phase (OL)||33
8548351|NCT00156910|21075166|P2|COMPLETED|Open-Label Phase (OL)||231
8548352|NCT00156910|21075167|P1|COMPLETED|Open-Label Phase (OL)||252
8548353|NCT00156910|21075166|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
8548354|NCT00156910|21075167|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
8548355|NCT00156910|21075166|P2|NOT COMPLETED|Double-Blind Phase (DB)||43
8548356|NCT00156910|21075167|P1|NOT COMPLETED|Double-Blind Phase (DB)||45
8548357|NCT00156910|21075166|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
8548358|NCT00156910|21075167|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
8548359|NCT00156910|21075166|P2|STARTED|Double-Blind Phase (DB)||338
8548360|NCT00156910|21075167|P1|STARTED|Double-Blind Phase (DB)||341
8548361|NCT00156819|21075184|P3|NOT COMPLETED|Overall Study||3
8548362|NCT00156819|21075185|P2|NOT COMPLETED|Overall Study||1
8548363|NCT00156819|21075186|P1|NOT COMPLETED|Overall Study||1
8548364|NCT00156819|21075184|P3|COMPLETED|Overall Study||162
8548365|NCT00156819|21075185|P2|COMPLETED|Overall Study||165
8548366|NCT00156819|21075186|P1|COMPLETED|Overall Study||168
8548367|NCT00156819|21075184|P3|STARTED|Overall Study||165
8548368|NCT00156819|21075185|P2|STARTED|Overall Study||166
8548369|NCT00156819|21075186|P1|STARTED|Overall Study||169
8548370|NCT00156715|21075194|P1|NOT COMPLETED|Overall Study||7
8548371|NCT00156715|21075194|P1|COMPLETED|Overall Study||16
8548372|NCT00156715|21075194|P1|STARTED|Overall Study||23
8548373|NCT00156533|21075203|P4|NOT COMPLETED|Overall Study||2
8548374|NCT00156533|21075204|P3|NOT COMPLETED|Overall Study||2
8548375|NCT00156533|21075205|P2|NOT COMPLETED|Overall Study||2
8548376|NCT00156533|21075206|P1|NOT COMPLETED|Overall Study||2
8548377|NCT00156533|21075203|P4|COMPLETED|Overall Study||3
8548378|NCT00156533|21075204|P3|COMPLETED|Overall Study||3
8548379|NCT00156533|21075205|P2|COMPLETED|Overall Study||3
8548380|NCT00156533|21075206|P1|COMPLETED|Overall Study||3
8548381|NCT00156533|21075203|P4|STARTED|Overall Study||5
8548382|NCT00156533|21075204|P3|STARTED|Overall Study||5
8548383|NCT00156533|21075205|P2|STARTED|Overall Study||5
8548384|NCT00156533|21075206|P1|STARTED|Overall Study||5
8548385|NCT00156390|21075222|P2|NOT COMPLETED|Overall Study||8
8548386|NCT00156390|21075223|P1|NOT COMPLETED|Overall Study||14
8548387|NCT00156390|21075222|P2|COMPLETED|Overall Study||69
8548388|NCT00156390|21075223|P1|COMPLETED|Overall Study||96
8548389|NCT00156390|21075222|P2|STARTED|Overall Study||77
8548390|NCT00156390|21075223|P1|STARTED|Overall Study||110
8548391|NCT00156247|21075231|P1|NOT COMPLETED|Overall Study||4
8548392|NCT00156247|21075231|P1|COMPLETED|Overall Study||5
8548393|NCT00156247|21075231|P1|STARTED|Overall Study||9
8548394|NCT00156065|21075240|P3|NOT COMPLETED|Overall Study||27
8548395|NCT00156065|21075241|P2|NOT COMPLETED|Overall Study||63
8548396|NCT00156065|21075242|P1|NOT COMPLETED|Overall Study||31
8548397|NCT00156065|21075240|P3|COMPLETED|Overall Study||16
8548398|NCT00156065|21075241|P2|COMPLETED|Overall Study||30
8548399|NCT00156065|21075242|P1|COMPLETED|Overall Study||20
8548400|NCT00156065|21075240|P3|STARTED|Overall Study||43
8548401|NCT00156065|21075241|P2|STARTED|Overall Study||93
8548402|NCT00156065|21075242|P1|STARTED|Overall Study||51
8548403|NCT00156013|21075253|P1|NOT COMPLETED|Overall Study||2
8548404|NCT00156013|21075253|P1|COMPLETED|Overall Study||31
8548405|NCT00156013|21075253|P1|STARTED|Overall Study||33
8548406|NCT00154466|21075262|P3|NOT COMPLETED|Overall Study||0
8548407|NCT00154466|21075263|P2|NOT COMPLETED|Overall Study||0
8548408|NCT00154466|21075264|P1|NOT COMPLETED|Overall Study||0
8548409|NCT00154466|21075262|P3|COMPLETED|Overall Study||19
8548410|NCT00154466|21075263|P2|COMPLETED|Overall Study||19
8548411|NCT00154466|21075264|P1|COMPLETED|Overall Study||20
8548412|NCT00154466|21075262|P3|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
8548413|NCT00154466|21075263|P2|STARTED|Overall Study||19
8548414|NCT00154466|21075264|P1|STARTED|Overall Study||20
8548415|NCT00154375|21075276|P2|NOT COMPLETED|Overall Study||106
8548416|NCT00154375|21075277|P1|NOT COMPLETED|Overall Study||113
8548417|NCT00154375|21075276|P2|COMPLETED|Overall Study||14
8548418|NCT00154375|21075277|P1|COMPLETED|Overall Study||7
8548419|NCT00154375|21075276|P2|Not Exposed to Study Treatment|Overall Study||2
8548420|NCT00154375|21075277|P1|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
8548421|NCT00154375|21075276|P2|Discontinued Study Treatment|Overall Study||104
8548422|NCT00154375|21075277|P1|Discontinued Study Treatment|Overall Study||111
8548423|NCT00154375|21075276|P2|STARTED|Overall Study||120
8548424|NCT00154375|21075277|P1|STARTED|Overall Study||120
8548425|NCT00154310|21075288|P2|NOT COMPLETED|Overall Study||28
8548426|NCT00154310|21075289|P1|NOT COMPLETED|Overall Study||37
8548427|NCT00154310|21075288|P2|COMPLETED|Overall Study||117
8548428|NCT00154310|21075289|P1|COMPLETED|Overall Study||118
8548429|NCT00154310|21075288|P2|STARTED|Overall Study||145
8548430|NCT00154310|21075289|P1|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
8548431|NCT00154297|21075305|P2|NOT COMPLETED|Overall Study||7
8548432|NCT00154297|21075306|P1|NOT COMPLETED|Overall Study||8
8548433|NCT00154297|21075305|P2|COMPLETED|Overall Study|Completed study by 12 month.|67
8548434|NCT00154297|21075306|P1|COMPLETED|Overall Study|Completed study by 12 month.|57
8548435|NCT00154297|21075305|P2|STARTED|Overall Study|Randomized population.|74
8548436|NCT00154297|21075306|P1|STARTED|Overall Study|Randomized population.|65
8548437|NCT00154284|21075324|P2|NOT COMPLETED|Overall Study||13
8548438|NCT00154284|21075325|P1|NOT COMPLETED|Overall Study||7
8548439|NCT00154284|21075324|P2|COMPLETED|Overall Study||42
8548440|NCT00154284|21075325|P1|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
8548441|NCT00154284|21075324|P2|Intent to Treat (ITT) Population|Overall Study||53
8548442|NCT00154284|21075325|P1|Intent to Treat (ITT) Population|Overall Study||57
8548443|NCT00154284|21075324|P2|STARTED|Overall Study||55
8548444|NCT00154284|21075325|P1|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
8548445|NCT00154102|21075339|P2|NOT COMPLETED|Overall Study||2
8548446|NCT00154102|21075340|P1|NOT COMPLETED|Overall Study||7
8548447|NCT00154102|21075339|P2|COMPLETED|Overall Study||597
8548448|NCT00154102|21075340|P1|COMPLETED|Overall Study||592
8548449|NCT00154102|21075339|P2|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
8548450|NCT00154102|21075340|P1|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
8548451|NCT00154063|21075376|P2|NOT COMPLETED|Overall Study||22
8548452|NCT00154063|21075377|P1|NOT COMPLETED|Overall Study||12
8548453|NCT00154063|21075376|P2|COMPLETED|Overall Study||80
8548454|NCT00154063|21075377|P1|COMPLETED|Overall Study||92
8548455|NCT00154063|21075376|P2|STARTED|Overall Study||102
8548456|NCT00154063|21075377|P1|STARTED|Overall Study||104
8548457|NCT00153985|21075433|P1|NOT COMPLETED|Overall Study||0
8548458|NCT00153985|21075433|P1|COMPLETED|Overall Study||2
8548459|NCT00153985|21075433|P1|STARTED|Overall Study||2
8548460|NCT00153920|21075439|P1|NOT COMPLETED|Overall Study||30
8548461|NCT00153920|21075439|P1|COMPLETED|Overall Study||36
8548462|NCT00153920|21075439|P1|Eligible and Treated|Overall Study||64
8548463|NCT00153920|21075439|P1|STARTED|Overall Study||66
8548464|NCT00153842|21075450|P2|NOT COMPLETED|Overall Study||0
8548465|NCT00153842|21075451|P1|NOT COMPLETED|Overall Study||0
8548466|NCT00153842|21075450|P2|COMPLETED|Overall Study||7
8548467|NCT00153842|21075451|P1|COMPLETED|Overall Study||26
8548468|NCT00153842|21075450|P2|STARTED|Overall Study||7
8548469|NCT00153842|21075451|P1|STARTED|Overall Study||26
8548470|NCT00153816|21075465|P6|NOT COMPLETED|Overall Study||27
8548471|NCT00153816|21075466|P5|NOT COMPLETED|Overall Study||17
8548472|NCT00153816|21075467|P4|NOT COMPLETED|Overall Study||31
8548473|NCT00153816|21075468|P3|NOT COMPLETED|Overall Study||32
8548474|NCT00153816|21075469|P2|NOT COMPLETED|Overall Study||32
8548475|NCT00153816|21075470|P1|NOT COMPLETED|Overall Study||32
8548476|NCT00153816|21075465|P6|COMPLETED|Overall Study||262
8548477|NCT00153816|21075466|P5|COMPLETED|Overall Study||278
8548478|NCT00153816|21075467|P4|COMPLETED|Overall Study||390
8548479|NCT00153816|21075468|P3|COMPLETED|Overall Study||388
8548480|NCT00153816|21075469|P2|COMPLETED|Overall Study||387
8548481|NCT00153816|21075470|P1|COMPLETED|Overall Study||383
8548482|NCT00153816|21075465|P6|STARTED|Overall Study||289
8548483|NCT00153816|21075466|P5|STARTED|Overall Study||295
8548484|NCT00153816|21075467|P4|STARTED|Overall Study||421
8548485|NCT00153816|21075468|P3|STARTED|Overall Study||420
8548486|NCT00153816|21075469|P2|STARTED|Overall Study||419
8548487|NCT00153816|21075470|P1|STARTED|Overall Study||415
8548488|NCT00153803|21075492|P2|NOT COMPLETED|Investigational Drug||42
8548489|NCT00153803|21075493|P1|NOT COMPLETED|Investigational Drug||41
8548490|NCT00153803|21075492|P2|COMPLETED|Investigational Drug||75
8548491|NCT00153803|21075493|P1|COMPLETED|Investigational Drug||77
8548492|NCT00153803|21075492|P2|Investigational Drug Dispensed|Investigational Drug||75
8548493|NCT00153803|21075493|P1|Investigational Drug Dispensed|Investigational Drug||77
8548494|NCT00153803|21075492|P2|STARTED|Investigational Drug||117
8548495|NCT00153803|21075493|P1|STARTED|Investigational Drug||118
8548496|NCT00153803|21075492|P2|NOT COMPLETED|Concurrent Chemoradiation||5
8548497|NCT00153803|21075493|P1|NOT COMPLETED|Concurrent Chemoradiation||5
8548498|NCT00153803|21075492|P2|COMPLETED|Concurrent Chemoradiation||117
8548499|NCT00153803|21075493|P1|COMPLETED|Concurrent Chemoradiation||118
8548500|NCT00153803|21075492|P2|Received Chemoradiation|Concurrent Chemoradiation||117
8548501|NCT00153803|21075493|P1|Received Chemoradiation|Concurrent Chemoradiation||118
8548502|NCT00153803|21075492|P2|STARTED|Concurrent Chemoradiation||122
8548503|NCT00153803|21075493|P1|STARTED|Concurrent Chemoradiation||123
8548504|NCT00153179|21075511|P4|NOT COMPLETED|Study Visit Day 2||2
8548505|NCT00153179|21075512|P3|NOT COMPLETED|Study Visit Day 2||2
8548506|NCT00153179|21075513|P2|NOT COMPLETED|Study Visit Day 2||0
8548507|NCT00153179|21075514|P1|NOT COMPLETED|Study Visit Day 2||1
8548508|NCT00153179|21075511|P4|COMPLETED|Study Visit Day 2||7
8548509|NCT00153179|21075512|P3|COMPLETED|Study Visit Day 2||11
8548510|NCT00153179|21075513|P2|COMPLETED|Study Visit Day 2||8
8548511|NCT00153179|21075514|P1|COMPLETED|Study Visit Day 2||9
8548512|NCT00153179|21075511|P4|STARTED|Study Visit Day 2||9
8548513|NCT00153179|21075512|P3|STARTED|Study Visit Day 2||13
8548514|NCT00153179|21075513|P2|STARTED|Study Visit Day 2||8
8548515|NCT00153179|21075514|P1|STARTED|Study Visit Day 2||10
8548516|NCT00153179|21075511|P4|NOT COMPLETED|Study Visit Day 1||0
8548517|NCT00153179|21075512|P3|NOT COMPLETED|Study Visit Day 1||0
8548518|NCT00153179|21075513|P2|NOT COMPLETED|Study Visit Day 1||0
8548519|NCT00153179|21075514|P1|NOT COMPLETED|Study Visit Day 1||0
8548520|NCT00153179|21075511|P4|COMPLETED|Study Visit Day 1||9
8548521|NCT00153179|21075512|P3|COMPLETED|Study Visit Day 1||13
8548522|NCT00153179|21075513|P2|COMPLETED|Study Visit Day 1||8
8548523|NCT00153179|21075514|P1|COMPLETED|Study Visit Day 1||10
8548524|NCT00153179|21075511|P4|STARTED|Study Visit Day 1||9
8548525|NCT00153179|21075512|P3|STARTED|Study Visit Day 1||13
8548526|NCT00153179|21075513|P2|STARTED|Study Visit Day 1||8
8548527|NCT00153179|21075514|P1|STARTED|Study Visit Day 1||10
8548528|NCT00153166|21075527|P3|NOT COMPLETED|Overall Study||0
8548529|NCT00153166|21075528|P2|NOT COMPLETED|Overall Study||0
8548530|NCT00153166|21075529|P1|NOT COMPLETED|Overall Study||0
8548531|NCT00153166|21075527|P3|COMPLETED|Overall Study||28
8548532|NCT00153166|21075528|P2|COMPLETED|Overall Study||37
8548533|NCT00153166|21075529|P1|COMPLETED|Overall Study||11
8548534|NCT00153166|21075527|P3|Received Placebo and Placebo|Overall Study||7
8548535|NCT00153166|21075528|P2|Received Placebo and Placebo|Overall Study||9
8548536|NCT00153166|21075529|P1|Received Placebo and Placebo|Overall Study||3
8548537|NCT00153166|21075527|P3|Received Placebo and Pioglitazone|Overall Study||7
8548538|NCT00153166|21075528|P2|Received Placebo and Pioglitazone|Overall Study||10
8548539|NCT00153166|21075529|P1|Received Placebo and Pioglitazone|Overall Study||3
8548540|NCT00153166|21075527|P3|Received Atorvastatin and Placebo|Overall Study||7
8548541|NCT00153166|21075528|P2|Received Atorvastatin and Placebo|Overall Study||9
8548542|NCT00153166|21075529|P1|Received Atorvastatin and Placebo|Overall Study||2
8548543|NCT00153166|21075527|P3|Received Atorvastatin and Pioglitazone|Overall Study||7
8548544|NCT00153166|21075528|P2|Received Atorvastatin and Pioglitazone|Overall Study||9
8548545|NCT00153166|21075529|P1|Received Atorvastatin and Pioglitazone|Overall Study||3
8548546|NCT00153166|21075527|P3|STARTED|Overall Study||28
8548547|NCT00153166|21075528|P2|STARTED|Overall Study||37
8548548|NCT00153166|21075529|P1|STARTED|Overall Study||11
8548549|NCT00153101|21075546|P5|NOT COMPLETED|Overall Study||10
8548550|NCT00153101|21075547|P4|NOT COMPLETED|Overall Study||8
8548551|NCT00153101|21075548|P3|NOT COMPLETED|Overall Study||15
8548552|NCT00153101|21075549|P2|NOT COMPLETED|Overall Study||18
8548553|NCT00153101|21075550|P1|NOT COMPLETED|Overall Study||17
8548554|NCT00153101|21075546|P5|COMPLETED|Overall Study||2962
8548555|NCT00153101|21075547|P4|COMPLETED|Overall Study||2946
8548556|NCT00153101|21075548|P3|COMPLETED|Overall Study||8561
8548557|NCT00153101|21075549|P2|COMPLETED|Overall Study||8524
8548558|NCT00153101|21075550|P1|COMPLETED|Overall Study||8485
8548559|NCT00153101|21075546|P5|STARTED|Overall Study||2972
8548560|NCT00153101|21075547|P4|STARTED|Overall Study||2954
8548561|NCT00153101|21075548|P3|STARTED|Overall Study||8576
8548562|NCT00153101|21075549|P2|STARTED|Overall Study||8542
8548563|NCT00153101|21075550|P1|STARTED|Overall Study||8502
8548564|NCT00153062|21075658|P4|NOT COMPLETED|Overall Study||411
8548565|NCT00153062|21075659|P3|NOT COMPLETED|Overall Study||415
8548566|NCT00153062|21075660|P2|NOT COMPLETED|Overall Study||406
8548567|NCT00153062|21075661|P1|NOT COMPLETED|Overall Study||387
8548568|NCT00153062|21075658|P4|COMPLETED|Overall Study||4680
8548569|NCT00153062|21075659|P3|COMPLETED|Overall Study||4645
8548570|NCT00153062|21075660|P2|COMPLETED|Overall Study||4689
8548571|NCT00153062|21075661|P1|COMPLETED|Overall Study||4699
8548572|NCT00153062|21075658|P4|STARTED|Overall Study||5091
8548573|NCT00153062|21075659|P3|STARTED|Overall Study||5060
8548574|NCT00153062|21075660|P2|STARTED|Overall Study||5095
8548575|NCT00153062|21075661|P1|STARTED|Overall Study||5086
8548576|NCT00152971|21075680|P3|NOT COMPLETED|Treatment||80
8548577|NCT00152971|21075681|P2|NOT COMPLETED|Treatment||63
8548578|NCT00152971|21075682|P1|NOT COMPLETED|Treatment||71
8548579|NCT00152971|21075680|P3|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
8548580|NCT00152971|21075681|P2|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
8548581|NCT00152971|21075682|P1|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
8548582|NCT00152971|21075680|P3|STARTED|Treatment||868
8548583|NCT00152971|21075681|P2|STARTED|Treatment||871
8548584|NCT00152971|21075682|P1|STARTED|Treatment||857
8548585|NCT00152971|21075680|P3|NOT COMPLETED|Overall Study||49
8548586|NCT00152971|21075681|P2|NOT COMPLETED|Overall Study||48
8548587|NCT00152971|21075682|P1|NOT COMPLETED|Overall Study||51
8548588|NCT00152971|21075680|P3|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
8548589|NCT00152971|21075681|P2|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
8548590|NCT00152971|21075682|P1|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
8548591|NCT00152971|21075680|P3|STARTED|Overall Study||868
8548592|NCT00152971|21075681|P2|STARTED|Overall Study||871
8548593|NCT00152971|21075682|P1|STARTED|Overall Study||857
8548594|NCT00152763|21075718|P4|NOT COMPLETED|Overall Study||14
8548595|NCT00152763|21075719|P3|NOT COMPLETED|Overall Study||4
8548596|NCT00152763|21075720|P2|NOT COMPLETED|Overall Study||5
8548597|NCT00152763|21075721|P1|NOT COMPLETED|Overall Study||10
8548598|NCT00152763|21075718|P4|COMPLETED|Overall Study||63
8548599|NCT00152763|21075719|P3|COMPLETED|Overall Study||16
8548600|NCT00152763|21075720|P2|COMPLETED|Overall Study||14
8548601|NCT00152763|21075721|P1|COMPLETED|Overall Study||67
8548602|NCT00152763|21075718|P4|STARTED|Overall Study||77
8548603|NCT00152763|21075719|P3|STARTED|Overall Study||20
8548604|NCT00152763|21075720|P2|STARTED|Overall Study||19
8548605|NCT00152763|21075721|P1|STARTED|Overall Study||77
8548606|NCT00152516|21075837|P1|NOT COMPLETED|Overall Study||75
8548607|NCT00152516|21075837|P1|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
8548608|NCT00152516|21075837|P1|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
8548609|NCT00152464|21075863|P2|NOT COMPLETED|Overall Study||36
8548610|NCT00152464|21075864|P1|NOT COMPLETED|Overall Study||40
8548611|NCT00152464|21075863|P2|COMPLETED|Overall Study||219
8548612|NCT00152464|21075864|P1|COMPLETED|Overall Study||215
8548613|NCT00152464|21075863|P2|STARTED|Overall Study||255
8548614|NCT00152464|21075864|P1|STARTED|Overall Study||255
8548639|NCT00151814|21075962|P3|NOT COMPLETED|Overall Study||0
8548640|NCT00151814|21075963|P2|NOT COMPLETED|Overall Study||0
8548641|NCT00151814|21075964|P1|NOT COMPLETED|Overall Study||0
8548642|NCT00151814|21075962|P3|COMPLETED|Overall Study||10
8548643|NCT00151814|21075963|P2|COMPLETED|Overall Study||10
8548644|NCT00151814|21075964|P1|COMPLETED|Overall Study||4
8548645|NCT00151814|21075962|P3|STARTED|Overall Study||10
8548646|NCT00151814|21075963|P2|STARTED|Overall Study||10
8548647|NCT00151814|21075964|P1|STARTED|Overall Study||4
8548648|NCT00151775|21075990|P12|NOT COMPLETED|Period 4: Open Label||0
8548649|NCT00151775|21075991|P11|NOT COMPLETED|Period 4: Open Label||0
8548650|NCT00151775|21075992|P10|NOT COMPLETED|Period 4: Open Label||21
8548651|NCT00151775|21075993|P9|NOT COMPLETED|Period 4: Open Label||0
8548652|NCT00151775|21075994|P8|NOT COMPLETED|Period 4: Open Label||0
8548653|NCT00151775|21075995|P7|NOT COMPLETED|Period 4: Open Label||0
8548654|NCT00151775|21075996|P6|NOT COMPLETED|Period 4: Open Label||0
8548655|NCT00151775|21075997|P5|NOT COMPLETED|Period 4: Open Label||30
8548656|NCT00151775|21075998|P4|NOT COMPLETED|Period 4: Open Label||0
8548657|NCT00151775|21075999|P3|NOT COMPLETED|Period 4: Open Label||0
8548658|NCT00151775|21076000|P2|NOT COMPLETED|Period 4: Open Label||0
8548659|NCT00151775|21076001|P1|NOT COMPLETED|Period 4: Open Label||0
8548660|NCT00151775|21075990|P12|COMPLETED|Period 4: Open Label||0
8548661|NCT00151775|21075991|P11|COMPLETED|Period 4: Open Label||57
8548662|NCT00151775|21075992|P10|COMPLETED|Period 4: Open Label||83
8548663|NCT00151775|21075993|P9|COMPLETED|Period 4: Open Label||0
8548664|NCT00151775|21075994|P8|COMPLETED|Period 4: Open Label||0
8548665|NCT00151775|21075995|P7|COMPLETED|Period 4: Open Label||0
8548666|NCT00151775|21075996|P6|COMPLETED|Period 4: Open Label||0
8548667|NCT00151775|21075997|P5|COMPLETED|Period 4: Open Label||149
8548668|NCT00151775|21075998|P4|COMPLETED|Period 4: Open Label||0
8548669|NCT00151775|21075999|P3|COMPLETED|Period 4: Open Label||0
8548670|NCT00151775|21076000|P2|COMPLETED|Period 4: Open Label||0
8548671|NCT00151775|21076001|P1|COMPLETED|Period 4: Open Label||0
8548672|NCT00151775|21075990|P12|STARTED|Period 4: Open Label||0
8548673|NCT00151775|21075991|P11|STARTED|Period 4: Open Label||57
8548674|NCT00151775|21075992|P10|STARTED|Period 4: Open Label||104
8548675|NCT00151775|21075993|P9|STARTED|Period 4: Open Label||0
8548676|NCT00151775|21075994|P8|STARTED|Period 4: Open Label||0
8548677|NCT00151775|21075995|P7|STARTED|Period 4: Open Label||0
8548678|NCT00151775|21075996|P6|STARTED|Period 4: Open Label||0
8548679|NCT00151775|21075997|P5|STARTED|Period 4: Open Label||179
8548680|NCT00151775|21075998|P4|STARTED|Period 4: Open Label||0
8548681|NCT00151775|21075999|P3|STARTED|Period 4: Open Label||0
8548682|NCT00151775|21076000|P2|STARTED|Period 4: Open Label||0
8548683|NCT00151775|21076001|P1|STARTED|Period 4: Open Label||0
8548684|NCT00151775|21075990|P12|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
8548685|NCT00151775|21075991|P11|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8548686|NCT00151775|21075992|P10|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8548687|NCT00151775|21075993|P9|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8548688|NCT00151775|21075994|P8|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
8548689|NCT00151775|21075995|P7|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
8548690|NCT00151775|21075996|P6|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
8548691|NCT00151775|21075997|P5|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8548692|NCT00151775|21075998|P4|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8548693|NCT00151775|21075999|P3|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
8548694|NCT00151775|21076000|P2|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8548695|NCT00151775|21076001|P1|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
8548696|NCT00151775|21075990|P12|COMPLETED|Period 3: Double-blind, Withdrawal||28
8548697|NCT00151775|21075991|P11|COMPLETED|Period 3: Double-blind, Withdrawal||29
8548698|NCT00151775|21075992|P10|COMPLETED|Period 3: Double-blind, Withdrawal||0
8548699|NCT00151775|21075993|P9|COMPLETED|Period 3: Double-blind, Withdrawal||26
8548700|NCT00151775|21075994|P8|COMPLETED|Period 3: Double-blind, Withdrawal||27
8548701|NCT00151775|21075995|P7|COMPLETED|Period 3: Double-blind, Withdrawal||26
8548702|NCT00151775|21075996|P6|COMPLETED|Period 3: Double-blind, Withdrawal||25
8548703|NCT00151775|21075997|P5|COMPLETED|Period 3: Double-blind, Withdrawal||0
8548704|NCT00151775|21075998|P4|COMPLETED|Period 3: Double-blind, Withdrawal||44
8548705|NCT00151775|21075999|P3|COMPLETED|Period 3: Double-blind, Withdrawal||42
8548706|NCT00151775|21076000|P2|COMPLETED|Period 3: Double-blind, Withdrawal||45
8548707|NCT00151775|21076001|P1|COMPLETED|Period 3: Double-blind, Withdrawal||48
8548708|NCT00151775|21075990|P12|STARTED|Period 3: Double-blind, Withdrawal||29
8548709|NCT00151775|21075991|P11|STARTED|Period 3: Double-blind, Withdrawal||29
8548710|NCT00151775|21075992|P10|STARTED|Period 3: Double-blind, Withdrawal||0
8548711|NCT00151775|21075993|P9|STARTED|Period 3: Double-blind, Withdrawal||26
8548712|NCT00151775|21075994|P8|STARTED|Period 3: Double-blind, Withdrawal||28
8548713|NCT00151775|21075995|P7|STARTED|Period 3: Double-blind, Withdrawal||27
8548714|NCT00151775|21075996|P6|STARTED|Period 3: Double-blind, Withdrawal||26
8548715|NCT00151775|21075997|P5|STARTED|Period 3: Double-blind, Withdrawal||0
8548716|NCT00151775|21075998|P4|STARTED|Period 3: Double-blind, Withdrawal||44
8548717|NCT00151775|21075999|P3|STARTED|Period 3: Double-blind, Withdrawal||45
8548718|NCT00151775|21076000|P2|STARTED|Period 3: Double-blind, Withdrawal||45
8548719|NCT00151775|21076001|P1|STARTED|Period 3: Double-blind, Withdrawal||48
8548720|NCT00151775|21075990|P12|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8548721|NCT00151775|21075991|P11|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
8548722|NCT00151775|21075992|P10|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8548723|NCT00151775|21075993|P9|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8548724|NCT00151775|21075994|P8|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8548725|NCT00151775|21075995|P7|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
8548726|NCT00151775|21075996|P6|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
8548727|NCT00151775|21075997|P5|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8548728|NCT00151775|21075998|P4|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8548729|NCT00151775|21075999|P3|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
8548730|NCT00151775|21076000|P2|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
8548731|NCT00151775|21076001|P1|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
8548732|NCT00151775|21075990|P12|COMPLETED|Period 2 - Double-Blind Dose Response||0
8548733|NCT00151775|21075991|P11|COMPLETED|Period 2 - Double-Blind Dose Response||59
8548734|NCT00151775|21075992|P10|COMPLETED|Period 2 - Double-Blind Dose Response||0
8548735|NCT00151775|21075993|P9|COMPLETED|Period 2 - Double-Blind Dose Response||0
8548736|NCT00151775|21075994|P8|COMPLETED|Period 2 - Double-Blind Dose Response||0
8548737|NCT00151775|21075995|P7|COMPLETED|Period 2 - Double-Blind Dose Response||53
8548738|NCT00151775|21075996|P6|COMPLETED|Period 2 - Double-Blind Dose Response||54
8548739|NCT00151775|21075997|P5|COMPLETED|Period 2 - Double-Blind Dose Response||0
8548740|NCT00151775|21075998|P4|COMPLETED|Period 2 - Double-Blind Dose Response||0
8548741|NCT00151775|21075999|P3|COMPLETED|Period 2 - Double-Blind Dose Response||0
8548742|NCT00151775|21076000|P2|COMPLETED|Period 2 - Double-Blind Dose Response||89
8548743|NCT00151775|21076001|P1|COMPLETED|Period 2 - Double-Blind Dose Response||93
8548744|NCT00151775|21075990|P12|STARTED|Period 2 - Double-Blind Dose Response||0
8548745|NCT00151775|21075991|P11|STARTED|Period 2 - Double-Blind Dose Response||60
8548746|NCT00151775|21075992|P10|STARTED|Period 2 - Double-Blind Dose Response||0
8548747|NCT00151775|21075993|P9|STARTED|Period 2 - Double-Blind Dose Response||0
8548748|NCT00151775|21075994|P8|STARTED|Period 2 - Double-Blind Dose Response||0
8548749|NCT00151775|21075995|P7|STARTED|Period 2 - Double-Blind Dose Response||56
8548750|NCT00151775|21075996|P6|STARTED|Period 2 - Double-Blind Dose Response||56
8548751|NCT00151775|21075997|P5|STARTED|Period 2 - Double-Blind Dose Response||0
8548752|NCT00151775|21075998|P4|STARTED|Period 2 - Double-Blind Dose Response||0
8548753|NCT00151775|21075999|P3|STARTED|Period 2 - Double-Blind Dose Response||0
8548754|NCT00151775|21076000|P2|STARTED|Period 2 - Double-Blind Dose Response||95
8548755|NCT00151775|21076001|P1|STARTED|Period 2 - Double-Blind Dose Response||95
8548756|NCT00151476|21076045|P2|NOT COMPLETED|FAP Analyzed Subjects||3
8548757|NCT00151476|21076046|P1|NOT COMPLETED|FAP Analyzed Subjects||0
8548758|NCT00151476|21076045|P2|COMPLETED|FAP Analyzed Subjects||51
8548759|NCT00151476|21076046|P1|COMPLETED|FAP Analyzed Subjects||13
8548760|NCT00151476|21076045|P2|STARTED|FAP Analyzed Subjects||54
8548761|NCT00151476|21076046|P1|STARTED|FAP Analyzed Subjects||13
8548762|NCT00151476|21076045|P2|NOT COMPLETED|FAP Identified Subjects||1
8548763|NCT00151476|21076046|P1|NOT COMPLETED|FAP Identified Subjects||0
8548764|NCT00151476|21076045|P2|COMPLETED|FAP Identified Subjects||54
8548765|NCT00151476|21076046|P1|COMPLETED|FAP Identified Subjects||13
8548766|NCT00151476|21076045|P2|STARTED|FAP Identified Subjects||55
8548767|NCT00151476|21076046|P1|STARTED|FAP Identified Subjects||13
8548768|NCT00151411|21076103|P2|NOT COMPLETED|Overall Study||43
8548769|NCT00151411|21076104|P1|NOT COMPLETED|Overall Study||33
8548770|NCT00151411|21076103|P2|COMPLETED|Overall Study||16
8548771|NCT00151411|21076104|P1|COMPLETED|Overall Study||22
8548772|NCT00151411|21076103|P2|STARTED|Overall Study||59
8548773|NCT00151411|21076104|P1|STARTED|Overall Study||55
8548774|NCT00151372|21076116|P2|NOT COMPLETED|Overall Study||29
8548775|NCT00151372|21076117|P1|NOT COMPLETED|Overall Study||29
8548776|NCT00151372|21076116|P2|COMPLETED|Overall Study||45
8548777|NCT00151372|21076117|P1|COMPLETED|Overall Study||38
8548778|NCT00151372|21076116|P2|STARTED|Overall Study||74
8548779|NCT00151372|21076117|P1|STARTED|Overall Study||67
8548780|NCT00151320|21076127|P1|NOT COMPLETED|Overall Study||0
8548781|NCT00151320|21076127|P1|COMPLETED|Overall Study||76
8548782|NCT00151320|21076127|P1|STARTED|Overall Study||76
8548783|NCT00151281|21076132|P1|NOT COMPLETED|Overall Study||3
8548784|NCT00151281|21076132|P1|COMPLETED|Overall Study||22
8548785|NCT00151281|21076132|P1|STARTED|Overall Study||25
8548786|NCT00150969|21076141|P2|NOT COMPLETED|24-48 Month Extension||100
8548787|NCT00150969|21076142|P1|NOT COMPLETED|24-48 Month Extension||88
8548788|NCT00150969|21076141|P2|COMPLETED|24-48 Month Extension||40
8548789|NCT00150969|21076142|P1|COMPLETED|24-48 Month Extension||33
8548790|NCT00150969|21076141|P2|STARTED|24-48 Month Extension||140
8548791|NCT00150969|21076142|P1|STARTED|24-48 Month Extension||121
8548792|NCT00150969|21076141|P2|NOT COMPLETED|24 Month Main Study||21
8548793|NCT00150969|21076142|P1|NOT COMPLETED|24 Month Main Study||19
8548794|NCT00150969|21076141|P2|COMPLETED|24 Month Main Study||202
8548795|NCT00150969|21076142|P1|COMPLETED|24 Month Main Study||198
8548796|NCT00150969|21076141|P2|STARTED|24 Month Main Study||223
8548797|NCT00150969|21076142|P1|STARTED|24 Month Main Study||217
8548798|NCT00150813|21076174|P1|NOT COMPLETED|Overall Study||18
8548799|NCT00150813|21076174|P1|COMPLETED|Overall Study||48
8548800|NCT00150813|21076174|P1|STARTED|Overall Study||66
8548825|NCT00150462|21076262|P11|NOT COMPLETED|Overall Study||3
8548826|NCT00150462|21076263|P10|NOT COMPLETED|Overall Study||6
8548827|NCT00150462|21076264|P9|NOT COMPLETED|Overall Study||6
8548828|NCT00150462|21076265|P8|NOT COMPLETED|Overall Study||8
8548829|NCT00150462|21076266|P7|NOT COMPLETED|Overall Study||3
8548830|NCT00150462|21076267|P6|NOT COMPLETED|Overall Study||4
8548831|NCT00150462|21076268|P5|NOT COMPLETED|Overall Study||3
8548832|NCT00150462|21076269|P4|NOT COMPLETED|Overall Study||3
8548833|NCT00150462|21076270|P3|NOT COMPLETED|Overall Study||4
8548834|NCT00150462|21076271|P2|NOT COMPLETED|Overall Study||3
8548835|NCT00150462|21076272|P1|NOT COMPLETED|Overall Study||3
8548836|NCT00150462|21076262|P11|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
8548837|NCT00150462|21076263|P10|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
8548838|NCT00150462|21076264|P9|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548839|NCT00150462|21076265|P8|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548840|NCT00150462|21076266|P7|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548841|NCT00150462|21076267|P6|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548842|NCT00150462|21076268|P5|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548843|NCT00150462|21076269|P4|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548844|NCT00150462|21076270|P3|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548845|NCT00150462|21076271|P2|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548846|NCT00150462|21076272|P1|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
8548847|NCT00150462|21076262|P11|STARTED|Overall Study||4
8548848|NCT00150462|21076263|P10|STARTED|Overall Study||7
8548849|NCT00150462|21076264|P9|STARTED|Overall Study||6
8548850|NCT00150462|21076265|P8|STARTED|Overall Study||8
8548851|NCT00150462|21076266|P7|STARTED|Overall Study||3
8548852|NCT00150462|21076267|P6|STARTED|Overall Study||4
8548853|NCT00150462|21076268|P5|STARTED|Overall Study||3
8548854|NCT00150462|21076269|P4|STARTED|Overall Study||3
8548855|NCT00150462|21076270|P3|STARTED|Overall Study||4
8548856|NCT00150462|21076271|P2|STARTED|Overall Study||3
8548857|NCT00150462|21076272|P1|STARTED|Overall Study||3
8548858|NCT00150345|21076382|P2|NOT COMPLETED|Overall Study||32
8548859|NCT00150345|21076383|P1|NOT COMPLETED|Overall Study||34
8548860|NCT00150345|21076382|P2|COMPLETED|Overall Study||34
8548861|NCT00150345|21076383|P1|COMPLETED|Overall Study||47
8548862|NCT00150345|21076382|P2|STARTED|Overall Study||66
8548863|NCT00150345|21076383|P1|STARTED|Overall Study||81
8548864|NCT00150176|21076447|P2|NOT COMPLETED|Overall Study||120
8548865|NCT00150176|21076448|P1|NOT COMPLETED|Overall Study||59
8548866|NCT00150176|21076447|P2|COMPLETED|Overall Study||72
8548867|NCT00150176|21076448|P1|COMPLETED|Overall Study||135
8548868|NCT00150176|21076447|P2|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
8548869|NCT00150176|21076448|P1|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
8548870|NCT00149994|21076459|P2|NOT COMPLETED|Overall Study||1
8548871|NCT00149994|21076460|P1|NOT COMPLETED|Overall Study||1
8548872|NCT00149994|21076459|P2|COMPLETED|Overall Study||85
8548873|NCT00149994|21076460|P1|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
8548874|NCT00149994|21076459|P2|STARTED|Overall Study||86
8548875|NCT00149994|21076460|P1|STARTED|Overall Study|"Started indicates Safety population."|85
8548876|NCT00149890|21076468|P2|NOT COMPLETED|Overall Study||18
8548877|NCT00149890|21076469|P1|NOT COMPLETED|Overall Study||13
8548878|NCT00149890|21076468|P2|COMPLETED|Overall Study||20
8548879|NCT00149890|21076469|P1|COMPLETED|Overall Study||26
8548880|NCT00149890|21076468|P2|STARTED|Overall Study||38
8548881|NCT00149890|21076469|P1|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
8548882|NCT00149838|21076489|P4|NOT COMPLETED|Phase III||24
8548883|NCT00149838|21076490|P3|NOT COMPLETED|Phase III||0
8548884|NCT00149838|21076491|P2|NOT COMPLETED|Phase III||0
8548885|NCT00149838|21076492|P1|NOT COMPLETED|Phase III||0
8548886|NCT00149838|21076489|P4|COMPLETED|Phase III||37
8548887|NCT00149838|21076490|P3|COMPLETED|Phase III||0
8548888|NCT00149838|21076491|P2|COMPLETED|Phase III||0
8548889|NCT00149838|21076492|P1|COMPLETED|Phase III||0
8548890|NCT00149838|21076489|P4|STARTED|Phase III||61
8548891|NCT00149838|21076490|P3|STARTED|Phase III||0
8548892|NCT00149838|21076491|P2|STARTED|Phase III||0
8548893|NCT00149838|21076492|P1|STARTED|Phase III||0
8548894|NCT00149838|21076489|P4|NOT COMPLETED|Phase II||0
8548895|NCT00149838|21076490|P3|NOT COMPLETED|Phase II||0
8548896|NCT00149838|21076491|P2|NOT COMPLETED|Phase II||0
8548897|NCT00149838|21076492|P1|NOT COMPLETED|Phase II||0
8548898|NCT00149838|21076489|P4|COMPLETED|Phase II||0
8548899|NCT00149838|21076490|P3|COMPLETED|Phase II||144
8548900|NCT00149838|21076491|P2|COMPLETED|Phase II||0
8548901|NCT00149838|21076492|P1|COMPLETED|Phase II||0
8548902|NCT00149838|21076489|P4|STARTED|Phase II||0
8548903|NCT00149838|21076490|P3|STARTED|Phase II||144
8548904|NCT00149838|21076491|P2|STARTED|Phase II||0
8548905|NCT00149838|21076492|P1|STARTED|Phase II||0
8548906|NCT00149838|21076489|P4|NOT COMPLETED|Phase I||0
8548907|NCT00149838|21076490|P3|NOT COMPLETED|Phase I||0
8548908|NCT00149838|21076491|P2|NOT COMPLETED|Phase I||16
8548909|NCT00149838|21076492|P1|NOT COMPLETED|Phase I||20
8548910|NCT00149838|21076489|P4|COMPLETED|Phase I||0
8548911|NCT00149838|21076490|P3|COMPLETED|Phase I||0
8548912|NCT00149838|21076491|P2|COMPLETED|Phase I||82
8548913|NCT00149838|21076492|P1|COMPLETED|Phase I||72
8548914|NCT00149838|21076489|P4|STARTED|Phase I||0
8548915|NCT00149838|21076490|P3|STARTED|Phase I||0
8548916|NCT00149838|21076491|P2|STARTED|Phase I||98
8548917|NCT00149838|21076492|P1|STARTED|Phase I||92
8548918|NCT00149825|21076504|P2|NOT COMPLETED|Overall Study||3
8548919|NCT00149825|21076505|P1|NOT COMPLETED|Overall Study||5
8548920|NCT00149825|21076504|P2|COMPLETED|Overall Study||12
8548921|NCT00149825|21076505|P1|COMPLETED|Overall Study||10
8548922|NCT00149825|21076504|P2|STARTED|Overall Study||15
8548923|NCT00149825|21076505|P1|STARTED|Overall Study||15
8548924|NCT00149799|21076515|P3|NOT COMPLETED|Discontinuation (Phase II)||9
8548925|NCT00149799|21076516|P2|NOT COMPLETED|Discontinuation (Phase II)||3
8548926|NCT00149799|21076517|P1|NOT COMPLETED|Discontinuation (Phase II)||0
8548927|NCT00149799|21076515|P3|COMPLETED|Discontinuation (Phase II)||21
8548928|NCT00149799|21076516|P2|COMPLETED|Discontinuation (Phase II)||25
8548929|NCT00149799|21076517|P1|COMPLETED|Discontinuation (Phase II)||0
8548930|NCT00149799|21076515|P3|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
8548931|NCT00149799|21076516|P2|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
8548932|NCT00149799|21076517|P1|STARTED|Discontinuation (Phase II)||0
8548933|NCT00149799|21076515|P3|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
8548934|NCT00149799|21076516|P2|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
8548935|NCT00149799|21076517|P1|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
8548936|NCT00149799|21076515|P3|COMPLETED|Open Label Escitalopram (Phase I)||0
8548937|NCT00149799|21076516|P2|COMPLETED|Open Label Escitalopram (Phase I)||0
8548938|NCT00149799|21076517|P1|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
8548939|NCT00149799|21076515|P3|STARTED|Open Label Escitalopram (Phase I)||0
8548940|NCT00149799|21076516|P2|STARTED|Open Label Escitalopram (Phase I)||0
8548941|NCT00149799|21076517|P1|STARTED|Open Label Escitalopram (Phase I)||100
8548942|NCT00149747|21076533|P2|NOT COMPLETED|Overall Study||3
8548943|NCT00149747|21076534|P1|NOT COMPLETED|Overall Study||4
8548944|NCT00149747|21076533|P2|COMPLETED|Overall Study||27
8548945|NCT00149747|21076534|P1|COMPLETED|Overall Study||32
8548946|NCT00149747|21076533|P2|STARTED|Overall Study||30
8548947|NCT00149747|21076534|P1|STARTED|Overall Study||36
8548948|NCT00149669|21076546|P2|NOT COMPLETED|Overall Study||5
8548949|NCT00149669|21076547|P1|NOT COMPLETED|Overall Study||3
8548950|NCT00149669|21076546|P2|COMPLETED|Overall Study||30
8548951|NCT00149669|21076547|P1|COMPLETED|Overall Study||29
8548952|NCT00149669|21076546|P2|STARTED|Overall Study||35
8548953|NCT00149669|21076547|P1|STARTED|Overall Study||32
8548954|NCT00149643|21076567|P2|NOT COMPLETED|Overall Study||36
8548955|NCT00149643|21076568|P1|NOT COMPLETED|Overall Study||34
8548956|NCT00149643|21076567|P2|COMPLETED|Overall Study||0
8548957|NCT00149643|21076568|P1|COMPLETED|Overall Study||0
8548958|NCT00149643|21076567|P2|STARTED|Overall Study||36
8548959|NCT00149643|21076568|P1|STARTED|Overall Study||34
8548960|NCT00149630|21076580|P2|NOT COMPLETED|Overall Study||5
8548961|NCT00149630|21076581|P1|NOT COMPLETED|Overall Study||8
8548962|NCT00149630|21076580|P2|COMPLETED|Overall Study||35
8548963|NCT00149630|21076581|P1|COMPLETED|Overall Study||26
8548964|NCT00149630|21076580|P2|STARTED|Overall Study||40
8548965|NCT00149630|21076581|P1|STARTED|Overall Study||34
8548966|NCT00149396|21076591|P1|NOT COMPLETED|Overall Study||23
8548967|NCT00149396|21076591|P1|COMPLETED|Overall Study||9
8548968|NCT00149396|21076591|P1|Completed NV1020 and Chemotherapy|Overall Study||9
8548969|NCT00149396|21076591|P1|Completed NV1020 Therapy|Overall Study||29
8548970|NCT00149396|21076591|P1|STARTED|Overall Study||32
8548971|NCT00149227|21076634|P2|NOT COMPLETED|Overall Study||0
8548972|NCT00149227|21076635|P1|NOT COMPLETED|Overall Study||0
8548973|NCT00149227|21076634|P2|COMPLETED|Overall Study||1514
8548974|NCT00149227|21076635|P1|COMPLETED|Overall Study||1517
8548975|NCT00149227|21076634|P2|STARTED|Overall Study||1514
8548976|NCT00149227|21076635|P1|STARTED|Overall Study||1517
8548977|NCT00149214|21076661|P2|NOT COMPLETED|Overall Study||17
8548978|NCT00149214|21076662|P1|NOT COMPLETED|Overall Study||26
8548979|NCT00149214|21076661|P2|COMPLETED|Overall Study||105
8548980|NCT00149214|21076662|P1|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
8548981|NCT00149214|21076661|P2|STARTED|Overall Study||122
8549072|NCT00147823|21076883|P2|STARTED|Overall Study||31
8548982|NCT00149214|21076662|P1|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
8548983|NCT00148954|21076678|P2|NOT COMPLETED|Overall Study||300
8548984|NCT00148954|21076679|P1|NOT COMPLETED|Overall Study||307
8548985|NCT00148954|21076678|P2|COMPLETED|Overall Study||677
8548986|NCT00148954|21076679|P1|COMPLETED|Overall Study||678
8548987|NCT00148954|21076678|P2|STARTED|Overall Study||977
8548988|NCT00148954|21076679|P1|STARTED|Overall Study||985
8548989|NCT00148941|21076689|P4|NOT COMPLETED|Overall Study||24
8548990|NCT00148941|21076690|P3|NOT COMPLETED|Overall Study||20
8548991|NCT00148941|21076691|P2|NOT COMPLETED|Overall Study||24
8548992|NCT00148941|21076692|P1|NOT COMPLETED|Overall Study||18
8548993|NCT00148941|21076689|P4|COMPLETED|Overall Study||1029
8548994|NCT00148941|21076690|P3|COMPLETED|Overall Study||1032
8548995|NCT00148941|21076691|P2|COMPLETED|Overall Study||1027
8548996|NCT00148941|21076692|P1|COMPLETED|Overall Study||1035
8548997|NCT00148941|21076689|P4|STARTED|Overall Study||1053
8548998|NCT00148941|21076690|P3|STARTED|Overall Study||1052
8548999|NCT00148941|21076691|P2|STARTED|Overall Study||1051
8549000|NCT00148941|21076692|P1|STARTED|Overall Study||1053
8549001|NCT00148798|21076784|P2|NOT COMPLETED|Overall Study||0
8549002|NCT00148798|21076785|P1|NOT COMPLETED|Overall Study||0
8549003|NCT00148798|21076784|P2|COMPLETED|Overall Study||568
8549004|NCT00148798|21076785|P1|COMPLETED|Overall Study||557
8549005|NCT00148798|21076784|P2|STARTED|Overall Study|ITT Population|568
8549006|NCT00148798|21076785|P1|STARTED|Overall Study|Intent To Treat (ITT) Population|557
8549007|NCT00148759|21076807|P2|NOT COMPLETED|Overall Study||1
8549008|NCT00148759|21076808|P1|NOT COMPLETED|Overall Study||2
8549009|NCT00148759|21076807|P2|COMPLETED|Overall Study||11
8549010|NCT00148759|21076808|P1|COMPLETED|Overall Study||9
8549011|NCT00148759|21076807|P2|24-hr PK Sampling|Overall Study||11
8549012|NCT00148759|21076808|P1|24-hr PK Sampling|Overall Study||9
8549013|NCT00148759|21076807|P2|STARTED|Overall Study||12
8549014|NCT00148759|21076808|P1|STARTED|Overall Study||11
8549021|NCT00148668|21076827|P2|NOT COMPLETED|Overall Study||0
8549022|NCT00148668|21076828|P1|NOT COMPLETED|Overall Study||0
8549023|NCT00148668|21076827|P2|COMPLETED|Overall Study||40
8549024|NCT00148668|21076828|P1|COMPLETED|Overall Study||41
8549025|NCT00148668|21076827|P2|STARTED|Overall Study||40
8549026|NCT00148668|21076828|P1|STARTED|Overall Study||41
8549027|NCT00148343|21076836|P2|NOT COMPLETED|Overall Study||11
8549028|NCT00148343|21076837|P1|NOT COMPLETED|Overall Study||15
8549029|NCT00148343|21076836|P2|COMPLETED|Overall Study||45
8549030|NCT00148343|21076837|P1|COMPLETED|Overall Study||39
8549031|NCT00148343|21076836|P2|STARTED|Overall Study||56
8549032|NCT00148343|21076837|P1|STARTED|Overall Study||54
8549033|NCT00148317|21076851|P1|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
8549034|NCT00148317|21076851|P1|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
8549035|NCT00148317|21076851|P1|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
8549036|NCT00148317|21076851|P1|NOT COMPLETED|Consolidation (VEL + DEX)||0
8549037|NCT00148317|21076851|P1|COMPLETED|Consolidation (VEL + DEX)||38
8549038|NCT00148317|21076851|P1|no DOXIL Added|Consolidation (VEL + DEX)||10
8549039|NCT00148317|21076851|P1|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
8549040|NCT00148317|21076851|P1|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
8549041|NCT00148317|21076851|P1|STARTED|Consolidation (VEL + DEX)||38
8549042|NCT00148122|21076858|P1|NOT COMPLETED|Overall Study||2
8549043|NCT00148122|21076858|P1|COMPLETED|Overall Study||38
8549044|NCT00148122|21076858|P1|STARTED|Overall Study||40
8549045|NCT00148109|21076866|P2|NOT COMPLETED|Overall Study||20
8549046|NCT00148109|21076867|P1|NOT COMPLETED|Overall Study||12
8549047|NCT00148109|21076866|P2|COMPLETED|Overall Study||1
8549048|NCT00148109|21076867|P1|COMPLETED|Overall Study||3
8549049|NCT00148109|21076866|P2|STARTED|Overall Study||21
8549050|NCT00148109|21076867|P1|STARTED|Overall Study||15
8549051|NCT00147966|21076877|P1|NOT COMPLETED|Overall Study||0
8549052|NCT00147966|21076877|P1|COMPLETED|Overall Study||24
8549053|NCT00147966|21076877|P1|STARTED|Overall Study||24
8549054|NCT00147823|21076883|P2|NOT COMPLETED|Overall Study||15
8549055|NCT00147823|21076884|P1|NOT COMPLETED|Overall Study||13
8549056|NCT00147823|21076883|P2|COMPLETED|Overall Study||16
8549057|NCT00147823|21076884|P1|COMPLETED|Overall Study||19
8549058|NCT00147823|21076883|P2|Month 24 Visit|Overall Study||18
8549059|NCT00147823|21076884|P1|Month 24 Visit|Overall Study||21
8549060|NCT00147823|21076883|P2|Month 18 Visit|Overall Study||20
8549061|NCT00147823|21076884|P1|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
8549062|NCT00147823|21076883|P2|Month 12 CT Scan|Overall Study||25
8549063|NCT00147823|21076884|P1|Month 12 CT Scan|Overall Study||20
8549064|NCT00147823|21076883|P2|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
8549065|NCT00147823|21076884|P1|Month 12 Visit|Overall Study||21
8549066|NCT00147823|21076883|P2|Month 6 Visit|Overall Study||21
8549067|NCT00147823|21076884|P1|Month 6 Visit|Overall Study||25
8549068|NCT00147823|21076883|P2|Month 3 Visit|Overall Study||24
8549069|NCT00147823|21076884|P1|Month 3 Visit|Overall Study||25
8549070|NCT00147823|21076883|P2|Week 6 Visit|Overall Study||28
8549071|NCT00147823|21076884|P1|Week 6 Visit|Overall Study||26
8549073|NCT00147823|21076884|P1|STARTED|Overall Study||32
8549074|NCT00147745|21076915|P3|NOT COMPLETED|Overall Study||0
8549075|NCT00147745|21076916|P2|NOT COMPLETED|Overall Study||0
8549076|NCT00147745|21076917|P1|NOT COMPLETED|Overall Study||1
8549077|NCT00147745|21076915|P3|COMPLETED|Overall Study||6
8549078|NCT00147745|21076916|P2|COMPLETED|Overall Study||14
8549079|NCT00147745|21076917|P1|COMPLETED|Overall Study||15
8549080|NCT00147745|21076915|P3|STARTED|Overall Study||6
8549081|NCT00147745|21076916|P2|STARTED|Overall Study||14
8549082|NCT00147745|21076917|P1|STARTED|Overall Study||16
8549083|NCT00147537|21076939|P11|NOT COMPLETED|Phase 2||52
8549084|NCT00147537|21076940|P10|NOT COMPLETED|Phase 2||161
8549085|NCT00147537|21076941|P9|NOT COMPLETED|Phase 2||0
8549086|NCT00147537|21076942|P8|NOT COMPLETED|Phase 2||0
8549087|NCT00147537|21076943|P7|NOT COMPLETED|Phase 2||0
8549088|NCT00147537|21076944|P6|NOT COMPLETED|Phase 2||0
8549089|NCT00147537|21076945|P5|NOT COMPLETED|Phase 2||0
8549090|NCT00147537|21076946|P4|NOT COMPLETED|Phase 2||0
8549091|NCT00147537|21076947|P3|NOT COMPLETED|Phase 2||0
8549092|NCT00147537|21076948|P2|NOT COMPLETED|Phase 2||0
8549093|NCT00147537|21076949|P1|NOT COMPLETED|Phase 2||0
8549094|NCT00147537|21076939|P11|COMPLETED|Phase 2||3
8549095|NCT00147537|21076940|P10|COMPLETED|Phase 2||5
8549096|NCT00147537|21076941|P9|COMPLETED|Phase 2||0
8549097|NCT00147537|21076942|P8|COMPLETED|Phase 2||0
8549098|NCT00147537|21076943|P7|COMPLETED|Phase 2||0
8549099|NCT00147537|21076944|P6|COMPLETED|Phase 2||0
8549100|NCT00147537|21076945|P5|COMPLETED|Phase 2||0
8549101|NCT00147537|21076946|P4|COMPLETED|Phase 2||0
8549102|NCT00147537|21076947|P3|COMPLETED|Phase 2||0
8549103|NCT00147537|21076948|P2|COMPLETED|Phase 2||0
8549104|NCT00147537|21076949|P1|COMPLETED|Phase 2||0
8549105|NCT00147537|21076939|P11|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
8549106|NCT00147537|21076940|P10|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
8549107|NCT00147537|21076941|P9|STARTED|Phase 2||0
8549108|NCT00147537|21076942|P8|STARTED|Phase 2||0
8549109|NCT00147537|21076943|P7|STARTED|Phase 2||0
8549110|NCT00147537|21076944|P6|STARTED|Phase 2||0
8549111|NCT00147537|21076945|P5|STARTED|Phase 2||0
8549112|NCT00147537|21076946|P4|STARTED|Phase 2||0
8549113|NCT00147537|21076947|P3|STARTED|Phase 2||0
8549114|NCT00147537|21076948|P2|STARTED|Phase 2||0
8549115|NCT00147537|21076949|P1|STARTED|Phase 2||0
8549116|NCT00147537|21076939|P11|NOT COMPLETED|Phase 1b||0
8549117|NCT00147537|21076940|P10|NOT COMPLETED|Phase 1b||0
8549118|NCT00147537|21076941|P9|NOT COMPLETED|Phase 1b||17
8549119|NCT00147537|21076942|P8|NOT COMPLETED|Phase 1b||7
8549120|NCT00147537|21076943|P7|NOT COMPLETED|Phase 1b||18
8549121|NCT00147537|21076944|P6|NOT COMPLETED|Phase 1b||3
8549122|NCT00147537|21076945|P5|NOT COMPLETED|Phase 1b||3
8549123|NCT00147537|21076946|P4|NOT COMPLETED|Phase 1b||2
8549124|NCT00147537|21076947|P3|NOT COMPLETED|Phase 1b||4
8549125|NCT00147537|21076948|P2|NOT COMPLETED|Phase 1b||2
8549126|NCT00147537|21076949|P1|NOT COMPLETED|Phase 1b||2
8549127|NCT00147537|21076939|P11|COMPLETED|Phase 1b||0
8549128|NCT00147537|21076940|P10|COMPLETED|Phase 1b||0
8549129|NCT00147537|21076941|P9|COMPLETED|Phase 1b||1
8549130|NCT00147537|21076942|P8|COMPLETED|Phase 1b||0
8549131|NCT00147537|21076943|P7|COMPLETED|Phase 1b||0
8549132|NCT00147537|21076944|P6|COMPLETED|Phase 1b||0
8549133|NCT00147537|21076945|P5|COMPLETED|Phase 1b||0
8549134|NCT00147537|21076946|P4|COMPLETED|Phase 1b||1
8549135|NCT00147537|21076947|P3|COMPLETED|Phase 1b||0
8549136|NCT00147537|21076948|P2|COMPLETED|Phase 1b||0
8549137|NCT00147537|21076949|P1|COMPLETED|Phase 1b||1
8549138|NCT00147537|21076939|P11|STARTED|Phase 1b||0
8549139|NCT00147537|21076940|P10|STARTED|Phase 1b||0
8549140|NCT00147537|21076941|P9|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
8549141|NCT00147537|21076942|P8|STARTED|Phase 1b||7
8549142|NCT00147537|21076943|P7|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
8549143|NCT00147537|21076944|P6|STARTED|Phase 1b||3
8549144|NCT00147537|21076945|P5|STARTED|Phase 1b||3
8549145|NCT00147537|21076946|P4|STARTED|Phase 1b||3
8549146|NCT00147537|21076947|P3|STARTED|Phase 1b||4
8549147|NCT00147537|21076948|P2|STARTED|Phase 1b||2
8549148|NCT00147537|21076949|P1|STARTED|Phase 1b||3
8549149|NCT00147498|21077132|P4|NOT COMPLETED|Overall Study||17
8549150|NCT00147498|21077133|P3|NOT COMPLETED|Overall Study||17
8549151|NCT00147498|21077134|P2|NOT COMPLETED|Overall Study||9
8549152|NCT00147498|21077135|P1|NOT COMPLETED|Overall Study||3
8549153|NCT00147498|21077132|P4|COMPLETED|Overall Study||48
8549154|NCT00147498|21077133|P3|COMPLETED|Overall Study||52
8549155|NCT00147498|21077134|P2|COMPLETED|Overall Study||60
8549156|NCT00147498|21077135|P1|COMPLETED|Overall Study||58
8549157|NCT00147498|21077132|P4|STARTED|Overall Study||65
8549158|NCT00147498|21077133|P3|STARTED|Overall Study||69
8549159|NCT00147498|21077134|P2|STARTED|Overall Study||69
8549160|NCT00147498|21077135|P1|STARTED|Overall Study||61
8549161|NCT00147446|21077231|P2|NOT COMPLETED|Overall Study||0
8549162|NCT00147446|21077232|P1|NOT COMPLETED|Overall Study||0
8549163|NCT00147446|21077231|P2|COMPLETED|Overall Study||61
8549164|NCT00147446|21077232|P1|COMPLETED|Overall Study||60
8549165|NCT00147446|21077231|P2|STARTED|Overall Study||61
8549166|NCT00147446|21077232|P1|STARTED|Overall Study||60
8549167|NCT00147316|21077240|P1|NOT COMPLETED|Overall Study||0
8549168|NCT00147316|21077240|P1|COMPLETED|Overall Study||103
8549169|NCT00147316|21077240|P1|STARTED|Overall Study||103
8549170|NCT00147290|21077247|P2|NOT COMPLETED|Overall Study||0
8549171|NCT00147290|21077248|P1|NOT COMPLETED|Overall Study||0
8549172|NCT00147290|21077247|P2|COMPLETED|Overall Study||260
8549173|NCT00147290|21077248|P1|COMPLETED|Overall Study||266
8549174|NCT00147290|21077247|P2|STARTED|Overall Study||260
8549175|NCT00147290|21077248|P1|STARTED|Overall Study||266
8549176|NCT00147277|21077254|P2|NOT COMPLETED|Overall Study||0
8549177|NCT00147277|21077255|P1|NOT COMPLETED|Overall Study||0
8549178|NCT00147277|21077254|P2|COMPLETED|Overall Study||450
8549179|NCT00147277|21077255|P1|COMPLETED|Overall Study||475
8549180|NCT00147277|21077254|P2|STARTED|Overall Study||450
8549181|NCT00147277|21077255|P1|STARTED|Overall Study||475
8549182|NCT00147238|21077259|P1|NOT COMPLETED|Overall Study||8
8549183|NCT00147238|21077259|P1|COMPLETED|Overall Study||2
8549184|NCT00147238|21077259|P1|STARTED|Overall Study||10
8549185|NCT00147225|21077269|P6|NOT COMPLETED|Overall Study||2
8549186|NCT00147225|21077270|P5|NOT COMPLETED|Overall Study||1
8549187|NCT00147225|21077271|P4|NOT COMPLETED|Overall Study||1
8549188|NCT00147225|21077272|P3|NOT COMPLETED|Overall Study||2
8549189|NCT00147225|21077273|P2|NOT COMPLETED|Overall Study||0
8549190|NCT00147225|21077274|P1|NOT COMPLETED|Overall Study||1
8549191|NCT00147225|21077269|P6|COMPLETED|Overall Study||10
8549192|NCT00147225|21077270|P5|COMPLETED|Overall Study||10
8549193|NCT00147225|21077271|P4|COMPLETED|Overall Study||10
8549194|NCT00147225|21077272|P3|COMPLETED|Overall Study||6
8549195|NCT00147225|21077273|P2|COMPLETED|Overall Study||6
8549196|NCT00147225|21077274|P1|COMPLETED|Overall Study||6
8549197|NCT00147225|21077269|P6|STARTED|Overall Study||12
8549198|NCT00147225|21077270|P5|STARTED|Overall Study||11
8549199|NCT00147225|21077271|P4|STARTED|Overall Study||11
8549200|NCT00147225|21077272|P3|STARTED|Overall Study||8
8549201|NCT00147225|21077273|P2|STARTED|Overall Study||6
8549202|NCT00147225|21077274|P1|STARTED|Overall Study||7
8549203|NCT00147212|21077294|P1|NOT COMPLETED|Overall Study||0
8549204|NCT00147212|21077294|P1|COMPLETED|Overall Study||50
8549205|NCT00147212|21077294|P1|STARTED|Overall Study||50
8549206|NCT00147199|21077300|P2|NOT COMPLETED|Overall Study||10
8549207|NCT00147199|21077301|P1|NOT COMPLETED|Overall Study||13
8549208|NCT00147199|21077300|P2|COMPLETED|Overall Study||110
8549209|NCT00147199|21077301|P1|COMPLETED|Overall Study||102
8549210|NCT00147199|21077300|P2|STARTED|Overall Study||120
8549211|NCT00147199|21077301|P1|STARTED|Overall Study||115
8549212|NCT00147082|21077326|P3|NOT COMPLETED|Overall Study||0
8549213|NCT00147082|21077327|P2|NOT COMPLETED|Overall Study||0
8549214|NCT00147082|21077328|P1|NOT COMPLETED|Overall Study||0
8549215|NCT00147082|21077326|P3|COMPLETED|Overall Study||30
8549216|NCT00147082|21077327|P2|COMPLETED|Overall Study||33
8549217|NCT00147082|21077328|P1|COMPLETED|Overall Study||37
8549218|NCT00147082|21077326|P3|STARTED|Overall Study||30
8549219|NCT00147082|21077327|P2|STARTED|Overall Study||33
8549220|NCT00147082|21077328|P1|STARTED|Overall Study||37
8549221|NCT00147069|21077346|P4|NOT COMPLETED|Overall Study||0
8549222|NCT00147069|21077347|P3|NOT COMPLETED|Overall Study||0
8549223|NCT00147069|21077348|P2|NOT COMPLETED|Overall Study||0
8549224|NCT00147069|21077349|P1|NOT COMPLETED|Overall Study||0
8549225|NCT00147069|21077346|P4|COMPLETED|Overall Study||15
8549226|NCT00147069|21077347|P3|COMPLETED|Overall Study||15
8549227|NCT00147069|21077348|P2|COMPLETED|Overall Study||15
8549228|NCT00147069|21077349|P1|COMPLETED|Overall Study||15
8549229|NCT00147069|21077346|P4|STARTED|Overall Study||15
8549230|NCT00147069|21077347|P3|STARTED|Overall Study||15
8549231|NCT00147069|21077348|P2|STARTED|Overall Study||15
8549232|NCT00147069|21077349|P1|STARTED|Overall Study||15
8549233|NCT00147043|21077371|P1|NOT COMPLETED|Overall Study||0
8549234|NCT00147043|21077371|P1|COMPLETED|Overall Study||5
8549235|NCT00147043|21077371|P1|STARTED|Overall Study||5
8549236|NCT00147030|21077378|P2|NOT COMPLETED|Overall Study||0
8549237|NCT00147030|21077379|P1|NOT COMPLETED|Overall Study||0
8549238|NCT00147030|21077378|P2|COMPLETED|Overall Study||162
8549239|NCT00147030|21077379|P1|COMPLETED|Overall Study||163
8549240|NCT00147030|21077378|P2|STARTED|Overall Study||162
8549241|NCT00147030|21077379|P1|STARTED|Overall Study||163
8549242|NCT00147017|21077430|P3|NOT COMPLETED|Overall Study||0
8549243|NCT00147017|21077431|P2|NOT COMPLETED|Overall Study||0
8549244|NCT00147017|21077432|P1|NOT COMPLETED|Overall Study||0
8549245|NCT00147017|21077430|P3|COMPLETED|Overall Study||4
8549246|NCT00147017|21077431|P2|COMPLETED|Overall Study||7
8549247|NCT00147017|21077432|P1|COMPLETED|Overall Study||6
8549248|NCT00147017|21077430|P3|STARTED|Overall Study||4
8549249|NCT00147017|21077431|P2|STARTED|Overall Study||7
8549250|NCT00147017|21077432|P1|STARTED|Overall Study||6
8549251|NCT00146848|21077449|P3|NOT COMPLETED|Post-randomization||39
8549252|NCT00146848|21077450|P2|NOT COMPLETED|Post-randomization||47
8549253|NCT00146848|21077451|P1|NOT COMPLETED|Post-randomization||38
8549254|NCT00146848|21077449|P3|COMPLETED|Post-randomization||431
8549255|NCT00146848|21077450|P2|COMPLETED|Post-randomization||441
8549256|NCT00146848|21077451|P1|COMPLETED|Post-randomization||437
8549257|NCT00146848|21077449|P3|STARTED|Post-randomization||470
8549258|NCT00146848|21077450|P2|STARTED|Post-randomization||488
8549259|NCT00146848|21077451|P1|STARTED|Post-randomization||475
8549260|NCT00146848|21077449|P3|NOT COMPLETED|Pre-randomization||0
8549261|NCT00146848|21077450|P2|NOT COMPLETED|Pre-randomization||0
8549262|NCT00146848|21077451|P1|NOT COMPLETED|Pre-randomization||309
8549263|NCT00146848|21077449|P3|COMPLETED|Pre-randomization||0
8549264|NCT00146848|21077450|P2|COMPLETED|Pre-randomization||0
8549265|NCT00146848|21077451|P1|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
8549266|NCT00146848|21077449|P3|STARTED|Pre-randomization||0
8549267|NCT00146848|21077450|P2|STARTED|Pre-randomization||0
8549268|NCT00146848|21077451|P1|STARTED|Pre-randomization|Registered|1742
8549269|NCT00146770|21077467|P2|NOT COMPLETED|Overall Study||0
8549270|NCT00146770|21077468|P1|NOT COMPLETED|Overall Study||5
8549271|NCT00146770|21077467|P2|COMPLETED|Overall Study||22
8549272|NCT00146770|21077468|P1|COMPLETED|Overall Study||18
8549273|NCT00146770|21077467|P2|STARTED|Overall Study||22
8549274|NCT00146770|21077468|P1|STARTED|Overall Study||23
8549275|NCT00146757|21077486|P2|NOT COMPLETED|Overall Study||0
8549276|NCT00146757|21077487|P1|NOT COMPLETED|Overall Study||2
8549277|NCT00146757|21077486|P2|COMPLETED|Overall Study||4
8549278|NCT00146757|21077487|P1|COMPLETED|Overall Study||14
8549279|NCT00146757|21077486|P2|STARTED|Overall Study||4
8549280|NCT00146757|21077487|P1|STARTED|Overall Study||16
8549281|NCT00146640|21077506|P2|NOT COMPLETED|Overall Study||14
8549282|NCT00146640|21077507|P1|NOT COMPLETED|Overall Study||23
8549283|NCT00146640|21077506|P2|COMPLETED|Overall Study||130
8549284|NCT00146640|21077507|P1|COMPLETED|Overall Study||121
8549285|NCT00146640|21077506|P2|STARTED|Overall Study||144
8549286|NCT00146640|21077507|P1|STARTED|Overall Study||144
8549287|NCT00146328|21077530|P3|NOT COMPLETED|Overall Study||291
8549288|NCT00146328|21077531|P2|NOT COMPLETED|Overall Study||154
8549289|NCT00146328|21077532|P1|NOT COMPLETED|Overall Study||141
8549290|NCT00146328|21077530|P3|COMPLETED|Overall Study||158
8549291|NCT00146328|21077531|P2|COMPLETED|Overall Study||101
8549292|NCT00146328|21077532|P1|COMPLETED|Overall Study||150
8549293|NCT00146328|21077530|P3|STARTED|Overall Study||449
8549294|NCT00146328|21077531|P2|STARTED|Overall Study||255
8549295|NCT00146328|21077532|P1|STARTED|Overall Study||291
8549296|NCT00146172|21077623|P8|NOT COMPLETED|Overall Study||40
8549297|NCT00146172|21077624|P7|NOT COMPLETED|Overall Study||6
8549298|NCT00146172|21077625|P6|NOT COMPLETED|Overall Study||7
8549299|NCT00146172|21077626|P5|NOT COMPLETED|Overall Study||3
8549300|NCT00146172|21077627|P4|NOT COMPLETED|Overall Study||6
8549301|NCT00146172|21077628|P3|NOT COMPLETED|Overall Study||4
8549302|NCT00146172|21077629|P2|NOT COMPLETED|Overall Study||4
8549303|NCT00146172|21077630|P1|NOT COMPLETED|Overall Study||3
8549304|NCT00146172|21077623|P8|COMPLETED|Overall Study||0
8549305|NCT00146172|21077624|P7|COMPLETED|Overall Study||0
8549306|NCT00146172|21077625|P6|COMPLETED|Overall Study||0
8549307|NCT00146172|21077626|P5|COMPLETED|Overall Study||0
8549308|NCT00146172|21077627|P4|COMPLETED|Overall Study||0
8549309|NCT00146172|21077628|P3|COMPLETED|Overall Study||0
8549310|NCT00146172|21077629|P2|COMPLETED|Overall Study||0
8549311|NCT00146172|21077630|P1|COMPLETED|Overall Study||0
8549312|NCT00146172|21077623|P8|Received Drug|Overall Study||39
8549313|NCT00146172|21077624|P7|Received Drug|Overall Study||6
8549314|NCT00146172|21077625|P6|Received Drug|Overall Study||7
8549315|NCT00146172|21077626|P5|Received Drug|Overall Study||3
8549316|NCT00146172|21077627|P4|Received Drug|Overall Study||6
8549317|NCT00146172|21077628|P3|Received Drug|Overall Study||4
8549318|NCT00146172|21077629|P2|Received Drug|Overall Study||4
8549319|NCT00146172|21077630|P1|Received Drug|Overall Study||3
8549320|NCT00146172|21077623|P8|STARTED|Overall Study||40
8549321|NCT00146172|21077624|P7|STARTED|Overall Study||6
8549322|NCT00146172|21077625|P6|STARTED|Overall Study||7
8549323|NCT00146172|21077626|P5|STARTED|Overall Study||3
8549324|NCT00146172|21077627|P4|STARTED|Overall Study||6
8549325|NCT00146172|21077628|P3|STARTED|Overall Study||4
8549326|NCT00146172|21077629|P2|STARTED|Overall Study||4
8549327|NCT00146172|21077630|P1|STARTED|Overall Study||3
8549328|NCT00145977|21077665|P2|NOT COMPLETED|Overall Study||4
8549329|NCT00145977|21077666|P1|NOT COMPLETED|Overall Study||2
8549330|NCT00145977|21077665|P2|COMPLETED|Overall Study||13
8549331|NCT00145977|21077666|P1|COMPLETED|Overall Study||17
8549332|NCT00145977|21077665|P2|STARTED|Overall Study||17
8549333|NCT00145977|21077666|P1|STARTED|Overall Study||19
8549334|NCT00145795|21077692|P2|NOT COMPLETED|Overall Study||0
8549335|NCT00145795|21077693|P1|NOT COMPLETED|Overall Study||1
8549336|NCT00145795|21077692|P2|COMPLETED|Overall Study||10
8549337|NCT00145795|21077693|P1|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
8549338|NCT00145795|21077692|P2|STARTED|Overall Study||10
8549339|NCT00145795|21077693|P1|STARTED|Overall Study||10
8549340|NCT00145704|21077719|P2|NOT COMPLETED|Overall Study||3
8549341|NCT00145704|21077720|P1|NOT COMPLETED|Overall Study||3
8549342|NCT00145704|21077719|P2|COMPLETED|Overall Study||0
8549343|NCT00145704|21077720|P1|COMPLETED|Overall Study||0
8549344|NCT00145704|21077719|P2|STARTED|Overall Study||3
8549345|NCT00145704|21077720|P1|STARTED|Overall Study||3
8549346|NCT00145626|21077728|P1|NOT COMPLETED|Overall Study||5
8549347|NCT00145626|21077728|P1|COMPLETED|Overall Study||14
8549348|NCT00145626|21077728|P1|STARTED|Overall Study||19
8549361|NCT00145587|21077891|P2|NOT COMPLETED|Overall Study||0
8549362|NCT00145587|21077892|P1|NOT COMPLETED|Overall Study||0
8549363|NCT00145587|21077891|P2|COMPLETED|Overall Study||1
8549364|NCT00145587|21077892|P1|COMPLETED|Overall Study||5
8549365|NCT00145587|21077891|P2|STARTED|Overall Study||1
8549366|NCT00145587|21077892|P1|STARTED|Overall Study||5
8549367|NCT00145574|21077901|P3|NOT COMPLETED|Open Label Long-term Extension||11
8549368|NCT00145574|21077902|P2|NOT COMPLETED|Open Label Long-term Extension||0
8549369|NCT00145574|21077903|P1|NOT COMPLETED|Open Label Long-term Extension||0
8549370|NCT00145574|21077901|P3|COMPLETED|Open Label Long-term Extension||173
8549371|NCT00145574|21077902|P2|COMPLETED|Open Label Long-term Extension||0
8549372|NCT00145574|21077903|P1|COMPLETED|Open Label Long-term Extension||0
8549373|NCT00145574|21077901|P3|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
8549374|NCT00145574|21077902|P2|STARTED|Open Label Long-term Extension||0
8549375|NCT00145574|21077903|P1|STARTED|Open Label Long-term Extension||0
8549376|NCT00145574|21077901|P3|NOT COMPLETED|Double Blind||2
8549377|NCT00145574|21077902|P2|NOT COMPLETED|Double Blind||5
8549378|NCT00145574|21077903|P1|NOT COMPLETED|Double Blind||1
8549379|NCT00145574|21077901|P3|COMPLETED|Double Blind||62
8549380|NCT00145574|21077902|P2|COMPLETED|Double Blind||60
8549381|NCT00145574|21077903|P1|COMPLETED|Double Blind||64
8549382|NCT00145574|21077901|P3|STARTED|Double Blind||64
8549383|NCT00145574|21077902|P2|STARTED|Double Blind||65
8549384|NCT00145574|21077903|P1|STARTED|Double Blind||65
8549385|NCT00145509|21077960|P2|NOT COMPLETED|Overall Study||21
8549386|NCT00145509|21077961|P1|NOT COMPLETED|Overall Study||22
8549387|NCT00145509|21077960|P2|COMPLETED|Overall Study||15
8549388|NCT00145509|21077961|P1|COMPLETED|Overall Study||19
8549389|NCT00145509|21077960|P2|STARTED|Overall Study||36
8549390|NCT00145509|21077961|P1|STARTED|Overall Study||41
8549391|NCT00145496|21077975|P2|NOT COMPLETED|Overall Study||81
8549392|NCT00145496|21077976|P1|NOT COMPLETED|Overall Study||123
8549393|NCT00145496|21077975|P2|COMPLETED|Overall Study||143
8549394|NCT00145496|21077976|P1|COMPLETED|Overall Study||121
8549395|NCT00145496|21077975|P2|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
8549396|NCT00145496|21077976|P1|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
8549397|NCT00145470|21077988|P2|NOT COMPLETED|Overall Study||98
8549398|NCT00145470|21077989|P1|NOT COMPLETED|Overall Study||112
8549399|NCT00145470|21077988|P2|COMPLETED|Overall Study||61
8549400|NCT00145470|21077989|P1|COMPLETED|Overall Study||55
8549401|NCT00145470|21077988|P2|Treated|Overall Study||158
8549402|NCT00145470|21077989|P1|Treated|Overall Study||166
8549403|NCT00145470|21077988|P2|STARTED|Overall Study||159
8549404|NCT00145470|21077989|P1|STARTED|Overall Study||167
8549405|NCT00145418|21078049|P1|NOT COMPLETED|Overall Study||0
8549406|NCT00145418|21078049|P1|COMPLETED|Overall Study||15
8549407|NCT00145418|21078049|P1|STARTED|Overall Study||15
8549408|NCT00145327|21078059|P3|NOT COMPLETED|Overall Study||248
8549409|NCT00145327|21078060|P2|NOT COMPLETED|Overall Study||124
8549410|NCT00145327|21078061|P1|NOT COMPLETED|Overall Study||142
8549411|NCT00145327|21078059|P3|COMPLETED|Overall Study||975
8549412|NCT00145327|21078060|P2|COMPLETED|Overall Study||493
8549413|NCT00145327|21078061|P1|COMPLETED|Overall Study||474
8549414|NCT00145327|21078059|P3|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
8549415|NCT00145327|21078060|P2|STARTED|Overall Study||617
8549416|NCT00145327|21078061|P1|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
8549417|NCT00145249|21078117|P3|NOT COMPLETED|Overall Study||17
8549418|NCT00145249|21078118|P2|NOT COMPLETED|Overall Study||15
8549419|NCT00145249|21078119|P1|NOT COMPLETED|Overall Study||11
8549420|NCT00145249|21078117|P3|COMPLETED|Overall Study||31
8549421|NCT00145249|21078118|P2|COMPLETED|Overall Study||33
8549422|NCT00145249|21078119|P1|COMPLETED|Overall Study||36
8549423|NCT00145249|21078117|P3|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
8549424|NCT00145249|21078118|P2|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
8549425|NCT00145249|21078119|P1|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
8549426|NCT00145119|21078160|P1|NOT COMPLETED|Overall Study||45
8549427|NCT00145119|21078160|P1|COMPLETED|Overall Study||267
8549428|NCT00145119|21078160|P1|STARTED|Overall Study||312
8549429|NCT00145041|21078164|P1|NOT COMPLETED|Overall Study||0
8549430|NCT00145041|21078164|P1|COMPLETED|Overall Study||7
8549431|NCT00145041|21078164|P1|STARTED|Overall Study||7
8549432|NCT00144963|21078170|P1|NOT COMPLETED|Overall Study||0
8549433|NCT00144963|21078170|P1|COMPLETED|Overall Study||36
8549434|NCT00144963|21078170|P1|STARTED|Overall Study||36
8549435|NCT00144781|21078178|P4|NOT COMPLETED|Overall Study||0
8549436|NCT00144781|21078179|P3|NOT COMPLETED|Overall Study||0
8549437|NCT00144781|21078180|P2|NOT COMPLETED|Overall Study||2
8549438|NCT00144781|21078181|P1|NOT COMPLETED|Overall Study||0
8549439|NCT00144781|21078178|P4|COMPLETED|Overall Study||9
8549440|NCT00144781|21078179|P3|COMPLETED|Overall Study||8
8549441|NCT00144781|21078180|P2|COMPLETED|Overall Study||7
8549442|NCT00144781|21078181|P1|COMPLETED|Overall Study||8
8549443|NCT00144781|21078178|P4|STARTED|Overall Study||9
8549444|NCT00144781|21078179|P3|STARTED|Overall Study||8
8549445|NCT00144781|21078180|P2|STARTED|Overall Study||9
8549446|NCT00144781|21078181|P1|STARTED|Overall Study||8
8549447|NCT00144391|21078201|P2|NOT COMPLETED|Overall Study||0
8549448|NCT00144391|21078202|P1|NOT COMPLETED|Overall Study||0
8549449|NCT00144391|21078201|P2|COMPLETED|Overall Study||9
8549450|NCT00144391|21078202|P1|COMPLETED|Overall Study||11
8549451|NCT00144391|21078201|P2|STARTED|Overall Study||9
8549452|NCT00144391|21078202|P1|STARTED|Overall Study||11
8549453|NCT00144339|21078210|P2|NOT COMPLETED|Overall Study||1099
8549454|NCT00144339|21078211|P1|NOT COMPLETED|Overall Study||1358
8549455|NCT00144339|21078210|P2|COMPLETED|Overall Study||1887
8549456|NCT00144339|21078211|P1|COMPLETED|Overall Study||1648
8549457|NCT00144339|21078210|P2|STARTED|Overall Study||2986
8549458|NCT00144339|21078211|P1|STARTED|Overall Study||3006
8549459|NCT00144300|21078419|P2|NOT COMPLETED|Overall Study||28
8549460|NCT00144300|21078420|P1|NOT COMPLETED|Overall Study||29
8549461|NCT00144300|21078419|P2|COMPLETED|Overall Study||97
8549462|NCT00144300|21078420|P1|COMPLETED|Overall Study||92
8549463|NCT00144300|21078419|P2|STARTED|Overall Study||125
8549464|NCT00144300|21078420|P1|STARTED|Overall Study||121
8549465|NCT00144170|21078468|P2|NOT COMPLETED|Overall Study||396
8549466|NCT00144170|21078469|P1|NOT COMPLETED|Overall Study||352
8549467|NCT00144170|21078468|P2|COMPLETED|Overall Study||32
8549468|NCT00144170|21078469|P1|COMPLETED|Overall Study||86
8549469|NCT00144170|21078468|P2|STARTED|Overall Study||428
8549470|NCT00144170|21078469|P1|STARTED|Overall Study||438
8549471|NCT00144027|21078659|P2|NOT COMPLETED|Overall Study||11
8549472|NCT00144027|21078660|P1|NOT COMPLETED|Overall Study||3
8549473|NCT00144027|21078659|P2|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
8549474|NCT00144027|21078660|P1|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
8549475|NCT00144027|21078659|P2|Completed 6 Month Assessment|Overall Study||24
8549476|NCT00144027|21078660|P1|Completed 6 Month Assessment|Overall Study||37
8549477|NCT00144027|21078659|P2|Completed Baseline Assessment|Overall Study||29
8549478|NCT00144027|21078660|P1|Completed Baseline Assessment|Overall Study||39
8549479|NCT00144027|21078659|P2|STARTED|Overall Study|participants who consented|36
8549480|NCT00144027|21078660|P1|STARTED|Overall Study|participants who consented|39
8549481|NCT00143845|21078666|P1|NOT COMPLETED|Overall Study||0
8549482|NCT00143845|21078666|P1|COMPLETED|Overall Study||54
8549483|NCT00143845|21078666|P1|STARTED|Overall Study||54
8549484|NCT00143819|21078674|P2|NOT COMPLETED|Overall Study||3
8549485|NCT00143819|21078675|P1|NOT COMPLETED|Overall Study||2
8549486|NCT00143819|21078674|P2|COMPLETED|Overall Study||5
8549487|NCT00143819|21078675|P1|COMPLETED|Overall Study||3
8549488|NCT00143819|21078674|P2|STARTED|Overall Study||8
8549489|NCT00143819|21078675|P1|STARTED|Overall Study||5
8549490|NCT00143598|21078690|P2|NOT COMPLETED|Overall Study||94
8549491|NCT00143598|21078691|P1|NOT COMPLETED|Overall Study||92
8549492|NCT00143598|21078690|P2|COMPLETED|Overall Study||302
8549493|NCT00143598|21078691|P1|COMPLETED|Overall Study||318
8549494|NCT00143598|21078690|P2|STARTED|Overall Study||396
8549495|NCT00143598|21078691|P1|STARTED|Overall Study||410
8549496|NCT00143507|21078705|P2|NOT COMPLETED|Overall Study||652
8549497|NCT00143507|21078706|P1|NOT COMPLETED|Overall Study||687
8549498|NCT00143507|21078705|P2|COMPLETED|Overall Study||4786
8549499|NCT00143507|21078706|P1|COMPLETED|Overall Study||4792
8549500|NCT00143507|21078705|P2|STARTED|Overall Study||5438
8549501|NCT00143507|21078706|P1|STARTED|Overall Study||5479
8549502|NCT00143455|21078740|P4|NOT COMPLETED|Cohort 2||93
8549503|NCT00143455|21078741|P3|NOT COMPLETED|Cohort 2||106
8549504|NCT00143455|21078742|P2|NOT COMPLETED|Cohort 2||0
8549505|NCT00143455|21078743|P1|NOT COMPLETED|Cohort 2||0
8549506|NCT00143455|21078740|P4|COMPLETED|Cohort 2||111
8549507|NCT00143455|21078741|P3|COMPLETED|Cohort 2||97
8549508|NCT00143455|21078742|P2|COMPLETED|Cohort 2||0
8549509|NCT00143455|21078743|P1|COMPLETED|Cohort 2||0
8549510|NCT00143455|21078740|P4|Received Treatment|Cohort 2||203
8549511|NCT00143455|21078741|P3|Received Treatment|Cohort 2||202
8549512|NCT00143455|21078742|P2|Received Treatment|Cohort 2||0
8549513|NCT00143455|21078743|P1|Received Treatment|Cohort 2||0
8549514|NCT00143455|21078740|P4|STARTED|Cohort 2||204
8549515|NCT00143455|21078741|P3|STARTED|Cohort 2||203
8549516|NCT00143455|21078742|P2|STARTED|Cohort 2||0
8549517|NCT00143455|21078743|P1|STARTED|Cohort 2||0
8549518|NCT00143455|21078740|P4|NOT COMPLETED|Cohort 1||0
8549519|NCT00143455|21078741|P3|NOT COMPLETED|Cohort 1||0
8549520|NCT00143455|21078742|P2|NOT COMPLETED|Cohort 1||17
8549521|NCT00143455|21078743|P1|NOT COMPLETED|Cohort 1||14
8549522|NCT00143455|21078740|P4|COMPLETED|Cohort 1||0
8549523|NCT00143455|21078741|P3|COMPLETED|Cohort 1||0
8549524|NCT00143455|21078742|P2|COMPLETED|Cohort 1||22
8549525|NCT00143455|21078743|P1|COMPLETED|Cohort 1||25
8549526|NCT00143455|21078740|P4|Received Treatment|Cohort 1||0
8549527|NCT00143455|21078741|P3|Received Treatment|Cohort 1||0
8549528|NCT00143455|21078742|P2|Received Treatment|Cohort 1||38
8549529|NCT00143455|21078743|P1|Received Treatment|Cohort 1||39
8549530|NCT00143455|21078740|P4|STARTED|Cohort 1||0
8549531|NCT00143455|21078741|P3|STARTED|Cohort 1||0
8549532|NCT00143455|21078742|P2|STARTED|Cohort 1||39
8549533|NCT00143455|21078743|P1|STARTED|Cohort 1||39
8549534|NCT00143403|21078777|P2|NOT COMPLETED|Overall Study||46
8549535|NCT00143403|21078778|P1|NOT COMPLETED|Overall Study||35
8549536|NCT00143403|21078777|P2|COMPLETED|Overall Study|Received maximum number of cycles.|115
8549537|NCT00143403|21078778|P1|COMPLETED|Overall Study|Received maximum number of cycles.|125
8549538|NCT00143403|21078777|P2|Treated|Overall Study||153
8549539|NCT00143403|21078778|P1|Treated|Overall Study||153
8549540|NCT00143403|21078777|P2|STARTED|Overall Study||161
8549541|NCT00143403|21078778|P1|STARTED|Overall Study||160
8549542|NCT00143390|21078788|P2|NOT COMPLETED|Overall Study||149
8549543|NCT00143390|21078789|P1|NOT COMPLETED|Overall Study||149
8549544|NCT00143390|21078788|P2|COMPLETED|Overall Study||0
8549545|NCT00143390|21078789|P1|COMPLETED|Overall Study||0
8549546|NCT00143390|21078788|P2|STARTED|Overall Study||149
8549547|NCT00143390|21078789|P1|STARTED|Overall Study||149
8549548|NCT00143312|21078805|P1|NOT COMPLETED|Overall Study||16
8549549|NCT00143312|21078805|P1|COMPLETED|Overall Study||29
8549550|NCT00143312|21078805|P1|STARTED|Overall Study||45
8549551|NCT00143247|21078815|P1|NOT COMPLETED|Overall Study||156
8549552|NCT00143247|21078815|P1|COMPLETED|Overall Study||17
8549553|NCT00143247|21078815|P1|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
8549554|NCT00142935|21078832|P3|NOT COMPLETED|Overall Study||7
8549555|NCT00142935|21078833|P2|NOT COMPLETED|Overall Study||8
8549556|NCT00142935|21078834|P1|NOT COMPLETED|Overall Study||3
8549557|NCT00142935|21078832|P3|COMPLETED|Overall Study||23
8549558|NCT00142935|21078833|P2|COMPLETED|Overall Study||20
8549559|NCT00142935|21078834|P1|COMPLETED|Overall Study||26
8549560|NCT00142935|21078832|P3|STARTED|Overall Study||30
8549561|NCT00142935|21078833|P2|STARTED|Overall Study||28
8549562|NCT00142935|21078834|P1|STARTED|Overall Study||29
8549563|NCT00142909|21078859|P2|NOT COMPLETED|Medications Begin||3
8549564|NCT00142909|21078860|P1|NOT COMPLETED|Medications Begin||9
8549565|NCT00142909|21078859|P2|COMPLETED|Medications Begin||31
8549566|NCT00142909|21078860|P1|COMPLETED|Medications Begin||26
8549567|NCT00142909|21078859|P2|STARTED|Medications Begin||34
8549568|NCT00142909|21078860|P1|STARTED|Medications Begin||35
8549569|NCT00142909|21078859|P2|NOT COMPLETED|Randomization||10
8549570|NCT00142909|21078860|P1|NOT COMPLETED|Randomization||7
8549571|NCT00142909|21078859|P2|COMPLETED|Randomization||34
8549572|NCT00142909|21078860|P1|COMPLETED|Randomization||35
8549573|NCT00142909|21078859|P2|STARTED|Randomization||44
8549574|NCT00142909|21078860|P1|STARTED|Randomization||42
8549575|NCT00142818|21078880|P4|NOT COMPLETED|Overall Study||22
8549576|NCT00142818|21078881|P3|NOT COMPLETED|Overall Study||13
8549577|NCT00142818|21078882|P2|NOT COMPLETED|Overall Study||21
8549578|NCT00142818|21078883|P1|NOT COMPLETED|Overall Study||17
8549579|NCT00142818|21078880|P4|COMPLETED|Overall Study||20
8549580|NCT00142818|21078881|P3|COMPLETED|Overall Study||24
8549581|NCT00142818|21078882|P2|COMPLETED|Overall Study||19
8549582|NCT00142818|21078883|P1|COMPLETED|Overall Study||28
8549583|NCT00142818|21078880|P4|STARTED|Overall Study||42
8549584|NCT00142818|21078881|P3|STARTED|Overall Study||37
8549585|NCT00142818|21078882|P2|STARTED|Overall Study||40
8549586|NCT00142818|21078883|P1|STARTED|Overall Study||45
8549587|NCT00142792|21078900|P3|NOT COMPLETED|Overall Study||12
8549588|NCT00142792|21078901|P2|NOT COMPLETED|Overall Study||15
8549589|NCT00142792|21078902|P1|NOT COMPLETED|Overall Study||12
8549590|NCT00142792|21078900|P3|COMPLETED|Overall Study||30
8549591|NCT00142792|21078901|P2|COMPLETED|Overall Study||26
8549592|NCT00142792|21078902|P1|COMPLETED|Overall Study||27
8549593|NCT00142792|21078900|P3|Completed Intervention|Overall Study||37
8549594|NCT00142792|21078901|P2|Completed Intervention|Overall Study||37
8549595|NCT00142792|21078902|P1|Completed Intervention|Overall Study||35
8549596|NCT00142792|21078900|P3|STARTED|Overall Study||42
8549597|NCT00142792|21078901|P2|STARTED|Overall Study||41
8549598|NCT00142792|21078902|P1|STARTED|Overall Study||39
8549599|NCT00142597|21078915|P2|NOT COMPLETED|Overall Study||1
8549600|NCT00142597|21078916|P1|NOT COMPLETED|Overall Study||3
8549601|NCT00142597|21078915|P2|COMPLETED|Overall Study|N=10 completed PET imaging|22
8549602|NCT00142597|21078916|P1|COMPLETED|Overall Study|N=10 completed PET imaging|20
8549603|NCT00142597|21078915|P2|STARTED|Overall Study|N=10 underwent PET imaging|23
8549604|NCT00142597|21078916|P1|STARTED|Overall Study|N=10 underwent PET imaging|23
8549605|NCT00142519|21078924|P2|NOT COMPLETED|Overall Study||16
8549606|NCT00142519|21078925|P1|NOT COMPLETED|Overall Study||18
8549607|NCT00142519|21078924|P2|COMPLETED|Overall Study||9
8549608|NCT00142519|21078925|P1|COMPLETED|Overall Study||7
8549609|NCT00142519|21078924|P2|STARTED|Overall Study||25
8549610|NCT00142519|21078925|P1|STARTED|Overall Study||25
8549611|NCT00142506|21078935|P2|NOT COMPLETED|Overall Study||29
8549612|NCT00142506|21078936|P1|NOT COMPLETED|Overall Study||72
8549613|NCT00142506|21078935|P2|COMPLETED|Overall Study||77
8549614|NCT00142506|21078936|P1|COMPLETED|Overall Study||112
8549615|NCT00142506|21078935|P2|STARTED|Overall Study||106
8549616|NCT00142506|21078936|P1|STARTED|Overall Study||184
8549617|NCT00142454|21078942|P1|NOT COMPLETED|Overall Study||0
8549618|NCT00142454|21078942|P1|COMPLETED|Overall Study||9
8549619|NCT00142454|21078942|P1|STARTED|Overall Study||9
8549620|NCT00142415|21078954|P6|NOT COMPLETED|Overall Study||2
8549621|NCT00142415|21078955|P5|NOT COMPLETED|Overall Study||1
8549622|NCT00142415|21078956|P4|NOT COMPLETED|Overall Study||0
8549623|NCT00142415|21078957|P3|NOT COMPLETED|Overall Study||0
8549624|NCT00142415|21078958|P2|NOT COMPLETED|Overall Study||0
8549625|NCT00142415|21078959|P1|NOT COMPLETED|Overall Study||0
8549626|NCT00142415|21078954|P6|COMPLETED|Overall Study||6
8549627|NCT00142415|21078955|P5|COMPLETED|Overall Study||2
8549628|NCT00142415|21078956|P4|COMPLETED|Overall Study||3
8549629|NCT00142415|21078957|P3|COMPLETED|Overall Study||6
8549630|NCT00142415|21078958|P2|COMPLETED|Overall Study||3
8549631|NCT00142415|21078959|P1|COMPLETED|Overall Study||3
8549632|NCT00142415|21078954|P6|STARTED|Overall Study||8
8549633|NCT00142415|21078955|P5|STARTED|Overall Study||3
8549634|NCT00142415|21078956|P4|STARTED|Overall Study||3
8549635|NCT00142415|21078957|P3|STARTED|Overall Study||6
8549636|NCT00142415|21078958|P2|STARTED|Overall Study||3
8549637|NCT00142415|21078959|P1|STARTED|Overall Study||3
8549638|NCT00142298|21078997|P10|NOT COMPLETED|Overall Study||0
8549639|NCT00142298|21078998|P9|NOT COMPLETED|Overall Study||5
8549640|NCT00142298|21078999|P8|NOT COMPLETED|Overall Study||8
8549641|NCT00142298|21079000|P7|NOT COMPLETED|Overall Study||8
8549642|NCT00142298|21079001|P6|NOT COMPLETED|Overall Study||16
8549643|NCT00142298|21079002|P5|NOT COMPLETED|Overall Study||10
8549644|NCT00142298|21079003|P4|NOT COMPLETED|Overall Study||85
8549645|NCT00142298|21079004|P3|NOT COMPLETED|Overall Study||33
8549646|NCT00142298|21079005|P2|NOT COMPLETED|Overall Study||176
8549647|NCT00142298|21079006|P1|NOT COMPLETED|Overall Study||160
8549648|NCT00142298|21078997|P10|COMPLETED|Overall Study||13
8549649|NCT00142298|21078998|P9|COMPLETED|Overall Study||52
8549650|NCT00142298|21078999|P8|COMPLETED|Overall Study||58
8549651|NCT00142298|21079000|P7|COMPLETED|Overall Study||15
8549652|NCT00142298|21079001|P6|COMPLETED|Overall Study||10
8549653|NCT00142298|21079002|P5|COMPLETED|Overall Study||46
8549654|NCT00142298|21079003|P4|COMPLETED|Overall Study||121
8549655|NCT00142298|21079004|P3|COMPLETED|Overall Study||90
8549656|NCT00142298|21079005|P2|COMPLETED|Overall Study||456
8549657|NCT00142298|21079006|P1|COMPLETED|Overall Study|Completed week 104/week 208.|507
8549658|NCT00142298|21078997|P10|Per Protocol Population|Overall Study||13
8549659|NCT00142298|21078998|P9|Per Protocol Population|Overall Study||56
8549660|NCT00142298|21078999|P8|Per Protocol Population|Overall Study||64
8549661|NCT00142298|21079000|P7|Per Protocol Population|Overall Study||19
8549662|NCT00142298|21079001|P6|Per Protocol Population|Overall Study||25
8549663|NCT00142298|21079002|P5|Per Protocol Population|Overall Study||50
8549664|NCT00142298|21079003|P4|Per Protocol Population|Overall Study||202
8549665|NCT00142298|21079004|P3|Per Protocol Population|Overall Study||120
8549666|NCT00142298|21079005|P2|Per Protocol Population|Overall Study||606
8549667|NCT00142298|21079006|P1|Per Protocol Population|Overall Study||635
8549668|NCT00142298|21078997|P10|Safety Population|Overall Study||13
8549669|NCT00142298|21078998|P9|Safety Population|Overall Study||57
8549670|NCT00142298|21078999|P8|Safety Population|Overall Study||66
8549671|NCT00142298|21079000|P7|Safety Population|Overall Study||23
8549672|NCT00142298|21079001|P6|Safety Population|Overall Study||26
8549673|NCT00142298|21079002|P5|Safety Population|Overall Study||50
8549674|NCT00142298|21079003|P4|Safety Population|Overall Study||206
8549675|NCT00142298|21079004|P3|Safety Population|Overall Study||122
8549676|NCT00142298|21079005|P2|Safety Population|Overall Study||626
8549677|NCT00142298|21079006|P1|Safety Population|Overall Study||655
8549678|NCT00142298|21078997|P10|STARTED|Overall Study||13
8549679|NCT00142298|21078998|P9|STARTED|Overall Study||57
8549680|NCT00142298|21078999|P8|STARTED|Overall Study||66
8549681|NCT00142298|21079000|P7|STARTED|Overall Study||23
8549682|NCT00142298|21079001|P6|STARTED|Overall Study||26
8549683|NCT00142298|21079002|P5|STARTED|Overall Study||56
8549684|NCT00142298|21079003|P4|STARTED|Overall Study||206
8549685|NCT00142298|21079004|P3|STARTED|Overall Study||123
8549686|NCT00142298|21079005|P2|STARTED|Overall Study||632
8549687|NCT00142298|21079006|P1|STARTED|Overall Study||667
8549688|NCT00142168|21079028|P1|NOT COMPLETED|Overall Study||0
8549689|NCT00142168|21079028|P1|COMPLETED|Overall Study||16
8549690|NCT00142168|21079028|P1|STARTED|Overall Study||16
8549691|NCT00142116|21079035|P1|NOT COMPLETED|Overall Study||0
8549692|NCT00142116|21079035|P1|COMPLETED|Overall Study||25
8549693|NCT00142116|21079035|P1|STARTED|Overall Study||25
8549694|NCT00141921|21079040|P1|NOT COMPLETED|Overall Study||141
8549695|NCT00141921|21079040|P1|COMPLETED|Overall Study||41
8549696|NCT00141921|21079040|P1|Received Treatment|Overall Study||181
8549697|NCT00141921|21079040|P1|STARTED|Overall Study||182
8549698|NCT00141817|21079066|P4|NOT COMPLETED|Overall Study||0
8549699|NCT00141817|21079067|P3|NOT COMPLETED|Overall Study||1
8549700|NCT00141817|21079068|P2|NOT COMPLETED|Overall Study||0
8549701|NCT00141817|21079069|P1|NOT COMPLETED|Overall Study||1
8549702|NCT00141817|21079066|P4|COMPLETED|Overall Study||13
8549703|NCT00141817|21079067|P3|COMPLETED|Overall Study||10
8549704|NCT00141817|21079068|P2|COMPLETED|Overall Study||10
8549705|NCT00141817|21079069|P1|COMPLETED|Overall Study||6
8549706|NCT00141817|21079066|P4|STARTED|Overall Study||13
8549707|NCT00141817|21079067|P3|STARTED|Overall Study||11
8549708|NCT00141817|21079068|P2|STARTED|Overall Study||10
8549709|NCT00141817|21079069|P1|STARTED|Overall Study||7
8549710|NCT00141778|21079110|P3|NOT COMPLETED|Started Study Medication||4
8549711|NCT00141778|21079111|P2|NOT COMPLETED|Started Study Medication||7
8549712|NCT00141778|21079112|P1|NOT COMPLETED|Started Study Medication||2
8549713|NCT00141778|21079110|P3|COMPLETED|Started Study Medication||143
8549714|NCT00141778|21079111|P2|COMPLETED|Started Study Medication||144
8549715|NCT00141778|21079112|P1|COMPLETED|Started Study Medication||145
8549716|NCT00141778|21079110|P3|STARTED|Started Study Medication||147
8549717|NCT00141778|21079111|P2|STARTED|Started Study Medication||151
8549718|NCT00141778|21079112|P1|STARTED|Started Study Medication||147
8549719|NCT00141778|21079110|P3|NOT COMPLETED|Randomization Prior to Study Med||6
8549720|NCT00141778|21079111|P2|NOT COMPLETED|Randomization Prior to Study Med||2
8549721|NCT00141778|21079112|P1|NOT COMPLETED|Randomization Prior to Study Med||5
8549722|NCT00141778|21079110|P3|COMPLETED|Randomization Prior to Study Med||147
8549723|NCT00141778|21079111|P2|COMPLETED|Randomization Prior to Study Med||151
8549724|NCT00141778|21079112|P1|COMPLETED|Randomization Prior to Study Med||147
8549725|NCT00141778|21079110|P3|STARTED|Randomization Prior to Study Med||153
8549726|NCT00141778|21079111|P2|STARTED|Randomization Prior to Study Med||153
8549727|NCT00141778|21079112|P1|STARTED|Randomization Prior to Study Med||152
8549728|NCT00141765|21079150|P1|NOT COMPLETED|Overall Study||0
8549729|NCT00141765|21079150|P1|COMPLETED|Overall Study||25
8549730|NCT00141765|21079150|P1|STARTED|Overall Study||25
8549731|NCT00141739|21079154|P1|NOT COMPLETED|Overall Study||0
8549732|NCT00141739|21079154|P1|COMPLETED|Overall Study||100
8549733|NCT00141739|21079154|P1|STARTED|Overall Study|Number of evaluable patients|100
8549734|NCT00141726|21079165|P1|NOT COMPLETED|Overall Study||3
8549735|NCT00141726|21079165|P1|COMPLETED|Overall Study||31
8549736|NCT00141726|21079165|P1|STARTED|Overall Study||34
8549737|NCT00141518|21079173|P3|NOT COMPLETED|Overall Study||6
8549738|NCT00141518|21079174|P2|NOT COMPLETED|Overall Study||6
8549739|NCT00141518|21079175|P1|NOT COMPLETED|Overall Study||16
8549740|NCT00141518|21079173|P3|COMPLETED|Overall Study||12
8549741|NCT00141518|21079174|P2|COMPLETED|Overall Study||16
8549742|NCT00141518|21079175|P1|COMPLETED|Overall Study||21
8549743|NCT00141518|21079173|P3|Full Analysis Sample|Overall Study||18
8549744|NCT00141518|21079174|P2|Full Analysis Sample|Overall Study||22
8549745|NCT00141518|21079175|P1|Full Analysis Sample|Overall Study||27
8549746|NCT00141518|21079173|P3|Safety Sample|Overall Study||18
8549747|NCT00141518|21079174|P2|Safety Sample|Overall Study||22
8549748|NCT00141518|21079175|P1|Safety Sample|Overall Study||36
8549749|NCT00141518|21079173|P3|STARTED|Overall Study||18
8549750|NCT00141518|21079174|P2|STARTED|Overall Study||22
8549751|NCT00141518|21079175|P1|STARTED|Overall Study||37
8549752|NCT00141453|21079364|P2|NOT COMPLETED|Overall Study||5
8549753|NCT00141453|21079365|P1|NOT COMPLETED|Overall Study||6
8549754|NCT00141453|21079364|P2|COMPLETED|Overall Study||284
8549755|NCT00141453|21079365|P1|COMPLETED|Overall Study||282
8549756|NCT00141453|21079364|P2|STARTED|Overall Study||289
8549757|NCT00141453|21079365|P1|STARTED|Overall Study||288
8549758|NCT00141297|21079379|P10|NOT COMPLETED|Overall Study||6
8549759|NCT00141297|21079380|P9|NOT COMPLETED|Overall Study||20
8549760|NCT00141297|21079381|P8|NOT COMPLETED|Overall Study||4
8549761|NCT00141297|21079382|P7|NOT COMPLETED|Overall Study||3
8549762|NCT00141297|21079383|P6|NOT COMPLETED|Overall Study||3
8549763|NCT00141297|21079384|P5|NOT COMPLETED|Overall Study||22
8549764|NCT00141297|21079385|P4|NOT COMPLETED|Overall Study||3
8549765|NCT00141297|21079386|P3|NOT COMPLETED|Overall Study||7
8549766|NCT00141297|21079387|P2|NOT COMPLETED|Overall Study||3
8549767|NCT00141297|21079388|P1|NOT COMPLETED|Overall Study||3
8549768|NCT00141297|21079379|P10|COMPLETED|Overall Study||0
8549769|NCT00141297|21079380|P9|COMPLETED|Overall Study||0
8549770|NCT00141297|21079381|P8|COMPLETED|Overall Study||0
8549771|NCT00141297|21079382|P7|COMPLETED|Overall Study||0
8549772|NCT00141297|21079383|P6|COMPLETED|Overall Study||0
8549773|NCT00141297|21079384|P5|COMPLETED|Overall Study||0
8549774|NCT00141297|21079385|P4|COMPLETED|Overall Study||0
8549775|NCT00141297|21079386|P3|COMPLETED|Overall Study||0
8549776|NCT00141297|21079387|P2|COMPLETED|Overall Study||0
8549777|NCT00141297|21079388|P1|COMPLETED|Overall Study||0
8549778|NCT00141297|21079379|P10|STARTED|Overall Study||6
8549779|NCT00141297|21079380|P9|STARTED|Overall Study||20
8549780|NCT00141297|21079381|P8|STARTED|Overall Study||4
8549781|NCT00141297|21079382|P7|STARTED|Overall Study||3
8549782|NCT00141297|21079383|P6|STARTED|Overall Study||3
8549783|NCT00141297|21079384|P5|STARTED|Overall Study||22
8549784|NCT00141297|21079385|P4|STARTED|Overall Study||3
8549785|NCT00141297|21079386|P3|STARTED|Overall Study||7
8549786|NCT00141297|21079387|P2|STARTED|Overall Study||3
8549787|NCT00141297|21079388|P1|STARTED|Overall Study||3
8549803|NCT00141115|21079840|P1|NOT COMPLETED|Overall Study||1
8549804|NCT00141115|21079840|P1|COMPLETED|Overall Study||2
8549805|NCT00141115|21079840|P1|STARTED|Overall Study||3
8549814|NCT00141037|21079888|P2|NOT COMPLETED|Overall Study||18
8549815|NCT00141037|21079889|P1|NOT COMPLETED|Overall Study||10
8549816|NCT00141037|21079888|P2|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
8549817|NCT00141037|21079889|P1|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
8549818|NCT00141037|21079888|P2|STARTED|Overall Study||70
8549819|NCT00141037|21079889|P1|STARTED|Overall Study||60
8549820|NCT00140842|21079899|P2|NOT COMPLETED|Overall Study||0
8549821|NCT00140842|21079900|P1|NOT COMPLETED|Overall Study||0
8549822|NCT00140842|21079899|P2|COMPLETED|Overall Study||15
8549823|NCT00140842|21079900|P1|COMPLETED|Overall Study||15
8549824|NCT00140842|21079899|P2|STARTED|Overall Study||15
8549825|NCT00140842|21079900|P1|STARTED|Overall Study||15
8549826|NCT00140621|21079908|P1|NOT COMPLETED|Overall Study||0
8549827|NCT00140621|21079908|P1|COMPLETED|Overall Study||6
8549828|NCT00140621|21079908|P1|STARTED|Overall Study||6
8549829|NCT00140556|21079918|P1|NOT COMPLETED|Chemoradiotherapy Period||0
8549830|NCT00140556|21079918|P1|COMPLETED|Chemoradiotherapy Period||28
8549831|NCT00140556|21079918|P1|STARTED|Chemoradiotherapy Period||28
8549832|NCT00140556|21079918|P1|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
8549833|NCT00140556|21079918|P1|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
8549834|NCT00140556|21079918|P1|STARTED|Pre Radiation Period: Avastin / Tarceva||28
8549835|NCT00140426|21079924|P2|NOT COMPLETED|Overall Study||3
8549836|NCT00140426|21079925|P1|NOT COMPLETED|Overall Study||0
8549837|NCT00140426|21079924|P2|COMPLETED|Overall Study||16
8549838|NCT00140426|21079925|P1|COMPLETED|Overall Study||22
8549839|NCT00140426|21079924|P2|STARTED|Overall Study||19
8549840|NCT00140426|21079925|P1|STARTED|Overall Study||22
8549841|NCT00140413|21079958|P2|NOT COMPLETED|Overall Study||0
8549842|NCT00140413|21079959|P1|NOT COMPLETED|Overall Study||3
8549843|NCT00140413|21079958|P2|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
8549844|NCT00140413|21079959|P1|COMPLETED|Overall Study||10
8549845|NCT00140413|21079958|P2|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
8549846|NCT00140413|21079959|P1|Received at Least One Dose of GH|Overall Study||13
8549847|NCT00140413|21079958|P2|STARTED|Overall Study||7
8549848|NCT00140413|21079959|P1|STARTED|Overall Study||13
8549849|NCT00140244|21079966|P2|NOT COMPLETED|Intervention 2||2
8549850|NCT00140244|21079967|P1|NOT COMPLETED|Intervention 2||0
8549851|NCT00140244|21079966|P2|COMPLETED|Intervention 2||2
8549852|NCT00140244|21079967|P1|COMPLETED|Intervention 2||3
8549853|NCT00140244|21079966|P2|STARTED|Intervention 2||4
8549854|NCT00140244|21079967|P1|STARTED|Intervention 2||3
8549855|NCT00140244|21079966|P2|NOT COMPLETED|Washout||0
8549856|NCT00140244|21079967|P1|NOT COMPLETED|Washout||0
8549857|NCT00140244|21079966|P2|COMPLETED|Washout||4
8549858|NCT00140244|21079967|P1|COMPLETED|Washout||3
8549859|NCT00140244|21079966|P2|STARTED|Washout||4
8549860|NCT00140244|21079967|P1|STARTED|Washout||3
8549861|NCT00140244|21079966|P2|NOT COMPLETED|Intervention 1||0
8549862|NCT00140244|21079967|P1|NOT COMPLETED|Intervention 1||0
8549863|NCT00140244|21079966|P2|COMPLETED|Intervention 1||4
8549864|NCT00140244|21079967|P1|COMPLETED|Intervention 1||3
8549865|NCT00140244|21079966|P2|STARTED|Intervention 1||4
8549866|NCT00140244|21079967|P1|STARTED|Intervention 1||3
8549867|NCT00140231|21079999|P2|NOT COMPLETED|Fasting State With Leptin and Crossover||0
8549868|NCT00140231|21080000|P1|NOT COMPLETED|Fasting State With Leptin and Crossover||0
8549869|NCT00140231|21079999|P2|COMPLETED|Fasting State With Leptin and Crossover||6
8549870|NCT00140231|21080000|P1|COMPLETED|Fasting State With Leptin and Crossover||7
8549871|NCT00140231|21079999|P2|STARTED|Fasting State With Leptin and Crossover||6
8549872|NCT00140231|21080000|P1|STARTED|Fasting State With Leptin and Crossover||7
8549873|NCT00140231|21079999|P2|NOT COMPLETED|Washout 8 Weeks||0
8549874|NCT00140231|21080000|P1|NOT COMPLETED|Washout 8 Weeks||0
8549875|NCT00140231|21079999|P2|COMPLETED|Washout 8 Weeks||6
8549876|NCT00140231|21080000|P1|COMPLETED|Washout 8 Weeks||7
8549877|NCT00140231|21079999|P2|STARTED|Washout 8 Weeks||6
8549878|NCT00140231|21080000|P1|STARTED|Washout 8 Weeks||7
8549879|NCT00140231|21079999|P2|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
8549880|NCT00140231|21080000|P1|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
8549881|NCT00140231|21079999|P2|COMPLETED|First Fasting State 3 Days With Placebo||6
8549882|NCT00140231|21080000|P1|COMPLETED|First Fasting State 3 Days With Placebo||7
8549883|NCT00140231|21079999|P2|STARTED|First Fasting State 3 Days With Placebo||6
8549884|NCT00140231|21080000|P1|STARTED|First Fasting State 3 Days With Placebo||7
8549885|NCT00140231|21079999|P2|NOT COMPLETED|Washout 8weeks||0
8549886|NCT00140231|21080000|P1|NOT COMPLETED|Washout 8weeks||0
8549887|NCT00140231|21079999|P2|COMPLETED|Washout 8weeks||6
8549888|NCT00140231|21080000|P1|COMPLETED|Washout 8weeks||7
8549889|NCT00140231|21079999|P2|STARTED|Washout 8weeks||6
8549890|NCT00140231|21080000|P1|STARTED|Washout 8weeks||7
8549891|NCT00140231|21079999|P2|NOT COMPLETED|Fed State 1 Day- day5||0
8549892|NCT00140231|21080000|P1|NOT COMPLETED|Fed State 1 Day- day5||0
8549893|NCT00140231|21079999|P2|COMPLETED|Fed State 1 Day- day5||6
8549894|NCT00140231|21080000|P1|COMPLETED|Fed State 1 Day- day5||7
8549895|NCT00140231|21079999|P2|STARTED|Fed State 1 Day- day5||6
8549896|NCT00140231|21080000|P1|STARTED|Fed State 1 Day- day5||7
8549897|NCT00140205|21080019|P3|NOT COMPLETED|Overall Study||0
8549898|NCT00140205|21080020|P2|NOT COMPLETED|Overall Study||0
8549899|NCT00140205|21080021|P1|NOT COMPLETED|Overall Study||0
8549900|NCT00140205|21080019|P3|COMPLETED|Overall Study||5
8549901|NCT00140205|21080020|P2|COMPLETED|Overall Study||5
8549902|NCT00140205|21080021|P1|COMPLETED|Overall Study||5
8549903|NCT00140205|21080019|P3|STARTED|Overall Study||5
8549904|NCT00140205|21080020|P2|STARTED|Overall Study||5
8549905|NCT00140205|21080021|P1|STARTED|Overall Study||5
8549906|NCT00140140|21080090|P3|NOT COMPLETED|Overall Study||2
8549907|NCT00140140|21080091|P2|NOT COMPLETED|Overall Study||2
8549908|NCT00140140|21080092|P1|NOT COMPLETED|Overall Study||2
8549909|NCT00140140|21080090|P3|COMPLETED|Overall Study|Progressive disease|4
8549910|NCT00140140|21080091|P2|COMPLETED|Overall Study|Progressive disease|4
8549911|NCT00140140|21080092|P1|COMPLETED|Overall Study|Progressive disease|2
8549912|NCT00140140|21080090|P3|STARTED|Overall Study||6
8549913|NCT00140140|21080091|P2|STARTED|Overall Study||6
8549914|NCT00140140|21080092|P1|STARTED|Overall Study||4
8549915|NCT00139997|21080131|P2|NOT COMPLETED|Overall Study||2
8549916|NCT00139997|21080132|P1|NOT COMPLETED|Overall Study||1
8549917|NCT00139997|21080131|P2|COMPLETED|Overall Study||9
8549918|NCT00139997|21080132|P1|COMPLETED|Overall Study||14
8549919|NCT00139997|21080131|P2|STARTED|Overall Study||11
8549920|NCT00139997|21080132|P1|STARTED|Overall Study||15
8549961|NCT00139659|21080186|P2|NOT COMPLETED|Overall Study||18
8549962|NCT00139659|21080187|P1|NOT COMPLETED|Overall Study||40
8549963|NCT00139659|21080186|P2|COMPLETED|Overall Study||123
8549964|NCT00139659|21080187|P1|COMPLETED|Overall Study||106
8549965|NCT00139659|21080186|P2|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
8549966|NCT00139659|21080187|P1|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
8549967|NCT00139477|21080265|P2|NOT COMPLETED|Second Intervention -6Months to 12Months||5
8549968|NCT00139477|21080266|P1|NOT COMPLETED|Second Intervention -6Months to 12Months||5
8549969|NCT00139477|21080265|P2|COMPLETED|Second Intervention -6Months to 12Months||18
8549970|NCT00139477|21080266|P1|COMPLETED|Second Intervention -6Months to 12Months||14
8549971|NCT00139477|21080265|P2|STARTED|Second Intervention -6Months to 12Months||23
8549972|NCT00139477|21080266|P1|STARTED|Second Intervention -6Months to 12Months||19
8549973|NCT00139477|21080265|P2|NOT COMPLETED|First Intervention -Baseline to 6Months||12
8549974|NCT00139477|21080266|P1|NOT COMPLETED|First Intervention -Baseline to 6Months||12
8549975|NCT00139477|21080265|P2|COMPLETED|First Intervention -Baseline to 6Months||23
8549976|NCT00139477|21080266|P1|COMPLETED|First Intervention -Baseline to 6Months||19
8549977|NCT00139477|21080265|P2|STARTED|First Intervention -Baseline to 6Months||35
8549978|NCT00139477|21080266|P1|STARTED|First Intervention -Baseline to 6Months||31
8549979|NCT00139399|21080288|P2|NOT COMPLETED|Overall Study||23
8549980|NCT00139399|21080289|P1|NOT COMPLETED|Overall Study||16
8549981|NCT00139399|21080288|P2|COMPLETED|Overall Study||59
8549982|NCT00139399|21080289|P1|COMPLETED|Overall Study||44
8549983|NCT00139399|21080288|P2|STARTED|Overall Study||82
8549984|NCT00139399|21080289|P1|STARTED|Overall Study||60
8549985|NCT00138671|21080301|P2|NOT COMPLETED|Overall Study||16
8549986|NCT00138671|21080302|P1|NOT COMPLETED|Overall Study||13
8549987|NCT00138671|21080301|P2|COMPLETED|Overall Study||30
8549988|NCT00138671|21080302|P1|COMPLETED|Overall Study||46
8549989|NCT00138671|21080301|P2|STARTED|Overall Study||46
8549990|NCT00138671|21080302|P1|STARTED|Overall Study||59
8549991|NCT00138658|21080352|P1|NOT COMPLETED|Overall Study||61
8549992|NCT00138658|21080352|P1|COMPLETED|Overall Study||20
8549993|NCT00138658|21080352|P1|STARTED|Overall Study||81
8549994|NCT00138645|21080364|P2|NOT COMPLETED|Overall Study||7
8549995|NCT00138645|21080365|P1|NOT COMPLETED|Overall Study||6
8549996|NCT00138645|21080364|P2|COMPLETED|Overall Study||23
8549997|NCT00138645|21080365|P1|COMPLETED|Overall Study||24
8549998|NCT00138645|21080364|P2|STARTED|Overall Study||30
8549999|NCT00138645|21080365|P1|STARTED|Overall Study||30
8550000|NCT00138424|21080375|P4|NOT COMPLETED|Overall Study||0
8550001|NCT00138424|21080376|P3|NOT COMPLETED|Overall Study||0
8550002|NCT00138424|21080377|P2|NOT COMPLETED|Overall Study||1
8550003|NCT00138424|21080378|P1|NOT COMPLETED|Overall Study||0
8550004|NCT00138424|21080375|P4|COMPLETED|Overall Study||3
8550005|NCT00138424|21080376|P3|COMPLETED|Overall Study||5
8550006|NCT00138424|21080377|P2|COMPLETED|Overall Study||4
8550007|NCT00138424|21080378|P1|COMPLETED|Overall Study||9
8550008|NCT00138424|21080375|P4|STARTED|Overall Study||3
8550009|NCT00138424|21080376|P3|STARTED|Overall Study||5
8550010|NCT00138424|21080377|P2|STARTED|Overall Study||5
8550011|NCT00138424|21080378|P1|STARTED|Overall Study||9
8550012|NCT00138294|21080444|P1|NOT COMPLETED|Overall Study||0
8550013|NCT00138294|21080444|P1|COMPLETED|Overall Study||29255
8550014|NCT00138294|21080444|P1|STARTED|Overall Study||29255
8550015|NCT00138203|21080454|P1|NOT COMPLETED|Overall Study||0
8550016|NCT00138203|21080454|P1|COMPLETED|Overall Study||16
8550017|NCT00138203|21080454|P1|STARTED|Overall Study||16
8550018|NCT00138151|21080461|P1|NOT COMPLETED|Overall Study||4
8550019|NCT00138151|21080461|P1|COMPLETED|Overall Study||29
8550020|NCT00138151|21080461|P1|STARTED|Overall Study||33
8550021|NCT00138125|21080467|P1|NOT COMPLETED|Overall Study||0
8550022|NCT00138125|21080467|P1|COMPLETED|Overall Study||2
8550023|NCT00138125|21080467|P1|STARTED|Overall Study||2
8550024|NCT00138073|21080476|P1|NOT COMPLETED|Overall Study||55
8550025|NCT00138073|21080476|P1|COMPLETED|Overall Study||0
8550026|NCT00138073|21080476|P1|Pre-intervention Testing|Overall Study||55
8550027|NCT00138073|21080476|P1|STARTED|Overall Study||55
8550028|NCT00138034|21080483|P2|NOT COMPLETED|Overall Study||3
8550029|NCT00138034|21080484|P1|NOT COMPLETED|Overall Study||3
8550030|NCT00138034|21080483|P2|COMPLETED|Overall Study||20
8550031|NCT00138034|21080484|P1|COMPLETED|Overall Study||23
8550032|NCT00138034|21080483|P2|STARTED|Overall Study||23
8550033|NCT00138034|21080484|P1|STARTED|Overall Study||26
8550034|NCT00137969|21080494|P2|NOT COMPLETED|Overall Study||21
8550035|NCT00137969|21080495|P1|NOT COMPLETED|Overall Study||67
8550036|NCT00137969|21080494|P2|COMPLETED|Overall Study||67
8550037|NCT00137969|21080495|P1|COMPLETED|Overall Study||107
8550038|NCT00137969|21080494|P2|Received Study Drug|Overall Study||88
8550039|NCT00137969|21080495|P1|Received Study Drug|Overall Study||169
8550040|NCT00137969|21080494|P2|STARTED|Overall Study||88
8550041|NCT00137969|21080495|P1|STARTED|Overall Study||174
8550042|NCT00137839|21080515|P1|NOT COMPLETED|Overall Study||84
8550043|NCT00137839|21080515|P1|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0
8550044|NCT00137839|21080515|P1|Treated|Overall Study||83
8550045|NCT00137839|21080515|P1|STARTED|Overall Study||84
8550046|NCT00137631|21080528|P2|NOT COMPLETED|Overall Study||41
8550047|NCT00137631|21080529|P1|NOT COMPLETED|Overall Study||37
8550048|NCT00137631|21080528|P2|COMPLETED|Overall Study||133
8550049|NCT00137631|21080529|P1|COMPLETED|Overall Study||127
8550050|NCT00137631|21080528|P2|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
8550051|NCT00137631|21080529|P1|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
8550052|NCT00137631|21080528|P2|Complete 3-month Follow-up|Overall Study||125
8550053|NCT00137631|21080529|P1|Complete 3-month Follow-up|Overall Study||120
8550054|NCT00137631|21080528|P2|STARTED|Overall Study||174
8550055|NCT00137631|21080529|P1|STARTED|Overall Study||164
8550056|NCT00137449|21080545|P2|NOT COMPLETED|Overall Study||18
8550057|NCT00137449|21080546|P1|NOT COMPLETED|Overall Study||16
8550058|NCT00137449|21080545|P2|COMPLETED|Overall Study||12
8550059|NCT00137449|21080546|P1|COMPLETED|Overall Study||14
8550060|NCT00137449|21080545|P2|STARTED|Overall Study||30
8550061|NCT00137449|21080546|P1|STARTED|Overall Study||30
8550062|NCT00137436|21080583|P1|NOT COMPLETED|Overall Study||43
8550063|NCT00137436|21080583|P1|COMPLETED|Overall Study||12
8550064|NCT00137436|21080583|P1|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
8550065|NCT00137423|21080602|P2|NOT COMPLETED|Overall Study||44
8550066|NCT00137423|21080603|P1|NOT COMPLETED|Overall Study||39
8550067|NCT00137423|21080602|P2|COMPLETED|Overall Study||9
8550068|NCT00137423|21080603|P1|COMPLETED|Overall Study||15
8550069|NCT00137423|21080602|P2|STARTED|Overall Study||53
8550070|NCT00137423|21080603|P1|STARTED|Overall Study||54
8550071|NCT00137280|21080625|P2|NOT COMPLETED|Overall Study||55
8550072|NCT00137280|21080626|P1|NOT COMPLETED|Overall Study||84
8550073|NCT00137280|21080625|P2|COMPLETED|Overall Study||357
8550074|NCT00137280|21080626|P1|COMPLETED|Overall Study||305
8550075|NCT00137280|21080625|P2|STARTED|Overall Study||412
8550076|NCT00137280|21080626|P1|STARTED|Overall Study||389
8550077|NCT00137267|21080640|P2|NOT COMPLETED|Overall Study||21
8550078|NCT00137267|21080641|P1|NOT COMPLETED|Overall Study||15
8550079|NCT00137267|21080640|P2|COMPLETED|Overall Study||26
8550080|NCT00137267|21080641|P1|COMPLETED|Overall Study||40
8550081|NCT00137267|21080640|P2|STARTED|Overall Study||47
8550082|NCT00137267|21080641|P1|STARTED|Overall Study||55
8550083|NCT00137111|21080653|P4|NOT COMPLETED|Total Therapy||0
8550084|NCT00137111|21080654|P3|NOT COMPLETED|Total Therapy||0
8550085|NCT00137111|21080655|P2|NOT COMPLETED|Total Therapy||0
8550086|NCT00137111|21080656|P1|NOT COMPLETED|Total Therapy||40
8550087|NCT00137111|21080653|P4|COMPLETED|Total Therapy||0
8550088|NCT00137111|21080654|P3|COMPLETED|Total Therapy||0
8550089|NCT00137111|21080655|P2|COMPLETED|Total Therapy||0
8550090|NCT00137111|21080656|P1|COMPLETED|Total Therapy||458
8550091|NCT00137111|21080653|P4|STARTED|Total Therapy||0
8550092|NCT00137111|21080654|P3|STARTED|Total Therapy||0
8550093|NCT00137111|21080655|P2|STARTED|Total Therapy||0
8550094|NCT00137111|21080656|P1|STARTED|Total Therapy||498
8550095|NCT00137111|21080653|P4|NOT COMPLETED|Window Therapy||0
8550096|NCT00137111|21080654|P3|NOT COMPLETED|Window Therapy||0
8550097|NCT00137111|21080655|P2|NOT COMPLETED|Window Therapy||0
8550098|NCT00137111|21080656|P1|NOT COMPLETED|Window Therapy||0
8550099|NCT00137111|21080653|P4|COMPLETED|Window Therapy||142
8550100|NCT00137111|21080654|P3|COMPLETED|Window Therapy||180
8550101|NCT00137111|21080655|P2|COMPLETED|Window Therapy||176
8550102|NCT00137111|21080656|P1|COMPLETED|Window Therapy||0
8550103|NCT00137111|21080653|P4|STARTED|Window Therapy||142
8550104|NCT00137111|21080654|P3|STARTED|Window Therapy||180
8550105|NCT00137111|21080655|P2|STARTED|Window Therapy||176
8550106|NCT00137111|21080656|P1|STARTED|Window Therapy||0
8550107|NCT00137046|21080670|P2|NOT COMPLETED|Overall Study||93
8550108|NCT00137046|21080671|P1|NOT COMPLETED|Overall Study||99
8550109|NCT00137046|21080670|P2|COMPLETED|Overall Study||198
8550110|NCT00137046|21080671|P1|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
8550111|NCT00137046|21080670|P2|Received Study Treatment|Overall Study||290
8550112|NCT00137046|21080671|P1|Received Study Treatment|Overall Study||290
8550113|NCT00137046|21080670|P2|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
8550114|NCT00137046|21080671|P1|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
8550115|NCT00136955|21080719|P1|NOT COMPLETED|Overall Study||23
8550116|NCT00136955|21080719|P1|COMPLETED|Overall Study||18
8550117|NCT00136955|21080719|P1|STARTED|Overall Study||41
8550118|NCT00136916|21080728|P2|NOT COMPLETED|Overall Study||104
8550119|NCT00136916|21080729|P1|NOT COMPLETED|Overall Study||125
8550120|NCT00136916|21080728|P2|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
8550121|NCT00136916|21080729|P1|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
8550122|NCT00136916|21080728|P2|Received Treatment|Overall Study||311
8550123|NCT00136916|21080729|P1|Received Treatment|Overall Study||316
8550124|NCT00136916|21080728|P2|STARTED|Overall Study||316
8550125|NCT00136916|21080729|P1|STARTED|Overall Study||319
8550126|NCT00136838|21080783|P2|NOT COMPLETED|Second Intervention ( 5 Days)||0
8550127|NCT00136838|21080784|P1|NOT COMPLETED|Second Intervention ( 5 Days)||0
8550128|NCT00136838|21080783|P2|COMPLETED|Second Intervention ( 5 Days)||6
8550129|NCT00136838|21080784|P1|COMPLETED|Second Intervention ( 5 Days)||6
8550130|NCT00136838|21080783|P2|STARTED|Second Intervention ( 5 Days)||6
8550131|NCT00136838|21080784|P1|STARTED|Second Intervention ( 5 Days)||6
8550132|NCT00136838|21080783|P2|NOT COMPLETED|First Intervention ( 5 Days)||0
8550133|NCT00136838|21080784|P1|NOT COMPLETED|First Intervention ( 5 Days)||0
8550134|NCT00136838|21080783|P2|COMPLETED|First Intervention ( 5 Days)||6
8550135|NCT00136838|21080784|P1|COMPLETED|First Intervention ( 5 Days)||6
8550136|NCT00136838|21080783|P2|STARTED|First Intervention ( 5 Days)||6
8550137|NCT00136838|21080784|P1|STARTED|First Intervention ( 5 Days)||6
8550138|NCT00136812|21080794|P2|NOT COMPLETED|Overall Study||0
8550139|NCT00136812|21080795|P1|NOT COMPLETED|Overall Study||0
8550140|NCT00136812|21080794|P2|COMPLETED|Overall Study||113
8550141|NCT00136812|21080795|P1|COMPLETED|Overall Study||111
8550142|NCT00136812|21080794|P2|STARTED|Overall Study||113
8550143|NCT00136812|21080795|P1|STARTED|Overall Study||111
8550144|NCT00136760|21080805|P4|NOT COMPLETED|Overall Study||0
8550145|NCT00136760|21080806|P3|NOT COMPLETED|Overall Study||0
8550146|NCT00136760|21080807|P2|NOT COMPLETED|Overall Study||0
8550147|NCT00136760|21080808|P1|NOT COMPLETED|Overall Study||0
8550148|NCT00136760|21080805|P4|COMPLETED|Overall Study||13
8550149|NCT00136760|21080806|P3|COMPLETED|Overall Study||11
8550150|NCT00136760|21080807|P2|COMPLETED|Overall Study||16
8550151|NCT00136760|21080808|P1|COMPLETED|Overall Study||12
8550152|NCT00136760|21080805|P4|STARTED|Overall Study||13
8550153|NCT00136760|21080806|P3|STARTED|Overall Study||11
8550154|NCT00136760|21080807|P2|STARTED|Overall Study||16
8550155|NCT00136760|21080808|P1|STARTED|Overall Study||12
8550156|NCT00136695|21080824|P2|NOT COMPLETED|Overall Study||8
8550157|NCT00136695|21080825|P1|NOT COMPLETED|Overall Study||11
8550158|NCT00136695|21080824|P2|COMPLETED|Overall Study||35
8550159|NCT00136695|21080825|P1|COMPLETED|Overall Study||34
8550160|NCT00136695|21080824|P2|STARTED|Overall Study||43
8550161|NCT00136695|21080825|P1|STARTED|Overall Study||45
8550162|NCT00136604|21080836|P5|NOT COMPLETED|Overall Study||1
8550163|NCT00136604|21080837|P4|NOT COMPLETED|Overall Study||0
8550164|NCT00136604|21080838|P3|NOT COMPLETED|Overall Study||0
8550165|NCT00136604|21080839|P2|NOT COMPLETED|Overall Study||1
8550166|NCT00136604|21080840|P1|NOT COMPLETED|Overall Study||1
8550167|NCT00136604|21080836|P5|COMPLETED|Overall Study||124
8550168|NCT00136604|21080837|P4|COMPLETED|Overall Study||41
8550169|NCT00136604|21080838|P3|COMPLETED|Overall Study||79
8550170|NCT00136604|21080839|P2|COMPLETED|Overall Study||122
8550171|NCT00136604|21080840|P1|COMPLETED|Overall Study||248
8550172|NCT00136604|21080836|P5|STARTED|Overall Study||125
8550173|NCT00136604|21080837|P4|STARTED|Overall Study||41
8550174|NCT00136604|21080838|P3|STARTED|Overall Study||79
8550175|NCT00136604|21080839|P2|STARTED|Overall Study||123
8550176|NCT00136604|21080840|P1|STARTED|Overall Study||249
8550177|NCT00136357|21080948|P2|NOT COMPLETED|Overall Study||2
8550178|NCT00136357|21080949|P1|NOT COMPLETED|Overall Study||3
8550179|NCT00136357|21080948|P2|COMPLETED|Overall Study||39
8550180|NCT00136357|21080949|P1|COMPLETED|Overall Study||38
8550181|NCT00136357|21080948|P2|STARTED|Overall Study||41
8550182|NCT00136357|21080949|P1|STARTED|Overall Study||41
8550183|NCT00136318|21080957|P2|NOT COMPLETED|Overall Study||7
8550184|NCT00136318|21080958|P1|NOT COMPLETED|Overall Study||7
8550185|NCT00136318|21080957|P2|COMPLETED|Overall Study||84
8550186|NCT00136318|21080958|P1|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
8550187|NCT00136318|21080957|P2|STARTED|Overall Study|Took first dose of study medication|91
8550188|NCT00136318|21080958|P1|STARTED|Overall Study|Took first dose of study medication|90
8550189|NCT00136214|21080974|P2|NOT COMPLETED|Overall Study||0
8550190|NCT00136214|21080975|P1|NOT COMPLETED|Overall Study||0
8550191|NCT00136214|21080974|P2|COMPLETED|Overall Study||7
8550192|NCT00136214|21080975|P1|COMPLETED|Overall Study||15
8550193|NCT00136214|21080974|P2|STARTED|Overall Study||7
8550194|NCT00136214|21080975|P1|STARTED|Overall Study||15
8550195|NCT00136084|21080985|P2|NOT COMPLETED|Overall Study||42
8550196|NCT00136084|21080986|P1|NOT COMPLETED|Overall Study||48
8550197|NCT00136084|21080985|P2|COMPLETED|Overall Study||72
8550198|NCT00136084|21080986|P1|COMPLETED|Overall Study||61
8550199|NCT00136084|21080985|P2|STARTED|Overall Study||114
8550200|NCT00136084|21080986|P1|STARTED|Overall Study||109
8550201|NCT00135798|21081002|P3|NOT COMPLETED|Overall Study||0
8550202|NCT00135798|21081003|P2|NOT COMPLETED|Overall Study||0
8550203|NCT00135798|21081004|P1|NOT COMPLETED|Overall Study||0
8550204|NCT00135798|21081002|P3|COMPLETED|Overall Study||32
8550205|NCT00135798|21081003|P2|COMPLETED|Overall Study||31
8550206|NCT00135798|21081004|P1|COMPLETED|Overall Study||16
8550207|NCT00135798|21081002|P3|STARTED|Overall Study||32
8550208|NCT00135798|21081003|P2|STARTED|Overall Study||31
8550209|NCT00135798|21081004|P1|STARTED|Overall Study||16
8550210|NCT00135707|21081022|P2|NOT COMPLETED|Overall Study||90
8550211|NCT00135707|21081023|P1|NOT COMPLETED|Overall Study||95
8550212|NCT00135707|21081022|P2|COMPLETED|Overall Study||4976
8550213|NCT00135707|21081023|P1|COMPLETED|Overall Study||4993
8550214|NCT00135707|21081022|P2|STARTED|Overall Study||5066
8550215|NCT00135707|21081023|P1|STARTED|Overall Study||5088
8550216|NCT00135694|21081106|P3|NOT COMPLETED|Overall Study||7
8550217|NCT00135694|21081107|P2|NOT COMPLETED|Overall Study||21
8550218|NCT00135694|21081108|P1|NOT COMPLETED|Overall Study||180
8550219|NCT00135694|21081106|P3|COMPLETED|Overall Study||11
8550220|NCT00135694|21081107|P2|COMPLETED|Overall Study||56
8550221|NCT00135694|21081108|P1|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
8550222|NCT00135694|21081106|P3|STARTED|Overall Study||18
8550223|NCT00135694|21081107|P2|STARTED|Overall Study||77
8550224|NCT00135694|21081108|P1|STARTED|Overall Study||180
8550225|NCT00135512|21081126|P1|NOT COMPLETED|Overall Study||123
8550226|NCT00135512|21081126|P1|COMPLETED|Overall Study||111
8550227|NCT00135512|21081126|P1|STARTED|Overall Study||234
8550228|NCT00135356|21081138|P2|NOT COMPLETED|Overall Study||9
8550229|NCT00135356|21081139|P1|NOT COMPLETED|Overall Study||17
8550230|NCT00135356|21081138|P2|COMPLETED|Overall Study||60
8550231|NCT00135356|21081139|P1|COMPLETED|Overall Study||114
8550232|NCT00135356|21081138|P2|Discontinued on or After Week 96 Visit|Overall Study||0
8550233|NCT00135356|21081139|P1|Discontinued on or After Week 96 Visit|Overall Study||1
8550234|NCT00135356|21081138|P2|Discontinued Prior to Week 96 Visit|Overall Study||9
8550235|NCT00135356|21081139|P1|Discontinued Prior to Week 96 Visit|Overall Study||16
8550236|NCT00135356|21081138|P2|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
8550237|NCT00135356|21081139|P1|STARTED|Overall Study|Number randomized and treated|131
8550238|NCT00135330|21081182|P3|NOT COMPLETED|Overall Study||11
8550239|NCT00135330|21081183|P2|NOT COMPLETED|Overall Study||13
8550240|NCT00135330|21081184|P1|NOT COMPLETED|Overall Study||12
8550241|NCT00135330|21081182|P3|COMPLETED|Overall Study||34
8550242|NCT00135330|21081183|P2|COMPLETED|Overall Study||34
8550243|NCT00135330|21081184|P1|COMPLETED|Overall Study||33
8550244|NCT00135330|21081182|P3|STARTED|Overall Study||45
8550245|NCT00135330|21081183|P2|STARTED|Overall Study||47
8550246|NCT00135330|21081184|P1|STARTED|Overall Study||45
8550262|NCT00134901|21081382|P2|NOT COMPLETED|Overall Study||15
8550263|NCT00134901|21081383|P1|NOT COMPLETED|Overall Study||17
8550264|NCT00134901|21081382|P2|COMPLETED|Overall Study||27
8550265|NCT00134901|21081383|P1|COMPLETED|Overall Study||22
8550266|NCT00134901|21081382|P2|STARTED|Overall Study||42
8550267|NCT00134901|21081383|P1|STARTED|Overall Study||39
8550268|NCT00134784|21081395|P4|NOT COMPLETED|Overall Study||1
8550269|NCT00134784|21081396|P3|NOT COMPLETED|Overall Study||2
8550270|NCT00134784|21081397|P2|NOT COMPLETED|Overall Study||2
8550271|NCT00134784|21081398|P1|NOT COMPLETED|Overall Study||2
8550272|NCT00134784|21081395|P4|COMPLETED|Overall Study||37
8550273|NCT00134784|21081396|P3|COMPLETED|Overall Study||35
8550274|NCT00134784|21081397|P2|COMPLETED|Overall Study||36
8550275|NCT00134784|21081398|P1|COMPLETED|Overall Study||27
8550276|NCT00134784|21081395|P4|STARTED|Overall Study||38
8550277|NCT00134784|21081396|P3|STARTED|Overall Study||37
8550278|NCT00134784|21081397|P2|STARTED|Overall Study||38
8550279|NCT00134784|21081398|P1|STARTED|Overall Study||29
8550280|NCT00134719|21081408|P3|NOT COMPLETED|Fourth Dose Vaccination Phase||1
8550281|NCT00134719|21081409|P2|NOT COMPLETED|Fourth Dose Vaccination Phase||3
8550282|NCT00134719|21081410|P1|NOT COMPLETED|Fourth Dose Vaccination Phase||2
8550283|NCT00134719|21081408|P3|COMPLETED|Fourth Dose Vaccination Phase||203
8550284|NCT00134719|21081409|P2|COMPLETED|Fourth Dose Vaccination Phase||203
8550285|NCT00134719|21081410|P1|COMPLETED|Fourth Dose Vaccination Phase||623
8550286|NCT00134719|21081408|P3|STARTED|Fourth Dose Vaccination Phase||204
8550287|NCT00134719|21081409|P2|STARTED|Fourth Dose Vaccination Phase||206
8550288|NCT00134719|21081410|P1|STARTED|Fourth Dose Vaccination Phase||625
8550289|NCT00134719|21081408|P3|NOT COMPLETED|Primary Vaccination Phase||5
8550290|NCT00134719|21081409|P2|NOT COMPLETED|Primary Vaccination Phase||6
8550291|NCT00134719|21081410|P1|NOT COMPLETED|Primary Vaccination Phase||14
8550292|NCT00134719|21081408|P3|COMPLETED|Primary Vaccination Phase||216
8550293|NCT00134719|21081409|P2|COMPLETED|Primary Vaccination Phase||215
8550294|NCT00134719|21081410|P1|COMPLETED|Primary Vaccination Phase||647
8550295|NCT00134719|21081408|P3|STARTED|Primary Vaccination Phase||221
8550296|NCT00134719|21081409|P2|STARTED|Primary Vaccination Phase||221
8550297|NCT00134719|21081410|P1|STARTED|Primary Vaccination Phase||661
8550298|NCT00134563|21081541|P3|NOT COMPLETED|Overall Study||96
8550299|NCT00134563|21081542|P2|NOT COMPLETED|Overall Study||92
8550300|NCT00134563|21081543|P1|NOT COMPLETED|Overall Study||104
8550301|NCT00134563|21081541|P3|COMPLETED|Overall Study|completed treatment period|263
8550302|NCT00134563|21081542|P2|COMPLETED|Overall Study|completed treatment period|274
8550303|NCT00134563|21081543|P1|COMPLETED|Overall Study|completed treatment period|259
8550304|NCT00134563|21081541|P3|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
8550305|NCT00134563|21081542|P2|Treated|Overall Study||365
8550306|NCT00134563|21081543|P1|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
8550307|NCT00134563|21081541|P3|STARTED|Overall Study|Randomized|359
8550308|NCT00134563|21081542|P2|STARTED|Overall Study|Randomized|366
8550309|NCT00134563|21081543|P1|STARTED|Overall Study|Randomized|363
8550310|NCT00134381|21081566|P6|NOT COMPLETED|Overall Study||2
8550311|NCT00134381|21081567|P5|NOT COMPLETED|Overall Study||0
8550312|NCT00134381|21081568|P4|NOT COMPLETED|Overall Study||0
8550313|NCT00134381|21081569|P3|NOT COMPLETED|Overall Study||0
8550314|NCT00134381|21081570|P2|NOT COMPLETED|Overall Study||0
8550315|NCT00134381|21081571|P1|NOT COMPLETED|Overall Study||0
8550316|NCT00134381|21081566|P6|COMPLETED|Overall Study||29
8550317|NCT00134381|21081567|P5|COMPLETED|Overall Study||31
8550318|NCT00134381|21081568|P4|COMPLETED|Overall Study||2
8550319|NCT00134381|21081569|P3|COMPLETED|Overall Study||1
8550320|NCT00134381|21081570|P2|COMPLETED|Overall Study||2
8550321|NCT00134381|21081571|P1|COMPLETED|Overall Study||1
8550322|NCT00134381|21081566|P6|STARTED|Overall Study||31
8550323|NCT00134381|21081567|P5|STARTED|Overall Study||31
8550324|NCT00134381|21081568|P4|STARTED|Overall Study||2
8550325|NCT00134381|21081569|P3|STARTED|Overall Study||1
8550326|NCT00134381|21081570|P2|STARTED|Overall Study||2
8550327|NCT00134381|21081571|P1|STARTED|Overall Study||1
8550328|NCT00134082|21081604|P1|NOT COMPLETED|Overall Study||3
8550329|NCT00134082|21081604|P1|COMPLETED|Overall Study||27
8550330|NCT00134082|21081604|P1|STARTED|Overall Study||30
8550331|NCT00134056|21081613|P2|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
8550332|NCT00134056|21081614|P1|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
8550333|NCT00134056|21081613|P2|COMPLETED|Eligible for Protocol Assigned Treatment||185
8550334|NCT00134056|21081614|P1|COMPLETED|Eligible for Protocol Assigned Treatment||169
8550335|NCT00134056|21081613|P2|STARTED|Eligible for Protocol Assigned Treatment||500
8550336|NCT00134056|21081614|P1|STARTED|Eligible for Protocol Assigned Treatment||496
8550337|NCT00134056|21081613|P2|NOT COMPLETED|Randomization||20
8550338|NCT00134056|21081614|P1|NOT COMPLETED|Randomization||22
8550339|NCT00134056|21081613|P2|COMPLETED|Randomization||500
8550340|NCT00134056|21081614|P1|COMPLETED|Randomization||496
8550341|NCT00134056|21081613|P2|STARTED|Randomization||520
8550342|NCT00134056|21081614|P1|STARTED|Randomization||518
8550343|NCT00134043|21081636|P2|NOT COMPLETED|Overall Study||0
8550344|NCT00134043|21081637|P1|NOT COMPLETED|Overall Study||0
8550345|NCT00134043|21081636|P2|COMPLETED|Overall Study||3
8550346|NCT00134043|21081637|P1|COMPLETED|Overall Study||16
8550347|NCT00134043|21081636|P2|STARTED|Overall Study||3
8550348|NCT00134043|21081637|P1|STARTED|Overall Study||16
8550349|NCT00134017|21081642|P1|NOT COMPLETED|Overall Study||0
8550350|NCT00134017|21081642|P1|COMPLETED|Overall Study||142
8550351|NCT00134017|21081642|P1|STARTED|Overall Study||142
8550352|NCT00134004|21081650|P1|NOT COMPLETED|Overall Study||0
8550353|NCT00134004|21081650|P1|COMPLETED|Overall Study||210
8550354|NCT00134004|21081650|P1|STARTED|Overall Study||210
8550355|NCT00133991|21081658|P1|NOT COMPLETED|Overall Study||4
8550356|NCT00133991|21081658|P1|COMPLETED|Overall Study||17
8550357|NCT00133991|21081658|P1|STARTED|Overall Study||21
8550358|NCT00133978|21081670|P4|NOT COMPLETED|Overall Study||2
8550359|NCT00133978|21081671|P3|NOT COMPLETED|Overall Study||0
8550360|NCT00133978|21081672|P2|NOT COMPLETED|Overall Study||1
8550361|NCT00133978|21081673|P1|NOT COMPLETED|Overall Study||2
8550362|NCT00133978|21081670|P4|COMPLETED|Overall Study||300
8550363|NCT00133978|21081671|P3|COMPLETED|Overall Study||310
8550364|NCT00133978|21081672|P2|COMPLETED|Overall Study||307
8550365|NCT00133978|21081673|P1|COMPLETED|Overall Study||301
8550366|NCT00133978|21081670|P4|STARTED|Overall Study||302
8550367|NCT00133978|21081671|P3|STARTED|Overall Study||310
8550368|NCT00133978|21081672|P2|STARTED|Overall Study||308
8550369|NCT00133978|21081673|P1|STARTED|Overall Study||303
8550370|NCT00133952|21081697|P2|NOT COMPLETED|Overall Study||28
8550371|NCT00133952|21081698|P1|NOT COMPLETED|Overall Study||42
8550372|NCT00133952|21081697|P2|COMPLETED|Overall Study||124
8550373|NCT00133952|21081698|P1|COMPLETED|Overall Study||115
8550374|NCT00133952|21081697|P2|Received at Least One Dose of Study Drug|Overall Study||149
8550375|NCT00133952|21081698|P1|Received at Least One Dose of Study Drug|Overall Study||153
8550376|NCT00133952|21081697|P2|STARTED|Overall Study||152
8550377|NCT00133952|21081698|P1|STARTED|Overall Study||157
8550378|NCT00133809|21081720|P1|NOT COMPLETED|Overall Study||0
8550379|NCT00133809|21081720|P1|COMPLETED|Overall Study||8
8550380|NCT00133809|21081720|P1|STARTED|Overall Study||8
8550381|NCT00133705|21081729|P2|NOT COMPLETED|Overall Study||3
8550382|NCT00133705|21081730|P1|NOT COMPLETED|Overall Study||2
8550383|NCT00133705|21081729|P2|COMPLETED|Overall Study||17
8550384|NCT00133705|21081730|P1|COMPLETED|Overall Study||20
8550385|NCT00133705|21081729|P2|STARTED|Overall Study||20
8550386|NCT00133705|21081730|P1|STARTED|Overall Study||22
8550387|NCT00133679|21081738|P2|NOT COMPLETED|Overall Study||0
8550388|NCT00133679|21081739|P1|NOT COMPLETED|Overall Study||0
8550389|NCT00133679|21081738|P2|COMPLETED|Overall Study||0
8550390|NCT00133679|21081739|P1|COMPLETED|Overall Study||0
8550391|NCT00133679|21081738|P2|STARTED|Overall Study||0
8550392|NCT00133679|21081739|P1|STARTED|Overall Study||0
8550393|NCT00133575|21081762|P7|NOT COMPLETED|Overall Study||3
8550394|NCT00133575|21081763|P6|NOT COMPLETED|Overall Study||1
8550395|NCT00133575|21081764|P5|NOT COMPLETED|Overall Study||4
8550396|NCT00133575|21081765|P4|NOT COMPLETED|Overall Study||1
8550397|NCT00133575|21081766|P3|NOT COMPLETED|Overall Study||2
8550398|NCT00133575|21081767|P2|NOT COMPLETED|Overall Study||0
8550399|NCT00133575|21081768|P1|NOT COMPLETED|Overall Study||0
8550400|NCT00133575|21081762|P7|COMPLETED|Overall Study||9
8550401|NCT00133575|21081763|P6|COMPLETED|Overall Study||9
8550402|NCT00133575|21081764|P5|COMPLETED|Overall Study||6
8550403|NCT00133575|21081765|P4|COMPLETED|Overall Study||9
8550404|NCT00133575|21081766|P3|COMPLETED|Overall Study||8
8550405|NCT00133575|21081767|P2|COMPLETED|Overall Study||10
8550406|NCT00133575|21081768|P1|COMPLETED|Overall Study||10
8550407|NCT00133575|21081762|P7|STARTED|Overall Study||12
8550408|NCT00133575|21081763|P6|STARTED|Overall Study||10
8550409|NCT00133575|21081764|P5|STARTED|Overall Study||10
8550410|NCT00133575|21081765|P4|STARTED|Overall Study||10
8550411|NCT00133575|21081766|P3|STARTED|Overall Study||10
8550412|NCT00133575|21081767|P2|STARTED|Overall Study||10
8550413|NCT00133575|21081768|P1|STARTED|Overall Study||10
8550414|NCT00132964|21081877|P2|NOT COMPLETED|Overall Study||3
8550415|NCT00132964|21081878|P1|NOT COMPLETED|Overall Study||4
8550416|NCT00132964|21081877|P2|COMPLETED|Overall Study||54
8550417|NCT00132964|21081878|P1|COMPLETED|Overall Study||50
8550418|NCT00132964|21081877|P2|STARTED|Overall Study||57
8550419|NCT00132964|21081878|P1|STARTED|Overall Study||54
8550420|NCT00132873|21081884|P1|NOT COMPLETED|Overall Study||9
8550421|NCT00132873|21081884|P1|COMPLETED|Overall Study||50
8550422|NCT00132873|21081884|P1|STARTED|Overall Study||59
8550423|NCT00132808|21081892|P3|NOT COMPLETED|Stratum II||9
8550424|NCT00132808|21081893|P2|NOT COMPLETED|Stratum II||15
8550425|NCT00132808|21081894|P1|NOT COMPLETED|Stratum II||8
8550426|NCT00132808|21081892|P3|COMPLETED|Stratum II||116
8550427|NCT00132808|21081893|P2|COMPLETED|Stratum II||96
8550428|NCT00132808|21081894|P1|COMPLETED|Stratum II||113
8550429|NCT00132808|21081892|P3|STARTED|Stratum II||125
8550430|NCT00132808|21081893|P2|STARTED|Stratum II||111
8550431|NCT00132808|21081894|P1|STARTED|Stratum II||121
8550432|NCT00132808|21081892|P3|NOT COMPLETED|Stratum I||5
8550433|NCT00132808|21081893|P2|NOT COMPLETED|Stratum I||12
8550434|NCT00132808|21081894|P1|NOT COMPLETED|Stratum I||9
8550435|NCT00132808|21081892|P3|COMPLETED|Stratum I||72
8550436|NCT00132808|21081893|P2|COMPLETED|Stratum I||58
8550437|NCT00132808|21081894|P1|COMPLETED|Stratum I||68
8550438|NCT00132808|21081892|P3|STARTED|Stratum I||77
8550439|NCT00132808|21081893|P2|STARTED|Stratum I||70
8550440|NCT00132808|21081894|P1|STARTED|Stratum I||77
8550441|NCT00132769|21081919|P2|NOT COMPLETED|Overall Study||11
8550442|NCT00132769|21081920|P1|NOT COMPLETED|Overall Study||11
8550443|NCT00132769|21081919|P2|COMPLETED|Overall Study||42
8550444|NCT00132769|21081920|P1|COMPLETED|Overall Study||42
8550445|NCT00132769|21081919|P2|STARTED|Overall Study||53
8550446|NCT00132769|21081920|P1|STARTED|Overall Study||53
8550447|NCT00132730|21081946|P6|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
8550448|NCT00132730|21081947|P5|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
8550449|NCT00132730|21081948|P4|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
8550450|NCT00132730|21081949|P3|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
8550451|NCT00132730|21081950|P2|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
8550452|NCT00132730|21081951|P1|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
8550453|NCT00132730|21081946|P6|COMPLETED|Period V - Open-label Extension (EXT2)||0
8550454|NCT00132730|21081947|P5|COMPLETED|Period V - Open-label Extension (EXT2)||0
8550455|NCT00132730|21081948|P4|COMPLETED|Period V - Open-label Extension (EXT2)||0
8550527|NCT00132730|21081948|P4|COMPLETED|Period I - Placebo Run-in (Base)||153
8550456|NCT00132730|21081949|P3|COMPLETED|Period V - Open-label Extension (EXT2)||0
8550457|NCT00132730|21081950|P2|COMPLETED|Period V - Open-label Extension (EXT2)||0
8550458|NCT00132730|21081951|P1|COMPLETED|Period V - Open-label Extension (EXT2)||0
8550459|NCT00132730|21081946|P6|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
8550460|NCT00132730|21081947|P5|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
8550461|NCT00132730|21081948|P4|STARTED|Period V - Open-label Extension (EXT2)||0
8550462|NCT00132730|21081949|P3|STARTED|Period V - Open-label Extension (EXT2)||0
8550463|NCT00132730|21081950|P2|STARTED|Period V - Open-label Extension (EXT2)||0
8550464|NCT00132730|21081951|P1|STARTED|Period V - Open-label Extension (EXT2)||0
8550465|NCT00132730|21081946|P6|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
8550466|NCT00132730|21081947|P5|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
8550467|NCT00132730|21081948|P4|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550468|NCT00132730|21081949|P3|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550469|NCT00132730|21081950|P2|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550470|NCT00132730|21081951|P1|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550471|NCT00132730|21081946|P6|COMPLETED|Period IV - Open-label Extension (EXT2)||3
8550472|NCT00132730|21081947|P5|COMPLETED|Period IV - Open-label Extension (EXT2)||8
8550473|NCT00132730|21081948|P4|COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550474|NCT00132730|21081949|P3|COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550475|NCT00132730|21081950|P2|COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550476|NCT00132730|21081951|P1|COMPLETED|Period IV - Open-label Extension (EXT2)||0
8550477|NCT00132730|21081946|P6|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
8550478|NCT00132730|21081947|P5|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
8550479|NCT00132730|21081948|P4|STARTED|Period IV - Open-label Extension (EXT2)||0
8550480|NCT00132730|21081949|P3|STARTED|Period IV - Open-label Extension (EXT2)||0
8550481|NCT00132730|21081950|P2|STARTED|Period IV - Open-label Extension (EXT2)||0
8550482|NCT00132730|21081951|P1|STARTED|Period IV - Open-label Extension (EXT2)||0
8550483|NCT00132730|21081946|P6|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
8550484|NCT00132730|21081947|P5|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
8550485|NCT00132730|21081948|P4|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
8550486|NCT00132730|21081949|P3|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
8550487|NCT00132730|21081950|P2|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
8550488|NCT00132730|21081951|P1|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
8550489|NCT00132730|21081946|P6|COMPLETED|Period III - Blinded Extension (EXT1)||0
8550490|NCT00132730|21081947|P5|COMPLETED|Period III - Blinded Extension (EXT1)||0
8550491|NCT00132730|21081948|P4|COMPLETED|Period III - Blinded Extension (EXT1)||82
8550492|NCT00132730|21081949|P3|COMPLETED|Period III - Blinded Extension (EXT1)||235
8550493|NCT00132730|21081950|P2|COMPLETED|Period III - Blinded Extension (EXT1)||0
8550494|NCT00132730|21081951|P1|COMPLETED|Period III - Blinded Extension (EXT1)||0
8550495|NCT00132730|21081946|P6|STARTED|Period III - Blinded Extension (EXT1)||0
8550496|NCT00132730|21081947|P5|STARTED|Period III - Blinded Extension (EXT1)||0
8550497|NCT00132730|21081948|P4|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
8550498|NCT00132730|21081949|P3|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
8550499|NCT00132730|21081950|P2|STARTED|Period III - Blinded Extension (EXT1)||0
8550500|NCT00132730|21081951|P1|STARTED|Period III - Blinded Extension (EXT1)||0
8550501|NCT00132730|21081946|P6|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
8550502|NCT00132730|21081947|P5|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
8550503|NCT00132730|21081948|P4|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
8550504|NCT00132730|21081949|P3|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
8550505|NCT00132730|21081950|P2|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
8550506|NCT00132730|21081951|P1|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
8550507|NCT00132730|21081946|P6|COMPLETED|Period II - 12-week Treatment (Base)||0
8550508|NCT00132730|21081947|P5|COMPLETED|Period II - 12-week Treatment (Base)||0
8550509|NCT00132730|21081948|P4|COMPLETED|Period II - 12-week Treatment (Base)||131
8550510|NCT00132730|21081949|P3|COMPLETED|Period II - 12-week Treatment (Base)||135
8550511|NCT00132730|21081950|P2|COMPLETED|Period II - 12-week Treatment (Base)||133
8550512|NCT00132730|21081951|P1|COMPLETED|Period II - 12-week Treatment (Base)||127
8550513|NCT00132730|21081946|P6|STARTED|Period II - 12-week Treatment (Base)||0
8550514|NCT00132730|21081947|P5|STARTED|Period II - 12-week Treatment (Base)||0
8550515|NCT00132730|21081948|P4|STARTED|Period II - 12-week Treatment (Base)||153
8550516|NCT00132730|21081949|P3|STARTED|Period II - 12-week Treatment (Base)||153
8550517|NCT00132730|21081950|P2|STARTED|Period II - 12-week Treatment (Base)||148
8550518|NCT00132730|21081951|P1|STARTED|Period II - 12-week Treatment (Base)||150
8550519|NCT00132730|21081946|P6|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8550520|NCT00132730|21081947|P5|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8550521|NCT00132730|21081948|P4|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8550522|NCT00132730|21081949|P3|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8550523|NCT00132730|21081950|P2|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8550524|NCT00132730|21081951|P1|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
8550525|NCT00132730|21081946|P6|COMPLETED|Period I - Placebo Run-in (Base)||0
8550526|NCT00132730|21081947|P5|COMPLETED|Period I - Placebo Run-in (Base)||0
8550528|NCT00132730|21081949|P3|COMPLETED|Period I - Placebo Run-in (Base)||153
8550529|NCT00132730|21081950|P2|COMPLETED|Period I - Placebo Run-in (Base)||148
8550530|NCT00132730|21081951|P1|COMPLETED|Period I - Placebo Run-in (Base)||150
8550531|NCT00132730|21081946|P6|STARTED|Period I - Placebo Run-in (Base)||0
8550532|NCT00132730|21081947|P5|STARTED|Period I - Placebo Run-in (Base)||0
8550533|NCT00132730|21081948|P4|STARTED|Period I - Placebo Run-in (Base)||153
8550534|NCT00132730|21081949|P3|STARTED|Period I - Placebo Run-in (Base)||153
8550535|NCT00132730|21081950|P2|STARTED|Period I - Placebo Run-in (Base)||148
8550536|NCT00132730|21081951|P1|STARTED|Period I - Placebo Run-in (Base)||150
8550537|NCT00132691|21081995|P2|NOT COMPLETED|Overall Study||12
8550538|NCT00132691|21081996|P1|NOT COMPLETED|Overall Study||11
8550539|NCT00132691|21081995|P2|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
8550540|NCT00132691|21081996|P1|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
8550541|NCT00132691|21081995|P2|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
8550542|NCT00132691|21081996|P1|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
8550543|NCT00132678|21082036|P3|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
8550544|NCT00132678|21082037|P2|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
8550545|NCT00132678|21082038|P1|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
8550546|NCT00132678|21082036|P3|COMPLETED|Period IV (Double-Blind Treatment)||0
8550547|NCT00132678|21082037|P2|COMPLETED|Period IV (Double-Blind Treatment)||109
8550548|NCT00132678|21082038|P1|COMPLETED|Period IV (Double-Blind Treatment)||117
8550549|NCT00132678|21082036|P3|STARTED|Period IV (Double-Blind Treatment)||0
8550550|NCT00132678|21082037|P2|STARTED|Period IV (Double-Blind Treatment)||149
8550551|NCT00132678|21082038|P1|STARTED|Period IV (Double-Blind Treatment)||154
8550552|NCT00132678|21082036|P3|NOT COMPLETED|Period III (Open-Label Stabilization)||0
8550553|NCT00132678|21082037|P2|NOT COMPLETED|Period III (Open-Label Stabilization)||0
8550554|NCT00132678|21082038|P1|NOT COMPLETED|Period III (Open-Label Stabilization)||198
8550555|NCT00132678|21082036|P3|COMPLETED|Period III (Open-Label Stabilization)||0
8550556|NCT00132678|21082037|P2|COMPLETED|Period III (Open-Label Stabilization)||0
8550557|NCT00132678|21082038|P1|COMPLETED|Period III (Open-Label Stabilization)||303
8550558|NCT00132678|21082036|P3|STARTED|Period III (Open-Label Stabilization)||0
8550559|NCT00132678|21082037|P2|STARTED|Period III (Open-Label Stabilization)||0
8550560|NCT00132678|21082038|P1|STARTED|Period III (Open-Label Stabilization)||501
8550561|NCT00132678|21082036|P3|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
8550562|NCT00132678|21082037|P2|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
8550563|NCT00132678|21082038|P1|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
8550564|NCT00132678|21082036|P3|COMPLETED|Period II (Open-Label Oral Risperidone)||382
8550565|NCT00132678|21082037|P2|COMPLETED|Period II (Open-Label Oral Risperidone)||0
8550566|NCT00132678|21082038|P1|COMPLETED|Period II (Open-Label Oral Risperidone)||0
8550567|NCT00132678|21082036|P3|STARTED|Period II (Open-Label Oral Risperidone)||440
8550568|NCT00132678|21082037|P2|STARTED|Period II (Open-Label Oral Risperidone)||0
8550569|NCT00132678|21082038|P1|STARTED|Period II (Open-Label Oral Risperidone)||0
8550570|NCT00132496|21082052|P2|NOT COMPLETED|Overall Study||2
8550571|NCT00132496|21082053|P1|NOT COMPLETED|Overall Study||2
8550572|NCT00132496|21082052|P2|COMPLETED|Overall Study||55
8550573|NCT00132496|21082053|P1|COMPLETED|Overall Study||52
8550574|NCT00132496|21082052|P2|STARTED|Overall Study||57
8550575|NCT00132496|21082053|P1|STARTED|Overall Study||54
8550576|NCT00132314|21082061|P2|NOT COMPLETED|Overall Study||72
8550577|NCT00132314|21082062|P1|NOT COMPLETED|Overall Study||73
8550578|NCT00132314|21082061|P2|COMPLETED|Overall Study||120
8550579|NCT00132314|21082062|P1|COMPLETED|Overall Study||117
8550580|NCT00132314|21082061|P2|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
8550581|NCT00132314|21082062|P1|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
8550582|NCT00132314|21082061|P2|Received Treatment|Overall Study||185
8550583|NCT00132314|21082062|P1|Received Treatment|Overall Study||188
8550584|NCT00132314|21082061|P2|STARTED|Overall Study||192
8550585|NCT00132314|21082062|P1|STARTED|Overall Study||190
8550586|NCT00132301|21082072|P2|NOT COMPLETED|Overall Study||13
8550587|NCT00132301|21082073|P1|NOT COMPLETED|Overall Study||20
8550588|NCT00132301|21082072|P2|COMPLETED|Overall Study||144
8550589|NCT00132301|21082073|P1|COMPLETED|Overall Study||121
8550590|NCT00132301|21082072|P2|STARTED|Overall Study||157
8550591|NCT00132301|21082073|P1|STARTED|Overall Study||141
8550592|NCT00132132|21082081|P2|NOT COMPLETED|Overall Study||2
8550593|NCT00132132|21082082|P1|NOT COMPLETED|Overall Study||7
8550594|NCT00132132|21082081|P2|COMPLETED|Overall Study||13
8550595|NCT00132132|21082082|P1|COMPLETED|Overall Study||8
8550596|NCT00132132|21082081|P2|STARTED|Overall Study||15
8550597|NCT00132132|21082082|P1|STARTED|Overall Study||15
8550598|NCT00132041|21082090|P1|NOT COMPLETED|18 Months Post Ablation||6
8550599|NCT00132041|21082090|P1|COMPLETED|18 Months Post Ablation||12
8550600|NCT00132041|21082090|P1|STARTED|18 Months Post Ablation||18
8550601|NCT00132041|21082090|P1|NOT COMPLETED|15 Months Post Ablation||8
8550602|NCT00132041|21082090|P1|COMPLETED|15 Months Post Ablation||18
8550603|NCT00132041|21082090|P1|STARTED|15 Months Post Ablation||26
8550604|NCT00132041|21082090|P1|NOT COMPLETED|12 Months Post Ablation||4
8550605|NCT00132041|21082090|P1|COMPLETED|12 Months Post Ablation||26
8550606|NCT00132041|21082090|P1|STARTED|12 Months Post Ablation||30
8550607|NCT00132041|21082090|P1|NOT COMPLETED|9 Months Post Ablation||2
8550608|NCT00132041|21082090|P1|COMPLETED|9 Months Post Ablation||30
8550609|NCT00132041|21082090|P1|STARTED|9 Months Post Ablation||32
8550610|NCT00132041|21082090|P1|NOT COMPLETED|6 Months Post Ablation||10
8550611|NCT00132041|21082090|P1|COMPLETED|6 Months Post Ablation||32
8550612|NCT00132041|21082090|P1|STARTED|6 Months Post Ablation||42
8550613|NCT00132041|21082090|P1|NOT COMPLETED|3 Months Post Ablation||3
8550614|NCT00132041|21082090|P1|COMPLETED|3 Months Post Ablation||42
8550615|NCT00132041|21082090|P1|STARTED|3 Months Post Ablation||45
8550616|NCT00132041|21082090|P1|NOT COMPLETED|Baseline||6
8550617|NCT00132041|21082090|P1|COMPLETED|Baseline||45
8550618|NCT00132041|21082090|P1|Eligible|Baseline||45
8550619|NCT00132041|21082090|P1|STARTED|Baseline||51
8550620|NCT00132028|21082105|P1|NOT COMPLETED|Overall Study||27
8550621|NCT00132028|21082105|P1|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
8550622|NCT00132028|21082105|P1|Eligible and Began Protocol Therapy|Overall Study||25
8550623|NCT00132028|21082105|P1|Eligible|Overall Study||25
8550624|NCT00132028|21082105|P1|STARTED|Overall Study||27
8550625|NCT00132002|21082111|P1|NOT COMPLETED|Overall Study||0
8550626|NCT00132002|21082111|P1|COMPLETED|Overall Study||14
8550627|NCT00132002|21082111|P1|STARTED|Overall Study||14
8550628|NCT00131937|21082117|P1|NOT COMPLETED|Overall Study||14
8550629|NCT00131937|21082117|P1|COMPLETED|Overall Study||0
8550630|NCT00131937|21082117|P1|STARTED|Overall Study||14
8550631|NCT00131911|21082125|P2|NOT COMPLETED|Overall Study||0
8550632|NCT00131911|21082126|P1|NOT COMPLETED|Overall Study||1
8550633|NCT00131911|21082125|P2|COMPLETED|Overall Study||42
8550634|NCT00131911|21082126|P1|COMPLETED|Overall Study||50
8550635|NCT00131911|21082125|P2|STARTED|Overall Study||42
8550636|NCT00131911|21082126|P1|STARTED|Overall Study||51
8550637|NCT00131885|21082143|P4|NOT COMPLETED|Time 2: Second Intervention||0
8550638|NCT00131885|21082144|P3|NOT COMPLETED|Time 2: Second Intervention||0
8550639|NCT00131885|21082145|P2|NOT COMPLETED|Time 2: Second Intervention||0
8550640|NCT00131885|21082146|P1|NOT COMPLETED|Time 2: Second Intervention||0
8550641|NCT00131885|21082143|P4|COMPLETED|Time 2: Second Intervention||9
8550642|NCT00131885|21082144|P3|COMPLETED|Time 2: Second Intervention||9
8550643|NCT00131885|21082145|P2|COMPLETED|Time 2: Second Intervention||9
8550644|NCT00131885|21082146|P1|COMPLETED|Time 2: Second Intervention||9
8550645|NCT00131885|21082143|P4|STARTED|Time 2: Second Intervention||9
8550646|NCT00131885|21082144|P3|STARTED|Time 2: Second Intervention||9
8550647|NCT00131885|21082145|P2|STARTED|Time 2: Second Intervention||9
8550648|NCT00131885|21082146|P1|STARTED|Time 2: Second Intervention||9
8550649|NCT00131885|21082143|P4|NOT COMPLETED|Time 1: First Intervention||0
8550650|NCT00131885|21082144|P3|NOT COMPLETED|Time 1: First Intervention||0
8550651|NCT00131885|21082145|P2|NOT COMPLETED|Time 1: First Intervention||0
8550652|NCT00131885|21082146|P1|NOT COMPLETED|Time 1: First Intervention||0
8550653|NCT00131885|21082143|P4|COMPLETED|Time 1: First Intervention||9
8550654|NCT00131885|21082144|P3|COMPLETED|Time 1: First Intervention||9
8550655|NCT00131885|21082145|P2|COMPLETED|Time 1: First Intervention||9
8550656|NCT00131885|21082146|P1|COMPLETED|Time 1: First Intervention||9
8550657|NCT00131885|21082143|P4|STARTED|Time 1: First Intervention||9
8550658|NCT00131885|21082144|P3|STARTED|Time 1: First Intervention||9
8550659|NCT00131885|21082145|P2|STARTED|Time 1: First Intervention||9
8550660|NCT00131885|21082146|P1|STARTED|Time 1: First Intervention||9
8550661|NCT00131677|21082178|P2|NOT COMPLETED|Overall Study||39
8550662|NCT00131677|21082179|P1|NOT COMPLETED|Overall Study||30
8550663|NCT00131677|21082178|P2|COMPLETED|Overall Study||160
8550664|NCT00131677|21082179|P1|COMPLETED|Overall Study||171
8550665|NCT00131677|21082178|P2|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
8550666|NCT00131677|21082179|P1|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
8550667|NCT00131664|21082196|P6|NOT COMPLETED|Second Period (Additional Drug Added)||3
8550668|NCT00131664|21082197|P5|NOT COMPLETED|Second Period (Additional Drug Added)||1
8550669|NCT00131664|21082198|P4|NOT COMPLETED|Second Period (Additional Drug Added)||2
8550670|NCT00131664|21082199|P3|NOT COMPLETED|Second Period (Additional Drug Added)||3
8550671|NCT00131664|21082200|P2|NOT COMPLETED|Second Period (Additional Drug Added)||4
8550672|NCT00131664|21082201|P1|NOT COMPLETED|Second Period (Additional Drug Added)||9
8550673|NCT00131664|21082196|P6|COMPLETED|Second Period (Additional Drug Added)||22
8550674|NCT00131664|21082197|P5|COMPLETED|Second Period (Additional Drug Added)||15
8550675|NCT00131664|21082198|P4|COMPLETED|Second Period (Additional Drug Added)||19
8550676|NCT00131664|21082199|P3|COMPLETED|Second Period (Additional Drug Added)||76
8550677|NCT00131664|21082200|P2|COMPLETED|Second Period (Additional Drug Added)||97
8550678|NCT00131664|21082201|P1|COMPLETED|Second Period (Additional Drug Added)||81
8550679|NCT00131664|21082196|P6|STARTED|Second Period (Additional Drug Added)||25
8550680|NCT00131664|21082197|P5|STARTED|Second Period (Additional Drug Added)||16
8550681|NCT00131664|21082198|P4|STARTED|Second Period (Additional Drug Added)||21
8550682|NCT00131664|21082199|P3|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
8550683|NCT00131664|21082200|P2|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
8550684|NCT00131664|21082201|P1|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
8550685|NCT00131664|21082196|P6|NOT COMPLETED|First Period (First 6 Months)||0
8550686|NCT00131664|21082197|P5|NOT COMPLETED|First Period (First 6 Months)||0
8550687|NCT00131664|21082198|P4|NOT COMPLETED|First Period (First 6 Months)||0
8550688|NCT00131664|21082199|P3|NOT COMPLETED|First Period (First 6 Months)||16
8550689|NCT00131664|21082200|P2|NOT COMPLETED|First Period (First 6 Months)||18
8550690|NCT00131664|21082201|P1|NOT COMPLETED|First Period (First 6 Months)||25
8550691|NCT00131664|21082196|P6|COMPLETED|First Period (First 6 Months)||0
8550692|NCT00131664|21082197|P5|COMPLETED|First Period (First 6 Months)||0
8550693|NCT00131664|21082198|P4|COMPLETED|First Period (First 6 Months)||0
8550694|NCT00131664|21082199|P3|COMPLETED|First Period (First 6 Months)||104
8550695|NCT00131664|21082200|P2|COMPLETED|First Period (First 6 Months)||117
8550696|NCT00131664|21082201|P1|COMPLETED|First Period (First 6 Months)||111
8550697|NCT00131664|21082196|P6|STARTED|First Period (First 6 Months)||0
8550698|NCT00131664|21082197|P5|STARTED|First Period (First 6 Months)||0
8550699|NCT00131664|21082198|P4|STARTED|First Period (First 6 Months)||0
8550700|NCT00131664|21082199|P3|STARTED|First Period (First 6 Months)||120
8550701|NCT00131664|21082200|P2|STARTED|First Period (First 6 Months)||135
8550702|NCT00131664|21082201|P1|STARTED|First Period (First 6 Months)||136
8550703|NCT00131573|21082262|P2|NOT COMPLETED|Overall Study||26
8550704|NCT00131573|21082263|P1|NOT COMPLETED|Overall Study||33
8550705|NCT00131573|21082262|P2|COMPLETED|Overall Study||13
8550706|NCT00131573|21082263|P1|COMPLETED|Overall Study||13
8550707|NCT00131573|21082262|P2|STARTED|Overall Study||39
8550708|NCT00131573|21082263|P1|STARTED|Overall Study||46
8550709|NCT00131508|21082273|P2|NOT COMPLETED|Overall Study||8
8550710|NCT00131508|21082274|P1|NOT COMPLETED|Overall Study||3
8550711|NCT00131508|21082273|P2|COMPLETED|Overall Study||5
8550712|NCT00131508|21082274|P1|COMPLETED|Overall Study||9
8550713|NCT00131508|21082273|P2|STARTED|Overall Study||13
8550714|NCT00131508|21082274|P1|STARTED|Overall Study||12
8550715|NCT00131469|21082298|P2|NOT COMPLETED|Overall Study||13
8550716|NCT00131469|21082299|P1|NOT COMPLETED|Overall Study||9
8550717|NCT00131469|21082298|P2|COMPLETED|Overall Study||27
8550718|NCT00131469|21082299|P1|COMPLETED|Overall Study||29
8550719|NCT00131469|21082298|P2|STARTED|Overall Study||40
8550720|NCT00131469|21082299|P1|STARTED|Overall Study||38
8550721|NCT00131456|21082309|P2|NOT COMPLETED|Overall Study||20
8550722|NCT00131456|21082310|P1|NOT COMPLETED|Overall Study||19
8550723|NCT00131456|21082309|P2|COMPLETED|Overall Study||31
8550724|NCT00131456|21082310|P1|COMPLETED|Overall Study||33
8550725|NCT00131456|21082309|P2|STARTED|Overall Study||51
8550726|NCT00131456|21082310|P1|STARTED|Overall Study||52
8550727|NCT00131378|21082320|P4|NOT COMPLETED|Overall Study||9
8550728|NCT00131378|21082321|P3|NOT COMPLETED|Overall Study||10
8550729|NCT00131378|21082322|P2|NOT COMPLETED|Overall Study||18
8550730|NCT00131378|21082323|P1|NOT COMPLETED|Overall Study||11
8550731|NCT00131378|21082320|P4|COMPLETED|Overall Study||21
8550732|NCT00131378|21082321|P3|COMPLETED|Overall Study||22
8550733|NCT00131378|21082322|P2|COMPLETED|Overall Study||22
8550734|NCT00131378|21082323|P1|COMPLETED|Overall Study||29
8550735|NCT00131378|21082320|P4|STARTED|Overall Study||30
8550736|NCT00131378|21082321|P3|STARTED|Overall Study||32
8550737|NCT00131378|21082322|P2|STARTED|Overall Study||40
8550738|NCT00131378|21082323|P1|STARTED|Overall Study||40
8550739|NCT00131365|21082345|P1|NOT COMPLETED|Overall Study||4
8550740|NCT00131365|21082345|P1|COMPLETED|Overall Study||5
8550741|NCT00131365|21082345|P1|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9
8550742|NCT00131352|21082352|P2|NOT COMPLETED|Repeat Treatment Period||0
8550743|NCT00131352|21082353|P1|NOT COMPLETED|Repeat Treatment Period||2
8550744|NCT00131352|21082352|P2|COMPLETED|Repeat Treatment Period||0
8550745|NCT00131352|21082353|P1|COMPLETED|Repeat Treatment Period||158
8550746|NCT00131352|21082352|P2|STARTED|Repeat Treatment Period||0
8550747|NCT00131352|21082353|P1|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
8550748|NCT00131352|21082352|P2|NOT COMPLETED|Initial Treatment Period||12
8550749|NCT00131352|21082353|P1|NOT COMPLETED|Initial Treatment Period||9
8550750|NCT00131352|21082352|P2|COMPLETED|Initial Treatment Period||118
8550751|NCT00131352|21082353|P1|COMPLETED|Initial Treatment Period||114
8550752|NCT00131352|21082352|P2|Intent to Treat Population|Initial Treatment Period||129
8550753|NCT00131352|21082353|P1|Intent to Treat Population|Initial Treatment Period||124
8550754|NCT00131352|21082352|P2|STARTED|Initial Treatment Period|Safety population|130
8550755|NCT00131352|21082353|P1|STARTED|Initial Treatment Period|Safety population|123
8550756|NCT00131248|21082375|P2|NOT COMPLETED|Intervention 3 (4-day Course)||0
8550757|NCT00131248|21082376|P1|NOT COMPLETED|Intervention 3 (4-day Course)||0
8550758|NCT00131248|21082375|P2|COMPLETED|Intervention 3 (4-day Course)||9
8550759|NCT00131248|21082376|P1|COMPLETED|Intervention 3 (4-day Course)||8
8550760|NCT00131248|21082375|P2|STARTED|Intervention 3 (4-day Course)||9
8550761|NCT00131248|21082376|P1|STARTED|Intervention 3 (4-day Course)||8
8550762|NCT00131248|21082375|P2|NOT COMPLETED|Washout 2 (24 Hours)||0
8550763|NCT00131248|21082376|P1|NOT COMPLETED|Washout 2 (24 Hours)||0
8550764|NCT00131248|21082375|P2|COMPLETED|Washout 2 (24 Hours)||9
8550765|NCT00131248|21082376|P1|COMPLETED|Washout 2 (24 Hours)||8
8550766|NCT00131248|21082375|P2|STARTED|Washout 2 (24 Hours)||9
8550767|NCT00131248|21082376|P1|STARTED|Washout 2 (24 Hours)||8
8550768|NCT00131248|21082375|P2|NOT COMPLETED|Intervention 2 (7-day Course)||0
8550769|NCT00131248|21082376|P1|NOT COMPLETED|Intervention 2 (7-day Course)||0
8550770|NCT00131248|21082375|P2|COMPLETED|Intervention 2 (7-day Course)||9
8550771|NCT00131248|21082376|P1|COMPLETED|Intervention 2 (7-day Course)||8
8550772|NCT00131248|21082375|P2|STARTED|Intervention 2 (7-day Course)||9
8550773|NCT00131248|21082376|P1|STARTED|Intervention 2 (7-day Course)||8
8550774|NCT00131248|21082375|P2|NOT COMPLETED|Washout (24 Hour)||0
8550775|NCT00131248|21082376|P1|NOT COMPLETED|Washout (24 Hour)||0
8550776|NCT00131248|21082375|P2|COMPLETED|Washout (24 Hour)||9
8550777|NCT00131248|21082376|P1|COMPLETED|Washout (24 Hour)||8
8550778|NCT00131248|21082375|P2|STARTED|Washout (24 Hour)||9
8550779|NCT00131248|21082376|P1|STARTED|Washout (24 Hour)||8
8550780|NCT00131248|21082375|P2|NOT COMPLETED|Intervention 1 (3-day Course)||0
8550781|NCT00131248|21082376|P1|NOT COMPLETED|Intervention 1 (3-day Course)||1
8550782|NCT00131248|21082375|P2|COMPLETED|Intervention 1 (3-day Course)||9
8550783|NCT00131248|21082376|P1|COMPLETED|Intervention 1 (3-day Course)||8
8550784|NCT00131248|21082375|P2|STARTED|Intervention 1 (3-day Course)||9
8550785|NCT00131248|21082376|P1|STARTED|Intervention 1 (3-day Course)||9
8550786|NCT00130923|21082384|P2|NOT COMPLETED|Overall Study||14
8550787|NCT00130923|21082385|P1|NOT COMPLETED|Overall Study||13
8550788|NCT00130923|21082384|P2|COMPLETED|Overall Study||32
8550789|NCT00130923|21082385|P1|COMPLETED|Overall Study||36
8550790|NCT00130923|21082384|P2|STARTED|Overall Study||46
8550791|NCT00130923|21082385|P1|STARTED|Overall Study||49
8550792|NCT00130832|21082403|P2|NOT COMPLETED|Overall Study||17
8550793|NCT00130832|21082404|P1|NOT COMPLETED|Overall Study||16
8550794|NCT00130832|21082403|P2|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
8550795|NCT00130832|21082404|P1|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
8550796|NCT00130832|21082403|P2|STARTED|Overall Study||363
8550797|NCT00130832|21082404|P1|STARTED|Overall Study||372
8550798|NCT00130793|21082416|P2|NOT COMPLETED|Overall Study||4
8550799|NCT00130793|21082417|P1|NOT COMPLETED|Overall Study||3
8550800|NCT00130793|21082416|P2|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
8550801|NCT00130793|21082417|P1|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
8550802|NCT00130793|21082416|P2|Vaccinated|Overall Study||185
8550803|NCT00130793|21082417|P1|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
8550804|NCT00130793|21082416|P2|STARTED|Overall Study||185
8550805|NCT00130793|21082417|P1|STARTED|Overall Study||183
8550806|NCT00130780|21082429|P2|NOT COMPLETED|Overall Study||0
8550807|NCT00130780|21082430|P1|NOT COMPLETED|Overall Study||0
8550808|NCT00130780|21082429|P2|COMPLETED|Overall Study||20
8550809|NCT00130780|21082430|P1|COMPLETED|Overall Study||51
8550810|NCT00130780|21082429|P2|STARTED|Overall Study||20
8550811|NCT00130780|21082430|P1|STARTED|Overall Study||51
8550812|NCT00130728|21082438|P2|NOT COMPLETED|Overall Study||260
8550813|NCT00130728|21082439|P1|NOT COMPLETED|Overall Study||262
8550814|NCT00130728|21082438|P2|COMPLETED|Overall Study||57
8550815|NCT00130728|21082439|P1|COMPLETED|Overall Study||57
8550816|NCT00130728|21082438|P2|Received Study Drug (Safety Population)|Overall Study||313
8550817|NCT00130728|21082439|P1|Received Study Drug (Safety Population)|Overall Study||313
8550818|NCT00130728|21082438|P2|STARTED|Overall Study||317
8550819|NCT00130728|21082439|P1|STARTED|Overall Study||319
8550820|NCT00130689|21082451|P1|NOT COMPLETED|Overall Study||43
8550821|NCT00130689|21082451|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
8550822|NCT00130689|21082451|P1|Treated|Overall Study||35
8550823|NCT00130689|21082451|P1|Eligible|Overall Study||37
8550824|NCT00130689|21082451|P1|STARTED|Overall Study||43
8550825|NCT00130637|21082455|P1|NOT COMPLETED|Overall Study||3
8550826|NCT00130637|21082455|P1|COMPLETED|Overall Study||3
8550827|NCT00130637|21082455|P1|STARTED|Overall Study||6
8550828|NCT00130533|21082462|P2|NOT COMPLETED|Overall Study||30
8550829|NCT00130533|21082463|P1|NOT COMPLETED|Overall Study||111
8550830|NCT00130533|21082462|P2|COMPLETED|Overall Study||398
8550831|NCT00130533|21082463|P1|COMPLETED|Overall Study||337
8550832|NCT00130533|21082462|P2|STARTED|Overall Study||428
8550833|NCT00130533|21082463|P1|STARTED|Overall Study||448
8550834|NCT00130520|21082475|P1|NOT COMPLETED|Overall Study||39
8550835|NCT00130520|21082475|P1|COMPLETED|Overall Study||1
8550836|NCT00130520|21082475|P1|Completion of at Least One Cycle|Overall Study||39
8550837|NCT00130520|21082475|P1|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
8550838|NCT00130442|21082483|P2|NOT COMPLETED|Overall Study||2
8550839|NCT00130442|21082484|P1|NOT COMPLETED|Overall Study||1
8550840|NCT00130442|21082483|P2|COMPLETED|Overall Study||66
8550841|NCT00130442|21082484|P1|COMPLETED|Overall Study||65
8550842|NCT00130442|21082483|P2|STARTED|Overall Study||68
8550843|NCT00130442|21082484|P1|STARTED|Overall Study||66
8550844|NCT00130286|21082502|P4|NOT COMPLETED|Overall Study||2
8550845|NCT00130286|21082503|P3|NOT COMPLETED|Overall Study||4
8550846|NCT00130286|21082504|P2|NOT COMPLETED|Overall Study||3
8550847|NCT00130286|21082505|P1|NOT COMPLETED|Overall Study||0
8550848|NCT00130286|21082502|P4|COMPLETED|Overall Study||17
8550849|NCT00130286|21082503|P3|COMPLETED|Overall Study||13
8550850|NCT00130286|21082504|P2|COMPLETED|Overall Study||16
8550851|NCT00130286|21082505|P1|COMPLETED|Overall Study||22
8550852|NCT00130286|21082502|P4|STARTED|Overall Study||19
8550853|NCT00130286|21082503|P3|STARTED|Overall Study||17
8550854|NCT00130286|21082504|P2|STARTED|Overall Study||19
8550855|NCT00130286|21082505|P1|STARTED|Overall Study||22
8550856|NCT00130247|21082525|P2|NOT COMPLETED|Overall Study||4
8550857|NCT00130247|21082526|P1|NOT COMPLETED|Overall Study||2
8550858|NCT00130247|21082525|P2|COMPLETED|Overall Study||194
8550859|NCT00130247|21082526|P1|COMPLETED|Overall Study||194
8550860|NCT00130247|21082525|P2|STARTED|Overall Study||198
8550861|NCT00130247|21082526|P1|STARTED|Overall Study||196
8550862|NCT00130208|21082544|P2|NOT COMPLETED|Washout Period (8 Weeks)||12
8550863|NCT00130208|21082545|P1|NOT COMPLETED|Washout Period (8 Weeks)||6
8550864|NCT00130208|21082544|P2|COMPLETED|Washout Period (8 Weeks)||490
8550865|NCT00130208|21082545|P1|COMPLETED|Washout Period (8 Weeks)||494
8550866|NCT00130208|21082544|P2|STARTED|Washout Period (8 Weeks)||502
8550867|NCT00130208|21082545|P1|STARTED|Washout Period (8 Weeks)||500
8550868|NCT00130208|21082544|P2|NOT COMPLETED|Maintenance Period (26 Weeks)||30
8550869|NCT00130208|21082545|P1|NOT COMPLETED|Maintenance Period (26 Weeks)||24
8550870|NCT00130208|21082544|P2|COMPLETED|Maintenance Period (26 Weeks)||502
8550871|NCT00130208|21082545|P1|COMPLETED|Maintenance Period (26 Weeks)||500
8550872|NCT00130208|21082544|P2|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
8550873|NCT00130208|21082545|P1|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
8550874|NCT00130208|21082544|P2|STARTED|Maintenance Period (26 Weeks)||532
8550875|NCT00130208|21082545|P1|STARTED|Maintenance Period (26 Weeks)||524
8550876|NCT00130117|21082557|P2|NOT COMPLETED|Overall Study||3
8550877|NCT00130117|21082558|P1|NOT COMPLETED|Overall Study||4
8550878|NCT00130117|21082557|P2|COMPLETED|Overall Study||6
8550879|NCT00130117|21082558|P1|COMPLETED|Overall Study||7
8550880|NCT00130117|21082557|P2|STARTED|Overall Study||9
8550881|NCT00130117|21082558|P1|STARTED|Overall Study||11
8550882|NCT00130039|21082581|P2|NOT COMPLETED|Overall Study||18
8550883|NCT00130039|21082582|P1|NOT COMPLETED|Overall Study||30
8550884|NCT00130039|21082581|P2|COMPLETED|Overall Study|full analysis set|207
8550885|NCT00130039|21082582|P1|COMPLETED|Overall Study|full analysis set|202
8550886|NCT00130039|21082581|P2|STARTED|Overall Study||225
8550887|NCT00130039|21082582|P1|STARTED|Overall Study||232
8550888|NCT00129987|21082600|P2|NOT COMPLETED|1 Year||21
8550889|NCT00129987|21082601|P1|NOT COMPLETED|1 Year||32
8550890|NCT00129987|21082600|P2|COMPLETED|1 Year||150
8550891|NCT00129987|21082601|P1|COMPLETED|1 Year||114
8550892|NCT00129987|21082600|P2|STARTED|1 Year||171
8550893|NCT00129987|21082601|P1|STARTED|1 Year||146
8550894|NCT00129987|21082600|P2|NOT COMPLETED|1st Educational Session||109
8550895|NCT00129987|21082601|P1|NOT COMPLETED|1st Educational Session||141
8550896|NCT00129987|21082600|P2|COMPLETED|1st Educational Session||171
8550897|NCT00129987|21082601|P1|COMPLETED|1st Educational Session||146
8550898|NCT00129987|21082600|P2|STARTED|1st Educational Session||280
8550899|NCT00129987|21082601|P1|STARTED|1st Educational Session||287
8550900|NCT00129974|21082613|P1|NOT COMPLETED|Overall Study||1
8550901|NCT00129974|21082613|P1|COMPLETED|Overall Study||0
8550902|NCT00129974|21082613|P1|STARTED|Overall Study||1
8550903|NCT00129961|21082620|P2|NOT COMPLETED|Overall Study||23
8550904|NCT00129961|21082621|P1|NOT COMPLETED|Overall Study||19
8550905|NCT00129961|21082620|P2|COMPLETED|Overall Study||24
8550906|NCT00129961|21082621|P1|COMPLETED|Overall Study||20
8550907|NCT00129961|21082620|P2|STARTED|Overall Study||47
8550908|NCT00129961|21082621|P1|STARTED|Overall Study||39
8550909|NCT00129935|21082657|P2|NOT COMPLETED|Overall Study||92
8550910|NCT00129935|21082658|P1|NOT COMPLETED|Overall Study||36
8550911|NCT00129935|21082657|P2|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623
8550912|NCT00129935|21082658|P1|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633
8550913|NCT00129935|21082657|P2|STARTED|Overall Study||715
8550914|NCT00129935|21082658|P1|STARTED|Overall Study||669
8550915|NCT00129766|21082676|P2|NOT COMPLETED|Overall Study||59
8550916|NCT00129766|21082677|P1|NOT COMPLETED|Overall Study||60
8550917|NCT00129766|21082676|P2|COMPLETED|Overall Study||3270
8550918|NCT00129766|21082677|P1|COMPLETED|Overall Study||3246
8550919|NCT00129766|21082676|P2|STARTED|Overall Study||3329
8550920|NCT00129766|21082677|P1|STARTED|Overall Study||3306
8550921|NCT00129740|21082715|P1|NOT COMPLETED|Overall Study||0
8550922|NCT00129740|21082715|P1|COMPLETED|Overall Study||148
8550923|NCT00129740|21082715|P1|STARTED|Overall Study||148
8550924|NCT00129727|21082720|P1|NOT COMPLETED|Overall Study||5
8550925|NCT00129727|21082720|P1|COMPLETED|Overall Study||57
8550926|NCT00129727|21082720|P1|STARTED|Overall Study||62
8550927|NCT00129701|21082726|P1|NOT COMPLETED|Overall Study||33
8550928|NCT00129701|21082726|P1|COMPLETED|Overall Study||71
8550929|NCT00129701|21082726|P1|STARTED|Overall Study||104
8550930|NCT00129649|21082735|P2|NOT COMPLETED|Overall Study||65
8550931|NCT00129649|21082736|P1|NOT COMPLETED|Overall Study||76
8550932|NCT00129649|21082735|P2|COMPLETED|Overall Study||181
8550933|NCT00129649|21082736|P1|COMPLETED|Overall Study||182
8550934|NCT00129649|21082735|P2|STARTED|Overall Study||246
8550935|NCT00129649|21082736|P1|STARTED|Overall Study||258
8550936|NCT00129623|21082744|P2|NOT COMPLETED|Overall Study||12
8550937|NCT00129623|21082745|P1|NOT COMPLETED|Overall Study||10
8550938|NCT00129623|21082744|P2|COMPLETED|Overall Study||65
8550939|NCT00129623|21082745|P1|COMPLETED|Overall Study||73
8550940|NCT00129623|21082744|P2|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
8550941|NCT00129623|21082745|P1|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
8550942|NCT00129623|21082744|P2|STARTED|Overall Study||77
8550943|NCT00129623|21082745|P1|STARTED|Overall Study||83
8550944|NCT00129545|21082770|P3|NOT COMPLETED|Overall Study||111
8550945|NCT00129545|21082771|P2|NOT COMPLETED|Overall Study||164
8550946|NCT00129545|21082772|P1|NOT COMPLETED|Overall Study||26
8550947|NCT00129545|21082770|P3|COMPLETED|Overall Study||133
8550948|NCT00129545|21082771|P2|COMPLETED|Overall Study||299
8550949|NCT00129545|21082772|P1|COMPLETED|Overall Study||67
8550950|NCT00129545|21082770|P3|STARTED|Overall Study||244
8550951|NCT00129545|21082771|P2|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
8550952|NCT00129545|21082772|P1|STARTED|Overall Study||93
8550953|NCT00129480|21082784|P2|NOT COMPLETED|Overall Study||0
8550954|NCT00129480|21082785|P1|NOT COMPLETED|Overall Study||0
8550955|NCT00129480|21082784|P2|COMPLETED|Overall Study||214
8550956|NCT00129480|21082785|P1|COMPLETED|Overall Study||187
8550957|NCT00129480|21082784|P2|STARTED|Overall Study||214
8550958|NCT00129480|21082785|P1|STARTED|Overall Study||187
8550959|NCT00129467|21082801|P2|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
8550960|NCT00129467|21082802|P1|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
8550961|NCT00129467|21082801|P2|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
8550962|NCT00129467|21082802|P1|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
8550963|NCT00129467|21082801|P2|STARTED|Open Label for SSRI+Methylphenidate Arm||0
8550964|NCT00129467|21082802|P1|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
8550965|NCT00129467|21082801|P2|NOT COMPLETED|Received Intervention||4
8550966|NCT00129467|21082802|P1|NOT COMPLETED|Received Intervention||6
8550967|NCT00129467|21082801|P2|COMPLETED|Received Intervention||13
8550968|NCT00129467|21082802|P1|COMPLETED|Received Intervention||9
8550969|NCT00129467|21082801|P2|STARTED|Received Intervention||17
8550970|NCT00129467|21082802|P1|STARTED|Received Intervention||15
8550971|NCT00129441|21082810|P2|NOT COMPLETED|Overall Study||0
8550972|NCT00129441|21082811|P1|NOT COMPLETED|Overall Study||0
8550973|NCT00129441|21082810|P2|COMPLETED|Overall Study||6
8550974|NCT00129441|21082811|P1|COMPLETED|Overall Study||9
8550975|NCT00129441|21082810|P2|Year 1, Visit 8|Overall Study||6
8550976|NCT00129441|21082811|P1|Year 1, Visit 8|Overall Study||9
8550977|NCT00129441|21082810|P2|Week 26, Visit 7|Overall Study||6
8550978|NCT00129441|21082811|P1|Week 26, Visit 7|Overall Study||9
8550979|NCT00129441|21082810|P2|Week 5, Visit 6|Overall Study||6
8550980|NCT00129441|21082811|P1|Week 5, Visit 6|Overall Study||9
8550981|NCT00129441|21082810|P2|Week 4, Visit 5|Overall Study||6
8550982|NCT00129441|21082811|P1|Week 4, Visit 5|Overall Study||9
8550983|NCT00129441|21082810|P2|Week 3, Visit 4|Overall Study||6
8550984|NCT00129441|21082811|P1|Week 3, Visit 4|Overall Study||9
8550985|NCT00129441|21082810|P2|Week 2, Visit 3|Overall Study||6
8550986|NCT00129441|21082811|P1|Week 2, Visit 3|Overall Study||9
8550987|NCT00129441|21082810|P2|Week 1, Visit 2|Overall Study||6
8550988|NCT00129441|21082811|P1|Week 1, Visit 2|Overall Study||9
8550989|NCT00129441|21082810|P2|Baseline, Visit 1|Overall Study||6
8550990|NCT00129441|21082811|P1|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
8550991|NCT00129441|21082810|P2|STARTED|Overall Study||6
8550992|NCT00129441|21082811|P1|STARTED|Overall Study||9
8550993|NCT00129402|21082833|P7|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
8550994|NCT00129402|21082834|P6|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8550995|NCT00129402|21082835|P5|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8550996|NCT00129402|21082836|P4|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8550997|NCT00129402|21082837|P3|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8550998|NCT00129402|21082838|P2|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8550999|NCT00129402|21082839|P1|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551000|NCT00129402|21082833|P7|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
8551001|NCT00129402|21082834|P6|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551002|NCT00129402|21082835|P5|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551003|NCT00129402|21082836|P4|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551004|NCT00129402|21082837|P3|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551005|NCT00129402|21082838|P2|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551006|NCT00129402|21082839|P1|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
8551007|NCT00129402|21082833|P7|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
8551008|NCT00129402|21082834|P6|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551009|NCT00129402|21082835|P5|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551010|NCT00129402|21082836|P4|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551011|NCT00129402|21082837|P3|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551012|NCT00129402|21082838|P2|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551013|NCT00129402|21082839|P1|STARTED|Start Period3 to End Period3(Week 34-53)||0
8551014|NCT00129402|21082833|P7|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551015|NCT00129402|21082834|P6|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
8551016|NCT00129402|21082835|P5|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551017|NCT00129402|21082836|P4|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551018|NCT00129402|21082837|P3|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
8551019|NCT00129402|21082838|P2|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551020|NCT00129402|21082839|P1|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551021|NCT00129402|21082833|P7|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551022|NCT00129402|21082834|P6|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
8551023|NCT00129402|21082835|P5|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551024|NCT00129402|21082836|P4|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551025|NCT00129402|21082837|P3|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
8551026|NCT00129402|21082838|P2|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551027|NCT00129402|21082839|P1|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
8551028|NCT00129402|21082833|P7|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551109|NCT00129220|21082948|P2|STARTED|Study Period III||8
8551029|NCT00129402|21082834|P6|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
8551030|NCT00129402|21082835|P5|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551031|NCT00129402|21082836|P4|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551032|NCT00129402|21082837|P3|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
8551033|NCT00129402|21082838|P2|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551034|NCT00129402|21082839|P1|STARTED|Start Period2 to End Period2 (Week 7-33)||0
8551035|NCT00129402|21082833|P7|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
8551036|NCT00129402|21082834|P6|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
8551037|NCT00129402|21082835|P5|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
8551038|NCT00129402|21082836|P4|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
8551039|NCT00129402|21082837|P3|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
8551040|NCT00129402|21082838|P2|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
8551041|NCT00129402|21082839|P1|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
8551042|NCT00129402|21082833|P7|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
8551043|NCT00129402|21082834|P6|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
8551044|NCT00129402|21082835|P5|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
8551045|NCT00129402|21082836|P4|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
8551046|NCT00129402|21082837|P3|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
8551047|NCT00129402|21082838|P2|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
8551048|NCT00129402|21082839|P1|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
8551049|NCT00129402|21082833|P7|STARTED|Start Period1 to End Period1 (Week 1-6)||0
8551050|NCT00129402|21082834|P6|STARTED|Start Period1 to End Period1 (Week 1-6)||42
8551051|NCT00129402|21082835|P5|STARTED|Start Period1 to End Period1 (Week 1-6)||40
8551052|NCT00129402|21082836|P4|STARTED|Start Period1 to End Period1 (Week 1-6)||40
8551053|NCT00129402|21082837|P3|STARTED|Start Period1 to End Period1 (Week 1-6)||43
8551054|NCT00129402|21082838|P2|STARTED|Start Period1 to End Period1 (Week 1-6)||40
8551055|NCT00129402|21082839|P1|STARTED|Start Period1 to End Period1 (Week 1-6)||43
8551056|NCT00129389|21082858|P2|NOT COMPLETED|Overall Study||140
8551057|NCT00129389|21082859|P1|NOT COMPLETED|Overall Study||33
8551058|NCT00129389|21082858|P2|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811
8551059|NCT00129389|21082859|P1|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941
8551060|NCT00129389|21082858|P2|STARTED|Overall Study||951
8551061|NCT00129389|21082859|P1|STARTED|Overall Study||974
8551062|NCT00129376|21082867|P1|NOT COMPLETED|Overall Study||2
8551063|NCT00129376|21082867|P1|COMPLETED|Overall Study||61
8551064|NCT00129376|21082867|P1|STARTED|Overall Study||63
8551065|NCT00129311|21082877|P2|NOT COMPLETED|Overall Study||19
8551066|NCT00129311|21082878|P1|NOT COMPLETED|Overall Study||12
8551067|NCT00129311|21082877|P2|COMPLETED|Overall Study||31
8551068|NCT00129311|21082878|P1|COMPLETED|Overall Study||39
8551069|NCT00129311|21082877|P2|STARTED|Overall Study||50
8551070|NCT00129311|21082878|P1|STARTED|Overall Study||51
8551071|NCT00129285|21082889|P3|NOT COMPLETED|Overall Study||38
8551072|NCT00129285|21082890|P2|NOT COMPLETED|Overall Study||27
8551073|NCT00129285|21082891|P1|NOT COMPLETED|Overall Study||25
8551074|NCT00129285|21082889|P3|COMPLETED|Overall Study||37
8551075|NCT00129285|21082890|P2|COMPLETED|Overall Study||43
8551076|NCT00129285|21082891|P1|COMPLETED|Overall Study||40
8551077|NCT00129285|21082889|P3|STARTED|Overall Study||75
8551078|NCT00129285|21082890|P2|STARTED|Overall Study||70
8551079|NCT00129285|21082891|P1|STARTED|Overall Study||65
8551080|NCT00129272|21082907|P2|NOT COMPLETED|Overall Study||22
8551081|NCT00129272|21082908|P1|NOT COMPLETED|Overall Study||17
8551082|NCT00129272|21082907|P2|COMPLETED|Overall Study||51
8551083|NCT00129272|21082908|P1|COMPLETED|Overall Study||54
8551084|NCT00129272|21082907|P2|STARTED|Overall Study||73
8551085|NCT00129272|21082908|P1|STARTED|Overall Study||71
8551086|NCT00129259|21082918|P2|NOT COMPLETED|Overall Study||3
8551087|NCT00129259|21082919|P1|NOT COMPLETED|Overall Study||3
8551088|NCT00129259|21082918|P2|COMPLETED|Overall Study||22
8551089|NCT00129259|21082919|P1|COMPLETED|Overall Study||49
8551090|NCT00129259|21082918|P2|Received All or Part of Cycle 2|Overall Study||0
8551091|NCT00129259|21082919|P1|Received All or Part of Cycle 2|Overall Study||40
8551092|NCT00129259|21082918|P2|Received All or Part of Cycle 1|Overall Study||0
8551093|NCT00129259|21082919|P1|Received All or Part of Cycle 1|Overall Study||52
8551094|NCT00129259|21082918|P2|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
8551095|NCT00129259|21082919|P1|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
8551096|NCT00129246|21082931|P2|NOT COMPLETED|Overall Study||0
8551097|NCT00129246|21082932|P1|NOT COMPLETED|Overall Study||0
8551098|NCT00129246|21082931|P2|COMPLETED|Overall Study||20
8551099|NCT00129246|21082932|P1|COMPLETED|Overall Study||20
8551100|NCT00129246|21082931|P2|STARTED|Overall Study||20
8551101|NCT00129246|21082932|P1|STARTED|Overall Study||20
8551102|NCT00129220|21082947|P3|NOT COMPLETED|Study Period III||10
8551103|NCT00129220|21082948|P2|NOT COMPLETED|Study Period III||1
8551104|NCT00129220|21082949|P1|NOT COMPLETED|Study Period III||13
8551105|NCT00129220|21082947|P3|COMPLETED|Study Period III||42
8551106|NCT00129220|21082948|P2|COMPLETED|Study Period III||7
8551107|NCT00129220|21082949|P1|COMPLETED|Study Period III||59
8551108|NCT00129220|21082947|P3|STARTED|Study Period III||52
8551110|NCT00129220|21082949|P1|STARTED|Study Period III||72
8551111|NCT00129220|21082947|P3|NOT COMPLETED|Study Period II||47
8551112|NCT00129220|21082948|P2|NOT COMPLETED|Study Period II||12
8551113|NCT00129220|21082949|P1|NOT COMPLETED|Study Period II||33
8551114|NCT00129220|21082947|P3|COMPLETED|Study Period II||52
8551115|NCT00129220|21082948|P2|COMPLETED|Study Period II||8
8551116|NCT00129220|21082949|P1|COMPLETED|Study Period II||72
8551117|NCT00129220|21082947|P3|Received at Least One Dose of Study Drug|Study Period II||97
8551118|NCT00129220|21082948|P2|Received at Least One Dose of Study Drug|Study Period II||20
8551119|NCT00129220|21082949|P1|Received at Least One Dose of Study Drug|Study Period II||104
8551120|NCT00129220|21082947|P3|STARTED|Study Period II||99
8551121|NCT00129220|21082948|P2|STARTED|Study Period II||20
8551122|NCT00129220|21082949|P1|STARTED|Study Period II||105
8551123|NCT00129129|21082989|P5|NOT COMPLETED|Fourth Dose Phase||6
8551124|NCT00129129|21082990|P4|NOT COMPLETED|Fourth Dose Phase||4
8551125|NCT00129129|21082991|P3|NOT COMPLETED|Fourth Dose Phase||0
8551126|NCT00129129|21082992|P2|NOT COMPLETED|Fourth Dose Phase||0
8551127|NCT00129129|21082993|P1|NOT COMPLETED|Fourth Dose Phase||4
8551128|NCT00129129|21082989|P5|COMPLETED|Fourth Dose Phase||124
8551129|NCT00129129|21082990|P4|COMPLETED|Fourth Dose Phase||128
8551130|NCT00129129|21082991|P3|COMPLETED|Fourth Dose Phase||0
8551131|NCT00129129|21082992|P2|COMPLETED|Fourth Dose Phase||0
8551132|NCT00129129|21082993|P1|COMPLETED|Fourth Dose Phase||232
8551133|NCT00129129|21082989|P5|STARTED|Fourth Dose Phase||130
8551134|NCT00129129|21082990|P4|STARTED|Fourth Dose Phase||132
8551135|NCT00129129|21082991|P3|STARTED|Fourth Dose Phase||0
8551136|NCT00129129|21082992|P2|STARTED|Fourth Dose Phase||0
8551137|NCT00129129|21082993|P1|STARTED|Fourth Dose Phase||236
8551138|NCT00129129|21082989|P5|NOT COMPLETED|Primary Phase||0
8551139|NCT00129129|21082990|P4|NOT COMPLETED|Primary Phase||0
8551140|NCT00129129|21082991|P3|NOT COMPLETED|Primary Phase||0
8551141|NCT00129129|21082992|P2|NOT COMPLETED|Primary Phase||25
8551142|NCT00129129|21082993|P1|NOT COMPLETED|Primary Phase||25
8551143|NCT00129129|21082989|P5|COMPLETED|Primary Phase||0
8551144|NCT00129129|21082990|P4|COMPLETED|Primary Phase||0
8551145|NCT00129129|21082991|P3|COMPLETED|Primary Phase||150
8551146|NCT00129129|21082992|P2|COMPLETED|Primary Phase||294
8551147|NCT00129129|21082993|P1|COMPLETED|Primary Phase||262
8551148|NCT00129129|21082989|P5|STARTED|Primary Phase||0
8551149|NCT00129129|21082990|P4|STARTED|Primary Phase||0
8551150|NCT00129129|21082991|P3|STARTED|Primary Phase||150
8551151|NCT00129129|21082992|P2|STARTED|Primary Phase||319
8551152|NCT00129129|21082993|P1|STARTED|Primary Phase||287
8551153|NCT00129116|21083200|P5|NOT COMPLETED|Booster Phase||1
8551154|NCT00129116|21083201|P4|NOT COMPLETED|Booster Phase||0
8551155|NCT00129116|21083202|P3|NOT COMPLETED|Booster Phase||0
8551156|NCT00129116|21083203|P2|NOT COMPLETED|Booster Phase||0
8551157|NCT00129116|21083204|P1|NOT COMPLETED|Booster Phase||2
8551158|NCT00129116|21083200|P5|COMPLETED|Booster Phase||43
8551159|NCT00129116|21083201|P4|COMPLETED|Booster Phase||44
8551160|NCT00129116|21083202|P3|COMPLETED|Booster Phase||44
8551161|NCT00129116|21083203|P2|COMPLETED|Booster Phase||42
8551162|NCT00129116|21083204|P1|COMPLETED|Booster Phase||45
8551163|NCT00129116|21083200|P5|STARTED|Booster Phase||44
8551164|NCT00129116|21083201|P4|STARTED|Booster Phase||44
8551165|NCT00129116|21083202|P3|STARTED|Booster Phase||44
8551166|NCT00129116|21083203|P2|STARTED|Booster Phase||42
8551167|NCT00129116|21083204|P1|STARTED|Booster Phase||47
8551168|NCT00129116|21083200|P5|NOT COMPLETED|Primary Phase||1
8551169|NCT00129116|21083201|P4|NOT COMPLETED|Primary Phase||1
8551170|NCT00129116|21083202|P3|NOT COMPLETED|Primary Phase||1
8551171|NCT00129116|21083203|P2|NOT COMPLETED|Primary Phase||4
8551172|NCT00129116|21083204|P1|NOT COMPLETED|Primary Phase||2
8551173|NCT00129116|21083200|P5|COMPLETED|Primary Phase||76
8551174|NCT00129116|21083201|P4|COMPLETED|Primary Phase||77
8551175|NCT00129116|21083202|P3|COMPLETED|Primary Phase||77
8551176|NCT00129116|21083203|P2|COMPLETED|Primary Phase||73
8551177|NCT00129116|21083204|P1|COMPLETED|Primary Phase||76
8551178|NCT00129116|21083200|P5|STARTED|Primary Phase||77
8551179|NCT00129116|21083201|P4|STARTED|Primary Phase||78
8551180|NCT00129116|21083202|P3|STARTED|Primary Phase||78
8551181|NCT00129116|21083203|P2|STARTED|Primary Phase||77
8551182|NCT00129116|21083204|P1|STARTED|Primary Phase||78
8551183|NCT00128921|21083469|P3|NOT COMPLETED|Overall Study||0
8551184|NCT00128921|21083470|P2|NOT COMPLETED|Overall Study||5
8551185|NCT00128921|21083471|P1|NOT COMPLETED|Overall Study||5
8551186|NCT00128921|21083469|P3|COMPLETED|Overall Study||0
8551187|NCT00128921|21083470|P2|COMPLETED|Overall Study||3
8551188|NCT00128921|21083471|P1|COMPLETED|Overall Study||5
8551189|NCT00128921|21083469|P3|Received Bortezomib|Overall Study||0
8551190|NCT00128921|21083470|P2|Received Bortezomib|Overall Study||6
8551191|NCT00128921|21083471|P1|Received Bortezomib|Overall Study||10
8551192|NCT00128921|21083469|P3|STARTED|Overall Study||0
8551193|NCT00128921|21083470|P2|STARTED|Overall Study||8
8551194|NCT00128921|21083471|P1|STARTED|Overall Study||10
8551195|NCT00128830|21083488|P1|NOT COMPLETED|Overall Study||72
8551196|NCT00128830|21083488|P1|COMPLETED|Overall Study||139
8551197|NCT00128830|21083488|P1|STARTED|Overall Study||211
8551198|NCT00128713|21083506|P3|NOT COMPLETED|Overall Study||0
8551199|NCT00128713|21083507|P2|NOT COMPLETED|Overall Study||0
8551200|NCT00128713|21083508|P1|NOT COMPLETED|Overall Study||0
8551201|NCT00128713|21083506|P3|COMPLETED|Overall Study||449
8551202|NCT00128713|21083507|P2|COMPLETED|Overall Study||449
8551203|NCT00128713|21083508|P1|COMPLETED|Overall Study||453
8551204|NCT00128713|21083506|P3|STARTED|Overall Study||449
8551205|NCT00128713|21083507|P2|STARTED|Overall Study||449
8551206|NCT00128713|21083508|P1|STARTED|Overall Study||453
8551207|NCT00128661|21083530|P2|NOT COMPLETED|Overall Study||258
8551208|NCT00128661|21083531|P1|NOT COMPLETED|Overall Study||274
8551209|NCT00128661|21083530|P2|COMPLETED|Overall Study||3481
8551210|NCT00128661|21083531|P1|COMPLETED|Overall Study||3453
8551211|NCT00128661|21083530|P2|STARTED|Overall Study||3739
8551212|NCT00128661|21083531|P1|STARTED|Overall Study||3727
8551213|NCT00128492|21083577|P2|NOT COMPLETED|Overall Study||59
8551214|NCT00128492|21083578|P1|NOT COMPLETED|Overall Study||20
8551215|NCT00128492|21083577|P2|COMPLETED|Overall Study||130
8551216|NCT00128492|21083578|P1|COMPLETED|Overall Study||65
8551217|NCT00128492|21083577|P2|STARTED|Overall Study||189
8551218|NCT00128492|21083578|P1|STARTED|Overall Study||85
8551219|NCT00128401|21083638|P2|NOT COMPLETED|Overall Study||4
8551220|NCT00128401|21083639|P1|NOT COMPLETED|Overall Study||6
8551221|NCT00128401|21083638|P2|COMPLETED|Overall Study||15
8551222|NCT00128401|21083639|P1|COMPLETED|Overall Study||14
8551223|NCT00128401|21083638|P2|STARTED|Overall Study||19
8551224|NCT00128401|21083639|P1|STARTED|Overall Study||20
8551225|NCT00128219|21083650|P2|NOT COMPLETED|Overall Study||71
8551226|NCT00128219|21083651|P1|NOT COMPLETED|Overall Study||69
8551227|NCT00128219|21083650|P2|COMPLETED|Overall Study||263
8551228|NCT00128219|21083651|P1|COMPLETED|Overall Study||264
8551229|NCT00128219|21083650|P2|STARTED|Overall Study||334
8551230|NCT00128219|21083651|P1|STARTED|Overall Study||333
8551231|NCT00128206|21083735|P2|NOT COMPLETED|Overall Study||120
8551232|NCT00128206|21083736|P1|NOT COMPLETED|Overall Study||137
8551233|NCT00128206|21083735|P2|COMPLETED|Overall Study||60
8551234|NCT00128206|21083736|P1|COMPLETED|Overall Study||47
8551235|NCT00128206|21083735|P2|STARTED|Overall Study||180
8551236|NCT00128206|21083736|P1|STARTED|Overall Study||184
8551237|NCT00128193|21083758|P12|NOT COMPLETED|Overall Study||2
8551238|NCT00128193|21083759|P11|NOT COMPLETED|Overall Study||3
8551239|NCT00128193|21083760|P10|NOT COMPLETED|Overall Study||2
8551240|NCT00128193|21083761|P9|NOT COMPLETED|Overall Study||2
8551241|NCT00128193|21083762|P8|NOT COMPLETED|Overall Study||0
8551242|NCT00128193|21083763|P7|NOT COMPLETED|Overall Study||4
8551243|NCT00128193|21083764|P6|NOT COMPLETED|Overall Study||3
8551244|NCT00128193|21083765|P5|NOT COMPLETED|Overall Study||2
8551245|NCT00128193|21083766|P4|NOT COMPLETED|Overall Study||1
8551246|NCT00128193|21083767|P3|NOT COMPLETED|Overall Study||3
8551247|NCT00128193|21083768|P2|NOT COMPLETED|Overall Study||0
8551248|NCT00128193|21083769|P1|NOT COMPLETED|Overall Study||0
8551249|NCT00128193|21083758|P12|COMPLETED|Overall Study||18
8551250|NCT00128193|21083759|P11|COMPLETED|Overall Study||17
8551251|NCT00128193|21083760|P10|COMPLETED|Overall Study||18
8551252|NCT00128193|21083761|P9|COMPLETED|Overall Study||18
8551253|NCT00128193|21083762|P8|COMPLETED|Overall Study||20
8551254|NCT00128193|21083763|P7|COMPLETED|Overall Study||16
8551255|NCT00128193|21083764|P6|COMPLETED|Overall Study||17
8551256|NCT00128193|21083765|P5|COMPLETED|Overall Study||18
8551257|NCT00128193|21083766|P4|COMPLETED|Overall Study||44
8551258|NCT00128193|21083767|P3|COMPLETED|Overall Study||42
8551259|NCT00128193|21083768|P2|COMPLETED|Overall Study||5
8551260|NCT00128193|21083769|P1|COMPLETED|Overall Study||5
8551261|NCT00128193|21083758|P12|STARTED|Overall Study||20
8551262|NCT00128193|21083759|P11|STARTED|Overall Study||20
8551263|NCT00128193|21083760|P10|STARTED|Overall Study||20
8551264|NCT00128193|21083761|P9|STARTED|Overall Study||20
8551265|NCT00128193|21083762|P8|STARTED|Overall Study||20
8551266|NCT00128193|21083763|P7|STARTED|Overall Study||20
8551267|NCT00128193|21083764|P6|STARTED|Overall Study||20
8551268|NCT00128193|21083765|P5|STARTED|Overall Study||20
8551269|NCT00128193|21083766|P4|STARTED|Overall Study||45
8551270|NCT00128193|21083767|P3|STARTED|Overall Study||45
8551271|NCT00128193|21083768|P2|STARTED|Overall Study||5
8551272|NCT00128193|21083769|P1|STARTED|Overall Study||5
8551273|NCT00128180|21084005|P2|NOT COMPLETED|Overall Study||0
8551274|NCT00128180|21084006|P1|NOT COMPLETED|Overall Study||0
8551275|NCT00128180|21084005|P2|COMPLETED|Overall Study||34
8551276|NCT00128180|21084006|P1|COMPLETED|Overall Study||32
8551277|NCT00128180|21084005|P2|STARTED|Overall Study||34
8551278|NCT00128180|21084006|P1|STARTED|Overall Study||32
8551279|NCT00128102|21084032|P2|NOT COMPLETED|Overall Study||332
8551280|NCT00128102|21084033|P1|NOT COMPLETED|Overall Study||328
8551281|NCT00128102|21084032|P2|COMPLETED|Overall Study||0
8551282|NCT00128102|21084033|P1|COMPLETED|Overall Study||1
8551283|NCT00128102|21084032|P2|Treated|Overall Study||329
8551284|NCT00128102|21084033|P1|Treated|Overall Study||329
8551285|NCT00128102|21084032|P2|STARTED|Overall Study||332
8551286|NCT00128102|21084033|P1|STARTED|Overall Study||329
8551287|NCT00127933|21084059|P2|NOT COMPLETED|Overall Study||0
8551288|NCT00127933|21084060|P1|NOT COMPLETED|Overall Study||1
8551289|NCT00127933|21084059|P2|COMPLETED|Overall Study||34
8551290|NCT00127933|21084060|P1|COMPLETED|Overall Study||122
8551291|NCT00127933|21084059|P2|Postoperative|Overall Study||27
8551292|NCT00127933|21084060|P1|Postoperative|Overall Study||98
8551293|NCT00127933|21084059|P2|Quality of Life Population|Overall Study||33
8551294|NCT00127933|21084060|P1|Quality of Life Population|Overall Study||118
8551295|NCT00127933|21084059|P2|Safety Population|Overall Study||34
8551296|NCT00127933|21084060|P1|Safety Population|Overall Study||122
8551297|NCT00127933|21084059|P2|Clinical Response|Overall Study||34
8551298|NCT00127933|21084060|P1|Clinical Response|Overall Study||122
8551299|NCT00127933|21084059|P2|Pathological Response|Overall Study||28
8551300|NCT00127933|21084060|P1|Pathological Response|Overall Study||101
8551301|NCT00127933|21084059|P2|STARTED|Overall Study||34
8551302|NCT00127933|21084060|P1|STARTED|Overall Study||123
8551303|NCT00127855|21084081|P5|NOT COMPLETED|Polysaccharide Challenge Dose||0
8551304|NCT00127855|21084082|P4|NOT COMPLETED|Polysaccharide Challenge Dose||0
8551305|NCT00127855|21084083|P3|NOT COMPLETED|Polysaccharide Challenge Dose||0
8551306|NCT00127855|21084084|P2|NOT COMPLETED|Polysaccharide Challenge Dose||0
8551307|NCT00127855|21084085|P1|NOT COMPLETED|Polysaccharide Challenge Dose||0
8551308|NCT00127855|21084081|P5|COMPLETED|Polysaccharide Challenge Dose||77
8551309|NCT00127855|21084082|P4|COMPLETED|Polysaccharide Challenge Dose||81
8551310|NCT00127855|21084083|P3|COMPLETED|Polysaccharide Challenge Dose||77
8551311|NCT00127855|21084084|P2|COMPLETED|Polysaccharide Challenge Dose||79
8551312|NCT00127855|21084085|P1|COMPLETED|Polysaccharide Challenge Dose||80
8551313|NCT00127855|21084081|P5|STARTED|Polysaccharide Challenge Dose||77
8551314|NCT00127855|21084082|P4|STARTED|Polysaccharide Challenge Dose||81
8551315|NCT00127855|21084083|P3|STARTED|Polysaccharide Challenge Dose||77
8551316|NCT00127855|21084084|P2|STARTED|Polysaccharide Challenge Dose||79
8551317|NCT00127855|21084085|P1|STARTED|Polysaccharide Challenge Dose||80
8551318|NCT00127855|21084081|P5|NOT COMPLETED|Primary Vaccination Course||4
8551319|NCT00127855|21084082|P4|NOT COMPLETED|Primary Vaccination Course||0
8551320|NCT00127855|21084083|P3|NOT COMPLETED|Primary Vaccination Course||2
8551321|NCT00127855|21084084|P2|NOT COMPLETED|Primary Vaccination Course||1
8551322|NCT00127855|21084085|P1|NOT COMPLETED|Primary Vaccination Course||2
8551323|NCT00127855|21084081|P5|COMPLETED|Primary Vaccination Course||78
8551324|NCT00127855|21084082|P4|COMPLETED|Primary Vaccination Course||81
8551325|NCT00127855|21084083|P3|COMPLETED|Primary Vaccination Course||78
8551326|NCT00127855|21084084|P2|COMPLETED|Primary Vaccination Course||81
8551327|NCT00127855|21084085|P1|COMPLETED|Primary Vaccination Course||80
8551328|NCT00127855|21084081|P5|STARTED|Primary Vaccination Course||82
8551329|NCT00127855|21084082|P4|STARTED|Primary Vaccination Course||81
8551330|NCT00127855|21084083|P3|STARTED|Primary Vaccination Course||80
8551331|NCT00127855|21084084|P2|STARTED|Primary Vaccination Course||82
8551332|NCT00127855|21084085|P1|STARTED|Primary Vaccination Course||82
8551333|NCT00127842|21084267|P1|NOT COMPLETED|Overall Study||39
8551334|NCT00127842|21084267|P1|COMPLETED|Overall Study||71
8551335|NCT00127842|21084267|P1|STARTED|Overall Study||110
8551336|NCT00127803|21084285|P4|NOT COMPLETED|Overall Study||1
8551337|NCT00127803|21084286|P3|NOT COMPLETED|Overall Study||0
8551338|NCT00127803|21084287|P2|NOT COMPLETED|Overall Study||0
8551339|NCT00127803|21084288|P1|NOT COMPLETED|Overall Study||3
8551340|NCT00127803|21084285|P4|COMPLETED|Overall Study||11
8551341|NCT00127803|21084286|P3|COMPLETED|Overall Study||12
8551342|NCT00127803|21084287|P2|COMPLETED|Overall Study||13
8551343|NCT00127803|21084288|P1|COMPLETED|Overall Study||10
8551344|NCT00127803|21084285|P4|STARTED|Overall Study||12
8551345|NCT00127803|21084286|P3|STARTED|Overall Study||12
8551346|NCT00127803|21084287|P2|STARTED|Overall Study||13
8551347|NCT00127803|21084288|P1|STARTED|Overall Study||13
8551348|NCT00127790|21084310|P4|NOT COMPLETED|Post-Treatment||0
8551349|NCT00127790|21084311|P3|NOT COMPLETED|Post-Treatment||0
8551350|NCT00127790|21084312|P2|NOT COMPLETED|Post-Treatment||0
8551351|NCT00127790|21084313|P1|NOT COMPLETED|Post-Treatment||0
8551352|NCT00127790|21084310|P4|COMPLETED|Post-Treatment||4
8551353|NCT00127790|21084311|P3|COMPLETED|Post-Treatment||6
8551354|NCT00127790|21084312|P2|COMPLETED|Post-Treatment||5
8551355|NCT00127790|21084313|P1|COMPLETED|Post-Treatment||6
8551356|NCT00127790|21084310|P4|STARTED|Post-Treatment||4
8551357|NCT00127790|21084311|P3|STARTED|Post-Treatment||6
8551358|NCT00127790|21084312|P2|STARTED|Post-Treatment||5
8551359|NCT00127790|21084313|P1|STARTED|Post-Treatment||6
8551360|NCT00127790|21084310|P4|NOT COMPLETED|Pre-Treatment||0
8551361|NCT00127790|21084311|P3|NOT COMPLETED|Pre-Treatment||0
8551362|NCT00127790|21084312|P2|NOT COMPLETED|Pre-Treatment||0
8551363|NCT00127790|21084313|P1|NOT COMPLETED|Pre-Treatment||0
8551364|NCT00127790|21084310|P4|COMPLETED|Pre-Treatment||4
8551365|NCT00127790|21084311|P3|COMPLETED|Pre-Treatment||6
8551366|NCT00127790|21084312|P2|COMPLETED|Pre-Treatment||5
8551367|NCT00127790|21084313|P1|COMPLETED|Pre-Treatment||6
8551368|NCT00127790|21084310|P4|STARTED|Pre-Treatment||4
8551369|NCT00127790|21084311|P3|STARTED|Pre-Treatment||6
8551370|NCT00127790|21084312|P2|STARTED|Pre-Treatment||5
8551371|NCT00127790|21084313|P1|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
8551372|NCT00127712|21084337|P2|NOT COMPLETED|Overall Study||0
8551373|NCT00127712|21084338|P1|NOT COMPLETED|Overall Study||5
8551374|NCT00127712|21084337|P2|COMPLETED|Overall Study||65
8551375|NCT00127712|21084338|P1|COMPLETED|Overall Study||60
8551376|NCT00127712|21084337|P2|STARTED|Overall Study||65
8551377|NCT00127712|21084338|P1|STARTED|Overall Study||65
8551378|NCT00127660|21084354|P4|NOT COMPLETED|Overall Study||0
8551379|NCT00127660|21084355|P3|NOT COMPLETED|Overall Study||5
8551380|NCT00127660|21084356|P2|NOT COMPLETED|Overall Study||3
8551381|NCT00127660|21084357|P1|NOT COMPLETED|Overall Study||3
8551382|NCT00127660|21084354|P4|COMPLETED|Overall Study||150
8551383|NCT00127660|21084355|P3|COMPLETED|Overall Study||143
8551384|NCT00127660|21084356|P2|COMPLETED|Overall Study||151
8551385|NCT00127660|21084357|P1|COMPLETED|Overall Study||150
8551386|NCT00127660|21084354|P4|STARTED|Overall Study||150
8551387|NCT00127660|21084355|P3|STARTED|Overall Study||148
8551388|NCT00127660|21084356|P2|STARTED|Overall Study||154
8551389|NCT00127660|21084357|P1|STARTED|Overall Study||153
8551390|NCT00127608|21084367|P1|NOT COMPLETED|Overall Study||1
8551391|NCT00127608|21084367|P1|COMPLETED|Overall Study||35
8551392|NCT00127608|21084367|P1|STARTED|Overall Study||36
8551393|NCT00127530|21084375|P2|NOT COMPLETED|Overall Study||21
8551394|NCT00127530|21084376|P1|NOT COMPLETED|Overall Study||1
8551395|NCT00127530|21084375|P2|COMPLETED|Overall Study||207
8551396|NCT00127530|21084376|P1|COMPLETED|Overall Study||71
8551397|NCT00127530|21084375|P2|STARTED|Overall Study||228
8551398|NCT00127530|21084376|P1|STARTED|Overall Study||72
8551399|NCT00127439|21084384|P2|NOT COMPLETED|Overall Study||0
8551400|NCT00127439|21084385|P1|NOT COMPLETED|Overall Study||0
8551401|NCT00127439|21084384|P2|COMPLETED|Overall Study||10
8551402|NCT00127439|21084385|P1|COMPLETED|Overall Study||9
8551403|NCT00127439|21084384|P2|STARTED|Overall Study||10
8551404|NCT00127439|21084385|P1|STARTED|Overall Study||9
8551405|NCT00127413|21084411|P4|NOT COMPLETED|Overall Study||2
8551406|NCT00127413|21084412|P3|NOT COMPLETED|Overall Study||8
8551407|NCT00127413|21084413|P2|NOT COMPLETED|Overall Study||4
8551408|NCT00127413|21084414|P1|NOT COMPLETED|Overall Study||6
8551409|NCT00127413|21084411|P4|COMPLETED|Overall Study||5
8551410|NCT00127413|21084412|P3|COMPLETED|Overall Study||5
8551411|NCT00127413|21084413|P2|COMPLETED|Overall Study||6
8551412|NCT00127413|21084414|P1|COMPLETED|Overall Study||6
8551413|NCT00127413|21084411|P4|STARTED|Overall Study||7
8551414|NCT00127413|21084412|P3|STARTED|Overall Study||13
8551415|NCT00127413|21084413|P2|STARTED|Overall Study||10
8551416|NCT00127413|21084414|P1|STARTED|Overall Study||12
8551417|NCT00127231|21084426|P2|NOT COMPLETED|Overall Study||6
8551418|NCT00127231|21084427|P1|NOT COMPLETED|Overall Study||6
8551419|NCT00127231|21084426|P2|COMPLETED|Overall Study||68
8551420|NCT00127231|21084427|P1|COMPLETED|Overall Study||68
8551421|NCT00127231|21084426|P2|STARTED|Overall Study||74
8551422|NCT00127231|21084427|P1|STARTED|Overall Study||74
8551423|NCT00127218|21084443|P2|NOT COMPLETED|Overall Study||15
8551424|NCT00127218|21084444|P1|NOT COMPLETED|Overall Study||13
8551425|NCT00127218|21084443|P2|COMPLETED|Overall Study||58
8551426|NCT00127218|21084444|P1|COMPLETED|Overall Study||59
8551427|NCT00127218|21084443|P2|STARTED|Overall Study||73
8551428|NCT00127218|21084444|P1|STARTED|Overall Study||72
8551438|NCT00127192|21084479|P5|NOT COMPLETED|Overall Study||5
8551439|NCT00127192|21084480|P4|NOT COMPLETED|Overall Study||1
8551440|NCT00127192|21084481|P3|NOT COMPLETED|Overall Study||2
8551441|NCT00127192|21084482|P2|NOT COMPLETED|Overall Study||1
8551442|NCT00127192|21084483|P1|NOT COMPLETED|Overall Study||3
8551443|NCT00127192|21084479|P5|COMPLETED|Overall Study||68
8551444|NCT00127192|21084480|P4|COMPLETED|Overall Study||67
8551445|NCT00127192|21084481|P3|COMPLETED|Overall Study||68
8551446|NCT00127192|21084482|P2|COMPLETED|Overall Study||71
8551447|NCT00127192|21084483|P1|COMPLETED|Overall Study||77
8551448|NCT00127192|21084479|P5|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
8551449|NCT00127192|21084480|P4|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
8551450|NCT00127192|21084481|P3|STARTED|Overall Study|Study enrolled as per the target of N=70|70
8551451|NCT00127192|21084482|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
8551452|NCT00127192|21084483|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
8551453|NCT00127166|21084507|P2|NOT COMPLETED|Period II||0
8551454|NCT00127166|21084508|P1|NOT COMPLETED|Period II||3
8551455|NCT00127166|21084507|P2|COMPLETED|Period II||73
8551456|NCT00127166|21084508|P1|COMPLETED|Period II||72
8551457|NCT00127166|21084507|P2|STARTED|Period II||73
8551458|NCT00127166|21084508|P1|STARTED|Period II||75
8551459|NCT00127166|21084507|P2|NOT COMPLETED|Washout Period||1
8551460|NCT00127166|21084508|P1|NOT COMPLETED|Washout Period||0
8551461|NCT00127166|21084507|P2|COMPLETED|Washout Period||73
8551462|NCT00127166|21084508|P1|COMPLETED|Washout Period||75
8551463|NCT00127166|21084507|P2|STARTED|Washout Period||74
8551464|NCT00127166|21084508|P1|STARTED|Washout Period||75
8551465|NCT00127166|21084507|P2|NOT COMPLETED|Period I||2
8551466|NCT00127166|21084508|P1|NOT COMPLETED|Period I||3
8551467|NCT00127166|21084507|P2|COMPLETED|Period I||74
8551468|NCT00127166|21084508|P1|COMPLETED|Period I||75
8551469|NCT00127166|21084507|P2|STARTED|Period I||76
8551470|NCT00127166|21084508|P1|STARTED|Period I||78
8551471|NCT00127101|21084528|P6|NOT COMPLETED|Continuation Phase||3
8551472|NCT00127101|21084529|P5|NOT COMPLETED|Continuation Phase||3
8551473|NCT00127101|21084530|P4|NOT COMPLETED|Continuation Phase||0
8551474|NCT00127101|21084531|P3|NOT COMPLETED|Continuation Phase||1
8551475|NCT00127101|21084532|P2|NOT COMPLETED|Continuation Phase||0
8551476|NCT00127101|21084533|P1|NOT COMPLETED|Continuation Phase||0
8551477|NCT00127101|21084528|P6|COMPLETED|Continuation Phase||0
8551478|NCT00127101|21084529|P5|COMPLETED|Continuation Phase||0
8551479|NCT00127101|21084530|P4|COMPLETED|Continuation Phase||0
8551480|NCT00127101|21084531|P3|COMPLETED|Continuation Phase||0
8551481|NCT00127101|21084532|P2|COMPLETED|Continuation Phase||0
8551482|NCT00127101|21084533|P1|COMPLETED|Continuation Phase||0
8551483|NCT00127101|21084528|P6|STARTED|Continuation Phase||3
8551484|NCT00127101|21084529|P5|STARTED|Continuation Phase||3
8551485|NCT00127101|21084530|P4|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
8551486|NCT00127101|21084531|P3|STARTED|Continuation Phase||1
8551487|NCT00127101|21084532|P2|STARTED|Continuation Phase||0
8551488|NCT00127101|21084533|P1|STARTED|Continuation Phase||0
8551489|NCT00127101|21084528|P6|NOT COMPLETED|Base Protocol||1
8551490|NCT00127101|21084529|P5|NOT COMPLETED|Base Protocol||2
8551491|NCT00127101|21084530|P4|NOT COMPLETED|Base Protocol||0
8551492|NCT00127101|21084531|P3|NOT COMPLETED|Base Protocol||2
8551493|NCT00127101|21084532|P2|NOT COMPLETED|Base Protocol||4
8551494|NCT00127101|21084533|P1|NOT COMPLETED|Base Protocol||2
8551495|NCT00127101|21084528|P6|COMPLETED|Base Protocol||3
8551496|NCT00127101|21084529|P5|COMPLETED|Base Protocol||3
8551497|NCT00127101|21084530|P4|COMPLETED|Base Protocol||3
8551498|NCT00127101|21084531|P3|COMPLETED|Base Protocol||1
8551499|NCT00127101|21084532|P2|COMPLETED|Base Protocol||1
8551500|NCT00127101|21084533|P1|COMPLETED|Base Protocol||1
8551501|NCT00127101|21084528|P6|STARTED|Base Protocol||4
8551502|NCT00127101|21084529|P5|STARTED|Base Protocol||5
8551503|NCT00127101|21084530|P4|STARTED|Base Protocol||3
8551504|NCT00127101|21084531|P3|STARTED|Base Protocol||3
8551505|NCT00127101|21084532|P2|STARTED|Base Protocol||5
8551506|NCT00127101|21084533|P1|STARTED|Base Protocol||3
8551507|NCT00127062|21084555|P2|NOT COMPLETED|Second intervention_Hyde Park||0
8551508|NCT00127062|21084556|P1|NOT COMPLETED|Second intervention_Hyde Park||0
8551509|NCT00127062|21084555|P2|COMPLETED|Second intervention_Hyde Park||29
8551510|NCT00127062|21084556|P1|COMPLETED|Second intervention_Hyde Park||31
8551511|NCT00127062|21084555|P2|STARTED|Second intervention_Hyde Park||29
8551512|NCT00127062|21084556|P1|STARTED|Second intervention_Hyde Park||31
8551513|NCT00127062|21084555|P2|NOT COMPLETED|First intervention_Oxford Street||0
8551514|NCT00127062|21084556|P1|NOT COMPLETED|First intervention_Oxford Street||0
8551515|NCT00127062|21084555|P2|COMPLETED|First intervention_Oxford Street||29
8551516|NCT00127062|21084556|P1|COMPLETED|First intervention_Oxford Street||31
8551517|NCT00127062|21084555|P2|STARTED|First intervention_Oxford Street||29
8551518|NCT00127062|21084556|P1|STARTED|First intervention_Oxford Street||31
8551519|NCT00127036|21084568|P2|NOT COMPLETED|Overall Study||11
8551520|NCT00127036|21084569|P1|NOT COMPLETED|Overall Study||8
8551521|NCT00127036|21084568|P2|COMPLETED|Overall Study|20 Participants were evaluable.|20
8551522|NCT00127036|21084569|P1|COMPLETED|Overall Study|26 Participants were evaluable.|26
8551523|NCT00127036|21084568|P2|STARTED|Overall Study||31
8551524|NCT00127036|21084569|P1|STARTED|Overall Study||34
8551525|NCT00126776|21084581|P2|NOT COMPLETED|Overall Study||0
8551526|NCT00126776|21084582|P1|NOT COMPLETED|Overall Study||0
8551527|NCT00126776|21084581|P2|COMPLETED|Overall Study||371
8551528|NCT00126776|21084582|P1|COMPLETED|Overall Study||372
8551529|NCT00126776|21084581|P2|STARTED|Overall Study||371
8551530|NCT00126776|21084582|P1|STARTED|Overall Study||372
8551531|NCT00126750|21084588|P2|NOT COMPLETED|Overall Study||266
8551532|NCT00126750|21084589|P1|NOT COMPLETED|Overall Study||180
8551533|NCT00126750|21084588|P2|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
8551534|NCT00126750|21084589|P1|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
8551535|NCT00126750|21084588|P2|STARTED|Overall Study|Number of providers from 84 clinics|462
8551536|NCT00126750|21084589|P1|STARTED|Overall Study|Number of providers from 84 clinics|385
8551537|NCT00126737|21084599|P4|NOT COMPLETED|Overall Study||7
8551538|NCT00126737|21084600|P3|NOT COMPLETED|Overall Study||6
8551539|NCT00126737|21084601|P2|NOT COMPLETED|Overall Study||3
8551540|NCT00126737|21084602|P1|NOT COMPLETED|Overall Study||6
8551541|NCT00126737|21084599|P4|COMPLETED|Overall Study||18
8551542|NCT00126737|21084600|P3|COMPLETED|Overall Study||24
8551543|NCT00126737|21084601|P2|COMPLETED|Overall Study||24
8551544|NCT00126737|21084602|P1|COMPLETED|Overall Study||22
8551545|NCT00126737|21084599|P4|STARTED|Overall Study||25
8551546|NCT00126737|21084600|P3|STARTED|Overall Study||30
8551547|NCT00126737|21084601|P2|STARTED|Overall Study||27
8551548|NCT00126737|21084602|P1|STARTED|Overall Study||28
8551549|NCT00126659|21084631|P3|NOT COMPLETED|Overall Study||2
8551550|NCT00126659|21084632|P2|NOT COMPLETED|Overall Study||0
8551551|NCT00126659|21084633|P1|NOT COMPLETED|Overall Study||0
8551552|NCT00126659|21084631|P3|COMPLETED|Overall Study||2
8551553|NCT00126659|21084632|P2|COMPLETED|Overall Study||3
8551554|NCT00126659|21084633|P1|COMPLETED|Overall Study||3
8551555|NCT00126659|21084631|P3|STARTED|Overall Study||4
8551556|NCT00126659|21084632|P2|STARTED|Overall Study||3
8551557|NCT00126659|21084633|P1|STARTED|Overall Study||3
8551558|NCT00126594|21084641|P2|NOT COMPLETED|Overall Study||37
8551559|NCT00126594|21084642|P1|NOT COMPLETED|Overall Study||39
8551560|NCT00126594|21084641|P2|COMPLETED|Overall Study||3
8551561|NCT00126594|21084642|P1|COMPLETED|Overall Study||1
8551562|NCT00126594|21084641|P2|STARTED|Overall Study||40
8551563|NCT00126594|21084642|P1|STARTED|Overall Study||40
8551564|NCT00126581|21084659|P2|NOT COMPLETED|Overall Study||20
8551565|NCT00126581|21084660|P1|NOT COMPLETED|Overall Study||13
8551566|NCT00126581|21084659|P2|COMPLETED|Overall Study||80
8551567|NCT00126581|21084660|P1|COMPLETED|Overall Study||68
8551568|NCT00126581|21084659|P2|STARTED|Overall Study||100
8551569|NCT00126581|21084660|P1|STARTED|Overall Study||81
8551570|NCT00126568|21084680|P1|NOT COMPLETED|Overall Study||2
8551571|NCT00126568|21084680|P1|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
8551572|NCT00126568|21084680|P1|STARTED|Overall Study||20
8551573|NCT00126555|21084687|P1|NOT COMPLETED|Overall Study||6
8551574|NCT00126555|21084687|P1|COMPLETED|Overall Study||17
8551575|NCT00126555|21084687|P1|Stratum 2- Unresectable|Overall Study||4
8551576|NCT00126555|21084687|P1|Stratum 1- Resectable|Overall Study|1 participant did not participate|18
8551577|NCT00126555|21084687|P1|STARTED|Overall Study||23
8551578|NCT00126503|21084709|P2|NOT COMPLETED|Overall Study||21
8551579|NCT00126503|21084710|P1|NOT COMPLETED|Overall Study||47
8551580|NCT00126503|21084709|P2|COMPLETED|Overall Study||0
8551581|NCT00126503|21084710|P1|COMPLETED|Overall Study||1
8551582|NCT00126503|21084709|P2|STARTED|Overall Study||21
8551583|NCT00126503|21084710|P1|STARTED|Overall Study||48
8551584|NCT00126490|21084722|P1|NOT COMPLETED|Overall Study||1
8551585|NCT00126490|21084722|P1|COMPLETED|Overall Study||18
8551586|NCT00126490|21084722|P1|STARTED|Overall Study||19
8551587|NCT00126438|21084732|P2|NOT COMPLETED|Overall Study||10
8551588|NCT00126438|21084733|P1|NOT COMPLETED|Overall Study||34
8551589|NCT00126438|21084732|P2|COMPLETED|Overall Study||52
8551590|NCT00126438|21084733|P1|COMPLETED|Overall Study||419
8551591|NCT00126438|21084732|P2|STARTED|Overall Study||62
8551592|NCT00126438|21084733|P1|STARTED|Overall Study||453
8551593|NCT00126425|21084741|P2|NOT COMPLETED|Overall Study||11
8551594|NCT00126425|21084742|P1|NOT COMPLETED|Overall Study||41
8551595|NCT00126425|21084741|P2|COMPLETED|Overall Study||37
8551596|NCT00126425|21084742|P1|COMPLETED|Overall Study||498
8551597|NCT00126425|21084741|P2|STARTED|Overall Study||48
8551598|NCT00126425|21084742|P1|STARTED|Overall Study||539
8551599|NCT00126191|21084750|P2|NOT COMPLETED|Overall Study||2
8551600|NCT00126191|21084751|P1|NOT COMPLETED|Overall Study||0
8551601|NCT00126191|21084750|P2|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
8551602|NCT00126191|21084751|P1|COMPLETED|Overall Study||2
8551603|NCT00126191|21084750|P2|STARTED|Overall Study||8
8551604|NCT00126191|21084751|P1|STARTED|Overall Study||2
8551605|NCT00126126|21084761|P2|NOT COMPLETED|Overall Study||2
8551606|NCT00126126|21084762|P1|NOT COMPLETED|Overall Study||0
8551607|NCT00126126|21084761|P2|COMPLETED|Overall Study||7
8551608|NCT00126126|21084762|P1|COMPLETED|Overall Study||9
8551609|NCT00126126|21084761|P2|STARTED|Overall Study||9
8551610|NCT00126126|21084762|P1|STARTED|Overall Study||9
8551611|NCT00126113|21084772|P2|NOT COMPLETED|Overall Study||2
8551612|NCT00126113|21084773|P1|NOT COMPLETED|Overall Study||3
8551613|NCT00126113|21084772|P2|COMPLETED|Overall Study||35
8551614|NCT00126113|21084773|P1|COMPLETED|Overall Study||34
8551615|NCT00126113|21084772|P2|STARTED|Overall Study||37
8551616|NCT00126113|21084773|P1|STARTED|Overall Study||37
8551617|NCT00125957|21084787|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8551618|NCT00125957|21084788|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8551619|NCT00125957|21084787|P2|COMPLETED|Second Intervention (3 Weeks)||17
8551620|NCT00125957|21084788|P1|COMPLETED|Second Intervention (3 Weeks)||15
8551621|NCT00125957|21084787|P2|STARTED|Second Intervention (3 Weeks)||17
8551622|NCT00125957|21084788|P1|STARTED|Second Intervention (3 Weeks)||15
8551623|NCT00125957|21084787|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
8551624|NCT00125957|21084788|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
8551625|NCT00125957|21084787|P2|COMPLETED|First Intervention (3 Weeks)||17
8551626|NCT00125957|21084788|P1|COMPLETED|First Intervention (3 Weeks)||15
8551627|NCT00125957|21084787|P2|STARTED|First Intervention (3 Weeks)||17
8551628|NCT00125957|21084788|P1|STARTED|First Intervention (3 Weeks)||15
8551629|NCT00125931|21084796|P1|NOT COMPLETED|Overall Study||0
8551630|NCT00125931|21084796|P1|COMPLETED|Overall Study||10
8551631|NCT00125931|21084796|P1|STARTED|Overall Study||10
8551632|NCT00125853|21084801|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
8551633|NCT00125853|21084802|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
8551634|NCT00125853|21084801|P2|COMPLETED|Second Intervention (8 Weeks)||20
8551635|NCT00125853|21084802|P1|COMPLETED|Second Intervention (8 Weeks)||24
8551636|NCT00125853|21084801|P2|STARTED|Second Intervention (8 Weeks)||20
8551637|NCT00125853|21084802|P1|STARTED|Second Intervention (8 Weeks)||24
8551638|NCT00125853|21084801|P2|NOT COMPLETED|Wash-out (4 Weeks)||7
8551639|NCT00125853|21084802|P1|NOT COMPLETED|Wash-out (4 Weeks)||3
8551640|NCT00125853|21084801|P2|COMPLETED|Wash-out (4 Weeks)||20
8551641|NCT00125853|21084802|P1|COMPLETED|Wash-out (4 Weeks)||24
8551642|NCT00125853|21084801|P2|STARTED|Wash-out (4 Weeks)||27
8551643|NCT00125853|21084802|P1|STARTED|Wash-out (4 Weeks)||27
8551644|NCT00125853|21084801|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
8551645|NCT00125853|21084802|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
8551646|NCT00125853|21084801|P2|COMPLETED|First Intervention (8 Weeks)||27
8551647|NCT00125853|21084802|P1|COMPLETED|First Intervention (8 Weeks)||27
8551648|NCT00125853|21084801|P2|STARTED|First Intervention (8 Weeks)||27
8551649|NCT00125853|21084802|P1|STARTED|First Intervention (8 Weeks)||27
8551650|NCT00125853|21084801|P2|NOT COMPLETED|Wash-out (4 Weeks)||0
8551651|NCT00125853|21084802|P1|NOT COMPLETED|Wash-out (4 Weeks)||0
8551652|NCT00125853|21084801|P2|COMPLETED|Wash-out (4 Weeks)||27
8551653|NCT00125853|21084802|P1|COMPLETED|Wash-out (4 Weeks)||27
8551654|NCT00125853|21084801|P2|STARTED|Wash-out (4 Weeks)||27
8551655|NCT00125853|21084802|P1|STARTED|Wash-out (4 Weeks)||27
8551656|NCT00125762|21084816|P1|NOT COMPLETED|Overall Study||159
8551657|NCT00125762|21084816|P1|COMPLETED|Overall Study||748
8551658|NCT00125762|21084816|P1|STARTED|Overall Study||907
8551659|NCT00125658|21084823|P2|NOT COMPLETED|Overall Study||0
8551660|NCT00125658|21084824|P1|NOT COMPLETED|Overall Study||0
8551661|NCT00125658|21084823|P2|COMPLETED|Overall Study||6
8551662|NCT00125658|21084824|P1|COMPLETED|Overall Study||8
8551663|NCT00125658|21084823|P2|STARTED|Overall Study||6
8551664|NCT00125658|21084824|P1|STARTED|Overall Study||8
8551665|NCT00125619|21084844|P2|NOT COMPLETED|Overall Study||0
8551666|NCT00125619|21084845|P1|NOT COMPLETED|Overall Study||0
8551667|NCT00125619|21084844|P2|COMPLETED|Overall Study||8
8551668|NCT00125619|21084845|P1|COMPLETED|Overall Study||8
8551669|NCT00125619|21084844|P2|STARTED|Overall Study||8
8551670|NCT00125619|21084845|P1|STARTED|Overall Study||8
8551671|NCT00125593|21084865|P2|NOT COMPLETED|Overall Study||103
8551672|NCT00125593|21084866|P1|NOT COMPLETED|Overall Study||101
8551673|NCT00125593|21084865|P2|COMPLETED|Overall Study||4517
8551674|NCT00125593|21084866|P1|COMPLETED|Overall Study||4549
8551675|NCT00125593|21084865|P2|STARTED|Overall Study||4620
8551676|NCT00125593|21084866|P1|STARTED|Overall Study||4650
8551677|NCT00125528|21084886|P2|NOT COMPLETED|Overall Study||1
8551678|NCT00125528|21084887|P1|NOT COMPLETED|Overall Study||2
8551679|NCT00125528|21084886|P2|COMPLETED|Overall Study||20
8551680|NCT00125528|21084887|P1|COMPLETED|Overall Study||18
8551681|NCT00125528|21084886|P2|STARTED|Overall Study||21
8551682|NCT00125528|21084887|P1|STARTED|Overall Study||20
8551683|NCT00125515|21084898|P3|NOT COMPLETED|Overall Study||21
8551684|NCT00125515|21084899|P2|NOT COMPLETED|Overall Study||20
8551685|NCT00125515|21084900|P1|NOT COMPLETED|Overall Study||20
8551686|NCT00125515|21084898|P3|COMPLETED|Overall Study||6
8551687|NCT00125515|21084899|P2|COMPLETED|Overall Study||7
8551688|NCT00125515|21084900|P1|COMPLETED|Overall Study||7
8551689|NCT00125515|21084898|P3|STARTED|Overall Study||27
8551690|NCT00125515|21084899|P2|STARTED|Overall Study||27
8551691|NCT00125515|21084900|P1|STARTED|Overall Study||27
8551692|NCT00125372|21084908|P1|NOT COMPLETED|Overall Study||2
8551693|NCT00125372|21084908|P1|COMPLETED|Overall Study||10
8551694|NCT00125372|21084908|P1|STARTED|Overall Study||12
8551695|NCT00125359|21084916|P1|NOT COMPLETED|Overall Study||23
8551696|NCT00125359|21084916|P1|COMPLETED|Overall Study||19
8551697|NCT00125359|21084916|P1|STARTED|Overall Study||42
8551698|NCT00125268|21084925|P2|NOT COMPLETED|Overall Study||1
8551699|NCT00125268|21084926|P1|NOT COMPLETED|Overall Study||1
8551700|NCT00125268|21084925|P2|COMPLETED|Overall Study||13
8551701|NCT00125268|21084926|P1|COMPLETED|Overall Study||15
8551702|NCT00125268|21084925|P2|STARTED|Overall Study||14
8551703|NCT00125268|21084926|P1|STARTED|Overall Study||16
8551704|NCT00125242|21084938|P2|NOT COMPLETED|Overall Study||2
8551705|NCT00125242|21084939|P1|NOT COMPLETED|Overall Study||7
8551706|NCT00125242|21084938|P2|COMPLETED|Overall Study||14
8551707|NCT00125242|21084939|P1|COMPLETED|Overall Study||87
8551708|NCT00125242|21084938|P2|STARTED|Overall Study||16
8551709|NCT00125242|21084939|P1|STARTED|Overall Study||94
8551710|NCT00125190|21084944|P1|NOT COMPLETED|Overall Study||15
8551711|NCT00125190|21084944|P1|COMPLETED|Overall Study||30
8551712|NCT00125190|21084944|P1|Completed 34 Weeks of Study|Overall Study||43
8551713|NCT00125190|21084944|P1|STARTED|Overall Study||45
8551714|NCT00125164|21084960|P4|NOT COMPLETED|Overall Study||6
8551715|NCT00125164|21084961|P3|NOT COMPLETED|Overall Study||4
8551716|NCT00125164|21084962|P2|NOT COMPLETED|Overall Study||0
8551717|NCT00125164|21084963|P1|NOT COMPLETED|Overall Study||2
8551718|NCT00125164|21084960|P4|COMPLETED|Overall Study||45
8551719|NCT00125164|21084961|P3|COMPLETED|Overall Study||40
8551720|NCT00125164|21084962|P2|COMPLETED|Overall Study||16
8551721|NCT00125164|21084963|P1|COMPLETED|Overall Study||23
8551722|NCT00125164|21084960|P4|STARTED|Overall Study||51
8551723|NCT00125164|21084961|P3|STARTED|Overall Study||44
8551724|NCT00125164|21084962|P2|STARTED|Overall Study||16
8551725|NCT00125164|21084963|P1|STARTED|Overall Study||25
8551726|NCT00125138|21085017|P4|NOT COMPLETED|Overall Study||5
8551727|NCT00125138|21085018|P3|NOT COMPLETED|Overall Study||4
8551728|NCT00125138|21085019|P2|NOT COMPLETED|Overall Study||3
8551729|NCT00125138|21085020|P1|NOT COMPLETED|Overall Study||3
8551730|NCT00125138|21085017|P4|COMPLETED|Overall Study||25
8551731|NCT00125138|21085018|P3|COMPLETED|Overall Study||21
8551732|NCT00125138|21085019|P2|COMPLETED|Overall Study||17
8551733|NCT00125138|21085020|P1|COMPLETED|Overall Study||12
8551734|NCT00125138|21085017|P4|STARTED|Overall Study||30
8551735|NCT00125138|21085018|P3|STARTED|Overall Study||25
8551736|NCT00125138|21085019|P2|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
8551737|NCT00125138|21085020|P1|STARTED|Overall Study||15
8551738|NCT00125034|21085036|P2|NOT COMPLETED|Overall Study||0
8551739|NCT00125034|21085037|P1|NOT COMPLETED|Overall Study||0
8551740|NCT00125034|21085036|P2|COMPLETED|Overall Study||168
8551741|NCT00125034|21085037|P1|COMPLETED|Overall Study||170
8551742|NCT00125034|21085036|P2|STARTED|Overall Study|Randomized & treated|168
8551743|NCT00125034|21085037|P1|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
8551744|NCT00124982|21085069|P3|NOT COMPLETED|Long-term Period||89
8551745|NCT00124982|21085070|P2|NOT COMPLETED|Long-term Period||0
8551746|NCT00124982|21085071|P1|NOT COMPLETED|Long-term Period||0
8551747|NCT00124982|21085069|P3|COMPLETED|Long-term Period||441
8551748|NCT00124982|21085070|P2|COMPLETED|Long-term Period||0
8551749|NCT00124982|21085071|P1|COMPLETED|Long-term Period||0
8551750|NCT00124982|21085069|P3|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
8551751|NCT00124982|21085070|P2|STARTED|Long-term Period||0
8551752|NCT00124982|21085071|P1|STARTED|Long-term Period||0
8551753|NCT00124982|21085069|P3|NOT COMPLETED|Short-term Period||0
8551754|NCT00124982|21085070|P2|NOT COMPLETED|Short-term Period||114
8551755|NCT00124982|21085071|P1|NOT COMPLETED|Short-term Period||72
8551756|NCT00124982|21085069|P3|COMPLETED|Short-term Period||0
8551757|NCT00124982|21085070|P2|COMPLETED|Short-term Period||483
8551758|NCT00124982|21085071|P1|COMPLETED|Short-term Period||377
8551759|NCT00124982|21085069|P3|STARTED|Short-term Period||0
8551760|NCT00124982|21085070|P2|STARTED|Short-term Period||597
8551761|NCT00124982|21085071|P1|STARTED|Short-term Period||449
8551762|NCT00124943|21085153|P4|NOT COMPLETED|Phase II||5
8551763|NCT00124943|21085154|P3|NOT COMPLETED|Phase II||0
8551764|NCT00124943|21085155|P2|NOT COMPLETED|Phase II||2
8551765|NCT00124943|21085156|P1|NOT COMPLETED|Phase II||0
8551766|NCT00124943|21085153|P4|COMPLETED|Phase II||50
8551767|NCT00124943|21085154|P3|COMPLETED|Phase II||3
8551768|NCT00124943|21085155|P2|COMPLETED|Phase II||49
8551769|NCT00124943|21085156|P1|COMPLETED|Phase II||3
8551770|NCT00124943|21085153|P4|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
8551771|NCT00124943|21085154|P3|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
8551772|NCT00124943|21085155|P2|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
8551773|NCT00124943|21085156|P1|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
8551774|NCT00124943|21085153|P4|NOT COMPLETED|Phase I||0
8551775|NCT00124943|21085154|P3|NOT COMPLETED|Phase I||0
8551776|NCT00124943|21085155|P2|NOT COMPLETED|Phase I||0
8551777|NCT00124943|21085156|P1|NOT COMPLETED|Phase I||0
8551778|NCT00124943|21085153|P4|COMPLETED|Phase I||3
8551779|NCT00124943|21085154|P3|COMPLETED|Phase I||3
8551780|NCT00124943|21085155|P2|COMPLETED|Phase I||3
8551781|NCT00124943|21085156|P1|COMPLETED|Phase I||3
8551782|NCT00124943|21085153|P4|STARTED|Phase I||3
8551783|NCT00124943|21085154|P3|STARTED|Phase I||3
8551784|NCT00124943|21085155|P2|STARTED|Phase I||3
8551785|NCT00124943|21085156|P1|STARTED|Phase I||3
8551786|NCT00124917|21085194|P1|NOT COMPLETED|Overall Study||3
8551787|NCT00124917|21085194|P1|COMPLETED|Overall Study||3
8551788|NCT00124917|21085194|P1|STARTED|Overall Study||6
8551789|NCT00124748|21085204|P2|NOT COMPLETED|Overall Study||284
8551790|NCT00124748|21085205|P1|NOT COMPLETED|Overall Study||143
8551791|NCT00124748|21085204|P2|COMPLETED|Overall Study||35
8551792|NCT00124748|21085205|P1|COMPLETED|Overall Study||14
8551793|NCT00124748|21085204|P2|Safety Population|Overall Study||316
8551794|NCT00124748|21085205|P1|Safety Population|Overall Study||157
8551795|NCT00124748|21085204|P2|STARTED|Overall Study||319
8551796|NCT00124748|21085205|P1|STARTED|Overall Study||157
8551797|NCT00124735|21085257|P10|NOT COMPLETED|Overall Study||2
8551798|NCT00124735|21085258|P9|NOT COMPLETED|Overall Study||3
8551799|NCT00124735|21085259|P8|NOT COMPLETED|Overall Study||1
8551800|NCT00124735|21085260|P7|NOT COMPLETED|Overall Study||0
8551801|NCT00124735|21085261|P6|NOT COMPLETED|Overall Study||2
8551802|NCT00124735|21085262|P5|NOT COMPLETED|Overall Study||2
8551803|NCT00124735|21085263|P4|NOT COMPLETED|Overall Study||3
8551804|NCT00124735|21085264|P3|NOT COMPLETED|Overall Study||0
8551805|NCT00124735|21085265|P2|NOT COMPLETED|Overall Study||2
8551806|NCT00124735|21085266|P1|NOT COMPLETED|Overall Study||1
8551807|NCT00124735|21085257|P10|COMPLETED|Overall Study||18
8551808|NCT00124735|21085258|P9|COMPLETED|Overall Study||22
8551809|NCT00124735|21085259|P8|COMPLETED|Overall Study||19
8551810|NCT00124735|21085260|P7|COMPLETED|Overall Study||6
8551811|NCT00124735|21085261|P6|COMPLETED|Overall Study||5
8551812|NCT00124735|21085262|P5|COMPLETED|Overall Study||17
8551813|NCT00124735|21085263|P4|COMPLETED|Overall Study||18
8551814|NCT00124735|21085264|P3|COMPLETED|Overall Study||18
8551815|NCT00124735|21085265|P2|COMPLETED|Overall Study||6
8551816|NCT00124735|21085266|P1|COMPLETED|Overall Study||4
8551817|NCT00124735|21085257|P10|STARTED|Overall Study||20
8551818|NCT00124735|21085258|P9|STARTED|Overall Study||25
8551819|NCT00124735|21085259|P8|STARTED|Overall Study||20
8551820|NCT00124735|21085260|P7|STARTED|Overall Study||6
8551821|NCT00124735|21085261|P6|STARTED|Overall Study||7
8551822|NCT00124735|21085262|P5|STARTED|Overall Study||19
8551823|NCT00124735|21085263|P4|STARTED|Overall Study||21
8551824|NCT00124735|21085264|P3|STARTED|Overall Study||18
8551825|NCT00124735|21085265|P2|STARTED|Overall Study||8
8551826|NCT00124735|21085266|P1|STARTED|Overall Study||5
8551827|NCT00124709|21085312|P2|NOT COMPLETED|Overall Study||272
8551828|NCT00124709|21085313|P1|NOT COMPLETED|Overall Study||255
8551829|NCT00124709|21085312|P2|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
8551830|NCT00124709|21085313|P1|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
8551831|NCT00124709|21085312|P2|Patients Who Received Study Medication|Overall Study||544
8551832|NCT00124709|21085313|P1|Patients Who Received Study Medication|Overall Study||543
8551833|NCT00124709|21085312|P2|STARTED|Overall Study||545
8551834|NCT00124709|21085313|P1|STARTED|Overall Study||546
8551835|NCT00124657|21085330|P3|NOT COMPLETED|Overall Study||32
8551836|NCT00124657|21085331|P2|NOT COMPLETED|Overall Study||5
8551837|NCT00124657|21085332|P1|NOT COMPLETED|Overall Study||16
8551838|NCT00124657|21085330|P3|COMPLETED|Overall Study||7
8551839|NCT00124657|21085331|P2|COMPLETED|Overall Study||0
8551840|NCT00124657|21085332|P1|COMPLETED|Overall Study||2
8551841|NCT00124657|21085330|P3|STARTED|Overall Study||39
8551842|NCT00124657|21085331|P2|STARTED|Overall Study||5
8551843|NCT00124657|21085332|P1|STARTED|Overall Study||18
8551844|NCT00124618|21085367|P1|NOT COMPLETED|Overall Study||1
8551845|NCT00124618|21085367|P1|COMPLETED|Overall Study||57
8551846|NCT00124618|21085367|P1|STARTED|Overall Study||58
8551847|NCT00124579|21085374|P1|NOT COMPLETED|Maintenance||2
8551848|NCT00124579|21085374|P1|COMPLETED|Maintenance||0
8551849|NCT00124579|21085374|P1|STARTED|Maintenance||2
8551850|NCT00124579|21085374|P1|NOT COMPLETED|Induction||5
8551851|NCT00124579|21085374|P1|COMPLETED|Induction||2
8551852|NCT00124579|21085374|P1|STARTED|Induction||7
8551853|NCT00124514|21085385|P5|NOT COMPLETED|Overall Study||1
8551854|NCT00124514|21085386|P4|NOT COMPLETED|Overall Study||1
8551855|NCT00124514|21085387|P3|NOT COMPLETED|Overall Study||1
8551856|NCT00124514|21085388|P2|NOT COMPLETED|Overall Study||2
8551857|NCT00124514|21085389|P1|NOT COMPLETED|Overall Study||4
8551858|NCT00124514|21085385|P5|COMPLETED|Overall Study||1
8551859|NCT00124514|21085386|P4|COMPLETED|Overall Study||5
8551860|NCT00124514|21085387|P3|COMPLETED|Overall Study||7
8551861|NCT00124514|21085388|P2|COMPLETED|Overall Study||7
8551862|NCT00124514|21085389|P1|COMPLETED|Overall Study||2
8551863|NCT00124514|21085385|P5|STARTED|Overall Study||2
8551864|NCT00124514|21085386|P4|STARTED|Overall Study||6
8551865|NCT00124514|21085387|P3|STARTED|Overall Study||8
8551866|NCT00124514|21085388|P2|STARTED|Overall Study||9
8551867|NCT00124514|21085389|P1|STARTED|Overall Study||6
8551868|NCT00124462|21085399|P2|NOT COMPLETED|Overall Study||13
8551869|NCT00124462|21085400|P1|NOT COMPLETED|Overall Study||11
8551870|NCT00124462|21085399|P2|COMPLETED|Overall Study||27
8551871|NCT00124462|21085400|P1|COMPLETED|Overall Study||29
8551872|NCT00124462|21085399|P2|STARTED|Overall Study||40
8551873|NCT00124462|21085400|P1|STARTED|Overall Study||40
8551874|NCT00124449|21085410|P2|NOT COMPLETED|18-Month Untreated Observation Period||13
8551875|NCT00124449|21085411|P1|NOT COMPLETED|18-Month Untreated Observation Period||15
8551876|NCT00124449|21085410|P2|COMPLETED|18-Month Untreated Observation Period||4
8551877|NCT00124449|21085411|P1|COMPLETED|18-Month Untreated Observation Period||7
8551878|NCT00124449|21085410|P2|Completed Year 1 of Study|18-Month Untreated Observation Period||9
8551879|NCT00124449|21085411|P1|Completed Year 1 of Study|18-Month Untreated Observation Period||14
8551880|NCT00124449|21085410|P2|STARTED|18-Month Untreated Observation Period||17
8551881|NCT00124449|21085411|P1|STARTED|18-Month Untreated Observation Period||22
8551882|NCT00124449|21085410|P2|NOT COMPLETED|6-month Double-Blind Treatment Period||11
8551883|NCT00124449|21085411|P1|NOT COMPLETED|6-month Double-Blind Treatment Period||6
8551884|NCT00124449|21085410|P2|COMPLETED|6-month Double-Blind Treatment Period||17
8551885|NCT00124449|21085411|P1|COMPLETED|6-month Double-Blind Treatment Period||22
8551886|NCT00124449|21085410|P2|STARTED|6-month Double-Blind Treatment Period||28
8551887|NCT00124449|21085411|P1|STARTED|6-month Double-Blind Treatment Period||28
8551888|NCT00124176|21085446|P2|NOT COMPLETED|Overall Study||0
8551889|NCT00124176|21085447|P1|NOT COMPLETED|Overall Study||0
8551890|NCT00124176|21085446|P2|COMPLETED|Overall Study||41
8551891|NCT00124176|21085447|P1|COMPLETED|Overall Study||40
8551892|NCT00124176|21085446|P2|Received Study Drug|Overall Study||41
8551893|NCT00124176|21085447|P1|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
8551894|NCT00124176|21085446|P2|STARTED|Overall Study||41
8551895|NCT00124176|21085447|P1|STARTED|Overall Study||40
8551896|NCT00124072|21085465|P4|NOT COMPLETED|Overall Study||500
8551897|NCT00124072|21085466|P3|NOT COMPLETED|Overall Study||492
8551898|NCT00124072|21085467|P2|NOT COMPLETED|Overall Study||512
8551899|NCT00124072|21085468|P1|NOT COMPLETED|Overall Study||514
8551900|NCT00124072|21085465|P4|COMPLETED|Overall Study||2515
8551901|NCT00124072|21085466|P3|COMPLETED|Overall Study||2524
8551902|NCT00124072|21085467|P2|COMPLETED|Overall Study||2504
8551903|NCT00124072|21085468|P1|COMPLETED|Overall Study||2503
8551904|NCT00124072|21085465|P4|STARTED|Overall Study||3015
8551905|NCT00124072|21085466|P3|STARTED|Overall Study||3016
8551906|NCT00124072|21085467|P2|STARTED|Overall Study||3016
8551907|NCT00124072|21085468|P1|STARTED|Overall Study||3017
8551908|NCT00124020|21085480|P2|NOT COMPLETED|Overall Study||91
8551909|NCT00124020|21085481|P1|NOT COMPLETED|Overall Study||88
8551910|NCT00124020|21085480|P2|COMPLETED|Overall Study||289
8551911|NCT00124020|21085481|P1|COMPLETED|Overall Study||289
8551912|NCT00124020|21085480|P2|STARTED|Overall Study||380
8551913|NCT00124020|21085481|P1|STARTED|Overall Study||377
8551914|NCT00123955|21085489|P2|NOT COMPLETED|Overall Study||4
8551915|NCT00123955|21085490|P1|NOT COMPLETED|Overall Study||5
8551916|NCT00123955|21085489|P2|COMPLETED|Overall Study||34
8551917|NCT00123955|21085490|P1|COMPLETED|Overall Study||37
8551918|NCT00123955|21085489|P2|STARTED|Overall Study||38
8551919|NCT00123955|21085490|P1|STARTED|Overall Study||42
8551920|NCT00123734|21085502|P1|NOT COMPLETED|Overall Study||8
8551921|NCT00123734|21085502|P1|COMPLETED|Overall Study||74
8551922|NCT00123734|21085502|P1|STARTED|Overall Study||82
8551923|NCT00123682|21085537|P4|NOT COMPLETED|Overall Study||95
8551924|NCT00123682|21085538|P3|NOT COMPLETED|Overall Study||154
8551925|NCT00123682|21085539|P2|NOT COMPLETED|Overall Study||203
8551926|NCT00123682|21085540|P1|NOT COMPLETED|Overall Study||320
8551927|NCT00123682|21085537|P4|COMPLETED|Overall Study||430
8551928|NCT00123682|21085538|P3|COMPLETED|Overall Study||438
8551929|NCT00123682|21085539|P2|COMPLETED|Overall Study||731
8551930|NCT00123682|21085540|P1|COMPLETED|Overall Study||749
8551931|NCT00123682|21085537|P4|STARTED|Overall Study||525
8551932|NCT00123682|21085538|P3|STARTED|Overall Study||592
8551933|NCT00123682|21085539|P2|STARTED|Overall Study||934
8551934|NCT00123682|21085540|P1|STARTED|Overall Study||1069
8551935|NCT00123643|21085560|P2|NOT COMPLETED|Overall Study||0
8551936|NCT00123643|21085561|P1|NOT COMPLETED|Overall Study||0
8551937|NCT00123643|21085560|P2|COMPLETED|Overall Study||16
8551938|NCT00123643|21085561|P1|COMPLETED|Overall Study||20
8551939|NCT00123643|21085560|P2|STARTED|Overall Study||16
8551940|NCT00123643|21085561|P1|STARTED|Overall Study||20
8551941|NCT00123630|21085569|P2|NOT COMPLETED|Overall Study||0
8551942|NCT00123630|21085570|P1|NOT COMPLETED|Overall Study||0
8551943|NCT00123630|21085569|P2|COMPLETED|Overall Study||15
8551944|NCT00123630|21085570|P1|COMPLETED|Overall Study||15
8551945|NCT00123630|21085569|P2|STARTED|Overall Study||15
8551946|NCT00123630|21085570|P1|STARTED|Overall Study||15
8551947|NCT00123604|21085578|P2|NOT COMPLETED|Overall Study||1
8551948|NCT00123604|21085579|P1|NOT COMPLETED|Overall Study||1
8551949|NCT00123604|21085578|P2|COMPLETED|Overall Study||16
8551950|NCT00123604|21085579|P1|COMPLETED|Overall Study||18
8551951|NCT00123604|21085578|P2|STARTED|Overall Study||17
8551952|NCT00123604|21085579|P1|STARTED|Overall Study||19
8551953|NCT00123487|21085587|P2|NOT COMPLETED|Treated With Study Drug||305
8551954|NCT00123487|21085588|P1|NOT COMPLETED|Treated With Study Drug||304
8551955|NCT00123487|21085587|P2|COMPLETED|Treated With Study Drug||0
8551956|NCT00123487|21085588|P1|COMPLETED|Treated With Study Drug||0
8551957|NCT00123487|21085587|P2|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
8551958|NCT00123487|21085588|P1|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
8551959|NCT00123487|21085587|P2|NOT COMPLETED|Randomized||1
8551960|NCT00123487|21085588|P1|NOT COMPLETED|Randomized||1
8551961|NCT00123487|21085587|P2|COMPLETED|Randomized||304
8551962|NCT00123487|21085588|P1|COMPLETED|Randomized||305
8551963|NCT00123487|21085587|P2|STARTED|Randomized||305
8551964|NCT00123487|21085588|P1|STARTED|Randomized||306
8551965|NCT00123474|21085632|P4|NOT COMPLETED|As Treated at Study Closure||167
8551966|NCT00123474|21085633|P3|NOT COMPLETED|As Treated at Study Closure||167
8551967|NCT00123474|21085634|P2|NOT COMPLETED|As Treated at Study Closure||163
8551968|NCT00123474|21085635|P1|NOT COMPLETED|As Treated at Study Closure||165
8551969|NCT00123474|21085632|P4|COMPLETED|As Treated at Study Closure||0
8551970|NCT00123474|21085633|P3|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
8551971|NCT00123474|21085634|P2|COMPLETED|As Treated at Study Closure||0
8551972|NCT00123474|21085635|P1|COMPLETED|As Treated at Study Closure||0
8551973|NCT00123474|21085632|P4|STARTED|As Treated at Study Closure||167
8551974|NCT00123474|21085633|P3|STARTED|As Treated at Study Closure||167
8551975|NCT00123474|21085634|P2|STARTED|As Treated at Study Closure||163
8551976|NCT00123474|21085635|P1|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
8551977|NCT00123474|21085632|P4|NOT COMPLETED|Randomized to Treatment||1
8551978|NCT00123474|21085633|P3|NOT COMPLETED|Randomized to Treatment||2
8551979|NCT00123474|21085634|P2|NOT COMPLETED|Randomized to Treatment||4
8551980|NCT00123474|21085635|P1|NOT COMPLETED|Randomized to Treatment||1
8551981|NCT00123474|21085632|P4|COMPLETED|Randomized to Treatment||167
8551982|NCT00123474|21085633|P3|COMPLETED|Randomized to Treatment||166
8551983|NCT00123474|21085634|P2|COMPLETED|Randomized to Treatment||163
8551984|NCT00123474|21085635|P1|COMPLETED|Randomized to Treatment||166
8551985|NCT00123474|21085632|P4|STARTED|Randomized to Treatment||168
8551986|NCT00123474|21085633|P3|STARTED|Randomized to Treatment||168
8551987|NCT00123474|21085634|P2|STARTED|Randomized to Treatment||167
8551988|NCT00123474|21085635|P1|STARTED|Randomized to Treatment||167
8551989|NCT00123422|21085729|P3|NOT COMPLETED|Overall Study||10
8551990|NCT00123422|21085730|P2|NOT COMPLETED|Overall Study||6
8551991|NCT00123422|21085731|P1|NOT COMPLETED|Overall Study||4
8551992|NCT00123422|21085729|P3|COMPLETED|Overall Study||25
8551993|NCT00123422|21085730|P2|COMPLETED|Overall Study||27
8551994|NCT00123422|21085731|P1|COMPLETED|Overall Study||31
8551995|NCT00123422|21085729|P3|8-week Testing|Overall Study||27
8551996|NCT00123422|21085730|P2|8-week Testing|Overall Study||30
8551997|NCT00123422|21085731|P1|8-week Testing|Overall Study||32
8551998|NCT00123422|21085729|P3|STARTED|Overall Study||35
8551999|NCT00123422|21085730|P2|STARTED|Overall Study||33
8552000|NCT00123422|21085731|P1|STARTED|Overall Study||35
8552001|NCT00123409|21085744|P2|NOT COMPLETED|Overall Study||3
8552002|NCT00123409|21085745|P1|NOT COMPLETED|Overall Study||4
8552003|NCT00123409|21085744|P2|COMPLETED|Overall Study||71
8552004|NCT00123409|21085745|P1|COMPLETED|Overall Study||68
8552005|NCT00123409|21085744|P2|STARTED|Overall Study||74
8552006|NCT00123409|21085745|P1|STARTED|Overall Study||72
8552007|NCT00123162|21085755|P2|NOT COMPLETED|Overall Study||0
8552008|NCT00123162|21085756|P1|NOT COMPLETED|Overall Study||0
8552009|NCT00123162|21085755|P2|COMPLETED|Overall Study||12
8552010|NCT00123162|21085756|P1|COMPLETED|Overall Study||13
8552011|NCT00123162|21085755|P2|STARTED|Overall Study||12
8552012|NCT00123162|21085756|P1|STARTED|Overall Study||13
8552022|NCT00123110|21085783|P3|NOT COMPLETED|Overall Study||0
8552023|NCT00123110|21085784|P2|NOT COMPLETED|Overall Study||0
8552024|NCT00123110|21085785|P1|NOT COMPLETED|Overall Study||0
8552025|NCT00123110|21085783|P3|COMPLETED|Overall Study||11
8552026|NCT00123110|21085784|P2|COMPLETED|Overall Study||12
8552027|NCT00123110|21085785|P1|COMPLETED|Overall Study||12
8552028|NCT00123110|21085783|P3|STARTED|Overall Study||11
8552029|NCT00123110|21085784|P2|STARTED|Overall Study||12
8552030|NCT00123110|21085785|P1|STARTED|Overall Study||12
8552031|NCT00122980|21085819|P2|NOT COMPLETED|Overall Study||40
8552032|NCT00122980|21085820|P1|NOT COMPLETED|Overall Study||43
8552033|NCT00122980|21085819|P2|COMPLETED|Overall Study|Study terminated early|26
8552034|NCT00122980|21085820|P1|COMPLETED|Overall Study|Study terminated early|24
8552035|NCT00122980|21085819|P2|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
8552036|NCT00122980|21085820|P1|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
8552037|NCT00122954|21085844|P2|NOT COMPLETED|Overall Study||3
8552038|NCT00122954|21085845|P1|NOT COMPLETED|Overall Study||2
8552039|NCT00122954|21085844|P2|COMPLETED|Overall Study||18
8552040|NCT00122954|21085845|P1|COMPLETED|Overall Study||16
8552041|NCT00122954|21085844|P2|STARTED|Overall Study||21
8552042|NCT00122954|21085845|P1|STARTED|Overall Study||18
8552043|NCT00122681|21085855|P2|NOT COMPLETED|Overall Study||1521
8552044|NCT00122681|21085856|P1|NOT COMPLETED|Overall Study||1514
8552045|NCT00122681|21085855|P2|COMPLETED|Overall Study||7798
8552046|NCT00122681|21085856|P1|COMPLETED|Overall Study||7811
8552047|NCT00122681|21085855|P2|STARTED|Overall Study||9319
8552048|NCT00122681|21085856|P1|STARTED|Overall Study||9325
8552049|NCT00122460|21085930|P2|NOT COMPLETED|Overall Study||1
8552050|NCT00122460|21085931|P1|NOT COMPLETED|Overall Study||7
8552051|NCT00122460|21085930|P2|COMPLETED|Overall Study||219
8552052|NCT00122460|21085931|P1|COMPLETED|Overall Study||215
8552053|NCT00122460|21085930|P2|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
8552054|NCT00122460|21085931|P1|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
8552055|NCT00122447|21085957|P4|NOT COMPLETED|Overall Study||3
8552056|NCT00122447|21085958|P3|NOT COMPLETED|Overall Study||1
8552057|NCT00122447|21085959|P2|NOT COMPLETED|Overall Study||5
8552058|NCT00122447|21085960|P1|NOT COMPLETED|Overall Study||1
8552059|NCT00122447|21085957|P4|COMPLETED|Overall Study||14
8552060|NCT00122447|21085958|P3|COMPLETED|Overall Study||16
8552061|NCT00122447|21085959|P2|COMPLETED|Overall Study||13
8552062|NCT00122447|21085960|P1|COMPLETED|Overall Study||17
8552063|NCT00122447|21085957|P4|STARTED|Overall Study||17
8552064|NCT00122447|21085958|P3|STARTED|Overall Study||17
8552065|NCT00122447|21085959|P2|STARTED|Overall Study||18
8552066|NCT00122447|21085960|P1|STARTED|Overall Study||18
8552067|NCT00122382|21085980|P3|NOT COMPLETED|Open-Label Study||26
8552068|NCT00122382|21085981|P2|NOT COMPLETED|Open-Label Study||0
8552069|NCT00122382|21085982|P1|NOT COMPLETED|Open-Label Study||0
8552070|NCT00122382|21085980|P3|COMPLETED|Open-Label Study||433
8552071|NCT00122382|21085981|P2|COMPLETED|Open-Label Study||0
8552072|NCT00122382|21085982|P1|COMPLETED|Open-Label Study||0
8552073|NCT00122382|21085980|P3|STARTED|Open-Label Study||459
8552074|NCT00122382|21085981|P2|STARTED|Open-Label Study||0
8552075|NCT00122382|21085982|P1|STARTED|Open-Label Study||0
8552076|NCT00122382|21085980|P3|NOT COMPLETED|Double-Blind Study||0
8552077|NCT00122382|21085981|P2|NOT COMPLETED|Double-Blind Study||28
8552078|NCT00122382|21085982|P1|NOT COMPLETED|Double-Blind Study||24
8552079|NCT00122382|21085980|P3|COMPLETED|Double-Blind Study||0
8552080|NCT00122382|21085981|P2|COMPLETED|Double-Blind Study||227
8552081|NCT00122382|21085982|P1|COMPLETED|Double-Blind Study||232
8552082|NCT00122382|21085980|P3|Treated|Double-Blind Study||0
8552083|NCT00122382|21085981|P2|Treated|Double-Blind Study||253
8552084|NCT00122382|21085982|P1|Treated|Double-Blind Study||256
8552085|NCT00122382|21085980|P3|STARTED|Double-Blind Study||0
8552086|NCT00122382|21085981|P2|STARTED|Double-Blind Study|participants randomized|255
8552087|NCT00122382|21085982|P1|STARTED|Double-Blind Study|participants randomized|256
8552088|NCT00122369|21086035|P3|NOT COMPLETED|Overall Study||0
8552089|NCT00122369|21086036|P2|NOT COMPLETED|Overall Study||0
8552090|NCT00122369|21086037|P1|NOT COMPLETED|Overall Study||0
8552091|NCT00122369|21086035|P3|COMPLETED|Overall Study||78
8552092|NCT00122369|21086036|P2|COMPLETED|Overall Study||82
8552093|NCT00122369|21086037|P1|COMPLETED|Overall Study||76
8552094|NCT00122369|21086035|P3|STARTED|Overall Study||78
8552095|NCT00122369|21086036|P2|STARTED|Overall Study||82
8552096|NCT00122369|21086037|P1|STARTED|Overall Study||76
8552097|NCT00122317|21086126|P1|NOT COMPLETED|Overall Study||11
8552098|NCT00122317|21086126|P1|COMPLETED|Overall Study||176
8552099|NCT00122317|21086126|P1|STARTED|Overall Study||187
8552100|NCT00122278|21086135|P2|NOT COMPLETED|Overall Study||0
8552101|NCT00122278|21086136|P1|NOT COMPLETED|Overall Study||2
8552102|NCT00122278|21086135|P2|COMPLETED|Overall Study||99
8552103|NCT00122278|21086136|P1|COMPLETED|Overall Study||104
8552104|NCT00122278|21086135|P2|STARTED|Overall Study||99
8552105|NCT00122278|21086136|P1|STARTED|Overall Study||106
8552106|NCT00122187|21086146|P2|NOT COMPLETED|Overall Study||2
8552107|NCT00122187|21086147|P1|NOT COMPLETED|Overall Study||2
8552108|NCT00122187|21086146|P2|COMPLETED|Overall Study||2
8552109|NCT00122187|21086147|P1|COMPLETED|Overall Study||2
8552110|NCT00122187|21086146|P2|Post-intervention Data Collection|Overall Study||2
8552111|NCT00122187|21086147|P1|Post-intervention Data Collection|Overall Study||2
8552112|NCT00122187|21086146|P2|Intervention Implemented|Overall Study||4
8552113|NCT00122187|21086147|P1|Intervention Implemented|Overall Study||3
8552114|NCT00122187|21086146|P2|Randomized to Intervention or Usual Care|Overall Study||4
8552115|NCT00122187|21086147|P1|Randomized to Intervention or Usual Care|Overall Study||4
8552116|NCT00122187|21086146|P2|Matched by Colonoscopy Volume|Overall Study||4
8552117|NCT00122187|21086147|P1|Matched by Colonoscopy Volume|Overall Study||4
8552118|NCT00122187|21086146|P2|STARTED|Overall Study||4
8552119|NCT00122187|21086147|P1|STARTED|Overall Study||4
8552120|NCT00122135|21086161|P2|NOT COMPLETED|Overall Study||0
8552121|NCT00122135|21086162|P1|NOT COMPLETED|Overall Study||3
8552122|NCT00122135|21086161|P2|COMPLETED|Overall Study||60
8552123|NCT00122135|21086162|P1|COMPLETED|Overall Study||57
8552124|NCT00122135|21086161|P2|STARTED|Overall Study||60
8552125|NCT00122135|21086162|P1|STARTED|Overall Study||60
8552126|NCT00122109|21086170|P2|NOT COMPLETED|Overall Study||7
8552127|NCT00122109|21086171|P1|NOT COMPLETED|Overall Study||6
8552128|NCT00122109|21086170|P2|COMPLETED|Overall Study||57
8552129|NCT00122109|21086171|P1|COMPLETED|Overall Study||55
8552130|NCT00122109|21086170|P2|STARTED|Overall Study|ITT|64
8552131|NCT00122109|21086171|P1|STARTED|Overall Study|ITT|61
8552132|NCT00121992|21086197|P2|NOT COMPLETED|Overall Study||11
8552133|NCT00121992|21086198|P1|NOT COMPLETED|Overall Study||2
8552134|NCT00121992|21086197|P2|COMPLETED|Overall Study||528
8552135|NCT00121992|21086198|P1|COMPLETED|Overall Study||519
8552136|NCT00121992|21086197|P2|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||103
8552137|NCT00121992|21086198|P1|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||92
8552138|NCT00121992|21086197|P2|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||220
8552139|NCT00121992|21086198|P1|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||209
8552140|NCT00121992|21086197|P2|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||22
8552141|NCT00121992|21086198|P1|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||24
8552142|NCT00121992|21086197|P2|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||30
8552143|NCT00121992|21086198|P1|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||28
8552144|NCT00121992|21086197|P2|STARTED|Overall Study||539
8552145|NCT00121992|21086198|P1|STARTED|Overall Study||521
8552146|NCT00121836|21086218|P1|NOT COMPLETED|Overall Study||55
8552147|NCT00121836|21086218|P1|COMPLETED|Overall Study||54
8552148|NCT00121836|21086218|P1|STARTED|Overall Study||109
8552149|NCT00121810|21086229|P2|NOT COMPLETED|Overall Study||39
8552150|NCT00121810|21086230|P1|NOT COMPLETED|Overall Study||30
8552151|NCT00121810|21086229|P2|COMPLETED|Overall Study||115
8552152|NCT00121810|21086230|P1|COMPLETED|Overall Study||121
8552153|NCT00121810|21086229|P2|Intent-to-Treat (ITT) Population|Overall Study||151
8552154|NCT00121810|21086230|P1|Intent-to-Treat (ITT) Population|Overall Study||148
8552155|NCT00121810|21086229|P2|Safety Population|Overall Study||153
8552156|NCT00121810|21086230|P1|Safety Population|Overall Study||148
8552157|NCT00121810|21086229|P2|STARTED|Overall Study||154
8552158|NCT00121810|21086230|P1|STARTED|Overall Study||151
8552159|NCT00121719|21086256|P14|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552160|NCT00121719|21086257|P13|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552161|NCT00121719|21086258|P12|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552162|NCT00121719|21086259|P11|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552163|NCT00121719|21086260|P10|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552164|NCT00121719|21086261|P9|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552165|NCT00121719|21086262|P8|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552166|NCT00121719|21086263|P7|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552167|NCT00121719|21086264|P6|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552168|NCT00121719|21086265|P5|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552169|NCT00121719|21086266|P4|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552170|NCT00121719|21086267|P3|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552171|NCT00121719|21086268|P2|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552172|NCT00121719|21086269|P1|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552173|NCT00121719|21086256|P14|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552174|NCT00121719|21086257|P13|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552175|NCT00121719|21086258|P12|COMPLETED|Food-Effect Pilot Study (4 Weeks)||5
8552176|NCT00121719|21086259|P11|COMPLETED|Food-Effect Pilot Study (4 Weeks)||6
8552177|NCT00121719|21086260|P10|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552178|NCT00121719|21086261|P9|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552179|NCT00121719|21086262|P8|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552180|NCT00121719|21086263|P7|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552181|NCT00121719|21086264|P6|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552182|NCT00121719|21086265|P5|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552183|NCT00121719|21086266|P4|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552184|NCT00121719|21086267|P3|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552185|NCT00121719|21086268|P2|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552186|NCT00121719|21086269|P1|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
8552187|NCT00121719|21086256|P14|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552188|NCT00121719|21086257|P13|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552189|NCT00121719|21086258|P12|STARTED|Food-Effect Pilot Study (4 Weeks)||5
8552190|NCT00121719|21086259|P11|STARTED|Food-Effect Pilot Study (4 Weeks)||6
8552191|NCT00121719|21086260|P10|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552192|NCT00121719|21086261|P9|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552193|NCT00121719|21086262|P8|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552194|NCT00121719|21086263|P7|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552195|NCT00121719|21086264|P6|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552196|NCT00121719|21086265|P5|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552197|NCT00121719|21086266|P4|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552198|NCT00121719|21086267|P3|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552199|NCT00121719|21086268|P2|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552200|NCT00121719|21086269|P1|STARTED|Food-Effect Pilot Study (4 Weeks)||0
8552201|NCT00121719|21086256|P14|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552202|NCT00121719|21086257|P13|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552203|NCT00121719|21086258|P12|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552204|NCT00121719|21086259|P11|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552205|NCT00121719|21086260|P10|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552206|NCT00121719|21086261|P9|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552207|NCT00121719|21086262|P8|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552208|NCT00121719|21086263|P7|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552209|NCT00121719|21086264|P6|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552210|NCT00121719|21086265|P5|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552211|NCT00121719|21086266|P4|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552212|NCT00121719|21086267|P3|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552213|NCT00121719|21086268|P2|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552214|NCT00121719|21086269|P1|NOT COMPLETED|Dose Escalation (4 Weeks)||0
8552215|NCT00121719|21086256|P14|COMPLETED|Dose Escalation (4 Weeks)||7
8552216|NCT00121719|21086257|P13|COMPLETED|Dose Escalation (4 Weeks)||24
8552217|NCT00121719|21086258|P12|COMPLETED|Dose Escalation (4 Weeks)||0
8552218|NCT00121719|21086259|P11|COMPLETED|Dose Escalation (4 Weeks)||0
8552219|NCT00121719|21086260|P10|COMPLETED|Dose Escalation (4 Weeks)||3
8552220|NCT00121719|21086261|P9|COMPLETED|Dose Escalation (4 Weeks)||6
8552221|NCT00121719|21086262|P8|COMPLETED|Dose Escalation (4 Weeks)||9
8552222|NCT00121719|21086263|P7|COMPLETED|Dose Escalation (4 Weeks)||12
8552223|NCT00121719|21086264|P6|COMPLETED|Dose Escalation (4 Weeks)||3
8552224|NCT00121719|21086265|P5|COMPLETED|Dose Escalation (4 Weeks)||3
8552225|NCT00121719|21086266|P4|COMPLETED|Dose Escalation (4 Weeks)||3
8552226|NCT00121719|21086267|P3|COMPLETED|Dose Escalation (4 Weeks)||4
8552227|NCT00121719|21086268|P2|COMPLETED|Dose Escalation (4 Weeks)||4
8552228|NCT00121719|21086269|P1|COMPLETED|Dose Escalation (4 Weeks)||4
8552229|NCT00121719|21086256|P14|STARTED|Dose Escalation (4 Weeks)||7
8552230|NCT00121719|21086257|P13|STARTED|Dose Escalation (4 Weeks)||24
8552231|NCT00121719|21086258|P12|STARTED|Dose Escalation (4 Weeks)||0
8552232|NCT00121719|21086259|P11|STARTED|Dose Escalation (4 Weeks)||0
8552233|NCT00121719|21086260|P10|STARTED|Dose Escalation (4 Weeks)||3
8552234|NCT00121719|21086261|P9|STARTED|Dose Escalation (4 Weeks)||6
8552235|NCT00121719|21086262|P8|STARTED|Dose Escalation (4 Weeks)||9
8552236|NCT00121719|21086263|P7|STARTED|Dose Escalation (4 Weeks)||12
8552237|NCT00121719|21086264|P6|STARTED|Dose Escalation (4 Weeks)||3
8552238|NCT00121719|21086265|P5|STARTED|Dose Escalation (4 Weeks)||3
8552239|NCT00121719|21086266|P4|STARTED|Dose Escalation (4 Weeks)||3
8552240|NCT00121719|21086267|P3|STARTED|Dose Escalation (4 Weeks)||4
8552241|NCT00121719|21086268|P2|STARTED|Dose Escalation (4 Weeks)||4
8552242|NCT00121719|21086269|P1|STARTED|Dose Escalation (4 Weeks)||4
8552243|NCT00121667|21086460|P4|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
8552244|NCT00121667|21086461|P3|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
8552245|NCT00121667|21086462|P2|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
8552246|NCT00121667|21086463|P1|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
8552247|NCT00121667|21086460|P4|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
8552248|NCT00121667|21086461|P3|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
8552249|NCT00121667|21086462|P2|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
8552250|NCT00121667|21086463|P1|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
8552251|NCT00121667|21086460|P4|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
8552252|NCT00121667|21086461|P3|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
8552253|NCT00121667|21086462|P2|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
8552254|NCT00121667|21086463|P1|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
8552255|NCT00121667|21086460|P4|STARTED|Short Term (ST) + Long Term (LT) Period||179
8552256|NCT00121667|21086461|P3|STARTED|Short Term (ST) + Long Term (LT) Period||181
8552257|NCT00121667|21086462|P2|STARTED|Short Term (ST) + Long Term (LT) Period||191
8552258|NCT00121667|21086463|P1|STARTED|Short Term (ST) + Long Term (LT) Period||192
8552259|NCT00121667|21086460|P4|NOT COMPLETED|Short Term (ST) Period||67
8552260|NCT00121667|21086461|P3|NOT COMPLETED|Short Term (ST) Period||41
8552261|NCT00121667|21086462|P2|NOT COMPLETED|Short Term (ST) Period||48
8552262|NCT00121667|21086463|P1|NOT COMPLETED|Short Term (ST) Period||44
8552263|NCT00121667|21086460|P4|COMPLETED|Short Term (ST) Period||112
8552264|NCT00121667|21086461|P3|COMPLETED|Short Term (ST) Period||140
8552265|NCT00121667|21086462|P2|COMPLETED|Short Term (ST) Period||143
8552266|NCT00121667|21086463|P1|COMPLETED|Short Term (ST) Period||148
8552267|NCT00121667|21086460|P4|STARTED|Short Term (ST) Period||179
8552268|NCT00121667|21086461|P3|STARTED|Short Term (ST) Period||181
8552269|NCT00121667|21086462|P2|STARTED|Short Term (ST) Period||191
8552270|NCT00121667|21086463|P1|STARTED|Short Term (ST) Period||192
8552271|NCT00121641|21086561|P5|NOT COMPLETED|48-month Short Term + Long Term Period||58
8552272|NCT00121641|21086562|P4|NOT COMPLETED|48-month Short Term + Long Term Period||71
8552273|NCT00121641|21086563|P3|NOT COMPLETED|48-month Short Term + Long Term Period||70
8552274|NCT00121641|21086564|P2|NOT COMPLETED|48-month Short Term + Long Term Period||82
8552275|NCT00121641|21086565|P1|NOT COMPLETED|48-month Short Term + Long Term Period||79
8552276|NCT00121641|21086561|P5|COMPLETED|48-month Short Term + Long Term Period||8
8552277|NCT00121641|21086562|P4|COMPLETED|48-month Short Term + Long Term Period||24
8552278|NCT00121641|21086563|P3|COMPLETED|48-month Short Term + Long Term Period||28
8552279|NCT00121641|21086564|P2|COMPLETED|48-month Short Term + Long Term Period||24
8552280|NCT00121641|21086565|P1|COMPLETED|48-month Short Term + Long Term Period||23
8552281|NCT00121641|21086561|P5|STARTED|48-month Short Term + Long Term Period||66
8552282|NCT00121641|21086562|P4|STARTED|48-month Short Term + Long Term Period||95
8552283|NCT00121641|21086563|P3|STARTED|48-month Short Term + Long Term Period||98
8552284|NCT00121641|21086564|P2|STARTED|48-month Short Term + Long Term Period||106
8552285|NCT00121641|21086565|P1|STARTED|48-month Short Term + Long Term Period||102
8552286|NCT00121641|21086561|P5|NOT COMPLETED|24-week Short-term Treatment Period||41
8552287|NCT00121641|21086562|P4|NOT COMPLETED|24-week Short-term Treatment Period||40
8552288|NCT00121641|21086563|P3|NOT COMPLETED|24-week Short-term Treatment Period||29
8552289|NCT00121641|21086564|P2|NOT COMPLETED|24-week Short-term Treatment Period||38
8552290|NCT00121641|21086565|P1|NOT COMPLETED|24-week Short-term Treatment Period||29
8552291|NCT00121641|21086561|P5|COMPLETED|24-week Short-term Treatment Period||25
8552292|NCT00121641|21086562|P4|COMPLETED|24-week Short-term Treatment Period||55
8552293|NCT00121641|21086563|P3|COMPLETED|24-week Short-term Treatment Period||69
8552294|NCT00121641|21086564|P2|COMPLETED|24-week Short-term Treatment Period||68
8552295|NCT00121641|21086565|P1|COMPLETED|24-week Short-term Treatment Period||73
8552296|NCT00121641|21086561|P5|STARTED|24-week Short-term Treatment Period||66
8552297|NCT00121641|21086562|P4|STARTED|24-week Short-term Treatment Period||95
8552298|NCT00121641|21086563|P3|STARTED|24-week Short-term Treatment Period||98
8552299|NCT00121641|21086564|P2|STARTED|24-week Short-term Treatment Period||106
8552300|NCT00121641|21086565|P1|STARTED|24-week Short-term Treatment Period||102
8552301|NCT00121485|21086678|P2|NOT COMPLETED|Overall Study||7
8552302|NCT00121485|21086679|P1|NOT COMPLETED|Overall Study||1
8552303|NCT00121485|21086678|P2|COMPLETED|Overall Study||59
8552304|NCT00121485|21086679|P1|COMPLETED|Overall Study||133
8552305|NCT00121485|21086678|P2|STARTED|Overall Study||66
8552306|NCT00121485|21086679|P1|STARTED|Overall Study||134
8552307|NCT00121472|21086713|P1|NOT COMPLETED|Overall Study||0
8552308|NCT00121472|21086713|P1|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
8552309|NCT00121472|21086713|P1|STARTED|Overall Study||194
8552310|NCT00121238|21086724|P1|NOT COMPLETED|Overall Study||3
8552311|NCT00121238|21086724|P1|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
8552312|NCT00121238|21086724|P1|STARTED|Overall Study||16
8552313|NCT00121225|21086732|P1|NOT COMPLETED|Overall Study||0
8552314|NCT00121225|21086732|P1|COMPLETED|Overall Study||32
8552315|NCT00121225|21086732|P1|STARTED|Overall Study||32
8552316|NCT00121199|21086740|P1|NOT COMPLETED|Overall Study||28
8552317|NCT00121199|21086740|P1|COMPLETED|Overall Study||45
8552318|NCT00121199|21086740|P1|Eligible and Began Protocol Therapy|Overall Study||64
8552319|NCT00121199|21086740|P1|Eligible|Overall Study||64
8552320|NCT00121199|21086740|P1|STARTED|Overall Study||73
8552321|NCT00121186|21086747|P1|NOT COMPLETED|Overall Study||0
8552322|NCT00121186|21086747|P1|COMPLETED|Overall Study||1
8552323|NCT00121186|21086747|P1|STARTED|Overall Study||1
8552324|NCT00121173|21086755|P3|NOT COMPLETED|Overall Study||0
8552325|NCT00121173|21086756|P2|NOT COMPLETED|Overall Study||0
8552326|NCT00121173|21086757|P1|NOT COMPLETED|Overall Study||1
8552327|NCT00121173|21086755|P3|COMPLETED|Overall Study||9
8552328|NCT00121173|21086756|P2|COMPLETED|Overall Study||3
8552329|NCT00121173|21086757|P1|COMPLETED|Overall Study||3
8552330|NCT00121173|21086755|P3|STARTED|Overall Study||9
8552331|NCT00121173|21086756|P2|STARTED|Overall Study||3
8552332|NCT00121173|21086757|P1|STARTED|Overall Study||4
8552333|NCT00121134|21086784|P4|NOT COMPLETED|Overall Study||9
8552334|NCT00121134|21086785|P3|NOT COMPLETED|Overall Study||21
8552335|NCT00121134|21086786|P2|NOT COMPLETED|Overall Study||15
8552336|NCT00121134|21086787|P1|NOT COMPLETED|Overall Study||16
8552337|NCT00121134|21086784|P4|COMPLETED|Overall Study||31
8552338|NCT00121134|21086785|P3|COMPLETED|Overall Study||20
8552339|NCT00121134|21086786|P2|COMPLETED|Overall Study||26
8552340|NCT00121134|21086787|P1|COMPLETED|Overall Study||24
8552341|NCT00121134|21086784|P4|STARTED|Overall Study||40
8552342|NCT00121134|21086785|P3|STARTED|Overall Study||41
8552343|NCT00121134|21086786|P2|STARTED|Overall Study||41
8552344|NCT00121134|21086787|P1|STARTED|Overall Study||40
8552345|NCT00120874|21086799|P2|NOT COMPLETED|Overall Study||1
8552346|NCT00120874|21086800|P1|NOT COMPLETED|Overall Study||0
8552347|NCT00120874|21086799|P2|COMPLETED|Overall Study||9
8552348|NCT00120874|21086800|P1|COMPLETED|Overall Study||10
8552349|NCT00120874|21086799|P2|Completed Study; Started Extension Study|Overall Study||10
8552350|NCT00120874|21086800|P1|Completed Study; Started Extension Study|Overall Study||10
8552351|NCT00120874|21086799|P2|STARTED|Overall Study||10
8552352|NCT00120874|21086800|P1|STARTED|Overall Study||10
8552353|NCT00120627|21086838|P2|NOT COMPLETED|Overall Study||5
8552354|NCT00120627|21086839|P1|NOT COMPLETED|Overall Study||5
8552355|NCT00120627|21086838|P2|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
8552356|NCT00120627|21086839|P1|COMPLETED|Overall Study||66
8552357|NCT00120627|21086838|P2|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
8552358|NCT00120627|21086839|P1|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
8552359|NCT00120627|21086838|P2|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
8552360|NCT00120627|21086839|P1|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
8552361|NCT00120627|21086838|P2|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
8552450|NCT00119158|21087049|P2|COMPLETED|Placebo Treatment||45
8552362|NCT00120627|21086839|P1|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
8552363|NCT00120523|21086865|P2|NOT COMPLETED|Follow-Up Period||24
8552364|NCT00120523|21086866|P1|NOT COMPLETED|Follow-Up Period||30
8552365|NCT00120523|21086865|P2|COMPLETED|Follow-Up Period||46
8552366|NCT00120523|21086866|P1|COMPLETED|Follow-Up Period||90
8552367|NCT00120523|21086865|P2|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
8552368|NCT00120523|21086866|P1|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
8552369|NCT00120523|21086865|P2|NOT COMPLETED|Treatment Period||339
8552370|NCT00120523|21086866|P1|NOT COMPLETED|Treatment Period||369
8552371|NCT00120523|21086865|P2|COMPLETED|Treatment Period||874
8552372|NCT00120523|21086866|P1|COMPLETED|Treatment Period||836
8552373|NCT00120523|21086865|P2|STARTED|Treatment Period||1213
8552374|NCT00120523|21086866|P1|STARTED|Treatment Period||1205
8552375|NCT00120406|21086890|P2|NOT COMPLETED|Overall Study||16
8552376|NCT00120406|21086891|P1|NOT COMPLETED|Overall Study||19
8552377|NCT00120406|21086890|P2|COMPLETED|Overall Study||222
8552378|NCT00120406|21086891|P1|COMPLETED|Overall Study||217
8552379|NCT00120406|21086890|P2|STARTED|Overall Study||238
8552380|NCT00120406|21086891|P1|STARTED|Overall Study||236
8552381|NCT00120289|21086901|P2|NOT COMPLETED|Overall Study||109
8552382|NCT00120289|21086902|P1|NOT COMPLETED|Overall Study||121
8552383|NCT00120289|21086901|P2|COMPLETED|Overall Study||1587
8552384|NCT00120289|21086902|P1|COMPLETED|Overall Study||1597
8552385|NCT00120289|21086901|P2|STARTED|Overall Study||1696
8552386|NCT00120289|21086902|P1|STARTED|Overall Study||1718
8552387|NCT00120250|21086914|P2|NOT COMPLETED|Overall Study||2
8552388|NCT00120250|21086915|P1|NOT COMPLETED|Overall Study||1
8552389|NCT00120250|21086914|P2|COMPLETED|Overall Study||12
8552390|NCT00120250|21086915|P1|COMPLETED|Overall Study||12
8552391|NCT00120250|21086914|P2|STARTED|Overall Study||14
8552392|NCT00120250|21086915|P1|STARTED|Overall Study||13
8552393|NCT00120042|21086931|P3|NOT COMPLETED|Overall Study||0
8552394|NCT00120042|21086932|P2|NOT COMPLETED|Overall Study||0
8552395|NCT00120042|21086933|P1|NOT COMPLETED|Overall Study||0
8552396|NCT00120042|21086931|P3|COMPLETED|Overall Study||83
8552397|NCT00120042|21086932|P2|COMPLETED|Overall Study||83
8552398|NCT00120042|21086933|P1|COMPLETED|Overall Study||85
8552399|NCT00120042|21086931|P3|STARTED|Overall Study||83
8552400|NCT00120042|21086932|P2|STARTED|Overall Study||83
8552401|NCT00120042|21086933|P1|STARTED|Overall Study||85
8552402|NCT00119847|21086943|P2|NOT COMPLETED|Overall Study||32
8552403|NCT00119847|21086944|P1|NOT COMPLETED|Overall Study||31
8552404|NCT00119847|21086943|P2|COMPLETED|Overall Study||119
8552405|NCT00119847|21086944|P1|COMPLETED|Overall Study||118
8552406|NCT00119847|21086943|P2|STARTED|Overall Study||151
8552407|NCT00119847|21086944|P1|STARTED|Overall Study||149
8552408|NCT00119678|21086956|P2|NOT COMPLETED|Open-label Treatment Period||0
8552409|NCT00119678|21086957|P1|NOT COMPLETED|Open-label Treatment Period||110
8552410|NCT00119678|21086956|P2|COMPLETED|Open-label Treatment Period||0
8552411|NCT00119678|21086957|P1|COMPLETED|Open-label Treatment Period||0
8552412|NCT00119678|21086956|P2|STARTED|Open-label Treatment Period||0
8552413|NCT00119678|21086957|P1|STARTED|Open-label Treatment Period|Number of participants treated|110
8552414|NCT00119678|21086956|P2|NOT COMPLETED|Double-blind Treatment Period||26
8552415|NCT00119678|21086957|P1|NOT COMPLETED|Double-blind Treatment Period||41
8552416|NCT00119678|21086956|P2|COMPLETED|Double-blind Treatment Period||35
8552417|NCT00119678|21086957|P1|COMPLETED|Double-blind Treatment Period||81
8552418|NCT00119678|21086956|P2|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
8552419|NCT00119678|21086957|P1|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
8552420|NCT00119678|21086956|P2|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
8552421|NCT00119678|21086957|P1|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
8552422|NCT00119678|21086956|P2|STARTED|Double-blind Treatment Period||61
8552423|NCT00119678|21086957|P1|STARTED|Double-blind Treatment Period||122
8552424|NCT00119405|21087003|P1|NOT COMPLETED|Overall Study||1
8552425|NCT00119405|21087003|P1|COMPLETED|Overall Study||17
8552426|NCT00119405|21087003|P1|STARTED|Overall Study||18
8552427|NCT00119392|21087007|P1|NOT COMPLETED|Overall Study||5
8552428|NCT00119392|21087007|P1|COMPLETED|Overall Study||40
8552429|NCT00119392|21087007|P1|STARTED|Overall Study||45
8552430|NCT00119379|21087017|P2|NOT COMPLETED|Overall Study||1
8552431|NCT00119379|21087018|P1|NOT COMPLETED|Overall Study||4
8552432|NCT00119379|21087017|P2|COMPLETED|Overall Study||23
8552433|NCT00119379|21087018|P1|COMPLETED|Overall Study||22
8552434|NCT00119379|21087017|P2|STARTED|Overall Study||24
8552435|NCT00119379|21087018|P1|STARTED|Overall Study||26
8552436|NCT00119262|21087036|P2|NOT COMPLETED|Overall Study||58
8552437|NCT00119262|21087037|P1|NOT COMPLETED|Overall Study||46
8552438|NCT00119262|21087036|P2|COMPLETED|Overall Study||64
8552439|NCT00119262|21087037|P1|COMPLETED|Overall Study||58
8552440|NCT00119262|21087036|P2|Eligible and Treated|Overall Study||119
8552441|NCT00119262|21087037|P1|Eligible and Treated|Overall Study||102
8552442|NCT00119262|21087036|P2|Treated|Overall Study||120
8552443|NCT00119262|21087037|P1|Treated|Overall Study||103
8552444|NCT00119262|21087036|P2|Eligible|Overall Study||120
8552445|NCT00119262|21087037|P1|Eligible|Overall Study||103
8552446|NCT00119262|21087036|P2|STARTED|Overall Study||122
8552447|NCT00119262|21087037|P1|STARTED|Overall Study||104
8552448|NCT00119158|21087049|P2|NOT COMPLETED|Placebo Treatment||0
8552449|NCT00119158|21087050|P1|NOT COMPLETED|Placebo Treatment||0
8552451|NCT00119158|21087050|P1|COMPLETED|Placebo Treatment||45
8552452|NCT00119158|21087049|P2|STARTED|Placebo Treatment||45
8552453|NCT00119158|21087050|P1|STARTED|Placebo Treatment||45
8552454|NCT00119158|21087049|P2|NOT COMPLETED|Active Treatment||0
8552455|NCT00119158|21087050|P1|NOT COMPLETED|Active Treatment||0
8552456|NCT00119158|21087049|P2|COMPLETED|Active Treatment||45
8552457|NCT00119158|21087050|P1|COMPLETED|Active Treatment||45
8552458|NCT00119158|21087049|P2|STARTED|Active Treatment||45
8552459|NCT00119158|21087050|P1|STARTED|Active Treatment|patients are self controls|45
8552466|NCT00119041|21087084|P3|NOT COMPLETED|Overall Study||0
8552467|NCT00119041|21087085|P2|NOT COMPLETED|Overall Study||0
8552468|NCT00119041|21087086|P1|NOT COMPLETED|Overall Study||0
8552469|NCT00119041|21087084|P3|COMPLETED|Overall Study||22
8552470|NCT00119041|21087085|P2|COMPLETED|Overall Study||83
8552471|NCT00119041|21087086|P1|COMPLETED|Overall Study||199
8552472|NCT00119041|21087084|P3|STARTED|Overall Study||22
8552473|NCT00119041|21087085|P2|STARTED|Overall Study||83
8552474|NCT00119041|21087086|P1|STARTED|Overall Study||199
8552475|NCT00119015|21087097|P3|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
8552476|NCT00119015|21087098|P2|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
8552477|NCT00119015|21087099|P1|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
8552478|NCT00119015|21087097|P3|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
8552479|NCT00119015|21087098|P2|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
8552480|NCT00119015|21087099|P1|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
8552481|NCT00119015|21087097|P3|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
8552482|NCT00119015|21087098|P2|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
8552483|NCT00119015|21087099|P1|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
8552484|NCT00119015|21087097|P3|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
8552485|NCT00119015|21087098|P2|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
8552486|NCT00119015|21087099|P1|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
8552487|NCT00119015|21087097|P3|COMPLETED|Open-Label Phase (2 Weeks)||0
8552488|NCT00119015|21087098|P2|COMPLETED|Open-Label Phase (2 Weeks)||0
8552489|NCT00119015|21087099|P1|COMPLETED|Open-Label Phase (2 Weeks)||54
8552490|NCT00119015|21087097|P3|STARTED|Open-Label Phase (2 Weeks)||0
8552491|NCT00119015|21087098|P2|STARTED|Open-Label Phase (2 Weeks)||0
8552492|NCT00119015|21087099|P1|STARTED|Open-Label Phase (2 Weeks)||102
8552493|NCT00118911|21087115|P2|NOT COMPLETED|Overall Study||5
8552494|NCT00118911|21087116|P1|NOT COMPLETED|Overall Study||2
8552495|NCT00118911|21087115|P2|COMPLETED|Overall Study||38
8552496|NCT00118911|21087116|P1|COMPLETED|Overall Study||41
8552497|NCT00118911|21087115|P2|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
8552498|NCT00118911|21087116|P1|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
8552499|NCT00118911|21087115|P2|6 Month Follow-up|Overall Study||30
8552500|NCT00118911|21087116|P1|6 Month Follow-up|Overall Study||37
8552501|NCT00118911|21087115|P2|Completed Post-Treatment Assessment|Overall Study||37
8552502|NCT00118911|21087116|P1|Completed Post-Treatment Assessment|Overall Study||41
8552503|NCT00118911|21087115|P2|Received Intervention as Assigned|Overall Study||38
8552504|NCT00118911|21087116|P1|Received Intervention as Assigned|Overall Study||41
8552505|NCT00118911|21087115|P2|STARTED|Overall Study||43
8552506|NCT00118911|21087116|P1|STARTED|Overall Study||43
8552507|NCT00118898|21087128|P4|NOT COMPLETED|Overall Study||141
8552508|NCT00118898|21087129|P3|NOT COMPLETED|Overall Study||123
8552509|NCT00118898|21087130|P2|NOT COMPLETED|Overall Study||141
8552510|NCT00118898|21087131|P1|NOT COMPLETED|Overall Study||121
8552511|NCT00118898|21087128|P4|COMPLETED|Overall Study||322
8552512|NCT00118898|21087129|P3|COMPLETED|Overall Study||342
8552513|NCT00118898|21087130|P2|COMPLETED|Overall Study||324
8552514|NCT00118898|21087131|P1|COMPLETED|Overall Study||343
8552515|NCT00118898|21087128|P4|Initiated Treatment|Overall Study||462
8552516|NCT00118898|21087129|P3|Initiated Treatment|Overall Study||464
8552517|NCT00118898|21087130|P2|Initiated Treatment|Overall Study||461
8552518|NCT00118898|21087131|P1|Initiated Treatment|Overall Study||461
8552519|NCT00118898|21087128|P4|STARTED|Overall Study||463
8552520|NCT00118898|21087129|P3|STARTED|Overall Study||465
8552521|NCT00118898|21087130|P2|STARTED|Overall Study||465
8552522|NCT00118898|21087131|P1|STARTED|Overall Study||464
8552523|NCT00118755|21087227|P2|NOT COMPLETED|Overall Study||215
8552524|NCT00118755|21087228|P1|NOT COMPLETED|Overall Study||210
8552525|NCT00118755|21087227|P2|COMPLETED|Overall Study||3
8552526|NCT00118755|21087228|P1|COMPLETED|Overall Study||7
8552527|NCT00118755|21087227|P2|Safety Population|Overall Study||211
8552528|NCT00118755|21087228|P1|Safety Population|Overall Study||208
8552529|NCT00118755|21087227|P2|STARTED|Overall Study||218
8552530|NCT00118755|21087228|P1|STARTED|Overall Study||217
8552531|NCT00118742|21087242|P2|NOT COMPLETED|Overall Study||66
8552532|NCT00118742|21087243|P1|NOT COMPLETED|Overall Study||49
8552533|NCT00118742|21087242|P2|COMPLETED|Overall Study||82
8552534|NCT00118742|21087243|P1|COMPLETED|Overall Study||96
8552535|NCT00118742|21087242|P2|STARTED|Overall Study||148
8552536|NCT00118742|21087243|P1|STARTED|Overall Study||145
8552537|NCT00118716|21087257|P2|NOT COMPLETED|Overall Study||22
8552538|NCT00118716|21087258|P1|NOT COMPLETED|Overall Study||13
8552539|NCT00118716|21087257|P2|COMPLETED|Overall Study||102
8552540|NCT00118716|21087258|P1|COMPLETED|Overall Study||111
8552541|NCT00118716|21087257|P2|STARTED|Overall Study||124
8552542|NCT00118716|21087258|P1|STARTED|Overall Study||124
8552543|NCT00118703|21087278|P2|NOT COMPLETED|Overall Study||9
8552544|NCT00118703|21087279|P1|NOT COMPLETED|Overall Study||5
8552545|NCT00118703|21087278|P2|COMPLETED|Overall Study||165
8552546|NCT00118703|21087279|P1|COMPLETED|Overall Study||168
8552547|NCT00118703|21087278|P2|STARTED|Overall Study||174
8552548|NCT00118703|21087279|P1|STARTED|Overall Study||173
8552549|NCT00118534|21087291|P2|NOT COMPLETED|Overall Study||0
8552550|NCT00118534|21087292|P1|NOT COMPLETED|Overall Study||0
8552551|NCT00118534|21087291|P2|COMPLETED|Overall Study||471
8552552|NCT00118534|21087292|P1|COMPLETED|Overall Study||472
8552553|NCT00118534|21087291|P2|STARTED|Overall Study||471
8552554|NCT00118534|21087292|P1|STARTED|Overall Study||472
8552555|NCT00118482|21087376|P2|NOT COMPLETED|Overall Study||29
8552556|NCT00118482|21087377|P1|NOT COMPLETED|Overall Study||30
8552557|NCT00118482|21087376|P2|COMPLETED|Overall Study||76
8552558|NCT00118482|21087377|P1|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
8552559|NCT00118482|21087376|P2|STARTED|Overall Study||105
8552560|NCT00118482|21087377|P1|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
8552561|NCT00118430|21087392|P3|NOT COMPLETED|Overall Study||28
8552562|NCT00118430|21087393|P2|NOT COMPLETED|Overall Study||24
8552563|NCT00118430|21087394|P1|NOT COMPLETED|Overall Study||21
8552564|NCT00118430|21087392|P3|COMPLETED|Overall Study||222
8552565|NCT00118430|21087393|P2|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
8552566|NCT00118430|21087394|P1|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
8552567|NCT00118430|21087392|P3|STARTED|Overall Study||250
8552568|NCT00118430|21087393|P2|STARTED|Overall Study||127
8552569|NCT00118430|21087394|P1|STARTED|Overall Study||123
8552570|NCT00118417|21087409|P2|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
8552571|NCT00118417|21087410|P1|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
8552572|NCT00118417|21087409|P2|COMPLETED|Phase III (Weeks 12 to 24)||9
8552573|NCT00118417|21087410|P1|COMPLETED|Phase III (Weeks 12 to 24)||8
8552574|NCT00118417|21087409|P2|STARTED|Phase III (Weeks 12 to 24)||10
8552575|NCT00118417|21087410|P1|STARTED|Phase III (Weeks 12 to 24)||9
8552576|NCT00118417|21087409|P2|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
8552577|NCT00118417|21087410|P1|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
8552578|NCT00118417|21087409|P2|COMPLETED|Phase II (Weeks 6 to 12)||10
8552579|NCT00118417|21087410|P1|COMPLETED|Phase II (Weeks 6 to 12)||9
8552580|NCT00118417|21087409|P2|STARTED|Phase II (Weeks 6 to 12)||13
8552581|NCT00118417|21087410|P1|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
8552582|NCT00118417|21087409|P2|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
8552583|NCT00118417|21087410|P1|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
8552584|NCT00118417|21087409|P2|COMPLETED|Phase I (Weeks 0 to 6)||0
8552585|NCT00118417|21087410|P1|COMPLETED|Phase I (Weeks 0 to 6)||21
8552586|NCT00118417|21087409|P2|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
8552587|NCT00118417|21087410|P1|STARTED|Phase I (Weeks 0 to 6)||39
8552588|NCT00118404|21087423|P3|NOT COMPLETED|Overall Study||20
8552589|NCT00118404|21087424|P2|NOT COMPLETED|Overall Study||16
8552590|NCT00118404|21087425|P1|NOT COMPLETED|Overall Study||24
8552591|NCT00118404|21087423|P3|COMPLETED|Overall Study||49
8552592|NCT00118404|21087424|P2|COMPLETED|Overall Study||70
8552593|NCT00118404|21087425|P1|COMPLETED|Overall Study||62
8552594|NCT00118404|21087423|P3|STARTED|Overall Study||69
8552595|NCT00118404|21087424|P2|STARTED|Overall Study||86
8552596|NCT00118404|21087425|P1|STARTED|Overall Study||86
8552597|NCT00118378|21087441|P2|NOT COMPLETED|Overall Study||8
8552598|NCT00118378|21087442|P1|NOT COMPLETED|Overall Study||2
8552599|NCT00118378|21087441|P2|COMPLETED|Overall Study||45
8552600|NCT00118378|21087442|P1|COMPLETED|Overall Study||60
8552601|NCT00118378|21087441|P2|STARTED|Overall Study||53
8552602|NCT00118378|21087442|P1|STARTED|Overall Study||62
8552603|NCT00118365|21087456|P2|NOT COMPLETED|Overall Study||60
8552604|NCT00118365|21087457|P1|NOT COMPLETED|Overall Study||59
8552605|NCT00118365|21087456|P2|COMPLETED|Overall Study||124
8552606|NCT00118365|21087457|P1|COMPLETED|Overall Study||132
8552607|NCT00118365|21087456|P2|STARTED|Overall Study||184
8552608|NCT00118365|21087457|P1|STARTED|Overall Study||191
8552609|NCT00118352|21087526|P3|NOT COMPLETED|Overall Study||0
8552610|NCT00118352|21087527|P2|NOT COMPLETED|Overall Study||0
8552611|NCT00118352|21087528|P1|NOT COMPLETED|Overall Study||0
8552612|NCT00118352|21087526|P3|COMPLETED|Overall Study||0
8552613|NCT00118352|21087527|P2|COMPLETED|Overall Study||0
8552614|NCT00118352|21087528|P1|COMPLETED|Overall Study||12
8552615|NCT00118352|21087526|P3|STARTED|Overall Study||0
8552616|NCT00118352|21087527|P2|STARTED|Overall Study||0
8552617|NCT00118352|21087528|P1|STARTED|Overall Study||12
8552618|NCT00118287|21087554|P1|NOT COMPLETED|Overall Study||2
8552619|NCT00118287|21087554|P1|COMPLETED|Overall Study||30
8552620|NCT00118287|21087554|P1|STARTED|Overall Study||32
8552621|NCT00118248|21087560|P2|NOT COMPLETED|Overall Study||0
8552622|NCT00118248|21087561|P1|NOT COMPLETED|Overall Study||0
8552623|NCT00118248|21087560|P2|COMPLETED|Overall Study||24
8552624|NCT00118248|21087561|P1|COMPLETED|Overall Study||17
8552625|NCT00118248|21087560|P2|STARTED|Overall Study||24
8552626|NCT00118248|21087561|P1|STARTED|Overall Study||17
8552627|NCT00118209|21087576|P2|NOT COMPLETED|Overall Study||21
8552628|NCT00118209|21087577|P1|NOT COMPLETED|Overall Study||12
8552629|NCT00118209|21087576|P2|COMPLETED|Overall Study||241
8552630|NCT00118209|21087577|P1|COMPLETED|Overall Study||250
8552631|NCT00118209|21087576|P2|Evaluable for Safety Analysis|Overall Study||237
8552632|NCT00118209|21087577|P1|Evaluable for Safety Analysis|Overall Study||243
8552633|NCT00118209|21087576|P2|Evaluable for Primary Endpoint|Overall Study||241
8552634|NCT00118209|21087577|P1|Evaluable for Primary Endpoint|Overall Study||250
8552635|NCT00118209|21087576|P2|STARTED|Overall Study||262
8552636|NCT00118209|21087577|P1|STARTED|Overall Study||262
8552637|NCT00118157|21087587|P1|NOT COMPLETED|Overall Study||12
8552638|NCT00118157|21087587|P1|COMPLETED|Overall Study||7
8552639|NCT00118157|21087587|P1|STARTED|Overall Study||19
8552640|NCT00118144|21087592|P1|NOT COMPLETED|Overall Study||1
8552641|NCT00118144|21087592|P1|COMPLETED|Overall Study||41
8552642|NCT00118144|21087592|P1|STARTED|Overall Study||42
8552643|NCT00118131|21087598|P1|NOT COMPLETED|Overall Study||0
8552644|NCT00118131|21087598|P1|COMPLETED|Overall Study||49
8552645|NCT00118131|21087598|P1|STARTED|Overall Study||49
8552646|NCT00118092|21087605|P1|NOT COMPLETED|Overall Study||2
8552647|NCT00118092|21087605|P1|COMPLETED|Overall Study||15
8552648|NCT00118092|21087605|P1|STARTED|Overall Study||17
8552649|NCT00118053|21087613|P1|NOT COMPLETED|Overall Study||0
8552650|NCT00118053|21087613|P1|COMPLETED|Overall Study||5
8552651|NCT00118053|21087613|P1|STARTED|Overall Study||5
8552661|NCT00117988|21087686|P1|NOT COMPLETED|Overall Study||4
8552662|NCT00117988|21087686|P1|COMPLETED|Overall Study||18
8552663|NCT00117988|21087686|P1|STARTED|Overall Study||22
8552664|NCT00117962|21087692|P2|NOT COMPLETED|Overall Study||25
8552665|NCT00117962|21087693|P1|NOT COMPLETED|Overall Study||22
8552666|NCT00117962|21087692|P2|COMPLETED|Overall Study||28
8552667|NCT00117962|21087693|P1|COMPLETED|Overall Study||26
8552668|NCT00117962|21087692|P2|STARTED|Overall Study||53
8552669|NCT00117962|21087693|P1|STARTED|Overall Study||48
8552670|NCT00117949|21087709|P4|NOT COMPLETED|Overall Study||24
8552671|NCT00117949|21087710|P3|NOT COMPLETED|Overall Study||24
8552672|NCT00117949|21087711|P2|NOT COMPLETED|Overall Study||24
8552673|NCT00117949|21087712|P1|NOT COMPLETED|Overall Study||10
8552674|NCT00117949|21087709|P4|COMPLETED|Overall Study||0
8552675|NCT00117949|21087710|P3|COMPLETED|Overall Study||0
8552676|NCT00117949|21087711|P2|COMPLETED|Overall Study||0
8552677|NCT00117949|21087712|P1|COMPLETED|Overall Study||0
8552678|NCT00117949|21087709|P4|STARTED|Overall Study||24
8552679|NCT00117949|21087710|P3|STARTED|Overall Study||24
8552680|NCT00117949|21087711|P2|STARTED|Overall Study||24
8552681|NCT00117949|21087712|P1|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
8552682|NCT00117845|21087746|P1|NOT COMPLETED|Overall Study||1
8552683|NCT00117845|21087746|P1|COMPLETED|Overall Study||16
8552684|NCT00117845|21087746|P1|STARTED|Overall Study||17
8552685|NCT00117806|21087753|P2|NOT COMPLETED|Overall Study||16
8552686|NCT00117806|21087754|P1|NOT COMPLETED|Overall Study||38
8552687|NCT00117806|21087753|P2|COMPLETED|Overall Study||60
8552688|NCT00117806|21087754|P1|COMPLETED|Overall Study||43
8552689|NCT00117806|21087753|P2|STARTED|Overall Study||76
8552690|NCT00117806|21087754|P1|STARTED|Overall Study||81
8552691|NCT00117793|21087764|P1|NOT COMPLETED|Overall Study||12
8552692|NCT00117793|21087764|P1|COMPLETED|Overall Study||5
8552693|NCT00117793|21087764|P1|STARTED|Overall Study||17
8552694|NCT00117715|21087779|P1|NOT COMPLETED|Overall Study||72
8552695|NCT00117715|21087779|P1|COMPLETED|Overall Study||49
8552696|NCT00117715|21087779|P1|5 Year|Overall Study||49
8552697|NCT00117715|21087779|P1|4.5 Year|Overall Study||55
8552698|NCT00117715|21087779|P1|4 Year|Overall Study||58
8552699|NCT00117715|21087779|P1|3.5 Year|Overall Study||60
8552700|NCT00117715|21087779|P1|3 Year|Overall Study||61
8552701|NCT00117715|21087779|P1|2.5 Year|Overall Study||70
8552702|NCT00117715|21087779|P1|2 Year|Overall Study||76
8552703|NCT00117715|21087779|P1|1.5 Year|Overall Study||85
8552704|NCT00117715|21087779|P1|1 Year|Overall Study||88
8552705|NCT00117715|21087779|P1|STARTED|Overall Study||121
8552706|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
8552707|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
8552708|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 433 - 480||41
8552709|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 433 - 480||80
8552710|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
8552711|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 433 - 480||82
8552712|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
8552713|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
8552714|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 385 - 432||44
8552715|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 385 - 432||82
8552790|NCT00117598|21087956|P2|COMPLETED|After Treament Cross Over||0
8552716|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
8552717|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
8552718|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
8552719|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
8552720|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 337 - 384||90
8552721|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 337 - 384||176
8552722|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 337 - 384||93
8552723|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 337 - 384||183
8552724|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
8552725|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
8552726|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 289 - 336||93
8552727|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 289 - 336||183
8552728|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 289 - 336||100
8552729|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 289 - 336||192
8552730|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
8552731|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
8552732|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 241 - 288||100
8552733|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 241 - 288||192
8552734|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 241 - 288||103
8552735|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 241 - 288||202
8552736|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
8552737|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
8552738|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 193 - 240||103
8552739|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 193 - 240||202
8552740|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 193 - 240||106
8552741|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 193 - 240||209
8552742|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
8552743|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
8552744|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 145 - 192||106
8552745|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 145 - 192||209
8552746|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 145 - 192||109
8552747|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 145 - 192||219
8552748|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
8552749|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
8552750|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 97 - 144||109
8552751|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 97 - 144||219
8552752|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 97 - 144||110
8552753|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 97 - 144||225
8552754|NCT00117676|21087787|P2|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
8552755|NCT00117676|21087788|P1|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
8552756|NCT00117676|21087787|P2|COMPLETED|Open-label Period: Weeks 49 - 96||110
8552757|NCT00117676|21087788|P1|COMPLETED|Open-label Period: Weeks 49 - 96||225
8552758|NCT00117676|21087787|P2|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
8552759|NCT00117676|21087788|P1|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
8552760|NCT00117676|21087787|P2|NOT COMPLETED|Double-blind Period Through Week 48||7
8552761|NCT00117676|21087788|P1|NOT COMPLETED|Double-blind Period Through Week 48||10
8552762|NCT00117676|21087787|P2|COMPLETED|Double-blind Period Through Week 48||121
8552763|NCT00117676|21087788|P1|COMPLETED|Double-blind Period Through Week 48||244
8552764|NCT00117676|21087787|P2|STARTED|Double-blind Period Through Week 48||128
8552765|NCT00117676|21087788|P1|STARTED|Double-blind Period Through Week 48||254
8552766|NCT00117637|21087877|P2|NOT COMPLETED|Second Intervention (Period 2)||22
8552767|NCT00117637|21087878|P1|NOT COMPLETED|Second Intervention (Period 2)||10
8552768|NCT00117637|21087877|P2|COMPLETED|Second Intervention (Period 2)||39
8552769|NCT00117637|21087878|P1|COMPLETED|Second Intervention (Period 2)||39
8552770|NCT00117637|21087877|P2|Subjects Received Treatment|Second Intervention (Period 2)||61
8552771|NCT00117637|21087878|P1|Subjects Received Treatment|Second Intervention (Period 2)||49
8552772|NCT00117637|21087877|P2|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
8552773|NCT00117637|21087878|P1|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
8552774|NCT00117637|21087877|P2|NOT COMPLETED|First Intervention (Period 1)||25
8552775|NCT00117637|21087878|P1|NOT COMPLETED|First Intervention (Period 1)||18
8552776|NCT00117637|21087877|P2|COMPLETED|First Intervention (Period 1)||67
8552777|NCT00117637|21087878|P1|COMPLETED|First Intervention (Period 1)||79
8552778|NCT00117637|21087877|P2|Subjects Received Treatment|First Intervention (Period 1)||90
8552779|NCT00117637|21087878|P1|Subjects Received Treatment|First Intervention (Period 1)||97
8552780|NCT00117637|21087877|P2|STARTED|First Intervention (Period 1)||92
8552781|NCT00117637|21087878|P1|STARTED|First Intervention (Period 1)||97
8552782|NCT00117598|21087953|P5|NOT COMPLETED|After Treament Cross Over||4
8552783|NCT00117598|21087954|P4|NOT COMPLETED|After Treament Cross Over||3
8552784|NCT00117598|21087955|P3|NOT COMPLETED|After Treament Cross Over||0
8552785|NCT00117598|21087956|P2|NOT COMPLETED|After Treament Cross Over||0
8552786|NCT00117598|21087957|P1|NOT COMPLETED|After Treament Cross Over||0
8552787|NCT00117598|21087953|P5|COMPLETED|After Treament Cross Over||0
8552788|NCT00117598|21087954|P4|COMPLETED|After Treament Cross Over||0
8552789|NCT00117598|21087955|P3|COMPLETED|After Treament Cross Over||0
8552791|NCT00117598|21087957|P1|COMPLETED|After Treament Cross Over||0
8552792|NCT00117598|21087953|P5|STARTED|After Treament Cross Over||4
8552793|NCT00117598|21087954|P4|STARTED|After Treament Cross Over||3
8552794|NCT00117598|21087955|P3|STARTED|After Treament Cross Over||0
8552795|NCT00117598|21087956|P2|STARTED|After Treament Cross Over||0
8552796|NCT00117598|21087957|P1|STARTED|After Treament Cross Over||0
8552797|NCT00117598|21087953|P5|NOT COMPLETED|Prior to Treatment Cross Over||0
8552798|NCT00117598|21087954|P4|NOT COMPLETED|Prior to Treatment Cross Over||0
8552799|NCT00117598|21087955|P3|NOT COMPLETED|Prior to Treatment Cross Over||52
8552800|NCT00117598|21087956|P2|NOT COMPLETED|Prior to Treatment Cross Over||53
8552801|NCT00117598|21087957|P1|NOT COMPLETED|Prior to Treatment Cross Over||57
8552802|NCT00117598|21087953|P5|COMPLETED|Prior to Treatment Cross Over||0
8552803|NCT00117598|21087954|P4|COMPLETED|Prior to Treatment Cross Over||0
8552804|NCT00117598|21087955|P3|COMPLETED|Prior to Treatment Cross Over||4
8552805|NCT00117598|21087956|P2|COMPLETED|Prior to Treatment Cross Over||3
8552806|NCT00117598|21087957|P1|COMPLETED|Prior to Treatment Cross Over||0
8552807|NCT00117598|21087953|P5|STARTED|Prior to Treatment Cross Over||0
8552808|NCT00117598|21087954|P4|STARTED|Prior to Treatment Cross Over||0
8552809|NCT00117598|21087955|P3|STARTED|Prior to Treatment Cross Over||56
8552810|NCT00117598|21087956|P2|STARTED|Prior to Treatment Cross Over||56
8552811|NCT00117598|21087957|P1|STARTED|Prior to Treatment Cross Over||57
8552812|NCT00117585|21087985|P1|NOT COMPLETED|Overall Study||0
8552813|NCT00117585|21087985|P1|COMPLETED|Overall Study||341
8552814|NCT00117585|21087985|P1|STARTED|Overall Study||341
8552815|NCT00117572|21087991|P2|NOT COMPLETED|Overall Study||6
8552816|NCT00117572|21087992|P1|NOT COMPLETED|Overall Study||6
8552817|NCT00117572|21087991|P2|COMPLETED|Overall Study||135
8552818|NCT00117572|21087992|P1|COMPLETED|Overall Study||138
8552819|NCT00117572|21087991|P2|STARTED|Overall Study||141
8552820|NCT00117572|21087992|P1|STARTED|Overall Study||144
8552821|NCT00117559|21088024|P2|NOT COMPLETED|Overall Study||1
8552822|NCT00117559|21088025|P1|NOT COMPLETED|Overall Study||1
8552823|NCT00117559|21088024|P2|COMPLETED|Overall Study||9
8552824|NCT00117559|21088025|P1|COMPLETED|Overall Study||8
8552825|NCT00117559|21088024|P2|STARTED|Overall Study||10
8552826|NCT00117559|21088025|P1|STARTED|Overall Study||9
8552827|NCT00117338|21088033|P2|NOT COMPLETED|Overall Study||4
8552828|NCT00117338|21088034|P1|NOT COMPLETED|Overall Study||5
8552829|NCT00117338|21088033|P2|COMPLETED|Overall Study||127
8552830|NCT00117338|21088034|P1|COMPLETED|Overall Study||140
8552831|NCT00117338|21088033|P2|STARTED|Overall Study||131
8552832|NCT00117338|21088034|P1|STARTED|Overall Study||145
8552833|NCT00117325|21088054|P2|NOT COMPLETED|Overall Study||12
8552834|NCT00117325|21088055|P1|NOT COMPLETED|Overall Study||13
8552835|NCT00117325|21088054|P2|COMPLETED|Overall Study||167
8552836|NCT00117325|21088055|P1|COMPLETED|Overall Study||160
8552837|NCT00117325|21088054|P2|STARTED|Overall Study||179
8552838|NCT00117325|21088055|P1|STARTED|Overall Study||173
8552839|NCT00117312|21088087|P4|NOT COMPLETED|Overall Study||21
8552840|NCT00117312|21088088|P3|NOT COMPLETED|Overall Study||24
8552841|NCT00117312|21088089|P2|NOT COMPLETED|Overall Study||20
8552842|NCT00117312|21088090|P1|NOT COMPLETED|Overall Study||10
8552843|NCT00117312|21088087|P4|COMPLETED|Overall Study||3
8552844|NCT00117312|21088088|P3|COMPLETED|Overall Study||0
8552845|NCT00117312|21088089|P2|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
8552846|NCT00117312|21088090|P1|COMPLETED|Overall Study||0
8552847|NCT00117312|21088087|P4|Started FE200486 CS06A|Overall Study||9
8552848|NCT00117312|21088088|P3|Started FE200486 CS06A|Overall Study||16
8552849|NCT00117312|21088089|P2|Started FE200486 CS06A|Overall Study||11
8552850|NCT00117312|21088090|P1|Started FE200486 CS06A|Overall Study||1
8552851|NCT00117312|21088087|P4|STARTED|Overall Study||24
8552852|NCT00117312|21088088|P3|STARTED|Overall Study||24
8552853|NCT00117312|21088089|P2|STARTED|Overall Study||24
8552854|NCT00117312|21088090|P1|STARTED|Overall Study||10
8552855|NCT00117286|21088106|P2|NOT COMPLETED|Overall Study||21
8552856|NCT00117286|21088107|P1|NOT COMPLETED|Overall Study||28
8552857|NCT00117286|21088106|P2|COMPLETED|Overall Study||6
8552858|NCT00117286|21088107|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
8552859|NCT00117286|21088106|P2|Switched to Higher Dose|Overall Study||17
8552860|NCT00117286|21088107|P1|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
8552861|NCT00117286|21088106|P2|STARTED|Overall Study||27
8552862|NCT00117286|21088107|P1|STARTED|Overall Study|Safety analysis set|30
8552863|NCT00117156|21088115|P1|NOT COMPLETED|Overall Study||11
8552864|NCT00117156|21088115|P1|COMPLETED|Overall Study||15
8552865|NCT00117156|21088115|P1|STARTED|Overall Study||26
8552866|NCT00117143|21088127|P4|NOT COMPLETED|Overall Study||0
8552867|NCT00117143|21088128|P3|NOT COMPLETED|Overall Study||0
8552868|NCT00117143|21088129|P2|NOT COMPLETED|Overall Study||0
8552869|NCT00117143|21088130|P1|NOT COMPLETED|Overall Study||0
8552870|NCT00117143|21088127|P4|COMPLETED|Overall Study||1
8552871|NCT00117143|21088128|P3|COMPLETED|Overall Study||7
8552872|NCT00117143|21088129|P2|COMPLETED|Overall Study||4
8552873|NCT00117143|21088130|P1|COMPLETED|Overall Study||4
8552874|NCT00117143|21088127|P4|Received Second Dose|Overall Study||0
8552875|NCT00117143|21088128|P3|Received Second Dose|Overall Study||6
8552876|NCT00117143|21088129|P2|Received Second Dose|Overall Study||4
8552877|NCT00117143|21088130|P1|Received Second Dose|Overall Study||4
8552878|NCT00117143|21088127|P4|Received First Dose|Overall Study||1
8552879|NCT00117143|21088128|P3|Received First Dose|Overall Study||7
8552880|NCT00117143|21088129|P2|Received First Dose|Overall Study||4
8552881|NCT00117143|21088130|P1|Received First Dose|Overall Study||4
8552882|NCT00117143|21088127|P4|STARTED|Overall Study||1
8552883|NCT00117143|21088128|P3|STARTED|Overall Study||7
8552884|NCT00117143|21088129|P2|STARTED|Overall Study||4
8552885|NCT00117143|21088130|P1|STARTED|Overall Study||4
8552886|NCT00116857|21088174|P2|NOT COMPLETED|Overall Study||4
8552887|NCT00116857|21088175|P1|NOT COMPLETED|Overall Study||3
8552888|NCT00116857|21088174|P2|COMPLETED|Overall Study||56
8552889|NCT00116857|21088175|P1|COMPLETED|Overall Study||59
8552890|NCT00116857|21088174|P2|STARTED|Overall Study||60
8552891|NCT00116857|21088175|P1|STARTED|Overall Study||62
8552892|NCT00116844|21088183|P2|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
8552893|NCT00116844|21088184|P1|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
8552894|NCT00116844|21088183|P2|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
8552895|NCT00116844|21088184|P1|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
8552896|NCT00116844|21088183|P2|STARTED|Period 1: Treatment Period 2 (60 Days)||33
8552897|NCT00116844|21088184|P1|STARTED|Period 1: Treatment Period 2 (60 Days)||28
8552898|NCT00116844|21088183|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8552899|NCT00116844|21088184|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
8552900|NCT00116844|21088183|P2|COMPLETED|Period 2: Washout Period (7 Days)||33
8552901|NCT00116844|21088184|P1|COMPLETED|Period 2: Washout Period (7 Days)||28
8552902|NCT00116844|21088183|P2|STARTED|Period 2: Washout Period (7 Days)||33
8552903|NCT00116844|21088184|P1|STARTED|Period 2: Washout Period (7 Days)||28
8552904|NCT00116844|21088183|P2|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
8552905|NCT00116844|21088184|P1|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
8552906|NCT00116844|21088183|P2|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
8552907|NCT00116844|21088184|P1|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
8552908|NCT00116844|21088183|P2|STARTED|Period 1: Treatment Period 1 (60 Days)||36
8552909|NCT00116844|21088184|P1|STARTED|Period 1: Treatment Period 1 (60 Days)||35
8552910|NCT00116831|21088202|P2|NOT COMPLETED|Overall Study||72
8552911|NCT00116831|21088203|P1|NOT COMPLETED|Overall Study||73
8552912|NCT00116831|21088202|P2|COMPLETED|Overall Study||259
8552913|NCT00116831|21088203|P1|COMPLETED|Overall Study||264
8552914|NCT00116831|21088202|P2|STARTED|Overall Study||331
8552915|NCT00116831|21088203|P1|STARTED|Overall Study||337
8552916|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
8552917|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
8552918|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 433 - 480||29
8552919|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 433 - 480||53
8552920|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
8552921|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 433 - 480||57
8552922|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
8552923|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
8552924|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 385 - 432||30
8552925|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 385 - 432||57
8552926|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
8552927|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
8552928|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
8552929|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
8552930|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 337 - 384||56
8552931|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 337 - 384||90
8552932|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 337 - 384||57
8552933|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 337 - 384||98
8552934|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
8552935|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
8552936|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 289 - 336||57
8552937|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 289 - 336||98
8552938|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 289 - 336||64
8552939|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 289 - 336||104
8552940|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
8552941|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
8552942|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 241 - 288||64
8552943|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 241 - 288||104
8552944|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 241 - 288||64
8552945|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 241 - 288||110
8552946|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
8552947|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
8552948|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 193 - 240||64
8552949|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 193 - 240||110
8552950|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 193 - 240||68
8552951|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 193 - 240||123
8552952|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
8552953|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
8552954|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 145 - 192||68
8552955|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 145 - 192||123
8552956|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 145 - 192||74
8552957|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 145 - 192||133
8552958|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
8552959|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
8552960|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 97 - 144||74
8552961|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 97 - 144||133
8552962|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 97 - 144||83
8552963|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 97 - 144||144
8552964|NCT00116805|21088281|P2|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
8552965|NCT00116805|21088282|P1|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
8552966|NCT00116805|21088281|P2|COMPLETED|Open-label Period Weeks 49 - 96||83
8552967|NCT00116805|21088282|P1|COMPLETED|Open-label Period Weeks 49 - 96||144
8552968|NCT00116805|21088281|P2|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
8552969|NCT00116805|21088282|P1|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
8552970|NCT00116805|21088281|P2|NOT COMPLETED|Double-blind Period Through Week 48||5
8552971|NCT00116805|21088282|P1|NOT COMPLETED|Double-blind Period Through Week 48||11
8552972|NCT00116805|21088281|P2|COMPLETED|Double-blind Period Through Week 48||85
8552973|NCT00116805|21088282|P1|COMPLETED|Double-blind Period Through Week 48||165
8552974|NCT00116805|21088281|P2|STARTED|Double-blind Period Through Week 48||90
8552975|NCT00116805|21088282|P1|STARTED|Double-blind Period Through Week 48||176
8552976|NCT00116779|21088375|P2|NOT COMPLETED|Overall Study||19
8552977|NCT00116779|21088376|P1|NOT COMPLETED|Overall Study||21
8552978|NCT00116779|21088375|P2|COMPLETED|Overall Study||45
8552979|NCT00116779|21088376|P1|COMPLETED|Overall Study||42
8552980|NCT00116779|21088375|P2|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
8552981|NCT00116779|21088376|P1|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
8552982|NCT00116753|21088409|P3|NOT COMPLETED|Overall Study||24
8552983|NCT00116753|21088410|P2|NOT COMPLETED|Overall Study||30
8552984|NCT00116753|21088411|P1|NOT COMPLETED|Overall Study||32
8552985|NCT00116753|21088409|P3|COMPLETED|Overall Study||128
8552986|NCT00116753|21088410|P2|COMPLETED|Overall Study||125
8552987|NCT00116753|21088411|P1|COMPLETED|Overall Study||121
8552988|NCT00116753|21088409|P3|ITT Population|Overall Study||147
8552989|NCT00116753|21088410|P2|ITT Population|Overall Study||150
8552990|NCT00116753|21088411|P1|ITT Population|Overall Study||150
8552991|NCT00116753|21088409|P3|STARTED|Overall Study||152
8552992|NCT00116753|21088410|P2|STARTED|Overall Study||155
8552993|NCT00116753|21088411|P1|STARTED|Overall Study|Randomised.|153
8552994|NCT00116688|21088433|P2|NOT COMPLETED|Overall Study||4
8552995|NCT00116688|21088434|P1|NOT COMPLETED|Overall Study||92
8552996|NCT00116688|21088433|P2|COMPLETED|Overall Study||17
8552997|NCT00116688|21088434|P1|COMPLETED|Overall Study||200
8552998|NCT00116688|21088433|P2|Received Study Medication|Overall Study||20
8552999|NCT00116688|21088434|P1|Received Study Medication|Overall Study||291
8553000|NCT00116688|21088433|P2|STARTED|Overall Study||21
8553001|NCT00116688|21088434|P1|STARTED|Overall Study||292
8553002|NCT00116649|21088449|P1|NOT COMPLETED|Overall Study||155
8553003|NCT00116649|21088449|P1|COMPLETED|Overall Study||396
8553004|NCT00116649|21088449|P1|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
8553005|NCT00116584|21088456|P2|NOT COMPLETED|Overall Study||1
8553006|NCT00116584|21088457|P1|NOT COMPLETED|Overall Study||2
8553007|NCT00116584|21088456|P2|COMPLETED|Overall Study||35
8553008|NCT00116584|21088457|P1|COMPLETED|Overall Study||34
8553009|NCT00116584|21088456|P2|STARTED|Overall Study||36
8553010|NCT00116584|21088457|P1|STARTED|Overall Study||36
8553011|NCT00116558|21088470|P3|NOT COMPLETED|Overall Study||33
8553012|NCT00116558|21088471|P2|NOT COMPLETED|Overall Study||15
8553013|NCT00116558|21088472|P1|NOT COMPLETED|Overall Study||31
8553014|NCT00116558|21088470|P3|COMPLETED|Overall Study||14
8553015|NCT00116558|21088471|P2|COMPLETED|Overall Study||11
8553016|NCT00116558|21088472|P1|COMPLETED|Overall Study||49
8553017|NCT00116558|21088470|P3|STARTED|Overall Study||47
8553018|NCT00116558|21088471|P2|STARTED|Overall Study||26
8553019|NCT00116558|21088472|P1|STARTED|Overall Study||80
8553020|NCT00116428|21088483|P2|NOT COMPLETED|Overall Study||5
8553021|NCT00116428|21088484|P1|NOT COMPLETED|Overall Study||3
8553022|NCT00116428|21088483|P2|COMPLETED|Overall Study||56
8553023|NCT00116428|21088484|P1|COMPLETED|Overall Study||103
8553024|NCT00116428|21088483|P2|Underwent Study Ablation Procedure|Overall Study||36
8553025|NCT00116428|21088484|P1|Underwent Study Ablation Procedure|Overall Study||103
8553026|NCT00116428|21088483|P2|STARTED|Overall Study||61
8553027|NCT00116428|21088484|P1|STARTED|Overall Study||106
8553028|NCT00116337|21088500|P1|NOT COMPLETED|Overall Study||0
8553029|NCT00116337|21088500|P1|COMPLETED|Overall Study||17
8553030|NCT00116337|21088500|P1|STARTED|Overall Study||17
8553031|NCT00116272|21088513|P2|NOT COMPLETED|Overall Study||6
8553032|NCT00116272|21088514|P1|NOT COMPLETED|Overall Study||11
8553033|NCT00116272|21088513|P2|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
8553034|NCT00116272|21088514|P1|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
8553035|NCT00116272|21088513|P2|STARTED|Overall Study||164
8553036|NCT00116272|21088514|P1|STARTED|Overall Study||370
8553037|NCT00116207|21088566|P2|NOT COMPLETED|Overall Study||4
8553038|NCT00116207|21088567|P1|NOT COMPLETED|Overall Study||9
8553039|NCT00116207|21088566|P2|COMPLETED|Overall Study||18
8553040|NCT00116207|21088567|P1|COMPLETED|Overall Study||13
8553041|NCT00116207|21088566|P2|STARTED|Overall Study||22
8553042|NCT00116207|21088567|P1|STARTED|Overall Study||22
8553043|NCT00116168|21088583|P4|NOT COMPLETED|Overall Study||0
8553044|NCT00116168|21088584|P3|NOT COMPLETED|Overall Study||0
8553045|NCT00116168|21088585|P2|NOT COMPLETED|Overall Study||5
8553046|NCT00116168|21088586|P1|NOT COMPLETED|Overall Study||6
8553047|NCT00116168|21088583|P4|COMPLETED|Overall Study||6
8553048|NCT00116168|21088584|P3|COMPLETED|Overall Study||6
8553049|NCT00116168|21088585|P2|COMPLETED|Overall Study||6
8553050|NCT00116168|21088586|P1|COMPLETED|Overall Study||0
8553051|NCT00116168|21088583|P4|STARTED|Overall Study||6
8553052|NCT00116168|21088584|P3|STARTED|Overall Study||6
8553053|NCT00116168|21088585|P2|STARTED|Overall Study||11
8553054|NCT00116168|21088586|P1|STARTED|Overall Study||6
8553055|NCT00115934|21088650|P2|NOT COMPLETED|Overall Study||2
8553056|NCT00115934|21088651|P1|NOT COMPLETED|Overall Study||4
8553057|NCT00115934|21088650|P2|COMPLETED|Overall Study||274
8553058|NCT00115934|21088651|P1|COMPLETED|Overall Study||275
8553059|NCT00115934|21088650|P2|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
8553060|NCT00115934|21088651|P1|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
8553061|NCT00115869|21088691|P2|NOT COMPLETED|Overall Study||296
8553062|NCT00115869|21088692|P1|NOT COMPLETED|Overall Study||317
8553063|NCT00115869|21088691|P2|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
8553064|NCT00115869|21088692|P1|COMPLETED|Overall Study||3894
8553065|NCT00115869|21088691|P2|Completed Data Collection at 12th Grade|Overall Study||3847
8553066|NCT00115869|21088692|P1|Completed Data Collection at 12th Grade|Overall Study||3876
8553067|NCT00115869|21088691|P2|STARTED|Overall Study||4177
8553068|NCT00115869|21088692|P1|STARTED|Overall Study||4211
8553069|NCT00115804|21088700|P1|NOT COMPLETED|Overall Study||2
8553070|NCT00115804|21088700|P1|COMPLETED|Overall Study||4
8553071|NCT00115804|21088700|P1|STARTED|Overall Study||6
8553072|NCT00115778|21088711|P2|NOT COMPLETED|Overall Study||1
8553073|NCT00115778|21088712|P1|NOT COMPLETED|Overall Study||0
8553074|NCT00115778|21088711|P2|COMPLETED|Overall Study||4
8553075|NCT00115778|21088712|P1|COMPLETED|Overall Study||6
8553076|NCT00115778|21088711|P2|STARTED|Overall Study||5
8553077|NCT00115778|21088712|P1|STARTED|Overall Study||6
8553078|NCT00115765|21088732|P4|NOT COMPLETED|Overall Study||31
8553079|NCT00115765|21088733|P3|NOT COMPLETED|Overall Study||121
8553080|NCT00115765|21088734|P2|NOT COMPLETED|Overall Study||100
8553081|NCT00115765|21088735|P1|NOT COMPLETED|Overall Study||35
8553082|NCT00115765|21088732|P4|COMPLETED|Overall Study|Participants who were on study at closure or died|84
8553083|NCT00115765|21088733|P3|COMPLETED|Overall Study|Participants who were on study at closure or died|289
8553084|NCT00115765|21088734|P2|COMPLETED|Overall Study|Participants who were on study at closure or died|313
8553085|NCT00115765|21088735|P1|COMPLETED|Overall Study|Participants who were on study at closure or died|80
8553086|NCT00115765|21088732|P4|STARTED|Overall Study||115
8553087|NCT00115765|21088733|P3|STARTED|Overall Study||410
8553088|NCT00115765|21088734|P2|STARTED|Overall Study||413
8553089|NCT00115765|21088735|P1|STARTED|Overall Study||115
8553090|NCT00115739|21088773|P1|NOT COMPLETED|Overall Study||3
8553091|NCT00115739|21088773|P1|COMPLETED|Overall Study||8
8553092|NCT00115739|21088773|P1|STARTED|Overall Study||11
8553093|NCT00115349|21088782|P2|NOT COMPLETED|Overall Study||9
8553094|NCT00115349|21088783|P1|NOT COMPLETED|Overall Study||11
8553095|NCT00115349|21088782|P2|COMPLETED|Overall Study|study closed due to low enrollment.|0
8553096|NCT00115349|21088783|P1|COMPLETED|Overall Study|Study closed due to low enrollment.|0
8553097|NCT00115349|21088782|P2|STARTED|Overall Study|Target was 43 subjects in this arm.|9
8553098|NCT00115349|21088783|P1|STARTED|Overall Study|Target was 43 subjects in this arm.|11
8553099|NCT00115336|21088791|P2|NOT COMPLETED|Overall Study||1
8553100|NCT00115336|21088792|P1|NOT COMPLETED|Overall Study||0
8553101|NCT00115336|21088791|P2|COMPLETED|Overall Study||3
8553102|NCT00115336|21088792|P1|COMPLETED|Overall Study||6
8553103|NCT00115336|21088791|P2|STARTED|Overall Study||4
8553104|NCT00115336|21088792|P1|STARTED|Overall Study||6
8553105|NCT00115297|21088816|P2|NOT COMPLETED|Overall Study||0
8553106|NCT00115297|21088817|P1|NOT COMPLETED|Overall Study||0
8553107|NCT00115297|21088816|P2|COMPLETED|Overall Study||32
8553108|NCT00115297|21088817|P1|COMPLETED|Overall Study||30
8553109|NCT00115297|21088816|P2|STARTED|Overall Study||32
8553110|NCT00115297|21088817|P1|STARTED|Overall Study||30
8553111|NCT00115063|21088829|P2|NOT COMPLETED|Overall Study||104
8553112|NCT00115063|21088830|P1|NOT COMPLETED|Overall Study||99
8553113|NCT00115063|21088829|P2|COMPLETED|Overall Study||86
8553114|NCT00115063|21088830|P1|COMPLETED|Overall Study||101
8553115|NCT00115063|21088829|P2|STARTED|Overall Study||190
8553116|NCT00115063|21088830|P1|STARTED|Overall Study||200
8553117|NCT00115037|21088848|P6|NOT COMPLETED|Phase2||12
8553118|NCT00115037|21088849|P5|NOT COMPLETED|Phase2||6
8553119|NCT00115037|21088850|P4|NOT COMPLETED|Phase2||15
8553120|NCT00115037|21088851|P3|NOT COMPLETED|Phase2||15
8553121|NCT00115037|21088852|P2|NOT COMPLETED|Phase2||0
8553122|NCT00115037|21088853|P1|NOT COMPLETED|Phase2||0
8553123|NCT00115037|21088848|P6|COMPLETED|Phase2||21
8553124|NCT00115037|21088849|P5|COMPLETED|Phase2||28
8553125|NCT00115037|21088850|P4|COMPLETED|Phase2||77
8553126|NCT00115037|21088851|P3|COMPLETED|Phase2||76
8553127|NCT00115037|21088852|P2|COMPLETED|Phase2||0
8553128|NCT00115037|21088853|P1|COMPLETED|Phase2||0
8553129|NCT00115037|21088848|P6|STARTED|Phase2||33
8553130|NCT00115037|21088849|P5|STARTED|Phase2||34
8553131|NCT00115037|21088850|P4|STARTED|Phase2||92
8553132|NCT00115037|21088851|P3|STARTED|Phase2||91
8553133|NCT00115037|21088852|P2|STARTED|Phase2||0
8553134|NCT00115037|21088853|P1|STARTED|Phase2||0
8553135|NCT00115037|21088848|P6|NOT COMPLETED|Phase1||0
8553136|NCT00115037|21088849|P5|NOT COMPLETED|Phase1||0
8553137|NCT00115037|21088850|P4|NOT COMPLETED|Phase1||0
8553138|NCT00115037|21088851|P3|NOT COMPLETED|Phase1||0
8553139|NCT00115037|21088852|P2|NOT COMPLETED|Phase1||27
8553140|NCT00115037|21088853|P1|NOT COMPLETED|Phase1||25
8553141|NCT00115037|21088848|P6|COMPLETED|Phase1||0
8553142|NCT00115037|21088849|P5|COMPLETED|Phase1||0
8553143|NCT00115037|21088850|P4|COMPLETED|Phase1||0
8553144|NCT00115037|21088851|P3|COMPLETED|Phase1||0
8553145|NCT00115037|21088852|P2|COMPLETED|Phase1||123
8553146|NCT00115037|21088853|P1|COMPLETED|Phase1||127
8553147|NCT00115037|21088848|P6|STARTED|Phase1||0
8553148|NCT00115037|21088849|P5|STARTED|Phase1||0
8553149|NCT00115037|21088850|P4|STARTED|Phase1||0
8553150|NCT00115037|21088851|P3|STARTED|Phase1||0
8553151|NCT00115037|21088852|P2|STARTED|Phase1||150
8553152|NCT00115037|21088853|P1|STARTED|Phase1||152
8553153|NCT00114972|21088869|P2|NOT COMPLETED|Overall Study||12
8553154|NCT00114972|21088870|P1|NOT COMPLETED|Overall Study||48
8553155|NCT00114972|21088869|P2|COMPLETED|Overall Study||891
8553156|NCT00114972|21088870|P1|COMPLETED|Overall Study||849
8553157|NCT00114972|21088869|P2|STARTED|Overall Study||903
8553158|NCT00114972|21088870|P1|STARTED|Overall Study||897
8553159|NCT00114959|21088890|P1|NOT COMPLETED|Overall Study||8
8553160|NCT00114959|21088890|P1|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
8553161|NCT00114959|21088890|P1|STARTED|Overall Study||15
8553162|NCT00114777|21088900|P3|NOT COMPLETED|Long-Term Extension to Month 84||30
8553163|NCT00114777|21088901|P2|NOT COMPLETED|Long-Term Extension to Month 84||29
8553164|NCT00114777|21088902|P1|NOT COMPLETED|Long-Term Extension to Month 84||30
8553165|NCT00114777|21088900|P3|COMPLETED|Long-Term Extension to Month 84||57
8553166|NCT00114777|21088901|P2|COMPLETED|Long-Term Extension to Month 84||84
8553167|NCT00114777|21088902|P1|COMPLETED|Long-Term Extension to Month 84||74
8553168|NCT00114777|21088900|P3|STARTED|Long-Term Extension to Month 84||87
8553169|NCT00114777|21088901|P2|STARTED|Long-Term Extension to Month 84||113
8553170|NCT00114777|21088902|P1|STARTED|Long-Term Extension to Month 84||104
8553171|NCT00114777|21088900|P3|NOT COMPLETED|Randomization to Month 36||84
8553172|NCT00114777|21088901|P2|NOT COMPLETED|Randomization to Month 36||61
8553173|NCT00114777|21088902|P1|NOT COMPLETED|Randomization to Month 36||75
8553174|NCT00114777|21088900|P3|COMPLETED|Randomization to Month 36||100
8553175|NCT00114777|21088901|P2|COMPLETED|Randomization to Month 36||114
8553176|NCT00114777|21088902|P1|COMPLETED|Randomization to Month 36||109
8553177|NCT00114777|21088900|P3|STARTED|Randomization to Month 36||184
8553178|NCT00114777|21088901|P2|STARTED|Randomization to Month 36||175
8553179|NCT00114777|21088902|P1|STARTED|Randomization to Month 36||184
8553180|NCT00114738|21088976|P3|NOT COMPLETED|Randomization||0
8553181|NCT00114738|21088977|P2|NOT COMPLETED|Randomization||0
8553182|NCT00114738|21088978|P1|NOT COMPLETED|Randomization||0
8553183|NCT00114738|21088976|P3|COMPLETED|Randomization||16
8553184|NCT00114738|21088977|P2|COMPLETED|Randomization||14
8553185|NCT00114738|21088978|P1|COMPLETED|Randomization||0
8553186|NCT00114738|21088976|P3|STARTED|Randomization||16
8553187|NCT00114738|21088977|P2|STARTED|Randomization||14
8553188|NCT00114738|21088978|P1|STARTED|Randomization||0
8553189|NCT00114738|21088976|P3|NOT COMPLETED|Screening for Randomization||0
8553190|NCT00114738|21088977|P2|NOT COMPLETED|Screening for Randomization||0
8553191|NCT00114738|21088978|P1|NOT COMPLETED|Screening for Randomization||21
8553192|NCT00114738|21088976|P3|COMPLETED|Screening for Randomization||0
8553193|NCT00114738|21088977|P2|COMPLETED|Screening for Randomization||0
8553194|NCT00114738|21088978|P1|COMPLETED|Screening for Randomization||30
8553195|NCT00114738|21088976|P3|STARTED|Screening for Randomization||0
8553196|NCT00114738|21088977|P2|STARTED|Screening for Randomization||0
8553197|NCT00114738|21088978|P1|STARTED|Screening for Randomization||51
8553198|NCT00114738|21088976|P3|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
8553199|NCT00114738|21088977|P2|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
8553200|NCT00114738|21088978|P1|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
8553201|NCT00114738|21088976|P3|COMPLETED|Bortezomib Then Bortezomib + Induction||0
8553202|NCT00114738|21088977|P2|COMPLETED|Bortezomib Then Bortezomib + Induction||0
8553203|NCT00114738|21088978|P1|COMPLETED|Bortezomib Then Bortezomib + Induction||51
8553204|NCT00114738|21088976|P3|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
8553205|NCT00114738|21088977|P2|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
8553206|NCT00114738|21088978|P1|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
8553207|NCT00114738|21088976|P3|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
8553208|NCT00114738|21088977|P2|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
8553209|NCT00114738|21088978|P1|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
8553210|NCT00114738|21088976|P3|STARTED|Bortezomib Then Bortezomib + Induction||0
8553211|NCT00114738|21088977|P2|STARTED|Bortezomib Then Bortezomib + Induction||0
8553212|NCT00114738|21088978|P1|STARTED|Bortezomib Then Bortezomib + Induction||53
8553213|NCT00114634|21088991|P1|NOT COMPLETED|Overall Study||3
8553214|NCT00114634|21088991|P1|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
8553215|NCT00114634|21088991|P1|STARTED|Overall Study||13
8553313|NCT00113763|21089351|P1|NOT COMPLETED|Overall Study||73
8553222|NCT00114517|21089117|P4|NOT COMPLETED|Overall Study||10
8553223|NCT00114517|21089118|P3|NOT COMPLETED|Overall Study||14
8553224|NCT00114517|21089119|P2|NOT COMPLETED|Overall Study||11
8553225|NCT00114517|21089120|P1|NOT COMPLETED|Overall Study||12
8553226|NCT00114517|21089117|P4|COMPLETED|Overall Study||176
8553227|NCT00114517|21089118|P3|COMPLETED|Overall Study||172
8553228|NCT00114517|21089119|P2|COMPLETED|Overall Study||123
8553229|NCT00114517|21089120|P1|COMPLETED|Overall Study||125
8553230|NCT00114517|21089117|P4|STARTED|Overall Study||186
8553231|NCT00114517|21089118|P3|STARTED|Overall Study||186
8553232|NCT00114517|21089119|P2|STARTED|Overall Study||134
8553233|NCT00114517|21089120|P1|STARTED|Overall Study||137
8553234|NCT00114504|21089132|P2|NOT COMPLETED|Overall Study||0
8553235|NCT00114504|21089133|P1|NOT COMPLETED|Overall Study||0
8553236|NCT00114504|21089132|P2|COMPLETED|Overall Study||22
8553237|NCT00114504|21089133|P1|COMPLETED|Overall Study||21
8553238|NCT00114504|21089132|P2|STARTED|Overall Study||22
8553239|NCT00114504|21089133|P1|STARTED|Overall Study||21
8553240|NCT00114244|21089145|P2|NOT COMPLETED|Overall Study||7
8553241|NCT00114244|21089146|P1|NOT COMPLETED|Overall Study||2
8553242|NCT00114244|21089145|P2|COMPLETED|Overall Study||30
8553243|NCT00114244|21089146|P1|COMPLETED|Overall Study||13
8553244|NCT00114244|21089145|P2|STARTED|Overall Study||37
8553245|NCT00114244|21089146|P1|STARTED|Overall Study||15
8553246|NCT00114231|21089158|P2|NOT COMPLETED|Overall Study||2
8553247|NCT00114231|21089159|P1|NOT COMPLETED|Overall Study||9
8553248|NCT00114231|21089158|P2|COMPLETED|Overall Study||26
8553249|NCT00114231|21089159|P1|COMPLETED|Overall Study||53
8553250|NCT00114231|21089158|P2|STARTED|Overall Study||28
8553251|NCT00114231|21089159|P1|STARTED|Overall Study||62
8553252|NCT00114218|21089168|P1|NOT COMPLETED|Overall Study||4
8553253|NCT00114218|21089168|P1|COMPLETED|Overall Study||24
8553254|NCT00114218|21089168|P1|STARTED|Overall Study||28
8553255|NCT00114166|21089175|P2|NOT COMPLETED|Overall Study||1
8553256|NCT00114166|21089176|P1|NOT COMPLETED|Overall Study||0
8553257|NCT00114166|21089175|P2|COMPLETED|Overall Study||65
8553258|NCT00114166|21089176|P1|COMPLETED|Overall Study||15
8553259|NCT00114166|21089175|P2|STARTED|Overall Study||66
8553260|NCT00114166|21089176|P1|STARTED|Overall Study||15
8553261|NCT00114140|21089186|P1|NOT COMPLETED|Overall Study||7
8553262|NCT00114140|21089186|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
8553263|NCT00114140|21089186|P1|STARTED|Overall Study||136
8553264|NCT00114127|21089200|P2|NOT COMPLETED|Overall Study||4
8553265|NCT00114127|21089201|P1|NOT COMPLETED|Overall Study||4
8553266|NCT00114127|21089200|P2|COMPLETED|Overall Study||11
8553267|NCT00114127|21089201|P1|COMPLETED|Overall Study||9
8553268|NCT00114127|21089200|P2|STARTED|Overall Study||15
8553269|NCT00114127|21089201|P1|STARTED|Overall Study||13
8553270|NCT00114114|21089215|P6|NOT COMPLETED|Overall Study||1
8553271|NCT00114114|21089216|P5|NOT COMPLETED|Overall Study||2
8553272|NCT00114114|21089217|P4|NOT COMPLETED|Overall Study||4
8553273|NCT00114114|21089218|P3|NOT COMPLETED|Overall Study||1
8553274|NCT00114114|21089219|P2|NOT COMPLETED|Overall Study||1
8553275|NCT00114114|21089220|P1|NOT COMPLETED|Overall Study||5
8553276|NCT00114114|21089215|P6|COMPLETED|Overall Study||30
8553277|NCT00114114|21089216|P5|COMPLETED|Overall Study||27
8553278|NCT00114114|21089217|P4|COMPLETED|Overall Study||31
8553279|NCT00114114|21089218|P3|COMPLETED|Overall Study||30
8553280|NCT00114114|21089219|P2|COMPLETED|Overall Study||24
8553281|NCT00114114|21089220|P1|COMPLETED|Overall Study||21
8553282|NCT00114114|21089215|P6|STARTED|Overall Study||31
8553283|NCT00114114|21089216|P5|STARTED|Overall Study||29
8553284|NCT00114114|21089217|P4|STARTED|Overall Study||35
8553285|NCT00114114|21089218|P3|STARTED|Overall Study||31
8553286|NCT00114114|21089219|P2|STARTED|Overall Study||25
8553287|NCT00114114|21089220|P1|STARTED|Overall Study||26
8553294|NCT00113919|21089273|P1|NOT COMPLETED|Overall Study||14
8553295|NCT00113919|21089273|P1|COMPLETED|Overall Study||0
8553296|NCT00113919|21089273|P1|STARTED|Overall Study||14
8553297|NCT00113880|21089280|P3|NOT COMPLETED|Overall Study||0
8553298|NCT00113880|21089281|P2|NOT COMPLETED|Overall Study||0
8553299|NCT00113880|21089282|P1|NOT COMPLETED|Overall Study||0
8553300|NCT00113880|21089280|P3|COMPLETED|Overall Study||62492
8553301|NCT00113880|21089281|P2|COMPLETED|Overall Study||71949
8553302|NCT00113880|21089282|P1|COMPLETED|Overall Study||63061
8553303|NCT00113880|21089280|P3|STARTED|Overall Study||62492
8553304|NCT00113880|21089281|P2|STARTED|Overall Study||71949
8553305|NCT00113880|21089282|P1|STARTED|Overall Study||63061
8553306|NCT00113841|21089341|P2|NOT COMPLETED|Overall Study||2
8553307|NCT00113841|21089342|P1|NOT COMPLETED|Overall Study||1
8553308|NCT00113841|21089341|P2|COMPLETED|Overall Study||15
8553309|NCT00113841|21089342|P1|COMPLETED|Overall Study||15
8553310|NCT00113841|21089341|P2|STARTED|Overall Study||17
8553311|NCT00113841|21089342|P1|STARTED|Overall Study||16
8553312|NCT00113763|21089350|P2|NOT COMPLETED|Overall Study||26
8553314|NCT00113763|21089350|P2|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
8553315|NCT00113763|21089351|P1|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
8553316|NCT00113763|21089350|P2|Received Study Drug|Overall Study||0
8553317|NCT00113763|21089351|P1|Received Study Drug|Overall Study||229
8553318|NCT00113763|21089350|P2|STARTED|Overall Study||232
8553319|NCT00113763|21089351|P1|STARTED|Overall Study||231
8553320|NCT00113607|21089377|P2|NOT COMPLETED|Overall Study||337
8553321|NCT00113607|21089378|P1|NOT COMPLETED|Overall Study||335
8553322|NCT00113607|21089377|P2|COMPLETED|Overall Study||0
8553323|NCT00113607|21089378|P1|COMPLETED|Overall Study||0
8553324|NCT00113607|21089377|P2|STARTED|Overall Study|Number of randomized participants|337
8553325|NCT00113607|21089378|P1|STARTED|Overall Study|Number of randomized participants|335
8553326|NCT00113568|21089392|P1|NOT COMPLETED|Overall Study||545
8553327|NCT00113568|21089392|P1|COMPLETED|Overall Study||239
8553328|NCT00113568|21089392|P1|Intent to Treat Population|Overall Study||723
8553329|NCT00113568|21089392|P1|STARTED|Overall Study||784
8553330|NCT00113555|21089404|P1|NOT COMPLETED|Overall Study||79
8553331|NCT00113555|21089404|P1|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
8553332|NCT00113555|21089404|P1|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
8553333|NCT00113555|21089404|P1|STARTED|Overall Study||221
8553334|NCT00113529|21089414|P1|NOT COMPLETED|Overall Study||34
8553335|NCT00113529|21089414|P1|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
8553336|NCT00113529|21089414|P1|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
8553337|NCT00113516|21089447|P2|NOT COMPLETED|Part 2||66
8553338|NCT00113516|21089448|P1|NOT COMPLETED|Part 2||0
8553339|NCT00113516|21089447|P2|COMPLETED|Part 2||0
8553340|NCT00113516|21089448|P1|COMPLETED|Part 2||0
8553341|NCT00113516|21089447|P2|STARTED|Part 2||66
8553342|NCT00113516|21089448|P1|STARTED|Part 2||0
8553343|NCT00113516|21089447|P2|NOT COMPLETED|Part 1||0
8553344|NCT00113516|21089448|P1|NOT COMPLETED|Part 1||84
8553345|NCT00113516|21089447|P2|COMPLETED|Part 1||0
8553346|NCT00113516|21089448|P1|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
8553347|NCT00113516|21089447|P2|STARTED|Part 1||0
8553348|NCT00113516|21089448|P1|STARTED|Part 1||84
8553349|NCT00113490|21089491|P2|NOT COMPLETED|Overall Study||3
8553350|NCT00113490|21089492|P1|NOT COMPLETED|Overall Study||2
8553351|NCT00113490|21089491|P2|COMPLETED|Overall Study||67
8553352|NCT00113490|21089492|P1|COMPLETED|Overall Study||64
8553353|NCT00113490|21089491|P2|STARTED|Overall Study||70
8553354|NCT00113490|21089492|P1|STARTED|Overall Study||66
8553355|NCT00113425|21089505|P1|NOT COMPLETED|Overall Study||15
8553356|NCT00113425|21089505|P1|COMPLETED|Overall Study||29
8553357|NCT00113425|21089505|P1|STARTED|Overall Study||44
8553358|NCT00113399|21089525|P2|NOT COMPLETED|Overall Study||5
8553359|NCT00113399|21089526|P1|NOT COMPLETED|Overall Study||2
8553360|NCT00113399|21089525|P2|COMPLETED|Overall Study||3
8553361|NCT00113399|21089526|P1|COMPLETED|Overall Study||5
8553362|NCT00113399|21089525|P2|STARTED|Overall Study||8
8553363|NCT00113399|21089526|P1|STARTED|Overall Study||7
8553364|NCT00113386|21089534|P2|NOT COMPLETED|Overall Study||4
8553365|NCT00113386|21089535|P1|NOT COMPLETED|Overall Study||7
8553366|NCT00113386|21089534|P2|COMPLETED|Overall Study||5
8553367|NCT00113386|21089535|P1|COMPLETED|Overall Study||3
8553368|NCT00113386|21089534|P2|STARTED|Overall Study||9
8553369|NCT00113386|21089535|P1|STARTED|Overall Study||10
8553370|NCT00113373|21089541|P1|NOT COMPLETED|Overall Study||3
8553371|NCT00113373|21089541|P1|COMPLETED|Overall Study|Eligible and treated patients.|25
8553372|NCT00113373|21089541|P1|STARTED|Overall Study||28
8553373|NCT00113360|21089556|P1|NOT COMPLETED|Overall Study||7
8553374|NCT00113360|21089556|P1|COMPLETED|Overall Study||60
8553375|NCT00113360|21089556|P1|STARTED|Overall Study|67 participants were enrolled for screening.|67
8553376|NCT00113334|21089560|P1|NOT COMPLETED|Overall Study||0
8553377|NCT00113334|21089560|P1|COMPLETED|Overall Study||6
8553378|NCT00113334|21089560|P1|STARTED|Overall Study||6
8553379|NCT00113321|21089564|P1|NOT COMPLETED|Overall Study||0
8553380|NCT00113321|21089564|P1|COMPLETED|Overall Study||16
8553381|NCT00113321|21089564|P1|STARTED|Overall Study||16
8553382|NCT00113295|21089570|P2|NOT COMPLETED|Overall Study||1
8553383|NCT00113295|21089571|P1|NOT COMPLETED|Overall Study||5
8553384|NCT00113295|21089570|P2|COMPLETED|Overall Study||10
8553385|NCT00113295|21089571|P1|COMPLETED|Overall Study||6
8553386|NCT00113295|21089570|P2|STARTED|Overall Study||11
8553387|NCT00113295|21089571|P1|STARTED|Overall Study||11
8553388|NCT00113269|21089590|P4|NOT COMPLETED|Overall Study||40
8553389|NCT00113269|21089591|P3|NOT COMPLETED|Overall Study||41
8553390|NCT00113269|21089592|P2|NOT COMPLETED|Overall Study||22
8553391|NCT00113269|21089593|P1|NOT COMPLETED|Overall Study||25
8553392|NCT00113269|21089590|P4|COMPLETED|Overall Study||140
8553393|NCT00113269|21089591|P3|COMPLETED|Overall Study||134
8553394|NCT00113269|21089592|P2|COMPLETED|Overall Study||48
8553395|NCT00113269|21089593|P1|COMPLETED|Overall Study||51
8553396|NCT00113269|21089590|P4|Received Treatment|Overall Study||171
8553397|NCT00113269|21089591|P3|Received Treatment|Overall Study||164
8553398|NCT00113269|21089592|P2|Received Treatment|Overall Study||69
8553399|NCT00113269|21089593|P1|Received Treatment|Overall Study||70
8553400|NCT00113269|21089590|P4|STARTED|Overall Study||180
8553401|NCT00113269|21089591|P3|STARTED|Overall Study||175
8553402|NCT00113269|21089592|P2|STARTED|Overall Study||70
8553403|NCT00113269|21089593|P1|STARTED|Overall Study||76
8553404|NCT00113230|21089643|P1|NOT COMPLETED|Overall Study||0
8553405|NCT00113230|21089643|P1|COMPLETED|Overall Study||25
8553406|NCT00113230|21089643|P1|STARTED|Overall Study||25
8553407|NCT00113217|21089647|P1|NOT COMPLETED|Overall Study||0
8553408|NCT00113217|21089647|P1|COMPLETED|Overall Study||50
8553409|NCT00113217|21089647|P1|STARTED|Overall Study||50
8553410|NCT00113087|21089653|P2|NOT COMPLETED|Overall Study||21
8553411|NCT00113087|21089654|P1|NOT COMPLETED|Overall Study||24
8553412|NCT00113087|21089653|P2|COMPLETED|Overall Study||94
8553413|NCT00113087|21089654|P1|COMPLETED|Overall Study||91
8553414|NCT00113087|21089653|P2|STARTED|Overall Study||115
8553415|NCT00113087|21089654|P1|STARTED|Overall Study||115
8553416|NCT00113022|21089718|P2|NOT COMPLETED|Overall Study||2
8553417|NCT00113022|21089719|P1|NOT COMPLETED|Overall Study||3
8553418|NCT00113022|21089718|P2|COMPLETED|Overall Study||2
8553419|NCT00113022|21089719|P1|COMPLETED|Overall Study||2
8553420|NCT00113022|21089718|P2|STARTED|Overall Study||4
8553421|NCT00113022|21089719|P1|STARTED|Overall Study||5
8553422|NCT00112957|21089725|P1|NOT COMPLETED|Overall Study||19
8553423|NCT00112957|21089725|P1|COMPLETED|Overall Study||4
8553424|NCT00112957|21089725|P1|STARTED|Overall Study||23
8553425|NCT00112918|21089740|P3|NOT COMPLETED|Overall Study||299
8553426|NCT00112918|21089741|P2|NOT COMPLETED|Overall Study||345
8553427|NCT00112918|21089742|P1|NOT COMPLETED|Overall Study||297
8553428|NCT00112918|21089740|P3|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
8553429|NCT00112918|21089741|P2|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
8553430|NCT00112918|21089742|P1|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
8553431|NCT00112918|21089740|P3|Stage III Disease Population|Overall Study||952
8553432|NCT00112918|21089741|P2|Stage III Disease Population|Overall Study||960
8553433|NCT00112918|21089742|P1|Stage III Disease Population|Overall Study||955
8553434|NCT00112918|21089740|P3|Received Treatment|Overall Study||1135
8553435|NCT00112918|21089741|P2|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
8553436|NCT00112918|21089742|P1|Received Treatment|Overall Study||1126
8553437|NCT00112918|21089740|P3|STARTED|Overall Study||1145
8553438|NCT00112918|21089741|P2|STARTED|Overall Study||1155
8553439|NCT00112918|21089742|P1|STARTED|Overall Study||1151
8553440|NCT00112905|21089765|P1|NOT COMPLETED|Overall Study||12
8553441|NCT00112905|21089765|P1|COMPLETED|Overall Study||15
8553442|NCT00112905|21089765|P1|Eligible and Treated|Overall Study||22
8553443|NCT00112905|21089765|P1|STARTED|Overall Study||27
8553444|NCT00112866|21089774|P2|NOT COMPLETED|Overall Study||2
8553445|NCT00112866|21089775|P1|NOT COMPLETED|Overall Study||2
8553446|NCT00112866|21089774|P2|COMPLETED|Overall Study||13
8553447|NCT00112866|21089775|P1|COMPLETED|Overall Study||13
8553448|NCT00112866|21089774|P2|STARTED|Overall Study||15
8553449|NCT00112866|21089775|P1|STARTED|Overall Study||15
8553450|NCT00112840|21089797|P3|NOT COMPLETED|Overall Study||6
8553451|NCT00112840|21089798|P2|NOT COMPLETED|Overall Study||0
8553452|NCT00112840|21089799|P1|NOT COMPLETED|Overall Study||2
8553453|NCT00112840|21089797|P3|COMPLETED|Overall Study||40
8553454|NCT00112840|21089798|P2|COMPLETED|Overall Study||6
8553455|NCT00112840|21089799|P1|COMPLETED|Overall Study||6
8553456|NCT00112840|21089797|P3|STARTED|Overall Study||46
8553457|NCT00112840|21089798|P2|STARTED|Overall Study||6
8553458|NCT00112840|21089799|P1|STARTED|Overall Study||8
8553459|NCT00112736|21089818|P2|NOT COMPLETED|Overall Study||0
8553460|NCT00112736|21089819|P1|NOT COMPLETED|Overall Study||1
8553461|NCT00112736|21089818|P2|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
8553462|NCT00112736|21089819|P1|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
8553463|NCT00112736|21089818|P2|STARTED|Overall Study||47
8553464|NCT00112736|21089819|P1|STARTED|Overall Study||22
8553465|NCT00112723|21089832|P3|NOT COMPLETED|Overall Study||2
8553466|NCT00112723|21089833|P2|NOT COMPLETED|Overall Study||7
8553467|NCT00112723|21089834|P1|NOT COMPLETED|Overall Study||2
8553468|NCT00112723|21089832|P3|COMPLETED|Overall Study||12
8553469|NCT00112723|21089833|P2|COMPLETED|Overall Study||12
8553470|NCT00112723|21089834|P1|COMPLETED|Overall Study||11
8553471|NCT00112723|21089832|P3|Patients Evaluable for Toxicity|Overall Study||12
8553472|NCT00112723|21089833|P2|Patients Evaluable for Toxicity|Overall Study||12
8553473|NCT00112723|21089834|P1|Patients Evaluable for Toxicity|Overall Study||11
8553474|NCT00112723|21089832|P3|STARTED|Overall Study||14
8553475|NCT00112723|21089833|P2|STARTED|Overall Study||19
8553476|NCT00112723|21089834|P1|STARTED|Overall Study||13
8553477|NCT00112671|21089859|P1|NOT COMPLETED|Overall Study||0
8553478|NCT00112671|21089859|P1|COMPLETED|Overall Study||17
8553479|NCT00112671|21089859|P1|STARTED|Overall Study||17
8553480|NCT00112593|21089867|P1|NOT COMPLETED|Overall Study||0
8553481|NCT00112593|21089867|P1|COMPLETED|Overall Study||5
8553482|NCT00112593|21089867|P1|STARTED|Overall Study||5
8553483|NCT00112489|21089876|P1|NOT COMPLETED|Overall Study||40
8553484|NCT00112489|21089876|P1|COMPLETED|Overall Study|Completed regimen due to progression|15
8553485|NCT00112489|21089876|P1|STARTED|Overall Study|All patients enrolled on study|55
8553486|NCT00112463|21089886|P1|NOT COMPLETED|Overall Study||39
8553487|NCT00112463|21089886|P1|COMPLETED|Overall Study||1
8553488|NCT00112463|21089886|P1|STARTED|Overall Study||40
8553489|NCT00112437|21089898|P26|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
8553490|NCT00112437|21089899|P25|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
8553491|NCT00112437|21089900|P24|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
8553492|NCT00112437|21089901|P23|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
8553493|NCT00112437|21089902|P22|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553494|NCT00112437|21089903|P21|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553495|NCT00112437|21089904|P20|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553496|NCT00112437|21089905|P19|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553497|NCT00112437|21089906|P18|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553498|NCT00112437|21089907|P17|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553499|NCT00112437|21089908|P16|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553500|NCT00112437|21089909|P15|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553501|NCT00112437|21089910|P14|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553502|NCT00112437|21089911|P13|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553503|NCT00112437|21089912|P12|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553504|NCT00112437|21089913|P11|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553505|NCT00112437|21089914|P10|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553506|NCT00112437|21089915|P9|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553507|NCT00112437|21089916|P8|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553508|NCT00112437|21089917|P7|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553509|NCT00112437|21089918|P6|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553510|NCT00112437|21089919|P5|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553511|NCT00112437|21089920|P4|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553512|NCT00112437|21089921|P3|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553513|NCT00112437|21089922|P2|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553514|NCT00112437|21089923|P1|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
8553515|NCT00112437|21089898|P26|COMPLETED|Years 6-10 (60-Month Extension)||27
8553516|NCT00112437|21089899|P25|COMPLETED|Years 6-10 (60-Month Extension)||22
8553517|NCT00112437|21089900|P24|COMPLETED|Years 6-10 (60-Month Extension)||22
8553518|NCT00112437|21089901|P23|COMPLETED|Years 6-10 (60-Month Extension)||23
8553519|NCT00112437|21089902|P22|COMPLETED|Years 6-10 (60-Month Extension)||0
8553520|NCT00112437|21089903|P21|COMPLETED|Years 6-10 (60-Month Extension)||0
8553521|NCT00112437|21089904|P20|COMPLETED|Years 6-10 (60-Month Extension)||0
8553522|NCT00112437|21089905|P19|COMPLETED|Years 6-10 (60-Month Extension)||0
8553523|NCT00112437|21089906|P18|COMPLETED|Years 6-10 (60-Month Extension)||0
8553524|NCT00112437|21089907|P17|COMPLETED|Years 6-10 (60-Month Extension)||0
8553525|NCT00112437|21089908|P16|COMPLETED|Years 6-10 (60-Month Extension)||0
8553526|NCT00112437|21089909|P15|COMPLETED|Years 6-10 (60-Month Extension)||0
8553527|NCT00112437|21089910|P14|COMPLETED|Years 6-10 (60-Month Extension)||0
8553528|NCT00112437|21089911|P13|COMPLETED|Years 6-10 (60-Month Extension)||0
8553529|NCT00112437|21089912|P12|COMPLETED|Years 6-10 (60-Month Extension)||0
8553530|NCT00112437|21089913|P11|COMPLETED|Years 6-10 (60-Month Extension)||0
8553531|NCT00112437|21089914|P10|COMPLETED|Years 6-10 (60-Month Extension)||0
8553532|NCT00112437|21089915|P9|COMPLETED|Years 6-10 (60-Month Extension)||0
8553533|NCT00112437|21089916|P8|COMPLETED|Years 6-10 (60-Month Extension)||0
8553534|NCT00112437|21089917|P7|COMPLETED|Years 6-10 (60-Month Extension)||0
8553535|NCT00112437|21089918|P6|COMPLETED|Years 6-10 (60-Month Extension)||0
8553536|NCT00112437|21089919|P5|COMPLETED|Years 6-10 (60-Month Extension)||0
8553537|NCT00112437|21089920|P4|COMPLETED|Years 6-10 (60-Month Extension)||0
8553538|NCT00112437|21089921|P3|COMPLETED|Years 6-10 (60-Month Extension)||0
8553539|NCT00112437|21089922|P2|COMPLETED|Years 6-10 (60-Month Extension)||0
8553540|NCT00112437|21089923|P1|COMPLETED|Years 6-10 (60-Month Extension)||0
8553541|NCT00112437|21089898|P26|STARTED|Years 6-10 (60-Month Extension)||32
8553542|NCT00112437|21089899|P25|STARTED|Years 6-10 (60-Month Extension)||23
8553543|NCT00112437|21089900|P24|STARTED|Years 6-10 (60-Month Extension)||34
8553544|NCT00112437|21089901|P23|STARTED|Years 6-10 (60-Month Extension)||28
8553545|NCT00112437|21089902|P22|STARTED|Years 6-10 (60-Month Extension)||0
8553546|NCT00112437|21089903|P21|STARTED|Years 6-10 (60-Month Extension)||0
8553547|NCT00112437|21089904|P20|STARTED|Years 6-10 (60-Month Extension)||0
8553548|NCT00112437|21089905|P19|STARTED|Years 6-10 (60-Month Extension)||0
8553549|NCT00112437|21089906|P18|STARTED|Years 6-10 (60-Month Extension)||0
8553550|NCT00112437|21089907|P17|STARTED|Years 6-10 (60-Month Extension)||0
8553551|NCT00112437|21089908|P16|STARTED|Years 6-10 (60-Month Extension)||0
8553552|NCT00112437|21089909|P15|STARTED|Years 6-10 (60-Month Extension)||0
8553553|NCT00112437|21089910|P14|STARTED|Years 6-10 (60-Month Extension)||0
8553554|NCT00112437|21089911|P13|STARTED|Years 6-10 (60-Month Extension)||0
8553555|NCT00112437|21089912|P12|STARTED|Years 6-10 (60-Month Extension)||0
8553556|NCT00112437|21089913|P11|STARTED|Years 6-10 (60-Month Extension)||0
8553557|NCT00112437|21089914|P10|STARTED|Years 6-10 (60-Month Extension)||0
8553558|NCT00112437|21089915|P9|STARTED|Years 6-10 (60-Month Extension)||0
8553559|NCT00112437|21089916|P8|STARTED|Years 6-10 (60-Month Extension)||0
8553560|NCT00112437|21089917|P7|STARTED|Years 6-10 (60-Month Extension)||0
8553561|NCT00112437|21089918|P6|STARTED|Years 6-10 (60-Month Extension)||0
8553562|NCT00112437|21089919|P5|STARTED|Years 6-10 (60-Month Extension)||0
8553563|NCT00112437|21089920|P4|STARTED|Years 6-10 (60-Month Extension)||0
8553564|NCT00112437|21089921|P3|STARTED|Years 6-10 (60-Month Extension)||0
8553565|NCT00112437|21089922|P2|STARTED|Years 6-10 (60-Month Extension)||0
8553566|NCT00112437|21089923|P1|STARTED|Years 6-10 (60-Month Extension)||0
8553567|NCT00112437|21089898|P26|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553568|NCT00112437|21089899|P25|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553569|NCT00112437|21089900|P24|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553570|NCT00112437|21089901|P23|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553571|NCT00112437|21089902|P22|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
8553572|NCT00112437|21089903|P21|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
8553573|NCT00112437|21089904|P20|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553574|NCT00112437|21089905|P19|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553575|NCT00112437|21089906|P18|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553576|NCT00112437|21089907|P17|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553577|NCT00112437|21089908|P16|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553578|NCT00112437|21089909|P15|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553579|NCT00112437|21089910|P14|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553580|NCT00112437|21089911|P13|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553581|NCT00112437|21089912|P12|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553582|NCT00112437|21089913|P11|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553583|NCT00112437|21089914|P10|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553584|NCT00112437|21089915|P9|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553585|NCT00112437|21089916|P8|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553586|NCT00112437|21089917|P7|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553587|NCT00112437|21089918|P6|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553588|NCT00112437|21089919|P5|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553589|NCT00112437|21089920|P4|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553590|NCT00112437|21089921|P3|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553591|NCT00112437|21089922|P2|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553592|NCT00112437|21089923|P1|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
8553593|NCT00112437|21089898|P26|COMPLETED|Years 4-5 (24-Month Extension)||0
8553594|NCT00112437|21089899|P25|COMPLETED|Years 4-5 (24-Month Extension)||0
8553595|NCT00112437|21089900|P24|COMPLETED|Years 4-5 (24-Month Extension)||0
8553596|NCT00112437|21089901|P23|COMPLETED|Years 4-5 (24-Month Extension)||0
8553597|NCT00112437|21089902|P22|COMPLETED|Years 4-5 (24-Month Extension)||92
8553598|NCT00112437|21089903|P21|COMPLETED|Years 4-5 (24-Month Extension)||37
8553599|NCT00112437|21089904|P20|COMPLETED|Years 4-5 (24-Month Extension)||0
8553600|NCT00112437|21089905|P19|COMPLETED|Years 4-5 (24-Month Extension)||0
8553601|NCT00112437|21089906|P18|COMPLETED|Years 4-5 (24-Month Extension)||0
8553602|NCT00112437|21089907|P17|COMPLETED|Years 4-5 (24-Month Extension)||0
8553603|NCT00112437|21089908|P16|COMPLETED|Years 4-5 (24-Month Extension)||0
8553604|NCT00112437|21089909|P15|COMPLETED|Years 4-5 (24-Month Extension)||0
8553605|NCT00112437|21089910|P14|COMPLETED|Years 4-5 (24-Month Extension)||0
8553606|NCT00112437|21089911|P13|COMPLETED|Years 4-5 (24-Month Extension)||0
8553607|NCT00112437|21089912|P12|COMPLETED|Years 4-5 (24-Month Extension)||0
8553608|NCT00112437|21089913|P11|COMPLETED|Years 4-5 (24-Month Extension)||0
8553609|NCT00112437|21089914|P10|COMPLETED|Years 4-5 (24-Month Extension)||0
8553610|NCT00112437|21089915|P9|COMPLETED|Years 4-5 (24-Month Extension)||0
8553611|NCT00112437|21089916|P8|COMPLETED|Years 4-5 (24-Month Extension)||0
8553612|NCT00112437|21089917|P7|COMPLETED|Years 4-5 (24-Month Extension)||0
8553613|NCT00112437|21089918|P6|COMPLETED|Years 4-5 (24-Month Extension)||0
8553614|NCT00112437|21089919|P5|COMPLETED|Years 4-5 (24-Month Extension)||0
8553615|NCT00112437|21089920|P4|COMPLETED|Years 4-5 (24-Month Extension)||0
8553616|NCT00112437|21089921|P3|COMPLETED|Years 4-5 (24-Month Extension)||0
8553617|NCT00112437|21089922|P2|COMPLETED|Years 4-5 (24-Month Extension)||0
8553618|NCT00112437|21089923|P1|COMPLETED|Years 4-5 (24-Month Extension)||0
8553619|NCT00112437|21089898|P26|STARTED|Years 4-5 (24-Month Extension)||0
8553620|NCT00112437|21089899|P25|STARTED|Years 4-5 (24-Month Extension)||0
8553621|NCT00112437|21089900|P24|STARTED|Years 4-5 (24-Month Extension)||0
8553622|NCT00112437|21089901|P23|STARTED|Years 4-5 (24-Month Extension)||0
8553623|NCT00112437|21089902|P22|STARTED|Years 4-5 (24-Month Extension)||100
8553624|NCT00112437|21089903|P21|STARTED|Years 4-5 (24-Month Extension)||41
8553625|NCT00112437|21089904|P20|STARTED|Years 4-5 (24-Month Extension)||0
8553626|NCT00112437|21089905|P19|STARTED|Years 4-5 (24-Month Extension)||0
8553627|NCT00112437|21089906|P18|STARTED|Years 4-5 (24-Month Extension)||0
8553628|NCT00112437|21089907|P17|STARTED|Years 4-5 (24-Month Extension)||0
8553629|NCT00112437|21089908|P16|STARTED|Years 4-5 (24-Month Extension)||0
8553630|NCT00112437|21089909|P15|STARTED|Years 4-5 (24-Month Extension)||0
8553631|NCT00112437|21089910|P14|STARTED|Years 4-5 (24-Month Extension)||0
8553632|NCT00112437|21089911|P13|STARTED|Years 4-5 (24-Month Extension)||0
8553633|NCT00112437|21089912|P12|STARTED|Years 4-5 (24-Month Extension)||0
8553634|NCT00112437|21089913|P11|STARTED|Years 4-5 (24-Month Extension)||0
8553635|NCT00112437|21089914|P10|STARTED|Years 4-5 (24-Month Extension)||0
8553636|NCT00112437|21089915|P9|STARTED|Years 4-5 (24-Month Extension)||0
8553637|NCT00112437|21089916|P8|STARTED|Years 4-5 (24-Month Extension)||0
8553638|NCT00112437|21089917|P7|STARTED|Years 4-5 (24-Month Extension)||0
8553639|NCT00112437|21089918|P6|STARTED|Years 4-5 (24-Month Extension)||0
8553640|NCT00112437|21089919|P5|STARTED|Years 4-5 (24-Month Extension)||0
8553641|NCT00112437|21089920|P4|STARTED|Years 4-5 (24-Month Extension)||0
8553642|NCT00112437|21089921|P3|STARTED|Years 4-5 (24-Month Extension)||0
8553643|NCT00112437|21089922|P2|STARTED|Years 4-5 (24-Month Extension)||0
8553644|NCT00112437|21089923|P1|STARTED|Years 4-5 (24-Month Extension)||0
8553645|NCT00112437|21089898|P26|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553646|NCT00112437|21089899|P25|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553647|NCT00112437|21089900|P24|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553648|NCT00112437|21089901|P23|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553649|NCT00112437|21089902|P22|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553650|NCT00112437|21089903|P21|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553651|NCT00112437|21089904|P20|NOT COMPLETED|Year 3 (12-Month Extension)||1
8553652|NCT00112437|21089905|P19|NOT COMPLETED|Year 3 (12-Month Extension)||2
8553653|NCT00112437|21089906|P18|NOT COMPLETED|Year 3 (12-Month Extension)||1
8553654|NCT00112437|21089907|P17|NOT COMPLETED|Year 3 (12-Month Extension)||3
8553655|NCT00112437|21089908|P16|NOT COMPLETED|Year 3 (12-Month Extension)||4
8553656|NCT00112437|21089909|P15|NOT COMPLETED|Year 3 (12-Month Extension)||1
8553657|NCT00112437|21089910|P14|NOT COMPLETED|Year 3 (12-Month Extension)||1
8553658|NCT00112437|21089911|P13|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553659|NCT00112437|21089912|P12|NOT COMPLETED|Year 3 (12-Month Extension)||5
8553660|NCT00112437|21089913|P11|NOT COMPLETED|Year 3 (12-Month Extension)||2
8553661|NCT00112437|21089914|P10|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553662|NCT00112437|21089915|P9|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553663|NCT00112437|21089916|P8|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553664|NCT00112437|21089917|P7|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553665|NCT00112437|21089918|P6|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553666|NCT00112437|21089919|P5|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553667|NCT00112437|21089920|P4|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553668|NCT00112437|21089921|P3|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553669|NCT00112437|21089922|P2|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553670|NCT00112437|21089923|P1|NOT COMPLETED|Year 3 (12-Month Extension)||0
8553671|NCT00112437|21089898|P26|COMPLETED|Year 3 (12-Month Extension)||0
8553672|NCT00112437|21089899|P25|COMPLETED|Year 3 (12-Month Extension)||0
8553673|NCT00112437|21089900|P24|COMPLETED|Year 3 (12-Month Extension)||0
8553674|NCT00112437|21089901|P23|COMPLETED|Year 3 (12-Month Extension)||0
8553675|NCT00112437|21089902|P22|COMPLETED|Year 3 (12-Month Extension)||0
8553676|NCT00112437|21089903|P21|COMPLETED|Year 3 (12-Month Extension)||0
8553677|NCT00112437|21089904|P20|COMPLETED|Year 3 (12-Month Extension)||19
8553678|NCT00112437|21089905|P19|COMPLETED|Year 3 (12-Month Extension)||16
8553679|NCT00112437|21089906|P18|COMPLETED|Year 3 (12-Month Extension)||20
8553680|NCT00112437|21089907|P17|COMPLETED|Year 3 (12-Month Extension)||16
8553681|NCT00112437|21089908|P16|COMPLETED|Year 3 (12-Month Extension)||13
8553682|NCT00112437|21089909|P15|COMPLETED|Year 3 (12-Month Extension)||17
8553683|NCT00112437|21089910|P14|COMPLETED|Year 3 (12-Month Extension)||16
8553684|NCT00112437|21089911|P13|COMPLETED|Year 3 (12-Month Extension)||18
8553685|NCT00112437|21089912|P12|COMPLETED|Year 3 (12-Month Extension)||17
8553686|NCT00112437|21089913|P11|COMPLETED|Year 3 (12-Month Extension)||17
8553687|NCT00112437|21089914|P10|COMPLETED|Year 3 (12-Month Extension)||0
8553688|NCT00112437|21089915|P9|COMPLETED|Year 3 (12-Month Extension)||0
8553689|NCT00112437|21089916|P8|COMPLETED|Year 3 (12-Month Extension)||0
8553690|NCT00112437|21089917|P7|COMPLETED|Year 3 (12-Month Extension)||0
8553691|NCT00112437|21089918|P6|COMPLETED|Year 3 (12-Month Extension)||0
8553692|NCT00112437|21089919|P5|COMPLETED|Year 3 (12-Month Extension)||0
8553693|NCT00112437|21089920|P4|COMPLETED|Year 3 (12-Month Extension)||0
8553694|NCT00112437|21089921|P3|COMPLETED|Year 3 (12-Month Extension)||0
8553695|NCT00112437|21089922|P2|COMPLETED|Year 3 (12-Month Extension)||0
8553696|NCT00112437|21089923|P1|COMPLETED|Year 3 (12-Month Extension)||0
8553697|NCT00112437|21089898|P26|STARTED|Year 3 (12-Month Extension)||0
8553698|NCT00112437|21089899|P25|STARTED|Year 3 (12-Month Extension)||0
8553699|NCT00112437|21089900|P24|STARTED|Year 3 (12-Month Extension)||0
8553700|NCT00112437|21089901|P23|STARTED|Year 3 (12-Month Extension)||0
8553701|NCT00112437|21089902|P22|STARTED|Year 3 (12-Month Extension)||0
8553702|NCT00112437|21089903|P21|STARTED|Year 3 (12-Month Extension)||0
8553703|NCT00112437|21089904|P20|STARTED|Year 3 (12-Month Extension)||20
8553704|NCT00112437|21089905|P19|STARTED|Year 3 (12-Month Extension)||18
8553705|NCT00112437|21089906|P18|STARTED|Year 3 (12-Month Extension)||21
8553706|NCT00112437|21089907|P17|STARTED|Year 3 (12-Month Extension)||19
8553707|NCT00112437|21089908|P16|STARTED|Year 3 (12-Month Extension)||17
8553708|NCT00112437|21089909|P15|STARTED|Year 3 (12-Month Extension)||18
8553709|NCT00112437|21089910|P14|STARTED|Year 3 (12-Month Extension)||17
8553710|NCT00112437|21089911|P13|STARTED|Year 3 (12-Month Extension)||18
8553711|NCT00112437|21089912|P12|STARTED|Year 3 (12-Month Extension)||22
8553712|NCT00112437|21089913|P11|STARTED|Year 3 (12-Month Extension)||19
8553713|NCT00112437|21089914|P10|STARTED|Year 3 (12-Month Extension)||0
8553714|NCT00112437|21089915|P9|STARTED|Year 3 (12-Month Extension)||0
8553715|NCT00112437|21089916|P8|STARTED|Year 3 (12-Month Extension)||0
8553716|NCT00112437|21089917|P7|STARTED|Year 3 (12-Month Extension)||0
8553717|NCT00112437|21089918|P6|STARTED|Year 3 (12-Month Extension)||0
8553718|NCT00112437|21089919|P5|STARTED|Year 3 (12-Month Extension)||0
8553719|NCT00112437|21089920|P4|STARTED|Year 3 (12-Month Extension)||0
8553720|NCT00112437|21089921|P3|STARTED|Year 3 (12-Month Extension)||0
8553721|NCT00112437|21089922|P2|STARTED|Year 3 (12-Month Extension)||0
8553722|NCT00112437|21089923|P1|STARTED|Year 3 (12-Month Extension)||0
8553723|NCT00112437|21089898|P26|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553724|NCT00112437|21089899|P25|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553725|NCT00112437|21089900|P24|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553726|NCT00112437|21089901|P23|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553727|NCT00112437|21089902|P22|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553728|NCT00112437|21089903|P21|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553729|NCT00112437|21089904|P20|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553730|NCT00112437|21089905|P19|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553731|NCT00112437|21089906|P18|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553732|NCT00112437|21089907|P17|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553733|NCT00112437|21089908|P16|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553734|NCT00112437|21089909|P15|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553735|NCT00112437|21089910|P14|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553736|NCT00112437|21089911|P13|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553737|NCT00112437|21089912|P12|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553738|NCT00112437|21089913|P11|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553739|NCT00112437|21089914|P10|NOT COMPLETED|Year 2 (12-Month Extension)||13
8553740|NCT00112437|21089915|P9|NOT COMPLETED|Year 2 (12-Month Extension)||7
8553741|NCT00112437|21089916|P8|NOT COMPLETED|Year 2 (12-Month Extension)||8
8553742|NCT00112437|21089917|P7|NOT COMPLETED|Year 2 (12-Month Extension)||9
8553743|NCT00112437|21089918|P6|NOT COMPLETED|Year 2 (12-Month Extension)||3
8553744|NCT00112437|21089919|P5|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553745|NCT00112437|21089920|P4|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553746|NCT00112437|21089921|P3|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553747|NCT00112437|21089922|P2|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553748|NCT00112437|21089923|P1|NOT COMPLETED|Year 2 (12-Month Extension)||0
8553749|NCT00112437|21089898|P26|COMPLETED|Year 2 (12-Month Extension)||0
8553750|NCT00112437|21089899|P25|COMPLETED|Year 2 (12-Month Extension)||0
8553751|NCT00112437|21089900|P24|COMPLETED|Year 2 (12-Month Extension)||0
8553752|NCT00112437|21089901|P23|COMPLETED|Year 2 (12-Month Extension)||0
8553753|NCT00112437|21089902|P22|COMPLETED|Year 2 (12-Month Extension)||0
8553754|NCT00112437|21089903|P21|COMPLETED|Year 2 (12-Month Extension)||0
8553755|NCT00112437|21089904|P20|COMPLETED|Year 2 (12-Month Extension)||0
8553756|NCT00112437|21089905|P19|COMPLETED|Year 2 (12-Month Extension)||0
8553757|NCT00112437|21089906|P18|COMPLETED|Year 2 (12-Month Extension)||0
8553758|NCT00112437|21089907|P17|COMPLETED|Year 2 (12-Month Extension)||0
8553759|NCT00112437|21089908|P16|COMPLETED|Year 2 (12-Month Extension)||0
8553760|NCT00112437|21089909|P15|COMPLETED|Year 2 (12-Month Extension)||0
8553761|NCT00112437|21089910|P14|COMPLETED|Year 2 (12-Month Extension)||0
8553762|NCT00112437|21089911|P13|COMPLETED|Year 2 (12-Month Extension)||0
8553763|NCT00112437|21089912|P12|COMPLETED|Year 2 (12-Month Extension)||0
8553764|NCT00112437|21089913|P11|COMPLETED|Year 2 (12-Month Extension)||0
8553765|NCT00112437|21089914|P10|COMPLETED|Year 2 (12-Month Extension)||50
8553766|NCT00112437|21089915|P9|COMPLETED|Year 2 (12-Month Extension)||62
8553767|NCT00112437|21089916|P8|COMPLETED|Year 2 (12-Month Extension)||55
8553768|NCT00112437|21089917|P7|COMPLETED|Year 2 (12-Month Extension)||53
8553769|NCT00112437|21089918|P6|COMPLETED|Year 2 (12-Month Extension)||60
8553770|NCT00112437|21089919|P5|COMPLETED|Year 2 (12-Month Extension)||0
8553771|NCT00112437|21089920|P4|COMPLETED|Year 2 (12-Month Extension)||0
8553772|NCT00112437|21089921|P3|COMPLETED|Year 2 (12-Month Extension)||0
8553773|NCT00112437|21089922|P2|COMPLETED|Year 2 (12-Month Extension)||0
8553774|NCT00112437|21089923|P1|COMPLETED|Year 2 (12-Month Extension)||0
8553775|NCT00112437|21089898|P26|STARTED|Year 2 (12-Month Extension)||0
8553776|NCT00112437|21089899|P25|STARTED|Year 2 (12-Month Extension)||0
8553777|NCT00112437|21089900|P24|STARTED|Year 2 (12-Month Extension)||0
8553778|NCT00112437|21089901|P23|STARTED|Year 2 (12-Month Extension)||0
8553779|NCT00112437|21089902|P22|STARTED|Year 2 (12-Month Extension)||0
8553780|NCT00112437|21089903|P21|STARTED|Year 2 (12-Month Extension)||0
8553781|NCT00112437|21089904|P20|STARTED|Year 2 (12-Month Extension)||0
8553782|NCT00112437|21089905|P19|STARTED|Year 2 (12-Month Extension)||0
8553783|NCT00112437|21089906|P18|STARTED|Year 2 (12-Month Extension)||0
8553784|NCT00112437|21089907|P17|STARTED|Year 2 (12-Month Extension)||0
8553785|NCT00112437|21089908|P16|STARTED|Year 2 (12-Month Extension)||0
8553786|NCT00112437|21089909|P15|STARTED|Year 2 (12-Month Extension)||0
8553787|NCT00112437|21089910|P14|STARTED|Year 2 (12-Month Extension)||0
8553788|NCT00112437|21089911|P13|STARTED|Year 2 (12-Month Extension)||0
8553789|NCT00112437|21089912|P12|STARTED|Year 2 (12-Month Extension)||0
8553790|NCT00112437|21089913|P11|STARTED|Year 2 (12-Month Extension)||0
8553791|NCT00112437|21089914|P10|STARTED|Year 2 (12-Month Extension)||63
8553792|NCT00112437|21089915|P9|STARTED|Year 2 (12-Month Extension)||69
8553793|NCT00112437|21089916|P8|STARTED|Year 2 (12-Month Extension)||63
8553794|NCT00112437|21089917|P7|STARTED|Year 2 (12-Month Extension)||62
8553795|NCT00112437|21089918|P6|STARTED|Year 2 (12-Month Extension)||63
8553796|NCT00112437|21089919|P5|STARTED|Year 2 (12-Month Extension)||0
8553797|NCT00112437|21089920|P4|STARTED|Year 2 (12-Month Extension)||0
8553798|NCT00112437|21089921|P3|STARTED|Year 2 (12-Month Extension)||0
8553799|NCT00112437|21089922|P2|STARTED|Year 2 (12-Month Extension)||0
8553800|NCT00112437|21089923|P1|STARTED|Year 2 (12-Month Extension)||0
8553801|NCT00112437|21089898|P26|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553802|NCT00112437|21089899|P25|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553803|NCT00112437|21089900|P24|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553804|NCT00112437|21089901|P23|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553805|NCT00112437|21089902|P22|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553806|NCT00112437|21089903|P21|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553807|NCT00112437|21089904|P20|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553808|NCT00112437|21089905|P19|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553809|NCT00112437|21089906|P18|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553810|NCT00112437|21089907|P17|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553811|NCT00112437|21089908|P16|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553812|NCT00112437|21089909|P15|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553813|NCT00112437|21089910|P14|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553814|NCT00112437|21089911|P13|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553815|NCT00112437|21089912|P12|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553816|NCT00112437|21089913|P11|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553817|NCT00112437|21089914|P10|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553818|NCT00112437|21089915|P9|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553819|NCT00112437|21089916|P8|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553820|NCT00112437|21089917|P7|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553821|NCT00112437|21089918|P6|NOT COMPLETED|Year 1 (12-Month Base Study)||0
8553822|NCT00112437|21089919|P5|NOT COMPLETED|Year 1 (12-Month Base Study)||12
8553823|NCT00112437|21089920|P4|NOT COMPLETED|Year 1 (12-Month Base Study)||8
8553824|NCT00112437|21089921|P3|NOT COMPLETED|Year 1 (12-Month Base Study)||12
8553825|NCT00112437|21089922|P2|NOT COMPLETED|Year 1 (12-Month Base Study)||18
8553826|NCT00112437|21089923|P1|NOT COMPLETED|Year 1 (12-Month Base Study)||15
8553827|NCT00112437|21089898|P26|COMPLETED|Year 1 (12-Month Base Study)||0
8553828|NCT00112437|21089899|P25|COMPLETED|Year 1 (12-Month Base Study)||0
8553829|NCT00112437|21089900|P24|COMPLETED|Year 1 (12-Month Base Study)||0
8553830|NCT00112437|21089901|P23|COMPLETED|Year 1 (12-Month Base Study)||0
8553831|NCT00112437|21089902|P22|COMPLETED|Year 1 (12-Month Base Study)||0
8553832|NCT00112437|21089903|P21|COMPLETED|Year 1 (12-Month Base Study)||0
8553833|NCT00112437|21089904|P20|COMPLETED|Year 1 (12-Month Base Study)||0
8553834|NCT00112437|21089905|P19|COMPLETED|Year 1 (12-Month Base Study)||0
8553835|NCT00112437|21089906|P18|COMPLETED|Year 1 (12-Month Base Study)||0
8553836|NCT00112437|21089907|P17|COMPLETED|Year 1 (12-Month Base Study)||0
8553837|NCT00112437|21089908|P16|COMPLETED|Year 1 (12-Month Base Study)||0
8553838|NCT00112437|21089909|P15|COMPLETED|Year 1 (12-Month Base Study)||0
8553839|NCT00112437|21089910|P14|COMPLETED|Year 1 (12-Month Base Study)||0
8553840|NCT00112437|21089911|P13|COMPLETED|Year 1 (12-Month Base Study)||0
8553841|NCT00112437|21089912|P12|COMPLETED|Year 1 (12-Month Base Study)||0
8553842|NCT00112437|21089913|P11|COMPLETED|Year 1 (12-Month Base Study)||0
8553843|NCT00112437|21089914|P10|COMPLETED|Year 1 (12-Month Base Study)||0
8553844|NCT00112437|21089915|P9|COMPLETED|Year 1 (12-Month Base Study)||0
8553845|NCT00112437|21089916|P8|COMPLETED|Year 1 (12-Month Base Study)||0
8553846|NCT00112437|21089917|P7|COMPLETED|Year 1 (12-Month Base Study)||0
8553847|NCT00112437|21089918|P6|COMPLETED|Year 1 (12-Month Base Study)||0
8553848|NCT00112437|21089919|P5|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
8553849|NCT00112437|21089920|P4|COMPLETED|Year 1 (12-Month Base Study)||71
8553850|NCT00112437|21089921|P3|COMPLETED|Year 1 (12-Month Base Study)||65
8553851|NCT00112437|21089922|P2|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
8553852|NCT00112437|21089923|P1|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
8553853|NCT00112437|21089898|P26|STARTED|Year 1 (12-Month Base Study)||0
8553854|NCT00112437|21089899|P25|STARTED|Year 1 (12-Month Base Study)||0
8553855|NCT00112437|21089900|P24|STARTED|Year 1 (12-Month Base Study)||0
8553856|NCT00112437|21089901|P23|STARTED|Year 1 (12-Month Base Study)||0
8553857|NCT00112437|21089902|P22|STARTED|Year 1 (12-Month Base Study)||0
8553858|NCT00112437|21089903|P21|STARTED|Year 1 (12-Month Base Study)||0
8553859|NCT00112437|21089904|P20|STARTED|Year 1 (12-Month Base Study)||0
8553860|NCT00112437|21089905|P19|STARTED|Year 1 (12-Month Base Study)||0
8553861|NCT00112437|21089906|P18|STARTED|Year 1 (12-Month Base Study)||0
8553862|NCT00112437|21089907|P17|STARTED|Year 1 (12-Month Base Study)||0
8553863|NCT00112437|21089908|P16|STARTED|Year 1 (12-Month Base Study)||0
8553864|NCT00112437|21089909|P15|STARTED|Year 1 (12-Month Base Study)||0
8553865|NCT00112437|21089910|P14|STARTED|Year 1 (12-Month Base Study)||0
8553866|NCT00112437|21089911|P13|STARTED|Year 1 (12-Month Base Study)||0
8553867|NCT00112437|21089912|P12|STARTED|Year 1 (12-Month Base Study)||0
8553868|NCT00112437|21089913|P11|STARTED|Year 1 (12-Month Base Study)||0
8553869|NCT00112437|21089914|P10|STARTED|Year 1 (12-Month Base Study)||0
8553870|NCT00112437|21089915|P9|STARTED|Year 1 (12-Month Base Study)||0
8553871|NCT00112437|21089916|P8|STARTED|Year 1 (12-Month Base Study)||0
8553872|NCT00112437|21089917|P7|STARTED|Year 1 (12-Month Base Study)||0
8553873|NCT00112437|21089918|P6|STARTED|Year 1 (12-Month Base Study)||0
8553874|NCT00112437|21089919|P5|STARTED|Year 1 (12-Month Base Study)||78
8553875|NCT00112437|21089920|P4|STARTED|Year 1 (12-Month Base Study)||79
8553876|NCT00112437|21089921|P3|STARTED|Year 1 (12-Month Base Study)||77
8553877|NCT00112437|21089922|P2|STARTED|Year 1 (12-Month Base Study)||82
8553878|NCT00112437|21089923|P1|STARTED|Year 1 (12-Month Base Study)||83
8553879|NCT00112385|21090203|P2|NOT COMPLETED|Overall Study||1
8553880|NCT00112385|21090204|P1|NOT COMPLETED|Overall Study||1
8553881|NCT00112385|21090203|P2|COMPLETED|Overall Study||4
8553882|NCT00112385|21090204|P1|COMPLETED|Overall Study||10
8553883|NCT00112385|21090203|P2|STARTED|Overall Study||5
8553884|NCT00112385|21090204|P1|STARTED|Overall Study||11
8553885|NCT00112359|21090294|P2|NOT COMPLETED|Overall Study||13
8553886|NCT00112359|21090295|P1|NOT COMPLETED|Overall Study||27
8553887|NCT00112359|21090294|P2|COMPLETED|Overall Study||67
8553888|NCT00112359|21090295|P1|COMPLETED|Overall Study||57
8553889|NCT00112359|21090294|P2|STARTED|Overall Study||80
8553890|NCT00112359|21090295|P1|STARTED|Overall Study||84
8553891|NCT00112294|21090321|P2|NOT COMPLETED|Overall Study||0
8553892|NCT00112294|21090322|P1|NOT COMPLETED|Overall Study||5
8553893|NCT00112294|21090321|P2|COMPLETED|Overall Study|Off all study therapies.|320
8553894|NCT00112294|21090322|P1|COMPLETED|Overall Study|Off all study therapies.|320
8553895|NCT00112294|21090321|P2|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
8553896|NCT00112294|21090322|P1|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
8553897|NCT00112294|21090321|P2|STARTED|Overall Study|338 randomized and 320 treated.|320
8553898|NCT00112294|21090322|P1|STARTED|Overall Study|338 randomized and 325 treated.|325
8553899|NCT00112242|21090365|P5|NOT COMPLETED|Overall Study||7
8553900|NCT00112242|21090366|P4|NOT COMPLETED|Overall Study||6
8553901|NCT00112242|21090367|P3|NOT COMPLETED|Overall Study||1
8553902|NCT00112242|21090368|P2|NOT COMPLETED|Overall Study||2
8553903|NCT00112242|21090369|P1|NOT COMPLETED|Overall Study||5
8553904|NCT00112242|21090365|P5|COMPLETED|Overall Study||2
8553905|NCT00112242|21090366|P4|COMPLETED|Overall Study||4
8553906|NCT00112242|21090367|P3|COMPLETED|Overall Study||4
8553907|NCT00112242|21090368|P2|COMPLETED|Overall Study||3
8553908|NCT00112242|21090369|P1|COMPLETED|Overall Study||5
8553909|NCT00112242|21090365|P5|Cycle 3 Completed|Overall Study||2
8553910|NCT00112242|21090366|P4|Cycle 3 Completed|Overall Study||4
8553911|NCT00112242|21090367|P3|Cycle 3 Completed|Overall Study||4
8553912|NCT00112242|21090368|P2|Cycle 3 Completed|Overall Study||3
8553913|NCT00112242|21090369|P1|Cycle 3 Completed|Overall Study||5
8553914|NCT00112242|21090365|P5|Cycle 2 Completed|Overall Study||4
8553915|NCT00112242|21090366|P4|Cycle 2 Completed|Overall Study||8
8553916|NCT00112242|21090367|P3|Cycle 2 Completed|Overall Study||4
8553917|NCT00112242|21090368|P2|Cycle 2 Completed|Overall Study||3
8553918|NCT00112242|21090369|P1|Cycle 2 Completed|Overall Study||8
8553919|NCT00112242|21090365|P5|Cycle 1 Completed|Overall Study||7
8553920|NCT00112242|21090366|P4|Cycle 1 Completed|Overall Study||9
8553921|NCT00112242|21090367|P3|Cycle 1 Completed|Overall Study||5
8553922|NCT00112242|21090368|P2|Cycle 1 Completed|Overall Study||5
8553923|NCT00112242|21090369|P1|Cycle 1 Completed|Overall Study||10
8553924|NCT00112242|21090365|P5|STARTED|Overall Study|One patient received only 1 vaccine however this minimum dose allowed the safety evaluation|9
8553925|NCT00112242|21090366|P4|STARTED|Overall Study||10
8553926|NCT00112242|21090367|P3|STARTED|Overall Study||5
8553927|NCT00112242|21090368|P2|STARTED|Overall Study||5
8553928|NCT00112242|21090369|P1|STARTED|Overall Study||10
8553929|NCT00112151|21090432|P6|NOT COMPLETED|Overall Study||3
8553930|NCT00112151|21090433|P5|NOT COMPLETED|Overall Study||6
8553931|NCT00112151|21090434|P4|NOT COMPLETED|Overall Study||3
8553932|NCT00112151|21090435|P3|NOT COMPLETED|Overall Study||3
8553933|NCT00112151|21090436|P2|NOT COMPLETED|Overall Study||5
8553934|NCT00112151|21090437|P1|NOT COMPLETED|Overall Study||4
8553935|NCT00112151|21090432|P6|COMPLETED|Overall Study||25
8553936|NCT00112151|21090433|P5|COMPLETED|Overall Study||22
8553937|NCT00112151|21090434|P4|COMPLETED|Overall Study||24
8553938|NCT00112151|21090435|P3|COMPLETED|Overall Study||25
8553939|NCT00112151|21090436|P2|COMPLETED|Overall Study||23
8553940|NCT00112151|21090437|P1|COMPLETED|Overall Study||24
8553941|NCT00112151|21090432|P6|STARTED|Overall Study||28
8553942|NCT00112151|21090433|P5|STARTED|Overall Study||28
8553943|NCT00112151|21090434|P4|STARTED|Overall Study||27
8553944|NCT00112151|21090435|P3|STARTED|Overall Study||28
8553945|NCT00112151|21090436|P2|STARTED|Overall Study||28
8553946|NCT00112151|21090437|P1|STARTED|Overall Study||28
8553947|NCT00112125|21090468|P2|NOT COMPLETED|Overall Study||22
8553948|NCT00112125|21090469|P1|NOT COMPLETED|Overall Study||24
8553949|NCT00112125|21090468|P2|COMPLETED|Overall Study||193
8553950|NCT00112125|21090469|P1|COMPLETED|Overall Study||189
8553951|NCT00112125|21090468|P2|STARTED|Overall Study||215
8553952|NCT00112125|21090469|P1|STARTED|Overall Study||213
8553953|NCT00112112|21090487|P2|NOT COMPLETED|Overall Study||0
8553954|NCT00112112|21090488|P1|NOT COMPLETED|Overall Study||0
8553955|NCT00112112|21090487|P2|COMPLETED|Overall Study||10
8553956|NCT00112112|21090488|P1|COMPLETED|Overall Study||10
8553957|NCT00112112|21090487|P2|STARTED|Overall Study||10
8553958|NCT00112112|21090488|P1|STARTED|Overall Study||10
8553959|NCT00112047|21090630|P2|NOT COMPLETED|Atripla Phase||20
8553960|NCT00112047|21090631|P1|NOT COMPLETED|Atripla Phase||18
8553961|NCT00112047|21090630|P2|COMPLETED|Atripla Phase||106
8553962|NCT00112047|21090631|P1|COMPLETED|Atripla Phase||142
8553963|NCT00112047|21090630|P2|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
8553964|NCT00112047|21090631|P1|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
8553965|NCT00112047|21090630|P2|NOT COMPLETED|Randomized Phase||88
8553966|NCT00112047|21090631|P1|NOT COMPLETED|Randomized Phase||70
8553967|NCT00112047|21090630|P2|COMPLETED|Randomized Phase||166
8553968|NCT00112047|21090631|P1|COMPLETED|Randomized Phase||187
8553969|NCT00112047|21090630|P2|STARTED|Randomized Phase|ITT analysis population|254
8553970|NCT00112047|21090631|P1|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
8553971|NCT00111917|21090731|P2|NOT COMPLETED|Overall Study||1
8553972|NCT00111917|21090732|P1|NOT COMPLETED|Overall Study||1
8553973|NCT00111917|21090731|P2|COMPLETED|Overall Study||3
8553974|NCT00111917|21090732|P1|COMPLETED|Overall Study||8
8553975|NCT00111917|21090731|P2|STARTED|Overall Study||4
8553976|NCT00111917|21090732|P1|STARTED|Overall Study||9
8553977|NCT00111839|21090747|P3|NOT COMPLETED|Overall Study||49
8553978|NCT00111839|21090748|P2|NOT COMPLETED|Overall Study||46
8553979|NCT00111839|21090749|P1|NOT COMPLETED|Overall Study||48
8553980|NCT00111839|21090747|P3|COMPLETED|Overall Study||0
8553981|NCT00111839|21090748|P2|COMPLETED|Overall Study||5
8553982|NCT00111839|21090749|P1|COMPLETED|Overall Study||2
8553983|NCT00111839|21090747|P3|Treated|Overall Study||47
8553984|NCT00111839|21090748|P2|Treated|Overall Study||51
8553985|NCT00111839|21090749|P1|Treated|Overall Study||50
8553986|NCT00111839|21090747|P3|STARTED|Overall Study||49
8553987|NCT00111839|21090748|P2|STARTED|Overall Study||51
8553988|NCT00111839|21090749|P1|STARTED|Overall Study||50
8553989|NCT00111813|21090769|P6|NOT COMPLETED|Overall Study||6
8553990|NCT00111813|21090770|P5|NOT COMPLETED|Overall Study||6
8553991|NCT00111813|21090771|P4|NOT COMPLETED|Overall Study||5
8553992|NCT00111813|21090772|P3|NOT COMPLETED|Overall Study||10
8553993|NCT00111813|21090773|P2|NOT COMPLETED|Overall Study||3
8553994|NCT00111813|21090774|P1|NOT COMPLETED|Overall Study||3
8553995|NCT00111813|21090769|P6|COMPLETED|Overall Study||0
8553996|NCT00111813|21090770|P5|COMPLETED|Overall Study||0
8553997|NCT00111813|21090771|P4|COMPLETED|Overall Study||1
8553998|NCT00111813|21090772|P3|COMPLETED|Overall Study||0
8553999|NCT00111813|21090773|P2|COMPLETED|Overall Study||0
8554000|NCT00111813|21090774|P1|COMPLETED|Overall Study||0
8554001|NCT00111813|21090769|P6|STARTED|Overall Study||6
8554002|NCT00111813|21090770|P5|STARTED|Overall Study||6
8554003|NCT00111813|21090771|P4|STARTED|Overall Study||6
8554004|NCT00111813|21090772|P3|STARTED|Overall Study||10
8554005|NCT00111813|21090773|P2|STARTED|Overall Study||3
8554006|NCT00111813|21090774|P1|STARTED|Overall Study||3
8554007|NCT00111800|21090813|P6|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
8554008|NCT00111800|21090814|P5|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
8554009|NCT00111800|21090815|P4|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
8554010|NCT00111800|21090816|P3|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
8554011|NCT00111800|21090817|P2|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
8554012|NCT00111800|21090818|P1|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
8554013|NCT00111800|21090813|P6|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
8554014|NCT00111800|21090814|P5|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
8554015|NCT00111800|21090815|P4|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
8554016|NCT00111800|21090816|P3|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
8554017|NCT00111800|21090817|P2|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
8554018|NCT00111800|21090818|P1|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
8554019|NCT00111800|21090813|P6|STARTED|Period 2: Extension Phase (12 Weeks)||55
8554020|NCT00111800|21090814|P5|STARTED|Period 2: Extension Phase (12 Weeks)||55
8554021|NCT00111800|21090815|P4|STARTED|Period 2: Extension Phase (12 Weeks)||59
8554022|NCT00111800|21090816|P3|STARTED|Period 2: Extension Phase (12 Weeks)||54
8554023|NCT00111800|21090817|P2|STARTED|Period 2: Extension Phase (12 Weeks)||47
8554024|NCT00111800|21090818|P1|STARTED|Period 2: Extension Phase (12 Weeks)||48
8554025|NCT00111800|21090813|P6|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
8554026|NCT00111800|21090814|P5|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
8554027|NCT00111800|21090815|P4|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
8554028|NCT00111800|21090816|P3|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
8554029|NCT00111800|21090817|P2|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
8554030|NCT00111800|21090818|P1|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
8554031|NCT00111800|21090813|P6|COMPLETED|Period 1: Main Phase (12 Weeks)||56
8554032|NCT00111800|21090814|P5|COMPLETED|Period 1: Main Phase (12 Weeks)||55
8554033|NCT00111800|21090815|P4|COMPLETED|Period 1: Main Phase (12 Weeks)||60
8554034|NCT00111800|21090816|P3|COMPLETED|Period 1: Main Phase (12 Weeks)||54
8554035|NCT00111800|21090817|P2|COMPLETED|Period 1: Main Phase (12 Weeks)||47
8554036|NCT00111800|21090818|P1|COMPLETED|Period 1: Main Phase (12 Weeks)||49
8554037|NCT00111800|21090813|P6|STARTED|Period 1: Main Phase (12 Weeks)||61
8554038|NCT00111800|21090814|P5|STARTED|Period 1: Main Phase (12 Weeks)||60
8554039|NCT00111800|21090815|P4|STARTED|Period 1: Main Phase (12 Weeks)||66
8554040|NCT00111800|21090816|P3|STARTED|Period 1: Main Phase (12 Weeks)||63
8554041|NCT00111800|21090817|P2|STARTED|Period 1: Main Phase (12 Weeks)||61
8554042|NCT00111800|21090818|P1|STARTED|Period 1: Main Phase (12 Weeks)||64
8554043|NCT00111761|21090988|P2|NOT COMPLETED|Part 2||0
8554044|NCT00111761|21090989|P1|NOT COMPLETED|Part 2||8
8554045|NCT00111761|21090988|P2|COMPLETED|Part 2||0
8554046|NCT00111761|21090989|P1|COMPLETED|Part 2||16
8554047|NCT00111761|21090988|P2|STARTED|Part 2|This treatment group was used in Part 1 only|0
8554048|NCT00111761|21090989|P1|STARTED|Part 2||24
8554049|NCT00111761|21090988|P2|NOT COMPLETED|Part 1||5
8554050|NCT00111761|21090989|P1|NOT COMPLETED|Part 1||0
8554051|NCT00111761|21090988|P2|COMPLETED|Part 1|Completed through safety followup|14
8554052|NCT00111761|21090989|P1|COMPLETED|Part 1||0
8554053|NCT00111761|21090988|P2|STARTED|Part 1||19
8554054|NCT00111761|21090989|P1|STARTED|Part 1|This treatment group was not initiated until Part 2|0
8554055|NCT00111657|21091006|P1|NOT COMPLETED|Overall Study||16
8554056|NCT00111657|21091006|P1|COMPLETED|Overall Study|Completed all intended doses.|21
8554057|NCT00111657|21091006|P1|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
8554058|NCT00111475|21091026|P10|NOT COMPLETED|Overall Study||0
8554059|NCT00111475|21091027|P9|NOT COMPLETED|Overall Study||0
8554060|NCT00111475|21091028|P8|NOT COMPLETED|Overall Study||0
8554061|NCT00111475|21091029|P7|NOT COMPLETED|Overall Study||0
8554062|NCT00111475|21091030|P6|NOT COMPLETED|Overall Study||1
8554063|NCT00111475|21091031|P5|NOT COMPLETED|Overall Study||0
8554064|NCT00111475|21091032|P4|NOT COMPLETED|Overall Study||0
8554065|NCT00111475|21091033|P3|NOT COMPLETED|Overall Study||0
8554066|NCT00111475|21091034|P2|NOT COMPLETED|Overall Study||0
8554067|NCT00111475|21091035|P1|NOT COMPLETED|Overall Study||0
8554068|NCT00111475|21091026|P10|COMPLETED|Overall Study||1
8554069|NCT00111475|21091027|P9|COMPLETED|Overall Study||8
8554070|NCT00111475|21091028|P8|COMPLETED|Overall Study||8
8554071|NCT00111475|21091029|P7|COMPLETED|Overall Study||4
8554072|NCT00111475|21091030|P6|COMPLETED|Overall Study||3
8554073|NCT00111475|21091031|P5|COMPLETED|Overall Study||4
8554074|NCT00111475|21091032|P4|COMPLETED|Overall Study||4
8554075|NCT00111475|21091033|P3|COMPLETED|Overall Study||4
8554076|NCT00111475|21091034|P2|COMPLETED|Overall Study||4
8554077|NCT00111475|21091035|P1|COMPLETED|Overall Study||4
8554078|NCT00111475|21091026|P10|STARTED|Overall Study||1
8554079|NCT00111475|21091027|P9|STARTED|Overall Study||8
8554080|NCT00111475|21091028|P8|STARTED|Overall Study||8
8554081|NCT00111475|21091029|P7|STARTED|Overall Study||4
8554082|NCT00111475|21091030|P6|STARTED|Overall Study||4
8554083|NCT00111475|21091031|P5|STARTED|Overall Study||4
8554084|NCT00111475|21091032|P4|STARTED|Overall Study||4
8554085|NCT00111475|21091033|P3|STARTED|Overall Study||4
8554086|NCT00111475|21091034|P2|STARTED|Overall Study||4
8554087|NCT00111475|21091035|P1|STARTED|Overall Study||4
8554088|NCT00111241|21091153|P2|NOT COMPLETED|Overall Study||8
8554089|NCT00111241|21091154|P1|NOT COMPLETED|Overall Study||15
8554090|NCT00111241|21091153|P2|COMPLETED|Overall Study||62
8554091|NCT00111241|21091154|P1|COMPLETED|Overall Study||30
8554092|NCT00111241|21091153|P2|STARTED|Overall Study||70
8554093|NCT00111241|21091154|P1|STARTED|Overall Study||45
8554094|NCT00111228|21091165|P3|NOT COMPLETED|Overall Study||0
8554095|NCT00111228|21091166|P2|NOT COMPLETED|Overall Study||1
8554096|NCT00111228|21091167|P1|NOT COMPLETED|Overall Study||5
8554097|NCT00111228|21091165|P3|COMPLETED|Overall Study||54
8554098|NCT00111228|21091166|P2|COMPLETED|Overall Study||53
8554099|NCT00111228|21091167|P1|COMPLETED|Overall Study||49
8554100|NCT00111228|21091165|P3|STARTED|Overall Study||54
8554101|NCT00111228|21091166|P2|STARTED|Overall Study||54
8554102|NCT00111228|21091167|P1|STARTED|Overall Study||54
8554103|NCT00111007|21091180|P2|NOT COMPLETED|Long Term Follow-up||45
8554104|NCT00111007|21091181|P1|NOT COMPLETED|Long Term Follow-up||47
8554105|NCT00111007|21091180|P2|COMPLETED|Long Term Follow-up||62
8554106|NCT00111007|21091181|P1|COMPLETED|Long Term Follow-up||54
8554107|NCT00111007|21091180|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
8554108|NCT00111007|21091181|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
8554109|NCT00111007|21091180|P2|NOT COMPLETED|Active Follow-up||2
8554110|NCT00111007|21091181|P1|NOT COMPLETED|Active Follow-up||6
8554111|NCT00111007|21091180|P2|COMPLETED|Active Follow-up||2
8554112|NCT00111007|21091181|P1|COMPLETED|Active Follow-up||0
8554113|NCT00111007|21091180|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
8554114|NCT00111007|21091181|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
8554115|NCT00111007|21091180|P2|NOT COMPLETED|Double-blind (DB) Treatment||111
8554116|NCT00111007|21091181|P1|NOT COMPLETED|Double-blind (DB) Treatment||108
8554117|NCT00111007|21091180|P2|COMPLETED|Double-blind (DB) Treatment||24
8554118|NCT00111007|21091181|P1|COMPLETED|Double-blind (DB) Treatment||27
8554119|NCT00111007|21091180|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|134
8554120|NCT00111007|21091181|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|134
8554121|NCT00111007|21091180|P2|STARTED|Double-blind (DB) Treatment|ITT population|135
8554122|NCT00111007|21091181|P1|STARTED|Double-blind (DB) Treatment|ITT population|135
8554123|NCT00110994|21091197|P2|NOT COMPLETED|Long Term Follow-up||17
8554124|NCT00110994|21091198|P1|NOT COMPLETED|Long Term Follow-up||19
8554125|NCT00110994|21091197|P2|COMPLETED|Long Term Follow-up||30
8554126|NCT00110994|21091198|P1|COMPLETED|Long Term Follow-up||22
8554127|NCT00110994|21091197|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
8554128|NCT00110994|21091198|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
8554129|NCT00110994|21091197|P2|NOT COMPLETED|Active Follow-up||2
8554130|NCT00110994|21091198|P1|NOT COMPLETED|Active Follow-up||1
8554131|NCT00110994|21091197|P2|COMPLETED|Active Follow-up||0
8554132|NCT00110994|21091198|P1|COMPLETED|Active Follow-up||0
8554133|NCT00110994|21091197|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
8554134|NCT00110994|21091198|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
8554135|NCT00110994|21091197|P2|NOT COMPLETED|Double-blind (DB) Treatment||47
8554136|NCT00110994|21091198|P1|NOT COMPLETED|Double-blind (DB) Treatment||42
8554137|NCT00110994|21091197|P2|COMPLETED|Double-blind (DB) Treatment||3
8554138|NCT00110994|21091198|P1|COMPLETED|Double-blind (DB) Treatment||9
8554139|NCT00110994|21091197|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|50
8554140|NCT00110994|21091198|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|51
8554141|NCT00110994|21091197|P2|STARTED|Double-blind (DB) Treatment|ITT population|50
8554142|NCT00110994|21091198|P1|STARTED|Double-blind (DB) Treatment|ITT population|51
8554143|NCT00110890|21091224|P2|NOT COMPLETED|Overall Study||179
8554144|NCT00110890|21091225|P1|NOT COMPLETED|Overall Study||361
8554145|NCT00110890|21091224|P2|COMPLETED|Overall Study|Follow-up Phase|5
8554146|NCT00110890|21091225|P1|COMPLETED|Overall Study|Follow-up Phase|7
8554147|NCT00110890|21091224|P2|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
8554148|NCT00110890|21091225|P1|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
8554149|NCT00110890|21091224|P2|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
8554150|NCT00110890|21091225|P1|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
8554151|NCT00110890|21091224|P2|STARTED|Overall Study||184
8554152|NCT00110890|21091225|P1|STARTED|Overall Study||368
8554153|NCT00110812|21091242|P3|NOT COMPLETED|Extended Follow-up||4
8554154|NCT00110812|21091243|P2|NOT COMPLETED|Extended Follow-up||4
8554155|NCT00110812|21091244|P1|NOT COMPLETED|Extended Follow-up||2
8554156|NCT00110812|21091242|P3|COMPLETED|Extended Follow-up||69
8554157|NCT00110812|21091243|P2|COMPLETED|Extended Follow-up||65
8554158|NCT00110812|21091244|P1|COMPLETED|Extended Follow-up||78
8554159|NCT00110812|21091242|P3|STARTED|Extended Follow-up||73
8554160|NCT00110812|21091243|P2|STARTED|Extended Follow-up||69
8554161|NCT00110812|21091244|P1|STARTED|Extended Follow-up||80
8554162|NCT00110812|21091242|P3|NOT COMPLETED|Main Study||13
8554163|NCT00110812|21091243|P2|NOT COMPLETED|Main Study||11
8554164|NCT00110812|21091244|P1|NOT COMPLETED|Main Study||8
8554165|NCT00110812|21091242|P3|COMPLETED|Main Study||74
8554166|NCT00110812|21091243|P2|COMPLETED|Main Study||78
8554167|NCT00110812|21091244|P1|COMPLETED|Main Study||83
8554168|NCT00110812|21091242|P3|STARTED|Main Study||87
8554169|NCT00110812|21091243|P2|STARTED|Main Study||89
8554170|NCT00110812|21091244|P1|STARTED|Main Study||91
8554171|NCT00110617|21091289|P2|NOT COMPLETED|Overall Study||29
8554172|NCT00110617|21091290|P1|NOT COMPLETED|Overall Study||39
8554173|NCT00110617|21091289|P2|COMPLETED|Overall Study||39
8554174|NCT00110617|21091290|P1|COMPLETED|Overall Study||96
8554175|NCT00110617|21091289|P2|On Going at Week 24|Overall Study||53
8554176|NCT00110617|21091290|P1|On Going at Week 24|Overall Study||126
8554177|NCT00110617|21091289|P2|Full Analysis 2; Received ICL670|Overall Study||53
8554178|NCT00110617|21091290|P1|Full Analysis 2; Received ICL670|Overall Study||135
8554179|NCT00110617|21091289|P2|Safety Set 1; Received Study Drug|Overall Study||56
8554180|NCT00110617|21091290|P1|Safety Set 1; Received Study Drug|Overall Study||135
8554181|NCT00110617|21091289|P2|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
8554182|NCT00110617|21091290|P1|STARTED|Overall Study||135
8554183|NCT00110513|21091303|P1|NOT COMPLETED|Overall Study||0
8554184|NCT00110513|21091303|P1|COMPLETED|Overall Study||18
8554185|NCT00110513|21091303|P1|STARTED|Overall Study||18
8554186|NCT00110461|21091310|P3|NOT COMPLETED|Acute Phase||23
8554187|NCT00110461|21091311|P2|NOT COMPLETED|Acute Phase||22
8554188|NCT00110461|21091312|P1|NOT COMPLETED|Acute Phase||14
8554189|NCT00110461|21091310|P3|COMPLETED|Acute Phase||76
8554190|NCT00110461|21091311|P2|COMPLETED|Acute Phase||77
8554191|NCT00110461|21091312|P1|COMPLETED|Acute Phase||84
8554192|NCT00110461|21091310|P3|STARTED|Acute Phase||99
8554193|NCT00110461|21091311|P2|STARTED|Acute Phase||99
8554194|NCT00110461|21091312|P1|STARTED|Acute Phase||98
8554195|NCT00110461|21091310|P3|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
8554196|NCT00110461|21091311|P2|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
8554197|NCT00110461|21091312|P1|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
8554198|NCT00110461|21091310|P3|COMPLETED|30-Week, Double-blind Treatment Phase||12
8554199|NCT00110461|21091311|P2|COMPLETED|30-Week, Double-blind Treatment Phase||22
8554200|NCT00110461|21091312|P1|COMPLETED|30-Week, Double-blind Treatment Phase||34
8554201|NCT00110461|21091310|P3|STARTED|30-Week, Double-blind Treatment Phase||99
8554202|NCT00110461|21091311|P2|STARTED|30-Week, Double-blind Treatment Phase||99
8554203|NCT00110461|21091312|P1|STARTED|30-Week, Double-blind Treatment Phase||98
8554204|NCT00110396|21091407|P1|NOT COMPLETED|Overall Study||36
8554205|NCT00110396|21091407|P1|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
8554206|NCT00110396|21091407|P1|STARTED|Overall Study||260
8554207|NCT00110357|21091415|P2|NOT COMPLETED|Overall Study||19
8554208|NCT00110357|21091416|P1|NOT COMPLETED|Overall Study||27
8554209|NCT00110357|21091415|P2|COMPLETED|Overall Study|Number Still on Study|0
8554210|NCT00110357|21091416|P1|COMPLETED|Overall Study|Number Still on Study|0
8554211|NCT00110357|21091415|P2|STARTED|Overall Study||19
8554212|NCT00110357|21091416|P1|STARTED|Overall Study||27
8554213|NCT00110305|21091504|P2|NOT COMPLETED|Overall Study||32
8554214|NCT00110305|21091505|P1|NOT COMPLETED|Overall Study||114
8554215|NCT00110305|21091504|P2|COMPLETED|Overall Study||57
8554216|NCT00110305|21091505|P1|COMPLETED|Overall Study||165
8554217|NCT00110305|21091504|P2|STARTED|Overall Study||89
8554218|NCT00110305|21091505|P1|STARTED|Overall Study||279
8554219|NCT00110214|21091558|P2|NOT COMPLETED|Overall Study||503
8554220|NCT00110214|21091559|P1|NOT COMPLETED|Overall Study||509
8554221|NCT00110214|21091558|P2|COMPLETED|Overall Study||21
8554222|NCT00110214|21091559|P1|COMPLETED|Overall Study||17
8554223|NCT00110214|21091558|P2|STARTED|Overall Study||524
8554224|NCT00110214|21091559|P1|STARTED|Overall Study||526
8554225|NCT00110149|21091571|P1|NOT COMPLETED|Overall Study||3
8554226|NCT00110149|21091571|P1|COMPLETED|Overall Study||9
8554227|NCT00110149|21091571|P1|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
8554228|NCT00110149|21091571|P1|STARTED|Overall Study|total number that signed consent to be screened.|12
8554229|NCT00110136|21091576|P1|NOT COMPLETED|Overall Study||0
8554230|NCT00110136|21091576|P1|COMPLETED|Overall Study||9
8554231|NCT00110136|21091576|P1|STARTED|Overall Study||9
8554232|NCT00110084|21091585|P1|NOT COMPLETED|Overall Study||28
8554233|NCT00110084|21091585|P1|COMPLETED|Overall Study||22
8554234|NCT00110084|21091585|P1|STARTED|Overall Study||50
8554235|NCT00110019|21091594|P2|NOT COMPLETED|Overall Study||413
8554236|NCT00110019|21091595|P1|NOT COMPLETED|Overall Study||406
8554237|NCT00110019|21091594|P2|COMPLETED|Overall Study||0
8554238|NCT00110019|21091595|P1|COMPLETED|Overall Study||4
8554239|NCT00110019|21091594|P2|Treated|Overall Study||397
8554240|NCT00110019|21091595|P1|Treated|Overall Study||393
8554241|NCT00110019|21091594|P2|Eligible|Overall Study||398
8554242|NCT00110019|21091595|P1|Eligible|Overall Study||395
8554243|NCT00110019|21091594|P2|STARTED|Overall Study||413
8554244|NCT00110019|21091595|P1|STARTED|Overall Study||410
8554245|NCT00109967|21091607|P2|NOT COMPLETED|Overall Study||6
8554246|NCT00109967|21091608|P1|NOT COMPLETED|Overall Study||20
8554247|NCT00109967|21091607|P2|COMPLETED|Overall Study||15
8554248|NCT00109967|21091608|P1|COMPLETED|Overall Study||30
8554249|NCT00109967|21091607|P2|STARTED|Overall Study||21
8554250|NCT00109967|21091608|P1|STARTED|Overall Study||50
8554251|NCT00109928|21091622|P1|NOT COMPLETED|Overall Study||13
8554252|NCT00109928|21091622|P1|COMPLETED|Overall Study||21
8554253|NCT00109928|21091622|P1|Eligible and Began Protocol Therapy|Overall Study||33
8554254|NCT00109928|21091622|P1|Eligible|Overall Study||33
8554255|NCT00109928|21091622|P1|STARTED|Overall Study||34
8554256|NCT00109876|21091629|P1|NOT COMPLETED|Overall Study||0
8554257|NCT00109876|21091629|P1|COMPLETED|Overall Study||51
8554258|NCT00109876|21091629|P1|STARTED|Overall Study||51
8554259|NCT00109850|21091639|P1|NOT COMPLETED|Overall Study||4
8554260|NCT00109850|21091639|P1|COMPLETED|Overall Study||18
8554261|NCT00109850|21091639|P1|Eligible and Began Protocol Therapy|Overall Study||21
8554262|NCT00109850|21091639|P1|Eligible|Overall Study||21
8554263|NCT00109850|21091639|P1|STARTED|Overall Study||22
8554264|NCT00109837|21091646|P1|NOT COMPLETED|Overall Study||23
8554265|NCT00109837|21091646|P1|COMPLETED|Overall Study||56
8554266|NCT00109837|21091646|P1|Eligible and Ph- and Treated|Overall Study||60
8554267|NCT00109837|21091646|P1|Eligible and Ph-|Overall Study||61
8554268|NCT00109837|21091646|P1|Eligible|Overall Study||78
8554269|NCT00109837|21091646|P1|STARTED|Overall Study||79
8554270|NCT00109772|21091656|P2|NOT COMPLETED|Open-label Extension||49
8554271|NCT00109772|21091657|P1|NOT COMPLETED|Open-label Extension||45
8554272|NCT00109772|21091656|P2|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
8554273|NCT00109772|21091657|P1|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
8554274|NCT00109772|21091656|P2|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
8554275|NCT00109772|21091657|P1|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
8554276|NCT00109772|21091656|P2|NOT COMPLETED|Double-blind Treatment||15
8554277|NCT00109772|21091657|P1|NOT COMPLETED|Double-blind Treatment||22
8554278|NCT00109772|21091656|P2|COMPLETED|Double-blind Treatment||79
8554279|NCT00109772|21091657|P1|COMPLETED|Double-blind Treatment||68
8554280|NCT00109772|21091656|P2|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
8554281|NCT00109772|21091657|P1|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
8554282|NCT00109772|21091656|P2|STARTED|Double-blind Treatment||94
8554283|NCT00109772|21091657|P1|STARTED|Double-blind Treatment||90
8554284|NCT00109733|21091697|P2|NOT COMPLETED|Overall Study||4
8554285|NCT00109733|21091698|P1|NOT COMPLETED|Overall Study||2
8554286|NCT00109733|21091697|P2|COMPLETED|Overall Study||12
8554287|NCT00109733|21091698|P1|COMPLETED|Overall Study||13
8554288|NCT00109733|21091697|P2|STARTED|Overall Study||16
8554289|NCT00109733|21091698|P1|STARTED|Overall Study||15
8554290|NCT00109590|21091715|P3|NOT COMPLETED|Overall Study||4
8554291|NCT00109590|21091716|P2|NOT COMPLETED|Overall Study||2
8554292|NCT00109590|21091717|P1|NOT COMPLETED|Overall Study||2
8554293|NCT00109590|21091715|P3|COMPLETED|Overall Study||56
8554294|NCT00109590|21091716|P2|COMPLETED|Overall Study||56
8554295|NCT00109590|21091717|P1|COMPLETED|Overall Study||55
8554296|NCT00109590|21091715|P3|RECEIVED TREATMENT|Overall Study||57
8554297|NCT00109590|21091716|P2|RECEIVED TREATMENT|Overall Study||56
8554298|NCT00109590|21091717|P1|RECEIVED TREATMENT|Overall Study||56
8554299|NCT00109590|21091715|P3|STARTED|Overall Study||60
8554300|NCT00109590|21091716|P2|STARTED|Overall Study||58
8554301|NCT00109590|21091717|P1|STARTED|Overall Study||57
8554302|NCT00109577|21091759|P2|NOT COMPLETED|Overall Study||3
8554303|NCT00109577|21091760|P1|NOT COMPLETED|Overall Study||3
8554304|NCT00109577|21091759|P2|COMPLETED|Overall Study||17
8554305|NCT00109577|21091760|P1|COMPLETED|Overall Study||17
8554306|NCT00109577|21091759|P2|STARTED|Overall Study||20
8554307|NCT00109577|21091760|P1|STARTED|Overall Study||20
8554308|NCT00109473|21091768|P2|NOT COMPLETED|52 Week Extension Phase||5
8554309|NCT00109473|21091769|P1|NOT COMPLETED|52 Week Extension Phase||4
8554310|NCT00109473|21091768|P2|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
8554311|NCT00109473|21091769|P1|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
8554312|NCT00109473|21091768|P2|Analyzed|52 Week Extension Phase||8
8554313|NCT00109473|21091769|P1|Analyzed|52 Week Extension Phase||9
8554314|NCT00109473|21091768|P2|STARTED|52 Week Extension Phase||8
8554315|NCT00109473|21091769|P1|STARTED|52 Week Extension Phase||9
8554316|NCT00109473|21091768|P2|NOT COMPLETED|Week 12 to Week 24||0
8554317|NCT00109473|21091769|P1|NOT COMPLETED|Week 12 to Week 24||1
8554318|NCT00109473|21091768|P2|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
8554319|NCT00109473|21091769|P1|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
8554320|NCT00109473|21091768|P2|Analyzed|Week 12 to Week 24||9
8554321|NCT00109473|21091769|P1|Analyzed|Week 12 to Week 24||9
8554322|NCT00109473|21091768|P2|STARTED|Week 12 to Week 24||9
8554323|NCT00109473|21091769|P1|STARTED|Week 12 to Week 24||10
8554324|NCT00109473|21091768|P2|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
8554325|NCT00109473|21091769|P1|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
8554326|NCT00109473|21091768|P2|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
8554327|NCT00109473|21091769|P1|COMPLETED|Baseline (0 Through 12 Weeks)||10
8554328|NCT00109473|21091768|P2|Analyzed|Baseline (0 Through 12 Weeks)||10
8554329|NCT00109473|21091769|P1|Analyzed|Baseline (0 Through 12 Weeks)||10
8554330|NCT00109473|21091768|P2|STARTED|Baseline (0 Through 12 Weeks)||10
8554331|NCT00109473|21091769|P1|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
8554332|NCT00109343|21091793|P3|NOT COMPLETED|Overall Study||30
8554333|NCT00109343|21091794|P2|NOT COMPLETED|Overall Study||37
8554334|NCT00109343|21091795|P1|NOT COMPLETED|Overall Study||64
8554335|NCT00109343|21091793|P3|COMPLETED|Overall Study||229
8554336|NCT00109343|21091794|P2|COMPLETED|Overall Study||221
8554337|NCT00109343|21091795|P1|COMPLETED|Overall Study||446
8554338|NCT00109343|21091793|P3|Vaccinated at Visit 4|Overall Study||240
8554339|NCT00109343|21091794|P2|Vaccinated at Visit 4|Overall Study||235
8554340|NCT00109343|21091795|P1|Vaccinated at Visit 4|Overall Study||466
8554341|NCT00109343|21091793|P3|Vaccinated at Visit 2|Overall Study||246
8554342|NCT00109343|21091794|P2|Vaccinated at Visit 2|Overall Study||246
8554343|NCT00109343|21091795|P1|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
8554344|NCT00109343|21091793|P3|Vaccinated at Visit 1|Overall Study||259
8554345|NCT00109343|21091794|P2|Vaccinated at Visit 1|Overall Study||258
8554346|NCT00109343|21091795|P1|Vaccinated at Visit 1|Overall Study||510
8554347|NCT00109343|21091793|P3|STARTED|Overall Study||259
8554348|NCT00109343|21091794|P2|STARTED|Overall Study||258
8554349|NCT00109343|21091795|P1|STARTED|Overall Study||510
8554350|NCT00109031|21091840|P4|NOT COMPLETED|Overall Study||0
8554351|NCT00109031|21091841|P3|NOT COMPLETED|Overall Study||2
8554352|NCT00109031|21091842|P2|NOT COMPLETED|Overall Study||2
8554353|NCT00109031|21091843|P1|NOT COMPLETED|Overall Study||0
8554354|NCT00109031|21091840|P4|COMPLETED|Overall Study||12
8554355|NCT00109031|21091841|P3|COMPLETED|Overall Study||12
8554356|NCT00109031|21091842|P2|COMPLETED|Overall Study||8
8554357|NCT00109031|21091843|P1|COMPLETED|Overall Study||11
8554358|NCT00109031|21091840|P4|STARTED|Overall Study||12
8554359|NCT00109031|21091841|P3|STARTED|Overall Study||14
8554360|NCT00109031|21091842|P2|STARTED|Overall Study||10
8554361|NCT00109031|21091843|P1|STARTED|Overall Study||11
8554362|NCT00109005|21091879|P2|NOT COMPLETED|Overall Study||0
8554363|NCT00109005|21091880|P1|NOT COMPLETED|Overall Study||0
8554364|NCT00109005|21091879|P2|COMPLETED|Overall Study||9
8554365|NCT00109005|21091880|P1|COMPLETED|Overall Study||8
8554366|NCT00109005|21091879|P2|STARTED|Overall Study||9
8554367|NCT00109005|21091880|P1|STARTED|Overall Study||8
8554368|NCT00108953|21091894|P2|NOT COMPLETED|Follow-up||33
8554369|NCT00108953|21091895|P1|NOT COMPLETED|Follow-up||29
8554370|NCT00108953|21091894|P2|COMPLETED|Follow-up||12
8554371|NCT00108953|21091895|P1|COMPLETED|Follow-up||11
8554372|NCT00108953|21091894|P2|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
8554373|NCT00108953|21091895|P1|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
8554374|NCT00108953|21091894|P2|NOT COMPLETED|Treatment Period||0
8554375|NCT00108953|21091895|P1|NOT COMPLETED|Treatment Period||0
8554376|NCT00108953|21091894|P2|COMPLETED|Treatment Period|No patient under study medication anymore|49
8554377|NCT00108953|21091895|P1|COMPLETED|Treatment Period|No patient under study medication anymore|47
8554378|NCT00108953|21091894|P2|STARTED|Treatment Period|ITT population|49
8554379|NCT00108953|21091895|P1|STARTED|Treatment Period|ITT population|47
8554380|NCT00108862|21091917|P2|NOT COMPLETED|Overall Study||62
8554381|NCT00108862|21091918|P1|NOT COMPLETED|Overall Study||68
8554382|NCT00108862|21091917|P2|COMPLETED|Overall Study||339
8554383|NCT00108862|21091918|P1|COMPLETED|Overall Study||337
8554384|NCT00108862|21091917|P2|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
8554385|NCT00108862|21091918|P1|STARTED|Overall Study||405
8554386|NCT00108732|21091946|P1|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
8554387|NCT00108732|21091946|P1|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
8554388|NCT00108732|21091946|P1|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
8554389|NCT00108732|21091946|P1|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
8554390|NCT00108732|21091946|P1|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
8554391|NCT00108732|21091946|P1|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
8554392|NCT00108732|21091946|P1|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
8554393|NCT00108628|21091955|P2|NOT COMPLETED|Overall Study||10
8554394|NCT00108628|21091956|P1|NOT COMPLETED|Overall Study||20
8554395|NCT00108628|21091955|P2|COMPLETED|Overall Study||53
8554396|NCT00108628|21091956|P1|COMPLETED|Overall Study||41
8554397|NCT00108628|21091955|P2|Completed Treatment|Overall Study||57
8554398|NCT00108628|21091956|P1|Completed Treatment|Overall Study||42
8554399|NCT00108628|21091955|P2|Received One or More Sessions|Overall Study||58
8554400|NCT00108628|21091956|P1|Received One or More Sessions|Overall Study||53
8554401|NCT00108628|21091955|P2|STARTED|Overall Study||63
8554402|NCT00108628|21091956|P1|STARTED|Overall Study||61
8554403|NCT00108550|21091982|P2|NOT COMPLETED|Overall Study||16
8554404|NCT00108550|21091983|P1|NOT COMPLETED|Overall Study||16
8554405|NCT00108550|21091982|P2|COMPLETED|Overall Study||37
8554406|NCT00108550|21091983|P1|COMPLETED|Overall Study||39
8554407|NCT00108550|21091982|P2|STARTED|Overall Study||53
8554408|NCT00108550|21091983|P1|STARTED|Overall Study||55
8554409|NCT00108524|21091993|P2|NOT COMPLETED|Overall Study||18
8554410|NCT00108524|21091994|P1|NOT COMPLETED|Overall Study||29
8554411|NCT00108524|21091993|P2|COMPLETED|Overall Study||61
8554412|NCT00108524|21091994|P1|COMPLETED|Overall Study||52
8554413|NCT00108524|21091993|P2|STARTED|Overall Study||79
8554414|NCT00108524|21091994|P1|STARTED|Overall Study||81
8554415|NCT00108485|21092006|P2|NOT COMPLETED|Overall Study||2
8554416|NCT00108485|21092007|P1|NOT COMPLETED|Overall Study||3
8554417|NCT00108485|21092006|P2|COMPLETED|Overall Study||2
8554418|NCT00108485|21092007|P1|COMPLETED|Overall Study||2
8554419|NCT00108485|21092006|P2|STARTED|Overall Study||4
8554420|NCT00108485|21092007|P1|STARTED|Overall Study||5
8554421|NCT00108433|21092015|P2|NOT COMPLETED|Overall Study||17
8554422|NCT00108433|21092016|P1|NOT COMPLETED|Overall Study||21
8554423|NCT00108433|21092015|P2|COMPLETED|Overall Study||14
8554424|NCT00108433|21092016|P1|COMPLETED|Overall Study||9
8554425|NCT00108433|21092015|P2|STARTED|Overall Study||31
8554426|NCT00108433|21092016|P1|STARTED|Overall Study||30
8554427|NCT00108355|21092032|P2|NOT COMPLETED|Overall Study||2
8554428|NCT00108355|21092033|P1|NOT COMPLETED|Overall Study||2
8554429|NCT00108355|21092032|P2|COMPLETED|Overall Study||12
8554430|NCT00108355|21092033|P1|COMPLETED|Overall Study||13
8554431|NCT00108355|21092032|P2|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
8554432|NCT00108355|21092033|P1|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
8554433|NCT00108342|21092043|P2|NOT COMPLETED|Overall Study||0
8554434|NCT00108342|21092044|P1|NOT COMPLETED|Overall Study||1
8554435|NCT00108342|21092043|P2|COMPLETED|Overall Study||9
8554436|NCT00108342|21092044|P1|COMPLETED|Overall Study||7
8554437|NCT00108342|21092043|P2|STARTED|Overall Study||9
8554438|NCT00108342|21092044|P1|STARTED|Overall Study||8
8554439|NCT00108303|21092053|P3|NOT COMPLETED|Overall Study||0
8554440|NCT00108303|21092054|P2|NOT COMPLETED|Overall Study||0
8554441|NCT00108303|21092055|P1|NOT COMPLETED|Overall Study||0
8554442|NCT00108303|21092053|P3|COMPLETED|Overall Study||180
8554443|NCT00108303|21092054|P2|COMPLETED|Overall Study||179
8554444|NCT00108303|21092055|P1|COMPLETED|Overall Study||179
8554445|NCT00108303|21092053|P3|STARTED|Overall Study||180
8554446|NCT00108303|21092054|P2|STARTED|Overall Study||179
8554447|NCT00108303|21092055|P1|STARTED|Overall Study||179
8554448|NCT00108277|21092070|P3|NOT COMPLETED|Overall Study||16
8554449|NCT00108277|21092071|P2|NOT COMPLETED|Overall Study||12
8554450|NCT00108277|21092072|P1|NOT COMPLETED|Overall Study||10
8554451|NCT00108277|21092070|P3|COMPLETED|Overall Study||19
8554452|NCT00108277|21092071|P2|COMPLETED|Overall Study||16
8554453|NCT00108277|21092072|P1|COMPLETED|Overall Study||19
8554454|NCT00108277|21092070|P3|STARTED|Overall Study||35
8554455|NCT00108277|21092071|P2|STARTED|Overall Study||28
8554456|NCT00108277|21092072|P1|STARTED|Overall Study||29
8554457|NCT00108160|21092082|P2|NOT COMPLETED|Overall Study||21
8554458|NCT00108160|21092083|P1|NOT COMPLETED|Overall Study||39
8554459|NCT00108160|21092082|P2|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
8554460|NCT00108160|21092083|P1|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
8554461|NCT00108160|21092082|P2|Completed Visit 7 (18 mo)|Overall Study||31
8554462|NCT00108160|21092083|P1|Completed Visit 7 (18 mo)|Overall Study||34
8554463|NCT00108160|21092082|P2|Completed Visit 6 (15 mo)|Overall Study||33
8554464|NCT00108160|21092083|P1|Completed Visit 6 (15 mo)|Overall Study||36
8554465|NCT00108160|21092082|P2|Completed Visit 5 (12 mo)|Overall Study||37
8554466|NCT00108160|21092083|P1|Completed Visit 5 (12 mo)|Overall Study||37
8554467|NCT00108160|21092082|P2|Completed Visit 4 (9 mo)|Overall Study||37
8554468|NCT00108160|21092083|P1|Completed Visit 4 (9 mo)|Overall Study||38
8554469|NCT00108160|21092082|P2|Completed Visit 3 (6 mo)|Overall Study||38
8554470|NCT00108160|21092083|P1|Completed Visit 3 (6 mo)|Overall Study||44
8554471|NCT00108160|21092082|P2|Completed Visit 2 (3 mo)|Overall Study||46
8554472|NCT00108160|21092083|P1|Completed Visit 2 (3 mo)|Overall Study||54
8554473|NCT00108160|21092082|P2|Completed Visit 1 (2 Wks)|Overall Study||54
8554474|NCT00108160|21092083|P1|Completed Visit 1 (2 Wks)|Overall Study||72
8554475|NCT00108160|21092082|P2|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
8554476|NCT00108160|21092083|P1|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
8554477|NCT00108160|21092082|P2|STARTED|Overall Study||63
8554478|NCT00108160|21092083|P1|STARTED|Overall Study||83
8554479|NCT00108082|21092096|P3|NOT COMPLETED|Overall Study||43
8554480|NCT00108082|21092097|P2|NOT COMPLETED|Overall Study||32
8554481|NCT00108082|21092098|P1|NOT COMPLETED|Overall Study||38
8554482|NCT00108082|21092096|P3|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
8554483|NCT00108082|21092097|P2|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
8554484|NCT00108082|21092098|P1|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
8554485|NCT00108082|21092096|P3|STARTED|Overall Study||96
8554486|NCT00108082|21092097|P2|STARTED|Overall Study||100
8554487|NCT00108082|21092098|P1|STARTED|Overall Study||91
8554488|NCT00108069|21092147|P2|NOT COMPLETED|Overall Study||13
8554489|NCT00108069|21092148|P1|NOT COMPLETED|Overall Study||30
8554490|NCT00108069|21092147|P2|COMPLETED|Overall Study||0
8554491|NCT00108069|21092148|P1|COMPLETED|Overall Study||0
8554492|NCT00108069|21092147|P2|STARTED|Overall Study||13
8554493|NCT00108069|21092148|P1|STARTED|Overall Study||30
8554494|NCT00107991|21092162|P1|NOT COMPLETED|18-Week Post Treatment Assessment||2
8554495|NCT00107991|21092162|P1|COMPLETED|18-Week Post Treatment Assessment||8
8554496|NCT00107991|21092162|P1|STARTED|18-Week Post Treatment Assessment||10
8554497|NCT00107991|21092162|P1|NOT COMPLETED|12 Week Treatment Period||5
8554498|NCT00107991|21092162|P1|COMPLETED|12 Week Treatment Period||10
8554499|NCT00107991|21092162|P1|STARTED|12 Week Treatment Period||15
8554500|NCT00107991|21092162|P1|NOT COMPLETED|Eligibility Assessment||23
8554501|NCT00107991|21092162|P1|COMPLETED|Eligibility Assessment||15
8554502|NCT00107991|21092162|P1|STARTED|Eligibility Assessment||38
8554503|NCT00107978|21092172|P2|NOT COMPLETED|Overall Study||50
8554504|NCT00107978|21092173|P1|NOT COMPLETED|Overall Study||33
8554505|NCT00107978|21092172|P2|COMPLETED|Overall Study||431
8554506|NCT00107978|21092173|P1|COMPLETED|Overall Study||425
8554507|NCT00107978|21092172|P2|STARTED|Overall Study||481
8554508|NCT00107978|21092173|P1|STARTED|Overall Study||458
8554509|NCT00107952|21092181|P2|NOT COMPLETED|Overall Study||81
8554510|NCT00107952|21092182|P1|NOT COMPLETED|Overall Study||95
8554511|NCT00107952|21092181|P2|COMPLETED|Overall Study||299
8554512|NCT00107952|21092182|P1|COMPLETED|Overall Study||286
8554513|NCT00107952|21092181|P2|STARTED|Overall Study||380
8554514|NCT00107952|21092182|P1|STARTED|Overall Study||381
8554515|NCT00107900|21092194|P6|NOT COMPLETED|Overall Study||9
8554516|NCT00107900|21092195|P5|NOT COMPLETED|Overall Study||21
8554517|NCT00107900|21092196|P4|NOT COMPLETED|Overall Study||12
8554518|NCT00107900|21092197|P3|NOT COMPLETED|Overall Study||25
8554519|NCT00107900|21092198|P2|NOT COMPLETED|Overall Study||3
8554520|NCT00107900|21092199|P1|NOT COMPLETED|Overall Study||10
8554521|NCT00107900|21092194|P6|COMPLETED|Overall Study||94
8554522|NCT00107900|21092195|P5|COMPLETED|Overall Study||94
8554523|NCT00107900|21092196|P4|COMPLETED|Overall Study||87
8554524|NCT00107900|21092197|P3|COMPLETED|Overall Study||104
8554525|NCT00107900|21092198|P2|COMPLETED|Overall Study||72
8554526|NCT00107900|21092199|P1|COMPLETED|Overall Study||75
8554527|NCT00107900|21092194|P6|STARTED|Overall Study||103
8554528|NCT00107900|21092195|P5|STARTED|Overall Study||115
8554529|NCT00107900|21092196|P4|STARTED|Overall Study||99
8554530|NCT00107900|21092197|P3|STARTED|Overall Study||129
8554531|NCT00107900|21092198|P2|STARTED|Overall Study||75
8554532|NCT00107900|21092199|P1|STARTED|Overall Study||85
8554539|NCT00107744|21092251|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8554540|NCT00107744|21092252|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8554541|NCT00107744|21092253|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8554542|NCT00107744|21092251|P3|COMPLETED|Intervention 3 (8 Weeks)||88
8554543|NCT00107744|21092252|P2|COMPLETED|Intervention 3 (8 Weeks)||92
8554544|NCT00107744|21092253|P1|COMPLETED|Intervention 3 (8 Weeks)||93
8554545|NCT00107744|21092251|P3|STARTED|Intervention 3 (8 Weeks)||88
8554546|NCT00107744|21092252|P2|STARTED|Intervention 3 (8 Weeks)||92
8554547|NCT00107744|21092253|P1|STARTED|Intervention 3 (8 Weeks)||93
8554548|NCT00107744|21092251|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
8554549|NCT00107744|21092252|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
8554550|NCT00107744|21092253|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
8554551|NCT00107744|21092251|P3|COMPLETED|Intervention 2 (8 Weeks)||88
8554552|NCT00107744|21092252|P2|COMPLETED|Intervention 2 (8 Weeks)||92
8554553|NCT00107744|21092253|P1|COMPLETED|Intervention 2 (8 Weeks)||93
8554554|NCT00107744|21092251|P3|STARTED|Intervention 2 (8 Weeks)||101
8554555|NCT00107744|21092252|P2|STARTED|Intervention 2 (8 Weeks)||104
8554556|NCT00107744|21092253|P1|STARTED|Intervention 2 (8 Weeks)||101
8554557|NCT00107744|21092251|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
8554558|NCT00107744|21092252|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
8554559|NCT00107744|21092253|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
8554560|NCT00107744|21092251|P3|COMPLETED|Intervention 1 (8 Weeks)||101
8554561|NCT00107744|21092252|P2|COMPLETED|Intervention 1 (8 Weeks)||104
8554562|NCT00107744|21092253|P1|COMPLETED|Intervention 1 (8 Weeks)||101
8554563|NCT00107744|21092251|P3|STARTED|Intervention 1 (8 Weeks)||118
8554564|NCT00107744|21092252|P2|STARTED|Intervention 1 (8 Weeks)||117
8554565|NCT00107744|21092253|P1|STARTED|Intervention 1 (8 Weeks)||117
8554566|NCT00107653|21092269|P2|NOT COMPLETED|Overall Study||76
8554567|NCT00107653|21092270|P1|NOT COMPLETED|Overall Study||79
8554568|NCT00107653|21092269|P2|COMPLETED|Overall Study||224
8554569|NCT00107653|21092270|P1|COMPLETED|Overall Study||190
8554570|NCT00107653|21092269|P2|STARTED|Overall Study||300
8554571|NCT00107653|21092270|P1|STARTED|Overall Study||269
8554572|NCT00107614|21092316|P1|NOT COMPLETED|Overall Study||12
8554573|NCT00107614|21092316|P1|COMPLETED|Overall Study||0
8554574|NCT00107614|21092316|P1|STARTED|Overall Study||12
8554575|NCT00107575|21092322|P2|NOT COMPLETED|Overall Study||10
8554576|NCT00107575|21092323|P1|NOT COMPLETED|Overall Study||11
8554577|NCT00107575|21092322|P2|COMPLETED|Overall Study||107
8554578|NCT00107575|21092323|P1|COMPLETED|Overall Study||108
8554579|NCT00107575|21092322|P2|STARTED|Overall Study||117
8554580|NCT00107575|21092323|P1|STARTED|Overall Study||119
8554581|NCT00107536|21092337|P1|NOT COMPLETED|Overall Study||0
8554582|NCT00107536|21092337|P1|COMPLETED|Overall Study||26
8554583|NCT00107536|21092337|P1|STARTED|Overall Study||26
8554584|NCT00107380|21092347|P1|NOT COMPLETED|Overall Study||30
8554585|NCT00107380|21092347|P1|COMPLETED|Overall Study||56
8554586|NCT00107380|21092347|P1|Eligible|Overall Study||84
8554587|NCT00107380|21092347|P1|STARTED|Overall Study||86
8554588|NCT00107315|21092353|P1|NOT COMPLETED|Overall Study||15
8554589|NCT00107315|21092353|P1|COMPLETED|Overall Study||1
8554590|NCT00107315|21092353|P1|STARTED|Overall Study||16
8554591|NCT00107276|21092360|P1|NOT COMPLETED|Overall Study||72
8554592|NCT00107276|21092360|P1|COMPLETED|Overall Study||40
8554593|NCT00107276|21092360|P1|Eligible|Overall Study||96
8554594|NCT00107276|21092360|P1|STARTED|Overall Study||112
8554595|NCT00107198|21092366|P1|NOT COMPLETED|Overall Study||52
8554596|NCT00107198|21092366|P1|COMPLETED|Overall Study||136
8554597|NCT00107198|21092366|P1|STARTED|Overall Study||188
8554598|NCT00107172|21092376|P2|NOT COMPLETED|Overall Study||5
8554599|NCT00107172|21092377|P1|NOT COMPLETED|Overall Study||5
8554600|NCT00107172|21092376|P2|COMPLETED|Overall Study||103
8554601|NCT00107172|21092377|P1|COMPLETED|Overall Study||109
8554602|NCT00107172|21092376|P2|STARTED|Overall Study||108
8554603|NCT00107172|21092377|P1|STARTED|Overall Study||114
8554604|NCT00107120|21092407|P2|NOT COMPLETED|Overall Study||24
8554605|NCT00107120|21092408|P1|NOT COMPLETED|Overall Study||29
8554606|NCT00107120|21092407|P2|COMPLETED|Overall Study||133
8554607|NCT00107120|21092408|P1|COMPLETED|Overall Study||126
8554608|NCT00107120|21092407|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
8554609|NCT00107120|21092408|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
8554610|NCT00107042|21092420|P2|NOT COMPLETED|Overall Study||16
8554611|NCT00107042|21092421|P1|NOT COMPLETED|Overall Study||22
8554612|NCT00107042|21092420|P2|COMPLETED|Overall Study||47
8554613|NCT00107042|21092421|P1|COMPLETED|Overall Study||38
8554614|NCT00107042|21092420|P2|STARTED|Overall Study||63
8554615|NCT00107042|21092421|P1|STARTED|Overall Study||60
8554616|NCT00106964|21092487|P3|NOT COMPLETED|Overall Study||7
8554617|NCT00106964|21092488|P2|NOT COMPLETED|Overall Study||15
8554618|NCT00106964|21092489|P1|NOT COMPLETED|Overall Study||13
8554619|NCT00106964|21092487|P3|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
8554620|NCT00106964|21092488|P2|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
8554621|NCT00106964|21092489|P1|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
8554622|NCT00106964|21092487|P3|STARTED|Overall Study||127
8554623|NCT00106964|21092488|P2|STARTED|Overall Study||126
8554624|NCT00106964|21092489|P1|STARTED|Overall Study||118
8554625|NCT00106938|21092514|P2|NOT COMPLETED|Overall Study||71
8554626|NCT00106938|21092515|P1|NOT COMPLETED|Overall Study||176
8554627|NCT00106938|21092514|P2|COMPLETED|Overall Study||293
8554628|NCT00106938|21092515|P1|COMPLETED|Overall Study||913
8554629|NCT00106938|21092514|P2|STARTED|Overall Study||364
8554630|NCT00106938|21092515|P1|STARTED|Overall Study||1089
8554631|NCT00106704|21092584|P2|NOT COMPLETED|Overall Study||151
8554632|NCT00106704|21092585|P1|NOT COMPLETED|Overall Study||131
8554633|NCT00106704|21092584|P2|COMPLETED|Overall Study||68
8554634|NCT00106704|21092585|P1|COMPLETED|Overall Study||91
8554635|NCT00106704|21092584|P2|STARTED|Overall Study||219
8554636|NCT00106704|21092585|P1|STARTED|Overall Study||222
8554637|NCT00106639|21092596|P3|NOT COMPLETED|Overall Study||2
8554638|NCT00106639|21092597|P2|NOT COMPLETED|Overall Study||7
8554639|NCT00106639|21092598|P1|NOT COMPLETED|Overall Study||3
8554640|NCT00106639|21092596|P3|COMPLETED|Overall Study||19
8554641|NCT00106639|21092597|P2|COMPLETED|Overall Study||13
8554642|NCT00106639|21092598|P1|COMPLETED|Overall Study||17
8554643|NCT00106639|21092596|P3|STARTED|Overall Study||21
8554644|NCT00106639|21092597|P2|STARTED|Overall Study||20
8554645|NCT00106639|21092598|P1|STARTED|Overall Study||20
8554646|NCT00106626|21092725|P4|NOT COMPLETED|Overall Study||13
8554647|NCT00106626|21092726|P3|NOT COMPLETED|Overall Study||12
8554648|NCT00106626|21092727|P2|NOT COMPLETED|Overall Study||6
8554649|NCT00106626|21092728|P1|NOT COMPLETED|Overall Study||10
8554650|NCT00106626|21092725|P4|COMPLETED|Overall Study||3
8554651|NCT00106626|21092726|P3|COMPLETED|Overall Study||2
8554652|NCT00106626|21092727|P2|COMPLETED|Overall Study||3
8554653|NCT00106626|21092728|P1|COMPLETED|Overall Study||3
8554654|NCT00106626|21092725|P4|STARTED|Overall Study||16
8554655|NCT00106626|21092726|P3|STARTED|Overall Study||14
8554656|NCT00106626|21092727|P2|STARTED|Overall Study||9
8554657|NCT00106626|21092728|P1|STARTED|Overall Study||13
8554658|NCT00106535|21092746|P4|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
8554659|NCT00106535|21092747|P3|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8554660|NCT00106535|21092748|P2|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8554661|NCT00106535|21092749|P1|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8554662|NCT00106535|21092746|P4|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
8554663|NCT00106535|21092747|P3|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8554664|NCT00106535|21092748|P2|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8554665|NCT00106535|21092749|P1|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
8554666|NCT00106535|21092746|P4|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
8554667|NCT00106535|21092747|P3|STARTED|Long-term Extension Period (Year 3 to 5)||0
8554668|NCT00106535|21092748|P2|STARTED|Long-term Extension Period (Year 3 to 5)||0
8554669|NCT00106535|21092749|P1|STARTED|Long-term Extension Period (Year 3 to 5)||0
8554670|NCT00106535|21092746|P4|NOT COMPLETED|2-year Placebo Controlled Period||0
8554671|NCT00106535|21092747|P3|NOT COMPLETED|2-year Placebo Controlled Period||91
8554672|NCT00106535|21092748|P2|NOT COMPLETED|2-year Placebo Controlled Period||92
8554673|NCT00106535|21092749|P1|NOT COMPLETED|2-year Placebo Controlled Period||107
8554674|NCT00106535|21092746|P4|COMPLETED|2-year Placebo Controlled Period||0
8554675|NCT00106535|21092747|P3|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
8554676|NCT00106535|21092748|P2|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
8554677|NCT00106535|21092749|P1|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
8554678|NCT00106535|21092746|P4|Completed Week 52|2-year Placebo Controlled Period||0
8554679|NCT00106535|21092747|P3|Completed Week 52|2-year Placebo Controlled Period||338
8554680|NCT00106535|21092748|P2|Completed Week 52|2-year Placebo Controlled Period||342
8554681|NCT00106535|21092749|P1|Completed Week 52|2-year Placebo Controlled Period||326
8554682|NCT00106535|21092746|P4|Completed Week 24|2-year Placebo Controlled Period||0
8554683|NCT00106535|21092747|P3|Completed Week 24|2-year Placebo Controlled Period||366
8554684|NCT00106535|21092748|P2|Completed Week 24|2-year Placebo Controlled Period||373
8554685|NCT00106535|21092749|P1|Completed Week 24|2-year Placebo Controlled Period||356
8554686|NCT00106535|21092746|P4|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
8554687|NCT00106535|21092747|P3|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
8554688|NCT00106535|21092748|P2|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
8554689|NCT00106535|21092749|P1|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
8554690|NCT00106535|21092746|P4|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
8554691|NCT00106535|21092747|P3|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
8554692|NCT00106535|21092748|P2|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
8554693|NCT00106535|21092749|P1|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
8554694|NCT00106535|21092746|P4|STARTED|2-year Placebo Controlled Period||0
8554695|NCT00106535|21092747|P3|STARTED|2-year Placebo Controlled Period||401
8554696|NCT00106535|21092748|P2|STARTED|2-year Placebo Controlled Period||401
8554697|NCT00106535|21092749|P1|STARTED|2-year Placebo Controlled Period||394
8554698|NCT00106431|21093042|P1|NOT COMPLETED|Overall Study||65
8554699|NCT00106431|21093042|P1|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
8554700|NCT00106431|21093042|P1|STARTED|Overall Study||102
8554701|NCT00106392|21093054|P2|NOT COMPLETED|Overall Study||27
8554702|NCT00106392|21093055|P1|NOT COMPLETED|Overall Study||26
8554703|NCT00106392|21093054|P2|COMPLETED|Overall Study||42
8554704|NCT00106392|21093055|P1|COMPLETED|Overall Study||36
8554705|NCT00106392|21093054|P2|Full Analysis Set (FAS)|Overall Study||61
8554706|NCT00106392|21093055|P1|Full Analysis Set (FAS)|Overall Study||53
8554707|NCT00106392|21093054|P2|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
8554708|NCT00106392|21093055|P1|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
8554709|NCT00106392|21093054|P2|STARTED|Overall Study||69
8554710|NCT00106392|21093055|P1|STARTED|Overall Study||62
8554711|NCT00106353|21093073|P7|NOT COMPLETED|Part 2||16
8554712|NCT00106353|21093074|P6|NOT COMPLETED|Part 2||18
8554713|NCT00106353|21093075|P5|NOT COMPLETED|Part 2||16
8554714|NCT00106353|21093076|P4|NOT COMPLETED|Part 2||0
8554715|NCT00106353|21093077|P3|NOT COMPLETED|Part 2||0
8554716|NCT00106353|21093078|P2|NOT COMPLETED|Part 2||0
8554717|NCT00106353|21093079|P1|NOT COMPLETED|Part 2||0
8554718|NCT00106353|21093073|P7|COMPLETED|Part 2||0
8554719|NCT00106353|21093074|P6|COMPLETED|Part 2||1
8554720|NCT00106353|21093075|P5|COMPLETED|Part 2||1
8554721|NCT00106353|21093076|P4|COMPLETED|Part 2||0
8554722|NCT00106353|21093077|P3|COMPLETED|Part 2||0
8554723|NCT00106353|21093078|P2|COMPLETED|Part 2||0
8554724|NCT00106353|21093079|P1|COMPLETED|Part 2||0
8554725|NCT00106353|21093073|P7|STARTED|Part 2||16
8554726|NCT00106353|21093074|P6|STARTED|Part 2||19
8554727|NCT00106353|21093075|P5|STARTED|Part 2||17
8554728|NCT00106353|21093076|P4|STARTED|Part 2||0
8554729|NCT00106353|21093077|P3|STARTED|Part 2||0
8554730|NCT00106353|21093078|P2|STARTED|Part 2||0
8554731|NCT00106353|21093079|P1|STARTED|Part 2||0
8554732|NCT00106353|21093073|P7|NOT COMPLETED|Part 1||0
8554733|NCT00106353|21093074|P6|NOT COMPLETED|Part 1||0
8554734|NCT00106353|21093075|P5|NOT COMPLETED|Part 1||0
8554735|NCT00106353|21093076|P4|NOT COMPLETED|Part 1||7
8554736|NCT00106353|21093077|P3|NOT COMPLETED|Part 1||3
8554737|NCT00106353|21093078|P2|NOT COMPLETED|Part 1||5
8554738|NCT00106353|21093079|P1|NOT COMPLETED|Part 1||4
8554739|NCT00106353|21093073|P7|COMPLETED|Part 1||0
8554740|NCT00106353|21093074|P6|COMPLETED|Part 1||0
8554741|NCT00106353|21093075|P5|COMPLETED|Part 1||0
8554742|NCT00106353|21093076|P4|COMPLETED|Part 1||0
8554743|NCT00106353|21093077|P3|COMPLETED|Part 1||0
8554744|NCT00106353|21093078|P2|COMPLETED|Part 1||0
8554745|NCT00106353|21093079|P1|COMPLETED|Part 1||0
8554746|NCT00106353|21093073|P7|STARTED|Part 1||0
8554747|NCT00106353|21093074|P6|STARTED|Part 1||0
8554748|NCT00106353|21093075|P5|STARTED|Part 1||0
8554749|NCT00106353|21093076|P4|STARTED|Part 1||7
8554750|NCT00106353|21093077|P3|STARTED|Part 1||3
8554751|NCT00106353|21093078|P2|STARTED|Part 1||5
8554752|NCT00106353|21093079|P1|STARTED|Part 1||4
8554753|NCT00106249|21093206|P2|NOT COMPLETED|Overall Study||2
8554754|NCT00106249|21093207|P1|NOT COMPLETED|Overall Study||3
8554755|NCT00106249|21093206|P2|COMPLETED|Overall Study||11
8554756|NCT00106249|21093207|P1|COMPLETED|Overall Study||11
8554757|NCT00106249|21093206|P2|STARTED|Overall Study||13
8554758|NCT00106249|21093207|P1|STARTED|Overall Study||14
8554759|NCT00106184|21093219|P2|NOT COMPLETED|Overall Study||2
8554760|NCT00106184|21093220|P1|NOT COMPLETED|Overall Study||3
8554761|NCT00106184|21093219|P2|COMPLETED|Overall Study||102
8554762|NCT00106184|21093220|P1|COMPLETED|Overall Study||93
8554763|NCT00106184|21093219|P2|Treated|Overall Study|104 subjects were randomized.|102
8554764|NCT00106184|21093220|P1|Treated|Overall Study|96 subjects were randomized.|93
8554765|NCT00106184|21093219|P2|STARTED|Overall Study||104
8554766|NCT00106184|21093220|P1|STARTED|Overall Study||96
8554767|NCT00106119|21093230|P2|NOT COMPLETED|Second Intervention||0
8554768|NCT00106119|21093231|P1|NOT COMPLETED|Second Intervention||0
8554769|NCT00106119|21093230|P2|COMPLETED|Second Intervention||7
8554770|NCT00106119|21093231|P1|COMPLETED|Second Intervention||7
8554771|NCT00106119|21093230|P2|STARTED|Second Intervention||7
8554772|NCT00106119|21093231|P1|STARTED|Second Intervention||7
8554773|NCT00106119|21093230|P2|NOT COMPLETED|Washout Period of 30 Days||0
8554774|NCT00106119|21093231|P1|NOT COMPLETED|Washout Period of 30 Days||0
8554775|NCT00106119|21093230|P2|COMPLETED|Washout Period of 30 Days||7
8554776|NCT00106119|21093231|P1|COMPLETED|Washout Period of 30 Days||7
8554777|NCT00106119|21093230|P2|STARTED|Washout Period of 30 Days||7
8554778|NCT00106119|21093231|P1|STARTED|Washout Period of 30 Days||7
8554779|NCT00106119|21093230|P2|NOT COMPLETED|First Intervention||0
8554780|NCT00106119|21093231|P1|NOT COMPLETED|First Intervention||0
8554781|NCT00106119|21093230|P2|COMPLETED|First Intervention||7
8554782|NCT00106119|21093231|P1|COMPLETED|First Intervention||7
8554783|NCT00106119|21093230|P2|STARTED|First Intervention||7
8554784|NCT00106119|21093231|P1|STARTED|First Intervention||7
8554785|NCT00106106|21093251|P2|NOT COMPLETED|Overall Study||4
8554786|NCT00106106|21093252|P1|NOT COMPLETED|Overall Study||4
8554787|NCT00106106|21093251|P2|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
8554788|NCT00106106|21093252|P1|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
8554789|NCT00106106|21093251|P2|Completed Both MRS Scans|Overall Study||15
8554790|NCT00106106|21093252|P1|Completed Both MRS Scans|Overall Study||18
8554791|NCT00106106|21093251|P2|STARTED|Overall Study||23
8554792|NCT00106106|21093252|P1|STARTED|Overall Study||26
8554793|NCT00106080|21093262|P2|NOT COMPLETED|Overall Study||27
8554794|NCT00106080|21093263|P1|NOT COMPLETED|Overall Study||43
8554795|NCT00106080|21093262|P2|COMPLETED|Overall Study||155
8554796|NCT00106080|21093263|P1|COMPLETED|Overall Study||151
8554797|NCT00106080|21093262|P2|STARTED|Overall Study||182
8554798|NCT00106080|21093263|P1|STARTED|Overall Study||194
8554799|NCT00106028|21093273|P2|NOT COMPLETED|Overall Study||12
8554800|NCT00106028|21093274|P1|NOT COMPLETED|Overall Study||6
8554801|NCT00106028|21093273|P2|COMPLETED|Overall Study|Completed Month 36|82
8554802|NCT00106028|21093274|P1|COMPLETED|Overall Study|Completed Month 36|43
8554803|NCT00106028|21093273|P2|Month 12 Completed/Started Open Label|Overall Study||87
8554804|NCT00106028|21093274|P1|Month 12 Completed/Started Open Label|Overall Study||49
8554805|NCT00106028|21093273|P2|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
8554806|NCT00106028|21093274|P1|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
8554807|NCT00106002|21093368|P1|NOT COMPLETED|Overall Study||2
8554808|NCT00106002|21093368|P1|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
8554809|NCT00106002|21093368|P1|STARTED|Overall Study||37
8554810|NCT00105989|21093376|P2|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
8554811|NCT00105989|21093377|P1|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
8554812|NCT00105989|21093376|P2|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
8554813|NCT00105989|21093377|P1|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
8554814|NCT00105989|21093376|P2|STARTED|Maintenance - Double-Blind:Week 34-86||142
8554815|NCT00105989|21093377|P1|STARTED|Maintenance - Double-Blind:Week 34-86||146
8554816|NCT00105989|21093376|P2|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
8554817|NCT00105989|21093377|P1|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
8554818|NCT00105989|21093376|P2|COMPLETED|Continuation - Open Label:Week 10-34||0
8554819|NCT00105989|21093377|P1|COMPLETED|Continuation - Open Label:Week 10-34||288
8554820|NCT00105989|21093376|P2|STARTED|Continuation - Open Label:Week 10-34||0
8554821|NCT00105989|21093377|P1|STARTED|Continuation - Open Label:Week 10-34||413
8554822|NCT00105989|21093376|P2|NOT COMPLETED|Acute - Open Label: Week 0-10||0
8554823|NCT00105989|21093377|P1|NOT COMPLETED|Acute - Open Label: Week 0-10||101
8554824|NCT00105989|21093376|P2|COMPLETED|Acute - Open Label: Week 0-10||0
8554825|NCT00105989|21093377|P1|COMPLETED|Acute - Open Label: Week 0-10||413
8554826|NCT00105989|21093376|P2|STARTED|Acute - Open Label: Week 0-10||0
8554827|NCT00105989|21093377|P1|STARTED|Acute - Open Label: Week 0-10||514
8554828|NCT00105586|21093493|P2|NOT COMPLETED|Overall Study||16
8554829|NCT00105586|21093494|P1|NOT COMPLETED|Overall Study||17
8554830|NCT00105586|21093493|P2|COMPLETED|Overall Study||69
8554831|NCT00105586|21093494|P1|COMPLETED|Overall Study||75
8554832|NCT00105586|21093493|P2|STARTED|Overall Study||85
8554833|NCT00105586|21093494|P1|STARTED|Overall Study||92
8554834|NCT00105560|21093502|P1|NOT COMPLETED|Overall Study||1
8554835|NCT00105560|21093502|P1|COMPLETED|Overall Study||58
8554836|NCT00105560|21093502|P1|STARTED|Overall Study||59
8554837|NCT00105534|21093524|P2|NOT COMPLETED|Overall Study||33
8554838|NCT00105534|21093525|P1|NOT COMPLETED|Overall Study||22
8554839|NCT00105534|21093524|P2|COMPLETED|Overall Study||317
8554840|NCT00105534|21093525|P1|COMPLETED|Overall Study||313
8554841|NCT00105534|21093524|P2|STARTED|Overall Study||350
8554842|NCT00105534|21093525|P1|STARTED|Overall Study||335
8554843|NCT00105521|21093537|P4|NOT COMPLETED|Overall Study||17
8554844|NCT00105521|21093538|P3|NOT COMPLETED|Overall Study||17
8554845|NCT00105521|21093539|P2|NOT COMPLETED|Overall Study||11
8554846|NCT00105521|21093540|P1|NOT COMPLETED|Overall Study||15
8554847|NCT00105521|21093537|P4|COMPLETED|Overall Study||85
8554848|NCT00105521|21093538|P3|COMPLETED|Overall Study||80
8554849|NCT00105521|21093539|P2|COMPLETED|Overall Study||90
8554850|NCT00105521|21093540|P1|COMPLETED|Overall Study||83
8554851|NCT00105521|21093537|P4|STARTED|Overall Study||102
8554852|NCT00105521|21093538|P3|STARTED|Overall Study||97
8554853|NCT00105521|21093539|P2|STARTED|Overall Study||101
8554854|NCT00105521|21093540|P1|STARTED|Overall Study||98
8554855|NCT00105508|21093564|P2|NOT COMPLETED|Overall Study||36
8554856|NCT00105508|21093565|P1|NOT COMPLETED|Overall Study||40
8554857|NCT00105508|21093564|P2|COMPLETED|Overall Study||217
8554858|NCT00105508|21093565|P1|COMPLETED|Overall Study||213
8554859|NCT00105508|21093564|P2|STARTED|Overall Study||253
8554860|NCT00105508|21093565|P1|STARTED|Overall Study||253
8554861|NCT00105482|21093579|P2|NOT COMPLETED|Overall Study||55
8554862|NCT00105482|21093580|P1|NOT COMPLETED|Overall Study||59
8554863|NCT00105482|21093579|P2|COMPLETED|Overall Study||30
8554864|NCT00105482|21093580|P1|COMPLETED|Overall Study||28
8554865|NCT00105482|21093579|P2|STARTED|Overall Study||85
8554866|NCT00105482|21093580|P1|STARTED|Overall Study||87
8554867|NCT00105469|21093596|P2|NOT COMPLETED|Overall Study||11
8554868|NCT00105469|21093597|P1|NOT COMPLETED|Overall Study||22
8554869|NCT00105469|21093596|P2|COMPLETED|Overall Study||367
8554870|NCT00105469|21093597|P1|COMPLETED|Overall Study||343
8554871|NCT00105469|21093596|P2|STARTED|Overall Study||378
8554872|NCT00105469|21093597|P1|STARTED|Overall Study||365
8554873|NCT00105443|21093607|P4|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
8554874|NCT00105443|21093608|P3|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
8554875|NCT00105443|21093609|P2|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
8554876|NCT00105443|21093610|P1|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
8554877|NCT00105443|21093607|P4|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
8554878|NCT00105443|21093608|P3|COMPLETED|Follow-up and/or Open Label Nexavar||0
8554879|NCT00105443|21093609|P2|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
8554880|NCT00105443|21093610|P1|COMPLETED|Follow-up and/or Open Label Nexavar||0
8554881|NCT00105443|21093607|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
8554882|NCT00105443|21093608|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
8554883|NCT00105443|21093609|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
8554884|NCT00105443|21093610|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
8554885|NCT00105443|21093607|P4|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
8554886|NCT00105443|21093608|P3|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
8554887|NCT00105443|21093609|P2|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
8554888|NCT00105443|21093610|P1|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
8554889|NCT00105443|21093607|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
8554890|NCT00105443|21093608|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
8554891|NCT00105443|21093609|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
8554892|NCT00105443|21093610|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
8554893|NCT00105443|21093607|P4|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
8554894|NCT00105443|21093608|P3|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
8554895|NCT00105443|21093609|P2|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
8554896|NCT00105443|21093610|P1|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
8554897|NCT00105443|21093607|P4|NOT COMPLETED|Double-Blind Treatment||0
8554898|NCT00105443|21093608|P3|NOT COMPLETED|Double-Blind Treatment||11
8554899|NCT00105443|21093609|P2|NOT COMPLETED|Double-Blind Treatment||0
8554900|NCT00105443|21093610|P1|NOT COMPLETED|Double-Blind Treatment||14
8554901|NCT00105443|21093607|P4|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
8554902|NCT00105443|21093608|P3|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
8554903|NCT00105443|21093609|P2|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
8554904|NCT00105443|21093610|P1|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
8554905|NCT00105443|21093607|P4|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
8554906|NCT00105443|21093608|P3|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
8554907|NCT00105443|21093609|P2|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
8554908|NCT00105443|21093610|P1|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
8554909|NCT00105443|21093607|P4|STARTED|Double-Blind Treatment||47
8554910|NCT00105443|21093608|P3|STARTED|Double-Blind Treatment||256
8554911|NCT00105443|21093609|P2|STARTED|Double-Blind Treatment||57
8554912|NCT00105443|21093610|P1|STARTED|Double-Blind Treatment||242
8554913|NCT00105235|21093637|P1|NOT COMPLETED|Overall Study||7
8554914|NCT00105235|21093637|P1|COMPLETED|Overall Study||20
8554915|NCT00105235|21093637|P1|STARTED|Overall Study||27
8554916|NCT00105196|21093650|P2|NOT COMPLETED|Overall Study||23
8554917|NCT00105196|21093651|P1|NOT COMPLETED|Overall Study||30
8554918|NCT00105196|21093650|P2|COMPLETED|Overall Study||149
8554919|NCT00105196|21093651|P1|COMPLETED|Overall Study||147
8554920|NCT00105196|21093650|P2|STARTED|Overall Study||172
8554921|NCT00105196|21093651|P1|STARTED|Overall Study||177
8554922|NCT00105183|21093674|P3|NOT COMPLETED|Overall Study||23
8554923|NCT00105183|21093675|P2|NOT COMPLETED|Overall Study||19
8554924|NCT00105183|21093676|P1|NOT COMPLETED|Overall Study||22
8554925|NCT00105183|21093674|P3|COMPLETED|Overall Study|Completed at least 12 months follow up|39
8554926|NCT00105183|21093675|P2|COMPLETED|Overall Study|Completed at least 12 months follow up|60
8554927|NCT00105183|21093676|P1|COMPLETED|Overall Study|Completed at least 12 months follow up|60
8554928|NCT00105183|21093674|P3|STARTED|Overall Study|Randomized|62
8554929|NCT00105183|21093675|P2|STARTED|Overall Study|Randomized|79
8554930|NCT00105183|21093676|P1|STARTED|Overall Study|Randomized|82
8554931|NCT00105157|21093712|P4|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
8554932|NCT00105157|21093713|P3|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
8554933|NCT00105157|21093714|P2|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
8554934|NCT00105157|21093715|P1|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
8554935|NCT00105157|21093712|P4|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
8554936|NCT00105157|21093713|P3|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
8554937|NCT00105157|21093714|P2|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
8554938|NCT00105157|21093715|P1|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
8554939|NCT00105157|21093712|P4|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
8554940|NCT00105157|21093713|P3|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
8554941|NCT00105157|21093714|P2|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
8554942|NCT00105157|21093715|P1|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
8554943|NCT00105157|21093712|P4|NOT COMPLETED|Open-Label Continuation of DB||1
8554944|NCT00105157|21093713|P3|NOT COMPLETED|Open-Label Continuation of DB||9
8554945|NCT00105157|21093714|P2|NOT COMPLETED|Open-Label Continuation of DB||10
8554946|NCT00105157|21093715|P1|NOT COMPLETED|Open-Label Continuation of DB||7
8554947|NCT00105157|21093712|P4|COMPLETED|Open-Label Continuation of DB||5
8554948|NCT00105157|21093713|P3|COMPLETED|Open-Label Continuation of DB||24
8554949|NCT00105157|21093714|P2|COMPLETED|Open-Label Continuation of DB||21
8554950|NCT00105157|21093715|P1|COMPLETED|Open-Label Continuation of DB||23
8554951|NCT00105157|21093712|P4|STARTED|Open-Label Continuation of DB||6
8554952|NCT00105157|21093713|P3|STARTED|Open-Label Continuation of DB||33
8554953|NCT00105157|21093714|P2|STARTED|Open-Label Continuation of DB||31
8554954|NCT00105157|21093715|P1|STARTED|Open-Label Continuation of DB||30
8554955|NCT00105157|21093712|P4|NOT COMPLETED|Double-Blind (DB)||39
8554956|NCT00105157|21093713|P3|NOT COMPLETED|Double-Blind (DB)||12
8554957|NCT00105157|21093714|P2|NOT COMPLETED|Double-Blind (DB)||14
8554958|NCT00105157|21093715|P1|NOT COMPLETED|Double-Blind (DB)||14
8554959|NCT00105157|21093712|P4|COMPLETED|Double-Blind (DB)||6
8554960|NCT00105157|21093713|P3|COMPLETED|Double-Blind (DB)||33
8554961|NCT00105157|21093714|P2|COMPLETED|Double-Blind (DB)||31
8554962|NCT00105157|21093715|P1|COMPLETED|Double-Blind (DB)||30
8554963|NCT00105157|21093712|P4|Treated|Double-Blind (DB)||45
8554964|NCT00105157|21093713|P3|Treated|Double-Blind (DB)||45
8554965|NCT00105157|21093714|P2|Treated|Double-Blind (DB)||45
8554966|NCT00105157|21093715|P1|Treated|Double-Blind (DB)||43
8554967|NCT00105157|21093712|P4|STARTED|Double-Blind (DB)||45
8554968|NCT00105157|21093713|P3|STARTED|Double-Blind (DB)||45
8554969|NCT00105157|21093714|P2|STARTED|Double-Blind (DB)||45
8554970|NCT00105157|21093715|P1|STARTED|Double-Blind (DB)||44
8554971|NCT00105079|21093909|P2|NOT COMPLETED|Overall Study||35
8554972|NCT00105079|21093910|P1|NOT COMPLETED|Overall Study||39
8554973|NCT00105079|21093909|P2|COMPLETED|Overall Study||135
8554974|NCT00105079|21093910|P1|COMPLETED|Overall Study||128
8554975|NCT00105079|21093909|P2|Safety Population|Overall Study||168
8554976|NCT00105079|21093910|P1|Safety Population|Overall Study||163
8554977|NCT00105079|21093909|P2|STARTED|Overall Study||170
8554978|NCT00105079|21093910|P1|STARTED|Overall Study||167
8554979|NCT00105066|21093928|P2|NOT COMPLETED|Overall Study||5
8554980|NCT00105066|21093929|P1|NOT COMPLETED|Overall Study||2
8554981|NCT00105066|21093928|P2|COMPLETED|Overall Study||45
8554982|NCT00105066|21093929|P1|COMPLETED|Overall Study||25
8554983|NCT00105066|21093928|P2|STARTED|Overall Study||50
8554984|NCT00105066|21093929|P1|STARTED|Overall Study||27
8554985|NCT00105027|21093945|P6|NOT COMPLETED|Overall Study||13
8554986|NCT00105027|21093946|P5|NOT COMPLETED|Overall Study||15
8554987|NCT00105027|21093947|P4|NOT COMPLETED|Overall Study||16
8554988|NCT00105027|21093948|P3|NOT COMPLETED|Overall Study||9
8554989|NCT00105027|21093949|P2|NOT COMPLETED|Overall Study||9
8554990|NCT00105027|21093950|P1|NOT COMPLETED|Overall Study||15
8554991|NCT00105027|21093945|P6|COMPLETED|Overall Study||125
8554992|NCT00105027|21093946|P5|COMPLETED|Overall Study||121
8554993|NCT00105027|21093947|P4|COMPLETED|Overall Study||121
8554994|NCT00105027|21093948|P3|COMPLETED|Overall Study||82
8554995|NCT00105027|21093949|P2|COMPLETED|Overall Study||83
8554996|NCT00105027|21093950|P1|COMPLETED|Overall Study||73
8554997|NCT00105027|21093945|P6|STARTED|Overall Study||138
8554998|NCT00105027|21093946|P5|STARTED|Overall Study||136
8554999|NCT00105027|21093947|P4|STARTED|Overall Study||137
8555000|NCT00105027|21093948|P3|STARTED|Overall Study||91
8555001|NCT00105027|21093949|P2|STARTED|Overall Study||92
8555002|NCT00105027|21093950|P1|STARTED|Overall Study||88
8555003|NCT00105001|21093985|P3|NOT COMPLETED|Overall Study||0
8555004|NCT00105001|21093986|P2|NOT COMPLETED|Overall Study||0
8555005|NCT00105001|21093987|P1|NOT COMPLETED|Overall Study||0
8555006|NCT00105001|21093985|P3|COMPLETED|Overall Study||69
8555007|NCT00105001|21093986|P2|COMPLETED|Overall Study||71
8555008|NCT00105001|21093987|P1|COMPLETED|Overall Study||70
8555009|NCT00105001|21093985|P3|STARTED|Overall Study||69
8555010|NCT00105001|21093986|P2|STARTED|Overall Study||71
8555011|NCT00105001|21093987|P1|STARTED|Overall Study||70
8555012|NCT00104884|21094007|P1|NOT COMPLETED|Overall Study||4
8555013|NCT00104884|21094007|P1|COMPLETED|Overall Study||0
8555014|NCT00104884|21094007|P1|STARTED|Overall Study||4
8555015|NCT00104871|21094011|P1|NOT COMPLETED|Overall Study||1
8555016|NCT00104871|21094011|P1|COMPLETED|Overall Study||21
8555017|NCT00104871|21094011|P1|STARTED|Overall Study||22
8555018|NCT00104858|21094017|P1|NOT COMPLETED|Overall Study||0
8555019|NCT00104858|21094017|P1|COMPLETED|Overall Study||52
8555020|NCT00104858|21094017|P1|STARTED|Overall Study||52
8555021|NCT00104728|21094032|P1|NOT COMPLETED|Overall Study||19
8555022|NCT00104728|21094032|P1|COMPLETED|Overall Study||23
8555023|NCT00104728|21094032|P1|STARTED|Overall Study|42 consented on study|42
8555024|NCT00104650|21094040|P3|NOT COMPLETED|Follow-up Period||10
8555025|NCT00104650|21094041|P2|NOT COMPLETED|Follow-up Period||13
8555026|NCT00104650|21094042|P1|NOT COMPLETED|Follow-up Period||11
8555027|NCT00104650|21094040|P3|COMPLETED|Follow-up Period||18
8555028|NCT00104650|21094041|P2|COMPLETED|Follow-up Period||12
8555029|NCT00104650|21094042|P1|COMPLETED|Follow-up Period||14
8555030|NCT00104650|21094040|P3|STARTED|Follow-up Period||28
8555031|NCT00104650|21094041|P2|STARTED|Follow-up Period||25
8555032|NCT00104650|21094042|P1|STARTED|Follow-up Period||25
8555033|NCT00104650|21094040|P3|NOT COMPLETED|Treatment Period (25 Weeks)||10
8555034|NCT00104650|21094041|P2|NOT COMPLETED|Treatment Period (25 Weeks)||11
8555035|NCT00104650|21094042|P1|NOT COMPLETED|Treatment Period (25 Weeks)||12
8555036|NCT00104650|21094040|P3|COMPLETED|Treatment Period (25 Weeks)||28
8555037|NCT00104650|21094041|P2|COMPLETED|Treatment Period (25 Weeks)||25
8555038|NCT00104650|21094042|P1|COMPLETED|Treatment Period (25 Weeks)||25
8555039|NCT00104650|21094040|P3|Received Investigational Product|Treatment Period (25 Weeks)||38
8555040|NCT00104650|21094041|P2|Received Investigational Product|Treatment Period (25 Weeks)||35
8555041|NCT00104650|21094042|P1|Received Investigational Product|Treatment Period (25 Weeks)||35
8555042|NCT00104650|21094040|P3|STARTED|Treatment Period (25 Weeks)||38
8555043|NCT00104650|21094041|P2|STARTED|Treatment Period (25 Weeks)||36
8555044|NCT00104650|21094042|P1|STARTED|Treatment Period (25 Weeks)||37
8555045|NCT00104637|21094074|P2|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
8555046|NCT00104637|21094075|P1|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
8555047|NCT00104637|21094074|P2|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
8555048|NCT00104637|21094075|P1|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
8555049|NCT00104637|21094074|P2|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
8555050|NCT00104637|21094075|P1|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
8555051|NCT00104637|21094074|P2|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
8555052|NCT00104637|21094075|P1|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
8555053|NCT00104637|21094074|P2|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
8555054|NCT00104637|21094075|P1|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
8555055|NCT00104637|21094074|P2|STARTED|Period 2 (WASHOUT: 1 Week)||4
8555056|NCT00104637|21094075|P1|STARTED|Period 2 (WASHOUT: 1 Week)||5
8555057|NCT00104637|21094074|P2|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
8555058|NCT00104637|21094075|P1|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
8555059|NCT00104637|21094074|P2|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
8555060|NCT00104637|21094075|P1|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
8555061|NCT00104637|21094074|P2|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
8555062|NCT00104637|21094075|P1|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
8555063|NCT00104572|21094104|P3|NOT COMPLETED|Overall Study||0
8555064|NCT00104572|21094105|P2|NOT COMPLETED|Overall Study||3
8555065|NCT00104572|21094106|P1|NOT COMPLETED|Overall Study||3
8555066|NCT00104572|21094104|P3|COMPLETED|Overall Study||9
8555067|NCT00104572|21094105|P2|COMPLETED|Overall Study||10
8555068|NCT00104572|21094106|P1|COMPLETED|Overall Study||10
8555069|NCT00104572|21094104|P3|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
8555070|NCT00104572|21094105|P2|STARTED|Overall Study|These are the analysed subjects|13
8555071|NCT00104572|21094106|P1|STARTED|Overall Study|These are the analysed subjects|13
8555072|NCT00104520|21094125|P2|NOT COMPLETED|Overall Study||71
8555073|NCT00104520|21094126|P1|NOT COMPLETED|Overall Study||50
8555074|NCT00104520|21094125|P2|COMPLETED|Overall Study||64
8555075|NCT00104520|21094126|P1|COMPLETED|Overall Study||26
8555076|NCT00104520|21094125|P2|STARTED|Overall Study||135
8555077|NCT00104520|21094126|P1|STARTED|Overall Study||76
8555078|NCT00104416|21094146|P5|NOT COMPLETED|Continuation Phase||5
8555079|NCT00104416|21094147|P4|NOT COMPLETED|Continuation Phase||2
8555080|NCT00104416|21094148|P3|NOT COMPLETED|Continuation Phase||6
8555081|NCT00104416|21094149|P2|NOT COMPLETED|Continuation Phase||0
8555082|NCT00104416|21094150|P1|NOT COMPLETED|Continuation Phase||0
8555083|NCT00104416|21094146|P5|COMPLETED|Continuation Phase||27
8555084|NCT00104416|21094147|P4|COMPLETED|Continuation Phase||65
8555085|NCT00104416|21094148|P3|COMPLETED|Continuation Phase||63
8555086|NCT00104416|21094149|P2|COMPLETED|Continuation Phase||0
8555087|NCT00104416|21094150|P1|COMPLETED|Continuation Phase||0
8555088|NCT00104416|21094146|P5|STARTED|Continuation Phase||32
8555089|NCT00104416|21094147|P4|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
8555090|NCT00104416|21094148|P3|STARTED|Continuation Phase||69
8555091|NCT00104416|21094149|P2|STARTED|Continuation Phase||0
8555092|NCT00104416|21094150|P1|STARTED|Continuation Phase||0
8555093|NCT00104416|21094146|P5|NOT COMPLETED|Double-Blind Phase||0
8555094|NCT00104416|21094147|P4|NOT COMPLETED|Double-Blind Phase||0
8555095|NCT00104416|21094148|P3|NOT COMPLETED|Double-Blind Phase||0
8555096|NCT00104416|21094149|P2|NOT COMPLETED|Double-Blind Phase||10
8555097|NCT00104416|21094150|P1|NOT COMPLETED|Double-Blind Phase||8
8555098|NCT00104416|21094146|P5|COMPLETED|Double-Blind Phase||0
8555099|NCT00104416|21094147|P4|COMPLETED|Double-Blind Phase||0
8555100|NCT00104416|21094148|P3|COMPLETED|Double-Blind Phase||0
8555101|NCT00104416|21094149|P2|COMPLETED|Double-Blind Phase||66
8555102|NCT00104416|21094150|P1|COMPLETED|Double-Blind Phase||69
8555103|NCT00104416|21094146|P5|STARTED|Double-Blind Phase||0
8555104|NCT00104416|21094147|P4|STARTED|Double-Blind Phase||0
8555105|NCT00104416|21094148|P3|STARTED|Double-Blind Phase||0
8555106|NCT00104416|21094149|P2|STARTED|Double-Blind Phase||76
8555107|NCT00104416|21094150|P1|STARTED|Double-Blind Phase||77
8555108|NCT00104299|21094195|P2|NOT COMPLETED|Overall Study||10
8555109|NCT00104299|21094196|P1|NOT COMPLETED|Overall Study||9
8555110|NCT00104299|21094195|P2|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
8555111|NCT00104299|21094196|P1|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
8555112|NCT00104299|21094195|P2|STARTED|Overall Study||98
8555113|NCT00104299|21094196|P1|STARTED|Overall Study||99
8555114|NCT00104247|21094218|P2|NOT COMPLETED|Overall Study||1
8555115|NCT00104247|21094219|P1|NOT COMPLETED|Overall Study||1
8555116|NCT00104247|21094218|P2|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
8555117|NCT00104247|21094219|P1|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
8555118|NCT00104247|21094218|P2|STARTED|Overall Study||47
8555119|NCT00104247|21094219|P1|STARTED|Overall Study||42
8555120|NCT00104234|21094227|P2|NOT COMPLETED|Overall Study||1
8555121|NCT00104234|21094228|P1|NOT COMPLETED|Overall Study||0
8555122|NCT00104234|21094227|P2|COMPLETED|Overall Study||19
8555123|NCT00104234|21094228|P1|COMPLETED|Overall Study||19
8555124|NCT00104234|21094227|P2|STARTED|Overall Study||20
8555125|NCT00104234|21094228|P1|STARTED|Overall Study||19
8555126|NCT00104104|21094238|P2|NOT COMPLETED|Overall Study||72
8555127|NCT00104104|21094239|P1|NOT COMPLETED|Overall Study||75
8555128|NCT00104104|21094238|P2|COMPLETED|Overall Study||17
8555129|NCT00104104|21094239|P1|COMPLETED|Overall Study||15
8555130|NCT00104104|21094238|P2|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
8555131|NCT00104104|21094239|P1|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
8555132|NCT00104104|21094238|P2|Safety Population (Including Site 74)|Overall Study||88
8555133|NCT00104104|21094239|P1|Safety Population (Including Site 74)|Overall Study||88
8555134|NCT00104104|21094238|P2|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
8555135|NCT00104104|21094239|P1|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
8555136|NCT00104052|21094253|P1|NOT COMPLETED|Overall Study||29
8555137|NCT00104052|21094253|P1|COMPLETED|Overall Study||78
8555138|NCT00104052|21094253|P1|STARTED|Overall Study||107
8555139|NCT00103857|21094264|P7|NOT COMPLETED|50-Week Extension Study||0
8555140|NCT00103857|21094265|P6|NOT COMPLETED|50-Week Extension Study||20
8555141|NCT00103857|21094266|P5|NOT COMPLETED|50-Week Extension Study||21
8555142|NCT00103857|21094267|P4|NOT COMPLETED|50-Week Extension Study||36
8555143|NCT00103857|21094268|P3|NOT COMPLETED|50-Week Extension Study||26
8555144|NCT00103857|21094269|P2|NOT COMPLETED|50-Week Extension Study||27
8555145|NCT00103857|21094270|P1|NOT COMPLETED|50-Week Extension Study||38
8555146|NCT00103857|21094264|P7|COMPLETED|50-Week Extension Study||0
8555147|NCT00103857|21094265|P6|COMPLETED|50-Week Extension Study||78
8555148|NCT00103857|21094266|P5|COMPLETED|50-Week Extension Study||101
8555149|NCT00103857|21094267|P4|COMPLETED|50-Week Extension Study||98
8555150|NCT00103857|21094268|P3|COMPLETED|50-Week Extension Study||95
8555151|NCT00103857|21094269|P2|COMPLETED|50-Week Extension Study||80
8555152|NCT00103857|21094270|P1|COMPLETED|50-Week Extension Study||65
8555153|NCT00103857|21094264|P7|STARTED|50-Week Extension Study||0
8555154|NCT00103857|21094265|P6|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
8555155|NCT00103857|21094266|P5|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
8555156|NCT00103857|21094267|P4|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
8555157|NCT00103857|21094268|P3|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
8555158|NCT00103857|21094269|P2|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
8555159|NCT00103857|21094270|P1|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
8555160|NCT00103857|21094264|P7|NOT COMPLETED|54-Week Base Study||38
8555161|NCT00103857|21094265|P6|NOT COMPLETED|54-Week Base Study||61
8555162|NCT00103857|21094266|P5|NOT COMPLETED|54-Week Base Study||41
8555163|NCT00103857|21094267|P4|NOT COMPLETED|54-Week Base Study||42
8555164|NCT00103857|21094268|P3|NOT COMPLETED|54-Week Base Study||47
8555165|NCT00103857|21094269|P2|NOT COMPLETED|54-Week Base Study||56
8555166|NCT00103857|21094270|P1|NOT COMPLETED|54-Week Base Study||57
8555167|NCT00103857|21094264|P7|COMPLETED|54-Week Base Study||79
8555168|NCT00103857|21094265|P6|COMPLETED|54-Week Base Study||115
8555169|NCT00103857|21094266|P5|COMPLETED|54-Week Base Study||141
8555170|NCT00103857|21094267|P4|COMPLETED|54-Week Base Study||148
8555171|NCT00103857|21094268|P3|COMPLETED|54-Week Base Study||135
8555172|NCT00103857|21094269|P2|COMPLETED|54-Week Base Study||126
8555173|NCT00103857|21094270|P1|COMPLETED|54-Week Base Study||122
8555174|NCT00103857|21094264|P7|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
8555175|NCT00103857|21094265|P6|STARTED|54-Week Base Study||176
8555176|NCT00103857|21094266|P5|STARTED|54-Week Base Study||182
8555177|NCT00103857|21094267|P4|STARTED|54-Week Base Study||190
8555178|NCT00103857|21094268|P3|STARTED|54-Week Base Study||182
8555179|NCT00103857|21094269|P2|STARTED|54-Week Base Study||182
8555180|NCT00103857|21094270|P1|STARTED|54-Week Base Study||179
8555181|NCT00103844|21094335|P2|NOT COMPLETED|Overall Study||0
8555182|NCT00103844|21094336|P1|NOT COMPLETED|Overall Study||0
8555183|NCT00103844|21094335|P2|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
8555184|NCT00103844|21094336|P1|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
8555185|NCT00103844|21094335|P2|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
8555186|NCT00103844|21094336|P1|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
8555187|NCT00103844|21094335|P2|STARTED|Overall Study||49
8555188|NCT00103844|21094336|P1|STARTED|Overall Study||101
8555189|NCT00103740|21094369|P2|NOT COMPLETED|Period 2 - Extended Observation Period||36
8555190|NCT00103740|21094370|P1|NOT COMPLETED|Period 2 - Extended Observation Period||69
8555191|NCT00103740|21094369|P2|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
8555192|NCT00103740|21094370|P1|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
8555193|NCT00103740|21094369|P2|STARTED|Period 2 - Extended Observation Period||63
8555194|NCT00103740|21094370|P1|STARTED|Period 2 - Extended Observation Period||78
8555195|NCT00103740|21094369|P2|NOT COMPLETED|Period 1 - Core||4
8555196|NCT00103740|21094370|P1|NOT COMPLETED|Period 1 - Core||7
8555197|NCT00103740|21094369|P2|COMPLETED|Period 1 - Core||89
8555198|NCT00103740|21094370|P1|COMPLETED|Period 1 - Core||85
8555199|NCT00103740|21094369|P2|STARTED|Period 1 - Core||93
8555200|NCT00103740|21094370|P1|STARTED|Period 1 - Core||92
8555201|NCT00103662|21094398|P2|NOT COMPLETED|Overall Study||33
8555202|NCT00103662|21094399|P1|NOT COMPLETED|Overall Study||19
8555203|NCT00103662|21094398|P2|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
8555204|NCT00103662|21094399|P1|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
8555205|NCT00103662|21094398|P2|STARTED|Overall Study||154
8555206|NCT00103662|21094399|P1|STARTED|Overall Study||148
8555207|NCT00103610|21094425|P2|NOT COMPLETED|Overall Study||80
8555208|NCT00103610|21094426|P1|NOT COMPLETED|Overall Study||38
8555209|NCT00103610|21094425|P2|COMPLETED|Overall Study||68
8555210|NCT00103610|21094426|P1|COMPLETED|Overall Study||112
8555211|NCT00103610|21094425|P2|STARTED|Overall Study||148
8555212|NCT00103610|21094426|P1|STARTED|Overall Study||150
8555213|NCT00103506|21094450|P2|NOT COMPLETED|Overall Study||324
8555214|NCT00103506|21094451|P1|NOT COMPLETED|Overall Study||322
8555215|NCT00103506|21094450|P2|COMPLETED|Overall Study||0
8555216|NCT00103506|21094451|P1|COMPLETED|Overall Study||0
8555217|NCT00103506|21094450|P2|STARTED|Overall Study||324
8555218|NCT00103506|21094451|P1|STARTED|Overall Study||322
8555219|NCT00103402|21094463|P2|NOT COMPLETED|Overall Study||17
8555220|NCT00103402|21094464|P1|NOT COMPLETED|Overall Study||22
8555221|NCT00103402|21094463|P2|COMPLETED|Overall Study||117
8555222|NCT00103402|21094464|P1|COMPLETED|Overall Study||116
8555223|NCT00103402|21094463|P2|STARTED|Overall Study||134
8555224|NCT00103402|21094464|P1|STARTED|Overall Study||138
8555225|NCT00103376|21094487|P3|NOT COMPLETED|Overall Study||0
8555226|NCT00103376|21094488|P2|NOT COMPLETED|Overall Study||0
8555227|NCT00103376|21094489|P1|NOT COMPLETED|Overall Study||0
8555228|NCT00103376|21094487|P3|COMPLETED|Overall Study||8
8555229|NCT00103376|21094488|P2|COMPLETED|Overall Study||7
8555230|NCT00103376|21094489|P1|COMPLETED|Overall Study||8
8555231|NCT00103376|21094487|P3|STARTED|Overall Study||8
8555232|NCT00103376|21094488|P2|STARTED|Overall Study||7
8555233|NCT00103376|21094489|P1|STARTED|Overall Study||8
8555234|NCT00103311|21094505|P2|NOT COMPLETED|Overall Study||1
8555235|NCT00103311|21094506|P1|NOT COMPLETED|Overall Study||4
8555236|NCT00103311|21094505|P2|COMPLETED|Overall Study||30
8555237|NCT00103311|21094506|P1|COMPLETED|Overall Study||29
8555238|NCT00103311|21094505|P2|STARTED|Overall Study||31
8555239|NCT00103311|21094506|P1|STARTED|Overall Study||33
8555288|NCT00103259|21094552|P2|NOT COMPLETED|Overall Study||12
8555289|NCT00103259|21094553|P1|NOT COMPLETED|Overall Study||12
8555290|NCT00103259|21094552|P2|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
8555291|NCT00103259|21094553|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
8555292|NCT00103259|21094552|P2|Eligible Patients Who Cross Over|Overall Study||10
8555293|NCT00103259|21094553|P1|Eligible Patients Who Cross Over|Overall Study||0
8555294|NCT00103259|21094552|P2|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
8555295|NCT00103259|21094553|P1|Cross Over to the Other Arm|Overall Study||0
8555296|NCT00103259|21094552|P2|Eligible and Treated|Overall Study||38
8555297|NCT00103259|21094553|P1|Eligible and Treated|Overall Study||23
8555298|NCT00103259|21094552|P2|Treated|Overall Study||41
8555299|NCT00103259|21094553|P1|Treated|Overall Study||23
8555300|NCT00103259|21094552|P2|Eligible|Overall Study||41
8555301|NCT00103259|21094553|P1|Eligible|Overall Study||27
8555302|NCT00103259|21094552|P2|STARTED|Overall Study||44
8555303|NCT00103259|21094553|P1|STARTED|Overall Study||27
8555304|NCT00103207|21094565|P1|NOT COMPLETED|Overall Study||38
8555305|NCT00103207|21094565|P1|COMPLETED|Overall Study||34
8555306|NCT00103207|21094565|P1|Eligible Patients w/ Smoking Status Data|Overall Study||37
8555307|NCT00103207|21094565|P1|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
8555308|NCT00103207|21094565|P1|STARTED|Overall Study||72
8555309|NCT00103194|21094575|P1|NOT COMPLETED|Overall Study||31
8555310|NCT00103194|21094575|P1|COMPLETED|Overall Study||18
8555311|NCT00103194|21094575|P1|Eligible and Treated|Overall Study||35
8555312|NCT00103194|21094575|P1|Eligible|Overall Study||35
8555313|NCT00103194|21094575|P1|Treated|Overall Study||49
8555314|NCT00103194|21094575|P1|STARTED|Overall Study||49
8555315|NCT00103142|21094584|P2|NOT COMPLETED|Overall Study||1
8555316|NCT00103142|21094585|P1|NOT COMPLETED|Overall Study||3
8555317|NCT00103142|21094584|P2|COMPLETED|Overall Study||36
8555318|NCT00103142|21094585|P1|COMPLETED|Overall Study||33
8555319|NCT00103142|21094584|P2|STARTED|Overall Study||37
8555320|NCT00103142|21094585|P1|STARTED|Overall Study||36
8555321|NCT00103116|21094593|P1|NOT COMPLETED|Overall Study||0
8555322|NCT00103116|21094593|P1|COMPLETED|Overall Study||32
8555323|NCT00103116|21094593|P1|STARTED|Overall Study||32
8555324|NCT00103012|21094601|P3|NOT COMPLETED|Overall Study||4
8555325|NCT00103012|21094602|P2|NOT COMPLETED|Overall Study||1
8555326|NCT00103012|21094603|P1|NOT COMPLETED|Overall Study||3
8555327|NCT00103012|21094601|P3|COMPLETED|Overall Study||12
8555328|NCT00103012|21094602|P2|COMPLETED|Overall Study||13
8555329|NCT00103012|21094603|P1|COMPLETED|Overall Study||14
8555330|NCT00103012|21094601|P3|STARTED|Overall Study||16
8555331|NCT00103012|21094602|P2|STARTED|Overall Study||14
8555332|NCT00103012|21094603|P1|STARTED|Overall Study||17
8555333|NCT00102960|21094614|P3|NOT COMPLETED|Overall Study||28
8555334|NCT00102960|21094615|P2|NOT COMPLETED|Overall Study||23
8555335|NCT00102960|21094616|P1|NOT COMPLETED|Overall Study||30
8555336|NCT00102960|21094614|P3|COMPLETED|Overall Study||98
8555337|NCT00102960|21094615|P2|COMPLETED|Overall Study||103
8555338|NCT00102960|21094616|P1|COMPLETED|Overall Study||95
8555339|NCT00102960|21094614|P3|STARTED|Overall Study||126
8555340|NCT00102960|21094615|P2|STARTED|Overall Study||126
8555341|NCT00102960|21094616|P1|STARTED|Overall Study||125
8555342|NCT00102804|21094665|P2|NOT COMPLETED|Overall Study||222
8555343|NCT00102804|21094666|P1|NOT COMPLETED|Overall Study||441
8555344|NCT00102804|21094665|P2|COMPLETED|Overall Study||0
8555345|NCT00102804|21094666|P1|COMPLETED|Overall Study||0
8555346|NCT00102804|21094665|P2|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
8555347|NCT00102804|21094666|P1|Received at Least 1 Dose of Study Drug|Overall Study||434
8555348|NCT00102804|21094665|P2|STARTED|Overall Study||222
8555349|NCT00102804|21094666|P1|STARTED|Overall Study||441
8555350|NCT00102687|21094687|P5|NOT COMPLETED|Maintenance Period||13
8555351|NCT00102687|21094688|P4|NOT COMPLETED|Maintenance Period||10
8555352|NCT00102687|21094689|P3|NOT COMPLETED|Maintenance Period||6
8555353|NCT00102687|21094690|P2|NOT COMPLETED|Maintenance Period||4
8555354|NCT00102687|21094691|P1|NOT COMPLETED|Maintenance Period||7
8555355|NCT00102687|21094687|P5|COMPLETED|Maintenance Period||8
8555356|NCT00102687|21094688|P4|COMPLETED|Maintenance Period||12
8555357|NCT00102687|21094689|P3|COMPLETED|Maintenance Period||2
8555358|NCT00102687|21094690|P2|COMPLETED|Maintenance Period||2
8555359|NCT00102687|21094691|P1|COMPLETED|Maintenance Period||6
8555360|NCT00102687|21094687|P5|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
8555361|NCT00102687|21094688|P4|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
8555362|NCT00102687|21094689|P3|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
8555363|NCT00102687|21094690|P2|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
8555364|NCT00102687|21094691|P1|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
8555365|NCT00102687|21094687|P5|NOT COMPLETED|Initial Period||0
8555366|NCT00102687|21094688|P4|NOT COMPLETED|Initial Period||0
8555367|NCT00102687|21094689|P3|NOT COMPLETED|Initial Period||26
8555368|NCT00102687|21094690|P2|NOT COMPLETED|Initial Period||28
8555369|NCT00102687|21094691|P1|NOT COMPLETED|Initial Period||18
8555370|NCT00102687|21094687|P5|COMPLETED|Initial Period||0
8555371|NCT00102687|21094688|P4|COMPLETED|Initial Period||0
8555372|NCT00102687|21094689|P3|COMPLETED|Initial Period||25
8555373|NCT00102687|21094690|P2|COMPLETED|Initial Period||22
8555374|NCT00102687|21094691|P1|COMPLETED|Initial Period||32
8555375|NCT00102687|21094687|P5|STARTED|Initial Period||0
8555376|NCT00102687|21094688|P4|STARTED|Initial Period||0
8555377|NCT00102687|21094689|P3|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
8555378|NCT00102687|21094690|P2|STARTED|Initial Period||50
8555379|NCT00102687|21094691|P1|STARTED|Initial Period||50
8555380|NCT00102596|21094755|P2|NOT COMPLETED|Part C||0
8555381|NCT00102596|21094756|P1|NOT COMPLETED|Part C||0
8555382|NCT00102596|21094755|P2|COMPLETED|Part C||2
8555383|NCT00102596|21094756|P1|COMPLETED|Part C||0
8555384|NCT00102596|21094755|P2|STARTED|Part C|Only 2 patients participated in Part C|2
8555385|NCT00102596|21094756|P1|STARTED|Part C||0
8555386|NCT00102596|21094755|P2|NOT COMPLETED|Part B||0
8555387|NCT00102596|21094756|P1|NOT COMPLETED|Part B||0
8555388|NCT00102596|21094755|P2|COMPLETED|Part B||10
8555389|NCT00102596|21094756|P1|COMPLETED|Part B||0
8555390|NCT00102596|21094755|P2|STARTED|Part B||10
8555391|NCT00102596|21094756|P1|STARTED|Part B|Participants from Part A did not continue to Part B|0
8555392|NCT00102596|21094755|P2|NOT COMPLETED|Part A||0
8555393|NCT00102596|21094756|P1|NOT COMPLETED|Part A||7
8555394|NCT00102596|21094755|P2|COMPLETED|Part A||0
8555395|NCT00102596|21094756|P1|COMPLETED|Part A||4
8555396|NCT00102596|21094755|P2|Participants Assigned Treatment|Part A||0
8555397|NCT00102596|21094756|P1|Participants Assigned Treatment|Part A||5
8555398|NCT00102596|21094755|P2|STARTED|Part A||0
8555399|NCT00102596|21094756|P1|STARTED|Part A||11
8555400|NCT00102531|21094767|P2|NOT COMPLETED|Overall Study||11
8555401|NCT00102531|21094768|P1|NOT COMPLETED|Overall Study||5
8555402|NCT00102531|21094767|P2|COMPLETED|Overall Study||1
8555403|NCT00102531|21094768|P1|COMPLETED|Overall Study||2
8555404|NCT00102531|21094767|P2|STARTED|Overall Study||12
8555405|NCT00102531|21094768|P1|STARTED|Overall Study||7
8555406|NCT00102518|21094774|P1|NOT COMPLETED|Overall Study||87
8555407|NCT00102518|21094774|P1|COMPLETED|Overall Study||238
8555408|NCT00102518|21094774|P1|STARTED|Overall Study||325
8555409|NCT00102440|21094783|P3|NOT COMPLETED|Overall Study||66
8555410|NCT00102440|21094784|P2|NOT COMPLETED|Overall Study||98
8555411|NCT00102440|21094785|P1|NOT COMPLETED|Overall Study||88
8555412|NCT00102440|21094783|P3|COMPLETED|Overall Study||187
8555413|NCT00102440|21094784|P2|COMPLETED|Overall Study||153
8555414|NCT00102440|21094785|P1|COMPLETED|Overall Study||168
8555415|NCT00102440|21094783|P3|STARTED|Overall Study||253
8555416|NCT00102440|21094784|P2|STARTED|Overall Study||251
8555417|NCT00102440|21094785|P1|STARTED|Overall Study||256
8555418|NCT00102063|21094835|P3|NOT COMPLETED|Overall Study||10
8555419|NCT00102063|21094836|P2|NOT COMPLETED|Overall Study||18
8555420|NCT00102063|21094837|P1|NOT COMPLETED|Overall Study||16
8555421|NCT00102063|21094835|P3|COMPLETED|Overall Study||90
8555422|NCT00102063|21094836|P2|COMPLETED|Overall Study||84
8555423|NCT00102063|21094837|P1|COMPLETED|Overall Study||84
8555424|NCT00102063|21094835|P3|STARTED|Overall Study||100
8555425|NCT00102063|21094836|P2|STARTED|Overall Study||102
8555426|NCT00102063|21094837|P1|STARTED|Overall Study||100
8555427|NCT00101933|21094868|P2|NOT COMPLETED|Overall Study||0
8555428|NCT00101933|21094869|P1|NOT COMPLETED|Overall Study||0
8555429|NCT00101933|21094868|P2|COMPLETED|Overall Study||55
8555430|NCT00101933|21094869|P1|COMPLETED|Overall Study||54
8555431|NCT00101933|21094868|P2|STARTED|Overall Study||55
8555432|NCT00101933|21094869|P1|STARTED|Overall Study||54
8555433|NCT00101907|21094895|P6|NOT COMPLETED|Overall Study||0
8555434|NCT00101907|21094896|P5|NOT COMPLETED|Overall Study||5
8555435|NCT00101907|21094897|P4|NOT COMPLETED|Overall Study||1
8555436|NCT00101907|21094898|P3|NOT COMPLETED|Overall Study||1
8555437|NCT00101907|21094899|P2|NOT COMPLETED|Overall Study||1
8555438|NCT00101907|21094900|P1|NOT COMPLETED|Overall Study||2
8555439|NCT00101907|21094895|P6|COMPLETED|Overall Study||2
8555440|NCT00101907|21094896|P5|COMPLETED|Overall Study||6
8555441|NCT00101907|21094897|P4|COMPLETED|Overall Study||5
8555442|NCT00101907|21094898|P3|COMPLETED|Overall Study||5
8555443|NCT00101907|21094899|P2|COMPLETED|Overall Study||7
8555444|NCT00101907|21094900|P1|COMPLETED|Overall Study||6
8555445|NCT00101907|21094895|P6|STARTED|Overall Study||2
8555446|NCT00101907|21094896|P5|STARTED|Overall Study||11
8555447|NCT00101907|21094897|P4|STARTED|Overall Study||6
8555448|NCT00101907|21094898|P3|STARTED|Overall Study||6
8555449|NCT00101907|21094899|P2|STARTED|Overall Study||8
8555450|NCT00101907|21094900|P1|STARTED|Overall Study||8
8555451|NCT00101868|21094942|P2|NOT COMPLETED|Overall Study||32
8555452|NCT00101868|21094943|P1|NOT COMPLETED|Overall Study||29
8555453|NCT00101868|21094942|P2|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
8555454|NCT00101868|21094943|P1|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
8555455|NCT00101868|21094942|P2|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
8555456|NCT00101868|21094943|P1|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
8555457|NCT00101816|21094955|P2|NOT COMPLETED|Overall Study||0
8555458|NCT00101816|21094956|P1|NOT COMPLETED|Overall Study||0
8555459|NCT00101816|21094955|P2|COMPLETED|Overall Study||99
8555460|NCT00101816|21094956|P1|COMPLETED|Overall Study||10
8555461|NCT00101816|21094955|P2|STARTED|Overall Study||99
8555462|NCT00101816|21094956|P1|STARTED|Overall Study||10
8555463|NCT00101686|21095013|P10|NOT COMPLETED|Overall Study||30
8555464|NCT00101686|21095014|P9|NOT COMPLETED|Overall Study||30
8555465|NCT00101686|21095015|P8|NOT COMPLETED|Overall Study||30
8555466|NCT00101686|21095016|P7|NOT COMPLETED|Overall Study||27
8555467|NCT00101686|21095017|P6|NOT COMPLETED|Overall Study||72
8555468|NCT00101686|21095018|P5|NOT COMPLETED|Overall Study||73
8555469|NCT00101686|21095019|P4|NOT COMPLETED|Overall Study||72
8555470|NCT00101686|21095020|P3|NOT COMPLETED|Overall Study||69
8555471|NCT00101686|21095021|P2|NOT COMPLETED|Overall Study||73
8555472|NCT00101686|21095022|P1|NOT COMPLETED|Overall Study||71
8555473|NCT00101686|21095013|P10|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555474|NCT00101686|21095014|P9|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555475|NCT00101686|21095015|P8|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555476|NCT00101686|21095016|P7|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555477|NCT00101686|21095017|P6|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555478|NCT00101686|21095018|P5|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555479|NCT00101686|21095019|P4|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555480|NCT00101686|21095020|P3|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555481|NCT00101686|21095021|P2|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555482|NCT00101686|21095022|P1|COMPLETED|Overall Study|Patients treated until disease progression.|0
8555483|NCT00101686|21095013|P10|Received Treatment|Overall Study||29
8555484|NCT00101686|21095014|P9|Received Treatment|Overall Study||30
8555485|NCT00101686|21095015|P8|Received Treatment|Overall Study||29
8555486|NCT00101686|21095016|P7|Received Treatment|Overall Study||27
8555487|NCT00101686|21095017|P6|Received Treatment|Overall Study||70
8555488|NCT00101686|21095018|P5|Received Treatment|Overall Study||71
8555489|NCT00101686|21095019|P4|Received Treatment|Overall Study||70
8555490|NCT00101686|21095020|P3|Received Treatment|Overall Study||67
8555491|NCT00101686|21095021|P2|Received Treatment|Overall Study||67
8555492|NCT00101686|21095022|P1|Received Treatment|Overall Study||70
8555493|NCT00101686|21095013|P10|STARTED|Overall Study||30
8555494|NCT00101686|21095014|P9|STARTED|Overall Study||30
8555495|NCT00101686|21095015|P8|STARTED|Overall Study||30
8555496|NCT00101686|21095016|P7|STARTED|Overall Study||27
8555497|NCT00101686|21095017|P6|STARTED|Overall Study||72
8555498|NCT00101686|21095018|P5|STARTED|Overall Study||73
8555499|NCT00101686|21095019|P4|STARTED|Overall Study||72
8555500|NCT00101686|21095020|P3|STARTED|Overall Study||69
8555501|NCT00101686|21095021|P2|STARTED|Overall Study||73
8555502|NCT00101686|21095022|P1|STARTED|Overall Study||71
8555503|NCT00101660|21095069|P2|NOT COMPLETED|Overall Study||0
8555504|NCT00101660|21095070|P1|NOT COMPLETED|Overall Study||0
8555505|NCT00101660|21095069|P2|COMPLETED|Overall Study||288
8555506|NCT00101660|21095070|P1|COMPLETED|Overall Study||99
8555507|NCT00101660|21095069|P2|STARTED|Overall Study||288
8555508|NCT00101660|21095070|P1|STARTED|Overall Study||99
8555509|NCT00101647|21095088|P2|NOT COMPLETED|Overall Study||0
8555510|NCT00101647|21095089|P1|NOT COMPLETED|Overall Study||0
8555511|NCT00101647|21095088|P2|COMPLETED|Overall Study||161
8555512|NCT00101647|21095089|P1|COMPLETED|Overall Study||13
8555513|NCT00101647|21095088|P2|STARTED|Overall Study|Randomized|161
8555514|NCT00101647|21095089|P1|STARTED|Overall Study|Randomized|13
8555515|NCT00101582|21095139|P2|NOT COMPLETED|Overall Study||15
8555516|NCT00101582|21095140|P1|NOT COMPLETED|Overall Study||11
8555517|NCT00101582|21095139|P2|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
8555518|NCT00101582|21095140|P1|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
8555519|NCT00101582|21095139|P2|Received Study Drug|Overall Study||94
8555520|NCT00101582|21095140|P1|Received Study Drug|Overall Study||91
8555521|NCT00101582|21095139|P2|STARTED|Overall Study||94
8555522|NCT00101582|21095140|P1|STARTED|Overall Study||94
8555523|NCT00101452|21095163|P3|NOT COMPLETED|Overall Study||43
8555524|NCT00101452|21095164|P2|NOT COMPLETED|Overall Study||43
8555525|NCT00101452|21095165|P1|NOT COMPLETED|Overall Study||44
8555526|NCT00101452|21095163|P3|COMPLETED|Overall Study||22
8555527|NCT00101452|21095164|P2|COMPLETED|Overall Study||26
8555528|NCT00101452|21095165|P1|COMPLETED|Overall Study||21
8555529|NCT00101452|21095163|P3|STARTED|Overall Study||65
8555530|NCT00101452|21095164|P2|STARTED|Overall Study||69
8555531|NCT00101452|21095165|P1|STARTED|Overall Study||65
8555532|NCT00101439|21095179|P2|NOT COMPLETED|Period 2||2
8555533|NCT00101439|21095180|P1|NOT COMPLETED|Period 2||0
8555534|NCT00101439|21095179|P2|COMPLETED|Period 2||28
8555535|NCT00101439|21095180|P1|COMPLETED|Period 2||28
8555536|NCT00101439|21095179|P2|STARTED|Period 2||30
8555537|NCT00101439|21095180|P1|STARTED|Period 2||28
8555538|NCT00101439|21095179|P2|NOT COMPLETED|Period 1||0
8555539|NCT00101439|21095180|P1|NOT COMPLETED|Period 1||0
8555540|NCT00101439|21095179|P2|COMPLETED|Period 1||30
8555541|NCT00101439|21095180|P1|COMPLETED|Period 1||28
8555542|NCT00101439|21095179|P2|STARTED|Period 1||30
8555543|NCT00101439|21095180|P1|STARTED|Period 1||28
8555544|NCT00101413|21095188|P1|NOT COMPLETED|Overall Study||0
8555545|NCT00101413|21095188|P1|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
8555546|NCT00101413|21095188|P1|STARTED|Overall Study||52
8555547|NCT00101400|21095196|P1|NOT COMPLETED|Survival Follow-Up||7
8555548|NCT00101400|21095196|P1|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
8555549|NCT00101400|21095196|P1|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
8555550|NCT00101400|21095196|P1|NOT COMPLETED|Treatment||0
8555551|NCT00101400|21095196|P1|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
8555552|NCT00101400|21095196|P1|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
8555553|NCT00101361|21095207|P2|NOT COMPLETED|Overall Study||0
8555554|NCT00101361|21095208|P1|NOT COMPLETED|Overall Study||0
8555555|NCT00101361|21095207|P2|COMPLETED|Overall Study||104
8555556|NCT00101361|21095208|P1|COMPLETED|Overall Study||108
8555557|NCT00101361|21095207|P2|STARTED|Overall Study||104
8555558|NCT00101361|21095208|P1|STARTED|Overall Study||108
8555559|NCT00101283|21095216|P2|NOT COMPLETED|Overall Study||3
8555560|NCT00101283|21095217|P1|NOT COMPLETED|Overall Study||0
8555561|NCT00101283|21095216|P2|COMPLETED|Overall Study||13
8555562|NCT00101283|21095217|P1|COMPLETED|Overall Study||16
8555563|NCT00101283|21095216|P2|Began Treatment|Overall Study||13
8555564|NCT00101283|21095217|P1|Began Treatment|Overall Study||16
8555565|NCT00101283|21095216|P2|STARTED|Overall Study||16
8555566|NCT00101283|21095217|P1|STARTED|Overall Study||16
8555567|NCT00101192|21095227|P1|NOT COMPLETED|Overall Study||7
8555568|NCT00101192|21095227|P1|COMPLETED|Overall Study||69
8555569|NCT00101192|21095227|P1|STARTED|Overall Study||76
8555570|NCT00101166|21095231|P1|NOT COMPLETED|Overall Study||10
8555571|NCT00101166|21095231|P1|COMPLETED|Overall Study||18
8555572|NCT00101166|21095231|P1|STARTED|Overall Study||28
8555573|NCT00101101|21095239|P1|NOT COMPLETED|Overall Study||20
8555574|NCT00101101|21095239|P1|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
8555575|NCT00101101|21095239|P1|STARTED|Overall Study||43
8555576|NCT00101036|21095247|P2|NOT COMPLETED|Overall Study||0
8555577|NCT00101036|21095248|P1|NOT COMPLETED|Overall Study||0
8555578|NCT00101036|21095247|P2|COMPLETED|Overall Study||40
8555579|NCT00101036|21095248|P1|COMPLETED|Overall Study||17
8555580|NCT00101036|21095247|P2|STARTED|Overall Study||40
8555581|NCT00101036|21095248|P1|STARTED|Overall Study||17
8555582|NCT00101010|21095260|P1|NOT COMPLETED|Overall Study||1
8555583|NCT00101010|21095260|P1|COMPLETED|Overall Study||79
8555584|NCT00101010|21095260|P1|STARTED|Overall Study||80
8555585|NCT00100932|21095267|P2|NOT COMPLETED|Overall Study||27
8555586|NCT00100932|21095268|P1|NOT COMPLETED|Overall Study||73
8555587|NCT00100932|21095267|P2|COMPLETED|Overall Study||1
8555588|NCT00100932|21095268|P1|COMPLETED|Overall Study||5
8555589|NCT00100932|21095267|P2|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
8555590|NCT00100932|21095268|P1|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
8555591|NCT00100841|21095278|P1|NOT COMPLETED|Overall Study||0
8555592|NCT00100841|21095278|P1|COMPLETED|Overall Study||66
8555593|NCT00100841|21095278|P1|STARTED|Overall Study||66
8555594|NCT00100828|21095283|P1|NOT COMPLETED|Overall Study||6
8555595|NCT00100828|21095283|P1|COMPLETED|Overall Study||0
8555596|NCT00100828|21095283|P1|STARTED|Overall Study||6
8555597|NCT00100815|21095287|P1|NOT COMPLETED|Overall Study||49
8555598|NCT00100815|21095287|P1|COMPLETED|Overall Study||1
8555599|NCT00100815|21095287|P1|STARTED|Overall Study||50
8555600|NCT00100802|21095295|P1|NOT COMPLETED|Overall Study||80
8555601|NCT00100802|21095295|P1|COMPLETED|Overall Study||38
8555602|NCT00100802|21095295|P1|STARTED|Overall Study||118
8555603|NCT00100789|21095300|P1|NOT COMPLETED|Overall Study||64
8555604|NCT00100789|21095300|P1|COMPLETED|Overall Study||3
8555605|NCT00100789|21095300|P1|Eligible and Began Protocol Therapy|Overall Study||63
8555606|NCT00100789|21095300|P1|Eligible|Overall Study||64
8555607|NCT00100789|21095300|P1|STARTED|Overall Study||67
8555608|NCT00100698|21095309|P2|NOT COMPLETED|Overall Study||2
8555609|NCT00100698|21095310|P1|NOT COMPLETED|Overall Study||6
8555610|NCT00100698|21095309|P2|COMPLETED|Overall Study||27
8555611|NCT00100698|21095310|P1|COMPLETED|Overall Study||21
8555612|NCT00100698|21095309|P2|STARTED|Overall Study||29
8555613|NCT00100698|21095310|P1|STARTED|Overall Study||27
8555614|NCT00100659|21095352|P2|NOT COMPLETED|Overall Study||2
8555615|NCT00100659|21095353|P1|NOT COMPLETED|Overall Study||3
8555616|NCT00100659|21095352|P2|COMPLETED|Overall Study||57
8555617|NCT00100659|21095353|P1|COMPLETED|Overall Study||52
8555618|NCT00100659|21095352|P2|STARTED|Overall Study||59
8555619|NCT00100659|21095353|P1|STARTED|Overall Study||55
8555620|NCT00100230|21095363|P2|NOT COMPLETED|Overall Study||15
8555621|NCT00100230|21095364|P1|NOT COMPLETED|Overall Study||12
8555622|NCT00100230|21095363|P2|COMPLETED|Overall Study||22
8555623|NCT00100230|21095364|P1|COMPLETED|Overall Study||29
8555624|NCT00100230|21095363|P2|STARTED|Overall Study||37
8555625|NCT00100230|21095364|P1|STARTED|Overall Study||41
8555626|NCT00100178|21095377|P3|NOT COMPLETED|Overall Study||10
8555627|NCT00100178|21095378|P2|NOT COMPLETED|Overall Study||10
8555628|NCT00100178|21095379|P1|NOT COMPLETED|Overall Study||9
8555629|NCT00100178|21095377|P3|COMPLETED|Overall Study||32
8555630|NCT00100178|21095378|P2|COMPLETED|Overall Study||21
8555631|NCT00100178|21095379|P1|COMPLETED|Overall Study||32
8555632|NCT00100178|21095377|P3|STARTED|Overall Study||42
8555633|NCT00100178|21095378|P2|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
8555634|NCT00100178|21095379|P1|STARTED|Overall Study||41
8555635|NCT00100165|21095390|P3|NOT COMPLETED|Third Intervention (4 Weeks)||0
8555636|NCT00100165|21095391|P2|NOT COMPLETED|Third Intervention (4 Weeks)||0
8555637|NCT00100165|21095392|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
8555638|NCT00100165|21095390|P3|COMPLETED|Third Intervention (4 Weeks)||9
8555639|NCT00100165|21095391|P2|COMPLETED|Third Intervention (4 Weeks)||10
8555640|NCT00100165|21095392|P1|COMPLETED|Third Intervention (4 Weeks)||10
8555641|NCT00100165|21095390|P3|STARTED|Third Intervention (4 Weeks)||9
8555642|NCT00100165|21095391|P2|STARTED|Third Intervention (4 Weeks)||10
8555643|NCT00100165|21095392|P1|STARTED|Third Intervention (4 Weeks)||10
8555644|NCT00100165|21095390|P3|NOT COMPLETED|Washout (1 Week)||0
8555645|NCT00100165|21095391|P2|NOT COMPLETED|Washout (1 Week)||0
8555646|NCT00100165|21095392|P1|NOT COMPLETED|Washout (1 Week)||0
8555647|NCT00100165|21095390|P3|COMPLETED|Washout (1 Week)||9
8555648|NCT00100165|21095391|P2|COMPLETED|Washout (1 Week)||10
8555649|NCT00100165|21095392|P1|COMPLETED|Washout (1 Week)||10
8555650|NCT00100165|21095390|P3|STARTED|Washout (1 Week)||9
8555651|NCT00100165|21095391|P2|STARTED|Washout (1 Week)||10
8555652|NCT00100165|21095392|P1|STARTED|Washout (1 Week)||10
8555653|NCT00100165|21095390|P3|NOT COMPLETED|Second Intervention (4 Weeks)||0
8555654|NCT00100165|21095391|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
8555655|NCT00100165|21095392|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8555656|NCT00100165|21095390|P3|COMPLETED|Second Intervention (4 Weeks)||9
8555657|NCT00100165|21095391|P2|COMPLETED|Second Intervention (4 Weeks)||10
8555658|NCT00100165|21095392|P1|COMPLETED|Second Intervention (4 Weeks)||10
8555659|NCT00100165|21095390|P3|STARTED|Second Intervention (4 Weeks)||9
8555660|NCT00100165|21095391|P2|STARTED|Second Intervention (4 Weeks)||10
8555661|NCT00100165|21095392|P1|STARTED|Second Intervention (4 Weeks)||10
8555662|NCT00100165|21095390|P3|NOT COMPLETED|Washout (1 Week)||0
8555663|NCT00100165|21095391|P2|NOT COMPLETED|Washout (1 Week)||0
8555664|NCT00100165|21095392|P1|NOT COMPLETED|Washout (1 Week)||0
8555665|NCT00100165|21095390|P3|COMPLETED|Washout (1 Week)||9
8555666|NCT00100165|21095391|P2|COMPLETED|Washout (1 Week)||10
8555667|NCT00100165|21095392|P1|COMPLETED|Washout (1 Week)||10
8555668|NCT00100165|21095390|P3|STARTED|Washout (1 Week)||9
8555669|NCT00100165|21095391|P2|STARTED|Washout (1 Week)||10
8555670|NCT00100165|21095392|P1|STARTED|Washout (1 Week)||10
8555671|NCT00100165|21095390|P3|NOT COMPLETED|First Intervention (4 Weeks)||0
8555672|NCT00100165|21095391|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8555673|NCT00100165|21095392|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8555674|NCT00100165|21095390|P3|COMPLETED|First Intervention (4 Weeks)||9
8555675|NCT00100165|21095391|P2|COMPLETED|First Intervention (4 Weeks)||10
8555676|NCT00100165|21095392|P1|COMPLETED|First Intervention (4 Weeks)||10
8555677|NCT00100165|21095390|P3|STARTED|First Intervention (4 Weeks)||9
8555678|NCT00100165|21095391|P2|STARTED|First Intervention (4 Weeks)||10
8555679|NCT00100165|21095392|P1|STARTED|First Intervention (4 Weeks)||10
8555680|NCT00100165|21095390|P3|NOT COMPLETED|Baseline||0
8555681|NCT00100165|21095391|P2|NOT COMPLETED|Baseline||0
8555682|NCT00100165|21095392|P1|NOT COMPLETED|Baseline||0
8555683|NCT00100165|21095390|P3|COMPLETED|Baseline||9
8555684|NCT00100165|21095391|P2|COMPLETED|Baseline||10
8555685|NCT00100165|21095392|P1|COMPLETED|Baseline||10
8555686|NCT00100165|21095390|P3|STARTED|Baseline||9
8555687|NCT00100165|21095391|P2|STARTED|Baseline||10
8555688|NCT00100165|21095392|P1|STARTED|Baseline||10
8555689|NCT00100048|21095408|P6|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
8555690|NCT00100048|21095409|P5|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
8555691|NCT00100048|21095410|P4|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
8555692|NCT00100048|21095411|P3|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
8555693|NCT00100048|21095412|P2|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
8555694|NCT00100048|21095413|P1|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
8555695|NCT00100048|21095408|P6|COMPLETED|Cohort I & II-Combination Therapy Phase||26
8555696|NCT00100048|21095409|P5|COMPLETED|Cohort I & II-Combination Therapy Phase||0
8555697|NCT00100048|21095410|P4|COMPLETED|Cohort I & II-Combination Therapy Phase||30
8555698|NCT00100048|21095411|P3|COMPLETED|Cohort I & II-Combination Therapy Phase||28
8555699|NCT00100048|21095412|P2|COMPLETED|Cohort I & II-Combination Therapy Phase||31
8555700|NCT00100048|21095413|P1|COMPLETED|Cohort I & II-Combination Therapy Phase||27
8555701|NCT00100048|21095408|P6|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
8555702|NCT00100048|21095409|P5|Never Treated|Cohort I & II-Combination Therapy Phase||0
8555703|NCT00100048|21095410|P4|Never Treated|Cohort I & II-Combination Therapy Phase||0
8555704|NCT00100048|21095411|P3|Never Treated|Cohort I & II-Combination Therapy Phase||0
8555705|NCT00100048|21095412|P2|Never Treated|Cohort I & II-Combination Therapy Phase||0
8555706|NCT00100048|21095413|P1|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
8555707|NCT00100048|21095408|P6|Treated|Cohort I & II-Combination Therapy Phase||38
8555708|NCT00100048|21095409|P5|Treated|Cohort I & II-Combination Therapy Phase||0
8555709|NCT00100048|21095410|P4|Treated|Cohort I & II-Combination Therapy Phase||40
8555710|NCT00100048|21095411|P3|Treated|Cohort I & II-Combination Therapy Phase||41
8555711|NCT00100048|21095412|P2|Treated|Cohort I & II-Combination Therapy Phase||40
8555712|NCT00100048|21095413|P1|Treated|Cohort I & II-Combination Therapy Phase||39
8555713|NCT00100048|21095408|P6|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
8555714|NCT00100048|21095409|P5|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
8555715|NCT00100048|21095410|P4|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
8555716|NCT00100048|21095411|P3|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
8555717|NCT00100048|21095412|P2|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
8555718|NCT00100048|21095413|P1|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
8555719|NCT00100048|21095408|P6|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8555720|NCT00100048|21095409|P5|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8555721|NCT00100048|21095410|P4|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8555722|NCT00100048|21095411|P3|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8555723|NCT00100048|21095412|P2|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8555724|NCT00100048|21095413|P1|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8555725|NCT00100048|21095408|P6|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
8555726|NCT00100048|21095409|P5|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
8555727|NCT00100048|21095410|P4|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
8555728|NCT00100048|21095411|P3|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
8555729|NCT00100048|21095412|P2|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
8555730|NCT00100048|21095413|P1|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
8555731|NCT00100048|21095408|P6|Treated|Cohort I-Monotherapy Phase 10 Days||0
8555732|NCT00100048|21095409|P5|Treated|Cohort I-Monotherapy Phase 10 Days||7
8555733|NCT00100048|21095410|P4|Treated|Cohort I-Monotherapy Phase 10 Days||8
8555734|NCT00100048|21095411|P3|Treated|Cohort I-Monotherapy Phase 10 Days||6
8555735|NCT00100048|21095412|P2|Treated|Cohort I-Monotherapy Phase 10 Days||7
8555736|NCT00100048|21095413|P1|Treated|Cohort I-Monotherapy Phase 10 Days||7
8555737|NCT00100048|21095408|P6|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
8555738|NCT00100048|21095409|P5|STARTED|Cohort I-Monotherapy Phase 10 Days||7
8555739|NCT00100048|21095410|P4|STARTED|Cohort I-Monotherapy Phase 10 Days||8
8555740|NCT00100048|21095411|P3|STARTED|Cohort I-Monotherapy Phase 10 Days||6
8555741|NCT00100048|21095412|P2|STARTED|Cohort I-Monotherapy Phase 10 Days||7
8555742|NCT00100048|21095413|P1|STARTED|Cohort I-Monotherapy Phase 10 Days||7
8555743|NCT00099983|21095522|P2|NOT COMPLETED|Overall Study||25
8555744|NCT00099983|21095523|P1|NOT COMPLETED|Overall Study||24
8555745|NCT00099983|21095522|P2|COMPLETED|Overall Study||124
8555746|NCT00099983|21095523|P1|COMPLETED|Overall Study||123
8555747|NCT00099983|21095522|P2|STARTED|Overall Study||149
8555748|NCT00099983|21095523|P1|STARTED|Overall Study||147
8555749|NCT00099632|21095535|P6|NOT COMPLETED|Overall Study||2
8555750|NCT00099632|21095536|P5|NOT COMPLETED|Overall Study||1
8555751|NCT00099632|21095537|P4|NOT COMPLETED|Overall Study||1
8555752|NCT00099632|21095538|P3|NOT COMPLETED|Overall Study||3
8555753|NCT00099632|21095539|P2|NOT COMPLETED|Overall Study||1
8555754|NCT00099632|21095540|P1|NOT COMPLETED|Overall Study||1
8555755|NCT00099632|21095535|P6|COMPLETED|Overall Study||66
8555756|NCT00099632|21095536|P5|COMPLETED|Overall Study||70
8555757|NCT00099632|21095537|P4|COMPLETED|Overall Study||66
8555758|NCT00099632|21095538|P3|COMPLETED|Overall Study||72
8555759|NCT00099632|21095539|P2|COMPLETED|Overall Study||67
8555760|NCT00099632|21095540|P1|COMPLETED|Overall Study||72
8555761|NCT00099632|21095535|P6|STARTED|Overall Study||68
8555762|NCT00099632|21095536|P5|STARTED|Overall Study||71
8555763|NCT00099632|21095537|P4|STARTED|Overall Study||67
8555764|NCT00099632|21095538|P3|STARTED|Overall Study||75
8555765|NCT00099632|21095539|P2|STARTED|Overall Study||68
8555766|NCT00099632|21095540|P1|STARTED|Overall Study||73
8555773|NCT00099359|21095604|P3|NOT COMPLETED|Overall Study||68
8555774|NCT00099359|21095605|P2|NOT COMPLETED|Overall Study||65
8555775|NCT00099359|21095606|P1|NOT COMPLETED|Overall Study||54
8555776|NCT00099359|21095604|P3|COMPLETED|Overall Study||506
8555777|NCT00099359|21095605|P2|COMPLETED|Overall Study||515
8555778|NCT00099359|21095606|P1|COMPLETED|Overall Study||527
8555779|NCT00099359|21095604|P3|STARTED|Overall Study||574
8555780|NCT00099359|21095605|P2|STARTED|Overall Study||580
8555781|NCT00099359|21095606|P1|STARTED|Overall Study||581
8555782|NCT00099268|21095629|P2|NOT COMPLETED|Overall Study||82
8555783|NCT00099268|21095630|P1|NOT COMPLETED|Overall Study||92
8555784|NCT00099268|21095629|P2|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
8555785|NCT00099268|21095630|P1|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
8555786|NCT00099268|21095629|P2|Intent-to-Treat|Overall Study||372
8555787|NCT00099268|21095630|P1|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
8555788|NCT00099268|21095629|P2|STARTED|Overall Study||373
8555789|NCT00099268|21095630|P1|STARTED|Overall Study||374
8555790|NCT00099047|21095648|P2|NOT COMPLETED|Overall Study||0
8555791|NCT00099047|21095649|P1|NOT COMPLETED|Overall Study||0
8555792|NCT00099047|21095648|P2|COMPLETED|Overall Study||12
8555793|NCT00099047|21095649|P1|COMPLETED|Overall Study||11
8555794|NCT00099047|21095648|P2|STARTED|Overall Study||12
8555795|NCT00099047|21095649|P1|STARTED|Overall Study||11
8555796|NCT00099021|21095655|P1|NOT COMPLETED|Overall Study||0
8555797|NCT00099021|21095655|P1|COMPLETED|Overall Study||21
8555798|NCT00099021|21095655|P1|STARTED|Overall Study||21
8555799|NCT00098956|21095661|P1|NOT COMPLETED|Overall Study||0
8555800|NCT00098956|21095661|P1|COMPLETED|Overall Study||19
8555801|NCT00098956|21095661|P1|STARTED|Overall Study||19
8555802|NCT00098865|21095670|P1|NOT COMPLETED|Overall Study||9
8555803|NCT00098865|21095670|P1|COMPLETED|Overall Study||6
8555804|NCT00098865|21095670|P1|STARTED|Overall Study||15
8555805|NCT00098839|21095678|P2|NOT COMPLETED|Overall Study||33
8555806|NCT00098839|21095679|P1|NOT COMPLETED|Overall Study||32
8555807|NCT00098839|21095678|P2|COMPLETED|Overall Study||27
8555808|NCT00098839|21095679|P1|COMPLETED|Overall Study||24
8555809|NCT00098839|21095678|P2|STARTED|Overall Study||60
8555810|NCT00098839|21095679|P1|STARTED|Overall Study||56
8555811|NCT00098813|21095690|P1|NOT COMPLETED|Overall Study||19
8555812|NCT00098813|21095690|P1|COMPLETED|Overall Study||1
8555813|NCT00098813|21095690|P1|STARTED|Overall Study||20
8555814|NCT00098787|21095697|P3|NOT COMPLETED|Overall Study||63
8555815|NCT00098787|21095698|P2|NOT COMPLETED|Overall Study||75
8555816|NCT00098787|21095699|P1|NOT COMPLETED|Overall Study||73
8555817|NCT00098787|21095697|P3|COMPLETED|Overall Study||0
8555818|NCT00098787|21095698|P2|COMPLETED|Overall Study||0
8555819|NCT00098787|21095699|P1|COMPLETED|Overall Study||0
8555820|NCT00098787|21095697|P3|Eligible and Treated|Overall Study||59
8555821|NCT00098787|21095698|P2|Eligible and Treated|Overall Study||66
8555822|NCT00098787|21095699|P1|Eligible and Treated|Overall Study||61
8555823|NCT00098787|21095697|P3|Treated|Overall Study||62
8555824|NCT00098787|21095698|P2|Treated|Overall Study||73
8555825|NCT00098787|21095699|P1|Treated|Overall Study||70
8555826|NCT00098787|21095697|P3|STARTED|Overall Study||63
8555827|NCT00098787|21095698|P2|STARTED|Overall Study||75
8555828|NCT00098787|21095699|P1|STARTED|Overall Study||73
8555829|NCT00098774|21095713|P1|NOT COMPLETED|Overall Study||18
8555830|NCT00098774|21095713|P1|COMPLETED|Overall Study||26
8555831|NCT00098774|21095713|P1|STARTED|Overall Study||44
8555832|NCT00098748|21095723|P3|NOT COMPLETED|Continued on Open-Label Treatment||0
8555833|NCT00098748|21095724|P2|NOT COMPLETED|Continued on Open-Label Treatment||15
8555834|NCT00098748|21095725|P1|NOT COMPLETED|Continued on Open-Label Treatment||8
8555835|NCT00098748|21095723|P3|COMPLETED|Continued on Open-Label Treatment||0
8555836|NCT00098748|21095724|P2|COMPLETED|Continued on Open-Label Treatment||10
8555837|NCT00098748|21095725|P1|COMPLETED|Continued on Open-Label Treatment||7
8555838|NCT00098748|21095723|P3|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
8555839|NCT00098748|21095724|P2|STARTED|Continued on Open-Label Treatment||25
8555840|NCT00098748|21095725|P1|STARTED|Continued on Open-Label Treatment||15
8555841|NCT00098748|21095723|P3|NOT COMPLETED|Received Study Treatment||44
8555842|NCT00098748|21095724|P2|NOT COMPLETED|Received Study Treatment||36
8555843|NCT00098748|21095725|P1|NOT COMPLETED|Received Study Treatment||48
8555844|NCT00098748|21095723|P3|COMPLETED|Received Study Treatment||18
8555845|NCT00098748|21095724|P2|COMPLETED|Received Study Treatment||25
8555846|NCT00098748|21095725|P1|COMPLETED|Received Study Treatment||15
8555847|NCT00098748|21095723|P3|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
8555848|NCT00098748|21095724|P2|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
8555849|NCT00098748|21095725|P1|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
8555850|NCT00098748|21095723|P3|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
8555851|NCT00098748|21095724|P2|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
8555852|NCT00098748|21095725|P1|STARTED|Received Study Treatment||63
8555853|NCT00098748|21095723|P3|NOT COMPLETED|Assigned to Study Treatment||2
8555854|NCT00098748|21095724|P2|NOT COMPLETED|Assigned to Study Treatment||2
8555855|NCT00098748|21095725|P1|NOT COMPLETED|Assigned to Study Treatment||0
8555856|NCT00098748|21095723|P3|COMPLETED|Assigned to Study Treatment||62
8555857|NCT00098748|21095724|P2|COMPLETED|Assigned to Study Treatment||61
8555858|NCT00098748|21095725|P1|COMPLETED|Assigned to Study Treatment||63
8555859|NCT00098748|21095723|P3|STARTED|Assigned to Study Treatment||64
8555860|NCT00098748|21095724|P2|STARTED|Assigned to Study Treatment||63
8555861|NCT00098748|21095725|P1|STARTED|Assigned to Study Treatment||63
8555862|NCT00098722|21095781|P7|NOT COMPLETED|Observation Phase||17
8555863|NCT00098722|21095782|P6|NOT COMPLETED|Observation Phase||45
8555864|NCT00098722|21095783|P5|NOT COMPLETED|Observation Phase||0
8555865|NCT00098722|21095784|P4|NOT COMPLETED|Observation Phase||0
8555866|NCT00098722|21095785|P3|NOT COMPLETED|Observation Phase||0
8555867|NCT00098722|21095786|P2|NOT COMPLETED|Observation Phase||0
8555868|NCT00098722|21095787|P1|NOT COMPLETED|Observation Phase||0
8555869|NCT00098722|21095781|P7|COMPLETED|Observation Phase||48
8555870|NCT00098722|21095782|P6|COMPLETED|Observation Phase||160
8555871|NCT00098722|21095783|P5|COMPLETED|Observation Phase||0
8555872|NCT00098722|21095784|P4|COMPLETED|Observation Phase||0
8555873|NCT00098722|21095785|P3|COMPLETED|Observation Phase||0
8555874|NCT00098722|21095786|P2|COMPLETED|Observation Phase||0
8555875|NCT00098722|21095787|P1|COMPLETED|Observation Phase||0
8555876|NCT00098722|21095781|P7|STARTED|Observation Phase||65
8555877|NCT00098722|21095782|P6|STARTED|Observation Phase||205
8555878|NCT00098722|21095783|P5|STARTED|Observation Phase||0
8555879|NCT00098722|21095784|P4|STARTED|Observation Phase||0
8555880|NCT00098722|21095785|P3|STARTED|Observation Phase||0
8555881|NCT00098722|21095786|P2|STARTED|Observation Phase||0
8555882|NCT00098722|21095787|P1|STARTED|Observation Phase||0
8555883|NCT00098722|21095781|P7|NOT COMPLETED|Open Label Phase||0
8555884|NCT00098722|21095782|P6|NOT COMPLETED|Open Label Phase||0
8555885|NCT00098722|21095783|P5|NOT COMPLETED|Open Label Phase||50
8555886|NCT00098722|21095784|P4|NOT COMPLETED|Open Label Phase||272
8555887|NCT00098722|21095785|P3|NOT COMPLETED|Open Label Phase||0
8555888|NCT00098722|21095786|P2|NOT COMPLETED|Open Label Phase||0
8555889|NCT00098722|21095787|P1|NOT COMPLETED|Open Label Phase||0
8555890|NCT00098722|21095781|P7|COMPLETED|Open Label Phase||0
8555891|NCT00098722|21095782|P6|COMPLETED|Open Label Phase||0
8555892|NCT00098722|21095783|P5|COMPLETED|Open Label Phase||0
8555893|NCT00098722|21095784|P4|COMPLETED|Open Label Phase||0
8555894|NCT00098722|21095785|P3|COMPLETED|Open Label Phase||0
8555895|NCT00098722|21095786|P2|COMPLETED|Open Label Phase||0
8555896|NCT00098722|21095787|P1|COMPLETED|Open Label Phase||0
8555897|NCT00098722|21095781|P7|STARTED|Open Label Phase||0
8555898|NCT00098722|21095782|P6|STARTED|Open Label Phase||0
8555899|NCT00098722|21095783|P5|STARTED|Open Label Phase||50
8555900|NCT00098722|21095784|P4|STARTED|Open Label Phase||272
8555901|NCT00098722|21095785|P3|STARTED|Open Label Phase||0
8555902|NCT00098722|21095786|P2|STARTED|Open Label Phase||0
8555903|NCT00098722|21095787|P1|STARTED|Open Label Phase||0
8555904|NCT00098722|21095781|P7|NOT COMPLETED|Double Blind Phase||0
8555905|NCT00098722|21095782|P6|NOT COMPLETED|Double Blind Phase||0
8555906|NCT00098722|21095783|P5|NOT COMPLETED|Double Blind Phase||0
8555907|NCT00098722|21095784|P4|NOT COMPLETED|Double Blind Phase||0
8555908|NCT00098722|21095785|P3|NOT COMPLETED|Double Blind Phase||94
8555909|NCT00098722|21095786|P2|NOT COMPLETED|Double Blind Phase||194
8555910|NCT00098722|21095787|P1|NOT COMPLETED|Double Blind Phase||186
8555911|NCT00098722|21095781|P7|COMPLETED|Double Blind Phase||0
8555912|NCT00098722|21095782|P6|COMPLETED|Double Blind Phase||0
8555913|NCT00098722|21095783|P5|COMPLETED|Double Blind Phase||0
8555914|NCT00098722|21095784|P4|COMPLETED|Double Blind Phase||0
8555915|NCT00098722|21095785|P3|COMPLETED|Double Blind Phase||0
8555916|NCT00098722|21095786|P2|COMPLETED|Double Blind Phase||0
8555917|NCT00098722|21095787|P1|COMPLETED|Double Blind Phase||0
8555918|NCT00098722|21095781|P7|Treated|Double Blind Phase||0
8555919|NCT00098722|21095782|P6|Treated|Double Blind Phase||0
8555920|NCT00098722|21095783|P5|Treated|Double Blind Phase||0
8555921|NCT00098722|21095784|P4|Treated|Double Blind Phase||0
8555922|NCT00098722|21095785|P3|Treated|Double Blind Phase||91
8555923|NCT00098722|21095786|P2|Treated|Double Blind Phase||191
8555924|NCT00098722|21095787|P1|Treated|Double Blind Phase||182
8555925|NCT00098722|21095781|P7|STARTED|Double Blind Phase||0
8555926|NCT00098722|21095782|P6|STARTED|Double Blind Phase||0
8555927|NCT00098722|21095783|P5|STARTED|Double Blind Phase||0
8555928|NCT00098722|21095784|P4|STARTED|Double Blind Phase||0
8555929|NCT00098722|21095785|P3|STARTED|Double Blind Phase||94
8555930|NCT00098722|21095786|P2|STARTED|Double Blind Phase||194
8555931|NCT00098722|21095787|P1|STARTED|Double Blind Phase||186
8555932|NCT00098670|21095850|P1|NOT COMPLETED|Overall Study||0
8555933|NCT00098670|21095850|P1|COMPLETED|Overall Study||102
8555934|NCT00098670|21095850|P1|STARTED|Overall Study||102
8555975|NCT00098371|21095876|P1|NOT COMPLETED|Overall Study||0
8555976|NCT00098371|21095876|P1|COMPLETED|Overall Study||64
8555977|NCT00098371|21095876|P1|STARTED|Overall Study||64
8555978|NCT00098345|21095901|P1|NOT COMPLETED|Overall Study||13
8555979|NCT00098345|21095901|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
8555980|NCT00098345|21095901|P1|STARTED|Overall Study||30
8555981|NCT00098306|21095914|P7|NOT COMPLETED|Observational Phase||26
8555982|NCT00098306|21095915|P6|NOT COMPLETED|Observational Phase||46
8555983|NCT00098306|21095916|P5|NOT COMPLETED|Observational Phase||0
8555984|NCT00098306|21095917|P4|NOT COMPLETED|Observational Phase||0
8555985|NCT00098306|21095918|P3|NOT COMPLETED|Observational Phase||0
8555986|NCT00098306|21095919|P2|NOT COMPLETED|Observational Phase||0
8555987|NCT00098306|21095920|P1|NOT COMPLETED|Observational Phase||0
8555988|NCT00098306|21095914|P7|COMPLETED|Observational Phase||55
8555989|NCT00098306|21095915|P6|COMPLETED|Observational Phase||204
8555990|NCT00098306|21095916|P5|COMPLETED|Observational Phase||0
8555991|NCT00098306|21095917|P4|COMPLETED|Observational Phase||0
8555992|NCT00098306|21095918|P3|COMPLETED|Observational Phase||0
8555993|NCT00098306|21095919|P2|COMPLETED|Observational Phase||0
8555994|NCT00098306|21095920|P1|COMPLETED|Observational Phase||0
8555995|NCT00098306|21095914|P7|STARTED|Observational Phase||81
8555996|NCT00098306|21095915|P6|STARTED|Observational Phase||250
8555997|NCT00098306|21095916|P5|STARTED|Observational Phase||0
8555998|NCT00098306|21095917|P4|STARTED|Observational Phase||0
8555999|NCT00098306|21095918|P3|STARTED|Observational Phase||0
8556000|NCT00098306|21095919|P2|STARTED|Observational Phase||0
8556001|NCT00098306|21095920|P1|STARTED|Observational Phase||0
8556002|NCT00098306|21095914|P7|NOT COMPLETED|Open Label||0
8556003|NCT00098306|21095915|P6|NOT COMPLETED|Open Label||0
8556004|NCT00098306|21095916|P5|NOT COMPLETED|Open Label||62
8556005|NCT00098306|21095917|P4|NOT COMPLETED|Open Label||327
8556006|NCT00098306|21095918|P3|NOT COMPLETED|Open Label||0
8556007|NCT00098306|21095919|P2|NOT COMPLETED|Open Label||0
8556008|NCT00098306|21095920|P1|NOT COMPLETED|Open Label||0
8556009|NCT00098306|21095914|P7|COMPLETED|Open Label||0
8556010|NCT00098306|21095915|P6|COMPLETED|Open Label||0
8556011|NCT00098306|21095916|P5|COMPLETED|Open Label||0
8556012|NCT00098306|21095917|P4|COMPLETED|Open Label||0
8556013|NCT00098306|21095918|P3|COMPLETED|Open Label||0
8556014|NCT00098306|21095919|P2|COMPLETED|Open Label||0
8556015|NCT00098306|21095920|P1|COMPLETED|Open Label||0
8556016|NCT00098306|21095914|P7|STARTED|Open Label||0
8556017|NCT00098306|21095915|P6|STARTED|Open Label||0
8556018|NCT00098306|21095916|P5|STARTED|Open Label||62
8556019|NCT00098306|21095917|P4|STARTED|Open Label||327
8556020|NCT00098306|21095918|P3|STARTED|Open Label||0
8556021|NCT00098306|21095919|P2|STARTED|Open Label||0
8556022|NCT00098306|21095920|P1|STARTED|Open Label||0
8556023|NCT00098306|21095914|P7|NOT COMPLETED|Double Blind||0
8556024|NCT00098306|21095915|P6|NOT COMPLETED|Double Blind||0
8556025|NCT00098306|21095916|P5|NOT COMPLETED|Double Blind||0
8556026|NCT00098306|21095917|P4|NOT COMPLETED|Double Blind||0
8556027|NCT00098306|21095918|P3|NOT COMPLETED|Double Blind||120
8556028|NCT00098306|21095919|P2|NOT COMPLETED|Double Blind||240
8556029|NCT00098306|21095920|P1|NOT COMPLETED|Double Blind||241
8556030|NCT00098306|21095914|P7|COMPLETED|Double Blind||0
8556031|NCT00098306|21095915|P6|COMPLETED|Double Blind||0
8556032|NCT00098306|21095916|P5|COMPLETED|Double Blind||0
8556033|NCT00098306|21095917|P4|COMPLETED|Double Blind||0
8556034|NCT00098306|21095918|P3|COMPLETED|Double Blind||0
8556035|NCT00098306|21095919|P2|COMPLETED|Double Blind||0
8556036|NCT00098306|21095920|P1|COMPLETED|Double Blind||0
8556037|NCT00098306|21095914|P7|Treated|Double Blind||0
8556038|NCT00098306|21095915|P6|Treated|Double Blind||0
8556039|NCT00098306|21095916|P5|Treated|Double Blind||0
8556040|NCT00098306|21095917|P4|Treated|Double Blind||0
8556041|NCT00098306|21095918|P3|Treated|Double Blind||118
8556042|NCT00098306|21095919|P2|Treated|Double Blind||235
8556043|NCT00098306|21095920|P1|Treated|Double Blind||232
8556044|NCT00098306|21095914|P7|STARTED|Double Blind||0
8556045|NCT00098306|21095915|P6|STARTED|Double Blind||0
8556046|NCT00098306|21095916|P5|STARTED|Double Blind||0
8556047|NCT00098306|21095917|P4|STARTED|Double Blind||0
8556048|NCT00098306|21095918|P3|STARTED|Double Blind||120
8556049|NCT00098306|21095919|P2|STARTED|Double Blind||240
8556050|NCT00098306|21095920|P1|STARTED|Double Blind||241
8556051|NCT00098293|21095986|P5|NOT COMPLETED|Supplemental Phase (SP)||33
8556052|NCT00098293|21095987|P4|NOT COMPLETED|Supplemental Phase (SP)||0
8556053|NCT00098293|21095988|P3|NOT COMPLETED|Supplemental Phase (SP)||0
8556054|NCT00098293|21095989|P2|NOT COMPLETED|Supplemental Phase (SP)||0
8556055|NCT00098293|21095990|P1|NOT COMPLETED|Supplemental Phase (SP)||0
8556056|NCT00098293|21095986|P5|COMPLETED|Supplemental Phase (SP)||94
8556057|NCT00098293|21095987|P4|COMPLETED|Supplemental Phase (SP)||0
8556058|NCT00098293|21095988|P3|COMPLETED|Supplemental Phase (SP)||0
8556059|NCT00098293|21095989|P2|COMPLETED|Supplemental Phase (SP)||0
8556060|NCT00098293|21095990|P1|COMPLETED|Supplemental Phase (SP)||0
8556061|NCT00098293|21095986|P5|STARTED|Supplemental Phase (SP)||127
8556062|NCT00098293|21095987|P4|STARTED|Supplemental Phase (SP)||0
8556063|NCT00098293|21095988|P3|STARTED|Supplemental Phase (SP)||0
8556064|NCT00098293|21095989|P2|STARTED|Supplemental Phase (SP)||0
8556065|NCT00098293|21095990|P1|STARTED|Supplemental Phase (SP)||0
8556066|NCT00098293|21095986|P5|NOT COMPLETED|Open-label (OL) Phase||0
8556067|NCT00098293|21095987|P4|NOT COMPLETED|Open-label (OL) Phase||65
8556068|NCT00098293|21095988|P3|NOT COMPLETED|Open-label (OL) Phase||41
8556069|NCT00098293|21095989|P2|NOT COMPLETED|Open-label (OL) Phase||25
8556070|NCT00098293|21095990|P1|NOT COMPLETED|Open-label (OL) Phase||0
8556071|NCT00098293|21095986|P5|COMPLETED|Open-label (OL) Phase||0
8556072|NCT00098293|21095987|P4|COMPLETED|Open-label (OL) Phase||65
8556073|NCT00098293|21095988|P3|COMPLETED|Open-label (OL) Phase||158
8556074|NCT00098293|21095989|P2|COMPLETED|Open-label (OL) Phase||177
8556075|NCT00098293|21095990|P1|COMPLETED|Open-label (OL) Phase||0
8556076|NCT00098293|21095986|P5|STARTED|Open-label (OL) Phase||0
8556077|NCT00098293|21095987|P4|STARTED|Open-label (OL) Phase||130
8556078|NCT00098293|21095988|P3|STARTED|Open-label (OL) Phase||199
8556079|NCT00098293|21095989|P2|STARTED|Open-label (OL) Phase||202
8556080|NCT00098293|21095990|P1|STARTED|Open-label (OL) Phase||0
8556081|NCT00098293|21095986|P5|NOT COMPLETED|Between DB and OL Phase||0
8556082|NCT00098293|21095987|P4|NOT COMPLETED|Between DB and OL Phase||0
8556083|NCT00098293|21095988|P3|NOT COMPLETED|Between DB and OL Phase||3
8556084|NCT00098293|21095989|P2|NOT COMPLETED|Between DB and OL Phase||0
8556085|NCT00098293|21095990|P1|NOT COMPLETED|Between DB and OL Phase||0
8556086|NCT00098293|21095986|P5|COMPLETED|Between DB and OL Phase||0
8556087|NCT00098293|21095987|P4|COMPLETED|Between DB and OL Phase||0
8556088|NCT00098293|21095988|P3|COMPLETED|Between DB and OL Phase||199
8556089|NCT00098293|21095989|P2|COMPLETED|Between DB and OL Phase||202
8556090|NCT00098293|21095990|P1|COMPLETED|Between DB and OL Phase||0
8556091|NCT00098293|21095986|P5|STARTED|Between DB and OL Phase||0
8556092|NCT00098293|21095987|P4|STARTED|Between DB and OL Phase||0
8556093|NCT00098293|21095988|P3|STARTED|Between DB and OL Phase||202
8556094|NCT00098293|21095989|P2|STARTED|Between DB and OL Phase||202
8556095|NCT00098293|21095990|P1|STARTED|Between DB and OL Phase||0
8556096|NCT00098293|21095986|P5|NOT COMPLETED|Double-blind (DB) Phase||0
8556097|NCT00098293|21095987|P4|NOT COMPLETED|Double-blind (DB) Phase||0
8556098|NCT00098293|21095988|P3|NOT COMPLETED|Double-blind (DB) Phase||170
8556099|NCT00098293|21095989|P2|NOT COMPLETED|Double-blind (DB) Phase||166
8556100|NCT00098293|21095990|P1|NOT COMPLETED|Double-blind (DB) Phase||177
8556101|NCT00098293|21095986|P5|COMPLETED|Double-blind (DB) Phase||0
8556102|NCT00098293|21095987|P4|COMPLETED|Double-blind (DB) Phase||0
8556103|NCT00098293|21095988|P3|COMPLETED|Double-blind (DB) Phase||202
8556104|NCT00098293|21095989|P2|COMPLETED|Double-blind (DB) Phase||202
8556105|NCT00098293|21095990|P1|COMPLETED|Double-blind (DB) Phase||0
8556106|NCT00098293|21095986|P5|Treated|Double-blind (DB) Phase||0
8556107|NCT00098293|21095987|P4|Treated|Double-blind (DB) Phase||0
8556108|NCT00098293|21095988|P3|Treated|Double-blind (DB) Phase||361
8556109|NCT00098293|21095989|P2|Treated|Double-blind (DB) Phase||360
8556110|NCT00098293|21095990|P1|Treated|Double-blind (DB) Phase||174
8556111|NCT00098293|21095986|P5|STARTED|Double-blind (DB) Phase||0
8556112|NCT00098293|21095987|P4|STARTED|Double-blind (DB) Phase||0
8556113|NCT00098293|21095988|P3|STARTED|Double-blind (DB) Phase||372
8556114|NCT00098293|21095989|P2|STARTED|Double-blind (DB) Phase||368
8556115|NCT00098293|21095990|P1|STARTED|Double-blind (DB) Phase||177
8556116|NCT00098254|21096043|P1|NOT COMPLETED|Overall Study||3
8556117|NCT00098254|21096043|P1|COMPLETED|Overall Study||34
8556118|NCT00098254|21096043|P1|STARTED|Overall Study||37
8556119|NCT00098059|21096064|P2|NOT COMPLETED|Overall Study||1
8556120|NCT00098059|21096065|P1|NOT COMPLETED|Overall Study||0
8556121|NCT00098059|21096064|P2|COMPLETED|Overall Study||46
8556122|NCT00098059|21096065|P1|COMPLETED|Overall Study||27
8556123|NCT00098059|21096064|P2|STARTED|Overall Study||47
8556124|NCT00098059|21096065|P1|STARTED|Overall Study||27
8556125|NCT00098020|21096109|P1|NOT COMPLETED|Overall Study||6
8556126|NCT00098020|21096109|P1|COMPLETED|Overall Study||6
8556127|NCT00098020|21096109|P1|Started Isotretinoin|Overall Study||8
8556128|NCT00098020|21096109|P1|STARTED|Overall Study||12
8556129|NCT00097981|21096116|P2|NOT COMPLETED|Overall Study||100
8556130|NCT00097981|21096117|P1|NOT COMPLETED|Overall Study||106
8556131|NCT00097981|21096116|P2|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
8556132|NCT00097981|21096117|P1|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
8556133|NCT00097981|21096116|P2|Received Study Medication|Overall Study||106
8556134|NCT00097981|21096117|P1|Received Study Medication|Overall Study||110
8556135|NCT00097981|21096116|P2|STARTED|Overall Study|Enrollment at randomization|112
8556136|NCT00097981|21096117|P1|STARTED|Overall Study|Enrollment at randomization|113
8556137|NCT00097786|21096139|P4|NOT COMPLETED|Overall Study||310
8556138|NCT00097786|21096140|P3|NOT COMPLETED|Overall Study||313
8556139|NCT00097786|21096141|P2|NOT COMPLETED|Overall Study||292
8556140|NCT00097786|21096142|P1|NOT COMPLETED|Overall Study||296
8556141|NCT00097786|21096139|P4|COMPLETED|Overall Study||2036
8556142|NCT00097786|21096140|P3|COMPLETED|Overall Study||2016
8556143|NCT00097786|21096141|P2|COMPLETED|Overall Study||2023
8556144|NCT00097786|21096142|P1|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
8556145|NCT00097786|21096139|P4|Complete Follow-up for Core CV EPs|Overall Study||1988
8556146|NCT00097786|21096140|P3|Complete Follow-up for Core CV EPs|Overall Study||1966
8556147|NCT00097786|21096141|P2|Complete Follow-up for Core CV EPs|Overall Study||1963
8556148|NCT00097786|21096142|P1|Complete Follow-up for Core CV EPs|Overall Study||1948
8556149|NCT00097786|21096139|P4|Complete Follow-up for Extended CV EPs|Overall Study||2015
8556150|NCT00097786|21096140|P3|Complete Follow-up for Extended CV EPs|Overall Study||1987
8556151|NCT00097786|21096141|P2|Complete Follow-up for Extended CV EPs|Overall Study||1985
8556152|NCT00097786|21096142|P1|Complete Follow-up for Extended CV EPs|Overall Study||1969
8556153|NCT00097786|21096139|P4|Complete FU for Progression to Diabetes|Overall Study||1762
8556154|NCT00097786|21096140|P3|Complete FU for Progression to Diabetes|Overall Study||1734
8556155|NCT00097786|21096141|P2|Complete FU for Progression to Diabetes|Overall Study||1712
8556156|NCT00097786|21096142|P1|Complete FU for Progression to Diabetes|Overall Study||1709
8556157|NCT00097786|21096139|P4|STARTED|Overall Study||2346
8556158|NCT00097786|21096140|P3|STARTED|Overall Study||2329
8556159|NCT00097786|21096141|P2|STARTED|Overall Study||2315
8556160|NCT00097786|21096142|P1|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
8556161|NCT00097773|21096164|P4|NOT COMPLETED|Overall Study||3
8556162|NCT00097773|21096165|P3|NOT COMPLETED|Overall Study||8
8556163|NCT00097773|21096166|P2|NOT COMPLETED|Overall Study||8
8556164|NCT00097773|21096167|P1|NOT COMPLETED|Overall Study||8
8556165|NCT00097773|21096164|P4|COMPLETED|Overall Study||73
8556166|NCT00097773|21096165|P3|COMPLETED|Overall Study||68
8556167|NCT00097773|21096166|P2|COMPLETED|Overall Study||68
8556168|NCT00097773|21096167|P1|COMPLETED|Overall Study||68
8556169|NCT00097773|21096164|P4|STARTED|Overall Study||76
8556170|NCT00097773|21096165|P3|STARTED|Overall Study||76
8556171|NCT00097773|21096166|P2|STARTED|Overall Study||76
8556172|NCT00097773|21096167|P1|STARTED|Overall Study||76
8556173|NCT00097721|21096187|P2|NOT COMPLETED|Overall Study||33
8556174|NCT00097721|21096188|P1|NOT COMPLETED|Overall Study||71
8556175|NCT00097721|21096187|P2|COMPLETED|Overall Study||0
8556176|NCT00097721|21096188|P1|COMPLETED|Overall Study||0
8556177|NCT00097721|21096187|P2|STARTED|Overall Study||33
8556178|NCT00097721|21096188|P1|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
8556179|NCT00097708|21096205|P3|NOT COMPLETED|Overall Study||65
8556180|NCT00097708|21096206|P2|NOT COMPLETED|Overall Study||56
8556181|NCT00097708|21096207|P1|NOT COMPLETED|Overall Study||64
8556182|NCT00097708|21096205|P3|COMPLETED|Overall Study||97
8556183|NCT00097708|21096206|P2|COMPLETED|Overall Study||120
8556184|NCT00097708|21096207|P1|COMPLETED|Overall Study||109
8556185|NCT00097708|21096205|P3|Treated|Overall Study||160
8556186|NCT00097708|21096206|P2|Treated|Overall Study||176
8556187|NCT00097708|21096207|P1|Treated|Overall Study||171
8556188|NCT00097708|21096205|P3|Intent-to-Treat (ITT)|Overall Study||149
8556189|NCT00097708|21096206|P2|Intent-to-Treat (ITT)|Overall Study||169
8556190|NCT00097708|21096207|P1|Intent-to-Treat (ITT)|Overall Study||165
8556191|NCT00097708|21096205|P3|STARTED|Overall Study||162
8556192|NCT00097708|21096206|P2|STARTED|Overall Study||176
8556193|NCT00097708|21096207|P1|STARTED|Overall Study||173
8556218|NCT00097669|21096238|P2|NOT COMPLETED|Overall Study||0
8556219|NCT00097669|21096239|P1|NOT COMPLETED|Overall Study||0
8556220|NCT00097669|21096238|P2|COMPLETED|Overall Study||4075
8556221|NCT00097669|21096239|P1|COMPLETED|Overall Study||4089
8556222|NCT00097669|21096238|P2|STARTED|Overall Study||4075
8556223|NCT00097669|21096239|P1|STARTED|Overall Study||4089
8556224|NCT00097591|21096247|P2|NOT COMPLETED|Overall Study||394
8556225|NCT00097591|21096248|P1|NOT COMPLETED|Overall Study||410
8556226|NCT00097591|21096247|P2|COMPLETED|Overall Study||6401
8556227|NCT00097591|21096248|P1|COMPLETED|Overall Study||6403
8556228|NCT00097591|21096247|P2|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
8556229|NCT00097591|21096248|P1|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
8556230|NCT00097539|21096271|P7|NOT COMPLETED|Overall Study||171
8556231|NCT00097539|21096272|P6|NOT COMPLETED|Overall Study||5892
8556232|NCT00097539|21096273|P5|NOT COMPLETED|Overall Study||1758
8556233|NCT00097539|21096274|P4|NOT COMPLETED|Overall Study||3585
8556234|NCT00097539|21096275|P3|NOT COMPLETED|Overall Study||9108
8556235|NCT00097539|21096276|P2|NOT COMPLETED|Overall Study||6531
8556236|NCT00097539|21096277|P1|NOT COMPLETED|Overall Study||19066
8556237|NCT00097539|21096271|P7|COMPLETED|Overall Study||68
8556238|NCT00097539|21096272|P6|COMPLETED|Overall Study||2118
8556239|NCT00097539|21096273|P5|COMPLETED|Overall Study||386
8556240|NCT00097539|21096274|P4|COMPLETED|Overall Study||2066
8556241|NCT00097539|21096275|P3|COMPLETED|Overall Study||3411
8556242|NCT00097539|21096276|P2|COMPLETED|Overall Study||2825
8556243|NCT00097539|21096277|P1|COMPLETED|Overall Study||8220
8556244|NCT00097539|21096271|P7|STARTED|Overall Study||239
8556245|NCT00097539|21096272|P6|STARTED|Overall Study||8010
8556246|NCT00097539|21096273|P5|STARTED|Overall Study||2144
8556247|NCT00097539|21096274|P4|STARTED|Overall Study||5651
8556248|NCT00097539|21096275|P3|STARTED|Overall Study||12519
8556249|NCT00097539|21096276|P2|STARTED|Overall Study||9356
8556250|NCT00097539|21096277|P1|STARTED|Overall Study||27286
8556251|NCT00097500|21096323|P2|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
8556252|NCT00097500|21096324|P1|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
8556253|NCT00097500|21096323|P2|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
8556254|NCT00097500|21096324|P1|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
8556255|NCT00097500|21096323|P2|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
8556256|NCT00097500|21096324|P1|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
8556257|NCT00097500|21096323|P2|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
8556258|NCT00097500|21096324|P1|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
8556259|NCT00097500|21096323|P2|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
8556260|NCT00097500|21096324|P1|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
8556261|NCT00097500|21096323|P2|STARTED|On-drug Period (Week 0 to Week 52)||33
8556262|NCT00097500|21096324|P1|STARTED|On-drug Period (Week 0 to Week 52)||36
8556263|NCT00097448|21096348|P2|NOT COMPLETED|Overall Study||1
8556264|NCT00097448|21096349|P1|NOT COMPLETED|Overall Study||4
8556265|NCT00097448|21096348|P2|COMPLETED|Overall Study||129
8556266|NCT00097448|21096349|P1|COMPLETED|Overall Study||121
8556267|NCT00097448|21096348|P2|STARTED|Overall Study||130
8556268|NCT00097448|21096349|P1|STARTED|Overall Study||125
8556269|NCT00097370|21096355|P1|NOT COMPLETED|Stage 3||59
8556270|NCT00097370|21096355|P1|COMPLETED|Stage 3||0
8556271|NCT00097370|21096355|P1|STARTED|Stage 3|Participants continued from Stage 2.|59
8556272|NCT00097370|21096355|P1|NOT COMPLETED|Stage 2||13
8556273|NCT00097370|21096355|P1|COMPLETED|Stage 2||59
8556274|NCT00097370|21096355|P1|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
8556275|NCT00097370|21096355|P1|NOT COMPLETED|Stage 1||6
8556276|NCT00097370|21096355|P1|COMPLETED|Stage 1||31
8556277|NCT00097370|21096355|P1|STARTED|Stage 1|Participants entered from study MHE100185.|37
8556278|NCT00097253|21096372|P1|NOT COMPLETED|Water (Control)||0
8556279|NCT00097253|21096372|P1|COMPLETED|Water (Control)||56
8556280|NCT00097253|21096372|P1|STARTED|Water (Control)||56
8556281|NCT00097253|21096372|P1|NOT COMPLETED|Lemon||0
8556282|NCT00097253|21096372|P1|COMPLETED|Lemon||56
8556283|NCT00097253|21096372|P1|STARTED|Lemon||56
8556284|NCT00097253|21096372|P1|NOT COMPLETED|Lavender||0
8556285|NCT00097253|21096372|P1|COMPLETED|Lavender||56
8556286|NCT00097253|21096372|P1|STARTED|Lavender||56
8556287|NCT00096993|21096389|P2|NOT COMPLETED|Overall Study||65
8556288|NCT00096993|21096390|P1|NOT COMPLETED|Overall Study||65
8556289|NCT00096993|21096389|P2|COMPLETED|Overall Study||0
8556290|NCT00096993|21096390|P1|COMPLETED|Overall Study||1
8556291|NCT00096993|21096389|P2|STARTED|Overall Study||65
8556292|NCT00096993|21096390|P1|STARTED|Overall Study||66
8556293|NCT00096954|21096406|P2|NOT COMPLETED|Overall Study||20
8556294|NCT00096954|21096407|P1|NOT COMPLETED|Overall Study||24
8556295|NCT00096954|21096406|P2|COMPLETED|Overall Study||154
8556296|NCT00096954|21096407|P1|COMPLETED|Overall Study||135
8556297|NCT00096954|21096406|P2|Received Study Drug|Overall Study||171
8556298|NCT00096954|21096407|P1|Received Study Drug|Overall Study||157
8556299|NCT00096954|21096406|P2|STARTED|Overall Study||174
8556300|NCT00096954|21096407|P1|STARTED|Overall Study||159
8556301|NCT00096941|21096419|P1|NOT COMPLETED|Overall Study||3
8556302|NCT00096941|21096419|P1|COMPLETED|Overall Study||0
8556303|NCT00096941|21096419|P1|STARTED|Overall Study||3
8556304|NCT00096785|21096426|P2|NOT COMPLETED|Overall Study||1
8556305|NCT00096785|21096427|P1|NOT COMPLETED|Overall Study||2
8556306|NCT00096785|21096426|P2|COMPLETED|Overall Study|As randomized cohort|33
8556307|NCT00096785|21096427|P1|COMPLETED|Overall Study|As randomized cohort|33
8556308|NCT00096785|21096426|P2|As-Treated Population|Overall Study||33
8556309|NCT00096785|21096427|P1|As-Treated Population|Overall Study||36
8556310|NCT00096785|21096426|P2|As-Randomized Population|Overall Study||34
8556311|NCT00096785|21096427|P1|As-Randomized Population|Overall Study||35
8556312|NCT00096785|21096426|P2|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
8556313|NCT00096785|21096427|P1|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
8556314|NCT00096681|21096451|P1|NOT COMPLETED|Overall Study||0
8556315|NCT00096681|21096451|P1|COMPLETED|Overall Study||762
8556316|NCT00096681|21096451|P1|STARTED|Overall Study||762
8556317|NCT00096538|21096456|P1|NOT COMPLETED|Overall Study||1
8556318|NCT00096538|21096456|P1|COMPLETED|Overall Study||5
8556319|NCT00096538|21096456|P1|STARTED|Overall Study||6
8556320|NCT00096486|21096464|P4|NOT COMPLETED|Overall Study||2
8556321|NCT00096486|21096465|P3|NOT COMPLETED|Overall Study||2
8556322|NCT00096486|21096466|P2|NOT COMPLETED|Overall Study||0
8556323|NCT00096486|21096467|P1|NOT COMPLETED|Overall Study||0
8556324|NCT00096486|21096464|P4|COMPLETED|Overall Study||36
8556325|NCT00096486|21096465|P3|COMPLETED|Overall Study||24
8556326|NCT00096486|21096466|P2|COMPLETED|Overall Study||6
8556327|NCT00096486|21096467|P1|COMPLETED|Overall Study||4
8556328|NCT00096486|21096464|P4|STARTED|Overall Study||38
8556329|NCT00096486|21096465|P3|STARTED|Overall Study||26
8556330|NCT00096486|21096466|P2|STARTED|Overall Study||6
8556331|NCT00096486|21096467|P1|STARTED|Overall Study||4
8556332|NCT00096460|21096479|P2|NOT COMPLETED|Overall Study||1
8556333|NCT00096460|21096480|P1|NOT COMPLETED|Overall Study||7
8556334|NCT00096460|21096479|P2|COMPLETED|Overall Study||7
8556335|NCT00096460|21096480|P1|COMPLETED|Overall Study||15
8556336|NCT00096460|21096479|P2|STARTED|Overall Study||8
8556337|NCT00096460|21096480|P1|STARTED|Overall Study||22
8556338|NCT00096447|21096486|P1|NOT COMPLETED|Overall Study||1
8556339|NCT00096447|21096486|P1|COMPLETED|Overall Study|Eligible and treated patients.|30
8556340|NCT00096447|21096486|P1|STARTED|Overall Study||31
8556341|NCT00096382|21096502|P2|NOT COMPLETED|Overall Study||0
8556342|NCT00096382|21096503|P1|NOT COMPLETED|Overall Study||2
8556343|NCT00096382|21096502|P2|COMPLETED|Overall Study||3
8556344|NCT00096382|21096503|P1|COMPLETED|Overall Study||21
8556345|NCT00096382|21096502|P2|STARTED|Overall Study||3
8556346|NCT00096382|21096503|P1|STARTED|Overall Study||23
8556347|NCT00096356|21096513|P2|NOT COMPLETED|Overall Study||53
8556348|NCT00096356|21096514|P1|NOT COMPLETED|Overall Study||44
8556349|NCT00096356|21096513|P2|COMPLETED|Overall Study||61
8556350|NCT00096356|21096514|P1|COMPLETED|Overall Study||78
8556351|NCT00096356|21096513|P2|STARTED|Overall Study||114
8556352|NCT00096356|21096514|P1|STARTED|Overall Study||122
8556353|NCT00096278|21096526|P2|NOT COMPLETED|Overall Study||20
8556354|NCT00096278|21096527|P1|NOT COMPLETED|Overall Study||18
8556355|NCT00096278|21096526|P2|COMPLETED|Overall Study||1334
8556356|NCT00096278|21096527|P1|COMPLETED|Overall Study||1338
8556357|NCT00096278|21096526|P2|STARTED|Overall Study||1354
8556358|NCT00096278|21096527|P1|STARTED|Overall Study||1356
8556359|NCT00096265|21096546|P3|NOT COMPLETED|Overall Study||0
8556360|NCT00096265|21096547|P2|NOT COMPLETED|Overall Study||0
8556361|NCT00096265|21096548|P1|NOT COMPLETED|Overall Study||1
8556362|NCT00096265|21096546|P3|COMPLETED|Overall Study||41
8556363|NCT00096265|21096547|P2|COMPLETED|Overall Study||40
8556364|NCT00096265|21096548|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
8556365|NCT00096265|21096546|P3|STARTED|Overall Study||41
8556366|NCT00096265|21096547|P2|STARTED|Overall Study||40
8556367|NCT00096265|21096548|P1|STARTED|Overall Study||45
8556368|NCT00096226|21096574|P1|NOT COMPLETED|Overall Study||3
8556369|NCT00096226|21096574|P1|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57
8556370|NCT00096226|21096574|P1|Eligible and Underwent Surgery|Overall Study||37
8556371|NCT00096226|21096574|P1|Eligible|Overall Study||57
8556372|NCT00096226|21096574|P1|STARTED|Overall Study||60
8556373|NCT00096200|21096588|P3|NOT COMPLETED|Overall Study||0
8556374|NCT00096200|21096589|P2|NOT COMPLETED|Overall Study||7
8556375|NCT00096200|21096590|P1|NOT COMPLETED|Overall Study||1
8556376|NCT00096200|21096588|P3|COMPLETED|Overall Study||5
8556377|NCT00096200|21096589|P2|COMPLETED|Overall Study||23
8556378|NCT00096200|21096590|P1|COMPLETED|Overall Study||8
8556379|NCT00096200|21096588|P3|STARTED|Overall Study||5
8556380|NCT00096200|21096589|P2|STARTED|Overall Study||30
8556381|NCT00096200|21096590|P1|STARTED|Overall Study||9
8556382|NCT00096174|21096604|P1|NOT COMPLETED|Overall Study||62
8556383|NCT00096174|21096604|P1|COMPLETED|Overall Study||7
8556384|NCT00096174|21096604|P1|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
8556385|NCT00096174|21096604|P1|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
8556386|NCT00096174|21096604|P1|STARTED|Overall Study||69
8556387|NCT00096161|21096614|P4|NOT COMPLETED|Overall Study||0
8556388|NCT00096161|21096615|P3|NOT COMPLETED|Overall Study||0
8556389|NCT00096161|21096616|P2|NOT COMPLETED|Overall Study||0
8556390|NCT00096161|21096617|P1|NOT COMPLETED|Overall Study||0
8556391|NCT00096161|21096614|P4|COMPLETED|Overall Study||0
8556392|NCT00096161|21096615|P3|COMPLETED|Overall Study||6
8556393|NCT00096161|21096616|P2|COMPLETED|Overall Study||10
8556394|NCT00096161|21096617|P1|COMPLETED|Overall Study||20
8556395|NCT00096161|21096614|P4|STARTED|Overall Study||0
8556396|NCT00096161|21096615|P3|STARTED|Overall Study||6
8556397|NCT00096161|21096616|P2|STARTED|Overall Study||10
8556398|NCT00096161|21096617|P1|STARTED|Overall Study||20
8556399|NCT00096135|21096649|P2|NOT COMPLETED|Overall Study||15
8556400|NCT00096135|21096650|P1|NOT COMPLETED|Overall Study||63
8556401|NCT00096135|21096649|P2|COMPLETED|Overall Study||27
8556402|NCT00096135|21096650|P1|COMPLETED|Overall Study||63
8556403|NCT00096135|21096649|P2|STARTED|Overall Study||42
8556404|NCT00096135|21096650|P1|STARTED|Overall Study||126
8556405|NCT00096122|21096656|P1|NOT COMPLETED|Overall Study||0
8556406|NCT00096122|21096656|P1|COMPLETED|Overall Study||95
8556407|NCT00096122|21096656|P1|STARTED|Overall Study||95
8556408|NCT00096109|21096660|P1|NOT COMPLETED|Overall Study||0
8556409|NCT00096109|21096660|P1|COMPLETED|Overall Study||11
8556410|NCT00096109|21096660|P1|STARTED|Overall Study||11
8556411|NCT00096044|21096666|P1|NOT COMPLETED|Overall Study||34
8556412|NCT00096044|21096666|P1|COMPLETED|Overall Study||11
8556413|NCT00096044|21096666|P1|STARTED|Overall Study||45
8556414|NCT00096031|21096675|P1|NOT COMPLETED|Overall Study||63
8556415|NCT00096031|21096675|P1|COMPLETED|Overall Study||0
8556416|NCT00096031|21096675|P1|Eligible and Began Protocol Therapy|Overall Study||55
8556417|NCT00096031|21096675|P1|Eligible|Overall Study||57
8556418|NCT00096031|21096675|P1|STARTED|Overall Study||63
8556419|NCT00096018|21096683|P2|NOT COMPLETED|Overall Study||14
8556420|NCT00096018|21096684|P1|NOT COMPLETED|Overall Study||2
8556421|NCT00096018|21096683|P2|COMPLETED|Overall Study||16
8556422|NCT00096018|21096684|P1|COMPLETED|Overall Study||11
8556423|NCT00096018|21096683|P2|Treated With Study Therapy|Overall Study||25
8556424|NCT00096018|21096684|P1|Treated With Study Therapy|Overall Study||13
8556425|NCT00096018|21096683|P2|STARTED|Overall Study||30
8556426|NCT00096018|21096684|P1|STARTED|Overall Study||13
8556427|NCT00095979|21096692|P1|NOT COMPLETED|Overall Study||2
8556428|NCT00095979|21096692|P1|COMPLETED|Overall Study||50
8556429|NCT00095979|21096692|P1|STARTED|Overall Study||52
8556430|NCT00095940|21096710|P9|NOT COMPLETED|Lapatinib Continuation/Phase II||13
8556431|NCT00095940|21096711|P8|NOT COMPLETED|Lapatinib Continuation/Phase II||2
8556432|NCT00095940|21096712|P7|NOT COMPLETED|Lapatinib Continuation/Phase II||2
8556433|NCT00095940|21096713|P6|NOT COMPLETED|Lapatinib Continuation/Phase II||13
8556434|NCT00095940|21096714|P5|NOT COMPLETED|Lapatinib Continuation/Phase II||0
8556435|NCT00095940|21096715|P4|NOT COMPLETED|Lapatinib Continuation/Phase II||0
8556436|NCT00095940|21096716|P3|NOT COMPLETED|Lapatinib Continuation/Phase II||16
8556437|NCT00095940|21096717|P2|NOT COMPLETED|Lapatinib Continuation/Phase II||2
8556438|NCT00095940|21096718|P1|NOT COMPLETED|Lapatinib Continuation/Phase II||2
8556439|NCT00095940|21096710|P9|COMPLETED|Lapatinib Continuation/Phase II||1
8556440|NCT00095940|21096711|P8|COMPLETED|Lapatinib Continuation/Phase II||0
8556441|NCT00095940|21096712|P7|COMPLETED|Lapatinib Continuation/Phase II||0
8556442|NCT00095940|21096713|P6|COMPLETED|Lapatinib Continuation/Phase II||0
8556443|NCT00095940|21096714|P5|COMPLETED|Lapatinib Continuation/Phase II||0
8556444|NCT00095940|21096715|P4|COMPLETED|Lapatinib Continuation/Phase II||0
8556445|NCT00095940|21096716|P3|COMPLETED|Lapatinib Continuation/Phase II||1
8556446|NCT00095940|21096717|P2|COMPLETED|Lapatinib Continuation/Phase II||0
8556447|NCT00095940|21096718|P1|COMPLETED|Lapatinib Continuation/Phase II||0
8556448|NCT00095940|21096710|P9|STARTED|Lapatinib Continuation/Phase II||14
8556449|NCT00095940|21096711|P8|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
8556450|NCT00095940|21096712|P7|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
8556451|NCT00095940|21096713|P6|STARTED|Lapatinib Continuation/Phase II||13
8556452|NCT00095940|21096714|P5|STARTED|Lapatinib Continuation/Phase II||0
8556453|NCT00095940|21096715|P4|STARTED|Lapatinib Continuation/Phase II||0
8556454|NCT00095940|21096716|P3|STARTED|Lapatinib Continuation/Phase II||17
8556455|NCT00095940|21096717|P2|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
8556456|NCT00095940|21096718|P1|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
8556457|NCT00095940|21096710|P9|NOT COMPLETED|Molecular Biology Phase||0
8556458|NCT00095940|21096711|P8|NOT COMPLETED|Molecular Biology Phase||0
8556459|NCT00095940|21096712|P7|NOT COMPLETED|Molecular Biology Phase||0
8556460|NCT00095940|21096713|P6|NOT COMPLETED|Molecular Biology Phase||0
8556461|NCT00095940|21096714|P5|NOT COMPLETED|Molecular Biology Phase||0
8556462|NCT00095940|21096715|P4|NOT COMPLETED|Molecular Biology Phase||0
8556463|NCT00095940|21096716|P3|NOT COMPLETED|Molecular Biology Phase||0
8556464|NCT00095940|21096717|P2|NOT COMPLETED|Molecular Biology Phase||0
8556465|NCT00095940|21096718|P1|NOT COMPLETED|Molecular Biology Phase||0
8556466|NCT00095940|21096710|P9|COMPLETED|Molecular Biology Phase||0
8556467|NCT00095940|21096711|P8|COMPLETED|Molecular Biology Phase||2
8556468|NCT00095940|21096712|P7|COMPLETED|Molecular Biology Phase||2
8556469|NCT00095940|21096713|P6|COMPLETED|Molecular Biology Phase||0
8556470|NCT00095940|21096714|P5|COMPLETED|Molecular Biology Phase||0
8556471|NCT00095940|21096715|P4|COMPLETED|Molecular Biology Phase||0
8556472|NCT00095940|21096716|P3|COMPLETED|Molecular Biology Phase||0
8556473|NCT00095940|21096717|P2|COMPLETED|Molecular Biology Phase||2
8556474|NCT00095940|21096718|P1|COMPLETED|Molecular Biology Phase||2
8556475|NCT00095940|21096710|P9|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
8556476|NCT00095940|21096711|P8|STARTED|Molecular Biology Phase||2
8556477|NCT00095940|21096712|P7|STARTED|Molecular Biology Phase||2
8556478|NCT00095940|21096713|P6|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
8556479|NCT00095940|21096714|P5|STARTED|Molecular Biology Phase||0
8556480|NCT00095940|21096715|P4|STARTED|Molecular Biology Phase||0
8556481|NCT00095940|21096716|P3|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
8556482|NCT00095940|21096717|P2|STARTED|Molecular Biology Phase||2
8556483|NCT00095940|21096718|P1|STARTED|Molecular Biology Phase||2
8556484|NCT00095875|21096742|P2|NOT COMPLETED|Overall Study||9
8556485|NCT00095875|21096743|P1|NOT COMPLETED|Overall Study||14
8556486|NCT00095875|21096742|P2|COMPLETED|Overall Study||66
8556487|NCT00095875|21096743|P1|COMPLETED|Overall Study||56
8556488|NCT00095875|21096742|P2|STARTED|Overall Study||75
8556489|NCT00095875|21096743|P1|STARTED|Overall Study||70
8556490|NCT00095836|21096751|P1|NOT COMPLETED|Overall Study||4
8556491|NCT00095836|21096751|P1|COMPLETED|Overall Study||23
8556492|NCT00095836|21096751|P1|STARTED|Overall Study||27
8556496|NCT00095628|21096781|P1|NOT COMPLETED|Overall Study||1
8556497|NCT00095628|21096781|P1|COMPLETED|Overall Study||20
8556498|NCT00095628|21096781|P1|STARTED|Overall Study||21
8556499|NCT00095576|21096792|P2|NOT COMPLETED|Overall Study||1481
8556500|NCT00095576|21096793|P1|NOT COMPLETED|Overall Study||1475
8556501|NCT00095576|21096792|P2|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
8556502|NCT00095576|21096793|P1|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
8556503|NCT00095576|21096792|P2|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
8556504|NCT00095576|21096793|P1|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
8556505|NCT00095576|21096792|P2|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
8556506|NCT00095576|21096793|P1|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
8556507|NCT00095576|21096792|P2|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
8556508|NCT00095576|21096793|P1|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
8556509|NCT00095576|21096792|P2|STARTED|Overall Study||1495
8556510|NCT00095576|21096793|P1|STARTED|Overall Study||1484
8556511|NCT00095563|21096805|P1|NOT COMPLETED|Overall Study||0
8556512|NCT00095563|21096805|P1|COMPLETED|Overall Study||39
8556513|NCT00095563|21096805|P1|STARTED|Overall Study||39
8556514|NCT00095498|21096817|P3|NOT COMPLETED|Overall Study||39
8556515|NCT00095498|21096818|P2|NOT COMPLETED|Overall Study||35
8556516|NCT00095498|21096819|P1|NOT COMPLETED|Overall Study||37
8556517|NCT00095498|21096817|P3|COMPLETED|Overall Study||39
8556518|NCT00095498|21096818|P2|COMPLETED|Overall Study||38
8556519|NCT00095498|21096819|P1|COMPLETED|Overall Study||39
8556520|NCT00095498|21096817|P3|Received Investigational Product|Overall Study||75
8556521|NCT00095498|21096818|P2|Received Investigational Product|Overall Study||71
8556522|NCT00095498|21096819|P1|Received Investigational Product|Overall Study||72
8556523|NCT00095498|21096817|P3|STARTED|Overall Study||78
8556524|NCT00095498|21096818|P2|STARTED|Overall Study||73
8556525|NCT00095498|21096819|P1|STARTED|Overall Study||76
8556526|NCT00095303|21097246|P2|NOT COMPLETED|Follow Up Study||58
8556527|NCT00095303|21097247|P1|NOT COMPLETED|Follow Up Study||59
8556528|NCT00095303|21097246|P2|COMPLETED|Follow Up Study||121
8556529|NCT00095303|21097247|P1|COMPLETED|Follow Up Study||140
8556530|NCT00095303|21097246|P2|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
8556531|NCT00095303|21097247|P1|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
8556532|NCT00095303|21097246|P2|NOT COMPLETED|Main Study||87
8556533|NCT00095303|21097247|P1|NOT COMPLETED|Main Study||91
8556534|NCT00095303|21097246|P2|COMPLETED|Main Study||148
8556535|NCT00095303|21097247|P1|COMPLETED|Main Study||154
8556536|NCT00095303|21097246|P2|STARTED|Main Study||235
8556537|NCT00095303|21097247|P1|STARTED|Main Study||245
8556538|NCT00095238|21097315|P2|NOT COMPLETED|Overall Study||852
8556539|NCT00095238|21097316|P1|NOT COMPLETED|Overall Study||857
8556540|NCT00095238|21097315|P2|COMPLETED|Overall Study|completed double-blind therapy|1209
8556541|NCT00095238|21097316|P1|COMPLETED|Overall Study|completed double-blind therapy|1210
8556542|NCT00095238|21097315|P2|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
8556543|NCT00095238|21097316|P1|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
8556544|NCT00095238|21097315|P2|STARTED|Overall Study|number randomized|2061
8556545|NCT00095238|21097316|P1|STARTED|Overall Study|number randomized|2067
8556546|NCT00095212|21097378|P2|NOT COMPLETED|Overall Study||3
8556547|NCT00095212|21097379|P1|NOT COMPLETED|Overall Study||1
8556548|NCT00095212|21097378|P2|COMPLETED|Overall Study||9
8556549|NCT00095212|21097379|P1|COMPLETED|Overall Study||12
8556550|NCT00095212|21097378|P2|STARTED|Overall Study||12
8556551|NCT00095212|21097379|P1|STARTED|Overall Study||13
8556552|NCT00095199|21097409|P4|NOT COMPLETED|Overall Study||143
8556553|NCT00095199|21097410|P3|NOT COMPLETED|Overall Study||160
8556554|NCT00095199|21097411|P2|NOT COMPLETED|Overall Study||242
8556555|NCT00095199|21097412|P1|NOT COMPLETED|Overall Study||296
8556556|NCT00095199|21097409|P4|COMPLETED|Overall Study||23
8556557|NCT00095199|21097410|P3|COMPLETED|Overall Study||7
8556558|NCT00095199|21097411|P2|COMPLETED|Overall Study||62
8556559|NCT00095199|21097412|P1|COMPLETED|Overall Study||6
8556560|NCT00095199|21097409|P4|STARTED|Overall Study||166
8556561|NCT00095199|21097410|P3|STARTED|Overall Study||167
8556562|NCT00095199|21097411|P2|STARTED|Overall Study||304
8556563|NCT00095199|21097412|P1|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
8556564|NCT00095173|21097450|P6|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
8556565|NCT00095173|21097451|P5|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
8556566|NCT00095173|21097452|P4|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
8556567|NCT00095173|21097453|P3|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
8556568|NCT00095173|21097454|P2|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
8556569|NCT00095173|21097455|P1|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
8556570|NCT00095173|21097450|P6|COMPLETED|Open-Label Extension Phase (Period C)||27
8556571|NCT00095173|21097451|P5|COMPLETED|Open-Label Extension Phase (Period C)||29
8556572|NCT00095173|21097452|P4|COMPLETED|Open-Label Extension Phase (Period C)||13
8556573|NCT00095173|21097453|P3|COMPLETED|Open-Label Extension Phase (Period C)||0
8556574|NCT00095173|21097454|P2|COMPLETED|Open-Label Extension Phase (Period C)||0
8556575|NCT00095173|21097455|P1|COMPLETED|Open-Label Extension Phase (Period C)||0
8556576|NCT00095173|21097450|P6|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
8556577|NCT00095173|21097451|P5|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
8556578|NCT00095173|21097452|P4|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
8556579|NCT00095173|21097453|P3|STARTED|Open-Label Extension Phase (Period C)||0
8556580|NCT00095173|21097454|P2|STARTED|Open-Label Extension Phase (Period C)||0
8556581|NCT00095173|21097455|P1|STARTED|Open-Label Extension Phase (Period C)||0
8556582|NCT00095173|21097450|P6|NOT COMPLETED|Double-Blind Phase (Period B)||0
8556583|NCT00095173|21097451|P5|NOT COMPLETED|Double-Blind Phase (Period B)||0
8556584|NCT00095173|21097452|P4|NOT COMPLETED|Double-Blind Phase (Period B)||0
8556585|NCT00095173|21097453|P3|NOT COMPLETED|Double-Blind Phase (Period B)||31
8556586|NCT00095173|21097454|P2|NOT COMPLETED|Double-Blind Phase (Period B)||11
8556587|NCT00095173|21097455|P1|NOT COMPLETED|Double-Blind Phase (Period B)||0
8556588|NCT00095173|21097450|P6|COMPLETED|Double-Blind Phase (Period B)||0
8556589|NCT00095173|21097451|P5|COMPLETED|Double-Blind Phase (Period B)||0
8556590|NCT00095173|21097452|P4|COMPLETED|Double-Blind Phase (Period B)||0
8556591|NCT00095173|21097453|P3|COMPLETED|Double-Blind Phase (Period B)||31
8556592|NCT00095173|21097454|P2|COMPLETED|Double-Blind Phase (Period B)||49
8556593|NCT00095173|21097455|P1|COMPLETED|Double-Blind Phase (Period B)||0
8556594|NCT00095173|21097450|P6|STARTED|Double-Blind Phase (Period B)||0
8556595|NCT00095173|21097451|P5|STARTED|Double-Blind Phase (Period B)||0
8556596|NCT00095173|21097452|P4|STARTED|Double-Blind Phase (Period B)||0
8556597|NCT00095173|21097453|P3|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
8556598|NCT00095173|21097454|P2|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
8556599|NCT00095173|21097455|P1|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
8556600|NCT00095173|21097450|P6|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556601|NCT00095173|21097451|P5|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556602|NCT00095173|21097452|P4|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556603|NCT00095173|21097453|P3|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556604|NCT00095173|21097454|P2|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556605|NCT00095173|21097455|P1|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
8556606|NCT00095173|21097450|P6|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556607|NCT00095173|21097451|P5|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556608|NCT00095173|21097452|P4|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556609|NCT00095173|21097453|P3|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556610|NCT00095173|21097454|P2|COMPLETED|Open-Label Lead-In Phase (Period A)||0
8556611|NCT00095173|21097455|P1|COMPLETED|Open-Label Lead-In Phase (Period A)||170
8556612|NCT00095173|21097450|P6|STARTED|Open-Label Lead-In Phase (Period A)||0
8556613|NCT00095173|21097451|P5|STARTED|Open-Label Lead-In Phase (Period A)||0
8556614|NCT00095173|21097452|P4|STARTED|Open-Label Lead-In Phase (Period A)||0
8556615|NCT00095173|21097453|P3|STARTED|Open-Label Lead-In Phase (Period A)||0
8556616|NCT00095173|21097454|P2|STARTED|Open-Label Lead-In Phase (Period A)||0
8556617|NCT00095173|21097455|P1|STARTED|Open-Label Lead-In Phase (Period A)||190
8556618|NCT00095147|21097493|P5|NOT COMPLETED|Long-term Extension Period||45
8556619|NCT00095147|21097494|P4|NOT COMPLETED|Long-term Extension Period||0
8556620|NCT00095147|21097495|P3|NOT COMPLETED|Long-term Extension Period||0
8556621|NCT00095147|21097496|P2|NOT COMPLETED|Long-term Extension Period||0
8556622|NCT00095147|21097497|P1|NOT COMPLETED|Long-term Extension Period||0
8556623|NCT00095147|21097493|P5|COMPLETED|Long-term Extension Period||327
8556624|NCT00095147|21097494|P4|COMPLETED|Long-term Extension Period||0
8556625|NCT00095147|21097495|P3|COMPLETED|Long-term Extension Period||0
8556626|NCT00095147|21097496|P2|COMPLETED|Long-term Extension Period||0
8556627|NCT00095147|21097497|P1|COMPLETED|Long-term Extension Period||0
8556628|NCT00095147|21097493|P5|STARTED|Long-term Extension Period||372
8556629|NCT00095147|21097494|P4|STARTED|Long-term Extension Period||0
8556630|NCT00095147|21097495|P3|STARTED|Long-term Extension Period||0
8556631|NCT00095147|21097496|P2|STARTED|Long-term Extension Period||0
8556632|NCT00095147|21097497|P1|STARTED|Long-term Extension Period||0
8556633|NCT00095147|21097493|P5|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
8556634|NCT00095147|21097494|P4|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
8556635|NCT00095147|21097495|P3|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
8556636|NCT00095147|21097496|P2|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
8556637|NCT00095147|21097497|P1|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
8556638|NCT00095147|21097493|P5|COMPLETED|Double-blind Period 2 (Days 198-365)||0
8556639|NCT00095147|21097494|P4|COMPLETED|Double-blind Period 2 (Days 198-365)||104
8556640|NCT00095147|21097495|P3|COMPLETED|Double-blind Period 2 (Days 198-365)||0
8556641|NCT00095147|21097496|P2|COMPLETED|Double-blind Period 2 (Days 198-365)||141
8556642|NCT00095147|21097497|P1|COMPLETED|Double-blind Period 2 (Days 198-365)||139
8556643|NCT00095147|21097493|P5|STARTED|Double-blind Period 2 (Days 198-365)||0
8556644|NCT00095147|21097494|P4|STARTED|Double-blind Period 2 (Days 198-365)||107
8556645|NCT00095147|21097495|P3|STARTED|Double-blind Period 2 (Days 198-365)||0
8556646|NCT00095147|21097496|P2|STARTED|Double-blind Period 2 (Days 198-365)||152
8556647|NCT00095147|21097497|P1|STARTED|Double-blind Period 2 (Days 198-365)||147
8556648|NCT00095147|21097493|P5|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
8556649|NCT00095147|21097494|P4|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
8556650|NCT00095147|21097495|P3|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
8556651|NCT00095147|21097496|P2|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
8556652|NCT00095147|21097497|P1|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
8556653|NCT00095147|21097493|P5|COMPLETED|Double-blind Period 1 (Days 1-197)||0
8556654|NCT00095147|21097494|P4|COMPLETED|Double-blind Period 1 (Days 1-197)||0
8556655|NCT00095147|21097495|P3|COMPLETED|Double-blind Period 1 (Days 1-197)||107
8556656|NCT00095147|21097496|P2|COMPLETED|Double-blind Period 1 (Days 1-197)||152
8556657|NCT00095147|21097497|P1|COMPLETED|Double-blind Period 1 (Days 1-197)||147
8556658|NCT00095147|21097493|P5|STARTED|Double-blind Period 1 (Days 1-197)||0
8556659|NCT00095147|21097494|P4|STARTED|Double-blind Period 1 (Days 1-197)||0
8556660|NCT00095147|21097495|P3|STARTED|Double-blind Period 1 (Days 1-197)||110
8556661|NCT00095147|21097496|P2|STARTED|Double-blind Period 1 (Days 1-197)||165
8556662|NCT00095147|21097497|P1|STARTED|Double-blind Period 1 (Days 1-197)||156
8556663|NCT00095121|21097692|P2|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
8556664|NCT00095121|21097693|P1|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
8556665|NCT00095121|21097692|P2|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
8556666|NCT00095121|21097693|P1|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
8556667|NCT00095121|21097692|P2|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
8556668|NCT00095121|21097693|P1|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
8556669|NCT00095121|21097692|P2|STARTED|Open-Label (Study Weeks 49 Through 240)||54
8556670|NCT00095121|21097693|P1|STARTED|Open-Label (Study Weeks 49 Through 240)||108
8556671|NCT00095121|21097692|P2|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
8556672|NCT00095121|21097693|P1|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
8556673|NCT00095121|21097692|P2|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
8556674|NCT00095121|21097693|P1|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
8556675|NCT00095121|21097692|P2|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
8556676|NCT00095121|21097693|P1|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
8556677|NCT00095056|21097739|P2|NOT COMPLETED|Phase B (Weeks 12-54)||5
8556678|NCT00095056|21097740|P1|NOT COMPLETED|Phase B (Weeks 12-54)||10
8556679|NCT00095056|21097739|P2|COMPLETED|Phase B (Weeks 12-54)||20
8556680|NCT00095056|21097740|P1|COMPLETED|Phase B (Weeks 12-54)||46
8556681|NCT00095056|21097739|P2|STARTED|Phase B (Weeks 12-54)||25
8556682|NCT00095056|21097740|P1|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
8556683|NCT00095056|21097739|P2|NOT COMPLETED|Phase A (Weeks 0-12)||1
8556684|NCT00095056|21097740|P1|NOT COMPLETED|Phase A (Weeks 0-12)||7
8556685|NCT00095056|21097739|P2|COMPLETED|Phase A (Weeks 0-12)||25
8556686|NCT00095056|21097740|P1|COMPLETED|Phase A (Weeks 0-12)||58
8556687|NCT00095056|21097739|P2|STARTED|Phase A (Weeks 0-12)||26
8556688|NCT00095056|21097740|P1|STARTED|Phase A (Weeks 0-12)||65
8556689|NCT00094900|21097748|P1|NOT COMPLETED|Overall Study||1
8556690|NCT00094900|21097748|P1|COMPLETED|Overall Study||10
8556691|NCT00094900|21097748|P1|STARTED|Overall Study||11
8556692|NCT00094887|21097850|P2|NOT COMPLETED|Overall Study||4
8556693|NCT00094887|21097851|P1|NOT COMPLETED|Overall Study||4
8556694|NCT00094887|21097850|P2|COMPLETED|Overall Study||71
8556695|NCT00094887|21097851|P1|COMPLETED|Overall Study||71
8556696|NCT00094887|21097850|P2|Primary Efficacy Population|Overall Study||64
8556697|NCT00094887|21097851|P1|Primary Efficacy Population|Overall Study||65
8556698|NCT00094887|21097850|P2|Per Protocol Analysis Set|Overall Study||71
8556699|NCT00094887|21097851|P1|Per Protocol Analysis Set|Overall Study||71
8556700|NCT00094887|21097850|P2|Intent to Treat Population|Overall Study||75
8556701|NCT00094887|21097851|P1|Intent to Treat Population|Overall Study||75
8556702|NCT00094887|21097850|P2|Safety Population|Overall Study||75
8556703|NCT00094887|21097851|P1|Safety Population|Overall Study||75
8556704|NCT00094887|21097850|P2|STARTED|Overall Study||75
8556705|NCT00094887|21097851|P1|STARTED|Overall Study||75
8556706|NCT00094861|21097869|P2|NOT COMPLETED|Overall Study||9
8556707|NCT00094861|21097870|P1|NOT COMPLETED|Overall Study||18
8556708|NCT00094861|21097869|P2|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
8556709|NCT00094861|21097870|P1|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
8556710|NCT00094861|21097869|P2|Participants Treated|Overall Study||48
8556711|NCT00094861|21097870|P1|Participants Treated|Overall Study||46
8556712|NCT00094861|21097869|P2|STARTED|Overall Study||49
8556713|NCT00094861|21097870|P1|STARTED|Overall Study||46
8556714|NCT00094835|21097897|P7|NOT COMPLETED|Overall Study||2
8556715|NCT00094835|21097898|P6|NOT COMPLETED|Overall Study||3
8556716|NCT00094835|21097899|P5|NOT COMPLETED|Overall Study||4
8556717|NCT00094835|21097900|P4|NOT COMPLETED|Overall Study||1
8556718|NCT00094835|21097901|P3|NOT COMPLETED|Overall Study||3
8556719|NCT00094835|21097902|P2|NOT COMPLETED|Overall Study||3
8556720|NCT00094835|21097903|P1|NOT COMPLETED|Overall Study||4
8556721|NCT00094835|21097897|P7|COMPLETED|Overall Study||4
8556722|NCT00094835|21097898|P6|COMPLETED|Overall Study||3
8556723|NCT00094835|21097899|P5|COMPLETED|Overall Study||3
8556724|NCT00094835|21097900|P4|COMPLETED|Overall Study||4
8556725|NCT00094835|21097901|P3|COMPLETED|Overall Study||4
8556726|NCT00094835|21097902|P2|COMPLETED|Overall Study||8
8556727|NCT00094835|21097903|P1|COMPLETED|Overall Study||5
8556728|NCT00094835|21097897|P7|Treated With Motesanib|Overall Study||6
8556729|NCT00094835|21097898|P6|Treated With Motesanib|Overall Study||5
8556730|NCT00094835|21097899|P5|Treated With Motesanib|Overall Study||7
8556731|NCT00094835|21097900|P4|Treated With Motesanib|Overall Study||4
8556732|NCT00094835|21097901|P3|Treated With Motesanib|Overall Study||6
8556733|NCT00094835|21097902|P2|Treated With Motesanib|Overall Study||11
8556734|NCT00094835|21097903|P1|Treated With Motesanib|Overall Study||6
8556735|NCT00094835|21097897|P7|STARTED|Overall Study||6
8556736|NCT00094835|21097898|P6|STARTED|Overall Study||6
8556737|NCT00094835|21097899|P5|STARTED|Overall Study||7
8556738|NCT00094835|21097900|P4|STARTED|Overall Study||5
8556739|NCT00094835|21097901|P3|STARTED|Overall Study||7
8556740|NCT00094835|21097902|P2|STARTED|Overall Study||11
8556741|NCT00094835|21097903|P1|STARTED|Overall Study||9
8556742|NCT00094809|21097981|P2|NOT COMPLETED|Overall Study||65
8556743|NCT00094809|21097982|P1|NOT COMPLETED|Overall Study||52
8556744|NCT00094809|21097981|P2|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
8556745|NCT00094809|21097982|P1|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
8556746|NCT00094809|21097981|P2|Completed All 4 Cycles of Treatment|Overall Study||90
8556747|NCT00094809|21097982|P1|Completed All 4 Cycles of Treatment|Overall Study||98
8556748|NCT00094809|21097981|P2|Properly Consented; Received Study Drug|Overall Study||118
8556749|NCT00094809|21097982|P1|Properly Consented; Received Study Drug|Overall Study||123
8556750|NCT00094809|21097981|P2|Received Study Drug|Overall Study||118
8556751|NCT00094809|21097982|P1|Received Study Drug|Overall Study||124
8556752|NCT00094809|21097981|P2|STARTED|Overall Study||126
8556753|NCT00094809|21097982|P1|STARTED|Overall Study||126
8556754|NCT00094770|21098008|P2|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
8556755|NCT00094770|21098009|P1|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
8556756|NCT00094770|21098008|P2|COMPLETED|Year 2 (Week 0 to Week 104)||264
8556757|NCT00094770|21098009|P1|COMPLETED|Year 2 (Week 0 to Week 104)||255
8556758|NCT00094770|21098008|P2|STARTED|Year 2 (Week 0 to Week 104)||584
8556759|NCT00094770|21098009|P1|STARTED|Year 2 (Week 0 to Week 104)||588
8556760|NCT00094770|21098008|P2|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
8556761|NCT00094770|21098009|P1|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
8556762|NCT00094770|21098008|P2|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
8556763|NCT00094770|21098009|P1|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
8556764|NCT00094770|21098008|P2|STARTED|Year 1 ( Week 0 to Week 52)||584
8556765|NCT00094770|21098009|P1|STARTED|Year 1 ( Week 0 to Week 52)||588
8556766|NCT00094757|21098040|P3|NOT COMPLETED|Overall Study||30
8556767|NCT00094757|21098041|P2|NOT COMPLETED|Overall Study||62
8556768|NCT00094757|21098042|P1|NOT COMPLETED|Overall Study||53
8556769|NCT00094757|21098040|P3|COMPLETED|Overall Study||80
8556770|NCT00094757|21098041|P2|COMPLETED|Overall Study||144
8556771|NCT00094757|21098042|P1|COMPLETED|Overall Study||152
8556772|NCT00094757|21098040|P3|STARTED|Overall Study||110
8556773|NCT00094757|21098041|P2|STARTED|Overall Study||206
8556774|NCT00094757|21098042|P1|STARTED|Overall Study||205
8556775|NCT00094653|21098062|P3|NOT COMPLETED|Overall Study||126
8556776|NCT00094653|21098063|P2|NOT COMPLETED|Overall Study||106
8556777|NCT00094653|21098064|P1|NOT COMPLETED|Overall Study||321
8556778|NCT00094653|21098062|P3|COMPLETED|Overall Study||10
8556779|NCT00094653|21098063|P2|COMPLETED|Overall Study||31
8556780|NCT00094653|21098064|P1|COMPLETED|Overall Study||82
8556781|NCT00094653|21098062|P3|Treated|Overall Study||131
8556782|NCT00094653|21098063|P2|Treated|Overall Study||131
8556783|NCT00094653|21098064|P1|Treated|Overall Study||381
8556784|NCT00094653|21098062|P3|STARTED|Overall Study||136
8556785|NCT00094653|21098063|P2|STARTED|Overall Study||137
8556786|NCT00094653|21098064|P1|STARTED|Overall Study||403
8556787|NCT00094575|21098127|P2|NOT COMPLETED|Overall Study||146
8556788|NCT00094575|21098128|P1|NOT COMPLETED|Overall Study||146
8556789|NCT00094575|21098127|P2|COMPLETED|Overall Study||291
8556790|NCT00094575|21098128|P1|COMPLETED|Overall Study||298
8556791|NCT00094575|21098127|P2|STARTED|Overall Study||437
8556792|NCT00094575|21098128|P1|STARTED|Overall Study||444
8556793|NCT00094536|21098148|P1|NOT COMPLETED|Treatment and Follow-up||31
8556794|NCT00094536|21098148|P1|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
8556795|NCT00094536|21098148|P1|36 Month Follow-up|Treatment and Follow-up||51
8556796|NCT00094536|21098148|P1|24 Month Follow-up|Treatment and Follow-up||53
8556797|NCT00094536|21098148|P1|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
8556798|NCT00094536|21098148|P1|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
8556799|NCT00094536|21098148|P1|NOT COMPLETED|Inclusion Exclusion Evaluation||24
8556800|NCT00094536|21098148|P1|COMPLETED|Inclusion Exclusion Evaluation||82
8556801|NCT00094536|21098148|P1|STARTED|Inclusion Exclusion Evaluation||106
8556802|NCT00094497|21098154|P2|NOT COMPLETED|Overall Study||0
8556803|NCT00094497|21098155|P1|NOT COMPLETED|Overall Study||0
8556804|NCT00094497|21098154|P2|COMPLETED|Overall Study||153
8556805|NCT00094497|21098155|P1|COMPLETED|Overall Study||151
8556806|NCT00094497|21098154|P2|Received Second Line Therapy|Overall Study||101
8556807|NCT00094497|21098155|P1|Received Second Line Therapy|Overall Study||84
8556808|NCT00094497|21098154|P2|Treated|Overall Study||149
8556809|NCT00094497|21098155|P1|Treated|Overall Study||148
8556810|NCT00094497|21098154|P2|STARTED|Overall Study||153
8556811|NCT00094497|21098155|P1|STARTED|Overall Study||151
8556812|NCT00094458|21098172|P6|NOT COMPLETED|OLE: Open-Label Extension||4
8556813|NCT00094458|21098173|P5|NOT COMPLETED|OLE: Open-Label Extension||5
8556814|NCT00094458|21098174|P4|NOT COMPLETED|OLE: Open-Label Extension||1
8556815|NCT00094458|21098175|P3|NOT COMPLETED|OLE: Open-Label Extension||0
8556816|NCT00094458|21098176|P2|NOT COMPLETED|OLE: Open-Label Extension||0
8556817|NCT00094458|21098177|P1|NOT COMPLETED|OLE: Open-Label Extension||0
8556818|NCT00094458|21098172|P6|COMPLETED|OLE: Open-Label Extension||13
8556819|NCT00094458|21098173|P5|COMPLETED|OLE: Open-Label Extension||13
8556820|NCT00094458|21098174|P4|COMPLETED|OLE: Open-Label Extension||7
8556821|NCT00094458|21098175|P3|COMPLETED|OLE: Open-Label Extension||0
8556822|NCT00094458|21098176|P2|COMPLETED|OLE: Open-Label Extension||0
8556823|NCT00094458|21098177|P1|COMPLETED|OLE: Open-Label Extension||0
8556824|NCT00094458|21098172|P6|STARTED|OLE: Open-Label Extension||17
8556825|NCT00094458|21098173|P5|STARTED|OLE: Open-Label Extension||18
8556826|NCT00094458|21098174|P4|STARTED|OLE: Open-Label Extension||8
8556827|NCT00094458|21098175|P3|STARTED|OLE: Open-Label Extension||0
8556828|NCT00094458|21098176|P2|STARTED|OLE: Open-Label Extension||0
8556829|NCT00094458|21098177|P1|STARTED|OLE: Open-Label Extension||0
8556830|NCT00094458|21098172|P6|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
8556831|NCT00094458|21098173|P5|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
8556832|NCT00094458|21098174|P4|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
8556833|NCT00094458|21098175|P3|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
8556834|NCT00094458|21098176|P2|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
8556835|NCT00094458|21098177|P1|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
8556836|NCT00094458|21098172|P6|COMPLETED|Study Extension: Week 30 Through Week 50||0
8556837|NCT00094458|21098173|P5|COMPLETED|Study Extension: Week 30 Through Week 50||0
8556838|NCT00094458|21098174|P4|COMPLETED|Study Extension: Week 30 Through Week 50||0
8556839|NCT00094458|21098175|P3|COMPLETED|Study Extension: Week 30 Through Week 50||90
8556840|NCT00094458|21098176|P2|COMPLETED|Study Extension: Week 30 Through Week 50||85
8556841|NCT00094458|21098177|P1|COMPLETED|Study Extension: Week 30 Through Week 50||67
8556842|NCT00094458|21098172|P6|STARTED|Study Extension: Week 30 Through Week 50||0
8556843|NCT00094458|21098173|P5|STARTED|Study Extension: Week 30 Through Week 50||0
8556844|NCT00094458|21098174|P4|STARTED|Study Extension: Week 30 Through Week 50||0
8556845|NCT00094458|21098175|P3|STARTED|Study Extension: Week 30 Through Week 50||108
8556846|NCT00094458|21098176|P2|STARTED|Study Extension: Week 30 Through Week 50||97
8556847|NCT00094458|21098177|P1|STARTED|Study Extension: Week 30 Through Week 50||75
8556848|NCT00094458|21098172|P6|NOT COMPLETED|Main Study: Through Week 30||0
8556849|NCT00094458|21098173|P5|NOT COMPLETED|Main Study: Through Week 30||0
8556850|NCT00094458|21098174|P4|NOT COMPLETED|Main Study: Through Week 30||0
8556851|NCT00094458|21098175|P3|NOT COMPLETED|Main Study: Through Week 30||48
8556852|NCT00094458|21098176|P2|NOT COMPLETED|Main Study: Through Week 30||58
8556853|NCT00094458|21098177|P1|NOT COMPLETED|Main Study: Through Week 30||84
8556854|NCT00094458|21098172|P6|COMPLETED|Main Study: Through Week 30||0
8556855|NCT00094458|21098173|P5|COMPLETED|Main Study: Through Week 30||0
8556856|NCT00094458|21098174|P4|COMPLETED|Main Study: Through Week 30||0
8556857|NCT00094458|21098175|P3|COMPLETED|Main Study: Through Week 30||121
8556858|NCT00094458|21098176|P2|COMPLETED|Main Study: Through Week 30||111
8556859|NCT00094458|21098177|P1|COMPLETED|Main Study: Through Week 30||86
8556860|NCT00094458|21098172|P6|STARTED|Main Study: Through Week 30||0
8556861|NCT00094458|21098173|P5|STARTED|Main Study: Through Week 30||0
8556862|NCT00094458|21098174|P4|STARTED|Main Study: Through Week 30||0
8556863|NCT00094458|21098175|P3|STARTED|Main Study: Through Week 30||169
8556864|NCT00094458|21098176|P2|STARTED|Main Study: Through Week 30||169
8556865|NCT00094458|21098177|P1|STARTED|Main Study: Through Week 30||170
8556866|NCT00094445|21098215|P1|NOT COMPLETED|Overall Study||6
8556867|NCT00094445|21098215|P1|COMPLETED|Overall Study||44
8556868|NCT00094445|21098215|P1|STARTED|Overall Study||50
8556869|NCT00094328|21098219|P1|NOT COMPLETED|Overall Study||1
8556870|NCT00094328|21098219|P1|COMPLETED|Overall Study|Completed 12 months on treatment|13
8556871|NCT00094328|21098219|P1|STARTED|Overall Study|Received treatment|14
8556872|NCT00094302|21098233|P2|NOT COMPLETED|Overall Study||406
8556873|NCT00094302|21098234|P1|NOT COMPLETED|Overall Study||417
8556874|NCT00094302|21098233|P2|COMPLETED|Overall Study||1316
8556875|NCT00094302|21098234|P1|COMPLETED|Overall Study||1306
8556876|NCT00094302|21098233|P2|STARTED|Overall Study||1722
8556877|NCT00094302|21098234|P1|STARTED|Overall Study||1723
8556878|NCT00094211|21098292|P4|NOT COMPLETED|Overall Study||7
8556879|NCT00094211|21098293|P3|NOT COMPLETED|Overall Study||10
8556880|NCT00094211|21098294|P2|NOT COMPLETED|Overall Study||8
8556881|NCT00094211|21098295|P1|NOT COMPLETED|Overall Study||9
8556882|NCT00094211|21098292|P4|COMPLETED|Overall Study||179
8556883|NCT00094211|21098293|P3|COMPLETED|Overall Study||220
8556884|NCT00094211|21098294|P2|COMPLETED|Overall Study||251
8556885|NCT00094211|21098295|P1|COMPLETED|Overall Study||212
8556886|NCT00094211|21098292|P4|STARTED|Overall Study||186
8556887|NCT00094211|21098293|P3|STARTED|Overall Study||230
8556888|NCT00094211|21098294|P2|STARTED|Overall Study||259
8556889|NCT00094211|21098295|P1|STARTED|Overall Study||221
8556890|NCT00094172|21098323|P2|NOT COMPLETED|Overall Study||7
8556891|NCT00094172|21098324|P1|NOT COMPLETED|Overall Study||14
8556892|NCT00094172|21098323|P2|COMPLETED|Overall Study||25
8556893|NCT00094172|21098324|P1|COMPLETED|Overall Study||36
8556894|NCT00094172|21098323|P2|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
8556895|NCT00094172|21098324|P1|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
8556896|NCT00094107|21098334|P1|NOT COMPLETED|Overall Study||32
8556897|NCT00094107|21098334|P1|COMPLETED|Overall Study||0
8556898|NCT00094107|21098334|P1|STARTED|Overall Study||32
8556899|NCT00094094|21098343|P1|NOT COMPLETED|Overall Study||32
8556900|NCT00094094|21098343|P1|COMPLETED|Overall Study||0
8556901|NCT00094094|21098343|P1|STARTED|Overall Study||32
8556902|NCT00094055|21098352|P1|NOT COMPLETED|Overall Study||60
8556903|NCT00094055|21098352|P1|COMPLETED|Overall Study||0
8556904|NCT00094055|21098352|P1|STARTED|Overall Study||60
8556905|NCT00093964|21098363|P2|NOT COMPLETED|Overall Study||0
8556906|NCT00093964|21098364|P1|NOT COMPLETED|Overall Study||0
8556907|NCT00093964|21098363|P2|COMPLETED|Overall Study||40
8556908|NCT00093964|21098364|P1|COMPLETED|Overall Study||41
8556909|NCT00093964|21098363|P2|STARTED|Overall Study||40
8556910|NCT00093964|21098364|P1|STARTED|Overall Study||41
8556911|NCT00093847|21098400|P2|NOT COMPLETED|Overall Study||10
8556912|NCT00093847|21098401|P1|NOT COMPLETED|Overall Study||8
8556913|NCT00093847|21098400|P2|COMPLETED|Overall Study||24
8556914|NCT00093847|21098401|P1|COMPLETED|Overall Study||31
8556915|NCT00093847|21098400|P2|STARTED|Overall Study||34
8556916|NCT00093847|21098401|P1|STARTED|Overall Study||39
8556917|NCT00093808|21098409|P1|NOT COMPLETED|Overall Study||2
8556918|NCT00093808|21098409|P1|COMPLETED|Overall Study||45
8556919|NCT00093808|21098409|P1|STARTED|Overall Study||47
8556920|NCT00093795|21098419|P3|NOT COMPLETED|Overall Study||17
8556921|NCT00093795|21098420|P2|NOT COMPLETED|Overall Study||16
8556922|NCT00093795|21098421|P1|NOT COMPLETED|Overall Study||20
8556923|NCT00093795|21098419|P3|COMPLETED|Overall Study||1613
8556924|NCT00093795|21098420|P2|COMPLETED|Overall Study||1618
8556925|NCT00093795|21098421|P1|COMPLETED|Overall Study||1610
8556926|NCT00093795|21098419|P3|STARTED|Overall Study||1630
8556927|NCT00093795|21098420|P2|STARTED|Overall Study||1634
8556928|NCT00093795|21098421|P1|STARTED|Overall Study||1630
8556929|NCT00093782|21098441|P1|NOT COMPLETED|Overall Study||0
8556930|NCT00093782|21098441|P1|COMPLETED|Overall Study||36
8556931|NCT00093782|21098441|P1|STARTED|Overall Study||36
8556932|NCT00093756|21098453|P2|NOT COMPLETED|Overall Study||0
8556933|NCT00093756|21098454|P1|NOT COMPLETED|Overall Study||0
8556934|NCT00093756|21098453|P2|COMPLETED|Overall Study||21
8556935|NCT00093756|21098454|P1|COMPLETED|Overall Study||27
8556936|NCT00093756|21098453|P2|STARTED|Overall Study||21
8556937|NCT00093756|21098454|P1|STARTED|Overall Study||27
8556938|NCT00093496|21098466|P2|NOT COMPLETED|Overall Study||3
8556939|NCT00093496|21098467|P1|NOT COMPLETED|Overall Study||1
8556940|NCT00093496|21098466|P2|COMPLETED|Overall Study||11
8556941|NCT00093496|21098467|P1|COMPLETED|Overall Study||14
8556942|NCT00093496|21098466|P2|STARTED|Overall Study||14
8556943|NCT00093496|21098467|P1|STARTED|Overall Study||15
8556944|NCT00093470|21098480|P2|NOT COMPLETED|Overall Study||0
8556945|NCT00093470|21098481|P1|NOT COMPLETED|Overall Study||73
8556946|NCT00093470|21098480|P2|COMPLETED|Overall Study|Patients underwent observation only.|71
8556947|NCT00093470|21098481|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
8556948|NCT00093470|21098480|P2|Patients With Toxicity Assessment|Overall Study||69
8556949|NCT00093470|21098481|P1|Patients With Toxicity Assessment|Overall Study||72
8556950|NCT00093470|21098480|P2|Treated|Overall Study||71
8556951|NCT00093470|21098481|P1|Treated|Overall Study||72
8556952|NCT00093470|21098480|P2|STARTED|Overall Study||71
8556953|NCT00093470|21098481|P1|STARTED|Overall Study||73
8556954|NCT00093379|21098489|P1|NOT COMPLETED|Overall Study||0
8556955|NCT00093379|21098489|P1|COMPLETED|Overall Study||20
8556956|NCT00093379|21098489|P1|STARTED|Overall Study||20
8556957|NCT00093145|21098495|P1|NOT COMPLETED|Overall Study||17
8556958|NCT00093145|21098495|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
8556959|NCT00093145|21098495|P1|At Least One Response Assessment|Overall Study||31
8556960|NCT00093145|21098495|P1|STARTED|Overall Study||32
8556961|NCT00093041|21098510|P6|NOT COMPLETED|Overall Study||3
8556962|NCT00093041|21098511|P5|NOT COMPLETED|Overall Study||1
8556963|NCT00093041|21098512|P4|NOT COMPLETED|Overall Study||1
8556964|NCT00093041|21098513|P3|NOT COMPLETED|Overall Study||2
8556965|NCT00093041|21098514|P2|NOT COMPLETED|Overall Study||3
8556966|NCT00093041|21098515|P1|NOT COMPLETED|Overall Study||2
8556967|NCT00093041|21098510|P6|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
8556968|NCT00093041|21098511|P5|COMPLETED|Overall Study|One discontinued during multiple dose period|3
8556969|NCT00093041|21098512|P4|COMPLETED|Overall Study|One discontinued during single dose period|3
8556970|NCT00093041|21098513|P3|COMPLETED|Overall Study|Two discontinued during single dose period|3
8556971|NCT00093041|21098514|P2|COMPLETED|Overall Study|Three discontinued during single dose period|1
8556972|NCT00093041|21098515|P1|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
8556973|NCT00093041|21098510|P6|STARTED|Overall Study||7
8556974|NCT00093041|21098511|P5|STARTED|Overall Study||4
8556975|NCT00093041|21098512|P4|STARTED|Overall Study||4
8556976|NCT00093041|21098513|P3|STARTED|Overall Study||5
8556977|NCT00093041|21098514|P2|STARTED|Overall Study||4
8556978|NCT00093041|21098515|P1|STARTED|Overall Study||4
8556979|NCT00093015|21098537|P2|NOT COMPLETED|Overall Study||664
8556980|NCT00093015|21098538|P1|NOT COMPLETED|Overall Study||665
8556981|NCT00093015|21098537|P2|COMPLETED|Overall Study||1348
8556982|NCT00093015|21098538|P1|COMPLETED|Overall Study||1361
8556983|NCT00093015|21098537|P2|Received Study Medication|Overall Study||2004
8556984|NCT00093015|21098538|P1|Received Study Medication|Overall Study||2019
8556985|NCT00093015|21098537|P2|STARTED|Overall Study||2012
8556986|NCT00093015|21098538|P1|STARTED|Overall Study||2026
8556987|NCT00092677|21098566|P2|NOT COMPLETED|Overall Study||11
8556988|NCT00092677|21098567|P1|NOT COMPLETED|Overall Study||5
8556989|NCT00092677|21098566|P2|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
8556990|NCT00092677|21098567|P1|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
8556991|NCT00092677|21098566|P2|STARTED|Overall Study||929
8556992|NCT00092677|21098567|P1|STARTED|Overall Study||944
8556993|NCT00092547|21098611|P3|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
8556994|NCT00092547|21098612|P2|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
8556995|NCT00092547|21098613|P1|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
8556996|NCT00092547|21098611|P3|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
8556997|NCT00092547|21098612|P2|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
8556998|NCT00092547|21098613|P1|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
8556999|NCT00092547|21098611|P3|STARTED|Long-term Follow-up (Month 126 Visit)||211
8557000|NCT00092547|21098612|P2|STARTED|Long-term Follow-up (Month 126 Visit)||0
8557001|NCT00092547|21098613|P1|STARTED|Long-term Follow-up (Month 126 Visit)||454
8557002|NCT00092547|21098611|P3|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
8557003|NCT00092547|21098612|P2|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
8557004|NCT00092547|21098613|P1|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
8557005|NCT00092547|21098611|P3|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
8557006|NCT00092547|21098612|P2|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
8557007|NCT00092547|21098613|P1|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
8557008|NCT00092547|21098611|P3|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
8557009|NCT00092547|21098612|P2|STARTED|Long-term Follow-up (Month 96 Visit)||0
8557010|NCT00092547|21098613|P1|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
8557011|NCT00092547|21098611|P3|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
8557012|NCT00092547|21098612|P2|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
8557013|NCT00092547|21098613|P1|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
8557014|NCT00092547|21098611|P3|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
8557015|NCT00092547|21098612|P2|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
8557016|NCT00092547|21098613|P1|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
8557017|NCT00092547|21098611|P3|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
8557018|NCT00092547|21098612|P2|STARTED|Long-term Follow-up (Month 72 Visit)||0
8557019|NCT00092547|21098613|P1|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
8557020|NCT00092547|21098611|P3|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
8557021|NCT00092547|21098612|P2|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
8557022|NCT00092547|21098613|P1|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
8557023|NCT00092547|21098611|P3|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
8557024|NCT00092547|21098612|P2|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
8557025|NCT00092547|21098613|P1|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
8557026|NCT00092547|21098611|P3|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
8557027|NCT00092547|21098612|P2|STARTED|Long-term Follow-up (Month 42 Visit)||0
8557028|NCT00092547|21098613|P1|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
8557029|NCT00092547|21098611|P3|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
8557030|NCT00092547|21098612|P2|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
8557031|NCT00092547|21098613|P1|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
8557032|NCT00092547|21098611|P3|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
8557033|NCT00092547|21098612|P2|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
8557034|NCT00092547|21098613|P1|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
8557035|NCT00092547|21098611|P3|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
8557036|NCT00092547|21098612|P2|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
8557037|NCT00092547|21098613|P1|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
8557038|NCT00092547|21098611|P3|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
8557039|NCT00092547|21098612|P2|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
8557040|NCT00092547|21098613|P1|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
8557041|NCT00092547|21098611|P3|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
8557042|NCT00092547|21098612|P2|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
8557043|NCT00092547|21098613|P1|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
8557044|NCT00092547|21098611|P3|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
8557045|NCT00092547|21098612|P2|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
8557046|NCT00092547|21098613|P1|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
8557047|NCT00092547|21098611|P3|STARTED|Base Follow-up Phase (Month 18 to 30)||0
8557048|NCT00092547|21098612|P2|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
8557049|NCT00092547|21098613|P1|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
8557050|NCT00092547|21098611|P3|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
8557051|NCT00092547|21098612|P2|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
8557052|NCT00092547|21098613|P1|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
8557053|NCT00092547|21098611|P3|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
8557054|NCT00092547|21098612|P2|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
8557055|NCT00092547|21098613|P1|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
8557056|NCT00092547|21098611|P3|STARTED|Base Follow-up Phase (Month 7 to 18)||0
8557057|NCT00092547|21098612|P2|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
8557058|NCT00092547|21098613|P1|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
8557059|NCT00092547|21098611|P3|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
8557060|NCT00092547|21098612|P2|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
8557061|NCT00092547|21098613|P1|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
8557062|NCT00092547|21098611|P3|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
8557063|NCT00092547|21098612|P2|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
8557064|NCT00092547|21098613|P1|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
8557065|NCT00092547|21098611|P3|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
8557066|NCT00092547|21098612|P2|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
8557067|NCT00092547|21098613|P1|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
8557068|NCT00092547|21098611|P3|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
8557069|NCT00092547|21098612|P2|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
8557070|NCT00092547|21098613|P1|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
8557071|NCT00092534|21098657|P5|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8557072|NCT00092534|21098658|P4|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1
8557073|NCT00092534|21098659|P3|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8557074|NCT00092534|21098660|P2|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8557075|NCT00092534|21098661|P1|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8557076|NCT00092534|21098657|P5|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097
8557077|NCT00092534|21098658|P4|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749
8557078|NCT00092534|21098659|P3|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8557079|NCT00092534|21098660|P2|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8557080|NCT00092534|21098661|P1|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
8557081|NCT00092534|21098657|P5|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888
8557082|NCT00092534|21098658|P4|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448
8557083|NCT00092534|21098659|P3|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
8557084|NCT00092534|21098660|P2|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
8557085|NCT00092534|21098661|P1|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
8557086|NCT00092534|21098657|P5|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849
8557087|NCT00092534|21098658|P4|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385
8557088|NCT00092534|21098659|P3|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
8557089|NCT00092534|21098660|P2|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
8557090|NCT00092534|21098661|P1|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
8557091|NCT00092534|21098657|P5|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050
8557092|NCT00092534|21098658|P4|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650
8557093|NCT00092534|21098659|P3|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
8557094|NCT00092534|21098660|P2|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
8557095|NCT00092534|21098661|P1|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
8557096|NCT00092534|21098657|P5|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2097
8557097|NCT00092534|21098658|P4|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2750
8557098|NCT00092534|21098659|P3|STARTED|Long-Term Follow-Up (LTFU) Study||0
8557099|NCT00092534|21098660|P2|STARTED|Long-Term Follow-Up (LTFU) Study||0
8557100|NCT00092534|21098661|P1|STARTED|Long-Term Follow-Up (LTFU) Study||0
8557101|NCT00092534|21098657|P5|NOT COMPLETED|Base Study EXT||0
8557102|NCT00092534|21098658|P4|NOT COMPLETED|Base Study EXT||0
8557103|NCT00092534|21098659|P3|NOT COMPLETED|Base Study EXT||145
8557104|NCT00092534|21098660|P2|NOT COMPLETED|Base Study EXT||0
8557105|NCT00092534|21098661|P1|NOT COMPLETED|Base Study EXT||0
8557106|NCT00092534|21098657|P5|COMPLETED|Base Study EXT||0
8557107|NCT00092534|21098658|P4|COMPLETED|Base Study EXT||0
8557108|NCT00092534|21098659|P3|COMPLETED|Base Study EXT||449
8557109|NCT00092534|21098660|P2|COMPLETED|Base Study EXT||0
8557110|NCT00092534|21098661|P1|COMPLETED|Base Study EXT||0
8557111|NCT00092534|21098657|P5|STARTED|Base Study EXT||0
8557112|NCT00092534|21098658|P4|STARTED|Base Study EXT||0
8557113|NCT00092534|21098659|P3|STARTED|Base Study EXT||594
8557114|NCT00092534|21098660|P2|STARTED|Base Study EXT||0
8557115|NCT00092534|21098661|P1|STARTED|Base Study EXT||0
8557116|NCT00092534|21098657|P5|NOT COMPLETED|Base Study Follow-Up Period||0
8557117|NCT00092534|21098658|P4|NOT COMPLETED|Base Study Follow-Up Period||0
8557118|NCT00092534|21098659|P3|NOT COMPLETED|Base Study Follow-Up Period||0
8557119|NCT00092534|21098660|P2|NOT COMPLETED|Base Study Follow-Up Period||694
8557120|NCT00092534|21098661|P1|NOT COMPLETED|Base Study Follow-Up Period||316
8557121|NCT00092534|21098657|P5|COMPLETED|Base Study Follow-Up Period||0
8557122|NCT00092534|21098658|P4|COMPLETED|Base Study Follow-Up Period||0
8557123|NCT00092534|21098659|P3|COMPLETED|Base Study Follow-Up Period||0
8557124|NCT00092534|21098660|P2|COMPLETED|Base Study Follow-Up Period||5277
8557125|NCT00092534|21098661|P1|COMPLETED|Base Study Follow-Up Period||5626
8557126|NCT00092534|21098657|P5|STARTED|Base Study Follow-Up Period||0
8557127|NCT00092534|21098658|P4|STARTED|Base Study Follow-Up Period||0
8557128|NCT00092534|21098659|P3|STARTED|Base Study Follow-Up Period||0
8557129|NCT00092534|21098660|P2|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
8557130|NCT00092534|21098661|P1|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
8557131|NCT00092534|21098657|P5|NOT COMPLETED|Base Study Vaccination Period||0
8557132|NCT00092534|21098658|P4|NOT COMPLETED|Base Study Vaccination Period||0
8557133|NCT00092534|21098659|P3|NOT COMPLETED|Base Study Vaccination Period||0
8557134|NCT00092534|21098660|P2|NOT COMPLETED|Base Study Vaccination Period||126
8557135|NCT00092534|21098661|P1|NOT COMPLETED|Base Study Vaccination Period||171
8557136|NCT00092534|21098657|P5|COMPLETED|Base Study Vaccination Period||0
8557137|NCT00092534|21098658|P4|COMPLETED|Base Study Vaccination Period||0
8557138|NCT00092534|21098659|P3|COMPLETED|Base Study Vaccination Period||0
8557139|NCT00092534|21098660|P2|COMPLETED|Base Study Vaccination Period||5954
8557140|NCT00092534|21098661|P1|COMPLETED|Base Study Vaccination Period||5916
8557141|NCT00092534|21098657|P5|STARTED|Base Study Vaccination Period||0
8557142|NCT00092534|21098658|P4|STARTED|Base Study Vaccination Period||0
8557143|NCT00092534|21098659|P3|STARTED|Base Study Vaccination Period||0
8557144|NCT00092534|21098660|P2|STARTED|Base Study Vaccination Period||6080
8557145|NCT00092534|21098661|P1|STARTED|Base Study Vaccination Period||6087
8557146|NCT00092521|21098692|P4|NOT COMPLETED|Extension Study (Group 4)||209
8557147|NCT00092521|21098693|P3|NOT COMPLETED|Extension Study (Group 4)||0
8557148|NCT00092521|21098694|P2|NOT COMPLETED|Extension Study (Group 4)||0
8557149|NCT00092521|21098695|P1|NOT COMPLETED|Extension Study (Group 4)||0
8557150|NCT00092521|21098692|P4|COMPLETED|Extension Study (Group 4)||635
8557151|NCT00092521|21098693|P3|COMPLETED|Extension Study (Group 4)||0
8557152|NCT00092521|21098694|P2|COMPLETED|Extension Study (Group 4)||0
8557153|NCT00092521|21098695|P1|COMPLETED|Extension Study (Group 4)||0
8557154|NCT00092521|21098692|P4|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
8557155|NCT00092521|21098693|P3|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
8557156|NCT00092521|21098694|P2|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
8557157|NCT00092521|21098695|P1|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
8557158|NCT00092521|21098692|P4|Initiated Extension Study|Extension Study (Group 4)||829
8557159|NCT00092521|21098693|P3|Initiated Extension Study|Extension Study (Group 4)||0
8557160|NCT00092521|21098694|P2|Initiated Extension Study|Extension Study (Group 4)||0
8557161|NCT00092521|21098695|P1|Initiated Extension Study|Extension Study (Group 4)||0
8557162|NCT00092521|21098692|P4|STARTED|Extension Study (Group 4)||844
8557163|NCT00092521|21098693|P3|STARTED|Extension Study (Group 4)||0
8557164|NCT00092521|21098694|P2|STARTED|Extension Study (Group 4)||0
8557165|NCT00092521|21098695|P1|STARTED|Extension Study (Group 4)||0
8557166|NCT00092521|21098692|P4|NOT COMPLETED|Follow-Up (After Month 7)||0
8557167|NCT00092521|21098693|P3|NOT COMPLETED|Follow-Up (After Month 7)||648
8557168|NCT00092521|21098694|P2|NOT COMPLETED|Follow-Up (After Month 7)||136
8557169|NCT00092521|21098695|P1|NOT COMPLETED|Follow-Up (After Month 7)||246
8557170|NCT00092521|21098692|P4|COMPLETED|Follow-Up (After Month 7)||0
8557171|NCT00092521|21098693|P3|COMPLETED|Follow-Up (After Month 7)||1959
8557172|NCT00092521|21098694|P2|COMPLETED|Follow-Up (After Month 7)||155
8557173|NCT00092521|21098695|P1|COMPLETED|Follow-Up (After Month 7)||2353
8557174|NCT00092521|21098692|P4|STARTED|Follow-Up (After Month 7)||0
8557175|NCT00092521|21098693|P3|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
8557176|NCT00092521|21098694|P2|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
8557177|NCT00092521|21098695|P1|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
8557178|NCT00092521|21098692|P4|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
8557179|NCT00092521|21098693|P3|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
8557180|NCT00092521|21098694|P2|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
8557181|NCT00092521|21098695|P1|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
8557182|NCT00092521|21098692|P4|COMPLETED|Vaccination (Day 1 Through Month 7)||0
8557183|NCT00092521|21098693|P3|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
8557184|NCT00092521|21098694|P2|COMPLETED|Vaccination (Day 1 Through Month 7)||290
8557185|NCT00092521|21098695|P1|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
8557186|NCT00092521|21098692|P4|STARTED|Vaccination (Day 1 Through Month 7)||0
8557187|NCT00092521|21098693|P3|STARTED|Vaccination (Day 1 Through Month 7)||2732
8557188|NCT00092521|21098694|P2|STARTED|Vaccination (Day 1 Through Month 7)||304
8557189|NCT00092521|21098695|P1|STARTED|Vaccination (Day 1 Through Month 7)||2723
8557190|NCT00092495|21098709|P5|NOT COMPLETED|Extension Study||0
8557191|NCT00092495|21098710|P4|NOT COMPLETED|Extension Study||0
8557192|NCT00092495|21098711|P3|NOT COMPLETED|Extension Study||0
8557193|NCT00092495|21098712|P2|NOT COMPLETED|Extension Study||0
8557194|NCT00092495|21098713|P1|NOT COMPLETED|Extension Study||0
8557195|NCT00092495|21098709|P5|COMPLETED|Extension Study||12
8557196|NCT00092495|21098710|P4|COMPLETED|Extension Study||0
8557197|NCT00092495|21098711|P3|COMPLETED|Extension Study||0
8557198|NCT00092495|21098712|P2|COMPLETED|Extension Study||0
8557199|NCT00092495|21098713|P1|COMPLETED|Extension Study||0
8557200|NCT00092495|21098709|P5|STARTED|Extension Study||12
8557201|NCT00092495|21098710|P4|STARTED|Extension Study||0
8557202|NCT00092495|21098711|P3|STARTED|Extension Study||0
8557203|NCT00092495|21098712|P2|STARTED|Extension Study||0
8557204|NCT00092495|21098713|P1|STARTED|Extension Study||0
8557205|NCT00092495|21098709|P5|NOT COMPLETED|Base Study Follow-up Period||0
8557206|NCT00092495|21098710|P4|NOT COMPLETED|Base Study Follow-up Period||14
8557207|NCT00092495|21098711|P3|NOT COMPLETED|Base Study Follow-up Period||4
8557208|NCT00092495|21098712|P2|NOT COMPLETED|Base Study Follow-up Period||3
8557209|NCT00092495|21098713|P1|NOT COMPLETED|Base Study Follow-up Period||3
8557210|NCT00092495|21098709|P5|COMPLETED|Base Study Follow-up Period||0
8557211|NCT00092495|21098710|P4|COMPLETED|Base Study Follow-up Period||446
8557212|NCT00092495|21098711|P3|COMPLETED|Base Study Follow-up Period||126
8557213|NCT00092495|21098712|P2|COMPLETED|Base Study Follow-up Period||122
8557214|NCT00092495|21098713|P1|COMPLETED|Base Study Follow-up Period||112
8557215|NCT00092495|21098709|P5|STARTED|Base Study Follow-up Period||0
8557216|NCT00092495|21098710|P4|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
8557217|NCT00092495|21098711|P3|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
8557218|NCT00092495|21098712|P2|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
8557219|NCT00092495|21098713|P1|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
8557220|NCT00092495|21098709|P5|NOT COMPLETED|Base Study Vaccination Period||0
8557221|NCT00092495|21098710|P4|NOT COMPLETED|Base Study Vaccination Period||88
8557222|NCT00092495|21098711|P3|NOT COMPLETED|Base Study Vaccination Period||34
8557223|NCT00092495|21098712|P2|NOT COMPLETED|Base Study Vaccination Period||22
8557224|NCT00092495|21098713|P1|NOT COMPLETED|Base Study Vaccination Period||37
8557225|NCT00092495|21098709|P5|COMPLETED|Base Study Vaccination Period||0
8557226|NCT00092495|21098710|P4|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
8557227|NCT00092495|21098711|P3|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
8557228|NCT00092495|21098712|P2|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
8557229|NCT00092495|21098713|P1|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
8557230|NCT00092495|21098709|P5|Without Long-term Follow-up|Base Study Vaccination Period||0
8557231|NCT00092495|21098710|P4|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
8557232|NCT00092495|21098711|P3|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
8557233|NCT00092495|21098712|P2|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
8557234|NCT00092495|21098713|P1|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
8557235|NCT00092495|21098709|P5|With Long-term Follow-up *|Base Study Vaccination Period||0
8557236|NCT00092495|21098710|P4|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
8557237|NCT00092495|21098711|P3|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
8557238|NCT00092495|21098712|P2|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
8557239|NCT00092495|21098713|P1|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
8557240|NCT00092495|21098709|P5|STARTED|Base Study Vaccination Period||0
8557241|NCT00092495|21098710|P4|STARTED|Base Study Vaccination Period||1529
8557242|NCT00092495|21098711|P3|STARTED|Base Study Vaccination Period||508
8557243|NCT00092495|21098712|P2|STARTED|Base Study Vaccination Period||514
8557244|NCT00092495|21098713|P1|STARTED|Base Study Vaccination Period||504
8557245|NCT00092456|21098779|P4|NOT COMPLETED|Overall Study||16
8557246|NCT00092456|21098780|P3|NOT COMPLETED|Overall Study||29
8557247|NCT00092456|21098781|P2|NOT COMPLETED|Overall Study||17
8557248|NCT00092456|21098782|P1|NOT COMPLETED|Overall Study||25
8557249|NCT00092456|21098779|P4|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
8557250|NCT00092456|21098780|P3|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
8557251|NCT00092456|21098781|P2|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
8557252|NCT00092456|21098782|P1|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
8557253|NCT00092456|21098779|P4|Vaccinated at Visit 3|Overall Study||98
8557254|NCT00092456|21098780|P3|Vaccinated at Visit 3|Overall Study||200
8557255|NCT00092456|21098781|P2|Vaccinated at Visit 3|Overall Study||210
8557256|NCT00092456|21098782|P1|Vaccinated at Visit 3|Overall Study||202
8557257|NCT00092456|21098779|P4|Vaccinated at Visit 2|Overall Study||104
8557258|NCT00092456|21098780|P3|Vaccinated at Visit 2|Overall Study||210
8557259|NCT00092456|21098781|P2|Vaccinated at Visit 2|Overall Study||217
8557260|NCT00092456|21098782|P1|Vaccinated at Visit 2|Overall Study||208
8557261|NCT00092456|21098779|P4|Vaccinated at Visit 1|Overall Study||113
8557262|NCT00092456|21098780|P3|Vaccinated at Visit 1|Overall Study||229
8557263|NCT00092456|21098781|P2|Vaccinated at Visit 1|Overall Study||225
8557264|NCT00092456|21098782|P1|Vaccinated at Visit 1|Overall Study||226
8557265|NCT00092456|21098779|P4|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
8557266|NCT00092456|21098780|P3|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
8557267|NCT00092456|21098781|P2|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
8557268|NCT00092456|21098782|P1|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
8557269|NCT00092443|21098830|P2|NOT COMPLETED|Overall Study||54
8557270|NCT00092443|21098831|P1|NOT COMPLETED|Overall Study||58
8557271|NCT00092443|21098830|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
8557272|NCT00092443|21098831|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
8557273|NCT00092443|21098830|P2|Vaccinated at Visit 3|Overall Study||608
8557274|NCT00092443|21098831|P1|Vaccinated at Visit 3|Overall Study||593
8557275|NCT00092443|21098830|P2|Vaccinated at Visit 2|Overall Study||627
8557276|NCT00092443|21098831|P1|Vaccinated at Visit 2|Overall Study||618
8557277|NCT00092443|21098830|P2|Vaccinated at Visit 1|Overall Study||660
8557278|NCT00092443|21098831|P1|Vaccinated at Visit 1|Overall Study||650
8557279|NCT00092443|21098830|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
8557280|NCT00092443|21098831|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
8557281|NCT00092417|21098849|P2|NOT COMPLETED|Overall Study||1
8557282|NCT00092417|21098850|P1|NOT COMPLETED|Overall Study||5
8557283|NCT00092417|21098849|P2|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
8557284|NCT00092417|21098850|P1|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
8557285|NCT00092417|21098849|P2|Vaccinated|Overall Study||234
8557286|NCT00092417|21098850|P1|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
8557287|NCT00092417|21098849|P2|STARTED|Overall Study|Started Period Group 2|234
8557288|NCT00092417|21098850|P1|STARTED|Overall Study|Started Period Group 1|464
8557289|NCT00092131|21098864|P2|NOT COMPLETED|Treatment Period II||1
8557290|NCT00092131|21098865|P1|NOT COMPLETED|Treatment Period II||0
8557291|NCT00092131|21098864|P2|COMPLETED|Treatment Period II||25
8557292|NCT00092131|21098865|P1|COMPLETED|Treatment Period II||24
8557293|NCT00092131|21098864|P2|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
8557294|NCT00092131|21098865|P1|STARTED|Treatment Period II||24
8557295|NCT00092131|21098864|P2|NOT COMPLETED|Treatment Period I||0
8557296|NCT00092131|21098865|P1|NOT COMPLETED|Treatment Period I||1
8557297|NCT00092131|21098864|P2|COMPLETED|Treatment Period I||26
8557298|NCT00092131|21098865|P1|COMPLETED|Treatment Period I||24
8557299|NCT00092131|21098864|P2|STARTED|Treatment Period I||26
8557300|NCT00092131|21098865|P1|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
8557301|NCT00092118|21098895|P2|NOT COMPLETED|Overall Study||89
8557302|NCT00092118|21098896|P1|NOT COMPLETED|Overall Study||84
8557303|NCT00092118|21098895|P2|COMPLETED|Overall Study||913
8557304|NCT00092118|21098896|P1|COMPLETED|Overall Study||906
8557305|NCT00092118|21098895|P2|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
8557395|NCT00091026|21099199|P2|NOT COMPLETED|Overall Study||3
8557306|NCT00092118|21098896|P1|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
8557307|NCT00091962|21098909|P3|NOT COMPLETED|Overall Study||0
8557308|NCT00091962|21098910|P2|NOT COMPLETED|Overall Study||0
8557309|NCT00091962|21098911|P1|NOT COMPLETED|Overall Study||0
8557310|NCT00091962|21098909|P3|COMPLETED|Overall Study||151
8557311|NCT00091962|21098910|P2|COMPLETED|Overall Study||152
8557312|NCT00091962|21098911|P1|COMPLETED|Overall Study||150
8557313|NCT00091962|21098909|P3|STARTED|Overall Study||151
8557314|NCT00091962|21098910|P2|STARTED|Overall Study||152
8557315|NCT00091962|21098911|P1|STARTED|Overall Study||150
8557316|NCT00091949|21098930|P2|NOT COMPLETED|Overall Study||151
8557317|NCT00091949|21098931|P1|NOT COMPLETED|Overall Study||175
8557318|NCT00091949|21098930|P2|COMPLETED|Overall Study||1786
8557319|NCT00091949|21098931|P1|COMPLETED|Overall Study||1764
8557320|NCT00091949|21098930|P2|STARTED|Overall Study||1937
8557321|NCT00091949|21098931|P1|STARTED|Overall Study||1939
8557322|NCT00091832|21098955|P6|NOT COMPLETED|Overall Study||11
8557323|NCT00091832|21098956|P5|NOT COMPLETED|Overall Study||15
8557324|NCT00091832|21098957|P4|NOT COMPLETED|Overall Study||14
8557325|NCT00091832|21098958|P3|NOT COMPLETED|Overall Study||12
8557326|NCT00091832|21098959|P2|NOT COMPLETED|Overall Study||11
8557327|NCT00091832|21098960|P1|NOT COMPLETED|Overall Study||14
8557328|NCT00091832|21098955|P6|COMPLETED|Overall Study||32
8557329|NCT00091832|21098956|P5|COMPLETED|Overall Study||27
8557330|NCT00091832|21098957|P4|COMPLETED|Overall Study||29
8557331|NCT00091832|21098958|P3|COMPLETED|Overall Study||30
8557332|NCT00091832|21098959|P2|COMPLETED|Overall Study||31
8557333|NCT00091832|21098960|P1|COMPLETED|Overall Study||29
8557334|NCT00091832|21098955|P6|Received Study Medication|Overall Study||43
8557335|NCT00091832|21098956|P5|Received Study Medication|Overall Study||42
8557336|NCT00091832|21098957|P4|Received Study Medication|Overall Study||43
8557337|NCT00091832|21098958|P3|Received Study Medication|Overall Study||41
8557338|NCT00091832|21098959|P2|Received Study Medication|Overall Study||42
8557339|NCT00091832|21098960|P1|Received Study Medication|Overall Study||43
8557340|NCT00091832|21098955|P6|STARTED|Overall Study||43
8557341|NCT00091832|21098956|P5|STARTED|Overall Study||42
8557342|NCT00091832|21098957|P4|STARTED|Overall Study||43
8557343|NCT00091832|21098958|P3|STARTED|Overall Study||42
8557344|NCT00091832|21098959|P2|STARTED|Overall Study||42
8557345|NCT00091832|21098960|P1|STARTED|Overall Study||43
8557346|NCT00091819|21099078|P2|NOT COMPLETED|Overall Study||46
8557347|NCT00091819|21099079|P1|NOT COMPLETED|Overall Study||42
8557348|NCT00091819|21099078|P2|COMPLETED|Overall Study||387
8557349|NCT00091819|21099079|P1|COMPLETED|Overall Study||387
8557350|NCT00091819|21099078|P2|STARTED|Overall Study||433
8557351|NCT00091819|21099079|P1|STARTED|Overall Study||429
8557352|NCT00091793|21099087|P2|NOT COMPLETED|Overall Study||22
8557353|NCT00091793|21099088|P1|NOT COMPLETED|Overall Study||24
8557354|NCT00091793|21099087|P2|COMPLETED|Overall Study||144
8557355|NCT00091793|21099088|P1|COMPLETED|Overall Study||142
8557356|NCT00091793|21099087|P2|STARTED|Overall Study||166
8557357|NCT00091793|21099088|P1|STARTED|Overall Study||166
8557358|NCT00091572|21099112|P2|NOT COMPLETED|Overall Study||82
8557359|NCT00091572|21099113|P1|NOT COMPLETED|Overall Study||95
8557360|NCT00091572|21099112|P2|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
8557361|NCT00091572|21099113|P1|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
8557362|NCT00091572|21099112|P2|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
8557363|NCT00091572|21099113|P1|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
8557364|NCT00091507|21099127|P2|NOT COMPLETED|Overall Study||19
8557365|NCT00091507|21099128|P1|NOT COMPLETED|Overall Study||21
8557366|NCT00091507|21099127|P2|COMPLETED|Overall Study||460
8557367|NCT00091507|21099128|P1|COMPLETED|Overall Study||411
8557368|NCT00091507|21099127|P2|STARTED|Overall Study||479
8557369|NCT00091507|21099128|P1|STARTED|Overall Study||432
8557370|NCT00091442|21099144|P2|NOT COMPLETED|Overall Study||373
8557371|NCT00091442|21099145|P1|NOT COMPLETED|Overall Study||369
8557372|NCT00091442|21099144|P2|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
8557373|NCT00091442|21099145|P1|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
8557374|NCT00091442|21099144|P2|STARTED|Overall Study||378
8557375|NCT00091442|21099145|P1|STARTED|Overall Study||373
8557376|NCT00091390|21099155|P1|NOT COMPLETED|Overall Study||4
8557377|NCT00091390|21099155|P1|COMPLETED|Overall Study|Subjects contributing data to results are considered to have completed the study.|125
8557378|NCT00091390|21099155|P1|Eligible, Started Treatment, Has AE Data|Overall Study||115
8557379|NCT00091390|21099155|P1|Eligible and Started Study Treatment|Overall Study||125
8557380|NCT00091390|21099155|P1|STARTED|Overall Study||129
8557381|NCT00091273|21099166|P1|NOT COMPLETED|Overall Study||0
8557382|NCT00091273|21099166|P1|COMPLETED|Overall Study||9
8557383|NCT00091273|21099166|P1|STARTED|Overall Study||9
8557384|NCT00091260|21099172|P1|NOT COMPLETED|Overall Study||0
8557385|NCT00091260|21099172|P1|COMPLETED|Overall Study||82
8557386|NCT00091260|21099172|P1|STARTED|Overall Study||82
8557387|NCT00091169|21099180|P2|NOT COMPLETED|Overall Study||53
8557388|NCT00091169|21099181|P1|NOT COMPLETED|Overall Study||57
8557389|NCT00091169|21099180|P2|COMPLETED|Overall Study||134
8557390|NCT00091169|21099181|P1|COMPLETED|Overall Study||132
8557391|NCT00091169|21099180|P2|Treated|Overall Study||170
8557392|NCT00091169|21099181|P1|Treated|Overall Study||163
8557393|NCT00091169|21099180|P2|STARTED|Overall Study||187
8557394|NCT00091169|21099181|P1|STARTED|Overall Study||189
8557396|NCT00091026|21099200|P1|NOT COMPLETED|Overall Study||1
8557397|NCT00091026|21099199|P2|COMPLETED|Overall Study||68
8557398|NCT00091026|21099200|P1|COMPLETED|Overall Study||71
8557399|NCT00091026|21099199|P2|STARTED|Overall Study||71
8557400|NCT00091026|21099200|P1|STARTED|Overall Study||72
8557401|NCT00090987|21099210|P1|NOT COMPLETED|Overall Study||21
8557402|NCT00090987|21099210|P1|COMPLETED|Overall Study||9
8557403|NCT00090987|21099210|P1|STARTED|Overall Study||30
8557404|NCT00090870|21099214|P1|NOT COMPLETED|Overall Study||0
8557405|NCT00090870|21099214|P1|COMPLETED|Overall Study||10
8557406|NCT00090870|21099214|P1|STARTED|Overall Study||10
8557407|NCT00090857|21099223|P2|NOT COMPLETED|Overall Study||3
8557408|NCT00090857|21099224|P1|NOT COMPLETED|Overall Study||4
8557409|NCT00090857|21099223|P2|COMPLETED|Overall Study||13
8557410|NCT00090857|21099224|P1|COMPLETED|Overall Study||29
8557411|NCT00090857|21099223|P2|STARTED|Overall Study||16
8557412|NCT00090857|21099224|P1|STARTED|Overall Study||33
8557413|NCT00090779|21099254|P2|NOT COMPLETED|Step 3||5
8557414|NCT00090779|21099255|P1|NOT COMPLETED|Step 3||7
8557415|NCT00090779|21099254|P2|COMPLETED|Step 3||0
8557416|NCT00090779|21099255|P1|COMPLETED|Step 3||0
8557417|NCT00090779|21099254|P2|STARTED|Step 3||5
8557418|NCT00090779|21099255|P1|STARTED|Step 3||7
8557419|NCT00090779|21099254|P2|NOT COMPLETED|Step 2||18
8557420|NCT00090779|21099255|P1|NOT COMPLETED|Step 2||6
8557421|NCT00090779|21099254|P2|COMPLETED|Step 2||1
8557422|NCT00090779|21099255|P1|COMPLETED|Step 2||0
8557423|NCT00090779|21099254|P2|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
8557424|NCT00090779|21099255|P1|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
8557425|NCT00090779|21099254|P2|NOT COMPLETED|Step 1||15
8557426|NCT00090779|21099255|P1|NOT COMPLETED|Step 1||11
8557427|NCT00090779|21099254|P2|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
8557428|NCT00090779|21099255|P1|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
8557429|NCT00090779|21099254|P2|STARTED|Step 1||64
8557430|NCT00090779|21099255|P1|STARTED|Step 1||66
8557431|NCT00090766|21099279|P3|NOT COMPLETED|Overall Study||3
8557432|NCT00090766|21099280|P2|NOT COMPLETED|Overall Study||2
8557433|NCT00090766|21099281|P1|NOT COMPLETED|Overall Study||3
8557434|NCT00090766|21099279|P3|COMPLETED|Overall Study||22
8557435|NCT00090766|21099280|P2|COMPLETED|Overall Study||19
8557436|NCT00090766|21099281|P1|COMPLETED|Overall Study||14
8557437|NCT00090766|21099279|P3|STARTED|Overall Study||25
8557438|NCT00090766|21099280|P2|STARTED|Overall Study||21
8557439|NCT00090766|21099281|P1|STARTED|Overall Study||17
8557440|NCT00090753|21099323|P2|NOT COMPLETED|Extended Treatment Period||191
8557441|NCT00090753|21099324|P1|NOT COMPLETED|Extended Treatment Period||359
8557442|NCT00090753|21099323|P2|COMPLETED|Extended Treatment Period||59
8557443|NCT00090753|21099324|P1|COMPLETED|Extended Treatment Period||94
8557444|NCT00090753|21099323|P2|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
8557445|NCT00090753|21099324|P1|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
8557446|NCT00090753|21099323|P2|NOT COMPLETED|First Treatment Period||178
8557447|NCT00090753|21099324|P1|NOT COMPLETED|First Treatment Period||256
8557448|NCT00090753|21099323|P2|COMPLETED|First Treatment Period||302
8557449|NCT00090753|21099324|P1|COMPLETED|First Treatment Period||492
8557450|NCT00090753|21099323|P2|STARTED|First Treatment Period||480
8557451|NCT00090753|21099324|P1|STARTED|First Treatment Period||748
8557452|NCT00090610|21099334|P2|NOT COMPLETED|Overall Study||1
8557453|NCT00090610|21099335|P1|NOT COMPLETED|Overall Study||1
8557454|NCT00090610|21099334|P2|COMPLETED|Overall Study||74
8557455|NCT00090610|21099335|P1|COMPLETED|Overall Study||74
8557456|NCT00090610|21099334|P2|STARTED|Overall Study||75
8557457|NCT00090610|21099335|P1|STARTED|Overall Study||75
8557458|NCT00090584|21099351|P2|NOT COMPLETED|Baseline to 8 Months||41
8557459|NCT00090584|21099352|P1|NOT COMPLETED|Baseline to 8 Months||44
8557460|NCT00090584|21099351|P2|COMPLETED|Baseline to 8 Months||112
8557461|NCT00090584|21099352|P1|COMPLETED|Baseline to 8 Months||110
8557462|NCT00090584|21099351|P2|STARTED|Baseline to 8 Months||153
8557463|NCT00090584|21099352|P1|STARTED|Baseline to 8 Months||154
8557464|NCT00090584|21099351|P2|NOT COMPLETED|Baseline to 10 Weeks||12
8557465|NCT00090584|21099352|P1|NOT COMPLETED|Baseline to 10 Weeks||15
8557466|NCT00090584|21099351|P2|COMPLETED|Baseline to 10 Weeks||141
8557467|NCT00090584|21099352|P1|COMPLETED|Baseline to 10 Weeks||139
8557468|NCT00090584|21099351|P2|STARTED|Baseline to 10 Weeks||153
8557469|NCT00090584|21099352|P1|STARTED|Baseline to 10 Weeks||154
8557470|NCT00090519|21099384|P2|NOT COMPLETED|Overall Study||75
8557471|NCT00090519|21099385|P1|NOT COMPLETED|Overall Study||73
8557472|NCT00090519|21099384|P2|COMPLETED|Overall Study||285
8557473|NCT00090519|21099385|P1|COMPLETED|Overall Study||298
8557474|NCT00090519|21099384|P2|STARTED|Overall Study||360
8557475|NCT00090519|21099385|P1|STARTED|Overall Study||371
8557476|NCT00090493|21099409|P1|NOT COMPLETED|Overall Study||2
8557477|NCT00090493|21099409|P1|COMPLETED|Overall Study||2
8557478|NCT00090493|21099409|P1|STARTED|Overall Study||4
8557479|NCT00090363|21099416|P3|NOT COMPLETED|Overall Study||96
8557480|NCT00090363|21099417|P2|NOT COMPLETED|Overall Study||107
8557481|NCT00090363|21099418|P1|NOT COMPLETED|Overall Study||106
8557482|NCT00090363|21099416|P3|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
8557483|NCT00090363|21099417|P2|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
8557484|NCT00090363|21099418|P1|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
8557485|NCT00090363|21099416|P3|Received Study Treatment.|Overall Study||98
8557486|NCT00090363|21099417|P2|Received Study Treatment.|Overall Study||107
8557487|NCT00090363|21099418|P1|Received Study Treatment.|Overall Study||107
8557488|NCT00090363|21099416|P3|STARTED|Overall Study||98
8557489|NCT00090363|21099417|P2|STARTED|Overall Study||107
8557490|NCT00090363|21099418|P1|STARTED|Overall Study||107
8557491|NCT00090545|21099440|P2|NOT COMPLETED|Overall Study||24
8557492|NCT00090545|21099441|P1|NOT COMPLETED|Overall Study||22
8557493|NCT00090545|21099440|P2|COMPLETED|Overall Study||0
8557494|NCT00090545|21099441|P1|COMPLETED|Overall Study||0
8557495|NCT00090545|21099440|P2|STARTED|Overall Study||24
8557496|NCT00090545|21099441|P1|STARTED|Overall Study||22
8557497|NCT00090285|21099461|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||203
8557498|NCT00090285|21099462|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||227
8557499|NCT00090285|21099463|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557500|NCT00090285|21099464|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557501|NCT00090285|21099465|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557502|NCT00090285|21099466|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557503|NCT00090285|21099461|P6|COMPLETED|Long-term Follow-up (EXT2)||664
8557504|NCT00090285|21099462|P5|COMPLETED|Long-term Follow-up (EXT2)||709
8557505|NCT00090285|21099463|P4|COMPLETED|Long-term Follow-up (EXT2)||0
8557506|NCT00090285|21099464|P3|COMPLETED|Long-term Follow-up (EXT2)||0
8557507|NCT00090285|21099465|P2|COMPLETED|Long-term Follow-up (EXT2)||0
8557508|NCT00090285|21099466|P1|COMPLETED|Long-term Follow-up (EXT2)||0
8557509|NCT00090285|21099461|P6|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
8557510|NCT00090285|21099462|P5|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
8557511|NCT00090285|21099463|P4|STARTED|Long-term Follow-up (EXT2)||0
8557512|NCT00090285|21099464|P3|STARTED|Long-term Follow-up (EXT2)||0
8557513|NCT00090285|21099465|P2|STARTED|Long-term Follow-up (EXT2)||0
8557514|NCT00090285|21099466|P1|STARTED|Long-term Follow-up (EXT2)||0
8557515|NCT00090285|21099461|P6|NOT COMPLETED|Extension 1||0
8557516|NCT00090285|21099462|P5|NOT COMPLETED|Extension 1||0
8557517|NCT00090285|21099463|P4|NOT COMPLETED|Extension 1||1
8557518|NCT00090285|21099464|P3|NOT COMPLETED|Extension 1||57
8557519|NCT00090285|21099465|P2|NOT COMPLETED|Extension 1||0
8557520|NCT00090285|21099466|P1|NOT COMPLETED|Extension 1||0
8557521|NCT00090285|21099461|P6|COMPLETED|Extension 1||0
8557522|NCT00090285|21099462|P5|COMPLETED|Extension 1||0
8557523|NCT00090285|21099463|P4|COMPLETED|Extension 1||15
8557524|NCT00090285|21099464|P3|COMPLETED|Extension 1||1041
8557525|NCT00090285|21099465|P2|COMPLETED|Extension 1||0
8557526|NCT00090285|21099466|P1|COMPLETED|Extension 1||0
8557527|NCT00090285|21099461|P6|STARTED|Extension 1||0
8557528|NCT00090285|21099462|P5|STARTED|Extension 1||0
8557529|NCT00090285|21099463|P4|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
8557530|NCT00090285|21099464|P3|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
8557531|NCT00090285|21099465|P2|STARTED|Extension 1||0
8557532|NCT00090285|21099466|P1|STARTED|Extension 1||0
8557533|NCT00090285|21099461|P6|NOT COMPLETED|Base Study Follow-up Period||0
8557534|NCT00090285|21099462|P5|NOT COMPLETED|Base Study Follow-up Period||0
8557535|NCT00090285|21099463|P4|NOT COMPLETED|Base Study Follow-up Period||0
8557536|NCT00090285|21099464|P3|NOT COMPLETED|Base Study Follow-up Period||0
8557537|NCT00090285|21099465|P2|NOT COMPLETED|Base Study Follow-up Period||342
8557538|NCT00090285|21099466|P1|NOT COMPLETED|Base Study Follow-up Period||335
8557539|NCT00090285|21099461|P6|COMPLETED|Base Study Follow-up Period||0
8557540|NCT00090285|21099462|P5|COMPLETED|Base Study Follow-up Period||0
8557541|NCT00090285|21099463|P4|COMPLETED|Base Study Follow-up Period||0
8557542|NCT00090285|21099464|P3|COMPLETED|Base Study Follow-up Period||0
8557543|NCT00090285|21099465|P2|COMPLETED|Base Study Follow-up Period||1479
8557544|NCT00090285|21099466|P1|COMPLETED|Base Study Follow-up Period||1487
8557545|NCT00090285|21099461|P6|STARTED|Base Study Follow-up Period||0
8557546|NCT00090285|21099462|P5|STARTED|Base Study Follow-up Period||0
8557547|NCT00090285|21099463|P4|STARTED|Base Study Follow-up Period||0
8557548|NCT00090285|21099464|P3|STARTED|Base Study Follow-up Period||0
8557549|NCT00090285|21099465|P2|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
8557550|NCT00090285|21099466|P1|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
8557551|NCT00090285|21099461|P6|NOT COMPLETED|Base Study Vaccination Period||0
8557552|NCT00090285|21099462|P5|NOT COMPLETED|Base Study Vaccination Period||0
8557553|NCT00090285|21099463|P4|NOT COMPLETED|Base Study Vaccination Period||0
8557554|NCT00090285|21099464|P3|NOT COMPLETED|Base Study Vaccination Period||0
8557555|NCT00090285|21099465|P2|NOT COMPLETED|Base Study Vaccination Period||219
8557556|NCT00090285|21099466|P1|NOT COMPLETED|Base Study Vaccination Period||214
8557557|NCT00090285|21099461|P6|COMPLETED|Base Study Vaccination Period||0
8557558|NCT00090285|21099462|P5|COMPLETED|Base Study Vaccination Period||0
8557559|NCT00090285|21099463|P4|COMPLETED|Base Study Vaccination Period||0
8557560|NCT00090285|21099464|P3|COMPLETED|Base Study Vaccination Period||0
8557561|NCT00090285|21099465|P2|COMPLETED|Base Study Vaccination Period||1814
8557562|NCT00090285|21099466|P1|COMPLETED|Base Study Vaccination Period||1818
8557563|NCT00090285|21099461|P6|Vaccinated|Base Study Vaccination Period||0
8557564|NCT00090285|21099462|P5|Vaccinated|Base Study Vaccination Period||0
8557565|NCT00090285|21099463|P4|Vaccinated|Base Study Vaccination Period||0
8557566|NCT00090285|21099464|P3|Vaccinated|Base Study Vaccination Period||0
8557567|NCT00090285|21099465|P2|Vaccinated|Base Study Vaccination Period||2030
8557568|NCT00090285|21099466|P1|Vaccinated|Base Study Vaccination Period||2025
8557569|NCT00090285|21099461|P6|STARTED|Base Study Vaccination Period||0
8557570|NCT00090285|21099462|P5|STARTED|Base Study Vaccination Period||0
8557571|NCT00090285|21099463|P4|STARTED|Base Study Vaccination Period||0
8557572|NCT00090285|21099464|P3|STARTED|Base Study Vaccination Period||0
8557573|NCT00090285|21099465|P2|STARTED|Base Study Vaccination Period||2033
8557574|NCT00090285|21099466|P1|STARTED|Base Study Vaccination Period||2032
8557575|NCT00090259|21099503|P2|NOT COMPLETED|Overall Study||48
8557576|NCT00090259|21099504|P1|NOT COMPLETED|Overall Study||62
8557577|NCT00090259|21099503|P2|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
8557578|NCT00090259|21099504|P1|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
8557579|NCT00090259|21099503|P2|STARTED|Overall Study||1921
8557580|NCT00090259|21099504|P1|STARTED|Overall Study||1913
8557581|NCT00090233|21099520|P2|NOT COMPLETED|Overall Study||5065
8557582|NCT00090233|21099521|P1|NOT COMPLETED|Overall Study||4999
8557583|NCT00090233|21099520|P2|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
8557584|NCT00090233|21099521|P1|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
8557585|NCT00090233|21099520|P2|Vaccinated at Visit 3|Overall Study||29598
8557586|NCT00090233|21099521|P1|Vaccinated at Visit 3|Overall Study||29667
8557587|NCT00090233|21099520|P2|Vaccinated at Visit 2|Overall Study||31066
8557588|NCT00090233|21099521|P1|Vaccinated at Visit 2|Overall Study||31052
8557589|NCT00090233|21099520|P2|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
8557590|NCT00090233|21099521|P1|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
8557591|NCT00090233|21099520|P2|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
8557592|NCT00090233|21099521|P1|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
8557593|NCT00090220|21099545|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||28
8557594|NCT00090220|21099546|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||44
8557595|NCT00090220|21099547|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557596|NCT00090220|21099548|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557597|NCT00090220|21099549|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557598|NCT00090220|21099550|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
8557599|NCT00090220|21099545|P6|COMPLETED|Long-term Follow-up (EXT2)||623
8557600|NCT00090220|21099546|P5|COMPLETED|Long-term Follow-up (EXT2)||641
8557601|NCT00090220|21099547|P4|COMPLETED|Long-term Follow-up (EXT2)||0
8557602|NCT00090220|21099548|P3|COMPLETED|Long-term Follow-up (EXT2)||0
8557603|NCT00090220|21099549|P2|COMPLETED|Long-term Follow-up (EXT2)||0
8557604|NCT00090220|21099550|P1|COMPLETED|Long-term Follow-up (EXT2)||0
8557605|NCT00090220|21099545|P6|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
8557606|NCT00090220|21099546|P5|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
8557607|NCT00090220|21099547|P4|STARTED|Long-term Follow-up (EXT2)||0
8557608|NCT00090220|21099548|P3|STARTED|Long-term Follow-up (EXT2)||0
8557609|NCT00090220|21099549|P2|STARTED|Long-term Follow-up (EXT2)||0
8557610|NCT00090220|21099550|P1|STARTED|Long-term Follow-up (EXT2)||0
8557611|NCT00090220|21099545|P6|NOT COMPLETED|Extension 1 (EXT1)||0
8557612|NCT00090220|21099546|P5|NOT COMPLETED|Extension 1 (EXT1)||0
8557613|NCT00090220|21099547|P4|NOT COMPLETED|Extension 1 (EXT1)||2
8557614|NCT00090220|21099548|P3|NOT COMPLETED|Extension 1 (EXT1)||55
8557615|NCT00090220|21099549|P2|NOT COMPLETED|Extension 1 (EXT1)||0
8557616|NCT00090220|21099550|P1|NOT COMPLETED|Extension 1 (EXT1)||0
8557617|NCT00090220|21099545|P6|COMPLETED|Extension 1 (EXT1)||0
8557618|NCT00090220|21099546|P5|COMPLETED|Extension 1 (EXT1)||0
8557619|NCT00090220|21099547|P4|COMPLETED|Extension 1 (EXT1)||5
8557620|NCT00090220|21099548|P3|COMPLETED|Extension 1 (EXT1)||1267
8557621|NCT00090220|21099549|P2|COMPLETED|Extension 1 (EXT1)||0
8557622|NCT00090220|21099550|P1|COMPLETED|Extension 1 (EXT1)||0
8557623|NCT00090220|21099545|P6|Vaccinated|Extension 1 (EXT1)||0
8557624|NCT00090220|21099546|P5|Vaccinated|Extension 1 (EXT1)||0
8557625|NCT00090220|21099547|P4|Vaccinated|Extension 1 (EXT1)||7
8557626|NCT00090220|21099548|P3|Vaccinated|Extension 1 (EXT1)||1321
8557627|NCT00090220|21099549|P2|Vaccinated|Extension 1 (EXT1)||0
8557628|NCT00090220|21099550|P1|Vaccinated|Extension 1 (EXT1)||0
8557629|NCT00090220|21099545|P6|STARTED|Extension 1 (EXT1)||0
8557630|NCT00090220|21099546|P5|STARTED|Extension 1 (EXT1)||0
8557631|NCT00090220|21099547|P4|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
8557632|NCT00090220|21099548|P3|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
8557633|NCT00090220|21099549|P2|STARTED|Extension 1 (EXT1)||0
8557634|NCT00090220|21099550|P1|STARTED|Extension 1 (EXT1)||0
8557635|NCT00090220|21099545|P6|NOT COMPLETED|Base Study Follow-up Period||0
8557636|NCT00090220|21099546|P5|NOT COMPLETED|Base Study Follow-up Period||0
8557637|NCT00090220|21099547|P4|NOT COMPLETED|Base Study Follow-up Period||0
8557638|NCT00090220|21099548|P3|NOT COMPLETED|Base Study Follow-up Period||0
8557639|NCT00090220|21099549|P2|NOT COMPLETED|Base Study Follow-up Period||164
8557640|NCT00090220|21099550|P1|NOT COMPLETED|Base Study Follow-up Period||160
8557641|NCT00090220|21099545|P6|COMPLETED|Base Study Follow-up Period||0
8557642|NCT00090220|21099546|P5|COMPLETED|Base Study Follow-up Period||0
8557643|NCT00090220|21099547|P4|COMPLETED|Base Study Follow-up Period||0
8557644|NCT00090220|21099548|P3|COMPLETED|Base Study Follow-up Period||0
8557645|NCT00090220|21099549|P2|COMPLETED|Base Study Follow-up Period||1687
8557646|NCT00090220|21099550|P1|COMPLETED|Base Study Follow-up Period||1695
8557647|NCT00090220|21099545|P6|STARTED|Base Study Follow-up Period||0
8557648|NCT00090220|21099546|P5|STARTED|Base Study Follow-up Period||0
8557649|NCT00090220|21099547|P4|STARTED|Base Study Follow-up Period||0
8557650|NCT00090220|21099548|P3|STARTED|Base Study Follow-up Period||0
8557651|NCT00090220|21099549|P2|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
8557652|NCT00090220|21099550|P1|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
8557653|NCT00090220|21099545|P6|NOT COMPLETED|Base Study Vaccination Period||0
8557654|NCT00090220|21099546|P5|NOT COMPLETED|Base Study Vaccination Period||0
8557655|NCT00090220|21099547|P4|NOT COMPLETED|Base Study Vaccination Period||0
8557656|NCT00090220|21099548|P3|NOT COMPLETED|Base Study Vaccination Period||0
8557657|NCT00090220|21099549|P2|NOT COMPLETED|Base Study Vaccination Period||63
8557658|NCT00090220|21099550|P1|NOT COMPLETED|Base Study Vaccination Period||64
8557659|NCT00090220|21099545|P6|COMPLETED|Base Study Vaccination Period||0
8557660|NCT00090220|21099546|P5|COMPLETED|Base Study Vaccination Period||0
8557661|NCT00090220|21099547|P4|COMPLETED|Base Study Vaccination Period||0
8557662|NCT00090220|21099548|P3|COMPLETED|Base Study Vaccination Period||0
8557663|NCT00090220|21099549|P2|COMPLETED|Base Study Vaccination Period||1845
8557664|NCT00090220|21099550|P1|COMPLETED|Base Study Vaccination Period||1847
8557665|NCT00090220|21099545|P6|Vaccinated|Base Study Vaccination Period||0
8557666|NCT00090220|21099546|P5|Vaccinated|Base Study Vaccination Period||0
8557667|NCT00090220|21099547|P4|Vaccinated|Base Study Vaccination Period||0
8557668|NCT00090220|21099548|P3|Vaccinated|Base Study Vaccination Period||0
8557669|NCT00090220|21099549|P2|Vaccinated|Base Study Vaccination Period||1907
8557670|NCT00090220|21099550|P1|Vaccinated|Base Study Vaccination Period||1910
8557671|NCT00090220|21099545|P6|STARTED|Base Study Vaccination Period||0
8557672|NCT00090220|21099546|P5|STARTED|Base Study Vaccination Period||0
8557673|NCT00090220|21099547|P4|STARTED|Base Study Vaccination Period||0
8557674|NCT00090220|21099548|P3|STARTED|Base Study Vaccination Period||0
8557675|NCT00090220|21099549|P2|STARTED|Base Study Vaccination Period||1908
8557676|NCT00090220|21099550|P1|STARTED|Base Study Vaccination Period||1911
8557677|NCT00090402|21099645|P3|NOT COMPLETED|Overall Study||1
8557678|NCT00090402|21099646|P2|NOT COMPLETED|Overall Study||2
8557679|NCT00090402|21099647|P1|NOT COMPLETED|Overall Study||2
8557680|NCT00090402|21099645|P3|COMPLETED|Overall Study||12
8557681|NCT00090402|21099646|P2|COMPLETED|Overall Study||11
8557682|NCT00090402|21099647|P1|COMPLETED|Overall Study||11
8557683|NCT00090402|21099645|P3|STARTED|Overall Study||13
8557684|NCT00090402|21099646|P2|STARTED|Overall Study||13
8557685|NCT00090402|21099647|P1|STARTED|Overall Study||13
8557686|NCT00090142|21099661|P2|NOT COMPLETED|Treatment Period II||0
8557687|NCT00090142|21099662|P1|NOT COMPLETED|Treatment Period II||1
8557688|NCT00090142|21099661|P2|COMPLETED|Treatment Period II||28
8557689|NCT00090142|21099662|P1|COMPLETED|Treatment Period II||25
8557690|NCT00090142|21099661|P2|STARTED|Treatment Period II||28
8557691|NCT00090142|21099662|P1|STARTED|Treatment Period II||26
8557692|NCT00090142|21099661|P2|NOT COMPLETED|Treatment Period I||3
8557693|NCT00090142|21099662|P1|NOT COMPLETED|Treatment Period I||5
8557694|NCT00090142|21099661|P2|COMPLETED|Treatment Period I||28
8557695|NCT00090142|21099662|P1|COMPLETED|Treatment Period I||26
8557696|NCT00090142|21099661|P2|STARTED|Treatment Period I||31
8557697|NCT00090142|21099662|P1|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
8557698|NCT00090103|21099693|P3|NOT COMPLETED|16-Week Safety Follow-up Period||457
8557699|NCT00090103|21099694|P2|NOT COMPLETED|16-Week Safety Follow-up Period||410
8557700|NCT00090103|21099695|P1|NOT COMPLETED|16-Week Safety Follow-up Period||374
8557701|NCT00090103|21099693|P3|COMPLETED|16-Week Safety Follow-up Period||1143
8557702|NCT00090103|21099694|P2|COMPLETED|16-Week Safety Follow-up Period||1205
8557703|NCT00090103|21099695|P1|COMPLETED|16-Week Safety Follow-up Period||1224
8557704|NCT00090103|21099693|P3|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
8557705|NCT00090103|21099694|P2|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
8557706|NCT00090103|21099695|P1|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
8557707|NCT00090103|21099693|P3|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
8557708|NCT00090103|21099694|P2|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
8557709|NCT00090103|21099695|P1|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
8557710|NCT00090103|21099693|P3|COMPLETED|Four-Year Double-Blind Treatment Period||989
8557711|NCT00090103|21099694|P2|COMPLETED|Four-Year Double-Blind Treatment Period||1093
8557712|NCT00090103|21099695|P1|COMPLETED|Four-Year Double-Blind Treatment Period||1113
8557713|NCT00090103|21099693|P3|STARTED|Four-Year Double-Blind Treatment Period||1611
8557714|NCT00090103|21099694|P2|STARTED|Four-Year Double-Blind Treatment Period||1623
8557715|NCT00090103|21099695|P1|STARTED|Four-Year Double-Blind Treatment Period||1610
8557716|NCT00090051|21099795|P2|NOT COMPLETED|Overall Study||95
8557717|NCT00090051|21099796|P1|NOT COMPLETED|Overall Study||109
8557718|NCT00090051|21099795|P2|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
8557719|NCT00090051|21099796|P1|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
8557720|NCT00090051|21099795|P2|Safety Population; Received Study Drug|Overall Study||274
8557721|NCT00090051|21099796|P1|Safety Population; Received Study Drug|Overall Study||272
8557722|NCT00090051|21099795|P2|STARTED|Overall Study||276
8557723|NCT00090051|21099796|P1|STARTED|Overall Study||276
8557724|NCT00003224|21099836|P6|NOT COMPLETED|Overall Study||0
8557725|NCT00003224|21099837|P5|NOT COMPLETED|Overall Study||0
8557726|NCT00003224|21099838|P4|NOT COMPLETED|Overall Study||0
8557727|NCT00003224|21099839|P3|NOT COMPLETED|Overall Study||0
8557728|NCT00003224|21099840|P2|NOT COMPLETED|Overall Study||0
8557729|NCT00003224|21099841|P1|NOT COMPLETED|Overall Study||0
8557730|NCT00003224|21099836|P6|COMPLETED|Overall Study||3
8557731|NCT00003224|21099837|P5|COMPLETED|Overall Study||4
8557732|NCT00003224|21099838|P4|COMPLETED|Overall Study||2
8557733|NCT00003224|21099839|P3|COMPLETED|Overall Study||4
8557734|NCT00003224|21099840|P2|COMPLETED|Overall Study||5
8557735|NCT00003224|21099841|P1|COMPLETED|Overall Study||4
8557736|NCT00003224|21099836|P6|STARTED|Overall Study||3
8557737|NCT00003224|21099837|P5|STARTED|Overall Study||4
8557738|NCT00003224|21099838|P4|STARTED|Overall Study||2
8557739|NCT00003224|21099839|P3|STARTED|Overall Study||4
8557740|NCT00003224|21099840|P2|STARTED|Overall Study||5
8557741|NCT00003224|21099841|P1|STARTED|Overall Study||4
8557742|NCT00089999|21099861|P2|NOT COMPLETED|Overall Study||69
8557743|NCT00089999|21099862|P1|NOT COMPLETED|Overall Study||69
8557744|NCT00089999|21099861|P2|COMPLETED|Overall Study||0
8557745|NCT00089999|21099862|P1|COMPLETED|Overall Study||0
8557746|NCT00089999|21099861|P2|STARTED|Overall Study||69
8557747|NCT00089999|21099862|P1|STARTED|Overall Study||69
8557748|NCT00089986|21099885|P3|NOT COMPLETED|Overall Study||10
8557749|NCT00089986|21099886|P2|NOT COMPLETED|Overall Study||24
8557750|NCT00089986|21099887|P1|NOT COMPLETED|Overall Study||15
8557751|NCT00089986|21099885|P3|COMPLETED|Overall Study||172
8557752|NCT00089986|21099886|P2|COMPLETED|Overall Study||574
8557753|NCT00089986|21099887|P1|COMPLETED|Overall Study||584
8557754|NCT00089986|21099885|P3|STARTED|Overall Study||182
8557755|NCT00089986|21099886|P2|STARTED|Overall Study||598
8557756|NCT00089986|21099887|P1|STARTED|Overall Study||599
8557757|NCT00089973|21099904|P1|NOT COMPLETED|Overall Study||50
8557758|NCT00089973|21099904|P1|COMPLETED|Overall Study||0
8557759|NCT00089973|21099904|P1|STARTED|Overall Study||50
8557760|NCT00089895|21099919|P2|NOT COMPLETED|Overall Study||42
8557761|NCT00089895|21099920|P1|NOT COMPLETED|Overall Study||35
8557762|NCT00089895|21099919|P2|COMPLETED|Overall Study|Number of Subjects treated|4642
8557763|NCT00089895|21099920|P1|COMPLETED|Overall Study|Number of Subjects treated|4687
8557764|NCT00089895|21099919|P2|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
8557765|NCT00089895|21099920|P1|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
8557766|NCT00089843|21099932|P4|NOT COMPLETED|Overall Study||7
8557767|NCT00089843|21099933|P3|NOT COMPLETED|Overall Study||5
8557768|NCT00089843|21099934|P2|NOT COMPLETED|Overall Study||4
8557769|NCT00089843|21099935|P1|NOT COMPLETED|Overall Study||2
8557770|NCT00089843|21099932|P4|COMPLETED|Overall Study||11
8557771|NCT00089843|21099933|P3|COMPLETED|Overall Study||15
8557772|NCT00089843|21099934|P2|COMPLETED|Overall Study||16
8557773|NCT00089843|21099935|P1|COMPLETED|Overall Study||17
8557774|NCT00089843|21099932|P4|STARTED|Overall Study||18
8557775|NCT00089843|21099933|P3|STARTED|Overall Study||20
8557776|NCT00089843|21099934|P2|STARTED|Overall Study||20
8557777|NCT00089843|21099935|P1|STARTED|Overall Study||19
8557778|NCT00089791|21099947|P2|NOT COMPLETED|Overall Study||630
8557779|NCT00089791|21099948|P1|NOT COMPLETED|Overall Study||700
8557780|NCT00089791|21099947|P2|COMPLETED|Overall Study||3272
8557781|NCT00089791|21099948|P1|COMPLETED|Overall Study||3206
8557782|NCT00089791|21099947|P2|Safety Analysis Set|Overall Study||3886
8557783|NCT00089791|21099948|P1|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
8557784|NCT00089791|21099947|P2|Received Study Medication|Overall Study||3879
8557785|NCT00089791|21099948|P1|Received Study Medication|Overall Study||3883
8557786|NCT00089791|21099947|P2|STARTED|Overall Study||3902
8557787|NCT00089791|21099948|P1|STARTED|Overall Study||3906
8557788|NCT00089752|21099960|P2|NOT COMPLETED|Overall Study||22
8557789|NCT00089752|21099961|P1|NOT COMPLETED|Overall Study||20
8557790|NCT00089752|21099960|P2|COMPLETED|Overall Study||118
8557791|NCT00089752|21099961|P1|COMPLETED|Overall Study||121
8557792|NCT00089752|21099960|P2|STARTED|Overall Study||140
8557793|NCT00089752|21099961|P1|STARTED|Overall Study||141
8557794|NCT00089778|21099982|P3|NOT COMPLETED|Overall Study||1
8557795|NCT00089778|21099983|P2|NOT COMPLETED|Overall Study||0
8557796|NCT00089778|21099984|P1|NOT COMPLETED|Overall Study||0
8557797|NCT00089778|21099982|P3|COMPLETED|Overall Study||7
8557798|NCT00089778|21099983|P2|COMPLETED|Overall Study||1
8557799|NCT00089778|21099984|P1|COMPLETED|Overall Study||2
8557800|NCT00089778|21099982|P3|STARTED|Overall Study||8
8557801|NCT00089778|21099983|P2|STARTED|Overall Study||1
8557802|NCT00089778|21099984|P1|STARTED|Overall Study||2
8557803|NCT00089674|21099997|P2|NOT COMPLETED|Overall Study||267
8557804|NCT00089674|21099998|P1|NOT COMPLETED|Overall Study||289
8557805|NCT00089674|21099997|P2|COMPLETED|Overall Study||467
8557806|NCT00089674|21099998|P1|COMPLETED|Overall Study||445
8557807|NCT00089674|21099997|P2|Received Study Drug|Overall Study||726
8557808|NCT00089674|21099998|P1|Received Study Drug|Overall Study||730
8557809|NCT00089674|21099997|P2|STARTED|Overall Study||734
8557810|NCT00089674|21099998|P1|STARTED|Overall Study||734
8557811|NCT00089661|21100024|P2|NOT COMPLETED|Overall Study||26
8557812|NCT00089661|21100025|P1|NOT COMPLETED|Overall Study||21
8557813|NCT00089661|21100024|P2|COMPLETED|Overall Study||99
8557814|NCT00089661|21100025|P1|COMPLETED|Overall Study||106
8557815|NCT00089661|21100024|P2|STARTED|Overall Study||125
8557816|NCT00089661|21100025|P1|STARTED|Overall Study||127
8557817|NCT00089648|21100041|P1|NOT COMPLETED|Overall Study||41
8557818|NCT00089648|21100041|P1|COMPLETED|Overall Study||20
8557819|NCT00089648|21100041|P1|STARTED|Overall Study||61
8557820|NCT00089635|21100057|P1|NOT COMPLETED|Overall Study||43
8557821|NCT00089635|21100057|P1|COMPLETED|Overall Study||160
8557822|NCT00089635|21100057|P1|STARTED|Overall Study||203
8557823|NCT00089583|21100071|P2|NOT COMPLETED|Overall Study||38
8557824|NCT00089583|21100072|P1|NOT COMPLETED|Overall Study||7
8557825|NCT00089583|21100071|P2|COMPLETED|Overall Study||51
8557826|NCT00089583|21100072|P1|COMPLETED|Overall Study||13
8557827|NCT00089583|21100071|P2|STARTED|Overall Study||89
8557828|NCT00089583|21100072|P1|STARTED|Overall Study||20
8557829|NCT00089609|21100166|P2|NOT COMPLETED|Overall Study||1
8557830|NCT00089609|21100167|P1|NOT COMPLETED|Overall Study||3
8557831|NCT00089609|21100166|P2|COMPLETED|Overall Study||12
8557832|NCT00089609|21100167|P1|COMPLETED|Overall Study||57
8557833|NCT00089609|21100166|P2|STARTED|Overall Study||13
8557834|NCT00089609|21100167|P1|STARTED|Overall Study||60
8557835|NCT00089544|21100186|P2|NOT COMPLETED|Overall Study||0
8557836|NCT00089544|21100187|P1|NOT COMPLETED|Overall Study||1
8557837|NCT00089544|21100186|P2|COMPLETED|Overall Study||7
8557838|NCT00089544|21100187|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
8557839|NCT00089544|21100186|P2|STARTED|Overall Study||7
8557840|NCT00089544|21100187|P1|STARTED|Overall Study||16
8557841|NCT00089505|21100201|P4|NOT COMPLETED|Overall Study||21
8557842|NCT00089505|21100202|P3|NOT COMPLETED|Overall Study||21
8557843|NCT00089505|21100203|P2|NOT COMPLETED|Overall Study||2
8557844|NCT00089505|21100204|P1|NOT COMPLETED|Overall Study||9
8557845|NCT00089505|21100201|P4|COMPLETED|Overall Study||230
8557846|NCT00089505|21100202|P3|COMPLETED|Overall Study||228
8557847|NCT00089505|21100203|P2|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
8557848|NCT00089505|21100204|P1|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
8557849|NCT00089505|21100201|P4|STARTED|Overall Study||251
8557850|NCT00089505|21100202|P3|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
8557851|NCT00089505|21100203|P2|STARTED|Overall Study||120
8557852|NCT00089505|21100204|P1|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
8557853|NCT00089479|21100248|P2|NOT COMPLETED|Overall Study||289
8557854|NCT00089479|21100249|P1|NOT COMPLETED|Overall Study||331
8557855|NCT00089479|21100248|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
8557856|NCT00089479|21100249|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
8557857|NCT00089479|21100248|P2|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
8557858|NCT00089479|21100249|P1|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
8557859|NCT00089479|21100248|P2|STARTED|Overall Study||1307
8557860|NCT00089479|21100249|P1|STARTED|Overall Study||1304
8557861|NCT00089414|21100276|P3|NOT COMPLETED|Overall Study||0
8557862|NCT00089414|21100277|P2|NOT COMPLETED|Overall Study||0
8557863|NCT00089414|21100278|P1|NOT COMPLETED|Overall Study||0
8557864|NCT00089414|21100276|P3|COMPLETED|Overall Study||2
8557865|NCT00089414|21100277|P2|COMPLETED|Overall Study||1
8557866|NCT00089414|21100278|P1|COMPLETED|Overall Study||2
8557867|NCT00089414|21100276|P3|STARTED|Overall Study||2
8557868|NCT00089414|21100277|P2|STARTED|Overall Study||1
8557869|NCT00089414|21100278|P1|STARTED|Overall Study||2
8557870|NCT00089297|21100292|P1|NOT COMPLETED|Overall Study||38
8557871|NCT00089297|21100292|P1|COMPLETED|Overall Study||36
8557872|NCT00089297|21100292|P1|Eligible|Overall Study||63
8557873|NCT00089297|21100292|P1|Treated|Overall Study||70
8557874|NCT00089297|21100292|P1|STARTED|Overall Study||74
8557875|NCT00089284|21100304|P7|NOT COMPLETED|Overall Study||1
8557876|NCT00089284|21100305|P6|NOT COMPLETED|Overall Study||0
8557877|NCT00089284|21100306|P5|NOT COMPLETED|Overall Study||0
8557878|NCT00089284|21100307|P4|NOT COMPLETED|Overall Study||0
8557879|NCT00089284|21100308|P3|NOT COMPLETED|Overall Study||0
8557880|NCT00089284|21100309|P2|NOT COMPLETED|Overall Study||0
8557881|NCT00089284|21100310|P1|NOT COMPLETED|Overall Study||0
8557882|NCT00089284|21100304|P7|COMPLETED|Overall Study||7
8557883|NCT00089284|21100305|P6|COMPLETED|Overall Study||0
8557884|NCT00089284|21100306|P5|COMPLETED|Overall Study||0
8557885|NCT00089284|21100307|P4|COMPLETED|Overall Study||6
8557886|NCT00089284|21100308|P3|COMPLETED|Overall Study||6
8557887|NCT00089284|21100309|P2|COMPLETED|Overall Study||3
8557888|NCT00089284|21100310|P1|COMPLETED|Overall Study||7
8557889|NCT00089284|21100304|P7|STARTED|Overall Study||8
8557890|NCT00089284|21100305|P6|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
8557891|NCT00089284|21100306|P5|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
8557892|NCT00089284|21100307|P4|STARTED|Overall Study||6
8557893|NCT00089284|21100308|P3|STARTED|Overall Study||6
8557894|NCT00089284|21100309|P2|STARTED|Overall Study||3
8557895|NCT00089284|21100310|P1|STARTED|Overall Study||7
8557896|NCT00089141|21100347|P2|NOT COMPLETED|Overall Study||24
8557897|NCT00089141|21100348|P1|NOT COMPLETED|Overall Study||18
8557898|NCT00089141|21100347|P2|COMPLETED|Overall Study||53
8557899|NCT00089141|21100348|P1|COMPLETED|Overall Study||56
8557900|NCT00089141|21100347|P2|STARTED|Overall Study||77
8557901|NCT00089141|21100348|P1|STARTED|Overall Study||74
8557902|NCT00089128|21100370|P1|NOT COMPLETED|Overall Study||0
8557903|NCT00089128|21100370|P1|COMPLETED|Overall Study||16
8557904|NCT00089128|21100370|P1|STARTED|Overall Study||16
8557905|NCT00089102|21100377|P1|NOT COMPLETED|Overall Study||0
8557906|NCT00089102|21100377|P1|COMPLETED|Overall Study||9
8557907|NCT00089102|21100377|P1|STARTED|Overall Study||9
8557908|NCT00089076|21100384|P1|NOT COMPLETED|Overall Study||10
8557909|NCT00089076|21100384|P1|COMPLETED|Overall Study||8
8557910|NCT00089076|21100384|P1|STARTED|Overall Study||18
8557911|NCT00089024|21100395|P1|NOT COMPLETED|Overall Study||5
8557912|NCT00089024|21100395|P1|COMPLETED|Overall Study||24
8557913|NCT00089024|21100395|P1|Treated Subjects|Overall Study||29
8557914|NCT00089024|21100395|P1|STARTED|Overall Study||29
8557915|NCT00089011|21100402|P2|NOT COMPLETED|Overall Study||0
8557916|NCT00089011|21100403|P1|NOT COMPLETED|Overall Study||0
8557917|NCT00089011|21100402|P2|COMPLETED|Overall Study||50
8557918|NCT00089011|21100403|P1|COMPLETED|Overall Study||100
8557919|NCT00089011|21100402|P2|STARTED|Overall Study||50
8557920|NCT00089011|21100403|P1|STARTED|Overall Study||100
8557921|NCT00088985|21100423|P1|NOT COMPLETED|Overall Study||3
8557922|NCT00088985|21100423|P1|COMPLETED|Overall Study||4
8557923|NCT00088985|21100423|P1|STARTED|Overall Study||7
8557924|NCT00088972|21100430|P2|NOT COMPLETED|Overall Study||4
8557925|NCT00088972|21100431|P1|NOT COMPLETED|Overall Study||2
8557926|NCT00088972|21100430|P2|COMPLETED|Overall Study||1
8557927|NCT00088972|21100431|P1|COMPLETED|Overall Study||1
8557928|NCT00088972|21100430|P2|STARTED|Overall Study||5
8557929|NCT00088972|21100431|P1|STARTED|Overall Study||3
8557930|NCT00088907|21100441|P2|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
8557931|NCT00088907|21100442|P1|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
8557932|NCT00088907|21100441|P2|COMPLETED|Single Gefitinib Treatment (Step 2)||0
8557933|NCT00088907|21100442|P1|COMPLETED|Single Gefitinib Treatment (Step 2)||0
8557934|NCT00088907|21100441|P2|Treated|Single Gefitinib Treatment (Step 2)||0
8557935|NCT00088907|21100442|P1|Treated|Single Gefitinib Treatment (Step 2)||19
8557936|NCT00088907|21100441|P2|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
8557937|NCT00088907|21100442|P1|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
8557938|NCT00088907|21100441|P2|NOT COMPLETED|Randomized Study (Step 1)||134
8557939|NCT00088907|21100442|P1|NOT COMPLETED|Randomized Study (Step 1)||136
8557940|NCT00088907|21100441|P2|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
8557941|NCT00088907|21100442|P1|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
8557942|NCT00088907|21100441|P2|Eligible and Treated|Randomized Study (Step 1)||122
8557943|NCT00088907|21100442|P1|Eligible and Treated|Randomized Study (Step 1)||117
8557944|NCT00088907|21100441|P2|Eligible|Randomized Study (Step 1)||122
8557945|NCT00088907|21100442|P1|Eligible|Randomized Study (Step 1)||117
8557946|NCT00088907|21100441|P2|Treated|Randomized Study (Step 1)||124
8557947|NCT00088907|21100442|P1|Treated|Randomized Study (Step 1)||129
8557948|NCT00088907|21100441|P2|STARTED|Randomized Study (Step 1)||134
8557949|NCT00088907|21100442|P1|STARTED|Randomized Study (Step 1)||136
8557950|NCT00088881|21100453|P1|NOT COMPLETED|Step 3 - Radiation Therapy||0
8557951|NCT00088881|21100453|P1|COMPLETED|Step 3 - Radiation Therapy||1
8557952|NCT00088881|21100453|P1|STARTED|Step 3 - Radiation Therapy||1
8557953|NCT00088881|21100453|P1|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
8557954|NCT00088881|21100453|P1|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
8557955|NCT00088881|21100453|P1|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
8557956|NCT00088881|21100453|P1|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
8557957|NCT00088881|21100453|P1|NOT COMPLETED|Step 1 - R-CHOP||14
8557958|NCT00088881|21100453|P1|COMPLETED|Step 1 - R-CHOP||48
8557959|NCT00088881|21100453|P1|Eligible and Treated|Step 1 - R-CHOP||53
8557960|NCT00088881|21100453|P1|STARTED|Step 1 - R-CHOP||62
8557961|NCT00088829|21100462|P1|NOT COMPLETED|Overall Study||22
8557962|NCT00088829|21100462|P1|COMPLETED|Overall Study||0
8557963|NCT00088829|21100462|P1|STARTED|Overall Study||22
8557964|NCT00088699|21100468|P4|NOT COMPLETED|Infusion 2||1
8557965|NCT00088699|21100469|P3|NOT COMPLETED|Infusion 2||0
8557966|NCT00088699|21100470|P2|NOT COMPLETED|Infusion 2||0
8557967|NCT00088699|21100471|P1|NOT COMPLETED|Infusion 2||0
8557968|NCT00088699|21100468|P4|COMPLETED|Infusion 2||10
8557969|NCT00088699|21100469|P3|COMPLETED|Infusion 2||11
8557970|NCT00088699|21100470|P2|COMPLETED|Infusion 2||18
8557971|NCT00088699|21100471|P1|COMPLETED|Infusion 2||19
8557972|NCT00088699|21100468|P4|STARTED|Infusion 2||11
8557973|NCT00088699|21100469|P3|STARTED|Infusion 2||11
8557974|NCT00088699|21100470|P2|STARTED|Infusion 2||18
8557975|NCT00088699|21100471|P1|STARTED|Infusion 2||19
8557976|NCT00088699|21100468|P4|NOT COMPLETED|Infusion 1||2
8557977|NCT00088699|21100469|P3|NOT COMPLETED|Infusion 1||1
8557978|NCT00088699|21100470|P2|NOT COMPLETED|Infusion 1||0
8557979|NCT00088699|21100471|P1|NOT COMPLETED|Infusion 1||1
8557980|NCT00088699|21100468|P4|COMPLETED|Infusion 1||10
8557981|NCT00088699|21100469|P3|COMPLETED|Infusion 1||12
8557982|NCT00088699|21100470|P2|COMPLETED|Infusion 1||19
8557983|NCT00088699|21100471|P1|COMPLETED|Infusion 1||22
8557984|NCT00088699|21100468|P4|STARTED|Infusion 1||12
8557985|NCT00088699|21100469|P3|STARTED|Infusion 1||13
8557986|NCT00088699|21100470|P2|STARTED|Infusion 1||19
8557987|NCT00088699|21100471|P1|STARTED|Infusion 1||23
8557988|NCT00088634|21100487|P2|NOT COMPLETED|Overall Study||43
8557989|NCT00088634|21100488|P1|NOT COMPLETED|Overall Study||38
8557990|NCT00088634|21100487|P2|COMPLETED|Overall Study||47
8557991|NCT00088634|21100488|P1|COMPLETED|Overall Study||52
8557992|NCT00088634|21100487|P2|STARTED|Overall Study||90
8557993|NCT00088634|21100488|P1|STARTED|Overall Study||90
8557994|NCT00088621|21100500|P1|NOT COMPLETED|Overall Study||54
8557995|NCT00088621|21100500|P1|COMPLETED|Overall Study||7
8557996|NCT00088621|21100500|P1|STARTED|Overall Study||61
8557997|NCT00088595|21100504|P1|NOT COMPLETED|Overall Study||28
8557998|NCT00088595|21100504|P1|COMPLETED|Overall Study||17
8557999|NCT00088595|21100504|P1|STARTED|Overall Study||45
8558000|NCT00088530|21100522|P2|NOT COMPLETED|Overall Study||54
8558001|NCT00088530|21100523|P1|NOT COMPLETED|Overall Study||50
8558002|NCT00088530|21100522|P2|COMPLETED|Overall Study||16
8558003|NCT00088530|21100523|P1|COMPLETED|Overall Study||20
8558004|NCT00088530|21100522|P2|STARTED|Overall Study||70
8558005|NCT00088530|21100523|P1|STARTED|Overall Study||70
8558006|NCT00088465|21100535|P1|NOT COMPLETED|Overall Study||561
8558007|NCT00088465|21100535|P1|COMPLETED|Overall Study||370
8558008|NCT00088465|21100535|P1|STARTED|Overall Study||931
8558009|NCT00088452|21100561|P3|NOT COMPLETED|Overall Study||1
8558010|NCT00088452|21100562|P2|NOT COMPLETED|Overall Study||0
8558011|NCT00088452|21100563|P1|NOT COMPLETED|Overall Study||1
8558012|NCT00088452|21100561|P3|COMPLETED|Overall Study||147
8558013|NCT00088452|21100562|P2|COMPLETED|Overall Study||149
8558014|NCT00088452|21100563|P1|COMPLETED|Overall Study||155
8558015|NCT00088452|21100561|P3|STARTED|Overall Study||148
8558016|NCT00088452|21100562|P2|STARTED|Overall Study||149
8558017|NCT00088452|21100563|P1|STARTED|Overall Study||156
8558018|NCT00088413|21100581|P4|NOT COMPLETED|Overall Study||14
8558019|NCT00088413|21100582|P3|NOT COMPLETED|Overall Study||12
8558020|NCT00088413|21100583|P2|NOT COMPLETED|Overall Study||15
8558021|NCT00088413|21100584|P1|NOT COMPLETED|Overall Study||10
8558022|NCT00088413|21100581|P4|COMPLETED|Overall Study||0
8558023|NCT00088413|21100582|P3|COMPLETED|Overall Study||0
8558024|NCT00088413|21100583|P2|COMPLETED|Overall Study||0
8558025|NCT00088413|21100584|P1|COMPLETED|Overall Study||0
8558026|NCT00088413|21100581|P4|STARTED|Overall Study||14
8558027|NCT00088413|21100582|P3|STARTED|Overall Study||12
8558028|NCT00088413|21100583|P2|STARTED|Overall Study||15
8558029|NCT00088413|21100584|P1|STARTED|Overall Study||10
8558030|NCT00088374|21100598|P1|NOT COMPLETED|Overall Study||2
8558031|NCT00088374|21100598|P1|COMPLETED|Overall Study||7
8558032|NCT00088374|21100598|P1|STARTED|Overall Study||9
8558033|NCT00088218|21100609|P2|NOT COMPLETED|Overall Study||0
8558034|NCT00088218|21100610|P1|NOT COMPLETED|Overall Study||0
8558035|NCT00088218|21100609|P2|COMPLETED|Overall Study||79
8558036|NCT00088218|21100610|P1|COMPLETED|Overall Study||16
8558037|NCT00088218|21100609|P2|STARTED|Overall Study||79
8558038|NCT00088218|21100610|P1|STARTED|Overall Study||16
8558039|NCT00088205|21100616|P1|NOT COMPLETED|Overall Study||60
8558040|NCT00088205|21100616|P1|COMPLETED|Overall Study||0
8558041|NCT00088205|21100616|P1|Efficacy Population|Overall Study|Participants with diagnosis of relapsed mantle cell lymphoma.|59
8558042|NCT00088205|21100616|P1|Received at Least 1 Dose of Study Drug|Overall Study||60
8558043|NCT00088205|21100616|P1|STARTED|Overall Study||60
8558044|NCT00088166|21100633|P2|NOT COMPLETED|Overall Study||61
8558045|NCT00088166|21100634|P1|NOT COMPLETED|Overall Study||53
8558046|NCT00088166|21100633|P2|COMPLETED|Overall Study||39
8558047|NCT00088166|21100634|P1|COMPLETED|Overall Study||47
8558048|NCT00088166|21100633|P2|STARTED|Overall Study||100
8558049|NCT00088166|21100634|P1|STARTED|Overall Study||100
8558050|NCT00088153|21100658|P2|NOT COMPLETED|Overall Study||25
8558051|NCT00088153|21100659|P1|NOT COMPLETED|Overall Study||24
8558052|NCT00088153|21100658|P2|COMPLETED|Overall Study||30
8558053|NCT00088153|21100659|P1|COMPLETED|Overall Study||31
8558054|NCT00088153|21100658|P2|STARTED|Overall Study||55
8558055|NCT00088153|21100659|P1|STARTED|Overall Study||55
8558056|NCT00087698|21100669|P1|NOT COMPLETED|Overall Study||36
8558057|NCT00087698|21100669|P1|COMPLETED|Overall Study||41
8558058|NCT00087698|21100669|P1|STARTED|Overall Study||77
8558059|NCT00087685|21100678|P1|NOT COMPLETED|Overall Study||14
8558060|NCT00087685|21100678|P1|COMPLETED|Overall Study||21
8558061|NCT00087685|21100678|P1|STARTED|Overall Study||35
8558062|NCT00087672|21100683|P1|NOT COMPLETED|Overall Study||0
8558063|NCT00087672|21100683|P1|COMPLETED|Overall Study||41
8558064|NCT00087672|21100683|P1|STARTED|Overall Study||41
8558065|NCT00087646|21100691|P4|NOT COMPLETED|Overall Study||84
8558066|NCT00087646|21100692|P3|NOT COMPLETED|Overall Study||65
8558067|NCT00087646|21100693|P2|NOT COMPLETED|Overall Study||42
8558068|NCT00087646|21100694|P1|NOT COMPLETED|Overall Study||135
8558069|NCT00087646|21100691|P4|COMPLETED|Overall Study||229
8558070|NCT00087646|21100692|P3|COMPLETED|Overall Study||91
8558071|NCT00087646|21100693|P2|COMPLETED|Overall Study||114
8558072|NCT00087646|21100694|P1|COMPLETED|Overall Study||182
8558073|NCT00087646|21100691|P4|STARTED|Overall Study||313
8558074|NCT00087646|21100692|P3|STARTED|Overall Study||156
8558075|NCT00087646|21100693|P2|STARTED|Overall Study||156
8558076|NCT00087646|21100694|P1|STARTED|Overall Study||317
8558077|NCT00087633|21100722|P2|NOT COMPLETED|Overall Study||17
8558078|NCT00087633|21100723|P1|NOT COMPLETED|Overall Study||24
8558079|NCT00087633|21100722|P2|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
8558080|NCT00087633|21100723|P1|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
8558081|NCT00087633|21100722|P2|STARTED|Overall Study|Randomized|60
8558082|NCT00087633|21100723|P1|STARTED|Overall Study|Randomized|55
8558083|NCT00087607|21100733|P2|NOT COMPLETED|Overall Study||122
8558084|NCT00087607|21100734|P1|NOT COMPLETED|Overall Study||122
8558085|NCT00087607|21100733|P2|COMPLETED|Overall Study||71
8558086|NCT00087607|21100734|P1|COMPLETED|Overall Study||70
8558087|NCT00087607|21100733|P2|STARTED|Overall Study||193
8558088|NCT00087607|21100734|P1|STARTED|Overall Study||192
8558089|NCT00087594|21100774|P2|NOT COMPLETED|Overall Study||12
8558090|NCT00087594|21100775|P1|NOT COMPLETED|Overall Study||8
8558091|NCT00087594|21100774|P2|COMPLETED|Overall Study||12
8558092|NCT00087594|21100775|P1|COMPLETED|Overall Study||16
8558093|NCT00087594|21100774|P2|STARTED|Overall Study||24
8558094|NCT00087594|21100775|P1|STARTED|Overall Study||24
8558095|NCT00087568|21100809|P2|NOT COMPLETED|Overall Study||2
8558096|NCT00087568|21100810|P1|NOT COMPLETED|Overall Study||30
8558097|NCT00087568|21100809|P2|COMPLETED|Overall Study||23
8558098|NCT00087568|21100810|P1|COMPLETED|Overall Study||2
8558099|NCT00087568|21100809|P2|STARTED|Overall Study||25
8558100|NCT00087568|21100810|P1|STARTED|Overall Study||32
8558101|NCT00087555|21100837|P3|NOT COMPLETED|Overall Study||21
8558102|NCT00087555|21100838|P2|NOT COMPLETED|Overall Study||11
8558103|NCT00087555|21100839|P1|NOT COMPLETED|Overall Study||12
8558104|NCT00087555|21100837|P3|COMPLETED|Overall Study||46
8558105|NCT00087555|21100838|P2|COMPLETED|Overall Study||51
8558106|NCT00087555|21100839|P1|COMPLETED|Overall Study||54
8558107|NCT00087555|21100837|P3|Treated|Overall Study||67
8558108|NCT00087555|21100838|P2|Treated|Overall Study||60
8558109|NCT00087555|21100839|P1|Treated|Overall Study||65
8558110|NCT00087555|21100837|P3|STARTED|Overall Study||67
8558111|NCT00087555|21100838|P2|STARTED|Overall Study||62
8558112|NCT00087555|21100839|P1|STARTED|Overall Study||66
8558113|NCT00087529|21100849|P2|NOT COMPLETED|Overall Study||68
8558114|NCT00087529|21100850|P1|NOT COMPLETED|Overall Study||31
8558115|NCT00087529|21100849|P2|COMPLETED|Overall Study||224
8558116|NCT00087529|21100850|P1|COMPLETED|Overall Study||116
8558117|NCT00087529|21100849|P2|STARTED|Overall Study||292
8558118|NCT00087529|21100850|P1|STARTED|Overall Study||147
8558119|NCT00087516|21100865|P4|NOT COMPLETED|Overall Study||85
8558120|NCT00087516|21100866|P3|NOT COMPLETED|Overall Study||97
8558121|NCT00087516|21100867|P2|NOT COMPLETED|Overall Study||169
8558122|NCT00087516|21100868|P1|NOT COMPLETED|Overall Study||161
8558123|NCT00087516|21100865|P4|COMPLETED|Overall Study||38
8558124|NCT00087516|21100866|P3|COMPLETED|Overall Study||33
8558125|NCT00087516|21100867|P2|COMPLETED|Overall Study||81
8558126|NCT00087516|21100868|P1|COMPLETED|Overall Study||77
8558127|NCT00087516|21100865|P4|STARTED|Overall Study||123
8558128|NCT00087516|21100866|P3|STARTED|Overall Study||130
8558129|NCT00087516|21100867|P2|STARTED|Overall Study||250
8558130|NCT00087516|21100868|P1|STARTED|Overall Study||238
8558131|NCT00087490|21100897|P2|NOT COMPLETED|Overall Study||269
8558132|NCT00087490|21100898|P1|NOT COMPLETED|Overall Study||258
8558133|NCT00087490|21100897|P2|COMPLETED|Overall Study||264
8558134|NCT00087490|21100898|P1|COMPLETED|Overall Study||286
8558135|NCT00087490|21100897|P2|Treated|Overall Study||515
8558136|NCT00087490|21100898|P1|Treated|Overall Study||537
8558137|NCT00087490|21100897|P2|STARTED|Overall Study||533
8558138|NCT00087490|21100898|P1|STARTED|Overall Study||544
8558139|NCT00087438|21100932|P1|NOT COMPLETED|Overall Study||4
8558140|NCT00087438|21100932|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
8558141|NCT00087438|21100932|P1|STARTED|Overall Study||59
8558142|NCT00087152|21100942|P1|NOT COMPLETED|Overall Study||6
8558143|NCT00087152|21100942|P1|COMPLETED|Overall Study||21
8558144|NCT00087152|21100942|P1|STARTED|Overall Study||27
8558145|NCT00087139|21100951|P3|NOT COMPLETED|Overall Study||36
8558146|NCT00087139|21100952|P2|NOT COMPLETED|Overall Study||49
8558147|NCT00087139|21100953|P1|NOT COMPLETED|Overall Study||39
8558148|NCT00087139|21100951|P3|COMPLETED|Overall Study||0
8558149|NCT00087139|21100952|P2|COMPLETED|Overall Study||0
8558150|NCT00087139|21100953|P1|COMPLETED|Overall Study||0
8558151|NCT00087139|21100951|P3|Patients w/ Measurable Disease Response|Overall Study||0
8558152|NCT00087139|21100952|P2|Patients w/ Measurable Disease Response|Overall Study||2
8558153|NCT00087139|21100953|P1|Patients w/ Measurable Disease Response|Overall Study||5
8558154|NCT00087139|21100951|P3|Patients With PSA Response|Overall Study||4
8558155|NCT00087139|21100952|P2|Patients With PSA Response|Overall Study||8
8558156|NCT00087139|21100953|P1|Patients With PSA Response|Overall Study||10
8558157|NCT00087139|21100951|P3|Patients With Measurable Disease|Overall Study||24
8558158|NCT00087139|21100952|P2|Patients With Measurable Disease|Overall Study||25
8558159|NCT00087139|21100953|P1|Patients With Measurable Disease|Overall Study||22
8558160|NCT00087139|21100951|P3|Patients for the Analysis of PSA Respons|Overall Study||22
8558161|NCT00087139|21100952|P2|Patients for the Analysis of PSA Respons|Overall Study||34
8558162|NCT00087139|21100953|P1|Patients for the Analysis of PSA Respons|Overall Study||30
8558163|NCT00087139|21100951|P3|Eligible and Treated|Overall Study||32
8558164|NCT00087139|21100952|P2|Eligible and Treated|Overall Study||42
8558165|NCT00087139|21100953|P1|Eligible and Treated|Overall Study||35
8558166|NCT00087139|21100951|P3|Treated|Overall Study||36
8558167|NCT00087139|21100952|P2|Treated|Overall Study||48
8558168|NCT00087139|21100953|P1|Treated|Overall Study||39
8558169|NCT00087139|21100951|P3|STARTED|Overall Study||36
8558170|NCT00087139|21100952|P2|STARTED|Overall Study||49
8558171|NCT00087139|21100953|P1|STARTED|Overall Study||39
8558172|NCT00087126|21100968|P1|NOT COMPLETED|Overall Study||2
8558173|NCT00087126|21100968|P1|COMPLETED|Overall Study||25
8558174|NCT00087126|21100968|P1|STARTED|Overall Study||27
8558175|NCT00087022|21100979|P2|NOT COMPLETED|Overall Study||55
8558176|NCT00087022|21100980|P1|NOT COMPLETED|Overall Study||54
8558177|NCT00087022|21100979|P2|COMPLETED|Overall Study||376
8558178|NCT00087022|21100980|P1|COMPLETED|Overall Study||379
8558179|NCT00087022|21100979|P2|Treated (Safety Population)|Overall Study||424
8558180|NCT00087022|21100980|P1|Treated (Safety Population)|Overall Study||431
8558181|NCT00087022|21100979|P2|STARTED|Overall Study||431
8558182|NCT00087022|21100980|P1|STARTED|Overall Study||433
8558183|NCT00086996|21100993|P1|NOT COMPLETED|Overall Study||64
8558184|NCT00086996|21100993|P1|COMPLETED|Overall Study||34
8558185|NCT00086996|21100993|P1|Eligible and Began Protocol Therapy|Overall Study||93
8558186|NCT00086996|21100993|P1|Eligible|Overall Study||93
8558187|NCT00086996|21100993|P1|STARTED|Overall Study||98
8558188|NCT00086957|21101000|P3|NOT COMPLETED|Overall Study||0
8558189|NCT00086957|21101001|P2|NOT COMPLETED|Overall Study||0
8558190|NCT00086957|21101002|P1|NOT COMPLETED|Overall Study||0
8558191|NCT00086957|21101000|P3|COMPLETED|Overall Study||22
8558192|NCT00086957|21101001|P2|COMPLETED|Overall Study||7
8558193|NCT00086957|21101002|P1|COMPLETED|Overall Study||2
8558194|NCT00086957|21101000|P3|STARTED|Overall Study||22
8558195|NCT00086957|21101001|P2|STARTED|Overall Study||7
8558196|NCT00086957|21101002|P1|STARTED|Overall Study||2
8558197|NCT00086684|21101015|P3|NOT COMPLETED|Overall Study||53
8558198|NCT00086684|21101016|P2|NOT COMPLETED|Overall Study||55
8558199|NCT00086684|21101017|P1|NOT COMPLETED|Overall Study||55
8558200|NCT00086684|21101015|P3|COMPLETED|Overall Study||69
8558201|NCT00086684|21101016|P2|COMPLETED|Overall Study||74
8558202|NCT00086684|21101017|P1|COMPLETED|Overall Study||63
8558203|NCT00086684|21101015|P3|STARTED|Overall Study||122
8558204|NCT00086684|21101016|P2|STARTED|Overall Study||129
8558205|NCT00086684|21101017|P1|STARTED|Overall Study||118
8558206|NCT00086619|21101030|P2|NOT COMPLETED|Overall Study||17
8558207|NCT00086619|21101031|P1|NOT COMPLETED|Overall Study||15
8558208|NCT00086619|21101030|P2|COMPLETED|Overall Study||23
8558209|NCT00086619|21101031|P1|COMPLETED|Overall Study||25
8558210|NCT00086619|21101030|P2|Completed 12 Month Visit|Overall Study||26
8558211|NCT00086619|21101031|P1|Completed 12 Month Visit|Overall Study||26
8558212|NCT00086619|21101030|P2|Completed Baseline Visit|Overall Study||36
8558213|NCT00086619|21101031|P1|Completed Baseline Visit|Overall Study||34
8558214|NCT00086619|21101030|P2|STARTED|Overall Study||40
8558215|NCT00086619|21101031|P1|STARTED|Overall Study||40
8558216|NCT00086580|21101041|P2|NOT COMPLETED|Observation Period||65
8558217|NCT00086580|21101042|P1|NOT COMPLETED|Observation Period||46
8558218|NCT00086580|21101041|P2|COMPLETED|Observation Period||56
8558219|NCT00086580|21101042|P1|COMPLETED|Observation Period||49
8558220|NCT00086580|21101041|P2|STARTED|Observation Period||121
8558221|NCT00086580|21101042|P1|STARTED|Observation Period||95
8558222|NCT00086580|21101041|P2|NOT COMPLETED|Follow-up Period||119
8558223|NCT00086580|21101042|P1|NOT COMPLETED|Follow-up Period||104
8558224|NCT00086580|21101041|P2|COMPLETED|Follow-up Period||18
8558225|NCT00086580|21101042|P1|COMPLETED|Follow-up Period||37
8558226|NCT00086580|21101041|P2|STARTED|Follow-up Period||137
8558227|NCT00086580|21101042|P1|STARTED|Follow-up Period||141
8558228|NCT00086580|21101041|P2|NOT COMPLETED|Treatment Period||60
8558229|NCT00086580|21101042|P1|NOT COMPLETED|Treatment Period||65
8558230|NCT00086580|21101041|P2|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
8558231|NCT00086580|21101042|P1|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
8558232|NCT00086580|21101041|P2|Safety Population|Treatment Period|Two participants did not receive treatment|165
8558233|NCT00086580|21101042|P1|Safety Population|Treatment Period|Four participants did not receive treatment|164
8558234|NCT00086580|21101041|P2|STARTED|Treatment Period||167
8558235|NCT00086580|21101042|P1|STARTED|Treatment Period||168
8558236|NCT00086411|21101090|P4|NOT COMPLETED|Overall Study||12
8558237|NCT00086411|21101091|P3|NOT COMPLETED|Overall Study||13
8558238|NCT00086411|21101092|P2|NOT COMPLETED|Overall Study||11
8558239|NCT00086411|21101093|P1|NOT COMPLETED|Overall Study||11
8558240|NCT00086411|21101090|P4|COMPLETED|Overall Study||53
8558241|NCT00086411|21101091|P3|COMPLETED|Overall Study||49
8558242|NCT00086411|21101092|P2|COMPLETED|Overall Study||52
8558243|NCT00086411|21101093|P1|COMPLETED|Overall Study||59
8558244|NCT00086411|21101090|P4|STARTED|Overall Study||65
8558245|NCT00086411|21101091|P3|STARTED|Overall Study||62
8558246|NCT00086411|21101092|P2|STARTED|Overall Study||63
8558247|NCT00086411|21101093|P1|STARTED|Overall Study||70
8558248|NCT00086385|21101111|P4|NOT COMPLETED|Overall Study||1
8558249|NCT00086385|21101112|P3|NOT COMPLETED|Overall Study||1
8558250|NCT00086385|21101113|P2|NOT COMPLETED|Overall Study||2
8558251|NCT00086385|21101114|P1|NOT COMPLETED|Overall Study||2
8558252|NCT00086385|21101111|P4|COMPLETED|Overall Study||98
8558253|NCT00086385|21101112|P3|COMPLETED|Overall Study||103
8558254|NCT00086385|21101113|P2|COMPLETED|Overall Study||97
8558255|NCT00086385|21101114|P1|COMPLETED|Overall Study||98
8558256|NCT00086385|21101111|P4|STARTED|Overall Study||99
8558257|NCT00086385|21101112|P3|STARTED|Overall Study||104
8558258|NCT00086385|21101113|P2|STARTED|Overall Study||99
8558259|NCT00086385|21101114|P1|STARTED|Overall Study||100
8558260|NCT00086515|21101126|P2|NOT COMPLETED|Phase B (Weeks 24-104)||55
8558261|NCT00086515|21101127|P1|NOT COMPLETED|Phase B (Weeks 24-104)||190
8558262|NCT00086515|21101126|P2|COMPLETED|Phase B (Weeks 24-104)||109
8558263|NCT00086515|21101127|P1|COMPLETED|Phase B (Weeks 24-104)||201
8558264|NCT00086515|21101126|P2|STARTED|Phase B (Weeks 24-104)||164
8558265|NCT00086515|21101127|P1|STARTED|Phase B (Weeks 24-104)||391
8558266|NCT00086515|21101126|P2|NOT COMPLETED|Phase A to Phase B Transition Period||28
8558267|NCT00086515|21101127|P1|NOT COMPLETED|Phase A to Phase B Transition Period||24
8558268|NCT00086515|21101126|P2|COMPLETED|Phase A to Phase B Transition Period||164
8558269|NCT00086515|21101127|P1|COMPLETED|Phase A to Phase B Transition Period||391
8558270|NCT00086515|21101126|P2|STARTED|Phase A to Phase B Transition Period||192
8558271|NCT00086515|21101127|P1|STARTED|Phase A to Phase B Transition Period||415
8558272|NCT00086515|21101126|P2|NOT COMPLETED|Phase A (Weeks 0-24)||45
8558273|NCT00086515|21101127|P1|NOT COMPLETED|Phase A (Weeks 0-24)||49
8558274|NCT00086515|21101126|P2|COMPLETED|Phase A (Weeks 0-24)||192
8558275|NCT00086515|21101127|P1|COMPLETED|Phase A (Weeks 0-24)||415
8558276|NCT00086515|21101126|P2|STARTED|Phase A (Weeks 0-24)||237
8558277|NCT00086515|21101127|P1|STARTED|Phase A (Weeks 0-24)||464
8558278|NCT00086502|21101139|P2|NOT COMPLETED|Overall Study||20
8558279|NCT00086502|21101140|P1|NOT COMPLETED|Overall Study||26
8558280|NCT00086502|21101139|P2|COMPLETED|Overall Study||158
8558281|NCT00086502|21101140|P1|COMPLETED|Overall Study||149
8558282|NCT00086502|21101139|P2|STARTED|Overall Study||178
8558283|NCT00086502|21101140|P1|STARTED|Overall Study||175
8558284|NCT00086450|21101150|P2|NOT COMPLETED|Overall Study||0
8558285|NCT00086450|21101151|P1|NOT COMPLETED|Overall Study||0
8558286|NCT00086450|21101150|P2|COMPLETED|Overall Study||947
8558287|NCT00086450|21101151|P1|COMPLETED|Overall Study||953
8558288|NCT00086450|21101150|P2|STARTED|Overall Study||947
8558289|NCT00086450|21101151|P1|STARTED|Overall Study||953
8558290|NCT00086346|21101165|P2|NOT COMPLETED|Patients Dosed With Test Article||23
8558291|NCT00086346|21101166|P1|NOT COMPLETED|Patients Dosed With Test Article||140
8558292|NCT00086346|21101165|P2|COMPLETED|Patients Dosed With Test Article||187
8558293|NCT00086346|21101166|P1|COMPLETED|Patients Dosed With Test Article||249
8558294|NCT00086346|21101165|P2|STARTED|Patients Dosed With Test Article||210
8558295|NCT00086346|21101166|P1|STARTED|Patients Dosed With Test Article||389
8558296|NCT00086346|21101165|P2|NOT COMPLETED|Randomization||4
8558297|NCT00086346|21101166|P1|NOT COMPLETED|Randomization||4
8558298|NCT00086346|21101165|P2|COMPLETED|Randomization||210
8558299|NCT00086346|21101166|P1|COMPLETED|Randomization||389
8558300|NCT00086346|21101165|P2|STARTED|Randomization||214
8558301|NCT00086346|21101166|P1|STARTED|Randomization||393
8558302|NCT00086281|21101193|P15|NOT COMPLETED|Phase 2||0
8558303|NCT00086281|21101194|P14|NOT COMPLETED|Phase 2||1
8558304|NCT00086281|21101195|P13|NOT COMPLETED|Phase 2||1
8558305|NCT00086281|21101196|P12|NOT COMPLETED|Phase 2||0
8558306|NCT00086281|21101197|P11|NOT COMPLETED|Phase 2||0
8558307|NCT00086281|21101198|P10|NOT COMPLETED|Phase 2||0
8558308|NCT00086281|21101199|P9|NOT COMPLETED|Phase 2||0
8558309|NCT00086281|21101200|P8|NOT COMPLETED|Phase 2||0
8558310|NCT00086281|21101201|P7|NOT COMPLETED|Phase 2||0
8558311|NCT00086281|21101202|P6|NOT COMPLETED|Phase 2||0
8558312|NCT00086281|21101203|P5|NOT COMPLETED|Phase 2||0
8558313|NCT00086281|21101204|P4|NOT COMPLETED|Phase 2||0
8558314|NCT00086281|21101205|P3|NOT COMPLETED|Phase 2||0
8558315|NCT00086281|21101206|P2|NOT COMPLETED|Phase 2||0
8558316|NCT00086281|21101207|P1|NOT COMPLETED|Phase 2||0
8558317|NCT00086281|21101193|P15|COMPLETED|Phase 2||0
8558318|NCT00086281|21101194|P14|COMPLETED|Phase 2||26
8558319|NCT00086281|21101195|P13|COMPLETED|Phase 2||22
8558320|NCT00086281|21101196|P12|COMPLETED|Phase 2||0
8558321|NCT00086281|21101197|P11|COMPLETED|Phase 2||0
8558322|NCT00086281|21101198|P10|COMPLETED|Phase 2||0
8558323|NCT00086281|21101199|P9|COMPLETED|Phase 2||0
8558324|NCT00086281|21101200|P8|COMPLETED|Phase 2||0
8558325|NCT00086281|21101201|P7|COMPLETED|Phase 2||0
8558326|NCT00086281|21101202|P6|COMPLETED|Phase 2||0
8558327|NCT00086281|21101203|P5|COMPLETED|Phase 2||0
8558328|NCT00086281|21101204|P4|COMPLETED|Phase 2||0
8558329|NCT00086281|21101205|P3|COMPLETED|Phase 2||0
8558330|NCT00086281|21101206|P2|COMPLETED|Phase 2||0
8558331|NCT00086281|21101207|P1|COMPLETED|Phase 2||0
8558332|NCT00086281|21101193|P15|STARTED|Phase 2||0
8558333|NCT00086281|21101194|P14|STARTED|Phase 2||27
8558334|NCT00086281|21101195|P13|STARTED|Phase 2||23
8558335|NCT00086281|21101196|P12|STARTED|Phase 2||0
8558336|NCT00086281|21101197|P11|STARTED|Phase 2||0
8558337|NCT00086281|21101198|P10|STARTED|Phase 2||0
8558338|NCT00086281|21101199|P9|STARTED|Phase 2||0
8558339|NCT00086281|21101200|P8|STARTED|Phase 2||0
8558340|NCT00086281|21101201|P7|STARTED|Phase 2||0
8558341|NCT00086281|21101202|P6|STARTED|Phase 2||0
8558342|NCT00086281|21101203|P5|STARTED|Phase 2||0
8558343|NCT00086281|21101204|P4|STARTED|Phase 2||0
8558344|NCT00086281|21101205|P3|STARTED|Phase 2||0
8558345|NCT00086281|21101206|P2|STARTED|Phase 2||0
8558346|NCT00086281|21101207|P1|STARTED|Phase 2||0
8558347|NCT00086281|21101193|P15|NOT COMPLETED|Phase 1||3
8558348|NCT00086281|21101194|P14|NOT COMPLETED|Phase 1||1
8558349|NCT00086281|21101195|P13|NOT COMPLETED|Phase 1||1
8558350|NCT00086281|21101196|P12|NOT COMPLETED|Phase 1||1
8558351|NCT00086281|21101197|P11|NOT COMPLETED|Phase 1||3
8558352|NCT00086281|21101198|P10|NOT COMPLETED|Phase 1||1
8558353|NCT00086281|21101199|P9|NOT COMPLETED|Phase 1||0
8558354|NCT00086281|21101200|P8|NOT COMPLETED|Phase 1||0
8558355|NCT00086281|21101201|P7|NOT COMPLETED|Phase 1||0
8558356|NCT00086281|21101202|P6|NOT COMPLETED|Phase 1||0
8558357|NCT00086281|21101203|P5|NOT COMPLETED|Phase 1||0
8558358|NCT00086281|21101204|P4|NOT COMPLETED|Phase 1||0
8558359|NCT00086281|21101205|P3|NOT COMPLETED|Phase 1||0
8558360|NCT00086281|21101206|P2|NOT COMPLETED|Phase 1||0
8558361|NCT00086281|21101207|P1|NOT COMPLETED|Phase 1||0
8558362|NCT00086281|21101193|P15|COMPLETED|Phase 1||0
8558363|NCT00086281|21101194|P14|COMPLETED|Phase 1||0
8558364|NCT00086281|21101195|P13|COMPLETED|Phase 1||0
8558365|NCT00086281|21101196|P12|COMPLETED|Phase 1||0
8558366|NCT00086281|21101197|P11|COMPLETED|Phase 1||0
8558367|NCT00086281|21101198|P10|COMPLETED|Phase 1||0
8558368|NCT00086281|21101199|P9|COMPLETED|Phase 1||2
8558369|NCT00086281|21101200|P8|COMPLETED|Phase 1||1
8558370|NCT00086281|21101201|P7|COMPLETED|Phase 1||1
8558371|NCT00086281|21101202|P6|COMPLETED|Phase 1||3
8558372|NCT00086281|21101203|P5|COMPLETED|Phase 1||1
8558373|NCT00086281|21101204|P4|COMPLETED|Phase 1||11
8558374|NCT00086281|21101205|P3|COMPLETED|Phase 1||8
8558375|NCT00086281|21101206|P2|COMPLETED|Phase 1||12
8558376|NCT00086281|21101207|P1|COMPLETED|Phase 1||11
8558377|NCT00086281|21101193|P15|STARTED|Phase 1||3
8558378|NCT00086281|21101194|P14|STARTED|Phase 1||1
8558379|NCT00086281|21101195|P13|STARTED|Phase 1||1
8558380|NCT00086281|21101196|P12|STARTED|Phase 1||1
8558381|NCT00086281|21101197|P11|STARTED|Phase 1||3
8558382|NCT00086281|21101198|P10|STARTED|Phase 1||1
8558383|NCT00086281|21101199|P9|STARTED|Phase 1||2
8558384|NCT00086281|21101200|P8|STARTED|Phase 1||1
8558385|NCT00086281|21101201|P7|STARTED|Phase 1||1
8558386|NCT00086281|21101202|P6|STARTED|Phase 1||3
8558387|NCT00086281|21101203|P5|STARTED|Phase 1||1
8558388|NCT00086281|21101204|P4|STARTED|Phase 1||11
8558389|NCT00086281|21101205|P3|STARTED|Phase 1||8
8558390|NCT00086281|21101206|P2|STARTED|Phase 1||12
8558391|NCT00086281|21101207|P1|STARTED|Phase 1||11
8558392|NCT00086307|21101220|P3|NOT COMPLETED|Overall Study||8
8558393|NCT00086307|21101221|P2|NOT COMPLETED|Overall Study||1
8558394|NCT00086307|21101222|P1|NOT COMPLETED|Overall Study||2
8558395|NCT00086307|21101220|P3|COMPLETED|Overall Study||5
8558396|NCT00086307|21101221|P2|COMPLETED|Overall Study||12
8558397|NCT00086307|21101222|P1|COMPLETED|Overall Study||11
8558398|NCT00086307|21101220|P3|STARTED|Overall Study||13
8558399|NCT00086307|21101221|P2|STARTED|Overall Study||13
8558400|NCT00086307|21101222|P1|STARTED|Overall Study||13
8558401|NCT00086190|21101233|P3|NOT COMPLETED|Overall Study||6
8558402|NCT00086190|21101234|P2|NOT COMPLETED|Overall Study||4
8558403|NCT00086190|21101235|P1|NOT COMPLETED|Overall Study||8
8558404|NCT00086190|21101233|P3|COMPLETED|Overall Study||33
8558405|NCT00086190|21101234|P2|COMPLETED|Overall Study||30
8558406|NCT00086190|21101235|P1|COMPLETED|Overall Study||34
8558407|NCT00086190|21101233|P3|STARTED|Overall Study||39
8558408|NCT00086190|21101234|P2|STARTED|Overall Study||34
8558409|NCT00086190|21101235|P1|STARTED|Overall Study||42
8558410|NCT00086138|21101293|P2|NOT COMPLETED|Overall Study||3
8558411|NCT00086138|21101294|P1|NOT COMPLETED|Overall Study||4
8558412|NCT00086138|21101293|P2|COMPLETED|Overall Study||64
8558413|NCT00086138|21101294|P1|COMPLETED|Overall Study||60
8558414|NCT00086138|21101293|P2|STARTED|Overall Study||67
8558415|NCT00086138|21101294|P1|STARTED|Overall Study||64
8558416|NCT00086047|21101304|P2|NOT COMPLETED|Overall Study||7
8558417|NCT00086047|21101305|P1|NOT COMPLETED|Overall Study||7
8558418|NCT00086047|21101304|P2|COMPLETED|Overall Study||50
8558419|NCT00086047|21101305|P1|COMPLETED|Overall Study||50
8558420|NCT00086047|21101304|P2|STARTED|Overall Study||57
8558421|NCT00086047|21101305|P1|STARTED|Overall Study||57
8558422|NCT00085917|21101313|P2|NOT COMPLETED|Overall Study||3
8558423|NCT00085917|21101314|P1|NOT COMPLETED|Overall Study||4
8558424|NCT00085917|21101313|P2|COMPLETED|Overall Study||11
8558425|NCT00085917|21101314|P1|COMPLETED|Overall Study||11
8558426|NCT00085917|21101313|P2|STARTED|Overall Study||14
8558427|NCT00085917|21101314|P1|STARTED|Overall Study||15
8558428|NCT00085839|21101326|P2|NOT COMPLETED|Overall Study||0
8558429|NCT00085839|21101327|P1|NOT COMPLETED|Overall Study||0
8558430|NCT00085839|21101326|P2|COMPLETED|Overall Study||51
8558431|NCT00085839|21101327|P1|COMPLETED|Overall Study||52
8558432|NCT00085839|21101326|P2|STARTED|Overall Study||51
8558433|NCT00085839|21101327|P1|STARTED|Overall Study||52
8558452|NCT00085709|21101403|P2|NOT COMPLETED|Overall Study||50
8558453|NCT00085709|21101404|P1|NOT COMPLETED|Overall Study||53
8558454|NCT00085709|21101403|P2|COMPLETED|Overall Study||270
8558455|NCT00085709|21101404|P1|COMPLETED|Overall Study||264
8558456|NCT00085709|21101403|P2|Eligible and Did Not Withdraw Consent|Overall Study||300
8558457|NCT00085709|21101404|P1|Eligible and Did Not Withdraw Consent|Overall Study||296
8558458|NCT00085709|21101403|P2|Eligible|Overall Study||301
8558459|NCT00085709|21101404|P1|Eligible|Overall Study||298
8558460|NCT00085709|21101403|P2|STARTED|Overall Study||320
8558461|NCT00085709|21101404|P1|STARTED|Overall Study||317
8558462|NCT00085644|21101420|P3|NOT COMPLETED|Open-Label Period||109
8558463|NCT00085644|21101421|P2|NOT COMPLETED|Open-Label Period||0
8558464|NCT00085644|21101422|P1|NOT COMPLETED|Open-Label Period||0
8558465|NCT00085644|21101420|P3|COMPLETED|Open-Label Period||202
8558466|NCT00085644|21101421|P2|COMPLETED|Open-Label Period||0
8558467|NCT00085644|21101422|P1|COMPLETED|Open-Label Period||0
8558468|NCT00085644|21101420|P3|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
8558469|NCT00085644|21101421|P2|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
8558470|NCT00085644|21101422|P1|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
8558471|NCT00085644|21101420|P3|NOT COMPLETED|Double-Blind Period||0
8558472|NCT00085644|21101421|P2|NOT COMPLETED|Double-Blind Period||6
8558473|NCT00085644|21101422|P1|NOT COMPLETED|Double-Blind Period||13
8558474|NCT00085644|21101420|P3|COMPLETED|Double-Blind Period||0
8558475|NCT00085644|21101421|P2|COMPLETED|Double-Blind Period||101
8558476|NCT00085644|21101422|P1|COMPLETED|Double-Blind Period||195
8558477|NCT00085644|21101420|P3|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
8558478|NCT00085644|21101421|P2|STARTED|Double-Blind Period||107
8558479|NCT00085644|21101422|P1|STARTED|Double-Blind Period||208
8558480|NCT00085631|21101463|P3|NOT COMPLETED|Overall Study||7
8558481|NCT00085631|21101464|P2|NOT COMPLETED|Overall Study||11
8558482|NCT00085631|21101465|P1|NOT COMPLETED|Overall Study||4
8558483|NCT00085631|21101463|P3|COMPLETED|Overall Study||32
8558484|NCT00085631|21101464|P2|COMPLETED|Overall Study||38
8558485|NCT00085631|21101465|P1|COMPLETED|Overall Study||9
8558486|NCT00085631|21101463|P3|STARTED|Overall Study||39
8558487|NCT00085631|21101464|P2|STARTED|Overall Study||49
8558488|NCT00085631|21101465|P1|STARTED|Overall Study||13
8558489|NCT00085566|21101475|P3|NOT COMPLETED|Overall Study||14
8558490|NCT00085566|21101476|P2|NOT COMPLETED|Overall Study||0
8558491|NCT00085566|21101477|P1|NOT COMPLETED|Overall Study||0
8558492|NCT00085566|21101475|P3|COMPLETED|Overall Study||43
8558493|NCT00085566|21101476|P2|COMPLETED|Overall Study||3
8558494|NCT00085566|21101477|P1|COMPLETED|Overall Study||3
8558495|NCT00085566|21101475|P3|STARTED|Overall Study||57
8558496|NCT00085566|21101476|P2|STARTED|Overall Study||3
8558497|NCT00085566|21101477|P1|STARTED|Overall Study||3
8558498|NCT00085540|21101487|P2|NOT COMPLETED|Overall Study||2
8558499|NCT00085540|21101488|P1|NOT COMPLETED|Overall Study||0
8558500|NCT00085540|21101487|P2|COMPLETED|Overall Study||40
8558501|NCT00085540|21101488|P1|COMPLETED|Overall Study||8
8558502|NCT00085540|21101487|P2|STARTED|Overall Study||42
8558503|NCT00085540|21101488|P1|STARTED|Overall Study||8
8558504|NCT00085436|21101495|P1|NOT COMPLETED|Overall Study||0
8558505|NCT00085436|21101495|P1|COMPLETED|Overall Study||18
8558506|NCT00085436|21101495|P1|STARTED|Overall Study||18
8558507|NCT00085423|21101500|P1|NOT COMPLETED|Overall Study||2
8558508|NCT00085423|21101500|P1|COMPLETED|Overall Study||18
8558509|NCT00085423|21101500|P1|STARTED|Overall Study||20
8558510|NCT00085410|21101506|P1|NOT COMPLETED|Overall Study||0
8558511|NCT00085410|21101506|P1|COMPLETED|Overall Study||20
8558512|NCT00085410|21101506|P1|STARTED|Overall Study||20
8558513|NCT00085293|21101520|P1|NOT COMPLETED|Overall Study||0
8558514|NCT00085293|21101520|P1|COMPLETED|Overall Study||12
8558515|NCT00085293|21101520|P1|STARTED|Overall Study||12
8558516|NCT00085254|21101533|P3|NOT COMPLETED|Overall Study||0
8558517|NCT00085254|21101534|P2|NOT COMPLETED|Overall Study||0
8558518|NCT00085254|21101535|P1|NOT COMPLETED|Overall Study||0
8558519|NCT00085254|21101533|P3|COMPLETED|Overall Study||48
8558520|NCT00085254|21101534|P2|COMPLETED|Overall Study||46
8558521|NCT00085254|21101535|P1|COMPLETED|Overall Study||18
8558522|NCT00085254|21101533|P3|STARTED|Overall Study||48
8558523|NCT00085254|21101534|P2|STARTED|Overall Study||46
8558524|NCT00085254|21101535|P1|STARTED|Overall Study||18
8558525|NCT00085202|21101551|P2|NOT COMPLETED|Overall Study||24
8558526|NCT00085202|21101552|P1|NOT COMPLETED|Overall Study||18
8558527|NCT00085202|21101551|P2|COMPLETED|Overall Study||120
8558528|NCT00085202|21101552|P1|COMPLETED|Overall Study||251
8558529|NCT00085202|21101551|P2|STARTED|Overall Study||144
8558530|NCT00085202|21101552|P1|STARTED|Overall Study||269
8558531|NCT00085098|21101573|P2|NOT COMPLETED|Overall Study||2
8558532|NCT00085098|21101574|P1|NOT COMPLETED|Overall Study||1
8558533|NCT00085098|21101573|P2|COMPLETED|Overall Study||11
8558534|NCT00085098|21101574|P1|COMPLETED|Overall Study||10
8558535|NCT00085098|21101573|P2|STARTED|Overall Study||13
8558536|NCT00085098|21101574|P1|STARTED|Overall Study||11
8558537|NCT00084929|21101584|P1|NOT COMPLETED|Overall Study||69
8558538|NCT00084929|21101584|P1|COMPLETED|Overall Study||2531
8558539|NCT00084929|21101584|P1|STARTED|Overall Study||2600
8558540|NCT00084864|21101606|P4|NOT COMPLETED|Overall Study||0
8558541|NCT00084864|21101607|P3|NOT COMPLETED|Overall Study||0
8558542|NCT00084864|21101608|P2|NOT COMPLETED|Overall Study||0
8558543|NCT00084864|21101609|P1|NOT COMPLETED|Overall Study||1
8558544|NCT00084864|21101606|P4|COMPLETED|Overall Study||4
8558545|NCT00084864|21101607|P3|COMPLETED|Overall Study||4
8558546|NCT00084864|21101608|P2|COMPLETED|Overall Study||7
8558547|NCT00084864|21101609|P1|COMPLETED|Overall Study||9
8558548|NCT00084864|21101606|P4|STARTED|Overall Study||4
8558549|NCT00084864|21101607|P3|STARTED|Overall Study||4
8558550|NCT00084864|21101608|P2|STARTED|Overall Study||7
8558551|NCT00084864|21101609|P1|STARTED|Overall Study||10
8558552|NCT00084838|21101635|P1|NOT COMPLETED|Overall Study||13
8558553|NCT00084838|21101635|P1|COMPLETED|Overall Study||12
8558554|NCT00084838|21101635|P1|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
8558555|NCT00084838|21101635|P1|STARTED|Overall Study||25
8558556|NCT00084747|21101657|P1|NOT COMPLETED|Overall Study||13
8558557|NCT00084747|21101657|P1|COMPLETED|Overall Study||17
8558558|NCT00084747|21101657|P1|STARTED|Overall Study||30
8558562|NCT00084617|21101666|P1|NOT COMPLETED|Overall Study||9
8558563|NCT00084617|21101666|P1|COMPLETED|Overall Study||30
8558564|NCT00084617|21101666|P1|STARTED|Overall Study||39
8558565|NCT00084487|21101672|P1|NOT COMPLETED|Overall Study||1
8558566|NCT00084487|21101672|P1|COMPLETED|Overall Study||20
8558567|NCT00084487|21101672|P1|STARTED|Overall Study||21
8558568|NCT00084409|21101682|P2|NOT COMPLETED|Overall Study||12
8558569|NCT00084409|21101683|P1|NOT COMPLETED|Overall Study||15
8558570|NCT00084409|21101682|P2|COMPLETED|Overall Study|4 Current, 8 former|65
8558571|NCT00084409|21101683|P1|COMPLETED|Overall Study|9 current, 6 former|60
8558572|NCT00084409|21101682|P2|STARTED|Overall Study|41 current, 36 former|77
8558573|NCT00084409|21101683|P1|STARTED|Overall Study|40 Current, 35 former|75
8558574|NCT00084383|21101709|P1|NOT COMPLETED|Overall Study||47
8558575|NCT00084383|21101709|P1|COMPLETED|Overall Study||13
8558576|NCT00084383|21101709|P1|STARTED|Overall Study||60
8558577|NCT00084318|21101716|P2|NOT COMPLETED|Overall Study||13
8558578|NCT00084318|21101717|P1|NOT COMPLETED|Overall Study||22
8558579|NCT00084318|21101716|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
8558580|NCT00084318|21101717|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
8558581|NCT00084318|21101716|P2|STARTED|Overall Study||119
8558582|NCT00084318|21101717|P1|STARTED|Overall Study||119
8558583|NCT00084266|21101737|P2|NOT COMPLETED|Overall Study||423
8558584|NCT00084266|21101738|P1|NOT COMPLETED|Overall Study||441
8558585|NCT00084266|21101737|P2|COMPLETED|Overall Study||184
8558586|NCT00084266|21101738|P1|COMPLETED|Overall Study||177
8558587|NCT00084266|21101737|P2|Treated|Overall Study||587
8558588|NCT00084266|21101738|P1|Treated|Overall Study||597
8558589|NCT00084266|21101737|P2|STARTED|Overall Study||607
8558590|NCT00084266|21101738|P1|STARTED|Overall Study||618
8558591|NCT00084149|21101774|P2|NOT COMPLETED|Overall Study||5
8558592|NCT00084149|21101775|P1|NOT COMPLETED|Overall Study||8
8558593|NCT00084149|21101774|P2|COMPLETED|Overall Study||13
8558594|NCT00084149|21101775|P1|COMPLETED|Overall Study||28
8558595|NCT00084149|21101774|P2|STARTED|Overall Study||18
8558596|NCT00084149|21101775|P1|STARTED|Overall Study||36
8558597|NCT00084136|21101796|P3|NOT COMPLETED|NRTI Comparison||82
8558598|NCT00084136|21101797|P2|NOT COMPLETED|NRTI Comparison||0
8558599|NCT00084136|21101798|P1|NOT COMPLETED|NRTI Comparison||101
8558600|NCT00084136|21101796|P3|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
8558601|NCT00084136|21101797|P2|COMPLETED|NRTI Comparison||0
8558602|NCT00084136|21101798|P1|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
8558603|NCT00084136|21101796|P3|STARTED|NRTI Comparison||526
8558604|NCT00084136|21101797|P2|STARTED|NRTI Comparison||0
8558605|NCT00084136|21101798|P1|STARTED|NRTI Comparison||519
8558606|NCT00084136|21101796|P3|NOT COMPLETED|PI Comparison||0
8558607|NCT00084136|21101797|P2|NOT COMPLETED|PI Comparison||47
8558608|NCT00084136|21101798|P1|NOT COMPLETED|PI Comparison||55
8558609|NCT00084136|21101796|P3|COMPLETED|PI Comparison||0
8558610|NCT00084136|21101797|P2|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
8558611|NCT00084136|21101798|P1|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
8558612|NCT00084136|21101796|P3|STARTED|PI Comparison||0
8558613|NCT00084136|21101797|P2|STARTED|PI Comparison||526
8558614|NCT00084136|21101798|P1|STARTED|PI Comparison||519
8558621|NCT00083915|21101867|P2|NOT COMPLETED|Overall Study||37
8558622|NCT00083915|21101868|P1|NOT COMPLETED|Overall Study||50
8558623|NCT00083915|21101867|P2|COMPLETED|Overall Study||8
8558624|NCT00083915|21101868|P1|COMPLETED|Overall Study||2
8558625|NCT00083915|21101867|P2|STARTED|Overall Study||45
8558626|NCT00083915|21101868|P1|STARTED|Overall Study||52
8558627|NCT00083889|21101876|P2|NOT COMPLETED|Overall Study||375
8558628|NCT00083889|21101877|P1|NOT COMPLETED|Overall Study||375
8558629|NCT00083889|21101876|P2|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
8558630|NCT00083889|21101877|P1|COMPLETED|Overall Study||0
8558798|NCT00082017|21102222|P2|COMPLETED|Overall Study||9
8558631|NCT00083889|21101876|P2|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
8558632|NCT00083889|21101877|P1|Received Treatment|Overall Study||375
8558633|NCT00083889|21101876|P2|STARTED|Overall Study||375
8558634|NCT00083889|21101877|P1|STARTED|Overall Study||375
8558635|NCT00004146|21101926|P1|NOT COMPLETED|Overall Study||0
8558636|NCT00004146|21101926|P1|COMPLETED|Overall Study||55
8558637|NCT00004146|21101926|P1|STARTED|Overall Study||55
8558638|NCT00083759|21101935|P2|NOT COMPLETED|Overall Study||83
8558639|NCT00083759|21101936|P1|NOT COMPLETED|Overall Study||84
8558640|NCT00083759|21101935|P2|COMPLETED|Overall Study||66
8558641|NCT00083759|21101936|P1|COMPLETED|Overall Study||66
8558642|NCT00083759|21101935|P2|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
8558643|NCT00083759|21101936|P1|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
8558644|NCT00083720|21101944|P1|NOT COMPLETED|Overall Study||0
8558645|NCT00083720|21101944|P1|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
8558646|NCT00083720|21101944|P1|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
8558647|NCT00083616|21101954|P1|NOT COMPLETED|Overall Study||31
8558648|NCT00083616|21101954|P1|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
8558649|NCT00083616|21101954|P1|Received Study Medication|Overall Study||182
8558650|NCT00083616|21101954|P1|STARTED|Overall Study||185
8558651|NCT00083551|21101968|P2|NOT COMPLETED|Overall Study||0
8558652|NCT00083551|21101969|P1|NOT COMPLETED|Overall Study||0
8558653|NCT00083551|21101968|P2|COMPLETED|Overall Study||345
8558654|NCT00083551|21101969|P1|COMPLETED|Overall Study||323
8558655|NCT00083551|21101968|P2|STARTED|Overall Study||345
8558656|NCT00083551|21101969|P1|STARTED|Overall Study||323
8558657|NCT00083382|21101975|P1|NOT COMPLETED|Overall Study||0
8558658|NCT00083382|21101975|P1|COMPLETED|Overall Study||83
8558659|NCT00083382|21101975|P1|STARTED|Overall Study||83
8558660|NCT00082888|21101982|P3|NOT COMPLETED|Overall Study||0
8558661|NCT00082888|21101983|P2|NOT COMPLETED|Overall Study||0
8558662|NCT00082888|21101984|P1|NOT COMPLETED|Overall Study||1
8558663|NCT00082888|21101982|P3|COMPLETED|Overall Study||36
8558664|NCT00082888|21101983|P2|COMPLETED|Overall Study||15
8558665|NCT00082888|21101984|P1|COMPLETED|Overall Study||41
8558666|NCT00082888|21101982|P3|STARTED|Overall Study||36
8558667|NCT00082888|21101983|P2|STARTED|Overall Study||15
8558668|NCT00082888|21101984|P1|STARTED|Overall Study||42
8558669|NCT00082810|21102004|P1|NOT COMPLETED|Overall Study||31
8558670|NCT00082810|21102004|P1|COMPLETED|Overall Study||2
8558671|NCT00082810|21102004|P1|STARTED|Overall Study||33
8558672|NCT00082758|21102015|P3|NOT COMPLETED|Overall Study||0
8558673|NCT00082758|21102016|P2|NOT COMPLETED|Overall Study||17
8558674|NCT00082758|21102017|P1|NOT COMPLETED|Overall Study||15
8558675|NCT00082758|21102015|P3|COMPLETED|Overall Study||0
8558676|NCT00082758|21102016|P2|COMPLETED|Overall Study||7
8558677|NCT00082758|21102017|P1|COMPLETED|Overall Study||0
8558678|NCT00082758|21102015|P3|STARTED|Overall Study||0
8558679|NCT00082758|21102016|P2|STARTED|Overall Study||24
8558680|NCT00082758|21102017|P1|STARTED|Overall Study||15
8558681|NCT00082641|21102027|P2|NOT COMPLETED|Overall Study||0
8558682|NCT00082641|21102028|P1|NOT COMPLETED|Overall Study||0
8558683|NCT00082641|21102027|P2|COMPLETED|Overall Study||12
8558684|NCT00082641|21102028|P1|COMPLETED|Overall Study||11
8558685|NCT00082641|21102027|P2|STARTED|Overall Study||12
8558686|NCT00082641|21102028|P1|STARTED|Overall Study||11
8558687|NCT00083226|21102037|P1|NOT COMPLETED|Overall Study||42
8558688|NCT00083226|21102037|P1|COMPLETED|Overall Study||0
8558689|NCT00083226|21102037|P1|STARTED|Overall Study||42
8558690|NCT00083174|21102045|P3|NOT COMPLETED|Open-label Extension||0
8558691|NCT00083174|21102046|P2|NOT COMPLETED|Open-label Extension||0
8558692|NCT00083174|21102047|P1|NOT COMPLETED|Open-label Extension||0
8558693|NCT00083174|21102045|P3|COMPLETED|Open-label Extension||2831
8558694|NCT00083174|21102046|P2|COMPLETED|Open-label Extension||0
8558695|NCT00083174|21102047|P1|COMPLETED|Open-label Extension||0
8558696|NCT00083174|21102045|P3|STARTED|Open-label Extension||2831
8558697|NCT00083174|21102046|P2|STARTED|Open-label Extension||0
8558698|NCT00083174|21102047|P1|STARTED|Open-label Extension||0
8558699|NCT00083174|21102045|P3|NOT COMPLETED|Randomization Period||0
8558700|NCT00083174|21102046|P2|NOT COMPLETED|Randomization Period||0
8558701|NCT00083174|21102047|P1|NOT COMPLETED|Randomization Period||0
8558702|NCT00083174|21102045|P3|COMPLETED|Randomization Period||0
8558703|NCT00083174|21102046|P2|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
8558704|NCT00083174|21102047|P1|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
8558705|NCT00083174|21102045|P3|STARTED|Randomization Period||0
8558706|NCT00083174|21102046|P2|STARTED|Randomization Period||2275
8558707|NCT00083174|21102047|P1|STARTED|Randomization Period||2285
8558708|NCT00083122|21102069|P2|NOT COMPLETED|Overall Study||0
8558709|NCT00083122|21102070|P1|NOT COMPLETED|Overall Study||0
8558710|NCT00083122|21102069|P2|COMPLETED|Overall Study||5
8558711|NCT00083122|21102070|P1|COMPLETED|Overall Study||40
8558712|NCT00083122|21102069|P2|STARTED|Overall Study||5
8558713|NCT00083122|21102070|P1|STARTED|Overall Study||40
8558714|NCT00082628|21102081|P5|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
8558715|NCT00082628|21102082|P4|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
8558716|NCT00082628|21102083|P3|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
8558717|NCT00082628|21102084|P2|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
8558718|NCT00082628|21102085|P1|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
8558719|NCT00082628|21102081|P5|COMPLETED|Treatment Period II: Week 12 to Week 36||55
8558720|NCT00082628|21102082|P4|COMPLETED|Treatment Period II: Week 12 to Week 36||76
8558721|NCT00082628|21102083|P3|COMPLETED|Treatment Period II: Week 12 to Week 36||78
8558722|NCT00082628|21102084|P2|COMPLETED|Treatment Period II: Week 12 to Week 36||0
8558723|NCT00082628|21102085|P1|COMPLETED|Treatment Period II: Week 12 to Week 36||0
8558724|NCT00082628|21102081|P5|STARTED|Treatment Period II: Week 12 to Week 36||73
8558725|NCT00082628|21102082|P4|STARTED|Treatment Period II: Week 12 to Week 36||92
8558726|NCT00082628|21102083|P3|STARTED|Treatment Period II: Week 12 to Week 36||93
8558727|NCT00082628|21102084|P2|STARTED|Treatment Period II: Week 12 to Week 36||0
8558728|NCT00082628|21102085|P1|STARTED|Treatment Period II: Week 12 to Week 36||0
8558729|NCT00082628|21102081|P5|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8558730|NCT00082628|21102082|P4|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8558731|NCT00082628|21102083|P3|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8558732|NCT00082628|21102084|P2|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
8558733|NCT00082628|21102085|P1|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
8558734|NCT00082628|21102081|P5|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8558735|NCT00082628|21102082|P4|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8558736|NCT00082628|21102083|P3|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
8558737|NCT00082628|21102084|P2|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
8558738|NCT00082628|21102085|P1|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
8558739|NCT00082628|21102081|P5|STARTED|Treatment Period I (Week 1 to Week 12)||0
8558740|NCT00082628|21102082|P4|STARTED|Treatment Period I (Week 1 to Week 12)||0
8558741|NCT00082628|21102083|P3|STARTED|Treatment Period I (Week 1 to Week 12)||0
8558742|NCT00082628|21102084|P2|STARTED|Treatment Period I (Week 1 to Week 12)||245
8558743|NCT00082628|21102085|P1|STARTED|Treatment Period I (Week 1 to Week 12)||81
8558744|NCT00082433|21102105|P2|NOT COMPLETED|Overall Study||597
8558745|NCT00082433|21102106|P1|NOT COMPLETED|Overall Study||594
8558746|NCT00082433|21102105|P2|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
8558747|NCT00082433|21102106|P1|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
8558748|NCT00082433|21102105|P2|STARTED|Overall Study||612
8558749|NCT00082433|21102106|P1|STARTED|Overall Study||609
8558750|NCT00082381|21102126|P2|NOT COMPLETED|Overall Study||26
8558751|NCT00082381|21102127|P1|NOT COMPLETED|Overall Study||55
8558752|NCT00082381|21102126|P2|COMPLETED|Overall Study||242
8558753|NCT00082381|21102127|P1|COMPLETED|Overall Study||228
8558754|NCT00082381|21102126|P2|Received Treatment (Intent to Treat)|Overall Study||267
8558755|NCT00082381|21102127|P1|Received Treatment (Intent to Treat)|Overall Study||282
8558756|NCT00082381|21102126|P2|STARTED|Overall Study||268
8558757|NCT00082381|21102127|P1|STARTED|Overall Study||283
8558758|NCT00082407|21102147|P2|NOT COMPLETED|Overall Study||27
8558759|NCT00082407|21102148|P1|NOT COMPLETED|Overall Study||56
8558760|NCT00082407|21102147|P2|COMPLETED|Overall Study||223
8558761|NCT00082407|21102148|P1|COMPLETED|Overall Study||199
8558762|NCT00082407|21102147|P2|Received Treatment (Intent to Treat)|Overall Study||248
8558763|NCT00082407|21102148|P1|Received Treatment (Intent to Treat)|Overall Study||253
8558764|NCT00082407|21102147|P2|STARTED|Overall Study||250
8558765|NCT00082407|21102148|P1|STARTED|Overall Study||255
8558766|NCT00082368|21102166|P1|NOT COMPLETED|Overall Study||1
8558767|NCT00082368|21102166|P1|COMPLETED|Overall Study||11
8558768|NCT00082368|21102166|P1|STARTED|Overall Study||12
8558769|NCT00082355|21102171|P1|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
8558770|NCT00082355|21102171|P1|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
8558771|NCT00082355|21102171|P1|STARTED|5 Year Recurrent Thromboembolism Rate||28
8558772|NCT00082355|21102171|P1|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
8558773|NCT00082355|21102171|P1|COMPLETED|Initial Results of Thrombolytic Therapy||28
8558774|NCT00082355|21102171|P1|STARTED|Initial Results of Thrombolytic Therapy||30
8558775|NCT00082342|21102178|P2|NOT COMPLETED|Overall Study||0
8558776|NCT00082342|21102179|P1|NOT COMPLETED|Overall Study||0
8558777|NCT00082342|21102178|P2|COMPLETED|Overall Study||12
8558778|NCT00082342|21102179|P1|COMPLETED|Overall Study||13
8558779|NCT00082342|21102178|P2|STARTED|Overall Study||12
8558780|NCT00082342|21102179|P1|STARTED|Overall Study||13
8558784|NCT00082173|21102205|P2|NOT COMPLETED|Overall Study||11
8558785|NCT00082173|21102206|P1|NOT COMPLETED|Overall Study||10
8558786|NCT00082173|21102205|P2|COMPLETED|Overall Study||61
8558787|NCT00082173|21102206|P1|COMPLETED|Overall Study||64
8558788|NCT00082173|21102205|P2|STARTED|Overall Study||72
8558789|NCT00082173|21102206|P1|STARTED|Overall Study||74
8558790|NCT00003726|21102214|P1|NOT COMPLETED|Overall Study||1
8558791|NCT00003726|21102214|P1|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
8558792|NCT00003726|21102214|P1|STARTED|Overall Study||1
8558793|NCT00081939|21102218|P1|NOT COMPLETED|Overall Study||0
8558794|NCT00081939|21102218|P1|COMPLETED|Overall Study||303
8558795|NCT00081939|21102218|P1|STARTED|Overall Study||303
8558796|NCT00082017|21102222|P2|NOT COMPLETED|Overall Study||0
8558797|NCT00082017|21102223|P1|NOT COMPLETED|Overall Study||0
8558799|NCT00082017|21102223|P1|COMPLETED|Overall Study||11
8558800|NCT00082017|21102222|P2|STARTED|Overall Study||9
8558801|NCT00082017|21102223|P1|STARTED|Overall Study||11
8558802|NCT00081861|21102239|P1|NOT COMPLETED|Overall Study||0
8558803|NCT00081861|21102239|P1|COMPLETED|Overall Study||13
8558804|NCT00081861|21102239|P1|STARTED|Overall Study||13
8558805|NCT00003270|21102243|P1|NOT COMPLETED|Overall Study||0
8558806|NCT00003270|21102243|P1|COMPLETED|Overall Study||20
8558807|NCT00003270|21102243|P1|STARTED|Overall Study||20
8558808|NCT00081770|21102251|P3|NOT COMPLETED|Overall Study||456
8558809|NCT00081770|21102252|P2|NOT COMPLETED|Overall Study||546
8558810|NCT00081770|21102253|P1|NOT COMPLETED|Overall Study||502
8558811|NCT00081770|21102251|P3|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
8558812|NCT00081770|21102252|P2|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
8558813|NCT00081770|21102253|P1|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
8558814|NCT00081770|21102251|P3|STARTED|Overall Study||1035
8558815|NCT00081770|21102252|P2|STARTED|Overall Study||1016
8558816|NCT00081770|21102253|P1|STARTED|Overall Study||1019
8558817|NCT00081731|21102272|P2|NOT COMPLETED|Overall Study||8
8558818|NCT00081731|21102273|P1|NOT COMPLETED|Overall Study||8
8558819|NCT00081731|21102272|P2|COMPLETED|Overall Study||459
8558820|NCT00081731|21102273|P1|COMPLETED|Overall Study||472
8558821|NCT00081731|21102272|P2|STARTED|Overall Study||467
8558822|NCT00081731|21102273|P1|STARTED|Overall Study||480
8558823|NCT00081653|21102293|P2|NOT COMPLETED|Overall Study||37
8558824|NCT00081653|21102294|P1|NOT COMPLETED|Overall Study||47
8558825|NCT00081653|21102293|P2|COMPLETED|Overall Study|Completed 3 years of treatment|324
8558826|NCT00081653|21102294|P1|COMPLETED|Overall Study|Completed 3 years of treatment|311
8558827|NCT00081653|21102293|P2|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
8558828|NCT00081653|21102294|P1|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
8558829|NCT00081497|21102312|P2|NOT COMPLETED|Overall Study||2
8558830|NCT00081497|21102313|P1|NOT COMPLETED|Overall Study||3
8558831|NCT00081497|21102312|P2|COMPLETED|Overall Study||37
8558832|NCT00081497|21102313|P1|COMPLETED|Overall Study||25
8558833|NCT00081497|21102312|P2|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
8558834|NCT00081497|21102313|P1|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
8558856|NCT00081289|21102389|P2|NOT COMPLETED|Overall Study||21
8558857|NCT00081289|21102390|P1|NOT COMPLETED|Overall Study||21
8558858|NCT00081289|21102389|P2|COMPLETED|Overall Study||52
8558859|NCT00081289|21102390|P1|COMPLETED|Overall Study||52
8558860|NCT00081289|21102389|P2|Defecation Symptom Score at Two Years|Overall Study||15
8558861|NCT00081289|21102390|P1|Defecation Symptom Score at Two Years|Overall Study||13
8558862|NCT00081289|21102389|P2|DS Score at End of Post-op CT|Overall Study||14
8558863|NCT00081289|21102390|P1|DS Score at End of Post-op CT|Overall Study||12
8558864|NCT00081289|21102389|P2|Defecation Symptom Score at End of CR|Overall Study||32
8558865|NCT00081289|21102390|P1|Defecation Symptom Score at End of CR|Overall Study||32
8558866|NCT00081289|21102389|P2|GI Symptom Score at Two Years|Overall Study||20
8558867|NCT00081289|21102390|P1|GI Symptom Score at Two Years|Overall Study||21
8558868|NCT00081289|21102389|P2|GI Symptom Score at End of Post-op CT|Overall Study||27
8558869|NCT00081289|21102390|P1|GI Symptom Score at End of Post-op CT|Overall Study||22
8558870|NCT00081289|21102389|P2|GI Symptom Score at End of CR|Overall Study||33
8558871|NCT00081289|21102390|P1|GI Symptom Score at End of CR|Overall Study||34
8558872|NCT00081289|21102389|P2|GHS at Two Years|Overall Study||20
8558873|NCT00081289|21102390|P1|GHS at Two Years|Overall Study||21
8558874|NCT00081289|21102389|P2|GHS at End of Post-op CT|Overall Study||28
8558875|NCT00081289|21102390|P1|GHS at End of Post-op CT|Overall Study||20
8558876|NCT00081289|21102389|P2|Global Health Status Score at End of CR|Overall Study||32
8558877|NCT00081289|21102390|P1|Global Health Status Score at End of CR|Overall Study|European Organization for Research & Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ]|34
8558878|NCT00081289|21102389|P2|Surgery|Overall Study||51
8558879|NCT00081289|21102390|P1|Surgery|Overall Study||47
8558880|NCT00081289|21102389|P2|Full AE Population|Overall Study||68
8558881|NCT00081289|21102390|P1|Full AE Population|Overall Study||70
8558882|NCT00081289|21102389|P2|General Analysis Population|Overall Study||52
8558883|NCT00081289|21102390|P1|General Analysis Population|Overall Study||52
8558884|NCT00081289|21102389|P2|Primary Endpoint Population|Overall Study||48
8558885|NCT00081289|21102390|P1|Primary Endpoint Population|Overall Study||48
8558886|NCT00081289|21102389|P2|STARTED|Overall Study||73
8558887|NCT00081289|21102390|P1|STARTED|Overall Study||73
8558888|NCT00081263|21102434|P2|NOT COMPLETED|Overall Study||22
8558889|NCT00081263|21102435|P1|NOT COMPLETED|Overall Study||17
8558890|NCT00081263|21102434|P2|COMPLETED|Overall Study||41
8558891|NCT00081263|21102435|P1|COMPLETED|Overall Study||50
8558892|NCT00081263|21102434|P2|STARTED|Overall Study||63
8558893|NCT00081263|21102435|P1|STARTED|Overall Study||67
8558894|NCT00081159|21102445|P2|NOT COMPLETED|Overall Study||5
8558895|NCT00081159|21102446|P1|NOT COMPLETED|Overall Study||2
8558896|NCT00081159|21102445|P2|COMPLETED|Overall Study||35
8558897|NCT00081159|21102446|P1|COMPLETED|Overall Study||37
8558898|NCT00081159|21102445|P2|STARTED|Overall Study||40
8558899|NCT00081159|21102446|P1|STARTED|Overall Study||39
8558900|NCT00080938|21102456|P1|NOT COMPLETED|Overall Study||24
8558901|NCT00080938|21102456|P1|COMPLETED|Overall Study||2
8558902|NCT00080938|21102456|P1|Eligible and Treated|Overall Study||21
8558903|NCT00080938|21102456|P1|Began Protocol Therapy|Overall Study||25
8558904|NCT00080938|21102456|P1|STARTED|Overall Study||26
8558905|NCT00080912|21102465|P2|NOT COMPLETED|Overall Study||0
8558906|NCT00080912|21102466|P1|NOT COMPLETED|Overall Study||0
8558907|NCT00080912|21102465|P2|COMPLETED|Overall Study||425
8558908|NCT00080912|21102466|P1|COMPLETED|Overall Study||425
8558909|NCT00080912|21102465|P2|STARTED|Overall Study||425
8558910|NCT00080912|21102466|P1|STARTED|Overall Study||425
8558911|NCT00080899|21102472|P1|NOT COMPLETED|Overall Study||1
8558912|NCT00080899|21102472|P1|COMPLETED|Overall Study||22
8558913|NCT00080899|21102472|P1|STARTED|Overall Study||23
8558914|NCT00080535|21102477|P1|NOT COMPLETED|Overall Study||0
8558915|NCT00080535|21102477|P1|COMPLETED|Overall Study||10
8558916|NCT00080535|21102477|P1|STARTED|Overall Study||10
8558917|NCT00080483|21102484|P2|NOT COMPLETED|Overall Study||2
8558918|NCT00080483|21102485|P1|NOT COMPLETED|Overall Study||2
8558919|NCT00080483|21102484|P2|COMPLETED|Overall Study||16
8558920|NCT00080483|21102485|P1|COMPLETED|Overall Study||15
8558921|NCT00080483|21102484|P2|STARTED|Overall Study||18
8558922|NCT00080483|21102485|P1|STARTED|Overall Study||17
8558923|NCT00002525|21102493|P2|NOT COMPLETED|Overall Study||0
8558924|NCT00002525|21102494|P1|NOT COMPLETED|Overall Study||186
8558925|NCT00002525|21102493|P2|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
8558926|NCT00002525|21102494|P1|COMPLETED|Overall Study||241
8558927|NCT00002525|21102493|P2|Dukes' B2 Stage|Overall Study||139
8558928|NCT00002525|21102494|P1|Dukes' B2 Stage|Overall Study||150
8558929|NCT00002525|21102493|P2|Dukes' B3 or C Stage|Overall Study||158
8558930|NCT00002525|21102494|P1|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
8558931|NCT00002525|21102493|P2|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
8558932|NCT00002525|21102494|P1|Treated|Overall Study||419
8558933|NCT00002525|21102493|P2|STARTED|Overall Study||428
8558934|NCT00002525|21102494|P1|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
8558935|NCT00080470|21102510|P2|NOT COMPLETED|Overall Study||28
8558936|NCT00080470|21102511|P1|NOT COMPLETED|Overall Study||34
8558937|NCT00080470|21102510|P2|COMPLETED|Overall Study||14
8558938|NCT00080470|21102511|P1|COMPLETED|Overall Study||11
8558939|NCT00080470|21102510|P2|STARTED|Overall Study||42
8558940|NCT00080470|21102511|P1|STARTED|Overall Study||45
8558941|NCT00080301|21102521|P2|NOT COMPLETED|Overall Study||11
8558942|NCT00080301|21102522|P1|NOT COMPLETED|Overall Study||5
8558943|NCT00080301|21102521|P2|COMPLETED|Overall Study|Participants who are off treatment|366
8558944|NCT00080301|21102522|P1|COMPLETED|Overall Study|Participants who are off treatment|370
8558945|NCT00080301|21102521|P2|Still on Treatment|Overall Study||1
8558946|NCT00080301|21102522|P1|Still on Treatment|Overall Study||0
8558947|NCT00080301|21102521|P2|Never Treated|Overall Study||10
8558948|NCT00080301|21102522|P1|Never Treated|Overall Study||5
8558949|NCT00080301|21102521|P2|STARTED|Overall Study||377
8558950|NCT00080301|21102522|P1|STARTED|Overall Study||375
8558951|NCT00080288|21102542|P2|NOT COMPLETED|Overall Study||38
8558952|NCT00080288|21102543|P1|NOT COMPLETED|Overall Study||30
8558953|NCT00080288|21102542|P2|COMPLETED|Overall Study||89
8558954|NCT00080288|21102543|P1|COMPLETED|Overall Study||97
8558955|NCT00080288|21102542|P2|STARTED|Overall Study||127
8558956|NCT00080288|21102543|P1|STARTED|Overall Study||127
8558957|NCT00080223|21102551|P1|NOT COMPLETED|Overall Study||76
8558958|NCT00080223|21102551|P1|COMPLETED|Overall Study||7
8558959|NCT00080223|21102551|P1|STARTED|Overall Study||83
8558966|NCT00080119|21102592|P4|NOT COMPLETED|Overall Study||163
8558967|NCT00080119|21102593|P3|NOT COMPLETED|Overall Study||165
8558968|NCT00080119|21102594|P2|NOT COMPLETED|Overall Study||62
8558969|NCT00080119|21102595|P1|NOT COMPLETED|Overall Study||56
8558970|NCT00080119|21102592|P4|COMPLETED|Overall Study||111
8558971|NCT00080119|21102593|P3|COMPLETED|Overall Study||108
8558972|NCT00080119|21102594|P2|COMPLETED|Overall Study||339
8558973|NCT00080119|21102595|P1|COMPLETED|Overall Study||347
8558974|NCT00080119|21102592|P4|STARTED|Overall Study||274
8558975|NCT00080119|21102593|P3|STARTED|Overall Study||273
8558976|NCT00080119|21102594|P2|STARTED|Overall Study||401
8558977|NCT00080119|21102595|P1|STARTED|Overall Study||403
8558978|NCT00079937|21102629|P2|NOT COMPLETED|Overall Study||32
8558979|NCT00079937|21102630|P1|NOT COMPLETED|Overall Study||69
8558980|NCT00079937|21102629|P2|COMPLETED|Overall Study||175
8558981|NCT00079937|21102630|P1|COMPLETED|Overall Study||352
8558982|NCT00079937|21102629|P2|STARTED|Overall Study||207
8558983|NCT00079937|21102630|P1|STARTED|Overall Study||421
8558984|NCT00009737|21102648|P2|NOT COMPLETED|Overall Study||123
8558985|NCT00009737|21102649|P1|NOT COMPLETED|Overall Study||170
8558986|NCT00009737|21102648|P2|COMPLETED|Overall Study||860
8558987|NCT00009737|21102649|P1|COMPLETED|Overall Study||834
8558988|NCT00009737|21102648|P2|STARTED|Overall Study||983
8558989|NCT00009737|21102649|P1|STARTED|Overall Study||1004
8558990|NCT00079781|21102668|P3|NOT COMPLETED|Follow-up Period||2
8558991|NCT00079781|21102669|P2|NOT COMPLETED|Follow-up Period||0
8558992|NCT00079781|21102670|P1|NOT COMPLETED|Follow-up Period||4
8558993|NCT00079781|21102668|P3|COMPLETED|Follow-up Period||12
8558994|NCT00079781|21102669|P2|COMPLETED|Follow-up Period||9
8558995|NCT00079781|21102670|P1|COMPLETED|Follow-up Period||38
8558996|NCT00079781|21102668|P3|STARTED|Follow-up Period||14
8558997|NCT00079781|21102669|P2|STARTED|Follow-up Period||9
8558998|NCT00079781|21102670|P1|STARTED|Follow-up Period||42
8558999|NCT00079781|21102668|P3|NOT COMPLETED|Evaluation Period||0
8559000|NCT00079781|21102669|P2|NOT COMPLETED|Evaluation Period||0
8559001|NCT00079781|21102670|P1|NOT COMPLETED|Evaluation Period||0
8559002|NCT00079781|21102668|P3|COMPLETED|Evaluation Period||14
8559003|NCT00079781|21102669|P2|COMPLETED|Evaluation Period||9
8559004|NCT00079781|21102670|P1|COMPLETED|Evaluation Period||42
8559005|NCT00079781|21102668|P3|STARTED|Evaluation Period||14
8559006|NCT00079781|21102669|P2|STARTED|Evaluation Period||9
8559007|NCT00079781|21102670|P1|STARTED|Evaluation Period||42
8559008|NCT00079781|21102668|P3|NOT COMPLETED|Pre-implant Period||1
8559009|NCT00079781|21102669|P2|NOT COMPLETED|Pre-implant Period||1
8559010|NCT00079781|21102670|P1|NOT COMPLETED|Pre-implant Period||3
8559011|NCT00079781|21102668|P3|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
8559012|NCT00079781|21102669|P2|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
8559013|NCT00079781|21102670|P1|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
8559014|NCT00079781|21102668|P3|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
8559015|NCT00079781|21102669|P2|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
8559016|NCT00079781|21102670|P1|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
8559017|NCT00079677|21102679|P2|NOT COMPLETED|Overall Study||14
8559018|NCT00079677|21102680|P1|NOT COMPLETED|Overall Study||20
8559019|NCT00079677|21102679|P2|COMPLETED|Overall Study||118
8559020|NCT00079677|21102680|P1|COMPLETED|Overall Study||111
8559021|NCT00079677|21102679|P2|STARTED|Overall Study||132
8559022|NCT00079677|21102680|P1|STARTED|Overall Study||131
8559023|NCT00002601|21102688|P1|NOT COMPLETED|Overall Study||0
8559024|NCT00002601|21102688|P1|COMPLETED|Overall Study||13
8559025|NCT00002601|21102688|P1|STARTED|Overall Study||13
8559026|NCT00079417|21102696|P1|NOT COMPLETED|Overall Study||9
8559027|NCT00079417|21102696|P1|COMPLETED|Overall Study||19
8559028|NCT00079417|21102696|P1|STARTED|Overall Study||28
8559029|NCT00079391|21102704|P1|NOT COMPLETED|Overall Study||1
8559030|NCT00079391|21102704|P1|COMPLETED|Overall Study||49
8559031|NCT00079391|21102704|P1|STARTED|Overall Study|1 of these withdrew after consent.|50
8559032|NCT00079339|21102716|P3|NOT COMPLETED|Overall Study||6
8559033|NCT00079339|21102717|P2|NOT COMPLETED|Overall Study||39
8559034|NCT00079339|21102718|P1|NOT COMPLETED|Overall Study||5
8559035|NCT00079339|21102716|P3|COMPLETED|Overall Study||0
8559036|NCT00079339|21102717|P2|COMPLETED|Overall Study||1
8559037|NCT00079339|21102718|P1|COMPLETED|Overall Study||0
8559038|NCT00079339|21102716|P3|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
8559039|NCT00079339|21102717|P2|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
8559040|NCT00079339|21102718|P1|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
8559041|NCT00079339|21102716|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
8559042|NCT00079339|21102717|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
8559043|NCT00079339|21102718|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
8559044|NCT00079339|21102716|P3|Enrolled in Phase I|Overall Study||6
8559045|NCT00079339|21102717|P2|Enrolled in Phase I|Overall Study||6
8559046|NCT00079339|21102718|P1|Enrolled in Phase I|Overall Study||5
8559047|NCT00079339|21102716|P3|STARTED|Overall Study||6
8559048|NCT00079339|21102717|P2|STARTED|Overall Study||40
8559049|NCT00079339|21102718|P1|STARTED|Overall Study||5
8559050|NCT00079326|21102734|P2|NOT COMPLETED|Overall Study||0
8559051|NCT00079326|21102735|P1|NOT COMPLETED|Overall Study||0
8559052|NCT00079326|21102734|P2|COMPLETED|Overall Study||24
8559053|NCT00079326|21102735|P1|COMPLETED|Overall Study||15
8559054|NCT00079326|21102734|P2|STARTED|Overall Study||24
8559055|NCT00079326|21102735|P1|STARTED|Overall Study||15
8559056|NCT00079274|21102749|P7|NOT COMPLETED|Overall Study||0
8559057|NCT00079274|21102750|P6|NOT COMPLETED|Overall Study||20
8559058|NCT00079274|21102751|P5|NOT COMPLETED|Overall Study||15
8559059|NCT00079274|21102752|P4|NOT COMPLETED|Overall Study||444
8559060|NCT00079274|21102753|P3|NOT COMPLETED|Overall Study||27
8559061|NCT00079274|21102754|P2|NOT COMPLETED|Overall Study||27
8559062|NCT00079274|21102755|P1|NOT COMPLETED|Overall Study||321
8559063|NCT00079274|21102749|P7|COMPLETED|Overall Study||332
8559064|NCT00079274|21102750|P6|COMPLETED|Overall Study||26
8559065|NCT00079274|21102751|P5|COMPLETED|Overall Study||30
8559066|NCT00079274|21102752|P4|COMPLETED|Overall Study||906
8559067|NCT00079274|21102753|P3|COMPLETED|Overall Study||84
8559068|NCT00079274|21102754|P2|COMPLETED|Overall Study||84
8559069|NCT00079274|21102755|P1|COMPLETED|Overall Study||1081
8559070|NCT00079274|21102749|P7|STARTED|Overall Study||332
8559071|NCT00079274|21102750|P6|STARTED|Overall Study||46
8559072|NCT00079274|21102751|P5|STARTED|Overall Study||45
8559073|NCT00079274|21102752|P4|STARTED|Overall Study||1350
8559074|NCT00079274|21102753|P3|STARTED|Overall Study||111
8559075|NCT00079274|21102754|P2|STARTED|Overall Study||111
8559076|NCT00079274|21102755|P1|STARTED|Overall Study||1402
8559077|NCT00079183|21102776|P1|NOT COMPLETED|Overall Study||7
8559078|NCT00079183|21102776|P1|COMPLETED|Overall Study||37
8559079|NCT00079183|21102776|P1|Drop Outs|Overall Study||7
8559080|NCT00079183|21102776|P1|STARTED|Overall Study||44
8559081|NCT00079040|21102791|P1|NOT COMPLETED|Overall Study||2
8559082|NCT00079040|21102791|P1|COMPLETED|Overall Study||63
8559083|NCT00079040|21102791|P1|STARTED|Overall Study||65
8559084|NCT00079001|21102799|P2|NOT COMPLETED|Overall Study||0
8559085|NCT00079001|21102800|P1|NOT COMPLETED|Overall Study||0
8559086|NCT00079001|21102799|P2|COMPLETED|Overall Study||322
8559087|NCT00079001|21102800|P1|COMPLETED|Overall Study||323
8559088|NCT00079001|21102799|P2|STARTED|Overall Study||322
8559089|NCT00079001|21102800|P1|STARTED|Overall Study||323
8559090|NCT00078949|21102814|P4|NOT COMPLETED|Overall Study||3
8559091|NCT00078949|21102815|P3|NOT COMPLETED|Overall Study||3
8559092|NCT00078949|21102816|P2|NOT COMPLETED|Overall Study||5
8559093|NCT00078949|21102817|P1|NOT COMPLETED|Overall Study||4
8559094|NCT00078949|21102814|P4|COMPLETED|Overall Study||112
8559095|NCT00078949|21102815|P3|COMPLETED|Overall Study||112
8559096|NCT00078949|21102816|P2|COMPLETED|Overall Study||304
8559097|NCT00078949|21102817|P1|COMPLETED|Overall Study||306
8559098|NCT00078949|21102814|P4|STARTED|Overall Study||115
8559099|NCT00078949|21102815|P3|STARTED|Overall Study||115
8559100|NCT00078949|21102816|P2|STARTED|Overall Study||309
8559101|NCT00078949|21102817|P1|STARTED|Overall Study||310
8559102|NCT00078897|21102835|P2|NOT COMPLETED|Overall Study||123
8559103|NCT00078897|21102836|P1|NOT COMPLETED|Overall Study||124
8559104|NCT00078897|21102835|P2|COMPLETED|Overall Study||689
8559105|NCT00078897|21102836|P1|COMPLETED|Overall Study||685
8559106|NCT00078897|21102835|P2|STARTED|Overall Study||812
8559107|NCT00078897|21102836|P1|STARTED|Overall Study||809
8559108|NCT00078819|21102846|P4|NOT COMPLETED|Re-treatment Period||0
8559109|NCT00078819|21102847|P3|NOT COMPLETED|Re-treatment Period||0
8559110|NCT00078819|21102848|P2|NOT COMPLETED|Re-treatment Period||0
8559111|NCT00078819|21102849|P1|NOT COMPLETED|Re-treatment Period||0
8559112|NCT00078819|21102846|P4|COMPLETED|Re-treatment Period||13
8559113|NCT00078819|21102847|P3|COMPLETED|Re-treatment Period||29
8559114|NCT00078819|21102848|P2|COMPLETED|Re-treatment Period||0
8559115|NCT00078819|21102849|P1|COMPLETED|Re-treatment Period||0
8559116|NCT00078819|21102846|P4|Received Study Drug|Re-treatment Period||12
8559117|NCT00078819|21102847|P3|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30
8559118|NCT00078819|21102848|P2|Received Study Drug|Re-treatment Period||0
8559119|NCT00078819|21102849|P1|Received Study Drug|Re-treatment Period||0
8559120|NCT00078819|21102846|P4|STARTED|Re-treatment Period||13
8559121|NCT00078819|21102847|P3|STARTED|Re-treatment Period||29
8559122|NCT00078819|21102848|P2|STARTED|Re-treatment Period||0
8559123|NCT00078819|21102849|P1|STARTED|Re-treatment Period||0
8559124|NCT00078819|21102846|P4|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14
8559125|NCT00078819|21102847|P3|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29
8559126|NCT00078819|21102848|P2|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
8559127|NCT00078819|21102849|P1|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
8559128|NCT00078819|21102846|P4|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55
8559129|NCT00078819|21102847|P3|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40
8559130|NCT00078819|21102848|P2|COMPLETED|Withdrawal Period: Weeks 37-48||0
8559131|NCT00078819|21102849|P1|COMPLETED|Withdrawal Period: Weeks 37-48||0
8559132|NCT00078819|21102846|P4|Received Study Drug|Withdrawal Period: Weeks 37-48||68
8559133|NCT00078819|21102847|P3|Received Study Drug|Withdrawal Period: Weeks 37-48||69
8559134|NCT00078819|21102848|P2|Received Study Drug|Withdrawal Period: Weeks 37-48||0
8559135|NCT00078819|21102849|P1|Received Study Drug|Withdrawal Period: Weeks 37-48||0
8559136|NCT00078819|21102846|P4|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
8559137|NCT00078819|21102847|P3|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
8559138|NCT00078819|21102848|P2|STARTED|Withdrawal Period: Weeks 37-48||0
8559139|NCT00078819|21102849|P1|STARTED|Withdrawal Period: Weeks 37-48||0
8559140|NCT00078819|21102846|P4|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
8559141|NCT00078819|21102847|P3|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
8559142|NCT00078819|21102848|P2|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30
8559143|NCT00078819|21102849|P1|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40
8559144|NCT00078819|21102846|P4|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
8559145|NCT00078819|21102847|P3|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
8559146|NCT00078819|21102848|P2|COMPLETED|Open-label Treatment Period: Weeks 13-36||75
8559147|NCT00078819|21102849|P1|COMPLETED|Open-label Treatment Period: Weeks 13-36||63
8559148|NCT00078819|21102846|P4|STARTED|Open-label Treatment Period: Weeks 13-36||0
8559149|NCT00078819|21102847|P3|STARTED|Open-label Treatment Period: Weeks 13-36||0
8559150|NCT00078819|21102848|P2|STARTED|Open-label Treatment Period: Weeks 13-36||105
8559151|NCT00078819|21102849|P1|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103
8559152|NCT00078819|21102846|P4|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
8559153|NCT00078819|21102847|P3|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
8559154|NCT00078819|21102848|P2|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
8559155|NCT00078819|21102849|P1|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
8559156|NCT00078819|21102846|P4|COMPLETED|Double-blind Treatment Period: Week 1-12||0
8559157|NCT00078819|21102847|P3|COMPLETED|Double-blind Treatment Period: Week 1-12||0
8559158|NCT00078819|21102848|P2|COMPLETED|Double-blind Treatment Period: Week 1-12||105
8559159|NCT00078819|21102849|P1|COMPLETED|Double-blind Treatment Period: Week 1-12||104
8559160|NCT00078819|21102846|P4|Entered Escape|Double-blind Treatment Period: Week 1-12||0
8559161|NCT00078819|21102847|P3|Entered Escape|Double-blind Treatment Period: Week 1-12||0
8559162|NCT00078819|21102848|P2|Entered Escape|Double-blind Treatment Period: Week 1-12||5
8559163|NCT00078819|21102849|P1|Entered Escape|Double-blind Treatment Period: Week 1-12||27
8559164|NCT00078819|21102846|P4|STARTED|Double-blind Treatment Period: Week 1-12||0
8559165|NCT00078819|21102847|P3|STARTED|Double-blind Treatment Period: Week 1-12||0
8559166|NCT00078819|21102848|P2|STARTED|Double-blind Treatment Period: Week 1-12||106
8559167|NCT00078819|21102849|P1|STARTED|Double-blind Treatment Period: Week 1-12||105
8559168|NCT00078806|21102874|P4|NOT COMPLETED|Part 3||0
8559169|NCT00078806|21102875|P3|NOT COMPLETED|Part 3||0
8559170|NCT00078806|21102876|P2|NOT COMPLETED|Part 3||0
8559171|NCT00078806|21102877|P1|NOT COMPLETED|Part 3||0
8559172|NCT00078806|21102874|P4|COMPLETED|Part 3||9
8559173|NCT00078806|21102875|P3|COMPLETED|Part 3||0
8559174|NCT00078806|21102876|P2|COMPLETED|Part 3||0
8559175|NCT00078806|21102877|P1|COMPLETED|Part 3||0
8559176|NCT00078806|21102874|P4|STARTED|Part 3||9
8559177|NCT00078806|21102875|P3|STARTED|Part 3||0
8559178|NCT00078806|21102876|P2|STARTED|Part 3||0
8559179|NCT00078806|21102877|P1|STARTED|Part 3||0
8559180|NCT00078806|21102874|P4|NOT COMPLETED|Part 2||0
8559181|NCT00078806|21102875|P3|NOT COMPLETED|Part 2||0
8559182|NCT00078806|21102876|P2|NOT COMPLETED|Part 2||1
8559183|NCT00078806|21102877|P1|NOT COMPLETED|Part 2||0
8559184|NCT00078806|21102874|P4|COMPLETED|Part 2||0
8559185|NCT00078806|21102875|P3|COMPLETED|Part 2||4
8559186|NCT00078806|21102876|P2|COMPLETED|Part 2||5
8559187|NCT00078806|21102877|P1|COMPLETED|Part 2||0
8559188|NCT00078806|21102874|P4|Received Study Drug|Part 2||0
8559189|NCT00078806|21102875|P3|Received Study Drug|Part 2||4
8559190|NCT00078806|21102876|P2|Received Study Drug|Part 2||5
8559191|NCT00078806|21102877|P1|Received Study Drug|Part 2||0
8559192|NCT00078806|21102874|P4|STARTED|Part 2||0
8559193|NCT00078806|21102875|P3|STARTED|Part 2||4
8559194|NCT00078806|21102876|P2|STARTED|Part 2||6
8559195|NCT00078806|21102877|P1|STARTED|Part 2||0
8559196|NCT00078806|21102874|P4|NOT COMPLETED|Part 1B||0
8559197|NCT00078806|21102875|P3|NOT COMPLETED|Part 1B||0
8559198|NCT00078806|21102876|P2|NOT COMPLETED|Part 1B||0
8559199|NCT00078806|21102877|P1|NOT COMPLETED|Part 1B||8
8559200|NCT00078806|21102874|P4|COMPLETED|Part 1B||0
8559201|NCT00078806|21102875|P3|COMPLETED|Part 1B||0
8559202|NCT00078806|21102876|P2|COMPLETED|Part 1B||0
8559203|NCT00078806|21102877|P1|COMPLETED|Part 1B||2
8559204|NCT00078806|21102874|P4|STARTED|Part 1B||0
8559205|NCT00078806|21102875|P3|STARTED|Part 1B||0
8559206|NCT00078806|21102876|P2|STARTED|Part 1B||0
8559207|NCT00078806|21102877|P1|STARTED|Part 1B||10
8559208|NCT00078806|21102874|P4|NOT COMPLETED|Part 1A||0
8559209|NCT00078806|21102875|P3|NOT COMPLETED|Part 1A||0
8559210|NCT00078806|21102876|P2|NOT COMPLETED|Part 1A||0
8559211|NCT00078806|21102877|P1|NOT COMPLETED|Part 1A||10
8559212|NCT00078806|21102874|P4|COMPLETED|Part 1A||0
8559213|NCT00078806|21102875|P3|COMPLETED|Part 1A||0
8559214|NCT00078806|21102876|P2|COMPLETED|Part 1A||0
8559215|NCT00078806|21102877|P1|COMPLETED|Part 1A||9
8559216|NCT00078806|21102874|P4|STARTED|Part 1A||0
8559217|NCT00078806|21102875|P3|STARTED|Part 1A||0
8559218|NCT00078806|21102876|P2|STARTED|Part 1A||0
8559219|NCT00078806|21102877|P1|STARTED|Part 1A||19
8559220|NCT00078767|21102913|P2|NOT COMPLETED|Overall Study||1
8559221|NCT00078767|21102914|P1|NOT COMPLETED|Overall Study||1
8559222|NCT00078767|21102913|P2|COMPLETED|Overall Study||11
8559223|NCT00078767|21102914|P1|COMPLETED|Overall Study||11
8559224|NCT00078767|21102913|P2|STARTED|Overall Study||12
8559225|NCT00078767|21102914|P1|STARTED|Overall Study||12
8559235|NCT00078728|21102943|P2|NOT COMPLETED|Overall Study||3
8559236|NCT00078728|21102944|P1|NOT COMPLETED|Overall Study||4
8559237|NCT00078728|21102943|P2|COMPLETED|Overall Study||17
8559238|NCT00078728|21102944|P1|COMPLETED|Overall Study||16
8559239|NCT00078728|21102943|P2|STARTED|Overall Study||20
8559240|NCT00078728|21102944|P1|STARTED|Overall Study||20
8559241|NCT00078715|21102952|P2|NOT COMPLETED|Second Intervention||0
8559242|NCT00078715|21102953|P1|NOT COMPLETED|Second Intervention||0
8559243|NCT00078715|21102952|P2|COMPLETED|Second Intervention||4
8559244|NCT00078715|21102953|P1|COMPLETED|Second Intervention||2
8559245|NCT00078715|21102952|P2|STARTED|Second Intervention||4
8559246|NCT00078715|21102953|P1|STARTED|Second Intervention||2
8559247|NCT00078715|21102952|P2|NOT COMPLETED|First Intervention||0
8559248|NCT00078715|21102953|P1|NOT COMPLETED|First Intervention||0
8559249|NCT00078715|21102952|P2|COMPLETED|First Intervention||4
8559250|NCT00078715|21102953|P1|COMPLETED|First Intervention||2
8559251|NCT00078715|21102952|P2|STARTED|First Intervention||4
8559252|NCT00078715|21102953|P1|STARTED|First Intervention||2
8559253|NCT00005947|21102961|P2|NOT COMPLETED|Overall Study||41
8559254|NCT00005947|21102962|P1|NOT COMPLETED|Overall Study||57
8559255|NCT00005947|21102961|P2|COMPLETED|Overall Study||4
8559256|NCT00005947|21102962|P1|COMPLETED|Overall Study||25
8559257|NCT00005947|21102961|P2|STARTED|Overall Study||45
8559258|NCT00005947|21102962|P1|STARTED|Overall Study||82
8559259|NCT00078559|21102970|P1|NOT COMPLETED|Overall Study||0
8559260|NCT00078559|21102970|P1|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
8559261|NCT00078559|21102970|P1|STARTED|Overall Study||10
8559262|NCT00002597|21102998|P2|NOT COMPLETED|Overall Study||23
8559263|NCT00002597|21102999|P1|NOT COMPLETED|Overall Study||26
8559264|NCT00002597|21102998|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
8559265|NCT00002597|21102999|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
8559266|NCT00002597|21102998|P2|STARTED|Overall Study||1015
8559267|NCT00002597|21102999|P1|STARTED|Overall Study||1013
8559268|NCT00078377|21103024|P3|NOT COMPLETED|Overall Study||9
8559269|NCT00078377|21103025|P2|NOT COMPLETED|Overall Study||16
8559270|NCT00078377|21103026|P1|NOT COMPLETED|Overall Study||11
8559271|NCT00078377|21103024|P3|COMPLETED|Overall Study||55
8559272|NCT00078377|21103025|P2|COMPLETED|Overall Study||49
8559273|NCT00078377|21103026|P1|COMPLETED|Overall Study||56
8559274|NCT00078377|21103024|P3|STARTED|Overall Study||64
8559275|NCT00078377|21103025|P2|STARTED|Overall Study||65
8559276|NCT00078377|21103026|P1|STARTED|Overall Study||67
8559277|NCT00078338|21103041|P2|NOT COMPLETED|Overall Study||54
8559278|NCT00078338|21103042|P1|NOT COMPLETED|Overall Study||85
8559279|NCT00078338|21103041|P2|COMPLETED|Overall Study||324
8559280|NCT00078338|21103042|P1|COMPLETED|Overall Study||301
8559281|NCT00078338|21103041|P2|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
8559282|NCT00078338|21103042|P1|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
8559283|NCT00078338|21103041|P2|STARTED|Overall Study||378
8559284|NCT00078338|21103042|P1|STARTED|Overall Study||386
8559285|NCT00076687|21103051|P3|NOT COMPLETED|Overall Study||4
8559286|NCT00076687|21103052|P2|NOT COMPLETED|Overall Study||5
8559287|NCT00076687|21103053|P1|NOT COMPLETED|Overall Study||6
8559288|NCT00076687|21103051|P3|COMPLETED|Overall Study||51
8559289|NCT00076687|21103052|P2|COMPLETED|Overall Study||47
8559290|NCT00076687|21103053|P1|COMPLETED|Overall Study||42
8559291|NCT00076687|21103051|P3|STARTED|Overall Study||55
8559292|NCT00076687|21103052|P2|STARTED|Overall Study||52
8559293|NCT00076687|21103053|P1|STARTED|Overall Study||48
8559294|NCT00078403|21103073|P3|NOT COMPLETED|Overall Study||28
8559295|NCT00078403|21103074|P2|NOT COMPLETED|Overall Study||16
8559296|NCT00078403|21103075|P1|NOT COMPLETED|Overall Study||18
8559297|NCT00078403|21103073|P3|COMPLETED|Overall Study||141
8559298|NCT00078403|21103074|P2|COMPLETED|Overall Study||26
8559299|NCT00078403|21103075|P1|COMPLETED|Overall Study||26
8559300|NCT00078403|21103073|P3|STARTED|Overall Study||169
8559301|NCT00078403|21103074|P2|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
8559302|NCT00078403|21103075|P1|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
8559303|NCT00078325|21103135|P3|NOT COMPLETED|Overall Study||11
8559304|NCT00078325|21103136|P2|NOT COMPLETED|Overall Study||19
8559305|NCT00078325|21103137|P1|NOT COMPLETED|Overall Study||21
8559306|NCT00078325|21103135|P3|COMPLETED|Overall Study||120
8559307|NCT00078325|21103136|P2|COMPLETED|Overall Study||114
8559308|NCT00078325|21103137|P1|COMPLETED|Overall Study||110
8559309|NCT00078325|21103135|P3|STARTED|Overall Study||131
8559310|NCT00078325|21103136|P2|STARTED|Overall Study||133
8559311|NCT00078325|21103137|P1|STARTED|Overall Study||131
8559312|NCT00078312|21103148|P1|NOT COMPLETED|Overall Study||177
8559313|NCT00078312|21103148|P1|COMPLETED|Overall Study||151
8559314|NCT00078312|21103148|P1|STARTED|Overall Study||328
8559315|NCT00078286|21103154|P2|NOT COMPLETED|Overall Study||83
8559316|NCT00078286|21103155|P1|NOT COMPLETED|Overall Study||96
8559317|NCT00078286|21103154|P2|COMPLETED|Overall Study||152
8559318|NCT00078286|21103155|P1|COMPLETED|Overall Study||138
8559319|NCT00078286|21103154|P2|STARTED|Overall Study||235
8559320|NCT00078286|21103155|P1|STARTED|Overall Study||234
8559321|NCT00077974|21103163|P1|NOT COMPLETED|Overall Study||104
8559322|NCT00077974|21103163|P1|COMPLETED|Overall Study||2
8559323|NCT00077974|21103163|P1|STARTED|Overall Study||106
8559324|NCT00077857|21103180|P2|NOT COMPLETED|Overall Study||204
8559325|NCT00077857|21103181|P1|NOT COMPLETED|Overall Study||201
8559326|NCT00077857|21103180|P2|COMPLETED|Overall Study||31
8559327|NCT00077857|21103181|P1|COMPLETED|Overall Study||34
8559328|NCT00077857|21103180|P2|Safety Population: Actual Dose Received|Overall Study||248
8559329|NCT00077857|21103181|P1|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
8559330|NCT00077857|21103180|P2|Received Study Drug|Overall Study||234
8559331|NCT00077857|21103181|P1|Received Study Drug|Overall Study||231
8559332|NCT00077857|21103180|P2|STARTED|Overall Study||235
8559333|NCT00077857|21103181|P1|STARTED|Overall Study||235
8559334|NCT00077766|21103201|P2|NOT COMPLETED|Overall Study||25
8559335|NCT00077766|21103202|P1|NOT COMPLETED|Overall Study||39
8559336|NCT00077766|21103201|P2|COMPLETED|Overall Study||131
8559337|NCT00077766|21103202|P1|COMPLETED|Overall Study||118
8559338|NCT00077766|21103201|P2|STARTED|Overall Study||156
8559339|NCT00077766|21103202|P1|STARTED|Overall Study||157
8559340|NCT00077922|21103220|P1|NOT COMPLETED|Overall Study||0
8559341|NCT00077922|21103220|P1|COMPLETED|Overall Study||15
8559342|NCT00077922|21103220|P1|STARTED|Overall Study||15
8559343|NCT00077675|21103227|P2|NOT COMPLETED|Overall Study||9
8559344|NCT00077675|21103228|P1|NOT COMPLETED|Overall Study||11
8559345|NCT00077675|21103227|P2|COMPLETED|Overall Study||89
8559346|NCT00077675|21103228|P1|COMPLETED|Overall Study||92
8559347|NCT00077675|21103227|P2|STARTED|Overall Study||98
8559348|NCT00077675|21103228|P1|STARTED|Overall Study||103
8559349|NCT00077649|21103238|P4|NOT COMPLETED|Overall Study||17
8559350|NCT00077649|21103239|P3|NOT COMPLETED|Overall Study||15
8559351|NCT00077649|21103240|P2|NOT COMPLETED|Overall Study||9
8559352|NCT00077649|21103241|P1|NOT COMPLETED|Overall Study||14
8559353|NCT00077649|21103238|P4|COMPLETED|Overall Study||30
8559354|NCT00077649|21103239|P3|COMPLETED|Overall Study||32
8559355|NCT00077649|21103240|P2|COMPLETED|Overall Study||38
8559356|NCT00077649|21103241|P1|COMPLETED|Overall Study||33
8559357|NCT00077649|21103238|P4|Completed 24 Weeks of Follow-up|Overall Study||31
8559358|NCT00077649|21103239|P3|Completed 24 Weeks of Follow-up|Overall Study||36
8559359|NCT00077649|21103240|P2|Completed 24 Weeks of Follow-up|Overall Study||40
8559360|NCT00077649|21103241|P1|Completed 24 Weeks of Follow-up|Overall Study||36
8559361|NCT00077649|21103238|P4|STARTED|Overall Study||47
8559362|NCT00077649|21103239|P3|STARTED|Overall Study||47
8559363|NCT00077649|21103240|P2|STARTED|Overall Study||47
8559364|NCT00077649|21103241|P1|STARTED|Overall Study||47
8559365|NCT00077636|21103289|P2|NOT COMPLETED|Overall Study||92
8559366|NCT00077636|21103290|P1|NOT COMPLETED|Overall Study||44
8559367|NCT00077636|21103289|P2|COMPLETED|Overall Study||641
8559368|NCT00077636|21103290|P1|COMPLETED|Overall Study||692
8559369|NCT00077636|21103289|P2|STARTED|Overall Study||733
8559370|NCT00077636|21103290|P1|STARTED|Overall Study||736
8559371|NCT00077623|21103311|P3|NOT COMPLETED|Overall Study||32
8559372|NCT00077623|21103312|P2|NOT COMPLETED|Overall Study||43
8559373|NCT00077623|21103313|P1|NOT COMPLETED|Overall Study||36
8559374|NCT00077623|21103311|P3|COMPLETED|Overall Study||159
8559375|NCT00077623|21103312|P2|COMPLETED|Overall Study||148
8559376|NCT00077623|21103313|P1|COMPLETED|Overall Study||154
8559377|NCT00077623|21103311|P3|STARTED|Overall Study||191
8559378|NCT00077623|21103312|P2|STARTED|Overall Study||191
8559379|NCT00077623|21103313|P1|STARTED|Overall Study||190
8559380|NCT00077610|21103348|P3|NOT COMPLETED|Overall Study||46
8559381|NCT00077610|21103349|P2|NOT COMPLETED|Overall Study||56
8559382|NCT00077610|21103350|P1|NOT COMPLETED|Overall Study||54
8559383|NCT00077610|21103348|P3|COMPLETED|Overall Study||180
8559384|NCT00077610|21103349|P2|COMPLETED|Overall Study||168
8559385|NCT00077610|21103350|P1|COMPLETED|Overall Study||169
8559386|NCT00077610|21103348|P3|Started Treatment|Overall Study||225
8559387|NCT00077610|21103349|P2|Started Treatment|Overall Study||220
8559388|NCT00077610|21103350|P1|Started Treatment|Overall Study||221
8559389|NCT00077610|21103348|P3|STARTED|Overall Study||226
8559390|NCT00077610|21103349|P2|STARTED|Overall Study||224
8559391|NCT00077610|21103350|P1|STARTED|Overall Study||223
8559392|NCT00077376|21103379|P1|NOT COMPLETED|Overall Study||22
8559393|NCT00077376|21103379|P1|COMPLETED|Overall Study||39
8559394|NCT00077376|21103379|P1|HER2+ in Central Testing|Overall Study||39
8559395|NCT00077376|21103379|P1|Treated|Overall Study||59
8559396|NCT00077376|21103379|P1|STARTED|Overall Study||61
8559397|NCT00077207|21103390|P1|NOT COMPLETED|Overall Study||30
8559398|NCT00077207|21103390|P1|COMPLETED|Overall Study||36
8559399|NCT00077207|21103390|P1|STARTED|Overall Study||66
8559400|NCT00077064|21103402|P2|NOT COMPLETED|Overall Study||6
8559401|NCT00077064|21103403|P1|NOT COMPLETED|Overall Study||0
8559402|NCT00077064|21103402|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
8559403|NCT00077064|21103403|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
8559404|NCT00077064|21103402|P2|STARTED|Overall Study||16
8559405|NCT00077064|21103403|P1|STARTED|Overall Study||17
8559406|NCT00076999|21103419|P5|NOT COMPLETED|Overall Study||25
8559407|NCT00076999|21103420|P4|NOT COMPLETED|Overall Study||1
8559408|NCT00076999|21103421|P3|NOT COMPLETED|Overall Study||17
8559409|NCT00076999|21103422|P2|NOT COMPLETED|Overall Study||24
8559410|NCT00076999|21103423|P1|NOT COMPLETED|Overall Study||12
8559411|NCT00076999|21103419|P5|COMPLETED|Overall Study||9
8559412|NCT00076999|21103420|P4|COMPLETED|Overall Study||5
8559413|NCT00076999|21103421|P3|COMPLETED|Overall Study||2
8559414|NCT00076999|21103422|P2|COMPLETED|Overall Study||7
8559415|NCT00076999|21103423|P1|COMPLETED|Overall Study||13
8559416|NCT00076999|21103419|P5|STARTED|Overall Study||34
8559417|NCT00076999|21103420|P4|STARTED|Overall Study||6
8559418|NCT00076999|21103421|P3|STARTED|Overall Study||19
8559419|NCT00076999|21103422|P2|STARTED|Overall Study||31
8559420|NCT00076999|21103423|P1|STARTED|Overall Study||25
8559421|NCT00003222|21103542|P2|NOT COMPLETED|Overall Study||1
8559422|NCT00003222|21103543|P1|NOT COMPLETED|Overall Study||0
8559423|NCT00003222|21103542|P2|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
8559424|NCT00003222|21103543|P1|COMPLETED|Overall Study||13
8559425|NCT00003222|21103542|P2|STARTED|Overall Study||28
8559426|NCT00003222|21103543|P1|STARTED|Overall Study||13
8559427|NCT00076804|21103555|P2|NOT COMPLETED|Overall Study||69
8559428|NCT00076804|21103556|P1|NOT COMPLETED|Overall Study||60
8559429|NCT00076804|21103555|P2|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
8559430|NCT00076804|21103556|P1|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
8559431|NCT00076804|21103555|P2|STARTED|Overall Study||137
8559432|NCT00076804|21103556|P1|STARTED|Overall Study||137
8559433|NCT00076752|21103568|P1|NOT COMPLETED|Overall Study||3
8559434|NCT00076752|21103568|P1|COMPLETED|Overall Study||6
8559435|NCT00076752|21103568|P1|STARTED|Overall Study||9
8559436|NCT00076622|21103591|P4|NOT COMPLETED|Overall Study||0
8559437|NCT00076622|21103592|P3|NOT COMPLETED|Overall Study||0
8559438|NCT00076622|21103593|P2|NOT COMPLETED|Overall Study||0
8559439|NCT00076622|21103594|P1|NOT COMPLETED|Overall Study||0
8559440|NCT00076622|21103591|P4|COMPLETED|Overall Study||18
8559441|NCT00076622|21103592|P3|COMPLETED|Overall Study||40
8559442|NCT00076622|21103593|P2|COMPLETED|Overall Study||13
8559443|NCT00076622|21103594|P1|COMPLETED|Overall Study||23
8559444|NCT00076622|21103591|P4|STARTED|Overall Study||18
8559445|NCT00076622|21103592|P3|STARTED|Overall Study||40
8559446|NCT00076622|21103593|P2|STARTED|Overall Study||13
8559447|NCT00076622|21103594|P1|STARTED|Overall Study||23
8559448|NCT00076570|21103614|P2|NOT COMPLETED|Overall Study||8
8559449|NCT00076570|21103615|P1|NOT COMPLETED|Overall Study||8
8559450|NCT00076570|21103614|P2|COMPLETED|Overall Study||8
8559451|NCT00076570|21103615|P1|COMPLETED|Overall Study||7
8559452|NCT00076570|21103614|P2|STARTED|Overall Study||16
8559453|NCT00076570|21103615|P1|STARTED|Overall Study||15
8559454|NCT00003298|21103623|P1|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
8559455|NCT00003298|21103623|P1|COMPLETED|Step 2 (Adjuvant Therapy)||4
8559456|NCT00003298|21103623|P1|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
8559457|NCT00003298|21103623|P1|STARTED|Step 2 (Adjuvant Therapy)||10
8559458|NCT00003298|21103623|P1|NOT COMPLETED|Re-register to Step 2 After Surgery||18
8559459|NCT00003298|21103623|P1|COMPLETED|Re-register to Step 2 After Surgery||10
8559460|NCT00003298|21103623|P1|STARTED|Re-register to Step 2 After Surgery||28
8559461|NCT00003298|21103623|P1|NOT COMPLETED|Surgery||7
8559462|NCT00003298|21103623|P1|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
8559463|NCT00003298|21103623|P1|STARTED|Surgery||35
8559464|NCT00003298|21103623|P1|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
8559465|NCT00003298|21103623|P1|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
8559466|NCT00003298|21103623|P1|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
8559467|NCT00003298|21103623|P1|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
8559468|NCT00003298|21103623|P1|STARTED|Step 1 (Neoadjuvant Therapy)||39
8559469|NCT00076336|21103633|P2|NOT COMPLETED|Overall Study||56
8559470|NCT00076336|21103634|P1|NOT COMPLETED|Overall Study||52
8559471|NCT00076336|21103633|P2|COMPLETED|Overall Study||60
8559472|NCT00076336|21103634|P1|COMPLETED|Overall Study||64
8559473|NCT00076336|21103633|P2|Completed Week 104|Overall Study||62
8559474|NCT00076336|21103634|P1|Completed Week 104|Overall Study||70
8559475|NCT00076336|21103633|P2|Completed Week 52|Overall Study||94
8559476|NCT00076336|21103634|P1|Completed Week 52|Overall Study||97
8559477|NCT00076336|21103633|P2|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
8559478|NCT00076336|21103634|P1|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
8559479|NCT00076336|21103633|P2|Safety Population|Overall Study||116
8559480|NCT00076336|21103634|P1|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
8559481|NCT00076336|21103633|P2|STARTED|Overall Study||116
8559482|NCT00076336|21103634|P1|STARTED|Overall Study||116
8559483|NCT00076258|21103650|P2|NOT COMPLETED|Overall Study||3
8559484|NCT00076258|21103651|P1|NOT COMPLETED|Overall Study||1
8559485|NCT00076258|21103650|P2|COMPLETED|Overall Study||61
8559486|NCT00076258|21103651|P1|COMPLETED|Overall Study||61
8559487|NCT00076258|21103650|P2|STARTED|Overall Study||64
8559488|NCT00076258|21103651|P1|STARTED|Overall Study||62
8559489|NCT00076245|21103661|P4|NOT COMPLETED|Overall Study||1
8559490|NCT00076245|21103662|P3|NOT COMPLETED|Overall Study||0
8559491|NCT00076245|21103663|P2|NOT COMPLETED|Overall Study||0
8559492|NCT00076245|21103664|P1|NOT COMPLETED|Overall Study||0
8559493|NCT00076245|21103661|P4|COMPLETED|Overall Study||14
8559494|NCT00076245|21103662|P3|COMPLETED|Overall Study||15
8559495|NCT00076245|21103663|P2|COMPLETED|Overall Study||15
8559496|NCT00076245|21103664|P1|COMPLETED|Overall Study||16
8559497|NCT00076245|21103661|P4|STARTED|Overall Study||15
8559498|NCT00076245|21103662|P3|STARTED|Overall Study||15
8559499|NCT00076245|21103663|P2|STARTED|Overall Study||15
8559500|NCT00076245|21103664|P1|STARTED|Overall Study||16
8559501|NCT00076219|21103680|P2|NOT COMPLETED|Overall Study||11
8559502|NCT00076219|21103681|P1|NOT COMPLETED|Overall Study||18
8559503|NCT00076219|21103680|P2|COMPLETED|Overall Study||550
8559504|NCT00076219|21103681|P1|COMPLETED|Overall Study||545
8559505|NCT00076219|21103680|P2|STARTED|Overall Study||561
8559506|NCT00076219|21103681|P1|STARTED|Overall Study||563
8559507|NCT00076102|21103687|P1|NOT COMPLETED|Overall Study||5
8559508|NCT00076102|21103687|P1|COMPLETED|Overall Study||31
8559509|NCT00076102|21103687|P1|STARTED|Overall Study||36
8559510|NCT00076050|21103701|P2|NOT COMPLETED|Overall Study||43
8559511|NCT00076050|21103702|P1|NOT COMPLETED|Overall Study||23
8559512|NCT00076050|21103701|P2|COMPLETED|Overall Study||83
8559513|NCT00076050|21103702|P1|COMPLETED|Overall Study||99
8559514|NCT00076050|21103701|P2|STARTED|Overall Study||126
8559515|NCT00076050|21103702|P1|STARTED|Overall Study||122
8559516|NCT00076024|21103715|P4|NOT COMPLETED|Phase 2, Open-label||16
8559517|NCT00076024|21103716|P3|NOT COMPLETED|Phase 2, Open-label||0
8559518|NCT00076024|21103717|P2|NOT COMPLETED|Phase 2, Open-label||0
8559519|NCT00076024|21103718|P1|NOT COMPLETED|Phase 2, Open-label||0
8559520|NCT00076024|21103715|P4|COMPLETED|Phase 2, Open-label||0
8559521|NCT00076024|21103716|P3|COMPLETED|Phase 2, Open-label||0
8559522|NCT00076024|21103717|P2|COMPLETED|Phase 2, Open-label||0
8559523|NCT00076024|21103718|P1|COMPLETED|Phase 2, Open-label||0
8559524|NCT00076024|21103715|P4|STARTED|Phase 2, Open-label||16
8559525|NCT00076024|21103716|P3|STARTED|Phase 2, Open-label||0
8559526|NCT00076024|21103717|P2|STARTED|Phase 2, Open-label||0
8559527|NCT00076024|21103718|P1|STARTED|Phase 2, Open-label||0
8559528|NCT00076024|21103715|P4|NOT COMPLETED|Phase 2, Double-blind||0
8559529|NCT00076024|21103716|P3|NOT COMPLETED|Phase 2, Double-blind||56
8559530|NCT00076024|21103717|P2|NOT COMPLETED|Phase 2, Double-blind||112
8559531|NCT00076024|21103718|P1|NOT COMPLETED|Phase 2, Double-blind||0
8559532|NCT00076024|21103715|P4|COMPLETED|Phase 2, Double-blind||0
8559533|NCT00076024|21103716|P3|COMPLETED|Phase 2, Double-blind||0
8559534|NCT00076024|21103717|P2|COMPLETED|Phase 2, Double-blind||0
8559535|NCT00076024|21103718|P1|COMPLETED|Phase 2, Double-blind||0
8559536|NCT00076024|21103715|P4|Treated|Phase 2, Double-blind||0
8559537|NCT00076024|21103716|P3|Treated|Phase 2, Double-blind||56
8559538|NCT00076024|21103717|P2|Treated|Phase 2, Double-blind||111
8559539|NCT00076024|21103718|P1|Treated|Phase 2, Double-blind||0
8559540|NCT00076024|21103715|P4|STARTED|Phase 2, Double-blind||0
8559541|NCT00076024|21103716|P3|STARTED|Phase 2, Double-blind||56
8559542|NCT00076024|21103717|P2|STARTED|Phase 2, Double-blind||112
8559543|NCT00076024|21103718|P1|STARTED|Phase 2, Double-blind||0
8559544|NCT00076024|21103715|P4|NOT COMPLETED|Phase 1, Lead-in||0
8559545|NCT00076024|21103716|P3|NOT COMPLETED|Phase 1, Lead-in||0
8559546|NCT00076024|21103717|P2|NOT COMPLETED|Phase 1, Lead-in||0
8559547|NCT00076024|21103718|P1|NOT COMPLETED|Phase 1, Lead-in||6
8559548|NCT00076024|21103715|P4|COMPLETED|Phase 1, Lead-in||0
8559549|NCT00076024|21103716|P3|COMPLETED|Phase 1, Lead-in||0
8559550|NCT00076024|21103717|P2|COMPLETED|Phase 1, Lead-in||0
8559551|NCT00076024|21103718|P1|COMPLETED|Phase 1, Lead-in||0
8559552|NCT00076024|21103715|P4|STARTED|Phase 1, Lead-in||0
8559553|NCT00076024|21103716|P3|STARTED|Phase 1, Lead-in||0
8559554|NCT00076024|21103717|P2|STARTED|Phase 1, Lead-in||0
8559555|NCT00076024|21103718|P1|STARTED|Phase 1, Lead-in||6
8559556|NCT00076011|21103732|P1|NOT COMPLETED|Overall Study||52
8559557|NCT00076011|21103732|P1|COMPLETED|Overall Study||0
8559558|NCT00076011|21103732|P1|STARTED|Overall Study||52
8559559|NCT00075946|21103744|P5|NOT COMPLETED|Overall Study||188
8559560|NCT00075946|21103745|P4|NOT COMPLETED|Overall Study||30
8559561|NCT00075946|21103746|P3|NOT COMPLETED|Overall Study||28
8559562|NCT00075946|21103747|P2|NOT COMPLETED|Overall Study||151
8559563|NCT00075946|21103748|P1|NOT COMPLETED|Overall Study||148
8559564|NCT00075946|21103744|P5|COMPLETED|Overall Study||0
8559565|NCT00075946|21103745|P4|COMPLETED|Overall Study||0
8559566|NCT00075946|21103746|P3|COMPLETED|Overall Study||0
8559567|NCT00075946|21103747|P2|COMPLETED|Overall Study||0
8559568|NCT00075946|21103748|P1|COMPLETED|Overall Study||0
8559569|NCT00075946|21103744|P5|Included in Primary Analysis|Overall Study||0
8559570|NCT00075946|21103745|P4|Included in Primary Analysis|Overall Study||29
8559571|NCT00075946|21103746|P3|Included in Primary Analysis|Overall Study||23
8559572|NCT00075946|21103747|P2|Included in Primary Analysis|Overall Study||146
8559573|NCT00075946|21103748|P1|Included in Primary Analysis|Overall Study||143
8559574|NCT00075946|21103744|P5|Treated and With Toxicity Data Available|Overall Study||154
8559575|NCT00075946|21103745|P4|Treated and With Toxicity Data Available|Overall Study||29
8559576|NCT00075946|21103746|P3|Treated and With Toxicity Data Available|Overall Study||27
8559577|NCT00075946|21103747|P2|Treated and With Toxicity Data Available|Overall Study||148
8559578|NCT00075946|21103748|P1|Treated and With Toxicity Data Available|Overall Study||142
8559579|NCT00075946|21103744|P5|STARTED|Overall Study||188
8559580|NCT00075946|21103745|P4|STARTED|Overall Study||30
8559581|NCT00075946|21103746|P3|STARTED|Overall Study||28
8559582|NCT00075946|21103747|P2|STARTED|Overall Study||151
8559583|NCT00075946|21103748|P1|STARTED|Overall Study||148
8559584|NCT00075881|21103763|P1|NOT COMPLETED|Overall Study||43
8559585|NCT00075881|21103763|P1|COMPLETED|Overall Study||1
8559586|NCT00075881|21103763|P1|Reinduction Treatment|Overall Study||7
8559587|NCT00075881|21103763|P1|Maintenance Treatment|Overall Study||15
8559588|NCT00075881|21103763|P1|Induction Treatment|Overall Study||42
8559589|NCT00075881|21103763|P1|Treated|Overall Study||42
8559590|NCT00075881|21103763|P1|Eligible|Overall Study||43
8559591|NCT00075881|21103763|P1|STARTED|Overall Study||44
8559592|NCT00075829|21103774|P4|NOT COMPLETED|Overall Study||24
8559593|NCT00075829|21103775|P3|NOT COMPLETED|Overall Study||34
8559594|NCT00075829|21103776|P2|NOT COMPLETED|Overall Study||118
8559595|NCT00075829|21103777|P1|NOT COMPLETED|Overall Study||258
8559596|NCT00075829|21103774|P4|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
8559597|NCT00075829|21103775|P3|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
8559598|NCT00075829|21103776|P2|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
8559599|NCT00075829|21103777|P1|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
8559600|NCT00075829|21103774|P4|STARTED|Overall Study||37
8559601|NCT00075829|21103775|P3|STARTED|Overall Study||48
8559602|NCT00075829|21103776|P2|STARTED|Overall Study||189
8559603|NCT00075829|21103777|P1|STARTED|Overall Study||436
8559604|NCT00075816|21103807|P2|NOT COMPLETED|Overall Study||11
8559605|NCT00075816|21103808|P1|NOT COMPLETED|Overall Study||14
8559606|NCT00075816|21103807|P2|COMPLETED|Overall Study||262
8559607|NCT00075816|21103808|P1|COMPLETED|Overall Study||264
8559608|NCT00075816|21103807|P2|STARTED|Overall Study||273
8559609|NCT00075816|21103808|P1|STARTED|Overall Study||278
8559610|NCT00075803|21103848|P2|NOT COMPLETED|Overall Study||0
8559611|NCT00075803|21103849|P1|NOT COMPLETED|Overall Study||0
8559612|NCT00075803|21103848|P2|COMPLETED|Overall Study||305
8559613|NCT00075803|21103849|P1|COMPLETED|Overall Study||295
8559614|NCT00075803|21103848|P2|STARTED|Overall Study||305
8559615|NCT00075803|21103849|P1|STARTED|Overall Study||295
8559616|NCT00075764|21103877|P2|NOT COMPLETED|Overall Study||349
8559617|NCT00075764|21103878|P1|NOT COMPLETED|Overall Study||345
8559618|NCT00075764|21103877|P2|COMPLETED|Overall Study||0
8559619|NCT00075764|21103878|P1|COMPLETED|Overall Study||0
8559620|NCT00075764|21103877|P2|STARTED|Overall Study||349
8559621|NCT00075764|21103878|P1|STARTED|Overall Study||345
8559658|NCT00075608|21104002|P1|NOT COMPLETED|Overall Study||0
8559659|NCT00075608|21104002|P1|COMPLETED|Overall Study||12
8559660|NCT00075608|21104002|P1|STARTED|Overall Study||12
8559661|NCT00075582|21104010|P2|NOT COMPLETED|Overall Study||35
8559662|NCT00075582|21104011|P1|NOT COMPLETED|Overall Study||50
8559663|NCT00075582|21104010|P2|COMPLETED|Overall Study||50
8559664|NCT00075582|21104011|P1|COMPLETED|Overall Study||255
8559665|NCT00075582|21104010|P2|STARTED|Overall Study||85
8559666|NCT00075582|21104011|P1|STARTED|Overall Study||305
8559667|NCT00075504|21104025|P2|NOT COMPLETED|Overall Study||7
8559668|NCT00075504|21104026|P1|NOT COMPLETED|Overall Study||9
8559669|NCT00075504|21104025|P2|COMPLETED|Overall Study||3
8559670|NCT00075504|21104026|P1|COMPLETED|Overall Study||14
8559671|NCT00075504|21104025|P2|STARTED|Overall Study||10
8559672|NCT00075504|21104026|P1|STARTED|Overall Study||23
8559673|NCT00075478|21104038|P2|NOT COMPLETED|Overall Study||1
8559674|NCT00075478|21104039|P1|NOT COMPLETED|Overall Study||1
8559675|NCT00075478|21104038|P2|COMPLETED|Overall Study||44
8559676|NCT00075478|21104039|P1|COMPLETED|Overall Study||41
8559677|NCT00075478|21104038|P2|STARTED|Overall Study||45
8559678|NCT00075478|21104039|P1|STARTED|Overall Study||42
8559679|NCT00075400|21104059|P1|NOT COMPLETED|Overall Study||3
8559680|NCT00075400|21104059|P1|COMPLETED|Overall Study|Eligible and treated patients.|23
8559681|NCT00075400|21104059|P1|STARTED|Overall Study||26
8559682|NCT00075335|21104073|P1|NOT COMPLETED|Overall Study||0
8559683|NCT00075335|21104073|P1|COMPLETED|Overall Study||8
8559684|NCT00075335|21104073|P1|STARTED|Overall Study||8
8559685|NCT00075270|21104080|P2|NOT COMPLETED|Overall Study||284
8559686|NCT00075270|21104081|P1|NOT COMPLETED|Overall Study||286
8559687|NCT00075270|21104080|P2|COMPLETED|Overall Study||4
8559688|NCT00075270|21104081|P1|COMPLETED|Overall Study||5
8559689|NCT00075270|21104080|P2|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
8559690|NCT00075270|21104081|P1|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
8559691|NCT00075270|21104080|P2|STARTED|Overall Study||288
8559692|NCT00075270|21104081|P1|STARTED|Overall Study||291
8559693|NCT00075218|21104127|P3|NOT COMPLETED|Open-Label Treatment||255
8559694|NCT00075218|21104128|P2|NOT COMPLETED|Open-Label Treatment||0
8559695|NCT00075218|21104129|P1|NOT COMPLETED|Open-Label Treatment||0
8559696|NCT00075218|21104127|P3|COMPLETED|Open-Label Treatment||0
8559697|NCT00075218|21104128|P2|COMPLETED|Open-Label Treatment||0
8559698|NCT00075218|21104129|P1|COMPLETED|Open-Label Treatment||0
8559699|NCT00075218|21104127|P3|STARTED|Open-Label Treatment||255
8559700|NCT00075218|21104128|P2|STARTED|Open-Label Treatment||0
8559701|NCT00075218|21104129|P1|STARTED|Open-Label Treatment||0
8559702|NCT00075218|21104127|P3|NOT COMPLETED|Double-Blind Treatment||0
8559703|NCT00075218|21104128|P2|NOT COMPLETED|Double-Blind Treatment||15
8559704|NCT00075218|21104129|P1|NOT COMPLETED|Double-Blind Treatment||91
8559705|NCT00075218|21104127|P3|COMPLETED|Double-Blind Treatment||0
8559706|NCT00075218|21104128|P2|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
8559707|NCT00075218|21104129|P1|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
8559708|NCT00075218|21104127|P3|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
8559709|NCT00075218|21104128|P2|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
8559710|NCT00075218|21104129|P1|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
8559711|NCT00075218|21104127|P3|Received Double-Blind Treatment|Double-Blind Treatment||0
8559712|NCT00075218|21104128|P2|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
8559713|NCT00075218|21104129|P1|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
8559714|NCT00075218|21104127|P3|STARTED|Double-Blind Treatment||0
8559715|NCT00075218|21104128|P2|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
8559716|NCT00075218|21104129|P1|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
8559717|NCT00075088|21104164|P2|NOT COMPLETED|Overall Study||0
8559718|NCT00075088|21104165|P1|NOT COMPLETED|Overall Study||0
8559719|NCT00075088|21104164|P2|COMPLETED|Overall Study||391
8559720|NCT00075088|21104165|P1|COMPLETED|Overall Study||403
8559721|NCT00075088|21104164|P2|STARTED|Overall Study||391
8559722|NCT00075088|21104165|P1|STARTED|Overall Study||403
8559723|NCT00075023|21104178|P2|NOT COMPLETED|Part Two||0
8559724|NCT00075023|21104179|P1|NOT COMPLETED|Part Two||0
8559725|NCT00075023|21104178|P2|COMPLETED|Part Two||0
8559726|NCT00075023|21104179|P1|COMPLETED|Part Two||0
8559727|NCT00075023|21104178|P2|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
8559728|NCT00075023|21104179|P1|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
8559729|NCT00075023|21104178|P2|NOT COMPLETED|Pilot Study||2
8559730|NCT00075023|21104179|P1|NOT COMPLETED|Pilot Study||2
8559731|NCT00075023|21104178|P2|COMPLETED|Pilot Study||3
8559732|NCT00075023|21104179|P1|COMPLETED|Pilot Study||3
8559733|NCT00075023|21104178|P2|STARTED|Pilot Study||5
8559734|NCT00075023|21104179|P1|STARTED|Pilot Study||5
8559735|NCT00074984|21104188|P2|NOT COMPLETED|Overall Study||8
8559736|NCT00074984|21104189|P1|NOT COMPLETED|Overall Study||3
8559737|NCT00074984|21104188|P2|COMPLETED|Overall Study||43
8559738|NCT00074984|21104189|P1|COMPLETED|Overall Study||28
8559739|NCT00074984|21104188|P2|STARTED|Overall Study||51
8559740|NCT00074984|21104189|P1|STARTED|Overall Study||31
8559741|NCT00074958|21104204|P1|NOT COMPLETED|Overall Study||1
8559742|NCT00074958|21104204|P1|COMPLETED|Overall Study||15
8559743|NCT00074958|21104204|P1|STARTED|Overall Study||16
8559744|NCT00074815|21104212|P3|NOT COMPLETED|Overall Study||12
8559745|NCT00074815|21104213|P2|NOT COMPLETED|Overall Study||6
8559746|NCT00074815|21104214|P1|NOT COMPLETED|Overall Study||5
8559747|NCT00074815|21104212|P3|COMPLETED|Overall Study||30
8559748|NCT00074815|21104213|P2|COMPLETED|Overall Study||34
8559749|NCT00074815|21104214|P1|COMPLETED|Overall Study||37
8559750|NCT00074815|21104212|P3|STARTED|Overall Study||42
8559751|NCT00074815|21104213|P2|STARTED|Overall Study||40
8559752|NCT00074815|21104214|P1|STARTED|Overall Study||42
8559753|NCT00074802|21104224|P2|NOT COMPLETED|Overall Study||7
8559754|NCT00074802|21104225|P1|NOT COMPLETED|Overall Study||9
8559755|NCT00074802|21104224|P2|COMPLETED|Overall Study||25
8559756|NCT00074802|21104225|P1|COMPLETED|Overall Study||20
8559757|NCT00074802|21104224|P2|STARTED|Overall Study||32
8559758|NCT00074802|21104225|P1|STARTED|Overall Study||29
8559759|NCT00074711|21104245|P2|NOT COMPLETED|Overall Study||15
8559760|NCT00074711|21104246|P1|NOT COMPLETED|Overall Study||15
8559761|NCT00074711|21104245|P2|COMPLETED|Overall Study||106
8559762|NCT00074711|21104246|P1|COMPLETED|Overall Study||105
8559763|NCT00074711|21104245|P2|STARTED|Overall Study||121
8559764|NCT00074711|21104246|P1|STARTED|Overall Study||120
8559765|NCT00074581|21104264|P2|NOT COMPLETED|Overall Study||226
8559766|NCT00074581|21104265|P1|NOT COMPLETED|Overall Study||244
8559767|NCT00074581|21104264|P2|COMPLETED|Overall Study||1541
8559768|NCT00074581|21104265|P1|COMPLETED|Overall Study||1545
8559769|NCT00074581|21104264|P2|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
8559770|NCT00074581|21104265|P1|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
8559771|NCT00074490|21104278|P6|NOT COMPLETED|Overall Study||0
8559772|NCT00074490|21104279|P5|NOT COMPLETED|Overall Study||3
8559773|NCT00074490|21104280|P4|NOT COMPLETED|Overall Study||0
8559774|NCT00074490|21104281|P3|NOT COMPLETED|Overall Study||0
8559775|NCT00074490|21104282|P2|NOT COMPLETED|Overall Study||7
8559776|NCT00074490|21104283|P1|NOT COMPLETED|Overall Study||0
8559777|NCT00074490|21104278|P6|COMPLETED|Overall Study||221
8559778|NCT00074490|21104279|P5|COMPLETED|Overall Study||42
8559779|NCT00074490|21104280|P4|COMPLETED|Overall Study||44
8559780|NCT00074490|21104281|P3|COMPLETED|Overall Study||40
8559781|NCT00074490|21104282|P2|COMPLETED|Overall Study||27
8559782|NCT00074490|21104283|P1|COMPLETED|Overall Study||1
8559783|NCT00074490|21104278|P6|STARTED|Overall Study||221
8559784|NCT00074490|21104279|P5|STARTED|Overall Study||45
8559785|NCT00074490|21104280|P4|STARTED|Overall Study||44
8559786|NCT00074490|21104281|P3|STARTED|Overall Study||40
8559787|NCT00074490|21104282|P2|STARTED|Overall Study||34
8559788|NCT00074490|21104283|P1|STARTED|Overall Study||1
8559789|NCT00074412|21104317|P2|NOT COMPLETED|Overall Study||84
8559790|NCT00074412|21104318|P1|NOT COMPLETED|Overall Study||82
8559791|NCT00074412|21104317|P2|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
8559792|NCT00074412|21104318|P1|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
8559793|NCT00074412|21104317|P2|Month 12 Visit|Overall Study||735
8559794|NCT00074412|21104318|P1|Month 12 Visit|Overall Study||733
8559795|NCT00074412|21104317|P2|Month 9 Visit|Overall Study||741
8559796|NCT00074412|21104318|P1|Month 9 Visit|Overall Study||741
8559797|NCT00074412|21104317|P2|Month 6 Visit|Overall Study||748
8559798|NCT00074412|21104318|P1|Month 6 Visit|Overall Study||748
8559799|NCT00074412|21104317|P2|Month 5 Visit|Overall Study||750
8559800|NCT00074412|21104318|P1|Month 5 Visit|Overall Study||756
8559801|NCT00074412|21104317|P2|Month 4 Visit|Overall Study||752
8559802|NCT00074412|21104318|P1|Month 4 Visit|Overall Study||758
8559803|NCT00074412|21104317|P2|Month 3 Visit|Overall Study||755
8559804|NCT00074412|21104318|P1|Month 3 Visit|Overall Study||759
8559805|NCT00074412|21104317|P2|Week 8 Visit|Overall Study||759
8559806|NCT00074412|21104318|P1|Week 8 Visit|Overall Study||759
8559807|NCT00074412|21104317|P2|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
8559808|NCT00074412|21104318|P1|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
8559809|NCT00074308|21104334|P5|NOT COMPLETED|Overall Study||0
8559810|NCT00074308|21104335|P4|NOT COMPLETED|Overall Study||0
8559811|NCT00074308|21104336|P3|NOT COMPLETED|Overall Study||0
8559812|NCT00074308|21104337|P2|NOT COMPLETED|Overall Study||0
8559813|NCT00074308|21104338|P1|NOT COMPLETED|Overall Study||0
8559814|NCT00074308|21104334|P5|COMPLETED|Overall Study||23
8559815|NCT00074308|21104335|P4|COMPLETED|Overall Study||8
8559816|NCT00074308|21104336|P3|COMPLETED|Overall Study||3
8559817|NCT00074308|21104337|P2|COMPLETED|Overall Study||3
8559818|NCT00074308|21104338|P1|COMPLETED|Overall Study||3
8559819|NCT00074308|21104334|P5|STARTED|Overall Study||23
8559820|NCT00074308|21104335|P4|STARTED|Overall Study||8
8559821|NCT00074308|21104336|P3|STARTED|Overall Study||3
8559822|NCT00074308|21104337|P2|STARTED|Overall Study||3
8559823|NCT00074308|21104338|P1|STARTED|Overall Study||3
8559824|NCT00074282|21104349|P3|NOT COMPLETED|Step 2||24
8559825|NCT00074282|21104350|P2|NOT COMPLETED|Step 2||2
8559826|NCT00074282|21104351|P1|NOT COMPLETED|Step 2||0
8559827|NCT00074282|21104349|P3|COMPLETED|Step 2||7
8559828|NCT00074282|21104350|P2|COMPLETED|Step 2||7
8559829|NCT00074282|21104351|P1|COMPLETED|Step 2||0
8559830|NCT00074282|21104349|P3|STARTED|Step 2||31
8559831|NCT00074282|21104350|P2|STARTED|Step 2||9
8559832|NCT00074282|21104351|P1|STARTED|Step 2||0
8559833|NCT00074282|21104349|P3|NOT COMPLETED|Step 1||0
8559834|NCT00074282|21104350|P2|NOT COMPLETED|Step 1||0
8559835|NCT00074282|21104351|P1|NOT COMPLETED|Step 1||58
8559836|NCT00074282|21104349|P3|COMPLETED|Step 1||0
8559837|NCT00074282|21104350|P2|COMPLETED|Step 1||0
8559838|NCT00074282|21104351|P1|COMPLETED|Step 1||44
8559839|NCT00074282|21104349|P3|Started Treatment|Step 1||0
8559840|NCT00074282|21104350|P2|Started Treatment|Step 1||0
8559841|NCT00074282|21104351|P1|Started Treatment|Step 1||96
8559842|NCT00074282|21104349|P3|Eligible|Step 1||0
8559843|NCT00074282|21104350|P2|Eligible|Step 1||0
8559844|NCT00074282|21104351|P1|Eligible|Step 1||98
8559845|NCT00074282|21104349|P3|STARTED|Step 1||0
8559846|NCT00074282|21104350|P2|STARTED|Step 1||0
8559847|NCT00074282|21104351|P1|STARTED|Step 1||102
8559848|NCT00074269|21104361|P1|NOT COMPLETED|Overall Study||0
8559849|NCT00074269|21104361|P1|COMPLETED|Overall Study||5
8559850|NCT00074269|21104361|P1|STARTED|Overall Study||5
8559851|NCT00074165|21104371|P1|NOT COMPLETED|Overall Study||0
8559852|NCT00074165|21104371|P1|COMPLETED|Overall Study||17
8559853|NCT00074165|21104371|P1|STARTED|Overall Study||17
8559854|NCT00074152|21104378|P2|NOT COMPLETED|Overall Study||33
8559855|NCT00074152|21104379|P1|NOT COMPLETED|Overall Study||55
8559856|NCT00074152|21104378|P2|COMPLETED|Overall Study||52
8559857|NCT00074152|21104379|P1|COMPLETED|Overall Study||22
8559858|NCT00074152|21104378|P2|STARTED|Overall Study||85
8559859|NCT00074152|21104379|P1|STARTED|Overall Study||77
8559860|NCT00074035|21104389|P1|NOT COMPLETED|Overall Study||0
8559861|NCT00074035|21104389|P1|COMPLETED|Overall Study||38
8559862|NCT00074035|21104389|P1|STARTED|Overall Study||38
8559863|NCT00073983|21104396|P1|NOT COMPLETED|Overall Study||1
8559864|NCT00073983|21104396|P1|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
8559865|NCT00073983|21104396|P1|STARTED|Overall Study||54
8559866|NCT00073957|21104411|P1|NOT COMPLETED|Overall Study||0
8559867|NCT00073957|21104411|P1|COMPLETED|Overall Study||25
8559868|NCT00073957|21104411|P1|STARTED|Overall Study||25
8559869|NCT00073918|21104417|P1|NOT COMPLETED|Overall Study||4
8559870|NCT00073918|21104417|P1|COMPLETED|Overall Study||107
8559871|NCT00073918|21104417|P1|STARTED|Overall Study||111
8559872|NCT00073749|21104431|P7|NOT COMPLETED|Overall Study||40
8559873|NCT00073749|21104432|P6|NOT COMPLETED|Overall Study||6
8559874|NCT00073749|21104433|P5|NOT COMPLETED|Overall Study||6
8559875|NCT00073749|21104434|P4|NOT COMPLETED|Overall Study||6
8559876|NCT00073749|21104435|P3|NOT COMPLETED|Overall Study||11
8559877|NCT00073749|21104436|P2|NOT COMPLETED|Overall Study||5
8559878|NCT00073749|21104437|P1|NOT COMPLETED|Overall Study||2
8559879|NCT00073749|21104431|P7|COMPLETED|Overall Study||3
8559880|NCT00073749|21104432|P6|COMPLETED|Overall Study||0
8559881|NCT00073749|21104433|P5|COMPLETED|Overall Study||0
8559882|NCT00073749|21104434|P4|COMPLETED|Overall Study||0
8559883|NCT00073749|21104435|P3|COMPLETED|Overall Study||0
8559884|NCT00073749|21104436|P2|COMPLETED|Overall Study||0
8559885|NCT00073749|21104437|P1|COMPLETED|Overall Study||0
8559886|NCT00073749|21104431|P7|STARTED|Overall Study||43
8559887|NCT00073749|21104432|P6|STARTED|Overall Study||6
8559888|NCT00073749|21104433|P5|STARTED|Overall Study||6
8559889|NCT00073749|21104434|P4|STARTED|Overall Study||6
8559890|NCT00073749|21104435|P3|STARTED|Overall Study||11
8559891|NCT00073749|21104436|P2|STARTED|Overall Study||5
8559892|NCT00073749|21104437|P1|STARTED|Overall Study||2
8559901|NCT00073333|21104546|P3|NOT COMPLETED|Overall Study||0
8559902|NCT00073333|21104547|P2|NOT COMPLETED|Overall Study||14
8559903|NCT00073333|21104548|P1|NOT COMPLETED|Overall Study||14
8559904|NCT00073333|21104546|P3|COMPLETED|Overall Study||19
8559905|NCT00073333|21104547|P2|COMPLETED|Overall Study||27
8559906|NCT00073333|21104548|P1|COMPLETED|Overall Study||32
8559907|NCT00073333|21104546|P3|STARTED|Overall Study||19
8559908|NCT00073333|21104547|P2|STARTED|Overall Study||41
8559909|NCT00073333|21104548|P1|STARTED|Overall Study||46
8559910|NCT00073307|21104558|P3|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
8559911|NCT00073307|21104559|P2|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
8559912|NCT00073307|21104560|P1|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
8559913|NCT00073307|21104558|P3|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
8559914|NCT00073307|21104559|P2|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
8559915|NCT00073307|21104560|P1|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
8559916|NCT00073307|21104558|P3|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
8559917|NCT00073307|21104559|P2|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
8559918|NCT00073307|21104560|P1|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
8559919|NCT00073307|21104558|P3|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
8559920|NCT00073307|21104559|P2|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
8559921|NCT00073307|21104560|P1|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
8559922|NCT00073307|21104558|P3|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
8559923|NCT00073307|21104559|P2|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
8559924|NCT00073307|21104560|P1|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
8559925|NCT00073307|21104558|P3|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
8559926|NCT00073307|21104559|P2|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
8559927|NCT00073307|21104560|P1|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
8559928|NCT00073307|21104558|P3|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
8559929|NCT00073307|21104559|P2|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
8559930|NCT00073307|21104560|P1|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
8559931|NCT00073307|21104558|P3|STARTED|Double-Blind (DB, as of ~31May2005)||0
8559932|NCT00073307|21104559|P2|STARTED|Double-Blind (DB, as of ~31May2005)||452
8559933|NCT00073307|21104560|P1|STARTED|Double-Blind (DB, as of ~31May2005)||451
8559934|NCT00073073|21104578|P1|NOT COMPLETED|Overall Study||4
8559935|NCT00073073|21104578|P1|COMPLETED|Overall Study||42
8559936|NCT00073073|21104578|P1|STARTED|Overall Study||46
8559937|NCT00073021|21104591|P2|NOT COMPLETED|Overall Study||16
8559938|NCT00073021|21104592|P1|NOT COMPLETED|Overall Study||26
8559939|NCT00073021|21104591|P2|COMPLETED|Overall Study||113
8559940|NCT00073021|21104592|P1|COMPLETED|Overall Study||113
8559941|NCT00073021|21104591|P2|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
8559942|NCT00073021|21104592|P1|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
8559943|NCT00073008|21104622|P2|NOT COMPLETED|Overall Study||63
8559944|NCT00073008|21104623|P1|NOT COMPLETED|Overall Study||62
8559945|NCT00073008|21104622|P2|COMPLETED|Overall Study||3
8559946|NCT00073008|21104623|P1|COMPLETED|Overall Study||3
8559947|NCT00073008|21104622|P2|STARTED|Overall Study||66
8559948|NCT00073008|21104623|P1|STARTED|Overall Study||65
8559949|NCT00072761|21104655|P2|NOT COMPLETED|Overall Study||2
8559950|NCT00072761|21104656|P1|NOT COMPLETED|Overall Study||9
8559951|NCT00072761|21104655|P2|COMPLETED|Overall Study||95
8559952|NCT00072761|21104656|P1|COMPLETED|Overall Study||90
8559953|NCT00072761|21104655|P2|STARTED|Overall Study||97
8559954|NCT00072761|21104656|P1|STARTED|Overall Study||99
8559955|NCT00072475|21104662|P1|NOT COMPLETED|Overall Study||97
8559956|NCT00072475|21104662|P1|COMPLETED|Overall Study||45
8559957|NCT00072475|21104662|P1|STARTED|Overall Study||142
8559958|NCT00072449|21104670|P1|NOT COMPLETED|Overall Study||0
8559959|NCT00072449|21104670|P1|COMPLETED|Overall Study||12
8559960|NCT00072449|21104670|P1|STARTED|Overall Study||12
8559964|NCT00072293|21104690|P2|NOT COMPLETED|Overall Study||2
8559965|NCT00072293|21104691|P1|NOT COMPLETED|Overall Study||1
8559966|NCT00072293|21104690|P2|COMPLETED|Overall Study||467
8559967|NCT00072293|21104691|P1|COMPLETED|Overall Study||464
8559968|NCT00072293|21104690|P2|STARTED|Overall Study||469
8559969|NCT00072293|21104691|P1|STARTED|Overall Study||465
8559970|NCT00072280|21104703|P2|NOT COMPLETED|Follow-up||2
8559971|NCT00072280|21104704|P1|NOT COMPLETED|Follow-up||2
8559972|NCT00072280|21104703|P2|COMPLETED|Follow-up||0
8559973|NCT00072280|21104704|P1|COMPLETED|Follow-up||0
8559974|NCT00072280|21104703|P2|STARTED|Follow-up||2
8559975|NCT00072280|21104704|P1|STARTED|Follow-up||2
8559976|NCT00072280|21104703|P2|NOT COMPLETED|Treatment||2
8559977|NCT00072280|21104704|P1|NOT COMPLETED|Treatment||1
8559978|NCT00072280|21104703|P2|COMPLETED|Treatment||2
8559979|NCT00072280|21104704|P1|COMPLETED|Treatment||2
8559980|NCT00072280|21104703|P2|STARTED|Treatment||4
8559981|NCT00072280|21104704|P1|STARTED|Treatment||3
8559982|NCT00072189|21104709|P1|NOT COMPLETED|Overall Study||1
8559983|NCT00072189|21104709|P1|COMPLETED|Overall Study||16
8559984|NCT00072189|21104709|P1|STARTED|Overall Study||17
8559985|NCT00072176|21104717|P2|NOT COMPLETED|Overall Study||1
8559986|NCT00072176|21104718|P1|NOT COMPLETED|Overall Study||1
8559987|NCT00072176|21104717|P2|COMPLETED|Overall Study||27
8559988|NCT00072176|21104718|P1|COMPLETED|Overall Study||33
8559989|NCT00072176|21104717|P2|STARTED|Overall Study||28
8559990|NCT00072176|21104718|P1|STARTED|Overall Study||34
8559991|NCT00071981|21104730|P4|NOT COMPLETED|Overall Study||45
8559992|NCT00071981|21104731|P3|NOT COMPLETED|Overall Study||37
8559993|NCT00071981|21104732|P2|NOT COMPLETED|Overall Study||41
8559994|NCT00071981|21104733|P1|NOT COMPLETED|Overall Study||46
8559995|NCT00071981|21104730|P4|COMPLETED|Overall Study||3
8559996|NCT00071981|21104731|P3|COMPLETED|Overall Study||0
8559997|NCT00071981|21104732|P2|COMPLETED|Overall Study||2
8559998|NCT00071981|21104733|P1|COMPLETED|Overall Study||1
8559999|NCT00071981|21104730|P4|Have Helper T Cell Response Data|Overall Study||39
8560000|NCT00071981|21104731|P3|Have Helper T Cell Response Data|Overall Study||25
8560001|NCT00071981|21104732|P2|Have Helper T Cell Response Data|Overall Study||27
8560002|NCT00071981|21104733|P1|Have Helper T Cell Response Data|Overall Study||37
8560003|NCT00071981|21104730|P4|Have CTL Response Data|Overall Study||41
8560004|NCT00071981|21104731|P3|Have CTL Response Data|Overall Study||29
8560005|NCT00071981|21104732|P2|Have CTL Response Data|Overall Study||30
8560006|NCT00071981|21104733|P1|Have CTL Response Data|Overall Study||40
8560007|NCT00071981|21104730|P4|Eligible and Treated|Overall Study||42
8560008|NCT00071981|21104731|P3|Eligible and Treated|Overall Study||32
8560009|NCT00071981|21104732|P2|Eligible and Treated|Overall Study||33
8560010|NCT00071981|21104733|P1|Eligible and Treated|Overall Study||41
8560011|NCT00071981|21104730|P4|Treated|Overall Study||48
8560012|NCT00071981|21104731|P3|Treated|Overall Study||36
8560013|NCT00071981|21104732|P2|Treated|Overall Study||38
8560014|NCT00071981|21104733|P1|Treated|Overall Study||45
8560015|NCT00071981|21104730|P4|Eligible|Overall Study||42
8560016|NCT00071981|21104731|P3|Eligible|Overall Study||33
8560017|NCT00071981|21104732|P2|Eligible|Overall Study||36
8560018|NCT00071981|21104733|P1|Eligible|Overall Study||43
8560019|NCT00071981|21104730|P4|STARTED|Overall Study||48
8560020|NCT00071981|21104731|P3|STARTED|Overall Study||37
8560021|NCT00071981|21104732|P2|STARTED|Overall Study||43
8560022|NCT00071981|21104733|P1|STARTED|Overall Study||47
8560023|NCT00072566|21104759|P1|NOT COMPLETED|Overall Study||0
8560024|NCT00072566|21104759|P1|COMPLETED|Overall Study||70
8560025|NCT00072566|21104759|P1|STARTED|Overall Study||70
8560026|NCT00072514|21104765|P1|NOT COMPLETED|Overall Study||4
8560027|NCT00072514|21104765|P1|COMPLETED|Overall Study||51
8560028|NCT00072514|21104765|P1|STARTED|Overall Study||55
8560029|NCT00071812|21104776|P4|NOT COMPLETED|24-Week Open-Label Extension Period||40
8560030|NCT00071812|21104777|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
8560031|NCT00071812|21104778|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
8560032|NCT00071812|21104779|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
8560033|NCT00071812|21104776|P4|COMPLETED|24-Week Open-Label Extension Period||178
8560034|NCT00071812|21104777|P3|COMPLETED|24-Week Open-Label Extension Period||7
8560035|NCT00071812|21104778|P2|COMPLETED|24-Week Open-Label Extension Period||11
8560036|NCT00071812|21104779|P1|COMPLETED|24-Week Open-Label Extension Period||0
8560111|NCT00071396|21105015|P1|NOT COMPLETED|Overall Study||3
8560037|NCT00071812|21104776|P4|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
8560038|NCT00071812|21104777|P3|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
8560039|NCT00071812|21104778|P2|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
8560040|NCT00071812|21104779|P1|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
8560041|NCT00071812|21104776|P4|NOT COMPLETED|24-Week Double-Blind Period||11
8560042|NCT00071812|21104777|P3|NOT COMPLETED|24-Week Double-Blind Period||8
8560043|NCT00071812|21104778|P2|NOT COMPLETED|24-Week Double-Blind Period||6
8560044|NCT00071812|21104779|P1|NOT COMPLETED|24-Week Double-Blind Period||10
8560045|NCT00071812|21104776|P4|COMPLETED|24-Week Double-Blind Period||60
8560046|NCT00071812|21104777|P3|COMPLETED|24-Week Double-Blind Period||63
8560047|NCT00071812|21104778|P2|COMPLETED|24-Week Double-Blind Period||66
8560048|NCT00071812|21104779|P1|COMPLETED|24-Week Double-Blind Period||59
8560049|NCT00071812|21104776|P4|STARTED|24-Week Double-Blind Period||71
8560050|NCT00071812|21104777|P3|STARTED|24-Week Double-Blind Period||71
8560051|NCT00071812|21104778|P2|STARTED|24-Week Double-Blind Period||72
8560052|NCT00071812|21104779|P1|STARTED|24-Week Double-Blind Period||69
8560053|NCT00071799|21104821|P2|NOT COMPLETED|Overall Study||98
8560054|NCT00071799|21104822|P1|NOT COMPLETED|Overall Study||70
8560055|NCT00071799|21104821|P2|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
8560056|NCT00071799|21104822|P1|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
8560057|NCT00071799|21104821|P2|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
8560058|NCT00071799|21104822|P1|STARTED|Overall Study||179
8560059|NCT00071890|21104864|P2|NOT COMPLETED|Overall Study||0
8560060|NCT00071890|21104865|P1|NOT COMPLETED|Overall Study||0
8560061|NCT00071890|21104864|P2|COMPLETED|Overall Study|"1 withdrawal
~1 lost of follow-up
~1 death 67 patients analysed"|67
8560062|NCT00071890|21104865|P1|COMPLETED|Overall Study|"1 withdrawal
~1 death 81 patients analysed"|81
8560063|NCT00071890|21104864|P2|STARTED|Overall Study|1 patients stopped HAART at week 0|67
8560064|NCT00071890|21104865|P1|STARTED|Overall Study|3 patients did not received Interleukin-2|81
8560065|NCT00071760|21104875|P1|NOT COMPLETED|Overall Study||54
8560066|NCT00071760|21104875|P1|COMPLETED|Overall Study||0
8560067|NCT00071760|21104875|P1|Ongoing|Overall Study||25
8560068|NCT00071760|21104875|P1|STARTED|Overall Study||54
8560069|NCT00071721|21104936|P2|NOT COMPLETED|Overall Study||91
8560070|NCT00071721|21104937|P1|NOT COMPLETED|Overall Study||72
8560071|NCT00071721|21104936|P2|COMPLETED|Overall Study||69
8560072|NCT00071721|21104937|P1|COMPLETED|Overall Study||81
8560073|NCT00071721|21104936|P2|STARTED|Overall Study||160
8560074|NCT00071721|21104937|P1|STARTED|Overall Study||153
8560075|NCT00071513|21104955|P2|NOT COMPLETED|Follow-up Assessment||6
8560076|NCT00071513|21104956|P1|NOT COMPLETED|Follow-up Assessment||6
8560077|NCT00071513|21104955|P2|COMPLETED|Follow-up Assessment||247
8560078|NCT00071513|21104956|P1|COMPLETED|Follow-up Assessment||233
8560079|NCT00071513|21104955|P2|STARTED|Follow-up Assessment||253
8560080|NCT00071513|21104956|P1|STARTED|Follow-up Assessment||239
8560081|NCT00071513|21104955|P2|NOT COMPLETED|Intervention Component||3
8560082|NCT00071513|21104956|P1|NOT COMPLETED|Intervention Component||2
8560083|NCT00071513|21104955|P2|COMPLETED|Intervention Component||253
8560084|NCT00071513|21104956|P1|COMPLETED|Intervention Component||239
8560085|NCT00071513|21104955|P2|STARTED|Intervention Component||256
8560086|NCT00071513|21104956|P1|STARTED|Intervention Component||241
8560087|NCT00071487|21104968|P4|NOT COMPLETED|24-Week Open-Label Extension Period||23
8560088|NCT00071487|21104969|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
8560089|NCT00071487|21104970|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
8560090|NCT00071487|21104971|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
8560091|NCT00071487|21104968|P4|COMPLETED|24-Week Open-Label Extension Period||279
8560092|NCT00071487|21104969|P3|COMPLETED|24-Week Open-Label Extension Period||23
8560093|NCT00071487|21104970|P2|COMPLETED|24-Week Open-Label Extension Period||19
8560094|NCT00071487|21104971|P1|COMPLETED|24-Week Open-Label Extension Period||0
8560095|NCT00071487|21104968|P4|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
8560096|NCT00071487|21104969|P3|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
8560097|NCT00071487|21104970|P2|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
8560098|NCT00071487|21104971|P1|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
8560099|NCT00071487|21104968|P4|NOT COMPLETED|52-Week Double-Blind Period||21
8560100|NCT00071487|21104969|P3|NOT COMPLETED|52-Week Double-Blind Period||17
8560101|NCT00071487|21104970|P2|NOT COMPLETED|52-Week Double-Blind Period||27
8560102|NCT00071487|21104971|P1|NOT COMPLETED|52-Week Double-Blind Period||20
8560103|NCT00071487|21104968|P4|COMPLETED|52-Week Double-Blind Period||90
8560104|NCT00071487|21104969|P3|COMPLETED|52-Week Double-Blind Period||94
8560105|NCT00071487|21104970|P2|COMPLETED|52-Week Double-Blind Period||87
8560106|NCT00071487|21104971|P1|COMPLETED|52-Week Double-Blind Period||93
8560107|NCT00071487|21104968|P4|STARTED|52-Week Double-Blind Period||111
8560108|NCT00071487|21104969|P3|STARTED|52-Week Double-Blind Period||111
8560109|NCT00071487|21104970|P2|STARTED|52-Week Double-Blind Period||114
8560110|NCT00071487|21104971|P1|STARTED|52-Week Double-Blind Period||113
8560112|NCT00071396|21105015|P1|COMPLETED|Overall Study|Evaluable for response.|41
8560113|NCT00071396|21105015|P1|STARTED|Overall Study||44
8560114|NCT00071110|21105021|P2|NOT COMPLETED|Overall Study||4
8560115|NCT00071110|21105022|P1|NOT COMPLETED|Overall Study||0
8560116|NCT00071110|21105021|P2|COMPLETED|Overall Study||25
8560117|NCT00071110|21105022|P1|COMPLETED|Overall Study||28
8560118|NCT00071110|21105021|P2|STARTED|Overall Study||29
8560119|NCT00071110|21105022|P1|STARTED|Overall Study||28
8560120|NCT00071032|21105036|P2|NOT COMPLETED|Overall Study||8
8560121|NCT00071032|21105037|P1|NOT COMPLETED|Overall Study||9
8560122|NCT00071032|21105036|P2|COMPLETED|Overall Study||1001
8560123|NCT00071032|21105037|P1|COMPLETED|Overall Study||998
8560124|NCT00071032|21105036|P2|STARTED|Overall Study||1009
8560125|NCT00071032|21105037|P1|STARTED|Overall Study||1007
8560126|NCT00071006|21105073|P1|NOT COMPLETED|Overall Study||12
8560127|NCT00071006|21105073|P1|COMPLETED|Overall Study||0
8560128|NCT00071006|21105073|P1|STARTED|Overall Study||12
8560129|NCT00070941|21105086|P3|NOT COMPLETED|Overall Study||4
8560130|NCT00070941|21105087|P2|NOT COMPLETED|Overall Study||8
8560131|NCT00070941|21105088|P1|NOT COMPLETED|Overall Study||10
8560132|NCT00070941|21105086|P3|COMPLETED|Overall Study||2
8560133|NCT00070941|21105087|P2|COMPLETED|Overall Study||3
8560134|NCT00070941|21105088|P1|COMPLETED|Overall Study||2
8560135|NCT00070941|21105086|P3|STARTED|Overall Study||6
8560136|NCT00070941|21105087|P2|STARTED|Overall Study||11
8560137|NCT00070941|21105088|P1|STARTED|Overall Study||12
8560138|NCT00071058|21105096|P1|NOT COMPLETED|Overall Study||1
8560139|NCT00071058|21105096|P1|COMPLETED|Overall Study||49
8560140|NCT00071058|21105096|P1|STARTED|Overall Study||50
8560141|NCT00070707|21105103|P2|NOT COMPLETED|Overall Study||7
8560142|NCT00070707|21105104|P1|NOT COMPLETED|Overall Study||14
8560143|NCT00070707|21105103|P2|COMPLETED|Overall Study||68
8560144|NCT00070707|21105104|P1|COMPLETED|Overall Study||99
8560145|NCT00070707|21105103|P2|STARTED|Overall Study||75
8560146|NCT00070707|21105104|P1|STARTED|Overall Study||113
8560147|NCT00003907|21105152|P2|NOT COMPLETED|Overall Study||23
8560148|NCT00003907|21105153|P1|NOT COMPLETED|Overall Study||13
8560149|NCT00003907|21105152|P2|COMPLETED|Overall Study||8
8560150|NCT00003907|21105153|P1|COMPLETED|Overall Study||6
8560151|NCT00003907|21105152|P2|Eligible and Treated|Overall Study||29
8560152|NCT00003907|21105153|P1|Eligible and Treated|Overall Study||17
8560153|NCT00003907|21105152|P2|Received Protocol Therapy (Treated)|Overall Study||31
8560154|NCT00003907|21105153|P1|Received Protocol Therapy (Treated)|Overall Study||18
8560155|NCT00003907|21105152|P2|Eligible|Overall Study||29
8560156|NCT00003907|21105153|P1|Eligible|Overall Study||18
8560157|NCT00003907|21105152|P2|STARTED|Overall Study||31
8560158|NCT00003907|21105153|P1|STARTED|Overall Study||19
8560159|NCT00070564|21105169|P6|NOT COMPLETED|Overall Study||52
8560160|NCT00070564|21105170|P5|NOT COMPLETED|Overall Study||79
8560161|NCT00070564|21105171|P4|NOT COMPLETED|Overall Study||167
8560162|NCT00070564|21105172|P3|NOT COMPLETED|Overall Study||171
8560163|NCT00070564|21105173|P2|NOT COMPLETED|Overall Study||203
8560164|NCT00070564|21105174|P1|NOT COMPLETED|Overall Study||200
8560165|NCT00070564|21105169|P6|COMPLETED|Overall Study||244
8560166|NCT00070564|21105170|P5|COMPLETED|Overall Study||203
8560167|NCT00070564|21105171|P4|COMPLETED|Overall Study||481
8560168|NCT00070564|21105172|P3|COMPLETED|Overall Study||526
8560169|NCT00070564|21105173|P2|COMPLETED|Overall Study||490
8560170|NCT00070564|21105174|P1|COMPLETED|Overall Study||478
8560171|NCT00070564|21105169|P6|STARTED|Overall Study||296
8560172|NCT00070564|21105170|P5|STARTED|Overall Study||282
8560173|NCT00070564|21105171|P4|STARTED|Overall Study||648
8560174|NCT00070564|21105172|P3|STARTED|Overall Study||697
8560175|NCT00070564|21105173|P2|STARTED|Overall Study||693
8560176|NCT00070564|21105174|P1|STARTED|Overall Study||678
8560197|NCT00070317|21105257|P1|NOT COMPLETED|Overall Study||13
8560198|NCT00070317|21105257|P1|COMPLETED|Overall Study||89
8560199|NCT00070317|21105257|P1|STARTED|Overall Study||102
8560200|NCT00070291|21105262|P1|NOT COMPLETED|Step 2||1
8560201|NCT00070291|21105262|P1|COMPLETED|Step 2||0
8560202|NCT00070291|21105262|P1|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
8560203|NCT00070291|21105262|P1|NOT COMPLETED|Step 1||2
8560204|NCT00070291|21105262|P1|COMPLETED|Step 1||2
8560205|NCT00070291|21105262|P1|Treated|Step 1||3
8560206|NCT00070291|21105262|P1|STARTED|Step 1||4
8560207|NCT00070135|21105267|P1|NOT COMPLETED|Overall Study||0
8560208|NCT00070135|21105267|P1|COMPLETED|Overall Study||114
8560209|NCT00070135|21105267|P1|STARTED|Overall Study||114
8560210|NCT00070109|21105278|P5|NOT COMPLETED|Overall Study||8
8560211|NCT00070109|21105279|P4|NOT COMPLETED|Overall Study||20
8560212|NCT00070109|21105280|P3|NOT COMPLETED|Overall Study||8
8560213|NCT00070109|21105281|P2|NOT COMPLETED|Overall Study||6
8560214|NCT00070109|21105282|P1|NOT COMPLETED|Overall Study||8
8560215|NCT00070109|21105278|P5|COMPLETED|Overall Study||0
8560216|NCT00070109|21105279|P4|COMPLETED|Overall Study||0
8560217|NCT00070109|21105280|P3|COMPLETED|Overall Study||0
8560218|NCT00070109|21105281|P2|COMPLETED|Overall Study||0
8560219|NCT00070109|21105282|P1|COMPLETED|Overall Study||0
8560220|NCT00070109|21105278|P5|STARTED|Overall Study||8
8560221|NCT00070109|21105279|P4|STARTED|Overall Study||20
8560222|NCT00070109|21105280|P3|STARTED|Overall Study||8
8560223|NCT00070109|21105281|P2|STARTED|Overall Study||6
8560224|NCT00070109|21105282|P1|STARTED|Overall Study||8
8560230|NCT00069953|21105314|P1|NOT COMPLETED|Overall Study||2
8560231|NCT00069953|21105314|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
8560232|NCT00069953|21105314|P1|STARTED|Overall Study||43
8560233|NCT00069784|21105320|P2|NOT COMPLETED|Overall Study||0
8560234|NCT00069784|21105321|P1|NOT COMPLETED|Overall Study||1212
8560235|NCT00069784|21105320|P2|COMPLETED|Overall Study|not applicable (no treatment)|6273
8560236|NCT00069784|21105321|P1|COMPLETED|Overall Study|completed study treatment|5052
8560237|NCT00069784|21105320|P2|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
8560238|NCT00069784|21105321|P1|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
8560239|NCT00069784|21105320|P2|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
8560240|NCT00069784|21105321|P1|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
8560241|NCT00069823|21105341|P2|NOT COMPLETED|Overall Study||3
8560242|NCT00069823|21105342|P1|NOT COMPLETED|Overall Study||6
8560243|NCT00069823|21105341|P2|COMPLETED|Overall Study||200
8560244|NCT00069823|21105342|P1|COMPLETED|Overall Study||193
8560245|NCT00069823|21105341|P2|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
8560246|NCT00069823|21105342|P1|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
8560256|NCT00069576|21105414|P2|NOT COMPLETED|Follow-up Study at 5-10 Years||204
8560257|NCT00069576|21105415|P1|NOT COMPLETED|Follow-up Study at 5-10 Years||196
8560258|NCT00069576|21105414|P2|COMPLETED|Follow-up Study at 5-10 Years||236
8560259|NCT00069576|21105415|P1|COMPLETED|Follow-up Study at 5-10 Years||264
8560260|NCT00069576|21105414|P2|STARTED|Follow-up Study at 5-10 Years||440
8560261|NCT00069576|21105415|P1|STARTED|Follow-up Study at 5-10 Years||460
8560262|NCT00069576|21105414|P2|NOT COMPLETED|Original Trial||33
8560263|NCT00069576|21105415|P1|NOT COMPLETED|Original Trial||25
8560264|NCT00069576|21105414|P2|COMPLETED|Original Trial||440
8560265|NCT00069576|21105415|P1|COMPLETED|Original Trial||460
8560266|NCT00069576|21105414|P2|STARTED|Original Trial||473
8560267|NCT00069576|21105415|P1|STARTED|Original Trial||485
8560268|NCT00069277|21105465|P1|NOT COMPLETED|Overall Study||21
8560269|NCT00069277|21105465|P1|COMPLETED|Overall Study||0
8560270|NCT00069277|21105465|P1|STARTED|Overall Study||21
8560271|NCT00069264|21105469|P1|NOT COMPLETED|Overall Study||32
8560272|NCT00069264|21105469|P1|COMPLETED|Overall Study||0
8560273|NCT00069264|21105469|P1|STARTED|Overall Study||32
8560274|NCT00069329|21105473|P1|NOT COMPLETED|Overall Study||2
8560275|NCT00069329|21105473|P1|COMPLETED|Overall Study||41
8560276|NCT00069329|21105473|P1|STARTED|Overall Study||43
8560304|NCT00069121|21105507|P2|NOT COMPLETED|Overall Study||325
8560305|NCT00069121|21105508|P1|NOT COMPLETED|Overall Study||367
8560306|NCT00069121|21105507|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|619
8560307|NCT00069121|21105508|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|575
8560308|NCT00069121|21105507|P2|Received Treatment|Overall Study|Safety Population|938
8560309|NCT00069121|21105508|P1|Received Treatment|Overall Study|Safety Population|926
8560310|NCT00069121|21105507|P2|STARTED|Overall Study||944
8560311|NCT00069121|21105508|P1|STARTED|Overall Study||942
8560312|NCT00069108|21105530|P2|NOT COMPLETED|Overall Study||219
8560313|NCT00069108|21105531|P1|NOT COMPLETED|Overall Study||213
8560314|NCT00069108|21105530|P2|COMPLETED|Overall Study||95
8560315|NCT00069108|21105531|P1|COMPLETED|Overall Study||100
8560316|NCT00069108|21105530|P2|STARTED|Overall Study||314
8560317|NCT00069108|21105531|P1|STARTED|Overall Study||313
8560318|NCT00069095|21105563|P6|NOT COMPLETED|Follow-up Phase||101
8560319|NCT00069095|21105564|P5|NOT COMPLETED|Follow-up Phase||92
8560320|NCT00069095|21105565|P4|NOT COMPLETED|Follow-up Phase||112
8560321|NCT00069095|21105566|P3|NOT COMPLETED|Follow-up Phase||120
8560322|NCT00069095|21105567|P2|NOT COMPLETED|Follow-up Phase||206
8560323|NCT00069095|21105568|P1|NOT COMPLETED|Follow-up Phase||174
8560324|NCT00069095|21105563|P6|COMPLETED|Follow-up Phase||171
8560325|NCT00069095|21105564|P5|COMPLETED|Follow-up Phase||186
8560326|NCT00069095|21105565|P4|COMPLETED|Follow-up Phase||187
8560327|NCT00069095|21105566|P3|COMPLETED|Follow-up Phase||178
8560328|NCT00069095|21105567|P2|COMPLETED|Follow-up Phase||93
8560329|NCT00069095|21105568|P1|COMPLETED|Follow-up Phase||110
8560330|NCT00069095|21105563|P6|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
8560331|NCT00069095|21105564|P5|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
8560332|NCT00069095|21105565|P4|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
8560333|NCT00069095|21105566|P3|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
8560334|NCT00069095|21105567|P2|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
8560335|NCT00069095|21105568|P1|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
8560336|NCT00069095|21105563|P6|NOT COMPLETED|Post-study Treatment Phase||29
8560337|NCT00069095|21105564|P5|NOT COMPLETED|Post-study Treatment Phase||36
8560338|NCT00069095|21105565|P4|NOT COMPLETED|Post-study Treatment Phase||17
8560339|NCT00069095|21105566|P3|NOT COMPLETED|Post-study Treatment Phase||21
8560340|NCT00069095|21105567|P2|NOT COMPLETED|Post-study Treatment Phase||13
8560341|NCT00069095|21105568|P1|NOT COMPLETED|Post-study Treatment Phase||8
8560342|NCT00069095|21105563|P6|COMPLETED|Post-study Treatment Phase||0
8560343|NCT00069095|21105564|P5|COMPLETED|Post-study Treatment Phase||0
8560344|NCT00069095|21105565|P4|COMPLETED|Post-study Treatment Phase||0
8560345|NCT00069095|21105566|P3|COMPLETED|Post-study Treatment Phase||0
8560346|NCT00069095|21105567|P2|COMPLETED|Post-study Treatment Phase||0
8560347|NCT00069095|21105568|P1|COMPLETED|Post-study Treatment Phase||0
8560348|NCT00069095|21105563|P6|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
8560349|NCT00069095|21105564|P5|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
8560350|NCT00069095|21105565|P4|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
8560351|NCT00069095|21105566|P3|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
8560352|NCT00069095|21105567|P2|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
8560353|NCT00069095|21105568|P1|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
8560354|NCT00069095|21105563|P6|NOT COMPLETED|Primary Treatment Phase||301
8560355|NCT00069095|21105564|P5|NOT COMPLETED|Primary Treatment Phase||302
8560356|NCT00069095|21105565|P4|NOT COMPLETED|Primary Treatment Phase||320
8560357|NCT00069095|21105566|P3|NOT COMPLETED|Primary Treatment Phase||314
8560358|NCT00069095|21105567|P2|NOT COMPLETED|Primary Treatment Phase||302
8560359|NCT00069095|21105568|P1|NOT COMPLETED|Primary Treatment Phase||295
8560360|NCT00069095|21105563|P6|COMPLETED|Primary Treatment Phase||48
8560361|NCT00069095|21105564|P5|COMPLETED|Primary Treatment Phase||48
8560362|NCT00069095|21105565|P4|COMPLETED|Primary Treatment Phase||31
8560363|NCT00069095|21105566|P3|COMPLETED|Primary Treatment Phase||36
8560364|NCT00069095|21105567|P2|COMPLETED|Primary Treatment Phase||15
8560365|NCT00069095|21105568|P1|COMPLETED|Primary Treatment Phase||22
8560366|NCT00069095|21105563|P6|STARTED|Primary Treatment Phase||349
8560367|NCT00069095|21105564|P5|STARTED|Primary Treatment Phase||350
8560368|NCT00069095|21105565|P4|STARTED|Primary Treatment Phase||351
8560369|NCT00069095|21105566|P3|STARTED|Primary Treatment Phase||350
8560370|NCT00069095|21105567|P2|STARTED|Primary Treatment Phase||317
8560371|NCT00069095|21105568|P1|STARTED|Primary Treatment Phase||317
8560372|NCT00069160|21105622|P2|NOT COMPLETED|Overall Study||0
8560373|NCT00069160|21105623|P1|NOT COMPLETED|Overall Study||0
8560374|NCT00069160|21105622|P2|COMPLETED|Overall Study||25
8560375|NCT00069160|21105623|P1|COMPLETED|Overall Study||23
8560376|NCT00069160|21105622|P2|STARTED|Overall Study||25
8560377|NCT00069160|21105623|P1|STARTED|Overall Study||23
8560378|NCT00068822|21105638|P2|NOT COMPLETED|Optional Crossover Intervention||0
8560379|NCT00068822|21105639|P1|NOT COMPLETED|Optional Crossover Intervention||0
8560380|NCT00068822|21105638|P2|COMPLETED|Optional Crossover Intervention||29
8560381|NCT00068822|21105639|P1|COMPLETED|Optional Crossover Intervention||9
8560382|NCT00068822|21105638|P2|Crossover at Month 3|Optional Crossover Intervention||27
8560383|NCT00068822|21105639|P1|Crossover at Month 3|Optional Crossover Intervention||8
8560384|NCT00068822|21105638|P2|Crossover at Month 1|Optional Crossover Intervention||2
8560385|NCT00068822|21105639|P1|Crossover at Month 1|Optional Crossover Intervention||1
8560386|NCT00068822|21105638|P2|STARTED|Optional Crossover Intervention||29
8560387|NCT00068822|21105639|P1|STARTED|Optional Crossover Intervention||9
8560388|NCT00068822|21105638|P2|NOT COMPLETED|First Randomized Intervention||2
8560389|NCT00068822|21105639|P1|NOT COMPLETED|First Randomized Intervention||1
8560390|NCT00068822|21105638|P2|COMPLETED|First Randomized Intervention||61
8560391|NCT00068822|21105639|P1|COMPLETED|First Randomized Intervention||67
8560392|NCT00068822|21105638|P2|STARTED|First Randomized Intervention||63
8560393|NCT00068822|21105639|P1|STARTED|First Randomized Intervention||68
8560394|NCT00068770|21105651|P2|NOT COMPLETED|Overall Study||0
8560395|NCT00068770|21105652|P1|NOT COMPLETED|Overall Study||0
8560396|NCT00068770|21105651|P2|COMPLETED|Overall Study||22
8560397|NCT00068770|21105652|P1|COMPLETED|Overall Study||13
8560398|NCT00068770|21105651|P2|STARTED|Overall Study||22
8560399|NCT00068770|21105652|P1|STARTED|Overall Study||13
8560400|NCT00068718|21105660|P1|NOT COMPLETED|Overall Study||0
8560401|NCT00068718|21105660|P1|COMPLETED|Overall Study||35
8560402|NCT00068718|21105660|P1|STARTED|Overall Study||35
8560403|NCT00068692|21105673|P8|NOT COMPLETED|Step 2: Randomization||8
8560404|NCT00068692|21105674|P7|NOT COMPLETED|Step 2: Randomization||4
8560405|NCT00068692|21105675|P6|NOT COMPLETED|Step 2: Randomization||6
8560406|NCT00068692|21105676|P5|NOT COMPLETED|Step 2: Randomization||9
8560407|NCT00068692|21105677|P4|NOT COMPLETED|Step 2: Randomization||12
8560408|NCT00068692|21105678|P3|NOT COMPLETED|Step 2: Randomization||10
8560409|NCT00068692|21105679|P2|NOT COMPLETED|Step 2: Randomization||0
8560410|NCT00068692|21105680|P1|NOT COMPLETED|Step 2: Randomization||0
8560411|NCT00068692|21105673|P8|COMPLETED|Step 2: Randomization||24
8560412|NCT00068692|21105674|P7|COMPLETED|Step 2: Randomization||29
8560413|NCT00068692|21105675|P6|COMPLETED|Step 2: Randomization||25
8560414|NCT00068692|21105676|P5|COMPLETED|Step 2: Randomization||21
8560415|NCT00068692|21105677|P4|COMPLETED|Step 2: Randomization||13
8560416|NCT00068692|21105678|P3|COMPLETED|Step 2: Randomization||18
8560417|NCT00068692|21105679|P2|COMPLETED|Step 2: Randomization||0
8560418|NCT00068692|21105680|P1|COMPLETED|Step 2: Randomization||0
8560419|NCT00068692|21105673|P8|Reported AE Data|Step 2: Randomization||32
8560420|NCT00068692|21105674|P7|Reported AE Data|Step 2: Randomization||33
8560421|NCT00068692|21105675|P6|Reported AE Data|Step 2: Randomization||31
8560422|NCT00068692|21105676|P5|Reported AE Data|Step 2: Randomization||28
8560423|NCT00068692|21105677|P4|Reported AE Data|Step 2: Randomization||22
8560424|NCT00068692|21105678|P3|Reported AE Data|Step 2: Randomization||27
8560425|NCT00068692|21105679|P2|Reported AE Data|Step 2: Randomization||0
8560426|NCT00068692|21105680|P1|Reported AE Data|Step 2: Randomization||0
8560427|NCT00068692|21105673|P8|Had Sphincter Preservation|Step 2: Randomization||30
8560428|NCT00068692|21105674|P7|Had Sphincter Preservation|Step 2: Randomization||33
8560429|NCT00068692|21105675|P6|Had Sphincter Preservation|Step 2: Randomization||31
8560430|NCT00068692|21105676|P5|Had Sphincter Preservation|Step 2: Randomization||28
8560431|NCT00068692|21105677|P4|Had Sphincter Preservation|Step 2: Randomization||25
8560432|NCT00068692|21105678|P3|Had Sphincter Preservation|Step 2: Randomization||28
8560433|NCT00068692|21105679|P2|Had Sphincter Preservation|Step 2: Randomization||0
8560434|NCT00068692|21105680|P1|Had Sphincter Preservation|Step 2: Randomization||0
8560435|NCT00068692|21105673|P8|Treated|Step 2: Randomization||32
8560436|NCT00068692|21105674|P7|Treated|Step 2: Randomization||33
8560437|NCT00068692|21105675|P6|Treated|Step 2: Randomization||31
8560438|NCT00068692|21105676|P5|Treated|Step 2: Randomization||29
8560439|NCT00068692|21105677|P4|Treated|Step 2: Randomization||25
8560440|NCT00068692|21105678|P3|Treated|Step 2: Randomization||27
8560441|NCT00068692|21105679|P2|Treated|Step 2: Randomization||0
8560442|NCT00068692|21105680|P1|Treated|Step 2: Randomization||0
8560443|NCT00068692|21105673|P8|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
8560444|NCT00068692|21105674|P7|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
8560445|NCT00068692|21105675|P6|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
8560446|NCT00068692|21105676|P5|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
8560447|NCT00068692|21105677|P4|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
8560448|NCT00068692|21105678|P3|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
8560449|NCT00068692|21105679|P2|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
8560450|NCT00068692|21105680|P1|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
8560451|NCT00068692|21105673|P8|NOT COMPLETED|Step 1: Registration||0
8560452|NCT00068692|21105674|P7|NOT COMPLETED|Step 1: Registration||0
8560453|NCT00068692|21105675|P6|NOT COMPLETED|Step 1: Registration||0
8560454|NCT00068692|21105676|P5|NOT COMPLETED|Step 1: Registration||0
8560455|NCT00068692|21105677|P4|NOT COMPLETED|Step 1: Registration||0
8560456|NCT00068692|21105678|P3|NOT COMPLETED|Step 1: Registration||0
8560457|NCT00068692|21105679|P2|NOT COMPLETED|Step 1: Registration||1
8560458|NCT00068692|21105680|P1|NOT COMPLETED|Step 1: Registration||40
8560459|NCT00068692|21105673|P8|COMPLETED|Step 1: Registration||0
8560460|NCT00068692|21105674|P7|COMPLETED|Step 1: Registration||0
8560461|NCT00068692|21105675|P6|COMPLETED|Step 1: Registration||0
8560462|NCT00068692|21105676|P5|COMPLETED|Step 1: Registration||0
8560463|NCT00068692|21105677|P4|COMPLETED|Step 1: Registration||0
8560464|NCT00068692|21105678|P3|COMPLETED|Step 1: Registration||0
8560465|NCT00068692|21105679|P2|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
8560466|NCT00068692|21105680|P1|COMPLETED|Step 1: Registration||88
8560467|NCT00068692|21105673|P8|Reported AE Data|Step 1: Registration||0
8560468|NCT00068692|21105674|P7|Reported AE Data|Step 1: Registration||0
8560469|NCT00068692|21105675|P6|Reported AE Data|Step 1: Registration||0
8560470|NCT00068692|21105676|P5|Reported AE Data|Step 1: Registration||0
8560471|NCT00068692|21105677|P4|Reported AE Data|Step 1: Registration||0
8560472|NCT00068692|21105678|P3|Reported AE Data|Step 1: Registration||0
8560473|NCT00068692|21105679|P2|Reported AE Data|Step 1: Registration||0
8560474|NCT00068692|21105680|P1|Reported AE Data|Step 1: Registration||123
8560475|NCT00068692|21105673|P8|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8560476|NCT00068692|21105674|P7|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8560477|NCT00068692|21105675|P6|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8560478|NCT00068692|21105676|P5|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8560479|NCT00068692|21105677|P4|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8560480|NCT00068692|21105678|P3|Started Concurrent Chemo/Radiation|Step 1: Registration||0
8560481|NCT00068692|21105679|P2|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
8560482|NCT00068692|21105680|P1|Started Concurrent Chemo/Radiation|Step 1: Registration||125
8560483|NCT00068692|21105673|P8|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
8560484|NCT00068692|21105674|P7|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
8560485|NCT00068692|21105675|P6|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
8560486|NCT00068692|21105676|P5|STARTED|Step 1: Registration||0
8560487|NCT00068692|21105677|P4|STARTED|Step 1: Registration||0
8560488|NCT00068692|21105678|P3|STARTED|Step 1: Registration||0
8560489|NCT00068692|21105679|P2|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
8560490|NCT00068692|21105680|P1|STARTED|Step 1: Registration||128
8560491|NCT00068601|21105703|P2|NOT COMPLETED|Overall Study||60
8560492|NCT00068601|21105704|P1|NOT COMPLETED|Overall Study||62
8560493|NCT00068601|21105703|P2|COMPLETED|Overall Study||66
8560494|NCT00068601|21105704|P1|COMPLETED|Overall Study||69
8560495|NCT00068601|21105703|P2|STARTED|Overall Study||126
8560496|NCT00068601|21105704|P1|STARTED|Overall Study||131
8560497|NCT00068588|21105717|P3|NOT COMPLETED|Overall Study||4
8560498|NCT00068588|21105718|P2|NOT COMPLETED|Overall Study||0
8560499|NCT00068588|21105719|P1|NOT COMPLETED|Overall Study||0
8560500|NCT00068588|21105717|P3|COMPLETED|Overall Study||17
8560501|NCT00068588|21105718|P2|COMPLETED|Overall Study||3
8560502|NCT00068588|21105719|P1|COMPLETED|Overall Study||0
8560503|NCT00068588|21105717|P3|STARTED|Overall Study||21
8560504|NCT00068588|21105718|P2|STARTED|Overall Study||3
8560505|NCT00068588|21105719|P1|STARTED|Overall Study||0
8560506|NCT00068575|21105729|P1|NOT COMPLETED|Overall Study||0
8560507|NCT00068575|21105729|P1|COMPLETED|Overall Study||28
8560508|NCT00068575|21105729|P1|STARTED|Overall Study||28
8560509|NCT00068445|21105735|P2|NOT COMPLETED|Treatment||16
8560510|NCT00068445|21105736|P1|NOT COMPLETED|Treatment||29
8560511|NCT00068445|21105735|P2|COMPLETED|Treatment||46
8560512|NCT00068445|21105736|P1|COMPLETED|Treatment||34
8560513|NCT00068445|21105735|P2|STARTED|Treatment||62
8560514|NCT00068445|21105736|P1|STARTED|Treatment||63
8560515|NCT00068445|21105735|P2|NOT COMPLETED|Randomization||4
8560516|NCT00068445|21105736|P1|NOT COMPLETED|Randomization||2
8560517|NCT00068445|21105735|P2|COMPLETED|Randomization||62
8560518|NCT00068445|21105736|P1|COMPLETED|Randomization||63
8560519|NCT00068445|21105735|P2|STARTED|Randomization||66
8560520|NCT00068445|21105736|P1|STARTED|Randomization||65
8560521|NCT00068419|21105760|P1|NOT COMPLETED|Overall Study||60
8560522|NCT00068419|21105760|P1|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
8560523|NCT00068419|21105760|P1|STARTED|Overall Study||70
8560524|NCT00068406|21105769|P1|NOT COMPLETED|Overall Study||3
8560525|NCT00068406|21105769|P1|COMPLETED|Overall Study||58
8560526|NCT00068406|21105769|P1|STARTED|Overall Study||61
8560527|NCT00068393|21105774|P1|NOT COMPLETED|Overall Study||10
8560528|NCT00068393|21105774|P1|COMPLETED|Overall Study||29
8560529|NCT00068393|21105774|P1|Eligible and Treated|Overall Study||38
8560530|NCT00068393|21105774|P1|STARTED|Overall Study||39
8560531|NCT00068380|21105780|P1|NOT COMPLETED|Overall Study||5
8560532|NCT00068380|21105780|P1|COMPLETED|Overall Study||12
8560533|NCT00068380|21105780|P1|STARTED|Overall Study||17
8560534|NCT00068367|21105789|P1|NOT COMPLETED|Overall Study||0
8560535|NCT00068367|21105789|P1|COMPLETED|Overall Study||20
8560536|NCT00068367|21105789|P1|STARTED|Overall Study||20
8560537|NCT00068341|21105798|P3|NOT COMPLETED|Overall Study||0
8560538|NCT00068341|21105799|P2|NOT COMPLETED|Overall Study||0
8560539|NCT00068341|21105800|P1|NOT COMPLETED|Overall Study||0
8560540|NCT00068341|21105798|P3|COMPLETED|Overall Study||44
8560541|NCT00068341|21105799|P2|COMPLETED|Overall Study||15
8560542|NCT00068341|21105800|P1|COMPLETED|Overall Study||15
8560543|NCT00068341|21105798|P3|STARTED|Overall Study||44
8560544|NCT00068341|21105799|P2|STARTED|Overall Study||15
8560545|NCT00068341|21105800|P1|STARTED|Overall Study||15
8560546|NCT00068250|21105824|P4|NOT COMPLETED|Phase II: Dose Level 2||0
8560547|NCT00068250|21105825|P3|NOT COMPLETED|Phase II: Dose Level 2||0
8560548|NCT00068250|21105826|P2|NOT COMPLETED|Phase II: Dose Level 2||0
8560549|NCT00068250|21105827|P1|NOT COMPLETED|Phase II: Dose Level 2||0
8560550|NCT00068250|21105824|P4|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
8560551|NCT00068250|21105825|P3|COMPLETED|Phase II: Dose Level 2||0
8560552|NCT00068250|21105826|P2|COMPLETED|Phase II: Dose Level 2||0
8560553|NCT00068250|21105827|P1|COMPLETED|Phase II: Dose Level 2||0
8560554|NCT00068250|21105824|P4|STARTED|Phase II: Dose Level 2||47
8560555|NCT00068250|21105825|P3|STARTED|Phase II: Dose Level 2||0
8560556|NCT00068250|21105826|P2|STARTED|Phase II: Dose Level 2||0
8560557|NCT00068250|21105827|P1|STARTED|Phase II: Dose Level 2||0
8560558|NCT00068250|21105824|P4|NOT COMPLETED|Phase I: Dose Level 2||0
8560559|NCT00068250|21105825|P3|NOT COMPLETED|Phase I: Dose Level 2||0
8560560|NCT00068250|21105826|P2|NOT COMPLETED|Phase I: Dose Level 2||1
8560561|NCT00068250|21105827|P1|NOT COMPLETED|Phase I: Dose Level 2||0
8560562|NCT00068250|21105824|P4|COMPLETED|Phase I: Dose Level 2||0
8560563|NCT00068250|21105825|P3|COMPLETED|Phase I: Dose Level 2||0
8560564|NCT00068250|21105826|P2|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
8560565|NCT00068250|21105827|P1|COMPLETED|Phase I: Dose Level 2||0
8560566|NCT00068250|21105824|P4|STARTED|Phase I: Dose Level 2||0
8560567|NCT00068250|21105825|P3|STARTED|Phase I: Dose Level 2||0
8560568|NCT00068250|21105826|P2|STARTED|Phase I: Dose Level 2||7
8560569|NCT00068250|21105827|P1|STARTED|Phase I: Dose Level 2||0
8560570|NCT00068250|21105824|P4|NOT COMPLETED|Phase I: Dose Level 1||0
8560571|NCT00068250|21105825|P3|NOT COMPLETED|Phase I: Dose Level 1||0
8560572|NCT00068250|21105826|P2|NOT COMPLETED|Phase I: Dose Level 1||0
8560573|NCT00068250|21105827|P1|NOT COMPLETED|Phase I: Dose Level 1||0
8560574|NCT00068250|21105824|P4|COMPLETED|Phase I: Dose Level 1||0
8560575|NCT00068250|21105825|P3|COMPLETED|Phase I: Dose Level 1||0
8560576|NCT00068250|21105826|P2|COMPLETED|Phase I: Dose Level 1||0
8560577|NCT00068250|21105827|P1|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
8560578|NCT00068250|21105824|P4|STARTED|Phase I: Dose Level 1||0
8560579|NCT00068250|21105825|P3|STARTED|Phase I: Dose Level 1||0
8560580|NCT00068250|21105826|P2|STARTED|Phase I: Dose Level 1||0
8560581|NCT00068250|21105827|P1|STARTED|Phase I: Dose Level 1||6
8560582|NCT00068237|21105837|P1|NOT COMPLETED|Overall Study||5
8560583|NCT00068237|21105837|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
8560584|NCT00068237|21105837|P1|STARTED|Overall Study||49
8560585|NCT00068107|21105849|P1|NOT COMPLETED|Overall Study||9
8560586|NCT00068107|21105849|P1|COMPLETED|Overall Study||3
8560587|NCT00068107|21105849|P1|STARTED|Overall Study||12
8560588|NCT00067990|21105862|P2|NOT COMPLETED|Overall Study||22
8560589|NCT00067990|21105863|P1|NOT COMPLETED|Overall Study||10
8560590|NCT00067990|21105862|P2|COMPLETED|Overall Study||54
8560591|NCT00067990|21105863|P1|COMPLETED|Overall Study||67
8560592|NCT00067990|21105862|P2|STARTED|Overall Study||76
8560593|NCT00067990|21105863|P1|STARTED|Overall Study||77
8560594|NCT00067808|21105874|P3|NOT COMPLETED|Overall Study||0
8560595|NCT00067808|21105875|P2|NOT COMPLETED|Overall Study||0
8560596|NCT00067808|21105876|P1|NOT COMPLETED|Overall Study||0
8560597|NCT00067808|21105874|P3|COMPLETED|Overall Study||14
8560598|NCT00067808|21105875|P2|COMPLETED|Overall Study||93
8560599|NCT00067808|21105876|P1|COMPLETED|Overall Study||17
8560600|NCT00067808|21105874|P3|STARTED|Overall Study||14
8560601|NCT00067808|21105875|P2|STARTED|Overall Study||93
8560602|NCT00067808|21105876|P1|STARTED|Overall Study||17
8560603|NCT00067470|21105886|P2|NOT COMPLETED|Overall Study||1
8560604|NCT00067470|21105887|P1|NOT COMPLETED|Overall Study||0
8560605|NCT00067470|21105886|P2|COMPLETED|Overall Study||19
8560606|NCT00067470|21105887|P1|COMPLETED|Overall Study||19
8560607|NCT00067470|21105886|P2|STARTED|Overall Study||20
8560608|NCT00067470|21105887|P1|STARTED|Overall Study||19
8560609|NCT00067236|21105899|P2|NOT COMPLETED|Overall Study||26
8560610|NCT00067236|21105900|P1|NOT COMPLETED|Overall Study||20
8560611|NCT00067236|21105899|P2|COMPLETED|Overall Study||99
8560612|NCT00067236|21105900|P1|COMPLETED|Overall Study||108
8560613|NCT00067236|21105899|P2|STARTED|Overall Study||125
8560614|NCT00067236|21105900|P1|STARTED|Overall Study||128
8560615|NCT00067028|21105909|P3|NOT COMPLETED|Overall Study||0
8560616|NCT00067028|21105910|P2|NOT COMPLETED|Overall Study||0
8560617|NCT00067028|21105911|P1|NOT COMPLETED|Overall Study||0
8560618|NCT00067028|21105909|P3|COMPLETED|Overall Study||63
8560619|NCT00067028|21105910|P2|COMPLETED|Overall Study||36
8560620|NCT00067028|21105911|P1|COMPLETED|Overall Study||17
8560621|NCT00067028|21105909|P3|STARTED|Overall Study||63
8560622|NCT00067028|21105910|P2|STARTED|Overall Study||36
8560623|NCT00067028|21105911|P1|STARTED|Overall Study||17
8560624|NCT00067002|21105924|P2|NOT COMPLETED|Overall Study||9
8560625|NCT00067002|21105925|P1|NOT COMPLETED|Overall Study||7
8560626|NCT00067002|21105924|P2|COMPLETED|Overall Study||44
8560627|NCT00067002|21105925|P1|COMPLETED|Overall Study||45
8560628|NCT00067002|21105924|P2|STARTED|Overall Study||53
8560629|NCT00067002|21105925|P1|STARTED|Overall Study||52
8560630|NCT00066963|21105942|P3|NOT COMPLETED|Overall Study||39
8560631|NCT00066963|21105943|P2|NOT COMPLETED|Overall Study||31
8560632|NCT00066963|21105944|P1|NOT COMPLETED|Overall Study||26
8560633|NCT00066963|21105942|P3|COMPLETED|Overall Study||87
8560634|NCT00066963|21105943|P2|COMPLETED|Overall Study||93
8560635|NCT00066963|21105944|P1|COMPLETED|Overall Study|any follow-up|100
8560636|NCT00066963|21105942|P3|STARTED|Overall Study||126
8560637|NCT00066963|21105943|P2|STARTED|Overall Study||124
8560638|NCT00066963|21105944|P1|STARTED|Overall Study||126
8560639|NCT00066937|21105956|P4|NOT COMPLETED|6 Month Follow-up||1
8560640|NCT00066937|21105957|P3|NOT COMPLETED|6 Month Follow-up||3
8560641|NCT00066937|21105958|P2|NOT COMPLETED|6 Month Follow-up||3
8560642|NCT00066937|21105959|P1|NOT COMPLETED|6 Month Follow-up||7
8560643|NCT00066937|21105956|P4|COMPLETED|6 Month Follow-up||14
8560644|NCT00066937|21105957|P3|COMPLETED|6 Month Follow-up||22
8560645|NCT00066937|21105958|P2|COMPLETED|6 Month Follow-up||29
8560646|NCT00066937|21105959|P1|COMPLETED|6 Month Follow-up||26
8560647|NCT00066937|21105956|P4|STARTED|6 Month Follow-up||15
8560648|NCT00066937|21105957|P3|STARTED|6 Month Follow-up||25
8560649|NCT00066937|21105958|P2|STARTED|6 Month Follow-up||32
8560650|NCT00066937|21105959|P1|STARTED|6 Month Follow-up||33
8560651|NCT00066937|21105956|P4|NOT COMPLETED|3 Month Follow-up||4
8560652|NCT00066937|21105957|P3|NOT COMPLETED|3 Month Follow-up||1
8560653|NCT00066937|21105958|P2|NOT COMPLETED|3 Month Follow-up||1
8560654|NCT00066937|21105959|P1|NOT COMPLETED|3 Month Follow-up||5
8560655|NCT00066937|21105956|P4|COMPLETED|3 Month Follow-up||15
8560656|NCT00066937|21105957|P3|COMPLETED|3 Month Follow-up||25
8560657|NCT00066937|21105958|P2|COMPLETED|3 Month Follow-up||32
8560658|NCT00066937|21105959|P1|COMPLETED|3 Month Follow-up||33
8560659|NCT00066937|21105956|P4|STARTED|3 Month Follow-up||19
8560660|NCT00066937|21105957|P3|STARTED|3 Month Follow-up||26
8560661|NCT00066937|21105958|P2|STARTED|3 Month Follow-up||33
8560662|NCT00066937|21105959|P1|STARTED|3 Month Follow-up||38
8560663|NCT00066937|21105956|P4|NOT COMPLETED|Treatment Phase||5
8560664|NCT00066937|21105957|P3|NOT COMPLETED|Treatment Phase||11
8560665|NCT00066937|21105958|P2|NOT COMPLETED|Treatment Phase||5
8560666|NCT00066937|21105959|P1|NOT COMPLETED|Treatment Phase||3
8560667|NCT00066937|21105956|P4|COMPLETED|Treatment Phase||19
8560668|NCT00066937|21105957|P3|COMPLETED|Treatment Phase||26
8560669|NCT00066937|21105958|P2|COMPLETED|Treatment Phase||33
8560670|NCT00066937|21105959|P1|COMPLETED|Treatment Phase||38
8560671|NCT00066937|21105956|P4|STARTED|Treatment Phase||24
8560672|NCT00066937|21105957|P3|STARTED|Treatment Phase||37
8560673|NCT00066937|21105958|P2|STARTED|Treatment Phase||38
8560674|NCT00066937|21105959|P1|STARTED|Treatment Phase||41
8560675|NCT00066807|21105983|P2|NOT COMPLETED|Overall Study||15
8560676|NCT00066807|21105984|P1|NOT COMPLETED|Overall Study||14
8560677|NCT00066807|21105983|P2|COMPLETED|Overall Study||0
8560678|NCT00066807|21105984|P1|COMPLETED|Overall Study||0
8560679|NCT00066807|21105983|P2|STARTED|Overall Study||15
8560680|NCT00066807|21105984|P1|STARTED|Overall Study||14
8560681|NCT00066781|21105998|P2|NOT COMPLETED|Overall Study||0
8560682|NCT00066781|21105999|P1|NOT COMPLETED|Overall Study||0
8560683|NCT00066781|21105998|P2|COMPLETED|Overall Study||17
8560684|NCT00066781|21105999|P1|COMPLETED|Overall Study||14
8560685|NCT00066781|21105998|P2|STARTED|Overall Study||17
8560686|NCT00066781|21105999|P1|STARTED|Overall Study||14
8560687|NCT00066742|21106009|P1|NOT COMPLETED|Consolidation Chemotherapy||3
8560688|NCT00066742|21106009|P1|COMPLETED|Consolidation Chemotherapy||39
8560689|NCT00066742|21106009|P1|Eligible|Consolidation Chemotherapy||40
8560690|NCT00066742|21106009|P1|STARTED|Consolidation Chemotherapy||42
8560691|NCT00066742|21106009|P1|NOT COMPLETED|Induction Chemoradiotherapy||29
8560692|NCT00066742|21106009|P1|COMPLETED|Induction Chemoradiotherapy||43
8560693|NCT00066742|21106009|P1|Began Protocol Treatment|Induction Chemoradiotherapy||68
8560694|NCT00066742|21106009|P1|Eligible|Induction Chemoradiotherapy||69
8560695|NCT00066742|21106009|P1|STARTED|Induction Chemoradiotherapy||72
8560711|NCT00066573|21106055|P2|NOT COMPLETED|Overall Study||28
8560712|NCT00066573|21106056|P1|NOT COMPLETED|Overall Study||28
8560713|NCT00066573|21106055|P2|COMPLETED|Overall Study||3759
8560714|NCT00066573|21106056|P1|COMPLETED|Overall Study||3761
8560715|NCT00066573|21106055|P2|STARTED|Overall Study||3787
8560716|NCT00066573|21106056|P1|STARTED|Overall Study||3789
8560717|NCT00066469|21106068|P1|NOT COMPLETED|Overall Study||16
8560718|NCT00066469|21106068|P1|COMPLETED|Overall Study||39
8560719|NCT00066469|21106068|P1|STARTED|Overall Study||55
8560720|NCT00066365|21106074|P2|NOT COMPLETED|Overall Study||14
8560721|NCT00066365|21106075|P1|NOT COMPLETED|Overall Study||23
8560722|NCT00066365|21106074|P2|COMPLETED|Overall Study||4
8560723|NCT00066365|21106075|P1|COMPLETED|Overall Study||8
8560724|NCT00066365|21106074|P2|STARTED|Overall Study||18
8560725|NCT00066365|21106075|P1|STARTED|Overall Study||31
8560726|NCT00066222|21106103|P1|NOT COMPLETED|Overall Study||1
8560727|NCT00066222|21106103|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
8560728|NCT00066222|21106103|P1|STARTED|Overall Study||72
8560729|NCT00066170|21106116|P4|NOT COMPLETED|Overall Study||9
8560730|NCT00066170|21106117|P3|NOT COMPLETED|Overall Study||4
8560731|NCT00066170|21106118|P2|NOT COMPLETED|Overall Study||10
8560732|NCT00066170|21106119|P1|NOT COMPLETED|Overall Study||7
8560733|NCT00066170|21106116|P4|COMPLETED|Overall Study||48
8560734|NCT00066170|21106117|P3|COMPLETED|Overall Study||59
8560735|NCT00066170|21106118|P2|COMPLETED|Overall Study||45
8560736|NCT00066170|21106119|P1|COMPLETED|Overall Study||49
8560737|NCT00066170|21106116|P4|Intent to Treat|Overall Study||54
8560738|NCT00066170|21106117|P3|Intent to Treat|Overall Study||63
8560739|NCT00066170|21106118|P2|Intent to Treat|Overall Study||50
8560740|NCT00066170|21106119|P1|Intent to Treat|Overall Study||55
8560741|NCT00066170|21106116|P4|STARTED|Overall Study||57
8560742|NCT00066170|21106117|P3|STARTED|Overall Study||63
8560743|NCT00066170|21106118|P2|STARTED|Overall Study||55
8560744|NCT00066170|21106119|P1|STARTED|Overall Study||56
8560745|NCT00066066|21106132|P6|NOT COMPLETED|Overall Study||5
8560746|NCT00066066|21106133|P5|NOT COMPLETED|Overall Study||3
8560747|NCT00066066|21106134|P4|NOT COMPLETED|Overall Study||4
8560748|NCT00066066|21106135|P3|NOT COMPLETED|Overall Study||7
8560749|NCT00066066|21106136|P2|NOT COMPLETED|Overall Study||4
8560750|NCT00066066|21106137|P1|NOT COMPLETED|Overall Study||6
8560751|NCT00066066|21106132|P6|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
8560752|NCT00066066|21106133|P5|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
8560753|NCT00066066|21106134|P4|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
8560754|NCT00066066|21106135|P3|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
8560755|NCT00066066|21106136|P2|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
8560756|NCT00066066|21106137|P1|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
8560757|NCT00066066|21106132|P6|12 Month|Overall Study||9
8560758|NCT00066066|21106133|P5|12 Month|Overall Study||19
8560759|NCT00066066|21106134|P4|12 Month|Overall Study||11
8560760|NCT00066066|21106135|P3|12 Month|Overall Study||21
8560761|NCT00066066|21106136|P2|12 Month|Overall Study||11
8560762|NCT00066066|21106137|P1|12 Month|Overall Study||18
8560763|NCT00066066|21106132|P6|6 Month|Overall Study||14
8560764|NCT00066066|21106133|P5|6 Month|Overall Study||21
8560765|NCT00066066|21106134|P4|6 Month|Overall Study||13
8560766|NCT00066066|21106135|P3|6 Month|Overall Study||23
8560767|NCT00066066|21106136|P2|6 Month|Overall Study||13
8560768|NCT00066066|21106137|P1|6 Month|Overall Study||19
8560769|NCT00066066|21106132|P6|3 Month|Overall Study||15
8560770|NCT00066066|21106133|P5|3 Month|Overall Study||22
8560771|NCT00066066|21106134|P4|3 Month|Overall Study||16
8560772|NCT00066066|21106135|P3|3 Month|Overall Study||23
8560773|NCT00066066|21106136|P2|3 Month|Overall Study||17
8560774|NCT00066066|21106137|P1|3 Month|Overall Study||21
8560775|NCT00066066|21106132|P6|Baseline|Overall Study||20
8560776|NCT00066066|21106133|P5|Baseline|Overall Study||27
8560777|NCT00066066|21106134|P4|Baseline|Overall Study||20
8560778|NCT00066066|21106135|P3|Baseline|Overall Study||30
8560779|NCT00066066|21106136|P2|Baseline|Overall Study||22
8560780|NCT00066066|21106137|P1|Baseline|Overall Study||27
8560781|NCT00066066|21106132|P6|STARTED|Overall Study||20
8560782|NCT00066066|21106133|P5|STARTED|Overall Study||27
8560783|NCT00066066|21106134|P4|STARTED|Overall Study||20
8560784|NCT00066066|21106135|P3|STARTED|Overall Study||30
8560785|NCT00066066|21106136|P2|STARTED|Overall Study||22
8560786|NCT00066066|21106137|P1|STARTED|Overall Study||27
8560787|NCT00065806|21106153|P2|NOT COMPLETED|Overall Study||19
8560788|NCT00065806|21106154|P1|NOT COMPLETED|Overall Study||20
8560789|NCT00065806|21106153|P2|COMPLETED|Overall Study||89
8560790|NCT00065806|21106154|P1|COMPLETED|Overall Study||93
8560791|NCT00065806|21106153|P2|STARTED|Overall Study||108
8560792|NCT00065806|21106154|P1|STARTED|Overall Study||113
8560793|NCT00014560|21106196|P1|NOT COMPLETED|Overall Study||3
8560794|NCT00014560|21106196|P1|COMPLETED|Overall Study||0
8560795|NCT00014560|21106196|P1|STARTED|Overall Study||3
8560796|NCT00065611|21106202|P2|NOT COMPLETED|Overall Study||1
8560797|NCT00065611|21106203|P1|NOT COMPLETED|Overall Study||0
8560798|NCT00065611|21106202|P2|COMPLETED|Overall Study||3
8560799|NCT00065611|21106203|P1|COMPLETED|Overall Study||4
8560800|NCT00065611|21106202|P2|STARTED|Overall Study||4
8560801|NCT00065611|21106203|P1|STARTED|Overall Study||4
8560802|NCT00065507|21106215|P2|NOT COMPLETED|Overall Study||29
8560803|NCT00065507|21106216|P1|NOT COMPLETED|Overall Study||29
8560804|NCT00065507|21106215|P2|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
8560805|NCT00065507|21106216|P1|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
8560806|NCT00065507|21106215|P2|Treated, 24-Week Follow-Up Population|Overall Study||28
8560807|NCT00065507|21106216|P1|Treated, 24-Week Follow-Up Population|Overall Study||25
8560808|NCT00065507|21106215|P2|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
8560809|NCT00065507|21106216|P1|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
8560810|NCT00065507|21106215|P2|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
8560811|NCT00065507|21106216|P1|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
8560812|NCT00065507|21106215|P2|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
8560813|NCT00065507|21106216|P1|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
8560814|NCT00065507|21106215|P2|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
8560815|NCT00065507|21106216|P1|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
8560816|NCT00065468|21106281|P3|NOT COMPLETED|Overall Study||210
8560817|NCT00065468|21106282|P2|NOT COMPLETED|Overall Study||209
8560818|NCT00065468|21106283|P1|NOT COMPLETED|Overall Study||207
8560819|NCT00065468|21106281|P3|COMPLETED|Overall Study||0
8560820|NCT00065468|21106282|P2|COMPLETED|Overall Study||0
8560821|NCT00065468|21106283|P1|COMPLETED|Overall Study||0
8560822|NCT00065468|21106281|P3|Received Treatment|Overall Study||208
8560823|NCT00065468|21106282|P2|Received Treatment|Overall Study||208
8560824|NCT00065468|21106283|P1|Received Treatment|Overall Study||200
8560825|NCT00065468|21106281|P3|STARTED|Overall Study||210
8560826|NCT00065468|21106282|P2|STARTED|Overall Study||209
8560827|NCT00065468|21106283|P1|STARTED|Overall Study||207
8560828|NCT00065442|21106314|P2|NOT COMPLETED|Overall Study||220
8560829|NCT00065442|21106315|P1|NOT COMPLETED|Overall Study||125
8560830|NCT00065442|21106314|P2|COMPLETED|Overall Study||121
8560831|NCT00065442|21106315|P1|COMPLETED|Overall Study||46
8560832|NCT00065442|21106314|P2|STARTED|Overall Study||341
8560833|NCT00065442|21106315|P1|STARTED|Overall Study||171
8560834|NCT00065429|21106330|P7|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560835|NCT00065429|21106331|P6|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560836|NCT00065429|21106332|P5|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
8560837|NCT00065429|21106333|P4|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560838|NCT00065429|21106334|P3|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560839|NCT00065429|21106335|P2|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560840|NCT00065429|21106336|P1|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560841|NCT00065429|21106330|P7|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560842|NCT00065429|21106331|P6|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560843|NCT00065429|21106332|P5|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
8560844|NCT00065429|21106333|P4|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560845|NCT00065429|21106334|P3|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560846|NCT00065429|21106335|P2|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560847|NCT00065429|21106336|P1|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
8560848|NCT00065429|21106330|P7|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8560849|NCT00065429|21106331|P6|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8560850|NCT00065429|21106332|P5|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
8560851|NCT00065429|21106333|P4|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8560852|NCT00065429|21106334|P3|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8560853|NCT00065429|21106335|P2|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8560854|NCT00065429|21106336|P1|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
8560855|NCT00065429|21106330|P7|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
8560856|NCT00065429|21106331|P6|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
8560857|NCT00065429|21106332|P5|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8560858|NCT00065429|21106333|P4|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8560859|NCT00065429|21106334|P3|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8560860|NCT00065429|21106335|P2|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
8560861|NCT00065429|21106336|P1|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
8560862|NCT00065429|21106330|P7|COMPLETED|Phase I - May 2001 - Oct 2002||2
8560863|NCT00065429|21106331|P6|COMPLETED|Phase I - May 2001 - Oct 2002||2
8560864|NCT00065429|21106332|P5|COMPLETED|Phase I - May 2001 - Oct 2002||8
8560865|NCT00065429|21106333|P4|COMPLETED|Phase I - May 2001 - Oct 2002||3
8560866|NCT00065429|21106334|P3|COMPLETED|Phase I - May 2001 - Oct 2002||3
8560867|NCT00065429|21106335|P2|COMPLETED|Phase I - May 2001 - Oct 2002||3
8560868|NCT00065429|21106336|P1|COMPLETED|Phase I - May 2001 - Oct 2002||3
8560869|NCT00065429|21106330|P7|STARTED|Phase I - May 2001 - Oct 2002||4
8560870|NCT00065429|21106331|P6|STARTED|Phase I - May 2001 - Oct 2002||4
8560871|NCT00065429|21106332|P5|STARTED|Phase I - May 2001 - Oct 2002||9
8560872|NCT00065429|21106333|P4|STARTED|Phase I - May 2001 - Oct 2002||4
8560873|NCT00065429|21106334|P3|STARTED|Phase I - May 2001 - Oct 2002||4
8560874|NCT00065429|21106335|P2|STARTED|Phase I - May 2001 - Oct 2002||3
8560875|NCT00065429|21106336|P1|STARTED|Phase I - May 2001 - Oct 2002||4
8560882|NCT00065182|21106359|P2|NOT COMPLETED|Overall Study||37
8560883|NCT00065182|21106360|P1|NOT COMPLETED|Overall Study||48
8560884|NCT00065182|21106359|P2|COMPLETED|Overall Study||160
8560885|NCT00065182|21106360|P1|COMPLETED|Overall Study||154
8560886|NCT00065182|21106359|P2|STARTED|Overall Study||197
8560887|NCT00065182|21106360|P1|STARTED|Overall Study||202
8560888|NCT00065156|21106386|P1|NOT COMPLETED|Overall Study||124
8560889|NCT00065156|21106386|P1|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
8560890|NCT00065156|21106386|P1|Modified Intent to Treat Population|Overall Study||94
8560891|NCT00065156|21106386|P1|STARTED|Overall Study||148
8560892|NCT00065065|21106403|P2|NOT COMPLETED|Overall Study||20
8560893|NCT00065065|21106404|P1|NOT COMPLETED|Overall Study||10
8560894|NCT00065065|21106403|P2|COMPLETED|Overall Study||33
8560895|NCT00065065|21106404|P1|COMPLETED|Overall Study||42
8560896|NCT00065065|21106403|P2|STARTED|Overall Study||53
8560897|NCT00065065|21106404|P1|STARTED|Overall Study||52
8560898|NCT00003895|21106416|P2|NOT COMPLETED|Overall Study||4
8560899|NCT00003895|21106417|P1|NOT COMPLETED|Overall Study||7
8560900|NCT00003895|21106416|P2|COMPLETED|Overall Study||14
8560901|NCT00003895|21106417|P1|COMPLETED|Overall Study||11
8560902|NCT00003895|21106416|P2|STARTED|Overall Study||18
8560903|NCT00003895|21106417|P1|STARTED|Overall Study||18
8560904|NCT00064987|21106425|P2|NOT COMPLETED|Overall Study||0
8560905|NCT00064987|21106426|P1|NOT COMPLETED|Overall Study||3
8560906|NCT00064987|21106425|P2|COMPLETED|Overall Study||6
8560907|NCT00064987|21106426|P1|COMPLETED|Overall Study||7
8560908|NCT00064987|21106425|P2|STARTED|Overall Study||6
8560909|NCT00064987|21106426|P1|STARTED|Overall Study||10
8560924|NCT00064753|21106457|P2|NOT COMPLETED|Overall Study||648
8560925|NCT00064753|21106458|P1|NOT COMPLETED|Overall Study||674
8560926|NCT00064753|21106457|P2|COMPLETED|Overall Study||1406
8560927|NCT00064753|21106458|P1|COMPLETED|Overall Study||1382
8560928|NCT00064753|21106457|P2|STARTED|Overall Study||2054
8560929|NCT00064753|21106458|P1|STARTED|Overall Study||2056
8560930|NCT00003645|21106488|P2|NOT COMPLETED|Overall Study||12
8560931|NCT00003645|21106489|P1|NOT COMPLETED|Overall Study||12
8560932|NCT00003645|21106488|P2|COMPLETED|Overall Study||22
8560933|NCT00003645|21106489|P1|COMPLETED|Overall Study||18
8560934|NCT00003645|21106488|P2|STARTED|Overall Study||34
8560935|NCT00003645|21106489|P1|STARTED|Overall Study||30
8560936|NCT00064792|21106503|P2|NOT COMPLETED|Overall Study||0
8560937|NCT00064792|21106504|P1|NOT COMPLETED|Overall Study||5
8560938|NCT00064792|21106503|P2|COMPLETED|Overall Study||10
8560939|NCT00064792|21106504|P1|COMPLETED|Overall Study||8
8560940|NCT00064792|21106503|P2|STARTED|Overall Study||10
8560941|NCT00064792|21106504|P1|STARTED|Overall Study||13
8560942|NCT00064701|21106515|P3|NOT COMPLETED|Clinical Continuation Phase||140
8560943|NCT00064701|21106516|P2|NOT COMPLETED|Clinical Continuation Phase||178
8560944|NCT00064701|21106517|P1|NOT COMPLETED|Clinical Continuation Phase||170
8560945|NCT00064701|21106515|P3|COMPLETED|Clinical Continuation Phase||11
8560946|NCT00064701|21106516|P2|COMPLETED|Clinical Continuation Phase||4
8560947|NCT00064701|21106517|P1|COMPLETED|Clinical Continuation Phase||9
8560948|NCT00064701|21106515|P3|STARTED|Clinical Continuation Phase||151
8560949|NCT00064701|21106516|P2|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
8560950|NCT00064701|21106517|P1|STARTED|Clinical Continuation Phase||179
8560951|NCT00064701|21106515|P3|NOT COMPLETED|One Year Post-transplant||72
8560952|NCT00064701|21106516|P2|NOT COMPLETED|One Year Post-transplant||43
8560953|NCT00064701|21106517|P1|NOT COMPLETED|One Year Post-transplant||40
8560954|NCT00064701|21106515|P3|COMPLETED|One Year Post-transplant||151
8560955|NCT00064701|21106516|P2|COMPLETED|One Year Post-transplant||183
8560956|NCT00064701|21106517|P1|COMPLETED|One Year Post-transplant||179
8560957|NCT00064701|21106515|P3|Received Study Drug|One Year Post-transplant||212
8560958|NCT00064701|21106516|P2|Received Study Drug|One Year Post-transplant||214
8560959|NCT00064701|21106517|P1|Received Study Drug|One Year Post-transplant||212
8560960|NCT00064701|21106515|P3|STARTED|One Year Post-transplant||223
8560961|NCT00064701|21106516|P2|STARTED|One Year Post-transplant||226
8560962|NCT00064701|21106517|P1|STARTED|One Year Post-transplant||219
8560963|NCT00064662|21106569|P2|NOT COMPLETED|Overall Study||61
8560964|NCT00064662|21106570|P1|NOT COMPLETED|Overall Study||74
8560965|NCT00064662|21106569|P2|COMPLETED|Overall Study||265
8560966|NCT00064662|21106570|P1|COMPLETED|Overall Study||255
8560967|NCT00064662|21106569|P2|STARTED|Overall Study||326
8560968|NCT00064662|21106570|P1|STARTED|Overall Study||329
8560969|NCT00064350|21106581|P3|NOT COMPLETED|Cross-Over||0
8560970|NCT00064350|21106582|P2|NOT COMPLETED|Cross-Over||14
8560971|NCT00064350|21106583|P1|NOT COMPLETED|Cross-Over||6
8560972|NCT00064350|21106581|P3|COMPLETED|Cross-Over||0
8560973|NCT00064350|21106582|P2|COMPLETED|Cross-Over||13
8560974|NCT00064350|21106583|P1|COMPLETED|Cross-Over||4
8560975|NCT00064350|21106581|P3|Eligible and Treated|Cross-Over||0
8560976|NCT00064350|21106582|P2|Eligible and Treated|Cross-Over||21
8560977|NCT00064350|21106583|P1|Eligible and Treated|Cross-Over||7
8560978|NCT00064350|21106581|P3|Treated|Cross-Over||0
8560979|NCT00064350|21106582|P2|Treated|Cross-Over||26
8560980|NCT00064350|21106583|P1|Treated|Cross-Over||9
8560981|NCT00064350|21106581|P3|STARTED|Cross-Over||0
8560982|NCT00064350|21106582|P2|STARTED|Cross-Over||27
8560983|NCT00064350|21106583|P1|STARTED|Cross-Over||10
8560984|NCT00064350|21106581|P3|NOT COMPLETED|Randomization||0
8560985|NCT00064350|21106582|P2|NOT COMPLETED|Randomization||18
8560986|NCT00064350|21106583|P1|NOT COMPLETED|Randomization||26
8560987|NCT00064350|21106581|P3|COMPLETED|Randomization||0
8560988|NCT00064350|21106582|P2|COMPLETED|Randomization||28
8560989|NCT00064350|21106583|P1|COMPLETED|Randomization||33
8560990|NCT00064350|21106581|P3|Eligible and Treated|Randomization||0
8560991|NCT00064350|21106582|P2|Eligible and Treated|Randomization||31
8560992|NCT00064350|21106583|P1|Eligible and Treated|Randomization||50
8560993|NCT00064350|21106581|P3|Treated|Randomization||0
8560994|NCT00064350|21106582|P2|Treated|Randomization||40
8560995|NCT00064350|21106583|P1|Treated|Randomization||55
8560996|NCT00064350|21106581|P3|STARTED|Randomization||0
8560997|NCT00064350|21106582|P2|STARTED|Randomization||46
8560998|NCT00064350|21106583|P1|STARTED|Randomization||59
8560999|NCT00064350|21106581|P3|NOT COMPLETED|Induction Treatment||236
8561000|NCT00064350|21106582|P2|NOT COMPLETED|Induction Treatment||9
8561001|NCT00064350|21106583|P1|NOT COMPLETED|Induction Treatment||8
8561002|NCT00064350|21106581|P3|COMPLETED|Induction Treatment||1
8561003|NCT00064350|21106582|P2|COMPLETED|Induction Treatment||37
8561004|NCT00064350|21106583|P1|COMPLETED|Induction Treatment||51
8561005|NCT00064350|21106581|P3|Eligible and Treated|Induction Treatment||194
8561006|NCT00064350|21106582|P2|Eligible and Treated|Induction Treatment||46
8561007|NCT00064350|21106583|P1|Eligible and Treated|Induction Treatment||59
8561008|NCT00064350|21106581|P3|Treated|Induction Treatment||228
8561009|NCT00064350|21106582|P2|Treated|Induction Treatment||46
8561010|NCT00064350|21106583|P1|Treated|Induction Treatment||59
8561011|NCT00064350|21106581|P3|STARTED|Induction Treatment||237
8561012|NCT00064350|21106582|P2|STARTED|Induction Treatment||46
8561013|NCT00064350|21106583|P1|STARTED|Induction Treatment||59
8561014|NCT00064337|21106598|P1|NOT COMPLETED|Maintenance||10
8561015|NCT00064337|21106598|P1|COMPLETED|Maintenance||3
8561016|NCT00064337|21106598|P1|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
8561017|NCT00064337|21106598|P1|NOT COMPLETED|Transplant||21
8561018|NCT00064337|21106598|P1|COMPLETED|Transplant||46
8561019|NCT00064337|21106598|P1|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
8561020|NCT00064337|21106598|P1|NOT COMPLETED|PBSCC or Induction/PBSCC||20
8561021|NCT00064337|21106598|P1|COMPLETED|PBSCC or Induction/PBSCC||73
8561022|NCT00064337|21106598|P1|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
8561023|NCT00064298|21106607|P2|NOT COMPLETED|Overall Study||5
8561024|NCT00064298|21106608|P1|NOT COMPLETED|Overall Study||6
8561025|NCT00064298|21106607|P2|COMPLETED|Overall Study||57
8561026|NCT00064298|21106608|P1|COMPLETED|Overall Study||66
8561027|NCT00064298|21106607|P2|STARTED|Overall Study||62
8561028|NCT00064298|21106608|P1|STARTED|Overall Study||72
8561041|NCT00064077|21106627|P4|NOT COMPLETED|Overall Study||7
8561042|NCT00064077|21106628|P3|NOT COMPLETED|Overall Study||7
8561043|NCT00064077|21106629|P2|NOT COMPLETED|Overall Study||9
8561044|NCT00064077|21106630|P1|NOT COMPLETED|Overall Study||15
8561045|NCT00064077|21106627|P4|COMPLETED|Overall Study|Evaluable (treatment)|111
8561046|NCT00064077|21106628|P3|COMPLETED|Overall Study|Evaluable (treatment)|112
8561047|NCT00064077|21106629|P2|COMPLETED|Overall Study|Evaluable (treatment)|108
8561048|NCT00064077|21106630|P1|COMPLETED|Overall Study|Evaluable (treatment)|103
8561049|NCT00064077|21106627|P4|STARTED|Overall Study||118
8561050|NCT00064077|21106628|P3|STARTED|Overall Study||119
8561051|NCT00064077|21106629|P2|STARTED|Overall Study||117
8561052|NCT00064077|21106630|P1|STARTED|Overall Study||118
8561053|NCT00064038|21106662|P3|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
8561054|NCT00064038|21106663|P2|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
8561055|NCT00064038|21106664|P1|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
8561056|NCT00064038|21106662|P3|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
8561057|NCT00064038|21106663|P2|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8561058|NCT00064038|21106664|P1|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
8561059|NCT00064038|21106662|P3|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
8561060|NCT00064038|21106663|P2|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8561061|NCT00064038|21106664|P1|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
8561062|NCT00064038|21106662|P3|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
8561063|NCT00064038|21106663|P2|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8561064|NCT00064038|21106664|P1|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
8561065|NCT00064038|21106662|P3|STARTED|Crossover to Lenalidomide+Dexamethasone||42
8561066|NCT00064038|21106663|P2|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
8561067|NCT00064038|21106664|P1|STARTED|Crossover to Lenalidomide+Dexamethasone||0
8561068|NCT00064038|21106662|P3|NOT COMPLETED|Initial Randomization||0
8561069|NCT00064038|21106663|P2|NOT COMPLETED|Initial Randomization||98
8561070|NCT00064038|21106664|P1|NOT COMPLETED|Initial Randomization||100
8561071|NCT00064038|21106662|P3|COMPLETED|Initial Randomization||0
8561072|NCT00064038|21106663|P2|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
8561073|NCT00064038|21106664|P1|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
8561074|NCT00064038|21106662|P3|Safety Population|Initial Randomization||0
8561075|NCT00064038|21106663|P2|Safety Population|Initial Randomization||94
8561076|NCT00064038|21106664|P1|Safety Population|Initial Randomization||96
8561077|NCT00064038|21106662|P3|Eligible and Analyzable|Initial Randomization||0
8561078|NCT00064038|21106663|P2|Eligible and Analyzable|Initial Randomization||95
8561079|NCT00064038|21106664|P1|Eligible and Analyzable|Initial Randomization||97
8561080|NCT00064038|21106662|P3|STARTED|Initial Randomization||0
8561081|NCT00064038|21106663|P2|STARTED|Initial Randomization||98
8561082|NCT00064038|21106664|P1|STARTED|Initial Randomization||100
8561083|NCT00064025|21106674|P1|NOT COMPLETED|Overall Study||7
8561084|NCT00064025|21106674|P1|COMPLETED|Overall Study||68
8561085|NCT00064025|21106674|P1|STARTED|Overall Study||75
8561086|NCT00063999|21106683|P2|NOT COMPLETED|Overall Study||24
8561087|NCT00063999|21106684|P1|NOT COMPLETED|Overall Study||45
8561088|NCT00063999|21106683|P2|COMPLETED|Overall Study||665
8561089|NCT00063999|21106684|P1|COMPLETED|Overall Study||647
8561090|NCT00063999|21106683|P2|STARTED|Overall Study||689
8561091|NCT00063999|21106684|P1|STARTED|Overall Study||692
8561092|NCT00063986|21106700|P1|NOT COMPLETED|Overall Study||6
8561093|NCT00063986|21106700|P1|COMPLETED|Overall Study||104
8561094|NCT00063986|21106700|P1|Eligible and Treated|Overall Study||104
8561095|NCT00063986|21106700|P1|Treated|Overall Study||105
8561096|NCT00063986|21106700|P1|STARTED|Overall Study||110
8561097|NCT00063934|21106712|P1|NOT COMPLETED|Overall Study||1
8561098|NCT00063934|21106712|P1|COMPLETED|Overall Study||30
8561099|NCT00063934|21106712|P1|STARTED|Overall Study||31
8561100|NCT00063882|21106721|P2|NOT COMPLETED|Overall Study||4
8561101|NCT00063882|21106722|P1|NOT COMPLETED|Overall Study||5
8561102|NCT00063882|21106721|P2|COMPLETED|Overall Study||292
8561103|NCT00063882|21106722|P1|COMPLETED|Overall Study||287
8561104|NCT00063882|21106721|P2|Eligible Patients|Overall Study||292
8561105|NCT00063882|21106722|P1|Eligible Patients|Overall Study||287
8561106|NCT00063882|21106721|P2|Has Baseline/24-month EPIC Data|Overall Study||219
8561107|NCT00063882|21106722|P1|Has Baseline/24-month EPIC Data|Overall Study||201
8561108|NCT00063882|21106721|P2|Has Baseline/4-month EPIC Data|Overall Study||241
8561109|NCT00063882|21106722|P1|Has Baseline/4-month EPIC Data|Overall Study||222
8561110|NCT00063882|21106721|P2|Has Late Adverse Event Data|Overall Study||287
8561111|NCT00063882|21106722|P1|Has Late Adverse Event Data|Overall Study||282
8561112|NCT00063882|21106721|P2|Has Acute Adverse Event Data|Overall Study||288
8561113|NCT00063882|21106722|P1|Has Acute Adverse Event Data|Overall Study||282
8561114|NCT00063882|21106721|P2|STARTED|Overall Study||296
8561115|NCT00063882|21106722|P1|STARTED|Overall Study||292
8561116|NCT00063635|21106753|P3|NOT COMPLETED|Overall Study||9
8561117|NCT00063635|21106754|P2|NOT COMPLETED|Overall Study||8
8561118|NCT00063635|21106755|P1|NOT COMPLETED|Overall Study||6
8561119|NCT00063635|21106753|P3|COMPLETED|Overall Study||49
8561120|NCT00063635|21106754|P2|COMPLETED|Overall Study||50
8561121|NCT00063635|21106755|P1|COMPLETED|Overall Study||51
8561122|NCT00063635|21106753|P3|STARTED|Overall Study||58
8561123|NCT00063635|21106754|P2|STARTED|Overall Study||58
8561124|NCT00063635|21106755|P1|STARTED|Overall Study||57
8561125|NCT00063622|21106796|P3|NOT COMPLETED|Overall Study||11
8561126|NCT00063622|21106797|P2|NOT COMPLETED|Overall Study||4
8561127|NCT00063622|21106798|P1|NOT COMPLETED|Overall Study||10
8561128|NCT00063622|21106796|P3|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
8561129|NCT00063622|21106797|P2|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
8561224|NCT00062868|21106893|P18|NOT COMPLETED|Dose Level 2||0
8561130|NCT00063622|21106798|P1|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
8561131|NCT00063622|21106796|P3|STARTED|Overall Study||83
8561132|NCT00063622|21106797|P2|STARTED|Overall Study||84
8561133|NCT00063622|21106798|P1|STARTED|Overall Study||80
8561134|NCT00063570|21106823|P2|NOT COMPLETED|Overall Study||0
8561135|NCT00063570|21106824|P1|NOT COMPLETED|Overall Study||0
8561136|NCT00063570|21106823|P2|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
8561137|NCT00063570|21106824|P1|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
8561138|NCT00063570|21106823|P2|STARTED|Overall Study||21
8561139|NCT00063570|21106824|P1|STARTED|Overall Study||52
8561140|NCT00063362|21106840|P2|NOT COMPLETED|Overall Study||4
8561141|NCT00063362|21106841|P1|NOT COMPLETED|Overall Study||4
8561142|NCT00063362|21106840|P2|COMPLETED|Overall Study||22
8561143|NCT00063362|21106841|P1|COMPLETED|Overall Study||19
8561144|NCT00063362|21106840|P2|STARTED|Overall Study||26
8561145|NCT00063362|21106841|P1|STARTED|Overall Study||23
8561146|NCT00063258|21106849|P2|NOT COMPLETED|Overall Study||0
8561147|NCT00063258|21106850|P1|NOT COMPLETED|Overall Study||4
8561148|NCT00063258|21106849|P2|COMPLETED|Overall Study||0
8561149|NCT00063258|21106850|P1|COMPLETED|Overall Study||1
8561150|NCT00063258|21106849|P2|STARTED|Overall Study||0
8561151|NCT00063258|21106850|P1|STARTED|Overall Study||5
8561152|NCT00063154|21106856|P1|NOT COMPLETED|Overall Study||51
8561153|NCT00063154|21106856|P1|COMPLETED|Overall Study||0
8561154|NCT00063154|21106856|P1|STARTED|Overall Study||51
8561155|NCT00063232|21106863|P1|NOT COMPLETED|Overall Study||0
8561156|NCT00063232|21106863|P1|COMPLETED|Overall Study||26
8561157|NCT00063232|21106863|P1|STARTED|Overall Study||26
8561158|NCT00062868|21106890|P21|NOT COMPLETED|Dose Level 3||0
8561159|NCT00062868|21106891|P20|NOT COMPLETED|Dose Level 3||0
8561160|NCT00062868|21106892|P19|NOT COMPLETED|Dose Level 3||0
8561161|NCT00062868|21106893|P18|NOT COMPLETED|Dose Level 3||1
8561162|NCT00062868|21106894|P17|NOT COMPLETED|Dose Level 3||0
8561163|NCT00062868|21106895|P16|NOT COMPLETED|Dose Level 3||0
8561164|NCT00062868|21106896|P15|NOT COMPLETED|Dose Level 3||1
8561165|NCT00062868|21106897|P14|NOT COMPLETED|Dose Level 3||0
8561166|NCT00062868|21106898|P13|NOT COMPLETED|Dose Level 3||0
8561167|NCT00062868|21106899|P12|NOT COMPLETED|Dose Level 3||1
8561168|NCT00062868|21106900|P11|NOT COMPLETED|Dose Level 3||0
8561169|NCT00062868|21106901|P10|NOT COMPLETED|Dose Level 3||0
8561170|NCT00062868|21106902|P9|NOT COMPLETED|Dose Level 3||0
8561171|NCT00062868|21106903|P8|NOT COMPLETED|Dose Level 3||0
8561172|NCT00062868|21106904|P7|NOT COMPLETED|Dose Level 3||0
8561173|NCT00062868|21106905|P6|NOT COMPLETED|Dose Level 3||0
8561174|NCT00062868|21106906|P5|NOT COMPLETED|Dose Level 3||0
8561175|NCT00062868|21106907|P4|NOT COMPLETED|Dose Level 3||0
8561176|NCT00062868|21106908|P3|NOT COMPLETED|Dose Level 3||2
8561177|NCT00062868|21106909|P2|NOT COMPLETED|Dose Level 3||0
8561178|NCT00062868|21106910|P1|NOT COMPLETED|Dose Level 3||0
8561179|NCT00062868|21106890|P21|COMPLETED|Dose Level 3||0
8561180|NCT00062868|21106891|P20|COMPLETED|Dose Level 3||0
8561181|NCT00062868|21106892|P19|COMPLETED|Dose Level 3||0
8561182|NCT00062868|21106893|P18|COMPLETED|Dose Level 3||3
8561183|NCT00062868|21106894|P17|COMPLETED|Dose Level 3||0
8561184|NCT00062868|21106895|P16|COMPLETED|Dose Level 3||0
8561185|NCT00062868|21106896|P15|COMPLETED|Dose Level 3||2
8561186|NCT00062868|21106897|P14|COMPLETED|Dose Level 3||0
8561187|NCT00062868|21106898|P13|COMPLETED|Dose Level 3||0
8561188|NCT00062868|21106899|P12|COMPLETED|Dose Level 3||4
8561189|NCT00062868|21106900|P11|COMPLETED|Dose Level 3||0
8561190|NCT00062868|21106901|P10|COMPLETED|Dose Level 3||0
8561191|NCT00062868|21106902|P9|COMPLETED|Dose Level 3||0
8561192|NCT00062868|21106903|P8|COMPLETED|Dose Level 3||0
8561193|NCT00062868|21106904|P7|COMPLETED|Dose Level 3||0
8561194|NCT00062868|21106905|P6|COMPLETED|Dose Level 3||0
8561195|NCT00062868|21106906|P5|COMPLETED|Dose Level 3||0
8561196|NCT00062868|21106907|P4|COMPLETED|Dose Level 3||0
8561197|NCT00062868|21106908|P3|COMPLETED|Dose Level 3||1
8561198|NCT00062868|21106909|P2|COMPLETED|Dose Level 3||0
8561199|NCT00062868|21106910|P1|COMPLETED|Dose Level 3||0
8561200|NCT00062868|21106890|P21|STARTED|Dose Level 3||0
8561201|NCT00062868|21106891|P20|STARTED|Dose Level 3||0
8561202|NCT00062868|21106892|P19|STARTED|Dose Level 3||0
8561203|NCT00062868|21106893|P18|STARTED|Dose Level 3||4
8561204|NCT00062868|21106894|P17|STARTED|Dose Level 3||0
8561205|NCT00062868|21106895|P16|STARTED|Dose Level 3||0
8561206|NCT00062868|21106896|P15|STARTED|Dose Level 3||3
8561207|NCT00062868|21106897|P14|STARTED|Dose Level 3||0
8561208|NCT00062868|21106898|P13|STARTED|Dose Level 3||0
8561209|NCT00062868|21106899|P12|STARTED|Dose Level 3||5
8561210|NCT00062868|21106900|P11|STARTED|Dose Level 3||0
8561211|NCT00062868|21106901|P10|STARTED|Dose Level 3||0
8561212|NCT00062868|21106902|P9|STARTED|Dose Level 3||0
8561213|NCT00062868|21106903|P8|STARTED|Dose Level 3||0
8561214|NCT00062868|21106904|P7|STARTED|Dose Level 3||0
8561215|NCT00062868|21106905|P6|STARTED|Dose Level 3||0
8561216|NCT00062868|21106906|P5|STARTED|Dose Level 3||0
8561217|NCT00062868|21106907|P4|STARTED|Dose Level 3||0
8561218|NCT00062868|21106908|P3|STARTED|Dose Level 3||3
8561219|NCT00062868|21106909|P2|STARTED|Dose Level 3||0
8561220|NCT00062868|21106910|P1|STARTED|Dose Level 3||0
8561221|NCT00062868|21106890|P21|NOT COMPLETED|Dose Level 2||0
8561222|NCT00062868|21106891|P20|NOT COMPLETED|Dose Level 2||0
8561223|NCT00062868|21106892|P19|NOT COMPLETED|Dose Level 2||0
8561225|NCT00062868|21106894|P17|NOT COMPLETED|Dose Level 2||3
8561226|NCT00062868|21106895|P16|NOT COMPLETED|Dose Level 2||0
8561227|NCT00062868|21106896|P15|NOT COMPLETED|Dose Level 2||0
8561228|NCT00062868|21106897|P14|NOT COMPLETED|Dose Level 2||1
8561229|NCT00062868|21106898|P13|NOT COMPLETED|Dose Level 2||0
8561230|NCT00062868|21106899|P12|NOT COMPLETED|Dose Level 2||0
8561231|NCT00062868|21106900|P11|NOT COMPLETED|Dose Level 2||1
8561232|NCT00062868|21106901|P10|NOT COMPLETED|Dose Level 2||0
8561233|NCT00062868|21106902|P9|NOT COMPLETED|Dose Level 2||0
8561234|NCT00062868|21106903|P8|NOT COMPLETED|Dose Level 2||0
8561235|NCT00062868|21106904|P7|NOT COMPLETED|Dose Level 2||0
8561236|NCT00062868|21106905|P6|NOT COMPLETED|Dose Level 2||0
8561237|NCT00062868|21106906|P5|NOT COMPLETED|Dose Level 2||2
8561238|NCT00062868|21106907|P4|NOT COMPLETED|Dose Level 2||0
8561239|NCT00062868|21106908|P3|NOT COMPLETED|Dose Level 2||0
8561240|NCT00062868|21106909|P2|NOT COMPLETED|Dose Level 2||3
8561241|NCT00062868|21106910|P1|NOT COMPLETED|Dose Level 2||0
8561242|NCT00062868|21106890|P21|COMPLETED|Dose Level 2||0
8561243|NCT00062868|21106891|P20|COMPLETED|Dose Level 2||0
8561244|NCT00062868|21106892|P19|COMPLETED|Dose Level 2||0
8561245|NCT00062868|21106893|P18|COMPLETED|Dose Level 2||0
8561246|NCT00062868|21106894|P17|COMPLETED|Dose Level 2||0
8561247|NCT00062868|21106895|P16|COMPLETED|Dose Level 2||0
8561248|NCT00062868|21106896|P15|COMPLETED|Dose Level 2||0
8561249|NCT00062868|21106897|P14|COMPLETED|Dose Level 2||2
8561250|NCT00062868|21106898|P13|COMPLETED|Dose Level 2||0
8561251|NCT00062868|21106899|P12|COMPLETED|Dose Level 2||0
8561252|NCT00062868|21106900|P11|COMPLETED|Dose Level 2||3
8561253|NCT00062868|21106901|P10|COMPLETED|Dose Level 2||0
8561254|NCT00062868|21106902|P9|COMPLETED|Dose Level 2||0
8561255|NCT00062868|21106903|P8|COMPLETED|Dose Level 2||0
8561256|NCT00062868|21106904|P7|COMPLETED|Dose Level 2||0
8561257|NCT00062868|21106905|P6|COMPLETED|Dose Level 2||0
8561258|NCT00062868|21106906|P5|COMPLETED|Dose Level 2||1
8561259|NCT00062868|21106907|P4|COMPLETED|Dose Level 2||0
8561260|NCT00062868|21106908|P3|COMPLETED|Dose Level 2||0
8561261|NCT00062868|21106909|P2|COMPLETED|Dose Level 2||3
8561262|NCT00062868|21106910|P1|COMPLETED|Dose Level 2||0
8561263|NCT00062868|21106890|P21|STARTED|Dose Level 2||0
8561264|NCT00062868|21106891|P20|STARTED|Dose Level 2||0
8561265|NCT00062868|21106892|P19|STARTED|Dose Level 2||0
8561266|NCT00062868|21106893|P18|STARTED|Dose Level 2||0
8561267|NCT00062868|21106894|P17|STARTED|Dose Level 2||3
8561268|NCT00062868|21106895|P16|STARTED|Dose Level 2||0
8561269|NCT00062868|21106896|P15|STARTED|Dose Level 2||0
8561270|NCT00062868|21106897|P14|STARTED|Dose Level 2||3
8561271|NCT00062868|21106898|P13|STARTED|Dose Level 2||0
8561272|NCT00062868|21106899|P12|STARTED|Dose Level 2||0
8561273|NCT00062868|21106900|P11|STARTED|Dose Level 2||4
8561274|NCT00062868|21106901|P10|STARTED|Dose Level 2||0
8561275|NCT00062868|21106902|P9|STARTED|Dose Level 2||0
8561276|NCT00062868|21106903|P8|STARTED|Dose Level 2||0
8561277|NCT00062868|21106904|P7|STARTED|Dose Level 2||0
8561278|NCT00062868|21106905|P6|STARTED|Dose Level 2||0
8561279|NCT00062868|21106906|P5|STARTED|Dose Level 2||3
8561280|NCT00062868|21106907|P4|STARTED|Dose Level 2||0
8561281|NCT00062868|21106908|P3|STARTED|Dose Level 2||0
8561282|NCT00062868|21106909|P2|STARTED|Dose Level 2||6
8561283|NCT00062868|21106910|P1|STARTED|Dose Level 2||0
8561284|NCT00062868|21106890|P21|NOT COMPLETED|Dose Level 1||2
8561285|NCT00062868|21106891|P20|NOT COMPLETED|Dose Level 1||0
8561286|NCT00062868|21106892|P19|NOT COMPLETED|Dose Level 1||9
8561287|NCT00062868|21106893|P18|NOT COMPLETED|Dose Level 1||0
8561288|NCT00062868|21106894|P17|NOT COMPLETED|Dose Level 1||0
8561289|NCT00062868|21106895|P16|NOT COMPLETED|Dose Level 1||0
8561290|NCT00062868|21106896|P15|NOT COMPLETED|Dose Level 1||0
8561291|NCT00062868|21106897|P14|NOT COMPLETED|Dose Level 1||0
8561292|NCT00062868|21106898|P13|NOT COMPLETED|Dose Level 1||1
8561293|NCT00062868|21106899|P12|NOT COMPLETED|Dose Level 1||0
8561294|NCT00062868|21106900|P11|NOT COMPLETED|Dose Level 1||0
8561295|NCT00062868|21106901|P10|NOT COMPLETED|Dose Level 1||0
8561296|NCT00062868|21106902|P9|NOT COMPLETED|Dose Level 1||0
8561297|NCT00062868|21106903|P8|NOT COMPLETED|Dose Level 1||0
8561298|NCT00062868|21106904|P7|NOT COMPLETED|Dose Level 1||3
8561299|NCT00062868|21106905|P6|NOT COMPLETED|Dose Level 1||0
8561300|NCT00062868|21106906|P5|NOT COMPLETED|Dose Level 1||0
8561301|NCT00062868|21106907|P4|NOT COMPLETED|Dose Level 1||2
8561302|NCT00062868|21106908|P3|NOT COMPLETED|Dose Level 1||0
8561303|NCT00062868|21106909|P2|NOT COMPLETED|Dose Level 1||0
8561304|NCT00062868|21106910|P1|NOT COMPLETED|Dose Level 1||2
8561305|NCT00062868|21106890|P21|COMPLETED|Dose Level 1||1
8561306|NCT00062868|21106891|P20|COMPLETED|Dose Level 1||2
8561307|NCT00062868|21106892|P19|COMPLETED|Dose Level 1||7
8561308|NCT00062868|21106893|P18|COMPLETED|Dose Level 1||0
8561309|NCT00062868|21106894|P17|COMPLETED|Dose Level 1||0
8561310|NCT00062868|21106895|P16|COMPLETED|Dose Level 1||3
8561311|NCT00062868|21106896|P15|COMPLETED|Dose Level 1||0
8561312|NCT00062868|21106897|P14|COMPLETED|Dose Level 1||0
8561313|NCT00062868|21106898|P13|COMPLETED|Dose Level 1||2
8561314|NCT00062868|21106899|P12|COMPLETED|Dose Level 1||0
8561315|NCT00062868|21106900|P11|COMPLETED|Dose Level 1||0
8561316|NCT00062868|21106901|P10|COMPLETED|Dose Level 1||3
8561317|NCT00062868|21106902|P9|COMPLETED|Dose Level 1||0
8561318|NCT00062868|21106903|P8|COMPLETED|Dose Level 1||0
8561319|NCT00062868|21106904|P7|COMPLETED|Dose Level 1||1
8561320|NCT00062868|21106905|P6|COMPLETED|Dose Level 1||0
8561321|NCT00062868|21106906|P5|COMPLETED|Dose Level 1||0
8561322|NCT00062868|21106907|P4|COMPLETED|Dose Level 1||1
8561323|NCT00062868|21106908|P3|COMPLETED|Dose Level 1||0
8561324|NCT00062868|21106909|P2|COMPLETED|Dose Level 1||0
8561325|NCT00062868|21106910|P1|COMPLETED|Dose Level 1||1
8561326|NCT00062868|21106890|P21|STARTED|Dose Level 1||3
8561327|NCT00062868|21106891|P20|STARTED|Dose Level 1||2
8561328|NCT00062868|21106892|P19|STARTED|Dose Level 1||16
8561329|NCT00062868|21106893|P18|STARTED|Dose Level 1||0
8561330|NCT00062868|21106894|P17|STARTED|Dose Level 1||0
8561331|NCT00062868|21106895|P16|STARTED|Dose Level 1||3
8561332|NCT00062868|21106896|P15|STARTED|Dose Level 1||0
8561333|NCT00062868|21106897|P14|STARTED|Dose Level 1||0
8561334|NCT00062868|21106898|P13|STARTED|Dose Level 1||3
8561335|NCT00062868|21106899|P12|STARTED|Dose Level 1||0
8561336|NCT00062868|21106900|P11|STARTED|Dose Level 1||0
8561337|NCT00062868|21106901|P10|STARTED|Dose Level 1||3
8561338|NCT00062868|21106902|P9|STARTED|Dose Level 1||0
8561339|NCT00062868|21106903|P8|STARTED|Dose Level 1||0
8561340|NCT00062868|21106904|P7|STARTED|Dose Level 1||4
8561341|NCT00062868|21106905|P6|STARTED|Dose Level 1||0
8561342|NCT00062868|21106906|P5|STARTED|Dose Level 1||0
8561343|NCT00062868|21106907|P4|STARTED|Dose Level 1||3
8561344|NCT00062868|21106908|P3|STARTED|Dose Level 1||0
8561345|NCT00062868|21106909|P2|STARTED|Dose Level 1||0
8561346|NCT00062868|21106910|P1|STARTED|Dose Level 1||3
8561347|NCT00062764|21106996|P1|NOT COMPLETED|Overall Study||0
8561348|NCT00062764|21106996|P1|COMPLETED|Overall Study||18
8561349|NCT00062764|21106996|P1|STARTED|Overall Study||18
8561350|NCT00062751|21107009|P5|NOT COMPLETED|Overall Study||6
8561351|NCT00062751|21107010|P4|NOT COMPLETED|Overall Study||5
8561352|NCT00062751|21107011|P3|NOT COMPLETED|Overall Study||30
8561353|NCT00062751|21107012|P2|NOT COMPLETED|Overall Study||30
8561354|NCT00062751|21107013|P1|NOT COMPLETED|Overall Study||33
8561355|NCT00062751|21107009|P5|COMPLETED|Overall Study||0
8561356|NCT00062751|21107010|P4|COMPLETED|Overall Study||1
8561357|NCT00062751|21107011|P3|COMPLETED|Overall Study||3
8561358|NCT00062751|21107012|P2|COMPLETED|Overall Study||0
8561359|NCT00062751|21107013|P1|COMPLETED|Overall Study||0
8561360|NCT00062751|21107009|P5|STARTED|Overall Study||6
8561361|NCT00062751|21107010|P4|STARTED|Overall Study||6
8561362|NCT00062751|21107011|P3|STARTED|Overall Study||33
8561363|NCT00062751|21107012|P2|STARTED|Overall Study||30
8561364|NCT00062751|21107013|P1|STARTED|Overall Study||33
8561365|NCT00062738|21107084|P3|NOT COMPLETED|Overall Study||0
8561366|NCT00062738|21107085|P2|NOT COMPLETED|Overall Study||0
8561367|NCT00062738|21107086|P1|NOT COMPLETED|Overall Study||0
8561368|NCT00062738|21107084|P3|COMPLETED|Overall Study||17
8561369|NCT00062738|21107085|P2|COMPLETED|Overall Study||18
8561370|NCT00062738|21107086|P1|COMPLETED|Overall Study||17
8561371|NCT00062738|21107084|P3|STARTED|Overall Study||17
8561372|NCT00062738|21107085|P2|STARTED|Overall Study||18
8561373|NCT00062738|21107086|P1|STARTED|Overall Study||17
8561374|NCT00062647|21107099|P2|NOT COMPLETED|Overall Study||13
8561375|NCT00062647|21107100|P1|NOT COMPLETED|Overall Study||16
8561376|NCT00062647|21107099|P2|COMPLETED|Overall Study||17
8561377|NCT00062647|21107100|P1|COMPLETED|Overall Study||14
8561378|NCT00062647|21107099|P2|STARTED|Overall Study||30
8561379|NCT00062647|21107100|P1|STARTED|Overall Study||30
8561380|NCT00062439|21107106|P1|NOT COMPLETED|Consolidation Chemotherapy||2
8561381|NCT00062439|21107106|P1|COMPLETED|Consolidation Chemotherapy||20
8561382|NCT00062439|21107106|P1|STARTED|Consolidation Chemotherapy||22
8561383|NCT00062439|21107106|P1|NOT COMPLETED|Surgery||7
8561384|NCT00062439|21107106|P1|COMPLETED|Surgery||22
8561385|NCT00062439|21107106|P1|STARTED|Surgery||29
8561386|NCT00062439|21107106|P1|NOT COMPLETED|Post Chemoradiation Assessment||9
8561387|NCT00062439|21107106|P1|COMPLETED|Post Chemoradiation Assessment||29
8561388|NCT00062439|21107106|P1|STARTED|Post Chemoradiation Assessment||38
8561389|NCT00062439|21107106|P1|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
8561390|NCT00062439|21107106|P1|COMPLETED|Induction Chemotherapy + Radiotherapy||38
8561391|NCT00062439|21107106|P1|STARTED|Induction Chemotherapy + Radiotherapy||46
8561392|NCT00062374|21107118|P1|NOT COMPLETED|Overall Study||12
8561393|NCT00062374|21107118|P1|COMPLETED|Overall Study||43
8561394|NCT00062374|21107118|P1|STARTED|Overall Study||55
8561395|NCT00062166|21107123|P1|NOT COMPLETED|Overall Study||6
8561396|NCT00062166|21107123|P1|COMPLETED|Overall Study||334
8561397|NCT00062166|21107123|P1|STARTED|Overall Study||340
8561398|NCT00062010|21107131|P1|NOT COMPLETED|Overall Study||3
8561399|NCT00062010|21107131|P1|COMPLETED|Overall Study||34
8561400|NCT00062010|21107131|P1|Eligible and Treated|Overall Study||34
8561401|NCT00062010|21107131|P1|STARTED|Overall Study||37
8561402|NCT00061945|21107139|P2|NOT COMPLETED|Course IV: Alemtuzumab||16
8561403|NCT00061945|21107140|P1|NOT COMPLETED|Course IV: Alemtuzumab||7
8561404|NCT00061945|21107139|P2|COMPLETED|Course IV: Alemtuzumab||50
8561405|NCT00061945|21107140|P1|COMPLETED|Course IV: Alemtuzumab||18
8561406|NCT00061945|21107139|P2|STARTED|Course IV: Alemtuzumab||66
8561407|NCT00061945|21107140|P1|STARTED|Course IV: Alemtuzumab||25
8561408|NCT00061945|21107139|P2|NOT COMPLETED|Registration Through Course 3||115
8561409|NCT00061945|21107140|P1|NOT COMPLETED|Registration Through Course 3||94
8561410|NCT00061945|21107139|P2|COMPLETED|Registration Through Course 3||66
8561411|NCT00061945|21107140|P1|COMPLETED|Registration Through Course 3||25
8561412|NCT00061945|21107139|P2|STARTED|Registration Through Course 3||181
8561413|NCT00061945|21107140|P1|STARTED|Registration Through Course 3||119
8561420|NCT00061893|21107157|P1|NOT COMPLETED|Overall Study||18
8561421|NCT00061893|21107157|P1|COMPLETED|Overall Study||20
8561422|NCT00061893|21107157|P1|STARTED|Overall Study||38
8561423|NCT00061633|21107164|P2|NOT COMPLETED|Overall Study||11
8561424|NCT00061633|21107165|P1|NOT COMPLETED|Overall Study||5
8561425|NCT00061633|21107164|P2|COMPLETED|Overall Study||74
8561426|NCT00061633|21107165|P1|COMPLETED|Overall Study||79
8561427|NCT00061633|21107164|P2|STARTED|Overall Study||85
8561428|NCT00061633|21107165|P1|STARTED|Overall Study||84
8561429|NCT00061373|21107173|P2|NOT COMPLETED|Overall Study||0
8561430|NCT00061373|21107174|P1|NOT COMPLETED|Overall Study||0
8561431|NCT00061373|21107173|P2|COMPLETED|Overall Study||3
8561432|NCT00061373|21107174|P1|COMPLETED|Overall Study||15
8561433|NCT00061373|21107173|P2|Aspirin and Tinzaparin|Overall Study||3
8561434|NCT00061373|21107174|P1|Aspirin and Tinzaparin|Overall Study||15
8561435|NCT00061373|21107173|P2|STARTED|Overall Study||3
8561436|NCT00061373|21107174|P1|STARTED|Overall Study||15
8561437|NCT00061048|21107190|P1|NOT COMPLETED|Overall Study||22
8561438|NCT00061048|21107190|P1|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
8561439|NCT00061048|21107190|P1|STARTED|Overall Study||29
8561440|NCT00060944|21107200|P2|NOT COMPLETED|Overall Study||134
8561441|NCT00060944|21107201|P1|NOT COMPLETED|Overall Study||136
8561442|NCT00060944|21107200|P2|COMPLETED|Overall Study||0
8561443|NCT00060944|21107201|P1|COMPLETED|Overall Study||0
8561444|NCT00060944|21107200|P2|Treated|Overall Study||130
8561445|NCT00060944|21107201|P1|Treated|Overall Study||130
8561446|NCT00060944|21107200|P2|STARTED|Overall Study||134
8561447|NCT00060944|21107201|P1|STARTED|Overall Study||136
8561448|NCT00060840|21107217|P2|NOT COMPLETED|Overall Study||9
8561449|NCT00060840|21107218|P1|NOT COMPLETED|Overall Study||4
8561450|NCT00060840|21107217|P2|COMPLETED|Overall Study||68
8561451|NCT00060840|21107218|P1|COMPLETED|Overall Study||69
8561452|NCT00060840|21107217|P2|STARTED|Overall Study||77
8561453|NCT00060840|21107218|P1|STARTED|Overall Study||73
8561454|NCT00060606|21107226|P2|NOT COMPLETED|Overall Study||1
8561455|NCT00060606|21107227|P1|NOT COMPLETED|Overall Study||0
8561456|NCT00060606|21107226|P2|COMPLETED|Overall Study||91
8561457|NCT00060606|21107227|P1|COMPLETED|Overall Study||91
8561458|NCT00060606|21107226|P2|First Primary Outcome - Shunt at 12 Mont|Overall Study||92
8561459|NCT00060606|21107227|P1|First Primary Outcome - Shunt at 12 Mont|Overall Study||91
8561460|NCT00060606|21107226|P2|STARTED|Overall Study||92
8561461|NCT00060606|21107227|P1|STARTED|Overall Study||91
8561462|NCT00060528|21107237|P4|NOT COMPLETED|Overall Study||0
8561463|NCT00060528|21107238|P3|NOT COMPLETED|Overall Study||0
8561464|NCT00060528|21107239|P2|NOT COMPLETED|Overall Study||0
8561465|NCT00060528|21107240|P1|NOT COMPLETED|Overall Study||0
8561466|NCT00060528|21107237|P4|COMPLETED|Overall Study||8
8561467|NCT00060528|21107238|P3|COMPLETED|Overall Study||7
8561468|NCT00060528|21107239|P2|COMPLETED|Overall Study||9
8561469|NCT00060528|21107240|P1|COMPLETED|Overall Study||8
8561470|NCT00060528|21107237|P4|STARTED|Overall Study||8
8561471|NCT00060528|21107238|P3|STARTED|Overall Study||7
8561472|NCT00060528|21107239|P2|STARTED|Overall Study||9
8561473|NCT00060528|21107240|P1|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
8561474|NCT00060424|21107254|P1|NOT COMPLETED|Overall Study||0
8561475|NCT00060424|21107254|P1|COMPLETED|Overall Study||21
8561476|NCT00060424|21107254|P1|STARTED|Overall Study||21
8561477|NCT00060346|21107262|P1|NOT COMPLETED|Overall Study||0
8561478|NCT00060346|21107262|P1|COMPLETED|Overall Study||16
8561479|NCT00060346|21107262|P1|Eligible and Treated|Overall Study||16
8561480|NCT00060346|21107262|P1|STARTED|Overall Study||16
8561481|NCT00060333|21107266|P1|NOT COMPLETED|Overall Study||0
8561482|NCT00060333|21107266|P1|COMPLETED|Overall Study||20
8561483|NCT00060333|21107266|P1|STARTED|Overall Study||20
8561484|NCT00060008|21107277|P1|NOT COMPLETED|Overall Study||0
8561485|NCT00060008|21107277|P1|COMPLETED|Overall Study||18
8561486|NCT00060008|21107277|P1|STARTED|Overall Study||18
8561487|NCT00059839|21107284|P2|NOT COMPLETED|Overall Study||17
8561488|NCT00059839|21107285|P1|NOT COMPLETED|Overall Study||12
8561489|NCT00059839|21107284|P2|COMPLETED|Overall Study||47
8561490|NCT00059839|21107285|P1|COMPLETED|Overall Study||53
8561491|NCT00059839|21107284|P2|STARTED|Overall Study||64
8561492|NCT00059839|21107285|P1|STARTED|Overall Study||65
8561493|NCT00059787|21107291|P1|NOT COMPLETED|Overall Study||20
8561494|NCT00059787|21107291|P1|COMPLETED|Overall Study||36
8561495|NCT00059787|21107291|P1|STARTED|Overall Study||56
8561496|NCT00059475|21107307|P8|NOT COMPLETED|Overall Study||0
8561497|NCT00059475|21107308|P7|NOT COMPLETED|Overall Study||0
8561498|NCT00059475|21107309|P6|NOT COMPLETED|Overall Study||0
8561499|NCT00059475|21107310|P5|NOT COMPLETED|Overall Study||0
8561500|NCT00059475|21107311|P4|NOT COMPLETED|Overall Study||0
8561501|NCT00059475|21107312|P3|NOT COMPLETED|Overall Study||0
8561502|NCT00059475|21107313|P2|NOT COMPLETED|Overall Study||0
8561503|NCT00059475|21107314|P1|NOT COMPLETED|Overall Study||0
8561504|NCT00059475|21107307|P8|COMPLETED|Overall Study||7
8561505|NCT00059475|21107308|P7|COMPLETED|Overall Study||34
8561506|NCT00059475|21107309|P6|COMPLETED|Overall Study||2
8561507|NCT00059475|21107310|P5|COMPLETED|Overall Study||33
8561508|NCT00059475|21107311|P4|COMPLETED|Overall Study||3
8561509|NCT00059475|21107312|P3|COMPLETED|Overall Study||24
8561510|NCT00059475|21107313|P2|COMPLETED|Overall Study||2
8561511|NCT00059475|21107314|P1|COMPLETED|Overall Study||33
8561512|NCT00059475|21107307|P8|STARTED|Overall Study||7
8561513|NCT00059475|21107308|P7|STARTED|Overall Study||34
8561514|NCT00059475|21107309|P6|STARTED|Overall Study||2
8561515|NCT00059475|21107310|P5|STARTED|Overall Study||33
8561516|NCT00059475|21107311|P4|STARTED|Overall Study||3
8561517|NCT00059475|21107312|P3|STARTED|Overall Study||24
8561518|NCT00059475|21107313|P2|STARTED|Overall Study||2
8561519|NCT00059475|21107314|P1|STARTED|Overall Study||33
8561520|NCT00059332|21107342|P2|NOT COMPLETED|Overall Study||2
8561521|NCT00059332|21107343|P1|NOT COMPLETED|Overall Study||3
8561522|NCT00059332|21107342|P2|COMPLETED|Overall Study||855
8561523|NCT00059332|21107343|P1|COMPLETED|Overall Study||840
8561524|NCT00059332|21107342|P2|STARTED|Overall Study||857
8561525|NCT00059332|21107343|P1|STARTED|Overall Study||843
8561526|NCT00059215|21107369|P4|NOT COMPLETED|Overall Study||15
8561527|NCT00059215|21107370|P3|NOT COMPLETED|Overall Study||15
8561528|NCT00059215|21107371|P2|NOT COMPLETED|Overall Study||14
8561529|NCT00059215|21107372|P1|NOT COMPLETED|Overall Study||13
8561530|NCT00059215|21107369|P4|COMPLETED|Overall Study||239
8561531|NCT00059215|21107370|P3|COMPLETED|Overall Study||236
8561532|NCT00059215|21107371|P2|COMPLETED|Overall Study||186
8561533|NCT00059215|21107372|P1|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
8561534|NCT00059215|21107369|P4|STARTED|Overall Study||254
8561535|NCT00059215|21107370|P3|STARTED|Overall Study||251
8561536|NCT00059215|21107371|P2|STARTED|Overall Study||200
8561537|NCT00059215|21107372|P1|STARTED|Overall Study||200
8561538|NCT00059228|21107400|P2|NOT COMPLETED|Overall Study||1
8561539|NCT00059228|21107401|P1|NOT COMPLETED|Overall Study||0
8561540|NCT00059228|21107400|P2|COMPLETED|Overall Study||5
8561541|NCT00059228|21107401|P1|COMPLETED|Overall Study||6
8561542|NCT00059228|21107400|P2|STARTED|Overall Study||6
8561543|NCT00059228|21107401|P1|STARTED|Overall Study||6
8561544|NCT00058825|21107409|P1|NOT COMPLETED|Overall Study||22
8561545|NCT00058825|21107409|P1|COMPLETED|Overall Study||5
8561546|NCT00058825|21107409|P1|STARTED|Overall Study||27
8561547|NCT00058552|21107425|P2|NOT COMPLETED|Overall Study||62
8561548|NCT00058552|21107426|P1|NOT COMPLETED|Overall Study||65
8561549|NCT00058552|21107425|P2|COMPLETED|Overall Study||2
8561550|NCT00058552|21107426|P1|COMPLETED|Overall Study||0
8561551|NCT00058552|21107425|P2|STARTED|Overall Study||64
8561552|NCT00058552|21107426|P1|STARTED|Overall Study||65
8561553|NCT00058539|21107444|P1|NOT COMPLETED|Overall Study||42
8561554|NCT00058539|21107444|P1|COMPLETED|Overall Study||0
8561555|NCT00058539|21107444|P1|STARTED|Overall Study||42
8561556|NCT00058422|21107454|P1|NOT COMPLETED|Overall Study||2
8561557|NCT00058422|21107454|P1|COMPLETED|Overall Study||63
8561558|NCT00058422|21107454|P1|STARTED|Overall Study||65
8561559|NCT00058370|21107462|P1|NOT COMPLETED|Overall Study||0
8561560|NCT00058370|21107462|P1|COMPLETED|Overall Study||6
8561561|NCT00058370|21107462|P1|STARTED|Overall Study||6
8561562|NCT00058240|21107472|P4|NOT COMPLETED|Second Dose Level||0
8561563|NCT00058240|21107473|P3|NOT COMPLETED|Second Dose Level||0
8561564|NCT00058240|21107474|P2|NOT COMPLETED|Second Dose Level||0
8561565|NCT00058240|21107475|P1|NOT COMPLETED|Second Dose Level||0
8561566|NCT00058240|21107472|P4|COMPLETED|Second Dose Level||4
8561567|NCT00058240|21107473|P3|COMPLETED|Second Dose Level||2
8561568|NCT00058240|21107474|P2|COMPLETED|Second Dose Level||0
8561569|NCT00058240|21107475|P1|COMPLETED|Second Dose Level||0
8561570|NCT00058240|21107472|P4|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
8561571|NCT00058240|21107473|P3|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
8561572|NCT00058240|21107474|P2|STARTED|Second Dose Level||0
8561573|NCT00058240|21107475|P1|STARTED|Second Dose Level||0
8561574|NCT00058240|21107472|P4|NOT COMPLETED|First Dose Level||0
8561575|NCT00058240|21107473|P3|NOT COMPLETED|First Dose Level||0
8561576|NCT00058240|21107474|P2|NOT COMPLETED|First Dose Level||0
8561577|NCT00058240|21107475|P1|NOT COMPLETED|First Dose Level||0
8561578|NCT00058240|21107472|P4|COMPLETED|First Dose Level||12
8561579|NCT00058240|21107473|P3|COMPLETED|First Dose Level||17
8561580|NCT00058240|21107474|P2|COMPLETED|First Dose Level||3
8561581|NCT00058240|21107475|P1|COMPLETED|First Dose Level||20
8561582|NCT00058240|21107472|P4|Treated|First Dose Level||12
8561583|NCT00058240|21107473|P3|Treated|First Dose Level||17
8561584|NCT00058240|21107474|P2|Treated|First Dose Level||3
8561585|NCT00058240|21107475|P1|Treated|First Dose Level||20
8561586|NCT00058240|21107472|P4|STARTED|First Dose Level||12
8561587|NCT00058240|21107473|P3|STARTED|First Dose Level||17
8561588|NCT00058240|21107474|P2|STARTED|First Dose Level||3
8561589|NCT00058240|21107475|P1|STARTED|First Dose Level||20
8561590|NCT00058214|21107485|P1|NOT COMPLETED|Overall Study||1
8561591|NCT00058214|21107485|P1|COMPLETED|Overall Study||24
8561592|NCT00058214|21107485|P1|STARTED|Overall Study||25
8561593|NCT00058188|21107492|P2|NOT COMPLETED|Overall Study||0
8561594|NCT00058188|21107493|P1|NOT COMPLETED|Overall Study||0
8561595|NCT00058188|21107492|P2|COMPLETED|Overall Study||0
8561596|NCT00058188|21107493|P1|COMPLETED|Overall Study||0
8561597|NCT00058188|21107492|P2|STARTED|Overall Study||0
8561598|NCT00058188|21107493|P1|STARTED|Overall Study||0
8561599|NCT00058123|21107507|P1|NOT COMPLETED|Overall Study||10
8561600|NCT00058123|21107507|P1|COMPLETED|Overall Study||45
8561601|NCT00058123|21107507|P1|STARTED|Overall Study||55
8561602|NCT00058058|21107514|P1|NOT COMPLETED|Overall Study||38
8561603|NCT00058058|21107514|P1|COMPLETED|Overall Study||969
8561604|NCT00058058|21107514|P1|STARTED|Overall Study||1007
8561605|NCT00058019|21107525|P2|NOT COMPLETED|Overall Study||0
8561606|NCT00058019|21107526|P1|NOT COMPLETED|Overall Study||0
8561607|NCT00058019|21107525|P2|COMPLETED|Overall Study||12
8561608|NCT00058019|21107526|P1|COMPLETED|Overall Study||39
8561609|NCT00058019|21107525|P2|STARTED|Overall Study||12
8561610|NCT00058019|21107526|P1|STARTED|Overall Study||39
8561611|NCT00057954|21107539|P1|NOT COMPLETED|Overall Study||2
8561612|NCT00057954|21107539|P1|COMPLETED|Overall Study||4
8561613|NCT00057954|21107539|P1|STARTED|Overall Study||6
8561614|NCT00057941|21107547|P2|NOT COMPLETED|Overall Study||74
8561615|NCT00057941|21107548|P1|NOT COMPLETED|Overall Study||74
8561616|NCT00057941|21107547|P2|COMPLETED|Overall Study||0
8561617|NCT00057941|21107548|P1|COMPLETED|Overall Study||0
8561618|NCT00057941|21107547|P2|Eligible|Overall Study||69
8561619|NCT00057941|21107548|P1|Eligible|Overall Study||72
8561620|NCT00057941|21107547|P2|Treated|Overall Study||74
8561621|NCT00057941|21107548|P1|Treated|Overall Study||74
8561622|NCT00057941|21107547|P2|STARTED|Overall Study||74
8561623|NCT00057941|21107548|P1|STARTED|Overall Study||74
8561624|NCT00057876|21107556|P2|NOT COMPLETED|Overall Study||27
8561625|NCT00057876|21107557|P1|NOT COMPLETED|Overall Study||29
8561626|NCT00057876|21107556|P2|COMPLETED|Overall Study||9
8561627|NCT00057876|21107557|P1|COMPLETED|Overall Study||9
8561628|NCT00057876|21107556|P2|Eligible and Treated|Overall Study||34
8561629|NCT00057876|21107557|P1|Eligible and Treated|Overall Study||34
8561630|NCT00057876|21107556|P2|Began Protocol Therapy|Overall Study||34
8561631|NCT00057876|21107557|P1|Began Protocol Therapy|Overall Study||35
8561632|NCT00057876|21107556|P2|Eligible|Overall Study||34
8561633|NCT00057876|21107557|P1|Eligible|Overall Study||37
8561634|NCT00057876|21107556|P2|STARTED|Overall Study||36
8561635|NCT00057876|21107557|P1|STARTED|Overall Study||38
8561636|NCT00057863|21107567|P1|NOT COMPLETED|Overall Study||3
8561637|NCT00057863|21107567|P1|COMPLETED|Overall Study||32
8561638|NCT00057863|21107567|P1|STARTED|Overall Study||35
8561639|NCT00057837|21107576|P2|NOT COMPLETED|Overall Study||39
8561640|NCT00057837|21107577|P1|NOT COMPLETED|Overall Study||31
8561641|NCT00057837|21107576|P2|COMPLETED|Overall Study||31
8561642|NCT00057837|21107577|P1|COMPLETED|Overall Study||39
8561643|NCT00057837|21107576|P2|Patients With Response|Overall Study||38
8561644|NCT00057837|21107577|P1|Patients With Response|Overall Study||46
8561645|NCT00057837|21107576|P2|Eligible and Treated|Overall Study||66
8561646|NCT00057837|21107577|P1|Eligible and Treated|Overall Study||66
8561647|NCT00057837|21107576|P2|Treated|Overall Study||68
8561648|NCT00057837|21107577|P1|Treated|Overall Study||69
8561649|NCT00057837|21107576|P2|STARTED|Overall Study||70
8561650|NCT00057837|21107577|P1|STARTED|Overall Study||70
8561651|NCT00057811|21107589|P2|NOT COMPLETED|Overall Study||12
8561652|NCT00057811|21107590|P1|NOT COMPLETED|Overall Study||10
8561653|NCT00057811|21107589|P2|COMPLETED|Overall Study||34
8561654|NCT00057811|21107590|P1|COMPLETED|Overall Study||41
8561655|NCT00057811|21107589|P2|STARTED|Overall Study||46
8561656|NCT00057811|21107590|P1|STARTED|Overall Study||51
8561657|NCT00057785|21107602|P1|NOT COMPLETED|Overall Study||0
8561658|NCT00057785|21107602|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
8561659|NCT00057785|21107602|P1|STARTED|Overall Study||68
8561660|NCT00057746|21107609|P3|NOT COMPLETED|Overall Study||1
8561661|NCT00057746|21107610|P2|NOT COMPLETED|Overall Study||0
8561662|NCT00057746|21107611|P1|NOT COMPLETED|Overall Study||0
8561663|NCT00057746|21107609|P3|COMPLETED|Overall Study||66
8561664|NCT00057746|21107610|P2|COMPLETED|Overall Study||67
8561665|NCT00057746|21107611|P1|COMPLETED|Overall Study||131
8561666|NCT00057746|21107609|P3|STARTED|Overall Study||67
8561667|NCT00057746|21107610|P2|STARTED|Overall Study||67
8561668|NCT00057746|21107611|P1|STARTED|Overall Study||131
8561669|NCT00023673|21107622|P4|NOT COMPLETED|Overall Study||2
8561670|NCT00023673|21107623|P3|NOT COMPLETED|Overall Study||0
8561671|NCT00023673|21107624|P2|NOT COMPLETED|Overall Study||0
8561672|NCT00023673|21107625|P1|NOT COMPLETED|Overall Study||0
8561673|NCT00023673|21107622|P4|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
8561674|NCT00023673|21107623|P3|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
8561675|NCT00023673|21107624|P2|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
8561676|NCT00023673|21107625|P1|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
8561677|NCT00023673|21107622|P4|STARTED|Overall Study||46
8561678|NCT00023673|21107623|P3|STARTED|Overall Study||0
8561679|NCT00023673|21107624|P2|STARTED|Overall Study||9
8561680|NCT00023673|21107625|P1|STARTED|Overall Study||8
8561681|NCT00057681|21107641|P3|NOT COMPLETED|Overall Study||34
8561682|NCT00057681|21107642|P2|NOT COMPLETED|Overall Study||72
8561683|NCT00057681|21107643|P1|NOT COMPLETED|Overall Study||65
8561684|NCT00057681|21107641|P3|COMPLETED|Overall Study||69
8561685|NCT00057681|21107642|P2|COMPLETED|Overall Study||67
8561686|NCT00057681|21107643|P1|COMPLETED|Overall Study||72
8561687|NCT00057681|21107641|P3|STARTED|Overall Study||103
8561688|NCT00057681|21107642|P2|STARTED|Overall Study||139
8561689|NCT00057681|21107643|P1|STARTED|Overall Study||137
8561690|NCT00057577|21107659|P2|NOT COMPLETED|Overall Study||0
8561691|NCT00057577|21107660|P1|NOT COMPLETED|Overall Study||0
8561692|NCT00057577|21107659|P2|COMPLETED|Overall Study||225
8561693|NCT00057577|21107660|P1|COMPLETED|Overall Study||227
8561694|NCT00057577|21107659|P2|STARTED|Overall Study||225
8561695|NCT00057577|21107660|P1|STARTED|Overall Study||227
8561696|NCT00057551|21107677|P3|NOT COMPLETED|Overall Study||16
8561697|NCT00057551|21107678|P2|NOT COMPLETED|Overall Study||27
8561698|NCT00057551|21107679|P1|NOT COMPLETED|Overall Study||25
8561699|NCT00057551|21107677|P3|COMPLETED|Overall Study||80
8561700|NCT00057551|21107678|P2|COMPLETED|Overall Study||168
8561701|NCT00057551|21107679|P1|COMPLETED|Overall Study||175
8561702|NCT00057551|21107677|P3|STARTED|Overall Study||96
8561703|NCT00057551|21107678|P2|STARTED|Overall Study||195
8561704|NCT00057551|21107679|P1|STARTED|Overall Study||200
8561705|NCT00057330|21107689|P2|NOT COMPLETED|Overall Study||920
8561706|NCT00057330|21107690|P1|NOT COMPLETED|Overall Study||1132
8561707|NCT00057330|21107689|P2|COMPLETED|Overall Study||2826
8561708|NCT00057330|21107690|P1|COMPLETED|Overall Study||3445
8561709|NCT00057330|21107689|P2|STARTED|Overall Study||3746
8561710|NCT00057330|21107690|P1|STARTED|Overall Study||4577
8561711|NCT00056862|21107720|P2|NOT COMPLETED|Overall Study||0
8561712|NCT00056862|21107721|P1|NOT COMPLETED|Overall Study||1
8561713|NCT00056862|21107720|P2|COMPLETED|Overall Study||27
8561714|NCT00056862|21107721|P1|COMPLETED|Overall Study||30
8561715|NCT00056862|21107720|P2|STARTED|Overall Study||27
8561716|NCT00056862|21107721|P1|STARTED|Overall Study||31
8561717|NCT00056563|21107737|P2|NOT COMPLETED|Overall Study||0
8561718|NCT00056563|21107738|P1|NOT COMPLETED|Overall Study||0
8561719|NCT00056563|21107737|P2|COMPLETED|Overall Study||134
8561720|NCT00056563|21107738|P1|COMPLETED|Overall Study||121
8561721|NCT00056563|21107737|P2|STARTED|Overall Study||134
8561722|NCT00056563|21107738|P1|STARTED|Overall Study||121
8561723|NCT00056550|21107746|P1|NOT COMPLETED|Overall Study||0
8561724|NCT00056550|21107746|P1|COMPLETED|Overall Study||14
8561725|NCT00056550|21107746|P1|STARTED|Overall Study||14
8561726|NCT00056498|21107753|P2|NOT COMPLETED|Overall Study||7
8561727|NCT00056498|21107754|P1|NOT COMPLETED|Overall Study||5
8561728|NCT00056498|21107753|P2|COMPLETED|Overall Study||28
8561729|NCT00056498|21107754|P1|COMPLETED|Overall Study||25
8561730|NCT00056498|21107753|P2|STARTED|Overall Study||35
8561731|NCT00056498|21107754|P1|STARTED|Overall Study||30
8561732|NCT00056472|21107766|P2|NOT COMPLETED|Overall Study||69
8561733|NCT00056472|21107767|P1|NOT COMPLETED|Overall Study||48
8561734|NCT00056472|21107766|P2|COMPLETED|Overall Study||61
8561735|NCT00056472|21107767|P1|COMPLETED|Overall Study||81
8561736|NCT00056472|21107766|P2|STARTED|Overall Study||130
8561737|NCT00056472|21107767|P1|STARTED|Overall Study||129
8561738|NCT00056407|21107779|P2|NOT COMPLETED|Overall Study||1193
8561739|NCT00056407|21107780|P1|NOT COMPLETED|Overall Study||1211
8561740|NCT00056407|21107779|P2|COMPLETED|Overall Study||2912
8561741|NCT00056407|21107780|P1|COMPLETED|Overall Study||2915
8561742|NCT00056407|21107779|P2|STARTED|Overall Study||4105
8561743|NCT00056407|21107780|P1|STARTED|Overall Study||4126
8561744|NCT00056316|21107838|P2|NOT COMPLETED|Overall Study||3
8561745|NCT00056316|21107839|P1|NOT COMPLETED|Overall Study||3
8561746|NCT00056316|21107838|P2|COMPLETED|Overall Study||38
8561747|NCT00056316|21107839|P1|COMPLETED|Overall Study||30
8561748|NCT00056316|21107838|P2|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
8561749|NCT00056316|21107839|P1|STARTED|Overall Study||33
8561750|NCT00056160|21107853|P2|NOT COMPLETED|Final Follow-up||0
8561751|NCT00056160|21107854|P1|NOT COMPLETED|Final Follow-up||6
8561752|NCT00056160|21107853|P2|COMPLETED|Final Follow-up||0
8561753|NCT00056160|21107854|P1|COMPLETED|Final Follow-up||0
8561754|NCT00056160|21107853|P2|STARTED|Final Follow-up||0
8561755|NCT00056160|21107854|P1|STARTED|Final Follow-up||6
8561756|NCT00056160|21107853|P2|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
8561757|NCT00056160|21107854|P1|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
8561758|NCT00056160|21107853|P2|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
8561759|NCT00056160|21107854|P1|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
8561760|NCT00056160|21107853|P2|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
8561761|NCT00056160|21107854|P1|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
8561762|NCT00056160|21107853|P2|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
8561763|NCT00056160|21107854|P1|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
8561764|NCT00056160|21107853|P2|COMPLETED|Up to Unblinding (07 Jun 2005)||13
8561765|NCT00056160|21107854|P1|COMPLETED|Up to Unblinding (07 Jun 2005)||64
8561766|NCT00056160|21107853|P2|STARTED|Up to Unblinding (07 Jun 2005)||176
8561767|NCT00056160|21107854|P1|STARTED|Up to Unblinding (07 Jun 2005)||177
8561768|NCT00055692|21107866|P1|NOT COMPLETED|Overall Study||0
8561769|NCT00055692|21107866|P1|COMPLETED|Overall Study||46
8561770|NCT00055692|21107866|P1|STARTED|Overall Study||46
8561771|NCT00055601|21107877|P2|NOT COMPLETED|Overall Study||2
8561772|NCT00055601|21107878|P1|NOT COMPLETED|Overall Study||2
8561773|NCT00055601|21107877|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
8561774|NCT00055601|21107878|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
8561775|NCT00055601|21107877|P2|STARTED|Overall Study||49
8561776|NCT00055601|21107878|P1|STARTED|Overall Study||48
8561777|NCT00055497|21107892|P4|NOT COMPLETED|Overall Study||90
8561778|NCT00055497|21107893|P3|NOT COMPLETED|Overall Study||2
8561779|NCT00055497|21107894|P2|NOT COMPLETED|Overall Study||3
8561780|NCT00055497|21107895|P1|NOT COMPLETED|Overall Study||5
8561865|NCT00054327|21108241|P5|COMPLETED|Overall Study||10
8561781|NCT00055497|21107892|P4|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
8561782|NCT00055497|21107893|P3|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
8561783|NCT00055497|21107894|P2|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
8561784|NCT00055497|21107895|P1|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
8561785|NCT00055497|21107892|P4|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
8561786|NCT00055497|21107893|P3|STARTED|Overall Study||18
8561787|NCT00055497|21107894|P2|STARTED|Overall Study||19
8561788|NCT00055497|21107895|P1|STARTED|Overall Study||18
8561789|NCT00055471|21107940|P3|NOT COMPLETED|Period 2: Extension Period||0
8561790|NCT00055471|21107941|P2|NOT COMPLETED|Period 2: Extension Period||0
8561791|NCT00055471|21107942|P1|NOT COMPLETED|Period 2: Extension Period||0
8561792|NCT00055471|21107940|P3|COMPLETED|Period 2: Extension Period||0
8561793|NCT00055471|21107941|P2|COMPLETED|Period 2: Extension Period||6
8561794|NCT00055471|21107942|P1|COMPLETED|Period 2: Extension Period||3
8561795|NCT00055471|21107940|P3|STARTED|Period 2: Extension Period||0
8561796|NCT00055471|21107941|P2|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
8561797|NCT00055471|21107942|P1|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
8561798|NCT00055471|21107940|P3|NOT COMPLETED|Period 1: Dose Escalation Period||3
8561799|NCT00055471|21107941|P2|NOT COMPLETED|Period 1: Dose Escalation Period||2
8561800|NCT00055471|21107942|P1|NOT COMPLETED|Period 1: Dose Escalation Period||0
8561801|NCT00055471|21107940|P3|COMPLETED|Period 1: Dose Escalation Period||0
8561802|NCT00055471|21107941|P2|COMPLETED|Period 1: Dose Escalation Period||8
8561803|NCT00055471|21107942|P1|COMPLETED|Period 1: Dose Escalation Period||3
8561804|NCT00055471|21107940|P3|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
8561805|NCT00055471|21107941|P2|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
8561806|NCT00055471|21107942|P1|STARTED|Period 1: Dose Escalation Period||3
8561807|NCT00055237|21107970|P2|NOT COMPLETED|Overall Study||0
8561808|NCT00055237|21107971|P1|NOT COMPLETED|Overall Study||0
8561809|NCT00055237|21107970|P2|COMPLETED|Overall Study||2
8561810|NCT00055237|21107971|P1|COMPLETED|Overall Study||17
8561811|NCT00055237|21107970|P2|STARTED|Overall Study||2
8561812|NCT00055237|21107971|P1|STARTED|Overall Study||17
8561813|NCT00054847|21107978|P2|NOT COMPLETED|Overall Study||100
8561814|NCT00054847|21107979|P1|NOT COMPLETED|Overall Study||98
8561815|NCT00054847|21107978|P2|COMPLETED|Overall Study||266
8561816|NCT00054847|21107979|P1|COMPLETED|Overall Study||269
8561817|NCT00054847|21107978|P2|STARTED|Overall Study||366
8561818|NCT00054847|21107979|P1|STARTED|Overall Study||367
8561819|NCT00054756|21107991|P1|NOT COMPLETED|Overall Study||2
8561820|NCT00054756|21107991|P1|COMPLETED|Overall Study||94
8561821|NCT00054756|21107991|P1|STARTED|Overall Study||96
8561822|NCT00054717|21107997|P2|NOT COMPLETED|Overall Study||299
8561823|NCT00054717|21107998|P1|NOT COMPLETED|Overall Study||262
8561824|NCT00054717|21107997|P2|COMPLETED|Overall Study||18
8561825|NCT00054717|21107998|P1|COMPLETED|Overall Study||51
8561826|NCT00054717|21107997|P2|STARTED|Overall Study||317
8561827|NCT00054717|21107998|P1|STARTED|Overall Study||313
8561828|NCT00054704|21108186|P2|NOT COMPLETED|Overall Study||5
8561829|NCT00054704|21108187|P1|NOT COMPLETED|Overall Study||5
8561830|NCT00054704|21108186|P2|COMPLETED|Overall Study||6
8561831|NCT00054704|21108187|P1|COMPLETED|Overall Study||3
8561832|NCT00054704|21108186|P2|STARTED|Overall Study||11
8561833|NCT00054704|21108187|P1|STARTED|Overall Study||8
8561834|NCT00054691|21108193|P1|NOT COMPLETED|Overall Study||3
8561835|NCT00054691|21108193|P1|COMPLETED|Overall Study||37
8561836|NCT00054691|21108193|P1|STARTED|Overall Study||40
8561837|NCT00054665|21108198|P2|NOT COMPLETED|Part B||0
8561838|NCT00054665|21108199|P1|NOT COMPLETED|Part B||0
8561839|NCT00054665|21108198|P2|COMPLETED|Part B||44
8561840|NCT00054665|21108199|P1|COMPLETED|Part B||0
8561841|NCT00054665|21108198|P2|STARTED|Part B|26 participants received only Part B|44
8561842|NCT00054665|21108199|P1|STARTED|Part B||0
8561843|NCT00054665|21108198|P2|NOT COMPLETED|Part A||0
8561844|NCT00054665|21108199|P1|NOT COMPLETED|Part A||0
8561845|NCT00054665|21108198|P2|COMPLETED|Part A||0
8561846|NCT00054665|21108199|P1|COMPLETED|Part A||23
8561847|NCT00054665|21108198|P2|STARTED|Part A||0
8561848|NCT00054665|21108199|P1|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
8561849|NCT00054639|21108207|P1|NOT COMPLETED|Overall Study||2
8561850|NCT00054639|21108207|P1|COMPLETED|Overall Study||46
8561851|NCT00054639|21108207|P1|STARTED|Overall Study||48
8561852|NCT00054353|21108213|P2|NOT COMPLETED|Overall Study||0
8561853|NCT00054353|21108214|P1|NOT COMPLETED|Overall Study||0
8561854|NCT00054353|21108213|P2|COMPLETED|Overall Study||4
8561855|NCT00054353|21108214|P1|COMPLETED|Overall Study||12
8561856|NCT00054353|21108213|P2|STARTED|Overall Study||4
8561857|NCT00054353|21108214|P1|STARTED|Overall Study||12
8561858|NCT00054327|21108240|P6|NOT COMPLETED|Overall Study||0
8561859|NCT00054327|21108241|P5|NOT COMPLETED|Overall Study||0
8561860|NCT00054327|21108242|P4|NOT COMPLETED|Overall Study||0
8561861|NCT00054327|21108243|P3|NOT COMPLETED|Overall Study||0
8561862|NCT00054327|21108244|P2|NOT COMPLETED|Overall Study||0
8561863|NCT00054327|21108245|P1|NOT COMPLETED|Overall Study||1
8561864|NCT00054327|21108240|P6|COMPLETED|Overall Study||2
8561866|NCT00054327|21108242|P4|COMPLETED|Overall Study||4
8561867|NCT00054327|21108243|P3|COMPLETED|Overall Study||3
8561868|NCT00054327|21108244|P2|COMPLETED|Overall Study||4
8561869|NCT00054327|21108245|P1|COMPLETED|Overall Study||10
8561870|NCT00054327|21108240|P6|STARTED|Overall Study||2
8561871|NCT00054327|21108241|P5|STARTED|Overall Study||10
8561872|NCT00054327|21108242|P4|STARTED|Overall Study||4
8561873|NCT00054327|21108243|P3|STARTED|Overall Study||3
8561874|NCT00054327|21108244|P2|STARTED|Overall Study||4
8561875|NCT00054327|21108245|P1|STARTED|Overall Study||11
8561876|NCT00054275|21108283|P1|NOT COMPLETED|Overall Study||11
8561877|NCT00054275|21108283|P1|COMPLETED|Overall Study||28
8561878|NCT00054275|21108283|P1|STARTED|Overall Study||39
8561879|NCT00054132|21108289|P1|NOT COMPLETED|Overall Study||1
8561880|NCT00054132|21108289|P1|COMPLETED|Overall Study||37
8561881|NCT00054132|21108289|P1|STARTED|Overall Study||38
8561882|NCT00054028|21108300|P1|NOT COMPLETED|Overall Study||0
8561883|NCT00054028|21108300|P1|COMPLETED|Overall Study||31
8561884|NCT00054028|21108300|P1|Phase II|Overall Study||22
8561885|NCT00054028|21108300|P1|Phase I|Overall Study||9
8561886|NCT00054028|21108300|P1|STARTED|Overall Study||31
8561887|NCT00053989|21108306|P1|NOT COMPLETED|Overall Study||0
8561888|NCT00053989|21108306|P1|COMPLETED|Overall Study||41
8561889|NCT00053989|21108306|P1|STARTED|Overall Study||41
8561890|NCT00053898|21108316|P2|NOT COMPLETED|Overall Study||13
8561891|NCT00053898|21108317|P1|NOT COMPLETED|Overall Study||14
8561892|NCT00053898|21108316|P2|COMPLETED|Overall Study||1539
8561893|NCT00053898|21108317|P1|COMPLETED|Overall Study||1538
8561894|NCT00053898|21108316|P2|STARTED|Overall Study||1552
8561895|NCT00053898|21108317|P1|STARTED|Overall Study||1552
8561896|NCT00053846|21108343|P2|NOT COMPLETED|Overall Study||27
8561897|NCT00053846|21108344|P1|NOT COMPLETED|Overall Study||26
8561898|NCT00053846|21108343|P2|COMPLETED|Overall Study||192
8561899|NCT00053846|21108344|P1|COMPLETED|Overall Study||187
8561900|NCT00053846|21108343|P2|STARTED|Overall Study||219
8561901|NCT00053846|21108344|P1|STARTED|Overall Study||213
8561902|NCT00053703|21108353|P3|NOT COMPLETED|Overall Study||15
8561903|NCT00053703|21108354|P2|NOT COMPLETED|Overall Study||13
8561904|NCT00053703|21108355|P1|NOT COMPLETED|Overall Study||18
8561905|NCT00053703|21108353|P3|COMPLETED|Overall Study||25
8561906|NCT00053703|21108354|P2|COMPLETED|Overall Study||28
8561907|NCT00053703|21108355|P1|COMPLETED|Overall Study||17
8561908|NCT00053703|21108353|P3|STARTED|Overall Study||40
8561909|NCT00053703|21108354|P2|STARTED|Overall Study||41
8561910|NCT00053703|21108355|P1|STARTED|Overall Study||35
8561911|NCT00053677|21108380|P2|NOT COMPLETED|Overall Study||6
8561912|NCT00053677|21108381|P1|NOT COMPLETED|Overall Study||22
8561913|NCT00053677|21108380|P2|COMPLETED|Overall Study||13
8561914|NCT00053677|21108381|P1|COMPLETED|Overall Study||36
8561915|NCT00053677|21108380|P2|STARTED|Overall Study||19
8561916|NCT00053677|21108381|P1|STARTED|Overall Study||58
8561917|NCT00053495|21108392|P5|NOT COMPLETED|Overall Study||0
8561918|NCT00053495|21108393|P4|NOT COMPLETED|Overall Study||0
8561919|NCT00053495|21108394|P3|NOT COMPLETED|Overall Study||0
8561920|NCT00053495|21108395|P2|NOT COMPLETED|Overall Study||0
8561921|NCT00053495|21108396|P1|NOT COMPLETED|Overall Study||0
8561922|NCT00053495|21108392|P5|COMPLETED|Overall Study||49
8561923|NCT00053495|21108393|P4|COMPLETED|Overall Study||51
8561924|NCT00053495|21108394|P3|COMPLETED|Overall Study||101
8561925|NCT00053495|21108395|P2|COMPLETED|Overall Study||101
8561926|NCT00053495|21108396|P1|COMPLETED|Overall Study||51
8561927|NCT00053495|21108392|P5|STARTED|Overall Study||49
8561928|NCT00053495|21108393|P4|STARTED|Overall Study||51
8561929|NCT00053495|21108394|P3|STARTED|Overall Study||101
8561930|NCT00053495|21108395|P2|STARTED|Overall Study||101
8561931|NCT00053495|21108396|P1|STARTED|Overall Study||51
8561932|NCT00053482|21108448|P5|NOT COMPLETED|Overall Study||0
8561933|NCT00053482|21108449|P4|NOT COMPLETED|Overall Study||0
8561934|NCT00053482|21108450|P3|NOT COMPLETED|Overall Study||0
8561935|NCT00053482|21108451|P2|NOT COMPLETED|Overall Study||0
8561936|NCT00053482|21108452|P1|NOT COMPLETED|Overall Study||0
8561937|NCT00053482|21108448|P5|COMPLETED|Overall Study||52
8561938|NCT00053482|21108449|P4|COMPLETED|Overall Study||50
8561939|NCT00053482|21108450|P3|COMPLETED|Overall Study||102
8561940|NCT00053482|21108451|P2|COMPLETED|Overall Study||102
8561941|NCT00053482|21108452|P1|COMPLETED|Overall Study||51
8561942|NCT00053482|21108448|P5|STARTED|Overall Study||52
8561943|NCT00053482|21108449|P4|STARTED|Overall Study||50
8561944|NCT00053482|21108450|P3|STARTED|Overall Study||102
8561945|NCT00053482|21108451|P2|STARTED|Overall Study||102
8561946|NCT00053482|21108452|P1|STARTED|Overall Study||51
8561947|NCT00053417|21108503|P4|NOT COMPLETED|Overall Study||6
8561948|NCT00053417|21108504|P3|NOT COMPLETED|Overall Study||1
8561949|NCT00053417|21108505|P2|NOT COMPLETED|Overall Study||2
8561950|NCT00053417|21108506|P1|NOT COMPLETED|Overall Study||2
8561951|NCT00053417|21108503|P4|COMPLETED|Overall Study||51
8561952|NCT00053417|21108504|P3|COMPLETED|Overall Study||49
8561953|NCT00053417|21108505|P2|COMPLETED|Overall Study||50
8561954|NCT00053417|21108506|P1|COMPLETED|Overall Study||45
8561955|NCT00053417|21108503|P4|STARTED|Overall Study||57
8561956|NCT00053417|21108504|P3|STARTED|Overall Study||50
8561957|NCT00053417|21108505|P2|STARTED|Overall Study||52
8561958|NCT00053417|21108506|P1|STARTED|Overall Study||47
8561959|NCT00053365|21108516|P1|NOT COMPLETED|Overall Study||6
8561960|NCT00053365|21108516|P1|COMPLETED|Overall Study||55
8561961|NCT00053365|21108516|P1|STARTED|Overall Study||61
8561968|NCT00053014|21108535|P1|NOT COMPLETED|Overall Study||0
8561969|NCT00053014|21108535|P1|COMPLETED|Overall Study||5
8561970|NCT00053014|21108535|P1|STARTED|Overall Study||5
8561971|NCT00003830|21108542|P2|NOT COMPLETED|Overall Study||793
8561972|NCT00003830|21108543|P1|NOT COMPLETED|Overall Study||832
8561973|NCT00003830|21108542|P2|COMPLETED|Overall Study||2011
8561974|NCT00003830|21108543|P1|COMPLETED|Overall Study||1975
8561975|NCT00003830|21108542|P2|STARTED|Overall Study||2804
8561976|NCT00003830|21108543|P1|STARTED|Overall Study||2807
8561977|NCT00052962|21108569|P2|NOT COMPLETED|Overall Study||2
8561978|NCT00052962|21108570|P1|NOT COMPLETED|Overall Study||1
8561979|NCT00052962|21108569|P2|COMPLETED|Overall Study||15
8561980|NCT00052962|21108570|P1|COMPLETED|Overall Study||12
8561981|NCT00052962|21108569|P2|STARTED|Overall Study||17
8561982|NCT00052962|21108570|P1|STARTED|Overall Study||13
8561983|NCT00052910|21108580|P2|NOT COMPLETED|Overall Study||0
8561984|NCT00052910|21108581|P1|NOT COMPLETED|Overall Study||0
8561985|NCT00052910|21108580|P2|COMPLETED|Overall Study||266
8561986|NCT00052910|21108581|P1|COMPLETED|Overall Study||280
8561987|NCT00052910|21108580|P2|STARTED|Overall Study||266
8561988|NCT00052910|21108581|P1|STARTED|Overall Study||280
8561989|NCT00052715|21108589|P1|NOT COMPLETED|Overall Study||1
8561990|NCT00052715|21108589|P1|COMPLETED|Overall Study||30
8561991|NCT00052715|21108589|P1|STARTED|Overall Study||31
8561992|NCT00052429|21108598|P1|NOT COMPLETED|Overall Study||0
8561993|NCT00052429|21108598|P1|COMPLETED|Overall Study||25
8561994|NCT00052429|21108598|P1|STARTED|Overall Study||25
8561995|NCT00049673|21108605|P2|NOT COMPLETED|Overall Study||3
8561996|NCT00049673|21108606|P1|NOT COMPLETED|Overall Study||1
8561997|NCT00049673|21108605|P2|COMPLETED|Overall Study||163
8561998|NCT00049673|21108606|P1|COMPLETED|Overall Study||165
8561999|NCT00049673|21108605|P2|STARTED|Overall Study||166
8562000|NCT00049673|21108606|P1|STARTED|Overall Study||166
8562001|NCT00049543|21108616|P2|NOT COMPLETED|Overall Study||9
8562002|NCT00049543|21108617|P1|NOT COMPLETED|Overall Study||2
8562003|NCT00049543|21108616|P2|COMPLETED|Overall Study||243
8562004|NCT00049543|21108617|P1|COMPLETED|Overall Study||249
8562005|NCT00049543|21108616|P2|STARTED|Overall Study||252
8562006|NCT00049543|21108617|P1|STARTED|Overall Study||251
8562007|NCT00049530|21108627|P1|NOT COMPLETED|Overall Study||32
8562008|NCT00049530|21108627|P1|COMPLETED|Overall Study||0
8562009|NCT00049530|21108627|P1|Eligible and Treated|Overall Study||29
8562010|NCT00049530|21108627|P1|STARTED|Overall Study||32
8562011|NCT00049517|21108636|P6|NOT COMPLETED|Conditioning/Transplant||6
8562012|NCT00049517|21108637|P5|NOT COMPLETED|Conditioning/Transplant||6
8562013|NCT00049517|21108638|P4|NOT COMPLETED|Conditioning/Transplant||43
8562014|NCT00049517|21108639|P3|NOT COMPLETED|Conditioning/Transplant||38
8562015|NCT00049517|21108640|P2|NOT COMPLETED|Conditioning/Transplant||50
8562016|NCT00049517|21108641|P1|NOT COMPLETED|Conditioning/Transplant||52
8562017|NCT00049517|21108636|P6|COMPLETED|Conditioning/Transplant||18
8562018|NCT00049517|21108637|P5|COMPLETED|Conditioning/Transplant||15
8562019|NCT00049517|21108638|P4|COMPLETED|Conditioning/Transplant||32
8562020|NCT00049517|21108639|P3|COMPLETED|Conditioning/Transplant||25
8562021|NCT00049517|21108640|P2|COMPLETED|Conditioning/Transplant||40
8562022|NCT00049517|21108641|P1|COMPLETED|Conditioning/Transplant||27
8562023|NCT00049517|21108636|P6|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
8562024|NCT00049517|21108637|P5|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
8562025|NCT00049517|21108638|P4|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
8562026|NCT00049517|21108639|P3|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
8562027|NCT00049517|21108640|P2|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
8562028|NCT00049517|21108641|P1|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
8562029|NCT00049517|21108636|P6|STARTED|Conditioning/Transplant||24
8562030|NCT00049517|21108637|P5|STARTED|Conditioning/Transplant||21
8562031|NCT00049517|21108638|P4|STARTED|Conditioning/Transplant||75
8562032|NCT00049517|21108639|P3|STARTED|Conditioning/Transplant||63
8562033|NCT00049517|21108640|P2|STARTED|Conditioning/Transplant||90
8562034|NCT00049517|21108641|P1|STARTED|Conditioning/Transplant||79
8562035|NCT00049517|21108636|P6|NOT COMPLETED|Induction||54
8562036|NCT00049517|21108637|P5|NOT COMPLETED|Induction||60
8562037|NCT00049517|21108638|P4|NOT COMPLETED|Induction||0
8562038|NCT00049517|21108639|P3|NOT COMPLETED|Induction||0
8562039|NCT00049517|21108640|P2|NOT COMPLETED|Induction||0
8562040|NCT00049517|21108641|P1|NOT COMPLETED|Induction||0
8562041|NCT00049517|21108636|P6|COMPLETED|Induction||108
8562042|NCT00049517|21108637|P5|COMPLETED|Induction||128
8562043|NCT00049517|21108638|P4|COMPLETED|Induction||75
8562044|NCT00049517|21108639|P3|COMPLETED|Induction||63
8562045|NCT00049517|21108640|P2|COMPLETED|Induction||90
8562046|NCT00049517|21108641|P1|COMPLETED|Induction||79
8562047|NCT00049517|21108636|P6|Treated|Induction||160
8562048|NCT00049517|21108637|P5|Treated|Induction||186
8562049|NCT00049517|21108638|P4|Treated|Induction||75
8562050|NCT00049517|21108639|P3|Treated|Induction||63
8562051|NCT00049517|21108640|P2|Treated|Induction||90
8562052|NCT00049517|21108641|P1|Treated|Induction||79
8562053|NCT00049517|21108636|P6|STARTED|Induction||162
8562054|NCT00049517|21108637|P5|STARTED|Induction||188
8562055|NCT00049517|21108638|P4|STARTED|Induction||75
8562056|NCT00049517|21108639|P3|STARTED|Induction||63
8562057|NCT00049517|21108640|P2|STARTED|Induction||90
8562058|NCT00049517|21108641|P1|STARTED|Induction||79
8562059|NCT00049504|21108651|P1|NOT COMPLETED|Overall Study||0
8562060|NCT00049504|21108651|P1|COMPLETED|Overall Study||55
8562061|NCT00049504|21108651|P1|STARTED|Overall Study||55
8562062|NCT00049322|21108659|P2|NOT COMPLETED|Overall Study||6
8562063|NCT00049322|21108660|P1|NOT COMPLETED|Overall Study||1
8562064|NCT00049322|21108659|P2|COMPLETED|Overall Study||9
8562065|NCT00049322|21108660|P1|COMPLETED|Overall Study||14
8562066|NCT00049322|21108659|P2|STARTED|Overall Study||15
8562067|NCT00049322|21108660|P1|STARTED|Overall Study||15
8562068|NCT00049257|21108672|P1|NOT COMPLETED|Follow-up Period for Survival Status||4
8562069|NCT00049257|21108672|P1|COMPLETED|Follow-up Period for Survival Status||41
8562070|NCT00049257|21108672|P1|STARTED|Follow-up Period for Survival Status||45
8562071|NCT00049257|21108672|P1|NOT COMPLETED|Carboplatin, Paclitaxel||13
8562072|NCT00049257|21108672|P1|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
8562073|NCT00049257|21108672|P1|STARTED|Carboplatin, Paclitaxel||58
8562074|NCT00049127|21108684|P5|NOT COMPLETED|Overall Study||0
8562075|NCT00049127|21108685|P4|NOT COMPLETED|Overall Study||0
8562076|NCT00049127|21108686|P3|NOT COMPLETED|Overall Study||1
8562077|NCT00049127|21108687|P2|NOT COMPLETED|Overall Study||0
8562078|NCT00049127|21108688|P1|NOT COMPLETED|Overall Study||0
8562079|NCT00049127|21108684|P5|COMPLETED|Overall Study||12
8562080|NCT00049127|21108685|P4|COMPLETED|Overall Study||0
8562081|NCT00049127|21108686|P3|COMPLETED|Overall Study||39
8562082|NCT00049127|21108687|P2|COMPLETED|Overall Study||0
8562083|NCT00049127|21108688|P1|COMPLETED|Overall Study||12
8562084|NCT00049127|21108684|P5|STARTED|Overall Study||12
8562085|NCT00049127|21108685|P4|STARTED|Overall Study||0
8562086|NCT00049127|21108686|P3|STARTED|Overall Study||40
8562087|NCT00049127|21108687|P2|STARTED|Overall Study||0
8562088|NCT00049127|21108688|P1|STARTED|Overall Study||12
8562089|NCT00049036|21108717|P2|NOT COMPLETED|Overall Study||0
8562090|NCT00049036|21108718|P1|NOT COMPLETED|Overall Study||0
8562091|NCT00049036|21108717|P2|COMPLETED|Overall Study||55
8562092|NCT00049036|21108718|P1|COMPLETED|Overall Study||51
8562093|NCT00049036|21108717|P2|STARTED|Overall Study||55
8562094|NCT00049036|21108718|P1|STARTED|Overall Study||51
8562095|NCT00048997|21108726|P2|NOT COMPLETED|Overall Study||3
8562096|NCT00048997|21108727|P1|NOT COMPLETED|Overall Study||13
8562097|NCT00048997|21108726|P2|COMPLETED|Overall Study||177
8562098|NCT00048997|21108727|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
8562099|NCT00048997|21108726|P2|STARTED|Overall Study||180
8562100|NCT00048997|21108727|P1|STARTED|Overall Study||176
8562101|NCT00047385|21108750|P2|NOT COMPLETED|Overall Study||500
8562102|NCT00047385|21108751|P1|NOT COMPLETED|Overall Study||267
8562103|NCT00047385|21108750|P2|COMPLETED|Overall Study||26232
8562104|NCT00047385|21108751|P1|COMPLETED|Overall Study|Had at least one screening exam.|26455
8562105|NCT00047385|21108750|P2|STARTED|Overall Study||26732
8562106|NCT00047385|21108751|P1|STARTED|Overall Study||26722
8562107|NCT00047320|21108769|P1|NOT COMPLETED|Overall Study||28
8562108|NCT00047320|21108769|P1|COMPLETED|Overall Study||76
8562109|NCT00047320|21108769|P1|STARTED|Overall Study||104
8562110|NCT00047060|21108778|P1|NOT COMPLETED|Overall Study||2
8562111|NCT00047060|21108778|P1|COMPLETED|Overall Study||3
8562112|NCT00047060|21108778|P1|STARTED|Overall Study||5
8562113|NCT00047008|21108784|P2|NOT COMPLETED|Overall Study||11
8562114|NCT00047008|21108785|P1|NOT COMPLETED|Overall Study||11
8562115|NCT00047008|21108784|P2|COMPLETED|Overall Study||360
8562116|NCT00047008|21108785|P1|COMPLETED|Overall Study||361
8562117|NCT00047008|21108784|P2|STARTED|Overall Study||371
8562118|NCT00047008|21108785|P1|STARTED|Overall Study||372
8562119|NCT00046930|21108793|P2|NOT COMPLETED|Overall Study||4
8562120|NCT00046930|21108794|P1|NOT COMPLETED|Overall Study||12
8562121|NCT00046930|21108793|P2|COMPLETED|Overall Study||221
8562122|NCT00046930|21108794|P1|COMPLETED|Overall Study||212
8562123|NCT00046930|21108793|P2|STARTED|Overall Study||225
8562124|NCT00046930|21108794|P1|STARTED|Overall Study||224
8562125|NCT00046891|21108809|P2|NOT COMPLETED|Overall Study||30
8562126|NCT00046891|21108810|P1|NOT COMPLETED|Overall Study||29
8562127|NCT00046891|21108809|P2|COMPLETED|Overall Study||83
8562128|NCT00046891|21108810|P1|COMPLETED|Overall Study||84
8562129|NCT00046891|21108809|P2|STARTED|Overall Study||113
8562130|NCT00046891|21108810|P1|STARTED|Overall Study||113
8562131|NCT00046839|21108830|P2|NOT COMPLETED|Overall Study||2
8562132|NCT00046839|21108831|P1|NOT COMPLETED|Overall Study||1
8562133|NCT00046839|21108830|P2|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
8562134|NCT00046839|21108831|P1|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
8562135|NCT00046839|21108830|P2|STARTED|Overall Study||13
8562136|NCT00046839|21108831|P1|STARTED|Overall Study||8
8562137|NCT00045734|21108838|P1|NOT COMPLETED|Overall Study||1
8562138|NCT00045734|21108838|P1|COMPLETED|Overall Study||22
8562139|NCT00045734|21108838|P1|STARTED|Overall Study||23
8562140|NCT00045708|21108853|P3|NOT COMPLETED|Phase 2||0
8562141|NCT00045708|21108854|P2|NOT COMPLETED|Phase 2||0
8562142|NCT00045708|21108855|P1|NOT COMPLETED|Phase 2||0
8562143|NCT00045708|21108853|P3|COMPLETED|Phase 2||19
8562144|NCT00045708|21108854|P2|COMPLETED|Phase 2||0
8562145|NCT00045708|21108855|P1|COMPLETED|Phase 2||0
8562146|NCT00045708|21108853|P3|STARTED|Phase 2||19
8562147|NCT00045708|21108854|P2|STARTED|Phase 2||0
8562148|NCT00045708|21108855|P1|STARTED|Phase 2||0
8562149|NCT00045708|21108853|P3|NOT COMPLETED|Phase 1||0
8562150|NCT00045708|21108854|P2|NOT COMPLETED|Phase 1||1
8562151|NCT00045708|21108855|P1|NOT COMPLETED|Phase 1||0
8562152|NCT00045708|21108853|P3|COMPLETED|Phase 1||0
8562153|NCT00045708|21108854|P2|COMPLETED|Phase 1||16
8562154|NCT00045708|21108855|P1|COMPLETED|Phase 1||21
8562155|NCT00045708|21108853|P3|STARTED|Phase 1||0
8562156|NCT00045708|21108854|P2|STARTED|Phase 1||17
8562157|NCT00045708|21108855|P1|STARTED|Phase 1||21
8562158|NCT00045630|21108880|P1|NOT COMPLETED|Overall Study||6
8562159|NCT00045630|21108880|P1|COMPLETED|Overall Study||71
8562160|NCT00045630|21108880|P1|Eligible and Began Protocol Therapy|Overall Study||74
8562161|NCT00045630|21108880|P1|Eligible|Overall Study||75
8562162|NCT00045630|21108880|P1|STARTED|Overall Study||77
8562163|NCT00045487|21108886|P1|NOT COMPLETED|Overall Study||11
8562164|NCT00045487|21108886|P1|COMPLETED|Overall Study||30
8562165|NCT00045487|21108886|P1|STARTED|Overall Study||41
8562166|NCT00045435|21108890|P1|NOT COMPLETED|Overall Study||0
8562167|NCT00045435|21108890|P1|COMPLETED|Overall Study||17
8562168|NCT00045435|21108890|P1|STARTED|Overall Study||17
8562169|NCT00045305|21108899|P1|NOT COMPLETED|Overall Study||14
8562170|NCT00045305|21108899|P1|COMPLETED|Overall Study||3
8562171|NCT00045305|21108899|P1|Eligible and Treated|Overall Study||17
8562172|NCT00045305|21108899|P1|STARTED|Overall Study||17
8562173|NCT00045162|21108910|P2|NOT COMPLETED|Overall Study||118
8562174|NCT00045162|21108911|P1|NOT COMPLETED|Overall Study||142
8562175|NCT00045162|21108910|P2|COMPLETED|Overall Study||217
8562176|NCT00045162|21108911|P1|COMPLETED|Overall Study||194
8562177|NCT00045162|21108910|P2|STARTED|Overall Study||335
8562178|NCT00045162|21108911|P1|STARTED|Overall Study||336
8562179|NCT00045110|21108926|P3|NOT COMPLETED|775mg Dose Escalation||0
8562180|NCT00045110|21108927|P2|NOT COMPLETED|775mg Dose Escalation||0
8562181|NCT00045110|21108928|P1|NOT COMPLETED|775mg Dose Escalation||0
8562182|NCT00045110|21108926|P3|COMPLETED|775mg Dose Escalation||0
8562183|NCT00045110|21108927|P2|COMPLETED|775mg Dose Escalation||0
8562184|NCT00045110|21108928|P1|COMPLETED|775mg Dose Escalation||7
8562185|NCT00045110|21108926|P3|STARTED|775mg Dose Escalation||0
8562186|NCT00045110|21108927|P2|STARTED|775mg Dose Escalation||0
8562187|NCT00045110|21108928|P1|STARTED|775mg Dose Escalation||7
8562188|NCT00045110|21108926|P3|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
8562189|NCT00045110|21108927|P2|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
8562190|NCT00045110|21108928|P1|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
8562191|NCT00045110|21108926|P3|COMPLETED|650mg Phase 1 Dose Escalation||0
8562192|NCT00045110|21108927|P2|COMPLETED|650mg Phase 1 Dose Escalation||0
8562193|NCT00045110|21108928|P1|COMPLETED|650mg Phase 1 Dose Escalation||6
8562194|NCT00045110|21108926|P3|STARTED|650mg Phase 1 Dose Escalation||0
8562195|NCT00045110|21108927|P2|STARTED|650mg Phase 1 Dose Escalation||0
8562196|NCT00045110|21108928|P1|STARTED|650mg Phase 1 Dose Escalation||6
8562197|NCT00045110|21108926|P3|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
8562198|NCT00045110|21108927|P2|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
8562199|NCT00045110|21108928|P1|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
8562200|NCT00045110|21108926|P3|COMPLETED|525mg Phase 1 Dose Escalation||0
8562201|NCT00045110|21108927|P2|COMPLETED|525mg Phase 1 Dose Escalation||0
8562202|NCT00045110|21108928|P1|COMPLETED|525mg Phase 1 Dose Escalation||3
8562203|NCT00045110|21108926|P3|STARTED|525mg Phase 1 Dose Escalation||0
8562204|NCT00045110|21108927|P2|STARTED|525mg Phase 1 Dose Escalation||0
8562205|NCT00045110|21108928|P1|STARTED|525mg Phase 1 Dose Escalation||3
8562206|NCT00045110|21108926|P3|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
8562207|NCT00045110|21108927|P2|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
8562208|NCT00045110|21108928|P1|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
8562209|NCT00045110|21108926|P3|COMPLETED|400mg Phase 1 Dose Escalation||0
8562210|NCT00045110|21108927|P2|COMPLETED|400mg Phase 1 Dose Escalation||0
8562211|NCT00045110|21108928|P1|COMPLETED|400mg Phase 1 Dose Escalation||3
8562212|NCT00045110|21108926|P3|STARTED|400mg Phase 1 Dose Escalation||0
8562213|NCT00045110|21108927|P2|STARTED|400mg Phase 1 Dose Escalation||0
8562214|NCT00045110|21108928|P1|STARTED|400mg Phase 1 Dose Escalation||3
8562215|NCT00045110|21108926|P3|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
8562216|NCT00045110|21108927|P2|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
8562217|NCT00045110|21108928|P1|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
8562218|NCT00045110|21108926|P3|COMPLETED|275mg Phase 1 Dose Escalation||0
8562219|NCT00045110|21108927|P2|COMPLETED|275mg Phase 1 Dose Escalation||0
8562220|NCT00045110|21108928|P1|COMPLETED|275mg Phase 1 Dose Escalation||3
8562221|NCT00045110|21108926|P3|STARTED|275mg Phase 1 Dose Escalation||0
8562222|NCT00045110|21108927|P2|STARTED|275mg Phase 1 Dose Escalation||0
8562223|NCT00045110|21108928|P1|STARTED|275mg Phase 1 Dose Escalation||3
8562224|NCT00045110|21108926|P3|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
8562225|NCT00045110|21108927|P2|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
8562226|NCT00045110|21108928|P1|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
8562227|NCT00045110|21108926|P3|COMPLETED|200mg Phase 1 Dose Escalation||0
8562228|NCT00045110|21108927|P2|COMPLETED|200mg Phase 1 Dose Escalation||0
8562229|NCT00045110|21108928|P1|COMPLETED|200mg Phase 1 Dose Escalation||4
8562230|NCT00045110|21108926|P3|STARTED|200mg Phase 1 Dose Escalation||0
8562231|NCT00045110|21108927|P2|STARTED|200mg Phase 1 Dose Escalation||0
8562232|NCT00045110|21108928|P1|STARTED|200mg Phase 1 Dose Escalation||4
8562233|NCT00045110|21108926|P3|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
8562234|NCT00045110|21108927|P2|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
8562235|NCT00045110|21108928|P1|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
8562236|NCT00045110|21108926|P3|COMPLETED|100mg Phase 1 Dose Escalalation||43
8562237|NCT00045110|21108927|P2|COMPLETED|100mg Phase 1 Dose Escalalation||53
8562238|NCT00045110|21108928|P1|COMPLETED|100mg Phase 1 Dose Escalalation||6
8562239|NCT00045110|21108926|P3|STARTED|100mg Phase 1 Dose Escalalation||45
8562240|NCT00045110|21108927|P2|STARTED|100mg Phase 1 Dose Escalalation||59
8562241|NCT00045110|21108928|P1|STARTED|100mg Phase 1 Dose Escalalation||6
8562242|NCT00045032|21108977|P3|NOT COMPLETED|Overall Study||726
8562243|NCT00045032|21108978|P2|NOT COMPLETED|Overall Study||708
8562244|NCT00045032|21108979|P1|NOT COMPLETED|Overall Study||863
8562245|NCT00045032|21108977|P3|COMPLETED|Overall Study||974
8562246|NCT00045032|21108978|P2|COMPLETED|Overall Study||994
8562247|NCT00045032|21108979|P1|COMPLETED|Overall Study||834
8562248|NCT00045032|21108977|P3|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
8562249|NCT00045032|21108978|P2|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
8562250|NCT00045032|21108979|P1|Crossover to Adjuvant Herceptin|Overall Study||888
8562251|NCT00045032|21108977|P3|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
8562252|NCT00045032|21108978|P2|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
8562253|NCT00045032|21108979|P1|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
8562254|NCT00042991|21109113|P7|NOT COMPLETED|Overall Study||2
8562255|NCT00042991|21109114|P6|NOT COMPLETED|Overall Study||5
8562256|NCT00042991|21109115|P5|NOT COMPLETED|Overall Study||3
8562257|NCT00042991|21109116|P4|NOT COMPLETED|Overall Study||2
8562258|NCT00042991|21109117|P3|NOT COMPLETED|Overall Study||6
8562259|NCT00042991|21109118|P2|NOT COMPLETED|Overall Study||40
8562260|NCT00042991|21109119|P1|NOT COMPLETED|Overall Study||6
8562261|NCT00042991|21109113|P7|COMPLETED|Overall Study||1
8562262|NCT00042991|21109114|P6|COMPLETED|Overall Study||0
8562263|NCT00042991|21109115|P5|COMPLETED|Overall Study||0
8562264|NCT00042991|21109116|P4|COMPLETED|Overall Study||0
8562265|NCT00042991|21109117|P3|COMPLETED|Overall Study||1
8562266|NCT00042991|21109118|P2|COMPLETED|Overall Study||3
8562267|NCT00042991|21109119|P1|COMPLETED|Overall Study||0
8562268|NCT00042991|21109113|P7|Phase-II Trial|Overall Study||0
8562269|NCT00042991|21109114|P6|Phase-II Trial|Overall Study||0
8562270|NCT00042991|21109115|P5|Phase-II Trial|Overall Study||0
8562271|NCT00042991|21109116|P4|Phase-II Trial|Overall Study||0
8562272|NCT00042991|21109117|P3|Phase-II Trial|Overall Study||0
8562273|NCT00042991|21109118|P2|Phase-II Trial|Overall Study||36
8562274|NCT00042991|21109119|P1|Phase-II Trial|Overall Study||0
8562275|NCT00042991|21109113|P7|Phase-I Trial|Overall Study||3
8562276|NCT00042991|21109114|P6|Phase-I Trial|Overall Study||5
8562277|NCT00042991|21109115|P5|Phase-I Trial|Overall Study||3
8562278|NCT00042991|21109116|P4|Phase-I Trial|Overall Study||2
8562279|NCT00042991|21109117|P3|Phase-I Trial|Overall Study||7
8562280|NCT00042991|21109118|P2|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
8562281|NCT00042991|21109119|P1|Phase-I Trial|Overall Study||6
8562282|NCT00042991|21109113|P7|STARTED|Overall Study||3
8562283|NCT00042991|21109114|P6|STARTED|Overall Study||5
8562284|NCT00042991|21109115|P5|STARTED|Overall Study||3
8562285|NCT00042991|21109116|P4|STARTED|Overall Study||2
8562286|NCT00042991|21109117|P3|STARTED|Overall Study||7
8562287|NCT00042991|21109118|P2|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
8562288|NCT00042991|21109119|P1|STARTED|Overall Study||6
8562289|NCT00042939|21109162|P2|NOT COMPLETED|Overall Study||21
8562290|NCT00042939|21109163|P1|NOT COMPLETED|Overall Study||24
8562291|NCT00042939|21109162|P2|COMPLETED|Overall Study||25
8562292|NCT00042939|21109163|P1|COMPLETED|Overall Study||24
8562293|NCT00042939|21109162|P2|Patients With EGFR Results Available|Overall Study||31
8562294|NCT00042939|21109163|P1|Patients With EGFR Results Available|Overall Study||30
8562295|NCT00042939|21109162|P2|Eligible and Began Protocol Therapy|Overall Study||43
8562296|NCT00042939|21109163|P1|Eligible and Began Protocol Therapy|Overall Study||44
8562297|NCT00042939|21109162|P2|Treated|Overall Study||45
8562298|NCT00042939|21109163|P1|Treated|Overall Study||46
8562299|NCT00042939|21109162|P2|STARTED|Overall Study||46
8562300|NCT00042939|21109163|P1|STARTED|Overall Study||48
8562301|NCT00041132|21109177|P1|NOT COMPLETED|Overall Study||30
8562302|NCT00041132|21109177|P1|COMPLETED|Overall Study||26
8562303|NCT00041132|21109177|P1|Eligible and Began Protocol Therapy|Overall Study||49
8562304|NCT00041132|21109177|P1|Eligible|Overall Study||49
8562305|NCT00041132|21109177|P1|STARTED|Overall Study||56
8562306|NCT00041119|21109187|P4|NOT COMPLETED|Overall Study||0
8562307|NCT00041119|21109188|P3|NOT COMPLETED|Overall Study||0
8562308|NCT00041119|21109189|P2|NOT COMPLETED|Overall Study||0
8562309|NCT00041119|21109190|P1|NOT COMPLETED|Overall Study||0
8562310|NCT00041119|21109187|P4|COMPLETED|Overall Study||789
8562311|NCT00041119|21109188|P3|COMPLETED|Overall Study||1151
8562312|NCT00041119|21109189|P2|COMPLETED|Overall Study||789
8562313|NCT00041119|21109190|P1|COMPLETED|Overall Study||1142
8562314|NCT00041119|21109187|P4|STARTED|Overall Study||789
8562315|NCT00041119|21109188|P3|STARTED|Overall Study||1151
8562316|NCT00041119|21109189|P2|STARTED|Overall Study||789
8562317|NCT00041119|21109190|P1|STARTED|Overall Study||1142
8562318|NCT00041080|21109212|P2|NOT COMPLETED|Overall Study||10
8562319|NCT00041080|21109213|P1|NOT COMPLETED|Overall Study||30
8562320|NCT00041080|21109212|P2|COMPLETED|Overall Study||60
8562321|NCT00041080|21109213|P1|COMPLETED|Overall Study||39
8562322|NCT00041080|21109212|P2|STARTED|Overall Study|number patients enrolled on study|70
8562323|NCT00041080|21109213|P1|STARTED|Overall Study|number patients enrolled on study|69
8562324|NCT00041067|21109219|P1|NOT COMPLETED|Overall Study||76
8562325|NCT00041067|21109219|P1|COMPLETED|Overall Study||0
8562326|NCT00041067|21109219|P1|Eligible|Overall Study||74
8562327|NCT00041067|21109219|P1|STARTED|Overall Study||76
8562328|NCT00040937|21109226|P1|NOT COMPLETED|Maintenance||0
8562329|NCT00040937|21109226|P1|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
8562330|NCT00040937|21109226|P1|STARTED|Maintenance||76
8562331|NCT00040937|21109226|P1|NOT COMPLETED|Autologous PBSCT||31
8562332|NCT00040937|21109226|P1|COMPLETED|Autologous PBSCT||77
8562333|NCT00040937|21109226|P1|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
8562334|NCT00040937|21109226|P1|NOT COMPLETED|Induction/PBSC Mobilization||37
8562335|NCT00040937|21109226|P1|COMPLETED|Induction/PBSC Mobilization||110
8562336|NCT00040937|21109226|P1|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
8562337|NCT00040846|21109239|P6|NOT COMPLETED|Overall Study||0
8562338|NCT00040846|21109240|P5|NOT COMPLETED|Overall Study||0
8562339|NCT00040846|21109241|P4|NOT COMPLETED|Overall Study||0
8562340|NCT00040846|21109242|P3|NOT COMPLETED|Overall Study||0
8562341|NCT00040846|21109243|P2|NOT COMPLETED|Overall Study||0
8562342|NCT00040846|21109244|P1|NOT COMPLETED|Overall Study||0
8562343|NCT00040846|21109239|P6|COMPLETED|Overall Study||0
8562344|NCT00040846|21109240|P5|COMPLETED|Overall Study||0
8562345|NCT00040846|21109241|P4|COMPLETED|Overall Study||0
8562346|NCT00040846|21109242|P3|COMPLETED|Overall Study||0
8562347|NCT00040846|21109243|P2|COMPLETED|Overall Study||0
8562348|NCT00040846|21109244|P1|COMPLETED|Overall Study||60
8562349|NCT00040846|21109239|P6|STARTED|Overall Study||0
8562350|NCT00040846|21109240|P5|STARTED|Overall Study||0
8562351|NCT00040846|21109241|P4|STARTED|Overall Study||0
8562352|NCT00040846|21109242|P3|STARTED|Overall Study||0
8562353|NCT00040846|21109243|P2|STARTED|Overall Study||0
8562354|NCT00040846|21109244|P1|STARTED|Overall Study||60
8562355|NCT00040742|21109286|P4|NOT COMPLETED|Overall Study||34
8562356|NCT00040742|21109287|P3|NOT COMPLETED|Overall Study||46
8562357|NCT00040742|21109288|P2|NOT COMPLETED|Overall Study||49
8562358|NCT00040742|21109289|P1|NOT COMPLETED|Overall Study||39
8562359|NCT00040742|21109286|P4|COMPLETED|Overall Study||152
8562360|NCT00040742|21109287|P3|COMPLETED|Overall Study||141
8562361|NCT00040742|21109288|P2|COMPLETED|Overall Study||134
8562362|NCT00040742|21109289|P1|COMPLETED|Overall Study||149
8562363|NCT00040742|21109286|P4|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
8562364|NCT00040742|21109287|P3|STARTED|Overall Study||187
8562365|NCT00040742|21109288|P2|STARTED|Overall Study||183
8562366|NCT00040742|21109289|P1|STARTED|Overall Study||188
8562367|NCT00039377|21109303|P4|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8562368|NCT00039377|21109304|P3|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8562369|NCT00039377|21109305|P2|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8562370|NCT00039377|21109306|P1|NOT COMPLETED|Course 5 (Transplant Assignments)||0
8562371|NCT00039377|21109303|P4|COMPLETED|Course 5 (Transplant Assignments)||1
8562372|NCT00039377|21109304|P3|COMPLETED|Course 5 (Transplant Assignments)||19
8562373|NCT00039377|21109305|P2|COMPLETED|Course 5 (Transplant Assignments)||15
8562374|NCT00039377|21109306|P1|COMPLETED|Course 5 (Transplant Assignments)||0
8562375|NCT00039377|21109303|P4|STARTED|Course 5 (Transplant Assignments)||1
8562376|NCT00039377|21109304|P3|STARTED|Course 5 (Transplant Assignments)||19
8562377|NCT00039377|21109305|P2|STARTED|Course 5 (Transplant Assignments)||15
8562378|NCT00039377|21109306|P1|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
8562379|NCT00039377|21109303|P4|NOT COMPLETED|Initial Registration||0
8562380|NCT00039377|21109304|P3|NOT COMPLETED|Initial Registration||0
8562381|NCT00039377|21109305|P2|NOT COMPLETED|Initial Registration||0
8562382|NCT00039377|21109306|P1|NOT COMPLETED|Initial Registration||22
8562383|NCT00039377|21109303|P4|COMPLETED|Initial Registration||0
8562384|NCT00039377|21109304|P3|COMPLETED|Initial Registration||0
8562385|NCT00039377|21109305|P2|COMPLETED|Initial Registration||0
8562386|NCT00039377|21109306|P1|COMPLETED|Initial Registration||35
8562387|NCT00039377|21109303|P4|STARTED|Initial Registration||0
8562388|NCT00039377|21109304|P3|STARTED|Initial Registration||0
8562389|NCT00039377|21109305|P2|STARTED|Initial Registration||0
8562390|NCT00039377|21109306|P1|STARTED|Initial Registration||57
8562391|NCT00039195|21109318|P1|NOT COMPLETED|Overall Study||0
8562392|NCT00039195|21109318|P1|COMPLETED|Overall Study||98
8562393|NCT00039195|21109318|P1|STARTED|Overall Study||98
8562394|NCT00039130|21109322|P1|NOT COMPLETED|Overall Study||30
8562395|NCT00039130|21109322|P1|COMPLETED|Overall Study||75
8562396|NCT00039130|21109322|P1|STARTED|Overall Study||105
8562397|NCT00036738|21109328|P1|NOT COMPLETED|Overall Study||0
8562398|NCT00036738|21109328|P1|COMPLETED|Overall Study||28
8562399|NCT00036738|21109328|P1|STARTED|Overall Study||28
8562400|NCT00033657|21109338|P2|NOT COMPLETED|Adjuvant Chemotherapy||17
8562401|NCT00033657|21109339|P1|NOT COMPLETED|Adjuvant Chemotherapy||18
8562402|NCT00033657|21109338|P2|COMPLETED|Adjuvant Chemotherapy||16
8562403|NCT00033657|21109339|P1|COMPLETED|Adjuvant Chemotherapy||18
8562404|NCT00033657|21109338|P2|STARTED|Adjuvant Chemotherapy||33
8562405|NCT00033657|21109339|P1|STARTED|Adjuvant Chemotherapy||36
8562406|NCT00033657|21109338|P2|NOT COMPLETED|Surgical Resection||3
8562407|NCT00033657|21109339|P1|NOT COMPLETED|Surgical Resection||0
8562408|NCT00033657|21109338|P2|COMPLETED|Surgical Resection||33
8562409|NCT00033657|21109339|P1|COMPLETED|Surgical Resection||36
8562410|NCT00033657|21109338|P2|STARTED|Surgical Resection||36
8562411|NCT00033657|21109339|P1|STARTED|Surgical Resection||36
8562412|NCT00033657|21109338|P2|NOT COMPLETED|Neoadjuvant Chemotherapy||11
8562413|NCT00033657|21109339|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||14
8562414|NCT00033657|21109338|P2|COMPLETED|Neoadjuvant Chemotherapy||36
8562415|NCT00033657|21109339|P1|COMPLETED|Neoadjuvant Chemotherapy||36
8562416|NCT00033657|21109338|P2|Eligible and Treated|Neoadjuvant Chemotherapy||42
8562417|NCT00033657|21109339|P1|Eligible and Treated|Neoadjuvant Chemotherapy||39
8562418|NCT00033657|21109338|P2|Eligible|Neoadjuvant Chemotherapy||43
8562419|NCT00033657|21109339|P1|Eligible|Neoadjuvant Chemotherapy||42
8562420|NCT00033657|21109338|P2|STARTED|Neoadjuvant Chemotherapy||47
8562421|NCT00033657|21109339|P1|STARTED|Neoadjuvant Chemotherapy||50
8562428|NCT00033540|21109372|P1|NOT COMPLETED|Overall Study||57
8562429|NCT00033540|21109372|P1|COMPLETED|Overall Study||0
8562430|NCT00033540|21109372|P1|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
8562431|NCT00033540|21109372|P1|Eligible|Overall Study||54
8562432|NCT00033540|21109372|P1|STARTED|Overall Study||57
8562433|NCT00033514|21109382|P2|NOT COMPLETED|Overall Study||4
8562434|NCT00033514|21109383|P1|NOT COMPLETED|Overall Study||1
8562435|NCT00033514|21109382|P2|COMPLETED|Overall Study||7
8562436|NCT00033514|21109383|P1|COMPLETED|Overall Study||15
8562437|NCT00033514|21109382|P2|STARTED|Overall Study||11
8562438|NCT00033514|21109383|P1|STARTED|Overall Study||16
8562439|NCT00033371|21109393|P2|NOT COMPLETED|Overall Study||10
8562440|NCT00033371|21109394|P1|NOT COMPLETED|Overall Study||6
8562441|NCT00033371|21109393|P2|COMPLETED|Overall Study||47
8562442|NCT00033371|21109394|P1|COMPLETED|Overall Study||49
8562443|NCT00033371|21109393|P2|STARTED|Overall Study||57
8562444|NCT00033371|21109394|P1|STARTED|Overall Study||55
8562445|NCT00033293|21109412|P2|NOT COMPLETED|Overall Study||18
8562446|NCT00033293|21109413|P1|NOT COMPLETED|Overall Study||10
8562447|NCT00033293|21109412|P2|COMPLETED|Overall Study||9
8562448|NCT00033293|21109413|P1|COMPLETED|Overall Study||16
8562449|NCT00033293|21109412|P2|STARTED|Overall Study||27
8562450|NCT00033293|21109413|P1|STARTED|Overall Study||26
8562454|NCT00031590|21109435|P1|NOT COMPLETED|Overall Study||3
8562455|NCT00031590|21109435|P1|COMPLETED|Overall Study||25
8562456|NCT00031590|21109435|P1|STARTED|Overall Study||28
8562457|NCT00030901|21109442|P3|NOT COMPLETED|Randomization||88
8562458|NCT00030901|21109443|P2|NOT COMPLETED|Randomization||101
8562459|NCT00030901|21109444|P1|NOT COMPLETED|Randomization||0
8562460|NCT00030901|21109442|P3|COMPLETED|Randomization||137
8562461|NCT00030901|21109443|P2|COMPLETED|Randomization||126
8562462|NCT00030901|21109444|P1|COMPLETED|Randomization||0
8562463|NCT00030901|21109442|P3|Eligible|Randomization||211
8562464|NCT00030901|21109443|P2|Eligible|Randomization||212
8562465|NCT00030901|21109444|P1|Eligible|Randomization||0
8562466|NCT00030901|21109442|P3|STARTED|Randomization||225
8562467|NCT00030901|21109443|P2|STARTED|Randomization||227
8562468|NCT00030901|21109444|P1|STARTED|Randomization||0
8562469|NCT00030901|21109442|P3|NOT COMPLETED|Initial Registration||0
8562470|NCT00030901|21109443|P2|NOT COMPLETED|Initial Registration||0
8562471|NCT00030901|21109444|P1|NOT COMPLETED|Initial Registration||167
8562472|NCT00030901|21109442|P3|COMPLETED|Initial Registration||0
8562473|NCT00030901|21109443|P2|COMPLETED|Initial Registration||0
8562474|NCT00030901|21109444|P1|COMPLETED|Initial Registration||452
8562475|NCT00030901|21109442|P3|STARTED|Initial Registration||0
8562476|NCT00030901|21109443|P2|STARTED|Initial Registration||0
8562477|NCT00030901|21109444|P1|STARTED|Initial Registration||619
8562478|NCT00030823|21109452|P1|NOT COMPLETED|Overall Study||1
8562479|NCT00030823|21109452|P1|COMPLETED|Overall Study||13
8562480|NCT00030823|21109452|P1|STARTED|Overall Study||14
8562481|NCT00030264|21109456|P1|NOT COMPLETED|Overall Study||0
8562482|NCT00030264|21109456|P1|COMPLETED|Overall Study||23
8562483|NCT00030264|21109456|P1|STARTED|Overall Study||23
8562484|NCT00028769|21109460|P1|NOT COMPLETED|Overall Study||41
8562485|NCT00028769|21109460|P1|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
8562486|NCT00028769|21109460|P1|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
8562487|NCT00028769|21109460|P1|Eligible|Overall Study||36
8562488|NCT00028769|21109460|P1|STARTED|Overall Study||41
8562489|NCT00028002|21109466|P1|NOT COMPLETED|Overall Study||11
8562490|NCT00028002|21109466|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
8562491|NCT00028002|21109466|P1|STARTED|Overall Study||63
8562492|NCT00027846|21109476|P3|NOT COMPLETED|Overall Study||37
8562493|NCT00027846|21109477|P2|NOT COMPLETED|Overall Study||68
8562494|NCT00027846|21109478|P1|NOT COMPLETED|Overall Study||2
8562495|NCT00027846|21109476|P3|COMPLETED|Overall Study||41
8562496|NCT00027846|21109477|P2|COMPLETED|Overall Study||219
8562497|NCT00027846|21109478|P1|COMPLETED|Overall Study||11
8562498|NCT00027846|21109476|P3|STARTED|Overall Study||78
8562499|NCT00027846|21109477|P2|STARTED|Overall Study||287
8562500|NCT00027846|21109478|P1|STARTED|Overall Study||13
8562501|NCT00027560|21109496|P1|NOT COMPLETED|Overall Study||1
8562502|NCT00027560|21109496|P1|COMPLETED|Overall Study||50
8562503|NCT00027560|21109496|P1|STARTED|Overall Study||51
8562504|NCT00026494|21109509|P4|NOT COMPLETED|Overall Study||0
8562505|NCT00026494|21109510|P3|NOT COMPLETED|Overall Study||6
8562506|NCT00026494|21109511|P2|NOT COMPLETED|Overall Study||0
8562507|NCT00026494|21109512|P1|NOT COMPLETED|Overall Study||2
8562508|NCT00026494|21109509|P4|COMPLETED|Overall Study||16
8562509|NCT00026494|21109510|P3|COMPLETED|Overall Study||16
8562510|NCT00026494|21109511|P2|COMPLETED|Overall Study||4
8562511|NCT00026494|21109512|P1|COMPLETED|Overall Study||5
8562512|NCT00026494|21109509|P4|STARTED|Overall Study||16
8562513|NCT00026494|21109510|P3|STARTED|Overall Study||22
8562514|NCT00026494|21109511|P2|STARTED|Overall Study||4
8562515|NCT00026494|21109512|P1|STARTED|Overall Study||7
8562522|NCT00026221|21109543|P3|NOT COMPLETED|Overall Study||0
8562523|NCT00026221|21109544|P2|NOT COMPLETED|Overall Study||0
8562524|NCT00026221|21109545|P1|NOT COMPLETED|Overall Study||0
8562525|NCT00026221|21109543|P3|COMPLETED|Overall Study||25
8562526|NCT00026221|21109544|P2|COMPLETED|Overall Study||16
8562527|NCT00026221|21109545|P1|COMPLETED|Overall Study||16
8562528|NCT00026221|21109543|P3|STARTED|Overall Study||25
8562529|NCT00026221|21109544|P2|STARTED|Overall Study||16
8562530|NCT00026221|21109545|P1|STARTED|Overall Study||16
8562531|NCT00026208|21109564|P2|NOT COMPLETED|Overall Study||0
8562532|NCT00026208|21109565|P1|NOT COMPLETED|Overall Study||1
8562533|NCT00026208|21109564|P2|COMPLETED|Overall Study||4
8562534|NCT00026208|21109565|P1|COMPLETED|Overall Study||71
8562535|NCT00026208|21109564|P2|STARTED|Overall Study||4
8562536|NCT00026208|21109565|P1|STARTED|Overall Study||72
8562537|NCT00025662|21109583|P1|NOT COMPLETED|Overall Study||3
8562538|NCT00025662|21109583|P1|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
8562539|NCT00025662|21109583|P1|STARTED|Overall Study||25
8562540|NCT00025506|21109591|P1|NOT COMPLETED|Overall Study||10
8562541|NCT00025506|21109591|P1|COMPLETED|Overall Study|Eligible and treated patients.|45
8562542|NCT00025506|21109591|P1|STARTED|Overall Study||55
8562543|NCT00025259|21109612|P7|NOT COMPLETED|Overall Study||51
8562544|NCT00025259|21109613|P6|NOT COMPLETED|Overall Study||52
8562545|NCT00025259|21109614|P5|NOT COMPLETED|Overall Study||36
8562546|NCT00025259|21109615|P4|NOT COMPLETED|Overall Study||114
8562547|NCT00025259|21109616|P3|NOT COMPLETED|Overall Study||81
8562548|NCT00025259|21109617|P2|NOT COMPLETED|Overall Study||89
8562549|NCT00025259|21109618|P1|NOT COMPLETED|Overall Study||45
8562550|NCT00025259|21109612|P7|COMPLETED|Overall Study||102
8562551|NCT00025259|21109613|P6|COMPLETED|Overall Study||101
8562552|NCT00025259|21109614|P5|COMPLETED|Overall Study||6
8562553|NCT00025259|21109615|P4|COMPLETED|Overall Study||457
8562554|NCT00025259|21109616|P3|COMPLETED|Overall Study||301
8562555|NCT00025259|21109617|P2|COMPLETED|Overall Study||292
8562556|NCT00025259|21109618|P1|COMPLETED|Overall Study||7
8562557|NCT00025259|21109612|P7|STARTED|Overall Study||153
8562558|NCT00025259|21109613|P6|STARTED|Overall Study||153
8562559|NCT00025259|21109614|P5|STARTED|Overall Study||42
8562560|NCT00025259|21109615|P4|STARTED|Overall Study||571
8562561|NCT00025259|21109616|P3|STARTED|Overall Study||382
8562562|NCT00025259|21109617|P2|STARTED|Overall Study||381
8562563|NCT00025259|21109618|P1|STARTED|Overall Study||52
8562564|NCT00025233|21109654|P1|NOT COMPLETED|Overall Study||4
8562565|NCT00025233|21109654|P1|COMPLETED|Overall Study||46
8562566|NCT00025233|21109654|P1|STARTED|Overall Study||50
8562567|NCT00025155|21109669|P1|NOT COMPLETED|Overall Study||2
8562568|NCT00025155|21109669|P1|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
8562569|NCT00025155|21109669|P1|STARTED|Overall Study||51
8562570|NCT00024258|21109680|P1|NOT COMPLETED|Overall Study||9
8562571|NCT00024258|21109680|P1|COMPLETED|Overall Study||13
8562572|NCT00024258|21109680|P1|STARTED|Overall Study||22
8562573|NCT00024167|21109687|P2|NOT COMPLETED|Overall Study||47
8562574|NCT00024167|21109688|P1|NOT COMPLETED|Overall Study||53
8562575|NCT00024167|21109687|P2|COMPLETED|Overall Study||15
8562576|NCT00024167|21109688|P1|COMPLETED|Overall Study||12
8562577|NCT00024167|21109687|P2|Induction Treatment Option 2 Completed|Overall Study||41
8562578|NCT00024167|21109688|P1|Induction Treatment Option 2 Completed|Overall Study||43
8562579|NCT00024167|21109687|P2|Induction Treatment Option 1 Completed|Overall Study||21
8562580|NCT00024167|21109688|P1|Induction Treatment Option 1 Completed|Overall Study||22
8562581|NCT00024167|21109687|P2|STARTED|Overall Study||62
8562582|NCT00024167|21109688|P1|STARTED|Overall Study||65
8562583|NCT00024102|21109699|P2|NOT COMPLETED|Overall Study||0
8562584|NCT00024102|21109700|P1|NOT COMPLETED|Overall Study||0
8562585|NCT00024102|21109699|P2|COMPLETED|Overall Study||307
8562586|NCT00024102|21109700|P1|COMPLETED|Overall Study||326
8562587|NCT00024102|21109699|P2|STARTED|Overall Study||307
8562588|NCT00024102|21109700|P1|STARTED|Overall Study||326
8562589|NCT00023764|21109712|P1|NOT COMPLETED|Overall Study||14
8562590|NCT00023764|21109712|P1|COMPLETED|Overall Study||89
8562591|NCT00023764|21109712|P1|STARTED|Overall Study||103
8562592|NCT00023712|21109719|P2|NOT COMPLETED|Overall Study||1
8562593|NCT00023712|21109720|P1|NOT COMPLETED|Overall Study||2
8562594|NCT00023712|21109719|P2|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
8562595|NCT00023712|21109720|P1|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
8562596|NCT00023712|21109719|P2|STARTED|Overall Study|total number of participants enrolled on study|30
8562597|NCT00023712|21109720|P1|STARTED|Overall Study|total number of participants enrolled on study|28
8562598|NCT00022698|21109744|P2|NOT COMPLETED|Overall Study||35
8562599|NCT00022698|21109745|P1|NOT COMPLETED|Overall Study||8
8562600|NCT00022698|21109744|P2|COMPLETED|Overall Study||17
8562601|NCT00022698|21109745|P1|COMPLETED|Overall Study||7
8562602|NCT00022698|21109744|P2|STARTED|Overall Study||52
8562603|NCT00022698|21109745|P1|STARTED|Overall Study||15
8562604|NCT00022672|21109770|P2|NOT COMPLETED|Extension Phase||51
8562605|NCT00022672|21109771|P1|NOT COMPLETED|Extension Phase||3
8562606|NCT00022672|21109770|P2|COMPLETED|Extension Phase||7
8562607|NCT00022672|21109771|P1|COMPLETED|Extension Phase||11
8562608|NCT00022672|21109770|P2|Safety Set: Received Study Drug|Extension Phase||58
8562609|NCT00022672|21109771|P1|Safety Set: Received Study Drug|Extension Phase||14
8562610|NCT00022672|21109770|P2|STARTED|Extension Phase||58
8562611|NCT00022672|21109771|P1|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
8562612|NCT00022672|21109770|P2|NOT COMPLETED|Main Phase: 24 Months||100
8562613|NCT00022672|21109771|P1|NOT COMPLETED|Main Phase: 24 Months||87
8562614|NCT00022672|21109770|P2|COMPLETED|Main Phase: 24 Months||4
8562615|NCT00022672|21109771|P1|COMPLETED|Main Phase: 24 Months||16
8562616|NCT00022672|21109770|P2|Safety Set: Received Study Drug|Main Phase: 24 Months||104
8562617|NCT00022672|21109771|P1|Safety Set: Received Study Drug|Main Phase: 24 Months||103
8562618|NCT00022672|21109770|P2|STARTED|Main Phase: 24 Months||104
8562619|NCT00022672|21109771|P1|STARTED|Main Phase: 24 Months||103
8562620|NCT00022659|21109804|P1|NOT COMPLETED|Overall Study||2
8562621|NCT00022659|21109804|P1|COMPLETED|Overall Study|Eligible and treated patients.|62
8562622|NCT00022659|21109804|P1|STARTED|Overall Study||64
8562623|NCT00022633|21109817|P2|NOT COMPLETED|Overall Study||5
8562624|NCT00022633|21109818|P1|NOT COMPLETED|Overall Study||32
8562625|NCT00022633|21109817|P2|COMPLETED|Overall Study||5
8562626|NCT00022633|21109818|P1|COMPLETED|Overall Study||23
8562627|NCT00022633|21109817|P2|Eligible|Overall Study||10
8562628|NCT00022633|21109818|P1|Eligible|Overall Study||51
8562629|NCT00022633|21109817|P2|STARTED|Overall Study||10
8562630|NCT00022633|21109818|P1|STARTED|Overall Study||55
8562631|NCT00022516|21109831|P2|NOT COMPLETED|Overall Study||230
8562632|NCT00022516|21109832|P1|NOT COMPLETED|Overall Study||3
8562633|NCT00022516|21109831|P2|COMPLETED|Overall Study||314
8562634|NCT00022516|21109832|P1|COMPLETED|Overall Study||539
8562635|NCT00022516|21109831|P2|STARTED|Overall Study||544
8562636|NCT00022516|21109832|P1|STARTED|Overall Study||542
8562637|NCT00022490|21109844|P1|NOT COMPLETED|Overall Study||0
8562638|NCT00022490|21109844|P1|COMPLETED|Overall Study||24
8562639|NCT00022490|21109844|P1|STARTED|Overall Study||24
8562640|NCT00021255|21109851|P3|NOT COMPLETED|Overall Study||149
8562641|NCT00021255|21109852|P2|NOT COMPLETED|Overall Study||270
8562642|NCT00021255|21109853|P1|NOT COMPLETED|Overall Study||121
8562643|NCT00021255|21109851|P3|COMPLETED|Overall Study||926
8562644|NCT00021255|21109852|P2|COMPLETED|Overall Study||804
8562645|NCT00021255|21109853|P1|COMPLETED|Overall Study||952
8562646|NCT00021255|21109851|P3|Safety Population|Overall Study|1056 participants received TCH.|1056
8562647|NCT00021255|21109852|P2|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
8562648|NCT00021255|21109853|P1|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
8562649|NCT00021255|21109851|P3|Treated|Overall Study||1057
8562650|NCT00021255|21109852|P2|Treated|Overall Study||1072
8562651|NCT00021255|21109853|P1|Treated|Overall Study||1045
8562652|NCT00021255|21109851|P3|STARTED|Overall Study|Randomized|1075
8562653|NCT00021255|21109852|P2|STARTED|Overall Study|Randomized|1074
8562654|NCT00021255|21109853|P1|STARTED|Overall Study|Randomized|1073
8562655|NCT00021229|21109870|P3|NOT COMPLETED|Overall Study||16
8562656|NCT00021229|21109871|P2|NOT COMPLETED|Overall Study||33
8562657|NCT00021229|21109872|P1|NOT COMPLETED|Overall Study||35
8562658|NCT00021229|21109870|P3|COMPLETED|Overall Study||0
8562659|NCT00021229|21109871|P2|COMPLETED|Overall Study||0
8562660|NCT00021229|21109872|P1|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
8562661|NCT00021229|21109870|P3|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
8562662|NCT00021229|21109871|P2|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
8562663|NCT00021229|21109872|P1|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
8562664|NCT00021229|21109870|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
8562665|NCT00021229|21109871|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
8562666|NCT00021229|21109872|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
8562667|NCT00021229|21109870|P3|Enrolled in Phase I|Overall Study||16
8562668|NCT00021229|21109871|P2|Enrolled in Phase I|Overall Study||33
8562669|NCT00021229|21109872|P1|Enrolled in Phase I|Overall Study||35
8562670|NCT00021229|21109870|P3|STARTED|Overall Study||16
8562671|NCT00021229|21109871|P2|STARTED|Overall Study||33
8562672|NCT00021229|21109872|P1|STARTED|Overall Study||36
8562673|NCT00020722|21109898|P1|NOT COMPLETED|Overall Study||0
8562674|NCT00020722|21109898|P1|COMPLETED|Overall Study||7
8562675|NCT00020722|21109898|P1|STARTED|Overall Study||7
8562676|NCT00019747|21109905|P2|NOT COMPLETED|Overall Study||0
8562677|NCT00019747|21109906|P1|NOT COMPLETED|Overall Study||0
8562678|NCT00019747|21109905|P2|COMPLETED|Overall Study||16
8562679|NCT00019747|21109906|P1|COMPLETED|Overall Study||23
8562680|NCT00019747|21109905|P2|STARTED|Overall Study||16
8562681|NCT00019747|21109906|P1|STARTED|Overall Study||23
8562682|NCT00019682|21109914|P2|NOT COMPLETED|Overall Study||6
8562683|NCT00019682|21109915|P1|NOT COMPLETED|Overall Study||1
8562684|NCT00019682|21109914|P2|COMPLETED|Overall Study||85
8562685|NCT00019682|21109915|P1|COMPLETED|Overall Study||93
8562686|NCT00019682|21109914|P2|STARTED|Overall Study||91
8562687|NCT00019682|21109915|P1|STARTED|Overall Study||94
8562688|NCT00019604|21109927|P1|NOT COMPLETED|Overall Study||39
8562689|NCT00019604|21109927|P1|COMPLETED|Overall Study||5
8562690|NCT00019604|21109927|P1|STARTED|Overall Study||44
8562691|NCT00017563|21109940|P1|NOT COMPLETED|Overall Study||1
8562692|NCT00017563|21109940|P1|COMPLETED|Overall Study||56
8562693|NCT00017563|21109940|P1|STARTED|Overall Study||57
8562694|NCT00016913|21109944|P1|NOT COMPLETED|Overall Study||0
8562695|NCT00016913|21109944|P1|COMPLETED|Overall Study||27
8562696|NCT00016913|21109944|P1|STARTED|Overall Study||27
8562697|NCT00016354|21109950|P8|NOT COMPLETED|Overall Study||1
8562698|NCT00016354|21109951|P7|NOT COMPLETED|Overall Study||0
8562699|NCT00016354|21109952|P6|NOT COMPLETED|Overall Study||0
8562700|NCT00016354|21109953|P5|NOT COMPLETED|Overall Study||0
8562701|NCT00016354|21109954|P4|NOT COMPLETED|Overall Study||0
8562702|NCT00016354|21109955|P3|NOT COMPLETED|Overall Study||0
8562703|NCT00016354|21109956|P2|NOT COMPLETED|Overall Study||0
8562704|NCT00016354|21109957|P1|NOT COMPLETED|Overall Study||0
8562705|NCT00016354|21109950|P8|COMPLETED|Overall Study||6
8562706|NCT00016354|21109951|P7|COMPLETED|Overall Study||6
8562707|NCT00016354|21109952|P6|COMPLETED|Overall Study||1
8562708|NCT00016354|21109953|P5|COMPLETED|Overall Study||1
8562709|NCT00016354|21109954|P4|COMPLETED|Overall Study||1
8562710|NCT00016354|21109955|P3|COMPLETED|Overall Study||1
8562711|NCT00016354|21109956|P2|COMPLETED|Overall Study||1
8562712|NCT00016354|21109957|P1|COMPLETED|Overall Study||1
8562713|NCT00016354|21109950|P8|STARTED|Overall Study||7
8562714|NCT00016354|21109951|P7|STARTED|Overall Study||6
8562715|NCT00016354|21109952|P6|STARTED|Overall Study||1
8562716|NCT00016354|21109953|P5|STARTED|Overall Study||1
8562717|NCT00016354|21109954|P4|STARTED|Overall Study||1
8562718|NCT00016354|21109955|P3|STARTED|Overall Study||1
8562719|NCT00016354|21109956|P2|STARTED|Overall Study||1
8562720|NCT00016354|21109957|P1|STARTED|Overall Study||1
8562721|NCT00015847|21109961|P1|NOT COMPLETED|Overall Study||0
8562722|NCT00015847|21109961|P1|COMPLETED|Overall Study||25
8562723|NCT00015847|21109961|P1|STARTED|Overall Study||25
8562724|NCT00014495|21109971|P4|NOT COMPLETED|Overall Study||1
8562725|NCT00014495|21109972|P3|NOT COMPLETED|Overall Study||1
8562726|NCT00014495|21109973|P2|NOT COMPLETED|Overall Study||0
8562727|NCT00014495|21109974|P1|NOT COMPLETED|Overall Study||0
8562728|NCT00014495|21109971|P4|COMPLETED|Overall Study||5
8562729|NCT00014495|21109972|P3|COMPLETED|Overall Study||19
8562730|NCT00014495|21109973|P2|COMPLETED|Overall Study||3
8562731|NCT00014495|21109974|P1|COMPLETED|Overall Study||3
8562732|NCT00014495|21109971|P4|STARTED|Overall Study||6
8562733|NCT00014495|21109972|P3|STARTED|Overall Study||20
8562734|NCT00014495|21109973|P2|STARTED|Overall Study||3
8562735|NCT00014495|21109974|P1|STARTED|Overall Study||3
8562736|NCT00014222|21109984|P3|NOT COMPLETED|Overall Study||27
8562737|NCT00014222|21109985|P2|NOT COMPLETED|Overall Study||13
8562738|NCT00014222|21109986|P1|NOT COMPLETED|Overall Study||21
8562739|NCT00014222|21109984|P3|COMPLETED|Overall Study||675
8562740|NCT00014222|21109985|P2|COMPLETED|Overall Study||688
8562741|NCT00014222|21109986|P1|COMPLETED|Overall Study||680
8562742|NCT00014222|21109984|P3|STARTED|Overall Study||702
8562743|NCT00014222|21109985|P2|STARTED|Overall Study||701
8562744|NCT00014222|21109986|P1|STARTED|Overall Study||701
8562745|NCT00012298|21110004|P7|NOT COMPLETED|Overall Study||0
8562746|NCT00012298|21110005|P6|NOT COMPLETED|Overall Study||0
8562747|NCT00012298|21110006|P5|NOT COMPLETED|Overall Study||0
8562748|NCT00012298|21110007|P4|NOT COMPLETED|Overall Study||0
8562749|NCT00012298|21110008|P3|NOT COMPLETED|Overall Study||0
8562750|NCT00012298|21110009|P2|NOT COMPLETED|Overall Study||0
8562751|NCT00012298|21110010|P1|NOT COMPLETED|Overall Study||0
8562752|NCT00012298|21110004|P7|COMPLETED|Overall Study||39
8562753|NCT00012298|21110005|P6|COMPLETED|Overall Study||6
8562754|NCT00012298|21110006|P5|COMPLETED|Overall Study||5
8562755|NCT00012298|21110007|P4|COMPLETED|Overall Study||4
8562756|NCT00012298|21110008|P3|COMPLETED|Overall Study||9
8562757|NCT00012298|21110009|P2|COMPLETED|Overall Study||7
8562758|NCT00012298|21110010|P1|COMPLETED|Overall Study||11
8562759|NCT00012298|21110004|P7|STARTED|Overall Study||39
8562760|NCT00012298|21110005|P6|STARTED|Overall Study||6
8562761|NCT00012298|21110006|P5|STARTED|Overall Study||5
8562762|NCT00012298|21110007|P4|STARTED|Overall Study||4
8562763|NCT00012298|21110008|P3|STARTED|Overall Study||9
8562764|NCT00012298|21110009|P2|STARTED|Overall Study||7
8562765|NCT00012298|21110010|P1|STARTED|Overall Study||11
8562766|NCT00012012|21110040|P2|NOT COMPLETED|Overall Study||3
8562767|NCT00012012|21110041|P1|NOT COMPLETED|Overall Study||1
8562768|NCT00012012|21110040|P2|COMPLETED|Overall Study||15
8562769|NCT00012012|21110041|P1|COMPLETED|Overall Study||26
8562770|NCT00012012|21110040|P2|STARTED|Overall Study||18
8562771|NCT00012012|21110041|P1|STARTED|Overall Study||27
8562772|NCT00011986|21110052|P5|NOT COMPLETED|Overall Study||0
8562773|NCT00011986|21110053|P4|NOT COMPLETED|Overall Study||0
8562774|NCT00011986|21110054|P3|NOT COMPLETED|Overall Study||0
8562775|NCT00011986|21110055|P2|NOT COMPLETED|Overall Study||0
8562776|NCT00011986|21110056|P1|NOT COMPLETED|Overall Study||0
8562777|NCT00011986|21110052|P5|COMPLETED|Overall Study||861
8562778|NCT00011986|21110053|P4|COMPLETED|Overall Study||861
8562779|NCT00011986|21110054|P3|COMPLETED|Overall Study||862
8562780|NCT00011986|21110055|P2|COMPLETED|Overall Study||864
8562781|NCT00011986|21110056|P1|COMPLETED|Overall Study||864
8562782|NCT00011986|21110052|P5|Initiated Treatment|Overall Study||851
8562783|NCT00011986|21110053|P4|Initiated Treatment|Overall Study||846
8562784|NCT00011986|21110054|P3|Initiated Treatment|Overall Study||854
8562785|NCT00011986|21110055|P2|Initiated Treatment|Overall Study||860
8562786|NCT00011986|21110056|P1|Initiated Treatment|Overall Study||862
8562787|NCT00011986|21110052|P5|STARTED|Overall Study||861
8562788|NCT00011986|21110053|P4|STARTED|Overall Study||861
8562789|NCT00011986|21110054|P3|STARTED|Overall Study||862
8562790|NCT00011986|21110055|P2|STARTED|Overall Study||864
8562791|NCT00011986|21110056|P1|STARTED|Overall Study||864
8562792|NCT00010257|21110080|P2|NOT COMPLETED|Overall Study||0
8562793|NCT00010257|21110081|P1|NOT COMPLETED|Overall Study||1
8562794|NCT00010257|21110080|P2|COMPLETED|Overall Study||21
8562795|NCT00010257|21110081|P1|COMPLETED|Overall Study||24
8562796|NCT00010257|21110080|P2|STARTED|Overall Study||21
8562797|NCT00010257|21110081|P1|STARTED|Overall Study||25
8562798|NCT00009945|21110091|P2|NOT COMPLETED|Overall Study||5
8562799|NCT00009945|21110092|P1|NOT COMPLETED|Overall Study||7
8562800|NCT00009945|21110091|P2|COMPLETED|Overall Study||1656
8562801|NCT00009945|21110092|P1|COMPLETED|Overall Study||1655
8562802|NCT00009945|21110091|P2|STARTED|Overall Study||1661
8562803|NCT00009945|21110092|P1|STARTED|Overall Study||1662
8562804|NCT00008385|21110108|P2|NOT COMPLETED|Overall Study||802
8562805|NCT00008385|21110109|P1|NOT COMPLETED|Overall Study||387
8562806|NCT00008385|21110108|P2|COMPLETED|Overall Study||238
8562807|NCT00008385|21110109|P1|COMPLETED|Overall Study||134
8562808|NCT00008385|21110108|P2|Off Treatment Reasons Reported|Overall Study||795
8562809|NCT00008385|21110109|P1|Off Treatment Reasons Reported|Overall Study||398
8562810|NCT00008385|21110108|P2|Treated|Overall Study||865
8562811|NCT00008385|21110109|P1|Treated|Overall Study||477
8562812|NCT00008385|21110108|P2|STARTED|Overall Study||1040
8562813|NCT00008385|21110109|P1|STARTED|Overall Study||521
8562814|NCT00008138|21110119|P1|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
8562815|NCT00008138|21110119|P1|COMPLETED|Post-Cytoreduction Chemotherapy||18
8562816|NCT00008138|21110119|P1|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
8562817|NCT00008138|21110119|P1|NOT COMPLETED|Interval Debulking||2
8562818|NCT00008138|21110119|P1|COMPLETED|Interval Debulking||36
8562819|NCT00008138|21110119|P1|Received Protocol Surgery|Interval Debulking||36
8562820|NCT00008138|21110119|P1|STARTED|Interval Debulking||38
8562821|NCT00008138|21110119|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||20
8562822|NCT00008138|21110119|P1|COMPLETED|Neoadjuvant Chemotherapy||38
8562823|NCT00008138|21110119|P1|Eligible|Neoadjuvant Chemotherapy||58
8562824|NCT00008138|21110119|P1|STARTED|Neoadjuvant Chemotherapy||58
8562825|NCT00006916|21110125|P1|NOT COMPLETED|Overall Study||5
8562826|NCT00006916|21110125|P1|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
8562827|NCT00006916|21110125|P1|STARTED|Overall Study||19
8562828|NCT00006903|21110131|P3|NOT COMPLETED|Overall Study||6
8562829|NCT00006903|21110132|P2|NOT COMPLETED|Overall Study||4
8562830|NCT00006903|21110133|P1|NOT COMPLETED|Overall Study||10
8562831|NCT00006903|21110131|P3|COMPLETED|Overall Study||27
8562832|NCT00006903|21110132|P2|COMPLETED|Overall Study||20
8562833|NCT00006903|21110133|P1|COMPLETED|Overall Study||0
8562834|NCT00006903|21110131|P3|STARTED|Overall Study||33
8562835|NCT00006903|21110132|P2|STARTED|Overall Study||24
8562836|NCT00006903|21110133|P1|STARTED|Overall Study||10
8562837|NCT00006721|21110146|P3|NOT COMPLETED|Overall Study||33
8562838|NCT00006721|21110147|P2|NOT COMPLETED|Overall Study||25
8562839|NCT00006721|21110148|P1|NOT COMPLETED|Overall Study||4
8562840|NCT00006721|21110146|P3|COMPLETED|Overall Study||242
8562841|NCT00006721|21110147|P2|COMPLETED|Overall Study||254
8562842|NCT00006721|21110148|P1|COMPLETED|Overall Study||13
8562843|NCT00006721|21110146|P3|Eligible and Began Protocol Therapy|Overall Study||265
8562844|NCT00006721|21110147|P2|Eligible and Began Protocol Therapy|Overall Study||267
8562845|NCT00006721|21110148|P1|Eligible and Began Protocol Therapy|Overall Study||14
8562846|NCT00006721|21110146|P3|Eligible|Overall Study||265
8562847|NCT00006721|21110147|P2|Eligible|Overall Study||267
8562848|NCT00006721|21110148|P1|Eligible|Overall Study||15
8562849|NCT00006721|21110146|P3|STARTED|Overall Study||275
8562850|NCT00006721|21110147|P2|STARTED|Overall Study||279
8562851|NCT00006721|21110148|P1|STARTED|Overall Study||17
8562852|NCT00006478|21110166|P1|NOT COMPLETED|Overall Study||7
8562853|NCT00006478|21110166|P1|COMPLETED|Overall Study||12
8562854|NCT00006478|21110166|P1|STARTED|Overall Study||19
8562855|NCT00006392|21110177|P4|NOT COMPLETED|Overall Study||160
8562856|NCT00006392|21110178|P3|NOT COMPLETED|Overall Study||160
8562857|NCT00006392|21110179|P2|NOT COMPLETED|Overall Study||158
8562858|NCT00006392|21110180|P1|NOT COMPLETED|Overall Study||167
8562859|NCT00006392|21110177|P4|COMPLETED|Overall Study||8696
8562860|NCT00006392|21110178|P3|COMPLETED|Overall Study||8703
8562861|NCT00006392|21110179|P2|COMPLETED|Overall Study||8752
8562862|NCT00006392|21110180|P1|COMPLETED|Overall Study||8737
8562863|NCT00006392|21110177|P4|STARTED|Overall Study||8856
8562864|NCT00006392|21110178|P3|STARTED|Overall Study||8863
8562865|NCT00006392|21110179|P2|STARTED|Overall Study||8910
8562866|NCT00006392|21110180|P1|STARTED|Overall Study||8904
8562867|NCT00006389|21110210|P1|NOT COMPLETED|Overall Study||1
8562868|NCT00006389|21110210|P1|COMPLETED|Overall Study||11
8562869|NCT00006389|21110210|P1|STARTED|Overall Study||12
8562870|NCT00006244|21110216|P1|NOT COMPLETED|Overall Study||0
8562871|NCT00006244|21110216|P1|COMPLETED|Overall Study||36
8562872|NCT00006244|21110216|P1|STARTED|Overall Study||36
8562873|NCT00006237|21110227|P2|NOT COMPLETED|Overall Study||61
8562874|NCT00006237|21110228|P1|NOT COMPLETED|Overall Study||125
8562875|NCT00006237|21110227|P2|COMPLETED|Overall Study||159
8562876|NCT00006237|21110228|P1|COMPLETED|Overall Study||87
8562877|NCT00006237|21110227|P2|Eligible and Treated|Overall Study||199
8562878|NCT00006237|21110228|P1|Eligible and Treated|Overall Study||203
8562879|NCT00006237|21110227|P2|Eligible|Overall Study||200
8562880|NCT00006237|21110228|P1|Eligible|Overall Study||203
8562881|NCT00006237|21110227|P2|STARTED|Overall Study||220
8562882|NCT00006237|21110228|P1|STARTED|Overall Study||212
8562883|NCT00006227|21110238|P1|NOT COMPLETED|Overall Study||0
8562884|NCT00006227|21110238|P1|COMPLETED|Overall Study||31
8562885|NCT00006227|21110238|P1|STARTED|Overall Study||31
8562886|NCT00006110|21110246|P2|NOT COMPLETED|Overall Study||0
8562887|NCT00006110|21110247|P1|NOT COMPLETED|Overall Study||0
8562888|NCT00006110|21110246|P2|COMPLETED|Overall Study||30
8562889|NCT00006110|21110247|P1|COMPLETED|Overall Study||52
8562890|NCT00006110|21110246|P2|STARTED|Overall Study||30
8562891|NCT00006110|21110247|P1|STARTED|Overall Study||52
8562892|NCT00006101|21110261|P2|NOT COMPLETED|Overall Study||5
8562893|NCT00006101|21110262|P1|NOT COMPLETED|Overall Study||5
8562894|NCT00006101|21110261|P2|COMPLETED|Overall Study||33
8562895|NCT00006101|21110262|P1|COMPLETED|Overall Study||33
8562896|NCT00006101|21110261|P2|STARTED|Overall Study||38
8562897|NCT00006101|21110262|P1|STARTED|Overall Study||38
8562898|NCT00006011|21110271|P3|NOT COMPLETED|Overall Study||73
8562899|NCT00006011|21110272|P2|NOT COMPLETED|Overall Study||77
8562900|NCT00006011|21110273|P1|NOT COMPLETED|Overall Study||65
8562901|NCT00006011|21110271|P3|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
8562902|NCT00006011|21110272|P2|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
8562903|NCT00006011|21110273|P1|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
8562904|NCT00006011|21110271|P3|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
8562905|NCT00006011|21110272|P2|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
8562906|NCT00006011|21110273|P1|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
8562907|NCT00005957|21110281|P2|NOT COMPLETED|Overall Study||28
8562908|NCT00005957|21110282|P1|NOT COMPLETED|Overall Study||8
8562909|NCT00005957|21110281|P2|COMPLETED|Overall Study||888
8562910|NCT00005957|21110282|P1|COMPLETED|Overall Study||908
8562911|NCT00005957|21110281|P2|STARTED|Overall Study||916
8562912|NCT00005957|21110282|P1|STARTED|Overall Study||916
8562913|NCT00005879|21110292|P2|NOT COMPLETED|Overall Study||10
8562914|NCT00005879|21110293|P1|NOT COMPLETED|Overall Study||8
8562915|NCT00005879|21110292|P2|COMPLETED|Overall Study||88
8562916|NCT00005879|21110293|P1|COMPLETED|Overall Study||93
8562917|NCT00005879|21110292|P2|STARTED|Overall Study||98
8562918|NCT00005879|21110293|P1|STARTED|Overall Study||101
8562919|NCT00005803|21110301|P1|NOT COMPLETED|Overall Study||22
8562920|NCT00005803|21110301|P1|COMPLETED|Overall Study||54
8562921|NCT00005803|21110301|P1|STARTED|Overall Study||76
8562922|NCT00005047|21110316|P4|NOT COMPLETED|Overall Study||0
8562923|NCT00005047|21110317|P3|NOT COMPLETED|Overall Study||0
8562924|NCT00005047|21110318|P2|NOT COMPLETED|Overall Study||0
8562925|NCT00005047|21110319|P1|NOT COMPLETED|Overall Study||19
8562926|NCT00005047|21110316|P4|COMPLETED|Overall Study||158
8562927|NCT00005047|21110317|P3|COMPLETED|Overall Study||227
8562928|NCT00005047|21110318|P2|COMPLETED|Overall Study||56
8562929|NCT00005047|21110319|P1|COMPLETED|Overall Study||39
8562930|NCT00005047|21110316|P4|STARTED|Overall Study||158
8562931|NCT00005047|21110317|P3|STARTED|Overall Study||227
8562932|NCT00005047|21110318|P2|STARTED|Overall Study||56
8562933|NCT00005047|21110319|P1|STARTED|Overall Study||58
8562934|NCT00005044|21110335|P2|NOT COMPLETED|Overall Study||52
8562935|NCT00005044|21110336|P1|NOT COMPLETED|Overall Study||38
8562936|NCT00005044|21110335|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
8562937|NCT00005044|21110336|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
8562938|NCT00005044|21110335|P2|STARTED|Overall Study||789
8562939|NCT00005044|21110336|P1|STARTED|Overall Study||790
8562940|NCT00004888|21110356|P2|NOT COMPLETED|Overall Study||24
8562941|NCT00004888|21110357|P1|NOT COMPLETED|Overall Study||11
8562942|NCT00004888|21110356|P2|COMPLETED|Overall Study||22
8562943|NCT00004888|21110357|P1|COMPLETED|Overall Study||27
8562944|NCT00004888|21110356|P2|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
8562945|NCT00004888|21110357|P1|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
8562946|NCT00004859|21110375|P2|NOT COMPLETED|Overall Study||282
8562947|NCT00004859|21110376|P1|NOT COMPLETED|Overall Study||118
8562948|NCT00004859|21110375|P2|COMPLETED|Overall Study||12
8562949|NCT00004859|21110376|P1|COMPLETED|Overall Study||177
8562950|NCT00004859|21110375|P2|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
8562951|NCT00004859|21110376|P1|Treated and Having Toxicity Data|Overall Study||289
8562952|NCT00004859|21110375|P2|Treated|Overall Study||289
8562953|NCT00004859|21110376|P1|Treated|Overall Study||289
8562954|NCT00004859|21110375|P2|Eligible|Overall Study||271
8562955|NCT00004859|21110376|P1|Eligible|Overall Study||275
8562956|NCT00004859|21110375|P2|STARTED|Overall Study||294
8562957|NCT00004859|21110376|P1|STARTED|Overall Study||295
8562958|NCT00004259|21110390|P4|NOT COMPLETED|Overall Study||0
8562959|NCT00004259|21110391|P3|NOT COMPLETED|Overall Study||0
8562960|NCT00004259|21110392|P2|NOT COMPLETED|Overall Study||4
8562961|NCT00004259|21110393|P1|NOT COMPLETED|Overall Study||1
8562962|NCT00004259|21110390|P4|COMPLETED|Overall Study||14
8562963|NCT00004259|21110391|P3|COMPLETED|Overall Study||15
8562964|NCT00004259|21110392|P2|COMPLETED|Overall Study||99
8562965|NCT00004259|21110393|P1|COMPLETED|Overall Study||97
8562966|NCT00004259|21110390|P4|STARTED|Overall Study||14
8562967|NCT00004259|21110391|P3|STARTED|Overall Study||15
8562968|NCT00004259|21110392|P2|STARTED|Overall Study||103
8562969|NCT00004259|21110393|P1|STARTED|Overall Study||98
8562970|NCT00004228|21110418|P7|NOT COMPLETED|Overall Study||12
8562971|NCT00004228|21110419|P6|NOT COMPLETED|Overall Study||14
8562972|NCT00004228|21110420|P5|NOT COMPLETED|Overall Study||16
8562973|NCT00004228|21110421|P4|NOT COMPLETED|Overall Study||7
8562974|NCT00004228|21110422|P3|NOT COMPLETED|Overall Study||19
8562975|NCT00004228|21110423|P2|NOT COMPLETED|Overall Study||15
8562976|NCT00004228|21110424|P1|NOT COMPLETED|Overall Study||9
8562977|NCT00004228|21110418|P7|COMPLETED|Overall Study||45
8562978|NCT00004228|21110419|P6|COMPLETED|Overall Study||51
8562979|NCT00004228|21110420|P5|COMPLETED|Overall Study||51
8562980|NCT00004228|21110421|P4|COMPLETED|Overall Study||6
8562981|NCT00004228|21110422|P3|COMPLETED|Overall Study||46
8562982|NCT00004228|21110423|P2|COMPLETED|Overall Study||51
8562983|NCT00004228|21110424|P1|COMPLETED|Overall Study||51
8562984|NCT00004228|21110418|P7|STARTED|Overall Study||57
8562985|NCT00004228|21110419|P6|STARTED|Overall Study||65
8562986|NCT00004228|21110420|P5|STARTED|Overall Study||67
8562987|NCT00004228|21110421|P4|STARTED|Overall Study||13
8562988|NCT00004228|21110422|P3|STARTED|Overall Study||65
8562989|NCT00004228|21110423|P2|STARTED|Overall Study||66
8562990|NCT00004228|21110424|P1|STARTED|Overall Study||60
8562991|NCT00004143|21110447|P1|NOT COMPLETED|Overall Study||0
8562992|NCT00004143|21110447|P1|COMPLETED|Overall Study||2
8562993|NCT00004143|21110447|P1|STARTED|Overall Study||2
8563000|NCT00004092|21110475|P2|NOT COMPLETED|Overall Study||0
8563001|NCT00004092|21110476|P1|NOT COMPLETED|Overall Study||0
8563002|NCT00004092|21110475|P2|COMPLETED|Overall Study||51
8563003|NCT00004092|21110476|P1|COMPLETED|Overall Study||21
8563004|NCT00004092|21110475|P2|STARTED|Overall Study||51
8563005|NCT00004092|21110476|P1|STARTED|Overall Study||21
8563006|NCT00004088|21110484|P1|NOT COMPLETED|Overall Study||9
8563007|NCT00004088|21110484|P1|COMPLETED|Overall Study||68
8563008|NCT00004088|21110484|P1|STARTED|Overall Study||77
8563009|NCT00004054|21110495|P2|NOT COMPLETED|Overall Study||0
8563010|NCT00004054|21110496|P1|NOT COMPLETED|Overall Study||0
8563011|NCT00004054|21110495|P2|COMPLETED|Overall Study||200
8563012|NCT00004054|21110496|P1|COMPLETED|Overall Study||197
8563013|NCT00004054|21110495|P2|STARTED|Overall Study||200
8563014|NCT00004054|21110496|P1|STARTED|Overall Study||197
8563015|NCT00003910|21110510|P2|NOT COMPLETED|Step 2||0
8563016|NCT00003910|21110511|P1|NOT COMPLETED|Step 2||0
8563017|NCT00003910|21110510|P2|COMPLETED|Step 2||16
8563018|NCT00003910|21110511|P1|COMPLETED|Step 2||0
8563019|NCT00003910|21110510|P2|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
8563020|NCT00003910|21110511|P1|STARTED|Step 2||0
8563021|NCT00003910|21110510|P2|NOT COMPLETED|Step 1||0
8563022|NCT00003910|21110511|P1|NOT COMPLETED|Step 1||0
8563023|NCT00003910|21110510|P2|COMPLETED|Step 1||0
8563024|NCT00003910|21110511|P1|COMPLETED|Step 1||55
8563025|NCT00003910|21110510|P2|STARTED|Step 1||0
8563026|NCT00003910|21110511|P1|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
8563027|NCT00003901|21110517|P1|NOT COMPLETED|Overall Study||17
8563028|NCT00003901|21110517|P1|COMPLETED|Overall Study||1030
8563029|NCT00003901|21110517|P1|STARTED|Overall Study||1047
8563030|NCT00003896|21110528|P1|NOT COMPLETED|Overall Study||29
8563031|NCT00003896|21110528|P1|COMPLETED|Overall Study||39
8563032|NCT00003896|21110528|P1|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
8563033|NCT00003896|21110528|P1|STARTED|Overall Study||68
8563034|NCT00003875|21110534|P1|NOT COMPLETED|Overall Study||1
8563035|NCT00003875|21110534|P1|COMPLETED|Overall Study||29
8563036|NCT00003875|21110534|P1|STARTED|Overall Study||30
8563037|NCT00003869|21110543|P2|NOT COMPLETED|Overall Study||12
8563038|NCT00003869|21110544|P1|NOT COMPLETED|Overall Study||41
8563039|NCT00003869|21110543|P2|COMPLETED|Overall Study||80
8563040|NCT00003869|21110544|P1|COMPLETED|Overall Study||53
8563041|NCT00003869|21110543|P2|STARTED|Overall Study||92
8563042|NCT00003869|21110544|P1|STARTED|Overall Study||94
8563043|NCT00003820|21110560|P2|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
8563044|NCT00003820|21110561|P1|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
8563045|NCT00003820|21110560|P2|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
8563046|NCT00003820|21110561|P1|COMPLETED|Cycle 4 (Maintenance Treatment)||0
8563047|NCT00003820|21110560|P2|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
8563048|NCT00003820|21110561|P1|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
8563049|NCT00003820|21110560|P2|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
8563050|NCT00003820|21110561|P1|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
8563051|NCT00003820|21110560|P2|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
8563052|NCT00003820|21110561|P1|COMPLETED|Cycle 3 (Maintenance Treatment)||0
8563053|NCT00003820|21110560|P2|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
8563054|NCT00003820|21110561|P1|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
8563055|NCT00003820|21110560|P2|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
8563056|NCT00003820|21110561|P1|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
8563057|NCT00003820|21110560|P2|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
8563058|NCT00003820|21110561|P1|COMPLETED|Cycle 2 (Maintenance Treatment)||0
8563059|NCT00003820|21110560|P2|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
8563060|NCT00003820|21110561|P1|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
8563061|NCT00003820|21110560|P2|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
8563062|NCT00003820|21110561|P1|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
8563063|NCT00003820|21110560|P2|COMPLETED|Cycle 1 (Initial Treatment)||16
8563064|NCT00003820|21110561|P1|COMPLETED|Cycle 1 (Initial Treatment)||23
8563065|NCT00003820|21110560|P2|STARTED|Cycle 1 (Initial Treatment)||16
8563066|NCT00003820|21110561|P1|STARTED|Cycle 1 (Initial Treatment)||23
8563067|NCT00003782|21110570|P3|NOT COMPLETED|Overall Study||26
8563068|NCT00003782|21110571|P2|NOT COMPLETED|Overall Study||31
8563069|NCT00003782|21110572|P1|NOT COMPLETED|Overall Study||30
8563070|NCT00003782|21110570|P3|COMPLETED|Overall Study||1758
8563071|NCT00003782|21110571|P2|COMPLETED|Overall Study||1753
8563072|NCT00003782|21110572|P1|COMPLETED|Overall Study||1753
8563073|NCT00003782|21110570|P3|STARTED|Overall Study||1784
8563074|NCT00003782|21110571|P2|STARTED|Overall Study||1784
8563075|NCT00003782|21110572|P1|STARTED|Overall Study||1783
8563076|NCT00003702|21110582|P2|NOT COMPLETED|Overall Study||11
8563077|NCT00003702|21110583|P1|NOT COMPLETED|Overall Study||13
8563078|NCT00003702|21110582|P2|COMPLETED|Overall Study||109
8563079|NCT00003702|21110583|P1|COMPLETED|Overall Study||107
8563080|NCT00003702|21110582|P2|STARTED|Overall Study||120
8563081|NCT00003702|21110583|P1|STARTED|Overall Study||120
8563082|NCT00003659|21110592|P1|NOT COMPLETED|Overall Study||3
8563083|NCT00003659|21110592|P1|COMPLETED|Overall Study||36
8563084|NCT00003659|21110592|P1|STARTED|Overall Study||39
8563085|NCT00003644|21110600|P2|NOT COMPLETED|Overall Study||14
8563086|NCT00003644|21110601|P1|NOT COMPLETED|Overall Study||15
8563087|NCT00003644|21110600|P2|COMPLETED|Overall Study||268
8563088|NCT00003644|21110601|P1|COMPLETED|Overall Study||274
8563089|NCT00003644|21110600|P2|STARTED|Overall Study||282
8563090|NCT00003644|21110601|P1|STARTED|Overall Study||289
8563091|NCT00003641|21110613|P2|NOT COMPLETED|Overall Study||174
8563092|NCT00003641|21110614|P1|NOT COMPLETED|Overall Study||569
8563093|NCT00003641|21110613|P2|COMPLETED|Overall Study||407
8563094|NCT00003641|21110614|P1|COMPLETED|Overall Study||0
8563095|NCT00003641|21110613|P2|Toxicity Assessed|Overall Study||568
8563096|NCT00003641|21110614|P1|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
8563097|NCT00003641|21110613|P2|Treated|Overall Study||569
8563098|NCT00003641|21110614|P1|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
8563099|NCT00003641|21110613|P2|STARTED|Overall Study||581
8563100|NCT00003641|21110614|P1|STARTED|Overall Study||569
8563101|NCT00003631|21110625|P3|NOT COMPLETED|Overall Study||9
8563102|NCT00003631|21110626|P2|NOT COMPLETED|Overall Study||1
8563103|NCT00003631|21110627|P1|NOT COMPLETED|Overall Study||3
8563104|NCT00003631|21110625|P3|COMPLETED|Overall Study||15
8563105|NCT00003631|21110626|P2|COMPLETED|Overall Study||43
8563106|NCT00003631|21110627|P1|COMPLETED|Overall Study||47
8563107|NCT00003631|21110625|P3|STARTED|Overall Study||24
8563108|NCT00003631|21110626|P2|STARTED|Overall Study||44
8563109|NCT00003631|21110627|P1|STARTED|Overall Study||50
8563110|NCT00003590|21110635|P1|NOT COMPLETED|Overall Study||22
8563111|NCT00003590|21110635|P1|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
8563112|NCT00003590|21110635|P1|Eligible and Began Protocol Therapy|Overall Study||28
8563113|NCT00003590|21110635|P1|Eligible|Overall Study||28
8563114|NCT00003590|21110635|P1|STARTED|Overall Study||29
8563115|NCT00003537|21110640|P1|NOT COMPLETED|Overall Study||1
8563116|NCT00003537|21110640|P1|COMPLETED|Overall Study||18
8563117|NCT00003537|21110640|P1|STARTED|Overall Study||19
8563118|NCT00003535|21110645|P1|NOT COMPLETED|Overall Study||5
8563119|NCT00003535|21110645|P1|COMPLETED|Overall Study||4
8563120|NCT00003535|21110645|P1|STARTED|Overall Study||9
8563121|NCT00003531|21110650|P1|NOT COMPLETED|Overall Study||10
8563122|NCT00003531|21110650|P1|COMPLETED|Overall Study||5
8563123|NCT00003531|21110650|P1|STARTED|Overall Study||15
8563124|NCT00003526|21110654|P1|NOT COMPLETED|Overall Study||6
8563125|NCT00003526|21110654|P1|COMPLETED|Overall Study||2
8563126|NCT00003526|21110654|P1|STARTED|Overall Study||8
8563127|NCT00003509|21110658|P1|NOT COMPLETED|Overall Study||5
8563128|NCT00003509|21110658|P1|COMPLETED|Overall Study||8
8563129|NCT00003509|21110658|P1|STARTED|Overall Study||13
8563130|NCT00003499|21110662|P1|NOT COMPLETED|Overall Study||8
8563131|NCT00003499|21110662|P1|COMPLETED|Overall Study||23
8563132|NCT00003499|21110662|P1|STARTED|Overall Study||31
8563133|NCT00003498|21110667|P1|NOT COMPLETED|Overall Study||4
8563134|NCT00003498|21110667|P1|COMPLETED|Overall Study||1
8563135|NCT00003498|21110667|P1|STARTED|Overall Study||5
8563136|NCT00003492|21110671|P1|NOT COMPLETED|Overall Study||6
8563137|NCT00003492|21110671|P1|COMPLETED|Overall Study||3
8563138|NCT00003492|21110671|P1|STARTED|Overall Study||9
8563139|NCT00003483|21110675|P1|NOT COMPLETED|Overall Study||1
8563140|NCT00003483|21110675|P1|COMPLETED|Overall Study||2
8563141|NCT00003483|21110675|P1|STARTED|Overall Study||3
8563142|NCT00003479|21110680|P1|NOT COMPLETED|Overall Study||3
8563143|NCT00003479|21110680|P1|COMPLETED|Overall Study||6
8563144|NCT00003479|21110680|P1|STARTED|Overall Study||9
8563145|NCT00003477|21110685|P1|NOT COMPLETED|Overall Study||4
8563146|NCT00003477|21110685|P1|COMPLETED|Overall Study||8
8563147|NCT00003477|21110685|P1|STARTED|Overall Study||12
8563148|NCT00003476|21110690|P1|NOT COMPLETED|Overall Study||1
8563149|NCT00003476|21110690|P1|COMPLETED|Overall Study||7
8563150|NCT00003476|21110690|P1|STARTED|Overall Study||8
8563151|NCT00003475|21110695|P1|NOT COMPLETED|Overall Study||13
8563152|NCT00003475|21110695|P1|COMPLETED|Overall Study||27
8563153|NCT00003475|21110695|P1|STARTED|Overall Study||40
8563154|NCT00003474|21110700|P1|NOT COMPLETED|Overall Study||14
8563155|NCT00003474|21110700|P1|COMPLETED|Overall Study||26
8563156|NCT00003474|21110700|P1|STARTED|Overall Study||40
8563157|NCT00003473|21110705|P1|NOT COMPLETED|Overall Study||3
8563158|NCT00003473|21110705|P1|COMPLETED|Overall Study||17
8563159|NCT00003473|21110705|P1|STARTED|Overall Study||20
8563160|NCT00003472|21110710|P1|NOT COMPLETED|Overall Study||3
8563161|NCT00003472|21110710|P1|COMPLETED|Overall Study||10
8563162|NCT00003472|21110710|P1|STARTED|Overall Study||13
8563163|NCT00003471|21110715|P1|NOT COMPLETED|Overall Study||4
8563164|NCT00003471|21110715|P1|COMPLETED|Overall Study||3
8563165|NCT00003471|21110715|P1|STARTED|Overall Study||7
8563166|NCT00003470|21110720|P1|NOT COMPLETED|Overall Study||6
8563167|NCT00003470|21110720|P1|COMPLETED|Overall Study||21
8563168|NCT00003470|21110720|P1|STARTED|Overall Study||27
8563169|NCT00003469|21110725|P1|NOT COMPLETED|Overall Study||0
8563170|NCT00003469|21110725|P1|COMPLETED|Overall Study||4
8563171|NCT00003469|21110725|P1|STARTED|Overall Study||4
8563172|NCT00003468|21110730|P1|NOT COMPLETED|Overall Study||2
8563173|NCT00003468|21110730|P1|COMPLETED|Overall Study|Two patients were not evaluable.|9
8563174|NCT00003468|21110730|P1|STARTED|Overall Study||11
8563175|NCT00003460|21110735|P1|NOT COMPLETED|Overall Study||1
8563176|NCT00003460|21110735|P1|COMPLETED|Overall Study|One patient was not evaluable.|12
8563177|NCT00003460|21110735|P1|STARTED|Overall Study||13
8563178|NCT00003459|21110740|P1|NOT COMPLETED|Overall Study||9
8563179|NCT00003459|21110740|P1|COMPLETED|Overall Study|Nine patients were not evaluable.|31
8563180|NCT00003459|21110740|P1|STARTED|Overall Study||40
8563181|NCT00003458|21110745|P1|NOT COMPLETED|Overall Study||4
8563182|NCT00003458|21110745|P1|COMPLETED|Overall Study||30
8563183|NCT00003458|21110745|P1|STARTED|Overall Study||34
8563184|NCT00003457|21110750|P1|NOT COMPLETED|Overall Study||9
8563185|NCT00003457|21110750|P1|COMPLETED|Overall Study||31
8563186|NCT00003457|21110750|P1|STARTED|Overall Study||40
8563187|NCT00003456|21110755|P1|NOT COMPLETED|Overall Study||8
8563188|NCT00003456|21110755|P1|COMPLETED|Overall Study||32
8563189|NCT00003456|21110755|P1|STARTED|Overall Study||40
8563190|NCT00003453|21110760|P1|NOT COMPLETED|Overall Study||1
8563191|NCT00003453|21110760|P1|COMPLETED|Overall Study|One patient was not evaluable|5
8563192|NCT00003453|21110760|P1|STARTED|Overall Study||6
8563193|NCT00003404|21110765|P1|NOT COMPLETED|Overall Study||0
8563194|NCT00003404|21110765|P1|COMPLETED|Overall Study||46
8563195|NCT00003404|21110765|P1|STARTED|Overall Study||46
8563196|NCT00003389|21110772|P2|NOT COMPLETED|Overall Study||60
8563197|NCT00003389|21110773|P1|NOT COMPLETED|Overall Study||98
8563198|NCT00003389|21110772|P2|COMPLETED|Overall Study||366
8563199|NCT00003389|21110773|P1|COMPLETED|Overall Study||330
8563200|NCT00003389|21110772|P2|Eligible Patients|Overall Study||399
8563201|NCT00003389|21110773|P1|Eligible Patients|Overall Study||395
8563202|NCT00003389|21110772|P2|Treated Pts w/ Toxicity Data Available|Overall Study||422
8563203|NCT00003389|21110773|P1|Treated Pts w/ Toxicity Data Available|Overall Study||414
8563204|NCT00003389|21110772|P2|STARTED|Overall Study||426
8563205|NCT00003389|21110773|P1|STARTED|Overall Study||428
8563206|NCT00003377|21110788|P5|NOT COMPLETED|Period II||1
8563207|NCT00003377|21110789|P4|NOT COMPLETED|Period II||0
8563208|NCT00003377|21110790|P3|NOT COMPLETED|Period II||0
8563209|NCT00003377|21110791|P2|NOT COMPLETED|Period II||0
8563210|NCT00003377|21110792|P1|NOT COMPLETED|Period II||0
8563211|NCT00003377|21110788|P5|COMPLETED|Period II||16
8563212|NCT00003377|21110789|P4|COMPLETED|Period II||0
8563213|NCT00003377|21110790|P3|COMPLETED|Period II||0
8563214|NCT00003377|21110791|P2|COMPLETED|Period II||0
8563215|NCT00003377|21110792|P1|COMPLETED|Period II||0
8563216|NCT00003377|21110788|P5|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
8563217|NCT00003377|21110789|P4|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8563218|NCT00003377|21110790|P3|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8563219|NCT00003377|21110791|P2|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8563220|NCT00003377|21110792|P1|STARTED|Period II|Patients participated at this dose level only in Period I.|0
8563221|NCT00003377|21110788|P5|NOT COMPLETED|Period I||0
8563222|NCT00003377|21110789|P4|NOT COMPLETED|Period I||1
8563223|NCT00003377|21110790|P3|NOT COMPLETED|Period I||1
8563224|NCT00003377|21110791|P2|NOT COMPLETED|Period I||0
8563225|NCT00003377|21110792|P1|NOT COMPLETED|Period I||0
8563226|NCT00003377|21110788|P5|COMPLETED|Period I||0
8563227|NCT00003377|21110789|P4|COMPLETED|Period I||2
8563228|NCT00003377|21110790|P3|COMPLETED|Period I||2
8563229|NCT00003377|21110791|P2|COMPLETED|Period I||3
8563230|NCT00003377|21110792|P1|COMPLETED|Period I||3
8563231|NCT00003377|21110788|P5|STARTED|Period I||0
8563232|NCT00003377|21110789|P4|STARTED|Period I||3
8563233|NCT00003377|21110790|P3|STARTED|Period I||3
8563234|NCT00003377|21110791|P2|STARTED|Period I||3
8563235|NCT00003377|21110792|P1|STARTED|Period I||3
8563236|NCT00003199|21110806|P1|NOT COMPLETED|Overall Study||22
8563237|NCT00003199|21110806|P1|COMPLETED|Overall Study||28
8563238|NCT00003199|21110806|P1|STARTED|Overall Study||50
8563239|NCT00003138|21110814|P2|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
8563240|NCT00003138|21110815|P1|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
8563241|NCT00003138|21110814|P2|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
8563242|NCT00003138|21110815|P1|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
8563243|NCT00003138|21110814|P2|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
8563244|NCT00003138|21110815|P1|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
8563245|NCT00003138|21110814|P2|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
8563246|NCT00003138|21110815|P1|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
8563247|NCT00003138|21110814|P2|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
8563248|NCT00003138|21110815|P1|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
8563249|NCT00003138|21110814|P2|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
8563250|NCT00003138|21110815|P1|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
8563251|NCT00003138|21110814|P2|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
8563252|NCT00003138|21110815|P1|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
8563253|NCT00003138|21110814|P2|NOT COMPLETED|Step 2 (Cross Over)||0
8563254|NCT00003138|21110815|P1|NOT COMPLETED|Step 2 (Cross Over)||26
8563255|NCT00003138|21110814|P2|COMPLETED|Step 2 (Cross Over)||0
8563256|NCT00003138|21110815|P1|COMPLETED|Step 2 (Cross Over)||0
8563257|NCT00003138|21110814|P2|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
8563258|NCT00003138|21110815|P1|STARTED|Step 2 (Cross Over)||26
8563259|NCT00003138|21110814|P2|NOT COMPLETED|Step 1||57
8563260|NCT00003138|21110815|P1|NOT COMPLETED|Step 1||61
8563261|NCT00003138|21110814|P2|COMPLETED|Step 1||0
8563262|NCT00003138|21110815|P1|COMPLETED|Step 1||0
8563263|NCT00003138|21110814|P2|Patients With Transfusion Data|Step 1||42
8563264|NCT00003138|21110815|P1|Patients With Transfusion Data|Step 1||37
8563265|NCT00003138|21110814|P2|Patients With QOL Data at 4 Months|Step 1||42
8563266|NCT00003138|21110815|P1|Patients With QOL Data at 4 Months|Step 1||42
8563267|NCT00003138|21110814|P2|Eligible and Treated|Step 1||50
8563268|NCT00003138|21110815|P1|Eligible and Treated|Step 1||52
8563269|NCT00003138|21110814|P2|Treated|Step 1||53
8563270|NCT00003138|21110815|P1|Treated|Step 1||56
8563271|NCT00003138|21110814|P2|Patients With Complete Data|Step 1||53
8563272|NCT00003138|21110815|P1|Patients With Complete Data|Step 1||57
8563273|NCT00003138|21110814|P2|STARTED|Step 1||57
8563274|NCT00003138|21110815|P1|STARTED|Step 1||61
8563275|NCT00002975|21110828|P1|NOT COMPLETED|Overall Study||5
8563276|NCT00002975|21110828|P1|COMPLETED|Overall Study||175
8563277|NCT00002975|21110828|P1|Treated With Study Therapy|Overall Study||175
8563278|NCT00002975|21110828|P1|STARTED|Overall Study||180
8563279|NCT00002931|21110832|P1|NOT COMPLETED|Overall Study||2
8563280|NCT00002931|21110832|P1|COMPLETED|Overall Study||46
8563281|NCT00002931|21110832|P1|STARTED|Overall Study||48
8563282|NCT00002874|21110840|P2|NOT COMPLETED|Overall Study||35
8563283|NCT00002874|21110841|P1|NOT COMPLETED|Overall Study||45
8563284|NCT00002874|21110840|P2|COMPLETED|Overall Study||384
8563285|NCT00002874|21110841|P1|COMPLETED|Overall Study||376
8563286|NCT00002874|21110840|P2|STARTED|Overall Study||419
8563287|NCT00002874|21110841|P1|STARTED|Overall Study||421
8563288|NCT00002850|21110866|P3|NOT COMPLETED|Overall Study||4
8563289|NCT00002850|21110867|P2|NOT COMPLETED|Overall Study||2
8563290|NCT00002850|21110868|P1|NOT COMPLETED|Overall Study||5
8563291|NCT00002850|21110866|P3|COMPLETED|Overall Study||63
8563292|NCT00002850|21110867|P2|COMPLETED|Overall Study||74
8563293|NCT00002850|21110868|P1|COMPLETED|Overall Study||64
8563294|NCT00002850|21110866|P3|STARTED|Overall Study||67
8563295|NCT00002850|21110867|P2|STARTED|Overall Study||76
8563296|NCT00002850|21110868|P1|STARTED|Overall Study||69
8563297|NCT00002842|21110876|P1|NOT COMPLETED|Overall Study||27
8563298|NCT00002842|21110876|P1|COMPLETED|Overall Study||22
8563299|NCT00002842|21110876|P1|STARTED|Overall Study||49
8563300|NCT00002766|21110882|P2|NOT COMPLETED|Overall Study||4
8563301|NCT00002766|21110883|P1|NOT COMPLETED|Overall Study||3
8563302|NCT00002766|21110882|P2|COMPLETED|Overall Study||85
8563303|NCT00002766|21110883|P1|COMPLETED|Overall Study||78
8563304|NCT00002766|21110882|P2|STARTED|Overall Study||89
8563305|NCT00002766|21110883|P1|STARTED|Overall Study||81
8563306|NCT00002651|21110891|P3|NOT COMPLETED|Consolidation and Randomization||860
8563307|NCT00002651|21110892|P2|NOT COMPLETED|Consolidation and Randomization||838
8563308|NCT00002651|21110893|P1|NOT COMPLETED|Consolidation and Randomization||0
8563309|NCT00002651|21110891|P3|COMPLETED|Consolidation and Randomization||22
8563310|NCT00002651|21110892|P2|COMPLETED|Consolidation and Randomization||29
8563311|NCT00002651|21110893|P1|COMPLETED|Consolidation and Randomization||0
8563312|NCT00002651|21110891|P3|Assessable for Toxicity|Consolidation and Randomization||702
8563313|NCT00002651|21110892|P2|Assessable for Toxicity|Consolidation and Randomization||732
8563314|NCT00002651|21110893|P1|Assessable for Toxicity|Consolidation and Randomization||0
8563315|NCT00002651|21110891|P3|Eligible|Consolidation and Randomization||770
8563316|NCT00002651|21110892|P2|Eligible|Consolidation and Randomization||765
8563317|NCT00002651|21110893|P1|Eligible|Consolidation and Randomization||0
8563318|NCT00002651|21110891|P3|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
8563319|NCT00002651|21110892|P2|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
8563320|NCT00002651|21110893|P1|STARTED|Consolidation and Randomization||0
8563321|NCT00002651|21110891|P3|NOT COMPLETED|Induction||0
8563322|NCT00002651|21110892|P2|NOT COMPLETED|Induction||0
8563323|NCT00002651|21110893|P1|NOT COMPLETED|Induction||1343
8563324|NCT00002651|21110891|P3|COMPLETED|Induction||0
8563325|NCT00002651|21110892|P2|COMPLETED|Induction||0
8563326|NCT00002651|21110893|P1|COMPLETED|Induction||1697
8563327|NCT00002651|21110891|P3|Eligible and Began Protocol Therapy|Induction||0
8563328|NCT00002651|21110892|P2|Eligible and Began Protocol Therapy|Induction||0
8563329|NCT00002651|21110893|P1|Eligible and Began Protocol Therapy|Induction||2950
8563330|NCT00002651|21110891|P3|Eligible|Induction||0
8563331|NCT00002651|21110892|P2|Eligible|Induction||0
8563332|NCT00002651|21110893|P1|Eligible|Induction||2950
8563333|NCT00002651|21110891|P3|STARTED|Induction||0
8563334|NCT00002651|21110892|P2|STARTED|Induction||0
8563335|NCT00002651|21110893|P1|STARTED|Induction||3040
8563336|NCT00002558|21110911|P2|NOT COMPLETED|Overall Study||1
8563337|NCT00002558|21110912|P1|NOT COMPLETED|Overall Study||0
8563338|NCT00002558|21110911|P2|COMPLETED|Overall Study||15
8563339|NCT00002558|21110912|P1|COMPLETED|Overall Study||92
8563340|NCT00002558|21110911|P2|STARTED|Overall Study||16
8563341|NCT00002558|21110912|P1|STARTED|Overall Study||92
8563342|NCT00052078|21110922|P4|NOT COMPLETED|Overall Study||15
8563343|NCT00052078|21110923|P3|NOT COMPLETED|Overall Study||13
8563344|NCT00052078|21110924|P2|NOT COMPLETED|Overall Study||6
8563345|NCT00052078|21110925|P1|NOT COMPLETED|Overall Study||23
8563346|NCT00052078|21110922|P4|COMPLETED|Overall Study||61
8563347|NCT00052078|21110923|P3|COMPLETED|Overall Study||127
8563348|NCT00052078|21110924|P2|COMPLETED|Overall Study||133
8563349|NCT00052078|21110925|P1|COMPLETED|Overall Study||110
8563350|NCT00052078|21110922|P4|STARTED|Overall Study||76
8563351|NCT00052078|21110923|P3|STARTED|Overall Study||140
8563352|NCT00052078|21110924|P2|STARTED|Overall Study||139
8563353|NCT00052078|21110925|P1|STARTED|Overall Study||133
8563354|NCT00051636|21110937|P2|NOT COMPLETED|Period 2- Extended Observation Period||30
8563355|NCT00051636|21110938|P1|NOT COMPLETED|Period 2- Extended Observation Period||70
8563356|NCT00051636|21110937|P2|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
8563357|NCT00051636|21110938|P1|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
8563358|NCT00051636|21110937|P2|STARTED|Period 2- Extended Observation Period||52
8563359|NCT00051636|21110938|P1|STARTED|Period 2- Extended Observation Period||75
8563360|NCT00051636|21110937|P2|NOT COMPLETED|Period 1 - Core||6
8563361|NCT00051636|21110938|P1|NOT COMPLETED|Period 1 - Core||4
8563362|NCT00051636|21110937|P2|COMPLETED|Period 1 - Core||76
8563363|NCT00051636|21110938|P1|COMPLETED|Period 1 - Core||86
8563364|NCT00051636|21110937|P2|STARTED|Period 1 - Core||82
8563365|NCT00051636|21110938|P1|STARTED|Period 1 - Core||90
8563366|NCT00051558|21110966|P2|NOT COMPLETED|Overall Study||96
8563367|NCT00051558|21110967|P1|NOT COMPLETED|Overall Study||91
8563368|NCT00051558|21110966|P2|COMPLETED|Overall Study||118
8563369|NCT00051558|21110967|P1|COMPLETED|Overall Study||123
8563370|NCT00051558|21110966|P2|STARTED|Overall Study||214
8563371|NCT00051558|21110967|P1|STARTED|Overall Study||214
8563372|NCT00051363|21111003|P2|NOT COMPLETED|Overall Study||144
8563373|NCT00051363|21111004|P1|NOT COMPLETED|Overall Study||115
8563374|NCT00051363|21111003|P2|COMPLETED|Overall Study||403
8563375|NCT00051363|21111004|P1|COMPLETED|Overall Study||443
8563376|NCT00051363|21111003|P2|Completed 6M Vist On-Study|Overall Study||403
8563377|NCT00051363|21111004|P1|Completed 6M Vist On-Study|Overall Study||443
8563378|NCT00051363|21111003|P2|Completed 6M Visit On-Treatment|Overall Study||372
8563379|NCT00051363|21111004|P1|Completed 6M Visit On-Treatment|Overall Study||427
8563380|NCT00051363|21111003|P2|Completed 2M Visit On-Study|Overall Study||432
8563381|NCT00051363|21111004|P1|Completed 2M Visit On-Study|Overall Study||468
8563382|NCT00051363|21111003|P2|Completed 2M Visit On-Treatment|Overall Study||417
8563383|NCT00051363|21111004|P1|Completed 2M Visit On-Treatment|Overall Study||456
8563384|NCT00051363|21111003|P2|Randomized & Analyzed|Overall Study||542
8563385|NCT00051363|21111004|P1|Randomized & Analyzed|Overall Study||556
8563386|NCT00051363|21111003|P2|STARTED|Overall Study||547
8563387|NCT00051363|21111004|P1|STARTED|Overall Study||558
8563388|NCT00051168|21111038|P1|NOT COMPLETED|Overall Study||135
8563389|NCT00051168|21111038|P1|COMPLETED|Overall Study||367
8563390|NCT00051168|21111038|P1|STARTED|Overall Study||502
8563391|NCT00051025|21111044|P2|NOT COMPLETED|Overall Study||4
8563392|NCT00051025|21111045|P1|NOT COMPLETED|Overall Study||2
8563393|NCT00051025|21111044|P2|COMPLETED|Overall Study||0
8563394|NCT00051025|21111045|P1|COMPLETED|Overall Study||3
8563395|NCT00051025|21111044|P2|STARTED|Overall Study||4
8563396|NCT00051025|21111045|P1|STARTED|Overall Study||5
8563397|NCT00050986|21111053|P1|NOT COMPLETED|Overall Study||2
8563398|NCT00050986|21111053|P1|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
8563399|NCT00050986|21111053|P1|STARTED|Overall Study||55
8563400|NCT00050960|21111059|P2|NOT COMPLETED|Overall Study||304
8563401|NCT00050960|21111060|P1|NOT COMPLETED|Overall Study||302
8563402|NCT00050960|21111059|P2|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
8563403|NCT00050960|21111060|P1|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
8563404|NCT00050960|21111059|P2|STARTED|Overall Study||306
8563405|NCT00050960|21111060|P1|STARTED|Overall Study||306
8563406|NCT00050778|21111069|P3|NOT COMPLETED|Overall Study||18
8563407|NCT00050778|21111070|P2|NOT COMPLETED|Overall Study||21
8563408|NCT00050778|21111071|P1|NOT COMPLETED|Overall Study||45
8563409|NCT00050778|21111069|P3|COMPLETED|Overall Study||92
8563410|NCT00050778|21111070|P2|COMPLETED|Overall Study||92
8563411|NCT00050778|21111071|P1|COMPLETED|Overall Study||66
8563412|NCT00050778|21111069|P3|Treated|Overall Study||108
8563413|NCT00050778|21111070|P2|Treated|Overall Study||108
8563414|NCT00050778|21111071|P1|Treated|Overall Study||107
8563415|NCT00050778|21111069|P3|STARTED|Overall Study||110
8563416|NCT00050778|21111070|P2|STARTED|Overall Study||113
8563417|NCT00050778|21111071|P1|STARTED|Overall Study|Randomized.|111
8563418|NCT00050622|21111097|P1|NOT COMPLETED|Overall Study||1
8563419|NCT00050622|21111097|P1|COMPLETED|Overall Study||153
8563420|NCT00050622|21111097|P1|STARTED|Overall Study||154
8563421|NCT00050167|21111135|P2|NOT COMPLETED|Overall Study||1
8563422|NCT00050167|21111136|P1|NOT COMPLETED|Overall Study||1
8563423|NCT00050167|21111135|P2|COMPLETED|Overall Study||300
8563424|NCT00050167|21111136|P1|COMPLETED|Overall Study||301
8563425|NCT00050167|21111135|P2|STARTED|Overall Study||301
8563426|NCT00050167|21111136|P1|STARTED|Overall Study||302
8563427|NCT00050089|21111146|P4|NOT COMPLETED|Overall Study||0
8563428|NCT00050089|21111147|P3|NOT COMPLETED|Overall Study||0
8563429|NCT00050089|21111148|P2|NOT COMPLETED|Overall Study||0
8563430|NCT00050089|21111149|P1|NOT COMPLETED|Overall Study||0
8563431|NCT00050089|21111146|P4|COMPLETED|Overall Study|For primary outcome assessment|78
8563432|NCT00050089|21111147|P3|COMPLETED|Overall Study|For primary outcome assessment|86
8563433|NCT00050089|21111148|P2|COMPLETED|Overall Study|For primary outcome assessment|98
8563434|NCT00050089|21111149|P1|COMPLETED|Overall Study|For primary outcome assessment|106
8563435|NCT00050089|21111146|P4|Baseline|Overall Study||78
8563436|NCT00050089|21111147|P3|Baseline|Overall Study||86
8563437|NCT00050089|21111148|P2|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
8563438|NCT00050089|21111149|P1|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
8563439|NCT00050089|21111146|P4|STARTED|Overall Study||78
8563440|NCT00050089|21111147|P3|STARTED|Overall Study||86
8563441|NCT00050089|21111148|P2|STARTED|Overall Study||98
8563442|NCT00050089|21111149|P1|STARTED|Overall Study||106
8563443|NCT00050011|21111169|P2|NOT COMPLETED|Overall Study||126
8563444|NCT00050011|21111170|P1|NOT COMPLETED|Overall Study||121
8563445|NCT00050011|21111169|P2|COMPLETED|Overall Study||175
8563446|NCT00050011|21111170|P1|COMPLETED|Overall Study||180
8563447|NCT00050011|21111169|P2|Intent-to-treat Population|Overall Study||300
8563448|NCT00050011|21111170|P1|Intent-to-treat Population|Overall Study||300
8563449|NCT00050011|21111169|P2|STARTED|Overall Study||301
8563450|NCT00050011|21111170|P1|STARTED|Overall Study||301
8563451|NCT00049842|21111192|P2|NOT COMPLETED|Follow-up Phase||5
8563452|NCT00049842|21111193|P1|NOT COMPLETED|Follow-up Phase||7
8563453|NCT00049842|21111192|P2|COMPLETED|Follow-up Phase||189
8563454|NCT00049842|21111193|P1|COMPLETED|Follow-up Phase||211
8563455|NCT00049842|21111192|P2|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
8563456|NCT00049842|21111193|P1|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
8563457|NCT00049842|21111192|P2|NOT COMPLETED|Treatment Phase||78
8563458|NCT00049842|21111193|P1|NOT COMPLETED|Treatment Phase||93
8563459|NCT00049842|21111192|P2|COMPLETED|Treatment Phase||192
8563460|NCT00049842|21111193|P1|COMPLETED|Treatment Phase||177
8563461|NCT00049842|21111192|P2|STARTED|Treatment Phase||270
8563462|NCT00049842|21111193|P1|STARTED|Treatment Phase||270
8563463|NCT00048932|21111211|P3|NOT COMPLETED|Open Label Period (OL)||441
8563464|NCT00048932|21111212|P2|NOT COMPLETED|Open Label Period (OL)||0
8563465|NCT00048932|21111213|P1|NOT COMPLETED|Open Label Period (OL)||0
8563466|NCT00048932|21111211|P3|COMPLETED|Open Label Period (OL)||743
8563467|NCT00048932|21111212|P2|COMPLETED|Open Label Period (OL)||0
8563468|NCT00048932|21111213|P1|COMPLETED|Open Label Period (OL)||0
8563469|NCT00048932|21111211|P3|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
8563470|NCT00048932|21111212|P2|STARTED|Open Label Period (OL)||0
8563471|NCT00048932|21111213|P1|STARTED|Open Label Period (OL)||0
8563472|NCT00048932|21111211|P3|NOT COMPLETED|Double Blind Period (DB)||0
8563473|NCT00048932|21111212|P2|NOT COMPLETED|Double Blind Period (DB)||87
8563474|NCT00048932|21111213|P1|NOT COMPLETED|Double Blind Period (DB)||123
8563475|NCT00048932|21111211|P3|COMPLETED|Double Blind Period (DB)||0
8563476|NCT00048932|21111212|P2|COMPLETED|Double Blind Period (DB)||395
8563477|NCT00048932|21111213|P1|COMPLETED|Double Blind Period (DB)||836
8563478|NCT00048932|21111211|P3|STARTED|Double Blind Period (DB)||0
8563479|NCT00048932|21111212|P2|STARTED|Double Blind Period (DB)|Number Treated|482
8563480|NCT00048932|21111213|P1|STARTED|Double Blind Period (DB)|Number Treated|959
8563481|NCT00048815|21111240|P3|NOT COMPLETED|Overall Study||4
8563482|NCT00048815|21111241|P2|NOT COMPLETED|Overall Study||4
8563483|NCT00048815|21111242|P1|NOT COMPLETED|Overall Study||6
8563484|NCT00048815|21111240|P3|COMPLETED|Overall Study||19
8563485|NCT00048815|21111241|P2|COMPLETED|Overall Study||22
8563486|NCT00048815|21111242|P1|COMPLETED|Overall Study||18
8563487|NCT00048815|21111240|P3|STARTED|Overall Study||23
8563488|NCT00048815|21111241|P2|STARTED|Overall Study||26
8563489|NCT00048815|21111242|P1|STARTED|Overall Study||24
8563490|NCT00048581|21111255|P3|NOT COMPLETED|Open-Label Period||167
8563491|NCT00048581|21111256|P2|NOT COMPLETED|Open-Label Period||0
8563492|NCT00048581|21111257|P1|NOT COMPLETED|Open-Label Period||0
8563493|NCT00048581|21111255|P3|COMPLETED|Open-Label Period||150
8563494|NCT00048581|21111256|P2|COMPLETED|Open-Label Period||0
8563495|NCT00048581|21111257|P1|COMPLETED|Open-Label Period||0
8563496|NCT00048581|21111255|P3|STARTED|Open-Label Period||317
8563497|NCT00048581|21111256|P2|STARTED|Open-Label Period||0
8563498|NCT00048581|21111257|P1|STARTED|Open-Label Period||0
8563499|NCT00048581|21111255|P3|NOT COMPLETED|Double-Blind Period||0
8563500|NCT00048581|21111256|P2|NOT COMPLETED|Double-Blind Period||34
8563501|NCT00048581|21111257|P1|NOT COMPLETED|Double-Blind Period||35
8563502|NCT00048581|21111255|P3|COMPLETED|Double-Blind Period||0
8563503|NCT00048581|21111256|P2|COMPLETED|Double-Blind Period||99
8563504|NCT00048581|21111257|P1|COMPLETED|Double-Blind Period||223
8563505|NCT00048581|21111255|P3|STARTED|Double-Blind Period||0
8563506|NCT00048581|21111256|P2|STARTED|Double-Blind Period||133
8563507|NCT00048581|21111257|P1|STARTED|Double-Blind Period||258
8563508|NCT00048568|21111424|P3|NOT COMPLETED|Open-Label Period||160
8563509|NCT00048568|21111425|P2|NOT COMPLETED|Open-Label Period||0
8563510|NCT00048568|21111426|P1|NOT COMPLETED|Open-Label Period||0
8563511|NCT00048568|21111424|P3|COMPLETED|Open-Label Period||379
8563512|NCT00048568|21111425|P2|COMPLETED|Open-Label Period||0
8563513|NCT00048568|21111426|P1|COMPLETED|Open-Label Period||0
8563514|NCT00048568|21111424|P3|STARTED|Open-Label Period||539
8563515|NCT00048568|21111425|P2|STARTED|Open-Label Period||0
8563516|NCT00048568|21111426|P1|STARTED|Open-Label Period||0
8563517|NCT00048568|21111424|P3|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
8563518|NCT00048568|21111425|P2|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
8563519|NCT00048568|21111426|P1|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
8563520|NCT00048568|21111424|P3|COMPLETED|Double-Blind Period Days 170 to 365||0
8563521|NCT00048568|21111425|P2|COMPLETED|Double-Blind Period Days 170 to 365||162
8563522|NCT00048568|21111426|P1|COMPLETED|Double-Blind Period Days 170 to 365||385
8563523|NCT00048568|21111424|P3|STARTED|Double-Blind Period Days 170 to 365||0
8563524|NCT00048568|21111425|P2|STARTED|Double-Blind Period Days 170 to 365||174
8563525|NCT00048568|21111426|P1|STARTED|Double-Blind Period Days 170 to 365||401
8563526|NCT00048568|21111424|P3|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
8563527|NCT00048568|21111425|P2|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
8563528|NCT00048568|21111426|P1|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
8563529|NCT00048568|21111424|P3|COMPLETED|Double-Blind Period Days 1 to 169||0
8563530|NCT00048568|21111425|P2|COMPLETED|Double-Blind Period Days 1 to 169||174
8563531|NCT00048568|21111426|P1|COMPLETED|Double-Blind Period Days 1 to 169||401
8563532|NCT00048568|21111424|P3|STARTED|Double-Blind Period Days 1 to 169||0
8563533|NCT00048568|21111425|P2|STARTED|Double-Blind Period Days 1 to 169||219
8563534|NCT00048568|21111426|P1|STARTED|Double-Blind Period Days 1 to 169||433
8563535|NCT00048893|21111714|P1|NOT COMPLETED|Overall Study||0
8563536|NCT00048893|21111714|P1|COMPLETED|Overall Study||37
8563537|NCT00048893|21111714|P1|STARTED|Overall Study||37
8563538|NCT00048737|21111725|P1|NOT COMPLETED|Overall Study||0
8563539|NCT00048737|21111725|P1|COMPLETED|Overall Study||70
8563540|NCT00048737|21111725|P1|STARTED|Overall Study||70
8563541|NCT00048724|21111731|P2|NOT COMPLETED|Overall Study||118
8563542|NCT00048724|21111732|P1|NOT COMPLETED|Overall Study||116
8563543|NCT00048724|21111731|P2|COMPLETED|Overall Study||197
8563544|NCT00048724|21111732|P1|COMPLETED|Overall Study||195
8563545|NCT00048724|21111731|P2|STARTED|Overall Study||315
8563546|NCT00048724|21111732|P1|STARTED|Overall Study||311
8563547|NCT00048542|21111744|P8|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
8563548|NCT00048542|21111745|P7|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
8563549|NCT00048542|21111746|P6|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563550|NCT00048542|21111747|P5|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563551|NCT00048542|21111748|P4|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563552|NCT00048542|21111749|P3|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563553|NCT00048542|21111750|P2|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563554|NCT00048542|21111751|P1|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563555|NCT00048542|21111744|P8|COMPLETED|Open-Label Extension Fixed Dose Phase||25
8563556|NCT00048542|21111745|P7|COMPLETED|Open-Label Extension Fixed Dose Phase||37
8563557|NCT00048542|21111746|P6|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563558|NCT00048542|21111747|P5|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563559|NCT00048542|21111748|P4|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563560|NCT00048542|21111749|P3|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563561|NCT00048542|21111750|P2|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563562|NCT00048542|21111751|P1|COMPLETED|Open-Label Extension Fixed Dose Phase||0
8563563|NCT00048542|21111744|P8|STARTED|Open-Label Extension Fixed Dose Phase||47
8563564|NCT00048542|21111745|P7|STARTED|Open-Label Extension Fixed Dose Phase||59
8563565|NCT00048542|21111746|P6|STARTED|Open-Label Extension Fixed Dose Phase||0
8563566|NCT00048542|21111747|P5|STARTED|Open-Label Extension Fixed Dose Phase||0
8563567|NCT00048542|21111748|P4|STARTED|Open-Label Extension Fixed Dose Phase||0
8563568|NCT00048542|21111749|P3|STARTED|Open-Label Extension Fixed Dose Phase||0
8563569|NCT00048542|21111750|P2|STARTED|Open-Label Extension Fixed Dose Phase||0
8563570|NCT00048542|21111751|P1|STARTED|Open-Label Extension Fixed Dose Phase||0
8563571|NCT00048542|21111744|P8|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563572|NCT00048542|21111745|P7|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563573|NCT00048542|21111746|P6|NOT COMPLETED|Open-Label Extension BSA Phase||10
8563574|NCT00048542|21111747|P5|NOT COMPLETED|Open-Label Extension BSA Phase||12
8563575|NCT00048542|21111748|P4|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563576|NCT00048542|21111749|P3|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563577|NCT00048542|21111750|P2|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563578|NCT00048542|21111751|P1|NOT COMPLETED|Open-Label Extension BSA Phase||0
8563579|NCT00048542|21111744|P8|COMPLETED|Open-Label Extension BSA Phase||0
8563580|NCT00048542|21111745|P7|COMPLETED|Open-Label Extension BSA Phase||0
8563581|NCT00048542|21111746|P6|COMPLETED|Open-Label Extension BSA Phase||47
8563582|NCT00048542|21111747|P5|COMPLETED|Open-Label Extension BSA Phase||59
8563583|NCT00048542|21111748|P4|COMPLETED|Open-Label Extension BSA Phase||0
8563584|NCT00048542|21111749|P3|COMPLETED|Open-Label Extension BSA Phase||0
8563585|NCT00048542|21111750|P2|COMPLETED|Open-Label Extension BSA Phase||0
8563586|NCT00048542|21111751|P1|COMPLETED|Open-Label Extension BSA Phase||0
8563587|NCT00048542|21111744|P8|STARTED|Open-Label Extension BSA Phase||0
8563588|NCT00048542|21111745|P7|STARTED|Open-Label Extension BSA Phase||0
8563589|NCT00048542|21111746|P6|STARTED|Open-Label Extension BSA Phase||57
8563590|NCT00048542|21111747|P5|STARTED|Open-Label Extension BSA Phase||71
8563591|NCT00048542|21111748|P4|STARTED|Open-Label Extension BSA Phase||0
8563592|NCT00048542|21111749|P3|STARTED|Open-Label Extension BSA Phase||0
8563593|NCT00048542|21111750|P2|STARTED|Open-Label Extension BSA Phase||0
8563594|NCT00048542|21111751|P1|STARTED|Open-Label Extension BSA Phase||0
8563595|NCT00048542|21111744|P8|NOT COMPLETED|Double-Blind Phase||0
8563596|NCT00048542|21111745|P7|NOT COMPLETED|Double-Blind Phase||0
8563597|NCT00048542|21111746|P6|NOT COMPLETED|Double-Blind Phase||0
8563598|NCT00048542|21111747|P5|NOT COMPLETED|Double-Blind Phase||0
8563599|NCT00048542|21111748|P4|NOT COMPLETED|Double-Blind Phase||0
8563600|NCT00048542|21111749|P3|NOT COMPLETED|Double-Blind Phase||1
8563601|NCT00048542|21111750|P2|NOT COMPLETED|Double-Blind Phase||1
8563602|NCT00048542|21111751|P1|NOT COMPLETED|Double-Blind Phase||3
8563603|NCT00048542|21111744|P8|COMPLETED|Double-Blind Phase||0
8563604|NCT00048542|21111745|P7|COMPLETED|Double-Blind Phase||0
8563605|NCT00048542|21111746|P6|COMPLETED|Double-Blind Phase||0
8563606|NCT00048542|21111747|P5|COMPLETED|Double-Blind Phase||0
8563607|NCT00048542|21111748|P4|COMPLETED|Double-Blind Phase||28
8563608|NCT00048542|21111749|P3|COMPLETED|Double-Blind Phase||29
8563609|NCT00048542|21111750|P2|COMPLETED|Double-Blind Phase||36
8563610|NCT00048542|21111751|P1|COMPLETED|Double-Blind Phase||35
8563611|NCT00048542|21111744|P8|STARTED|Double-Blind Phase||0
8563612|NCT00048542|21111745|P7|STARTED|Double-Blind Phase||0
8563613|NCT00048542|21111746|P6|STARTED|Double-Blind Phase||0
8563614|NCT00048542|21111747|P5|STARTED|Double-Blind Phase||0
8563615|NCT00048542|21111748|P4|STARTED|Double-Blind Phase||28
8563616|NCT00048542|21111749|P3|STARTED|Double-Blind Phase||30
8563617|NCT00048542|21111750|P2|STARTED|Double-Blind Phase||37
8563618|NCT00048542|21111751|P1|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
8563619|NCT00048347|21111817|P1|NOT COMPLETED|Overall Study||2
8563620|NCT00048347|21111817|P1|COMPLETED|Overall Study||16
8563621|NCT00048347|21111817|P1|STARTED|Overall Study||18
8563622|NCT00048165|21111823|P2|NOT COMPLETED|Completed 12 Months Study||3
8563623|NCT00048165|21111824|P1|NOT COMPLETED|Completed 12 Months Study||3
8563624|NCT00048165|21111823|P2|COMPLETED|Completed 12 Months Study||167
8563625|NCT00048165|21111824|P1|COMPLETED|Completed 12 Months Study||162
8563626|NCT00048165|21111823|P2|STARTED|Completed 12 Months Study||170
8563627|NCT00048165|21111824|P1|STARTED|Completed 12 Months Study||165
8563628|NCT00048165|21111823|P2|NOT COMPLETED|Completed 6 Months Study||48
8563629|NCT00048165|21111824|P1|NOT COMPLETED|Completed 6 Months Study||51
8563630|NCT00048165|21111823|P2|COMPLETED|Completed 6 Months Study||170
8563631|NCT00048165|21111824|P1|COMPLETED|Completed 6 Months Study||165
8563632|NCT00048165|21111823|P2|STARTED|Completed 6 Months Study||218
8563633|NCT00048165|21111824|P1|STARTED|Completed 6 Months Study||216
8563634|NCT00048074|21111859|P3|NOT COMPLETED|Overall Study||97
8563635|NCT00048074|21111860|P2|NOT COMPLETED|Overall Study||87
8563636|NCT00048074|21111861|P1|NOT COMPLETED|Overall Study||81
8563637|NCT00048074|21111859|P3|COMPLETED|Overall Study||372
8563638|NCT00048074|21111860|P2|COMPLETED|Overall Study||361
8563639|NCT00048074|21111861|P1|COMPLETED|Overall Study||384
8563640|NCT00048074|21111859|P3|STARTED|Overall Study||469
8563641|NCT00048074|21111860|P2|STARTED|Overall Study||448
8563642|NCT00048074|21111861|P1|STARTED|Overall Study||465
8563643|NCT00048061|21111918|P4|NOT COMPLETED|Overall Study||79
8563644|NCT00048061|21111919|P3|NOT COMPLETED|Overall Study||84
8563645|NCT00048061|21111920|P2|NOT COMPLETED|Overall Study||73
8563646|NCT00048061|21111921|P1|NOT COMPLETED|Overall Study||75
8563647|NCT00048061|21111918|P4|COMPLETED|Overall Study||322
8563648|NCT00048061|21111919|P3|COMPLETED|Overall Study||316
8563649|NCT00048061|21111920|P2|COMPLETED|Overall Study||328
8563650|NCT00048061|21111921|P1|COMPLETED|Overall Study||325
8563651|NCT00048061|21111918|P4|STARTED|Overall Study||401
8563652|NCT00048061|21111919|P3|STARTED|Overall Study||400
8563653|NCT00048061|21111920|P2|STARTED|Overall Study||401
8563654|NCT00048061|21111921|P1|STARTED|Overall Study||400
8563655|NCT00048048|21112000|P12|NOT COMPLETED|Extension Year 2||2
8563656|NCT00048048|21112001|P11|NOT COMPLETED|Extension Year 2||4
8563657|NCT00048048|21112002|P10|NOT COMPLETED|Extension Year 2||0
8563658|NCT00048048|21112003|P9|NOT COMPLETED|Extension Year 2||0
8563659|NCT00048048|21112004|P8|NOT COMPLETED|Extension Year 2||0
8563660|NCT00048048|21112005|P7|NOT COMPLETED|Extension Year 2||0
8563661|NCT00048048|21112006|P6|NOT COMPLETED|Extension Year 2||0
8563662|NCT00048048|21112007|P5|NOT COMPLETED|Extension Year 2||0
8563663|NCT00048048|21112008|P4|NOT COMPLETED|Extension Year 2||0
8563664|NCT00048048|21112009|P3|NOT COMPLETED|Extension Year 2||0
8563665|NCT00048048|21112010|P2|NOT COMPLETED|Extension Year 2||0
8563666|NCT00048048|21112011|P1|NOT COMPLETED|Extension Year 2||0
8563667|NCT00048048|21112000|P12|COMPLETED|Extension Year 2||13
8563668|NCT00048048|21112001|P11|COMPLETED|Extension Year 2||19
8563669|NCT00048048|21112002|P10|COMPLETED|Extension Year 2||2
8563670|NCT00048048|21112003|P9|COMPLETED|Extension Year 2||0
8563671|NCT00048048|21112004|P8|COMPLETED|Extension Year 2||0
8563672|NCT00048048|21112005|P7|COMPLETED|Extension Year 2||0
8563673|NCT00048048|21112006|P6|COMPLETED|Extension Year 2||0
8563674|NCT00048048|21112007|P5|COMPLETED|Extension Year 2||0
8563675|NCT00048048|21112008|P4|COMPLETED|Extension Year 2||0
8563676|NCT00048048|21112009|P3|COMPLETED|Extension Year 2||0
8563677|NCT00048048|21112010|P2|COMPLETED|Extension Year 2||0
8563678|NCT00048048|21112011|P1|COMPLETED|Extension Year 2||0
8563679|NCT00048048|21112000|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
8563680|NCT00048048|21112001|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
8563681|NCT00048048|21112002|P10|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
8563682|NCT00048048|21112003|P9|STARTED|Extension Year 2||0
8563683|NCT00048048|21112004|P8|STARTED|Extension Year 2||0
8563684|NCT00048048|21112005|P7|STARTED|Extension Year 2||0
8563685|NCT00048048|21112006|P6|STARTED|Extension Year 2||0
8563686|NCT00048048|21112007|P5|STARTED|Extension Year 2||0
8563687|NCT00048048|21112008|P4|STARTED|Extension Year 2||0
8563688|NCT00048048|21112009|P3|STARTED|Extension Year 2||0
8563689|NCT00048048|21112010|P2|STARTED|Extension Year 2||0
8563690|NCT00048048|21112011|P1|STARTED|Extension Year 2||0
8563691|NCT00048048|21112000|P12|NOT COMPLETED|Extension Year 1||4
8563692|NCT00048048|21112001|P11|NOT COMPLETED|Extension Year 1||2
8563693|NCT00048048|21112002|P10|NOT COMPLETED|Extension Year 1||2
8563694|NCT00048048|21112003|P9|NOT COMPLETED|Extension Year 1||0
8563695|NCT00048048|21112004|P8|NOT COMPLETED|Extension Year 1||0
8563696|NCT00048048|21112005|P7|NOT COMPLETED|Extension Year 1||0
8563697|NCT00048048|21112006|P6|NOT COMPLETED|Extension Year 1||0
8563698|NCT00048048|21112007|P5|NOT COMPLETED|Extension Year 1||0
8563699|NCT00048048|21112008|P4|NOT COMPLETED|Extension Year 1||0
8563700|NCT00048048|21112009|P3|NOT COMPLETED|Extension Year 1||0
8563701|NCT00048048|21112010|P2|NOT COMPLETED|Extension Year 1||0
8563702|NCT00048048|21112011|P1|NOT COMPLETED|Extension Year 1||0
8563703|NCT00048048|21112000|P12|COMPLETED|Extension Year 1||15
8563704|NCT00048048|21112001|P11|COMPLETED|Extension Year 1||14
8563705|NCT00048048|21112002|P10|COMPLETED|Extension Year 1||14
8563706|NCT00048048|21112003|P9|COMPLETED|Extension Year 1||0
8563707|NCT00048048|21112004|P8|COMPLETED|Extension Year 1||0
8563708|NCT00048048|21112005|P7|COMPLETED|Extension Year 1||0
8563709|NCT00048048|21112006|P6|COMPLETED|Extension Year 1||0
8563710|NCT00048048|21112007|P5|COMPLETED|Extension Year 1||0
8563711|NCT00048048|21112008|P4|COMPLETED|Extension Year 1||0
8563712|NCT00048048|21112009|P3|COMPLETED|Extension Year 1||0
8563713|NCT00048048|21112010|P2|COMPLETED|Extension Year 1||0
8563714|NCT00048048|21112011|P1|COMPLETED|Extension Year 1||0
8563715|NCT00048048|21112000|P12|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
8563716|NCT00048048|21112001|P11|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
8563717|NCT00048048|21112002|P10|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
8563718|NCT00048048|21112003|P9|STARTED|Extension Year 1||0
8563719|NCT00048048|21112004|P8|STARTED|Extension Year 1||0
8563720|NCT00048048|21112005|P7|STARTED|Extension Year 1||0
8563721|NCT00048048|21112006|P6|STARTED|Extension Year 1||0
8563722|NCT00048048|21112007|P5|STARTED|Extension Year 1||0
8563723|NCT00048048|21112008|P4|STARTED|Extension Year 1||0
8563724|NCT00048048|21112009|P3|STARTED|Extension Year 1||0
8563725|NCT00048048|21112010|P2|STARTED|Extension Year 1||0
8563726|NCT00048048|21112011|P1|STARTED|Extension Year 1||0
8563727|NCT00048048|21112000|P12|NOT COMPLETED|Core Treatment||0
8563728|NCT00048048|21112001|P11|NOT COMPLETED|Core Treatment||0
8563729|NCT00048048|21112002|P10|NOT COMPLETED|Core Treatment||0
8563730|NCT00048048|21112003|P9|NOT COMPLETED|Core Treatment||0
8563731|NCT00048048|21112004|P8|NOT COMPLETED|Core Treatment||1
8563732|NCT00048048|21112005|P7|NOT COMPLETED|Core Treatment||0
8563733|NCT00048048|21112006|P6|NOT COMPLETED|Core Treatment||0
8563734|NCT00048048|21112007|P5|NOT COMPLETED|Core Treatment||0
8563735|NCT00048048|21112008|P4|NOT COMPLETED|Core Treatment||0
8563736|NCT00048048|21112009|P3|NOT COMPLETED|Core Treatment||1
8563737|NCT00048048|21112010|P2|NOT COMPLETED|Core Treatment||0
8563738|NCT00048048|21112011|P1|NOT COMPLETED|Core Treatment||0
8563739|NCT00048048|21112000|P12|COMPLETED|Core Treatment||0
8563740|NCT00048048|21112001|P11|COMPLETED|Core Treatment||0
8563741|NCT00048048|21112002|P10|COMPLETED|Core Treatment||0
8563742|NCT00048048|21112003|P9|COMPLETED|Core Treatment||10
8563743|NCT00048048|21112004|P8|COMPLETED|Core Treatment||5
8563744|NCT00048048|21112005|P7|COMPLETED|Core Treatment||6
8563745|NCT00048048|21112006|P6|COMPLETED|Core Treatment||9
8563746|NCT00048048|21112007|P5|COMPLETED|Core Treatment||6
8563747|NCT00048048|21112008|P4|COMPLETED|Core Treatment||6
8563748|NCT00048048|21112009|P3|COMPLETED|Core Treatment||9
8563749|NCT00048048|21112010|P2|COMPLETED|Core Treatment||6
8563750|NCT00048048|21112011|P1|COMPLETED|Core Treatment||6
8563751|NCT00048048|21112000|P12|STARTED|Core Treatment||0
8563752|NCT00048048|21112001|P11|STARTED|Core Treatment||0
8563753|NCT00048048|21112002|P10|STARTED|Core Treatment||0
8563754|NCT00048048|21112003|P9|STARTED|Core Treatment||10
8563755|NCT00048048|21112004|P8|STARTED|Core Treatment||6
8563756|NCT00048048|21112005|P7|STARTED|Core Treatment||6
8563757|NCT00048048|21112006|P6|STARTED|Core Treatment||9
8563758|NCT00048048|21112007|P5|STARTED|Core Treatment||6
8563759|NCT00048048|21112008|P4|STARTED|Core Treatment||6
8563760|NCT00048048|21112009|P3|STARTED|Core Treatment||10
8563761|NCT00048048|21112010|P2|STARTED|Core Treatment||6
8563762|NCT00048048|21112011|P1|STARTED|Core Treatment||6
8563763|NCT00048035|21112067|P8|NOT COMPLETED|Extension Year 2||3
8563764|NCT00048035|21112068|P7|NOT COMPLETED|Extension Year 2||3
8563765|NCT00048035|21112069|P6|NOT COMPLETED|Extension Year 2||0
8563766|NCT00048035|21112070|P5|NOT COMPLETED|Extension Year 2||0
8563767|NCT00048035|21112071|P4|NOT COMPLETED|Extension Year 2||0
8563768|NCT00048035|21112072|P3|NOT COMPLETED|Extension Year 2||0
8563769|NCT00048035|21112073|P2|NOT COMPLETED|Extension Year 2||0
8563770|NCT00048035|21112074|P1|NOT COMPLETED|Extension Year 2||0
8563771|NCT00048035|21112067|P8|COMPLETED|Extension Year 2||10
8563772|NCT00048035|21112068|P7|COMPLETED|Extension Year 2||11
8563773|NCT00048035|21112069|P6|COMPLETED|Extension Year 2||0
8563774|NCT00048035|21112070|P5|COMPLETED|Extension Year 2||0
8563775|NCT00048035|21112071|P4|COMPLETED|Extension Year 2||0
8563776|NCT00048035|21112072|P3|COMPLETED|Extension Year 2||0
8563777|NCT00048035|21112073|P2|COMPLETED|Extension Year 2||0
8563778|NCT00048035|21112074|P1|COMPLETED|Extension Year 2||0
8563779|NCT00048035|21112067|P8|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
8563780|NCT00048035|21112068|P7|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
8563781|NCT00048035|21112069|P6|STARTED|Extension Year 2||0
8563782|NCT00048035|21112070|P5|STARTED|Extension Year 2||0
8563783|NCT00048035|21112071|P4|STARTED|Extension Year 2||0
8563784|NCT00048035|21112072|P3|STARTED|Extension Year 2||0
8563785|NCT00048035|21112073|P2|STARTED|Extension Year 2||0
8563786|NCT00048035|21112074|P1|STARTED|Extension Year 2||0
8563787|NCT00048035|21112067|P8|NOT COMPLETED|Extension Year 1||11
8563788|NCT00048035|21112068|P7|NOT COMPLETED|Extension Year 1||11
8563789|NCT00048035|21112069|P6|NOT COMPLETED|Extension Year 1||0
8563790|NCT00048035|21112070|P5|NOT COMPLETED|Extension Year 1||0
8563791|NCT00048035|21112071|P4|NOT COMPLETED|Extension Year 1||0
8563792|NCT00048035|21112072|P3|NOT COMPLETED|Extension Year 1||0
8563793|NCT00048035|21112073|P2|NOT COMPLETED|Extension Year 1||0
8563794|NCT00048035|21112074|P1|NOT COMPLETED|Extension Year 1||0
8563795|NCT00048035|21112067|P8|COMPLETED|Extension Year 1||15
8563796|NCT00048035|21112068|P7|COMPLETED|Extension Year 1||16
8563797|NCT00048035|21112069|P6|COMPLETED|Extension Year 1||0
8563798|NCT00048035|21112070|P5|COMPLETED|Extension Year 1||0
8563799|NCT00048035|21112071|P4|COMPLETED|Extension Year 1||0
8563800|NCT00048035|21112072|P3|COMPLETED|Extension Year 1||0
8563801|NCT00048035|21112073|P2|COMPLETED|Extension Year 1||0
8563802|NCT00048035|21112074|P1|COMPLETED|Extension Year 1||0
8563803|NCT00048035|21112067|P8|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
8563804|NCT00048035|21112068|P7|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
8563805|NCT00048035|21112069|P6|STARTED|Extension Year 1||0
8563806|NCT00048035|21112070|P5|STARTED|Extension Year 1||0
8563807|NCT00048035|21112071|P4|STARTED|Extension Year 1||0
8563808|NCT00048035|21112072|P3|STARTED|Extension Year 1||0
8563809|NCT00048035|21112073|P2|STARTED|Extension Year 1||0
8563810|NCT00048035|21112074|P1|STARTED|Extension Year 1||0
8563811|NCT00048035|21112067|P8|NOT COMPLETED|Core Period||0
8563812|NCT00048035|21112068|P7|NOT COMPLETED|Core Period||0
8563813|NCT00048035|21112069|P6|NOT COMPLETED|Core Period||1
8563814|NCT00048035|21112070|P5|NOT COMPLETED|Core Period||1
8563815|NCT00048035|21112071|P4|NOT COMPLETED|Core Period||1
8563816|NCT00048035|21112072|P3|NOT COMPLETED|Core Period||1
8563817|NCT00048035|21112073|P2|NOT COMPLETED|Core Period||2
8563818|NCT00048035|21112074|P1|NOT COMPLETED|Core Period||4
8563819|NCT00048035|21112067|P8|COMPLETED|Core Period||0
8563820|NCT00048035|21112068|P7|COMPLETED|Core Period||0
8563821|NCT00048035|21112069|P6|COMPLETED|Core Period||14
8563822|NCT00048035|21112070|P5|COMPLETED|Core Period||15
8563823|NCT00048035|21112071|P4|COMPLETED|Core Period||14
8563824|NCT00048035|21112072|P3|COMPLETED|Core Period||14
8563825|NCT00048035|21112073|P2|COMPLETED|Core Period||13
8563826|NCT00048035|21112074|P1|COMPLETED|Core Period||11
8563827|NCT00048035|21112067|P8|STARTED|Core Period||0
8563828|NCT00048035|21112068|P7|STARTED|Core Period||0
8563829|NCT00048035|21112069|P6|STARTED|Core Period||15
8563830|NCT00048035|21112070|P5|STARTED|Core Period||16
8563831|NCT00048035|21112071|P4|STARTED|Core Period||15
8563832|NCT00048035|21112072|P3|STARTED|Core Period||15
8563833|NCT00048035|21112073|P2|STARTED|Core Period||15
8563834|NCT00048035|21112074|P1|STARTED|Core Period||15
8563835|NCT00047879|21112112|P2|NOT COMPLETED|Overall Study||3
8563836|NCT00047879|21112113|P1|NOT COMPLETED|Overall Study||4
8563837|NCT00047879|21112112|P2|COMPLETED|Overall Study||0
8563838|NCT00047879|21112113|P1|COMPLETED|Overall Study||0
8563839|NCT00047879|21112112|P2|STARTED|Overall Study||3
8563840|NCT00047879|21112113|P1|STARTED|Overall Study||4
8563841|NCT00047697|21112125|P2|NOT COMPLETED|Overall Study||2
8563842|NCT00047697|21112126|P1|NOT COMPLETED|Overall Study||0
8563843|NCT00047697|21112125|P2|COMPLETED|Overall Study||14
8563844|NCT00047697|21112126|P1|COMPLETED|Overall Study||18
8563845|NCT00047697|21112125|P2|STARTED|Overall Study||16
8563846|NCT00047697|21112126|P1|STARTED|Overall Study||18
8563847|NCT00047619|21112138|P2|NOT COMPLETED|Overall Study||0
8563848|NCT00047619|21112139|P1|NOT COMPLETED|Overall Study||0
8563849|NCT00047619|21112138|P2|COMPLETED|Overall Study||14
8563850|NCT00047619|21112139|P1|COMPLETED|Overall Study||14
8563851|NCT00047619|21112138|P2|STARTED|Overall Study||14
8563852|NCT00047619|21112139|P1|STARTED|Overall Study||14
8563853|NCT00047463|21112149|P2|NOT COMPLETED|Overall Study||3
8563854|NCT00047463|21112150|P1|NOT COMPLETED|Overall Study||0
8563855|NCT00047463|21112149|P2|COMPLETED|Overall Study||19
8563856|NCT00047463|21112150|P1|COMPLETED|Overall Study||13
8563857|NCT00047463|21112149|P2|STARTED|Overall Study||22
8563858|NCT00047463|21112150|P1|STARTED|Overall Study||13
8563895|NCT00046566|21112202|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8563896|NCT00046566|21112203|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8563897|NCT00046566|21112204|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
8563898|NCT00046566|21112202|P3|COMPLETED|Intervention 3 (8 Weeks)||88
8563899|NCT00046566|21112203|P2|COMPLETED|Intervention 3 (8 Weeks)||92
8563900|NCT00046566|21112204|P1|COMPLETED|Intervention 3 (8 Weeks)||93
8563901|NCT00046566|21112202|P3|STARTED|Intervention 3 (8 Weeks)||88
8563902|NCT00046566|21112203|P2|STARTED|Intervention 3 (8 Weeks)||92
8563903|NCT00046566|21112204|P1|STARTED|Intervention 3 (8 Weeks)||93
8563904|NCT00046566|21112202|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
8563905|NCT00046566|21112203|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
8563906|NCT00046566|21112204|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
8563907|NCT00046566|21112202|P3|COMPLETED|Intervention 2 (8 Weeks)||88
8563908|NCT00046566|21112203|P2|COMPLETED|Intervention 2 (8 Weeks)||92
8563909|NCT00046566|21112204|P1|COMPLETED|Intervention 2 (8 Weeks)||93
8563910|NCT00046566|21112202|P3|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
8563911|NCT00046566|21112203|P2|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
8563912|NCT00046566|21112204|P1|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
8563913|NCT00046566|21112202|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
8563914|NCT00046566|21112203|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
8563915|NCT00046566|21112204|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
8563916|NCT00046566|21112202|P3|COMPLETED|Intervention 1 (8 Weeks)||101
8563917|NCT00046566|21112203|P2|COMPLETED|Intervention 1 (8 Weeks)||104
8563918|NCT00046566|21112204|P1|COMPLETED|Intervention 1 (8 Weeks)||101
8563919|NCT00046566|21112202|P3|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
8563920|NCT00046566|21112203|P2|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
8563921|NCT00046566|21112204|P1|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
8563922|NCT00046228|21112221|P3|NOT COMPLETED|1 Year||12
8563923|NCT00046228|21112222|P2|NOT COMPLETED|1 Year||14
8563924|NCT00046228|21112223|P1|NOT COMPLETED|1 Year||19
8563925|NCT00046228|21112221|P3|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
8563926|NCT00046228|21112222|P2|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
8563927|NCT00046228|21112223|P1|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
8563928|NCT00046228|21112221|P3|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
8563929|NCT00046228|21112222|P2|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
8563930|NCT00046228|21112223|P1|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
8563931|NCT00046228|21112221|P3|NOT COMPLETED|90 Days||15
8563932|NCT00046228|21112222|P2|NOT COMPLETED|90 Days||8
8563933|NCT00046228|21112223|P1|NOT COMPLETED|90 Days||13
8563934|NCT00046228|21112221|P3|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
8563935|NCT00046228|21112222|P2|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
8563936|NCT00046228|21112223|P1|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
8563937|NCT00046228|21112221|P3|STARTED|90 Days||828
8563938|NCT00046228|21112222|P2|STARTED|90 Days||818
8563939|NCT00046228|21112223|P1|STARTED|90 Days||806
8563940|NCT00045942|21112267|P9|NOT COMPLETED|PKC412A2104E2||6
8563941|NCT00045942|21112268|P8|NOT COMPLETED|PKC412A2104E2||7
8563942|NCT00045942|21112269|P7|NOT COMPLETED|PKC412A2104E2||7
8563943|NCT00045942|21112270|P6|NOT COMPLETED|PKC412A2104E2||9
8563944|NCT00045942|21112271|P5|NOT COMPLETED|PKC412A2104E2||0
8563945|NCT00045942|21112272|P4|NOT COMPLETED|PKC412A2104E2||0
8563946|NCT00045942|21112273|P3|NOT COMPLETED|PKC412A2104E2||0
8563947|NCT00045942|21112274|P2|NOT COMPLETED|PKC412A2104E2||0
8563948|NCT00045942|21112275|P1|NOT COMPLETED|PKC412A2104E2||0
8563949|NCT00045942|21112267|P9|COMPLETED|PKC412A2104E2||0
8563950|NCT00045942|21112268|P8|COMPLETED|PKC412A2104E2||0
8563951|NCT00045942|21112269|P7|COMPLETED|PKC412A2104E2||0
8563952|NCT00045942|21112270|P6|COMPLETED|PKC412A2104E2||0
8563953|NCT00045942|21112271|P5|COMPLETED|PKC412A2104E2||0
8563954|NCT00045942|21112272|P4|COMPLETED|PKC412A2104E2||0
8563955|NCT00045942|21112273|P3|COMPLETED|PKC412A2104E2||0
8563956|NCT00045942|21112274|P2|COMPLETED|PKC412A2104E2||0
8563957|NCT00045942|21112275|P1|COMPLETED|PKC412A2104E2||0
8563958|NCT00045942|21112267|P9|Primary Efficacy|PKC412A2104E2||6
8563959|NCT00045942|21112268|P8|Primary Efficacy|PKC412A2104E2||7
8563960|NCT00045942|21112269|P7|Primary Efficacy|PKC412A2104E2||7
8563961|NCT00045942|21112270|P6|Primary Efficacy|PKC412A2104E2||9
8563962|NCT00045942|21112271|P5|Primary Efficacy|PKC412A2104E2||0
8563963|NCT00045942|21112272|P4|Primary Efficacy|PKC412A2104E2||0
8563964|NCT00045942|21112273|P3|Primary Efficacy|PKC412A2104E2||0
8563965|NCT00045942|21112274|P2|Primary Efficacy|PKC412A2104E2||0
8563966|NCT00045942|21112275|P1|Primary Efficacy|PKC412A2104E2||0
8563967|NCT00045942|21112267|P9|STARTED|PKC412A2104E2||6
8563968|NCT00045942|21112268|P8|STARTED|PKC412A2104E2||7
8563969|NCT00045942|21112269|P7|STARTED|PKC412A2104E2||7
8563970|NCT00045942|21112270|P6|STARTED|PKC412A2104E2||9
8563971|NCT00045942|21112271|P5|STARTED|PKC412A2104E2||0
8563972|NCT00045942|21112272|P4|STARTED|PKC412A2104E2||0
8563973|NCT00045942|21112273|P3|STARTED|PKC412A2104E2||0
8563974|NCT00045942|21112274|P2|STARTED|PKC412A2104E2||0
8563975|NCT00045942|21112275|P1|STARTED|PKC412A2104E2||0
8563976|NCT00045942|21112267|P9|NOT COMPLETED|PKC412A2104E1||0
8563977|NCT00045942|21112268|P8|NOT COMPLETED|PKC412A2104E1||0
8563978|NCT00045942|21112269|P7|NOT COMPLETED|PKC412A2104E1||0
8563979|NCT00045942|21112270|P6|NOT COMPLETED|PKC412A2104E1||0
8563980|NCT00045942|21112271|P5|NOT COMPLETED|PKC412A2104E1||27
8563981|NCT00045942|21112272|P4|NOT COMPLETED|PKC412A2104E1||33
8563982|NCT00045942|21112273|P3|NOT COMPLETED|PKC412A2104E1||17
8563983|NCT00045942|21112274|P2|NOT COMPLETED|PKC412A2104E1||18
8563984|NCT00045942|21112275|P1|NOT COMPLETED|PKC412A2104E1||0
8563985|NCT00045942|21112267|P9|COMPLETED|PKC412A2104E1||0
8563986|NCT00045942|21112268|P8|COMPLETED|PKC412A2104E1||0
8563987|NCT00045942|21112269|P7|COMPLETED|PKC412A2104E1||0
8563988|NCT00045942|21112270|P6|COMPLETED|PKC412A2104E1||0
8563989|NCT00045942|21112271|P5|COMPLETED|PKC412A2104E1||0
8563990|NCT00045942|21112272|P4|COMPLETED|PKC412A2104E1||0
8563991|NCT00045942|21112273|P3|COMPLETED|PKC412A2104E1||0
8563992|NCT00045942|21112274|P2|COMPLETED|PKC412A2104E1||0
8563993|NCT00045942|21112275|P1|COMPLETED|PKC412A2104E1||0
8563994|NCT00045942|21112267|P9|Primary Efficacy|PKC412A2104E1||0
8563995|NCT00045942|21112268|P8|Primary Efficacy|PKC412A2104E1||0
8563996|NCT00045942|21112269|P7|Primary Efficacy|PKC412A2104E1||0
8563997|NCT00045942|21112270|P6|Primary Efficacy|PKC412A2104E1||0
8563998|NCT00045942|21112271|P5|Primary Efficacy|PKC412A2104E1||25
8563999|NCT00045942|21112272|P4|Primary Efficacy|PKC412A2104E1||32
8564000|NCT00045942|21112273|P3|Primary Efficacy|PKC412A2104E1||17
8564001|NCT00045942|21112274|P2|Primary Efficacy|PKC412A2104E1||18
8564002|NCT00045942|21112275|P1|Primary Efficacy|PKC412A2104E1||0
8564003|NCT00045942|21112267|P9|STARTED|PKC412A2104E1||0
8564004|NCT00045942|21112268|P8|STARTED|PKC412A2104E1||0
8564005|NCT00045942|21112269|P7|STARTED|PKC412A2104E1||0
8564006|NCT00045942|21112270|P6|STARTED|PKC412A2104E1||0
8564007|NCT00045942|21112271|P5|STARTED|PKC412A2104E1||27
8564008|NCT00045942|21112272|P4|STARTED|PKC412A2104E1||33
8564009|NCT00045942|21112273|P3|STARTED|PKC412A2104E1||17
8564010|NCT00045942|21112274|P2|STARTED|PKC412A2104E1||18
8564011|NCT00045942|21112275|P1|STARTED|PKC412A2104E1||0
8564012|NCT00045942|21112267|P9|NOT COMPLETED|PKC412A2104 (Core)||0
8564013|NCT00045942|21112268|P8|NOT COMPLETED|PKC412A2104 (Core)||0
8564014|NCT00045942|21112269|P7|NOT COMPLETED|PKC412A2104 (Core)||0
8564015|NCT00045942|21112270|P6|NOT COMPLETED|PKC412A2104 (Core)||0
8564016|NCT00045942|21112271|P5|NOT COMPLETED|PKC412A2104 (Core)||0
8564017|NCT00045942|21112272|P4|NOT COMPLETED|PKC412A2104 (Core)||0
8564018|NCT00045942|21112273|P3|NOT COMPLETED|PKC412A2104 (Core)||0
8564019|NCT00045942|21112274|P2|NOT COMPLETED|PKC412A2104 (Core)||0
8564020|NCT00045942|21112275|P1|NOT COMPLETED|PKC412A2104 (Core)||20
8564021|NCT00045942|21112267|P9|COMPLETED|PKC412A2104 (Core)||0
8564022|NCT00045942|21112268|P8|COMPLETED|PKC412A2104 (Core)||0
8564023|NCT00045942|21112269|P7|COMPLETED|PKC412A2104 (Core)||0
8564024|NCT00045942|21112270|P6|COMPLETED|PKC412A2104 (Core)||0
8564025|NCT00045942|21112271|P5|COMPLETED|PKC412A2104 (Core)||0
8564026|NCT00045942|21112272|P4|COMPLETED|PKC412A2104 (Core)||0
8564027|NCT00045942|21112273|P3|COMPLETED|PKC412A2104 (Core)||0
8564028|NCT00045942|21112274|P2|COMPLETED|PKC412A2104 (Core)||0
8564029|NCT00045942|21112275|P1|COMPLETED|PKC412A2104 (Core)||0
8564030|NCT00045942|21112267|P9|Core Primary Efficacy|PKC412A2104 (Core)||0
8564031|NCT00045942|21112268|P8|Core Primary Efficacy|PKC412A2104 (Core)||0
8564032|NCT00045942|21112269|P7|Core Primary Efficacy|PKC412A2104 (Core)||0
8564033|NCT00045942|21112270|P6|Core Primary Efficacy|PKC412A2104 (Core)||0
8564034|NCT00045942|21112271|P5|Core Primary Efficacy|PKC412A2104 (Core)||0
8564035|NCT00045942|21112272|P4|Core Primary Efficacy|PKC412A2104 (Core)||0
8564036|NCT00045942|21112273|P3|Core Primary Efficacy|PKC412A2104 (Core)||0
8564037|NCT00045942|21112274|P2|Core Primary Efficacy|PKC412A2104 (Core)||0
8564038|NCT00045942|21112275|P1|Core Primary Efficacy|PKC412A2104 (Core)||20
8564039|NCT00045942|21112267|P9|STARTED|PKC412A2104 (Core)||0
8564040|NCT00045942|21112268|P8|STARTED|PKC412A2104 (Core)||0
8564041|NCT00045942|21112269|P7|STARTED|PKC412A2104 (Core)||0
8564042|NCT00045942|21112270|P6|STARTED|PKC412A2104 (Core)||0
8564043|NCT00045942|21112271|P5|STARTED|PKC412A2104 (Core)||0
8564044|NCT00045942|21112272|P4|STARTED|PKC412A2104 (Core)||0
8564045|NCT00045942|21112273|P3|STARTED|PKC412A2104 (Core)||0
8564046|NCT00045942|21112274|P2|STARTED|PKC412A2104 (Core)||0
8564047|NCT00045942|21112275|P1|STARTED|PKC412A2104 (Core)||20
8564048|NCT00044655|21112357|P2|NOT COMPLETED|Overall Study||38
8564049|NCT00044655|21112358|P1|NOT COMPLETED|Overall Study||20
8564050|NCT00044655|21112357|P2|COMPLETED|Overall Study||79
8564051|NCT00044655|21112358|P1|COMPLETED|Overall Study||82
8564052|NCT00044655|21112357|P2|STARTED|Overall Study||117
8564053|NCT00044655|21112358|P1|STARTED|Overall Study||102
8564054|NCT00044512|21112364|P1|NOT COMPLETED|Follow Up||2
8564055|NCT00044512|21112364|P1|COMPLETED|Follow Up||135
8564056|NCT00044512|21112364|P1|STARTED|Follow Up||137
8564057|NCT00044512|21112364|P1|NOT COMPLETED|Treatment||0
8564058|NCT00044512|21112364|P1|COMPLETED|Treatment||137
8564059|NCT00044512|21112364|P1|STARTED|Treatment||137
8564060|NCT00044213|21112379|P4|NOT COMPLETED|Overall Study||136
8564061|NCT00044213|21112380|P3|NOT COMPLETED|Overall Study||138
8564062|NCT00044213|21112381|P2|NOT COMPLETED|Overall Study||112
8564063|NCT00044213|21112382|P1|NOT COMPLETED|Overall Study||100
8564064|NCT00044213|21112379|P4|COMPLETED|Overall Study||301
8564065|NCT00044213|21112380|P3|COMPLETED|Overall Study||294
8564066|NCT00044213|21112381|P2|COMPLETED|Overall Study||306
8564067|NCT00044213|21112382|P1|COMPLETED|Overall Study||321
8564068|NCT00044213|21112379|P4|STARTED|Overall Study||437
8564069|NCT00044213|21112380|P3|STARTED|Overall Study||432
8564070|NCT00044213|21112381|P2|STARTED|Overall Study||418
8564071|NCT00044213|21112382|P1|STARTED|Overall Study||421
8564072|NCT00044044|21112401|P5|NOT COMPLETED|Overall Study||36
8564073|NCT00044044|21112402|P4|NOT COMPLETED|Overall Study||44
8564074|NCT00044044|21112403|P3|NOT COMPLETED|Overall Study||40
8564075|NCT00044044|21112404|P2|NOT COMPLETED|Overall Study||41
8564076|NCT00044044|21112405|P1|NOT COMPLETED|Overall Study||44
8564077|NCT00044044|21112401|P5|COMPLETED|Overall Study||36
8564078|NCT00044044|21112402|P4|COMPLETED|Overall Study||29
8564079|NCT00044044|21112403|P3|COMPLETED|Overall Study||31
8564080|NCT00044044|21112404|P2|COMPLETED|Overall Study||28
8564081|NCT00044044|21112405|P1|COMPLETED|Overall Study||27
8564082|NCT00044044|21112401|P5|STARTED|Overall Study||72
8564083|NCT00044044|21112402|P4|STARTED|Overall Study||73
8564084|NCT00044044|21112403|P3|STARTED|Overall Study||71
8564085|NCT00044044|21112404|P2|STARTED|Overall Study||69
8564086|NCT00044044|21112405|P1|STARTED|Overall Study||71
8564087|NCT00044005|21112435|P3|NOT COMPLETED|Overall Study||22
8564088|NCT00044005|21112436|P2|NOT COMPLETED|Overall Study||14
8564089|NCT00044005|21112437|P1|NOT COMPLETED|Overall Study||19
8564090|NCT00044005|21112435|P3|COMPLETED|Overall Study||11
8564091|NCT00044005|21112436|P2|COMPLETED|Overall Study||19
8564092|NCT00044005|21112437|P1|COMPLETED|Overall Study||13
8564093|NCT00044005|21112435|P3|STARTED|Overall Study||33
8564094|NCT00044005|21112436|P2|STARTED|Overall Study||33
8564095|NCT00044005|21112437|P1|STARTED|Overall Study||32
8564096|NCT00044083|21112447|P2|NOT COMPLETED|Second Intervention (One Week) Patients||1
8564097|NCT00044083|21112448|P1|NOT COMPLETED|Second Intervention (One Week) Patients||0
8564098|NCT00044083|21112447|P2|COMPLETED|Second Intervention (One Week) Patients||29
8564099|NCT00044083|21112448|P1|COMPLETED|Second Intervention (One Week) Patients||30
8564100|NCT00044083|21112447|P2|STARTED|Second Intervention (One Week) Patients||30
8564101|NCT00044083|21112448|P1|STARTED|Second Intervention (One Week) Patients||30
8564102|NCT00044083|21112447|P2|NOT COMPLETED|First Intervention (One Week) Patients||2
8564103|NCT00044083|21112448|P1|NOT COMPLETED|First Intervention (One Week) Patients||1
8564104|NCT00044083|21112447|P2|COMPLETED|First Intervention (One Week) Patients||30
8564105|NCT00044083|21112448|P1|COMPLETED|First Intervention (One Week) Patients||30
8564106|NCT00044083|21112447|P2|STARTED|First Intervention (One Week) Patients||32
8564107|NCT00044083|21112448|P1|STARTED|First Intervention (One Week) Patients||31
8564108|NCT00044083|21112447|P2|NOT COMPLETED|Second Intervention (One Week) HV's||0
8564109|NCT00044083|21112448|P1|NOT COMPLETED|Second Intervention (One Week) HV's||0
8564110|NCT00044083|21112447|P2|COMPLETED|Second Intervention (One Week) HV's||66
8564111|NCT00044083|21112448|P1|COMPLETED|Second Intervention (One Week) HV's||64
8564112|NCT00044083|21112447|P2|STARTED|Second Intervention (One Week) HV's||66
8564113|NCT00044083|21112448|P1|STARTED|Second Intervention (One Week) HV's||64
8564114|NCT00044083|21112447|P2|NOT COMPLETED|First Intervention (One Week)- HV's||7
8564115|NCT00044083|21112448|P1|NOT COMPLETED|First Intervention (One Week)- HV's||10
8564116|NCT00044083|21112447|P2|COMPLETED|First Intervention (One Week)- HV's||66
8564117|NCT00044083|21112448|P1|COMPLETED|First Intervention (One Week)- HV's||64
8564118|NCT00044083|21112447|P2|STARTED|First Intervention (One Week)- HV's||73
8564119|NCT00044083|21112448|P1|STARTED|First Intervention (One Week)- HV's||74
8564120|NCT00043979|21112486|P3|NOT COMPLETED|Period 2||0
8564121|NCT00043979|21112487|P2|NOT COMPLETED|Period 2||0
8564122|NCT00043979|21112488|P1|NOT COMPLETED|Period 2||0
8564123|NCT00043979|21112486|P3|COMPLETED|Period 2||10
8564124|NCT00043979|21112487|P2|COMPLETED|Period 2||13
8564125|NCT00043979|21112488|P1|COMPLETED|Period 2||0
8564126|NCT00043979|21112486|P3|STARTED|Period 2||10
8564127|NCT00043979|21112487|P2|STARTED|Period 2||13
8564128|NCT00043979|21112488|P1|STARTED|Period 2||0
8564129|NCT00043979|21112486|P3|NOT COMPLETED|Period 1||3
8564130|NCT00043979|21112487|P2|NOT COMPLETED|Period 1||4
8564131|NCT00043979|21112488|P1|NOT COMPLETED|Period 1||7
8564132|NCT00043979|21112486|P3|COMPLETED|Period 1||10
8564133|NCT00043979|21112487|P2|COMPLETED|Period 1||13
8564134|NCT00043979|21112488|P1|COMPLETED|Period 1||23
8564135|NCT00043979|21112486|P3|STARTED|Period 1||13
8564136|NCT00043979|21112487|P2|STARTED|Period 1||17
8564137|NCT00043979|21112488|P1|STARTED|Period 1||30
8564138|NCT00043550|21112509|P3|NOT COMPLETED|Overall Study||20
8564139|NCT00043550|21112510|P2|NOT COMPLETED|Overall Study||12
8564140|NCT00043550|21112511|P1|NOT COMPLETED|Overall Study||22
8564141|NCT00043550|21112509|P3|COMPLETED|Overall Study||30
8564142|NCT00043550|21112510|P2|COMPLETED|Overall Study||39
8564143|NCT00043550|21112511|P1|COMPLETED|Overall Study||33
8564144|NCT00043550|21112509|P3|Week 8 Completed|Overall Study||35
8564145|NCT00043550|21112510|P2|Week 8 Completed|Overall Study||40
8564146|NCT00043550|21112511|P1|Week 8 Completed|Overall Study||35
8564147|NCT00043550|21112509|P3|STARTED|Overall Study||50
8564148|NCT00043550|21112510|P2|STARTED|Overall Study||51
8564149|NCT00043550|21112511|P1|STARTED|Overall Study||55
8564150|NCT00043186|21112528|P9|NOT COMPLETED|Overall Study||17
8564151|NCT00043186|21112529|P8|NOT COMPLETED|Overall Study||16
8564152|NCT00043186|21112530|P7|NOT COMPLETED|Overall Study||17
8564153|NCT00043186|21112531|P6|NOT COMPLETED|Overall Study||8
8564154|NCT00043186|21112532|P5|NOT COMPLETED|Overall Study||18
8564155|NCT00043186|21112533|P4|NOT COMPLETED|Overall Study||22
8564156|NCT00043186|21112534|P3|NOT COMPLETED|Overall Study||20
8564157|NCT00043186|21112535|P2|NOT COMPLETED|Overall Study||15
8564158|NCT00043186|21112536|P1|NOT COMPLETED|Overall Study||17
8564159|NCT00043186|21112528|P9|COMPLETED|Overall Study||30
8564160|NCT00043186|21112529|P8|COMPLETED|Overall Study||31
8564161|NCT00043186|21112530|P7|COMPLETED|Overall Study||25
8564162|NCT00043186|21112531|P6|COMPLETED|Overall Study||39
8564163|NCT00043186|21112532|P5|COMPLETED|Overall Study||36
8564164|NCT00043186|21112533|P4|COMPLETED|Overall Study||19
8564165|NCT00043186|21112534|P3|COMPLETED|Overall Study||24
8564166|NCT00043186|21112535|P2|COMPLETED|Overall Study||29
8564167|NCT00043186|21112536|P1|COMPLETED|Overall Study||29
8564168|NCT00043186|21112528|P9|STARTED|Overall Study||47
8564169|NCT00043186|21112529|P8|STARTED|Overall Study||47
8564170|NCT00043186|21112530|P7|STARTED|Overall Study||42
8564171|NCT00043186|21112531|P6|STARTED|Overall Study||47
8564172|NCT00043186|21112532|P5|STARTED|Overall Study||54
8564173|NCT00043186|21112533|P4|STARTED|Overall Study||41
8564174|NCT00043186|21112534|P3|STARTED|Overall Study||44
8564175|NCT00043186|21112535|P2|STARTED|Overall Study||44
8564176|NCT00043186|21112536|P1|STARTED|Overall Study||46
8564177|NCT00042666|21112862|P1|NOT COMPLETED|Overall Study||54
8564178|NCT00042666|21112862|P1|COMPLETED|Overall Study||1
8564179|NCT00042666|21112862|P1|Completed at Least 1 Cycle of Study Drug|Overall Study||42
8564180|NCT00042666|21112862|P1|Received at Least 1 Dose of Study Drug|Overall Study||55
8564181|NCT00042666|21112862|P1|STARTED|Overall Study||55
8564182|NCT00042432|21112874|P2|NOT COMPLETED|Overall Study||7
8564183|NCT00042432|21112875|P1|NOT COMPLETED|Overall Study||9
8564184|NCT00042432|21112874|P2|COMPLETED|Overall Study||20
8564185|NCT00042432|21112875|P1|COMPLETED|Overall Study||18
8564186|NCT00042432|21112874|P2|STARTED|Overall Study||27
8564187|NCT00042432|21112875|P1|STARTED|Overall Study||27
8564188|NCT00042224|21112885|P2|NOT COMPLETED|Overall Study||3
8564189|NCT00042224|21112886|P1|NOT COMPLETED|Overall Study||3
8564190|NCT00042224|21112885|P2|COMPLETED|Overall Study||16
8564191|NCT00042224|21112886|P1|COMPLETED|Overall Study||17
8564192|NCT00042224|21112885|P2|STARTED|Overall Study||19
8564193|NCT00042224|21112886|P1|STARTED|Overall Study||20
8564194|NCT00041938|21112894|P2|NOT COMPLETED|Overall Study||31
8564195|NCT00041938|21112895|P1|NOT COMPLETED|Overall Study||38
8564196|NCT00041938|21112894|P2|COMPLETED|Overall Study||1111
8564197|NCT00041938|21112895|P1|COMPLETED|Overall Study||1125
8564198|NCT00041938|21112894|P2|Withdrew Consent|Overall Study||14
8564199|NCT00041938|21112895|P1|Withdrew Consent|Overall Study||20
8564200|NCT00041938|21112894|P2|Lost to Follow-up|Overall Study||17
8564201|NCT00041938|21112895|P1|Lost to Follow-up|Overall Study||18
8564202|NCT00041938|21112894|P2|Only Vital Status Known|Overall Study||46
8564203|NCT00041938|21112895|P1|Only Vital Status Known|Overall Study||44
8564204|NCT00041938|21112894|P2|Primary Endpoint|Overall Study||302
8564205|NCT00041938|21112895|P1|Primary Endpoint|Overall Study||320
8564206|NCT00041938|21112894|P2|Completed Follow-up|Overall Study||745
8564207|NCT00041938|21112895|P1|Completed Follow-up|Overall Study||761
8564208|NCT00041938|21112894|P2|STARTED|Overall Study||1142
8564209|NCT00041938|21112895|P1|STARTED|Overall Study||1163
8564210|NCT00041756|21112928|P5|NOT COMPLETED|Overall Study||60
8564211|NCT00041756|21112929|P4|NOT COMPLETED|Overall Study||16
8564212|NCT00041756|21112930|P3|NOT COMPLETED|Overall Study||13
8564213|NCT00041756|21112931|P2|NOT COMPLETED|Overall Study||15
8564214|NCT00041756|21112932|P1|NOT COMPLETED|Overall Study||8
8564215|NCT00041756|21112928|P5|COMPLETED|Overall Study||19
8564216|NCT00041756|21112929|P4|COMPLETED|Overall Study||64
8564217|NCT00041756|21112930|P3|COMPLETED|Overall Study||66
8564218|NCT00041756|21112931|P2|COMPLETED|Overall Study||65
8564219|NCT00041756|21112932|P1|COMPLETED|Overall Study||69
8564220|NCT00041756|21112928|P5|STARTED|Overall Study||79
8564221|NCT00041756|21112929|P4|STARTED|Overall Study||80
8564222|NCT00041756|21112930|P3|STARTED|Overall Study||79
8564223|NCT00041756|21112931|P2|STARTED|Overall Study||80
8564224|NCT00041756|21112932|P1|STARTED|Overall Study||77
8564225|NCT00041717|21112951|P2|NOT COMPLETED|Overall Study||12
8564226|NCT00041717|21112952|P1|NOT COMPLETED|Overall Study||33
8564227|NCT00041717|21112951|P2|COMPLETED|Overall Study||86
8564228|NCT00041717|21112952|P1|COMPLETED|Overall Study||81
8564229|NCT00041717|21112951|P2|STARTED|Overall Study||98
8564230|NCT00041717|21112952|P1|STARTED|Overall Study||114
8564231|NCT00041470|21112960|P1|NOT COMPLETED|Overall Study||38
8564232|NCT00041470|21112960|P1|COMPLETED|Overall Study||0
8564233|NCT00041470|21112960|P1|STARTED|Overall Study||38
8564234|NCT00040664|21112965|P4|NOT COMPLETED|Overall Study||27
8564235|NCT00040664|21112966|P3|NOT COMPLETED|Overall Study||13
8564236|NCT00040664|21112967|P2|NOT COMPLETED|Overall Study||13
8564237|NCT00040664|21112968|P1|NOT COMPLETED|Overall Study||53
8564238|NCT00040664|21112965|P4|COMPLETED|Overall Study||8
8564239|NCT00040664|21112966|P3|COMPLETED|Overall Study||4
8564240|NCT00040664|21112967|P2|COMPLETED|Overall Study||4
8564241|NCT00040664|21112968|P1|COMPLETED|Overall Study||16
8564242|NCT00040664|21112965|P4|STARTED|Overall Study||35
8564243|NCT00040664|21112966|P3|STARTED|Overall Study||17
8564244|NCT00040664|21112967|P2|STARTED|Overall Study||17
8564245|NCT00040664|21112968|P1|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
8564246|NCT00041392|21113018|P2|NOT COMPLETED|Overall Study||0
8564247|NCT00041392|21113019|P1|NOT COMPLETED|Overall Study||0
8564248|NCT00041392|21113018|P2|COMPLETED|Overall Study||191
8564249|NCT00041392|21113019|P1|COMPLETED|Overall Study||198
8564250|NCT00041392|21113018|P2|STARTED|Overall Study||191
8564251|NCT00041392|21113019|P1|STARTED|Overall Study||198
8564252|NCT00040443|21113027|P2|NOT COMPLETED|Overall Study||0
8564253|NCT00040443|21113028|P1|NOT COMPLETED|Overall Study||0
8564254|NCT00040443|21113027|P2|COMPLETED|Overall Study||91
8564255|NCT00040443|21113028|P1|COMPLETED|Overall Study||84
8564256|NCT00040443|21113027|P2|STARTED|Overall Study||91
8564257|NCT00040443|21113028|P1|STARTED|Overall Study||84
8564258|NCT00040365|21113034|P1|NOT COMPLETED|Overall Study||11
8564259|NCT00040365|21113034|P1|COMPLETED|Overall Study||19
8564260|NCT00040365|21113034|P1|Completed Follow Up Phase|Overall Study||19
8564261|NCT00040365|21113034|P1|STARTED|Overall Study||30
8564262|NCT00039871|21113043|P1|NOT COMPLETED|Overall Study||1384
8564263|NCT00039871|21113043|P1|COMPLETED|Overall Study||928
8564264|NCT00039871|21113043|P1|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
8564265|NCT00039741|21113053|P4|NOT COMPLETED|Overall Study||14
8564266|NCT00039741|21113054|P3|NOT COMPLETED|Overall Study||11
8564267|NCT00039741|21113055|P2|NOT COMPLETED|Overall Study||12
8564268|NCT00039741|21113056|P1|NOT COMPLETED|Overall Study||15
8564269|NCT00039741|21113053|P4|COMPLETED|Overall Study||50
8564270|NCT00039741|21113054|P3|COMPLETED|Overall Study||54
8564271|NCT00039741|21113055|P2|COMPLETED|Overall Study||56
8564272|NCT00039741|21113056|P1|COMPLETED|Overall Study||51
8564273|NCT00039741|21113053|P4|Death|Overall Study||0
8564274|NCT00039741|21113054|P3|Death|Overall Study||0
8564275|NCT00039741|21113055|P2|Death|Overall Study||1
8564276|NCT00039741|21113056|P1|Death|Overall Study||0
8564277|NCT00039741|21113053|P4|STARTED|Overall Study||64
8564278|NCT00039741|21113054|P3|STARTED|Overall Study||65
8564279|NCT00039741|21113055|P2|STARTED|Overall Study||68
8564280|NCT00039741|21113056|P1|STARTED|Overall Study||66
8564281|NCT00038948|21113100|P2|NOT COMPLETED|Overall Study||77
8564282|NCT00038948|21113101|P1|NOT COMPLETED|Overall Study||169
8564283|NCT00038948|21113100|P2|COMPLETED|Overall Study||198
8564284|NCT00038948|21113101|P1|COMPLETED|Overall Study||386
8564285|NCT00038948|21113100|P2|STARTED|Overall Study||275
8564286|NCT00038948|21113101|P1|STARTED|Overall Study||555
8564287|NCT00038857|21113113|P1|NOT COMPLETED|Overall Study||1
8564288|NCT00038857|21113113|P1|COMPLETED|Overall Study||28
8564289|NCT00038857|21113113|P1|STARTED|Overall Study||29
8564311|NCT00038649|21113136|P1|NOT COMPLETED|Overall Study||9
8564312|NCT00038649|21113136|P1|COMPLETED|Overall Study||105
8564313|NCT00038649|21113136|P1|STARTED|Overall Study||114
8564314|NCT00038610|21113141|P1|NOT COMPLETED|Overall Study||0
8564315|NCT00038610|21113141|P1|COMPLETED|Overall Study||54
8564316|NCT00038610|21113141|P1|STARTED|Overall Study||54
8564317|NCT00038467|21113149|P2|NOT COMPLETED|Overall Study||542
8564318|NCT00038467|21113150|P1|NOT COMPLETED|Overall Study||542
8564319|NCT00038467|21113149|P2|COMPLETED|Overall Study||1830
8564320|NCT00038467|21113150|P1|COMPLETED|Overall Study||1810
8564321|NCT00038467|21113149|P2|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
8564322|NCT00038467|21113150|P1|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
8564323|NCT00038467|21113149|P2|STARTED|Overall Study||2372
8564324|NCT00038467|21113150|P1|STARTED|Overall Study||2352
8564325|NCT00038142|21113212|P2|NOT COMPLETED|Overall Study||7
8564326|NCT00038142|21113213|P1|NOT COMPLETED|Overall Study||22
8564327|NCT00038142|21113212|P2|COMPLETED|Overall Study||7
8564328|NCT00038142|21113213|P1|COMPLETED|Overall Study||10
8564329|NCT00038142|21113212|P2|STARTED|Overall Study||14
8564330|NCT00038142|21113213|P1|STARTED|Overall Study||32
8564331|NCT00038103|21113221|P2|NOT COMPLETED|Overall Study||56
8564332|NCT00038103|21113222|P1|NOT COMPLETED|Overall Study||55
8564333|NCT00038103|21113221|P2|COMPLETED|Overall Study||0
8564334|NCT00038103|21113222|P1|COMPLETED|Overall Study||0
8564335|NCT00038103|21113221|P2|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
8564336|NCT00038103|21113222|P1|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
8564337|NCT00038103|21113221|P2|STARTED|Overall Study||56
8564338|NCT00038103|21113222|P1|STARTED|Overall Study||55
8564339|NCT00037830|21113245|P3|NOT COMPLETED|Overall Study||1
8564340|NCT00037830|21113246|P2|NOT COMPLETED|Overall Study||7
8564341|NCT00037830|21113247|P1|NOT COMPLETED|Overall Study||10
8564342|NCT00037830|21113245|P3|COMPLETED|Overall Study||16
8564343|NCT00037830|21113246|P2|COMPLETED|Overall Study||31
8564344|NCT00037830|21113247|P1|COMPLETED|Overall Study||29
8564345|NCT00037830|21113245|P3|STARTED|Overall Study||17
8564346|NCT00037830|21113246|P2|STARTED|Overall Study||38
8564347|NCT00037830|21113247|P1|STARTED|Overall Study||39
8564348|NCT00036569|21113268|P1|NOT COMPLETED|Overall Study||0
8564349|NCT00036569|21113268|P1|COMPLETED|Overall Study||32
8564350|NCT00036569|21113268|P1|STARTED|Overall Study||32
8564351|NCT00036270|21113279|P2|NOT COMPLETED|Study Treatment to 5 Year Report||3488
8564352|NCT00036270|21113280|P1|NOT COMPLETED|Study Treatment to 5 Year Report||2565
8564353|NCT00036270|21113279|P2|COMPLETED|Study Treatment to 5 Year Report||1380
8564354|NCT00036270|21113280|P1|COMPLETED|Study Treatment to 5 Year Report||2333
8564355|NCT00036270|21113279|P2|Treated|Study Treatment to 5 Year Report||4814
8564356|NCT00036270|21113280|P1|Treated|Study Treatment to 5 Year Report||4852
8564357|NCT00036270|21113279|P2|STARTED|Study Treatment to 5 Year Report||4868
8564358|NCT00036270|21113280|P1|STARTED|Study Treatment to 5 Year Report||4898
8564359|NCT00036270|21113279|P2|NOT COMPLETED|Randomized to Study Treatment||7
8564360|NCT00036270|21113280|P1|NOT COMPLETED|Randomized to Study Treatment||6
8564361|NCT00036270|21113279|P2|COMPLETED|Randomized to Study Treatment||4868
8564362|NCT00036270|21113280|P1|COMPLETED|Randomized to Study Treatment||4898
8564363|NCT00036270|21113279|P2|STARTED|Randomized to Study Treatment||4875
8564364|NCT00036270|21113280|P1|STARTED|Randomized to Study Treatment||4904
8564365|NCT00035932|21113299|P3|NOT COMPLETED|Overall Study||49
8564366|NCT00035932|21113300|P2|NOT COMPLETED|Overall Study||60
8564367|NCT00035932|21113301|P1|NOT COMPLETED|Overall Study||56
8564368|NCT00035932|21113299|P3|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
8564369|NCT00035932|21113300|P2|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
8564370|NCT00035932|21113301|P1|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
8564371|NCT00035932|21113299|P3|Discontinued on or After Week 96|Overall Study||6
8564372|NCT00035932|21113300|P2|Discontinued on or After Week 96|Overall Study||4
8564373|NCT00035932|21113301|P1|Discontinued on or After Week 96|Overall Study||4
8564374|NCT00035932|21113299|P3|Discontinued Between Weeks 48 and 96|Overall Study||30
8564375|NCT00035932|21113300|P2|Discontinued Between Weeks 48 and 96|Overall Study||27
8564376|NCT00035932|21113301|P1|Discontinued Between Weeks 48 and 96|Overall Study||26
8564377|NCT00035932|21113299|P3|Discontinued Prior to Week 48 Visit|Overall Study||13
8564378|NCT00035932|21113300|P2|Discontinued Prior to Week 48 Visit|Overall Study||29
8564379|NCT00035932|21113301|P1|Discontinued Prior to Week 48 Visit|Overall Study||26
8564380|NCT00035932|21113299|P3|STARTED|Overall Study|123 randomized, 118 treated|118
8564381|NCT00035932|21113300|P2|STARTED|Overall Study|115 randomized, 110 treated|110
8564382|NCT00035932|21113301|P1|STARTED|Overall Study|120 randomized, 119 treated|119
8564383|NCT00035815|21113427|P2|NOT COMPLETED|Overall Study||11
8564384|NCT00035815|21113428|P1|NOT COMPLETED|Overall Study||17
8564385|NCT00035815|21113427|P2|COMPLETED|Overall Study||152
8564386|NCT00035815|21113428|P1|COMPLETED|Overall Study||150
8564387|NCT00035815|21113427|P2|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
8564388|NCT00035815|21113428|P1|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
8564389|NCT00035555|21113441|P3|NOT COMPLETED|Overall Study||22
8564390|NCT00035555|21113442|P2|NOT COMPLETED|Overall Study||16
8564391|NCT00035555|21113443|P1|NOT COMPLETED|Overall Study||16
8564392|NCT00035555|21113441|P3|COMPLETED|Overall Study||51
8564393|NCT00035555|21113442|P2|COMPLETED|Overall Study||55
8564394|NCT00035555|21113443|P1|COMPLETED|Overall Study||58
8564395|NCT00035555|21113441|P3|Number Who Received Study Drug|Overall Study||71
8564396|NCT00035555|21113442|P2|Number Who Received Study Drug|Overall Study||71
8564397|NCT00035555|21113443|P1|Number Who Received Study Drug|Overall Study||74
8564398|NCT00035555|21113441|P3|Number Who Had Undergone Transplantation|Overall Study||73
8564399|NCT00035555|21113442|P2|Number Who Had Undergone Transplantation|Overall Study||71
8564400|NCT00035555|21113443|P1|Number Who Had Undergone Transplantation|Overall Study||74
8564401|NCT00035555|21113441|P3|STARTED|Overall Study|Randomized patients|73
8564402|NCT00035555|21113442|P2|STARTED|Overall Study|Randomized patients|71
8564403|NCT00035555|21113443|P1|STARTED|Overall Study|Randomized patients|74
8564404|NCT00033917|21113486|P2|NOT COMPLETED|Overall Study||0
8564405|NCT00033917|21113487|P1|NOT COMPLETED|Overall Study||0
8564406|NCT00033917|21113486|P2|COMPLETED|Overall Study||222
8564407|NCT00033917|21113487|P1|COMPLETED|Overall Study||209
8564408|NCT00033917|21113486|P2|STARTED|Overall Study||222
8564409|NCT00033917|21113487|P1|STARTED|Overall Study||209
8564410|NCT00032630|21113499|P2|NOT COMPLETED|Overall Study||43
8564411|NCT00032630|21113500|P1|NOT COMPLETED|Overall Study||49
8564412|NCT00032630|21113499|P2|COMPLETED|Overall Study||1061
8564413|NCT00032630|21113500|P1|COMPLETED|Overall Study||1050
8564414|NCT00032630|21113499|P2|STARTED|Overall Study||1104
8564415|NCT00032630|21113500|P1|STARTED|Overall Study||1099
8564416|NCT00032591|21113510|P2|NOT COMPLETED|Follow-up||5
8564417|NCT00032591|21113511|P1|NOT COMPLETED|Follow-up||2
8564418|NCT00032591|21113510|P2|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
8564419|NCT00032591|21113511|P1|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
8564420|NCT00032591|21113510|P2|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
8564421|NCT00032591|21113511|P1|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
8564422|NCT00032591|21113510|P2|NOT COMPLETED|Randomization||0
8564423|NCT00032591|21113511|P1|NOT COMPLETED|Randomization||0
8564424|NCT00032591|21113510|P2|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
8564425|NCT00032591|21113511|P1|COMPLETED|Randomization|1465 were assigned to self-testing|1465
8564426|NCT00032591|21113510|P2|STARTED|Randomization||1457
8564427|NCT00032591|21113511|P1|STARTED|Randomization|2922 underwent randomization|1465
8564428|NCT00032591|21113510|P2|NOT COMPLETED|Screening||415
8564429|NCT00032591|21113511|P1|NOT COMPLETED|Screening||408
8564430|NCT00032591|21113510|P2|COMPLETED|Screening||1457
8564431|NCT00032591|21113511|P1|COMPLETED|Screening|823 were excluded from the study|1465
8564432|NCT00032591|21113510|P2|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
8564433|NCT00032591|21113511|P1|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
8564434|NCT00032487|21113527|P2|NOT COMPLETED|Overall Study||120
8564435|NCT00032487|21113528|P1|NOT COMPLETED|Overall Study||139
8564436|NCT00032487|21113527|P2|COMPLETED|Overall Study||772
8564437|NCT00032487|21113528|P1|COMPLETED|Overall Study||760
8564438|NCT00032487|21113527|P2|STARTED|Overall Study||892
8564439|NCT00032487|21113528|P1|STARTED|Overall Study||899
8564440|NCT00031551|21113538|P2|NOT COMPLETED|Overall Study||0
8564441|NCT00031551|21113539|P1|NOT COMPLETED|Overall Study||2
8564442|NCT00031551|21113538|P2|COMPLETED|Overall Study||25
8564443|NCT00031551|21113539|P1|COMPLETED|Overall Study||0
8564444|NCT00031551|21113538|P2|STARTED|Overall Study||25
8564445|NCT00031551|21113539|P1|STARTED|Overall Study||2
8564446|NCT00031486|21113551|P2|NOT COMPLETED|Overall Study||12
8564447|NCT00031486|21113552|P1|NOT COMPLETED|Overall Study||7
8564448|NCT00031486|21113551|P2|COMPLETED|Overall Study||35
8564449|NCT00031486|21113552|P1|COMPLETED|Overall Study||33
8564450|NCT00031486|21113551|P2|STARTED|Overall Study||47
8564451|NCT00031486|21113552|P1|STARTED|Overall Study||40
8564452|NCT00031460|21113578|P2|NOT COMPLETED|Overall Study||14
8564453|NCT00031460|21113579|P1|NOT COMPLETED|Overall Study||9
8564454|NCT00031460|21113578|P2|COMPLETED|Overall Study||8
8564455|NCT00031460|21113579|P1|COMPLETED|Overall Study||15
8564456|NCT00031460|21113578|P2|STARTED|Overall Study||22
8564457|NCT00031460|21113579|P1|STARTED|Overall Study||24
8564458|NCT00031447|21113593|P2|NOT COMPLETED|Overall Study||7
8564459|NCT00031447|21113594|P1|NOT COMPLETED|Overall Study||10
8564460|NCT00031447|21113593|P2|COMPLETED|Overall Study||8
8564461|NCT00031447|21113594|P1|COMPLETED|Overall Study||4
8564462|NCT00031447|21113593|P2|STARTED|Overall Study||15
8564463|NCT00031447|21113594|P1|STARTED|Overall Study||14
8564464|NCT00030992|21113606|P1|NOT COMPLETED|Overall Study||0
8564465|NCT00030992|21113606|P1|COMPLETED|Overall Study||102
8564466|NCT00030992|21113606|P1|STARTED|Overall Study||102
8564467|NCT00030147|21113615|P4|NOT COMPLETED|Overall Study||0
8564468|NCT00030147|21113616|P3|NOT COMPLETED|Overall Study||0
8564469|NCT00030147|21113617|P2|NOT COMPLETED|Overall Study||1
8564470|NCT00030147|21113618|P1|NOT COMPLETED|Overall Study||0
8564471|NCT00030147|21113615|P4|COMPLETED|Overall Study||11
8564472|NCT00030147|21113616|P3|COMPLETED|Overall Study||16
8564473|NCT00030147|21113617|P2|COMPLETED|Overall Study||18
8564474|NCT00030147|21113618|P1|COMPLETED|Overall Study||17
8564475|NCT00030147|21113615|P4|STARTED|Overall Study||11
8564476|NCT00030147|21113616|P3|STARTED|Overall Study||16
8564477|NCT00030147|21113617|P2|STARTED|Overall Study||19
8564478|NCT00030147|21113618|P1|STARTED|Overall Study||17
8564479|NCT00029536|21113636|P4|NOT COMPLETED|Overall Study||0
8564480|NCT00029536|21113637|P3|NOT COMPLETED|Overall Study||0
8564481|NCT00029536|21113638|P2|NOT COMPLETED|Overall Study||0
8564482|NCT00029536|21113639|P1|NOT COMPLETED|Overall Study||0
8564483|NCT00029536|21113636|P4|COMPLETED|Overall Study||59
8564484|NCT00029536|21113637|P3|COMPLETED|Overall Study||105
8564485|NCT00029536|21113638|P2|COMPLETED|Overall Study||45
8564486|NCT00029536|21113639|P1|COMPLETED|Overall Study||85
8564487|NCT00029536|21113636|P4|STARTED|Overall Study||59
8564488|NCT00029536|21113637|P3|STARTED|Overall Study||105
8564489|NCT00029536|21113638|P2|STARTED|Overall Study||45
8564490|NCT00029536|21113639|P1|STARTED|Overall Study||85
8564491|NCT00029172|21113663|P1|NOT COMPLETED|Overall Study||6
8564492|NCT00029172|21113663|P1|COMPLETED|Overall Study||182
8564493|NCT00029172|21113663|P1|STARTED|Overall Study||188
8564494|NCT00029146|21113669|P2|NOT COMPLETED|Overall Study||1
8564495|NCT00029146|21113670|P1|NOT COMPLETED|Overall Study||2
8564496|NCT00029146|21113669|P2|COMPLETED|Overall Study||97
8564497|NCT00029146|21113670|P1|COMPLETED|Overall Study||95
8564498|NCT00029146|21113669|P2|STARTED|Overall Study||98
8564499|NCT00029146|21113670|P1|STARTED|Overall Study||97
8564500|NCT00029107|21113699|P2|NOT COMPLETED|Overall Study||0
8564501|NCT00029107|21113700|P1|NOT COMPLETED|Overall Study||0
8564502|NCT00029107|21113699|P2|COMPLETED|Overall Study||12
8564503|NCT00029107|21113700|P1|COMPLETED|Overall Study||12
8564504|NCT00029107|21113699|P2|STARTED|Overall Study||12
8564505|NCT00029107|21113700|P1|STARTED|Overall Study||12
8564506|NCT00028262|21113706|P1|NOT COMPLETED|Overall Study||1
8564507|NCT00028262|21113706|P1|COMPLETED|Overall Study||9
8564508|NCT00028262|21113706|P1|STARTED|Overall Study||10
8564509|NCT00028093|21113712|P2|NOT COMPLETED|Overall Study||0
8564510|NCT00028093|21113713|P1|NOT COMPLETED|Overall Study||0
8564511|NCT00028093|21113712|P2|COMPLETED|Overall Study||25
8564512|NCT00028093|21113713|P1|COMPLETED|Overall Study||25
8564513|NCT00028093|21113712|P2|STARTED|Overall Study||25
8564514|NCT00028093|21113713|P1|STARTED|Overall Study||25
8564515|NCT00027378|21113721|P2|NOT COMPLETED|Overall Study||3
8564516|NCT00027378|21113722|P1|NOT COMPLETED|Overall Study||0
8564517|NCT00027378|21113721|P2|COMPLETED|Overall Study||23
8564518|NCT00027378|21113722|P1|COMPLETED|Overall Study||24
8564519|NCT00027378|21113721|P2|STARTED|Overall Study||26
8564520|NCT00027378|21113722|P1|STARTED|Overall Study||24
8564521|NCT00027027|21113735|P5|NOT COMPLETED|Overall Study||8
8564522|NCT00027027|21113736|P4|NOT COMPLETED|Overall Study||3
8564523|NCT00027027|21113737|P3|NOT COMPLETED|Overall Study||4
8564524|NCT00027027|21113738|P2|NOT COMPLETED|Overall Study||3
8564525|NCT00027027|21113739|P1|NOT COMPLETED|Overall Study||3
8564526|NCT00027027|21113735|P5|COMPLETED|Overall Study||0
8564527|NCT00027027|21113736|P4|COMPLETED|Overall Study||0
8564528|NCT00027027|21113737|P3|COMPLETED|Overall Study||0
8564529|NCT00027027|21113738|P2|COMPLETED|Overall Study||0
8564530|NCT00027027|21113739|P1|COMPLETED|Overall Study||0
8564531|NCT00027027|21113735|P5|Treated Beyond Cycle 2|Overall Study||4
8564532|NCT00027027|21113736|P4|Treated Beyond Cycle 2|Overall Study||2
8564533|NCT00027027|21113737|P3|Treated Beyond Cycle 2|Overall Study||2
8564534|NCT00027027|21113738|P2|Treated Beyond Cycle 2|Overall Study||1
8564535|NCT00027027|21113739|P1|Treated Beyond Cycle 2|Overall Study||1
8564536|NCT00027027|21113735|P5|Discontinued at Cycle 2|Overall Study||3
8564537|NCT00027027|21113736|P4|Discontinued at Cycle 2|Overall Study||1
8564538|NCT00027027|21113737|P3|Discontinued at Cycle 2|Overall Study||1
8564539|NCT00027027|21113738|P2|Discontinued at Cycle 2|Overall Study||2
8564540|NCT00027027|21113739|P1|Discontinued at Cycle 2|Overall Study||2
8564541|NCT00027027|21113735|P5|Completed 2 Cycles of Treatment|Overall Study||7
8564542|NCT00027027|21113736|P4|Completed 2 Cycles of Treatment|Overall Study||3
8564543|NCT00027027|21113737|P3|Completed 2 Cycles of Treatment|Overall Study||3
8564544|NCT00027027|21113738|P2|Completed 2 Cycles of Treatment|Overall Study||3
8564545|NCT00027027|21113739|P1|Completed 2 Cycles of Treatment|Overall Study||3
8564546|NCT00027027|21113735|P5|Discontinued Before 2 Treatment Cycles|Overall Study||1
8564547|NCT00027027|21113736|P4|Discontinued Before 2 Treatment Cycles|Overall Study||0
8564548|NCT00027027|21113737|P3|Discontinued Before 2 Treatment Cycles|Overall Study||1
8564549|NCT00027027|21113738|P2|Discontinued Before 2 Treatment Cycles|Overall Study||0
8564550|NCT00027027|21113739|P1|Discontinued Before 2 Treatment Cycles|Overall Study||0
8564551|NCT00027027|21113735|P5|STARTED|Overall Study||8
8564552|NCT00027027|21113736|P4|STARTED|Overall Study||3
8564553|NCT00027027|21113737|P3|STARTED|Overall Study||4
8564554|NCT00027027|21113738|P2|STARTED|Overall Study||3
8564555|NCT00027027|21113739|P1|STARTED|Overall Study||3
8564556|NCT00026793|21113784|P1|NOT COMPLETED|Overall Study||8
8564557|NCT00026793|21113784|P1|COMPLETED|Overall Study||21
8564558|NCT00026793|21113784|P1|STARTED|Overall Study||29
8564559|NCT00025883|21113794|P1|NOT COMPLETED|Overall Study||17
8564560|NCT00025883|21113794|P1|COMPLETED|Overall Study||86
8564561|NCT00025883|21113794|P1|Partial Lipodystrophy|Overall Study||40
8564562|NCT00025883|21113794|P1|Generalized Lipodystrophy|Overall Study||63
8564563|NCT00025883|21113794|P1|STARTED|Overall Study||103
8564564|NCT00023595|21113806|P5|NOT COMPLETED|10 Year Follow up||0
8564565|NCT00023595|21113807|P4|NOT COMPLETED|10 Year Follow up||0
8564566|NCT00023595|21113808|P3|NOT COMPLETED|10 Year Follow up||3
8564567|NCT00023595|21113809|P2|NOT COMPLETED|10 Year Follow up||10
8564568|NCT00023595|21113810|P1|NOT COMPLETED|10 Year Follow up||12
8564569|NCT00023595|21113806|P5|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8564570|NCT00023595|21113807|P4|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8564571|NCT00023595|21113808|P3|COMPLETED|10 Year Follow up||73
8564572|NCT00023595|21113809|P2|COMPLETED|10 Year Follow up||524
8564573|NCT00023595|21113810|P1|COMPLETED|10 Year Follow up||590
8564574|NCT00023595|21113806|P5|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8564575|NCT00023595|21113807|P4|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
8564576|NCT00023595|21113808|P3|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
8564577|NCT00023595|21113809|P2|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
8564578|NCT00023595|21113810|P1|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
8564579|NCT00023595|21113806|P5|NOT COMPLETED|5 Year Follow up||3
8564580|NCT00023595|21113807|P4|NOT COMPLETED|5 Year Follow up||7
8564581|NCT00023595|21113808|P3|NOT COMPLETED|5 Year Follow up||1
8564582|NCT00023595|21113809|P2|NOT COMPLETED|5 Year Follow up||2
8564583|NCT00023595|21113810|P1|NOT COMPLETED|5 Year Follow up||2
8564584|NCT00023595|21113806|P5|COMPLETED|5 Year Follow up||498
8564585|NCT00023595|21113807|P4|COMPLETED|5 Year Follow up||416
8564586|NCT00023595|21113808|P3|COMPLETED|5 Year Follow up||75
8564587|NCT00023595|21113809|P2|COMPLETED|5 Year Follow up||532
8564588|NCT00023595|21113810|P1|COMPLETED|5 Year Follow up||600
8564589|NCT00023595|21113806|P5|STARTED|5 Year Follow up||501
8564590|NCT00023595|21113807|P4|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
8564591|NCT00023595|21113808|P3|STARTED|5 Year Follow up||76
8564592|NCT00023595|21113809|P2|STARTED|5 Year Follow up||534
8564593|NCT00023595|21113810|P1|STARTED|5 Year Follow up||602
8564594|NCT00023452|21114021|P2|NOT COMPLETED|Overall Study||872
8564595|NCT00023452|21114022|P1|NOT COMPLETED|Overall Study||1323
8564596|NCT00023452|21114021|P2|COMPLETED|Overall Study||3273
8564597|NCT00023452|21114022|P1|COMPLETED|Overall Study||2585
8564598|NCT00023452|21114021|P2|Completed Study|Overall Study||3475
8564599|NCT00023452|21114022|P1|Completed Study|Overall Study||3174
8564600|NCT00023452|21114021|P2|Not Treated|Overall Study||105
8564601|NCT00023452|21114022|P1|Not Treated|Overall Study||149
8564602|NCT00023452|21114021|P2|Completed Treatment|Overall Study||3273
8564603|NCT00023452|21114022|P1|Completed Treatment|Overall Study||2585
8564604|NCT00023452|21114021|P2|Enrolled as Part of a Cluster|Overall Study||971
8564605|NCT00023452|21114022|P1|Enrolled as Part of a Cluster|Overall Study||718
8564606|NCT00023452|21114021|P2|Randomized|Overall Study||3174
8564607|NCT00023452|21114022|P1|Randomized|Overall Study||3190
8564608|NCT00023452|21114021|P2|STARTED|Overall Study||4145
8564609|NCT00023452|21114022|P1|STARTED|Overall Study||3908
8564610|NCT00023322|21114046|P1|NOT COMPLETED|Overall Study||1
8564611|NCT00023322|21114046|P1|COMPLETED|Overall Study||12
8564612|NCT00023322|21114046|P1|STARTED|Overall Study||13
8564613|NCT00023309|21114053|P2|NOT COMPLETED|Overall Study||0
8564614|NCT00023309|21114054|P1|NOT COMPLETED|Overall Study||0
8564615|NCT00023309|21114053|P2|COMPLETED|Overall Study||19
8564616|NCT00023309|21114054|P1|COMPLETED|Overall Study||22
8564617|NCT00023309|21114053|P2|STARTED|Overall Study||19
8564618|NCT00023309|21114054|P1|STARTED|Overall Study||22
8564619|NCT00022763|21114070|P2|NOT COMPLETED|Overall Study||17
8564620|NCT00022763|21114071|P1|NOT COMPLETED|Overall Study||9
8564621|NCT00022763|21114070|P2|COMPLETED|Overall Study||11
8564622|NCT00022763|21114071|P1|COMPLETED|Overall Study||15
8564623|NCT00022763|21114070|P2|STARTED|Overall Study||28
8564624|NCT00022763|21114071|P1|STARTED|Overall Study||24
8564625|NCT00016718|21114097|P3|NOT COMPLETED|Overall Study||0
8564626|NCT00016718|21114098|P2|NOT COMPLETED|Overall Study||0
8564627|NCT00016718|21114099|P1|NOT COMPLETED|Overall Study||0
8564628|NCT00016718|21114097|P3|COMPLETED|Overall Study||16
8564629|NCT00016718|21114098|P2|COMPLETED|Overall Study||21
8564630|NCT00016718|21114099|P1|COMPLETED|Overall Study||6
8564631|NCT00016718|21114097|P3|STARTED|Overall Study||16
8564632|NCT00016718|21114098|P2|STARTED|Overall Study||21
8564633|NCT00016718|21114099|P1|STARTED|Overall Study||6
8564634|NCT00014911|21114113|P1|NOT COMPLETED|Overall Study||11
8564635|NCT00014911|21114113|P1|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
8564636|NCT00014911|21114113|P1|STARTED|Overall Study||36
8564637|NCT00006604|21114129|P17|NOT COMPLETED|Overall Study||9
8564638|NCT00006604|21114130|P16|NOT COMPLETED|Overall Study||5
8564639|NCT00006604|21114131|P15|NOT COMPLETED|Overall Study||10
8564640|NCT00006604|21114132|P14|NOT COMPLETED|Overall Study||6
8564641|NCT00006604|21114133|P13|NOT COMPLETED|Overall Study||4
8564642|NCT00006604|21114134|P12|NOT COMPLETED|Overall Study||6
8564643|NCT00006604|21114135|P11|NOT COMPLETED|Overall Study||8
8564644|NCT00006604|21114136|P10|NOT COMPLETED|Overall Study||19
8564645|NCT00006604|21114137|P9|NOT COMPLETED|Overall Study||1
8564646|NCT00006604|21114138|P8|NOT COMPLETED|Overall Study||3
8564647|NCT00006604|21114139|P7|NOT COMPLETED|Overall Study||9
8564648|NCT00006604|21114140|P6|NOT COMPLETED|Overall Study||3
8564649|NCT00006604|21114141|P5|NOT COMPLETED|Overall Study||2
8564650|NCT00006604|21114142|P4|NOT COMPLETED|Overall Study||5
8564651|NCT00006604|21114143|P3|NOT COMPLETED|Overall Study||4
8564652|NCT00006604|21114144|P2|NOT COMPLETED|Overall Study||0
8564653|NCT00006604|21114145|P1|NOT COMPLETED|Overall Study||2
8564654|NCT00006604|21114129|P17|COMPLETED|Overall Study||6
8564655|NCT00006604|21114130|P16|COMPLETED|Overall Study||1
8564656|NCT00006604|21114131|P15|COMPLETED|Overall Study||14
8564657|NCT00006604|21114132|P14|COMPLETED|Overall Study||0
8564658|NCT00006604|21114133|P13|COMPLETED|Overall Study||22
8564659|NCT00006604|21114134|P12|COMPLETED|Overall Study||6
8564660|NCT00006604|21114135|P11|COMPLETED|Overall Study||13
8564661|NCT00006604|21114136|P10|COMPLETED|Overall Study||6
8564662|NCT00006604|21114137|P9|COMPLETED|Overall Study||4
8564663|NCT00006604|21114138|P8|COMPLETED|Overall Study||2
8564664|NCT00006604|21114139|P7|COMPLETED|Overall Study||12
8564665|NCT00006604|21114140|P6|COMPLETED|Overall Study||2
8564666|NCT00006604|21114141|P5|COMPLETED|Overall Study||3
8564667|NCT00006604|21114142|P4|COMPLETED|Overall Study||1
8564668|NCT00006604|21114143|P3|COMPLETED|Overall Study||1
8564669|NCT00006604|21114144|P2|COMPLETED|Overall Study||2
8564670|NCT00006604|21114145|P1|COMPLETED|Overall Study||4
8564671|NCT00006604|21114129|P17|STARTED|Overall Study||15
8564672|NCT00006604|21114130|P16|STARTED|Overall Study||6
8564673|NCT00006604|21114131|P15|STARTED|Overall Study||24
8564674|NCT00006604|21114132|P14|STARTED|Overall Study||6
8564675|NCT00006604|21114133|P13|STARTED|Overall Study||26
8564676|NCT00006604|21114134|P12|STARTED|Overall Study||12
8564677|NCT00006604|21114135|P11|STARTED|Overall Study||21
8564678|NCT00006604|21114136|P10|STARTED|Overall Study||25
8564679|NCT00006604|21114137|P9|STARTED|Overall Study||5
8564680|NCT00006604|21114138|P8|STARTED|Overall Study||5
8564681|NCT00006604|21114139|P7|STARTED|Overall Study||21
8564682|NCT00006604|21114140|P6|STARTED|Overall Study||5
8564683|NCT00006604|21114141|P5|STARTED|Overall Study||5
8564684|NCT00006604|21114142|P4|STARTED|Overall Study||6
8564685|NCT00006604|21114143|P3|STARTED|Overall Study||5
8564686|NCT00006604|21114144|P2|STARTED|Overall Study||2
8564687|NCT00006604|21114145|P1|STARTED|Overall Study||6
8564688|NCT00004978|21114261|P2|NOT COMPLETED|Overall Study||270
8564689|NCT00004978|21114262|P1|NOT COMPLETED|Overall Study||244
8564690|NCT00004978|21114261|P2|COMPLETED|Overall Study||1790
8564691|NCT00004978|21114262|P1|COMPLETED|Overall Study||1846
8564692|NCT00004978|21114261|P2|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
8564693|NCT00004978|21114262|P1|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
8564694|NCT00021541|21114288|P2|NOT COMPLETED|Period 2-crossover||11
8564695|NCT00021541|21114289|P1|NOT COMPLETED|Period 2-crossover||10
8564696|NCT00021541|21114288|P2|COMPLETED|Period 2-crossover||12
8564697|NCT00021541|21114289|P1|COMPLETED|Period 2-crossover||10
8564698|NCT00021541|21114288|P2|STARTED|Period 2-crossover||23
8564699|NCT00021541|21114289|P1|STARTED|Period 2-crossover||20
8564700|NCT00021541|21114288|P2|NOT COMPLETED|Period 1-First Treatment||8
8564701|NCT00021541|21114289|P1|NOT COMPLETED|Period 1-First Treatment||11
8564702|NCT00021541|21114288|P2|COMPLETED|Period 1-First Treatment||23
8564703|NCT00021541|21114289|P1|COMPLETED|Period 1-First Treatment||20
8564704|NCT00021541|21114288|P2|Ineligible Patients|Period 1-First Treatment||2
8564705|NCT00021541|21114289|P1|Ineligible Patients|Period 1-First Treatment||0
8564706|NCT00021541|21114288|P2|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
8564707|NCT00021541|21114289|P1|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
8564708|NCT00021541|21114288|P2|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
8564709|NCT00021541|21114289|P1|STARTED|Period 1-First Treatment||31
8564710|NCT00018031|21114299|P1|NOT COMPLETED|Overall Study||0
8564711|NCT00018031|21114299|P1|COMPLETED|Overall Study||36
8564712|NCT00018031|21114299|P1|STARTED|Overall Study||36
8564713|NCT00015457|21114303|P2|NOT COMPLETED|Second Intervention||0
8564714|NCT00015457|21114304|P1|NOT COMPLETED|Second Intervention||1
8564715|NCT00015457|21114303|P2|COMPLETED|Second Intervention||5
8564716|NCT00015457|21114304|P1|COMPLETED|Second Intervention||7
8564717|NCT00015457|21114303|P2|STARTED|Second Intervention||5
8564718|NCT00015457|21114304|P1|STARTED|Second Intervention||8
8564719|NCT00015457|21114303|P2|NOT COMPLETED|First Intervention||3
8564720|NCT00015457|21114304|P1|NOT COMPLETED|First Intervention||0
8564721|NCT00015457|21114303|P2|COMPLETED|First Intervention||5
8564722|NCT00015457|21114304|P1|COMPLETED|First Intervention||8
8564723|NCT00015457|21114303|P2|STARTED|First Intervention||8
8564724|NCT00015457|21114304|P1|STARTED|First Intervention||8
8564725|NCT00013611|21114314|P2|NOT COMPLETED|Overall Study||100
8564726|NCT00013611|21114315|P1|NOT COMPLETED|Overall Study||91
8564727|NCT00013611|21114314|P2|COMPLETED|Overall Study||746
8564728|NCT00013611|21114315|P1|COMPLETED|Overall Study||758
8564729|NCT00013611|21114314|P2|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
8564730|NCT00013611|21114315|P1|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
8564731|NCT00010803|21114333|P2|NOT COMPLETED|Overall Study||98
8564732|NCT00010803|21114334|P1|NOT COMPLETED|Overall Study||97
8564733|NCT00010803|21114333|P2|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
8564734|NCT00010803|21114334|P1|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
8564735|NCT00010803|21114333|P2|STARTED|Overall Study|Randomized|1524
8564736|NCT00010803|21114334|P1|STARTED|Overall Study|Randomized|1545
8564737|NCT00010439|21114344|P1|NOT COMPLETED|Overall Study||0
8564738|NCT00010439|21114344|P1|COMPLETED|Overall Study||10
8564739|NCT00010439|21114344|P1|6 Months|Overall Study||10
8564740|NCT00010439|21114344|P1|STARTED|Overall Study||10
8564741|NCT00010374|21114349|P1|NOT COMPLETED|Overall Study||1
8564742|NCT00010374|21114349|P1|COMPLETED|Overall Study|One compassionate use participant was withheld from analysis per FDA instructions|53
8564743|NCT00010374|21114349|P1|STARTED|Overall Study||54
8564744|NCT00007644|21114357|P2|NOT COMPLETED|Overall Study||0
8564745|NCT00007644|21114358|P1|NOT COMPLETED|Overall Study||0
8564746|NCT00007644|21114357|P2|COMPLETED|Overall Study||367
8564747|NCT00007644|21114358|P1|COMPLETED|Overall Study||364
8564748|NCT00007644|21114357|P2|STARTED|Overall Study||367
8564749|NCT00007644|21114358|P1|STARTED|Overall Study||364
8564750|NCT00007475|21114367|P4|NOT COMPLETED|Overall Study||0
8564751|NCT00007475|21114368|P3|NOT COMPLETED|Overall Study||0
8564752|NCT00007475|21114369|P2|NOT COMPLETED|Overall Study||0
8564753|NCT00007475|21114370|P1|NOT COMPLETED|Overall Study||4
8564754|NCT00007475|21114367|P4|COMPLETED|Overall Study||0
8564755|NCT00007475|21114368|P3|COMPLETED|Overall Study||2
8564756|NCT00007475|21114369|P2|COMPLETED|Overall Study||1
8564757|NCT00007475|21114370|P1|COMPLETED|Overall Study||8
8564758|NCT00007475|21114367|P4|Initiate Cyclophosphamide|Overall Study||0
8564759|NCT00007475|21114368|P3|Initiate Cyclophosphamide|Overall Study||2
8564760|NCT00007475|21114369|P2|Initiate Cyclophosphamide|Overall Study||1
8564761|NCT00007475|21114370|P1|Initiate Cyclophosphamide|Overall Study||12
8564762|NCT00007475|21114367|P4|Initial Plasma Exchange|Overall Study||0
8564763|NCT00007475|21114368|P3|Initial Plasma Exchange|Overall Study||2
8564764|NCT00007475|21114369|P2|Initial Plasma Exchange|Overall Study||1
8564765|NCT00007475|21114370|P1|Initial Plasma Exchange|Overall Study||12
8564766|NCT00007475|21114367|P4|Post-initial Transplant Proteinuria|Overall Study||0
8564767|NCT00007475|21114368|P3|Post-initial Transplant Proteinuria|Overall Study||2
8564768|NCT00007475|21114369|P2|Post-initial Transplant Proteinuria|Overall Study||1
8564769|NCT00007475|21114370|P1|Post-initial Transplant Proteinuria|Overall Study||12
8564770|NCT00007475|21114367|P4|Initial Transplant|Overall Study||0
8564771|NCT00007475|21114368|P3|Initial Transplant|Overall Study||2
8564772|NCT00007475|21114369|P2|Initial Transplant|Overall Study||1
8564773|NCT00007475|21114370|P1|Initial Transplant|Overall Study||12
8564774|NCT00007475|21114367|P4|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
8564775|NCT00007475|21114368|P3|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
8564776|NCT00007475|21114369|P2|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
8564777|NCT00007475|21114370|P1|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
8564778|NCT00007475|21114367|P4|STARTED|Overall Study||0
8564779|NCT00007475|21114368|P3|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
8564780|NCT00007475|21114369|P2|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
8564781|NCT00007475|21114370|P1|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
8564782|NCT00007345|21114392|P2|NOT COMPLETED|Overall Study||11
8564783|NCT00007345|21114393|P1|NOT COMPLETED|Overall Study||2
8564784|NCT00007345|21114392|P2|COMPLETED|Overall Study||73
8564785|NCT00007345|21114393|P1|COMPLETED|Overall Study||45
8564786|NCT00007345|21114392|P2|STARTED|Overall Study||84
8564787|NCT00007345|21114393|P1|STARTED|Overall Study||47
8564788|NCT00007020|21114411|P1|NOT COMPLETED|Overall Study||44
8564789|NCT00007020|21114411|P1|COMPLETED|Overall Study||41
8564790|NCT00007020|21114411|P1|STARTED|Overall Study||85
8564791|NCT00006489|21114424|P4|NOT COMPLETED|Overall Study||11
8564792|NCT00006489|21114425|P3|NOT COMPLETED|Overall Study||15
8564793|NCT00006489|21114426|P2|NOT COMPLETED|Overall Study||14
8564794|NCT00006489|21114427|P1|NOT COMPLETED|Overall Study||13
8564795|NCT00006489|21114424|P4|COMPLETED|Overall Study||32
8564796|NCT00006489|21114425|P3|COMPLETED|Overall Study||25
8564797|NCT00006489|21114426|P2|COMPLETED|Overall Study||26
8564798|NCT00006489|21114427|P1|COMPLETED|Overall Study||29
8564799|NCT00006489|21114424|P4|STARTED|Overall Study||43
8564800|NCT00006489|21114425|P3|STARTED|Overall Study||40
8564801|NCT00006489|21114426|P2|STARTED|Overall Study||40
8564802|NCT00006489|21114427|P1|STARTED|Overall Study||42
8564803|NCT00006411|21114447|P2|NOT COMPLETED|Overall Study||0
8564804|NCT00006411|21114448|P1|NOT COMPLETED|Overall Study||0
8564805|NCT00006411|21114447|P2|COMPLETED|Overall Study||383
8564806|NCT00006411|21114448|P1|COMPLETED|Overall Study||707
8564807|NCT00006411|21114447|P2|STARTED|Overall Study||383
8564808|NCT00006411|21114448|P1|STARTED|Overall Study||707
8564809|NCT00006409|21114462|P6|NOT COMPLETED|Post-3 Year Intervention||62
8564810|NCT00006409|21114463|P5|NOT COMPLETED|Post-3 Year Intervention||62
8564811|NCT00006409|21114464|P4|NOT COMPLETED|Post-3 Year Intervention||0
8564812|NCT00006409|21114465|P3|NOT COMPLETED|Post-3 Year Intervention||0
8564813|NCT00006409|21114466|P2|NOT COMPLETED|Post-3 Year Intervention||0
8564814|NCT00006409|21114467|P1|NOT COMPLETED|Post-3 Year Intervention||0
8564815|NCT00006409|21114462|P6|COMPLETED|Post-3 Year Intervention||1714
8564816|NCT00006409|21114463|P5|COMPLETED|Post-3 Year Intervention||1664
8564817|NCT00006409|21114464|P4|COMPLETED|Post-3 Year Intervention||0
8564818|NCT00006409|21114465|P3|COMPLETED|Post-3 Year Intervention||0
8564819|NCT00006409|21114466|P2|COMPLETED|Post-3 Year Intervention||0
8564820|NCT00006409|21114467|P1|COMPLETED|Post-3 Year Intervention||0
8564821|NCT00006409|21114462|P6|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
8564822|NCT00006409|21114463|P5|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
8564823|NCT00006409|21114464|P4|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
8564824|NCT00006409|21114465|P3|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
8564825|NCT00006409|21114466|P2|STARTED|Post-3 Year Intervention||0
8564826|NCT00006409|21114467|P1|STARTED|Post-3 Year Intervention||0
8564827|NCT00006409|21114462|P6|NOT COMPLETED|Post-2 Year Intervention||0
8564828|NCT00006409|21114463|P5|NOT COMPLETED|Post-2 Year Intervention||0
8564829|NCT00006409|21114464|P4|NOT COMPLETED|Post-2 Year Intervention||168
8564830|NCT00006409|21114465|P3|NOT COMPLETED|Post-2 Year Intervention||251
8564831|NCT00006409|21114466|P2|NOT COMPLETED|Post-2 Year Intervention||0
8564832|NCT00006409|21114467|P1|NOT COMPLETED|Post-2 Year Intervention||0
8564833|NCT00006409|21114462|P6|COMPLETED|Post-2 Year Intervention||0
8564834|NCT00006409|21114463|P5|COMPLETED|Post-2 Year Intervention||0
8564835|NCT00006409|21114464|P4|COMPLETED|Post-2 Year Intervention||1545
8564836|NCT00006409|21114465|P3|COMPLETED|Post-2 Year Intervention||1540
8564837|NCT00006409|21114466|P2|COMPLETED|Post-2 Year Intervention||0
8564838|NCT00006409|21114467|P1|COMPLETED|Post-2 Year Intervention||0
8564839|NCT00006409|21114462|P6|STARTED|Post-2 Year Intervention||0
8564840|NCT00006409|21114463|P5|STARTED|Post-2 Year Intervention||0
8564841|NCT00006409|21114464|P4|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
8564842|NCT00006409|21114465|P3|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
8564843|NCT00006409|21114466|P2|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
8564844|NCT00006409|21114467|P1|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
8564845|NCT00006409|21114462|P6|NOT COMPLETED|Baseline||0
8564846|NCT00006409|21114463|P5|NOT COMPLETED|Baseline||0
8564847|NCT00006409|21114464|P4|NOT COMPLETED|Baseline||0
8564848|NCT00006409|21114465|P3|NOT COMPLETED|Baseline||0
8564849|NCT00006409|21114466|P2|NOT COMPLETED|Baseline||70
8564850|NCT00006409|21114467|P1|NOT COMPLETED|Baseline||48
8564851|NCT00006409|21114462|P6|COMPLETED|Baseline||0
8564852|NCT00006409|21114463|P5|COMPLETED|Baseline||0
8564853|NCT00006409|21114464|P4|COMPLETED|Baseline||0
8564854|NCT00006409|21114465|P3|COMPLETED|Baseline||0
8564855|NCT00006409|21114466|P2|COMPLETED|Baseline||786
8564856|NCT00006409|21114467|P1|COMPLETED|Baseline||817
8564857|NCT00006409|21114462|P6|STARTED|Baseline||0
8564858|NCT00006409|21114463|P5|STARTED|Baseline||0
8564859|NCT00006409|21114464|P4|STARTED|Baseline||0
8564860|NCT00006409|21114465|P3|STARTED|Baseline||0
8564861|NCT00006409|21114466|P2|STARTED|Baseline||856
8564862|NCT00006409|21114467|P1|STARTED|Baseline||865
8564863|NCT00006400|21114489|P2|NOT COMPLETED|Overall Study||13
8564864|NCT00006400|21114490|P1|NOT COMPLETED|Overall Study||13
8564865|NCT00006400|21114489|P2|COMPLETED|Overall Study||84
8564866|NCT00006400|21114490|P1|COMPLETED|Overall Study||83
8564867|NCT00006400|21114489|P2|STARTED|Overall Study||97
8564868|NCT00006400|21114490|P1|STARTED|Overall Study||96
8564869|NCT00006305|21114506|P4|NOT COMPLETED|Overall Study||14
8564870|NCT00006305|21114507|P3|NOT COMPLETED|Overall Study||15
8564871|NCT00006305|21114508|P2|NOT COMPLETED|Overall Study||10
8564872|NCT00006305|21114509|P1|NOT COMPLETED|Overall Study||17
8564873|NCT00006305|21114506|P4|COMPLETED|Overall Study||585
8564874|NCT00006305|21114507|P3|COMPLETED|Overall Study||578
8564875|NCT00006305|21114508|P2|COMPLETED|Overall Study||574
8564876|NCT00006305|21114509|P1|COMPLETED|Overall Study||575
8564877|NCT00006305|21114506|P4|STARTED|Overall Study||599
8564878|NCT00006305|21114507|P3|STARTED|Overall Study||593
8564879|NCT00006305|21114508|P2|STARTED|Overall Study||584
8564880|NCT00006305|21114509|P1|STARTED|Overall Study||592
8564881|NCT00006289|21114525|P2|NOT COMPLETED|Second Intervention (5 Weeks)||1
8564882|NCT00006289|21114526|P1|NOT COMPLETED|Second Intervention (5 Weeks)||1
8564883|NCT00006289|21114525|P2|COMPLETED|Second Intervention (5 Weeks)||9
8564884|NCT00006289|21114526|P1|COMPLETED|Second Intervention (5 Weeks)||9
8564885|NCT00006289|21114525|P2|STARTED|Second Intervention (5 Weeks)||10
8564886|NCT00006289|21114526|P1|STARTED|Second Intervention (5 Weeks)||10
8564887|NCT00006289|21114525|P2|NOT COMPLETED|Washout (>= 1 Week)||0
8564888|NCT00006289|21114526|P1|NOT COMPLETED|Washout (>= 1 Week)||0
8564889|NCT00006289|21114525|P2|COMPLETED|Washout (>= 1 Week)||10
8564890|NCT00006289|21114526|P1|COMPLETED|Washout (>= 1 Week)||10
8564891|NCT00006289|21114525|P2|STARTED|Washout (>= 1 Week)||10
8564892|NCT00006289|21114526|P1|STARTED|Washout (>= 1 Week)||10
8564893|NCT00006289|21114525|P2|NOT COMPLETED|First Intervention (5 Weeks)||0
8564894|NCT00006289|21114526|P1|NOT COMPLETED|First Intervention (5 Weeks)||1
8564895|NCT00006289|21114525|P2|COMPLETED|First Intervention (5 Weeks)||10
8564896|NCT00006289|21114526|P1|COMPLETED|First Intervention (5 Weeks)||10
8564897|NCT00006289|21114525|P2|STARTED|First Intervention (5 Weeks)||10
8564898|NCT00006289|21114526|P1|STARTED|First Intervention (5 Weeks)||11
8564899|NCT00006184|21114544|P2|NOT COMPLETED|Overall Study||0
8564900|NCT00006184|21114545|P1|NOT COMPLETED|Overall Study||1
8564901|NCT00006184|21114544|P2|COMPLETED|Overall Study||10
8564902|NCT00006184|21114545|P1|COMPLETED|Overall Study||9
8564903|NCT00006184|21114544|P2|STARTED|Overall Study||10
8564904|NCT00006184|21114545|P1|STARTED|Overall Study||10
8564905|NCT00006178|21114552|P1|NOT COMPLETED|Overall Study||0
8564906|NCT00006178|21114552|P1|COMPLETED|Overall Study||12
8564907|NCT00006178|21114552|P1|STARTED|Overall Study||12
8564908|NCT00006170|21114563|P4|NOT COMPLETED|Overall Study||39
8564909|NCT00006170|21114564|P3|NOT COMPLETED|Overall Study||43
8564910|NCT00006170|21114565|P2|NOT COMPLETED|Overall Study||50
8564911|NCT00006170|21114566|P1|NOT COMPLETED|Overall Study||49
8564912|NCT00006170|21114563|P4|COMPLETED|Overall Study||28
8564913|NCT00006170|21114564|P3|COMPLETED|Overall Study||46
8564914|NCT00006170|21114565|P2|COMPLETED|Overall Study||37
8564915|NCT00006170|21114566|P1|COMPLETED|Overall Study||57
8564916|NCT00006170|21114563|P4|STARTED|Overall Study||67
8564917|NCT00006170|21114564|P3|STARTED|Overall Study||89
8564918|NCT00006170|21114565|P2|STARTED|Overall Study||87
8564919|NCT00006170|21114566|P1|STARTED|Overall Study||106
8564920|NCT00006156|21114586|P2|NOT COMPLETED|Overall Study||0
8564921|NCT00006156|21114587|P1|NOT COMPLETED|Overall Study||0
8564922|NCT00006156|21114586|P2|COMPLETED|Overall Study||7
8564923|NCT00006156|21114587|P1|COMPLETED|Overall Study||42
8564924|NCT00006156|21114586|P2|STARTED|Overall Study||7
8564925|NCT00006156|21114587|P1|STARTED|Overall Study||42
8564926|NCT00006164|21114596|P2|NOT COMPLETED|Overall Study||81
8564927|NCT00006164|21114597|P1|NOT COMPLETED|Overall Study||70
8564928|NCT00006164|21114596|P2|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
8564929|NCT00006164|21114597|P1|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
8564930|NCT00006164|21114596|P2|STARTED|Overall Study||533
8564931|NCT00006164|21114597|P1|STARTED|Overall Study||517
8564932|NCT00006151|21114633|P2|NOT COMPLETED|Overall Study||14
8564933|NCT00006151|21114634|P1|NOT COMPLETED|Overall Study||13
8564934|NCT00006151|21114633|P2|COMPLETED|Overall Study||16
8564935|NCT00006151|21114634|P1|COMPLETED|Overall Study||17
8564936|NCT00006151|21114633|P2|STARTED|Overall Study||30
8564937|NCT00006151|21114634|P1|STARTED|Overall Study||30
8564938|NCT00005937|21114640|P1|NOT COMPLETED|Overall Study||5
8564939|NCT00005937|21114640|P1|COMPLETED|Overall Study||37
8564940|NCT00005937|21114640|P1|STARTED|Overall Study||42
8564941|NCT00005908|21114644|P2|NOT COMPLETED|Overall Study||0
8564942|NCT00005908|21114645|P1|NOT COMPLETED|Overall Study||1
8564943|NCT00005908|21114644|P2|COMPLETED|Overall Study||20
8564944|NCT00005908|21114645|P1|COMPLETED|Overall Study||9
8564945|NCT00005908|21114644|P2|STARTED|Overall Study||20
8564946|NCT00005908|21114645|P1|STARTED|Overall Study||10
8564947|NCT00005906|21114654|P1|NOT COMPLETED|Overall Study||3
8564948|NCT00005906|21114654|P1|COMPLETED|Overall Study||1
8564949|NCT00005906|21114654|P1|STARTED|Overall Study||4
8564950|NCT00005901|21114662|P2|NOT COMPLETED|Overall Study||0
8564951|NCT00005901|21114663|P1|NOT COMPLETED|Overall Study||0
8564952|NCT00005901|21114662|P2|COMPLETED|Overall Study||15
8564953|NCT00005901|21114663|P1|COMPLETED|Overall Study||19
8564954|NCT00005901|21114662|P2|STARTED|Overall Study||15
8564955|NCT00005901|21114663|P1|STARTED|Overall Study||19
8564956|NCT00005669|21114681|P2|NOT COMPLETED|Overall Study||7
8564957|NCT00005669|21114682|P1|NOT COMPLETED|Overall Study||8
8564958|NCT00005669|21114681|P2|COMPLETED|Overall Study||40
8564959|NCT00005669|21114682|P1|COMPLETED|Overall Study||45
8564960|NCT00005669|21114681|P2|STARTED|Overall Study||47
8564961|NCT00005669|21114682|P1|STARTED|Overall Study||53
8564962|NCT00004980|21114698|P2|NOT COMPLETED|Overall Study||2
8564963|NCT00004980|21114699|P1|NOT COMPLETED|Overall Study||2
8564964|NCT00004980|21114698|P2|COMPLETED|Overall Study||21
8564965|NCT00004980|21114699|P1|COMPLETED|Overall Study||25
8564966|NCT00004980|21114698|P2|STARTED|Overall Study||23
8564967|NCT00004980|21114699|P1|STARTED|Overall Study||27
8564968|NCT00004732|21114713|P2|NOT COMPLETED|Overall Study||111
8564969|NCT00004732|21114714|P1|NOT COMPLETED|Overall Study||69
8564970|NCT00004732|21114713|P2|COMPLETED|Overall Study||1129
8564971|NCT00004732|21114714|P1|COMPLETED|Overall Study||1193
8564972|NCT00004732|21114713|P2|STARTED|Overall Study||1240
8564973|NCT00004732|21114714|P1|STARTED|Overall Study||1262
8564974|NCT00004635|21114724|P2|NOT COMPLETED|Period Two||9
8564975|NCT00004635|21114725|P1|NOT COMPLETED|Period Two||6
8564976|NCT00004635|21114724|P2|COMPLETED|Period Two||50
8564977|NCT00004635|21114725|P1|COMPLETED|Period Two||38
8564978|NCT00004635|21114724|P2|STARTED|Period Two||59
8564979|NCT00004635|21114725|P1|STARTED|Period Two||44
8564980|NCT00004635|21114724|P2|NOT COMPLETED|Period One||6
8564981|NCT00004635|21114725|P1|NOT COMPLETED|Period One||6
8564982|NCT00004635|21114724|P2|COMPLETED|Period One||74
8564983|NCT00004635|21114725|P1|COMPLETED|Period One||73
8564984|NCT00004635|21114724|P2|Received Treatment|Period One||75
8564985|NCT00004635|21114725|P1|Received Treatment|Period One||73
8564986|NCT00004635|21114724|P2|STARTED|Period One||80
8564987|NCT00004635|21114725|P1|STARTED|Period One||79
8564988|NCT00004563|21114737|P2|NOT COMPLETED|Overall Study||24
8564989|NCT00004563|21114738|P1|NOT COMPLETED|Overall Study||25
8564990|NCT00004563|21114737|P2|COMPLETED|Overall Study||55
8564991|NCT00004563|21114738|P1|COMPLETED|Overall Study||54
8564992|NCT00004563|21114737|P2|STARTED|Overall Study||79
8564993|NCT00004563|21114738|P1|STARTED|Overall Study||79
8564994|NCT00004562|21114750|P2|NOT COMPLETED|Overall Study||91
8564995|NCT00004562|21114751|P1|NOT COMPLETED|Overall Study||102
8564996|NCT00004562|21114750|P2|COMPLETED|Overall Study||1009
8564997|NCT00004562|21114751|P1|COMPLETED|Overall Study||999
8564998|NCT00004562|21114750|P2|STARTED|Overall Study||1100
8564999|NCT00004562|21114751|P1|STARTED|Overall Study||1101
8565000|NCT00004547|21114762|P3|NOT COMPLETED|Overall Study||22
8565001|NCT00004547|21114763|P2|NOT COMPLETED|Overall Study||9
8565002|NCT00004547|21114764|P1|NOT COMPLETED|Overall Study||22
8565003|NCT00004547|21114762|P3|COMPLETED|Overall Study||35
8565004|NCT00004547|21114763|P2|COMPLETED|Overall Study||39
8565005|NCT00004547|21114764|P1|COMPLETED|Overall Study||61
8565006|NCT00004547|21114762|P3|Not Evaluable|Overall Study||23
8565007|NCT00004547|21114763|P2|Not Evaluable|Overall Study||9
8565008|NCT00004547|21114764|P1|Not Evaluable|Overall Study||21
8565009|NCT00004547|21114762|P3|STARTED|Overall Study||57
8565010|NCT00004547|21114763|P2|STARTED|Overall Study||48
8565011|NCT00004547|21114764|P1|STARTED|Overall Study||83
8565012|NCT00001984|21114782|P1|NOT COMPLETED|Overall Study||0
8565013|NCT00001984|21114782|P1|COMPLETED|Overall Study||5
8565014|NCT00001984|21114782|P1|STARTED|Overall Study||5
8565018|NCT00001959|21114796|P1|NOT COMPLETED|Overall Study||3
8565019|NCT00001959|21114796|P1|COMPLETED|Overall Study||18
8565020|NCT00001959|21114796|P1|STARTED|Overall Study||21
8565021|NCT00001941|21114802|P5|NOT COMPLETED|Overall Study||1
8565022|NCT00001941|21114803|P4|NOT COMPLETED|Overall Study||0
8565023|NCT00001941|21114804|P3|NOT COMPLETED|Overall Study||0
8565024|NCT00001941|21114805|P2|NOT COMPLETED|Overall Study||0
8565025|NCT00001941|21114806|P1|NOT COMPLETED|Overall Study||0
8565026|NCT00001941|21114802|P5|COMPLETED|Overall Study||19
8565027|NCT00001941|21114803|P4|COMPLETED|Overall Study||3
8565028|NCT00001941|21114804|P3|COMPLETED|Overall Study||3
8565029|NCT00001941|21114805|P2|COMPLETED|Overall Study||5
8565030|NCT00001941|21114806|P1|COMPLETED|Overall Study||3
8565031|NCT00001941|21114802|P5|STARTED|Overall Study||20
8565032|NCT00001941|21114803|P4|STARTED|Overall Study||3
8565033|NCT00001941|21114804|P3|STARTED|Overall Study||3
8565034|NCT00001941|21114805|P2|STARTED|Overall Study||5
8565035|NCT00001941|21114806|P1|STARTED|Overall Study||3
8565036|NCT00000392|21114815|P2|NOT COMPLETED|Overall Study||32
8565037|NCT00000392|21114816|P1|NOT COMPLETED|Overall Study||40
8565038|NCT00000392|21114815|P2|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
8565039|NCT00000392|21114816|P1|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
8565040|NCT00000392|21114815|P2|STARTED|Overall Study||109
8565041|NCT00000392|21114816|P1|STARTED|Overall Study||106
8565045|NCT00001832|21114853|P15|NOT COMPLETED|Treatment Period||0
8565046|NCT00001832|21114854|P14|NOT COMPLETED|Treatment Period||0
8565047|NCT00001832|21114855|P13|NOT COMPLETED|Treatment Period||0
8565048|NCT00001832|21114856|P12|NOT COMPLETED|Treatment Period||0
8565049|NCT00001832|21114857|P11|NOT COMPLETED|Treatment Period||0
8565050|NCT00001832|21114858|P10|NOT COMPLETED|Treatment Period||0
8565051|NCT00001832|21114859|P9|NOT COMPLETED|Treatment Period||0
8565052|NCT00001832|21114860|P8|NOT COMPLETED|Treatment Period||1
8565053|NCT00001832|21114861|P7|NOT COMPLETED|Treatment Period||0
8565054|NCT00001832|21114862|P6|NOT COMPLETED|Treatment Period||1
8565055|NCT00001832|21114863|P5|NOT COMPLETED|Treatment Period||0
8565056|NCT00001832|21114864|P4|NOT COMPLETED|Treatment Period||0
8565057|NCT00001832|21114865|P3|NOT COMPLETED|Treatment Period||0
8565058|NCT00001832|21114866|P2|NOT COMPLETED|Treatment Period||0
8565059|NCT00001832|21114867|P1|NOT COMPLETED|Treatment Period||0
8565060|NCT00001832|21114853|P15|COMPLETED|Treatment Period||2
8565061|NCT00001832|21114854|P14|COMPLETED|Treatment Period||3
8565062|NCT00001832|21114855|P13|COMPLETED|Treatment Period||6
8565063|NCT00001832|21114856|P12|COMPLETED|Treatment Period||7
8565064|NCT00001832|21114857|P11|COMPLETED|Treatment Period||1
8565065|NCT00001832|21114858|P10|COMPLETED|Treatment Period||6
8565066|NCT00001832|21114859|P9|COMPLETED|Treatment Period||8
8565067|NCT00001832|21114860|P8|COMPLETED|Treatment Period||6
8565068|NCT00001832|21114861|P7|COMPLETED|Treatment Period||4
8565069|NCT00001832|21114862|P6|COMPLETED|Treatment Period||50
8565070|NCT00001832|21114863|P5|COMPLETED|Treatment Period||6
8565071|NCT00001832|21114864|P4|COMPLETED|Treatment Period||3
8565072|NCT00001832|21114865|P3|COMPLETED|Treatment Period||3
8565073|NCT00001832|21114866|P2|COMPLETED|Treatment Period||3
8565074|NCT00001832|21114867|P1|COMPLETED|Treatment Period||0
8565075|NCT00001832|21114853|P15|STARTED|Treatment Period||2
8565076|NCT00001832|21114854|P14|STARTED|Treatment Period||3
8565077|NCT00001832|21114855|P13|STARTED|Treatment Period||6
8565078|NCT00001832|21114856|P12|STARTED|Treatment Period||7
8565079|NCT00001832|21114857|P11|STARTED|Treatment Period||1
8565080|NCT00001832|21114858|P10|STARTED|Treatment Period||6
8565081|NCT00001832|21114859|P9|STARTED|Treatment Period||8
8565082|NCT00001832|21114860|P8|STARTED|Treatment Period||7
8565083|NCT00001832|21114861|P7|STARTED|Treatment Period||4
8565084|NCT00001832|21114862|P6|STARTED|Treatment Period||51
8565085|NCT00001832|21114863|P5|STARTED|Treatment Period||6
8565086|NCT00001832|21114864|P4|STARTED|Treatment Period||3
8565087|NCT00001832|21114865|P3|STARTED|Treatment Period||3
8565088|NCT00001832|21114866|P2|STARTED|Treatment Period||3
8565089|NCT00001832|21114867|P1|STARTED|Treatment Period||0
8565090|NCT00001832|21114853|P15|NOT COMPLETED|Apheresis Period||0
8565091|NCT00001832|21114854|P14|NOT COMPLETED|Apheresis Period||0
8565092|NCT00001832|21114855|P13|NOT COMPLETED|Apheresis Period||0
8565093|NCT00001832|21114856|P12|NOT COMPLETED|Apheresis Period||0
8565094|NCT00001832|21114857|P11|NOT COMPLETED|Apheresis Period||0
8565095|NCT00001832|21114858|P10|NOT COMPLETED|Apheresis Period||0
8565096|NCT00001832|21114859|P9|NOT COMPLETED|Apheresis Period||0
8565097|NCT00001832|21114860|P8|NOT COMPLETED|Apheresis Period||0
8565098|NCT00001832|21114861|P7|NOT COMPLETED|Apheresis Period||0
8565099|NCT00001832|21114862|P6|NOT COMPLETED|Apheresis Period||0
8565100|NCT00001832|21114863|P5|NOT COMPLETED|Apheresis Period||0
8565101|NCT00001832|21114864|P4|NOT COMPLETED|Apheresis Period||0
8565102|NCT00001832|21114865|P3|NOT COMPLETED|Apheresis Period||0
8565103|NCT00001832|21114866|P2|NOT COMPLETED|Apheresis Period||0
8565104|NCT00001832|21114867|P1|NOT COMPLETED|Apheresis Period||60
8565105|NCT00001832|21114853|P15|COMPLETED|Apheresis Period||0
8565106|NCT00001832|21114854|P14|COMPLETED|Apheresis Period||0
8565107|NCT00001832|21114855|P13|COMPLETED|Apheresis Period||0
8565108|NCT00001832|21114856|P12|COMPLETED|Apheresis Period||0
8565109|NCT00001832|21114857|P11|COMPLETED|Apheresis Period||0
8565110|NCT00001832|21114858|P10|COMPLETED|Apheresis Period||0
8565111|NCT00001832|21114859|P9|COMPLETED|Apheresis Period||0
8565112|NCT00001832|21114860|P8|COMPLETED|Apheresis Period||0
8565113|NCT00001832|21114861|P7|COMPLETED|Apheresis Period||0
8565114|NCT00001832|21114862|P6|COMPLETED|Apheresis Period||0
8565115|NCT00001832|21114863|P5|COMPLETED|Apheresis Period||0
8565116|NCT00001832|21114864|P4|COMPLETED|Apheresis Period||0
8565117|NCT00001832|21114865|P3|COMPLETED|Apheresis Period||0
8565118|NCT00001832|21114866|P2|COMPLETED|Apheresis Period||0
8565119|NCT00001832|21114867|P1|COMPLETED|Apheresis Period||110
8565120|NCT00001832|21114853|P15|STARTED|Apheresis Period||0
8565121|NCT00001832|21114854|P14|STARTED|Apheresis Period||0
8565122|NCT00001832|21114855|P13|STARTED|Apheresis Period||0
8565123|NCT00001832|21114856|P12|STARTED|Apheresis Period||0
8565124|NCT00001832|21114857|P11|STARTED|Apheresis Period||0
8565125|NCT00001832|21114858|P10|STARTED|Apheresis Period||0
8565126|NCT00001832|21114859|P9|STARTED|Apheresis Period||0
8565127|NCT00001832|21114860|P8|STARTED|Apheresis Period||0
8565128|NCT00001832|21114861|P7|STARTED|Apheresis Period||0
8565129|NCT00001832|21114862|P6|STARTED|Apheresis Period||0
8565130|NCT00001832|21114863|P5|STARTED|Apheresis Period||0
8565131|NCT00001832|21114864|P4|STARTED|Apheresis Period||0
8565132|NCT00001832|21114865|P3|STARTED|Apheresis Period||0
8565133|NCT00001832|21114866|P2|STARTED|Apheresis Period||0
8565134|NCT00001832|21114867|P1|STARTED|Apheresis Period||170
8565135|NCT00001723|21114913|P2|NOT COMPLETED|Overall Study||16
8565136|NCT00001723|21114914|P1|NOT COMPLETED|Overall Study||13
8565137|NCT00001723|21114913|P2|COMPLETED|Overall Study||84
8565138|NCT00001723|21114914|P1|COMPLETED|Overall Study||87
8565139|NCT00001723|21114913|P2|STARTED|Overall Study||100
8565140|NCT00001723|21114914|P1|STARTED|Overall Study||100
8565141|NCT00001703|21114930|P1|NOT COMPLETED|Overall Study||5
8565142|NCT00001703|21114930|P1|COMPLETED|Overall Study||1
8565143|NCT00001703|21114930|P1|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
8565144|NCT00001703|21114930|P1|STARTED|Overall Study||6
8565145|NCT00001656|21114937|P2|NOT COMPLETED|Overall Study||0
8565146|NCT00001656|21114938|P1|NOT COMPLETED|Overall Study||1
8565147|NCT00001656|21114937|P2|COMPLETED|Overall Study||12
8565148|NCT00001656|21114938|P1|COMPLETED|Overall Study||12
8565149|NCT00001656|21114937|P2|STARTED|Overall Study||12
8565150|NCT00001656|21114938|P1|STARTED|Overall Study||13
8565151|NCT00001596|21114968|P2|NOT COMPLETED|Overall Study||10
8565152|NCT00001596|21114969|P1|NOT COMPLETED|Overall Study||17
8565153|NCT00001596|21114968|P2|COMPLETED|Overall Study||2
8565154|NCT00001596|21114969|P1|COMPLETED|Overall Study||6
8565155|NCT00001596|21114968|P2|STARTED|Overall Study||12
8565156|NCT00001596|21114969|P1|STARTED|Overall Study||23
8565157|NCT00001586|21114991|P2|NOT COMPLETED|Overall Study||0
8565158|NCT00001586|21114992|P1|NOT COMPLETED|Overall Study||0
8565159|NCT00001586|21114991|P2|COMPLETED|Overall Study||56
8565160|NCT00001586|21114992|P1|COMPLETED|Overall Study||49
8565161|NCT00001586|21114991|P2|STARTED|Overall Study||56
8565162|NCT00001586|21114992|P1|STARTED|Overall Study||49
8565163|NCT00001575|21115000|P1|NOT COMPLETED|Overall Study||45
8565164|NCT00001575|21115000|P1|COMPLETED|Overall Study||42
8565165|NCT00001575|21115000|P1|Treated|Overall Study||65
8565166|NCT00001575|21115000|P1|STARTED|Overall Study||87
8565167|NCT00001566|21115006|P1|NOT COMPLETED|Overall Study||19
8565168|NCT00001566|21115006|P1|COMPLETED|Overall Study||23
8565169|NCT00001566|21115006|P1|Completed Immunotherapy|Overall Study||23
8565170|NCT00001566|21115006|P1|STARTED|Overall Study||42
8565171|NCT00001305|21115018|P1|NOT COMPLETED|Overall Study||0
8565172|NCT00001305|21115018|P1|COMPLETED|Overall Study||42
8565173|NCT00001305|21115018|P1|STARTED|Overall Study||42
8565174|NCT00001304|21115024|P2|NOT COMPLETED|Overall Study||0
8565175|NCT00001304|21115025|P1|NOT COMPLETED|Overall Study||0
8565176|NCT00001304|21115024|P2|COMPLETED|Overall Study||14
8565177|NCT00001304|21115025|P1|COMPLETED|Overall Study||13
8565178|NCT00001304|21115024|P2|STARTED|Overall Study||14
8565179|NCT00001304|21115025|P1|STARTED|Overall Study||13
8565180|NCT00001262|21115046|P3|NOT COMPLETED|Overall Study||0
8565181|NCT00001262|21115047|P2|NOT COMPLETED|Overall Study||14
8565182|NCT00001262|21115048|P1|NOT COMPLETED|Overall Study||10
8565183|NCT00001262|21115046|P3|COMPLETED|Overall Study||3
8565184|NCT00001262|21115047|P2|COMPLETED|Overall Study||8
8565185|NCT00001262|21115048|P1|COMPLETED|Overall Study||25
8565186|NCT00001262|21115046|P3|STARTED|Overall Study||3
8565187|NCT00001262|21115047|P2|STARTED|Overall Study||22
8565188|NCT00001262|21115048|P1|STARTED|Overall Study||35
8565189|NCT00001213|21115074|P1|NOT COMPLETED|Overall Study||18
8565190|NCT00001213|21115074|P1|COMPLETED|Overall Study||310
8565191|NCT00001213|21115074|P1|STARTED|Overall Study||328
8565192|NCT00001151|21115079|P1|NOT COMPLETED|Overall Study||5
8565193|NCT00001151|21115079|P1|COMPLETED|Overall Study||1
8565194|NCT00001151|21115079|P1|STARTED|Overall Study||6
8565195|NCT00000378|21115085|P2|NOT COMPLETED|Overall Study||14
8565196|NCT00000378|21115086|P1|NOT COMPLETED|Overall Study||16
8565197|NCT00000378|21115085|P2|COMPLETED|Overall Study||38
8565198|NCT00000378|21115086|P1|COMPLETED|Overall Study||42
8565199|NCT00000378|21115085|P2|STARTED|Overall Study||52
8565200|NCT00000378|21115086|P1|STARTED|Overall Study||58
8565201|NCT00000371|21115094|P2|NOT COMPLETED|Overall Study||16
8565202|NCT00000371|21115095|P1|NOT COMPLETED|Overall Study||13
8565203|NCT00000371|21115094|P2|COMPLETED|Overall Study||12
8565204|NCT00000371|21115095|P1|COMPLETED|Overall Study||14
8565205|NCT00000371|21115094|P2|STARTED|Overall Study||28
8565206|NCT00000371|21115095|P1|STARTED|Overall Study||27
8565207|NCT00000620|21115103|P8|NOT COMPLETED|Overall Study||146
8565208|NCT00000620|21115104|P7|NOT COMPLETED|Overall Study||149
8565209|NCT00000620|21115105|P6|NOT COMPLETED|Overall Study||152
8565210|NCT00000620|21115106|P5|NOT COMPLETED|Overall Study||135
8565211|NCT00000620|21115107|P4|NOT COMPLETED|Overall Study||178
8565212|NCT00000620|21115108|P3|NOT COMPLETED|Overall Study||170
8565213|NCT00000620|21115109|P2|NOT COMPLETED|Overall Study||136
8565214|NCT00000620|21115110|P1|NOT COMPLETED|Overall Study||162
8565215|NCT00000620|21115103|P8|COMPLETED|Overall Study||1224
8565216|NCT00000620|21115104|P7|COMPLETED|Overall Study||1242
8565217|NCT00000620|21115105|P6|COMPLETED|Overall Study||1026
8565218|NCT00000620|21115106|P5|COMPLETED|Overall Study||1049
8565219|NCT00000620|21115107|P4|COMPLETED|Overall Study||1205
8565220|NCT00000620|21115108|P3|COMPLETED|Overall Study||1204
8565221|NCT00000620|21115109|P2|COMPLETED|Overall Study||1057
8565222|NCT00000620|21115110|P1|COMPLETED|Overall Study||1016
8565223|NCT00000620|21115103|P8|STARTED|Overall Study||1370
8565224|NCT00000620|21115104|P7|STARTED|Overall Study||1391
8565225|NCT00000620|21115105|P6|STARTED|Overall Study||1178
8565226|NCT00000620|21115106|P5|STARTED|Overall Study||1184
8565227|NCT00000620|21115107|P4|STARTED|Overall Study||1383
8565228|NCT00000620|21115108|P3|STARTED|Overall Study||1374
8565229|NCT00000620|21115109|P2|STARTED|Overall Study||1193
8565230|NCT00000620|21115110|P1|STARTED|Overall Study||1178
8565231|NCT00000575|21115129|P3|NOT COMPLETED|Overall Study||0
8565232|NCT00000575|21115130|P2|NOT COMPLETED|Overall Study||0
8565233|NCT00000575|21115131|P1|NOT COMPLETED|Overall Study||0
8565234|NCT00000575|21115129|P3|COMPLETED|Overall Study||418
8565235|NCT00000575|21115130|P2|COMPLETED|Overall Study||312
8565236|NCT00000575|21115131|P1|COMPLETED|Overall Study||311
8565237|NCT00000575|21115129|P3|STARTED|Overall Study||418
8565238|NCT00000575|21115130|P2|STARTED|Overall Study||312
8565239|NCT00000575|21115131|P1|STARTED|Overall Study||311
8565240|NCT00000479|21115161|P4|NOT COMPLETED|Overall Study||0
8565241|NCT00000479|21115162|P3|NOT COMPLETED|Overall Study||0
8565242|NCT00000479|21115163|P2|NOT COMPLETED|Overall Study||0
8565243|NCT00000479|21115164|P1|NOT COMPLETED|Overall Study||0
8565244|NCT00000479|21115161|P4|COMPLETED|Overall Study||9971
8565245|NCT00000479|21115162|P3|COMPLETED|Overall Study||9966
8565246|NCT00000479|21115163|P2|COMPLETED|Overall Study||9971
8565247|NCT00000479|21115164|P1|COMPLETED|Overall Study||9968
8565248|NCT00000479|21115161|P4|STARTED|Overall Study||9971
8565249|NCT00000479|21115162|P3|STARTED|Overall Study||9966
8565250|NCT00000479|21115163|P2|STARTED|Overall Study||9971
8565251|NCT00000479|21115164|P1|STARTED|Overall Study||9968
8565252|NCT00004500|21115180|P2|NOT COMPLETED|Overall Study||0
8565253|NCT00004500|21115181|P1|NOT COMPLETED|Overall Study||0
8565254|NCT00004500|21115180|P2|COMPLETED|Overall Study||31
8565255|NCT00004500|21115181|P1|COMPLETED|Overall Study||38
8565256|NCT00004500|21115180|P2|1 Year Follow-Up|Overall Study||24
8565257|NCT00004500|21115181|P1|1 Year Follow-Up|Overall Study||24
8565258|NCT00004500|21115180|P2|STARTED|Overall Study||31
8565259|NCT00004500|21115181|P1|STARTED|Overall Study||38
8565260|NCT00004445|21115191|P1|NOT COMPLETED|Overall Study||3
8565261|NCT00004445|21115191|P1|COMPLETED|Overall Study||15
8565262|NCT00004445|21115191|P1|STARTED|Overall Study||18
8565263|NCT00004418|21115196|P1|NOT COMPLETED|Overall Study||0
8565264|NCT00004418|21115196|P1|COMPLETED|Overall Study|The definition of completed is until the subject wished to stop taking the oil.|126
8565265|NCT00004418|21115196|P1|STARTED|Overall Study||126
8565266|NCT00004412|21115204|P3|NOT COMPLETED|Crossover Period||0
8565267|NCT00004412|21115205|P2|NOT COMPLETED|Crossover Period||0
8565268|NCT00004412|21115206|P1|NOT COMPLETED|Crossover Period||0
8565269|NCT00004412|21115204|P3|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
8565270|NCT00004412|21115205|P2|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
8565271|NCT00004412|21115206|P1|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
8565272|NCT00004412|21115204|P3|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
8565273|NCT00004412|21115205|P2|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
8565274|NCT00004412|21115206|P1|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
8565275|NCT00004412|21115204|P3|NOT COMPLETED|Randomized Period||0
8565276|NCT00004412|21115205|P2|NOT COMPLETED|Randomized Period||0
8565277|NCT00004412|21115206|P1|NOT COMPLETED|Randomized Period||3
8565278|NCT00004412|21115204|P3|COMPLETED|Randomized Period||0
8565279|NCT00004412|21115205|P2|COMPLETED|Randomized Period||12
8565280|NCT00004412|21115206|P1|COMPLETED|Randomized Period||8
8565281|NCT00004412|21115204|P3|STARTED|Randomized Period||0
8565282|NCT00004412|21115205|P2|STARTED|Randomized Period||12
8565283|NCT00004412|21115206|P1|STARTED|Randomized Period||11
8565284|NCT00000143|21115216|P2|NOT COMPLETED|Overall Study||0
8565285|NCT00000143|21115217|P1|NOT COMPLETED|Overall Study||0
8565286|NCT00000143|21115216|P2|COMPLETED|Overall Study||30
8565287|NCT00000143|21115217|P1|COMPLETED|Overall Study||31
8565288|NCT00000143|21115216|P2|STARTED|Overall Study||30
8565289|NCT00000143|21115217|P1|STARTED|Overall Study||31
8565290|NCT00000142|21115226|P3|NOT COMPLETED|Overall Study||0
8565291|NCT00000142|21115227|P2|NOT COMPLETED|Overall Study||0
8565292|NCT00000142|21115228|P1|NOT COMPLETED|Overall Study||0
8565293|NCT00000142|21115226|P3|COMPLETED|Overall Study||12
8565294|NCT00000142|21115227|P2|COMPLETED|Overall Study||26
8565295|NCT00000142|21115228|P1|COMPLETED|Overall Study||26
8565296|NCT00000142|21115226|P3|STARTED|Overall Study||12
8565297|NCT00000142|21115227|P2|STARTED|Overall Study||26
8565298|NCT00000142|21115228|P1|STARTED|Overall Study||26
8565299|NCT00000136|21115238|P2|NOT COMPLETED|Overall Study||0
8565300|NCT00000136|21115239|P1|NOT COMPLETED|Overall Study||0
8565301|NCT00000136|21115238|P2|COMPLETED|Overall Study||127
8565302|NCT00000136|21115239|P1|COMPLETED|Overall Study||107
8565303|NCT00000136|21115238|P2|STARTED|Overall Study||127
8565304|NCT00000136|21115239|P1|STARTED|Overall Study||107
8565305|NCT00000135|21115247|P2|NOT COMPLETED|Overall Study||14
8565306|NCT00000135|21115248|P1|NOT COMPLETED|Overall Study||27
8565307|NCT00000135|21115247|P2|COMPLETED|Overall Study||91
8565308|NCT00000135|21115248|P1|COMPLETED|Overall Study||77
8565309|NCT00000135|21115247|P2|STARTED|Overall Study||105
8565310|NCT00000135|21115248|P1|STARTED|Overall Study||104
8565311|NCT00000134|21115257|P3|NOT COMPLETED|Overall Study||0
8565312|NCT00000134|21115258|P2|NOT COMPLETED|Overall Study||0
8565313|NCT00000134|21115259|P1|NOT COMPLETED|Overall Study||0
8565314|NCT00000134|21115257|P3|COMPLETED|Overall Study||96
8565315|NCT00000134|21115258|P2|COMPLETED|Overall Study||94
8565316|NCT00000134|21115259|P1|COMPLETED|Overall Study||89
8565317|NCT00000134|21115257|P3|STARTED|Overall Study||96
8565318|NCT00000134|21115258|P2|STARTED|Overall Study||94
8565319|NCT00000134|21115259|P1|STARTED|Overall Study||89
8565320|NCT00000125|21115269|P2|NOT COMPLETED|Overall Study||238
8565321|NCT00000125|21115270|P1|NOT COMPLETED|Overall Study||239
8565322|NCT00000125|21115269|P2|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
8565323|NCT00000125|21115270|P1|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
8565324|NCT00000125|21115269|P2|Completed OHTS Phase I, June 2002|Overall Study||702
8565325|NCT00000125|21115270|P1|Completed OHTS Phase I, June 2002|Overall Study||706
8565326|NCT00000125|21115269|P2|STARTED|Overall Study||817
8565327|NCT00000125|21115270|P1|STARTED|Overall Study||819
8565357|NCT04160988|21115324|P1|NOT COMPLETED|Overall Study||28
8565358|NCT04160988|21115324|P1|COMPLETED|Overall Study||675
8565359|NCT04160988|21115324|P1|STARTED|Overall Study||703
8565366|NCT03972813|21115359|P18|NOT COMPLETED|Overall Study||2
8565367|NCT03972813|21115360|P17|NOT COMPLETED|Overall Study||3
8565368|NCT03972813|21115361|P16|NOT COMPLETED|Overall Study||6
8565369|NCT03972813|21115362|P15|NOT COMPLETED|Overall Study||2
8565370|NCT03972813|21115363|P14|NOT COMPLETED|Overall Study||3
8565371|NCT03972813|21115364|P13|NOT COMPLETED|Overall Study||3
8565372|NCT03972813|21115365|P12|NOT COMPLETED|Overall Study||4
8565373|NCT03972813|21115366|P11|NOT COMPLETED|Overall Study||5
8565374|NCT03972813|21115367|P10|NOT COMPLETED|Overall Study||2
8565375|NCT03972813|21115368|P9|NOT COMPLETED|Overall Study||5
8565376|NCT03972813|21115369|P8|NOT COMPLETED|Overall Study||3
8565377|NCT03972813|21115370|P7|NOT COMPLETED|Overall Study||4
8565378|NCT03972813|21115371|P6|NOT COMPLETED|Overall Study||2
8565379|NCT03972813|21115372|P5|NOT COMPLETED|Overall Study||4
8565380|NCT03972813|21115373|P4|NOT COMPLETED|Overall Study||4
8565381|NCT03972813|21115374|P3|NOT COMPLETED|Overall Study||6
8565382|NCT03972813|21115375|P2|NOT COMPLETED|Overall Study||4
8565383|NCT03972813|21115376|P1|NOT COMPLETED|Overall Study||6
8565384|NCT03972813|21115359|P18|COMPLETED|Overall Study||48
8565385|NCT03972813|21115360|P17|COMPLETED|Overall Study||48
8565386|NCT03972813|21115361|P16|COMPLETED|Overall Study||50
8565387|NCT03972813|21115362|P15|COMPLETED|Overall Study||56
8565388|NCT03972813|21115363|P14|COMPLETED|Overall Study||52
8565389|NCT03972813|21115364|P13|COMPLETED|Overall Study||55
8565390|NCT03972813|21115365|P12|COMPLETED|Overall Study||51
8565391|NCT03972813|21115366|P11|COMPLETED|Overall Study||57
8565392|NCT03972813|21115367|P10|COMPLETED|Overall Study||58
8565393|NCT03972813|21115368|P9|COMPLETED|Overall Study||53
8565394|NCT03972813|21115369|P8|COMPLETED|Overall Study||52
8565395|NCT03972813|21115370|P7|COMPLETED|Overall Study||49
8565396|NCT03972813|21115371|P6|COMPLETED|Overall Study||49
8565397|NCT03972813|21115372|P5|COMPLETED|Overall Study||48
8565398|NCT03972813|21115373|P4|COMPLETED|Overall Study||51
8565399|NCT03972813|21115374|P3|COMPLETED|Overall Study||52
8565400|NCT03972813|21115375|P2|COMPLETED|Overall Study||45
8565401|NCT03972813|21115376|P1|COMPLETED|Overall Study||79
8565402|NCT03972813|21115359|P18|STARTED|Overall Study||50
8565403|NCT03972813|21115360|P17|STARTED|Overall Study||51
8565404|NCT03972813|21115361|P16|STARTED|Overall Study||56
8565405|NCT03972813|21115362|P15|STARTED|Overall Study||58
8565406|NCT03972813|21115363|P14|STARTED|Overall Study||55
8565407|NCT03972813|21115364|P13|STARTED|Overall Study||58
8565408|NCT03972813|21115365|P12|STARTED|Overall Study||55
8565409|NCT03972813|21115366|P11|STARTED|Overall Study||62
8565410|NCT03972813|21115367|P10|STARTED|Overall Study||60
8565411|NCT03972813|21115368|P9|STARTED|Overall Study||58
8565412|NCT03972813|21115369|P8|STARTED|Overall Study||55
8565413|NCT03972813|21115370|P7|STARTED|Overall Study||53
8565414|NCT03972813|21115371|P6|STARTED|Overall Study||51
8565415|NCT03972813|21115372|P5|STARTED|Overall Study||52
8565416|NCT03972813|21115373|P4|STARTED|Overall Study||55
8565417|NCT03972813|21115374|P3|STARTED|Overall Study||58
8565418|NCT03972813|21115375|P2|STARTED|Overall Study||49
8565419|NCT03972813|21115376|P1|STARTED|Overall Study||85
8565420|NCT03888235|21115417|P3|NOT COMPLETED|Overall Study||0
8565421|NCT03888235|21115418|P2|NOT COMPLETED|Overall Study||0
8565422|NCT03888235|21115419|P1|NOT COMPLETED|Overall Study||0
8565423|NCT03888235|21115417|P3|COMPLETED|Overall Study||21
8565424|NCT03888235|21115418|P2|COMPLETED|Overall Study||20
8565425|NCT03888235|21115419|P1|COMPLETED|Overall Study||20
8565426|NCT03888235|21115417|P3|STARTED|Overall Study|1 participant dropped out after the first visit and was replaced. He completed the study after 5 mo,|21
8565518|NCT03377244|21115656|P2|COMPLETED|Baseline||14
8565427|NCT03888235|21115418|P2|STARTED|Overall Study|2 participants dropped out after the first visit and were replaced|20
8565428|NCT03888235|21115419|P1|STARTED|Overall Study|1 Participant dropped out after the first visit and was replaced.|20
8565436|NCT03792737|21115504|P3|NOT COMPLETED|Overall Study||9
8565437|NCT03792737|21115505|P2|NOT COMPLETED|Overall Study||8
8565438|NCT03792737|21115506|P1|NOT COMPLETED|Overall Study||6
8565439|NCT03792737|21115504|P3|COMPLETED|Overall Study||158
8565440|NCT03792737|21115505|P2|COMPLETED|Overall Study||159
8565441|NCT03792737|21115506|P1|COMPLETED|Overall Study||160
8565442|NCT03792737|21115504|P3|Full Analysis Set|Overall Study||162
8565443|NCT03792737|21115505|P2|Full Analysis Set|Overall Study||160
8565444|NCT03792737|21115506|P1|Full Analysis Set|Overall Study||162
8565445|NCT03792737|21115504|P3|Safety Analysis Set|Overall Study||162
8565446|NCT03792737|21115505|P2|Safety Analysis Set|Overall Study|one subject didn't participate screen visit or randomize, but receive IP treatment by mistake.|161
8565447|NCT03792737|21115506|P1|Safety Analysis Set|Overall Study||162
8565448|NCT03792737|21115504|P3|STARTED|Overall Study||167
8565449|NCT03792737|21115505|P2|STARTED|Overall Study||167
8565450|NCT03792737|21115506|P1|STARTED|Overall Study||166
8565457|NCT03650192|21115552|P1|NOT COMPLETED|Overall Study||0
8565458|NCT03650192|21115552|P1|COMPLETED|Overall Study||40
8565459|NCT03650192|21115552|P1|STARTED|Overall Study||40
8565463|NCT03520998|21115565|P2|NOT COMPLETED|Overall Study||2
8565464|NCT03520998|21115566|P1|NOT COMPLETED|Overall Study||6
8565465|NCT03520998|21115565|P2|COMPLETED|Overall Study||21
8565466|NCT03520998|21115566|P1|COMPLETED|Overall Study||18
8565467|NCT03520998|21115565|P2|STARTED|Overall Study||23
8565468|NCT03520998|21115566|P1|STARTED|Overall Study||24
8565472|NCT03492398|21115597|P9|NOT COMPLETED|Overall Study||0
8565473|NCT03492398|21115598|P8|NOT COMPLETED|Overall Study||1
8565474|NCT03492398|21115599|P7|NOT COMPLETED|Overall Study||1
8565475|NCT03492398|21115600|P6|NOT COMPLETED|Overall Study||0
8565476|NCT03492398|21115601|P5|NOT COMPLETED|Overall Study||0
8565477|NCT03492398|21115602|P4|NOT COMPLETED|Overall Study||0
8565478|NCT03492398|21115603|P3|NOT COMPLETED|Overall Study||0
8565479|NCT03492398|21115604|P2|NOT COMPLETED|Overall Study||0
8565480|NCT03492398|21115605|P1|NOT COMPLETED|Overall Study||0
8565481|NCT03492398|21115597|P9|COMPLETED|Overall Study||6
8565482|NCT03492398|21115598|P8|COMPLETED|Overall Study||5
8565483|NCT03492398|21115599|P7|COMPLETED|Overall Study||5
8565484|NCT03492398|21115600|P6|COMPLETED|Overall Study||6
8565485|NCT03492398|21115601|P5|COMPLETED|Overall Study||6
8565486|NCT03492398|21115602|P4|COMPLETED|Overall Study||6
8565487|NCT03492398|21115603|P3|COMPLETED|Overall Study||6
8565488|NCT03492398|21115604|P2|COMPLETED|Overall Study||6
8565489|NCT03492398|21115605|P1|COMPLETED|Overall Study||8
8565490|NCT03492398|21115597|P9|STARTED|Overall Study||6
8565491|NCT03492398|21115598|P8|STARTED|Overall Study||6
8565492|NCT03492398|21115599|P7|STARTED|Overall Study||6
8565493|NCT03492398|21115600|P6|STARTED|Overall Study||6
8565494|NCT03492398|21115601|P5|STARTED|Overall Study||6
8565495|NCT03492398|21115602|P4|STARTED|Overall Study||6
8565496|NCT03492398|21115603|P3|STARTED|Overall Study||6
8565497|NCT03492398|21115604|P2|STARTED|Overall Study||6
8565498|NCT03492398|21115605|P1|STARTED|Overall Study||8
8565505|NCT03377244|21115655|P3|NOT COMPLETED|6 Months Post-intervention||14
8565506|NCT03377244|21115656|P2|NOT COMPLETED|6 Months Post-intervention||7
8565507|NCT03377244|21115657|P1|NOT COMPLETED|6 Months Post-intervention||6
8565508|NCT03377244|21115655|P3|COMPLETED|6 Months Post-intervention||55
8565509|NCT03377244|21115656|P2|COMPLETED|6 Months Post-intervention||7
8565510|NCT03377244|21115657|P1|COMPLETED|6 Months Post-intervention||13
8565511|NCT03377244|21115655|P3|STARTED|6 Months Post-intervention||69
8565512|NCT03377244|21115656|P2|STARTED|6 Months Post-intervention||14
8565513|NCT03377244|21115657|P1|STARTED|6 Months Post-intervention||19
8565514|NCT03377244|21115655|P3|NOT COMPLETED|Baseline||0
8565515|NCT03377244|21115656|P2|NOT COMPLETED|Baseline||0
8565516|NCT03377244|21115657|P1|NOT COMPLETED|Baseline||0
8565517|NCT03377244|21115655|P3|COMPLETED|Baseline||69
8565519|NCT03377244|21115657|P1|COMPLETED|Baseline||19
8565520|NCT03377244|21115655|P3|STARTED|Baseline||69
8565521|NCT03377244|21115656|P2|STARTED|Baseline||14
8565522|NCT03377244|21115657|P1|STARTED|Baseline||19
8565544|NCT03284398|21115856|P2|NOT COMPLETED|Overall Study||0
8565545|NCT03284398|21115857|P1|NOT COMPLETED|Overall Study||0
8565546|NCT03284398|21115856|P2|COMPLETED|Overall Study||970
8565547|NCT03284398|21115857|P1|COMPLETED|Overall Study||2753
8565548|NCT03284398|21115856|P2|STARTED|Overall Study||970
8565549|NCT03284398|21115857|P1|STARTED|Overall Study||2753
8565558|NCT03250182|21115914|P1|NOT COMPLETED|Overall Study||1
8565559|NCT03250182|21115914|P1|COMPLETED|Overall Study||29
8565560|NCT03250182|21115914|P1|STARTED|Overall Study||30
8565581|NCT03142451|21115986|P2|NOT COMPLETED|Overall Study||24
8565582|NCT03142451|21115987|P1|NOT COMPLETED|Overall Study||58
8565583|NCT03142451|21115986|P2|COMPLETED|Overall Study||232
8565584|NCT03142451|21115987|P1|COMPLETED|Overall Study||437
8565585|NCT03142451|21115986|P2|STARTED|Overall Study||256
8565586|NCT03142451|21115987|P1|STARTED|Overall Study||495
8565608|NCT03066947|21116216|P1|NOT COMPLETED|Overall Study||10
8565609|NCT03066947|21116216|P1|COMPLETED|Overall Study||14
8565610|NCT03066947|21116216|P1|STARTED|Overall Study||24
8565611|NCT02916498|21116227|P2|NOT COMPLETED|Second Intervention, 21 Days||0
8565612|NCT02916498|21116228|P1|NOT COMPLETED|Second Intervention, 21 Days||0
8565613|NCT02916498|21116227|P2|COMPLETED|Second Intervention, 21 Days||4
8565614|NCT02916498|21116228|P1|COMPLETED|Second Intervention, 21 Days||2
8565615|NCT02916498|21116227|P2|STARTED|Second Intervention, 21 Days||4
8565616|NCT02916498|21116228|P1|STARTED|Second Intervention, 21 Days||2
8565617|NCT02916498|21116227|P2|NOT COMPLETED|First Intervention, 21 Days||0
8565618|NCT02916498|21116228|P1|NOT COMPLETED|First Intervention, 21 Days||0
8565619|NCT02916498|21116227|P2|COMPLETED|First Intervention, 21 Days||4
8565620|NCT02916498|21116228|P1|COMPLETED|First Intervention, 21 Days||2
8565621|NCT02916498|21116227|P2|STARTED|First Intervention, 21 Days||4
8565622|NCT02916498|21116228|P1|STARTED|First Intervention, 21 Days||2
8565635|NCT02833844|21116272|P2|NOT COMPLETED|Open-Label Period||2
8565636|NCT02833844|21116273|P1|NOT COMPLETED|Open-Label Period||2
8565637|NCT02833844|21116272|P2|COMPLETED|Open-Label Period||301
8565638|NCT02833844|21116273|P1|COMPLETED|Open-Label Period||150
8565639|NCT02833844|21116272|P2|Received Open-Label Study Drug|Open-Label Period||299
8565640|NCT02833844|21116273|P1|Received Open-Label Study Drug|Open-Label Period||152
8565641|NCT02833844|21116272|P2|STARTED|Open-Label Period||303
8565642|NCT02833844|21116273|P1|STARTED|Open-Label Period|3 participants did not continue to open-label period|152
8565643|NCT02833844|21116272|P2|NOT COMPLETED|Double-Blind Period||7
8565644|NCT02833844|21116273|P1|NOT COMPLETED|Double-Blind Period||2
8565645|NCT02833844|21116272|P2|COMPLETED|Double-Blind Period|completed double-blind period|303
8565646|NCT02833844|21116273|P1|COMPLETED|Double-Blind Period|completed double-blind period|155
8565647|NCT02833844|21116272|P2|Randomized and Treated|Double-Blind Period||307
8565648|NCT02833844|21116273|P1|Randomized and Treated|Double-Blind Period||157
8565649|NCT02833844|21116272|P2|STARTED|Double-Blind Period||310
8565650|NCT02833844|21116273|P1|STARTED|Double-Blind Period||157
8565651|NCT02754518|21116301|P1|NOT COMPLETED|Overall Study||0
8565652|NCT02754518|21116301|P1|COMPLETED|Overall Study||40
8565653|NCT02754518|21116301|P1|STARTED|Overall Study||40
8565657|NCT02728258|21116358|P1|NOT COMPLETED|Overall Study||0
8565658|NCT02728258|21116358|P1|COMPLETED|Overall Study||11
8565659|NCT02728258|21116358|P1|STARTED|Overall Study||11
8565708|NCT02668393|21116664|P2|NOT COMPLETED|Overall Study||6
8565709|NCT02668393|21116665|P1|NOT COMPLETED|Overall Study||7
8565710|NCT02668393|21116664|P2|COMPLETED|Overall Study||1
8565711|NCT02668393|21116665|P1|COMPLETED|Overall Study||0
8565712|NCT02668393|21116664|P2|STARTED|Overall Study||7
8565713|NCT02668393|21116665|P1|STARTED|Overall Study||7
8565723|NCT02635386|21116702|P5|NOT COMPLETED|Overall Study||9
8565724|NCT02635386|21116703|P4|NOT COMPLETED|Overall Study||7
8565725|NCT02635386|21116704|P3|NOT COMPLETED|Overall Study||2
8565726|NCT02635386|21116705|P2|NOT COMPLETED|Overall Study||6
8565727|NCT02635386|21116706|P1|NOT COMPLETED|Overall Study||3
8565728|NCT02635386|21116702|P5|COMPLETED|Overall Study||16
8565729|NCT02635386|21116703|P4|COMPLETED|Overall Study||19
8565730|NCT02635386|21116704|P3|COMPLETED|Overall Study||20
8565731|NCT02635386|21116705|P2|COMPLETED|Overall Study||17
8565732|NCT02635386|21116706|P1|COMPLETED|Overall Study||20
8565733|NCT02635386|21116702|P5|STARTED|Overall Study||25
8565734|NCT02635386|21116703|P4|STARTED|Overall Study||26
8565735|NCT02635386|21116704|P3|STARTED|Overall Study||22
8565736|NCT02635386|21116705|P2|STARTED|Overall Study||23
8565737|NCT02635386|21116706|P1|STARTED|Overall Study||23
8565750|NCT02454075|21116859|P1|NOT COMPLETED|Overall Study||0
8565751|NCT02454075|21116859|P1|COMPLETED|Overall Study||3
8565752|NCT02454075|21116859|P1|STARTED|Overall Study||3
8565759|NCT02332590|21116966|P2|NOT COMPLETED|Overall Study||19
8565760|NCT02332590|21116967|P1|NOT COMPLETED|Overall Study||29
8565761|NCT02332590|21116966|P2|COMPLETED|Overall Study|All 165 participants entered open-label treatment period.|165
8565762|NCT02332590|21116967|P1|COMPLETED|Overall Study|155 participants entered open-label treatment period and 1 did not enroll.|156
8565763|NCT02332590|21116966|P2|Treated|Overall Study||184
8565764|NCT02332590|21116967|P1|Treated|Overall Study||184
8565765|NCT02332590|21116966|P2|STARTED|Overall Study||184
8565766|NCT02332590|21116967|P1|STARTED|Overall Study||185
8565794|NCT02260258|21117182|P2|NOT COMPLETED|Overall Study||1
8565795|NCT02260258|21117183|P1|NOT COMPLETED|Overall Study||2
8565796|NCT02260258|21117182|P2|COMPLETED|Overall Study||43
8565797|NCT02260258|21117183|P1|COMPLETED|Overall Study||37
8565798|NCT02260258|21117182|P2|STARTED|Overall Study||44
8565799|NCT02260258|21117183|P1|STARTED|Overall Study||39
8565800|NCT02163824|21117205|P3|NOT COMPLETED|Overall Study||2
8565801|NCT02163824|21117206|P2|NOT COMPLETED|Overall Study||1
8565802|NCT02163824|21117207|P1|NOT COMPLETED|Overall Study||2
8565803|NCT02163824|21117205|P3|COMPLETED|Overall Study||124
8565804|NCT02163824|21117206|P2|COMPLETED|Overall Study||124
8565805|NCT02163824|21117207|P1|COMPLETED|Overall Study||127
8565806|NCT02163824|21117205|P3|STARTED|Overall Study||126
8565807|NCT02163824|21117206|P2|STARTED|Overall Study||125
8565808|NCT02163824|21117207|P1|STARTED|Overall Study||129
8565809|NCT01973283|21117230|P1|NOT COMPLETED|Overall Study||4
8565810|NCT01973283|21117230|P1|COMPLETED|Overall Study||96
8565811|NCT01973283|21117230|P1|STARTED|Overall Study||100
8565812|NCT01936519|21117258|P2|NOT COMPLETED|Overall Study||4
8565813|NCT01936519|21117259|P1|NOT COMPLETED|Overall Study||1
8565814|NCT01936519|21117258|P2|COMPLETED|Overall Study||8
8565815|NCT01936519|21117259|P1|COMPLETED|Overall Study||11
8565816|NCT01936519|21117258|P2|STARTED|Overall Study||12
8565817|NCT01936519|21117259|P1|STARTED|Overall Study||12
8565818|NCT01912456|21117277|P4|NOT COMPLETED|Period 2||1
8565819|NCT01912456|21117278|P3|NOT COMPLETED|Period 2||0
8565820|NCT01912456|21117279|P2|NOT COMPLETED|Period 2||2
8565821|NCT01912456|21117280|P1|NOT COMPLETED|Period 2||0
8565822|NCT01912456|21117277|P4|COMPLETED|Period 2||18
8565823|NCT01912456|21117278|P3|COMPLETED|Period 2||21
8565824|NCT01912456|21117279|P2|COMPLETED|Period 2||20
8565825|NCT01912456|21117280|P1|COMPLETED|Period 2||20
8565826|NCT01912456|21117277|P4|STARTED|Period 2||19
8565827|NCT01912456|21117278|P3|STARTED|Period 2||21
8565828|NCT01912456|21117279|P2|STARTED|Period 2||22
8565829|NCT01912456|21117280|P1|STARTED|Period 2||20
8565830|NCT01912456|21117277|P4|NOT COMPLETED|Period 1||3
8565831|NCT01912456|21117278|P3|NOT COMPLETED|Period 1||2
8565832|NCT01912456|21117279|P2|NOT COMPLETED|Period 1||1
8565833|NCT01912456|21117280|P1|NOT COMPLETED|Period 1||2
8565834|NCT01912456|21117277|P4|COMPLETED|Period 1||19
8565835|NCT01912456|21117278|P3|COMPLETED|Period 1||21
8565836|NCT01912456|21117279|P2|COMPLETED|Period 1||22
8565837|NCT01912456|21117280|P1|COMPLETED|Period 1||20
8565838|NCT01912456|21117277|P4|STARTED|Period 1||22
8565839|NCT01912456|21117278|P3|STARTED|Period 1||23
8565840|NCT01912456|21117279|P2|STARTED|Period 1||23
8565841|NCT01912456|21117280|P1|STARTED|Period 1||22
8565903|NCT01812109|21117428|P1|NOT COMPLETED|Overall Study||33
8565904|NCT01812109|21117428|P1|COMPLETED|Overall Study||121
8565905|NCT01812109|21117428|P1|Without Torsion|Overall Study||85
8565906|NCT01812109|21117428|P1|With Torsion|Overall Study||36
8565907|NCT01812109|21117428|P1|STARTED|Overall Study||154
8565908|NCT01804114|21117434|P2|NOT COMPLETED|Overall Study||0
8565909|NCT01804114|21117435|P1|NOT COMPLETED|Overall Study||0
8565910|NCT01804114|21117434|P2|COMPLETED|Overall Study||12
8565911|NCT01804114|21117435|P1|COMPLETED|Overall Study||17
8565912|NCT01804114|21117434|P2|STARTED|Overall Study||12
8565913|NCT01804114|21117435|P1|STARTED|Overall Study||17
8565990|NCT01380080|21117606|P2|NOT COMPLETED|Overall Study||83
8565991|NCT01380080|21117607|P1|NOT COMPLETED|Overall Study||85
8565992|NCT01380080|21117606|P2|COMPLETED|Overall Study||343
8565993|NCT01380080|21117607|P1|COMPLETED|Overall Study||339
8565994|NCT01380080|21117606|P2|STARTED|Overall Study||426
8565995|NCT01380080|21117607|P1|STARTED|Overall Study||424
8566011|NCT01271712|21117714|P2|NOT COMPLETED|Survival Follow-up||6
8566012|NCT01271712|21117715|P1|NOT COMPLETED|Survival Follow-up||15
8566013|NCT01271712|21117714|P2|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
8566014|NCT01271712|21117715|P1|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
8566015|NCT01271712|21117714|P2|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
8566016|NCT01271712|21117715|P1|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
8566017|NCT01271712|21117714|P2|NOT COMPLETED|Safety Follow-up||15
8566018|NCT01271712|21117715|P1|NOT COMPLETED|Safety Follow-up||21
8566019|NCT01271712|21117714|P2|COMPLETED|Safety Follow-up||37
8566020|NCT01271712|21117715|P1|COMPLETED|Safety Follow-up||97
8566021|NCT01271712|21117714|P2|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
8566022|NCT01271712|21117715|P1|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
8566023|NCT01271712|21117714|P2|NOT COMPLETED|Open Label Treatment||58
8566024|NCT01271712|21117715|P1|NOT COMPLETED|Open Label Treatment||91
8566025|NCT01271712|21117714|P2|COMPLETED|Open Label Treatment||0
8566026|NCT01271712|21117715|P1|COMPLETED|Open Label Treatment||0
8566027|NCT01271712|21117714|P2|STARTED|Open Label Treatment||58
8566028|NCT01271712|21117715|P1|STARTED|Open Label Treatment||91
8566029|NCT01271712|21117714|P2|NOT COMPLETED|Double Blind Treatment||8
8566030|NCT01271712|21117715|P1|NOT COMPLETED|Double Blind Treatment||42
8566031|NCT01271712|21117714|P2|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
8566032|NCT01271712|21117715|P1|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
8566033|NCT01271712|21117714|P2|Participants Received Treatment|Double Blind Treatment||66
8566034|NCT01271712|21117715|P1|Participants Received Treatment|Double Blind Treatment||132
8566035|NCT01271712|21117714|P2|STARTED|Double Blind Treatment||66
8566036|NCT01271712|21117715|P1|STARTED|Double Blind Treatment||133
8566091|NCT00923559|21117862|P2|NOT COMPLETED|Overall Study||3
8566092|NCT00923559|21117863|P1|NOT COMPLETED|Overall Study||2
8566093|NCT00923559|21117862|P2|COMPLETED|Overall Study||37
8566094|NCT00923559|21117863|P1|COMPLETED|Overall Study||38
8566095|NCT00923559|21117862|P2|STARTED|Overall Study||40
8566096|NCT00923559|21117863|P1|STARTED|Overall Study||40
8566130|NCT00664326|21117933|P1|NOT COMPLETED|Overall Study||48
8566131|NCT00664326|21117933|P1|COMPLETED|Overall Study|transitioned to rollover study|1
8566132|NCT00664326|21117933|P1|STARTED|Overall Study||49
8566213|NCT00125788|21118377|P2|NOT COMPLETED|Overall Study||4
8566214|NCT00125788|21118378|P1|NOT COMPLETED|Overall Study||4
8566215|NCT00125788|21118377|P2|COMPLETED|Overall Study||29
8566216|NCT00125788|21118378|P1|COMPLETED|Overall Study||33
8566217|NCT00125788|21118377|P2|STARTED|Overall Study||33
8566218|NCT00125788|21118378|P1|STARTED|Overall Study||37
8569887|NCT04674644|21129528|P1|NOT COMPLETED|Overall Study||37
8569888|NCT04674644|21129528|P1|COMPLETED|Overall Study||813
8569889|NCT04674644|21129528|P1|STARTED|Overall Study||850
8569890|NCT04633564|21129535|P2|NOT COMPLETED|Period 2||97
8569891|NCT04633564|21129536|P1|NOT COMPLETED|Period 2||93
8569892|NCT04633564|21129535|P2|COMPLETED|Period 2||102
8569893|NCT04633564|21129536|P1|COMPLETED|Period 2||107
8569894|NCT04633564|21129535|P2|STARTED|Period 2||199
8569895|NCT04633564|21129536|P1|STARTED|Period 2||200
8569896|NCT04633564|21129535|P2|NOT COMPLETED|Period 1||109
8569897|NCT04633564|21129536|P1|NOT COMPLETED|Period 1||108
8569898|NCT04633564|21129535|P2|COMPLETED|Period 1||220
8569899|NCT04633564|21129536|P1|COMPLETED|Period 1||227
8569900|NCT04633564|21129535|P2|STARTED|Period 1||329
8569901|NCT04633564|21129536|P1|STARTED|Period 1||335
8569920|NCT04194008|21129589|P1|NOT COMPLETED|Treatment Phase With Nerivio||8
8569921|NCT04194008|21129589|P1|COMPLETED|Treatment Phase With Nerivio||91
8569922|NCT04194008|21129589|P1|STARTED|Treatment Phase With Nerivio||99
8569923|NCT04194008|21129589|P1|NOT COMPLETED|Baseline (Run-in) Phase||27
8569924|NCT04194008|21129589|P1|COMPLETED|Baseline (Run-in) Phase||99
8569925|NCT04194008|21129589|P1|STARTED|Baseline (Run-in) Phase||126
8569935|NCT04152642|21129626|P1|NOT COMPLETED|Overall Study||7
8569936|NCT04152642|21129626|P1|COMPLETED|Overall Study||15
8569937|NCT04152642|21129626|P1|B (Experimental Rinse)|Overall Study||19
8569938|NCT04152642|21129626|P1|A (Marketed Rinse)|Overall Study||19
8569939|NCT04152642|21129626|P1|C (Water/Negative) Control|Overall Study||20
8569940|NCT04152642|21129626|P1|STARTED|Overall Study||22
8569941|NCT04144166|21129634|P1|NOT COMPLETED|Overall Study||3
8569942|NCT04144166|21129634|P1|COMPLETED|Overall Study||57
8569943|NCT04144166|21129634|P1|STARTED|Overall Study||60
8569953|NCT04011631|21129660|P1|NOT COMPLETED|Overall Study||0
8569954|NCT04011631|21129660|P1|COMPLETED|Overall Study||100
8569955|NCT04011631|21129660|P1|STARTED|Overall Study||100
8569974|NCT03862625|21129688|P2|NOT COMPLETED|Overall Study||1
8569975|NCT03862625|21129689|P1|NOT COMPLETED|Overall Study||0
8569976|NCT03862625|21129688|P2|COMPLETED|Overall Study||14
8569977|NCT03862625|21129689|P1|COMPLETED|Overall Study||15
8569978|NCT03862625|21129688|P2|STARTED|Overall Study||15
8569979|NCT03862625|21129689|P1|STARTED|Overall Study||15
8569980|NCT03821064|21129701|P1|NOT COMPLETED|Overall Study||1
8569981|NCT03821064|21129701|P1|COMPLETED|Overall Study||10
8569982|NCT03821064|21129701|P1|STARTED|Overall Study||11
8569983|NCT03807245|21129733|P3|NOT COMPLETED|Overall Study||0
8569984|NCT03807245|21129734|P2|NOT COMPLETED|Overall Study||0
8569985|NCT03807245|21129735|P1|NOT COMPLETED|Overall Study||1
8569986|NCT03807245|21129733|P3|COMPLETED|Overall Study||12
8569987|NCT03807245|21129734|P2|COMPLETED|Overall Study||24
8569988|NCT03807245|21129735|P1|COMPLETED|Overall Study||23
8569989|NCT03807245|21129733|P3|STARTED|Overall Study||12
8569990|NCT03807245|21129734|P2|STARTED|Overall Study||24
8569991|NCT03807245|21129735|P1|STARTED|Overall Study||24
8569998|NCT03799783|21129810|P1|NOT COMPLETED|Overall Study||0
8569999|NCT03799783|21129810|P1|COMPLETED|Overall Study||19
8570000|NCT03799783|21129810|P1|STARTED|Overall Study||19
8570001|NCT03798483|21129815|P1|NOT COMPLETED|Overall Study||2
8570002|NCT03798483|21129815|P1|COMPLETED|Overall Study||13
8570003|NCT03798483|21129815|P1|Returned All Follow-up Outcome Data|Overall Study||11
8570004|NCT03798483|21129815|P1|STARTED|Overall Study||15
8570071|NCT03629535|21130021|P1|NOT COMPLETED|Overall Study||0
8570072|NCT03629535|21130021|P1|COMPLETED|Overall Study||8
8570073|NCT03629535|21130021|P1|STARTED|Overall Study||8
8570074|NCT03629249|21130028|P3|NOT COMPLETED|Overall Study||202
8570075|NCT03629249|21130029|P2|NOT COMPLETED|Overall Study||201
8570076|NCT03629249|21130030|P1|NOT COMPLETED|Overall Study||201
8570077|NCT03629249|21130028|P3|COMPLETED|Overall Study||0
8570078|NCT03629249|21130029|P2|COMPLETED|Overall Study||0
8570079|NCT03629249|21130030|P1|COMPLETED|Overall Study||0
8570080|NCT03629249|21130028|P3|Safety Set (SAF)|Overall Study||201
8570081|NCT03629249|21130029|P2|Safety Set (SAF)|Overall Study||200
8570082|NCT03629249|21130030|P1|Safety Set (SAF)|Overall Study||201
8570083|NCT03629249|21130028|P3|Full Analysis Set (FAS)|Overall Study||201
8570084|NCT03629249|21130029|P2|Full Analysis Set (FAS)|Overall Study||200
8570085|NCT03629249|21130030|P1|Full Analysis Set (FAS)|Overall Study||201
8570086|NCT03629249|21130028|P3|STARTED|Overall Study||202
8570087|NCT03629249|21130029|P2|STARTED|Overall Study||201
8570088|NCT03629249|21130030|P1|STARTED|Overall Study||201
8570089|NCT03623373|21130062|P1|NOT COMPLETED|Overall Study||0
8570090|NCT03623373|21130062|P1|COMPLETED|Overall Study||13
8570091|NCT03623373|21130062|P1|STARTED|Overall Study||13
8570104|NCT03580343|21130090|P1|NOT COMPLETED|Overall Study||1
8570105|NCT03580343|21130090|P1|COMPLETED|Overall Study||4
8570106|NCT03580343|21130090|P1|STARTED|Overall Study||5
8570113|NCT03572634|21130111|P2|NOT COMPLETED|Overall Study||0
8570114|NCT03572634|21130112|P1|NOT COMPLETED|Overall Study||0
8570115|NCT03572634|21130111|P2|COMPLETED|Overall Study||2
8570116|NCT03572634|21130112|P1|COMPLETED|Overall Study||1
8570117|NCT03572634|21130111|P2|STARTED|Overall Study||2
8570118|NCT03572634|21130112|P1|STARTED|Overall Study||1
8570119|NCT03557125|21130130|P2|NOT COMPLETED|Overall Study||0
8570120|NCT03557125|21130131|P1|NOT COMPLETED|Overall Study||0
8570121|NCT03557125|21130130|P2|COMPLETED|Overall Study||24
8570122|NCT03557125|21130131|P1|COMPLETED|Overall Study||22
8570123|NCT03557125|21130130|P2|STARTED|Overall Study||24
8570124|NCT03557125|21130131|P1|STARTED|Overall Study||22
8570125|NCT03509974|21130149|P1|NOT COMPLETED|Overall Study||0
8570126|NCT03509974|21130149|P1|COMPLETED|Overall Study||14
8570127|NCT03509974|21130149|P1|STARTED|Overall Study||14
8570208|NCT03371355|21130354|P4|NOT COMPLETED|Overall Study||7
8570209|NCT03371355|21130355|P3|NOT COMPLETED|Overall Study||4
8570210|NCT03371355|21130356|P2|NOT COMPLETED|Overall Study||2
8570211|NCT03371355|21130357|P1|NOT COMPLETED|Overall Study||1
8570212|NCT03371355|21130354|P4|COMPLETED|Overall Study||19
8570213|NCT03371355|21130355|P3|COMPLETED|Overall Study||22
8570214|NCT03371355|21130356|P2|COMPLETED|Overall Study||24
8570215|NCT03371355|21130357|P1|COMPLETED|Overall Study||26
8570216|NCT03371355|21130354|P4|STARTED|Overall Study||26
8570217|NCT03371355|21130355|P3|STARTED|Overall Study||26
8570218|NCT03371355|21130356|P2|STARTED|Overall Study||26
8570219|NCT03371355|21130357|P1|STARTED|Overall Study||27
8570229|NCT03289455|21130531|P3|NOT COMPLETED|Overall Study||6
8570230|NCT03289455|21130532|P2|NOT COMPLETED|Overall Study||5
8570231|NCT03289455|21130533|P1|NOT COMPLETED|Overall Study||4
8570232|NCT03289455|21130531|P3|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
8570233|NCT03289455|21130532|P2|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
8570234|NCT03289455|21130533|P1|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
8570235|NCT03289455|21130531|P3|STARTED|Overall Study||6
8570236|NCT03289455|21130532|P2|STARTED|Overall Study||5
8570237|NCT03289455|21130533|P1|STARTED|Overall Study||4
8570268|NCT03227029|21130645|P3|NOT COMPLETED|Overall Study||4
8570269|NCT03227029|21130646|P2|NOT COMPLETED|Overall Study||4
8570270|NCT03227029|21130647|P1|NOT COMPLETED|Overall Study||4
8570271|NCT03227029|21130645|P3|COMPLETED|Overall Study||9
8570272|NCT03227029|21130646|P2|COMPLETED|Overall Study||22
8570273|NCT03227029|21130647|P1|COMPLETED|Overall Study||22
8570274|NCT03227029|21130645|P3|Received Inoculation|Overall Study||12
8570275|NCT03227029|21130646|P2|Received Inoculation|Overall Study||25
8570276|NCT03227029|21130647|P1|Received Inoculation|Overall Study||26
8570277|NCT03227029|21130645|P3|STARTED|Overall Study||13
8570278|NCT03227029|21130646|P2|STARTED|Overall Study||26
8570279|NCT03227029|21130647|P1|STARTED|Overall Study||26
8570289|NCT03178669|21130725|P5|NOT COMPLETED|Overall Study||4
8570290|NCT03178669|21130726|P4|NOT COMPLETED|Overall Study||4
8570291|NCT03178669|21130727|P3|NOT COMPLETED|Overall Study||7
8570292|NCT03178669|21130728|P2|NOT COMPLETED|Overall Study||1
8570293|NCT03178669|21130729|P1|NOT COMPLETED|Overall Study||5
8570294|NCT03178669|21130725|P5|COMPLETED|Overall Study||40
8570295|NCT03178669|21130726|P4|COMPLETED|Overall Study||38
8570296|NCT03178669|21130727|P3|COMPLETED|Overall Study||35
8570297|NCT03178669|21130728|P2|COMPLETED|Overall Study||42
8570298|NCT03178669|21130729|P1|COMPLETED|Overall Study||35
8570299|NCT03178669|21130725|P5|Completed Week 6|Overall Study||42
8570300|NCT03178669|21130726|P4|Completed Week 6|Overall Study||38
8570301|NCT03178669|21130727|P3|Completed Week 6|Overall Study||36
8570302|NCT03178669|21130728|P2|Completed Week 6|Overall Study||42
8570303|NCT03178669|21130729|P1|Completed Week 6|Overall Study||35
8570304|NCT03178669|21130725|P5|STARTED|Overall Study||44
8570305|NCT03178669|21130726|P4|STARTED|Overall Study||42
8570306|NCT03178669|21130727|P3|STARTED|Overall Study||42
8570307|NCT03178669|21130728|P2|STARTED|Overall Study||43
8570308|NCT03178669|21130729|P1|STARTED|Overall Study||40
8570309|NCT03172325|21130768|P2|NOT COMPLETED|Overall Study||4
8570310|NCT03172325|21130769|P1|NOT COMPLETED|Overall Study||4
8570311|NCT03172325|21130768|P2|COMPLETED|Overall Study||64
8570312|NCT03172325|21130769|P1|COMPLETED|Overall Study||64
8570313|NCT03172325|21130768|P2|STARTED|Overall Study||68
8570314|NCT03172325|21130769|P1|STARTED|Overall Study||68
8570342|NCT03125200|21131099|P7|NOT COMPLETED|Overall Study||3
8570343|NCT03125200|21131100|P6|NOT COMPLETED|Overall Study||3
8570344|NCT03125200|21131101|P5|NOT COMPLETED|Overall Study||4
8570345|NCT03125200|21131102|P4|NOT COMPLETED|Overall Study||5
8570346|NCT03125200|21131103|P3|NOT COMPLETED|Overall Study||2
8570347|NCT03125200|21131104|P2|NOT COMPLETED|Overall Study||2
8570348|NCT03125200|21131105|P1|NOT COMPLETED|Overall Study||2
8570349|NCT03125200|21131099|P7|COMPLETED|Overall Study||0
8570350|NCT03125200|21131100|P6|COMPLETED|Overall Study||0
8570351|NCT03125200|21131101|P5|COMPLETED|Overall Study||0
8570352|NCT03125200|21131102|P4|COMPLETED|Overall Study||0
8570353|NCT03125200|21131103|P3|COMPLETED|Overall Study||0
8570354|NCT03125200|21131104|P2|COMPLETED|Overall Study||0
8570355|NCT03125200|21131105|P1|COMPLETED|Overall Study||0
8570356|NCT03125200|21131099|P7|STARTED|Overall Study||3
8570357|NCT03125200|21131100|P6|STARTED|Overall Study||3
8570358|NCT03125200|21131101|P5|STARTED|Overall Study||4
8570359|NCT03125200|21131102|P4|STARTED|Overall Study||5
8570360|NCT03125200|21131103|P3|STARTED|Overall Study||2
8570361|NCT03125200|21131104|P2|STARTED|Overall Study||2
8570362|NCT03125200|21131105|P1|STARTED|Overall Study||2
8570419|NCT02956629|21131540|P6|NOT COMPLETED|Overall Study||1
8570420|NCT02956629|21131541|P5|NOT COMPLETED|Overall Study||0
8570421|NCT02956629|21131542|P4|NOT COMPLETED|Overall Study||1
8570422|NCT02956629|21131543|P3|NOT COMPLETED|Overall Study||4
8570423|NCT02956629|21131544|P2|NOT COMPLETED|Overall Study||6
8570424|NCT02956629|21131545|P1|NOT COMPLETED|Overall Study||5
8570425|NCT02956629|21131540|P6|COMPLETED|Overall Study||21
8570426|NCT02956629|21131541|P5|COMPLETED|Overall Study||18
8570427|NCT02956629|21131542|P4|COMPLETED|Overall Study||55
8570428|NCT02956629|21131543|P3|COMPLETED|Overall Study||57
8570429|NCT02956629|21131544|P2|COMPLETED|Overall Study||41
8570430|NCT02956629|21131545|P1|COMPLETED|Overall Study||73
8570431|NCT02956629|21131540|P6|STARTED|Overall Study||22
8570432|NCT02956629|21131541|P5|STARTED|Overall Study||18
8570433|NCT02956629|21131542|P4|STARTED|Overall Study||56
8570434|NCT02956629|21131543|P3|STARTED|Overall Study||61
8570435|NCT02956629|21131544|P2|STARTED|Overall Study||47
8570436|NCT02956629|21131545|P1|STARTED|Overall Study||78
8570491|NCT02865915|21131730|P2|NOT COMPLETED|Overall Study||30
8570492|NCT02865915|21131731|P1|NOT COMPLETED|Overall Study||25
8570493|NCT02865915|21131730|P2|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
8570494|NCT02865915|21131731|P1|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
8570495|NCT02865915|21131730|P2|STARTED|Overall Study||30
8570496|NCT02865915|21131731|P1|STARTED|Overall Study||25
8570506|NCT02810418|21131809|P7|NOT COMPLETED|Arm B Combination Therapy||0
8570507|NCT02810418|21131810|P6|NOT COMPLETED|Arm B Combination Therapy||0
8570508|NCT02810418|21131811|P5|NOT COMPLETED|Arm B Combination Therapy||0
8570509|NCT02810418|21131812|P4|NOT COMPLETED|Arm B Combination Therapy||0
8570510|NCT02810418|21131813|P3|NOT COMPLETED|Arm B Combination Therapy||0
8570511|NCT02810418|21131814|P2|NOT COMPLETED|Arm B Combination Therapy||0
8570512|NCT02810418|21131815|P1|NOT COMPLETED|Arm B Combination Therapy||0
8570513|NCT02810418|21131809|P7|COMPLETED|Arm B Combination Therapy||5
8570514|NCT02810418|21131810|P6|COMPLETED|Arm B Combination Therapy||0
8570515|NCT02810418|21131811|P5|COMPLETED|Arm B Combination Therapy||0
8570516|NCT02810418|21131812|P4|COMPLETED|Arm B Combination Therapy||0
8570517|NCT02810418|21131813|P3|COMPLETED|Arm B Combination Therapy||0
8570518|NCT02810418|21131814|P2|COMPLETED|Arm B Combination Therapy||0
8570519|NCT02810418|21131815|P1|COMPLETED|Arm B Combination Therapy||0
8570520|NCT02810418|21131809|P7|STARTED|Arm B Combination Therapy||5
8570521|NCT02810418|21131810|P6|STARTED|Arm B Combination Therapy||0
8570522|NCT02810418|21131811|P5|STARTED|Arm B Combination Therapy||0
8570523|NCT02810418|21131812|P4|STARTED|Arm B Combination Therapy||0
8570524|NCT02810418|21131813|P3|STARTED|Arm B Combination Therapy||0
8570525|NCT02810418|21131814|P2|STARTED|Arm B Combination Therapy||0
8570526|NCT02810418|21131815|P1|STARTED|Arm B Combination Therapy||0
8570527|NCT02810418|21131809|P7|NOT COMPLETED|Arm B Dose Escalation||0
8570528|NCT02810418|21131810|P6|NOT COMPLETED|Arm B Dose Escalation||2
8570529|NCT02810418|21131811|P5|NOT COMPLETED|Arm B Dose Escalation||1
8570530|NCT02810418|21131812|P4|NOT COMPLETED|Arm B Dose Escalation||0
8570531|NCT02810418|21131813|P3|NOT COMPLETED|Arm B Dose Escalation||0
8570532|NCT02810418|21131814|P2|NOT COMPLETED|Arm B Dose Escalation||0
8570533|NCT02810418|21131815|P1|NOT COMPLETED|Arm B Dose Escalation||0
8570534|NCT02810418|21131809|P7|COMPLETED|Arm B Dose Escalation||0
8570535|NCT02810418|21131810|P6|COMPLETED|Arm B Dose Escalation||4
8570536|NCT02810418|21131811|P5|COMPLETED|Arm B Dose Escalation||2
8570537|NCT02810418|21131812|P4|COMPLETED|Arm B Dose Escalation||6
8570538|NCT02810418|21131813|P3|COMPLETED|Arm B Dose Escalation||0
8570539|NCT02810418|21131814|P2|COMPLETED|Arm B Dose Escalation||0
8570540|NCT02810418|21131815|P1|COMPLETED|Arm B Dose Escalation||0
8570541|NCT02810418|21131809|P7|STARTED|Arm B Dose Escalation||0
8570542|NCT02810418|21131810|P6|STARTED|Arm B Dose Escalation||6
8570543|NCT02810418|21131811|P5|STARTED|Arm B Dose Escalation||3
8570544|NCT02810418|21131812|P4|STARTED|Arm B Dose Escalation||6
8570545|NCT02810418|21131813|P3|STARTED|Arm B Dose Escalation||0
8570546|NCT02810418|21131814|P2|STARTED|Arm B Dose Escalation||0
8570547|NCT02810418|21131815|P1|STARTED|Arm B Dose Escalation||0
8570548|NCT02810418|21131809|P7|NOT COMPLETED|Dose Expansion||0
8570549|NCT02810418|21131810|P6|NOT COMPLETED|Dose Expansion||0
8570550|NCT02810418|21131811|P5|NOT COMPLETED|Dose Expansion||0
8570551|NCT02810418|21131812|P4|NOT COMPLETED|Dose Expansion||0
8570552|NCT02810418|21131813|P3|NOT COMPLETED|Dose Expansion||3
8570553|NCT02810418|21131814|P2|NOT COMPLETED|Dose Expansion||1
8570554|NCT02810418|21131815|P1|NOT COMPLETED|Dose Expansion||0
8570555|NCT02810418|21131809|P7|COMPLETED|Dose Expansion||0
8570556|NCT02810418|21131810|P6|COMPLETED|Dose Expansion||0
8570557|NCT02810418|21131811|P5|COMPLETED|Dose Expansion||0
8570558|NCT02810418|21131812|P4|COMPLETED|Dose Expansion||0
8570559|NCT02810418|21131813|P3|COMPLETED|Dose Expansion||3
8570560|NCT02810418|21131814|P2|COMPLETED|Dose Expansion||7
8570561|NCT02810418|21131815|P1|COMPLETED|Dose Expansion||0
8570562|NCT02810418|21131809|P7|STARTED|Dose Expansion||0
8570563|NCT02810418|21131810|P6|STARTED|Dose Expansion||0
8570564|NCT02810418|21131811|P5|STARTED|Dose Expansion||0
8570565|NCT02810418|21131812|P4|STARTED|Dose Expansion||0
8570566|NCT02810418|21131813|P3|STARTED|Dose Expansion||6
8570567|NCT02810418|21131814|P2|STARTED|Dose Expansion||8
8570568|NCT02810418|21131815|P1|STARTED|Dose Expansion||0
8570569|NCT02810418|21131809|P7|NOT COMPLETED|Arm A Dose Escalation||0
8570570|NCT02810418|21131810|P6|NOT COMPLETED|Arm A Dose Escalation||0
8570571|NCT02810418|21131811|P5|NOT COMPLETED|Arm A Dose Escalation||0
8570572|NCT02810418|21131812|P4|NOT COMPLETED|Arm A Dose Escalation||0
8570573|NCT02810418|21131813|P3|NOT COMPLETED|Arm A Dose Escalation||0
8570574|NCT02810418|21131814|P2|NOT COMPLETED|Arm A Dose Escalation||1
8570575|NCT02810418|21131815|P1|NOT COMPLETED|Arm A Dose Escalation||2
8570576|NCT02810418|21131809|P7|COMPLETED|Arm A Dose Escalation||0
8570577|NCT02810418|21131810|P6|COMPLETED|Arm A Dose Escalation||0
8570578|NCT02810418|21131811|P5|COMPLETED|Arm A Dose Escalation||0
8570579|NCT02810418|21131812|P4|COMPLETED|Arm A Dose Escalation||0
8570580|NCT02810418|21131813|P3|COMPLETED|Arm A Dose Escalation||0
8570581|NCT02810418|21131814|P2|COMPLETED|Arm A Dose Escalation||7
8570582|NCT02810418|21131815|P1|COMPLETED|Arm A Dose Escalation||4
8570583|NCT02810418|21131809|P7|STARTED|Arm A Dose Escalation||0
8570584|NCT02810418|21131810|P6|STARTED|Arm A Dose Escalation||0
8570585|NCT02810418|21131811|P5|STARTED|Arm A Dose Escalation||0
8570586|NCT02810418|21131812|P4|STARTED|Arm A Dose Escalation||0
8570587|NCT02810418|21131813|P3|STARTED|Arm A Dose Escalation||0
8570588|NCT02810418|21131814|P2|STARTED|Arm A Dose Escalation||8
8570589|NCT02810418|21131815|P1|STARTED|Arm A Dose Escalation||6
8570590|NCT02782780|21131909|P2|NOT COMPLETED|Overall Study||7
8570591|NCT02782780|21131910|P1|NOT COMPLETED|Overall Study||7
8570592|NCT02782780|21131909|P2|COMPLETED|Overall Study||32
8570593|NCT02782780|21131910|P1|COMPLETED|Overall Study||39
8570594|NCT02782780|21131909|P2|STARTED|Overall Study||39
8570595|NCT02782780|21131910|P1|STARTED|Overall Study||46
8570635|NCT02746874|21131988|P2|NOT COMPLETED|Overall Study||3
8570636|NCT02746874|21131989|P1|NOT COMPLETED|Overall Study||0
8570637|NCT02746874|21131988|P2|COMPLETED|Overall Study||32
8570638|NCT02746874|21131989|P1|COMPLETED|Overall Study||35
8570639|NCT02746874|21131988|P2|STARTED|Overall Study||35
8570640|NCT02746874|21131989|P1|STARTED|Overall Study||35
8570647|NCT02708966|21132052|P2|NOT COMPLETED|Overall Study||2
8570648|NCT02708966|21132053|P1|NOT COMPLETED|Overall Study||2
8570649|NCT02708966|21132052|P2|COMPLETED|Overall Study||13
8570650|NCT02708966|21132053|P1|COMPLETED|Overall Study||13
8570651|NCT02708966|21132052|P2|STARTED|Overall Study||15
8570652|NCT02708966|21132053|P1|STARTED|Overall Study||15
8570674|NCT02688621|21132132|P2|NOT COMPLETED|Overall Study||18
8570675|NCT02688621|21132133|P1|NOT COMPLETED|Overall Study||40
8570676|NCT02688621|21132132|P2|COMPLETED|Overall Study||188
8570677|NCT02688621|21132133|P1|COMPLETED|Overall Study||172
8570678|NCT02688621|21132132|P2|STARTED|Overall Study||206
8570679|NCT02688621|21132133|P1|STARTED|Overall Study||212
8570731|NCT02658448|21132453|P1|NOT COMPLETED|Overall Study||1
8570732|NCT02658448|21132453|P1|COMPLETED|Overall Study|One patient was lost to follow-up after enrollment and prior to visit 1|18
8570733|NCT02658448|21132453|P1|STARTED|Overall Study||19
8570737|NCT02646423|21132475|P2|NOT COMPLETED|Overall Study||8
8570738|NCT02646423|21132476|P1|NOT COMPLETED|Overall Study||7
8570739|NCT02646423|21132475|P2|COMPLETED|Overall Study||735
8570740|NCT02646423|21132476|P1|COMPLETED|Overall Study||735
8570741|NCT02646423|21132475|P2|STARTED|Overall Study||743
8570742|NCT02646423|21132476|P1|STARTED|Overall Study||742
8570773|NCT02589977|21132560|P3|NOT COMPLETED|Overall Study||4
8570774|NCT02589977|21132561|P2|NOT COMPLETED|Overall Study||5
8570775|NCT02589977|21132562|P1|NOT COMPLETED|Overall Study||6
8570776|NCT02589977|21132560|P3|COMPLETED|Overall Study||8
8570777|NCT02589977|21132561|P2|COMPLETED|Overall Study||15
8570778|NCT02589977|21132562|P1|COMPLETED|Overall Study||17
8570779|NCT02589977|21132560|P3|STARTED|Overall Study||12
8570780|NCT02589977|21132561|P2|STARTED|Overall Study||20
8570781|NCT02589977|21132562|P1|STARTED|Overall Study||23
8570782|NCT02569632|21132582|P1|NOT COMPLETED|Overall Study||1
8570783|NCT02569632|21132582|P1|COMPLETED|Overall Study||17
8570784|NCT02569632|21132582|P1|STARTED|Overall Study||18
8570785|NCT02559687|21132587|P1|NOT COMPLETED|Overall Study||121
8570786|NCT02559687|21132587|P1|COMPLETED|Overall Study||0
8570787|NCT02559687|21132587|P1|STARTED|Overall Study||121
8570813|NCT02533934|21132672|P2|NOT COMPLETED|Overall Study||0
8570814|NCT02533934|21132673|P1|NOT COMPLETED|Overall Study||0
8570815|NCT02533934|21132672|P2|COMPLETED|Overall Study||26
8570816|NCT02533934|21132673|P1|COMPLETED|Overall Study||42
8570817|NCT02533934|21132672|P2|STARTED|Overall Study||26
8570818|NCT02533934|21132673|P1|STARTED|Overall Study||42
8570819|NCT02524288|21132686|P1|NOT COMPLETED|Overall Study||1941
8570820|NCT02524288|21132686|P1|COMPLETED|Overall Study||0
8570821|NCT02524288|21132686|P1|Treated|Overall Study||1936
8570822|NCT02524288|21132686|P1|STARTED|Overall Study||1941
8570823|NCT02524119|21132694|P1|NOT COMPLETED|Overall Study||0
8570824|NCT02524119|21132694|P1|COMPLETED|Overall Study||5
8570825|NCT02524119|21132694|P1|STARTED|Overall Study||5
8570832|NCT02465567|21132721|P4|NOT COMPLETED|Overall Study||508
8570833|NCT02465567|21132722|P3|NOT COMPLETED|Overall Study||563
8570834|NCT02465567|21132723|P2|NOT COMPLETED|Overall Study||424
8570835|NCT02465567|21132724|P1|NOT COMPLETED|Overall Study||449
8570836|NCT02465567|21132721|P4|COMPLETED|Overall Study||1643
8570837|NCT02465567|21132722|P3|COMPLETED|Overall Study||1580
8570838|NCT02465567|21132723|P2|COMPLETED|Overall Study||1713
8570839|NCT02465567|21132724|P1|COMPLETED|Overall Study||1708
8570840|NCT02465567|21132721|P4|STARTED|Overall Study||2151
8570841|NCT02465567|21132722|P3|STARTED|Overall Study||2143
8570842|NCT02465567|21132723|P2|STARTED|Overall Study||2137
8570843|NCT02465567|21132724|P1|STARTED|Overall Study||2157
8570871|NCT02367105|21132819|P2|NOT COMPLETED|Overall Study||8
8570872|NCT02367105|21132820|P1|NOT COMPLETED|Overall Study||5
8570873|NCT02367105|21132819|P2|COMPLETED|Overall Study||34
8570874|NCT02367105|21132820|P1|COMPLETED|Overall Study||36
8570875|NCT02367105|21132819|P2|STARTED|Overall Study||42
8570876|NCT02367105|21132820|P1|STARTED|Overall Study||41
8570886|NCT02292654|21132942|P3|NOT COMPLETED|Overall Study||0
8570887|NCT02292654|21132943|P2|NOT COMPLETED|Overall Study||0
8570888|NCT02292654|21132944|P1|NOT COMPLETED|Overall Study||0
8570889|NCT02292654|21132942|P3|COMPLETED|Overall Study||7
8570890|NCT02292654|21132943|P2|COMPLETED|Overall Study||9
8570891|NCT02292654|21132944|P1|COMPLETED|Overall Study||4
8570892|NCT02292654|21132942|P3|STARTED|Overall Study||7
8570893|NCT02292654|21132943|P2|STARTED|Overall Study||9
8570894|NCT02292654|21132944|P1|STARTED|Overall Study||4
8570895|NCT02286713|21133077|P2|NOT COMPLETED|Six Month Follow-Up||27
8570896|NCT02286713|21133078|P1|NOT COMPLETED|Six Month Follow-Up||32
8570897|NCT02286713|21133077|P2|COMPLETED|Six Month Follow-Up||225
8570898|NCT02286713|21133078|P1|COMPLETED|Six Month Follow-Up||218
8570899|NCT02286713|21133077|P2|STARTED|Six Month Follow-Up||252
8570900|NCT02286713|21133078|P1|STARTED|Six Month Follow-Up||250
8570901|NCT02286713|21133077|P2|NOT COMPLETED|Three Month Follow-Up||26
8570902|NCT02286713|21133078|P1|NOT COMPLETED|Three Month Follow-Up||28
8570903|NCT02286713|21133077|P2|COMPLETED|Three Month Follow-Up||228
8570904|NCT02286713|21133078|P1|COMPLETED|Three Month Follow-Up||224
8570905|NCT02286713|21133077|P2|STARTED|Three Month Follow-Up||254
8570906|NCT02286713|21133078|P1|STARTED|Three Month Follow-Up||252
8570907|NCT02286713|21133077|P2|NOT COMPLETED|One Week Follow-Up||24
8570908|NCT02286713|21133078|P1|NOT COMPLETED|One Week Follow-Up||24
8570909|NCT02286713|21133077|P2|COMPLETED|One Week Follow-Up||233
8570910|NCT02286713|21133078|P1|COMPLETED|One Week Follow-Up||235
8570911|NCT02286713|21133077|P2|STARTED|One Week Follow-Up||257
8570912|NCT02286713|21133078|P1|STARTED|One Week Follow-Up||259
8570913|NCT02283749|21133090|P1|NOT COMPLETED|Overall Study||0
8570914|NCT02283749|21133090|P1|COMPLETED|Overall Study||5
8570915|NCT02283749|21133090|P1|STARTED|Overall Study||5
8570948|NCT02260921|21133365|P2|NOT COMPLETED|Overall Study||4
8570949|NCT02260921|21133366|P1|NOT COMPLETED|Overall Study||14
8570950|NCT02260921|21133365|P2|COMPLETED|Overall Study||55
8570951|NCT02260921|21133366|P1|COMPLETED|Overall Study||107
8570952|NCT02260921|21133365|P2|Per-Protocol Population|Overall Study||56
8570953|NCT02260921|21133366|P1|Per-Protocol Population|Overall Study||112
8570954|NCT02260921|21133365|P2|STARTED|Overall Study||59
8570955|NCT02260921|21133366|P1|STARTED|Overall Study||121
8570956|NCT02210286|21133388|P1|NOT COMPLETED|Overall Study||2
8570957|NCT02210286|21133388|P1|COMPLETED|Overall Study||15
8570958|NCT02210286|21133388|P1|STARTED|Overall Study||17
8571046|NCT02114814|21133535|P2|NOT COMPLETED|Overall Study||9
8571047|NCT02114814|21133536|P1|NOT COMPLETED|Overall Study||15
8571048|NCT02114814|21133535|P2|COMPLETED|Overall Study||74
8571049|NCT02114814|21133536|P1|COMPLETED|Overall Study||88
8571050|NCT02114814|21133535|P2|STARTED|Overall Study||83
8571051|NCT02114814|21133536|P1|STARTED|Overall Study||103
8571063|NCT02049944|21133577|P1|NOT COMPLETED|Overall Study||2
8571064|NCT02049944|21133577|P1|COMPLETED|Overall Study||28
8571065|NCT02049944|21133577|P1|Extremely Obese (BMI >40kg/m^2)|Overall Study||14
8571066|NCT02049944|21133577|P1|Obese (BMI 30-40kg/m^2)|Overall Study||14
8571067|NCT02049944|21133577|P1|STARTED|Overall Study||30
8571068|NCT02025985|21133586|P5|NOT COMPLETED|Overall Study||20
8571069|NCT02025985|21133587|P4|NOT COMPLETED|Overall Study||21
8571070|NCT02025985|21133588|P3|NOT COMPLETED|Overall Study||25
8571071|NCT02025985|21133589|P2|NOT COMPLETED|Overall Study||23
8571072|NCT02025985|21133590|P1|NOT COMPLETED|Overall Study||25
8571073|NCT02025985|21133586|P5|COMPLETED|Overall Study||0
8571074|NCT02025985|21133587|P4|COMPLETED|Overall Study||0
8571075|NCT02025985|21133588|P3|COMPLETED|Overall Study||0
8571076|NCT02025985|21133589|P2|COMPLETED|Overall Study||0
8571077|NCT02025985|21133590|P1|COMPLETED|Overall Study||0
8571078|NCT02025985|21133586|P5|Modified Intent-to-treat(mITT)Population|Overall Study||20
8571079|NCT02025985|21133587|P4|Modified Intent-to-treat(mITT)Population|Overall Study||21
8571080|NCT02025985|21133588|P3|Modified Intent-to-treat(mITT)Population|Overall Study||25
8571081|NCT02025985|21133589|P2|Modified Intent-to-treat(mITT)Population|Overall Study||22
8571082|NCT02025985|21133590|P1|Modified Intent-to-treat(mITT)Population|Overall Study||23
8571083|NCT02025985|21133586|P5|STARTED|Overall Study||20
8571084|NCT02025985|21133587|P4|STARTED|Overall Study||21
8571085|NCT02025985|21133588|P3|STARTED|Overall Study||25
8571086|NCT02025985|21133589|P2|STARTED|Overall Study||23
8571087|NCT02025985|21133590|P1|STARTED|Overall Study||25
8571088|NCT02024204|21133650|P2|NOT COMPLETED|Overall Study||0
8571089|NCT02024204|21133651|P1|NOT COMPLETED|Overall Study||0
8571090|NCT02024204|21133650|P2|COMPLETED|Overall Study||11
8571091|NCT02024204|21133651|P1|COMPLETED|Overall Study||49
8571092|NCT02024204|21133650|P2|STARTED|Overall Study||11
8571093|NCT02024204|21133651|P1|STARTED|Overall Study||49
8571210|NCT01904903|21133788|P1|NOT COMPLETED|Overall Study||1
8571211|NCT01904903|21133788|P1|COMPLETED|Overall Study||30
8571212|NCT01904903|21133788|P1|STARTED|Overall Study||31
8571213|NCT01901679|21133794|P2|NOT COMPLETED|Overall Study||0
8571214|NCT01901679|21133795|P1|NOT COMPLETED|Overall Study||0
8571215|NCT01901679|21133794|P2|COMPLETED|Overall Study||5
8571216|NCT01901679|21133795|P1|COMPLETED|Overall Study||5
8571217|NCT01901679|21133794|P2|STARTED|Overall Study||5
8571218|NCT01901679|21133795|P1|STARTED|Overall Study||5
8571219|NCT01875367|21133803|P2|NOT COMPLETED|Overall Study||2
8571220|NCT01875367|21133804|P1|NOT COMPLETED|Overall Study||5
8571221|NCT01875367|21133803|P2|COMPLETED|Overall Study||83
8571222|NCT01875367|21133804|P1|COMPLETED|Overall Study||76
8571223|NCT01875367|21133803|P2|STARTED|Overall Study||85
8571224|NCT01875367|21133804|P1|STARTED|Overall Study||81
8571249|NCT01850524|21133839|P2|NOT COMPLETED|Overall Study||351
8571250|NCT01850524|21133840|P1|NOT COMPLETED|Overall Study||354
8571251|NCT01850524|21133839|P2|COMPLETED|Overall Study||0
8571252|NCT01850524|21133840|P1|COMPLETED|Overall Study||0
8571253|NCT01850524|21133839|P2|Participants With Exposure of ≥ 19 Cycles|Overall Study||191
8571254|NCT01850524|21133840|P1|Participants With Exposure of ≥ 19 Cycles|Overall Study||189
8571255|NCT01850524|21133839|P2|Per Protocol (PP) Population|Overall Study||298
8571256|NCT01850524|21133840|P1|Per Protocol (PP) Population|Overall Study||295
8571257|NCT01850524|21133839|P2|Participants Completed Study Treatment Per Protocol|Overall Study||264
8571258|NCT01850524|21133840|P1|Participants Completed Study Treatment Per Protocol|Overall Study||270
8571259|NCT01850524|21133839|P2|Safety Population|Overall Study|Included 4 participants from placebo who received ixazomib; 1 participant who withdrew was excluded.|354
8571260|NCT01850524|21133840|P1|Safety Population|Overall Study|1 participant in this arm who withdrew from the study was not included in the safety population.|349
8571261|NCT01850524|21133839|P2|Intent-to-Treat (ITT) Population|Overall Study||351
8571262|NCT01850524|21133840|P1|Intent-to-Treat (ITT) Population|Overall Study||354
8571263|NCT01850524|21133839|P2|STARTED|Overall Study||351
8571264|NCT01850524|21133840|P1|STARTED|Overall Study||354
8571265|NCT01833520|21133850|P4|NOT COMPLETED|Overall Study||3
8571266|NCT01833520|21133851|P3|NOT COMPLETED|Overall Study||8
8571267|NCT01833520|21133852|P2|NOT COMPLETED|Overall Study||3
8571268|NCT01833520|21133853|P1|NOT COMPLETED|Overall Study||3
8571269|NCT01833520|21133850|P4|COMPLETED|Overall Study||0
8571270|NCT01833520|21133851|P3|COMPLETED|Overall Study||1
8571271|NCT01833520|21133852|P2|COMPLETED|Overall Study||0
8571272|NCT01833520|21133853|P1|COMPLETED|Overall Study||0
8571273|NCT01833520|21133850|P4|STARTED|Overall Study||3
8571274|NCT01833520|21133851|P3|STARTED|Overall Study||9
8571275|NCT01833520|21133852|P2|STARTED|Overall Study||3
8571276|NCT01833520|21133853|P1|STARTED|Overall Study||3
8571277|NCT01831427|21133876|P11|NOT COMPLETED|Overall Study||3
8571278|NCT01831427|21133877|P10|NOT COMPLETED|Overall Study||1
8571279|NCT01831427|21133878|P9|NOT COMPLETED|Overall Study||0
8571280|NCT01831427|21133879|P8|NOT COMPLETED|Overall Study||1
8571281|NCT01831427|21133880|P7|NOT COMPLETED|Overall Study||2
8571282|NCT01831427|21133881|P6|NOT COMPLETED|Overall Study||1
8571283|NCT01831427|21133882|P5|NOT COMPLETED|Overall Study||0
8571284|NCT01831427|21133883|P4|NOT COMPLETED|Overall Study||1
8571285|NCT01831427|21133884|P3|NOT COMPLETED|Overall Study||0
8571286|NCT01831427|21133885|P2|NOT COMPLETED|Overall Study||1
8571287|NCT01831427|21133886|P1|NOT COMPLETED|Overall Study||0
8571288|NCT01831427|21133876|P11|COMPLETED|Overall Study||5
8571289|NCT01831427|21133877|P10|COMPLETED|Overall Study||9
8571290|NCT01831427|21133878|P9|COMPLETED|Overall Study||8
8571291|NCT01831427|21133879|P8|COMPLETED|Overall Study||7
8571292|NCT01831427|21133880|P7|COMPLETED|Overall Study||6
8571293|NCT01831427|21133881|P6|COMPLETED|Overall Study||7
8571294|NCT01831427|21133882|P5|COMPLETED|Overall Study||4
8571295|NCT01831427|21133883|P4|COMPLETED|Overall Study||4
8571296|NCT01831427|21133884|P3|COMPLETED|Overall Study||5
8571297|NCT01831427|21133885|P2|COMPLETED|Overall Study||4
8571298|NCT01831427|21133886|P1|COMPLETED|Overall Study||5
8571299|NCT01831427|21133876|P11|STARTED|Overall Study||8
8571300|NCT01831427|21133877|P10|STARTED|Overall Study||10
8571301|NCT01831427|21133878|P9|STARTED|Overall Study||8
8571302|NCT01831427|21133879|P8|STARTED|Overall Study||8
8571303|NCT01831427|21133880|P7|STARTED|Overall Study||8
8571304|NCT01831427|21133881|P6|STARTED|Overall Study||8
8571305|NCT01831427|21133882|P5|STARTED|Overall Study||4
8571306|NCT01831427|21133883|P4|STARTED|Overall Study||5
8571307|NCT01831427|21133884|P3|STARTED|Overall Study||5
8571308|NCT01831427|21133885|P2|STARTED|Overall Study||5
8571309|NCT01831427|21133886|P1|STARTED|Overall Study||5
8571310|NCT01801982|21133943|P1|NOT COMPLETED|Overall Study||1
8571311|NCT01801982|21133943|P1|COMPLETED|Overall Study||0
8571312|NCT01801982|21133943|P1|STARTED|Overall Study||1
8571374|NCT01751906|21134048|P2|NOT COMPLETED|Overall Study||131
8571375|NCT01751906|21134049|P1|NOT COMPLETED|Overall Study||263
8571376|NCT01751906|21134048|P2|COMPLETED|Overall Study||555
8571377|NCT01751906|21134049|P1|COMPLETED|Overall Study||1059
8571378|NCT01751906|21134048|P2|STARTED|Overall Study||686
8571379|NCT01751906|21134049|P1|STARTED|Overall Study||1322
8571425|NCT01642407|21134238|P1|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
8571426|NCT01642407|21134238|P1|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
8571427|NCT01642407|21134238|P1|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
8571428|NCT01642407|21134238|P1|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
8571429|NCT01642407|21134238|P1|COMPLETED|Part 1 (Screening Till Week 16)||3
8571430|NCT01642407|21134238|P1|STARTED|Part 1 (Screening Till Week 16)||6
8571449|NCT01593917|21134331|P1|NOT COMPLETED|Overall Study||170
8571450|NCT01593917|21134331|P1|COMPLETED|Overall Study||159
8571451|NCT01593917|21134331|P1|STARTED|Overall Study||329
8571461|NCT01576523|21134371|P6|NOT COMPLETED|Dosing Period 2||0
8571462|NCT01576523|21134372|P5|NOT COMPLETED|Dosing Period 2||0
8571463|NCT01576523|21134373|P4|NOT COMPLETED|Dosing Period 2||0
8571464|NCT01576523|21134374|P3|NOT COMPLETED|Dosing Period 2||0
8571465|NCT01576523|21134375|P2|NOT COMPLETED|Dosing Period 2||0
8571466|NCT01576523|21134376|P1|NOT COMPLETED|Dosing Period 2||0
8571467|NCT01576523|21134371|P6|COMPLETED|Dosing Period 2||3
8571468|NCT01576523|21134372|P5|COMPLETED|Dosing Period 2||3
8571469|NCT01576523|21134373|P4|COMPLETED|Dosing Period 2||3
8571470|NCT01576523|21134374|P3|COMPLETED|Dosing Period 2||3
8571471|NCT01576523|21134375|P2|COMPLETED|Dosing Period 2||3
8571472|NCT01576523|21134376|P1|COMPLETED|Dosing Period 2||3
8571473|NCT01576523|21134371|P6|STARTED|Dosing Period 2||3
8571474|NCT01576523|21134372|P5|STARTED|Dosing Period 2||3
8571475|NCT01576523|21134373|P4|STARTED|Dosing Period 2||3
8571476|NCT01576523|21134374|P3|STARTED|Dosing Period 2||3
8571477|NCT01576523|21134375|P2|STARTED|Dosing Period 2||3
8571478|NCT01576523|21134376|P1|STARTED|Dosing Period 2||3
8571479|NCT01576523|21134371|P6|NOT COMPLETED|Dosing Period 1||0
8571480|NCT01576523|21134372|P5|NOT COMPLETED|Dosing Period 1||0
8571481|NCT01576523|21134373|P4|NOT COMPLETED|Dosing Period 1||0
8571482|NCT01576523|21134374|P3|NOT COMPLETED|Dosing Period 1||0
8571483|NCT01576523|21134375|P2|NOT COMPLETED|Dosing Period 1||0
8571484|NCT01576523|21134376|P1|NOT COMPLETED|Dosing Period 1||0
8571485|NCT01576523|21134371|P6|COMPLETED|Dosing Period 1||3
8571486|NCT01576523|21134372|P5|COMPLETED|Dosing Period 1||3
8571487|NCT01576523|21134373|P4|COMPLETED|Dosing Period 1||3
8571488|NCT01576523|21134374|P3|COMPLETED|Dosing Period 1||3
8571489|NCT01576523|21134375|P2|COMPLETED|Dosing Period 1||3
8571490|NCT01576523|21134376|P1|COMPLETED|Dosing Period 1||3
8571491|NCT01576523|21134371|P6|STARTED|Dosing Period 1||3
8571492|NCT01576523|21134372|P5|STARTED|Dosing Period 1||3
8571493|NCT01576523|21134373|P4|STARTED|Dosing Period 1||3
8571494|NCT01576523|21134374|P3|STARTED|Dosing Period 1||3
8571495|NCT01576523|21134375|P2|STARTED|Dosing Period 1||3
8571496|NCT01576523|21134376|P1|STARTED|Dosing Period 1||3
8571503|NCT01557244|21134457|P7|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
8571504|NCT01557244|21134458|P6|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
8571505|NCT01557244|21134459|P5|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
8571506|NCT01557244|21134460|P4|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
8571507|NCT01557244|21134461|P3|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
8571508|NCT01557244|21134462|P2|NOT COMPLETED|Safety Extension Phase: 12 Weeks||4
8571509|NCT01557244|21134463|P1|NOT COMPLETED|Safety Extension Phase: 12 Weeks||3
8571510|NCT01557244|21134457|P7|COMPLETED|Safety Extension Phase: 12 Weeks||28
8571511|NCT01557244|21134458|P6|COMPLETED|Safety Extension Phase: 12 Weeks||20
8571512|NCT01557244|21134459|P5|COMPLETED|Safety Extension Phase: 12 Weeks||20
8571513|NCT01557244|21134460|P4|COMPLETED|Safety Extension Phase: 12 Weeks||15
8571514|NCT01557244|21134461|P3|COMPLETED|Safety Extension Phase: 12 Weeks||0
8571515|NCT01557244|21134462|P2|COMPLETED|Safety Extension Phase: 12 Weeks||36
8571516|NCT01557244|21134463|P1|COMPLETED|Safety Extension Phase: 12 Weeks||30
8571517|NCT01557244|21134457|P7|Treated|Safety Extension Phase: 12 Weeks||28
8571518|NCT01557244|21134458|P6|Treated|Safety Extension Phase: 12 Weeks||20
8571519|NCT01557244|21134459|P5|Treated|Safety Extension Phase: 12 Weeks||20
8571520|NCT01557244|21134460|P4|Treated|Safety Extension Phase: 12 Weeks||16
8571521|NCT01557244|21134461|P3|Treated|Safety Extension Phase: 12 Weeks||0
8571522|NCT01557244|21134462|P2|Treated|Safety Extension Phase: 12 Weeks||37
8571523|NCT01557244|21134463|P1|Treated|Safety Extension Phase: 12 Weeks||30
8571524|NCT01557244|21134457|P7|STARTED|Safety Extension Phase: 12 Weeks||28
8571525|NCT01557244|21134458|P6|STARTED|Safety Extension Phase: 12 Weeks||21
8571526|NCT01557244|21134459|P5|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|20
8571527|NCT01557244|21134460|P4|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|16
8571528|NCT01557244|21134461|P3|STARTED|Safety Extension Phase: 12 Weeks|Did not receive oxybutynin in safety extension phase.|0
8571529|NCT01557244|21134462|P2|STARTED|Safety Extension Phase: 12 Weeks||40
8571530|NCT01557244|21134463|P1|STARTED|Safety Extension Phase: 12 Weeks||33
8571531|NCT01557244|21134457|P7|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||1
8571532|NCT01557244|21134458|P6|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||7
8571533|NCT01557244|21134459|P5|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
8571534|NCT01557244|21134460|P4|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
8571535|NCT01557244|21134461|P3|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||4
8571536|NCT01557244|21134462|P2|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||2
8571537|NCT01557244|21134463|P1|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||9
8571538|NCT01557244|21134457|P7|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||28
8571539|NCT01557244|21134458|P6|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||21
8571540|NCT01557244|21134459|P5|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
8571541|NCT01557244|21134460|P4|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
8571542|NCT01557244|21134461|P3|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||36
8571543|NCT01557244|21134462|P2|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||40
8571544|NCT01557244|21134463|P1|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||33
8571545|NCT01557244|21134457|P7|Treated|Active Comparator/Efficacy Phase:12Weeks||29
8571546|NCT01557244|21134458|P6|Treated|Active Comparator/Efficacy Phase:12Weeks||28
8571547|NCT01557244|21134459|P5|Treated|Active Comparator/Efficacy Phase:12Weeks||0
8571548|NCT01557244|21134460|P4|Treated|Active Comparator/Efficacy Phase:12Weeks||0
8571549|NCT01557244|21134461|P3|Treated|Active Comparator/Efficacy Phase:12Weeks||40
8571550|NCT01557244|21134462|P2|Treated|Active Comparator/Efficacy Phase:12Weeks||42
8571551|NCT01557244|21134463|P1|Treated|Active Comparator/Efficacy Phase:12Weeks||42
8571552|NCT01557244|21134457|P7|STARTED|Active Comparator/Efficacy Phase:12Weeks||29
8571553|NCT01557244|21134458|P6|STARTED|Active Comparator/Efficacy Phase:12Weeks||28
8571554|NCT01557244|21134459|P5|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
8571555|NCT01557244|21134460|P4|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
8571556|NCT01557244|21134461|P3|STARTED|Active Comparator/Efficacy Phase:12Weeks||40
8571557|NCT01557244|21134462|P2|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
8571558|NCT01557244|21134463|P1|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
8571583|NCT01445080|21134797|P9|NOT COMPLETED|Overall Study||18
8571584|NCT01445080|21134798|P8|NOT COMPLETED|Overall Study||5
8571585|NCT01445080|21134799|P7|NOT COMPLETED|Overall Study||2
8571586|NCT01445080|21134800|P6|NOT COMPLETED|Overall Study||9
8571587|NCT01445080|21134801|P5|NOT COMPLETED|Overall Study||4
8571588|NCT01445080|21134802|P4|NOT COMPLETED|Overall Study||8
8571589|NCT01445080|21134803|P3|NOT COMPLETED|Overall Study||12
8571590|NCT01445080|21134804|P2|NOT COMPLETED|Overall Study||5
8571591|NCT01445080|21134805|P1|NOT COMPLETED|Overall Study||7
8571592|NCT01445080|21134797|P9|COMPLETED|Overall Study||0
8571593|NCT01445080|21134798|P8|COMPLETED|Overall Study||0
8571594|NCT01445080|21134799|P7|COMPLETED|Overall Study||0
8571595|NCT01445080|21134800|P6|COMPLETED|Overall Study||0
8571596|NCT01445080|21134801|P5|COMPLETED|Overall Study||0
8571597|NCT01445080|21134802|P4|COMPLETED|Overall Study||0
8571598|NCT01445080|21134803|P3|COMPLETED|Overall Study||0
8571599|NCT01445080|21134804|P2|COMPLETED|Overall Study||0
8571600|NCT01445080|21134805|P1|COMPLETED|Overall Study||0
8571601|NCT01445080|21134797|P9|STARTED|Overall Study||18
8571602|NCT01445080|21134798|P8|STARTED|Overall Study||5
8571603|NCT01445080|21134799|P7|STARTED|Overall Study||2
8571604|NCT01445080|21134800|P6|STARTED|Overall Study||9
8571605|NCT01445080|21134801|P5|STARTED|Overall Study||4
8571606|NCT01445080|21134802|P4|STARTED|Overall Study||8
8571607|NCT01445080|21134803|P3|STARTED|Overall Study||12
8571608|NCT01445080|21134804|P2|STARTED|Overall Study||5
8571609|NCT01445080|21134805|P1|STARTED|Overall Study||7
8571613|NCT01365585|21134915|P1|NOT COMPLETED|Overall Study||0
8571614|NCT01365585|21134915|P1|COMPLETED|Overall Study||227
8571615|NCT01365585|21134915|P1|STARTED|Overall Study||227
8571622|NCT01364389|21134941|P3|NOT COMPLETED|Overall Study||1
8571623|NCT01364389|21134942|P2|NOT COMPLETED|Overall Study||1
8571624|NCT01364389|21134943|P1|NOT COMPLETED|Overall Study||2
8571625|NCT01364389|21134941|P3|COMPLETED|Overall Study||4
8571626|NCT01364389|21134942|P2|COMPLETED|Overall Study||5
8571627|NCT01364389|21134943|P1|COMPLETED|Overall Study||3
8571628|NCT01364389|21134941|P3|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
8571629|NCT01364389|21134942|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||6
8571630|NCT01364389|21134943|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||5
8571631|NCT01364389|21134941|P3|STARTED|Overall Study||5
8571632|NCT01364389|21134942|P2|STARTED|Overall Study||6
8571633|NCT01364389|21134943|P1|STARTED|Overall Study||5
8571681|NCT01260324|21135128|P2|NOT COMPLETED|Overall Study||0
8571682|NCT01260324|21135129|P1|NOT COMPLETED|Overall Study||0
8571683|NCT01260324|21135128|P2|COMPLETED|Overall Study||20000
8571684|NCT01260324|21135129|P1|COMPLETED|Overall Study||1283
8571685|NCT01260324|21135128|P2|STARTED|Overall Study||20000
8571686|NCT01260324|21135129|P1|STARTED|Overall Study||1283
8571687|NCT01254396|21135143|P2|NOT COMPLETED|Second Intervention Period||0
8571688|NCT01254396|21135144|P1|NOT COMPLETED|Second Intervention Period||0
8571689|NCT01254396|21135143|P2|COMPLETED|Second Intervention Period||6
8571690|NCT01254396|21135144|P1|COMPLETED|Second Intervention Period||6
8571691|NCT01254396|21135143|P2|STARTED|Second Intervention Period||6
8571692|NCT01254396|21135144|P1|STARTED|Second Intervention Period||6
8571693|NCT01254396|21135143|P2|NOT COMPLETED|Washout Period (at Least 1 Day)||0
8571694|NCT01254396|21135144|P1|NOT COMPLETED|Washout Period (at Least 1 Day)||0
8571695|NCT01254396|21135143|P2|COMPLETED|Washout Period (at Least 1 Day)||6
8571696|NCT01254396|21135144|P1|COMPLETED|Washout Period (at Least 1 Day)||6
8571697|NCT01254396|21135143|P2|STARTED|Washout Period (at Least 1 Day)||6
8571698|NCT01254396|21135144|P1|STARTED|Washout Period (at Least 1 Day)||6
8571699|NCT01254396|21135143|P2|NOT COMPLETED|First Intervention Period||0
8571700|NCT01254396|21135144|P1|NOT COMPLETED|First Intervention Period||0
8571701|NCT01254396|21135143|P2|COMPLETED|First Intervention Period||6
8571702|NCT01254396|21135144|P1|COMPLETED|First Intervention Period||6
8571703|NCT01254396|21135143|P2|STARTED|First Intervention Period||6
8571704|NCT01254396|21135144|P1|STARTED|First Intervention Period||6
8571711|NCT01243177|21135173|P2|NOT COMPLETED|Overall Study||178
8571712|NCT01243177|21135174|P1|NOT COMPLETED|Overall Study||178
8571713|NCT01243177|21135173|P2|COMPLETED|Overall Study||264
8571714|NCT01243177|21135174|P1|COMPLETED|Overall Study||266
8571715|NCT01243177|21135173|P2|STARTED|Overall Study||442
8571716|NCT01243177|21135174|P1|STARTED|Overall Study||444
8571755|NCT01207440|21135265|P7|NOT COMPLETED|Overall Study||5
8571756|NCT01207440|21135266|P6|NOT COMPLETED|Overall Study||46
8571757|NCT01207440|21135267|P5|NOT COMPLETED|Overall Study||48
8571758|NCT01207440|21135268|P4|NOT COMPLETED|Overall Study||18
8571759|NCT01207440|21135269|P3|NOT COMPLETED|Overall Study||65
8571760|NCT01207440|21135270|P2|NOT COMPLETED|Overall Study||64
8571761|NCT01207440|21135271|P1|NOT COMPLETED|Overall Study||203
8571762|NCT01207440|21135265|P7|COMPLETED|Overall Study||0
8571763|NCT01207440|21135266|P6|COMPLETED|Overall Study||0
8571764|NCT01207440|21135267|P5|COMPLETED|Overall Study||0
8571765|NCT01207440|21135268|P4|COMPLETED|Overall Study||0
8571766|NCT01207440|21135269|P3|COMPLETED|Overall Study||0
8571767|NCT01207440|21135270|P2|COMPLETED|Overall Study||0
8571768|NCT01207440|21135271|P1|COMPLETED|Overall Study||0
8571769|NCT01207440|21135265|P7|STARTED|Overall Study||5
8571770|NCT01207440|21135266|P6|STARTED|Overall Study||46
8571771|NCT01207440|21135267|P5|STARTED|Overall Study||48
8571772|NCT01207440|21135268|P4|STARTED|Overall Study||18
8571773|NCT01207440|21135269|P3|STARTED|Overall Study||65
8571774|NCT01207440|21135270|P2|STARTED|Overall Study||64
8571775|NCT01207440|21135271|P1|STARTED|Overall Study||203
8571804|NCT01069861|21135396|P1|NOT COMPLETED|Overall Study||3
8571805|NCT01069861|21135396|P1|COMPLETED|Overall Study||1
8571806|NCT01069861|21135396|P1|STARTED|Overall Study||4
8571807|NCT01062113|21135412|P3|NOT COMPLETED|Overall Study||31
8571808|NCT01062113|21135413|P2|NOT COMPLETED|Overall Study||22
8571809|NCT01062113|21135414|P1|NOT COMPLETED|Overall Study||40
8571810|NCT01062113|21135412|P3|COMPLETED|Overall Study||27
8571811|NCT01062113|21135413|P2|COMPLETED|Overall Study||42
8571812|NCT01062113|21135414|P1|COMPLETED|Overall Study||93
8571813|NCT01062113|21135412|P3|STARTED|Overall Study||58
8571814|NCT01062113|21135413|P2|STARTED|Overall Study||64
8571815|NCT01062113|21135414|P1|STARTED|Overall Study||133
8571816|NCT01058070|21135427|P1|NOT COMPLETED|Overall Study||11
8571817|NCT01058070|21135427|P1|COMPLETED|Overall Study||33
8571818|NCT01058070|21135427|P1|STARTED|Overall Study||44
8571846|NCT00994461|21135498|P3|NOT COMPLETED|Overall Study||0
8571847|NCT00994461|21135499|P2|NOT COMPLETED|Overall Study||1
8571848|NCT00994461|21135500|P1|NOT COMPLETED|Overall Study||2
8571849|NCT00994461|21135498|P3|COMPLETED|Overall Study||37
8571850|NCT00994461|21135499|P2|COMPLETED|Overall Study||75
8571851|NCT00994461|21135500|P1|COMPLETED|Overall Study||74
8571852|NCT00994461|21135498|P3|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
8571853|NCT00994461|21135499|P2|STARTED|Overall Study||76
8571854|NCT00994461|21135500|P1|STARTED|Overall Study||76
8571855|NCT00976716|21135526|P1|NOT COMPLETED|Overall Study||1
8571856|NCT00976716|21135526|P1|COMPLETED|Overall Study||79
8571857|NCT00976716|21135526|P1|STARTED|Overall Study||80
8571858|NCT00946114|21135544|P2|NOT COMPLETED|Overall Study||2
8571859|NCT00946114|21135545|P1|NOT COMPLETED|Overall Study||8
8571860|NCT00946114|21135544|P2|COMPLETED|Overall Study||10
8571861|NCT00946114|21135545|P1|COMPLETED|Overall Study||12
8571862|NCT00946114|21135544|P2|STARTED|Overall Study||12
8571863|NCT00946114|21135545|P1|STARTED|Overall Study||20
8571864|NCT00934934|21135553|P2|NOT COMPLETED|Overall Study||0
8571865|NCT00934934|21135554|P1|NOT COMPLETED|Overall Study||1
8571866|NCT00934934|21135553|P2|COMPLETED|Overall Study||31
8571867|NCT00934934|21135554|P1|COMPLETED|Overall Study||29
8571868|NCT00934934|21135553|P2|STARTED|Overall Study||31
8571869|NCT00934934|21135554|P1|STARTED|Overall Study||30
8571882|NCT00904748|21135611|P6|NOT COMPLETED|Overall Study||0
8571883|NCT00904748|21135612|P5|NOT COMPLETED|Overall Study||1
8571884|NCT00904748|21135613|P4|NOT COMPLETED|Overall Study||2
8571885|NCT00904748|21135614|P3|NOT COMPLETED|Overall Study||1
8571886|NCT00904748|21135615|P2|NOT COMPLETED|Overall Study||1
8571887|NCT00904748|21135616|P1|NOT COMPLETED|Overall Study||1
8571888|NCT00904748|21135611|P6|COMPLETED|Overall Study||8
8571889|NCT00904748|21135612|P5|COMPLETED|Overall Study||7
8571890|NCT00904748|21135613|P4|COMPLETED|Overall Study||6
8571891|NCT00904748|21135614|P3|COMPLETED|Overall Study||7
8571892|NCT00904748|21135615|P2|COMPLETED|Overall Study||7
8571893|NCT00904748|21135616|P1|COMPLETED|Overall Study||7
8571894|NCT00904748|21135611|P6|Received Treatment|Overall Study||8
8571895|NCT00904748|21135612|P5|Received Treatment|Overall Study||7
8571896|NCT00904748|21135613|P4|Received Treatment|Overall Study||8
8571897|NCT00904748|21135614|P3|Received Treatment|Overall Study||8
8571898|NCT00904748|21135615|P2|Received Treatment|Overall Study||8
8571899|NCT00904748|21135616|P1|Received Treatment|Overall Study||8
8571900|NCT00904748|21135611|P6|STARTED|Overall Study||8
8571901|NCT00904748|21135612|P5|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
8571902|NCT00904748|21135613|P4|STARTED|Overall Study||8
8571903|NCT00904748|21135614|P3|STARTED|Overall Study||8
8571904|NCT00904748|21135615|P2|STARTED|Overall Study||8
8571905|NCT00904748|21135616|P1|STARTED|Overall Study||8
8571906|NCT00894790|21135642|P2|NOT COMPLETED|Overall Study||2
8571907|NCT00894790|21135643|P1|NOT COMPLETED|Overall Study||1
8571908|NCT00894790|21135642|P2|COMPLETED|Overall Study||2
8571909|NCT00894790|21135643|P1|COMPLETED|Overall Study||3
8571910|NCT00894790|21135642|P2|STARTED|Overall Study||4
8571911|NCT00894790|21135643|P1|STARTED|Overall Study||4
8571947|NCT00807846|21135866|P2|NOT COMPLETED|Overall Study||4
8571948|NCT00807846|21135867|P1|NOT COMPLETED|Overall Study||12
8571949|NCT00807846|21135866|P2|COMPLETED|Overall Study||94
8571950|NCT00807846|21135867|P1|COMPLETED|Overall Study||88
8571951|NCT00807846|21135866|P2|STARTED|Overall Study||98
8571952|NCT00807846|21135867|P1|STARTED|Overall Study||100
8571956|NCT00762463|21135907|P4|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
8571957|NCT00762463|21135908|P3|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
8571958|NCT00762463|21135909|P2|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
8571959|NCT00762463|21135910|P1|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
8571960|NCT00762463|21135907|P4|COMPLETED|Extension Phase (Week 6 to Week 12)||52
8571961|NCT00762463|21135908|P3|COMPLETED|Extension Phase (Week 6 to Week 12)||50
8571962|NCT00762463|21135909|P2|COMPLETED|Extension Phase (Week 6 to Week 12)||54
8571963|NCT00762463|21135910|P1|COMPLETED|Extension Phase (Week 6 to Week 12)||52
8571964|NCT00762463|21135907|P4|STARTED|Extension Phase (Week 6 to Week 12)||54
8571965|NCT00762463|21135908|P3|STARTED|Extension Phase (Week 6 to Week 12)||54
8571966|NCT00762463|21135909|P2|STARTED|Extension Phase (Week 6 to Week 12)||55
8571967|NCT00762463|21135910|P1|STARTED|Extension Phase (Week 6 to Week 12)||55
8571968|NCT00762463|21135907|P4|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
8571969|NCT00762463|21135908|P3|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
8571970|NCT00762463|21135909|P2|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
8571971|NCT00762463|21135910|P1|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
8571972|NCT00762463|21135907|P4|COMPLETED|Enrollment in Extension Phase (Week 6)||0
8571973|NCT00762463|21135908|P3|COMPLETED|Enrollment in Extension Phase (Week 6)||0
8571974|NCT00762463|21135909|P2|COMPLETED|Enrollment in Extension Phase (Week 6)||109
8571975|NCT00762463|21135910|P1|COMPLETED|Enrollment in Extension Phase (Week 6)||109
8571976|NCT00762463|21135907|P4|STARTED|Enrollment in Extension Phase (Week 6)||0
8571977|NCT00762463|21135908|P3|STARTED|Enrollment in Extension Phase (Week 6)||0
8571978|NCT00762463|21135909|P2|STARTED|Enrollment in Extension Phase (Week 6)||110
8571979|NCT00762463|21135910|P1|STARTED|Enrollment in Extension Phase (Week 6)||113
8571980|NCT00762463|21135907|P4|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
8571981|NCT00762463|21135908|P3|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
8571982|NCT00762463|21135909|P2|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
8571983|NCT00762463|21135910|P1|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
8571984|NCT00762463|21135907|P4|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
8571985|NCT00762463|21135908|P3|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
8571986|NCT00762463|21135909|P2|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
8571987|NCT00762463|21135910|P1|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
8571988|NCT00762463|21135907|P4|STARTED|Double-blind Phase (Baseline to Week 6)||0
8571989|NCT00762463|21135908|P3|STARTED|Double-blind Phase (Baseline to Week 6)||0
8571990|NCT00762463|21135909|P2|STARTED|Double-blind Phase (Baseline to Week 6)||120
8571991|NCT00762463|21135910|P1|STARTED|Double-blind Phase (Baseline to Week 6)||120
8571992|NCT00759174|21135994|P2|NOT COMPLETED|Overall Study||2
8571993|NCT00759174|21135995|P1|NOT COMPLETED|Overall Study||0
8571994|NCT00759174|21135994|P2|COMPLETED|Overall Study||595
8571995|NCT00759174|21135995|P1|COMPLETED|Overall Study||76
8571996|NCT00759174|21135994|P2|STARTED|Overall Study||597
8571997|NCT00759174|21135995|P1|STARTED|Overall Study||76
8571998|NCT00750919|21136004|P1|NOT COMPLETED|Overall Study||58
8571999|NCT00750919|21136004|P1|COMPLETED|Overall Study||126
8572000|NCT00750919|21136004|P1|STARTED|Overall Study||184
8572009|NCT00688545|21136041|P2|NOT COMPLETED|Overall Study||15
8572010|NCT00688545|21136042|P1|NOT COMPLETED|Overall Study||5
8572011|NCT00688545|21136041|P2|COMPLETED|Overall Study||204
8572012|NCT00688545|21136042|P1|COMPLETED|Overall Study||50
8572013|NCT00688545|21136041|P2|Switched Treatment at Least Once|Overall Study||13
8572014|NCT00688545|21136042|P1|Switched Treatment at Least Once|Overall Study||6
8572015|NCT00688545|21136041|P2|STARTED|Overall Study||219
8572016|NCT00688545|21136042|P1|STARTED|Overall Study||55
8572017|NCT00682448|21136052|P2|NOT COMPLETED|Overall Study||6
8572018|NCT00682448|21136053|P1|NOT COMPLETED|Overall Study||5
8572019|NCT00682448|21136052|P2|COMPLETED|Overall Study||7
8572020|NCT00682448|21136053|P1|COMPLETED|Overall Study||7
8572021|NCT00682448|21136052|P2|STARTED|Overall Study||13
8572022|NCT00682448|21136053|P1|STARTED|Overall Study||12
8572023|NCT00666198|21136061|P1|NOT COMPLETED|Overall Study||33
8572024|NCT00666198|21136061|P1|COMPLETED|Overall Study||3304
8572025|NCT00666198|21136061|P1|STARTED|Overall Study||3337
8572026|NCT00653068|21136078|P1|NOT COMPLETED|Overall Study||50
8572027|NCT00653068|21136078|P1|COMPLETED|Overall Study||20
8572028|NCT00653068|21136078|P1|STARTED|Overall Study||70
8572093|NCT00638157|21136264|P2|NOT COMPLETED|Overall Study||4
8572094|NCT00638157|21136265|P1|NOT COMPLETED|Overall Study||7
8572095|NCT00638157|21136264|P2|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
8572096|NCT00638157|21136265|P1|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
8572097|NCT00638157|21136264|P2|Treated|Overall Study||12
8572098|NCT00638157|21136265|P1|Treated|Overall Study||10
8572099|NCT00638157|21136264|P2|STARTED|Overall Study||12
8572100|NCT00638157|21136265|P1|STARTED|Overall Study||12
8572110|NCT00604500|21136295|P1|NOT COMPLETED|Overall Study||11
8572111|NCT00604500|21136295|P1|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
8572112|NCT00604500|21136295|P1|STARTED|Overall Study||272
8572116|NCT00591630|21136312|P4|NOT COMPLETED|Overall Study||0
8572117|NCT00591630|21136313|P3|NOT COMPLETED|Overall Study||1
8572118|NCT00591630|21136314|P2|NOT COMPLETED|Overall Study||0
8572119|NCT00591630|21136315|P1|NOT COMPLETED|Overall Study||0
8572120|NCT00591630|21136312|P4|COMPLETED|Overall Study||6
8572121|NCT00591630|21136313|P3|COMPLETED|Overall Study||9
8572122|NCT00591630|21136314|P2|COMPLETED|Overall Study||8
8572123|NCT00591630|21136315|P1|COMPLETED|Overall Study||6
8572124|NCT00591630|21136312|P4|STARTED|Overall Study||6
8572125|NCT00591630|21136313|P3|STARTED|Overall Study||10
8572126|NCT00591630|21136314|P2|STARTED|Overall Study||8
8572127|NCT00591630|21136315|P1|STARTED|Overall Study||6
8572128|NCT00586209|21136327|P2|NOT COMPLETED|Overall Study||0
8572129|NCT00586209|21136328|P1|NOT COMPLETED|Overall Study||0
8572130|NCT00586209|21136327|P2|COMPLETED|Overall Study||10
8572131|NCT00586209|21136328|P1|COMPLETED|Overall Study||5
8572132|NCT00586209|21136327|P2|STARTED|Overall Study||10
8572133|NCT00586209|21136328|P1|STARTED|Overall Study||5
8572140|NCT00579878|21136356|P3|NOT COMPLETED|Overall Study||10
8572141|NCT00579878|21136357|P2|NOT COMPLETED|Overall Study||3
8572142|NCT00579878|21136358|P1|NOT COMPLETED|Overall Study||7
8572143|NCT00579878|21136356|P3|COMPLETED|Overall Study||14
8572144|NCT00579878|21136357|P2|COMPLETED|Overall Study||20
8572145|NCT00579878|21136358|P1|COMPLETED|Overall Study||15
8572146|NCT00579878|21136356|P3|STARTED|Overall Study||24
8572147|NCT00579878|21136357|P2|STARTED|Overall Study||23
8572148|NCT00579878|21136358|P1|STARTED|Overall Study||22
8572192|NCT00537017|21136449|P1|NOT COMPLETED|Follow-up Phase||9
8572193|NCT00537017|21136449|P1|COMPLETED|Follow-up Phase||126
8572194|NCT00537017|21136449|P1|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
8572195|NCT00537017|21136449|P1|NOT COMPLETED|Treatment Phase||34
8572196|NCT00537017|21136449|P1|COMPLETED|Treatment Phase||106
8572197|NCT00537017|21136449|P1|STARTED|Treatment Phase||140
8572310|NCT00401986|21136499|P1|NOT COMPLETED|Overall Study||2
8572311|NCT00401986|21136499|P1|COMPLETED|Overall Study||12
8572312|NCT00401986|21136499|P1|STARTED|Overall Study||14
8572313|NCT00399490|21136509|P1|NOT COMPLETED|Overall Study||98
8572314|NCT00399490|21136509|P1|COMPLETED|Overall Study||183
8572315|NCT00399490|21136509|P1|STARTED|Overall Study||281
8572334|NCT00323297|21136600|P2|NOT COMPLETED|Part B (Open-label)||12
8572335|NCT00323297|21136601|P1|NOT COMPLETED|Part B (Open-label)||9
8572336|NCT00323297|21136600|P2|COMPLETED|Part B (Open-label)||31
8572337|NCT00323297|21136601|P1|COMPLETED|Part B (Open-label)||39
8572338|NCT00323297|21136600|P2|STARTED|Part B (Open-label)||43
8572339|NCT00323297|21136601|P1|STARTED|Part B (Open-label)||48
8572340|NCT00323297|21136600|P2|NOT COMPLETED|Part A (Double Blind Randomized)||7
8572341|NCT00323297|21136601|P1|NOT COMPLETED|Part A (Double Blind Randomized)||5
8572342|NCT00323297|21136600|P2|COMPLETED|Part A (Double Blind Randomized)||43
8572343|NCT00323297|21136601|P1|COMPLETED|Part A (Double Blind Randomized)||48
8572344|NCT00323297|21136600|P2|STARTED|Part A (Double Blind Randomized)||50
8572345|NCT00323297|21136601|P1|STARTED|Part A (Double Blind Randomized)||53
8572370|NCT00301262|21136656|P2|NOT COMPLETED|Open Label Phase (OL)||2
8572371|NCT00301262|21136657|P1|NOT COMPLETED|Open Label Phase (OL)||4
8572372|NCT00301262|21136656|P2|COMPLETED|Open Label Phase (OL)||67
8572373|NCT00301262|21136657|P1|COMPLETED|Open Label Phase (OL)||79
8572374|NCT00301262|21136656|P2|STARTED|Open Label Phase (OL)||69
8572375|NCT00301262|21136657|P1|STARTED|Open Label Phase (OL)||83
8572376|NCT00301262|21136656|P2|NOT COMPLETED|Double Blind Phase (DB)||13
8572377|NCT00301262|21136657|P1|NOT COMPLETED|Double Blind Phase (DB)||10
8572378|NCT00301262|21136656|P2|COMPLETED|Double Blind Phase (DB)||69
8572379|NCT00301262|21136657|P1|COMPLETED|Double Blind Phase (DB)||84
8572380|NCT00301262|21136656|P2|STARTED|Double Blind Phase (DB)||82
8572381|NCT00301262|21136657|P1|STARTED|Double Blind Phase (DB)||94
8572382|NCT00189436|21136817|P2|NOT COMPLETED|Overall Study||5
8572383|NCT00189436|21136818|P1|NOT COMPLETED|Overall Study||8
8572384|NCT00189436|21136817|P2|COMPLETED|Overall Study||25
8572385|NCT00189436|21136818|P1|COMPLETED|Overall Study||23
8572386|NCT00189436|21136817|P2|STARTED|Overall Study||30
8572387|NCT00189436|21136818|P1|STARTED|Overall Study||31
8572388|NCT00159874|21136835|P7|NOT COMPLETED|Overall Study||5
8572389|NCT00159874|21136836|P6|NOT COMPLETED|Overall Study||12
8572390|NCT00159874|21136837|P5|NOT COMPLETED|Overall Study||8
8572391|NCT00159874|21136838|P4|NOT COMPLETED|Overall Study||6
8572392|NCT00159874|21136839|P3|NOT COMPLETED|Overall Study||43
8572393|NCT00159874|21136840|P2|NOT COMPLETED|Overall Study||30
8572394|NCT00159874|21136841|P1|NOT COMPLETED|Overall Study||20
8572395|NCT00159874|21136835|P7|COMPLETED|Overall Study||0
8572396|NCT00159874|21136836|P6|COMPLETED|Overall Study||11
8572397|NCT00159874|21136837|P5|COMPLETED|Overall Study||11
8572398|NCT00159874|21136838|P4|COMPLETED|Overall Study||7
8572399|NCT00159874|21136839|P3|COMPLETED|Overall Study||34
8572400|NCT00159874|21136840|P2|COMPLETED|Overall Study||25
8572401|NCT00159874|21136841|P1|COMPLETED|Overall Study||22
8572402|NCT00159874|21136835|P7|Treated|Overall Study||5
8572403|NCT00159874|21136836|P6|Treated|Overall Study||23
8572404|NCT00159874|21136837|P5|Treated|Overall Study||19
8572405|NCT00159874|21136838|P4|Treated|Overall Study||13
8572406|NCT00159874|21136839|P3|Treated|Overall Study||77
8572407|NCT00159874|21136840|P2|Treated|Overall Study||55
8572408|NCT00159874|21136841|P1|Treated|Overall Study||42
8572409|NCT00159874|21136835|P7|STARTED|Overall Study||5
8572410|NCT00159874|21136836|P6|STARTED|Overall Study||23
8572411|NCT00159874|21136837|P5|STARTED|Overall Study||19
8572412|NCT00159874|21136838|P4|STARTED|Overall Study||13
8572413|NCT00159874|21136839|P3|STARTED|Overall Study||77
8572414|NCT00159874|21136840|P2|STARTED|Overall Study||55
8572415|NCT00159874|21136841|P1|STARTED|Overall Study||42
8572416|NCT00159861|21137011|P2|NOT COMPLETED|Extension Study - up to 3 Years||71
8572417|NCT00159861|21137012|P1|NOT COMPLETED|Extension Study - up to 3 Years||62
8572418|NCT00159861|21137011|P2|COMPLETED|Extension Study - up to 3 Years||56
8572419|NCT00159861|21137012|P1|COMPLETED|Extension Study - up to 3 Years||53
8572420|NCT00159861|21137011|P2|Treated|Extension Study - up to 3 Years||127
8572421|NCT00159861|21137012|P1|Treated|Extension Study - up to 3 Years||115
8572422|NCT00159861|21137011|P2|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
8572423|NCT00159861|21137012|P1|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
8572424|NCT00159861|21137011|P2|NOT COMPLETED|Core Study - 16 Weeks||12
8572425|NCT00159861|21137012|P1|NOT COMPLETED|Core Study - 16 Weeks||25
8572426|NCT00159861|21137011|P2|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
8572427|NCT00159861|21137012|P1|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
8572428|NCT00159861|21137011|P2|Treated|Core Study - 16 Weeks||134
8572429|NCT00159861|21137012|P1|Treated|Core Study - 16 Weeks||131
8572430|NCT00159861|21137011|P2|STARTED|Core Study - 16 Weeks||134
8572431|NCT00159861|21137012|P1|STARTED|Core Study - 16 Weeks||133
8572432|NCT00061932|21137035|P2|NOT COMPLETED|Overall Study||4
8572433|NCT00061932|21137036|P1|NOT COMPLETED|Overall Study||13
8572434|NCT00061932|21137035|P2|COMPLETED|Overall Study||8
8572435|NCT00061932|21137036|P1|COMPLETED|Overall Study||16
8572436|NCT00061932|21137035|P2|STARTED|Overall Study||12
8572437|NCT00061932|21137036|P1|STARTED|Overall Study||29
8572438|NCT00004031|21137046|P2|NOT COMPLETED|Overall Study||21
8572439|NCT00004031|21137047|P1|NOT COMPLETED|Overall Study||25
8572440|NCT00004031|21137046|P2|COMPLETED|Overall Study||104
8572441|NCT00004031|21137047|P1|COMPLETED|Overall Study||103
8572442|NCT00004031|21137046|P2|Assessed for Adverse Events|Overall Study||113
8572443|NCT00004031|21137047|P1|Assessed for Adverse Events|Overall Study||123
8572444|NCT00004031|21137046|P2|STARTED|Overall Study||125
8572445|NCT00004031|21137047|P1|STARTED|Overall Study||128
8572471|NCT04096365|21137109|P1|NOT COMPLETED|Overall Study||1
8572472|NCT04096365|21137109|P1|COMPLETED|Overall Study||11
8572473|NCT04096365|21137109|P1|STARTED|Overall Study||12
8572750|NCT03645954|21137308|P2|NOT COMPLETED|Overall Study||0
8572751|NCT03645954|21137309|P1|NOT COMPLETED|Overall Study||3
8572752|NCT03645954|21137308|P2|COMPLETED|Overall Study||40
8572753|NCT03645954|21137309|P1|COMPLETED|Overall Study||37
8572754|NCT03645954|21137308|P2|STARTED|Overall Study||40
8572755|NCT03645954|21137309|P1|STARTED|Overall Study||40
8572786|NCT03575754|21137410|P2|NOT COMPLETED|Overall Study||0
8572787|NCT03575754|21137411|P1|NOT COMPLETED|Overall Study||0
8572788|NCT03575754|21137410|P2|COMPLETED|Overall Study||25
8572789|NCT03575754|21137411|P1|COMPLETED|Overall Study||25
8572790|NCT03575754|21137410|P2|STARTED|Overall Study||25
8572791|NCT03575754|21137411|P1|STARTED|Overall Study||25
8572808|NCT03478982|21137447|P4|NOT COMPLETED|Overall Study||0
8572809|NCT03478982|21137448|P3|NOT COMPLETED|Overall Study||0
8572810|NCT03478982|21137449|P2|NOT COMPLETED|Overall Study||0
8572811|NCT03478982|21137450|P1|NOT COMPLETED|Overall Study||0
8572812|NCT03478982|21137447|P4|COMPLETED|Overall Study||48
8572813|NCT03478982|21137448|P3|COMPLETED|Overall Study||47
8572814|NCT03478982|21137449|P2|COMPLETED|Overall Study||50
8572815|NCT03478982|21137450|P1|COMPLETED|Overall Study||11
8572816|NCT03478982|21137447|P4|Intent-to-treat (ITT) Population|Overall Study||38
8572817|NCT03478982|21137448|P3|Intent-to-treat (ITT) Population|Overall Study||38
8572818|NCT03478982|21137449|P2|Intent-to-treat (ITT) Population|Overall Study||40
8572819|NCT03478982|21137450|P1|Intent-to-treat (ITT) Population|Overall Study||8
8572820|NCT03478982|21137447|P4|Enrolled Participants But Not Treated|Overall Study||10
8572821|NCT03478982|21137448|P3|Enrolled Participants But Not Treated|Overall Study||9
8572822|NCT03478982|21137449|P2|Enrolled Participants But Not Treated|Overall Study||10
8572823|NCT03478982|21137450|P1|Enrolled Participants But Not Treated|Overall Study||3
8572824|NCT03478982|21137447|P4|STARTED|Overall Study||48
8572825|NCT03478982|21137448|P3|STARTED|Overall Study||47
8572826|NCT03478982|21137449|P2|STARTED|Overall Study||50
8572827|NCT03478982|21137450|P1|STARTED|Overall Study||11
8572863|NCT03407313|21137575|P1|NOT COMPLETED|Overall Study||2
8572864|NCT03407313|21137575|P1|COMPLETED|Overall Study||66
8572865|NCT03407313|21137575|P1|STARTED|Overall Study||68
8572866|NCT03391765|21137585|P4|NOT COMPLETED|Overall Study||23
8572867|NCT03391765|21137586|P3|NOT COMPLETED|Overall Study||23
8572868|NCT03391765|21137587|P2|NOT COMPLETED|Overall Study||45
8572869|NCT03391765|21137588|P1|NOT COMPLETED|Overall Study||51
8572870|NCT03391765|21137585|P4|COMPLETED|Overall Study||0
8572871|NCT03391765|21137586|P3|COMPLETED|Overall Study||0
8572872|NCT03391765|21137587|P2|COMPLETED|Overall Study||0
8572873|NCT03391765|21137588|P1|COMPLETED|Overall Study||0
8572874|NCT03391765|21137585|P4|STARTED|Overall Study||23
8572875|NCT03391765|21137586|P3|STARTED|Overall Study||23
8572876|NCT03391765|21137587|P2|STARTED|Overall Study||45
8572877|NCT03391765|21137588|P1|STARTED|Overall Study||51
8572878|NCT03382847|21137626|P1|NOT COMPLETED|Overall Study||0
8572879|NCT03382847|21137626|P1|COMPLETED|Overall Study||25
8572880|NCT03382847|21137626|P1|STARTED|Overall Study||25
8572881|NCT03380624|21137630|P2|NOT COMPLETED|Overall Study||0
8572882|NCT03380624|21137631|P1|NOT COMPLETED|Overall Study||0
8572883|NCT03380624|21137630|P2|COMPLETED|Overall Study||9
8572884|NCT03380624|21137631|P1|COMPLETED|Overall Study||10
8572885|NCT03380624|21137630|P2|STARTED|Overall Study||9
8572886|NCT03380624|21137631|P1|STARTED|Overall Study||10
8572916|NCT03334630|21137729|P2|NOT COMPLETED|Overall Study||13
8572917|NCT03334630|21137730|P1|NOT COMPLETED|Overall Study||14
8572918|NCT03334630|21137729|P2|COMPLETED|Overall Study||230
8572919|NCT03334630|21137730|P1|COMPLETED|Overall Study||225
8572920|NCT03334630|21137729|P2|STARTED|Overall Study||243
8572921|NCT03334630|21137730|P1|STARTED|Overall Study||239
8572934|NCT03287843|21137798|P2|NOT COMPLETED|Overall Study||8
8572935|NCT03287843|21137799|P1|NOT COMPLETED|Overall Study||15
8572936|NCT03287843|21137798|P2|COMPLETED|Overall Study||167
8572937|NCT03287843|21137799|P1|COMPLETED|Overall Study||160
8572938|NCT03287843|21137798|P2|Lost to Follow up|Overall Study||0
8572939|NCT03287843|21137799|P1|Lost to Follow up|Overall Study||3
8572940|NCT03287843|21137798|P2|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8
8572941|NCT03287843|21137799|P1|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12
8572942|NCT03287843|21137798|P2|STARTED|Overall Study||175
8572943|NCT03287843|21137799|P1|STARTED|Overall Study||175
8572956|NCT03206749|21137839|P3|NOT COMPLETED|Overall Study||7
8572957|NCT03206749|21137840|P2|NOT COMPLETED|Overall Study||3
8572958|NCT03206749|21137841|P1|NOT COMPLETED|Overall Study||5
8572959|NCT03206749|21137839|P3|COMPLETED|Overall Study||75
8572960|NCT03206749|21137840|P2|COMPLETED|Overall Study||78
8572961|NCT03206749|21137841|P1|COMPLETED|Overall Study||75
8572962|NCT03206749|21137839|P3|STARTED|Overall Study||82
8572963|NCT03206749|21137840|P2|STARTED|Overall Study||81
8572964|NCT03206749|21137841|P1|STARTED|Overall Study||80
8572965|NCT03162796|21137871|P3|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
8572966|NCT03162796|21137872|P2|NOT COMPLETED|Safety Follow-up: Week 52 - 60||2
8572967|NCT03162796|21137873|P1|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
8572968|NCT03162796|21137871|P3|COMPLETED|Safety Follow-up: Week 52 - 60||123
8572969|NCT03162796|21137872|P2|COMPLETED|Safety Follow-up: Week 52 - 60||114
8572970|NCT03162796|21137873|P1|COMPLETED|Safety Follow-up: Week 52 - 60||106
8572971|NCT03162796|21137871|P3|STARTED|Safety Follow-up: Week 52 - 60||124
8572972|NCT03162796|21137872|P2|STARTED|Safety Follow-up: Week 52 - 60||116
8572973|NCT03162796|21137873|P1|STARTED|Safety Follow-up: Week 52 - 60||107
8572974|NCT03162796|21137871|P3|NOT COMPLETED|Active Treatment Period: Week 24 - 52||1
8572975|NCT03162796|21137872|P2|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
8572976|NCT03162796|21137873|P1|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
8572977|NCT03162796|21137871|P3|COMPLETED|Active Treatment Period: Week 24 - 52||124
8572978|NCT03162796|21137872|P2|COMPLETED|Active Treatment Period: Week 24 - 52||116
8572979|NCT03162796|21137873|P1|COMPLETED|Active Treatment Period: Week 24 - 52||107
8572980|NCT03162796|21137871|P3|STARTED|Active Treatment Period: Week 24 - 52||125
8572981|NCT03162796|21137872|P2|STARTED|Active Treatment Period: Week 24 - 52||123
8572982|NCT03162796|21137873|P1|STARTED|Active Treatment Period: Week 24 - 52||114
8572983|NCT03162796|21137871|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||3
8572984|NCT03162796|21137872|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||4
8572985|NCT03162796|21137873|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||12
8572986|NCT03162796|21137871|P3|COMPLETED|Placebo Controlled Period: Week 0 - 24||125
8572987|NCT03162796|21137872|P2|COMPLETED|Placebo Controlled Period: Week 0 - 24||123
8572988|NCT03162796|21137873|P1|COMPLETED|Placebo Controlled Period: Week 0 - 24||114
8572989|NCT03162796|21137871|P3|STARTED|Placebo Controlled Period: Week 0 - 24||128
8572990|NCT03162796|21137872|P2|STARTED|Placebo Controlled Period: Week 0 - 24||127
8572991|NCT03162796|21137873|P1|STARTED|Placebo Controlled Period: Week 0 - 24||126
8572992|NCT03118466|21138177|P1|NOT COMPLETED|Overall Study||0
8572993|NCT03118466|21138177|P1|COMPLETED|Overall Study||40
8572994|NCT03118466|21138177|P1|STARTED|Overall Study||40
8572995|NCT03116152|21138188|P2|NOT COMPLETED|Overall Study||95
8572996|NCT03116152|21138189|P1|NOT COMPLETED|Overall Study||91
8572997|NCT03116152|21138188|P2|COMPLETED|Overall Study||0
8572998|NCT03116152|21138189|P1|COMPLETED|Overall Study||4
8572999|NCT03116152|21138188|P2|Treated|Overall Study||87
8573000|NCT03116152|21138189|P1|Treated|Overall Study||94
8573001|NCT03116152|21138188|P2|STARTED|Overall Study||95
8573002|NCT03116152|21138189|P1|STARTED|Overall Study||95
8573024|NCT02985879|21138286|P3|NOT COMPLETED|Overall Study||77
8573025|NCT02985879|21138287|P2|NOT COMPLETED|Overall Study||75
8573026|NCT02985879|21138288|P1|NOT COMPLETED|Overall Study||76
8573027|NCT02985879|21138286|P3|COMPLETED|Overall Study||48
8573028|NCT02985879|21138287|P2|COMPLETED|Overall Study||52
8573029|NCT02985879|21138288|P1|COMPLETED|Overall Study||50
8573030|NCT02985879|21138286|P3|STARTED|Overall Study||125
8573031|NCT02985879|21138287|P2|STARTED|Overall Study||127
8573032|NCT02985879|21138288|P1|STARTED|Overall Study||126
8573078|NCT02956486|21138526|P3|NOT COMPLETED|Extension Phase||19
8573079|NCT02956486|21138527|P2|NOT COMPLETED|Extension Phase||0
8573080|NCT02956486|21138528|P1|NOT COMPLETED|Extension Phase||0
8573081|NCT02956486|21138526|P3|COMPLETED|Extension Phase||0
8573082|NCT02956486|21138527|P2|COMPLETED|Extension Phase||0
8573083|NCT02956486|21138528|P1|COMPLETED|Extension Phase||0
8573084|NCT02956486|21138526|P3|Safety Analysis Set (SAS)|Extension Phase||18
8573085|NCT02956486|21138527|P2|Safety Analysis Set (SAS)|Extension Phase||0
8573086|NCT02956486|21138528|P1|Safety Analysis Set (SAS)|Extension Phase||0
8573087|NCT02956486|21138526|P3|Treated|Extension Phase||18
8573088|NCT02956486|21138527|P2|Treated|Extension Phase||0
8573089|NCT02956486|21138528|P1|Treated|Extension Phase||0
8573090|NCT02956486|21138526|P3|STARTED|Extension Phase|Eligible participants who completed core and consented for extension phase, entered extension phase.|19
8573091|NCT02956486|21138527|P2|STARTED|Extension Phase||0
8573092|NCT02956486|21138528|P1|STARTED|Extension Phase||0
8573093|NCT02956486|21138526|P3|NOT COMPLETED|Core Phase||0
8573094|NCT02956486|21138527|P2|NOT COMPLETED|Core Phase||1072
8573095|NCT02956486|21138528|P1|NOT COMPLETED|Core Phase||1079
8573096|NCT02956486|21138526|P3|COMPLETED|Core Phase||0
8573097|NCT02956486|21138527|P2|COMPLETED|Core Phase||32
8573098|NCT02956486|21138528|P1|COMPLETED|Core Phase||29
8573099|NCT02956486|21138526|P3|Full Analysis Set (FAS)|Core Phase||0
8573100|NCT02956486|21138527|P2|Full Analysis Set (FAS)|Core Phase||1062
8573101|NCT02956486|21138528|P1|Full Analysis Set (FAS)|Core Phase||1084
8573102|NCT02956486|21138526|P3|Safety Analysis Set (SAS)|Core Phase||0
8573103|NCT02956486|21138527|P2|Safety Analysis Set (SAS)|Core Phase||1099
8573104|NCT02956486|21138528|P1|Safety Analysis Set (SAS)|Core Phase||1105
8573105|NCT02956486|21138526|P3|Treated|Core Phase||0
8573106|NCT02956486|21138527|P2|Treated|Core Phase||1101
8573107|NCT02956486|21138528|P1|Treated|Core Phase||1108
8573108|NCT02956486|21138526|P3|STARTED|Core Phase||0
8573109|NCT02956486|21138527|P2|STARTED|Core Phase||1104
8573110|NCT02956486|21138528|P1|STARTED|Core Phase||1108
8573124|NCT02891915|21138603|P2|NOT COMPLETED|Overall Study||12
8573125|NCT02891915|21138604|P1|NOT COMPLETED|Overall Study||13
8573126|NCT02891915|21138603|P2|COMPLETED|Overall Study||181
8573127|NCT02891915|21138604|P1|COMPLETED|Overall Study||179
8573128|NCT02891915|21138603|P2|STARTED|Overall Study||193
8573129|NCT02891915|21138604|P1|STARTED|Overall Study||192
8573144|NCT02813265|21138686|P2|NOT COMPLETED|Overall Study||3
8573145|NCT02813265|21138687|P1|NOT COMPLETED|Overall Study||4
8573146|NCT02813265|21138686|P2|COMPLETED|Overall Study||453
8573147|NCT02813265|21138687|P1|COMPLETED|Overall Study||455
8573148|NCT02813265|21138686|P2|STARTED|Overall Study||456
8573149|NCT02813265|21138687|P1|STARTED|Overall Study||459
8573195|NCT02749799|21138791|P1|NOT COMPLETED|Overall Study||8
8573196|NCT02749799|21138791|P1|COMPLETED|Overall Study||37
8573197|NCT02749799|21138791|P1|STARTED|Overall Study||45
8573252|NCT02617589|21138934|P2|NOT COMPLETED|Treatment Period||274
8573253|NCT02617589|21138935|P1|NOT COMPLETED|Treatment Period||274
8573254|NCT02617589|21138934|P2|COMPLETED|Treatment Period||1
8573255|NCT02617589|21138935|P1|COMPLETED|Treatment Period||4
8573256|NCT02617589|21138934|P2|STARTED|Treatment Period||275
8573257|NCT02617589|21138935|P1|STARTED|Treatment Period||278
8573258|NCT02617589|21138934|P2|NOT COMPLETED|All Randomized||5
8573259|NCT02617589|21138935|P1|NOT COMPLETED|All Randomized||2
8573260|NCT02617589|21138934|P2|COMPLETED|All Randomized||275
8573261|NCT02617589|21138935|P1|COMPLETED|All Randomized||278
8573262|NCT02617589|21138934|P2|STARTED|All Randomized||280
8573263|NCT02617589|21138935|P1|STARTED|All Randomized||280
8573264|NCT02613884|21138949|P1|NOT COMPLETED|Overall Study||2
8573265|NCT02613884|21138949|P1|COMPLETED|Overall Study||24
8573266|NCT02613884|21138949|P1|Efficacy Timepoint 3|Overall Study||24
8573267|NCT02613884|21138949|P1|Efficacy Timepoint 2|Overall Study||25
8573268|NCT02613884|21138949|P1|Efficacy Endpoint 1|Overall Study||25
8573269|NCT02613884|21138949|P1|Safety Endpoint 2|Overall Study||26
8573270|NCT02613884|21138949|P1|Feasibility Questionnaire|Overall Study||26
8573271|NCT02613884|21138949|P1|Safety Endpoint 1|Overall Study||26
8573272|NCT02613884|21138949|P1|STARTED|Overall Study||26
8573294|NCT02550938|21139020|P4|NOT COMPLETED|Overall Study||11
8573295|NCT02550938|21139021|P3|NOT COMPLETED|Overall Study||12
8573296|NCT02550938|21139022|P2|NOT COMPLETED|Overall Study||7
8573297|NCT02550938|21139023|P1|NOT COMPLETED|Overall Study||8
8573298|NCT02550938|21139020|P4|COMPLETED|Overall Study||70
8573299|NCT02550938|21139021|P3|COMPLETED|Overall Study||31
8573300|NCT02550938|21139022|P2|COMPLETED|Overall Study||78
8573301|NCT02550938|21139023|P1|COMPLETED|Overall Study||36
8573302|NCT02550938|21139020|P4|STARTED|Overall Study||81
8573303|NCT02550938|21139021|P3|STARTED|Overall Study||43
8573304|NCT02550938|21139022|P2|STARTED|Overall Study||85
8573305|NCT02550938|21139023|P1|STARTED|Overall Study||44
8573395|NCT02273908|21139405|P2|NOT COMPLETED|Overall Study||5
8573396|NCT02273908|21139406|P1|NOT COMPLETED|Overall Study||33
8573397|NCT02273908|21139405|P2|COMPLETED|Overall Study||169
8573398|NCT02273908|21139406|P1|COMPLETED|Overall Study||124
8573399|NCT02273908|21139405|P2|STARTED|Overall Study||174
8573400|NCT02273908|21139406|P1|STARTED|Overall Study||157
8573425|NCT02145403|21139531|P4|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573426|NCT02145403|21139532|P3|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1
8573427|NCT02145403|21139533|P2|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573428|NCT02145403|21139534|P1|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573429|NCT02145403|21139531|P4|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573430|NCT02145403|21139532|P3|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36
8573431|NCT02145403|21139533|P2|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573432|NCT02145403|21139534|P1|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573433|NCT02145403|21139531|P4|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573434|NCT02145403|21139532|P3|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37
8573435|NCT02145403|21139533|P2|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573436|NCT02145403|21139534|P1|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
8573437|NCT02145403|21139531|P4|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
8573438|NCT02145403|21139532|P3|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573439|NCT02145403|21139533|P2|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573440|NCT02145403|21139534|P1|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573441|NCT02145403|21139531|P4|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
8573442|NCT02145403|21139532|P3|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573443|NCT02145403|21139533|P2|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573444|NCT02145403|21139534|P1|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573445|NCT02145403|21139531|P4|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4
8573446|NCT02145403|21139532|P3|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573447|NCT02145403|21139533|P2|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573448|NCT02145403|21139534|P1|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
8573449|NCT02145403|21139531|P4|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573450|NCT02145403|21139532|P3|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1
8573451|NCT02145403|21139533|P2|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573452|NCT02145403|21139534|P1|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573453|NCT02145403|21139531|P4|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573454|NCT02145403|21139532|P3|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3
8573455|NCT02145403|21139533|P2|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573456|NCT02145403|21139534|P1|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573457|NCT02145403|21139531|P4|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573458|NCT02145403|21139532|P3|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4
8573459|NCT02145403|21139533|P2|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573460|NCT02145403|21139534|P1|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
8573461|NCT02145403|21139531|P4|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573462|NCT02145403|21139532|P3|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573463|NCT02145403|21139533|P2|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573464|NCT02145403|21139534|P1|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573465|NCT02145403|21139531|P4|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573466|NCT02145403|21139532|P3|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573467|NCT02145403|21139533|P2|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
8573468|NCT02145403|21139534|P1|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573469|NCT02145403|21139531|P4|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573470|NCT02145403|21139532|P3|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573471|NCT02145403|21139533|P2|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
8573472|NCT02145403|21139534|P1|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
8573473|NCT02145403|21139531|P4|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573474|NCT02145403|21139532|P3|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573475|NCT02145403|21139533|P2|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573476|NCT02145403|21139534|P1|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573477|NCT02145403|21139531|P4|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573478|NCT02145403|21139532|P3|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573479|NCT02145403|21139533|P2|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573480|NCT02145403|21139534|P1|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
8573481|NCT02145403|21139531|P4|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573482|NCT02145403|21139532|P3|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573483|NCT02145403|21139533|P2|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
8573484|NCT02145403|21139534|P1|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
8573547|NCT02075554|21139744|P1|NOT COMPLETED|Overall Study||15
8573548|NCT02075554|21139744|P1|COMPLETED|Overall Study||43
8573549|NCT02075554|21139744|P1|STARTED|Overall Study||58
8573550|NCT01993329|21139757|P6|NOT COMPLETED|Period 3||0
8573551|NCT01993329|21139758|P5|NOT COMPLETED|Period 3||0
8573552|NCT01993329|21139759|P4|NOT COMPLETED|Period 3||0
8573553|NCT01993329|21139760|P3|NOT COMPLETED|Period 3||0
8573554|NCT01993329|21139761|P2|NOT COMPLETED|Period 3||0
8573555|NCT01993329|21139762|P1|NOT COMPLETED|Period 3||0
8573556|NCT01993329|21139757|P6|COMPLETED|Period 3||3
8573557|NCT01993329|21139758|P5|COMPLETED|Period 3||3
8573558|NCT01993329|21139759|P4|COMPLETED|Period 3||3
8573559|NCT01993329|21139760|P3|COMPLETED|Period 3||3
8573560|NCT01993329|21139761|P2|COMPLETED|Period 3||3
8573561|NCT01993329|21139762|P1|COMPLETED|Period 3||3
8573562|NCT01993329|21139757|P6|STARTED|Period 3||3
8573563|NCT01993329|21139758|P5|STARTED|Period 3||3
8573564|NCT01993329|21139759|P4|STARTED|Period 3||3
8573565|NCT01993329|21139760|P3|STARTED|Period 3||3
8573566|NCT01993329|21139761|P2|STARTED|Period 3||3
8573567|NCT01993329|21139762|P1|STARTED|Period 3||3
8573568|NCT01993329|21139757|P6|NOT COMPLETED|Wash-out||0
8573569|NCT01993329|21139758|P5|NOT COMPLETED|Wash-out||0
8573570|NCT01993329|21139759|P4|NOT COMPLETED|Wash-out||0
8573571|NCT01993329|21139760|P3|NOT COMPLETED|Wash-out||0
8573572|NCT01993329|21139761|P2|NOT COMPLETED|Wash-out||1
8573573|NCT01993329|21139762|P1|NOT COMPLETED|Wash-out||0
8573574|NCT01993329|21139757|P6|COMPLETED|Wash-out||3
8573575|NCT01993329|21139758|P5|COMPLETED|Wash-out||3
8573576|NCT01993329|21139759|P4|COMPLETED|Wash-out||3
8573577|NCT01993329|21139760|P3|COMPLETED|Wash-out||3
8573578|NCT01993329|21139761|P2|COMPLETED|Wash-out||3
8573579|NCT01993329|21139762|P1|COMPLETED|Wash-out||3
8573580|NCT01993329|21139757|P6|STARTED|Wash-out||3
8573581|NCT01993329|21139758|P5|STARTED|Wash-out||3
8573582|NCT01993329|21139759|P4|STARTED|Wash-out||3
8573583|NCT01993329|21139760|P3|STARTED|Wash-out||3
8573584|NCT01993329|21139761|P2|STARTED|Wash-out||4
8573585|NCT01993329|21139762|P1|STARTED|Wash-out||3
8573586|NCT01993329|21139757|P6|NOT COMPLETED|Period 2||1
8573587|NCT01993329|21139758|P5|NOT COMPLETED|Period 2||0
8573588|NCT01993329|21139759|P4|NOT COMPLETED|Period 2||0
8573589|NCT01993329|21139760|P3|NOT COMPLETED|Period 2||0
8573590|NCT01993329|21139761|P2|NOT COMPLETED|Period 2||0
8573591|NCT01993329|21139762|P1|NOT COMPLETED|Period 2||0
8573592|NCT01993329|21139757|P6|COMPLETED|Period 2||3
8573593|NCT01993329|21139758|P5|COMPLETED|Period 2||3
8573594|NCT01993329|21139759|P4|COMPLETED|Period 2||3
8573595|NCT01993329|21139760|P3|COMPLETED|Period 2||3
8573596|NCT01993329|21139761|P2|COMPLETED|Period 2||4
8573597|NCT01993329|21139762|P1|COMPLETED|Period 2||3
8573598|NCT01993329|21139757|P6|STARTED|Period 2||4
8573599|NCT01993329|21139758|P5|STARTED|Period 2||3
8573600|NCT01993329|21139759|P4|STARTED|Period 2||3
8573601|NCT01993329|21139760|P3|STARTED|Period 2||3
8573602|NCT01993329|21139761|P2|STARTED|Period 2||4
8573603|NCT01993329|21139762|P1|STARTED|Period 2||3
8573604|NCT01993329|21139757|P6|NOT COMPLETED|Wash-out||0
8573605|NCT01993329|21139758|P5|NOT COMPLETED|Wash-out||0
8573606|NCT01993329|21139759|P4|NOT COMPLETED|Wash-out||0
8573607|NCT01993329|21139760|P3|NOT COMPLETED|Wash-out||0
8573608|NCT01993329|21139761|P2|NOT COMPLETED|Wash-out||0
8573609|NCT01993329|21139762|P1|NOT COMPLETED|Wash-out||0
8573610|NCT01993329|21139757|P6|COMPLETED|Wash-out||4
8573611|NCT01993329|21139758|P5|COMPLETED|Wash-out||3
8573612|NCT01993329|21139759|P4|COMPLETED|Wash-out||3
8573613|NCT01993329|21139760|P3|COMPLETED|Wash-out||3
8573614|NCT01993329|21139761|P2|COMPLETED|Wash-out||4
8573615|NCT01993329|21139762|P1|COMPLETED|Wash-out||3
8573616|NCT01993329|21139757|P6|STARTED|Wash-out||4
8573617|NCT01993329|21139758|P5|STARTED|Wash-out||3
8573618|NCT01993329|21139759|P4|STARTED|Wash-out||3
8573619|NCT01993329|21139760|P3|STARTED|Wash-out||3
8573620|NCT01993329|21139761|P2|STARTED|Wash-out||4
8573621|NCT01993329|21139762|P1|STARTED|Wash-out||3
8573622|NCT01993329|21139757|P6|NOT COMPLETED|Period 1||0
8573623|NCT01993329|21139758|P5|NOT COMPLETED|Period 1||0
8573624|NCT01993329|21139759|P4|NOT COMPLETED|Period 1||0
8573625|NCT01993329|21139760|P3|NOT COMPLETED|Period 1||0
8573626|NCT01993329|21139761|P2|NOT COMPLETED|Period 1||0
8573627|NCT01993329|21139762|P1|NOT COMPLETED|Period 1||0
8573628|NCT01993329|21139757|P6|COMPLETED|Period 1||4
8573629|NCT01993329|21139758|P5|COMPLETED|Period 1||3
8573630|NCT01993329|21139759|P4|COMPLETED|Period 1||3
8573631|NCT01993329|21139760|P3|COMPLETED|Period 1||3
8573632|NCT01993329|21139761|P2|COMPLETED|Period 1||4
8573633|NCT01993329|21139762|P1|COMPLETED|Period 1||3
8573634|NCT01993329|21139757|P6|STARTED|Period 1||4
8573635|NCT01993329|21139758|P5|STARTED|Period 1||3
8573636|NCT01993329|21139759|P4|STARTED|Period 1||3
8573637|NCT01993329|21139760|P3|STARTED|Period 1||3
8573638|NCT01993329|21139761|P2|STARTED|Period 1||4
8573639|NCT01993329|21139762|P1|STARTED|Period 1||3
8573760|NCT01790113|21139856|P2|NOT COMPLETED|Overall Study||75
8573761|NCT01790113|21139857|P1|NOT COMPLETED|Overall Study||3
8573762|NCT01790113|21139856|P2|COMPLETED|Overall Study||149
8573763|NCT01790113|21139857|P1|COMPLETED|Overall Study||76
8573764|NCT01790113|21139856|P2|STARTED|Overall Study||224
8573765|NCT01790113|21139857|P1|STARTED|Overall Study||79
8573919|NCT01554371|21140331|P3|NOT COMPLETED|Overall Study||0
8573920|NCT01554371|21140332|P2|NOT COMPLETED|Overall Study||0
8573921|NCT01554371|21140333|P1|NOT COMPLETED|Overall Study||0
8573922|NCT01554371|21140331|P3|COMPLETED|Overall Study||38
8573923|NCT01554371|21140332|P2|COMPLETED|Overall Study||3
8573924|NCT01554371|21140333|P1|COMPLETED|Overall Study||3
8573925|NCT01554371|21140331|P3|STARTED|Overall Study||38
8573926|NCT01554371|21140332|P2|STARTED|Overall Study||3
8573927|NCT01554371|21140333|P1|STARTED|Overall Study||3
8573956|NCT01496885|21140409|P1|NOT COMPLETED|Overall Study||23
8573957|NCT01496885|21140409|P1|COMPLETED|Overall Study||97
8573958|NCT01496885|21140409|P1|STARTED|Overall Study||120
8573959|NCT01481545|21140420|P2|NOT COMPLETED|Overall Study||6
8573960|NCT01481545|21140421|P1|NOT COMPLETED|Overall Study||5
8573961|NCT01481545|21140420|P2|COMPLETED|Overall Study||40
8573962|NCT01481545|21140421|P1|COMPLETED|Overall Study||11
8573963|NCT01481545|21140420|P2|STARTED|Overall Study||46
8573964|NCT01481545|21140421|P1|STARTED|Overall Study||16
8573965|NCT01441401|21140439|P1|NOT COMPLETED|Overall Study||0
8573966|NCT01441401|21140439|P1|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
8573967|NCT01441401|21140439|P1|STARTED|Overall Study||82
8573968|NCT01365156|21140467|P2|NOT COMPLETED|Overall Study||0
8573969|NCT01365156|21140468|P1|NOT COMPLETED|Overall Study||0
8573970|NCT01365156|21140467|P2|COMPLETED|Overall Study||14
8573971|NCT01365156|21140468|P1|COMPLETED|Overall Study||14
8573972|NCT01365156|21140467|P2|STARTED|Overall Study||14
8573973|NCT01365156|21140468|P1|STARTED|Overall Study||14
8573974|NCT01349907|21140476|P2|NOT COMPLETED|Overall Study||43
8573975|NCT01349907|21140477|P1|NOT COMPLETED|Overall Study||139
8573976|NCT01349907|21140476|P2|COMPLETED|Overall Study||38
8573977|NCT01349907|21140477|P1|COMPLETED|Overall Study||102
8573978|NCT01349907|21140476|P2|STARTED|Overall Study|Enrolled and Treated|81
8573979|NCT01349907|21140477|P1|STARTED|Overall Study|Enrolled and Treated|241
8573980|NCT01279057|21140516|P3|NOT COMPLETED|Overall Study||3
8573981|NCT01279057|21140517|P2|NOT COMPLETED|Overall Study||5
8573982|NCT01279057|21140518|P1|NOT COMPLETED|Overall Study||6
8573983|NCT01279057|21140516|P3|COMPLETED|Overall Study||144
8573984|NCT01279057|21140517|P2|COMPLETED|Overall Study||287
8573985|NCT01279057|21140518|P1|COMPLETED|Overall Study||282
8573986|NCT01279057|21140516|P3|Intent-to-Treat (ITT) Population|Overall Study||144
8573987|NCT01279057|21140517|P2|Intent-to-Treat (ITT) Population|Overall Study||285
8573988|NCT01279057|21140518|P1|Intent-to-Treat (ITT) Population|Overall Study||284
8573989|NCT01279057|21140516|P3|Per-Protocol (PPP) Population|Overall Study||126
8573990|NCT01279057|21140517|P2|Per-Protocol (PPP) Population|Overall Study||245
8573991|NCT01279057|21140518|P1|Per-Protocol (PPP) Population|Overall Study||257
8573992|NCT01279057|21140516|P3|STARTED|Overall Study||147
8573993|NCT01279057|21140517|P2|STARTED|Overall Study||292
8573994|NCT01279057|21140518|P1|STARTED|Overall Study||288
8573995|NCT01265719|21140545|P2|NOT COMPLETED|Overall Study||13
8573996|NCT01265719|21140546|P1|NOT COMPLETED|Overall Study||14
8573997|NCT01265719|21140545|P2|COMPLETED|Overall Study||60
8573998|NCT01265719|21140546|P1|COMPLETED|Overall Study||88
8573999|NCT01265719|21140545|P2|STARTED|Overall Study||73
8574000|NCT01265719|21140546|P1|STARTED|Overall Study||102
8574007|NCT01231516|21140593|P2|NOT COMPLETED|Open-label Phase||26
8574008|NCT01231516|21140594|P1|NOT COMPLETED|Open-label Phase||295
8574009|NCT01231516|21140593|P2|COMPLETED|Open-label Phase||1
8574010|NCT01231516|21140594|P1|COMPLETED|Open-label Phase||0
8574011|NCT01231516|21140593|P2|Ongoing at the Time of Analysis|Open-label Phase||23
8574012|NCT01231516|21140594|P1|Ongoing at the Time of Analysis|Open-label Phase||282
8574013|NCT01231516|21140593|P2|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
8574014|NCT01231516|21140594|P1|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
8574015|NCT01231516|21140593|P2|NOT COMPLETED|48 Week Double-blind Phase||79
8574016|NCT01231516|21140594|P1|NOT COMPLETED|48 Week Double-blind Phase||58
8574017|NCT01231516|21140593|P2|COMPLETED|48 Week Double-blind Phase||283
8574018|NCT01231516|21140594|P1|COMPLETED|48 Week Double-blind Phase||299
8574019|NCT01231516|21140593|P2|STARTED|48 Week Double-blind Phase||362
8574020|NCT01231516|21140594|P1|STARTED|48 Week Double-blind Phase||357
8574033|NCT01190267|21140644|P2|NOT COMPLETED|Overall Study||4
8574034|NCT01190267|21140645|P1|NOT COMPLETED|Overall Study||41
8574035|NCT01190267|21140644|P2|COMPLETED|Overall Study||4
8574036|NCT01190267|21140645|P1|COMPLETED|Overall Study||155
8574037|NCT01190267|21140644|P2|STARTED|Overall Study||8
8574038|NCT01190267|21140645|P1|STARTED|Overall Study||196
8574097|NCT01038427|21140735|P3|NOT COMPLETED|Overall Study||4
8574098|NCT01038427|21140736|P2|NOT COMPLETED|Overall Study||6
8574099|NCT01038427|21140737|P1|NOT COMPLETED|Overall Study||3
8574100|NCT01038427|21140735|P3|COMPLETED|Overall Study||154
8574101|NCT01038427|21140736|P2|COMPLETED|Overall Study||314
8574102|NCT01038427|21140737|P1|COMPLETED|Overall Study||314
8574103|NCT01038427|21140735|P3|Intent-to-Treat (ITT) Population|Overall Study||156
8574104|NCT01038427|21140736|P2|Intent-to-Treat (ITT) Population|Overall Study||314
8574105|NCT01038427|21140737|P1|Intent-to-Treat (ITT) Population|Overall Study||314
8574106|NCT01038427|21140735|P3|Per-Protocol (PPP) Population|Overall Study||150
8574107|NCT01038427|21140736|P2|Per-Protocol (PPP) Population|Overall Study||307
8574108|NCT01038427|21140737|P1|Per-Protocol (PPP) Population|Overall Study||306
8574109|NCT01038427|21140735|P3|STARTED|Overall Study||158
8574110|NCT01038427|21140736|P2|STARTED|Overall Study||320
8574111|NCT01038427|21140737|P1|STARTED|Overall Study||317
8574112|NCT00914732|21140761|P3|NOT COMPLETED|Overall Study||11
8574113|NCT00914732|21140762|P2|NOT COMPLETED|Overall Study||7
8574114|NCT00914732|21140763|P1|NOT COMPLETED|Overall Study||10
8574115|NCT00914732|21140761|P3|COMPLETED|Overall Study||180
8574116|NCT00914732|21140762|P2|COMPLETED|Overall Study||160
8574117|NCT00914732|21140763|P1|COMPLETED|Overall Study||155
8574118|NCT00914732|21140761|P3|Received Second Vaccination|Overall Study||153
8574119|NCT00914732|21140762|P2|Received Second Vaccination|Overall Study||157
8574120|NCT00914732|21140763|P1|Received Second Vaccination|Overall Study||150
8574121|NCT00914732|21140761|P3|STARTED|Overall Study||191
8574122|NCT00914732|21140762|P2|STARTED|Overall Study||167
8574123|NCT00914732|21140763|P1|STARTED|Overall Study||165
8574136|NCT00810498|21140921|P2|NOT COMPLETED|Overall Study||0
8574137|NCT00810498|21140922|P1|NOT COMPLETED|Overall Study||0
8574138|NCT00810498|21140921|P2|COMPLETED|Overall Study||5
8574139|NCT00810498|21140922|P1|COMPLETED|Overall Study||6
8574140|NCT00810498|21140921|P2|STARTED|Overall Study||5
8574141|NCT00810498|21140922|P1|STARTED|Overall Study||6
8574142|NCT00810459|21140936|P2|NOT COMPLETED|Overall Study||0
8574143|NCT00810459|21140937|P1|NOT COMPLETED|Overall Study||0
8574144|NCT00810459|21140936|P2|COMPLETED|Overall Study||2
8574145|NCT00810459|21140937|P1|COMPLETED|Overall Study||4
8574146|NCT00810459|21140936|P2|STARTED|Overall Study||2
8574147|NCT00810459|21140937|P1|STARTED|Overall Study||4
8574148|NCT00785772|21140951|P1|NOT COMPLETED|Overall Study||0
8574149|NCT00785772|21140951|P1|COMPLETED|Overall Study||1
8574150|NCT00785772|21140951|P1|STARTED|Overall Study||1
8574151|NCT00716859|21140959|P2|NOT COMPLETED|Overall Study||5
8574152|NCT00716859|21140960|P1|NOT COMPLETED|Overall Study||9
8574153|NCT00716859|21140959|P2|COMPLETED|Overall Study||64
8574154|NCT00716859|21140960|P1|COMPLETED|Overall Study||61
8574155|NCT00716859|21140959|P2|Received Treatment|Overall Study||68
8574156|NCT00716859|21140960|P1|Received Treatment|Overall Study||69
8574157|NCT00716859|21140959|P2|STARTED|Overall Study||69
8574158|NCT00716859|21140960|P1|STARTED|Overall Study||70
8574187|NCT00642941|21141012|P12|NOT COMPLETED|Overall Study||11
8574188|NCT00642941|21141013|P11|NOT COMPLETED|Overall Study||12
8574189|NCT00642941|21141014|P10|NOT COMPLETED|Overall Study||9
8574190|NCT00642941|21141015|P9|NOT COMPLETED|Overall Study||11
8574191|NCT00642941|21141016|P8|NOT COMPLETED|Overall Study||14
8574192|NCT00642941|21141017|P7|NOT COMPLETED|Overall Study||23
8574193|NCT00642941|21141018|P6|NOT COMPLETED|Overall Study||41
8574194|NCT00642941|21141019|P5|NOT COMPLETED|Overall Study||25
8574195|NCT00642941|21141020|P4|NOT COMPLETED|Overall Study||40
8574196|NCT00642941|21141021|P3|NOT COMPLETED|Overall Study||7
8574197|NCT00642941|21141022|P2|NOT COMPLETED|Overall Study||54
8574198|NCT00642941|21141023|P1|NOT COMPLETED|Overall Study||70
8574199|NCT00642941|21141012|P12|COMPLETED|Overall Study||0
8574200|NCT00642941|21141013|P11|COMPLETED|Overall Study||0
8574201|NCT00642941|21141014|P10|COMPLETED|Overall Study||0
8574202|NCT00642941|21141015|P9|COMPLETED|Overall Study||0
8574203|NCT00642941|21141016|P8|COMPLETED|Overall Study||0
8574204|NCT00642941|21141017|P7|COMPLETED|Overall Study||0
8574205|NCT00642941|21141018|P6|COMPLETED|Overall Study||0
8574206|NCT00642941|21141019|P5|COMPLETED|Overall Study||0
8574207|NCT00642941|21141020|P4|COMPLETED|Overall Study||0
8574208|NCT00642941|21141021|P3|COMPLETED|Overall Study||0
8574209|NCT00642941|21141022|P2|COMPLETED|Overall Study||0
8574210|NCT00642941|21141023|P1|COMPLETED|Overall Study||0
8574211|NCT00642941|21141012|P12|STARTED|Overall Study||11
8574212|NCT00642941|21141013|P11|STARTED|Overall Study||12
8574213|NCT00642941|21141014|P10|STARTED|Overall Study||9
8574214|NCT00642941|21141015|P9|STARTED|Overall Study||11
8574215|NCT00642941|21141016|P8|STARTED|Overall Study||14
8574216|NCT00642941|21141017|P7|STARTED|Overall Study||23
8574217|NCT00642941|21141018|P6|STARTED|Overall Study||41
8574218|NCT00642941|21141019|P5|STARTED|Overall Study||25
8574219|NCT00642941|21141020|P4|STARTED|Overall Study||40
8574220|NCT00642941|21141021|P3|STARTED|Overall Study||7
8574221|NCT00642941|21141022|P2|STARTED|Overall Study||54
8574222|NCT00642941|21141023|P1|STARTED|Overall Study||70
8574223|NCT00635570|21141159|P2|NOT COMPLETED|Overall Study||11
8574224|NCT00635570|21141160|P1|NOT COMPLETED|Overall Study||15
8574225|NCT00635570|21141159|P2|COMPLETED|Overall Study||126
8574226|NCT00635570|21141160|P1|COMPLETED|Overall Study||121
8574227|NCT00635570|21141159|P2|STARTED|Overall Study||137
8574228|NCT00635570|21141160|P1|STARTED|Overall Study||136
8574229|NCT00620555|21141172|P1|NOT COMPLETED|Overall Study||21
8574230|NCT00620555|21141172|P1|COMPLETED|Overall Study||44
8574231|NCT00620555|21141172|P1|STARTED|Overall Study||65
8574232|NCT00603473|21141179|P1|NOT COMPLETED|Overall Study||9
8574233|NCT00603473|21141179|P1|COMPLETED|Overall Study||80
8574234|NCT00603473|21141179|P1|STARTED|Overall Study||89
8574235|NCT00583011|21141187|P2|NOT COMPLETED|Overall Study||0
8574236|NCT00583011|21141188|P1|NOT COMPLETED|Overall Study||0
8574237|NCT00583011|21141187|P2|COMPLETED|Overall Study||40
8574238|NCT00583011|21141188|P1|COMPLETED|Overall Study||36
8574239|NCT00583011|21141187|P2|STARTED|Overall Study||40
8574240|NCT00583011|21141188|P1|STARTED|Overall Study||36
8574241|NCT00567268|21141196|P1|NOT COMPLETED|Overall Study||50
8574242|NCT00567268|21141196|P1|COMPLETED|Overall Study||1144
8574243|NCT00567268|21141196|P1|STARTED|Overall Study||1194
8574403|NCT04467424|21141455|P2|NOT COMPLETED|Overall Study||0
8574404|NCT04467424|21141456|P1|NOT COMPLETED|Overall Study||0
8574405|NCT04467424|21141455|P2|COMPLETED|Overall Study||100
8574406|NCT04467424|21141456|P1|COMPLETED|Overall Study||100
8574407|NCT04467424|21141455|P2|STARTED|Overall Study||100
8574408|NCT04467424|21141456|P1|STARTED|Overall Study||100
8574413|NCT04162795|21141472|P1|NOT COMPLETED|Overall Study||26
8574414|NCT04162795|21141472|P1|COMPLETED|Overall Study||442
8574415|NCT04162795|21141472|P1|STARTED|Overall Study||468
8574626|NCT03913377|21141552|P3|NOT COMPLETED|Period 2||0
8574627|NCT03913377|21141553|P2|NOT COMPLETED|Period 2||0
8574628|NCT03913377|21141554|P1|NOT COMPLETED|Period 2||0
8574629|NCT03913377|21141552|P3|COMPLETED|Period 2||21
8574630|NCT03913377|21141553|P2|COMPLETED|Period 2||21
8574631|NCT03913377|21141554|P1|COMPLETED|Period 2||0
8574632|NCT03913377|21141552|P3|STARTED|Period 2||21
8574633|NCT03913377|21141553|P2|STARTED|Period 2||21
8574634|NCT03913377|21141554|P1|STARTED|Period 2||0
8574635|NCT03913377|21141552|P3|NOT COMPLETED|Period 1||1
8574636|NCT03913377|21141553|P2|NOT COMPLETED|Period 1||1
8574637|NCT03913377|21141554|P1|NOT COMPLETED|Period 1||0
8574638|NCT03913377|21141552|P3|COMPLETED|Period 1||21
8574639|NCT03913377|21141553|P2|COMPLETED|Period 1||21
8574640|NCT03913377|21141554|P1|COMPLETED|Period 1||21
8574641|NCT03913377|21141552|P3|STARTED|Period 1||22
8574642|NCT03913377|21141553|P2|STARTED|Period 1||22
8574643|NCT03913377|21141554|P1|STARTED|Period 1||21
8574647|NCT03782272|21141578|P2|NOT COMPLETED|Overall Study||0
8574648|NCT03782272|21141579|P1|NOT COMPLETED|Overall Study||0
8574649|NCT03782272|21141578|P2|COMPLETED|Overall Study||6
8574650|NCT03782272|21141579|P1|COMPLETED|Overall Study||6
8574651|NCT03782272|21141578|P2|STARTED|Overall Study||6
8574652|NCT03782272|21141579|P1|STARTED|Overall Study||6
8574659|NCT03725033|21141643|P2|NOT COMPLETED|Overall Study||0
8574660|NCT03725033|21141644|P1|NOT COMPLETED|Overall Study||0
8574661|NCT03725033|21141643|P2|COMPLETED|Overall Study||97
8574662|NCT03725033|21141644|P1|COMPLETED|Overall Study||105
8574663|NCT03725033|21141643|P2|STARTED|Overall Study||97
8574664|NCT03725033|21141644|P1|STARTED|Overall Study||105
8574668|NCT03680911|21141666|P2|NOT COMPLETED|Visit 3 (4 Month Follow up)||1
8574669|NCT03680911|21141667|P1|NOT COMPLETED|Visit 3 (4 Month Follow up)||0
8574670|NCT03680911|21141666|P2|COMPLETED|Visit 3 (4 Month Follow up)||0
8574671|NCT03680911|21141667|P1|COMPLETED|Visit 3 (4 Month Follow up)||0
8574672|NCT03680911|21141666|P2|STARTED|Visit 3 (4 Month Follow up)||1
8574673|NCT03680911|21141667|P1|STARTED|Visit 3 (4 Month Follow up)||0
8574674|NCT03680911|21141666|P2|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
8574675|NCT03680911|21141667|P1|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
8574676|NCT03680911|21141666|P2|COMPLETED|Visit 2 (1 Month Follow up)||1
8574677|NCT03680911|21141667|P1|COMPLETED|Visit 2 (1 Month Follow up)||0
8574678|NCT03680911|21141666|P2|STARTED|Visit 2 (1 Month Follow up)||1
8574679|NCT03680911|21141667|P1|STARTED|Visit 2 (1 Month Follow up)||0
8574680|NCT03680911|21141666|P2|NOT COMPLETED|At Home Treatment||3
8574681|NCT03680911|21141667|P1|NOT COMPLETED|At Home Treatment||3
8574682|NCT03680911|21141666|P2|COMPLETED|At Home Treatment||1
8574683|NCT03680911|21141667|P1|COMPLETED|At Home Treatment||0
8574684|NCT03680911|21141666|P2|STARTED|At Home Treatment||4
8574685|NCT03680911|21141667|P1|STARTED|At Home Treatment||3
8574686|NCT03680911|21141666|P2|NOT COMPLETED|Visit 1 (Baseline)||0
8574687|NCT03680911|21141667|P1|NOT COMPLETED|Visit 1 (Baseline)||0
8574688|NCT03680911|21141666|P2|COMPLETED|Visit 1 (Baseline)||4
8574689|NCT03680911|21141667|P1|COMPLETED|Visit 1 (Baseline)||3
8574690|NCT03680911|21141666|P2|STARTED|Visit 1 (Baseline)||4
8574691|NCT03680911|21141667|P1|STARTED|Visit 1 (Baseline)||3
8574729|NCT03468933|21141765|P2|NOT COMPLETED|Overall Study||0
8574730|NCT03468933|21141766|P1|NOT COMPLETED|Overall Study||0
8574731|NCT03468933|21141765|P2|COMPLETED|Overall Study||16
8574732|NCT03468933|21141766|P1|COMPLETED|Overall Study||16
8574733|NCT03468933|21141765|P2|STARTED|Overall Study||16
8574734|NCT03468933|21141766|P1|STARTED|Overall Study||16
8574741|NCT03430349|21141791|P2|NOT COMPLETED|Overall Study||0
8574742|NCT03430349|21141792|P1|NOT COMPLETED|Overall Study||0
8574743|NCT03430349|21141791|P2|COMPLETED|Overall Study||15
8574744|NCT03430349|21141792|P1|COMPLETED|Overall Study||15
8574745|NCT03430349|21141791|P2|Received nOPV Vaccination|Overall Study||15
8574746|NCT03430349|21141792|P1|Received nOPV Vaccination|Overall Study||15
8574747|NCT03430349|21141791|P2|STARTED|Overall Study||15
8574748|NCT03430349|21141792|P1|STARTED|Overall Study||15
8574755|NCT03413618|21141833|P2|NOT COMPLETED|Overall Study||0
8574756|NCT03413618|21141834|P1|NOT COMPLETED|Overall Study||0
8574757|NCT03413618|21141833|P2|COMPLETED|Overall Study||45
8574758|NCT03413618|21141834|P1|COMPLETED|Overall Study||45
8574759|NCT03413618|21141833|P2|STARTED|Overall Study||45
8574760|NCT03413618|21141834|P1|STARTED|Overall Study||45
8574799|NCT03245723|21141964|P2|NOT COMPLETED|Overall Study||1
8574800|NCT03245723|21141965|P1|NOT COMPLETED|Overall Study||5
8574801|NCT03245723|21141964|P2|COMPLETED|Overall Study||17
8574802|NCT03245723|21141965|P1|COMPLETED|Overall Study||27
8574803|NCT03245723|21141964|P2|STARTED|Overall Study||18
8574804|NCT03245723|21141965|P1|STARTED|Overall Study||32
8574805|NCT03242928|21141975|P2|NOT COMPLETED|Overall Study||5
8574806|NCT03242928|21141976|P1|NOT COMPLETED|Overall Study||9
8574807|NCT03242928|21141975|P2|COMPLETED|Overall Study||32
8574808|NCT03242928|21141976|P1|COMPLETED|Overall Study||22
8574809|NCT03242928|21141975|P2|STARTED|Overall Study||37
8574810|NCT03242928|21141976|P1|STARTED|Overall Study||31
8574811|NCT03073876|21141989|P2|NOT COMPLETED|Overall Study||0
8574812|NCT03073876|21141990|P1|NOT COMPLETED|Overall Study||0
8574813|NCT03073876|21141989|P2|COMPLETED|Overall Study||11
8574814|NCT03073876|21141990|P1|COMPLETED|Overall Study||12
8574815|NCT03073876|21141989|P2|STARTED|Overall Study||11
8574816|NCT03073876|21141990|P1|STARTED|Overall Study||12
8574817|NCT03044574|21142031|P2|NOT COMPLETED|Overall Study||45
8574818|NCT03044574|21142032|P1|NOT COMPLETED|Overall Study||37
8574819|NCT03044574|21142031|P2|COMPLETED|Overall Study||158
8574820|NCT03044574|21142032|P1|COMPLETED|Overall Study||167
8574821|NCT03044574|21142031|P2|180 Days After Surgery|Overall Study||158
8574822|NCT03044574|21142032|P1|180 Days After Surgery|Overall Study||167
8574823|NCT03044574|21142031|P2|30 Days After Surgery|Overall Study||194
8574824|NCT03044574|21142032|P1|30 Days After Surgery|Overall Study||193
8574825|NCT03044574|21142031|P2|Inpatient Period|Overall Study||203
8574826|NCT03044574|21142032|P1|Inpatient Period|Overall Study||204
8574827|NCT03044574|21142031|P2|STARTED|Overall Study||203
8574828|NCT03044574|21142032|P1|STARTED|Overall Study||204
8574829|NCT03020888|21142058|P1|NOT COMPLETED|Overall Study||13
8574830|NCT03020888|21142058|P1|COMPLETED|Overall Study||107
8574831|NCT03020888|21142058|P1|STARTED|Overall Study||120
8574832|NCT02979626|21142071|P2|NOT COMPLETED|Overall Study||0
8574833|NCT02979626|21142072|P1|NOT COMPLETED|Overall Study||0
8574834|NCT02979626|21142071|P2|COMPLETED|Overall Study||98
8574835|NCT02979626|21142072|P1|COMPLETED|Overall Study||313
8574836|NCT02979626|21142071|P2|STARTED|Overall Study||98
8574837|NCT02979626|21142072|P1|STARTED|Overall Study||313
8574887|NCT02921737|21142253|P1|NOT COMPLETED|Overall Study||0
8574888|NCT02921737|21142253|P1|COMPLETED|Overall Study||7
8574889|NCT02921737|21142253|P1|STARTED|Overall Study||7
8574908|NCT02696902|21142318|P3|NOT COMPLETED|Overall Study||28
8574909|NCT02696902|21142319|P2|NOT COMPLETED|Overall Study||4
8574910|NCT02696902|21142320|P1|NOT COMPLETED|Overall Study||22
8574911|NCT02696902|21142318|P3|COMPLETED|Overall Study||59
8574912|NCT02696902|21142319|P2|COMPLETED|Overall Study||12
8574913|NCT02696902|21142320|P1|COMPLETED|Overall Study||63
8574914|NCT02696902|21142318|P3|Modified Intent-to-treat (mITT) Population|Overall Study||85
8574915|NCT02696902|21142319|P2|Modified Intent-to-treat (mITT) Population|Overall Study||16
8574916|NCT02696902|21142320|P1|Modified Intent-to-treat (mITT) Population|Overall Study||83
8574917|NCT02696902|21142318|P3|As-treated Population|Overall Study||85
8574918|NCT02696902|21142319|P2|As-treated Population|Overall Study||16
8574919|NCT02696902|21142320|P1|As-treated Population|Overall Study||83
8574920|NCT02696902|21142318|P3|Intent-to-treat (ITT) Population|Overall Study||87
8574921|NCT02696902|21142319|P2|Intent-to-treat (ITT) Population|Overall Study||16
8574922|NCT02696902|21142320|P1|Intent-to-treat (ITT) Population|Overall Study||85
8574923|NCT02696902|21142318|P3|Treated|Overall Study||85
8574924|NCT02696902|21142319|P2|Treated|Overall Study||16
8574925|NCT02696902|21142320|P1|Treated|Overall Study||83
8574926|NCT02696902|21142318|P3|STARTED|Overall Study||87
8574927|NCT02696902|21142319|P2|STARTED|Overall Study||16
8574928|NCT02696902|21142320|P1|STARTED|Overall Study||85
8574950|NCT02655887|21142413|P1|NOT COMPLETED|Overall Study||14
8574951|NCT02655887|21142413|P1|COMPLETED|Overall Study|Completed 12-month follow-up.|156
8574952|NCT02655887|21142413|P1|STARTED|Overall Study|Intent to Treat (ITT) population.|170
8574974|NCT02535572|21142490|P2|NOT COMPLETED|Overall Study||3
8574975|NCT02535572|21142491|P1|NOT COMPLETED|Overall Study||4
8574976|NCT02535572|21142490|P2|COMPLETED|Overall Study||17
8574977|NCT02535572|21142491|P1|COMPLETED|Overall Study||17
8574978|NCT02535572|21142490|P2|STARTED|Overall Study||20
8574979|NCT02535572|21142491|P1|STARTED|Overall Study||21
8575051|NCT02278341|21142727|P2|NOT COMPLETED|Overall Study||92
8575052|NCT02278341|21142728|P1|NOT COMPLETED|Overall Study||118
8575053|NCT02278341|21142727|P2|COMPLETED|Overall Study||329
8575054|NCT02278341|21142728|P1|COMPLETED|Overall Study||297
8575055|NCT02278341|21142727|P2|Received Treatment|Overall Study||420
8575056|NCT02278341|21142728|P1|Received Treatment|Overall Study||414
8575057|NCT02278341|21142727|P2|STARTED|Overall Study||421
8575058|NCT02278341|21142728|P1|STARTED|Overall Study||415
8575083|NCT02139358|21142921|P1|NOT COMPLETED|Overall Study||0
8575084|NCT02139358|21142921|P1|COMPLETED|Overall Study||15
8575085|NCT02139358|21142921|P1|STARTED|Overall Study||15
8575122|NCT02110108|21143067|P1|NOT COMPLETED|Overall Study||4
8575123|NCT02110108|21143067|P1|COMPLETED|Overall Study||6
8575124|NCT02110108|21143067|P1|RevLite Combo Wavelength|Overall Study||10
8575125|NCT02110108|21143067|P1|RevLite Single Wavelength|Overall Study||10
8575126|NCT02110108|21143067|P1|STARTED|Overall Study||10
8575127|NCT02108821|21143075|P1|NOT COMPLETED|Overall Study||0
8575128|NCT02108821|21143075|P1|COMPLETED|Overall Study||23
8575129|NCT02108821|21143075|P1|STARTED|Overall Study||23
8575145|NCT01932762|21143121|P4|NOT COMPLETED|Overall Study||1
8575146|NCT01932762|21143122|P3|NOT COMPLETED|Overall Study||0
8575147|NCT01932762|21143123|P2|NOT COMPLETED|Overall Study||2
8575148|NCT01932762|21143124|P1|NOT COMPLETED|Overall Study||6
8575149|NCT01932762|21143121|P4|COMPLETED|Overall Study||18
8575150|NCT01932762|21143122|P3|COMPLETED|Overall Study||19
8575151|NCT01932762|21143123|P2|COMPLETED|Overall Study||28
8575152|NCT01932762|21143124|P1|COMPLETED|Overall Study||24
8575153|NCT01932762|21143121|P4|STARTED|Overall Study||19
8575154|NCT01932762|21143122|P3|STARTED|Overall Study||19
8575155|NCT01932762|21143123|P2|STARTED|Overall Study||30
8575156|NCT01932762|21143124|P1|STARTED|Overall Study||30
8575265|NCT01781403|21143197|P3|NOT COMPLETED|Overall Study||0
8575266|NCT01781403|21143198|P2|NOT COMPLETED|Overall Study||0
8575267|NCT01781403|21143199|P1|NOT COMPLETED|Overall Study||0
8575268|NCT01781403|21143197|P3|COMPLETED|Overall Study||18
8575269|NCT01781403|21143198|P2|COMPLETED|Overall Study||2
8575270|NCT01781403|21143199|P1|COMPLETED|Overall Study||2
8575271|NCT01781403|21143197|P3|STARTED|Overall Study||18
8575272|NCT01781403|21143198|P2|STARTED|Overall Study||2
8575273|NCT01781403|21143199|P1|STARTED|Overall Study||2
8575289|NCT01757392|21143240|P1|NOT COMPLETED|Overall Study||4
8575290|NCT01757392|21143240|P1|COMPLETED|Overall Study||35
8575291|NCT01757392|21143240|P1|STARTED|Overall Study||39
8575372|NCT01710501|21143552|P3|NOT COMPLETED|Overall Study||0
8575373|NCT01710501|21143553|P2|NOT COMPLETED|Overall Study||0
8575374|NCT01710501|21143554|P1|NOT COMPLETED|Overall Study||2
8575375|NCT01710501|21143552|P3|COMPLETED|Overall Study||30
8575376|NCT01710501|21143553|P2|COMPLETED|Overall Study||28
8575377|NCT01710501|21143554|P1|COMPLETED|Overall Study||27
8575378|NCT01710501|21143552|P3|STARTED|Overall Study||30
8575379|NCT01710501|21143553|P2|STARTED|Overall Study||28
8575380|NCT01710501|21143554|P1|STARTED|Overall Study||29
8575406|NCT01538745|21143628|P2|NOT COMPLETED|Overall Study||0
8575407|NCT01538745|21143629|P1|NOT COMPLETED|Overall Study||0
8575408|NCT01538745|21143628|P2|COMPLETED|Overall Study||21
8575409|NCT01538745|21143629|P1|COMPLETED|Overall Study||24
8575410|NCT01538745|21143628|P2|STARTED|Overall Study||21
8575411|NCT01538745|21143629|P1|STARTED|Overall Study||24
8575431|NCT01243593|21143683|P2|NOT COMPLETED|Overall Study||0
8575432|NCT01243593|21143684|P1|NOT COMPLETED|Overall Study||0
8575433|NCT01243593|21143683|P2|COMPLETED|Overall Study||16
8575434|NCT01243593|21143684|P1|COMPLETED|Overall Study||16
8575435|NCT01243593|21143683|P2|STARTED|Overall Study||16
8575436|NCT01243593|21143684|P1|STARTED|Overall Study||16
8575443|NCT01211340|21143709|P2|NOT COMPLETED|Overall Study||0
8575444|NCT01211340|21143710|P1|NOT COMPLETED|Overall Study||0
8575445|NCT01211340|21143709|P2|COMPLETED|Overall Study||223
8575446|NCT01211340|21143710|P1|COMPLETED|Overall Study||223
8575447|NCT01211340|21143709|P2|STARTED|Overall Study||223
8575448|NCT01211340|21143710|P1|STARTED|Overall Study||223
8575507|NCT00863772|21143802|P3|NOT COMPLETED|Overall Study||61
8575508|NCT00863772|21143803|P2|NOT COMPLETED|Overall Study||65
8575509|NCT00863772|21143804|P1|NOT COMPLETED|Overall Study||68
8575510|NCT00863772|21143802|P3|COMPLETED|Overall Study||11
8575511|NCT00863772|21143803|P2|COMPLETED|Overall Study||9
8575512|NCT00863772|21143804|P1|COMPLETED|Overall Study||6
8575513|NCT00863772|21143802|P3|Treated|Overall Study||72
8575514|NCT00863772|21143803|P2|Treated|Overall Study||74
8575515|NCT00863772|21143804|P1|Treated|Overall Study||73
8575516|NCT00863772|21143802|P3|STARTED|Overall Study||72
8575517|NCT00863772|21143803|P2|STARTED|Overall Study||74
8575518|NCT00863772|21143804|P1|STARTED|Overall Study||74
8575519|NCT00644189|21143930|P4|NOT COMPLETED|Phase II||0
8575520|NCT00644189|21143931|P3|NOT COMPLETED|Phase II||0
8575521|NCT00644189|21143932|P2|NOT COMPLETED|Phase II||0
8575522|NCT00644189|21143933|P1|NOT COMPLETED|Phase II||0
8575523|NCT00644189|21143930|P4|COMPLETED|Phase II||50
8575524|NCT00644189|21143931|P3|COMPLETED|Phase II||0
8575525|NCT00644189|21143932|P2|COMPLETED|Phase II||0
8575526|NCT00644189|21143933|P1|COMPLETED|Phase II||0
8575527|NCT00644189|21143930|P4|Completed All 6 Cycles of Treatment|Phase II||19
8575528|NCT00644189|21143931|P3|Completed All 6 Cycles of Treatment|Phase II||0
8575529|NCT00644189|21143932|P2|Completed All 6 Cycles of Treatment|Phase II||0
8575530|NCT00644189|21143933|P1|Completed All 6 Cycles of Treatment|Phase II||0
8575531|NCT00644189|21143930|P4|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
8575532|NCT00644189|21143931|P3|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
8575533|NCT00644189|21143932|P2|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
8575534|NCT00644189|21143933|P1|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
8575535|NCT00644189|21143930|P4|NOT COMPLETED|Phase I||0
8575536|NCT00644189|21143931|P3|NOT COMPLETED|Phase I||0
8575537|NCT00644189|21143932|P2|NOT COMPLETED|Phase I||0
8575538|NCT00644189|21143933|P1|NOT COMPLETED|Phase I||0
8575539|NCT00644189|21143930|P4|COMPLETED|Phase I||18
8575540|NCT00644189|21143931|P3|COMPLETED|Phase I||6
8575541|NCT00644189|21143932|P2|COMPLETED|Phase I||3
8575542|NCT00644189|21143933|P1|COMPLETED|Phase I||3
8575543|NCT00644189|21143930|P4|STARTED|Phase I||18
8575544|NCT00644189|21143931|P3|STARTED|Phase I||6
8575545|NCT00644189|21143932|P2|STARTED|Phase I||3
8575546|NCT00644189|21143933|P1|STARTED|Phase I||3
8575579|NCT04470375|21144054|P1|NOT COMPLETED|Overall Study||0
8575580|NCT04470375|21144054|P1|COMPLETED|Overall Study||20
8575581|NCT04470375|21144054|P1|STARTED|Overall Study||20
8575592|NCT03996694|21144081|P6|NOT COMPLETED|Sixth Intervention (1 Day)||0
8575593|NCT03996694|21144082|P5|NOT COMPLETED|Sixth Intervention (1 Day)||0
8575594|NCT03996694|21144083|P4|NOT COMPLETED|Sixth Intervention (1 Day)||0
8575595|NCT03996694|21144084|P3|NOT COMPLETED|Sixth Intervention (1 Day)||0
8575596|NCT03996694|21144085|P2|NOT COMPLETED|Sixth Intervention (1 Day)||0
8575597|NCT03996694|21144086|P1|NOT COMPLETED|Sixth Intervention (1 Day)||0
8575598|NCT03996694|21144081|P6|COMPLETED|Sixth Intervention (1 Day)||3
8575599|NCT03996694|21144082|P5|COMPLETED|Sixth Intervention (1 Day)||2
8575600|NCT03996694|21144083|P4|COMPLETED|Sixth Intervention (1 Day)||3
8575601|NCT03996694|21144084|P3|COMPLETED|Sixth Intervention (1 Day)||2
8575602|NCT03996694|21144085|P2|COMPLETED|Sixth Intervention (1 Day)||2
8575603|NCT03996694|21144086|P1|COMPLETED|Sixth Intervention (1 Day)||3
8575604|NCT03996694|21144081|P6|STARTED|Sixth Intervention (1 Day)||3
8575605|NCT03996694|21144082|P5|STARTED|Sixth Intervention (1 Day)||2
8575606|NCT03996694|21144083|P4|STARTED|Sixth Intervention (1 Day)||3
8575607|NCT03996694|21144084|P3|STARTED|Sixth Intervention (1 Day)||2
8575608|NCT03996694|21144085|P2|STARTED|Sixth Intervention (1 Day)||2
8575609|NCT03996694|21144086|P1|STARTED|Sixth Intervention (1 Day)||3
8575610|NCT03996694|21144081|P6|NOT COMPLETED|Fifth Washout (7 Days)||0
8575611|NCT03996694|21144082|P5|NOT COMPLETED|Fifth Washout (7 Days)||0
8575612|NCT03996694|21144083|P4|NOT COMPLETED|Fifth Washout (7 Days)||0
8575613|NCT03996694|21144084|P3|NOT COMPLETED|Fifth Washout (7 Days)||0
8575614|NCT03996694|21144085|P2|NOT COMPLETED|Fifth Washout (7 Days)||0
8575615|NCT03996694|21144086|P1|NOT COMPLETED|Fifth Washout (7 Days)||0
8575616|NCT03996694|21144081|P6|COMPLETED|Fifth Washout (7 Days)||3
8575617|NCT03996694|21144082|P5|COMPLETED|Fifth Washout (7 Days)||2
8575618|NCT03996694|21144083|P4|COMPLETED|Fifth Washout (7 Days)||3
8575619|NCT03996694|21144084|P3|COMPLETED|Fifth Washout (7 Days)||2
8575620|NCT03996694|21144085|P2|COMPLETED|Fifth Washout (7 Days)||2
8575621|NCT03996694|21144086|P1|COMPLETED|Fifth Washout (7 Days)||3
8575622|NCT03996694|21144081|P6|STARTED|Fifth Washout (7 Days)||3
8575623|NCT03996694|21144082|P5|STARTED|Fifth Washout (7 Days)||2
8575624|NCT03996694|21144083|P4|STARTED|Fifth Washout (7 Days)||3
8575625|NCT03996694|21144084|P3|STARTED|Fifth Washout (7 Days)||2
8575626|NCT03996694|21144085|P2|STARTED|Fifth Washout (7 Days)||2
8575627|NCT03996694|21144086|P1|STARTED|Fifth Washout (7 Days)||3
8575628|NCT03996694|21144081|P6|NOT COMPLETED|Fifth Intervention (1 Day)||0
8575629|NCT03996694|21144082|P5|NOT COMPLETED|Fifth Intervention (1 Day)||0
8575630|NCT03996694|21144083|P4|NOT COMPLETED|Fifth Intervention (1 Day)||0
8575631|NCT03996694|21144084|P3|NOT COMPLETED|Fifth Intervention (1 Day)||0
8575632|NCT03996694|21144085|P2|NOT COMPLETED|Fifth Intervention (1 Day)||0
8575633|NCT03996694|21144086|P1|NOT COMPLETED|Fifth Intervention (1 Day)||0
8575634|NCT03996694|21144081|P6|COMPLETED|Fifth Intervention (1 Day)||3
8575635|NCT03996694|21144082|P5|COMPLETED|Fifth Intervention (1 Day)||2
8575636|NCT03996694|21144083|P4|COMPLETED|Fifth Intervention (1 Day)||3
8575637|NCT03996694|21144084|P3|COMPLETED|Fifth Intervention (1 Day)||2
8575638|NCT03996694|21144085|P2|COMPLETED|Fifth Intervention (1 Day)||2
8575639|NCT03996694|21144086|P1|COMPLETED|Fifth Intervention (1 Day)||3
8575640|NCT03996694|21144081|P6|STARTED|Fifth Intervention (1 Day)||3
8575641|NCT03996694|21144082|P5|STARTED|Fifth Intervention (1 Day)||2
8575642|NCT03996694|21144083|P4|STARTED|Fifth Intervention (1 Day)||3
8575643|NCT03996694|21144084|P3|STARTED|Fifth Intervention (1 Day)||2
8575644|NCT03996694|21144085|P2|STARTED|Fifth Intervention (1 Day)||2
8575645|NCT03996694|21144086|P1|STARTED|Fifth Intervention (1 Day)||3
8575646|NCT03996694|21144081|P6|NOT COMPLETED|Fourth Washout (7 Days)||0
8575647|NCT03996694|21144082|P5|NOT COMPLETED|Fourth Washout (7 Days)||0
8575648|NCT03996694|21144083|P4|NOT COMPLETED|Fourth Washout (7 Days)||0
8575649|NCT03996694|21144084|P3|NOT COMPLETED|Fourth Washout (7 Days)||0
8575650|NCT03996694|21144085|P2|NOT COMPLETED|Fourth Washout (7 Days)||0
8575651|NCT03996694|21144086|P1|NOT COMPLETED|Fourth Washout (7 Days)||0
8575652|NCT03996694|21144081|P6|COMPLETED|Fourth Washout (7 Days)||3
8575653|NCT03996694|21144082|P5|COMPLETED|Fourth Washout (7 Days)||2
8575654|NCT03996694|21144083|P4|COMPLETED|Fourth Washout (7 Days)||3
8575655|NCT03996694|21144084|P3|COMPLETED|Fourth Washout (7 Days)||2
8575656|NCT03996694|21144085|P2|COMPLETED|Fourth Washout (7 Days)||2
8575657|NCT03996694|21144086|P1|COMPLETED|Fourth Washout (7 Days)||3
8575658|NCT03996694|21144081|P6|STARTED|Fourth Washout (7 Days)||3
8575659|NCT03996694|21144082|P5|STARTED|Fourth Washout (7 Days)||2
8575660|NCT03996694|21144083|P4|STARTED|Fourth Washout (7 Days)||3
8575661|NCT03996694|21144084|P3|STARTED|Fourth Washout (7 Days)||2
8575662|NCT03996694|21144085|P2|STARTED|Fourth Washout (7 Days)||2
8575663|NCT03996694|21144086|P1|STARTED|Fourth Washout (7 Days)||3
8575664|NCT03996694|21144081|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
8575665|NCT03996694|21144082|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
8575666|NCT03996694|21144083|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
8575667|NCT03996694|21144084|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
8575668|NCT03996694|21144085|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
8575669|NCT03996694|21144086|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
8575670|NCT03996694|21144081|P6|COMPLETED|Fourth Intervention (1 Day)||3
8575671|NCT03996694|21144082|P5|COMPLETED|Fourth Intervention (1 Day)||2
8575672|NCT03996694|21144083|P4|COMPLETED|Fourth Intervention (1 Day)||3
8575673|NCT03996694|21144084|P3|COMPLETED|Fourth Intervention (1 Day)||2
8575674|NCT03996694|21144085|P2|COMPLETED|Fourth Intervention (1 Day)||2
8575675|NCT03996694|21144086|P1|COMPLETED|Fourth Intervention (1 Day)||3
8575676|NCT03996694|21144081|P6|STARTED|Fourth Intervention (1 Day)||3
8575677|NCT03996694|21144082|P5|STARTED|Fourth Intervention (1 Day)||2
8575678|NCT03996694|21144083|P4|STARTED|Fourth Intervention (1 Day)||3
8575679|NCT03996694|21144084|P3|STARTED|Fourth Intervention (1 Day)||2
8575680|NCT03996694|21144085|P2|STARTED|Fourth Intervention (1 Day)||2
8575681|NCT03996694|21144086|P1|STARTED|Fourth Intervention (1 Day)||3
8575682|NCT03996694|21144081|P6|NOT COMPLETED|Third Washout (7 Days)||0
8575683|NCT03996694|21144082|P5|NOT COMPLETED|Third Washout (7 Days)||1
8575684|NCT03996694|21144083|P4|NOT COMPLETED|Third Washout (7 Days)||0
8575685|NCT03996694|21144084|P3|NOT COMPLETED|Third Washout (7 Days)||0
8575686|NCT03996694|21144085|P2|NOT COMPLETED|Third Washout (7 Days)||0
8575687|NCT03996694|21144086|P1|NOT COMPLETED|Third Washout (7 Days)||0
8575688|NCT03996694|21144081|P6|COMPLETED|Third Washout (7 Days)||3
8575689|NCT03996694|21144082|P5|COMPLETED|Third Washout (7 Days)||2
8575690|NCT03996694|21144083|P4|COMPLETED|Third Washout (7 Days)||3
8575691|NCT03996694|21144084|P3|COMPLETED|Third Washout (7 Days)||2
8575692|NCT03996694|21144085|P2|COMPLETED|Third Washout (7 Days)||2
8575693|NCT03996694|21144086|P1|COMPLETED|Third Washout (7 Days)||3
8575694|NCT03996694|21144081|P6|STARTED|Third Washout (7 Days)||3
8575695|NCT03996694|21144082|P5|STARTED|Third Washout (7 Days)||3
8575696|NCT03996694|21144083|P4|STARTED|Third Washout (7 Days)||3
8575697|NCT03996694|21144084|P3|STARTED|Third Washout (7 Days)||2
8575698|NCT03996694|21144085|P2|STARTED|Third Washout (7 Days)||2
8575699|NCT03996694|21144086|P1|STARTED|Third Washout (7 Days)||3
8575700|NCT03996694|21144081|P6|NOT COMPLETED|Third Intervention (1 Day)||0
8575701|NCT03996694|21144082|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8575702|NCT03996694|21144083|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8575703|NCT03996694|21144084|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8575704|NCT03996694|21144085|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8575705|NCT03996694|21144086|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8575706|NCT03996694|21144081|P6|COMPLETED|Third Intervention (1 Day)||3
8575707|NCT03996694|21144082|P5|COMPLETED|Third Intervention (1 Day)||3
8575708|NCT03996694|21144083|P4|COMPLETED|Third Intervention (1 Day)||3
8575709|NCT03996694|21144084|P3|COMPLETED|Third Intervention (1 Day)||2
8575710|NCT03996694|21144085|P2|COMPLETED|Third Intervention (1 Day)||2
8575711|NCT03996694|21144086|P1|COMPLETED|Third Intervention (1 Day)||3
8575712|NCT03996694|21144081|P6|STARTED|Third Intervention (1 Day)||3
8575713|NCT03996694|21144082|P5|STARTED|Third Intervention (1 Day)||3
8575714|NCT03996694|21144083|P4|STARTED|Third Intervention (1 Day)||3
8575715|NCT03996694|21144084|P3|STARTED|Third Intervention (1 Day)||2
8575716|NCT03996694|21144085|P2|STARTED|Third Intervention (1 Day)||2
8575717|NCT03996694|21144086|P1|STARTED|Third Intervention (1 Day)||3
8575718|NCT03996694|21144081|P6|NOT COMPLETED|Second Washout (7 Days)||0
8575719|NCT03996694|21144082|P5|NOT COMPLETED|Second Washout (7 Days)||0
8575720|NCT03996694|21144083|P4|NOT COMPLETED|Second Washout (7 Days)||0
8575721|NCT03996694|21144084|P3|NOT COMPLETED|Second Washout (7 Days)||0
8575722|NCT03996694|21144085|P2|NOT COMPLETED|Second Washout (7 Days)||0
8575723|NCT03996694|21144086|P1|NOT COMPLETED|Second Washout (7 Days)||0
8575724|NCT03996694|21144081|P6|COMPLETED|Second Washout (7 Days)||3
8575725|NCT03996694|21144082|P5|COMPLETED|Second Washout (7 Days)||3
8575726|NCT03996694|21144083|P4|COMPLETED|Second Washout (7 Days)||3
8575727|NCT03996694|21144084|P3|COMPLETED|Second Washout (7 Days)||2
8575728|NCT03996694|21144085|P2|COMPLETED|Second Washout (7 Days)||2
8575729|NCT03996694|21144086|P1|COMPLETED|Second Washout (7 Days)||3
8575730|NCT03996694|21144081|P6|STARTED|Second Washout (7 Days)||3
8575731|NCT03996694|21144082|P5|STARTED|Second Washout (7 Days)||3
8575732|NCT03996694|21144083|P4|STARTED|Second Washout (7 Days)||3
8575733|NCT03996694|21144084|P3|STARTED|Second Washout (7 Days)||2
8575734|NCT03996694|21144085|P2|STARTED|Second Washout (7 Days)||2
8575735|NCT03996694|21144086|P1|STARTED|Second Washout (7 Days)||3
8575736|NCT03996694|21144081|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8575737|NCT03996694|21144082|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8575738|NCT03996694|21144083|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8575739|NCT03996694|21144084|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8575740|NCT03996694|21144085|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8575741|NCT03996694|21144086|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8575742|NCT03996694|21144081|P6|COMPLETED|Second Intervention (1 Day)||3
8575743|NCT03996694|21144082|P5|COMPLETED|Second Intervention (1 Day)||3
8575744|NCT03996694|21144083|P4|COMPLETED|Second Intervention (1 Day)||3
8575745|NCT03996694|21144084|P3|COMPLETED|Second Intervention (1 Day)||2
8575746|NCT03996694|21144085|P2|COMPLETED|Second Intervention (1 Day)||2
8575747|NCT03996694|21144086|P1|COMPLETED|Second Intervention (1 Day)||3
8575748|NCT03996694|21144081|P6|STARTED|Second Intervention (1 Day)||3
8575749|NCT03996694|21144082|P5|STARTED|Second Intervention (1 Day)||3
8575750|NCT03996694|21144083|P4|STARTED|Second Intervention (1 Day)||3
8575751|NCT03996694|21144084|P3|STARTED|Second Intervention (1 Day)||2
8575752|NCT03996694|21144085|P2|STARTED|Second Intervention (1 Day)||2
8575753|NCT03996694|21144086|P1|STARTED|Second Intervention (1 Day)||3
8575754|NCT03996694|21144081|P6|NOT COMPLETED|First Washout (7 Days)||0
8575755|NCT03996694|21144082|P5|NOT COMPLETED|First Washout (7 Days)||0
8575756|NCT03996694|21144083|P4|NOT COMPLETED|First Washout (7 Days)||0
8575757|NCT03996694|21144084|P3|NOT COMPLETED|First Washout (7 Days)||2
8575758|NCT03996694|21144085|P2|NOT COMPLETED|First Washout (7 Days)||1
8575759|NCT03996694|21144086|P1|NOT COMPLETED|First Washout (7 Days)||0
8575760|NCT03996694|21144081|P6|COMPLETED|First Washout (7 Days)||3
8575761|NCT03996694|21144082|P5|COMPLETED|First Washout (7 Days)||3
8575762|NCT03996694|21144083|P4|COMPLETED|First Washout (7 Days)||3
8575763|NCT03996694|21144084|P3|COMPLETED|First Washout (7 Days)||2
8575764|NCT03996694|21144085|P2|COMPLETED|First Washout (7 Days)||2
8575765|NCT03996694|21144086|P1|COMPLETED|First Washout (7 Days)||3
8575766|NCT03996694|21144081|P6|STARTED|First Washout (7 Days)||3
8575767|NCT03996694|21144082|P5|STARTED|First Washout (7 Days)||3
8575768|NCT03996694|21144083|P4|STARTED|First Washout (7 Days)||3
8575769|NCT03996694|21144084|P3|STARTED|First Washout (7 Days)||4
8575770|NCT03996694|21144085|P2|STARTED|First Washout (7 Days)||3
8575771|NCT03996694|21144086|P1|STARTED|First Washout (7 Days)||3
8575772|NCT03996694|21144081|P6|NOT COMPLETED|First Intervention (1 Day)||0
8575773|NCT03996694|21144082|P5|NOT COMPLETED|First Intervention (1 Day)||0
8575774|NCT03996694|21144083|P4|NOT COMPLETED|First Intervention (1 Day)||0
8575775|NCT03996694|21144084|P3|NOT COMPLETED|First Intervention (1 Day)||0
8575776|NCT03996694|21144085|P2|NOT COMPLETED|First Intervention (1 Day)||0
8575777|NCT03996694|21144086|P1|NOT COMPLETED|First Intervention (1 Day)||0
8575778|NCT03996694|21144081|P6|COMPLETED|First Intervention (1 Day)||3
8575779|NCT03996694|21144082|P5|COMPLETED|First Intervention (1 Day)||3
8575780|NCT03996694|21144083|P4|COMPLETED|First Intervention (1 Day)||3
8575781|NCT03996694|21144084|P3|COMPLETED|First Intervention (1 Day)||4
8575782|NCT03996694|21144085|P2|COMPLETED|First Intervention (1 Day)||3
8575783|NCT03996694|21144086|P1|COMPLETED|First Intervention (1 Day)||3
8575784|NCT03996694|21144081|P6|STARTED|First Intervention (1 Day)||3
8575785|NCT03996694|21144082|P5|STARTED|First Intervention (1 Day)||3
8575786|NCT03996694|21144083|P4|STARTED|First Intervention (1 Day)||3
8575787|NCT03996694|21144084|P3|STARTED|First Intervention (1 Day)||4
8575788|NCT03996694|21144085|P2|STARTED|First Intervention (1 Day)||3
8575789|NCT03996694|21144086|P1|STARTED|First Intervention (1 Day)||3
8575790|NCT03979274|21144118|P2|NOT COMPLETED|Treatment Period 2||1
8575791|NCT03979274|21144119|P1|NOT COMPLETED|Treatment Period 2||0
8575792|NCT03979274|21144118|P2|COMPLETED|Treatment Period 2||21
8575793|NCT03979274|21144119|P1|COMPLETED|Treatment Period 2||22
8575794|NCT03979274|21144118|P2|STARTED|Treatment Period 2||22
8575795|NCT03979274|21144119|P1|STARTED|Treatment Period 2||22
8575796|NCT03979274|21144118|P2|NOT COMPLETED|Treatment Period 1||0
8575797|NCT03979274|21144119|P1|NOT COMPLETED|Treatment Period 1||0
8575798|NCT03979274|21144118|P2|COMPLETED|Treatment Period 1||22
8575799|NCT03979274|21144119|P1|COMPLETED|Treatment Period 1||22
8575800|NCT03979274|21144118|P2|STARTED|Treatment Period 1||22
8575801|NCT03979274|21144119|P1|STARTED|Treatment Period 1||22
8575805|NCT03714919|21144152|P1|NOT COMPLETED|Overall Study||0
8575806|NCT03714919|21144152|P1|COMPLETED|Overall Study||10
8575807|NCT03714919|21144152|P1|STARTED|Overall Study||10
8575860|NCT03477838|21144262|P1|NOT COMPLETED|Overall Study||14
8575861|NCT03477838|21144262|P1|COMPLETED|Overall Study||14
8575862|NCT03477838|21144262|P1|STARTED|Overall Study||28
8575871|NCT03437044|21144307|P2|NOT COMPLETED|Overall Study||2
8575872|NCT03437044|21144308|P1|NOT COMPLETED|Overall Study||3
8575873|NCT03437044|21144307|P2|COMPLETED|Overall Study||18
8575874|NCT03437044|21144308|P1|COMPLETED|Overall Study||17
8575875|NCT03437044|21144307|P2|STARTED|Overall Study||20
8575876|NCT03437044|21144308|P1|STARTED|Overall Study||20
8575877|NCT03429348|21144316|P2|NOT COMPLETED|Overall Study||0
8575878|NCT03429348|21144317|P1|NOT COMPLETED|Overall Study||0
8575879|NCT03429348|21144316|P2|COMPLETED|Overall Study||12
8575880|NCT03429348|21144317|P1|COMPLETED|Overall Study||12
8575881|NCT03429348|21144316|P2|STARTED|Overall Study||12
8575882|NCT03429348|21144317|P1|STARTED|Overall Study|4 participants had no additional rehab & had no corresponding sauna rehab participant to compare to.|12
8575893|NCT03351608|21144385|P5|NOT COMPLETED|Overall Study||2
8575894|NCT03351608|21144386|P4|NOT COMPLETED|Overall Study||8
8575895|NCT03351608|21144387|P3|NOT COMPLETED|Overall Study||3
8575896|NCT03351608|21144388|P2|NOT COMPLETED|Overall Study||2
8575897|NCT03351608|21144389|P1|NOT COMPLETED|Overall Study||1
8575898|NCT03351608|21144385|P5|COMPLETED|Overall Study||33
8575899|NCT03351608|21144386|P4|COMPLETED|Overall Study||168
8575900|NCT03351608|21144387|P3|COMPLETED|Overall Study||32
8575901|NCT03351608|21144388|P2|COMPLETED|Overall Study||21
8575902|NCT03351608|21144389|P1|COMPLETED|Overall Study||18
8575903|NCT03351608|21144385|P5|Treated|Overall Study||34
8575904|NCT03351608|21144386|P4|Treated|Overall Study||169
8575905|NCT03351608|21144387|P3|Treated|Overall Study||33
8575906|NCT03351608|21144388|P2|Treated|Overall Study||22
8575907|NCT03351608|21144389|P1|Treated|Overall Study||18
8575908|NCT03351608|21144385|P5|STARTED|Overall Study||35
8575909|NCT03351608|21144386|P4|STARTED|Overall Study||176
8575910|NCT03351608|21144387|P3|STARTED|Overall Study||35
8575911|NCT03351608|21144388|P2|STARTED|Overall Study||23
8575912|NCT03351608|21144389|P1|STARTED|Overall Study||19
8576034|NCT02933489|21144781|P2|NOT COMPLETED|Overall Study||28
8576035|NCT02933489|21144782|P1|NOT COMPLETED|Overall Study||44
8576036|NCT02933489|21144781|P2|COMPLETED|Overall Study||731
8576037|NCT02933489|21144782|P1|COMPLETED|Overall Study||713
8576038|NCT02933489|21144781|P2|AB MR Performed|Overall Study||733
8576039|NCT02933489|21144782|P1|AB MR Performed|Overall Study||713
8576040|NCT02933489|21144781|P2|DBTperformed|Overall Study||737
8576041|NCT02933489|21144782|P1|DBTperformed|Overall Study||726
8576042|NCT02933489|21144781|P2|STARTED|Overall Study||759
8576043|NCT02933489|21144782|P1|STARTED|Overall Study||757
8576164|NCT02816398|21144863|P1|NOT COMPLETED|Overall Study||14
8576165|NCT02816398|21144863|P1|COMPLETED|Overall Study||12
8576166|NCT02816398|21144863|P1|STARTED|Overall Study||26
8576188|NCT02681523|21144926|P1|NOT COMPLETED|Overall Study||2
8576189|NCT02681523|21144926|P1|COMPLETED|Overall Study||6
8576190|NCT02681523|21144926|P1|STARTED|Overall Study||8
8576238|NCT02593006|21145189|P3|NOT COMPLETED|Overall Study||5
8576239|NCT02593006|21145190|P2|NOT COMPLETED|Overall Study||7
8576240|NCT02593006|21145191|P1|NOT COMPLETED|Overall Study||7
8576241|NCT02593006|21145189|P3|COMPLETED|Overall Study||38
8576242|NCT02593006|21145190|P2|COMPLETED|Overall Study||93
8576243|NCT02593006|21145191|P1|COMPLETED|Overall Study||250
8576244|NCT02593006|21145189|P3|STARTED|Overall Study||43
8576245|NCT02593006|21145190|P2|STARTED|Overall Study||100
8576246|NCT02593006|21145191|P1|STARTED|Overall Study||257
8576259|NCT02526160|21145249|P2|NOT COMPLETED|Open-Label Treatment Extension Period II||0
8576260|NCT02526160|21145250|P1|NOT COMPLETED|Open-Label Treatment Extension Period II||1
8576261|NCT02526160|21145249|P2|COMPLETED|Open-Label Treatment Extension Period II||49
8576262|NCT02526160|21145250|P1|COMPLETED|Open-Label Treatment Extension Period II||51
8576263|NCT02526160|21145249|P2|STARTED|Open-Label Treatment Extension Period II||49
8576264|NCT02526160|21145250|P1|STARTED|Open-Label Treatment Extension Period II||52
8576265|NCT02526160|21145249|P2|NOT COMPLETED|Open-Label Treatment Extension Period I||4
8576266|NCT02526160|21145250|P1|NOT COMPLETED|Open-Label Treatment Extension Period I||3
8576267|NCT02526160|21145249|P2|COMPLETED|Open-Label Treatment Extension Period I||59
8576268|NCT02526160|21145250|P1|COMPLETED|Open-Label Treatment Extension Period I||60
8576269|NCT02526160|21145249|P2|STARTED|Open-Label Treatment Extension Period I||63
8576270|NCT02526160|21145250|P1|STARTED|Open-Label Treatment Extension Period I||63
8576271|NCT02526160|21145249|P2|NOT COMPLETED|Open-label Treatment Continuation Period||4
8576272|NCT02526160|21145250|P1|NOT COMPLETED|Open-label Treatment Continuation Period||3
8576273|NCT02526160|21145249|P2|COMPLETED|Open-label Treatment Continuation Period||63
8576274|NCT02526160|21145250|P1|COMPLETED|Open-label Treatment Continuation Period||63
8576275|NCT02526160|21145249|P2|STARTED|Open-label Treatment Continuation Period||67
8576276|NCT02526160|21145250|P1|STARTED|Open-label Treatment Continuation Period||66
8576277|NCT02526160|21145249|P2|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||1
8576278|NCT02526160|21145250|P1|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||0
8576279|NCT02526160|21145249|P2|COMPLETED|Double-Blind (Placebo-Controlled) Period||67
8576280|NCT02526160|21145250|P1|COMPLETED|Double-Blind (Placebo-Controlled) Period||66
8576281|NCT02526160|21145249|P2|STARTED|Double-Blind (Placebo-Controlled) Period||68
8576282|NCT02526160|21145250|P1|STARTED|Double-Blind (Placebo-Controlled) Period||66
8576288|NCT02481869|21145356|P2|NOT COMPLETED|Overall Study||4
8576289|NCT02481869|21145357|P1|NOT COMPLETED|Overall Study||5
8576290|NCT02481869|21145356|P2|COMPLETED|Overall Study||2
8576291|NCT02481869|21145357|P1|COMPLETED|Overall Study||0
8576292|NCT02481869|21145356|P2|STARTED|Overall Study||6
8576293|NCT02481869|21145357|P1|STARTED|Overall Study||5
8576318|NCT02432183|21145391|P4|NOT COMPLETED|Overall Study||0
8576319|NCT02432183|21145392|P3|NOT COMPLETED|Overall Study||0
8576320|NCT02432183|21145393|P2|NOT COMPLETED|Overall Study||0
8576321|NCT02432183|21145394|P1|NOT COMPLETED|Overall Study||0
8576322|NCT02432183|21145391|P4|COMPLETED|Overall Study||17
8576323|NCT02432183|21145392|P3|COMPLETED|Overall Study||26
8576324|NCT02432183|21145393|P2|COMPLETED|Overall Study||47
8576325|NCT02432183|21145394|P1|COMPLETED|Overall Study||44
8576326|NCT02432183|21145391|P4|STARTED|Overall Study||17
8576327|NCT02432183|21145392|P3|STARTED|Overall Study||26
8576328|NCT02432183|21145393|P2|STARTED|Overall Study||47
8576329|NCT02432183|21145394|P1|STARTED|Overall Study||44
8576366|NCT02363972|21145531|P1|NOT COMPLETED|Overall Study||26
8576367|NCT02363972|21145531|P1|COMPLETED|Overall Study||77
8576368|NCT02363972|21145531|P1|STARTED|Overall Study||103
8576387|NCT02138890|21145599|P2|NOT COMPLETED|Overall Study||0
8576388|NCT02138890|21145600|P1|NOT COMPLETED|Overall Study||1
8576389|NCT02138890|21145599|P2|COMPLETED|Overall Study||15
8576390|NCT02138890|21145600|P1|COMPLETED|Overall Study||30
8576391|NCT02138890|21145599|P2|STARTED|Overall Study||15
8576392|NCT02138890|21145600|P1|STARTED|Overall Study||31
8576393|NCT02133131|21145647|P7|NOT COMPLETED|Overall Study||12
8576394|NCT02133131|21145648|P6|NOT COMPLETED|Overall Study||14
8576395|NCT02133131|21145649|P5|NOT COMPLETED|Overall Study||15
8576396|NCT02133131|21145650|P4|NOT COMPLETED|Overall Study||6
8576397|NCT02133131|21145651|P3|NOT COMPLETED|Overall Study||1
8576398|NCT02133131|21145652|P2|NOT COMPLETED|Overall Study||5
8576399|NCT02133131|21145653|P1|NOT COMPLETED|Overall Study||5
8576400|NCT02133131|21145647|P7|COMPLETED|Overall Study||0
8576401|NCT02133131|21145648|P6|COMPLETED|Overall Study||0
8576402|NCT02133131|21145649|P5|COMPLETED|Overall Study||0
8576403|NCT02133131|21145650|P4|COMPLETED|Overall Study||15
8576404|NCT02133131|21145651|P3|COMPLETED|Overall Study||19
8576405|NCT02133131|21145652|P2|COMPLETED|Overall Study||25
8576406|NCT02133131|21145653|P1|COMPLETED|Overall Study||26
8576407|NCT02133131|21145647|P7|STARTED|Overall Study||12
8576408|NCT02133131|21145648|P6|STARTED|Overall Study||14
8576409|NCT02133131|21145649|P5|STARTED|Overall Study||15
8576410|NCT02133131|21145650|P4|STARTED|Overall Study||21
8576411|NCT02133131|21145651|P3|STARTED|Overall Study||20
8576412|NCT02133131|21145652|P2|STARTED|Overall Study||30
8576413|NCT02133131|21145653|P1|STARTED|Overall Study||31
8576414|NCT02124746|21145693|P3|NOT COMPLETED|Overall Study||22
8576415|NCT02124746|21145694|P2|NOT COMPLETED|Overall Study||18
8576416|NCT02124746|21145695|P1|NOT COMPLETED|Overall Study||19
8576417|NCT02124746|21145693|P3|COMPLETED|Overall Study||0
8576418|NCT02124746|21145694|P2|COMPLETED|Overall Study||4
8576419|NCT02124746|21145695|P1|COMPLETED|Overall Study||11
8576420|NCT02124746|21145693|P3|STARTED|Overall Study||22
8576421|NCT02124746|21145694|P2|STARTED|Overall Study||22
8576422|NCT02124746|21145695|P1|STARTED|Overall Study||30
8576423|NCT02105701|21145740|P4|NOT COMPLETED|Overall Study||2
8576424|NCT02105701|21145741|P3|NOT COMPLETED|Overall Study||3
8576425|NCT02105701|21145742|P2|NOT COMPLETED|Overall Study||1
8576426|NCT02105701|21145743|P1|NOT COMPLETED|Overall Study||4
8576427|NCT02105701|21145740|P4|COMPLETED|Overall Study||104
8576428|NCT02105701|21145741|P3|COMPLETED|Overall Study||102
8576429|NCT02105701|21145742|P2|COMPLETED|Overall Study||103
8576430|NCT02105701|21145743|P1|COMPLETED|Overall Study||101
8576431|NCT02105701|21145740|P4|STARTED|Overall Study||106
8576432|NCT02105701|21145741|P3|STARTED|Overall Study||105
8576433|NCT02105701|21145742|P2|STARTED|Overall Study||104
8576434|NCT02105701|21145743|P1|STARTED|Overall Study||105
8576435|NCT02105662|21145765|P1|NOT COMPLETED|Overall Study||6
8576436|NCT02105662|21145765|P1|COMPLETED|Overall Study||212
8576437|NCT02105662|21145765|P1|STARTED|Overall Study||218
8576525|NCT01717326|21145818|P20|NOT COMPLETED|Overall Study||6
8576526|NCT01717326|21145819|P19|NOT COMPLETED|Overall Study||4
8576527|NCT01717326|21145820|P18|NOT COMPLETED|Overall Study||0
8576528|NCT01717326|21145821|P17|NOT COMPLETED|Overall Study||1
8576529|NCT01717326|21145822|P16|NOT COMPLETED|Overall Study||3
8576530|NCT01717326|21145823|P15|NOT COMPLETED|Overall Study||0
8576531|NCT01717326|21145824|P14|NOT COMPLETED|Overall Study||0
8576532|NCT01717326|21145825|P13|NOT COMPLETED|Overall Study||1
8576533|NCT01717326|21145826|P12|NOT COMPLETED|Overall Study||0
8576534|NCT01717326|21145827|P11|NOT COMPLETED|Overall Study||2
8576535|NCT01717326|21145828|P10|NOT COMPLETED|Overall Study||2
8576536|NCT01717326|21145829|P9|NOT COMPLETED|Overall Study||0
8576537|NCT01717326|21145830|P8|NOT COMPLETED|Overall Study||0
8576538|NCT01717326|21145831|P7|NOT COMPLETED|Overall Study||1
8576539|NCT01717326|21145832|P6|NOT COMPLETED|Overall Study||0
8576540|NCT01717326|21145833|P5|NOT COMPLETED|Overall Study||2
8576541|NCT01717326|21145834|P4|NOT COMPLETED|Overall Study||2
8576542|NCT01717326|21145835|P3|NOT COMPLETED|Overall Study||0
8576543|NCT01717326|21145836|P2|NOT COMPLETED|Overall Study||1
8576544|NCT01717326|21145837|P1|NOT COMPLETED|Overall Study||3
8576545|NCT01717326|21145818|P20|COMPLETED|Overall Study||15
8576546|NCT01717326|21145819|P19|COMPLETED|Overall Study||16
8576547|NCT01717326|21145820|P18|COMPLETED|Overall Study||31
8576548|NCT01717326|21145821|P17|COMPLETED|Overall Study||29
8576549|NCT01717326|21145822|P16|COMPLETED|Overall Study||27
8576550|NCT01717326|21145823|P15|COMPLETED|Overall Study||29
8576551|NCT01717326|21145824|P14|COMPLETED|Overall Study||32
8576552|NCT01717326|21145825|P13|COMPLETED|Overall Study||32
8576553|NCT01717326|21145826|P12|COMPLETED|Overall Study||33
8576554|NCT01717326|21145827|P11|COMPLETED|Overall Study||30
8576555|NCT01717326|21145828|P10|COMPLETED|Overall Study||29
8576556|NCT01717326|21145829|P9|COMPLETED|Overall Study||32
8576557|NCT01717326|21145830|P8|COMPLETED|Overall Study||29
8576558|NCT01717326|21145831|P7|COMPLETED|Overall Study||30
8576559|NCT01717326|21145832|P6|COMPLETED|Overall Study||31
8576560|NCT01717326|21145833|P5|COMPLETED|Overall Study||31
8576561|NCT01717326|21145834|P4|COMPLETED|Overall Study||28
8576562|NCT01717326|21145835|P3|COMPLETED|Overall Study||13
8576563|NCT01717326|21145836|P2|COMPLETED|Overall Study||26
8576564|NCT01717326|21145837|P1|COMPLETED|Overall Study||22
8576565|NCT01717326|21145818|P20|Treated|Overall Study||21
8576566|NCT01717326|21145819|P19|Treated|Overall Study||20
8576567|NCT01717326|21145820|P18|Treated|Overall Study||31
8576568|NCT01717326|21145821|P17|Treated|Overall Study||30
8576569|NCT01717326|21145822|P16|Treated|Overall Study||30
8576570|NCT01717326|21145823|P15|Treated|Overall Study||29
8576571|NCT01717326|21145824|P14|Treated|Overall Study||32
8576572|NCT01717326|21145825|P13|Treated|Overall Study||33
8576573|NCT01717326|21145826|P12|Treated|Overall Study||33
8576574|NCT01717326|21145827|P11|Treated|Overall Study||32
8576575|NCT01717326|21145828|P10|Treated|Overall Study||31
8576576|NCT01717326|21145829|P9|Treated|Overall Study||32
8576577|NCT01717326|21145830|P8|Treated|Overall Study||29
8576578|NCT01717326|21145831|P7|Treated|Overall Study||31
8576579|NCT01717326|21145832|P6|Treated|Overall Study||31
8576580|NCT01717326|21145833|P5|Treated|Overall Study||33
8576581|NCT01717326|21145834|P4|Treated|Overall Study||30
8576582|NCT01717326|21145835|P3|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
8576583|NCT01717326|21145836|P2|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
8576584|NCT01717326|21145837|P1|Treated|Overall Study||25
8576585|NCT01717326|21145818|P20|STARTED|Overall Study||21
8576586|NCT01717326|21145819|P19|STARTED|Overall Study||20
8576587|NCT01717326|21145820|P18|STARTED|Overall Study||31
8576588|NCT01717326|21145821|P17|STARTED|Overall Study||30
8576589|NCT01717326|21145822|P16|STARTED|Overall Study||30
8576590|NCT01717326|21145823|P15|STARTED|Overall Study||29
8576591|NCT01717326|21145824|P14|STARTED|Overall Study||32
8576592|NCT01717326|21145825|P13|STARTED|Overall Study||33
8576593|NCT01717326|21145826|P12|STARTED|Overall Study||33
8576594|NCT01717326|21145827|P11|STARTED|Overall Study||32
8576595|NCT01717326|21145828|P10|STARTED|Overall Study||31
8576596|NCT01717326|21145829|P9|STARTED|Overall Study||32
8576597|NCT01717326|21145830|P8|STARTED|Overall Study||29
8576598|NCT01717326|21145831|P7|STARTED|Overall Study||31
8576599|NCT01717326|21145832|P6|STARTED|Overall Study||31
8576600|NCT01717326|21145833|P5|STARTED|Overall Study||33
8576601|NCT01717326|21145834|P4|STARTED|Overall Study||30
8576602|NCT01717326|21145835|P3|STARTED|Overall Study||13
8576603|NCT01717326|21145836|P2|STARTED|Overall Study||27
8576604|NCT01717326|21145837|P1|STARTED|Overall Study||25
8576624|NCT01680640|21146129|P2|NOT COMPLETED|Overall Study||5
8576625|NCT01680640|21146130|P1|NOT COMPLETED|Overall Study||10
8576626|NCT01680640|21146129|P2|COMPLETED|Overall Study||44
8576627|NCT01680640|21146130|P1|COMPLETED|Overall Study||45
8576628|NCT01680640|21146129|P2|STARTED|Overall Study||49
8576629|NCT01680640|21146130|P1|STARTED|Overall Study||55
8576642|NCT01551745|21146179|P1|NOT COMPLETED|Overall Study||3
8576643|NCT01551745|21146179|P1|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
8576644|NCT01551745|21146179|P1|STARTED|Overall Study||5
8576645|NCT01532908|21146188|P2|NOT COMPLETED|Overall Study||0
8576646|NCT01532908|21146189|P1|NOT COMPLETED|Overall Study||1
8576647|NCT01532908|21146188|P2|COMPLETED|Overall Study||2
8576648|NCT01532908|21146189|P1|COMPLETED|Overall Study||8
8576649|NCT01532908|21146188|P2|Transplanted|Overall Study||2
8576650|NCT01532908|21146189|P1|Transplanted|Overall Study||8
8576651|NCT01532908|21146188|P2|Infused|Overall Study||2
8576652|NCT01532908|21146189|P1|Infused|Overall Study||9
8576653|NCT01532908|21146188|P2|STARTED|Overall Study||2
8576654|NCT01532908|21146189|P1|STARTED|Overall Study||9
8576685|NCT01505166|21146259|P3|NOT COMPLETED|Overall Study||0
8576686|NCT01505166|21146260|P2|NOT COMPLETED|Overall Study||0
8576687|NCT01505166|21146261|P1|NOT COMPLETED|Overall Study||0
8576688|NCT01505166|21146259|P3|COMPLETED|Overall Study||0
8576689|NCT01505166|21146260|P2|COMPLETED|Overall Study||0
8576690|NCT01505166|21146261|P1|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
8576691|NCT01505166|21146259|P3|STARTED|Overall Study||0
8576692|NCT01505166|21146260|P2|STARTED|Overall Study||0
8576693|NCT01505166|21146261|P1|STARTED|Overall Study||3
8576853|NCT00551642|21146480|P2|NOT COMPLETED|7-Year Follow-up||0
8576854|NCT00551642|21146481|P1|NOT COMPLETED|7-Year Follow-up||0
8576855|NCT00551642|21146480|P2|COMPLETED|7-Year Follow-up||153
8576856|NCT00551642|21146481|P1|COMPLETED|7-Year Follow-up||152
8576857|NCT00551642|21146480|P2|STARTED|7-Year Follow-up||153
8576858|NCT00551642|21146481|P1|STARTED|7-Year Follow-up||152
8576859|NCT00551642|21146480|P2|NOT COMPLETED|Treatment Period||63
8576860|NCT00551642|21146481|P1|NOT COMPLETED|Treatment Period||61
8576861|NCT00551642|21146480|P2|COMPLETED|Treatment Period||338
8576862|NCT00551642|21146481|P1|COMPLETED|Treatment Period||338
8576863|NCT00551642|21146480|P2|Safety Population|Treatment Period||397
8576864|NCT00551642|21146481|P1|Safety Population|Treatment Period||395
8576865|NCT00551642|21146480|P2|STARTED|Treatment Period||401
8576866|NCT00551642|21146481|P1|STARTED|Treatment Period||399
8576985|NCT00186888|21146553|P3|NOT COMPLETED|Overall Study||0
8576986|NCT00186888|21146554|P2|NOT COMPLETED|Overall Study||3
8576987|NCT00186888|21146555|P1|NOT COMPLETED|Overall Study||4
8576988|NCT00186888|21146553|P3|COMPLETED|Overall Study||55
8576989|NCT00186888|21146554|P2|COMPLETED|Overall Study||24
8576990|NCT00186888|21146555|P1|COMPLETED|Overall Study||19
8576991|NCT00186888|21146553|P3|Window Therapy|Overall Study||0
8576992|NCT00186888|21146554|P2|Window Therapy|Overall Study||27
8576993|NCT00186888|21146555|P1|Window Therapy|Overall Study||0
8576994|NCT00186888|21146553|P3|STARTED|Overall Study||55
8576995|NCT00186888|21146554|P2|STARTED|Overall Study||27
8576996|NCT00186888|21146555|P1|STARTED|Overall Study||23
8585005|NCT04334681|21168052|P2|NOT COMPLETED|Overall Study||0
8585006|NCT04334681|21168053|P1|NOT COMPLETED|Overall Study||0
8585007|NCT04334681|21168052|P2|COMPLETED|Overall Study||143
8585008|NCT04334681|21168053|P1|COMPLETED|Overall Study||135
8585009|NCT04334681|21168052|P2|STARTED|Overall Study||143
8585010|NCT04334681|21168053|P1|STARTED|Overall Study||135
8585038|NCT03918811|21168134|P2|NOT COMPLETED|Overall Study||13
8585039|NCT03918811|21168135|P1|NOT COMPLETED|Overall Study||4
8585040|NCT03918811|21168134|P2|COMPLETED|Overall Study||345
8585041|NCT03918811|21168135|P1|COMPLETED|Overall Study||363
8585042|NCT03918811|21168134|P2|STARTED|Overall Study||358
8585043|NCT03918811|21168135|P1|STARTED|Overall Study||367
8585044|NCT03896022|21168154|P3|NOT COMPLETED|Overall Study||0
8585045|NCT03896022|21168155|P2|NOT COMPLETED|Overall Study||0
8585046|NCT03896022|21168156|P1|NOT COMPLETED|Overall Study||4
8585047|NCT03896022|21168154|P3|COMPLETED|Overall Study||52
8585048|NCT03896022|21168155|P2|COMPLETED|Overall Study||51
8585049|NCT03896022|21168156|P1|COMPLETED|Overall Study||70
8585050|NCT03896022|21168154|P3|STARTED|Overall Study||52
8585051|NCT03896022|21168155|P2|STARTED|Overall Study||51
8585052|NCT03896022|21168156|P1|STARTED|Overall Study||74
8585125|NCT03661346|21168287|P2|NOT COMPLETED|Overall Study||0
8585126|NCT03661346|21168288|P1|NOT COMPLETED|Overall Study||0
8585127|NCT03661346|21168287|P2|COMPLETED|Overall Study||15
8585128|NCT03661346|21168288|P1|COMPLETED|Overall Study||13
8585129|NCT03661346|21168287|P2|STARTED|Overall Study||15
8585130|NCT03661346|21168288|P1|STARTED|Overall Study|Esmolol administration|13
8585131|NCT03652610|21168304|P2|NOT COMPLETED|Overall Study||5
8585132|NCT03652610|21168305|P1|NOT COMPLETED|Overall Study||4
8585133|NCT03652610|21168304|P2|COMPLETED|Overall Study||484
8585134|NCT03652610|21168305|P1|COMPLETED|Overall Study||486
8585135|NCT03652610|21168304|P2|STARTED|Overall Study||489
8585136|NCT03652610|21168305|P1|STARTED|Overall Study||490
8585143|NCT03594071|21168350|P1|NOT COMPLETED|Overall Study||5
8585144|NCT03594071|21168350|P1|COMPLETED|Overall Study||289
8585145|NCT03594071|21168350|P1|STARTED|Overall Study||294
8585170|NCT03506386|21168436|P1|NOT COMPLETED|Overall Study||0
8585171|NCT03506386|21168436|P1|COMPLETED|Overall Study||943
8585172|NCT03506386|21168436|P1|STARTED|Overall Study||943
8585173|NCT03475056|21168445|P2|NOT COMPLETED|Overall Study||3
8585174|NCT03475056|21168446|P1|NOT COMPLETED|Overall Study||0
8585175|NCT03475056|21168445|P2|COMPLETED|Overall Study||17
8585176|NCT03475056|21168446|P1|COMPLETED|Overall Study||20
8585177|NCT03475056|21168445|P2|Received Product Administration|Overall Study||20
8585178|NCT03475056|21168446|P1|Received Product Administration|Overall Study||20
8585179|NCT03475056|21168445|P2|STARTED|Overall Study||20
8585180|NCT03475056|21168446|P1|STARTED|Overall Study||20
8585187|NCT03411902|21168505|P2|NOT COMPLETED|Overall Study||0
8585188|NCT03411902|21168506|P1|NOT COMPLETED|Overall Study||3
8585189|NCT03411902|21168505|P2|COMPLETED|Overall Study||13
8585190|NCT03411902|21168506|P1|COMPLETED|Overall Study||8
8585191|NCT03411902|21168505|P2|STARTED|Overall Study||13
8585192|NCT03411902|21168506|P1|STARTED|Overall Study||11
8585193|NCT03404648|21168524|P1|NOT COMPLETED|Overall Study||0
8585194|NCT03404648|21168524|P1|COMPLETED|Overall Study||19
8585195|NCT03404648|21168524|P1|STARTED|Overall Study||19
8585196|NCT03400787|21168531|P2|NOT COMPLETED|Overall Study||8
8585197|NCT03400787|21168532|P1|NOT COMPLETED|Overall Study||2
8585198|NCT03400787|21168531|P2|COMPLETED|Overall Study||63
8585199|NCT03400787|21168532|P1|COMPLETED|Overall Study||64
8585200|NCT03400787|21168531|P2|3-Month Follow-up|Overall Study||63
8585201|NCT03400787|21168532|P1|3-Month Follow-up|Overall Study||64
8585202|NCT03400787|21168531|P2|STARTED|Overall Study||71
8585203|NCT03400787|21168532|P1|STARTED|Overall Study||66
8585204|NCT03380091|21168540|P2|NOT COMPLETED|Overall Study||1
8585205|NCT03380091|21168541|P1|NOT COMPLETED|Overall Study||2
8585206|NCT03380091|21168540|P2|COMPLETED|Overall Study||1
8585207|NCT03380091|21168541|P1|COMPLETED|Overall Study||1
8585208|NCT03380091|21168540|P2|Began Arm Treatment|Overall Study|1 of the 2 participant assigned to Metformin withdrew from the study just after enrolling.|1
8585209|NCT03380091|21168541|P1|Began Arm Treatment|Overall Study|1 participant withdrew after completing baseline measures and another withdrew just after enrolling.|1
8585210|NCT03380091|21168540|P2|STARTED|Overall Study||2
8585211|NCT03380091|21168541|P1|STARTED|Overall Study||3
8585218|NCT03368859|21168576|P2|NOT COMPLETED|Overall Study||34
8585219|NCT03368859|21168577|P1|NOT COMPLETED|Overall Study||36
8585220|NCT03368859|21168576|P2|COMPLETED|Overall Study||0
8585221|NCT03368859|21168577|P1|COMPLETED|Overall Study||0
8585222|NCT03368859|21168576|P2|STARTED|Overall Study||34
8585223|NCT03368859|21168577|P1|STARTED|Overall Study||36
8585376|NCT03261336|21168814|P1|NOT COMPLETED|Overall Study||1
8585377|NCT03261336|21168814|P1|COMPLETED|Overall Study||0
8585378|NCT03261336|21168814|P1|STARTED|Overall Study||1
8585385|NCT03225859|21168829|P1|NOT COMPLETED|Overall Study||1
8585386|NCT03225859|21168829|P1|COMPLETED|Overall Study||11
8585387|NCT03225859|21168829|P1|STARTED|Overall Study||12
8585400|NCT03219840|21168874|P2|NOT COMPLETED|Overall Study||0
8585401|NCT03219840|21168875|P1|NOT COMPLETED|Overall Study||4
8585402|NCT03219840|21168874|P2|COMPLETED|Overall Study||31
8585403|NCT03219840|21168875|P1|COMPLETED|Overall Study||34
8585404|NCT03219840|21168874|P2|Day 22 Visit for 2nd Period|Overall Study||31
8585405|NCT03219840|21168875|P1|Day 22 Visit for 2nd Period|Overall Study||34
8585406|NCT03219840|21168874|P2|2nd Intervention Period of 21 Days|Overall Study||31
8585407|NCT03219840|21168875|P1|2nd Intervention Period of 21 Days|Overall Study||34
8585408|NCT03219840|21168874|P2|Day 1 Visit for 2nd Period|Overall Study||31
8585409|NCT03219840|21168875|P1|Day 1 Visit for 2nd Period|Overall Study||34
8585410|NCT03219840|21168874|P2|Washout Period of 21 Days|Overall Study||31
8585411|NCT03219840|21168875|P1|Washout Period of 21 Days|Overall Study||34
8585412|NCT03219840|21168874|P2|Day 22 Visit for 1st Period|Overall Study||31
8585413|NCT03219840|21168875|P1|Day 22 Visit for 1st Period|Overall Study||34
8585414|NCT03219840|21168874|P2|1st Intervention Period of 21 Days|Overall Study||31
8585415|NCT03219840|21168875|P1|1st Intervention Period of 21 Days|Overall Study||34
8585416|NCT03219840|21168874|P2|Day 1 Visit for 1st Period|Overall Study||31
8585417|NCT03219840|21168875|P1|Day 1 Visit for 1st Period|Overall Study||37
8585418|NCT03219840|21168874|P2|STARTED|Overall Study||31
8585419|NCT03219840|21168875|P1|STARTED|Overall Study||38
8585490|NCT03066804|21169106|P2|NOT COMPLETED|Overall Study||50
8585491|NCT03066804|21169107|P1|NOT COMPLETED|Overall Study||51
8585492|NCT03066804|21169106|P2|COMPLETED|Overall Study||1236
8585493|NCT03066804|21169107|P1|COMPLETED|Overall Study||1235
8585494|NCT03066804|21169106|P2|STARTED|Overall Study||1286
8585495|NCT03066804|21169107|P1|STARTED|Overall Study||1286
8585500|NCT03040986|21169136|P2|NOT COMPLETED|Overall Study||2
8585501|NCT03040986|21169137|P1|NOT COMPLETED|Overall Study||6
8585502|NCT03040986|21169136|P2|COMPLETED|Overall Study||0
8585503|NCT03040986|21169137|P1|COMPLETED|Overall Study||0
8585504|NCT03040986|21169136|P2|STARTED|Overall Study||2
8585505|NCT03040986|21169137|P1|STARTED|Overall Study||6
8585506|NCT03020992|21169176|P1|NOT COMPLETED|Overall Study||6
8585507|NCT03020992|21169176|P1|COMPLETED|Overall Study||83
8585508|NCT03020992|21169176|P1|STARTED|Overall Study||89
8585518|NCT02973321|21169319|P5|NOT COMPLETED|Overall Study||5
8585519|NCT02973321|21169320|P4|NOT COMPLETED|Overall Study||16
8585520|NCT02973321|21169321|P3|NOT COMPLETED|Overall Study||14
8585521|NCT02973321|21169322|P2|NOT COMPLETED|Overall Study||15
8585522|NCT02973321|21169323|P1|NOT COMPLETED|Overall Study||1
8585523|NCT02973321|21169319|P5|COMPLETED|Overall Study||62
8585524|NCT02973321|21169320|P4|COMPLETED|Overall Study||48
8585525|NCT02973321|21169321|P3|COMPLETED|Overall Study||52
8585526|NCT02973321|21169322|P2|COMPLETED|Overall Study||51
8585527|NCT02973321|21169323|P1|COMPLETED|Overall Study||32
8585528|NCT02973321|21169319|P5|STARTED|Overall Study||67
8585529|NCT02973321|21169320|P4|STARTED|Overall Study||64
8585530|NCT02973321|21169321|P3|STARTED|Overall Study||66
8585531|NCT02973321|21169322|P2|STARTED|Overall Study||66
8585532|NCT02973321|21169323|P1|STARTED|Overall Study||33
8585553|NCT02953639|21169430|P3|NOT COMPLETED|Overall Study||16
8585554|NCT02953639|21169431|P2|NOT COMPLETED|Overall Study||14
8585555|NCT02953639|21169432|P1|NOT COMPLETED|Overall Study||20
8585556|NCT02953639|21169430|P3|COMPLETED|Overall Study||62
8585557|NCT02953639|21169431|P2|COMPLETED|Overall Study||40
8585558|NCT02953639|21169432|P1|COMPLETED|Overall Study||61
8585559|NCT02953639|21169430|P3|STARTED|Overall Study||78
8585560|NCT02953639|21169431|P2|STARTED|Overall Study||54
8585561|NCT02953639|21169432|P1|STARTED|Overall Study||81
8585619|NCT02911025|21169616|P1|NOT COMPLETED|Overall Study||3
8585620|NCT02911025|21169616|P1|COMPLETED|Overall Study||10
8585621|NCT02911025|21169616|P1|STARTED|Overall Study||13
8585622|NCT02901431|21169629|P13|NOT COMPLETED|Open Label Part||3
8585623|NCT02901431|21169630|P12|NOT COMPLETED|Open Label Part||39
8585624|NCT02901431|21169631|P11|NOT COMPLETED|Open Label Part||29
8585625|NCT02901431|21169632|P10|NOT COMPLETED|Open Label Part||24
8585626|NCT02901431|21169633|P9|NOT COMPLETED|Open Label Part||48
8585627|NCT02901431|21169634|P8|NOT COMPLETED|Open Label Part||0
8585628|NCT02901431|21169635|P7|NOT COMPLETED|Open Label Part||0
8585629|NCT02901431|21169636|P6|NOT COMPLETED|Open Label Part||0
8585630|NCT02901431|21169637|P5|NOT COMPLETED|Open Label Part||0
8585631|NCT02901431|21169638|P4|NOT COMPLETED|Open Label Part||0
8585632|NCT02901431|21169639|P3|NOT COMPLETED|Open Label Part||0
8585633|NCT02901431|21169640|P2|NOT COMPLETED|Open Label Part||0
8585634|NCT02901431|21169641|P1|NOT COMPLETED|Open Label Part||0
8585635|NCT02901431|21169629|P13|COMPLETED|Open Label Part||2
8585636|NCT02901431|21169630|P12|COMPLETED|Open Label Part||7
8585637|NCT02901431|21169631|P11|COMPLETED|Open Label Part||11
8585638|NCT02901431|21169632|P10|COMPLETED|Open Label Part||11
8585639|NCT02901431|21169633|P9|COMPLETED|Open Label Part||20
8585640|NCT02901431|21169634|P8|COMPLETED|Open Label Part||0
8585641|NCT02901431|21169635|P7|COMPLETED|Open Label Part||0
8585642|NCT02901431|21169636|P6|COMPLETED|Open Label Part||0
8585643|NCT02901431|21169637|P5|COMPLETED|Open Label Part||0
8585644|NCT02901431|21169638|P4|COMPLETED|Open Label Part||0
8585645|NCT02901431|21169639|P3|COMPLETED|Open Label Part||0
8585646|NCT02901431|21169640|P2|COMPLETED|Open Label Part||0
8585647|NCT02901431|21169641|P1|COMPLETED|Open Label Part||0
8585648|NCT02901431|21169629|P13|STARTED|Open Label Part||5
8585649|NCT02901431|21169630|P12|STARTED|Open Label Part||46
8585650|NCT02901431|21169631|P11|STARTED|Open Label Part||40
8585651|NCT02901431|21169632|P10|STARTED|Open Label Part||35
8585652|NCT02901431|21169633|P9|STARTED|Open Label Part||68
8585653|NCT02901431|21169634|P8|STARTED|Open Label Part||0
8585654|NCT02901431|21169635|P7|STARTED|Open Label Part||0
8585655|NCT02901431|21169636|P6|STARTED|Open Label Part||0
8585656|NCT02901431|21169637|P5|STARTED|Open Label Part||0
8585657|NCT02901431|21169638|P4|STARTED|Open Label Part||0
8585658|NCT02901431|21169639|P3|STARTED|Open Label Part||0
8585659|NCT02901431|21169640|P2|STARTED|Open Label Part||0
8585660|NCT02901431|21169641|P1|STARTED|Open Label Part||0
8585661|NCT02901431|21169629|P13|NOT COMPLETED|Main Treatment Part||0
8585662|NCT02901431|21169630|P12|NOT COMPLETED|Main Treatment Part||0
8585663|NCT02901431|21169631|P11|NOT COMPLETED|Main Treatment Part||0
8585664|NCT02901431|21169632|P10|NOT COMPLETED|Main Treatment Part||0
8585665|NCT02901431|21169633|P9|NOT COMPLETED|Main Treatment Part||0
8585666|NCT02901431|21169634|P8|NOT COMPLETED|Main Treatment Part||0
8585667|NCT02901431|21169635|P7|NOT COMPLETED|Main Treatment Part||11
8585668|NCT02901431|21169636|P6|NOT COMPLETED|Main Treatment Part||12
8585669|NCT02901431|21169637|P5|NOT COMPLETED|Main Treatment Part||7
8585670|NCT02901431|21169638|P4|NOT COMPLETED|Main Treatment Part||26
8585671|NCT02901431|21169639|P3|NOT COMPLETED|Main Treatment Part||0
8585672|NCT02901431|21169640|P2|NOT COMPLETED|Main Treatment Part||0
8585673|NCT02901431|21169641|P1|NOT COMPLETED|Main Treatment Part||0
8585674|NCT02901431|21169629|P13|COMPLETED|Main Treatment Part||0
8585675|NCT02901431|21169630|P12|COMPLETED|Main Treatment Part||0
8585676|NCT02901431|21169631|P11|COMPLETED|Main Treatment Part||0
8585677|NCT02901431|21169632|P10|COMPLETED|Main Treatment Part||0
8585678|NCT02901431|21169633|P9|COMPLETED|Main Treatment Part||0
8585679|NCT02901431|21169634|P8|COMPLETED|Main Treatment Part||7
8585680|NCT02901431|21169635|P7|COMPLETED|Main Treatment Part||55
8585681|NCT02901431|21169636|P6|COMPLETED|Main Treatment Part||54
8585682|NCT02901431|21169637|P5|COMPLETED|Main Treatment Part||50
8585683|NCT02901431|21169638|P4|COMPLETED|Main Treatment Part||86
8585684|NCT02901431|21169639|P3|COMPLETED|Main Treatment Part||0
8585685|NCT02901431|21169640|P2|COMPLETED|Main Treatment Part||0
8585686|NCT02901431|21169641|P1|COMPLETED|Main Treatment Part||0
8585687|NCT02901431|21169629|P13|STARTED|Main Treatment Part||0
8585688|NCT02901431|21169630|P12|STARTED|Main Treatment Part||0
8585689|NCT02901431|21169631|P11|STARTED|Main Treatment Part||0
8585690|NCT02901431|21169632|P10|STARTED|Main Treatment Part||0
8585691|NCT02901431|21169633|P9|STARTED|Main Treatment Part||0
8585692|NCT02901431|21169634|P8|STARTED|Main Treatment Part||7
8585693|NCT02901431|21169635|P7|STARTED|Main Treatment Part||66
8585694|NCT02901431|21169636|P6|STARTED|Main Treatment Part||66
8585695|NCT02901431|21169637|P5|STARTED|Main Treatment Part||57
8585696|NCT02901431|21169638|P4|STARTED|Main Treatment Part||112
8585697|NCT02901431|21169639|P3|STARTED|Main Treatment Part||0
8585698|NCT02901431|21169640|P2|STARTED|Main Treatment Part||0
8585699|NCT02901431|21169641|P1|STARTED|Main Treatment Part||0
8585700|NCT02901431|21169629|P13|NOT COMPLETED|PK Part||0
8585701|NCT02901431|21169630|P12|NOT COMPLETED|PK Part||0
8585702|NCT02901431|21169631|P11|NOT COMPLETED|PK Part||0
8585703|NCT02901431|21169632|P10|NOT COMPLETED|PK Part||0
8585704|NCT02901431|21169633|P9|NOT COMPLETED|PK Part||0
8585705|NCT02901431|21169634|P8|NOT COMPLETED|PK Part||0
8585706|NCT02901431|21169635|P7|NOT COMPLETED|PK Part||0
8585707|NCT02901431|21169636|P6|NOT COMPLETED|PK Part||0
8585708|NCT02901431|21169637|P5|NOT COMPLETED|PK Part||0
8585709|NCT02901431|21169638|P4|NOT COMPLETED|PK Part||0
8585710|NCT02901431|21169639|P3|NOT COMPLETED|PK Part||9
8585711|NCT02901431|21169640|P2|NOT COMPLETED|PK Part||6
8585712|NCT02901431|21169641|P1|NOT COMPLETED|PK Part||7
8585713|NCT02901431|21169629|P13|COMPLETED|PK Part||0
8585714|NCT02901431|21169630|P12|COMPLETED|PK Part||0
8585715|NCT02901431|21169631|P11|COMPLETED|PK Part||0
8585716|NCT02901431|21169632|P10|COMPLETED|PK Part||0
8585717|NCT02901431|21169633|P9|COMPLETED|PK Part||0
8585718|NCT02901431|21169634|P8|COMPLETED|PK Part||0
8585719|NCT02901431|21169635|P7|COMPLETED|PK Part||0
8585720|NCT02901431|21169636|P6|COMPLETED|PK Part||0
8585721|NCT02901431|21169637|P5|COMPLETED|PK Part||0
8585722|NCT02901431|21169638|P4|COMPLETED|PK Part||0
8585723|NCT02901431|21169639|P3|COMPLETED|PK Part||6
8585724|NCT02901431|21169640|P2|COMPLETED|PK Part||5
8585725|NCT02901431|21169641|P1|COMPLETED|PK Part||5
8585726|NCT02901431|21169629|P13|STARTED|PK Part||0
8585727|NCT02901431|21169630|P12|STARTED|PK Part||0
8585728|NCT02901431|21169631|P11|STARTED|PK Part||0
8585729|NCT02901431|21169632|P10|STARTED|PK Part||0
8585730|NCT02901431|21169633|P9|STARTED|PK Part||0
8585731|NCT02901431|21169634|P8|STARTED|PK Part||0
8585732|NCT02901431|21169635|P7|STARTED|PK Part||0
8585733|NCT02901431|21169636|P6|STARTED|PK Part||0
8585734|NCT02901431|21169637|P5|STARTED|PK Part||0
8585735|NCT02901431|21169638|P4|STARTED|PK Part||0
8585736|NCT02901431|21169639|P3|STARTED|PK Part||15
8585737|NCT02901431|21169640|P2|STARTED|PK Part||11
8585738|NCT02901431|21169641|P1|STARTED|PK Part||12
8585750|NCT02825849|21169715|P2|NOT COMPLETED|Overall Study||0
8585751|NCT02825849|21169716|P1|NOT COMPLETED|Overall Study||0
8585752|NCT02825849|21169715|P2|COMPLETED|Overall Study||5
8585753|NCT02825849|21169716|P1|COMPLETED|Overall Study||22
8585754|NCT02825849|21169715|P2|STARTED|Overall Study||5
8585755|NCT02825849|21169716|P1|STARTED|Overall Study||22
8585756|NCT02765256|21169726|P2|NOT COMPLETED|Overall Study||0
8585757|NCT02765256|21169727|P1|NOT COMPLETED|Overall Study||0
8585758|NCT02765256|21169726|P2|COMPLETED|Overall Study||4
8585759|NCT02765256|21169727|P1|COMPLETED|Overall Study||4
8585760|NCT02765256|21169726|P2|STARTED|Overall Study||4
8585761|NCT02765256|21169727|P1|STARTED|Overall Study||4
8585872|NCT02685995|21170260|P2|NOT COMPLETED|Overall Study||1
8585873|NCT02685995|21170261|P1|NOT COMPLETED|Overall Study||1
8585874|NCT02685995|21170260|P2|COMPLETED|Overall Study||49
8585875|NCT02685995|21170261|P1|COMPLETED|Overall Study||49
8585876|NCT02685995|21170260|P2|STARTED|Overall Study||50
8585877|NCT02685995|21170261|P1|STARTED|Overall Study||50
8585884|NCT02637895|21170295|P2|NOT COMPLETED|Overall Study||3
8585885|NCT02637895|21170296|P1|NOT COMPLETED|Overall Study||6
8585886|NCT02637895|21170295|P2|COMPLETED|Overall Study||17
8585887|NCT02637895|21170296|P1|COMPLETED|Overall Study||15
8585888|NCT02637895|21170295|P2|STARTED|Overall Study||20
8585889|NCT02637895|21170296|P1|STARTED|Overall Study||21
8585919|NCT02597478|21170513|P2|NOT COMPLETED|Overall Study||1
8585920|NCT02597478|21170514|P1|NOT COMPLETED|Overall Study||3
8585921|NCT02597478|21170513|P2|COMPLETED|Overall Study||17
8585922|NCT02597478|21170514|P1|COMPLETED|Overall Study||13
8585923|NCT02597478|21170513|P2|STARTED|Overall Study||18
8585924|NCT02597478|21170514|P1|STARTED|Overall Study||16
8585949|NCT02548949|21170558|P1|NOT COMPLETED|Overall Study||0
8585950|NCT02548949|21170558|P1|COMPLETED|Overall Study||700
8585951|NCT02548949|21170558|P1|STARTED|Overall Study||700
8586023|NCT02474199|21170788|P4|NOT COMPLETED|Overall Study||3
8586024|NCT02474199|21170789|P3|NOT COMPLETED|Overall Study||2
8586025|NCT02474199|21170790|P2|NOT COMPLETED|Overall Study||3
8586026|NCT02474199|21170791|P1|NOT COMPLETED|Overall Study||2
8586027|NCT02474199|21170788|P4|COMPLETED|Overall Study||0
8586028|NCT02474199|21170789|P3|COMPLETED|Overall Study||0
8586029|NCT02474199|21170790|P2|COMPLETED|Overall Study||2
8586030|NCT02474199|21170791|P1|COMPLETED|Overall Study||3
8586031|NCT02474199|21170788|P4|STARTED|Overall Study||3
8586032|NCT02474199|21170789|P3|STARTED|Overall Study||2
8586033|NCT02474199|21170790|P2|STARTED|Overall Study|Insufficient numbers of darTregs for infusion (4 of these 5 participants)|5
8586034|NCT02474199|21170791|P1|STARTED|Overall Study||5
8586309|NCT02416453|21171159|P11|NOT COMPLETED|Overall Study||0
8586310|NCT02416453|21171160|P10|NOT COMPLETED|Overall Study||0
8586311|NCT02416453|21171161|P9|NOT COMPLETED|Overall Study||5
8586312|NCT02416453|21171162|P8|NOT COMPLETED|Overall Study||12
8586313|NCT02416453|21171163|P7|NOT COMPLETED|Overall Study||2
8586314|NCT02416453|21171164|P6|NOT COMPLETED|Overall Study||16
8586315|NCT02416453|21171165|P5|NOT COMPLETED|Overall Study||1
8586316|NCT02416453|21171166|P4|NOT COMPLETED|Overall Study||15
8586317|NCT02416453|21171167|P3|NOT COMPLETED|Overall Study||1
8586318|NCT02416453|21171168|P2|NOT COMPLETED|Overall Study||3
8586319|NCT02416453|21171169|P1|NOT COMPLETED|Overall Study||3
8586320|NCT02416453|21171159|P11|COMPLETED|Overall Study||2
8586321|NCT02416453|21171160|P10|COMPLETED|Overall Study||13
8586322|NCT02416453|21171161|P9|COMPLETED|Overall Study||13
8586323|NCT02416453|21171162|P8|COMPLETED|Overall Study||94
8586324|NCT02416453|21171163|P7|COMPLETED|Overall Study||11
8586325|NCT02416453|21171164|P6|COMPLETED|Overall Study||98
8586326|NCT02416453|21171165|P5|COMPLETED|Overall Study||12
8586327|NCT02416453|21171166|P4|COMPLETED|Overall Study||97
8586328|NCT02416453|21171167|P3|COMPLETED|Overall Study||9
8586329|NCT02416453|21171168|P2|COMPLETED|Overall Study||7
8586330|NCT02416453|21171169|P1|COMPLETED|Overall Study||7
8586331|NCT02416453|21171159|P11|STARTED|Overall Study||2
8586332|NCT02416453|21171160|P10|STARTED|Overall Study||13
8586333|NCT02416453|21171161|P9|STARTED|Overall Study||18
8586334|NCT02416453|21171162|P8|STARTED|Overall Study||106
8586335|NCT02416453|21171163|P7|STARTED|Overall Study||13
8586336|NCT02416453|21171164|P6|STARTED|Overall Study||114
8586337|NCT02416453|21171165|P5|STARTED|Overall Study||13
8586338|NCT02416453|21171166|P4|STARTED|Overall Study||112
8586339|NCT02416453|21171167|P3|STARTED|Overall Study||10
8586340|NCT02416453|21171168|P2|STARTED|Overall Study||10
8586341|NCT02416453|21171169|P1|STARTED|Overall Study||10
8586444|NCT02394548|21171413|P1|NOT COMPLETED|Overall Study||1
8586445|NCT02394548|21171413|P1|COMPLETED|Overall Study||25
8586446|NCT02394548|21171413|P1|STARTED|Overall Study||26
8586501|NCT02346708|21171574|P2|NOT COMPLETED|Overall Study||1
8586502|NCT02346708|21171575|P1|NOT COMPLETED|Overall Study||2
8586503|NCT02346708|21171574|P2|COMPLETED|Overall Study||24
8586504|NCT02346708|21171575|P1|COMPLETED|Overall Study||22
8586505|NCT02346708|21171574|P2|STARTED|Overall Study||25
8586506|NCT02346708|21171575|P1|STARTED|Overall Study||24
8586524|NCT02303704|21171692|P2|NOT COMPLETED|Overall Study||9
8586525|NCT02303704|21171693|P1|NOT COMPLETED|Overall Study||5
8586526|NCT02303704|21171692|P2|COMPLETED|Overall Study||219
8586527|NCT02303704|21171693|P1|COMPLETED|Overall Study||215
8586528|NCT02303704|21171692|P2|STARTED|Overall Study||228
8586529|NCT02303704|21171693|P1|STARTED|Overall Study||220
8586530|NCT02303184|21171711|P2|NOT COMPLETED|Overall Study||0
8586531|NCT02303184|21171712|P1|NOT COMPLETED|Overall Study||0
8586532|NCT02303184|21171711|P2|COMPLETED|Overall Study||23
8586533|NCT02303184|21171712|P1|COMPLETED|Overall Study||23
8586534|NCT02303184|21171711|P2|STARTED|Overall Study||23
8586535|NCT02303184|21171712|P1|STARTED|Overall Study||23
8586566|NCT02255032|21171789|P2|NOT COMPLETED|Overall Study||0
8586567|NCT02255032|21171790|P1|NOT COMPLETED|Overall Study||0
8586568|NCT02255032|21171789|P2|COMPLETED|Overall Study||5
8586569|NCT02255032|21171790|P1|COMPLETED|Overall Study||17
8586570|NCT02255032|21171789|P2|STARTED|Overall Study||5
8586571|NCT02255032|21171790|P1|STARTED|Overall Study||17
8586647|NCT02176382|21171948|P2|NOT COMPLETED|DATA-HD Extension||0
8586648|NCT02176382|21171949|P1|NOT COMPLETED|DATA-HD Extension||1
8586649|NCT02176382|21171948|P2|COMPLETED|DATA-HD Extension||26
8586650|NCT02176382|21171949|P1|COMPLETED|DATA-HD Extension||26
8586651|NCT02176382|21171948|P2|STARTED|DATA-HD Extension||26
8586652|NCT02176382|21171949|P1|STARTED|DATA-HD Extension||27
8586653|NCT02176382|21171948|P2|NOT COMPLETED|DATA-HD Study||8
8586654|NCT02176382|21171949|P1|NOT COMPLETED|DATA-HD Study||8
8586655|NCT02176382|21171948|P2|COMPLETED|DATA-HD Study||29
8586656|NCT02176382|21171949|P1|COMPLETED|DATA-HD Study||31
8586657|NCT02176382|21171948|P2|STARTED|DATA-HD Study||37
8586658|NCT02176382|21171949|P1|STARTED|DATA-HD Study||39
8586659|NCT02154672|21171955|P1|NOT COMPLETED|Overall Study||0
8586660|NCT02154672|21171955|P1|COMPLETED|Overall Study||1
8586661|NCT02154672|21171955|P1|STARTED|Overall Study||1
8586680|NCT02110121|21172001|P2|NOT COMPLETED|Overall Study||0
8586681|NCT02110121|21172002|P1|NOT COMPLETED|Overall Study||16
8586682|NCT02110121|21172001|P2|COMPLETED|Overall Study||5
8586683|NCT02110121|21172002|P1|COMPLETED|Overall Study||42
8586684|NCT02110121|21172001|P2|STARTED|Overall Study||5
8586685|NCT02110121|21172002|P1|STARTED|Overall Study||58
8586689|NCT02095678|21172019|P2|NOT COMPLETED|Overall Study||18
8586690|NCT02095678|21172020|P1|NOT COMPLETED|Overall Study||17
8586691|NCT02095678|21172019|P2|COMPLETED|Overall Study||0
8586692|NCT02095678|21172020|P1|COMPLETED|Overall Study||17
8586693|NCT02095678|21172019|P2|STARTED|Overall Study||18
8586694|NCT02095678|21172020|P1|STARTED|Overall Study||34
8586698|NCT02053077|21172043|P1|NOT COMPLETED|Overall Study||0
8586699|NCT02053077|21172043|P1|COMPLETED|Overall Study||150
8586700|NCT02053077|21172043|P1|STARTED|Overall Study||150
8586758|NCT01912274|21172203|P1|NOT COMPLETED|Overall Study||0
8586759|NCT01912274|21172203|P1|COMPLETED|Overall Study||50
8586760|NCT01912274|21172203|P1|STARTED|Overall Study||50
8586847|NCT01745211|21172522|P1|NOT COMPLETED|Overall Study||18
8586848|NCT01745211|21172522|P1|COMPLETED|Overall Study||27
8586849|NCT01745211|21172522|P1|STARTED|Overall Study||45
8586850|NCT01717053|21172526|P1|NOT COMPLETED|Overall Study||4
8586851|NCT01717053|21172526|P1|COMPLETED|Overall Study||33
8586852|NCT01717053|21172526|P1|STARTED|Overall Study||37
8586960|NCT01627288|21172710|P4|NOT COMPLETED|Overall Study||0
8586961|NCT01627288|21172711|P3|NOT COMPLETED|Overall Study||0
8586962|NCT01627288|21172712|P2|NOT COMPLETED|Overall Study||0
8586963|NCT01627288|21172713|P1|NOT COMPLETED|Overall Study||0
8586964|NCT01627288|21172710|P4|COMPLETED|Overall Study||0
8586965|NCT01627288|21172711|P3|COMPLETED|Overall Study||6
8586966|NCT01627288|21172712|P2|COMPLETED|Overall Study||3
8586967|NCT01627288|21172713|P1|COMPLETED|Overall Study||3
8586968|NCT01627288|21172710|P4|STARTED|Overall Study||0
8586969|NCT01627288|21172711|P3|STARTED|Overall Study||6
8586970|NCT01627288|21172712|P2|STARTED|Overall Study||3
8586971|NCT01627288|21172713|P1|STARTED|Overall Study||3
8586981|NCT01557751|21172772|P1|NOT COMPLETED|Overall Study||3
8586982|NCT01557751|21172772|P1|COMPLETED|Overall Study||153
8586983|NCT01557751|21172772|P1|STARTED|Overall Study||156
8586990|NCT01532687|21172795|P2|NOT COMPLETED|Overall Study||2
8586991|NCT01532687|21172796|P1|NOT COMPLETED|Overall Study||14
8586992|NCT01532687|21172795|P2|COMPLETED|Overall Study|Participants remain on treatment until time of progression|23
8586993|NCT01532687|21172796|P1|COMPLETED|Overall Study|Participants remain on treatment until time of progression and through the AE assessment period|15
8586994|NCT01532687|21172795|P2|Crossover to Open-label Pazopanib|Overall Study||14
8586995|NCT01532687|21172796|P1|Crossover to Open-label Pazopanib|Overall Study||0
8586996|NCT01532687|21172795|P2|STARTED|Overall Study||25
8586997|NCT01532687|21172796|P1|STARTED|Overall Study||29
8586998|NCT01515319|21172818|P10|NOT COMPLETED|Overall Study||0
8586999|NCT01515319|21172819|P9|NOT COMPLETED|Overall Study||5
8587000|NCT01515319|21172820|P8|NOT COMPLETED|Overall Study||0
8587001|NCT01515319|21172821|P7|NOT COMPLETED|Overall Study||1
8587002|NCT01515319|21172822|P6|NOT COMPLETED|Overall Study||0
8587003|NCT01515319|21172823|P5|NOT COMPLETED|Overall Study||0
8587004|NCT01515319|21172824|P4|NOT COMPLETED|Overall Study||0
8587005|NCT01515319|21172825|P3|NOT COMPLETED|Overall Study||0
8587006|NCT01515319|21172826|P2|NOT COMPLETED|Overall Study||0
8587007|NCT01515319|21172827|P1|NOT COMPLETED|Overall Study||0
8587008|NCT01515319|21172818|P10|COMPLETED|Overall Study||8
8587009|NCT01515319|21172819|P9|COMPLETED|Overall Study||9
8587010|NCT01515319|21172820|P8|COMPLETED|Overall Study||6
8587011|NCT01515319|21172821|P7|COMPLETED|Overall Study||9
8587012|NCT01515319|21172822|P6|COMPLETED|Overall Study||6
8587013|NCT01515319|21172823|P5|COMPLETED|Overall Study||6
8587014|NCT01515319|21172824|P4|COMPLETED|Overall Study||6
8587015|NCT01515319|21172825|P3|COMPLETED|Overall Study||6
8587016|NCT01515319|21172826|P2|COMPLETED|Overall Study||3
8587017|NCT01515319|21172827|P1|COMPLETED|Overall Study||3
8587018|NCT01515319|21172818|P10|STARTED|Overall Study||8
8587019|NCT01515319|21172819|P9|STARTED|Overall Study||14
8587020|NCT01515319|21172820|P8|STARTED|Overall Study||6
8587021|NCT01515319|21172821|P7|STARTED|Overall Study||10
8587022|NCT01515319|21172822|P6|STARTED|Overall Study||6
8587023|NCT01515319|21172823|P5|STARTED|Overall Study||6
8587024|NCT01515319|21172824|P4|STARTED|Overall Study||6
8587025|NCT01515319|21172825|P3|STARTED|Overall Study||6
8587026|NCT01515319|21172826|P2|STARTED|Overall Study||3
8587027|NCT01515319|21172827|P1|STARTED|Overall Study||3
8587042|NCT01425203|21172906|P3|NOT COMPLETED|Follow-up Phase||0
8587043|NCT01425203|21172907|P2|NOT COMPLETED|Follow-up Phase||0
8587044|NCT01425203|21172908|P1|NOT COMPLETED|Follow-up Phase||0
8587045|NCT01425203|21172906|P3|COMPLETED|Follow-up Phase||27
8587046|NCT01425203|21172907|P2|COMPLETED|Follow-up Phase||49
8587047|NCT01425203|21172908|P1|COMPLETED|Follow-up Phase||153
8587048|NCT01425203|21172906|P3|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
8587049|NCT01425203|21172907|P2|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
8587050|NCT01425203|21172908|P1|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
8587051|NCT01425203|21172906|P3|NOT COMPLETED|Crossover Phase||6
8587052|NCT01425203|21172907|P2|NOT COMPLETED|Crossover Phase||0
8587053|NCT01425203|21172908|P1|NOT COMPLETED|Crossover Phase||0
8587054|NCT01425203|21172906|P3|COMPLETED|Crossover Phase||21
8587055|NCT01425203|21172907|P2|COMPLETED|Crossover Phase||0
8587056|NCT01425203|21172908|P1|COMPLETED|Crossover Phase||0
8587057|NCT01425203|21172906|P3|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
8587058|NCT01425203|21172907|P2|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
8587059|NCT01425203|21172908|P1|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
8587060|NCT01425203|21172906|P3|NOT COMPLETED|Treatment Phase||0
8587061|NCT01425203|21172907|P2|NOT COMPLETED|Treatment Phase||37
8587062|NCT01425203|21172908|P1|NOT COMPLETED|Treatment Phase||27
8587063|NCT01425203|21172906|P3|COMPLETED|Treatment Phase||0
8587064|NCT01425203|21172907|P2|COMPLETED|Treatment Phase||42
8587065|NCT01425203|21172908|P1|COMPLETED|Treatment Phase||132
8587066|NCT01425203|21172906|P3|Treated (FAS)|Treatment Phase||0
8587067|NCT01425203|21172907|P2|Treated (FAS)|Treatment Phase||78
8587068|NCT01425203|21172908|P1|Treated (FAS)|Treatment Phase||159
8587069|NCT01425203|21172906|P3|STARTED|Treatment Phase||0
8587070|NCT01425203|21172907|P2|STARTED|Treatment Phase||79
8587071|NCT01425203|21172908|P1|STARTED|Treatment Phase||159
8587131|NCT01233518|21173147|P1|NOT COMPLETED|Overall Study||33
8587132|NCT01233518|21173147|P1|COMPLETED|Overall Study||252
8587133|NCT01233518|21173147|P1|STARTED|Overall Study||285
8587155|NCT01170715|21173183|P1|NOT COMPLETED|Overall Study||7
8587156|NCT01170715|21173183|P1|COMPLETED|Overall Study||14
8587157|NCT01170715|21173183|P1|STARTED|Overall Study||21
8587182|NCT01150838|21173453|P6|NOT COMPLETED|Overall Study||0
8587183|NCT01150838|21173454|P5|NOT COMPLETED|Overall Study||0
8587184|NCT01150838|21173455|P4|NOT COMPLETED|Overall Study||0
8587185|NCT01150838|21173456|P3|NOT COMPLETED|Overall Study||0
8587186|NCT01150838|21173457|P2|NOT COMPLETED|Overall Study||0
8587187|NCT01150838|21173458|P1|NOT COMPLETED|Overall Study||0
8587188|NCT01150838|21173453|P6|COMPLETED|Overall Study||2
8587189|NCT01150838|21173454|P5|COMPLETED|Overall Study||16
8587190|NCT01150838|21173455|P4|COMPLETED|Overall Study||15
8587191|NCT01150838|21173456|P3|COMPLETED|Overall Study||24
8587192|NCT01150838|21173457|P2|COMPLETED|Overall Study||26
8587193|NCT01150838|21173458|P1|COMPLETED|Overall Study||19
8587194|NCT01150838|21173453|P6|STARTED|Overall Study||2
8587195|NCT01150838|21173454|P5|STARTED|Overall Study||16
8587196|NCT01150838|21173455|P4|STARTED|Overall Study||15
8587197|NCT01150838|21173456|P3|STARTED|Overall Study||24
8587198|NCT01150838|21173457|P2|STARTED|Overall Study||26
8587199|NCT01150838|21173458|P1|STARTED|Overall Study||19
8587200|NCT01146795|21173466|P1|NOT COMPLETED|Overall Study||20
8587201|NCT01146795|21173466|P1|COMPLETED|Overall Study||12
8587202|NCT01146795|21173466|P1|STARTED|Overall Study||32
8587916|NCT01023035|21173687|P3|NOT COMPLETED|Follow-up Period (up to Week 72)||39
8587917|NCT01023035|21173688|P2|NOT COMPLETED|Follow-up Period (up to Week 72)||28
8587918|NCT01023035|21173689|P1|NOT COMPLETED|Follow-up Period (up to Week 72)||28
8587919|NCT01023035|21173687|P3|COMPLETED|Follow-up Period (up to Week 72)||108
8587920|NCT01023035|21173688|P2|COMPLETED|Follow-up Period (up to Week 72)||207
8587921|NCT01023035|21173689|P1|COMPLETED|Follow-up Period (up to Week 72)||210
8587922|NCT01023035|21173687|P3|STARTED|Follow-up Period (up to Week 72)||147
8587923|NCT01023035|21173688|P2|STARTED|Follow-up Period (up to Week 72)||235
8587924|NCT01023035|21173689|P1|STARTED|Follow-up Period (up to Week 72)||238
8587925|NCT01023035|21173687|P3|NOT COMPLETED|Treatment Period||118
8587926|NCT01023035|21173688|P2|NOT COMPLETED|Treatment Period||85
8587927|NCT01023035|21173689|P1|NOT COMPLETED|Treatment Period||72
8587928|NCT01023035|21173687|P3|COMPLETED|Treatment Period||69
8587929|NCT01023035|21173688|P2|COMPLETED|Treatment Period||166
8587930|NCT01023035|21173689|P1|COMPLETED|Treatment Period||177
8587931|NCT01023035|21173687|P3|STARTED|Treatment Period||187
8587932|NCT01023035|21173688|P2|STARTED|Treatment Period||251
8587933|NCT01023035|21173689|P1|STARTED|Treatment Period||249
8587952|NCT00960804|21173749|P3|NOT COMPLETED|Overall Study||10
8587953|NCT00960804|21173750|P2|NOT COMPLETED|Overall Study||4
8587954|NCT00960804|21173751|P1|NOT COMPLETED|Overall Study||7
8587955|NCT00960804|21173749|P3|COMPLETED|Overall Study||0
8587956|NCT00960804|21173750|P2|COMPLETED|Overall Study||0
8587957|NCT00960804|21173751|P1|COMPLETED|Overall Study||0
8587958|NCT00960804|21173749|P3|STARTED|Overall Study||10
8587959|NCT00960804|21173750|P2|STARTED|Overall Study||4
8587960|NCT00960804|21173751|P1|STARTED|Overall Study||7
8587976|NCT00944528|21173852|P3|NOT COMPLETED|Overall Study||0
8587977|NCT00944528|21173853|P2|NOT COMPLETED|Overall Study||2
8587978|NCT00944528|21173854|P1|NOT COMPLETED|Overall Study||1
8587979|NCT00944528|21173852|P3|COMPLETED|Overall Study||16
8587980|NCT00944528|21173853|P2|COMPLETED|Overall Study||8
8587981|NCT00944528|21173854|P1|COMPLETED|Overall Study||8
8587982|NCT00944528|21173852|P3|STARTED|Overall Study||16
8587983|NCT00944528|21173853|P2|STARTED|Overall Study||10
8587984|NCT00944528|21173854|P1|STARTED|Overall Study||9
8587985|NCT00943761|21173868|P2|NOT COMPLETED|Overall Study||1
8587986|NCT00943761|21173869|P1|NOT COMPLETED|Overall Study||4
8587987|NCT00943761|21173868|P2|COMPLETED|Overall Study||23
8587988|NCT00943761|21173869|P1|COMPLETED|Overall Study||17
8587989|NCT00943761|21173868|P2|STARTED|Overall Study||24
8587990|NCT00943761|21173869|P1|STARTED|Overall Study||21
8588033|NCT00910624|21173946|P4|NOT COMPLETED|Follow-Up Phase||0
8588034|NCT00910624|21173947|P3|NOT COMPLETED|Follow-Up Phase||4
8588035|NCT00910624|21173948|P2|NOT COMPLETED|Follow-Up Phase||4
8588036|NCT00910624|21173949|P1|NOT COMPLETED|Follow-Up Phase||6
8588037|NCT00910624|21173946|P4|COMPLETED|Follow-Up Phase||2
8588038|NCT00910624|21173947|P3|COMPLETED|Follow-Up Phase||25
8588039|NCT00910624|21173948|P2|COMPLETED|Follow-Up Phase||76
8588040|NCT00910624|21173949|P1|COMPLETED|Follow-Up Phase||42
8588041|NCT00910624|21173946|P4|STARTED|Follow-Up Phase||2
8588042|NCT00910624|21173947|P3|STARTED|Follow-Up Phase||29
8588043|NCT00910624|21173948|P2|STARTED|Follow-Up Phase||80
8588044|NCT00910624|21173949|P1|STARTED|Follow-Up Phase||48
8588045|NCT00910624|21173946|P4|NOT COMPLETED|Treatment Phase||0
8588046|NCT00910624|21173947|P3|NOT COMPLETED|Treatment Phase||9
8588047|NCT00910624|21173948|P2|NOT COMPLETED|Treatment Phase||21
8588048|NCT00910624|21173949|P1|NOT COMPLETED|Treatment Phase||30
8588049|NCT00910624|21173946|P4|COMPLETED|Treatment Phase||2
8588050|NCT00910624|21173947|P3|COMPLETED|Treatment Phase||20
8588051|NCT00910624|21173948|P2|COMPLETED|Treatment Phase||64
8588052|NCT00910624|21173949|P1|COMPLETED|Treatment Phase||22
8588053|NCT00910624|21173946|P4|STARTED|Treatment Phase||2
8588054|NCT00910624|21173947|P3|STARTED|Treatment Phase||29
8588055|NCT00910624|21173948|P2|STARTED|Treatment Phase||85
8588056|NCT00910624|21173949|P1|STARTED|Treatment Phase||52
8588108|NCT00768664|21174090|P1|NOT COMPLETED|Overall Study||69
8588109|NCT00768664|21174090|P1|COMPLETED|Overall Study||0
8588110|NCT00768664|21174090|P1|STARTED|Overall Study||69
8588135|NCT00654940|21174270|P2|NOT COMPLETED|Period 2||0
8588136|NCT00654940|21174271|P1|NOT COMPLETED|Period 2||0
8588137|NCT00654940|21174270|P2|COMPLETED|Period 2||11
8588138|NCT00654940|21174271|P1|COMPLETED|Period 2||12
8588139|NCT00654940|21174270|P2|STARTED|Period 2||11
8588140|NCT00654940|21174271|P1|STARTED|Period 2||12
8588141|NCT00654940|21174270|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
8588142|NCT00654940|21174271|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
8588143|NCT00654940|21174270|P2|COMPLETED|Washout Period of 2 Weeks||11
8588144|NCT00654940|21174271|P1|COMPLETED|Washout Period of 2 Weeks||12
8588145|NCT00654940|21174270|P2|STARTED|Washout Period of 2 Weeks||11
8588146|NCT00654940|21174271|P1|STARTED|Washout Period of 2 Weeks||12
8588147|NCT00654940|21174270|P2|NOT COMPLETED|Period 1||1
8588148|NCT00654940|21174271|P1|NOT COMPLETED|Period 1||1
8588149|NCT00654940|21174270|P2|COMPLETED|Period 1||11
8588150|NCT00654940|21174271|P1|COMPLETED|Period 1||12
8588151|NCT00654940|21174270|P2|Received Study Treatment|Period 1||12
8588152|NCT00654940|21174271|P1|Received Study Treatment|Period 1||12
8588153|NCT00654940|21174270|P2|STARTED|Period 1|Assigned to study treatment.|12
8588154|NCT00654940|21174271|P1|STARTED|Period 1|Assigned to study treatment.|13
8588225|NCT00467272|21174567|P1|NOT COMPLETED|Overall Study||3
8588226|NCT00467272|21174567|P1|COMPLETED|Overall Study||38
8588227|NCT00467272|21174567|P1|STARTED|Overall Study||41
8588288|NCT00437034|21174909|P1|NOT COMPLETED|Overall Study||6
8588289|NCT00437034|21174909|P1|COMPLETED|Overall Study||0
8588290|NCT00437034|21174909|P1|STARTED|Overall Study||6
8588423|NCT00407511|21175064|P1|NOT COMPLETED|Overall Study||22
8588424|NCT00407511|21175064|P1|COMPLETED|Overall Study||99
8588425|NCT00407511|21175064|P1|STARTED|Overall Study||121
8588426|NCT00394901|21175082|P4|NOT COMPLETED|Double-blind Phase||27
8588427|NCT00394901|21175083|P3|NOT COMPLETED|Double-blind Phase||18
8588428|NCT00394901|21175084|P2|NOT COMPLETED|Double-blind Phase||14
8588429|NCT00394901|21175085|P1|NOT COMPLETED|Double-blind Phase||15
8588430|NCT00394901|21175082|P4|COMPLETED|Double-blind Phase||70
8588431|NCT00394901|21175083|P3|COMPLETED|Double-blind Phase||71
8588432|NCT00394901|21175084|P2|COMPLETED|Double-blind Phase||73
8588433|NCT00394901|21175085|P1|COMPLETED|Double-blind Phase||83
8588434|NCT00394901|21175082|P4|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
8588435|NCT00394901|21175083|P3|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
8588436|NCT00394901|21175084|P2|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
8588437|NCT00394901|21175085|P1|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
8588438|NCT00394901|21175082|P4|NOT COMPLETED|Baseline Phase||0
8588439|NCT00394901|21175083|P3|NOT COMPLETED|Baseline Phase||1
8588440|NCT00394901|21175084|P2|NOT COMPLETED|Baseline Phase||0
8588441|NCT00394901|21175085|P1|NOT COMPLETED|Baseline Phase||0
8588442|NCT00394901|21175082|P4|COMPLETED|Baseline Phase||97
8588443|NCT00394901|21175083|P3|COMPLETED|Baseline Phase||89
8588444|NCT00394901|21175084|P2|COMPLETED|Baseline Phase||87
8588445|NCT00394901|21175085|P1|COMPLETED|Baseline Phase||98
8588446|NCT00394901|21175082|P4|STARTED|Baseline Phase|Subjects randomized|97
8588447|NCT00394901|21175083|P3|STARTED|Baseline Phase|Subjects randomized|90
8588448|NCT00394901|21175084|P2|STARTED|Baseline Phase|Subjects randomized|87
8588449|NCT00394901|21175085|P1|STARTED|Baseline Phase|Subjects randomized|98
8588456|NCT00368745|21175331|P2|NOT COMPLETED|Double-blind Treatment Period||31
8588457|NCT00368745|21175332|P1|NOT COMPLETED|Double-blind Treatment Period||26
8588458|NCT00368745|21175331|P2|COMPLETED|Double-blind Treatment Period||19
8588459|NCT00368745|21175332|P1|COMPLETED|Double-blind Treatment Period||30
8588460|NCT00368745|21175331|P2|STARTED|Double-blind Treatment Period||50
8588461|NCT00368745|21175332|P1|STARTED|Double-blind Treatment Period||56
8588462|NCT00368745|21175331|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
8588463|NCT00368745|21175332|P1|NOT COMPLETED|Randomized to Double-blind Treatment||1
8588464|NCT00368745|21175331|P2|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
8588465|NCT00368745|21175332|P1|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
8588466|NCT00368745|21175331|P2|STARTED|Randomized to Double-blind Treatment||51
8588467|NCT00368745|21175332|P1|STARTED|Randomized to Double-blind Treatment||57
8588480|NCT00350298|21175419|P2|NOT COMPLETED|Overall Study||13
8588481|NCT00350298|21175420|P1|NOT COMPLETED|Overall Study||9
8588482|NCT00350298|21175419|P2|COMPLETED|Overall Study||86
8588483|NCT00350298|21175420|P1|COMPLETED|Overall Study||92
8588484|NCT00350298|21175419|P2|STARTED|Overall Study||99
8588485|NCT00350298|21175420|P1|STARTED|Overall Study||101
8588508|NCT00313820|21175524|P2|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
8588509|NCT00313820|21175525|P1|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
8588510|NCT00313820|21175524|P2|COMPLETED|Pregabalin or Placebo Treatment Period||90
8588511|NCT00313820|21175525|P1|COMPLETED|Pregabalin or Placebo Treatment Period||93
8588512|NCT00313820|21175524|P2|STARTED|Pregabalin or Placebo Treatment Period||109
8588513|NCT00313820|21175525|P1|STARTED|Pregabalin or Placebo Treatment Period||110
8588514|NCT00313820|21175524|P2|NOT COMPLETED|Assigned to Treatment||0
8588515|NCT00313820|21175525|P1|NOT COMPLETED|Assigned to Treatment||1
8588516|NCT00313820|21175524|P2|COMPLETED|Assigned to Treatment||109
8588517|NCT00313820|21175525|P1|COMPLETED|Assigned to Treatment||110
8588518|NCT00313820|21175524|P2|STARTED|Assigned to Treatment||109
8588519|NCT00313820|21175525|P1|STARTED|Assigned to Treatment||111
8588529|NCT00292188|21175724|P3|NOT COMPLETED|Double-Blind||29
8588530|NCT00292188|21175725|P2|NOT COMPLETED|Double-Blind||31
8588531|NCT00292188|21175726|P1|NOT COMPLETED|Double-Blind||0
8588532|NCT00292188|21175724|P3|COMPLETED|Double-Blind||98
8588533|NCT00292188|21175725|P2|COMPLETED|Double-Blind||96
8588534|NCT00292188|21175726|P1|COMPLETED|Double-Blind||0
8588535|NCT00292188|21175724|P3|STARTED|Double-Blind||127
8588536|NCT00292188|21175725|P2|STARTED|Double-Blind||127
8588537|NCT00292188|21175726|P1|STARTED|Double-Blind||0
8588538|NCT00292188|21175724|P3|NOT COMPLETED|Single-Blind||0
8588539|NCT00292188|21175725|P2|NOT COMPLETED|Single-Blind||0
8588540|NCT00292188|21175726|P1|NOT COMPLETED|Single-Blind||114
8588541|NCT00292188|21175724|P3|COMPLETED|Single-Blind||0
8588542|NCT00292188|21175725|P2|COMPLETED|Single-Blind||0
8588543|NCT00292188|21175726|P1|COMPLETED|Single-Blind||254
8588544|NCT00292188|21175724|P3|Received Treatment|Single-Blind||0
8588545|NCT00292188|21175725|P2|Received Treatment|Single-Blind||0
8588546|NCT00292188|21175726|P1|Received Treatment|Single-Blind||367
8588547|NCT00292188|21175724|P3|STARTED|Single-Blind||0
8588548|NCT00292188|21175725|P2|STARTED|Single-Blind||0
8588549|NCT00292188|21175726|P1|STARTED|Single-Blind||368
8588562|NCT00232141|21175809|P2|NOT COMPLETED|Overall Study||26
8588563|NCT00232141|21175810|P1|NOT COMPLETED|Overall Study||31
8588564|NCT00232141|21175809|P2|COMPLETED|Overall Study||125
8588565|NCT00232141|21175810|P1|COMPLETED|Overall Study||120
8588566|NCT00232141|21175809|P2|STARTED|Overall Study||151
8588567|NCT00232141|21175810|P1|STARTED|Overall Study||151
8588610|NCT00148733|21176052|P2|NOT COMPLETED|Overall Study||15
8588611|NCT00148733|21176053|P1|NOT COMPLETED|Overall Study||14
8588612|NCT00148733|21176052|P2|COMPLETED|Overall Study||1299
8588613|NCT00148733|21176053|P1|COMPLETED|Overall Study||1300
8588614|NCT00148733|21176052|P2|STARTED|Overall Study||1314
8588615|NCT00148733|21176053|P1|STARTED|Overall Study||1314
8588616|NCT00141219|21176061|P2|NOT COMPLETED|Overall Study||16
8588617|NCT00141219|21176062|P1|NOT COMPLETED|Overall Study||24
8588618|NCT00141219|21176061|P2|COMPLETED|Overall Study||62
8588619|NCT00141219|21176062|P1|COMPLETED|Overall Study||138
8588620|NCT00141219|21176061|P2|STARTED|Overall Study||78
8588621|NCT00141219|21176062|P1|STARTED|Overall Study||162
8588631|NCT00115076|21176140|P1|NOT COMPLETED|Overall Study||0
8588632|NCT00115076|21176140|P1|COMPLETED|Overall Study||30
8588633|NCT00115076|21176140|P1|STARTED|Overall Study||30
8588715|NCT03616600|21176308|P2|NOT COMPLETED|Overall Study||0
8588716|NCT03616600|21176309|P1|NOT COMPLETED|Overall Study||1
8588717|NCT03616600|21176308|P2|COMPLETED|Overall Study||15
8588718|NCT03616600|21176309|P1|COMPLETED|Overall Study||15
8588719|NCT03616600|21176308|P2|STARTED|Overall Study||15
8588720|NCT03616600|21176309|P1|STARTED|Overall Study||16
8588754|NCT03363854|21176440|P8|NOT COMPLETED|Safety Follow-up Period||216
8588755|NCT03363854|21176441|P7|NOT COMPLETED|Safety Follow-up Period||0
8588756|NCT03363854|21176442|P6|NOT COMPLETED|Safety Follow-up Period||0
8588757|NCT03363854|21176443|P5|NOT COMPLETED|Safety Follow-up Period||0
8588758|NCT03363854|21176444|P4|NOT COMPLETED|Safety Follow-up Period||0
8588759|NCT03363854|21176445|P3|NOT COMPLETED|Safety Follow-up Period||0
8588760|NCT03363854|21176446|P2|NOT COMPLETED|Safety Follow-up Period||0
8588761|NCT03363854|21176447|P1|NOT COMPLETED|Safety Follow-up Period||0
8588762|NCT03363854|21176440|P8|COMPLETED|Safety Follow-up Period||62
8588763|NCT03363854|21176441|P7|COMPLETED|Safety Follow-up Period||0
8588764|NCT03363854|21176442|P6|COMPLETED|Safety Follow-up Period||0
8588765|NCT03363854|21176443|P5|COMPLETED|Safety Follow-up Period||0
8588766|NCT03363854|21176444|P4|COMPLETED|Safety Follow-up Period||0
8588767|NCT03363854|21176445|P3|COMPLETED|Safety Follow-up Period||0
8588768|NCT03363854|21176446|P2|COMPLETED|Safety Follow-up Period||0
8588769|NCT03363854|21176447|P1|COMPLETED|Safety Follow-up Period||0
8588770|NCT03363854|21176440|P8|STARTED|Safety Follow-up Period||278
8588771|NCT03363854|21176441|P7|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
8588772|NCT03363854|21176442|P6|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
8588773|NCT03363854|21176443|P5|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
8588774|NCT03363854|21176444|P4|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
8588775|NCT03363854|21176445|P3|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
8588776|NCT03363854|21176446|P2|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
8588777|NCT03363854|21176447|P1|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
8588778|NCT03363854|21176440|P8|NOT COMPLETED|Continuation Treatment Period||0
8588779|NCT03363854|21176441|P7|NOT COMPLETED|Continuation Treatment Period||3
8588780|NCT03363854|21176442|P6|NOT COMPLETED|Continuation Treatment Period||7
8588781|NCT03363854|21176443|P5|NOT COMPLETED|Continuation Treatment Period||8
8588782|NCT03363854|21176444|P4|NOT COMPLETED|Continuation Treatment Period||4
8588783|NCT03363854|21176445|P3|NOT COMPLETED|Continuation Treatment Period||1
8588784|NCT03363854|21176446|P2|NOT COMPLETED|Continuation Treatment Period||0
8588785|NCT03363854|21176447|P1|NOT COMPLETED|Continuation Treatment Period||0
8588786|NCT03363854|21176440|P8|COMPLETED|Continuation Treatment Period||0
8588787|NCT03363854|21176441|P7|COMPLETED|Continuation Treatment Period||38
8588788|NCT03363854|21176442|P6|COMPLETED|Continuation Treatment Period||72
8588789|NCT03363854|21176443|P5|COMPLETED|Continuation Treatment Period||87
8588790|NCT03363854|21176444|P4|COMPLETED|Continuation Treatment Period||65
8588791|NCT03363854|21176445|P3|COMPLETED|Continuation Treatment Period||68
8588792|NCT03363854|21176446|P2|COMPLETED|Continuation Treatment Period||0
8588793|NCT03363854|21176447|P1|COMPLETED|Continuation Treatment Period||0
8588794|NCT03363854|21176440|P8|STARTED|Continuation Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
8588795|NCT03363854|21176441|P7|STARTED|Continuation Treatment Period||41
8588796|NCT03363854|21176442|P6|STARTED|Continuation Treatment Period||79
8588797|NCT03363854|21176443|P5|STARTED|Continuation Treatment Period||95
8588798|NCT03363854|21176444|P4|STARTED|Continuation Treatment Period||69
8588799|NCT03363854|21176445|P3|STARTED|Continuation Treatment Period||69
8588800|NCT03363854|21176446|P2|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
8588801|NCT03363854|21176447|P1|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
8588802|NCT03363854|21176440|P8|NOT COMPLETED|Initial Treatment Period||0
8588803|NCT03363854|21176441|P7|NOT COMPLETED|Initial Treatment Period||0
8588804|NCT03363854|21176442|P6|NOT COMPLETED|Initial Treatment Period||0
8588805|NCT03363854|21176443|P5|NOT COMPLETED|Initial Treatment Period||0
8588806|NCT03363854|21176444|P4|NOT COMPLETED|Initial Treatment Period||0
8588807|NCT03363854|21176445|P3|NOT COMPLETED|Initial Treatment Period||0
8588808|NCT03363854|21176446|P2|NOT COMPLETED|Initial Treatment Period||7
8588809|NCT03363854|21176447|P1|NOT COMPLETED|Initial Treatment Period||18
8588810|NCT03363854|21176440|P8|COMPLETED|Initial Treatment Period||0
8588811|NCT03363854|21176441|P7|COMPLETED|Initial Treatment Period||0
8588812|NCT03363854|21176442|P6|COMPLETED|Initial Treatment Period||0
8588813|NCT03363854|21176443|P5|COMPLETED|Initial Treatment Period||0
8588814|NCT03363854|21176444|P4|COMPLETED|Initial Treatment Period||0
8588815|NCT03363854|21176445|P3|COMPLETED|Initial Treatment Period||0
8588816|NCT03363854|21176446|P2|COMPLETED|Initial Treatment Period||120
8588817|NCT03363854|21176447|P1|COMPLETED|Initial Treatment Period||235
8588818|NCT03363854|21176440|P8|STARTED|Initial Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
8588819|NCT03363854|21176441|P7|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
8588820|NCT03363854|21176442|P6|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
8588821|NCT03363854|21176443|P5|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
8588822|NCT03363854|21176444|P4|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
8588823|NCT03363854|21176445|P3|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
8588824|NCT03363854|21176446|P2|STARTED|Initial Treatment Period||127
8588825|NCT03363854|21176447|P1|STARTED|Initial Treatment Period||253
8588848|NCT03280121|21176549|P1|NOT COMPLETED|Overall Study||6
8588849|NCT03280121|21176549|P1|COMPLETED|Overall Study||8
8588850|NCT03280121|21176549|P1|STARTED|Overall Study||14
8588851|NCT03274466|21176557|P2|NOT COMPLETED|Overall Study||29
8588852|NCT03274466|21176558|P1|NOT COMPLETED|Overall Study||23
8588853|NCT03274466|21176557|P2|COMPLETED|Overall Study||118
8588854|NCT03274466|21176558|P1|COMPLETED|Overall Study||124
8588855|NCT03274466|21176557|P2|STARTED|Overall Study||147
8588856|NCT03274466|21176558|P1|STARTED|Overall Study||147
8588899|NCT03106844|21176706|P1|NOT COMPLETED|Overall Study||1
8588900|NCT03106844|21176706|P1|COMPLETED|Overall Study||49
8588901|NCT03106844|21176706|P1|STARTED|Overall Study||50
8588932|NCT03057496|21176784|P1|NOT COMPLETED|Overall Study||18
8588933|NCT03057496|21176784|P1|COMPLETED|Overall Study||31
8588934|NCT03057496|21176784|P1|Started Home-use Trial|Overall Study||36
8588935|NCT03057496|21176784|P1|STARTED|Overall Study||49
8588936|NCT02981524|21176792|P1|NOT COMPLETED|Overall Study||17
8588937|NCT02981524|21176792|P1|COMPLETED|Overall Study||0
8588938|NCT02981524|21176792|P1|STARTED|Overall Study||17
8588939|NCT02980666|21176802|P2|NOT COMPLETED|Overall Study||0
8588940|NCT02980666|21176803|P1|NOT COMPLETED|Overall Study||0
8588941|NCT02980666|21176802|P2|COMPLETED|Overall Study||2
8588942|NCT02980666|21176803|P1|COMPLETED|Overall Study||8
8588943|NCT02980666|21176802|P2|STARTED|Overall Study||2
8588944|NCT02980666|21176803|P1|STARTED|Overall Study||8
8588945|NCT02949219|21176895|P1|NOT COMPLETED|Overall Study||1
8588946|NCT02949219|21176895|P1|COMPLETED|Overall Study||40
8588947|NCT02949219|21176895|P1|STARTED|Overall Study||41
8588948|NCT02940574|21176904|P2|NOT COMPLETED|1-year Follow-up||4
8588949|NCT02940574|21176905|P1|NOT COMPLETED|1-year Follow-up||3
8588950|NCT02940574|21176904|P2|COMPLETED|1-year Follow-up||14
8588951|NCT02940574|21176905|P1|COMPLETED|1-year Follow-up||18
8588952|NCT02940574|21176904|P2|STARTED|1-year Follow-up||18
8588953|NCT02940574|21176905|P1|STARTED|1-year Follow-up||21
8588954|NCT02940574|21176904|P2|NOT COMPLETED|From Study Start to 1-month Follow-up||0
8588955|NCT02940574|21176905|P1|NOT COMPLETED|From Study Start to 1-month Follow-up||1
8588956|NCT02940574|21176904|P2|COMPLETED|From Study Start to 1-month Follow-up|All participants completed, but data from 1 participant was not included in analyses.|18
8588957|NCT02940574|21176905|P1|COMPLETED|From Study Start to 1-month Follow-up|Discontinued intervention (N=1): self-termination unrelated to treatment|21
8588958|NCT02940574|21176904|P2|STARTED|From Study Start to 1-month Follow-up||18
8588959|NCT02940574|21176905|P1|STARTED|From Study Start to 1-month Follow-up||22
8589013|NCT02758899|21177072|P2|NOT COMPLETED|Overall Study||1
8589014|NCT02758899|21177073|P1|NOT COMPLETED|Overall Study||2
8589015|NCT02758899|21177072|P2|COMPLETED|Overall Study||9
8589016|NCT02758899|21177073|P1|COMPLETED|Overall Study||9
8589017|NCT02758899|21177072|P2|STARTED|Overall Study||10
8589018|NCT02758899|21177073|P1|STARTED|Overall Study||11
8589337|NCT02369874|21177853|P3|NOT COMPLETED|Overall Study||61
8589338|NCT02369874|21177854|P2|NOT COMPLETED|Overall Study||57
8589339|NCT02369874|21177855|P1|NOT COMPLETED|Overall Study||44
8589340|NCT02369874|21177853|P3|COMPLETED|Overall Study||188
8589341|NCT02369874|21177854|P2|COMPLETED|Overall Study||183
8589342|NCT02369874|21177855|P1|COMPLETED|Overall Study||203
8589343|NCT02369874|21177853|P3|Received Treatment|Overall Study||240
8589344|NCT02369874|21177854|P2|Received Treatment|Overall Study||237
8589345|NCT02369874|21177855|P1|Received Treatment|Overall Study||246
8589346|NCT02369874|21177853|P3|STARTED|Overall Study||249
8589347|NCT02369874|21177854|P2|STARTED|Overall Study||240
8589348|NCT02369874|21177855|P1|STARTED|Overall Study||247
8589349|NCT02326363|21177904|P2|NOT COMPLETED|Overall Study||56
8589350|NCT02326363|21177905|P1|NOT COMPLETED|Overall Study||51
8589351|NCT02326363|21177904|P2|COMPLETED|Overall Study||50
8589352|NCT02326363|21177905|P1|COMPLETED|Overall Study||47
8589353|NCT02326363|21177904|P2|STARTED|Overall Study||106
8589354|NCT02326363|21177905|P1|STARTED|Overall Study||98
8589396|NCT02232061|21178078|P1|NOT COMPLETED|Overall Study||2
8589397|NCT02232061|21178078|P1|COMPLETED|Overall Study||4
8589398|NCT02232061|21178078|P1|STARTED|Overall Study||6
8589465|NCT02152345|21178215|P2|NOT COMPLETED|Overall Study||5
8589466|NCT02152345|21178216|P1|NOT COMPLETED|Overall Study||4
8589467|NCT02152345|21178215|P2|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24
8589468|NCT02152345|21178216|P1|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24
8589469|NCT02152345|21178215|P2|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29
8589470|NCT02152345|21178216|P1|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28
8589564|NCT01887600|21178450|P2|NOT COMPLETED|Overall Study||114
8589565|NCT01887600|21178451|P1|NOT COMPLETED|Overall Study||146
8589566|NCT01887600|21178450|P2|COMPLETED|Overall Study||89
8589567|NCT01887600|21178451|P1|COMPLETED|Overall Study||245
8589568|NCT01887600|21178450|P2|Treatment Received|Overall Study||203
8589569|NCT01887600|21178451|P1|Treatment Received|Overall Study||391
8589570|NCT01887600|21178450|P2|STARTED|Overall Study||203
8589571|NCT01887600|21178451|P1|STARTED|Overall Study||391
8589605|NCT01804816|21178676|P1|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1
8589606|NCT01804816|21178676|P1|COMPLETED|Acupuncture (Second 5 Weeks)||10
8589607|NCT01804816|21178676|P1|STARTED|Acupuncture (Second 5 Weeks)||11
8589608|NCT01804816|21178676|P1|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3
8589609|NCT01804816|21178676|P1|COMPLETED|No Acupuncture (Initial 5 Weeks)||11
8589610|NCT01804816|21178676|P1|STARTED|No Acupuncture (Initial 5 Weeks)||14
8589611|NCT01784588|21178690|P2|NOT COMPLETED|Overall Study||32
8589612|NCT01784588|21178691|P1|NOT COMPLETED|Overall Study||37
8589613|NCT01784588|21178690|P2|COMPLETED|Overall Study||108
8589614|NCT01784588|21178691|P1|COMPLETED|Overall Study||104
8589615|NCT01784588|21178690|P2|STARTED|Overall Study||140
8589616|NCT01784588|21178691|P1|STARTED|Overall Study||141
8589673|NCT01671423|21178790|P2|NOT COMPLETED|Overall Study||11
8589674|NCT01671423|21178791|P1|NOT COMPLETED|Overall Study||6
8589675|NCT01671423|21178790|P2|COMPLETED|Overall Study||9
8589676|NCT01671423|21178791|P1|COMPLETED|Overall Study||14
8589677|NCT01671423|21178790|P2|STARTED|Overall Study||20
8589678|NCT01671423|21178791|P1|STARTED|Overall Study||20
8589788|NCT01297959|21179096|P2|NOT COMPLETED|Overall Study||16
8589789|NCT01297959|21179097|P1|NOT COMPLETED|Overall Study||20
8589790|NCT01297959|21179096|P2|COMPLETED|Overall Study||226
8589791|NCT01297959|21179097|P1|COMPLETED|Overall Study||241
8589792|NCT01297959|21179096|P2|STARTED|Overall Study||242
8589793|NCT01297959|21179097|P1|STARTED|Overall Study||261
8589851|NCT01165177|21179351|P2|NOT COMPLETED|Overall Study||902
8589852|NCT01165177|21179352|P1|NOT COMPLETED|Overall Study||922
8589853|NCT01165177|21179351|P2|COMPLETED|Overall Study||6808
8589854|NCT01165177|21179352|P1|COMPLETED|Overall Study||6773
8589855|NCT01165177|21179351|P2|STARTED|Overall Study||7710
8589856|NCT01165177|21179352|P1|STARTED|Overall Study||7695
8590596|NCT00928564|21179684|P2|NOT COMPLETED|Overall Study||0
8590597|NCT00928564|21179685|P1|NOT COMPLETED|Overall Study||6
8590598|NCT00928564|21179684|P2|COMPLETED|Overall Study||12
8590599|NCT00928564|21179685|P1|COMPLETED|Overall Study||22
8590600|NCT00928564|21179684|P2|STARTED|Overall Study||12
8590601|NCT00928564|21179685|P1|STARTED|Overall Study||28
8590608|NCT00843284|21179704|P1|NOT COMPLETED|Overall Study||72
8590609|NCT00843284|21179704|P1|COMPLETED|Overall Study||619
8590610|NCT00843284|21179704|P1|STARTED|Overall Study||691
8590632|NCT00684424|21179750|P1|NOT COMPLETED|Overall Study||5
8590633|NCT00684424|21179750|P1|COMPLETED|Overall Study||194
8590634|NCT00684424|21179750|P1|STARTED|Overall Study||199
8590635|NCT00676403|21179771|P6|NOT COMPLETED|Overall Study||5
8590636|NCT00676403|21179772|P5|NOT COMPLETED|Overall Study||1
8590637|NCT00676403|21179773|P4|NOT COMPLETED|Overall Study||5
8590638|NCT00676403|21179774|P3|NOT COMPLETED|Overall Study||1
8590639|NCT00676403|21179775|P2|NOT COMPLETED|Overall Study||2
8590640|NCT00676403|21179776|P1|NOT COMPLETED|Overall Study||2
8590641|NCT00676403|21179771|P6|COMPLETED|Overall Study||18
8590642|NCT00676403|21179772|P5|COMPLETED|Overall Study||23
8590643|NCT00676403|21179773|P4|COMPLETED|Overall Study||17
8590644|NCT00676403|21179774|P3|COMPLETED|Overall Study||22
8590645|NCT00676403|21179775|P2|COMPLETED|Overall Study||20
8590646|NCT00676403|21179776|P1|COMPLETED|Overall Study||21
8590647|NCT00676403|21179771|P6|STARTED|Overall Study||23
8590648|NCT00676403|21179772|P5|STARTED|Overall Study||24
8590649|NCT00676403|21179773|P4|STARTED|Overall Study||22
8590650|NCT00676403|21179774|P3|STARTED|Overall Study||23
8590651|NCT00676403|21179775|P2|STARTED|Overall Study||22
8590652|NCT00676403|21179776|P1|STARTED|Overall Study||23
8590690|NCT00546455|21179952|P2|NOT COMPLETED|Overall Study||0
8590691|NCT00546455|21179953|P1|NOT COMPLETED|Overall Study||0
8590692|NCT00546455|21179952|P2|COMPLETED|Overall Study||0
8590693|NCT00546455|21179953|P1|COMPLETED|Overall Study||0
8590694|NCT00546455|21179952|P2|STARTED|Overall Study||0
8590695|NCT00546455|21179953|P1|STARTED|Overall Study||0
8590702|NCT00468845|21179983|P3|NOT COMPLETED|Overall Study||30
8590703|NCT00468845|21179984|P2|NOT COMPLETED|Overall Study||34
8590704|NCT00468845|21179985|P1|NOT COMPLETED|Overall Study||21
8590705|NCT00468845|21179983|P3|COMPLETED|Overall Study||139
8590706|NCT00468845|21179984|P2|COMPLETED|Overall Study||136
8590707|NCT00468845|21179985|P1|COMPLETED|Overall Study||141
8590708|NCT00468845|21179983|P3|Received Treatment|Overall Study||167
8590709|NCT00468845|21179984|P2|Received Treatment|Overall Study||166
8590710|NCT00468845|21179985|P1|Received Treatment|Overall Study||161
8590711|NCT00468845|21179983|P3|STARTED|Overall Study||169
8590712|NCT00468845|21179984|P2|STARTED|Overall Study||170
8590713|NCT00468845|21179985|P1|STARTED|Overall Study||162
8590780|NCT00413010|21180481|P2|NOT COMPLETED|Overall Study||63
8590781|NCT00413010|21180482|P1|NOT COMPLETED|Overall Study||72
8590782|NCT00413010|21180481|P2|COMPLETED|Overall Study||113
8590783|NCT00413010|21180482|P1|COMPLETED|Overall Study||108
8590784|NCT00413010|21180481|P2|STARTED|Overall Study||176
8590785|NCT00413010|21180482|P1|STARTED|Overall Study||180
8590828|NCT00318591|21180698|P2|NOT COMPLETED|Overall Study||45
8590829|NCT00318591|21180699|P1|NOT COMPLETED|Overall Study||60
8590830|NCT00318591|21180698|P2|COMPLETED|Overall Study||69
8590831|NCT00318591|21180699|P1|COMPLETED|Overall Study||45
8590832|NCT00318591|21180698|P2|STARTED|Overall Study||114
8590833|NCT00318591|21180699|P1|STARTED|Overall Study||105
8590900|NCT00119106|21181079|P2|NOT COMPLETED|Overall Study||178
8590901|NCT00119106|21181080|P1|NOT COMPLETED|Overall Study||179
8590902|NCT00119106|21181079|P2|COMPLETED|Overall Study||1031
8590903|NCT00119106|21181080|P1|COMPLETED|Overall Study||1025
8590904|NCT00119106|21181079|P2|STARTED|Overall Study|2 participants later found to be HIV infected at baseline. Therefore 1207 in mITT analysis|1209
8590905|NCT00119106|21181080|P1|STARTED|Overall Study||1204
8592717|NCT04438785|21184383|P2|NOT COMPLETED|Overall Study||10
8592718|NCT04438785|21184384|P1|NOT COMPLETED|Overall Study||2
8592719|NCT04438785|21184383|P2|COMPLETED|Overall Study||10
8592720|NCT04438785|21184384|P1|COMPLETED|Overall Study||18
8592721|NCT04438785|21184383|P2|STARTED|Overall Study||20
8592722|NCT04438785|21184384|P1|STARTED|Overall Study||20
8592760|NCT04060654|21184495|P1|NOT COMPLETED|Overall Study||6
8592761|NCT04060654|21184495|P1|COMPLETED|Overall Study||11
8592762|NCT04060654|21184495|P1|STARTED|Overall Study||17
8592763|NCT03970395|21184501|P2|NOT COMPLETED|Overall Study||12
8592764|NCT03970395|21184502|P1|NOT COMPLETED|Overall Study||7
8592765|NCT03970395|21184501|P2|COMPLETED|Overall Study||36
8592766|NCT03970395|21184502|P1|COMPLETED|Overall Study||41
8592767|NCT03970395|21184501|P2|STARTED|Overall Study||48
8592768|NCT03970395|21184502|P1|STARTED|Overall Study||48
8592772|NCT03926208|21184526|P2|NOT COMPLETED|Overall Study||0
8592773|NCT03926208|21184527|P1|NOT COMPLETED|Overall Study||0
8592774|NCT03926208|21184526|P2|COMPLETED|Overall Study||123
8592775|NCT03926208|21184527|P1|COMPLETED|Overall Study||119
8592776|NCT03926208|21184526|P2|STARTED|Overall Study||123
8592777|NCT03926208|21184527|P1|STARTED|Overall Study||119
8592784|NCT03836677|21184545|P2|NOT COMPLETED|Period 2||0
8592785|NCT03836677|21184546|P1|NOT COMPLETED|Period 2||1
8592786|NCT03836677|21184545|P2|COMPLETED|Period 2||9
8592787|NCT03836677|21184546|P1|COMPLETED|Period 2||12
8592788|NCT03836677|21184545|P2|STARTED|Period 2||9
8592789|NCT03836677|21184546|P1|STARTED|Period 2||13
8592790|NCT03836677|21184545|P2|NOT COMPLETED|Washout||0
8592791|NCT03836677|21184546|P1|NOT COMPLETED|Washout||0
8592792|NCT03836677|21184545|P2|COMPLETED|Washout||9
8592793|NCT03836677|21184546|P1|COMPLETED|Washout||13
8592794|NCT03836677|21184545|P2|STARTED|Washout||9
8592795|NCT03836677|21184546|P1|STARTED|Washout||13
8592796|NCT03836677|21184545|P2|NOT COMPLETED|Period 1||1
8592797|NCT03836677|21184546|P1|NOT COMPLETED|Period 1||0
8592798|NCT03836677|21184545|P2|COMPLETED|Period 1||9
8592799|NCT03836677|21184546|P1|COMPLETED|Period 1||13
8592800|NCT03836677|21184545|P2|STARTED|Period 1||10
8592801|NCT03836677|21184546|P1|STARTED|Period 1||13
8592802|NCT03736928|21184567|P5|NOT COMPLETED|Overall Study||11
8592803|NCT03736928|21184568|P4|NOT COMPLETED|Overall Study||5
8592804|NCT03736928|21184569|P3|NOT COMPLETED|Overall Study||5
8592805|NCT03736928|21184570|P2|NOT COMPLETED|Overall Study||2
8592806|NCT03736928|21184571|P1|NOT COMPLETED|Overall Study||7
8592807|NCT03736928|21184567|P5|COMPLETED|Overall Study||67
8592808|NCT03736928|21184568|P4|COMPLETED|Overall Study||76
8592809|NCT03736928|21184569|P3|COMPLETED|Overall Study||75
8592810|NCT03736928|21184570|P2|COMPLETED|Overall Study||78
8592811|NCT03736928|21184571|P1|COMPLETED|Overall Study||73
8592812|NCT03736928|21184567|P5|STARTED|Overall Study||78
8592813|NCT03736928|21184568|P4|STARTED|Overall Study||81
8592814|NCT03736928|21184569|P3|STARTED|Overall Study||80
8592815|NCT03736928|21184570|P2|STARTED|Overall Study||80
8592816|NCT03736928|21184571|P1|STARTED|Overall Study||80
8592817|NCT03693742|21184585|P2|NOT COMPLETED|Overall Study||0
8592818|NCT03693742|21184586|P1|NOT COMPLETED|Overall Study||0
8592819|NCT03693742|21184585|P2|COMPLETED|Overall Study||3
8592820|NCT03693742|21184586|P1|COMPLETED|Overall Study||7
8592821|NCT03693742|21184585|P2|STARTED|Overall Study||3
8592822|NCT03693742|21184586|P1|STARTED|Overall Study||7
8592835|NCT03522948|21184630|P1|NOT COMPLETED|Overall Study||1
8592836|NCT03522948|21184630|P1|COMPLETED|Overall Study||7
8592837|NCT03522948|21184630|P1|STARTED|Overall Study||8
8592850|NCT03450083|21184678|P2|NOT COMPLETED|Overall Study||0
8592851|NCT03450083|21184679|P1|NOT COMPLETED|Overall Study||0
8592852|NCT03450083|21184678|P2|COMPLETED|Overall Study||12
8592853|NCT03450083|21184679|P1|COMPLETED|Overall Study||12
8592854|NCT03450083|21184678|P2|STARTED|Overall Study||12
8592855|NCT03450083|21184679|P1|STARTED|Overall Study||12
8592856|NCT03376061|21184701|P2|NOT COMPLETED|Overall Study||0
8592857|NCT03376061|21184702|P1|NOT COMPLETED|Overall Study||0
8592858|NCT03376061|21184701|P2|COMPLETED|Overall Study||48
8592859|NCT03376061|21184702|P1|COMPLETED|Overall Study||49
8592860|NCT03376061|21184701|P2|STARTED|Overall Study||48
8592861|NCT03376061|21184702|P1|STARTED|Overall Study||49
8592865|NCT03312218|21184729|P2|NOT COMPLETED|Overall Study||58
8592866|NCT03312218|21184730|P1|NOT COMPLETED|Overall Study||54
8592867|NCT03312218|21184729|P2|COMPLETED|Overall Study||241
8592868|NCT03312218|21184730|P1|COMPLETED|Overall Study||281
8592869|NCT03312218|21184729|P2|STARTED|Overall Study||299
8592870|NCT03312218|21184730|P1|STARTED|Overall Study||335
8592871|NCT03293485|21184736|P1|NOT COMPLETED|Overall Study||5
8592872|NCT03293485|21184736|P1|COMPLETED|Overall Study||78
8592873|NCT03293485|21184736|P1|Treated|Overall Study||81
8592874|NCT03293485|21184736|P1|STARTED|Overall Study||83
8592881|NCT03248037|21184770|P2|NOT COMPLETED|Overall Study||9
8592882|NCT03248037|21184771|P1|NOT COMPLETED|Overall Study||21
8592883|NCT03248037|21184770|P2|COMPLETED|Overall Study||87
8592884|NCT03248037|21184771|P1|COMPLETED|Overall Study||74
8592885|NCT03248037|21184770|P2|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|96
8592886|NCT03248037|21184771|P1|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|95
8592887|NCT03126370|21184777|P1|NOT COMPLETED|TAF With a Boosted PI||0
8592888|NCT03126370|21184777|P1|COMPLETED|TAF With a Boosted PI||10
8592889|NCT03126370|21184777|P1|STARTED|TAF With a Boosted PI||10
8592890|NCT03126370|21184777|P1|NOT COMPLETED|TAF With a Boosted PI and LDV/SOF||0
8592891|NCT03126370|21184777|P1|COMPLETED|TAF With a Boosted PI and LDV/SOF||10
8592892|NCT03126370|21184777|P1|STARTED|TAF With a Boosted PI and LDV/SOF||10
8592893|NCT03126370|21184777|P1|NOT COMPLETED|TAF With a Boosted PI||0
8592894|NCT03126370|21184777|P1|COMPLETED|TAF With a Boosted PI||10
8592895|NCT03126370|21184777|P1|STARTED|TAF With a Boosted PI||10
8592896|NCT03126370|21184777|P1|NOT COMPLETED|TDF With a Boosted PI||0
8592897|NCT03126370|21184777|P1|COMPLETED|TDF With a Boosted PI||10
8592898|NCT03126370|21184777|P1|STARTED|TDF With a Boosted PI||10
8592905|NCT03102645|21184850|P2|NOT COMPLETED|Overall Study||0
8592906|NCT03102645|21184851|P1|NOT COMPLETED|Overall Study||0
8592907|NCT03102645|21184850|P2|COMPLETED|Overall Study||8
8592908|NCT03102645|21184851|P1|COMPLETED|Overall Study||8
8592909|NCT03102645|21184850|P2|STARTED|Overall Study||8
8592910|NCT03102645|21184851|P1|STARTED|Overall Study||8
8592911|NCT03093662|21184861|P2|NOT COMPLETED|Second Intervention (3 Minutes)||0
8592912|NCT03093662|21184862|P1|NOT COMPLETED|Second Intervention (3 Minutes)||0
8592913|NCT03093662|21184861|P2|COMPLETED|Second Intervention (3 Minutes)||19
8592914|NCT03093662|21184862|P1|COMPLETED|Second Intervention (3 Minutes)||18
8592915|NCT03093662|21184861|P2|STARTED|Second Intervention (3 Minutes)||19
8592916|NCT03093662|21184862|P1|STARTED|Second Intervention (3 Minutes)||18
8592917|NCT03093662|21184861|P2|NOT COMPLETED|Washout Period (5 Minutes)||0
8592918|NCT03093662|21184862|P1|NOT COMPLETED|Washout Period (5 Minutes)||0
8592919|NCT03093662|21184861|P2|COMPLETED|Washout Period (5 Minutes)||19
8592920|NCT03093662|21184862|P1|COMPLETED|Washout Period (5 Minutes)||18
8592921|NCT03093662|21184861|P2|STARTED|Washout Period (5 Minutes)||19
8592922|NCT03093662|21184862|P1|STARTED|Washout Period (5 Minutes)||18
8592923|NCT03093662|21184861|P2|NOT COMPLETED|First Intervention (3 Minutes)||0
8592924|NCT03093662|21184862|P1|NOT COMPLETED|First Intervention (3 Minutes)||0
8592925|NCT03093662|21184861|P2|COMPLETED|First Intervention (3 Minutes)||19
8592926|NCT03093662|21184862|P1|COMPLETED|First Intervention (3 Minutes)||18
8592927|NCT03093662|21184861|P2|STARTED|First Intervention (3 Minutes)||19
8592928|NCT03093662|21184862|P1|STARTED|First Intervention (3 Minutes)||18
8592929|NCT03072160|21184870|P2|NOT COMPLETED|Overall Study||4
8592930|NCT03072160|21184871|P1|NOT COMPLETED|Overall Study||11
8592931|NCT03072160|21184870|P2|COMPLETED|Overall Study||0
8592932|NCT03072160|21184871|P1|COMPLETED|Overall Study||2
8592933|NCT03072160|21184870|P2|STARTED|Overall Study||4
8592934|NCT03072160|21184871|P1|STARTED|Overall Study||13
8592941|NCT02933372|21184942|P2|NOT COMPLETED|Overall Study||0
8592942|NCT02933372|21184943|P1|NOT COMPLETED|Overall Study||0
8592943|NCT02933372|21184942|P2|COMPLETED|Overall Study||10
8592944|NCT02933372|21184943|P1|COMPLETED|Overall Study||15
8592945|NCT02933372|21184942|P2|STARTED|Overall Study||10
8592946|NCT02933372|21184943|P1|STARTED|Overall Study||15
8592947|NCT02930226|21184955|P6|NOT COMPLETED|Overall Study||0
8592948|NCT02930226|21184956|P5|NOT COMPLETED|Overall Study||1
8592949|NCT02930226|21184957|P4|NOT COMPLETED|Overall Study||0
8592950|NCT02930226|21184958|P3|NOT COMPLETED|Overall Study||0
8592951|NCT02930226|21184959|P2|NOT COMPLETED|Overall Study||0
8592952|NCT02930226|21184960|P1|NOT COMPLETED|Overall Study||0
8592953|NCT02930226|21184955|P6|COMPLETED|Overall Study||4
8592954|NCT02930226|21184956|P5|COMPLETED|Overall Study||3
8592955|NCT02930226|21184957|P4|COMPLETED|Overall Study||4
8592956|NCT02930226|21184958|P3|COMPLETED|Overall Study||4
8592957|NCT02930226|21184959|P2|COMPLETED|Overall Study||4
8592958|NCT02930226|21184960|P1|COMPLETED|Overall Study||4
8592959|NCT02930226|21184955|P6|STARTED|Overall Study||4
8592960|NCT02930226|21184956|P5|STARTED|Overall Study||4
8592961|NCT02930226|21184957|P4|STARTED|Overall Study||4
8592962|NCT02930226|21184958|P3|STARTED|Overall Study||4
8592963|NCT02930226|21184959|P2|STARTED|Overall Study||4
8592964|NCT02930226|21184960|P1|STARTED|Overall Study||4
8592965|NCT02929979|21184996|P2|NOT COMPLETED|Overall Study||10
8592966|NCT02929979|21184997|P1|NOT COMPLETED|Overall Study||27
8592967|NCT02929979|21184996|P2|COMPLETED|Overall Study||28
8592968|NCT02929979|21184997|P1|COMPLETED|Overall Study||25
8592969|NCT02929979|21184996|P2|STARTED|Overall Study||38
8592970|NCT02929979|21184997|P1|STARTED|Overall Study||52
8592983|NCT02832284|21185042|P1|NOT COMPLETED|Overall Study||0
8592984|NCT02832284|21185042|P1|COMPLETED|Overall Study||23
8592985|NCT02832284|21185042|P1|STARTED|Overall Study||23
8592986|NCT02737332|21185052|P2|NOT COMPLETED|Overall Study||1
8592987|NCT02737332|21185053|P1|NOT COMPLETED|Overall Study||1
8592988|NCT02737332|21185052|P2|COMPLETED|Overall Study||23
8592989|NCT02737332|21185053|P1|COMPLETED|Overall Study||28
8592990|NCT02737332|21185052|P2|STARTED|Overall Study||24
8592991|NCT02737332|21185053|P1|STARTED|Overall Study||29
8593069|NCT02616146|21185275|P2|NOT COMPLETED|Overall Study||504
8593070|NCT02616146|21185276|P1|NOT COMPLETED|Overall Study||1512
8593071|NCT02616146|21185275|P2|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0
8593072|NCT02616146|21185276|P1|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0
8593073|NCT02616146|21185275|P2|STARTED|Overall Study||504
8593074|NCT02616146|21185276|P1|STARTED|Overall Study||1512
8593081|NCT02547987|21185303|P1|NOT COMPLETED|Overall Study||3
8593082|NCT02547987|21185303|P1|COMPLETED|Overall Study||22
8593083|NCT02547987|21185303|P1|STARTED|Overall Study||25
8593084|NCT02505425|21185311|P4|NOT COMPLETED|Overall Study||26
8593085|NCT02505425|21185312|P3|NOT COMPLETED|Overall Study||50
8593086|NCT02505425|21185313|P2|NOT COMPLETED|Overall Study||82
8593087|NCT02505425|21185314|P1|NOT COMPLETED|Overall Study||88
8593088|NCT02505425|21185311|P4|COMPLETED|Overall Study||50
8593089|NCT02505425|21185312|P3|COMPLETED|Overall Study||32
8593090|NCT02505425|21185313|P2|COMPLETED|Overall Study||125
8593091|NCT02505425|21185314|P1|COMPLETED|Overall Study||120
8593092|NCT02505425|21185311|P4|STARTED|Overall Study||76
8593093|NCT02505425|21185312|P3|STARTED|Overall Study||82
8593094|NCT02505425|21185313|P2|STARTED|Overall Study||207
8593095|NCT02505425|21185314|P1|STARTED|Overall Study||208
8593128|NCT02460991|21185515|P2|NOT COMPLETED|Overall Study||2
8593129|NCT02460991|21185516|P1|NOT COMPLETED|Overall Study||0
8593130|NCT02460991|21185515|P2|COMPLETED|Overall Study||0
8593131|NCT02460991|21185516|P1|COMPLETED|Overall Study||0
8593132|NCT02460991|21185515|P2|STARTED|Overall Study||2
8593133|NCT02460991|21185516|P1|STARTED|Overall Study||0
8593134|NCT02458092|21185532|P2|NOT COMPLETED|Overall Study||0
8593135|NCT02458092|21185533|P1|NOT COMPLETED|Overall Study||1
8593136|NCT02458092|21185532|P2|COMPLETED|Overall Study||10
8593137|NCT02458092|21185533|P1|COMPLETED|Overall Study||19
8593138|NCT02458092|21185532|P2|STARTED|Overall Study||10
8593139|NCT02458092|21185533|P1|STARTED|Overall Study||20
8593140|NCT02445963|21185549|P4|NOT COMPLETED|Overall Study||0
8593141|NCT02445963|21185550|P3|NOT COMPLETED|Overall Study||1
8593142|NCT02445963|21185551|P2|NOT COMPLETED|Overall Study||0
8593143|NCT02445963|21185552|P1|NOT COMPLETED|Overall Study||2
8593144|NCT02445963|21185549|P4|COMPLETED|Overall Study||10
8593145|NCT02445963|21185550|P3|COMPLETED|Overall Study||9
8593146|NCT02445963|21185551|P2|COMPLETED|Overall Study||9
8593147|NCT02445963|21185552|P1|COMPLETED|Overall Study||7
8593148|NCT02445963|21185549|P4|STARTED|Overall Study||10
8593149|NCT02445963|21185550|P3|STARTED|Overall Study||10
8593150|NCT02445963|21185551|P2|STARTED|Overall Study||9
8593151|NCT02445963|21185552|P1|STARTED|Overall Study||9
8593158|NCT02397460|21185601|P8|NOT COMPLETED|Treatment Period 4||0
8593159|NCT02397460|21185602|P7|NOT COMPLETED|Treatment Period 4||0
8593160|NCT02397460|21185603|P6|NOT COMPLETED|Treatment Period 4||0
8593161|NCT02397460|21185604|P5|NOT COMPLETED|Treatment Period 4||1
8593162|NCT02397460|21185605|P4|NOT COMPLETED|Treatment Period 4||0
8593163|NCT02397460|21185606|P3|NOT COMPLETED|Treatment Period 4||0
8593164|NCT02397460|21185607|P2|NOT COMPLETED|Treatment Period 4||1
8593165|NCT02397460|21185608|P1|NOT COMPLETED|Treatment Period 4||0
8593166|NCT02397460|21185601|P8|COMPLETED|Treatment Period 4||5
8593167|NCT02397460|21185602|P7|COMPLETED|Treatment Period 4||6
8593168|NCT02397460|21185603|P6|COMPLETED|Treatment Period 4||6
8593169|NCT02397460|21185604|P5|COMPLETED|Treatment Period 4||5
8593170|NCT02397460|21185605|P4|COMPLETED|Treatment Period 4||6
8593171|NCT02397460|21185606|P3|COMPLETED|Treatment Period 4||6
8593172|NCT02397460|21185607|P2|COMPLETED|Treatment Period 4||6
8593173|NCT02397460|21185608|P1|COMPLETED|Treatment Period 4||7
8593174|NCT02397460|21185601|P8|STARTED|Treatment Period 4||5
8593175|NCT02397460|21185602|P7|STARTED|Treatment Period 4||6
8593176|NCT02397460|21185603|P6|STARTED|Treatment Period 4||6
8593177|NCT02397460|21185604|P5|STARTED|Treatment Period 4||6
8593178|NCT02397460|21185605|P4|STARTED|Treatment Period 4||6
8593179|NCT02397460|21185606|P3|STARTED|Treatment Period 4||6
8593180|NCT02397460|21185607|P2|STARTED|Treatment Period 4||7
8593181|NCT02397460|21185608|P1|STARTED|Treatment Period 4||7
8593182|NCT02397460|21185601|P8|NOT COMPLETED|Treatment Period 3||0
8593183|NCT02397460|21185602|P7|NOT COMPLETED|Treatment Period 3||0
8593184|NCT02397460|21185603|P6|NOT COMPLETED|Treatment Period 3||0
8593185|NCT02397460|21185604|P5|NOT COMPLETED|Treatment Period 3||0
8593186|NCT02397460|21185605|P4|NOT COMPLETED|Treatment Period 3||0
8593187|NCT02397460|21185606|P3|NOT COMPLETED|Treatment Period 3||0
8593188|NCT02397460|21185607|P2|NOT COMPLETED|Treatment Period 3||0
8593189|NCT02397460|21185608|P1|NOT COMPLETED|Treatment Period 3||0
8593190|NCT02397460|21185601|P8|COMPLETED|Treatment Period 3||5
8593191|NCT02397460|21185602|P7|COMPLETED|Treatment Period 3||6
8593192|NCT02397460|21185603|P6|COMPLETED|Treatment Period 3||6
8593193|NCT02397460|21185604|P5|COMPLETED|Treatment Period 3||6
8593194|NCT02397460|21185605|P4|COMPLETED|Treatment Period 3||6
8593195|NCT02397460|21185606|P3|COMPLETED|Treatment Period 3||6
8593196|NCT02397460|21185607|P2|COMPLETED|Treatment Period 3||7
8593197|NCT02397460|21185608|P1|COMPLETED|Treatment Period 3||7
8593198|NCT02397460|21185601|P8|STARTED|Treatment Period 3||5
8593199|NCT02397460|21185602|P7|STARTED|Treatment Period 3||6
8593200|NCT02397460|21185603|P6|STARTED|Treatment Period 3||6
8593201|NCT02397460|21185604|P5|STARTED|Treatment Period 3||6
8593202|NCT02397460|21185605|P4|STARTED|Treatment Period 3||6
8593203|NCT02397460|21185606|P3|STARTED|Treatment Period 3||6
8593204|NCT02397460|21185607|P2|STARTED|Treatment Period 3||7
8593205|NCT02397460|21185608|P1|STARTED|Treatment Period 3||7
8593206|NCT02397460|21185601|P8|NOT COMPLETED|Treatment Period 2||1
8593207|NCT02397460|21185602|P7|NOT COMPLETED|Treatment Period 2||0
8593208|NCT02397460|21185603|P6|NOT COMPLETED|Treatment Period 2||0
8593209|NCT02397460|21185604|P5|NOT COMPLETED|Treatment Period 2||0
8593210|NCT02397460|21185605|P4|NOT COMPLETED|Treatment Period 2||0
8593211|NCT02397460|21185606|P3|NOT COMPLETED|Treatment Period 2||0
8593212|NCT02397460|21185607|P2|NOT COMPLETED|Treatment Period 2||0
8593213|NCT02397460|21185608|P1|NOT COMPLETED|Treatment Period 2||0
8593214|NCT02397460|21185601|P8|COMPLETED|Treatment Period 2||5
8593215|NCT02397460|21185602|P7|COMPLETED|Treatment Period 2||6
8593216|NCT02397460|21185603|P6|COMPLETED|Treatment Period 2||6
8593217|NCT02397460|21185604|P5|COMPLETED|Treatment Period 2||6
8593218|NCT02397460|21185605|P4|COMPLETED|Treatment Period 2||6
8593219|NCT02397460|21185606|P3|COMPLETED|Treatment Period 2||6
8593220|NCT02397460|21185607|P2|COMPLETED|Treatment Period 2||7
8593221|NCT02397460|21185608|P1|COMPLETED|Treatment Period 2||7
8593222|NCT02397460|21185601|P8|STARTED|Treatment Period 2||6
8593223|NCT02397460|21185602|P7|STARTED|Treatment Period 2||6
8593224|NCT02397460|21185603|P6|STARTED|Treatment Period 2||6
8593225|NCT02397460|21185604|P5|STARTED|Treatment Period 2||6
8593226|NCT02397460|21185605|P4|STARTED|Treatment Period 2||6
8593227|NCT02397460|21185606|P3|STARTED|Treatment Period 2||6
8593228|NCT02397460|21185607|P2|STARTED|Treatment Period 2||7
8593229|NCT02397460|21185608|P1|STARTED|Treatment Period 2||7
8593230|NCT02397460|21185601|P8|NOT COMPLETED|Treatment Period 1||0
8593231|NCT02397460|21185602|P7|NOT COMPLETED|Treatment Period 1||0
8593232|NCT02397460|21185603|P6|NOT COMPLETED|Treatment Period 1||0
8593233|NCT02397460|21185604|P5|NOT COMPLETED|Treatment Period 1||0
8593234|NCT02397460|21185605|P4|NOT COMPLETED|Treatment Period 1||0
8593235|NCT02397460|21185606|P3|NOT COMPLETED|Treatment Period 1||0
8593236|NCT02397460|21185607|P2|NOT COMPLETED|Treatment Period 1||0
8593237|NCT02397460|21185608|P1|NOT COMPLETED|Treatment Period 1||0
8593238|NCT02397460|21185601|P8|COMPLETED|Treatment Period 1||6
8593239|NCT02397460|21185602|P7|COMPLETED|Treatment Period 1||6
8593240|NCT02397460|21185603|P6|COMPLETED|Treatment Period 1||6
8593241|NCT02397460|21185604|P5|COMPLETED|Treatment Period 1||6
8593242|NCT02397460|21185605|P4|COMPLETED|Treatment Period 1||6
8593243|NCT02397460|21185606|P3|COMPLETED|Treatment Period 1||6
8593244|NCT02397460|21185607|P2|COMPLETED|Treatment Period 1||7
8593245|NCT02397460|21185608|P1|COMPLETED|Treatment Period 1||7
8593246|NCT02397460|21185601|P8|STARTED|Treatment Period 1||6
8593247|NCT02397460|21185602|P7|STARTED|Treatment Period 1||6
8593248|NCT02397460|21185603|P6|STARTED|Treatment Period 1||6
8593249|NCT02397460|21185604|P5|STARTED|Treatment Period 1||6
8593250|NCT02397460|21185605|P4|STARTED|Treatment Period 1||6
8593251|NCT02397460|21185606|P3|STARTED|Treatment Period 1||6
8593252|NCT02397460|21185607|P2|STARTED|Treatment Period 1||7
8593253|NCT02397460|21185608|P1|STARTED|Treatment Period 1||7
8593254|NCT02392351|21185728|P2|NOT COMPLETED|Overall Study||17
8593255|NCT02392351|21185729|P1|NOT COMPLETED|Overall Study||34
8593256|NCT02392351|21185728|P2|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
8593257|NCT02392351|21185729|P1|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
8593258|NCT02392351|21185728|P2|STARTED|Overall Study||17
8593259|NCT02392351|21185729|P1|STARTED|Overall Study||34
8593266|NCT02385318|21185793|P3|NOT COMPLETED|Overall Study||6
8593267|NCT02385318|21185794|P2|NOT COMPLETED|Overall Study||7
8593268|NCT02385318|21185795|P1|NOT COMPLETED|Overall Study||4
8593269|NCT02385318|21185793|P3|COMPLETED|Overall Study||99
8593270|NCT02385318|21185794|P2|COMPLETED|Overall Study||203
8593271|NCT02385318|21185795|P1|COMPLETED|Overall Study||200
8593272|NCT02385318|21185793|P3|STARTED|Overall Study||105
8593273|NCT02385318|21185794|P2|STARTED|Overall Study||210
8593274|NCT02385318|21185795|P1|STARTED|Overall Study||204
8593275|NCT02372383|21185805|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8593276|NCT02372383|21185806|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8593277|NCT02372383|21185807|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8593278|NCT02372383|21185805|P3|COMPLETED|Second Intervention (1 Day)||10
8593279|NCT02372383|21185806|P2|COMPLETED|Second Intervention (1 Day)||10
8593280|NCT02372383|21185807|P1|COMPLETED|Second Intervention (1 Day)||10
8593281|NCT02372383|21185805|P3|STARTED|Second Intervention (1 Day)||10
8593282|NCT02372383|21185806|P2|STARTED|Second Intervention (1 Day)||10
8593283|NCT02372383|21185807|P1|STARTED|Second Intervention (1 Day)||10
8593284|NCT02372383|21185805|P3|NOT COMPLETED|Washout (14 Days)||0
8593285|NCT02372383|21185806|P2|NOT COMPLETED|Washout (14 Days)||0
8593286|NCT02372383|21185807|P1|NOT COMPLETED|Washout (14 Days)||0
8593287|NCT02372383|21185805|P3|COMPLETED|Washout (14 Days)||10
8593288|NCT02372383|21185806|P2|COMPLETED|Washout (14 Days)||10
8593289|NCT02372383|21185807|P1|COMPLETED|Washout (14 Days)||10
8593290|NCT02372383|21185805|P3|STARTED|Washout (14 Days)||10
8593291|NCT02372383|21185806|P2|STARTED|Washout (14 Days)||10
8593292|NCT02372383|21185807|P1|STARTED|Washout (14 Days)||10
8593293|NCT02372383|21185805|P3|NOT COMPLETED|First Intervention (1 Day)||0
8593294|NCT02372383|21185806|P2|NOT COMPLETED|First Intervention (1 Day)||1
8593295|NCT02372383|21185807|P1|NOT COMPLETED|First Intervention (1 Day)||0
8593296|NCT02372383|21185805|P3|COMPLETED|First Intervention (1 Day)||10
8593297|NCT02372383|21185806|P2|COMPLETED|First Intervention (1 Day)||10
8593298|NCT02372383|21185807|P1|COMPLETED|First Intervention (1 Day)||10
8593299|NCT02372383|21185805|P3|STARTED|First Intervention (1 Day)||10
8593300|NCT02372383|21185806|P2|STARTED|First Intervention (1 Day)||11
8593301|NCT02372383|21185807|P1|STARTED|First Intervention (1 Day)||10
8593317|NCT02314000|21185885|P2|NOT COMPLETED|Overall Study||8
8593318|NCT02314000|21185886|P1|NOT COMPLETED|Overall Study||13
8593319|NCT02314000|21185885|P2|COMPLETED|Overall Study||57
8593320|NCT02314000|21185886|P1|COMPLETED|Overall Study||62
8593321|NCT02314000|21185885|P2|STARTED|Overall Study||65
8593322|NCT02314000|21185886|P1|STARTED|Overall Study||75
8593323|NCT02304367|21185893|P1|NOT COMPLETED|Overall Study||17
8593324|NCT02304367|21185893|P1|COMPLETED|Overall Study||0
8593325|NCT02304367|21185893|P1|Completed 144 Weeks of Study Drug|Overall Study||11
8593326|NCT02304367|21185893|P1|Completed 48 Weeks of Study Drug|Overall Study||16
8593327|NCT02304367|21185893|P1|STARTED|Overall Study||17
8593355|NCT02226159|21186026|P2|NOT COMPLETED|Overall Study||6
8593356|NCT02226159|21186027|P1|NOT COMPLETED|Overall Study||6
8593357|NCT02226159|21186026|P2|COMPLETED|Overall Study||26
8593358|NCT02226159|21186027|P1|COMPLETED|Overall Study||27
8593359|NCT02226159|21186026|P2|STARTED|Overall Study||32
8593360|NCT02226159|21186027|P1|STARTED|Overall Study||33
8593361|NCT02195921|21186061|P4|NOT COMPLETED|Overall Study||0
8593362|NCT02195921|21186062|P3|NOT COMPLETED|Overall Study||1
8593363|NCT02195921|21186063|P2|NOT COMPLETED|Overall Study||1
8593364|NCT02195921|21186064|P1|NOT COMPLETED|Overall Study||1
8593365|NCT02195921|21186061|P4|COMPLETED|Overall Study||40
8593366|NCT02195921|21186062|P3|COMPLETED|Overall Study||39
8593367|NCT02195921|21186063|P2|COMPLETED|Overall Study||39
8593368|NCT02195921|21186064|P1|COMPLETED|Overall Study||39
8593369|NCT02195921|21186061|P4|STARTED|Overall Study||40
8593370|NCT02195921|21186062|P3|STARTED|Overall Study||40
8593371|NCT02195921|21186063|P2|STARTED|Overall Study||40
8593372|NCT02195921|21186064|P1|STARTED|Overall Study||40
8593415|NCT02116205|21186155|P4|NOT COMPLETED|Overall Study||6
8593416|NCT02116205|21186156|P3|NOT COMPLETED|Overall Study||4
8593417|NCT02116205|21186157|P2|NOT COMPLETED|Overall Study||7
8593418|NCT02116205|21186158|P1|NOT COMPLETED|Overall Study||2
8593419|NCT02116205|21186155|P4|COMPLETED|Overall Study||27
8593420|NCT02116205|21186156|P3|COMPLETED|Overall Study||29
8593421|NCT02116205|21186157|P2|COMPLETED|Overall Study||26
8593422|NCT02116205|21186158|P1|COMPLETED|Overall Study||29
8593423|NCT02116205|21186155|P4|STARTED|Overall Study||33
8593424|NCT02116205|21186156|P3|STARTED|Overall Study||33
8593425|NCT02116205|21186157|P2|STARTED|Overall Study||33
8593426|NCT02116205|21186158|P1|STARTED|Overall Study||31
8593439|NCT02063724|21186217|P1|NOT COMPLETED|Overall Study||1
8593440|NCT02063724|21186217|P1|COMPLETED|Overall Study||14
8593441|NCT02063724|21186217|P1|STARTED|Overall Study||15
8593442|NCT02047734|21186226|P3|NOT COMPLETED|Overall Study||46
8593443|NCT02047734|21186227|P2|NOT COMPLETED|Overall Study||69
8593444|NCT02047734|21186228|P1|NOT COMPLETED|Overall Study||67
8593445|NCT02047734|21186226|P3|COMPLETED|Overall Study||388
8593446|NCT02047734|21186227|P2|COMPLETED|Overall Study||374
8593447|NCT02047734|21186228|P1|COMPLETED|Overall Study||376
8593448|NCT02047734|21186226|P3|Received Treatment|Overall Study||433
8593449|NCT02047734|21186227|P2|Received Treatment|Overall Study|One participant received ozanimod 1.0 mg in error|439
8593450|NCT02047734|21186228|P1|Received Treatment|Overall Study|One participant received ozanimod 0.5 mg in error|441
8593451|NCT02047734|21186226|P3|STARTED|Overall Study||434
8593452|NCT02047734|21186227|P2|STARTED|Overall Study||443
8593453|NCT02047734|21186228|P1|STARTED|Overall Study||443
8593508|NCT01908634|21186734|P1|NOT COMPLETED|Water-based Strawberry Beverage w/o Meal||0
8593509|NCT01908634|21186734|P1|COMPLETED|Water-based Strawberry Beverage w/o Meal||4
8593510|NCT01908634|21186734|P1|STARTED|Water-based Strawberry Beverage w/o Meal||4
8593511|NCT01908634|21186734|P1|NOT COMPLETED|Milk-based Strawberry Beverage w/o Meal||5
8593512|NCT01908634|21186734|P1|COMPLETED|Milk-based Strawberry Beverage w/o Meal||4
8593513|NCT01908634|21186734|P1|STARTED|Milk-based Strawberry Beverage w/o Meal||9
8593514|NCT01908634|21186734|P1|NOT COMPLETED|Water-based Strawberry Beverage Wit Meal||1
8593515|NCT01908634|21186734|P1|COMPLETED|Water-based Strawberry Beverage Wit Meal||9
8593516|NCT01908634|21186734|P1|STARTED|Water-based Strawberry Beverage Wit Meal||10
8593517|NCT01908634|21186734|P1|NOT COMPLETED|Milk-based Strawberry Beverage With Meal||0
8593518|NCT01908634|21186734|P1|COMPLETED|Milk-based Strawberry Beverage With Meal||10
8593519|NCT01908634|21186734|P1|STARTED|Milk-based Strawberry Beverage With Meal||10
8593520|NCT01899300|21186742|P2|NOT COMPLETED|Overall Study||0
8593521|NCT01899300|21186743|P1|NOT COMPLETED|Overall Study||0
8593522|NCT01899300|21186742|P2|COMPLETED|Overall Study||0
8593523|NCT01899300|21186743|P1|COMPLETED|Overall Study||1
8593524|NCT01899300|21186742|P2|STARTED|Overall Study||0
8593525|NCT01899300|21186743|P1|STARTED|Overall Study||1
8593526|NCT01886378|21186759|P1|NOT COMPLETED|Overall Study||5
8593527|NCT01886378|21186759|P1|COMPLETED|Overall Study||24
8593528|NCT01886378|21186759|P1|Completed 24 Weeks of UX007 Treatment|Overall Study||25
8593529|NCT01886378|21186759|P1|STARTED|Overall Study||29
8593544|NCT01835158|21186822|P2|NOT COMPLETED|Overall Study||6
8593545|NCT01835158|21186823|P1|NOT COMPLETED|Overall Study||1
8593546|NCT01835158|21186822|P2|COMPLETED|Overall Study||72
8593547|NCT01835158|21186823|P1|COMPLETED|Overall Study||78
8593548|NCT01835158|21186822|P2|STARTED|Overall Study||78
8593549|NCT01835158|21186823|P1|STARTED|Overall Study||79
8593550|NCT01822353|21186836|P3|NOT COMPLETED|Overall Study||1
8593551|NCT01822353|21186837|P2|NOT COMPLETED|Overall Study||5
8593552|NCT01822353|21186838|P1|NOT COMPLETED|Overall Study||4
8593553|NCT01822353|21186836|P3|COMPLETED|Overall Study||3
8593554|NCT01822353|21186837|P2|COMPLETED|Overall Study||4
8593555|NCT01822353|21186838|P1|COMPLETED|Overall Study||6
8593556|NCT01822353|21186836|P3|STARTED|Overall Study||4
8593557|NCT01822353|21186837|P2|STARTED|Overall Study||9
8593558|NCT01822353|21186838|P1|STARTED|Overall Study||10
8593580|NCT01767792|21186909|P1|NOT COMPLETED|Overall Study||2
8593581|NCT01767792|21186909|P1|COMPLETED|Overall Study||20
8593582|NCT01767792|21186909|P1|STARTED|Overall Study||22
8593589|NCT01709084|21186930|P2|NOT COMPLETED|Overall Study||15
8593590|NCT01709084|21186931|P1|NOT COMPLETED|Overall Study||16
8593591|NCT01709084|21186930|P2|COMPLETED|Overall Study||198
8593592|NCT01709084|21186931|P1|COMPLETED|Overall Study||197
8593593|NCT01709084|21186930|P2|Treated|Overall Study||211
8593594|NCT01709084|21186931|P1|Treated|Overall Study||213
8593595|NCT01709084|21186930|P2|STARTED|Overall Study||213
8593596|NCT01709084|21186931|P1|STARTED|Overall Study||213
8593597|NCT01685320|21186949|P2|NOT COMPLETED|Overall Study||0
8593598|NCT01685320|21186950|P1|NOT COMPLETED|Overall Study||0
8593599|NCT01685320|21186949|P2|COMPLETED|Overall Study||15
8593600|NCT01685320|21186950|P1|COMPLETED|Overall Study||15
8593601|NCT01685320|21186949|P2|STARTED|Overall Study||15
8593602|NCT01685320|21186950|P1|STARTED|Overall Study||15
8593603|NCT01644565|21186958|P9|NOT COMPLETED|Overall Study||1
8593604|NCT01644565|21186959|P8|NOT COMPLETED|Overall Study||2
8593605|NCT01644565|21186960|P7|NOT COMPLETED|Overall Study||0
8593606|NCT01644565|21186961|P6|NOT COMPLETED|Overall Study||0
8593607|NCT01644565|21186962|P5|NOT COMPLETED|Overall Study||1
8593608|NCT01644565|21186963|P4|NOT COMPLETED|Overall Study||1
8593609|NCT01644565|21186964|P3|NOT COMPLETED|Overall Study||0
8593610|NCT01644565|21186965|P2|NOT COMPLETED|Overall Study||0
8593611|NCT01644565|21186966|P1|NOT COMPLETED|Overall Study||1
8593612|NCT01644565|21186958|P9|COMPLETED|Overall Study||7
8593613|NCT01644565|21186959|P8|COMPLETED|Overall Study||8
8593614|NCT01644565|21186960|P7|COMPLETED|Overall Study||7
8593615|NCT01644565|21186961|P6|COMPLETED|Overall Study||7
8593616|NCT01644565|21186962|P5|COMPLETED|Overall Study||4
8593617|NCT01644565|21186963|P4|COMPLETED|Overall Study||4
8593618|NCT01644565|21186964|P3|COMPLETED|Overall Study||5
8593619|NCT01644565|21186965|P2|COMPLETED|Overall Study||5
8593620|NCT01644565|21186966|P1|COMPLETED|Overall Study||4
8593621|NCT01644565|21186958|P9|STARTED|Overall Study||8
8593622|NCT01644565|21186959|P8|STARTED|Overall Study||10
8593623|NCT01644565|21186960|P7|STARTED|Overall Study||7
8593624|NCT01644565|21186961|P6|STARTED|Overall Study||7
8593625|NCT01644565|21186962|P5|STARTED|Overall Study||5
8593626|NCT01644565|21186963|P4|STARTED|Overall Study||5
8593627|NCT01644565|21186964|P3|STARTED|Overall Study||5
8593628|NCT01644565|21186965|P2|STARTED|Overall Study||5
8593629|NCT01644565|21186966|P1|STARTED|Overall Study||5
8593630|NCT01628393|21187007|P5|NOT COMPLETED|Blinded Active Extension Period||6
8593631|NCT01628393|21187008|P4|NOT COMPLETED|Blinded Active Extension Period||4
8593632|NCT01628393|21187009|P3|NOT COMPLETED|Blinded Active Extension Period||6
8593633|NCT01628393|21187010|P2|NOT COMPLETED|Blinded Active Extension Period||10
8593634|NCT01628393|21187011|P1|NOT COMPLETED|Blinded Active Extension Period||0
8593635|NCT01628393|21187007|P5|COMPLETED|Blinded Active Extension Period||36
8593636|NCT01628393|21187008|P4|COMPLETED|Blinded Active Extension Period||37
8593637|NCT01628393|21187009|P3|COMPLETED|Blinded Active Extension Period||75
8593638|NCT01628393|21187010|P2|COMPLETED|Blinded Active Extension Period||75
8593639|NCT01628393|21187011|P1|COMPLETED|Blinded Active Extension Period||0
8593640|NCT01628393|21187007|P5|STARTED|Blinded Active Extension Period||42
8593641|NCT01628393|21187008|P4|STARTED|Blinded Active Extension Period||41
8593642|NCT01628393|21187009|P3|STARTED|Blinded Active Extension Period||81
8593643|NCT01628393|21187010|P2|STARTED|Blinded Active Extension Period||85
8593644|NCT01628393|21187011|P1|STARTED|Blinded Active Extension Period||0
8593645|NCT01628393|21187007|P5|NOT COMPLETED|Placebo-controlled Treatment Period||0
8593646|NCT01628393|21187008|P4|NOT COMPLETED|Placebo-controlled Treatment Period||0
8593647|NCT01628393|21187009|P3|NOT COMPLETED|Placebo-controlled Treatment Period||1
8593648|NCT01628393|21187010|P2|NOT COMPLETED|Placebo-controlled Treatment Period||2
8593649|NCT01628393|21187011|P1|NOT COMPLETED|Placebo-controlled Treatment Period||3
8593650|NCT01628393|21187007|P5|COMPLETED|Placebo-controlled Treatment Period||0
8593651|NCT01628393|21187008|P4|COMPLETED|Placebo-controlled Treatment Period||0
8593652|NCT01628393|21187009|P3|COMPLETED|Placebo-controlled Treatment Period||82
8593653|NCT01628393|21187010|P2|COMPLETED|Placebo-controlled Treatment Period||85
8593654|NCT01628393|21187011|P1|COMPLETED|Placebo-controlled Treatment Period||85
8593655|NCT01628393|21187007|P5|STARTED|Placebo-controlled Treatment Period||0
8593656|NCT01628393|21187008|P4|STARTED|Placebo-controlled Treatment Period||0
8593657|NCT01628393|21187009|P3|STARTED|Placebo-controlled Treatment Period||83
8593658|NCT01628393|21187010|P2|STARTED|Placebo-controlled Treatment Period||87
8593659|NCT01628393|21187011|P1|STARTED|Placebo-controlled Treatment Period||88
8593672|NCT01536795|21187081|P2|NOT COMPLETED|Overall Study||2
8593673|NCT01536795|21187082|P1|NOT COMPLETED|Overall Study||1
8593674|NCT01536795|21187081|P2|COMPLETED|Overall Study||22
8593675|NCT01536795|21187082|P1|COMPLETED|Overall Study||23
8593676|NCT01536795|21187081|P2|STARTED|Overall Study||24
8593677|NCT01536795|21187082|P1|STARTED|Overall Study||24
8593687|NCT01501955|21187111|P2|NOT COMPLETED|Overall Study||3
8593688|NCT01501955|21187112|P1|NOT COMPLETED|Overall Study||2
8593689|NCT01501955|21187111|P2|COMPLETED|Overall Study||6
8593690|NCT01501955|21187112|P1|COMPLETED|Overall Study||9
8593691|NCT01501955|21187111|P2|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
8593692|NCT01501955|21187112|P1|2 Years Postop|Overall Study||9
8593693|NCT01501955|21187111|P2|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
8593694|NCT01501955|21187112|P1|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
8593695|NCT01501955|21187111|P2|6 Weeks Postop|Overall Study||9
8593696|NCT01501955|21187112|P1|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
8593697|NCT01501955|21187111|P2|Surgery|Overall Study||9
8593698|NCT01501955|21187112|P1|Surgery|Overall Study||11
8593699|NCT01501955|21187111|P2|STARTED|Overall Study||9
8593700|NCT01501955|21187112|P1|STARTED|Overall Study||11
8593701|NCT01422304|21187156|P2|NOT COMPLETED|Overall Study||37
8593702|NCT01422304|21187157|P1|NOT COMPLETED|Overall Study||24
8593703|NCT01422304|21187156|P2|COMPLETED|Overall Study||563
8593704|NCT01422304|21187157|P1|COMPLETED|Overall Study||574
8593705|NCT01422304|21187156|P2|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
8593706|NCT01422304|21187157|P1|Treated|Overall Study||595
8593707|NCT01422304|21187156|P2|STARTED|Overall Study|Randomized|600
8593708|NCT01422304|21187157|P1|STARTED|Overall Study|Randomized|598
8593709|NCT01383018|21187187|P1|NOT COMPLETED|Overall Study||375
8593710|NCT01383018|21187187|P1|COMPLETED|Overall Study||1082
8593711|NCT01383018|21187187|P1|STARTED|Overall Study||1457
8593718|NCT01321151|21187242|P2|NOT COMPLETED|Overall Study||0
8593719|NCT01321151|21187243|P1|NOT COMPLETED|Overall Study||0
8593720|NCT01321151|21187242|P2|COMPLETED|Overall Study||6
8593721|NCT01321151|21187243|P1|COMPLETED|Overall Study||6
8593722|NCT01321151|21187242|P2|STARTED|Overall Study|The boxer was treated with once-a-day for 30 days.|6
8593723|NCT01321151|21187243|P1|STARTED|Overall Study|The boxer was treated once-a-day for 30 days.|6
8593730|NCT01272284|21187280|P1|NOT COMPLETED|12-month Follow-up Visit||4
8593731|NCT01272284|21187280|P1|COMPLETED|12-month Follow-up Visit||105
8593732|NCT01272284|21187280|P1|STARTED|12-month Follow-up Visit||109
8593733|NCT01272284|21187280|P1|NOT COMPLETED|6-month Follow-up Visit||3
8593734|NCT01272284|21187280|P1|COMPLETED|6-month Follow-up Visit||109
8593735|NCT01272284|21187280|P1|STARTED|6-month Follow-up Visit||112
8593736|NCT01272284|21187280|P1|NOT COMPLETED|3-month Follow-up Visit||1
8593737|NCT01272284|21187280|P1|COMPLETED|3-month Follow-up Visit||112
8593738|NCT01272284|21187280|P1|STARTED|3-month Follow-up Visit||113
8593739|NCT01250912|21187294|P1|NOT COMPLETED|Overall Study||1
8593740|NCT01250912|21187294|P1|COMPLETED|Overall Study||19
8593741|NCT01250912|21187294|P1|STARTED|Overall Study||20
8593742|NCT01199848|21187301|P1|NOT COMPLETED|40G STRB Arm||0
8593743|NCT01199848|21187301|P1|COMPLETED|40G STRB Arm||21
8593744|NCT01199848|21187301|P1|STARTED|40G STRB Arm||21
8593745|NCT01199848|21187301|P1|NOT COMPLETED|20G STRB Arm||0
8593746|NCT01199848|21187301|P1|COMPLETED|20G STRB Arm||21
8593747|NCT01199848|21187301|P1|STARTED|20G STRB Arm||21
8593748|NCT01199848|21187301|P1|NOT COMPLETED|10g STR Arm||0
8593749|NCT01199848|21187301|P1|COMPLETED|10g STR Arm||21
8593750|NCT01199848|21187301|P1|STARTED|10g STR Arm||21
8593751|NCT01199848|21187301|P1|NOT COMPLETED|Placebo Arm||8
8593752|NCT01199848|21187301|P1|COMPLETED|Placebo Arm||21
8593753|NCT01199848|21187301|P1|STARTED|Placebo Arm||29
8593754|NCT01169259|21187319|P4|NOT COMPLETED|Overall Study||0
8593755|NCT01169259|21187320|P3|NOT COMPLETED|Overall Study||0
8593756|NCT01169259|21187321|P2|NOT COMPLETED|Overall Study||0
8593757|NCT01169259|21187322|P1|NOT COMPLETED|Overall Study||0
8593758|NCT01169259|21187319|P4|COMPLETED|Overall Study||6474
8593759|NCT01169259|21187320|P3|COMPLETED|Overall Study||6470
8593760|NCT01169259|21187321|P2|COMPLETED|Overall Study||6464
8593761|NCT01169259|21187322|P1|COMPLETED|Overall Study||6463
8593762|NCT01169259|21187319|P4|STARTED|Overall Study||6474
8593763|NCT01169259|21187320|P3|STARTED|Overall Study||6470
8593764|NCT01169259|21187321|P2|STARTED|Overall Study||6464
8593765|NCT01169259|21187322|P1|STARTED|Overall Study||6463
8594396|NCT01052493|21187486|P3|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
8594397|NCT01052493|21187487|P2|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
8594398|NCT01052493|21187488|P1|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
8594399|NCT01052493|21187486|P3|COMPLETED|Intervention 3 (up to 10 Days)||4
8594400|NCT01052493|21187487|P2|COMPLETED|Intervention 3 (up to 10 Days)||4
8594401|NCT01052493|21187488|P1|COMPLETED|Intervention 3 (up to 10 Days)||4
8594402|NCT01052493|21187486|P3|STARTED|Intervention 3 (up to 10 Days)||4
8594403|NCT01052493|21187487|P2|STARTED|Intervention 3 (up to 10 Days)||4
8594404|NCT01052493|21187488|P1|STARTED|Intervention 3 (up to 10 Days)||4
8594405|NCT01052493|21187486|P3|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
8594406|NCT01052493|21187487|P2|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
8594407|NCT01052493|21187488|P1|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
8594408|NCT01052493|21187486|P3|COMPLETED|Washout Period 2 (up to 5 Days)||4
8594409|NCT01052493|21187487|P2|COMPLETED|Washout Period 2 (up to 5 Days)||4
8594410|NCT01052493|21187488|P1|COMPLETED|Washout Period 2 (up to 5 Days)||4
8594411|NCT01052493|21187486|P3|STARTED|Washout Period 2 (up to 5 Days)||4
8594412|NCT01052493|21187487|P2|STARTED|Washout Period 2 (up to 5 Days)||4
8594413|NCT01052493|21187488|P1|STARTED|Washout Period 2 (up to 5 Days)||4
8594414|NCT01052493|21187486|P3|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
8594415|NCT01052493|21187487|P2|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
8594416|NCT01052493|21187488|P1|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
8594417|NCT01052493|21187486|P3|COMPLETED|Intervention 2 (up to 10 Days)||4
8594418|NCT01052493|21187487|P2|COMPLETED|Intervention 2 (up to 10 Days)||4
8594419|NCT01052493|21187488|P1|COMPLETED|Intervention 2 (up to 10 Days)||4
8594420|NCT01052493|21187486|P3|STARTED|Intervention 2 (up to 10 Days)||4
8594421|NCT01052493|21187487|P2|STARTED|Intervention 2 (up to 10 Days)||4
8594422|NCT01052493|21187488|P1|STARTED|Intervention 2 (up to 10 Days)|Replacement subject recruited|4
8594423|NCT01052493|21187486|P3|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
8594424|NCT01052493|21187487|P2|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
8594425|NCT01052493|21187488|P1|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
8594426|NCT01052493|21187486|P3|COMPLETED|Washout Period 1 (up to 5 Days)||4
8594427|NCT01052493|21187487|P2|COMPLETED|Washout Period 1 (up to 5 Days)||4
8594428|NCT01052493|21187488|P1|COMPLETED|Washout Period 1 (up to 5 Days)||3
8594429|NCT01052493|21187486|P3|STARTED|Washout Period 1 (up to 5 Days)||4
8594430|NCT01052493|21187487|P2|STARTED|Washout Period 1 (up to 5 Days)||4
8594431|NCT01052493|21187488|P1|STARTED|Washout Period 1 (up to 5 Days)||3
8594432|NCT01052493|21187486|P3|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
8594433|NCT01052493|21187487|P2|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
8594434|NCT01052493|21187488|P1|NOT COMPLETED|Intervention 1 (Up to 10 Days)||1
8594435|NCT01052493|21187486|P3|COMPLETED|Intervention 1 (Up to 10 Days)||4
8594436|NCT01052493|21187487|P2|COMPLETED|Intervention 1 (Up to 10 Days)||4
8594437|NCT01052493|21187488|P1|COMPLETED|Intervention 1 (Up to 10 Days)||3
8594438|NCT01052493|21187486|P3|STARTED|Intervention 1 (Up to 10 Days)||4
8594439|NCT01052493|21187487|P2|STARTED|Intervention 1 (Up to 10 Days)||4
8594440|NCT01052493|21187488|P1|STARTED|Intervention 1 (Up to 10 Days)||4
8594441|NCT01015131|21187513|P1|NOT COMPLETED|Overall Study||8
8594442|NCT01015131|21187513|P1|COMPLETED|Overall Study||36
8594443|NCT01015131|21187513|P1|STARTED|Overall Study||44
8594534|NCT00979732|21187638|P2|NOT COMPLETED|Overall Study||1
8594535|NCT00979732|21187639|P1|NOT COMPLETED|Overall Study||3
8594536|NCT00979732|21187638|P2|COMPLETED|Overall Study||17
8594537|NCT00979732|21187639|P1|COMPLETED|Overall Study||12
8594538|NCT00979732|21187638|P2|STARTED|Overall Study||18
8594539|NCT00979732|21187639|P1|STARTED|Overall Study||15
8594540|NCT00948675|21187649|P2|NOT COMPLETED|Overall Study||4
8594541|NCT00948675|21187650|P1|NOT COMPLETED|Overall Study||7
8594542|NCT00948675|21187649|P2|COMPLETED|Overall Study||175
8594543|NCT00948675|21187650|P1|COMPLETED|Overall Study||175
8594544|NCT00948675|21187649|P2|STARTED|Overall Study||179
8594545|NCT00948675|21187650|P1|STARTED|Overall Study||182
8594582|NCT00813124|21187712|P1|NOT COMPLETED|Overall Study||12
8594583|NCT00813124|21187712|P1|COMPLETED|Overall Study||12
8594584|NCT00813124|21187712|P1|STARTED|Overall Study||24
8594597|NCT00790478|21187741|P2|NOT COMPLETED|Overall Study||0
8594598|NCT00790478|21187742|P1|NOT COMPLETED|Overall Study||0
8594599|NCT00790478|21187741|P2|COMPLETED|Overall Study||0
8594600|NCT00790478|21187742|P1|COMPLETED|Overall Study||0
8594601|NCT00790478|21187741|P2|STARTED|Overall Study||0
8594602|NCT00790478|21187742|P1|STARTED|Overall Study||0
8594603|NCT00662012|21187750|P1|NOT COMPLETED|Overall Study||87
8594604|NCT00662012|21187750|P1|COMPLETED|Overall Study||327
8594605|NCT00662012|21187750|P1|STARTED|Overall Study||414
8594636|NCT00437281|21187823|P20|NOT COMPLETED|Overall Study||1
8594637|NCT00437281|21187824|P19|NOT COMPLETED|Overall Study||1
8594638|NCT00437281|21187825|P18|NOT COMPLETED|Overall Study||0
8594639|NCT00437281|21187826|P17|NOT COMPLETED|Overall Study||0
8594640|NCT00437281|21187827|P16|NOT COMPLETED|Overall Study||0
8594641|NCT00437281|21187828|P15|NOT COMPLETED|Overall Study||1
8594642|NCT00437281|21187829|P14|NOT COMPLETED|Overall Study||1
8594643|NCT00437281|21187830|P13|NOT COMPLETED|Overall Study||0
8594644|NCT00437281|21187831|P12|NOT COMPLETED|Overall Study||0
8594645|NCT00437281|21187832|P11|NOT COMPLETED|Overall Study||0
8594646|NCT00437281|21187833|P10|NOT COMPLETED|Overall Study||1
8594647|NCT00437281|21187834|P9|NOT COMPLETED|Overall Study||0
8594648|NCT00437281|21187835|P8|NOT COMPLETED|Overall Study||0
8594649|NCT00437281|21187836|P7|NOT COMPLETED|Overall Study||0
8594650|NCT00437281|21187837|P6|NOT COMPLETED|Overall Study||1
8594651|NCT00437281|21187838|P5|NOT COMPLETED|Overall Study||0
8594652|NCT00437281|21187839|P4|NOT COMPLETED|Overall Study||1
8594653|NCT00437281|21187840|P3|NOT COMPLETED|Overall Study||0
8594654|NCT00437281|21187841|P2|NOT COMPLETED|Overall Study||0
8594655|NCT00437281|21187842|P1|NOT COMPLETED|Overall Study||0
8594656|NCT00437281|21187823|P20|COMPLETED|Overall Study||2
8594657|NCT00437281|21187824|P19|COMPLETED|Overall Study||1
8594658|NCT00437281|21187825|P18|COMPLETED|Overall Study||4
8594659|NCT00437281|21187826|P17|COMPLETED|Overall Study||3
8594660|NCT00437281|21187827|P16|COMPLETED|Overall Study||3
8594661|NCT00437281|21187828|P15|COMPLETED|Overall Study||4
8594662|NCT00437281|21187829|P14|COMPLETED|Overall Study||2
8594663|NCT00437281|21187830|P13|COMPLETED|Overall Study||2
8594664|NCT00437281|21187831|P12|COMPLETED|Overall Study||3
8594665|NCT00437281|21187832|P11|COMPLETED|Overall Study||3
8594666|NCT00437281|21187833|P10|COMPLETED|Overall Study||4
8594667|NCT00437281|21187834|P9|COMPLETED|Overall Study||3
8594668|NCT00437281|21187835|P8|COMPLETED|Overall Study||3
8594669|NCT00437281|21187836|P7|COMPLETED|Overall Study||3
8594670|NCT00437281|21187837|P6|COMPLETED|Overall Study||3
8594671|NCT00437281|21187838|P5|COMPLETED|Overall Study||4
8594672|NCT00437281|21187839|P4|COMPLETED|Overall Study||2
8594673|NCT00437281|21187840|P3|COMPLETED|Overall Study||3
8594674|NCT00437281|21187841|P2|COMPLETED|Overall Study||3
8594675|NCT00437281|21187842|P1|COMPLETED|Overall Study||3
8594676|NCT00437281|21187823|P20|STARTED|Overall Study||3
8594677|NCT00437281|21187824|P19|STARTED|Overall Study||2
8594678|NCT00437281|21187825|P18|STARTED|Overall Study||4
8594679|NCT00437281|21187826|P17|STARTED|Overall Study||3
8594680|NCT00437281|21187827|P16|STARTED|Overall Study||3
8594681|NCT00437281|21187828|P15|STARTED|Overall Study||5
8594682|NCT00437281|21187829|P14|STARTED|Overall Study||3
8594683|NCT00437281|21187830|P13|STARTED|Overall Study||2
8594684|NCT00437281|21187831|P12|STARTED|Overall Study||3
8594685|NCT00437281|21187832|P11|STARTED|Overall Study||3
8594686|NCT00437281|21187833|P10|STARTED|Overall Study||5
8594687|NCT00437281|21187834|P9|STARTED|Overall Study||3
8594688|NCT00437281|21187835|P8|STARTED|Overall Study||3
8594689|NCT00437281|21187836|P7|STARTED|Overall Study||3
8594690|NCT00437281|21187837|P6|STARTED|Overall Study||4
8594691|NCT00437281|21187838|P5|STARTED|Overall Study||4
8594692|NCT00437281|21187839|P4|STARTED|Overall Study||3
8594693|NCT00437281|21187840|P3|STARTED|Overall Study||3
8594694|NCT00437281|21187841|P2|STARTED|Overall Study||3
8594695|NCT00437281|21187842|P1|STARTED|Overall Study||3
8594696|NCT00415623|21188138|P2|NOT COMPLETED|Overall Study||5
8594697|NCT00415623|21188139|P1|NOT COMPLETED|Overall Study||5
8594698|NCT00415623|21188138|P2|COMPLETED|Overall Study||146
8594699|NCT00415623|21188139|P1|COMPLETED|Overall Study||149
8594700|NCT00415623|21188138|P2|STARTED|Overall Study||151
8594701|NCT00415623|21188139|P1|STARTED|Overall Study||154
8594702|NCT00412113|21188165|P2|NOT COMPLETED|Overall Study||15
8594703|NCT00412113|21188166|P1|NOT COMPLETED|Overall Study||12
8594704|NCT00412113|21188165|P2|COMPLETED|Overall Study|15-April-2008|107
8594705|NCT00412113|21188166|P1|COMPLETED|Overall Study|15-April-2008|111
8594706|NCT00412113|21188165|P2|Received Treatment|Overall Study||122
8594707|NCT00412113|21188166|P1|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
8594708|NCT00412113|21188165|P2|STARTED|Overall Study|15-January-2007|122
8594709|NCT00412113|21188166|P1|STARTED|Overall Study|15-January-2007|123
8594710|NCT00380874|21188220|P2|NOT COMPLETED|Overall Study||10
8594711|NCT00380874|21188221|P1|NOT COMPLETED|Overall Study||13
8594712|NCT00380874|21188220|P2|COMPLETED|Overall Study||19
8594713|NCT00380874|21188221|P1|COMPLETED|Overall Study||19
8594714|NCT00380874|21188220|P2|STARTED|Overall Study||29
8594715|NCT00380874|21188221|P1|STARTED|Overall Study||32
8594716|NCT00350337|21188241|P4|NOT COMPLETED|Overall Study||0
8594717|NCT00350337|21188242|P3|NOT COMPLETED|Overall Study||3
8594718|NCT00350337|21188243|P2|NOT COMPLETED|Overall Study||3
8594719|NCT00350337|21188244|P1|NOT COMPLETED|Overall Study||5
8594720|NCT00350337|21188241|P4|COMPLETED|Overall Study||21
8594721|NCT00350337|21188242|P3|COMPLETED|Overall Study||18
8594722|NCT00350337|21188243|P2|COMPLETED|Overall Study||19
8594723|NCT00350337|21188244|P1|COMPLETED|Overall Study||17
8594724|NCT00350337|21188241|P4|STARTED|Overall Study||21
8594725|NCT00350337|21188242|P3|STARTED|Overall Study||21
8594726|NCT00350337|21188243|P2|STARTED|Overall Study||22
8594727|NCT00350337|21188244|P1|STARTED|Overall Study||22
8594728|NCT00333866|21188296|P4|NOT COMPLETED|Overall Study||66
8594729|NCT00333866|21188297|P3|NOT COMPLETED|Overall Study||51
8594730|NCT00333866|21188298|P2|NOT COMPLETED|Overall Study||64
8594731|NCT00333866|21188299|P1|NOT COMPLETED|Overall Study||48
8594732|NCT00333866|21188296|P4|COMPLETED|Overall Study||121
8594733|NCT00333866|21188297|P3|COMPLETED|Overall Study||133
8594734|NCT00333866|21188298|P2|COMPLETED|Overall Study||123
8594735|NCT00333866|21188299|P1|COMPLETED|Overall Study||141
8594736|NCT00333866|21188296|P4|TREATED|Overall Study||186
8594737|NCT00333866|21188297|P3|TREATED|Overall Study||182
8594738|NCT00333866|21188298|P2|TREATED|Overall Study||184
8594739|NCT00333866|21188299|P1|TREATED|Overall Study||184
8594740|NCT00333866|21188296|P4|STARTED|Overall Study||187
8594741|NCT00333866|21188297|P3|STARTED|Overall Study||184
8594742|NCT00333866|21188298|P2|STARTED|Overall Study||187
8594743|NCT00333866|21188299|P1|STARTED|Overall Study||189
8594753|NCT00283283|21188395|P4|NOT COMPLETED|Overall Study||0
8594754|NCT00283283|21188396|P3|NOT COMPLETED|Overall Study||0
8594755|NCT00283283|21188397|P2|NOT COMPLETED|Overall Study||0
8594756|NCT00283283|21188398|P1|NOT COMPLETED|Overall Study||0
8594757|NCT00283283|21188395|P4|COMPLETED|Overall Study||276
8594758|NCT00283283|21188396|P3|COMPLETED|Overall Study||280
8594759|NCT00283283|21188397|P2|COMPLETED|Overall Study||284
8594760|NCT00283283|21188398|P1|COMPLETED|Overall Study||274
8594761|NCT00283283|21188395|P4|STARTED|Overall Study||276
8594762|NCT00283283|21188396|P3|STARTED|Overall Study||280
8594763|NCT00283283|21188397|P2|STARTED|Overall Study||284
8594764|NCT00283283|21188398|P1|STARTED|Overall Study||274
8594765|NCT00223990|21188415|P2|NOT COMPLETED|Overall Study||9
8594766|NCT00223990|21188416|P1|NOT COMPLETED|Overall Study||7
8594767|NCT00223990|21188415|P2|COMPLETED|Overall Study||191
8594768|NCT00223990|21188416|P1|COMPLETED|Overall Study||193
8594769|NCT00223990|21188415|P2|STARTED|Overall Study||200
8594770|NCT00223990|21188416|P1|STARTED|Overall Study||200
8594771|NCT00214539|21188440|P2|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
8594772|NCT00214539|21188441|P1|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
8594773|NCT00214539|21188440|P2|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
8594774|NCT00214539|21188441|P1|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
8594775|NCT00214539|21188440|P2|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
8594776|NCT00214539|21188441|P1|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
8594777|NCT00214539|21188440|P2|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
8594778|NCT00214539|21188441|P1|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
8594779|NCT00214539|21188440|P2|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
8594780|NCT00214539|21188441|P1|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
8594781|NCT00214539|21188440|P2|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
8594782|NCT00214539|21188441|P1|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
8594783|NCT00214539|21188440|P2|NOT COMPLETED|Treatment Period||0
8594784|NCT00214539|21188441|P1|NOT COMPLETED|Treatment Period||0
8594785|NCT00214539|21188440|P2|COMPLETED|Treatment Period||17
8594786|NCT00214539|21188441|P1|COMPLETED|Treatment Period||15
8594787|NCT00214539|21188440|P2|STARTED|Treatment Period||17
8594788|NCT00214539|21188441|P1|STARTED|Treatment Period||15
8594789|NCT00214539|21188440|P2|NOT COMPLETED|Randomized||0
8594790|NCT00214539|21188441|P1|NOT COMPLETED|Randomized||2
8594791|NCT00214539|21188440|P2|COMPLETED|Randomized||17
8594792|NCT00214539|21188441|P1|COMPLETED|Randomized||15
8594793|NCT00214539|21188440|P2|STARTED|Randomized||17
8594794|NCT00214539|21188441|P1|STARTED|Randomized||17
8594795|NCT00197054|21188468|P3|NOT COMPLETED|Overall Study||12
8594796|NCT00197054|21188469|P2|NOT COMPLETED|Overall Study||21
8594797|NCT00197054|21188470|P1|NOT COMPLETED|Overall Study||17
8594798|NCT00197054|21188468|P3|COMPLETED|Overall Study||73
8594799|NCT00197054|21188469|P2|COMPLETED|Overall Study||64
8594800|NCT00197054|21188470|P1|COMPLETED|Overall Study||68
8594801|NCT00197054|21188468|P3|STARTED|Overall Study||85
8594802|NCT00197054|21188469|P2|STARTED|Overall Study||85
8594803|NCT00197054|21188470|P1|STARTED|Overall Study||85
8594804|NCT00180323|21188578|P1|NOT COMPLETED|Overall Study||0
8594805|NCT00180323|21188578|P1|COMPLETED|Overall Study||43
8594806|NCT00180323|21188578|P1|STARTED|Overall Study||43
8594807|NCT00135200|21188585|P1|NOT COMPLETED|Overall Study||0
8594808|NCT00135200|21188585|P1|COMPLETED|Overall Study||16
8594809|NCT00135200|21188585|P1|STARTED|Overall Study||16
8597207|NCT04071158|21196045|P5|NOT COMPLETED|Overall Study||5
8597208|NCT04071158|21196046|P4|NOT COMPLETED|Overall Study||3
8597209|NCT04071158|21196047|P3|NOT COMPLETED|Overall Study||3
8597210|NCT04071158|21196048|P2|NOT COMPLETED|Overall Study||4
8597211|NCT04071158|21196049|P1|NOT COMPLETED|Overall Study||3
8597212|NCT04071158|21196045|P5|COMPLETED|Overall Study||136
8597213|NCT04071158|21196046|P4|COMPLETED|Overall Study||140
8597214|NCT04071158|21196047|P3|COMPLETED|Overall Study||140
8597215|NCT04071158|21196048|P2|COMPLETED|Overall Study||139
8597216|NCT04071158|21196049|P1|COMPLETED|Overall Study||140
8597217|NCT04071158|21196045|P5|Safety Population|Overall Study||141
8597218|NCT04071158|21196046|P4|Safety Population|Overall Study|1 participant of this arm actually received RSV vaccine 240 mcg with aluminum hydroxide with Tdap|144
8597219|NCT04071158|21196047|P3|Safety Population|Overall Study|1 participant randomized to this arm received RSV vaccine 240 mcg with aluminum hydroxide withTdap|142
8597220|NCT04071158|21196048|P2|Safety Population|Overall Study||141
8597221|NCT04071158|21196049|P1|Safety Population|Overall Study||141
8597222|NCT04071158|21196045|P5|Treated|Overall Study||141
8597223|NCT04071158|21196046|P4|Treated|Overall Study||143
8597224|NCT04071158|21196047|P3|Treated|Overall Study||143
8597225|NCT04071158|21196048|P2|Treated|Overall Study||141
8597226|NCT04071158|21196049|P1|Treated|Overall Study||141
8597227|NCT04071158|21196045|P5|STARTED|Overall Study||141
8597228|NCT04071158|21196046|P4|STARTED|Overall Study||143
8597229|NCT04071158|21196047|P3|STARTED|Overall Study||143
8597230|NCT04071158|21196048|P2|STARTED|Overall Study||143
8597231|NCT04071158|21196049|P1|STARTED|Overall Study||143
8597232|NCT04066426|21196104|P4|NOT COMPLETED|Overall Study||3
8597233|NCT04066426|21196105|P3|NOT COMPLETED|Overall Study||8
8597234|NCT04066426|21196106|P2|NOT COMPLETED|Overall Study||10
8597235|NCT04066426|21196107|P1|NOT COMPLETED|Overall Study||10
8597236|NCT04066426|21196104|P4|COMPLETED|Overall Study||47
8597237|NCT04066426|21196105|P3|COMPLETED|Overall Study||42
8597238|NCT04066426|21196106|P2|COMPLETED|Overall Study||40
8597239|NCT04066426|21196107|P1|COMPLETED|Overall Study||40
8597240|NCT04066426|21196104|P4|STARTED|Overall Study||50
8597241|NCT04066426|21196105|P3|STARTED|Overall Study||50
8597242|NCT04066426|21196106|P2|STARTED|Overall Study||50
8597243|NCT04066426|21196107|P1|STARTED|Overall Study||50
8597520|NCT03332628|21197262|P1|NOT COMPLETED|Overall Study||2
8597521|NCT03332628|21197262|P1|COMPLETED|Overall Study||111
8597522|NCT03332628|21197262|P1|STARTED|Overall Study||113
8597717|NCT02934555|21197757|P2|NOT COMPLETED|Overall Study||3
8597718|NCT02934555|21197758|P1|NOT COMPLETED|Overall Study||2
8597719|NCT02934555|21197757|P2|COMPLETED|Overall Study||22
8597720|NCT02934555|21197758|P1|COMPLETED|Overall Study||21
8597721|NCT02934555|21197757|P2|STARTED|Overall Study||25
8597722|NCT02934555|21197758|P1|STARTED|Overall Study||23
8597816|NCT02713711|21198367|P4|NOT COMPLETED|Overall Study||0
8597817|NCT02713711|21198368|P3|NOT COMPLETED|Overall Study||0
8597818|NCT02713711|21198369|P2|NOT COMPLETED|Overall Study||0
8597819|NCT02713711|21198370|P1|NOT COMPLETED|Overall Study||0
8597820|NCT02713711|21198367|P4|COMPLETED|Overall Study||10
8597821|NCT02713711|21198368|P3|COMPLETED|Overall Study||6
8597822|NCT02713711|21198369|P2|COMPLETED|Overall Study||6
8597823|NCT02713711|21198370|P1|COMPLETED|Overall Study||9
8597824|NCT02713711|21198367|P4|STARTED|Overall Study||10
8597825|NCT02713711|21198368|P3|STARTED|Overall Study||6
8597826|NCT02713711|21198369|P2|STARTED|Overall Study||6
8597827|NCT02713711|21198370|P1|STARTED|Overall Study||9
8597924|NCT02607046|21198843|P2|NOT COMPLETED|Overall Study||3
8597925|NCT02607046|21198844|P1|NOT COMPLETED|Overall Study||8
8597926|NCT02607046|21198843|P2|COMPLETED|Overall Study||10
8597927|NCT02607046|21198844|P1|COMPLETED|Overall Study||14
8597928|NCT02607046|21198843|P2|STARTED|Overall Study||13
8597929|NCT02607046|21198844|P1|STARTED|Overall Study||22
8598267|NCT02389959|21199334|P2|NOT COMPLETED|Overall Study||1
8598268|NCT02389959|21199335|P1|NOT COMPLETED|Overall Study||2
8598269|NCT02389959|21199334|P2|COMPLETED|Overall Study||19
8598270|NCT02389959|21199335|P1|COMPLETED|Overall Study||18
8598271|NCT02389959|21199334|P2|STARTED|Overall Study||20
8598272|NCT02389959|21199335|P1|STARTED|Overall Study||20
8598301|NCT02314780|21199408|P3|NOT COMPLETED|Overall Study||0
8598302|NCT02314780|21199409|P2|NOT COMPLETED|Overall Study||3
8598303|NCT02314780|21199410|P1|NOT COMPLETED|Overall Study||0
8598304|NCT02314780|21199408|P3|COMPLETED|Overall Study||8
8598305|NCT02314780|21199409|P2|COMPLETED|Overall Study||7
8598306|NCT02314780|21199410|P1|COMPLETED|Overall Study||9
8598307|NCT02314780|21199408|P3|STARTED|Overall Study||8
8598308|NCT02314780|21199409|P2|STARTED|Overall Study||10
8598309|NCT02314780|21199410|P1|STARTED|Overall Study||9
8598339|NCT02237417|21199532|P3|NOT COMPLETED|Overall Study||9
8598340|NCT02237417|21199533|P2|NOT COMPLETED|Overall Study||6
8598341|NCT02237417|21199534|P1|NOT COMPLETED|Overall Study||0
8598342|NCT02237417|21199532|P3|COMPLETED|Overall Study||7
8598343|NCT02237417|21199533|P2|COMPLETED|Overall Study||9
8598344|NCT02237417|21199534|P1|COMPLETED|Overall Study||16
8598345|NCT02237417|21199532|P3|STARTED|Overall Study||16
8598346|NCT02237417|21199533|P2|STARTED|Overall Study||15
8598347|NCT02237417|21199534|P1|STARTED|Overall Study||16
8598435|NCT02147626|21199752|P2|NOT COMPLETED|Overall Study||7
8598436|NCT02147626|21199753|P1|NOT COMPLETED|Overall Study||5
8598437|NCT02147626|21199752|P2|COMPLETED|Overall Study||69
8598438|NCT02147626|21199753|P1|COMPLETED|Overall Study||70
8598439|NCT02147626|21199752|P2|STARTED|Overall Study||76
8598440|NCT02147626|21199753|P1|STARTED|Overall Study||75
8598453|NCT02094417|21199831|P4|NOT COMPLETED|Overall Study||7
8598454|NCT02094417|21199832|P3|NOT COMPLETED|Overall Study||5
8598455|NCT02094417|21199833|P2|NOT COMPLETED|Overall Study||8
8598456|NCT02094417|21199834|P1|NOT COMPLETED|Overall Study||5
8598457|NCT02094417|21199831|P4|COMPLETED|Overall Study||3
8598458|NCT02094417|21199832|P3|COMPLETED|Overall Study||4
8598459|NCT02094417|21199833|P2|COMPLETED|Overall Study||1
8598460|NCT02094417|21199834|P1|COMPLETED|Overall Study||2
8598461|NCT02094417|21199831|P4|STARTED|Overall Study||10
8598462|NCT02094417|21199832|P3|STARTED|Overall Study||9
8598463|NCT02094417|21199833|P2|STARTED|Overall Study||9
8598464|NCT02094417|21199834|P1|STARTED|Overall Study||7
8598527|NCT01986881|21200048|P3|NOT COMPLETED|Overall Study||358
8598528|NCT01986881|21200049|P2|NOT COMPLETED|Overall Study||346
8598529|NCT01986881|21200050|P1|NOT COMPLETED|Overall Study||330
8598530|NCT01986881|21200048|P3|COMPLETED|Overall Study||2389
8598531|NCT01986881|21200049|P2|COMPLETED|Overall Study||2401
8598532|NCT01986881|21200050|P1|COMPLETED|Overall Study||2422
8598533|NCT01986881|21200048|P3|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||117
8598534|NCT01986881|21200049|P2|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||113
8598535|NCT01986881|21200050|P1|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||100
8598536|NCT01986881|21200048|P3|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||48
8598537|NCT01986881|21200049|P2|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||54
8598538|NCT01986881|21200050|P1|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||55
8598539|NCT01986881|21200048|P3|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||347
8598540|NCT01986881|21200049|P2|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||370
8598541|NCT01986881|21200050|P1|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||348
8598542|NCT01986881|21200048|P3|Treated|Overall Study||2745
8598543|NCT01986881|21200049|P2|Treated|Overall Study||2747
8598544|NCT01986881|21200050|P1|Treated|Overall Study||2746
8598545|NCT01986881|21200048|P3|STARTED|Overall Study||2747
8598546|NCT01986881|21200049|P2|STARTED|Overall Study||2747
8598547|NCT01986881|21200050|P1|STARTED|Overall Study||2752
8598660|NCT01779856|21200691|P1|NOT COMPLETED|Overall Study||24
8598661|NCT01779856|21200691|P1|COMPLETED|Overall Study||57
8598662|NCT01779856|21200691|P1|STARTED|Overall Study||81
8598821|NCT01599286|21201016|P2|NOT COMPLETED|Overall Study||0
8598822|NCT01599286|21201017|P1|NOT COMPLETED|Overall Study||0
8598823|NCT01599286|21201016|P2|COMPLETED|Overall Study||23
8598824|NCT01599286|21201017|P1|COMPLETED|Overall Study||24
8598825|NCT01599286|21201016|P2|STARTED|Overall Study||23
8598826|NCT01599286|21201017|P1|STARTED|Overall Study||24
8598874|NCT01502072|21201155|P3|NOT COMPLETED|Overall Study||0
8598875|NCT01502072|21201156|P2|NOT COMPLETED|Overall Study||1
8598876|NCT01502072|21201157|P1|NOT COMPLETED|Overall Study||1
8598877|NCT01502072|21201155|P3|COMPLETED|Overall Study||20
8598878|NCT01502072|21201156|P2|COMPLETED|Overall Study||9
8598879|NCT01502072|21201157|P1|COMPLETED|Overall Study||13
8598880|NCT01502072|21201155|P3|STARTED|Overall Study||20
8598881|NCT01502072|21201156|P2|STARTED|Overall Study||10
8598882|NCT01502072|21201157|P1|STARTED|Overall Study||14
8599018|NCT00991276|21201419|P6|NOT COMPLETED|Third Intervention Period||1
8599019|NCT00991276|21201420|P5|NOT COMPLETED|Third Intervention Period||0
8599020|NCT00991276|21201421|P4|NOT COMPLETED|Third Intervention Period||1
8599021|NCT00991276|21201422|P3|NOT COMPLETED|Third Intervention Period||1
8599022|NCT00991276|21201423|P2|NOT COMPLETED|Third Intervention Period||0
8599023|NCT00991276|21201424|P1|NOT COMPLETED|Third Intervention Period||1
8599024|NCT00991276|21201419|P6|COMPLETED|Third Intervention Period||10
8599025|NCT00991276|21201420|P5|COMPLETED|Third Intervention Period||10
8599026|NCT00991276|21201421|P4|COMPLETED|Third Intervention Period||8
8599027|NCT00991276|21201422|P3|COMPLETED|Third Intervention Period||13
8599028|NCT00991276|21201423|P2|COMPLETED|Third Intervention Period||8
8599029|NCT00991276|21201424|P1|COMPLETED|Third Intervention Period||13
8599030|NCT00991276|21201419|P6|STARTED|Third Intervention Period||11
8599031|NCT00991276|21201420|P5|STARTED|Third Intervention Period||10
8599032|NCT00991276|21201421|P4|STARTED|Third Intervention Period||9
8599033|NCT00991276|21201422|P3|STARTED|Third Intervention Period||14
8599034|NCT00991276|21201423|P2|STARTED|Third Intervention Period||8
8599035|NCT00991276|21201424|P1|STARTED|Third Intervention Period||14
8599036|NCT00991276|21201419|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599037|NCT00991276|21201420|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599038|NCT00991276|21201421|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599039|NCT00991276|21201422|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599040|NCT00991276|21201423|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599041|NCT00991276|21201424|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599042|NCT00991276|21201419|P6|COMPLETED|Placebo Wash-out Period (7 Days)||11
8599043|NCT00991276|21201420|P5|COMPLETED|Placebo Wash-out Period (7 Days)||10
8599044|NCT00991276|21201421|P4|COMPLETED|Placebo Wash-out Period (7 Days)||9
8599045|NCT00991276|21201422|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
8599046|NCT00991276|21201423|P2|COMPLETED|Placebo Wash-out Period (7 Days)||8
8599047|NCT00991276|21201424|P1|COMPLETED|Placebo Wash-out Period (7 Days)||14
8599048|NCT00991276|21201419|P6|STARTED|Placebo Wash-out Period (7 Days)||11
8599049|NCT00991276|21201420|P5|STARTED|Placebo Wash-out Period (7 Days)||10
8599050|NCT00991276|21201421|P4|STARTED|Placebo Wash-out Period (7 Days)||9
8599051|NCT00991276|21201422|P3|STARTED|Placebo Wash-out Period (7 Days)||14
8599052|NCT00991276|21201423|P2|STARTED|Placebo Wash-out Period (7 Days)||8
8599053|NCT00991276|21201424|P1|STARTED|Placebo Wash-out Period (7 Days)||14
8599054|NCT00991276|21201419|P6|NOT COMPLETED|Second Intervention Period||1
8599055|NCT00991276|21201420|P5|NOT COMPLETED|Second Intervention Period||1
8599056|NCT00991276|21201421|P4|NOT COMPLETED|Second Intervention Period||2
8599057|NCT00991276|21201422|P3|NOT COMPLETED|Second Intervention Period||0
8599058|NCT00991276|21201423|P2|NOT COMPLETED|Second Intervention Period||2
8599059|NCT00991276|21201424|P1|NOT COMPLETED|Second Intervention Period||1
8599060|NCT00991276|21201419|P6|COMPLETED|Second Intervention Period||11
8599061|NCT00991276|21201420|P5|COMPLETED|Second Intervention Period||10
8599062|NCT00991276|21201421|P4|COMPLETED|Second Intervention Period||9
8599063|NCT00991276|21201422|P3|COMPLETED|Second Intervention Period||14
8599064|NCT00991276|21201423|P2|COMPLETED|Second Intervention Period||8
8599065|NCT00991276|21201424|P1|COMPLETED|Second Intervention Period||14
8599066|NCT00991276|21201419|P6|STARTED|Second Intervention Period||12
8599067|NCT00991276|21201420|P5|STARTED|Second Intervention Period||11
8599068|NCT00991276|21201421|P4|STARTED|Second Intervention Period||11
8599069|NCT00991276|21201422|P3|STARTED|Second Intervention Period||14
8599070|NCT00991276|21201423|P2|STARTED|Second Intervention Period||10
8599071|NCT00991276|21201424|P1|STARTED|Second Intervention Period||15
8599072|NCT00991276|21201419|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599073|NCT00991276|21201420|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599074|NCT00991276|21201421|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599075|NCT00991276|21201422|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599076|NCT00991276|21201423|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599077|NCT00991276|21201424|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
8599078|NCT00991276|21201419|P6|COMPLETED|Placebo Wash-out Period (7 Days)||12
8599079|NCT00991276|21201420|P5|COMPLETED|Placebo Wash-out Period (7 Days)||11
8599080|NCT00991276|21201421|P4|COMPLETED|Placebo Wash-out Period (7 Days)||11
8599081|NCT00991276|21201422|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
8599082|NCT00991276|21201423|P2|COMPLETED|Placebo Wash-out Period (7 Days)||10
8599083|NCT00991276|21201424|P1|COMPLETED|Placebo Wash-out Period (7 Days)||15
8599084|NCT00991276|21201419|P6|STARTED|Placebo Wash-out Period (7 Days)||12
8599085|NCT00991276|21201420|P5|STARTED|Placebo Wash-out Period (7 Days)||11
8599086|NCT00991276|21201421|P4|STARTED|Placebo Wash-out Period (7 Days)||11
8599087|NCT00991276|21201422|P3|STARTED|Placebo Wash-out Period (7 Days)||14
8599088|NCT00991276|21201423|P2|STARTED|Placebo Wash-out Period (7 Days)||10
8599089|NCT00991276|21201424|P1|STARTED|Placebo Wash-out Period (7 Days)||15
8599090|NCT00991276|21201419|P6|NOT COMPLETED|First Intervention Period||1
8599091|NCT00991276|21201420|P5|NOT COMPLETED|First Intervention Period||4
8599092|NCT00991276|21201421|P4|NOT COMPLETED|First Intervention Period||4
8599093|NCT00991276|21201422|P3|NOT COMPLETED|First Intervention Period||0
8599094|NCT00991276|21201423|P2|NOT COMPLETED|First Intervention Period||3
8599095|NCT00991276|21201424|P1|NOT COMPLETED|First Intervention Period||0
8599096|NCT00991276|21201419|P6|COMPLETED|First Intervention Period||12
8599097|NCT00991276|21201420|P5|COMPLETED|First Intervention Period||11
8599098|NCT00991276|21201421|P4|COMPLETED|First Intervention Period||11
8599099|NCT00991276|21201422|P3|COMPLETED|First Intervention Period||14
8599100|NCT00991276|21201423|P2|COMPLETED|First Intervention Period||10
8599101|NCT00991276|21201424|P1|COMPLETED|First Intervention Period||15
8599102|NCT00991276|21201419|P6|STARTED|First Intervention Period||13
8599103|NCT00991276|21201420|P5|STARTED|First Intervention Period||15
8599104|NCT00991276|21201421|P4|STARTED|First Intervention Period||15
8599105|NCT00991276|21201422|P3|STARTED|First Intervention Period||14
8599106|NCT00991276|21201423|P2|STARTED|First Intervention Period||13
8599107|NCT00991276|21201424|P1|STARTED|First Intervention Period||15
8599225|NCT00539981|21201830|P2|NOT COMPLETED|Overall Study||282
8599226|NCT00539981|21201831|P1|NOT COMPLETED|Overall Study||295
8599227|NCT00539981|21201830|P2|COMPLETED|Overall Study||2022
8599228|NCT00539981|21201831|P1|COMPLETED|Overall Study||2049
8599229|NCT00539981|21201830|P2|STARTED|Overall Study||2304
8599230|NCT00539981|21201831|P1|STARTED|Overall Study||2344
8599324|NCT00317369|21202061|P3|NOT COMPLETED|Overall Study||2
8599325|NCT00317369|21202062|P2|NOT COMPLETED|Overall Study||2
8599326|NCT00317369|21202063|P1|NOT COMPLETED|Overall Study||2
8599327|NCT00317369|21202061|P3|COMPLETED|Overall Study||8
8599328|NCT00317369|21202062|P2|COMPLETED|Overall Study||7
8599329|NCT00317369|21202063|P1|COMPLETED|Overall Study||8
8599330|NCT00317369|21202061|P3|STARTED|Overall Study||10
8599331|NCT00317369|21202062|P2|STARTED|Overall Study||9
8599332|NCT00317369|21202063|P1|STARTED|Overall Study||10
8599369|NCT04245202|21202199|P2|NOT COMPLETED|Overall Study||1
8599370|NCT04245202|21202200|P1|NOT COMPLETED|Overall Study||10
8599371|NCT04245202|21202199|P2|COMPLETED|Overall Study||38
8599372|NCT04245202|21202200|P1|COMPLETED|Overall Study||38
8599373|NCT04245202|21202199|P2|STARTED|Overall Study|After getting consent|39
8599374|NCT04245202|21202200|P1|STARTED|Overall Study|After getting consent.|48
8599405|NCT04184999|21202257|P2|NOT COMPLETED|Overall Study||0
8599406|NCT04184999|21202258|P1|NOT COMPLETED|Overall Study||0
8599407|NCT04184999|21202257|P2|COMPLETED|Overall Study||40
8599408|NCT04184999|21202258|P1|COMPLETED|Overall Study||40
8599409|NCT04184999|21202257|P2|3 Week Tear Film Osmolarity Testing|Overall Study||40
8599410|NCT04184999|21202258|P1|3 Week Tear Film Osmolarity Testing|Overall Study||40
8599411|NCT04184999|21202257|P2|STARTED|Overall Study||40
8599412|NCT04184999|21202258|P1|STARTED|Overall Study||40
8599413|NCT04170686|21202266|P2|NOT COMPLETED|Randomization and Treatment||15
8599414|NCT04170686|21202267|P1|NOT COMPLETED|Randomization and Treatment||26
8599415|NCT04170686|21202266|P2|COMPLETED|Randomization and Treatment||44
8599416|NCT04170686|21202267|P1|COMPLETED|Randomization and Treatment||36
8599417|NCT04170686|21202266|P2|STARTED|Randomization and Treatment||59
8599418|NCT04170686|21202267|P1|STARTED|Randomization and Treatment||62
8599419|NCT04170686|21202266|P2|NOT COMPLETED|Screening||13
8599420|NCT04170686|21202267|P1|NOT COMPLETED|Screening||12
8599421|NCT04170686|21202266|P2|COMPLETED|Screening||59
8599422|NCT04170686|21202267|P1|COMPLETED|Screening||62
8599423|NCT04170686|21202266|P2|STARTED|Screening||72
8599424|NCT04170686|21202267|P1|STARTED|Screening||74
8599425|NCT04161807|21202289|P1|NOT COMPLETED|Overall Study||4
8599426|NCT04161807|21202289|P1|COMPLETED|Overall Study||38
8599427|NCT04161807|21202289|P1|STARTED|Overall Study||42
8599428|NCT04093258|21202301|P2|NOT COMPLETED|Period 2||0
8599429|NCT04093258|21202302|P1|NOT COMPLETED|Period 2||1
8599430|NCT04093258|21202301|P2|COMPLETED|Period 2||20
8599431|NCT04093258|21202302|P1|COMPLETED|Period 2||20
8599432|NCT04093258|21202301|P2|STARTED|Period 2||20
8599433|NCT04093258|21202302|P1|STARTED|Period 2||21
8599434|NCT04093258|21202301|P2|NOT COMPLETED|Period 1||0
8599435|NCT04093258|21202302|P1|NOT COMPLETED|Period 1||0
8599436|NCT04093258|21202301|P2|COMPLETED|Period 1||20
8599437|NCT04093258|21202302|P1|COMPLETED|Period 1||21
8599438|NCT04093258|21202301|P2|STARTED|Period 1||20
8599439|NCT04093258|21202302|P1|STARTED|Period 1||21
8599494|NCT03784079|21202436|P7|NOT COMPLETED|Part 2: Up to Day 12||0
8599495|NCT03784079|21202437|P6|NOT COMPLETED|Part 2: Up to Day 12||0
8599496|NCT03784079|21202438|P5|NOT COMPLETED|Part 2: Up to Day 12||0
8599497|NCT03784079|21202439|P4|NOT COMPLETED|Part 2: Up to Day 12||0
8599498|NCT03784079|21202440|P3|NOT COMPLETED|Part 2: Up to Day 12||0
8599499|NCT03784079|21202441|P2|NOT COMPLETED|Part 2: Up to Day 12||0
8599500|NCT03784079|21202442|P1|NOT COMPLETED|Part 2: Up to Day 12||0
8599501|NCT03784079|21202436|P7|COMPLETED|Part 2: Up to Day 12||2
8599502|NCT03784079|21202437|P6|COMPLETED|Part 2: Up to Day 12||6
8599503|NCT03784079|21202438|P5|COMPLETED|Part 2: Up to Day 12||6
8599504|NCT03784079|21202439|P4|COMPLETED|Part 2: Up to Day 12||6
8599505|NCT03784079|21202440|P3|COMPLETED|Part 2: Up to Day 12||0
8599506|NCT03784079|21202441|P2|COMPLETED|Part 2: Up to Day 12||0
8599507|NCT03784079|21202442|P1|COMPLETED|Part 2: Up to Day 12||0
8599508|NCT03784079|21202436|P7|STARTED|Part 2: Up to Day 12||2
8599509|NCT03784079|21202437|P6|STARTED|Part 2: Up to Day 12||6
8599510|NCT03784079|21202438|P5|STARTED|Part 2: Up to Day 12||6
8599511|NCT03784079|21202439|P4|STARTED|Part 2: Up to Day 12||6
8599512|NCT03784079|21202440|P3|STARTED|Part 2: Up to Day 12||0
8599513|NCT03784079|21202441|P2|STARTED|Part 2: Up to Day 12||0
8599514|NCT03784079|21202442|P1|STARTED|Part 2: Up to Day 12||0
8599515|NCT03784079|21202436|P7|NOT COMPLETED|Part 1: Up to Day 24||0
8599516|NCT03784079|21202437|P6|NOT COMPLETED|Part 1: Up to Day 24||0
8599517|NCT03784079|21202438|P5|NOT COMPLETED|Part 1: Up to Day 24||0
8599518|NCT03784079|21202439|P4|NOT COMPLETED|Part 1: Up to Day 24||0
8599519|NCT03784079|21202440|P3|NOT COMPLETED|Part 1: Up to Day 24||0
8599520|NCT03784079|21202441|P2|NOT COMPLETED|Part 1: Up to Day 24||0
8599521|NCT03784079|21202442|P1|NOT COMPLETED|Part 1: Up to Day 24||0
8599522|NCT03784079|21202436|P7|COMPLETED|Part 1: Up to Day 24||0
8599523|NCT03784079|21202437|P6|COMPLETED|Part 1: Up to Day 24||0
8599524|NCT03784079|21202438|P5|COMPLETED|Part 1: Up to Day 24||0
8599525|NCT03784079|21202439|P4|COMPLETED|Part 1: Up to Day 24||0
8599526|NCT03784079|21202440|P3|COMPLETED|Part 1: Up to Day 24||2
8599527|NCT03784079|21202441|P2|COMPLETED|Part 1: Up to Day 24||6
8599528|NCT03784079|21202442|P1|COMPLETED|Part 1: Up to Day 24||6
8599529|NCT03784079|21202436|P7|STARTED|Part 1: Up to Day 24||0
8599530|NCT03784079|21202437|P6|STARTED|Part 1: Up to Day 24||0
8599531|NCT03784079|21202438|P5|STARTED|Part 1: Up to Day 24||0
8599532|NCT03784079|21202439|P4|STARTED|Part 1: Up to Day 24||0
8599533|NCT03784079|21202440|P3|STARTED|Part 1: Up to Day 24||2
8599534|NCT03784079|21202441|P2|STARTED|Part 1: Up to Day 24||6
8599535|NCT03784079|21202442|P1|STARTED|Part 1: Up to Day 24||6
8599536|NCT03769649|21202817|P1|NOT COMPLETED|Overall Study||4
8599537|NCT03769649|21202817|P1|COMPLETED|Overall Study||11
8599538|NCT03769649|21202817|P1|STARTED|Overall Study||15
8599560|NCT03607539|21202927|P2|NOT COMPLETED|Overall Study||131
8599561|NCT03607539|21202928|P1|NOT COMPLETED|Overall Study||266
8599562|NCT03607539|21202927|P2|COMPLETED|Overall Study||0
8599563|NCT03607539|21202928|P1|COMPLETED|Overall Study||0
8599564|NCT03607539|21202927|P2|STARTED|Overall Study||131
8599565|NCT03607539|21202928|P1|STARTED|Overall Study||266
8599584|NCT03521635|21203021|P2|NOT COMPLETED|Overall Study||6
8599585|NCT03521635|21203022|P1|NOT COMPLETED|Overall Study||4
8599586|NCT03521635|21203021|P2|COMPLETED|Overall Study||43
8599587|NCT03521635|21203022|P1|COMPLETED|Overall Study||45
8599588|NCT03521635|21203021|P2|STARTED|Overall Study||49
8599589|NCT03521635|21203022|P1|STARTED|Overall Study||49
8599590|NCT03514420|21203046|P1|NOT COMPLETED|Overall Study||0
8599591|NCT03514420|21203046|P1|COMPLETED|Overall Study||4
8599592|NCT03514420|21203046|P1|STARTED|Overall Study||4
8599602|NCT03499873|21203113|P3|NOT COMPLETED|Overall Study||27
8599603|NCT03499873|21203114|P2|NOT COMPLETED|Overall Study||20
8599604|NCT03499873|21203115|P1|NOT COMPLETED|Overall Study||20
8599605|NCT03499873|21203113|P3|COMPLETED|Overall Study||56
8599606|NCT03499873|21203114|P2|COMPLETED|Overall Study||162
8599607|NCT03499873|21203115|P1|COMPLETED|Overall Study||163
8599608|NCT03499873|21203113|P3|Modified-Intent-to-Treat|Overall Study||77
8599609|NCT03499873|21203114|P2|Modified-Intent-to-Treat|Overall Study||168
8599610|NCT03499873|21203115|P1|Modified-Intent-to-Treat|Overall Study||170
8599611|NCT03499873|21203113|P3|Per-Protocol Population|Overall Study||58
8599612|NCT03499873|21203114|P2|Per-Protocol Population|Overall Study||143
8599613|NCT03499873|21203115|P1|Per-Protocol Population|Overall Study||144
8599614|NCT03499873|21203113|P3|Safety Population|Overall Study||80
8599615|NCT03499873|21203114|P2|Safety Population|Overall Study||174
8599616|NCT03499873|21203115|P1|Safety Population|Overall Study||175
8599617|NCT03499873|21203113|P3|STARTED|Overall Study||83
8599618|NCT03499873|21203114|P2|STARTED|Overall Study||182
8599619|NCT03499873|21203115|P1|STARTED|Overall Study||183
8599683|NCT03389555|21203305|P2|NOT COMPLETED|Overall Study||3
8599684|NCT03389555|21203306|P1|NOT COMPLETED|Overall Study||2
8599685|NCT03389555|21203305|P2|COMPLETED|Overall Study||99
8599686|NCT03389555|21203306|P1|COMPLETED|Overall Study||101
8599687|NCT03389555|21203305|P2|STARTED|Overall Study||102
8599688|NCT03389555|21203306|P1|STARTED|Overall Study||103
8599707|NCT03359889|21203435|P1|NOT COMPLETED|Overall Study||0
8599708|NCT03359889|21203435|P1|COMPLETED|Overall Study||5
8599709|NCT03359889|21203435|P1|STARTED|Overall Study||5
8599755|NCT03197025|21203623|P1|NOT COMPLETED|Overall Study||0
8599756|NCT03197025|21203623|P1|COMPLETED|Overall Study||1
8599757|NCT03197025|21203623|P1|STARTED|Overall Study||1
8599762|NCT03173313|21203636|P2|NOT COMPLETED|Overall Study||5
8599763|NCT03173313|21203637|P1|NOT COMPLETED|Overall Study||9
8599764|NCT03173313|21203636|P2|COMPLETED|Overall Study||48
8599765|NCT03173313|21203637|P1|COMPLETED|Overall Study||49
8599766|NCT03173313|21203636|P2|12-month Follow-up|Overall Study||48
8599767|NCT03173313|21203637|P1|12-month Follow-up|Overall Study||49
8599768|NCT03173313|21203636|P2|30-day Follow-up|Overall Study||51
8599769|NCT03173313|21203637|P1|30-day Follow-up|Overall Study||52
8599770|NCT03173313|21203636|P2|4-6 Day Follow-up|Overall Study||53
8599771|NCT03173313|21203637|P1|4-6 Day Follow-up|Overall Study||57
8599772|NCT03173313|21203636|P2|Cooled|Overall Study||0
8599773|NCT03173313|21203637|P1|Cooled|Overall Study||54
8599774|NCT03173313|21203636|P2|Randomized|Overall Study||53
8599775|NCT03173313|21203637|P1|Randomized|Overall Study||58
8599776|NCT03173313|21203636|P2|Informed Consent Signed|Overall Study||53
8599777|NCT03173313|21203637|P1|Informed Consent Signed|Overall Study||58
8599778|NCT03173313|21203636|P2|STARTED|Overall Study||53
8599779|NCT03173313|21203637|P1|STARTED|Overall Study||58
8599811|NCT03017924|21203738|P2|NOT COMPLETED|Overall Study||3
8599812|NCT03017924|21203739|P1|NOT COMPLETED|Overall Study||2
8599813|NCT03017924|21203738|P2|COMPLETED|Overall Study||8
8599814|NCT03017924|21203739|P1|COMPLETED|Overall Study||10
8599815|NCT03017924|21203738|P2|STARTED|Overall Study||11
8599816|NCT03017924|21203739|P1|STARTED|Overall Study||12
8599880|NCT02971735|21203856|P2|NOT COMPLETED|Overall Study||0
8599881|NCT02971735|21203857|P1|NOT COMPLETED|Overall Study||0
8599882|NCT02971735|21203856|P2|COMPLETED|Overall Study||30
8599883|NCT02971735|21203857|P1|COMPLETED|Overall Study||30
8599884|NCT02971735|21203856|P2|STARTED|Overall Study||30
8599885|NCT02971735|21203857|P1|STARTED|Overall Study||30
8599886|NCT02964338|21203878|P3|NOT COMPLETED|Overall Study||19
8599887|NCT02964338|21203879|P2|NOT COMPLETED|Overall Study||24
8599888|NCT02964338|21203880|P1|NOT COMPLETED|Overall Study||17
8599889|NCT02964338|21203878|P3|COMPLETED|Overall Study||68
8599890|NCT02964338|21203879|P2|COMPLETED|Overall Study||64
8599891|NCT02964338|21203880|P1|COMPLETED|Overall Study||67
8599892|NCT02964338|21203878|P3|Full Analysis Set|Overall Study||87
8599893|NCT02964338|21203879|P2|Full Analysis Set|Overall Study||86
8599894|NCT02964338|21203880|P1|Full Analysis Set|Overall Study||81
8599895|NCT02964338|21203878|P3|Safety Analysis Set|Overall Study||87
8599896|NCT02964338|21203879|P2|Safety Analysis Set|Overall Study||88
8599897|NCT02964338|21203880|P1|Safety Analysis Set|Overall Study||83
8599898|NCT02964338|21203878|P3|STARTED|Overall Study||87
8599899|NCT02964338|21203879|P2|STARTED|Overall Study||88
8599900|NCT02964338|21203880|P1|STARTED|Overall Study||84
8599931|NCT02891681|21204090|P3|NOT COMPLETED|Overall Study||1
8599932|NCT02891681|21204091|P2|NOT COMPLETED|Overall Study||0
8599933|NCT02891681|21204092|P1|NOT COMPLETED|Overall Study||3
8599934|NCT02891681|21204090|P3|COMPLETED|Overall Study||0
8599935|NCT02891681|21204091|P2|COMPLETED|Overall Study||1
8599936|NCT02891681|21204092|P1|COMPLETED|Overall Study||36
8599937|NCT02891681|21204090|P3|STARTED|Overall Study||1
8599938|NCT02891681|21204091|P2|STARTED|Overall Study||1
8599939|NCT02891681|21204092|P1|STARTED|Overall Study||39
8599955|NCT02865538|21204171|P5|NOT COMPLETED|Overall Study||0
8599956|NCT02865538|21204172|P4|NOT COMPLETED|Overall Study||0
8599957|NCT02865538|21204173|P3|NOT COMPLETED|Overall Study||1
8599958|NCT02865538|21204174|P2|NOT COMPLETED|Overall Study||0
8599959|NCT02865538|21204175|P1|NOT COMPLETED|Overall Study||1
8599960|NCT02865538|21204171|P5|COMPLETED|Overall Study||13
8599961|NCT02865538|21204172|P4|COMPLETED|Overall Study||15
8599962|NCT02865538|21204173|P3|COMPLETED|Overall Study||14
8599963|NCT02865538|21204174|P2|COMPLETED|Overall Study||15
8599964|NCT02865538|21204175|P1|COMPLETED|Overall Study||17
8599965|NCT02865538|21204171|P5|STARTED|Overall Study||13
8599966|NCT02865538|21204172|P4|STARTED|Overall Study||15
8599967|NCT02865538|21204173|P3|STARTED|Overall Study||15
8599968|NCT02865538|21204174|P2|STARTED|Overall Study||15
8599969|NCT02865538|21204175|P1|STARTED|Overall Study||18
8599985|NCT02772978|21204501|P2|NOT COMPLETED|Overall Study||1
8599986|NCT02772978|21204502|P1|NOT COMPLETED|Overall Study||1
8599987|NCT02772978|21204501|P2|COMPLETED|Overall Study||8
8599988|NCT02772978|21204502|P1|COMPLETED|Overall Study|Last participant enrolled|9
8599989|NCT02772978|21204501|P2|STARTED|Overall Study||9
8599990|NCT02772978|21204502|P1|STARTED|Overall Study|First participant enrolled|10
8599997|NCT02734147|21204521|P2|NOT COMPLETED|Overall Study||1
8599998|NCT02734147|21204522|P1|NOT COMPLETED|Overall Study||3
8599999|NCT02734147|21204521|P2|COMPLETED|Overall Study||11
8600000|NCT02734147|21204522|P1|COMPLETED|Overall Study||9
8600001|NCT02734147|21204521|P2|STARTED|Overall Study||12
8600002|NCT02734147|21204522|P1|STARTED|Overall Study||12
8600003|NCT02704156|21204542|P2|NOT COMPLETED|Overall Study||0
8600004|NCT02704156|21204543|P1|NOT COMPLETED|Overall Study||0
8600005|NCT02704156|21204542|P2|COMPLETED|Overall Study||85
8600006|NCT02704156|21204543|P1|COMPLETED|Overall Study||85
8600007|NCT02704156|21204542|P2|STARTED|Overall Study||85
8600008|NCT02704156|21204543|P1|STARTED|Overall Study||85
8600060|NCT02638207|21204917|P3|NOT COMPLETED|Overall Study||4
8600061|NCT02638207|21204918|P2|NOT COMPLETED|Overall Study||8
8600062|NCT02638207|21204919|P1|NOT COMPLETED|Overall Study||7
8600063|NCT02638207|21204917|P3|COMPLETED|Overall Study||34
8600064|NCT02638207|21204918|P2|COMPLETED|Overall Study||61
8600065|NCT02638207|21204919|P1|COMPLETED|Overall Study||28
8600066|NCT02638207|21204917|P3|STARTED|Overall Study||38
8600067|NCT02638207|21204918|P2|STARTED|Overall Study||69
8600068|NCT02638207|21204919|P1|STARTED|Overall Study||35
8600151|NCT02528370|21205121|P2|NOT COMPLETED|Overall Study||1
8600152|NCT02528370|21205122|P1|NOT COMPLETED|Overall Study||17
8600153|NCT02528370|21205121|P2|COMPLETED|Overall Study||77
8600154|NCT02528370|21205122|P1|COMPLETED|Overall Study||102
8600155|NCT02528370|21205121|P2|STARTED|Overall Study||78
8600156|NCT02528370|21205122|P1|STARTED|Overall Study||119
8600157|NCT02499159|21205130|P2|NOT COMPLETED|30-Day Follow-Up Phone Call||2
8600158|NCT02499159|21205131|P1|NOT COMPLETED|30-Day Follow-Up Phone Call||7
8600159|NCT02499159|21205130|P2|COMPLETED|30-Day Follow-Up Phone Call||47
8600160|NCT02499159|21205131|P1|COMPLETED|30-Day Follow-Up Phone Call||42
8600161|NCT02499159|21205130|P2|STARTED|30-Day Follow-Up Phone Call||49
8600162|NCT02499159|21205131|P1|STARTED|30-Day Follow-Up Phone Call||49
8600163|NCT02499159|21205130|P2|NOT COMPLETED|Randomization||1
8600164|NCT02499159|21205131|P1|NOT COMPLETED|Randomization||1
8600165|NCT02499159|21205130|P2|COMPLETED|Randomization||49
8600166|NCT02499159|21205131|P1|COMPLETED|Randomization||49
8600167|NCT02499159|21205130|P2|STARTED|Randomization||50
8600168|NCT02499159|21205131|P1|STARTED|Randomization||50
8600487|NCT02235298|21205615|P2|NOT COMPLETED|Overall Study||8
8600488|NCT02235298|21205616|P1|NOT COMPLETED|Overall Study||8
8600489|NCT02235298|21205615|P2|COMPLETED|Overall Study||42
8600490|NCT02235298|21205616|P1|COMPLETED|Overall Study||42
8600491|NCT02235298|21205615|P2|STARTED|Overall Study||50
8600492|NCT02235298|21205616|P1|STARTED|Overall Study||50
8600528|NCT02206685|21205671|P2|NOT COMPLETED|Overall Study||7
8600529|NCT02206685|21205672|P1|NOT COMPLETED|Overall Study||5
8600530|NCT02206685|21205671|P2|COMPLETED|Overall Study||30
8600531|NCT02206685|21205672|P1|COMPLETED|Overall Study||32
8600532|NCT02206685|21205671|P2|STARTED|Overall Study||37
8600533|NCT02206685|21205672|P1|STARTED|Overall Study||37
8600544|NCT02190747|21205718|P3|NOT COMPLETED|Overall Study||0
8600545|NCT02190747|21205719|P2|NOT COMPLETED|Overall Study||0
8600546|NCT02190747|21205720|P1|NOT COMPLETED|Overall Study||0
8600547|NCT02190747|21205718|P3|COMPLETED|Overall Study||10
8600548|NCT02190747|21205719|P2|COMPLETED|Overall Study||9
8600549|NCT02190747|21205720|P1|COMPLETED|Overall Study||21
8600550|NCT02190747|21205718|P3|STARTED|Overall Study||10
8600551|NCT02190747|21205719|P2|STARTED|Overall Study||9
8600552|NCT02190747|21205720|P1|STARTED|Overall Study||21
8600559|NCT02178722|21205805|P5|NOT COMPLETED|Overall Study||382
8600560|NCT02178722|21205806|P4|NOT COMPLETED|Overall Study||20
8600561|NCT02178722|21205807|P3|NOT COMPLETED|Overall Study||18
8600562|NCT02178722|21205808|P2|NOT COMPLETED|Overall Study||20
8600563|NCT02178722|21205809|P1|NOT COMPLETED|Overall Study||4
8600564|NCT02178722|21205805|P5|COMPLETED|Overall Study||0
8600565|NCT02178722|21205806|P4|COMPLETED|Overall Study||0
8600566|NCT02178722|21205807|P3|COMPLETED|Overall Study||0
8600567|NCT02178722|21205808|P2|COMPLETED|Overall Study||0
8600568|NCT02178722|21205809|P1|COMPLETED|Overall Study||0
8600569|NCT02178722|21205805|P5|STARTED|Overall Study||382
8600570|NCT02178722|21205806|P4|STARTED|Overall Study||20
8600571|NCT02178722|21205807|P3|STARTED|Overall Study||18
8600572|NCT02178722|21205808|P2|STARTED|Overall Study||20
8600573|NCT02178722|21205809|P1|STARTED|Overall Study||4
8600574|NCT02139280|21205823|P2|NOT COMPLETED|Overall Study||0
8600575|NCT02139280|21205824|P1|NOT COMPLETED|Overall Study||2
8600576|NCT02139280|21205823|P2|COMPLETED|Overall Study||20
8600577|NCT02139280|21205824|P1|COMPLETED|Overall Study||32
8600578|NCT02139280|21205823|P2|STARTED|Overall Study||20
8600579|NCT02139280|21205824|P1|STARTED|Overall Study||34
8600675|NCT01928524|21206121|P7|NOT COMPLETED|Overall Study||0
8600676|NCT01928524|21206122|P6|NOT COMPLETED|Overall Study||0
8600677|NCT01928524|21206123|P5|NOT COMPLETED|Overall Study||0
8600678|NCT01928524|21206124|P4|NOT COMPLETED|Overall Study||0
8600679|NCT01928524|21206125|P3|NOT COMPLETED|Overall Study||0
8600680|NCT01928524|21206126|P2|NOT COMPLETED|Overall Study||0
8600681|NCT01928524|21206127|P1|NOT COMPLETED|Overall Study||0
8600682|NCT01928524|21206121|P7|COMPLETED|Overall Study||5
8600683|NCT01928524|21206122|P6|COMPLETED|Overall Study||8
8600684|NCT01928524|21206123|P5|COMPLETED|Overall Study||3
8600685|NCT01928524|21206124|P4|COMPLETED|Overall Study||6
8600686|NCT01928524|21206125|P3|COMPLETED|Overall Study||6
8600687|NCT01928524|21206126|P2|COMPLETED|Overall Study||3
8600688|NCT01928524|21206127|P1|COMPLETED|Overall Study||3
8600689|NCT01928524|21206121|P7|STARTED|Overall Study||5
8600690|NCT01928524|21206122|P6|STARTED|Overall Study||8
8600691|NCT01928524|21206123|P5|STARTED|Overall Study||3
8600692|NCT01928524|21206124|P4|STARTED|Overall Study||6
8600693|NCT01928524|21206125|P3|STARTED|Overall Study||6
8600694|NCT01928524|21206126|P2|STARTED|Overall Study||3
8600695|NCT01928524|21206127|P1|STARTED|Overall Study||3
8600763|NCT01756898|21206314|P4|NOT COMPLETED|Overall Study||16
8600764|NCT01756898|21206315|P3|NOT COMPLETED|Overall Study||17
8600765|NCT01756898|21206316|P2|NOT COMPLETED|Overall Study||19
8600766|NCT01756898|21206317|P1|NOT COMPLETED|Overall Study||19
8600767|NCT01756898|21206314|P4|COMPLETED|Overall Study||77
8600768|NCT01756898|21206315|P3|COMPLETED|Overall Study||76
8600769|NCT01756898|21206316|P2|COMPLETED|Overall Study||73
8600770|NCT01756898|21206317|P1|COMPLETED|Overall Study||73
8600771|NCT01756898|21206314|P4|STARTED|Overall Study||93
8600772|NCT01756898|21206315|P3|STARTED|Overall Study||93
8600773|NCT01756898|21206316|P2|STARTED|Overall Study||92
8600774|NCT01756898|21206317|P1|STARTED|Overall Study||92
8600916|NCT01581593|21206609|P1|NOT COMPLETED|Overall Study||1
8600917|NCT01581593|21206609|P1|COMPLETED|Overall Study||44
8600918|NCT01581593|21206609|P1|STARTED|Overall Study||45
8601049|NCT01212627|21206882|P1|NOT COMPLETED|Overall Study||0
8601050|NCT01212627|21206882|P1|COMPLETED|Overall Study||12
8601051|NCT01212627|21206882|P1|STARTED|Overall Study||12
8601073|NCT01102231|21206927|P1|NOT COMPLETED|Overall Study||15
8601074|NCT01102231|21206927|P1|COMPLETED|Overall Study||91
8601075|NCT01102231|21206927|P1|STARTED|Overall Study||106
8601124|NCT00866697|21207027|P2|NOT COMPLETED|Overall Study||228
8601125|NCT00866697|21207028|P1|NOT COMPLETED|Overall Study||214
8601126|NCT00866697|21207027|P2|COMPLETED|Overall Study||244
8601127|NCT00866697|21207028|P1|COMPLETED|Overall Study||254
8601128|NCT00866697|21207027|P2|STARTED|Overall Study||472
8601129|NCT00866697|21207028|P1|STARTED|Overall Study||468
8601211|NCT00470301|21207284|P1|NOT COMPLETED|Overall Study||5
8601212|NCT00470301|21207284|P1|COMPLETED|Overall Study||55
8601213|NCT00470301|21207284|P1|STARTED|Overall Study||60
8601328|NCT04563767|21207567|P1|NOT COMPLETED|Overall Study||0
8601329|NCT04563767|21207567|P1|COMPLETED|Overall Study||4
8601330|NCT04563767|21207567|P1|STARTED|Overall Study||4
8601364|NCT04073823|21207601|P2|NOT COMPLETED|Overall Study||0
8601365|NCT04073823|21207602|P1|NOT COMPLETED|Overall Study||0
8601366|NCT04073823|21207601|P2|COMPLETED|Overall Study||1
8601367|NCT04073823|21207602|P1|COMPLETED|Overall Study||1
8601368|NCT04073823|21207601|P2|STARTED|Overall Study||1
8601369|NCT04073823|21207602|P1|STARTED|Overall Study||1
8601397|NCT03905096|21207673|P2|NOT COMPLETED|Period 2 for Trial Part 1 and 2||0
8601398|NCT03905096|21207674|P1|NOT COMPLETED|Period 2 for Trial Part 1 and 2||1
8601399|NCT03905096|21207673|P2|COMPLETED|Period 2 for Trial Part 1 and 2||14
8601400|NCT03905096|21207674|P1|COMPLETED|Period 2 for Trial Part 1 and 2||17
8601401|NCT03905096|21207673|P2|STARTED|Period 2 for Trial Part 1 and 2||14
8601402|NCT03905096|21207674|P1|STARTED|Period 2 for Trial Part 1 and 2||18
8601403|NCT03905096|21207673|P2|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
8601404|NCT03905096|21207674|P1|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
8601405|NCT03905096|21207673|P2|COMPLETED|Period 1 for Trial Part 1 and 2||14
8601406|NCT03905096|21207674|P1|COMPLETED|Period 1 for Trial Part 1 and 2||18
8601407|NCT03905096|21207673|P2|STARTED|Period 1 for Trial Part 1 and 2||14
8601408|NCT03905096|21207674|P1|STARTED|Period 1 for Trial Part 1 and 2||18
8601409|NCT03790865|21207697|P3|NOT COMPLETED|Overall Study||0
8601410|NCT03790865|21207698|P2|NOT COMPLETED|Overall Study||2
8601411|NCT03790865|21207699|P1|NOT COMPLETED|Overall Study||0
8601412|NCT03790865|21207697|P3|COMPLETED|Overall Study||54
8601413|NCT03790865|21207698|P2|COMPLETED|Overall Study||50
8601414|NCT03790865|21207699|P1|COMPLETED|Overall Study||52
8601415|NCT03790865|21207697|P3|STARTED|Overall Study||54
8601416|NCT03790865|21207698|P2|STARTED|Overall Study||52
8601417|NCT03790865|21207699|P1|STARTED|Overall Study||52
8601418|NCT03723447|21207718|P2|NOT COMPLETED|Overall Study||0
8601419|NCT03723447|21207719|P1|NOT COMPLETED|Overall Study||0
8601420|NCT03723447|21207718|P2|COMPLETED|Overall Study||51
8601421|NCT03723447|21207719|P1|COMPLETED|Overall Study||50
8601422|NCT03723447|21207718|P2|STARTED|Overall Study||51
8601423|NCT03723447|21207719|P1|STARTED|Overall Study||50
8601439|NCT03576066|21207805|P2|NOT COMPLETED|Overall Study||1
8601440|NCT03576066|21207806|P1|NOT COMPLETED|Overall Study||0
8601441|NCT03576066|21207805|P2|COMPLETED|Overall Study||27
8601442|NCT03576066|21207806|P1|COMPLETED|Overall Study||45
8601443|NCT03576066|21207805|P2|STARTED|Overall Study||28
8601444|NCT03576066|21207806|P1|STARTED|Overall Study||45
8601487|NCT03442036|21207970|P2|NOT COMPLETED|Overall Study||0
8601488|NCT03442036|21207971|P1|NOT COMPLETED|Overall Study||0
8601489|NCT03442036|21207970|P2|COMPLETED|Overall Study||35
8601490|NCT03442036|21207971|P1|COMPLETED|Overall Study||35
8601491|NCT03442036|21207970|P2|STARTED|Overall Study||35
8601492|NCT03442036|21207971|P1|STARTED|Overall Study||35
8601493|NCT03433482|21207987|P4|NOT COMPLETED|Overall Study||1
8601494|NCT03433482|21207988|P3|NOT COMPLETED|Overall Study||4
8601495|NCT03433482|21207989|P2|NOT COMPLETED|Overall Study||0
8601496|NCT03433482|21207990|P1|NOT COMPLETED|Overall Study||1
8601497|NCT03433482|21207987|P4|COMPLETED|Overall Study||418
8601498|NCT03433482|21207988|P3|COMPLETED|Overall Study||423
8601499|NCT03433482|21207989|P2|COMPLETED|Overall Study||424
8601500|NCT03433482|21207990|P1|COMPLETED|Overall Study||419
8601501|NCT03433482|21207987|P4|STARTED|Overall Study||419
8601502|NCT03433482|21207988|P3|STARTED|Overall Study||427
8601503|NCT03433482|21207989|P2|STARTED|Overall Study||424
8601504|NCT03433482|21207990|P1|STARTED|Overall Study||420
8601505|NCT03425097|21208040|P2|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
8601506|NCT03425097|21208041|P1|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
8601507|NCT03425097|21208040|P2|COMPLETED|Second Treatment Period (2 Weeks)||5
8601508|NCT03425097|21208041|P1|COMPLETED|Second Treatment Period (2 Weeks)||6
8601509|NCT03425097|21208040|P2|STARTED|Second Treatment Period (2 Weeks)||5
8601510|NCT03425097|21208041|P1|STARTED|Second Treatment Period (2 Weeks)||6
8601511|NCT03425097|21208040|P2|NOT COMPLETED|Washout Period (1 Week)||0
8601512|NCT03425097|21208041|P1|NOT COMPLETED|Washout Period (1 Week)||0
8601513|NCT03425097|21208040|P2|COMPLETED|Washout Period (1 Week)||5
8601514|NCT03425097|21208041|P1|COMPLETED|Washout Period (1 Week)||6
8601515|NCT03425097|21208040|P2|STARTED|Washout Period (1 Week)||5
8601516|NCT03425097|21208041|P1|STARTED|Washout Period (1 Week)||6
8601517|NCT03425097|21208040|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
8601518|NCT03425097|21208041|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
8601519|NCT03425097|21208040|P2|COMPLETED|Treatment Period 1 (2 Weeks)||5
8601520|NCT03425097|21208041|P1|COMPLETED|Treatment Period 1 (2 Weeks)||6
8601521|NCT03425097|21208040|P2|STARTED|Treatment Period 1 (2 Weeks)||5
8601522|NCT03425097|21208041|P1|STARTED|Treatment Period 1 (2 Weeks)||6
8601575|NCT03226652|21208304|P1|NOT COMPLETED|Overall Study||0
8601576|NCT03226652|21208304|P1|COMPLETED|Overall Study||101
8601577|NCT03226652|21208304|P1|STARTED|Overall Study||101
8601578|NCT03193736|21208308|P1|NOT COMPLETED|Overall Study||5
8601579|NCT03193736|21208308|P1|COMPLETED|Overall Study||21
8601580|NCT03193736|21208308|P1|Received Implant|Overall Study||25
8601581|NCT03193736|21208308|P1|STARTED|Overall Study||26
8601603|NCT03008915|21208392|P2|NOT COMPLETED|Treatment 2||0
8601604|NCT03008915|21208393|P1|NOT COMPLETED|Treatment 2||0
8601605|NCT03008915|21208392|P2|COMPLETED|Treatment 2||6
8601606|NCT03008915|21208393|P1|COMPLETED|Treatment 2||8
8601607|NCT03008915|21208392|P2|STARTED|Treatment 2||6
8601608|NCT03008915|21208393|P1|STARTED|Treatment 2||8
8601609|NCT03008915|21208392|P2|NOT COMPLETED|Treatment 1||1
8601610|NCT03008915|21208393|P1|NOT COMPLETED|Treatment 1||0
8601611|NCT03008915|21208392|P2|COMPLETED|Treatment 1||6
8601612|NCT03008915|21208393|P1|COMPLETED|Treatment 1||8
8601613|NCT03008915|21208392|P2|STARTED|Treatment 1||7
8601614|NCT03008915|21208393|P1|STARTED|Treatment 1||8
8601621|NCT02978781|21208423|P5|NOT COMPLETED|Part C||4
8601622|NCT02978781|21208424|P4|NOT COMPLETED|Part C||0
8601623|NCT02978781|21208425|P3|NOT COMPLETED|Part C||0
8601624|NCT02978781|21208426|P2|NOT COMPLETED|Part C||0
8601625|NCT02978781|21208427|P1|NOT COMPLETED|Part C||0
8601626|NCT02978781|21208423|P5|COMPLETED|Part C||14
8601627|NCT02978781|21208424|P4|COMPLETED|Part C||0
8601628|NCT02978781|21208425|P3|COMPLETED|Part C||0
8601629|NCT02978781|21208426|P2|COMPLETED|Part C||0
8601630|NCT02978781|21208427|P1|COMPLETED|Part C||0
8601631|NCT02978781|21208423|P5|STARTED|Part C||18
8601632|NCT02978781|21208424|P4|STARTED|Part C||0
8601633|NCT02978781|21208425|P3|STARTED|Part C||0
8601634|NCT02978781|21208426|P2|STARTED|Part C||0
8601635|NCT02978781|21208427|P1|STARTED|Part C||0
8601636|NCT02978781|21208423|P5|NOT COMPLETED|Part B||0
8601637|NCT02978781|21208424|P4|NOT COMPLETED|Part B||1
8601638|NCT02978781|21208425|P3|NOT COMPLETED|Part B||0
8601639|NCT02978781|21208426|P2|NOT COMPLETED|Part B||0
8601640|NCT02978781|21208427|P1|NOT COMPLETED|Part B||0
8601641|NCT02978781|21208423|P5|COMPLETED|Part B||0
8601642|NCT02978781|21208424|P4|COMPLETED|Part B||3
8601643|NCT02978781|21208425|P3|COMPLETED|Part B||4
8601644|NCT02978781|21208426|P2|COMPLETED|Part B||0
8601645|NCT02978781|21208427|P1|COMPLETED|Part B||0
8601646|NCT02978781|21208423|P5|STARTED|Part B||0
8601647|NCT02978781|21208424|P4|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
8601648|NCT02978781|21208425|P3|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
8601649|NCT02978781|21208426|P2|STARTED|Part B||0
8601650|NCT02978781|21208427|P1|STARTED|Part B||0
8601651|NCT02978781|21208423|P5|NOT COMPLETED|Part A||0
8601652|NCT02978781|21208424|P4|NOT COMPLETED|Part A||0
8601653|NCT02978781|21208425|P3|NOT COMPLETED|Part A||0
8601654|NCT02978781|21208426|P2|NOT COMPLETED|Part A||2
8601655|NCT02978781|21208427|P1|NOT COMPLETED|Part A||1
8601656|NCT02978781|21208423|P5|COMPLETED|Part A||0
8601657|NCT02978781|21208424|P4|COMPLETED|Part A||0
8601658|NCT02978781|21208425|P3|COMPLETED|Part A||0
8601659|NCT02978781|21208426|P2|COMPLETED|Part A||12
8601660|NCT02978781|21208427|P1|COMPLETED|Part A||1
8601661|NCT02978781|21208423|P5|STARTED|Part A||0
8601662|NCT02978781|21208424|P4|STARTED|Part A||0
8601663|NCT02978781|21208425|P3|STARTED|Part A||0
8601664|NCT02978781|21208426|P2|STARTED|Part A||14
8601665|NCT02978781|21208427|P1|STARTED|Part A||2
8601669|NCT02935452|21208505|P2|NOT COMPLETED|Overall Study||1
8601670|NCT02935452|21208506|P1|NOT COMPLETED|Overall Study||3
8601671|NCT02935452|21208505|P2|COMPLETED|Overall Study||29
8601672|NCT02935452|21208506|P1|COMPLETED|Overall Study||27
8601673|NCT02935452|21208505|P2|STARTED|Overall Study||30
8601674|NCT02935452|21208506|P1|STARTED|Overall Study||30
8601678|NCT02928224|21208526|P4|NOT COMPLETED|Overall Study||221
8601679|NCT02928224|21208527|P3|NOT COMPLETED|Overall Study||220
8601680|NCT02928224|21208528|P2|NOT COMPLETED|Overall Study||224
8601681|NCT02928224|21208529|P1|NOT COMPLETED|Overall Study||37
8601682|NCT02928224|21208526|P4|COMPLETED|Overall Study||0
8601683|NCT02928224|21208527|P3|COMPLETED|Overall Study||0
8601684|NCT02928224|21208528|P2|COMPLETED|Overall Study||0
8601685|NCT02928224|21208529|P1|COMPLETED|Overall Study||0
8601686|NCT02928224|21208526|P4|STARTED|Overall Study||221
8601687|NCT02928224|21208527|P3|STARTED|Overall Study||220
8601688|NCT02928224|21208528|P2|STARTED|Overall Study||224
8601689|NCT02928224|21208529|P1|STARTED|Overall Study||37
8601690|NCT02924883|21208633|P2|NOT COMPLETED|Overall Study||69
8601691|NCT02924883|21208634|P1|NOT COMPLETED|Overall Study||133
8601692|NCT02924883|21208633|P2|COMPLETED|Overall Study||0
8601693|NCT02924883|21208634|P1|COMPLETED|Overall Study||0
8601694|NCT02924883|21208633|P2|STARTED|Overall Study||69
8601695|NCT02924883|21208634|P1|STARTED|Overall Study||133
8601705|NCT02832622|21208686|P1|NOT COMPLETED|Overall Study||1736
8601706|NCT02832622|21208686|P1|COMPLETED|Overall Study||433
8601707|NCT02832622|21208686|P1|STARTED|Overall Study||2169
8601711|NCT02748616|21208703|P1|NOT COMPLETED|Overall Study||7
8601712|NCT02748616|21208703|P1|COMPLETED|Overall Study||2
8601713|NCT02748616|21208703|P1|STARTED|Overall Study||9
8601717|NCT02691702|21208725|P11|NOT COMPLETED|Overall Study||2
8601718|NCT02691702|21208726|P10|NOT COMPLETED|Overall Study||2
8601719|NCT02691702|21208727|P9|NOT COMPLETED|Overall Study||2
8601720|NCT02691702|21208728|P8|NOT COMPLETED|Overall Study||0
8601721|NCT02691702|21208729|P7|NOT COMPLETED|Overall Study||3
8601722|NCT02691702|21208730|P6|NOT COMPLETED|Overall Study||3
8601723|NCT02691702|21208731|P5|NOT COMPLETED|Overall Study||0
8601724|NCT02691702|21208732|P4|NOT COMPLETED|Overall Study||0
8601725|NCT02691702|21208733|P3|NOT COMPLETED|Overall Study||1
8601726|NCT02691702|21208734|P2|NOT COMPLETED|Overall Study||1
8601727|NCT02691702|21208735|P1|NOT COMPLETED|Overall Study||2
8601728|NCT02691702|21208725|P11|COMPLETED|Overall Study||6
8601729|NCT02691702|21208726|P10|COMPLETED|Overall Study||6
8601730|NCT02691702|21208727|P9|COMPLETED|Overall Study||6
8601731|NCT02691702|21208728|P8|COMPLETED|Overall Study||12
8601732|NCT02691702|21208729|P7|COMPLETED|Overall Study||5
8601733|NCT02691702|21208730|P6|COMPLETED|Overall Study||5
8601734|NCT02691702|21208731|P5|COMPLETED|Overall Study||8
8601735|NCT02691702|21208732|P4|COMPLETED|Overall Study||8
8601736|NCT02691702|21208733|P3|COMPLETED|Overall Study||7
8601737|NCT02691702|21208734|P2|COMPLETED|Overall Study||10
8601738|NCT02691702|21208735|P1|COMPLETED|Overall Study||8
8601739|NCT02691702|21208725|P11|STARTED|Overall Study||8
8601740|NCT02691702|21208726|P10|STARTED|Overall Study||8
8601741|NCT02691702|21208727|P9|STARTED|Overall Study||8
8601742|NCT02691702|21208728|P8|STARTED|Overall Study||12
8601743|NCT02691702|21208729|P7|STARTED|Overall Study||8
8601744|NCT02691702|21208730|P6|STARTED|Overall Study||8
8601745|NCT02691702|21208731|P5|STARTED|Overall Study||8
8601746|NCT02691702|21208732|P4|STARTED|Overall Study||8
8601747|NCT02691702|21208733|P3|STARTED|Overall Study||8
8601748|NCT02691702|21208734|P2|STARTED|Overall Study||11
8601749|NCT02691702|21208735|P1|STARTED|Overall Study||10
8601771|NCT02586025|21209088|P2|NOT COMPLETED|Treatment-Free Follow-Up||35
8601772|NCT02586025|21209089|P1|NOT COMPLETED|Treatment-Free Follow-Up||56
8601773|NCT02586025|21209088|P2|COMPLETED|Treatment-Free Follow-Up||3
8601774|NCT02586025|21209089|P1|COMPLETED|Treatment-Free Follow-Up||3
8601775|NCT02586025|21209088|P2|STARTED|Treatment-Free Follow-Up||38
8601776|NCT02586025|21209089|P1|STARTED|Treatment-Free Follow-Up||59
8601777|NCT02586025|21209088|P2|NOT COMPLETED|Adjuvant Treatment||69
8601778|NCT02586025|21209089|P1|NOT COMPLETED|Adjuvant Treatment||139
8601779|NCT02586025|21209088|P2|COMPLETED|Adjuvant Treatment||34
8601780|NCT02586025|21209089|P1|COMPLETED|Adjuvant Treatment||69
8601781|NCT02586025|21209088|P2|Started Adjuvant HER2 Treatment|Adjuvant Treatment||99
8601782|NCT02586025|21209089|P1|Started Adjuvant HER2 Treatment|Adjuvant Treatment||204
8601783|NCT02586025|21209088|P2|Started Adjuvant FEC Treatment|Adjuvant Treatment||103
8601784|NCT02586025|21209089|P1|Started Adjuvant FEC Treatment|Adjuvant Treatment||208
8601785|NCT02586025|21209088|P2|STARTED|Adjuvant Treatment||103
8601786|NCT02586025|21209089|P1|STARTED|Adjuvant Treatment||208
8601787|NCT02586025|21209088|P2|NOT COMPLETED|Neoadjuvant Treatment||7
8601788|NCT02586025|21209089|P1|NOT COMPLETED|Neoadjuvant Treatment||11
8601789|NCT02586025|21209088|P2|COMPLETED|Neoadjuvant Treatment||103
8601790|NCT02586025|21209089|P1|COMPLETED|Neoadjuvant Treatment||208
8601791|NCT02586025|21209088|P2|Underwent Surgery|Neoadjuvant Treatment||105
8601792|NCT02586025|21209089|P1|Underwent Surgery|Neoadjuvant Treatment||210
8601793|NCT02586025|21209088|P2|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108
8601794|NCT02586025|21209089|P1|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214
8601795|NCT02586025|21209088|P2|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||110
8601796|NCT02586025|21209089|P1|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||218
8601797|NCT02586025|21209088|P2|STARTED|Neoadjuvant Treatment||110
8601798|NCT02586025|21209089|P1|STARTED|Neoadjuvant Treatment||219
8601817|NCT02462759|21209158|P3|NOT COMPLETED|Part 2: Open-Label Phase||0
8601818|NCT02462759|21209159|P2|NOT COMPLETED|Part 2: Open-Label Phase||0
8601819|NCT02462759|21209160|P1|NOT COMPLETED|Part 2: Open-Label Phase||0
8601820|NCT02462759|21209158|P3|COMPLETED|Part 2: Open-Label Phase||20
8601821|NCT02462759|21209159|P2|COMPLETED|Part 2: Open-Label Phase||0
8601822|NCT02462759|21209160|P1|COMPLETED|Part 2: Open-Label Phase||0
8601823|NCT02462759|21209158|P3|STARTED|Part 2: Open-Label Phase||20
8601824|NCT02462759|21209159|P2|STARTED|Part 2: Open-Label Phase||0
8601825|NCT02462759|21209160|P1|STARTED|Part 2: Open-Label Phase||0
8601826|NCT02462759|21209158|P3|NOT COMPLETED|Part 1: Double Blind||0
8601827|NCT02462759|21209159|P2|NOT COMPLETED|Part 1: Double Blind||0
8601828|NCT02462759|21209160|P1|NOT COMPLETED|Part 1: Double Blind||1
8601829|NCT02462759|21209158|P3|COMPLETED|Part 1: Double Blind||0
8601830|NCT02462759|21209159|P2|COMPLETED|Part 1: Double Blind||14
8601831|NCT02462759|21209160|P1|COMPLETED|Part 1: Double Blind||6
8601832|NCT02462759|21209158|P3|STARTED|Part 1: Double Blind||0
8601833|NCT02462759|21209159|P2|STARTED|Part 1: Double Blind||14
8601834|NCT02462759|21209160|P1|STARTED|Part 1: Double Blind||7
8601835|NCT02443740|21209212|P11|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601836|NCT02443740|21209213|P10|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601837|NCT02443740|21209214|P9|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601838|NCT02443740|21209215|P8|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601839|NCT02443740|21209216|P7|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601840|NCT02443740|21209217|P6|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601841|NCT02443740|21209218|P5|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601842|NCT02443740|21209219|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601843|NCT02443740|21209220|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601844|NCT02443740|21209221|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601845|NCT02443740|21209222|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||0
8601846|NCT02443740|21209212|P11|COMPLETED|Intervention Period 4 (3 Days)||0
8601847|NCT02443740|21209213|P10|COMPLETED|Intervention Period 4 (3 Days)||0
8601848|NCT02443740|21209214|P9|COMPLETED|Intervention Period 4 (3 Days)||0
8601849|NCT02443740|21209215|P8|COMPLETED|Intervention Period 4 (3 Days)||2
8601850|NCT02443740|21209216|P7|COMPLETED|Intervention Period 4 (3 Days)||2
8601851|NCT02443740|21209217|P6|COMPLETED|Intervention Period 4 (3 Days)||2
8601852|NCT02443740|21209218|P5|COMPLETED|Intervention Period 4 (3 Days)||2
8601853|NCT02443740|21209219|P4|COMPLETED|Intervention Period 4 (3 Days)||3
8601854|NCT02443740|21209220|P3|COMPLETED|Intervention Period 4 (3 Days)||2
8601855|NCT02443740|21209221|P2|COMPLETED|Intervention Period 4 (3 Days)||2
8601856|NCT02443740|21209222|P1|COMPLETED|Intervention Period 4 (3 Days)||1
8601857|NCT02443740|21209212|P11|STARTED|Intervention Period 4 (3 Days)||0
8601858|NCT02443740|21209213|P10|STARTED|Intervention Period 4 (3 Days)||0
8601859|NCT02443740|21209214|P9|STARTED|Intervention Period 4 (3 Days)||0
8601860|NCT02443740|21209215|P8|STARTED|Intervention Period 4 (3 Days)||2
8601861|NCT02443740|21209216|P7|STARTED|Intervention Period 4 (3 Days)||2
8601862|NCT02443740|21209217|P6|STARTED|Intervention Period 4 (3 Days)||2
8601863|NCT02443740|21209218|P5|STARTED|Intervention Period 4 (3 Days)||2
8601864|NCT02443740|21209219|P4|STARTED|Intervention Period 4 (3 Days)||3
8601865|NCT02443740|21209220|P3|STARTED|Intervention Period 4 (3 Days)||2
8601866|NCT02443740|21209221|P2|STARTED|Intervention Period 4 (3 Days)||2
8601867|NCT02443740|21209222|P1|STARTED|Intervention Period 4 (3 Days)||1
8601868|NCT02443740|21209212|P11|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601869|NCT02443740|21209213|P10|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601870|NCT02443740|21209214|P9|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601871|NCT02443740|21209215|P8|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601872|NCT02443740|21209216|P7|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601873|NCT02443740|21209217|P6|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601874|NCT02443740|21209218|P5|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601875|NCT02443740|21209219|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601876|NCT02443740|21209220|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601877|NCT02443740|21209221|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601878|NCT02443740|21209222|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8601879|NCT02443740|21209212|P11|COMPLETED|Washout Period 3 (7 Days)||0
8601880|NCT02443740|21209213|P10|COMPLETED|Washout Period 3 (7 Days)||0
8601881|NCT02443740|21209214|P9|COMPLETED|Washout Period 3 (7 Days)||0
8601882|NCT02443740|21209215|P8|COMPLETED|Washout Period 3 (7 Days)||2
8601883|NCT02443740|21209216|P7|COMPLETED|Washout Period 3 (7 Days)||2
8601884|NCT02443740|21209217|P6|COMPLETED|Washout Period 3 (7 Days)||2
8601885|NCT02443740|21209218|P5|COMPLETED|Washout Period 3 (7 Days)||2
8601886|NCT02443740|21209219|P4|COMPLETED|Washout Period 3 (7 Days)||3
8601887|NCT02443740|21209220|P3|COMPLETED|Washout Period 3 (7 Days)||2
8601888|NCT02443740|21209221|P2|COMPLETED|Washout Period 3 (7 Days)||2
8601889|NCT02443740|21209222|P1|COMPLETED|Washout Period 3 (7 Days)||1
8601890|NCT02443740|21209212|P11|STARTED|Washout Period 3 (7 Days)||0
8601891|NCT02443740|21209213|P10|STARTED|Washout Period 3 (7 Days)||0
8601892|NCT02443740|21209214|P9|STARTED|Washout Period 3 (7 Days)||0
8601893|NCT02443740|21209215|P8|STARTED|Washout Period 3 (7 Days)||2
8601894|NCT02443740|21209216|P7|STARTED|Washout Period 3 (7 Days)||2
8601895|NCT02443740|21209217|P6|STARTED|Washout Period 3 (7 Days)||2
8601896|NCT02443740|21209218|P5|STARTED|Washout Period 3 (7 Days)||2
8601897|NCT02443740|21209219|P4|STARTED|Washout Period 3 (7 Days)||3
8601898|NCT02443740|21209220|P3|STARTED|Washout Period 3 (7 Days)||2
8601899|NCT02443740|21209221|P2|STARTED|Washout Period 3 (7 Days)||2
8601900|NCT02443740|21209222|P1|STARTED|Washout Period 3 (7 Days)||1
8601901|NCT02443740|21209212|P11|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601902|NCT02443740|21209213|P10|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601903|NCT02443740|21209214|P9|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601904|NCT02443740|21209215|P8|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601905|NCT02443740|21209216|P7|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601906|NCT02443740|21209217|P6|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601907|NCT02443740|21209218|P5|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601908|NCT02443740|21209219|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601909|NCT02443740|21209220|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601910|NCT02443740|21209221|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601911|NCT02443740|21209222|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
8601912|NCT02443740|21209212|P11|COMPLETED|Intervention Period 3 (3 Days)||0
8601913|NCT02443740|21209213|P10|COMPLETED|Intervention Period 3 (3 Days)||0
8601914|NCT02443740|21209214|P9|COMPLETED|Intervention Period 3 (3 Days)||0
8601915|NCT02443740|21209215|P8|COMPLETED|Intervention Period 3 (3 Days)||2
8601916|NCT02443740|21209216|P7|COMPLETED|Intervention Period 3 (3 Days)||2
8601917|NCT02443740|21209217|P6|COMPLETED|Intervention Period 3 (3 Days)||2
8601918|NCT02443740|21209218|P5|COMPLETED|Intervention Period 3 (3 Days)||2
8601919|NCT02443740|21209219|P4|COMPLETED|Intervention Period 3 (3 Days)||3
8601920|NCT02443740|21209220|P3|COMPLETED|Intervention Period 3 (3 Days)||2
8601921|NCT02443740|21209221|P2|COMPLETED|Intervention Period 3 (3 Days)||2
8601922|NCT02443740|21209222|P1|COMPLETED|Intervention Period 3 (3 Days)||1
8601923|NCT02443740|21209212|P11|STARTED|Intervention Period 3 (3 Days)||0
8601924|NCT02443740|21209213|P10|STARTED|Intervention Period 3 (3 Days)||0
8601925|NCT02443740|21209214|P9|STARTED|Intervention Period 3 (3 Days)||0
8601926|NCT02443740|21209215|P8|STARTED|Intervention Period 3 (3 Days)||2
8601927|NCT02443740|21209216|P7|STARTED|Intervention Period 3 (3 Days)||2
8601928|NCT02443740|21209217|P6|STARTED|Intervention Period 3 (3 Days)||2
8601929|NCT02443740|21209218|P5|STARTED|Intervention Period 3 (3 Days)||2
8601930|NCT02443740|21209219|P4|STARTED|Intervention Period 3 (3 Days)||3
8601931|NCT02443740|21209220|P3|STARTED|Intervention Period 3 (3 Days)||2
8601932|NCT02443740|21209221|P2|STARTED|Intervention Period 3 (3 Days)||2
8601933|NCT02443740|21209222|P1|STARTED|Intervention Period 3 (3 Days)||1
8601934|NCT02443740|21209212|P11|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601935|NCT02443740|21209213|P10|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601936|NCT02443740|21209214|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601937|NCT02443740|21209215|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601938|NCT02443740|21209216|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601939|NCT02443740|21209217|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601940|NCT02443740|21209218|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601941|NCT02443740|21209219|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601942|NCT02443740|21209220|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601943|NCT02443740|21209221|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601944|NCT02443740|21209222|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8601945|NCT02443740|21209212|P11|COMPLETED|Washout Period 2 (7 Days)||0
8601946|NCT02443740|21209213|P10|COMPLETED|Washout Period 2 (7 Days)||0
8601947|NCT02443740|21209214|P9|COMPLETED|Washout Period 2 (7 Days)||0
8601948|NCT02443740|21209215|P8|COMPLETED|Washout Period 2 (7 Days)||2
8601949|NCT02443740|21209216|P7|COMPLETED|Washout Period 2 (7 Days)||2
8601950|NCT02443740|21209217|P6|COMPLETED|Washout Period 2 (7 Days)||2
8601951|NCT02443740|21209218|P5|COMPLETED|Washout Period 2 (7 Days)||2
8601952|NCT02443740|21209219|P4|COMPLETED|Washout Period 2 (7 Days)||3
8601953|NCT02443740|21209220|P3|COMPLETED|Washout Period 2 (7 Days)||2
8601954|NCT02443740|21209221|P2|COMPLETED|Washout Period 2 (7 Days)||2
8601955|NCT02443740|21209222|P1|COMPLETED|Washout Period 2 (7 Days)||1
8601956|NCT02443740|21209212|P11|STARTED|Washout Period 2 (7 Days)||0
8601957|NCT02443740|21209213|P10|STARTED|Washout Period 2 (7 Days)||0
8601958|NCT02443740|21209214|P9|STARTED|Washout Period 2 (7 Days)||0
8601959|NCT02443740|21209215|P8|STARTED|Washout Period 2 (7 Days)||2
8601960|NCT02443740|21209216|P7|STARTED|Washout Period 2 (7 Days)||2
8601961|NCT02443740|21209217|P6|STARTED|Washout Period 2 (7 Days)||2
8601962|NCT02443740|21209218|P5|STARTED|Washout Period 2 (7 Days)||2
8601963|NCT02443740|21209219|P4|STARTED|Washout Period 2 (7 Days)||3
8601964|NCT02443740|21209220|P3|STARTED|Washout Period 2 (7 Days)||2
8601965|NCT02443740|21209221|P2|STARTED|Washout Period 2 (7 Days)||2
8601966|NCT02443740|21209222|P1|STARTED|Washout Period 2 (7 Days)||1
8601967|NCT02443740|21209212|P11|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601968|NCT02443740|21209213|P10|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601969|NCT02443740|21209214|P9|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601970|NCT02443740|21209215|P8|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601971|NCT02443740|21209216|P7|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601972|NCT02443740|21209217|P6|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601973|NCT02443740|21209218|P5|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601974|NCT02443740|21209219|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601975|NCT02443740|21209220|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601976|NCT02443740|21209221|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601977|NCT02443740|21209222|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
8601978|NCT02443740|21209212|P11|COMPLETED|Intervention Period 2 (3 Days)||3
8601979|NCT02443740|21209213|P10|COMPLETED|Intervention Period 2 (3 Days)||3
8601980|NCT02443740|21209214|P9|COMPLETED|Intervention Period 2 (3 Days)||0
8601981|NCT02443740|21209215|P8|COMPLETED|Intervention Period 2 (3 Days)||2
8601982|NCT02443740|21209216|P7|COMPLETED|Intervention Period 2 (3 Days)||2
8601983|NCT02443740|21209217|P6|COMPLETED|Intervention Period 2 (3 Days)||2
8601984|NCT02443740|21209218|P5|COMPLETED|Intervention Period 2 (3 Days)||2
8601985|NCT02443740|21209219|P4|COMPLETED|Intervention Period 2 (3 Days)||3
8601986|NCT02443740|21209220|P3|COMPLETED|Intervention Period 2 (3 Days)||2
8601987|NCT02443740|21209221|P2|COMPLETED|Intervention Period 2 (3 Days)||2
8601988|NCT02443740|21209222|P1|COMPLETED|Intervention Period 2 (3 Days)||1
8601989|NCT02443740|21209212|P11|STARTED|Intervention Period 2 (3 Days)||3
8601990|NCT02443740|21209213|P10|STARTED|Intervention Period 2 (3 Days)||3
8601991|NCT02443740|21209214|P9|STARTED|Intervention Period 2 (3 Days)||0
8601992|NCT02443740|21209215|P8|STARTED|Intervention Period 2 (3 Days)||2
8601993|NCT02443740|21209216|P7|STARTED|Intervention Period 2 (3 Days)||2
8601994|NCT02443740|21209217|P6|STARTED|Intervention Period 2 (3 Days)||2
8601995|NCT02443740|21209218|P5|STARTED|Intervention Period 2 (3 Days)||2
8601996|NCT02443740|21209219|P4|STARTED|Intervention Period 2 (3 Days)||3
8601997|NCT02443740|21209220|P3|STARTED|Intervention Period 2 (3 Days)||2
8601998|NCT02443740|21209221|P2|STARTED|Intervention Period 2 (3 Days)||2
8601999|NCT02443740|21209222|P1|STARTED|Intervention Period 2 (3 Days)||1
8602000|NCT02443740|21209212|P11|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602001|NCT02443740|21209213|P10|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602002|NCT02443740|21209214|P9|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602003|NCT02443740|21209215|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602004|NCT02443740|21209216|P7|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602005|NCT02443740|21209217|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602006|NCT02443740|21209218|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602007|NCT02443740|21209219|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602008|NCT02443740|21209220|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602009|NCT02443740|21209221|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602010|NCT02443740|21209222|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8602011|NCT02443740|21209212|P11|COMPLETED|Washout Period 1 (7 Days)||3
8602012|NCT02443740|21209213|P10|COMPLETED|Washout Period 1 (7 Days)||3
8602013|NCT02443740|21209214|P9|COMPLETED|Washout Period 1 (7 Days)||0
8602014|NCT02443740|21209215|P8|COMPLETED|Washout Period 1 (7 Days)||2
8602015|NCT02443740|21209216|P7|COMPLETED|Washout Period 1 (7 Days)||2
8602016|NCT02443740|21209217|P6|COMPLETED|Washout Period 1 (7 Days)||2
8602017|NCT02443740|21209218|P5|COMPLETED|Washout Period 1 (7 Days)||2
8602018|NCT02443740|21209219|P4|COMPLETED|Washout Period 1 (7 Days)||3
8602019|NCT02443740|21209220|P3|COMPLETED|Washout Period 1 (7 Days)||2
8602020|NCT02443740|21209221|P2|COMPLETED|Washout Period 1 (7 Days)||2
8602021|NCT02443740|21209222|P1|COMPLETED|Washout Period 1 (7 Days)||1
8602022|NCT02443740|21209212|P11|STARTED|Washout Period 1 (7 Days)||3
8602023|NCT02443740|21209213|P10|STARTED|Washout Period 1 (7 Days)||3
8602024|NCT02443740|21209214|P9|STARTED|Washout Period 1 (7 Days)||0
8602025|NCT02443740|21209215|P8|STARTED|Washout Period 1 (7 Days)||2
8602026|NCT02443740|21209216|P7|STARTED|Washout Period 1 (7 Days)||2
8602027|NCT02443740|21209217|P6|STARTED|Washout Period 1 (7 Days)||2
8602028|NCT02443740|21209218|P5|STARTED|Washout Period 1 (7 Days)||2
8602029|NCT02443740|21209219|P4|STARTED|Washout Period 1 (7 Days)||3
8602030|NCT02443740|21209220|P3|STARTED|Washout Period 1 (7 Days)||2
8602031|NCT02443740|21209221|P2|STARTED|Washout Period 1 (7 Days)||2
8602032|NCT02443740|21209222|P1|STARTED|Washout Period 1 (7 Days)||1
8602033|NCT02443740|21209212|P11|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602034|NCT02443740|21209213|P10|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602035|NCT02443740|21209214|P9|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602036|NCT02443740|21209215|P8|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602037|NCT02443740|21209216|P7|NOT COMPLETED|Intervention Period 1 (3 Days)||1
8602038|NCT02443740|21209217|P6|NOT COMPLETED|Intervention Period 1 (3 Days)||2
8602039|NCT02443740|21209218|P5|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602040|NCT02443740|21209219|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602041|NCT02443740|21209220|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602042|NCT02443740|21209221|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
8602043|NCT02443740|21209222|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||1
8602044|NCT02443740|21209212|P11|COMPLETED|Intervention Period 1 (3 Days)||3
8602045|NCT02443740|21209213|P10|COMPLETED|Intervention Period 1 (3 Days)||3
8602046|NCT02443740|21209214|P9|COMPLETED|Intervention Period 1 (3 Days)||6
8602047|NCT02443740|21209215|P8|COMPLETED|Intervention Period 1 (3 Days)||2
8602048|NCT02443740|21209216|P7|COMPLETED|Intervention Period 1 (3 Days)||2
8602049|NCT02443740|21209217|P6|COMPLETED|Intervention Period 1 (3 Days)||2
8602050|NCT02443740|21209218|P5|COMPLETED|Intervention Period 1 (3 Days)||2
8602051|NCT02443740|21209219|P4|COMPLETED|Intervention Period 1 (3 Days)||3
8602052|NCT02443740|21209220|P3|COMPLETED|Intervention Period 1 (3 Days)||2
8602053|NCT02443740|21209221|P2|COMPLETED|Intervention Period 1 (3 Days)||2
8602054|NCT02443740|21209222|P1|COMPLETED|Intervention Period 1 (3 Days)||1
8602055|NCT02443740|21209212|P11|STARTED|Intervention Period 1 (3 Days)||3
8602056|NCT02443740|21209213|P10|STARTED|Intervention Period 1 (3 Days)||3
8602057|NCT02443740|21209214|P9|STARTED|Intervention Period 1 (3 Days)||6
8602058|NCT02443740|21209215|P8|STARTED|Intervention Period 1 (3 Days)||2
8602059|NCT02443740|21209216|P7|STARTED|Intervention Period 1 (3 Days)||3
8602060|NCT02443740|21209217|P6|STARTED|Intervention Period 1 (3 Days)||4
8602061|NCT02443740|21209218|P5|STARTED|Intervention Period 1 (3 Days)||2
8602062|NCT02443740|21209219|P4|STARTED|Intervention Period 1 (3 Days)||3
8602063|NCT02443740|21209220|P3|STARTED|Intervention Period 1 (3 Days)||2
8602064|NCT02443740|21209221|P2|STARTED|Intervention Period 1 (3 Days)||2
8602065|NCT02443740|21209222|P1|STARTED|Intervention Period 1 (3 Days)||2
8602078|NCT02377752|21209464|P4|NOT COMPLETED|Overall Study||0
8602079|NCT02377752|21209465|P3|NOT COMPLETED|Overall Study||0
8602080|NCT02377752|21209466|P2|NOT COMPLETED|Overall Study||0
8602081|NCT02377752|21209467|P1|NOT COMPLETED|Overall Study||0
8602082|NCT02377752|21209464|P4|COMPLETED|Overall Study||6
8602083|NCT02377752|21209465|P3|COMPLETED|Overall Study||6
8602084|NCT02377752|21209466|P2|COMPLETED|Overall Study||6
8602085|NCT02377752|21209467|P1|COMPLETED|Overall Study||7
8602086|NCT02377752|21209464|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
8602087|NCT02377752|21209465|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8602088|NCT02377752|21209466|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
8602089|NCT02377752|21209467|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
8602090|NCT02377752|21209464|P4|STARTED|Overall Study||6
8602091|NCT02377752|21209465|P3|STARTED|Overall Study||6
8602092|NCT02377752|21209466|P2|STARTED|Overall Study||6
8602093|NCT02377752|21209467|P1|STARTED|Overall Study||7
8602109|NCT02292537|21209520|P2|NOT COMPLETED|Overall Study||0
8602110|NCT02292537|21209521|P1|NOT COMPLETED|Overall Study||0
8602111|NCT02292537|21209520|P2|COMPLETED|Overall Study||84
8602112|NCT02292537|21209521|P1|COMPLETED|Overall Study||42
8602113|NCT02292537|21209520|P2|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
8602114|NCT02292537|21209521|P1|Completed Treatment|Overall Study||42
8602115|NCT02292537|21209520|P2|STARTED|Overall Study||84
8602116|NCT02292537|21209521|P1|STARTED|Overall Study||42
8602164|NCT02193074|21209648|P2|NOT COMPLETED|Overall Study||15
8602165|NCT02193074|21209649|P1|NOT COMPLETED|Overall Study||17
8602166|NCT02193074|21209648|P2|COMPLETED|Overall Study||65
8602167|NCT02193074|21209649|P1|COMPLETED|Overall Study||24
8602168|NCT02193074|21209648|P2|Completed Due to Early Study Termination|Overall Study||39
8602169|NCT02193074|21209649|P1|Completed Due to Early Study Termination|Overall Study||13
8602170|NCT02193074|21209648|P2|Completed During Follow-Up Period|Overall Study||26
8602171|NCT02193074|21209649|P1|Completed During Follow-Up Period|Overall Study||11
8602172|NCT02193074|21209648|P2|STARTED|Overall Study|Randomized and received double-blind treatment.|80
8602173|NCT02193074|21209649|P1|STARTED|Overall Study|Randomized and received double-blind treatment.|41
8602183|NCT02114606|21209717|P1|NOT COMPLETED|Overall Study||6
8602184|NCT02114606|21209717|P1|COMPLETED|Overall Study||80
8602185|NCT02114606|21209717|P1|STARTED|Overall Study||86
8602301|NCT01839656|21210015|P2|NOT COMPLETED|Overall Study||16
8602302|NCT01839656|21210016|P1|NOT COMPLETED|Overall Study||3
8602303|NCT01839656|21210015|P2|COMPLETED|Overall Study||0
8602304|NCT01839656|21210016|P1|COMPLETED|Overall Study||2
8602305|NCT01839656|21210015|P2|Completed Loading Dose Period|Overall Study||15
8602306|NCT01839656|21210016|P1|Completed Loading Dose Period|Overall Study||4
8602307|NCT01839656|21210015|P2|STARTED|Overall Study||16
8602308|NCT01839656|21210016|P1|STARTED|Overall Study||5
8602327|NCT01670097|21210085|P2|NOT COMPLETED|Overall Study||4
8602328|NCT01670097|21210086|P1|NOT COMPLETED|Overall Study||2
8602329|NCT01670097|21210085|P2|COMPLETED|Overall Study||17
8602330|NCT01670097|21210086|P1|COMPLETED|Overall Study||18
8602331|NCT01670097|21210085|P2|Completed Week 2 Intervention|Overall Study||15
8602332|NCT01670097|21210086|P1|Completed Week 2 Intervention|Overall Study||13
8602333|NCT01670097|21210085|P2|Completed Week 1 Intervention|Overall Study||17
8602334|NCT01670097|21210086|P1|Completed Week 1 Intervention|Overall Study||18
8602335|NCT01670097|21210085|P2|STARTED|Overall Study||21
8602336|NCT01670097|21210086|P1|STARTED|Overall Study||20
8602337|NCT01609556|21210114|P16|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||40
8602338|NCT01609556|21210115|P15|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||27
8602339|NCT01609556|21210116|P14|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||24
8602340|NCT01609556|21210117|P13|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||46
8602341|NCT01609556|21210118|P12|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602342|NCT01609556|21210119|P11|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602343|NCT01609556|21210120|P10|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602344|NCT01609556|21210121|P9|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602345|NCT01609556|21210122|P8|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602346|NCT01609556|21210123|P7|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602347|NCT01609556|21210124|P6|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602348|NCT01609556|21210125|P5|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602349|NCT01609556|21210126|P4|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602350|NCT01609556|21210127|P3|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602351|NCT01609556|21210128|P2|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602352|NCT01609556|21210129|P1|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602353|NCT01609556|21210114|P16|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602354|NCT01609556|21210115|P15|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602355|NCT01609556|21210116|P14|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602356|NCT01609556|21210117|P13|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602357|NCT01609556|21210118|P12|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602358|NCT01609556|21210119|P11|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602359|NCT01609556|21210120|P10|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602360|NCT01609556|21210121|P9|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602361|NCT01609556|21210122|P8|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602362|NCT01609556|21210123|P7|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602363|NCT01609556|21210124|P6|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602364|NCT01609556|21210125|P5|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602365|NCT01609556|21210126|P4|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602366|NCT01609556|21210127|P3|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602367|NCT01609556|21210128|P2|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602368|NCT01609556|21210129|P1|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
8602369|NCT01609556|21210114|P16|STARTED|Dose Expansion: Maximum 124 Weeks||40
8602370|NCT01609556|21210115|P15|STARTED|Dose Expansion: Maximum 124 Weeks||27
8602371|NCT01609556|21210116|P14|STARTED|Dose Expansion: Maximum 124 Weeks||24
8602372|NCT01609556|21210117|P13|STARTED|Dose Expansion: Maximum 124 Weeks||46
8602373|NCT01609556|21210118|P12|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602374|NCT01609556|21210119|P11|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602375|NCT01609556|21210120|P10|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602376|NCT01609556|21210121|P9|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602377|NCT01609556|21210122|P8|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602378|NCT01609556|21210123|P7|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602379|NCT01609556|21210124|P6|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602380|NCT01609556|21210125|P5|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602381|NCT01609556|21210126|P4|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602382|NCT01609556|21210127|P3|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602383|NCT01609556|21210128|P2|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602384|NCT01609556|21210129|P1|STARTED|Dose Expansion: Maximum 124 Weeks||0
8602385|NCT01609556|21210114|P16|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602386|NCT01609556|21210115|P15|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602387|NCT01609556|21210116|P14|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602388|NCT01609556|21210117|P13|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602389|NCT01609556|21210118|P12|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
8602390|NCT01609556|21210119|P11|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
8602391|NCT01609556|21210120|P10|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||4
8602392|NCT01609556|21210121|P9|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
8602393|NCT01609556|21210122|P8|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
8602394|NCT01609556|21210123|P7|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
8602395|NCT01609556|21210124|P6|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||18
8602396|NCT01609556|21210125|P5|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
8602397|NCT01609556|21210126|P4|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
8602398|NCT01609556|21210127|P3|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
8602399|NCT01609556|21210128|P2|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
8602400|NCT01609556|21210129|P1|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||2
8602401|NCT01609556|21210114|P16|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602402|NCT01609556|21210115|P15|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602403|NCT01609556|21210116|P14|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602404|NCT01609556|21210117|P13|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602405|NCT01609556|21210118|P12|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602406|NCT01609556|21210119|P11|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602407|NCT01609556|21210120|P10|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602408|NCT01609556|21210121|P9|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602409|NCT01609556|21210122|P8|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602410|NCT01609556|21210123|P7|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602411|NCT01609556|21210124|P6|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602412|NCT01609556|21210125|P5|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602413|NCT01609556|21210126|P4|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602414|NCT01609556|21210127|P3|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602415|NCT01609556|21210128|P2|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602416|NCT01609556|21210129|P1|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
8602417|NCT01609556|21210114|P16|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
8602418|NCT01609556|21210115|P15|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
8602419|NCT01609556|21210116|P14|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
8602420|NCT01609556|21210117|P13|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
8602421|NCT01609556|21210118|P12|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
8602422|NCT01609556|21210119|P11|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
8602423|NCT01609556|21210120|P10|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||4
8602424|NCT01609556|21210121|P9|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
8602425|NCT01609556|21210122|P8|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
8602426|NCT01609556|21210123|P7|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
8602427|NCT01609556|21210124|P6|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||18
8602428|NCT01609556|21210125|P5|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
8602429|NCT01609556|21210126|P4|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
8602430|NCT01609556|21210127|P3|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
8602431|NCT01609556|21210128|P2|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
8602432|NCT01609556|21210129|P1|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||2
8602433|NCT01609556|21210114|P16|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
8602434|NCT01609556|21210115|P15|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
8602435|NCT01609556|21210116|P14|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
8602436|NCT01609556|21210117|P13|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
8602437|NCT01609556|21210118|P12|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
8602438|NCT01609556|21210119|P11|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
8602439|NCT01609556|21210120|P10|STARTED|Dose Escalation: Maximum 101.3 Weeks||4
8602440|NCT01609556|21210121|P9|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
8602441|NCT01609556|21210122|P8|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
8602442|NCT01609556|21210123|P7|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
8602443|NCT01609556|21210124|P6|STARTED|Dose Escalation: Maximum 101.3 Weeks||18
8602444|NCT01609556|21210125|P5|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
8602445|NCT01609556|21210126|P4|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
8602446|NCT01609556|21210127|P3|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
8602447|NCT01609556|21210128|P2|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
8602448|NCT01609556|21210129|P1|STARTED|Dose Escalation: Maximum 101.3 Weeks||2
8602449|NCT01584648|21210291|P2|NOT COMPLETED|Overall Study||212
8602450|NCT01584648|21210292|P1|NOT COMPLETED|Overall Study||211
8602451|NCT01584648|21210291|P2|COMPLETED|Overall Study||0
8602452|NCT01584648|21210292|P1|COMPLETED|Overall Study||0
8602453|NCT01584648|21210291|P2|Crossover Population|Overall Study||28
8602454|NCT01584648|21210292|P1|Crossover Population|Overall Study||0
8602455|NCT01584648|21210291|P2|Safety Set|Overall Study||211
8602456|NCT01584648|21210292|P1|Safety Set|Overall Study||209
8602457|NCT01584648|21210291|P2|STARTED|Overall Study||212
8602458|NCT01584648|21210292|P1|STARTED|Overall Study||211
8602459|NCT01571596|21210319|P3|NOT COMPLETED|Overall Study||1
8602460|NCT01571596|21210320|P2|NOT COMPLETED|Overall Study||1
8602461|NCT01571596|21210321|P1|NOT COMPLETED|Overall Study||2
8602462|NCT01571596|21210319|P3|COMPLETED|Overall Study||0
8602463|NCT01571596|21210320|P2|COMPLETED|Overall Study||0
8602464|NCT01571596|21210321|P1|COMPLETED|Overall Study||19
8602465|NCT01571596|21210319|P3|STARTED|Overall Study||1
8602466|NCT01571596|21210320|P2|STARTED|Overall Study||1
8602467|NCT01571596|21210321|P1|STARTED|Overall Study||21
8602477|NCT01530256|21210356|P1|NOT COMPLETED|Overall Study||2
8602478|NCT01530256|21210356|P1|COMPLETED|Overall Study||1
8602479|NCT01530256|21210356|P1|STARTED|Overall Study||3
8602528|NCT01470248|21210425|P1|NOT COMPLETED|Overall Study||1
8602529|NCT01470248|21210425|P1|COMPLETED|Overall Study||19
8602530|NCT01470248|21210425|P1|STARTED|Overall Study||20
8602567|NCT01270321|21210524|P3|NOT COMPLETED|Overall Study||9
8602568|NCT01270321|21210525|P2|NOT COMPLETED|Overall Study||10
8602569|NCT01270321|21210526|P1|NOT COMPLETED|Overall Study||10
8602570|NCT01270321|21210524|P3|COMPLETED|Overall Study||3
8602571|NCT01270321|21210525|P2|COMPLETED|Overall Study||1
8602572|NCT01270321|21210526|P1|COMPLETED|Overall Study||9
8602573|NCT01270321|21210524|P3|STARTED|Overall Study||12
8602574|NCT01270321|21210525|P2|STARTED|Overall Study||11
8602575|NCT01270321|21210526|P1|STARTED|Overall Study||19
8602663|NCT00696761|21210699|P4|NOT COMPLETED|Overall Study||10
8602664|NCT00696761|21210700|P3|NOT COMPLETED|Overall Study||11
8602665|NCT00696761|21210701|P2|NOT COMPLETED|Overall Study||26
8602666|NCT00696761|21210702|P1|NOT COMPLETED|Overall Study||20
8602667|NCT00696761|21210699|P4|COMPLETED|Overall Study||44
8602668|NCT00696761|21210700|P3|COMPLETED|Overall Study||30
8602669|NCT00696761|21210701|P2|COMPLETED|Overall Study||50
8602670|NCT00696761|21210702|P1|COMPLETED|Overall Study||41
8602671|NCT00696761|21210699|P4|STARTED|Overall Study||54
8602672|NCT00696761|21210700|P3|STARTED|Overall Study||41
8602673|NCT00696761|21210701|P2|STARTED|Overall Study||76
8602674|NCT00696761|21210702|P1|STARTED|Overall Study||61
8602693|NCT00616967|21210789|P3|NOT COMPLETED|Overall Study||1
8602694|NCT00616967|21210790|P2|NOT COMPLETED|Overall Study||0
8602695|NCT00616967|21210791|P1|NOT COMPLETED|Overall Study||0
8602696|NCT00616967|21210789|P3|COMPLETED|Overall Study||30
8602697|NCT00616967|21210790|P2|COMPLETED|Overall Study||31
8602698|NCT00616967|21210791|P1|COMPLETED|Overall Study||6
8602699|NCT00616967|21210789|P3|STARTED|Overall Study||31
8602700|NCT00616967|21210790|P2|STARTED|Overall Study||31
8602701|NCT00616967|21210791|P1|STARTED|Overall Study||6
8602720|NCT00497874|21210860|P2|NOT COMPLETED|Overall Study||116
8602721|NCT00497874|21210861|P1|NOT COMPLETED|Overall Study||147
8602722|NCT00497874|21210860|P2|COMPLETED|Overall Study||343
8602723|NCT00497874|21210861|P1|COMPLETED|Overall Study||296
8602724|NCT00497874|21210860|P2|STARTED|Overall Study||459
8602725|NCT00497874|21210861|P1|STARTED|Overall Study||443
8602729|NCT00448812|21210923|P2|NOT COMPLETED|Year 5||0
8602730|NCT00448812|21210924|P1|NOT COMPLETED|Year 5||1
8602731|NCT00448812|21210923|P2|COMPLETED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
8602732|NCT00448812|21210924|P1|COMPLETED|Year 5||42
8602733|NCT00448812|21210923|P2|STARTED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
8602734|NCT00448812|21210924|P1|STARTED|Year 5||43
8602735|NCT00448812|21210923|P2|NOT COMPLETED|Year 4||0
8602736|NCT00448812|21210924|P1|NOT COMPLETED|Year 4||0
8602737|NCT00448812|21210923|P2|COMPLETED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
8602738|NCT00448812|21210924|P1|COMPLETED|Year 4||43
8602739|NCT00448812|21210923|P2|STARTED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
8602740|NCT00448812|21210924|P1|STARTED|Year 4||43
8602741|NCT00448812|21210923|P2|NOT COMPLETED|Year 3||3
8602742|NCT00448812|21210924|P1|NOT COMPLETED|Year 3||4
8602743|NCT00448812|21210923|P2|COMPLETED|Year 3||21
8602744|NCT00448812|21210924|P1|COMPLETED|Year 3||41
8602745|NCT00448812|21210923|P2|STARTED|Year 3||24
8602746|NCT00448812|21210924|P1|STARTED|Year 3||45
8602747|NCT00448812|21210923|P2|NOT COMPLETED|Year 2||1
8602748|NCT00448812|21210924|P1|NOT COMPLETED|Year 2||4
8602749|NCT00448812|21210923|P2|COMPLETED|Year 2||23
8602750|NCT00448812|21210924|P1|COMPLETED|Year 2||41
8602751|NCT00448812|21210923|P2|STARTED|Year 2||24
8602752|NCT00448812|21210924|P1|STARTED|Year 2||45
8602753|NCT00448812|21210923|P2|NOT COMPLETED|Year 1||0
8602754|NCT00448812|21210924|P1|NOT COMPLETED|Year 1||0
8602755|NCT00448812|21210923|P2|COMPLETED|Year 1||24
8602756|NCT00448812|21210924|P1|COMPLETED|Year 1||45
8602757|NCT00448812|21210923|P2|STARTED|Year 1||24
8602758|NCT00448812|21210924|P1|STARTED|Year 1||45
8602819|NCT00064259|21211128|P4|NOT COMPLETED|Overall Study||1
8602820|NCT00064259|21211129|P3|NOT COMPLETED|Overall Study||0
8602821|NCT00064259|21211130|P2|NOT COMPLETED|Overall Study||0
8602822|NCT00064259|21211131|P1|NOT COMPLETED|Overall Study||1
8602823|NCT00064259|21211128|P4|COMPLETED|Overall Study||0
8602824|NCT00064259|21211129|P3|COMPLETED|Overall Study||6
8602825|NCT00064259|21211130|P2|COMPLETED|Overall Study||4
8602826|NCT00064259|21211131|P1|COMPLETED|Overall Study||3
8602827|NCT00064259|21211128|P4|STARTED|Overall Study||1
8602828|NCT00064259|21211129|P3|STARTED|Overall Study||6
8602829|NCT00064259|21211130|P2|STARTED|Overall Study||4
8602830|NCT00064259|21211131|P1|STARTED|Overall Study||4
8602840|NCT04331366|21211181|P1|NOT COMPLETED|Overall Study||0
8602841|NCT04331366|21211181|P1|COMPLETED|Overall Study||2
8602842|NCT04331366|21211181|P1|STARTED|Overall Study||2
8602843|NCT04203225|21211191|P2|NOT COMPLETED|Overall Study||0
8602844|NCT04203225|21211192|P1|NOT COMPLETED|Overall Study||0
8602845|NCT04203225|21211191|P2|COMPLETED|Overall Study||27
8602846|NCT04203225|21211192|P1|COMPLETED|Overall Study||21
8602847|NCT04203225|21211191|P2|STARTED|Overall Study||27
8602848|NCT04203225|21211192|P1|STARTED|Overall Study||21
8602852|NCT04005404|21211210|P3|NOT COMPLETED|Overall Study||0
8602853|NCT04005404|21211211|P2|NOT COMPLETED|Overall Study||1
8602854|NCT04005404|21211212|P1|NOT COMPLETED|Overall Study||1
8602855|NCT04005404|21211210|P3|COMPLETED|Overall Study||3
8602856|NCT04005404|21211211|P2|COMPLETED|Overall Study||33
8602857|NCT04005404|21211212|P1|COMPLETED|Overall Study||42
8602858|NCT04005404|21211210|P3|STARTED|Overall Study||3
8602859|NCT04005404|21211211|P2|STARTED|Overall Study||34
8602860|NCT04005404|21211212|P1|STARTED|Overall Study||43
8602942|NCT03650452|21211450|P2|NOT COMPLETED|Overall Study||5
8602943|NCT03650452|21211451|P1|NOT COMPLETED|Overall Study||10
8602944|NCT03650452|21211450|P2|COMPLETED|Overall Study||66
8602945|NCT03650452|21211451|P1|COMPLETED|Overall Study||60
8602946|NCT03650452|21211450|P2|STARTED|Overall Study||71
8602947|NCT03650452|21211451|P1|STARTED|Overall Study||70
8602960|NCT03574181|21211530|P1|NOT COMPLETED|Overall Study||9
8602961|NCT03574181|21211530|P1|COMPLETED|Overall Study||0
8602962|NCT03574181|21211530|P1|STARTED|Overall Study||9
8602978|NCT03538678|21211614|P2|NOT COMPLETED|Overall Study||11
8602979|NCT03538678|21211615|P1|NOT COMPLETED|Overall Study||15
8602980|NCT03538678|21211614|P2|COMPLETED|Overall Study||9
8602981|NCT03538678|21211615|P1|COMPLETED|Overall Study||5
8602982|NCT03538678|21211614|P2|STARTED|Overall Study||20
8602983|NCT03538678|21211615|P1|STARTED|Overall Study||20
8602984|NCT03511326|21211631|P1|NOT COMPLETED|Overall Study||1
8602985|NCT03511326|21211631|P1|COMPLETED|Overall Study||49
8602986|NCT03511326|21211631|P1|STARTED|Overall Study||50
8602987|NCT03502798|21211638|P2|NOT COMPLETED|Overall Study||7
8602988|NCT03502798|21211639|P1|NOT COMPLETED|Overall Study||0
8602989|NCT03502798|21211638|P2|COMPLETED|Overall Study||33
8602990|NCT03502798|21211639|P1|COMPLETED|Overall Study||5
8602991|NCT03502798|21211638|P2|STARTED|Overall Study||40
8602992|NCT03502798|21211639|P1|STARTED|Overall Study||5
8603002|NCT03489369|21211666|P4|NOT COMPLETED|Overall Study||6
8603003|NCT03489369|21211667|P3|NOT COMPLETED|Overall Study||3
8603004|NCT03489369|21211668|P2|NOT COMPLETED|Overall Study||3
8603005|NCT03489369|21211669|P1|NOT COMPLETED|Overall Study||3
8603006|NCT03489369|21211666|P4|COMPLETED|Overall Study||0
8603007|NCT03489369|21211667|P3|COMPLETED|Overall Study||0
8603008|NCT03489369|21211668|P2|COMPLETED|Overall Study||0
8603009|NCT03489369|21211669|P1|COMPLETED|Overall Study||0
8603010|NCT03489369|21211666|P4|STARTED|Overall Study||6
8603011|NCT03489369|21211667|P3|STARTED|Overall Study||3
8603012|NCT03489369|21211668|P2|STARTED|Overall Study||3
8603013|NCT03489369|21211669|P1|STARTED|Overall Study||3
8603032|NCT03391115|21211741|P2|NOT COMPLETED|Overall Study||0
8603033|NCT03391115|21211742|P1|NOT COMPLETED|Overall Study||0
8603034|NCT03391115|21211741|P2|COMPLETED|Overall Study|Two Nurse participants in the dyadic patient-nurse enrollment were not successfully recruited.|18
8603035|NCT03391115|21211742|P1|COMPLETED|Overall Study||20
8603036|NCT03391115|21211741|P2|STARTED|Overall Study||18
8603037|NCT03391115|21211742|P1|STARTED|Overall Study||20
8603044|NCT03364751|21211763|P4|NOT COMPLETED|Overall Study||0
8603045|NCT03364751|21211764|P3|NOT COMPLETED|Overall Study||0
8603046|NCT03364751|21211765|P2|NOT COMPLETED|Overall Study||1
8603047|NCT03364751|21211766|P1|NOT COMPLETED|Overall Study||1
8603048|NCT03364751|21211763|P4|COMPLETED|Overall Study||1
8603049|NCT03364751|21211764|P3|COMPLETED|Overall Study||17
8603050|NCT03364751|21211765|P2|COMPLETED|Overall Study||83
8603051|NCT03364751|21211766|P1|COMPLETED|Overall Study||69
8603052|NCT03364751|21211763|P4|STARTED|Overall Study||1
8603053|NCT03364751|21211764|P3|STARTED|Overall Study||17
8603054|NCT03364751|21211765|P2|STARTED|Overall Study||84
8603055|NCT03364751|21211766|P1|STARTED|Overall Study||70
8603076|NCT03334903|21211850|P2|NOT COMPLETED|Overall Study||5
8603077|NCT03334903|21211851|P1|NOT COMPLETED|Overall Study||4
8603078|NCT03334903|21211850|P2|COMPLETED|Overall Study||33
8603079|NCT03334903|21211851|P1|COMPLETED|Overall Study||35
8603080|NCT03334903|21211850|P2|STARTED|Overall Study||38
8603081|NCT03334903|21211851|P1|STARTED|Overall Study||39
8603122|NCT03284710|21212296|P4|NOT COMPLETED|Overall Study||8
8603123|NCT03284710|21212297|P3|NOT COMPLETED|Overall Study||4
8603124|NCT03284710|21212298|P2|NOT COMPLETED|Overall Study||5
8603125|NCT03284710|21212299|P1|NOT COMPLETED|Overall Study||6
8603126|NCT03284710|21212296|P4|COMPLETED|Overall Study||16
8603127|NCT03284710|21212297|P3|COMPLETED|Overall Study||32
8603128|NCT03284710|21212298|P2|COMPLETED|Overall Study||31
8603129|NCT03284710|21212299|P1|COMPLETED|Overall Study||30
8603130|NCT03284710|21212296|P4|Month 18 Immunogenicity Timepoint|Overall Study||0
8603131|NCT03284710|21212297|P3|Month 18 Immunogenicity Timepoint|Overall Study||0
8603132|NCT03284710|21212298|P2|Month 18 Immunogenicity Timepoint|Overall Study||0
8603133|NCT03284710|21212299|P1|Month 18 Immunogenicity Timepoint|Overall Study||0
8603134|NCT03284710|21212296|P4|Month 12.5 Immunogenicity Timepoint|Overall Study||0
8603135|NCT03284710|21212297|P3|Month 12.5 Immunogenicity Timepoint|Overall Study||0
8603136|NCT03284710|21212298|P2|Month 12.5 Immunogenicity Timepoint|Overall Study||0
8603137|NCT03284710|21212299|P1|Month 12.5 Immunogenicity Timepoint|Overall Study||0
8603138|NCT03284710|21212296|P4|Month 12 Immunogenicity Timepoint|Overall Study||17
8603139|NCT03284710|21212297|P3|Month 12 Immunogenicity Timepoint|Overall Study||31
8603140|NCT03284710|21212298|P2|Month 12 Immunogenicity Timepoint|Overall Study||31
8603141|NCT03284710|21212299|P1|Month 12 Immunogenicity Timepoint|Overall Study||30
8603142|NCT03284710|21212296|P4|Month 6.5 Immunogenicity Timepoint|Overall Study||18
8603143|NCT03284710|21212297|P3|Month 6.5 Immunogenicity Timepoint|Overall Study||31
8603144|NCT03284710|21212298|P2|Month 6.5 Immunogenicity Timepoint|Overall Study||31
8603145|NCT03284710|21212299|P1|Month 6.5 Immunogenicity Timepoint|Overall Study||31
8603146|NCT03284710|21212296|P4|STARTED|Overall Study||24
8603147|NCT03284710|21212297|P3|STARTED|Overall Study||36
8603148|NCT03284710|21212298|P2|STARTED|Overall Study||36
8603149|NCT03284710|21212299|P1|STARTED|Overall Study||36
8603171|NCT03168711|21212461|P2|NOT COMPLETED|Overall Study||2
8603172|NCT03168711|21212462|P1|NOT COMPLETED|Overall Study||2
8603173|NCT03168711|21212461|P2|COMPLETED|Overall Study||7
8603174|NCT03168711|21212462|P1|COMPLETED|Overall Study||12
8603175|NCT03168711|21212461|P2|STARTED|Overall Study||9
8603176|NCT03168711|21212462|P1|STARTED|Overall Study||14
8603280|NCT03078868|21212808|P1|NOT COMPLETED|Overall Study||3
8603281|NCT03078868|21212808|P1|COMPLETED|Overall Study||0
8603282|NCT03078868|21212808|P1|STARTED|Overall Study||3
8603283|NCT02994940|21212814|P2|NOT COMPLETED|Overall Study||1
8603284|NCT02994940|21212815|P1|NOT COMPLETED|Overall Study||7
8603285|NCT02994940|21212814|P2|COMPLETED|Overall Study||36
8603286|NCT02994940|21212815|P1|COMPLETED|Overall Study||30
8603287|NCT02994940|21212814|P2|STARTED|Overall Study||37
8603288|NCT02994940|21212815|P1|STARTED|Overall Study||37
8603298|NCT02957123|21212857|P1|NOT COMPLETED|Overall Study||0
8603299|NCT02957123|21212857|P1|COMPLETED|Overall Study||30
8603300|NCT02957123|21212857|P1|STARTED|Overall Study||30
8603337|NCT02932267|21213058|P1|NOT COMPLETED|Overall Study||8
8603338|NCT02932267|21213058|P1|COMPLETED|Overall Study||42
8603339|NCT02932267|21213058|P1|STARTED|Overall Study||50
8603340|NCT02870309|21213062|P1|NOT COMPLETED|Overall Study||0
8603341|NCT02870309|21213062|P1|COMPLETED|Overall Study||4
8603342|NCT02870309|21213062|P1|STARTED|Overall Study||4
8603355|NCT02735421|21213109|P1|NOT COMPLETED|Overall Study||13
8603356|NCT02735421|21213109|P1|COMPLETED|Overall Study||54
8603357|NCT02735421|21213109|P1|STARTED|Overall Study||67
8603433|NCT02641691|21213487|P1|NOT COMPLETED|Overall Study||0
8603434|NCT02641691|21213487|P1|COMPLETED|Overall Study||20
8603435|NCT02641691|21213487|P1|STARTED|Overall Study||20
8603436|NCT02620904|21213528|P2|NOT COMPLETED|Overall Study||0
8603437|NCT02620904|21213529|P1|NOT COMPLETED|Overall Study||0
8603438|NCT02620904|21213528|P2|COMPLETED|Overall Study||5
8603439|NCT02620904|21213529|P1|COMPLETED|Overall Study||4
8603440|NCT02620904|21213528|P2|STARTED|Overall Study||5
8603441|NCT02620904|21213529|P1|STARTED|Overall Study||4
8603442|NCT02616250|21213537|P2|NOT COMPLETED|Overall Study||9
8603443|NCT02616250|21213538|P1|NOT COMPLETED|Overall Study||10
8603444|NCT02616250|21213537|P2|COMPLETED|Overall Study||86
8603445|NCT02616250|21213538|P1|COMPLETED|Overall Study||85
8603446|NCT02616250|21213537|P2|STARTED|Overall Study||95
8603447|NCT02616250|21213538|P1|STARTED|Overall Study||95
8603448|NCT02589405|21213544|P1|NOT COMPLETED|Overall Study||4
8603449|NCT02589405|21213544|P1|COMPLETED|Overall Study||46
8603450|NCT02589405|21213544|P1|STARTED|Overall Study||50
8603471|NCT02536196|21213672|P3|NOT COMPLETED|Overall Study||0
8603472|NCT02536196|21213673|P2|NOT COMPLETED|Overall Study||14
8603473|NCT02536196|21213674|P1|NOT COMPLETED|Overall Study||29
8603474|NCT02536196|21213672|P3|COMPLETED|Overall Study||95
8603475|NCT02536196|21213673|P2|COMPLETED|Overall Study||107
8603476|NCT02536196|21213674|P1|COMPLETED|Overall Study||233
8603477|NCT02536196|21213672|P3|STARTED|Overall Study||95
8603478|NCT02536196|21213673|P2|STARTED|Overall Study||121
8603479|NCT02536196|21213674|P1|STARTED|Overall Study||262
8603480|NCT02480114|21213684|P2|NOT COMPLETED|Overall Study||8
8603481|NCT02480114|21213685|P1|NOT COMPLETED|Overall Study||9
8603482|NCT02480114|21213684|P2|COMPLETED|Overall Study||30
8603483|NCT02480114|21213685|P1|COMPLETED|Overall Study||32
8603484|NCT02480114|21213684|P2|STARTED|Overall Study||38
8603485|NCT02480114|21213685|P1|STARTED|Overall Study||41
8603512|NCT02366312|21213791|P2|NOT COMPLETED|Overall Study||1
8603513|NCT02366312|21213792|P1|NOT COMPLETED|Overall Study||0
8603514|NCT02366312|21213791|P2|COMPLETED|Overall Study|The subject did not attend the 2-year post-treatment visit (last visit).|0
8603515|NCT02366312|21213792|P1|COMPLETED|Overall Study||1
8603516|NCT02366312|21213791|P2|STARTED|Overall Study||1
8603517|NCT02366312|21213792|P1|STARTED|Overall Study||1
8603584|NCT02307266|21213921|P3|NOT COMPLETED|Overall Study||6
8603585|NCT02307266|21213922|P2|NOT COMPLETED|Overall Study||1
8603586|NCT02307266|21213923|P1|NOT COMPLETED|Overall Study||8
8603587|NCT02307266|21213921|P3|COMPLETED|Overall Study||25
8603588|NCT02307266|21213922|P2|COMPLETED|Overall Study||32
8603589|NCT02307266|21213923|P1|COMPLETED|Overall Study||25
8603590|NCT02307266|21213921|P3|STARTED|Overall Study||31
8603591|NCT02307266|21213922|P2|STARTED|Overall Study||33
8603592|NCT02307266|21213923|P1|STARTED|Overall Study||33
8603596|NCT02287493|21213947|P2|NOT COMPLETED|Overall Study||0
8603597|NCT02287493|21213948|P1|NOT COMPLETED|Overall Study||0
8603598|NCT02287493|21213947|P2|COMPLETED|Overall Study||16
8603599|NCT02287493|21213948|P1|COMPLETED|Overall Study||19
8603600|NCT02287493|21213947|P2|STARTED|Overall Study||16
8603601|NCT02287493|21213948|P1|STARTED|Overall Study||19
8603602|NCT02283333|21213962|P2|NOT COMPLETED|Overall Study||14
8603603|NCT02283333|21213963|P1|NOT COMPLETED|Overall Study||14
8603604|NCT02283333|21213962|P2|COMPLETED|Overall Study||64
8603605|NCT02283333|21213963|P1|COMPLETED|Overall Study||63
8603606|NCT02283333|21213962|P2|STARTED|Overall Study||78
8603607|NCT02283333|21213963|P1|STARTED|Overall Study||77
8603608|NCT02226796|21213991|P2|NOT COMPLETED|Second Intervention Phase (Week 6)||0
8603609|NCT02226796|21213992|P1|NOT COMPLETED|Second Intervention Phase (Week 6)||0
8603610|NCT02226796|21213991|P2|COMPLETED|Second Intervention Phase (Week 6)||1
8603611|NCT02226796|21213992|P1|COMPLETED|Second Intervention Phase (Week 6)||2
8603612|NCT02226796|21213991|P2|Follow Up Assessment|Second Intervention Phase (Week 6)||1
8603613|NCT02226796|21213992|P1|Follow Up Assessment|Second Intervention Phase (Week 6)||2
8603614|NCT02226796|21213991|P2|Baseline Assessment|Second Intervention Phase (Week 6)||1
8603615|NCT02226796|21213992|P1|Baseline Assessment|Second Intervention Phase (Week 6)||2
8603616|NCT02226796|21213991|P2|STARTED|Second Intervention Phase (Week 6)||1
8603617|NCT02226796|21213992|P1|STARTED|Second Intervention Phase (Week 6)||2
8603618|NCT02226796|21213991|P2|NOT COMPLETED|Washout (Weeks 2-5)||0
8603619|NCT02226796|21213992|P1|NOT COMPLETED|Washout (Weeks 2-5)||0
8603620|NCT02226796|21213991|P2|COMPLETED|Washout (Weeks 2-5)||1
8603621|NCT02226796|21213992|P1|COMPLETED|Washout (Weeks 2-5)||2
8603622|NCT02226796|21213991|P2|STARTED|Washout (Weeks 2-5)||1
8603623|NCT02226796|21213992|P1|STARTED|Washout (Weeks 2-5)||2
8603624|NCT02226796|21213991|P2|NOT COMPLETED|First Intervention Phase (Week 1)||0
8603625|NCT02226796|21213992|P1|NOT COMPLETED|First Intervention Phase (Week 1)||0
8603626|NCT02226796|21213991|P2|COMPLETED|First Intervention Phase (Week 1)||1
8603627|NCT02226796|21213992|P1|COMPLETED|First Intervention Phase (Week 1)||2
8603628|NCT02226796|21213991|P2|Follow Up Assessment|First Intervention Phase (Week 1)||1
8603629|NCT02226796|21213992|P1|Follow Up Assessment|First Intervention Phase (Week 1)||2
8603630|NCT02226796|21213991|P2|Baseline Assessment|First Intervention Phase (Week 1)||1
8603631|NCT02226796|21213992|P1|Baseline Assessment|First Intervention Phase (Week 1)||2
8603632|NCT02226796|21213991|P2|STARTED|First Intervention Phase (Week 1)||1
8603633|NCT02226796|21213992|P1|STARTED|First Intervention Phase (Week 1)||2
8603634|NCT02225925|21214006|P1|NOT COMPLETED|Overall Study||0
8603635|NCT02225925|21214006|P1|COMPLETED|Overall Study||45
8603636|NCT02225925|21214006|P1|STARTED|Overall Study||45
8603652|NCT02207946|21214049|P2|NOT COMPLETED|Overall Study||1
8603653|NCT02207946|21214050|P1|NOT COMPLETED|Overall Study||1
8603654|NCT02207946|21214049|P2|COMPLETED|Overall Study||10
8603655|NCT02207946|21214050|P1|COMPLETED|Overall Study||18
8603656|NCT02207946|21214049|P2|STARTED|Overall Study||11
8603657|NCT02207946|21214050|P1|STARTED|Overall Study||19
8603667|NCT02186665|21214081|P2|NOT COMPLETED|Overall Study||1
8603668|NCT02186665|21214082|P1|NOT COMPLETED|Overall Study||0
8603669|NCT02186665|21214081|P2|COMPLETED|Overall Study||10
8603670|NCT02186665|21214082|P1|COMPLETED|Overall Study||8
8603671|NCT02186665|21214081|P2|STARTED|Overall Study||11
8603672|NCT02186665|21214082|P1|STARTED|Overall Study||8
8603679|NCT02125279|21214129|P1|NOT COMPLETED|Overall Study||13
8603680|NCT02125279|21214129|P1|COMPLETED|Overall Study||41
8603681|NCT02125279|21214129|P1|STARTED|Overall Study||54
8603688|NCT02065570|21214173|P4|NOT COMPLETED|Maintenance Study||19
8603689|NCT02065570|21214174|P3|NOT COMPLETED|Maintenance Study||22
8603690|NCT02065570|21214175|P2|NOT COMPLETED|Maintenance Study||0
8603691|NCT02065570|21214176|P1|NOT COMPLETED|Maintenance Study||0
8603692|NCT02065570|21214173|P4|COMPLETED|Maintenance Study||90
8603693|NCT02065570|21214174|P3|COMPLETED|Maintenance Study||87
8603694|NCT02065570|21214175|P2|COMPLETED|Maintenance Study||0
8603695|NCT02065570|21214176|P1|COMPLETED|Maintenance Study||0
8603696|NCT02065570|21214173|P4|STARTED|Maintenance Study||109
8603697|NCT02065570|21214174|P3|STARTED|Maintenance Study||109
8603698|NCT02065570|21214175|P2|STARTED|Maintenance Study||0
8603699|NCT02065570|21214176|P1|STARTED|Maintenance Study||0
8603700|NCT02065570|21214173|P4|NOT COMPLETED|Induction Study||0
8603701|NCT02065570|21214174|P3|NOT COMPLETED|Induction Study||0
8603702|NCT02065570|21214175|P2|NOT COMPLETED|Induction Study||21
8603703|NCT02065570|21214176|P1|NOT COMPLETED|Induction Study||14
8603704|NCT02065570|21214173|P4|COMPLETED|Induction Study||0
8603705|NCT02065570|21214174|P3|COMPLETED|Induction Study||0
8603706|NCT02065570|21214175|P2|COMPLETED|Induction Study||287
8603707|NCT02065570|21214176|P1|COMPLETED|Induction Study||192
8603708|NCT02065570|21214173|P4|STARTED|Induction Study||0
8603709|NCT02065570|21214174|P3|STARTED|Induction Study||0
8603710|NCT02065570|21214175|P2|STARTED|Induction Study||308
8603711|NCT02065570|21214176|P1|STARTED|Induction Study||206
8603810|NCT01948427|21214766|P5|NOT COMPLETED|Overall Study||14
8603811|NCT01948427|21214767|P4|NOT COMPLETED|Overall Study||0
8603812|NCT01948427|21214768|P3|NOT COMPLETED|Overall Study||0
8603813|NCT01948427|21214769|P2|NOT COMPLETED|Overall Study||17
8603814|NCT01948427|21214770|P1|NOT COMPLETED|Overall Study||7
8603815|NCT01948427|21214766|P5|COMPLETED|Overall Study||46
8603816|NCT01948427|21214767|P4|COMPLETED|Overall Study||1
8603817|NCT01948427|21214768|P3|COMPLETED|Overall Study||4
8603818|NCT01948427|21214769|P2|COMPLETED|Overall Study||72
8603819|NCT01948427|21214770|P1|COMPLETED|Overall Study||42
8603820|NCT01948427|21214766|P5|STARTED|Overall Study||60
8603821|NCT01948427|21214767|P4|STARTED|Overall Study||1
8603822|NCT01948427|21214768|P3|STARTED|Overall Study||4
8603823|NCT01948427|21214769|P2|STARTED|Overall Study||89
8603824|NCT01948427|21214770|P1|STARTED|Overall Study||49
8603843|NCT01927341|21214840|P5|NOT COMPLETED|Phase 2||8
8603844|NCT01927341|21214841|P4|NOT COMPLETED|Phase 2||15
8603845|NCT01927341|21214842|P3|NOT COMPLETED|Phase 2||5
8603846|NCT01927341|21214843|P2|NOT COMPLETED|Phase 2||15
8603847|NCT01927341|21214844|P1|NOT COMPLETED|Phase 2||0
8603848|NCT01927341|21214840|P5|COMPLETED|Phase 2||0
8603849|NCT01927341|21214841|P4|COMPLETED|Phase 2||0
8603850|NCT01927341|21214842|P3|COMPLETED|Phase 2||0
8603851|NCT01927341|21214843|P2|COMPLETED|Phase 2||0
8603852|NCT01927341|21214844|P1|COMPLETED|Phase 2||0
8603853|NCT01927341|21214840|P5|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|8
8603854|NCT01927341|21214841|P4|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
8603855|NCT01927341|21214842|P3|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|5
8603856|NCT01927341|21214843|P2|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
8603857|NCT01927341|21214844|P1|STARTED|Phase 2||0
8603858|NCT01927341|21214840|P5|NOT COMPLETED|Phase 1b||0
8603859|NCT01927341|21214841|P4|NOT COMPLETED|Phase 1b||0
8603860|NCT01927341|21214842|P3|NOT COMPLETED|Phase 1b||0
8603861|NCT01927341|21214843|P2|NOT COMPLETED|Phase 1b||0
8603862|NCT01927341|21214844|P1|NOT COMPLETED|Phase 1b||10
8603863|NCT01927341|21214840|P5|COMPLETED|Phase 1b||0
8603864|NCT01927341|21214841|P4|COMPLETED|Phase 1b||0
8603865|NCT01927341|21214842|P3|COMPLETED|Phase 1b||0
8603866|NCT01927341|21214843|P2|COMPLETED|Phase 1b||0
8603867|NCT01927341|21214844|P1|COMPLETED|Phase 1b||0
8603868|NCT01927341|21214840|P5|STARTED|Phase 1b||0
8603869|NCT01927341|21214841|P4|STARTED|Phase 1b||0
8603870|NCT01927341|21214842|P3|STARTED|Phase 1b||0
8603871|NCT01927341|21214843|P2|STARTED|Phase 1b||0
8603872|NCT01927341|21214844|P1|STARTED|Phase 1b||10
8603960|NCT01821391|21214938|P2|NOT COMPLETED|Overall Study||0
8603961|NCT01821391|21214939|P1|NOT COMPLETED|Overall Study||1
8603962|NCT01821391|21214938|P2|COMPLETED|Overall Study||23
8603963|NCT01821391|21214939|P1|COMPLETED|Overall Study||107
8603964|NCT01821391|21214938|P2|STARTED|Overall Study||23
8603965|NCT01821391|21214939|P1|STARTED|Overall Study||108
8603969|NCT01766440|21214954|P1|NOT COMPLETED|Overall Study||1
8603970|NCT01766440|21214954|P1|COMPLETED|Overall Study||17
8603971|NCT01766440|21214954|P1|STARTED|Overall Study||18
8603972|NCT01759277|21214965|P2|NOT COMPLETED|Overall Study||0
8603973|NCT01759277|21214966|P1|NOT COMPLETED|Overall Study||0
8603974|NCT01759277|21214965|P2|COMPLETED|Overall Study||39
8603975|NCT01759277|21214966|P1|COMPLETED|Overall Study||41
8603976|NCT01759277|21214965|P2|STARTED|Overall Study||39
8603977|NCT01759277|21214966|P1|STARTED|Overall Study||41
8603987|NCT01545765|21215004|P1|NOT COMPLETED|Overall Study||0
8603988|NCT01545765|21215004|P1|COMPLETED|Overall Study||31
8603989|NCT01545765|21215004|P1|STARTED|Overall Study||31
8603990|NCT01531803|21215017|P2|NOT COMPLETED|Overall Study||0
8603991|NCT01531803|21215018|P1|NOT COMPLETED|Overall Study||0
8603992|NCT01531803|21215017|P2|COMPLETED|Overall Study||2
8603993|NCT01531803|21215018|P1|COMPLETED|Overall Study||1
8603994|NCT01531803|21215017|P2|STARTED|Overall Study||2
8603995|NCT01531803|21215018|P1|STARTED|Overall Study||1
8603996|NCT01529203|21215028|P1|NOT COMPLETED|Overall Study||3
8603997|NCT01529203|21215028|P1|COMPLETED|Overall Study||57
8603998|NCT01529203|21215028|P1|STARTED|Overall Study||60
8603999|NCT01494467|21215036|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
8604000|NCT01494467|21215037|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
8604001|NCT01494467|21215036|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||159
8604002|NCT01494467|21215037|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||353
8604003|NCT01494467|21215036|P2|STARTED|Part C Safety Follow up (4 Weeks)||159
8604004|NCT01494467|21215037|P1|STARTED|Part C Safety Follow up (4 Weeks)||353
8604005|NCT01494467|21215036|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
8604006|NCT01494467|21215037|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
8604007|NCT01494467|21215036|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||159
8604008|NCT01494467|21215037|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||353
8604009|NCT01494467|21215036|P2|STARTED|Part B Long Term Active Control 40 Weeks||208
8604010|NCT01494467|21215037|P1|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
8604011|NCT01494467|21215036|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
8604012|NCT01494467|21215037|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
8604013|NCT01494467|21215036|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||208
8604014|NCT01494467|21215037|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||429
8604015|NCT01494467|21215036|P2|STARTED|Part A Vehicle Control (12 Weeks)||229
8604016|NCT01494467|21215037|P1|STARTED|Part A Vehicle Control (12 Weeks)||459
8604017|NCT01493687|21215055|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
8604018|NCT01493687|21215056|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
8604019|NCT01493687|21215055|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||174
8604020|NCT01493687|21215056|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||350
8604021|NCT01493687|21215055|P2|STARTED|Part C Safety Follow up (4 Weeks)||175
8604022|NCT01493687|21215056|P1|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
8604023|NCT01493687|21215055|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
8604024|NCT01493687|21215056|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
8604025|NCT01493687|21215055|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||175
8604026|NCT01493687|21215056|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||351
8604027|NCT01493687|21215055|P2|STARTED|Part B Long Term Active Control 40 Weeks||210
8604028|NCT01493687|21215056|P1|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
8604029|NCT01493687|21215055|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
8604030|NCT01493687|21215056|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
8604031|NCT01493687|21215055|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||210
8604032|NCT01493687|21215056|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||414
8604033|NCT01493687|21215055|P2|STARTED|Part A Vehicle Control (12 Weeks)||232
8604034|NCT01493687|21215056|P1|STARTED|Part A Vehicle Control (12 Weeks)||451
8604035|NCT01475071|21215072|P1|NOT COMPLETED|Overall Study||8
8604036|NCT01475071|21215072|P1|COMPLETED|Overall Study||92
8604037|NCT01475071|21215072|P1|STARTED|Overall Study||100
8604038|NCT01474590|21215082|P2|NOT COMPLETED|Overall Study||17
8604039|NCT01474590|21215083|P1|NOT COMPLETED|Overall Study||28
8604040|NCT01474590|21215082|P2|COMPLETED|Overall Study||116
8604041|NCT01474590|21215083|P1|COMPLETED|Overall Study||105
8604042|NCT01474590|21215082|P2|STARTED|Overall Study||133
8604043|NCT01474590|21215083|P1|STARTED|Overall Study||133
8604050|NCT01361633|21215108|P2|NOT COMPLETED|Overall Study||3
8604051|NCT01361633|21215109|P1|NOT COMPLETED|Overall Study||6
8604052|NCT01361633|21215108|P2|COMPLETED|Overall Study||23
8604053|NCT01361633|21215109|P1|COMPLETED|Overall Study||19
8604054|NCT01361633|21215108|P2|STARTED|Overall Study||26
8604055|NCT01361633|21215109|P1|STARTED|Overall Study||25
8604056|NCT01355471|21215129|P2|NOT COMPLETED|Overall Study||3
8604057|NCT01355471|21215130|P1|NOT COMPLETED|Overall Study||7
8604058|NCT01355471|21215129|P2|COMPLETED|Overall Study||142
8604059|NCT01355471|21215130|P1|COMPLETED|Overall Study||141
8604060|NCT01355471|21215129|P2|STARTED|Overall Study||145
8604061|NCT01355471|21215130|P1|STARTED|Overall Study||148
8604062|NCT01355458|21215138|P2|NOT COMPLETED|Overall Study||4
8604063|NCT01355458|21215139|P1|NOT COMPLETED|Overall Study||2
8604064|NCT01355458|21215138|P2|COMPLETED|Overall Study||127
8604065|NCT01355458|21215139|P1|COMPLETED|Overall Study||127
8604066|NCT01355458|21215138|P2|STARTED|Overall Study||131
8604067|NCT01355458|21215139|P1|STARTED|Overall Study||129
8604089|NCT01320033|21215219|P3|NOT COMPLETED|Overall Study||53
8604090|NCT01320033|21215220|P2|NOT COMPLETED|Overall Study||64
8604091|NCT01320033|21215221|P1|NOT COMPLETED|Overall Study||58
8604092|NCT01320033|21215219|P3|COMPLETED|Overall Study||169
8604093|NCT01320033|21215220|P2|COMPLETED|Overall Study||160
8604094|NCT01320033|21215221|P1|COMPLETED|Overall Study||158
8604095|NCT01320033|21215219|P3|STARTED|Overall Study||222
8604096|NCT01320033|21215220|P2|STARTED|Overall Study||224
8604097|NCT01320033|21215221|P1|STARTED|Overall Study||216
8604098|NCT01318733|21215247|P1|NOT COMPLETED|Overall Study||170
8604099|NCT01318733|21215247|P1|COMPLETED|Overall Study||279
8604100|NCT01318733|21215247|P1|STARTED|Overall Study||449
8604113|NCT01213199|21215285|P1|NOT COMPLETED|Overall Study||4
8604114|NCT01213199|21215285|P1|COMPLETED|Overall Study||16
8604115|NCT01213199|21215285|P1|STARTED|Overall Study||20
8604131|NCT01188538|21215316|P2|NOT COMPLETED|Overall Study||1
8604132|NCT01188538|21215317|P1|NOT COMPLETED|Overall Study||0
8604133|NCT01188538|21215316|P2|COMPLETED|Overall Study||19
8604134|NCT01188538|21215317|P1|COMPLETED|Overall Study||20
8604135|NCT01188538|21215316|P2|STARTED|Overall Study||20
8604136|NCT01188538|21215317|P1|STARTED|Overall Study||20
8604146|NCT01138735|21215344|P2|NOT COMPLETED|Overall Study||17
8604147|NCT01138735|21215345|P1|NOT COMPLETED|Overall Study||8
8604148|NCT01138735|21215344|P2|COMPLETED|Overall Study||126
8604149|NCT01138735|21215345|P1|COMPLETED|Overall Study||134
8604150|NCT01138735|21215344|P2|STARTED|Overall Study||143
8604151|NCT01138735|21215345|P1|STARTED|Overall Study||142
8604155|NCT01014871|21215363|P1|NOT COMPLETED|Overall Study||0
8604156|NCT01014871|21215363|P1|COMPLETED|Overall Study||30
8604157|NCT01014871|21215363|P1|STARTED|Overall Study||30
8604158|NCT01014689|21215371|P2|NOT COMPLETED|Overall Study||13
8604159|NCT01014689|21215372|P1|NOT COMPLETED|Overall Study||13
8604160|NCT01014689|21215371|P2|COMPLETED|Overall Study||174
8604161|NCT01014689|21215372|P1|COMPLETED|Overall Study||178
8604162|NCT01014689|21215371|P2|STARTED|Overall Study||187
8604163|NCT01014689|21215372|P1|STARTED|Overall Study||191
8604164|NCT00993915|21215380|P1|NOT COMPLETED|Overall Study||9
8604165|NCT00993915|21215380|P1|COMPLETED|Overall Study||678
8604166|NCT00993915|21215380|P1|STARTED|Overall Study||687
8604167|NCT00989014|21215393|P4|NOT COMPLETED|Overall Study||0
8604168|NCT00989014|21215394|P3|NOT COMPLETED|Overall Study||0
8604169|NCT00989014|21215395|P2|NOT COMPLETED|Overall Study||0
8604170|NCT00989014|21215396|P1|NOT COMPLETED|Overall Study||0
8604171|NCT00989014|21215393|P4|COMPLETED|Overall Study||32
8604172|NCT00989014|21215394|P3|COMPLETED|Overall Study||28
8604173|NCT00989014|21215395|P2|COMPLETED|Overall Study||31
8604174|NCT00989014|21215396|P1|COMPLETED|Overall Study||31
8604175|NCT00989014|21215393|P4|STARTED|Overall Study||32
8604176|NCT00989014|21215394|P3|STARTED|Overall Study||28
8604177|NCT00989014|21215395|P2|STARTED|Overall Study||31
8604178|NCT00989014|21215396|P1|STARTED|Overall Study||31
8604179|NCT00971282|21215406|P1|NOT COMPLETED|Overall Study||0
8604180|NCT00971282|21215406|P1|COMPLETED|Overall Study||30
8604181|NCT00971282|21215406|P1|STARTED|Overall Study||30
8604188|NCT00919763|21215463|P2|NOT COMPLETED|Overall Study||4
8604189|NCT00919763|21215464|P1|NOT COMPLETED|Overall Study||12
8604190|NCT00919763|21215463|P2|COMPLETED|Overall Study||45
8604191|NCT00919763|21215464|P1|COMPLETED|Overall Study||41
8604192|NCT00919763|21215463|P2|STARTED|Overall Study||49
8604193|NCT00919763|21215464|P1|STARTED|Overall Study||53
8604212|NCT00883233|21215489|P4|NOT COMPLETED|Overall Study||5
8604213|NCT00883233|21215490|P3|NOT COMPLETED|Overall Study||4
8604214|NCT00883233|21215491|P2|NOT COMPLETED|Overall Study||4
8604215|NCT00883233|21215492|P1|NOT COMPLETED|Overall Study||5
8604216|NCT00883233|21215489|P4|COMPLETED|Overall Study||25
8604217|NCT00883233|21215490|P3|COMPLETED|Overall Study||25
8604218|NCT00883233|21215491|P2|COMPLETED|Overall Study||28
8604219|NCT00883233|21215492|P1|COMPLETED|Overall Study||27
8604220|NCT00883233|21215489|P4|STARTED|Overall Study||30
8604221|NCT00883233|21215490|P3|STARTED|Overall Study||29
8604222|NCT00883233|21215491|P2|STARTED|Overall Study||32
8604223|NCT00883233|21215492|P1|STARTED|Overall Study||32
8604227|NCT00862654|21215514|P4|NOT COMPLETED|Overall Study||6
8604228|NCT00862654|21215515|P3|NOT COMPLETED|Overall Study||6
8604229|NCT00862654|21215516|P2|NOT COMPLETED|Overall Study||8
8604230|NCT00862654|21215517|P1|NOT COMPLETED|Overall Study||6
8604231|NCT00862654|21215514|P4|COMPLETED|Overall Study||74
8604232|NCT00862654|21215515|P3|COMPLETED|Overall Study||76
8604233|NCT00862654|21215516|P2|COMPLETED|Overall Study||74
8604234|NCT00862654|21215517|P1|COMPLETED|Overall Study||76
8604235|NCT00862654|21215514|P4|STARTED|Overall Study||80
8604236|NCT00862654|21215515|P3|STARTED|Overall Study||82
8604237|NCT00862654|21215516|P2|STARTED|Overall Study||82
8604238|NCT00862654|21215517|P1|STARTED|Overall Study||82
8604321|NCT00697541|21215680|P2|NOT COMPLETED|Overall Study||1
8604322|NCT00697541|21215681|P1|NOT COMPLETED|Overall Study||2
8604323|NCT00697541|21215680|P2|COMPLETED|Overall Study||9
8604324|NCT00697541|21215681|P1|COMPLETED|Overall Study||8
8604325|NCT00697541|21215680|P2|STARTED|Overall Study||10
8604326|NCT00697541|21215681|P1|STARTED|Overall Study||10
8604327|NCT00688064|21215693|P2|NOT COMPLETED|Overall Study||26
8604328|NCT00688064|21215694|P1|NOT COMPLETED|Overall Study||21
8604329|NCT00688064|21215693|P2|COMPLETED|Overall Study||201
8604330|NCT00688064|21215694|P1|COMPLETED|Overall Study||211
8604331|NCT00688064|21215693|P2|STARTED|Overall Study||227
8604332|NCT00688064|21215694|P1|STARTED|Overall Study||232
8604333|NCT00687908|21215710|P2|NOT COMPLETED|Overall Study||42
8604334|NCT00687908|21215711|P1|NOT COMPLETED|Overall Study||18
8604335|NCT00687908|21215710|P2|COMPLETED|Overall Study||78
8604336|NCT00687908|21215711|P1|COMPLETED|Overall Study||105
8604337|NCT00687908|21215710|P2|STARTED|Overall Study||120
8604338|NCT00687908|21215711|P1|STARTED|Overall Study||123
8604416|NCT00660985|21216171|P2|NOT COMPLETED|Overall Study||0
8604417|NCT00660985|21216172|P1|NOT COMPLETED|Overall Study||1
8604418|NCT00660985|21216171|P2|COMPLETED|Overall Study||25
8604419|NCT00660985|21216172|P1|COMPLETED|Overall Study||25
8604420|NCT00660985|21216171|P2|STARTED|Overall Study||25
8604421|NCT00660985|21216172|P1|STARTED|Overall Study||26
8604430|NCT00599521|21216211|P2|NOT COMPLETED|Overall Study||69
8604431|NCT00599521|21216212|P1|NOT COMPLETED|Overall Study||60
8604432|NCT00599521|21216211|P2|COMPLETED|Overall Study||462
8604433|NCT00599521|21216212|P1|COMPLETED|Overall Study||475
8604434|NCT00599521|21216211|P2|STARTED|Overall Study||531
8604435|NCT00599521|21216212|P1|STARTED|Overall Study||535
8604436|NCT00598832|21216228|P2|NOT COMPLETED|Overall Study||82
8604437|NCT00598832|21216229|P1|NOT COMPLETED|Overall Study||62
8604438|NCT00598832|21216228|P2|COMPLETED|Overall Study||460
8604439|NCT00598832|21216229|P1|COMPLETED|Overall Study||471
8604440|NCT00598832|21216228|P2|STARTED|Overall Study||542
8604441|NCT00598832|21216229|P1|STARTED|Overall Study||533
8604450|NCT00560703|21216260|P2|NOT COMPLETED|Overall Study||6
8604451|NCT00560703|21216261|P1|NOT COMPLETED|Overall Study||0
8604452|NCT00560703|21216260|P2|COMPLETED|Overall Study||18
8604453|NCT00560703|21216261|P1|COMPLETED|Overall Study||46
8604454|NCT00560703|21216260|P2|STARTED|Overall Study||24
8604455|NCT00560703|21216261|P1|STARTED|Overall Study||46
8604472|NCT00468650|21216342|P1|NOT COMPLETED|Overall Study||7
8604473|NCT00468650|21216342|P1|COMPLETED|Overall Study||110
8604474|NCT00468650|21216342|P1|STARTED|Overall Study||117
8604499|NCT00438399|21216534|P6|NOT COMPLETED|Overall Study||6
8604500|NCT00438399|21216535|P5|NOT COMPLETED|Overall Study||3
8604501|NCT00438399|21216536|P4|NOT COMPLETED|Overall Study||4
8604502|NCT00438399|21216537|P3|NOT COMPLETED|Overall Study||7
8604503|NCT00438399|21216538|P2|NOT COMPLETED|Overall Study||8
8604504|NCT00438399|21216539|P1|NOT COMPLETED|Overall Study||8
8604505|NCT00438399|21216534|P6|COMPLETED|Overall Study||31
8604506|NCT00438399|21216535|P5|COMPLETED|Overall Study||30
8604507|NCT00438399|21216536|P4|COMPLETED|Overall Study||32
8604508|NCT00438399|21216537|P3|COMPLETED|Overall Study||28
8604509|NCT00438399|21216538|P2|COMPLETED|Overall Study||32
8604510|NCT00438399|21216539|P1|COMPLETED|Overall Study||30
8604511|NCT00438399|21216534|P6|TREATED & ANALYZED|Overall Study||31
8604512|NCT00438399|21216535|P5|TREATED & ANALYZED|Overall Study||30
8604513|NCT00438399|21216536|P4|TREATED & ANALYZED|Overall Study||32
8604514|NCT00438399|21216537|P3|TREATED & ANALYZED|Overall Study||28
8604515|NCT00438399|21216538|P2|TREATED & ANALYZED|Overall Study||32
8604516|NCT00438399|21216539|P1|TREATED & ANALYZED|Overall Study||30
8604517|NCT00438399|21216534|P6|STARTED|Overall Study||37
8604518|NCT00438399|21216535|P5|STARTED|Overall Study||33
8604519|NCT00438399|21216536|P4|STARTED|Overall Study||36
8604520|NCT00438399|21216537|P3|STARTED|Overall Study||35
8604521|NCT00438399|21216538|P2|STARTED|Overall Study||40
8604522|NCT00438399|21216539|P1|STARTED|Overall Study||38
8604523|NCT00421993|21216552|P4|NOT COMPLETED|Overall Study||57
8604524|NCT00421993|21216553|P3|NOT COMPLETED|Overall Study||52
8604525|NCT00421993|21216554|P2|NOT COMPLETED|Overall Study||49
8604526|NCT00421993|21216555|P1|NOT COMPLETED|Overall Study||53
8604527|NCT00421993|21216552|P4|COMPLETED|Overall Study||361
8604528|NCT00421993|21216553|P3|COMPLETED|Overall Study||363
8604529|NCT00421993|21216554|P2|COMPLETED|Overall Study||369
8604530|NCT00421993|21216555|P1|COMPLETED|Overall Study||366
8604531|NCT00421993|21216552|P4|STARTED|Overall Study||418
8604532|NCT00421993|21216553|P3|STARTED|Overall Study||415
8604533|NCT00421993|21216554|P2|STARTED|Overall Study||418
8604534|NCT00421993|21216555|P1|STARTED|Overall Study||419
8604535|NCT00419666|21216585|P1|NOT COMPLETED|Overall Study||0
8604536|NCT00419666|21216585|P1|COMPLETED|Overall Study||25
8604537|NCT00419666|21216585|P1|STARTED|Overall Study||25
8604552|NCT00335738|21216624|P2|NOT COMPLETED|Overall Study||4
8604553|NCT00335738|21216625|P1|NOT COMPLETED|Overall Study||11
8604554|NCT00335738|21216624|P2|COMPLETED|Overall Study||219
8604555|NCT00335738|21216625|P1|COMPLETED|Overall Study||97
8604556|NCT00335738|21216624|P2|STARTED|Overall Study||223
8604557|NCT00335738|21216625|P1|STARTED|Overall Study||108
8604582|NCT00244933|21216677|P1|NOT COMPLETED|Overall Study||2
8604583|NCT00244933|21216677|P1|COMPLETED|Overall Study||17
8604584|NCT00244933|21216677|P1|STARTED|Overall Study||19
8604585|NCT00159913|21216685|P4|NOT COMPLETED|Overall Study||2
8604586|NCT00159913|21216686|P3|NOT COMPLETED|Overall Study||2
8604587|NCT00159913|21216687|P2|NOT COMPLETED|Overall Study||0
8604588|NCT00159913|21216688|P1|NOT COMPLETED|Overall Study||2
8604589|NCT00159913|21216685|P4|COMPLETED|Overall Study||58
8604590|NCT00159913|21216686|P3|COMPLETED|Overall Study||75
8604591|NCT00159913|21216687|P2|COMPLETED|Overall Study||55
8604592|NCT00159913|21216688|P1|COMPLETED|Overall Study||40
8604593|NCT00159913|21216685|P4|STARTED|Overall Study||60
8604594|NCT00159913|21216686|P3|STARTED|Overall Study||77
8604595|NCT00159913|21216687|P2|STARTED|Overall Study||55
8604596|NCT00159913|21216688|P1|STARTED|Overall Study||42
8607562|NCT04155567|21226849|P1|NOT COMPLETED|Overall Study||0
8607563|NCT04155567|21226849|P1|COMPLETED|Overall Study||10
8607564|NCT04155567|21226849|P1|STARTED|Overall Study||10
8607609|NCT03920865|21227014|P3|NOT COMPLETED|Overall Study||0
8607610|NCT03920865|21227015|P2|NOT COMPLETED|Overall Study||0
8607611|NCT03920865|21227016|P1|NOT COMPLETED|Overall Study||0
8607612|NCT03920865|21227014|P3|COMPLETED|Overall Study||10
8607613|NCT03920865|21227015|P2|COMPLETED|Overall Study||8
8607614|NCT03920865|21227016|P1|COMPLETED|Overall Study||8
8607615|NCT03920865|21227014|P3|STARTED|Overall Study||10
8607616|NCT03920865|21227015|P2|STARTED|Overall Study||8
8607617|NCT03920865|21227016|P1|STARTED|Overall Study||8
8607624|NCT03835975|21227127|P5|NOT COMPLETED|Overall Study||0
8607625|NCT03835975|21227128|P4|NOT COMPLETED|Overall Study||1
8607626|NCT03835975|21227129|P3|NOT COMPLETED|Overall Study||3
8607627|NCT03835975|21227130|P2|NOT COMPLETED|Overall Study||3
8607628|NCT03835975|21227131|P1|NOT COMPLETED|Overall Study||3
8607629|NCT03835975|21227127|P5|COMPLETED|Overall Study||125
8607630|NCT03835975|21227128|P4|COMPLETED|Overall Study||126
8607631|NCT03835975|21227129|P3|COMPLETED|Overall Study||245
8607632|NCT03835975|21227130|P2|COMPLETED|Overall Study||119
8607633|NCT03835975|21227131|P1|COMPLETED|Overall Study||250
8607634|NCT03835975|21227127|P5|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||121
8607635|NCT03835975|21227128|P4|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
8607636|NCT03835975|21227129|P3|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||243
8607637|NCT03835975|21227130|P2|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
8607638|NCT03835975|21227131|P1|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||247
8607639|NCT03835975|21227127|P5|Safety Population|Overall Study||125
8607640|NCT03835975|21227128|P4|Safety Population|Overall Study||127
8607641|NCT03835975|21227129|P3|Safety Population|Overall Study||246
8607642|NCT03835975|21227130|P2|Safety Population|Overall Study||122
8607643|NCT03835975|21227131|P1|Safety Population|Overall Study||253
8607644|NCT03835975|21227127|P5|Vaccinated|Overall Study||125
8607645|NCT03835975|21227128|P4|Vaccinated|Overall Study||127
8607646|NCT03835975|21227129|P3|Vaccinated|Overall Study||246
8607647|NCT03835975|21227130|P2|Vaccinated|Overall Study||122
8607648|NCT03835975|21227131|P1|Vaccinated|Overall Study||253
8607649|NCT03835975|21227127|P5|STARTED|Overall Study||125
8607650|NCT03835975|21227128|P4|STARTED|Overall Study||127
8607651|NCT03835975|21227129|P3|STARTED|Overall Study||248
8607652|NCT03835975|21227130|P2|STARTED|Overall Study||122
8607653|NCT03835975|21227131|P1|STARTED|Overall Study||253
8607705|NCT03805386|21227294|P2|NOT COMPLETED|Overall Study||0
8607706|NCT03805386|21227295|P1|NOT COMPLETED|Overall Study||0
8607707|NCT03805386|21227294|P2|COMPLETED|Overall Study||33
8607708|NCT03805386|21227295|P1|COMPLETED|Overall Study||32
8607709|NCT03805386|21227294|P2|STARTED|Overall Study||33
8607710|NCT03805386|21227295|P1|STARTED|Overall Study||32
8607729|NCT03712189|21227369|P2|NOT COMPLETED|Overall Study||0
8607730|NCT03712189|21227370|P1|NOT COMPLETED|Overall Study||0
8607731|NCT03712189|21227369|P2|COMPLETED|Overall Study||15
8607732|NCT03712189|21227370|P1|COMPLETED|Overall Study||15
8607733|NCT03712189|21227369|P2|STARTED|Overall Study||15
8607734|NCT03712189|21227370|P1|STARTED|Overall Study||15
8607735|NCT03663283|21227382|P2|NOT COMPLETED|Overall Study||0
8607736|NCT03663283|21227383|P1|NOT COMPLETED|Overall Study||0
8607737|NCT03663283|21227382|P2|COMPLETED|Overall Study||52
8607738|NCT03663283|21227383|P1|COMPLETED|Overall Study||52
8607739|NCT03663283|21227382|P2|STARTED|Overall Study||52
8607740|NCT03663283|21227383|P1|STARTED|Overall Study||52
8607741|NCT03645785|21227395|P1|NOT COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||0
8607742|NCT03645785|21227395|P1|COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||23
8607743|NCT03645785|21227395|P1|STARTED|Day 2-4 (Double Fluid and Add Citrate)||23
8607744|NCT03645785|21227395|P1|NOT COMPLETED|Day 1 (Normal Fluid Intake and Diet)||0
8607745|NCT03645785|21227395|P1|COMPLETED|Day 1 (Normal Fluid Intake and Diet)||23
8607746|NCT03645785|21227395|P1|STARTED|Day 1 (Normal Fluid Intake and Diet)||23
8607747|NCT03638622|21227435|P1|NOT COMPLETED|Overall Study||1
8607748|NCT03638622|21227435|P1|COMPLETED|Overall Study||29
8607749|NCT03638622|21227435|P1|STARTED|Overall Study||30
8607784|NCT03542305|21227502|P4|NOT COMPLETED|Overall Study||0
8607785|NCT03542305|21227503|P3|NOT COMPLETED|Overall Study||0
8607786|NCT03542305|21227504|P2|NOT COMPLETED|Overall Study||0
8607787|NCT03542305|21227505|P1|NOT COMPLETED|Overall Study||0
8607788|NCT03542305|21227502|P4|COMPLETED|Overall Study||5
8607789|NCT03542305|21227503|P3|COMPLETED|Overall Study||8
8607790|NCT03542305|21227504|P2|COMPLETED|Overall Study||8
8607791|NCT03542305|21227505|P1|COMPLETED|Overall Study||8
8607792|NCT03542305|21227502|P4|STARTED|Overall Study||5
8607793|NCT03542305|21227503|P3|STARTED|Overall Study||8
8607794|NCT03542305|21227504|P2|STARTED|Overall Study||8
8607795|NCT03542305|21227505|P1|STARTED|Overall Study||8
8607796|NCT03490942|21227562|P3|NOT COMPLETED|Overall Study||7
8607797|NCT03490942|21227563|P2|NOT COMPLETED|Overall Study||10
8607798|NCT03490942|21227564|P1|NOT COMPLETED|Overall Study||10
8607799|NCT03490942|21227562|P3|COMPLETED|Overall Study||9
8607800|NCT03490942|21227563|P2|COMPLETED|Overall Study||8
8607801|NCT03490942|21227564|P1|COMPLETED|Overall Study||5
8607802|NCT03490942|21227562|P3|STARTED|Overall Study||16
8607803|NCT03490942|21227563|P2|STARTED|Overall Study||18
8607804|NCT03490942|21227564|P1|STARTED|Overall Study||15
8607846|NCT03390114|21227642|P2|NOT COMPLETED|Overall Study||2
8607847|NCT03390114|21227643|P1|NOT COMPLETED|Overall Study||4
8607848|NCT03390114|21227642|P2|COMPLETED|Overall Study||8
8607849|NCT03390114|21227643|P1|COMPLETED|Overall Study||6
8607850|NCT03390114|21227642|P2|STARTED|Overall Study||10
8607851|NCT03390114|21227643|P1|STARTED|Overall Study||10
8607856|NCT03359590|21227660|P2|NOT COMPLETED|Second Intervention||0
8607857|NCT03359590|21227661|P1|NOT COMPLETED|Second Intervention||0
8607858|NCT03359590|21227660|P2|COMPLETED|Second Intervention||8
8607859|NCT03359590|21227661|P1|COMPLETED|Second Intervention||9
8607860|NCT03359590|21227660|P2|Discontinued|Second Intervention||0
8607861|NCT03359590|21227661|P1|Discontinued|Second Intervention||0
8607862|NCT03359590|21227660|P2|Exposed|Second Intervention||8
8607863|NCT03359590|21227661|P1|Exposed|Second Intervention||9
8607864|NCT03359590|21227660|P2|STARTED|Second Intervention||8
8607865|NCT03359590|21227661|P1|STARTED|Second Intervention||9
8607866|NCT03359590|21227660|P2|NOT COMPLETED|First Intervention||2
8607867|NCT03359590|21227661|P1|NOT COMPLETED|First Intervention||1
8607868|NCT03359590|21227660|P2|COMPLETED|First Intervention||8
8607869|NCT03359590|21227661|P1|COMPLETED|First Intervention||9
8607870|NCT03359590|21227660|P2|Discontinued|First Intervention||2
8607871|NCT03359590|21227661|P1|Discontinued|First Intervention||1
8607872|NCT03359590|21227660|P2|Exposed|First Intervention||10
8607873|NCT03359590|21227661|P1|Exposed|First Intervention||9
8607874|NCT03359590|21227660|P2|STARTED|First Intervention||10
8607875|NCT03359590|21227661|P1|STARTED|First Intervention||10
8607910|NCT03308097|21227781|P2|NOT COMPLETED|Overall Study||1
8607911|NCT03308097|21227782|P1|NOT COMPLETED|Overall Study||2
8607912|NCT03308097|21227781|P2|COMPLETED|Overall Study||31
8607913|NCT03308097|21227782|P1|COMPLETED|Overall Study||31
8607914|NCT03308097|21227781|P2|STARTED|Overall Study||32
8607915|NCT03308097|21227782|P1|STARTED|Overall Study||33
8607916|NCT03303469|21227806|P1|NOT COMPLETED|Overall Study||2
8607917|NCT03303469|21227806|P1|COMPLETED|Overall Study||1
8607918|NCT03303469|21227806|P1|STARTED|Overall Study||3
8607925|NCT03300050|21227830|P5|NOT COMPLETED|Overall Study||1
8607926|NCT03300050|21227831|P4|NOT COMPLETED|Overall Study||1
8607927|NCT03300050|21227832|P3|NOT COMPLETED|Overall Study||3
8607928|NCT03300050|21227833|P2|NOT COMPLETED|Overall Study||2
8607929|NCT03300050|21227834|P1|NOT COMPLETED|Overall Study||3
8607930|NCT03300050|21227830|P5|COMPLETED|Overall Study||9
8607931|NCT03300050|21227831|P4|COMPLETED|Overall Study||15
8607932|NCT03300050|21227832|P3|COMPLETED|Overall Study||2
8607933|NCT03300050|21227833|P2|COMPLETED|Overall Study||13
8607934|NCT03300050|21227834|P1|COMPLETED|Overall Study||17
8607935|NCT03300050|21227830|P5|Received All Scheduled Treatments|Overall Study||10
8607936|NCT03300050|21227831|P4|Received All Scheduled Treatments|Overall Study||15
8607937|NCT03300050|21227832|P3|Received All Scheduled Treatments|Overall Study||2
8607938|NCT03300050|21227833|P2|Received All Scheduled Treatments|Overall Study||13
8607939|NCT03300050|21227834|P1|Received All Scheduled Treatments|Overall Study||16
8607940|NCT03300050|21227830|P5|Received Treatment|Overall Study||10
8607941|NCT03300050|21227831|P4|Received Treatment|Overall Study||15
8607942|NCT03300050|21227832|P3|Received Treatment|Overall Study||3
8607943|NCT03300050|21227833|P2|Received Treatment|Overall Study||14
8607944|NCT03300050|21227834|P1|Received Treatment|Overall Study||19
8607945|NCT03300050|21227830|P5|STARTED|Overall Study||10
8607946|NCT03300050|21227831|P4|STARTED|Overall Study||16
8607947|NCT03300050|21227832|P3|STARTED|Overall Study||5
8607948|NCT03300050|21227833|P2|STARTED|Overall Study||15
8607949|NCT03300050|21227834|P1|STARTED|Overall Study||20
8607960|NCT03263780|21228244|P1|NOT COMPLETED|Overall Study||10
8607961|NCT03263780|21228244|P1|COMPLETED|Overall Study|13 evaluable for primary outcome, but 11 total completed study.|11
8607962|NCT03263780|21228244|P1|STARTED|Overall Study||21
8608005|NCT03164538|21228337|P2|NOT COMPLETED|Overall Study||6
8608006|NCT03164538|21228338|P1|NOT COMPLETED|Overall Study||7
8608007|NCT03164538|21228337|P2|COMPLETED|Overall Study||29
8608008|NCT03164538|21228338|P1|COMPLETED|Overall Study||28
8608009|NCT03164538|21228337|P2|STARTED|Overall Study||35
8608010|NCT03164538|21228338|P1|STARTED|Overall Study||35
8608028|NCT03146663|21228435|P2|NOT COMPLETED|Overall Study||1
8608029|NCT03146663|21228436|P1|NOT COMPLETED|Overall Study||1
8608030|NCT03146663|21228435|P2|COMPLETED|Overall Study||27
8608031|NCT03146663|21228436|P1|COMPLETED|Overall Study||24
8608032|NCT03146663|21228435|P2|STARTED|Overall Study||28
8608033|NCT03146663|21228436|P1|STARTED|Overall Study||25
8608034|NCT03145766|21228449|P5|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
8608035|NCT03145766|21228450|P4|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
8608036|NCT03145766|21228451|P3|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||5
8608037|NCT03145766|21228452|P2|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||2
8608038|NCT03145766|21228453|P1|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||7
8608039|NCT03145766|21228449|P5|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||34
8608040|NCT03145766|21228450|P4|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||30
8608041|NCT03145766|21228451|P3|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||73
8608042|NCT03145766|21228452|P2|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||75
8608043|NCT03145766|21228453|P1|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||67
8608044|NCT03145766|21228449|P5|STARTED|Follow-up Phase (Day 56 Till Month 7)||37
8608045|NCT03145766|21228450|P4|STARTED|Follow-up Phase (Day 56 Till Month 7)||33
8608046|NCT03145766|21228451|P3|STARTED|Follow-up Phase (Day 56 Till Month 7)||78
8608047|NCT03145766|21228452|P2|STARTED|Follow-up Phase (Day 56 Till Month 7)||77
8608048|NCT03145766|21228453|P1|STARTED|Follow-up Phase (Day 56 Till Month 7)||74
8608049|NCT03145766|21228449|P5|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
8608050|NCT03145766|21228450|P4|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||7
8608051|NCT03145766|21228451|P3|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||2
8608052|NCT03145766|21228452|P2|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
8608053|NCT03145766|21228453|P1|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||6
8608054|NCT03145766|21228449|P5|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||37
8608055|NCT03145766|21228450|P4|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||33
8608056|NCT03145766|21228451|P3|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||78
8608057|NCT03145766|21228452|P2|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||77
8608058|NCT03145766|21228453|P1|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||74
8608059|NCT03145766|21228449|P5|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||37
8608060|NCT03145766|21228450|P4|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||34
8608061|NCT03145766|21228451|P3|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||79
8608062|NCT03145766|21228452|P2|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||78
8608063|NCT03145766|21228453|P1|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||75
8608064|NCT03145766|21228449|P5|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
8608065|NCT03145766|21228450|P4|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
8608066|NCT03145766|21228451|P3|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||80
8608067|NCT03145766|21228452|P2|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||79
8608068|NCT03145766|21228453|P1|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||78
8608069|NCT03145766|21228449|P5|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||38
8608070|NCT03145766|21228450|P4|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||39
8608071|NCT03145766|21228451|P3|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||80
8608072|NCT03145766|21228452|P2|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||79
8608073|NCT03145766|21228453|P1|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||78
8608074|NCT03145766|21228449|P5|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
8608075|NCT03145766|21228450|P4|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
8608076|NCT03145766|21228451|P3|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||80
8608077|NCT03145766|21228452|P2|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 1 received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety.|81
8608078|NCT03145766|21228453|P1|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety analysis.|77
8608079|NCT03145766|21228449|P5|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 4 received Imovax Rabies, and counted in Group 5 for safety analysis.|41
8608080|NCT03145766|21228450|P4|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of this arm received Imovax Rabies, and counted in Group 5 for safety analysis.|39
8608081|NCT03145766|21228451|P3|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
8608082|NCT03145766|21228452|P2|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
8608083|NCT03145766|21228453|P1|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
8608084|NCT03145766|21228449|P5|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
8608085|NCT03145766|21228450|P4|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
8608086|NCT03145766|21228451|P3|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
8608087|NCT03145766|21228452|P2|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
8608088|NCT03145766|21228453|P1|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
8608089|NCT03140722|21228582|P2|NOT COMPLETED|Overall Study||0
8608090|NCT03140722|21228583|P1|NOT COMPLETED|Overall Study||0
8608091|NCT03140722|21228582|P2|COMPLETED|Overall Study||2
8608092|NCT03140722|21228583|P1|COMPLETED|Overall Study||0
8608093|NCT03140722|21228582|P2|STARTED|Overall Study||2
8608094|NCT03140722|21228583|P1|STARTED|Overall Study||0
8608098|NCT03135210|21228613|P2|NOT COMPLETED|Overall Study||1
8608099|NCT03135210|21228614|P1|NOT COMPLETED|Overall Study||0
8608100|NCT03135210|21228613|P2|COMPLETED|Overall Study||1
8608101|NCT03135210|21228614|P1|COMPLETED|Overall Study||2
8608102|NCT03135210|21228613|P2|STARTED|Overall Study||2
8608103|NCT03135210|21228614|P1|STARTED|Overall Study||2
8608104|NCT03087851|21228623|P3|NOT COMPLETED|Overall Study||2
8608105|NCT03087851|21228624|P2|NOT COMPLETED|Overall Study||1
8608106|NCT03087851|21228625|P1|NOT COMPLETED|Overall Study||0
8608107|NCT03087851|21228623|P3|COMPLETED|Overall Study||19
8608108|NCT03087851|21228624|P2|COMPLETED|Overall Study||19
8608109|NCT03087851|21228625|P1|COMPLETED|Overall Study||20
8608110|NCT03087851|21228623|P3|STARTED|Overall Study||21
8608111|NCT03087851|21228624|P2|STARTED|Overall Study||20
8608112|NCT03087851|21228625|P1|STARTED|Overall Study||20
8608165|NCT02980705|21228832|P2|NOT COMPLETED|Overall Study||11
8608166|NCT02980705|21228833|P1|NOT COMPLETED|Overall Study||8
8608167|NCT02980705|21228832|P2|COMPLETED|Overall Study||40
8608168|NCT02980705|21228833|P1|COMPLETED|Overall Study||42
8608169|NCT02980705|21228832|P2|STARTED|Overall Study||51
8608170|NCT02980705|21228833|P1|STARTED|Overall Study||50
8608233|NCT02937116|21228998|P12|NOT COMPLETED|Overall Study||7
8608234|NCT02937116|21228999|P11|NOT COMPLETED|Overall Study||7
8608235|NCT02937116|21229000|P10|NOT COMPLETED|Overall Study||20
8608236|NCT02937116|21229001|P9|NOT COMPLETED|Overall Study||20
8608237|NCT02937116|21229002|P8|NOT COMPLETED|Overall Study||21
8608238|NCT02937116|21229003|P7|NOT COMPLETED|Overall Study||37
8608239|NCT02937116|21229004|P6|NOT COMPLETED|Overall Study||87
8608240|NCT02937116|21229005|P5|NOT COMPLETED|Overall Study||22
8608241|NCT02937116|21229006|P4|NOT COMPLETED|Overall Study||3
8608242|NCT02937116|21229007|P3|NOT COMPLETED|Overall Study||3
8608243|NCT02937116|21229008|P2|NOT COMPLETED|Overall Study||3
8608244|NCT02937116|21229009|P1|NOT COMPLETED|Overall Study||3
8608245|NCT02937116|21228998|P12|COMPLETED|Overall Study||0
8608246|NCT02937116|21228999|P11|COMPLETED|Overall Study||0
8608247|NCT02937116|21229000|P10|COMPLETED|Overall Study||0
8608248|NCT02937116|21229001|P9|COMPLETED|Overall Study||0
8608249|NCT02937116|21229002|P8|COMPLETED|Overall Study||0
8608250|NCT02937116|21229003|P7|COMPLETED|Overall Study||0
8608251|NCT02937116|21229004|P6|COMPLETED|Overall Study||0
8608252|NCT02937116|21229005|P5|COMPLETED|Overall Study||0
8608253|NCT02937116|21229006|P4|COMPLETED|Overall Study||0
8608254|NCT02937116|21229007|P3|COMPLETED|Overall Study||0
8608255|NCT02937116|21229008|P2|COMPLETED|Overall Study||0
8608256|NCT02937116|21229009|P1|COMPLETED|Overall Study||0
8608257|NCT02937116|21228998|P12|STARTED|Overall Study||7
8608258|NCT02937116|21228999|P11|STARTED|Overall Study||7
8608259|NCT02937116|21229000|P10|STARTED|Overall Study||20
8608260|NCT02937116|21229001|P9|STARTED|Overall Study||20
8608261|NCT02937116|21229002|P8|STARTED|Overall Study||21
8608262|NCT02937116|21229003|P7|STARTED|Overall Study||37
8608263|NCT02937116|21229004|P6|STARTED|Overall Study||87
8608264|NCT02937116|21229005|P5|STARTED|Overall Study||22
8608265|NCT02937116|21229006|P4|STARTED|Overall Study||3
8608266|NCT02937116|21229007|P3|STARTED|Overall Study||3
8608267|NCT02937116|21229008|P2|STARTED|Overall Study||3
8608268|NCT02937116|21229009|P1|STARTED|Overall Study||3
8608346|NCT02799667|21229343|P2|NOT COMPLETED|Overall Study||1
8608347|NCT02799667|21229344|P1|NOT COMPLETED|Overall Study||1
8608348|NCT02799667|21229343|P2|COMPLETED|Overall Study||54
8608349|NCT02799667|21229344|P1|COMPLETED|Overall Study||54
8608350|NCT02799667|21229343|P2|STARTED|Overall Study||55
8608351|NCT02799667|21229344|P1|STARTED|Overall Study||55
8608382|NCT02731729|21229468|P2|NOT COMPLETED|Overall Study||8
8608383|NCT02731729|21229469|P1|NOT COMPLETED|Overall Study||9
8608384|NCT02731729|21229468|P2|COMPLETED|Overall Study||2
8608385|NCT02731729|21229469|P1|COMPLETED|Overall Study||1
8608386|NCT02731729|21229468|P2|STARTED|Overall Study||10
8608387|NCT02731729|21229469|P1|STARTED|Overall Study||10
8608391|NCT02724020|21229495|P3|NOT COMPLETED|Overall Study||32
8608392|NCT02724020|21229496|P2|NOT COMPLETED|Overall Study||32
8608393|NCT02724020|21229497|P1|NOT COMPLETED|Overall Study||32
8608394|NCT02724020|21229495|P3|COMPLETED|Overall Study||0
8608395|NCT02724020|21229496|P2|COMPLETED|Overall Study||0
8608396|NCT02724020|21229497|P1|COMPLETED|Overall Study||0
8608397|NCT02724020|21229495|P3|Treated (Safety Analysis Set)|Overall Study||31
8608398|NCT02724020|21229496|P2|Treated (Safety Analysis Set)|Overall Study||32
8608399|NCT02724020|21229497|P1|Treated (Safety Analysis Set)|Overall Study||32
8608400|NCT02724020|21229495|P3|STARTED|Overall Study||32
8608401|NCT02724020|21229496|P2|STARTED|Overall Study||32
8608402|NCT02724020|21229497|P1|STARTED|Overall Study||32
8608403|NCT02699749|21229537|P14|NOT COMPLETED|Overall Study||6
8608404|NCT02699749|21229538|P13|NOT COMPLETED|Overall Study||3
8608405|NCT02699749|21229539|P12|NOT COMPLETED|Overall Study||4
8608406|NCT02699749|21229540|P11|NOT COMPLETED|Overall Study||6
8608407|NCT02699749|21229541|P10|NOT COMPLETED|Overall Study||6
8608408|NCT02699749|21229542|P9|NOT COMPLETED|Overall Study||6
8608409|NCT02699749|21229543|P8|NOT COMPLETED|Overall Study||6
8608410|NCT02699749|21229544|P7|NOT COMPLETED|Overall Study||6
8608411|NCT02699749|21229545|P6|NOT COMPLETED|Overall Study||9
8608412|NCT02699749|21229546|P5|NOT COMPLETED|Overall Study||3
8608413|NCT02699749|21229547|P4|NOT COMPLETED|Overall Study||3
8608414|NCT02699749|21229548|P3|NOT COMPLETED|Overall Study||16
8608415|NCT02699749|21229549|P2|NOT COMPLETED|Overall Study||3
8608416|NCT02699749|21229550|P1|NOT COMPLETED|Overall Study||3
8608417|NCT02699749|21229537|P14|COMPLETED|Overall Study||0
8608418|NCT02699749|21229538|P13|COMPLETED|Overall Study||0
8608419|NCT02699749|21229539|P12|COMPLETED|Overall Study||0
8608420|NCT02699749|21229540|P11|COMPLETED|Overall Study||0
8608421|NCT02699749|21229541|P10|COMPLETED|Overall Study||0
8608422|NCT02699749|21229542|P9|COMPLETED|Overall Study||0
8608423|NCT02699749|21229543|P8|COMPLETED|Overall Study||0
8608424|NCT02699749|21229544|P7|COMPLETED|Overall Study||0
8608425|NCT02699749|21229545|P6|COMPLETED|Overall Study||0
8608426|NCT02699749|21229546|P5|COMPLETED|Overall Study||0
8608427|NCT02699749|21229547|P4|COMPLETED|Overall Study||0
8608428|NCT02699749|21229548|P3|COMPLETED|Overall Study||0
8608429|NCT02699749|21229549|P2|COMPLETED|Overall Study||0
8608430|NCT02699749|21229550|P1|COMPLETED|Overall Study||0
8608431|NCT02699749|21229537|P14|STARTED|Overall Study||6
8608432|NCT02699749|21229538|P13|STARTED|Overall Study||3
8608433|NCT02699749|21229539|P12|STARTED|Overall Study||4
8608434|NCT02699749|21229540|P11|STARTED|Overall Study||6
8608435|NCT02699749|21229541|P10|STARTED|Overall Study||6
8608436|NCT02699749|21229542|P9|STARTED|Overall Study||6
8608437|NCT02699749|21229543|P8|STARTED|Overall Study||6
8608438|NCT02699749|21229544|P7|STARTED|Overall Study||6
8608439|NCT02699749|21229545|P6|STARTED|Overall Study||9
8608440|NCT02699749|21229546|P5|STARTED|Overall Study||3
8608441|NCT02699749|21229547|P4|STARTED|Overall Study||3
8608442|NCT02699749|21229548|P3|STARTED|Overall Study||16
8608443|NCT02699749|21229549|P2|STARTED|Overall Study||3
8608444|NCT02699749|21229550|P1|STARTED|Overall Study||3
8608445|NCT02679560|21229786|P2|NOT COMPLETED|Overall Study||0
8608446|NCT02679560|21229787|P1|NOT COMPLETED|Overall Study||0
8608447|NCT02679560|21229786|P2|COMPLETED|Overall Study||2
8608448|NCT02679560|21229787|P1|COMPLETED|Overall Study||1
8608449|NCT02679560|21229786|P2|STARTED|Overall Study||2
8608450|NCT02679560|21229787|P1|STARTED|Overall Study||1
8608469|NCT02667392|21230025|P1|NOT COMPLETED|Overall Study||0
8608470|NCT02667392|21230025|P1|COMPLETED|Overall Study||11
8608471|NCT02667392|21230025|P1|STARTED|Overall Study||11
8608592|NCT02565615|21230227|P5|NOT COMPLETED|Overall Study||1601
8608593|NCT02565615|21230228|P4|NOT COMPLETED|Overall Study||3
8608594|NCT02565615|21230229|P3|NOT COMPLETED|Overall Study||0
8608595|NCT02565615|21230230|P2|NOT COMPLETED|Overall Study||36
8608596|NCT02565615|21230231|P1|NOT COMPLETED|Overall Study||3
8608597|NCT02565615|21230227|P5|COMPLETED|Overall Study||21
8608598|NCT02565615|21230228|P4|COMPLETED|Overall Study||98
8608599|NCT02565615|21230229|P3|COMPLETED|Overall Study||21
8608600|NCT02565615|21230230|P2|COMPLETED|Overall Study||3044
8608601|NCT02565615|21230231|P1|COMPLETED|Overall Study||288
8608602|NCT02565615|21230227|P5|Treated|Overall Study||1055
8608603|NCT02565615|21230228|P4|Treated|Overall Study||101
8608604|NCT02565615|21230229|P3|Treated|Overall Study||21
8608605|NCT02565615|21230230|P2|Treated|Overall Study||3080
8608606|NCT02565615|21230231|P1|Treated|Overall Study||291
8608607|NCT02565615|21230227|P5|STARTED|Overall Study||1622
8608608|NCT02565615|21230228|P4|STARTED|Overall Study||101
8608609|NCT02565615|21230229|P3|STARTED|Overall Study||21
8608610|NCT02565615|21230230|P2|STARTED|Overall Study||3080
8608611|NCT02565615|21230231|P1|STARTED|Overall Study||291
8608641|NCT02470091|21230551|P2|NOT COMPLETED|Overall Study||2
8608642|NCT02470091|21230552|P1|NOT COMPLETED|Overall Study||1
8608643|NCT02470091|21230551|P2|COMPLETED|Overall Study||38
8608644|NCT02470091|21230552|P1|COMPLETED|Overall Study||15
8608645|NCT02470091|21230551|P2|Follow-up Report|Overall Study||10
8608646|NCT02470091|21230552|P1|Follow-up Report|Overall Study||1
8608647|NCT02470091|21230551|P2|STARTED|Overall Study||40
8608648|NCT02470091|21230552|P1|STARTED|Overall Study||16
8608759|NCT02324504|21230938|P1|STARTED|Overall Study||60
8608697|NCT02371889|21230800|P2|NOT COMPLETED|Overall Study||14
8608698|NCT02371889|21230801|P1|NOT COMPLETED|Overall Study||19
8608699|NCT02371889|21230800|P2|COMPLETED|Overall Study||71
8608700|NCT02371889|21230801|P1|COMPLETED|Overall Study||66
8608701|NCT02371889|21230800|P2|STARTED|Overall Study||85
8608702|NCT02371889|21230801|P1|STARTED|Overall Study||85
8608733|NCT02348775|21230884|P2|NOT COMPLETED|Overall Study||0
8608734|NCT02348775|21230885|P1|NOT COMPLETED|Overall Study||0
8608735|NCT02348775|21230884|P2|COMPLETED|Overall Study||8
8608736|NCT02348775|21230885|P1|COMPLETED|Overall Study||8
8608737|NCT02348775|21230884|P2|STARTED|Overall Study||8
8608738|NCT02348775|21230885|P1|STARTED|Overall Study||8
8608757|NCT02324504|21230938|P1|NOT COMPLETED|Overall Study||0
8608758|NCT02324504|21230938|P1|COMPLETED|Overall Study||60
8608778|NCT02308735|21230974|P4|NOT COMPLETED|Overall Study||2
8608779|NCT02308735|21230975|P3|NOT COMPLETED|Overall Study||0
8608780|NCT02308735|21230976|P2|NOT COMPLETED|Overall Study||0
8608781|NCT02308735|21230977|P1|NOT COMPLETED|Overall Study||2
8608782|NCT02308735|21230974|P4|COMPLETED|Overall Study||0
8608783|NCT02308735|21230975|P3|COMPLETED|Overall Study||0
8608784|NCT02308735|21230976|P2|COMPLETED|Overall Study||0
8608785|NCT02308735|21230977|P1|COMPLETED|Overall Study||0
8608786|NCT02308735|21230974|P4|STARTED|Overall Study||2
8608787|NCT02308735|21230975|P3|STARTED|Overall Study||0
8608788|NCT02308735|21230976|P2|STARTED|Overall Study||0
8608789|NCT02308735|21230977|P1|STARTED|Overall Study||2
8608790|NCT02299141|21230987|P1|NOT COMPLETED|Overall Study||0
8608791|NCT02299141|21230987|P1|COMPLETED|Overall Study||20
8608792|NCT02299141|21230987|P1|STARTED|Overall Study||20
8608960|NCT02217501|21231503|P2|NOT COMPLETED|Overall Study||4
8608961|NCT02217501|21231504|P1|NOT COMPLETED|Overall Study||3
8608962|NCT02217501|21231503|P2|COMPLETED|Overall Study||78
8608963|NCT02217501|21231504|P1|COMPLETED|Overall Study||74
8608964|NCT02217501|21231503|P2|STARTED|Overall Study||82
8608965|NCT02217501|21231504|P1|STARTED|Overall Study||77
8608966|NCT02208466|21231515|P3|NOT COMPLETED|Overall Study||0
8608967|NCT02208466|21231516|P2|NOT COMPLETED|Overall Study||0
8608968|NCT02208466|21231517|P1|NOT COMPLETED|Overall Study||0
8608969|NCT02208466|21231515|P3|COMPLETED|Overall Study||8
8608970|NCT02208466|21231516|P2|COMPLETED|Overall Study||10
8608971|NCT02208466|21231517|P1|COMPLETED|Overall Study||9
8608972|NCT02208466|21231515|P3|STARTED|Overall Study||8
8608973|NCT02208466|21231516|P2|STARTED|Overall Study||10
8608974|NCT02208466|21231517|P1|STARTED|Overall Study||9
8609008|NCT02172911|21231707|P2|NOT COMPLETED|Overall Study||2
8609009|NCT02172911|21231708|P1|NOT COMPLETED|Overall Study||1
8609010|NCT02172911|21231707|P2|COMPLETED|Overall Study||1
8609011|NCT02172911|21231708|P1|COMPLETED|Overall Study||6
8609012|NCT02172911|21231707|P2|STARTED|Overall Study||3
8609013|NCT02172911|21231708|P1|STARTED|Overall Study||7
8609023|NCT02078102|21231766|P2|NOT COMPLETED|Overall Study||1
8609024|NCT02078102|21231767|P1|NOT COMPLETED|Overall Study||2
8609025|NCT02078102|21231766|P2|COMPLETED|Overall Study||12
8609026|NCT02078102|21231767|P1|COMPLETED|Overall Study||23
8609027|NCT02078102|21231766|P2|STARTED|Overall Study||13
8609028|NCT02078102|21231767|P1|STARTED|Overall Study||25
8609040|NCT02059239|21231815|P2|NOT COMPLETED|Overall Study||3
8609041|NCT02059239|21231816|P1|NOT COMPLETED|Overall Study||2
8609042|NCT02059239|21231815|P2|COMPLETED|Overall Study||13
8609043|NCT02059239|21231816|P1|COMPLETED|Overall Study||16
8609044|NCT02059239|21231815|P2|STARTED|Overall Study||16
8609045|NCT02059239|21231816|P1|STARTED|Overall Study||18
8609092|NCT01984164|21231963|P2|NOT COMPLETED|Overall Study||25
8609093|NCT01984164|21231964|P1|NOT COMPLETED|Overall Study||10
8609094|NCT01984164|21231963|P2|COMPLETED|Overall Study||64
8609095|NCT01984164|21231964|P1|COMPLETED|Overall Study||77
8609096|NCT01984164|21231963|P2|STARTED|Overall Study||89
8609097|NCT01984164|21231964|P1|STARTED|Overall Study||87
8609098|NCT01970865|21232001|P17|NOT COMPLETED|Overall Study||3
8609099|NCT01970865|21232002|P16|NOT COMPLETED|Overall Study||47
8609100|NCT01970865|21232003|P15|NOT COMPLETED|Overall Study||46
8609101|NCT01970865|21232004|P14|NOT COMPLETED|Overall Study||66
8609102|NCT01970865|21232005|P13|NOT COMPLETED|Overall Study||60
8609103|NCT01970865|21232006|P12|NOT COMPLETED|Overall Study||27
8609104|NCT01970865|21232007|P11|NOT COMPLETED|Overall Study||30
8609105|NCT01970865|21232008|P10|NOT COMPLETED|Overall Study||4
8609106|NCT01970865|21232009|P9|NOT COMPLETED|Overall Study||3
8609107|NCT01970865|21232010|P8|NOT COMPLETED|Overall Study||3
8609108|NCT01970865|21232011|P7|NOT COMPLETED|Overall Study||3
8609109|NCT01970865|21232012|P6|NOT COMPLETED|Overall Study||3
8609110|NCT01970865|21232013|P5|NOT COMPLETED|Overall Study||17
8609111|NCT01970865|21232014|P4|NOT COMPLETED|Overall Study||13
8609112|NCT01970865|21232015|P3|NOT COMPLETED|Overall Study||3
8609113|NCT01970865|21232016|P2|NOT COMPLETED|Overall Study||3
8609114|NCT01970865|21232017|P1|NOT COMPLETED|Overall Study||3
8609115|NCT01970865|21232001|P17|COMPLETED|Overall Study||0
8609116|NCT01970865|21232002|P16|COMPLETED|Overall Study||0
8609117|NCT01970865|21232003|P15|COMPLETED|Overall Study||0
8609118|NCT01970865|21232004|P14|COMPLETED|Overall Study||0
8609119|NCT01970865|21232005|P13|COMPLETED|Overall Study||0
8609120|NCT01970865|21232006|P12|COMPLETED|Overall Study||0
8609121|NCT01970865|21232007|P11|COMPLETED|Overall Study||0
8609122|NCT01970865|21232008|P10|COMPLETED|Overall Study||0
8609123|NCT01970865|21232009|P9|COMPLETED|Overall Study||0
8609124|NCT01970865|21232010|P8|COMPLETED|Overall Study||0
8609125|NCT01970865|21232011|P7|COMPLETED|Overall Study||0
8609126|NCT01970865|21232012|P6|COMPLETED|Overall Study||0
8609127|NCT01970865|21232013|P5|COMPLETED|Overall Study||0
8609128|NCT01970865|21232014|P4|COMPLETED|Overall Study||0
8609129|NCT01970865|21232015|P3|COMPLETED|Overall Study||0
8609130|NCT01970865|21232016|P2|COMPLETED|Overall Study||0
8609131|NCT01970865|21232017|P1|COMPLETED|Overall Study||0
8609132|NCT01970865|21232001|P17|Received Treatment|Overall Study||3
8609133|NCT01970865|21232002|P16|Received Treatment|Overall Study||47
8609134|NCT01970865|21232003|P15|Received Treatment|Overall Study||46
8609135|NCT01970865|21232004|P14|Received Treatment|Overall Study||65
8609136|NCT01970865|21232005|P13|Received Treatment|Overall Study||60
8609137|NCT01970865|21232006|P12|Received Treatment|Overall Study||27
8609138|NCT01970865|21232007|P11|Received Treatment|Overall Study||30
8609139|NCT01970865|21232008|P10|Received Treatment|Overall Study||4
8609140|NCT01970865|21232009|P9|Received Treatment|Overall Study||3
8609141|NCT01970865|21232010|P8|Received Treatment|Overall Study||3
8609142|NCT01970865|21232011|P7|Received Treatment|Overall Study||3
8609143|NCT01970865|21232012|P6|Received Treatment|Overall Study||3
8609144|NCT01970865|21232013|P5|Received Treatment|Overall Study||17
8609145|NCT01970865|21232014|P4|Received Treatment|Overall Study||12
8609146|NCT01970865|21232015|P3|Received Treatment|Overall Study||3
8609147|NCT01970865|21232016|P2|Received Treatment|Overall Study||3
8609148|NCT01970865|21232017|P1|Received Treatment|Overall Study||3
8609149|NCT01970865|21232001|P17|STARTED|Overall Study||3
8609150|NCT01970865|21232002|P16|STARTED|Overall Study||47
8609151|NCT01970865|21232003|P15|STARTED|Overall Study||46
8609152|NCT01970865|21232004|P14|STARTED|Overall Study||66
8609153|NCT01970865|21232005|P13|STARTED|Overall Study||60
8609154|NCT01970865|21232006|P12|STARTED|Overall Study||27
8609155|NCT01970865|21232007|P11|STARTED|Overall Study||30
8609156|NCT01970865|21232008|P10|STARTED|Overall Study||4
8609157|NCT01970865|21232009|P9|STARTED|Overall Study||3
8609158|NCT01970865|21232010|P8|STARTED|Overall Study||3
8609159|NCT01970865|21232011|P7|STARTED|Overall Study||3
8609160|NCT01970865|21232012|P6|STARTED|Overall Study||3
8609161|NCT01970865|21232013|P5|STARTED|Overall Study||17
8609162|NCT01970865|21232014|P4|STARTED|Overall Study||13
8609163|NCT01970865|21232015|P3|STARTED|Overall Study||3
8609164|NCT01970865|21232016|P2|STARTED|Overall Study||3
8609165|NCT01970865|21232017|P1|STARTED|Overall Study||3
8609166|NCT01969916|21232441|P1|NOT COMPLETED|Overall Study||45
8609167|NCT01969916|21232441|P1|COMPLETED|Overall Study||105
8609168|NCT01969916|21232441|P1|STARTED|Overall Study||150
8609169|NCT01964326|21232445|P1|NOT COMPLETED|Overall Study||297
8609170|NCT01964326|21232445|P1|COMPLETED|Overall Study||1014
8609171|NCT01964326|21232445|P1|STARTED|Overall Study||1311
8609172|NCT01945021|21232452|P1|NOT COMPLETED|Overall Study||83
8609173|NCT01945021|21232452|P1|COMPLETED|Overall Study||44
8609174|NCT01945021|21232452|P1|Patient Reported Outcome Evaluable|Overall Study|Received at least 1 dose of study drug, completed baseline with at least 1 post-baseline assessment.|123
8609175|NCT01945021|21232452|P1|Response Evaluable Population|Overall Study|Received at least 1 dose of study drug and an adequate baseline tumor assessment.|127
8609176|NCT01945021|21232452|P1|Safety Population|Overall Study|Received at least 1 dose of study medication.|127
8609177|NCT01945021|21232452|P1|STARTED|Overall Study||127
8609194|NCT01888497|21232504|P4|NOT COMPLETED|Fourth Intervention Period||0
8609195|NCT01888497|21232505|P3|NOT COMPLETED|Fourth Intervention Period||0
8609196|NCT01888497|21232506|P2|NOT COMPLETED|Fourth Intervention Period||0
8609197|NCT01888497|21232507|P1|NOT COMPLETED|Fourth Intervention Period||0
8609198|NCT01888497|21232504|P4|COMPLETED|Fourth Intervention Period||14
8609199|NCT01888497|21232505|P3|COMPLETED|Fourth Intervention Period||14
8609200|NCT01888497|21232506|P2|COMPLETED|Fourth Intervention Period||14
8609201|NCT01888497|21232507|P1|COMPLETED|Fourth Intervention Period||13
8609202|NCT01888497|21232504|P4|STARTED|Fourth Intervention Period||14
8609203|NCT01888497|21232505|P3|STARTED|Fourth Intervention Period||14
8609204|NCT01888497|21232506|P2|STARTED|Fourth Intervention Period||14
8609205|NCT01888497|21232507|P1|STARTED|Fourth Intervention Period||13
8609206|NCT01888497|21232504|P4|NOT COMPLETED|Washout Period 3||0
8609207|NCT01888497|21232505|P3|NOT COMPLETED|Washout Period 3||0
8609208|NCT01888497|21232506|P2|NOT COMPLETED|Washout Period 3||0
8609209|NCT01888497|21232507|P1|NOT COMPLETED|Washout Period 3||0
8609210|NCT01888497|21232504|P4|COMPLETED|Washout Period 3||14
8609211|NCT01888497|21232505|P3|COMPLETED|Washout Period 3||14
8609212|NCT01888497|21232506|P2|COMPLETED|Washout Period 3||14
8609213|NCT01888497|21232507|P1|COMPLETED|Washout Period 3||13
8609214|NCT01888497|21232504|P4|STARTED|Washout Period 3||14
8609215|NCT01888497|21232505|P3|STARTED|Washout Period 3||14
8609216|NCT01888497|21232506|P2|STARTED|Washout Period 3||14
8609217|NCT01888497|21232507|P1|STARTED|Washout Period 3||13
8609218|NCT01888497|21232504|P4|NOT COMPLETED|Third Intervention Period||0
8609219|NCT01888497|21232505|P3|NOT COMPLETED|Third Intervention Period||0
8609220|NCT01888497|21232506|P2|NOT COMPLETED|Third Intervention Period||0
8609221|NCT01888497|21232507|P1|NOT COMPLETED|Third Intervention Period||0
8609222|NCT01888497|21232504|P4|COMPLETED|Third Intervention Period||14
8609223|NCT01888497|21232505|P3|COMPLETED|Third Intervention Period||14
8609224|NCT01888497|21232506|P2|COMPLETED|Third Intervention Period||14
8609225|NCT01888497|21232507|P1|COMPLETED|Third Intervention Period||13
8609226|NCT01888497|21232504|P4|STARTED|Third Intervention Period||14
8609227|NCT01888497|21232505|P3|STARTED|Third Intervention Period||14
8609228|NCT01888497|21232506|P2|STARTED|Third Intervention Period||14
8609229|NCT01888497|21232507|P1|STARTED|Third Intervention Period||13
8609230|NCT01888497|21232504|P4|NOT COMPLETED|Washout Period 2||2
8609231|NCT01888497|21232505|P3|NOT COMPLETED|Washout Period 2||0
8609232|NCT01888497|21232506|P2|NOT COMPLETED|Washout Period 2||0
8609233|NCT01888497|21232507|P1|NOT COMPLETED|Washout Period 2||0
8609234|NCT01888497|21232504|P4|COMPLETED|Washout Period 2||14
8609235|NCT01888497|21232505|P3|COMPLETED|Washout Period 2||14
8609236|NCT01888497|21232506|P2|COMPLETED|Washout Period 2||14
8609237|NCT01888497|21232507|P1|COMPLETED|Washout Period 2||13
8609238|NCT01888497|21232504|P4|STARTED|Washout Period 2||16
8609239|NCT01888497|21232505|P3|STARTED|Washout Period 2||14
8609240|NCT01888497|21232506|P2|STARTED|Washout Period 2||14
8609241|NCT01888497|21232507|P1|STARTED|Washout Period 2||13
8609242|NCT01888497|21232504|P4|NOT COMPLETED|Second Intervention Period||0
8609243|NCT01888497|21232505|P3|NOT COMPLETED|Second Intervention Period||0
8609244|NCT01888497|21232506|P2|NOT COMPLETED|Second Intervention Period||0
8609245|NCT01888497|21232507|P1|NOT COMPLETED|Second Intervention Period||0
8609246|NCT01888497|21232504|P4|COMPLETED|Second Intervention Period||16
8609247|NCT01888497|21232505|P3|COMPLETED|Second Intervention Period||14
8609248|NCT01888497|21232506|P2|COMPLETED|Second Intervention Period||14
8609249|NCT01888497|21232507|P1|COMPLETED|Second Intervention Period||13
8609250|NCT01888497|21232504|P4|STARTED|Second Intervention Period||16
8609251|NCT01888497|21232505|P3|STARTED|Second Intervention Period||14
8609252|NCT01888497|21232506|P2|STARTED|Second Intervention Period||14
8609253|NCT01888497|21232507|P1|STARTED|Second Intervention Period||13
8609254|NCT01888497|21232504|P4|NOT COMPLETED|Washout Period 1||1
8609255|NCT01888497|21232505|P3|NOT COMPLETED|Washout Period 1||1
8609256|NCT01888497|21232506|P2|NOT COMPLETED|Washout Period 1||0
8609257|NCT01888497|21232507|P1|NOT COMPLETED|Washout Period 1||0
8609258|NCT01888497|21232504|P4|COMPLETED|Washout Period 1||16
8609259|NCT01888497|21232505|P3|COMPLETED|Washout Period 1||14
8609260|NCT01888497|21232506|P2|COMPLETED|Washout Period 1||14
8609261|NCT01888497|21232507|P1|COMPLETED|Washout Period 1||13
8609262|NCT01888497|21232504|P4|STARTED|Washout Period 1||17
8609263|NCT01888497|21232505|P3|STARTED|Washout Period 1||15
8609264|NCT01888497|21232506|P2|STARTED|Washout Period 1||14
8609265|NCT01888497|21232507|P1|STARTED|Washout Period 1||13
8609266|NCT01888497|21232504|P4|NOT COMPLETED|First Intervention Period||0
8609267|NCT01888497|21232505|P3|NOT COMPLETED|First Intervention Period||0
8609268|NCT01888497|21232506|P2|NOT COMPLETED|First Intervention Period||0
8609269|NCT01888497|21232507|P1|NOT COMPLETED|First Intervention Period||0
8609270|NCT01888497|21232504|P4|COMPLETED|First Intervention Period||17
8609271|NCT01888497|21232505|P3|COMPLETED|First Intervention Period||15
8609272|NCT01888497|21232506|P2|COMPLETED|First Intervention Period||14
8609273|NCT01888497|21232507|P1|COMPLETED|First Intervention Period||13
8609274|NCT01888497|21232504|P4|STARTED|First Intervention Period||17
8609275|NCT01888497|21232505|P3|STARTED|First Intervention Period||15
8609276|NCT01888497|21232506|P2|STARTED|First Intervention Period||14
8609277|NCT01888497|21232507|P1|STARTED|First Intervention Period||13
8609278|NCT01885195|21232525|P1|NOT COMPLETED|Overall Study||110
8609279|NCT01885195|21232525|P1|COMPLETED|Overall Study||0
8609280|NCT01885195|21232525|P1|STARTED|Overall Study||110
8609323|NCT01789320|21232586|P1|NOT COMPLETED|Overall Study||2
8609324|NCT01789320|21232586|P1|COMPLETED|Overall Study||9
8609325|NCT01789320|21232586|P1|STARTED|Overall Study||11
8609386|NCT01616563|21232693|P1|NOT COMPLETED|Overall Study||40
8609387|NCT01616563|21232693|P1|COMPLETED|Overall Study||253
8609388|NCT01616563|21232693|P1|STARTED|Overall Study||293
8609467|NCT01327612|21232994|P7|NOT COMPLETED|Overall Study||2
8609468|NCT01327612|21232995|P6|NOT COMPLETED|Overall Study||3
8609469|NCT01327612|21232996|P5|NOT COMPLETED|Overall Study||2
8609470|NCT01327612|21232997|P4|NOT COMPLETED|Overall Study||1
8609471|NCT01327612|21232998|P3|NOT COMPLETED|Overall Study||1
8609472|NCT01327612|21232999|P2|NOT COMPLETED|Overall Study||1
8609473|NCT01327612|21233000|P1|NOT COMPLETED|Overall Study||1
8609474|NCT01327612|21232994|P7|COMPLETED|Overall Study||0
8609475|NCT01327612|21232995|P6|COMPLETED|Overall Study||0
8609476|NCT01327612|21232996|P5|COMPLETED|Overall Study||0
8609477|NCT01327612|21232997|P4|COMPLETED|Overall Study||0
8609478|NCT01327612|21232998|P3|COMPLETED|Overall Study||0
8609479|NCT01327612|21232999|P2|COMPLETED|Overall Study||0
8609480|NCT01327612|21233000|P1|COMPLETED|Overall Study||1
8609481|NCT01327612|21232994|P7|STARTED|Overall Study||2
8609482|NCT01327612|21232995|P6|STARTED|Overall Study||3
8609483|NCT01327612|21232996|P5|STARTED|Overall Study||2
8609484|NCT01327612|21232997|P4|STARTED|Overall Study||1
8609485|NCT01327612|21232998|P3|STARTED|Overall Study||1
8609486|NCT01327612|21232999|P2|STARTED|Overall Study||1
8609487|NCT01327612|21233000|P1|STARTED|Overall Study||2
8609488|NCT01304641|21233060|P2|NOT COMPLETED|Overall Study||0
8609489|NCT01304641|21233061|P1|NOT COMPLETED|Overall Study||0
8609490|NCT01304641|21233060|P2|COMPLETED|Overall Study||20132
8609491|NCT01304641|21233061|P1|COMPLETED|Overall Study||11470
8609492|NCT01304641|21233060|P2|STARTED|Overall Study||20132
8609493|NCT01304641|21233061|P1|STARTED|Overall Study||11470
8609580|NCT01191008|21233254|P1|NOT COMPLETED|Overall Study||15
8609581|NCT01191008|21233254|P1|COMPLETED|Overall Study||618
8609582|NCT01191008|21233254|P1|STARTED|Overall Study||633
8609589|NCT01169532|21233271|P1|NOT COMPLETED|Overall Study||1
8609590|NCT01169532|21233271|P1|COMPLETED|Overall Study||15
8609591|NCT01169532|21233271|P1|STARTED|Overall Study||16
8609652|NCT00924170|21233455|P2|NOT COMPLETED|Overall Study||8
8609653|NCT00924170|21233456|P1|NOT COMPLETED|Overall Study||7
8609654|NCT00924170|21233455|P2|COMPLETED|Overall Study||0
8609655|NCT00924170|21233456|P1|COMPLETED|Overall Study||3
8609656|NCT00924170|21233455|P2|STARTED|Overall Study||8
8609657|NCT00924170|21233456|P1|STARTED|Overall Study||10
8609658|NCT00917644|21233494|P2|NOT COMPLETED|Period 2: Second Intervention||0
8609659|NCT00917644|21233495|P1|NOT COMPLETED|Period 2: Second Intervention||1
8609660|NCT00917644|21233494|P2|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
8609661|NCT00917644|21233495|P1|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
8609662|NCT00917644|21233494|P2|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
8609663|NCT00917644|21233495|P1|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
8609664|NCT00917644|21233494|P2|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
8609665|NCT00917644|21233495|P1|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
8609666|NCT00917644|21233494|P2|COMPLETED|Period: Washout Period of > = 2 Weeks||37
8609667|NCT00917644|21233495|P1|COMPLETED|Period: Washout Period of > = 2 Weeks||37
8609668|NCT00917644|21233494|P2|STARTED|Period: Washout Period of > = 2 Weeks||37
8609669|NCT00917644|21233495|P1|STARTED|Period: Washout Period of > = 2 Weeks||39
8609670|NCT00917644|21233494|P2|NOT COMPLETED|Period 1: First Intervention||0
8609671|NCT00917644|21233495|P1|NOT COMPLETED|Period 1: First Intervention||0
8609672|NCT00917644|21233494|P2|COMPLETED|Period 1: First Intervention||37
8609673|NCT00917644|21233495|P1|COMPLETED|Period 1: First Intervention||39
8609674|NCT00917644|21233494|P2|STARTED|Period 1: First Intervention||37
8609675|NCT00917644|21233495|P1|STARTED|Period 1: First Intervention||39
8609680|NCT00879879|21233520|P1|NOT COMPLETED|Overall Study||3
8609681|NCT00879879|21233520|P1|COMPLETED|Overall Study||17
8609682|NCT00879879|21233520|P1|STARTED|Overall Study||20
8609691|NCT00840177|21233548|P3|NOT COMPLETED|Overall Study||11
8609692|NCT00840177|21233549|P2|NOT COMPLETED|Overall Study||9
8609693|NCT00840177|21233550|P1|NOT COMPLETED|Overall Study||18
8609694|NCT00840177|21233548|P3|COMPLETED|Overall Study||39
8609695|NCT00840177|21233549|P2|COMPLETED|Overall Study||20
8609696|NCT00840177|21233550|P1|COMPLETED|Overall Study||18
8609697|NCT00840177|21233548|P3|Assessed for AEs|Overall Study||46
8609698|NCT00840177|21233549|P2|Assessed for AEs|Overall Study||29
8609699|NCT00840177|21233550|P1|Assessed for AEs|Overall Study||35
8609700|NCT00840177|21233548|P3|Treated|Overall Study||46
8609701|NCT00840177|21233549|P2|Treated|Overall Study||29
8609702|NCT00840177|21233550|P1|Treated|Overall Study||36
8609703|NCT00840177|21233548|P3|STARTED|Overall Study||50
8609704|NCT00840177|21233549|P2|STARTED|Overall Study||29
8609705|NCT00840177|21233550|P1|STARTED|Overall Study||36
8609706|NCT00828945|21233567|P1|NOT COMPLETED|Overall Study||41
8609707|NCT00828945|21233567|P1|COMPLETED|Overall Study||216
8609708|NCT00828945|21233567|P1|STARTED|Overall Study||257
8609709|NCT00827606|21233583|P2|NOT COMPLETED|Overall Study||38
8609710|NCT00827606|21233584|P1|NOT COMPLETED|Overall Study||27
8609711|NCT00827606|21233583|P2|COMPLETED|Overall Study||94
8609712|NCT00827606|21233584|P1|COMPLETED|Overall Study||112
8609713|NCT00827606|21233583|P2|STARTED|Overall Study||132
8609714|NCT00827606|21233584|P1|STARTED|Overall Study||139
8609719|NCT00822120|21233654|P6|NOT COMPLETED|PET-directed Therapy||0
8609720|NCT00822120|21233655|P5|NOT COMPLETED|PET-directed Therapy||0
8609721|NCT00822120|21233656|P4|NOT COMPLETED|PET-directed Therapy||10
8609722|NCT00822120|21233657|P3|NOT COMPLETED|PET-directed Therapy||0
8609723|NCT00822120|21233658|P2|NOT COMPLETED|PET-directed Therapy||0
8609724|NCT00822120|21233659|P1|NOT COMPLETED|PET-directed Therapy||0
8609725|NCT00822120|21233654|P6|COMPLETED|PET-directed Therapy||1
8609726|NCT00822120|21233655|P5|COMPLETED|PET-directed Therapy||10
8609727|NCT00822120|21233656|P4|COMPLETED|PET-directed Therapy||45
8609728|NCT00822120|21233657|P3|COMPLETED|PET-directed Therapy||270
8609729|NCT00822120|21233658|P2|COMPLETED|PET-directed Therapy||0
8609730|NCT00822120|21233659|P1|COMPLETED|PET-directed Therapy||0
8609731|NCT00822120|21233654|P6|Eligibile and Evaluable Patients|PET-directed Therapy||1
8609732|NCT00822120|21233655|P5|Eligibile and Evaluable Patients|PET-directed Therapy||10
8609733|NCT00822120|21233656|P4|Eligibile and Evaluable Patients|PET-directed Therapy||55
8609734|NCT00822120|21233657|P3|Eligibile and Evaluable Patients|PET-directed Therapy||270
8609735|NCT00822120|21233658|P2|Eligibile and Evaluable Patients|PET-directed Therapy||0
8609736|NCT00822120|21233659|P1|Eligibile and Evaluable Patients|PET-directed Therapy||0
8609737|NCT00822120|21233654|P6|STARTED|PET-directed Therapy||1
8609738|NCT00822120|21233655|P5|STARTED|PET-directed Therapy||10
8609739|NCT00822120|21233656|P4|STARTED|PET-directed Therapy||55
8609740|NCT00822120|21233657|P3|STARTED|PET-directed Therapy||270
8609741|NCT00822120|21233658|P2|STARTED|PET-directed Therapy||0
8609742|NCT00822120|21233659|P1|STARTED|PET-directed Therapy||0
8609743|NCT00822120|21233654|P6|NOT COMPLETED|Initial Registration||0
8609744|NCT00822120|21233655|P5|NOT COMPLETED|Initial Registration||0
8609745|NCT00822120|21233656|P4|NOT COMPLETED|Initial Registration||0
8609746|NCT00822120|21233657|P3|NOT COMPLETED|Initial Registration||0
8609747|NCT00822120|21233658|P2|NOT COMPLETED|Initial Registration||1
8609748|NCT00822120|21233659|P1|NOT COMPLETED|Initial Registration||26
8609749|NCT00822120|21233654|P6|COMPLETED|Initial Registration||0
8609750|NCT00822120|21233655|P5|COMPLETED|Initial Registration||0
8609751|NCT00822120|21233656|P4|COMPLETED|Initial Registration||0
8609752|NCT00822120|21233657|P3|COMPLETED|Initial Registration||0
8609753|NCT00822120|21233658|P2|COMPLETED|Initial Registration||12
8609754|NCT00822120|21233659|P1|COMPLETED|Initial Registration||332
8609755|NCT00822120|21233654|P6|Eligible and Evaluable Patients|Initial Registration||0
8609756|NCT00822120|21233655|P5|Eligible and Evaluable Patients|Initial Registration||0
8609757|NCT00822120|21233656|P4|Eligible and Evaluable Patients|Initial Registration||0
8609758|NCT00822120|21233657|P3|Eligible and Evaluable Patients|Initial Registration||0
8609759|NCT00822120|21233658|P2|Eligible and Evaluable Patients|Initial Registration||12
8609760|NCT00822120|21233659|P1|Eligible and Evaluable Patients|Initial Registration||336
8609761|NCT00822120|21233654|P6|STARTED|Initial Registration||0
8609762|NCT00822120|21233655|P5|STARTED|Initial Registration||0
8609763|NCT00822120|21233656|P4|STARTED|Initial Registration||0
8609764|NCT00822120|21233657|P3|STARTED|Initial Registration||0
8609765|NCT00822120|21233658|P2|STARTED|Initial Registration||13
8609766|NCT00822120|21233659|P1|STARTED|Initial Registration||358
8609794|NCT00728988|21233757|P2|NOT COMPLETED|Overall Study||88
8609795|NCT00728988|21233758|P1|NOT COMPLETED|Overall Study||93
8609796|NCT00728988|21233757|P2|COMPLETED|Overall Study||164
8609797|NCT00728988|21233758|P1|COMPLETED|Overall Study||154
8609798|NCT00728988|21233757|P2|Full Analysis Set|Overall Study||172
8609799|NCT00728988|21233758|P1|Full Analysis Set|Overall Study||163
8609800|NCT00728988|21233757|P2|Treated|Overall Study||250
8609801|NCT00728988|21233758|P1|Treated|Overall Study||245
8609802|NCT00728988|21233757|P2|STARTED|Overall Study||252
8609803|NCT00728988|21233758|P1|STARTED|Overall Study||247
8609810|NCT00673660|21233815|P1|NOT COMPLETED|Overall Study||107
8609811|NCT00673660|21233815|P1|COMPLETED|Overall Study||268
8609812|NCT00673660|21233815|P1|STARTED|Overall Study||375
8609813|NCT00669409|21233832|P11|NOT COMPLETED|Part 2||0
8609814|NCT00669409|21233833|P10|NOT COMPLETED|Part 2||1
8609815|NCT00669409|21233834|P9|NOT COMPLETED|Part 2||0
8609816|NCT00669409|21233835|P8|NOT COMPLETED|Part 2||0
8609817|NCT00669409|21233836|P7|NOT COMPLETED|Part 2||0
8609818|NCT00669409|21233837|P6|NOT COMPLETED|Part 2||0
8609819|NCT00669409|21233838|P5|NOT COMPLETED|Part 2||0
8609820|NCT00669409|21233839|P4|NOT COMPLETED|Part 2||0
8609821|NCT00669409|21233840|P3|NOT COMPLETED|Part 2||0
8609822|NCT00669409|21233841|P2|NOT COMPLETED|Part 2||0
8609823|NCT00669409|21233842|P1|NOT COMPLETED|Part 2||0
8609824|NCT00669409|21233832|P11|COMPLETED|Part 2||4
8609825|NCT00669409|21233833|P10|COMPLETED|Part 2||9
8609826|NCT00669409|21233834|P9|COMPLETED|Part 2||9
8609827|NCT00669409|21233835|P8|COMPLETED|Part 2||9
8609828|NCT00669409|21233836|P7|COMPLETED|Part 2||9
8609829|NCT00669409|21233837|P6|COMPLETED|Part 2||0
8609830|NCT00669409|21233838|P5|COMPLETED|Part 2||0
8609831|NCT00669409|21233839|P4|COMPLETED|Part 2||0
8609832|NCT00669409|21233840|P3|COMPLETED|Part 2||0
8609833|NCT00669409|21233841|P2|COMPLETED|Part 2||0
8609834|NCT00669409|21233842|P1|COMPLETED|Part 2||0
8609835|NCT00669409|21233832|P11|STARTED|Part 2||4
8609836|NCT00669409|21233833|P10|STARTED|Part 2||10
8609837|NCT00669409|21233834|P9|STARTED|Part 2||9
8609838|NCT00669409|21233835|P8|STARTED|Part 2||9
8609839|NCT00669409|21233836|P7|STARTED|Part 2||9
8609840|NCT00669409|21233837|P6|STARTED|Part 2||0
8609841|NCT00669409|21233838|P5|STARTED|Part 2||0
8609842|NCT00669409|21233839|P4|STARTED|Part 2||0
8609843|NCT00669409|21233840|P3|STARTED|Part 2||0
8609844|NCT00669409|21233841|P2|STARTED|Part 2||0
8609845|NCT00669409|21233842|P1|STARTED|Part 2||0
8609846|NCT00669409|21233832|P11|NOT COMPLETED|Part 1||0
8609847|NCT00669409|21233833|P10|NOT COMPLETED|Part 1||0
8609848|NCT00669409|21233834|P9|NOT COMPLETED|Part 1||0
8609849|NCT00669409|21233835|P8|NOT COMPLETED|Part 1||0
8609850|NCT00669409|21233836|P7|NOT COMPLETED|Part 1||0
8609851|NCT00669409|21233837|P6|NOT COMPLETED|Part 1||0
8609852|NCT00669409|21233838|P5|NOT COMPLETED|Part 1||0
8609853|NCT00669409|21233839|P4|NOT COMPLETED|Part 1||0
8609854|NCT00669409|21233840|P3|NOT COMPLETED|Part 1||0
8609855|NCT00669409|21233841|P2|NOT COMPLETED|Part 1||0
8609856|NCT00669409|21233842|P1|NOT COMPLETED|Part 1||0
8609857|NCT00669409|21233832|P11|COMPLETED|Part 1||0
8609858|NCT00669409|21233833|P10|COMPLETED|Part 1||0
8609859|NCT00669409|21233834|P9|COMPLETED|Part 1||0
8609860|NCT00669409|21233835|P8|COMPLETED|Part 1||0
8609861|NCT00669409|21233836|P7|COMPLETED|Part 1||0
8609862|NCT00669409|21233837|P6|COMPLETED|Part 1||12
8609863|NCT00669409|21233838|P5|COMPLETED|Part 1||6
8609864|NCT00669409|21233839|P4|COMPLETED|Part 1||6
8609865|NCT00669409|21233840|P3|COMPLETED|Part 1||6
8609866|NCT00669409|21233841|P2|COMPLETED|Part 1||6
8609867|NCT00669409|21233842|P1|COMPLETED|Part 1||6
8609868|NCT00669409|21233832|P11|STARTED|Part 1||0
8609869|NCT00669409|21233833|P10|STARTED|Part 1||0
8609870|NCT00669409|21233834|P9|STARTED|Part 1||0
8609871|NCT00669409|21233835|P8|STARTED|Part 1||0
8609872|NCT00669409|21233836|P7|STARTED|Part 1||0
8609873|NCT00669409|21233837|P6|STARTED|Part 1||12
8609874|NCT00669409|21233838|P5|STARTED|Part 1||6
8609875|NCT00669409|21233839|P4|STARTED|Part 1||6
8609876|NCT00669409|21233840|P3|STARTED|Part 1||6
8609877|NCT00669409|21233841|P2|STARTED|Part 1||6
8609878|NCT00669409|21233842|P1|STARTED|Part 1||6
8609879|NCT00662558|21234226|P2|NOT COMPLETED|Overall Study||110
8609880|NCT00662558|21234227|P1|NOT COMPLETED|Overall Study||56
8609881|NCT00662558|21234226|P2|COMPLETED|Overall Study||294
8609882|NCT00662558|21234227|P1|COMPLETED|Overall Study||342
8609883|NCT00662558|21234226|P2|Received Treatment|Overall Study||396
8609884|NCT00662558|21234227|P1|Received Treatment|Overall Study||396
8609885|NCT00662558|21234226|P2|STARTED|Overall Study||404
8609886|NCT00662558|21234227|P1|STARTED|Overall Study||398
8609895|NCT00585312|21234276|P2|NOT COMPLETED|Overall Study||44
8609896|NCT00585312|21234277|P1|NOT COMPLETED|Overall Study||51
8609897|NCT00585312|21234276|P2|COMPLETED|Overall Study||7
8609898|NCT00585312|21234277|P1|COMPLETED|Overall Study||4
8609899|NCT00585312|21234276|P2|Treated|Overall Study||48
8609900|NCT00585312|21234277|P1|Treated|Overall Study||53
8609901|NCT00585312|21234276|P2|STARTED|Overall Study|STARTED=Randomized|51
8609902|NCT00585312|21234277|P1|STARTED|Overall Study|STARTED=Randomized|55
8609903|NCT00549549|21234293|P4|NOT COMPLETED|Overall Study||25
8609904|NCT00549549|21234294|P3|NOT COMPLETED|Overall Study||17
8609905|NCT00549549|21234295|P2|NOT COMPLETED|Overall Study||22
8609906|NCT00549549|21234296|P1|NOT COMPLETED|Overall Study||24
8609907|NCT00549549|21234293|P4|COMPLETED|Overall Study||78
8609908|NCT00549549|21234294|P3|COMPLETED|Overall Study||82
8609909|NCT00549549|21234295|P2|COMPLETED|Overall Study||77
8609910|NCT00549549|21234296|P1|COMPLETED|Overall Study||77
8609911|NCT00549549|21234293|P4|Treated|Overall Study||102
8609912|NCT00549549|21234294|P3|Treated|Overall Study||98
8609913|NCT00549549|21234295|P2|Treated|Overall Study||99
8609914|NCT00549549|21234296|P1|Treated|Overall Study||101
8609915|NCT00549549|21234293|P4|STARTED|Overall Study||103
8609916|NCT00549549|21234294|P3|STARTED|Overall Study||99
8609917|NCT00549549|21234295|P2|STARTED|Overall Study||99
8609918|NCT00549549|21234296|P1|STARTED|Overall Study||101
8609925|NCT00462020|21234379|P2|NOT COMPLETED|Overall Study||0
8609926|NCT00462020|21234380|P1|NOT COMPLETED|Overall Study||0
8609927|NCT00462020|21234379|P2|COMPLETED|Overall Study||50
8609928|NCT00462020|21234380|P1|COMPLETED|Overall Study||52
8609929|NCT00462020|21234379|P2|STARTED|Overall Study||50
8609930|NCT00462020|21234380|P1|STARTED|Overall Study||52
8609931|NCT00454207|21234396|P2|NOT COMPLETED|Overall Study||2
8609932|NCT00454207|21234397|P1|NOT COMPLETED|Overall Study||4
8609933|NCT00454207|21234396|P2|COMPLETED|Overall Study||21
8609934|NCT00454207|21234397|P1|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
8609935|NCT00454207|21234396|P2|STARTED|Overall Study||23
8609936|NCT00454207|21234397|P1|STARTED|Overall Study||21
8609937|NCT00446797|21234442|P2|NOT COMPLETED|Overall Study||12
8609938|NCT00446797|21234443|P1|NOT COMPLETED|Overall Study||8
8609939|NCT00446797|21234442|P2|COMPLETED|Overall Study||125
8609940|NCT00446797|21234443|P1|COMPLETED|Overall Study||133
8609941|NCT00446797|21234442|P2|STARTED|Overall Study||137
8609942|NCT00446797|21234443|P1|STARTED|Overall Study||141
8609943|NCT00443599|21234489|P2|NOT COMPLETED|Overall Study||3
8609944|NCT00443599|21234490|P1|NOT COMPLETED|Overall Study||6
8609945|NCT00443599|21234489|P2|COMPLETED|Overall Study|Included in per-protocol analysis|490
8609946|NCT00443599|21234490|P1|COMPLETED|Overall Study|Included in per-protocol analysis|490
8609947|NCT00443599|21234489|P2|STARTED|Overall Study|Randomly Assigned to Standard Care|493
8609948|NCT00443599|21234490|P1|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
8610002|NCT00070018|21234671|P1|NOT COMPLETED|Overall Study||4
8610003|NCT00070018|21234671|P1|COMPLETED|Overall Study||42
8610004|NCT00070018|21234671|P1|Eligible and Began Protocol Therapy|Overall Study||46
8610005|NCT00070018|21234671|P1|Eligible|Overall Study||46
8610006|NCT00070018|21234671|P1|STARTED|Overall Study||46
8614244|NCT04174638|21248531|P2|NOT COMPLETED|Overall Study||0
8614245|NCT04174638|21248532|P1|NOT COMPLETED|Overall Study||0
8614246|NCT04174638|21248531|P2|COMPLETED|Overall Study||28
8614247|NCT04174638|21248532|P1|COMPLETED|Overall Study||32
8614248|NCT04174638|21248531|P2|STARTED|Overall Study||28
8614249|NCT04174638|21248532|P1|STARTED|Overall Study||32
8614250|NCT04149925|21248552|P2|NOT COMPLETED|Overall Study||0
8614251|NCT04149925|21248553|P1|NOT COMPLETED|Overall Study||0
8614252|NCT04149925|21248552|P2|COMPLETED|Overall Study||30
8614253|NCT04149925|21248553|P1|COMPLETED|Overall Study||30
8614254|NCT04149925|21248552|P2|STARTED|Overall Study||30
8614255|NCT04149925|21248553|P1|STARTED|Overall Study||30
8614274|NCT04076787|21248617|P3|NOT COMPLETED|Overall Study||0
8614275|NCT04076787|21248618|P2|NOT COMPLETED|Overall Study||0
8614276|NCT04076787|21248619|P1|NOT COMPLETED|Overall Study||0
8614277|NCT04076787|21248617|P3|COMPLETED|Overall Study||420
8614278|NCT04076787|21248618|P2|COMPLETED|Overall Study||1031
8614279|NCT04076787|21248619|P1|COMPLETED|Overall Study||318
8614280|NCT04076787|21248617|P3|STARTED|Overall Study||420
8614281|NCT04076787|21248618|P2|STARTED|Overall Study||1031
8614282|NCT04076787|21248619|P1|STARTED|Overall Study||318
8614301|NCT03981861|21248711|P1|NOT COMPLETED|Overall Study||3
8614302|NCT03981861|21248711|P1|COMPLETED|Overall Study||9
8614303|NCT03981861|21248711|P1|STARTED|Overall Study||12
8614315|NCT03867838|21248757|P1|NOT COMPLETED|Overall Study||0
8614316|NCT03867838|21248757|P1|COMPLETED|Overall Study||6
8614317|NCT03867838|21248757|P1|STARTED|Overall Study||6
8614357|NCT03820388|21248966|P3|NOT COMPLETED|Overall Study||0
8614358|NCT03820388|21248967|P2|NOT COMPLETED|Overall Study||0
8614359|NCT03820388|21248968|P1|NOT COMPLETED|Overall Study||0
8614360|NCT03820388|21248966|P3|COMPLETED|Overall Study||25
8614361|NCT03820388|21248967|P2|COMPLETED|Overall Study||25
8614362|NCT03820388|21248968|P1|COMPLETED|Overall Study||25
8614363|NCT03820388|21248966|P3|STARTED|Overall Study||25
8614364|NCT03820388|21248967|P2|STARTED|Overall Study||25
8614365|NCT03820388|21248968|P1|STARTED|Overall Study||25
8614366|NCT03815292|21248999|P2|NOT COMPLETED|Overall Study||0
8614367|NCT03815292|21249000|P1|NOT COMPLETED|Overall Study||0
8614368|NCT03815292|21248999|P2|COMPLETED|Overall Study||140
8614369|NCT03815292|21249000|P1|COMPLETED|Overall Study||135
8614370|NCT03815292|21248999|P2|STARTED|Overall Study||140
8614371|NCT03815292|21249000|P1|STARTED|Overall Study||135
8614414|NCT03760068|21249090|P2|NOT COMPLETED|Overall Study||23
8614415|NCT03760068|21249091|P1|NOT COMPLETED|Overall Study||14
8614416|NCT03760068|21249090|P2|COMPLETED|Overall Study||217
8614417|NCT03760068|21249091|P1|COMPLETED|Overall Study||224
8614418|NCT03760068|21249090|P2|STARTED|Overall Study||240
8614419|NCT03760068|21249091|P1|STARTED|Overall Study||238
8614530|NCT03483935|21249417|P1|NOT COMPLETED|Stage 2: Randomised Controlled Trial||0
8614531|NCT03483935|21249417|P1|COMPLETED|Stage 2: Randomised Controlled Trial||11
8614532|NCT03483935|21249417|P1|AKs Not Treated|Stage 2: Randomised Controlled Trial||11
8614533|NCT03483935|21249417|P1|AKs Treated|Stage 2: Randomised Controlled Trial||11
8614534|NCT03483935|21249417|P1|STARTED|Stage 2: Randomised Controlled Trial|Participants were randomised to receiving treatment on the left or right side.|11
8614535|NCT03483935|21249417|P1|NOT COMPLETED|Stage 1: Dose Setting Study||0
8614536|NCT03483935|21249417|P1|COMPLETED|Stage 1: Dose Setting Study||7
8614537|NCT03483935|21249417|P1|STARTED|Stage 1: Dose Setting Study||7
8614553|NCT03415022|21249477|P2|NOT COMPLETED|Overall Study||5
8614554|NCT03415022|21249478|P1|NOT COMPLETED|Overall Study||5
8614555|NCT03415022|21249477|P2|COMPLETED|Overall Study||15
8614556|NCT03415022|21249478|P1|COMPLETED|Overall Study||16
8614557|NCT03415022|21249477|P2|STARTED|Overall Study||20
8614558|NCT03415022|21249478|P1|STARTED|Overall Study||21
8614599|NCT03335150|21249593|P2|NOT COMPLETED|Overall Study||5
8614600|NCT03335150|21249594|P1|NOT COMPLETED|Overall Study||10
8614601|NCT03335150|21249593|P2|COMPLETED|Overall Study||50
8614602|NCT03335150|21249594|P1|COMPLETED|Overall Study||45
8614603|NCT03335150|21249593|P2|POST Testing Session|Overall Study||50
8614604|NCT03335150|21249594|P1|POST Testing Session|Overall Study||45
8614605|NCT03335150|21249593|P2|Commenced Group|Overall Study||52
8614606|NCT03335150|21249594|P1|Commenced Group|Overall Study||47
8614607|NCT03335150|21249593|P2|PRE Testing Session|Overall Study||55
8614608|NCT03335150|21249594|P1|PRE Testing Session|Overall Study||53
8614609|NCT03335150|21249593|P2|Enrolled + Assigned Group|Overall Study||55
8614610|NCT03335150|21249594|P1|Enrolled + Assigned Group|Overall Study||54
8614611|NCT03335150|21249593|P2|STARTED|Overall Study||55
8614612|NCT03335150|21249594|P1|STARTED|Overall Study||55
8614613|NCT03329690|21249621|P5|NOT COMPLETED|Overall Study||22
8614614|NCT03329690|21249622|P4|NOT COMPLETED|Overall Study||21
8614615|NCT03329690|21249623|P3|NOT COMPLETED|Overall Study||6
8614616|NCT03329690|21249624|P2|NOT COMPLETED|Overall Study||53
8614617|NCT03329690|21249625|P1|NOT COMPLETED|Overall Study||98
8614618|NCT03329690|21249621|P5|COMPLETED|Overall Study||2
8614619|NCT03329690|21249622|P4|COMPLETED|Overall Study||0
8614620|NCT03329690|21249623|P3|COMPLETED|Overall Study||1
8614621|NCT03329690|21249624|P2|COMPLETED|Overall Study||2
8614622|NCT03329690|21249625|P1|COMPLETED|Overall Study||28
8614623|NCT03329690|21249621|P5|Received Treatment|Overall Study||24
8614624|NCT03329690|21249622|P4|Received Treatment|Overall Study||20
8614625|NCT03329690|21249623|P3|Received Treatment|Overall Study||7
8614626|NCT03329690|21249624|P2|Received Treatment|Overall Study||55
8614627|NCT03329690|21249625|P1|Received Treatment|Overall Study||125
8614628|NCT03329690|21249621|P5|STARTED|Overall Study||24
8614629|NCT03329690|21249622|P4|STARTED|Overall Study||21
8614630|NCT03329690|21249623|P3|STARTED|Overall Study||7
8614631|NCT03329690|21249624|P2|STARTED|Overall Study||55
8614632|NCT03329690|21249625|P1|STARTED|Overall Study||126
8614633|NCT03282357|21249703|P1|NOT COMPLETED|Overall Study||17
8614634|NCT03282357|21249703|P1|COMPLETED|Overall Study||164
8614635|NCT03282357|21249703|P1|Safety Evaluation Set|Overall Study||176
8614636|NCT03282357|21249703|P1|STARTED|Overall Study||181
8614658|NCT03224585|21249779|P2|NOT COMPLETED|Overall Study||0
8614659|NCT03224585|21249780|P1|NOT COMPLETED|Overall Study||0
8614660|NCT03224585|21249779|P2|COMPLETED|Overall Study||3
8614661|NCT03224585|21249780|P1|COMPLETED|Overall Study||2
8614662|NCT03224585|21249779|P2|STARTED|Overall Study||3
8614663|NCT03224585|21249780|P1|STARTED|Overall Study||2
8614670|NCT03202134|21249805|P2|NOT COMPLETED|Overall Study||0
8614671|NCT03202134|21249806|P1|NOT COMPLETED|Overall Study||0
8614672|NCT03202134|21249805|P2|COMPLETED|Overall Study||149
8614673|NCT03202134|21249806|P1|COMPLETED|Overall Study||55
8614674|NCT03202134|21249805|P2|STARTED|Overall Study||149
8614675|NCT03202134|21249806|P1|STARTED|Overall Study||55
8614676|NCT03157089|21249824|P2|NOT COMPLETED|Overall Study||12
8614677|NCT03157089|21249825|P1|NOT COMPLETED|Overall Study||12
8614678|NCT03157089|21249824|P2|COMPLETED|Overall Study||0
8614679|NCT03157089|21249825|P1|COMPLETED|Overall Study||0
8614680|NCT03157089|21249824|P2|Treated|Overall Study||12
8614681|NCT03157089|21249825|P1|Treated|Overall Study||12
8614682|NCT03157089|21249824|P2|STARTED|Overall Study||12
8614683|NCT03157089|21249825|P1|STARTED|Overall Study||12
8614723|NCT03078907|21249917|P2|NOT COMPLETED|Overall Study||1
8614724|NCT03078907|21249918|P1|NOT COMPLETED|Overall Study||3
8614725|NCT03078907|21249917|P2|COMPLETED|Overall Study||54
8614726|NCT03078907|21249918|P1|COMPLETED|Overall Study||50
8614727|NCT03078907|21249917|P2|STARTED|Overall Study||55
8614728|NCT03078907|21249918|P1|STARTED|Overall Study||53
8614729|NCT03077646|21249955|P3|NOT COMPLETED|Overall Study||31
8614730|NCT03077646|21249956|P2|NOT COMPLETED|Overall Study||30
8614731|NCT03077646|21249957|P1|NOT COMPLETED|Overall Study||29
8614732|NCT03077646|21249955|P3|COMPLETED|Overall Study|Of these 43, there were 20 paired samples for primary outcome|43
8614733|NCT03077646|21249956|P2|COMPLETED|Overall Study|Of these 45, there were 27 paired samples for primary outcome|45
8614734|NCT03077646|21249957|P1|COMPLETED|Overall Study|Of these 47, there were 25 paired samples for primary outcome|47
8614735|NCT03077646|21249955|P3|STARTED|Overall Study||74
8614736|NCT03077646|21249956|P2|STARTED|Overall Study||75
8614737|NCT03077646|21249957|P1|STARTED|Overall Study||76
8614747|NCT03061812|21249987|P2|NOT COMPLETED|Overall Study||0
8614748|NCT03061812|21249988|P1|NOT COMPLETED|Overall Study||0
8614749|NCT03061812|21249987|P2|COMPLETED|Overall Study||296
8614750|NCT03061812|21249988|P1|COMPLETED|Overall Study||148
8614751|NCT03061812|21249987|P2|STARTED|Overall Study||296
8614752|NCT03061812|21249988|P1|STARTED|Overall Study||148
8614753|NCT03045653|21250004|P1|NOT COMPLETED|Overall Study||0
8614754|NCT03045653|21250004|P1|COMPLETED|Overall Study||30
8614755|NCT03045653|21250004|P1|STARTED|Overall Study||30
8614811|NCT02968563|21250276|P2|NOT COMPLETED|Overall Study||23
8614812|NCT02968563|21250277|P1|NOT COMPLETED|Overall Study||1
8614813|NCT02968563|21250276|P2|COMPLETED|Overall Study||7
8614814|NCT02968563|21250277|P1|COMPLETED|Overall Study||4
8614815|NCT02968563|21250276|P2|STARTED|Overall Study||30
8614816|NCT02968563|21250277|P1|STARTED|Overall Study||5
8614951|NCT02875080|21250558|P3|NOT COMPLETED|Overall Study||0
8614952|NCT02875080|21250559|P2|NOT COMPLETED|Overall Study||0
8614953|NCT02875080|21250560|P1|NOT COMPLETED|Overall Study||2
8614954|NCT02875080|21250558|P3|COMPLETED|Overall Study||6
8614955|NCT02875080|21250559|P2|COMPLETED|Overall Study||6
8614956|NCT02875080|21250560|P1|COMPLETED|Overall Study||4
8614957|NCT02875080|21250558|P3|STARTED|Overall Study||6
8614958|NCT02875080|21250559|P2|STARTED|Overall Study||6
8614959|NCT02875080|21250560|P1|STARTED|Overall Study||6
8614963|NCT02840474|21250584|P2|NOT COMPLETED|Overall Study||0
8614964|NCT02840474|21250585|P1|NOT COMPLETED|Overall Study||1
8614965|NCT02840474|21250584|P2|COMPLETED|Overall Study||9
8614966|NCT02840474|21250585|P1|COMPLETED|Overall Study||6
8614967|NCT02840474|21250584|P2|Received Study Product|Overall Study||9
8614968|NCT02840474|21250585|P1|Received Study Product|Overall Study||7
8614969|NCT02840474|21250584|P2|STARTED|Overall Study||9
8614970|NCT02840474|21250585|P1|STARTED|Overall Study||7
8615007|NCT02774226|21250760|P2|NOT COMPLETED|Overall Study||0
8615008|NCT02774226|21250761|P1|NOT COMPLETED|Overall Study||0
8615009|NCT02774226|21250760|P2|COMPLETED|Overall Study||7
8615010|NCT02774226|21250761|P1|COMPLETED|Overall Study||8
8615011|NCT02774226|21250760|P2|STARTED|Overall Study||7
8615012|NCT02774226|21250761|P1|STARTED|Overall Study||8
8615013|NCT02755818|21250777|P4|NOT COMPLETED|Overall Study||3
8615014|NCT02755818|21250778|P3|NOT COMPLETED|Overall Study||1
8615015|NCT02755818|21250779|P2|NOT COMPLETED|Overall Study||0
8615016|NCT02755818|21250780|P1|NOT COMPLETED|Overall Study||0
8615017|NCT02755818|21250777|P4|COMPLETED|Overall Study||14
8615018|NCT02755818|21250778|P3|COMPLETED|Overall Study||1
8615019|NCT02755818|21250779|P2|COMPLETED|Overall Study||2
8615020|NCT02755818|21250780|P1|COMPLETED|Overall Study||30
8615021|NCT02755818|21250777|P4|STARTED|Overall Study||17
8615022|NCT02755818|21250778|P3|STARTED|Overall Study||2
8615023|NCT02755818|21250779|P2|STARTED|Overall Study||2
8615024|NCT02755818|21250780|P1|STARTED|Overall Study||30
8615025|NCT02737553|21250816|P2|NOT COMPLETED|Overall Study||0
8615026|NCT02737553|21250817|P1|NOT COMPLETED|Overall Study||0
8615027|NCT02737553|21250816|P2|COMPLETED|Overall Study||48
8615028|NCT02737553|21250817|P1|COMPLETED|Overall Study||49
8615029|NCT02737553|21250816|P2|STARTED|Overall Study||48
8615030|NCT02737553|21250817|P1|STARTED|Overall Study||49
8615031|NCT02728830|21250829|P1|NOT COMPLETED|Overall Study||24
8615032|NCT02728830|21250829|P1|COMPLETED|Overall Study||15
8615033|NCT02728830|21250829|P1|STARTED|Overall Study||39
8615110|NCT02659150|21251251|P1|NOT COMPLETED|Follow-up Imaging||0
8615111|NCT02659150|21251251|P1|COMPLETED|Follow-up Imaging||8
8615112|NCT02659150|21251251|P1|STARTED|Follow-up Imaging||8
8615113|NCT02659150|21251251|P1|NOT COMPLETED|Study Drug Dosing||1
8615114|NCT02659150|21251251|P1|COMPLETED|Study Drug Dosing||8
8615115|NCT02659150|21251251|P1|STARTED|Study Drug Dosing||9
8615116|NCT02659150|21251251|P1|NOT COMPLETED|Baseline Imaging||2
8615117|NCT02659150|21251251|P1|COMPLETED|Baseline Imaging||9
8615118|NCT02659150|21251251|P1|STARTED|Baseline Imaging||11
8615119|NCT02659150|21251251|P1|NOT COMPLETED|Subject Enrollment||5
8615120|NCT02659150|21251251|P1|COMPLETED|Subject Enrollment||11
8615121|NCT02659150|21251251|P1|STARTED|Subject Enrollment||16
8615149|NCT02628444|21251349|P9|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||99
8615150|NCT02628444|21251350|P8|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||98
8615151|NCT02628444|21251351|P7|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||96
8615152|NCT02628444|21251352|P6|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||95
8615153|NCT02628444|21251353|P5|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||93
8615154|NCT02628444|21251354|P4|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||90
8615155|NCT02628444|21251355|P3|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615156|NCT02628444|21251356|P2|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615157|NCT02628444|21251357|P1|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615158|NCT02628444|21251349|P9|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||52
8615159|NCT02628444|21251350|P8|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||54
8615160|NCT02628444|21251351|P7|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||53
8615161|NCT02628444|21251352|P6|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||62
8615162|NCT02628444|21251353|P5|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||59
8615163|NCT02628444|21251354|P4|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||55
8615164|NCT02628444|21251355|P3|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615165|NCT02628444|21251356|P2|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615166|NCT02628444|21251357|P1|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615167|NCT02628444|21251349|P9|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
8615168|NCT02628444|21251350|P8|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||56
8615169|NCT02628444|21251351|P7|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
8615170|NCT02628444|21251352|P6|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||62
8615171|NCT02628444|21251353|P5|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||59
8615172|NCT02628444|21251354|P4|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||55
8615173|NCT02628444|21251355|P3|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615174|NCT02628444|21251356|P2|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615175|NCT02628444|21251357|P1|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615176|NCT02628444|21251349|P9|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||151
8615177|NCT02628444|21251350|P8|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
8615178|NCT02628444|21251351|P7|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||149
8615179|NCT02628444|21251352|P6|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||157
8615180|NCT02628444|21251353|P5|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
8615181|NCT02628444|21251354|P4|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||145
8615182|NCT02628444|21251355|P3|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615183|NCT02628444|21251356|P2|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615184|NCT02628444|21251357|P1|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
8615185|NCT02628444|21251349|P9|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615186|NCT02628444|21251350|P8|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615187|NCT02628444|21251351|P7|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615188|NCT02628444|21251352|P6|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615189|NCT02628444|21251353|P5|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615190|NCT02628444|21251354|P4|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615191|NCT02628444|21251355|P3|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||42
8615192|NCT02628444|21251356|P2|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||39
8615193|NCT02628444|21251357|P1|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||36
8615194|NCT02628444|21251349|P9|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615195|NCT02628444|21251350|P8|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615196|NCT02628444|21251351|P7|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615197|NCT02628444|21251352|P6|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615198|NCT02628444|21251353|P5|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615199|NCT02628444|21251354|P4|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615200|NCT02628444|21251355|P3|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||310
8615201|NCT02628444|21251356|P2|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||309
8615202|NCT02628444|21251357|P1|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||314
8615203|NCT02628444|21251349|P9|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615204|NCT02628444|21251350|P8|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615205|NCT02628444|21251351|P7|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615206|NCT02628444|21251352|P6|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615207|NCT02628444|21251353|P5|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615208|NCT02628444|21251354|P4|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615209|NCT02628444|21251355|P3|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||332
8615210|NCT02628444|21251356|P2|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||328
8615211|NCT02628444|21251357|P1|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||333
8615212|NCT02628444|21251349|P9|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615213|NCT02628444|21251350|P8|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615214|NCT02628444|21251351|P7|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615215|NCT02628444|21251352|P6|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615216|NCT02628444|21251353|P5|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615217|NCT02628444|21251354|P4|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615218|NCT02628444|21251355|P3|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||352
8615219|NCT02628444|21251356|P2|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
8615220|NCT02628444|21251357|P1|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
8615221|NCT02628444|21251349|P9|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615222|NCT02628444|21251350|P8|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615223|NCT02628444|21251351|P7|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615224|NCT02628444|21251352|P6|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615225|NCT02628444|21251353|P5|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615226|NCT02628444|21251354|P4|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
8615227|NCT02628444|21251355|P3|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||352
8615228|NCT02628444|21251356|P2|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||348
8615229|NCT02628444|21251357|P1|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||350
8615242|NCT02586207|21251463|P1|NOT COMPLETED|Overall Study||2
8615243|NCT02586207|21251463|P1|COMPLETED|Overall Study||57
8615244|NCT02586207|21251463|P1|STARTED|Overall Study||59
8615278|NCT02535065|21251512|P1|NOT COMPLETED|Overall Study||62
8615279|NCT02535065|21251512|P1|COMPLETED|Overall Study||0
8615280|NCT02535065|21251512|P1|12-Month Follow-up|Overall Study||61
8615281|NCT02535065|21251512|P1|1-Month Follow-up|Overall Study||62
8615282|NCT02535065|21251512|P1|STARTED|Overall Study||62
8615301|NCT02457910|21251713|P6|NOT COMPLETED|Overall Study||11
8615302|NCT02457910|21251714|P5|NOT COMPLETED|Overall Study||5
8615303|NCT02457910|21251715|P4|NOT COMPLETED|Overall Study||2
8615304|NCT02457910|21251716|P3|NOT COMPLETED|Overall Study||3
8615305|NCT02457910|21251717|P2|NOT COMPLETED|Overall Study||5
8615306|NCT02457910|21251718|P1|NOT COMPLETED|Overall Study||3
8615307|NCT02457910|21251713|P6|COMPLETED|Overall Study||1
8615308|NCT02457910|21251714|P5|COMPLETED|Overall Study||0
8615309|NCT02457910|21251715|P4|COMPLETED|Overall Study||0
8615310|NCT02457910|21251716|P3|COMPLETED|Overall Study||0
8615311|NCT02457910|21251717|P2|COMPLETED|Overall Study||0
8615312|NCT02457910|21251718|P1|COMPLETED|Overall Study||0
8615313|NCT02457910|21251713|P6|STARTED|Overall Study||12
8615314|NCT02457910|21251714|P5|STARTED|Overall Study|3 participants crossed over to enzalutamide and taselisib|5
8615315|NCT02457910|21251715|P4|STARTED|Overall Study||2
8615316|NCT02457910|21251716|P3|STARTED|Overall Study||3
8615317|NCT02457910|21251717|P2|STARTED|Overall Study|In dose escalation, two patients receiving the 4 mg dose of taselisib were removed for toxicities|5
8615318|NCT02457910|21251718|P1|STARTED|Overall Study||3
8615407|NCT02403622|21252414|P1|NOT COMPLETED|Overall Study||2
8615408|NCT02403622|21252414|P1|COMPLETED|Overall Study||13
8615409|NCT02403622|21252414|P1|STARTED|Overall Study||15
8615410|NCT02380612|21252419|P1|NOT COMPLETED|Overall Study||3
8615411|NCT02380612|21252419|P1|COMPLETED|Overall Study||27
8615412|NCT02380612|21252419|P1|STARTED|Overall Study||30
8615413|NCT02376790|21252434|P3|NOT COMPLETED|Overall Study||53
8615414|NCT02376790|21252435|P2|NOT COMPLETED|Overall Study||47
8615415|NCT02376790|21252436|P1|NOT COMPLETED|Overall Study||60
8615416|NCT02376790|21252434|P3|COMPLETED|Overall Study||230
8615417|NCT02376790|21252435|P2|COMPLETED|Overall Study||237
8615418|NCT02376790|21252436|P1|COMPLETED|Overall Study||224
8615419|NCT02376790|21252434|P3|Received Treatment|Overall Study||282
8615420|NCT02376790|21252435|P2|Received Treatment|Overall Study||284
8615421|NCT02376790|21252436|P1|Received Treatment|Overall Study||282
8615422|NCT02376790|21252434|P3|STARTED|Overall Study||283
8615423|NCT02376790|21252435|P2|STARTED|Overall Study||284
8615424|NCT02376790|21252436|P1|STARTED|Overall Study||284
8615425|NCT02376361|21252554|P2|NOT COMPLETED|Overall Study||117
8615426|NCT02376361|21252555|P1|NOT COMPLETED|Overall Study||171
8615427|NCT02376361|21252554|P2|COMPLETED|Overall Study||90
8615428|NCT02376361|21252555|P1|COMPLETED|Overall Study||58
8615429|NCT02376361|21252554|P2|STARTED|Overall Study||207
8615430|NCT02376361|21252555|P1|STARTED|Overall Study||229
8615440|NCT02337465|21252597|P1|NOT COMPLETED|Overall Study||0
8615441|NCT02337465|21252597|P1|COMPLETED|Overall Study||30
8615442|NCT02337465|21252597|P1|STARTED|Overall Study||30
8615601|NCT02273739|21252970|P4|NOT COMPLETED|Overall Study||7
8615602|NCT02273739|21252971|P3|NOT COMPLETED|Overall Study||7
8615603|NCT02273739|21252972|P2|NOT COMPLETED|Overall Study||4
8615604|NCT02273739|21252973|P1|NOT COMPLETED|Overall Study||3
8615605|NCT02273739|21252970|P4|COMPLETED|Overall Study||0
8615606|NCT02273739|21252971|P3|COMPLETED|Overall Study||0
8615607|NCT02273739|21252972|P2|COMPLETED|Overall Study||0
8615608|NCT02273739|21252973|P1|COMPLETED|Overall Study||0
8615609|NCT02273739|21252970|P4|STARTED|Overall Study||7
8615610|NCT02273739|21252971|P3|STARTED|Overall Study||7
8615611|NCT02273739|21252972|P2|STARTED|Overall Study||4
8615612|NCT02273739|21252973|P1|STARTED|Overall Study||3
8615674|NCT02123485|21253358|P2|NOT COMPLETED|Overall Study||0
8615675|NCT02123485|21253359|P1|NOT COMPLETED|Overall Study||1
8615676|NCT02123485|21253358|P2|COMPLETED|Overall Study||17
8615677|NCT02123485|21253359|P1|COMPLETED|Overall Study||17
8615678|NCT02123485|21253358|P2|STARTED|Overall Study||17
8615679|NCT02123485|21253359|P1|STARTED|Overall Study||18
8615764|NCT01989546|21253667|P1|NOT COMPLETED|Overall Study||9
8615765|NCT01989546|21253667|P1|COMPLETED|Overall Study||0
8615766|NCT01989546|21253667|P1|STARTED|Overall Study||9
8615879|NCT01754753|21253890|P2|NOT COMPLETED|Overall Study||49
8615880|NCT01754753|21253891|P1|NOT COMPLETED|Overall Study||52
8615881|NCT01754753|21253890|P2|COMPLETED|Overall Study||30
8615882|NCT01754753|21253891|P1|COMPLETED|Overall Study||26
8615883|NCT01754753|21253890|P2|STARTED|Overall Study||79
8615884|NCT01754753|21253891|P1|STARTED|Overall Study||78
8615968|NCT01609842|21254106|P2|NOT COMPLETED|Concurrent Intervention Control||0
8615969|NCT01609842|21254107|P1|NOT COMPLETED|Concurrent Intervention Control||2
8615970|NCT01609842|21254106|P2|COMPLETED|Concurrent Intervention Control||4869
8615971|NCT01609842|21254107|P1|COMPLETED|Concurrent Intervention Control||706
8615972|NCT01609842|21254106|P2|STARTED|Concurrent Intervention Control|Nonintervention sites patients during the period prior and post enrollment at the intervention sites|4869
8615973|NCT01609842|21254107|P1|STARTED|Concurrent Intervention Control||708
8615974|NCT01609842|21254106|P2|NOT COMPLETED|Post-Intervention Control||0
8615975|NCT01609842|21254107|P1|NOT COMPLETED|Post-Intervention Control||0
8615976|NCT01609842|21254106|P2|COMPLETED|Post-Intervention Control||2917
8615977|NCT01609842|21254107|P1|COMPLETED|Post-Intervention Control||0
8615978|NCT01609842|21254106|P2|STARTED|Post-Intervention Control|Intervention sites patients after enrollment period ended who did not receive the intervention.|2917
8615979|NCT01609842|21254107|P1|STARTED|Post-Intervention Control||0
8615980|NCT01609842|21254106|P2|NOT COMPLETED|Pre-Intervention Control||0
8615981|NCT01609842|21254107|P1|NOT COMPLETED|Pre-Intervention Control||0
8615982|NCT01609842|21254106|P2|COMPLETED|Pre-Intervention Control||6081
8615983|NCT01609842|21254107|P1|COMPLETED|Pre-Intervention Control||0
8615984|NCT01609842|21254106|P2|STARTED|Pre-Intervention Control|Intervention sites patients prior to enrollment period who did not receive the intervention|6081
8615985|NCT01609842|21254107|P1|STARTED|Pre-Intervention Control||0
8616054|NCT01302834|21254407|P2|NOT COMPLETED|Overall Study||26
8616055|NCT01302834|21254408|P1|NOT COMPLETED|Overall Study||18
8616056|NCT01302834|21254407|P2|COMPLETED|Overall Study||399
8616057|NCT01302834|21254408|P1|COMPLETED|Overall Study||406
8616058|NCT01302834|21254407|P2|Progressed|Overall Study||122
8616059|NCT01302834|21254408|P1|Progressed|Overall Study||76
8616060|NCT01302834|21254407|P2|Feeding Tube Assessed|Overall Study||356
8616061|NCT01302834|21254408|P1|Feeding Tube Assessed|Overall Study||368
8616062|NCT01302834|21254407|P2|Dental Health Assessed 5 Years PT|Overall Study||43
8616063|NCT01302834|21254408|P1|Dental Health Assessed 5 Years PT|Overall Study||44
8616064|NCT01302834|21254407|P2|Dental Health Assessed 2 Years PT|Overall Study||201
8616065|NCT01302834|21254408|P1|Dental Health Assessed 2 Years PT|Overall Study||208
8616066|NCT01302834|21254407|P2|Dental Health Assessed 1 Year PT|Overall Study||267
8616067|NCT01302834|21254408|P1|Dental Health Assessed 1 Year PT|Overall Study||267
8616068|NCT01302834|21254407|P2|AE Assessed 5 Years PT|Overall Study||86
8616069|NCT01302834|21254408|P1|AE Assessed 5 Years PT|Overall Study||92
8616070|NCT01302834|21254407|P2|AE Assessed 2 Years PT|Overall Study||303
8616071|NCT01302834|21254408|P1|AE Assessed 2 Years PT|Overall Study||311
8616072|NCT01302834|21254407|P2|AE Assessment 1 Year PT|Overall Study||351
8616073|NCT01302834|21254408|P1|AE Assessment 1 Year PT|Overall Study||360
8616074|NCT01302834|21254407|P2|AE Assessed 6 Months PT|Overall Study||352
8616075|NCT01302834|21254408|P1|AE Assessed 6 Months PT|Overall Study||361
8616076|NCT01302834|21254407|P2|AE Assessed 3 Months PT|Overall Study||367
8616077|NCT01302834|21254408|P1|AE Assessed 3 Months PT|Overall Study||359
8616078|NCT01302834|21254407|P2|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363
8616079|NCT01302834|21254408|P1|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369
8616080|NCT01302834|21254407|P2|Started Treatment|Overall Study||394
8616081|NCT01302834|21254408|P1|Started Treatment|Overall Study||398
8616082|NCT01302834|21254407|P2|Eligible|Overall Study||399
8616083|NCT01302834|21254408|P1|Eligible|Overall Study||406
8616084|NCT01302834|21254407|P2|STARTED|Overall Study||425
8616085|NCT01302834|21254408|P1|STARTED|Overall Study||424
8616104|NCT01216683|21254533|P3|NOT COMPLETED|Continuation||43
8616105|NCT01216683|21254534|P2|NOT COMPLETED|Continuation||15
8616106|NCT01216683|21254535|P1|NOT COMPLETED|Continuation||15
8616107|NCT01216683|21254533|P3|COMPLETED|Continuation||51
8616108|NCT01216683|21254534|P2|COMPLETED|Continuation||56
8616109|NCT01216683|21254535|P1|COMPLETED|Continuation||44
8616110|NCT01216683|21254533|P3|Received Continuation Treatment|Continuation||89
8616111|NCT01216683|21254534|P2|Received Continuation Treatment|Continuation||70
8616112|NCT01216683|21254535|P1|Received Continuation Treatment|Continuation||59
8616113|NCT01216683|21254533|P3|STARTED|Continuation||94
8616114|NCT01216683|21254534|P2|STARTED|Continuation||71
8616115|NCT01216683|21254535|P1|STARTED|Continuation||59
8616116|NCT01216683|21254533|P3|NOT COMPLETED|Induction||21
8616117|NCT01216683|21254534|P2|NOT COMPLETED|Induction||19
8616118|NCT01216683|21254535|P1|NOT COMPLETED|Induction||4
8616119|NCT01216683|21254533|P3|COMPLETED|Induction||104
8616120|NCT01216683|21254534|P2|COMPLETED|Induction||80
8616121|NCT01216683|21254535|P1|COMPLETED|Induction||61
8616122|NCT01216683|21254533|P3|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||89
8616123|NCT01216683|21254534|P2|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||85
8616124|NCT01216683|21254535|P1|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||48
8616125|NCT01216683|21254533|P3|Eligible and Treated|Induction||114
8616126|NCT01216683|21254534|P2|Eligible and Treated|Induction||85
8616127|NCT01216683|21254535|P1|Eligible and Treated|Induction||59
8616128|NCT01216683|21254533|P3|Received Treatment and Assessed for Toxicities|Induction||122
8616129|NCT01216683|21254534|P2|Received Treatment and Assessed for Toxicities|Induction||93
8616130|NCT01216683|21254535|P1|Received Treatment and Assessed for Toxicities|Induction||65
8616131|NCT01216683|21254533|P3|STARTED|Induction||125
8616132|NCT01216683|21254534|P2|STARTED|Induction||99
8616133|NCT01216683|21254535|P1|STARTED|Induction||65
8616159|NCT01107626|21254689|P4|NOT COMPLETED|Step 2: Maintenance Therapy||292
8616160|NCT01107626|21254690|P3|NOT COMPLETED|Step 2: Maintenance Therapy||294
8616161|NCT01107626|21254691|P2|NOT COMPLETED|Step 2: Maintenance Therapy||286
8616162|NCT01107626|21254692|P1|NOT COMPLETED|Step 2: Maintenance Therapy||0
8616163|NCT01107626|21254689|P4|COMPLETED|Step 2: Maintenance Therapy||1
8616164|NCT01107626|21254690|P3|COMPLETED|Step 2: Maintenance Therapy||0
8616165|NCT01107626|21254691|P2|COMPLETED|Step 2: Maintenance Therapy||1
8616166|NCT01107626|21254692|P1|COMPLETED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
8616167|NCT01107626|21254689|P4|STARTED|Step 2: Maintenance Therapy||293
8616168|NCT01107626|21254690|P3|STARTED|Step 2: Maintenance Therapy||294
8616169|NCT01107626|21254691|P2|STARTED|Step 2: Maintenance Therapy||287
8616170|NCT01107626|21254692|P1|STARTED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
8616171|NCT01107626|21254689|P4|NOT COMPLETED|Step 1: Induction Therapy||0
8616172|NCT01107626|21254690|P3|NOT COMPLETED|Step 1: Induction Therapy||0
8616173|NCT01107626|21254691|P2|NOT COMPLETED|Step 1: Induction Therapy||0
8616174|NCT01107626|21254692|P1|NOT COMPLETED|Step 1: Induction Therapy||577
8616175|NCT01107626|21254689|P4|COMPLETED|Step 1: Induction Therapy||293
8616176|NCT01107626|21254690|P3|COMPLETED|Step 1: Induction Therapy||294
8616177|NCT01107626|21254691|P2|COMPLETED|Step 1: Induction Therapy||287
8616178|NCT01107626|21254692|P1|COMPLETED|Step 1: Induction Therapy||65
8616179|NCT01107626|21254689|P4|STARTED|Step 1: Induction Therapy||293
8616180|NCT01107626|21254690|P3|STARTED|Step 1: Induction Therapy||294
8616181|NCT01107626|21254691|P2|STARTED|Step 1: Induction Therapy||287
8616182|NCT01107626|21254692|P1|STARTED|Step 1: Induction Therapy||642
8616270|NCT01004874|21255106|P1|NOT COMPLETED|Overall Study||0
8616271|NCT01004874|21255106|P1|COMPLETED|Overall Study||80
8616272|NCT01004874|21255106|P1|STARTED|Overall Study||80
8616347|NCT00794339|21255393|P1|NOT COMPLETED|Overall Study||14
8616348|NCT00794339|21255393|P1|COMPLETED|Overall Study||59
8616349|NCT00794339|21255393|P1|Evaluable|Overall Study||59
8616350|NCT00794339|21255393|P1|Eligible|Overall Study||69
8616351|NCT00794339|21255393|P1|STARTED|Overall Study||73
8616515|NCT00537095|21255829|P2|NOT COMPLETED|Overall Study||57
8616516|NCT00537095|21255830|P1|NOT COMPLETED|Overall Study||51
8616517|NCT00537095|21255829|P2|COMPLETED|Overall Study||16
8616518|NCT00537095|21255830|P1|COMPLETED|Overall Study||21
8616519|NCT00537095|21255829|P2|STARTED|Overall Study||73
8616520|NCT00537095|21255830|P1|STARTED|Overall Study||72
8616539|NCT00324740|21256125|P3|NOT COMPLETED|Overall Study||1
8616540|NCT00324740|21256126|P2|NOT COMPLETED|Overall Study||0
8616541|NCT00324740|21256127|P1|NOT COMPLETED|Overall Study||1
8616542|NCT00324740|21256125|P3|COMPLETED|Overall Study||3
8616543|NCT00324740|21256126|P2|COMPLETED|Overall Study||3
8616544|NCT00324740|21256127|P1|COMPLETED|Overall Study||6
8616545|NCT00324740|21256125|P3|STARTED|Overall Study||4
8616546|NCT00324740|21256126|P2|STARTED|Overall Study||3
8616547|NCT00324740|21256127|P1|STARTED|Overall Study||7
8616628|NCT04082663|21256566|P1|NOT COMPLETED|Overall Study||7
8616629|NCT04082663|21256566|P1|COMPLETED|Overall Study||13
8616630|NCT04082663|21256566|P1|STARTED|Overall Study||20
8616649|NCT03974334|21256642|P1|NOT COMPLETED|Overall Study||1
8616650|NCT03974334|21256642|P1|COMPLETED|Overall Study||24
8616651|NCT03974334|21256642|P1|STARTED|Overall Study||25
8616652|NCT03944668|21256650|P1|NOT COMPLETED|Overall Study||9
8616653|NCT03944668|21256650|P1|COMPLETED|Overall Study|Completed 75% of Comprehensive Cardiac Rehabilitation Sessions|8
8616654|NCT03944668|21256650|P1|Participated in Intervention|Overall Study|Started Cardiac Rehabilitation|10
8616655|NCT03944668|21256650|P1|Able to Use Patient Data|Overall Study|3 Patient's Data Unusable|14
8616656|NCT03944668|21256650|P1|STARTED|Overall Study|Enrolled in Study|17
8616657|NCT03881163|21256659|P1|NOT COMPLETED|Overall Study||0
8616658|NCT03881163|21256659|P1|COMPLETED|Overall Study||24
8616659|NCT03881163|21256659|P1|STARTED|Overall Study||24
8616699|NCT03790878|21256884|P3|NOT COMPLETED|Overall Study||0
8616700|NCT03790878|21256885|P2|NOT COMPLETED|Overall Study||0
8616701|NCT03790878|21256886|P1|NOT COMPLETED|Overall Study||0
8616702|NCT03790878|21256884|P3|COMPLETED|Overall Study||27
8616703|NCT03790878|21256885|P2|COMPLETED|Overall Study||27
8616704|NCT03790878|21256886|P1|COMPLETED|Overall Study||26
8616705|NCT03790878|21256884|P3|STARTED|Overall Study||27
8616706|NCT03790878|21256885|P2|STARTED|Overall Study||27
8616707|NCT03790878|21256886|P1|STARTED|Overall Study||26
8616757|NCT03631355|21257031|P2|NOT COMPLETED|Overall Study||2
8616758|NCT03631355|21257032|P1|NOT COMPLETED|Overall Study||1
8616759|NCT03631355|21257031|P2|COMPLETED|Overall Study||53
8616760|NCT03631355|21257032|P1|COMPLETED|Overall Study||54
8616761|NCT03631355|21257031|P2|STARTED|Overall Study||55
8616762|NCT03631355|21257032|P1|STARTED|Overall Study||55
8616782|NCT03567382|21257076|P4|NOT COMPLETED|Overall Study||33
8616783|NCT03567382|21257077|P3|NOT COMPLETED|Overall Study||2
8616784|NCT03567382|21257078|P2|NOT COMPLETED|Overall Study||35
8616785|NCT03567382|21257079|P1|NOT COMPLETED|Overall Study||3
8616786|NCT03567382|21257076|P4|COMPLETED|Overall Study||46
8616787|NCT03567382|21257077|P3|COMPLETED|Overall Study||7
8616788|NCT03567382|21257078|P2|COMPLETED|Overall Study||46
8616789|NCT03567382|21257079|P1|COMPLETED|Overall Study||7
8616790|NCT03567382|21257076|P4|Received Tenofovir|Overall Study||0
8616791|NCT03567382|21257077|P3|Received Tenofovir|Overall Study||0
8616792|NCT03567382|21257078|P2|Received Tenofovir|Overall Study||0
8616793|NCT03567382|21257079|P1|Received Tenofovir|Overall Study||9
8616794|NCT03567382|21257076|P4|STARTED|Overall Study||79
8616795|NCT03567382|21257077|P3|STARTED|Overall Study||9
8616796|NCT03567382|21257078|P2|STARTED|Overall Study||81
8616797|NCT03567382|21257079|P1|STARTED|Overall Study||10
8616804|NCT03547687|21257103|P1|NOT COMPLETED|Overall Study||2
8616805|NCT03547687|21257103|P1|COMPLETED|Overall Study||7
8616806|NCT03547687|21257103|P1|STARTED|Overall Study||9
8616854|NCT03372096|21257287|P1|NOT COMPLETED|Overall Study||8
8616855|NCT03372096|21257287|P1|COMPLETED|Overall Study||10
8616856|NCT03372096|21257287|P1|Received Intervention|Overall Study||10
8616857|NCT03372096|21257287|P1|STARTED|Overall Study||18
8616894|NCT03150043|21257395|P1|NOT COMPLETED|Overall Study||0
8616895|NCT03150043|21257395|P1|COMPLETED|Overall Study||65
8616896|NCT03150043|21257395|P1|STARTED|Overall Study||65
8616936|NCT03028896|21257466|P2|NOT COMPLETED|Overall Study||0
8616937|NCT03028896|21257467|P1|NOT COMPLETED|Overall Study||3
8616938|NCT03028896|21257466|P2|COMPLETED|Overall Study||66
8616939|NCT03028896|21257467|P1|COMPLETED|Overall Study||63
8616940|NCT03028896|21257466|P2|STARTED|Overall Study||66
8616941|NCT03028896|21257467|P1|STARTED|Overall Study||66
8616942|NCT03009396|21257479|P2|NOT COMPLETED|Overall Study||17
8616943|NCT03009396|21257480|P1|NOT COMPLETED|Overall Study||7
8616944|NCT03009396|21257479|P2|COMPLETED|Overall Study||21
8616945|NCT03009396|21257480|P1|COMPLETED|Overall Study||9
8616946|NCT03009396|21257479|P2|STARTED|Overall Study||38
8616947|NCT03009396|21257480|P1|STARTED|Overall Study||16
8616960|NCT02990338|21257643|P2|NOT COMPLETED|Overall Study||89
8616961|NCT02990338|21257644|P1|NOT COMPLETED|Overall Study||118
8616962|NCT02990338|21257643|P2|COMPLETED|Overall Study||65
8616963|NCT02990338|21257644|P1|COMPLETED|Overall Study||35
8616964|NCT02990338|21257643|P2|Ongoing|Overall Study||65
8616965|NCT02990338|21257644|P1|Ongoing|Overall Study||35
8616966|NCT02990338|21257643|P2|Treated|Overall Study||152
8616967|NCT02990338|21257644|P1|Treated|Overall Study||149
8616968|NCT02990338|21257643|P2|STARTED|Overall Study||154
8616969|NCT02990338|21257644|P1|STARTED|Overall Study||153
8616970|NCT02987959|21257690|P1|NOT COMPLETED|Overall Study||6
8616971|NCT02987959|21257690|P1|COMPLETED|Overall Study||0
8616972|NCT02987959|21257690|P1|STARTED|Overall Study||6
8617041|NCT02939014|21257813|P2|NOT COMPLETED|Overall Study||3
8617042|NCT02939014|21257814|P1|NOT COMPLETED|Overall Study||5
8617043|NCT02939014|21257813|P2|COMPLETED|Overall Study||6
8617044|NCT02939014|21257814|P1|COMPLETED|Overall Study||25
8617045|NCT02939014|21257813|P2|STARTED|Overall Study||9
8617046|NCT02939014|21257814|P1|STARTED|Overall Study||30
8617122|NCT02832037|21257992|P5|NOT COMPLETED|Overall Study||19
8617123|NCT02832037|21257993|P4|NOT COMPLETED|Overall Study||7
8617124|NCT02832037|21257994|P3|NOT COMPLETED|Overall Study||8
8617125|NCT02832037|21257995|P2|NOT COMPLETED|Overall Study||12
8617126|NCT02832037|21257996|P1|NOT COMPLETED|Overall Study||19
8617127|NCT02832037|21257992|P5|COMPLETED|Overall Study||151
8617128|NCT02832037|21257993|P4|COMPLETED|Overall Study||78
8617129|NCT02832037|21257994|P3|COMPLETED|Overall Study||77
8617130|NCT02832037|21257995|P2|COMPLETED|Overall Study||72
8617131|NCT02832037|21257996|P1|COMPLETED|Overall Study||66
8617132|NCT02832037|21257992|P5|STARTED|Overall Study||170
8617133|NCT02832037|21257993|P4|STARTED|Overall Study||85
8617134|NCT02832037|21257994|P3|STARTED|Overall Study||85
8617135|NCT02832037|21257995|P2|STARTED|Overall Study||84
8617136|NCT02832037|21257996|P1|STARTED|Overall Study||85
8617146|NCT02807857|21258067|P1|NOT COMPLETED|Follow-Up Set||184
8617147|NCT02807857|21258067|P1|COMPLETED|Follow-Up Set||680
8617148|NCT02807857|21258067|P1|STARTED|Follow-Up Set||864
8617149|NCT02807857|21258067|P1|NOT COMPLETED|Enrolled Set||551
8617150|NCT02807857|21258067|P1|COMPLETED|Enrolled Set||864
8617151|NCT02807857|21258067|P1|STARTED|Enrolled Set||1415
8617231|NCT02649608|21258373|P7|NOT COMPLETED|Overall Study||0
8617232|NCT02649608|21258374|P6|NOT COMPLETED|Overall Study||0
8617233|NCT02649608|21258375|P5|NOT COMPLETED|Overall Study||0
8617234|NCT02649608|21258376|P4|NOT COMPLETED|Overall Study||0
8617235|NCT02649608|21258377|P3|NOT COMPLETED|Overall Study||0
8617236|NCT02649608|21258378|P2|NOT COMPLETED|Overall Study||0
8617237|NCT02649608|21258379|P1|NOT COMPLETED|Overall Study||0
8617238|NCT02649608|21258373|P7|COMPLETED|Overall Study||1
8617239|NCT02649608|21258374|P6|COMPLETED|Overall Study||2
8617240|NCT02649608|21258375|P5|COMPLETED|Overall Study||3
8617241|NCT02649608|21258376|P4|COMPLETED|Overall Study||3
8617242|NCT02649608|21258377|P3|COMPLETED|Overall Study||3
8617243|NCT02649608|21258378|P2|COMPLETED|Overall Study||1
8617244|NCT02649608|21258379|P1|COMPLETED|Overall Study||2
8617245|NCT02649608|21258373|P7|STARTED|Overall Study||1
8617246|NCT02649608|21258374|P6|STARTED|Overall Study||2
8617247|NCT02649608|21258375|P5|STARTED|Overall Study||3
8617248|NCT02649608|21258376|P4|STARTED|Overall Study||3
8617249|NCT02649608|21258377|P3|STARTED|Overall Study||3
8617250|NCT02649608|21258378|P2|STARTED|Overall Study||1
8617251|NCT02649608|21258379|P1|STARTED|Overall Study||2
8617282|NCT02557178|21258449|P2|NOT COMPLETED|Overall Study||11
8617283|NCT02557178|21258450|P1|NOT COMPLETED|Overall Study||16
8617284|NCT02557178|21258449|P2|COMPLETED|Overall Study||63
8617285|NCT02557178|21258450|P1|COMPLETED|Overall Study||56
8617286|NCT02557178|21258449|P2|STARTED|Overall Study||74
8617287|NCT02557178|21258450|P1|STARTED|Overall Study||72
8617412|NCT02312986|21259235|P1|NOT COMPLETED|Overall Study||0
8617413|NCT02312986|21259235|P1|COMPLETED|Overall Study||1
8617414|NCT02312986|21259235|P1|STARTED|Overall Study||1
8617543|NCT02285361|21259516|P1|NOT COMPLETED|Overall Study||51
8617544|NCT02285361|21259516|P1|COMPLETED|Overall Study||1221
8617545|NCT02285361|21259516|P1|STARTED|Overall Study||1272
8617546|NCT02278289|21259525|P2|NOT COMPLETED|Overall Study||7
8617547|NCT02278289|21259526|P1|NOT COMPLETED|Overall Study||6
8617548|NCT02278289|21259525|P2|COMPLETED|Overall Study||23
8617549|NCT02278289|21259526|P1|COMPLETED|Overall Study||24
8617550|NCT02278289|21259525|P2|STARTED|Overall Study||30
8617551|NCT02278289|21259526|P1|STARTED|Overall Study||30
8617608|NCT02076997|21259839|P1|NOT COMPLETED|Overall Study||1
8617609|NCT02076997|21259839|P1|COMPLETED|Overall Study||22
8617610|NCT02076997|21259839|P1|STARTED|Overall Study||23
8617619|NCT02039726|21259887|P2|NOT COMPLETED|Overall Study||16
8617620|NCT02039726|21259888|P1|NOT COMPLETED|Overall Study||45
8617621|NCT02039726|21259887|P2|COMPLETED|Overall Study||106
8617622|NCT02039726|21259888|P1|COMPLETED|Overall Study||200
8617623|NCT02039726|21259887|P2|Did Not Receive Treatment|Overall Study||28
8617624|NCT02039726|21259888|P1|Did Not Receive Treatment|Overall Study||4
8617625|NCT02039726|21259887|P2|Ongoing (as of Data Cutoff)|Overall Study||16
8617626|NCT02039726|21259888|P1|Ongoing (as of Data Cutoff)|Overall Study||45
8617627|NCT02039726|21259887|P2|STARTED|Overall Study||122
8617628|NCT02039726|21259888|P1|STARTED|Overall Study||245
8617635|NCT01894620|21259907|P2|NOT COMPLETED|Overall Study||1
8617636|NCT01894620|21259908|P1|NOT COMPLETED|Overall Study||0
8617637|NCT01894620|21259907|P2|COMPLETED|Overall Study||4
8617638|NCT01894620|21259908|P1|COMPLETED|Overall Study||6
8617639|NCT01894620|21259907|P2|STARTED|Overall Study||5
8617640|NCT01894620|21259908|P1|STARTED|Overall Study||6
8617641|NCT01863186|21259919|P4|NOT COMPLETED|Open-label Phase||13
8617642|NCT01863186|21259920|P3|NOT COMPLETED|Open-label Phase||0
8617643|NCT01863186|21259921|P2|NOT COMPLETED|Open-label Phase||0
8617644|NCT01863186|21259922|P1|NOT COMPLETED|Open-label Phase||0
8617645|NCT01863186|21259919|P4|COMPLETED|Open-label Phase||70
8617646|NCT01863186|21259920|P3|COMPLETED|Open-label Phase||0
8617647|NCT01863186|21259921|P2|COMPLETED|Open-label Phase||0
8617648|NCT01863186|21259922|P1|COMPLETED|Open-label Phase||0
8617649|NCT01863186|21259919|P4|STARTED|Open-label Phase|36 from 2.4 mg group, 28 from 3.2mg group, and 19 from Placebo continued to the Open-label phase.|83
8617650|NCT01863186|21259920|P3|STARTED|Open-label Phase|No placebo group in the Open-label Phase.|0
8617651|NCT01863186|21259921|P2|STARTED|Open-label Phase||0
8617652|NCT01863186|21259922|P1|STARTED|Open-label Phase||0
8617653|NCT01863186|21259919|P4|NOT COMPLETED|Double-blind Phase||0
8617654|NCT01863186|21259920|P3|NOT COMPLETED|Double-blind Phase||109
8617655|NCT01863186|21259921|P2|NOT COMPLETED|Double-blind Phase||134
8617656|NCT01863186|21259922|P1|NOT COMPLETED|Double-blind Phase||134
8617657|NCT01863186|21259919|P4|COMPLETED|Double-blind Phase||0
8617658|NCT01863186|21259920|P3|COMPLETED|Double-blind Phase||42
8617659|NCT01863186|21259921|P2|COMPLETED|Double-blind Phase||88
8617660|NCT01863186|21259922|P1|COMPLETED|Double-blind Phase||95
8617661|NCT01863186|21259919|P4|STARTED|Double-blind Phase||0
8617662|NCT01863186|21259920|P3|STARTED|Double-blind Phase||151
8617663|NCT01863186|21259921|P2|STARTED|Double-blind Phase||222
8617664|NCT01863186|21259922|P1|STARTED|Double-blind Phase|Original number of 230. One participant was randomly assigned into the study, but not dosed.|229
8617737|NCT01736943|21260093|P1|NOT COMPLETED|Overall Study||0
8617738|NCT01736943|21260093|P1|COMPLETED|Overall Study||25
8617739|NCT01736943|21260093|P1|STARTED|Overall Study||25
8617790|NCT01597908|21260386|P3|NOT COMPLETED|Crossover Phase||34
8617791|NCT01597908|21260387|P2|NOT COMPLETED|Crossover Phase||0
8617792|NCT01597908|21260388|P1|NOT COMPLETED|Crossover Phase||0
8617793|NCT01597908|21260386|P3|COMPLETED|Crossover Phase||0
8617794|NCT01597908|21260387|P2|COMPLETED|Crossover Phase||0
8617795|NCT01597908|21260388|P1|COMPLETED|Crossover Phase||0
8617796|NCT01597908|21260386|P3|STARTED|Crossover Phase||34
8617797|NCT01597908|21260387|P2|STARTED|Crossover Phase||0
8617798|NCT01597908|21260388|P1|STARTED|Crossover Phase||0
8617799|NCT01597908|21260386|P3|NOT COMPLETED|Randomized Phase||0
8617800|NCT01597908|21260387|P2|NOT COMPLETED|Randomized Phase||352
8617801|NCT01597908|21260388|P1|NOT COMPLETED|Randomized Phase||351
8617802|NCT01597908|21260386|P3|COMPLETED|Randomized Phase||0
8617803|NCT01597908|21260387|P2|COMPLETED|Randomized Phase||0
8617804|NCT01597908|21260388|P1|COMPLETED|Randomized Phase||1
8617805|NCT01597908|21260386|P3|Safety Set|Randomized Phase||0
8617806|NCT01597908|21260387|P2|Safety Set|Randomized Phase||349
8617807|NCT01597908|21260388|P1|Safety Set|Randomized Phase||350
8617808|NCT01597908|21260386|P3|STARTED|Randomized Phase||0
8617809|NCT01597908|21260387|P2|STARTED|Randomized Phase||352
8617810|NCT01597908|21260388|P1|STARTED|Randomized Phase||352
8617811|NCT01586871|21260408|P3|NOT COMPLETED|Overall Study||0
8617812|NCT01586871|21260409|P2|NOT COMPLETED|Overall Study||0
8617813|NCT01586871|21260410|P1|NOT COMPLETED|Overall Study||0
8617814|NCT01586871|21260408|P3|COMPLETED|Overall Study||33
8617815|NCT01586871|21260409|P2|COMPLETED|Overall Study||554
8617816|NCT01586871|21260410|P1|COMPLETED|Overall Study||560
8617817|NCT01586871|21260408|P3|STARTED|Overall Study||33
8617818|NCT01586871|21260409|P2|STARTED|Overall Study||554
8617819|NCT01586871|21260410|P1|STARTED|Overall Study||560
8617880|NCT01087203|21260629|P2|NOT COMPLETED|Overall Study||35
8617881|NCT01087203|21260630|P1|NOT COMPLETED|Overall Study||32
8617882|NCT01087203|21260629|P2|COMPLETED|Overall Study||3
8617883|NCT01087203|21260630|P1|COMPLETED|Overall Study||3
8617884|NCT01087203|21260629|P2|STARTED|Overall Study||38
8617885|NCT01087203|21260630|P1|STARTED|Overall Study||35
8617952|NCT01038778|21260958|P3|NOT COMPLETED|Overall Study||3
8617953|NCT01038778|21260959|P2|NOT COMPLETED|Overall Study||2
8617954|NCT01038778|21260960|P1|NOT COMPLETED|Overall Study||0
8617955|NCT01038778|21260958|P3|COMPLETED|Overall Study||33
8617956|NCT01038778|21260959|P2|COMPLETED|Overall Study||6
8617957|NCT01038778|21260960|P1|COMPLETED|Overall Study||3
8617958|NCT01038778|21260958|P3|STARTED|Overall Study||36
8617959|NCT01038778|21260959|P2|STARTED|Overall Study||8
8617960|NCT01038778|21260960|P1|STARTED|Overall Study||3
8618003|NCT00904345|21261140|P1|NOT COMPLETED|Overall Study||3
8618004|NCT00904345|21261140|P1|COMPLETED|Overall Study||18
8618005|NCT00904345|21261140|P1|Stopped or Modified Treatment Due to Toxicity|Overall Study||3
8618006|NCT00904345|21261140|P1|STARTED|Overall Study||21
8618007|NCT00871858|21261153|P2|NOT COMPLETED|Overall Study||7
8618008|NCT00871858|21261154|P1|NOT COMPLETED|Overall Study||5
8618009|NCT00871858|21261153|P2|COMPLETED|Overall Study||52
8618010|NCT00871858|21261154|P1|COMPLETED|Overall Study||56
8618011|NCT00871858|21261153|P2|Evaluable for Safety|Overall Study|1 patient refused to continue study after randomization and therefore did not received treatment.|58
8618012|NCT00871858|21261154|P1|Evaluable for Safety|Overall Study|1 patient refused to continue study and therefore did not received treatment.|60
8618013|NCT00871858|21261153|P2|STARTED|Overall Study||59
8618014|NCT00871858|21261154|P1|STARTED|Overall Study||61
8618034|NCT00827359|21261288|P1|NOT COMPLETED|Overall Study||25
8618035|NCT00827359|21261288|P1|COMPLETED|Overall Study||0
8618036|NCT00827359|21261288|P1|Treated|Overall Study||24
8618037|NCT00827359|21261288|P1|STARTED|Overall Study||25
8618054|NCT00711880|21261430|P2|NOT COMPLETED|Overall Study||7
8618055|NCT00711880|21261431|P1|NOT COMPLETED|Overall Study||13
8618056|NCT00711880|21261430|P2|COMPLETED|Overall Study||55
8618057|NCT00711880|21261431|P1|COMPLETED|Overall Study||50
8618058|NCT00711880|21261430|P2|STARTED|Overall Study||62
8618059|NCT00711880|21261431|P1|STARTED|Overall Study||63
8618230|NCT00073528|21262181|P2|NOT COMPLETED|Overall Study||628
8618231|NCT00073528|21262182|P1|NOT COMPLETED|Overall Study||630
8618232|NCT00073528|21262181|P2|COMPLETED|Overall Study||14
8618233|NCT00073528|21262182|P1|COMPLETED|Overall Study||14
8618234|NCT00073528|21262181|P2|STARTED|Overall Study||642
8618235|NCT00073528|21262182|P1|STARTED|Overall Study||644
8619607|NCT04089761|21267556|P1|NOT COMPLETED|"Follow Up Phase (Optional)"||0
8619608|NCT04089761|21267556|P1|COMPLETED|"Follow Up Phase (Optional)"||27
8619609|NCT04089761|21267556|P1|STARTED|"Follow Up Phase (Optional)"|"Due to the COVID-19 pandemic, Only 27 participants were able to continue to the folllow Up phase"|27
8619610|NCT04089761|21267556|P1|NOT COMPLETED|"Treatment Phase"||6
8619611|NCT04089761|21267556|P1|COMPLETED|"Treatment Phase"||39
8619612|NCT04089761|21267556|P1|STARTED|"Treatment Phase"||45
8619613|NCT04089761|21267556|P1|NOT COMPLETED|"Run In Phase"||15
8619614|NCT04089761|21267556|P1|COMPLETED|"Run In Phase"||45
8619615|NCT04089761|21267556|P1|STARTED|"Run In Phase"||60
8619631|NCT03859323|21267609|P13|NOT COMPLETED|Overall Study||1
8619632|NCT03859323|21267610|P12|NOT COMPLETED|Overall Study||2
8619633|NCT03859323|21267611|P11|NOT COMPLETED|Overall Study||1
8619634|NCT03859323|21267612|P10|NOT COMPLETED|Overall Study||2
8619635|NCT03859323|21267613|P9|NOT COMPLETED|Overall Study||0
8619636|NCT03859323|21267614|P8|NOT COMPLETED|Overall Study||0
8619637|NCT03859323|21267615|P7|NOT COMPLETED|Overall Study||1
8619638|NCT03859323|21267616|P6|NOT COMPLETED|Overall Study||1
8619639|NCT03859323|21267617|P5|NOT COMPLETED|Overall Study||0
8619640|NCT03859323|21267618|P4|NOT COMPLETED|Overall Study||0
8619641|NCT03859323|21267619|P3|NOT COMPLETED|Overall Study||1
8619642|NCT03859323|21267620|P2|NOT COMPLETED|Overall Study||0
8619643|NCT03859323|21267621|P1|NOT COMPLETED|Overall Study||0
8619644|NCT03859323|21267609|P13|COMPLETED|Overall Study||9
8619645|NCT03859323|21267610|P12|COMPLETED|Overall Study||10
8619646|NCT03859323|21267611|P11|COMPLETED|Overall Study||9
8619647|NCT03859323|21267612|P10|COMPLETED|Overall Study||8
8619648|NCT03859323|21267613|P9|COMPLETED|Overall Study||10
8619649|NCT03859323|21267614|P8|COMPLETED|Overall Study||10
8619650|NCT03859323|21267615|P7|COMPLETED|Overall Study||11
8619651|NCT03859323|21267616|P6|COMPLETED|Overall Study||4
8619652|NCT03859323|21267617|P5|COMPLETED|Overall Study||5
8619653|NCT03859323|21267618|P4|COMPLETED|Overall Study||5
8619654|NCT03859323|21267619|P3|COMPLETED|Overall Study||4
8619655|NCT03859323|21267620|P2|COMPLETED|Overall Study||5
8619656|NCT03859323|21267621|P1|COMPLETED|Overall Study||5
8619657|NCT03859323|21267609|P13|STARTED|Overall Study||10
8619658|NCT03859323|21267610|P12|STARTED|Overall Study||12
8619659|NCT03859323|21267611|P11|STARTED|Overall Study||10
8619660|NCT03859323|21267612|P10|STARTED|Overall Study||10
8619661|NCT03859323|21267613|P9|STARTED|Overall Study||10
8619662|NCT03859323|21267614|P8|STARTED|Overall Study||10
8619663|NCT03859323|21267615|P7|STARTED|Overall Study||12
8619664|NCT03859323|21267616|P6|STARTED|Overall Study||5
8619665|NCT03859323|21267617|P5|STARTED|Overall Study||5
8619666|NCT03859323|21267618|P4|STARTED|Overall Study||5
8619667|NCT03859323|21267619|P3|STARTED|Overall Study||5
8619668|NCT03859323|21267620|P2|STARTED|Overall Study||5
8619669|NCT03859323|21267621|P1|STARTED|Overall Study||5
8619735|NCT03579290|21267958|P1|NOT COMPLETED|Overall Study||9
8619736|NCT03579290|21267958|P1|COMPLETED|Overall Study||31
8619737|NCT03579290|21267958|P1|STARTED|Overall Study||40
8619738|NCT03553823|21267966|P2|NOT COMPLETED|Overall Study||1
8619739|NCT03553823|21267967|P1|NOT COMPLETED|Overall Study||0
8619740|NCT03553823|21267966|P2|COMPLETED|Overall Study||19
8619741|NCT03553823|21267967|P1|COMPLETED|Overall Study||20
8619742|NCT03553823|21267966|P2|STARTED|Overall Study||20
8619743|NCT03553823|21267967|P1|STARTED|Overall Study||20
8619744|NCT03494725|21267975|P2|NOT COMPLETED|Overall Study||2
8619745|NCT03494725|21267976|P1|NOT COMPLETED|Overall Study||1
8619746|NCT03494725|21267975|P2|COMPLETED|Overall Study||58
8619747|NCT03494725|21267976|P1|COMPLETED|Overall Study||59
8619748|NCT03494725|21267975|P2|Intervention (Post 2 Weeks run-in)|Overall Study||59
8619749|NCT03494725|21267976|P1|Intervention (Post 2 Weeks run-in)|Overall Study||59
8619750|NCT03494725|21267975|P2|STARTED|Overall Study||60
8619751|NCT03494725|21267976|P1|STARTED|Overall Study||60
8619752|NCT03432819|21268048|P2|NOT COMPLETED|Overall Study||5
8619753|NCT03432819|21268049|P1|NOT COMPLETED|Overall Study||7
8619754|NCT03432819|21268048|P2|COMPLETED|Overall Study||33
8619755|NCT03432819|21268049|P1|COMPLETED|Overall Study||31
8619756|NCT03432819|21268048|P2|STARTED|Overall Study||38
8619757|NCT03432819|21268049|P1|STARTED|Overall Study||38
8619758|NCT03404375|21268075|P2|NOT COMPLETED|Overall Study||0
8619759|NCT03404375|21268076|P1|NOT COMPLETED|Overall Study||0
8619760|NCT03404375|21268075|P2|COMPLETED|Overall Study||172
8619761|NCT03404375|21268076|P1|COMPLETED|Overall Study||70
8619762|NCT03404375|21268075|P2|STARTED|Overall Study||172
8619763|NCT03404375|21268076|P1|STARTED|Overall Study||70
8619800|NCT03341975|21268189|P2|NOT COMPLETED|Overall Study||0
8619801|NCT03341975|21268190|P1|NOT COMPLETED|Overall Study||0
8619802|NCT03341975|21268189|P2|COMPLETED|Overall Study||47
8619803|NCT03341975|21268190|P1|COMPLETED|Overall Study||44
8619804|NCT03341975|21268189|P2|STARTED|Overall Study||47
8619805|NCT03341975|21268190|P1|STARTED|Overall Study||44
8619872|NCT03247322|21268580|P2|NOT COMPLETED|Overall Study||0
8619873|NCT03247322|21268581|P1|NOT COMPLETED|Overall Study||2
8619874|NCT03247322|21268580|P2|COMPLETED|Overall Study||68
8619875|NCT03247322|21268581|P1|COMPLETED|Overall Study||66
8619876|NCT03247322|21268580|P2|STARTED|Overall Study||68
8619877|NCT03247322|21268581|P1|STARTED|Overall Study||68
8619878|NCT03208530|21268597|P1|NOT COMPLETED|Overall Study||27
8619879|NCT03208530|21268597|P1|COMPLETED|Overall Study||48
8619880|NCT03208530|21268597|P1|STARTED|Overall Study||75
8619881|NCT03125226|21268606|P1|NOT COMPLETED|Overall Study||0
8619882|NCT03125226|21268606|P1|COMPLETED|Overall Study||12
8619883|NCT03125226|21268606|P1|STARTED|Overall Study||12
8619926|NCT02997176|21268733|P4|NOT COMPLETED|Overall Study||11
8619927|NCT02997176|21268734|P3|NOT COMPLETED|Overall Study||2
8619928|NCT02997176|21268735|P2|NOT COMPLETED|Overall Study||2
8619929|NCT02997176|21268736|P1|NOT COMPLETED|Overall Study||1
8619930|NCT02997176|21268733|P4|COMPLETED|Overall Study||5
8619931|NCT02997176|21268734|P3|COMPLETED|Overall Study||3
8619932|NCT02997176|21268735|P2|COMPLETED|Overall Study||8
8619933|NCT02997176|21268736|P1|COMPLETED|Overall Study||6
8619934|NCT02997176|21268733|P4|STARTED|Overall Study||16
8619935|NCT02997176|21268734|P3|STARTED|Overall Study||5
8619936|NCT02997176|21268735|P2|STARTED|Overall Study||10
8619937|NCT02997176|21268736|P1|STARTED|Overall Study||7
8619950|NCT02970981|21268891|P1|NOT COMPLETED|Overall Study||0
8619951|NCT02970981|21268891|P1|COMPLETED|Overall Study||16
8619952|NCT02970981|21268891|P1|STARTED|Overall Study||16
8620046|NCT02808429|21269121|P3|NOT COMPLETED|Overall Study||2
8620047|NCT02808429|21269122|P2|NOT COMPLETED|Overall Study||1
8620048|NCT02808429|21269123|P1|NOT COMPLETED|Overall Study||3
8620049|NCT02808429|21269121|P3|COMPLETED|Overall Study||3
8620050|NCT02808429|21269122|P2|COMPLETED|Overall Study||5
8620051|NCT02808429|21269123|P1|COMPLETED|Overall Study||2
8620052|NCT02808429|21269121|P3|STARTED|Overall Study||5
8620053|NCT02808429|21269122|P2|STARTED|Overall Study||6
8620054|NCT02808429|21269123|P1|STARTED|Overall Study||5
8620061|NCT02783950|21269187|P2|NOT COMPLETED|Overall Study||9
8620062|NCT02783950|21269188|P1|NOT COMPLETED|Overall Study||7
8620063|NCT02783950|21269187|P2|COMPLETED|Overall Study||165
8620064|NCT02783950|21269188|P1|COMPLETED|Overall Study||175
8620065|NCT02783950|21269187|P2|STARTED|Overall Study||174
8620066|NCT02783950|21269188|P1|STARTED|Overall Study||182
8620191|NCT02654691|21269667|P1|NOT COMPLETED|Overall Study||0
8620192|NCT02654691|21269667|P1|COMPLETED|Overall Study||63
8620193|NCT02654691|21269667|P1|STARTED|Overall Study||63
8620333|NCT02356705|21270425|P3|NOT COMPLETED|Overall Study||0
8620334|NCT02356705|21270426|P2|NOT COMPLETED|Overall Study||0
8620335|NCT02356705|21270427|P1|NOT COMPLETED|Overall Study||0
8620336|NCT02356705|21270425|P3|COMPLETED|Overall Study||14
8620337|NCT02356705|21270426|P2|COMPLETED|Overall Study||14
8620338|NCT02356705|21270427|P1|COMPLETED|Overall Study||14
8620339|NCT02356705|21270425|P3|STARTED|Overall Study||14
8620340|NCT02356705|21270426|P2|STARTED|Overall Study||14
8620341|NCT02356705|21270427|P1|STARTED|Overall Study||14
8620412|NCT02152670|21270652|P1|NOT COMPLETED|Overall Study||0
8620413|NCT02152670|21270652|P1|COMPLETED|Overall Study||1
8620414|NCT02152670|21270652|P1|STARTED|Overall Study||1
8620455|NCT01839799|21270870|P2|NOT COMPLETED|Overall Study||0
8620456|NCT01839799|21270871|P1|NOT COMPLETED|Overall Study||0
8620457|NCT01839799|21270870|P2|COMPLETED|Overall Study||15
8620458|NCT01839799|21270871|P1|COMPLETED|Overall Study||17
8620459|NCT01839799|21270870|P2|STARTED|Overall Study||15
8620460|NCT01839799|21270871|P1|STARTED|Overall Study||17
8620476|NCT01817959|21270924|P2|NOT COMPLETED|Overall Study||3
8620477|NCT01817959|21270925|P1|NOT COMPLETED|Overall Study||4
8620478|NCT01817959|21270924|P2|COMPLETED|Overall Study||16
8620479|NCT01817959|21270925|P1|COMPLETED|Overall Study||25
8620480|NCT01817959|21270924|P2|STARTED|Overall Study||19
8620481|NCT01817959|21270925|P1|STARTED|Overall Study||29
8620538|NCT01610206|21271134|P2|NOT COMPLETED|Overall Study||30
8620539|NCT01610206|21271135|P1|NOT COMPLETED|Overall Study||10
8620540|NCT01610206|21271134|P2|COMPLETED|Overall Study||45
8620541|NCT01610206|21271135|P1|COMPLETED|Overall Study||63
8620542|NCT01610206|21271134|P2|STARTED|Overall Study||75
8620543|NCT01610206|21271135|P1|STARTED|Overall Study||73
8620550|NCT01429454|21271162|P2|NOT COMPLETED|Overall Study||30
8620551|NCT01429454|21271163|P1|NOT COMPLETED|Overall Study||27
8620552|NCT01429454|21271162|P2|COMPLETED|Overall Study||35
8620553|NCT01429454|21271163|P1|COMPLETED|Overall Study||35
8620554|NCT01429454|21271162|P2|STARTED|Overall Study||65
8620555|NCT01429454|21271163|P1|STARTED|Overall Study||62
8620564|NCT01379573|21271190|P1|NOT COMPLETED|Overall Study||11
8620565|NCT01379573|21271190|P1|COMPLETED|Overall Study||63
8620566|NCT01379573|21271190|P1|STARTED|Overall Study||74
8620573|NCT01254409|21271215|P4|NOT COMPLETED|Overall Study||0
8620574|NCT01254409|21271216|P3|NOT COMPLETED|Overall Study||0
8620575|NCT01254409|21271217|P2|NOT COMPLETED|Overall Study||1
8620576|NCT01254409|21271218|P1|NOT COMPLETED|Overall Study||0
8620577|NCT01254409|21271215|P4|COMPLETED|Overall Study||4
8620578|NCT01254409|21271216|P3|COMPLETED|Overall Study||5
8620579|NCT01254409|21271217|P2|COMPLETED|Overall Study||5
8620580|NCT01254409|21271218|P1|COMPLETED|Overall Study||6
8620581|NCT01254409|21271215|P4|STARTED|Overall Study||4
8620582|NCT01254409|21271216|P3|STARTED|Overall Study||5
8620583|NCT01254409|21271217|P2|STARTED|Overall Study||6
8620584|NCT01254409|21271218|P1|STARTED|Overall Study||6
8620664|NCT01012245|21271571|P1|NOT COMPLETED|Overall Study||2427
8620665|NCT01012245|21271571|P1|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
8620666|NCT01012245|21271571|P1|STARTED|Overall Study||28812
8620697|NCT00950690|21271717|P1|NOT COMPLETED|Overall Study||244
8620698|NCT00950690|21271717|P1|COMPLETED|Overall Study||1105
8620699|NCT00950690|21271717|P1|STARTED|Overall Study||1349
8620700|NCT00910481|21271724|P2|NOT COMPLETED|Overall Study||0
8620701|NCT00910481|21271725|P1|NOT COMPLETED|Overall Study||0
8620702|NCT00910481|21271724|P2|COMPLETED|Overall Study||150
8620703|NCT00910481|21271725|P1|COMPLETED|Overall Study||151
8620704|NCT00910481|21271724|P2|STARTED|Overall Study||150
8620705|NCT00910481|21271725|P1|STARTED|Overall Study||151
8620869|NCT00445978|21272204|P1|NOT COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||1
8620870|NCT00445978|21272204|P1|COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||23
8620871|NCT00445978|21272204|P1|Received Escalated Dose|Week 12 - Week 16 (20 mg/kg/Day)||21
8620872|NCT00445978|21272204|P1|STARTED|Week 12 - Week 16 (20 mg/kg/Day)||24
8620873|NCT00445978|21272204|P1|NOT COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||1
8620874|NCT00445978|21272204|P1|COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||24
8620875|NCT00445978|21272204|P1|Received Escalated Dose|Week 8 - Week 12 (10 mg/kg/Day)||25
8620876|NCT00445978|21272204|P1|STARTED|Week 8 - Week 12 (10 mg/kg/Day)||25
8620877|NCT00445978|21272204|P1|NOT COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||4
8620878|NCT00445978|21272204|P1|COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||25
8620879|NCT00445978|21272204|P1|Received Escalated Dose|Week 4 - Week 8 (5 mg/kg/Day)||29
8620880|NCT00445978|21272204|P1|STARTED|Week 4 - Week 8 (5 mg/kg/Day)||29
8620881|NCT00445978|21272204|P1|NOT COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||3
8620882|NCT00445978|21272204|P1|COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||29
8620883|NCT00445978|21272204|P1|STARTED|Week 0 - Week 4 (2.5 mg/kg/Day)||32
8620920|NCT00085735|21272709|P6|NOT COMPLETED|Overall Study||31
8620921|NCT00085735|21272710|P5|NOT COMPLETED|Overall Study||42
8620922|NCT00085735|21272711|P4|NOT COMPLETED|Overall Study||19
8620923|NCT00085735|21272712|P3|NOT COMPLETED|Overall Study||17
8620924|NCT00085735|21272713|P2|NOT COMPLETED|Overall Study||10
8620925|NCT00085735|21272714|P1|NOT COMPLETED|Overall Study||12
8620926|NCT00085735|21272709|P6|COMPLETED|Overall Study||115
8620927|NCT00085735|21272710|P5|COMPLETED|Overall Study||105
8620928|NCT00085735|21272711|P4|COMPLETED|Overall Study||46
8620929|NCT00085735|21272712|P3|COMPLETED|Overall Study||46
8620930|NCT00085735|21272713|P2|COMPLETED|Overall Study||54
8620931|NCT00085735|21272714|P1|COMPLETED|Overall Study||52
8620932|NCT00085735|21272709|P6|STARTED|Overall Study||146
8620933|NCT00085735|21272710|P5|STARTED|Overall Study||147
8620934|NCT00085735|21272711|P4|STARTED|Overall Study||65
8620935|NCT00085735|21272712|P3|STARTED|Overall Study||63
8620936|NCT00085735|21272713|P2|STARTED|Overall Study||64
8620937|NCT00085735|21272714|P1|STARTED|Overall Study||64
8620938|NCT00084552|21272769|P2|NOT COMPLETED|Overall Study||0
8620939|NCT00084552|21272770|P1|NOT COMPLETED|Overall Study||0
8620940|NCT00084552|21272769|P2|COMPLETED|Overall Study||62
8620941|NCT00084552|21272770|P1|COMPLETED|Overall Study||54
8620942|NCT00084552|21272769|P2|STARTED|Overall Study||62
8620943|NCT00084552|21272770|P1|STARTED|Overall Study||54
8620960|NCT04186481|21272810|P1|NOT COMPLETED|Overall Study||0
8620961|NCT04186481|21272810|P1|COMPLETED|Overall Study||32
8620962|NCT04186481|21272810|P1|Completed 12 Month Visit|Overall Study||4
8620963|NCT04186481|21272810|P1|Completed 6 Month Visit|Overall Study||31
8620964|NCT04186481|21272810|P1|STARTED|Overall Study||32
8620965|NCT04173429|21272818|P2|NOT COMPLETED|Overall Study||2
8620966|NCT04173429|21272819|P1|NOT COMPLETED|Overall Study||2
8620967|NCT04173429|21272818|P2|COMPLETED|Overall Study||30
8620968|NCT04173429|21272819|P1|COMPLETED|Overall Study||30
8620969|NCT04173429|21272818|P2|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||0
8620970|NCT04173429|21272819|P1|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||32
8620971|NCT04173429|21272818|P2|STARTED|Overall Study||32
8620972|NCT04173429|21272819|P1|STARTED|Overall Study||32
8620973|NCT04102956|21272829|P2|NOT COMPLETED|Overall Study||0
8620974|NCT04102956|21272830|P1|NOT COMPLETED|Overall Study||0
8620975|NCT04102956|21272829|P2|COMPLETED|Overall Study||38
8620976|NCT04102956|21272830|P1|COMPLETED|Overall Study||42
8620977|NCT04102956|21272829|P2|STARTED|Overall Study||38
8620978|NCT04102956|21272830|P1|STARTED|Overall Study||42
8620985|NCT03967444|21272861|P2|NOT COMPLETED|Overall Study||2
8620986|NCT03967444|21272862|P1|NOT COMPLETED|Overall Study||1
8620987|NCT03967444|21272861|P2|COMPLETED|Overall Study||38
8620988|NCT03967444|21272862|P1|COMPLETED|Overall Study||18
8620989|NCT03967444|21272861|P2|STARTED|Overall Study||40
8620990|NCT03967444|21272862|P1|STARTED|Overall Study||19
8620991|NCT03811951|21272870|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8620992|NCT03811951|21272871|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8620993|NCT03811951|21272870|P2|COMPLETED|Second Intervention (1 Day)||2
8620994|NCT03811951|21272871|P1|COMPLETED|Second Intervention (1 Day)||2
8620995|NCT03811951|21272870|P2|STARTED|Second Intervention (1 Day)||2
8620996|NCT03811951|21272871|P1|STARTED|Second Intervention (1 Day)||2
8620997|NCT03811951|21272870|P2|NOT COMPLETED|Washout (1 Week)||0
8620998|NCT03811951|21272871|P1|NOT COMPLETED|Washout (1 Week)||0
8620999|NCT03811951|21272870|P2|COMPLETED|Washout (1 Week)||2
8621000|NCT03811951|21272871|P1|COMPLETED|Washout (1 Week)||2
8621001|NCT03811951|21272870|P2|STARTED|Washout (1 Week)||2
8621002|NCT03811951|21272871|P1|STARTED|Washout (1 Week)||2
8621003|NCT03811951|21272870|P2|NOT COMPLETED|First Intervention (1 Day)||0
8621004|NCT03811951|21272871|P1|NOT COMPLETED|First Intervention (1 Day)||0
8621005|NCT03811951|21272870|P2|COMPLETED|First Intervention (1 Day)||2
8621006|NCT03811951|21272871|P1|COMPLETED|First Intervention (1 Day)||2
8621007|NCT03811951|21272870|P2|STARTED|First Intervention (1 Day)||2
8621008|NCT03811951|21272871|P1|STARTED|First Intervention (1 Day)||2
8621009|NCT03801928|21272885|P6|NOT COMPLETED|Overall Study||5
8621010|NCT03801928|21272886|P5|NOT COMPLETED|Overall Study||4
8621011|NCT03801928|21272887|P4|NOT COMPLETED|Overall Study||8
8621012|NCT03801928|21272888|P3|NOT COMPLETED|Overall Study||5
8621013|NCT03801928|21272889|P2|NOT COMPLETED|Overall Study||3
8621014|NCT03801928|21272890|P1|NOT COMPLETED|Overall Study||6
8621015|NCT03801928|21272885|P6|COMPLETED|Overall Study||5
8621016|NCT03801928|21272886|P5|COMPLETED|Overall Study||32
8621017|NCT03801928|21272887|P4|COMPLETED|Overall Study||13
8621018|NCT03801928|21272888|P3|COMPLETED|Overall Study||4
8621019|NCT03801928|21272889|P2|COMPLETED|Overall Study||18
8621020|NCT03801928|21272890|P1|COMPLETED|Overall Study||12
8621021|NCT03801928|21272885|P6|STARTED|Overall Study||10
8621022|NCT03801928|21272886|P5|STARTED|Overall Study||36
8621023|NCT03801928|21272887|P4|STARTED|Overall Study||21
8621024|NCT03801928|21272888|P3|STARTED|Overall Study||9
8621025|NCT03801928|21272889|P2|STARTED|Overall Study||21
8621026|NCT03801928|21272890|P1|STARTED|Overall Study||18
8621027|NCT03773796|21273096|P1|NOT COMPLETED|Overall Study||3
8621028|NCT03773796|21273096|P1|COMPLETED|Overall Study||19
8621029|NCT03773796|21273096|P1|STARTED|Overall Study||22
8621030|NCT03769896|21273121|P2|NOT COMPLETED|Double-blind Treatment Phase||0
8621031|NCT03769896|21273122|P1|NOT COMPLETED|Double-blind Treatment Phase||0
8621032|NCT03769896|21273121|P2|COMPLETED|Double-blind Treatment Phase||19
8621033|NCT03769896|21273122|P1|COMPLETED|Double-blind Treatment Phase||19
8621034|NCT03769896|21273121|P2|STARTED|Double-blind Treatment Phase||19
8621035|NCT03769896|21273122|P1|STARTED|Double-blind Treatment Phase||19
8621036|NCT03769896|21273121|P2|NOT COMPLETED|Open-label Phase||0
8621037|NCT03769896|21273122|P1|NOT COMPLETED|Open-label Phase||9
8621038|NCT03769896|21273121|P2|COMPLETED|Open-label Phase||0
8621039|NCT03769896|21273122|P1|COMPLETED|Open-label Phase||38
8621040|NCT03769896|21273121|P2|STARTED|Open-label Phase||0
8621041|NCT03769896|21273122|P1|STARTED|Open-label Phase||47
8621042|NCT03730961|21273173|P2|NOT COMPLETED|Overall Study||1
8621043|NCT03730961|21273174|P1|NOT COMPLETED|Overall Study||0
8621044|NCT03730961|21273173|P2|COMPLETED|Overall Study||10
8621045|NCT03730961|21273174|P1|COMPLETED|Overall Study||12
8621046|NCT03730961|21273173|P2|Period 2 Completion|Overall Study|1 participant discontinued study due to AE|10
8621047|NCT03730961|21273174|P1|Period 2 Completion|Overall Study|1 participant did not complete Period 2 due to hypotension but remained in the study|11
8621048|NCT03730961|21273173|P2|Period 1 Completion|Overall Study||11
8621049|NCT03730961|21273174|P1|Period 1 Completion|Overall Study||12
8621050|NCT03730961|21273173|P2|STARTED|Overall Study||11
8621051|NCT03730961|21273174|P1|STARTED|Overall Study||12
8621058|NCT03606187|21273235|P2|NOT COMPLETED|Overall Study||0
8621059|NCT03606187|21273236|P1|NOT COMPLETED|Overall Study||0
8621060|NCT03606187|21273235|P2|COMPLETED|Overall Study||61
8621061|NCT03606187|21273236|P1|COMPLETED|Overall Study||67
8621062|NCT03606187|21273235|P2|STARTED|Overall Study||61
8621063|NCT03606187|21273236|P1|STARTED|Overall Study||67
8621064|NCT03599193|21273244|P2|NOT COMPLETED|Overall Study||3
8621065|NCT03599193|21273245|P1|NOT COMPLETED|Overall Study||2
8621066|NCT03599193|21273244|P2|COMPLETED|Overall Study||21
8621067|NCT03599193|21273245|P1|COMPLETED|Overall Study||32
8621068|NCT03599193|21273244|P2|STARTED|Overall Study||24
8621069|NCT03599193|21273245|P1|STARTED|Overall Study||34
8621070|NCT03543878|21273259|P2|NOT COMPLETED|Overall Study||0
8621071|NCT03543878|21273260|P1|NOT COMPLETED|Overall Study||0
8621072|NCT03543878|21273259|P2|COMPLETED|Overall Study||5
8621073|NCT03543878|21273260|P1|COMPLETED|Overall Study||5
8621074|NCT03543878|21273259|P2|STARTED|Overall Study||5
8621075|NCT03543878|21273260|P1|STARTED|Overall Study||5
8621076|NCT03512288|21273269|P2|NOT COMPLETED|Overall Study||43
8621077|NCT03512288|21273270|P1|NOT COMPLETED|Overall Study||41
8621078|NCT03512288|21273269|P2|COMPLETED|Overall Study||185
8621079|NCT03512288|21273270|P1|COMPLETED|Overall Study||191
8621080|NCT03512288|21273269|P2|Vaccination 4|Overall Study||194
8621081|NCT03512288|21273270|P1|Vaccination 4|Overall Study||197
8621082|NCT03512288|21273269|P2|Vaccination 3|Overall Study||206
8621083|NCT03512288|21273270|P1|Vaccination 3|Overall Study||210
8621084|NCT03512288|21273269|P2|Vaccination 2|Overall Study||213
8621085|NCT03512288|21273270|P1|Vaccination 2|Overall Study||222
8621086|NCT03512288|21273269|P2|Vaccination 1|Overall Study||227
8621087|NCT03512288|21273270|P1|Vaccination 1|Overall Study||231
8621088|NCT03512288|21273269|P2|STARTED|Overall Study||228
8621089|NCT03512288|21273270|P1|STARTED|Overall Study||232
8621090|NCT03495908|21273306|P2|NOT COMPLETED|Overall Study||13
8621091|NCT03495908|21273307|P1|NOT COMPLETED|Overall Study||10
8621092|NCT03495908|21273306|P2|COMPLETED|Overall Study||54
8621093|NCT03495908|21273307|P1|COMPLETED|Overall Study||59
8621094|NCT03495908|21273306|P2|STARTED|Overall Study||67
8621095|NCT03495908|21273307|P1|STARTED|Overall Study||69
8621096|NCT03485911|21273328|P3|NOT COMPLETED|Overall Study||4
8621097|NCT03485911|21273329|P2|NOT COMPLETED|Overall Study||2
8621098|NCT03485911|21273330|P1|NOT COMPLETED|Overall Study||1
8621099|NCT03485911|21273328|P3|COMPLETED|Overall Study||36
8621100|NCT03485911|21273329|P2|COMPLETED|Overall Study||38
8621101|NCT03485911|21273330|P1|COMPLETED|Overall Study||40
8621102|NCT03485911|21273328|P3|STARTED|Overall Study||40
8621103|NCT03485911|21273329|P2|STARTED|Overall Study||40
8621104|NCT03485911|21273330|P1|STARTED|Overall Study||41
8621105|NCT03400163|21273349|P2|NOT COMPLETED|Follow-up Period||0
8621106|NCT03400163|21273350|P1|NOT COMPLETED|Follow-up Period||0
8621107|NCT03400163|21273349|P2|COMPLETED|Follow-up Period||2
8621108|NCT03400163|21273350|P1|COMPLETED|Follow-up Period||1
8621109|NCT03400163|21273349|P2|STARTED|Follow-up Period||2
8621110|NCT03400163|21273350|P1|STARTED|Follow-up Period||1
8621111|NCT03400163|21273349|P2|NOT COMPLETED|Treatment Period||0
8621112|NCT03400163|21273350|P1|NOT COMPLETED|Treatment Period||0
8621113|NCT03400163|21273349|P2|COMPLETED|Treatment Period||2
8621114|NCT03400163|21273350|P1|COMPLETED|Treatment Period||1
8621115|NCT03400163|21273349|P2|STARTED|Treatment Period||2
8621116|NCT03400163|21273350|P1|STARTED|Treatment Period||1
8621123|NCT03387033|21273391|P1|NOT COMPLETED|Overall Study||0
8621124|NCT03387033|21273391|P1|COMPLETED|Overall Study||20
8621125|NCT03387033|21273391|P1|STARTED|Overall Study||20
8621126|NCT03361137|21273403|P5|NOT COMPLETED|Overall Study||0
8621127|NCT03361137|21273404|P4|NOT COMPLETED|Overall Study||0
8621128|NCT03361137|21273405|P3|NOT COMPLETED|Overall Study||0
8621129|NCT03361137|21273406|P2|NOT COMPLETED|Overall Study||0
8621130|NCT03361137|21273407|P1|NOT COMPLETED|Overall Study||1
8621131|NCT03361137|21273403|P5|COMPLETED|Overall Study||1
8621132|NCT03361137|21273404|P4|COMPLETED|Overall Study||2
8621133|NCT03361137|21273405|P3|COMPLETED|Overall Study||1
8621134|NCT03361137|21273406|P2|COMPLETED|Overall Study||9
8621135|NCT03361137|21273407|P1|COMPLETED|Overall Study||0
8621136|NCT03361137|21273403|P5|STARTED|Overall Study||1
8621137|NCT03361137|21273404|P4|STARTED|Overall Study||2
8621138|NCT03361137|21273405|P3|STARTED|Overall Study||1
8621139|NCT03361137|21273406|P2|STARTED|Overall Study||9
8621140|NCT03361137|21273407|P1|STARTED|Overall Study||1
8621141|NCT03340961|21273450|P4|NOT COMPLETED|Overall Study||18
8621142|NCT03340961|21273451|P3|NOT COMPLETED|Overall Study||9
8621143|NCT03340961|21273452|P2|NOT COMPLETED|Overall Study||12
8621144|NCT03340961|21273453|P1|NOT COMPLETED|Overall Study||6
8621145|NCT03340961|21273450|P4|COMPLETED|Overall Study||35
8621146|NCT03340961|21273451|P3|COMPLETED|Overall Study||40
8621147|NCT03340961|21273452|P2|COMPLETED|Overall Study||38
8621148|NCT03340961|21273453|P1|COMPLETED|Overall Study||47
8621149|NCT03340961|21273450|P4|STARTED|Overall Study||53
8621150|NCT03340961|21273451|P3|STARTED|Overall Study||49
8621151|NCT03340961|21273452|P2|STARTED|Overall Study||50
8621152|NCT03340961|21273453|P1|STARTED|Overall Study||53
8621153|NCT03338062|21273473|P2|NOT COMPLETED|Overall Study||0
8621154|NCT03338062|21273474|P1|NOT COMPLETED|Overall Study||1
8621155|NCT03338062|21273473|P2|COMPLETED|Overall Study||5
8621156|NCT03338062|21273474|P1|COMPLETED|Overall Study||9
8621157|NCT03338062|21273473|P2|STARTED|Overall Study||5
8621158|NCT03338062|21273474|P1|STARTED|Overall Study||10
8621159|NCT03330119|21273499|P2|NOT COMPLETED|Overall Study||282
8621160|NCT03330119|21273500|P1|NOT COMPLETED|Overall Study||166
8621161|NCT03330119|21273499|P2|COMPLETED|Overall Study||571
8621162|NCT03330119|21273500|P1|COMPLETED|Overall Study||475
8621163|NCT03330119|21273499|P2|STARTED|Overall Study||853
8621164|NCT03330119|21273500|P1|STARTED|Overall Study||641
8621165|NCT03292640|21273508|P2|NOT COMPLETED|Overall Study||42
8621166|NCT03292640|21273509|P1|NOT COMPLETED|Overall Study||61
8621167|NCT03292640|21273508|P2|COMPLETED|Overall Study||230
8621168|NCT03292640|21273509|P1|COMPLETED|Overall Study||214
8621169|NCT03292640|21273508|P2|STARTED|Overall Study||272
8621170|NCT03292640|21273509|P1|STARTED|Overall Study||275
8621171|NCT03290027|21273521|P2|NOT COMPLETED|Overall Study||45
8621172|NCT03290027|21273522|P1|NOT COMPLETED|Overall Study||58
8621173|NCT03290027|21273521|P2|COMPLETED|Overall Study||228
8621174|NCT03290027|21273522|P1|COMPLETED|Overall Study||219
8621175|NCT03290027|21273521|P2|STARTED|Overall Study||273
8621176|NCT03290027|21273522|P1|STARTED|Overall Study||277
8621177|NCT03287310|21273538|P6|NOT COMPLETED|Overall Study||0
8621178|NCT03287310|21273539|P5|NOT COMPLETED|Overall Study||0
8621179|NCT03287310|21273540|P4|NOT COMPLETED|Overall Study||0
8621180|NCT03287310|21273541|P3|NOT COMPLETED|Overall Study||0
8621181|NCT03287310|21273542|P2|NOT COMPLETED|Overall Study||0
8621182|NCT03287310|21273543|P1|NOT COMPLETED|Overall Study||0
8621183|NCT03287310|21273538|P6|COMPLETED|Overall Study||6
8621184|NCT03287310|21273539|P5|COMPLETED|Overall Study||9
8621185|NCT03287310|21273540|P4|COMPLETED|Overall Study||9
8621186|NCT03287310|21273541|P3|COMPLETED|Overall Study||6
8621187|NCT03287310|21273542|P2|COMPLETED|Overall Study||6
8621188|NCT03287310|21273543|P1|COMPLETED|Overall Study||12
8621189|NCT03287310|21273538|P6|STARTED|Overall Study||6
8621190|NCT03287310|21273539|P5|STARTED|Overall Study||9
8621191|NCT03287310|21273540|P4|STARTED|Overall Study||9
8621192|NCT03287310|21273541|P3|STARTED|Overall Study||6
8621193|NCT03287310|21273542|P2|STARTED|Overall Study||6
8621194|NCT03287310|21273543|P1|STARTED|Overall Study||12
8621213|NCT03103438|21273844|P7|NOT COMPLETED|Overall Study||0
8621214|NCT03103438|21273845|P6|NOT COMPLETED|Overall Study||0
8621215|NCT03103438|21273846|P5|NOT COMPLETED|Overall Study||0
8621216|NCT03103438|21273847|P4|NOT COMPLETED|Overall Study||0
8621217|NCT03103438|21273848|P3|NOT COMPLETED|Overall Study||0
8621218|NCT03103438|21273849|P2|NOT COMPLETED|Overall Study||0
8621219|NCT03103438|21273850|P1|NOT COMPLETED|Overall Study||0
8621220|NCT03103438|21273844|P7|COMPLETED|Overall Study||3
8621221|NCT03103438|21273845|P6|COMPLETED|Overall Study||3
8621222|NCT03103438|21273846|P5|COMPLETED|Overall Study||3
8621223|NCT03103438|21273847|P4|COMPLETED|Overall Study||3
8621224|NCT03103438|21273848|P3|COMPLETED|Overall Study||3
8621225|NCT03103438|21273849|P2|COMPLETED|Overall Study||3
8621226|NCT03103438|21273850|P1|COMPLETED|Overall Study||1
8621227|NCT03103438|21273844|P7|STARTED|Overall Study||3
8621228|NCT03103438|21273845|P6|STARTED|Overall Study||3
8621229|NCT03103438|21273846|P5|STARTED|Overall Study||3
8621230|NCT03103438|21273847|P4|STARTED|Overall Study||3
8621231|NCT03103438|21273848|P3|STARTED|Overall Study||3
8621232|NCT03103438|21273849|P2|STARTED|Overall Study||3
8621233|NCT03103438|21273850|P1|STARTED|Overall Study||1
8621234|NCT03099694|21273868|P2|NOT COMPLETED|Overall Study||18
8621235|NCT03099694|21273869|P1|NOT COMPLETED|Overall Study||20
8621236|NCT03099694|21273868|P2|COMPLETED|Overall Study||152
8621237|NCT03099694|21273869|P1|COMPLETED|Overall Study||150
8621238|NCT03099694|21273868|P2|STARTED|Overall Study||170
8621239|NCT03099694|21273869|P1|STARTED|Overall Study||170
8621249|NCT03067441|21273912|P2|NOT COMPLETED|Overall Study||57
8621250|NCT03067441|21273913|P1|NOT COMPLETED|Overall Study||33
8621251|NCT03067441|21273912|P2|COMPLETED|Overall Study||913
8621252|NCT03067441|21273913|P1|COMPLETED|Overall Study||459
8621253|NCT03067441|21273912|P2|STARTED|Overall Study||970
8621254|NCT03067441|21273913|P1|STARTED|Overall Study||492
8621255|NCT03061214|21273972|P3|NOT COMPLETED|Overall Study||10
8621256|NCT03061214|21273973|P2|NOT COMPLETED|Overall Study||28
8621257|NCT03061214|21273974|P1|NOT COMPLETED|Overall Study||25
8621258|NCT03061214|21273972|P3|COMPLETED|Overall Study||280
8621259|NCT03061214|21273973|P2|COMPLETED|Overall Study||262
8621260|NCT03061214|21273974|P1|COMPLETED|Overall Study||263
8621261|NCT03061214|21273972|P3|Safety Analysis Set (SAS)|Overall Study||290
8621262|NCT03061214|21273973|P2|Safety Analysis Set (SAS)|Overall Study||290
8621263|NCT03061214|21273974|P1|Safety Analysis Set (SAS)|Overall Study||287
8621264|NCT03061214|21273972|P3|Full Analysis Set (FAS)|Overall Study||290
8621265|NCT03061214|21273973|P2|Full Analysis Set (FAS)|Overall Study||290
8621266|NCT03061214|21273974|P1|Full Analysis Set (FAS)|Overall Study||288
8621267|NCT03061214|21273972|P3|Exposed|Overall Study||290
8621268|NCT03061214|21273973|P2|Exposed|Overall Study||290
8621269|NCT03061214|21273974|P1|Exposed|Overall Study||287
8621270|NCT03061214|21273972|P3|STARTED|Overall Study||290
8621271|NCT03061214|21273973|P2|STARTED|Overall Study||290
8621272|NCT03061214|21273974|P1|STARTED|Overall Study||288
8621273|NCT03053271|21274196|P1|NOT COMPLETED|Overall Study||4
8621274|NCT03053271|21274196|P1|COMPLETED|Overall Study|All completed the open-label dose escalation, but did not meet criteria for randomization|0
8621275|NCT03053271|21274196|P1|STARTED|Overall Study||4
8621282|NCT03015220|21274241|P4|NOT COMPLETED|Overall Study||2
8621283|NCT03015220|21274242|P3|NOT COMPLETED|Overall Study||3
8621284|NCT03015220|21274243|P2|NOT COMPLETED|Overall Study||2
8621285|NCT03015220|21274244|P1|NOT COMPLETED|Overall Study||3
8621286|NCT03015220|21274241|P4|COMPLETED|Overall Study||63
8621287|NCT03015220|21274242|P3|COMPLETED|Overall Study||127
8621288|NCT03015220|21274243|P2|COMPLETED|Overall Study||130
8621289|NCT03015220|21274244|P1|COMPLETED|Overall Study||128
8621290|NCT03015220|21274241|P4|Safety Analysis Set (SAS)|Overall Study||65
8621291|NCT03015220|21274242|P3|Safety Analysis Set (SAS)|Overall Study||130
8621292|NCT03015220|21274243|P2|Safety Analysis Set (SAS)|Overall Study||132
8621293|NCT03015220|21274244|P1|Safety Analysis Set (SAS)|Overall Study||131
8621294|NCT03015220|21274241|P4|Full Analysis Set (FAS)|Overall Study||65
8621295|NCT03015220|21274242|P3|Full Analysis Set (FAS)|Overall Study||130
8621296|NCT03015220|21274243|P2|Full Analysis Set (FAS)|Overall Study||132
8621297|NCT03015220|21274244|P1|Full Analysis Set (FAS)|Overall Study||131
8621298|NCT03015220|21274241|P4|STARTED|Overall Study||65
8621299|NCT03015220|21274242|P3|STARTED|Overall Study||130
8621300|NCT03015220|21274243|P2|STARTED|Overall Study||132
8621301|NCT03015220|21274244|P1|STARTED|Overall Study||131
8621302|NCT03008460|21274384|P2|NOT COMPLETED|Overall Study||14
8621303|NCT03008460|21274385|P1|NOT COMPLETED|Overall Study||7
8621304|NCT03008460|21274384|P2|COMPLETED|Overall Study||110
8621305|NCT03008460|21274385|P1|COMPLETED|Overall Study||119
8621306|NCT03008460|21274384|P2|STARTED|Overall Study||124
8621307|NCT03008460|21274385|P1|STARTED|Overall Study||126
8621308|NCT03002506|21274415|P1|NOT COMPLETED|Overall Study||0
8621309|NCT03002506|21274415|P1|COMPLETED|Overall Study||6
8621310|NCT03002506|21274415|P1|STARTED|Overall Study||6
8621311|NCT02953782|21274427|P8|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
8621312|NCT02953782|21274428|P7|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
8621313|NCT02953782|21274429|P6|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||16
8621314|NCT02953782|21274430|P5|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621315|NCT02953782|21274431|P4|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621316|NCT02953782|21274432|P3|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621317|NCT02953782|21274433|P2|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621318|NCT02953782|21274434|P1|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621319|NCT02953782|21274427|P8|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621320|NCT02953782|21274428|P7|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621321|NCT02953782|21274429|P6|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621322|NCT02953782|21274430|P5|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621323|NCT02953782|21274431|P4|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621324|NCT02953782|21274432|P3|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621325|NCT02953782|21274433|P2|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621326|NCT02953782|21274434|P1|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621327|NCT02953782|21274427|P8|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
8621328|NCT02953782|21274428|P7|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
8621329|NCT02953782|21274429|P6|STARTED|Phase 2 (Maximum Duration: 11.1 Months)|11 participants were included in safety run-in to evaluate DLT. 9 out of 11 were evaluable for DLT.|16
8621330|NCT02953782|21274430|P5|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621331|NCT02953782|21274431|P4|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621332|NCT02953782|21274432|P3|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621333|NCT02953782|21274433|P2|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621334|NCT02953782|21274434|P1|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
8621335|NCT02953782|21274427|P8|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8621336|NCT02953782|21274428|P7|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8621337|NCT02953782|21274429|P6|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8621338|NCT02953782|21274430|P5|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
8621339|NCT02953782|21274431|P4|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||8
8621340|NCT02953782|21274432|P3|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||9
8621341|NCT02953782|21274433|P2|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||3
8621342|NCT02953782|21274434|P1|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
8621343|NCT02953782|21274427|P8|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8621344|NCT02953782|21274428|P7|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8621345|NCT02953782|21274429|P6|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8621346|NCT02953782|21274430|P5|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8621347|NCT02953782|21274431|P4|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8621348|NCT02953782|21274432|P3|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8621349|NCT02953782|21274433|P2|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8621350|NCT02953782|21274434|P1|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
8621351|NCT02953782|21274427|P8|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
8621352|NCT02953782|21274428|P7|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
8621353|NCT02953782|21274429|P6|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
8621354|NCT02953782|21274430|P5|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
8621355|NCT02953782|21274431|P4|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||8
8621356|NCT02953782|21274432|P3|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||9
8621357|NCT02953782|21274433|P2|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||3
8621358|NCT02953782|21274434|P1|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
8621359|NCT02913521|21274509|P3|NOT COMPLETED|Overall Study||45
8621360|NCT02913521|21274510|P2|NOT COMPLETED|Overall Study||50
8621361|NCT02913521|21274511|P1|NOT COMPLETED|Overall Study||53
8621362|NCT02913521|21274509|P3|COMPLETED|Overall Study||261
8621363|NCT02913521|21274510|P2|COMPLETED|Overall Study||262
8621364|NCT02913521|21274511|P1|COMPLETED|Overall Study||263
8621365|NCT02913521|21274509|P3|STARTED|Overall Study||306
8621366|NCT02913521|21274510|P2|STARTED|Overall Study||312
8621367|NCT02913521|21274511|P1|STARTED|Overall Study||316
8621368|NCT02891850|21274524|P2|NOT COMPLETED|Overall Study||7
8621369|NCT02891850|21274525|P1|NOT COMPLETED|Overall Study||7
8621370|NCT02891850|21274524|P2|COMPLETED|Overall Study||107
8621371|NCT02891850|21274525|P1|COMPLETED|Overall Study||104
8621372|NCT02891850|21274524|P2|STARTED|Overall Study||114
8621373|NCT02891850|21274525|P1|STARTED|Overall Study||111
8621374|NCT02889510|21274539|P2|NOT COMPLETED|Overall Study||5
8621375|NCT02889510|21274540|P1|NOT COMPLETED|Overall Study||8
8621376|NCT02889510|21274539|P2|COMPLETED|Overall Study||32
8621377|NCT02889510|21274540|P1|COMPLETED|Overall Study||27
8621378|NCT02889510|21274539|P2|STARTED|Overall Study||37
8621379|NCT02889510|21274540|P1|STARTED|Overall Study||35
8621380|NCT02864355|21274562|P2|NOT COMPLETED|Overall Study||3
8621381|NCT02864355|21274563|P1|NOT COMPLETED|Overall Study||2
8621382|NCT02864355|21274562|P2|COMPLETED|Overall Study||25
8621383|NCT02864355|21274563|P1|COMPLETED|Overall Study||23
8621384|NCT02864355|21274562|P2|STARTED|Overall Study||28
8621385|NCT02864355|21274563|P1|STARTED|Overall Study||25
8621386|NCT02787850|21274581|P2|NOT COMPLETED|Overall Study||1
8621387|NCT02787850|21274582|P1|NOT COMPLETED|Overall Study||0
8621388|NCT02787850|21274581|P2|COMPLETED|Overall Study||9
8621389|NCT02787850|21274582|P1|COMPLETED|Overall Study||10
8621390|NCT02787850|21274581|P2|STARTED|Overall Study||10
8621391|NCT02787850|21274582|P1|STARTED|Overall Study||10
8621437|NCT02729740|21274834|P1|NOT COMPLETED|Overall Study||131
8621438|NCT02729740|21274834|P1|COMPLETED|Overall Study||864
8621439|NCT02729740|21274834|P1|STARTED|Overall Study||995
8621440|NCT02711553|21274845|P4|NOT COMPLETED|Overall Study||7
8621441|NCT02711553|21274846|P3|NOT COMPLETED|Overall Study||27
8621442|NCT02711553|21274847|P2|NOT COMPLETED|Overall Study||15
8621443|NCT02711553|21274848|P1|NOT COMPLETED|Overall Study||18
8621444|NCT02711553|21274845|P4|COMPLETED|Overall Study||42
8621445|NCT02711553|21274846|P3|COMPLETED|Overall Study||75
8621446|NCT02711553|21274847|P2|COMPLETED|Overall Study||37
8621447|NCT02711553|21274848|P1|COMPLETED|Overall Study||88
8621448|NCT02711553|21274845|P4|Received at Least 1 Dose of Study Drug|Overall Study||48
8621449|NCT02711553|21274846|P3|Received at Least 1 Dose of Study Drug|Overall Study||102
8621450|NCT02711553|21274847|P2|Received at Least 1 Dose of Study Drug|Overall Study||52
8621451|NCT02711553|21274848|P1|Received at Least 1 Dose of Study Drug|Overall Study||104
8621452|NCT02711553|21274845|P4|STARTED|Overall Study||49
8621453|NCT02711553|21274846|P3|STARTED|Overall Study||102
8621454|NCT02711553|21274847|P2|STARTED|Overall Study||52
8621455|NCT02711553|21274848|P1|STARTED|Overall Study||106
8621456|NCT02697591|21274878|P10|NOT COMPLETED|Overall Study||20
8621457|NCT02697591|21274879|P9|NOT COMPLETED|Overall Study||9
8621458|NCT02697591|21274880|P8|NOT COMPLETED|Overall Study||3
8621459|NCT02697591|21274881|P7|NOT COMPLETED|Overall Study||16
8621460|NCT02697591|21274882|P6|NOT COMPLETED|Overall Study||16
8621461|NCT02697591|21274883|P5|NOT COMPLETED|Overall Study||13
8621462|NCT02697591|21274884|P4|NOT COMPLETED|Overall Study||3
8621463|NCT02697591|21274885|P3|NOT COMPLETED|Overall Study||3
8621464|NCT02697591|21274886|P2|NOT COMPLETED|Overall Study||4
8621465|NCT02697591|21274887|P1|NOT COMPLETED|Overall Study||4
8621466|NCT02697591|21274878|P10|COMPLETED|Overall Study||2
8621467|NCT02697591|21274879|P9|COMPLETED|Overall Study||1
8621468|NCT02697591|21274880|P8|COMPLETED|Overall Study||1
8621469|NCT02697591|21274881|P7|COMPLETED|Overall Study||0
8621470|NCT02697591|21274882|P6|COMPLETED|Overall Study||2
8621471|NCT02697591|21274883|P5|COMPLETED|Overall Study||2
8621472|NCT02697591|21274884|P4|COMPLETED|Overall Study||0
8621473|NCT02697591|21274885|P3|COMPLETED|Overall Study||1
8621474|NCT02697591|21274886|P2|COMPLETED|Overall Study||0
8621475|NCT02697591|21274887|P1|COMPLETED|Overall Study||0
8621476|NCT02697591|21274878|P10|STARTED|Overall Study||22
8621477|NCT02697591|21274879|P9|STARTED|Overall Study||10
8621478|NCT02697591|21274880|P8|STARTED|Overall Study||4
8621479|NCT02697591|21274881|P7|STARTED|Overall Study||16
8621480|NCT02697591|21274882|P6|STARTED|Overall Study||18
8621481|NCT02697591|21274883|P5|STARTED|Overall Study||15
8621482|NCT02697591|21274884|P4|STARTED|Overall Study||3
8621483|NCT02697591|21274885|P3|STARTED|Overall Study||4
8621484|NCT02697591|21274886|P2|STARTED|Overall Study||4
8621485|NCT02697591|21274887|P1|STARTED|Overall Study||4
8621486|NCT02684617|21274993|P3|NOT COMPLETED|Overall Study||40
8621487|NCT02684617|21274994|P2|NOT COMPLETED|Overall Study||17
8621488|NCT02684617|21274995|P1|NOT COMPLETED|Overall Study||18
8621489|NCT02684617|21274993|P3|COMPLETED|Overall Study||0
8621490|NCT02684617|21274994|P2|COMPLETED|Overall Study||0
8621491|NCT02684617|21274995|P1|COMPLETED|Overall Study||0
8621492|NCT02684617|21274993|P3|Treated|Overall Study||38
8621493|NCT02684617|21274994|P2|Treated|Overall Study||17
8621494|NCT02684617|21274995|P1|Treated|Overall Study||17
8621495|NCT02684617|21274993|P3|STARTED|Overall Study||40
8621496|NCT02684617|21274994|P2|STARTED|Overall Study||17
8621497|NCT02684617|21274995|P1|STARTED|Overall Study||18
8621504|NCT02660489|21275034|P2|NOT COMPLETED|Overall Study||8
8621505|NCT02660489|21275035|P1|NOT COMPLETED|Overall Study||6
8621506|NCT02660489|21275034|P2|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|14
8621507|NCT02660489|21275035|P1|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|16
8621508|NCT02660489|21275034|P2|STARTED|Overall Study||22
8621509|NCT02660489|21275035|P1|STARTED|Overall Study||22
8621510|NCT02658630|21275055|P1|NOT COMPLETED|Overall Study||4
8621511|NCT02658630|21275055|P1|COMPLETED|Overall Study||42
8621512|NCT02658630|21275055|P1|STARTED|Overall Study||46
8621528|NCT02576509|21275099|P2|NOT COMPLETED|Follow-up Period||52
8621529|NCT02576509|21275100|P1|NOT COMPLETED|Follow-up Period||49
8621530|NCT02576509|21275099|P2|COMPLETED|Follow-up Period||311
8621531|NCT02576509|21275100|P1|COMPLETED|Follow-up Period||318
8621532|NCT02576509|21275099|P2|STARTED|Follow-up Period||363
8621533|NCT02576509|21275100|P1|STARTED|Follow-up Period||367
8621534|NCT02576509|21275099|P2|NOT COMPLETED|Treatment Period||355
8621535|NCT02576509|21275100|P1|NOT COMPLETED|Treatment Period||329
8621536|NCT02576509|21275099|P2|COMPLETED|Treatment Period||8
8621537|NCT02576509|21275100|P1|COMPLETED|Treatment Period||38
8621538|NCT02576509|21275099|P2|STARTED|Treatment Period||363
8621539|NCT02576509|21275100|P1|STARTED|Treatment Period||367
8621540|NCT02576509|21275099|P2|NOT COMPLETED|Pre-Treatment Period||9
8621541|NCT02576509|21275100|P1|NOT COMPLETED|Pre-Treatment Period||4
8621542|NCT02576509|21275099|P2|COMPLETED|Pre-Treatment Period||363
8621543|NCT02576509|21275100|P1|COMPLETED|Pre-Treatment Period||367
8621544|NCT02576509|21275099|P2|STARTED|Pre-Treatment Period||372
8621545|NCT02576509|21275100|P1|STARTED|Pre-Treatment Period||371
8621546|NCT02573493|21275118|P4|NOT COMPLETED|Overall Study||1
8621547|NCT02573493|21275119|P3|NOT COMPLETED|Overall Study||0
8621548|NCT02573493|21275120|P2|NOT COMPLETED|Overall Study||0
8621549|NCT02573493|21275121|P1|NOT COMPLETED|Overall Study||0
8621550|NCT02573493|21275118|P4|COMPLETED|Overall Study||0
8621551|NCT02573493|21275119|P3|COMPLETED|Overall Study||15
8621552|NCT02573493|21275120|P2|COMPLETED|Overall Study||40
8621553|NCT02573493|21275121|P1|COMPLETED|Overall Study||40
8621554|NCT02573493|21275118|P4|STARTED|Overall Study||1
8621555|NCT02573493|21275119|P3|STARTED|Overall Study||15
8621556|NCT02573493|21275120|P2|STARTED|Overall Study||40
8621557|NCT02573493|21275121|P1|STARTED|Overall Study||40
8621564|NCT02536508|21275223|P3|NOT COMPLETED|Overall Study||23
8621565|NCT02536508|21275224|P2|NOT COMPLETED|Overall Study||44
8621566|NCT02536508|21275225|P1|NOT COMPLETED|Overall Study||52
8621567|NCT02536508|21275223|P3|COMPLETED|Overall Study||65
8621568|NCT02536508|21275224|P2|COMPLETED|Overall Study||130
8621569|NCT02536508|21275225|P1|COMPLETED|Overall Study||142
8621570|NCT02536508|21275223|P3|STARTED|Overall Study||88
8621571|NCT02536508|21275224|P2|STARTED|Overall Study||174
8621572|NCT02536508|21275225|P1|STARTED|Overall Study||194
8621573|NCT02442869|21275242|P6|NOT COMPLETED|Overall Study||0
8621574|NCT02442869|21275243|P5|NOT COMPLETED|Overall Study||2
8621575|NCT02442869|21275244|P4|NOT COMPLETED|Overall Study||1
8621576|NCT02442869|21275245|P3|NOT COMPLETED|Overall Study||0
8621577|NCT02442869|21275246|P2|NOT COMPLETED|Overall Study||9
8621578|NCT02442869|21275247|P1|NOT COMPLETED|Overall Study||5
8621579|NCT02442869|21275242|P6|COMPLETED|Overall Study||2
8621580|NCT02442869|21275243|P5|COMPLETED|Overall Study||3
8621581|NCT02442869|21275244|P4|COMPLETED|Overall Study||1
8621582|NCT02442869|21275245|P3|COMPLETED|Overall Study||6
8621583|NCT02442869|21275246|P2|COMPLETED|Overall Study||20
8621584|NCT02442869|21275247|P1|COMPLETED|Overall Study||13
8621585|NCT02442869|21275242|P6|STARTED|Overall Study||2
8621586|NCT02442869|21275243|P5|STARTED|Overall Study||5
8621587|NCT02442869|21275244|P4|STARTED|Overall Study||2
8621588|NCT02442869|21275245|P3|STARTED|Overall Study||6
8621589|NCT02442869|21275246|P2|STARTED|Overall Study||29
8621590|NCT02442869|21275247|P1|STARTED|Overall Study||18
8621591|NCT02435381|21275293|P2|NOT COMPLETED|Overall Study||1
8621592|NCT02435381|21275294|P1|NOT COMPLETED|Overall Study||2
8621593|NCT02435381|21275293|P2|COMPLETED|Overall Study||5
8621594|NCT02435381|21275294|P1|COMPLETED|Overall Study||3
8621595|NCT02435381|21275293|P2|STARTED|Overall Study||6
8621596|NCT02435381|21275294|P1|STARTED|Overall Study||5
8621597|NCT02432742|21275318|P1|NOT COMPLETED|Overall Study||5
8621598|NCT02432742|21275318|P1|COMPLETED|Overall Study||95
8621599|NCT02432742|21275318|P1|STARTED|Overall Study||100
8621600|NCT02432274|21275331|P8|NOT COMPLETED|Overall Study||20
8621601|NCT02432274|21275332|P7|NOT COMPLETED|Overall Study||15
8621602|NCT02432274|21275333|P6|NOT COMPLETED|Overall Study||7
8621603|NCT02432274|21275334|P5|NOT COMPLETED|Overall Study||31
8621604|NCT02432274|21275335|P4|NOT COMPLETED|Overall Study||1
8621605|NCT02432274|21275336|P3|NOT COMPLETED|Overall Study||11
8621606|NCT02432274|21275337|P2|NOT COMPLETED|Overall Study||9
8621607|NCT02432274|21275338|P1|NOT COMPLETED|Overall Study||3
8621608|NCT02432274|21275331|P8|COMPLETED|Overall Study||0
8621609|NCT02432274|21275332|P7|COMPLETED|Overall Study||0
8621610|NCT02432274|21275333|P6|COMPLETED|Overall Study||0
8621611|NCT02432274|21275334|P5|COMPLETED|Overall Study||0
8621612|NCT02432274|21275335|P4|COMPLETED|Overall Study||0
8621613|NCT02432274|21275336|P3|COMPLETED|Overall Study||0
8621614|NCT02432274|21275337|P2|COMPLETED|Overall Study||0
8621615|NCT02432274|21275338|P1|COMPLETED|Overall Study||0
8621616|NCT02432274|21275331|P8|Treated (Safety Population)|Overall Study||20
8621617|NCT02432274|21275332|P7|Treated (Safety Population)|Overall Study||11
8621618|NCT02432274|21275333|P6|Treated (Safety Population)|Overall Study|4 participants assigned to lenvatinib14mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|11
8621619|NCT02432274|21275334|P5|Treated (Safety Population)|Overall Study||31
8621620|NCT02432274|21275335|P4|Treated (Safety Population)|Overall Study||1
8621621|NCT02432274|21275336|P3|Treated (Safety Population)|Overall Study||7
8621622|NCT02432274|21275337|P2|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 14mg/m^2 (dose capped at 24 mg/day).|11
8621623|NCT02432274|21275338|P1|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|5
8621624|NCT02432274|21275331|P8|Underwent Run-in Period|Overall Study||0
8621625|NCT02432274|21275332|P7|Underwent Run-in Period|Overall Study||0
8621626|NCT02432274|21275333|P6|Underwent Run-in Period|Overall Study||0
8621627|NCT02432274|21275334|P5|Underwent Run-in Period|Overall Study||0
8621628|NCT02432274|21275335|P4|Underwent Run-in Period|Overall Study||0
8621629|NCT02432274|21275336|P3|Underwent Run-in Period|Overall Study||0
8621630|NCT02432274|21275337|P2|Underwent Run-in Period|Overall Study||1
8621631|NCT02432274|21275338|P1|Underwent Run-in Period|Overall Study||1
8621632|NCT02432274|21275331|P8|STARTED|Overall Study||20
8621633|NCT02432274|21275332|P7|STARTED|Overall Study||15
8621634|NCT02432274|21275333|P6|STARTED|Overall Study||7
8621635|NCT02432274|21275334|P5|STARTED|Overall Study||31
8621636|NCT02432274|21275335|P4|STARTED|Overall Study||1
8621637|NCT02432274|21275336|P3|STARTED|Overall Study||11
8621638|NCT02432274|21275337|P2|STARTED|Overall Study||9
8621639|NCT02432274|21275338|P1|STARTED|Overall Study||3
8621640|NCT02413372|21275454|P3|NOT COMPLETED|Follow-up||2
8621641|NCT02413372|21275455|P2|NOT COMPLETED|Follow-up||1
8621642|NCT02413372|21275456|P1|NOT COMPLETED|Follow-up||2
8621643|NCT02413372|21275454|P3|COMPLETED|Follow-up||23
8621644|NCT02413372|21275455|P2|COMPLETED|Follow-up||20
8621645|NCT02413372|21275456|P1|COMPLETED|Follow-up||20
8621646|NCT02413372|21275454|P3|STARTED|Follow-up||25
8621647|NCT02413372|21275455|P2|STARTED|Follow-up||21
8621648|NCT02413372|21275456|P1|STARTED|Follow-up||22
8621649|NCT02413372|21275454|P3|NOT COMPLETED|Treatment||1
8621650|NCT02413372|21275455|P2|NOT COMPLETED|Treatment||2
8621651|NCT02413372|21275456|P1|NOT COMPLETED|Treatment||1
8621652|NCT02413372|21275454|P3|COMPLETED|Treatment||25
8621653|NCT02413372|21275455|P2|COMPLETED|Treatment||22
8621654|NCT02413372|21275456|P1|COMPLETED|Treatment||24
8621655|NCT02413372|21275454|P3|STARTED|Treatment||26
8621656|NCT02413372|21275455|P2|STARTED|Treatment||24
8621657|NCT02413372|21275456|P1|STARTED|Treatment||25
8621670|NCT02327351|21275624|P1|NOT COMPLETED|Overall Study||0
8621671|NCT02327351|21275624|P1|COMPLETED|Overall Study||98
8621672|NCT02327351|21275624|P1|STARTED|Overall Study||98
8621673|NCT02324543|21275643|P6|NOT COMPLETED|Overall Study||0
8621674|NCT02324543|21275644|P5|NOT COMPLETED|Overall Study||0
8621675|NCT02324543|21275645|P4|NOT COMPLETED|Overall Study||0
8621676|NCT02324543|21275646|P3|NOT COMPLETED|Overall Study||0
8621677|NCT02324543|21275647|P2|NOT COMPLETED|Overall Study||0
8621678|NCT02324543|21275648|P1|NOT COMPLETED|Overall Study||0
8621679|NCT02324543|21275643|P6|COMPLETED|Overall Study||24
8621680|NCT02324543|21275644|P5|COMPLETED|Overall Study||4
8621681|NCT02324543|21275645|P4|COMPLETED|Overall Study||4
8621682|NCT02324543|21275646|P3|COMPLETED|Overall Study||3
8621683|NCT02324543|21275647|P2|COMPLETED|Overall Study||6
8621684|NCT02324543|21275648|P1|COMPLETED|Overall Study||6
8621685|NCT02324543|21275643|P6|STARTED|Overall Study||24
8621686|NCT02324543|21275644|P5|STARTED|Overall Study||4
8621687|NCT02324543|21275645|P4|STARTED|Overall Study||4
8621688|NCT02324543|21275646|P3|STARTED|Overall Study||3
8621689|NCT02324543|21275647|P2|STARTED|Overall Study||6
8621690|NCT02324543|21275648|P1|STARTED|Overall Study||6
8621691|NCT02264990|21275668|P2|NOT COMPLETED|Overall Study||259
8621692|NCT02264990|21275669|P1|NOT COMPLETED|Overall Study||260
8621693|NCT02264990|21275668|P2|COMPLETED|Overall Study||39
8621694|NCT02264990|21275669|P1|COMPLETED|Overall Study||37
8621695|NCT02264990|21275668|P2|Received Maintenance Therapy|Overall Study||123
8621696|NCT02264990|21275669|P1|Received Maintenance Therapy|Overall Study||148
8621697|NCT02264990|21275668|P2|Received Treatment|Overall Study||293
8621698|NCT02264990|21275669|P1|Received Treatment|Overall Study||288
8621699|NCT02264990|21275668|P2|STARTED|Overall Study||298
8621700|NCT02264990|21275669|P1|STARTED|Overall Study||297
8621701|NCT02255461|21275690|P5|NOT COMPLETED|Overall Study||2
8621702|NCT02255461|21275691|P4|NOT COMPLETED|Overall Study||0
8621703|NCT02255461|21275692|P3|NOT COMPLETED|Overall Study||1
8621704|NCT02255461|21275693|P2|NOT COMPLETED|Overall Study||2
8621705|NCT02255461|21275694|P1|NOT COMPLETED|Overall Study||0
8621706|NCT02255461|21275690|P5|COMPLETED|Overall Study||8
8621707|NCT02255461|21275691|P4|COMPLETED|Overall Study||4
8621708|NCT02255461|21275692|P3|COMPLETED|Overall Study||5
8621709|NCT02255461|21275693|P2|COMPLETED|Overall Study||10
8621710|NCT02255461|21275694|P1|COMPLETED|Overall Study||3
8621711|NCT02255461|21275690|P5|STARTED|Overall Study||10
8621712|NCT02255461|21275691|P4|STARTED|Overall Study||4
8621713|NCT02255461|21275692|P3|STARTED|Overall Study||6
8621714|NCT02255461|21275693|P2|STARTED|Overall Study||12
8621715|NCT02255461|21275694|P1|STARTED|Overall Study||3
8621716|NCT02239263|21275766|P1|NOT COMPLETED|Overall Study||6
8621717|NCT02239263|21275766|P1|COMPLETED|Overall Study||34
8621718|NCT02239263|21275766|P1|STARTED|Overall Study||40
8621731|NCT02199743|21275905|P2|NOT COMPLETED|Overall Study||2
8621732|NCT02199743|21275906|P1|NOT COMPLETED|Overall Study||0
8621733|NCT02199743|21275905|P2|COMPLETED|Overall Study||8
8621734|NCT02199743|21275906|P1|COMPLETED|Overall Study||14
8621735|NCT02199743|21275905|P2|STARTED|Overall Study||10
8621736|NCT02199743|21275906|P1|STARTED|Overall Study||14
8621737|NCT02198794|21275914|P3|NOT COMPLETED|Part B: Randomized (13 Weeks)||3
8621738|NCT02198794|21275915|P2|NOT COMPLETED|Part B: Randomized (13 Weeks)||5
8621739|NCT02198794|21275916|P1|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
8621740|NCT02198794|21275914|P3|COMPLETED|Part B: Randomized (13 Weeks)||68
8621741|NCT02198794|21275915|P2|COMPLETED|Part B: Randomized (13 Weeks)||66
8621742|NCT02198794|21275916|P1|COMPLETED|Part B: Randomized (13 Weeks)||0
8621743|NCT02198794|21275914|P3|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||65
8621744|NCT02198794|21275915|P2|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||63
8621745|NCT02198794|21275916|P1|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
8621746|NCT02198794|21275914|P3|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
8621747|NCT02198794|21275915|P2|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
8621748|NCT02198794|21275916|P1|STARTED|Part B: Randomized (13 Weeks)||0
8621749|NCT02198794|21275914|P3|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
8621750|NCT02198794|21275915|P2|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
8621751|NCT02198794|21275916|P1|NOT COMPLETED|Part A: Open-Label (158 Weeks)||305
8621752|NCT02198794|21275914|P3|COMPLETED|Part A: Open-Label (158 Weeks)||0
8621753|NCT02198794|21275915|P2|COMPLETED|Part A: Open-Label (158 Weeks)||0
8621754|NCT02198794|21275916|P1|COMPLETED|Part A: Open-Label (158 Weeks)||32
8621755|NCT02198794|21275914|P3|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
8621756|NCT02198794|21275915|P2|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
8621757|NCT02198794|21275916|P1|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||142
8621758|NCT02198794|21275914|P3|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
8621759|NCT02198794|21275915|P2|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
8621760|NCT02198794|21275916|P1|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||195
8621761|NCT02198794|21275914|P3|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
8621762|NCT02198794|21275915|P2|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
8621763|NCT02198794|21275916|P1|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||337
8621764|NCT02198794|21275914|P3|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
8621765|NCT02198794|21275915|P2|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
8621766|NCT02198794|21275916|P1|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||337
8621767|NCT02198794|21275914|P3|STARTED|Part A: Open-Label (158 Weeks)||0
8621768|NCT02198794|21275915|P2|STARTED|Part A: Open-Label (158 Weeks)||0
8621769|NCT02198794|21275916|P1|STARTED|Part A: Open-Label (158 Weeks)||337
8621770|NCT02194439|21275932|P1|NOT COMPLETED|Overall Study||0
8621771|NCT02194439|21275932|P1|COMPLETED|Overall Study||415
8621772|NCT02194439|21275932|P1|STARTED|Overall Study||415
8621793|NCT02087046|21275970|P1|NOT COMPLETED|Overall Study||11
8621794|NCT02087046|21275970|P1|COMPLETED|Overall Study||116
8621795|NCT02087046|21275970|P1|Primary Endpoint|Overall Study||121
8621796|NCT02087046|21275970|P1|STARTED|Overall Study||127
8621800|NCT02081196|21276046|P1|NOT COMPLETED|Overall Study||1
8621801|NCT02081196|21276046|P1|COMPLETED|Overall Study|One (1) subject was lost to FU.|44
8621802|NCT02081196|21276046|P1|Untreated Control Flank|Overall Study||45
8621803|NCT02081196|21276046|P1|STARTED|Overall Study|Treatment on one flank. Contralateral flank was untreated control.|45
8621804|NCT02068547|21276057|P2|NOT COMPLETED|Overall Study||3
8621805|NCT02068547|21276058|P1|NOT COMPLETED|Overall Study||4
8621806|NCT02068547|21276057|P2|COMPLETED|Overall Study||1
8621807|NCT02068547|21276058|P1|COMPLETED|Overall Study||0
8621808|NCT02068547|21276057|P2|STARTED|Overall Study||4
8621809|NCT02068547|21276058|P1|STARTED|Overall Study||4
8621810|NCT02064855|21276068|P1|NOT COMPLETED|Overall Study||55
8621811|NCT02064855|21276068|P1|COMPLETED|Overall Study||53
8621812|NCT02064855|21276068|P1|STARTED|Overall Study||108
8621821|NCT01919606|21276152|P2|NOT COMPLETED|Overall Study||0
8621822|NCT01919606|21276153|P1|NOT COMPLETED|Overall Study||0
8621823|NCT01919606|21276152|P2|COMPLETED|Overall Study||0
8621824|NCT01919606|21276153|P1|COMPLETED|Overall Study||1
8621825|NCT01919606|21276152|P2|STARTED|Overall Study||0
8621826|NCT01919606|21276153|P1|STARTED|Overall Study||1
8621833|NCT01838317|21276174|P2|NOT COMPLETED|Overall Study||0
8621834|NCT01838317|21276175|P1|NOT COMPLETED|Overall Study||0
8621835|NCT01838317|21276174|P2|COMPLETED|Overall Study||5
8621836|NCT01838317|21276175|P1|COMPLETED|Overall Study||9
8621837|NCT01838317|21276174|P2|STARTED|Overall Study||5
8621838|NCT01838317|21276175|P1|STARTED|Overall Study||9
8621839|NCT01835470|21276199|P1|NOT COMPLETED|Long Term Treatment Period||4
8621840|NCT01835470|21276199|P1|COMPLETED|Long Term Treatment Period|Completed LT period|16
8621841|NCT01835470|21276199|P1|STARTED|Long Term Treatment Period||20
8621842|NCT01835470|21276199|P1|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
8621843|NCT01835470|21276199|P1|COMPLETED|Short Term Treatment Period (to Week 16)||20
8621844|NCT01835470|21276199|P1|STARTED|Short Term Treatment Period (to Week 16)||20
8621845|NCT01820754|21276209|P1|NOT COMPLETED|Overall Study||0
8621846|NCT01820754|21276209|P1|COMPLETED|Overall Study||24
8621847|NCT01820754|21276209|P1|STARTED|Overall Study||24
8621848|NCT01801930|21276221|P4|NOT COMPLETED|Overall Study||6
8621849|NCT01801930|21276222|P3|NOT COMPLETED|Overall Study||6
8621850|NCT01801930|21276223|P2|NOT COMPLETED|Overall Study||6
8621851|NCT01801930|21276224|P1|NOT COMPLETED|Overall Study||6
8621852|NCT01801930|21276221|P4|COMPLETED|Overall Study||0
8621853|NCT01801930|21276222|P3|COMPLETED|Overall Study||0
8621854|NCT01801930|21276223|P2|COMPLETED|Overall Study||0
8621855|NCT01801930|21276224|P1|COMPLETED|Overall Study||0
8621856|NCT01801930|21276221|P4|STARTED|Overall Study||6
8621857|NCT01801930|21276222|P3|STARTED|Overall Study||6
8621858|NCT01801930|21276223|P2|STARTED|Overall Study||6
8621859|NCT01801930|21276224|P1|STARTED|Overall Study||6
8621860|NCT01783444|21276245|P3|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||91
8621861|NCT01783444|21276246|P2|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||93
8621862|NCT01783444|21276247|P1|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||96
8621863|NCT01783444|21276245|P3|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8621864|NCT01783444|21276246|P2|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8621865|NCT01783444|21276247|P1|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
8621866|NCT01783444|21276245|P3|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|91
8621867|NCT01783444|21276246|P2|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|93
8621868|NCT01783444|21276247|P1|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|96
8621869|NCT01783444|21276245|P3|NOT COMPLETED|Treatment Phase||102
8621870|NCT01783444|21276246|P2|NOT COMPLETED|Treatment Phase||103
8621871|NCT01783444|21276247|P1|NOT COMPLETED|Treatment Phase||104
8621872|NCT01783444|21276245|P3|COMPLETED|Treatment Phase||0
8621873|NCT01783444|21276246|P2|COMPLETED|Treatment Phase||0
8621874|NCT01783444|21276247|P1|COMPLETED|Treatment Phase||0
8621875|NCT01783444|21276245|P3|Safety Set|Treatment Phase||102
8621876|NCT01783444|21276246|P2|Safety Set|Treatment Phase||103
8621877|NCT01783444|21276247|P1|Safety Set|Treatment Phase||104
8621878|NCT01783444|21276245|P3|STARTED|Treatment Phase||102
8621879|NCT01783444|21276246|P2|STARTED|Treatment Phase||103
8621880|NCT01783444|21276247|P1|STARTED|Treatment Phase||104
8621881|NCT01746225|21276280|P3|NOT COMPLETED|Overall Study||43
8621882|NCT01746225|21276281|P2|NOT COMPLETED|Overall Study||46
8621883|NCT01746225|21276282|P1|NOT COMPLETED|Overall Study||40
8621884|NCT01746225|21276280|P3|COMPLETED|Overall Study||43
8621885|NCT01746225|21276281|P2|COMPLETED|Overall Study||40
8621886|NCT01746225|21276282|P1|COMPLETED|Overall Study||43
8621887|NCT01746225|21276280|P3|STARTED|Overall Study||86
8621888|NCT01746225|21276281|P2|STARTED|Overall Study||86
8621889|NCT01746225|21276282|P1|STARTED|Overall Study||83
8621890|NCT01743976|21276307|P2|NOT COMPLETED|Overall Study||0
8621891|NCT01743976|21276308|P1|NOT COMPLETED|Overall Study||0
8621892|NCT01743976|21276307|P2|COMPLETED|Overall Study||3
8621893|NCT01743976|21276308|P1|COMPLETED|Overall Study||2
8621894|NCT01743976|21276307|P2|STARTED|Overall Study||3
8621895|NCT01743976|21276308|P1|STARTED|Overall Study||2
8621896|NCT01716195|21276322|P1|NOT COMPLETED|Overall Study||1
8621897|NCT01716195|21276322|P1|COMPLETED|Overall Study||17
8621898|NCT01716195|21276322|P1|STARTED|Overall Study||18
8621899|NCT01714817|21276330|P2|NOT COMPLETED|Long-Term Extension (LTE) Period||70
8621900|NCT01714817|21276331|P1|NOT COMPLETED|Long-Term Extension (LTE) Period||67
8621901|NCT01714817|21276330|P2|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|53
8621902|NCT01714817|21276331|P1|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|62
8621903|NCT01714817|21276330|P2|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|123
8621904|NCT01714817|21276331|P1|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|129
8621905|NCT01714817|21276330|P2|NOT COMPLETED|Year 2 Period||38
8621906|NCT01714817|21276331|P1|NOT COMPLETED|Year 2 Period||26
8621907|NCT01714817|21276330|P2|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|123
8621908|NCT01714817|21276331|P1|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|129
8621909|NCT01714817|21276330|P2|STARTED|Year 2 Period|Started = Completed Year 1|161
8621910|NCT01714817|21276331|P1|STARTED|Year 2 Period|Started = Completed Year 1|155
8621911|NCT01714817|21276330|P2|NOT COMPLETED|Year 1 Period||42
8621912|NCT01714817|21276331|P1|NOT COMPLETED|Year 1 Period||48
8621913|NCT01714817|21276330|P2|COMPLETED|Year 1 Period|Completed = continued study through Year 1|161
8621914|NCT01714817|21276331|P1|COMPLETED|Year 1 Period|Completed = continued study through Year 1|155
8621915|NCT01714817|21276330|P2|Treated|Year 1 Period||203
8621916|NCT01714817|21276331|P1|Treated|Year 1 Period||202
8621917|NCT01714817|21276330|P2|STARTED|Year 1 Period||203
8621918|NCT01714817|21276331|P1|STARTED|Year 1 Period||203
8621919|NCT01653847|21276427|P2|NOT COMPLETED|Overall Study||0
8621920|NCT01653847|21276428|P1|NOT COMPLETED|Overall Study||1
8621921|NCT01653847|21276427|P2|COMPLETED|Overall Study||20
8621922|NCT01653847|21276428|P1|COMPLETED|Overall Study||19
8621923|NCT01653847|21276427|P2|STARTED|Overall Study||20
8621924|NCT01653847|21276428|P1|STARTED|Overall Study||20
8621925|NCT01641380|21276444|P2|NOT COMPLETED|Third Injection Cycle||5
8621926|NCT01641380|21276445|P1|NOT COMPLETED|Third Injection Cycle||3
8621927|NCT01641380|21276444|P2|COMPLETED|Third Injection Cycle||33
8621928|NCT01641380|21276445|P1|COMPLETED|Third Injection Cycle||36
8621929|NCT01641380|21276444|P2|STARTED|Third Injection Cycle||38
8621930|NCT01641380|21276445|P1|STARTED|Third Injection Cycle||39
8621931|NCT01641380|21276444|P2|NOT COMPLETED|Second Injection Cycle||6
8621932|NCT01641380|21276445|P1|NOT COMPLETED|Second Injection Cycle||4
8621933|NCT01641380|21276444|P2|COMPLETED|Second Injection Cycle||38
8621934|NCT01641380|21276445|P1|COMPLETED|Second Injection Cycle||39
8621935|NCT01641380|21276444|P2|STARTED|Second Injection Cycle||44
8621936|NCT01641380|21276445|P1|STARTED|Second Injection Cycle||43
8621937|NCT01641380|21276444|P2|NOT COMPLETED|First Injection Cycle||6
8621938|NCT01641380|21276445|P1|NOT COMPLETED|First Injection Cycle||7
8621939|NCT01641380|21276444|P2|COMPLETED|First Injection Cycle||44
8621940|NCT01641380|21276445|P1|COMPLETED|First Injection Cycle||43
8621941|NCT01641380|21276444|P2|STARTED|First Injection Cycle||50
8621942|NCT01641380|21276445|P1|STARTED|First Injection Cycle||50
8621943|NCT01641133|21276459|P3|NOT COMPLETED|Overall Study||8
8621944|NCT01641133|21276460|P2|NOT COMPLETED|Overall Study||9
8621945|NCT01641133|21276461|P1|NOT COMPLETED|Overall Study||10
8621946|NCT01641133|21276459|P3|COMPLETED|Overall Study||90
8621947|NCT01641133|21276460|P2|COMPLETED|Overall Study||90
8621948|NCT01641133|21276461|P1|COMPLETED|Overall Study||87
8621949|NCT01641133|21276459|P3|STARTED|Overall Study||98
8621950|NCT01641133|21276460|P2|STARTED|Overall Study||99
8621951|NCT01641133|21276461|P1|STARTED|Overall Study||97
8621952|NCT01605071|21276504|P2|NOT COMPLETED|Overall Study||2
8621953|NCT01605071|21276505|P1|NOT COMPLETED|Overall Study||3
8621954|NCT01605071|21276504|P2|COMPLETED|Overall Study||24
8621955|NCT01605071|21276505|P1|COMPLETED|Overall Study||24
8621956|NCT01605071|21276504|P2|STARTED|Overall Study||26
8621957|NCT01605071|21276505|P1|STARTED|Overall Study||27
8621958|NCT01475370|21276522|P3|NOT COMPLETED|Overall Study||3
8621959|NCT01475370|21276523|P2|NOT COMPLETED|Overall Study||3
8621960|NCT01475370|21276524|P1|NOT COMPLETED|Overall Study||3
8621961|NCT01475370|21276522|P3|COMPLETED|Overall Study||0
8621962|NCT01475370|21276523|P2|COMPLETED|Overall Study||0
8621963|NCT01475370|21276524|P1|COMPLETED|Overall Study||0
8621964|NCT01475370|21276522|P3|STARTED|Overall Study||3
8621965|NCT01475370|21276523|P2|STARTED|Overall Study||3
8621966|NCT01475370|21276524|P1|STARTED|Overall Study||3
8621967|NCT01402284|21276532|P1|NOT COMPLETED|Overall Study||14
8621968|NCT01402284|21276532|P1|COMPLETED|Overall Study||31
8621969|NCT01402284|21276532|P1|STARTED|Overall Study||45
8621970|NCT01401582|21276545|P2|NOT COMPLETED|Overall Study||117
8621971|NCT01401582|21276546|P1|NOT COMPLETED|Overall Study||110
8621972|NCT01401582|21276545|P2|COMPLETED|Overall Study||291
8621973|NCT01401582|21276546|P1|COMPLETED|Overall Study||116
8621974|NCT01401582|21276545|P2|Baseline Completed|Overall Study||348
8621975|NCT01401582|21276546|P1|Baseline Completed|Overall Study||168
8621976|NCT01401582|21276545|P2|STARTED|Overall Study||408
8621977|NCT01401582|21276546|P1|STARTED|Overall Study||226
8621978|NCT01311024|21276564|P2|NOT COMPLETED|Overall Study||22
8621979|NCT01311024|21276565|P1|NOT COMPLETED|Overall Study||35
8621980|NCT01311024|21276564|P2|COMPLETED|Overall Study||789
8621981|NCT01311024|21276565|P1|COMPLETED|Overall Study||1495
8621982|NCT01311024|21276564|P2|STARTED|Overall Study||811
8621983|NCT01311024|21276565|P1|STARTED|Overall Study||1530
8621984|NCT01209624|21276571|P1|NOT COMPLETED|Overall Study||326
8621985|NCT01209624|21276571|P1|COMPLETED|Overall Study||576
8621986|NCT01209624|21276571|P1|Per Protocol Population|Overall Study||469
8621987|NCT01209624|21276571|P1|STARTED|Overall Study||902
8621988|NCT01206608|21276604|P2|NOT COMPLETED|Overall Study||0
8621989|NCT01206608|21276605|P1|NOT COMPLETED|Overall Study||0
8621990|NCT01206608|21276604|P2|COMPLETED|Overall Study||20
8621991|NCT01206608|21276605|P1|COMPLETED|Overall Study||20
8621992|NCT01206608|21276604|P2|STARTED|Overall Study||20
8621993|NCT01206608|21276605|P1|STARTED|Overall Study||20
8621994|NCT01174030|21276616|P5|NOT COMPLETED|Overall Study||1
8621995|NCT01174030|21276617|P4|NOT COMPLETED|Overall Study||2
8621996|NCT01174030|21276618|P3|NOT COMPLETED|Overall Study||2
8621997|NCT01174030|21276619|P2|NOT COMPLETED|Overall Study||2
8621998|NCT01174030|21276620|P1|NOT COMPLETED|Overall Study||2
8621999|NCT01174030|21276616|P5|COMPLETED|Overall Study||52
8622000|NCT01174030|21276617|P4|COMPLETED|Overall Study||53
8622001|NCT01174030|21276618|P3|COMPLETED|Overall Study||52
8622002|NCT01174030|21276619|P2|COMPLETED|Overall Study||52
8622003|NCT01174030|21276620|P1|COMPLETED|Overall Study||51
8622004|NCT01174030|21276616|P5|STARTED|Overall Study||53
8622005|NCT01174030|21276617|P4|STARTED|Overall Study||55
8622006|NCT01174030|21276618|P3|STARTED|Overall Study||54
8622007|NCT01174030|21276619|P2|STARTED|Overall Study||54
8622008|NCT01174030|21276620|P1|STARTED|Overall Study||53
8622009|NCT01171898|21276646|P4|NOT COMPLETED|Overall Study||6
8622010|NCT01171898|21276647|P3|NOT COMPLETED|Overall Study||12
8622011|NCT01171898|21276648|P2|NOT COMPLETED|Overall Study||19
8622012|NCT01171898|21276649|P1|NOT COMPLETED|Overall Study||4
8622013|NCT01171898|21276646|P4|COMPLETED|Overall Study||15
8622014|NCT01171898|21276647|P3|COMPLETED|Overall Study||13
8622015|NCT01171898|21276648|P2|COMPLETED|Overall Study||32
8622016|NCT01171898|21276649|P1|COMPLETED|Overall Study||26
8622017|NCT01171898|21276646|P4|STARTED|Overall Study||21
8622018|NCT01171898|21276647|P3|STARTED|Overall Study||25
8622019|NCT01171898|21276648|P2|STARTED|Overall Study||51
8622020|NCT01171898|21276649|P1|STARTED|Overall Study||30
8622021|NCT01136811|21276671|P1|NOT COMPLETED|Overall Study||11
8622022|NCT01136811|21276671|P1|COMPLETED|Overall Study||0
8622023|NCT01136811|21276671|P1|STARTED|Overall Study||11
8622024|NCT01129024|21276678|P1|NOT COMPLETED|Overall Study||19
8622025|NCT01129024|21276678|P1|COMPLETED|Overall Study||0
8622026|NCT01129024|21276678|P1|STARTED|Overall Study||19
8622063|NCT01051661|21276722|P6|NOT COMPLETED|Overall Study||67
8622064|NCT01051661|21276723|P5|NOT COMPLETED|Overall Study||35
8622065|NCT01051661|21276724|P4|NOT COMPLETED|Overall Study||56
8622066|NCT01051661|21276725|P3|NOT COMPLETED|Overall Study||39
8622067|NCT01051661|21276726|P2|NOT COMPLETED|Overall Study||63
8622068|NCT01051661|21276727|P1|NOT COMPLETED|Overall Study||34
8622069|NCT01051661|21276722|P6|COMPLETED|Overall Study||1369
8622070|NCT01051661|21276723|P5|COMPLETED|Overall Study||578
8622071|NCT01051661|21276724|P4|COMPLETED|Overall Study||1380
8622072|NCT01051661|21276725|P3|COMPLETED|Overall Study||573
8622073|NCT01051661|21276726|P2|COMPLETED|Overall Study||1375
8622074|NCT01051661|21276727|P1|COMPLETED|Overall Study||576
8622075|NCT01051661|21276722|P6|STARTED|Overall Study||1436
8622076|NCT01051661|21276723|P5|STARTED|Overall Study||613
8622077|NCT01051661|21276724|P4|STARTED|Overall Study||1436
8622078|NCT01051661|21276725|P3|STARTED|Overall Study||612
8622079|NCT01051661|21276726|P2|STARTED|Overall Study||1438
8622080|NCT01051661|21276727|P1|STARTED|Overall Study||610
8622081|NCT00981474|21276908|P2|NOT COMPLETED|Overall Study||0
8622082|NCT00981474|21276909|P1|NOT COMPLETED|Overall Study||0
8622083|NCT00981474|21276908|P2|COMPLETED|Overall Study||232
8622084|NCT00981474|21276909|P1|COMPLETED|Overall Study||228
8622085|NCT00981474|21276908|P2|STARTED|Overall Study||232
8622086|NCT00981474|21276909|P1|STARTED|Overall Study||228
8622087|NCT00955682|21276937|P2|NOT COMPLETED|Year 5 Period||0
8622088|NCT00955682|21276938|P1|NOT COMPLETED|Year 5 Period||0
8622089|NCT00955682|21276937|P2|COMPLETED|Year 5 Period||47
8622090|NCT00955682|21276938|P1|COMPLETED|Year 5 Period||239
8622091|NCT00955682|21276937|P2|STARTED|Year 5 Period||47
8622092|NCT00955682|21276938|P1|STARTED|Year 5 Period||239
8622093|NCT00955682|21276937|P2|NOT COMPLETED|Booster Period (Month 48- 49)||1
8622094|NCT00955682|21276938|P1|NOT COMPLETED|Booster Period (Month 48- 49)||1
8622095|NCT00955682|21276937|P2|COMPLETED|Booster Period (Month 48- 49)||47
8622096|NCT00955682|21276938|P1|COMPLETED|Booster Period (Month 48- 49)||244
8622097|NCT00955682|21276937|P2|STARTED|Booster Period (Month 48- 49)||48
8622098|NCT00955682|21276938|P1|STARTED|Booster Period (Month 48- 49)||245
8622099|NCT00955682|21276937|P2|NOT COMPLETED|Year 4 Period||0
8622100|NCT00955682|21276938|P1|NOT COMPLETED|Year 4 Period||0
8622101|NCT00955682|21276937|P2|COMPLETED|Year 4 Period||48
8622102|NCT00955682|21276938|P1|COMPLETED|Year 4 Period||246
8622103|NCT00955682|21276937|P2|STARTED|Year 4 Period||48
8622104|NCT00955682|21276938|P1|STARTED|Year 4 Period||246
8622105|NCT00955682|21276937|P2|NOT COMPLETED|Year 3 Period||0
8622106|NCT00955682|21276938|P1|NOT COMPLETED|Year 3 Period||0
8622107|NCT00955682|21276937|P2|COMPLETED|Year 3 Period||47
8622108|NCT00955682|21276938|P1|COMPLETED|Year 3 Period||273
8622109|NCT00955682|21276937|P2|STARTED|Year 3 Period||47
8622110|NCT00955682|21276938|P1|STARTED|Year 3 Period||273
8622111|NCT00955682|21276937|P2|NOT COMPLETED|Year 2 Period||0
8622112|NCT00955682|21276938|P1|NOT COMPLETED|Year 2 Period||0
8622113|NCT00955682|21276937|P2|COMPLETED|Year 2 Period||42
8622114|NCT00955682|21276938|P1|COMPLETED|Year 2 Period||253
8622115|NCT00955682|21276937|P2|STARTED|Year 2 Period||42
8622116|NCT00955682|21276938|P1|STARTED|Year 2 Period||253
8622117|NCT00864097|21277048|P4|NOT COMPLETED|Overall Study||125
8622118|NCT00864097|21277049|P3|NOT COMPLETED|Overall Study||132
8622119|NCT00864097|21277050|P2|NOT COMPLETED|Overall Study||137
8622120|NCT00864097|21277051|P1|NOT COMPLETED|Overall Study||139
8622121|NCT00864097|21277048|P4|COMPLETED|Overall Study||20
8622122|NCT00864097|21277049|P3|COMPLETED|Overall Study||19
8622123|NCT00864097|21277050|P2|COMPLETED|Overall Study||20
8622124|NCT00864097|21277051|P1|COMPLETED|Overall Study||15
8622125|NCT00864097|21277048|P4|Treated|Overall Study||145
8622126|NCT00864097|21277049|P3|Treated|Overall Study||150
8622127|NCT00864097|21277050|P2|Treated|Overall Study||157
8622128|NCT00864097|21277051|P1|Treated|Overall Study||152
8622129|NCT00864097|21277048|P4|STARTED|Overall Study||145
8622130|NCT00864097|21277049|P3|STARTED|Overall Study||151
8622131|NCT00864097|21277050|P2|STARTED|Overall Study||157
8622132|NCT00864097|21277051|P1|STARTED|Overall Study||154
8622136|NCT00846742|21277164|P1|NOT COMPLETED|Overall Study||1
8622137|NCT00846742|21277164|P1|COMPLETED|Overall Study||84
8622138|NCT00846742|21277164|P1|Without Radiation Therapy (RT)|Overall Study||68
8622139|NCT00846742|21277164|P1|With Radiation Therapy (RT)|Overall Study||17
8622140|NCT00846742|21277164|P1|STARTED|Overall Study||85
8622141|NCT00746603|21277170|P1|NOT COMPLETED|Overall Study||0
8622142|NCT00746603|21277170|P1|COMPLETED|Overall Study||3
8622143|NCT00746603|21277170|P1|STARTED|Overall Study||3
8622144|NCT00744471|21277180|P4|NOT COMPLETED|Overall Study||148
8622145|NCT00744471|21277181|P3|NOT COMPLETED|Overall Study||152
8622146|NCT00744471|21277182|P2|NOT COMPLETED|Overall Study||145
8622147|NCT00744471|21277183|P1|NOT COMPLETED|Overall Study||143
8622148|NCT00744471|21277180|P4|COMPLETED|Overall Study||9
8622149|NCT00744471|21277181|P3|COMPLETED|Overall Study||6
8622150|NCT00744471|21277182|P2|COMPLETED|Overall Study||11
8622151|NCT00744471|21277183|P1|COMPLETED|Overall Study||13
8622152|NCT00744471|21277180|P4|Treated|Overall Study||157
8622153|NCT00744471|21277181|P3|Treated|Overall Study||154
8622154|NCT00744471|21277182|P2|Treated|Overall Study||155
8622155|NCT00744471|21277183|P1|Treated|Overall Study||155
8622156|NCT00744471|21277180|P4|STARTED|Overall Study||157
8622157|NCT00744471|21277181|P3|STARTED|Overall Study||158
8622158|NCT00744471|21277182|P2|STARTED|Overall Study||156
8622159|NCT00744471|21277183|P1|STARTED|Overall Study||156
8622160|NCT00688181|21277309|P1|NOT COMPLETED|Overall Study||23
8622161|NCT00688181|21277309|P1|COMPLETED|Overall Study||13
8622162|NCT00688181|21277309|P1|STARTED|Overall Study||36
8622212|NCT00486252|21277502|P1|NOT COMPLETED|Overall Study||58
8622213|NCT00486252|21277502|P1|COMPLETED|Overall Study||938
8622214|NCT00486252|21277502|P1|STARTED|Overall Study||996
8622215|NCT00485433|21277521|P4|NOT COMPLETED|Overall Study||0
8622216|NCT00485433|21277522|P3|NOT COMPLETED|Overall Study||0
8622217|NCT00485433|21277523|P2|NOT COMPLETED|Overall Study||0
8622218|NCT00485433|21277524|P1|NOT COMPLETED|Overall Study||0
8622219|NCT00485433|21277521|P4|COMPLETED|Overall Study||25
8622220|NCT00485433|21277522|P3|COMPLETED|Overall Study||24
8622221|NCT00485433|21277523|P2|COMPLETED|Overall Study||25
8622222|NCT00485433|21277524|P1|COMPLETED|Overall Study||24
8622223|NCT00485433|21277521|P4|STARTED|Overall Study||25
8622224|NCT00485433|21277522|P3|STARTED|Overall Study||24
8622225|NCT00485433|21277523|P2|STARTED|Overall Study||25
8622226|NCT00485433|21277524|P1|STARTED|Overall Study||24
8622227|NCT00427193|21277534|P2|NOT COMPLETED|Overall Study||4
8622228|NCT00427193|21277535|P1|NOT COMPLETED|Overall Study||26
8622229|NCT00427193|21277534|P2|COMPLETED|Overall Study||71
8622230|NCT00427193|21277535|P1|COMPLETED|Overall Study||117
8622231|NCT00427193|21277534|P2|STARTED|Overall Study||75
8622232|NCT00427193|21277535|P1|STARTED|Overall Study||143
8622236|NCT00376948|21277562|P1|NOT COMPLETED|Overall Study||0
8622237|NCT00376948|21277562|P1|COMPLETED|Overall Study||20
8622238|NCT00376948|21277562|P1|STARTED|Overall Study||20
8622242|NCT00306202|21277845|P3|NOT COMPLETED|Overall Study||0
8622243|NCT00306202|21277846|P2|NOT COMPLETED|Overall Study||0
8622244|NCT00306202|21277847|P1|NOT COMPLETED|Overall Study||0
8622245|NCT00306202|21277845|P3|COMPLETED|Overall Study|Completed = Off-treatment|24
8622246|NCT00306202|21277846|P2|COMPLETED|Overall Study|Completed = Off-treatment|17
8622247|NCT00306202|21277847|P1|COMPLETED|Overall Study|Completed = Off-treatment|17
8622248|NCT00306202|21277845|P3|STARTED|Overall Study|Started = Treated. 25 were enrolled; 1 no longer met study criteria and was never treated|24
8622249|NCT00306202|21277846|P2|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
8622250|NCT00306202|21277847|P1|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
8622251|NCT00112827|21278008|P5|NOT COMPLETED|Overall Study||0
8622252|NCT00112827|21278009|P4|NOT COMPLETED|Overall Study||0
8622253|NCT00112827|21278010|P3|NOT COMPLETED|Overall Study||0
8622254|NCT00112827|21278011|P2|NOT COMPLETED|Overall Study||0
8622255|NCT00112827|21278012|P1|NOT COMPLETED|Overall Study||0
8622256|NCT00112827|21278008|P5|COMPLETED|Overall Study||7
8622257|NCT00112827|21278009|P4|COMPLETED|Overall Study||36
8622258|NCT00112827|21278010|P3|COMPLETED|Overall Study||4
8622259|NCT00112827|21278011|P2|COMPLETED|Overall Study||4
8622260|NCT00112827|21278012|P1|COMPLETED|Overall Study||3
8622261|NCT00112827|21278008|P5|STARTED|Overall Study||7
8622262|NCT00112827|21278009|P4|STARTED|Overall Study||36
8622263|NCT00112827|21278010|P3|STARTED|Overall Study||4
8622264|NCT00112827|21278011|P2|STARTED|Overall Study||4
8622265|NCT00112827|21278012|P1|STARTED|Overall Study||3
8622266|NCT00069238|21278026|P3|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
8622267|NCT00069238|21278027|P2|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8622268|NCT00069238|21278028|P1|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8622269|NCT00069238|21278026|P3|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
8622270|NCT00069238|21278027|P2|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8622271|NCT00069238|21278028|P1|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8622272|NCT00069238|21278026|P3|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
8622273|NCT00069238|21278027|P2|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8622274|NCT00069238|21278028|P1|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
8622275|NCT00069238|21278026|P3|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8622276|NCT00069238|21278027|P2|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
8622277|NCT00069238|21278028|P1|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8622278|NCT00069238|21278026|P3|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8622279|NCT00069238|21278027|P2|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
8622280|NCT00069238|21278028|P1|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8622281|NCT00069238|21278026|P3|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8622282|NCT00069238|21278027|P2|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
8622283|NCT00069238|21278028|P1|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
8622284|NCT00069238|21278026|P3|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8622285|NCT00069238|21278027|P2|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8622286|NCT00069238|21278028|P1|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
8622287|NCT00069238|21278026|P3|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8622288|NCT00069238|21278027|P2|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8622289|NCT00069238|21278028|P1|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
8622290|NCT00069238|21278026|P3|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8622291|NCT00069238|21278027|P2|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
8622292|NCT00069238|21278028|P1|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
8622293|NCT00038727|21278037|P3|NOT COMPLETED|Overall Study||0
8622294|NCT00038727|21278038|P2|NOT COMPLETED|Overall Study||0
8622295|NCT00038727|21278039|P1|NOT COMPLETED|Overall Study||0
8622296|NCT00038727|21278037|P3|COMPLETED|Overall Study||936
8622297|NCT00038727|21278038|P2|COMPLETED|Overall Study||927
8622298|NCT00038727|21278039|P1|COMPLETED|Overall Study||916
8622299|NCT00038727|21278037|P3|DPPOS Phase 3 Enrolled|Overall Study||936
8622300|NCT00038727|21278038|P2|DPPOS Phase 3 Enrolled|Overall Study||927
8622301|NCT00038727|21278039|P1|DPPOS Phase 3 Enrolled|Overall Study||916
8622302|NCT00038727|21278037|P3|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
8622303|NCT00038727|21278038|P2|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
8622304|NCT00038727|21278039|P1|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
8622305|NCT00038727|21278037|P3|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
8622306|NCT00038727|21278038|P2|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
8622307|NCT00038727|21278039|P1|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
8622308|NCT00038727|21278037|P3|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
8622309|NCT00038727|21278038|P2|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
8622310|NCT00038727|21278039|P1|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
8622311|NCT00038727|21278037|P3|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
8622312|NCT00038727|21278038|P2|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
8622313|NCT00038727|21278039|P1|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
8622314|NCT04693078|21278053|P1|NOT COMPLETED|Overall Study||0
8622315|NCT04693078|21278053|P1|COMPLETED|Overall Study||100
8622316|NCT04693078|21278053|P1|STARTED|Overall Study||100
8622323|NCT04263142|21278071|P5|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
8622324|NCT04263142|21278072|P4|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
8622325|NCT04263142|21278073|P3|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
8622326|NCT04263142|21278074|P2|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
8622327|NCT04263142|21278075|P1|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
8622328|NCT04263142|21278071|P5|COMPLETED|Part 2 Period 3 (Up to Day 5)||5
8622329|NCT04263142|21278072|P4|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
8622330|NCT04263142|21278073|P3|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
8622331|NCT04263142|21278074|P2|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
8622332|NCT04263142|21278075|P1|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
8622333|NCT04263142|21278071|P5|STARTED|Part 2 Period 3 (Up to Day 5)||5
8622334|NCT04263142|21278072|P4|STARTED|Part 2 Period 3 (Up to Day 5)||7
8622335|NCT04263142|21278073|P3|STARTED|Part 2 Period 3 (Up to Day 5)||7
8622336|NCT04263142|21278074|P2|STARTED|Part 2 Period 3 (Up to Day 5)||0
8622337|NCT04263142|21278075|P1|STARTED|Part 2 Period 3 (Up to Day 5)||0
8622338|NCT04263142|21278071|P5|NOT COMPLETED|Part 2 Period 2 (Day 1)||1
8622339|NCT04263142|21278072|P4|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
8622340|NCT04263142|21278073|P3|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
8622341|NCT04263142|21278074|P2|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
8622342|NCT04263142|21278075|P1|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
8622343|NCT04263142|21278071|P5|COMPLETED|Part 2 Period 2 (Day 1)||5
8622344|NCT04263142|21278072|P4|COMPLETED|Part 2 Period 2 (Day 1)||7
8622345|NCT04263142|21278073|P3|COMPLETED|Part 2 Period 2 (Day 1)||7
8622346|NCT04263142|21278074|P2|COMPLETED|Part 2 Period 2 (Day 1)||0
8622347|NCT04263142|21278075|P1|COMPLETED|Part 2 Period 2 (Day 1)||0
8622348|NCT04263142|21278071|P5|STARTED|Part 2 Period 2 (Day 1)||6
8622349|NCT04263142|21278072|P4|STARTED|Part 2 Period 2 (Day 1)||7
8622350|NCT04263142|21278073|P3|STARTED|Part 2 Period 2 (Day 1)||7
8622351|NCT04263142|21278074|P2|STARTED|Part 2 Period 2 (Day 1)||0
8622352|NCT04263142|21278075|P1|STARTED|Part 2 Period 2 (Day 1)||0
8622353|NCT04263142|21278071|P5|NOT COMPLETED|Part 2 Period 1 (Day 1)||1
8622354|NCT04263142|21278072|P4|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
8622355|NCT04263142|21278073|P3|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
8622356|NCT04263142|21278074|P2|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
8622357|NCT04263142|21278075|P1|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
8622358|NCT04263142|21278071|P5|COMPLETED|Part 2 Period 1 (Day 1)||6
8622359|NCT04263142|21278072|P4|COMPLETED|Part 2 Period 1 (Day 1)||7
8622360|NCT04263142|21278073|P3|COMPLETED|Part 2 Period 1 (Day 1)||7
8622361|NCT04263142|21278074|P2|COMPLETED|Part 2 Period 1 (Day 1)||0
8622362|NCT04263142|21278075|P1|COMPLETED|Part 2 Period 1 (Day 1)||0
8622363|NCT04263142|21278071|P5|STARTED|Part 2 Period 1 (Day 1)||7
8622364|NCT04263142|21278072|P4|STARTED|Part 2 Period 1 (Day 1)||7
8622365|NCT04263142|21278073|P3|STARTED|Part 2 Period 1 (Day 1)||7
8622366|NCT04263142|21278074|P2|STARTED|Part 2 Period 1 (Day 1)||0
8622367|NCT04263142|21278075|P1|STARTED|Part 2 Period 1 (Day 1)||0
8622368|NCT04263142|21278071|P5|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
8622369|NCT04263142|21278072|P4|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
8622370|NCT04263142|21278073|P3|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
8622371|NCT04263142|21278074|P2|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
8622372|NCT04263142|21278075|P1|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
8622373|NCT04263142|21278071|P5|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
8622374|NCT04263142|21278072|P4|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
8622375|NCT04263142|21278073|P3|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
8622376|NCT04263142|21278074|P2|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
8622377|NCT04263142|21278075|P1|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
8622378|NCT04263142|21278071|P5|STARTED|Part 1 Period 2 (Up to Day 5)||0
8622379|NCT04263142|21278072|P4|STARTED|Part 1 Period 2 (Up to Day 5)||0
8622380|NCT04263142|21278073|P3|STARTED|Part 1 Period 2 (Up to Day 5)||0
8622381|NCT04263142|21278074|P2|STARTED|Part 1 Period 2 (Up to Day 5)||9
8622382|NCT04263142|21278075|P1|STARTED|Part 1 Period 2 (Up to Day 5)||9
8622383|NCT04263142|21278071|P5|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
8622384|NCT04263142|21278072|P4|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
8622385|NCT04263142|21278073|P3|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
8622386|NCT04263142|21278074|P2|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
8622387|NCT04263142|21278075|P1|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
8622388|NCT04263142|21278071|P5|COMPLETED|Part 1 Period 1 (Day 1)||0
8622389|NCT04263142|21278072|P4|COMPLETED|Part 1 Period 1 (Day 1)||0
8622390|NCT04263142|21278073|P3|COMPLETED|Part 1 Period 1 (Day 1)||0
8622391|NCT04263142|21278074|P2|COMPLETED|Part 1 Period 1 (Day 1)||9
8622392|NCT04263142|21278075|P1|COMPLETED|Part 1 Period 1 (Day 1)||9
8622393|NCT04263142|21278071|P5|STARTED|Part 1 Period 1 (Day 1)||0
8622394|NCT04263142|21278072|P4|STARTED|Part 1 Period 1 (Day 1)||0
8622395|NCT04263142|21278073|P3|STARTED|Part 1 Period 1 (Day 1)||0
8622396|NCT04263142|21278074|P2|STARTED|Part 1 Period 1 (Day 1)||9
8622397|NCT04263142|21278075|P1|STARTED|Part 1 Period 1 (Day 1)||9
8622398|NCT04011735|21278330|P3|NOT COMPLETED|Overall Study||1
8622399|NCT04011735|21278331|P2|NOT COMPLETED|Overall Study||1
8622400|NCT04011735|21278332|P1|NOT COMPLETED|Overall Study||1
8622401|NCT04011735|21278330|P3|COMPLETED|Overall Study||55
8622402|NCT04011735|21278331|P2|COMPLETED|Overall Study||70
8622403|NCT04011735|21278332|P1|COMPLETED|Overall Study||132
8622404|NCT04011735|21278330|P3|STARTED|Overall Study||56
8622405|NCT04011735|21278331|P2|STARTED|Overall Study||71
8622406|NCT04011735|21278332|P1|STARTED|Overall Study||133
8622407|NCT03990415|21278360|P3|NOT COMPLETED|Overall Study||0
8622408|NCT03990415|21278361|P2|NOT COMPLETED|Overall Study||2
8622409|NCT03990415|21278362|P1|NOT COMPLETED|Overall Study||4
8622410|NCT03990415|21278360|P3|COMPLETED|Overall Study||14
8622411|NCT03990415|21278361|P2|COMPLETED|Overall Study||17
8622412|NCT03990415|21278362|P1|COMPLETED|Overall Study||15
8622413|NCT03990415|21278360|P3|STARTED|Overall Study||14
8622414|NCT03990415|21278361|P2|STARTED|Overall Study||19
8622415|NCT03990415|21278362|P1|STARTED|Overall Study||19
8622419|NCT03638011|21278407|P2|NOT COMPLETED|Overall Study||0
8622420|NCT03638011|21278408|P1|NOT COMPLETED|Overall Study||0
8622421|NCT03638011|21278407|P2|COMPLETED|Overall Study||33
8622422|NCT03638011|21278408|P1|COMPLETED|Overall Study||38
8622423|NCT03638011|21278407|P2|STARTED|Overall Study||33
8622424|NCT03638011|21278408|P1|STARTED|Overall Study||38
8622425|NCT03619837|21278420|P1|NOT COMPLETED|Main Study||0
8622426|NCT03619837|21278420|P1|COMPLETED|Main Study||24
8622427|NCT03619837|21278420|P1|STARTED|Main Study||24
8622428|NCT03619837|21278420|P1|NOT COMPLETED|Screening||98
8622429|NCT03619837|21278420|P1|COMPLETED|Screening||24
8622430|NCT03619837|21278420|P1|STARTED|Screening||122
8622431|NCT03532048|21278428|P2|NOT COMPLETED|Overall Study||17
8622432|NCT03532048|21278429|P1|NOT COMPLETED|Overall Study||19
8622433|NCT03532048|21278428|P2|COMPLETED|Overall Study|50 individuals (13 fathers, 24 children & 13 mothers)|50
8622434|NCT03532048|21278429|P1|COMPLETED|Overall Study|49 individuals (14 fathers, 22 children, 13 mothers). 1 father only took part in interview|49
8622435|NCT03532048|21278428|P2|STARTED|Overall Study|67 individuals (17 fathers, 33 children & 17 mothers)|67
8622436|NCT03532048|21278429|P1|STARTED|Overall Study|68 individuals (19 fathers, 31 children & 18 mothers)|68
8622437|NCT03490981|21278445|P2|NOT COMPLETED|Overall Study||2
8622438|NCT03490981|21278446|P1|NOT COMPLETED|Overall Study||1
8622439|NCT03490981|21278445|P2|COMPLETED|Overall Study||13
8622440|NCT03490981|21278446|P1|COMPLETED|Overall Study||14
8622441|NCT03490981|21278445|P2|STARTED|Overall Study||15
8622442|NCT03490981|21278446|P1|STARTED|Overall Study||15
8622446|NCT03294213|21278470|P1|NOT COMPLETED|Overall Study||0
8622447|NCT03294213|21278470|P1|COMPLETED|Overall Study||176
8622448|NCT03294213|21278470|P1|STARTED|Overall Study||176
8622449|NCT03284359|21278476|P2|NOT COMPLETED|Overall Study||0
8622450|NCT03284359|21278477|P1|NOT COMPLETED|Overall Study||0
8622451|NCT03284359|21278476|P2|COMPLETED|Overall Study||89
8622452|NCT03284359|21278477|P1|COMPLETED|Overall Study||93
8622453|NCT03284359|21278476|P2|STARTED|Overall Study||89
8622454|NCT03284359|21278477|P1|STARTED|Overall Study||93
8622455|NCT03067311|21278487|P2|NOT COMPLETED|Overall Study||2
8622456|NCT03067311|21278488|P1|NOT COMPLETED|Overall Study||2
8622457|NCT03067311|21278487|P2|COMPLETED|Overall Study||17
8622458|NCT03067311|21278488|P1|COMPLETED|Overall Study||17
8622459|NCT03067311|21278487|P2|STARTED|Overall Study||19
8622460|NCT03067311|21278488|P1|STARTED|Overall Study||19
8622472|NCT03008590|21278560|P2|NOT COMPLETED|Overall Study||3
8622473|NCT03008590|21278561|P1|NOT COMPLETED|Overall Study||3
8622474|NCT03008590|21278560|P2|COMPLETED|Overall Study||12
8622475|NCT03008590|21278561|P1|COMPLETED|Overall Study||11
8622476|NCT03008590|21278560|P2|STARTED|Overall Study||15
8622477|NCT03008590|21278561|P1|STARTED|Overall Study||14
8622478|NCT02939131|21278589|P2|NOT COMPLETED|Overall Study||9
8622479|NCT02939131|21278590|P1|NOT COMPLETED|Overall Study||11
8622480|NCT02939131|21278589|P2|COMPLETED|Overall Study||66
8622481|NCT02939131|21278590|P1|COMPLETED|Overall Study||70
8622482|NCT02939131|21278589|P2|Week 24 Visit|Overall Study||72
8622483|NCT02939131|21278590|P1|Week 24 Visit|Overall Study|These are the numbers still on study at week 24|74
8622484|NCT02939131|21278589|P2|STARTED|Overall Study||75
8622485|NCT02939131|21278590|P1|STARTED|Overall Study|One additional site in the COMB-R group withdrew prior to the start of participant enrollment.|81
8622486|NCT02796144|21278687|P3|NOT COMPLETED|Overall Study||6
8622487|NCT02796144|21278688|P2|NOT COMPLETED|Overall Study||3
8622488|NCT02796144|21278689|P1|NOT COMPLETED|Overall Study||5
8622489|NCT02796144|21278687|P3|COMPLETED|Overall Study||18
8622490|NCT02796144|21278688|P2|COMPLETED|Overall Study||21
8622491|NCT02796144|21278689|P1|COMPLETED|Overall Study||18
8622492|NCT02796144|21278687|P3|STARTED|Overall Study||24
8622493|NCT02796144|21278688|P2|STARTED|Overall Study||24
8622494|NCT02796144|21278689|P1|STARTED|Overall Study||23
8622501|NCT02561156|21278770|P13|NOT COMPLETED|Part 2||0
8622502|NCT02561156|21278771|P12|NOT COMPLETED|Part 2||1
8622503|NCT02561156|21278772|P11|NOT COMPLETED|Part 2||0
8622504|NCT02561156|21278773|P10|NOT COMPLETED|Part 2||0
8622505|NCT02561156|21278774|P9|NOT COMPLETED|Part 2||0
8622506|NCT02561156|21278775|P8|NOT COMPLETED|Part 2||0
8622507|NCT02561156|21278776|P7|NOT COMPLETED|Part 2||0
8622508|NCT02561156|21278777|P6|NOT COMPLETED|Part 2||0
8622509|NCT02561156|21278778|P5|NOT COMPLETED|Part 2||0
8622510|NCT02561156|21278779|P4|NOT COMPLETED|Part 2||0
8622511|NCT02561156|21278780|P3|NOT COMPLETED|Part 2||0
8622512|NCT02561156|21278781|P2|NOT COMPLETED|Part 2||0
8622513|NCT02561156|21278782|P1|NOT COMPLETED|Part 2||0
8622514|NCT02561156|21278770|P13|COMPLETED|Part 2||6
8622515|NCT02561156|21278771|P12|COMPLETED|Part 2||5
8622516|NCT02561156|21278772|P11|COMPLETED|Part 2||6
8622517|NCT02561156|21278773|P10|COMPLETED|Part 2||6
8622518|NCT02561156|21278774|P9|COMPLETED|Part 2||6
8622519|NCT02561156|21278775|P8|COMPLETED|Part 2||10
8622520|NCT02561156|21278776|P7|COMPLETED|Part 2||0
8622521|NCT02561156|21278777|P6|COMPLETED|Part 2||0
8622522|NCT02561156|21278778|P5|COMPLETED|Part 2||0
8622523|NCT02561156|21278779|P4|COMPLETED|Part 2||0
8622524|NCT02561156|21278780|P3|COMPLETED|Part 2||0
8622525|NCT02561156|21278781|P2|COMPLETED|Part 2||0
8622526|NCT02561156|21278782|P1|COMPLETED|Part 2||0
8622527|NCT02561156|21278770|P13|STARTED|Part 2||6
8622528|NCT02561156|21278771|P12|STARTED|Part 2||6
8622529|NCT02561156|21278772|P11|STARTED|Part 2||6
8622530|NCT02561156|21278773|P10|STARTED|Part 2||6
8622531|NCT02561156|21278774|P9|STARTED|Part 2||6
8622532|NCT02561156|21278775|P8|STARTED|Part 2||10
8622533|NCT02561156|21278776|P7|STARTED|Part 2||0
8622534|NCT02561156|21278777|P6|STARTED|Part 2||0
8622535|NCT02561156|21278778|P5|STARTED|Part 2||0
8622536|NCT02561156|21278779|P4|STARTED|Part 2||0
8622537|NCT02561156|21278780|P3|STARTED|Part 2||0
8622538|NCT02561156|21278781|P2|STARTED|Part 2||0
8622539|NCT02561156|21278782|P1|STARTED|Part 2||0
8622540|NCT02561156|21278770|P13|NOT COMPLETED|Part 1||0
8622541|NCT02561156|21278771|P12|NOT COMPLETED|Part 1||0
8622542|NCT02561156|21278772|P11|NOT COMPLETED|Part 1||0
8622543|NCT02561156|21278773|P10|NOT COMPLETED|Part 1||0
8622544|NCT02561156|21278774|P9|NOT COMPLETED|Part 1||0
8622545|NCT02561156|21278775|P8|NOT COMPLETED|Part 1||0
8622546|NCT02561156|21278776|P7|NOT COMPLETED|Part 1||0
8622547|NCT02561156|21278777|P6|NOT COMPLETED|Part 1||0
8622548|NCT02561156|21278778|P5|NOT COMPLETED|Part 1||0
8622549|NCT02561156|21278779|P4|NOT COMPLETED|Part 1||0
8622550|NCT02561156|21278780|P3|NOT COMPLETED|Part 1||0
8622551|NCT02561156|21278781|P2|NOT COMPLETED|Part 1||0
8622552|NCT02561156|21278782|P1|NOT COMPLETED|Part 1||0
8622553|NCT02561156|21278770|P13|COMPLETED|Part 1||0
8622554|NCT02561156|21278771|P12|COMPLETED|Part 1||0
8622555|NCT02561156|21278772|P11|COMPLETED|Part 1||0
8622556|NCT02561156|21278773|P10|COMPLETED|Part 1||0
8622557|NCT02561156|21278774|P9|COMPLETED|Part 1||0
8622558|NCT02561156|21278775|P8|COMPLETED|Part 1||0
8622559|NCT02561156|21278776|P7|COMPLETED|Part 1||6
8622560|NCT02561156|21278777|P6|COMPLETED|Part 1||6
8622561|NCT02561156|21278778|P5|COMPLETED|Part 1||6
8622562|NCT02561156|21278779|P4|COMPLETED|Part 1||6
8622563|NCT02561156|21278780|P3|COMPLETED|Part 1||6
8622564|NCT02561156|21278781|P2|COMPLETED|Part 1||6
8622565|NCT02561156|21278782|P1|COMPLETED|Part 1||12
8622566|NCT02561156|21278770|P13|STARTED|Part 1||0
8622567|NCT02561156|21278771|P12|STARTED|Part 1||0
8622568|NCT02561156|21278772|P11|STARTED|Part 1||0
8622569|NCT02561156|21278773|P10|STARTED|Part 1||0
8622570|NCT02561156|21278774|P9|STARTED|Part 1||0
8622571|NCT02561156|21278775|P8|STARTED|Part 1||0
8622572|NCT02561156|21278776|P7|STARTED|Part 1||6
8622573|NCT02561156|21278777|P6|STARTED|Part 1||6
8622574|NCT02561156|21278778|P5|STARTED|Part 1||6
8622575|NCT02561156|21278779|P4|STARTED|Part 1||6
8622576|NCT02561156|21278780|P3|STARTED|Part 1||6
8622577|NCT02561156|21278781|P2|STARTED|Part 1||6
8622578|NCT02561156|21278782|P1|STARTED|Part 1||12
8622579|NCT02556255|21278952|P1|NOT COMPLETED|Overall Study||4
8622580|NCT02556255|21278952|P1|COMPLETED|Overall Study||46
8622581|NCT02556255|21278952|P1|STARTED|Overall Study||50
8622601|NCT02475850|21279040|P2|NOT COMPLETED|Overall Study||484
8622602|NCT02475850|21279041|P1|NOT COMPLETED|Overall Study||593
8622603|NCT02475850|21279040|P2|COMPLETED|Overall Study||2165
8622604|NCT02475850|21279041|P1|COMPLETED|Overall Study||2209
8622605|NCT02475850|21279040|P2|STARTED|Overall Study||2649
8622606|NCT02475850|21279041|P1|STARTED|Overall Study||2802
8622607|NCT02448537|21279064|P3|NOT COMPLETED|Overall Study||1
8622608|NCT02448537|21279065|P2|NOT COMPLETED|Overall Study||1
8622609|NCT02448537|21279066|P1|NOT COMPLETED|Overall Study||1
8622610|NCT02448537|21279064|P3|COMPLETED|Overall Study||11
8622611|NCT02448537|21279065|P2|COMPLETED|Overall Study||9
8622612|NCT02448537|21279066|P1|COMPLETED|Overall Study||19
8622613|NCT02448537|21279064|P3|STARTED|Overall Study||12
8622614|NCT02448537|21279065|P2|STARTED|Overall Study||10
8622615|NCT02448537|21279066|P1|STARTED|Overall Study||20
8622622|NCT02393339|21279095|P2|NOT COMPLETED|Overall Study||5
8622623|NCT02393339|21279096|P1|NOT COMPLETED|Overall Study||7
8622624|NCT02393339|21279095|P2|COMPLETED|Overall Study||51
8622625|NCT02393339|21279096|P1|COMPLETED|Overall Study||51
8622626|NCT02393339|21279095|P2|STARTED|Overall Study||56
8622627|NCT02393339|21279096|P1|STARTED|Overall Study||58
8622628|NCT02380287|21279110|P8|NOT COMPLETED|Overall Study||0
8622629|NCT02380287|21279111|P7|NOT COMPLETED|Overall Study||0
8622630|NCT02380287|21279112|P6|NOT COMPLETED|Overall Study||0
8622631|NCT02380287|21279113|P5|NOT COMPLETED|Overall Study||0
8622632|NCT02380287|21279114|P4|NOT COMPLETED|Overall Study||0
8622633|NCT02380287|21279115|P3|NOT COMPLETED|Overall Study||1
8622634|NCT02380287|21279116|P2|NOT COMPLETED|Overall Study||0
8622635|NCT02380287|21279117|P1|NOT COMPLETED|Overall Study||0
8622636|NCT02380287|21279110|P8|COMPLETED|Overall Study||3
8622637|NCT02380287|21279111|P7|COMPLETED|Overall Study||3
8622638|NCT02380287|21279112|P6|COMPLETED|Overall Study||3
8622639|NCT02380287|21279113|P5|COMPLETED|Overall Study||3
8622640|NCT02380287|21279114|P4|COMPLETED|Overall Study||3
8622641|NCT02380287|21279115|P3|COMPLETED|Overall Study||2
8622642|NCT02380287|21279116|P2|COMPLETED|Overall Study||3
8622643|NCT02380287|21279117|P1|COMPLETED|Overall Study||1
8622644|NCT02380287|21279110|P8|STARTED|Overall Study||3
8622645|NCT02380287|21279111|P7|STARTED|Overall Study||3
8622646|NCT02380287|21279112|P6|STARTED|Overall Study||3
8622647|NCT02380287|21279113|P5|STARTED|Overall Study||3
8622648|NCT02380287|21279114|P4|STARTED|Overall Study||3
8622649|NCT02380287|21279115|P3|STARTED|Overall Study||3
8622650|NCT02380287|21279116|P2|STARTED|Overall Study||3
8622651|NCT02380287|21279117|P1|STARTED|Overall Study||1
8622652|NCT02348684|21279217|P1|NOT COMPLETED|Overall Study||0
8622653|NCT02348684|21279217|P1|COMPLETED|Overall Study||20
8622654|NCT02348684|21279217|P1|STARTED|Overall Study||20
8622655|NCT02340156|21279221|P1|NOT COMPLETED|Overall Study||0
8622656|NCT02340156|21279221|P1|COMPLETED|Overall Study||1
8622657|NCT02340156|21279221|P1|STARTED|Overall Study||1
8622666|NCT02195232|21279262|P2|NOT COMPLETED|Overall Study||3
8622667|NCT02195232|21279263|P1|NOT COMPLETED|Overall Study||4
8622668|NCT02195232|21279262|P2|COMPLETED|Overall Study|Evaluated for VTE and safety|29
8622669|NCT02195232|21279263|P1|COMPLETED|Overall Study|Evaluated for VTE and safety|28
8622670|NCT02195232|21279262|P2|STARTED|Overall Study|patients consented|32
8622671|NCT02195232|21279263|P1|STARTED|Overall Study|patients consented|32
8622672|NCT02165397|21279276|P3|NOT COMPLETED|Overall Study||10
8622673|NCT02165397|21279277|P2|NOT COMPLETED|Overall Study||19
8622674|NCT02165397|21279278|P1|NOT COMPLETED|Overall Study||14
8622675|NCT02165397|21279276|P3|COMPLETED|Overall Study||21
8622676|NCT02165397|21279277|P2|COMPLETED|Overall Study||56
8622677|NCT02165397|21279278|P1|COMPLETED|Overall Study||61
8622678|NCT02165397|21279276|P3|STARTED|Overall Study||31
8622679|NCT02165397|21279277|P2|STARTED|Overall Study||75
8622680|NCT02165397|21279278|P1|STARTED|Overall Study||75
8622681|NCT01976728|21279305|P4|NOT COMPLETED|Overall Study||0
8622682|NCT01976728|21279306|P3|NOT COMPLETED|Overall Study||0
8622683|NCT01976728|21279307|P2|NOT COMPLETED|Overall Study||0
8622684|NCT01976728|21279308|P1|NOT COMPLETED|Overall Study||1
8622685|NCT01976728|21279305|P4|COMPLETED|Overall Study||10
8622686|NCT01976728|21279306|P3|COMPLETED|Overall Study||10
8622687|NCT01976728|21279307|P2|COMPLETED|Overall Study||9
8622688|NCT01976728|21279308|P1|COMPLETED|Overall Study||9
8622689|NCT01976728|21279305|P4|Dosed|Overall Study||10
8622690|NCT01976728|21279306|P3|Dosed|Overall Study||10
8622691|NCT01976728|21279307|P2|Dosed|Overall Study||9
8622692|NCT01976728|21279308|P1|Dosed|Overall Study||10
8622693|NCT01976728|21279305|P4|STARTED|Overall Study||10
8622694|NCT01976728|21279306|P3|STARTED|Overall Study||10
8622695|NCT01976728|21279307|P2|STARTED|Overall Study||9
8622696|NCT01976728|21279308|P1|STARTED|Overall Study||10
8622697|NCT01937884|21279385|P2|NOT COMPLETED|Overall Study||0
8622698|NCT01937884|21279386|P1|NOT COMPLETED|Overall Study||1
8622699|NCT01937884|21279385|P2|COMPLETED|Overall Study||11
8622700|NCT01937884|21279386|P1|COMPLETED|Overall Study||6
8622701|NCT01937884|21279385|P2|STARTED|Overall Study||11
8622702|NCT01937884|21279386|P1|STARTED|Overall Study||7
8622715|NCT01920152|21279442|P2|NOT COMPLETED|Overall Study||2
8622716|NCT01920152|21279443|P1|NOT COMPLETED|Overall Study||1
8622717|NCT01920152|21279442|P2|COMPLETED|Overall Study||13
8622718|NCT01920152|21279443|P1|COMPLETED|Overall Study||18
8622719|NCT01920152|21279442|P2|STARTED|Overall Study||15
8622720|NCT01920152|21279443|P1|STARTED|Overall Study||19
8622739|NCT01729754|21279535|P10|NOT COMPLETED|Part 3||7
8622740|NCT01729754|21279536|P9|NOT COMPLETED|Part 3||1
8622741|NCT01729754|21279537|P8|NOT COMPLETED|Part 3||3
8622742|NCT01729754|21279538|P7|NOT COMPLETED|Part 3||0
8622743|NCT01729754|21279539|P6|NOT COMPLETED|Part 3||13
8622744|NCT01729754|21279540|P5|NOT COMPLETED|Part 3||4
8622745|NCT01729754|21279541|P4|NOT COMPLETED|Part 3||0
8622746|NCT01729754|21279542|P3|NOT COMPLETED|Part 3||5
8622747|NCT01729754|21279543|P2|NOT COMPLETED|Part 3||5
8622748|NCT01729754|21279544|P1|NOT COMPLETED|Part 3||0
8622749|NCT01729754|21279535|P10|COMPLETED|Part 3||114
8622750|NCT01729754|21279536|P9|COMPLETED|Part 3||65
8622751|NCT01729754|21279537|P8|COMPLETED|Part 3||66
8622752|NCT01729754|21279538|P7|COMPLETED|Part 3||0
8622753|NCT01729754|21279539|P6|COMPLETED|Part 3||224
8622754|NCT01729754|21279540|P5|COMPLETED|Part 3||17
8622755|NCT01729754|21279541|P4|COMPLETED|Part 3||0
8622756|NCT01729754|21279542|P3|COMPLETED|Part 3||105
8622757|NCT01729754|21279543|P2|COMPLETED|Part 3||165
8622758|NCT01729754|21279544|P1|COMPLETED|Part 3||0
8622759|NCT01729754|21279535|P10|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
8622760|NCT01729754|21279536|P9|STARTED|Part 3||66
8622761|NCT01729754|21279537|P8|STARTED|Part 3||69
8622762|NCT01729754|21279538|P7|STARTED|Part 3||0
8622763|NCT01729754|21279539|P6|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
8622764|NCT01729754|21279540|P5|STARTED|Part 3||21
8622765|NCT01729754|21279541|P4|STARTED|Part 3||0
8622766|NCT01729754|21279542|P3|STARTED|Part 3||110
8622767|NCT01729754|21279543|P2|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
8622768|NCT01729754|21279544|P1|STARTED|Part 3||0
8622769|NCT01729754|21279535|P10|NOT COMPLETED|Part 2||12
8622770|NCT01729754|21279536|P9|NOT COMPLETED|Part 2||4
8622771|NCT01729754|21279537|P8|NOT COMPLETED|Part 2||3
8622772|NCT01729754|21279538|P7|NOT COMPLETED|Part 2||0
8622773|NCT01729754|21279539|P6|NOT COMPLETED|Part 2||0
8622774|NCT01729754|21279540|P5|NOT COMPLETED|Part 2||0
8622775|NCT01729754|21279541|P4|NOT COMPLETED|Part 2||5
8622776|NCT01729754|21279542|P3|NOT COMPLETED|Part 2||0
8622777|NCT01729754|21279543|P2|NOT COMPLETED|Part 2||0
8622778|NCT01729754|21279544|P1|NOT COMPLETED|Part 2||6
8622779|NCT01729754|21279535|P10|COMPLETED|Part 2||277
8622780|NCT01729754|21279536|P9|COMPLETED|Part 2||66
8622781|NCT01729754|21279537|P8|COMPLETED|Part 2||69
8622782|NCT01729754|21279538|P7|COMPLETED|Part 2||0
8622783|NCT01729754|21279539|P6|COMPLETED|Part 2||268
8622784|NCT01729754|21279540|P5|COMPLETED|Part 2||21
8622785|NCT01729754|21279541|P4|COMPLETED|Part 2||0
8622786|NCT01729754|21279542|P3|COMPLETED|Part 2||110
8622787|NCT01729754|21279543|P2|COMPLETED|Part 2||184
8622788|NCT01729754|21279544|P1|COMPLETED|Part 2||0
8622789|NCT01729754|21279535|P10|STARTED|Part 2||289
8622790|NCT01729754|21279536|P9|STARTED|Part 2||70
8622791|NCT01729754|21279537|P8|STARTED|Part 2||72
8622792|NCT01729754|21279538|P7|STARTED|Part 2||0
8622793|NCT01729754|21279539|P6|STARTED|Part 2||268
8622794|NCT01729754|21279540|P5|STARTED|Part 2||21
8622795|NCT01729754|21279541|P4|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
8622796|NCT01729754|21279542|P3|STARTED|Part 2||110
8622797|NCT01729754|21279543|P2|STARTED|Part 2||184
8622798|NCT01729754|21279544|P1|STARTED|Part 2||6
8622799|NCT01729754|21279535|P10|NOT COMPLETED|Part 1||24
8622800|NCT01729754|21279536|P9|NOT COMPLETED|Part 1||0
8622801|NCT01729754|21279537|P8|NOT COMPLETED|Part 1||0
8622802|NCT01729754|21279538|P7|NOT COMPLETED|Part 1||14
8622803|NCT01729754|21279539|P6|NOT COMPLETED|Part 1||0
8622804|NCT01729754|21279540|P5|NOT COMPLETED|Part 1||0
8622805|NCT01729754|21279541|P4|NOT COMPLETED|Part 1||12
8622806|NCT01729754|21279542|P3|NOT COMPLETED|Part 1||0
8622807|NCT01729754|21279543|P2|NOT COMPLETED|Part 1||0
8622808|NCT01729754|21279544|P1|NOT COMPLETED|Part 1||14
8622809|NCT01729754|21279535|P10|COMPLETED|Part 1||289
8622810|NCT01729754|21279536|P9|COMPLETED|Part 1||70
8622811|NCT01729754|21279537|P8|COMPLETED|Part 1||72
8622812|NCT01729754|21279538|P7|COMPLETED|Part 1||0
8622813|NCT01729754|21279539|P6|COMPLETED|Part 1||268
8622814|NCT01729754|21279540|P5|COMPLETED|Part 1||21
8622815|NCT01729754|21279541|P4|COMPLETED|Part 1||6
8622816|NCT01729754|21279542|P3|COMPLETED|Part 1||110
8622817|NCT01729754|21279543|P2|COMPLETED|Part 1||184
8622818|NCT01729754|21279544|P1|COMPLETED|Part 1||6
8622819|NCT01729754|21279535|P10|STARTED|Part 1||313
8622820|NCT01729754|21279536|P9|STARTED|Part 1||70
8622821|NCT01729754|21279537|P8|STARTED|Part 1||72
8622822|NCT01729754|21279538|P7|STARTED|Part 1||14
8622823|NCT01729754|21279539|P6|STARTED|Part 1||268
8622824|NCT01729754|21279540|P5|STARTED|Part 1||21
8622825|NCT01729754|21279541|P4|STARTED|Part 1||18
8622826|NCT01729754|21279542|P3|STARTED|Part 1||110
8622827|NCT01729754|21279543|P2|STARTED|Part 1||184
8622828|NCT01729754|21279544|P1|STARTED|Part 1||20
8622829|NCT01450540|21279750|P2|NOT COMPLETED|Overall Study||36
8622830|NCT01450540|21279751|P1|NOT COMPLETED|Overall Study||22
8622831|NCT01450540|21279750|P2|COMPLETED|Overall Study||82
8622832|NCT01450540|21279751|P1|COMPLETED|Overall Study||101
8622833|NCT01450540|21279750|P2|STARTED|Overall Study||118
8622834|NCT01450540|21279751|P1|STARTED|Overall Study||123
8622835|NCT01358877|21279763|P2|NOT COMPLETED|Overall Study||2404
8622836|NCT01358877|21279764|P1|NOT COMPLETED|Overall Study||2400
8622837|NCT01358877|21279763|P2|COMPLETED|Overall Study||0
8622838|NCT01358877|21279764|P1|COMPLETED|Overall Study||0
8622839|NCT01358877|21279763|P2|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
8622840|NCT01358877|21279764|P1|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
8622841|NCT01358877|21279763|P2|Did Not Receive Study Drug|Overall Study||13
8622842|NCT01358877|21279764|P1|Did Not Receive Study Drug|Overall Study||22
8622843|NCT01358877|21279763|P2|STARTED|Overall Study||2404
8622844|NCT01358877|21279764|P1|STARTED|Overall Study||2400
8622845|NCT01113541|21279826|P1|NOT COMPLETED|Overall Study||13
8622846|NCT01113541|21279826|P1|COMPLETED|Overall Study||0
8622847|NCT01113541|21279826|P1|STARTED|Overall Study||13
8622848|NCT01075516|21279861|P2|NOT COMPLETED|Overall Study||16
8622849|NCT01075516|21279862|P1|NOT COMPLETED|Overall Study||18
8622850|NCT01075516|21279861|P2|COMPLETED|Overall Study||86
8622851|NCT01075516|21279862|P1|COMPLETED|Overall Study||89
8622852|NCT01075516|21279861|P2|STARTED|Overall Study||102
8622853|NCT01075516|21279862|P1|STARTED|Overall Study||107
8622854|NCT01053429|21279872|P1|NOT COMPLETED|Overall Study||373
8622855|NCT01053429|21279872|P1|COMPLETED|Overall Study||3018
8622856|NCT01053429|21279872|P1|STARTED|Overall Study||3391
8622857|NCT01041248|21279881|P1|NOT COMPLETED|Overall Study||0
8622858|NCT01041248|21279881|P1|COMPLETED|Overall Study||1
8622859|NCT01041248|21279881|P1|STARTED|Overall Study|January 2010|1
8622860|NCT00748566|21279887|P1|NOT COMPLETED|Overall Study||112
8622861|NCT00748566|21279887|P1|COMPLETED|Overall Study||60
8622862|NCT00748566|21279887|P1|STARTED|Overall Study||172
8622863|NCT00723606|21279917|P2|NOT COMPLETED|Overall Study||7
8622864|NCT00723606|21279918|P1|NOT COMPLETED|Overall Study||4
8622865|NCT00723606|21279917|P2|COMPLETED|Overall Study||180
8622866|NCT00723606|21279918|P1|COMPLETED|Overall Study||185
8622867|NCT00723606|21279917|P2|STARTED|Overall Study||187
8622868|NCT00723606|21279918|P1|STARTED|Overall Study||189
8622869|NCT00708916|21279934|P1|NOT COMPLETED|Overall Study||4
8622870|NCT00708916|21279934|P1|COMPLETED|Overall Study||8
8622871|NCT00708916|21279934|P1|STARTED|Overall Study||12
8622872|NCT00485693|21279945|P2|NOT COMPLETED|Overall Study||0
8622873|NCT00485693|21279946|P1|NOT COMPLETED|Overall Study||0
8622874|NCT00485693|21279945|P2|COMPLETED|Overall Study||104
8622875|NCT00485693|21279946|P1|COMPLETED|Overall Study||34
8622876|NCT00485693|21279945|P2|STARTED|Overall Study||104
8622877|NCT00485693|21279946|P1|STARTED|Overall Study||34
8622878|NCT00458536|21279955|P1|NOT COMPLETED|Overall Study||19
8622879|NCT00458536|21279955|P1|COMPLETED|Overall Study||19
8622880|NCT00458536|21279955|P1|STARTED|Overall Study||38
8622881|NCT00402987|21279963|P4|NOT COMPLETED|Overall Study||0
8622882|NCT00402987|21279964|P3|NOT COMPLETED|Overall Study||1
8622883|NCT00402987|21279965|P2|NOT COMPLETED|Overall Study||0
8622884|NCT00402987|21279966|P1|NOT COMPLETED|Overall Study||0
8622885|NCT00402987|21279963|P4|COMPLETED|Overall Study||89
8622886|NCT00402987|21279964|P3|COMPLETED|Overall Study||44
8622887|NCT00402987|21279965|P2|COMPLETED|Overall Study||45
8622888|NCT00402987|21279966|P1|COMPLETED|Overall Study||90
8622889|NCT00402987|21279963|P4|STARTED|Overall Study||89
8622890|NCT00402987|21279964|P3|STARTED|Overall Study||45
8622891|NCT00402987|21279965|P2|STARTED|Overall Study||45
8622892|NCT00402987|21279966|P1|STARTED|Overall Study||90
8622893|NCT00373685|21280130|P2|NOT COMPLETED|Overall Study||1421
8622894|NCT00373685|21280131|P1|NOT COMPLETED|Overall Study||1439
8622895|NCT00373685|21280130|P2|COMPLETED|Overall Study||2611
8622896|NCT00373685|21280131|P1|COMPLETED|Overall Study||2596
8622897|NCT00373685|21280130|P2|Treated|Overall Study||3955
8622898|NCT00373685|21280131|P1|Treated|Overall Study||3984
8622899|NCT00373685|21280130|P2|STARTED|Overall Study||4032
8622900|NCT00373685|21280131|P1|STARTED|Overall Study||4035
8622901|NCT00346216|21280168|P3|NOT COMPLETED|Overall Study||2348
8622902|NCT00346216|21280169|P2|NOT COMPLETED|Overall Study||2460
8622903|NCT00346216|21280170|P1|NOT COMPLETED|Overall Study||2408
8622904|NCT00346216|21280168|P3|COMPLETED|Overall Study||5621
8622905|NCT00346216|21280169|P2|COMPLETED|Overall Study||5580
8622906|NCT00346216|21280170|P1|COMPLETED|Overall Study||5664
8622907|NCT00346216|21280168|P3|STARTED|Overall Study||7969
8622908|NCT00346216|21280169|P2|STARTED|Overall Study||8040
8622909|NCT00346216|21280170|P1|STARTED|Overall Study||8072
8622910|NCT00265382|21280187|P1|NOT COMPLETED|Overall Study||145
8622911|NCT00265382|21280187|P1|COMPLETED|Overall Study||76
8622912|NCT00265382|21280187|P1|STARTED|Overall Study||221
8622913|NCT00257166|21280207|P2|NOT COMPLETED|Overall Study||37
8622914|NCT00257166|21280208|P1|NOT COMPLETED|Overall Study||53
8622915|NCT00257166|21280207|P2|COMPLETED|Overall Study||51
8622916|NCT00257166|21280208|P1|COMPLETED|Overall Study||97
8622917|NCT00257166|21280207|P2|Treated|Overall Study||88
8622918|NCT00257166|21280208|P1|Treated|Overall Study||149
8622919|NCT00257166|21280207|P2|STARTED|Overall Study||88
8622920|NCT00257166|21280208|P1|STARTED|Overall Study||150
8622921|NCT00141102|21280222|P2|NOT COMPLETED|Overall Study||625
8622922|NCT00141102|21280223|P1|NOT COMPLETED|Overall Study||508
8622923|NCT00141102|21280222|P2|COMPLETED|Overall Study||1621
8622924|NCT00141102|21280223|P1|COMPLETED|Overall Study||1730
8622925|NCT00141102|21280222|P2|Received Treatment|Overall Study||2237
8622926|NCT00141102|21280223|P1|Received Treatment|Overall Study||2223
8622927|NCT00141102|21280222|P2|STARTED|Overall Study||2246
8622928|NCT00141102|21280223|P1|STARTED|Overall Study||2238
8622929|NCT00139737|21280261|P1|NOT COMPLETED|Overall Study||341
8622930|NCT00139737|21280261|P1|COMPLETED|Overall Study||3
8622931|NCT00139737|21280261|P1|Received Treatment|Overall Study||331
8622932|NCT00139737|21280261|P1|STARTED|Overall Study||344
8622939|NCT04495374|21280290|P2|NOT COMPLETED|Overall Study||1
8622940|NCT04495374|21280291|P1|NOT COMPLETED|Overall Study||2
8622941|NCT04495374|21280290|P2|COMPLETED|Overall Study||27
8622942|NCT04495374|21280291|P1|COMPLETED|Overall Study||28
8622943|NCT04495374|21280290|P2|STARTED|Overall Study||28
8622944|NCT04495374|21280291|P1|STARTED|Overall Study||30
8622945|NCT04048460|21280307|P1|NOT COMPLETED|Overall Study||0
8622946|NCT04048460|21280307|P1|COMPLETED|Overall Study||10
8622947|NCT04048460|21280307|P1|STARTED|Overall Study||10
8622948|NCT03873116|21280317|P3|NOT COMPLETED|Overall Study||1
8622949|NCT03873116|21280318|P2|NOT COMPLETED|Overall Study||0
8622950|NCT03873116|21280319|P1|NOT COMPLETED|Overall Study||0
8622951|NCT03873116|21280317|P3|COMPLETED|Overall Study||5
8622952|NCT03873116|21280318|P2|COMPLETED|Overall Study||7
8622953|NCT03873116|21280319|P1|COMPLETED|Overall Study||6
8622954|NCT03873116|21280317|P3|STARTED|Overall Study||6
8622955|NCT03873116|21280318|P2|STARTED|Overall Study||7
8622956|NCT03873116|21280319|P1|STARTED|Overall Study||6
8622957|NCT03812224|21280338|P2|NOT COMPLETED|Overall Study||3
8622958|NCT03812224|21280339|P1|NOT COMPLETED|Overall Study||4
8622959|NCT03812224|21280338|P2|COMPLETED|Overall Study||127
8622960|NCT03812224|21280339|P1|COMPLETED|Overall Study||127
8622961|NCT03812224|21280338|P2|STARTED|Overall Study||130
8622962|NCT03812224|21280339|P1|STARTED|Overall Study||131
8622963|NCT03718871|21280351|P2|NOT COMPLETED|Overall Study||0
8622964|NCT03718871|21280352|P1|NOT COMPLETED|Overall Study||0
8622965|NCT03718871|21280351|P2|COMPLETED|Overall Study||250
8622966|NCT03718871|21280352|P1|COMPLETED|Overall Study||250
8622967|NCT03718871|21280351|P2|STARTED|Overall Study||250
8622968|NCT03718871|21280352|P1|STARTED|Overall Study||250
8622969|NCT03669549|21280368|P1|NOT COMPLETED|Overall Study||6
8622970|NCT03669549|21280368|P1|COMPLETED|Overall Study||9
8622971|NCT03669549|21280368|P1|STARTED|Overall Study||15
8623092|NCT03519243|21280752|P4|NOT COMPLETED|Overall Study||1
8623093|NCT03519243|21280753|P3|NOT COMPLETED|Overall Study||0
8623094|NCT03519243|21280754|P2|NOT COMPLETED|Overall Study||4
8623095|NCT03519243|21280755|P1|NOT COMPLETED|Overall Study||5
8623096|NCT03519243|21280752|P4|COMPLETED|Overall Study||24
8623097|NCT03519243|21280753|P3|COMPLETED|Overall Study||0
8623098|NCT03519243|21280754|P2|COMPLETED|Overall Study||21
8623099|NCT03519243|21280755|P1|COMPLETED|Overall Study||20
8623100|NCT03519243|21280752|P4|STARTED|Overall Study||25
8623101|NCT03519243|21280753|P3|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0
8623102|NCT03519243|21280754|P2|STARTED|Overall Study||25
8623103|NCT03519243|21280755|P1|STARTED|Overall Study||25
8623104|NCT03492281|21280787|P3|NOT COMPLETED|Overall Study||46
8623105|NCT03492281|21280788|P2|NOT COMPLETED|Overall Study||45
8623106|NCT03492281|21280789|P1|NOT COMPLETED|Overall Study||54
8623107|NCT03492281|21280787|P3|COMPLETED|Overall Study||385
8623108|NCT03492281|21280788|P2|COMPLETED|Overall Study||502
8623109|NCT03492281|21280789|P1|COMPLETED|Overall Study||486
8623110|NCT03492281|21280787|P3|STARTED|Overall Study||431
8623111|NCT03492281|21280788|P2|STARTED|Overall Study||547
8623112|NCT03492281|21280789|P1|STARTED|Overall Study||540
8623113|NCT03481309|21280845|P6|NOT COMPLETED|Third Intervention (1 Day)||0
8623114|NCT03481309|21280846|P5|NOT COMPLETED|Third Intervention (1 Day)||0
8623115|NCT03481309|21280847|P4|NOT COMPLETED|Third Intervention (1 Day)||0
8623116|NCT03481309|21280848|P3|NOT COMPLETED|Third Intervention (1 Day)||0
8623117|NCT03481309|21280849|P2|NOT COMPLETED|Third Intervention (1 Day)||0
8623118|NCT03481309|21280850|P1|NOT COMPLETED|Third Intervention (1 Day)||0
8623119|NCT03481309|21280845|P6|COMPLETED|Third Intervention (1 Day)||3
8623120|NCT03481309|21280846|P5|COMPLETED|Third Intervention (1 Day)||3
8623121|NCT03481309|21280847|P4|COMPLETED|Third Intervention (1 Day)||3
8623122|NCT03481309|21280848|P3|COMPLETED|Third Intervention (1 Day)||3
8623123|NCT03481309|21280849|P2|COMPLETED|Third Intervention (1 Day)||3
8623124|NCT03481309|21280850|P1|COMPLETED|Third Intervention (1 Day)||3
8623125|NCT03481309|21280845|P6|STARTED|Third Intervention (1 Day)||3
8623126|NCT03481309|21280846|P5|STARTED|Third Intervention (1 Day)||3
8623127|NCT03481309|21280847|P4|STARTED|Third Intervention (1 Day)||3
8623128|NCT03481309|21280848|P3|STARTED|Third Intervention (1 Day)||3
8623129|NCT03481309|21280849|P2|STARTED|Third Intervention (1 Day)||3
8623130|NCT03481309|21280850|P1|STARTED|Third Intervention (1 Day)||3
8623131|NCT03481309|21280845|P6|NOT COMPLETED|Washout (at Least 3 Days)||0
8623132|NCT03481309|21280846|P5|NOT COMPLETED|Washout (at Least 3 Days)||0
8623133|NCT03481309|21280847|P4|NOT COMPLETED|Washout (at Least 3 Days)||0
8623134|NCT03481309|21280848|P3|NOT COMPLETED|Washout (at Least 3 Days)||0
8623135|NCT03481309|21280849|P2|NOT COMPLETED|Washout (at Least 3 Days)||0
8623136|NCT03481309|21280850|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
8623137|NCT03481309|21280845|P6|COMPLETED|Washout (at Least 3 Days)||3
8623138|NCT03481309|21280846|P5|COMPLETED|Washout (at Least 3 Days)||3
8623139|NCT03481309|21280847|P4|COMPLETED|Washout (at Least 3 Days)||3
8623140|NCT03481309|21280848|P3|COMPLETED|Washout (at Least 3 Days)||3
8623141|NCT03481309|21280849|P2|COMPLETED|Washout (at Least 3 Days)||3
8623142|NCT03481309|21280850|P1|COMPLETED|Washout (at Least 3 Days)||3
8623143|NCT03481309|21280845|P6|STARTED|Washout (at Least 3 Days)||3
8623144|NCT03481309|21280846|P5|STARTED|Washout (at Least 3 Days)||3
8623145|NCT03481309|21280847|P4|STARTED|Washout (at Least 3 Days)||3
8623146|NCT03481309|21280848|P3|STARTED|Washout (at Least 3 Days)||3
8623147|NCT03481309|21280849|P2|STARTED|Washout (at Least 3 Days)||3
8623148|NCT03481309|21280850|P1|STARTED|Washout (at Least 3 Days)||3
8623149|NCT03481309|21280845|P6|NOT COMPLETED|Second Intervention (1 Day)||0
8623150|NCT03481309|21280846|P5|NOT COMPLETED|Second Intervention (1 Day)||0
8623151|NCT03481309|21280847|P4|NOT COMPLETED|Second Intervention (1 Day)||0
8623152|NCT03481309|21280848|P3|NOT COMPLETED|Second Intervention (1 Day)||0
8623153|NCT03481309|21280849|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8623154|NCT03481309|21280850|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8623155|NCT03481309|21280845|P6|COMPLETED|Second Intervention (1 Day)||3
8623156|NCT03481309|21280846|P5|COMPLETED|Second Intervention (1 Day)||3
8623157|NCT03481309|21280847|P4|COMPLETED|Second Intervention (1 Day)||3
8623158|NCT03481309|21280848|P3|COMPLETED|Second Intervention (1 Day)||3
8623159|NCT03481309|21280849|P2|COMPLETED|Second Intervention (1 Day)||3
8623160|NCT03481309|21280850|P1|COMPLETED|Second Intervention (1 Day)||3
8623161|NCT03481309|21280845|P6|STARTED|Second Intervention (1 Day)||3
8623162|NCT03481309|21280846|P5|STARTED|Second Intervention (1 Day)||3
8623163|NCT03481309|21280847|P4|STARTED|Second Intervention (1 Day)||3
8623164|NCT03481309|21280848|P3|STARTED|Second Intervention (1 Day)||3
8623165|NCT03481309|21280849|P2|STARTED|Second Intervention (1 Day)||3
8623166|NCT03481309|21280850|P1|STARTED|Second Intervention (1 Day)||3
8623167|NCT03481309|21280845|P6|NOT COMPLETED|Washout (at Least 3 Days)||0
8623168|NCT03481309|21280846|P5|NOT COMPLETED|Washout (at Least 3 Days)||0
8623169|NCT03481309|21280847|P4|NOT COMPLETED|Washout (at Least 3 Days)||0
8623170|NCT03481309|21280848|P3|NOT COMPLETED|Washout (at Least 3 Days)||0
8623171|NCT03481309|21280849|P2|NOT COMPLETED|Washout (at Least 3 Days)||0
8623172|NCT03481309|21280850|P1|NOT COMPLETED|Washout (at Least 3 Days)||1
8623173|NCT03481309|21280845|P6|COMPLETED|Washout (at Least 3 Days)||3
8623174|NCT03481309|21280846|P5|COMPLETED|Washout (at Least 3 Days)||3
8623175|NCT03481309|21280847|P4|COMPLETED|Washout (at Least 3 Days)||3
8623176|NCT03481309|21280848|P3|COMPLETED|Washout (at Least 3 Days)||3
8623177|NCT03481309|21280849|P2|COMPLETED|Washout (at Least 3 Days)||3
8623178|NCT03481309|21280850|P1|COMPLETED|Washout (at Least 3 Days)||3
8623179|NCT03481309|21280845|P6|STARTED|Washout (at Least 3 Days)||3
8623180|NCT03481309|21280846|P5|STARTED|Washout (at Least 3 Days)||3
8623181|NCT03481309|21280847|P4|STARTED|Washout (at Least 3 Days)||3
8623182|NCT03481309|21280848|P3|STARTED|Washout (at Least 3 Days)||3
8623183|NCT03481309|21280849|P2|STARTED|Washout (at Least 3 Days)||3
8623184|NCT03481309|21280850|P1|STARTED|Washout (at Least 3 Days)||4
8623185|NCT03481309|21280845|P6|NOT COMPLETED|First Intervention (1 Day)||0
8623186|NCT03481309|21280846|P5|NOT COMPLETED|First Intervention (1 Day)||0
8623187|NCT03481309|21280847|P4|NOT COMPLETED|First Intervention (1 Day)||0
8623188|NCT03481309|21280848|P3|NOT COMPLETED|First Intervention (1 Day)||0
8623189|NCT03481309|21280849|P2|NOT COMPLETED|First Intervention (1 Day)||0
8623190|NCT03481309|21280850|P1|NOT COMPLETED|First Intervention (1 Day)||0
8623191|NCT03481309|21280845|P6|COMPLETED|First Intervention (1 Day)||3
8623192|NCT03481309|21280846|P5|COMPLETED|First Intervention (1 Day)||3
8623193|NCT03481309|21280847|P4|COMPLETED|First Intervention (1 Day)||3
8623194|NCT03481309|21280848|P3|COMPLETED|First Intervention (1 Day)||3
8623195|NCT03481309|21280849|P2|COMPLETED|First Intervention (1 Day)||3
8623196|NCT03481309|21280850|P1|COMPLETED|First Intervention (1 Day)||4
8623197|NCT03481309|21280845|P6|STARTED|First Intervention (1 Day)||3
8623198|NCT03481309|21280846|P5|STARTED|First Intervention (1 Day)||3
8623199|NCT03481309|21280847|P4|STARTED|First Intervention (1 Day)||3
8623200|NCT03481309|21280848|P3|STARTED|First Intervention (1 Day)||3
8623201|NCT03481309|21280849|P2|STARTED|First Intervention (1 Day)||3
8623202|NCT03481309|21280850|P1|STARTED|First Intervention (1 Day)||4
8623203|NCT03418714|21280864|P1|NOT COMPLETED|Overall Study||1
8623204|NCT03418714|21280864|P1|COMPLETED|Overall Study|One participant moved too much during the practice session and was therefore excluded from the scan.|12
8623205|NCT03418714|21280864|P1|STARTED|Overall Study||13
8623206|NCT03371836|21280869|P1|NOT COMPLETED|Overall Study||2
8623207|NCT03371836|21280869|P1|COMPLETED|Overall Study||18
8623208|NCT03371836|21280869|P1|STARTED|Overall Study||20
8623209|NCT03355742|21280873|P1|NOT COMPLETED|Overall Study||99
8623210|NCT03355742|21280873|P1|COMPLETED|Overall Study||864
8623211|NCT03355742|21280873|P1|STARTED|Overall Study||963
8623212|NCT03340337|21280912|P1|NOT COMPLETED|Overall Study||0
8623213|NCT03340337|21280912|P1|COMPLETED|Overall Study||30
8623214|NCT03340337|21280912|P1|Received RBS|Overall Study||30
8623215|NCT03340337|21280912|P1|Received Aussie|Overall Study||30
8623216|NCT03340337|21280912|P1|Received Neo-Russian|Overall Study||30
8623217|NCT03340337|21280912|P1|STARTED|Overall Study||30
8623230|NCT03198221|21280943|P4|NOT COMPLETED|Overall Study||0
8623231|NCT03198221|21280944|P3|NOT COMPLETED|Overall Study||0
8623232|NCT03198221|21280945|P2|NOT COMPLETED|Overall Study||0
8623233|NCT03198221|21280946|P1|NOT COMPLETED|Overall Study||0
8623234|NCT03198221|21280943|P4|COMPLETED|Overall Study||2
8623235|NCT03198221|21280944|P3|COMPLETED|Overall Study||7
8623236|NCT03198221|21280945|P2|COMPLETED|Overall Study||2
8623237|NCT03198221|21280946|P1|COMPLETED|Overall Study||3
8623238|NCT03198221|21280943|P4|STARTED|Overall Study||2
8623239|NCT03198221|21280944|P3|STARTED|Overall Study||7
8623240|NCT03198221|21280945|P2|STARTED|Overall Study||2
8623241|NCT03198221|21280946|P1|STARTED|Overall Study||3
8623292|NCT02793674|21281130|P2|NOT COMPLETED|Overall Study||0
8623293|NCT02793674|21281131|P1|NOT COMPLETED|Overall Study||0
8623294|NCT02793674|21281130|P2|COMPLETED|Overall Study||12
8623295|NCT02793674|21281131|P1|COMPLETED|Overall Study||9
8623296|NCT02793674|21281130|P2|STARTED|Overall Study||12
8623297|NCT02793674|21281131|P1|STARTED|Overall Study||9
8623298|NCT02690207|21281143|P1|NOT COMPLETED|Overall Study||253
8623299|NCT02690207|21281143|P1|COMPLETED|Overall Study||8434
8623300|NCT02690207|21281143|P1|STARTED|Overall Study||8687
8623301|NCT02630953|21281152|P2|NOT COMPLETED|12 Month Assessment||38
8623302|NCT02630953|21281153|P1|NOT COMPLETED|12 Month Assessment||24
8623303|NCT02630953|21281152|P2|COMPLETED|12 Month Assessment||64
8623304|NCT02630953|21281153|P1|COMPLETED|12 Month Assessment||73
8623305|NCT02630953|21281152|P2|STARTED|12 Month Assessment||102
8623306|NCT02630953|21281153|P1|STARTED|12 Month Assessment||97
8623307|NCT02630953|21281152|P2|NOT COMPLETED|6 Month Assessment||32
8623308|NCT02630953|21281153|P1|NOT COMPLETED|6 Month Assessment||14
8623309|NCT02630953|21281152|P2|COMPLETED|6 Month Assessment||70
8623310|NCT02630953|21281153|P1|COMPLETED|6 Month Assessment||83
8623311|NCT02630953|21281152|P2|STARTED|6 Month Assessment||102
8623312|NCT02630953|21281153|P1|STARTED|6 Month Assessment||97
8623313|NCT02372006|21281170|P3|NOT COMPLETED|Overall Study||39
8623314|NCT02372006|21281171|P2|NOT COMPLETED|Overall Study||9
8623315|NCT02372006|21281172|P1|NOT COMPLETED|Overall Study||8
8623316|NCT02372006|21281170|P3|COMPLETED|Overall Study||0
8623317|NCT02372006|21281171|P2|COMPLETED|Overall Study||0
8623318|NCT02372006|21281172|P1|COMPLETED|Overall Study||0
8623319|NCT02372006|21281170|P3|STARTED|Overall Study||39
8623320|NCT02372006|21281171|P2|STARTED|Overall Study||9
8623321|NCT02372006|21281172|P1|STARTED|Overall Study||8
8623322|NCT02346916|21281204|P1|NOT COMPLETED|Overall Study||0
8623323|NCT02346916|21281204|P1|COMPLETED|Overall Study||20
8623324|NCT02346916|21281204|P1|STARTED|Overall Study||20
8623325|NCT02346903|21281209|P1|NOT COMPLETED|Overall Study||0
8623326|NCT02346903|21281209|P1|COMPLETED|Overall Study||99
8623327|NCT02346903|21281209|P1|STARTED|Overall Study||99
8623328|NCT02211456|21281214|P1|NOT COMPLETED|Overall Study||0
8623329|NCT02211456|21281214|P1|COMPLETED|Overall Study||15
8623330|NCT02211456|21281214|P1|STARTED|Overall Study||15
8623331|NCT02017379|21281221|P3|NOT COMPLETED|Overall Study||0
8623332|NCT02017379|21281222|P2|NOT COMPLETED|Overall Study||0
8623333|NCT02017379|21281223|P1|NOT COMPLETED|Overall Study||0
8623334|NCT02017379|21281221|P3|COMPLETED|Overall Study||0
8623335|NCT02017379|21281222|P2|COMPLETED|Overall Study||0
8623336|NCT02017379|21281223|P1|COMPLETED|Overall Study||0
8623337|NCT02017379|21281221|P3|STARTED|Overall Study||0
8623338|NCT02017379|21281222|P2|STARTED|Overall Study||0
8623339|NCT02017379|21281223|P1|STARTED|Overall Study||0
8623340|NCT01810991|21281246|P1|NOT COMPLETED|Overall Study||2
8623341|NCT01810991|21281246|P1|COMPLETED|Overall Study||17
8623342|NCT01810991|21281246|P1|STARTED|Overall Study||19
8623343|NCT01804166|21281252|P1|NOT COMPLETED|Overall Study||0
8623344|NCT01804166|21281252|P1|COMPLETED|Overall Study||1
8623345|NCT01804166|21281252|P1|STARTED|Overall Study||1
8623346|NCT01749995|21281256|P1|NOT COMPLETED|Overall Study||4
8623347|NCT01749995|21281256|P1|COMPLETED|Overall Study||196
8623348|NCT01749995|21281256|P1|STARTED|Overall Study||200
8623349|NCT01490580|21281262|P2|NOT COMPLETED|Overall Study||2
8623350|NCT01490580|21281263|P1|NOT COMPLETED|Overall Study||0
8623351|NCT01490580|21281262|P2|COMPLETED|Overall Study||89
8623352|NCT01490580|21281263|P1|COMPLETED|Overall Study||82
8623353|NCT01490580|21281262|P2|STARTED|Overall Study||91
8623354|NCT01490580|21281263|P1|STARTED|Overall Study||82
8623355|NCT01266902|21281287|P3|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||8
8623356|NCT01266902|21281288|P2|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
8623357|NCT01266902|21281289|P1|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
8623358|NCT01266902|21281287|P3|COMPLETED|Period 2 (After Protocol Amendment 3)||37
8623359|NCT01266902|21281288|P2|COMPLETED|Period 2 (After Protocol Amendment 3)||0
8623360|NCT01266902|21281289|P1|COMPLETED|Period 2 (After Protocol Amendment 3)||0
8623361|NCT01266902|21281287|P3|STARTED|Period 2 (After Protocol Amendment 3)||45
8623362|NCT01266902|21281288|P2|STARTED|Period 2 (After Protocol Amendment 3)||0
8623363|NCT01266902|21281289|P1|STARTED|Period 2 (After Protocol Amendment 3)||0
8623364|NCT01266902|21281287|P3|NOT COMPLETED|Period 1 (Main Study)||0
8623365|NCT01266902|21281288|P2|NOT COMPLETED|Period 1 (Main Study)||81
8623366|NCT01266902|21281289|P1|NOT COMPLETED|Period 1 (Main Study)||30
8623367|NCT01266902|21281287|P3|COMPLETED|Period 1 (Main Study)||0
8623368|NCT01266902|21281288|P2|COMPLETED|Period 1 (Main Study)||282
8623369|NCT01266902|21281289|P1|COMPLETED|Period 1 (Main Study)||89
8623370|NCT01266902|21281287|P3|STARTED|Period 1 (Main Study)||0
8623371|NCT01266902|21281288|P2|STARTED|Period 1 (Main Study)||363
8623372|NCT01266902|21281289|P1|STARTED|Period 1 (Main Study)||119
8623373|NCT00529126|21281313|P4|NOT COMPLETED|Overall Study||0
8623374|NCT00529126|21281314|P3|NOT COMPLETED|Overall Study||0
8623375|NCT00529126|21281315|P2|NOT COMPLETED|Overall Study||0
8623376|NCT00529126|21281316|P1|NOT COMPLETED|Overall Study||0
8623377|NCT00529126|21281313|P4|COMPLETED|Overall Study||26
8623378|NCT00529126|21281314|P3|COMPLETED|Overall Study||24
8623379|NCT00529126|21281315|P2|COMPLETED|Overall Study||25
8623380|NCT00529126|21281316|P1|COMPLETED|Overall Study||25
8623381|NCT00529126|21281313|P4|STARTED|Overall Study||26
8623382|NCT00529126|21281314|P3|STARTED|Overall Study||24
8623383|NCT00529126|21281315|P2|STARTED|Overall Study||25
8623384|NCT00529126|21281316|P1|STARTED|Overall Study||25
8623385|NCT00291499|21281328|P2|NOT COMPLETED|Overall Study||15
8623386|NCT00291499|21281329|P1|NOT COMPLETED|Overall Study||9
8623387|NCT00291499|21281328|P2|COMPLETED|Overall Study||67
8623388|NCT00291499|21281329|P1|COMPLETED|Overall Study||72
8623389|NCT00291499|21281328|P2|Safety Population|Overall Study||82
8623390|NCT00291499|21281329|P1|Safety Population|Overall Study||81
8623391|NCT00291499|21281328|P2|Per Protocol (PP)|Overall Study||67
8623392|NCT00291499|21281329|P1|Per Protocol (PP)|Overall Study||72
8623393|NCT00291499|21281328|P2|Intention to Treat (ITT)|Overall Study||82
8623394|NCT00291499|21281329|P1|Intention to Treat (ITT)|Overall Study||80
8623395|NCT00291499|21281328|P2|STARTED|Overall Study||82
8623396|NCT00291499|21281329|P1|STARTED|Overall Study||81
8623397|NCT04027686|21281347|P2|NOT COMPLETED|Overall Study||1
8623398|NCT04027686|21281348|P1|NOT COMPLETED|Overall Study||2
8623399|NCT04027686|21281347|P2|COMPLETED|Overall Study||5
8623400|NCT04027686|21281348|P1|COMPLETED|Overall Study||15
8623401|NCT04027686|21281347|P2|STARTED|Overall Study||6
8623402|NCT04027686|21281348|P1|STARTED|Overall Study||17
8623409|NCT03681353|21281387|P1|NOT COMPLETED|Overall Study||7
8623410|NCT03681353|21281387|P1|COMPLETED|Overall Study||18
8623411|NCT03681353|21281387|P1|STARTED|Overall Study||25
8623412|NCT03617770|21281399|P2|NOT COMPLETED|Overall Study||0
8623413|NCT03617770|21281400|P1|NOT COMPLETED|Overall Study||1
8623414|NCT03617770|21281399|P2|COMPLETED|Overall Study||5
8623415|NCT03617770|21281400|P1|COMPLETED|Overall Study|8|8
8623416|NCT03617770|21281399|P2|STARTED|Overall Study|5|5
8623417|NCT03617770|21281400|P1|STARTED|Overall Study|9|9
8623418|NCT03596177|21281416|P2|NOT COMPLETED|Double Blind Period||6
8623419|NCT03596177|21281417|P1|NOT COMPLETED|Double Blind Period||0
8623420|NCT03596177|21281416|P2|COMPLETED|Double Blind Period||12
8623421|NCT03596177|21281417|P1|COMPLETED|Double Blind Period||7
8623422|NCT03596177|21281416|P2|STARTED|Double Blind Period||18
8623423|NCT03596177|21281417|P1|STARTED|Double Blind Period||7
8623424|NCT03596177|21281416|P2|NOT COMPLETED|Single Blind Period||1
8623425|NCT03596177|21281417|P1|NOT COMPLETED|Single Blind Period||2
8623426|NCT03596177|21281416|P2|COMPLETED|Single Blind Period||18
8623427|NCT03596177|21281417|P1|COMPLETED|Single Blind Period||7
8623428|NCT03596177|21281416|P2|STARTED|Single Blind Period||19
8623429|NCT03596177|21281417|P1|STARTED|Single Blind Period||9
8623430|NCT03562377|21281469|P2|NOT COMPLETED|Safety Follow-up Period||57
8623431|NCT03562377|21281470|P1|NOT COMPLETED|Safety Follow-up Period||59
8623432|NCT03562377|21281469|P2|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|18
8623433|NCT03562377|21281470|P1|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|16
8623434|NCT03562377|21281469|P2|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
8623435|NCT03562377|21281470|P1|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
8623436|NCT03562377|21281469|P2|NOT COMPLETED|Treatment Period||19
8623437|NCT03562377|21281470|P1|NOT COMPLETED|Treatment Period||7
8623438|NCT03562377|21281469|P2|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|89
8623439|NCT03562377|21281470|P1|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|100
8623440|NCT03562377|21281469|P2|Full Analysis Set|Treatment Period||108
8623441|NCT03562377|21281470|P1|Full Analysis Set|Treatment Period||106
8623442|NCT03562377|21281469|P2|Per Protocol Anaysis Set|Treatment Period||78
8623443|NCT03562377|21281470|P1|Per Protocol Anaysis Set|Treatment Period||88
8623444|NCT03562377|21281469|P2|Safety Analysis Set|Treatment Period||107
8623445|NCT03562377|21281470|P1|Safety Analysis Set|Treatment Period||107
8623446|NCT03562377|21281469|P2|STARTED|Treatment Period|Number of participants assigned to treatment|108
8623447|NCT03562377|21281470|P1|STARTED|Treatment Period|Number of participants assigned to treatment|107
8623451|NCT03428815|21281493|P2|NOT COMPLETED|Overall Study||5
8623452|NCT03428815|21281494|P1|NOT COMPLETED|Overall Study||10
8623453|NCT03428815|21281493|P2|COMPLETED|Overall Study||14
8623454|NCT03428815|21281494|P1|COMPLETED|Overall Study||7
8623455|NCT03428815|21281493|P2|STARTED|Overall Study||19
8623456|NCT03428815|21281494|P1|STARTED|Overall Study||17
8623457|NCT03179410|21281502|P1|NOT COMPLETED|Overall Study||0
8623458|NCT03179410|21281502|P1|COMPLETED|Overall Study||15
8623459|NCT03179410|21281502|P1|STARTED|Overall Study||15
8623470|NCT03149328|21281543|P2|NOT COMPLETED|Overall Study||47
8623471|NCT03149328|21281544|P1|NOT COMPLETED|Overall Study||84
8623472|NCT03149328|21281543|P2|COMPLETED|Overall Study||212
8623473|NCT03149328|21281544|P1|COMPLETED|Overall Study||200
8623474|NCT03149328|21281543|P2|STARTED|Overall Study||259
8623475|NCT03149328|21281544|P1|STARTED|Overall Study||284
8623476|NCT03010683|21281562|P2|NOT COMPLETED|Overall Study||0
8623477|NCT03010683|21281563|P1|NOT COMPLETED|Overall Study||0
8623478|NCT03010683|21281562|P2|COMPLETED|Overall Study||30
8623479|NCT03010683|21281563|P1|COMPLETED|Overall Study||30
8623480|NCT03010683|21281562|P2|STARTED|Overall Study||30
8623481|NCT03010683|21281563|P1|STARTED|Overall Study||30
8623482|NCT02940392|21281579|P1|NOT COMPLETED|Overall Study||8
8623483|NCT02940392|21281579|P1|COMPLETED|Overall Study||7
8623484|NCT02940392|21281579|P1|STARTED|Overall Study||15
8623485|NCT02855281|21281589|P1|NOT COMPLETED|Overall Study||0
8623486|NCT02855281|21281589|P1|COMPLETED|Overall Study||50
8623487|NCT02855281|21281589|P1|STARTED|Overall Study||50
8623488|NCT02830776|21281599|P1|NOT COMPLETED|Overall Study||1
8623489|NCT02830776|21281599|P1|COMPLETED|Overall Study||14
8623490|NCT02830776|21281599|P1|STARTED|Overall Study||15
8623491|NCT02764164|21281604|P1|NOT COMPLETED|Overall Study||0
8623492|NCT02764164|21281604|P1|COMPLETED|Overall Study|Duration flexible up to 12mo, ended early (funding), 2 week time point achieved|1
8623493|NCT02764164|21281604|P1|STARTED|Overall Study||1
8623500|NCT02592798|21281627|P2|NOT COMPLETED|Open Label Period (OLE)||9
8623501|NCT02592798|21281628|P1|NOT COMPLETED|Open Label Period (OLE)||4
8623502|NCT02592798|21281627|P2|COMPLETED|Open Label Period (OLE)||4
8623503|NCT02592798|21281628|P1|COMPLETED|Open Label Period (OLE)||6
8623504|NCT02592798|21281627|P2|STARTED|Open Label Period (OLE)||13
8623505|NCT02592798|21281628|P1|STARTED|Open Label Period (OLE)||10
8623506|NCT02592798|21281627|P2|NOT COMPLETED|Transition From DB2 to OLE||0
8623507|NCT02592798|21281628|P1|NOT COMPLETED|Transition From DB2 to OLE||1
8623508|NCT02592798|21281627|P2|COMPLETED|Transition From DB2 to OLE||9
8623509|NCT02592798|21281628|P1|COMPLETED|Transition From DB2 to OLE||5
8623510|NCT02592798|21281627|P2|STARTED|Transition From DB2 to OLE||9
8623511|NCT02592798|21281628|P1|STARTED|Transition From DB2 to OLE||6
8623512|NCT02592798|21281627|P2|NOT COMPLETED|Double-Blind Period 2 (DB2)||2
8623513|NCT02592798|21281628|P1|NOT COMPLETED|Double-Blind Period 2 (DB2)||5
8623514|NCT02592798|21281627|P2|COMPLETED|Double-Blind Period 2 (DB2)||9
8623515|NCT02592798|21281628|P1|COMPLETED|Double-Blind Period 2 (DB2)||6
8623516|NCT02592798|21281627|P2|STARTED|Double-Blind Period 2 (DB2)||11
8623517|NCT02592798|21281628|P1|STARTED|Double-Blind Period 2 (DB2)||11
8623518|NCT02592798|21281627|P2|NOT COMPLETED|Transition From DB1 to DB2||2
8623519|NCT02592798|21281628|P1|NOT COMPLETED|Transition From DB1 to DB2||3
8623520|NCT02592798|21281627|P2|COMPLETED|Transition From DB1 to DB2||11
8623521|NCT02592798|21281628|P1|COMPLETED|Transition From DB1 to DB2||11
8623522|NCT02592798|21281627|P2|STARTED|Transition From DB1 to DB2||13
8623523|NCT02592798|21281628|P1|STARTED|Transition From DB1 to DB2||14
8623524|NCT02592798|21281627|P2|NOT COMPLETED|Double-Blind Period 1 (DB1)||6
8623525|NCT02592798|21281628|P1|NOT COMPLETED|Double-Blind Period 1 (DB1)||3
8623526|NCT02592798|21281627|P2|COMPLETED|Double-Blind Period 1 (DB1)||13
8623527|NCT02592798|21281628|P1|COMPLETED|Double-Blind Period 1 (DB1)||14
8623528|NCT02592798|21281627|P2|STARTED|Double-Blind Period 1 (DB1)||19
8623529|NCT02592798|21281628|P1|STARTED|Double-Blind Period 1 (DB1)||17
8623536|NCT02466386|21281672|P1|NOT COMPLETED|Overall Study||44
8623537|NCT02466386|21281672|P1|COMPLETED|Overall Study||69
8623538|NCT02466386|21281672|P1|STARTED|Overall Study||113
8623568|NCT02322021|21281758|P5|NOT COMPLETED|Extension Phase||41
8623569|NCT02322021|21281759|P4|NOT COMPLETED|Extension Phase||0
8623570|NCT02322021|21281760|P3|NOT COMPLETED|Extension Phase||0
8623571|NCT02322021|21281761|P2|NOT COMPLETED|Extension Phase||0
8623572|NCT02322021|21281762|P1|NOT COMPLETED|Extension Phase||0
8623573|NCT02322021|21281758|P5|COMPLETED|Extension Phase||0
8623574|NCT02322021|21281759|P4|COMPLETED|Extension Phase||0
8623575|NCT02322021|21281760|P3|COMPLETED|Extension Phase||0
8623576|NCT02322021|21281761|P2|COMPLETED|Extension Phase||0
8623577|NCT02322021|21281762|P1|COMPLETED|Extension Phase||0
8623578|NCT02322021|21281758|P5|STARTED|Extension Phase|Participants who completed Core Phase, were eligible and gave consent, entered Extension Phase.|41
8623579|NCT02322021|21281759|P4|STARTED|Extension Phase||0
8623580|NCT02322021|21281760|P3|STARTED|Extension Phase||0
8623581|NCT02322021|21281761|P2|STARTED|Extension Phase||0
8623582|NCT02322021|21281762|P1|STARTED|Extension Phase||0
8623583|NCT02322021|21281758|P5|NOT COMPLETED|Core Phase||0
8623584|NCT02322021|21281759|P4|NOT COMPLETED|Core Phase||5
8623585|NCT02322021|21281760|P3|NOT COMPLETED|Core Phase||9
8623586|NCT02322021|21281761|P2|NOT COMPLETED|Core Phase||8
8623587|NCT02322021|21281762|P1|NOT COMPLETED|Core Phase||5
8623588|NCT02322021|21281758|P5|COMPLETED|Core Phase||0
8623589|NCT02322021|21281759|P4|COMPLETED|Core Phase||12
8623590|NCT02322021|21281760|P3|COMPLETED|Core Phase||10
8623591|NCT02322021|21281761|P2|COMPLETED|Core Phase||9
8623592|NCT02322021|21281762|P1|COMPLETED|Core Phase||12
8623593|NCT02322021|21281758|P5|STARTED|Core Phase||0
8623594|NCT02322021|21281759|P4|STARTED|Core Phase||17
8623595|NCT02322021|21281760|P3|STARTED|Core Phase||19
8623596|NCT02322021|21281761|P2|STARTED|Core Phase||17
8623597|NCT02322021|21281762|P1|STARTED|Core Phase||17
8623598|NCT02293993|21281815|P4|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||1
8623599|NCT02293993|21281816|P3|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
8623600|NCT02293993|21281817|P2|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
8623601|NCT02293993|21281818|P1|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||2
8623602|NCT02293993|21281815|P4|COMPLETED|Course ≥2 (Extended Treatment Period)||2
8623603|NCT02293993|21281816|P3|COMPLETED|Course ≥2 (Extended Treatment Period)||1
8623604|NCT02293993|21281817|P2|COMPLETED|Course ≥2 (Extended Treatment Period)||0
8623605|NCT02293993|21281818|P1|COMPLETED|Course ≥2 (Extended Treatment Period)||0
8623606|NCT02293993|21281815|P4|STARTED|Course ≥2 (Extended Treatment Period)||3
8623607|NCT02293993|21281816|P3|STARTED|Course ≥2 (Extended Treatment Period)||6
8623608|NCT02293993|21281817|P2|STARTED|Course ≥2 (Extended Treatment Period)||5
8623609|NCT02293993|21281818|P1|STARTED|Course ≥2 (Extended Treatment Period)||2
8623610|NCT02293993|21281815|P4|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
8623611|NCT02293993|21281816|P3|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
8623612|NCT02293993|21281817|P2|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
8623613|NCT02293993|21281818|P1|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
8623614|NCT02293993|21281815|P4|COMPLETED|Course 1 (DLT Evaluation Period)||3
8623615|NCT02293993|21281816|P3|COMPLETED|Course 1 (DLT Evaluation Period)||7
8623616|NCT02293993|21281817|P2|COMPLETED|Course 1 (DLT Evaluation Period)||6
8623617|NCT02293993|21281818|P1|COMPLETED|Course 1 (DLT Evaluation Period)||3
8623618|NCT02293993|21281815|P4|STARTED|Course 1 (DLT Evaluation Period)||4
8623619|NCT02293993|21281816|P3|STARTED|Course 1 (DLT Evaluation Period)||7
8623620|NCT02293993|21281817|P2|STARTED|Course 1 (DLT Evaluation Period)||6
8623621|NCT02293993|21281818|P1|STARTED|Course 1 (DLT Evaluation Period)||4
8623637|NCT02063828|21281930|P3|NOT COMPLETED|Overall Study||4
8623638|NCT02063828|21281931|P2|NOT COMPLETED|Overall Study||6
8623639|NCT02063828|21281932|P1|NOT COMPLETED|Overall Study||4
8623640|NCT02063828|21281930|P3|COMPLETED|Overall Study||14
8623641|NCT02063828|21281931|P2|COMPLETED|Overall Study||8
8623642|NCT02063828|21281932|P1|COMPLETED|Overall Study||10
8623643|NCT02063828|21281930|P3|Week 6|Overall Study||14
8623644|NCT02063828|21281931|P2|Week 6|Overall Study||9
8623645|NCT02063828|21281932|P1|Week 6|Overall Study||11
8623646|NCT02063828|21281930|P3|STARTED|Overall Study||18
8623647|NCT02063828|21281931|P2|STARTED|Overall Study||14
8623648|NCT02063828|21281932|P1|STARTED|Overall Study||14
8623669|NCT01876082|21282060|P2|NOT COMPLETED|Overall Study||4
8623670|NCT01876082|21282061|P1|NOT COMPLETED|Overall Study||2
8623671|NCT01876082|21282060|P2|COMPLETED|Overall Study||20
8623672|NCT01876082|21282061|P1|COMPLETED|Overall Study||46
8623673|NCT01876082|21282060|P2|Safety Population|Overall Study|2 patients did not start control treatment|22
8623674|NCT01876082|21282061|P1|Safety Population|Overall Study||48
8623675|NCT01876082|21282060|P2|STARTED|Overall Study||24
8623676|NCT01876082|21282061|P1|STARTED|Overall Study||48
8623677|NCT01807091|21282073|P1|NOT COMPLETED|Overall Study||0
8623678|NCT01807091|21282073|P1|COMPLETED|Overall Study||17
8623679|NCT01807091|21282073|P1|STARTED|Overall Study||17
8623680|NCT01798004|21282078|P1|NOT COMPLETED|Overall Study||87
8623681|NCT01798004|21282078|P1|COMPLETED|Overall Study||63
8623682|NCT01798004|21282078|P1|STARTED|Overall Study||150
8623683|NCT01745822|21282084|P2|NOT COMPLETED|Overall Study||0
8623684|NCT01745822|21282085|P1|NOT COMPLETED|Overall Study||0
8623685|NCT01745822|21282084|P2|COMPLETED|Overall Study||323
8623686|NCT01745822|21282085|P1|COMPLETED|Overall Study||331
8623687|NCT01745822|21282084|P2|STARTED|Overall Study|163 mothers and 160 infants|323
8623688|NCT01745822|21282085|P1|STARTED|Overall Study|168 mothers and 163 infants|331
8623699|NCT01586039|21282112|P4|NOT COMPLETED|Overall Study||0
8623700|NCT01586039|21282113|P3|NOT COMPLETED|Overall Study||0
8623701|NCT01586039|21282114|P2|NOT COMPLETED|Overall Study||1
8623702|NCT01586039|21282115|P1|NOT COMPLETED|Overall Study||0
8623703|NCT01586039|21282112|P4|COMPLETED|Overall Study||8
8623704|NCT01586039|21282113|P3|COMPLETED|Overall Study||8
8623705|NCT01586039|21282114|P2|COMPLETED|Overall Study||8
8623706|NCT01586039|21282115|P1|COMPLETED|Overall Study||8
8623707|NCT01586039|21282112|P4|STARTED|Overall Study||8
8623708|NCT01586039|21282113|P3|STARTED|Overall Study||8
8623709|NCT01586039|21282114|P2|STARTED|Overall Study||9
8623710|NCT01586039|21282115|P1|STARTED|Overall Study||8
8623711|NCT01350336|21282125|P1|NOT COMPLETED|Overall Study||57
8623712|NCT01350336|21282125|P1|COMPLETED|Overall Study||227
8623713|NCT01350336|21282125|P1|STARTED|Overall Study||284
8623723|NCT01276236|21282288|P1|NOT COMPLETED|Overall Study||6
8623724|NCT01276236|21282288|P1|COMPLETED|Overall Study||7
8623725|NCT01276236|21282288|P1|Week 76 Visit|Overall Study||8
8623726|NCT01276236|21282288|P1|Week 56 Visit|Overall Study||9
8623727|NCT01276236|21282288|P1|Week 36 Visit|Overall Study||13
8623728|NCT01276236|21282288|P1|STARTED|Overall Study||13
8623763|NCT00796445|21282431|P2|NOT COMPLETED|Overall Study||292
8623764|NCT00796445|21282432|P1|NOT COMPLETED|Overall Study||585
8623765|NCT00796445|21282431|P2|COMPLETED|Overall Study||158
8623766|NCT00796445|21282432|P1|COMPLETED|Overall Study||310
8623767|NCT00796445|21282431|P2|STARTED|Overall Study||450
8623768|NCT00796445|21282432|P1|STARTED|Overall Study||895
8623769|NCT00729378|21282484|P2|NOT COMPLETED|36-months||6
8623770|NCT00729378|21282485|P1|NOT COMPLETED|36-months||15
8623771|NCT00729378|21282484|P2|COMPLETED|36-months||95
8623772|NCT00729378|21282485|P1|COMPLETED|36-months||105
8623773|NCT00729378|21282484|P2|STARTED|36-months||101
8623774|NCT00729378|21282485|P1|STARTED|36-months||120
8623775|NCT00729378|21282484|P2|NOT COMPLETED|24-months||51
8623776|NCT00729378|21282485|P1|NOT COMPLETED|24-months||72
8623777|NCT00729378|21282484|P2|COMPLETED|24-months||101
8623778|NCT00729378|21282485|P1|COMPLETED|24-months||120
8623779|NCT00729378|21282484|P2|STARTED|24-months||152
8623780|NCT00729378|21282485|P1|STARTED|24-months||192
8623781|NCT00729378|21282484|P2|NOT COMPLETED|12-months||65
8623782|NCT00729378|21282485|P1|NOT COMPLETED|12-months||100
8623783|NCT00729378|21282484|P2|COMPLETED|12-months||152
8623784|NCT00729378|21282485|P1|COMPLETED|12-months||192
8623785|NCT00729378|21282484|P2|STARTED|12-months||217
8623786|NCT00729378|21282485|P1|STARTED|12-months||292
8623787|NCT00729378|21282484|P2|NOT COMPLETED|Baseline||92
8623788|NCT00729378|21282485|P1|NOT COMPLETED|Baseline||138
8623789|NCT00729378|21282484|P2|COMPLETED|Baseline||217
8623790|NCT00729378|21282485|P1|COMPLETED|Baseline||292
8623791|NCT00729378|21282484|P2|STARTED|Baseline||309
8623792|NCT00729378|21282485|P1|STARTED|Baseline||430
8623793|NCT00606502|21282683|P2|NOT COMPLETED|Treatment||3
8623794|NCT00606502|21282684|P1|NOT COMPLETED|Treatment||0
8623795|NCT00606502|21282683|P2|COMPLETED|Treatment||98
8623796|NCT00606502|21282684|P1|COMPLETED|Treatment||97
8623797|NCT00606502|21282683|P2|STARTED|Treatment||101
8623798|NCT00606502|21282684|P1|STARTED|Treatment||97
8623799|NCT00606502|21282683|P2|NOT COMPLETED|Randomization||0
8623800|NCT00606502|21282684|P1|NOT COMPLETED|Randomization||3
8623801|NCT00606502|21282683|P2|COMPLETED|Randomization||101
8623802|NCT00606502|21282684|P1|COMPLETED|Randomization||97
8623803|NCT00606502|21282683|P2|STARTED|Randomization||101
8623804|NCT00606502|21282684|P1|STARTED|Randomization||100
8623805|NCT00495079|21282696|P1|NOT COMPLETED|Overall Study||0
8623806|NCT00495079|21282696|P1|COMPLETED|Overall Study||65
8623807|NCT00495079|21282696|P1|STARTED|Overall Study||65
8623814|NCT00084682|21282726|P1|NOT COMPLETED|Overall Study||1
8623815|NCT00084682|21282726|P1|COMPLETED|Overall Study||13
8623816|NCT00084682|21282726|P1|STARTED|Overall Study||14
8623817|NCT00066677|21282735|P2|NOT COMPLETED|Overall Study||0
8623818|NCT00066677|21282736|P1|NOT COMPLETED|Overall Study||0
8623819|NCT00066677|21282735|P2|COMPLETED|Overall Study||16
8623820|NCT00066677|21282736|P1|COMPLETED|Overall Study||16
8623821|NCT00066677|21282735|P2|STARTED|Overall Study||16
8623822|NCT00066677|21282736|P1|STARTED|Overall Study||16
8623823|NCT04116684|21282750|P2|NOT COMPLETED|Overall Study||0
8623824|NCT04116684|21282751|P1|NOT COMPLETED|Overall Study||2
8623825|NCT04116684|21282750|P2|COMPLETED|Overall Study||1
8623826|NCT04116684|21282751|P1|COMPLETED|Overall Study||1
8623827|NCT04116684|21282750|P2|STARTED|Overall Study||1
8623828|NCT04116684|21282751|P1|STARTED|Overall Study||3
8623829|NCT03756012|21282769|P1|NOT COMPLETED|Overall Study||0
8623830|NCT03756012|21282769|P1|COMPLETED|Overall Study||15
8623831|NCT03756012|21282769|P1|STARTED|Overall Study||15
8623832|NCT03736785|21282783|P3|NOT COMPLETED|Overall Study||14
8623833|NCT03736785|21282784|P2|NOT COMPLETED|Overall Study||17
8623834|NCT03736785|21282785|P1|NOT COMPLETED|Overall Study||17
8623835|NCT03736785|21282783|P3|COMPLETED|Overall Study||118
8623836|NCT03736785|21282784|P2|COMPLETED|Overall Study||115
8623837|NCT03736785|21282785|P1|COMPLETED|Overall Study||118
8623838|NCT03736785|21282783|P3|STARTED|Overall Study||132
8623839|NCT03736785|21282784|P2|STARTED|Overall Study||132
8623840|NCT03736785|21282785|P1|STARTED|Overall Study||135
8623841|NCT03571646|21282812|P2|NOT COMPLETED|Overall Study||1
8623842|NCT03571646|21282813|P1|NOT COMPLETED|Overall Study||2
8623843|NCT03571646|21282812|P2|COMPLETED|Overall Study||2
8623844|NCT03571646|21282813|P1|COMPLETED|Overall Study||1
8623845|NCT03571646|21282812|P2|STARTED|Overall Study||3
8623846|NCT03571646|21282813|P1|STARTED|Overall Study||3
8623847|NCT03409731|21282821|P1|NOT COMPLETED|Overall Study||3
8623848|NCT03409731|21282821|P1|COMPLETED|Overall Study||132
8623849|NCT03409731|21282821|P1|STARTED|Overall Study||135
8623853|NCT03274999|21282898|P2|NOT COMPLETED|Second Intervention (Day 14)||0
8623854|NCT03274999|21282899|P1|NOT COMPLETED|Second Intervention (Day 14)||0
8623855|NCT03274999|21282898|P2|COMPLETED|Second Intervention (Day 14)||5
8623856|NCT03274999|21282899|P1|COMPLETED|Second Intervention (Day 14)||5
8623857|NCT03274999|21282898|P2|STARTED|Second Intervention (Day 14)||5
8623858|NCT03274999|21282899|P1|STARTED|Second Intervention (Day 14)||5
8623859|NCT03274999|21282898|P2|NOT COMPLETED|First Intervention (Day 0)||0
8623860|NCT03274999|21282899|P1|NOT COMPLETED|First Intervention (Day 0)||0
8623861|NCT03274999|21282898|P2|COMPLETED|First Intervention (Day 0)||5
8623862|NCT03274999|21282899|P1|COMPLETED|First Intervention (Day 0)||5
8623863|NCT03274999|21282898|P2|STARTED|First Intervention (Day 0)||5
8623864|NCT03274999|21282899|P1|STARTED|First Intervention (Day 0)||5
8623871|NCT03155724|21282958|P1|NOT COMPLETED|Overall Study||11
8623872|NCT03155724|21282958|P1|COMPLETED|Overall Study||42
8623873|NCT03155724|21282958|P1|STARTED|Overall Study||53
8623886|NCT02580058|21282997|P3|NOT COMPLETED|Overall Study||86
8623887|NCT02580058|21282998|P2|NOT COMPLETED|Overall Study||86
8623888|NCT02580058|21282999|P1|NOT COMPLETED|Overall Study||79
8623889|NCT02580058|21282997|P3|COMPLETED|Overall Study||104
8623890|NCT02580058|21282998|P2|COMPLETED|Overall Study||102
8623891|NCT02580058|21282999|P1|COMPLETED|Overall Study||109
8623892|NCT02580058|21282997|P3|Treated|Overall Study||177
8623893|NCT02580058|21282998|P2|Treated|Overall Study||182
8623894|NCT02580058|21282999|P1|Treated|Overall Study||187
8623895|NCT02580058|21282997|P3|STARTED|Overall Study||190
8623896|NCT02580058|21282998|P2|STARTED|Overall Study||188
8623897|NCT02580058|21282999|P1|STARTED|Overall Study||188
8623898|NCT02561195|21283070|P14|NOT COMPLETED|Extension Stage (Vaccination 4)||5
8623899|NCT02561195|21283071|P13|NOT COMPLETED|Extension Stage (Vaccination 4)||7
8623900|NCT02561195|21283072|P12|NOT COMPLETED|Extension Stage (Vaccination 4)||7
8623901|NCT02561195|21283073|P11|NOT COMPLETED|Extension Stage (Vaccination 4)||8
8623902|NCT02561195|21283074|P10|NOT COMPLETED|Extension Stage (Vaccination 4)||2
8623903|NCT02561195|21283075|P9|NOT COMPLETED|Extension Stage (Vaccination 4)||3
8623904|NCT02561195|21283076|P8|NOT COMPLETED|Extension Stage (Vaccination 4)||1
8623905|NCT02561195|21283077|P7|NOT COMPLETED|Extension Stage (Vaccination 4)||2
8623906|NCT02561195|21283078|P6|NOT COMPLETED|Extension Stage (Vaccination 4)||0
8623907|NCT02561195|21283079|P5|NOT COMPLETED|Extension Stage (Vaccination 4)||0
8623908|NCT02561195|21283080|P4|NOT COMPLETED|Extension Stage (Vaccination 4)||0
8623909|NCT02561195|21283081|P3|NOT COMPLETED|Extension Stage (Vaccination 4)||0
8623910|NCT02561195|21283082|P2|NOT COMPLETED|Extension Stage (Vaccination 4)||0
8623911|NCT02561195|21283083|P1|NOT COMPLETED|Extension Stage (Vaccination 4)||0
8623912|NCT02561195|21283070|P14|COMPLETED|Extension Stage (Vaccination 4)||54
8623913|NCT02561195|21283071|P13|COMPLETED|Extension Stage (Vaccination 4)||51
8623914|NCT02561195|21283072|P12|COMPLETED|Extension Stage (Vaccination 4)||45
8623915|NCT02561195|21283073|P11|COMPLETED|Extension Stage (Vaccination 4)||43
8623916|NCT02561195|21283074|P10|COMPLETED|Extension Stage (Vaccination 4)||20
8623917|NCT02561195|21283075|P9|COMPLETED|Extension Stage (Vaccination 4)||21
8623918|NCT02561195|21283076|P8|COMPLETED|Extension Stage (Vaccination 4)||17
8623919|NCT02561195|21283077|P7|COMPLETED|Extension Stage (Vaccination 4)||14
8623920|NCT02561195|21283078|P6|COMPLETED|Extension Stage (Vaccination 4)||0
8623921|NCT02561195|21283079|P5|COMPLETED|Extension Stage (Vaccination 4)||0
8623922|NCT02561195|21283080|P4|COMPLETED|Extension Stage (Vaccination 4)||0
8623923|NCT02561195|21283081|P3|COMPLETED|Extension Stage (Vaccination 4)||0
8623924|NCT02561195|21283082|P2|COMPLETED|Extension Stage (Vaccination 4)||0
8623925|NCT02561195|21283083|P1|COMPLETED|Extension Stage (Vaccination 4)||0
8623926|NCT02561195|21283070|P14|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|59
8623927|NCT02561195|21283071|P13|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|58
8623928|NCT02561195|21283072|P12|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|52
8623929|NCT02561195|21283073|P11|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|51
8623930|NCT02561195|21283074|P10|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|22
8623931|NCT02561195|21283075|P9|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|24
8623932|NCT02561195|21283076|P8|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|18
8623933|NCT02561195|21283077|P7|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|16
8623934|NCT02561195|21283078|P6|STARTED|Extension Stage (Vaccination 4)||0
8623935|NCT02561195|21283079|P5|STARTED|Extension Stage (Vaccination 4)||0
8623936|NCT02561195|21283080|P4|STARTED|Extension Stage (Vaccination 4)||0
8623937|NCT02561195|21283081|P3|STARTED|Extension Stage (Vaccination 4)||0
8623938|NCT02561195|21283082|P2|STARTED|Extension Stage (Vaccination 4)||0
8623939|NCT02561195|21283083|P1|STARTED|Extension Stage (Vaccination 4)||0
8623940|NCT02561195|21283070|P14|NOT COMPLETED|Vaccination 1 to 3||0
8623941|NCT02561195|21283071|P13|NOT COMPLETED|Vaccination 1 to 3||0
8623942|NCT02561195|21283072|P12|NOT COMPLETED|Vaccination 1 to 3||0
8623943|NCT02561195|21283073|P11|NOT COMPLETED|Vaccination 1 to 3||0
8623944|NCT02561195|21283074|P10|NOT COMPLETED|Vaccination 1 to 3||0
8623945|NCT02561195|21283075|P9|NOT COMPLETED|Vaccination 1 to 3||0
8623946|NCT02561195|21283076|P8|NOT COMPLETED|Vaccination 1 to 3||0
8623947|NCT02561195|21283077|P7|NOT COMPLETED|Vaccination 1 to 3||0
8623948|NCT02561195|21283078|P6|NOT COMPLETED|Vaccination 1 to 3||10
8623949|NCT02561195|21283079|P5|NOT COMPLETED|Vaccination 1 to 3||28
8623950|NCT02561195|21283080|P4|NOT COMPLETED|Vaccination 1 to 3||26
8623951|NCT02561195|21283081|P3|NOT COMPLETED|Vaccination 1 to 3||6
8623952|NCT02561195|21283082|P2|NOT COMPLETED|Vaccination 1 to 3||22
8623953|NCT02561195|21283083|P1|NOT COMPLETED|Vaccination 1 to 3||23
8623954|NCT02561195|21283070|P14|COMPLETED|Vaccination 1 to 3||0
8623955|NCT02561195|21283071|P13|COMPLETED|Vaccination 1 to 3||0
8623956|NCT02561195|21283072|P12|COMPLETED|Vaccination 1 to 3||0
8623957|NCT02561195|21283073|P11|COMPLETED|Vaccination 1 to 3||0
8623958|NCT02561195|21283074|P10|COMPLETED|Vaccination 1 to 3||0
8623959|NCT02561195|21283075|P9|COMPLETED|Vaccination 1 to 3||0
8623960|NCT02561195|21283076|P8|COMPLETED|Vaccination 1 to 3||0
8623961|NCT02561195|21283077|P7|COMPLETED|Vaccination 1 to 3||0
8623962|NCT02561195|21283078|P6|COMPLETED|Vaccination 1 to 3||51
8623963|NCT02561195|21283079|P5|COMPLETED|Vaccination 1 to 3||155
8623964|NCT02561195|21283080|P4|COMPLETED|Vaccination 1 to 3||157
8623965|NCT02561195|21283081|P3|COMPLETED|Vaccination 1 to 3||55
8623966|NCT02561195|21283082|P2|COMPLETED|Vaccination 1 to 3||162
8623967|NCT02561195|21283083|P1|COMPLETED|Vaccination 1 to 3||160
8623968|NCT02561195|21283070|P14|Treated|Vaccination 1 to 3||0
8623969|NCT02561195|21283071|P13|Treated|Vaccination 1 to 3||0
8623970|NCT02561195|21283072|P12|Treated|Vaccination 1 to 3||0
8623971|NCT02561195|21283073|P11|Treated|Vaccination 1 to 3||0
8623972|NCT02561195|21283074|P10|Treated|Vaccination 1 to 3||0
8623973|NCT02561195|21283075|P9|Treated|Vaccination 1 to 3||0
8623974|NCT02561195|21283076|P8|Treated|Vaccination 1 to 3||0
8623975|NCT02561195|21283077|P7|Treated|Vaccination 1 to 3||0
8623976|NCT02561195|21283078|P6|Treated|Vaccination 1 to 3||61
8623977|NCT02561195|21283079|P5|Treated|Vaccination 1 to 3||183
8623978|NCT02561195|21283080|P4|Treated|Vaccination 1 to 3||183
8623979|NCT02561195|21283081|P3|Treated|Vaccination 1 to 3||61
8623980|NCT02561195|21283082|P2|Treated|Vaccination 1 to 3||184
8623981|NCT02561195|21283083|P1|Treated|Vaccination 1 to 3||182
8623982|NCT02561195|21283070|P14|STARTED|Vaccination 1 to 3||0
8623983|NCT02561195|21283071|P13|STARTED|Vaccination 1 to 3||0
8623984|NCT02561195|21283072|P12|STARTED|Vaccination 1 to 3||0
8623985|NCT02561195|21283073|P11|STARTED|Vaccination 1 to 3||0
8623986|NCT02561195|21283074|P10|STARTED|Vaccination 1 to 3||0
8623987|NCT02561195|21283075|P9|STARTED|Vaccination 1 to 3||0
8623988|NCT02561195|21283076|P8|STARTED|Vaccination 1 to 3||0
8623989|NCT02561195|21283077|P7|STARTED|Vaccination 1 to 3||0
8623990|NCT02561195|21283078|P6|STARTED|Vaccination 1 to 3||61
8623991|NCT02561195|21283079|P5|STARTED|Vaccination 1 to 3||183
8623992|NCT02561195|21283080|P4|STARTED|Vaccination 1 to 3||183
8623993|NCT02561195|21283081|P3|STARTED|Vaccination 1 to 3||61
8623994|NCT02561195|21283082|P2|STARTED|Vaccination 1 to 3||184
8623995|NCT02561195|21283083|P1|STARTED|Vaccination 1 to 3||183
8623996|NCT02300220|21283339|P2|NOT COMPLETED|Overall Study||7
8623997|NCT02300220|21283340|P1|NOT COMPLETED|Overall Study||4
8623998|NCT02300220|21283339|P2|COMPLETED|Overall Study||65
8623999|NCT02300220|21283340|P1|COMPLETED|Overall Study||68
8624000|NCT02300220|21283339|P2|STARTED|Overall Study||72
8624001|NCT02300220|21283340|P1|STARTED|Overall Study||72
8624005|NCT02284386|21283360|P1|NOT COMPLETED|Overall Study||0
8624006|NCT02284386|21283360|P1|COMPLETED|Overall Study||15
8624007|NCT02284386|21283360|P1|STARTED|Overall Study||15
8624008|NCT02275819|21283371|P2|NOT COMPLETED|Overall Study||1
8624009|NCT02275819|21283372|P1|NOT COMPLETED|Overall Study||0
8624010|NCT02275819|21283371|P2|COMPLETED|Overall Study||5
8624011|NCT02275819|21283372|P1|COMPLETED|Overall Study||5
8624012|NCT02275819|21283371|P2|STARTED|Overall Study||6
8624013|NCT02275819|21283372|P1|STARTED|Overall Study||5
8624014|NCT02255500|21283388|P2|NOT COMPLETED|Overall Study||0
8624015|NCT02255500|21283389|P1|NOT COMPLETED|Overall Study||1
8624016|NCT02255500|21283388|P2|COMPLETED|Overall Study||7
8624017|NCT02255500|21283389|P1|COMPLETED|Overall Study||15
8624018|NCT02255500|21283388|P2|STARTED|Overall Study||7
8624019|NCT02255500|21283389|P1|STARTED|Overall Study||16
8624032|NCT02199574|21283423|P1|NOT COMPLETED|Overall Study||0
8624033|NCT02199574|21283423|P1|COMPLETED|Overall Study||12
8624034|NCT02199574|21283423|P1|STARTED|Overall Study||12
8624041|NCT01801124|21283451|P1|NOT COMPLETED|Overall Study||0
8624042|NCT01801124|21283451|P1|COMPLETED|Overall Study||13
8624043|NCT01801124|21283451|P1|STARTED|Overall Study||13
8624044|NCT01801007|21283456|P1|NOT COMPLETED|Overall Study||11
8624045|NCT01801007|21283456|P1|COMPLETED|Overall Study||134
8624046|NCT01801007|21283456|P1|STARTED|Overall Study||145
8624062|NCT01669928|21283485|P2|NOT COMPLETED|Second Intervention||0
8624063|NCT01669928|21283486|P1|NOT COMPLETED|Second Intervention||0
8624064|NCT01669928|21283485|P2|COMPLETED|Second Intervention||47
8624065|NCT01669928|21283486|P1|COMPLETED|Second Intervention||48
8624066|NCT01669928|21283485|P2|STARTED|Second Intervention||47
8624067|NCT01669928|21283486|P1|STARTED|Second Intervention||48
8624068|NCT01669928|21283485|P2|NOT COMPLETED|First Intervention||5
8624069|NCT01669928|21283486|P1|NOT COMPLETED|First Intervention||3
8624070|NCT01669928|21283485|P2|COMPLETED|First Intervention||47
8624071|NCT01669928|21283486|P1|COMPLETED|First Intervention||48
8624072|NCT01669928|21283485|P2|STARTED|First Intervention||52
8624073|NCT01669928|21283486|P1|STARTED|First Intervention||51
8624074|NCT01500733|21283510|P2|NOT COMPLETED|Overall Study||3
8624075|NCT01500733|21283511|P1|NOT COMPLETED|Overall Study||2
8624076|NCT01500733|21283510|P2|COMPLETED|Overall Study||48
8624077|NCT01500733|21283511|P1|COMPLETED|Overall Study||33
8624078|NCT01500733|21283510|P2|STARTED|Overall Study||51
8624079|NCT01500733|21283511|P1|STARTED|Overall Study||35
8624080|NCT01440920|21283520|P3|NOT COMPLETED|Overall Study||0
8624081|NCT01440920|21283521|P2|NOT COMPLETED|Overall Study||0
8624082|NCT01440920|21283522|P1|NOT COMPLETED|Overall Study||0
8624083|NCT01440920|21283520|P3|COMPLETED|Overall Study||3
8624084|NCT01440920|21283521|P2|COMPLETED|Overall Study||3
8624085|NCT01440920|21283522|P1|COMPLETED|Overall Study||3
8624086|NCT01440920|21283520|P3|STARTED|Overall Study||3
8624087|NCT01440920|21283521|P2|STARTED|Overall Study||3
8624088|NCT01440920|21283522|P1|STARTED|Overall Study||3
8624095|NCT01253070|21283537|P1|NOT COMPLETED|Overall Study||0
8624096|NCT01253070|21283537|P1|COMPLETED|Overall Study||54
8624097|NCT01253070|21283537|P1|STARTED|Overall Study||54
8624098|NCT01145209|21283548|P2|NOT COMPLETED|Overall Study||1
8624099|NCT01145209|21283549|P1|NOT COMPLETED|Overall Study||3
8624100|NCT01145209|21283548|P2|COMPLETED|Overall Study||18
8624101|NCT01145209|21283549|P1|COMPLETED|Overall Study||10
8624102|NCT01145209|21283548|P2|STARTED|Overall Study||19
8624103|NCT01145209|21283549|P1|STARTED|Overall Study||13
8624104|NCT01044576|21283555|P1|NOT COMPLETED|Overall Study||0
8624105|NCT01044576|21283555|P1|COMPLETED|Overall Study||200
8624106|NCT01044576|21283555|P1|STARTED|Overall Study||200
8624128|NCT04161144|21283628|P2|NOT COMPLETED|Overall Study||1
8624129|NCT04161144|21283629|P1|NOT COMPLETED|Overall Study||1
8624130|NCT04161144|21283628|P2|COMPLETED|Overall Study||9
8624131|NCT04161144|21283629|P1|COMPLETED|Overall Study||11
8624132|NCT04161144|21283628|P2|STARTED|Overall Study||10
8624133|NCT04161144|21283629|P1|STARTED|Overall Study||12
8624134|NCT04036110|21283642|P3|NOT COMPLETED|Overall Study||2
8624135|NCT04036110|21283643|P2|NOT COMPLETED|Overall Study||7
8624136|NCT04036110|21283644|P1|NOT COMPLETED|Overall Study||7
8624137|NCT04036110|21283642|P3|COMPLETED|Overall Study||10
8624138|NCT04036110|21283643|P2|COMPLETED|Overall Study||5
8624139|NCT04036110|21283644|P1|COMPLETED|Overall Study||5
8624140|NCT04036110|21283642|P3|STARTED|Overall Study||12
8624141|NCT04036110|21283643|P2|STARTED|Overall Study||12
8624142|NCT04036110|21283644|P1|STARTED|Overall Study||12
8624143|NCT03946059|21283669|P2|NOT COMPLETED|Overall Study||1
8624144|NCT03946059|21283670|P1|NOT COMPLETED|Overall Study||0
8624145|NCT03946059|21283669|P2|COMPLETED|Overall Study||11
8624146|NCT03946059|21283670|P1|COMPLETED|Overall Study||13
8624147|NCT03946059|21283669|P2|STARTED|Overall Study||12
8624148|NCT03946059|21283670|P1|STARTED|Overall Study||13
8624149|NCT03861338|21283678|P1|NOT COMPLETED|Overall Study||2
8624150|NCT03861338|21283678|P1|COMPLETED|Overall Study||8
8624151|NCT03861338|21283678|P1|STARTED|Overall Study||10
8624152|NCT03750955|21283684|P2|NOT COMPLETED|Resolution Phase of 2 Weeks||0
8624153|NCT03750955|21283685|P1|NOT COMPLETED|Resolution Phase of 2 Weeks||0
8624154|NCT03750955|21283684|P2|COMPLETED|Resolution Phase of 2 Weeks||13
8624155|NCT03750955|21283685|P1|COMPLETED|Resolution Phase of 2 Weeks||13
8624156|NCT03750955|21283684|P2|STARTED|Resolution Phase of 2 Weeks|Oral hygiene maintenance continued.|13
8624157|NCT03750955|21283685|P1|STARTED|Resolution Phase of 2 Weeks|No stent in use; oral hygiene resumed.|13
8624158|NCT03750955|21283684|P2|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
8624159|NCT03750955|21283685|P1|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
8624160|NCT03750955|21283684|P2|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 randomized to R max. sextant oral hygiene maintenance (OHM); 7 randomized to L max. sextant OHM.|13
8624161|NCT03750955|21283685|P1|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 participants randomized to L maxillary sextant SIBO; 7 randomized to R maxillary sextant SIBO.|13
8624162|NCT03750955|21283684|P2|STARTED|Gingivitis Induction Phase of 2 Weeks||13
8624163|NCT03750955|21283685|P1|STARTED|Gingivitis Induction Phase of 2 Weeks||13
8624164|NCT03750955|21283684|P2|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
8624165|NCT03750955|21283685|P1|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
8624166|NCT03750955|21283684|P2|COMPLETED|Hygiene Phase of 2 Weeks||13
8624167|NCT03750955|21283685|P1|COMPLETED|Hygiene Phase of 2 Weeks||13
8624168|NCT03750955|21283684|P2|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
8624169|NCT03750955|21283685|P1|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
8624170|NCT03661983|21283701|P4|NOT COMPLETED|Double-blind Randomized Phase||8
8624171|NCT03661983|21283702|P3|NOT COMPLETED|Double-blind Randomized Phase||1
8624172|NCT03661983|21283703|P2|NOT COMPLETED|Double-blind Randomized Phase||2
8624173|NCT03661983|21283704|P1|NOT COMPLETED|Double-blind Randomized Phase||0
8624174|NCT03661983|21283701|P4|COMPLETED|Double-blind Randomized Phase||0
8624175|NCT03661983|21283702|P3|COMPLETED|Double-blind Randomized Phase||7
8624176|NCT03661983|21283703|P2|COMPLETED|Double-blind Randomized Phase||7
8624177|NCT03661983|21283704|P1|COMPLETED|Double-blind Randomized Phase||0
8624178|NCT03661983|21283701|P4|STARTED|Double-blind Randomized Phase||8
8624179|NCT03661983|21283702|P3|STARTED|Double-blind Randomized Phase||8
8624180|NCT03661983|21283703|P2|STARTED|Double-blind Randomized Phase||9
8624181|NCT03661983|21283704|P1|STARTED|Double-blind Randomized Phase||0
8624182|NCT03661983|21283701|P4|NOT COMPLETED|Open Label Stabilization Phase||0
8624183|NCT03661983|21283702|P3|NOT COMPLETED|Open Label Stabilization Phase||0
8624184|NCT03661983|21283703|P2|NOT COMPLETED|Open Label Stabilization Phase||0
8624185|NCT03661983|21283704|P1|NOT COMPLETED|Open Label Stabilization Phase||11
8624186|NCT03661983|21283701|P4|COMPLETED|Open Label Stabilization Phase||0
8624187|NCT03661983|21283702|P3|COMPLETED|Open Label Stabilization Phase||0
8624188|NCT03661983|21283703|P2|COMPLETED|Open Label Stabilization Phase||0
8624189|NCT03661983|21283704|P1|COMPLETED|Open Label Stabilization Phase||25
8624190|NCT03661983|21283701|P4|STARTED|Open Label Stabilization Phase||0
8624191|NCT03661983|21283702|P3|STARTED|Open Label Stabilization Phase||0
8624192|NCT03661983|21283703|P2|STARTED|Open Label Stabilization Phase||0
8624193|NCT03661983|21283704|P1|STARTED|Open Label Stabilization Phase||36
8624194|NCT03572478|21283713|P1|NOT COMPLETED|Overall Study||0
8624195|NCT03572478|21283713|P1|COMPLETED|Overall Study||12
8624196|NCT03572478|21283713|P1|STARTED|Overall Study||12
8624197|NCT03515824|21283727|P4|NOT COMPLETED|Overall Study||0
8624198|NCT03515824|21283728|P3|NOT COMPLETED|Overall Study||15
8624199|NCT03515824|21283729|P2|NOT COMPLETED|Overall Study||4
8624200|NCT03515824|21283730|P1|NOT COMPLETED|Overall Study||3
8624201|NCT03515824|21283727|P4|COMPLETED|Overall Study||0
8624202|NCT03515824|21283728|P3|COMPLETED|Overall Study||0
8624203|NCT03515824|21283729|P2|COMPLETED|Overall Study||0
8624204|NCT03515824|21283730|P1|COMPLETED|Overall Study||0
8624205|NCT03515824|21283727|P4|STARTED|Overall Study||0
8624206|NCT03515824|21283728|P3|STARTED|Overall Study||15
8624207|NCT03515824|21283729|P2|STARTED|Overall Study||4
8624208|NCT03515824|21283730|P1|STARTED|Overall Study||3
8624209|NCT03395808|21283762|P1|NOT COMPLETED|Overall Study||0
8624210|NCT03395808|21283762|P1|COMPLETED|Overall Study||251
8624211|NCT03395808|21283762|P1|STARTED|Overall Study||251
8624212|NCT03333109|21283769|P3|NOT COMPLETED|Safety Follow-up Period||13
8624213|NCT03333109|21283770|P2|NOT COMPLETED|Safety Follow-up Period||4
8624214|NCT03333109|21283771|P1|NOT COMPLETED|Safety Follow-up Period||13
8624215|NCT03333109|21283769|P3|COMPLETED|Safety Follow-up Period||315
8624216|NCT03333109|21283770|P2|COMPLETED|Safety Follow-up Period||214
8624217|NCT03333109|21283771|P1|COMPLETED|Safety Follow-up Period||311
8624218|NCT03333109|21283769|P3|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|328
8624219|NCT03333109|21283770|P2|STARTED|Safety Follow-up Period||218
8624220|NCT03333109|21283771|P1|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|324
8624221|NCT03333109|21283769|P3|NOT COMPLETED|Double-blind Treatment Period (DBTP)||12
8624222|NCT03333109|21283770|P2|NOT COMPLETED|Double-blind Treatment Period (DBTP)||6
8624223|NCT03333109|21283771|P1|NOT COMPLETED|Double-blind Treatment Period (DBTP)||17
8624224|NCT03333109|21283769|P3|COMPLETED|Double-blind Treatment Period (DBTP)||326
8624225|NCT03333109|21283770|P2|COMPLETED|Double-blind Treatment Period (DBTP)||218
8624226|NCT03333109|21283771|P1|COMPLETED|Double-blind Treatment Period (DBTP)||321
8624227|NCT03333109|21283769|P3|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
8624228|NCT03333109|21283770|P2|Safety Analysis Set|Double-blind Treatment Period (DBTP)||224
8624229|NCT03333109|21283771|P1|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
8624230|NCT03333109|21283769|P3|Full Analysis Set|Double-blind Treatment Period (DBTP)||330
8624231|NCT03333109|21283770|P2|Full Analysis Set|Double-blind Treatment Period (DBTP)||219
8624232|NCT03333109|21283771|P1|Full Analysis Set|Double-blind Treatment Period (DBTP)||329
8624233|NCT03333109|21283769|P3|STARTED|Double-blind Treatment Period (DBTP)||338
8624234|NCT03333109|21283770|P2|STARTED|Double-blind Treatment Period (DBTP)||224
8624235|NCT03333109|21283771|P1|STARTED|Double-blind Treatment Period (DBTP)||338
8624248|NCT03225313|21283834|P3|NOT COMPLETED|Overall Study||0
8624249|NCT03225313|21283835|P2|NOT COMPLETED|Overall Study||0
8624250|NCT03225313|21283836|P1|NOT COMPLETED|Overall Study||0
8624251|NCT03225313|21283834|P3|COMPLETED|Overall Study|25 Patients|25
8624252|NCT03225313|21283835|P2|COMPLETED|Overall Study|25 Patients|25
8624253|NCT03225313|21283836|P1|COMPLETED|Overall Study|25 Patients|25
8624254|NCT03225313|21283834|P3|STARTED|Overall Study|25 Patients|25
8624255|NCT03225313|21283835|P2|STARTED|Overall Study|25 Patients|25
8624256|NCT03225313|21283836|P1|STARTED|Overall Study|25 Patients|25
8624257|NCT03225001|21283868|P1|NOT COMPLETED|Overall Study||9
8624258|NCT03225001|21283868|P1|COMPLETED|Overall Study||188
8624259|NCT03225001|21283868|P1|Valve-Implanted|Overall Study||195
8624260|NCT03225001|21283868|P1|STARTED|Overall Study||197
8624261|NCT03001843|21283875|P2|NOT COMPLETED|Overall Study||0
8624262|NCT03001843|21283876|P1|NOT COMPLETED|Overall Study||0
8624263|NCT03001843|21283875|P2|COMPLETED|Overall Study||27
8624264|NCT03001843|21283876|P1|COMPLETED|Overall Study||27
8624265|NCT03001843|21283875|P2|STARTED|Overall Study||27
8624266|NCT03001843|21283876|P1|STARTED|Overall Study||27
8624267|NCT02939651|21283884|P1|NOT COMPLETED|Overall Study||0
8624268|NCT02939651|21283884|P1|COMPLETED|Overall Study||21
8624269|NCT02939651|21283884|P1|STARTED|Overall Study||21
8624300|NCT02880176|21284452|P2|NOT COMPLETED|Overall Study||2
8624301|NCT02880176|21284453|P1|NOT COMPLETED|Overall Study||3
8624302|NCT02880176|21284452|P2|COMPLETED|Overall Study||9
8624303|NCT02880176|21284453|P1|COMPLETED|Overall Study||20
8624304|NCT02880176|21284452|P2|Responded to 30 Day Survey|Overall Study||9
8624305|NCT02880176|21284453|P1|Responded to 30 Day Survey|Overall Study||20
8624306|NCT02880176|21284452|P2|Collected Postop Step Data|Overall Study||11
8624307|NCT02880176|21284453|P1|Collected Postop Step Data|Overall Study||22
8624308|NCT02880176|21284452|P2|Underwent Cystectomy|Overall Study||11
8624309|NCT02880176|21284453|P1|Underwent Cystectomy|Overall Study||22
8624310|NCT02880176|21284452|P2|STARTED|Overall Study||11
8624311|NCT02880176|21284453|P1|STARTED|Overall Study||23
8624321|NCT02839876|21284600|P2|NOT COMPLETED|Overall Study||11
8624322|NCT02839876|21284601|P1|NOT COMPLETED|Overall Study||10
8624323|NCT02839876|21284600|P2|COMPLETED|Overall Study||29
8624324|NCT02839876|21284601|P1|COMPLETED|Overall Study||31
8624325|NCT02839876|21284600|P2|STARTED|Overall Study||40
8624326|NCT02839876|21284601|P1|STARTED|Overall Study||41
8624327|NCT02818920|21284663|P1|NOT COMPLETED|Overall Study||18
8624328|NCT02818920|21284663|P1|COMPLETED|Overall Study||12
8624329|NCT02818920|21284663|P1|Received Adjuvant Therapy|Overall Study||17
8624330|NCT02818920|21284663|P1|Completed Surgery|Overall Study||25
8624331|NCT02818920|21284663|P1|STARTED|Overall Study||30
8624338|NCT02643459|21284678|P2|NOT COMPLETED|Overall Study||0
8624339|NCT02643459|21284679|P1|NOT COMPLETED|Overall Study||0
8624340|NCT02643459|21284678|P2|COMPLETED|Overall Study||8900
8624341|NCT02643459|21284679|P1|COMPLETED|Overall Study||7901
8624342|NCT02643459|21284678|P2|STARTED|Overall Study||8900
8624343|NCT02643459|21284679|P1|STARTED|Overall Study||7901
8624344|NCT02633540|21284699|P1|NOT COMPLETED|Overall Study||0
8624345|NCT02633540|21284699|P1|COMPLETED|Overall Study||2
8624346|NCT02633540|21284699|P1|STARTED|Overall Study||2
8624347|NCT02583711|21284708|P3|NOT COMPLETED|Overall Study||0
8624348|NCT02583711|21284709|P2|NOT COMPLETED|Overall Study||10
8624349|NCT02583711|21284710|P1|NOT COMPLETED|Overall Study||0
8624350|NCT02583711|21284708|P3|COMPLETED|Overall Study||10
8624351|NCT02583711|21284709|P2|COMPLETED|Overall Study||28
8624352|NCT02583711|21284710|P1|COMPLETED|Overall Study||11
8624353|NCT02583711|21284708|P3|STARTED|Overall Study||10
8624354|NCT02583711|21284709|P2|STARTED|Overall Study||38
8624355|NCT02583711|21284710|P1|STARTED|Overall Study||11
8624356|NCT02561000|21284736|P3|NOT COMPLETED|Overall Study||0
8624357|NCT02561000|21284737|P2|NOT COMPLETED|Overall Study||4
8624358|NCT02561000|21284738|P1|NOT COMPLETED|Overall Study||2
8624359|NCT02561000|21284736|P3|COMPLETED|Overall Study||31
8624360|NCT02561000|21284737|P2|COMPLETED|Overall Study||31
8624361|NCT02561000|21284738|P1|COMPLETED|Overall Study||32
8624362|NCT02561000|21284736|P3|Intent-to-Treat (ITT) Population at 90 Days|Overall Study||31
8624363|NCT02561000|21284737|P2|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 4 patients: 2 patients withdrew full consent immediately after randomization; 1 patient followed only for 30 day ITT outcome (did not receive any study drug due to adverse event post randomization); and 1 patient withdrew consent for follow-up 7 days after study drug dosing.|31
8624364|NCT02561000|21284738|P1|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 1 patient who withdrew consent for follow-up 21 days after study drug dosing.|33
8624365|NCT02561000|21284736|P3|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||31
8624366|NCT02561000|21284737|P2|Intent-to-Treat (ITT) Population at 30 Days|Overall Study|Excludes 2 patients who withdrew full consent immediately after randomization.|33
8624367|NCT02561000|21284738|P1|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||34
8624368|NCT02561000|21284736|P3|Safety Population|Overall Study||31
8624369|NCT02561000|21284737|P2|Safety Population|Overall Study|Excludes 4 patients who did not receive the study drug as allocated: 1 patient received placebo in error and was evaluated as placebo for primary safety outcome and adverse events; 2 patients withdrew full consent immediately after randomization prior to receiving any study drug; and 1 patient had an adverse event shortly after randomization prior to receiving any study drug.|31
8624370|NCT02561000|21284738|P1|Safety Population|Overall Study|Includes 1 additional patient who was assigned PZ-128 0.3 mg/kg but received placebo in error (evaluated as placebo for primary safety outcome and adverse events).|35
8624371|NCT02561000|21284736|P3|STARTED|Overall Study||31
8624372|NCT02561000|21284737|P2|STARTED|Overall Study||35
8624373|NCT02561000|21284738|P1|STARTED|Overall Study||34
8624374|NCT02539459|21284752|P1|NOT COMPLETED|Overall Study||2
8624375|NCT02539459|21284752|P1|COMPLETED|Overall Study||18
8624376|NCT02539459|21284752|P1|STARTED|Overall Study||20
8624380|NCT02399475|21284765|P2|NOT COMPLETED|Overall Study||0
8624381|NCT02399475|21284766|P1|NOT COMPLETED|Overall Study||1
8624382|NCT02399475|21284765|P2|COMPLETED|Overall Study||7
8624383|NCT02399475|21284766|P1|COMPLETED|Overall Study||6
8624384|NCT02399475|21284765|P2|STARTED|Overall Study||7
8624385|NCT02399475|21284766|P1|STARTED|Overall Study||7
8624386|NCT02396849|21284780|P2|NOT COMPLETED|Overall Study||2
8624387|NCT02396849|21284781|P1|NOT COMPLETED|Overall Study||2
8624388|NCT02396849|21284780|P2|COMPLETED|Overall Study||28
8624389|NCT02396849|21284781|P1|COMPLETED|Overall Study||27
8624390|NCT02396849|21284780|P2|STARTED|Overall Study||30
8624391|NCT02396849|21284781|P1|STARTED|Overall Study||29
8624392|NCT02355067|21284791|P2|NOT COMPLETED|Overall Study||8
8624393|NCT02355067|21284792|P1|NOT COMPLETED|Overall Study||8
8624394|NCT02355067|21284791|P2|COMPLETED|Overall Study||12
8624395|NCT02355067|21284792|P1|COMPLETED|Overall Study||12
8624396|NCT02355067|21284791|P2|STARTED|Overall Study||20
8624397|NCT02355067|21284792|P1|STARTED|Overall Study||20
8624398|NCT02249832|21284804|P1|NOT COMPLETED|Overall Study||13
8624399|NCT02249832|21284804|P1|COMPLETED|Overall Study||42
8624400|NCT02249832|21284804|P1|STARTED|Overall Study||55
8624401|NCT02181413|21284818|P2|NOT COMPLETED|Overall Study||197
8624402|NCT02181413|21284819|P1|NOT COMPLETED|Overall Study||152
8624403|NCT02181413|21284818|P2|COMPLETED|Overall Study||198
8624404|NCT02181413|21284819|P1|COMPLETED|Overall Study||109
8624405|NCT02181413|21284818|P2|Per Protocol (PP) Population|Overall Study||387
8624406|NCT02181413|21284819|P1|Per Protocol (PP) Population|Overall Study||256
8624407|NCT02181413|21284818|P2|Safety Population|Overall Study||394
8624408|NCT02181413|21284819|P1|Safety Population|Overall Study||259
8624409|NCT02181413|21284818|P2|Intent-to-Treat (ITT) Population|Overall Study||395
8624410|NCT02181413|21284819|P1|Intent-to-Treat (ITT) Population|Overall Study||261
8624411|NCT02181413|21284818|P2|STARTED|Overall Study||395
8624412|NCT02181413|21284819|P1|STARTED|Overall Study||261
8624413|NCT02110758|21284830|P5|NOT COMPLETED|Follow-Up: January-July 2016||0
8624414|NCT02110758|21284831|P4|NOT COMPLETED|Follow-Up: January-July 2016||0
8624415|NCT02110758|21284832|P3|NOT COMPLETED|Follow-Up: January-July 2016||0
8624416|NCT02110758|21284833|P2|NOT COMPLETED|Follow-Up: January-July 2016||0
8624417|NCT02110758|21284834|P1|NOT COMPLETED|Follow-Up: January-July 2016||0
8624418|NCT02110758|21284830|P5|COMPLETED|Follow-Up: January-July 2016||349
8624419|NCT02110758|21284831|P4|COMPLETED|Follow-Up: January-July 2016||24392
8624420|NCT02110758|21284832|P3|COMPLETED|Follow-Up: January-July 2016||6451
8624421|NCT02110758|21284833|P2|COMPLETED|Follow-Up: January-July 2016||179
8624422|NCT02110758|21284834|P1|COMPLETED|Follow-Up: January-July 2016||81
8624423|NCT02110758|21284830|P5|STARTED|Follow-Up: January-July 2016||349
8624424|NCT02110758|21284831|P4|STARTED|Follow-Up: January-July 2016||24392
8624425|NCT02110758|21284832|P3|STARTED|Follow-Up: January-July 2016||6451
8624426|NCT02110758|21284833|P2|STARTED|Follow-Up: January-July 2016||179
8624427|NCT02110758|21284834|P1|STARTED|Follow-Up: January-July 2016||81
8624428|NCT02110758|21284830|P5|NOT COMPLETED|Intervention: July 2014-December 2015||0
8624429|NCT02110758|21284831|P4|NOT COMPLETED|Intervention: July 2014-December 2015||0
8624430|NCT02110758|21284832|P3|NOT COMPLETED|Intervention: July 2014-December 2015||0
8624431|NCT02110758|21284833|P2|NOT COMPLETED|Intervention: July 2014-December 2015||0
8624432|NCT02110758|21284834|P1|NOT COMPLETED|Intervention: July 2014-December 2015||0
8624433|NCT02110758|21284830|P5|COMPLETED|Intervention: July 2014-December 2015||0
8624434|NCT02110758|21284831|P4|COMPLETED|Intervention: July 2014-December 2015||33012
8624435|NCT02110758|21284832|P3|COMPLETED|Intervention: July 2014-December 2015||10106
8624436|NCT02110758|21284833|P2|COMPLETED|Intervention: July 2014-December 2015||0
8624437|NCT02110758|21284834|P1|COMPLETED|Intervention: July 2014-December 2015||0
8624438|NCT02110758|21284830|P5|STARTED|Intervention: July 2014-December 2015||0
8624439|NCT02110758|21284831|P4|STARTED|Intervention: July 2014-December 2015||33012
8624440|NCT02110758|21284832|P3|STARTED|Intervention: July 2014-December 2015||10106
8624441|NCT02110758|21284833|P2|STARTED|Intervention: July 2014-December 2015||0
8624442|NCT02110758|21284834|P1|STARTED|Intervention: July 2014-December 2015||0
8624443|NCT02110758|21284830|P5|NOT COMPLETED|Start-Up: August 2013-June 2014||0
8624444|NCT02110758|21284831|P4|NOT COMPLETED|Start-Up: August 2013-June 2014||0
8624445|NCT02110758|21284832|P3|NOT COMPLETED|Start-Up: August 2013-June 2014||0
8624446|NCT02110758|21284833|P2|NOT COMPLETED|Start-Up: August 2013-June 2014||0
8624447|NCT02110758|21284834|P1|NOT COMPLETED|Start-Up: August 2013-June 2014||0
8624448|NCT02110758|21284830|P5|COMPLETED|Start-Up: August 2013-June 2014||0
8624449|NCT02110758|21284831|P4|COMPLETED|Start-Up: August 2013-June 2014||12883
8624450|NCT02110758|21284832|P3|COMPLETED|Start-Up: August 2013-June 2014||8057
8624451|NCT02110758|21284833|P2|COMPLETED|Start-Up: August 2013-June 2014||431
8624452|NCT02110758|21284834|P1|COMPLETED|Start-Up: August 2013-June 2014||175
8624453|NCT02110758|21284830|P5|STARTED|Start-Up: August 2013-June 2014||0
8624454|NCT02110758|21284831|P4|STARTED|Start-Up: August 2013-June 2014||12883
8624455|NCT02110758|21284832|P3|STARTED|Start-Up: August 2013-June 2014||8057
8624456|NCT02110758|21284833|P2|STARTED|Start-Up: August 2013-June 2014||431
8624457|NCT02110758|21284834|P1|STARTED|Start-Up: August 2013-June 2014||175
8624458|NCT02110758|21284830|P5|NOT COMPLETED|Baseline: August 2011-July 2013||0
8624459|NCT02110758|21284831|P4|NOT COMPLETED|Baseline: August 2011-July 2013||0
8624460|NCT02110758|21284832|P3|NOT COMPLETED|Baseline: August 2011-July 2013||0
8624461|NCT02110758|21284833|P2|NOT COMPLETED|Baseline: August 2011-July 2013||0
8624462|NCT02110758|21284834|P1|NOT COMPLETED|Baseline: August 2011-July 2013||0
8624463|NCT02110758|21284830|P5|COMPLETED|Baseline: August 2011-July 2013||308
8624464|NCT02110758|21284831|P4|COMPLETED|Baseline: August 2011-July 2013||18994
8624465|NCT02110758|21284832|P3|COMPLETED|Baseline: August 2011-July 2013||9832
8624466|NCT02110758|21284833|P2|COMPLETED|Baseline: August 2011-July 2013||0
8624467|NCT02110758|21284834|P1|COMPLETED|Baseline: August 2011-July 2013||0
8624468|NCT02110758|21284830|P5|STARTED|Baseline: August 2011-July 2013||308
8624469|NCT02110758|21284831|P4|STARTED|Baseline: August 2011-July 2013||18994
8624470|NCT02110758|21284832|P3|STARTED|Baseline: August 2011-July 2013||9832
8624471|NCT02110758|21284833|P2|STARTED|Baseline: August 2011-July 2013||0
8624472|NCT02110758|21284834|P1|STARTED|Baseline: August 2011-July 2013||0
8624473|NCT02110238|21284848|P2|NOT COMPLETED|14 Week Blinded Extension Phase||12
8624474|NCT02110238|21284849|P1|NOT COMPLETED|14 Week Blinded Extension Phase||12
8624475|NCT02110238|21284848|P2|COMPLETED|14 Week Blinded Extension Phase||188
8624476|NCT02110238|21284849|P1|COMPLETED|14 Week Blinded Extension Phase||190
8624477|NCT02110238|21284848|P2|STARTED|14 Week Blinded Extension Phase||200
8624478|NCT02110238|21284849|P1|STARTED|14 Week Blinded Extension Phase||202
8624479|NCT02110238|21284848|P2|NOT COMPLETED|12 Week Pivotal Phase||9
8624480|NCT02110238|21284849|P1|NOT COMPLETED|12 Week Pivotal Phase||10
8624481|NCT02110238|21284848|P2|COMPLETED|12 Week Pivotal Phase||200
8624482|NCT02110238|21284849|P1|COMPLETED|12 Week Pivotal Phase||202
8624483|NCT02110238|21284848|P2|STARTED|12 Week Pivotal Phase||209
8624484|NCT02110238|21284849|P1|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
8624485|NCT02108600|21284857|P2|NOT COMPLETED|Overall Study||1
8624486|NCT02108600|21284858|P1|NOT COMPLETED|Overall Study||3
8624487|NCT02108600|21284857|P2|COMPLETED|Overall Study|1 patient lost to follow up after the primary endpoint biopsy|15
8624488|NCT02108600|21284858|P1|COMPLETED|Overall Study||14
8624489|NCT02108600|21284857|P2|STARTED|Overall Study||16
8624490|NCT02108600|21284858|P1|STARTED|Overall Study||17
8624532|NCT01939275|21285008|P1|NOT COMPLETED|Overall Study||0
8624533|NCT01939275|21285008|P1|COMPLETED|Overall Study||8
8624534|NCT01939275|21285008|P1|STARTED|Overall Study||8
8624535|NCT01927367|21285014|P2|NOT COMPLETED|Overall Study||5
8624536|NCT01927367|21285015|P1|NOT COMPLETED|Overall Study||7
8624537|NCT01927367|21285014|P2|COMPLETED|Overall Study||543
8624538|NCT01927367|21285015|P1|COMPLETED|Overall Study||590
8624539|NCT01927367|21285014|P2|STARTED|Overall Study||548
8624540|NCT01927367|21285015|P1|STARTED|Overall Study||597
8624549|NCT01862536|21285040|P2|NOT COMPLETED|Overall Study||7
8624550|NCT01862536|21285041|P1|NOT COMPLETED|Overall Study||3
8624551|NCT01862536|21285040|P2|COMPLETED|Overall Study||16
8624552|NCT01862536|21285041|P1|COMPLETED|Overall Study||10
8624553|NCT01862536|21285040|P2|STARTED|Overall Study||23
8624554|NCT01862536|21285041|P1|STARTED|Overall Study||13
8624555|NCT01778465|21285063|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8624556|NCT01778465|21285064|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8624557|NCT01778465|21285063|P2|COMPLETED|Second Intervention (7 Days)||4
8624558|NCT01778465|21285064|P1|COMPLETED|Second Intervention (7 Days)||3
8624559|NCT01778465|21285063|P2|STARTED|Second Intervention (7 Days)||4
8624560|NCT01778465|21285064|P1|STARTED|Second Intervention (7 Days)||3
8624561|NCT01778465|21285063|P2|NOT COMPLETED|First Intervention (7 Days)||0
8624562|NCT01778465|21285064|P1|NOT COMPLETED|First Intervention (7 Days)||0
8624563|NCT01778465|21285063|P2|COMPLETED|First Intervention (7 Days)||4
8624564|NCT01778465|21285064|P1|COMPLETED|First Intervention (7 Days)||3
8624565|NCT01778465|21285063|P2|STARTED|First Intervention (7 Days)||4
8624566|NCT01778465|21285064|P1|STARTED|First Intervention (7 Days)||3
8624603|NCT01206296|21285162|P1|NOT COMPLETED|Overall Study||0
8624604|NCT01206296|21285162|P1|COMPLETED|Overall Study||0
8624605|NCT01206296|21285162|P1|STARTED|Overall Study||0
8624875|NCT00947661|21285484|P2|NOT COMPLETED|Overall Study||15
8624876|NCT00947661|21285485|P1|NOT COMPLETED|Overall Study||13
8624877|NCT00947661|21285484|P2|COMPLETED|Overall Study||274
8624878|NCT00947661|21285485|P1|COMPLETED|Overall Study||276
8624879|NCT00947661|21285484|P2|STARTED|Overall Study||289
8624880|NCT00947661|21285485|P1|STARTED|Overall Study||289
8624881|NCT00945958|21285491|P1|NOT COMPLETED|Overall Study||12
8624882|NCT00945958|21285491|P1|COMPLETED|Overall Study||149
8624883|NCT00945958|21285491|P1|STARTED|Overall Study||161
8624884|NCT00794677|21285498|P2|NOT COMPLETED|Second Intervention||0
8624885|NCT00794677|21285499|P1|NOT COMPLETED|Second Intervention||0
8624886|NCT00794677|21285498|P2|COMPLETED|Second Intervention||13
8624887|NCT00794677|21285499|P1|COMPLETED|Second Intervention||11
8624888|NCT00794677|21285498|P2|STARTED|Second Intervention||13
8624889|NCT00794677|21285499|P1|STARTED|Second Intervention||11
8624890|NCT00794677|21285498|P2|NOT COMPLETED|First Intervention||0
8624891|NCT00794677|21285499|P1|NOT COMPLETED|First Intervention||2
8624892|NCT00794677|21285498|P2|COMPLETED|First Intervention||13
8624893|NCT00794677|21285499|P1|COMPLETED|First Intervention||11
8624894|NCT00794677|21285498|P2|STARTED|First Intervention||13
8624895|NCT00794677|21285499|P1|STARTED|First Intervention||13
8624914|NCT00614744|21285582|P2|NOT COMPLETED|Overall Study||6
8624915|NCT00614744|21285583|P1|NOT COMPLETED|Overall Study||5
8624916|NCT00614744|21285582|P2|COMPLETED|Overall Study||79
8624917|NCT00614744|21285583|P1|COMPLETED|Overall Study||78
8624918|NCT00614744|21285582|P2|STARTED|Overall Study||85
8624919|NCT00614744|21285583|P1|STARTED|Overall Study||83
8624944|NCT00565617|21285635|P1|NOT COMPLETED|Overall Study||1
8624945|NCT00565617|21285635|P1|COMPLETED|Overall Study||5
8624946|NCT00565617|21285635|P1|STARTED|Overall Study||6
8624959|NCT00214890|21285675|P2|NOT COMPLETED|Overall Study||0
8624960|NCT00214890|21285676|P1|NOT COMPLETED|Overall Study||0
8624961|NCT00214890|21285675|P2|COMPLETED|Overall Study||11
8624962|NCT00214890|21285676|P1|COMPLETED|Overall Study||10
8624963|NCT00214890|21285675|P2|STARTED|Overall Study||11
8624964|NCT00214890|21285676|P1|STARTED|Overall Study||10
8625008|NCT04637997|21285715|P2|NOT COMPLETED|Overall Study||0
8625009|NCT04637997|21285716|P1|NOT COMPLETED|Overall Study||0
8625010|NCT04637997|21285715|P2|COMPLETED|Overall Study||9
8625011|NCT04637997|21285716|P1|COMPLETED|Overall Study||9
8625012|NCT04637997|21285715|P2|STARTED|Overall Study||9
8625013|NCT04637997|21285716|P1|STARTED|Overall Study||9
8625017|NCT04419311|21285738|P2|NOT COMPLETED|Overall Study||0
8625018|NCT04419311|21285739|P1|NOT COMPLETED|Overall Study||1
8625019|NCT04419311|21285738|P2|COMPLETED|Overall Study||33
8625020|NCT04419311|21285739|P1|COMPLETED|Overall Study||32
8625021|NCT04419311|21285738|P2|STARTED|Overall Study||33
8625022|NCT04419311|21285739|P1|STARTED|Overall Study||33
8625026|NCT04370028|21285779|P1|NOT COMPLETED|Overall Study||707
8625027|NCT04370028|21285779|P1|COMPLETED|Overall Study||1876
8625028|NCT04370028|21285779|P1|STARTED|Overall Study||2583
8625047|NCT04332991|21285821|P2|NOT COMPLETED|Overall Study||0
8625048|NCT04332991|21285822|P1|NOT COMPLETED|Overall Study||0
8625049|NCT04332991|21285821|P2|COMPLETED|Overall Study||237
8625050|NCT04332991|21285822|P1|COMPLETED|Overall Study||242
8625051|NCT04332991|21285821|P2|STARTED|Overall Study||237
8625052|NCT04332991|21285822|P1|STARTED|Overall Study||242
8625056|NCT04179474|21285888|P2|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
8625057|NCT04179474|21285889|P1|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
8625058|NCT04179474|21285888|P2|COMPLETED|Treatment Period 3 (Third Intervention)||19
8625059|NCT04179474|21285889|P1|COMPLETED|Treatment Period 3 (Third Intervention)||19
8625060|NCT04179474|21285888|P2|STARTED|Treatment Period 3 (Third Intervention)|1 participant did not receive Intervention D.|19
8625061|NCT04179474|21285889|P1|STARTED|Treatment Period 3 (Third Intervention)||19
8625062|NCT04179474|21285888|P2|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
8625063|NCT04179474|21285889|P1|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
8625064|NCT04179474|21285888|P2|COMPLETED|Treatment Period 2 (Second Intervention)||20
8625065|NCT04179474|21285889|P1|COMPLETED|Treatment Period 2 (Second Intervention)||19
8625066|NCT04179474|21285888|P2|STARTED|Treatment Period 2 (Second Intervention)||20
8625067|NCT04179474|21285889|P1|STARTED|Treatment Period 2 (Second Intervention)|1 participant did not receive Intervention B.|19
8625068|NCT04179474|21285888|P2|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
8625069|NCT04179474|21285889|P1|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
8625070|NCT04179474|21285888|P2|COMPLETED|Treatment Period 1 (First Intervention)||20
8625071|NCT04179474|21285889|P1|COMPLETED|Treatment Period 1 (First Intervention)||20
8625072|NCT04179474|21285888|P2|STARTED|Treatment Period 1 (First Intervention)||20
8625073|NCT04179474|21285889|P1|STARTED|Treatment Period 1 (First Intervention)||20
8625074|NCT04156646|21285945|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||1
8625075|NCT04156646|21285946|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
8625076|NCT04156646|21285945|P2|COMPLETED|Treatment Period 3 (6 Days)||7
8625077|NCT04156646|21285946|P1|COMPLETED|Treatment Period 3 (6 Days)||8
8625078|NCT04156646|21285945|P2|STARTED|Treatment Period 3 (6 Days)||8
8625079|NCT04156646|21285946|P1|STARTED|Treatment Period 3 (6 Days)||8
8625080|NCT04156646|21285945|P2|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
8625081|NCT04156646|21285946|P1|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
8625082|NCT04156646|21285945|P2|COMPLETED|Wash-out Period (12- to 21-days)||8
8625083|NCT04156646|21285946|P1|COMPLETED|Wash-out Period (12- to 21-days)||8
8625084|NCT04156646|21285945|P2|STARTED|Wash-out Period (12- to 21-days)||8
8625085|NCT04156646|21285946|P1|STARTED|Wash-out Period (12- to 21-days)||8
8625086|NCT04156646|21285945|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8625087|NCT04156646|21285946|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
8625088|NCT04156646|21285945|P2|COMPLETED|Treatment Period 2 (6 Days)||8
8625089|NCT04156646|21285946|P1|COMPLETED|Treatment Period 2 (6 Days)||8
8625090|NCT04156646|21285945|P2|STARTED|Treatment Period 2 (6 Days)||8
8625091|NCT04156646|21285946|P1|STARTED|Treatment Period 2 (6 Days)||8
8625092|NCT04156646|21285945|P2|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
8625093|NCT04156646|21285946|P1|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
8625094|NCT04156646|21285945|P2|COMPLETED|Wash-out Period (12- to 21-days)||8
8625095|NCT04156646|21285946|P1|COMPLETED|Wash-out Period (12- to 21-days)||8
8625096|NCT04156646|21285945|P2|STARTED|Wash-out Period (12- to 21-days)||8
8625097|NCT04156646|21285946|P1|STARTED|Wash-out Period (12- to 21-days)||8
8625098|NCT04156646|21285945|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8625099|NCT04156646|21285946|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
8625100|NCT04156646|21285945|P2|COMPLETED|Treatment Period 1 (6 Days)||8
8625101|NCT04156646|21285946|P1|COMPLETED|Treatment Period 1 (6 Days)||8
8625102|NCT04156646|21285945|P2|STARTED|Treatment Period 1 (6 Days)||8
8625103|NCT04156646|21285946|P1|STARTED|Treatment Period 1 (6 Days)||8
8625104|NCT04149405|21286066|P4|NOT COMPLETED|Overall Study||0
8625105|NCT04149405|21286067|P3|NOT COMPLETED|Overall Study||0
8625106|NCT04149405|21286068|P2|NOT COMPLETED|Overall Study||0
8625107|NCT04149405|21286069|P1|NOT COMPLETED|Overall Study||0
8625108|NCT04149405|21286066|P4|COMPLETED|Overall Study||10
8625109|NCT04149405|21286067|P3|COMPLETED|Overall Study||11
8625110|NCT04149405|21286068|P2|COMPLETED|Overall Study||10
8625111|NCT04149405|21286069|P1|COMPLETED|Overall Study||12
8625112|NCT04149405|21286066|P4|STARTED|Overall Study||10
8625113|NCT04149405|21286067|P3|STARTED|Overall Study||11
8625114|NCT04149405|21286068|P2|STARTED|Overall Study||10
8625115|NCT04149405|21286069|P1|STARTED|Overall Study||12
8625116|NCT04102345|21286093|P2|NOT COMPLETED|Overall Study||0
8625117|NCT04102345|21286094|P1|NOT COMPLETED|Overall Study||1
8625118|NCT04102345|21286093|P2|COMPLETED|Overall Study||32
8625119|NCT04102345|21286094|P1|COMPLETED|Overall Study||25
8625120|NCT04102345|21286093|P2|STARTED|Overall Study||32
8625121|NCT04102345|21286094|P1|STARTED|Overall Study||26
8625122|NCT04059250|21286114|P2|NOT COMPLETED|Overall Study||0
8625123|NCT04059250|21286115|P1|NOT COMPLETED|Overall Study||0
8625124|NCT04059250|21286114|P2|COMPLETED|Overall Study||25
8625125|NCT04059250|21286115|P1|COMPLETED|Overall Study||25
8625126|NCT04059250|21286114|P2|STARTED|Overall Study||25
8625127|NCT04059250|21286115|P1|STARTED|Overall Study||25
8625128|NCT04043728|21286124|P3|NOT COMPLETED|Overall Study||0
8625129|NCT04043728|21286125|P2|NOT COMPLETED|Overall Study||2
8625130|NCT04043728|21286126|P1|NOT COMPLETED|Overall Study||1
8625131|NCT04043728|21286124|P3|COMPLETED|Overall Study||6
8625132|NCT04043728|21286125|P2|COMPLETED|Overall Study||4
8625133|NCT04043728|21286126|P1|COMPLETED|Overall Study||5
8625134|NCT04043728|21286124|P3|STARTED|Overall Study||6
8625135|NCT04043728|21286125|P2|STARTED|Overall Study||6
8625136|NCT04043728|21286126|P1|STARTED|Overall Study||6
8625137|NCT04036799|21286137|P1|NOT COMPLETED|Overall Study||0
8625138|NCT04036799|21286137|P1|COMPLETED|Overall Study||572
8625139|NCT04036799|21286137|P1|STARTED|Overall Study||572
8625157|NCT03971721|21286154|P1|NOT COMPLETED|Overall Study||0
8625158|NCT03971721|21286154|P1|COMPLETED|Overall Study||3
8625159|NCT03971721|21286154|P1|STARTED|Overall Study||3
8625160|NCT03941015|21286164|P2|NOT COMPLETED|Overall Study||3
8625161|NCT03941015|21286165|P1|NOT COMPLETED|Overall Study||0
8625162|NCT03941015|21286164|P2|COMPLETED|Overall Study||204
8625163|NCT03941015|21286165|P1|COMPLETED|Overall Study||38
8625164|NCT03941015|21286164|P2|STARTED|Overall Study||207
8625165|NCT03941015|21286165|P1|STARTED|Overall Study||38
8625166|NCT03931785|21286187|P4|NOT COMPLETED|Overall Study||11
8625167|NCT03931785|21286188|P3|NOT COMPLETED|Overall Study||13
8625168|NCT03931785|21286189|P2|NOT COMPLETED|Overall Study||7
8625169|NCT03931785|21286190|P1|NOT COMPLETED|Overall Study||5
8625170|NCT03931785|21286187|P4|COMPLETED|Overall Study||86
8625171|NCT03931785|21286188|P3|COMPLETED|Overall Study||84
8625172|NCT03931785|21286189|P2|COMPLETED|Overall Study||90
8625173|NCT03931785|21286190|P1|COMPLETED|Overall Study||92
8625174|NCT03931785|21286187|P4|STARTED|Overall Study||97
8625175|NCT03931785|21286188|P3|STARTED|Overall Study||97
8625176|NCT03931785|21286189|P2|STARTED|Overall Study||97
8625177|NCT03931785|21286190|P1|STARTED|Overall Study||97
8625178|NCT03917823|21286206|P2|NOT COMPLETED|Overall Study||2
8625179|NCT03917823|21286207|P1|NOT COMPLETED|Overall Study||1
8625180|NCT03917823|21286206|P2|COMPLETED|Overall Study||0
8625181|NCT03917823|21286207|P1|COMPLETED|Overall Study||1
8625182|NCT03917823|21286206|P2|STARTED|Overall Study||2
8625183|NCT03917823|21286207|P1|STARTED|Overall Study||2
8625208|NCT03888365|21286238|P2|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
8625209|NCT03888365|21286239|P1|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
8625210|NCT03888365|21286238|P2|COMPLETED|Cohort A Trough Level/Cohort B Period 2||23
8625211|NCT03888365|21286239|P1|COMPLETED|Cohort A Trough Level/Cohort B Period 2||20
8625212|NCT03888365|21286238|P2|STARTED|Cohort A Trough Level/Cohort B Period 2||23
8625213|NCT03888365|21286239|P1|STARTED|Cohort A Trough Level/Cohort B Period 2||20
8625214|NCT03888365|21286238|P2|NOT COMPLETED|Rest - At Least 1 h||0
8625215|NCT03888365|21286239|P1|NOT COMPLETED|Rest - At Least 1 h||0
8625216|NCT03888365|21286238|P2|COMPLETED|Rest - At Least 1 h||23
8625217|NCT03888365|21286239|P1|COMPLETED|Rest - At Least 1 h||20
8625218|NCT03888365|21286238|P2|STARTED|Rest - At Least 1 h||23
8625219|NCT03888365|21286239|P1|STARTED|Rest - At Least 1 h||20
8625220|NCT03888365|21286238|P2|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
8625221|NCT03888365|21286239|P1|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
8625222|NCT03888365|21286238|P2|COMPLETED|Cohort A Peak Level/Cohort B Period 1||23
8625223|NCT03888365|21286239|P1|COMPLETED|Cohort A Peak Level/Cohort B Period 1||20
8625224|NCT03888365|21286238|P2|Safety Population|Cohort A Peak Level/Cohort B Period 1||23
8625225|NCT03888365|21286239|P1|Safety Population|Cohort A Peak Level/Cohort B Period 1||20
8625226|NCT03888365|21286238|P2|STARTED|Cohort A Peak Level/Cohort B Period 1||23
8625227|NCT03888365|21286239|P1|STARTED|Cohort A Peak Level/Cohort B Period 1||20
8625252|NCT03875482|21286320|P2|NOT COMPLETED|Overall Study||20
8625253|NCT03875482|21286321|P1|NOT COMPLETED|Overall Study||13
8625254|NCT03875482|21286320|P2|COMPLETED|Overall Study||32
8625255|NCT03875482|21286321|P1|COMPLETED|Overall Study||92
8625256|NCT03875482|21286320|P2|STARTED|Overall Study||52
8625257|NCT03875482|21286321|P1|STARTED|Overall Study||105
8625258|NCT03872843|21286337|P2|NOT COMPLETED|Overall Study||7
8625259|NCT03872843|21286338|P1|NOT COMPLETED|Overall Study||5
8625260|NCT03872843|21286337|P2|COMPLETED|Overall Study||3
8625261|NCT03872843|21286338|P1|COMPLETED|Overall Study||7
8625262|NCT03872843|21286337|P2|STARTED|Overall Study||10
8625263|NCT03872843|21286338|P1|STARTED|Overall Study||12
8625264|NCT03839355|21286350|P2|NOT COMPLETED|Overall Study||0
8625265|NCT03839355|21286351|P1|NOT COMPLETED|Overall Study||1
8625266|NCT03839355|21286350|P2|COMPLETED|Overall Study||16
8625267|NCT03839355|21286351|P1|COMPLETED|Overall Study||17
8625268|NCT03839355|21286350|P2|STARTED|Overall Study||16
8625269|NCT03839355|21286351|P1|STARTED|Overall Study||18
8625270|NCT03809052|21286372|P11|NOT COMPLETED|Overall Study||0
8625271|NCT03809052|21286373|P10|NOT COMPLETED|Overall Study||0
8625272|NCT03809052|21286374|P9|NOT COMPLETED|Overall Study||0
8625273|NCT03809052|21286375|P8|NOT COMPLETED|Overall Study||0
8625274|NCT03809052|21286376|P7|NOT COMPLETED|Overall Study||0
8625275|NCT03809052|21286377|P6|NOT COMPLETED|Overall Study||0
8625276|NCT03809052|21286378|P5|NOT COMPLETED|Overall Study||0
8625277|NCT03809052|21286379|P4|NOT COMPLETED|Overall Study||0
8625278|NCT03809052|21286380|P3|NOT COMPLETED|Overall Study||0
8625279|NCT03809052|21286381|P2|NOT COMPLETED|Overall Study||0
8625280|NCT03809052|21286382|P1|NOT COMPLETED|Overall Study||0
8625281|NCT03809052|21286372|P11|COMPLETED|Overall Study||6
8625282|NCT03809052|21286373|P10|COMPLETED|Overall Study||8
8625283|NCT03809052|21286374|P9|COMPLETED|Overall Study||8
8625284|NCT03809052|21286375|P8|COMPLETED|Overall Study||14
8625285|NCT03809052|21286376|P7|COMPLETED|Overall Study||6
8625286|NCT03809052|21286377|P6|COMPLETED|Overall Study||6
8625287|NCT03809052|21286378|P5|COMPLETED|Overall Study||6
8625288|NCT03809052|21286379|P4|COMPLETED|Overall Study||6
8625289|NCT03809052|21286380|P3|COMPLETED|Overall Study||6
8625290|NCT03809052|21286381|P2|COMPLETED|Overall Study||6
8625291|NCT03809052|21286382|P1|COMPLETED|Overall Study||6
8625292|NCT03809052|21286372|P11|STARTED|Overall Study||6
8625293|NCT03809052|21286373|P10|STARTED|Overall Study||8
8625294|NCT03809052|21286374|P9|STARTED|Overall Study||8
8625295|NCT03809052|21286375|P8|STARTED|Overall Study||14
8625296|NCT03809052|21286376|P7|STARTED|Overall Study||6
8625297|NCT03809052|21286377|P6|STARTED|Overall Study||6
8625298|NCT03809052|21286378|P5|STARTED|Overall Study||6
8625299|NCT03809052|21286379|P4|STARTED|Overall Study||6
8625300|NCT03809052|21286380|P3|STARTED|Overall Study||6
8625301|NCT03809052|21286381|P2|STARTED|Overall Study||6
8625302|NCT03809052|21286382|P1|STARTED|Overall Study||6
8625303|NCT03802565|21286413|P5|NOT COMPLETED|Overall Study||6
8625304|NCT03802565|21286414|P4|NOT COMPLETED|Overall Study||8
8625305|NCT03802565|21286415|P3|NOT COMPLETED|Overall Study||9
8625306|NCT03802565|21286416|P2|NOT COMPLETED|Overall Study||4
8625307|NCT03802565|21286417|P1|NOT COMPLETED|Overall Study||5
8625308|NCT03802565|21286413|P5|COMPLETED|Overall Study||72
8625309|NCT03802565|21286414|P4|COMPLETED|Overall Study||77
8625310|NCT03802565|21286415|P3|COMPLETED|Overall Study||74
8625311|NCT03802565|21286416|P2|COMPLETED|Overall Study||83
8625312|NCT03802565|21286417|P1|COMPLETED|Overall Study||77
8625313|NCT03802565|21286413|P5|STARTED|Overall Study||78
8625314|NCT03802565|21286414|P4|STARTED|Overall Study||85
8625315|NCT03802565|21286415|P3|STARTED|Overall Study||83
8625316|NCT03802565|21286416|P2|STARTED|Overall Study||87
8625317|NCT03802565|21286417|P1|STARTED|Overall Study||82
8625318|NCT03787615|21286429|P1|NOT COMPLETED|Overall Study||4
8625319|NCT03787615|21286429|P1|COMPLETED|Overall Study||27
8625320|NCT03787615|21286429|P1|STARTED|Overall Study||31
8625324|NCT03748264|21286453|P3|NOT COMPLETED|Overall Study||0
8625325|NCT03748264|21286454|P2|NOT COMPLETED|Overall Study||0
8625326|NCT03748264|21286455|P1|NOT COMPLETED|Overall Study||0
8625327|NCT03748264|21286453|P3|COMPLETED|Overall Study||20
8625328|NCT03748264|21286454|P2|COMPLETED|Overall Study||21
8625329|NCT03748264|21286455|P1|COMPLETED|Overall Study||21
8625330|NCT03748264|21286453|P3|STARTED|Overall Study||20
8625331|NCT03748264|21286454|P2|STARTED|Overall Study||21
8625332|NCT03748264|21286455|P1|STARTED|Overall Study||21
8625333|NCT03724812|21286484|P1|NOT COMPLETED|Overall Study||1
8625334|NCT03724812|21286484|P1|COMPLETED|Overall Study||45
8625335|NCT03724812|21286484|P1|30 Days Follow-Up|Overall Study||45
8625336|NCT03724812|21286484|P1|STARTED|Overall Study||46
8625337|NCT03719378|21286502|P2|NOT COMPLETED|Overall Study||10
8625338|NCT03719378|21286503|P1|NOT COMPLETED|Overall Study||10
8625339|NCT03719378|21286502|P2|COMPLETED|Overall Study||65
8625340|NCT03719378|21286503|P1|COMPLETED|Overall Study||65
8625341|NCT03719378|21286502|P2|STARTED|Overall Study||75
8625342|NCT03719378|21286503|P1|STARTED|Overall Study||75
8625343|NCT03703817|21286551|P2|NOT COMPLETED|Overall Study||4
8625344|NCT03703817|21286552|P1|NOT COMPLETED|Overall Study||7
8625345|NCT03703817|21286551|P2|COMPLETED|Overall Study||129
8625346|NCT03703817|21286552|P1|COMPLETED|Overall Study||281
8625347|NCT03703817|21286551|P2|STARTED|Overall Study||133
8625348|NCT03703817|21286552|P1|STARTED|Overall Study||288
8625349|NCT03703466|21286565|P3|NOT COMPLETED|Overall Study||2
8625350|NCT03703466|21286566|P2|NOT COMPLETED|Overall Study||6
8625351|NCT03703466|21286567|P1|NOT COMPLETED|Overall Study||4
8625352|NCT03703466|21286565|P3|COMPLETED|Overall Study||22
8625353|NCT03703466|21286566|P2|COMPLETED|Overall Study||18
8625354|NCT03703466|21286567|P1|COMPLETED|Overall Study||20
8625355|NCT03703466|21286565|P3|Received at Least One Dose of Study Drug|Overall Study||24
8625356|NCT03703466|21286566|P2|Received at Least One Dose of Study Drug|Overall Study||23
8625357|NCT03703466|21286567|P1|Received at Least One Dose of Study Drug|Overall Study||24
8625358|NCT03703466|21286565|P3|STARTED|Overall Study||24
8625359|NCT03703466|21286566|P2|STARTED|Overall Study||24
8625360|NCT03703466|21286567|P1|STARTED|Overall Study||24
8625361|NCT03696758|21286599|P2|NOT COMPLETED|Second Intervention||0
8625362|NCT03696758|21286600|P1|NOT COMPLETED|Second Intervention||0
8625363|NCT03696758|21286599|P2|COMPLETED|Second Intervention||6
8625364|NCT03696758|21286600|P1|COMPLETED|Second Intervention||3
8625365|NCT03696758|21286599|P2|STARTED|Second Intervention||6
8625366|NCT03696758|21286600|P1|STARTED|Second Intervention||3
8625367|NCT03696758|21286599|P2|NOT COMPLETED|Wash Out>12 Hours||0
8625368|NCT03696758|21286600|P1|NOT COMPLETED|Wash Out>12 Hours||0
8625369|NCT03696758|21286599|P2|COMPLETED|Wash Out>12 Hours||6
8625370|NCT03696758|21286600|P1|COMPLETED|Wash Out>12 Hours||3
8625371|NCT03696758|21286599|P2|STARTED|Wash Out>12 Hours||6
8625372|NCT03696758|21286600|P1|STARTED|Wash Out>12 Hours||3
8625373|NCT03696758|21286599|P2|NOT COMPLETED|First Intervention||0
8625374|NCT03696758|21286600|P1|NOT COMPLETED|First Intervention||0
8625375|NCT03696758|21286599|P2|COMPLETED|First Intervention||6
8625376|NCT03696758|21286600|P1|COMPLETED|First Intervention||3
8625377|NCT03696758|21286599|P2|STARTED|First Intervention||6
8625378|NCT03696758|21286600|P1|STARTED|First Intervention||3
8625397|NCT03630198|21286653|P2|NOT COMPLETED|Overall Study||0
8625398|NCT03630198|21286654|P1|NOT COMPLETED|Overall Study||0
8625399|NCT03630198|21286653|P2|COMPLETED|Overall Study||18
8625400|NCT03630198|21286654|P1|COMPLETED|Overall Study||13
8625401|NCT03630198|21286653|P2|STARTED|Overall Study||18
8625402|NCT03630198|21286654|P1|STARTED|Overall Study||13
8625403|NCT03624972|21286665|P3|NOT COMPLETED|Overall Study||0
8625404|NCT03624972|21286666|P2|NOT COMPLETED|Overall Study||2
8625405|NCT03624972|21286667|P1|NOT COMPLETED|Overall Study||2
8625406|NCT03624972|21286665|P3|COMPLETED|Overall Study||9
8625407|NCT03624972|21286666|P2|COMPLETED|Overall Study||71
8625408|NCT03624972|21286667|P1|COMPLETED|Overall Study||69
8625409|NCT03624972|21286665|P3|STARTED|Overall Study||9
8625410|NCT03624972|21286666|P2|STARTED|Overall Study||73
8625411|NCT03624972|21286667|P1|STARTED|Overall Study||71
8625412|NCT03621657|21286723|P3|NOT COMPLETED|Overall Study||0
8625413|NCT03621657|21286724|P2|NOT COMPLETED|Overall Study||0
8625414|NCT03621657|21286725|P1|NOT COMPLETED|Overall Study||0
8625415|NCT03621657|21286723|P3|COMPLETED|Overall Study||1
8625416|NCT03621657|21286724|P2|COMPLETED|Overall Study||0
8625417|NCT03621657|21286725|P1|COMPLETED|Overall Study||0
8625418|NCT03621657|21286723|P3|STARTED|Overall Study||1
8625419|NCT03621657|21286724|P2|STARTED|Overall Study||0
8625420|NCT03621657|21286725|P1|STARTED|Overall Study||0
8625421|NCT03600428|21286744|P2|NOT COMPLETED|Overall Study||5
8625422|NCT03600428|21286745|P1|NOT COMPLETED|Overall Study||5
8625423|NCT03600428|21286744|P2|COMPLETED|Overall Study||68
8625424|NCT03600428|21286745|P1|COMPLETED|Overall Study||74
8625425|NCT03600428|21286744|P2|43-day Follow-up|Overall Study||68
8625426|NCT03600428|21286745|P1|43-day Follow-up|Overall Study||74
8625427|NCT03600428|21286744|P2|15-day Follow-up|Overall Study||70
8625428|NCT03600428|21286745|P1|15-day Follow-up|Overall Study||76
8625429|NCT03600428|21286744|P2|STARTED|Overall Study||73
8625430|NCT03600428|21286745|P1|STARTED|Overall Study||79
8625437|NCT03557333|21286770|P1|NOT COMPLETED|Overall Study||92
8625438|NCT03557333|21286770|P1|COMPLETED|Overall Study||262
8625439|NCT03557333|21286770|P1|STARTED|Overall Study||354
8625440|NCT03548987|21286784|P2|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
8625441|NCT03548987|21286785|P1|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
8625442|NCT03548987|21286784|P2|COMPLETED|Maintenance Period (Week 20 to Week 68)||237
8625443|NCT03548987|21286785|P1|COMPLETED|Maintenance Period (Week 20 to Week 68)||504
8625444|NCT03548987|21286784|P2|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||268
8625445|NCT03548987|21286785|P1|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||535
8625446|NCT03548987|21286784|P2|STARTED|Maintenance Period (Week 20 to Week 68)||268
8625447|NCT03548987|21286785|P1|STARTED|Maintenance Period (Week 20 to Week 68)||535
8625448|NCT03548987|21286784|P2|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||0
8625449|NCT03548987|21286785|P1|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||99
8625450|NCT03548987|21286784|P2|COMPLETED|Run-in Period (Week 0 to Week 20)||0
8625451|NCT03548987|21286785|P1|COMPLETED|Run-in Period (Week 0 to Week 20)||803
8625452|NCT03548987|21286784|P2|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||0
8625453|NCT03548987|21286785|P1|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||902
8625454|NCT03548987|21286784|P2|STARTED|Run-in Period (Week 0 to Week 20)||0
8625455|NCT03548987|21286785|P1|STARTED|Run-in Period (Week 0 to Week 20)||902
8625468|NCT03540147|21286913|P1|NOT COMPLETED|Overall Study||0
8625469|NCT03540147|21286913|P1|COMPLETED|Overall Study||20
8625470|NCT03540147|21286913|P1|STARTED|Overall Study||20
8625489|NCT03496974|21287011|P2|NOT COMPLETED|Overall Study||8
8625490|NCT03496974|21287012|P1|NOT COMPLETED|Overall Study||1
8625491|NCT03496974|21287011|P2|COMPLETED|Overall Study||20
8625492|NCT03496974|21287012|P1|COMPLETED|Overall Study||9
8625493|NCT03496974|21287011|P2|STARTED|Overall Study||28
8625494|NCT03496974|21287012|P1|STARTED|Overall Study||10
8625495|NCT03474406|21287046|P1|NOT COMPLETED|Overall Study||78
8625496|NCT03474406|21287046|P1|COMPLETED|Overall Study||72
8625497|NCT03474406|21287046|P1|STARTED|Overall Study||150
8625498|NCT03456700|21287056|P1|NOT COMPLETED|Overall Study||1
8625499|NCT03456700|21287056|P1|COMPLETED|Overall Study||21
8625500|NCT03456700|21287056|P1|STARTED|Overall Study||22
8625507|NCT03440411|21287079|P4|NOT COMPLETED|Overall Study||2
8625508|NCT03440411|21287080|P3|NOT COMPLETED|Overall Study||2
8625509|NCT03440411|21287081|P2|NOT COMPLETED|Overall Study||1
8625510|NCT03440411|21287082|P1|NOT COMPLETED|Overall Study||3
8625511|NCT03440411|21287079|P4|COMPLETED|Overall Study||0
8625512|NCT03440411|21287080|P3|COMPLETED|Overall Study||0
8625513|NCT03440411|21287081|P2|COMPLETED|Overall Study||0
8625514|NCT03440411|21287082|P1|COMPLETED|Overall Study||0
8625515|NCT03440411|21287079|P4|STARTED|Overall Study||2
8625516|NCT03440411|21287080|P3|STARTED|Overall Study||2
8625517|NCT03440411|21287081|P2|STARTED|Overall Study||1
8625518|NCT03440411|21287082|P1|STARTED|Overall Study||3
8625519|NCT03403036|21287114|P1|NOT COMPLETED|Overall Study||5
8625520|NCT03403036|21287114|P1|COMPLETED|Overall Study||34
8625521|NCT03403036|21287114|P1|STARTED|Overall Study||39
8625522|NCT03400852|21287122|P3|NOT COMPLETED|Open Label Period||22
8625523|NCT03400852|21287123|P2|NOT COMPLETED|Open Label Period||0
8625524|NCT03400852|21287124|P1|NOT COMPLETED|Open Label Period||0
8625525|NCT03400852|21287122|P3|COMPLETED|Open Label Period||2
8625526|NCT03400852|21287123|P2|COMPLETED|Open Label Period||0
8625527|NCT03400852|21287124|P1|COMPLETED|Open Label Period||0
8625528|NCT03400852|21287122|P3|STARTED|Open Label Period||24
8625529|NCT03400852|21287123|P2|STARTED|Open Label Period||0
8625530|NCT03400852|21287124|P1|STARTED|Open Label Period||0
8625531|NCT03400852|21287122|P3|NOT COMPLETED|Blinded Treatment Period||0
8625532|NCT03400852|21287123|P2|NOT COMPLETED|Blinded Treatment Period||6
8625533|NCT03400852|21287124|P1|NOT COMPLETED|Blinded Treatment Period||9
8625534|NCT03400852|21287122|P3|COMPLETED|Blinded Treatment Period||0
8625535|NCT03400852|21287123|P2|COMPLETED|Blinded Treatment Period||9
8625536|NCT03400852|21287124|P1|COMPLETED|Blinded Treatment Period||20
8625537|NCT03400852|21287122|P3|STARTED|Blinded Treatment Period||0
8625538|NCT03400852|21287123|P2|STARTED|Blinded Treatment Period||15
8625539|NCT03400852|21287124|P1|STARTED|Blinded Treatment Period||29
8625540|NCT03388138|21287146|P2|NOT COMPLETED|Overall Study||0
8625541|NCT03388138|21287147|P1|NOT COMPLETED|Overall Study||1
8625542|NCT03388138|21287146|P2|COMPLETED|Overall Study||47
8625543|NCT03388138|21287147|P1|COMPLETED|Overall Study||93
8625544|NCT03388138|21287146|P2|STARTED|Overall Study||47
8625545|NCT03388138|21287147|P1|STARTED|Overall Study||94
8625554|NCT03361293|21287193|P2|NOT COMPLETED|Overall Study||5
8625555|NCT03361293|21287194|P1|NOT COMPLETED|Overall Study||1
8625556|NCT03361293|21287193|P2|COMPLETED|Overall Study||19
8625557|NCT03361293|21287194|P1|COMPLETED|Overall Study||19
8625558|NCT03361293|21287193|P2|STARTED|Overall Study||24
8625559|NCT03361293|21287194|P1|STARTED|Overall Study||20
8625572|NCT03330262|21287247|P2|NOT COMPLETED|Second Six Weeks||1
8625573|NCT03330262|21287248|P1|NOT COMPLETED|Second Six Weeks||2
8625574|NCT03330262|21287247|P2|COMPLETED|Second Six Weeks||5
8625575|NCT03330262|21287248|P1|COMPLETED|Second Six Weeks||5
8625576|NCT03330262|21287247|P2|STARTED|Second Six Weeks||6
8625577|NCT03330262|21287248|P1|STARTED|Second Six Weeks||7
8625578|NCT03330262|21287247|P2|NOT COMPLETED|First Six Weeks||0
8625579|NCT03330262|21287248|P1|NOT COMPLETED|First Six Weeks||0
8625580|NCT03330262|21287247|P2|COMPLETED|First Six Weeks||6
8625581|NCT03330262|21287248|P1|COMPLETED|First Six Weeks||7
8625582|NCT03330262|21287247|P2|STARTED|First Six Weeks||6
8625583|NCT03330262|21287248|P1|STARTED|First Six Weeks||7
8625584|NCT03325816|21287262|P2|NOT COMPLETED|Overall Study||0
8625585|NCT03325816|21287263|P1|NOT COMPLETED|Overall Study||0
8625586|NCT03325816|21287262|P2|COMPLETED|Overall Study||6
8625587|NCT03325816|21287263|P1|COMPLETED|Overall Study||3
8625588|NCT03325816|21287262|P2|STARTED|Overall Study||6
8625589|NCT03325816|21287263|P1|STARTED|Overall Study||3
8625590|NCT03309605|21287283|P8|NOT COMPLETED|Overall Study||2
8625591|NCT03309605|21287284|P7|NOT COMPLETED|Overall Study||3
8625592|NCT03309605|21287285|P6|NOT COMPLETED|Overall Study||0
8625593|NCT03309605|21287286|P5|NOT COMPLETED|Overall Study||1
8625594|NCT03309605|21287287|P4|NOT COMPLETED|Overall Study||1
8625595|NCT03309605|21287288|P3|NOT COMPLETED|Overall Study||0
8625596|NCT03309605|21287289|P2|NOT COMPLETED|Overall Study||0
8625597|NCT03309605|21287290|P1|NOT COMPLETED|Overall Study||0
8625598|NCT03309605|21287283|P8|COMPLETED|Overall Study||19
8625599|NCT03309605|21287284|P7|COMPLETED|Overall Study||3
8625600|NCT03309605|21287285|P6|COMPLETED|Overall Study||6
8625601|NCT03309605|21287286|P5|COMPLETED|Overall Study||5
8625602|NCT03309605|21287287|P4|COMPLETED|Overall Study||5
8625603|NCT03309605|21287288|P3|COMPLETED|Overall Study||6
8625604|NCT03309605|21287289|P2|COMPLETED|Overall Study||5
8625605|NCT03309605|21287290|P1|COMPLETED|Overall Study||6
8625606|NCT03309605|21287283|P8|STARTED|Overall Study||21
8625607|NCT03309605|21287284|P7|STARTED|Overall Study||6
8625608|NCT03309605|21287285|P6|STARTED|Overall Study||6
8625609|NCT03309605|21287286|P5|STARTED|Overall Study||6
8625610|NCT03309605|21287287|P4|STARTED|Overall Study||6
8625611|NCT03309605|21287288|P3|STARTED|Overall Study||6
8625612|NCT03309605|21287289|P2|STARTED|Overall Study||5
8625613|NCT03309605|21287290|P1|STARTED|Overall Study||6
8625614|NCT03303950|21287394|P1|NOT COMPLETED|Overall Study||0
8625615|NCT03303950|21287394|P1|COMPLETED|Overall Study||6
8625616|NCT03303950|21287394|P1|STARTED|Overall Study||6
8625617|NCT03292432|21287407|P2|NOT COMPLETED|Overall Study||11
8625618|NCT03292432|21287408|P1|NOT COMPLETED|Overall Study||15
8625619|NCT03292432|21287407|P2|COMPLETED|Overall Study||32
8625620|NCT03292432|21287408|P1|COMPLETED|Overall Study||31
8625621|NCT03292432|21287407|P2|Started Study Intervention|Overall Study||43
8625622|NCT03292432|21287408|P1|Started Study Intervention|Overall Study||45
8625623|NCT03292432|21287407|P2|STARTED|Overall Study||43
8625624|NCT03292432|21287408|P1|STARTED|Overall Study||46
8625625|NCT03289052|21287435|P3|NOT COMPLETED|Overall Study||5
8625626|NCT03289052|21287436|P2|NOT COMPLETED|Overall Study||3
8625627|NCT03289052|21287437|P1|NOT COMPLETED|Overall Study||0
8625628|NCT03289052|21287435|P3|COMPLETED|Overall Study||32
8625629|NCT03289052|21287436|P2|COMPLETED|Overall Study||108
8625630|NCT03289052|21287437|P1|COMPLETED|Overall Study||20
8625631|NCT03289052|21287435|P3|STARTED|Overall Study||37
8625632|NCT03289052|21287436|P2|STARTED|Overall Study||111
8625633|NCT03289052|21287437|P1|STARTED|Overall Study||20
8625634|NCT03285490|21287447|P2|NOT COMPLETED|Recurrence Follow-up Period||61
8625635|NCT03285490|21287448|P1|NOT COMPLETED|Recurrence Follow-up Period||18
8625636|NCT03285490|21287447|P2|COMPLETED|Recurrence Follow-up Period||36
8625637|NCT03285490|21287448|P1|COMPLETED|Recurrence Follow-up Period||4
8625638|NCT03285490|21287447|P2|STARTED|Recurrence Follow-up Period||97
8625639|NCT03285490|21287448|P1|STARTED|Recurrence Follow-up Period||22
8625640|NCT03285490|21287447|P2|NOT COMPLETED|Treatment and Response Assessment Period||0
8625641|NCT03285490|21287448|P1|NOT COMPLETED|Treatment and Response Assessment Period||0
8625642|NCT03285490|21287447|P2|COMPLETED|Treatment and Response Assessment Period||178
8625643|NCT03285490|21287448|P1|COMPLETED|Treatment and Response Assessment Period||173
8625644|NCT03285490|21287447|P2|STARTED|Treatment and Response Assessment Period||178
8625645|NCT03285490|21287448|P1|STARTED|Treatment and Response Assessment Period||173
8625664|NCT03262389|21287528|P1|NOT COMPLETED|Overall Study||3
8625665|NCT03262389|21287528|P1|COMPLETED|Overall Study||7
8625666|NCT03262389|21287528|P1|STARTED|Overall Study||10
8625667|NCT03236246|21287535|P2|NOT COMPLETED|24-Week Dose Maintenance Period||6
8625668|NCT03236246|21287536|P1|NOT COMPLETED|24-Week Dose Maintenance Period||3
8625669|NCT03236246|21287535|P2|COMPLETED|24-Week Dose Maintenance Period||66
8625670|NCT03236246|21287536|P1|COMPLETED|24-Week Dose Maintenance Period||73
8625671|NCT03236246|21287535|P2|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|72
8625672|NCT03236246|21287536|P1|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|76
8625673|NCT03236246|21287535|P2|NOT COMPLETED|24-Week Dose Titration Period||27
8625674|NCT03236246|21287536|P1|NOT COMPLETED|24-Week Dose Titration Period||24
8625675|NCT03236246|21287535|P2|COMPLETED|24-Week Dose Titration Period||75
8625676|NCT03236246|21287536|P1|COMPLETED|24-Week Dose Titration Period||80
8625677|NCT03236246|21287535|P2|STARTED|24-Week Dose Titration Period||102
8625678|NCT03236246|21287536|P1|STARTED|24-Week Dose Titration Period||104
8625679|NCT03209973|21287596|P1|NOT COMPLETED|Overall Study||4
8625680|NCT03209973|21287596|P1|COMPLETED|Overall Study||66
8625681|NCT03209973|21287596|P1|STARTED|Overall Study||70
8625682|NCT03205566|21287602|P2|NOT COMPLETED|Phase 2||0
8625683|NCT03205566|21287603|P1|NOT COMPLETED|Phase 2||0
8625684|NCT03205566|21287602|P2|COMPLETED|Phase 2||18
8625685|NCT03205566|21287603|P1|COMPLETED|Phase 2||18
8625686|NCT03205566|21287602|P2|STARTED|Phase 2||18
8625687|NCT03205566|21287603|P1|STARTED|Phase 2||18
8625688|NCT03205566|21287602|P2|NOT COMPLETED|Phase 1||1
8625689|NCT03205566|21287603|P1|NOT COMPLETED|Phase 1||1
8625690|NCT03205566|21287602|P2|COMPLETED|Phase 1||18
8625691|NCT03205566|21287603|P1|COMPLETED|Phase 1||18
8625692|NCT03205566|21287602|P2|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
8625693|NCT03205566|21287603|P1|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
8625718|NCT03181594|21287639|P1|NOT COMPLETED|Long-term Extension (15-24 Month FU)||5
8625719|NCT03181594|21287639|P1|COMPLETED|Long-term Extension (15-24 Month FU)||57
8625720|NCT03181594|21287639|P1|24-month Follow-up|Long-term Extension (15-24 Month FU)||57
8625721|NCT03181594|21287639|P1|21-month Follow-up|Long-term Extension (15-24 Month FU)||55
8625722|NCT03181594|21287639|P1|18-month Follow-up|Long-term Extension (15-24 Month FU)||57
8625723|NCT03181594|21287639|P1|15-month Follow-up|Long-term Extension (15-24 Month FU)||56
8625724|NCT03181594|21287639|P1|STARTED|Long-term Extension (15-24 Month FU)||62
8625725|NCT03181594|21287639|P1|NOT COMPLETED|Initial Study Protocol (12-month FU)||9
8625726|NCT03181594|21287639|P1|COMPLETED|Initial Study Protocol (12-month FU)||91
8625727|NCT03181594|21287639|P1|12-month Follow-up|Initial Study Protocol (12-month FU)||91
8625728|NCT03181594|21287639|P1|9-month Follow-up|Initial Study Protocol (12-month FU)||95
8625729|NCT03181594|21287639|P1|6-month Follow-up|Initial Study Protocol (12-month FU)||98
8625730|NCT03181594|21287639|P1|90-day Follow-up|Initial Study Protocol (12-month FU)||98
8625731|NCT03181594|21287639|P1|30-day Follow-up|Initial Study Protocol (12-month FU)||99
8625732|NCT03181594|21287639|P1|STARTED|Initial Study Protocol (12-month FU)||100
8625733|NCT03154658|21287648|P2|NOT COMPLETED|Overall Study||1
8625734|NCT03154658|21287649|P1|NOT COMPLETED|Overall Study||1
8625735|NCT03154658|21287648|P2|COMPLETED|Overall Study||32
8625736|NCT03154658|21287649|P1|COMPLETED|Overall Study||32
8625737|NCT03154658|21287648|P2|STARTED|Overall Study||33
8625738|NCT03154658|21287649|P1|STARTED|Overall Study||33
8625739|NCT03113071|21287669|P2|NOT COMPLETED|Overall Study||0
8625740|NCT03113071|21287670|P1|NOT COMPLETED|Overall Study||1
8625741|NCT03113071|21287669|P2|COMPLETED|Overall Study||0
8625742|NCT03113071|21287670|P1|COMPLETED|Overall Study||0
8625743|NCT03113071|21287669|P2|STARTED|Overall Study||0
8625744|NCT03113071|21287670|P1|STARTED|Overall Study||1
8625760|NCT03086057|21287745|P4|NOT COMPLETED|Stage 2: PrEP Adherence||2
8625761|NCT03086057|21287746|P3|NOT COMPLETED|Stage 2: PrEP Adherence||6
8625762|NCT03086057|21287747|P2|NOT COMPLETED|Stage 2: PrEP Adherence||0
8625763|NCT03086057|21287748|P1|NOT COMPLETED|Stage 2: PrEP Adherence||0
8625764|NCT03086057|21287745|P4|COMPLETED|Stage 2: PrEP Adherence||16
8625765|NCT03086057|21287746|P3|COMPLETED|Stage 2: PrEP Adherence||11
8625766|NCT03086057|21287747|P2|COMPLETED|Stage 2: PrEP Adherence||0
8625767|NCT03086057|21287748|P1|COMPLETED|Stage 2: PrEP Adherence||0
8625768|NCT03086057|21287745|P4|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|18
8625769|NCT03086057|21287746|P3|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|17
8625770|NCT03086057|21287747|P2|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
8625771|NCT03086057|21287748|P1|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
8625772|NCT03086057|21287745|P4|NOT COMPLETED|Stage 1: PrEP Uptake||0
8625773|NCT03086057|21287746|P3|NOT COMPLETED|Stage 1: PrEP Uptake||0
8625774|NCT03086057|21287747|P2|NOT COMPLETED|Stage 1: PrEP Uptake||10
8625775|NCT03086057|21287748|P1|NOT COMPLETED|Stage 1: PrEP Uptake||11
8625776|NCT03086057|21287745|P4|COMPLETED|Stage 1: PrEP Uptake||0
8625777|NCT03086057|21287746|P3|COMPLETED|Stage 1: PrEP Uptake||0
8625778|NCT03086057|21287747|P2|COMPLETED|Stage 1: PrEP Uptake||45
8625779|NCT03086057|21287748|P1|COMPLETED|Stage 1: PrEP Uptake||44
8625780|NCT03086057|21287745|P4|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
8625781|NCT03086057|21287746|P3|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
8625782|NCT03086057|21287747|P2|STARTED|Stage 1: PrEP Uptake||55
8625783|NCT03086057|21287748|P1|STARTED|Stage 1: PrEP Uptake||55
8625784|NCT03078751|21287762|P2|NOT COMPLETED|Overall Study||28
8625785|NCT03078751|21287763|P1|NOT COMPLETED|Overall Study||13
8625786|NCT03078751|21287762|P2|COMPLETED|Overall Study||0
8625787|NCT03078751|21287763|P1|COMPLETED|Overall Study||13
8625788|NCT03078751|21287762|P2|Safety Set|Overall Study||24
8625789|NCT03078751|21287763|P1|Safety Set|Overall Study||26
8625790|NCT03078751|21287762|P2|Untreated Participants|Overall Study||4
8625791|NCT03078751|21287763|P1|Untreated Participants|Overall Study||0
8625792|NCT03078751|21287762|P2|STARTED|Overall Study||28
8625793|NCT03078751|21287763|P1|STARTED|Overall Study||26
8625794|NCT03075891|21287773|P2|NOT COMPLETED|Overall Study||13
8625795|NCT03075891|21287774|P1|NOT COMPLETED|Overall Study||9
8625796|NCT03075891|21287773|P2|COMPLETED|Overall Study||125
8625797|NCT03075891|21287774|P1|COMPLETED|Overall Study||126
8625798|NCT03075891|21287773|P2|STARTED|Overall Study||138
8625799|NCT03075891|21287774|P1|STARTED|Overall Study||135
8625800|NCT03070236|21287830|P1|NOT COMPLETED|Overall Study||0
8625801|NCT03070236|21287830|P1|COMPLETED|Overall Study||912
8625802|NCT03070236|21287830|P1|Active Surveillance (AS) Arm|Overall Study||374
8625803|NCT03070236|21287830|P1|Guideline Concordant Care (GCC) Arm|Overall Study||538
8625804|NCT03070236|21287830|P1|STARTED|Overall Study||912
8625811|NCT03051256|21287849|P3|NOT COMPLETED|Overall Study||1
8625812|NCT03051256|21287850|P2|NOT COMPLETED|Overall Study||0
8625813|NCT03051256|21287851|P1|NOT COMPLETED|Overall Study||0
8625814|NCT03051256|21287849|P3|COMPLETED|Overall Study||21
8625815|NCT03051256|21287850|P2|COMPLETED|Overall Study||21
8625816|NCT03051256|21287851|P1|COMPLETED|Overall Study||19
8625817|NCT03051256|21287849|P3|STARTED|Overall Study||22
8625818|NCT03051256|21287850|P2|STARTED|Overall Study||21
8625819|NCT03051256|21287851|P1|STARTED|Overall Study||19
8625820|NCT03028415|21287901|P2|NOT COMPLETED|Overall Study||3
8625821|NCT03028415|21287902|P1|NOT COMPLETED|Overall Study||8
8625822|NCT03028415|21287901|P2|COMPLETED|Overall Study||14
8625823|NCT03028415|21287902|P1|COMPLETED|Overall Study||31
8625824|NCT03028415|21287901|P2|Modified Intention-to-treat (mITT) Population|Overall Study||17
8625825|NCT03028415|21287902|P1|Modified Intention-to-treat (mITT) Population|Overall Study||39
8625826|NCT03028415|21287901|P2|STARTED|Overall Study||17
8625827|NCT03028415|21287902|P1|STARTED|Overall Study||39
8625828|NCT03007979|21287939|P1|NOT COMPLETED|Overall Study||1
8625829|NCT03007979|21287939|P1|COMPLETED|Overall Study||54
8625830|NCT03007979|21287939|P1|STARTED|Overall Study||55
8625831|NCT02985801|21287945|P2|NOT COMPLETED|Overall Study||0
8625832|NCT02985801|21287946|P1|NOT COMPLETED|Overall Study||0
8625833|NCT02985801|21287945|P2|COMPLETED|Overall Study||8
8625834|NCT02985801|21287946|P1|COMPLETED|Overall Study||8
8625835|NCT02985801|21287945|P2|STARTED|Overall Study||8
8625836|NCT02985801|21287946|P1|STARTED|Overall Study||8
8625846|NCT02943070|21288009|P1|NOT COMPLETED|Overall Study||43
8625847|NCT02943070|21288009|P1|COMPLETED|Overall Study||7
8625848|NCT02943070|21288009|P1|STARTED|Overall Study||50
8625855|NCT02919683|21288052|P2|NOT COMPLETED|Post-Surgery Follow-Up||2
8625856|NCT02919683|21288053|P1|NOT COMPLETED|Post-Surgery Follow-Up||3
8625857|NCT02919683|21288052|P2|COMPLETED|Post-Surgery Follow-Up||13
8625858|NCT02919683|21288053|P1|COMPLETED|Post-Surgery Follow-Up||12
8625859|NCT02919683|21288052|P2|STARTED|Post-Surgery Follow-Up||15
8625860|NCT02919683|21288053|P1|STARTED|Post-Surgery Follow-Up||15
8625861|NCT02919683|21288052|P2|NOT COMPLETED|Pre-Surgery Intervention||0
8625862|NCT02919683|21288053|P1|NOT COMPLETED|Pre-Surgery Intervention||0
8625863|NCT02919683|21288052|P2|COMPLETED|Pre-Surgery Intervention||15
8625864|NCT02919683|21288053|P1|COMPLETED|Pre-Surgery Intervention||15
8625865|NCT02919683|21288052|P2|STARTED|Pre-Surgery Intervention||15
8625866|NCT02919683|21288053|P1|STARTED|Pre-Surgery Intervention||15
8625882|NCT02896855|21288126|P2|NOT COMPLETED|Overall Study||122
8625883|NCT02896855|21288127|P1|NOT COMPLETED|Overall Study||121
8625884|NCT02896855|21288126|P2|COMPLETED|Overall Study||0
8625885|NCT02896855|21288127|P1|COMPLETED|Overall Study||0
8625886|NCT02896855|21288126|P2|Received Any Study Treatment|Overall Study||122
8625887|NCT02896855|21288127|P1|Received Any Study Treatment|Overall Study||120
8625888|NCT02896855|21288126|P2|STARTED|Overall Study||122
8625889|NCT02896855|21288127|P1|STARTED|Overall Study||121
8625890|NCT02894502|21288160|P3|NOT COMPLETED|Third Follow up||3
8625891|NCT02894502|21288161|P2|NOT COMPLETED|Third Follow up||7
8625892|NCT02894502|21288162|P1|NOT COMPLETED|Third Follow up||6
8625893|NCT02894502|21288160|P3|COMPLETED|Third Follow up||76
8625894|NCT02894502|21288161|P2|COMPLETED|Third Follow up||89
8625895|NCT02894502|21288162|P1|COMPLETED|Third Follow up||73
8625896|NCT02894502|21288160|P3|STARTED|Third Follow up||79
8625897|NCT02894502|21288161|P2|STARTED|Third Follow up||96
8625898|NCT02894502|21288162|P1|STARTED|Third Follow up||79
8625899|NCT02894502|21288160|P3|NOT COMPLETED|Second Follow up||14
8625900|NCT02894502|21288161|P2|NOT COMPLETED|Second Follow up||18
8625901|NCT02894502|21288162|P1|NOT COMPLETED|Second Follow up||15
8625902|NCT02894502|21288160|P3|COMPLETED|Second Follow up||79
8625903|NCT02894502|21288161|P2|COMPLETED|Second Follow up||96
8625904|NCT02894502|21288162|P1|COMPLETED|Second Follow up||79
8625905|NCT02894502|21288160|P3|STARTED|Second Follow up||93
8625906|NCT02894502|21288161|P2|STARTED|Second Follow up||114
8625907|NCT02894502|21288162|P1|STARTED|Second Follow up||94
8625908|NCT02894502|21288160|P3|NOT COMPLETED|First Follow up||40
8625909|NCT02894502|21288161|P2|NOT COMPLETED|First Follow up||31
8625910|NCT02894502|21288162|P1|NOT COMPLETED|First Follow up||34
8625911|NCT02894502|21288160|P3|COMPLETED|First Follow up||93
8625912|NCT02894502|21288161|P2|COMPLETED|First Follow up||114
8625913|NCT02894502|21288162|P1|COMPLETED|First Follow up||94
8625914|NCT02894502|21288160|P3|STARTED|First Follow up||133
8625915|NCT02894502|21288161|P2|STARTED|First Follow up||145
8625916|NCT02894502|21288162|P1|STARTED|First Follow up||128
8625917|NCT02894502|21288160|P3|NOT COMPLETED|Baseline||45
8625918|NCT02894502|21288161|P2|NOT COMPLETED|Baseline||32
8625919|NCT02894502|21288162|P1|NOT COMPLETED|Baseline||27
8625920|NCT02894502|21288160|P3|COMPLETED|Baseline||133
8625921|NCT02894502|21288161|P2|COMPLETED|Baseline||145
8625922|NCT02894502|21288162|P1|COMPLETED|Baseline||128
8625923|NCT02894502|21288160|P3|STARTED|Baseline||178
8625924|NCT02894502|21288161|P2|STARTED|Baseline||177
8625925|NCT02894502|21288162|P1|STARTED|Baseline||155
8625940|NCT02859454|21288208|P1|NOT COMPLETED|Overall Study||1
8625941|NCT02859454|21288208|P1|COMPLETED|Overall Study||12
8625942|NCT02859454|21288208|P1|STARTED|Overall Study||13
8625943|NCT02851615|21288221|P2|NOT COMPLETED|Overall Study||4
8625944|NCT02851615|21288222|P1|NOT COMPLETED|Overall Study||1
8625945|NCT02851615|21288221|P2|COMPLETED|Overall Study||27
8625946|NCT02851615|21288222|P1|COMPLETED|Overall Study||26
8625947|NCT02851615|21288221|P2|STARTED|Overall Study||31
8625948|NCT02851615|21288222|P1|STARTED|Overall Study||27
8625949|NCT02837744|21288231|P1|NOT COMPLETED|Overall Study||0
8625950|NCT02837744|21288231|P1|COMPLETED|Overall Study||70
8625951|NCT02837744|21288231|P1|STARTED|Overall Study||70
8625952|NCT02804178|21288240|P1|NOT COMPLETED|Overall Study||1
8625953|NCT02804178|21288240|P1|COMPLETED|Overall Study||9
8625954|NCT02804178|21288240|P1|STARTED|Overall Study||10
8625955|NCT02759575|21288244|P1|NOT COMPLETED|Overall Study||0
8625956|NCT02759575|21288244|P1|COMPLETED|Overall Study||9
8625957|NCT02759575|21288244|P1|STARTED|Overall Study||9
8625958|NCT02759055|21288252|P2|NOT COMPLETED|Overall Study||1508
8625959|NCT02759055|21288253|P1|NOT COMPLETED|Overall Study||1927
8625960|NCT02759055|21288252|P2|COMPLETED|Overall Study||7454
8625961|NCT02759055|21288253|P1|COMPLETED|Overall Study||10775
8625962|NCT02759055|21288252|P2|STARTED|Overall Study||8962
8625963|NCT02759055|21288253|P1|STARTED|Overall Study||12702
8625964|NCT02709018|21288261|P2|NOT COMPLETED|Overall Study||16
8625965|NCT02709018|21288262|P1|NOT COMPLETED|Overall Study||16
8625966|NCT02709018|21288261|P2|COMPLETED|Overall Study||58
8625967|NCT02709018|21288262|P1|COMPLETED|Overall Study||59
8625968|NCT02709018|21288261|P2|STARTED|Overall Study||74
8625969|NCT02709018|21288262|P1|STARTED|Overall Study||75
8625970|NCT02707861|21288272|P2|NOT COMPLETED|Overall Study||38
8625971|NCT02707861|21288273|P1|NOT COMPLETED|Overall Study||41
8625972|NCT02707861|21288272|P2|COMPLETED|Overall Study||0
8625973|NCT02707861|21288273|P1|COMPLETED|Overall Study||0
8625974|NCT02707861|21288272|P2|STARTED|Overall Study||38
8625975|NCT02707861|21288273|P1|STARTED|Overall Study||41
8625990|NCT02665052|21288329|P4|NOT COMPLETED|Overall Study||5
8625991|NCT02665052|21288330|P3|NOT COMPLETED|Overall Study||0
8625992|NCT02665052|21288331|P2|NOT COMPLETED|Overall Study||2
8625993|NCT02665052|21288332|P1|NOT COMPLETED|Overall Study||3
8625994|NCT02665052|21288329|P4|COMPLETED|Overall Study||14
8625995|NCT02665052|21288330|P3|COMPLETED|Overall Study||9
8625996|NCT02665052|21288331|P2|COMPLETED|Overall Study||7
8625997|NCT02665052|21288332|P1|COMPLETED|Overall Study||8
8625998|NCT02665052|21288329|P4|STARTED|Overall Study||19
8625999|NCT02665052|21288330|P3|STARTED|Overall Study||9
8626000|NCT02665052|21288331|P2|STARTED|Overall Study||9
8626001|NCT02665052|21288332|P1|STARTED|Overall Study||11
8626002|NCT02660944|21288349|P2|NOT COMPLETED|Overall Study||10
8626003|NCT02660944|21288350|P1|NOT COMPLETED|Overall Study||17
8626004|NCT02660944|21288349|P2|COMPLETED|Overall Study||12
8626005|NCT02660944|21288350|P1|COMPLETED|Overall Study||25
8626006|NCT02660944|21288349|P2|STARTED|Overall Study||22
8626007|NCT02660944|21288350|P1|STARTED|Overall Study||42
8626023|NCT02631070|21288411|P2|NOT COMPLETED|Overall Study||76
8626024|NCT02631070|21288412|P1|NOT COMPLETED|Overall Study||112
8626025|NCT02631070|21288411|P2|COMPLETED|Overall Study||0
8626026|NCT02631070|21288412|P1|COMPLETED|Overall Study||41
8626027|NCT02631070|21288411|P2|Completed 48 Weeks of Treatment|Overall Study||12
8626028|NCT02631070|21288412|P1|Completed 48 Weeks of Treatment|Overall Study||83
8626029|NCT02631070|21288411|P2|Completed 24 Weeks of Treatment|Overall Study||68
8626030|NCT02631070|21288412|P1|Completed 24 Weeks of Treatment|Overall Study||128
8626031|NCT02631070|21288411|P2|STARTED|Overall Study||76
8626032|NCT02631070|21288412|P1|STARTED|Overall Study||153
8626047|NCT02599129|21288612|P2|NOT COMPLETED|Overall Study||3
8626048|NCT02599129|21288613|P1|NOT COMPLETED|Overall Study||5
8626049|NCT02599129|21288612|P2|COMPLETED|Overall Study||1
8626050|NCT02599129|21288613|P1|COMPLETED|Overall Study||2
8626051|NCT02599129|21288612|P2|STARTED|Overall Study||4
8626052|NCT02599129|21288613|P1|STARTED|Overall Study||7
8626061|NCT02576977|21288652|P2|NOT COMPLETED|Overall Study||125
8626062|NCT02576977|21288653|P1|NOT COMPLETED|Overall Study||126
8626063|NCT02576977|21288652|P2|COMPLETED|Overall Study||0
8626064|NCT02576977|21288653|P1|COMPLETED|Overall Study||0
8626065|NCT02576977|21288652|P2|Treated|Overall Study||123
8626066|NCT02576977|21288653|P1|Treated|Overall Study||122
8626067|NCT02576977|21288652|P2|STARTED|Overall Study||125
8626068|NCT02576977|21288653|P1|STARTED|Overall Study||126
8626069|NCT02550743|21288675|P4|NOT COMPLETED|Overall Study||0
8626070|NCT02550743|21288676|P3|NOT COMPLETED|Overall Study||0
8626071|NCT02550743|21288677|P2|NOT COMPLETED|Overall Study||0
8626072|NCT02550743|21288678|P1|NOT COMPLETED|Overall Study||0
8626073|NCT02550743|21288675|P4|COMPLETED|Overall Study||0
8626074|NCT02550743|21288676|P3|COMPLETED|Overall Study||1
8626075|NCT02550743|21288677|P2|COMPLETED|Overall Study||3
8626076|NCT02550743|21288678|P1|COMPLETED|Overall Study||3
8626077|NCT02550743|21288675|P4|STARTED|Overall Study||0
8626078|NCT02550743|21288676|P3|STARTED|Overall Study||1
8626079|NCT02550743|21288677|P2|STARTED|Overall Study||3
8626080|NCT02550743|21288678|P1|STARTED|Overall Study||3
8626113|NCT02536833|21288743|P4|NOT COMPLETED|Overall Study||19
8626114|NCT02536833|21288744|P3|NOT COMPLETED|Overall Study||15
8626115|NCT02536833|21288745|P2|NOT COMPLETED|Overall Study||10
8626116|NCT02536833|21288746|P1|NOT COMPLETED|Overall Study||9
8626117|NCT02536833|21288743|P4|COMPLETED|Overall Study||97
8626118|NCT02536833|21288744|P3|COMPLETED|Overall Study||95
8626119|NCT02536833|21288745|P2|COMPLETED|Overall Study||107
8626120|NCT02536833|21288746|P1|COMPLETED|Overall Study||103
8626121|NCT02536833|21288743|P4|STARTED|Overall Study||116
8626122|NCT02536833|21288744|P3|STARTED|Overall Study||110
8626123|NCT02536833|21288745|P2|STARTED|Overall Study||117
8626124|NCT02536833|21288746|P1|STARTED|Overall Study||112
8626125|NCT02522767|21288807|P2|NOT COMPLETED|Open-label||7
8626126|NCT02522767|21288808|P1|NOT COMPLETED|Open-label||5
8626127|NCT02522767|21288807|P2|COMPLETED|Open-label||75
8626128|NCT02522767|21288808|P1|COMPLETED|Open-label||83
8626129|NCT02522767|21288807|P2|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|82
8626130|NCT02522767|21288808|P1|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|88
8626131|NCT02522767|21288807|P2|NOT COMPLETED|Double-blind||24
8626132|NCT02522767|21288808|P1|NOT COMPLETED|Double-blind||11
8626133|NCT02522767|21288807|P2|COMPLETED|Double-blind||90
8626134|NCT02522767|21288808|P1|COMPLETED|Double-blind||103
8626135|NCT02522767|21288807|P2|STARTED|Double-blind||114
8626136|NCT02522767|21288808|P1|STARTED|Double-blind||114
8626143|NCT02494583|21288861|P3|NOT COMPLETED|Overall Study||250
8626144|NCT02494583|21288862|P2|NOT COMPLETED|Overall Study||257
8626145|NCT02494583|21288863|P1|NOT COMPLETED|Overall Study||256
8626146|NCT02494583|21288861|P3|COMPLETED|Overall Study||0
8626147|NCT02494583|21288862|P2|COMPLETED|Overall Study||0
8626148|NCT02494583|21288863|P1|COMPLETED|Overall Study||0
8626149|NCT02494583|21288861|P3|Treated|Overall Study||244
8626150|NCT02494583|21288862|P2|Treated|Overall Study||250
8626151|NCT02494583|21288863|P1|Treated|Overall Study|1 participant randomized to the pembro combo arm received pembrolizumab monotherapy by mistake.|254
8626152|NCT02494583|21288861|P3|STARTED|Overall Study||250
8626153|NCT02494583|21288862|P2|STARTED|Overall Study||257
8626154|NCT02494583|21288863|P1|STARTED|Overall Study||256
8626155|NCT02489630|21288918|P2|NOT COMPLETED|Overall Study||2
8626156|NCT02489630|21288919|P1|NOT COMPLETED|Overall Study||2
8626157|NCT02489630|21288918|P2|COMPLETED|Overall Study||61
8626158|NCT02489630|21288919|P1|COMPLETED|Overall Study||51
8626159|NCT02489630|21288918|P2|STARTED|Overall Study||63
8626160|NCT02489630|21288919|P1|STARTED|Overall Study||53
8626173|NCT02442336|21288955|P1|NOT COMPLETED|Overall Study||36
8626174|NCT02442336|21288955|P1|COMPLETED|Overall Study||44
8626175|NCT02442336|21288955|P1|Provided Access to Intervention|Overall Study||55
8626176|NCT02442336|21288955|P1|Evaluation Phase|Overall Study||74
8626177|NCT02442336|21288955|P1|Developmental Phase|Overall Study||6
8626178|NCT02442336|21288955|P1|STARTED|Overall Study||80
8626187|NCT02432209|21288980|P2|NOT COMPLETED|Overall Study||40
8626188|NCT02432209|21288981|P1|NOT COMPLETED|Overall Study||31
8626189|NCT02432209|21288980|P2|COMPLETED|Overall Study||151
8626190|NCT02432209|21288981|P1|COMPLETED|Overall Study||157
8626191|NCT02432209|21288980|P2|STARTED|Overall Study||191
8626192|NCT02432209|21288981|P1|STARTED|Overall Study||188
8626193|NCT02431559|21289003|P4|NOT COMPLETED|Overall Study||31
8626194|NCT02431559|21289004|P3|NOT COMPLETED|Overall Study||4
8626195|NCT02431559|21289005|P2|NOT COMPLETED|Overall Study||3
8626196|NCT02431559|21289006|P1|NOT COMPLETED|Overall Study||2
8626197|NCT02431559|21289003|P4|COMPLETED|Overall Study||9
8626198|NCT02431559|21289004|P3|COMPLETED|Overall Study||2
8626199|NCT02431559|21289005|P2|COMPLETED|Overall Study||1
8626200|NCT02431559|21289006|P1|COMPLETED|Overall Study||1
8626201|NCT02431559|21289003|P4|STARTED|Overall Study||40
8626202|NCT02431559|21289004|P3|STARTED|Overall Study||6
8626203|NCT02431559|21289005|P2|STARTED|Overall Study||4
8626204|NCT02431559|21289006|P1|STARTED|Overall Study||3
8626318|NCT02404805|21289364|P6|NOT COMPLETED|Overall Study||0
8626319|NCT02404805|21289365|P5|NOT COMPLETED|Overall Study||0
8626320|NCT02404805|21289366|P4|NOT COMPLETED|Overall Study||0
8626321|NCT02404805|21289367|P3|NOT COMPLETED|Overall Study||0
8626322|NCT02404805|21289368|P2|NOT COMPLETED|Overall Study||0
8626323|NCT02404805|21289369|P1|NOT COMPLETED|Overall Study||1
8626324|NCT02404805|21289364|P6|COMPLETED|Overall Study||4
8626325|NCT02404805|21289365|P5|COMPLETED|Overall Study||3
8626326|NCT02404805|21289366|P4|COMPLETED|Overall Study||5
8626327|NCT02404805|21289367|P3|COMPLETED|Overall Study||5
8626328|NCT02404805|21289368|P2|COMPLETED|Overall Study||3
8626329|NCT02404805|21289369|P1|COMPLETED|Overall Study||4
8626330|NCT02404805|21289364|P6|STARTED|Overall Study||4
8626331|NCT02404805|21289365|P5|STARTED|Overall Study||3
8626332|NCT02404805|21289366|P4|STARTED|Overall Study||5
8626333|NCT02404805|21289367|P3|STARTED|Overall Study||5
8626334|NCT02404805|21289368|P2|STARTED|Overall Study||3
8626335|NCT02404805|21289369|P1|STARTED|Overall Study||5
8626336|NCT02397889|21289380|P2|NOT COMPLETED|Overall Study||0
8626337|NCT02397889|21289381|P1|NOT COMPLETED|Overall Study||1
8626338|NCT02397889|21289380|P2|COMPLETED|Overall Study||15
8626339|NCT02397889|21289381|P1|COMPLETED|Overall Study||14
8626340|NCT02397889|21289380|P2|STARTED|Overall Study||15
8626341|NCT02397889|21289381|P1|STARTED|Overall Study||15
8626342|NCT02391545|21289399|P2|NOT COMPLETED|Overall Study||28
8626343|NCT02391545|21289400|P1|NOT COMPLETED|Overall Study||26
8626344|NCT02391545|21289399|P2|COMPLETED|Overall Study||0
8626345|NCT02391545|21289400|P1|COMPLETED|Overall Study||1
8626346|NCT02391545|21289399|P2|STARTED|Overall Study||28
8626347|NCT02391545|21289400|P1|STARTED|Overall Study||27
8626348|NCT02387294|21289420|P2|NOT COMPLETED|Overall Study||0
8626349|NCT02387294|21289421|P1|NOT COMPLETED|Overall Study||0
8626350|NCT02387294|21289420|P2|COMPLETED|Overall Study||60
8626351|NCT02387294|21289421|P1|COMPLETED|Overall Study||60
8626352|NCT02387294|21289420|P2|STARTED|Overall Study||60
8626353|NCT02387294|21289421|P1|STARTED|Overall Study||60
8626354|NCT02383966|21289445|P2|NOT COMPLETED|Overall Study||7
8626355|NCT02383966|21289446|P1|NOT COMPLETED|Overall Study||26
8626356|NCT02383966|21289445|P2|COMPLETED|Overall Study||72
8626357|NCT02383966|21289446|P1|COMPLETED|Overall Study||138
8626358|NCT02383966|21289445|P2|STARTED|Overall Study||79
8626359|NCT02383966|21289446|P1|STARTED|Overall Study||164
8626372|NCT02346383|21289489|P1|NOT COMPLETED|Overall Study||0
8626373|NCT02346383|21289489|P1|COMPLETED|Overall Study||40
8626374|NCT02346383|21289489|P1|STARTED|Overall Study||40
8626381|NCT02313597|21289529|P2|NOT COMPLETED|Overall Study||0
8626382|NCT02313597|21289530|P1|NOT COMPLETED|Overall Study||0
8626383|NCT02313597|21289529|P2|COMPLETED|Overall Study||40
8626384|NCT02313597|21289530|P1|COMPLETED|Overall Study||40
8626385|NCT02313597|21289529|P2|STARTED|Overall Study||40
8626386|NCT02313597|21289530|P1|STARTED|Overall Study||40
8626399|NCT02292940|21289603|P2|NOT COMPLETED|Overall Study||1176
8626400|NCT02292940|21289604|P1|NOT COMPLETED|Overall Study||0
8626401|NCT02292940|21289603|P2|COMPLETED|Overall Study||1824
8626402|NCT02292940|21289604|P1|COMPLETED|Overall Study||165477
8626403|NCT02292940|21289603|P2|STARTED|Overall Study||3000
8626404|NCT02292940|21289604|P1|STARTED|Overall Study||165477
8626405|NCT02291614|21289622|P11|NOT COMPLETED|Overall Study||2
8626406|NCT02291614|21289623|P10|NOT COMPLETED|Overall Study||2
8626407|NCT02291614|21289624|P9|NOT COMPLETED|Overall Study||0
8626408|NCT02291614|21289625|P8|NOT COMPLETED|Overall Study||1
8626409|NCT02291614|21289626|P7|NOT COMPLETED|Overall Study||1
8626410|NCT02291614|21289627|P6|NOT COMPLETED|Overall Study||1
8626411|NCT02291614|21289628|P5|NOT COMPLETED|Overall Study||1
8626412|NCT02291614|21289629|P4|NOT COMPLETED|Overall Study||1
8626413|NCT02291614|21289630|P3|NOT COMPLETED|Overall Study||1
8626414|NCT02291614|21289631|P2|NOT COMPLETED|Overall Study||1
8626415|NCT02291614|21289632|P1|NOT COMPLETED|Overall Study||0
8626416|NCT02291614|21289622|P11|COMPLETED|Overall Study||0
8626417|NCT02291614|21289623|P10|COMPLETED|Overall Study||9
8626418|NCT02291614|21289624|P9|COMPLETED|Overall Study||3
8626419|NCT02291614|21289625|P8|COMPLETED|Overall Study||2
8626420|NCT02291614|21289626|P7|COMPLETED|Overall Study||5
8626421|NCT02291614|21289627|P6|COMPLETED|Overall Study||2
8626422|NCT02291614|21289628|P5|COMPLETED|Overall Study||2
8626423|NCT02291614|21289629|P4|COMPLETED|Overall Study||4
8626424|NCT02291614|21289630|P3|COMPLETED|Overall Study||2
8626425|NCT02291614|21289631|P2|COMPLETED|Overall Study||2
8626426|NCT02291614|21289632|P1|COMPLETED|Overall Study||3
8626427|NCT02291614|21289622|P11|Received AMG 211|Overall Study||2
8626428|NCT02291614|21289623|P10|Received AMG 211|Overall Study||10
8626429|NCT02291614|21289624|P9|Received AMG 211|Overall Study||3
8626430|NCT02291614|21289625|P8|Received AMG 211|Overall Study||3
8626431|NCT02291614|21289626|P7|Received AMG 211|Overall Study||6
8626432|NCT02291614|21289627|P6|Received AMG 211|Overall Study||3
8626433|NCT02291614|21289628|P5|Received AMG 211|Overall Study||3
8626434|NCT02291614|21289629|P4|Received AMG 211|Overall Study||5
8626435|NCT02291614|21289630|P3|Received AMG 211|Overall Study||3
8626436|NCT02291614|21289631|P2|Received AMG 211|Overall Study||3
8626437|NCT02291614|21289632|P1|Received AMG 211|Overall Study||3
8626438|NCT02291614|21289622|P11|STARTED|Overall Study||2
8626439|NCT02291614|21289623|P10|STARTED|Overall Study||11
8626440|NCT02291614|21289624|P9|STARTED|Overall Study||3
8626441|NCT02291614|21289625|P8|STARTED|Overall Study||3
8626442|NCT02291614|21289626|P7|STARTED|Overall Study||6
8626443|NCT02291614|21289627|P6|STARTED|Overall Study||3
8626444|NCT02291614|21289628|P5|STARTED|Overall Study||3
8626445|NCT02291614|21289629|P4|STARTED|Overall Study||5
8626446|NCT02291614|21289630|P3|STARTED|Overall Study||3
8626447|NCT02291614|21289631|P2|STARTED|Overall Study||3
8626448|NCT02291614|21289632|P1|STARTED|Overall Study||3
8626449|NCT02255474|21289813|P3|NOT COMPLETED|Overall Study||3
8626450|NCT02255474|21289814|P2|NOT COMPLETED|Overall Study||2
8626451|NCT02255474|21289815|P1|NOT COMPLETED|Overall Study||2
8626452|NCT02255474|21289813|P3|COMPLETED|Overall Study||95
8626453|NCT02255474|21289814|P2|COMPLETED|Overall Study||96
8626454|NCT02255474|21289815|P1|COMPLETED|Overall Study||96
8626455|NCT02255474|21289813|P3|STARTED|Overall Study||98
8626456|NCT02255474|21289814|P2|STARTED|Overall Study||98
8626457|NCT02255474|21289815|P1|STARTED|Overall Study||98
8626458|NCT02233946|21289834|P2|NOT COMPLETED|12-month Follow-up||11
8626459|NCT02233946|21289835|P1|NOT COMPLETED|12-month Follow-up||28
8626460|NCT02233946|21289834|P2|COMPLETED|12-month Follow-up||190
8626461|NCT02233946|21289835|P1|COMPLETED|12-month Follow-up||502
8626462|NCT02233946|21289834|P2|STARTED|12-month Follow-up||201
8626463|NCT02233946|21289835|P1|STARTED|12-month Follow-up||530
8626464|NCT02233946|21289834|P2|NOT COMPLETED|9-month Follow-up||11
8626465|NCT02233946|21289835|P1|NOT COMPLETED|9-month Follow-up||20
8626466|NCT02233946|21289834|P2|COMPLETED|9-month Follow-up||201
8626467|NCT02233946|21289835|P1|COMPLETED|9-month Follow-up||530
8626468|NCT02233946|21289834|P2|STARTED|9-month Follow-up||212
8626469|NCT02233946|21289835|P1|STARTED|9-month Follow-up||550
8626470|NCT02233946|21289834|P2|NOT COMPLETED|6-months Follow-up||2
8626471|NCT02233946|21289835|P1|NOT COMPLETED|6-months Follow-up||21
8626472|NCT02233946|21289834|P2|COMPLETED|6-months Follow-up||212
8626473|NCT02233946|21289835|P1|COMPLETED|6-months Follow-up||550
8626474|NCT02233946|21289834|P2|STARTED|6-months Follow-up||214
8626475|NCT02233946|21289835|P1|STARTED|6-months Follow-up||571
8626476|NCT02233946|21289834|P2|NOT COMPLETED|3-months Follow-up||29
8626477|NCT02233946|21289835|P1|NOT COMPLETED|3-months Follow-up||53
8626478|NCT02233946|21289834|P2|COMPLETED|3-months Follow-up||214
8626479|NCT02233946|21289835|P1|COMPLETED|3-months Follow-up||571
8626480|NCT02233946|21289834|P2|STARTED|3-months Follow-up||243
8626481|NCT02233946|21289835|P1|STARTED|3-months Follow-up||624
8626482|NCT02233946|21289834|P2|NOT COMPLETED|Immediate Post-visit Questionnaire||0
8626483|NCT02233946|21289835|P1|NOT COMPLETED|Immediate Post-visit Questionnaire||2
8626484|NCT02233946|21289834|P2|COMPLETED|Immediate Post-visit Questionnaire||243
8626485|NCT02233946|21289835|P1|COMPLETED|Immediate Post-visit Questionnaire||624
8626486|NCT02233946|21289834|P2|STARTED|Immediate Post-visit Questionnaire||243
8626487|NCT02233946|21289835|P1|STARTED|Immediate Post-visit Questionnaire||626
8626488|NCT02233946|21289834|P2|NOT COMPLETED|Baseline||0
8626489|NCT02233946|21289835|P1|NOT COMPLETED|Baseline||2
8626490|NCT02233946|21289834|P2|COMPLETED|Baseline|Completed baseline assessment|243
8626491|NCT02233946|21289835|P1|COMPLETED|Baseline|Completed baseline assessment|626
8626492|NCT02233946|21289834|P2|STARTED|Baseline|Allocated to and received usual care|243
8626493|NCT02233946|21289835|P1|STARTED|Baseline|Allocated to and received the intervention|628
8626494|NCT02230696|21289850|P3|NOT COMPLETED|Overall Study||4
8626495|NCT02230696|21289851|P2|NOT COMPLETED|Overall Study||11
8626496|NCT02230696|21289852|P1|NOT COMPLETED|Overall Study||15
8626497|NCT02230696|21289850|P3|COMPLETED|Overall Study||190
8626498|NCT02230696|21289851|P2|COMPLETED|Overall Study||365
8626499|NCT02230696|21289852|P1|COMPLETED|Overall Study||366
8626500|NCT02230696|21289850|P3|STARTED|Overall Study||194
8626501|NCT02230696|21289851|P2|STARTED|Overall Study||376
8626502|NCT02230696|21289852|P1|STARTED|Overall Study||381
8626503|NCT02229864|21289866|P1|NOT COMPLETED|Overall Study||3
8626504|NCT02229864|21289866|P1|COMPLETED|Overall Study||9
8626505|NCT02229864|21289866|P1|STARTED|Overall Study||12
8626506|NCT02204982|21289889|P2|NOT COMPLETED|Overall Study||7
8626507|NCT02204982|21289890|P1|NOT COMPLETED|Overall Study||4
8626508|NCT02204982|21289889|P2|COMPLETED|Overall Study||0
8626509|NCT02204982|21289890|P1|COMPLETED|Overall Study||2
8626510|NCT02204982|21289889|P2|STARTED|Overall Study||7
8626511|NCT02204982|21289890|P1|STARTED|Overall Study||6
8626524|NCT02193347|21289923|P1|NOT COMPLETED|Overall Study||0
8626525|NCT02193347|21289923|P1|COMPLETED|Overall Study||24
8626526|NCT02193347|21289923|P1|STARTED|Overall Study||24
8626527|NCT02189850|21289930|P2|NOT COMPLETED|Overall Study||2
8626528|NCT02189850|21289931|P1|NOT COMPLETED|Overall Study||2
8626529|NCT02189850|21289930|P2|COMPLETED|Overall Study||11
8626530|NCT02189850|21289931|P1|COMPLETED|Overall Study||14
8626531|NCT02189850|21289930|P2|STARTED|Overall Study||13
8626532|NCT02189850|21289931|P1|STARTED|Overall Study||16
8626533|NCT02184520|21289939|P2|NOT COMPLETED|Overall Study||0
8626534|NCT02184520|21289940|P1|NOT COMPLETED|Overall Study||0
8626535|NCT02184520|21289939|P2|COMPLETED|Overall Study||0
8626536|NCT02184520|21289940|P1|COMPLETED|Overall Study||0
8626537|NCT02184520|21289939|P2|STARTED|Overall Study||0
8626538|NCT02184520|21289940|P1|STARTED|Overall Study||0
8626539|NCT02182947|21289946|P1|NOT COMPLETED|Overall Study||18
8626540|NCT02182947|21289946|P1|COMPLETED|Overall Study||27
8626541|NCT02182947|21289946|P1|STARTED|Overall Study||45
8626542|NCT02181790|21289959|P2|NOT COMPLETED|Overall Study||0
8626543|NCT02181790|21289960|P1|NOT COMPLETED|Overall Study||2
8626544|NCT02181790|21289959|P2|COMPLETED|Overall Study||0
8626545|NCT02181790|21289960|P1|COMPLETED|Overall Study||0
8626546|NCT02181790|21289959|P2|STARTED|Overall Study||0
8626547|NCT02181790|21289960|P1|STARTED|Overall Study||2
8626548|NCT02180672|21289970|P2|NOT COMPLETED|Overall Study||7
8626549|NCT02180672|21289971|P1|NOT COMPLETED|Overall Study||5
8626550|NCT02180672|21289970|P2|COMPLETED|Overall Study||36
8626551|NCT02180672|21289971|P1|COMPLETED|Overall Study||86
8626552|NCT02180672|21289970|P2|STARTED|Overall Study||43
8626553|NCT02180672|21289971|P1|STARTED|Overall Study||91
8626554|NCT02169739|21289997|P2|NOT COMPLETED|Overall Study||4
8626555|NCT02169739|21289998|P1|NOT COMPLETED|Overall Study||0
8626556|NCT02169739|21289997|P2|COMPLETED|Overall Study||0
8626557|NCT02169739|21289998|P1|COMPLETED|Overall Study||2
8626558|NCT02169739|21289997|P2|STARTED|Overall Study||4
8626559|NCT02169739|21289998|P1|STARTED|Overall Study||2
8626560|NCT02162719|21290009|P2|NOT COMPLETED|Overall Study||62
8626561|NCT02162719|21290010|P1|NOT COMPLETED|Overall Study||62
8626562|NCT02162719|21290009|P2|COMPLETED|Overall Study||0
8626563|NCT02162719|21290010|P1|COMPLETED|Overall Study||0
8626564|NCT02162719|21290009|P2|STARTED|Overall Study||62
8626565|NCT02162719|21290010|P1|STARTED|Overall Study||62
8626566|NCT02132598|21290052|P1|NOT COMPLETED|Overall Study||0
8626567|NCT02132598|21290052|P1|COMPLETED|Overall Study||5
8626568|NCT02132598|21290052|P1|STARTED|Overall Study||5
8626569|NCT02108262|21290068|P4|NOT COMPLETED|Overall Study||42
8626570|NCT02108262|21290069|P3|NOT COMPLETED|Overall Study||42
8626571|NCT02108262|21290070|P2|NOT COMPLETED|Overall Study||44
8626572|NCT02108262|21290071|P1|NOT COMPLETED|Overall Study||0
8626573|NCT02108262|21290068|P4|COMPLETED|Overall Study||376
8626574|NCT02108262|21290069|P3|COMPLETED|Overall Study||379
8626575|NCT02108262|21290070|P2|COMPLETED|Overall Study||375
8626576|NCT02108262|21290071|P1|COMPLETED|Overall Study||9
8626577|NCT02108262|21290068|P4|STARTED|Overall Study||418
8626578|NCT02108262|21290069|P3|STARTED|Overall Study||421
8626579|NCT02108262|21290070|P2|STARTED|Overall Study||419
8626580|NCT02108262|21290071|P1|STARTED|Overall Study||9
8626581|NCT02094573|21290268|P2|NOT COMPLETED|Overall Study||110
8626582|NCT02094573|21290269|P1|NOT COMPLETED|Overall Study||112
8626583|NCT02094573|21290268|P2|COMPLETED|Overall Study||0
8626584|NCT02094573|21290269|P1|COMPLETED|Overall Study||0
8626585|NCT02094573|21290268|P2|Treated|Overall Study||110
8626586|NCT02094573|21290269|P1|Treated|Overall Study||109
8626587|NCT02094573|21290268|P2|STARTED|Overall Study||110
8626588|NCT02094573|21290269|P1|STARTED|Overall Study||112
8626589|NCT02086552|21290301|P1|NOT COMPLETED|Overall Study||1
8626590|NCT02086552|21290301|P1|COMPLETED|Overall Study||27
8626591|NCT02086552|21290301|P1|STARTED|Overall Study||28
8626601|NCT02020252|21290323|P1|NOT COMPLETED|Overall Study||0
8626602|NCT02020252|21290323|P1|COMPLETED|Overall Study||120
8626603|NCT02020252|21290323|P1|STARTED|Overall Study||120
8626604|NCT02004522|21290331|P2|NOT COMPLETED|Overall Study||159
8626605|NCT02004522|21290332|P1|NOT COMPLETED|Overall Study||126
8626606|NCT02004522|21290331|P2|COMPLETED|Overall Study|Completed defined here as still on treatment.|0
8626607|NCT02004522|21290332|P1|COMPLETED|Overall Study|Completed defined here as still on treatment.|34
8626608|NCT02004522|21290331|P2|Number of Subjects Treated|Overall Study||155
8626609|NCT02004522|21290332|P1|Number of Subjects Treated|Overall Study||158
8626610|NCT02004522|21290331|P2|STARTED|Overall Study||159
8626611|NCT02004522|21290332|P1|STARTED|Overall Study||160
8626651|NCT01996943|21290487|P2|NOT COMPLETED|Overall Study||0
8626652|NCT01996943|21290488|P1|NOT COMPLETED|Overall Study||0
8626653|NCT01996943|21290487|P2|COMPLETED|Overall Study||50
8626654|NCT01996943|21290488|P1|COMPLETED|Overall Study||50
8626655|NCT01996943|21290487|P2|STARTED|Overall Study||50
8626656|NCT01996943|21290488|P1|STARTED|Overall Study||50
8626699|NCT01965860|21290621|P3|NOT COMPLETED|Overall Study||1
8626700|NCT01965860|21290622|P2|NOT COMPLETED|Overall Study||0
8626701|NCT01965860|21290623|P1|NOT COMPLETED|Overall Study||2
8626702|NCT01965860|21290621|P3|COMPLETED|Overall Study||10
8626703|NCT01965860|21290622|P2|COMPLETED|Overall Study||10
8626704|NCT01965860|21290623|P1|COMPLETED|Overall Study||9
8626705|NCT01965860|21290621|P3|STARTED|Overall Study||11
8626706|NCT01965860|21290622|P2|STARTED|Overall Study||10
8626707|NCT01965860|21290623|P1|STARTED|Overall Study||11
8626708|NCT01951638|21290639|P5|NOT COMPLETED|Follow-up Period||5
8626709|NCT01951638|21290640|P4|NOT COMPLETED|Follow-up Period||8
8626710|NCT01951638|21290641|P3|NOT COMPLETED|Follow-up Period||5
8626711|NCT01951638|21290642|P2|NOT COMPLETED|Follow-up Period||9
8626712|NCT01951638|21290643|P1|NOT COMPLETED|Follow-up Period||2
8626713|NCT01951638|21290639|P5|COMPLETED|Follow-up Period||89
8626714|NCT01951638|21290640|P4|COMPLETED|Follow-up Period||80
8626715|NCT01951638|21290641|P3|COMPLETED|Follow-up Period||90
8626716|NCT01951638|21290642|P2|COMPLETED|Follow-up Period||86
8626717|NCT01951638|21290643|P1|COMPLETED|Follow-up Period||87
8626718|NCT01951638|21290639|P5|STARTED|Follow-up Period||94
8626719|NCT01951638|21290640|P4|STARTED|Follow-up Period||88
8626720|NCT01951638|21290641|P3|STARTED|Follow-up Period||95
8626721|NCT01951638|21290642|P2|STARTED|Follow-up Period||95
8626722|NCT01951638|21290643|P1|STARTED|Follow-up Period||89
8626723|NCT01951638|21290639|P5|NOT COMPLETED|Treatment Period||10
8626724|NCT01951638|21290640|P4|NOT COMPLETED|Treatment Period||16
8626725|NCT01951638|21290641|P3|NOT COMPLETED|Treatment Period||13
8626726|NCT01951638|21290642|P2|NOT COMPLETED|Treatment Period||14
8626727|NCT01951638|21290643|P1|NOT COMPLETED|Treatment Period||13
8626728|NCT01951638|21290639|P5|COMPLETED|Treatment Period||86
8626729|NCT01951638|21290640|P4|COMPLETED|Treatment Period||80
8626730|NCT01951638|21290641|P3|COMPLETED|Treatment Period||83
8626731|NCT01951638|21290642|P2|COMPLETED|Treatment Period||82
8626732|NCT01951638|21290643|P1|COMPLETED|Treatment Period||80
8626733|NCT01951638|21290639|P5|STARTED|Treatment Period||96
8626734|NCT01951638|21290640|P4|STARTED|Treatment Period||96
8626735|NCT01951638|21290641|P3|STARTED|Treatment Period||96
8626736|NCT01951638|21290642|P2|STARTED|Treatment Period||96
8626737|NCT01951638|21290643|P1|STARTED|Treatment Period||93
8626762|NCT01883362|21290746|P2|NOT COMPLETED|Post Treatment Follow-up||14
8626763|NCT01883362|21290747|P1|NOT COMPLETED|Post Treatment Follow-up||16
8626764|NCT01883362|21290746|P2|COMPLETED|Post Treatment Follow-up||13
8626765|NCT01883362|21290747|P1|COMPLETED|Post Treatment Follow-up||10
8626766|NCT01883362|21290746|P2|STARTED|Post Treatment Follow-up||27
8626767|NCT01883362|21290747|P1|STARTED|Post Treatment Follow-up||26
8626768|NCT01883362|21290746|P2|NOT COMPLETED|Treatment||14
8626769|NCT01883362|21290747|P1|NOT COMPLETED|Treatment||16
8626770|NCT01883362|21290746|P2|COMPLETED|Treatment||16
8626771|NCT01883362|21290747|P1|COMPLETED|Treatment||14
8626772|NCT01883362|21290746|P2|STARTED|Treatment||30
8626773|NCT01883362|21290747|P1|STARTED|Treatment||30
8626774|NCT01882803|21290771|P1|NOT COMPLETED|Overall Study||94
8626775|NCT01882803|21290771|P1|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
8626776|NCT01882803|21290771|P1|STARTED|Overall Study||129
8626777|NCT01872325|21290784|P2|NOT COMPLETED|Overall Study||0
8626778|NCT01872325|21290785|P1|NOT COMPLETED|Overall Study||0
8626779|NCT01872325|21290784|P2|COMPLETED|Overall Study||387
8626780|NCT01872325|21290785|P1|COMPLETED|Overall Study||689
8626781|NCT01872325|21290784|P2|STARTED|Overall Study||387
8626782|NCT01872325|21290785|P1|STARTED|Overall Study||689
8626783|NCT01846182|21290800|P3|NOT COMPLETED|Overall Study||0
8626784|NCT01846182|21290801|P2|NOT COMPLETED|Overall Study||0
8626785|NCT01846182|21290802|P1|NOT COMPLETED|Overall Study||0
8626786|NCT01846182|21290800|P3|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
8626787|NCT01846182|21290801|P2|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
8626788|NCT01846182|21290802|P1|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
8626789|NCT01846182|21290800|P3|STARTED|Overall Study|Unclear due to assignment records.|0
8626790|NCT01846182|21290801|P2|STARTED|Overall Study|Unclear due to assignment records.|0
8626791|NCT01846182|21290802|P1|STARTED|Overall Study|Unclear due to assignment records.|0
8626792|NCT01841047|21290816|P1|NOT COMPLETED|Overall Study||0
8626793|NCT01841047|21290816|P1|COMPLETED|Overall Study||48
8626794|NCT01841047|21290816|P1|STARTED|Overall Study||48
8626795|NCT01795079|21290828|P2|NOT COMPLETED|Overall Study||3
8626796|NCT01795079|21290829|P1|NOT COMPLETED|Overall Study||3
8626797|NCT01795079|21290828|P2|COMPLETED|Overall Study||12
8626798|NCT01795079|21290829|P1|COMPLETED|Overall Study||13
8626799|NCT01795079|21290828|P2|STARTED|Overall Study||15
8626800|NCT01795079|21290829|P1|STARTED|Overall Study||16
8626801|NCT01700439|21290843|P1|NOT COMPLETED|Overall Study||889
8626802|NCT01700439|21290843|P1|COMPLETED|Overall Study||0
8626803|NCT01700439|21290843|P1|2 Year|Overall Study||215
8626804|NCT01700439|21290843|P1|1 Year|Overall Study||573
8626805|NCT01700439|21290843|P1|3 Month|Overall Study||778
8626806|NCT01700439|21290843|P1|Discharge|Overall Study||831
8626807|NCT01700439|21290843|P1|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
8626808|NCT01700439|21290843|P1|STARTED|Overall Study||889
8626809|NCT01681745|21290866|P1|NOT COMPLETED|Overall Study||0
8626810|NCT01681745|21290866|P1|COMPLETED|Overall Study||0
8626811|NCT01681745|21290866|P1|STARTED|Overall Study||0
8626812|NCT01668602|21290873|P2|NOT COMPLETED|Overall Study||4
8626813|NCT01668602|21290874|P1|NOT COMPLETED|Overall Study||0
8626814|NCT01668602|21290873|P2|COMPLETED|Overall Study||18
8626815|NCT01668602|21290874|P1|COMPLETED|Overall Study||2
8626816|NCT01668602|21290873|P2|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study||18
8626817|NCT01668602|21290874|P1|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study|This milestone does not apply to Cohort 1.|0
8626818|NCT01668602|21290873|P2|Cohort 2 - Began Fast Walking Sessions|Overall Study||20
8626819|NCT01668602|21290874|P1|Cohort 2 - Began Fast Walking Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
8626820|NCT01668602|21290873|P2|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study||19
8626821|NCT01668602|21290874|P1|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study|This milestone does not apply to Cohort 1.|0
8626822|NCT01668602|21290873|P2|Cohort 2 - Began FastFES Sessions|Overall Study||20
8626823|NCT01668602|21290874|P1|Cohort 2 - Began FastFES Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
8626824|NCT01668602|21290873|P2|STARTED|Overall Study||22
8626825|NCT01668602|21290874|P1|STARTED|Overall Study||2
8626826|NCT01659255|21290905|P17|NOT COMPLETED|Overall Study||3
8626827|NCT01659255|21290906|P16|NOT COMPLETED|Overall Study||5
8626828|NCT01659255|21290907|P15|NOT COMPLETED|Overall Study||8
8626829|NCT01659255|21290908|P14|NOT COMPLETED|Overall Study||18
8626830|NCT01659255|21290909|P13|NOT COMPLETED|Overall Study||8
8626831|NCT01659255|21290910|P12|NOT COMPLETED|Overall Study||4
8626832|NCT01659255|21290911|P11|NOT COMPLETED|Overall Study||3
8626833|NCT01659255|21290912|P10|NOT COMPLETED|Overall Study||3
8626834|NCT01659255|21290913|P9|NOT COMPLETED|Overall Study||1
8626835|NCT01659255|21290914|P8|NOT COMPLETED|Overall Study||2
8626836|NCT01659255|21290915|P7|NOT COMPLETED|Overall Study||2
8626837|NCT01659255|21290916|P6|NOT COMPLETED|Overall Study||1
8626838|NCT01659255|21290917|P5|NOT COMPLETED|Overall Study||0
8626839|NCT01659255|21290918|P4|NOT COMPLETED|Overall Study||0
8626840|NCT01659255|21290919|P3|NOT COMPLETED|Overall Study||0
8626841|NCT01659255|21290920|P2|NOT COMPLETED|Overall Study||1
8626842|NCT01659255|21290921|P1|NOT COMPLETED|Overall Study||2
8626843|NCT01659255|21290905|P17|COMPLETED|Overall Study||0
8626844|NCT01659255|21290906|P16|COMPLETED|Overall Study||4
8626845|NCT01659255|21290907|P15|COMPLETED|Overall Study||2
8626846|NCT01659255|21290908|P14|COMPLETED|Overall Study||3
8626847|NCT01659255|21290909|P13|COMPLETED|Overall Study||0
8626848|NCT01659255|21290910|P12|COMPLETED|Overall Study||1
8626849|NCT01659255|21290911|P11|COMPLETED|Overall Study||0
8626850|NCT01659255|21290912|P10|COMPLETED|Overall Study||0
8626851|NCT01659255|21290913|P9|COMPLETED|Overall Study||2
8626852|NCT01659255|21290914|P8|COMPLETED|Overall Study||1
8626853|NCT01659255|21290915|P7|COMPLETED|Overall Study||1
8626854|NCT01659255|21290916|P6|COMPLETED|Overall Study||2
8626855|NCT01659255|21290917|P5|COMPLETED|Overall Study||3
8626856|NCT01659255|21290918|P4|COMPLETED|Overall Study||3
8626857|NCT01659255|21290919|P3|COMPLETED|Overall Study||4
8626858|NCT01659255|21290920|P2|COMPLETED|Overall Study||2
8626859|NCT01659255|21290921|P1|COMPLETED|Overall Study||1
8626860|NCT01659255|21290905|P17|STARTED|Overall Study||3
8626861|NCT01659255|21290906|P16|STARTED|Overall Study||9
8626862|NCT01659255|21290907|P15|STARTED|Overall Study||10
8626863|NCT01659255|21290908|P14|STARTED|Overall Study||21
8626864|NCT01659255|21290909|P13|STARTED|Overall Study||8
8626865|NCT01659255|21290910|P12|STARTED|Overall Study||5
8626866|NCT01659255|21290911|P11|STARTED|Overall Study||3
8626867|NCT01659255|21290912|P10|STARTED|Overall Study||3
8626868|NCT01659255|21290913|P9|STARTED|Overall Study||3
8626869|NCT01659255|21290914|P8|STARTED|Overall Study||3
8626870|NCT01659255|21290915|P7|STARTED|Overall Study||3
8626871|NCT01659255|21290916|P6|STARTED|Overall Study||3
8626872|NCT01659255|21290917|P5|STARTED|Overall Study||3
8626873|NCT01659255|21290918|P4|STARTED|Overall Study||3
8626874|NCT01659255|21290919|P3|STARTED|Overall Study||4
8626875|NCT01659255|21290920|P2|STARTED|Overall Study||3
8626876|NCT01659255|21290921|P1|STARTED|Overall Study||3
8626918|NCT01589302|21291092|P1|NOT COMPLETED|Overall Study||2
8626919|NCT01589302|21291092|P1|COMPLETED|Overall Study||152
8626920|NCT01589302|21291092|P1|Non-Del17p Patients|Overall Study||76
8626921|NCT01589302|21291092|P1|Del17p Patients|Overall Study||76
8626922|NCT01589302|21291092|P1|STARTED|Overall Study||154
8626923|NCT01585168|21291113|P4|NOT COMPLETED|Overall Study||1
8626924|NCT01585168|21291114|P3|NOT COMPLETED|Overall Study||1
8626925|NCT01585168|21291115|P2|NOT COMPLETED|Overall Study||1
8626926|NCT01585168|21291116|P1|NOT COMPLETED|Overall Study||3
8626927|NCT01585168|21291113|P4|COMPLETED|Overall Study||18
8626928|NCT01585168|21291114|P3|COMPLETED|Overall Study||15
8626929|NCT01585168|21291115|P2|COMPLETED|Overall Study||17
8626930|NCT01585168|21291116|P1|COMPLETED|Overall Study||15
8626931|NCT01585168|21291113|P4|STARTED|Overall Study||19
8626932|NCT01585168|21291114|P3|STARTED|Overall Study||16
8626933|NCT01585168|21291115|P2|STARTED|Overall Study||18
8626934|NCT01585168|21291116|P1|STARTED|Overall Study||18
8626935|NCT01568320|21291136|P1|NOT COMPLETED|Overall Study||41
8626936|NCT01568320|21291136|P1|COMPLETED|Overall Study||32
8626937|NCT01568320|21291136|P1|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|36
8626938|NCT01568320|21291136|P1|STARTED|Overall Study||73
8626945|NCT01539863|21291192|P2|NOT COMPLETED|Overall Study||4
8626946|NCT01539863|21291193|P1|NOT COMPLETED|Overall Study||5
8626947|NCT01539863|21291192|P2|COMPLETED|Overall Study||158
8626948|NCT01539863|21291193|P1|COMPLETED|Overall Study||161
8626949|NCT01539863|21291192|P2|STARTED|Overall Study||162
8626950|NCT01539863|21291193|P1|STARTED|Overall Study||166
8626951|NCT01539239|21291201|P2|NOT COMPLETED|Overall Study||17
8626952|NCT01539239|21291202|P1|NOT COMPLETED|Overall Study||12
8626953|NCT01539239|21291201|P2|COMPLETED|Overall Study||170
8626954|NCT01539239|21291202|P1|COMPLETED|Overall Study||357
8626955|NCT01539239|21291201|P2|STARTED|Overall Study||187
8626956|NCT01539239|21291202|P1|STARTED|Overall Study||369
8626957|NCT01525875|21291212|P2|NOT COMPLETED|Open-label Period||2
8626958|NCT01525875|21291213|P1|NOT COMPLETED|Open-label Period||0
8626959|NCT01525875|21291212|P2|COMPLETED|Open-label Period||18
8626960|NCT01525875|21291213|P1|COMPLETED|Open-label Period||21
8626961|NCT01525875|21291212|P2|STARTED|Open-label Period||20
8626962|NCT01525875|21291213|P1|STARTED|Open-label Period||21
8626963|NCT01525875|21291212|P2|NOT COMPLETED|Placebo-controlled Period||2
8626964|NCT01525875|21291213|P1|NOT COMPLETED|Placebo-controlled Period||1
8626965|NCT01525875|21291212|P2|COMPLETED|Placebo-controlled Period||20
8626966|NCT01525875|21291213|P1|COMPLETED|Placebo-controlled Period||21
8626967|NCT01525875|21291212|P2|STARTED|Placebo-controlled Period||22
8626968|NCT01525875|21291213|P1|STARTED|Placebo-controlled Period||22
8626978|NCT01519960|21291258|P3|NOT COMPLETED|Overall Study||10
8626979|NCT01519960|21291259|P2|NOT COMPLETED|Overall Study||50
8626980|NCT01519960|21291260|P1|NOT COMPLETED|Overall Study||101
8626981|NCT01519960|21291258|P3|COMPLETED|Overall Study||0
8626982|NCT01519960|21291259|P2|COMPLETED|Overall Study||0
8626983|NCT01519960|21291260|P1|COMPLETED|Overall Study||0
8626984|NCT01519960|21291258|P3|Completed FU Week 24|Overall Study||10
8626985|NCT01519960|21291259|P2|Completed FU Week 24|Overall Study||15
8626986|NCT01519960|21291260|P1|Completed FU Week 24|Overall Study||101
8626987|NCT01519960|21291258|P3|Completed Follow-Up (FU) Week 12|Overall Study||10
8626988|NCT01519960|21291259|P2|Completed Follow-Up (FU) Week 12|Overall Study||26
8626989|NCT01519960|21291260|P1|Completed Follow-Up (FU) Week 12|Overall Study||101
8626990|NCT01519960|21291258|P3|Completed Week 48|Overall Study||10
8626991|NCT01519960|21291259|P2|Completed Week 48|Overall Study||47
8626992|NCT01519960|21291260|P1|Completed Week 48|Overall Study||99
8626993|NCT01519960|21291258|P3|STARTED|Overall Study||10
8626994|NCT01519960|21291259|P2|STARTED|Overall Study||50
8626995|NCT01519960|21291260|P1|STARTED|Overall Study||101
8626996|NCT01468844|21291368|P2|NOT COMPLETED|Overall Study||0
8626997|NCT01468844|21291369|P1|NOT COMPLETED|Overall Study||2
8626998|NCT01468844|21291368|P2|COMPLETED|Overall Study||2
8626999|NCT01468844|21291369|P1|COMPLETED|Overall Study||2
8627000|NCT01468844|21291368|P2|STARTED|Overall Study||2
8627001|NCT01468844|21291369|P1|STARTED|Overall Study||4
8627002|NCT01378858|21291409|P2|NOT COMPLETED|Overall Study||4
8627003|NCT01378858|21291410|P1|NOT COMPLETED|Overall Study||4
8627004|NCT01378858|21291409|P2|COMPLETED|Overall Study||46
8627005|NCT01378858|21291410|P1|COMPLETED|Overall Study||46
8627006|NCT01378858|21291409|P2|STARTED|Overall Study||50
8627007|NCT01378858|21291410|P1|STARTED|Overall Study||50
8627008|NCT01347541|21291422|P2|NOT COMPLETED|Overall Study||0
8627009|NCT01347541|21291423|P1|NOT COMPLETED|Overall Study||0
8627010|NCT01347541|21291422|P2|COMPLETED|Overall Study||1
8627011|NCT01347541|21291423|P1|COMPLETED|Overall Study||3
8627012|NCT01347541|21291422|P2|STARTED|Overall Study||1
8627013|NCT01347541|21291423|P1|STARTED|Overall Study||3
8627026|NCT01280643|21291472|P9|NOT COMPLETED|Overall Study||0
8627027|NCT01280643|21291473|P8|NOT COMPLETED|Overall Study||0
8627028|NCT01280643|21291474|P7|NOT COMPLETED|Overall Study||0
8627029|NCT01280643|21291475|P6|NOT COMPLETED|Overall Study||0
8627030|NCT01280643|21291476|P5|NOT COMPLETED|Overall Study||0
8627031|NCT01280643|21291477|P4|NOT COMPLETED|Overall Study||0
8627032|NCT01280643|21291478|P3|NOT COMPLETED|Overall Study||0
8627033|NCT01280643|21291479|P2|NOT COMPLETED|Overall Study||1
8627034|NCT01280643|21291480|P1|NOT COMPLETED|Overall Study||0
8627035|NCT01280643|21291472|P9|COMPLETED|Overall Study||0
8627036|NCT01280643|21291473|P8|COMPLETED|Overall Study||0
8627037|NCT01280643|21291474|P7|COMPLETED|Overall Study||0
8627038|NCT01280643|21291475|P6|COMPLETED|Overall Study||0
8627039|NCT01280643|21291476|P5|COMPLETED|Overall Study||0
8627040|NCT01280643|21291477|P4|COMPLETED|Overall Study||1
8627041|NCT01280643|21291478|P3|COMPLETED|Overall Study||1
8627042|NCT01280643|21291479|P2|COMPLETED|Overall Study||0
8627043|NCT01280643|21291480|P1|COMPLETED|Overall Study||0
8627044|NCT01280643|21291472|P9|STARTED|Overall Study||0
8627045|NCT01280643|21291473|P8|STARTED|Overall Study||0
8627046|NCT01280643|21291474|P7|STARTED|Overall Study||0
8627047|NCT01280643|21291475|P6|STARTED|Overall Study||0
8627048|NCT01280643|21291476|P5|STARTED|Overall Study||0
8627049|NCT01280643|21291477|P4|STARTED|Overall Study||1
8627050|NCT01280643|21291478|P3|STARTED|Overall Study||1
8627051|NCT01280643|21291479|P2|STARTED|Overall Study||1
8627052|NCT01280643|21291480|P1|STARTED|Overall Study||0
8627053|NCT01280617|21291529|P2|NOT COMPLETED|Overall Study||1
8627054|NCT01280617|21291530|P1|NOT COMPLETED|Overall Study||0
8627055|NCT01280617|21291529|P2|COMPLETED|Overall Study||20
8627056|NCT01280617|21291530|P1|COMPLETED|Overall Study||23
8627057|NCT01280617|21291529|P2|STARTED|Overall Study||21
8627058|NCT01280617|21291530|P1|STARTED|Overall Study||23
8627065|NCT01271868|21291559|P1|NOT COMPLETED|Treatment Study||0
8627066|NCT01271868|21291559|P1|COMPLETED|Treatment Study||9
8627067|NCT01271868|21291559|P1|STARTED|Treatment Study||9
8627068|NCT01271868|21291559|P1|NOT COMPLETED|Pharmacokinetic Study||0
8627069|NCT01271868|21291559|P1|COMPLETED|Pharmacokinetic Study||9
8627070|NCT01271868|21291559|P1|STARTED|Pharmacokinetic Study||9
8627071|NCT01270139|21291573|P3|NOT COMPLETED|Overall Study||20
8627072|NCT01270139|21291574|P2|NOT COMPLETED|Overall Study||26
8627073|NCT01270139|21291575|P1|NOT COMPLETED|Overall Study||18
8627074|NCT01270139|21291573|P3|COMPLETED|Overall Study|Pre-treatment evaluable population|40
8627075|NCT01270139|21291574|P2|COMPLETED|Overall Study|Pre-treatment evaluable population|34
8627076|NCT01270139|21291575|P1|COMPLETED|Overall Study|Pre-treatment evaluable population|42
8627077|NCT01270139|21291573|P3|STARTED|Overall Study|Intention-to-treat population|60
8627078|NCT01270139|21291574|P2|STARTED|Overall Study|Intention-to-treat population|60
8627079|NCT01270139|21291575|P1|STARTED|Overall Study|Intention-to-treat population|60
8627080|NCT01262638|21291637|P4|NOT COMPLETED|Overall Study||7
8627081|NCT01262638|21291638|P3|NOT COMPLETED|Overall Study||6
8627082|NCT01262638|21291639|P2|NOT COMPLETED|Overall Study||6
8627083|NCT01262638|21291640|P1|NOT COMPLETED|Overall Study||7
8627084|NCT01262638|21291637|P4|COMPLETED|Overall Study||37
8627085|NCT01262638|21291638|P3|COMPLETED|Overall Study||38
8627086|NCT01262638|21291639|P2|COMPLETED|Overall Study||38
8627087|NCT01262638|21291640|P1|COMPLETED|Overall Study||38
8627088|NCT01262638|21291637|P4|STARTED|Overall Study||44
8627089|NCT01262638|21291638|P3|STARTED|Overall Study||44
8627090|NCT01262638|21291639|P2|STARTED|Overall Study||44
8627091|NCT01262638|21291640|P1|STARTED|Overall Study||45
8627092|NCT01245270|21291720|P2|NOT COMPLETED|Overall Study||0
8627093|NCT01245270|21291721|P1|NOT COMPLETED|Overall Study||0
8627094|NCT01245270|21291720|P2|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
8627095|NCT01245270|21291721|P1|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
8627096|NCT01245270|21291720|P2|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
8627097|NCT01245270|21291721|P1|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
8627114|NCT01220856|21291752|P2|NOT COMPLETED|Overall Study||3
8627115|NCT01220856|21291753|P1|NOT COMPLETED|Overall Study||4
8627116|NCT01220856|21291752|P2|COMPLETED|Overall Study||0
8627117|NCT01220856|21291753|P1|COMPLETED|Overall Study||2
8627118|NCT01220856|21291752|P2|STARTED|Overall Study||3
8627119|NCT01220856|21291753|P1|STARTED|Overall Study||6
8627120|NCT01220024|21291803|P2|NOT COMPLETED|Overall Study||1
8627121|NCT01220024|21291804|P1|NOT COMPLETED|Overall Study||1
8627122|NCT01220024|21291803|P2|COMPLETED|Overall Study||24
8627123|NCT01220024|21291804|P1|COMPLETED|Overall Study||24
8627124|NCT01220024|21291803|P2|STARTED|Overall Study||25
8627125|NCT01220024|21291804|P1|STARTED|Overall Study||25
8627126|NCT01206166|21291822|P2|NOT COMPLETED|Overall Study||3
8627127|NCT01206166|21291823|P1|NOT COMPLETED|Overall Study||2
8627128|NCT01206166|21291822|P2|COMPLETED|Overall Study||49
8627129|NCT01206166|21291823|P1|COMPLETED|Overall Study||71
8627130|NCT01206166|21291822|P2|STARTED|Overall Study||52
8627131|NCT01206166|21291823|P1|STARTED|Overall Study||73
8627132|NCT01192776|21291891|P4|NOT COMPLETED|Overall Study||20
8627133|NCT01192776|21291892|P3|NOT COMPLETED|Overall Study||21
8627134|NCT01192776|21291893|P2|NOT COMPLETED|Overall Study||21
8627135|NCT01192776|21291894|P1|NOT COMPLETED|Overall Study||11
8627136|NCT01192776|21291891|P4|COMPLETED|Overall Study||63
8627137|NCT01192776|21291892|P3|COMPLETED|Overall Study||75
8627138|NCT01192776|21291893|P2|COMPLETED|Overall Study||69
8627139|NCT01192776|21291894|P1|COMPLETED|Overall Study||84
8627140|NCT01192776|21291891|P4|Died After Discharge|Overall Study||1
8627141|NCT01192776|21291892|P3|Died After Discharge|Overall Study||3
8627142|NCT01192776|21291893|P2|Died After Discharge|Overall Study||2
8627143|NCT01192776|21291894|P1|Died After Discharge|Overall Study||1
8627144|NCT01192776|21291891|P4|Died Prior to Discharge|Overall Study||14
8627145|NCT01192776|21291892|P3|Died Prior to Discharge|Overall Study||15
8627146|NCT01192776|21291893|P2|Died Prior to Discharge|Overall Study||13
8627147|NCT01192776|21291894|P1|Died Prior to Discharge|Overall Study||7
8627148|NCT01192776|21291891|P4|STARTED|Overall Study||83
8627149|NCT01192776|21291892|P3|STARTED|Overall Study||96
8627150|NCT01192776|21291893|P2|STARTED|Overall Study||90
8627151|NCT01192776|21291894|P1|STARTED|Overall Study||95
8627152|NCT01178411|21291948|P1|NOT COMPLETED|Overall Study||60
8627153|NCT01178411|21291948|P1|COMPLETED|Overall Study||0
8627154|NCT01178411|21291948|P1|STARTED|Overall Study||60
8627155|NCT01151436|21291954|P1|NOT COMPLETED|Overall Study||1
8627156|NCT01151436|21291954|P1|COMPLETED|Overall Study||76
8627157|NCT01151436|21291954|P1|STARTED|Overall Study||77
8627161|NCT01127893|21291988|P1|NOT COMPLETED|Overall Study||1
8627162|NCT01127893|21291988|P1|COMPLETED|Overall Study||0
8627163|NCT01127893|21291988|P1|STARTED|Overall Study||1
8627175|NCT01037790|21292065|P5|NOT COMPLETED|Overall Study||0
8627176|NCT01037790|21292066|P4|NOT COMPLETED|Overall Study||0
8627177|NCT01037790|21292067|P3|NOT COMPLETED|Overall Study||0
8627178|NCT01037790|21292068|P2|NOT COMPLETED|Overall Study||0
8627179|NCT01037790|21292069|P1|NOT COMPLETED|Overall Study||0
8627180|NCT01037790|21292065|P5|COMPLETED|Overall Study||11
8627181|NCT01037790|21292066|P4|COMPLETED|Overall Study||30
8627182|NCT01037790|21292067|P3|COMPLETED|Overall Study||19
8627183|NCT01037790|21292068|P2|COMPLETED|Overall Study||18
8627184|NCT01037790|21292069|P1|COMPLETED|Overall Study||63
8627185|NCT01037790|21292065|P5|STARTED|Overall Study||11
8627186|NCT01037790|21292066|P4|STARTED|Overall Study||30
8627187|NCT01037790|21292067|P3|STARTED|Overall Study||19
8627188|NCT01037790|21292068|P2|STARTED|Overall Study||18
8627189|NCT01037790|21292069|P1|STARTED|Overall Study||63
8627190|NCT01030575|21292085|P4|NOT COMPLETED|Overall Study||0
8627191|NCT01030575|21292086|P3|NOT COMPLETED|Overall Study||0
8627192|NCT01030575|21292087|P2|NOT COMPLETED|Overall Study||0
8627193|NCT01030575|21292088|P1|NOT COMPLETED|Overall Study||0
8627194|NCT01030575|21292085|P4|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|35
8627195|NCT01030575|21292086|P3|COMPLETED|Overall Study||28
8627196|NCT01030575|21292087|P2|COMPLETED|Overall Study||30
8627197|NCT01030575|21292088|P1|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|29
8627198|NCT01030575|21292085|P4|STARTED|Overall Study||35
8627199|NCT01030575|21292086|P3|STARTED|Overall Study||28
8627200|NCT01030575|21292087|P2|STARTED|Overall Study||30
8627201|NCT01030575|21292088|P1|STARTED|Overall Study||29
8627202|NCT01006369|21292103|P2|NOT COMPLETED|Overall Study||25
8627203|NCT01006369|21292104|P1|NOT COMPLETED|Overall Study||12
8627204|NCT01006369|21292103|P2|COMPLETED|Overall Study||0
8627205|NCT01006369|21292104|P1|COMPLETED|Overall Study||1
8627206|NCT01006369|21292103|P2|STARTED|Overall Study||25
8627207|NCT01006369|21292104|P1|STARTED|Overall Study||13
8627238|NCT00917579|21292148|P2|NOT COMPLETED|Period 2: 2nd Intervention||0
8627239|NCT00917579|21292149|P1|NOT COMPLETED|Period 2: 2nd Intervention||0
8627240|NCT00917579|21292148|P2|COMPLETED|Period 2: 2nd Intervention||37
8627241|NCT00917579|21292149|P1|COMPLETED|Period 2: 2nd Intervention||37
8627242|NCT00917579|21292148|P2|STARTED|Period 2: 2nd Intervention||37
8627243|NCT00917579|21292149|P1|STARTED|Period 2: 2nd Intervention||37
8627244|NCT00917579|21292148|P2|NOT COMPLETED|Washout >= 2 Weeks||0
8627245|NCT00917579|21292149|P1|NOT COMPLETED|Washout >= 2 Weeks||2
8627246|NCT00917579|21292148|P2|COMPLETED|Washout >= 2 Weeks||37
8627247|NCT00917579|21292149|P1|COMPLETED|Washout >= 2 Weeks||37
8627248|NCT00917579|21292148|P2|STARTED|Washout >= 2 Weeks||37
8627249|NCT00917579|21292149|P1|STARTED|Washout >= 2 Weeks||39
8627250|NCT00917579|21292148|P2|NOT COMPLETED|Period 1: 1st Intervention||0
8627251|NCT00917579|21292149|P1|NOT COMPLETED|Period 1: 1st Intervention||0
8627252|NCT00917579|21292148|P2|COMPLETED|Period 1: 1st Intervention||37
8627253|NCT00917579|21292149|P1|COMPLETED|Period 1: 1st Intervention||39
8627254|NCT00917579|21292148|P2|STARTED|Period 1: 1st Intervention||37
8627255|NCT00917579|21292149|P1|STARTED|Period 1: 1st Intervention||39
8627256|NCT00912873|21292165|P2|NOT COMPLETED|Overall Study||0
8627257|NCT00912873|21292166|P1|NOT COMPLETED|Overall Study||0
8627258|NCT00912873|21292165|P2|COMPLETED|Overall Study||24
8627259|NCT00912873|21292166|P1|COMPLETED|Overall Study||26
8627260|NCT00912873|21292165|P2|STARTED|Overall Study||24
8627261|NCT00912873|21292166|P1|STARTED|Overall Study||26
8627262|NCT00865280|21292186|P2|NOT COMPLETED|Overall Study||3
8627263|NCT00865280|21292187|P1|NOT COMPLETED|Overall Study||6
8627264|NCT00865280|21292186|P2|COMPLETED|Overall Study||70
8627265|NCT00865280|21292187|P1|COMPLETED|Overall Study||64
8627266|NCT00865280|21292186|P2|STARTED|Overall Study||73
8627267|NCT00865280|21292187|P1|STARTED|Overall Study||70
8627268|NCT00844376|21292205|P2|NOT COMPLETED|Period 2: Second Intervention||0
8627269|NCT00844376|21292206|P1|NOT COMPLETED|Period 2: Second Intervention||0
8627270|NCT00844376|21292205|P2|COMPLETED|Period 2: Second Intervention||6
8627271|NCT00844376|21292206|P1|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
8627272|NCT00844376|21292205|P2|STARTED|Period 2: Second Intervention||6
8627273|NCT00844376|21292206|P1|STARTED|Period 2: Second Intervention||5
8627274|NCT00844376|21292205|P2|NOT COMPLETED|Period 1: First Intervention||0
8627275|NCT00844376|21292206|P1|NOT COMPLETED|Period 1: First Intervention||1
8627276|NCT00844376|21292205|P2|COMPLETED|Period 1: First Intervention||6
8627277|NCT00844376|21292206|P1|COMPLETED|Period 1: First Intervention||5
8627278|NCT00844376|21292205|P2|STARTED|Period 1: First Intervention||6
8627279|NCT00844376|21292206|P1|STARTED|Period 1: First Intervention||6
8627280|NCT00775268|21292226|P2|NOT COMPLETED|After Completion||0
8627281|NCT00775268|21292227|P1|NOT COMPLETED|After Completion||1
8627282|NCT00775268|21292226|P2|COMPLETED|After Completion||0
8627283|NCT00775268|21292227|P1|COMPLETED|After Completion||6
8627284|NCT00775268|21292226|P2|STARTED|After Completion||0
8627285|NCT00775268|21292227|P1|STARTED|After Completion||7
8627286|NCT00775268|21292226|P2|NOT COMPLETED|After 2 Cycles||0
8627287|NCT00775268|21292227|P1|NOT COMPLETED|After 2 Cycles||1
8627288|NCT00775268|21292226|P2|COMPLETED|After 2 Cycles||0
8627289|NCT00775268|21292227|P1|COMPLETED|After 2 Cycles||7
8627290|NCT00775268|21292226|P2|STARTED|After 2 Cycles|These 21 patients were not scanned after 2-cycles in this Arm. They were only scanned at baseline.|0
8627291|NCT00775268|21292227|P1|STARTED|After 2 Cycles||8
8627292|NCT00775268|21292226|P2|NOT COMPLETED|Baseline||1
8627293|NCT00775268|21292227|P1|NOT COMPLETED|Baseline||1
8627294|NCT00775268|21292226|P2|COMPLETED|Baseline||21
8627295|NCT00775268|21292227|P1|COMPLETED|Baseline||8
8627296|NCT00775268|21292226|P2|STARTED|Baseline||22
8627297|NCT00775268|21292227|P1|STARTED|Baseline||9
8627298|NCT00739999|21292246|P2|NOT COMPLETED|Overall Study||0
8627299|NCT00739999|21292247|P1|NOT COMPLETED|Overall Study||0
8627300|NCT00739999|21292246|P2|COMPLETED|Overall Study||24
8627301|NCT00739999|21292247|P1|COMPLETED|Overall Study||15
8627302|NCT00739999|21292246|P2|STARTED|Overall Study||24
8627303|NCT00739999|21292247|P1|STARTED|Overall Study||15
8627304|NCT00706264|21292320|P2|NOT COMPLETED|Overall Study||2
8627305|NCT00706264|21292321|P1|NOT COMPLETED|Overall Study||3
8627306|NCT00706264|21292320|P2|COMPLETED|Overall Study||190
8627307|NCT00706264|21292321|P1|COMPLETED|Overall Study||190
8627308|NCT00706264|21292320|P2|STARTED|Overall Study||192
8627309|NCT00706264|21292321|P1|STARTED|Overall Study||193
8627310|NCT00703326|21292375|P2|NOT COMPLETED|Overall Study||225
8627311|NCT00703326|21292376|P1|NOT COMPLETED|Overall Study||447
8627312|NCT00703326|21292375|P2|COMPLETED|Overall Study||160
8627313|NCT00703326|21292376|P1|COMPLETED|Overall Study||312
8627314|NCT00703326|21292375|P2|Received at Least 1 Dose of Study Drug|Overall Study||382
8627315|NCT00703326|21292376|P1|Received at Least 1 Dose of Study Drug|Overall Study||752
8627316|NCT00703326|21292375|P2|STARTED|Overall Study||385
8627317|NCT00703326|21292376|P1|STARTED|Overall Study||759
8627318|NCT00700882|21292396|P1|NOT COMPLETED|Overall Study||59
8627319|NCT00700882|21292396|P1|COMPLETED|Overall Study||22
8627320|NCT00700882|21292396|P1|Eligible, Treated and KIT+ Patients|Overall Study||22
8627321|NCT00700882|21292396|P1|Eligible and Treated Patients|Overall Study||73
8627322|NCT00700882|21292396|P1|Received Protocol Therapy|Overall Study||75
8627323|NCT00700882|21292396|P1|STARTED|Overall Study||81
8627324|NCT00678496|21292402|P2|NOT COMPLETED|Overall Study||4
8627325|NCT00678496|21292403|P1|NOT COMPLETED|Overall Study||2
8627326|NCT00678496|21292402|P2|COMPLETED|Overall Study||8
8627327|NCT00678496|21292403|P1|COMPLETED|Overall Study||10
8627328|NCT00678496|21292402|P2|Completed 8 Weeks Follow-up|Overall Study||12
8627329|NCT00678496|21292403|P1|Completed 8 Weeks Follow-up|Overall Study||9
8627330|NCT00678496|21292402|P2|STARTED|Overall Study||12
8627331|NCT00678496|21292403|P1|STARTED|Overall Study||12
8627364|NCT00623363|21292454|P2|NOT COMPLETED|Overall Study||2
8627365|NCT00623363|21292455|P1|NOT COMPLETED|Overall Study||2
8627366|NCT00623363|21292454|P2|COMPLETED|Overall Study||18
8627367|NCT00623363|21292455|P1|COMPLETED|Overall Study||5
8627368|NCT00623363|21292454|P2|STARTED|Overall Study||20
8627369|NCT00623363|21292455|P1|STARTED|Overall Study||7
8627370|NCT00610935|21292488|P2|NOT COMPLETED|Overall Study||3
8627371|NCT00610935|21292489|P1|NOT COMPLETED|Overall Study||1
8627372|NCT00610935|21292488|P2|COMPLETED|Overall Study||54
8627373|NCT00610935|21292489|P1|COMPLETED|Overall Study||24
8627374|NCT00610935|21292488|P2|ITT Population|Overall Study||57
8627375|NCT00610935|21292489|P1|ITT Population|Overall Study||25
8627376|NCT00610935|21292488|P2|ITTI Population|Overall Study||55
8627377|NCT00610935|21292489|P1|ITTI Population|Overall Study||25
8627378|NCT00610935|21292488|P2|STARTED|Overall Study||57
8627379|NCT00610935|21292489|P1|STARTED|Overall Study||25
8627380|NCT00606801|21292499|P2|NOT COMPLETED|Intervention||3
8627381|NCT00606801|21292500|P1|NOT COMPLETED|Intervention||3
8627382|NCT00606801|21292499|P2|COMPLETED|Intervention||14
8627383|NCT00606801|21292500|P1|COMPLETED|Intervention||14
8627384|NCT00606801|21292499|P2|STARTED|Intervention||17
8627385|NCT00606801|21292500|P1|STARTED|Intervention||17
8627386|NCT00606801|21292499|P2|NOT COMPLETED|Adaptation||0
8627387|NCT00606801|21292500|P1|NOT COMPLETED|Adaptation||0
8627388|NCT00606801|21292499|P2|COMPLETED|Adaptation||17
8627389|NCT00606801|21292500|P1|COMPLETED|Adaptation||17
8627390|NCT00606801|21292499|P2|STARTED|Adaptation||17
8627391|NCT00606801|21292500|P1|STARTED|Adaptation||17
8627406|NCT00579670|21292571|P5|NOT COMPLETED|Overall Study||0
8627407|NCT00579670|21292572|P4|NOT COMPLETED|Overall Study||22
8627408|NCT00579670|21292573|P3|NOT COMPLETED|Overall Study||4
8627409|NCT00579670|21292574|P2|NOT COMPLETED|Overall Study||1
8627410|NCT00579670|21292575|P1|NOT COMPLETED|Overall Study||2
8627411|NCT00579670|21292571|P5|COMPLETED|Overall Study||5
8627412|NCT00579670|21292572|P4|COMPLETED|Overall Study||263
8627413|NCT00579670|21292573|P3|COMPLETED|Overall Study||84
8627414|NCT00579670|21292574|P2|COMPLETED|Overall Study||56
8627415|NCT00579670|21292575|P1|COMPLETED|Overall Study||13
8627416|NCT00579670|21292571|P5|Population: Within SmPC (Completed)|Overall Study||0
8627417|NCT00579670|21292572|P4|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
8627418|NCT00579670|21292573|P3|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
8627419|NCT00579670|21292574|P2|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
8627420|NCT00579670|21292575|P1|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
8627421|NCT00579670|21292571|P5|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
8627422|NCT00579670|21292572|P4|Population: Within SmPC (Started)|Overall Study||159
8627423|NCT00579670|21292573|P3|Population: Within SmPC (Started)|Overall Study||83
8627424|NCT00579670|21292574|P2|Population: Within SmPC (Started)|Overall Study||56
8627425|NCT00579670|21292575|P1|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
8627426|NCT00579670|21292571|P5|STARTED|Overall Study||5
8627427|NCT00579670|21292572|P4|STARTED|Overall Study||285
8627428|NCT00579670|21292573|P3|STARTED|Overall Study||88
8627429|NCT00579670|21292574|P2|STARTED|Overall Study||57
8627430|NCT00579670|21292575|P1|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
8627439|NCT00540293|21292806|P1|NOT COMPLETED|Overall Study||35
8627440|NCT00540293|21292806|P1|COMPLETED|Overall Study||390
8627441|NCT00540293|21292806|P1|STARTED|Overall Study||425
8627442|NCT00497289|21292851|P2|NOT COMPLETED|Overall Study||6
8627443|NCT00497289|21292852|P1|NOT COMPLETED|Overall Study||5
8627444|NCT00497289|21292851|P2|COMPLETED|Overall Study||18
8627445|NCT00497289|21292852|P1|COMPLETED|Overall Study||19
8627446|NCT00497289|21292851|P2|STARTED|Overall Study||24
8627447|NCT00497289|21292852|P1|STARTED|Overall Study||24
8627448|NCT00483548|21292862|P2|NOT COMPLETED|Overall Study||46
8627449|NCT00483548|21292863|P1|NOT COMPLETED|Overall Study||60
8627450|NCT00483548|21292862|P2|COMPLETED|Overall Study||104
8627451|NCT00483548|21292863|P1|COMPLETED|Overall Study||88
8627452|NCT00483548|21292862|P2|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
8627453|NCT00483548|21292863|P1|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
8627454|NCT00483548|21292862|P2|STARTED|Overall Study||150
8627455|NCT00483548|21292863|P1|STARTED|Overall Study||148
8627456|NCT00461773|21292903|P2|NOT COMPLETED|Overall Study||0
8627457|NCT00461773|21292904|P1|NOT COMPLETED|Overall Study||0
8627458|NCT00461773|21292903|P2|COMPLETED|Overall Study||2
8627459|NCT00461773|21292904|P1|COMPLETED|Overall Study||3
8627460|NCT00461773|21292903|P2|STARTED|Overall Study||2
8627461|NCT00461773|21292904|P1|STARTED|Overall Study||3
8627462|NCT00439296|21292922|P2|NOT COMPLETED|Overall Study||0
8627463|NCT00439296|21292923|P1|NOT COMPLETED|Overall Study||0
8627464|NCT00439296|21292922|P2|COMPLETED|Overall Study||4
8627465|NCT00439296|21292923|P1|COMPLETED|Overall Study||5
8627466|NCT00439296|21292922|P2|Treatment Course 2|Overall Study||1
8627467|NCT00439296|21292923|P1|Treatment Course 2|Overall Study||1
8627468|NCT00439296|21292922|P2|Treatment Course 1|Overall Study||3
8627469|NCT00439296|21292923|P1|Treatment Course 1|Overall Study||5
8627470|NCT00439296|21292922|P2|STARTED|Overall Study||4
8627471|NCT00439296|21292923|P1|STARTED|Overall Study||5
8627611|NCT00353366|21292991|P1|NOT COMPLETED|Overall Study||143
8627612|NCT00353366|21292991|P1|COMPLETED|Overall Study||1296
8627613|NCT00353366|21292991|P1|STARTED|Overall Study||1439
8627614|NCT00323960|21293001|P3|NOT COMPLETED|Overall Study||0
8627615|NCT00323960|21293002|P2|NOT COMPLETED|Overall Study||0
8627616|NCT00323960|21293003|P1|NOT COMPLETED|Overall Study||0
8627617|NCT00323960|21293001|P3|COMPLETED|Overall Study||46
8627618|NCT00323960|21293002|P2|COMPLETED|Overall Study||46
8627619|NCT00323960|21293003|P1|COMPLETED|Overall Study||47
8627620|NCT00323960|21293001|P3|STARTED|Overall Study||46
8627621|NCT00323960|21293002|P2|STARTED|Overall Study||46
8627622|NCT00323960|21293003|P1|STARTED|Overall Study||47
8627647|NCT00162370|21293057|P1|NOT COMPLETED|Efficacy Population||51
8627648|NCT00162370|21293057|P1|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
8627649|NCT00162370|21293057|P1|STARTED|Efficacy Population||366
8627650|NCT00162370|21293057|P1|NOT COMPLETED|Completed Echocardiography Imaging||0
8627651|NCT00162370|21293057|P1|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
8627652|NCT00162370|21293057|P1|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
8627662|NCT00066703|21293096|P2|NOT COMPLETED|Overall Study||582
8627663|NCT00066703|21293097|P1|NOT COMPLETED|Overall Study||612
8627664|NCT00066703|21293096|P2|COMPLETED|Overall Study||756
8627665|NCT00066703|21293097|P1|COMPLETED|Overall Study||722
8627666|NCT00066703|21293096|P2|STARTED|Overall Study||1338
8627667|NCT00066703|21293097|P1|STARTED|Overall Study||1334
8627668|NCT00066690|21293112|P3|NOT COMPLETED|Overall Study||564
8627669|NCT00066690|21293113|P2|NOT COMPLETED|Overall Study||522
8627670|NCT00066690|21293114|P1|NOT COMPLETED|Overall Study||598
8627671|NCT00066690|21293112|P3|COMPLETED|Overall Study||457
8627672|NCT00066690|21293113|P2|COMPLETED|Overall Study||502
8627673|NCT00066690|21293114|P1|COMPLETED|Overall Study||423
8627674|NCT00066690|21293112|P3|STARTED|Overall Study||1021
8627675|NCT00066690|21293113|P2|STARTED|Overall Study||1024
8627676|NCT00066690|21293114|P1|STARTED|Overall Study||1021
8627683|NCT04704713|21293162|P2|NOT COMPLETED|Overall Study||4
8627684|NCT04704713|21293163|P1|NOT COMPLETED|Overall Study||4
8627685|NCT04704713|21293162|P2|COMPLETED|Overall Study||12
8627686|NCT04704713|21293163|P1|COMPLETED|Overall Study||11
8627687|NCT04704713|21293162|P2|STARTED|Overall Study||16
8627688|NCT04704713|21293163|P1|STARTED|Overall Study||15
8627689|NCT04024501|21293169|P1|NOT COMPLETED|Overall Study||0
8627690|NCT04024501|21293169|P1|COMPLETED|Overall Study||25
8627691|NCT04024501|21293169|P1|STARTED|Overall Study||25
8627703|NCT03883113|21293275|P2|NOT COMPLETED|Overall Study||12
8627704|NCT03883113|21293276|P1|NOT COMPLETED|Overall Study||16
8627705|NCT03883113|21293275|P2|COMPLETED|Overall Study||46
8627706|NCT03883113|21293276|P1|COMPLETED|Overall Study||71
8627707|NCT03883113|21293275|P2|STARTED|Overall Study||58
8627708|NCT03883113|21293276|P1|STARTED|Overall Study||87
8627739|NCT03819218|21293387|P1|NOT COMPLETED|Overall Study||1
8627740|NCT03819218|21293387|P1|COMPLETED|Overall Study||6
8627741|NCT03819218|21293387|P1|STARTED|Overall Study||7
8627742|NCT03792672|21293398|P6|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8627743|NCT03792672|21293399|P5|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8627744|NCT03792672|21293400|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8627745|NCT03792672|21293401|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8627746|NCT03792672|21293402|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8627747|NCT03792672|21293403|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||1
8627748|NCT03792672|21293398|P6|COMPLETED|Treatment Period 4 (2 Days)||4
8627749|NCT03792672|21293399|P5|COMPLETED|Treatment Period 4 (2 Days)||4
8627750|NCT03792672|21293400|P4|COMPLETED|Treatment Period 4 (2 Days)||2
8627751|NCT03792672|21293401|P3|COMPLETED|Treatment Period 4 (2 Days)||3
8627752|NCT03792672|21293402|P2|COMPLETED|Treatment Period 4 (2 Days)||4
8627753|NCT03792672|21293403|P1|COMPLETED|Treatment Period 4 (2 Days)||2
8627754|NCT03792672|21293398|P6|STARTED|Treatment Period 4 (2 Days)||4
8627755|NCT03792672|21293399|P5|STARTED|Treatment Period 4 (2 Days)||4
8627756|NCT03792672|21293400|P4|STARTED|Treatment Period 4 (2 Days)||2
8627757|NCT03792672|21293401|P3|STARTED|Treatment Period 4 (2 Days)||3
8627758|NCT03792672|21293402|P2|STARTED|Treatment Period 4 (2 Days)||4
8627759|NCT03792672|21293403|P1|STARTED|Treatment Period 4 (2 Days)||3
8627760|NCT03792672|21293398|P6|NOT COMPLETED|Washout Period 3 (10 Days)||0
8627761|NCT03792672|21293399|P5|NOT COMPLETED|Washout Period 3 (10 Days)||0
8627762|NCT03792672|21293400|P4|NOT COMPLETED|Washout Period 3 (10 Days)||2
8627763|NCT03792672|21293401|P3|NOT COMPLETED|Washout Period 3 (10 Days)||1
8627764|NCT03792672|21293402|P2|NOT COMPLETED|Washout Period 3 (10 Days)||0
8627765|NCT03792672|21293403|P1|NOT COMPLETED|Washout Period 3 (10 Days)||1
8627766|NCT03792672|21293398|P6|COMPLETED|Washout Period 3 (10 Days)||4
8627767|NCT03792672|21293399|P5|COMPLETED|Washout Period 3 (10 Days)||4
8627768|NCT03792672|21293400|P4|COMPLETED|Washout Period 3 (10 Days)||2
8627769|NCT03792672|21293401|P3|COMPLETED|Washout Period 3 (10 Days)||3
8627770|NCT03792672|21293402|P2|COMPLETED|Washout Period 3 (10 Days)||4
8627771|NCT03792672|21293403|P1|COMPLETED|Washout Period 3 (10 Days)||3
8627772|NCT03792672|21293398|P6|STARTED|Washout Period 3 (10 Days)||4
8627773|NCT03792672|21293399|P5|STARTED|Washout Period 3 (10 Days)||4
8627774|NCT03792672|21293400|P4|STARTED|Washout Period 3 (10 Days)||4
8627775|NCT03792672|21293401|P3|STARTED|Washout Period 3 (10 Days)||4
8627776|NCT03792672|21293402|P2|STARTED|Washout Period 3 (10 Days)||4
8627777|NCT03792672|21293403|P1|STARTED|Washout Period 3 (10 Days)||4
8627778|NCT03792672|21293398|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8627779|NCT03792672|21293399|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8627780|NCT03792672|21293400|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8627781|NCT03792672|21293401|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8627782|NCT03792672|21293402|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8627783|NCT03792672|21293403|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
8627784|NCT03792672|21293398|P6|COMPLETED|Treatment Period 3 (1 Day)||4
8627785|NCT03792672|21293399|P5|COMPLETED|Treatment Period 3 (1 Day)||4
8627786|NCT03792672|21293400|P4|COMPLETED|Treatment Period 3 (1 Day)||4
8627787|NCT03792672|21293401|P3|COMPLETED|Treatment Period 3 (1 Day)||4
8627788|NCT03792672|21293402|P2|COMPLETED|Treatment Period 3 (1 Day)||4
8627789|NCT03792672|21293403|P1|COMPLETED|Treatment Period 3 (1 Day)||4
8627790|NCT03792672|21293398|P6|STARTED|Treatment Period 3 (1 Day)||4
8627791|NCT03792672|21293399|P5|STARTED|Treatment Period 3 (1 Day)||4
8627792|NCT03792672|21293400|P4|STARTED|Treatment Period 3 (1 Day)||4
8627793|NCT03792672|21293401|P3|STARTED|Treatment Period 3 (1 Day)||4
8627794|NCT03792672|21293402|P2|STARTED|Treatment Period 3 (1 Day)||4
8627795|NCT03792672|21293403|P1|STARTED|Treatment Period 3 (1 Day)||4
8627796|NCT03792672|21293398|P6|NOT COMPLETED|Washout Period 2 (10 Days)||0
8627797|NCT03792672|21293399|P5|NOT COMPLETED|Washout Period 2 (10 Days)||0
8627798|NCT03792672|21293400|P4|NOT COMPLETED|Washout Period 2 (10 Days)||0
8627799|NCT03792672|21293401|P3|NOT COMPLETED|Washout Period 2 (10 Days)||0
8627800|NCT03792672|21293402|P2|NOT COMPLETED|Washout Period 2 (10 Days)||0
8627801|NCT03792672|21293403|P1|NOT COMPLETED|Washout Period 2 (10 Days)||0
8627802|NCT03792672|21293398|P6|COMPLETED|Washout Period 2 (10 Days)||4
8627803|NCT03792672|21293399|P5|COMPLETED|Washout Period 2 (10 Days)||4
8627804|NCT03792672|21293400|P4|COMPLETED|Washout Period 2 (10 Days)||4
8627805|NCT03792672|21293401|P3|COMPLETED|Washout Period 2 (10 Days)||4
8627806|NCT03792672|21293402|P2|COMPLETED|Washout Period 2 (10 Days)||4
8627807|NCT03792672|21293403|P1|COMPLETED|Washout Period 2 (10 Days)||4
8627808|NCT03792672|21293398|P6|STARTED|Washout Period 2 (10 Days)||4
8627809|NCT03792672|21293399|P5|STARTED|Washout Period 2 (10 Days)||4
8627810|NCT03792672|21293400|P4|STARTED|Washout Period 2 (10 Days)||4
8627811|NCT03792672|21293401|P3|STARTED|Washout Period 2 (10 Days)||4
8627812|NCT03792672|21293402|P2|STARTED|Washout Period 2 (10 Days)||4
8627813|NCT03792672|21293403|P1|STARTED|Washout Period 2 (10 Days)||4
8627814|NCT03792672|21293398|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8627815|NCT03792672|21293399|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8627816|NCT03792672|21293400|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8627817|NCT03792672|21293401|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8627818|NCT03792672|21293402|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8627819|NCT03792672|21293403|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8627820|NCT03792672|21293398|P6|COMPLETED|Treatment Period 2 (1 Day)||4
8627821|NCT03792672|21293399|P5|COMPLETED|Treatment Period 2 (1 Day)||4
8627822|NCT03792672|21293400|P4|COMPLETED|Treatment Period 2 (1 Day)||4
8627823|NCT03792672|21293401|P3|COMPLETED|Treatment Period 2 (1 Day)||4
8627824|NCT03792672|21293402|P2|COMPLETED|Treatment Period 2 (1 Day)||4
8627825|NCT03792672|21293403|P1|COMPLETED|Treatment Period 2 (1 Day)||4
8627826|NCT03792672|21293398|P6|STARTED|Treatment Period 2 (1 Day)||4
8627827|NCT03792672|21293399|P5|STARTED|Treatment Period 2 (1 Day)||4
8627828|NCT03792672|21293400|P4|STARTED|Treatment Period 2 (1 Day)||4
8627829|NCT03792672|21293401|P3|STARTED|Treatment Period 2 (1 Day)||4
8627830|NCT03792672|21293402|P2|STARTED|Treatment Period 2 (1 Day)||4
8627831|NCT03792672|21293403|P1|STARTED|Treatment Period 2 (1 Day)||4
8627832|NCT03792672|21293398|P6|NOT COMPLETED|Washout Period 1 (10 Days)||0
8627833|NCT03792672|21293399|P5|NOT COMPLETED|Washout Period 1 (10 Days)||0
8627834|NCT03792672|21293400|P4|NOT COMPLETED|Washout Period 1 (10 Days)||0
8627835|NCT03792672|21293401|P3|NOT COMPLETED|Washout Period 1 (10 Days)||0
8627836|NCT03792672|21293402|P2|NOT COMPLETED|Washout Period 1 (10 Days)||0
8627837|NCT03792672|21293403|P1|NOT COMPLETED|Washout Period 1 (10 Days)||0
8627838|NCT03792672|21293398|P6|COMPLETED|Washout Period 1 (10 Days)||4
8627839|NCT03792672|21293399|P5|COMPLETED|Washout Period 1 (10 Days)||4
8627840|NCT03792672|21293400|P4|COMPLETED|Washout Period 1 (10 Days)||4
8627841|NCT03792672|21293401|P3|COMPLETED|Washout Period 1 (10 Days)||4
8627842|NCT03792672|21293402|P2|COMPLETED|Washout Period 1 (10 Days)||4
8627843|NCT03792672|21293403|P1|COMPLETED|Washout Period 1 (10 Days)||4
8627844|NCT03792672|21293398|P6|STARTED|Washout Period 1 (10 Days)||4
8627845|NCT03792672|21293399|P5|STARTED|Washout Period 1 (10 Days)||4
8627846|NCT03792672|21293400|P4|STARTED|Washout Period 1 (10 Days)||4
8627847|NCT03792672|21293401|P3|STARTED|Washout Period 1 (10 Days)||4
8627848|NCT03792672|21293402|P2|STARTED|Washout Period 1 (10 Days)||4
8627849|NCT03792672|21293403|P1|STARTED|Washout Period 1 (10 Days)||4
8627850|NCT03792672|21293398|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8627851|NCT03792672|21293399|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8627852|NCT03792672|21293400|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8627853|NCT03792672|21293401|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8627854|NCT03792672|21293402|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8627855|NCT03792672|21293403|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8627856|NCT03792672|21293398|P6|COMPLETED|Treatment Period 1 (1 Day)||4
8627857|NCT03792672|21293399|P5|COMPLETED|Treatment Period 1 (1 Day)||4
8627858|NCT03792672|21293400|P4|COMPLETED|Treatment Period 1 (1 Day)||4
8627859|NCT03792672|21293401|P3|COMPLETED|Treatment Period 1 (1 Day)||4
8627860|NCT03792672|21293402|P2|COMPLETED|Treatment Period 1 (1 Day)||4
8627861|NCT03792672|21293403|P1|COMPLETED|Treatment Period 1 (1 Day)||4
8627862|NCT03792672|21293398|P6|STARTED|Treatment Period 1 (1 Day)||4
8627863|NCT03792672|21293399|P5|STARTED|Treatment Period 1 (1 Day)||4
8627864|NCT03792672|21293400|P4|STARTED|Treatment Period 1 (1 Day)||4
8627865|NCT03792672|21293401|P3|STARTED|Treatment Period 1 (1 Day)||4
8627866|NCT03792672|21293402|P2|STARTED|Treatment Period 1 (1 Day)||4
8627867|NCT03792672|21293403|P1|STARTED|Treatment Period 1 (1 Day)||4
8627868|NCT03583372|21293427|P4|NOT COMPLETED|Overall Study||18
8627869|NCT03583372|21293428|P3|NOT COMPLETED|Overall Study||19
8627870|NCT03583372|21293429|P2|NOT COMPLETED|Overall Study||26
8627871|NCT03583372|21293430|P1|NOT COMPLETED|Overall Study||13
8627872|NCT03583372|21293427|P4|COMPLETED|Overall Study||123
8627873|NCT03583372|21293428|P3|COMPLETED|Overall Study||72
8627874|NCT03583372|21293429|P2|COMPLETED|Overall Study||156
8627875|NCT03583372|21293430|P1|COMPLETED|Overall Study||79
8627876|NCT03583372|21293427|P4|STARTED|Overall Study||141
8627877|NCT03583372|21293428|P3|STARTED|Overall Study||91
8627878|NCT03583372|21293429|P2|STARTED|Overall Study||182
8627879|NCT03583372|21293430|P1|STARTED|Overall Study||92
8627880|NCT03538431|21293444|P2|NOT COMPLETED|Overall Study||1
8627881|NCT03538431|21293445|P1|NOT COMPLETED|Overall Study||1
8627882|NCT03538431|21293444|P2|COMPLETED|Overall Study||12
8627883|NCT03538431|21293445|P1|COMPLETED|Overall Study||12
8627884|NCT03538431|21293444|P2|STARTED|Overall Study||13
8627885|NCT03538431|21293445|P1|STARTED|Overall Study||13
8627886|NCT03481725|21293455|P2|NOT COMPLETED|Overall Study||0
8627887|NCT03481725|21293456|P1|NOT COMPLETED|Overall Study||1
8627888|NCT03481725|21293455|P2|COMPLETED|Overall Study||34
8627889|NCT03481725|21293456|P1|COMPLETED|Overall Study||30
8627890|NCT03481725|21293455|P2|STARTED|Overall Study||34
8627891|NCT03481725|21293456|P1|STARTED|Overall Study||31
8627892|NCT03439657|21293480|P2|NOT COMPLETED|Overall Study||4
8627893|NCT03439657|21293481|P1|NOT COMPLETED|Overall Study||7
8627894|NCT03439657|21293480|P2|COMPLETED|Overall Study||459
8627895|NCT03439657|21293481|P1|COMPLETED|Overall Study||442
8627896|NCT03439657|21293480|P2|STARTED|Overall Study||463
8627897|NCT03439657|21293481|P1|STARTED|Overall Study||449
8627898|NCT03436082|21293516|P2|NOT COMPLETED|Overall Study||0
8627899|NCT03436082|21293517|P1|NOT COMPLETED|Overall Study||1
8627900|NCT03436082|21293516|P2|COMPLETED|Overall Study|Had procedure|30
8627901|NCT03436082|21293517|P1|COMPLETED|Overall Study|Had procedure|29
8627902|NCT03436082|21293516|P2|STARTED|Overall Study||30
8627903|NCT03436082|21293517|P1|STARTED|Overall Study||30
8627904|NCT03381989|21293529|P1|NOT COMPLETED|Overall Study||8
8627905|NCT03381989|21293529|P1|COMPLETED|Overall Study||22
8627906|NCT03381989|21293529|P1|STARTED|Overall Study||30
8627912|NCT03319953|21293555|P4|NOT COMPLETED|Period 2 (Day 49 to 154)||1
8627913|NCT03319953|21293556|P3|NOT COMPLETED|Period 2 (Day 49 to 154)||1
8627914|NCT03319953|21293557|P2|NOT COMPLETED|Period 2 (Day 49 to 154)||0
8627915|NCT03319953|21293558|P1|NOT COMPLETED|Period 2 (Day 49 to 154)||1
8627916|NCT03319953|21293555|P4|COMPLETED|Period 2 (Day 49 to 154)||6
8627917|NCT03319953|21293556|P3|COMPLETED|Period 2 (Day 49 to 154)||8
8627918|NCT03319953|21293557|P2|COMPLETED|Period 2 (Day 49 to 154)||4
8627919|NCT03319953|21293558|P1|COMPLETED|Period 2 (Day 49 to 154)||2
8627920|NCT03319953|21293555|P4|Treated|Period 2 (Day 49 to 154)||6
8627921|NCT03319953|21293556|P3|Treated|Period 2 (Day 49 to 154)||8
8627922|NCT03319953|21293557|P2|Treated|Period 2 (Day 49 to 154)||4
8627923|NCT03319953|21293558|P1|Treated|Period 2 (Day 49 to 154)||2
8627924|NCT03319953|21293555|P4|STARTED|Period 2 (Day 49 to 154)||7
8627925|NCT03319953|21293556|P3|STARTED|Period 2 (Day 49 to 154)||9
8627926|NCT03319953|21293557|P2|STARTED|Period 2 (Day 49 to 154)||4
8627927|NCT03319953|21293558|P1|STARTED|Period 2 (Day 49 to 154)||3
8627928|NCT03319953|21293555|P4|NOT COMPLETED|Washout Period (Day 15 to 49)||0
8627929|NCT03319953|21293556|P3|NOT COMPLETED|Washout Period (Day 15 to 49)||0
8627930|NCT03319953|21293557|P2|NOT COMPLETED|Washout Period (Day 15 to 49)||0
8627931|NCT03319953|21293558|P1|NOT COMPLETED|Washout Period (Day 15 to 49)||0
8627932|NCT03319953|21293555|P4|COMPLETED|Washout Period (Day 15 to 49)||7
8627933|NCT03319953|21293556|P3|COMPLETED|Washout Period (Day 15 to 49)||9
8627934|NCT03319953|21293557|P2|COMPLETED|Washout Period (Day 15 to 49)||4
8627935|NCT03319953|21293558|P1|COMPLETED|Washout Period (Day 15 to 49)||3
8627936|NCT03319953|21293555|P4|STARTED|Washout Period (Day 15 to 49)||7
8627937|NCT03319953|21293556|P3|STARTED|Washout Period (Day 15 to 49)||9
8627938|NCT03319953|21293557|P2|STARTED|Washout Period (Day 15 to 49)||4
8627939|NCT03319953|21293558|P1|STARTED|Washout Period (Day 15 to 49)||3
8627940|NCT03319953|21293555|P4|NOT COMPLETED|Period 1 (Day 1 to 14)||0
8627941|NCT03319953|21293556|P3|NOT COMPLETED|Period 1 (Day 1 to 14)||0
8627942|NCT03319953|21293557|P2|NOT COMPLETED|Period 1 (Day 1 to 14)||0
8627943|NCT03319953|21293558|P1|NOT COMPLETED|Period 1 (Day 1 to 14)||0
8627944|NCT03319953|21293555|P4|COMPLETED|Period 1 (Day 1 to 14)||7
8627945|NCT03319953|21293556|P3|COMPLETED|Period 1 (Day 1 to 14)||9
8627946|NCT03319953|21293557|P2|COMPLETED|Period 1 (Day 1 to 14)||4
8627947|NCT03319953|21293558|P1|COMPLETED|Period 1 (Day 1 to 14)||3
8627948|NCT03319953|21293555|P4|STARTED|Period 1 (Day 1 to 14)||7
8627949|NCT03319953|21293556|P3|STARTED|Period 1 (Day 1 to 14)||9
8627950|NCT03319953|21293557|P2|STARTED|Period 1 (Day 1 to 14)||4
8627951|NCT03319953|21293558|P1|STARTED|Period 1 (Day 1 to 14)||3
8627952|NCT03289858|21293586|P2|NOT COMPLETED|Overall Study||0
8627953|NCT03289858|21293587|P1|NOT COMPLETED|Overall Study||2
8627954|NCT03289858|21293586|P2|COMPLETED|Overall Study||28
8627955|NCT03289858|21293587|P1|COMPLETED|Overall Study||25
8627956|NCT03289858|21293586|P2|STARTED|Overall Study||28
8627957|NCT03289858|21293587|P1|STARTED|Overall Study||27
8627958|NCT03283553|21293595|P2|NOT COMPLETED|Care Partner Participant Flow||15
8627959|NCT03283553|21293596|P1|NOT COMPLETED|Care Partner Participant Flow||10
8627960|NCT03283553|21293595|P2|COMPLETED|Care Partner Participant Flow||48
8627961|NCT03283553|21293596|P1|COMPLETED|Care Partner Participant Flow||59
8627962|NCT03283553|21293595|P2|Care Partner 12-Month Interview|Care Partner Participant Flow||48
8627963|NCT03283553|21293596|P1|Care Partner 12-Month Interview|Care Partner Participant Flow||59
8627964|NCT03283553|21293595|P2|Care Partner 9-Month Interview|Care Partner Participant Flow||55
8627965|NCT03283553|21293596|P1|Care Partner 9-Month Interview|Care Partner Participant Flow||64
8627966|NCT03283553|21293595|P2|Care Partner 3-Month Interview|Care Partner Participant Flow||60
8627967|NCT03283553|21293596|P1|Care Partner 3-Month Interview|Care Partner Participant Flow||69
8627968|NCT03283553|21293595|P2|Care Partner Baseline Interview|Care Partner Participant Flow||63
8627969|NCT03283553|21293596|P1|Care Partner Baseline Interview|Care Partner Participant Flow||69
8627970|NCT03283553|21293595|P2|STARTED|Care Partner Participant Flow||63
8627971|NCT03283553|21293596|P1|STARTED|Care Partner Participant Flow||69
8627972|NCT03283553|21293595|P2|NOT COMPLETED|Patient Participant Flow||13
8627973|NCT03283553|21293596|P1|NOT COMPLETED|Patient Participant Flow||10
8627974|NCT03283553|21293595|P2|COMPLETED|Patient Participant Flow||50
8627975|NCT03283553|21293596|P1|COMPLETED|Patient Participant Flow||59
8627976|NCT03283553|21293595|P2|Patient 12-Month Interview|Patient Participant Flow||50
8627977|NCT03283553|21293596|P1|Patient 12-Month Interview|Patient Participant Flow||59
8627978|NCT03283553|21293595|P2|Patient 9-Month Interview|Patient Participant Flow||57
8627979|NCT03283553|21293596|P1|Patient 9-Month Interview|Patient Participant Flow||63
8627980|NCT03283553|21293595|P2|Patient 3-Month Interview|Patient Participant Flow||60
8627981|NCT03283553|21293596|P1|Patient 3-Month Interview|Patient Participant Flow||67
8627982|NCT03283553|21293595|P2|Patient Baseline Interview|Patient Participant Flow||62
8627983|NCT03283553|21293596|P1|Patient Baseline Interview|Patient Participant Flow||69
8627984|NCT03283553|21293595|P2|STARTED|Patient Participant Flow||63
8627985|NCT03283553|21293596|P1|STARTED|Patient Participant Flow||69
8627986|NCT03277794|21293628|P2|NOT COMPLETED|Overall Study||4
8627987|NCT03277794|21293629|P1|NOT COMPLETED|Overall Study||3
8627988|NCT03277794|21293628|P2|COMPLETED|Overall Study||30
8627989|NCT03277794|21293629|P1|COMPLETED|Overall Study||28
8627990|NCT03277794|21293628|P2|STARTED|Overall Study||34
8627991|NCT03277794|21293629|P1|STARTED|Overall Study||31
8627992|NCT03051620|21293661|P1|NOT COMPLETED|Overall Study||18
8627993|NCT03051620|21293661|P1|COMPLETED|Overall Study||124
8627994|NCT03051620|21293661|P1|STARTED|Overall Study||142
8628004|NCT03016403|21293686|P4|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||7
8628005|NCT03016403|21293687|P3|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||8
8628006|NCT03016403|21293688|P2|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||11
8628007|NCT03016403|21293689|P1|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||12
8628008|NCT03016403|21293686|P4|COMPLETED|3-month Follow-up and 6-month Follow-up||81
8628009|NCT03016403|21293687|P3|COMPLETED|3-month Follow-up and 6-month Follow-up||95
8628010|NCT03016403|21293688|P2|COMPLETED|3-month Follow-up and 6-month Follow-up||96
8628011|NCT03016403|21293689|P1|COMPLETED|3-month Follow-up and 6-month Follow-up||108
8628012|NCT03016403|21293686|P4|STARTED|3-month Follow-up and 6-month Follow-up||88
8628013|NCT03016403|21293687|P3|STARTED|3-month Follow-up and 6-month Follow-up||103
8628014|NCT03016403|21293688|P2|STARTED|3-month Follow-up and 6-month Follow-up||107
8628015|NCT03016403|21293689|P1|STARTED|3-month Follow-up and 6-month Follow-up||120
8628016|NCT03016403|21293686|P4|NOT COMPLETED|6-week Follow-up||9
8628017|NCT03016403|21293687|P3|NOT COMPLETED|6-week Follow-up||4
8628018|NCT03016403|21293688|P2|NOT COMPLETED|6-week Follow-up||13
8628019|NCT03016403|21293689|P1|NOT COMPLETED|6-week Follow-up||3
8628020|NCT03016403|21293686|P4|COMPLETED|6-week Follow-up||88
8628021|NCT03016403|21293687|P3|COMPLETED|6-week Follow-up||103
8628022|NCT03016403|21293688|P2|COMPLETED|6-week Follow-up||107
8628023|NCT03016403|21293689|P1|COMPLETED|6-week Follow-up||120
8628024|NCT03016403|21293686|P4|STARTED|6-week Follow-up||97
8628025|NCT03016403|21293687|P3|STARTED|6-week Follow-up||107
8628026|NCT03016403|21293688|P2|STARTED|6-week Follow-up||120
8628027|NCT03016403|21293689|P1|STARTED|6-week Follow-up|Anyone who had at least 1 follow-up after baseline.|123
8628028|NCT03016403|21293686|P4|NOT COMPLETED|Baseline||34
8628029|NCT03016403|21293687|P3|NOT COMPLETED|Baseline||11
8628030|NCT03016403|21293688|P2|NOT COMPLETED|Baseline||27
8628031|NCT03016403|21293689|P1|NOT COMPLETED|Baseline||16
8628032|NCT03016403|21293686|P4|COMPLETED|Baseline||97
8628033|NCT03016403|21293687|P3|COMPLETED|Baseline||107
8628034|NCT03016403|21293688|P2|COMPLETED|Baseline||120
8628035|NCT03016403|21293689|P1|COMPLETED|Baseline||123
8628036|NCT03016403|21293686|P4|STARTED|Baseline||131
8628037|NCT03016403|21293687|P3|STARTED|Baseline||118
8628038|NCT03016403|21293688|P2|STARTED|Baseline||147
8628039|NCT03016403|21293689|P1|STARTED|Baseline||139
8628040|NCT02989493|21293717|P2|NOT COMPLETED|Overall Study||0
8628041|NCT02989493|21293718|P1|NOT COMPLETED|Overall Study||0
8628042|NCT02989493|21293717|P2|COMPLETED|Overall Study||32
8628043|NCT02989493|21293718|P1|COMPLETED|Overall Study||29
8628044|NCT02989493|21293717|P2|STARTED|Overall Study||32
8628045|NCT02989493|21293718|P1|STARTED|Overall Study||29
8628046|NCT02959892|21293728|P2|NOT COMPLETED|Overall Study||1
8628047|NCT02959892|21293729|P1|NOT COMPLETED|Overall Study||1
8628048|NCT02959892|21293728|P2|COMPLETED|Overall Study||5
8628049|NCT02959892|21293729|P1|COMPLETED|Overall Study||5
8628050|NCT02959892|21293728|P2|STARTED|Overall Study||6
8628051|NCT02959892|21293729|P1|STARTED|Overall Study||6
8628052|NCT02949973|21293737|P1|NOT COMPLETED|Overall Study||1
8628053|NCT02949973|21293737|P1|COMPLETED|Overall Study||9
8628054|NCT02949973|21293737|P1|STARTED|Overall Study||10
8628055|NCT02940730|21293748|P2|NOT COMPLETED|Intervention 2||0
8628056|NCT02940730|21293749|P1|NOT COMPLETED|Intervention 2||7
8628057|NCT02940730|21293748|P2|COMPLETED|Intervention 2||0
8628058|NCT02940730|21293749|P1|COMPLETED|Intervention 2||3
8628059|NCT02940730|21293748|P2|Received Intervention|Intervention 2||0
8628060|NCT02940730|21293749|P1|Received Intervention|Intervention 2||3
8628061|NCT02940730|21293748|P2|STARTED|Intervention 2||0
8628062|NCT02940730|21293749|P1|STARTED|Intervention 2||10
8628063|NCT02940730|21293748|P2|NOT COMPLETED|Intervention 1||0
8628064|NCT02940730|21293749|P1|NOT COMPLETED|Intervention 1||0
8628065|NCT02940730|21293748|P2|COMPLETED|Intervention 1||0
8628066|NCT02940730|21293749|P1|COMPLETED|Intervention 1||10
8628067|NCT02940730|21293748|P2|Received Intervention|Intervention 1||0
8628068|NCT02940730|21293749|P1|Received Intervention|Intervention 1||10
8628069|NCT02940730|21293748|P2|STARTED|Intervention 1||0
8628070|NCT02940730|21293749|P1|STARTED|Intervention 1||10
8628071|NCT02748694|21293778|P15|NOT COMPLETED|Overall Study||2
8628072|NCT02748694|21293779|P14|NOT COMPLETED|Overall Study||0
8628073|NCT02748694|21293780|P13|NOT COMPLETED|Overall Study||0
8628074|NCT02748694|21293781|P12|NOT COMPLETED|Overall Study||0
8628075|NCT02748694|21293782|P11|NOT COMPLETED|Overall Study||0
8628076|NCT02748694|21293783|P10|NOT COMPLETED|Overall Study||0
8628077|NCT02748694|21293784|P9|NOT COMPLETED|Overall Study||0
8628078|NCT02748694|21293785|P8|NOT COMPLETED|Overall Study||0
8628079|NCT02748694|21293786|P7|NOT COMPLETED|Overall Study||0
8628080|NCT02748694|21293787|P6|NOT COMPLETED|Overall Study||0
8628081|NCT02748694|21293788|P5|NOT COMPLETED|Overall Study||0
8628082|NCT02748694|21293789|P4|NOT COMPLETED|Overall Study||0
8628083|NCT02748694|21293790|P3|NOT COMPLETED|Overall Study||0
8628084|NCT02748694|21293791|P2|NOT COMPLETED|Overall Study||0
8628085|NCT02748694|21293792|P1|NOT COMPLETED|Overall Study||0
8628086|NCT02748694|21293778|P15|COMPLETED|Overall Study||14
8628087|NCT02748694|21293779|P14|COMPLETED|Overall Study||8
8628088|NCT02748694|21293780|P13|COMPLETED|Overall Study||9
8628089|NCT02748694|21293781|P12|COMPLETED|Overall Study||9
8628090|NCT02748694|21293782|P11|COMPLETED|Overall Study||6
8628091|NCT02748694|21293783|P10|COMPLETED|Overall Study||6
8628092|NCT02748694|21293784|P9|COMPLETED|Overall Study||6
8628093|NCT02748694|21293785|P8|COMPLETED|Overall Study||6
8628094|NCT02748694|21293786|P7|COMPLETED|Overall Study||8
8628095|NCT02748694|21293787|P6|COMPLETED|Overall Study||6
8628096|NCT02748694|21293788|P5|COMPLETED|Overall Study||6
8628097|NCT02748694|21293789|P4|COMPLETED|Overall Study||6
8628098|NCT02748694|21293790|P3|COMPLETED|Overall Study||6
8628099|NCT02748694|21293791|P2|COMPLETED|Overall Study||6
8628100|NCT02748694|21293792|P1|COMPLETED|Overall Study||10
8628101|NCT02748694|21293778|P15|STARTED|Overall Study||16
8628102|NCT02748694|21293779|P14|STARTED|Overall Study||8
8628103|NCT02748694|21293780|P13|STARTED|Overall Study||9
8628104|NCT02748694|21293781|P12|STARTED|Overall Study||9
8628105|NCT02748694|21293782|P11|STARTED|Overall Study||6
8628106|NCT02748694|21293783|P10|STARTED|Overall Study||6
8628107|NCT02748694|21293784|P9|STARTED|Overall Study||6
8628108|NCT02748694|21293785|P8|STARTED|Overall Study||6
8628109|NCT02748694|21293786|P7|STARTED|Overall Study||8
8628110|NCT02748694|21293787|P6|STARTED|Overall Study||6
8628111|NCT02748694|21293788|P5|STARTED|Overall Study||6
8628112|NCT02748694|21293789|P4|STARTED|Overall Study||6
8628113|NCT02748694|21293790|P3|STARTED|Overall Study||6
8628114|NCT02748694|21293791|P2|STARTED|Overall Study||6
8628115|NCT02748694|21293792|P1|STARTED|Overall Study||10
8628116|NCT02662023|21294002|P2|NOT COMPLETED|Overall Study||0
8628117|NCT02662023|21294003|P1|NOT COMPLETED|Overall Study||0
8628118|NCT02662023|21294002|P2|COMPLETED|Overall Study||12
8628119|NCT02662023|21294003|P1|COMPLETED|Overall Study||12
8628120|NCT02662023|21294002|P2|STARTED|Overall Study||12
8628121|NCT02662023|21294003|P1|STARTED|Overall Study||12
8628132|NCT02648932|21294054|P2|NOT COMPLETED|Overall Study||1
8628133|NCT02648932|21294055|P1|NOT COMPLETED|Overall Study||3
8628134|NCT02648932|21294054|P2|COMPLETED|Overall Study||3
8628135|NCT02648932|21294055|P1|COMPLETED|Overall Study||2
8628136|NCT02648932|21294054|P2|STARTED|Overall Study||4
8628137|NCT02648932|21294055|P1|STARTED|Overall Study||5
8628141|NCT02609503|21294078|P1|NOT COMPLETED|Overall Study||4
8628142|NCT02609503|21294078|P1|COMPLETED|Overall Study||25
8628143|NCT02609503|21294078|P1|STARTED|Overall Study||29
8628198|NCT02553915|21294138|P4|NOT COMPLETED|Overall Study||3
8628199|NCT02553915|21294139|P3|NOT COMPLETED|Overall Study||3
8628200|NCT02553915|21294140|P2|NOT COMPLETED|Overall Study||1
8628201|NCT02553915|21294141|P1|NOT COMPLETED|Overall Study||4
8628202|NCT02553915|21294138|P4|COMPLETED|Overall Study||13
8628203|NCT02553915|21294139|P3|COMPLETED|Overall Study||12
8628204|NCT02553915|21294140|P2|COMPLETED|Overall Study||14
8628205|NCT02553915|21294141|P1|COMPLETED|Overall Study||11
8628206|NCT02553915|21294138|P4|STARTED|Overall Study||16
8628207|NCT02553915|21294139|P3|STARTED|Overall Study||15
8628208|NCT02553915|21294140|P2|STARTED|Overall Study||15
8628209|NCT02553915|21294141|P1|STARTED|Overall Study||15
8628210|NCT02548910|21294173|P2|NOT COMPLETED|Overall Study||0
8628211|NCT02548910|21294174|P1|NOT COMPLETED|Overall Study||0
8628212|NCT02548910|21294173|P2|COMPLETED|Overall Study||31
8628213|NCT02548910|21294174|P1|COMPLETED|Overall Study||31
8628214|NCT02548910|21294173|P2|STARTED|Overall Study||31
8628215|NCT02548910|21294174|P1|STARTED|Overall Study||31
8628216|NCT02369536|21294191|P2|NOT COMPLETED|Overall Study||6
8628217|NCT02369536|21294192|P1|NOT COMPLETED|Overall Study||7
8628218|NCT02369536|21294191|P2|COMPLETED|Overall Study||58
8628219|NCT02369536|21294192|P1|COMPLETED|Overall Study||55
8628220|NCT02369536|21294191|P2|STARTED|Overall Study||64
8628221|NCT02369536|21294192|P1|STARTED|Overall Study||62
8628222|NCT02308501|21294214|P2|NOT COMPLETED|Overall Study||0
8628223|NCT02308501|21294215|P1|NOT COMPLETED|Overall Study||0
8628224|NCT02308501|21294214|P2|COMPLETED|Overall Study||25
8628225|NCT02308501|21294215|P1|COMPLETED|Overall Study||25
8628226|NCT02308501|21294214|P2|Randomized Participant Eyes|Overall Study||25
8628227|NCT02308501|21294215|P1|Randomized Participant Eyes|Overall Study||25
8628228|NCT02308501|21294214|P2|STARTED|Overall Study||25
8628229|NCT02308501|21294215|P1|STARTED|Overall Study|25 participants received one drop of Lastacaft in one eye and Tears Naturale in the other eye.|25
8628239|NCT02242045|21294246|P1|NOT COMPLETED|Overall Study||6
8628240|NCT02242045|21294246|P1|COMPLETED|Overall Study||0
8628241|NCT02242045|21294246|P1|STARTED|Overall Study||6
8628242|NCT02225665|21294264|P2|NOT COMPLETED|Overall Study||1
8628243|NCT02225665|21294265|P1|NOT COMPLETED|Overall Study||1
8628244|NCT02225665|21294264|P2|COMPLETED|Overall Study||4
8628245|NCT02225665|21294265|P1|COMPLETED|Overall Study||2
8628246|NCT02225665|21294264|P2|STARTED|Overall Study||5
8628247|NCT02225665|21294265|P1|STARTED|Overall Study||3
8628248|NCT02219438|21294279|P2|NOT COMPLETED|Overall Study||0
8628249|NCT02219438|21294280|P1|NOT COMPLETED|Overall Study||0
8628250|NCT02219438|21294279|P2|COMPLETED|Overall Study||11
8628251|NCT02219438|21294280|P1|COMPLETED|Overall Study||13
8628252|NCT02219438|21294279|P2|STARTED|Overall Study||11
8628253|NCT02219438|21294280|P1|STARTED|Overall Study||13
8628254|NCT02144597|21294293|P3|NOT COMPLETED|Overall Study||4
8628255|NCT02144597|21294294|P2|NOT COMPLETED|Overall Study||4
8628256|NCT02144597|21294295|P1|NOT COMPLETED|Overall Study||6
8628257|NCT02144597|21294293|P3|COMPLETED|Overall Study||6
8628258|NCT02144597|21294294|P2|COMPLETED|Overall Study||6
8628259|NCT02144597|21294295|P1|COMPLETED|Overall Study||4
8628260|NCT02144597|21294293|P3|STARTED|Overall Study||10
8628261|NCT02144597|21294294|P2|STARTED|Overall Study||10
8628262|NCT02144597|21294295|P1|STARTED|Overall Study||10
8628263|NCT02083926|21294317|P2|NOT COMPLETED|Overall Study||0
8628264|NCT02083926|21294318|P1|NOT COMPLETED|Overall Study||1
8628265|NCT02083926|21294317|P2|COMPLETED|Overall Study||9
8628266|NCT02083926|21294318|P1|COMPLETED|Overall Study||8
8628267|NCT02083926|21294317|P2|STARTED|Overall Study||9
8628268|NCT02083926|21294318|P1|STARTED|Overall Study||9
8628275|NCT01898689|21294359|P2|NOT COMPLETED|Overall Study||0
8628276|NCT01898689|21294360|P1|NOT COMPLETED|Overall Study||0
8628277|NCT01898689|21294359|P2|COMPLETED|Overall Study||14
8628278|NCT01898689|21294360|P1|COMPLETED|Overall Study||10
8628279|NCT01898689|21294359|P2|STARTED|Overall Study||14
8628280|NCT01898689|21294360|P1|STARTED|Overall Study||10
8628281|NCT01837901|21294373|P3|NOT COMPLETED|Overall Study||3
8628282|NCT01837901|21294374|P2|NOT COMPLETED|Overall Study||6
8628283|NCT01837901|21294375|P1|NOT COMPLETED|Overall Study||2
8628284|NCT01837901|21294373|P3|COMPLETED|Overall Study||17
8628285|NCT01837901|21294374|P2|COMPLETED|Overall Study||15
8628286|NCT01837901|21294375|P1|COMPLETED|Overall Study||20
8628287|NCT01837901|21294373|P3|STARTED|Overall Study||20
8628288|NCT01837901|21294374|P2|STARTED|Overall Study||21
8628289|NCT01837901|21294375|P1|STARTED|Overall Study||22
8628293|NCT01757067|21294393|P2|NOT COMPLETED|Overall Study||0
8628294|NCT01757067|21294394|P1|NOT COMPLETED|Overall Study||0
8628295|NCT01757067|21294393|P2|COMPLETED|Overall Study|The study was closed due to low enrollment.|1
8628296|NCT01757067|21294394|P1|COMPLETED|Overall Study|The study was closed due to low enrollment.|2
8628297|NCT01757067|21294393|P2|STARTED|Overall Study|The study was closed due to low enrollment.|1
8628298|NCT01757067|21294394|P1|STARTED|Overall Study||2
8628299|NCT01684202|21294404|P4|NOT COMPLETED|Maintenance Period||1
8628300|NCT01684202|21294405|P3|NOT COMPLETED|Maintenance Period||1
8628301|NCT01684202|21294406|P2|NOT COMPLETED|Maintenance Period||3
8628302|NCT01684202|21294407|P1|NOT COMPLETED|Maintenance Period||1
8628303|NCT01684202|21294404|P4|COMPLETED|Maintenance Period||10
8628304|NCT01684202|21294405|P3|COMPLETED|Maintenance Period||8
8628305|NCT01684202|21294406|P2|COMPLETED|Maintenance Period||4
8628306|NCT01684202|21294407|P1|COMPLETED|Maintenance Period||13
8628307|NCT01684202|21294404|P4|STARTED|Maintenance Period||11
8628308|NCT01684202|21294405|P3|STARTED|Maintenance Period||9
8628309|NCT01684202|21294406|P2|STARTED|Maintenance Period||7
8628310|NCT01684202|21294407|P1|STARTED|Maintenance Period||14
8628311|NCT01684202|21294404|P4|NOT COMPLETED|Dose-escalation Period||0
8628312|NCT01684202|21294405|P3|NOT COMPLETED|Dose-escalation Period||0
8628313|NCT01684202|21294406|P2|NOT COMPLETED|Dose-escalation Period||1
8628314|NCT01684202|21294407|P1|NOT COMPLETED|Dose-escalation Period||1
8628315|NCT01684202|21294404|P4|COMPLETED|Dose-escalation Period||11
8628316|NCT01684202|21294405|P3|COMPLETED|Dose-escalation Period||9
8628317|NCT01684202|21294406|P2|COMPLETED|Dose-escalation Period||7
8628318|NCT01684202|21294407|P1|COMPLETED|Dose-escalation Period||14
8628319|NCT01684202|21294404|P4|STARTED|Dose-escalation Period||11
8628320|NCT01684202|21294405|P3|STARTED|Dose-escalation Period||9
8628321|NCT01684202|21294406|P2|STARTED|Dose-escalation Period||8
8628322|NCT01684202|21294407|P1|STARTED|Dose-escalation Period||15
8628323|NCT01639339|21294423|P2|NOT COMPLETED|Open-label Period (Up to Week 28)||8
8628324|NCT01639339|21294424|P1|NOT COMPLETED|Open-label Period (Up to Week 28)||1
8628325|NCT01639339|21294423|P2|COMPLETED|Open-label Period (Up to Week 28)||124
8628326|NCT01639339|21294424|P1|COMPLETED|Open-label Period (Up to Week 28)||122
8628327|NCT01639339|21294423|P2|STARTED|Open-label Period (Up to Week 28)||132
8628328|NCT01639339|21294424|P1|STARTED|Open-label Period (Up to Week 28)|Of the 356 participants who completed the double-blind period, 279 were eligible for open-label treatment. As enrolling into the open-label period was optional, only 257 participants enrolled, of whom 255 started open-label treatment.|123
8628329|NCT01639339|21294423|P2|NOT COMPLETED|Double-blind Period (Up to Week 104)||38
8628330|NCT01639339|21294424|P1|NOT COMPLETED|Double-blind Period (Up to Week 104)||54
8628331|NCT01639339|21294423|P2|COMPLETED|Double-blind Period (Up to Week 104)||186
8628332|NCT01639339|21294424|P1|COMPLETED|Double-blind Period (Up to Week 104)||170
8628333|NCT01639339|21294423|P2|STARTED|Double-blind Period (Up to Week 104)||224
8628334|NCT01639339|21294424|P1|STARTED|Double-blind Period (Up to Week 104)||224
8628341|NCT01596595|21294469|P1|NOT COMPLETED|Overall Study||965
8628342|NCT01596595|21294469|P1|COMPLETED|Overall Study||814
8628343|NCT01596595|21294469|P1|STARTED|Overall Study||1779
8628344|NCT01538628|21294475|P2|NOT COMPLETED|Overall Study||2
8628345|NCT01538628|21294476|P1|NOT COMPLETED|Overall Study||1
8628346|NCT01538628|21294475|P2|COMPLETED|Overall Study||71
8628347|NCT01538628|21294476|P1|COMPLETED|Overall Study||148
8628348|NCT01538628|21294475|P2|STARTED|Overall Study||73
8628349|NCT01538628|21294476|P1|STARTED|Overall Study||149
8628350|NCT01431573|21294492|P1|NOT COMPLETED|Overall Study||0
8628351|NCT01431573|21294492|P1|COMPLETED|Overall Study||8
8628352|NCT01431573|21294492|P1|STARTED|Overall Study||8
8628371|NCT01338987|21294574|P5|NOT COMPLETED|Overall Study||0
8628372|NCT01338987|21294575|P4|NOT COMPLETED|Overall Study||0
8628373|NCT01338987|21294576|P3|NOT COMPLETED|Overall Study||2
8628374|NCT01338987|21294577|P2|NOT COMPLETED|Overall Study||1
8628375|NCT01338987|21294578|P1|NOT COMPLETED|Overall Study||2
8628376|NCT01338987|21294574|P5|COMPLETED|Overall Study||2
8628377|NCT01338987|21294575|P4|COMPLETED|Overall Study||31
8628378|NCT01338987|21294576|P3|COMPLETED|Overall Study||20
8628379|NCT01338987|21294577|P2|COMPLETED|Overall Study||8
8628380|NCT01338987|21294578|P1|COMPLETED|Overall Study||10
8628381|NCT01338987|21294574|P5|STARTED|Overall Study||2
8628382|NCT01338987|21294575|P4|STARTED|Overall Study||31
8628383|NCT01338987|21294576|P3|STARTED|Overall Study||22
8628384|NCT01338987|21294577|P2|STARTED|Overall Study||9
8628385|NCT01338987|21294578|P1|STARTED|Overall Study||12
8628389|NCT01088048|21294616|P10|NOT COMPLETED|Overall Study||4
8628390|NCT01088048|21294617|P9|NOT COMPLETED|Overall Study||7
8628391|NCT01088048|21294618|P8|NOT COMPLETED|Overall Study||5
8628392|NCT01088048|21294619|P7|NOT COMPLETED|Overall Study||6
8628393|NCT01088048|21294620|P6|NOT COMPLETED|Overall Study||11
8628394|NCT01088048|21294621|P5|NOT COMPLETED|Overall Study||17
8628395|NCT01088048|21294622|P4|NOT COMPLETED|Overall Study||14
8628396|NCT01088048|21294623|P3|NOT COMPLETED|Overall Study||14
8628397|NCT01088048|21294624|P2|NOT COMPLETED|Overall Study||27
8628398|NCT01088048|21294625|P1|NOT COMPLETED|Overall Study||22
8628399|NCT01088048|21294616|P10|COMPLETED|Overall Study||3
8628400|NCT01088048|21294617|P9|COMPLETED|Overall Study||8
8628401|NCT01088048|21294618|P8|COMPLETED|Overall Study||10
8628402|NCT01088048|21294619|P7|COMPLETED|Overall Study||6
8628403|NCT01088048|21294620|P6|COMPLETED|Overall Study||10
8628404|NCT01088048|21294621|P5|COMPLETED|Overall Study||16
8628405|NCT01088048|21294622|P4|COMPLETED|Overall Study||4
8628406|NCT01088048|21294623|P3|COMPLETED|Overall Study||4
8628407|NCT01088048|21294624|P2|COMPLETED|Overall Study||24
8628408|NCT01088048|21294625|P1|COMPLETED|Overall Study||29
8628409|NCT01088048|21294616|P10|Participants With MCL|Overall Study||0
8628410|NCT01088048|21294617|P9|Participants With MCL|Overall Study||0
8628411|NCT01088048|21294618|P8|Participants With MCL|Overall Study||0
8628412|NCT01088048|21294619|P7|Participants With MCL|Overall Study||0
8628413|NCT01088048|21294620|P6|Participants With MCL|Overall Study||0
8628414|NCT01088048|21294621|P5|Participants With MCL|Overall Study||4
8628415|NCT01088048|21294622|P4|Participants With MCL|Overall Study||18
8628416|NCT01088048|21294623|P3|Participants With MCL|Overall Study||18
8628417|NCT01088048|21294624|P2|Participants With MCL|Overall Study||0
8628418|NCT01088048|21294625|P1|Participants With MCL|Overall Study||0
8628419|NCT01088048|21294616|P10|Participants With Indolent NHL|Overall Study||6
8628420|NCT01088048|21294617|P9|Participants With Indolent NHL|Overall Study||1
8628421|NCT01088048|21294618|P8|Participants With Indolent NHL|Overall Study||0
8628422|NCT01088048|21294619|P7|Participants With Indolent NHL|Overall Study||0
8628423|NCT01088048|21294620|P6|Participants With Indolent NHL|Overall Study||0
8628424|NCT01088048|21294621|P5|Participants With Indolent NHL|Overall Study||14
8628425|NCT01088048|21294622|P4|Participants With Indolent NHL|Overall Study||0
8628426|NCT01088048|21294623|P3|Participants With Indolent NHL|Overall Study||0
8628427|NCT01088048|21294624|P2|Participants With Indolent NHL|Overall Study||33
8628428|NCT01088048|21294625|P1|Participants With Indolent NHL|Overall Study||32
8628429|NCT01088048|21294616|P10|Participants With CLL|Overall Study||1
8628430|NCT01088048|21294617|P9|Participants With CLL|Overall Study||14
8628431|NCT01088048|21294618|P8|Participants With CLL|Overall Study||15
8628432|NCT01088048|21294619|P7|Participants With CLL|Overall Study||12
8628433|NCT01088048|21294620|P6|Participants With CLL|Overall Study||21
8628434|NCT01088048|21294621|P5|Participants With CLL|Overall Study||15
8628435|NCT01088048|21294622|P4|Participants With CLL|Overall Study||0
8628436|NCT01088048|21294623|P3|Participants With CLL|Overall Study||0
8628437|NCT01088048|21294624|P2|Participants With CLL|Overall Study||18
8628438|NCT01088048|21294625|P1|Participants With CLL|Overall Study||19
8628439|NCT01088048|21294616|P10|STARTED|Overall Study||7
8628440|NCT01088048|21294617|P9|STARTED|Overall Study||15
8628441|NCT01088048|21294618|P8|STARTED|Overall Study||15
8628442|NCT01088048|21294619|P7|STARTED|Overall Study||12
8628443|NCT01088048|21294620|P6|STARTED|Overall Study||21
8628444|NCT01088048|21294621|P5|STARTED|Overall Study||33
8628445|NCT01088048|21294622|P4|STARTED|Overall Study||18
8628446|NCT01088048|21294623|P3|STARTED|Overall Study||18
8628447|NCT01088048|21294624|P2|STARTED|Overall Study||51
8628448|NCT01088048|21294625|P1|STARTED|Overall Study||51
8628449|NCT01054443|21294722|P4|NOT COMPLETED|Overall Study||1
8628450|NCT01054443|21294723|P3|NOT COMPLETED|Overall Study||0
8628451|NCT01054443|21294724|P2|NOT COMPLETED|Overall Study||0
8628452|NCT01054443|21294725|P1|NOT COMPLETED|Overall Study||0
8628453|NCT01054443|21294722|P4|COMPLETED|Overall Study||4
8628454|NCT01054443|21294723|P3|COMPLETED|Overall Study||5
8628455|NCT01054443|21294724|P2|COMPLETED|Overall Study||5
8628456|NCT01054443|21294725|P1|COMPLETED|Overall Study||5
8628457|NCT01054443|21294722|P4|STARTED|Overall Study||5
8628458|NCT01054443|21294723|P3|STARTED|Overall Study||5
8628459|NCT01054443|21294724|P2|STARTED|Overall Study||5
8628460|NCT01054443|21294725|P1|STARTED|Overall Study||5
8628473|NCT00937157|21294837|P1|NOT COMPLETED|Overall Study||4
8628474|NCT00937157|21294837|P1|COMPLETED|Overall Study||8
8628475|NCT00937157|21294837|P1|STARTED|Overall Study||12
8628476|NCT00660790|21294841|P1|NOT COMPLETED|3 Months to 2 Years||17
8628477|NCT00660790|21294841|P1|COMPLETED|3 Months to 2 Years||77
8628478|NCT00660790|21294841|P1|STARTED|3 Months to 2 Years||94
8628479|NCT00660790|21294841|P1|NOT COMPLETED|Baseline to 3 Months||3
8628480|NCT00660790|21294841|P1|COMPLETED|Baseline to 3 Months||94
8628481|NCT00660790|21294841|P1|STARTED|Baseline to 3 Months||97
8628482|NCT04533204|21294847|P2|NOT COMPLETED|Overall Study||1
8628483|NCT04533204|21294848|P1|NOT COMPLETED|Overall Study||1
8628484|NCT04533204|21294847|P2|COMPLETED|Overall Study||29
8628485|NCT04533204|21294848|P1|COMPLETED|Overall Study||28
8628486|NCT04533204|21294847|P2|STARTED|Overall Study||30
8628487|NCT04533204|21294848|P1|STARTED|Overall Study||29
8628488|NCT04465422|21294858|P2|NOT COMPLETED|Overall Study||2
8628489|NCT04465422|21294859|P1|NOT COMPLETED|Overall Study||0
8628490|NCT04465422|21294858|P2|COMPLETED|Overall Study||14
8628491|NCT04465422|21294859|P1|COMPLETED|Overall Study||17
8628492|NCT04465422|21294858|P2|STARTED|Overall Study||16
8628493|NCT04465422|21294859|P1|STARTED|Overall Study||17
8628498|NCT04238650|21294875|P2|NOT COMPLETED|Overall Study||1
8628499|NCT04238650|21294876|P1|NOT COMPLETED|Overall Study||0
8628500|NCT04238650|21294875|P2|COMPLETED|Overall Study||24
8628501|NCT04238650|21294876|P1|COMPLETED|Overall Study||24
8628502|NCT04238650|21294875|P2|STARTED|Overall Study|One subject was enrolled and randomized to EU Avastin® but the subject was not dosed (subject withdrawal before study drug administration)|25
8628503|NCT04238650|21294876|P1|STARTED|Overall Study||24
8628504|NCT04207840|21294898|P3|NOT COMPLETED|Treatment Period 3||0
8628505|NCT04207840|21294899|P2|NOT COMPLETED|Treatment Period 3||0
8628506|NCT04207840|21294900|P1|NOT COMPLETED|Treatment Period 3||0
8628507|NCT04207840|21294898|P3|COMPLETED|Treatment Period 3||7
8628508|NCT04207840|21294899|P2|COMPLETED|Treatment Period 3||10
8628509|NCT04207840|21294900|P1|COMPLETED|Treatment Period 3||9
8628510|NCT04207840|21294898|P3|STARTED|Treatment Period 3||7
8628511|NCT04207840|21294899|P2|STARTED|Treatment Period 3||10
8628512|NCT04207840|21294900|P1|STARTED|Treatment Period 3||9
8628513|NCT04207840|21294898|P3|NOT COMPLETED|Washout Period 2 (2-7 Days)||1
8628514|NCT04207840|21294899|P2|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
8628515|NCT04207840|21294900|P1|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
8628516|NCT04207840|21294898|P3|COMPLETED|Washout Period 2 (2-7 Days)||7
8628517|NCT04207840|21294899|P2|COMPLETED|Washout Period 2 (2-7 Days)||10
8628518|NCT04207840|21294900|P1|COMPLETED|Washout Period 2 (2-7 Days)||9
8628519|NCT04207840|21294898|P3|STARTED|Washout Period 2 (2-7 Days)||8
8628520|NCT04207840|21294899|P2|STARTED|Washout Period 2 (2-7 Days)||10
8628521|NCT04207840|21294900|P1|STARTED|Washout Period 2 (2-7 Days)||9
8628522|NCT04207840|21294898|P3|NOT COMPLETED|Treatment Period 2||0
8628523|NCT04207840|21294899|P2|NOT COMPLETED|Treatment Period 2||0
8628524|NCT04207840|21294900|P1|NOT COMPLETED|Treatment Period 2||0
8628525|NCT04207840|21294898|P3|COMPLETED|Treatment Period 2||8
8628526|NCT04207840|21294899|P2|COMPLETED|Treatment Period 2||10
8628527|NCT04207840|21294900|P1|COMPLETED|Treatment Period 2||9
8628528|NCT04207840|21294898|P3|STARTED|Treatment Period 2||8
8628529|NCT04207840|21294899|P2|STARTED|Treatment Period 2||10
8628530|NCT04207840|21294900|P1|STARTED|Treatment Period 2||9
8628531|NCT04207840|21294898|P3|NOT COMPLETED|Washout Period 1 (2-7 Days)||1
8628532|NCT04207840|21294899|P2|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
8628533|NCT04207840|21294900|P1|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
8628534|NCT04207840|21294898|P3|COMPLETED|Washout Period 1 (2-7 Days)||8
8628535|NCT04207840|21294899|P2|COMPLETED|Washout Period 1 (2-7 Days)||10
8628536|NCT04207840|21294900|P1|COMPLETED|Washout Period 1 (2-7 Days)||9
8628537|NCT04207840|21294898|P3|STARTED|Washout Period 1 (2-7 Days)||9
8628538|NCT04207840|21294899|P2|STARTED|Washout Period 1 (2-7 Days)||10
8628539|NCT04207840|21294900|P1|STARTED|Washout Period 1 (2-7 Days)||9
8628540|NCT04207840|21294898|P3|NOT COMPLETED|Treatment Period 1||0
8628541|NCT04207840|21294899|P2|NOT COMPLETED|Treatment Period 1||0
8628542|NCT04207840|21294900|P1|NOT COMPLETED|Treatment Period 1||0
8628543|NCT04207840|21294898|P3|COMPLETED|Treatment Period 1||9
8628544|NCT04207840|21294899|P2|COMPLETED|Treatment Period 1||10
8628545|NCT04207840|21294900|P1|COMPLETED|Treatment Period 1||9
8628546|NCT04207840|21294898|P3|STARTED|Treatment Period 1||9
8628547|NCT04207840|21294899|P2|STARTED|Treatment Period 1||10
8628548|NCT04207840|21294900|P1|STARTED|Treatment Period 1||9
8628549|NCT04191668|21294923|P1|NOT COMPLETED|Overall Study||0
8628550|NCT04191668|21294923|P1|COMPLETED|Overall Study||106
8628551|NCT04191668|21294923|P1|STARTED|Overall Study||106
8628558|NCT04150250|21294946|P2|NOT COMPLETED|Overall Study||2
8628559|NCT04150250|21294947|P1|NOT COMPLETED|Overall Study||0
8628560|NCT04150250|21294946|P2|COMPLETED|Overall Study||22
8628561|NCT04150250|21294947|P1|COMPLETED|Overall Study||23
8628562|NCT04150250|21294946|P2|STARTED|Overall Study||24
8628563|NCT04150250|21294947|P1|STARTED|Overall Study||23
8628564|NCT04098575|21294980|P3|NOT COMPLETED|Overall Study||0
8628565|NCT04098575|21294981|P2|NOT COMPLETED|Overall Study||0
8628566|NCT04098575|21294982|P1|NOT COMPLETED|Overall Study||0
8628567|NCT04098575|21294980|P3|COMPLETED|Overall Study||6105
8628568|NCT04098575|21294981|P2|COMPLETED|Overall Study||2961
8628569|NCT04098575|21294982|P1|COMPLETED|Overall Study||505
8628570|NCT04098575|21294980|P3|STARTED|Overall Study||6105
8628571|NCT04098575|21294981|P2|STARTED|Overall Study||2961
8628572|NCT04098575|21294982|P1|STARTED|Overall Study||505
8628573|NCT04098458|21295029|P1|NOT COMPLETED|Overall Study||4
8628574|NCT04098458|21295029|P1|COMPLETED|Overall Study||14
8628575|NCT04098458|21295029|P1|STARTED|Overall Study||18
8628579|NCT04022694|21295061|P4|NOT COMPLETED|Overall Study||0
8628580|NCT04022694|21295062|P3|NOT COMPLETED|Overall Study||0
8628581|NCT04022694|21295063|P2|NOT COMPLETED|Overall Study||0
8628582|NCT04022694|21295064|P1|NOT COMPLETED|Overall Study||0
8628583|NCT04022694|21295061|P4|COMPLETED|Overall Study||173
8628584|NCT04022694|21295062|P3|COMPLETED|Overall Study||143
8628585|NCT04022694|21295063|P2|COMPLETED|Overall Study||145
8628586|NCT04022694|21295064|P1|COMPLETED|Overall Study||167
8628587|NCT04022694|21295061|P4|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|173
8628588|NCT04022694|21295062|P3|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|143
8628589|NCT04022694|21295063|P2|STARTED|Overall Study||145
8628590|NCT04022694|21295064|P1|STARTED|Overall Study||167
8628591|NCT03960658|21295102|P1|NOT COMPLETED|Overall Study||2
8628592|NCT03960658|21295102|P1|COMPLETED|Overall Study||10
8628593|NCT03960658|21295102|P1|STARTED|Overall Study||12
8628600|NCT03909100|21295121|P1|NOT COMPLETED|Overall Study||15
8628601|NCT03909100|21295121|P1|COMPLETED|Overall Study||105
8628602|NCT03909100|21295121|P1|Evaluable Population|Overall Study||106
8628603|NCT03909100|21295121|P1|Received Treatment in Session 2|Overall Study||107
8628604|NCT03909100|21295121|P1|Safety Population|Overall Study||112
8628605|NCT03909100|21295121|P1|STARTED|Overall Study||120
8628606|NCT03903822|21295142|P8|NOT COMPLETED|Follow up Phase (4 Weeks)||6
8628607|NCT03903822|21295143|P7|NOT COMPLETED|Follow up Phase (4 Weeks)||5
8628608|NCT03903822|21295144|P6|NOT COMPLETED|Follow up Phase (4 Weeks)||8
8628609|NCT03903822|21295145|P5|NOT COMPLETED|Follow up Phase (4 Weeks)||4
8628610|NCT03903822|21295146|P4|NOT COMPLETED|Follow up Phase (4 Weeks)||4
8628611|NCT03903822|21295147|P3|NOT COMPLETED|Follow up Phase (4 Weeks)||4
8628612|NCT03903822|21295148|P2|NOT COMPLETED|Follow up Phase (4 Weeks)||8
8628613|NCT03903822|21295149|P1|NOT COMPLETED|Follow up Phase (4 Weeks)||8
8628614|NCT03903822|21295142|P8|COMPLETED|Follow up Phase (4 Weeks)||31
8628615|NCT03903822|21295143|P7|COMPLETED|Follow up Phase (4 Weeks)||31
8628616|NCT03903822|21295144|P6|COMPLETED|Follow up Phase (4 Weeks)||28
8628617|NCT03903822|21295145|P5|COMPLETED|Follow up Phase (4 Weeks)||32
8628618|NCT03903822|21295146|P4|COMPLETED|Follow up Phase (4 Weeks)||33
8628619|NCT03903822|21295147|P3|COMPLETED|Follow up Phase (4 Weeks)||32
8628620|NCT03903822|21295148|P2|COMPLETED|Follow up Phase (4 Weeks)||29
8628621|NCT03903822|21295149|P1|COMPLETED|Follow up Phase (4 Weeks)||29
8628622|NCT03903822|21295142|P8|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
8628623|NCT03903822|21295143|P7|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
8628624|NCT03903822|21295144|P6|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
8628625|NCT03903822|21295145|P5|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
8628626|NCT03903822|21295146|P4|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
8628627|NCT03903822|21295147|P3|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
8628628|NCT03903822|21295148|P2|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
8628629|NCT03903822|21295149|P1|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
8628630|NCT03903822|21295142|P8|NOT COMPLETED|Treatment Phase (6 Weeks)||4
8628631|NCT03903822|21295143|P7|NOT COMPLETED|Treatment Phase (6 Weeks)||5
8628632|NCT03903822|21295144|P6|NOT COMPLETED|Treatment Phase (6 Weeks)||11
8628633|NCT03903822|21295145|P5|NOT COMPLETED|Treatment Phase (6 Weeks)||5
8628634|NCT03903822|21295146|P4|NOT COMPLETED|Treatment Phase (6 Weeks)||5
8628635|NCT03903822|21295147|P3|NOT COMPLETED|Treatment Phase (6 Weeks)||3
8628636|NCT03903822|21295148|P2|NOT COMPLETED|Treatment Phase (6 Weeks)||10
8628637|NCT03903822|21295149|P1|NOT COMPLETED|Treatment Phase (6 Weeks)||9
8628638|NCT03903822|21295142|P8|COMPLETED|Treatment Phase (6 Weeks)||33
8628639|NCT03903822|21295143|P7|COMPLETED|Treatment Phase (6 Weeks)||31
8628640|NCT03903822|21295144|P6|COMPLETED|Treatment Phase (6 Weeks)||25
8628641|NCT03903822|21295145|P5|COMPLETED|Treatment Phase (6 Weeks)||31
8628642|NCT03903822|21295146|P4|COMPLETED|Treatment Phase (6 Weeks)||32
8628643|NCT03903822|21295147|P3|COMPLETED|Treatment Phase (6 Weeks)||33
8628644|NCT03903822|21295148|P2|COMPLETED|Treatment Phase (6 Weeks)||27
8628645|NCT03903822|21295149|P1|COMPLETED|Treatment Phase (6 Weeks)||28
8628646|NCT03903822|21295142|P8|STARTED|Treatment Phase (6 Weeks)||37
8628647|NCT03903822|21295143|P7|STARTED|Treatment Phase (6 Weeks)||36
8628648|NCT03903822|21295144|P6|STARTED|Treatment Phase (6 Weeks)||36
8628649|NCT03903822|21295145|P5|STARTED|Treatment Phase (6 Weeks)||36
8628650|NCT03903822|21295146|P4|STARTED|Treatment Phase (6 Weeks)||37
8628651|NCT03903822|21295147|P3|STARTED|Treatment Phase (6 Weeks)||36
8628652|NCT03903822|21295148|P2|STARTED|Treatment Phase (6 Weeks)||37
8628653|NCT03903822|21295149|P1|STARTED|Treatment Phase (6 Weeks)||37
8628654|NCT03882528|21295375|P1|NOT COMPLETED|Overall Study||0
8628655|NCT03882528|21295375|P1|COMPLETED|Overall Study||12
8628656|NCT03882528|21295375|P1|STARTED|Overall Study||12
8628657|NCT03879603|21295388|P6|NOT COMPLETED|Overall Study||0
8628658|NCT03879603|21295389|P5|NOT COMPLETED|Overall Study||0
8628659|NCT03879603|21295390|P4|NOT COMPLETED|Overall Study||0
8628660|NCT03879603|21295391|P3|NOT COMPLETED|Overall Study||0
8628661|NCT03879603|21295392|P2|NOT COMPLETED|Overall Study||0
8628662|NCT03879603|21295393|P1|NOT COMPLETED|Overall Study||0
8628663|NCT03879603|21295388|P6|COMPLETED|Overall Study||5
8628664|NCT03879603|21295389|P5|COMPLETED|Overall Study||5
8628665|NCT03879603|21295390|P4|COMPLETED|Overall Study||5
8628666|NCT03879603|21295391|P3|COMPLETED|Overall Study||5
8628667|NCT03879603|21295392|P2|COMPLETED|Overall Study||5
8628668|NCT03879603|21295393|P1|COMPLETED|Overall Study||5
8628669|NCT03879603|21295388|P6|Received All Product Administrations|Overall Study||5
8628670|NCT03879603|21295389|P5|Received All Product Administrations|Overall Study||5
8628671|NCT03879603|21295390|P4|Received All Product Administrations|Overall Study||5
8628672|NCT03879603|21295391|P3|Received All Product Administrations|Overall Study||5
8628673|NCT03879603|21295392|P2|Received All Product Administrations|Overall Study||5
8628674|NCT03879603|21295393|P1|Received All Product Administrations|Overall Study|Second administration not completed due to a grade 3 neutropenia not related to study product.|4
8628675|NCT03879603|21295388|P6|Received First Product Administration|Overall Study||5
8628676|NCT03879603|21295389|P5|Received First Product Administration|Overall Study||5
8628677|NCT03879603|21295390|P4|Received First Product Administration|Overall Study||5
8628678|NCT03879603|21295391|P3|Received First Product Administration|Overall Study||5
8628679|NCT03879603|21295392|P2|Received First Product Administration|Overall Study||5
8628680|NCT03879603|21295393|P1|Received First Product Administration|Overall Study||5
8628681|NCT03879603|21295388|P6|STARTED|Overall Study||5
8628682|NCT03879603|21295389|P5|STARTED|Overall Study||5
8628683|NCT03879603|21295390|P4|STARTED|Overall Study||5
8628684|NCT03879603|21295391|P3|STARTED|Overall Study||5
8628685|NCT03879603|21295392|P2|STARTED|Overall Study||5
8628686|NCT03879603|21295393|P1|STARTED|Overall Study||5
8628687|NCT03861000|21295449|P2|NOT COMPLETED|Overall Study||0
8628688|NCT03861000|21295450|P1|NOT COMPLETED|Overall Study||0
8628689|NCT03861000|21295449|P2|COMPLETED|Overall Study||1
8628690|NCT03861000|21295450|P1|COMPLETED|Overall Study||2
8628691|NCT03861000|21295449|P2|STARTED|Overall Study||1
8628692|NCT03861000|21295450|P1|STARTED|Overall Study||2
8628693|NCT03840811|21295462|P3|NOT COMPLETED|Overall Study||1
8628694|NCT03840811|21295463|P2|NOT COMPLETED|Overall Study||0
8628695|NCT03840811|21295464|P1|NOT COMPLETED|Overall Study||0
8628696|NCT03840811|21295462|P3|COMPLETED|Overall Study||11
8628697|NCT03840811|21295463|P2|COMPLETED|Overall Study||6
8628698|NCT03840811|21295464|P1|COMPLETED|Overall Study||9
8628699|NCT03840811|21295462|P3|STARTED|Overall Study||12
8628700|NCT03840811|21295463|P2|STARTED|Overall Study||6
8628701|NCT03840811|21295464|P1|STARTED|Overall Study||9
8628702|NCT03767153|21295483|P2|NOT COMPLETED|Overall Study||0
8628703|NCT03767153|21295484|P1|NOT COMPLETED|Overall Study||0
8628704|NCT03767153|21295483|P2|COMPLETED|Overall Study||11
8628705|NCT03767153|21295484|P1|COMPLETED|Overall Study||14
8628706|NCT03767153|21295483|P2|STARTED|Overall Study||11
8628707|NCT03767153|21295484|P1|STARTED|Overall Study||14
8628708|NCT03756506|21295500|P2|NOT COMPLETED|Overall Study||0
8628709|NCT03756506|21295501|P1|NOT COMPLETED|Overall Study||1
8628710|NCT03756506|21295500|P2|COMPLETED|Overall Study||6
8628711|NCT03756506|21295501|P1|COMPLETED|Overall Study||6
8628712|NCT03756506|21295500|P2|STARTED|Overall Study||6
8628713|NCT03756506|21295501|P1|STARTED|Overall Study||7
8628714|NCT03743311|21295512|P3|NOT COMPLETED|Overall Study||0
8628715|NCT03743311|21295513|P2|NOT COMPLETED|Overall Study||0
8628716|NCT03743311|21295514|P1|NOT COMPLETED|Overall Study||0
8628717|NCT03743311|21295512|P3|COMPLETED|Overall Study||423
8628718|NCT03743311|21295513|P2|COMPLETED|Overall Study||298
8628719|NCT03743311|21295514|P1|COMPLETED|Overall Study||311
8628720|NCT03743311|21295512|P3|STARTED|Overall Study||423
8628721|NCT03743311|21295513|P2|STARTED|Overall Study||298
8628722|NCT03743311|21295514|P1|STARTED|Overall Study||311
8628729|NCT03652662|21295554|P2|NOT COMPLETED|Overall Study||1
8628730|NCT03652662|21295555|P1|NOT COMPLETED|Overall Study||3
8628731|NCT03652662|21295554|P2|COMPLETED|Overall Study||15
8628732|NCT03652662|21295555|P1|COMPLETED|Overall Study||15
8628733|NCT03652662|21295554|P2|STARTED|Overall Study||16
8628734|NCT03652662|21295555|P1|STARTED|Overall Study||18
8628738|NCT03643952|21295573|P1|NOT COMPLETED|Overall Study||1
8628739|NCT03643952|21295573|P1|COMPLETED|Overall Study||17
8628740|NCT03643952|21295573|P1|STARTED|Overall Study||18
8628747|NCT03628508|21295679|P1|NOT COMPLETED|Overall Study||1
8628748|NCT03628508|21295679|P1|COMPLETED|Overall Study||39
8628749|NCT03628508|21295679|P1|STARTED|Overall Study||40
8628753|NCT03615144|21295706|P2|NOT COMPLETED|Overall Study||0
8628754|NCT03615144|21295707|P1|NOT COMPLETED|Overall Study||1
8628755|NCT03615144|21295706|P2|COMPLETED|Overall Study||0
8628756|NCT03615144|21295707|P1|COMPLETED|Overall Study||0
8628757|NCT03615144|21295706|P2|STARTED|Overall Study||0
8628758|NCT03615144|21295707|P1|STARTED|Overall Study||1
8628765|NCT03593538|21295741|P3|NOT COMPLETED|Overall Study||11
8628766|NCT03593538|21295742|P2|NOT COMPLETED|Overall Study||6
8628767|NCT03593538|21295743|P1|NOT COMPLETED|Overall Study||11
8628768|NCT03593538|21295741|P3|COMPLETED|Overall Study||11
8628769|NCT03593538|21295742|P2|COMPLETED|Overall Study||15
8628770|NCT03593538|21295743|P1|COMPLETED|Overall Study||15
8628771|NCT03593538|21295741|P3|STARTED|Overall Study||22
8628772|NCT03593538|21295742|P2|STARTED|Overall Study||21
8628773|NCT03593538|21295743|P1|STARTED|Overall Study||26
8628774|NCT03576768|21295773|P4|NOT COMPLETED|Overall Study||0
8628775|NCT03576768|21295774|P3|NOT COMPLETED|Overall Study||0
8628776|NCT03576768|21295775|P2|NOT COMPLETED|Overall Study||3
8628777|NCT03576768|21295776|P1|NOT COMPLETED|Overall Study||3
8628778|NCT03576768|21295773|P4|COMPLETED|Overall Study||0
8628779|NCT03576768|21295774|P3|COMPLETED|Overall Study||0
8628780|NCT03576768|21295775|P2|COMPLETED|Overall Study||9
8628781|NCT03576768|21295776|P1|COMPLETED|Overall Study||10
8628782|NCT03576768|21295773|P4|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
8628783|NCT03576768|21295774|P3|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
8628784|NCT03576768|21295775|P2|STARTED|Overall Study||12
8628785|NCT03576768|21295776|P1|STARTED|Overall Study||13
8628786|NCT03569020|21295796|P2|NOT COMPLETED|Period 2||0
8628787|NCT03569020|21295797|P1|NOT COMPLETED|Period 2||0
8628788|NCT03569020|21295796|P2|COMPLETED|Period 2||21
8628789|NCT03569020|21295797|P1|COMPLETED|Period 2||22
8628790|NCT03569020|21295796|P2|STARTED|Period 2||21
8628791|NCT03569020|21295797|P1|STARTED|Period 2||22
8628792|NCT03569020|21295796|P2|NOT COMPLETED|Period 1||0
8628793|NCT03569020|21295797|P1|NOT COMPLETED|Period 1||0
8628794|NCT03569020|21295796|P2|COMPLETED|Period 1||21
8628795|NCT03569020|21295797|P1|COMPLETED|Period 1||22
8628796|NCT03569020|21295796|P2|STARTED|Period 1||21
8628797|NCT03569020|21295797|P1|STARTED|Period 1||22
8628798|NCT03567291|21295817|P4|NOT COMPLETED|Period III||85
8628799|NCT03567291|21295818|P3|NOT COMPLETED|Period III||0
8628800|NCT03567291|21295819|P2|NOT COMPLETED|Period III||0
8628801|NCT03567291|21295820|P1|NOT COMPLETED|Period III||0
8628802|NCT03567291|21295817|P4|COMPLETED|Period III||48
8628803|NCT03567291|21295818|P3|COMPLETED|Period III||0
8628804|NCT03567291|21295819|P2|COMPLETED|Period III||0
8628805|NCT03567291|21295820|P1|COMPLETED|Period III||0
8628806|NCT03567291|21295817|P4|STARTED|Period III||133
8628807|NCT03567291|21295818|P3|STARTED|Period III||0
8628808|NCT03567291|21295819|P2|STARTED|Period III||0
8628809|NCT03567291|21295820|P1|STARTED|Period III||0
8628810|NCT03567291|21295817|P4|NOT COMPLETED|Period II||0
8628811|NCT03567291|21295818|P3|NOT COMPLETED|Period II||1
8628812|NCT03567291|21295819|P2|NOT COMPLETED|Period II||3
8628813|NCT03567291|21295820|P1|NOT COMPLETED|Period II||0
8628814|NCT03567291|21295817|P4|COMPLETED|Period II||0
8628815|NCT03567291|21295818|P3|COMPLETED|Period II||45
8628816|NCT03567291|21295819|P2|COMPLETED|Period II||88
8628817|NCT03567291|21295820|P1|COMPLETED|Period II||0
8628818|NCT03567291|21295817|P4|STARTED|Period II||0
8628819|NCT03567291|21295818|P3|STARTED|Period II||46
8628820|NCT03567291|21295819|P2|STARTED|Period II||91
8628821|NCT03567291|21295820|P1|STARTED|Period II||0
8628822|NCT03567291|21295817|P4|NOT COMPLETED|Period I||0
8628823|NCT03567291|21295818|P3|NOT COMPLETED|Period I||0
8628824|NCT03567291|21295819|P2|NOT COMPLETED|Period I||0
8628825|NCT03567291|21295820|P1|NOT COMPLETED|Period I||91
8628826|NCT03567291|21295817|P4|COMPLETED|Period I||0
8628827|NCT03567291|21295818|P3|COMPLETED|Period I||0
8628828|NCT03567291|21295819|P2|COMPLETED|Period I||0
8628829|NCT03567291|21295820|P1|COMPLETED|Period I||137
8628830|NCT03567291|21295817|P4|Intent to Treat Set|Period I||0
8628831|NCT03567291|21295818|P3|Intent to Treat Set|Period I||0
8628832|NCT03567291|21295819|P2|Intent to Treat Set|Period I||0
8628833|NCT03567291|21295820|P1|Intent to Treat Set|Period I||228
8628834|NCT03567291|21295817|P4|Safety Set|Period I||0
8628835|NCT03567291|21295818|P3|Safety Set|Period I||0
8628836|NCT03567291|21295819|P2|Safety Set|Period I||0
8628837|NCT03567291|21295820|P1|Safety Set|Period I||227
8628838|NCT03567291|21295817|P4|STARTED|Period I||0
8628839|NCT03567291|21295818|P3|STARTED|Period I||0
8628840|NCT03567291|21295819|P2|STARTED|Period I||0
8628841|NCT03567291|21295820|P1|STARTED|Period I||228
8628842|NCT03565068|21295850|P9|NOT COMPLETED|Overall Study||1
8628843|NCT03565068|21295851|P8|NOT COMPLETED|Overall Study||8
8628844|NCT03565068|21295852|P7|NOT COMPLETED|Overall Study||1
8628845|NCT03565068|21295853|P6|NOT COMPLETED|Overall Study||1
8628846|NCT03565068|21295854|P5|NOT COMPLETED|Overall Study||4
8628847|NCT03565068|21295855|P4|NOT COMPLETED|Overall Study||0
8628848|NCT03565068|21295856|P3|NOT COMPLETED|Overall Study||1
8628849|NCT03565068|21295857|P2|NOT COMPLETED|Overall Study||0
8628850|NCT03565068|21295858|P1|NOT COMPLETED|Overall Study||0
8628851|NCT03565068|21295850|P9|COMPLETED|Overall Study||8
8628852|NCT03565068|21295851|P8|COMPLETED|Overall Study||9
8628853|NCT03565068|21295852|P7|COMPLETED|Overall Study||3
8628854|NCT03565068|21295853|P6|COMPLETED|Overall Study||0
8628855|NCT03565068|21295854|P5|COMPLETED|Overall Study||8
8628856|NCT03565068|21295855|P4|COMPLETED|Overall Study||4
8628857|NCT03565068|21295856|P3|COMPLETED|Overall Study||11
8628858|NCT03565068|21295857|P2|COMPLETED|Overall Study||4
8628859|NCT03565068|21295858|P1|COMPLETED|Overall Study||12
8628860|NCT03565068|21295850|P9|STARTED|Overall Study||9
8628861|NCT03565068|21295851|P8|STARTED|Overall Study||17
8628862|NCT03565068|21295852|P7|STARTED|Overall Study||4
8628863|NCT03565068|21295853|P6|STARTED|Overall Study||1
8628864|NCT03565068|21295854|P5|STARTED|Overall Study||12
8628865|NCT03565068|21295855|P4|STARTED|Overall Study||4
8628866|NCT03565068|21295856|P3|STARTED|Overall Study||12
8628867|NCT03565068|21295857|P2|STARTED|Overall Study||4
8628868|NCT03565068|21295858|P1|STARTED|Overall Study||12
8628869|NCT03538717|21296130|P1|NOT COMPLETED|Overall Study||0
8628870|NCT03538717|21296130|P1|COMPLETED|Overall Study||157
8628871|NCT03538717|21296130|P1|STARTED|Overall Study||157
8628872|NCT03535194|21296193|P5|NOT COMPLETED|Post-Treatment Followup Period||0
8628873|NCT03535194|21296194|P4|NOT COMPLETED|Post-Treatment Followup Period||24
8628874|NCT03535194|21296195|P3|NOT COMPLETED|Post-Treatment Followup Period||11
8628875|NCT03535194|21296196|P2|NOT COMPLETED|Post-Treatment Followup Period||14
8628876|NCT03535194|21296197|P1|NOT COMPLETED|Post-Treatment Followup Period||11
8628877|NCT03535194|21296193|P5|COMPLETED|Post-Treatment Followup Period||8
8628878|NCT03535194|21296194|P4|COMPLETED|Post-Treatment Followup Period||23
8628879|NCT03535194|21296195|P3|COMPLETED|Post-Treatment Followup Period||7
8628880|NCT03535194|21296196|P2|COMPLETED|Post-Treatment Followup Period||21
8628881|NCT03535194|21296197|P1|COMPLETED|Post-Treatment Followup Period||27
8628882|NCT03535194|21296193|P5|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|8
8628883|NCT03535194|21296194|P4|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|47
8628884|NCT03535194|21296195|P3|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|18
8628885|NCT03535194|21296196|P2|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|35
8628886|NCT03535194|21296197|P1|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|38
8628887|NCT03535194|21296193|P5|NOT COMPLETED|Maintenance Period||6
8628888|NCT03535194|21296194|P4|NOT COMPLETED|Maintenance Period||37
8628889|NCT03535194|21296195|P3|NOT COMPLETED|Maintenance Period||8
8628890|NCT03535194|21296196|P2|NOT COMPLETED|Maintenance Period||16
8628891|NCT03535194|21296197|P1|NOT COMPLETED|Maintenance Period||22
8628892|NCT03535194|21296193|P5|COMPLETED|Maintenance Period||13
8628893|NCT03535194|21296194|P4|COMPLETED|Maintenance Period||400
8628894|NCT03535194|21296195|P3|COMPLETED|Maintenance Period||96
8628895|NCT03535194|21296196|P2|COMPLETED|Maintenance Period||418
8628896|NCT03535194|21296197|P1|COMPLETED|Maintenance Period||421
8628897|NCT03535194|21296193|P5|STARTED|Maintenance Period||19
8628898|NCT03535194|21296194|P4|STARTED|Maintenance Period||437
8628899|NCT03535194|21296195|P3|STARTED|Maintenance Period||104
8628900|NCT03535194|21296196|P2|STARTED|Maintenance Period||434
8628901|NCT03535194|21296197|P1|STARTED|Maintenance Period||443
8628902|NCT03535194|21296193|P5|NOT COMPLETED|Induction Period||0
8628903|NCT03535194|21296194|P4|NOT COMPLETED|Induction Period||11
8628904|NCT03535194|21296195|P3|NOT COMPLETED|Induction Period||8
8628905|NCT03535194|21296196|P2|NOT COMPLETED|Induction Period||17
8628906|NCT03535194|21296197|P1|NOT COMPLETED|Induction Period||11
8628907|NCT03535194|21296193|P5|COMPLETED|Induction Period||19
8628908|NCT03535194|21296194|P4|COMPLETED|Induction Period||437
8628909|NCT03535194|21296195|P3|COMPLETED|Induction Period||104
8628910|NCT03535194|21296196|P2|COMPLETED|Induction Period||434
8628911|NCT03535194|21296197|P1|COMPLETED|Induction Period||443
8628912|NCT03535194|21296193|P5|Received at Least One Dose of Study Drug|Induction Period||19
8628913|NCT03535194|21296194|P4|Received at Least One Dose of Study Drug|Induction Period||448
8628914|NCT03535194|21296195|P3|Received at Least One Dose of Study Drug|Induction Period||112
8628915|NCT03535194|21296196|P2|Received at Least One Dose of Study Drug|Induction Period||450
8628916|NCT03535194|21296197|P1|Received at Least One Dose of Study Drug|Induction Period||454
8628917|NCT03535194|21296193|P5|STARTED|Induction Period|A plaque psoriasis participant was misrandomized by the site.|19
8628918|NCT03535194|21296194|P4|STARTED|Induction Period||448
8628919|NCT03535194|21296195|P3|STARTED|Induction Period||112
8628920|NCT03535194|21296196|P2|STARTED|Induction Period||451
8628921|NCT03535194|21296197|P1|STARTED|Induction Period||454
8628922|NCT03533608|21296266|P1|NOT COMPLETED|Overall Study||5
8628923|NCT03533608|21296266|P1|COMPLETED|Overall Study||34
8628924|NCT03533608|21296266|P1|STARTED|Overall Study||39
8628931|NCT03522506|21296292|P4|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8628932|NCT03522506|21296293|P3|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8628933|NCT03522506|21296294|P2|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8628934|NCT03522506|21296295|P1|NOT COMPLETED|Treatment Period 4 (2 Days)||0
8628935|NCT03522506|21296292|P4|COMPLETED|Treatment Period 4 (2 Days)||3
8628936|NCT03522506|21296293|P3|COMPLETED|Treatment Period 4 (2 Days)||5
8628937|NCT03522506|21296294|P2|COMPLETED|Treatment Period 4 (2 Days)||5
8628938|NCT03522506|21296295|P1|COMPLETED|Treatment Period 4 (2 Days)||5
8628939|NCT03522506|21296292|P4|STARTED|Treatment Period 4 (2 Days)||3
8628940|NCT03522506|21296293|P3|STARTED|Treatment Period 4 (2 Days)||5
8628941|NCT03522506|21296294|P2|STARTED|Treatment Period 4 (2 Days)||5
8628942|NCT03522506|21296295|P1|STARTED|Treatment Period 4 (2 Days)||5
8628943|NCT03522506|21296292|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
8628944|NCT03522506|21296293|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
8628945|NCT03522506|21296294|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
8628946|NCT03522506|21296295|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
8628947|NCT03522506|21296292|P4|COMPLETED|Washout Period 3 (7 Days)||3
8628948|NCT03522506|21296293|P3|COMPLETED|Washout Period 3 (7 Days)||5
8628949|NCT03522506|21296294|P2|COMPLETED|Washout Period 3 (7 Days)||5
8628950|NCT03522506|21296295|P1|COMPLETED|Washout Period 3 (7 Days)||5
8628951|NCT03522506|21296292|P4|STARTED|Washout Period 3 (7 Days)||3
8628952|NCT03522506|21296293|P3|STARTED|Washout Period 3 (7 Days)||5
8628953|NCT03522506|21296294|P2|STARTED|Washout Period 3 (7 Days)||5
8628954|NCT03522506|21296295|P1|STARTED|Washout Period 3 (7 Days)||5
8628955|NCT03522506|21296292|P4|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8628956|NCT03522506|21296293|P3|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8628957|NCT03522506|21296294|P2|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8628958|NCT03522506|21296295|P1|NOT COMPLETED|Treatment Period 3 (2 Days)||0
8628959|NCT03522506|21296292|P4|COMPLETED|Treatment Period 3 (2 Days)||3
8628960|NCT03522506|21296293|P3|COMPLETED|Treatment Period 3 (2 Days)||5
8628961|NCT03522506|21296294|P2|COMPLETED|Treatment Period 3 (2 Days)||5
8628962|NCT03522506|21296295|P1|COMPLETED|Treatment Period 3 (2 Days)||5
8628963|NCT03522506|21296292|P4|STARTED|Treatment Period 3 (2 Days)||3
8628964|NCT03522506|21296293|P3|STARTED|Treatment Period 3 (2 Days)||5
8628965|NCT03522506|21296294|P2|STARTED|Treatment Period 3 (2 Days)||5
8628966|NCT03522506|21296295|P1|STARTED|Treatment Period 3 (2 Days)||5
8628967|NCT03522506|21296292|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
8628968|NCT03522506|21296293|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
8628969|NCT03522506|21296294|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
8628970|NCT03522506|21296295|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
8628971|NCT03522506|21296292|P4|COMPLETED|Washout Period 2 (7 Days)||3
8628972|NCT03522506|21296293|P3|COMPLETED|Washout Period 2 (7 Days)||5
8628973|NCT03522506|21296294|P2|COMPLETED|Washout Period 2 (7 Days)||5
8628974|NCT03522506|21296295|P1|COMPLETED|Washout Period 2 (7 Days)||5
8628975|NCT03522506|21296292|P4|STARTED|Washout Period 2 (7 Days)||4
8628976|NCT03522506|21296293|P3|STARTED|Washout Period 2 (7 Days)||5
8628977|NCT03522506|21296294|P2|STARTED|Washout Period 2 (7 Days)||5
8628978|NCT03522506|21296295|P1|STARTED|Washout Period 2 (7 Days)||5
8628979|NCT03522506|21296292|P4|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8628980|NCT03522506|21296293|P3|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8628981|NCT03522506|21296294|P2|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8628982|NCT03522506|21296295|P1|NOT COMPLETED|Treatment Period 2 (2 Days)||0
8628983|NCT03522506|21296292|P4|COMPLETED|Treatment Period 2 (2 Days)||4
8628984|NCT03522506|21296293|P3|COMPLETED|Treatment Period 2 (2 Days)||5
8628985|NCT03522506|21296294|P2|COMPLETED|Treatment Period 2 (2 Days)||5
8628986|NCT03522506|21296295|P1|COMPLETED|Treatment Period 2 (2 Days)||5
8628987|NCT03522506|21296292|P4|STARTED|Treatment Period 2 (2 Days)||4
8628988|NCT03522506|21296293|P3|STARTED|Treatment Period 2 (2 Days)||5
8628989|NCT03522506|21296294|P2|STARTED|Treatment Period 2 (2 Days)||5
8628990|NCT03522506|21296295|P1|STARTED|Treatment Period 2 (2 Days)||5
8628991|NCT03522506|21296292|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
8628992|NCT03522506|21296293|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
8628993|NCT03522506|21296294|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
8628994|NCT03522506|21296295|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
8628995|NCT03522506|21296292|P4|COMPLETED|Washout Period 1 (7 Days)||4
8628996|NCT03522506|21296293|P3|COMPLETED|Washout Period 1 (7 Days)||5
8628997|NCT03522506|21296294|P2|COMPLETED|Washout Period 1 (7 Days)||5
8628998|NCT03522506|21296295|P1|COMPLETED|Washout Period 1 (7 Days)||5
8628999|NCT03522506|21296292|P4|STARTED|Washout Period 1 (7 Days)||5
8629000|NCT03522506|21296293|P3|STARTED|Washout Period 1 (7 Days)||5
8629001|NCT03522506|21296294|P2|STARTED|Washout Period 1 (7 Days)||5
8629002|NCT03522506|21296295|P1|STARTED|Washout Period 1 (7 Days)||5
8629003|NCT03522506|21296292|P4|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8629004|NCT03522506|21296293|P3|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8629005|NCT03522506|21296294|P2|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8629006|NCT03522506|21296295|P1|NOT COMPLETED|Treatment Period 1 (2 Days)||0
8629007|NCT03522506|21296292|P4|COMPLETED|Treatment Period 1 (2 Days)||5
8629008|NCT03522506|21296293|P3|COMPLETED|Treatment Period 1 (2 Days)||5
8629009|NCT03522506|21296294|P2|COMPLETED|Treatment Period 1 (2 Days)||5
8629010|NCT03522506|21296295|P1|COMPLETED|Treatment Period 1 (2 Days)||5
8629011|NCT03522506|21296292|P4|STARTED|Treatment Period 1 (2 Days)||5
8629012|NCT03522506|21296293|P3|STARTED|Treatment Period 1 (2 Days)||5
8629013|NCT03522506|21296294|P2|STARTED|Treatment Period 1 (2 Days)||5
8629014|NCT03522506|21296295|P1|STARTED|Treatment Period 1 (2 Days)||5
8629021|NCT03511937|21296356|P2|NOT COMPLETED|Overall Study||0
8629022|NCT03511937|21296357|P1|NOT COMPLETED|Overall Study||0
8629023|NCT03511937|21296356|P2|COMPLETED|Overall Study||200
8629024|NCT03511937|21296357|P1|COMPLETED|Overall Study||200
8629025|NCT03511937|21296356|P2|STARTED|Overall Study||200
8629026|NCT03511937|21296357|P1|STARTED|Overall Study||200
8629027|NCT03511105|21296407|P2|NOT COMPLETED|Overall Study||0
8629028|NCT03511105|21296408|P1|NOT COMPLETED|Overall Study||2
8629029|NCT03511105|21296407|P2|COMPLETED|Overall Study||22
8629030|NCT03511105|21296408|P1|COMPLETED|Overall Study||23
8629031|NCT03511105|21296407|P2|STARTED|Overall Study||22
8629032|NCT03511105|21296408|P1|STARTED|Overall Study||25
8629042|NCT03485222|21296515|P2|NOT COMPLETED|Overall Study||2
8629043|NCT03485222|21296516|P1|NOT COMPLETED|Overall Study||2
8629044|NCT03485222|21296515|P2|COMPLETED|Overall Study||40
8629045|NCT03485222|21296516|P1|COMPLETED|Overall Study||40
8629046|NCT03485222|21296515|P2|STARTED|Overall Study||42
8629047|NCT03485222|21296516|P1|STARTED|Overall Study||42
8629048|NCT03478657|21296534|P2|NOT COMPLETED|Overall Study||1
8629049|NCT03478657|21296535|P1|NOT COMPLETED|Overall Study||0
8629050|NCT03478657|21296534|P2|COMPLETED|Overall Study||133
8629051|NCT03478657|21296535|P1|COMPLETED|Overall Study||88
8629052|NCT03478657|21296534|P2|STARTED|Overall Study||134
8629053|NCT03478657|21296535|P1|STARTED|Overall Study||88
8629063|NCT03452189|21296567|P2|NOT COMPLETED|Intervention 2 (3 Months)||0
8629064|NCT03452189|21296568|P1|NOT COMPLETED|Intervention 2 (3 Months)||0
8629065|NCT03452189|21296567|P2|COMPLETED|Intervention 2 (3 Months)||5
8629066|NCT03452189|21296568|P1|COMPLETED|Intervention 2 (3 Months)||5
8629067|NCT03452189|21296567|P2|STARTED|Intervention 2 (3 Months)||5
8629068|NCT03452189|21296568|P1|STARTED|Intervention 2 (3 Months)||5
8629069|NCT03452189|21296567|P2|NOT COMPLETED|First Intervention (3 Months)||0
8629070|NCT03452189|21296568|P1|NOT COMPLETED|First Intervention (3 Months)||5
8629071|NCT03452189|21296567|P2|COMPLETED|First Intervention (3 Months)||5
8629072|NCT03452189|21296568|P1|COMPLETED|First Intervention (3 Months)||5
8629073|NCT03452189|21296567|P2|STARTED|First Intervention (3 Months)||5
8629074|NCT03452189|21296568|P1|STARTED|First Intervention (3 Months)||10
8629075|NCT03449030|21296586|P10|NOT COMPLETED|Overall Study||1
8629076|NCT03449030|21296587|P9|NOT COMPLETED|Overall Study||3
8629077|NCT03449030|21296588|P8|NOT COMPLETED|Overall Study||3
8629078|NCT03449030|21296589|P7|NOT COMPLETED|Overall Study||2
8629079|NCT03449030|21296590|P6|NOT COMPLETED|Overall Study||7
8629080|NCT03449030|21296591|P5|NOT COMPLETED|Overall Study||7
8629081|NCT03449030|21296592|P4|NOT COMPLETED|Overall Study||5
8629082|NCT03449030|21296593|P3|NOT COMPLETED|Overall Study||1
8629083|NCT03449030|21296594|P2|NOT COMPLETED|Overall Study||1
8629084|NCT03449030|21296595|P1|NOT COMPLETED|Overall Study||1
8629085|NCT03449030|21296586|P10|COMPLETED|Overall Study||0
8629086|NCT03449030|21296587|P9|COMPLETED|Overall Study||0
8629087|NCT03449030|21296588|P8|COMPLETED|Overall Study||0
8629088|NCT03449030|21296589|P7|COMPLETED|Overall Study||0
8629089|NCT03449030|21296590|P6|COMPLETED|Overall Study||0
8629090|NCT03449030|21296591|P5|COMPLETED|Overall Study||0
8629091|NCT03449030|21296592|P4|COMPLETED|Overall Study||0
8629092|NCT03449030|21296593|P3|COMPLETED|Overall Study||0
8629093|NCT03449030|21296594|P2|COMPLETED|Overall Study||0
8629094|NCT03449030|21296595|P1|COMPLETED|Overall Study||0
8629095|NCT03449030|21296586|P10|STARTED|Overall Study||1
8629096|NCT03449030|21296587|P9|STARTED|Overall Study||3
8629097|NCT03449030|21296588|P8|STARTED|Overall Study||3
8629098|NCT03449030|21296589|P7|STARTED|Overall Study||2
8629099|NCT03449030|21296590|P6|STARTED|Overall Study||7
8629100|NCT03449030|21296591|P5|STARTED|Overall Study||7
8629101|NCT03449030|21296592|P4|STARTED|Overall Study||5
8629102|NCT03449030|21296593|P3|STARTED|Overall Study||1
8629103|NCT03449030|21296594|P2|STARTED|Overall Study||1
8629104|NCT03449030|21296595|P1|STARTED|Overall Study||1
8629105|NCT03436810|21296770|P2|NOT COMPLETED|Overall Study||0
8629106|NCT03436810|21296771|P1|NOT COMPLETED|Overall Study||0
8629107|NCT03436810|21296770|P2|COMPLETED|Overall Study||20
8629108|NCT03436810|21296771|P1|COMPLETED|Overall Study||20
8629109|NCT03436810|21296770|P2|STARTED|Overall Study||20
8629110|NCT03436810|21296771|P1|STARTED|Overall Study||20
8629111|NCT03435224|21296793|P1|NOT COMPLETED|Overall Study||4
8629112|NCT03435224|21296793|P1|COMPLETED|Overall Study||25
8629113|NCT03435224|21296793|P1|STARTED|Overall Study||29
8629114|NCT03416621|21296800|P3|NOT COMPLETED|Overall Study||5
8629115|NCT03416621|21296801|P2|NOT COMPLETED|Overall Study||1
8629116|NCT03416621|21296802|P1|NOT COMPLETED|Overall Study||0
8629117|NCT03416621|21296800|P3|COMPLETED|Overall Study||1
8629118|NCT03416621|21296801|P2|COMPLETED|Overall Study||11
8629119|NCT03416621|21296802|P1|COMPLETED|Overall Study||13
8629120|NCT03416621|21296800|P3|STARTED|Overall Study||6
8629121|NCT03416621|21296801|P2|STARTED|Overall Study||12
8629122|NCT03416621|21296802|P1|STARTED|Overall Study||13
8629123|NCT03408730|21296818|P4|NOT COMPLETED|Overall Study||81
8629124|NCT03408730|21296819|P3|NOT COMPLETED|Overall Study||72
8629125|NCT03408730|21296820|P2|NOT COMPLETED|Overall Study||75
8629126|NCT03408730|21296821|P1|NOT COMPLETED|Overall Study||69
8629127|NCT03408730|21296818|P4|COMPLETED|Overall Study||625
8629128|NCT03408730|21296819|P3|COMPLETED|Overall Study||637
8629129|NCT03408730|21296820|P2|COMPLETED|Overall Study||636
8629130|NCT03408730|21296821|P1|COMPLETED|Overall Study||643
8629131|NCT03408730|21296818|P4|STARTED|Overall Study||706
8629132|NCT03408730|21296819|P3|STARTED|Overall Study||709
8629133|NCT03408730|21296820|P2|STARTED|Overall Study||711
8629134|NCT03408730|21296821|P1|STARTED|Overall Study||712
8629135|NCT03396432|21296838|P2|NOT COMPLETED|Overall Study||6
8629136|NCT03396432|21296839|P1|NOT COMPLETED|Overall Study||9
8629137|NCT03396432|21296838|P2|COMPLETED|Overall Study||277
8629138|NCT03396432|21296839|P1|COMPLETED|Overall Study||274
8629139|NCT03396432|21296838|P2|STARTED|Overall Study||283
8629140|NCT03396432|21296839|P1|STARTED|Overall Study||283
8629147|NCT03379545|21296862|P1|NOT COMPLETED|Overall Study||0
8629148|NCT03379545|21296862|P1|COMPLETED|Overall Study||29
8629149|NCT03379545|21296862|P1|STARTED|Overall Study||29
8629150|NCT03362957|21296869|P2|NOT COMPLETED|Overall Study||0
8629151|NCT03362957|21296870|P1|NOT COMPLETED|Overall Study||0
8629152|NCT03362957|21296869|P2|COMPLETED|Overall Study||7
8629153|NCT03362957|21296870|P1|COMPLETED|Overall Study||14
8629154|NCT03362957|21296869|P2|Crossover to Receive GAE Procedure|Overall Study||7
8629155|NCT03362957|21296870|P1|Crossover to Receive GAE Procedure|Overall Study||0
8629156|NCT03362957|21296869|P2|STARTED|Overall Study||7
8629157|NCT03362957|21296870|P1|STARTED|Overall Study||14
8629178|NCT03340415|21296938|P2|NOT COMPLETED|Overall Study||3
8629179|NCT03340415|21296939|P1|NOT COMPLETED|Overall Study||0
8629180|NCT03340415|21296938|P2|COMPLETED|Overall Study||21
8629181|NCT03340415|21296939|P1|COMPLETED|Overall Study||29
8629182|NCT03340415|21296938|P2|STARTED|Overall Study||24
8629183|NCT03340415|21296939|P1|STARTED|Overall Study||29
8629184|NCT03339245|21296961|P2|NOT COMPLETED|Overall Study||1
8629185|NCT03339245|21296962|P1|NOT COMPLETED|Overall Study||2
8629186|NCT03339245|21296961|P2|COMPLETED|Overall Study|1 withdrawn due to elevated glucose on baseline testing|6
8629187|NCT03339245|21296962|P1|COMPLETED|Overall Study|"1 withdrawn due to elevated glucose during pre-intervention testing
~1 withdrawn for personal reason"|4
8629188|NCT03339245|21296961|P2|STARTED|Overall Study||7
8629189|NCT03339245|21296962|P1|STARTED|Overall Study||6
8629190|NCT03338023|21296970|P2|NOT COMPLETED|Overall Study||10
8629191|NCT03338023|21296971|P1|NOT COMPLETED|Overall Study||9
8629192|NCT03338023|21296970|P2|COMPLETED|Overall Study||125
8629193|NCT03338023|21296971|P1|COMPLETED|Overall Study||128
8629194|NCT03338023|21296970|P2|Received at Least One Dose of Study Drug|Overall Study||135
8629195|NCT03338023|21296971|P1|Received at Least One Dose of Study Drug|Overall Study||137
8629196|NCT03338023|21296970|P2|STARTED|Overall Study||135
8629197|NCT03338023|21296971|P1|STARTED|Overall Study||137
8629198|NCT03332784|21297021|P20|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629199|NCT03332784|21297022|P19|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629200|NCT03332784|21297023|P18|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629201|NCT03332784|21297024|P17|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629202|NCT03332784|21297025|P16|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629203|NCT03332784|21297026|P15|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629204|NCT03332784|21297027|P14|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629205|NCT03332784|21297028|P13|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629206|NCT03332784|21297029|P12|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629207|NCT03332784|21297030|P11|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629208|NCT03332784|21297031|P10|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629209|NCT03332784|21297032|P9|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629210|NCT03332784|21297033|P8|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629211|NCT03332784|21297034|P7|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629212|NCT03332784|21297035|P6|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629213|NCT03332784|21297036|P5|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629214|NCT03332784|21297037|P4|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629215|NCT03332784|21297038|P3|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629216|NCT03332784|21297039|P2|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629217|NCT03332784|21297040|P1|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
8629218|NCT03332784|21297021|P20|COMPLETED|Part 1- Period 3 (1 Day)||0
8629219|NCT03332784|21297022|P19|COMPLETED|Part 1- Period 3 (1 Day)||0
8629220|NCT03332784|21297023|P18|COMPLETED|Part 1- Period 3 (1 Day)||0
8629221|NCT03332784|21297024|P17|COMPLETED|Part 1- Period 3 (1 Day)||0
8629222|NCT03332784|21297025|P16|COMPLETED|Part 1- Period 3 (1 Day)||0
8629223|NCT03332784|21297026|P15|COMPLETED|Part 1- Period 3 (1 Day)||0
8629224|NCT03332784|21297027|P14|COMPLETED|Part 1- Period 3 (1 Day)||0
8629225|NCT03332784|21297028|P13|COMPLETED|Part 1- Period 3 (1 Day)||0
8629226|NCT03332784|21297029|P12|COMPLETED|Part 1- Period 3 (1 Day)||0
8629227|NCT03332784|21297030|P11|COMPLETED|Part 1- Period 3 (1 Day)||0
8629228|NCT03332784|21297031|P10|COMPLETED|Part 1- Period 3 (1 Day)||0
8629229|NCT03332784|21297032|P9|COMPLETED|Part 1- Period 3 (1 Day)||0
8629230|NCT03332784|21297033|P8|COMPLETED|Part 1- Period 3 (1 Day)||2
8629231|NCT03332784|21297034|P7|COMPLETED|Part 1- Period 3 (1 Day)||2
8629232|NCT03332784|21297035|P6|COMPLETED|Part 1- Period 3 (1 Day)||2
8629233|NCT03332784|21297036|P5|COMPLETED|Part 1- Period 3 (1 Day)||2
8629234|NCT03332784|21297037|P4|COMPLETED|Part 1- Period 3 (1 Day)||2
8629235|NCT03332784|21297038|P3|COMPLETED|Part 1- Period 3 (1 Day)||2
8629236|NCT03332784|21297039|P2|COMPLETED|Part 1- Period 3 (1 Day)||1
8629237|NCT03332784|21297040|P1|COMPLETED|Part 1- Period 3 (1 Day)||2
8629238|NCT03332784|21297021|P20|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
8629239|NCT03332784|21297022|P19|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
8629240|NCT03332784|21297023|P18|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
8629241|NCT03332784|21297024|P17|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
8629242|NCT03332784|21297025|P16|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
8629243|NCT03332784|21297026|P15|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
8629244|NCT03332784|21297027|P14|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8629245|NCT03332784|21297028|P13|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8629246|NCT03332784|21297029|P12|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8629247|NCT03332784|21297030|P11|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8629248|NCT03332784|21297031|P10|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8629249|NCT03332784|21297032|P9|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8629250|NCT03332784|21297033|P8|STARTED|Part 1- Period 3 (1 Day)||2
8629251|NCT03332784|21297034|P7|STARTED|Part 1- Period 3 (1 Day)||2
8629252|NCT03332784|21297035|P6|STARTED|Part 1- Period 3 (1 Day)||2
8629253|NCT03332784|21297036|P5|STARTED|Part 1- Period 3 (1 Day)||2
8629254|NCT03332784|21297037|P4|STARTED|Part 1- Period 3 (1 Day)||2
8629255|NCT03332784|21297038|P3|STARTED|Part 1- Period 3 (1 Day)||2
8629256|NCT03332784|21297039|P2|STARTED|Part 1- Period 3 (1 Day)||1
8629257|NCT03332784|21297040|P1|STARTED|Part 1- Period 3 (1 Day)||2
8629258|NCT03332784|21297021|P20|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629259|NCT03332784|21297022|P19|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629260|NCT03332784|21297023|P18|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629261|NCT03332784|21297024|P17|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629262|NCT03332784|21297025|P16|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629263|NCT03332784|21297026|P15|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629264|NCT03332784|21297027|P14|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629265|NCT03332784|21297028|P13|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629266|NCT03332784|21297029|P12|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629267|NCT03332784|21297030|P11|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629268|NCT03332784|21297031|P10|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629269|NCT03332784|21297032|P9|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629270|NCT03332784|21297033|P8|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629271|NCT03332784|21297034|P7|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629272|NCT03332784|21297035|P6|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629273|NCT03332784|21297036|P5|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629274|NCT03332784|21297037|P4|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629275|NCT03332784|21297038|P3|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629276|NCT03332784|21297039|P2|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629277|NCT03332784|21297040|P1|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629278|NCT03332784|21297021|P20|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
8629279|NCT03332784|21297022|P19|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
8629280|NCT03332784|21297023|P18|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8629281|NCT03332784|21297024|P17|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8629282|NCT03332784|21297025|P16|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8629283|NCT03332784|21297026|P15|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
8629284|NCT03332784|21297027|P14|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629285|NCT03332784|21297028|P13|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629286|NCT03332784|21297029|P12|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629287|NCT03332784|21297030|P11|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629288|NCT03332784|21297031|P10|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629289|NCT03332784|21297032|P9|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
8629290|NCT03332784|21297033|P8|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8629291|NCT03332784|21297034|P7|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8629292|NCT03332784|21297035|P6|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8629293|NCT03332784|21297036|P5|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8629294|NCT03332784|21297037|P4|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8629295|NCT03332784|21297038|P3|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8629296|NCT03332784|21297039|P2|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
8629297|NCT03332784|21297040|P1|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
8629298|NCT03332784|21297021|P20|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
8629299|NCT03332784|21297022|P19|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
8629300|NCT03332784|21297023|P18|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8629301|NCT03332784|21297024|P17|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8629302|NCT03332784|21297025|P16|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8629303|NCT03332784|21297026|P15|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
8629304|NCT03332784|21297027|P14|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8629305|NCT03332784|21297028|P13|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8629306|NCT03332784|21297029|P12|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8629307|NCT03332784|21297030|P11|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8629308|NCT03332784|21297031|P10|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8629309|NCT03332784|21297032|P9|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
8629310|NCT03332784|21297033|P8|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8629311|NCT03332784|21297034|P7|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8629312|NCT03332784|21297035|P6|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8629313|NCT03332784|21297036|P5|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8629314|NCT03332784|21297037|P4|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8629315|NCT03332784|21297038|P3|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8629316|NCT03332784|21297039|P2|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
8629317|NCT03332784|21297040|P1|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
8629318|NCT03332784|21297021|P20|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629319|NCT03332784|21297022|P19|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629320|NCT03332784|21297023|P18|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629321|NCT03332784|21297024|P17|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629322|NCT03332784|21297025|P16|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629323|NCT03332784|21297026|P15|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
8629324|NCT03332784|21297027|P14|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629325|NCT03332784|21297028|P13|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629326|NCT03332784|21297029|P12|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629327|NCT03332784|21297030|P11|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629328|NCT03332784|21297031|P10|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629329|NCT03332784|21297032|P9|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629330|NCT03332784|21297033|P8|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629331|NCT03332784|21297034|P7|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629332|NCT03332784|21297035|P6|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629333|NCT03332784|21297036|P5|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629334|NCT03332784|21297037|P4|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629335|NCT03332784|21297038|P3|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629336|NCT03332784|21297039|P2|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
8629337|NCT03332784|21297040|P1|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
8629338|NCT03332784|21297021|P20|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
8629339|NCT03332784|21297022|P19|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
8629340|NCT03332784|21297023|P18|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8629341|NCT03332784|21297024|P17|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8629342|NCT03332784|21297025|P16|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8629343|NCT03332784|21297026|P15|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
8629344|NCT03332784|21297027|P14|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
8629345|NCT03332784|21297028|P13|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
8629346|NCT03332784|21297029|P12|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8629347|NCT03332784|21297030|P11|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
8629348|NCT03332784|21297031|P10|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
8629349|NCT03332784|21297032|P9|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
8629350|NCT03332784|21297033|P8|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8629351|NCT03332784|21297034|P7|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8629352|NCT03332784|21297035|P6|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8629353|NCT03332784|21297036|P5|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8629354|NCT03332784|21297037|P4|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8629355|NCT03332784|21297038|P3|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8629356|NCT03332784|21297039|P2|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
8629357|NCT03332784|21297040|P1|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
8629358|NCT03332784|21297021|P20|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
8629359|NCT03332784|21297022|P19|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
8629360|NCT03332784|21297023|P18|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
8629361|NCT03332784|21297024|P17|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
8629362|NCT03332784|21297025|P16|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
8629363|NCT03332784|21297026|P15|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
8629364|NCT03332784|21297027|P14|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
8629365|NCT03332784|21297028|P13|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
8629366|NCT03332784|21297029|P12|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8629367|NCT03332784|21297030|P11|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
8629368|NCT03332784|21297031|P10|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
8629369|NCT03332784|21297032|P9|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
8629370|NCT03332784|21297033|P8|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8629371|NCT03332784|21297034|P7|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8629372|NCT03332784|21297035|P6|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8629373|NCT03332784|21297036|P5|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8629374|NCT03332784|21297037|P4|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8629375|NCT03332784|21297038|P3|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8629376|NCT03332784|21297039|P2|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8629377|NCT03332784|21297040|P1|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
8629390|NCT03293654|21297316|P3|NOT COMPLETED|Overall Study||0
8629391|NCT03293654|21297317|P2|NOT COMPLETED|Overall Study||1
8629392|NCT03293654|21297318|P1|NOT COMPLETED|Overall Study||0
8629393|NCT03293654|21297316|P3|COMPLETED|Overall Study||38
8629394|NCT03293654|21297317|P2|COMPLETED|Overall Study||37
8629395|NCT03293654|21297318|P1|COMPLETED|Overall Study||38
8629396|NCT03293654|21297316|P3|STARTED|Overall Study||38
8629397|NCT03293654|21297317|P2|STARTED|Overall Study||38
8629398|NCT03293654|21297318|P1|STARTED|Overall Study||38
8629399|NCT03287674|21297356|P1|NOT COMPLETED|Overall Study||1
8629400|NCT03287674|21297356|P1|COMPLETED|Overall Study||6
8629401|NCT03287674|21297356|P1|All Treated With TILs|Overall Study||6
8629402|NCT03287674|21297356|P1|STARTED|Overall Study||7
8629403|NCT03278223|21297366|P2|NOT COMPLETED|Overall Study||4
8629404|NCT03278223|21297367|P1|NOT COMPLETED|Overall Study||3
8629405|NCT03278223|21297366|P2|COMPLETED|Overall Study||65
8629406|NCT03278223|21297367|P1|COMPLETED|Overall Study||122
8629407|NCT03278223|21297366|P2|STARTED|Overall Study||69
8629408|NCT03278223|21297367|P1|STARTED|Overall Study||125
8629417|NCT03273270|21297420|P2|NOT COMPLETED|Overall Study||0
8629418|NCT03273270|21297421|P1|NOT COMPLETED|Overall Study||0
8629419|NCT03273270|21297420|P2|COMPLETED|Overall Study||8
8629420|NCT03273270|21297421|P1|COMPLETED|Overall Study||12
8629421|NCT03273270|21297420|P2|STARTED|Overall Study||8
8629422|NCT03273270|21297421|P1|STARTED|Overall Study||12
8629423|NCT03261037|21297435|P4|NOT COMPLETED|Overall Study||28
8629424|NCT03261037|21297436|P3|NOT COMPLETED|Overall Study||0
8629425|NCT03261037|21297437|P2|NOT COMPLETED|Overall Study||21
8629426|NCT03261037|21297438|P1|NOT COMPLETED|Overall Study||4
8629427|NCT03261037|21297435|P4|COMPLETED|Overall Study||11
8629428|NCT03261037|21297436|P3|COMPLETED|Overall Study||9
8629429|NCT03261037|21297437|P2|COMPLETED|Overall Study||41
8629430|NCT03261037|21297438|P1|COMPLETED|Overall Study||64
8629431|NCT03261037|21297435|P4|STARTED|Overall Study||39
8629432|NCT03261037|21297436|P3|STARTED|Overall Study||9
8629433|NCT03261037|21297437|P2|STARTED|Overall Study||62
8629434|NCT03261037|21297438|P1|STARTED|Overall Study||68
8629435|NCT03250689|21297514|P2|NOT COMPLETED|Overall Study||0
8629436|NCT03250689|21297515|P1|NOT COMPLETED|Overall Study||0
8629437|NCT03250689|21297514|P2|COMPLETED|Overall Study||14
8629438|NCT03250689|21297515|P1|COMPLETED|Overall Study||5
8629439|NCT03250689|21297514|P2|STARTED|Overall Study||14
8629440|NCT03250689|21297515|P1|STARTED|Overall Study||5
8629441|NCT03241342|21297578|P3|NOT COMPLETED|Overall Study||27
8629442|NCT03241342|21297579|P2|NOT COMPLETED|Overall Study||31
8629443|NCT03241342|21297580|P1|NOT COMPLETED|Overall Study||22
8629444|NCT03241342|21297578|P3|COMPLETED|Overall Study||138
8629445|NCT03241342|21297579|P2|COMPLETED|Overall Study||132
8629446|NCT03241342|21297580|P1|COMPLETED|Overall Study||141
8629447|NCT03241342|21297578|P3|STARTED|Overall Study||165
8629448|NCT03241342|21297579|P2|STARTED|Overall Study||163
8629449|NCT03241342|21297580|P1|STARTED|Overall Study||163
8629456|NCT03224520|21297675|P4|NOT COMPLETED|Overall Study||173
8629457|NCT03224520|21297676|P3|NOT COMPLETED|Overall Study||184
8629458|NCT03224520|21297677|P2|NOT COMPLETED|Overall Study||163
8629459|NCT03224520|21297678|P1|NOT COMPLETED|Overall Study||166
8629460|NCT03224520|21297675|P4|COMPLETED|Overall Study||199
8629461|NCT03224520|21297676|P3|COMPLETED|Overall Study||190
8629462|NCT03224520|21297677|P2|COMPLETED|Overall Study||207
8629463|NCT03224520|21297678|P1|COMPLETED|Overall Study||205
8629464|NCT03224520|21297675|P4|STARTED|Overall Study||372
8629465|NCT03224520|21297676|P3|STARTED|Overall Study||374
8629466|NCT03224520|21297677|P2|STARTED|Overall Study||370
8629467|NCT03224520|21297678|P1|STARTED|Overall Study||371
8629468|NCT03206918|21297704|P1|NOT COMPLETED|Overall Study||6
8629469|NCT03206918|21297704|P1|COMPLETED|Overall Study||85
8629470|NCT03206918|21297704|P1|STARTED|Overall Study||91
8629471|NCT03199118|21297710|P2|NOT COMPLETED|Overall Study||0
8629472|NCT03199118|21297711|P1|NOT COMPLETED|Overall Study||0
8629473|NCT03199118|21297710|P2|COMPLETED|Overall Study|6 months follow-up|14
8629474|NCT03199118|21297711|P1|COMPLETED|Overall Study|6 months follow-up|14
8629475|NCT03199118|21297710|P2|STARTED|Overall Study||14
8629476|NCT03199118|21297711|P1|STARTED|Overall Study||14
8629477|NCT03191630|21297737|P2|NOT COMPLETED|Overall Study||7
8629478|NCT03191630|21297738|P1|NOT COMPLETED|Overall Study||7
8629479|NCT03191630|21297737|P2|COMPLETED|Overall Study||23
8629480|NCT03191630|21297738|P1|COMPLETED|Overall Study||23
8629481|NCT03191630|21297737|P2|STARTED|Overall Study||30
8629482|NCT03191630|21297738|P1|STARTED|Overall Study||30
8629483|NCT03189433|21297760|P2|NOT COMPLETED|Overall Study||0
8629484|NCT03189433|21297761|P1|NOT COMPLETED|Overall Study||2
8629485|NCT03189433|21297760|P2|COMPLETED|Overall Study||0
8629486|NCT03189433|21297761|P1|COMPLETED|Overall Study||0
8629487|NCT03189433|21297760|P2|STARTED|Overall Study||0
8629488|NCT03189433|21297761|P1|STARTED|Overall Study||2
8629489|NCT03183908|21297771|P2|NOT COMPLETED|Overall Study||2
8629490|NCT03183908|21297772|P1|NOT COMPLETED|Overall Study||0
8629491|NCT03183908|21297771|P2|COMPLETED|Overall Study||377
8629492|NCT03183908|21297772|P1|COMPLETED|Overall Study||378
8629493|NCT03183908|21297771|P2|STARTED|Overall Study||379
8629494|NCT03183908|21297772|P1|STARTED|Overall Study||378
8629495|NCT03178045|21297834|P2|NOT COMPLETED|Overall Study||83
8629496|NCT03178045|21297835|P1|NOT COMPLETED|Overall Study||86
8629497|NCT03178045|21297834|P2|COMPLETED|Overall Study||1314
8629498|NCT03178045|21297835|P1|COMPLETED|Overall Study||1310
8629499|NCT03178045|21297834|P2|STARTED|Overall Study||1397
8629500|NCT03178045|21297835|P1|STARTED|Overall Study||1396
8629501|NCT03162328|21297860|P3|NOT COMPLETED|Study Period||1
8629502|NCT03162328|21297861|P2|NOT COMPLETED|Study Period||0
8629503|NCT03162328|21297862|P1|NOT COMPLETED|Study Period||0
8629504|NCT03162328|21297860|P3|COMPLETED|Study Period||31
8629505|NCT03162328|21297861|P2|COMPLETED|Study Period||30
8629506|NCT03162328|21297862|P1|COMPLETED|Study Period||0
8629507|NCT03162328|21297860|P3|STARTED|Study Period||32
8629508|NCT03162328|21297861|P2|STARTED|Study Period||30
8629509|NCT03162328|21297862|P1|STARTED|Study Period||0
8629510|NCT03162328|21297860|P3|NOT COMPLETED|Screening Period||0
8629511|NCT03162328|21297861|P2|NOT COMPLETED|Screening Period||0
8629512|NCT03162328|21297862|P1|NOT COMPLETED|Screening Period||22
8629513|NCT03162328|21297860|P3|COMPLETED|Screening Period||0
8629514|NCT03162328|21297861|P2|COMPLETED|Screening Period||0
8629515|NCT03162328|21297862|P1|COMPLETED|Screening Period||62
8629516|NCT03162328|21297860|P3|STARTED|Screening Period||0
8629517|NCT03162328|21297861|P2|STARTED|Screening Period||0
8629518|NCT03162328|21297862|P1|STARTED|Screening Period||84
8629519|NCT03111316|21297893|P4|NOT COMPLETED|Overall Study||0
8629520|NCT03111316|21297894|P3|NOT COMPLETED|Overall Study||0
8629521|NCT03111316|21297895|P2|NOT COMPLETED|Overall Study||0
8629522|NCT03111316|21297896|P1|NOT COMPLETED|Overall Study||0
8629523|NCT03111316|21297893|P4|COMPLETED|Overall Study||25
8629524|NCT03111316|21297894|P3|COMPLETED|Overall Study||25
8629525|NCT03111316|21297895|P2|COMPLETED|Overall Study||24
8629526|NCT03111316|21297896|P1|COMPLETED|Overall Study||26
8629527|NCT03111316|21297893|P4|STARTED|Overall Study||25
8629528|NCT03111316|21297894|P3|STARTED|Overall Study||25
8629529|NCT03111316|21297895|P2|STARTED|Overall Study||24
8629530|NCT03111316|21297896|P1|STARTED|Overall Study||26
8629531|NCT03110380|21297912|P2|NOT COMPLETED|Overall Study||283
8629532|NCT03110380|21297913|P1|NOT COMPLETED|Overall Study||284
8629533|NCT03110380|21297912|P2|COMPLETED|Overall Study||0
8629534|NCT03110380|21297913|P1|COMPLETED|Overall Study||0
8629535|NCT03110380|21297912|P2|STARTED|Overall Study||283
8629536|NCT03110380|21297913|P1|STARTED|Overall Study||284
8629537|NCT03098433|21297923|P1|NOT COMPLETED|Overall Study||10
8629538|NCT03098433|21297923|P1|COMPLETED|Overall Study||12
8629539|NCT03098433|21297923|P1|STARTED|Overall Study||22
8629540|NCT03097653|21297930|P2|NOT COMPLETED|Overall Study||0
8629541|NCT03097653|21297931|P1|NOT COMPLETED|Overall Study||0
8629542|NCT03097653|21297930|P2|COMPLETED|Overall Study||529
8629543|NCT03097653|21297931|P1|COMPLETED|Overall Study||472
8629544|NCT03097653|21297930|P2|STARTED|Overall Study||529
8629545|NCT03097653|21297931|P1|STARTED|Overall Study||472
8629546|NCT03091738|21297952|P1|NOT COMPLETED|Overall Study||2
8629547|NCT03091738|21297952|P1|COMPLETED|Overall Study||8
8629548|NCT03091738|21297952|P1|STARTED|Overall Study||10
8629549|NCT03088800|21297961|P3|NOT COMPLETED|Overall Study||0
8629550|NCT03088800|21297962|P2|NOT COMPLETED|Overall Study||0
8629551|NCT03088800|21297963|P1|NOT COMPLETED|Overall Study||0
8629552|NCT03088800|21297961|P3|COMPLETED|Overall Study||30
8629553|NCT03088800|21297962|P2|COMPLETED|Overall Study||30
8629554|NCT03088800|21297963|P1|COMPLETED|Overall Study||30
8629555|NCT03088800|21297961|P3|STARTED|Overall Study||30
8629556|NCT03088800|21297962|P2|STARTED|Overall Study||30
8629557|NCT03088800|21297963|P1|STARTED|Overall Study||30
8629558|NCT03085758|21297974|P3|NOT COMPLETED|Overall Study||56
8629559|NCT03085758|21297975|P2|NOT COMPLETED|Overall Study||28
8629560|NCT03085758|21297976|P1|NOT COMPLETED|Overall Study||29
8629561|NCT03085758|21297974|P3|COMPLETED|Overall Study||96
8629562|NCT03085758|21297975|P2|COMPLETED|Overall Study||49
8629563|NCT03085758|21297976|P1|COMPLETED|Overall Study||43
8629564|NCT03085758|21297974|P3|STARTED|Overall Study||152
8629565|NCT03085758|21297975|P2|STARTED|Overall Study||77
8629566|NCT03085758|21297976|P1|STARTED|Overall Study||72
8629590|NCT03076333|21298278|P1|NOT COMPLETED|Overall Study||0
8629591|NCT03076333|21298278|P1|COMPLETED|Overall Study||3
8629592|NCT03076333|21298278|P1|STARTED|Overall Study||3
8629593|NCT03065179|21298283|P1|NOT COMPLETED|Overall Study||0
8629594|NCT03065179|21298283|P1|COMPLETED|Overall Study||25
8629595|NCT03065179|21298283|P1|STARTED|Overall Study||25
8629596|NCT03063255|21298291|P2|NOT COMPLETED|Overall Study||0
8629597|NCT03063255|21298292|P1|NOT COMPLETED|Overall Study||1
8629598|NCT03063255|21298291|P2|COMPLETED|Overall Study||30
8629599|NCT03063255|21298292|P1|COMPLETED|Overall Study||29
8629600|NCT03063255|21298291|P2|STARTED|Overall Study||30
8629601|NCT03063255|21298292|P1|STARTED|Overall Study||30
8629602|NCT03042312|21298304|P2|NOT COMPLETED|Overall Study||12
8629603|NCT03042312|21298305|P1|NOT COMPLETED|Overall Study||10
8629604|NCT03042312|21298304|P2|COMPLETED|Overall Study||31
8629605|NCT03042312|21298305|P1|COMPLETED|Overall Study||18
8629606|NCT03042312|21298304|P2|Safety Population|Overall Study||41
8629607|NCT03042312|21298305|P1|Safety Population|Overall Study||23
8629608|NCT03042312|21298304|P2|STARTED|Overall Study||43
8629609|NCT03042312|21298305|P1|STARTED|Overall Study||28
8629610|NCT03020082|21298329|P1|NOT COMPLETED|Overall Study||3
8629611|NCT03020082|21298329|P1|COMPLETED|Overall Study||138
8629612|NCT03020082|21298329|P1|STARTED|Overall Study||141
8629613|NCT03010488|21298335|P2|NOT COMPLETED|Overall Study||7
8629614|NCT03010488|21298336|P1|NOT COMPLETED|Overall Study||5
8629615|NCT03010488|21298335|P2|COMPLETED|Overall Study||15
8629616|NCT03010488|21298336|P1|COMPLETED|Overall Study||17
8629617|NCT03010488|21298335|P2|STARTED|Overall Study||22
8629618|NCT03010488|21298336|P1|STARTED|Overall Study||22
8629619|NCT03003949|21298346|P2|NOT COMPLETED|Overall Study||10
8629620|NCT03003949|21298347|P1|NOT COMPLETED|Overall Study||5
8629621|NCT03003949|21298346|P2|COMPLETED|Overall Study||32
8629622|NCT03003949|21298347|P1|COMPLETED|Overall Study||35
8629623|NCT03003949|21298346|P2|Week 24|Overall Study||32
8629624|NCT03003949|21298347|P1|Week 24|Overall Study||35
8629625|NCT03003949|21298346|P2|Week 20|Overall Study||33
8629626|NCT03003949|21298347|P1|Week 20|Overall Study||35
8629627|NCT03003949|21298346|P2|Week 16|Overall Study||35
8629628|NCT03003949|21298347|P1|Week 16|Overall Study||38
8629629|NCT03003949|21298346|P2|Week 8|Overall Study||42
8629630|NCT03003949|21298347|P1|Week 8|Overall Study||40
8629631|NCT03003949|21298346|P2|STARTED|Overall Study||42
8629632|NCT03003949|21298347|P1|STARTED|Overall Study||40
8629633|NCT02983825|21298361|P1|NOT COMPLETED|Overall Study||3
8629634|NCT02983825|21298361|P1|COMPLETED|Overall Study|Of 12 subjects starting intervention, 3 met specified stopping critieria|9
8629635|NCT02983825|21298361|P1|STARTED|Overall Study|Of 21 enrolled subjects, 9 became ineligible for between consent and intervention|12
8629636|NCT02971228|21298366|P5|NOT COMPLETED|Overall Study||0
8629637|NCT02971228|21298367|P4|NOT COMPLETED|Overall Study||0
8629638|NCT02971228|21298368|P3|NOT COMPLETED|Overall Study||0
8629639|NCT02971228|21298369|P2|NOT COMPLETED|Overall Study||2
8629640|NCT02971228|21298370|P1|NOT COMPLETED|Overall Study||1
8629641|NCT02971228|21298366|P5|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
8629642|NCT02971228|21298367|P4|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
8629643|NCT02971228|21298368|P3|COMPLETED|Overall Study||5
8629644|NCT02971228|21298369|P2|COMPLETED|Overall Study||5
8629645|NCT02971228|21298370|P1|COMPLETED|Overall Study||0
8629646|NCT02971228|21298366|P5|Randomized and Treated|Overall Study||0
8629647|NCT02971228|21298367|P4|Randomized and Treated|Overall Study||0
8629648|NCT02971228|21298368|P3|Randomized and Treated|Overall Study||5
8629649|NCT02971228|21298369|P2|Randomized and Treated|Overall Study||7
8629650|NCT02971228|21298370|P1|Randomized and Treated|Overall Study||0
8629651|NCT02971228|21298366|P5|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
8629652|NCT02971228|21298367|P4|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
8629653|NCT02971228|21298368|P3|STARTED|Overall Study||5
8629654|NCT02971228|21298369|P2|STARTED|Overall Study||7
8629655|NCT02971228|21298370|P1|STARTED|Overall Study||1
8629656|NCT02965989|21298414|P2|NOT COMPLETED|Overall Study||0
8629657|NCT02965989|21298415|P1|NOT COMPLETED|Overall Study||0
8629658|NCT02965989|21298414|P2|COMPLETED|Overall Study||22
8629659|NCT02965989|21298415|P1|COMPLETED|Overall Study||26
8629660|NCT02965989|21298414|P2|STARTED|Overall Study||22
8629661|NCT02965989|21298415|P1|STARTED|Overall Study||26
8629665|NCT02936076|21298447|P2|NOT COMPLETED|Overall Study||4
8629666|NCT02936076|21298448|P1|NOT COMPLETED|Overall Study||6
8629667|NCT02936076|21298447|P2|COMPLETED|Overall Study||20
8629668|NCT02936076|21298448|P1|COMPLETED|Overall Study||19
8629669|NCT02936076|21298447|P2|STARTED|Overall Study||24
8629670|NCT02936076|21298448|P1|STARTED|Overall Study||25
8629671|NCT02924688|21298466|P6|NOT COMPLETED|Overall Study||24
8629672|NCT02924688|21298467|P5|NOT COMPLETED|Overall Study||23
8629673|NCT02924688|21298468|P4|NOT COMPLETED|Overall Study||28
8629674|NCT02924688|21298469|P3|NOT COMPLETED|Overall Study||23
8629675|NCT02924688|21298470|P2|NOT COMPLETED|Overall Study||31
8629676|NCT02924688|21298471|P1|NOT COMPLETED|Overall Study||33
8629677|NCT02924688|21298466|P6|COMPLETED|Overall Study||384
8629678|NCT02924688|21298467|P5|COMPLETED|Overall Study||381
8629679|NCT02924688|21298468|P4|COMPLETED|Overall Study||378
8629680|NCT02924688|21298469|P3|COMPLETED|Overall Study||383
8629681|NCT02924688|21298470|P2|COMPLETED|Overall Study||374
8629682|NCT02924688|21298471|P1|COMPLETED|Overall Study||374
8629683|NCT02924688|21298466|P6|STARTED|Overall Study||408
8629684|NCT02924688|21298467|P5|STARTED|Overall Study||404
8629685|NCT02924688|21298468|P4|STARTED|Overall Study||406
8629686|NCT02924688|21298469|P3|STARTED|Overall Study||406
8629687|NCT02924688|21298470|P2|STARTED|Overall Study||405
8629688|NCT02924688|21298471|P1|STARTED|Overall Study||407
8629689|NCT02911116|21298541|P2|NOT COMPLETED|Overall Study||1
8629690|NCT02911116|21298542|P1|NOT COMPLETED|Overall Study||1
8629691|NCT02911116|21298541|P2|COMPLETED|Overall Study||2
8629692|NCT02911116|21298542|P1|COMPLETED|Overall Study||4
8629693|NCT02911116|21298541|P2|STARTED|Overall Study||3
8629694|NCT02911116|21298542|P1|STARTED|Overall Study||5
8629695|NCT02895100|21298594|P4|NOT COMPLETED|Overall Study||10
8629696|NCT02895100|21298595|P3|NOT COMPLETED|Overall Study||8
8629697|NCT02895100|21298596|P2|NOT COMPLETED|Overall Study||11
8629698|NCT02895100|21298597|P1|NOT COMPLETED|Overall Study||11
8629699|NCT02895100|21298594|P4|COMPLETED|Overall Study||15
8629700|NCT02895100|21298595|P3|COMPLETED|Overall Study||15
8629701|NCT02895100|21298596|P2|COMPLETED|Overall Study||14
8629702|NCT02895100|21298597|P1|COMPLETED|Overall Study||14
8629703|NCT02895100|21298594|P4|STARTED|Overall Study||25
8629704|NCT02895100|21298595|P3|STARTED|Overall Study||23
8629705|NCT02895100|21298596|P2|STARTED|Overall Study||25
8629706|NCT02895100|21298597|P1|STARTED|Overall Study||25
8629707|NCT02870972|21298612|P5|NOT COMPLETED|Overall Study||0
8629708|NCT02870972|21298613|P4|NOT COMPLETED|Overall Study||0
8629709|NCT02870972|21298614|P3|NOT COMPLETED|Overall Study||0
8629710|NCT02870972|21298615|P2|NOT COMPLETED|Overall Study||0
8629711|NCT02870972|21298616|P1|NOT COMPLETED|Overall Study||1
8629712|NCT02870972|21298612|P5|COMPLETED|Overall Study||22
8629713|NCT02870972|21298613|P4|COMPLETED|Overall Study||7
8629714|NCT02870972|21298614|P3|COMPLETED|Overall Study||14
8629715|NCT02870972|21298615|P2|COMPLETED|Overall Study||14
8629716|NCT02870972|21298616|P1|COMPLETED|Overall Study||17
8629717|NCT02870972|21298612|P5|STARTED|Overall Study||22
8629718|NCT02870972|21298613|P4|STARTED|Overall Study||7
8629719|NCT02870972|21298614|P3|STARTED|Overall Study||14
8629720|NCT02870972|21298615|P2|STARTED|Overall Study||14
8629721|NCT02870972|21298616|P1|STARTED|Overall Study||18
8629725|NCT02856802|21298700|P2|NOT COMPLETED|Double-Blind Treatment Period 2||0
8629726|NCT02856802|21298701|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
8629727|NCT02856802|21298700|P2|COMPLETED|Double-Blind Treatment Period 2||38
8629728|NCT02856802|21298701|P1|COMPLETED|Double-Blind Treatment Period 2||36
8629729|NCT02856802|21298700|P2|STARTED|Double-Blind Treatment Period 2|5 of 43 re-randomized subjects did not start; 4 had no migraines, for 1 prohibited drug use.|38
8629730|NCT02856802|21298701|P1|STARTED|Double-Blind Treatment Period 2|6 of 43 re-randomized subjects did not start; 5 had no migraines, for 1 protocol deviation.|37
8629731|NCT02856802|21298700|P2|NOT COMPLETED|Double-Blind Treatment Period 1||5
8629732|NCT02856802|21298701|P1|NOT COMPLETED|Double-Blind Treatment Period 1||2
8629733|NCT02856802|21298700|P2|COMPLETED|Double-Blind Treatment Period 1||38
8629734|NCT02856802|21298701|P1|COMPLETED|Double-Blind Treatment Period 1||48
8629735|NCT02856802|21298700|P2|STARTED|Double-Blind Treatment Period 1|10 of 53 randomized subjects did not start; 6 had no migraines, 3 withdrew, 1 sponsor terminated.|43
8629736|NCT02856802|21298701|P1|STARTED|Double-Blind Treatment Period 1|4 of 54 randomized subjects did not start; 2 had no migraines, 1 withdrew, 1 lost to follow-up.|50
8629737|NCT02833974|21298715|P2|NOT COMPLETED|Overall Study||3
8629738|NCT02833974|21298716|P1|NOT COMPLETED|Overall Study||1
8629739|NCT02833974|21298715|P2|COMPLETED|Overall Study||19
8629740|NCT02833974|21298716|P1|COMPLETED|Overall Study||13
8629741|NCT02833974|21298715|P2|STARTED|Overall Study||22
8629742|NCT02833974|21298716|P1|STARTED|Overall Study||14
8629752|NCT02782065|21298774|P1|NOT COMPLETED|Overall Study||0
8629753|NCT02782065|21298774|P1|COMPLETED|Overall Study||58
8629754|NCT02782065|21298774|P1|STARTED|Overall Study||58
8629755|NCT02777970|21298785|P3|NOT COMPLETED|Overall Study||0
8629756|NCT02777970|21298786|P2|NOT COMPLETED|Overall Study||1
8629757|NCT02777970|21298787|P1|NOT COMPLETED|Overall Study||1
8629758|NCT02777970|21298785|P3|COMPLETED|Overall Study||131
8629759|NCT02777970|21298786|P2|COMPLETED|Overall Study||261
8629760|NCT02777970|21298787|P1|COMPLETED|Overall Study||260
8629761|NCT02777970|21298785|P3|STARTED|Overall Study||131
8629762|NCT02777970|21298786|P2|STARTED|Overall Study||262
8629763|NCT02777970|21298787|P1|STARTED|Overall Study||261
8629764|NCT02762994|21298813|P4|NOT COMPLETED|Overall Study||2
8629765|NCT02762994|21298814|P3|NOT COMPLETED|Overall Study||2
8629766|NCT02762994|21298815|P2|NOT COMPLETED|Overall Study||1
8629767|NCT02762994|21298816|P1|NOT COMPLETED|Overall Study||1
8629768|NCT02762994|21298813|P4|COMPLETED|Overall Study||26
8629769|NCT02762994|21298814|P3|COMPLETED|Overall Study||28
8629770|NCT02762994|21298815|P2|COMPLETED|Overall Study||30
8629771|NCT02762994|21298816|P1|COMPLETED|Overall Study||30
8629772|NCT02762994|21298813|P4|STARTED|Overall Study||28
8629773|NCT02762994|21298814|P3|STARTED|Overall Study||30
8629774|NCT02762994|21298815|P2|STARTED|Overall Study||31
8629775|NCT02762994|21298816|P1|STARTED|Overall Study||31
8629776|NCT02756572|21298878|P1|NOT COMPLETED|Overall Study||0
8629777|NCT02756572|21298878|P1|COMPLETED|Overall Study||30
8629778|NCT02756572|21298878|P1|STARTED|Overall Study||30
8629779|NCT02750514|21298891|P5|NOT COMPLETED|Track 5||43
8629780|NCT02750514|21298892|P4|NOT COMPLETED|Track 5||0
8629781|NCT02750514|21298893|P3|NOT COMPLETED|Track 5||0
8629782|NCT02750514|21298894|P2|NOT COMPLETED|Track 5||0
8629783|NCT02750514|21298895|P1|NOT COMPLETED|Track 5||0
8629784|NCT02750514|21298891|P5|COMPLETED|Track 5||0
8629785|NCT02750514|21298892|P4|COMPLETED|Track 5||0
8629786|NCT02750514|21298893|P3|COMPLETED|Track 5||0
8629787|NCT02750514|21298894|P2|COMPLETED|Track 5||0
8629788|NCT02750514|21298895|P1|COMPLETED|Track 5||0
8629789|NCT02750514|21298891|P5|STARTED|Track 5|6 participants had prior treatment in track 1 (1 part.), 2 (2 part.), 3 (2 part.) or 4 (1 part.)|43
8629790|NCT02750514|21298892|P4|STARTED|Track 5||0
8629791|NCT02750514|21298893|P3|STARTED|Track 5||0
8629792|NCT02750514|21298894|P2|STARTED|Track 5||0
8629793|NCT02750514|21298895|P1|STARTED|Track 5||0
8629794|NCT02750514|21298891|P5|NOT COMPLETED|Track 4||0
8629795|NCT02750514|21298892|P4|NOT COMPLETED|Track 4||42
8629796|NCT02750514|21298893|P3|NOT COMPLETED|Track 4||0
8629797|NCT02750514|21298894|P2|NOT COMPLETED|Track 4||51
8629798|NCT02750514|21298895|P1|NOT COMPLETED|Track 4||0
8629799|NCT02750514|21298891|P5|COMPLETED|Track 4||0
8629800|NCT02750514|21298892|P4|COMPLETED|Track 4||18
8629801|NCT02750514|21298893|P3|COMPLETED|Track 4||0
8629802|NCT02750514|21298894|P2|COMPLETED|Track 4|1 participant was re-randomized to track 5|2
8629803|NCT02750514|21298895|P1|COMPLETED|Track 4||0
8629804|NCT02750514|21298891|P5|STARTED|Track 4||0
8629805|NCT02750514|21298892|P4|STARTED|Track 4||60
8629806|NCT02750514|21298893|P3|STARTED|Track 4||0
8629807|NCT02750514|21298894|P2|STARTED|Track 4||53
8629808|NCT02750514|21298895|P1|STARTED|Track 4||0
8629809|NCT02750514|21298891|P5|NOT COMPLETED|Track 3||0
8629810|NCT02750514|21298892|P4|NOT COMPLETED|Track 3||16
8629811|NCT02750514|21298893|P3|NOT COMPLETED|Track 3||15
8629812|NCT02750514|21298894|P2|NOT COMPLETED|Track 3||36
8629813|NCT02750514|21298895|P1|NOT COMPLETED|Track 3||0
8629814|NCT02750514|21298891|P5|COMPLETED|Track 3||0
8629815|NCT02750514|21298892|P4|COMPLETED|Track 3|1 participant was re-randomized to track 5|2
8629816|NCT02750514|21298893|P3|COMPLETED|Track 3||1
8629817|NCT02750514|21298894|P2|COMPLETED|Track 3|6 participants were re-randomized to track 3 (5 part.) or to track 5 (1 part.)|5
8629818|NCT02750514|21298895|P1|COMPLETED|Track 3||0
8629819|NCT02750514|21298891|P5|STARTED|Track 3||0
8629820|NCT02750514|21298892|P4|STARTED|Track 3|5 participants had prior treatment in track 1 (1 part.) or track 3 (4 part.)|18
8629821|NCT02750514|21298893|P3|STARTED|Track 3|1 participant had prior treatment in track 3|16
8629822|NCT02750514|21298894|P2|STARTED|Track 3|2 participants had prior treatment in track 1 (1 part.) or track 2 (1 part.)|41
8629823|NCT02750514|21298895|P1|STARTED|Track 3||0
8629824|NCT02750514|21298891|P5|NOT COMPLETED|Track 2||0
8629825|NCT02750514|21298892|P4|NOT COMPLETED|Track 2||7
8629826|NCT02750514|21298893|P3|NOT COMPLETED|Track 2||2
8629827|NCT02750514|21298894|P2|NOT COMPLETED|Track 2||8
8629828|NCT02750514|21298895|P1|NOT COMPLETED|Track 2||6
8629829|NCT02750514|21298891|P5|COMPLETED|Track 2||0
8629830|NCT02750514|21298892|P4|COMPLETED|Track 2|1 participant was re-randomized to track 5|5
8629831|NCT02750514|21298893|P3|COMPLETED|Track 2||0
8629832|NCT02750514|21298894|P2|COMPLETED|Track 2||0
8629833|NCT02750514|21298895|P1|COMPLETED|Track 2|2 participants were re-randomized to track 3 (1 part.) or track 5 (1 part.)|3
8629834|NCT02750514|21298891|P5|STARTED|Track 2||0
8629835|NCT02750514|21298892|P4|STARTED|Track 2||12
8629836|NCT02750514|21298893|P3|STARTED|Track 2||2
8629837|NCT02750514|21298894|P2|STARTED|Track 2||8
8629838|NCT02750514|21298895|P1|STARTED|Track 2||9
8629839|NCT02750514|21298891|P5|NOT COMPLETED|Track 1||0
8629840|NCT02750514|21298892|P4|NOT COMPLETED|Track 1||2
8629841|NCT02750514|21298893|P3|NOT COMPLETED|Track 1||0
8629842|NCT02750514|21298894|P2|NOT COMPLETED|Track 1||2
8629843|NCT02750514|21298895|P1|NOT COMPLETED|Track 1||27
8629844|NCT02750514|21298891|P5|COMPLETED|Track 1||0
8629845|NCT02750514|21298892|P4|COMPLETED|Track 1||1
8629846|NCT02750514|21298893|P3|COMPLETED|Track 1||0
8629847|NCT02750514|21298894|P2|COMPLETED|Track 1||2
8629848|NCT02750514|21298895|P1|COMPLETED|Track 1|3 participants were re-randomized to track 3 (2 part.) or track 5 (1 part.)|13
8629849|NCT02750514|21298891|P5|STARTED|Track 1||0
8629850|NCT02750514|21298892|P4|STARTED|Track 1||3
8629851|NCT02750514|21298893|P3|STARTED|Track 1||0
8629852|NCT02750514|21298894|P2|STARTED|Track 1||4
8629853|NCT02750514|21298895|P1|STARTED|Track 1||40
8629854|NCT02743442|21298955|P1|NOT COMPLETED|Overall Study||0
8629855|NCT02743442|21298955|P1|COMPLETED|Overall Study||8
8629856|NCT02743442|21298955|P1|STARTED|Overall Study||8
8629857|NCT02730130|21298959|P1|NOT COMPLETED|Overall Study||0
8629858|NCT02730130|21298959|P1|COMPLETED|Overall Study||17
8629859|NCT02730130|21298959|P1|STARTED|Overall Study||17
8629860|NCT02721979|21298965|P1|NOT COMPLETED|Overall Study||1
8629861|NCT02721979|21298965|P1|COMPLETED|Overall Study||22
8629862|NCT02721979|21298965|P1|STARTED|Overall Study||23
8629863|NCT02707770|21298972|P2|NOT COMPLETED|Overall Study||0
8629864|NCT02707770|21298973|P1|NOT COMPLETED|Overall Study||1
8629865|NCT02707770|21298972|P2|COMPLETED|Overall Study||10
8629866|NCT02707770|21298973|P1|COMPLETED|Overall Study|One patient withdrew from the study following consent, initial assessment and randomisation|9
8629867|NCT02707770|21298972|P2|STARTED|Overall Study||10
8629868|NCT02707770|21298973|P1|STARTED|Overall Study||10
8629869|NCT02697071|21298993|P2|NOT COMPLETED|Overall Study||0
8629870|NCT02697071|21298994|P1|NOT COMPLETED|Overall Study||0
8629871|NCT02697071|21298993|P2|COMPLETED|Overall Study||16
8629872|NCT02697071|21298994|P1|COMPLETED|Overall Study||18
8629873|NCT02697071|21298993|P2|STARTED|Overall Study||16
8629874|NCT02697071|21298994|P1|STARTED|Overall Study||18
8629875|NCT02689518|21299004|P1|NOT COMPLETED|Overall Study||3
8629876|NCT02689518|21299004|P1|COMPLETED|Overall Study||46
8629877|NCT02689518|21299004|P1|STARTED|Overall Study||49
8629878|NCT02689076|21299013|P3|NOT COMPLETED|Overall Study||0
8629879|NCT02689076|21299014|P2|NOT COMPLETED|Overall Study||222
8629880|NCT02689076|21299015|P1|NOT COMPLETED|Overall Study||181
8629881|NCT02689076|21299013|P3|COMPLETED|Overall Study||191
8629882|NCT02689076|21299014|P2|COMPLETED|Overall Study||115
8629883|NCT02689076|21299015|P1|COMPLETED|Overall Study||87
8629884|NCT02689076|21299013|P3|STARTED|Overall Study||191
8629885|NCT02689076|21299014|P2|STARTED|Overall Study||337
8629886|NCT02689076|21299015|P1|STARTED|Overall Study||268
8629887|NCT02679911|21299030|P1|NOT COMPLETED|Overall Study||0
8629888|NCT02679911|21299030|P1|COMPLETED|Overall Study||20
8629889|NCT02679911|21299030|P1|STARTED|Overall Study|Intra-individual study|20
8629906|NCT02673203|21299079|P2|NOT COMPLETED|Overall Study||0
8629907|NCT02673203|21299080|P1|NOT COMPLETED|Overall Study||0
8629908|NCT02673203|21299079|P2|COMPLETED|Overall Study||15
8629909|NCT02673203|21299080|P1|COMPLETED|Overall Study||16
8629910|NCT02673203|21299079|P2|STARTED|Overall Study||15
8629911|NCT02673203|21299080|P1|STARTED|Overall Study||16
8629912|NCT02670122|21299102|P1|NOT COMPLETED|Overall Study||4
8629913|NCT02670122|21299102|P1|COMPLETED|Overall Study|18 patients recieved liver transplantation|127
8629914|NCT02670122|21299102|P1|STARTED|Overall Study||131
8629915|NCT02662582|21299115|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8629916|NCT02662582|21299116|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
8629917|NCT02662582|21299115|P2|COMPLETED|Treatment Period 2 (14 Days)||19
8629918|NCT02662582|21299116|P1|COMPLETED|Treatment Period 2 (14 Days)||18
8629919|NCT02662582|21299115|P2|STARTED|Treatment Period 2 (14 Days)||19
8629920|NCT02662582|21299116|P1|STARTED|Treatment Period 2 (14 Days)||18
8629921|NCT02662582|21299115|P2|NOT COMPLETED|Washout Period (14 Days)||0
8629922|NCT02662582|21299116|P1|NOT COMPLETED|Washout Period (14 Days)||0
8629923|NCT02662582|21299115|P2|COMPLETED|Washout Period (14 Days)||19
8629924|NCT02662582|21299116|P1|COMPLETED|Washout Period (14 Days)||18
8629925|NCT02662582|21299115|P2|STARTED|Washout Period (14 Days)||19
8629926|NCT02662582|21299116|P1|STARTED|Washout Period (14 Days)||18
8629927|NCT02662582|21299115|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||4
8629928|NCT02662582|21299116|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||5
8629929|NCT02662582|21299115|P2|COMPLETED|Treatment Period 1 (14 Days)||19
8629930|NCT02662582|21299116|P1|COMPLETED|Treatment Period 1 (14 Days)||18
8629931|NCT02662582|21299115|P2|STARTED|Treatment Period 1 (14 Days)||23
8629932|NCT02662582|21299116|P1|STARTED|Treatment Period 1 (14 Days)||23
8629933|NCT02640625|21299170|P1|NOT COMPLETED|Overall Study||1
8629934|NCT02640625|21299170|P1|COMPLETED|Overall Study||19
8629935|NCT02640625|21299170|P1|STARTED|Overall Study||20
8629936|NCT02637076|21299178|P2|NOT COMPLETED|Overall Study||5
8629937|NCT02637076|21299179|P1|NOT COMPLETED|Overall Study||1
8629938|NCT02637076|21299178|P2|COMPLETED|Overall Study||10
8629939|NCT02637076|21299179|P1|COMPLETED|Overall Study||1
8629940|NCT02637076|21299178|P2|STARTED|Overall Study||15
8629941|NCT02637076|21299179|P1|STARTED|Overall Study||2
8629942|NCT02635724|21299204|P3|NOT COMPLETED|Overall Study||0
8629943|NCT02635724|21299205|P2|NOT COMPLETED|Overall Study||1
8629944|NCT02635724|21299206|P1|NOT COMPLETED|Overall Study||0
8629945|NCT02635724|21299204|P3|COMPLETED|Overall Study||7
8629946|NCT02635724|21299205|P2|COMPLETED|Overall Study||25
8629947|NCT02635724|21299206|P1|COMPLETED|Overall Study||41
8629948|NCT02635724|21299204|P3|E-R Population|Overall Study||5
8629949|NCT02635724|21299205|P2|E-R Population|Overall Study||19
8629950|NCT02635724|21299206|P1|E-R Population|Overall Study||28
8629951|NCT02635724|21299204|P3|ITTI Population|Overall Study||5
8629952|NCT02635724|21299205|P2|ITTI Population|Overall Study||19
8629953|NCT02635724|21299206|P1|ITTI Population|Overall Study||28
8629954|NCT02635724|21299204|P3|Safety Population|Overall Study||7
8629955|NCT02635724|21299205|P2|Safety Population|Overall Study||25
8629956|NCT02635724|21299206|P1|Safety Population|Overall Study||41
8629957|NCT02635724|21299204|P3|ITT Population|Overall Study||7
8629958|NCT02635724|21299205|P2|ITT Population|Overall Study||26
8629959|NCT02635724|21299206|P1|ITT Population|Overall Study||41
8629960|NCT02635724|21299204|P3|STARTED|Overall Study||7
8629961|NCT02635724|21299205|P2|STARTED|Overall Study||26
8629962|NCT02635724|21299206|P1|STARTED|Overall Study||41
8629963|NCT02630030|21299235|P1|NOT COMPLETED|Overall Study||0
8629964|NCT02630030|21299235|P1|COMPLETED|Overall Study||3
8629965|NCT02630030|21299235|P1|STARTED|Overall Study||3
8629966|NCT02618343|21299244|P2|NOT COMPLETED|Overall Study||0
8629967|NCT02618343|21299245|P1|NOT COMPLETED|Overall Study||0
8629968|NCT02618343|21299244|P2|COMPLETED|Overall Study||23
8629969|NCT02618343|21299245|P1|COMPLETED|Overall Study||28
8629970|NCT02618343|21299244|P2|STARTED|Overall Study||23
8629971|NCT02618343|21299245|P1|STARTED|Overall Study||28
8629972|NCT02613364|21299256|P3|NOT COMPLETED|Overall Study||76
8629973|NCT02613364|21299257|P2|NOT COMPLETED|Overall Study||90
8629974|NCT02613364|21299258|P1|NOT COMPLETED|Overall Study||66
8629975|NCT02613364|21299256|P3|COMPLETED|Overall Study||175
8629976|NCT02613364|21299257|P2|COMPLETED|Overall Study||148
8629977|NCT02613364|21299258|P1|COMPLETED|Overall Study||185
8629978|NCT02613364|21299256|P3|STARTED|Overall Study||251
8629979|NCT02613364|21299257|P2|STARTED|Overall Study||238
8629980|NCT02613364|21299258|P1|STARTED|Overall Study||251
8629981|NCT02608684|21299311|P1|NOT COMPLETED|Overall Study||3
8629982|NCT02608684|21299311|P1|COMPLETED|Overall Study||18
8629983|NCT02608684|21299311|P1|STARTED|Overall Study||21
8629990|NCT02593825|21299374|P2|NOT COMPLETED|Follow-up||0
8629991|NCT02593825|21299375|P1|NOT COMPLETED|Follow-up||0
8629992|NCT02593825|21299374|P2|COMPLETED|Follow-up||55
8629993|NCT02593825|21299375|P1|COMPLETED|Follow-up||57
8629994|NCT02593825|21299374|P2|STARTED|Follow-up||55
8629995|NCT02593825|21299375|P1|STARTED|Follow-up||57
8629996|NCT02593825|21299374|P2|NOT COMPLETED|Intervention||12
8629997|NCT02593825|21299375|P1|NOT COMPLETED|Intervention||10
8629998|NCT02593825|21299374|P2|COMPLETED|Intervention||55
8629999|NCT02593825|21299375|P1|COMPLETED|Intervention||57
8630000|NCT02593825|21299374|P2|STARTED|Intervention||67
8630001|NCT02593825|21299375|P1|STARTED|Intervention||67
8630002|NCT02589847|21299389|P2|NOT COMPLETED|Overall Study||71
8630003|NCT02589847|21299390|P1|NOT COMPLETED|Overall Study||55
8630004|NCT02589847|21299389|P2|COMPLETED|Overall Study||39
8630005|NCT02589847|21299390|P1|COMPLETED|Overall Study||107
8630006|NCT02589847|21299389|P2|Evaluable|Overall Study||75
8630007|NCT02589847|21299390|P1|Evaluable|Overall Study||142
8630008|NCT02589847|21299389|P2|Full Analysis Set (FAS)|Overall Study||104
8630009|NCT02589847|21299390|P1|Full Analysis Set (FAS)|Overall Study||149
8630010|NCT02589847|21299389|P2|Safety Population|Overall Study||0
8630011|NCT02589847|21299390|P1|Safety Population|Overall Study||149
8630012|NCT02589847|21299389|P2|STARTED|Overall Study||110
8630013|NCT02589847|21299390|P1|STARTED|Overall Study||162
8630014|NCT02578901|21299402|P2|NOT COMPLETED|Overall Study||21
8630015|NCT02578901|21299403|P1|NOT COMPLETED|Overall Study||20
8630016|NCT02578901|21299402|P2|COMPLETED|Overall Study||144
8630017|NCT02578901|21299403|P1|COMPLETED|Overall Study||145
8630018|NCT02578901|21299402|P2|STARTED|Overall Study||165
8630019|NCT02578901|21299403|P1|STARTED|Overall Study||165
8630020|NCT02569723|21299413|P1|NOT COMPLETED|Overall Study||0
8630021|NCT02569723|21299413|P1|COMPLETED|Overall Study||6
8630022|NCT02569723|21299413|P1|STARTED|Overall Study||6
8630023|NCT02555930|21299420|P1|NOT COMPLETED|Overall Study||0
8630024|NCT02555930|21299420|P1|COMPLETED|Overall Study||148
8630025|NCT02555930|21299420|P1|STARTED|Overall Study||148
8630026|NCT02550873|21299428|P3|NOT COMPLETED|Open Label Extension||111
8630027|NCT02550873|21299429|P2|NOT COMPLETED|Open Label Extension||0
8630028|NCT02550873|21299430|P1|NOT COMPLETED|Open Label Extension||0
8630029|NCT02550873|21299428|P3|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
8630030|NCT02550873|21299429|P2|COMPLETED|Open Label Extension||0
8630031|NCT02550873|21299430|P1|COMPLETED|Open Label Extension||0
8630032|NCT02550873|21299428|P3|STARTED|Open Label Extension||111
8630033|NCT02550873|21299429|P2|STARTED|Open Label Extension||0
8630034|NCT02550873|21299430|P1|STARTED|Open Label Extension||0
8630035|NCT02550873|21299428|P3|NOT COMPLETED|Randomized Double Blind||0
8630036|NCT02550873|21299429|P2|NOT COMPLETED|Randomized Double Blind||2
8630037|NCT02550873|21299430|P1|NOT COMPLETED|Randomized Double Blind||4
8630038|NCT02550873|21299428|P3|COMPLETED|Randomized Double Blind||0
8630039|NCT02550873|21299429|P2|COMPLETED|Randomized Double Blind||37
8630040|NCT02550873|21299430|P1|COMPLETED|Randomized Double Blind||74
8630041|NCT02550873|21299428|P3|Continue to Open Label Extension|Randomized Double Blind||0
8630042|NCT02550873|21299429|P2|Continue to Open Label Extension|Randomized Double Blind||37
8630043|NCT02550873|21299430|P1|Continue to Open Label Extension|Randomized Double Blind||74
8630044|NCT02550873|21299428|P3|Received Treatment|Randomized Double Blind||0
8630045|NCT02550873|21299429|P2|Received Treatment|Randomized Double Blind||39
8630046|NCT02550873|21299430|P1|Received Treatment|Randomized Double Blind||77
8630047|NCT02550873|21299428|P3|STARTED|Randomized Double Blind||0
8630048|NCT02550873|21299429|P2|STARTED|Randomized Double Blind||39
8630049|NCT02550873|21299430|P1|STARTED|Randomized Double Blind||78
8630050|NCT02528643|21299510|P2|NOT COMPLETED|Overall Study||85
8630051|NCT02528643|21299511|P1|NOT COMPLETED|Overall Study||39
8630052|NCT02528643|21299510|P2|COMPLETED|Overall Study||25
8630053|NCT02528643|21299511|P1|COMPLETED|Overall Study||16
8630054|NCT02528643|21299510|P2|Treated|Overall Study||107
8630055|NCT02528643|21299511|P1|Treated|Overall Study||55
8630056|NCT02528643|21299510|P2|STARTED|Overall Study||110
8630057|NCT02528643|21299511|P1|STARTED|Overall Study||55
8630058|NCT02522715|21299526|P2|NOT COMPLETED|Overall Study||0
8630059|NCT02522715|21299527|P1|NOT COMPLETED|Overall Study||0
8630060|NCT02522715|21299526|P2|COMPLETED|Overall Study||33
8630061|NCT02522715|21299527|P1|COMPLETED|Overall Study||3
8630062|NCT02522715|21299526|P2|STARTED|Overall Study|+1 early withdrawal|33
8630063|NCT02522715|21299527|P1|STARTED|Overall Study||3
8630064|NCT02520414|21299535|P1|NOT COMPLETED|Overall Study||0
8630065|NCT02520414|21299535|P1|COMPLETED|Overall Study||10
8630066|NCT02520414|21299535|P1|STARTED|Overall Study||10
8630073|NCT02489344|21299554|P1|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3
8630074|NCT02489344|21299554|P1|COMPLETED|LTS14116 (Extension Study): 31 Months||5
8630075|NCT02489344|21299554|P1|STARTED|LTS14116 (Extension Study): 31 Months||8
8630076|NCT02489344|21299554|P1|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2
8630077|NCT02489344|21299554|P1|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9
8630078|NCT02489344|21299554|P1|STARTED|ACT13739 (Initial Study): 26 Weeks||11
8630094|NCT02473393|21299654|P4|NOT COMPLETED|Overall Study||1
8630095|NCT02473393|21299655|P3|NOT COMPLETED|Overall Study||2
8630096|NCT02473393|21299656|P2|NOT COMPLETED|Overall Study||0
8630097|NCT02473393|21299657|P1|NOT COMPLETED|Overall Study||0
8630098|NCT02473393|21299654|P4|COMPLETED|Overall Study||12
8630099|NCT02473393|21299655|P3|COMPLETED|Overall Study||11
8630100|NCT02473393|21299656|P2|COMPLETED|Overall Study||12
8630101|NCT02473393|21299657|P1|COMPLETED|Overall Study||5
8630102|NCT02473393|21299654|P4|STARTED|Overall Study||13
8630103|NCT02473393|21299655|P3|STARTED|Overall Study||13
8630104|NCT02473393|21299656|P2|STARTED|Overall Study||12
8630105|NCT02473393|21299657|P1|STARTED|Overall Study||5
8630109|NCT02464033|21299717|P1|NOT COMPLETED|Overall Study||0
8630110|NCT02464033|21299717|P1|COMPLETED|Overall Study||20
8630111|NCT02464033|21299717|P1|STARTED|Overall Study||20
8630112|NCT02463357|21299759|P5|NOT COMPLETED|Overall Study||1
8630113|NCT02463357|21299760|P4|NOT COMPLETED|Overall Study||0
8630114|NCT02463357|21299761|P3|NOT COMPLETED|Overall Study||0
8630115|NCT02463357|21299762|P2|NOT COMPLETED|Overall Study||0
8630116|NCT02463357|21299763|P1|NOT COMPLETED|Overall Study||1
8630117|NCT02463357|21299759|P5|COMPLETED|Overall Study||19
8630118|NCT02463357|21299760|P4|COMPLETED|Overall Study||19
8630119|NCT02463357|21299761|P3|COMPLETED|Overall Study||20
8630120|NCT02463357|21299762|P2|COMPLETED|Overall Study||20
8630121|NCT02463357|21299763|P1|COMPLETED|Overall Study||19
8630122|NCT02463357|21299759|P5|STARTED|Overall Study||20
8630123|NCT02463357|21299760|P4|STARTED|Overall Study||19
8630124|NCT02463357|21299761|P3|STARTED|Overall Study||20
8630125|NCT02463357|21299762|P2|STARTED|Overall Study||20
8630126|NCT02463357|21299763|P1|STARTED|Overall Study||20
8630127|NCT02460198|21299797|P2|NOT COMPLETED|Overall Study||63
8630128|NCT02460198|21299798|P1|NOT COMPLETED|Overall Study||61
8630129|NCT02460198|21299797|P2|COMPLETED|Overall Study||0
8630130|NCT02460198|21299798|P1|COMPLETED|Overall Study||0
8630131|NCT02460198|21299797|P2|STARTED|Overall Study||63
8630132|NCT02460198|21299798|P1|STARTED|Overall Study||61
8630145|NCT02451943|21299902|P2|NOT COMPLETED|Overall Study||24
8630146|NCT02451943|21299903|P1|NOT COMPLETED|Overall Study||20
8630147|NCT02451943|21299902|P2|COMPLETED|Overall Study||227
8630148|NCT02451943|21299903|P1|COMPLETED|Overall Study||238
8630149|NCT02451943|21299902|P2|Leiomyosarcoma (LMS) Population|Overall Study||115
8630150|NCT02451943|21299903|P1|Leiomyosarcoma (LMS) Population|Overall Study||119
8630151|NCT02451943|21299902|P2|Received at Least One Dose of Study Drug|Overall Study||249
8630152|NCT02451943|21299903|P1|Received at Least One Dose of Study Drug|Overall Study||257
8630153|NCT02451943|21299902|P2|STARTED|Overall Study||251
8630154|NCT02451943|21299903|P1|STARTED|Overall Study||258
8630155|NCT02450903|21299929|P1|NOT COMPLETED|Overall Study||20
8630156|NCT02450903|21299929|P1|COMPLETED|Overall Study||0
8630157|NCT02450903|21299929|P1|Entered Survival Follow-up Phase|Overall Study||15
8630158|NCT02450903|21299929|P1|Entered Post-treatment Effic. f/u Phase|Overall Study||4
8630159|NCT02450903|21299929|P1|STARTED|Overall Study||20
8630160|NCT02447744|21299942|P2|NOT COMPLETED|Overall Study||1
8630161|NCT02447744|21299943|P1|NOT COMPLETED|Overall Study||6
8630162|NCT02447744|21299942|P2|COMPLETED|Overall Study||21
8630163|NCT02447744|21299943|P1|COMPLETED|Overall Study||15
8630164|NCT02447744|21299942|P2|STARTED|Overall Study||22
8630165|NCT02447744|21299943|P1|STARTED|Overall Study|6 subjects are enrolled in the mindfulness program after serving on the waiting list control group|21
8630189|NCT02400736|21300022|P2|NOT COMPLETED|Overall Study||8
8630190|NCT02400736|21300023|P1|NOT COMPLETED|Overall Study||11
8630191|NCT02400736|21300022|P2|COMPLETED|Overall Study||53
8630192|NCT02400736|21300023|P1|COMPLETED|Overall Study||47
8630193|NCT02400736|21300022|P2|STARTED|Overall Study||61
8630194|NCT02400736|21300023|P1|STARTED|Overall Study||58
8630195|NCT02395081|21300050|P3|NOT COMPLETED|Overall Study||4
8630196|NCT02395081|21300051|P2|NOT COMPLETED|Overall Study||5
8630197|NCT02395081|21300052|P1|NOT COMPLETED|Overall Study||7
8630198|NCT02395081|21300050|P3|COMPLETED|Overall Study||116
8630199|NCT02395081|21300051|P2|COMPLETED|Overall Study||116
8630200|NCT02395081|21300052|P1|COMPLETED|Overall Study||112
8630201|NCT02395081|21300050|P3|STARTED|Overall Study||120
8630202|NCT02395081|21300051|P2|STARTED|Overall Study||121
8630203|NCT02395081|21300052|P1|STARTED|Overall Study||119
8630204|NCT02394769|21300099|P3|NOT COMPLETED|Overall Study||6
8630205|NCT02394769|21300100|P2|NOT COMPLETED|Overall Study||3
8630206|NCT02394769|21300101|P1|NOT COMPLETED|Overall Study||2
8630207|NCT02394769|21300099|P3|COMPLETED|Overall Study||54
8630208|NCT02394769|21300100|P2|COMPLETED|Overall Study||57
8630209|NCT02394769|21300101|P1|COMPLETED|Overall Study||58
8630210|NCT02394769|21300099|P3|STARTED|Overall Study||60
8630211|NCT02394769|21300100|P2|STARTED|Overall Study||60
8630212|NCT02394769|21300101|P1|STARTED|Overall Study||60
8630213|NCT02389816|21300112|P3|NOT COMPLETED|Overall Study||12
8630214|NCT02389816|21300113|P2|NOT COMPLETED|Overall Study||13
8630215|NCT02389816|21300114|P1|NOT COMPLETED|Overall Study||15
8630216|NCT02389816|21300112|P3|COMPLETED|Overall Study||152
8630217|NCT02389816|21300113|P2|COMPLETED|Overall Study||152
8630218|NCT02389816|21300114|P1|COMPLETED|Overall Study||149
8630219|NCT02389816|21300112|P3|STARTED|Overall Study||164
8630220|NCT02389816|21300113|P2|STARTED|Overall Study||165
8630221|NCT02389816|21300114|P1|STARTED|Overall Study||164
8630222|NCT02369159|21300148|P2|NOT COMPLETED|Overall Study||2
8630223|NCT02369159|21300149|P1|NOT COMPLETED|Overall Study||8
8630224|NCT02369159|21300148|P2|COMPLETED|Overall Study||21
8630225|NCT02369159|21300149|P1|COMPLETED|Overall Study||106
8630226|NCT02369159|21300148|P2|E-R Population|Overall Study|Milestone only applied to Peramivir group|0
8630227|NCT02369159|21300149|P1|E-R Population|Overall Study||80
8630228|NCT02369159|21300148|P2|ITTI Population|Overall Study||16
8630229|NCT02369159|21300149|P1|ITTI Population|Overall Study||81
8630230|NCT02369159|21300148|P2|Safety Population|Overall Study||23
8630231|NCT02369159|21300149|P1|Safety Population|Overall Study||107
8630232|NCT02369159|21300148|P2|ITT Population|Overall Study||23
8630233|NCT02369159|21300149|P1|ITT Population|Overall Study||114
8630234|NCT02369159|21300148|P2|STARTED|Overall Study||23
8630235|NCT02369159|21300149|P1|STARTED|Overall Study||114
8630236|NCT02362503|21300190|P3|NOT COMPLETED|Open Label Period-Up to 96 Weeks||99
8630237|NCT02362503|21300191|P2|NOT COMPLETED|Open Label Period-Up to 96 Weeks||199
8630238|NCT02362503|21300192|P1|NOT COMPLETED|Open Label Period-Up to 96 Weeks||68
8630239|NCT02362503|21300190|P3|COMPLETED|Open Label Period-Up to 96 Weeks||0
8630240|NCT02362503|21300191|P2|COMPLETED|Open Label Period-Up to 96 Weeks||0
8630241|NCT02362503|21300192|P1|COMPLETED|Open Label Period-Up to 96 Weeks||0
8630242|NCT02362503|21300190|P3|STARTED|Open Label Period-Up to 96 Weeks||99
8630243|NCT02362503|21300191|P2|STARTED|Open Label Period-Up to 96 Weeks||199
8630244|NCT02362503|21300192|P1|STARTED|Open Label Period-Up to 96 Weeks||68
8630245|NCT02362503|21300190|P3|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
8630246|NCT02362503|21300191|P2|NOT COMPLETED|Double-blind Period-Up to 8 Days||4
8630247|NCT02362503|21300192|P1|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
8630248|NCT02362503|21300190|P3|COMPLETED|Double-blind Period-Up to 8 Days||0
8630249|NCT02362503|21300191|P2|COMPLETED|Double-blind Period-Up to 8 Days||199
8630250|NCT02362503|21300192|P1|COMPLETED|Double-blind Period-Up to 8 Days||68
8630251|NCT02362503|21300190|P3|STARTED|Double-blind Period-Up to 8 Days||0
8630252|NCT02362503|21300191|P2|STARTED|Double-blind Period-Up to 8 Days||203
8630253|NCT02362503|21300192|P1|STARTED|Double-blind Period-Up to 8 Days||69
8630254|NCT02359019|21300217|P1|NOT COMPLETED|Overall Study||0
8630255|NCT02359019|21300217|P1|COMPLETED|Overall Study||45
8630256|NCT02359019|21300217|P1|STARTED|Overall Study||45
8630257|NCT02353754|21300225|P2|NOT COMPLETED|Overall Study||0
8630258|NCT02353754|21300226|P1|NOT COMPLETED|Overall Study||2
8630259|NCT02353754|21300225|P2|COMPLETED|Overall Study||0
8630260|NCT02353754|21300226|P1|COMPLETED|Overall Study||10
8630261|NCT02353754|21300225|P2|STARTED|Overall Study||0
8630262|NCT02353754|21300226|P1|STARTED|Overall Study||12
8630263|NCT02352259|21300236|P1|NOT COMPLETED|Overall Study||0
8630264|NCT02352259|21300236|P1|COMPLETED|Overall Study||23
8630265|NCT02352259|21300236|P1|STARTED|Overall Study||23
8630266|NCT02327052|21300241|P1|NOT COMPLETED|Overall Study||0
8630267|NCT02327052|21300241|P1|COMPLETED|Overall Study||58
8630268|NCT02327052|21300241|P1|STARTED|Overall Study||58
8630277|NCT02290405|21300302|P2|NOT COMPLETED|Overall Study||0
8630278|NCT02290405|21300303|P1|NOT COMPLETED|Overall Study||1
8630279|NCT02290405|21300302|P2|COMPLETED|Overall Study||53
8630280|NCT02290405|21300303|P1|COMPLETED|Overall Study||35
8630281|NCT02290405|21300302|P2|STARTED|Overall Study||53
8630282|NCT02290405|21300303|P1|STARTED|Overall Study||36
8630283|NCT02290028|21300309|P1|NOT COMPLETED|Overall Study||2226
8630284|NCT02290028|21300309|P1|COMPLETED|Overall Study||0
8630285|NCT02290028|21300309|P1|STARTED|Overall Study||2226
8630286|NCT02284126|21300329|P2|NOT COMPLETED|Overall Study||62
8630287|NCT02284126|21300330|P1|NOT COMPLETED|Overall Study||68
8630288|NCT02284126|21300329|P2|COMPLETED|Overall Study||489
8630289|NCT02284126|21300330|P1|COMPLETED|Overall Study||484
8630290|NCT02284126|21300329|P2|STARTED|Overall Study||551
8630291|NCT02284126|21300330|P1|STARTED|Overall Study||552
8630306|NCT02267603|21300377|P1|NOT COMPLETED|Overall Study||44
8630307|NCT02267603|21300377|P1|COMPLETED|Overall Study||6
8630308|NCT02267603|21300377|P1|STARTED|Overall Study||50
8630309|NCT02232282|21300383|P2|NOT COMPLETED|Overall Study||0
8630310|NCT02232282|21300384|P1|NOT COMPLETED|Overall Study||0
8630311|NCT02232282|21300383|P2|COMPLETED|Overall Study||11
8630312|NCT02232282|21300384|P1|COMPLETED|Overall Study||10
8630313|NCT02232282|21300383|P2|STARTED|Overall Study||11
8630314|NCT02232282|21300384|P1|STARTED|Overall Study||10
8630315|NCT02222610|21300397|P3|NOT COMPLETED|Baseline to W104||6
8630316|NCT02222610|21300398|P2|NOT COMPLETED|Baseline to W104||5
8630317|NCT02222610|21300399|P1|NOT COMPLETED|Baseline to W104||0
8630318|NCT02222610|21300397|P3|COMPLETED|Baseline to W104||10
8630319|NCT02222610|21300398|P2|COMPLETED|Baseline to W104||11
8630320|NCT02222610|21300399|P1|COMPLETED|Baseline to W104||8
8630321|NCT02222610|21300397|P3|STARTED|Baseline to W104||16
8630322|NCT02222610|21300398|P2|STARTED|Baseline to W104||16
8630323|NCT02222610|21300399|P1|STARTED|Baseline to W104||8
8630324|NCT02222610|21300397|P3|NOT COMPLETED|Baseline to W48||1
8630325|NCT02222610|21300398|P2|NOT COMPLETED|Baseline to W48||2
8630326|NCT02222610|21300399|P1|NOT COMPLETED|Baseline to W48||0
8630327|NCT02222610|21300397|P3|COMPLETED|Baseline to W48||15
8630328|NCT02222610|21300398|P2|COMPLETED|Baseline to W48||14
8630329|NCT02222610|21300399|P1|COMPLETED|Baseline to W48||8
8630330|NCT02222610|21300397|P3|STARTED|Baseline to W48||16
8630331|NCT02222610|21300398|P2|STARTED|Baseline to W48||16
8630332|NCT02222610|21300399|P1|STARTED|Baseline to W48||8
8630333|NCT02195349|21300430|P11|NOT COMPLETED|Overall Study||0
8630334|NCT02195349|21300431|P10|NOT COMPLETED|Overall Study||0
8630335|NCT02195349|21300432|P9|NOT COMPLETED|Overall Study||0
8630336|NCT02195349|21300433|P8|NOT COMPLETED|Overall Study||0
8630337|NCT02195349|21300434|P7|NOT COMPLETED|Overall Study||0
8630338|NCT02195349|21300435|P6|NOT COMPLETED|Overall Study||0
8630339|NCT02195349|21300436|P5|NOT COMPLETED|Overall Study||0
8630340|NCT02195349|21300437|P4|NOT COMPLETED|Overall Study||0
8630341|NCT02195349|21300438|P3|NOT COMPLETED|Overall Study||0
8630342|NCT02195349|21300439|P2|NOT COMPLETED|Overall Study||0
8630343|NCT02195349|21300440|P1|NOT COMPLETED|Overall Study||0
8630344|NCT02195349|21300430|P11|COMPLETED|Overall Study||6
8630345|NCT02195349|21300431|P10|COMPLETED|Overall Study||6
8630346|NCT02195349|21300432|P9|COMPLETED|Overall Study||6
8630347|NCT02195349|21300433|P8|COMPLETED|Overall Study||9
8630348|NCT02195349|21300434|P7|COMPLETED|Overall Study||6
8630349|NCT02195349|21300435|P6|COMPLETED|Overall Study||6
8630350|NCT02195349|21300436|P5|COMPLETED|Overall Study||6
8630351|NCT02195349|21300437|P4|COMPLETED|Overall Study||6
8630352|NCT02195349|21300438|P3|COMPLETED|Overall Study||1
8630353|NCT02195349|21300439|P2|COMPLETED|Overall Study||1
8630354|NCT02195349|21300440|P1|COMPLETED|Overall Study||14
8630355|NCT02195349|21300430|P11|STARTED|Overall Study||6
8630356|NCT02195349|21300431|P10|STARTED|Overall Study||6
8630357|NCT02195349|21300432|P9|STARTED|Overall Study||6
8630358|NCT02195349|21300433|P8|STARTED|Overall Study||9
8630359|NCT02195349|21300434|P7|STARTED|Overall Study||6
8630360|NCT02195349|21300435|P6|STARTED|Overall Study||6
8630361|NCT02195349|21300436|P5|STARTED|Overall Study||6
8630362|NCT02195349|21300437|P4|STARTED|Overall Study||6
8630363|NCT02195349|21300438|P3|STARTED|Overall Study||1
8630364|NCT02195349|21300439|P2|STARTED|Overall Study||1
8630365|NCT02195349|21300440|P1|STARTED|Overall Study||14
8630366|NCT02192970|21300693|P2|NOT COMPLETED|Overall Study||0
8630367|NCT02192970|21300694|P1|NOT COMPLETED|Overall Study||6
8630368|NCT02192970|21300693|P2|COMPLETED|Overall Study||195
8630369|NCT02192970|21300694|P1|COMPLETED|Overall Study||95
8630370|NCT02192970|21300693|P2|STARTED|Overall Study||195
8630371|NCT02192970|21300694|P1|STARTED|Overall Study||101
8630408|NCT02166606|21300718|P1|NOT COMPLETED|Overall Study||78
8630409|NCT02166606|21300718|P1|COMPLETED|Overall Study||1106
8630410|NCT02166606|21300718|P1|Consent Eligible|Overall Study||1174
8630411|NCT02166606|21300718|P1|Actively Enrolled|Overall Study||1180
8630412|NCT02166606|21300718|P1|STARTED|Overall Study||1184
8630413|NCT02142608|21300723|P1|NOT COMPLETED|Overall Study||0
8630414|NCT02142608|21300723|P1|COMPLETED|Overall Study||18
8630415|NCT02142608|21300723|P1|STARTED|Overall Study||18
8630416|NCT02132130|21300732|P4|NOT COMPLETED|Overall Study||1
8630417|NCT02132130|21300733|P3|NOT COMPLETED|Overall Study||0
8630418|NCT02132130|21300734|P2|NOT COMPLETED|Overall Study||2
8630419|NCT02132130|21300735|P1|NOT COMPLETED|Overall Study||0
8630420|NCT02132130|21300732|P4|COMPLETED|Overall Study||2
8630421|NCT02132130|21300733|P3|COMPLETED|Overall Study||4
8630422|NCT02132130|21300734|P2|COMPLETED|Overall Study||10
8630423|NCT02132130|21300735|P1|COMPLETED|Overall Study||3
8630424|NCT02132130|21300732|P4|STARTED|Overall Study||3
8630425|NCT02132130|21300733|P3|STARTED|Overall Study||4
8630426|NCT02132130|21300734|P2|STARTED|Overall Study||12
8630427|NCT02132130|21300735|P1|STARTED|Overall Study||3
8630452|NCT02116777|21300943|P7|NOT COMPLETED|Overall Study||9
8630453|NCT02116777|21300944|P6|NOT COMPLETED|Overall Study||3
8630454|NCT02116777|21300945|P5|NOT COMPLETED|Overall Study||6
8630455|NCT02116777|21300946|P4|NOT COMPLETED|Overall Study||13
8630456|NCT02116777|21300947|P3|NOT COMPLETED|Overall Study||3
8630457|NCT02116777|21300948|P2|NOT COMPLETED|Overall Study||3
8630458|NCT02116777|21300949|P1|NOT COMPLETED|Overall Study||3
8630459|NCT02116777|21300943|P7|COMPLETED|Overall Study||0
8630460|NCT02116777|21300944|P6|COMPLETED|Overall Study||0
8630461|NCT02116777|21300945|P5|COMPLETED|Overall Study||0
8630462|NCT02116777|21300946|P4|COMPLETED|Overall Study||0
8630463|NCT02116777|21300947|P3|COMPLETED|Overall Study||0
8630464|NCT02116777|21300948|P2|COMPLETED|Overall Study||0
8630465|NCT02116777|21300949|P1|COMPLETED|Overall Study||0
8630466|NCT02116777|21300943|P7|STARTED|Overall Study||9
8630467|NCT02116777|21300944|P6|STARTED|Overall Study||3
8630468|NCT02116777|21300945|P5|STARTED|Overall Study||6
8630469|NCT02116777|21300946|P4|STARTED|Overall Study||13
8630470|NCT02116777|21300947|P3|STARTED|Overall Study||3
8630471|NCT02116777|21300948|P2|STARTED|Overall Study||3
8630472|NCT02116777|21300949|P1|STARTED|Overall Study||3
8630487|NCT02108457|21301000|P2|NOT COMPLETED|Overall Study||2
8630488|NCT02108457|21301001|P1|NOT COMPLETED|Overall Study||0
8630489|NCT02108457|21301000|P2|COMPLETED|Overall Study||10
8630490|NCT02108457|21301001|P1|COMPLETED|Overall Study||3
8630491|NCT02108457|21301000|P2|STARTED|Overall Study||12
8630492|NCT02108457|21301001|P1|STARTED|Overall Study||3
8630501|NCT02093962|21301029|P2|NOT COMPLETED|Overall Study||131
8630502|NCT02093962|21301030|P1|NOT COMPLETED|Overall Study||134
8630503|NCT02093962|21301029|P2|COMPLETED|Overall Study||0
8630504|NCT02093962|21301030|P1|COMPLETED|Overall Study||0
8630505|NCT02093962|21301029|P2|Received Treatment|Overall Study||130
8630506|NCT02093962|21301030|P1|Received Treatment|Overall Study||130
8630507|NCT02093962|21301029|P2|STARTED|Overall Study||131
8630508|NCT02093962|21301030|P1|STARTED|Overall Study||134
8630513|NCT02085070|21301049|P2|NOT COMPLETED|Overall Study||0
8630514|NCT02085070|21301050|P1|NOT COMPLETED|Overall Study||0
8630515|NCT02085070|21301049|P2|COMPLETED|Overall Study||42
8630516|NCT02085070|21301050|P1|COMPLETED|Overall Study||23
8630517|NCT02085070|21301049|P2|STARTED|Overall Study||42
8630518|NCT02085070|21301050|P1|STARTED|Overall Study||23
8630527|NCT02073279|21301081|P2|NOT COMPLETED|Open-label Extension Period||16
8630528|NCT02073279|21301082|P1|NOT COMPLETED|Open-label Extension Period||17
8630529|NCT02073279|21301081|P2|COMPLETED|Open-label Extension Period||0
8630530|NCT02073279|21301082|P1|COMPLETED|Open-label Extension Period||0
8630531|NCT02073279|21301081|P2|STARTED|Open-label Extension Period||16
8630532|NCT02073279|21301082|P1|STARTED|Open-label Extension Period||17
8630533|NCT02073279|21301081|P2|NOT COMPLETED|Double-blind Period||47
8630534|NCT02073279|21301082|P1|NOT COMPLETED|Double-blind Period||15
8630535|NCT02073279|21301081|P2|COMPLETED|Double-blind Period||16
8630536|NCT02073279|21301082|P1|COMPLETED|Double-blind Period||17
8630537|NCT02073279|21301081|P2|STARTED|Double-blind Period||63
8630538|NCT02073279|21301082|P1|STARTED|Double-blind Period||32
8630539|NCT02048826|21301156|P2|NOT COMPLETED|Overall Study||0
8630540|NCT02048826|21301157|P1|NOT COMPLETED|Overall Study||1
8630541|NCT02048826|21301156|P2|COMPLETED|Overall Study||15
8630542|NCT02048826|21301157|P1|COMPLETED|Overall Study||15
8630543|NCT02048826|21301156|P2|STARTED|Overall Study||15
8630544|NCT02048826|21301157|P1|STARTED|Overall Study||16
8630545|NCT02047045|21301169|P2|NOT COMPLETED|Follow-up Period (24 Weeks)||1
8630546|NCT02047045|21301170|P1|NOT COMPLETED|Follow-up Period (24 Weeks)||1
8630547|NCT02047045|21301169|P2|COMPLETED|Follow-up Period (24 Weeks)||262
8630548|NCT02047045|21301170|P1|COMPLETED|Follow-up Period (24 Weeks)||265
8630549|NCT02047045|21301169|P2|STARTED|Follow-up Period (24 Weeks)||263
8630550|NCT02047045|21301170|P1|STARTED|Follow-up Period (24 Weeks)||266
8630551|NCT02047045|21301169|P2|NOT COMPLETED|Treatment Period (8 Weeks )||15
8630552|NCT02047045|21301170|P1|NOT COMPLETED|Treatment Period (8 Weeks )||11
8630553|NCT02047045|21301169|P2|COMPLETED|Treatment Period (8 Weeks )||263
8630554|NCT02047045|21301170|P1|COMPLETED|Treatment Period (8 Weeks )||266
8630555|NCT02047045|21301169|P2|STARTED|Treatment Period (8 Weeks )||278
8630556|NCT02047045|21301170|P1|STARTED|Treatment Period (8 Weeks )||277
8630557|NCT02047045|21301169|P2|NOT COMPLETED|Baseline||2
8630558|NCT02047045|21301170|P1|NOT COMPLETED|Baseline||3
8630559|NCT02047045|21301169|P2|COMPLETED|Baseline||278
8630560|NCT02047045|21301170|P1|COMPLETED|Baseline||277
8630561|NCT02047045|21301169|P2|STARTED|Baseline||280
8630562|NCT02047045|21301170|P1|STARTED|Baseline||280
8630563|NCT02046174|21301202|P2|NOT COMPLETED|Overall Study||0
8630564|NCT02046174|21301203|P1|NOT COMPLETED|Overall Study||1
8630565|NCT02046174|21301202|P2|COMPLETED|Overall Study||3
8630566|NCT02046174|21301203|P1|COMPLETED|Overall Study||41
8630567|NCT02046174|21301202|P2|STARTED|Overall Study||3
8630568|NCT02046174|21301203|P1|STARTED|Overall Study||42
8630569|NCT02024087|21301290|P2|NOT COMPLETED|Overall Study||0
8630570|NCT02024087|21301291|P1|NOT COMPLETED|Overall Study||0
8630571|NCT02024087|21301290|P2|COMPLETED|Overall Study||16
8630572|NCT02024087|21301291|P1|COMPLETED|Overall Study||5
8630573|NCT02024087|21301290|P2|STARTED|Overall Study|Dose change to 0.4 mg/kg and cohort expanded to 16 participants in total at this dose level|16
8630574|NCT02024087|21301291|P1|STARTED|Overall Study||5
8630581|NCT01995487|21301434|P2|NOT COMPLETED|Overall Study||83
8630582|NCT01995487|21301435|P1|NOT COMPLETED|Overall Study||74
8630583|NCT01995487|21301434|P2|COMPLETED|Overall Study||878
8630584|NCT01995487|21301435|P1|COMPLETED|Overall Study||884
8630585|NCT01995487|21301434|P2|STARTED|Overall Study||961
8630586|NCT01995487|21301435|P1|STARTED|Overall Study||958
8630593|NCT01988779|21301466|P2|NOT COMPLETED|Overall Study||2
8630594|NCT01988779|21301467|P1|NOT COMPLETED|Overall Study||3
8630595|NCT01988779|21301466|P2|COMPLETED|Overall Study||11
8630596|NCT01988779|21301467|P1|COMPLETED|Overall Study||9
8630597|NCT01988779|21301466|P2|STARTED|Overall Study||13
8630598|NCT01988779|21301467|P1|STARTED|Overall Study||12
8630599|NCT01981187|21301481|P1|NOT COMPLETED|Overall Study||12
8630600|NCT01981187|21301481|P1|COMPLETED|Overall Study||0
8630601|NCT01981187|21301481|P1|STARTED|Overall Study||12
8630602|NCT01967823|21301498|P1|NOT COMPLETED|Overall Study||1
8630603|NCT01967823|21301498|P1|COMPLETED|Overall Study||10
8630604|NCT01967823|21301498|P1|STARTED|Overall Study||11
8630605|NCT01961882|21301509|P2|NOT COMPLETED|Overall Study||42
8630606|NCT01961882|21301510|P1|NOT COMPLETED|Overall Study||50
8630607|NCT01961882|21301509|P2|COMPLETED|Overall Study||23
8630608|NCT01961882|21301510|P1|COMPLETED|Overall Study||19
8630609|NCT01961882|21301509|P2|STARTED|Overall Study||65
8630610|NCT01961882|21301510|P1|STARTED|Overall Study||69
8630611|NCT01951625|21301523|P5|NOT COMPLETED|Follow Up Period||10
8630612|NCT01951625|21301524|P4|NOT COMPLETED|Follow Up Period||11
8630613|NCT01951625|21301525|P3|NOT COMPLETED|Follow Up Period||4
8630614|NCT01951625|21301526|P2|NOT COMPLETED|Follow Up Period||9
8630615|NCT01951625|21301527|P1|NOT COMPLETED|Follow Up Period||8
8630616|NCT01951625|21301523|P5|COMPLETED|Follow Up Period||78
8630617|NCT01951625|21301524|P4|COMPLETED|Follow Up Period||76
8630618|NCT01951625|21301525|P3|COMPLETED|Follow Up Period||84
8630619|NCT01951625|21301526|P2|COMPLETED|Follow Up Period||79
8630620|NCT01951625|21301527|P1|COMPLETED|Follow Up Period||79
8630621|NCT01951625|21301523|P5|STARTED|Follow Up Period||88
8630622|NCT01951625|21301524|P4|STARTED|Follow Up Period||87
8630623|NCT01951625|21301525|P3|STARTED|Follow Up Period||88
8630624|NCT01951625|21301526|P2|STARTED|Follow Up Period||88
8630625|NCT01951625|21301527|P1|STARTED|Follow Up Period||87
8630626|NCT01951625|21301523|P5|NOT COMPLETED|Treatment Period||17
8630627|NCT01951625|21301524|P4|NOT COMPLETED|Treatment Period||22
8630628|NCT01951625|21301525|P3|NOT COMPLETED|Treatment Period||15
8630629|NCT01951625|21301526|P2|NOT COMPLETED|Treatment Period||21
8630630|NCT01951625|21301527|P1|NOT COMPLETED|Treatment Period||19
8630631|NCT01951625|21301523|P5|COMPLETED|Treatment Period||74
8630632|NCT01951625|21301524|P4|COMPLETED|Treatment Period||69
8630633|NCT01951625|21301525|P3|COMPLETED|Treatment Period||76
8630634|NCT01951625|21301526|P2|COMPLETED|Treatment Period||70
8630635|NCT01951625|21301527|P1|COMPLETED|Treatment Period||73
8630636|NCT01951625|21301523|P5|STARTED|Treatment Period||91
8630637|NCT01951625|21301524|P4|STARTED|Treatment Period||91
8630638|NCT01951625|21301525|P3|STARTED|Treatment Period||91
8630639|NCT01951625|21301526|P2|STARTED|Treatment Period||91
8630640|NCT01951625|21301527|P1|STARTED|Treatment Period||92
8630641|NCT01951105|21301613|P3|NOT COMPLETED|Overall Study||2
8630642|NCT01951105|21301614|P2|NOT COMPLETED|Overall Study||10
8630643|NCT01951105|21301615|P1|NOT COMPLETED|Overall Study||1
8630644|NCT01951105|21301613|P3|COMPLETED|Overall Study||28
8630645|NCT01951105|21301614|P2|COMPLETED|Overall Study||21
8630646|NCT01951105|21301615|P1|COMPLETED|Overall Study||10
8630647|NCT01951105|21301613|P3|Completed 12 Weeks Treatment|Overall Study||28
8630648|NCT01951105|21301614|P2|Completed 12 Weeks Treatment|Overall Study||24
8630649|NCT01951105|21301615|P1|Completed 12 Weeks Treatment|Overall Study||10
8630650|NCT01951105|21301613|P3|STARTED|Overall Study||30
8630651|NCT01951105|21301614|P2|STARTED|Overall Study||31
8630652|NCT01951105|21301615|P1|STARTED|Overall Study||11
8630653|NCT01946802|21301629|P1|NOT COMPLETED|Overall Study||5
8630654|NCT01946802|21301629|P1|COMPLETED|Overall Study||39
8630655|NCT01946802|21301629|P1|STARTED|Overall Study||44
8630656|NCT01937351|21301640|P2|NOT COMPLETED|Overall Study||2
8630657|NCT01937351|21301641|P1|NOT COMPLETED|Overall Study||9
8630658|NCT01937351|21301640|P2|COMPLETED|Overall Study||26
8630659|NCT01937351|21301641|P1|COMPLETED|Overall Study||125
8630660|NCT01937351|21301640|P2|6-Month Follow-up|Overall Study||26
8630661|NCT01937351|21301641|P1|6-Month Follow-up|Overall Study||125
8630662|NCT01937351|21301640|P2|30-Day Follow-up|Overall Study||27
8630663|NCT01937351|21301641|P1|30-Day Follow-up|Overall Study||128
8630664|NCT01937351|21301640|P2|Treated w Study Device|Overall Study||28
8630665|NCT01937351|21301641|P1|Treated w Study Device|Overall Study||130
8630666|NCT01937351|21301640|P2|STARTED|Overall Study||28
8630667|NCT01937351|21301641|P1|STARTED|Overall Study||134
8630668|NCT01929642|21301672|P1|NOT COMPLETED|Overall Study||2
8630669|NCT01929642|21301672|P1|COMPLETED|Overall Study||1
8630670|NCT01929642|21301672|P1|STARTED|Overall Study||3
8630671|NCT01881789|21301689|P6|NOT COMPLETED|Overall Study||3
8630672|NCT01881789|21301690|P5|NOT COMPLETED|Overall Study||2
8630673|NCT01881789|21301691|P4|NOT COMPLETED|Overall Study||3
8630674|NCT01881789|21301692|P3|NOT COMPLETED|Overall Study||3
8630675|NCT01881789|21301693|P2|NOT COMPLETED|Overall Study||7
8630676|NCT01881789|21301694|P1|NOT COMPLETED|Overall Study||3
8630677|NCT01881789|21301689|P6|COMPLETED|Overall Study||0
8630678|NCT01881789|21301690|P5|COMPLETED|Overall Study||0
8630679|NCT01881789|21301691|P4|COMPLETED|Overall Study||0
8630680|NCT01881789|21301692|P3|COMPLETED|Overall Study||0
8630681|NCT01881789|21301693|P2|COMPLETED|Overall Study||0
8630682|NCT01881789|21301694|P1|COMPLETED|Overall Study||0
8630683|NCT01881789|21301689|P6|STARTED|Overall Study||3
8630684|NCT01881789|21301690|P5|STARTED|Overall Study||2
8630685|NCT01881789|21301691|P4|STARTED|Overall Study||3
8630686|NCT01881789|21301692|P3|STARTED|Overall Study||3
8630687|NCT01881789|21301693|P2|STARTED|Overall Study||7
8630688|NCT01881789|21301694|P1|STARTED|Overall Study||3
8630689|NCT01870401|21301737|P2|NOT COMPLETED|Overall Study||96
8630690|NCT01870401|21301738|P1|NOT COMPLETED|Overall Study||150
8630691|NCT01870401|21301737|P2|COMPLETED|Overall Study||59
8630692|NCT01870401|21301738|P1|COMPLETED|Overall Study||137
8630693|NCT01870401|21301737|P2|STARTED|Overall Study||155
8630694|NCT01870401|21301738|P1|STARTED|Overall Study||287
8630695|NCT01864538|21301796|P1|NOT COMPLETED|Overall Study||11
8630696|NCT01864538|21301796|P1|COMPLETED|Overall Study||0
8630697|NCT01864538|21301796|P1|STARTED|Overall Study||11
8630726|NCT01844076|21301895|P4|NOT COMPLETED|Overall Study||0
8630727|NCT01844076|21301896|P3|NOT COMPLETED|Overall Study||0
8630728|NCT01844076|21301897|P2|NOT COMPLETED|Overall Study||0
8630729|NCT01844076|21301898|P1|NOT COMPLETED|Overall Study||2
8630730|NCT01844076|21301895|P4|COMPLETED|Overall Study||7
8630731|NCT01844076|21301896|P3|COMPLETED|Overall Study||3
8630732|NCT01844076|21301897|P2|COMPLETED|Overall Study||6
8630733|NCT01844076|21301898|P1|COMPLETED|Overall Study||1
8630734|NCT01844076|21301895|P4|STARTED|Overall Study||7
8630735|NCT01844076|21301896|P3|STARTED|Overall Study||3
8630736|NCT01844076|21301897|P2|STARTED|Overall Study||6
8630737|NCT01844076|21301898|P1|STARTED|Overall Study||3
8630768|NCT01839279|21302134|P3|NOT COMPLETED|Overall Study||2
8630769|NCT01839279|21302135|P2|NOT COMPLETED|Overall Study||2
8630770|NCT01839279|21302136|P1|NOT COMPLETED|Overall Study||13
8630771|NCT01839279|21302134|P3|COMPLETED|Overall Study||30
8630772|NCT01839279|21302135|P2|COMPLETED|Overall Study||30
8630773|NCT01839279|21302136|P1|COMPLETED|Overall Study||59
8630774|NCT01839279|21302134|P3|PK/QTc Analysis Set|Overall Study||0
8630775|NCT01839279|21302135|P2|PK/QTc Analysis Set|Overall Study||0
8630776|NCT01839279|21302136|P1|PK/QTc Analysis Set|Overall Study||70
8630777|NCT01839279|21302134|P3|Moxifloxacin/Placebo Analysis Set|Overall Study||30
8630778|NCT01839279|21302135|P2|Moxifloxacin/Placebo Analysis Set|Overall Study||31
8630779|NCT01839279|21302136|P1|Moxifloxacin/Placebo Analysis Set|Overall Study||0
8630780|NCT01839279|21302134|P3|PK Analysis Set|Overall Study||0
8630781|NCT01839279|21302135|P2|PK Analysis Set|Overall Study||0
8630782|NCT01839279|21302136|P1|PK Analysis Set|Overall Study||70
8630783|NCT01839279|21302134|P3|QT/QTc Analysis Set|Overall Study||32
8630784|NCT01839279|21302135|P2|QT/QTc Analysis Set|Overall Study||32
8630785|NCT01839279|21302136|P1|QT/QTc Analysis Set|Overall Study||72
8630786|NCT01839279|21302134|P3|STARTED|Overall Study||32
8630787|NCT01839279|21302135|P2|STARTED|Overall Study||32
8630788|NCT01839279|21302136|P1|STARTED|Overall Study||72
8630795|NCT01825057|21302176|P3|NOT COMPLETED|Provider Study Flow||0
8630796|NCT01825057|21302177|P2|NOT COMPLETED|Provider Study Flow||0
8630797|NCT01825057|21302178|P1|NOT COMPLETED|Provider Study Flow||0
8630798|NCT01825057|21302176|P3|COMPLETED|Provider Study Flow||13
8630799|NCT01825057|21302177|P2|COMPLETED|Provider Study Flow||12
8630800|NCT01825057|21302178|P1|COMPLETED|Provider Study Flow||13
8630801|NCT01825057|21302176|P3|STARTED|Provider Study Flow||13
8630802|NCT01825057|21302177|P2|STARTED|Provider Study Flow||12
8630803|NCT01825057|21302178|P1|STARTED|Provider Study Flow||13
8630804|NCT01825057|21302176|P3|NOT COMPLETED|Patient Study Flow||0
8630805|NCT01825057|21302177|P2|NOT COMPLETED|Patient Study Flow||0
8630806|NCT01825057|21302178|P1|NOT COMPLETED|Patient Study Flow||0
8630807|NCT01825057|21302176|P3|COMPLETED|Patient Study Flow||458
8630808|NCT01825057|21302177|P2|COMPLETED|Patient Study Flow||379
8630809|NCT01825057|21302178|P1|COMPLETED|Patient Study Flow||336
8630810|NCT01825057|21302176|P3|STARTED|Patient Study Flow||458
8630811|NCT01825057|21302177|P2|STARTED|Patient Study Flow||379
8630812|NCT01825057|21302178|P1|STARTED|Patient Study Flow||336
8630816|NCT01802281|21302212|P2|NOT COMPLETED|Overall Study||6
8630817|NCT01802281|21302213|P1|NOT COMPLETED|Overall Study||8
8630818|NCT01802281|21302212|P2|COMPLETED|Overall Study||84
8630819|NCT01802281|21302213|P1|COMPLETED|Overall Study||85
8630820|NCT01802281|21302212|P2|Completed Year 2 Follow-up|Overall Study||84
8630821|NCT01802281|21302213|P1|Completed Year 2 Follow-up|Overall Study||87
8630822|NCT01802281|21302212|P2|Completed Year 1 Follow-up|Overall Study||86
8630823|NCT01802281|21302213|P1|Completed Year 1 Follow-up|Overall Study||88
8630824|NCT01802281|21302212|P2|Eligible and Received Randomized Treatment|Overall Study||87
8630825|NCT01802281|21302213|P1|Eligible and Received Randomized Treatment|Overall Study||88
8630826|NCT01802281|21302212|P2|STARTED|Overall Study||90
8630827|NCT01802281|21302213|P1|STARTED|Overall Study||93
8630828|NCT01777152|21302267|P2|NOT COMPLETED|Overall Study||226
8630829|NCT01777152|21302268|P1|NOT COMPLETED|Overall Study||226
8630830|NCT01777152|21302267|P2|COMPLETED|Overall Study||0
8630831|NCT01777152|21302268|P1|COMPLETED|Overall Study||0
8630832|NCT01777152|21302267|P2|STARTED|Overall Study||226
8630833|NCT01777152|21302268|P1|STARTED|Overall Study||226
8630846|NCT01767194|21302312|P2|NOT COMPLETED|Overall Study||43
8630847|NCT01767194|21302313|P1|NOT COMPLETED|Overall Study||18
8630848|NCT01767194|21302312|P2|COMPLETED|Overall Study||11
8630849|NCT01767194|21302313|P1|COMPLETED|Overall Study||1
8630850|NCT01767194|21302312|P2|STARTED|Overall Study||54
8630851|NCT01767194|21302313|P1|STARTED|Overall Study||19
8630852|NCT01765712|21302322|P2|NOT COMPLETED|Overall Study||0
8630853|NCT01765712|21302323|P1|NOT COMPLETED|Overall Study||0
8630854|NCT01765712|21302322|P2|COMPLETED|Overall Study||23
8630855|NCT01765712|21302323|P1|COMPLETED|Overall Study||27
8630856|NCT01765712|21302322|P2|STARTED|Overall Study||23
8630857|NCT01765712|21302323|P1|STARTED|Overall Study||27
8630858|NCT01763164|21302339|P2|NOT COMPLETED|Follow up Phase||75
8630859|NCT01763164|21302340|P1|NOT COMPLETED|Follow up Phase||197
8630860|NCT01763164|21302339|P2|COMPLETED|Follow up Phase||3
8630861|NCT01763164|21302340|P1|COMPLETED|Follow up Phase||3
8630862|NCT01763164|21302339|P2|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|78
8630957|NCT01609296|21302512|P1|STARTED|Overall Study||1406
8630863|NCT01763164|21302340|P1|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|200
8630864|NCT01763164|21302339|P2|NOT COMPLETED|Treatment Phase||133
8630865|NCT01763164|21302340|P1|NOT COMPLETED|Treatment Phase||269
8630866|NCT01763164|21302339|P2|COMPLETED|Treatment Phase||0
8630867|NCT01763164|21302340|P1|COMPLETED|Treatment Phase||0
8630868|NCT01763164|21302339|P2|Full Analysis Set|Treatment Phase||133
8630869|NCT01763164|21302340|P1|Full Analysis Set|Treatment Phase||269
8630870|NCT01763164|21302339|P2|Treated/Safety Set|Treatment Phase||114
8630871|NCT01763164|21302340|P1|Treated/Safety Set|Treatment Phase||269
8630872|NCT01763164|21302339|P2|STARTED|Treatment Phase||133
8630873|NCT01763164|21302340|P1|STARTED|Treatment Phase||269
8630880|NCT01716117|21302400|P2|NOT COMPLETED|Overall Study||2
8630881|NCT01716117|21302401|P1|NOT COMPLETED|Overall Study||7
8630882|NCT01716117|21302400|P2|COMPLETED|Overall Study||31
8630883|NCT01716117|21302401|P1|COMPLETED|Overall Study||173
8630884|NCT01716117|21302400|P2|6-Month Visit|Overall Study||32
8630885|NCT01716117|21302401|P1|6-Month Visit|Overall Study||174
8630886|NCT01716117|21302400|P2|1-Month Visit|Overall Study||33
8630887|NCT01716117|21302401|P1|1-Month Visit|Overall Study||176
8630888|NCT01716117|21302400|P2|Discharge|Overall Study||33
8630889|NCT01716117|21302401|P1|Discharge|Overall Study||177
8630890|NCT01716117|21302400|P2|STARTED|Overall Study||33
8630891|NCT01716117|21302401|P1|STARTED|Overall Study||180
8630901|NCT01660737|21302436|P1|NOT COMPLETED|Overall Study||0
8630902|NCT01660737|21302436|P1|COMPLETED|Overall Study||123
8630903|NCT01660737|21302436|P1|STARTED|Overall Study||123
8630913|NCT01651442|21302486|P6|NOT COMPLETED|Phase II Treatment||10
8630914|NCT01651442|21302487|P5|NOT COMPLETED|Phase II Treatment||6
8630915|NCT01651442|21302488|P4|NOT COMPLETED|Phase II Treatment||12
8630916|NCT01651442|21302489|P3|NOT COMPLETED|Phase II Treatment||2
8630917|NCT01651442|21302490|P2|NOT COMPLETED|Phase II Treatment||0
8630918|NCT01651442|21302491|P1|NOT COMPLETED|Phase II Treatment||0
8630919|NCT01651442|21302486|P6|COMPLETED|Phase II Treatment||17
8630920|NCT01651442|21302487|P5|COMPLETED|Phase II Treatment||21
8630921|NCT01651442|21302488|P4|COMPLETED|Phase II Treatment||15
8630922|NCT01651442|21302489|P3|COMPLETED|Phase II Treatment||25
8630923|NCT01651442|21302490|P2|COMPLETED|Phase II Treatment||0
8630924|NCT01651442|21302491|P1|COMPLETED|Phase II Treatment||0
8630925|NCT01651442|21302486|P6|STARTED|Phase II Treatment||27
8630926|NCT01651442|21302487|P5|STARTED|Phase II Treatment||27
8630927|NCT01651442|21302488|P4|STARTED|Phase II Treatment||27
8630928|NCT01651442|21302489|P3|STARTED|Phase II Treatment||27
8630929|NCT01651442|21302490|P2|STARTED|Phase II Treatment||0
8630930|NCT01651442|21302491|P1|STARTED|Phase II Treatment||0
8630931|NCT01651442|21302486|P6|NOT COMPLETED|Phase I Treatment||0
8630932|NCT01651442|21302487|P5|NOT COMPLETED|Phase I Treatment||0
8630933|NCT01651442|21302488|P4|NOT COMPLETED|Phase I Treatment||0
8630934|NCT01651442|21302489|P3|NOT COMPLETED|Phase I Treatment||0
8630935|NCT01651442|21302490|P2|NOT COMPLETED|Phase I Treatment||27
8630936|NCT01651442|21302491|P1|NOT COMPLETED|Phase I Treatment||16
8630937|NCT01651442|21302486|P6|COMPLETED|Phase I Treatment||0
8630938|NCT01651442|21302487|P5|COMPLETED|Phase I Treatment||0
8630939|NCT01651442|21302488|P4|COMPLETED|Phase I Treatment||0
8630940|NCT01651442|21302489|P3|COMPLETED|Phase I Treatment||0
8630941|NCT01651442|21302490|P2|COMPLETED|Phase I Treatment||80
8630942|NCT01651442|21302491|P1|COMPLETED|Phase I Treatment||88
8630943|NCT01651442|21302486|P6|STARTED|Phase I Treatment||0
8630944|NCT01651442|21302487|P5|STARTED|Phase I Treatment||0
8630945|NCT01651442|21302488|P4|STARTED|Phase I Treatment||0
8630946|NCT01651442|21302489|P3|STARTED|Phase I Treatment||0
8630947|NCT01651442|21302490|P2|STARTED|Phase I Treatment||107
8630948|NCT01651442|21302491|P1|STARTED|Phase I Treatment||104
8630949|NCT01615120|21302505|P2|NOT COMPLETED|Overall Study||20
8630950|NCT01615120|21302506|P1|NOT COMPLETED|Overall Study||15
8630951|NCT01615120|21302505|P2|COMPLETED|Overall Study||19
8630952|NCT01615120|21302506|P1|COMPLETED|Overall Study||23
8630953|NCT01615120|21302505|P2|STARTED|Overall Study||39
8630954|NCT01615120|21302506|P1|STARTED|Overall Study||38
8630955|NCT01609296|21302512|P1|NOT COMPLETED|Overall Study||488
8630956|NCT01609296|21302512|P1|COMPLETED|Overall Study||918
8630969|NCT01571232|21302686|P2|NOT COMPLETED|Overall Study||1
8630970|NCT01571232|21302687|P1|NOT COMPLETED|Overall Study||1
8630971|NCT01571232|21302686|P2|COMPLETED|Overall Study||9
8630972|NCT01571232|21302687|P1|COMPLETED|Overall Study||9
8630973|NCT01571232|21302686|P2|STARTED|Overall Study||10
8630974|NCT01571232|21302687|P1|STARTED|Overall Study||10
8630975|NCT01543490|21302703|P2|NOT COMPLETED|Overall Study||5
8630976|NCT01543490|21302704|P1|NOT COMPLETED|Overall Study||16
8630977|NCT01543490|21302703|P2|COMPLETED|Overall Study||185
8630978|NCT01543490|21302704|P1|COMPLETED|Overall Study||352
8630979|NCT01543490|21302703|P2|STARTED|Overall Study||190
8630980|NCT01543490|21302704|P1|STARTED|Overall Study||368
8630981|NCT01537302|21302712|P1|NOT COMPLETED|Overall Study||0
8630982|NCT01537302|21302712|P1|COMPLETED|Overall Study||100
8630983|NCT01537302|21302712|P1|STARTED|Overall Study||100
8630984|NCT01468896|21302727|P2|NOT COMPLETED|Overall Study||0
8630985|NCT01468896|21302728|P1|NOT COMPLETED|Overall Study||0
8630986|NCT01468896|21302727|P2|COMPLETED|Overall Study||17
8630987|NCT01468896|21302728|P1|COMPLETED|Overall Study||6
8630988|NCT01468896|21302727|P2|STARTED|Overall Study||17
8630989|NCT01468896|21302728|P1|STARTED|Overall Study||6
8630990|NCT01468701|21302761|P17|NOT COMPLETED|Overall Study||1
8630991|NCT01468701|21302762|P16|NOT COMPLETED|Overall Study||362
8630992|NCT01468701|21302763|P15|NOT COMPLETED|Overall Study||63
8630993|NCT01468701|21302764|P14|NOT COMPLETED|Overall Study||470
8630994|NCT01468701|21302765|P13|NOT COMPLETED|Overall Study||49
8630995|NCT01468701|21302766|P12|NOT COMPLETED|Overall Study||866
8630996|NCT01468701|21302767|P11|NOT COMPLETED|Overall Study||798
8630997|NCT01468701|21302768|P10|NOT COMPLETED|Overall Study||1182
8630998|NCT01468701|21302769|P9|NOT COMPLETED|Overall Study||660
8630999|NCT01468701|21302770|P8|NOT COMPLETED|Overall Study||5
8631000|NCT01468701|21302771|P7|NOT COMPLETED|Overall Study||1209
8631001|NCT01468701|21302772|P6|NOT COMPLETED|Overall Study||128
8631002|NCT01468701|21302773|P5|NOT COMPLETED|Overall Study||1736
8631003|NCT01468701|21302774|P4|NOT COMPLETED|Overall Study||715
8631004|NCT01468701|21302775|P3|NOT COMPLETED|Overall Study||1784
8631005|NCT01468701|21302776|P2|NOT COMPLETED|Overall Study||5103
8631006|NCT01468701|21302777|P1|NOT COMPLETED|Overall Study||999
8631007|NCT01468701|21302761|P17|COMPLETED|Overall Study||10
8631008|NCT01468701|21302762|P16|COMPLETED|Overall Study||1056
8631009|NCT01468701|21302763|P15|COMPLETED|Overall Study||151
8631010|NCT01468701|21302764|P14|COMPLETED|Overall Study||1712
8631011|NCT01468701|21302765|P13|COMPLETED|Overall Study||284
8631012|NCT01468701|21302766|P12|COMPLETED|Overall Study||3672
8631013|NCT01468701|21302767|P11|COMPLETED|Overall Study||3256
8631014|NCT01468701|21302768|P10|COMPLETED|Overall Study||3780
8631015|NCT01468701|21302769|P9|COMPLETED|Overall Study||3219
8631016|NCT01468701|21302770|P8|COMPLETED|Overall Study||0
8631017|NCT01468701|21302771|P7|COMPLETED|Overall Study||0
8631018|NCT01468701|21302772|P6|COMPLETED|Overall Study||0
8631019|NCT01468701|21302773|P5|COMPLETED|Overall Study||0
8631020|NCT01468701|21302774|P4|COMPLETED|Overall Study||0
8631021|NCT01468701|21302775|P3|COMPLETED|Overall Study||0
8631022|NCT01468701|21302776|P2|COMPLETED|Overall Study||0
8631023|NCT01468701|21302777|P1|COMPLETED|Overall Study||3965
8631024|NCT01468701|21302761|P17|All Eligible Patient|Overall Study||11
8631025|NCT01468701|21302762|P16|All Eligible Patient|Overall Study||1386
8631026|NCT01468701|21302763|P15|All Eligible Patient|Overall Study||213
8631027|NCT01468701|21302764|P14|All Eligible Patient|Overall Study||2163
8631028|NCT01468701|21302765|P13|All Eligible Patient|Overall Study||332
8631029|NCT01468701|21302766|P12|All Eligible Patient|Overall Study||4505
8631030|NCT01468701|21302767|P11|All Eligible Patient|Overall Study||4015
8631031|NCT01468701|21302768|P10|All Eligible Patient|Overall Study||4836
8631032|NCT01468701|21302769|P9|All Eligible Patient|Overall Study||3839
8631033|NCT01468701|21302770|P8|All Eligible Patient|Overall Study||4
8631034|NCT01468701|21302771|P7|All Eligible Patient|Overall Study||1170
8631035|NCT01468701|21302772|P6|All Eligible Patient|Overall Study||126
8631036|NCT01468701|21302773|P5|All Eligible Patient|Overall Study||1714
8631037|NCT01468701|21302774|P4|All Eligible Patient|Overall Study||703
8631038|NCT01468701|21302775|P3|All Eligible Patient|Overall Study||1755
8631039|NCT01468701|21302776|P2|All Eligible Patient|Overall Study||4963
8631040|NCT01468701|21302777|P1|All Eligible Patient|Overall Study||4873
8631041|NCT01468701|21302761|P17|STARTED|Overall Study||11
8631042|NCT01468701|21302762|P16|STARTED|Overall Study||1418
8631043|NCT01468701|21302763|P15|STARTED|Overall Study||214
8631044|NCT01468701|21302764|P14|STARTED|Overall Study||2182
8631045|NCT01468701|21302765|P13|STARTED|Overall Study||333
8631046|NCT01468701|21302766|P12|STARTED|Overall Study||4538
8631047|NCT01468701|21302767|P11|STARTED|Overall Study||4054
8631048|NCT01468701|21302768|P10|STARTED|Overall Study||4962
8631049|NCT01468701|21302769|P9|STARTED|Overall Study||3879
8631050|NCT01468701|21302770|P8|STARTED|Overall Study||5
8631051|NCT01468701|21302771|P7|STARTED|Overall Study||1209
8631052|NCT01468701|21302772|P6|STARTED|Overall Study||128
8631053|NCT01468701|21302773|P5|STARTED|Overall Study||1736
8631054|NCT01468701|21302774|P4|STARTED|Overall Study||715
8631055|NCT01468701|21302775|P3|STARTED|Overall Study||1784
8631056|NCT01468701|21302776|P2|STARTED|Overall Study||5103
8631057|NCT01468701|21302777|P1|STARTED|Overall Study||4964
8631058|NCT01468532|21302822|P1|NOT COMPLETED|Overall Study||0
8631059|NCT01468532|21302822|P1|COMPLETED|Overall Study||18
8631060|NCT01468532|21302822|P1|STARTED|Overall Study||18
8631061|NCT01454414|21302836|P2|NOT COMPLETED|Overall Study||16
8631062|NCT01454414|21302837|P1|NOT COMPLETED|Overall Study||13
8631063|NCT01454414|21302836|P2|COMPLETED|Overall Study||64
8631064|NCT01454414|21302837|P1|COMPLETED|Overall Study||66
8631065|NCT01454414|21302836|P2|Baseline: Subjects That Sent Uniforms|Overall Study||66
8631066|NCT01454414|21302837|P1|Baseline: Subjects That Sent Uniforms|Overall Study||67
8631067|NCT01454414|21302836|P2|STARTED|Overall Study||80
8631068|NCT01454414|21302837|P1|STARTED|Overall Study||79
8631077|NCT01438957|21302865|P5|NOT COMPLETED|Overall Study||0
8631078|NCT01438957|21302866|P4|NOT COMPLETED|Overall Study||1
8631079|NCT01438957|21302867|P3|NOT COMPLETED|Overall Study||0
8631080|NCT01438957|21302868|P2|NOT COMPLETED|Overall Study||1
8631081|NCT01438957|21302869|P1|NOT COMPLETED|Overall Study||1
8631082|NCT01438957|21302865|P5|COMPLETED|Overall Study||25
8631083|NCT01438957|21302866|P4|COMPLETED|Overall Study||24
8631084|NCT01438957|21302867|P3|COMPLETED|Overall Study||24
8631085|NCT01438957|21302868|P2|COMPLETED|Overall Study||22
8631086|NCT01438957|21302869|P1|COMPLETED|Overall Study||21
8631087|NCT01438957|21302865|P5|STARTED|Overall Study||25
8631088|NCT01438957|21302866|P4|STARTED|Overall Study||25
8631089|NCT01438957|21302867|P3|STARTED|Overall Study||24
8631090|NCT01438957|21302868|P2|STARTED|Overall Study||23
8631091|NCT01438957|21302869|P1|STARTED|Overall Study||22
8631101|NCT01403584|21303001|P2|NOT COMPLETED|Second Intervention(1 Night)||0
8631102|NCT01403584|21303002|P1|NOT COMPLETED|Second Intervention(1 Night)||0
8631103|NCT01403584|21303001|P2|COMPLETED|Second Intervention(1 Night)||11
8631104|NCT01403584|21303002|P1|COMPLETED|Second Intervention(1 Night)||10
8631105|NCT01403584|21303001|P2|STARTED|Second Intervention(1 Night)||11
8631106|NCT01403584|21303002|P1|STARTED|Second Intervention(1 Night)||10
8631107|NCT01403584|21303001|P2|NOT COMPLETED|First Intervention (1 Night)||0
8631108|NCT01403584|21303002|P1|NOT COMPLETED|First Intervention (1 Night)||0
8631109|NCT01403584|21303001|P2|COMPLETED|First Intervention (1 Night)||10
8631110|NCT01403584|21303002|P1|COMPLETED|First Intervention (1 Night)||11
8631111|NCT01403584|21303001|P2|STARTED|First Intervention (1 Night)||10
8631112|NCT01403584|21303002|P1|STARTED|First Intervention (1 Night)||11
8631113|NCT01349140|21303010|P1|NOT COMPLETED|Overall Study||0
8631114|NCT01349140|21303010|P1|COMPLETED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
8631115|NCT01349140|21303010|P1|STARTED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
8631116|NCT01312233|21303018|P3|NOT COMPLETED|Overall Study||7
8631117|NCT01312233|21303019|P2|NOT COMPLETED|Overall Study||0
8631118|NCT01312233|21303020|P1|NOT COMPLETED|Overall Study||2
8631119|NCT01312233|21303018|P3|COMPLETED|Overall Study||36
8631120|NCT01312233|21303019|P2|COMPLETED|Overall Study||44
8631121|NCT01312233|21303020|P1|COMPLETED|Overall Study||42
8631122|NCT01312233|21303018|P3|STARTED|Overall Study||43
8631123|NCT01312233|21303019|P2|STARTED|Overall Study||44
8631124|NCT01312233|21303020|P1|STARTED|Overall Study||44
8631125|NCT01307579|21303042|P2|NOT COMPLETED|Overall Study||145
8631126|NCT01307579|21303043|P1|NOT COMPLETED|Overall Study||140
8631127|NCT01307579|21303042|P2|COMPLETED|Overall Study||115
8631128|NCT01307579|21303043|P1|COMPLETED|Overall Study||117
8631129|NCT01307579|21303042|P2|STARTED|Overall Study||260
8631130|NCT01307579|21303043|P1|STARTED|Overall Study||257
8631131|NCT01293682|21303055|P1|NOT COMPLETED|Overall Study||0
8631132|NCT01293682|21303055|P1|COMPLETED|Overall Study||12
8631133|NCT01293682|21303055|P1|STARTED|Overall Study||12
8631164|NCT01231659|21303119|P1|NOT COMPLETED|Overall Study||72
8631165|NCT01231659|21303119|P1|COMPLETED|Overall Study||0
8631166|NCT01231659|21303119|P1|Safety Set|Overall Study||72
8631167|NCT01231659|21303119|P1|Per Protocol (PP) Set|Overall Study||72
8631168|NCT01231659|21303119|P1|STARTED|Overall Study||72
8631174|NCT01197547|21303143|P1|NOT COMPLETED|Overall Study||22
8631175|NCT01197547|21303143|P1|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
8631176|NCT01197547|21303143|P1|STARTED|Overall Study||1014
8631177|NCT01175356|21303149|P1|NOT COMPLETED|Overall Study||81
8631178|NCT01175356|21303149|P1|COMPLETED|Overall Study||18
8631179|NCT01175356|21303149|P1|STARTED|Overall Study||99
8631192|NCT01146561|21303190|P1|NOT COMPLETED|Overall Study||2
8631193|NCT01146561|21303190|P1|COMPLETED|Overall Study||0
8631194|NCT01146561|21303190|P1|STARTED|Overall Study||2
8631195|NCT01086540|21303213|P2|NOT COMPLETED|Overall Study||2
8631196|NCT01086540|21303214|P1|NOT COMPLETED|Overall Study||6
8631197|NCT01086540|21303213|P2|COMPLETED|Overall Study||26
8631198|NCT01086540|21303214|P1|COMPLETED|Overall Study||23
8631199|NCT01086540|21303213|P2|STARTED|Overall Study||28
8631200|NCT01086540|21303214|P1|STARTED|Overall Study||29
8631201|NCT01064817|21303258|P2|NOT COMPLETED|Study Completion||0
8631202|NCT01064817|21303259|P1|NOT COMPLETED|Study Completion||2
8631203|NCT01064817|21303258|P2|COMPLETED|Study Completion||62
8631204|NCT01064817|21303259|P1|COMPLETED|Study Completion||60
8631205|NCT01064817|21303258|P2|STARTED|Study Completion||62
8631206|NCT01064817|21303259|P1|STARTED|Study Completion||62
8631207|NCT01064817|21303258|P2|NOT COMPLETED|All Study Treatment Days 1-9||0
8631208|NCT01064817|21303259|P1|NOT COMPLETED|All Study Treatment Days 1-9||0
8631209|NCT01064817|21303258|P2|COMPLETED|All Study Treatment Days 1-9||62
8631210|NCT01064817|21303259|P1|COMPLETED|All Study Treatment Days 1-9||62
8631211|NCT01064817|21303258|P2|STARTED|All Study Treatment Days 1-9||62
8631212|NCT01064817|21303259|P1|STARTED|All Study Treatment Days 1-9||62
8631216|NCT01024231|21303284|P7|NOT COMPLETED|Overall Study||21
8631217|NCT01024231|21303285|P6|NOT COMPLETED|Overall Study||16
8631218|NCT01024231|21303286|P5|NOT COMPLETED|Overall Study||17
8631219|NCT01024231|21303287|P4|NOT COMPLETED|Overall Study||5
8631220|NCT01024231|21303288|P3|NOT COMPLETED|Overall Study||10
8631221|NCT01024231|21303289|P2|NOT COMPLETED|Overall Study||15
8631222|NCT01024231|21303290|P1|NOT COMPLETED|Overall Study||12
8631223|NCT01024231|21303284|P7|COMPLETED|Overall Study||20
8631224|NCT01024231|21303285|P6|COMPLETED|Overall Study||0
8631225|NCT01024231|21303286|P5|COMPLETED|Overall Study||0
8631226|NCT01024231|21303287|P4|COMPLETED|Overall Study||1
8631227|NCT01024231|21303288|P3|COMPLETED|Overall Study||6
8631228|NCT01024231|21303289|P2|COMPLETED|Overall Study||2
8631229|NCT01024231|21303290|P1|COMPLETED|Overall Study||2
8631230|NCT01024231|21303284|P7|STARTED|Overall Study||41
8631231|NCT01024231|21303285|P6|STARTED|Overall Study||16
8631232|NCT01024231|21303286|P5|STARTED|Overall Study||17
8631233|NCT01024231|21303287|P4|STARTED|Overall Study||6
8631234|NCT01024231|21303288|P3|STARTED|Overall Study||16
8631235|NCT01024231|21303289|P2|STARTED|Overall Study||17
8631236|NCT01024231|21303290|P1|STARTED|Overall Study||14
8631237|NCT01012609|21303443|P2|NOT COMPLETED|Overall Study||1
8631238|NCT01012609|21303444|P1|NOT COMPLETED|Overall Study||1
8631239|NCT01012609|21303443|P2|COMPLETED|Overall Study||25
8631240|NCT01012609|21303444|P1|COMPLETED|Overall Study||20
8631241|NCT01012609|21303443|P2|STARTED|Overall Study||26
8631242|NCT01012609|21303444|P1|STARTED|Overall Study||21
8631243|NCT01011179|21303467|P2|NOT COMPLETED|Overall Study||2
8631244|NCT01011179|21303468|P1|NOT COMPLETED|Overall Study||4
8631245|NCT01011179|21303467|P2|COMPLETED|Overall Study||20
8631246|NCT01011179|21303468|P1|COMPLETED|Overall Study||20
8631247|NCT01011179|21303467|P2|STARTED|Overall Study||22
8631248|NCT01011179|21303468|P1|STARTED|Overall Study||24
8631249|NCT01009918|21303487|P3|NOT COMPLETED|Overall Study||30
8631250|NCT01009918|21303488|P2|NOT COMPLETED|Overall Study||24
8631251|NCT01009918|21303489|P1|NOT COMPLETED|Overall Study||24
8631252|NCT01009918|21303487|P3|COMPLETED|Overall Study||124
8631253|NCT01009918|21303488|P2|COMPLETED|Overall Study||132
8631254|NCT01009918|21303489|P1|COMPLETED|Overall Study||134
8631255|NCT01009918|21303487|P3|STARTED|Overall Study||154
8631256|NCT01009918|21303488|P2|STARTED|Overall Study||156
8631257|NCT01009918|21303489|P1|STARTED|Overall Study||158
8631258|NCT00977691|21303512|P3|NOT COMPLETED|Overall Study||0
8631259|NCT00977691|21303513|P2|NOT COMPLETED|Overall Study||1
8631260|NCT00977691|21303514|P1|NOT COMPLETED|Overall Study||0
8631261|NCT00977691|21303512|P3|COMPLETED|Overall Study||12
8631262|NCT00977691|21303513|P2|COMPLETED|Overall Study||7
8631263|NCT00977691|21303514|P1|COMPLETED|Overall Study||3
8631264|NCT00977691|21303512|P3|STARTED|Overall Study||12
8631265|NCT00977691|21303513|P2|STARTED|Overall Study||8
8631266|NCT00977691|21303514|P1|STARTED|Overall Study||3
8631267|NCT00961064|21303522|P1|NOT COMPLETED|Overall Study||0
8631268|NCT00961064|21303522|P1|COMPLETED|Overall Study||30
8631269|NCT00961064|21303522|P1|STARTED|Overall Study||30
8631270|NCT00955409|21303536|P10|NOT COMPLETED|Overall Study||1
8631271|NCT00955409|21303537|P9|NOT COMPLETED|Overall Study||14
8631272|NCT00955409|21303538|P8|NOT COMPLETED|Overall Study||4
8631273|NCT00955409|21303539|P7|NOT COMPLETED|Overall Study||24
8631274|NCT00955409|21303540|P6|NOT COMPLETED|Overall Study||3
8631275|NCT00955409|21303541|P5|NOT COMPLETED|Overall Study||2
8631276|NCT00955409|21303542|P4|NOT COMPLETED|Overall Study||8
8631277|NCT00955409|21303543|P3|NOT COMPLETED|Overall Study||26
8631278|NCT00955409|21303544|P2|NOT COMPLETED|Overall Study||1
8631279|NCT00955409|21303545|P1|NOT COMPLETED|Overall Study||10
8631280|NCT00955409|21303536|P10|COMPLETED|Overall Study|Completed study|3
8631281|NCT00955409|21303537|P9|COMPLETED|Overall Study|Completed study|2
8631282|NCT00955409|21303538|P8|COMPLETED|Overall Study|Completed study|2
8631283|NCT00955409|21303539|P7|COMPLETED|Overall Study|Completed study|3
8631284|NCT00955409|21303540|P6|COMPLETED|Overall Study|Completed study|6
8631285|NCT00955409|21303541|P5|COMPLETED|Overall Study|Completed study|3
8631286|NCT00955409|21303542|P4|COMPLETED|Overall Study|Completed study|17
8631287|NCT00955409|21303543|P3|COMPLETED|Overall Study|Completed study|15
8631288|NCT00955409|21303544|P2|COMPLETED|Overall Study|Completed study|5
8631289|NCT00955409|21303545|P1|COMPLETED|Overall Study|Completed study|11
8631290|NCT00955409|21303536|P10|Completed Treatment|Overall Study||4
8631291|NCT00955409|21303537|P9|Completed Treatment|Overall Study||2
8631292|NCT00955409|21303538|P8|Completed Treatment|Overall Study||3
8631293|NCT00955409|21303539|P7|Completed Treatment|Overall Study||4
8631294|NCT00955409|21303540|P6|Completed Treatment|Overall Study||7
8631295|NCT00955409|21303541|P5|Completed Treatment|Overall Study||3
8631296|NCT00955409|21303542|P4|Completed Treatment|Overall Study||17
8631297|NCT00955409|21303543|P3|Completed Treatment|Overall Study||15
8631298|NCT00955409|21303544|P2|Completed Treatment|Overall Study||5
8631299|NCT00955409|21303545|P1|Completed Treatment|Overall Study||12
8631300|NCT00955409|21303536|P10|Treated|Overall Study||4
8631301|NCT00955409|21303537|P9|Treated|Overall Study||16
8631302|NCT00955409|21303538|P8|Treated|Overall Study||6
8631303|NCT00955409|21303539|P7|Treated|Overall Study||27
8631304|NCT00955409|21303540|P6|Treated|Overall Study||9
8631305|NCT00955409|21303541|P5|Treated|Overall Study||5
8631306|NCT00955409|21303542|P4|Treated|Overall Study||24
8631307|NCT00955409|21303543|P3|Treated|Overall Study||41
8631308|NCT00955409|21303544|P2|Treated|Overall Study||6
8631309|NCT00955409|21303545|P1|Treated|Overall Study||21
8631310|NCT00955409|21303536|P10|STARTED|Overall Study|Started=Randomized|4
8631311|NCT00955409|21303537|P9|STARTED|Overall Study|Started=Randomized|16
8631312|NCT00955409|21303538|P8|STARTED|Overall Study|Started=Randomized|6
8631313|NCT00955409|21303539|P7|STARTED|Overall Study|Started=Randomized|27
8631314|NCT00955409|21303540|P6|STARTED|Overall Study|Started=Randomized|9
8631315|NCT00955409|21303541|P5|STARTED|Overall Study|Started=Randomized|5
8631316|NCT00955409|21303542|P4|STARTED|Overall Study|Started=Randomized.|25
8631317|NCT00955409|21303543|P3|STARTED|Overall Study|Started=Randomized|41
8631318|NCT00955409|21303544|P2|STARTED|Overall Study|Started=Randomized|6
8631319|NCT00955409|21303545|P1|STARTED|Overall Study|Started=Randomized|21
8631320|NCT00945009|21303592|P3|NOT COMPLETED|Overall Study||3
8631321|NCT00945009|21303593|P2|NOT COMPLETED|Overall Study||7
8631322|NCT00945009|21303594|P1|NOT COMPLETED|Overall Study||45
8631323|NCT00945009|21303592|P3|COMPLETED|Overall Study||6
8631324|NCT00945009|21303593|P2|COMPLETED|Overall Study||32
8631325|NCT00945009|21303594|P1|COMPLETED|Overall Study||156
8631326|NCT00945009|21303592|P3|STARTED|Overall Study||9
8631327|NCT00945009|21303593|P2|STARTED|Overall Study||39
8631328|NCT00945009|21303594|P1|STARTED|Overall Study||201
8631329|NCT00944749|21303604|P1|NOT COMPLETED|Overall Study||1
8631330|NCT00944749|21303604|P1|COMPLETED|Overall Study||22
8631331|NCT00944749|21303604|P1|STARTED|Overall Study||23
8631332|NCT00906958|21303609|P2|NOT COMPLETED|Overall Study||0
8631333|NCT00906958|21303610|P1|NOT COMPLETED|Overall Study||0
8631334|NCT00906958|21303609|P2|COMPLETED|Overall Study||10
8631335|NCT00906958|21303610|P1|COMPLETED|Overall Study||10
8631336|NCT00906958|21303609|P2|STARTED|Overall Study||10
8631337|NCT00906958|21303610|P1|STARTED|Overall Study||10
8631338|NCT00905060|21303624|P1|NOT COMPLETED|Vaccination Treatment Period||0
8631339|NCT00905060|21303624|P1|COMPLETED|Vaccination Treatment Period||46
8631340|NCT00905060|21303624|P1|STARTED|Vaccination Treatment Period||46
8631341|NCT00905060|21303624|P1|NOT COMPLETED|Surgical Resection||24
8631342|NCT00905060|21303624|P1|COMPLETED|Surgical Resection||46
8631343|NCT00905060|21303624|P1|STARTED|Surgical Resection||70
8631344|NCT00886379|21303636|P5|NOT COMPLETED|Overall Study||3
8631345|NCT00886379|21303637|P4|NOT COMPLETED|Overall Study||3
8631346|NCT00886379|21303638|P3|NOT COMPLETED|Overall Study||6
8631347|NCT00886379|21303639|P2|NOT COMPLETED|Overall Study||3
8631348|NCT00886379|21303640|P1|NOT COMPLETED|Overall Study||3
8631349|NCT00886379|21303636|P5|COMPLETED|Overall Study||92
8631350|NCT00886379|21303637|P4|COMPLETED|Overall Study||109
8631351|NCT00886379|21303638|P3|COMPLETED|Overall Study||137
8631352|NCT00886379|21303639|P2|COMPLETED|Overall Study||140
8631353|NCT00886379|21303640|P1|COMPLETED|Overall Study||101
8631354|NCT00886379|21303636|P5|STARTED|Overall Study||95
8631355|NCT00886379|21303637|P4|STARTED|Overall Study||112
8631356|NCT00886379|21303638|P3|STARTED|Overall Study||143
8631357|NCT00886379|21303639|P2|STARTED|Overall Study||143
8631358|NCT00886379|21303640|P1|STARTED|Overall Study||104
8631359|NCT00866918|21303654|P2|NOT COMPLETED|Overall Study||12
8631360|NCT00866918|21303655|P1|NOT COMPLETED|Overall Study||16
8631361|NCT00866918|21303654|P2|COMPLETED|Overall Study||27
8631362|NCT00866918|21303655|P1|COMPLETED|Overall Study||53
8631363|NCT00866918|21303654|P2|STARTED|Overall Study||39
8631364|NCT00866918|21303655|P1|STARTED|Overall Study||69
8631383|NCT00857207|21303678|P2|NOT COMPLETED|Overall Study||0
8631384|NCT00857207|21303679|P1|NOT COMPLETED|Overall Study||34
8631385|NCT00857207|21303678|P2|COMPLETED|Overall Study||3
8631386|NCT00857207|21303679|P1|COMPLETED|Overall Study||14
8631387|NCT00857207|21303678|P2|STARTED|Overall Study||3
8631388|NCT00857207|21303679|P1|STARTED|Overall Study||48
8631425|NCT00758043|21303715|P4|NOT COMPLETED|Overall Study||100
8631426|NCT00758043|21303716|P3|NOT COMPLETED|Overall Study||39
8631427|NCT00758043|21303717|P2|NOT COMPLETED|Overall Study||41
8631428|NCT00758043|21303718|P1|NOT COMPLETED|Overall Study||1
8631429|NCT00758043|21303715|P4|COMPLETED|Overall Study||0
8631430|NCT00758043|21303716|P3|COMPLETED|Overall Study||79
8631431|NCT00758043|21303717|P2|COMPLETED|Overall Study||119
8631432|NCT00758043|21303718|P1|COMPLETED|Overall Study||161
8631433|NCT00758043|21303715|P4|STARTED|Overall Study||100
8631434|NCT00758043|21303716|P3|STARTED|Overall Study||118
8631435|NCT00758043|21303717|P2|STARTED|Overall Study||160
8631436|NCT00758043|21303718|P1|STARTED|Overall Study||162
8631437|NCT00733902|21303760|P4|NOT COMPLETED|Overall Study||164
8631438|NCT00733902|21303761|P3|NOT COMPLETED|Overall Study||161
8631439|NCT00733902|21303762|P2|NOT COMPLETED|Overall Study||162
8631440|NCT00733902|21303763|P1|NOT COMPLETED|Overall Study||164
8631441|NCT00733902|21303760|P4|COMPLETED|Overall Study||11
8631442|NCT00733902|21303761|P3|COMPLETED|Overall Study||13
8631443|NCT00733902|21303762|P2|COMPLETED|Overall Study||12
8631444|NCT00733902|21303763|P1|COMPLETED|Overall Study||10
8631445|NCT00733902|21303760|P4|Treated|Overall Study||174
8631446|NCT00733902|21303761|P3|Treated|Overall Study||172
8631447|NCT00733902|21303762|P2|Treated|Overall Study||172
8631448|NCT00733902|21303763|P1|Treated|Overall Study||172
8631449|NCT00733902|21303760|P4|STARTED|Overall Study||175
8631450|NCT00733902|21303761|P3|STARTED|Overall Study||174
8631451|NCT00733902|21303762|P2|STARTED|Overall Study||174
8631452|NCT00733902|21303763|P1|STARTED|Overall Study||174
8631453|NCT00725985|21303884|P12|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||14
8631454|NCT00725985|21303885|P11|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||36
8631455|NCT00725985|21303886|P10|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||34
8631456|NCT00725985|21303887|P9|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631457|NCT00725985|21303888|P8|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631458|NCT00725985|21303889|P7|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631459|NCT00725985|21303890|P6|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631460|NCT00725985|21303891|P5|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631461|NCT00725985|21303892|P4|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631462|NCT00725985|21303893|P3|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631463|NCT00725985|21303894|P2|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631464|NCT00725985|21303895|P1|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631465|NCT00725985|21303884|P12|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631466|NCT00725985|21303885|P11|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631467|NCT00725985|21303886|P10|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631468|NCT00725985|21303887|P9|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631469|NCT00725985|21303888|P8|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631470|NCT00725985|21303889|P7|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631471|NCT00725985|21303890|P6|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631472|NCT00725985|21303891|P5|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631473|NCT00725985|21303892|P4|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631474|NCT00725985|21303893|P3|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631475|NCT00725985|21303894|P2|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631476|NCT00725985|21303895|P1|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
8631477|NCT00725985|21303884|P12|STARTED|LTFU (No Cladribine) (48 Weeks)||14
8631478|NCT00725985|21303885|P11|STARTED|LTFU (No Cladribine) (48 Weeks)||36
8631479|NCT00725985|21303886|P10|STARTED|LTFU (No Cladribine) (48 Weeks)||34
8631480|NCT00725985|21303887|P9|STARTED|LTFU (No Cladribine) (48 Weeks)||0
8631481|NCT00725985|21303888|P8|STARTED|LTFU (No Cladribine) (48 Weeks)||0
8631482|NCT00725985|21303889|P7|STARTED|LTFU (No Cladribine) (48 Weeks)||0
8631483|NCT00725985|21303890|P6|STARTED|LTFU (No Cladribine) (48 Weeks)||0
8631484|NCT00725985|21303891|P5|STARTED|LTFU (No Cladribine) (48 Weeks)||0
8631485|NCT00725985|21303892|P4|STARTED|LTFU (No Cladribine) (48 Weeks)||0
8631486|NCT00725985|21303893|P3|STARTED|LTFU (No Cladribine) (48 Weeks)||0
8631487|NCT00725985|21303894|P2|STARTED|LTFU (No Cladribine) (48 Weeks)||0
8631488|NCT00725985|21303895|P1|STARTED|LTFU (No Cladribine) (48 Weeks)||0
8631489|NCT00725985|21303884|P12|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631490|NCT00725985|21303885|P11|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631491|NCT00725985|21303886|P10|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631492|NCT00725985|21303887|P9|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||17
8631493|NCT00725985|21303888|P8|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
8631494|NCT00725985|21303889|P7|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
8631495|NCT00725985|21303890|P6|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631496|NCT00725985|21303891|P5|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631497|NCT00725985|21303892|P4|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631498|NCT00725985|21303893|P3|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631499|NCT00725985|21303894|P2|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631500|NCT00725985|21303895|P1|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631501|NCT00725985|21303884|P12|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631502|NCT00725985|21303885|P11|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631503|NCT00725985|21303886|P10|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631504|NCT00725985|21303887|P9|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631505|NCT00725985|21303888|P8|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631506|NCT00725985|21303889|P7|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631507|NCT00725985|21303890|P6|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631508|NCT00725985|21303891|P5|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631509|NCT00725985|21303892|P4|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631510|NCT00725985|21303893|P3|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631511|NCT00725985|21303894|P2|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631512|NCT00725985|21303895|P1|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631513|NCT00725985|21303884|P12|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631514|NCT00725985|21303885|P11|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631515|NCT00725985|21303886|P10|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631516|NCT00725985|21303887|P9|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||17
8631517|NCT00725985|21303888|P8|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
8631518|NCT00725985|21303889|P7|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
8631519|NCT00725985|21303890|P6|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631520|NCT00725985|21303891|P5|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631521|NCT00725985|21303892|P4|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631522|NCT00725985|21303893|P3|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631523|NCT00725985|21303894|P2|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631524|NCT00725985|21303895|P1|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
8631525|NCT00725985|21303884|P12|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
8631526|NCT00725985|21303885|P11|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
8631527|NCT00725985|21303886|P10|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
8631528|NCT00725985|21303887|P9|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
8631529|NCT00725985|21303888|P8|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
8631530|NCT00725985|21303889|P7|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
8631531|NCT00725985|21303890|P6|NOT COMPLETED|OLMP (Up to 96 Weeks)||53
8631532|NCT00725985|21303891|P5|NOT COMPLETED|OLMP (Up to 96 Weeks)||23
8631533|NCT00725985|21303892|P4|NOT COMPLETED|OLMP (Up to 96 Weeks)||18
8631534|NCT00725985|21303893|P3|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
8631535|NCT00725985|21303894|P2|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
8631536|NCT00725985|21303895|P1|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
8631537|NCT00725985|21303884|P12|COMPLETED|OLMP (Up to 96 Weeks)||0
8631538|NCT00725985|21303885|P11|COMPLETED|OLMP (Up to 96 Weeks)||0
8631539|NCT00725985|21303886|P10|COMPLETED|OLMP (Up to 96 Weeks)||0
8631540|NCT00725985|21303887|P9|COMPLETED|OLMP (Up to 96 Weeks)||0
8631541|NCT00725985|21303888|P8|COMPLETED|OLMP (Up to 96 Weeks)||0
8631542|NCT00725985|21303889|P7|COMPLETED|OLMP (Up to 96 Weeks)||0
8631543|NCT00725985|21303890|P6|COMPLETED|OLMP (Up to 96 Weeks)||7
8631544|NCT00725985|21303891|P5|COMPLETED|OLMP (Up to 96 Weeks)||2
8631545|NCT00725985|21303892|P4|COMPLETED|OLMP (Up to 96 Weeks)||6
8631546|NCT00725985|21303893|P3|COMPLETED|OLMP (Up to 96 Weeks)||0
8631547|NCT00725985|21303894|P2|COMPLETED|OLMP (Up to 96 Weeks)||0
8631548|NCT00725985|21303895|P1|COMPLETED|OLMP (Up to 96 Weeks)||0
8631549|NCT00725985|21303884|P12|STARTED|OLMP (Up to 96 Weeks)||0
8631550|NCT00725985|21303885|P11|STARTED|OLMP (Up to 96 Weeks)||0
8631551|NCT00725985|21303886|P10|STARTED|OLMP (Up to 96 Weeks)||0
8631552|NCT00725985|21303887|P9|STARTED|OLMP (Up to 96 Weeks)||0
8631553|NCT00725985|21303888|P8|STARTED|OLMP (Up to 96 Weeks)||0
8631554|NCT00725985|21303889|P7|STARTED|OLMP (Up to 96 Weeks)||0
8631555|NCT00725985|21303890|P6|STARTED|OLMP (Up to 96 Weeks)||60
8631556|NCT00725985|21303891|P5|STARTED|OLMP (Up to 96 Weeks)||25
8631557|NCT00725985|21303892|P4|STARTED|OLMP (Up to 96 Weeks)||24
8631558|NCT00725985|21303893|P3|STARTED|OLMP (Up to 96 Weeks)||0
8631559|NCT00725985|21303894|P2|STARTED|OLMP (Up to 96 Weeks)||0
8631560|NCT00725985|21303895|P1|STARTED|OLMP (Up to 96 Weeks)||0
8631561|NCT00725985|21303884|P12|NOT COMPLETED|ITP- Treatment Disposition||0
8631562|NCT00725985|21303885|P11|NOT COMPLETED|ITP- Treatment Disposition||0
8631563|NCT00725985|21303886|P10|NOT COMPLETED|ITP- Treatment Disposition||0
8631564|NCT00725985|21303887|P9|NOT COMPLETED|ITP- Treatment Disposition||0
8631565|NCT00725985|21303888|P8|NOT COMPLETED|ITP- Treatment Disposition||0
8631566|NCT00725985|21303889|P7|NOT COMPLETED|ITP- Treatment Disposition||0
8631567|NCT00725985|21303890|P6|NOT COMPLETED|ITP- Treatment Disposition||0
8631568|NCT00725985|21303891|P5|NOT COMPLETED|ITP- Treatment Disposition||0
8631569|NCT00725985|21303892|P4|NOT COMPLETED|ITP- Treatment Disposition||0
8631570|NCT00725985|21303893|P3|NOT COMPLETED|ITP- Treatment Disposition||102
8631571|NCT00725985|21303894|P2|NOT COMPLETED|ITP- Treatment Disposition||75
8631572|NCT00725985|21303895|P1|NOT COMPLETED|ITP- Treatment Disposition||101
8631573|NCT00725985|21303884|P12|COMPLETED|ITP- Treatment Disposition||0
8631574|NCT00725985|21303885|P11|COMPLETED|ITP- Treatment Disposition||0
8631575|NCT00725985|21303886|P10|COMPLETED|ITP- Treatment Disposition||0
8631576|NCT00725985|21303887|P9|COMPLETED|ITP- Treatment Disposition||0
8631577|NCT00725985|21303888|P8|COMPLETED|ITP- Treatment Disposition||0
8631578|NCT00725985|21303889|P7|COMPLETED|ITP- Treatment Disposition||0
8631579|NCT00725985|21303890|P6|COMPLETED|ITP- Treatment Disposition||0
8631580|NCT00725985|21303891|P5|COMPLETED|ITP- Treatment Disposition||0
8631581|NCT00725985|21303892|P4|COMPLETED|ITP- Treatment Disposition||0
8631582|NCT00725985|21303893|P3|COMPLETED|ITP- Treatment Disposition||104
8631583|NCT00725985|21303894|P2|COMPLETED|ITP- Treatment Disposition||131
8631584|NCT00725985|21303895|P1|COMPLETED|ITP- Treatment Disposition||104
8631585|NCT00725985|21303884|P12|Treated|ITP- Treatment Disposition||0
8631586|NCT00725985|21303885|P11|Treated|ITP- Treatment Disposition||0
8631587|NCT00725985|21303886|P10|Treated|ITP- Treatment Disposition||0
8631588|NCT00725985|21303887|P9|Treated|ITP- Treatment Disposition||0
8631589|NCT00725985|21303888|P8|Treated|ITP- Treatment Disposition||0
8631590|NCT00725985|21303889|P7|Treated|ITP- Treatment Disposition||0
8631591|NCT00725985|21303890|P6|Treated|ITP- Treatment Disposition||0
8631592|NCT00725985|21303891|P5|Treated|ITP- Treatment Disposition||0
8631593|NCT00725985|21303892|P4|Treated|ITP- Treatment Disposition||0
8631594|NCT00725985|21303893|P3|Treated|ITP- Treatment Disposition||206
8631595|NCT00725985|21303894|P2|Treated|ITP- Treatment Disposition||206
8631596|NCT00725985|21303895|P1|Treated|ITP- Treatment Disposition||204
8631597|NCT00725985|21303884|P12|STARTED|ITP- Treatment Disposition||0
8631598|NCT00725985|21303885|P11|STARTED|ITP- Treatment Disposition||0
8631599|NCT00725985|21303886|P10|STARTED|ITP- Treatment Disposition||0
8631600|NCT00725985|21303887|P9|STARTED|ITP- Treatment Disposition||0
8631601|NCT00725985|21303888|P8|STARTED|ITP- Treatment Disposition||0
8631602|NCT00725985|21303889|P7|STARTED|ITP- Treatment Disposition||0
8631603|NCT00725985|21303890|P6|STARTED|ITP- Treatment Disposition||0
8631604|NCT00725985|21303891|P5|STARTED|ITP- Treatment Disposition||0
8631605|NCT00725985|21303892|P4|STARTED|ITP- Treatment Disposition||0
8631606|NCT00725985|21303893|P3|STARTED|ITP- Treatment Disposition||206
8631607|NCT00725985|21303894|P2|STARTED|ITP- Treatment Disposition||206
8631608|NCT00725985|21303895|P1|STARTED|ITP- Treatment Disposition||205
8631609|NCT00712712|21304056|P1|NOT COMPLETED|Overall Study||23
8631610|NCT00712712|21304056|P1|COMPLETED|Overall Study||55
8631611|NCT00712712|21304056|P1|STARTED|Overall Study||78
8631612|NCT00675025|21304084|P2|NOT COMPLETED|Overall Study||63
8631613|NCT00675025|21304085|P1|NOT COMPLETED|Overall Study||54
8631614|NCT00675025|21304084|P2|COMPLETED|Overall Study||0
8631615|NCT00675025|21304085|P1|COMPLETED|Overall Study||0
8631616|NCT00675025|21304084|P2|STARTED|Overall Study||63
8631617|NCT00675025|21304085|P1|STARTED|Overall Study||54
8631665|NCT00655889|21304175|P1|NOT COMPLETED|Overall Study||2
8631666|NCT00655889|21304175|P1|COMPLETED|Overall Study||11
8631667|NCT00655889|21304175|P1|STARTED|Overall Study||13
8631668|NCT00654511|21304184|P4|NOT COMPLETED|Overall Study||0
8631669|NCT00654511|21304185|P3|NOT COMPLETED|Overall Study||0
8631670|NCT00654511|21304186|P2|NOT COMPLETED|Overall Study||0
8631671|NCT00654511|21304187|P1|NOT COMPLETED|Overall Study||0
8631672|NCT00654511|21304184|P4|COMPLETED|Overall Study||25
8631673|NCT00654511|21304185|P3|COMPLETED|Overall Study||25
8631674|NCT00654511|21304186|P2|COMPLETED|Overall Study||25
8631675|NCT00654511|21304187|P1|COMPLETED|Overall Study||26
8631676|NCT00654511|21304184|P4|STARTED|Overall Study||25
8631677|NCT00654511|21304185|P3|STARTED|Overall Study||25
8631678|NCT00654511|21304186|P2|STARTED|Overall Study||25
8631679|NCT00654511|21304187|P1|STARTED|Overall Study||26
8631700|NCT00590681|21304214|P1|NOT COMPLETED|Overall Study||20
8631701|NCT00590681|21304214|P1|COMPLETED|Overall Study|The forty-two participants who did proceed to the post-RT phase|42
8631702|NCT00590681|21304214|P1|STARTED|Overall Study||62
8631703|NCT00570258|21304225|P2|NOT COMPLETED|Overall Study||15
8631704|NCT00570258|21304226|P1|NOT COMPLETED|Overall Study||12
8631705|NCT00570258|21304225|P2|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
8631706|NCT00570258|21304226|P1|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
8631707|NCT00570258|21304225|P2|STARTED|Overall Study||15
8631708|NCT00570258|21304226|P1|STARTED|Overall Study||12
8631732|NCT00557193|21304290|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
8631733|NCT00557193|21304291|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
8631734|NCT00557193|21304292|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
8631735|NCT00557193|21304293|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
8631736|NCT00557193|21304294|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
8631737|NCT00557193|21304295|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
8631738|NCT00557193|21304290|P6|COMPLETED|Post Induction Therapy by Tx Assignment||19
8631739|NCT00557193|21304291|P5|COMPLETED|Post Induction Therapy by Tx Assignment||4
8631740|NCT00557193|21304292|P4|COMPLETED|Post Induction Therapy by Tx Assignment||4
8631741|NCT00557193|21304293|P3|COMPLETED|Post Induction Therapy by Tx Assignment||22
8631742|NCT00557193|21304294|P2|COMPLETED|Post Induction Therapy by Tx Assignment||50
8631743|NCT00557193|21304295|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
8631744|NCT00557193|21304290|P6|STARTED|Post Induction Therapy by Tx Assignment||56
8631745|NCT00557193|21304291|P5|STARTED|Post Induction Therapy by Tx Assignment||11
8631746|NCT00557193|21304292|P4|STARTED|Post Induction Therapy by Tx Assignment||11
8631747|NCT00557193|21304293|P3|STARTED|Post Induction Therapy by Tx Assignment||54
8631748|NCT00557193|21304294|P2|STARTED|Post Induction Therapy by Tx Assignment||60
8631749|NCT00557193|21304295|P1|STARTED|Post Induction Therapy by Tx Assignment||0
8631750|NCT00557193|21304290|P6|NOT COMPLETED|Induction||0
8631751|NCT00557193|21304291|P5|NOT COMPLETED|Induction||0
8631752|NCT00557193|21304292|P4|NOT COMPLETED|Induction||0
8631753|NCT00557193|21304293|P3|NOT COMPLETED|Induction||0
8631754|NCT00557193|21304294|P2|NOT COMPLETED|Induction||0
8631755|NCT00557193|21304295|P1|NOT COMPLETED|Induction||26
8631756|NCT00557193|21304290|P6|COMPLETED|Induction||0
8631757|NCT00557193|21304291|P5|COMPLETED|Induction||0
8631758|NCT00557193|21304292|P4|COMPLETED|Induction||0
8631759|NCT00557193|21304293|P3|COMPLETED|Induction||0
8631760|NCT00557193|21304294|P2|COMPLETED|Induction||0
8631761|NCT00557193|21304295|P1|COMPLETED|Induction||192
8631762|NCT00557193|21304290|P6|STARTED|Induction||0
8631763|NCT00557193|21304291|P5|STARTED|Induction||0
8631764|NCT00557193|21304292|P4|STARTED|Induction||0
8631765|NCT00557193|21304293|P3|STARTED|Induction||0
8631766|NCT00557193|21304294|P2|STARTED|Induction||0
8631767|NCT00557193|21304295|P1|STARTED|Induction||218
8631768|NCT00556374|21304335|P2|NOT COMPLETED|Overall Study||220
8631769|NCT00556374|21304336|P1|NOT COMPLETED|Overall Study||247
8631770|NCT00556374|21304335|P2|COMPLETED|Overall Study|Indicates participants continuing study|1491
8631771|NCT00556374|21304336|P1|COMPLETED|Overall Study|Indicates participants continuing study|1462
8631772|NCT00556374|21304335|P2|Received Study Drug|Overall Study||1700
8631773|NCT00556374|21304336|P1|Received Study Drug|Overall Study||1699
8631774|NCT00556374|21304335|P2|STARTED|Overall Study||1711
8631775|NCT00556374|21304336|P1|STARTED|Overall Study||1709
8631779|NCT00461591|21304365|P2|NOT COMPLETED|Overall Study||85
8631780|NCT00461591|21304366|P1|NOT COMPLETED|Overall Study||89
8631781|NCT00461591|21304365|P2|COMPLETED|Overall Study||311
8631782|NCT00461591|21304366|P1|COMPLETED|Overall Study||317
8631783|NCT00461591|21304365|P2|STARTED|Overall Study||396
8631784|NCT00461591|21304366|P1|STARTED|Overall Study||406
8631785|NCT00450411|21304386|P1|NOT COMPLETED|Overall Study||8
8631786|NCT00450411|21304386|P1|COMPLETED|Overall Study||92
8631787|NCT00450411|21304386|P1|Eligible and Started Protocol Treatment|Overall Study||92
8631788|NCT00450411|21304386|P1|STARTED|Overall Study||100
8631789|NCT00443079|21304399|P2|NOT COMPLETED|Overall Study||1
8631790|NCT00443079|21304400|P1|NOT COMPLETED|Overall Study||0
8631791|NCT00443079|21304399|P2|COMPLETED|Overall Study||2
8631792|NCT00443079|21304400|P1|COMPLETED|Overall Study||3
8631793|NCT00443079|21304399|P2|STARTED|Overall Study||3
8631794|NCT00443079|21304400|P1|STARTED|Overall Study||3
8631907|NCT00406315|21304447|P1|NOT COMPLETED|Overall Study||141
8631908|NCT00406315|21304447|P1|COMPLETED|Overall Study||100
8631909|NCT00406315|21304447|P1|STARTED|Overall Study|Started = Treated|241
8631910|NCT00381940|21304465|P1|NOT COMPLETED|Overall Study||5
8631911|NCT00381940|21304465|P1|COMPLETED|Overall Study||21
8631912|NCT00381940|21304465|P1|STARTED|Overall Study||26
8631913|NCT00379340|21304479|P5|NOT COMPLETED|Overall Study||14
8631914|NCT00379340|21304480|P4|NOT COMPLETED|Overall Study||13
8631915|NCT00379340|21304481|P3|NOT COMPLETED|Overall Study||2
8631916|NCT00379340|21304482|P2|NOT COMPLETED|Overall Study||3
8631917|NCT00379340|21304483|P1|NOT COMPLETED|Overall Study||13
8631918|NCT00379340|21304479|P5|COMPLETED|Overall Study||9
8631919|NCT00379340|21304480|P4|COMPLETED|Overall Study||37
8631920|NCT00379340|21304481|P3|COMPLETED|Overall Study||50
8631921|NCT00379340|21304482|P2|COMPLETED|Overall Study||132
8631922|NCT00379340|21304483|P1|COMPLETED|Overall Study||107
8631923|NCT00379340|21304479|P5|STARTED|Overall Study||23
8631924|NCT00379340|21304480|P4|STARTED|Overall Study||50
8631925|NCT00379340|21304481|P3|STARTED|Overall Study||52
8631926|NCT00379340|21304482|P2|STARTED|Overall Study||135
8631927|NCT00379340|21304483|P1|STARTED|Overall Study||120
8631928|NCT00372593|21304499|P3|NOT COMPLETED|Overall Study||4
8631929|NCT00372593|21304500|P2|NOT COMPLETED|Overall Study||198
8631930|NCT00372593|21304501|P1|NOT COMPLETED|Overall Study||204
8631931|NCT00372593|21304499|P3|COMPLETED|Overall Study||3
8631932|NCT00372593|21304500|P2|COMPLETED|Overall Study||334
8631933|NCT00372593|21304501|P1|COMPLETED|Overall Study||327
8631934|NCT00372593|21304499|P3|STARTED|Overall Study||7
8631935|NCT00372593|21304500|P2|STARTED|Overall Study||532
8631936|NCT00372593|21304501|P1|STARTED|Overall Study||531
8631937|NCT00369317|21304527|P1|NOT COMPLETED|Overall Study||20
8631938|NCT00369317|21304527|P1|COMPLETED|Overall Study||185
8631939|NCT00369317|21304527|P1|STARTED|Overall Study||205
8631940|NCT00367380|21304544|P3|NOT COMPLETED|Overall Study||0
8631941|NCT00367380|21304545|P2|NOT COMPLETED|Overall Study||0
8631942|NCT00367380|21304546|P1|NOT COMPLETED|Overall Study||0
8631943|NCT00367380|21304544|P3|COMPLETED|Overall Study||6
8631944|NCT00367380|21304545|P2|COMPLETED|Overall Study||6
8631945|NCT00367380|21304546|P1|COMPLETED|Overall Study||6
8631946|NCT00367380|21304544|P3|STARTED|Overall Study||6
8631947|NCT00367380|21304545|P2|STARTED|Overall Study||6
8631948|NCT00367380|21304546|P1|STARTED|Overall Study||6
8631949|NCT00345345|21304554|P1|NOT COMPLETED|Overall Study||2
8631950|NCT00345345|21304554|P1|COMPLETED|Overall Study||27
8631951|NCT00345345|21304554|P1|STARTED|Overall Study||29
8631952|NCT00340678|21304562|P4|NOT COMPLETED|Overall Study||0
8631953|NCT00340678|21304563|P3|NOT COMPLETED|Overall Study||0
8631954|NCT00340678|21304564|P2|NOT COMPLETED|Overall Study||0
8631955|NCT00340678|21304565|P1|NOT COMPLETED|Overall Study||1
8631956|NCT00340678|21304562|P4|COMPLETED|Overall Study||39
8631957|NCT00340678|21304563|P3|COMPLETED|Overall Study||39
8631958|NCT00340678|21304564|P2|COMPLETED|Overall Study||46
8631959|NCT00340678|21304565|P1|COMPLETED|Overall Study||45
8631960|NCT00340678|21304562|P4|STARTED|Overall Study||39
8631961|NCT00340678|21304563|P3|STARTED|Overall Study||39
8631962|NCT00340678|21304564|P2|STARTED|Overall Study||46
8631963|NCT00340678|21304565|P1|STARTED|Overall Study||46
8631964|NCT00329108|21304579|P2|NOT COMPLETED|Overall Study||12
8631965|NCT00329108|21304580|P1|NOT COMPLETED|Overall Study||10
8631966|NCT00329108|21304579|P2|COMPLETED|Overall Study||2
8631967|NCT00329108|21304580|P1|COMPLETED|Overall Study||5
8631968|NCT00329108|21304579|P2|STARTED|Overall Study|study terminated due to poor recruitment|14
8631969|NCT00329108|21304580|P1|STARTED|Overall Study|study terminated due to poor recruitment|15
8631970|NCT00312494|21304589|P3|NOT COMPLETED|Overall Study||43
8631971|NCT00312494|21304590|P2|NOT COMPLETED|Overall Study||58
8631972|NCT00312494|21304591|P1|NOT COMPLETED|Overall Study||71
8631973|NCT00312494|21304589|P3|COMPLETED|Overall Study||179
8631974|NCT00312494|21304590|P2|COMPLETED|Overall Study||168
8631975|NCT00312494|21304591|P1|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
8631976|NCT00312494|21304589|P3|Received Study Treatment|Overall Study||217
8631977|NCT00312494|21304590|P2|Received Study Treatment|Overall Study||216
8631978|NCT00312494|21304591|P1|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
8631979|NCT00312494|21304589|P3|STARTED|Overall Study||222
8631980|NCT00312494|21304590|P2|STARTED|Overall Study||226
8631981|NCT00312494|21304591|P1|STARTED|Overall Study||232
8631982|NCT00304070|21304626|P3|NOT COMPLETED|Overall Study||12
8631983|NCT00304070|21304627|P2|NOT COMPLETED|Overall Study||7
8631984|NCT00304070|21304628|P1|NOT COMPLETED|Overall Study||3
8631985|NCT00304070|21304626|P3|COMPLETED|Overall Study||27
8631986|NCT00304070|21304627|P2|COMPLETED|Overall Study||8
8631987|NCT00304070|21304628|P1|COMPLETED|Overall Study||21
8631988|NCT00304070|21304626|P3|STARTED|Overall Study||39
8631989|NCT00304070|21304627|P2|STARTED|Overall Study||15
8631990|NCT00304070|21304628|P1|STARTED|Overall Study||24
8631991|NCT00302003|21304640|P1|NOT COMPLETED|Overall Study||80
8631992|NCT00302003|21304640|P1|COMPLETED|Overall Study||207
8631993|NCT00302003|21304640|P1|STARTED|Overall Study||287
8631994|NCT00282464|21304649|P2|NOT COMPLETED|Overall Study||62
8631995|NCT00282464|21304650|P1|NOT COMPLETED|Overall Study||73
8631996|NCT00282464|21304649|P2|COMPLETED|Overall Study||134
8631997|NCT00282464|21304650|P1|COMPLETED|Overall Study||112
8631998|NCT00282464|21304649|P2|STARTED|Overall Study||196
8631999|NCT00282464|21304650|P1|STARTED|Overall Study||185
8632018|NCT00280566|21304721|P3|NOT COMPLETED|Period 2 Double Blind||57
8632019|NCT00280566|21304722|P2|NOT COMPLETED|Period 2 Double Blind||43
8632020|NCT00280566|21304723|P1|NOT COMPLETED|Period 2 Double Blind||0
8632021|NCT00280566|21304721|P3|COMPLETED|Period 2 Double Blind||54
8632022|NCT00280566|21304722|P2|COMPLETED|Period 2 Double Blind||84
8632023|NCT00280566|21304723|P1|COMPLETED|Period 2 Double Blind||0
8632024|NCT00280566|21304721|P3|STARTED|Period 2 Double Blind||111
8632025|NCT00280566|21304722|P2|STARTED|Period 2 Double Blind||127
8632026|NCT00280566|21304723|P1|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
8632027|NCT00280566|21304721|P3|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
8632028|NCT00280566|21304722|P2|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
8632029|NCT00280566|21304723|P1|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
8632030|NCT00280566|21304721|P3|COMPLETED|Period 1 Open Label Ziprasidone||0
8632031|NCT00280566|21304722|P2|COMPLETED|Period 1 Open Label Ziprasidone||0
8632032|NCT00280566|21304723|P1|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
8632033|NCT00280566|21304721|P3|STARTED|Period 1 Open Label Ziprasidone||0
8632034|NCT00280566|21304722|P2|STARTED|Period 1 Open Label Ziprasidone||0
8632035|NCT00280566|21304723|P1|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
8632039|NCT00265330|21304757|P1|NOT COMPLETED|Overall Study||95
8632040|NCT00265330|21304757|P1|COMPLETED|Overall Study||67
8632041|NCT00265330|21304757|P1|STARTED|Overall Study||162
8632045|NCT00257192|21304787|P2|NOT COMPLETED|Overall Study||39
8632046|NCT00257192|21304788|P1|NOT COMPLETED|Overall Study||58
8632047|NCT00257192|21304787|P2|COMPLETED|Overall Study||52
8632048|NCT00257192|21304788|P1|COMPLETED|Overall Study||135
8632049|NCT00257192|21304787|P2|Received Study Treatment|Overall Study||90
8632050|NCT00257192|21304788|P1|Received Study Treatment|Overall Study||193
8632051|NCT00257192|21304787|P2|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
8632052|NCT00257192|21304788|P1|STARTED|Overall Study||193
8632059|NCT00174447|21304847|P1|NOT COMPLETED|Overall Study||38
8632060|NCT00174447|21304847|P1|COMPLETED|Overall Study||5
8632061|NCT00174447|21304847|P1|STARTED|Overall Study||43
8632062|NCT00145600|21304860|P4|NOT COMPLETED|Overall Study||16
8632063|NCT00145600|21304861|P3|NOT COMPLETED|Overall Study||5
8632064|NCT00145600|21304862|P2|NOT COMPLETED|Overall Study||10
8632065|NCT00145600|21304863|P1|NOT COMPLETED|Overall Study||8
8632066|NCT00145600|21304860|P4|COMPLETED|Overall Study||130
8632067|NCT00145600|21304861|P3|COMPLETED|Overall Study||8
8632068|NCT00145600|21304862|P2|COMPLETED|Overall Study||36
8632069|NCT00145600|21304863|P1|COMPLETED|Overall Study||83
8632070|NCT00145600|21304860|P4|STARTED|Overall Study||146
8632071|NCT00145600|21304861|P3|STARTED|Overall Study||13
8632072|NCT00145600|21304862|P2|STARTED|Overall Study||46
8632073|NCT00145600|21304863|P1|STARTED|Overall Study||91
8632074|NCT00141271|21304978|P3|NOT COMPLETED|Overall Study||57
8632075|NCT00141271|21304979|P2|NOT COMPLETED|Overall Study||63
8632076|NCT00141271|21304980|P1|NOT COMPLETED|Overall Study||80
8632077|NCT00141271|21304978|P3|COMPLETED|Overall Study||111
8632078|NCT00141271|21304979|P2|COMPLETED|Overall Study||102
8632079|NCT00141271|21304980|P1|COMPLETED|Overall Study||91
8632080|NCT00141271|21304978|P3|STARTED|Overall Study||168
8632081|NCT00141271|21304979|P2|STARTED|Overall Study||165
8632082|NCT00141271|21304980|P1|STARTED|Overall Study||171
8632083|NCT00139776|21305101|P4|NOT COMPLETED|Period III||106
8632084|NCT00139776|21305102|P3|NOT COMPLETED|Period III||76
8632085|NCT00139776|21305103|P2|NOT COMPLETED|Period III||0
8632086|NCT00139776|21305104|P1|NOT COMPLETED|Period III||0
8632087|NCT00139776|21305101|P4|COMPLETED|Period III||321
8632088|NCT00139776|21305102|P3|COMPLETED|Period III||355
8632089|NCT00139776|21305103|P2|COMPLETED|Period III||0
8632090|NCT00139776|21305104|P1|COMPLETED|Period III||0
8632091|NCT00139776|21305101|P4|STARTED|Period III|Randomized 435: 8 participants not treated|427
8632092|NCT00139776|21305102|P3|STARTED|Period III|Randomized 440: 9 participants not treated|431
8632093|NCT00139776|21305103|P2|STARTED|Period III||0
8632094|NCT00139776|21305104|P1|STARTED|Period III||0
8632095|NCT00139776|21305101|P4|NOT COMPLETED|Period II||0
8632096|NCT00139776|21305102|P3|NOT COMPLETED|Period II||0
8632097|NCT00139776|21305103|P2|NOT COMPLETED|Period II||322
8632098|NCT00139776|21305104|P1|NOT COMPLETED|Period II||0
8632099|NCT00139776|21305101|P4|COMPLETED|Period II||0
8632100|NCT00139776|21305102|P3|COMPLETED|Period II||0
8632101|NCT00139776|21305103|P2|COMPLETED|Period II||875
8632102|NCT00139776|21305104|P1|COMPLETED|Period II||0
8632103|NCT00139776|21305101|P4|STARTED|Period II||0
8632104|NCT00139776|21305102|P3|STARTED|Period II||0
8632105|NCT00139776|21305103|P2|STARTED|Period II||1197
8632106|NCT00139776|21305104|P1|STARTED|Period II||0
8632107|NCT00139776|21305101|P4|NOT COMPLETED|Period I||0
8632108|NCT00139776|21305102|P3|NOT COMPLETED|Period I||0
8632109|NCT00139776|21305103|P2|NOT COMPLETED|Period I||0
8632110|NCT00139776|21305104|P1|NOT COMPLETED|Period I||575
8632111|NCT00139776|21305101|P4|COMPLETED|Period I||0
8632112|NCT00139776|21305102|P3|COMPLETED|Period I||0
8632113|NCT00139776|21305103|P2|COMPLETED|Period I||0
8632114|NCT00139776|21305104|P1|COMPLETED|Period I||1197
8632115|NCT00139776|21305101|P4|STARTED|Period I||0
8632116|NCT00139776|21305102|P3|STARTED|Period I||0
8632117|NCT00139776|21305103|P2|STARTED|Period I||0
8632118|NCT00139776|21305104|P1|STARTED|Period I||1772
8632182|NCT00099372|21305349|P2|NOT COMPLETED|Followed up 7 Years After Index Surgery||32
8632183|NCT00099372|21305350|P1|NOT COMPLETED|Followed up 7 Years After Index Surgery||23
8632184|NCT00099372|21305349|P2|COMPLETED|Followed up 7 Years After Index Surgery||60
8632185|NCT00099372|21305350|P1|COMPLETED|Followed up 7 Years After Index Surgery||66
8632186|NCT00099372|21305349|P2|STARTED|Followed up 7 Years After Index Surgery||92
8632187|NCT00099372|21305350|P1|STARTED|Followed up 7 Years After Index Surgery||89
8632188|NCT00099372|21305349|P2|NOT COMPLETED|Followed up 5 Years After Index Surgery||19
8632189|NCT00099372|21305350|P1|NOT COMPLETED|Followed up 5 Years After Index Surgery||15
8632190|NCT00099372|21305349|P2|COMPLETED|Followed up 5 Years After Index Surgery||92
8632191|NCT00099372|21305350|P1|COMPLETED|Followed up 5 Years After Index Surgery||89
8632192|NCT00099372|21305349|P2|STARTED|Followed up 5 Years After Index Surgery||111
8632193|NCT00099372|21305350|P1|STARTED|Followed up 5 Years After Index Surgery||104
8632194|NCT00099372|21305349|P2|NOT COMPLETED|Enrolled in Extended CARE Trial||0
8632195|NCT00099372|21305350|P1|NOT COMPLETED|Enrolled in Extended CARE Trial||0
8632196|NCT00099372|21305349|P2|COMPLETED|Enrolled in Extended CARE Trial||111
8632197|NCT00099372|21305350|P1|COMPLETED|Enrolled in Extended CARE Trial||104
8632198|NCT00099372|21305349|P2|STARTED|Enrolled in Extended CARE Trial||111
8632199|NCT00099372|21305350|P1|STARTED|Enrolled in Extended CARE Trial||104
8632248|NCT04142450|21305601|P1|NOT COMPLETED|Overall Study||2
8632249|NCT04142450|21305601|P1|COMPLETED|Overall Study||48
8632250|NCT04142450|21305601|P1|Safety Population|Overall Study||49
8632251|NCT04142450|21305601|P1|STARTED|Overall Study||50
8632252|NCT04019054|21305612|P2|NOT COMPLETED|Overall Study||2
8632253|NCT04019054|21305613|P1|NOT COMPLETED|Overall Study||3
8632254|NCT04019054|21305612|P2|COMPLETED|Overall Study||9
8632255|NCT04019054|21305613|P1|COMPLETED|Overall Study||8
8632256|NCT04019054|21305612|P2|STARTED|Overall Study||11
8632257|NCT04019054|21305613|P1|STARTED|Overall Study||11
8632264|NCT03706313|21305654|P2|NOT COMPLETED|Overall Study||0
8632265|NCT03706313|21305655|P1|NOT COMPLETED|Overall Study||0
8632266|NCT03706313|21305654|P2|COMPLETED|Overall Study||20
8632267|NCT03706313|21305655|P1|COMPLETED|Overall Study||20
8632268|NCT03706313|21305654|P2|STARTED|Overall Study||20
8632269|NCT03706313|21305655|P1|STARTED|Overall Study||20
8632270|NCT03662997|21305683|P4|NOT COMPLETED|Overall Study||0
8632271|NCT03662997|21305684|P3|NOT COMPLETED|Overall Study||0
8632272|NCT03662997|21305685|P2|NOT COMPLETED|Overall Study||2
8632273|NCT03662997|21305686|P1|NOT COMPLETED|Overall Study||0
8632274|NCT03662997|21305683|P4|COMPLETED|Overall Study||8
8632275|NCT03662997|21305684|P3|COMPLETED|Overall Study||11
8632276|NCT03662997|21305685|P2|COMPLETED|Overall Study||8
8632277|NCT03662997|21305686|P1|COMPLETED|Overall Study||11
8632278|NCT03662997|21305683|P4|STARTED|Overall Study||8
8632279|NCT03662997|21305684|P3|STARTED|Overall Study||11
8632280|NCT03662997|21305685|P2|STARTED|Overall Study||10
8632281|NCT03662997|21305686|P1|STARTED|Overall Study||11
8632282|NCT03629925|21305714|P2|NOT COMPLETED|Overall Study||178
8632283|NCT03629925|21305715|P1|NOT COMPLETED|Overall Study||179
8632284|NCT03629925|21305714|P2|COMPLETED|Overall Study||0
8632285|NCT03629925|21305715|P1|COMPLETED|Overall Study||0
8632286|NCT03629925|21305714|P2|STARTED|Overall Study||178
8632287|NCT03629925|21305715|P1|STARTED|Overall Study||179
8632288|NCT03613818|21305733|P2|NOT COMPLETED|Overall Study||27
8632289|NCT03613818|21305734|P1|NOT COMPLETED|Overall Study||37
8632290|NCT03613818|21305733|P2|COMPLETED|Overall Study||110
8632291|NCT03613818|21305734|P1|COMPLETED|Overall Study||137
8632292|NCT03613818|21305733|P2|STARTED|Overall Study||137
8632293|NCT03613818|21305734|P1|STARTED|Overall Study||174
8632294|NCT03351114|21305750|P1|NOT COMPLETED|Overall Study||1
8632295|NCT03351114|21305750|P1|COMPLETED|Overall Study||7
8632296|NCT03351114|21305750|P1|STARTED|Overall Study||8
8632297|NCT03340883|21305758|P6|NOT COMPLETED|Overall Study||0
8632298|NCT03340883|21305759|P5|NOT COMPLETED|Overall Study||0
8632299|NCT03340883|21305760|P4|NOT COMPLETED|Overall Study||0
8632300|NCT03340883|21305761|P3|NOT COMPLETED|Overall Study||0
8632301|NCT03340883|21305762|P2|NOT COMPLETED|Overall Study||0
8632302|NCT03340883|21305763|P1|NOT COMPLETED|Overall Study||0
8632303|NCT03340883|21305758|P6|COMPLETED|Overall Study||3
8632304|NCT03340883|21305759|P5|COMPLETED|Overall Study||3
8632305|NCT03340883|21305760|P4|COMPLETED|Overall Study||4
8632306|NCT03340883|21305761|P3|COMPLETED|Overall Study||4
8632307|NCT03340883|21305762|P2|COMPLETED|Overall Study||3
8632308|NCT03340883|21305763|P1|COMPLETED|Overall Study||4
8632309|NCT03340883|21305758|P6|STARTED|Overall Study||3
8632310|NCT03340883|21305759|P5|STARTED|Overall Study||3
8632311|NCT03340883|21305760|P4|STARTED|Overall Study||4
8632312|NCT03340883|21305761|P3|STARTED|Overall Study||4
8632313|NCT03340883|21305762|P2|STARTED|Overall Study||3
8632314|NCT03340883|21305763|P1|STARTED|Overall Study||4
8632315|NCT03331666|21305821|P2|NOT COMPLETED|Overall Study||2
8632316|NCT03331666|21305822|P1|NOT COMPLETED|Overall Study||2
8632317|NCT03331666|21305821|P2|COMPLETED|Overall Study||0
8632318|NCT03331666|21305822|P1|COMPLETED|Overall Study||0
8632319|NCT03331666|21305821|P2|STARTED|Overall Study||2
8632320|NCT03331666|21305822|P1|STARTED|Overall Study||2
8632321|NCT03315208|21305832|P2|NOT COMPLETED|Overall Study||6
8632322|NCT03315208|21305833|P1|NOT COMPLETED|Overall Study||13
8632323|NCT03315208|21305832|P2|COMPLETED|Overall Study||12
8632324|NCT03315208|21305833|P1|COMPLETED|Overall Study||16
8632325|NCT03315208|21305832|P2|STARTED|Overall Study||18
8632326|NCT03315208|21305833|P1|STARTED|Overall Study||29
8632327|NCT03264092|21305858|P3|NOT COMPLETED|Overall Study||0
8632328|NCT03264092|21305859|P2|NOT COMPLETED|Overall Study||0
8632329|NCT03264092|21305860|P1|NOT COMPLETED|Overall Study||0
8632330|NCT03264092|21305858|P3|COMPLETED|Overall Study||18
8632331|NCT03264092|21305859|P2|COMPLETED|Overall Study||20
8632332|NCT03264092|21305860|P1|COMPLETED|Overall Study||17
8632333|NCT03264092|21305858|P3|STARTED|Overall Study||18
8632334|NCT03264092|21305859|P2|STARTED|Overall Study||20
8632335|NCT03264092|21305860|P1|STARTED|Overall Study||17
8632336|NCT03251937|21305874|P1|NOT COMPLETED|Overall Study||3
8632337|NCT03251937|21305874|P1|COMPLETED|Overall Study||37
8632338|NCT03251937|21305874|P1|STARTED|Overall Study||40
8632339|NCT03240133|21305881|P3|NOT COMPLETED|Overall Study||1
8632340|NCT03240133|21305882|P2|NOT COMPLETED|Overall Study||3
8632341|NCT03240133|21305883|P1|NOT COMPLETED|Overall Study||3
8632342|NCT03240133|21305881|P3|COMPLETED|Overall Study||10
8632343|NCT03240133|21305882|P2|COMPLETED|Overall Study||11
8632344|NCT03240133|21305883|P1|COMPLETED|Overall Study||30
8632345|NCT03240133|21305881|P3|Completed Period 3|Overall Study||11
8632346|NCT03240133|21305882|P2|Completed Period 3|Overall Study||11
8632347|NCT03240133|21305883|P1|Completed Period 3|Overall Study||30
8632348|NCT03240133|21305881|P3|Completed Period 2|Overall Study||11
8632349|NCT03240133|21305882|P2|Completed Period 2|Overall Study||11
8632350|NCT03240133|21305883|P1|Completed Period 2|Overall Study||32
8632351|NCT03240133|21305881|P3|Completed Period 1|Overall Study||11
8632352|NCT03240133|21305882|P2|Completed Period 1|Overall Study||14
8632353|NCT03240133|21305883|P1|Completed Period 1|Overall Study||33
8632354|NCT03240133|21305881|P3|STARTED|Overall Study||11
8632355|NCT03240133|21305882|P2|STARTED|Overall Study||14
8632356|NCT03240133|21305883|P1|STARTED|Overall Study||33
8632372|NCT03168334|21305955|P2|NOT COMPLETED|Overall Study||38
8632373|NCT03168334|21305956|P1|NOT COMPLETED|Overall Study||52
8632374|NCT03168334|21305955|P2|COMPLETED|Overall Study||366
8632375|NCT03168334|21305956|P1|COMPLETED|Overall Study||345
8632376|NCT03168334|21305955|P2|STARTED|Overall Study||404
8632377|NCT03168334|21305956|P1|STARTED|Overall Study||397
8632378|NCT03168321|21305974|P2|NOT COMPLETED|Overall Study||55
8632379|NCT03168321|21305975|P1|NOT COMPLETED|Overall Study||55
8632380|NCT03168321|21305974|P2|COMPLETED|Overall Study||356
8632381|NCT03168321|21305975|P1|COMPLETED|Overall Study||347
8632382|NCT03168321|21305974|P2|STARTED|Overall Study||411
8632383|NCT03168321|21305975|P1|STARTED|Overall Study||402
8632384|NCT03130959|21306001|P10|NOT COMPLETED|Follow-up Period||16
8632385|NCT03130959|21306002|P9|NOT COMPLETED|Follow-up Period||18
8632386|NCT03130959|21306003|P8|NOT COMPLETED|Follow-up Period||8
8632387|NCT03130959|21306004|P7|NOT COMPLETED|Follow-up Period||9
8632388|NCT03130959|21306005|P6|NOT COMPLETED|Follow-up Period||10
8632389|NCT03130959|21306006|P5|NOT COMPLETED|Follow-up Period||14
8632390|NCT03130959|21306007|P4|NOT COMPLETED|Follow-up Period||14
8632391|NCT03130959|21306008|P3|NOT COMPLETED|Follow-up Period||12
8632392|NCT03130959|21306009|P2|NOT COMPLETED|Follow-up Period||20
8632393|NCT03130959|21306010|P1|NOT COMPLETED|Follow-up Period||20
8632394|NCT03130959|21306001|P10|COMPLETED|Follow-up Period||3
8632395|NCT03130959|21306002|P9|COMPLETED|Follow-up Period||1
8632396|NCT03130959|21306003|P8|COMPLETED|Follow-up Period||2
8632397|NCT03130959|21306004|P7|COMPLETED|Follow-up Period||3
8632398|NCT03130959|21306005|P6|COMPLETED|Follow-up Period||5
8632399|NCT03130959|21306006|P5|COMPLETED|Follow-up Period||1
8632400|NCT03130959|21306007|P4|COMPLETED|Follow-up Period||1
8632401|NCT03130959|21306008|P3|COMPLETED|Follow-up Period||4
8632402|NCT03130959|21306009|P2|COMPLETED|Follow-up Period||2
8632403|NCT03130959|21306010|P1|COMPLETED|Follow-up Period||3
8632404|NCT03130959|21306001|P10|STARTED|Follow-up Period||19
8632405|NCT03130959|21306002|P9|STARTED|Follow-up Period||19
8632406|NCT03130959|21306003|P8|STARTED|Follow-up Period||10
8632407|NCT03130959|21306004|P7|STARTED|Follow-up Period||12
8632408|NCT03130959|21306005|P6|STARTED|Follow-up Period||15
8632409|NCT03130959|21306006|P5|STARTED|Follow-up Period||15
8632410|NCT03130959|21306007|P4|STARTED|Follow-up Period||15
8632411|NCT03130959|21306008|P3|STARTED|Follow-up Period||16
8632412|NCT03130959|21306009|P2|STARTED|Follow-up Period||22
8632413|NCT03130959|21306010|P1|STARTED|Follow-up Period||23
8632414|NCT03130959|21306001|P10|NOT COMPLETED|Treatment Period||18
8632415|NCT03130959|21306002|P9|NOT COMPLETED|Treatment Period||19
8632416|NCT03130959|21306003|P8|NOT COMPLETED|Treatment Period||10
8632417|NCT03130959|21306004|P7|NOT COMPLETED|Treatment Period||12
8632418|NCT03130959|21306005|P6|NOT COMPLETED|Treatment Period||15
8632419|NCT03130959|21306006|P5|NOT COMPLETED|Treatment Period||15
8632420|NCT03130959|21306007|P4|NOT COMPLETED|Treatment Period||15
8632421|NCT03130959|21306008|P3|NOT COMPLETED|Treatment Period||15
8632422|NCT03130959|21306009|P2|NOT COMPLETED|Treatment Period||21
8632423|NCT03130959|21306010|P1|NOT COMPLETED|Treatment Period||21
8632424|NCT03130959|21306001|P10|COMPLETED|Treatment Period||1
8632425|NCT03130959|21306002|P9|COMPLETED|Treatment Period||0
8632426|NCT03130959|21306003|P8|COMPLETED|Treatment Period||0
8632427|NCT03130959|21306004|P7|COMPLETED|Treatment Period||0
8632428|NCT03130959|21306005|P6|COMPLETED|Treatment Period||0
8632429|NCT03130959|21306006|P5|COMPLETED|Treatment Period||0
8632430|NCT03130959|21306007|P4|COMPLETED|Treatment Period||0
8632431|NCT03130959|21306008|P3|COMPLETED|Treatment Period||1
8632432|NCT03130959|21306009|P2|COMPLETED|Treatment Period||1
8632433|NCT03130959|21306010|P1|COMPLETED|Treatment Period||2
8632434|NCT03130959|21306001|P10|STARTED|Treatment Period||19
8632435|NCT03130959|21306002|P9|STARTED|Treatment Period||19
8632436|NCT03130959|21306003|P8|STARTED|Treatment Period||10
8632437|NCT03130959|21306004|P7|STARTED|Treatment Period||12
8632438|NCT03130959|21306005|P6|STARTED|Treatment Period||15
8632439|NCT03130959|21306006|P5|STARTED|Treatment Period||15
8632440|NCT03130959|21306007|P4|STARTED|Treatment Period||15
8632441|NCT03130959|21306008|P3|STARTED|Treatment Period||16
8632442|NCT03130959|21306009|P2|STARTED|Treatment Period||22
8632443|NCT03130959|21306010|P1|STARTED|Treatment Period||23
8632444|NCT03093454|21306139|P2|NOT COMPLETED|Overall Study||3
8632445|NCT03093454|21306140|P1|NOT COMPLETED|Overall Study||6
8632446|NCT03093454|21306139|P2|COMPLETED|Overall Study||27
8632447|NCT03093454|21306140|P1|COMPLETED|Overall Study||22
8632448|NCT03093454|21306139|P2|STARTED|Overall Study||30
8632449|NCT03093454|21306140|P1|STARTED|Overall Study||28
8632450|NCT03075527|21306150|P1|NOT COMPLETED|Overall Study||2
8632451|NCT03075527|21306150|P1|COMPLETED|Overall Study||17
8632452|NCT03075527|21306150|P1|STARTED|Overall Study||19
8632453|NCT03052608|21306156|P2|NOT COMPLETED|Long-Term Follow-up Phase||147
8632454|NCT03052608|21306157|P1|NOT COMPLETED|Long-Term Follow-up Phase||149
8632455|NCT03052608|21306156|P2|COMPLETED|Long-Term Follow-up Phase||0
8632456|NCT03052608|21306157|P1|COMPLETED|Long-Term Follow-up Phase||0
8632457|NCT03052608|21306156|P2|STARTED|Long-Term Follow-up Phase||147
8632458|NCT03052608|21306157|P1|STARTED|Long-Term Follow-up Phase||149
8632459|NCT03052608|21306156|P2|NOT COMPLETED|Treatment Phase||64
8632460|NCT03052608|21306157|P1|NOT COMPLETED|Treatment Phase||123
8632461|NCT03052608|21306156|P2|COMPLETED|Treatment Phase||83
8632462|NCT03052608|21306157|P1|COMPLETED|Treatment Phase||26
8632463|NCT03052608|21306156|P2|STARTED|Treatment Phase||147
8632464|NCT03052608|21306157|P1|STARTED|Treatment Phase||149
8632465|NCT03044249|21306217|P2|NOT COMPLETED|Overall Study||14
8632466|NCT03044249|21306218|P1|NOT COMPLETED|Overall Study||10
8632467|NCT03044249|21306217|P2|COMPLETED|Overall Study||25
8632468|NCT03044249|21306218|P1|COMPLETED|Overall Study||32
8632469|NCT03044249|21306217|P2|Received at Least One Dose of Study Drug|Overall Study||39
8632470|NCT03044249|21306218|P1|Received at Least One Dose of Study Drug|Overall Study||42
8632471|NCT03044249|21306217|P2|STARTED|Overall Study||39
8632472|NCT03044249|21306218|P1|STARTED|Overall Study||42
8632479|NCT02971800|21306273|P1|NOT COMPLETED|Overall Study||7
8632480|NCT02971800|21306273|P1|COMPLETED|Overall Study||30
8632481|NCT02971800|21306273|P1|STARTED|Overall Study||37
8632482|NCT02904200|21306279|P2|NOT COMPLETED|Overall Study||0
8632483|NCT02904200|21306280|P1|NOT COMPLETED|Overall Study||1
8632484|NCT02904200|21306279|P2|COMPLETED|Overall Study||0
8632485|NCT02904200|21306280|P1|COMPLETED|Overall Study||1
8632486|NCT02904200|21306279|P2|STARTED|Overall Study|No statistical evaluation was performed because only 2 subjects were included in one arm.|0
8632487|NCT02904200|21306280|P1|STARTED|Overall Study|One pat. early terminated on own decision, due to travelling distance between home and hospital.|2
8632488|NCT02852005|21306290|P5|NOT COMPLETED|Overall Study||1
8632489|NCT02852005|21306291|P4|NOT COMPLETED|Overall Study||0
8632490|NCT02852005|21306292|P3|NOT COMPLETED|Overall Study||0
8632491|NCT02852005|21306293|P2|NOT COMPLETED|Overall Study||0
8632492|NCT02852005|21306294|P1|NOT COMPLETED|Overall Study||1
8632493|NCT02852005|21306290|P5|COMPLETED|Overall Study||6
8632494|NCT02852005|21306291|P4|COMPLETED|Overall Study||6
8632495|NCT02852005|21306292|P3|COMPLETED|Overall Study||6
8632496|NCT02852005|21306293|P2|COMPLETED|Overall Study||4
8632497|NCT02852005|21306294|P1|COMPLETED|Overall Study||3
8632498|NCT02852005|21306290|P5|Month 10|Overall Study||7
8632499|NCT02852005|21306291|P4|Month 10|Overall Study||5
8632500|NCT02852005|21306292|P3|Month 10|Overall Study||6
8632501|NCT02852005|21306293|P2|Month 10|Overall Study||3
8632502|NCT02852005|21306294|P1|Month 10|Overall Study||3
8632503|NCT02852005|21306290|P5|Month 4.5|Overall Study||7
8632504|NCT02852005|21306291|P4|Month 4.5|Overall Study||6
8632505|NCT02852005|21306292|P3|Month 4.5|Overall Study||6
8632506|NCT02852005|21306293|P2|Month 4.5|Overall Study||4
8632507|NCT02852005|21306294|P1|Month 4.5|Overall Study||3
8632508|NCT02852005|21306290|P5|Month 0.5|Overall Study||7
8632509|NCT02852005|21306291|P4|Month 0.5|Overall Study||6
8632510|NCT02852005|21306292|P3|Month 0.5|Overall Study||6
8632511|NCT02852005|21306293|P2|Month 0.5|Overall Study||4
8632512|NCT02852005|21306294|P1|Month 0.5|Overall Study||3
8632513|NCT02852005|21306290|P5|STARTED|Overall Study||7
8632514|NCT02852005|21306291|P4|STARTED|Overall Study||6
8632515|NCT02852005|21306292|P3|STARTED|Overall Study||6
8632516|NCT02852005|21306293|P2|STARTED|Overall Study||4
8632517|NCT02852005|21306294|P1|STARTED|Overall Study||4
8632538|NCT02786498|21306489|P4|NOT COMPLETED|Overall Study||1
8632539|NCT02786498|21306490|P3|NOT COMPLETED|Overall Study||0
8632540|NCT02786498|21306491|P2|NOT COMPLETED|Overall Study||0
8632541|NCT02786498|21306492|P1|NOT COMPLETED|Overall Study||2
8632542|NCT02786498|21306489|P4|COMPLETED|Overall Study||26
8632543|NCT02786498|21306490|P3|COMPLETED|Overall Study||24
8632544|NCT02786498|21306491|P2|COMPLETED|Overall Study||24
8632545|NCT02786498|21306492|P1|COMPLETED|Overall Study||25
8632546|NCT02786498|21306489|P4|STARTED|Overall Study||27
8632547|NCT02786498|21306490|P3|STARTED|Overall Study||24
8632548|NCT02786498|21306491|P2|STARTED|Overall Study||24
8632549|NCT02786498|21306492|P1|STARTED|Overall Study||27
8632550|NCT02723006|21306545|P3|NOT COMPLETED|Overall Study||7
8632551|NCT02723006|21306546|P2|NOT COMPLETED|Overall Study||7
8632552|NCT02723006|21306547|P1|NOT COMPLETED|Overall Study||1
8632553|NCT02723006|21306545|P3|COMPLETED|Overall Study||5
8632554|NCT02723006|21306546|P2|COMPLETED|Overall Study||2
8632555|NCT02723006|21306547|P1|COMPLETED|Overall Study||0
8632556|NCT02723006|21306545|P3|STARTED|Overall Study||12
8632557|NCT02723006|21306546|P2|STARTED|Overall Study||9
8632558|NCT02723006|21306547|P1|STARTED|Overall Study||1
8632562|NCT02554903|21306578|P2|NOT COMPLETED|Overall Study||5
8632563|NCT02554903|21306579|P1|NOT COMPLETED|Overall Study||4
8632564|NCT02554903|21306578|P2|COMPLETED|Overall Study||24
8632565|NCT02554903|21306579|P1|COMPLETED|Overall Study||24
8632566|NCT02554903|21306578|P2|STARTED|Overall Study||29
8632567|NCT02554903|21306579|P1|STARTED|Overall Study||28
8632568|NCT02543203|21306603|P2|NOT COMPLETED|Overall Study||5
8632569|NCT02543203|21306604|P1|NOT COMPLETED|Overall Study||6
8632570|NCT02543203|21306603|P2|COMPLETED|Overall Study||10
8632571|NCT02543203|21306604|P1|COMPLETED|Overall Study||7
8632572|NCT02543203|21306603|P2|STARTED|Overall Study||15
8632573|NCT02543203|21306604|P1|STARTED|Overall Study||13
8632574|NCT02475954|21306620|P2|NOT COMPLETED|Overall Study||12
8632575|NCT02475954|21306621|P1|NOT COMPLETED|Overall Study||14
8632576|NCT02475954|21306620|P2|COMPLETED|Overall Study||75
8632577|NCT02475954|21306621|P1|COMPLETED|Overall Study||73
8632578|NCT02475954|21306620|P2|STARTED|Overall Study||87
8632579|NCT02475954|21306621|P1|STARTED|Overall Study||87
8632580|NCT02473250|21306629|P1|NOT COMPLETED|Overall Study||20
8632581|NCT02473250|21306629|P1|COMPLETED|Overall Study||20
8632582|NCT02473250|21306629|P1|STARTED|Overall Study||40
8632583|NCT02471586|21306639|P3|NOT COMPLETED|Overall Study||4
8632584|NCT02471586|21306640|P2|NOT COMPLETED|Overall Study||10
8632585|NCT02471586|21306641|P1|NOT COMPLETED|Overall Study||5
8632586|NCT02471586|21306639|P3|COMPLETED|Overall Study||142
8632587|NCT02471586|21306640|P2|COMPLETED|Overall Study||136
8632588|NCT02471586|21306641|P1|COMPLETED|Overall Study||153
8632589|NCT02471586|21306639|P3|STARTED|Overall Study||146
8632590|NCT02471586|21306640|P2|STARTED|Overall Study||146
8632591|NCT02471586|21306641|P1|STARTED|Overall Study||158
8632592|NCT02388633|21306748|P1|NOT COMPLETED|Overall Study||0
8632593|NCT02388633|21306748|P1|COMPLETED|Overall Study||8
8632594|NCT02388633|21306748|P1|STARTED|Overall Study||8
8632601|NCT02227238|21306772|P2|NOT COMPLETED|Overall Study||67
8632602|NCT02227238|21306773|P1|NOT COMPLETED|Overall Study||37
8632603|NCT02227238|21306772|P2|COMPLETED|Overall Study||245
8632604|NCT02227238|21306773|P1|COMPLETED|Overall Study||275
8632605|NCT02227238|21306772|P2|STARTED|Overall Study||312
8632606|NCT02227238|21306773|P1|STARTED|Overall Study||312
8632607|NCT02120352|21306837|P4|NOT COMPLETED|Maintenance Period (32 Weeks)||56
8632608|NCT02120352|21306838|P3|NOT COMPLETED|Maintenance Period (32 Weeks)||115
8632609|NCT02120352|21306839|P2|NOT COMPLETED|Maintenance Period (32 Weeks)||115
8632610|NCT02120352|21306840|P1|NOT COMPLETED|Maintenance Period (32 Weeks)||0
8632611|NCT02120352|21306837|P4|COMPLETED|Maintenance Period (32 Weeks)||0
8632612|NCT02120352|21306838|P3|COMPLETED|Maintenance Period (32 Weeks)||0
8632613|NCT02120352|21306839|P2|COMPLETED|Maintenance Period (32 Weeks)||0
8632614|NCT02120352|21306840|P1|COMPLETED|Maintenance Period (32 Weeks)||0
8632615|NCT02120352|21306837|P4|STARTED|Maintenance Period (32 Weeks)||56
8632616|NCT02120352|21306838|P3|STARTED|Maintenance Period (32 Weeks)||115
8632617|NCT02120352|21306839|P2|STARTED|Maintenance Period (32 Weeks)||115
8632618|NCT02120352|21306840|P1|STARTED|Maintenance Period (32 Weeks)||0
8632619|NCT02120352|21306837|P4|NOT COMPLETED|Induction Period (20 Weeks)||0
8632620|NCT02120352|21306838|P3|NOT COMPLETED|Induction Period (20 Weeks)||0
8632621|NCT02120352|21306839|P2|NOT COMPLETED|Induction Period (20 Weeks)||0
8632622|NCT02120352|21306840|P1|NOT COMPLETED|Induction Period (20 Weeks)||21
8632623|NCT02120352|21306837|P4|COMPLETED|Induction Period (20 Weeks)||0
8632624|NCT02120352|21306838|P3|COMPLETED|Induction Period (20 Weeks)||0
8632625|NCT02120352|21306839|P2|COMPLETED|Induction Period (20 Weeks)||0
8632626|NCT02120352|21306840|P1|COMPLETED|Induction Period (20 Weeks)||288
8632627|NCT02120352|21306837|P4|STARTED|Induction Period (20 Weeks)||0
8632628|NCT02120352|21306838|P3|STARTED|Induction Period (20 Weeks)||0
8632629|NCT02120352|21306839|P2|STARTED|Induction Period (20 Weeks)||0
8632630|NCT02120352|21306840|P1|STARTED|Induction Period (20 Weeks)||309
8632655|NCT02082717|21307023|P2|NOT COMPLETED|Overall Study||0
8632656|NCT02082717|21307024|P1|NOT COMPLETED|Overall Study||0
8632657|NCT02082717|21307023|P2|COMPLETED|Overall Study||9
8632658|NCT02082717|21307024|P1|COMPLETED|Overall Study||8
8632659|NCT02082717|21307023|P2|STARTED|Overall Study||9
8632660|NCT02082717|21307024|P1|STARTED|Overall Study||8
8632686|NCT01895855|21307113|P2|NOT COMPLETED|Overall Study||0
8632687|NCT01895855|21307114|P1|NOT COMPLETED|Overall Study||0
8632688|NCT01895855|21307113|P2|COMPLETED|Overall Study||102
8632689|NCT01895855|21307114|P1|COMPLETED|Overall Study||95
8632690|NCT01895855|21307113|P2|STARTED|Overall Study||102
8632691|NCT01895855|21307114|P1|STARTED|Overall Study||95
8632692|NCT01878006|21307144|P2|NOT COMPLETED|Study Session 2||0
8632693|NCT01878006|21307145|P1|NOT COMPLETED|Study Session 2||0
8632694|NCT01878006|21307144|P2|COMPLETED|Study Session 2||5
8632695|NCT01878006|21307145|P1|COMPLETED|Study Session 2||5
8632696|NCT01878006|21307144|P2|STARTED|Study Session 2||5
8632697|NCT01878006|21307145|P1|STARTED|Study Session 2||5
8632698|NCT01878006|21307144|P2|NOT COMPLETED|Study Session 1||0
8632699|NCT01878006|21307145|P1|NOT COMPLETED|Study Session 1||0
8632700|NCT01878006|21307144|P2|COMPLETED|Study Session 1||5
8632701|NCT01878006|21307145|P1|COMPLETED|Study Session 1||5
8632702|NCT01878006|21307144|P2|STARTED|Study Session 1||5
8632703|NCT01878006|21307145|P1|STARTED|Study Session 1||5
8632786|NCT01607892|21307244|P5|NOT COMPLETED|Overall Study||24
8632787|NCT01607892|21307245|P4|NOT COMPLETED|Overall Study||95
8632788|NCT01607892|21307246|P3|NOT COMPLETED|Overall Study||81
8632789|NCT01607892|21307247|P2|NOT COMPLETED|Overall Study||27
8632790|NCT01607892|21307248|P1|NOT COMPLETED|Overall Study||58
8632791|NCT01607892|21307244|P5|COMPLETED|Overall Study||0
8632792|NCT01607892|21307245|P4|COMPLETED|Overall Study||0
8632793|NCT01607892|21307246|P3|COMPLETED|Overall Study||0
8632794|NCT01607892|21307247|P2|COMPLETED|Overall Study||0
8632795|NCT01607892|21307248|P1|COMPLETED|Overall Study||0
8632796|NCT01607892|21307244|P5|STARTED|Overall Study||24
8632797|NCT01607892|21307245|P4|STARTED|Overall Study||95
8632798|NCT01607892|21307246|P3|STARTED|Overall Study||81
8632799|NCT01607892|21307247|P2|STARTED|Overall Study||27
8632800|NCT01607892|21307248|P1|STARTED|Overall Study||58
8632801|NCT01472562|21307390|P1|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
8632802|NCT01472562|21307390|P1|COMPLETED|Maintenance Phase (Week 49 to PD)||4
8632803|NCT01472562|21307390|P1|STARTED|Maintenance Phase (Week 49 to PD)||27
8632804|NCT01472562|21307390|P1|NOT COMPLETED|Induction Phase (Week 1- 48)||11
8632805|NCT01472562|21307390|P1|COMPLETED|Induction Phase (Week 1- 48)||27
8632806|NCT01472562|21307390|P1|STARTED|Induction Phase (Week 1- 48)||38
8632807|NCT01319396|21307394|P1|NOT COMPLETED|Overall Study||0
8632808|NCT01319396|21307394|P1|COMPLETED|Overall Study||24
8632809|NCT01319396|21307394|P1|STARTED|Overall Study||24
8632810|NCT01246466|21307398|P1|NOT COMPLETED|Overall Study||2
8632811|NCT01246466|21307398|P1|COMPLETED|Overall Study||22
8632812|NCT01246466|21307398|P1|STARTED|Overall Study||24
8632813|NCT01111305|21307411|P2|NOT COMPLETED|Overall Study||0
8632814|NCT01111305|21307412|P1|NOT COMPLETED|Overall Study||0
8632815|NCT01111305|21307411|P2|COMPLETED|Overall Study||4
8632816|NCT01111305|21307412|P1|COMPLETED|Overall Study||4
8632817|NCT01111305|21307411|P2|STARTED|Overall Study||4
8632818|NCT01111305|21307412|P1|STARTED|Overall Study||4
8632834|NCT00773838|21307443|P1|NOT COMPLETED|Overall Study||143
8632835|NCT00773838|21307443|P1|COMPLETED|Overall Study||0
8632836|NCT00773838|21307443|P1|STARTED|Overall Study||143
8632862|NCT00314366|21307603|P2|NOT COMPLETED|Overall Study||0
8632863|NCT00314366|21307604|P1|NOT COMPLETED|Overall Study||1
8632864|NCT00314366|21307603|P2|COMPLETED|Overall Study||10
8632865|NCT00314366|21307604|P1|COMPLETED|Overall Study||10
8632866|NCT00314366|21307603|P2|STARTED|Overall Study||10
8632867|NCT00314366|21307604|P1|STARTED|Overall Study||11
8632892|NCT00108745|21307672|P3|NOT COMPLETED|Overall Study||37
8632893|NCT00108745|21307673|P2|NOT COMPLETED|Overall Study||35
8632894|NCT00108745|21307674|P1|NOT COMPLETED|Overall Study||34
8632895|NCT00108745|21307672|P3|COMPLETED|Overall Study||349
8632896|NCT00108745|21307673|P2|COMPLETED|Overall Study||349
8632897|NCT00108745|21307674|P1|COMPLETED|Overall Study||353
8632898|NCT00108745|21307672|P3|STARTED|Overall Study||386
8632899|NCT00108745|21307673|P2|STARTED|Overall Study||384
8632900|NCT00108745|21307674|P1|STARTED|Overall Study||387
8632901|NCT04413929|21307694|P1|NOT COMPLETED|Overall Study||0
8632902|NCT04413929|21307694|P1|COMPLETED|Overall Study||8411
8632903|NCT04413929|21307694|P1|STARTED|Overall Study||8411
8632904|NCT04358081|21307706|P3|NOT COMPLETED|Study Completion Phase||2
8632905|NCT04358081|21307707|P2|NOT COMPLETED|Study Completion Phase||0
8632906|NCT04358081|21307708|P1|NOT COMPLETED|Study Completion Phase||1
8632907|NCT04358081|21307706|P3|COMPLETED|Study Completion Phase||3
8632908|NCT04358081|21307707|P2|COMPLETED|Study Completion Phase||7
8632909|NCT04358081|21307708|P1|COMPLETED|Study Completion Phase||6
8632910|NCT04358081|21307706|P3|STARTED|Study Completion Phase||5
8632911|NCT04358081|21307707|P2|STARTED|Study Completion Phase||7
8632912|NCT04358081|21307708|P1|STARTED|Study Completion Phase||7
8632913|NCT04358081|21307706|P3|NOT COMPLETED|Treatment Phase of Study||3
8632914|NCT04358081|21307707|P2|NOT COMPLETED|Treatment Phase of Study||1
8632915|NCT04358081|21307708|P1|NOT COMPLETED|Treatment Phase of Study||4
8632916|NCT04358081|21307706|P3|COMPLETED|Treatment Phase of Study||2
8632917|NCT04358081|21307707|P2|COMPLETED|Treatment Phase of Study||6
8632918|NCT04358081|21307708|P1|COMPLETED|Treatment Phase of Study||3
8632919|NCT04358081|21307706|P3|STARTED|Treatment Phase of Study||5
8632920|NCT04358081|21307707|P2|STARTED|Treatment Phase of Study||7
8632921|NCT04358081|21307708|P1|STARTED|Treatment Phase of Study||7
8632922|NCT04189224|21307726|P2|NOT COMPLETED|Period 2||1
8632923|NCT04189224|21307727|P1|NOT COMPLETED|Period 2||0
8632924|NCT04189224|21307726|P2|COMPLETED|Period 2||20
8632925|NCT04189224|21307727|P1|COMPLETED|Period 2||23
8632926|NCT04189224|21307726|P2|STARTED|Period 2||21
8632927|NCT04189224|21307727|P1|STARTED|Period 2||23
8632928|NCT04189224|21307726|P2|NOT COMPLETED|Period 1||0
8632929|NCT04189224|21307727|P1|NOT COMPLETED|Period 1||0
8632930|NCT04189224|21307726|P2|COMPLETED|Period 1||21
8632931|NCT04189224|21307727|P1|COMPLETED|Period 1||23
8632932|NCT04189224|21307726|P2|STARTED|Period 1||21
8632933|NCT04189224|21307727|P1|STARTED|Period 1||23
8632934|NCT04175262|21307745|P1|NOT COMPLETED|Overall Study||0
8632935|NCT04175262|21307745|P1|COMPLETED|Overall Study||102
8632936|NCT04175262|21307745|P1|STARTED|Overall Study||102
8632937|NCT04029311|21307759|P2|NOT COMPLETED|Overall Study||0
8632938|NCT04029311|21307760|P1|NOT COMPLETED|Overall Study||3
8632939|NCT04029311|21307759|P2|COMPLETED|Overall Study||13
8632940|NCT04029311|21307760|P1|COMPLETED|Overall Study||12
8632941|NCT04029311|21307759|P2|STARTED|Overall Study||13
8632942|NCT04029311|21307760|P1|STARTED|Overall Study||15
8632943|NCT04026750|21307780|P2|NOT COMPLETED|Overall Study||0
8632944|NCT04026750|21307781|P1|NOT COMPLETED|Overall Study||0
8632945|NCT04026750|21307780|P2|COMPLETED|Overall Study||2
8632946|NCT04026750|21307781|P1|COMPLETED|Overall Study||3
8632947|NCT04026750|21307780|P2|STARTED|Overall Study||2
8632948|NCT04026750|21307781|P1|STARTED|Overall Study||3
8632949|NCT03751657|21307791|P2|NOT COMPLETED|Overall Study||3
8632950|NCT03751657|21307792|P1|NOT COMPLETED|Overall Study||3
8632951|NCT03751657|21307791|P2|COMPLETED|Overall Study||119
8632952|NCT03751657|21307792|P1|COMPLETED|Overall Study||122
8632953|NCT03751657|21307791|P2|STARTED|Overall Study||122
8632954|NCT03751657|21307792|P1|STARTED|Overall Study||125
8632982|NCT03616899|21307882|P2|NOT COMPLETED|Overall Study||1
8632983|NCT03616899|21307883|P1|NOT COMPLETED|Overall Study||10
8632984|NCT03616899|21307882|P2|COMPLETED|Overall Study||453
8632985|NCT03616899|21307883|P1|COMPLETED|Overall Study||437
8632986|NCT03616899|21307882|P2|STARTED|Overall Study||454
8632987|NCT03616899|21307883|P1|STARTED|Overall Study||447
8633000|NCT03541980|21307928|P2|NOT COMPLETED|Overall Study||0
8633001|NCT03541980|21307929|P1|NOT COMPLETED|Overall Study||0
8633002|NCT03541980|21307928|P2|COMPLETED|Overall Study||36
8633003|NCT03541980|21307929|P1|COMPLETED|Overall Study||35
8633004|NCT03541980|21307928|P2|STARTED|Overall Study||36
8633005|NCT03541980|21307929|P1|STARTED|Overall Study||35
8633009|NCT03424187|21307954|P6|NOT COMPLETED|Overall Study||0
8633010|NCT03424187|21307955|P5|NOT COMPLETED|Overall Study||0
8633011|NCT03424187|21307956|P4|NOT COMPLETED|Overall Study||0
8633012|NCT03424187|21307957|P3|NOT COMPLETED|Overall Study||0
8633013|NCT03424187|21307958|P2|NOT COMPLETED|Overall Study||0
8633014|NCT03424187|21307959|P1|NOT COMPLETED|Overall Study||0
8633015|NCT03424187|21307954|P6|COMPLETED|Overall Study||3
8633016|NCT03424187|21307955|P5|COMPLETED|Overall Study||2
8633017|NCT03424187|21307956|P4|COMPLETED|Overall Study||3
8633018|NCT03424187|21307957|P3|COMPLETED|Overall Study||2
8633019|NCT03424187|21307958|P2|COMPLETED|Overall Study||3
8633020|NCT03424187|21307959|P1|COMPLETED|Overall Study||2
8633021|NCT03424187|21307954|P6|STARTED|Overall Study||3
8633022|NCT03424187|21307955|P5|STARTED|Overall Study||2
8633023|NCT03424187|21307956|P4|STARTED|Overall Study||3
8633024|NCT03424187|21307957|P3|STARTED|Overall Study||2
8633025|NCT03424187|21307958|P2|STARTED|Overall Study||3
8633026|NCT03424187|21307959|P1|STARTED|Overall Study||2
8633027|NCT03358472|21307980|P3|NOT COMPLETED|Overall Study||16
8633028|NCT03358472|21307981|P2|NOT COMPLETED|Overall Study||10
8633029|NCT03358472|21307982|P1|NOT COMPLETED|Overall Study||15
8633030|NCT03358472|21307980|P3|COMPLETED|Overall Study||19
8633031|NCT03358472|21307981|P2|COMPLETED|Overall Study||9
8633032|NCT03358472|21307982|P1|COMPLETED|Overall Study||20
8633033|NCT03358472|21307980|P3|All Participants as Treated (APaT)|Overall Study||34
8633034|NCT03358472|21307981|P2|All Participants as Treated (APaT)|Overall Study||19
8633035|NCT03358472|21307982|P1|All Participants as Treated (APaT)|Overall Study||34
8633036|NCT03358472|21307980|P3|Intention-to-Treat (ITT)|Overall Study||35
8633037|NCT03358472|21307981|P2|Intention-to-Treat (ITT)|Overall Study||19
8633038|NCT03358472|21307982|P1|Intention-to-Treat (ITT)|Overall Study||35
8633039|NCT03358472|21307980|P3|STARTED|Overall Study||35
8633040|NCT03358472|21307981|P2|STARTED|Overall Study||19
8633041|NCT03358472|21307982|P1|STARTED|Overall Study||35
8633054|NCT03247686|21308019|P2|NOT COMPLETED|Overall Study||2
8633055|NCT03247686|21308020|P1|NOT COMPLETED|Overall Study||1
8633056|NCT03247686|21308019|P2|COMPLETED|Overall Study||18
8633057|NCT03247686|21308020|P1|COMPLETED|Overall Study||7
8633058|NCT03247686|21308019|P2|STARTED|Overall Study||20
8633059|NCT03247686|21308020|P1|STARTED|Overall Study||8
8633060|NCT02740504|21308030|P1|NOT COMPLETED|Overall Study||0
8633061|NCT02740504|21308030|P1|COMPLETED|Overall Study||20
8633062|NCT02740504|21308030|P1|STARTED|Overall Study||20
8633063|NCT02740478|21308034|P1|NOT COMPLETED|Overall Study||1
8633064|NCT02740478|21308034|P1|COMPLETED|Overall Study|One volunteer was very high BMI and uncomfortable lying still during the recordings: test stopped.|20
8633065|NCT02740478|21308034|P1|STARTED|Overall Study|Volunteers recruited until quantity 20 completed the study|21
8633066|NCT02734576|21308038|P1|NOT COMPLETED|Overall Study||0
8633067|NCT02734576|21308038|P1|COMPLETED|Overall Study||10
8633068|NCT02734576|21308038|P1|STARTED|Overall Study||10
8633069|NCT02732600|21308049|P2|NOT COMPLETED|Overall Study||1978
8633070|NCT02732600|21308050|P1|NOT COMPLETED|Overall Study||3425
8633071|NCT02732600|21308049|P2|COMPLETED|Overall Study||113
8633072|NCT02732600|21308050|P1|COMPLETED|Overall Study||100
8633073|NCT02732600|21308049|P2|Supervisor 1-year (All 25 Sites)|Overall Study||10
8633074|NCT02732600|21308050|P1|Supervisor 1-year (All 25 Sites)|Overall Study||6
8633075|NCT02732600|21308049|P2|Supervisor Responses 6-months (All 25 Sites)|Overall Study||21
8633076|NCT02732600|21308050|P1|Supervisor Responses 6-months (All 25 Sites)|Overall Study||10
8633077|NCT02732600|21308049|P2|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||12
8633078|NCT02732600|21308050|P1|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||5
8633079|NCT02732600|21308049|P2|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||14
8633080|NCT02732600|21308050|P1|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||12
8633081|NCT02732600|21308049|P2|Veteran 1-year (Sub-set 23 Sites)|Overall Study||71
8633082|NCT02732600|21308050|P1|Veteran 1-year (Sub-set 23 Sites)|Overall Study||54
8633083|NCT02732600|21308049|P2|Veteran 6-months (Sub-set 23 Sites)|Overall Study||84
8633084|NCT02732600|21308050|P1|Veteran 6-months (Sub-set 23 Sites)|Overall Study||70
8633085|NCT02732600|21308049|P2|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||145
8633086|NCT02732600|21308050|P1|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||118
8633087|NCT02732600|21308049|P2|Sub-set of Sites Newly Delivering PS Services|Overall Study||1484
8633088|NCT02732600|21308050|P1|Sub-set of Sites Newly Delivering PS Services|Overall Study||899
8633089|NCT02732600|21308049|P2|STARTED|Overall Study||2091
8633090|NCT02732600|21308050|P1|STARTED|Overall Study||3525
8633091|NCT02658734|21308072|P1|NOT COMPLETED|Overall Study||57
8633092|NCT02658734|21308072|P1|COMPLETED|Overall Study||13
8633093|NCT02658734|21308072|P1|STARTED|Overall Study||70
8633094|NCT02639884|21308091|P1|NOT COMPLETED|Overall Study||4
8633095|NCT02639884|21308091|P1|COMPLETED|Overall Study||47
8633096|NCT02639884|21308091|P1|STARTED|Overall Study||51
8633097|NCT02631577|21308098|P2|NOT COMPLETED|Overall Study||4
8633098|NCT02631577|21308099|P1|NOT COMPLETED|Overall Study||1
8633099|NCT02631577|21308098|P2|COMPLETED|Overall Study||30
8633100|NCT02631577|21308099|P1|COMPLETED|Overall Study||3
8633101|NCT02631577|21308098|P2|STARTED|Overall Study||34
8633102|NCT02631577|21308099|P1|STARTED|Overall Study||4
8633103|NCT02562066|21308115|P3|NOT COMPLETED|Overall Study||4
8633104|NCT02562066|21308116|P2|NOT COMPLETED|Overall Study||1
8633105|NCT02562066|21308117|P1|NOT COMPLETED|Overall Study||1
8633106|NCT02562066|21308115|P3|COMPLETED|Overall Study||0
8633107|NCT02562066|21308116|P2|COMPLETED|Overall Study||7
8633108|NCT02562066|21308117|P1|COMPLETED|Overall Study||7
8633109|NCT02562066|21308115|P3|STARTED|Overall Study||4
8633110|NCT02562066|21308116|P2|STARTED|Overall Study||8
8633111|NCT02562066|21308117|P1|STARTED|Overall Study||8
8633112|NCT02468557|21308127|P1|NOT COMPLETED|Overall Study||16
8633113|NCT02468557|21308127|P1|COMPLETED|Overall Study||0
8633114|NCT02468557|21308127|P1|STARTED|Overall Study||16
8633133|NCT01977898|21308199|P2|NOT COMPLETED|Overall Study||1
8633134|NCT01977898|21308200|P1|NOT COMPLETED|Overall Study||1
8633135|NCT01977898|21308199|P2|COMPLETED|Overall Study||34
8633136|NCT01977898|21308200|P1|COMPLETED|Overall Study||27
8633137|NCT01977898|21308199|P2|STARTED|Overall Study||35
8633138|NCT01977898|21308200|P1|STARTED|Overall Study||28
8633145|NCT01694186|21308243|P2|NOT COMPLETED|Overall Study||7
8633146|NCT01694186|21308244|P1|NOT COMPLETED|Overall Study||6
8633147|NCT01694186|21308243|P2|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|80
8633148|NCT01694186|21308244|P1|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|36
8633149|NCT01694186|21308243|P2|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|87
8633150|NCT01694186|21308244|P1|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|42
8633151|NCT01678443|21308250|P1|NOT COMPLETED|Overall Study||0
8633152|NCT01678443|21308250|P1|COMPLETED|Overall Study||2
8633153|NCT01678443|21308250|P1|STARTED|Overall Study||2
8633154|NCT01563354|21308261|P3|NOT COMPLETED|Extension Phase||15
8633155|NCT01563354|21308262|P2|NOT COMPLETED|Extension Phase||14
8633156|NCT01563354|21308263|P1|NOT COMPLETED|Extension Phase||12
8633157|NCT01563354|21308261|P3|COMPLETED|Extension Phase||0
8633158|NCT01563354|21308262|P2|COMPLETED|Extension Phase||0
8633159|NCT01563354|21308263|P1|COMPLETED|Extension Phase||0
8633160|NCT01563354|21308261|P3|STARTED|Extension Phase||15
8633161|NCT01563354|21308262|P2|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|14
8633162|NCT01563354|21308263|P1|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|12
8633163|NCT01563354|21308261|P3|NOT COMPLETED|Core Phase||26
8633164|NCT01563354|21308262|P2|NOT COMPLETED|Core Phase||28
8633165|NCT01563354|21308263|P1|NOT COMPLETED|Core Phase||29
8633166|NCT01563354|21308261|P3|COMPLETED|Core Phase||15
8633167|NCT01563354|21308262|P2|COMPLETED|Core Phase||14
8633168|NCT01563354|21308263|P1|COMPLETED|Core Phase||12
8633169|NCT01563354|21308261|P3|Entered Extension Phase|Core Phase||15
8633170|NCT01563354|21308262|P2|Entered Extension Phase|Core Phase||14
8633171|NCT01563354|21308263|P1|Entered Extension Phase|Core Phase||12
8633172|NCT01563354|21308261|P3|STARTED|Core Phase||41
8633173|NCT01563354|21308262|P2|STARTED|Core Phase||42
8633174|NCT01563354|21308263|P1|STARTED|Core Phase||41
8633178|NCT01317199|21308314|P4|NOT COMPLETED|Randomized Phase 2||17
8633179|NCT01317199|21308315|P3|NOT COMPLETED|Randomized Phase 2||21
8633180|NCT01317199|21308316|P2|NOT COMPLETED|Randomized Phase 2||11
8633181|NCT01317199|21308317|P1|NOT COMPLETED|Randomized Phase 2||0
8633182|NCT01317199|21308314|P4|COMPLETED|Randomized Phase 2||32
8633183|NCT01317199|21308315|P3|COMPLETED|Randomized Phase 2||35
8633184|NCT01317199|21308316|P2|COMPLETED|Randomized Phase 2||13
8633185|NCT01317199|21308317|P1|COMPLETED|Randomized Phase 2||0
8633186|NCT01317199|21308314|P4|STARTED|Randomized Phase 2||49
8633187|NCT01317199|21308315|P3|STARTED|Randomized Phase 2||56
8633188|NCT01317199|21308316|P2|STARTED|Randomized Phase 2||24
8633189|NCT01317199|21308317|P1|STARTED|Randomized Phase 2||0
8633190|NCT01317199|21308314|P4|NOT COMPLETED|Dose-escalation Phase 1||0
8633191|NCT01317199|21308315|P3|NOT COMPLETED|Dose-escalation Phase 1||0
8633192|NCT01317199|21308316|P2|NOT COMPLETED|Dose-escalation Phase 1||0
8633193|NCT01317199|21308317|P1|NOT COMPLETED|Dose-escalation Phase 1||7
8633194|NCT01317199|21308314|P4|COMPLETED|Dose-escalation Phase 1||0
8633195|NCT01317199|21308315|P3|COMPLETED|Dose-escalation Phase 1||0
8633196|NCT01317199|21308316|P2|COMPLETED|Dose-escalation Phase 1||0
8633197|NCT01317199|21308317|P1|COMPLETED|Dose-escalation Phase 1||7
8633198|NCT01317199|21308314|P4|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8633199|NCT01317199|21308315|P3|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8633200|NCT01317199|21308316|P2|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8633201|NCT01317199|21308317|P1|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
8633202|NCT01317199|21308314|P4|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8633203|NCT01317199|21308315|P3|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8633204|NCT01317199|21308316|P2|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8633205|NCT01317199|21308317|P1|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
8633206|NCT01317199|21308314|P4|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8633207|NCT01317199|21308315|P3|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8633208|NCT01317199|21308316|P2|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8633209|NCT01317199|21308317|P1|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
8633210|NCT01317199|21308314|P4|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8633211|NCT01317199|21308315|P3|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8633212|NCT01317199|21308316|P2|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
8633213|NCT01317199|21308317|P1|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
8633214|NCT01317199|21308314|P4|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
8633215|NCT01317199|21308315|P3|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
8633216|NCT01317199|21308316|P2|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
8633217|NCT01317199|21308317|P1|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
8633218|NCT01317199|21308314|P4|STARTED|Dose-escalation Phase 1||0
8633219|NCT01317199|21308315|P3|STARTED|Dose-escalation Phase 1||0
8633220|NCT01317199|21308316|P2|STARTED|Dose-escalation Phase 1||0
8633221|NCT01317199|21308317|P1|STARTED|Dose-escalation Phase 1||14
8633232|NCT01208324|21308359|P4|NOT COMPLETED|Post-randomization of Patch||0
8633233|NCT01208324|21308360|P3|NOT COMPLETED|Post-randomization of Patch||0
8633234|NCT01208324|21308361|P2|NOT COMPLETED|Post-randomization of Patch||0
8633235|NCT01208324|21308362|P1|NOT COMPLETED|Post-randomization of Patch||1
8633236|NCT01208324|21308359|P4|COMPLETED|Post-randomization of Patch||5
8633237|NCT01208324|21308360|P3|COMPLETED|Post-randomization of Patch||8
8633238|NCT01208324|21308361|P2|COMPLETED|Post-randomization of Patch||15
8633239|NCT01208324|21308362|P1|COMPLETED|Post-randomization of Patch||13
8633240|NCT01208324|21308359|P4|Test Day 4|Post-randomization of Patch||5
8633241|NCT01208324|21308360|P3|Test Day 4|Post-randomization of Patch||8
8633242|NCT01208324|21308361|P2|Test Day 4|Post-randomization of Patch||15
8633243|NCT01208324|21308362|P1|Test Day 4|Post-randomization of Patch||13
8633244|NCT01208324|21308359|P4|Test Day 3|Post-randomization of Patch||5
8633245|NCT01208324|21308360|P3|Test Day 3|Post-randomization of Patch||8
8633246|NCT01208324|21308361|P2|Test Day 3|Post-randomization of Patch||15
8633247|NCT01208324|21308362|P1|Test Day 3|Post-randomization of Patch||13
8633248|NCT01208324|21308359|P4|STARTED|Post-randomization of Patch||5
8633249|NCT01208324|21308360|P3|STARTED|Post-randomization of Patch||8
8633250|NCT01208324|21308361|P2|STARTED|Post-randomization of Patch||15
8633251|NCT01208324|21308362|P1|STARTED|Post-randomization of Patch||14
8633252|NCT01208324|21308359|P4|NOT COMPLETED|Pre-randomization of Patch||3
8633253|NCT01208324|21308360|P3|NOT COMPLETED|Pre-randomization of Patch||2
8633254|NCT01208324|21308361|P2|NOT COMPLETED|Pre-randomization of Patch||0
8633255|NCT01208324|21308362|P1|NOT COMPLETED|Pre-randomization of Patch||0
8633256|NCT01208324|21308359|P4|COMPLETED|Pre-randomization of Patch||5
8633257|NCT01208324|21308360|P3|COMPLETED|Pre-randomization of Patch||8
8633258|NCT01208324|21308361|P2|COMPLETED|Pre-randomization of Patch||15
8633259|NCT01208324|21308362|P1|COMPLETED|Pre-randomization of Patch||14
8633260|NCT01208324|21308359|P4|Test Day 2|Pre-randomization of Patch||5
8633261|NCT01208324|21308360|P3|Test Day 2|Pre-randomization of Patch||8
8633262|NCT01208324|21308361|P2|Test Day 2|Pre-randomization of Patch||15
8633263|NCT01208324|21308362|P1|Test Day 2|Pre-randomization of Patch||14
8633264|NCT01208324|21308359|P4|Test Day 1|Pre-randomization of Patch||8
8633265|NCT01208324|21308360|P3|Test Day 1|Pre-randomization of Patch||10
8633266|NCT01208324|21308361|P2|Test Day 1|Pre-randomization of Patch||15
8633267|NCT01208324|21308362|P1|Test Day 1|Pre-randomization of Patch||14
8633268|NCT01208324|21308359|P4|STARTED|Pre-randomization of Patch||8
8633269|NCT01208324|21308360|P3|STARTED|Pre-randomization of Patch||10
8633270|NCT01208324|21308361|P2|STARTED|Pre-randomization of Patch||15
8633271|NCT01208324|21308362|P1|STARTED|Pre-randomization of Patch||14
8633278|NCT00744861|21308385|P4|NOT COMPLETED|Pivotal Stage 2||105
8633279|NCT00744861|21308386|P3|NOT COMPLETED|Pivotal Stage 2||102
8633280|NCT00744861|21308387|P2|NOT COMPLETED|Pivotal Stage 2||0
8633281|NCT00744861|21308388|P1|NOT COMPLETED|Pivotal Stage 2||0
8633282|NCT00744861|21308385|P4|COMPLETED|Pivotal Stage 2||51
8633283|NCT00744861|21308386|P3|COMPLETED|Pivotal Stage 2||52
8633284|NCT00744861|21308387|P2|COMPLETED|Pivotal Stage 2||0
8633285|NCT00744861|21308388|P1|COMPLETED|Pivotal Stage 2||0
8633286|NCT00744861|21308385|P4|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|156
8633287|NCT00744861|21308386|P3|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|154
8633288|NCT00744861|21308387|P2|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
8633289|NCT00744861|21308388|P1|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
8633290|NCT00744861|21308385|P4|NOT COMPLETED|Feasibility Stage 1||0
8633291|NCT00744861|21308386|P3|NOT COMPLETED|Feasibility Stage 1||0
8633292|NCT00744861|21308387|P2|NOT COMPLETED|Feasibility Stage 1||2
8633293|NCT00744861|21308388|P1|NOT COMPLETED|Feasibility Stage 1||1
8633294|NCT00744861|21308385|P4|COMPLETED|Feasibility Stage 1||0
8633295|NCT00744861|21308386|P3|COMPLETED|Feasibility Stage 1||0
8633296|NCT00744861|21308387|P2|COMPLETED|Feasibility Stage 1||8
8633297|NCT00744861|21308388|P1|COMPLETED|Feasibility Stage 1||7
8633298|NCT00744861|21308385|P4|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
8633299|NCT00744861|21308386|P3|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
8633300|NCT00744861|21308387|P2|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|10
8633301|NCT00744861|21308388|P1|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|8
8633302|NCT00539591|21308399|P3|NOT COMPLETED|Overall Study||3
8633303|NCT00539591|21308400|P2|NOT COMPLETED|Overall Study||2
8633304|NCT00539591|21308401|P1|NOT COMPLETED|Overall Study||5
8633305|NCT00539591|21308399|P3|COMPLETED|Overall Study||1
8633306|NCT00539591|21308400|P2|COMPLETED|Overall Study||0
8633307|NCT00539591|21308401|P1|COMPLETED|Overall Study||18
8633308|NCT00539591|21308399|P3|STARTED|Overall Study||4
8633309|NCT00539591|21308400|P2|STARTED|Overall Study||2
8633310|NCT00539591|21308401|P1|STARTED|Overall Study||23
8633311|NCT00512135|21308509|P1|NOT COMPLETED|Overall Study||84
8633312|NCT00512135|21308509|P1|COMPLETED|Overall Study||717
8633313|NCT00512135|21308509|P1|Treated|Overall Study||796
8633314|NCT00512135|21308509|P1|STARTED|Overall Study||801
8633333|NCT04474496|21308532|P1|NOT COMPLETED|Overall Study||0
8633334|NCT04474496|21308532|P1|COMPLETED|Overall Study|120 individuals were deemed eligible based on inclusion criteria, completed at least 10 survey items, and were included in the final analytical sample|120
8633335|NCT04474496|21308532|P1|STARTED|Overall Study||120
8633336|NCT03951805|21308557|P4|NOT COMPLETED|Overall Study||0
8633337|NCT03951805|21308558|P3|NOT COMPLETED|Overall Study||0
8633338|NCT03951805|21308559|P2|NOT COMPLETED|Overall Study||0
8633339|NCT03951805|21308560|P1|NOT COMPLETED|Overall Study||1
8633340|NCT03951805|21308557|P4|COMPLETED|Overall Study||51
8633341|NCT03951805|21308558|P3|COMPLETED|Overall Study||52
8633342|NCT03951805|21308559|P2|COMPLETED|Overall Study||51
8633343|NCT03951805|21308560|P1|COMPLETED|Overall Study||50
8633344|NCT03951805|21308557|P4|Safety Analysis Set (SAS)|Overall Study||51
8633345|NCT03951805|21308558|P3|Safety Analysis Set (SAS)|Overall Study||52
8633346|NCT03951805|21308559|P2|Safety Analysis Set (SAS)|Overall Study||51
8633347|NCT03951805|21308560|P1|Safety Analysis Set (SAS)|Overall Study||51
8633348|NCT03951805|21308557|P4|Full Analysis Set (FAS)|Overall Study||51
8633349|NCT03951805|21308558|P3|Full Analysis Set (FAS)|Overall Study||52
8633350|NCT03951805|21308559|P2|Full Analysis Set (FAS)|Overall Study||51
8633351|NCT03951805|21308560|P1|Full Analysis Set (FAS)|Overall Study||51
8633352|NCT03951805|21308557|P4|STARTED|Overall Study||51
8633353|NCT03951805|21308558|P3|STARTED|Overall Study||52
8633354|NCT03951805|21308559|P2|STARTED|Overall Study||51
8633355|NCT03951805|21308560|P1|STARTED|Overall Study||51
8633356|NCT03936387|21308602|P1|NOT COMPLETED|Overall Study||0
8633357|NCT03936387|21308602|P1|COMPLETED|Overall Study||10
8633358|NCT03936387|21308602|P1|STARTED|Overall Study||10
8633359|NCT03935399|21308609|P2|NOT COMPLETED|Second Study Day||0
8633360|NCT03935399|21308610|P1|NOT COMPLETED|Second Study Day||0
8633361|NCT03935399|21308609|P2|COMPLETED|Second Study Day||5
8633362|NCT03935399|21308610|P1|COMPLETED|Second Study Day||5
8633363|NCT03935399|21308609|P2|STARTED|Second Study Day||5
8633364|NCT03935399|21308610|P1|STARTED|Second Study Day||5
8633365|NCT03935399|21308609|P2|NOT COMPLETED|First Study Day||0
8633366|NCT03935399|21308610|P1|NOT COMPLETED|First Study Day||0
8633367|NCT03935399|21308609|P2|COMPLETED|First Study Day||5
8633368|NCT03935399|21308610|P1|COMPLETED|First Study Day||5
8633369|NCT03935399|21308609|P2|STARTED|First Study Day||5
8633370|NCT03935399|21308610|P1|STARTED|First Study Day||5
8633371|NCT03922750|21308631|P3|NOT COMPLETED|Overall Study||1
8633372|NCT03922750|21308632|P2|NOT COMPLETED|Overall Study||1
8633373|NCT03922750|21308633|P1|NOT COMPLETED|Overall Study||0
8633374|NCT03922750|21308631|P3|COMPLETED|Overall Study||49
8633375|NCT03922750|21308632|P2|COMPLETED|Overall Study||53
8633376|NCT03922750|21308633|P1|COMPLETED|Overall Study||50
8633377|NCT03922750|21308631|P3|Safety Analysis Set (SAS)|Overall Study||50
8633378|NCT03922750|21308632|P2|Safety Analysis Set (SAS)|Overall Study||54
8633379|NCT03922750|21308633|P1|Safety Analysis Set (SAS)|Overall Study||50
8633380|NCT03922750|21308631|P3|Full Analysis Set (FAS)|Overall Study||50
8633381|NCT03922750|21308632|P2|Full Analysis Set (FAS)|Overall Study||54
8633382|NCT03922750|21308633|P1|Full Analysis Set (FAS)|Overall Study||50
8633383|NCT03922750|21308631|P3|STARTED|Overall Study||50
8633384|NCT03922750|21308632|P2|STARTED|Overall Study||54
8633385|NCT03922750|21308633|P1|STARTED|Overall Study||50
8633386|NCT03912259|21308667|P2|NOT COMPLETED|Overall Study||6
8633387|NCT03912259|21308668|P1|NOT COMPLETED|Overall Study||17
8633388|NCT03912259|21308667|P2|COMPLETED|Overall Study||76
8633389|NCT03912259|21308668|P1|COMPLETED|Overall Study||66
8633390|NCT03912259|21308667|P2|STARTED|Overall Study||82
8633391|NCT03912259|21308668|P1|STARTED|Overall Study||83
8633418|NCT03470194|21308820|P2|NOT COMPLETED|Overall Study||17
8633419|NCT03470194|21308821|P1|NOT COMPLETED|Overall Study||11
8633420|NCT03470194|21308820|P2|COMPLETED|Overall Study||40
8633421|NCT03470194|21308821|P1|COMPLETED|Overall Study||38
8633422|NCT03470194|21308820|P2|STARTED|Overall Study||57
8633423|NCT03470194|21308821|P1|STARTED|Overall Study||49
8633424|NCT03381339|21308829|P2|NOT COMPLETED|Overall Study||4
8633425|NCT03381339|21308830|P1|NOT COMPLETED|Overall Study||4
8633426|NCT03381339|21308829|P2|COMPLETED|Overall Study||24
8633427|NCT03381339|21308830|P1|COMPLETED|Overall Study||23
8633428|NCT03381339|21308829|P2|STARTED|Overall Study||28
8633429|NCT03381339|21308830|P1|STARTED|Overall Study||27
8633430|NCT03366298|21308836|P4|NOT COMPLETED|Overall Study||0
8633431|NCT03366298|21308837|P3|NOT COMPLETED|Overall Study||0
8633432|NCT03366298|21308838|P2|NOT COMPLETED|Overall Study||0
8633433|NCT03366298|21308839|P1|NOT COMPLETED|Overall Study||0
8633434|NCT03366298|21308836|P4|COMPLETED|Overall Study||3
8633435|NCT03366298|21308837|P3|COMPLETED|Overall Study||3
8633436|NCT03366298|21308838|P2|COMPLETED|Overall Study||3
8633437|NCT03366298|21308839|P1|COMPLETED|Overall Study||3
8633438|NCT03366298|21308836|P4|STARTED|Overall Study||3
8633439|NCT03366298|21308837|P3|STARTED|Overall Study||3
8633440|NCT03366298|21308838|P2|STARTED|Overall Study||3
8633441|NCT03366298|21308839|P1|STARTED|Overall Study||3
8633448|NCT03137992|21308879|P6|NOT COMPLETED|Part 2 (Open-label Extension)||1
8633449|NCT03137992|21308880|P5|NOT COMPLETED|Part 2 (Open-label Extension)||0
8633450|NCT03137992|21308881|P4|NOT COMPLETED|Part 2 (Open-label Extension)||1
8633451|NCT03137992|21308882|P3|NOT COMPLETED|Part 2 (Open-label Extension)||1
8633452|NCT03137992|21308883|P2|NOT COMPLETED|Part 2 (Open-label Extension)||0
8633453|NCT03137992|21308884|P1|NOT COMPLETED|Part 2 (Open-label Extension)||2
8633454|NCT03137992|21308879|P6|COMPLETED|Part 2 (Open-label Extension)||21
8633455|NCT03137992|21308880|P5|COMPLETED|Part 2 (Open-label Extension)||18
8633456|NCT03137992|21308881|P4|COMPLETED|Part 2 (Open-label Extension)||24
8633457|NCT03137992|21308882|P3|COMPLETED|Part 2 (Open-label Extension)||20
8633458|NCT03137992|21308883|P2|COMPLETED|Part 2 (Open-label Extension)||17
8633459|NCT03137992|21308884|P1|COMPLETED|Part 2 (Open-label Extension)||20
8633460|NCT03137992|21308879|P6|STARTED|Part 2 (Open-label Extension)||22
8633461|NCT03137992|21308880|P5|STARTED|Part 2 (Open-label Extension)||18
8633462|NCT03137992|21308881|P4|STARTED|Part 2 (Open-label Extension)||25
8633463|NCT03137992|21308882|P3|STARTED|Part 2 (Open-label Extension)||21
8633464|NCT03137992|21308883|P2|STARTED|Part 2 (Open-label Extension)||17
8633465|NCT03137992|21308884|P1|STARTED|Part 2 (Open-label Extension)||22
8633466|NCT03137992|21308879|P6|NOT COMPLETED|Period 3 (Visit 04)||3
8633467|NCT03137992|21308880|P5|NOT COMPLETED|Period 3 (Visit 04)||3
8633468|NCT03137992|21308881|P4|NOT COMPLETED|Period 3 (Visit 04)||0
8633469|NCT03137992|21308882|P3|NOT COMPLETED|Period 3 (Visit 04)||3
8633470|NCT03137992|21308883|P2|NOT COMPLETED|Period 3 (Visit 04)||2
8633471|NCT03137992|21308884|P1|NOT COMPLETED|Period 3 (Visit 04)||6
8633472|NCT03137992|21308879|P6|COMPLETED|Period 3 (Visit 04)||47
8633473|NCT03137992|21308880|P5|COMPLETED|Period 3 (Visit 04)||50
8633474|NCT03137992|21308881|P4|COMPLETED|Period 3 (Visit 04)||57
8633475|NCT03137992|21308882|P3|COMPLETED|Period 3 (Visit 04)||55
8633476|NCT03137992|21308883|P2|COMPLETED|Period 3 (Visit 04)||48
8633477|NCT03137992|21308884|P1|COMPLETED|Period 3 (Visit 04)||48
8633478|NCT03137992|21308879|P6|STARTED|Period 3 (Visit 04)||50
8633479|NCT03137992|21308880|P5|STARTED|Period 3 (Visit 04)||53
8633480|NCT03137992|21308881|P4|STARTED|Period 3 (Visit 04)||57
8633481|NCT03137992|21308882|P3|STARTED|Period 3 (Visit 04)||58
8633482|NCT03137992|21308883|P2|STARTED|Period 3 (Visit 04)||50
8633483|NCT03137992|21308884|P1|STARTED|Period 3 (Visit 04)||54
8633484|NCT03137992|21308879|P6|NOT COMPLETED|Washout Period 2||1
8633485|NCT03137992|21308880|P5|NOT COMPLETED|Washout Period 2||3
8633486|NCT03137992|21308881|P4|NOT COMPLETED|Washout Period 2||1
8633487|NCT03137992|21308882|P3|NOT COMPLETED|Washout Period 2||0
8633488|NCT03137992|21308883|P2|NOT COMPLETED|Washout Period 2||2
8633489|NCT03137992|21308884|P1|NOT COMPLETED|Washout Period 2||2
8633490|NCT03137992|21308879|P6|COMPLETED|Washout Period 2||50
8633491|NCT03137992|21308880|P5|COMPLETED|Washout Period 2||53
8633492|NCT03137992|21308881|P4|COMPLETED|Washout Period 2||57
8633493|NCT03137992|21308882|P3|COMPLETED|Washout Period 2||58
8633494|NCT03137992|21308883|P2|COMPLETED|Washout Period 2||50
8633495|NCT03137992|21308884|P1|COMPLETED|Washout Period 2||54
8633496|NCT03137992|21308879|P6|STARTED|Washout Period 2||51
8633497|NCT03137992|21308880|P5|STARTED|Washout Period 2||56
8633498|NCT03137992|21308881|P4|STARTED|Washout Period 2||58
8633499|NCT03137992|21308882|P3|STARTED|Washout Period 2||58
8633500|NCT03137992|21308883|P2|STARTED|Washout Period 2||52
8633501|NCT03137992|21308884|P1|STARTED|Washout Period 2||56
8633502|NCT03137992|21308879|P6|NOT COMPLETED|Period 2 (Visit 3)||8
8633503|NCT03137992|21308880|P5|NOT COMPLETED|Period 2 (Visit 3)||4
8633504|NCT03137992|21308881|P4|NOT COMPLETED|Period 2 (Visit 3)||5
8633505|NCT03137992|21308882|P3|NOT COMPLETED|Period 2 (Visit 3)||3
8633506|NCT03137992|21308883|P2|NOT COMPLETED|Period 2 (Visit 3)||7
8633507|NCT03137992|21308884|P1|NOT COMPLETED|Period 2 (Visit 3)||3
8633508|NCT03137992|21308879|P6|COMPLETED|Period 2 (Visit 3)||51
8633509|NCT03137992|21308880|P5|COMPLETED|Period 2 (Visit 3)||56
8633510|NCT03137992|21308881|P4|COMPLETED|Period 2 (Visit 3)||58
8633511|NCT03137992|21308882|P3|COMPLETED|Period 2 (Visit 3)||58
8633512|NCT03137992|21308883|P2|COMPLETED|Period 2 (Visit 3)||52
8633513|NCT03137992|21308884|P1|COMPLETED|Period 2 (Visit 3)||56
8633514|NCT03137992|21308879|P6|STARTED|Period 2 (Visit 3)||59
8633515|NCT03137992|21308880|P5|STARTED|Period 2 (Visit 3)||60
8633516|NCT03137992|21308881|P4|STARTED|Period 2 (Visit 3)||63
8633517|NCT03137992|21308882|P3|STARTED|Period 2 (Visit 3)||61
8633518|NCT03137992|21308883|P2|STARTED|Period 2 (Visit 3)||59
8633519|NCT03137992|21308884|P1|STARTED|Period 2 (Visit 3)||59
8633520|NCT03137992|21308879|P6|NOT COMPLETED|Washout Period 1||2
8633521|NCT03137992|21308880|P5|NOT COMPLETED|Washout Period 1||2
8633522|NCT03137992|21308881|P4|NOT COMPLETED|Washout Period 1||0
8633523|NCT03137992|21308882|P3|NOT COMPLETED|Washout Period 1||2
8633524|NCT03137992|21308883|P2|NOT COMPLETED|Washout Period 1||4
8633525|NCT03137992|21308884|P1|NOT COMPLETED|Washout Period 1||3
8633526|NCT03137992|21308879|P6|COMPLETED|Washout Period 1||59
8633527|NCT03137992|21308880|P5|COMPLETED|Washout Period 1||60
8633528|NCT03137992|21308881|P4|COMPLETED|Washout Period 1||63
8633529|NCT03137992|21308882|P3|COMPLETED|Washout Period 1||61
8633530|NCT03137992|21308883|P2|COMPLETED|Washout Period 1||59
8633531|NCT03137992|21308884|P1|COMPLETED|Washout Period 1||59
8633532|NCT03137992|21308879|P6|STARTED|Washout Period 1||61
8633533|NCT03137992|21308880|P5|STARTED|Washout Period 1||62
8633534|NCT03137992|21308881|P4|STARTED|Washout Period 1||63
8633535|NCT03137992|21308882|P3|STARTED|Washout Period 1||63
8633536|NCT03137992|21308883|P2|STARTED|Washout Period 1||63
8633537|NCT03137992|21308884|P1|STARTED|Washout Period 1||62
8633538|NCT03137992|21308879|P6|NOT COMPLETED|Period 1 (Visit 2)||0
8633539|NCT03137992|21308880|P5|NOT COMPLETED|Period 1 (Visit 2)||0
8633540|NCT03137992|21308881|P4|NOT COMPLETED|Period 1 (Visit 2)||0
8633541|NCT03137992|21308882|P3|NOT COMPLETED|Period 1 (Visit 2)||0
8633542|NCT03137992|21308883|P2|NOT COMPLETED|Period 1 (Visit 2)||0
8633543|NCT03137992|21308884|P1|NOT COMPLETED|Period 1 (Visit 2)||0
8633544|NCT03137992|21308879|P6|COMPLETED|Period 1 (Visit 2)||61
8633545|NCT03137992|21308880|P5|COMPLETED|Period 1 (Visit 2)||62
8633546|NCT03137992|21308881|P4|COMPLETED|Period 1 (Visit 2)||63
8633547|NCT03137992|21308882|P3|COMPLETED|Period 1 (Visit 2)||63
8633548|NCT03137992|21308883|P2|COMPLETED|Period 1 (Visit 2)||63
8633549|NCT03137992|21308884|P1|COMPLETED|Period 1 (Visit 2)||62
8633550|NCT03137992|21308879|P6|STARTED|Period 1 (Visit 2)||61
8633551|NCT03137992|21308880|P5|STARTED|Period 1 (Visit 2)||62
8633552|NCT03137992|21308881|P4|STARTED|Period 1 (Visit 2)||63
8633553|NCT03137992|21308882|P3|STARTED|Period 1 (Visit 2)||63
8633554|NCT03137992|21308883|P2|STARTED|Period 1 (Visit 2)||63
8633555|NCT03137992|21308884|P1|STARTED|Period 1 (Visit 2)||62
8633556|NCT03080454|21308894|P1|NOT COMPLETED|Anodal FU (7 Days)||4
8633557|NCT03080454|21308894|P1|COMPLETED|Anodal FU (7 Days)||19
8633558|NCT03080454|21308894|P1|STARTED|Anodal FU (7 Days)||23
8633559|NCT03080454|21308894|P1|NOT COMPLETED|Anodal Doublestim (5 Days)||1
8633560|NCT03080454|21308894|P1|COMPLETED|Anodal Doublestim (5 Days)||23
8633561|NCT03080454|21308894|P1|STARTED|Anodal Doublestim (5 Days)||24
8633562|NCT03080454|21308894|P1|NOT COMPLETED|Sham FU (7days)||0
8633563|NCT03080454|21308894|P1|COMPLETED|Sham FU (7days)||24
8633564|NCT03080454|21308894|P1|STARTED|Sham FU (7days)||24
8633565|NCT03080454|21308894|P1|NOT COMPLETED|Sham Doublestim (5days)||0
8633566|NCT03080454|21308894|P1|COMPLETED|Sham Doublestim (5days)||24
8633567|NCT03080454|21308894|P1|STARTED|Sham Doublestim (5days)||24
8633568|NCT03080454|21308894|P1|NOT COMPLETED|Baseline||2
8633569|NCT03080454|21308894|P1|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24
8633570|NCT03080454|21308894|P1|STARTED|Baseline||26
8633571|NCT03050450|21308908|P5|NOT COMPLETED|Overall Study||0
8633572|NCT03050450|21308909|P4|NOT COMPLETED|Overall Study||0
8633573|NCT03050450|21308910|P3|NOT COMPLETED|Overall Study||0
8633574|NCT03050450|21308911|P2|NOT COMPLETED|Overall Study||0
8633575|NCT03050450|21308912|P1|NOT COMPLETED|Overall Study||1
8633576|NCT03050450|21308908|P5|COMPLETED|Overall Study||0
8633577|NCT03050450|21308909|P4|COMPLETED|Overall Study||0
8633578|NCT03050450|21308910|P3|COMPLETED|Overall Study||0
8633579|NCT03050450|21308911|P2|COMPLETED|Overall Study||0
8633580|NCT03050450|21308912|P1|COMPLETED|Overall Study||5
8633581|NCT03050450|21308908|P5|STARTED|Overall Study||0
8633582|NCT03050450|21308909|P4|STARTED|Overall Study||0
8633583|NCT03050450|21308910|P3|STARTED|Overall Study||0
8633584|NCT03050450|21308911|P2|STARTED|Overall Study||0
8633585|NCT03050450|21308912|P1|STARTED|Overall Study||6
8633586|NCT02767323|21308943|P4|NOT COMPLETED|Overall Study||0
8633587|NCT02767323|21308944|P3|NOT COMPLETED|Overall Study||30
8633588|NCT02767323|21308945|P2|NOT COMPLETED|Overall Study||25
8633589|NCT02767323|21308946|P1|NOT COMPLETED|Overall Study||34
8633590|NCT02767323|21308943|P4|COMPLETED|Overall Study||1
8633591|NCT02767323|21308944|P3|COMPLETED|Overall Study||28
8633592|NCT02767323|21308945|P2|COMPLETED|Overall Study||17
8633593|NCT02767323|21308946|P1|COMPLETED|Overall Study||49
8633594|NCT02767323|21308943|P4|STARTED|Overall Study||1
8633595|NCT02767323|21308944|P3|STARTED|Overall Study||58
8633596|NCT02767323|21308945|P2|STARTED|Overall Study||42
8633597|NCT02767323|21308946|P1|STARTED|Overall Study||83
8633598|NCT02530996|21308962|P2|NOT COMPLETED|Second Intervention||0
8633599|NCT02530996|21308963|P1|NOT COMPLETED|Second Intervention||0
8633600|NCT02530996|21308962|P2|COMPLETED|Second Intervention||6
8633601|NCT02530996|21308963|P1|COMPLETED|Second Intervention||6
8633602|NCT02530996|21308962|P2|STARTED|Second Intervention||6
8633603|NCT02530996|21308963|P1|STARTED|Second Intervention||6
8633604|NCT02530996|21308962|P2|NOT COMPLETED|Washout (5 Days)||0
8633605|NCT02530996|21308963|P1|NOT COMPLETED|Washout (5 Days)||0
8633606|NCT02530996|21308962|P2|COMPLETED|Washout (5 Days)||6
8633607|NCT02530996|21308963|P1|COMPLETED|Washout (5 Days)||6
8633608|NCT02530996|21308962|P2|STARTED|Washout (5 Days)||6
8633609|NCT02530996|21308963|P1|STARTED|Washout (5 Days)||6
8633610|NCT02530996|21308962|P2|NOT COMPLETED|First Intervention||0
8633611|NCT02530996|21308963|P1|NOT COMPLETED|First Intervention||0
8633612|NCT02530996|21308962|P2|COMPLETED|First Intervention||6
8633613|NCT02530996|21308963|P1|COMPLETED|First Intervention||6
8633614|NCT02530996|21308962|P2|STARTED|First Intervention||6
8633615|NCT02530996|21308963|P1|STARTED|First Intervention||6
8633616|NCT02447302|21308994|P3|NOT COMPLETED|Overall Study||6
8633617|NCT02447302|21308995|P2|NOT COMPLETED|Overall Study||4
8633618|NCT02447302|21308996|P1|NOT COMPLETED|Overall Study||5
8633619|NCT02447302|21308994|P3|COMPLETED|Overall Study||48
8633620|NCT02447302|21308995|P2|COMPLETED|Overall Study||46
8633621|NCT02447302|21308996|P1|COMPLETED|Overall Study||47
8633622|NCT02447302|21308994|P3|STARTED|Overall Study||54
8633623|NCT02447302|21308995|P2|STARTED|Overall Study||50
8633624|NCT02447302|21308996|P1|STARTED|Overall Study||52
8633625|NCT02416011|21309025|P3|NOT COMPLETED|Overall Study||53
8633626|NCT02416011|21309026|P2|NOT COMPLETED|Overall Study||53
8633627|NCT02416011|21309027|P1|NOT COMPLETED|Overall Study||14
8633628|NCT02416011|21309025|P3|COMPLETED|Overall Study||1114
8633629|NCT02416011|21309026|P2|COMPLETED|Overall Study||1101
8633630|NCT02416011|21309027|P1|COMPLETED|Overall Study||561
8633631|NCT02416011|21309025|P3|STARTED|Overall Study||1167
8633632|NCT02416011|21309026|P2|STARTED|Overall Study||1154
8633633|NCT02416011|21309027|P1|STARTED|Overall Study||575
8633634|NCT02249819|21309048|P2|NOT COMPLETED|Overall Study||0
8633635|NCT02249819|21309049|P1|NOT COMPLETED|Overall Study||0
8633636|NCT02249819|21309048|P2|COMPLETED|Overall Study||7
8633637|NCT02249819|21309049|P1|COMPLETED|Overall Study||8
8633638|NCT02249819|21309048|P2|STARTED|Overall Study||7
8633639|NCT02249819|21309049|P1|STARTED|Overall Study||8
8633652|NCT02068729|21309133|P1|NOT COMPLETED|Overall Study||75
8633653|NCT02068729|21309133|P1|COMPLETED|Overall Study||56
8633654|NCT02068729|21309133|P1|STARTED|Overall Study||131
8633663|NCT01863849|21309213|P2|NOT COMPLETED|Overall Study||0
8633664|NCT01863849|21309214|P1|NOT COMPLETED|Overall Study||1
8633665|NCT01863849|21309213|P2|COMPLETED|Overall Study||60
8633666|NCT01863849|21309214|P1|COMPLETED|Overall Study||59
8633667|NCT01863849|21309213|P2|STARTED|Overall Study||60
8633668|NCT01863849|21309214|P1|STARTED|Overall Study||60
8633723|NCT00963911|21309385|P1|NOT COMPLETED|Overall Study||0
8633724|NCT00963911|21309385|P1|COMPLETED|Overall Study||1674
8633725|NCT00963911|21309385|P1|STARTED|Overall Study||1674
8633726|NCT00830180|21309394|P1|NOT COMPLETED|Overall Study||26
8633727|NCT00830180|21309394|P1|COMPLETED|Overall Study||15
8633728|NCT00830180|21309394|P1|Received Placebo in Parent Study A4091003|Overall Study||22
8633729|NCT00830180|21309394|P1|Received Tanezumab in Parent Study A4091003|Overall Study||19
8633730|NCT00830180|21309394|P1|STARTED|Overall Study||41
8633731|NCT00795275|21309417|P2|NOT COMPLETED|Overall Study||2
8633732|NCT00795275|21309418|P1|NOT COMPLETED|Overall Study||1
8633733|NCT00795275|21309417|P2|COMPLETED|Overall Study||13
8633734|NCT00795275|21309418|P1|COMPLETED|Overall Study||10
8633735|NCT00795275|21309417|P2|STARTED|Overall Study||15
8633736|NCT00795275|21309418|P1|STARTED|Overall Study||11
8633864|NCT04439214|21309507|P1|NOT COMPLETED|Overall Study||47
8633865|NCT04439214|21309507|P1|COMPLETED|Overall Study||0
8633866|NCT04439214|21309507|P1|Eligible and Treated|Overall Study||42
8633867|NCT04439214|21309507|P1|Treated and Reported Adverse Event Data|Overall Study|One patient experienced disease progression in cycle 1 and an AE form was not submitted.|46
8633868|NCT04439214|21309507|P1|Treated|Overall Study||47
8633869|NCT04439214|21309507|P1|Eligible|Overall Study||42
8633870|NCT04439214|21309507|P1|STARTED|Overall Study||47
8633883|NCT03843632|21309538|P4|NOT COMPLETED|Overall Study||0
8633884|NCT03843632|21309539|P3|NOT COMPLETED|Overall Study||0
8633885|NCT03843632|21309540|P2|NOT COMPLETED|Overall Study||0
8633886|NCT03843632|21309541|P1|NOT COMPLETED|Overall Study||1
8633887|NCT03843632|21309538|P4|COMPLETED|Overall Study||37
8633888|NCT03843632|21309539|P3|COMPLETED|Overall Study||33
8633889|NCT03843632|21309540|P2|COMPLETED|Overall Study||30
8633890|NCT03843632|21309541|P1|COMPLETED|Overall Study||49
8633891|NCT03843632|21309538|P4|Vaccination 2|Overall Study||0
8633892|NCT03843632|21309539|P3|Vaccination 2|Overall Study||0
8633893|NCT03843632|21309540|P2|Vaccination 2|Overall Study||30
8633894|NCT03843632|21309541|P1|Vaccination 2|Overall Study||49
8633895|NCT03843632|21309538|P4|Vaccination 1|Overall Study||37
8633896|NCT03843632|21309539|P3|Vaccination 1|Overall Study||33
8633897|NCT03843632|21309540|P2|Vaccination 1|Overall Study||30
8633898|NCT03843632|21309541|P1|Vaccination 1|Overall Study||50
8633899|NCT03843632|21309538|P4|STARTED|Overall Study||37
8633900|NCT03843632|21309539|P3|STARTED|Overall Study||33
8633901|NCT03843632|21309540|P2|STARTED|Overall Study||30
8633902|NCT03843632|21309541|P1|STARTED|Overall Study||50
8633903|NCT03743038|21309623|P1|NOT COMPLETED|Overall Study||1
8633904|NCT03743038|21309623|P1|COMPLETED|Overall Study||11
8633905|NCT03743038|21309623|P1|Test Article B|Overall Study||12
8633906|NCT03743038|21309623|P1|Test Article A|Overall Study||12
8633907|NCT03743038|21309623|P1|STARTED|Overall Study||12
8633908|NCT03434834|21309645|P1|NOT COMPLETED|Overall Study||16
8633909|NCT03434834|21309645|P1|COMPLETED|Overall Study||37
8633910|NCT03434834|21309645|P1|STARTED|Overall Study||53
8633911|NCT03383627|21309651|P1|NOT COMPLETED|Overall Study||0
8633912|NCT03383627|21309651|P1|COMPLETED|Overall Study||80
8633913|NCT03383627|21309651|P1|STARTED|Overall Study||80
8633914|NCT03339999|21309665|P4|NOT COMPLETED|Overall Study||5
8633915|NCT03339999|21309666|P3|NOT COMPLETED|Overall Study||6
8633916|NCT03339999|21309667|P2|NOT COMPLETED|Overall Study||6
8633917|NCT03339999|21309668|P1|NOT COMPLETED|Overall Study||7
8633918|NCT03339999|21309665|P4|COMPLETED|Overall Study||0
8633919|NCT03339999|21309666|P3|COMPLETED|Overall Study||0
8633920|NCT03339999|21309667|P2|COMPLETED|Overall Study||0
8633921|NCT03339999|21309668|P1|COMPLETED|Overall Study||0
8633922|NCT03339999|21309665|P4|Safety Population: Received Treatment|Overall Study||4
8633923|NCT03339999|21309666|P3|Safety Population: Received Treatment|Overall Study||6
8633924|NCT03339999|21309667|P2|Safety Population: Received Treatment|Overall Study||6
8633925|NCT03339999|21309668|P1|Safety Population: Received Treatment|Overall Study||7
8633926|NCT03339999|21309665|P4|Modified Intent-to-Treat Population|Overall Study||4
8633927|NCT03339999|21309666|P3|Modified Intent-to-Treat Population|Overall Study||5
8633928|NCT03339999|21309667|P2|Modified Intent-to-Treat Population|Overall Study||6
8633929|NCT03339999|21309668|P1|Modified Intent-to-Treat Population|Overall Study||7
8633930|NCT03339999|21309665|P4|STARTED|Overall Study||5
8633931|NCT03339999|21309666|P3|STARTED|Overall Study||6
8633932|NCT03339999|21309667|P2|STARTED|Overall Study||6
8633933|NCT03339999|21309668|P1|STARTED|Overall Study||7
8633934|NCT03043599|21309709|P1|NOT COMPLETED|Overall Study||0
8633935|NCT03043599|21309709|P1|COMPLETED|Overall Study||21
8633936|NCT03043599|21309709|P1|STARTED|Overall Study||21
8633943|NCT02805660|21309730|P7|NOT COMPLETED|Overall Study||19
8633944|NCT02805660|21309731|P6|NOT COMPLETED|Overall Study||23
8633945|NCT02805660|21309732|P5|NOT COMPLETED|Overall Study||3
8633946|NCT02805660|21309733|P4|NOT COMPLETED|Overall Study||18
8633947|NCT02805660|21309734|P3|NOT COMPLETED|Overall Study||11
8633948|NCT02805660|21309735|P2|NOT COMPLETED|Overall Study||4
8633949|NCT02805660|21309736|P1|NOT COMPLETED|Overall Study||5
8633950|NCT02805660|21309730|P7|COMPLETED|Overall Study||0
8633951|NCT02805660|21309731|P6|COMPLETED|Overall Study||0
8633952|NCT02805660|21309732|P5|COMPLETED|Overall Study||0
8633953|NCT02805660|21309733|P4|COMPLETED|Overall Study||0
8633954|NCT02805660|21309734|P3|COMPLETED|Overall Study||0
8633955|NCT02805660|21309735|P2|COMPLETED|Overall Study||0
8633956|NCT02805660|21309736|P1|COMPLETED|Overall Study||0
8633957|NCT02805660|21309730|P7|STARTED|Overall Study||19
8633958|NCT02805660|21309731|P6|STARTED|Overall Study||23
8633959|NCT02805660|21309732|P5|STARTED|Overall Study||3
8633960|NCT02805660|21309733|P4|STARTED|Overall Study||18
8633961|NCT02805660|21309734|P3|STARTED|Overall Study||11
8633962|NCT02805660|21309735|P2|STARTED|Overall Study||4
8633963|NCT02805660|21309736|P1|STARTED|Overall Study||5
8633985|NCT02673333|21309848|P1|NOT COMPLETED|Overall Study||0
8633986|NCT02673333|21309848|P1|COMPLETED|Overall Study||39
8633987|NCT02673333|21309848|P1|STARTED|Overall Study||39
8633994|NCT02527265|21309877|P2|NOT COMPLETED|Overall Study||4
8633995|NCT02527265|21309878|P1|NOT COMPLETED|Overall Study||2
8633996|NCT02527265|21309877|P2|COMPLETED|Overall Study||11
8633997|NCT02527265|21309878|P1|COMPLETED|Overall Study||13
8633998|NCT02527265|21309877|P2|STARTED|Overall Study||15
8633999|NCT02527265|21309878|P1|STARTED|Overall Study||15
8634000|NCT02508649|21309894|P4|NOT COMPLETED|Overall Study||10
8634001|NCT02508649|21309895|P3|NOT COMPLETED|Overall Study||15
8634002|NCT02508649|21309896|P2|NOT COMPLETED|Overall Study||13
8634003|NCT02508649|21309897|P1|NOT COMPLETED|Overall Study||18
8634004|NCT02508649|21309894|P4|COMPLETED|Overall Study||189
8634005|NCT02508649|21309895|P3|COMPLETED|Overall Study||174
8634006|NCT02508649|21309896|P2|COMPLETED|Overall Study||184
8634007|NCT02508649|21309897|P1|COMPLETED|Overall Study||265
8634008|NCT02508649|21309894|P4|Dosed|Overall Study||194
8634009|NCT02508649|21309895|P3|Dosed|Overall Study||177
8634010|NCT02508649|21309896|P2|Dosed|Overall Study||191
8634011|NCT02508649|21309897|P1|Dosed|Overall Study||266
8634012|NCT02508649|21309894|P4|STARTED|Overall Study||199
8634013|NCT02508649|21309895|P3|STARTED|Overall Study||189
8634014|NCT02508649|21309896|P2|STARTED|Overall Study||197
8634015|NCT02508649|21309897|P1|STARTED|Overall Study||283
8634016|NCT02501902|21309994|P8|NOT COMPLETED|Overall Study||20
8634017|NCT02501902|21309995|P7|NOT COMPLETED|Overall Study||9
8634018|NCT02501902|21309996|P6|NOT COMPLETED|Overall Study||11
8634019|NCT02501902|21309997|P5|NOT COMPLETED|Overall Study||11
8634020|NCT02501902|21309998|P4|NOT COMPLETED|Overall Study||11
8634021|NCT02501902|21309999|P3|NOT COMPLETED|Overall Study||4
8634022|NCT02501902|21310000|P2|NOT COMPLETED|Overall Study||7
8634023|NCT02501902|21310001|P1|NOT COMPLETED|Overall Study||3
8634024|NCT02501902|21309994|P8|COMPLETED|Overall Study||0
8634025|NCT02501902|21309995|P7|COMPLETED|Overall Study||0
8634026|NCT02501902|21309996|P6|COMPLETED|Overall Study||0
8634027|NCT02501902|21309997|P5|COMPLETED|Overall Study||0
8634028|NCT02501902|21309998|P4|COMPLETED|Overall Study||0
8634029|NCT02501902|21309999|P3|COMPLETED|Overall Study||0
8634030|NCT02501902|21310000|P2|COMPLETED|Overall Study||0
8634031|NCT02501902|21310001|P1|COMPLETED|Overall Study||0
8634032|NCT02501902|21309994|P8|STARTED|Overall Study||20
8634033|NCT02501902|21309995|P7|STARTED|Overall Study||9
8634034|NCT02501902|21309996|P6|STARTED|Overall Study||11
8634035|NCT02501902|21309997|P5|STARTED|Overall Study||11
8634036|NCT02501902|21309998|P4|STARTED|Overall Study||11
8634037|NCT02501902|21309999|P3|STARTED|Overall Study||4
8634038|NCT02501902|21310000|P2|STARTED|Overall Study||7
8634039|NCT02501902|21310001|P1|STARTED|Overall Study||3
8634040|NCT02466009|21310262|P1|NOT COMPLETED|Overall Study||0
8634041|NCT02466009|21310262|P1|COMPLETED|Overall Study||27
8634042|NCT02466009|21310262|P1|STARTED|Overall Study||27
8634043|NCT02437084|21310266|P1|NOT COMPLETED|Overall Study||3
8634044|NCT02437084|21310266|P1|COMPLETED|Overall Study||72
8634045|NCT02437084|21310266|P1|STARTED|Overall Study||75
8634046|NCT02243371|21310277|P2|NOT COMPLETED|Overall Study||32
8634047|NCT02243371|21310278|P1|NOT COMPLETED|Overall Study||37
8634048|NCT02243371|21310277|P2|COMPLETED|Overall Study||10
8634049|NCT02243371|21310278|P1|COMPLETED|Overall Study||14
8634050|NCT02243371|21310277|P2|STARTED|Overall Study||42
8634051|NCT02243371|21310278|P1|STARTED|Overall Study||51
8634120|NCT02111577|21310449|P2|NOT COMPLETED|Overall Study||289
8634121|NCT02111577|21310450|P1|NOT COMPLETED|Overall Study||599
8634122|NCT02111577|21310449|P2|COMPLETED|Overall Study||106
8634123|NCT02111577|21310450|P1|COMPLETED|Overall Study||188
8634124|NCT02111577|21310449|P2|STARTED|Overall Study||395
8634125|NCT02111577|21310450|P1|STARTED|Overall Study||787
8634126|NCT02094118|21310486|P2|NOT COMPLETED|Overall Study||5
8634127|NCT02094118|21310487|P1|NOT COMPLETED|Overall Study||12
8634128|NCT02094118|21310486|P2|COMPLETED|Overall Study||81
8634129|NCT02094118|21310487|P1|COMPLETED|Overall Study||73
8634130|NCT02094118|21310486|P2|STARTED|Overall Study||86
8634131|NCT02094118|21310487|P1|STARTED|Overall Study||85
8634132|NCT02085460|21310514|P3|NOT COMPLETED|Overall Study||10
8634133|NCT02085460|21310515|P2|NOT COMPLETED|Overall Study||8
8634134|NCT02085460|21310516|P1|NOT COMPLETED|Overall Study||14
8634135|NCT02085460|21310514|P3|COMPLETED|Overall Study||21
8634136|NCT02085460|21310515|P2|COMPLETED|Overall Study||24
8634137|NCT02085460|21310516|P1|COMPLETED|Overall Study||17
8634138|NCT02085460|21310514|P3|STARTED|Overall Study||31
8634139|NCT02085460|21310515|P2|STARTED|Overall Study||32
8634140|NCT02085460|21310516|P1|STARTED|Overall Study||31
8634149|NCT02004613|21310552|P2|NOT COMPLETED|Overall Study||2
8634150|NCT02004613|21310553|P1|NOT COMPLETED|Overall Study||2
8634151|NCT02004613|21310552|P2|COMPLETED|Overall Study||396
8634152|NCT02004613|21310553|P1|COMPLETED|Overall Study||398
8634153|NCT02004613|21310552|P2|STARTED|Overall Study||398
8634154|NCT02004613|21310553|P1|STARTED|Overall Study||400
8634155|NCT01988493|21310570|P5|NOT COMPLETED|Overall Study||1
8634156|NCT01988493|21310571|P4|NOT COMPLETED|Overall Study||2
8634157|NCT01988493|21310572|P3|NOT COMPLETED|Overall Study||0
8634158|NCT01988493|21310573|P2|NOT COMPLETED|Overall Study||0
8634159|NCT01988493|21310574|P1|NOT COMPLETED|Overall Study||0
8634160|NCT01988493|21310570|P5|COMPLETED|Overall Study||44
8634161|NCT01988493|21310571|P4|COMPLETED|Overall Study||43
8634162|NCT01988493|21310572|P3|COMPLETED|Overall Study||6
8634163|NCT01988493|21310573|P2|COMPLETED|Overall Study||14
8634164|NCT01988493|21310574|P1|COMPLETED|Overall Study||7
8634165|NCT01988493|21310570|P5|Safety Population|Overall Study||44
8634166|NCT01988493|21310571|P4|Safety Population|Overall Study||45
8634167|NCT01988493|21310572|P3|Safety Population|Overall Study||6
8634168|NCT01988493|21310573|P2|Safety Population|Overall Study||14
8634169|NCT01988493|21310574|P1|Safety Population|Overall Study||7
8634170|NCT01988493|21310570|P5|Treated|Overall Study||44
8634171|NCT01988493|21310571|P4|Treated|Overall Study||45
8634172|NCT01988493|21310572|P3|Treated|Overall Study||6
8634173|NCT01988493|21310573|P2|Treated|Overall Study||14
8634174|NCT01988493|21310574|P1|Treated|Overall Study||7
8634175|NCT01988493|21310570|P5|STARTED|Overall Study||45
8634176|NCT01988493|21310571|P4|STARTED|Overall Study||45
8634177|NCT01988493|21310572|P3|STARTED|Overall Study||6
8634178|NCT01988493|21310573|P2|STARTED|Overall Study||14
8634179|NCT01988493|21310574|P1|STARTED|Overall Study||7
8634180|NCT01977599|21310645|P2|NOT COMPLETED|Overall Study||0
8634181|NCT01977599|21310646|P1|NOT COMPLETED|Overall Study||0
8634182|NCT01977599|21310645|P2|COMPLETED|Overall Study||1122
8634183|NCT01977599|21310646|P1|COMPLETED|Overall Study||1118
8634184|NCT01977599|21310645|P2|STARTED|Overall Study||1122
8634185|NCT01977599|21310646|P1|STARTED|Overall Study||1118
8634186|NCT01974102|21310656|P2|NOT COMPLETED|Overall Study||1
8634187|NCT01974102|21310657|P1|NOT COMPLETED|Overall Study||7
8634188|NCT01974102|21310656|P2|COMPLETED|Overall Study||19
8634189|NCT01974102|21310657|P1|COMPLETED|Overall Study||15
8634190|NCT01974102|21310656|P2|STARTED|Overall Study||20
8634191|NCT01974102|21310657|P1|STARTED|Overall Study||22
8634192|NCT01755767|21310669|P4|NOT COMPLETED|Overall Study||114
8634193|NCT01755767|21310670|P3|NOT COMPLETED|Overall Study||226
8634194|NCT01755767|21310671|P2|NOT COMPLETED|Overall Study||15
8634195|NCT01755767|21310672|P1|NOT COMPLETED|Overall Study||28
8634196|NCT01755767|21310669|P4|COMPLETED|Overall Study||0
8634197|NCT01755767|21310670|P3|COMPLETED|Overall Study||0
8634198|NCT01755767|21310671|P2|COMPLETED|Overall Study||0
8634199|NCT01755767|21310672|P1|COMPLETED|Overall Study||0
8634200|NCT01755767|21310669|P4|STARTED|Overall Study||114
8634201|NCT01755767|21310670|P3|STARTED|Overall Study||226
8634202|NCT01755767|21310671|P2|STARTED|Overall Study||15
8634203|NCT01755767|21310672|P1|STARTED|Overall Study||28
8634220|NCT01557452|21310736|P1|NOT COMPLETED|Overall Study||0
8634221|NCT01557452|21310736|P1|COMPLETED|Overall Study||1
8634222|NCT01557452|21310736|P1|STARTED|Overall Study||1
8634223|NCT01515306|21310744|P2|NOT COMPLETED|Overall Study||14
8634224|NCT01515306|21310745|P1|NOT COMPLETED|Overall Study||12
8634225|NCT01515306|21310744|P2|COMPLETED|Overall Study||2
8634226|NCT01515306|21310745|P1|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
8634227|NCT01515306|21310744|P2|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
8634228|NCT01515306|21310745|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
8634229|NCT01515306|21310744|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
8634230|NCT01515306|21310745|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
8634231|NCT01515306|21310744|P2|STARTED|Overall Study||16
8634232|NCT01515306|21310745|P1|STARTED|Overall Study||24
8634233|NCT01398566|21310756|P1|NOT COMPLETED|Overall Study||0
8634234|NCT01398566|21310756|P1|COMPLETED|Overall Study||20
8634235|NCT01398566|21310756|P1|STARTED|Overall Study|20 enrolled|20
8634239|NCT01244191|21310767|P2|NOT COMPLETED|Overall Study||498
8634240|NCT01244191|21310768|P1|NOT COMPLETED|Overall Study||480
8634241|NCT01244191|21310767|P2|COMPLETED|Overall Study||24
8634242|NCT01244191|21310768|P1|COMPLETED|Overall Study||46
8634243|NCT01244191|21310767|P2|Did Not Receive Treatment|Overall Study||5
8634244|NCT01244191|21310768|P1|Did Not Receive Treatment|Overall Study||6
8634245|NCT01244191|21310767|P2|STARTED|Overall Study||522
8634246|NCT01244191|21310768|P1|STARTED|Overall Study||526
8634271|NCT01055067|21310855|P1|NOT COMPLETED|Overall Study||0
8634272|NCT01055067|21310855|P1|COMPLETED|Overall Study||27
8634273|NCT01055067|21310855|P1|STARTED|Overall Study||27
8634274|NCT00989573|21310870|P3|NOT COMPLETED|Overall Study||8
8634275|NCT00989573|21310871|P2|NOT COMPLETED|Overall Study||22
8634276|NCT00989573|21310872|P1|NOT COMPLETED|Overall Study||13
8634277|NCT00989573|21310870|P3|COMPLETED|Overall Study||55
8634278|NCT00989573|21310871|P2|COMPLETED|Overall Study||41
8634279|NCT00989573|21310872|P1|COMPLETED|Overall Study||52
8634280|NCT00989573|21310870|P3|STARTED|Overall Study||63
8634281|NCT00989573|21310871|P2|STARTED|Overall Study||63
8634282|NCT00989573|21310872|P1|STARTED|Overall Study||65
8634298|NCT00896181|21310921|P1|NOT COMPLETED|Overall Study||0
8634299|NCT00896181|21310921|P1|COMPLETED|Overall Study||26
8634300|NCT00896181|21310921|P1|STARTED|Overall Study||26
8634301|NCT00774566|21310931|P2|NOT COMPLETED|Overall Study||15
8634302|NCT00774566|21310932|P1|NOT COMPLETED|Overall Study||18
8634303|NCT00774566|21310931|P2|COMPLETED|Overall Study||141
8634304|NCT00774566|21310932|P1|COMPLETED|Overall Study||141
8634305|NCT00774566|21310931|P2|12 Month Follow up|Overall Study||141
8634306|NCT00774566|21310932|P1|12 Month Follow up|Overall Study||141
8634307|NCT00774566|21310931|P2|6 Month Follow up|Overall Study||150
8634308|NCT00774566|21310932|P1|6 Month Follow up|Overall Study||154
8634309|NCT00774566|21310931|P2|STARTED|Overall Study||156
8634310|NCT00774566|21310932|P1|STARTED|Overall Study||159
8634311|NCT00768287|21310950|P6|NOT COMPLETED|Surgical Sub-study||0
8634312|NCT00768287|21310951|P5|NOT COMPLETED|Surgical Sub-study||0
8634313|NCT00768287|21310952|P4|NOT COMPLETED|Surgical Sub-study||0
8634314|NCT00768287|21310953|P3|NOT COMPLETED|Surgical Sub-study||0
8634315|NCT00768287|21310954|P2|NOT COMPLETED|Surgical Sub-study||0
8634316|NCT00768287|21310955|P1|NOT COMPLETED|Surgical Sub-study||0
8634317|NCT00768287|21310950|P6|COMPLETED|Surgical Sub-study||17
8634318|NCT00768287|21310951|P5|COMPLETED|Surgical Sub-study||0
8634319|NCT00768287|21310952|P4|COMPLETED|Surgical Sub-study||0
8634320|NCT00768287|21310953|P3|COMPLETED|Surgical Sub-study||0
8634321|NCT00768287|21310954|P2|COMPLETED|Surgical Sub-study||0
8634322|NCT00768287|21310955|P1|COMPLETED|Surgical Sub-study||0
8634323|NCT00768287|21310950|P6|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
8634324|NCT00768287|21310951|P5|STARTED|Surgical Sub-study||0
8634325|NCT00768287|21310952|P4|STARTED|Surgical Sub-study||0
8634326|NCT00768287|21310953|P3|STARTED|Surgical Sub-study||0
8634327|NCT00768287|21310954|P2|STARTED|Surgical Sub-study||0
8634328|NCT00768287|21310955|P1|STARTED|Surgical Sub-study||0
8634329|NCT00768287|21310950|P6|NOT COMPLETED|Treatment Study||0
8634330|NCT00768287|21310951|P5|NOT COMPLETED|Treatment Study||0
8634331|NCT00768287|21310952|P4|NOT COMPLETED|Treatment Study||0
8634332|NCT00768287|21310953|P3|NOT COMPLETED|Treatment Study||0
8634333|NCT00768287|21310954|P2|NOT COMPLETED|Treatment Study||0
8634334|NCT00768287|21310955|P1|NOT COMPLETED|Treatment Study||0
8634335|NCT00768287|21310950|P6|COMPLETED|Treatment Study||0
8634336|NCT00768287|21310951|P5|COMPLETED|Treatment Study||9
8634337|NCT00768287|21310952|P4|COMPLETED|Treatment Study||58
8634338|NCT00768287|21310953|P3|COMPLETED|Treatment Study||0
8634339|NCT00768287|21310954|P2|COMPLETED|Treatment Study||0
8634340|NCT00768287|21310955|P1|COMPLETED|Treatment Study||0
8634341|NCT00768287|21310950|P6|Treated|Treatment Study||0
8634342|NCT00768287|21310951|P5|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
8634343|NCT00768287|21310952|P4|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
8634344|NCT00768287|21310953|P3|Treated|Treatment Study||0
8634345|NCT00768287|21310954|P2|Treated|Treatment Study||0
8634346|NCT00768287|21310955|P1|Treated|Treatment Study||0
8634347|NCT00768287|21310950|P6|STARTED|Treatment Study||0
8634348|NCT00768287|21310951|P5|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
8634349|NCT00768287|21310952|P4|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
8634350|NCT00768287|21310953|P3|STARTED|Treatment Study||0
8634351|NCT00768287|21310954|P2|STARTED|Treatment Study||0
8634352|NCT00768287|21310955|P1|STARTED|Treatment Study||0
8634353|NCT00768287|21310950|P6|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8634354|NCT00768287|21310951|P5|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8634355|NCT00768287|21310952|P4|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8634356|NCT00768287|21310953|P3|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8634357|NCT00768287|21310954|P2|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8634358|NCT00768287|21310955|P1|NOT COMPLETED|Repeat Pharmacokinetic Study||0
8634359|NCT00768287|21310950|P6|COMPLETED|Repeat Pharmacokinetic Study||0
8634360|NCT00768287|21310951|P5|COMPLETED|Repeat Pharmacokinetic Study||0
8634361|NCT00768287|21310952|P4|COMPLETED|Repeat Pharmacokinetic Study||0
8634362|NCT00768287|21310953|P3|COMPLETED|Repeat Pharmacokinetic Study||14
8634363|NCT00768287|21310954|P2|COMPLETED|Repeat Pharmacokinetic Study||0
8634364|NCT00768287|21310955|P1|COMPLETED|Repeat Pharmacokinetic Study||0
8634365|NCT00768287|21310950|P6|STARTED|Repeat Pharmacokinetic Study||0
8634366|NCT00768287|21310951|P5|STARTED|Repeat Pharmacokinetic Study||0
8634367|NCT00768287|21310952|P4|STARTED|Repeat Pharmacokinetic Study||0
8634368|NCT00768287|21310953|P3|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
8634369|NCT00768287|21310954|P2|STARTED|Repeat Pharmacokinetic Study||0
8634370|NCT00768287|21310955|P1|STARTED|Repeat Pharmacokinetic Study||0
8634371|NCT00768287|21310950|P6|NOT COMPLETED|Pharmacokinetic Study||0
8634372|NCT00768287|21310951|P5|NOT COMPLETED|Pharmacokinetic Study||0
8634373|NCT00768287|21310952|P4|NOT COMPLETED|Pharmacokinetic Study||0
8634374|NCT00768287|21310953|P3|NOT COMPLETED|Pharmacokinetic Study||0
8634375|NCT00768287|21310954|P2|NOT COMPLETED|Pharmacokinetic Study||0
8634376|NCT00768287|21310955|P1|NOT COMPLETED|Pharmacokinetic Study||0
8634377|NCT00768287|21310950|P6|COMPLETED|Pharmacokinetic Study||0
8634378|NCT00768287|21310951|P5|COMPLETED|Pharmacokinetic Study||0
8634379|NCT00768287|21310952|P4|COMPLETED|Pharmacokinetic Study||0
8634380|NCT00768287|21310953|P3|COMPLETED|Pharmacokinetic Study||0
8634381|NCT00768287|21310954|P2|COMPLETED|Pharmacokinetic Study||16
8634382|NCT00768287|21310955|P1|COMPLETED|Pharmacokinetic Study||16
8634383|NCT00768287|21310950|P6|STARTED|Pharmacokinetic Study||0
8634384|NCT00768287|21310951|P5|STARTED|Pharmacokinetic Study||0
8634385|NCT00768287|21310952|P4|STARTED|Pharmacokinetic Study||0
8634386|NCT00768287|21310953|P3|STARTED|Pharmacokinetic Study||0
8634387|NCT00768287|21310954|P2|STARTED|Pharmacokinetic Study||16
8634388|NCT00768287|21310955|P1|STARTED|Pharmacokinetic Study||16
8634389|NCT00679042|21310990|P1|NOT COMPLETED|10-Year Follow Up||5
8634390|NCT00679042|21310990|P1|COMPLETED|10-Year Follow Up||0
8634391|NCT00679042|21310990|P1|STARTED|10-Year Follow Up||5
8634392|NCT00679042|21310990|P1|NOT COMPLETED|5-Year Follow Up||14
8634393|NCT00679042|21310990|P1|COMPLETED|5-Year Follow Up||5
8634394|NCT00679042|21310990|P1|STARTED|5-Year Follow Up||19
8634395|NCT00679042|21310990|P1|NOT COMPLETED|Transplant + 1 Year Follow Up||2
8634396|NCT00679042|21310990|P1|COMPLETED|Transplant + 1 Year Follow Up||19
8634397|NCT00679042|21310990|P1|STARTED|Transplant + 1 Year Follow Up||21
8634398|NCT00594997|21311000|P2|NOT COMPLETED|Overall Study||0
8634399|NCT00594997|21311001|P1|NOT COMPLETED|Overall Study||0
8634400|NCT00594997|21311000|P2|COMPLETED|Overall Study||2008
8634401|NCT00594997|21311001|P1|COMPLETED|Overall Study||1562
8634402|NCT00594997|21311000|P2|STARTED|Overall Study||2008
8634403|NCT00594997|21311001|P1|STARTED|Overall Study||1562
8634404|NCT00566813|21311011|P2|NOT COMPLETED|Overall Study||0
8634405|NCT00566813|21311012|P1|NOT COMPLETED|Overall Study||0
8634406|NCT00566813|21311011|P2|COMPLETED|Overall Study||6
8634407|NCT00566813|21311012|P1|COMPLETED|Overall Study||4
8634408|NCT00566813|21311011|P2|STARTED|Overall Study||6
8634409|NCT00566813|21311012|P1|STARTED|Overall Study||4
8634410|NCT00520767|21311022|P1|NOT COMPLETED|Overall Study||2
8634411|NCT00520767|21311022|P1|COMPLETED|Overall Study||33
8634412|NCT00520767|21311022|P1|STARTED|Overall Study||35
8634413|NCT00121251|21311026|P1|NOT COMPLETED|Overall Study||0
8634414|NCT00121251|21311026|P1|COMPLETED|Overall Study||17
8634415|NCT00121251|21311026|P1|STARTED|Overall Study||17
8634416|NCT04716426|21311034|P2|NOT COMPLETED|Overall Study||1
8634417|NCT04716426|21311035|P1|NOT COMPLETED|Overall Study||2
8634418|NCT04716426|21311034|P2|COMPLETED|Overall Study||49
8634419|NCT04716426|21311035|P1|COMPLETED|Overall Study||48
8634420|NCT04716426|21311034|P2|STARTED|Overall Study||50
8634421|NCT04716426|21311035|P1|STARTED|Overall Study||50
8634422|NCT04451707|21311049|P1|NOT COMPLETED|Overall Study||0
8634423|NCT04451707|21311049|P1|COMPLETED|Overall Study||67
8634424|NCT04451707|21311049|P1|STARTED|Overall Study||67
8634425|NCT04428359|21311061|P2|NOT COMPLETED|Overall Study||3
8634426|NCT04428359|21311062|P1|NOT COMPLETED|Overall Study||2
8634427|NCT04428359|21311061|P2|COMPLETED|Overall Study||30
8634428|NCT04428359|21311062|P1|COMPLETED|Overall Study||31
8634429|NCT04428359|21311061|P2|STARTED|Overall Study||33
8634430|NCT04428359|21311062|P1|STARTED|Overall Study||33
8634431|NCT04386902|21311084|P1|NOT COMPLETED|Overall Study||10
8634432|NCT04386902|21311084|P1|COMPLETED|Overall Study||50
8634433|NCT04386902|21311084|P1|STARTED|Overall Study||60
8634434|NCT04338009|21311090|P2|NOT COMPLETED|Overall Study||0
8634435|NCT04338009|21311091|P1|NOT COMPLETED|Overall Study||0
8634436|NCT04338009|21311090|P2|COMPLETED|Overall Study||75
8634437|NCT04338009|21311091|P1|COMPLETED|Overall Study||77
8634438|NCT04338009|21311090|P2|STARTED|Overall Study||75
8634439|NCT04338009|21311091|P1|STARTED|Overall Study||77
8634440|NCT04320823|21311111|P2|NOT COMPLETED|Overall Study||0
8634441|NCT04320823|21311112|P1|NOT COMPLETED|Overall Study||0
8634442|NCT04320823|21311111|P2|COMPLETED|Overall Study|Includes 38 donors who withdrew from the study after one or more donations.|1726
8634443|NCT04320823|21311112|P1|COMPLETED|Overall Study|Includes 47 donors who withdrew from the study after one or more donations.|1717
8634444|NCT04320823|21311111|P2|STARTED|Overall Study||1726
8634445|NCT04320823|21311112|P1|STARTED|Overall Study||1717
8634446|NCT04238663|21311145|P3|NOT COMPLETED|Overall Study||0
8634447|NCT04238663|21311146|P2|NOT COMPLETED|Overall Study||1
8634448|NCT04238663|21311147|P1|NOT COMPLETED|Overall Study||0
8634449|NCT04238663|21311145|P3|COMPLETED|Overall Study||38
8634450|NCT04238663|21311146|P2|COMPLETED|Overall Study||37
8634451|NCT04238663|21311147|P1|COMPLETED|Overall Study||38
8634452|NCT04238663|21311145|P3|STARTED|Overall Study||38
8634453|NCT04238663|21311146|P2|STARTED|Overall Study||38
8634454|NCT04238663|21311147|P1|STARTED|Overall Study||38
8634461|NCT04138498|21311189|P4|NOT COMPLETED|Overall Study||3
8634462|NCT04138498|21311190|P3|NOT COMPLETED|Overall Study||2
8634463|NCT04138498|21311191|P2|NOT COMPLETED|Overall Study||0
8634464|NCT04138498|21311192|P1|NOT COMPLETED|Overall Study||1
8634465|NCT04138498|21311189|P4|COMPLETED|Overall Study||9
8634466|NCT04138498|21311190|P3|COMPLETED|Overall Study||10
8634467|NCT04138498|21311191|P2|COMPLETED|Overall Study||10
8634468|NCT04138498|21311192|P1|COMPLETED|Overall Study||10
8634469|NCT04138498|21311189|P4|STARTED|Overall Study||12
8634470|NCT04138498|21311190|P3|STARTED|Overall Study||12
8634471|NCT04138498|21311191|P2|STARTED|Overall Study||10
8634472|NCT04138498|21311192|P1|STARTED|Overall Study||11
8634476|NCT04016077|21311250|P2|NOT COMPLETED|Overall Study||0
8634477|NCT04016077|21311251|P1|NOT COMPLETED|Overall Study||0
8634478|NCT04016077|21311250|P2|COMPLETED|Overall Study||8
8634479|NCT04016077|21311251|P1|COMPLETED|Overall Study||10
8634480|NCT04016077|21311250|P2|STARTED|Overall Study||8
8634481|NCT04016077|21311251|P1|STARTED|Overall Study||10
8634482|NCT03958071|21311270|P3|NOT COMPLETED|Overall Study||0
8634483|NCT03958071|21311271|P2|NOT COMPLETED|Overall Study||0
8634484|NCT03958071|21311272|P1|NOT COMPLETED|Overall Study||0
8634485|NCT03958071|21311270|P3|COMPLETED|Overall Study||12494
8634486|NCT03958071|21311271|P2|COMPLETED|Overall Study||423
8634487|NCT03958071|21311272|P1|COMPLETED|Overall Study||347
8634488|NCT03958071|21311270|P3|STARTED|Overall Study||12494
8634489|NCT03958071|21311271|P2|STARTED|Overall Study||423
8634490|NCT03958071|21311272|P1|STARTED|Overall Study||347
8634491|NCT03895853|21311298|P2|NOT COMPLETED|Overall Study||0
8634492|NCT03895853|21311299|P1|NOT COMPLETED|Overall Study||0
8634493|NCT03895853|21311298|P2|COMPLETED|Overall Study||2
8634494|NCT03895853|21311299|P1|COMPLETED|Overall Study||0
8634495|NCT03895853|21311298|P2|STARTED|Overall Study||2
8634496|NCT03895853|21311299|P1|STARTED|Overall Study||0
8634545|NCT03739866|21311438|P8|NOT COMPLETED|Overall Study||0
8634546|NCT03739866|21311439|P7|NOT COMPLETED|Overall Study||0
8634547|NCT03739866|21311440|P6|NOT COMPLETED|Overall Study||0
8634548|NCT03739866|21311441|P5|NOT COMPLETED|Overall Study||1
8634549|NCT03739866|21311442|P4|NOT COMPLETED|Overall Study||1
8634550|NCT03739866|21311443|P3|NOT COMPLETED|Overall Study||1
8634551|NCT03739866|21311444|P2|NOT COMPLETED|Overall Study||0
8634552|NCT03739866|21311445|P1|NOT COMPLETED|Overall Study||0
8634553|NCT03739866|21311438|P8|COMPLETED|Overall Study||5
8634554|NCT03739866|21311439|P7|COMPLETED|Overall Study||7
8634555|NCT03739866|21311440|P6|COMPLETED|Overall Study||10
8634556|NCT03739866|21311441|P5|COMPLETED|Overall Study||5
8634557|NCT03739866|21311442|P4|COMPLETED|Overall Study||5
8634558|NCT03739866|21311443|P3|COMPLETED|Overall Study||6
8634559|NCT03739866|21311444|P2|COMPLETED|Overall Study||6
8634560|NCT03739866|21311445|P1|COMPLETED|Overall Study||6
8634561|NCT03739866|21311438|P8|STARTED|Overall Study||5
8634562|NCT03739866|21311439|P7|STARTED|Overall Study||7
8634563|NCT03739866|21311440|P6|STARTED|Overall Study||10
8634564|NCT03739866|21311441|P5|STARTED|Overall Study||6
8634565|NCT03739866|21311442|P4|STARTED|Overall Study||6
8634566|NCT03739866|21311443|P3|STARTED|Overall Study||7
8634567|NCT03739866|21311444|P2|STARTED|Overall Study||6
8634568|NCT03739866|21311445|P1|STARTED|Overall Study||6
8634569|NCT03707041|21311533|P6|NOT COMPLETED|Overall Study||0
8634570|NCT03707041|21311534|P5|NOT COMPLETED|Overall Study||0
8634571|NCT03707041|21311535|P4|NOT COMPLETED|Overall Study||0
8634572|NCT03707041|21311536|P3|NOT COMPLETED|Overall Study||0
8634573|NCT03707041|21311537|P2|NOT COMPLETED|Overall Study||0
8634574|NCT03707041|21311538|P1|NOT COMPLETED|Overall Study||0
8634575|NCT03707041|21311533|P6|COMPLETED|Overall Study||3
8634576|NCT03707041|21311534|P5|COMPLETED|Overall Study||9
8634577|NCT03707041|21311535|P4|COMPLETED|Overall Study||3
8634578|NCT03707041|21311536|P3|COMPLETED|Overall Study||9
8634579|NCT03707041|21311537|P2|COMPLETED|Overall Study||2
8634580|NCT03707041|21311538|P1|COMPLETED|Overall Study||6
8634581|NCT03707041|21311533|P6|STARTED|Overall Study||3
8634582|NCT03707041|21311534|P5|STARTED|Overall Study||9
8634583|NCT03707041|21311535|P4|STARTED|Overall Study||3
8634584|NCT03707041|21311536|P3|STARTED|Overall Study||9
8634585|NCT03707041|21311537|P2|STARTED|Overall Study||2
8634586|NCT03707041|21311538|P1|STARTED|Overall Study||6
8634587|NCT03698279|21311575|P6|NOT COMPLETED|Overall Study||0
8634588|NCT03698279|21311576|P5|NOT COMPLETED|Overall Study||0
8634589|NCT03698279|21311577|P4|NOT COMPLETED|Overall Study||6
8634590|NCT03698279|21311578|P3|NOT COMPLETED|Overall Study||7
8634591|NCT03698279|21311579|P2|NOT COMPLETED|Overall Study||2
8634592|NCT03698279|21311580|P1|NOT COMPLETED|Overall Study||5
8634593|NCT03698279|21311575|P6|COMPLETED|Overall Study||13
8634594|NCT03698279|21311576|P5|COMPLETED|Overall Study||13
8634595|NCT03698279|21311577|P4|COMPLETED|Overall Study||228
8634596|NCT03698279|21311578|P3|COMPLETED|Overall Study||152
8634597|NCT03698279|21311579|P2|COMPLETED|Overall Study||120
8634598|NCT03698279|21311580|P1|COMPLETED|Overall Study||119
8634599|NCT03698279|21311575|P6|Safety Analysis Set Population (SafAS)|Overall Study||13
8634600|NCT03698279|21311576|P5|Safety Analysis Set Population (SafAS)|Overall Study||13
8634601|NCT03698279|21311577|P4|Safety Analysis Set Population (SafAS)|Overall Study||234
8634602|NCT03698279|21311578|P3|Safety Analysis Set Population (SafAS)|Overall Study||158
8634603|NCT03698279|21311579|P2|Safety Analysis Set Population (SafAS)|Overall Study||121
8634604|NCT03698279|21311580|P1|Safety Analysis Set Population (SafAS)|Overall Study||122
8634605|NCT03698279|21311575|P6|STARTED|Overall Study||13
8634606|NCT03698279|21311576|P5|STARTED|Overall Study||13
8634607|NCT03698279|21311577|P4|STARTED|Overall Study||234
8634608|NCT03698279|21311578|P3|STARTED|Overall Study||159
8634609|NCT03698279|21311579|P2|STARTED|Overall Study||122
8634610|NCT03698279|21311580|P1|STARTED|Overall Study||124
8634617|NCT03617913|21311683|P1|NOT COMPLETED|Overall Study||0
8634618|NCT03617913|21311683|P1|COMPLETED|Overall Study||2
8634619|NCT03617913|21311683|P1|STARTED|Overall Study||2
8634620|NCT03615924|21311694|P2|NOT COMPLETED|Overall Study||92
8634621|NCT03615924|21311695|P1|NOT COMPLETED|Overall Study||101
8634622|NCT03615924|21311694|P2|COMPLETED|Overall Study||0
8634623|NCT03615924|21311695|P1|COMPLETED|Overall Study||0
8634624|NCT03615924|21311694|P2|Received Treatment|Overall Study||92
8634625|NCT03615924|21311695|P1|Received Treatment|Overall Study||101
8634626|NCT03615924|21311694|P2|STARTED|Overall Study||92
8634627|NCT03615924|21311695|P1|STARTED|Overall Study||101
8634628|NCT03611777|21311737|P2|NOT COMPLETED|Overall Study||0
8634629|NCT03611777|21311738|P1|NOT COMPLETED|Overall Study||0
8634630|NCT03611777|21311737|P2|COMPLETED|Overall Study||469
8634631|NCT03611777|21311738|P1|COMPLETED|Overall Study||432
8634632|NCT03611777|21311737|P2|STARTED|Overall Study||469
8634633|NCT03611777|21311738|P1|STARTED|Overall Study||432
8634652|NCT03540134|21311872|P1|NOT COMPLETED|Overall Study||0
8634653|NCT03540134|21311872|P1|COMPLETED|Overall Study||4
8634654|NCT03540134|21311872|P1|STARTED|Overall Study||4
8634655|NCT03531840|21311884|P4|NOT COMPLETED|Overall Study||3
8634656|NCT03531840|21311885|P3|NOT COMPLETED|Overall Study||5
8634657|NCT03531840|21311886|P2|NOT COMPLETED|Overall Study||5
8634658|NCT03531840|21311887|P1|NOT COMPLETED|Overall Study||5
8634659|NCT03531840|21311884|P4|COMPLETED|Overall Study||1
8634660|NCT03531840|21311885|P3|COMPLETED|Overall Study||3
8634661|NCT03531840|21311886|P2|COMPLETED|Overall Study||1
8634662|NCT03531840|21311887|P1|COMPLETED|Overall Study||0
8634663|NCT03531840|21311884|P4|STARTED|Overall Study||4
8634664|NCT03531840|21311885|P3|STARTED|Overall Study||8
8634665|NCT03531840|21311886|P2|STARTED|Overall Study||6
8634666|NCT03531840|21311887|P1|STARTED|Overall Study||5
8634667|NCT03523715|21311910|P2|NOT COMPLETED|Overall Study||16
8634668|NCT03523715|21311911|P1|NOT COMPLETED|Overall Study||12
8634669|NCT03523715|21311910|P2|COMPLETED|Overall Study||23
8634670|NCT03523715|21311911|P1|COMPLETED|Overall Study||26
8634671|NCT03523715|21311910|P2|STARTED|Overall Study||39
8634672|NCT03523715|21311911|P1|STARTED|Overall Study||38
8634673|NCT03510455|21311929|P1|NOT COMPLETED|Overall Study||1
8634674|NCT03510455|21311929|P1|COMPLETED|Overall Study|3 of 4 patients completed the 24 week treatment phase of the study|3
8634675|NCT03510455|21311929|P1|Screening Failures|Overall Study||0
8634676|NCT03510455|21311929|P1|Extension Phase|Overall Study||1
8634677|NCT03510455|21311929|P1|Treated|Overall Study||4
8634678|NCT03510455|21311929|P1|STARTED|Overall Study||4
8634679|NCT03487276|21311957|P5|NOT COMPLETED|Extension Period (28 Weeks)||0
8634680|NCT03487276|21311958|P4|NOT COMPLETED|Extension Period (28 Weeks)||30
8634681|NCT03487276|21311959|P3|NOT COMPLETED|Extension Period (28 Weeks)||5
8634682|NCT03487276|21311960|P2|NOT COMPLETED|Extension Period (28 Weeks)||0
8634683|NCT03487276|21311961|P1|NOT COMPLETED|Extension Period (28 Weeks)||0
8634684|NCT03487276|21311957|P5|COMPLETED|Extension Period (28 Weeks)||0
8634685|NCT03487276|21311958|P4|COMPLETED|Extension Period (28 Weeks)||54
8634686|NCT03487276|21311959|P3|COMPLETED|Extension Period (28 Weeks)||67
8634687|NCT03487276|21311960|P2|COMPLETED|Extension Period (28 Weeks)||0
8634688|NCT03487276|21311961|P1|COMPLETED|Extension Period (28 Weeks)||0
8634689|NCT03487276|21311957|P5|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634690|NCT03487276|21311958|P4|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
8634691|NCT03487276|21311959|P3|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
8634692|NCT03487276|21311960|P2|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634693|NCT03487276|21311961|P1|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634694|NCT03487276|21311957|P5|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634695|NCT03487276|21311958|P4|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
8634696|NCT03487276|21311959|P3|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
8634697|NCT03487276|21311960|P2|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634698|NCT03487276|21311961|P1|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634699|NCT03487276|21311957|P5|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634700|NCT03487276|21311958|P4|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
8634701|NCT03487276|21311959|P3|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||17
8634702|NCT03487276|21311960|P2|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634703|NCT03487276|21311961|P1|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634704|NCT03487276|21311957|P5|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634705|NCT03487276|21311958|P4|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
8634706|NCT03487276|21311959|P3|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
8634707|NCT03487276|21311960|P2|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634708|NCT03487276|21311961|P1|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634709|NCT03487276|21311957|P5|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634710|NCT03487276|21311958|P4|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
8634711|NCT03487276|21311959|P3|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
8634712|NCT03487276|21311960|P2|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634713|NCT03487276|21311961|P1|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
8634714|NCT03487276|21311957|P5|STARTED|Extension Period (28 Weeks)||0
8634715|NCT03487276|21311958|P4|STARTED|Extension Period (28 Weeks)||84
8634716|NCT03487276|21311959|P3|STARTED|Extension Period (28 Weeks)||72
8634717|NCT03487276|21311960|P2|STARTED|Extension Period (28 Weeks)||0
8634718|NCT03487276|21311961|P1|STARTED|Extension Period (28 Weeks)||0
8634719|NCT03487276|21311957|P5|NOT COMPLETED|Main Period (16 Weeks)||5
8634720|NCT03487276|21311958|P4|NOT COMPLETED|Main Period (16 Weeks)||6
8634721|NCT03487276|21311959|P3|NOT COMPLETED|Main Period (16 Weeks)||4
8634722|NCT03487276|21311960|P2|NOT COMPLETED|Main Period (16 Weeks)||4
8634723|NCT03487276|21311961|P1|NOT COMPLETED|Main Period (16 Weeks)||3
8634724|NCT03487276|21311957|P5|COMPLETED|Main Period (16 Weeks)|One patient completed the Main Period but was lost to follow-up afterwards and not treated in the Extension Period|31
8634725|NCT03487276|21311958|P4|COMPLETED|Main Period (16 Weeks)||30
8634726|NCT03487276|21311959|P3|COMPLETED|Main Period (16 Weeks)||32
8634727|NCT03487276|21311960|P2|COMPLETED|Main Period (16 Weeks)||30
8634728|NCT03487276|21311961|P1|COMPLETED|Main Period (16 Weeks)||34
8634729|NCT03487276|21311957|P5|STARTED|Main Period (16 Weeks)||36
8634730|NCT03487276|21311958|P4|STARTED|Main Period (16 Weeks)||36
8634731|NCT03487276|21311959|P3|STARTED|Main Period (16 Weeks)||36
8634732|NCT03487276|21311960|P2|STARTED|Main Period (16 Weeks)||34
8634733|NCT03487276|21311961|P1|STARTED|Main Period (16 Weeks)||37
8634734|NCT03373383|21312034|P5|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
8634735|NCT03373383|21312035|P4|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
8634736|NCT03373383|21312036|P3|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
8634737|NCT03373383|21312037|P2|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
8634738|NCT03373383|21312038|P1|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
8634739|NCT03373383|21312034|P5|COMPLETED|Post-Treatment Period: Wk16-23||58
8634740|NCT03373383|21312035|P4|COMPLETED|Post-Treatment Period: Wk16-23||61
8634741|NCT03373383|21312036|P3|COMPLETED|Post-Treatment Period: Wk16-23||68
8634742|NCT03373383|21312037|P2|COMPLETED|Post-Treatment Period: Wk16-23||66
8634743|NCT03373383|21312038|P1|COMPLETED|Post-Treatment Period: Wk16-23||69
8634744|NCT03373383|21312034|P5|Enrolled in EP0093|Post-Treatment Period: Wk16-23||57
8634745|NCT03373383|21312035|P4|Enrolled in EP0093|Post-Treatment Period: Wk16-23||55
8634746|NCT03373383|21312036|P3|Enrolled in EP0093|Post-Treatment Period: Wk16-23||65
8634747|NCT03373383|21312037|P2|Enrolled in EP0093|Post-Treatment Period: Wk16-23||63
8634748|NCT03373383|21312038|P1|Enrolled in EP0093|Post-Treatment Period: Wk16-23||67
8634749|NCT03373383|21312034|P5|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||1
8634750|NCT03373383|21312035|P4|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||6
8634751|NCT03373383|21312036|P3|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
8634752|NCT03373383|21312037|P2|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
8634753|NCT03373383|21312038|P1|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
8634754|NCT03373383|21312034|P5|Completed Conversion Period|Post-Treatment Period: Wk16-23||57
8634755|NCT03373383|21312035|P4|Completed Conversion Period|Post-Treatment Period: Wk16-23||55
8634756|NCT03373383|21312036|P3|Completed Conversion Period|Post-Treatment Period: Wk16-23||66
8634757|NCT03373383|21312037|P2|Completed Conversion Period|Post-Treatment Period: Wk16-23||64
8634758|NCT03373383|21312038|P1|Completed Conversion Period|Post-Treatment Period: Wk16-23||68
8634759|NCT03373383|21312034|P5|Started Conversion Period|Post-Treatment Period: Wk16-23||57
8634760|NCT03373383|21312035|P4|Started Conversion Period|Post-Treatment Period: Wk16-23||55
8634761|NCT03373383|21312036|P3|Started Conversion Period|Post-Treatment Period: Wk16-23||66
8634762|NCT03373383|21312037|P2|Started Conversion Period|Post-Treatment Period: Wk16-23||64
8634763|NCT03373383|21312038|P1|Started Conversion Period|Post-Treatment Period: Wk16-23||69
8634764|NCT03373383|21312034|P5|STARTED|Post-Treatment Period: Wk16-23||58
8634765|NCT03373383|21312035|P4|STARTED|Post-Treatment Period: Wk16-23||61
8634766|NCT03373383|21312036|P3|STARTED|Post-Treatment Period: Wk16-23||68
8634767|NCT03373383|21312037|P2|STARTED|Post-Treatment Period: Wk16-23||66
8634768|NCT03373383|21312038|P1|STARTED|Post-Treatment Period: Wk16-23||70
8634769|NCT03373383|21312034|P5|NOT COMPLETED|Treatment Period: Wk0-16||24
8634770|NCT03373383|21312035|P4|NOT COMPLETED|Treatment Period: Wk0-16||21
8634771|NCT03373383|21312036|P3|NOT COMPLETED|Treatment Period: Wk0-16||15
8634772|NCT03373383|21312037|P2|NOT COMPLETED|Treatment Period: Wk0-16||15
8634773|NCT03373383|21312038|P1|NOT COMPLETED|Treatment Period: Wk0-16||13
8634774|NCT03373383|21312034|P5|COMPLETED|Treatment Period: Wk0-16||58
8634775|NCT03373383|21312035|P4|COMPLETED|Treatment Period: Wk0-16||61
8634776|NCT03373383|21312036|P3|COMPLETED|Treatment Period: Wk0-16||68
8634777|NCT03373383|21312037|P2|COMPLETED|Treatment Period: Wk0-16||66
8634778|NCT03373383|21312038|P1|COMPLETED|Treatment Period: Wk0-16||70
8634779|NCT03373383|21312034|P5|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||21
8634780|NCT03373383|21312035|P4|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||18
8634781|NCT03373383|21312036|P3|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||8
8634782|NCT03373383|21312037|P2|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||11
8634783|NCT03373383|21312038|P1|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||6
8634784|NCT03373383|21312034|P5|Completed Maintenance Period|Treatment Period: Wk0-16||58
8634785|NCT03373383|21312035|P4|Completed Maintenance Period|Treatment Period: Wk0-16||61
8634786|NCT03373383|21312036|P3|Completed Maintenance Period|Treatment Period: Wk0-16||68
8634787|NCT03373383|21312037|P2|Completed Maintenance Period|Treatment Period: Wk0-16||66
8634788|NCT03373383|21312038|P1|Completed Maintenance Period|Treatment Period: Wk0-16||70
8634789|NCT03373383|21312034|P5|Completed Titration and Stabilization|Treatment Period: Wk0-16||65
8634790|NCT03373383|21312035|P4|Completed Titration and Stabilization|Treatment Period: Wk0-16||68
8634791|NCT03373383|21312036|P3|Completed Titration and Stabilization|Treatment Period: Wk0-16||71
8634792|NCT03373383|21312037|P2|Completed Titration and Stabilization|Treatment Period: Wk0-16||72
8634793|NCT03373383|21312038|P1|Completed Titration and Stabilization|Treatment Period: Wk0-16||78
8634794|NCT03373383|21312034|P5|STARTED|Treatment Period: Wk0-16||82
8634795|NCT03373383|21312035|P4|STARTED|Treatment Period: Wk0-16||82
8634796|NCT03373383|21312036|P3|STARTED|Treatment Period: Wk0-16||83
8634797|NCT03373383|21312037|P2|STARTED|Treatment Period: Wk0-16||81
8634798|NCT03373383|21312038|P1|STARTED|Treatment Period: Wk0-16||83
8634799|NCT03347188|21312092|P2|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||29
8634800|NCT03347188|21312093|P1|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||27
8634801|NCT03347188|21312092|P2|COMPLETED|Open-label (OL) Period (12 Weeks)||6
8634802|NCT03347188|21312093|P1|COMPLETED|Open-label (OL) Period (12 Weeks)||8
8634803|NCT03347188|21312092|P2|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||7
8634804|NCT03347188|21312093|P1|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||9
8634805|NCT03347188|21312092|P2|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||28
8634806|NCT03347188|21312093|P1|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||26
8634807|NCT03347188|21312092|P2|STARTED|Open-label (OL) Period (12 Weeks)||35
8634808|NCT03347188|21312093|P1|STARTED|Open-label (OL) Period (12 Weeks)||35
8634809|NCT03347188|21312092|P2|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||17
8634810|NCT03347188|21312093|P1|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||15
8634811|NCT03347188|21312092|P2|COMPLETED|Double-blind (DB) Period (12 Weeks)||26
8634812|NCT03347188|21312093|P1|COMPLETED|Double-blind (DB) Period (12 Weeks)||29
8634813|NCT03347188|21312092|P2|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||43
8634814|NCT03347188|21312093|P1|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||42
8634815|NCT03347188|21312092|P2|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
8634816|NCT03347188|21312093|P1|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
8634817|NCT03347188|21312092|P2|STARTED|Double-blind (DB) Period (12 Weeks)||43
8634818|NCT03347188|21312093|P1|STARTED|Double-blind (DB) Period (12 Weeks)||44
8634819|NCT03345394|21312129|P2|NOT COMPLETED|Overall Study||0
8634820|NCT03345394|21312130|P1|NOT COMPLETED|Overall Study||0
8634821|NCT03345394|21312129|P2|COMPLETED|Overall Study||50
8634822|NCT03345394|21312130|P1|COMPLETED|Overall Study||48
8634823|NCT03345394|21312129|P2|STARTED|Overall Study||50
8634824|NCT03345394|21312130|P1|STARTED|Overall Study||48
8634825|NCT03341507|21312140|P1|NOT COMPLETED|Overall Study||34
8634826|NCT03341507|21312140|P1|COMPLETED|Overall Study||30
8634827|NCT03341507|21312140|P1|STARTED|Overall Study||64
8634843|NCT03298867|21312176|P2|NOT COMPLETED|Overall Study||2
8634844|NCT03298867|21312177|P1|NOT COMPLETED|Overall Study||2
8634845|NCT03298867|21312176|P2|COMPLETED|Overall Study||39
8634846|NCT03298867|21312177|P1|COMPLETED|Overall Study||40
8634847|NCT03298867|21312176|P2|STARTED|Overall Study||41
8634848|NCT03298867|21312177|P1|STARTED|Overall Study||42
8634849|NCT03292406|21312196|P3|NOT COMPLETED|Overall Study||13
8634850|NCT03292406|21312197|P2|NOT COMPLETED|Overall Study||13
8634851|NCT03292406|21312198|P1|NOT COMPLETED|Overall Study||13
8634852|NCT03292406|21312196|P3|COMPLETED|Overall Study||15
8634853|NCT03292406|21312197|P2|COMPLETED|Overall Study||15
8634854|NCT03292406|21312198|P1|COMPLETED|Overall Study||17
8634855|NCT03292406|21312196|P3|Participants Treated|Overall Study||27
8634856|NCT03292406|21312197|P2|Participants Treated|Overall Study||28
8634857|NCT03292406|21312198|P1|Participants Treated|Overall Study||30
8634858|NCT03292406|21312196|P3|STARTED|Overall Study||28
8634859|NCT03292406|21312197|P2|STARTED|Overall Study||28
8634860|NCT03292406|21312198|P1|STARTED|Overall Study||30
8634879|NCT03215706|21312288|P2|NOT COMPLETED|Treatment Period||246
8634880|NCT03215706|21312289|P1|NOT COMPLETED|Treatment Period||342
8634881|NCT03215706|21312288|P2|COMPLETED|Treatment Period||103
8634882|NCT03215706|21312289|P1|COMPLETED|Treatment Period||16
8634883|NCT03215706|21312288|P2|STARTED|Treatment Period||349
8634884|NCT03215706|21312289|P1|STARTED|Treatment Period||358
8634885|NCT03215706|21312288|P2|NOT COMPLETED|Randomization||9
8634886|NCT03215706|21312289|P1|NOT COMPLETED|Randomization||3
8634887|NCT03215706|21312288|P2|COMPLETED|Randomization||349
8634888|NCT03215706|21312289|P1|COMPLETED|Randomization||358
8634889|NCT03215706|21312288|P2|STARTED|Randomization||358
8634890|NCT03215706|21312289|P1|STARTED|Randomization||361
8634891|NCT03213210|21312309|P1|NOT COMPLETED|Overall Study||5
8634892|NCT03213210|21312309|P1|COMPLETED|Overall Study||0
8634893|NCT03213210|21312309|P1|6-month Follow-up|Overall Study||3
8634894|NCT03213210|21312309|P1|STARTED|Overall Study||5
8634902|NCT03201211|21312326|P3|NOT COMPLETED|Overall Study||1
8634903|NCT03201211|21312327|P2|NOT COMPLETED|Overall Study||1
8634904|NCT03201211|21312328|P1|NOT COMPLETED|Overall Study||2
8634905|NCT03201211|21312326|P3|COMPLETED|Overall Study||27
8634906|NCT03201211|21312327|P2|COMPLETED|Overall Study||25
8634907|NCT03201211|21312328|P1|COMPLETED|Overall Study||25
8634908|NCT03201211|21312326|P3|STARTED|Overall Study||28
8634909|NCT03201211|21312327|P2|STARTED|Overall Study||26
8634910|NCT03201211|21312328|P1|STARTED|Overall Study||27
8634911|NCT03196973|21312414|P3|NOT COMPLETED|Overall Study||5
8634912|NCT03196973|21312415|P2|NOT COMPLETED|Overall Study||12
8634913|NCT03196973|21312416|P1|NOT COMPLETED|Overall Study||9
8634914|NCT03196973|21312414|P3|COMPLETED|Overall Study||95
8634915|NCT03196973|21312415|P2|COMPLETED|Overall Study||184
8634916|NCT03196973|21312416|P1|COMPLETED|Overall Study||188
8634917|NCT03196973|21312414|P3|STARTED|Overall Study||100
8634918|NCT03196973|21312415|P2|STARTED|Overall Study||196
8634919|NCT03196973|21312416|P1|STARTED|Overall Study||197
8634920|NCT03194503|21312429|P2|NOT COMPLETED|Overall Study||0
8634921|NCT03194503|21312430|P1|NOT COMPLETED|Overall Study||0
8634922|NCT03194503|21312429|P2|COMPLETED|Overall Study||1054
8634923|NCT03194503|21312430|P1|COMPLETED|Overall Study||458
8634924|NCT03194503|21312429|P2|STARTED|Overall Study||1054
8634925|NCT03194503|21312430|P1|STARTED|Overall Study||458
8634926|NCT03188185|21312440|P4|NOT COMPLETED|Stage 2||6
8634927|NCT03188185|21312441|P3|NOT COMPLETED|Stage 2||9
8634928|NCT03188185|21312442|P2|NOT COMPLETED|Stage 2||0
8634929|NCT03188185|21312443|P1|NOT COMPLETED|Stage 2||0
8634930|NCT03188185|21312440|P4|COMPLETED|Stage 2||57
8634931|NCT03188185|21312441|P3|COMPLETED|Stage 2||55
8634932|NCT03188185|21312442|P2|COMPLETED|Stage 2||0
8634933|NCT03188185|21312443|P1|COMPLETED|Stage 2||0
8634934|NCT03188185|21312440|P4|STARTED|Stage 2||63
8634935|NCT03188185|21312441|P3|STARTED|Stage 2||64
8634936|NCT03188185|21312442|P2|STARTED|Stage 2||0
8634937|NCT03188185|21312443|P1|STARTED|Stage 2||0
8634938|NCT03188185|21312440|P4|NOT COMPLETED|Stage 1||0
8634939|NCT03188185|21312441|P3|NOT COMPLETED|Stage 1||0
8634940|NCT03188185|21312442|P2|NOT COMPLETED|Stage 1||16
8634941|NCT03188185|21312443|P1|NOT COMPLETED|Stage 1||19
8634942|NCT03188185|21312440|P4|COMPLETED|Stage 1||0
8634943|NCT03188185|21312441|P3|COMPLETED|Stage 1||0
8634944|NCT03188185|21312442|P2|COMPLETED|Stage 1||64
8634945|NCT03188185|21312443|P1|COMPLETED|Stage 1||179
8634946|NCT03188185|21312440|P4|STARTED|Stage 1||0
8634947|NCT03188185|21312441|P3|STARTED|Stage 1||0
8634948|NCT03188185|21312442|P2|STARTED|Stage 1||80
8634949|NCT03188185|21312443|P1|STARTED|Stage 1||198
8634950|NCT03155997|21312463|P2|NOT COMPLETED|Overall Study||2222
8634951|NCT03155997|21312464|P1|NOT COMPLETED|Overall Study||2158
8634952|NCT03155997|21312463|P2|COMPLETED|Overall Study||607
8634953|NCT03155997|21312464|P1|COMPLETED|Overall Study||650
8634954|NCT03155997|21312463|P2|Received at Least One Dose of Study Drug|Overall Study||2800
8634955|NCT03155997|21312464|P1|Received at Least One Dose of Study Drug|Overall Study||2791
8634956|NCT03155997|21312463|P2|STARTED|Overall Study||2829
8634957|NCT03155997|21312464|P1|STARTED|Overall Study||2808
8634958|NCT03125629|21312473|P1|NOT COMPLETED|Overall Study||3
8634959|NCT03125629|21312473|P1|COMPLETED|Overall Study||50
8634960|NCT03125629|21312473|P1|STARTED|Overall Study||53
8634961|NCT03111940|21312487|P2|NOT COMPLETED|Overall Study||0
8634962|NCT03111940|21312488|P1|NOT COMPLETED|Overall Study||0
8634963|NCT03111940|21312487|P2|COMPLETED|Overall Study||14
8634964|NCT03111940|21312488|P1|COMPLETED|Overall Study||21
8634965|NCT03111940|21312487|P2|STARTED|Overall Study||14
8634966|NCT03111940|21312488|P1|STARTED|Overall Study||21
8634967|NCT03054350|21312510|P6|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
8634968|NCT03054350|21312511|P5|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
8634969|NCT03054350|21312512|P4|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
8634970|NCT03054350|21312513|P3|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
8634971|NCT03054350|21312514|P2|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
8634972|NCT03054350|21312515|P1|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
8634973|NCT03054350|21312510|P6|COMPLETED|Dose Adjustment and Maintenance Period||2
8634974|NCT03054350|21312511|P5|COMPLETED|Dose Adjustment and Maintenance Period||1
8634975|NCT03054350|21312512|P4|COMPLETED|Dose Adjustment and Maintenance Period||2
8634976|NCT03054350|21312513|P3|COMPLETED|Dose Adjustment and Maintenance Period||12
8634977|NCT03054350|21312514|P2|COMPLETED|Dose Adjustment and Maintenance Period||13
8634978|NCT03054350|21312515|P1|COMPLETED|Dose Adjustment and Maintenance Period||10
8634979|NCT03054350|21312510|P6|STARTED|Dose Adjustment and Maintenance Period||2
8634980|NCT03054350|21312511|P5|STARTED|Dose Adjustment and Maintenance Period||1
8634981|NCT03054350|21312512|P4|STARTED|Dose Adjustment and Maintenance Period||3
8634982|NCT03054350|21312513|P3|STARTED|Dose Adjustment and Maintenance Period||13
8634983|NCT03054350|21312514|P2|STARTED|Dose Adjustment and Maintenance Period||13
8634984|NCT03054350|21312515|P1|STARTED|Dose Adjustment and Maintenance Period||11
8634985|NCT03054350|21312510|P6|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||3
8634986|NCT03054350|21312511|P5|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
8634987|NCT03054350|21312512|P4|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
8634988|NCT03054350|21312513|P3|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
8634989|NCT03054350|21312514|P2|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
8634990|NCT03054350|21312515|P1|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
8634991|NCT03054350|21312510|P6|COMPLETED|Primary Efficacy Period (6 Weeks)||2
8634992|NCT03054350|21312511|P5|COMPLETED|Primary Efficacy Period (6 Weeks)||1
8634993|NCT03054350|21312512|P4|COMPLETED|Primary Efficacy Period (6 Weeks)||3
8634994|NCT03054350|21312513|P3|COMPLETED|Primary Efficacy Period (6 Weeks)||13
8634995|NCT03054350|21312514|P2|COMPLETED|Primary Efficacy Period (6 Weeks)||13
8634996|NCT03054350|21312515|P1|COMPLETED|Primary Efficacy Period (6 Weeks)||11
8634997|NCT03054350|21312510|P6|STARTED|Primary Efficacy Period (6 Weeks)||5
8634998|NCT03054350|21312511|P5|STARTED|Primary Efficacy Period (6 Weeks)||5
8634999|NCT03054350|21312512|P4|STARTED|Primary Efficacy Period (6 Weeks)||5
8635000|NCT03054350|21312513|P3|STARTED|Primary Efficacy Period (6 Weeks)||15
8635001|NCT03054350|21312514|P2|STARTED|Primary Efficacy Period (6 Weeks)||15
8635002|NCT03054350|21312515|P1|STARTED|Primary Efficacy Period (6 Weeks)||15
8635003|NCT03054337|21312657|P6|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
8635004|NCT03054337|21312658|P5|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
8635005|NCT03054337|21312659|P4|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
8635006|NCT03054337|21312660|P3|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
8635007|NCT03054337|21312661|P2|NOT COMPLETED|Dose Adjustment and Maintenance Period||2
8635008|NCT03054337|21312662|P1|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
8635009|NCT03054337|21312657|P6|COMPLETED|Dose Adjustment and Maintenance Period||4
8635010|NCT03054337|21312658|P5|COMPLETED|Dose Adjustment and Maintenance Period||4
8635011|NCT03054337|21312659|P4|COMPLETED|Dose Adjustment and Maintenance Period||5
8635012|NCT03054337|21312660|P3|COMPLETED|Dose Adjustment and Maintenance Period||12
8635013|NCT03054337|21312661|P2|COMPLETED|Dose Adjustment and Maintenance Period||10
8635014|NCT03054337|21312662|P1|COMPLETED|Dose Adjustment and Maintenance Period||11
8635015|NCT03054337|21312657|P6|STARTED|Dose Adjustment and Maintenance Period||5
8635016|NCT03054337|21312658|P5|STARTED|Dose Adjustment and Maintenance Period||4
8635017|NCT03054337|21312659|P4|STARTED|Dose Adjustment and Maintenance Period||5
8635018|NCT03054337|21312660|P3|STARTED|Dose Adjustment and Maintenance Period||13
8635019|NCT03054337|21312661|P2|STARTED|Dose Adjustment and Maintenance Period||12
8635020|NCT03054337|21312662|P1|STARTED|Dose Adjustment and Maintenance Period||12
8635021|NCT03054337|21312657|P6|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
8635022|NCT03054337|21312658|P5|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
8635023|NCT03054337|21312659|P4|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
8635024|NCT03054337|21312660|P3|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
8635025|NCT03054337|21312661|P2|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
8635026|NCT03054337|21312662|P1|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
8635027|NCT03054337|21312657|P6|COMPLETED|Primary Efficacy Period (6 Weeks)||5
8635028|NCT03054337|21312658|P5|COMPLETED|Primary Efficacy Period (6 Weeks)||4
8635029|NCT03054337|21312659|P4|COMPLETED|Primary Efficacy Period (6 Weeks)||5
8635030|NCT03054337|21312660|P3|COMPLETED|Primary Efficacy Period (6 Weeks)||13
8635031|NCT03054337|21312661|P2|COMPLETED|Primary Efficacy Period (6 Weeks)||12
8635032|NCT03054337|21312662|P1|COMPLETED|Primary Efficacy Period (6 Weeks)||12
8635033|NCT03054337|21312657|P6|STARTED|Primary Efficacy Period (6 Weeks)||5
8635034|NCT03054337|21312658|P5|STARTED|Primary Efficacy Period (6 Weeks)||4
8635035|NCT03054337|21312659|P4|STARTED|Primary Efficacy Period (6 Weeks)||5
8635036|NCT03054337|21312660|P3|STARTED|Primary Efficacy Period (6 Weeks)||13
8635037|NCT03054337|21312661|P2|STARTED|Primary Efficacy Period (6 Weeks)||12
8635038|NCT03054337|21312662|P1|STARTED|Primary Efficacy Period (6 Weeks)||12
8635039|NCT03019575|21312808|P1|NOT COMPLETED|Overall Study||0
8635040|NCT03019575|21312808|P1|COMPLETED|Overall Study||17
8635041|NCT03019575|21312808|P1|STARTED|Overall Study||17
8635042|NCT03011892|21312834|P12|NOT COMPLETED|Open Label (OL) Period||3
8635043|NCT03011892|21312835|P11|NOT COMPLETED|Open Label (OL) Period||2
8635044|NCT03011892|21312836|P10|NOT COMPLETED|Open Label (OL) Period||0
8635045|NCT03011892|21312837|P9|NOT COMPLETED|Open Label (OL) Period||2
8635046|NCT03011892|21312838|P8|NOT COMPLETED|Open Label (OL) Period||3
8635047|NCT03011892|21312839|P7|NOT COMPLETED|Open Label (OL) Period||7
8635048|NCT03011892|21312840|P6|NOT COMPLETED|Open Label (OL) Period||0
8635049|NCT03011892|21312841|P5|NOT COMPLETED|Open Label (OL) Period||0
8635050|NCT03011892|21312842|P4|NOT COMPLETED|Open Label (OL) Period||0
8635051|NCT03011892|21312843|P3|NOT COMPLETED|Open Label (OL) Period||0
8635052|NCT03011892|21312844|P2|NOT COMPLETED|Open Label (OL) Period||0
8635053|NCT03011892|21312845|P1|NOT COMPLETED|Open Label (OL) Period||0
8635054|NCT03011892|21312834|P12|COMPLETED|Open Label (OL) Period||40
8635055|NCT03011892|21312835|P11|COMPLETED|Open Label (OL) Period||40
8635056|NCT03011892|21312836|P10|COMPLETED|Open Label (OL) Period||41
8635057|NCT03011892|21312837|P9|COMPLETED|Open Label (OL) Period||43
8635058|NCT03011892|21312838|P8|COMPLETED|Open Label (OL) Period||37
8635059|NCT03011892|21312839|P7|COMPLETED|Open Label (OL) Period||34
8635060|NCT03011892|21312840|P6|COMPLETED|Open Label (OL) Period||0
8635061|NCT03011892|21312841|P5|COMPLETED|Open Label (OL) Period||0
8635062|NCT03011892|21312842|P4|COMPLETED|Open Label (OL) Period||0
8635063|NCT03011892|21312843|P3|COMPLETED|Open Label (OL) Period||0
8635064|NCT03011892|21312844|P2|COMPLETED|Open Label (OL) Period||0
8635065|NCT03011892|21312845|P1|COMPLETED|Open Label (OL) Period||0
8635066|NCT03011892|21312834|P12|STARTED|Open Label (OL) Period||43
8635067|NCT03011892|21312835|P11|STARTED|Open Label (OL) Period||42
8635068|NCT03011892|21312836|P10|STARTED|Open Label (OL) Period||41
8635069|NCT03011892|21312837|P9|STARTED|Open Label (OL) Period||45
8635070|NCT03011892|21312838|P8|STARTED|Open Label (OL) Period||40
8635071|NCT03011892|21312839|P7|STARTED|Open Label (OL) Period||41
8635072|NCT03011892|21312840|P6|STARTED|Open Label (OL) Period||0
8635073|NCT03011892|21312841|P5|STARTED|Open Label (OL) Period||0
8635074|NCT03011892|21312842|P4|STARTED|Open Label (OL) Period||0
8635075|NCT03011892|21312843|P3|STARTED|Open Label (OL) Period||0
8635076|NCT03011892|21312844|P2|STARTED|Open Label (OL) Period||0
8635077|NCT03011892|21312845|P1|STARTED|Open Label (OL) Period||0
8635078|NCT03011892|21312834|P12|NOT COMPLETED|Double Blind (DB) Period||0
8635079|NCT03011892|21312835|P11|NOT COMPLETED|Double Blind (DB) Period||0
8635080|NCT03011892|21312836|P10|NOT COMPLETED|Double Blind (DB) Period||0
8635081|NCT03011892|21312837|P9|NOT COMPLETED|Double Blind (DB) Period||0
8635082|NCT03011892|21312838|P8|NOT COMPLETED|Double Blind (DB) Period||0
8635083|NCT03011892|21312839|P7|NOT COMPLETED|Double Blind (DB) Period||0
8635084|NCT03011892|21312840|P6|NOT COMPLETED|Double Blind (DB) Period||5
8635085|NCT03011892|21312841|P5|NOT COMPLETED|Double Blind (DB) Period||7
8635086|NCT03011892|21312842|P4|NOT COMPLETED|Double Blind (DB) Period||7
8635087|NCT03011892|21312843|P3|NOT COMPLETED|Double Blind (DB) Period||6
8635088|NCT03011892|21312844|P2|NOT COMPLETED|Double Blind (DB) Period||10
8635089|NCT03011892|21312845|P1|NOT COMPLETED|Double Blind (DB) Period||11
8635090|NCT03011892|21312834|P12|COMPLETED|Double Blind (DB) Period||0
8635091|NCT03011892|21312835|P11|COMPLETED|Double Blind (DB) Period||0
8635092|NCT03011892|21312836|P10|COMPLETED|Double Blind (DB) Period||0
8635093|NCT03011892|21312837|P9|COMPLETED|Double Blind (DB) Period||0
8635094|NCT03011892|21312838|P8|COMPLETED|Double Blind (DB) Period||0
8635095|NCT03011892|21312839|P7|COMPLETED|Double Blind (DB) Period||0
8635096|NCT03011892|21312840|P6|COMPLETED|Double Blind (DB) Period||45
8635097|NCT03011892|21312841|P5|COMPLETED|Double Blind (DB) Period||45
8635098|NCT03011892|21312842|P4|COMPLETED|Double Blind (DB) Period||44
8635099|NCT03011892|21312843|P3|COMPLETED|Double Blind (DB) Period||45
8635100|NCT03011892|21312844|P2|COMPLETED|Double Blind (DB) Period||41
8635101|NCT03011892|21312845|P1|COMPLETED|Double Blind (DB) Period||41
8635102|NCT03011892|21312834|P12|Completed Treatment Through Week 4|Double Blind (DB) Period||0
8635103|NCT03011892|21312835|P11|Completed Treatment Through Week 4|Double Blind (DB) Period||0
8635104|NCT03011892|21312836|P10|Completed Treatment Through Week 4|Double Blind (DB) Period||0
8635105|NCT03011892|21312837|P9|Completed Treatment Through Week 4|Double Blind (DB) Period||0
8635106|NCT03011892|21312838|P8|Completed Treatment Through Week 4|Double Blind (DB) Period||0
8635107|NCT03011892|21312839|P7|Completed Treatment Through Week 4|Double Blind (DB) Period||0
8635108|NCT03011892|21312840|P6|Completed Treatment Through Week 4|Double Blind (DB) Period||49
8635109|NCT03011892|21312841|P5|Completed Treatment Through Week 4|Double Blind (DB) Period||49
8635110|NCT03011892|21312842|P4|Completed Treatment Through Week 4|Double Blind (DB) Period||47
8635111|NCT03011892|21312843|P3|Completed Treatment Through Week 4|Double Blind (DB) Period||48
8635112|NCT03011892|21312844|P2|Completed Treatment Through Week 4|Double Blind (DB) Period||46
8635113|NCT03011892|21312845|P1|Completed Treatment Through Week 4|Double Blind (DB) Period||44
8635114|NCT03011892|21312834|P12|Treated in DB Period|Double Blind (DB) Period||0
8635115|NCT03011892|21312835|P11|Treated in DB Period|Double Blind (DB) Period||0
8635116|NCT03011892|21312836|P10|Treated in DB Period|Double Blind (DB) Period||0
8635117|NCT03011892|21312837|P9|Treated in DB Period|Double Blind (DB) Period||0
8635118|NCT03011892|21312838|P8|Treated in DB Period|Double Blind (DB) Period||0
8635119|NCT03011892|21312839|P7|Treated in DB Period|Double Blind (DB) Period||0
8635120|NCT03011892|21312840|P6|Treated in DB Period|Double Blind (DB) Period||50
8635121|NCT03011892|21312841|P5|Treated in DB Period|Double Blind (DB) Period||51
8635122|NCT03011892|21312842|P4|Treated in DB Period|Double Blind (DB) Period||51
8635123|NCT03011892|21312843|P3|Treated in DB Period|Double Blind (DB) Period||51
8635124|NCT03011892|21312844|P2|Treated in DB Period|Double Blind (DB) Period||51
8635125|NCT03011892|21312845|P1|Treated in DB Period|Double Blind (DB) Period||52
8635126|NCT03011892|21312834|P12|STARTED|Double Blind (DB) Period||0
8635127|NCT03011892|21312835|P11|STARTED|Double Blind (DB) Period||0
8635128|NCT03011892|21312836|P10|STARTED|Double Blind (DB) Period||0
8635129|NCT03011892|21312837|P9|STARTED|Double Blind (DB) Period||0
8635130|NCT03011892|21312838|P8|STARTED|Double Blind (DB) Period||0
8635131|NCT03011892|21312839|P7|STARTED|Double Blind (DB) Period||0
8635132|NCT03011892|21312840|P6|STARTED|Double Blind (DB) Period||50
8635133|NCT03011892|21312841|P5|STARTED|Double Blind (DB) Period||52
8635134|NCT03011892|21312842|P4|STARTED|Double Blind (DB) Period||51
8635135|NCT03011892|21312843|P3|STARTED|Double Blind (DB) Period||51
8635136|NCT03011892|21312844|P2|STARTED|Double Blind (DB) Period||51
8635137|NCT03011892|21312845|P1|STARTED|Double Blind (DB) Period||52
8635144|NCT02927457|21312945|P2|NOT COMPLETED|Overall Study||0
8635145|NCT02927457|21312946|P1|NOT COMPLETED|Overall Study||0
8635146|NCT02927457|21312945|P2|COMPLETED|Overall Study||11
8635147|NCT02927457|21312946|P1|COMPLETED|Overall Study||0
8635148|NCT02927457|21312945|P2|STARTED|Overall Study||11
8635149|NCT02927457|21312946|P1|STARTED|Overall Study||0
8635150|NCT02926677|21312981|P3|NOT COMPLETED|Overall Study||20
8635151|NCT02926677|21312982|P2|NOT COMPLETED|Overall Study||14
8635152|NCT02926677|21312983|P1|NOT COMPLETED|Overall Study||17
8635153|NCT02926677|21312981|P3|COMPLETED|Overall Study||6
8635154|NCT02926677|21312982|P2|COMPLETED|Overall Study||8
8635155|NCT02926677|21312983|P1|COMPLETED|Overall Study||8
8635156|NCT02926677|21312981|P3|STARTED|Overall Study||26
8635157|NCT02926677|21312982|P2|STARTED|Overall Study||22
8635158|NCT02926677|21312983|P1|STARTED|Overall Study||25
8635159|NCT02918851|21313006|P3|NOT COMPLETED|Overall Study||4
8635160|NCT02918851|21313007|P2|NOT COMPLETED|Overall Study||4
8635161|NCT02918851|21313008|P1|NOT COMPLETED|Overall Study||4
8635162|NCT02918851|21313006|P3|COMPLETED|Overall Study||10
8635163|NCT02918851|21313007|P2|COMPLETED|Overall Study||10
8635164|NCT02918851|21313008|P1|COMPLETED|Overall Study||10
8635165|NCT02918851|21313006|P3|STARTED|Overall Study||14
8635166|NCT02918851|21313007|P2|STARTED|Overall Study||14
8635167|NCT02918851|21313008|P1|STARTED|Overall Study||14
8635168|NCT02911948|21313021|P2|NOT COMPLETED|Overall Study||7
8635169|NCT02911948|21313022|P1|NOT COMPLETED|Overall Study||0
8635170|NCT02911948|21313021|P2|COMPLETED|Overall Study||98
8635171|NCT02911948|21313022|P1|COMPLETED|Overall Study||105
8635172|NCT02911948|21313021|P2|STARTED|Overall Study||105
8635173|NCT02911948|21313022|P1|STARTED|Overall Study||105
8635174|NCT02898103|21313084|P2|NOT COMPLETED|Overall Study||0
8635175|NCT02898103|21313085|P1|NOT COMPLETED|Overall Study||0
8635176|NCT02898103|21313084|P2|COMPLETED|Overall Study||3
8635177|NCT02898103|21313085|P1|COMPLETED|Overall Study||4
8635178|NCT02898103|21313084|P2|STARTED|Overall Study||3
8635179|NCT02898103|21313085|P1|STARTED|Overall Study||4
8635180|NCT02896075|21313103|P1|NOT COMPLETED|Overall Study||0
8635181|NCT02896075|21313103|P1|COMPLETED|Overall Study||40
8635182|NCT02896075|21313103|P1|Leg Soreness|Overall Study||40
8635183|NCT02896075|21313103|P1|STARTED|Overall Study||40
8635184|NCT02860286|21313114|P2|NOT COMPLETED|Overall Study||0
8635185|NCT02860286|21313115|P1|NOT COMPLETED|Overall Study||0
8635186|NCT02860286|21313114|P2|COMPLETED|Overall Study||61
8635187|NCT02860286|21313115|P1|COMPLETED|Overall Study||13
8635188|NCT02860286|21313114|P2|STARTED|Overall Study||61
8635189|NCT02860286|21313115|P1|STARTED|Overall Study||13
8635190|NCT02803229|21313138|P2|NOT COMPLETED|Overall Study||6
8635191|NCT02803229|21313139|P1|NOT COMPLETED|Overall Study||4
8635192|NCT02803229|21313138|P2|COMPLETED|Overall Study||7
8635193|NCT02803229|21313139|P1|COMPLETED|Overall Study||11
8635194|NCT02803229|21313138|P2|STARTED|Overall Study||13
8635195|NCT02803229|21313139|P1|STARTED|Overall Study||15
8635196|NCT02790788|21313149|P2|NOT COMPLETED|Overall Study||0
8635197|NCT02790788|21313150|P1|NOT COMPLETED|Overall Study||0
8635198|NCT02790788|21313149|P2|COMPLETED|Overall Study||54
8635199|NCT02790788|21313150|P1|COMPLETED|Overall Study||46
8635200|NCT02790788|21313149|P2|STARTED|Overall Study||54
8635201|NCT02790788|21313150|P1|STARTED|Overall Study||46
8635202|NCT02782741|21313202|P2|NOT COMPLETED|Open-label Long-term: Week 50 to 145||44
8635203|NCT02782741|21313203|P1|NOT COMPLETED|Open-label Long-term: Week 50 to 145||51
8635204|NCT02782741|21313202|P2|COMPLETED|Open-label Long-term: Week 50 to 145||0
8635205|NCT02782741|21313203|P1|COMPLETED|Open-label Long-term: Week 50 to 145||0
8635206|NCT02782741|21313202|P2|Safety Population|Open-label Long-term: Week 50 to 145||44
8635207|NCT02782741|21313203|P1|Safety Population|Open-label Long-term: Week 50 to 145||51
8635208|NCT02782741|21313202|P2|STARTED|Open-label Long-term: Week 50 to 145||44
8635209|NCT02782741|21313203|P1|STARTED|Open-label Long-term: Week 50 to 145||51
8635210|NCT02782741|21313202|P2|NOT COMPLETED|Blinded Treatment Period: up to Week 49||5
8635211|NCT02782741|21313203|P1|NOT COMPLETED|Blinded Treatment Period: up to Week 49||0
8635212|NCT02782741|21313202|P2|COMPLETED|Blinded Treatment Period: up to Week 49||44
8635213|NCT02782741|21313203|P1|COMPLETED|Blinded Treatment Period: up to Week 49||51
8635214|NCT02782741|21313202|P2|Safety Population|Blinded Treatment Period: up to Week 49||49
8635215|NCT02782741|21313203|P1|Safety Population|Blinded Treatment Period: up to Week 49||51
8635216|NCT02782741|21313202|P2|STARTED|Blinded Treatment Period: up to Week 49||49
8635217|NCT02782741|21313203|P1|STARTED|Blinded Treatment Period: up to Week 49||51
8635239|NCT02759120|21313269|P2|NOT COMPLETED|Overall Study||79
8635240|NCT02759120|21313270|P1|NOT COMPLETED|Overall Study||85
8635241|NCT02759120|21313269|P2|COMPLETED|Overall Study||180
8635242|NCT02759120|21313270|P1|COMPLETED|Overall Study||169
8635243|NCT02759120|21313269|P2|STARTED|Overall Study||259
8635244|NCT02759120|21313270|P1|STARTED|Overall Study||254
8635245|NCT02724592|21313310|P2|NOT COMPLETED|Overall Study||1
8635246|NCT02724592|21313311|P1|NOT COMPLETED|Overall Study||4
8635247|NCT02724592|21313310|P2|COMPLETED|Overall Study||34
8635248|NCT02724592|21313311|P1|COMPLETED|Overall Study||31
8635249|NCT02724592|21313310|P2|STARTED|Overall Study||35
8635250|NCT02724592|21313311|P1|STARTED|Overall Study||35
8635251|NCT02699996|21313325|P2|NOT COMPLETED|Overall Study||2
8635252|NCT02699996|21313326|P1|NOT COMPLETED|Overall Study||5
8635253|NCT02699996|21313325|P2|COMPLETED|Overall Study||9
8635254|NCT02699996|21313326|P1|COMPLETED|Overall Study||15
8635255|NCT02699996|21313325|P2|STARTED|Overall Study||11
8635256|NCT02699996|21313326|P1|STARTED|Overall Study||20
8635257|NCT02688192|21313344|P2|NOT COMPLETED|Overall Study||5
8635258|NCT02688192|21313345|P1|NOT COMPLETED|Overall Study||12
8635259|NCT02688192|21313344|P2|COMPLETED|Overall Study||19
8635260|NCT02688192|21313345|P1|COMPLETED|Overall Study||13
8635261|NCT02688192|21313344|P2|STARTED|Overall Study||24
8635262|NCT02688192|21313345|P1|STARTED|Overall Study||25
8635263|NCT02687035|21313362|P1|NOT COMPLETED|Overall Study||184
8635264|NCT02687035|21313362|P1|COMPLETED|Overall Study||1638
8635265|NCT02687035|21313362|P1|STARTED|Overall Study||1822
8635266|NCT02685267|21313381|P2|NOT COMPLETED|Overall Study||0
8635267|NCT02685267|21313382|P1|NOT COMPLETED|Overall Study||0
8635268|NCT02685267|21313381|P2|COMPLETED|Overall Study||4
8635269|NCT02685267|21313382|P1|COMPLETED|Overall Study||5
8635270|NCT02685267|21313381|P2|STARTED|Overall Study||4
8635271|NCT02685267|21313382|P1|STARTED|Overall Study||5
8635272|NCT02656290|21313392|P1|NOT COMPLETED|Overall Study||26
8635273|NCT02656290|21313392|P1|COMPLETED|Overall Study||0
8635274|NCT02656290|21313392|P1|3 Year|Overall Study||6
8635275|NCT02656290|21313392|P1|2 Year|Overall Study||17
8635276|NCT02656290|21313392|P1|1 Year|Overall Study|One subject missed the 1 year follow-up visit.|25
8635277|NCT02656290|21313392|P1|STARTED|Overall Study||26
8635278|NCT02639559|21313399|P2|NOT COMPLETED|Overall Study||3
8635279|NCT02639559|21313400|P1|NOT COMPLETED|Overall Study||1
8635280|NCT02639559|21313399|P2|COMPLETED|Overall Study||22
8635281|NCT02639559|21313400|P1|COMPLETED|Overall Study||24
8635282|NCT02639559|21313399|P2|STARTED|Overall Study||25
8635283|NCT02639559|21313400|P1|STARTED|Overall Study||25
8635284|NCT02633306|21313426|P1|NOT COMPLETED|Overall Study||3
8635285|NCT02633306|21313426|P1|COMPLETED|Overall Study||6
8635286|NCT02633306|21313426|P1|STARTED|Overall Study||9
8635287|NCT02607306|21313439|P3|NOT COMPLETED|Overall Study||10
8635288|NCT02607306|21313440|P2|NOT COMPLETED|Overall Study||23
8635289|NCT02607306|21313441|P1|NOT COMPLETED|Overall Study||21
8635290|NCT02607306|21313439|P3|COMPLETED|Overall Study||263
8635291|NCT02607306|21313440|P2|COMPLETED|Overall Study||248
8635292|NCT02607306|21313441|P1|COMPLETED|Overall Study||254
8635293|NCT02607306|21313439|P3|STARTED|Overall Study||273
8635294|NCT02607306|21313440|P2|STARTED|Overall Study||271
8635295|NCT02607306|21313441|P1|STARTED|Overall Study||275
8635296|NCT02595372|21313561|P1|NOT COMPLETED|Overall Study||9
8635297|NCT02595372|21313561|P1|COMPLETED|Overall Study||33
8635298|NCT02595372|21313561|P1|STARTED|Overall Study||42
8635299|NCT02583048|21313573|P3|NOT COMPLETED|Overall Study||1
8635300|NCT02583048|21313574|P2|NOT COMPLETED|Overall Study||1
8635301|NCT02583048|21313575|P1|NOT COMPLETED|Overall Study||0
8635302|NCT02583048|21313573|P3|COMPLETED|Overall Study||27
8635303|NCT02583048|21313574|P2|COMPLETED|Overall Study||27
8635304|NCT02583048|21313575|P1|COMPLETED|Overall Study||28
8635305|NCT02583048|21313573|P3|STARTED|Overall Study||28
8635306|NCT02583048|21313574|P2|STARTED|Overall Study||28
8635307|NCT02583048|21313575|P1|STARTED|Overall Study||28
8635308|NCT02552121|21313642|P8|NOT COMPLETED|Part 2: Cohort Expansion||3
8635309|NCT02552121|21313643|P7|NOT COMPLETED|Part 2: Cohort Expansion||1
8635310|NCT02552121|21313644|P6|NOT COMPLETED|Part 2: Cohort Expansion||4
8635311|NCT02552121|21313645|P5|NOT COMPLETED|Part 2: Cohort Expansion||1
8635312|NCT02552121|21313646|P4|NOT COMPLETED|Part 2: Cohort Expansion||3
8635313|NCT02552121|21313647|P3|NOT COMPLETED|Part 2: Cohort Expansion||11
8635314|NCT02552121|21313648|P2|NOT COMPLETED|Part 2: Cohort Expansion||0
8635315|NCT02552121|21313649|P1|NOT COMPLETED|Part 2: Cohort Expansion||0
8635316|NCT02552121|21313642|P8|COMPLETED|Part 2: Cohort Expansion||0
8635317|NCT02552121|21313643|P7|COMPLETED|Part 2: Cohort Expansion||0
8635318|NCT02552121|21313644|P6|COMPLETED|Part 2: Cohort Expansion||1
8635319|NCT02552121|21313645|P5|COMPLETED|Part 2: Cohort Expansion||0
8635320|NCT02552121|21313646|P4|COMPLETED|Part 2: Cohort Expansion||0
8635321|NCT02552121|21313647|P3|COMPLETED|Part 2: Cohort Expansion||0
8635322|NCT02552121|21313648|P2|COMPLETED|Part 2: Cohort Expansion||0
8635323|NCT02552121|21313649|P1|COMPLETED|Part 2: Cohort Expansion||0
8635324|NCT02552121|21313642|P8|STARTED|Part 2: Cohort Expansion||3
8635325|NCT02552121|21313643|P7|STARTED|Part 2: Cohort Expansion||1
8635326|NCT02552121|21313644|P6|STARTED|Part 2: Cohort Expansion||5
8635327|NCT02552121|21313645|P5|STARTED|Part 2: Cohort Expansion||1
8635328|NCT02552121|21313646|P4|STARTED|Part 2: Cohort Expansion||3
8635329|NCT02552121|21313647|P3|STARTED|Part 2: Cohort Expansion||11
8635330|NCT02552121|21313648|P2|STARTED|Part 2: Cohort Expansion||0
8635331|NCT02552121|21313649|P1|STARTED|Part 2: Cohort Expansion||0
8635332|NCT02552121|21313642|P8|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635333|NCT02552121|21313643|P7|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635334|NCT02552121|21313644|P6|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635335|NCT02552121|21313645|P5|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635336|NCT02552121|21313646|P4|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635337|NCT02552121|21313647|P3|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635338|NCT02552121|21313648|P2|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6
8635339|NCT02552121|21313649|P1|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635340|NCT02552121|21313642|P8|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635341|NCT02552121|21313643|P7|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635342|NCT02552121|21313644|P6|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635343|NCT02552121|21313645|P5|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635344|NCT02552121|21313646|P4|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635345|NCT02552121|21313647|P3|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635346|NCT02552121|21313648|P2|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635347|NCT02552121|21313649|P1|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
8635348|NCT02552121|21313642|P8|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8635349|NCT02552121|21313643|P7|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8635350|NCT02552121|21313644|P6|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8635351|NCT02552121|21313645|P5|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8635352|NCT02552121|21313646|P4|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8635353|NCT02552121|21313647|P3|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8635354|NCT02552121|21313648|P2|STARTED|Part 1: Dose Level 2 (Week 17-48)||6
8635355|NCT02552121|21313649|P1|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
8635356|NCT02552121|21313642|P8|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635357|NCT02552121|21313643|P7|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635358|NCT02552121|21313644|P6|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635359|NCT02552121|21313645|P5|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635360|NCT02552121|21313646|P4|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635361|NCT02552121|21313647|P3|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635362|NCT02552121|21313648|P2|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635363|NCT02552121|21313649|P1|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3
8635364|NCT02552121|21313642|P8|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635365|NCT02552121|21313643|P7|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635366|NCT02552121|21313644|P6|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635367|NCT02552121|21313645|P5|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635368|NCT02552121|21313646|P4|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635369|NCT02552121|21313647|P3|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635370|NCT02552121|21313648|P2|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635371|NCT02552121|21313649|P1|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635372|NCT02552121|21313642|P8|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635373|NCT02552121|21313643|P7|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635374|NCT02552121|21313644|P6|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635375|NCT02552121|21313645|P5|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635376|NCT02552121|21313646|P4|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635377|NCT02552121|21313647|P3|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635378|NCT02552121|21313648|P2|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
8635379|NCT02552121|21313649|P1|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3
8635390|NCT02515825|21313917|P2|NOT COMPLETED|Overall Study||0
8635391|NCT02515825|21313918|P1|NOT COMPLETED|Overall Study||0
8635392|NCT02515825|21313917|P2|COMPLETED|Overall Study||31
8635393|NCT02515825|21313918|P1|COMPLETED|Overall Study||70
8635394|NCT02515825|21313917|P2|STARTED|Overall Study||31
8635395|NCT02515825|21313918|P1|STARTED|Overall Study||70
8635405|NCT02443155|21313946|P4|NOT COMPLETED|Overall Study||16
8635406|NCT02443155|21313947|P3|NOT COMPLETED|Overall Study||9
8635407|NCT02443155|21313948|P2|NOT COMPLETED|Overall Study||14
8635408|NCT02443155|21313949|P1|NOT COMPLETED|Overall Study||12
8635409|NCT02443155|21313946|P4|COMPLETED|Overall Study||61
8635410|NCT02443155|21313947|P3|COMPLETED|Overall Study||67
8635411|NCT02443155|21313948|P2|COMPLETED|Overall Study||63
8635412|NCT02443155|21313949|P1|COMPLETED|Overall Study||65
8635413|NCT02443155|21313946|P4|Safety Analysis Set|Overall Study||77
8635414|NCT02443155|21313947|P3|Safety Analysis Set|Overall Study||76
8635415|NCT02443155|21313948|P2|Safety Analysis Set|Overall Study||77
8635416|NCT02443155|21313949|P1|Safety Analysis Set|Overall Study||77
8635417|NCT02443155|21313946|P4|PK Analysis Set|Overall Study||20
8635418|NCT02443155|21313947|P3|PK Analysis Set|Overall Study||22
8635419|NCT02443155|21313948|P2|PK Analysis Set|Overall Study||21
8635420|NCT02443155|21313949|P1|PK Analysis Set|Overall Study||21
8635421|NCT02443155|21313946|P4|Full Analysis Set|Overall Study||77
8635422|NCT02443155|21313947|P3|Full Analysis Set|Overall Study||76
8635423|NCT02443155|21313948|P2|Full Analysis Set|Overall Study||77
8635424|NCT02443155|21313949|P1|Full Analysis Set|Overall Study||77
8635425|NCT02443155|21313946|P4|STARTED|Overall Study||77
8635426|NCT02443155|21313947|P3|STARTED|Overall Study||76
8635427|NCT02443155|21313948|P2|STARTED|Overall Study||77
8635428|NCT02443155|21313949|P1|STARTED|Overall Study||77
8635437|NCT02386605|21314404|P2|NOT COMPLETED|Overall Study||10
8635438|NCT02386605|21314405|P1|NOT COMPLETED|Overall Study||7
8635439|NCT02386605|21314404|P2|COMPLETED|Overall Study||28
8635440|NCT02386605|21314405|P1|COMPLETED|Overall Study||34
8635441|NCT02386605|21314404|P2|STARTED|Overall Study||38
8635442|NCT02386605|21314405|P1|STARTED|Overall Study||41
8635443|NCT02344407|21314416|P3|NOT COMPLETED|Overall Study||6
8635444|NCT02344407|21314417|P2|NOT COMPLETED|Overall Study||9
8635445|NCT02344407|21314418|P1|NOT COMPLETED|Overall Study||8
8635446|NCT02344407|21314416|P3|COMPLETED|Overall Study||494
8635447|NCT02344407|21314417|P2|COMPLETED|Overall Study||491
8635448|NCT02344407|21314418|P1|COMPLETED|Overall Study||492
8635449|NCT02344407|21314416|P3|STARTED|Overall Study||500
8635450|NCT02344407|21314417|P2|STARTED|Overall Study||500
8635451|NCT02344407|21314418|P1|STARTED|Overall Study||500
8635452|NCT02333071|21314431|P2|NOT COMPLETED|Open Label Extension||75
8635453|NCT02333071|21314432|P1|NOT COMPLETED|Open Label Extension||144
8635454|NCT02333071|21314431|P2|COMPLETED|Open Label Extension||49
8635455|NCT02333071|21314432|P1|COMPLETED|Open Label Extension||95
8635456|NCT02333071|21314431|P2|STARTED|Open Label Extension||124
8635457|NCT02333071|21314432|P1|STARTED|Open Label Extension||239
8635458|NCT02333071|21314431|P2|NOT COMPLETED|Core Study||137
8635459|NCT02333071|21314432|P1|NOT COMPLETED|Core Study||52
8635460|NCT02333071|21314431|P2|COMPLETED|Core Study||190
8635461|NCT02333071|21314432|P1|COMPLETED|Core Study||274
8635462|NCT02333071|21314431|P2|Received Intervention|Core Study||324
8635463|NCT02333071|21314432|P1|Received Intervention|Core Study||319
8635464|NCT02333071|21314431|P2|STARTED|Core Study||327
8635465|NCT02333071|21314432|P1|STARTED|Core Study||326
8635466|NCT02298491|21314468|P1|NOT COMPLETED|Overall Study||1
8635467|NCT02298491|21314468|P1|COMPLETED|Overall Study||3
8635468|NCT02298491|21314468|P1|STARTED|Overall Study||4
8635469|NCT02293499|21314475|P3|NOT COMPLETED|15 Month Follow Up||7
8635470|NCT02293499|21314476|P2|NOT COMPLETED|15 Month Follow Up||22
8635471|NCT02293499|21314477|P1|NOT COMPLETED|15 Month Follow Up||22
8635472|NCT02293499|21314475|P3|COMPLETED|15 Month Follow Up||27
8635473|NCT02293499|21314476|P2|COMPLETED|15 Month Follow Up||139
8635474|NCT02293499|21314477|P1|COMPLETED|15 Month Follow Up||124
8635475|NCT02293499|21314475|P3|STARTED|15 Month Follow Up||34
8635476|NCT02293499|21314476|P2|STARTED|15 Month Follow Up||161
8635477|NCT02293499|21314477|P1|STARTED|15 Month Follow Up||146
8635478|NCT02293499|21314475|P3|NOT COMPLETED|12 Month Follow Up||6
8635479|NCT02293499|21314476|P2|NOT COMPLETED|12 Month Follow Up||26
8635480|NCT02293499|21314477|P1|NOT COMPLETED|12 Month Follow Up||26
8635481|NCT02293499|21314475|P3|COMPLETED|12 Month Follow Up||28
8635482|NCT02293499|21314476|P2|COMPLETED|12 Month Follow Up||136
8635483|NCT02293499|21314477|P1|COMPLETED|12 Month Follow Up||120
8635484|NCT02293499|21314475|P3|STARTED|12 Month Follow Up||34
8635485|NCT02293499|21314476|P2|STARTED|12 Month Follow Up||162
8635486|NCT02293499|21314477|P1|STARTED|12 Month Follow Up||146
8635487|NCT02293499|21314475|P3|NOT COMPLETED|9 Month Follow Up||4
8635488|NCT02293499|21314476|P2|NOT COMPLETED|9 Month Follow Up||28
8635489|NCT02293499|21314477|P1|NOT COMPLETED|9 Month Follow Up||26
8635490|NCT02293499|21314475|P3|COMPLETED|9 Month Follow Up||30
8635491|NCT02293499|21314476|P2|COMPLETED|9 Month Follow Up||134
8635492|NCT02293499|21314477|P1|COMPLETED|9 Month Follow Up||122
8635493|NCT02293499|21314475|P3|STARTED|9 Month Follow Up||34
8635494|NCT02293499|21314476|P2|STARTED|9 Month Follow Up||162
8635495|NCT02293499|21314477|P1|STARTED|9 Month Follow Up||148
8635496|NCT02293499|21314475|P3|NOT COMPLETED|6 Month Follow Up||7
8635497|NCT02293499|21314476|P2|NOT COMPLETED|6 Month Follow Up||27
8635498|NCT02293499|21314477|P1|NOT COMPLETED|6 Month Follow Up||17
8635499|NCT02293499|21314475|P3|COMPLETED|6 Month Follow Up||28
8635500|NCT02293499|21314476|P2|COMPLETED|6 Month Follow Up||135
8635501|NCT02293499|21314477|P1|COMPLETED|6 Month Follow Up||131
8635502|NCT02293499|21314475|P3|STARTED|6 Month Follow Up||35
8635503|NCT02293499|21314476|P2|STARTED|6 Month Follow Up||162
8635504|NCT02293499|21314477|P1|STARTED|6 Month Follow Up||148
8635505|NCT02293499|21314475|P3|NOT COMPLETED|3 Month Follow Up||10
8635506|NCT02293499|21314476|P2|NOT COMPLETED|3 Month Follow Up||15
8635507|NCT02293499|21314477|P1|NOT COMPLETED|3 Month Follow Up||15
8635508|NCT02293499|21314475|P3|COMPLETED|3 Month Follow Up||29
8635509|NCT02293499|21314476|P2|COMPLETED|3 Month Follow Up||147
8635510|NCT02293499|21314477|P1|COMPLETED|3 Month Follow Up||134
8635511|NCT02293499|21314475|P3|STARTED|3 Month Follow Up||39
8635512|NCT02293499|21314476|P2|STARTED|3 Month Follow Up||162
8635513|NCT02293499|21314477|P1|STARTED|3 Month Follow Up||149
8635514|NCT02293499|21314475|P3|NOT COMPLETED|Intervention - Camp||6
8635515|NCT02293499|21314476|P2|NOT COMPLETED|Intervention - Camp||34
8635516|NCT02293499|21314477|P1|NOT COMPLETED|Intervention - Camp||27
8635517|NCT02293499|21314475|P3|COMPLETED|Intervention - Camp||35
8635518|NCT02293499|21314476|P2|COMPLETED|Intervention - Camp||134
8635519|NCT02293499|21314477|P1|COMPLETED|Intervention - Camp||125
8635520|NCT02293499|21314475|P3|STARTED|Intervention - Camp||41
8635521|NCT02293499|21314476|P2|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|168
8635522|NCT02293499|21314477|P1|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|152
8635523|NCT02293499|21314475|P3|NOT COMPLETED|Training - Peer Leaders Only||10
8635524|NCT02293499|21314476|P2|NOT COMPLETED|Training - Peer Leaders Only||0
8635525|NCT02293499|21314477|P1|NOT COMPLETED|Training - Peer Leaders Only||0
8635526|NCT02293499|21314475|P3|COMPLETED|Training - Peer Leaders Only||41
8635527|NCT02293499|21314476|P2|COMPLETED|Training - Peer Leaders Only||0
8635528|NCT02293499|21314477|P1|COMPLETED|Training - Peer Leaders Only||0
8635529|NCT02293499|21314475|P3|STARTED|Training - Peer Leaders Only||51
8635530|NCT02293499|21314476|P2|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
8635531|NCT02293499|21314477|P1|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
8635532|NCT02293499|21314475|P3|NOT COMPLETED|Baseline - Enrollment||0
8635533|NCT02293499|21314476|P2|NOT COMPLETED|Baseline - Enrollment||0
8635534|NCT02293499|21314477|P1|NOT COMPLETED|Baseline - Enrollment||0
8635535|NCT02293499|21314475|P3|COMPLETED|Baseline - Enrollment||51
8635536|NCT02293499|21314476|P2|COMPLETED|Baseline - Enrollment||168
8635537|NCT02293499|21314477|P1|COMPLETED|Baseline - Enrollment||152
8635538|NCT02293499|21314475|P3|STARTED|Baseline - Enrollment||51
8635539|NCT02293499|21314476|P2|STARTED|Baseline - Enrollment||168
8635540|NCT02293499|21314477|P1|STARTED|Baseline - Enrollment||152
8635541|NCT02282332|21314509|P1|NOT COMPLETED|Overall Study||0
8635542|NCT02282332|21314509|P1|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
8635543|NCT02282332|21314509|P1|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
8635544|NCT02260804|21314516|P2|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||6
8635545|NCT02260804|21314517|P1|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||9
8635546|NCT02260804|21314516|P2|COMPLETED|2nd Year of the Maintenance Period (MP2)||97
8635547|NCT02260804|21314517|P1|COMPLETED|2nd Year of the Maintenance Period (MP2)||101
8635548|NCT02260804|21314516|P2|STARTED|2nd Year of the Maintenance Period (MP2)|Two subjects completed the MP1 but did not initiate this period in the Rituxan group.|103
8635549|NCT02260804|21314517|P1|STARTED|2nd Year of the Maintenance Period (MP2)|One subject completed the MP1 but did not initiate this period in the CT-P10 group.|110
8635550|NCT02260804|21314516|P2|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||15
8635551|NCT02260804|21314517|P1|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||12
8635552|NCT02260804|21314516|P2|COMPLETED|1st Year of the Maintenance Period (MP1)||105
8635553|NCT02260804|21314517|P1|COMPLETED|1st Year of the Maintenance Period (MP1)||111
8635554|NCT02260804|21314516|P2|STARTED|1st Year of the Maintenance Period (MP1)|Eight subjects completed the induction period but did not initiate this period in the Rituxan group.|120
8635555|NCT02260804|21314517|P1|STARTED|1st Year of the Maintenance Period (MP1)|Five subjects completed the induction period but did not initiate this period in the CT-P10 group.|123
8635556|NCT02260804|21314516|P2|NOT COMPLETED|Induction Study Period||0
8635557|NCT02260804|21314517|P1|NOT COMPLETED|Induction Study Period||2
8635558|NCT02260804|21314516|P2|COMPLETED|Induction Study Period||128
8635559|NCT02260804|21314517|P1|COMPLETED|Induction Study Period||128
8635560|NCT02260804|21314516|P2|STARTED|Induction Study Period||128
8635561|NCT02260804|21314517|P1|STARTED|Induction Study Period||130
8635562|NCT02257177|21314548|P11|NOT COMPLETED|Overall Study||0
8635563|NCT02257177|21314549|P10|NOT COMPLETED|Overall Study||1
8635564|NCT02257177|21314550|P9|NOT COMPLETED|Overall Study||0
8635565|NCT02257177|21314551|P8|NOT COMPLETED|Overall Study||0
8635566|NCT02257177|21314552|P7|NOT COMPLETED|Overall Study||0
8635567|NCT02257177|21314553|P6|NOT COMPLETED|Overall Study||0
8635568|NCT02257177|21314554|P5|NOT COMPLETED|Overall Study||0
8635569|NCT02257177|21314555|P4|NOT COMPLETED|Overall Study||0
8635570|NCT02257177|21314556|P3|NOT COMPLETED|Overall Study||0
8635571|NCT02257177|21314557|P2|NOT COMPLETED|Overall Study||0
8635572|NCT02257177|21314558|P1|NOT COMPLETED|Overall Study||0
8635573|NCT02257177|21314548|P11|COMPLETED|Overall Study||9
8635574|NCT02257177|21314549|P10|COMPLETED|Overall Study||4
8635575|NCT02257177|21314550|P9|COMPLETED|Overall Study||5
8635576|NCT02257177|21314551|P8|COMPLETED|Overall Study||5
8635577|NCT02257177|21314552|P7|COMPLETED|Overall Study||12
8635578|NCT02257177|21314553|P6|COMPLETED|Overall Study||4
8635579|NCT02257177|21314554|P5|COMPLETED|Overall Study||4
8635580|NCT02257177|21314555|P4|COMPLETED|Overall Study||4
8635581|NCT02257177|21314556|P3|COMPLETED|Overall Study||4
8635582|NCT02257177|21314557|P2|COMPLETED|Overall Study||4
8635583|NCT02257177|21314558|P1|COMPLETED|Overall Study||4
8635584|NCT02257177|21314548|P11|STARTED|Overall Study||9
8635585|NCT02257177|21314549|P10|STARTED|Overall Study||5
8635586|NCT02257177|21314550|P9|STARTED|Overall Study||5
8635587|NCT02257177|21314551|P8|STARTED|Overall Study||5
8635588|NCT02257177|21314552|P7|STARTED|Overall Study||12
8635589|NCT02257177|21314553|P6|STARTED|Overall Study||4
8635590|NCT02257177|21314554|P5|STARTED|Overall Study||4
8635591|NCT02257177|21314555|P4|STARTED|Overall Study||4
8635592|NCT02257177|21314556|P3|STARTED|Overall Study||4
8635593|NCT02257177|21314557|P2|STARTED|Overall Study||4
8635594|NCT02257177|21314558|P1|STARTED|Overall Study||4
8635595|NCT02213289|21314584|P2|NOT COMPLETED|Overall Study||0
8635596|NCT02213289|21314585|P1|NOT COMPLETED|Overall Study||0
8635597|NCT02213289|21314584|P2|COMPLETED|Overall Study||12
8635598|NCT02213289|21314585|P1|COMPLETED|Overall Study||68
8635599|NCT02213289|21314584|P2|Other (Non-ITT)|Overall Study||12
8635600|NCT02213289|21314585|P1|Other (Non-ITT)|Overall Study||0
8635601|NCT02213289|21314584|P2|All Negative|Overall Study||0
8635602|NCT02213289|21314585|P1|All Negative|Overall Study||9
8635603|NCT02213289|21314584|P2|EGFR Expressing|Overall Study||0
8635604|NCT02213289|21314585|P1|EGFR Expressing|Overall Study||9
8635605|NCT02213289|21314584|P2|MAPK/PIK3CA Aberrant|Overall Study||0
8635606|NCT02213289|21314585|P1|MAPK/PIK3CA Aberrant|Overall Study||20
8635607|NCT02213289|21314584|P2|FGFR2 Amplified|Overall Study||0
8635608|NCT02213289|21314585|P1|FGFR2 Amplified|Overall Study||1
8635609|NCT02213289|21314584|P2|EGFR Amplified|Overall Study||0
8635610|NCT02213289|21314585|P1|EGFR Amplified|Overall Study||8
8635611|NCT02213289|21314584|P2|HER2 Amplified|Overall Study||0
8635612|NCT02213289|21314585|P1|HER2 Amplified|Overall Study||16
8635613|NCT02213289|21314584|P2|Immuno-oncology|Overall Study||0
8635614|NCT02213289|21314585|P1|Immuno-oncology|Overall Study||5
8635615|NCT02213289|21314584|P2|STARTED|Overall Study||12
8635616|NCT02213289|21314585|P1|STARTED|Overall Study||68
8635617|NCT02186821|21314607|P1|NOT COMPLETED|Overall Study||47
8635618|NCT02186821|21314607|P1|COMPLETED|Overall Study||0
8635619|NCT02186821|21314607|P1|STARTED|Overall Study||47
8635626|NCT02163395|21314644|P1|NOT COMPLETED|Overall Study||5
8635627|NCT02163395|21314644|P1|COMPLETED|Overall Study||39
8635628|NCT02163395|21314644|P1|STARTED|Overall Study||44
8635629|NCT02036502|21314659|P8|NOT COMPLETED|Part 3:Dose Expansion||10
8635630|NCT02036502|21314660|P7|NOT COMPLETED|Part 3:Dose Expansion||1
8635631|NCT02036502|21314661|P6|NOT COMPLETED|Part 3:Dose Expansion||47
8635632|NCT02036502|21314662|P5|NOT COMPLETED|Part 3:Dose Expansion||0
8635633|NCT02036502|21314663|P4|NOT COMPLETED|Part 3:Dose Expansion||0
8635634|NCT02036502|21314664|P3|NOT COMPLETED|Part 3:Dose Expansion||0
8635635|NCT02036502|21314665|P2|NOT COMPLETED|Part 3:Dose Expansion||0
8635636|NCT02036502|21314666|P1|NOT COMPLETED|Part 3:Dose Expansion||0
8635637|NCT02036502|21314659|P8|COMPLETED|Part 3:Dose Expansion||0
8635638|NCT02036502|21314660|P7|COMPLETED|Part 3:Dose Expansion||0
8635639|NCT02036502|21314661|P6|COMPLETED|Part 3:Dose Expansion||0
8635640|NCT02036502|21314662|P5|COMPLETED|Part 3:Dose Expansion||0
8635641|NCT02036502|21314663|P4|COMPLETED|Part 3:Dose Expansion||0
8635642|NCT02036502|21314664|P3|COMPLETED|Part 3:Dose Expansion||0
8635643|NCT02036502|21314665|P2|COMPLETED|Part 3:Dose Expansion||0
8635644|NCT02036502|21314666|P1|COMPLETED|Part 3:Dose Expansion||0
8635645|NCT02036502|21314659|P8|Treated|Part 3:Dose Expansion||10
8635646|NCT02036502|21314660|P7|Treated|Part 3:Dose Expansion||1
8635647|NCT02036502|21314661|P6|Treated|Part 3:Dose Expansion||45
8635648|NCT02036502|21314662|P5|Treated|Part 3:Dose Expansion||0
8635649|NCT02036502|21314663|P4|Treated|Part 3:Dose Expansion||0
8635650|NCT02036502|21314664|P3|Treated|Part 3:Dose Expansion||0
8635651|NCT02036502|21314665|P2|Treated|Part 3:Dose Expansion||0
8635652|NCT02036502|21314666|P1|Treated|Part 3:Dose Expansion||0
8635653|NCT02036502|21314659|P8|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|10
8635654|NCT02036502|21314660|P7|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|1
8635655|NCT02036502|21314661|P6|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|47
8635656|NCT02036502|21314662|P5|STARTED|Part 3:Dose Expansion||0
8635657|NCT02036502|21314663|P4|STARTED|Part 3:Dose Expansion||0
8635658|NCT02036502|21314664|P3|STARTED|Part 3:Dose Expansion||0
8635659|NCT02036502|21314665|P2|STARTED|Part 3:Dose Expansion||0
8635660|NCT02036502|21314666|P1|STARTED|Part 3:Dose Expansion||0
8635661|NCT02036502|21314659|P8|NOT COMPLETED|Part 2:Dose Confirmation||0
8635662|NCT02036502|21314660|P7|NOT COMPLETED|Part 2:Dose Confirmation||0
8635663|NCT02036502|21314661|P6|NOT COMPLETED|Part 2:Dose Confirmation||0
8635664|NCT02036502|21314662|P5|NOT COMPLETED|Part 2:Dose Confirmation||1
8635665|NCT02036502|21314663|P4|NOT COMPLETED|Part 2:Dose Confirmation||2
8635666|NCT02036502|21314664|P3|NOT COMPLETED|Part 2:Dose Confirmation||6
8635667|NCT02036502|21314665|P2|NOT COMPLETED|Part 2:Dose Confirmation||0
8635668|NCT02036502|21314666|P1|NOT COMPLETED|Part 2:Dose Confirmation||0
8635669|NCT02036502|21314659|P8|COMPLETED|Part 2:Dose Confirmation||0
8635670|NCT02036502|21314660|P7|COMPLETED|Part 2:Dose Confirmation||0
8635671|NCT02036502|21314661|P6|COMPLETED|Part 2:Dose Confirmation||0
8635672|NCT02036502|21314662|P5|COMPLETED|Part 2:Dose Confirmation||0
8635673|NCT02036502|21314663|P4|COMPLETED|Part 2:Dose Confirmation||0
8635674|NCT02036502|21314664|P3|COMPLETED|Part 2:Dose Confirmation||0
8635675|NCT02036502|21314665|P2|COMPLETED|Part 2:Dose Confirmation||0
8635676|NCT02036502|21314666|P1|COMPLETED|Part 2:Dose Confirmation||0
8635677|NCT02036502|21314659|P8|Treated|Part 2:Dose Confirmation||0
8635678|NCT02036502|21314660|P7|Treated|Part 2:Dose Confirmation||0
8635679|NCT02036502|21314661|P6|Treated|Part 2:Dose Confirmation||0
8635680|NCT02036502|21314662|P5|Treated|Part 2:Dose Confirmation||1
8635681|NCT02036502|21314663|P4|Treated|Part 2:Dose Confirmation||1
8635682|NCT02036502|21314664|P3|Treated|Part 2:Dose Confirmation||6
8635683|NCT02036502|21314665|P2|Treated|Part 2:Dose Confirmation||0
8635684|NCT02036502|21314666|P1|Treated|Part 2:Dose Confirmation||0
8635685|NCT02036502|21314659|P8|STARTED|Part 2:Dose Confirmation||0
8635686|NCT02036502|21314660|P7|STARTED|Part 2:Dose Confirmation||0
8635687|NCT02036502|21314661|P6|STARTED|Part 2:Dose Confirmation||0
8635688|NCT02036502|21314662|P5|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|1
8635689|NCT02036502|21314663|P4|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|2
8635690|NCT02036502|21314664|P3|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|6
8635691|NCT02036502|21314665|P2|STARTED|Part 2:Dose Confirmation||0
8635692|NCT02036502|21314666|P1|STARTED|Part 2:Dose Confirmation||0
8635693|NCT02036502|21314659|P8|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
8635694|NCT02036502|21314660|P7|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
8635695|NCT02036502|21314661|P6|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
8635696|NCT02036502|21314662|P5|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
8635697|NCT02036502|21314663|P4|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
8635698|NCT02036502|21314664|P3|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
8635699|NCT02036502|21314665|P2|NOT COMPLETED|Part 1:Dose Determination/Escalation||4
8635700|NCT02036502|21314666|P1|NOT COMPLETED|Part 1:Dose Determination/Escalation||6
8635701|NCT02036502|21314659|P8|COMPLETED|Part 1:Dose Determination/Escalation||0
8635702|NCT02036502|21314660|P7|COMPLETED|Part 1:Dose Determination/Escalation||0
8635703|NCT02036502|21314661|P6|COMPLETED|Part 1:Dose Determination/Escalation||0
8635704|NCT02036502|21314662|P5|COMPLETED|Part 1:Dose Determination/Escalation||0
8635705|NCT02036502|21314663|P4|COMPLETED|Part 1:Dose Determination/Escalation||0
8635706|NCT02036502|21314664|P3|COMPLETED|Part 1:Dose Determination/Escalation||0
8635707|NCT02036502|21314665|P2|COMPLETED|Part 1:Dose Determination/Escalation||0
8635708|NCT02036502|21314666|P1|COMPLETED|Part 1:Dose Determination/Escalation||0
8635709|NCT02036502|21314659|P8|Treated|Part 1:Dose Determination/Escalation||0
8635710|NCT02036502|21314660|P7|Treated|Part 1:Dose Determination/Escalation||0
8635711|NCT02036502|21314661|P6|Treated|Part 1:Dose Determination/Escalation||0
8635712|NCT02036502|21314662|P5|Treated|Part 1:Dose Determination/Escalation||0
8635713|NCT02036502|21314663|P4|Treated|Part 1:Dose Determination/Escalation||0
8635714|NCT02036502|21314664|P3|Treated|Part 1:Dose Determination/Escalation||0
8635715|NCT02036502|21314665|P2|Treated|Part 1:Dose Determination/Escalation||3
8635716|NCT02036502|21314666|P1|Treated|Part 1:Dose Determination/Escalation||6
8635717|NCT02036502|21314659|P8|STARTED|Part 1:Dose Determination/Escalation||0
8635718|NCT02036502|21314660|P7|STARTED|Part 1:Dose Determination/Escalation||0
8635719|NCT02036502|21314661|P6|STARTED|Part 1:Dose Determination/Escalation||0
8635720|NCT02036502|21314662|P5|STARTED|Part 1:Dose Determination/Escalation||0
8635721|NCT02036502|21314663|P4|STARTED|Part 1:Dose Determination/Escalation||0
8635722|NCT02036502|21314664|P3|STARTED|Part 1:Dose Determination/Escalation||0
8635723|NCT02036502|21314665|P2|STARTED|Part 1:Dose Determination/Escalation||4
8635724|NCT02036502|21314666|P1|STARTED|Part 1:Dose Determination/Escalation||6
8635725|NCT02019888|21314763|P3|NOT COMPLETED|Overall Study||5
8635726|NCT02019888|21314764|P2|NOT COMPLETED|Overall Study||30
8635727|NCT02019888|21314765|P1|NOT COMPLETED|Overall Study||40
8635728|NCT02019888|21314763|P3|COMPLETED|Overall Study||54
8635729|NCT02019888|21314764|P2|COMPLETED|Overall Study||83
8635730|NCT02019888|21314765|P1|COMPLETED|Overall Study||108
8635731|NCT02019888|21314763|P3|STARTED|Overall Study||59
8635732|NCT02019888|21314764|P2|STARTED|Overall Study||113
8635733|NCT02019888|21314765|P1|STARTED|Overall Study||148
8635743|NCT01991977|21314801|P1|NOT COMPLETED|Overall Study||12
8635744|NCT01991977|21314801|P1|COMPLETED|Overall Study||79
8635745|NCT01991977|21314801|P1|Evaluable for the Primary Outcome|Overall Study||39
8635746|NCT01991977|21314801|P1|Received IMRT Treatment|Overall Study||79
8635747|NCT01991977|21314801|P1|Received PET Tracer|Overall Study||84
8635748|NCT01991977|21314801|P1|STARTED|Overall Study||91
8635749|NCT01990534|21314805|P1|NOT COMPLETED|Overall Study||35
8635750|NCT01990534|21314805|P1|COMPLETED|Overall Study||25
8635751|NCT01990534|21314805|P1|STARTED|Overall Study||60
8635752|NCT01970007|21314821|P1|NOT COMPLETED|Overall Study||55
8635753|NCT01970007|21314821|P1|COMPLETED|Overall Study||188
8635754|NCT01970007|21314821|P1|STARTED|Overall Study||243
8635755|NCT01951378|21314830|P2|NOT COMPLETED|Overall Study||17
8635756|NCT01951378|21314831|P1|NOT COMPLETED|Overall Study||23
8635757|NCT01951378|21314830|P2|COMPLETED|Overall Study||0
8635758|NCT01951378|21314831|P1|COMPLETED|Overall Study||0
8635759|NCT01951378|21314830|P2|STARTED|Overall Study||17
8635760|NCT01951378|21314831|P1|STARTED|Overall Study||23
8635761|NCT01910402|21314841|P2|NOT COMPLETED|Continuation Phase||0
8635762|NCT01910402|21314842|P1|NOT COMPLETED|Continuation Phase||90
8635763|NCT01910402|21314841|P2|COMPLETED|Continuation Phase||0
8635764|NCT01910402|21314842|P1|COMPLETED|Continuation Phase||30
8635765|NCT01910402|21314841|P2|STARTED|Continuation Phase||0
8635766|NCT01910402|21314842|P1|STARTED|Continuation Phase||120
8635767|NCT01910402|21314841|P2|NOT COMPLETED|Randomized Phase||55
8635768|NCT01910402|21314842|P1|NOT COMPLETED|Randomized Phase||42
8635769|NCT01910402|21314841|P2|COMPLETED|Randomized Phase||192
8635770|NCT01910402|21314842|P1|COMPLETED|Randomized Phase||206
8635771|NCT01910402|21314841|P2|STARTED|Randomized Phase||247
8635772|NCT01910402|21314842|P1|STARTED|Randomized Phase||248
8635781|NCT01876784|21314931|P2|NOT COMPLETED|Overall Study||119
8635782|NCT01876784|21314932|P1|NOT COMPLETED|Overall Study||119
8635783|NCT01876784|21314931|P2|COMPLETED|Overall Study||0
8635784|NCT01876784|21314932|P1|COMPLETED|Overall Study||0
8635785|NCT01876784|21314931|P2|Treated|Overall Study||118
8635786|NCT01876784|21314932|P1|Treated|Overall Study||117
8635787|NCT01876784|21314931|P2|STARTED|Overall Study||119
8635788|NCT01876784|21314932|P1|STARTED|Overall Study||119
8635808|NCT01818427|21314969|P2|NOT COMPLETED|Overall Study||13
8635809|NCT01818427|21314970|P1|NOT COMPLETED|Overall Study||9
8635810|NCT01818427|21314969|P2|COMPLETED|Overall Study||271
8635811|NCT01818427|21314970|P1|COMPLETED|Overall Study||230
8635812|NCT01818427|21314969|P2|STARTED|Overall Study||284
8635813|NCT01818427|21314970|P1|STARTED|Overall Study||239
8635848|NCT01610336|21315061|P11|NOT COMPLETED|Overall Study||47
8635849|NCT01610336|21315062|P10|NOT COMPLETED|Overall Study||53
8635850|NCT01610336|21315063|P9|NOT COMPLETED|Overall Study||8
8635851|NCT01610336|21315064|P8|NOT COMPLETED|Overall Study||7
8635852|NCT01610336|21315065|P7|NOT COMPLETED|Overall Study||5
8635853|NCT01610336|21315066|P6|NOT COMPLETED|Overall Study||12
8635854|NCT01610336|21315067|P5|NOT COMPLETED|Overall Study||4
8635855|NCT01610336|21315068|P4|NOT COMPLETED|Overall Study||7
8635856|NCT01610336|21315069|P3|NOT COMPLETED|Overall Study||6
8635857|NCT01610336|21315070|P2|NOT COMPLETED|Overall Study||7
8635858|NCT01610336|21315071|P1|NOT COMPLETED|Overall Study||5
8635859|NCT01610336|21315061|P11|COMPLETED|Overall Study||0
8635860|NCT01610336|21315062|P10|COMPLETED|Overall Study||0
8635861|NCT01610336|21315063|P9|COMPLETED|Overall Study||0
8635862|NCT01610336|21315064|P8|COMPLETED|Overall Study||0
8635863|NCT01610336|21315065|P7|COMPLETED|Overall Study||0
8635864|NCT01610336|21315066|P6|COMPLETED|Overall Study||0
8635865|NCT01610336|21315067|P5|COMPLETED|Overall Study||0
8635866|NCT01610336|21315068|P4|COMPLETED|Overall Study||0
8635867|NCT01610336|21315069|P3|COMPLETED|Overall Study||0
8635868|NCT01610336|21315070|P2|COMPLETED|Overall Study||0
8635869|NCT01610336|21315071|P1|COMPLETED|Overall Study||0
8635870|NCT01610336|21315061|P11|STARTED|Overall Study||47
8635871|NCT01610336|21315062|P10|STARTED|Overall Study||53
8635872|NCT01610336|21315063|P9|STARTED|Overall Study||8
8635873|NCT01610336|21315064|P8|STARTED|Overall Study||7
8635874|NCT01610336|21315065|P7|STARTED|Overall Study||5
8635875|NCT01610336|21315066|P6|STARTED|Overall Study||12
8635876|NCT01610336|21315067|P5|STARTED|Overall Study||4
8635877|NCT01610336|21315068|P4|STARTED|Overall Study||7
8635878|NCT01610336|21315069|P3|STARTED|Overall Study||6
8635879|NCT01610336|21315070|P2|STARTED|Overall Study||7
8635880|NCT01610336|21315071|P1|STARTED|Overall Study||5
8635887|NCT01565941|21315232|P2|NOT COMPLETED|Overall Study||4
8635888|NCT01565941|21315233|P1|NOT COMPLETED|Overall Study||11
8635889|NCT01565941|21315232|P2|COMPLETED|Overall Study||349
8635890|NCT01565941|21315233|P1|COMPLETED|Overall Study||349
8635891|NCT01565941|21315232|P2|STARTED|Overall Study||353
8635892|NCT01565941|21315233|P1|STARTED|Overall Study||360
8635893|NCT01504711|21315279|P1|NOT COMPLETED|Overall Study||3
8635894|NCT01504711|21315279|P1|COMPLETED|Overall Study||27
8635895|NCT01504711|21315279|P1|STARTED|Overall Study||30
8635896|NCT01441882|21315286|P1|NOT COMPLETED|Overall Study||6
8635897|NCT01441882|21315286|P1|COMPLETED|Overall Study||13
8635898|NCT01441882|21315286|P1|STARTED|Overall Study||19
8635899|NCT01317160|21315296|P2|NOT COMPLETED|Overall Study||6
8635900|NCT01317160|21315297|P1|NOT COMPLETED|Overall Study||4
8635901|NCT01317160|21315296|P2|COMPLETED|Overall Study||69
8635902|NCT01317160|21315297|P1|COMPLETED|Overall Study||71
8635903|NCT01317160|21315296|P2|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
8635904|NCT01317160|21315297|P1|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
8635905|NCT01317160|21315296|P2|STARTED|Overall Study||75
8635906|NCT01317160|21315297|P1|STARTED|Overall Study||75
8635907|NCT01295580|21315315|P2|NOT COMPLETED|Overall Study||8
8635908|NCT01295580|21315316|P1|NOT COMPLETED|Overall Study||10
8635909|NCT01295580|21315315|P2|COMPLETED|Overall Study||167
8635910|NCT01295580|21315316|P1|COMPLETED|Overall Study||164
8635911|NCT01295580|21315315|P2|STARTED|Overall Study||175
8635912|NCT01295580|21315316|P1|STARTED|Overall Study||174
8635929|NCT01216189|21315397|P2|NOT COMPLETED|Overall Study||5
8635930|NCT01216189|21315398|P1|NOT COMPLETED|Overall Study||25
8635931|NCT01216189|21315397|P2|COMPLETED|Overall Study||27
8635932|NCT01216189|21315398|P1|COMPLETED|Overall Study||85
8635933|NCT01216189|21315397|P2|STARTED|Overall Study||32
8635934|NCT01216189|21315398|P1|STARTED|Overall Study||110
8635935|NCT01207752|21315408|P2|NOT COMPLETED|Overall Study||7
8635936|NCT01207752|21315409|P1|NOT COMPLETED|Overall Study||2
8635937|NCT01207752|21315408|P2|COMPLETED|Overall Study||27
8635938|NCT01207752|21315409|P1|COMPLETED|Overall Study||33
8635939|NCT01207752|21315408|P2|STARTED|Overall Study||34
8635940|NCT01207752|21315409|P1|STARTED|Overall Study||35
8635941|NCT01146704|21315417|P2|NOT COMPLETED|Overall Study||0
8635942|NCT01146704|21315418|P1|NOT COMPLETED|Overall Study||0
8635943|NCT01146704|21315417|P2|COMPLETED|Overall Study||15
8635944|NCT01146704|21315418|P1|COMPLETED|Overall Study||16
8635945|NCT01146704|21315417|P2|STARTED|Overall Study||15
8635946|NCT01146704|21315418|P1|STARTED|Overall Study||16
8635947|NCT01075048|21315427|P3|NOT COMPLETED|Overall Study||62
8635948|NCT01075048|21315428|P2|NOT COMPLETED|Overall Study||60
8635949|NCT01075048|21315429|P1|NOT COMPLETED|Overall Study||9
8635950|NCT01075048|21315427|P3|COMPLETED|Overall Study||0
8635951|NCT01075048|21315428|P2|COMPLETED|Overall Study||0
8635952|NCT01075048|21315429|P1|COMPLETED|Overall Study||0
8635953|NCT01075048|21315427|P3|Did Not Receive Treatment|Overall Study||0
8635954|NCT01075048|21315428|P2|Did Not Receive Treatment|Overall Study||1
8635955|NCT01075048|21315429|P1|Did Not Receive Treatment|Overall Study||0
8635956|NCT01075048|21315427|P3|STARTED|Overall Study||62
8635957|NCT01075048|21315428|P2|STARTED|Overall Study||60
8635958|NCT01075048|21315429|P1|STARTED|Overall Study||9
8635959|NCT01045460|21315454|P2|NOT COMPLETED|Overall Study||3
8635960|NCT01045460|21315455|P1|NOT COMPLETED|Overall Study||6
8635961|NCT01045460|21315454|P2|COMPLETED|Overall Study||15
8635962|NCT01045460|21315455|P1|COMPLETED|Overall Study||11
8635963|NCT01045460|21315454|P2|STARTED|Overall Study||18
8635964|NCT01045460|21315455|P1|STARTED|Overall Study||17
8635965|NCT01033240|21315484|P3|NOT COMPLETED|Overall Study||53
8635966|NCT01033240|21315485|P2|NOT COMPLETED|Overall Study||50
8635967|NCT01033240|21315486|P1|NOT COMPLETED|Overall Study||49
8635968|NCT01033240|21315484|P3|COMPLETED|Overall Study||2
8635969|NCT01033240|21315485|P2|COMPLETED|Overall Study||3
8635970|NCT01033240|21315486|P1|COMPLETED|Overall Study||6
8635971|NCT01033240|21315484|P3|STARTED|Overall Study||55
8635972|NCT01033240|21315485|P2|STARTED|Overall Study||53
8635973|NCT01033240|21315486|P1|STARTED|Overall Study||55
8635974|NCT01004861|21315516|P13|NOT COMPLETED|Overall Study||20
8635975|NCT01004861|21315517|P12|NOT COMPLETED|Overall Study||8
8635976|NCT01004861|21315518|P11|NOT COMPLETED|Overall Study||9
8635977|NCT01004861|21315519|P10|NOT COMPLETED|Overall Study||11
8635978|NCT01004861|21315520|P9|NOT COMPLETED|Overall Study||39
8635979|NCT01004861|21315521|P8|NOT COMPLETED|Overall Study||4
8635980|NCT01004861|21315522|P7|NOT COMPLETED|Overall Study||7
8635981|NCT01004861|21315523|P6|NOT COMPLETED|Overall Study||6
8635982|NCT01004861|21315524|P5|NOT COMPLETED|Overall Study||7
8635983|NCT01004861|21315525|P4|NOT COMPLETED|Overall Study||6
8635984|NCT01004861|21315526|P3|NOT COMPLETED|Overall Study||6
8635985|NCT01004861|21315527|P2|NOT COMPLETED|Overall Study||6
8635986|NCT01004861|21315528|P1|NOT COMPLETED|Overall Study||3
8635987|NCT01004861|21315516|P13|COMPLETED|Overall Study||0
8635988|NCT01004861|21315517|P12|COMPLETED|Overall Study||0
8635989|NCT01004861|21315518|P11|COMPLETED|Overall Study||0
8635990|NCT01004861|21315519|P10|COMPLETED|Overall Study||0
8635991|NCT01004861|21315520|P9|COMPLETED|Overall Study||0
8635992|NCT01004861|21315521|P8|COMPLETED|Overall Study||0
8635993|NCT01004861|21315522|P7|COMPLETED|Overall Study||0
8635994|NCT01004861|21315523|P6|COMPLETED|Overall Study||0
8635995|NCT01004861|21315524|P5|COMPLETED|Overall Study||0
8635996|NCT01004861|21315525|P4|COMPLETED|Overall Study||0
8635997|NCT01004861|21315526|P3|COMPLETED|Overall Study||0
8635998|NCT01004861|21315527|P2|COMPLETED|Overall Study||0
8635999|NCT01004861|21315528|P1|COMPLETED|Overall Study||0
8636000|NCT01004861|21315516|P13|STARTED|Overall Study||20
8636001|NCT01004861|21315517|P12|STARTED|Overall Study||8
8636002|NCT01004861|21315518|P11|STARTED|Overall Study||9
8636003|NCT01004861|21315519|P10|STARTED|Overall Study||11
8636004|NCT01004861|21315520|P9|STARTED|Overall Study||39
8636005|NCT01004861|21315521|P8|STARTED|Overall Study||4
8636006|NCT01004861|21315522|P7|STARTED|Overall Study||7
8636007|NCT01004861|21315523|P6|STARTED|Overall Study||6
8636008|NCT01004861|21315524|P5|STARTED|Overall Study||7
8636009|NCT01004861|21315525|P4|STARTED|Overall Study||6
8636010|NCT01004861|21315526|P3|STARTED|Overall Study||6
8636011|NCT01004861|21315527|P2|STARTED|Overall Study||6
8636012|NCT01004861|21315528|P1|STARTED|Overall Study||3
8636013|NCT00945191|21315592|P1|NOT COMPLETED|Overall Study||24
8636014|NCT00945191|21315592|P1|COMPLETED|Overall Study||0
8636015|NCT00945191|21315592|P1|STARTED|Overall Study||24
8636016|NCT00896480|21315598|P1|NOT COMPLETED|Overall Study||21
8636017|NCT00896480|21315598|P1|COMPLETED|Overall Study||3
8636018|NCT00896480|21315598|P1|STARTED|Overall Study||24
8636019|NCT00858234|21315646|P1|NOT COMPLETED|Overall Study||9
8636020|NCT00858234|21315646|P1|COMPLETED|Overall Study||0
8636021|NCT00858234|21315646|P1|STARTED|Overall Study||9
8636022|NCT00780559|21315654|P2|NOT COMPLETED|Overall Study||7
8636023|NCT00780559|21315655|P1|NOT COMPLETED|Overall Study||3
8636024|NCT00780559|21315654|P2|COMPLETED|Overall Study||33
8636025|NCT00780559|21315655|P1|COMPLETED|Overall Study||29
8636026|NCT00780559|21315654|P2|STARTED|Overall Study||40
8636027|NCT00780559|21315655|P1|STARTED|Overall Study||32
8636028|NCT00737893|21315671|P2|NOT COMPLETED|Overall Study||0
8636029|NCT00737893|21315672|P1|NOT COMPLETED|Overall Study||0
8636030|NCT00737893|21315671|P2|COMPLETED|Overall Study||27
8636031|NCT00737893|21315672|P1|COMPLETED|Overall Study||29
8636032|NCT00737893|21315671|P2|STARTED|Overall Study||27
8636033|NCT00737893|21315672|P1|STARTED|Overall Study||29
8636034|NCT00630032|21315722|P2|NOT COMPLETED|Overall Study||95
8636035|NCT00630032|21315723|P1|NOT COMPLETED|Overall Study||90
8636036|NCT00630032|21315722|P2|COMPLETED|Overall Study||269
8636037|NCT00630032|21315723|P1|COMPLETED|Overall Study||308
8636038|NCT00630032|21315722|P2|STARTED|Overall Study||364
8636039|NCT00630032|21315723|P1|STARTED|Overall Study||398
8636049|NCT00521404|21315815|P1|NOT COMPLETED|Overall Study||62
8636050|NCT00521404|21315815|P1|COMPLETED|Overall Study||0
8636051|NCT00521404|21315815|P1|STARTED|Overall Study||62
8636060|NCT00212134|21315841|P2|NOT COMPLETED|Phase 3 (Age 10 Years)||21
8636061|NCT00212134|21315842|P1|NOT COMPLETED|Phase 3 (Age 10 Years)||21
8636062|NCT00212134|21315841|P2|COMPLETED|Phase 3 (Age 10 Years)||35
8636063|NCT00212134|21315842|P1|COMPLETED|Phase 3 (Age 10 Years)||36
8636064|NCT00212134|21315841|P2|STARTED|Phase 3 (Age 10 Years)||56
8636065|NCT00212134|21315842|P1|STARTED|Phase 3 (Age 10 Years)||57
8636066|NCT00212134|21315841|P2|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
8636067|NCT00212134|21315842|P1|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
8636068|NCT00212134|21315841|P2|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
8636069|NCT00212134|21315842|P1|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
8636070|NCT00212134|21315841|P2|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
8636071|NCT00212134|21315842|P1|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
8636072|NCT00212134|21315841|P2|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
8636073|NCT00212134|21315842|P1|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
8636074|NCT00212134|21315841|P2|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
8636075|NCT00212134|21315842|P1|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
8636076|NCT00212134|21315841|P2|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
8636077|NCT00212134|21315842|P1|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
8636078|NCT00212134|21315841|P2|STARTED|Phase 1 (to Age 1 Year)||57
8636079|NCT00212134|21315842|P1|STARTED|Phase 1 (to Age 1 Year)||57
8636080|NCT00199901|21315862|P2|NOT COMPLETED|Overall Study||24
8636081|NCT00199901|21315863|P1|NOT COMPLETED|Overall Study||27
8636082|NCT00199901|21315862|P2|COMPLETED|Overall Study||30
8636083|NCT00199901|21315863|P1|COMPLETED|Overall Study||29
8636084|NCT00199901|21315862|P2|STARTED|Overall Study||54
8636085|NCT00199901|21315863|P1|STARTED|Overall Study||56
8636092|NCT00074724|21315910|P2|NOT COMPLETED|Overall Study||0
8636093|NCT00074724|21315911|P1|NOT COMPLETED|Overall Study||0
8636094|NCT00074724|21315910|P2|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
8636095|NCT00074724|21315911|P1|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
8636096|NCT00074724|21315910|P2|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
8636097|NCT00074724|21315911|P1|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
8636116|NCT04009577|21316006|P4|NOT COMPLETED|Extension Phase||1
8636117|NCT04009577|21316007|P3|NOT COMPLETED|Extension Phase||4
8636118|NCT04009577|21316008|P2|NOT COMPLETED|Extension Phase||0
8636119|NCT04009577|21316009|P1|NOT COMPLETED|Extension Phase||0
8636120|NCT04009577|21316006|P4|COMPLETED|Extension Phase||16
8636121|NCT04009577|21316007|P3|COMPLETED|Extension Phase||13
8636122|NCT04009577|21316008|P2|COMPLETED|Extension Phase||3
8636123|NCT04009577|21316009|P1|COMPLETED|Extension Phase||6
8636124|NCT04009577|21316006|P4|LEM10|Extension Phase||17
8636125|NCT04009577|21316007|P3|LEM10|Extension Phase||12
8636126|NCT04009577|21316008|P2|LEM10|Extension Phase||3
8636127|NCT04009577|21316009|P1|LEM10|Extension Phase||5
8636128|NCT04009577|21316006|P4|LEM5|Extension Phase||8
8636129|NCT04009577|21316007|P3|LEM5|Extension Phase||15
8636130|NCT04009577|21316008|P2|LEM5|Extension Phase||3
8636131|NCT04009577|21316009|P1|LEM5|Extension Phase||6
8636132|NCT04009577|21316006|P4|Treated|Extension Phase||17
8636133|NCT04009577|21316007|P3|Treated|Extension Phase||15
8636134|NCT04009577|21316008|P2|Treated|Extension Phase||3
8636135|NCT04009577|21316009|P1|Treated|Extension Phase||6
8636136|NCT04009577|21316006|P4|STARTED|Extension Phase||17
8636137|NCT04009577|21316007|P3|STARTED|Extension Phase||17
8636138|NCT04009577|21316008|P2|STARTED|Extension Phase||3
8636139|NCT04009577|21316009|P1|STARTED|Extension Phase||6
8636140|NCT04009577|21316006|P4|NOT COMPLETED|Core Study||5
8636141|NCT04009577|21316007|P3|NOT COMPLETED|Core Study||4
8636142|NCT04009577|21316008|P2|NOT COMPLETED|Core Study||0
8636143|NCT04009577|21316009|P1|NOT COMPLETED|Core Study||1
8636144|NCT04009577|21316006|P4|COMPLETED|Core Study||17
8636145|NCT04009577|21316007|P3|COMPLETED|Core Study||17
8636146|NCT04009577|21316008|P2|COMPLETED|Core Study||3
8636147|NCT04009577|21316009|P1|COMPLETED|Core Study||6
8636148|NCT04009577|21316006|P4|LEM10|Core Study||22
8636149|NCT04009577|21316007|P3|LEM10|Core Study||10
8636150|NCT04009577|21316008|P2|LEM10|Core Study||2
8636151|NCT04009577|21316009|P1|LEM10|Core Study||3
8636152|NCT04009577|21316006|P4|LEM5|Core Study||5
8636153|NCT04009577|21316007|P3|LEM5|Core Study||21
8636154|NCT04009577|21316008|P2|LEM5|Core Study||3
8636155|NCT04009577|21316009|P1|LEM5|Core Study||7
8636156|NCT04009577|21316006|P4|STARTED|Core Study||22
8636157|NCT04009577|21316007|P3|STARTED|Core Study||21
8636158|NCT04009577|21316008|P2|STARTED|Core Study||3
8636159|NCT04009577|21316009|P1|STARTED|Core Study||7
8636160|NCT03984812|21316053|P11|NOT COMPLETED|Part 2 (Up to Day 49)||0
8636161|NCT03984812|21316054|P10|NOT COMPLETED|Part 2 (Up to Day 49)||0
8636162|NCT03984812|21316055|P9|NOT COMPLETED|Part 2 (Up to Day 49)||0
8636163|NCT03984812|21316056|P8|NOT COMPLETED|Part 2 (Up to Day 49)||0
8636164|NCT03984812|21316057|P7|NOT COMPLETED|Part 2 (Up to Day 49)||0
8636165|NCT03984812|21316058|P6|NOT COMPLETED|Part 2 (Up to Day 49)||0
8636166|NCT03984812|21316059|P5|NOT COMPLETED|Part 2 (Up to Day 49)||0
8636167|NCT03984812|21316060|P4|NOT COMPLETED|Part 2 (Up to Day 49)||0
8636168|NCT03984812|21316061|P3|NOT COMPLETED|Part 2 (Up to Day 49)||0
8636169|NCT03984812|21316062|P2|NOT COMPLETED|Part 2 (Up to Day 49)||0
8636170|NCT03984812|21316063|P1|NOT COMPLETED|Part 2 (Up to Day 49)||0
8636171|NCT03984812|21316053|P11|COMPLETED|Part 2 (Up to Day 49)||0
8636172|NCT03984812|21316054|P10|COMPLETED|Part 2 (Up to Day 49)||0
8636173|NCT03984812|21316055|P9|COMPLETED|Part 2 (Up to Day 49)||0
8636174|NCT03984812|21316056|P8|COMPLETED|Part 2 (Up to Day 49)||0
8636175|NCT03984812|21316057|P7|COMPLETED|Part 2 (Up to Day 49)||0
8636176|NCT03984812|21316058|P6|COMPLETED|Part 2 (Up to Day 49)||0
8636177|NCT03984812|21316059|P5|COMPLETED|Part 2 (Up to Day 49)||0
8636178|NCT03984812|21316060|P4|COMPLETED|Part 2 (Up to Day 49)||0
8636179|NCT03984812|21316061|P3|COMPLETED|Part 2 (Up to Day 49)||0
8636180|NCT03984812|21316062|P2|COMPLETED|Part 2 (Up to Day 49)||0
8636181|NCT03984812|21316063|P1|COMPLETED|Part 2 (Up to Day 49)||0
8636182|NCT03984812|21316053|P11|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
8636183|NCT03984812|21316054|P10|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
8636184|NCT03984812|21316055|P9|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
8636185|NCT03984812|21316056|P8|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
8636186|NCT03984812|21316057|P7|STARTED|Part 2 (Up to Day 49)||0
8636187|NCT03984812|21316058|P6|STARTED|Part 2 (Up to Day 49)||0
8636188|NCT03984812|21316059|P5|STARTED|Part 2 (Up to Day 49)||0
8636189|NCT03984812|21316060|P4|STARTED|Part 2 (Up to Day 49)||0
8636190|NCT03984812|21316061|P3|STARTED|Part 2 (Up to Day 49)||0
8636191|NCT03984812|21316062|P2|STARTED|Part 2 (Up to Day 49)||0
8636192|NCT03984812|21316063|P1|STARTED|Part 2 (Up to Day 49)||0
8636193|NCT03984812|21316053|P11|NOT COMPLETED|Part 1 (Up to Day 28)||0
8636194|NCT03984812|21316054|P10|NOT COMPLETED|Part 1 (Up to Day 28)||0
8636195|NCT03984812|21316055|P9|NOT COMPLETED|Part 1 (Up to Day 28)||0
8636196|NCT03984812|21316056|P8|NOT COMPLETED|Part 1 (Up to Day 28)||0
8636197|NCT03984812|21316057|P7|NOT COMPLETED|Part 1 (Up to Day 28)||0
8636198|NCT03984812|21316058|P6|NOT COMPLETED|Part 1 (Up to Day 28)||0
8636199|NCT03984812|21316059|P5|NOT COMPLETED|Part 1 (Up to Day 28)||0
8636200|NCT03984812|21316060|P4|NOT COMPLETED|Part 1 (Up to Day 28)||0
8636201|NCT03984812|21316061|P3|NOT COMPLETED|Part 1 (Up to Day 28)||1
8636202|NCT03984812|21316062|P2|NOT COMPLETED|Part 1 (Up to Day 28)||0
8636203|NCT03984812|21316063|P1|NOT COMPLETED|Part 1 (Up to Day 28)||0
8636204|NCT03984812|21316053|P11|COMPLETED|Part 1 (Up to Day 28)||0
8636205|NCT03984812|21316054|P10|COMPLETED|Part 1 (Up to Day 28)||0
8636206|NCT03984812|21316055|P9|COMPLETED|Part 1 (Up to Day 28)||0
8636207|NCT03984812|21316056|P8|COMPLETED|Part 1 (Up to Day 28)||0
8636208|NCT03984812|21316057|P7|COMPLETED|Part 1 (Up to Day 28)||0
8636209|NCT03984812|21316058|P6|COMPLETED|Part 1 (Up to Day 28)||0
8636210|NCT03984812|21316059|P5|COMPLETED|Part 1 (Up to Day 28)||0
8636211|NCT03984812|21316060|P4|COMPLETED|Part 1 (Up to Day 28)||6
8636212|NCT03984812|21316061|P3|COMPLETED|Part 1 (Up to Day 28)||5
8636213|NCT03984812|21316062|P2|COMPLETED|Part 1 (Up to Day 28)||6
8636214|NCT03984812|21316063|P1|COMPLETED|Part 1 (Up to Day 28)||6
8636215|NCT03984812|21316053|P11|STARTED|Part 1 (Up to Day 28)||0
8636216|NCT03984812|21316054|P10|STARTED|Part 1 (Up to Day 28)||0
8636217|NCT03984812|21316055|P9|STARTED|Part 1 (Up to Day 28)||0
8636218|NCT03984812|21316056|P8|STARTED|Part 1 (Up to Day 28)||0
8636219|NCT03984812|21316057|P7|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
8636220|NCT03984812|21316058|P6|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
8636221|NCT03984812|21316059|P5|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
8636222|NCT03984812|21316060|P4|STARTED|Part 1 (Up to Day 28)||6
8636223|NCT03984812|21316061|P3|STARTED|Part 1 (Up to Day 28)||6
8636224|NCT03984812|21316062|P2|STARTED|Part 1 (Up to Day 28)||6
8636225|NCT03984812|21316063|P1|STARTED|Part 1 (Up to Day 28)||6
8636226|NCT03950856|21316352|P4|NOT COMPLETED|Overall Study||6
8636227|NCT03950856|21316353|P3|NOT COMPLETED|Overall Study||18
8636228|NCT03950856|21316354|P2|NOT COMPLETED|Overall Study||15
8636229|NCT03950856|21316355|P1|NOT COMPLETED|Overall Study||19
8636230|NCT03950856|21316352|P4|COMPLETED|Overall Study||227
8636231|NCT03950856|21316353|P3|COMPLETED|Overall Study||683
8636232|NCT03950856|21316354|P2|COMPLETED|Overall Study||689
8636233|NCT03950856|21316355|P1|COMPLETED|Overall Study||683
8636234|NCT03950856|21316352|P4|Vaccinated|Overall Study||231
8636235|NCT03950856|21316353|P3|Vaccinated|Overall Study||700
8636236|NCT03950856|21316354|P2|Vaccinated|Overall Study||704
8636237|NCT03950856|21316355|P1|Vaccinated|Overall Study||698
8636238|NCT03950856|21316352|P4|STARTED|Overall Study||233
8636239|NCT03950856|21316353|P3|STARTED|Overall Study||701
8636240|NCT03950856|21316354|P2|STARTED|Overall Study||704
8636241|NCT03950856|21316355|P1|STARTED|Overall Study||702
8636242|NCT03562117|21316408|P3|NOT COMPLETED|Part 2, Up to 3 Days||0
8636243|NCT03562117|21316409|P2|NOT COMPLETED|Part 2, Up to 3 Days||0
8636244|NCT03562117|21316410|P1|NOT COMPLETED|Part 2, Up to 3 Days||0
8636245|NCT03562117|21316408|P3|COMPLETED|Part 2, Up to 3 Days||8
8636246|NCT03562117|21316409|P2|COMPLETED|Part 2, Up to 3 Days||0
8636247|NCT03562117|21316410|P1|COMPLETED|Part 2, Up to 3 Days||8
8636248|NCT03562117|21316408|P3|STARTED|Part 2, Up to 3 Days||8
8636249|NCT03562117|21316409|P2|STARTED|Part 2, Up to 3 Days||0
8636250|NCT03562117|21316410|P1|STARTED|Part 2, Up to 3 Days|Only 1 additional participant with normal hepatic function enrolled in Part 2 received dosing|8
8636251|NCT03562117|21316408|P3|NOT COMPLETED|Part 1, Up to 3 Days||0
8636252|NCT03562117|21316409|P2|NOT COMPLETED|Part 1, Up to 3 Days||0
8636253|NCT03562117|21316410|P1|NOT COMPLETED|Part 1, Up to 3 Days||1
8636254|NCT03562117|21316408|P3|COMPLETED|Part 1, Up to 3 Days||0
8636255|NCT03562117|21316409|P2|COMPLETED|Part 1, Up to 3 Days||8
8636256|NCT03562117|21316410|P1|COMPLETED|Part 1, Up to 3 Days||7
8636257|NCT03562117|21316408|P3|STARTED|Part 1, Up to 3 Days||0
8636258|NCT03562117|21316409|P2|STARTED|Part 1, Up to 3 Days||8
8636259|NCT03562117|21316410|P1|STARTED|Part 1, Up to 3 Days||8
8636266|NCT03415581|21316513|P2|NOT COMPLETED|Overall Study||5
8636267|NCT03415581|21316514|P1|NOT COMPLETED|Overall Study||6
8636268|NCT03415581|21316513|P2|COMPLETED|Overall Study||1
8636269|NCT03415581|21316514|P1|COMPLETED|Overall Study||1
8636270|NCT03415581|21316513|P2|STARTED|Overall Study||6
8636271|NCT03415581|21316514|P1|STARTED|Overall Study||7
8636272|NCT03380429|21316527|P5|NOT COMPLETED|Overall Study||5
8636273|NCT03380429|21316528|P4|NOT COMPLETED|Overall Study||10
8636274|NCT03380429|21316529|P3|NOT COMPLETED|Overall Study||11
8636275|NCT03380429|21316530|P2|NOT COMPLETED|Overall Study||7
8636276|NCT03380429|21316531|P1|NOT COMPLETED|Overall Study||5
8636277|NCT03380429|21316527|P5|COMPLETED|Overall Study||81
8636278|NCT03380429|21316528|P4|COMPLETED|Overall Study||78
8636279|NCT03380429|21316529|P3|COMPLETED|Overall Study||77
8636280|NCT03380429|21316530|P2|COMPLETED|Overall Study||81
8636281|NCT03380429|21316531|P1|COMPLETED|Overall Study||82
8636282|NCT03380429|21316527|P5|STARTED|Overall Study||86
8636283|NCT03380429|21316528|P4|STARTED|Overall Study||88
8636284|NCT03380429|21316529|P3|STARTED|Overall Study||88
8636285|NCT03380429|21316530|P2|STARTED|Overall Study||88
8636286|NCT03380429|21316531|P1|STARTED|Overall Study||87
8636293|NCT03194373|21316603|P1|NOT COMPLETED|Overall Study||2
8636294|NCT03194373|21316603|P1|COMPLETED|Overall Study||18
8636295|NCT03194373|21316603|P1|Received Palbociclib and Carboplatin|Overall Study||19
8636296|NCT03194373|21316603|P1|STARTED|Overall Study||20
8636297|NCT03094611|21316610|P1|NOT COMPLETED|Overall Study||2
8636298|NCT03094611|21316610|P1|COMPLETED|Overall Study||2
8636299|NCT03094611|21316610|P1|STARTED|Overall Study||4
8636300|NCT03056690|21316620|P2|NOT COMPLETED|Overall Study||16
8636301|NCT03056690|21316621|P1|NOT COMPLETED|Overall Study||14
8636302|NCT03056690|21316620|P2|COMPLETED|Overall Study||75
8636303|NCT03056690|21316621|P1|COMPLETED|Overall Study||81
8636304|NCT03056690|21316620|P2|Treated|Overall Study||90
8636305|NCT03056690|21316621|P1|Treated|Overall Study||94
8636306|NCT03056690|21316620|P2|STARTED|Overall Study||91
8636307|NCT03056690|21316621|P1|STARTED|Overall Study||95
8636308|NCT03050801|21316659|P6|NOT COMPLETED|Experiment 2||2
8636309|NCT03050801|21316660|P5|NOT COMPLETED|Experiment 2||4
8636310|NCT03050801|21316661|P4|NOT COMPLETED|Experiment 2||6
8636311|NCT03050801|21316662|P3|NOT COMPLETED|Experiment 2||0
8636312|NCT03050801|21316663|P2|NOT COMPLETED|Experiment 2||0
8636313|NCT03050801|21316664|P1|NOT COMPLETED|Experiment 2||0
8636314|NCT03050801|21316659|P6|COMPLETED|Experiment 2||2
8636315|NCT03050801|21316660|P5|COMPLETED|Experiment 2||15
8636316|NCT03050801|21316661|P4|COMPLETED|Experiment 2||15
8636317|NCT03050801|21316662|P3|COMPLETED|Experiment 2||0
8636318|NCT03050801|21316663|P2|COMPLETED|Experiment 2||0
8636319|NCT03050801|21316664|P1|COMPLETED|Experiment 2||0
8636320|NCT03050801|21316659|P6|STARTED|Experiment 2|Experiment 2 (Prefrontal Cortex Stimulation) was terminated early due to adverse events (intolerance of stimulation) in 2 of 4 participants.|4
8636321|NCT03050801|21316660|P5|STARTED|Experiment 2||19
8636322|NCT03050801|21316661|P4|STARTED|Experiment 2||21
8636323|NCT03050801|21316662|P3|STARTED|Experiment 2||0
8636324|NCT03050801|21316663|P2|STARTED|Experiment 2||0
8636325|NCT03050801|21316664|P1|STARTED|Experiment 2||0
8636326|NCT03050801|21316659|P6|NOT COMPLETED|Experiment 1||0
8636327|NCT03050801|21316660|P5|NOT COMPLETED|Experiment 1||0
8636328|NCT03050801|21316661|P4|NOT COMPLETED|Experiment 1||0
8636329|NCT03050801|21316662|P3|NOT COMPLETED|Experiment 1||2
8636330|NCT03050801|21316663|P2|NOT COMPLETED|Experiment 1||7
8636331|NCT03050801|21316664|P1|NOT COMPLETED|Experiment 1||0
8636332|NCT03050801|21316659|P6|COMPLETED|Experiment 1||0
8636333|NCT03050801|21316660|P5|COMPLETED|Experiment 1||0
8636334|NCT03050801|21316661|P4|COMPLETED|Experiment 1||0
8636335|NCT03050801|21316662|P3|COMPLETED|Experiment 1||6
8636336|NCT03050801|21316663|P2|COMPLETED|Experiment 1||6
8636337|NCT03050801|21316664|P1|COMPLETED|Experiment 1||3
8636338|NCT03050801|21316659|P6|STARTED|Experiment 1||0
8636339|NCT03050801|21316660|P5|STARTED|Experiment 1||0
8636340|NCT03050801|21316661|P4|STARTED|Experiment 1||0
8636341|NCT03050801|21316662|P3|STARTED|Experiment 1||8
8636342|NCT03050801|21316663|P2|STARTED|Experiment 1||13
8636343|NCT03050801|21316664|P1|STARTED|Experiment 1||3
8636344|NCT03008070|21316687|P3|NOT COMPLETED|Overall Study||7
8636345|NCT03008070|21316688|P2|NOT COMPLETED|Overall Study||6
8636346|NCT03008070|21316689|P1|NOT COMPLETED|Overall Study||6
8636347|NCT03008070|21316687|P3|COMPLETED|Overall Study||74
8636348|NCT03008070|21316688|P2|COMPLETED|Overall Study||77
8636349|NCT03008070|21316689|P1|COMPLETED|Overall Study||77
8636350|NCT03008070|21316687|P3|STARTED|Overall Study||81
8636351|NCT03008070|21316688|P2|STARTED|Overall Study||83
8636352|NCT03008070|21316689|P1|STARTED|Overall Study||83
8636353|NCT02975336|21316782|P8|NOT COMPLETED|LTE (104 Weeks)||72
8636354|NCT02975336|21316783|P7|NOT COMPLETED|LTE (104 Weeks)||80
8636355|NCT02975336|21316784|P6|NOT COMPLETED|LTE (104 Weeks)||69
8636356|NCT02975336|21316785|P5|NOT COMPLETED|LTE (104 Weeks)||62
8636357|NCT02975336|21316786|P4|NOT COMPLETED|LTE (104 Weeks)||0
8636358|NCT02975336|21316787|P3|NOT COMPLETED|LTE (104 Weeks)||0
8636359|NCT02975336|21316788|P2|NOT COMPLETED|LTE (104 Weeks)||0
8636360|NCT02975336|21316789|P1|NOT COMPLETED|LTE (104 Weeks)||0
8636361|NCT02975336|21316782|P8|COMPLETED|LTE (104 Weeks)||0
8636362|NCT02975336|21316783|P7|COMPLETED|LTE (104 Weeks)||0
8636363|NCT02975336|21316784|P6|COMPLETED|LTE (104 Weeks)||0
8636364|NCT02975336|21316785|P5|COMPLETED|LTE (104 Weeks)||0
8636365|NCT02975336|21316786|P4|COMPLETED|LTE (104 Weeks)||0
8636366|NCT02975336|21316787|P3|COMPLETED|LTE (104 Weeks)||0
8636367|NCT02975336|21316788|P2|COMPLETED|LTE (104 Weeks)||0
8636368|NCT02975336|21316789|P1|COMPLETED|LTE (104 Weeks)||0
8636369|NCT02975336|21316782|P8|STARTED|LTE (104 Weeks)||72
8636370|NCT02975336|21316783|P7|STARTED|LTE (104 Weeks)||80
8636371|NCT02975336|21316784|P6|STARTED|LTE (104 Weeks)||69
8636372|NCT02975336|21316785|P5|STARTED|LTE (104 Weeks)||62
8636373|NCT02975336|21316786|P4|STARTED|LTE (104 Weeks)||0
8636374|NCT02975336|21316787|P3|STARTED|LTE (104 Weeks)||0
8636375|NCT02975336|21316788|P2|STARTED|LTE (104 Weeks)||0
8636376|NCT02975336|21316789|P1|STARTED|LTE (104 Weeks)||0
8636377|NCT02975336|21316782|P8|NOT COMPLETED|DBPC (52 Weeks)||0
8636378|NCT02975336|21316783|P7|NOT COMPLETED|DBPC (52 Weeks)||0
8636379|NCT02975336|21316784|P6|NOT COMPLETED|DBPC (52 Weeks)||0
8636380|NCT02975336|21316785|P5|NOT COMPLETED|DBPC (52 Weeks)||0
8636381|NCT02975336|21316786|P4|NOT COMPLETED|DBPC (52 Weeks)||33
8636382|NCT02975336|21316787|P3|NOT COMPLETED|DBPC (52 Weeks)||27
8636383|NCT02975336|21316788|P2|NOT COMPLETED|DBPC (52 Weeks)||29
8636384|NCT02975336|21316789|P1|NOT COMPLETED|DBPC (52 Weeks)||32
8636385|NCT02975336|21316782|P8|COMPLETED|DBPC (52 Weeks)||0
8636386|NCT02975336|21316783|P7|COMPLETED|DBPC (52 Weeks)||0
8636387|NCT02975336|21316784|P6|COMPLETED|DBPC (52 Weeks)||0
8636388|NCT02975336|21316785|P5|COMPLETED|DBPC (52 Weeks)||0
8636389|NCT02975336|21316786|P4|COMPLETED|DBPC (52 Weeks)||84
8636390|NCT02975336|21316787|P3|COMPLETED|DBPC (52 Weeks)||90
8636391|NCT02975336|21316788|P2|COMPLETED|DBPC (52 Weeks)||89
8636392|NCT02975336|21316789|P1|COMPLETED|DBPC (52 Weeks)||85
8636393|NCT02975336|21316782|P8|STARTED|DBPC (52 Weeks)||0
8636394|NCT02975336|21316783|P7|STARTED|DBPC (52 Weeks)||0
8636395|NCT02975336|21316784|P6|STARTED|DBPC (52 Weeks)||0
8636396|NCT02975336|21316785|P5|STARTED|DBPC (52 Weeks)||0
8636397|NCT02975336|21316786|P4|STARTED|DBPC (52 Weeks)||117
8636398|NCT02975336|21316787|P3|STARTED|DBPC (52 Weeks)||117
8636399|NCT02975336|21316788|P2|STARTED|DBPC (52 Weeks)||118
8636400|NCT02975336|21316789|P1|STARTED|DBPC (52 Weeks)||117
8636401|NCT02955069|21317025|P2|NOT COMPLETED|Overall Study||21
8636402|NCT02955069|21317026|P1|NOT COMPLETED|Overall Study||95
8636403|NCT02955069|21317025|P2|COMPLETED|Overall Study||0
8636404|NCT02955069|21317026|P1|COMPLETED|Overall Study||0
8636405|NCT02955069|21317025|P2|IG Incidence Set|Overall Study||17
8636406|NCT02955069|21317026|P1|IG Incidence Set|Overall Study||84
8636407|NCT02955069|21317025|P2|Immunogenicity (IG) Prevalence Set|Overall Study||21
8636408|NCT02955069|21317026|P1|Immunogenicity (IG) Prevalence Set|Overall Study||94
8636409|NCT02955069|21317025|P2|Pharmacokinetic Analysis Set (PAS)|Overall Study||18
8636410|NCT02955069|21317026|P1|Pharmacokinetic Analysis Set (PAS)|Overall Study||94
8636411|NCT02955069|21317025|P2|Safety Set|Overall Study||21
8636412|NCT02955069|21317026|P1|Safety Set|Overall Study||95
8636413|NCT02955069|21317025|P2|Full Analysis Set (FAS)|Overall Study||21
8636414|NCT02955069|21317026|P1|Full Analysis Set (FAS)|Overall Study||95
8636415|NCT02955069|21317025|P2|STARTED|Overall Study||21
8636416|NCT02955069|21317026|P1|STARTED|Overall Study||95
8636429|NCT02597712|21317096|P2|NOT COMPLETED|Overall Study||1
8636430|NCT02597712|21317097|P1|NOT COMPLETED|Overall Study||3
8636431|NCT02597712|21317096|P2|COMPLETED|Overall Study||10
8636432|NCT02597712|21317097|P1|COMPLETED|Overall Study||10
8636433|NCT02597712|21317096|P2|STARTED|Overall Study||11
8636434|NCT02597712|21317097|P1|STARTED|Overall Study||13
8636455|NCT02411448|21317139|P3|NOT COMPLETED|Overall Study||52
8636456|NCT02411448|21317140|P2|NOT COMPLETED|Overall Study||83
8636457|NCT02411448|21317141|P1|NOT COMPLETED|Overall Study||4
8636458|NCT02411448|21317139|P3|COMPLETED|Overall Study||173
8636459|NCT02411448|21317140|P2|COMPLETED|Overall Study||141
8636460|NCT02411448|21317141|P1|COMPLETED|Overall Study||10
8636461|NCT02411448|21317139|P3|Received at Least One Dose of Study Drug|Overall Study||225
8636462|NCT02411448|21317140|P2|Received at Least One Dose of Study Drug|Overall Study||221
8636463|NCT02411448|21317141|P1|Received at Least One Dose of Study Drug|Overall Study||14
8636464|NCT02411448|21317139|P3|STARTED|Overall Study||225
8636465|NCT02411448|21317140|P2|STARTED|Overall Study||224
8636466|NCT02411448|21317141|P1|STARTED|Overall Study||14
8636467|NCT02390908|21317175|P5|NOT COMPLETED|Overall Study||0
8636468|NCT02390908|21317176|P4|NOT COMPLETED|Overall Study||0
8636469|NCT02390908|21317177|P3|NOT COMPLETED|Overall Study||0
8636470|NCT02390908|21317178|P2|NOT COMPLETED|Overall Study||0
8636471|NCT02390908|21317179|P1|NOT COMPLETED|Overall Study||0
8636472|NCT02390908|21317175|P5|COMPLETED|Overall Study||120
8636473|NCT02390908|21317176|P4|COMPLETED|Overall Study||90
8636474|NCT02390908|21317177|P3|COMPLETED|Overall Study||22
8636475|NCT02390908|21317178|P2|COMPLETED|Overall Study||22
8636476|NCT02390908|21317179|P1|COMPLETED|Overall Study||40
8636477|NCT02390908|21317175|P5|STARTED|Overall Study||120
8636478|NCT02390908|21317176|P4|STARTED|Overall Study||90
8636479|NCT02390908|21317177|P3|STARTED|Overall Study||22
8636480|NCT02390908|21317178|P2|STARTED|Overall Study||22
8636481|NCT02390908|21317179|P1|STARTED|Overall Study||40
8636482|NCT02388646|21317207|P3|NOT COMPLETED|Overall Study||6
8636483|NCT02388646|21317208|P2|NOT COMPLETED|Overall Study||1
8636484|NCT02388646|21317209|P1|NOT COMPLETED|Overall Study||4
8636485|NCT02388646|21317207|P3|COMPLETED|Overall Study||14
8636486|NCT02388646|21317208|P2|COMPLETED|Overall Study||19
8636487|NCT02388646|21317209|P1|COMPLETED|Overall Study||16
8636488|NCT02388646|21317207|P3|STARTED|Overall Study||20
8636489|NCT02388646|21317208|P2|STARTED|Overall Study||20
8636490|NCT02388646|21317209|P1|STARTED|Overall Study||20
8636491|NCT02242578|21317222|P2|NOT COMPLETED|Overall Study||0
8636492|NCT02242578|21317223|P1|NOT COMPLETED|Overall Study||0
8636493|NCT02242578|21317222|P2|COMPLETED|Overall Study||0
8636494|NCT02242578|21317223|P1|COMPLETED|Overall Study||0
8636495|NCT02242578|21317222|P2|STARTED|Overall Study||0
8636496|NCT02242578|21317223|P1|STARTED|Overall Study||0
8636500|NCT02062606|21317238|P1|NOT COMPLETED|Overall Study||89
8636501|NCT02062606|21317238|P1|COMPLETED|Overall Study||99
8636502|NCT02062606|21317238|P1|STARTED|Overall Study||188
8636533|NCT01844193|21317595|P2|NOT COMPLETED|Overall Study||6
8636534|NCT01844193|21317596|P1|NOT COMPLETED|Overall Study||6
8636535|NCT01844193|21317595|P2|COMPLETED|Overall Study||15
8636536|NCT01844193|21317596|P1|COMPLETED|Overall Study||13
8636537|NCT01844193|21317595|P2|STARTED|Overall Study||21
8636538|NCT01844193|21317596|P1|STARTED|Overall Study||19
8636539|NCT01794299|21317604|P1|NOT COMPLETED|Overall Study||22
8636540|NCT01794299|21317604|P1|COMPLETED|Overall Study||9
8636541|NCT01794299|21317604|P1|STARTED|Overall Study||31
8636557|NCT01626872|21317655|P3|NOT COMPLETED|Overall Study||24
8636558|NCT01626872|21317656|P2|NOT COMPLETED|Overall Study||66
8636559|NCT01626872|21317657|P1|NOT COMPLETED|Overall Study||52
8636560|NCT01626872|21317655|P3|COMPLETED|Overall Study||34
8636561|NCT01626872|21317656|P2|COMPLETED|Overall Study||43
8636562|NCT01626872|21317657|P1|COMPLETED|Overall Study||29
8636563|NCT01626872|21317655|P3|STARTED|Overall Study||58
8636564|NCT01626872|21317656|P2|STARTED|Overall Study||109
8636565|NCT01626872|21317657|P1|STARTED|Overall Study||81
8636566|NCT01626859|21317668|P3|NOT COMPLETED|Overall Study||4
8636567|NCT01626859|21317669|P2|NOT COMPLETED|Overall Study||8
8636568|NCT01626859|21317670|P1|NOT COMPLETED|Overall Study||2
8636569|NCT01626859|21317668|P3|COMPLETED|Overall Study||7
8636570|NCT01626859|21317669|P2|COMPLETED|Overall Study||8
8636571|NCT01626859|21317670|P1|COMPLETED|Overall Study||9
8636572|NCT01626859|21317668|P3|STARTED|Overall Study||11
8636573|NCT01626859|21317669|P2|STARTED|Overall Study||16
8636574|NCT01626859|21317670|P1|STARTED|Overall Study||11
8636575|NCT01625000|21317692|P5|NOT COMPLETED|Overall Study||55
8636576|NCT01625000|21317693|P4|NOT COMPLETED|Overall Study||19
8636577|NCT01625000|21317694|P3|NOT COMPLETED|Overall Study||33
8636578|NCT01625000|21317695|P2|NOT COMPLETED|Overall Study||52
8636579|NCT01625000|21317696|P1|NOT COMPLETED|Overall Study||52
8636580|NCT01625000|21317692|P5|COMPLETED|Overall Study||71
8636581|NCT01625000|21317693|P4|COMPLETED|Overall Study||37
8636582|NCT01625000|21317694|P3|COMPLETED|Overall Study||34
8636583|NCT01625000|21317695|P2|COMPLETED|Overall Study||81
8636584|NCT01625000|21317696|P1|COMPLETED|Overall Study||74
8636585|NCT01625000|21317692|P5|STARTED|Overall Study||126
8636586|NCT01625000|21317693|P4|STARTED|Overall Study||56
8636587|NCT01625000|21317694|P3|STARTED|Overall Study||67
8636588|NCT01625000|21317695|P2|STARTED|Overall Study||133
8636589|NCT01625000|21317696|P1|STARTED|Overall Study||126
8636590|NCT01362244|21317715|P2|NOT COMPLETED|Overall Study||32
8636591|NCT01362244|21317716|P1|NOT COMPLETED|Overall Study||32
8636592|NCT01362244|21317715|P2|COMPLETED|Overall Study||19
8636593|NCT01362244|21317716|P1|COMPLETED|Overall Study||22
8636594|NCT01362244|21317715|P2|STARTED|Overall Study||51
8636595|NCT01362244|21317716|P1|STARTED|Overall Study||54
8636596|NCT01351805|21317791|P4|NOT COMPLETED|Overall Study||0
8636597|NCT01351805|21317792|P3|NOT COMPLETED|Overall Study||0
8636598|NCT01351805|21317793|P2|NOT COMPLETED|Overall Study||0
8636599|NCT01351805|21317794|P1|NOT COMPLETED|Overall Study||0
8636600|NCT01351805|21317791|P4|COMPLETED|Overall Study||6474
8636601|NCT01351805|21317792|P3|COMPLETED|Overall Study||6470
8636602|NCT01351805|21317793|P2|COMPLETED|Overall Study||6464
8636603|NCT01351805|21317794|P1|COMPLETED|Overall Study||6463
8636604|NCT01351805|21317791|P4|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||385
8636605|NCT01351805|21317792|P3|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
8636606|NCT01351805|21317793|P2|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
8636607|NCT01351805|21317794|P1|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
8636608|NCT01351805|21317791|P4|Knee Pain Cohort Within VITAL Trial|Overall Study||371
8636609|NCT01351805|21317792|P3|Knee Pain Cohort Within VITAL Trial|Overall Study||353
8636610|NCT01351805|21317793|P2|Knee Pain Cohort Within VITAL Trial|Overall Study||332
8636611|NCT01351805|21317794|P1|Knee Pain Cohort Within VITAL Trial|Overall Study||342
8636612|NCT01351805|21317791|P4|STARTED|Overall Study||6474
8636613|NCT01351805|21317792|P3|STARTED|Overall Study||6470
8636614|NCT01351805|21317793|P2|STARTED|Overall Study||6464
8636615|NCT01351805|21317794|P1|STARTED|Overall Study||6463
8636616|NCT01270516|21317820|P4|NOT COMPLETED|Overall Study||5
8636617|NCT01270516|21317821|P3|NOT COMPLETED|Overall Study||5
8636618|NCT01270516|21317822|P2|NOT COMPLETED|Overall Study||4
8636619|NCT01270516|21317823|P1|NOT COMPLETED|Overall Study||3
8636620|NCT01270516|21317820|P4|COMPLETED|Overall Study||13
8636621|NCT01270516|21317821|P3|COMPLETED|Overall Study||13
8636622|NCT01270516|21317822|P2|COMPLETED|Overall Study||13
8636623|NCT01270516|21317823|P1|COMPLETED|Overall Study||17
8636624|NCT01270516|21317820|P4|STARTED|Overall Study||18
8636625|NCT01270516|21317821|P3|STARTED|Overall Study||18
8636626|NCT01270516|21317822|P2|STARTED|Overall Study||17
8636627|NCT01270516|21317823|P1|STARTED|Overall Study||20
8636637|NCT00862992|21317862|P3|NOT COMPLETED|Overall Study||3
8636638|NCT00862992|21317863|P2|NOT COMPLETED|Overall Study||1
8636639|NCT00862992|21317864|P1|NOT COMPLETED|Overall Study||3
8636640|NCT00862992|21317862|P3|COMPLETED|Overall Study||9
8636641|NCT00862992|21317863|P2|COMPLETED|Overall Study||9
8636642|NCT00862992|21317864|P1|COMPLETED|Overall Study||9
8636643|NCT00862992|21317862|P3|STARTED|Overall Study||12
8636644|NCT00862992|21317863|P2|STARTED|Overall Study||10
8636645|NCT00862992|21317864|P1|STARTED|Overall Study||12
8636658|NCT00724594|21317941|P4|NOT COMPLETED|Overall Study||1
8636659|NCT00724594|21317942|P3|NOT COMPLETED|Overall Study||0
8636660|NCT00724594|21317943|P2|NOT COMPLETED|Overall Study||0
8636661|NCT00724594|21317944|P1|NOT COMPLETED|Overall Study||0
8636662|NCT00724594|21317941|P4|COMPLETED|Overall Study||10
8636663|NCT00724594|21317942|P3|COMPLETED|Overall Study||11
8636664|NCT00724594|21317943|P2|COMPLETED|Overall Study||12
8636665|NCT00724594|21317944|P1|COMPLETED|Overall Study||12
8636666|NCT00724594|21317941|P4|STARTED|Overall Study||11
8636667|NCT00724594|21317942|P3|STARTED|Overall Study||11
8636668|NCT00724594|21317943|P2|STARTED|Overall Study||12
8636669|NCT00724594|21317944|P1|STARTED|Overall Study||12
8636680|NCT04091061|21317996|P4|NOT COMPLETED|Overall Study||0
8636681|NCT04091061|21317997|P3|NOT COMPLETED|Overall Study||0
8636682|NCT04091061|21317998|P2|NOT COMPLETED|Overall Study||0
8636683|NCT04091061|21317999|P1|NOT COMPLETED|Overall Study||0
8636684|NCT04091061|21317996|P4|COMPLETED|Overall Study||6
8636685|NCT04091061|21317997|P3|COMPLETED|Overall Study||6
8636686|NCT04091061|21317998|P2|COMPLETED|Overall Study||6
8636687|NCT04091061|21317999|P1|COMPLETED|Overall Study||6
8636688|NCT04091061|21317996|P4|STARTED|Overall Study||6
8636689|NCT04091061|21317997|P3|STARTED|Overall Study||6
8636690|NCT04091061|21317998|P2|STARTED|Overall Study||6
8636691|NCT04091061|21317999|P1|STARTED|Overall Study||6
8636803|NCT03635775|21318373|P2|STARTED|Overall Study||0
8636722|NCT04067050|21318080|P2|NOT COMPLETED|Two Month||0
8636723|NCT04067050|21318081|P1|NOT COMPLETED|Two Month||2
8636724|NCT04067050|21318080|P2|COMPLETED|Two Month||29
8636725|NCT04067050|21318081|P1|COMPLETED|Two Month||20
8636726|NCT04067050|21318080|P2|STARTED|Two Month||29
8636727|NCT04067050|21318081|P1|STARTED|Two Month|6 subjects discontinued after 1 month visit. 22 Subjects continued the study.|22
8636728|NCT04067050|21318080|P2|NOT COMPLETED|One Month||0
8636729|NCT04067050|21318081|P1|NOT COMPLETED|One Month||4
8636730|NCT04067050|21318080|P2|COMPLETED|One Month||29
8636731|NCT04067050|21318081|P1|COMPLETED|One Month||28
8636732|NCT04067050|21318080|P2|STARTED|One Month||29
8636733|NCT04067050|21318081|P1|STARTED|One Month||32
8636734|NCT04039867|21318181|P1|NOT COMPLETED|Overall Study||0
8636735|NCT04039867|21318181|P1|COMPLETED|Overall Study||17
8636736|NCT04039867|21318181|P1|STARTED|Overall Study||17
8636737|NCT03988803|21318187|P1|NOT COMPLETED|Period 3||0
8636738|NCT03988803|21318187|P1|COMPLETED|Period 3||13
8636739|NCT03988803|21318187|P1|STARTED|Period 3||13
8636740|NCT03988803|21318187|P1|NOT COMPLETED|Period 2||3
8636741|NCT03988803|21318187|P1|COMPLETED|Period 2||13
8636742|NCT03988803|21318187|P1|Started Days 22 - 35: Multiple Doses of 20 mg Memantine qd|Period 2||13
8636743|NCT03988803|21318187|P1|Started Days 15 - 21: Multiple Doses of 15 mg Memantine qd|Period 2||13
8636744|NCT03988803|21318187|P1|Started Days 8 - 14: Multiple Doses of 10 mg Memantine qd|Period 2||14
8636745|NCT03988803|21318187|P1|Started Days 1 - 7: Multiple Doses of 5 mg Memantine qd|Period 2||15
8636746|NCT03988803|21318187|P1|Treated|Period 2||15
8636747|NCT03988803|21318187|P1|STARTED|Period 2||16
8636748|NCT03988803|21318187|P1|NOT COMPLETED|Period 1||0
8636749|NCT03988803|21318187|P1|COMPLETED|Period 1||16
8636750|NCT03988803|21318187|P1|STARTED|Period 1||16
8636751|NCT03988803|21318187|P1|NOT COMPLETED|Screening||0
8636752|NCT03988803|21318187|P1|COMPLETED|Screening||16
8636753|NCT03988803|21318187|P1|STARTED|Screening||16
8636754|NCT03937791|21318200|P1|NOT COMPLETED|Overall Study||0
8636755|NCT03937791|21318200|P1|COMPLETED|Overall Study||1
8636756|NCT03937791|21318200|P1|STARTED|Overall Study||1
8636757|NCT03895307|21318210|P4|NOT COMPLETED|Overall Study||0
8636758|NCT03895307|21318211|P3|NOT COMPLETED|Overall Study||2
8636759|NCT03895307|21318212|P2|NOT COMPLETED|Overall Study||0
8636760|NCT03895307|21318213|P1|NOT COMPLETED|Overall Study||2
8636761|NCT03895307|21318210|P4|COMPLETED|Overall Study||21
8636762|NCT03895307|21318211|P3|COMPLETED|Overall Study||20
8636763|NCT03895307|21318212|P2|COMPLETED|Overall Study||20
8636764|NCT03895307|21318213|P1|COMPLETED|Overall Study||19
8636765|NCT03895307|21318210|P4|STARTED|Overall Study||21
8636766|NCT03895307|21318211|P3|STARTED|Overall Study||22
8636767|NCT03895307|21318212|P2|STARTED|Overall Study||20
8636768|NCT03895307|21318213|P1|STARTED|Overall Study||21
8636769|NCT03873987|21318301|P2|NOT COMPLETED|Overall Study||1
8636770|NCT03873987|21318302|P1|NOT COMPLETED|Overall Study||2
8636771|NCT03873987|21318301|P2|COMPLETED|Overall Study||49
8636772|NCT03873987|21318302|P1|COMPLETED|Overall Study||50
8636773|NCT03873987|21318301|P2|STARTED|Overall Study||50
8636774|NCT03873987|21318302|P1|STARTED|Overall Study||52
8636775|NCT03776539|21318316|P4|NOT COMPLETED|Overall Study||0
8636776|NCT03776539|21318317|P3|NOT COMPLETED|Overall Study||0
8636777|NCT03776539|21318318|P2|NOT COMPLETED|Overall Study||0
8636778|NCT03776539|21318319|P1|NOT COMPLETED|Overall Study||0
8636779|NCT03776539|21318316|P4|COMPLETED|Overall Study||6
8636780|NCT03776539|21318317|P3|COMPLETED|Overall Study||6
8636781|NCT03776539|21318318|P2|COMPLETED|Overall Study||6
8636782|NCT03776539|21318319|P1|COMPLETED|Overall Study||6
8636783|NCT03776539|21318316|P4|STARTED|Overall Study||6
8636784|NCT03776539|21318317|P3|STARTED|Overall Study||6
8636785|NCT03776539|21318318|P2|STARTED|Overall Study||6
8636786|NCT03776539|21318319|P1|STARTED|Overall Study||6
8636787|NCT03690375|21318355|P2|NOT COMPLETED|Overall Study||0
8636788|NCT03690375|21318356|P1|NOT COMPLETED|Overall Study||0
8636789|NCT03690375|21318355|P2|COMPLETED|Overall Study||10
8636790|NCT03690375|21318356|P1|COMPLETED|Overall Study||10
8636791|NCT03690375|21318355|P2|STARTED|Overall Study||10
8636792|NCT03690375|21318356|P1|STARTED|Overall Study||10
8636793|NCT03635775|21318371|P4|NOT COMPLETED|Overall Study||1
8636794|NCT03635775|21318372|P3|NOT COMPLETED|Overall Study||0
8636795|NCT03635775|21318373|P2|NOT COMPLETED|Overall Study||0
8636796|NCT03635775|21318374|P1|NOT COMPLETED|Overall Study||0
8636797|NCT03635775|21318371|P4|COMPLETED|Overall Study||9
8636798|NCT03635775|21318372|P3|COMPLETED|Overall Study||5
8636799|NCT03635775|21318373|P2|COMPLETED|Overall Study||0
8636800|NCT03635775|21318374|P1|COMPLETED|Overall Study||5
8636801|NCT03635775|21318371|P4|STARTED|Overall Study||10
8636802|NCT03635775|21318372|P3|STARTED|Overall Study||5
8636804|NCT03635775|21318374|P1|STARTED|Overall Study||5
8636805|NCT03604523|21318390|P2|NOT COMPLETED|Overall Study||0
8636806|NCT03604523|21318391|P1|NOT COMPLETED|Overall Study||1
8636807|NCT03604523|21318390|P2|COMPLETED|Overall Study||5
8636808|NCT03604523|21318391|P1|COMPLETED|Overall Study||4
8636809|NCT03604523|21318390|P2|STARTED|Overall Study||5
8636810|NCT03604523|21318391|P1|STARTED|Overall Study||5
8636811|NCT03555435|21318406|P3|NOT COMPLETED|Overall Study||8
8636812|NCT03555435|21318407|P2|NOT COMPLETED|Overall Study||19
8636813|NCT03555435|21318408|P1|NOT COMPLETED|Overall Study||17
8636814|NCT03555435|21318406|P3|COMPLETED|Overall Study||18
8636815|NCT03555435|21318407|P2|COMPLETED|Overall Study||8
8636816|NCT03555435|21318408|P1|COMPLETED|Overall Study||11
8636817|NCT03555435|21318406|P3|STARTED|Overall Study||26
8636818|NCT03555435|21318407|P2|STARTED|Overall Study||27
8636819|NCT03555435|21318408|P1|STARTED|Overall Study||28
8636820|NCT03512457|21318441|P2|NOT COMPLETED|Overall Study||40
8636821|NCT03512457|21318442|P1|NOT COMPLETED|Overall Study||34
8636822|NCT03512457|21318441|P2|COMPLETED|Overall Study||185
8636823|NCT03512457|21318442|P1|COMPLETED|Overall Study||161
8636824|NCT03512457|21318441|P2|STARTED|Overall Study||225
8636825|NCT03512457|21318442|P1|STARTED|Overall Study||195
8636826|NCT03509350|21318452|P2|NOT COMPLETED|Overall Study||2
8636827|NCT03509350|21318453|P1|NOT COMPLETED|Overall Study||0
8636828|NCT03509350|21318452|P2|COMPLETED|Overall Study||247
8636829|NCT03509350|21318453|P1|COMPLETED|Overall Study||252
8636830|NCT03509350|21318452|P2|STARTED|Overall Study||249
8636831|NCT03509350|21318453|P1|STARTED|Overall Study||252
8636832|NCT03503162|21318495|P1|NOT COMPLETED|Overall Study||1
8636833|NCT03503162|21318495|P1|COMPLETED|Overall Study||94
8636834|NCT03503162|21318495|P1|STARTED|Overall Study||95
8636835|NCT03488225|21318499|P1|NOT COMPLETED|Overall Study||4
8636836|NCT03488225|21318499|P1|COMPLETED|Overall Study||0
8636837|NCT03488225|21318499|P1|STARTED|Overall Study||4
8636838|NCT03452527|21318509|P2|NOT COMPLETED|Overall Study||4
8636839|NCT03452527|21318510|P1|NOT COMPLETED|Overall Study||3
8636840|NCT03452527|21318509|P2|COMPLETED|Overall Study||4
8636841|NCT03452527|21318510|P1|COMPLETED|Overall Study||4
8636842|NCT03452527|21318509|P2|STARTED|Overall Study||8
8636843|NCT03452527|21318510|P1|STARTED|Overall Study||7
8636844|NCT03382821|21318520|P2|NOT COMPLETED|Overall Study||3
8636845|NCT03382821|21318521|P1|NOT COMPLETED|Overall Study||0
8636846|NCT03382821|21318520|P2|COMPLETED|Overall Study||57
8636847|NCT03382821|21318521|P1|COMPLETED|Overall Study||60
8636848|NCT03382821|21318520|P2|STARTED|Overall Study||60
8636849|NCT03382821|21318521|P1|STARTED|Overall Study||60
8636850|NCT03332459|21318536|P3|NOT COMPLETED|Overall Study||0
8636851|NCT03332459|21318537|P2|NOT COMPLETED|Overall Study||0
8636852|NCT03332459|21318538|P1|NOT COMPLETED|Overall Study||0
8636853|NCT03332459|21318536|P3|COMPLETED|Overall Study||3
8636854|NCT03332459|21318537|P2|COMPLETED|Overall Study||1
8636855|NCT03332459|21318538|P1|COMPLETED|Overall Study||3
8636856|NCT03332459|21318536|P3|STARTED|Overall Study||3
8636857|NCT03332459|21318537|P2|STARTED|Overall Study||1
8636858|NCT03332459|21318538|P1|STARTED|Overall Study||3
8636859|NCT03285477|21318569|P2|NOT COMPLETED|Recurrence Follow-up Period||55
8636860|NCT03285477|21318570|P1|NOT COMPLETED|Recurrence Follow-up Period||6
8636861|NCT03285477|21318569|P2|COMPLETED|Recurrence Follow-up Period||22
8636862|NCT03285477|21318570|P1|COMPLETED|Recurrence Follow-up Period||2
8636863|NCT03285477|21318569|P2|STARTED|Recurrence Follow-up Period||77
8636864|NCT03285477|21318570|P1|STARTED|Recurrence Follow-up Period||8
8636865|NCT03285477|21318569|P2|NOT COMPLETED|Treatment and Response Assessment Period||0
8636866|NCT03285477|21318570|P1|NOT COMPLETED|Treatment and Response Assessment Period||2
8636867|NCT03285477|21318569|P2|COMPLETED|Treatment and Response Assessment Period||175
8636868|NCT03285477|21318570|P1|COMPLETED|Treatment and Response Assessment Period||174
8636869|NCT03285477|21318569|P2|STARTED|Treatment and Response Assessment Period||175
8636870|NCT03285477|21318570|P1|STARTED|Treatment and Response Assessment Period||176
8636871|NCT03255941|21318601|P4|NOT COMPLETED|Overall Study||6
8636872|NCT03255941|21318602|P3|NOT COMPLETED|Overall Study||5
8636873|NCT03255941|21318603|P2|NOT COMPLETED|Overall Study||46
8636874|NCT03255941|21318604|P1|NOT COMPLETED|Overall Study||38
8636875|NCT03255941|21318601|P4|COMPLETED|Overall Study||46
8636876|NCT03255941|21318602|P3|COMPLETED|Overall Study||48
8636877|NCT03255941|21318603|P2|COMPLETED|Overall Study||132
8636878|NCT03255941|21318604|P1|COMPLETED|Overall Study||139
8636879|NCT03255941|21318601|P4|Deemed Eligible to Receive DMPA|Overall Study||46
8636880|NCT03255941|21318602|P3|Deemed Eligible to Receive DMPA|Overall Study||48
8636881|NCT03255941|21318603|P2|Deemed Eligible to Receive DMPA|Overall Study||134
8636882|NCT03255941|21318604|P1|Deemed Eligible to Receive DMPA|Overall Study||140
8636883|NCT03255941|21318601|P4|STARTED|Overall Study||52
8636884|NCT03255941|21318602|P3|STARTED|Overall Study||53
8636885|NCT03255941|21318603|P2|STARTED|Overall Study||178
8636886|NCT03255941|21318604|P1|STARTED|Overall Study||177
8636887|NCT03242759|21318628|P2|NOT COMPLETED|Overall Study||7
8636888|NCT03242759|21318629|P1|NOT COMPLETED|Overall Study||35
8636889|NCT03242759|21318628|P2|COMPLETED|Overall Study||6
8636890|NCT03242759|21318629|P1|COMPLETED|Overall Study||53
8636891|NCT03242759|21318628|P2|STARTED|Overall Study||13
8636892|NCT03242759|21318629|P1|STARTED|Overall Study||88
8636893|NCT03111407|21318673|P2|NOT COMPLETED|Overall Study||1
8636894|NCT03111407|21318674|P1|NOT COMPLETED|Overall Study||1
8636895|NCT03111407|21318673|P2|COMPLETED|Overall Study||26
8636896|NCT03111407|21318674|P1|COMPLETED|Overall Study||44
8636897|NCT03111407|21318673|P2|STARTED|Overall Study||27
8636898|NCT03111407|21318674|P1|STARTED|Overall Study||45
8636911|NCT02929823|21318733|P3|NOT COMPLETED|Overall Study||4
8636912|NCT02929823|21318734|P2|NOT COMPLETED|Overall Study||6
8636913|NCT02929823|21318735|P1|NOT COMPLETED|Overall Study||3
8636914|NCT02929823|21318733|P3|COMPLETED|Overall Study||38
8636915|NCT02929823|21318734|P2|COMPLETED|Overall Study||40
8636916|NCT02929823|21318735|P1|COMPLETED|Overall Study||39
8636917|NCT02929823|21318733|P3|STARTED|Overall Study||42
8636918|NCT02929823|21318734|P2|STARTED|Overall Study||46
8636919|NCT02929823|21318735|P1|STARTED|Overall Study||42
8636920|NCT02910674|21318743|P1|NOT COMPLETED|Overall Study||0
8636921|NCT02910674|21318743|P1|COMPLETED|Overall Study||102
8636922|NCT02910674|21318743|P1|STARTED|Overall Study||102
8636923|NCT02875392|21318752|P2|NOT COMPLETED|Overall Study||8
8636924|NCT02875392|21318753|P1|NOT COMPLETED|Overall Study||7
8636925|NCT02875392|21318752|P2|COMPLETED|Overall Study||21
8636926|NCT02875392|21318753|P1|COMPLETED|Overall Study||21
8636927|NCT02875392|21318752|P2|STARTED|Overall Study||29
8636928|NCT02875392|21318753|P1|STARTED|Overall Study||28
8636929|NCT02808819|21318765|P2|NOT COMPLETED|Overall Study||31
8636930|NCT02808819|21318766|P1|NOT COMPLETED|Overall Study||31
8636931|NCT02808819|21318765|P2|COMPLETED|Overall Study||195
8636932|NCT02808819|21318766|P1|COMPLETED|Overall Study||189
8636933|NCT02808819|21318765|P2|Treated|Overall Study||226
8636934|NCT02808819|21318766|P1|Treated|Overall Study||220
8636935|NCT02808819|21318765|P2|STARTED|Overall Study||226
8636936|NCT02808819|21318766|P1|STARTED|Overall Study||220
8636937|NCT02737826|21318821|P3|NOT COMPLETED|Phase II - Randomization + Taper||14
8636938|NCT02737826|21318822|P2|NOT COMPLETED|Phase II - Randomization + Taper||12
8636939|NCT02737826|21318823|P1|NOT COMPLETED|Phase II - Randomization + Taper||0
8636940|NCT02737826|21318821|P3|COMPLETED|Phase II - Randomization + Taper||0
8636941|NCT02737826|21318822|P2|COMPLETED|Phase II - Randomization + Taper||1
8636942|NCT02737826|21318823|P1|COMPLETED|Phase II - Randomization + Taper||0
8636943|NCT02737826|21318821|P3|STARTED|Phase II - Randomization + Taper||14
8636944|NCT02737826|21318822|P2|STARTED|Phase II - Randomization + Taper||13
8636945|NCT02737826|21318823|P1|STARTED|Phase II - Randomization + Taper||0
8636946|NCT02737826|21318821|P3|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
8636947|NCT02737826|21318822|P2|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
8636948|NCT02737826|21318823|P1|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
8636949|NCT02737826|21318821|P3|COMPLETED|Phase I - Buprenorphine Initiation||0
8636950|NCT02737826|21318822|P2|COMPLETED|Phase I - Buprenorphine Initiation||0
8636951|NCT02737826|21318823|P1|COMPLETED|Phase I - Buprenorphine Initiation||27
8636952|NCT02737826|21318821|P3|STARTED|Phase I - Buprenorphine Initiation||0
8636953|NCT02737826|21318822|P2|STARTED|Phase I - Buprenorphine Initiation||0
8636954|NCT02737826|21318823|P1|STARTED|Phase I - Buprenorphine Initiation||27
8636955|NCT02699983|21318834|P2|NOT COMPLETED|Overall Study||0
8636956|NCT02699983|21318835|P1|NOT COMPLETED|Overall Study||1
8636957|NCT02699983|21318834|P2|COMPLETED|Overall Study||17
8636958|NCT02699983|21318835|P1|COMPLETED|Overall Study||17
8636959|NCT02699983|21318834|P2|STARTED|Overall Study||17
8636960|NCT02699983|21318835|P1|STARTED|Overall Study||18
8636961|NCT02615171|21318897|P2|NOT COMPLETED|Overall Study||1
8636962|NCT02615171|21318898|P1|NOT COMPLETED|Overall Study||2
8636963|NCT02615171|21318897|P2|COMPLETED|Overall Study||31
8636964|NCT02615171|21318898|P1|COMPLETED|Overall Study||30
8636965|NCT02615171|21318897|P2|STARTED|Overall Study||32
8636966|NCT02615171|21318898|P1|STARTED|Overall Study||32
8636979|NCT02558231|21318947|P2|NOT COMPLETED|Overall Study||26
8636980|NCT02558231|21318948|P1|NOT COMPLETED|Overall Study||25
8636981|NCT02558231|21318947|P2|COMPLETED|Overall Study||98
8636982|NCT02558231|21318948|P1|COMPLETED|Overall Study||98
8636983|NCT02558231|21318947|P2|Treated|Overall Study||123
8636984|NCT02558231|21318948|P1|Treated|Overall Study||123
8636985|NCT02558231|21318947|P2|STARTED|Overall Study||124
8636986|NCT02558231|21318948|P1|STARTED|Overall Study||123
8636987|NCT02452866|21318972|P1|NOT COMPLETED|Overall Study||4
8636988|NCT02452866|21318972|P1|COMPLETED|Overall Study||321
8636989|NCT02452866|21318972|P1|STARTED|Overall Study||325
8636990|NCT02431364|21318981|P5|NOT COMPLETED|Overall Study||0
8636991|NCT02431364|21318982|P4|NOT COMPLETED|Overall Study||1
8636992|NCT02431364|21318983|P3|NOT COMPLETED|Overall Study||0
8636993|NCT02431364|21318984|P2|NOT COMPLETED|Overall Study||1
8636994|NCT02431364|21318985|P1|NOT COMPLETED|Overall Study||0
8636995|NCT02431364|21318981|P5|COMPLETED|Overall Study||6
8636996|NCT02431364|21318982|P4|COMPLETED|Overall Study||6
8636997|NCT02431364|21318983|P3|COMPLETED|Overall Study||6
8636998|NCT02431364|21318984|P2|COMPLETED|Overall Study||5
8636999|NCT02431364|21318985|P1|COMPLETED|Overall Study||8
8637000|NCT02431364|21318981|P5|Treated|Overall Study||6
8637001|NCT02431364|21318982|P4|Treated|Overall Study||6
8637002|NCT02431364|21318983|P3|Treated|Overall Study||6
8637003|NCT02431364|21318984|P2|Treated|Overall Study||6
8637004|NCT02431364|21318985|P1|Treated|Overall Study||8
8637005|NCT02431364|21318981|P5|STARTED|Overall Study||6
8637006|NCT02431364|21318982|P4|STARTED|Overall Study||7
8637007|NCT02431364|21318983|P3|STARTED|Overall Study||6
8637008|NCT02431364|21318984|P2|STARTED|Overall Study||6
8637009|NCT02431364|21318985|P1|STARTED|Overall Study||8
8637016|NCT02418845|21319127|P2|NOT COMPLETED|Overall Study||12
8637017|NCT02418845|21319128|P1|NOT COMPLETED|Overall Study||16
8637018|NCT02418845|21319127|P2|COMPLETED|Overall Study||52
8637019|NCT02418845|21319128|P1|COMPLETED|Overall Study||109
8637020|NCT02418845|21319127|P2|STARTED|Overall Study||64
8637021|NCT02418845|21319128|P1|STARTED|Overall Study||125
8637022|NCT02367794|21319145|P3|NOT COMPLETED|Overall Study||249
8637023|NCT02367794|21319146|P2|NOT COMPLETED|Overall Study||240
8637024|NCT02367794|21319147|P1|NOT COMPLETED|Overall Study||258
8637025|NCT02367794|21319145|P3|COMPLETED|Overall Study||89
8637026|NCT02367794|21319146|P2|COMPLETED|Overall Study||103
8637027|NCT02367794|21319147|P1|COMPLETED|Overall Study||82
8637028|NCT02367794|21319145|P3|STARTED|Overall Study||338
8637029|NCT02367794|21319146|P2|STARTED|Overall Study||343
8637030|NCT02367794|21319147|P1|STARTED|Overall Study||340
8637054|NCT02041923|21319227|P2|NOT COMPLETED|Overall Study||30
8637055|NCT02041923|21319228|P1|NOT COMPLETED|Overall Study||26
8637056|NCT02041923|21319227|P2|COMPLETED|Overall Study||66
8637057|NCT02041923|21319228|P1|COMPLETED|Overall Study||76
8637058|NCT02041923|21319227|P2|STARTED|Overall Study||96
8637059|NCT02041923|21319228|P1|STARTED|Overall Study||102
8637072|NCT01965327|21319311|P1|NOT COMPLETED|Overall Study||2
8637073|NCT01965327|21319311|P1|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
8637074|NCT01965327|21319311|P1|STARTED|Overall Study||12
8637201|NCT01859403|21319346|P2|NOT COMPLETED|Secondary Endpoint Measure||8
8637202|NCT01859403|21319347|P1|NOT COMPLETED|Secondary Endpoint Measure||6
8637203|NCT01859403|21319346|P2|COMPLETED|Secondary Endpoint Measure||18
8637204|NCT01859403|21319347|P1|COMPLETED|Secondary Endpoint Measure||14
8637205|NCT01859403|21319346|P2|STARTED|Secondary Endpoint Measure||26
8637206|NCT01859403|21319347|P1|STARTED|Secondary Endpoint Measure||20
8637207|NCT01859403|21319346|P2|NOT COMPLETED|Primary Endpoint Measure||4
8637208|NCT01859403|21319347|P1|NOT COMPLETED|Primary Endpoint Measure||1
8637209|NCT01859403|21319346|P2|COMPLETED|Primary Endpoint Measure||26
8637210|NCT01859403|21319347|P1|COMPLETED|Primary Endpoint Measure||20
8637211|NCT01859403|21319346|P2|STARTED|Primary Endpoint Measure||30
8637212|NCT01859403|21319347|P1|STARTED|Primary Endpoint Measure||21
8637213|NCT01815736|21319357|P2|NOT COMPLETED|Extension Treatment Phase- After Week 96||26
8637214|NCT01815736|21319358|P1|NOT COMPLETED|Extension Treatment Phase- After Week 96||51
8637215|NCT01815736|21319357|P2|COMPLETED|Extension Treatment Phase- After Week 96||398
8637216|NCT01815736|21319358|P1|COMPLETED|Extension Treatment Phase- After Week 96||854
8637217|NCT01815736|21319357|P2|STARTED|Extension Treatment Phase- After Week 96|21 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|424
8637218|NCT01815736|21319358|P1|STARTED|Extension Treatment Phase- After Week 96|9 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|905
8637219|NCT01815736|21319357|P2|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||35
8637220|NCT01815736|21319358|P1|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||49
8637221|NCT01815736|21319357|P2|COMPLETED|Randomized Treatment Phase-Up to Week 96||445
8637222|NCT01815736|21319358|P1|COMPLETED|Randomized Treatment Phase-Up to Week 96||914
8637223|NCT01815736|21319357|P2|STARTED|Randomized Treatment Phase-Up to Week 96||480
8637224|NCT01815736|21319358|P1|STARTED|Randomized Treatment Phase-Up to Week 96||963
8637225|NCT01739309|21319384|P1|NOT COMPLETED|Overall Study||3
8637226|NCT01739309|21319384|P1|COMPLETED|Overall Study||25
8637227|NCT01739309|21319384|P1|Alive and on Study, Off Treatment|Overall Study||8
8637228|NCT01739309|21319384|P1|Death Due to Any Cause|Overall Study||17
8637229|NCT01739309|21319384|P1|Received at Least One Dose of Study Drug|Overall Study||28
8637230|NCT01739309|21319384|P1|STARTED|Overall Study||28
8637231|NCT01703988|21319405|P4|NOT COMPLETED|Overall Study||1
8637232|NCT01703988|21319406|P3|NOT COMPLETED|Overall Study||0
8637233|NCT01703988|21319407|P2|NOT COMPLETED|Overall Study||0
8637234|NCT01703988|21319408|P1|NOT COMPLETED|Overall Study||0
8637235|NCT01703988|21319405|P4|COMPLETED|Overall Study||8
8637236|NCT01703988|21319406|P3|COMPLETED|Overall Study||9
8637237|NCT01703988|21319407|P2|COMPLETED|Overall Study||8
8637238|NCT01703988|21319408|P1|COMPLETED|Overall Study||8
8637239|NCT01703988|21319405|P4|STARTED|Overall Study||9
8637240|NCT01703988|21319406|P3|STARTED|Overall Study||9
8637241|NCT01703988|21319407|P2|STARTED|Overall Study||8
8637242|NCT01703988|21319408|P1|STARTED|Overall Study||8
8637243|NCT01690910|21319437|P2|NOT COMPLETED|Overall Study||0
8637244|NCT01690910|21319438|P1|NOT COMPLETED|Overall Study||0
8637245|NCT01690910|21319437|P2|COMPLETED|Overall Study||0
8637246|NCT01690910|21319438|P1|COMPLETED|Overall Study||0
8637247|NCT01690910|21319437|P2|STARTED|Overall Study||0
8637248|NCT01690910|21319438|P1|STARTED|Overall Study|The study was never completed due to feasibility issues.|0
8637249|NCT01685411|21319446|P1|NOT COMPLETED|Overall Study||0
8637250|NCT01685411|21319446|P1|COMPLETED|Overall Study||5
8637251|NCT01685411|21319446|P1|STARTED|Overall Study||5
8637252|NCT01626885|21319464|P1|NOT COMPLETED|Overall Study||12
8637253|NCT01626885|21319464|P1|COMPLETED|Overall Study||30
8637254|NCT01626885|21319464|P1|STARTED|Overall Study||42
8637255|NCT01625897|21319470|P2|NOT COMPLETED|Overall Study||14
8637256|NCT01625897|21319471|P1|NOT COMPLETED|Overall Study||52
8637257|NCT01625897|21319470|P2|COMPLETED|Overall Study||28
8637258|NCT01625897|21319471|P1|COMPLETED|Overall Study||31
8637259|NCT01625897|21319470|P2|STARTED|Overall Study||42
8637260|NCT01625897|21319471|P1|STARTED|Overall Study||83
8637271|NCT01607073|21319506|P1|NOT COMPLETED|Overall Study||1
8637272|NCT01607073|21319506|P1|COMPLETED|Overall Study||1
8637273|NCT01607073|21319506|P1|STARTED|Overall Study||2
8637274|NCT01562028|21319517|P2|NOT COMPLETED|Overall Study||2
8637275|NCT01562028|21319518|P1|NOT COMPLETED|Overall Study||3
8637276|NCT01562028|21319517|P2|COMPLETED|Overall Study||70
8637277|NCT01562028|21319518|P1|COMPLETED|Overall Study||34
8637278|NCT01562028|21319517|P2|STARTED|Overall Study||72
8637279|NCT01562028|21319518|P1|STARTED|Overall Study||37
8637379|NCT01253668|21319675|P1|NOT COMPLETED|Overall Study||0
8637380|NCT01253668|21319675|P1|COMPLETED|Overall Study||0
8637381|NCT01253668|21319675|P1|STARTED|Overall Study||0
8637390|NCT01217060|21319701|P1|NOT COMPLETED|Overall Study||1
8637391|NCT01217060|21319701|P1|COMPLETED|Overall Study||3
8637392|NCT01217060|21319701|P1|STARTED|Overall Study||4
8637393|NCT01164228|21319708|P2|NOT COMPLETED|Overall Study||38
8637394|NCT01164228|21319709|P1|NOT COMPLETED|Overall Study||44
8637395|NCT01164228|21319708|P2|COMPLETED|Overall Study||2
8637396|NCT01164228|21319709|P1|COMPLETED|Overall Study||3
8637397|NCT01164228|21319708|P2|Treated and Eligible Patients|Overall Study||37
8637398|NCT01164228|21319709|P1|Treated and Eligible Patients|Overall Study||45
8637399|NCT01164228|21319708|P2|Receipt of Protocol Therapy|Overall Study||37
8637400|NCT01164228|21319709|P1|Receipt of Protocol Therapy|Overall Study||46
8637401|NCT01164228|21319708|P2|STARTED|Overall Study||40
8637402|NCT01164228|21319709|P1|STARTED|Overall Study||47
8637437|NCT01007994|21319875|P2|NOT COMPLETED|Overall Study||2
8637438|NCT01007994|21319876|P1|NOT COMPLETED|Overall Study||2
8637439|NCT01007994|21319875|P2|COMPLETED|Overall Study||14
8637440|NCT01007994|21319876|P1|COMPLETED|Overall Study||15
8637441|NCT01007994|21319875|P2|STARTED|Overall Study||16
8637442|NCT01007994|21319876|P1|STARTED|Overall Study||17
8637452|NCT00740870|21319913|P1|NOT COMPLETED|Overall Study||21
8637453|NCT00740870|21319913|P1|COMPLETED|Overall Study||150
8637454|NCT00740870|21319913|P1|STARTED|Overall Study||171
8637455|NCT00543777|21319932|P1|NOT COMPLETED|Overall Study||0
8637456|NCT00543777|21319932|P1|COMPLETED|Overall Study||44
8637457|NCT00543777|21319932|P1|STARTED|Overall Study||44
8637458|NCT00438204|21319938|P1|NOT COMPLETED|Overall Study||0
8637459|NCT00438204|21319938|P1|COMPLETED|Overall Study||39
8637460|NCT00438204|21319938|P1|STARTED|Overall Study||39
8637461|NCT00365417|21319946|P1|NOT COMPLETED|Overall Study||0
8637462|NCT00365417|21319946|P1|COMPLETED|Overall Study||45
8637463|NCT00365417|21319946|P1|STARTED|Overall Study||45
8637464|NCT00351611|21319959|P2|NOT COMPLETED|Overall Study||10
8637465|NCT00351611|21319960|P1|NOT COMPLETED|Overall Study||14
8637466|NCT00351611|21319959|P2|COMPLETED|Overall Study||88
8637467|NCT00351611|21319960|P1|COMPLETED|Overall Study||75
8637468|NCT00351611|21319959|P2|Treated|Overall Study||98
8637469|NCT00351611|21319960|P1|Treated|Overall Study||89
8637470|NCT00351611|21319959|P2|STARTED|Overall Study||98
8637471|NCT00351611|21319960|P1|STARTED|Overall Study||89
8637490|NCT04402970|21320021|P2|NOT COMPLETED|Overall Study||0
8637491|NCT04402970|21320022|P1|NOT COMPLETED|Overall Study||0
8637492|NCT04402970|21320021|P2|COMPLETED|Overall Study||20
8637493|NCT04402970|21320022|P1|COMPLETED|Overall Study||10
8637494|NCT04402970|21320021|P2|STARTED|Overall Study||20
8637495|NCT04402970|21320022|P1|STARTED|Overall Study||10
8637496|NCT03874377|21320040|P1|NOT COMPLETED|Overall Study||3
8637497|NCT03874377|21320040|P1|COMPLETED|Overall Study||8
8637498|NCT03874377|21320040|P1|STARTED|Overall Study||11
8637499|NCT03856320|21320053|P2|NOT COMPLETED|Overall Study||2
8637500|NCT03856320|21320054|P1|NOT COMPLETED|Overall Study||0
8637501|NCT03856320|21320053|P2|COMPLETED|Overall Study||20
8637502|NCT03856320|21320054|P1|COMPLETED|Overall Study||20
8637503|NCT03856320|21320053|P2|STARTED|Overall Study||22
8637504|NCT03856320|21320054|P1|STARTED|Overall Study||20
8637505|NCT03712852|21320063|P3|NOT COMPLETED|Overall Study||0
8637506|NCT03712852|21320064|P2|NOT COMPLETED|Overall Study||0
8637507|NCT03712852|21320065|P1|NOT COMPLETED|Overall Study||0
8637508|NCT03712852|21320063|P3|COMPLETED|Overall Study||20
8637509|NCT03712852|21320064|P2|COMPLETED|Overall Study||20
8637510|NCT03712852|21320065|P1|COMPLETED|Overall Study||20
8637511|NCT03712852|21320063|P3|STARTED|Overall Study||20
8637512|NCT03712852|21320064|P2|STARTED|Overall Study||20
8637513|NCT03712852|21320065|P1|STARTED|Overall Study||20
8637514|NCT03602482|21320087|P4|NOT COMPLETED|Overall Study||0
8637515|NCT03602482|21320088|P3|NOT COMPLETED|Overall Study||0
8637516|NCT03602482|21320089|P2|NOT COMPLETED|Overall Study||7
8637517|NCT03602482|21320090|P1|NOT COMPLETED|Overall Study||6
8637518|NCT03602482|21320087|P4|COMPLETED|Overall Study||19
8637519|NCT03602482|21320088|P3|COMPLETED|Overall Study||20
8637520|NCT03602482|21320089|P2|COMPLETED|Overall Study||43
8637521|NCT03602482|21320090|P1|COMPLETED|Overall Study||44
8637522|NCT03602482|21320087|P4|STARTED|Overall Study||19
8637523|NCT03602482|21320088|P3|STARTED|Overall Study||20
8637524|NCT03602482|21320089|P2|STARTED|Overall Study||50
8637525|NCT03602482|21320090|P1|STARTED|Overall Study||50
8637542|NCT03461289|21320136|P1|NOT COMPLETED|Overall Study||1
8637543|NCT03461289|21320136|P1|COMPLETED|Overall Study||32
8637544|NCT03461289|21320136|P1|STARTED|Overall Study||33
8637545|NCT03419403|21320144|P4|NOT COMPLETED|Overall Study||2
8637546|NCT03419403|21320145|P3|NOT COMPLETED|Overall Study||12
8637547|NCT03419403|21320146|P2|NOT COMPLETED|Overall Study||9
8637548|NCT03419403|21320147|P1|NOT COMPLETED|Overall Study||12
8637549|NCT03419403|21320144|P4|COMPLETED|Overall Study||0
8637550|NCT03419403|21320145|P3|COMPLETED|Overall Study||0
8637551|NCT03419403|21320146|P2|COMPLETED|Overall Study||3
8637552|NCT03419403|21320147|P1|COMPLETED|Overall Study||2
8637553|NCT03419403|21320144|P4|STARTED|Overall Study||2
8637554|NCT03419403|21320145|P3|STARTED|Overall Study||12
8637555|NCT03419403|21320146|P2|STARTED|Overall Study||12
8637556|NCT03419403|21320147|P1|STARTED|Overall Study||14
8637557|NCT03376321|21320193|P2|NOT COMPLETED|Overall Study||25
8637558|NCT03376321|21320194|P1|NOT COMPLETED|Overall Study||23
8637559|NCT03376321|21320193|P2|COMPLETED|Overall Study||141
8637560|NCT03376321|21320194|P1|COMPLETED|Overall Study||145
8637561|NCT03376321|21320193|P2|Treated|Overall Study||163
8637562|NCT03376321|21320194|P1|Treated|Overall Study||163
8637563|NCT03376321|21320193|P2|STARTED|Overall Study||166
8637564|NCT03376321|21320194|P1|STARTED|Overall Study||168
8637565|NCT03338400|21320219|P2|NOT COMPLETED|Overall Study||2
8637566|NCT03338400|21320220|P1|NOT COMPLETED|Overall Study||1
8637567|NCT03338400|21320219|P2|COMPLETED|Overall Study||24
8637568|NCT03338400|21320220|P1|COMPLETED|Overall Study||24
8637569|NCT03338400|21320219|P2|STARTED|Overall Study||26
8637570|NCT03338400|21320220|P1|STARTED|Overall Study||25
8637571|NCT03141905|21320236|P2|NOT COMPLETED|Overall Study||19
8637572|NCT03141905|21320237|P1|NOT COMPLETED|Overall Study||24
8637573|NCT03141905|21320236|P2|COMPLETED|Overall Study||147
8637574|NCT03141905|21320237|P1|COMPLETED|Overall Study||152
8637575|NCT03141905|21320236|P2|STARTED|Overall Study||166
8637576|NCT03141905|21320237|P1|STARTED|Overall Study||176
8637577|NCT03095976|21320250|P1|NOT COMPLETED|Overall Study||0
8637578|NCT03095976|21320250|P1|COMPLETED|Overall Study||4
8637579|NCT03095976|21320250|P1|STARTED|Overall Study||4
8637580|NCT03000348|21320261|P6|NOT COMPLETED|Overall Study||2
8637581|NCT03000348|21320262|P5|NOT COMPLETED|Overall Study||5
8637582|NCT03000348|21320263|P4|NOT COMPLETED|Overall Study||3
8637583|NCT03000348|21320264|P3|NOT COMPLETED|Overall Study||4
8637584|NCT03000348|21320265|P2|NOT COMPLETED|Overall Study||4
8637585|NCT03000348|21320266|P1|NOT COMPLETED|Overall Study||3
8637586|NCT03000348|21320261|P6|COMPLETED|Overall Study||13
8637587|NCT03000348|21320262|P5|COMPLETED|Overall Study||11
8637588|NCT03000348|21320263|P4|COMPLETED|Overall Study||12
8637589|NCT03000348|21320264|P3|COMPLETED|Overall Study||11
8637590|NCT03000348|21320265|P2|COMPLETED|Overall Study||7
8637591|NCT03000348|21320266|P1|COMPLETED|Overall Study||14
8637592|NCT03000348|21320261|P6|Day 14 Treatment Period|Overall Study||14
8637593|NCT03000348|21320262|P5|Day 14 Treatment Period|Overall Study||13
8637594|NCT03000348|21320263|P4|Day 14 Treatment Period|Overall Study||14
8637595|NCT03000348|21320264|P3|Day 14 Treatment Period|Overall Study||13
8637596|NCT03000348|21320265|P2|Day 14 Treatment Period|Overall Study||10
8637597|NCT03000348|21320266|P1|Day 14 Treatment Period|Overall Study||17
8637598|NCT03000348|21320261|P6|STARTED|Overall Study||15
8637599|NCT03000348|21320262|P5|STARTED|Overall Study||16
8637600|NCT03000348|21320263|P4|STARTED|Overall Study||15
8637601|NCT03000348|21320264|P3|STARTED|Overall Study||15
8637602|NCT03000348|21320265|P2|STARTED|Overall Study||11
8637603|NCT03000348|21320266|P1|STARTED|Overall Study||17
8637604|NCT02980874|21320360|P2|NOT COMPLETED|Overall Study||102
8637605|NCT02980874|21320361|P1|NOT COMPLETED|Overall Study||103
8637606|NCT02980874|21320360|P2|COMPLETED|Overall Study||127
8637607|NCT02980874|21320361|P1|COMPLETED|Overall Study||128
8637608|NCT02980874|21320360|P2|STARTED|Overall Study||229
8637609|NCT02980874|21320361|P1|STARTED|Overall Study||231
8637610|NCT02899299|21320373|P2|NOT COMPLETED|Treatment||284
8637611|NCT02899299|21320374|P1|NOT COMPLETED|Treatment||295
8637612|NCT02899299|21320373|P2|COMPLETED|Treatment||0
8637613|NCT02899299|21320374|P1|COMPLETED|Treatment||5
8637614|NCT02899299|21320373|P2|STARTED|Treatment||284
8637615|NCT02899299|21320374|P1|STARTED|Treatment||300
8637616|NCT02899299|21320373|P2|NOT COMPLETED|Pre-treatment||18
8637617|NCT02899299|21320374|P1|NOT COMPLETED|Pre-treatment||3
8637618|NCT02899299|21320373|P2|COMPLETED|Pre-treatment||284
8637619|NCT02899299|21320374|P1|COMPLETED|Pre-treatment||300
8637620|NCT02899299|21320373|P2|STARTED|Pre-treatment||302
8637621|NCT02899299|21320374|P1|STARTED|Pre-treatment||303
8637630|NCT02838628|21320413|P2|NOT COMPLETED|Recurrence Follow-up Period||17
8637631|NCT02838628|21320414|P1|NOT COMPLETED|Recurrence Follow-up Period||20
8637632|NCT02838628|21320413|P2|COMPLETED|Recurrence Follow-up Period||10
8637633|NCT02838628|21320414|P1|COMPLETED|Recurrence Follow-up Period||16
8637634|NCT02838628|21320413|P2|STARTED|Recurrence Follow-up Period||27
8637635|NCT02838628|21320414|P1|STARTED|Recurrence Follow-up Period||36
8637636|NCT02838628|21320413|P2|NOT COMPLETED|Treatment and Follow-up Period||0
8637637|NCT02838628|21320414|P1|NOT COMPLETED|Treatment and Follow-up Period||0
8637638|NCT02838628|21320413|P2|COMPLETED|Treatment and Follow-up Period||84
8637639|NCT02838628|21320414|P1|COMPLETED|Treatment and Follow-up Period||84
8637640|NCT02838628|21320413|P2|STARTED|Treatment and Follow-up Period||84
8637641|NCT02838628|21320414|P1|STARTED|Treatment and Follow-up Period||84
8637642|NCT02796755|21320448|P2|NOT COMPLETED|Overall Study||0
8637643|NCT02796755|21320449|P1|NOT COMPLETED|Overall Study||2
8637644|NCT02796755|21320448|P2|COMPLETED|Overall Study||15
8637645|NCT02796755|21320449|P1|COMPLETED|Overall Study||13
8637646|NCT02796755|21320448|P2|STARTED|Overall Study||15
8637647|NCT02796755|21320449|P1|STARTED|Overall Study||15
8637648|NCT02793622|21320461|P2|NOT COMPLETED|Overall Study||42
8637649|NCT02793622|21320462|P1|NOT COMPLETED|Overall Study||53
8637650|NCT02793622|21320461|P2|COMPLETED|Overall Study||349
8637651|NCT02793622|21320462|P1|COMPLETED|Overall Study||338
8637652|NCT02793622|21320461|P2|STARTED|Overall Study||391
8637653|NCT02793622|21320462|P1|STARTED|Overall Study||391
8637654|NCT02707757|21320496|P2|NOT COMPLETED|Overall Study||12
8637655|NCT02707757|21320497|P1|NOT COMPLETED|Overall Study||12
8637656|NCT02707757|21320496|P2|COMPLETED|Overall Study||84
8637657|NCT02707757|21320497|P1|COMPLETED|Overall Study||76
8637658|NCT02707757|21320496|P2|STARTED|Overall Study||96
8637659|NCT02707757|21320497|P1|STARTED|Overall Study||88
8637660|NCT02670382|21320503|P2|NOT COMPLETED|Second Active Intervention||0
8637661|NCT02670382|21320504|P1|NOT COMPLETED|Second Active Intervention||0
8637662|NCT02670382|21320503|P2|COMPLETED|Second Active Intervention||11
8637663|NCT02670382|21320504|P1|COMPLETED|Second Active Intervention||10
8637664|NCT02670382|21320503|P2|STARTED|Second Active Intervention||11
8637665|NCT02670382|21320504|P1|STARTED|Second Active Intervention||10
8637666|NCT02670382|21320503|P2|NOT COMPLETED|First Active Intervention||0
8637667|NCT02670382|21320504|P1|NOT COMPLETED|First Active Intervention||0
8637668|NCT02670382|21320503|P2|COMPLETED|First Active Intervention||11
8637669|NCT02670382|21320504|P1|COMPLETED|First Active Intervention||10
8637670|NCT02670382|21320503|P2|STARTED|First Active Intervention|Only 11 of the 12 enrolled subjects randomized to receive DHA as the first supplementation completed the lead-in placebo phase and then entered the EDHA supplementation phase.|11
8637671|NCT02670382|21320504|P1|STARTED|First Active Intervention|Only 10 of the 12 enrolled subjects randomized to receive EPA as the first supplementation completed the lead-in placebo phase and then entered the EPA supplementation phase.|10
8637672|NCT02670382|21320503|P2|NOT COMPLETED|Placebo lead-in Phase||1
8637673|NCT02670382|21320504|P1|NOT COMPLETED|Placebo lead-in Phase||2
8637674|NCT02670382|21320503|P2|COMPLETED|Placebo lead-in Phase|One enrolled subjects randomized to receive EDHA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 11 subjects continued to the DHA and then EPA supplementation phases. No data were collected from this subject.|11
8637675|NCT02670382|21320504|P1|COMPLETED|Placebo lead-in Phase|Two enrolled subjects randomized to receive EPA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 10 subjects continued to the EPA and then DHA supplementation phases. No data were collected from these two subjects.|10
8637676|NCT02670382|21320503|P2|STARTED|Placebo lead-in Phase||12
8637677|NCT02670382|21320504|P1|STARTED|Placebo lead-in Phase||12
8637690|NCT02554656|21320568|P1|NOT COMPLETED|Overall Study||3
8637691|NCT02554656|21320568|P1|COMPLETED|Overall Study||86
8637692|NCT02554656|21320568|P1|STARTED|Overall Study||89
8637793|NCT02318134|21320845|P2|NOT COMPLETED|Overall Study||1
8637794|NCT02318134|21320846|P1|NOT COMPLETED|Overall Study||2
8637795|NCT02318134|21320845|P2|COMPLETED|Overall Study||29
8637796|NCT02318134|21320846|P1|COMPLETED|Overall Study||28
8637797|NCT02318134|21320845|P2|STARTED|Overall Study||30
8637798|NCT02318134|21320846|P1|STARTED|Overall Study||30
8637874|NCT02041494|21321199|P2|NOT COMPLETED|Overall Study||20
8637875|NCT02041494|21321200|P1|NOT COMPLETED|Overall Study||19
8637876|NCT02041494|21321199|P2|COMPLETED|Overall Study||63
8637877|NCT02041494|21321200|P1|COMPLETED|Overall Study||63
8637878|NCT02041494|21321199|P2|STARTED|Overall Study||83
8637879|NCT02041494|21321200|P1|STARTED|Overall Study||82
8637880|NCT02030015|21321212|P1|NOT COMPLETED|Overall Study||16
8637881|NCT02030015|21321212|P1|COMPLETED|Overall Study||0
8637882|NCT02030015|21321212|P1|STARTED|Overall Study||16
8637883|NCT01950169|21321220|P3|NOT COMPLETED|Overall Study||1
8637884|NCT01950169|21321221|P2|NOT COMPLETED|Overall Study||8
8637885|NCT01950169|21321222|P1|NOT COMPLETED|Overall Study||3
8637886|NCT01950169|21321220|P3|COMPLETED|Overall Study||24
8637887|NCT01950169|21321221|P2|COMPLETED|Overall Study||18
8637888|NCT01950169|21321222|P1|COMPLETED|Overall Study||25
8637889|NCT01950169|21321220|P3|STARTED|Overall Study||25
8637890|NCT01950169|21321221|P2|STARTED|Overall Study||26
8637891|NCT01950169|21321222|P1|STARTED|Overall Study||28
8637892|NCT01945580|21321241|P2|NOT COMPLETED|Overall Study||84
8637893|NCT01945580|21321242|P1|NOT COMPLETED|Overall Study||52
8637894|NCT01945580|21321241|P2|COMPLETED|Overall Study||401
8637895|NCT01945580|21321242|P1|COMPLETED|Overall Study||176
8637896|NCT01945580|21321241|P2|STARTED|Overall Study||485
8637897|NCT01945580|21321242|P1|STARTED|Overall Study||228
8637898|NCT01898923|21321278|P2|NOT COMPLETED|Overall Study||21
8637899|NCT01898923|21321279|P1|NOT COMPLETED|Overall Study||16
8637900|NCT01898923|21321278|P2|COMPLETED|Overall Study||93
8637901|NCT01898923|21321279|P1|COMPLETED|Overall Study||106
8637902|NCT01898923|21321278|P2|STARTED|Overall Study||114
8637903|NCT01898923|21321279|P1|STARTED|Overall Study||122
8637930|NCT01826825|21321347|P2|NOT COMPLETED|Overall Study||2
8637931|NCT01826825|21321348|P1|NOT COMPLETED|Overall Study||0
8637932|NCT01826825|21321347|P2|COMPLETED|Overall Study||98
8637933|NCT01826825|21321348|P1|COMPLETED|Overall Study||100
8637934|NCT01826825|21321347|P2|STARTED|Overall Study||100
8637935|NCT01826825|21321348|P1|STARTED|Overall Study||100
8637936|NCT01806168|21321361|P3|NOT COMPLETED|Overall Study||3
8637937|NCT01806168|21321362|P2|NOT COMPLETED|Overall Study||1
8637938|NCT01806168|21321363|P1|NOT COMPLETED|Overall Study||1
8637939|NCT01806168|21321361|P3|COMPLETED|Overall Study||7
8637940|NCT01806168|21321362|P2|COMPLETED|Overall Study||9
8637941|NCT01806168|21321363|P1|COMPLETED|Overall Study||10
8637942|NCT01806168|21321361|P3|Received Allocated Intervention|Overall Study||9
8637943|NCT01806168|21321362|P2|Received Allocated Intervention|Overall Study||9
8637944|NCT01806168|21321363|P1|Received Allocated Intervention|Overall Study||11
8637945|NCT01806168|21321361|P3|STARTED|Overall Study||10
8637946|NCT01806168|21321362|P2|STARTED|Overall Study||10
8637947|NCT01806168|21321363|P1|STARTED|Overall Study||11
8637948|NCT01740297|21321389|P3|NOT COMPLETED|Overall Study||98
8637949|NCT01740297|21321390|P2|NOT COMPLETED|Overall Study||100
8637950|NCT01740297|21321391|P1|NOT COMPLETED|Overall Study||19
8637951|NCT01740297|21321389|P3|COMPLETED|Overall Study||0
8637952|NCT01740297|21321390|P2|COMPLETED|Overall Study||0
8637953|NCT01740297|21321391|P1|COMPLETED|Overall Study||0
8637954|NCT01740297|21321389|P3|Received Ipilimumab|Overall Study||92
8637955|NCT01740297|21321390|P2|Received Ipilimumab|Overall Study||95
8637956|NCT01740297|21321391|P1|Received Ipilimumab|Overall Study||18
8637957|NCT01740297|21321389|P3|Received Talimogene Laherparepvec|Overall Study||95
8637958|NCT01740297|21321390|P2|Received Talimogene Laherparepvec|Overall Study||0
8637959|NCT01740297|21321391|P1|Received Talimogene Laherparepvec|Overall Study||19
8637960|NCT01740297|21321389|P3|STARTED|Overall Study||98
8637961|NCT01740297|21321390|P2|STARTED|Overall Study||100
8637962|NCT01740297|21321391|P1|STARTED|Overall Study||19
8637963|NCT01736124|21321423|P2|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
8637964|NCT01736124|21321424|P1|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
8637965|NCT01736124|21321423|P2|COMPLETED|12 Mo. Post-Intervention Assessment||50
8637966|NCT01736124|21321424|P1|COMPLETED|12 Mo. Post-Intervention Assessment||46
8637967|NCT01736124|21321423|P2|STARTED|12 Mo. Post-Intervention Assessment|"Includes 4 who were temporarily away at Period 3 but did not permanently withdraw."|62
8637968|NCT01736124|21321424|P1|STARTED|12 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 3 but did not permanently withdraw."|58
8637969|NCT01736124|21321423|P2|NOT COMPLETED|6 Mo. Post-Intervention Assessment||12
8637970|NCT01736124|21321424|P1|NOT COMPLETED|6 Mo. Post-Intervention Assessment||5
8637971|NCT01736124|21321423|P2|COMPLETED|6 Mo. Post-Intervention Assessment||58
8637972|NCT01736124|21321424|P1|COMPLETED|6 Mo. Post-Intervention Assessment||57
8637973|NCT01736124|21321423|P2|STARTED|6 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 2 but did not permanently withdraw."|70
8637974|NCT01736124|21321424|P1|STARTED|6 Mo. Post-Intervention Assessment|"Includes 3 who were temporarily away at Period 2 who did not permanently withdraw from the study."|62
8637975|NCT01736124|21321423|P2|NOT COMPLETED|Post-intervention Assessment||21
8637976|NCT01736124|21321424|P1|NOT COMPLETED|Post-intervention Assessment||31
8637977|NCT01736124|21321423|P2|COMPLETED|Post-intervention Assessment||69
8637978|NCT01736124|21321424|P1|COMPLETED|Post-intervention Assessment||59
8637979|NCT01736124|21321423|P2|STARTED|Post-intervention Assessment||90
8637980|NCT01736124|21321424|P1|STARTED|Post-intervention Assessment||90
8637981|NCT01736124|21321423|P2|NOT COMPLETED|Baseline||0
8637982|NCT01736124|21321424|P1|NOT COMPLETED|Baseline||0
8637983|NCT01736124|21321423|P2|COMPLETED|Baseline||90
8637984|NCT01736124|21321424|P1|COMPLETED|Baseline||90
8637985|NCT01736124|21321423|P2|STARTED|Baseline||90
8637986|NCT01736124|21321424|P1|STARTED|Baseline||90
8638014|NCT01642056|21321472|P2|NOT COMPLETED|Second Intervention||2
8638015|NCT01642056|21321473|P1|NOT COMPLETED|Second Intervention||1
8638016|NCT01642056|21321472|P2|COMPLETED|Second Intervention||8
8638017|NCT01642056|21321473|P1|COMPLETED|Second Intervention||8
8638018|NCT01642056|21321472|P2|STARTED|Second Intervention||10
8638019|NCT01642056|21321473|P1|STARTED|Second Intervention||9
8638020|NCT01642056|21321472|P2|NOT COMPLETED|First Intervention||0
8638021|NCT01642056|21321473|P1|NOT COMPLETED|First Intervention||1
8638022|NCT01642056|21321472|P2|COMPLETED|First Intervention||10
8638023|NCT01642056|21321473|P1|COMPLETED|First Intervention||9
8638024|NCT01642056|21321472|P2|STARTED|First Intervention||10
8638025|NCT01642056|21321473|P1|STARTED|First Intervention||10
8638026|NCT01634191|21321489|P2|NOT COMPLETED|Overall Study||0
8638027|NCT01634191|21321490|P1|NOT COMPLETED|Overall Study||0
8638028|NCT01634191|21321489|P2|COMPLETED|Overall Study||18
8638029|NCT01634191|21321490|P1|COMPLETED|Overall Study||18
8638030|NCT01634191|21321489|P2|STARTED|Overall Study||18
8638031|NCT01634191|21321490|P1|STARTED|Overall Study||18
8638032|NCT01439815|21321533|P2|NOT COMPLETED|Overall Study||2
8638033|NCT01439815|21321534|P1|NOT COMPLETED|Overall Study||0
8638034|NCT01439815|21321533|P2|COMPLETED|Overall Study||9
8638035|NCT01439815|21321534|P1|COMPLETED|Overall Study||11
8638036|NCT01439815|21321533|P2|All Randomized Participant Population|Overall Study||11
8638037|NCT01439815|21321534|P1|All Randomized Participant Population|Overall Study||11
8638038|NCT01439815|21321533|P2|STARTED|Overall Study||11
8638039|NCT01439815|21321534|P1|STARTED|Overall Study||11
8638040|NCT01419535|21321550|P2|NOT COMPLETED|Overall Study||2
8638041|NCT01419535|21321551|P1|NOT COMPLETED|Overall Study||1
8638042|NCT01419535|21321550|P2|COMPLETED|Overall Study||8
8638043|NCT01419535|21321551|P1|COMPLETED|Overall Study||8
8638044|NCT01419535|21321550|P2|STARTED|Overall Study||10
8638045|NCT01419535|21321551|P1|STARTED|Overall Study||9
8638046|NCT01310231|21321569|P2|NOT COMPLETED|Overall Study||1
8638047|NCT01310231|21321570|P1|NOT COMPLETED|Overall Study||0
8638048|NCT01310231|21321569|P2|COMPLETED|Overall Study||17
8638049|NCT01310231|21321570|P1|COMPLETED|Overall Study||22
8638050|NCT01310231|21321569|P2|Analyzed for Response, Toxicity, QOL|Overall Study||17
8638051|NCT01310231|21321570|P1|Analyzed for Response, Toxicity, QOL|Overall Study||22
8638052|NCT01310231|21321569|P2|Analyzed for Survival|Overall Study||18
8638053|NCT01310231|21321570|P1|Analyzed for Survival|Overall Study||22
8638054|NCT01310231|21321569|P2|Discontinued Intervention|Overall Study||1
8638055|NCT01310231|21321570|P1|Discontinued Intervention|Overall Study||0
8638056|NCT01310231|21321569|P2|Received Intervention|Overall Study||17
8638057|NCT01310231|21321570|P1|Received Intervention|Overall Study||22
8638058|NCT01310231|21321569|P2|STARTED|Overall Study||18
8638059|NCT01310231|21321570|P1|STARTED|Overall Study||22
8638086|NCT01125176|21321641|P1|NOT COMPLETED|Post-treatment Follow-up Phase||11
8638087|NCT01125176|21321641|P1|COMPLETED|Post-treatment Follow-up Phase||2
8638088|NCT01125176|21321641|P1|STARTED|Post-treatment Follow-up Phase||13
8638089|NCT01125176|21321641|P1|NOT COMPLETED|Treatment Phase||1
8638090|NCT01125176|21321641|P1|COMPLETED|Treatment Phase||13
8638091|NCT01125176|21321641|P1|STARTED|Treatment Phase||14
8638098|NCT00924326|21321671|P9|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638099|NCT00924326|21321672|P8|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638100|NCT00924326|21321673|P7|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638101|NCT00924326|21321674|P6|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638102|NCT00924326|21321675|P5|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638103|NCT00924326|21321676|P4|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638104|NCT00924326|21321677|P3|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638105|NCT00924326|21321678|P2|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638106|NCT00924326|21321679|P1|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638107|NCT00924326|21321671|P9|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638108|NCT00924326|21321672|P8|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638109|NCT00924326|21321673|P7|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638110|NCT00924326|21321674|P6|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638111|NCT00924326|21321675|P5|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638112|NCT00924326|21321676|P4|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638113|NCT00924326|21321677|P3|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638114|NCT00924326|21321678|P2|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
8638115|NCT00924326|21321679|P1|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3
8638116|NCT00924326|21321671|P9|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8638117|NCT00924326|21321672|P8|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8638118|NCT00924326|21321673|P7|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8638119|NCT00924326|21321674|P6|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8638120|NCT00924326|21321675|P5|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8638121|NCT00924326|21321676|P4|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8638122|NCT00924326|21321677|P3|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8638123|NCT00924326|21321678|P2|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
8638124|NCT00924326|21321679|P1|STARTED|1x10^9-1x10^10 + High Dose Retreat||3
8638125|NCT00924326|21321671|P9|NOT COMPLETED|Dose Administration||0
8638126|NCT00924326|21321672|P8|NOT COMPLETED|Dose Administration||0
8638127|NCT00924326|21321673|P7|NOT COMPLETED|Dose Administration||0
8638128|NCT00924326|21321674|P6|NOT COMPLETED|Dose Administration||0
8638129|NCT00924326|21321675|P5|NOT COMPLETED|Dose Administration||0
8638130|NCT00924326|21321676|P4|NOT COMPLETED|Dose Administration||0
8638131|NCT00924326|21321677|P3|NOT COMPLETED|Dose Administration||0
8638132|NCT00924326|21321678|P2|NOT COMPLETED|Dose Administration||0
8638133|NCT00924326|21321679|P1|NOT COMPLETED|Dose Administration||0
8638134|NCT00924326|21321671|P9|COMPLETED|Dose Administration||2
8638135|NCT00924326|21321672|P8|COMPLETED|Dose Administration||2
8638136|NCT00924326|21321673|P7|COMPLETED|Dose Administration||1
8638137|NCT00924326|21321674|P6|COMPLETED|Dose Administration||10
8638138|NCT00924326|21321675|P5|COMPLETED|Dose Administration||7
8638139|NCT00924326|21321676|P4|COMPLETED|Dose Administration||6
8638140|NCT00924326|21321677|P3|COMPLETED|Dose Administration||5
8638141|NCT00924326|21321678|P2|COMPLETED|Dose Administration||2
8638142|NCT00924326|21321679|P1|COMPLETED|Dose Administration||8
8638143|NCT00924326|21321671|P9|STARTED|Dose Administration||2
8638144|NCT00924326|21321672|P8|STARTED|Dose Administration||2
8638145|NCT00924326|21321673|P7|STARTED|Dose Administration||1
8638146|NCT00924326|21321674|P6|STARTED|Dose Administration||10
8638147|NCT00924326|21321675|P5|STARTED|Dose Administration||7
8638148|NCT00924326|21321676|P4|STARTED|Dose Administration||6
8638149|NCT00924326|21321677|P3|STARTED|Dose Administration||5
8638150|NCT00924326|21321678|P2|STARTED|Dose Administration||2
8638151|NCT00924326|21321679|P1|STARTED|Dose Administration||8
8638160|NCT00484718|21321726|P6|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
8638161|NCT00484718|21321727|P5|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
8638162|NCT00484718|21321728|P4|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
8638163|NCT00484718|21321729|P3|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
8638164|NCT00484718|21321730|P2|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
8638165|NCT00484718|21321731|P1|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
8638166|NCT00484718|21321726|P6|COMPLETED|Treatment Period 3 (2 Weeks)||1
8638167|NCT00484718|21321727|P5|COMPLETED|Treatment Period 3 (2 Weeks)||1
8638168|NCT00484718|21321728|P4|COMPLETED|Treatment Period 3 (2 Weeks)||1
8638169|NCT00484718|21321729|P3|COMPLETED|Treatment Period 3 (2 Weeks)||1
8638170|NCT00484718|21321730|P2|COMPLETED|Treatment Period 3 (2 Weeks)||1
8638171|NCT00484718|21321731|P1|COMPLETED|Treatment Period 3 (2 Weeks)||1
8638172|NCT00484718|21321726|P6|STARTED|Treatment Period 3 (2 Weeks)||1
8638173|NCT00484718|21321727|P5|STARTED|Treatment Period 3 (2 Weeks)||1
8638174|NCT00484718|21321728|P4|STARTED|Treatment Period 3 (2 Weeks)||1
8638175|NCT00484718|21321729|P3|STARTED|Treatment Period 3 (2 Weeks)||1
8638176|NCT00484718|21321730|P2|STARTED|Treatment Period 3 (2 Weeks)||1
8638177|NCT00484718|21321731|P1|STARTED|Treatment Period 3 (2 Weeks)||1
8638178|NCT00484718|21321726|P6|NOT COMPLETED|Washout Period (2 Weeks)||0
8638179|NCT00484718|21321727|P5|NOT COMPLETED|Washout Period (2 Weeks)||0
8638180|NCT00484718|21321728|P4|NOT COMPLETED|Washout Period (2 Weeks)||0
8638181|NCT00484718|21321729|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
8638182|NCT00484718|21321730|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
8638183|NCT00484718|21321731|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
8638184|NCT00484718|21321726|P6|COMPLETED|Washout Period (2 Weeks)||1
8638185|NCT00484718|21321727|P5|COMPLETED|Washout Period (2 Weeks)||1
8638186|NCT00484718|21321728|P4|COMPLETED|Washout Period (2 Weeks)||1
8638187|NCT00484718|21321729|P3|COMPLETED|Washout Period (2 Weeks)||1
8638188|NCT00484718|21321730|P2|COMPLETED|Washout Period (2 Weeks)||1
8638189|NCT00484718|21321731|P1|COMPLETED|Washout Period (2 Weeks)||1
8638190|NCT00484718|21321726|P6|STARTED|Washout Period (2 Weeks)||1
8638191|NCT00484718|21321727|P5|STARTED|Washout Period (2 Weeks)||1
8638192|NCT00484718|21321728|P4|STARTED|Washout Period (2 Weeks)||1
8638193|NCT00484718|21321729|P3|STARTED|Washout Period (2 Weeks)||1
8638194|NCT00484718|21321730|P2|STARTED|Washout Period (2 Weeks)||1
8638195|NCT00484718|21321731|P1|STARTED|Washout Period (2 Weeks)||1
8638196|NCT00484718|21321726|P6|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
8638197|NCT00484718|21321727|P5|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
8638198|NCT00484718|21321728|P4|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
8638199|NCT00484718|21321729|P3|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
8638200|NCT00484718|21321730|P2|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
8638201|NCT00484718|21321731|P1|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
8638202|NCT00484718|21321726|P6|COMPLETED|Treatment Period 2 (2 Weeks)||1
8638203|NCT00484718|21321727|P5|COMPLETED|Treatment Period 2 (2 Weeks)||1
8638204|NCT00484718|21321728|P4|COMPLETED|Treatment Period 2 (2 Weeks)||1
8638205|NCT00484718|21321729|P3|COMPLETED|Treatment Period 2 (2 Weeks)||1
8638206|NCT00484718|21321730|P2|COMPLETED|Treatment Period 2 (2 Weeks)||1
8638207|NCT00484718|21321731|P1|COMPLETED|Treatment Period 2 (2 Weeks)||1
8638208|NCT00484718|21321726|P6|STARTED|Treatment Period 2 (2 Weeks)||1
8638209|NCT00484718|21321727|P5|STARTED|Treatment Period 2 (2 Weeks)||1
8638210|NCT00484718|21321728|P4|STARTED|Treatment Period 2 (2 Weeks)||1
8638211|NCT00484718|21321729|P3|STARTED|Treatment Period 2 (2 Weeks)||1
8638212|NCT00484718|21321730|P2|STARTED|Treatment Period 2 (2 Weeks)||1
8638213|NCT00484718|21321731|P1|STARTED|Treatment Period 2 (2 Weeks)||1
8638214|NCT00484718|21321726|P6|NOT COMPLETED|Washout Period (2 Weeks)||0
8638215|NCT00484718|21321727|P5|NOT COMPLETED|Washout Period (2 Weeks)||0
8638216|NCT00484718|21321728|P4|NOT COMPLETED|Washout Period (2 Weeks)||0
8638217|NCT00484718|21321729|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
8638218|NCT00484718|21321730|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
8638219|NCT00484718|21321731|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
8638220|NCT00484718|21321726|P6|COMPLETED|Washout Period (2 Weeks)||1
8638221|NCT00484718|21321727|P5|COMPLETED|Washout Period (2 Weeks)||1
8638222|NCT00484718|21321728|P4|COMPLETED|Washout Period (2 Weeks)||1
8638223|NCT00484718|21321729|P3|COMPLETED|Washout Period (2 Weeks)||1
8638224|NCT00484718|21321730|P2|COMPLETED|Washout Period (2 Weeks)||1
8638225|NCT00484718|21321731|P1|COMPLETED|Washout Period (2 Weeks)||1
8638226|NCT00484718|21321726|P6|STARTED|Washout Period (2 Weeks)||1
8638227|NCT00484718|21321727|P5|STARTED|Washout Period (2 Weeks)||1
8638228|NCT00484718|21321728|P4|STARTED|Washout Period (2 Weeks)||1
8638229|NCT00484718|21321729|P3|STARTED|Washout Period (2 Weeks)||1
8638230|NCT00484718|21321730|P2|STARTED|Washout Period (2 Weeks)||1
8638231|NCT00484718|21321731|P1|STARTED|Washout Period (2 Weeks)||1
8638232|NCT00484718|21321726|P6|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
8638233|NCT00484718|21321727|P5|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
8638234|NCT00484718|21321728|P4|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
8638235|NCT00484718|21321729|P3|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
8638236|NCT00484718|21321730|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
8638237|NCT00484718|21321731|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
8638238|NCT00484718|21321726|P6|COMPLETED|Treatment Period 1 (2 Weeks)||1
8638239|NCT00484718|21321727|P5|COMPLETED|Treatment Period 1 (2 Weeks)||1
8638240|NCT00484718|21321728|P4|COMPLETED|Treatment Period 1 (2 Weeks)||1
8638241|NCT00484718|21321729|P3|COMPLETED|Treatment Period 1 (2 Weeks)||1
8638242|NCT00484718|21321730|P2|COMPLETED|Treatment Period 1 (2 Weeks)||1
8638243|NCT00484718|21321731|P1|COMPLETED|Treatment Period 1 (2 Weeks)||1
8638244|NCT00484718|21321726|P6|STARTED|Treatment Period 1 (2 Weeks)||1
8638245|NCT00484718|21321727|P5|STARTED|Treatment Period 1 (2 Weeks)||1
8638246|NCT00484718|21321728|P4|STARTED|Treatment Period 1 (2 Weeks)||1
8638247|NCT00484718|21321729|P3|STARTED|Treatment Period 1 (2 Weeks)||1
8638248|NCT00484718|21321730|P2|STARTED|Treatment Period 1 (2 Weeks)||1
8638249|NCT00484718|21321731|P1|STARTED|Treatment Period 1 (2 Weeks)||1
8638274|NCT00001849|21321815|P1|NOT COMPLETED|Overall Study||14
8638275|NCT00001849|21321815|P1|COMPLETED|Overall Study|Patients completed when an ectopic ACTH-secreting tumor was identified|54
8638276|NCT00001849|21321815|P1|STARTED|Overall Study||68
8638277|NCT04365153|21321833|P3|NOT COMPLETED|Overall Study||0
8638278|NCT04365153|21321834|P2|NOT COMPLETED|Overall Study||0
8638279|NCT04365153|21321835|P1|NOT COMPLETED|Overall Study||0
8638280|NCT04365153|21321833|P3|COMPLETED|Overall Study||16
8638281|NCT04365153|21321834|P2|COMPLETED|Overall Study||14
8638282|NCT04365153|21321835|P1|COMPLETED|Overall Study||15
8638283|NCT04365153|21321833|P3|STARTED|Overall Study||16
8638284|NCT04365153|21321834|P2|STARTED|Overall Study||14
8638285|NCT04365153|21321835|P1|STARTED|Overall Study||15
8638286|NCT03993392|21321846|P1|NOT COMPLETED|Overall Study||6
8638287|NCT03993392|21321846|P1|COMPLETED|Overall Study||20
8638288|NCT03993392|21321846|P1|Treated With SUBLOCADE|Overall Study||24
8638289|NCT03993392|21321846|P1|STARTED|Overall Study||26
8638311|NCT03500692|21321911|P1|NOT COMPLETED|Overall Study||109
8638312|NCT03500692|21321911|P1|COMPLETED|Overall Study||391
8638313|NCT03500692|21321911|P1|STARTED|Overall Study||500
8638314|NCT03437577|21321919|P3|NOT COMPLETED|Post-Randomization||0
8638315|NCT03437577|21321920|P2|NOT COMPLETED|Post-Randomization||2
8638316|NCT03437577|21321921|P1|NOT COMPLETED|Post-Randomization||0
8638317|NCT03437577|21321919|P3|COMPLETED|Post-Randomization||0
8638318|NCT03437577|21321920|P2|COMPLETED|Post-Randomization||3
8638319|NCT03437577|21321921|P1|COMPLETED|Post-Randomization||3
8638320|NCT03437577|21321919|P3|STARTED|Post-Randomization||0
8638321|NCT03437577|21321920|P2|STARTED|Post-Randomization||5
8638322|NCT03437577|21321921|P1|STARTED|Post-Randomization||3
8638323|NCT03437577|21321919|P3|NOT COMPLETED|Pre-Randomization||10
8638324|NCT03437577|21321920|P2|NOT COMPLETED|Pre-Randomization||0
8638325|NCT03437577|21321921|P1|NOT COMPLETED|Pre-Randomization||0
8638326|NCT03437577|21321919|P3|COMPLETED|Pre-Randomization||0
8638327|NCT03437577|21321920|P2|COMPLETED|Pre-Randomization||0
8638328|NCT03437577|21321921|P1|COMPLETED|Pre-Randomization||0
8638329|NCT03437577|21321919|P3|STARTED|Pre-Randomization||10
8638330|NCT03437577|21321920|P2|STARTED|Pre-Randomization||0
8638331|NCT03437577|21321921|P1|STARTED|Pre-Randomization||0
8638338|NCT03224403|21321976|P4|NOT COMPLETED|Overall Study||0
8638339|NCT03224403|21321977|P3|NOT COMPLETED|Overall Study||0
8638340|NCT03224403|21321978|P2|NOT COMPLETED|Overall Study||0
8638341|NCT03224403|21321979|P1|NOT COMPLETED|Overall Study||0
8638342|NCT03224403|21321976|P4|COMPLETED|Overall Study||124
8638343|NCT03224403|21321977|P3|COMPLETED|Overall Study||232
8638344|NCT03224403|21321978|P2|COMPLETED|Overall Study||249
8638345|NCT03224403|21321979|P1|COMPLETED|Overall Study||59
8638346|NCT03224403|21321976|P4|STARTED|Overall Study||124
8638347|NCT03224403|21321977|P3|STARTED|Overall Study||232
8638348|NCT03224403|21321978|P2|STARTED|Overall Study||249
8638349|NCT03224403|21321979|P1|STARTED|Overall Study||59
8638353|NCT03125915|21322041|P4|NOT COMPLETED|6 Month Follow-up||3
8638354|NCT03125915|21322042|P3|NOT COMPLETED|6 Month Follow-up||6
8638355|NCT03125915|21322043|P2|NOT COMPLETED|6 Month Follow-up||3
8638356|NCT03125915|21322044|P1|NOT COMPLETED|6 Month Follow-up||7
8638357|NCT03125915|21322041|P4|COMPLETED|6 Month Follow-up||31
8638358|NCT03125915|21322042|P3|COMPLETED|6 Month Follow-up||28
8638359|NCT03125915|21322043|P2|COMPLETED|6 Month Follow-up||37
8638360|NCT03125915|21322044|P1|COMPLETED|6 Month Follow-up||25
8638361|NCT03125915|21322041|P4|STARTED|6 Month Follow-up||34
8638362|NCT03125915|21322042|P3|STARTED|6 Month Follow-up||34
8638363|NCT03125915|21322043|P2|STARTED|6 Month Follow-up||40
8638364|NCT03125915|21322044|P1|STARTED|6 Month Follow-up||32
8638365|NCT03125915|21322041|P4|NOT COMPLETED|3 Month Follow-up||2
8638366|NCT03125915|21322042|P3|NOT COMPLETED|3 Month Follow-up||4
8638367|NCT03125915|21322043|P2|NOT COMPLETED|3 Month Follow-up||4
8638368|NCT03125915|21322044|P1|NOT COMPLETED|3 Month Follow-up||6
8638369|NCT03125915|21322041|P4|COMPLETED|3 Month Follow-up||32
8638370|NCT03125915|21322042|P3|COMPLETED|3 Month Follow-up||30
8638371|NCT03125915|21322043|P2|COMPLETED|3 Month Follow-up||36
8638372|NCT03125915|21322044|P1|COMPLETED|3 Month Follow-up||26
8638373|NCT03125915|21322041|P4|STARTED|3 Month Follow-up||34
8638374|NCT03125915|21322042|P3|STARTED|3 Month Follow-up||34
8638375|NCT03125915|21322043|P2|STARTED|3 Month Follow-up||40
8638376|NCT03125915|21322044|P1|STARTED|3 Month Follow-up||32
8638377|NCT03125915|21322041|P4|NOT COMPLETED|1 Month Follow up||3
8638378|NCT03125915|21322042|P3|NOT COMPLETED|1 Month Follow up||2
8638379|NCT03125915|21322043|P2|NOT COMPLETED|1 Month Follow up||3
8638380|NCT03125915|21322044|P1|NOT COMPLETED|1 Month Follow up||3
8638381|NCT03125915|21322041|P4|COMPLETED|1 Month Follow up||31
8638382|NCT03125915|21322042|P3|COMPLETED|1 Month Follow up||32
8638383|NCT03125915|21322043|P2|COMPLETED|1 Month Follow up||37
8638384|NCT03125915|21322044|P1|COMPLETED|1 Month Follow up||29
8638385|NCT03125915|21322041|P4|STARTED|1 Month Follow up||34
8638386|NCT03125915|21322042|P3|STARTED|1 Month Follow up||34
8638387|NCT03125915|21322043|P2|STARTED|1 Month Follow up||40
8638388|NCT03125915|21322044|P1|STARTED|1 Month Follow up||32
8638389|NCT03125915|21322041|P4|NOT COMPLETED|Baseline and Intervention||0
8638390|NCT03125915|21322042|P3|NOT COMPLETED|Baseline and Intervention||0
8638391|NCT03125915|21322043|P2|NOT COMPLETED|Baseline and Intervention||0
8638392|NCT03125915|21322044|P1|NOT COMPLETED|Baseline and Intervention||0
8638393|NCT03125915|21322041|P4|COMPLETED|Baseline and Intervention||34
8638394|NCT03125915|21322042|P3|COMPLETED|Baseline and Intervention||34
8638395|NCT03125915|21322043|P2|COMPLETED|Baseline and Intervention||40
8638396|NCT03125915|21322044|P1|COMPLETED|Baseline and Intervention||32
8638397|NCT03125915|21322041|P4|STARTED|Baseline and Intervention||34
8638398|NCT03125915|21322042|P3|STARTED|Baseline and Intervention||34
8638399|NCT03125915|21322043|P2|STARTED|Baseline and Intervention||40
8638400|NCT03125915|21322044|P1|STARTED|Baseline and Intervention||32
8638404|NCT03105518|21322084|P1|NOT COMPLETED|Overall Study||0
8638405|NCT03105518|21322084|P1|COMPLETED|Overall Study||100
8638406|NCT03105518|21322084|P1|STARTED|Overall Study||100
8638407|NCT02966028|21322092|P3|NOT COMPLETED|Overall Study||31
8638408|NCT02966028|21322093|P2|NOT COMPLETED|Overall Study||34
8638409|NCT02966028|21322094|P1|NOT COMPLETED|Overall Study||24
8638410|NCT02966028|21322092|P3|COMPLETED|Overall Study||60
8638411|NCT02966028|21322093|P2|COMPLETED|Overall Study||57
8638412|NCT02966028|21322094|P1|COMPLETED|Overall Study||68
8638413|NCT02966028|21322092|P3|STARTED|Overall Study||91
8638414|NCT02966028|21322093|P2|STARTED|Overall Study||91
8638415|NCT02966028|21322094|P1|STARTED|Overall Study||92
8638416|NCT02920528|21322143|P3|NOT COMPLETED|Overall Study||5
8638417|NCT02920528|21322144|P2|NOT COMPLETED|Overall Study||1
8638418|NCT02920528|21322145|P1|NOT COMPLETED|Overall Study||3
8638419|NCT02920528|21322143|P3|COMPLETED|Overall Study||30
8638420|NCT02920528|21322144|P2|COMPLETED|Overall Study||35
8638421|NCT02920528|21322145|P1|COMPLETED|Overall Study||32
8638422|NCT02920528|21322143|P3|STARTED|Overall Study||35
8638423|NCT02920528|21322144|P2|STARTED|Overall Study||36
8638424|NCT02920528|21322145|P1|STARTED|Overall Study||35
8638425|NCT02915783|21322159|P1|NOT COMPLETED|Overall Study||14
8638426|NCT02915783|21322159|P1|COMPLETED|Overall Study||17
8638427|NCT02915783|21322159|P1|STARTED|Overall Study||31
8638436|NCT02805179|21322184|P1|NOT COMPLETED|Overall Study||3
8638437|NCT02805179|21322184|P1|COMPLETED|Overall Study||23
8638438|NCT02805179|21322184|P1|Subset of Participants, Boosted to Both High B-value Diffusion and Perfusion|Overall Study||13
8638439|NCT02805179|21322184|P1|Eligible Patients That Started Dose-intensified Chemo-radiation|Overall Study||23
8638440|NCT02805179|21322184|P1|STARTED|Overall Study||26
8638441|NCT02747238|21322195|P2|NOT COMPLETED|Overall Study||6
8638442|NCT02747238|21322196|P1|NOT COMPLETED|Overall Study||3
8638443|NCT02747238|21322195|P2|COMPLETED|Overall Study||14
8638444|NCT02747238|21322196|P1|COMPLETED|Overall Study||9
8638445|NCT02747238|21322195|P2|STARTED|Overall Study||20
8638446|NCT02747238|21322196|P1|STARTED|Overall Study||12
8638447|NCT02737631|21322208|P1|NOT COMPLETED|Overall Study||0
8638448|NCT02737631|21322208|P1|COMPLETED|Overall Study||222
8638449|NCT02737631|21322208|P1|STARTED|Overall Study||222
8638450|NCT02665988|21322214|P2|NOT COMPLETED|Overall Study||0
8638451|NCT02665988|21322215|P1|NOT COMPLETED|Overall Study||0
8638452|NCT02665988|21322214|P2|COMPLETED|Overall Study||2
8638453|NCT02665988|21322215|P1|COMPLETED|Overall Study||2
8638454|NCT02665988|21322214|P2|STARTED|Overall Study||2
8638455|NCT02665988|21322215|P1|STARTED|Overall Study||2
8638456|NCT02656680|21322223|P2|NOT COMPLETED|Overall Study||1
8638457|NCT02656680|21322224|P1|NOT COMPLETED|Overall Study||0
8638458|NCT02656680|21322223|P2|COMPLETED|Overall Study||39
8638459|NCT02656680|21322224|P1|COMPLETED|Overall Study||40
8638460|NCT02656680|21322223|P2|STARTED|Overall Study||40
8638461|NCT02656680|21322224|P1|STARTED|Overall Study||40
8638462|NCT02545907|21322240|P3|NOT COMPLETED|Overall Study||0
8638463|NCT02545907|21322241|P2|NOT COMPLETED|Overall Study||0
8638464|NCT02545907|21322242|P1|NOT COMPLETED|Overall Study||0
8638465|NCT02545907|21322240|P3|COMPLETED|Overall Study||4
8638466|NCT02545907|21322241|P2|COMPLETED|Overall Study||3
8638467|NCT02545907|21322242|P1|COMPLETED|Overall Study||3
8638468|NCT02545907|21322240|P3|STARTED|Overall Study||4
8638469|NCT02545907|21322241|P2|STARTED|Overall Study||3
8638470|NCT02545907|21322242|P1|STARTED|Overall Study||3
8638471|NCT02541409|21322271|P2|NOT COMPLETED|Overall Study||3
8638472|NCT02541409|21322272|P1|NOT COMPLETED|Overall Study||3
8638473|NCT02541409|21322271|P2|COMPLETED|Overall Study||22
8638474|NCT02541409|21322272|P1|COMPLETED|Overall Study||22
8638475|NCT02541409|21322271|P2|STARTED|Overall Study||25
8638476|NCT02541409|21322272|P1|STARTED|Overall Study||25
8638477|NCT02524769|21322284|P1|NOT COMPLETED|Overall Study||10
8638478|NCT02524769|21322284|P1|COMPLETED|Overall Study||17
8638479|NCT02524769|21322284|P1|STARTED|Overall Study||27
8638480|NCT02364271|21322294|P2|NOT COMPLETED|Overall Study||0
8638481|NCT02364271|21322295|P1|NOT COMPLETED|Overall Study||0
8638482|NCT02364271|21322294|P2|COMPLETED|Overall Study||123
8638483|NCT02364271|21322295|P1|COMPLETED|Overall Study||479
8638484|NCT02364271|21322294|P2|STARTED|Overall Study||123
8638485|NCT02364271|21322295|P1|STARTED|Overall Study||479
8638486|NCT02112877|21322307|P2|NOT COMPLETED|Overall Study||13
8638487|NCT02112877|21322308|P1|NOT COMPLETED|Overall Study||2
8638488|NCT02112877|21322307|P2|COMPLETED|Overall Study||157
8638489|NCT02112877|21322308|P1|COMPLETED|Overall Study||28
8638490|NCT02112877|21322307|P2|STARTED|Overall Study||170
8638491|NCT02112877|21322308|P1|STARTED|Overall Study||30
8638510|NCT01858545|21322372|P2|NOT COMPLETED|Overall Study||6
8638511|NCT01858545|21322373|P1|NOT COMPLETED|Overall Study||4
8638512|NCT01858545|21322372|P2|COMPLETED|Overall Study||23
8638513|NCT01858545|21322373|P1|COMPLETED|Overall Study||23
8638514|NCT01858545|21322372|P2|STARTED|Overall Study||29
8638515|NCT01858545|21322373|P1|STARTED|Overall Study||27
8638522|NCT01183221|21322402|P2|NOT COMPLETED|Second Dose||0
8638523|NCT01183221|21322403|P1|NOT COMPLETED|Second Dose||0
8638524|NCT01183221|21322402|P2|COMPLETED|Second Dose||14
8638525|NCT01183221|21322403|P1|COMPLETED|Second Dose||14
8638526|NCT01183221|21322402|P2|STARTED|Second Dose||14
8638527|NCT01183221|21322403|P1|STARTED|Second Dose||14
8638528|NCT01183221|21322402|P2|NOT COMPLETED|3 Weeks Wash Out||1
8638529|NCT01183221|21322403|P1|NOT COMPLETED|3 Weeks Wash Out||1
8638530|NCT01183221|21322402|P2|COMPLETED|3 Weeks Wash Out||14
8638531|NCT01183221|21322403|P1|COMPLETED|3 Weeks Wash Out||14
8638532|NCT01183221|21322402|P2|STARTED|3 Weeks Wash Out||15
8638533|NCT01183221|21322403|P1|STARTED|3 Weeks Wash Out||15
8638534|NCT01183221|21322402|P2|NOT COMPLETED|First Dose||0
8638535|NCT01183221|21322403|P1|NOT COMPLETED|First Dose||0
8638536|NCT01183221|21322402|P2|COMPLETED|First Dose||15
8638537|NCT01183221|21322403|P1|COMPLETED|First Dose||15
8638538|NCT01183221|21322402|P2|STARTED|First Dose||15
8638539|NCT01183221|21322403|P1|STARTED|First Dose||15
8638566|NCT00846040|21322457|P3|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
8638567|NCT00846040|21322458|P2|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
8638568|NCT00846040|21322459|P1|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
8638569|NCT00846040|21322457|P3|COMPLETED|Second Treatment: After Washout, 14 Day||0
8638570|NCT00846040|21322458|P2|COMPLETED|Second Treatment: After Washout, 14 Day||8
8638571|NCT00846040|21322459|P1|COMPLETED|Second Treatment: After Washout, 14 Day||9
8638572|NCT00846040|21322457|P3|STARTED|Second Treatment: After Washout, 14 Day||0
8638573|NCT00846040|21322458|P2|STARTED|Second Treatment: After Washout, 14 Day||8
8638574|NCT00846040|21322459|P1|STARTED|Second Treatment: After Washout, 14 Day||9
8638575|NCT00846040|21322457|P3|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
8638576|NCT00846040|21322458|P2|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||2
8638577|NCT00846040|21322459|P1|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
8638578|NCT00846040|21322457|P3|COMPLETED|Washout: 2 Weeks to 10 Weeks||0
8638579|NCT00846040|21322458|P2|COMPLETED|Washout: 2 Weeks to 10 Weeks||8
8638580|NCT00846040|21322459|P1|COMPLETED|Washout: 2 Weeks to 10 Weeks||9
8638581|NCT00846040|21322457|P3|STARTED|Washout: 2 Weeks to 10 Weeks||0
8638582|NCT00846040|21322458|P2|STARTED|Washout: 2 Weeks to 10 Weeks||10
8638583|NCT00846040|21322459|P1|STARTED|Washout: 2 Weeks to 10 Weeks||9
8638584|NCT00846040|21322457|P3|NOT COMPLETED|First Treatment Period: Days 6-14||0
8638585|NCT00846040|21322458|P2|NOT COMPLETED|First Treatment Period: Days 6-14||0
8638586|NCT00846040|21322459|P1|NOT COMPLETED|First Treatment Period: Days 6-14||0
8638587|NCT00846040|21322457|P3|COMPLETED|First Treatment Period: Days 6-14||0
8638588|NCT00846040|21322458|P2|COMPLETED|First Treatment Period: Days 6-14||10
8638589|NCT00846040|21322459|P1|COMPLETED|First Treatment Period: Days 6-14||9
8638590|NCT00846040|21322457|P3|STARTED|First Treatment Period: Days 6-14|This group participated in only the baseline period|0
8638591|NCT00846040|21322458|P2|STARTED|First Treatment Period: Days 6-14||10
8638592|NCT00846040|21322459|P1|STARTED|First Treatment Period: Days 6-14||9
8638593|NCT00846040|21322457|P3|NOT COMPLETED|Baseline: Days 1-5||0
8638594|NCT00846040|21322458|P2|NOT COMPLETED|Baseline: Days 1-5||0
8638595|NCT00846040|21322459|P1|NOT COMPLETED|Baseline: Days 1-5||1
8638596|NCT00846040|21322457|P3|COMPLETED|Baseline: Days 1-5||23
8638597|NCT00846040|21322458|P2|COMPLETED|Baseline: Days 1-5||10
8638598|NCT00846040|21322459|P1|COMPLETED|Baseline: Days 1-5||9
8638599|NCT00846040|21322457|P3|STARTED|Baseline: Days 1-5||23
8638600|NCT00846040|21322458|P2|STARTED|Baseline: Days 1-5||10
8638601|NCT00846040|21322459|P1|STARTED|Baseline: Days 1-5||10
8638753|NCT04274556|21322647|P1|NOT COMPLETED|Overall Study||0
8638754|NCT04274556|21322647|P1|COMPLETED|Overall Study||86
8638755|NCT04274556|21322647|P1|STARTED|Overall Study||86
8638756|NCT04177862|21322655|P2|NOT COMPLETED|Overall Study||7
8638757|NCT04177862|21322656|P1|NOT COMPLETED|Overall Study||2
8638758|NCT04177862|21322655|P2|COMPLETED|Overall Study||33
8638759|NCT04177862|21322656|P1|COMPLETED|Overall Study||33
8638760|NCT04177862|21322655|P2|STARTED|Overall Study||40
8638761|NCT04177862|21322656|P1|STARTED|Overall Study||35
8638762|NCT03997851|21322672|P1|NOT COMPLETED|Overall Study||0
8638763|NCT03997851|21322672|P1|COMPLETED|Overall Study||17
8638764|NCT03997851|21322672|P1|STARTED|Overall Study||17
8638768|NCT03927781|21322730|P1|NOT COMPLETED|Overall Study||0
8638769|NCT03927781|21322730|P1|COMPLETED|Overall Study||10
8638770|NCT03927781|21322730|P1|STARTED|Overall Study||10
8638771|NCT03911843|21322744|P2|NOT COMPLETED|Overall Study||1
8638772|NCT03911843|21322745|P1|NOT COMPLETED|Overall Study||4
8638773|NCT03911843|21322744|P2|COMPLETED|Overall Study||37
8638774|NCT03911843|21322745|P1|COMPLETED|Overall Study||22
8638775|NCT03911843|21322744|P2|STARTED|Overall Study||38
8638776|NCT03911843|21322745|P1|STARTED|Overall Study||26
8638777|NCT03878602|21322757|P2|NOT COMPLETED|Overall Study||1
8638778|NCT03878602|21322758|P1|NOT COMPLETED|Overall Study||9
8638779|NCT03878602|21322757|P2|COMPLETED|Overall Study||66
8638780|NCT03878602|21322758|P1|COMPLETED|Overall Study||66
8638781|NCT03878602|21322757|P2|STARTED|Overall Study||67
8638782|NCT03878602|21322758|P1|STARTED|Overall Study||75
8638783|NCT03798756|21322774|P1|NOT COMPLETED|Overall Study||0
8638784|NCT03798756|21322774|P1|COMPLETED|Overall Study||9274
8638785|NCT03798756|21322774|P1|STARTED|Overall Study||9274
8638823|NCT03520283|21322850|P2|NOT COMPLETED|Overall Study||0
8638824|NCT03520283|21322851|P1|NOT COMPLETED|Overall Study||0
8638825|NCT03520283|21322850|P2|COMPLETED|Overall Study||42
8638826|NCT03520283|21322851|P1|COMPLETED|Overall Study||24
8638827|NCT03520283|21322850|P2|STARTED|Overall Study||42
8638828|NCT03520283|21322851|P1|STARTED|Overall Study||24
8638857|NCT03083093|21322933|P2|NOT COMPLETED|Overall Study||0
8638858|NCT03083093|21322934|P1|NOT COMPLETED|Overall Study||0
8638859|NCT03083093|21322933|P2|COMPLETED|Overall Study||50
8638860|NCT03083093|21322934|P1|COMPLETED|Overall Study||50
8638861|NCT03083093|21322933|P2|STARTED|Overall Study||50
8638862|NCT03083093|21322934|P1|STARTED|Overall Study||50
8638863|NCT03028103|21322942|P2|NOT COMPLETED|Overall Study||0
8638864|NCT03028103|21322943|P1|NOT COMPLETED|Overall Study||0
8638865|NCT03028103|21322942|P2|COMPLETED|Overall Study||16
8638866|NCT03028103|21322943|P1|COMPLETED|Overall Study||16
8638867|NCT03028103|21322942|P2|STARTED|Overall Study||16
8638868|NCT03028103|21322943|P1|STARTED|Overall Study||16
8638869|NCT03023826|21322968|P6|NOT COMPLETED|Period 3||0
8638870|NCT03023826|21322969|P5|NOT COMPLETED|Period 3||0
8638871|NCT03023826|21322970|P4|NOT COMPLETED|Period 3||0
8638872|NCT03023826|21322971|P3|NOT COMPLETED|Period 3||0
8638873|NCT03023826|21322972|P2|NOT COMPLETED|Period 3||0
8638874|NCT03023826|21322973|P1|NOT COMPLETED|Period 3||0
8638875|NCT03023826|21322968|P6|COMPLETED|Period 3||5
8638876|NCT03023826|21322969|P5|COMPLETED|Period 3||3
8638877|NCT03023826|21322970|P4|COMPLETED|Period 3||4
8638878|NCT03023826|21322971|P3|COMPLETED|Period 3||5
8638879|NCT03023826|21322972|P2|COMPLETED|Period 3||4
8638880|NCT03023826|21322973|P1|COMPLETED|Period 3||4
8638881|NCT03023826|21322968|P6|STARTED|Period 3||5
8638882|NCT03023826|21322969|P5|STARTED|Period 3||3
8638883|NCT03023826|21322970|P4|STARTED|Period 3||4
8638884|NCT03023826|21322971|P3|STARTED|Period 3||5
8638885|NCT03023826|21322972|P2|STARTED|Period 3||4
8638886|NCT03023826|21322973|P1|STARTED|Period 3||4
8638887|NCT03023826|21322968|P6|NOT COMPLETED|Period 2||0
8638888|NCT03023826|21322969|P5|NOT COMPLETED|Period 2||0
8638889|NCT03023826|21322970|P4|NOT COMPLETED|Period 2||0
8638890|NCT03023826|21322971|P3|NOT COMPLETED|Period 2||0
8638891|NCT03023826|21322972|P2|NOT COMPLETED|Period 2||0
8638892|NCT03023826|21322973|P1|NOT COMPLETED|Period 2||0
8638893|NCT03023826|21322968|P6|COMPLETED|Period 2||5
8638894|NCT03023826|21322969|P5|COMPLETED|Period 2||3
8638895|NCT03023826|21322970|P4|COMPLETED|Period 2||4
8638896|NCT03023826|21322971|P3|COMPLETED|Period 2||5
8638897|NCT03023826|21322972|P2|COMPLETED|Period 2||4
8638898|NCT03023826|21322973|P1|COMPLETED|Period 2||4
8638899|NCT03023826|21322968|P6|STARTED|Period 2||5
8638900|NCT03023826|21322969|P5|STARTED|Period 2||3
8638901|NCT03023826|21322970|P4|STARTED|Period 2||4
8638902|NCT03023826|21322971|P3|STARTED|Period 2||5
8638903|NCT03023826|21322972|P2|STARTED|Period 2||4
8638904|NCT03023826|21322973|P1|STARTED|Period 2||4
8638905|NCT03023826|21322968|P6|NOT COMPLETED|Period 1||0
8638906|NCT03023826|21322969|P5|NOT COMPLETED|Period 1||1
8638907|NCT03023826|21322970|P4|NOT COMPLETED|Period 1||0
8638908|NCT03023826|21322971|P3|NOT COMPLETED|Period 1||0
8638909|NCT03023826|21322972|P2|NOT COMPLETED|Period 1||0
8638910|NCT03023826|21322973|P1|NOT COMPLETED|Period 1||0
8638911|NCT03023826|21322968|P6|COMPLETED|Period 1||5
8638912|NCT03023826|21322969|P5|COMPLETED|Period 1||3
8638913|NCT03023826|21322970|P4|COMPLETED|Period 1||4
8638914|NCT03023826|21322971|P3|COMPLETED|Period 1||5
8638915|NCT03023826|21322972|P2|COMPLETED|Period 1||4
8638916|NCT03023826|21322973|P1|COMPLETED|Period 1||4
8638917|NCT03023826|21322968|P6|Received at Least One Dose of Study Drug|Period 1||5
8638918|NCT03023826|21322969|P5|Received at Least One Dose of Study Drug|Period 1||4
8638919|NCT03023826|21322970|P4|Received at Least One Dose of Study Drug|Period 1||4
8638920|NCT03023826|21322971|P3|Received at Least One Dose of Study Drug|Period 1||5
8638921|NCT03023826|21322972|P2|Received at Least One Dose of Study Drug|Period 1||4
8638922|NCT03023826|21322973|P1|Received at Least One Dose of Study Drug|Period 1||4
8638923|NCT03023826|21322968|P6|STARTED|Period 1||5
8638924|NCT03023826|21322969|P5|STARTED|Period 1||4
8638925|NCT03023826|21322970|P4|STARTED|Period 1||4
8638926|NCT03023826|21322971|P3|STARTED|Period 1||5
8638927|NCT03023826|21322972|P2|STARTED|Period 1||4
8638928|NCT03023826|21322973|P1|STARTED|Period 1||4
8638935|NCT02899728|21323006|P2|NOT COMPLETED|Overall Study||1
8638936|NCT02899728|21323007|P1|NOT COMPLETED|Overall Study||1
8638937|NCT02899728|21323006|P2|COMPLETED|Overall Study||2
8638938|NCT02899728|21323007|P1|COMPLETED|Overall Study||4
8638939|NCT02899728|21323006|P2|STARTED|Overall Study||3
8638940|NCT02899728|21323007|P1|STARTED|Overall Study|0|5
8638945|NCT02791191|21323034|P3|NOT COMPLETED|Overall Study||120
8638946|NCT02791191|21323035|P2|NOT COMPLETED|Overall Study||111
8638947|NCT02791191|21323036|P1|NOT COMPLETED|Overall Study||38
8638948|NCT02791191|21323034|P3|COMPLETED|Overall Study||13
8638949|NCT02791191|21323035|P2|COMPLETED|Overall Study||17
8638950|NCT02791191|21323036|P1|COMPLETED|Overall Study||17
8638951|NCT02791191|21323034|P3|Received One Dose of Study Drug|Overall Study||133
8638952|NCT02791191|21323035|P2|Received One Dose of Study Drug|Overall Study||127
8638953|NCT02791191|21323036|P1|Received One Dose of Study Drug|Overall Study||55
8638954|NCT02791191|21323034|P3|STARTED|Overall Study||133
8638955|NCT02791191|21323035|P2|STARTED|Overall Study||128
8638956|NCT02791191|21323036|P1|STARTED|Overall Study||55
8638969|NCT02555449|21323086|P1|NOT COMPLETED|Overall Study||0
8638970|NCT02555449|21323086|P1|COMPLETED|Overall Study||6
8638971|NCT02555449|21323086|P1|STARTED|Overall Study||6
8638972|NCT02539225|21323098|P2|NOT COMPLETED|Part B||16
8638973|NCT02539225|21323099|P1|NOT COMPLETED|Part B||4
8638974|NCT02539225|21323098|P2|COMPLETED|Part B||48
8638975|NCT02539225|21323099|P1|COMPLETED|Part B||54
8638976|NCT02539225|21323098|P2|STARTED|Part B||64
8638977|NCT02539225|21323099|P1|STARTED|Part B||58
8638978|NCT02539225|21323098|P2|NOT COMPLETED|Pre Treatment for Part B||2
8638979|NCT02539225|21323099|P1|NOT COMPLETED|Pre Treatment for Part B||5
8638980|NCT02539225|21323098|P2|COMPLETED|Pre Treatment for Part B||64
8638981|NCT02539225|21323099|P1|COMPLETED|Pre Treatment for Part B||58
8638982|NCT02539225|21323098|P2|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|66
8638983|NCT02539225|21323099|P1|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|63
8638984|NCT02539225|21323098|P2|NOT COMPLETED|Part A||16
8638985|NCT02539225|21323099|P1|NOT COMPLETED|Part A||20
8638986|NCT02539225|21323098|P2|COMPLETED|Part A||78
8638987|NCT02539225|21323099|P1|COMPLETED|Part A||77
8638988|NCT02539225|21323098|P2|Received Any Quantity of Study Drug|Part A||93
8638989|NCT02539225|21323099|P1|Received Any Quantity of Study Drug|Part A||96
8638990|NCT02539225|21323098|P2|STARTED|Part A||94
8638991|NCT02539225|21323099|P1|STARTED|Part A||97
8638998|NCT02323334|21323141|P17|NOT COMPLETED|Period 4||0
8638999|NCT02323334|21323142|P16|NOT COMPLETED|Period 4||0
8639000|NCT02323334|21323143|P15|NOT COMPLETED|Period 4||0
8639001|NCT02323334|21323144|P14|NOT COMPLETED|Period 4||0
8639002|NCT02323334|21323145|P13|NOT COMPLETED|Period 4||0
8639003|NCT02323334|21323146|P12|NOT COMPLETED|Period 4||0
8639004|NCT02323334|21323147|P11|NOT COMPLETED|Period 4||0
8639005|NCT02323334|21323148|P10|NOT COMPLETED|Period 4||0
8639006|NCT02323334|21323149|P9|NOT COMPLETED|Period 4||0
8639007|NCT02323334|21323150|P8|NOT COMPLETED|Period 4||0
8639008|NCT02323334|21323151|P7|NOT COMPLETED|Period 4||0
8639009|NCT02323334|21323152|P6|NOT COMPLETED|Period 4||0
8639010|NCT02323334|21323153|P5|NOT COMPLETED|Period 4||0
8639011|NCT02323334|21323154|P4|NOT COMPLETED|Period 4||0
8639012|NCT02323334|21323155|P3|NOT COMPLETED|Period 4||0
8639013|NCT02323334|21323156|P2|NOT COMPLETED|Period 4||0
8639014|NCT02323334|21323157|P1|NOT COMPLETED|Period 4||0
8639015|NCT02323334|21323141|P17|COMPLETED|Period 4||0
8639016|NCT02323334|21323142|P16|COMPLETED|Period 4||0
8639017|NCT02323334|21323143|P15|COMPLETED|Period 4||0
8639018|NCT02323334|21323144|P14|COMPLETED|Period 4||0
8639019|NCT02323334|21323145|P13|COMPLETED|Period 4||0
8639020|NCT02323334|21323146|P12|COMPLETED|Period 4||0
8639021|NCT02323334|21323147|P11|COMPLETED|Period 4||0
8639022|NCT02323334|21323148|P10|COMPLETED|Period 4||0
8639023|NCT02323334|21323149|P9|COMPLETED|Period 4||0
8639024|NCT02323334|21323150|P8|COMPLETED|Period 4||0
8639025|NCT02323334|21323151|P7|COMPLETED|Period 4||0
8639026|NCT02323334|21323152|P6|COMPLETED|Period 4||4
8639027|NCT02323334|21323153|P5|COMPLETED|Period 4||4
8639028|NCT02323334|21323154|P4|COMPLETED|Period 4||4
8639029|NCT02323334|21323155|P3|COMPLETED|Period 4||3
8639030|NCT02323334|21323156|P2|COMPLETED|Period 4||4
8639031|NCT02323334|21323157|P1|COMPLETED|Period 4||3
8639032|NCT02323334|21323141|P17|STARTED|Period 4||0
8639033|NCT02323334|21323142|P16|STARTED|Period 4||0
8639034|NCT02323334|21323143|P15|STARTED|Period 4||0
8639035|NCT02323334|21323144|P14|STARTED|Period 4||0
8639036|NCT02323334|21323145|P13|STARTED|Period 4||0
8639037|NCT02323334|21323146|P12|STARTED|Period 4||0
8639038|NCT02323334|21323147|P11|STARTED|Period 4||0
8639039|NCT02323334|21323148|P10|STARTED|Period 4||0
8639040|NCT02323334|21323149|P9|STARTED|Period 4||0
8639041|NCT02323334|21323150|P8|STARTED|Period 4||0
8639042|NCT02323334|21323151|P7|STARTED|Period 4||0
8639043|NCT02323334|21323152|P6|STARTED|Period 4||4
8639044|NCT02323334|21323153|P5|STARTED|Period 4||4
8639045|NCT02323334|21323154|P4|STARTED|Period 4||4
8639046|NCT02323334|21323155|P3|STARTED|Period 4||3
8639047|NCT02323334|21323156|P2|STARTED|Period 4||4
8639048|NCT02323334|21323157|P1|STARTED|Period 4||3
8639049|NCT02323334|21323141|P17|NOT COMPLETED|Period 3||0
8639050|NCT02323334|21323142|P16|NOT COMPLETED|Period 3||0
8639051|NCT02323334|21323143|P15|NOT COMPLETED|Period 3||0
8639052|NCT02323334|21323144|P14|NOT COMPLETED|Period 3||0
8639053|NCT02323334|21323145|P13|NOT COMPLETED|Period 3||0
8639054|NCT02323334|21323146|P12|NOT COMPLETED|Period 3||0
8639055|NCT02323334|21323147|P11|NOT COMPLETED|Period 3||0
8639056|NCT02323334|21323148|P10|NOT COMPLETED|Period 3||0
8639057|NCT02323334|21323149|P9|NOT COMPLETED|Period 3||0
8639058|NCT02323334|21323150|P8|NOT COMPLETED|Period 3||0
8639059|NCT02323334|21323151|P7|NOT COMPLETED|Period 3||0
8639060|NCT02323334|21323152|P6|NOT COMPLETED|Period 3||0
8639061|NCT02323334|21323153|P5|NOT COMPLETED|Period 3||0
8639062|NCT02323334|21323154|P4|NOT COMPLETED|Period 3||0
8639063|NCT02323334|21323155|P3|NOT COMPLETED|Period 3||1
8639064|NCT02323334|21323156|P2|NOT COMPLETED|Period 3||0
8639065|NCT02323334|21323157|P1|NOT COMPLETED|Period 3||1
8639066|NCT02323334|21323141|P17|COMPLETED|Period 3||0
8639067|NCT02323334|21323142|P16|COMPLETED|Period 3||0
8639068|NCT02323334|21323143|P15|COMPLETED|Period 3||0
8639069|NCT02323334|21323144|P14|COMPLETED|Period 3||0
8639070|NCT02323334|21323145|P13|COMPLETED|Period 3||0
8639071|NCT02323334|21323146|P12|COMPLETED|Period 3||0
8639072|NCT02323334|21323147|P11|COMPLETED|Period 3||0
8639073|NCT02323334|21323148|P10|COMPLETED|Period 3||0
8639074|NCT02323334|21323149|P9|COMPLETED|Period 3||0
8639075|NCT02323334|21323150|P8|COMPLETED|Period 3||0
8639076|NCT02323334|21323151|P7|COMPLETED|Period 3||0
8639077|NCT02323334|21323152|P6|COMPLETED|Period 3||4
8639078|NCT02323334|21323153|P5|COMPLETED|Period 3||4
8639079|NCT02323334|21323154|P4|COMPLETED|Period 3||4
8639080|NCT02323334|21323155|P3|COMPLETED|Period 3||3
8639081|NCT02323334|21323156|P2|COMPLETED|Period 3||4
8639082|NCT02323334|21323157|P1|COMPLETED|Period 3||3
8639083|NCT02323334|21323141|P17|STARTED|Period 3||0
8639084|NCT02323334|21323142|P16|STARTED|Period 3||0
8639085|NCT02323334|21323143|P15|STARTED|Period 3||0
8639086|NCT02323334|21323144|P14|STARTED|Period 3||0
8639087|NCT02323334|21323145|P13|STARTED|Period 3||0
8639088|NCT02323334|21323146|P12|STARTED|Period 3||0
8639089|NCT02323334|21323147|P11|STARTED|Period 3||0
8639090|NCT02323334|21323148|P10|STARTED|Period 3||0
8639091|NCT02323334|21323149|P9|STARTED|Period 3||0
8639092|NCT02323334|21323150|P8|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
8639093|NCT02323334|21323151|P7|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
8639094|NCT02323334|21323152|P6|STARTED|Period 3||4
8639095|NCT02323334|21323153|P5|STARTED|Period 3||4
8639096|NCT02323334|21323154|P4|STARTED|Period 3||4
8639097|NCT02323334|21323155|P3|STARTED|Period 3||4
8639098|NCT02323334|21323156|P2|STARTED|Period 3||4
8639099|NCT02323334|21323157|P1|STARTED|Period 3||4
8639100|NCT02323334|21323141|P17|NOT COMPLETED|Period 2||0
8639101|NCT02323334|21323142|P16|NOT COMPLETED|Period 2||0
8639102|NCT02323334|21323143|P15|NOT COMPLETED|Period 2||0
8639103|NCT02323334|21323144|P14|NOT COMPLETED|Period 2||0
8639104|NCT02323334|21323145|P13|NOT COMPLETED|Period 2||0
8639105|NCT02323334|21323146|P12|NOT COMPLETED|Period 2||0
8639106|NCT02323334|21323147|P11|NOT COMPLETED|Period 2||0
8639107|NCT02323334|21323148|P10|NOT COMPLETED|Period 2||0
8639108|NCT02323334|21323149|P9|NOT COMPLETED|Period 2||0
8639109|NCT02323334|21323150|P8|NOT COMPLETED|Period 2||0
8639110|NCT02323334|21323151|P7|NOT COMPLETED|Period 2||0
8639111|NCT02323334|21323152|P6|NOT COMPLETED|Period 2||0
8639112|NCT02323334|21323153|P5|NOT COMPLETED|Period 2||0
8639113|NCT02323334|21323154|P4|NOT COMPLETED|Period 2||0
8639114|NCT02323334|21323155|P3|NOT COMPLETED|Period 2||0
8639115|NCT02323334|21323156|P2|NOT COMPLETED|Period 2||0
8639116|NCT02323334|21323157|P1|NOT COMPLETED|Period 2||0
8639117|NCT02323334|21323141|P17|COMPLETED|Period 2||0
8639118|NCT02323334|21323142|P16|COMPLETED|Period 2||0
8639119|NCT02323334|21323143|P15|COMPLETED|Period 2||0
8639120|NCT02323334|21323144|P14|COMPLETED|Period 2||0
8639121|NCT02323334|21323145|P13|COMPLETED|Period 2||0
8639122|NCT02323334|21323146|P12|COMPLETED|Period 2||0
8639123|NCT02323334|21323147|P11|COMPLETED|Period 2||0
8639124|NCT02323334|21323148|P10|COMPLETED|Period 2||0
8639125|NCT02323334|21323149|P9|COMPLETED|Period 2||0
8639126|NCT02323334|21323150|P8|COMPLETED|Period 2||6
8639127|NCT02323334|21323151|P7|COMPLETED|Period 2||6
8639128|NCT02323334|21323152|P6|COMPLETED|Period 2||4
8639129|NCT02323334|21323153|P5|COMPLETED|Period 2||4
8639130|NCT02323334|21323154|P4|COMPLETED|Period 2||4
8639131|NCT02323334|21323155|P3|COMPLETED|Period 2||4
8639132|NCT02323334|21323156|P2|COMPLETED|Period 2||4
8639133|NCT02323334|21323157|P1|COMPLETED|Period 2||4
8639134|NCT02323334|21323141|P17|STARTED|Period 2|Part D was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8639135|NCT02323334|21323142|P16|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8639136|NCT02323334|21323143|P15|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8639137|NCT02323334|21323144|P14|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8639138|NCT02323334|21323145|P13|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8639139|NCT02323334|21323146|P12|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8639140|NCT02323334|21323147|P11|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8639141|NCT02323334|21323148|P10|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8639142|NCT02323334|21323149|P9|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
8639143|NCT02323334|21323150|P8|STARTED|Period 2||6
8639144|NCT02323334|21323151|P7|STARTED|Period 2||6
8639145|NCT02323334|21323152|P6|STARTED|Period 2||4
8639146|NCT02323334|21323153|P5|STARTED|Period 2||4
8639147|NCT02323334|21323154|P4|STARTED|Period 2||4
8639148|NCT02323334|21323155|P3|STARTED|Period 2||4
8639149|NCT02323334|21323156|P2|STARTED|Period 2||4
8639150|NCT02323334|21323157|P1|STARTED|Period 2||4
8639151|NCT02323334|21323141|P17|NOT COMPLETED|Period 1||0
8639152|NCT02323334|21323142|P16|NOT COMPLETED|Period 1||0
8639153|NCT02323334|21323143|P15|NOT COMPLETED|Period 1||0
8639154|NCT02323334|21323144|P14|NOT COMPLETED|Period 1||0
8639155|NCT02323334|21323145|P13|NOT COMPLETED|Period 1||0
8639156|NCT02323334|21323146|P12|NOT COMPLETED|Period 1||0
8639157|NCT02323334|21323147|P11|NOT COMPLETED|Period 1||0
8639158|NCT02323334|21323148|P10|NOT COMPLETED|Period 1||0
8639159|NCT02323334|21323149|P9|NOT COMPLETED|Period 1||0
8639160|NCT02323334|21323150|P8|NOT COMPLETED|Period 1||0
8639161|NCT02323334|21323151|P7|NOT COMPLETED|Period 1||0
8639162|NCT02323334|21323152|P6|NOT COMPLETED|Period 1||0
8639163|NCT02323334|21323153|P5|NOT COMPLETED|Period 1||0
8639164|NCT02323334|21323154|P4|NOT COMPLETED|Period 1||0
8639165|NCT02323334|21323155|P3|NOT COMPLETED|Period 1||0
8639166|NCT02323334|21323156|P2|NOT COMPLETED|Period 1||0
8639167|NCT02323334|21323157|P1|NOT COMPLETED|Period 1||0
8639168|NCT02323334|21323141|P17|COMPLETED|Period 1||2
8639169|NCT02323334|21323142|P16|COMPLETED|Period 1||9
8639170|NCT02323334|21323143|P15|COMPLETED|Period 1||9
8639171|NCT02323334|21323144|P14|COMPLETED|Period 1||9
8639172|NCT02323334|21323145|P13|COMPLETED|Period 1||9
8639173|NCT02323334|21323146|P12|COMPLETED|Period 1||3
8639174|NCT02323334|21323147|P11|COMPLETED|Period 1||5
8639175|NCT02323334|21323148|P10|COMPLETED|Period 1||7
8639176|NCT02323334|21323149|P9|COMPLETED|Period 1||5
8639177|NCT02323334|21323150|P8|COMPLETED|Period 1||6
8639178|NCT02323334|21323151|P7|COMPLETED|Period 1||6
8639179|NCT02323334|21323152|P6|COMPLETED|Period 1||4
8639180|NCT02323334|21323153|P5|COMPLETED|Period 1||4
8639181|NCT02323334|21323154|P4|COMPLETED|Period 1||4
8639182|NCT02323334|21323155|P3|COMPLETED|Period 1||4
8639183|NCT02323334|21323156|P2|COMPLETED|Period 1||4
8639184|NCT02323334|21323157|P1|COMPLETED|Period 1||4
8639185|NCT02323334|21323141|P17|Received at Least One Dose of Study Drug|Period 1||2
8639186|NCT02323334|21323142|P16|Received at Least One Dose of Study Drug|Period 1||9
8639187|NCT02323334|21323143|P15|Received at Least One Dose of Study Drug|Period 1||9
8639188|NCT02323334|21323144|P14|Received at Least One Dose of Study Drug|Period 1||9
8639189|NCT02323334|21323145|P13|Received at Least One Dose of Study Drug|Period 1||9
8639190|NCT02323334|21323146|P12|Received at Least One Dose of Study Drug|Period 1||3
8639191|NCT02323334|21323147|P11|Received at Least One Dose of Study Drug|Period 1||5
8639192|NCT02323334|21323148|P10|Received at Least One Dose of Study Drug|Period 1||7
8639193|NCT02323334|21323149|P9|Received at Least One Dose of Study Drug|Period 1||5
8639194|NCT02323334|21323150|P8|Received at Least One Dose of Study Drug|Period 1||6
8639195|NCT02323334|21323151|P7|Received at Least One Dose of Study Drug|Period 1||6
8639196|NCT02323334|21323152|P6|Received at Least One Dose of Study Drug|Period 1||4
8639197|NCT02323334|21323153|P5|Received at Least One Dose of Study Drug|Period 1||4
8639198|NCT02323334|21323154|P4|Received at Least One Dose of Study Drug|Period 1||4
8639199|NCT02323334|21323155|P3|Received at Least One Dose of Study Drug|Period 1||4
8639200|NCT02323334|21323156|P2|Received at Least One Dose of Study Drug|Period 1||4
8639201|NCT02323334|21323157|P1|Received at Least One Dose of Study Drug|Period 1||4
8639202|NCT02323334|21323141|P17|STARTED|Period 1||2
8639203|NCT02323334|21323142|P16|STARTED|Period 1||9
8639204|NCT02323334|21323143|P15|STARTED|Period 1||9
8639205|NCT02323334|21323144|P14|STARTED|Period 1||9
8639206|NCT02323334|21323145|P13|STARTED|Period 1||9
8639207|NCT02323334|21323146|P12|STARTED|Period 1||3
8639208|NCT02323334|21323147|P11|STARTED|Period 1||5
8639209|NCT02323334|21323148|P10|STARTED|Period 1||7
8639210|NCT02323334|21323149|P9|STARTED|Period 1||5
8639211|NCT02323334|21323150|P8|STARTED|Period 1||6
8639212|NCT02323334|21323151|P7|STARTED|Period 1||6
8639213|NCT02323334|21323152|P6|STARTED|Period 1||4
8639214|NCT02323334|21323153|P5|STARTED|Period 1||4
8639215|NCT02323334|21323154|P4|STARTED|Period 1||4
8639216|NCT02323334|21323155|P3|STARTED|Period 1||4
8639217|NCT02323334|21323156|P2|STARTED|Period 1||4
8639218|NCT02323334|21323157|P1|STARTED|Period 1||4
8639219|NCT02130297|21323229|P1|NOT COMPLETED|Overall Study||4
8639220|NCT02130297|21323229|P1|COMPLETED|Overall Study||26
8639221|NCT02130297|21323229|P1|STARTED|Overall Study||30
8639222|NCT02127710|21323238|P3|NOT COMPLETED|Overall Study||0
8639223|NCT02127710|21323239|P2|NOT COMPLETED|Overall Study||0
8639224|NCT02127710|21323240|P1|NOT COMPLETED|Overall Study||0
8639225|NCT02127710|21323238|P3|COMPLETED|Overall Study||16
8639226|NCT02127710|21323239|P2|COMPLETED|Overall Study||47
8639227|NCT02127710|21323240|P1|COMPLETED|Overall Study||46
8639228|NCT02127710|21323238|P3|STARTED|Overall Study||16
8639229|NCT02127710|21323239|P2|STARTED|Overall Study||47
8639230|NCT02127710|21323240|P1|STARTED|Overall Study||46
8639231|NCT02104427|21323280|P1|NOT COMPLETED|Overall Study||0
8639232|NCT02104427|21323280|P1|COMPLETED|Overall Study||12
8639233|NCT02104427|21323280|P1|STARTED|Overall Study||12
8639252|NCT02001974|21323408|P3|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||26
8639253|NCT02001974|21323409|P2|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||3
8639254|NCT02001974|21323410|P1|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||4
8639255|NCT02001974|21323408|P3|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
8639256|NCT02001974|21323409|P2|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
8639257|NCT02001974|21323410|P1|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
8639258|NCT02001974|21323408|P3|STARTED|Reparixin + Paclitaxel (28-day Cycles)||26
8639259|NCT02001974|21323409|P2|STARTED|Reparixin + Paclitaxel (28-day Cycles)||3
8639260|NCT02001974|21323410|P1|STARTED|Reparixin + Paclitaxel (28-day Cycles)||4
8639261|NCT02001974|21323408|P3|NOT COMPLETED|Run-in Period||0
8639262|NCT02001974|21323409|P2|NOT COMPLETED|Run-in Period||0
8639263|NCT02001974|21323410|P1|NOT COMPLETED|Run-in Period||0
8639264|NCT02001974|21323408|P3|COMPLETED|Run-in Period||26
8639265|NCT02001974|21323409|P2|COMPLETED|Run-in Period||3
8639266|NCT02001974|21323410|P1|COMPLETED|Run-in Period||4
8639267|NCT02001974|21323408|P3|STARTED|Run-in Period||26
8639268|NCT02001974|21323409|P2|STARTED|Run-in Period||3
8639269|NCT02001974|21323410|P1|STARTED|Run-in Period||4
8639278|NCT01901289|21323543|P1|NOT COMPLETED|Overall Study||200
8639279|NCT01901289|21323543|P1|COMPLETED|Overall Study||0
8639280|NCT01901289|21323543|P1|12-Month Follow-up|Overall Study||175
8639281|NCT01901289|21323543|P1|STARTED|Overall Study||200
8639285|NCT01838551|21323551|P1|NOT COMPLETED|Overall Study||48
8639286|NCT01838551|21323551|P1|COMPLETED|Overall Study|46 subjects completed the Extended Evaluation phase|46
8639287|NCT01838551|21323551|P1|STARTED|Overall Study|94 subjects were enrolled and received at least 1 dose of levoketoconazole|94
8639288|NCT01780454|21323555|P1|NOT COMPLETED|Overall Study||0
8639289|NCT01780454|21323555|P1|COMPLETED|Overall Study||2
8639290|NCT01780454|21323555|P1|STARTED|Overall Study||2
8639303|NCT01526408|21323596|P2|NOT COMPLETED|Overall Study||0
8639304|NCT01526408|21323597|P1|NOT COMPLETED|Overall Study||0
8639305|NCT01526408|21323596|P2|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
8639306|NCT01526408|21323597|P1|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
8639307|NCT01526408|21323596|P2|STARTED|Overall Study|early termination of study and sponsor organization closed|0
8639308|NCT01526408|21323597|P1|STARTED|Overall Study|early termination of study and sponsor organization closed|0
8639309|NCT01463358|21323607|P2|NOT COMPLETED|Overall Study||5
8639310|NCT01463358|21323608|P1|NOT COMPLETED|Overall Study||3
8639311|NCT01463358|21323607|P2|COMPLETED|Overall Study||47
8639312|NCT01463358|21323608|P1|COMPLETED|Overall Study||46
8639313|NCT01463358|21323607|P2|STARTED|Overall Study||52
8639314|NCT01463358|21323608|P1|STARTED|Overall Study||49
8639315|NCT01458288|21323618|P1|NOT COMPLETED|Overall Study||0
8639316|NCT01458288|21323618|P1|COMPLETED|Overall Study||12
8639317|NCT01458288|21323618|P1|STARTED|Overall Study||12
8639338|NCT01342796|21323638|P2|NOT COMPLETED|Overall Study||3
8639339|NCT01342796|21323639|P1|NOT COMPLETED|Overall Study||3
8639340|NCT01342796|21323638|P2|COMPLETED|Overall Study||38
8639341|NCT01342796|21323639|P1|COMPLETED|Overall Study||40
8639342|NCT01342796|21323638|P2|STARTED|Overall Study||41
8639343|NCT01342796|21323639|P1|STARTED|Overall Study||43
8639344|NCT01050231|21323655|P2|NOT COMPLETED|Overall Study||0
8639345|NCT01050231|21323656|P1|NOT COMPLETED|Overall Study||0
8639346|NCT01050231|21323655|P2|COMPLETED|Overall Study||10
8639347|NCT01050231|21323656|P1|COMPLETED|Overall Study||10
8639348|NCT01050231|21323655|P2|STARTED|Overall Study||10
8639349|NCT01050231|21323656|P1|STARTED|Overall Study||10
8639353|NCT00570128|21323677|P2|NOT COMPLETED|Overall Study||0
8639354|NCT00570128|21323678|P1|NOT COMPLETED|Overall Study||4
8639355|NCT00570128|21323677|P2|COMPLETED|Overall Study||65
8639356|NCT00570128|21323678|P1|COMPLETED|Overall Study||60
8639357|NCT00570128|21323677|P2|Intent to Treat (ITT) Population|Overall Study||65
8639358|NCT00570128|21323678|P1|Intent to Treat (ITT) Population|Overall Study||62
8639359|NCT00570128|21323677|P2|STARTED|Overall Study||65
8639360|NCT00570128|21323678|P1|STARTED|Overall Study||64
8639361|NCT00391365|21323692|P2|NOT COMPLETED|Overall Study||19
8639362|NCT00391365|21323693|P1|NOT COMPLETED|Overall Study||25
8639363|NCT00391365|21323692|P2|COMPLETED|Overall Study||151
8639364|NCT00391365|21323693|P1|COMPLETED|Overall Study||78
8639365|NCT00391365|21323692|P2|STARTED|Overall Study||170
8639366|NCT00391365|21323693|P1|STARTED|Overall Study||103
8639385|NCT04737278|21323714|P2|NOT COMPLETED|Overall Study||3
8639386|NCT04737278|21323715|P1|NOT COMPLETED|Overall Study||4
8639387|NCT04737278|21323714|P2|COMPLETED|Overall Study||25
8639388|NCT04737278|21323715|P1|COMPLETED|Overall Study||24
8639389|NCT04737278|21323714|P2|STARTED|Overall Study||28
8639390|NCT04737278|21323715|P1|STARTED|Overall Study||28
8639391|NCT04521777|21323787|P1|NOT COMPLETED|Overall Study||4
8639392|NCT04521777|21323787|P1|COMPLETED|Overall Study||20
8639393|NCT04521777|21323787|P1|STARTED|Overall Study||24
8639394|NCT04392141|21323798|P2|NOT COMPLETED|Overall Study||0
8639395|NCT04392141|21323799|P1|NOT COMPLETED|Overall Study||0
8639396|NCT04392141|21323798|P2|COMPLETED|Overall Study||60
8639397|NCT04392141|21323799|P1|COMPLETED|Overall Study||60
8639398|NCT04392141|21323798|P2|STARTED|Overall Study||60
8639399|NCT04392141|21323799|P1|STARTED|Overall Study||60
8639400|NCT04041037|21323813|P1|NOT COMPLETED|Overall Study||0
8639401|NCT04041037|21323813|P1|COMPLETED|Overall Study||2
8639402|NCT04041037|21323813|P1|STARTED|Overall Study||2
8639406|NCT03891862|21323838|P3|NOT COMPLETED|Placebo-controlled Period and Follow-up||4
8639407|NCT03891862|21323839|P2|NOT COMPLETED|Placebo-controlled Period and Follow-up||6
8639408|NCT03891862|21323840|P1|NOT COMPLETED|Placebo-controlled Period and Follow-up||0
8639409|NCT03891862|21323838|P3|COMPLETED|Placebo-controlled Period and Follow-up||55
8639410|NCT03891862|21323839|P2|COMPLETED|Placebo-controlled Period and Follow-up||53
8639411|NCT03891862|21323840|P1|COMPLETED|Placebo-controlled Period and Follow-up||0
8639412|NCT03891862|21323838|P3|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||56
8639413|NCT03891862|21323839|P2|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||53
8639414|NCT03891862|21323840|P1|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||0
8639415|NCT03891862|21323838|P3|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||59
8639416|NCT03891862|21323839|P2|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||58
8639417|NCT03891862|21323840|P1|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||0
8639418|NCT03891862|21323838|P3|STARTED|Placebo-controlled Period and Follow-up||59
8639419|NCT03891862|21323839|P2|STARTED|Placebo-controlled Period and Follow-up||59
8639420|NCT03891862|21323840|P1|STARTED|Placebo-controlled Period and Follow-up||0
8639421|NCT03891862|21323838|P3|NOT COMPLETED|Open-label Period||0
8639422|NCT03891862|21323839|P2|NOT COMPLETED|Open-label Period||0
8639423|NCT03891862|21323840|P1|NOT COMPLETED|Open-label Period||16
8639424|NCT03891862|21323838|P3|COMPLETED|Open-label Period||0
8639425|NCT03891862|21323839|P2|COMPLETED|Open-label Period||0
8639426|NCT03891862|21323840|P1|COMPLETED|Open-label Period||119
8639427|NCT03891862|21323838|P3|Safety Analysis Set|Open-label Period||0
8639428|NCT03891862|21323839|P2|Safety Analysis Set|Open-label Period||0
8639429|NCT03891862|21323840|P1|Safety Analysis Set|Open-label Period||132
8639430|NCT03891862|21323838|P3|STARTED|Open-label Period||0
8639431|NCT03891862|21323839|P2|STARTED|Open-label Period||0
8639432|NCT03891862|21323840|P1|STARTED|Open-label Period||135
8639433|NCT03869684|21323854|P3|NOT COMPLETED|Overall Study||3
8639434|NCT03869684|21323855|P2|NOT COMPLETED|Overall Study||3
8639435|NCT03869684|21323856|P1|NOT COMPLETED|Overall Study||2
8639436|NCT03869684|21323854|P3|COMPLETED|Overall Study||2
8639437|NCT03869684|21323855|P2|COMPLETED|Overall Study||2
8639438|NCT03869684|21323856|P1|COMPLETED|Overall Study||1
8639439|NCT03869684|21323854|P3|STARTED|Overall Study||5
8639440|NCT03869684|21323855|P2|STARTED|Overall Study||5
8639441|NCT03869684|21323856|P1|STARTED|Overall Study||3
8639442|NCT03831191|21323871|P15|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639443|NCT03831191|21323872|P14|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639444|NCT03831191|21323873|P13|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639445|NCT03831191|21323874|P12|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639446|NCT03831191|21323875|P11|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639447|NCT03831191|21323876|P10|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639448|NCT03831191|21323877|P9|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639449|NCT03831191|21323878|P8|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639450|NCT03831191|21323879|P7|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639451|NCT03831191|21323880|P6|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639452|NCT03831191|21323881|P5|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639453|NCT03831191|21323882|P4|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639454|NCT03831191|21323883|P3|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639455|NCT03831191|21323884|P2|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639456|NCT03831191|21323885|P1|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639457|NCT03831191|21323871|P15|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639458|NCT03831191|21323872|P14|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639459|NCT03831191|21323873|P13|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639460|NCT03831191|21323874|P12|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639461|NCT03831191|21323875|P11|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639462|NCT03831191|21323876|P10|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639463|NCT03831191|21323877|P9|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639464|NCT03831191|21323878|P8|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639465|NCT03831191|21323879|P7|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639466|NCT03831191|21323880|P6|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639467|NCT03831191|21323881|P5|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639468|NCT03831191|21323882|P4|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639469|NCT03831191|21323883|P3|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639470|NCT03831191|21323884|P2|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639471|NCT03831191|21323885|P1|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639472|NCT03831191|21323871|P15|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639473|NCT03831191|21323872|P14|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639474|NCT03831191|21323873|P13|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639475|NCT03831191|21323874|P12|STARTED|Post-Treatment Follow-Up Period(8 Weeks)|No participant entered the post follow-up period.|0
8639476|NCT03831191|21323875|P11|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639477|NCT03831191|21323876|P10|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639478|NCT03831191|21323877|P9|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639479|NCT03831191|21323878|P8|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639480|NCT03831191|21323879|P7|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639481|NCT03831191|21323880|P6|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639482|NCT03831191|21323881|P5|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639483|NCT03831191|21323882|P4|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639484|NCT03831191|21323883|P3|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639485|NCT03831191|21323884|P2|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639486|NCT03831191|21323885|P1|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
8639487|NCT03831191|21323871|P15|NOT COMPLETED|Maintenance Period (36 Weeks)||9
8639488|NCT03831191|21323872|P14|NOT COMPLETED|Maintenance Period (36 Weeks)||1
8639489|NCT03831191|21323873|P13|NOT COMPLETED|Maintenance Period (36 Weeks)||1
8639490|NCT03831191|21323874|P12|NOT COMPLETED|Maintenance Period (36 Weeks)||7
8639491|NCT03831191|21323875|P11|NOT COMPLETED|Maintenance Period (36 Weeks)||4
8639492|NCT03831191|21323876|P10|NOT COMPLETED|Maintenance Period (36 Weeks)||1
8639493|NCT03831191|21323877|P9|NOT COMPLETED|Maintenance Period (36 Weeks)||8
8639494|NCT03831191|21323878|P8|NOT COMPLETED|Maintenance Period (36 Weeks)||4
8639495|NCT03831191|21323879|P7|NOT COMPLETED|Maintenance Period (36 Weeks)||2
8639496|NCT03831191|21323880|P6|NOT COMPLETED|Maintenance Period (36 Weeks)||5
8639497|NCT03831191|21323881|P5|NOT COMPLETED|Maintenance Period (36 Weeks)||4
8639498|NCT03831191|21323882|P4|NOT COMPLETED|Maintenance Period (36 Weeks)||0
8639499|NCT03831191|21323883|P3|NOT COMPLETED|Maintenance Period (36 Weeks)||0
8639500|NCT03831191|21323884|P2|NOT COMPLETED|Maintenance Period (36 Weeks)||0
8639501|NCT03831191|21323885|P1|NOT COMPLETED|Maintenance Period (36 Weeks)||0
8639502|NCT03831191|21323871|P15|COMPLETED|Maintenance Period (36 Weeks)||0
8639503|NCT03831191|21323872|P14|COMPLETED|Maintenance Period (36 Weeks)||0
8639504|NCT03831191|21323873|P13|COMPLETED|Maintenance Period (36 Weeks)||0
8639505|NCT03831191|21323874|P12|COMPLETED|Maintenance Period (36 Weeks)||1
8639506|NCT03831191|21323875|P11|COMPLETED|Maintenance Period (36 Weeks)||0
8639507|NCT03831191|21323876|P10|COMPLETED|Maintenance Period (36 Weeks)||0
8639508|NCT03831191|21323877|P9|COMPLETED|Maintenance Period (36 Weeks)||0
8639509|NCT03831191|21323878|P8|COMPLETED|Maintenance Period (36 Weeks)||0
8639510|NCT03831191|21323879|P7|COMPLETED|Maintenance Period (36 Weeks)||0
8639511|NCT03831191|21323880|P6|COMPLETED|Maintenance Period (36 Weeks)||0
8639512|NCT03831191|21323881|P5|COMPLETED|Maintenance Period (36 Weeks)||0
8639513|NCT03831191|21323882|P4|COMPLETED|Maintenance Period (36 Weeks)||0
8639514|NCT03831191|21323883|P3|COMPLETED|Maintenance Period (36 Weeks)||0
8639515|NCT03831191|21323884|P2|COMPLETED|Maintenance Period (36 Weeks)||0
8639516|NCT03831191|21323885|P1|COMPLETED|Maintenance Period (36 Weeks)||0
8639517|NCT03831191|21323871|P15|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|9
8639518|NCT03831191|21323872|P14|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
8639519|NCT03831191|21323873|P13|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
8639520|NCT03831191|21323874|P12|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
8639521|NCT03831191|21323875|P11|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
8639522|NCT03831191|21323876|P10|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
8639523|NCT03831191|21323877|P9|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
8639524|NCT03831191|21323878|P8|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
8639525|NCT03831191|21323879|P7|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|2
8639526|NCT03831191|21323880|P6|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|5
8639527|NCT03831191|21323881|P5|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
8639528|NCT03831191|21323882|P4|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
8639529|NCT03831191|21323883|P3|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
8639530|NCT03831191|21323884|P2|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
8639531|NCT03831191|21323885|P1|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
8639532|NCT03831191|21323871|P15|NOT COMPLETED|Induction Period (16 Weeks)||0
8639533|NCT03831191|21323872|P14|NOT COMPLETED|Induction Period (16 Weeks)||0
8639534|NCT03831191|21323873|P13|NOT COMPLETED|Induction Period (16 Weeks)||0
8639535|NCT03831191|21323874|P12|NOT COMPLETED|Induction Period (16 Weeks)||0
8639536|NCT03831191|21323875|P11|NOT COMPLETED|Induction Period (16 Weeks)||0
8639537|NCT03831191|21323876|P10|NOT COMPLETED|Induction Period (16 Weeks)||0
8639538|NCT03831191|21323877|P9|NOT COMPLETED|Induction Period (16 Weeks)||0
8639539|NCT03831191|21323878|P8|NOT COMPLETED|Induction Period (16 Weeks)||0
8639540|NCT03831191|21323879|P7|NOT COMPLETED|Induction Period (16 Weeks)||0
8639541|NCT03831191|21323880|P6|NOT COMPLETED|Induction Period (16 Weeks)||0
8639542|NCT03831191|21323881|P5|NOT COMPLETED|Induction Period (16 Weeks)||0
8639543|NCT03831191|21323882|P4|NOT COMPLETED|Induction Period (16 Weeks)||23
8639544|NCT03831191|21323883|P3|NOT COMPLETED|Induction Period (16 Weeks)||21
8639545|NCT03831191|21323884|P2|NOT COMPLETED|Induction Period (16 Weeks)||21
8639546|NCT03831191|21323885|P1|NOT COMPLETED|Induction Period (16 Weeks)||23
8639547|NCT03831191|21323871|P15|COMPLETED|Induction Period (16 Weeks)||0
8639548|NCT03831191|21323872|P14|COMPLETED|Induction Period (16 Weeks)||0
8639549|NCT03831191|21323873|P13|COMPLETED|Induction Period (16 Weeks)||0
8639550|NCT03831191|21323874|P12|COMPLETED|Induction Period (16 Weeks)||0
8639551|NCT03831191|21323875|P11|COMPLETED|Induction Period (16 Weeks)||0
8639552|NCT03831191|21323876|P10|COMPLETED|Induction Period (16 Weeks)||0
8639553|NCT03831191|21323877|P9|COMPLETED|Induction Period (16 Weeks)||0
8639554|NCT03831191|21323878|P8|COMPLETED|Induction Period (16 Weeks)||0
8639555|NCT03831191|21323879|P7|COMPLETED|Induction Period (16 Weeks)||0
8639556|NCT03831191|21323880|P6|COMPLETED|Induction Period (16 Weeks)||0
8639557|NCT03831191|21323881|P5|COMPLETED|Induction Period (16 Weeks)||0
8639558|NCT03831191|21323882|P4|COMPLETED|Induction Period (16 Weeks)||11
8639559|NCT03831191|21323883|P3|COMPLETED|Induction Period (16 Weeks)||13
8639560|NCT03831191|21323884|P2|COMPLETED|Induction Period (16 Weeks)||14
8639561|NCT03831191|21323885|P1|COMPLETED|Induction Period (16 Weeks)||10
8639562|NCT03831191|21323871|P15|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8639563|NCT03831191|21323872|P14|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8639564|NCT03831191|21323873|P13|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8639565|NCT03831191|21323874|P12|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8639566|NCT03831191|21323875|P11|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8639567|NCT03831191|21323876|P10|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8639568|NCT03831191|21323877|P9|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8639569|NCT03831191|21323878|P8|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8639570|NCT03831191|21323879|P7|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8639571|NCT03831191|21323880|P6|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8639572|NCT03831191|21323881|P5|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
8639573|NCT03831191|21323882|P4|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
8639574|NCT03831191|21323883|P3|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||34
8639575|NCT03831191|21323884|P2|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||35
8639576|NCT03831191|21323885|P1|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
8639577|NCT03831191|21323871|P15|STARTED|Induction Period (16 Weeks)||0
8639578|NCT03831191|21323872|P14|STARTED|Induction Period (16 Weeks)||0
8639579|NCT03831191|21323873|P13|STARTED|Induction Period (16 Weeks)||0
8639580|NCT03831191|21323874|P12|STARTED|Induction Period (16 Weeks)||0
8639581|NCT03831191|21323875|P11|STARTED|Induction Period (16 Weeks)||0
8639582|NCT03831191|21323876|P10|STARTED|Induction Period (16 Weeks)||0
8639583|NCT03831191|21323877|P9|STARTED|Induction Period (16 Weeks)||0
8639584|NCT03831191|21323878|P8|STARTED|Induction Period (16 Weeks)||0
8639585|NCT03831191|21323879|P7|STARTED|Induction Period (16 Weeks)||0
8639586|NCT03831191|21323880|P6|STARTED|Induction Period (16 Weeks)||0
8639587|NCT03831191|21323881|P5|STARTED|Induction Period (16 Weeks)||0
8639588|NCT03831191|21323882|P4|STARTED|Induction Period (16 Weeks)||34
8639589|NCT03831191|21323883|P3|STARTED|Induction Period (16 Weeks)||34
8639590|NCT03831191|21323884|P2|STARTED|Induction Period (16 Weeks)||35
8639591|NCT03831191|21323885|P1|STARTED|Induction Period (16 Weeks)||33
8639592|NCT03741088|21323938|P1|NOT COMPLETED|Overall Study||3
8639593|NCT03741088|21323938|P1|COMPLETED|Overall Study||5
8639594|NCT03741088|21323938|P1|STARTED|Overall Study||8
8639595|NCT03724968|21323961|P2|NOT COMPLETED|Overall Study||2
8639596|NCT03724968|21323962|P1|NOT COMPLETED|Overall Study||0
8639597|NCT03724968|21323961|P2|COMPLETED|Overall Study||0
8639598|NCT03724968|21323962|P1|COMPLETED|Overall Study||0
8639599|NCT03724968|21323961|P2|STARTED|Overall Study||2
8639600|NCT03724968|21323962|P1|STARTED|Overall Study||0
8639601|NCT03694275|21323978|P2|NOT COMPLETED|Overall Study||2
8639602|NCT03694275|21323979|P1|NOT COMPLETED|Overall Study||0
8639603|NCT03694275|21323978|P2|COMPLETED|Overall Study||10
8639604|NCT03694275|21323979|P1|COMPLETED|Overall Study||8
8639605|NCT03694275|21323978|P2|STARTED|Overall Study||12
8639606|NCT03694275|21323979|P1|STARTED|Overall Study||8
8639607|NCT03682965|21324004|P2|NOT COMPLETED|Overall Study||0
8639608|NCT03682965|21324005|P1|NOT COMPLETED|Overall Study||0
8639609|NCT03682965|21324004|P2|COMPLETED|Overall Study||10
8639610|NCT03682965|21324005|P1|COMPLETED|Overall Study||11
8639611|NCT03682965|21324004|P2|STARTED|Overall Study||10
8639612|NCT03682965|21324005|P1|STARTED|Overall Study||11
8639613|NCT03672396|21324025|P1|NOT COMPLETED|Overall Study||6
8639614|NCT03672396|21324025|P1|COMPLETED|Overall Study||16
8639615|NCT03672396|21324025|P1|STARTED|Overall Study||22
8639616|NCT03597009|21324048|P1|NOT COMPLETED|Overall Study||0
8639617|NCT03597009|21324048|P1|COMPLETED|Overall Study||1
8639618|NCT03597009|21324048|P1|STARTED|Overall Study||1
8639619|NCT03499028|21324060|P2|NOT COMPLETED|Overall Study||25
8639620|NCT03499028|21324061|P1|NOT COMPLETED|Overall Study||22
8639621|NCT03499028|21324060|P2|COMPLETED|Overall Study||195
8639622|NCT03499028|21324061|P1|COMPLETED|Overall Study||204
8639623|NCT03499028|21324060|P2|STARTED|Overall Study||220
8639624|NCT03499028|21324061|P1|STARTED|Overall Study||226
8639625|NCT03487848|21324085|P1|NOT COMPLETED|Overall Study||1
8639626|NCT03487848|21324085|P1|COMPLETED|Overall Study||4
8639627|NCT03487848|21324085|P1|STARTED|Overall Study||5
8639628|NCT03296345|21324097|P1|NOT COMPLETED|Overall Study||0
8639629|NCT03296345|21324097|P1|COMPLETED|Overall Study||62
8639630|NCT03296345|21324097|P1|STARTED|Overall Study||62
8639631|NCT03283787|21324116|P3|NOT COMPLETED|Overall Study||7
8639632|NCT03283787|21324117|P2|NOT COMPLETED|Overall Study||7
8639633|NCT03283787|21324118|P1|NOT COMPLETED|Overall Study||3
8639634|NCT03283787|21324116|P3|COMPLETED|Overall Study||13
8639635|NCT03283787|21324117|P2|COMPLETED|Overall Study||13
8639636|NCT03283787|21324118|P1|COMPLETED|Overall Study||17
8639637|NCT03283787|21324116|P3|STARTED|Overall Study||20
8639638|NCT03283787|21324117|P2|STARTED|Overall Study||20
8639639|NCT03283787|21324118|P1|STARTED|Overall Study||20
8639640|NCT03213457|21324135|P3|NOT COMPLETED|Overall Study||174
8639641|NCT03213457|21324136|P2|NOT COMPLETED|Overall Study||39
8639642|NCT03213457|21324137|P1|NOT COMPLETED|Overall Study||88
8639643|NCT03213457|21324135|P3|COMPLETED|Overall Study||215
8639644|NCT03213457|21324136|P2|COMPLETED|Overall Study||59
8639645|NCT03213457|21324137|P1|COMPLETED|Overall Study||106
8639646|NCT03213457|21324135|P3|Randomized and Treated|Overall Study||389
8639647|NCT03213457|21324136|P2|Randomized and Treated|Overall Study||97
8639648|NCT03213457|21324137|P1|Randomized and Treated|Overall Study||193
8639649|NCT03213457|21324135|P3|STARTED|Overall Study||389
8639650|NCT03213457|21324136|P2|STARTED|Overall Study||98
8639651|NCT03213457|21324137|P1|STARTED|Overall Study||194
8639652|NCT03172780|21324177|P3|NOT COMPLETED|Overall Study||16
8639653|NCT03172780|21324178|P2|NOT COMPLETED|Overall Study||20
8639654|NCT03172780|21324179|P1|NOT COMPLETED|Overall Study||18
8639655|NCT03172780|21324177|P3|COMPLETED|Overall Study||389
8639656|NCT03172780|21324178|P2|COMPLETED|Overall Study||389
8639657|NCT03172780|21324179|P1|COMPLETED|Overall Study||388
8639658|NCT03172780|21324177|P3|STARTED|Overall Study||405
8639659|NCT03172780|21324178|P2|STARTED|Overall Study||409
8639660|NCT03172780|21324179|P1|STARTED|Overall Study||406
8639676|NCT03061175|21324241|P2|NOT COMPLETED|Followup 2 at 6 Months||7
8639677|NCT03061175|21324242|P1|NOT COMPLETED|Followup 2 at 6 Months||4
8639678|NCT03061175|21324241|P2|COMPLETED|Followup 2 at 6 Months|39 participants completed the follow-up survey out of the 46 who were sent the survey|39
8639679|NCT03061175|21324242|P1|COMPLETED|Followup 2 at 6 Months|41 participants completed the 2nd follow-up survey out of the 45 who were sent the survey|41
8639680|NCT03061175|21324241|P2|STARTED|Followup 2 at 6 Months|1 participant withdrew from the study in between the 1st and 2nd follow-up survey so only 46 sent|46
8639681|NCT03061175|21324242|P1|STARTED|Followup 2 at 6 Months|Participants who skipped the first follow-up survey were still sent the second FU survey|45
8639682|NCT03061175|21324241|P2|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||3
8639683|NCT03061175|21324242|P1|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||6
8639684|NCT03061175|21324241|P2|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|44 participants completed the follow-up survey out of the 47 who were sent the survey|44
8639685|NCT03061175|21324242|P1|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|39 participants completed the follow-up survey out of the 45 who were sent the survey|39
8639686|NCT03061175|21324241|P2|STARTED|Followup 1 at 2-4 Weeks Post-surgery||47
8639687|NCT03061175|21324242|P1|STARTED|Followup 1 at 2-4 Weeks Post-surgery|1 Participant dropped out of the study before the follow-up survey was to be sent|45
8639688|NCT03061175|21324241|P2|NOT COMPLETED|Baseline||0
8639689|NCT03061175|21324242|P1|NOT COMPLETED|Baseline||1
8639690|NCT03061175|21324241|P2|COMPLETED|Baseline||47
8639691|NCT03061175|21324242|P1|COMPLETED|Baseline||46
8639692|NCT03061175|21324241|P2|STARTED|Baseline||47
8639693|NCT03061175|21324242|P1|STARTED|Baseline||47
8639694|NCT03040414|21324266|P2|NOT COMPLETED|Overall Study||1
8639695|NCT03040414|21324267|P1|NOT COMPLETED|Overall Study||1
8639696|NCT03040414|21324266|P2|COMPLETED|Overall Study||55
8639697|NCT03040414|21324267|P1|COMPLETED|Overall Study||56
8639698|NCT03040414|21324266|P2|Started Period 2|Overall Study||55
8639699|NCT03040414|21324267|P1|Started Period 2|Overall Study||56
8639700|NCT03040414|21324266|P2|Completed Period 1|Overall Study||55
8639701|NCT03040414|21324267|P1|Completed Period 1|Overall Study||56
8639702|NCT03040414|21324266|P2|STARTED|Overall Study||56
8639703|NCT03040414|21324267|P1|STARTED|Overall Study||57
8639704|NCT02960893|21324299|P2|NOT COMPLETED|Extension Phase (48-week)||13
8639705|NCT02960893|21324300|P1|NOT COMPLETED|Extension Phase (48-week)||14
8639706|NCT02960893|21324299|P2|COMPLETED|Extension Phase (48-week)||54
8639707|NCT02960893|21324300|P1|COMPLETED|Extension Phase (48-week)||50
8639708|NCT02960893|21324299|P2|STARTED|Extension Phase (48-week)|One participant in placebo arm who completed Randomization Phase did not continue to Extension Phase|67
8639709|NCT02960893|21324300|P1|STARTED|Extension Phase (48-week)||64
8639710|NCT02960893|21324299|P2|NOT COMPLETED|Randomization Phase (8-week)||2
8639711|NCT02960893|21324300|P1|NOT COMPLETED|Randomization Phase (8-week)||7
8639712|NCT02960893|21324299|P2|COMPLETED|Randomization Phase (8-week)||68
8639713|NCT02960893|21324300|P1|COMPLETED|Randomization Phase (8-week)||64
8639714|NCT02960893|21324299|P2|STARTED|Randomization Phase (8-week)||70
8639715|NCT02960893|21324300|P1|STARTED|Randomization Phase (8-week)||71
8639716|NCT02858076|21324318|P2|NOT COMPLETED|Overall Study||18
8639717|NCT02858076|21324319|P1|NOT COMPLETED|Overall Study||10
8639718|NCT02858076|21324318|P2|COMPLETED|Overall Study||87
8639719|NCT02858076|21324319|P1|COMPLETED|Overall Study||90
8639720|NCT02858076|21324318|P2|STARTED|Overall Study||105
8639721|NCT02858076|21324319|P1|STARTED|Overall Study||100
8639722|NCT02667301|21324355|P1|NOT COMPLETED|Overall Study||2
8639723|NCT02667301|21324355|P1|COMPLETED|Overall Study||14
8639724|NCT02667301|21324355|P1|STARTED|Overall Study||16
8639725|NCT02552888|21324363|P2|NOT COMPLETED|Overall Study||1
8639726|NCT02552888|21324364|P1|NOT COMPLETED|Overall Study||1
8639727|NCT02552888|21324363|P2|COMPLETED|Overall Study|34 participants completed the study|34
8639728|NCT02552888|21324364|P1|COMPLETED|Overall Study|34 participants completed the study.|34
8639729|NCT02552888|21324363|P2|STARTED|Overall Study|35 participants were enrolled.|35
8639730|NCT02552888|21324364|P1|STARTED|Overall Study|35 participants were enrolled.|35
8639731|NCT02542397|21324410|P1|NOT COMPLETED|Overall Study||16
8639732|NCT02542397|21324410|P1|COMPLETED|Overall Study|54 enrolled subjects provided pain scores at baseline and final assessments within 30 +/- 7 days.|59
8639733|NCT02542397|21324410|P1|STARTED|Overall Study|75 subjects were enrolled to the study (i.e., submitted buccal swab).|75
8639752|NCT02339506|21324462|P2|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
8639753|NCT02339506|21324463|P1|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
8639754|NCT02339506|21324462|P2|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
8639755|NCT02339506|21324463|P1|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
8639756|NCT02339506|21324462|P2|STARTED|Period 3 (Placebo or Cosyntropin)||10
8639757|NCT02339506|21324463|P1|STARTED|Period 3 (Placebo or Cosyntropin)||10
8639758|NCT02339506|21324462|P2|NOT COMPLETED|Washout (Period 2)||0
8639759|NCT02339506|21324463|P1|NOT COMPLETED|Washout (Period 2)||2
8639760|NCT02339506|21324462|P2|COMPLETED|Washout (Period 2)||10
8639761|NCT02339506|21324463|P1|COMPLETED|Washout (Period 2)||10
8639762|NCT02339506|21324462|P2|STARTED|Washout (Period 2)||10
8639763|NCT02339506|21324463|P1|STARTED|Washout (Period 2)||12
8639764|NCT02339506|21324462|P2|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
8639765|NCT02339506|21324463|P1|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
8639766|NCT02339506|21324462|P2|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
8639767|NCT02339506|21324463|P1|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
8639768|NCT02339506|21324462|P2|STARTED|Period 1 (Placebo or Cosyntropin)||11
8639769|NCT02339506|21324463|P1|STARTED|Period 1 (Placebo or Cosyntropin)||12
8639770|NCT02317562|21324471|P1|NOT COMPLETED|Overall Study||14
8639771|NCT02317562|21324471|P1|COMPLETED|Overall Study||5
8639772|NCT02317562|21324471|P1|STARTED|Overall Study||19
8639773|NCT02311361|21324479|P4|NOT COMPLETED|Overall Study||1
8639774|NCT02311361|21324480|P3|NOT COMPLETED|Overall Study||0
8639775|NCT02311361|21324481|P2|NOT COMPLETED|Overall Study||1
8639776|NCT02311361|21324482|P1|NOT COMPLETED|Overall Study||0
8639777|NCT02311361|21324479|P4|COMPLETED|Overall Study||20
8639778|NCT02311361|21324480|P3|COMPLETED|Overall Study||19
8639779|NCT02311361|21324481|P2|COMPLETED|Overall Study||10
8639780|NCT02311361|21324482|P1|COMPLETED|Overall Study||14
8639781|NCT02311361|21324479|P4|Received Radiation Therapy Only|Overall Study||1
8639782|NCT02311361|21324480|P3|Received Radiation Therapy Only|Overall Study||1
8639783|NCT02311361|21324481|P2|Received Radiation Therapy Only|Overall Study||1
8639784|NCT02311361|21324482|P1|Received Radiation Therapy Only|Overall Study||0
8639785|NCT02311361|21324479|P4|STARTED|Overall Study||21
8639786|NCT02311361|21324480|P3|STARTED|Overall Study||19
8639787|NCT02311361|21324481|P2|STARTED|Overall Study||11
8639788|NCT02311361|21324482|P1|STARTED|Overall Study||14
8639789|NCT02156154|21324518|P2|NOT COMPLETED|Overall Study||6
8639790|NCT02156154|21324519|P1|NOT COMPLETED|Overall Study||4
8639791|NCT02156154|21324518|P2|COMPLETED|Overall Study||283
8639792|NCT02156154|21324519|P1|COMPLETED|Overall Study||287
8639793|NCT02156154|21324518|P2|STARTED|Overall Study||289
8639794|NCT02156154|21324519|P1|STARTED|Overall Study||291
8639795|NCT02089230|21324546|P3|NOT COMPLETED|Overall Study||6
8639796|NCT02089230|21324547|P2|NOT COMPLETED|Overall Study||0
8639797|NCT02089230|21324548|P1|NOT COMPLETED|Overall Study||0
8639798|NCT02089230|21324546|P3|COMPLETED|Overall Study||6
8639799|NCT02089230|21324547|P2|COMPLETED|Overall Study||4
8639800|NCT02089230|21324548|P1|COMPLETED|Overall Study||3
8639801|NCT02089230|21324546|P3|STARTED|Overall Study||12
8639802|NCT02089230|21324547|P2|STARTED|Overall Study||4
8639803|NCT02089230|21324548|P1|STARTED|Overall Study||3
8639804|NCT02078726|21324561|P2|NOT COMPLETED|Overall Study||0
8639805|NCT02078726|21324562|P1|NOT COMPLETED|Overall Study||0
8639806|NCT02078726|21324561|P2|COMPLETED|Overall Study||36
8639807|NCT02078726|21324562|P1|COMPLETED|Overall Study||64
8639808|NCT02078726|21324561|P2|STARTED|Overall Study||36
8639809|NCT02078726|21324562|P1|STARTED|Overall Study||64
8639824|NCT01950039|21324608|P2|NOT COMPLETED|Overall Study||0
8639825|NCT01950039|21324609|P1|NOT COMPLETED|Overall Study||1
8639826|NCT01950039|21324608|P2|COMPLETED|Overall Study||13
8639827|NCT01950039|21324609|P1|COMPLETED|Overall Study||14
8639828|NCT01950039|21324608|P2|Completed Endothelial Evaluation|Overall Study||12
8639829|NCT01950039|21324609|P1|Completed Endothelial Evaluation|Overall Study||14
8639830|NCT01950039|21324608|P2|Completed MRI|Overall Study||12
8639831|NCT01950039|21324609|P1|Completed MRI|Overall Study||13
8639832|NCT01950039|21324608|P2|Completed Clamp|Overall Study||12
8639833|NCT01950039|21324609|P1|Completed Clamp|Overall Study||13
8639834|NCT01950039|21324608|P2|Study Drug Initiated|Overall Study||13
8639835|NCT01950039|21324609|P1|Study Drug Initiated|Overall Study||14
8639836|NCT01950039|21324608|P2|STARTED|Overall Study||13
8639837|NCT01950039|21324609|P1|STARTED|Overall Study||15
8639844|NCT01856673|21324666|P3|NOT COMPLETED|Overall Study||34
8639845|NCT01856673|21324667|P2|NOT COMPLETED|Overall Study||85
8639846|NCT01856673|21324668|P1|NOT COMPLETED|Overall Study||95
8639847|NCT01856673|21324666|P3|COMPLETED|Overall Study||137
8639848|NCT01856673|21324667|P2|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
8639849|NCT01856673|21324668|P1|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|80
8639850|NCT01856673|21324666|P3|Quibdó Participants|Overall Study||83
8639851|NCT01856673|21324667|P2|Quibdó Participants|Overall Study||86
8639852|NCT01856673|21324668|P1|Quibdó Participants|Overall Study||83
8639853|NCT01856673|21324666|P3|Buenaventura Participants|Overall Study||88
8639854|NCT01856673|21324667|P2|Buenaventura Participants|Overall Study||89
8639855|NCT01856673|21324668|P1|Buenaventura Participants|Overall Study||92
8639856|NCT01856673|21324666|P3|STARTED|Overall Study||171
8639857|NCT01856673|21324667|P2|STARTED|Overall Study||175
8639858|NCT01856673|21324668|P1|STARTED|Overall Study||175
8639962|NCT01084252|21324867|P7|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639907|NCT01493596|21324798|P7|NOT COMPLETED|Overall Study||0
8639908|NCT01493596|21324799|P6|NOT COMPLETED|Overall Study||0
8639909|NCT01493596|21324800|P5|NOT COMPLETED|Overall Study||0
8639910|NCT01493596|21324801|P4|NOT COMPLETED|Overall Study||0
8639911|NCT01493596|21324802|P3|NOT COMPLETED|Overall Study||0
8639912|NCT01493596|21324803|P2|NOT COMPLETED|Overall Study||0
8639913|NCT01493596|21324804|P1|NOT COMPLETED|Overall Study||0
8639914|NCT01493596|21324798|P7|COMPLETED|Overall Study||8
8639915|NCT01493596|21324799|P6|COMPLETED|Overall Study||8
8639916|NCT01493596|21324800|P5|COMPLETED|Overall Study||8
8639917|NCT01493596|21324801|P4|COMPLETED|Overall Study||8
8639918|NCT01493596|21324802|P3|COMPLETED|Overall Study||7
8639919|NCT01493596|21324803|P2|COMPLETED|Overall Study||8
8639920|NCT01493596|21324804|P1|COMPLETED|Overall Study||8
8639921|NCT01493596|21324798|P7|STARTED|Overall Study||8
8639922|NCT01493596|21324799|P6|STARTED|Overall Study||8
8639923|NCT01493596|21324800|P5|STARTED|Overall Study||8
8639924|NCT01493596|21324801|P4|STARTED|Overall Study||8
8639925|NCT01493596|21324802|P3|STARTED|Overall Study|Repeat of dose cohort because of incidences of hyperkalemia observed in cohort 2(a).|7
8639926|NCT01493596|21324803|P2|STARTED|Overall Study||8
8639927|NCT01493596|21324804|P1|STARTED|Overall Study||8
8639938|NCT01127373|21324831|P1|NOT COMPLETED|Overall Study||12
8639939|NCT01127373|21324831|P1|COMPLETED|Overall Study||104
8639940|NCT01127373|21324831|P1|STARTED|Overall Study||116
8639941|NCT01084252|21324860|P14|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||55
8639942|NCT01084252|21324861|P13|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||110
8639943|NCT01084252|21324862|P12|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639944|NCT01084252|21324863|P11|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639945|NCT01084252|21324864|P10|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639946|NCT01084252|21324865|P9|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639947|NCT01084252|21324866|P8|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639948|NCT01084252|21324867|P7|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639949|NCT01084252|21324868|P6|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639950|NCT01084252|21324869|P5|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639951|NCT01084252|21324870|P4|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639952|NCT01084252|21324871|P3|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639953|NCT01084252|21324872|P2|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639954|NCT01084252|21324873|P1|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639955|NCT01084252|21324860|P14|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639956|NCT01084252|21324861|P13|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639957|NCT01084252|21324862|P12|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639958|NCT01084252|21324863|P11|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639959|NCT01084252|21324864|P10|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639960|NCT01084252|21324865|P9|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639961|NCT01084252|21324866|P8|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639963|NCT01084252|21324868|P6|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639964|NCT01084252|21324869|P5|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639965|NCT01084252|21324870|P4|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639966|NCT01084252|21324871|P3|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639967|NCT01084252|21324872|P2|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639968|NCT01084252|21324873|P1|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
8639969|NCT01084252|21324860|P14|AT Population|Phase 2 Stage 2 (97 Weeks)||55
8639970|NCT01084252|21324861|P13|AT Population|Phase 2 Stage 2 (97 Weeks)||109
8639971|NCT01084252|21324862|P12|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8639972|NCT01084252|21324863|P11|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8639973|NCT01084252|21324864|P10|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8639974|NCT01084252|21324865|P9|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8639975|NCT01084252|21324866|P8|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8639976|NCT01084252|21324867|P7|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8639977|NCT01084252|21324868|P6|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8639978|NCT01084252|21324869|P5|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8639979|NCT01084252|21324870|P4|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8639980|NCT01084252|21324871|P3|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8639981|NCT01084252|21324872|P2|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8639982|NCT01084252|21324873|P1|AT Population|Phase 2 Stage 2 (97 Weeks)||0
8639983|NCT01084252|21324860|P14|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|55
8639984|NCT01084252|21324861|P13|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|110
8639985|NCT01084252|21324862|P12|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8639986|NCT01084252|21324863|P11|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8639987|NCT01084252|21324864|P10|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8639988|NCT01084252|21324865|P9|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8639989|NCT01084252|21324866|P8|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8639990|NCT01084252|21324867|P7|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8639991|NCT01084252|21324868|P6|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8639992|NCT01084252|21324869|P5|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8639993|NCT01084252|21324870|P4|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8639994|NCT01084252|21324871|P3|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8639995|NCT01084252|21324872|P2|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8639996|NCT01084252|21324873|P1|STARTED|Phase 2 Stage 2 (97 Weeks)||0
8639997|NCT01084252|21324860|P14|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8639998|NCT01084252|21324861|P13|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8639999|NCT01084252|21324862|P12|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
8640000|NCT01084252|21324863|P11|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
8640001|NCT01084252|21324864|P10|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
8640002|NCT01084252|21324865|P9|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
8640003|NCT01084252|21324866|P8|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640004|NCT01084252|21324867|P7|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640005|NCT01084252|21324868|P6|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640006|NCT01084252|21324869|P5|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640007|NCT01084252|21324870|P4|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640008|NCT01084252|21324871|P3|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640009|NCT01084252|21324872|P2|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640010|NCT01084252|21324873|P1|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640011|NCT01084252|21324860|P14|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640012|NCT01084252|21324861|P13|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640013|NCT01084252|21324862|P12|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640014|NCT01084252|21324863|P11|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640015|NCT01084252|21324864|P10|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640016|NCT01084252|21324865|P9|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640017|NCT01084252|21324866|P8|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640018|NCT01084252|21324867|P7|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640019|NCT01084252|21324868|P6|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640020|NCT01084252|21324869|P5|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640021|NCT01084252|21324870|P4|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640022|NCT01084252|21324871|P3|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640023|NCT01084252|21324872|P2|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640024|NCT01084252|21324873|P1|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640025|NCT01084252|21324860|P14|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640026|NCT01084252|21324861|P13|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640027|NCT01084252|21324862|P12|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
8640028|NCT01084252|21324863|P11|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
8640029|NCT01084252|21324864|P10|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
8640030|NCT01084252|21324865|P9|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
8640031|NCT01084252|21324866|P8|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640032|NCT01084252|21324867|P7|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640033|NCT01084252|21324868|P6|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640034|NCT01084252|21324869|P5|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640035|NCT01084252|21324870|P4|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640036|NCT01084252|21324871|P3|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640037|NCT01084252|21324872|P2|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640038|NCT01084252|21324873|P1|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640039|NCT01084252|21324860|P14|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640040|NCT01084252|21324861|P13|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640041|NCT01084252|21324862|P12|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
8640042|NCT01084252|21324863|P11|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
8640043|NCT01084252|21324864|P10|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|24
8640044|NCT01084252|21324865|P9|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|23
8640045|NCT01084252|21324866|P8|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640046|NCT01084252|21324867|P7|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640047|NCT01084252|21324868|P6|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640048|NCT01084252|21324869|P5|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640049|NCT01084252|21324870|P4|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640050|NCT01084252|21324871|P3|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640051|NCT01084252|21324872|P2|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640052|NCT01084252|21324873|P1|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
8640053|NCT01084252|21324860|P14|NOT COMPLETED|Phase 1 (120 Weeks)||0
8640054|NCT01084252|21324861|P13|NOT COMPLETED|Phase 1 (120 Weeks)||0
8640055|NCT01084252|21324862|P12|NOT COMPLETED|Phase 1 (120 Weeks)||0
8640056|NCT01084252|21324863|P11|NOT COMPLETED|Phase 1 (120 Weeks)||0
8640057|NCT01084252|21324864|P10|NOT COMPLETED|Phase 1 (120 Weeks)||0
8640058|NCT01084252|21324865|P9|NOT COMPLETED|Phase 1 (120 Weeks)||0
8640059|NCT01084252|21324866|P8|NOT COMPLETED|Phase 1 (120 Weeks)||7
8640060|NCT01084252|21324867|P7|NOT COMPLETED|Phase 1 (120 Weeks)||7
8640061|NCT01084252|21324868|P6|NOT COMPLETED|Phase 1 (120 Weeks)||6
8640062|NCT01084252|21324869|P5|NOT COMPLETED|Phase 1 (120 Weeks)||18
8640063|NCT01084252|21324870|P4|NOT COMPLETED|Phase 1 (120 Weeks)||26
8640064|NCT01084252|21324871|P3|NOT COMPLETED|Phase 1 (120 Weeks)||3
8640065|NCT01084252|21324872|P2|NOT COMPLETED|Phase 1 (120 Weeks)||6
8640066|NCT01084252|21324873|P1|NOT COMPLETED|Phase 1 (120 Weeks)||16
8640067|NCT01084252|21324860|P14|COMPLETED|Phase 1 (120 Weeks)||0
8640068|NCT01084252|21324861|P13|COMPLETED|Phase 1 (120 Weeks)||0
8640069|NCT01084252|21324862|P12|COMPLETED|Phase 1 (120 Weeks)||0
8640070|NCT01084252|21324863|P11|COMPLETED|Phase 1 (120 Weeks)||0
8640071|NCT01084252|21324864|P10|COMPLETED|Phase 1 (120 Weeks)||0
8640072|NCT01084252|21324865|P9|COMPLETED|Phase 1 (120 Weeks)||0
8640073|NCT01084252|21324866|P8|COMPLETED|Phase 1 (120 Weeks)||0
8640074|NCT01084252|21324867|P7|COMPLETED|Phase 1 (120 Weeks)||0
8640075|NCT01084252|21324868|P6|COMPLETED|Phase 1 (120 Weeks)||0
8640076|NCT01084252|21324869|P5|COMPLETED|Phase 1 (120 Weeks)||0
8640077|NCT01084252|21324870|P4|COMPLETED|Phase 1 (120 Weeks)||0
8640078|NCT01084252|21324871|P3|COMPLETED|Phase 1 (120 Weeks)||0
8640079|NCT01084252|21324872|P2|COMPLETED|Phase 1 (120 Weeks)||0
8640080|NCT01084252|21324873|P1|COMPLETED|Phase 1 (120 Weeks)||0
8640081|NCT01084252|21324860|P14|All Treated (AT) Population|Phase 1 (120 Weeks)||0
8640082|NCT01084252|21324861|P13|All Treated (AT) Population|Phase 1 (120 Weeks)||0
8640083|NCT01084252|21324862|P12|All Treated (AT) Population|Phase 1 (120 Weeks)||0
8640084|NCT01084252|21324863|P11|All Treated (AT) Population|Phase 1 (120 Weeks)||0
8640085|NCT01084252|21324864|P10|All Treated (AT) Population|Phase 1 (120 Weeks)||0
8640086|NCT01084252|21324865|P9|All Treated (AT) Population|Phase 1 (120 Weeks)||0
8640087|NCT01084252|21324866|P8|All Treated (AT) Population|Phase 1 (120 Weeks)||7
8640088|NCT01084252|21324867|P7|All Treated (AT) Population|Phase 1 (120 Weeks)||7
8640089|NCT01084252|21324868|P6|All Treated (AT) Population|Phase 1 (120 Weeks)||6
8640090|NCT01084252|21324869|P5|All Treated (AT) Population|Phase 1 (120 Weeks)||18
8640091|NCT01084252|21324870|P4|All Treated (AT) Population|Phase 1 (120 Weeks)||26
8640092|NCT01084252|21324871|P3|All Treated (AT) Population|Phase 1 (120 Weeks)||3
8640093|NCT01084252|21324872|P2|All Treated (AT) Population|Phase 1 (120 Weeks)||6
8640094|NCT01084252|21324873|P1|All Treated (AT) Population|Phase 1 (120 Weeks)||16
8640095|NCT01084252|21324860|P14|STARTED|Phase 1 (120 Weeks)||0
8640096|NCT01084252|21324861|P13|STARTED|Phase 1 (120 Weeks)||0
8640097|NCT01084252|21324862|P12|STARTED|Phase 1 (120 Weeks)||0
8640098|NCT01084252|21324863|P11|STARTED|Phase 1 (120 Weeks)||0
8640099|NCT01084252|21324864|P10|STARTED|Phase 1 (120 Weeks)||0
8640100|NCT01084252|21324865|P9|STARTED|Phase 1 (120 Weeks)||0
8640101|NCT01084252|21324866|P8|STARTED|Phase 1 (120 Weeks)||7
8640102|NCT01084252|21324867|P7|STARTED|Phase 1 (120 Weeks)||7
8640103|NCT01084252|21324868|P6|STARTED|Phase 1 (120 Weeks)||6
8640104|NCT01084252|21324869|P5|STARTED|Phase 1 (120 Weeks)||18
8640105|NCT01084252|21324870|P4|STARTED|Phase 1 (120 Weeks)||26
8640106|NCT01084252|21324871|P3|STARTED|Phase 1 (120 Weeks)||3
8640107|NCT01084252|21324872|P2|STARTED|Phase 1 (120 Weeks)||6
8640108|NCT01084252|21324873|P1|STARTED|Phase 1 (120 Weeks)||16
8640117|NCT00770809|21325071|P3|NOT COMPLETED|Overall Study||23
8640118|NCT00770809|21325072|P2|NOT COMPLETED|Overall Study||10
8640119|NCT00770809|21325073|P1|NOT COMPLETED|Overall Study||17
8640120|NCT00770809|21325071|P3|COMPLETED|Overall Study||44
8640121|NCT00770809|21325072|P2|COMPLETED|Overall Study||110
8640122|NCT00770809|21325073|P1|COMPLETED|Overall Study||101
8640123|NCT00770809|21325071|P3|STARTED|Overall Study||67
8640124|NCT00770809|21325072|P2|STARTED|Overall Study||120
8640125|NCT00770809|21325073|P1|STARTED|Overall Study||118
8640126|NCT00704730|21325083|P2|NOT COMPLETED|Overall Study||96
8640127|NCT00704730|21325084|P1|NOT COMPLETED|Overall Study||121
8640128|NCT00704730|21325083|P2|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
8640129|NCT00704730|21325084|P1|COMPLETED|Overall Study|Continuing treatment at data cutoff for primary analysis, but subsequently discontinued study|98
8640130|NCT00704730|21325083|P2|STARTED|Overall Study|Randomized|111
8640131|NCT00704730|21325084|P1|STARTED|Overall Study|Randomized|219
8640132|NCT00587067|21325100|P1|NOT COMPLETED|Overall Study||0
8640133|NCT00587067|21325100|P1|COMPLETED|Overall Study||34
8640134|NCT00587067|21325100|P1|STARTED|Overall Study||34
8640135|NCT00378105|21325108|P2|NOT COMPLETED|Overall Study||30
8640136|NCT00378105|21325109|P1|NOT COMPLETED|Overall Study||20
8640137|NCT00378105|21325108|P2|COMPLETED|Overall Study||5
8640138|NCT00378105|21325109|P1|COMPLETED|Overall Study||11
8640139|NCT00378105|21325108|P2|STARTED|Overall Study||35
8640140|NCT00378105|21325109|P1|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
8640144|NCT00118274|21325128|P4|NOT COMPLETED|Overall Study||15
8640145|NCT00118274|21325129|P3|NOT COMPLETED|Overall Study||17
8640146|NCT00118274|21325130|P2|NOT COMPLETED|Overall Study||22
8640147|NCT00118274|21325131|P1|NOT COMPLETED|Overall Study||20
8640148|NCT00118274|21325128|P4|COMPLETED|Overall Study||29
8640149|NCT00118274|21325129|P3|COMPLETED|Overall Study||25
8640150|NCT00118274|21325130|P2|COMPLETED|Overall Study||21
8640151|NCT00118274|21325131|P1|COMPLETED|Overall Study||21
8640152|NCT00118274|21325128|P4|STARTED|Overall Study||44
8640153|NCT00118274|21325129|P3|STARTED|Overall Study||42
8640154|NCT00118274|21325130|P2|STARTED|Overall Study||43
8640155|NCT00118274|21325131|P1|STARTED|Overall Study||41
8640162|NCT03981939|21325256|P3|NOT COMPLETED|Overall Study||0
8640163|NCT03981939|21325257|P2|NOT COMPLETED|Overall Study||0
8640164|NCT03981939|21325258|P1|NOT COMPLETED|Overall Study||0
8640165|NCT03981939|21325256|P3|COMPLETED|Overall Study||581
8640166|NCT03981939|21325257|P2|COMPLETED|Overall Study||1902
8640167|NCT03981939|21325258|P1|COMPLETED|Overall Study||549
8640168|NCT03981939|21325256|P3|STARTED|Overall Study||581
8640169|NCT03981939|21325257|P2|STARTED|Overall Study||1902
8640170|NCT03981939|21325258|P1|STARTED|Overall Study||549
8640171|NCT03762616|21325274|P1|NOT COMPLETED|Overall Study||2
8640172|NCT03762616|21325274|P1|COMPLETED|Overall Study||118
8640173|NCT03762616|21325274|P1|STARTED|Overall Study||120
8640174|NCT03688542|21325282|P2|NOT COMPLETED|Overall Study||0
8640175|NCT03688542|21325283|P1|NOT COMPLETED|Overall Study||0
8640176|NCT03688542|21325282|P2|COMPLETED|Overall Study|"1 nursing home withdrew from the study.
~No individual participants were recruited, only nursing homes."|0
8640177|NCT03688542|21325283|P1|COMPLETED|Overall Study|No individual participants were recruited, only nursing homes.|0
8640178|NCT03688542|21325282|P2|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|0
8640179|NCT03688542|21325283|P1|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|0
8640180|NCT03188718|21325303|P1|NOT COMPLETED|Overall Study||8
8640181|NCT03188718|21325303|P1|COMPLETED|Overall Study||37
8640182|NCT03188718|21325303|P1|STARTED|Overall Study||45
8640183|NCT03060447|21325317|P2|NOT COMPLETED|Overall Study||0
8640184|NCT03060447|21325318|P1|NOT COMPLETED|Overall Study||2
8640185|NCT03060447|21325317|P2|COMPLETED|Overall Study||8
8640186|NCT03060447|21325318|P1|COMPLETED|Overall Study||15
8640187|NCT03060447|21325317|P2|STARTED|Overall Study||8
8640188|NCT03060447|21325318|P1|STARTED|Overall Study||17
8640189|NCT03041636|21325347|P1|NOT COMPLETED|Overall Study||0
8640190|NCT03041636|21325347|P1|COMPLETED|Overall Study||1
8640191|NCT03041636|21325347|P1|STARTED|Overall Study||1
8640192|NCT03028025|21325356|P2|NOT COMPLETED|Overall Study||1
8640193|NCT03028025|21325357|P1|NOT COMPLETED|Overall Study||3
8640194|NCT03028025|21325356|P2|COMPLETED|Overall Study||93
8640195|NCT03028025|21325357|P1|COMPLETED|Overall Study||87
8640196|NCT03028025|21325356|P2|STARTED|Overall Study||94
8640197|NCT03028025|21325357|P1|STARTED|Overall Study||90
8640226|NCT02914522|21325738|P11|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||29
8640227|NCT02914522|21325739|P10|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||49
8640228|NCT02914522|21325740|P9|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||75
8640229|NCT02914522|21325741|P8|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||58
8640230|NCT02914522|21325742|P7|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||52
8640231|NCT02914522|21325743|P6|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
8640232|NCT02914522|21325744|P5|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
8640233|NCT02914522|21325745|P4|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
8640234|NCT02914522|21325746|P3|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
8640235|NCT02914522|21325747|P2|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
8640236|NCT02914522|21325748|P1|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
8640237|NCT02914522|21325738|P11|COMPLETED|Maintenance Study: Week 11 to Week 58||64
8640238|NCT02914522|21325739|P10|COMPLETED|Maintenance Study: Week 11 to Week 58||42
8640239|NCT02914522|21325740|P9|COMPLETED|Maintenance Study: Week 11 to Week 58||104
8640240|NCT02914522|21325741|P8|COMPLETED|Maintenance Study: Week 11 to Week 58||41
8640241|NCT02914522|21325742|P7|COMPLETED|Maintenance Study: Week 11 to Week 58||150
8640242|NCT02914522|21325743|P6|COMPLETED|Maintenance Study: Week 11 to Week 58||0
8640243|NCT02914522|21325744|P5|COMPLETED|Maintenance Study: Week 11 to Week 58||0
8640244|NCT02914522|21325745|P4|COMPLETED|Maintenance Study: Week 11 to Week 58||0
8640245|NCT02914522|21325746|P3|COMPLETED|Maintenance Study: Week 11 to Week 58||0
8640246|NCT02914522|21325747|P2|COMPLETED|Maintenance Study: Week 11 to Week 58||0
8640247|NCT02914522|21325748|P1|COMPLETED|Maintenance Study: Week 11 to Week 58||0
8640248|NCT02914522|21325738|P11|STARTED|Maintenance Study: Week 11 to Week 58||93
8640249|NCT02914522|21325739|P10|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|91
8640250|NCT02914522|21325740|P9|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|179
8640251|NCT02914522|21325741|P8|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|99
8640252|NCT02914522|21325742|P7|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|202
8640253|NCT02914522|21325743|P6|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
8640254|NCT02914522|21325744|P5|STARTED|Maintenance Study: Week 11 to Week 58||0
8640255|NCT02914522|21325745|P4|STARTED|Maintenance Study: Week 11 to Week 58||0
8640256|NCT02914522|21325746|P3|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
8640257|NCT02914522|21325747|P2|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
8640258|NCT02914522|21325748|P1|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
8640259|NCT02914522|21325738|P11|NOT COMPLETED|Induction Study: Up to Week 11||0
8640260|NCT02914522|21325739|P10|NOT COMPLETED|Induction Study: Up to Week 11||0
8640261|NCT02914522|21325740|P9|NOT COMPLETED|Induction Study: Up to Week 11||0
8640262|NCT02914522|21325741|P8|NOT COMPLETED|Induction Study: Up to Week 11||0
8640263|NCT02914522|21325742|P7|NOT COMPLETED|Induction Study: Up to Week 11||0
8640264|NCT02914522|21325743|P6|NOT COMPLETED|Induction Study: Up to Week 11||16
8640265|NCT02914522|21325744|P5|NOT COMPLETED|Induction Study: Up to Week 11||24
8640266|NCT02914522|21325745|P4|NOT COMPLETED|Induction Study: Up to Week 11||28
8640267|NCT02914522|21325746|P3|NOT COMPLETED|Induction Study: Up to Week 11||10
8640268|NCT02914522|21325747|P2|NOT COMPLETED|Induction Study: Up to Week 11||22
8640269|NCT02914522|21325748|P1|NOT COMPLETED|Induction Study: Up to Week 11||10
8640270|NCT02914522|21325738|P11|COMPLETED|Induction Study: Up to Week 11||0
8640271|NCT02914522|21325739|P10|COMPLETED|Induction Study: Up to Week 11||0
8640272|NCT02914522|21325740|P9|COMPLETED|Induction Study: Up to Week 11||0
8640273|NCT02914522|21325741|P8|COMPLETED|Induction Study: Up to Week 11||0
8640274|NCT02914522|21325742|P7|COMPLETED|Induction Study: Up to Week 11||0
8640275|NCT02914522|21325743|P6|COMPLETED|Induction Study: Up to Week 11||127
8640276|NCT02914522|21325744|P5|COMPLETED|Induction Study: Up to Week 11||262
8640277|NCT02914522|21325745|P4|COMPLETED|Induction Study: Up to Week 11||234
8640278|NCT02914522|21325746|P3|COMPLETED|Induction Study: Up to Week 11||127
8640279|NCT02914522|21325747|P2|COMPLETED|Induction Study: Up to Week 11||256
8640280|NCT02914522|21325748|P1|COMPLETED|Induction Study: Up to Week 11||235
8640281|NCT02914522|21325738|P11|STARTED|Induction Study: Up to Week 11||0
8640282|NCT02914522|21325739|P10|STARTED|Induction Study: Up to Week 11||0
8640283|NCT02914522|21325740|P9|STARTED|Induction Study: Up to Week 11||0
8640284|NCT02914522|21325741|P8|STARTED|Induction Study: Up to Week 11||0
8640285|NCT02914522|21325742|P7|STARTED|Induction Study: Up to Week 11||0
8640286|NCT02914522|21325743|P6|STARTED|Induction Study: Up to Week 11||143
8640287|NCT02914522|21325744|P5|STARTED|Induction Study: Up to Week 11||286
8640288|NCT02914522|21325745|P4|STARTED|Induction Study: Up to Week 11||262
8640289|NCT02914522|21325746|P3|STARTED|Induction Study: Up to Week 11||137
8640290|NCT02914522|21325747|P2|STARTED|Induction Study: Up to Week 11||278
8640291|NCT02914522|21325748|P1|STARTED|Induction Study: Up to Week 11||245
8640304|NCT02819973|21325875|P3|NOT COMPLETED|Overall Study||4
8640305|NCT02819973|21325876|P2|NOT COMPLETED|Overall Study||3
8640306|NCT02819973|21325877|P1|NOT COMPLETED|Overall Study||6
8640307|NCT02819973|21325875|P3|COMPLETED|Overall Study|2 withdrawn by request, 2 determined after randomization to be not eligible|111
8640308|NCT02819973|21325876|P2|COMPLETED|Overall Study|3 determined after randomization to be not eligible|111
8640309|NCT02819973|21325877|P1|COMPLETED|Overall Study|2 withdrawn by request, 4 determined after randomization to be not eligible|108
8640310|NCT02819973|21325875|P3|STARTED|Overall Study||115
8640311|NCT02819973|21325876|P2|STARTED|Overall Study||114
8640312|NCT02819973|21325877|P1|STARTED|Overall Study||114
8640313|NCT02792959|21325896|P1|NOT COMPLETED|Overall Study||1
8640314|NCT02792959|21325896|P1|COMPLETED|Overall Study||10
8640315|NCT02792959|21325896|P1|STARTED|Overall Study||11
8640316|NCT02788019|21325957|P2|NOT COMPLETED|Overall Study||5
8640317|NCT02788019|21325958|P1|NOT COMPLETED|Overall Study||4
8640318|NCT02788019|21325957|P2|COMPLETED|Overall Study||20
8640319|NCT02788019|21325958|P1|COMPLETED|Overall Study||23
8640320|NCT02788019|21325957|P2|STARTED|Overall Study||25
8640321|NCT02788019|21325958|P1|STARTED|Overall Study||27
8640322|NCT02728752|21325966|P2|NOT COMPLETED|Extension Period||11
8640323|NCT02728752|21325967|P1|NOT COMPLETED|Extension Period||11
8640324|NCT02728752|21325966|P2|COMPLETED|Extension Period||34
8640325|NCT02728752|21325967|P1|COMPLETED|Extension Period||35
8640326|NCT02728752|21325966|P2|STARTED|Extension Period||45
8640327|NCT02728752|21325967|P1|STARTED|Extension Period||46
8640328|NCT02728752|21325966|P2|NOT COMPLETED|First Period||2
8640329|NCT02728752|21325967|P1|NOT COMPLETED|First Period||2
8640330|NCT02728752|21325966|P2|COMPLETED|First Period||45
8640331|NCT02728752|21325967|P1|COMPLETED|First Period||46
8640332|NCT02728752|21325966|P2|STARTED|First Period||47
8640333|NCT02728752|21325967|P1|STARTED|First Period||48
8640334|NCT02724878|21326009|P1|NOT COMPLETED|Overall Study||65
8640335|NCT02724878|21326009|P1|COMPLETED|Overall Study||0
8640336|NCT02724878|21326009|P1|Responders|Overall Study||20
8640337|NCT02724878|21326009|P1|Treated|Overall Study||60
8640338|NCT02724878|21326009|P1|STARTED|Overall Study||65
8640339|NCT02649946|21326034|P2|NOT COMPLETED|Overall Study||15
8640340|NCT02649946|21326035|P1|NOT COMPLETED|Overall Study||12
8640341|NCT02649946|21326034|P2|COMPLETED|Overall Study||123
8640342|NCT02649946|21326035|P1|COMPLETED|Overall Study||130
8640343|NCT02649946|21326034|P2|STARTED|Overall Study||138
8640344|NCT02649946|21326035|P1|STARTED|Overall Study||142
8640353|NCT02608229|21326175|P2|NOT COMPLETED|Overall Study||0
8640354|NCT02608229|21326176|P1|NOT COMPLETED|Overall Study||0
8640355|NCT02608229|21326175|P2|COMPLETED|Overall Study||8
8640356|NCT02608229|21326176|P1|COMPLETED|Overall Study||10
8640357|NCT02608229|21326175|P2|450 mg BVD-523|Overall Study||6
8640358|NCT02608229|21326176|P1|450 mg BVD-523|Overall Study||0
8640359|NCT02608229|21326175|P2|600 mg BVD-523|Overall Study||2
8640360|NCT02608229|21326176|P1|600 mg BVD-523|Overall Study||10
8640361|NCT02608229|21326175|P2|STARTED|Overall Study||8
8640362|NCT02608229|21326176|P1|STARTED|Overall Study||10
8640381|NCT02465437|21326294|P4|NOT COMPLETED|Overall Study||1
8640382|NCT02465437|21326295|P3|NOT COMPLETED|Overall Study||1
8640383|NCT02465437|21326296|P2|NOT COMPLETED|Overall Study||1
8640384|NCT02465437|21326297|P1|NOT COMPLETED|Overall Study||1
8640385|NCT02465437|21326294|P4|COMPLETED|Overall Study||14
8640386|NCT02465437|21326295|P3|COMPLETED|Overall Study||8
8640387|NCT02465437|21326296|P2|COMPLETED|Overall Study||8
8640388|NCT02465437|21326297|P1|COMPLETED|Overall Study||8
8640389|NCT02465437|21326294|P4|STARTED|Overall Study||15
8640390|NCT02465437|21326295|P3|STARTED|Overall Study||9
8640391|NCT02465437|21326296|P2|STARTED|Overall Study||9
8640392|NCT02465437|21326297|P1|STARTED|Overall Study||9
8640393|NCT02462720|21326315|P2|NOT COMPLETED|Part 2||1
8640394|NCT02462720|21326316|P1|NOT COMPLETED|Part 2||1
8640395|NCT02462720|21326315|P2|COMPLETED|Part 2||16
8640396|NCT02462720|21326316|P1|COMPLETED|Part 2||17
8640397|NCT02462720|21326315|P2|STARTED|Part 2||17
8640398|NCT02462720|21326316|P1|STARTED|Part 2||18
8640399|NCT02462720|21326315|P2|NOT COMPLETED|Part 1||0
8640400|NCT02462720|21326316|P1|NOT COMPLETED|Part 1||0
8640401|NCT02462720|21326315|P2|COMPLETED|Part 1||17
8640402|NCT02462720|21326316|P1|COMPLETED|Part 1||18
8640403|NCT02462720|21326315|P2|STARTED|Part 1||17
8640404|NCT02462720|21326316|P1|STARTED|Part 1||18
8640405|NCT02177838|21326326|P1|NOT COMPLETED|Overall Study||3
8640406|NCT02177838|21326326|P1|COMPLETED|Overall Study||5
8640407|NCT02177838|21326326|P1|STARTED|Overall Study||8
8640421|NCT02049866|21326356|P1|NOT COMPLETED|Overall Study||1
8640422|NCT02049866|21326356|P1|COMPLETED|Overall Study||32
8640423|NCT02049866|21326356|P1|STARTED|Overall Study||33
8640424|NCT02041429|21326364|P4|NOT COMPLETED|Overall Study||6
8640425|NCT02041429|21326365|P3|NOT COMPLETED|Overall Study||7
8640426|NCT02041429|21326366|P2|NOT COMPLETED|Overall Study||4
8640427|NCT02041429|21326367|P1|NOT COMPLETED|Overall Study||3
8640428|NCT02041429|21326364|P4|COMPLETED|Overall Study||0
8640429|NCT02041429|21326365|P3|COMPLETED|Overall Study||0
8640430|NCT02041429|21326366|P2|COMPLETED|Overall Study||0
8640431|NCT02041429|21326367|P1|COMPLETED|Overall Study||0
8640432|NCT02041429|21326364|P4|Evaluable for Dose Limiting Toxicity|Overall Study||6
8640433|NCT02041429|21326365|P3|Evaluable for Dose Limiting Toxicity|Overall Study||6
8640434|NCT02041429|21326366|P2|Evaluable for Dose Limiting Toxicity|Overall Study||3
8640435|NCT02041429|21326367|P1|Evaluable for Dose Limiting Toxicity|Overall Study||3
8640436|NCT02041429|21326364|P4|Treated|Overall Study||6
8640437|NCT02041429|21326365|P3|Treated|Overall Study||7
8640438|NCT02041429|21326366|P2|Treated|Overall Study||3
8640439|NCT02041429|21326367|P1|Treated|Overall Study||3
8640440|NCT02041429|21326364|P4|STARTED|Overall Study||6
8640441|NCT02041429|21326365|P3|STARTED|Overall Study||7
8640442|NCT02041429|21326366|P2|STARTED|Overall Study||4
8640443|NCT02041429|21326367|P1|STARTED|Overall Study||3
8640447|NCT01887717|21326400|P2|NOT COMPLETED|Overall Study||11
8640448|NCT01887717|21326401|P1|NOT COMPLETED|Overall Study||6
8640449|NCT01887717|21326400|P2|COMPLETED|Overall Study||8
8640450|NCT01887717|21326401|P1|COMPLETED|Overall Study||11
8640451|NCT01887717|21326400|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
8640452|NCT01887717|21326401|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
8640453|NCT01887717|21326400|P2|STARTED|Overall Study||19
8640454|NCT01887717|21326401|P1|STARTED|Overall Study||17
8640467|NCT01775410|21326446|P1|NOT COMPLETED|Overall Study||0
8640468|NCT01775410|21326446|P1|COMPLETED|Overall Study||4
8640469|NCT01775410|21326446|P1|STARTED|Overall Study||4
8640479|NCT01634178|21326488|P2|NOT COMPLETED|Treatment Period 2||0
8640480|NCT01634178|21326489|P1|NOT COMPLETED|Treatment Period 2||1
8640481|NCT01634178|21326488|P2|COMPLETED|Treatment Period 2||22
8640482|NCT01634178|21326489|P1|COMPLETED|Treatment Period 2||22
8640483|NCT01634178|21326488|P2|STARTED|Treatment Period 2||22
8640484|NCT01634178|21326489|P1|STARTED|Treatment Period 2||23
8640485|NCT01634178|21326488|P2|NOT COMPLETED|Treatment Period 1||1
8640486|NCT01634178|21326489|P1|NOT COMPLETED|Treatment Period 1||0
8640487|NCT01634178|21326488|P2|COMPLETED|Treatment Period 1||22
8640488|NCT01634178|21326489|P1|COMPLETED|Treatment Period 1||23
8640489|NCT01634178|21326488|P2|STARTED|Treatment Period 1||23
8640490|NCT01634178|21326489|P1|STARTED|Treatment Period 1||23
8640506|NCT01428076|21326548|P2|NOT COMPLETED|Overall Study||1
8640507|NCT01428076|21326549|P1|NOT COMPLETED|Overall Study||0
8640508|NCT01428076|21326548|P2|COMPLETED|Overall Study||11
8640509|NCT01428076|21326549|P1|COMPLETED|Overall Study||9
8640510|NCT01428076|21326548|P2|STARTED|Overall Study||12
8640511|NCT01428076|21326549|P1|STARTED|Overall Study||9
8640532|NCT01343160|21326566|P1|NOT COMPLETED|Overall Study||5
8640533|NCT01343160|21326566|P1|COMPLETED|Overall Study||31
8640534|NCT01343160|21326566|P1|STARTED|Overall Study||36
8640535|NCT01281007|21326579|P2|NOT COMPLETED|Overall Study||8
8640536|NCT01281007|21326580|P1|NOT COMPLETED|Overall Study||4
8640537|NCT01281007|21326579|P2|COMPLETED|Overall Study||67
8640538|NCT01281007|21326580|P1|COMPLETED|Overall Study||71
8640539|NCT01281007|21326579|P2|STARTED|Overall Study||75
8640540|NCT01281007|21326580|P1|STARTED|Overall Study||75
8640541|NCT01231373|21326590|P4|NOT COMPLETED|Overall Study||1
8640542|NCT01231373|21326591|P3|NOT COMPLETED|Overall Study||0
8640543|NCT01231373|21326592|P2|NOT COMPLETED|Overall Study||1
8640544|NCT01231373|21326593|P1|NOT COMPLETED|Overall Study||3
8640545|NCT01231373|21326590|P4|COMPLETED|Overall Study||57
8640546|NCT01231373|21326591|P3|COMPLETED|Overall Study||60
8640547|NCT01231373|21326592|P2|COMPLETED|Overall Study||57
8640548|NCT01231373|21326593|P1|COMPLETED|Overall Study||56
8640549|NCT01231373|21326590|P4|Patients Receiving Blinded Treatment|Overall Study||58
8640550|NCT01231373|21326591|P3|Patients Receiving Blinded Treatment|Overall Study||60
8640551|NCT01231373|21326592|P2|Patients Receiving Blinded Treatment|Overall Study||57
8640552|NCT01231373|21326593|P1|Patients Receiving Blinded Treatment|Overall Study||57
8640553|NCT01231373|21326590|P4|STARTED|Overall Study||58
8640554|NCT01231373|21326591|P3|STARTED|Overall Study||60
8640555|NCT01231373|21326592|P2|STARTED|Overall Study||58
8640556|NCT01231373|21326593|P1|STARTED|Overall Study||59
8640557|NCT01201356|21326611|P1|NOT COMPLETED|Overall Study||644
8640558|NCT01201356|21326611|P1|COMPLETED|Overall Study||3481
8640559|NCT01201356|21326611|P1|Fingolimod Full Analysis Set|Overall Study||4046
8640560|NCT01201356|21326611|P1|Safety Set|Overall Study||4083
8640561|NCT01201356|21326611|P1|STARTED|Overall Study||4125
8640562|NCT01197833|21326628|P3|NOT COMPLETED|Overall Study||0
8640563|NCT01197833|21326629|P2|NOT COMPLETED|Overall Study||0
8640564|NCT01197833|21326630|P1|NOT COMPLETED|Overall Study||0
8640565|NCT01197833|21326628|P3|COMPLETED|Overall Study||40
8640566|NCT01197833|21326629|P2|COMPLETED|Overall Study||39
8640567|NCT01197833|21326630|P1|COMPLETED|Overall Study||38
8640568|NCT01197833|21326628|P3|STARTED|Overall Study||40
8640569|NCT01197833|21326629|P2|STARTED|Overall Study||39
8640570|NCT01197833|21326630|P1|STARTED|Overall Study||38
8640571|NCT01072877|21326646|P5|NOT COMPLETED|Overall Study||0
8640572|NCT01072877|21326647|P4|NOT COMPLETED|Overall Study||2
8640573|NCT01072877|21326648|P3|NOT COMPLETED|Overall Study||0
8640574|NCT01072877|21326649|P2|NOT COMPLETED|Overall Study||1
8640575|NCT01072877|21326650|P1|NOT COMPLETED|Overall Study||1
8640576|NCT01072877|21326646|P5|COMPLETED|Overall Study||63
8640577|NCT01072877|21326647|P4|COMPLETED|Overall Study||50
8640578|NCT01072877|21326648|P3|COMPLETED|Overall Study||51
8640579|NCT01072877|21326649|P2|COMPLETED|Overall Study||56
8640580|NCT01072877|21326650|P1|COMPLETED|Overall Study||55
8640581|NCT01072877|21326646|P5|STARTED|Overall Study||63
8640582|NCT01072877|21326647|P4|STARTED|Overall Study||52
8640583|NCT01072877|21326648|P3|STARTED|Overall Study||51
8640584|NCT01072877|21326649|P2|STARTED|Overall Study||57
8640585|NCT01072877|21326650|P1|STARTED|Overall Study||56
8640586|NCT00924664|21326674|P2|NOT COMPLETED|Overall Study||527
8640587|NCT00924664|21326675|P1|NOT COMPLETED|Overall Study||322
8640588|NCT00924664|21326674|P2|COMPLETED|Overall Study||0
8640589|NCT00924664|21326675|P1|COMPLETED|Overall Study||0
8640590|NCT00924664|21326674|P2|Treated|Overall Study||527
8640591|NCT00924664|21326675|P1|Treated|Overall Study||321
8640592|NCT00924664|21326674|P2|STARTED|Overall Study||527
8640593|NCT00924664|21326675|P1|STARTED|Overall Study||322
8640594|NCT00911508|21326779|P2|NOT COMPLETED|Overall Study||130
8640595|NCT00911508|21326780|P1|NOT COMPLETED|Overall Study||106
8640596|NCT00911508|21326779|P2|COMPLETED|Overall Study||966
8640597|NCT00911508|21326780|P1|COMPLETED|Overall Study||1002
8640598|NCT00911508|21326779|P2|STARTED|Overall Study||1096
8640599|NCT00911508|21326780|P1|STARTED|Overall Study||1108
8640600|NCT00893516|21326814|P2|NOT COMPLETED|Overall Study||0
8640601|NCT00893516|21326815|P1|NOT COMPLETED|Overall Study||0
8640602|NCT00893516|21326814|P2|COMPLETED|Overall Study||0
8640603|NCT00893516|21326815|P1|COMPLETED|Overall Study||0
8640604|NCT00893516|21326814|P2|STARTED|Overall Study||0
8640605|NCT00893516|21326815|P1|STARTED|Overall Study||0
8640606|NCT00758420|21326821|P2|NOT COMPLETED|Overall Study||0
8640607|NCT00758420|21326822|P1|NOT COMPLETED|Overall Study||0
8640608|NCT00758420|21326821|P2|COMPLETED|Overall Study||38
8640609|NCT00758420|21326822|P1|COMPLETED|Overall Study||39
8640610|NCT00758420|21326821|P2|STARTED|Overall Study||38
8640611|NCT00758420|21326822|P1|STARTED|Overall Study||39
8640612|NCT00717769|21326831|P3|NOT COMPLETED|Overall Study||11
8640613|NCT00717769|21326832|P2|NOT COMPLETED|Overall Study||18
8640614|NCT00717769|21326833|P1|NOT COMPLETED|Overall Study||16
8640615|NCT00717769|21326831|P3|COMPLETED|Overall Study||19
8640616|NCT00717769|21326832|P2|COMPLETED|Overall Study||102
8640617|NCT00717769|21326833|P1|COMPLETED|Overall Study||104
8640618|NCT00717769|21326831|P3|STARTED|Overall Study||30
8640619|NCT00717769|21326832|P2|STARTED|Overall Study||120
8640620|NCT00717769|21326833|P1|STARTED|Overall Study||120
8640621|NCT00610116|21326878|P1|NOT COMPLETED|Overall Study||13
8640622|NCT00610116|21326878|P1|COMPLETED|Overall Study|Number of analyzable patients|292
8640623|NCT00610116|21326878|P1|STARTED|Overall Study||305
8640624|NCT00442364|21326882|P1|NOT COMPLETED|Overall Study||0
8640625|NCT00442364|21326882|P1|COMPLETED|Overall Study||60
8640626|NCT00442364|21326882|P1|STARTED|Overall Study||60
8640627|NCT04358068|21326888|P2|NOT COMPLETED|Overall Study||2
8640628|NCT04358068|21326889|P1|NOT COMPLETED|Overall Study||2
8640629|NCT04358068|21326888|P2|COMPLETED|Overall Study||9
8640630|NCT04358068|21326889|P1|COMPLETED|Overall Study||7
8640631|NCT04358068|21326888|P2|STARTED|Overall Study||11
8640632|NCT04358068|21326889|P1|STARTED|Overall Study||9
8640641|NCT03906968|21326936|P1|NOT COMPLETED|Overall Study||0
8640642|NCT03906968|21326936|P1|COMPLETED|Overall Study||40
8640643|NCT03906968|21326936|P1|STARTED|Overall Study||40
8640644|NCT03758716|21326945|P1|NOT COMPLETED|Overall Study||0
8640645|NCT03758716|21326945|P1|COMPLETED|Overall Study||12
8640646|NCT03758716|21326945|P1|STARTED|Overall Study||12
8640647|NCT03446573|21326963|P2|NOT COMPLETED|Overall Study||372
8640648|NCT03446573|21326964|P1|NOT COMPLETED|Overall Study||369
8640649|NCT03446573|21326963|P2|COMPLETED|Overall Study||0
8640650|NCT03446573|21326964|P1|COMPLETED|Overall Study||0
8640651|NCT03446573|21326963|P2|STARTED|Overall Study||372
8640652|NCT03446573|21326964|P1|STARTED|Overall Study||369
8640653|NCT03425188|21327036|P1|NOT COMPLETED|Overall Study||1
8640654|NCT03425188|21327036|P1|COMPLETED|Overall Study||52
8640655|NCT03425188|21327036|P1|STARTED|Overall Study||53
8640656|NCT03423186|21327046|P2|NOT COMPLETED|Overall Study||0
8640657|NCT03423186|21327047|P1|NOT COMPLETED|Overall Study||0
8640658|NCT03423186|21327046|P2|COMPLETED|Overall Study||3
8640659|NCT03423186|21327047|P1|COMPLETED|Overall Study||3
8640660|NCT03423186|21327046|P2|STARTED|Overall Study||3
8640661|NCT03423186|21327047|P1|STARTED|Overall Study||3
8640662|NCT03393494|21327098|P3|NOT COMPLETED|Overall Study||25
8640663|NCT03393494|21327099|P2|NOT COMPLETED|Overall Study||75
8640664|NCT03393494|21327100|P1|NOT COMPLETED|Overall Study||68
8640665|NCT03393494|21327098|P3|COMPLETED|Overall Study||140
8640666|NCT03393494|21327099|P2|COMPLETED|Overall Study||256
8640667|NCT03393494|21327100|P1|COMPLETED|Overall Study||261
8640668|NCT03393494|21327098|P3|STARTED|Overall Study||165
8640669|NCT03393494|21327099|P2|STARTED|Overall Study||331
8640670|NCT03393494|21327100|P1|STARTED|Overall Study||329
8640671|NCT03298841|21327113|P2|NOT COMPLETED|Overall Study||0
8640672|NCT03298841|21327114|P1|NOT COMPLETED|Overall Study||0
8640673|NCT03298841|21327113|P2|COMPLETED|Overall Study||25
8640674|NCT03298841|21327114|P1|COMPLETED|Overall Study||25
8640675|NCT03298841|21327113|P2|STARTED|Overall Study||25
8640676|NCT03298841|21327114|P1|STARTED|Overall Study||25
8640677|NCT03274804|21327121|P1|NOT COMPLETED|Overall Study||0
8640678|NCT03274804|21327121|P1|COMPLETED|Overall Study||20
8640679|NCT03274804|21327121|P1|STARTED|Overall Study||20
8640680|NCT03242954|21327134|P4|NOT COMPLETED|Overall Study||0
8640681|NCT03242954|21327135|P3|NOT COMPLETED|Overall Study||0
8640682|NCT03242954|21327136|P2|NOT COMPLETED|Overall Study||0
8640683|NCT03242954|21327137|P1|NOT COMPLETED|Overall Study||0
8640684|NCT03242954|21327134|P4|COMPLETED|Overall Study||125
8640685|NCT03242954|21327135|P3|COMPLETED|Overall Study||41
8640686|NCT03242954|21327136|P2|COMPLETED|Overall Study||45
8640687|NCT03242954|21327137|P1|COMPLETED|Overall Study||43
8640688|NCT03242954|21327134|P4|STARTED|Overall Study||125
8640689|NCT03242954|21327135|P3|STARTED|Overall Study||41
8640690|NCT03242954|21327136|P2|STARTED|Overall Study||45
8640691|NCT03242954|21327137|P1|STARTED|Overall Study||43
8640692|NCT03224351|21327159|P8|NOT COMPLETED|Overall Study||0
8640693|NCT03224351|21327160|P7|NOT COMPLETED|Overall Study||0
8640694|NCT03224351|21327161|P6|NOT COMPLETED|Overall Study||0
8640695|NCT03224351|21327162|P5|NOT COMPLETED|Overall Study||0
8640696|NCT03224351|21327163|P4|NOT COMPLETED|Overall Study||0
8640697|NCT03224351|21327164|P3|NOT COMPLETED|Overall Study||0
8640698|NCT03224351|21327165|P2|NOT COMPLETED|Overall Study||0
8640699|NCT03224351|21327166|P1|NOT COMPLETED|Overall Study||0
8640700|NCT03224351|21327159|P8|COMPLETED|Overall Study||19
8640701|NCT03224351|21327160|P7|COMPLETED|Overall Study||6
8640702|NCT03224351|21327161|P6|COMPLETED|Overall Study||18
8640703|NCT03224351|21327162|P5|COMPLETED|Overall Study||11
8640704|NCT03224351|21327163|P4|COMPLETED|Overall Study||22
8640705|NCT03224351|21327164|P3|COMPLETED|Overall Study||20
8640706|NCT03224351|21327165|P2|COMPLETED|Overall Study||11
8640707|NCT03224351|21327166|P1|COMPLETED|Overall Study||10
8640708|NCT03224351|21327159|P8|STARTED|Overall Study||19
8640709|NCT03224351|21327160|P7|STARTED|Overall Study||6
8640710|NCT03224351|21327161|P6|STARTED|Overall Study||18
8640711|NCT03224351|21327162|P5|STARTED|Overall Study||11
8640712|NCT03224351|21327163|P4|STARTED|Overall Study||22
8640713|NCT03224351|21327164|P3|STARTED|Overall Study||20
8640714|NCT03224351|21327165|P2|STARTED|Overall Study||11
8640715|NCT03224351|21327166|P1|STARTED|Overall Study||10
8640716|NCT03187262|21327222|P1|NOT COMPLETED|Maintenance||0
8640717|NCT03187262|21327222|P1|COMPLETED|Maintenance||2
8640718|NCT03187262|21327222|P1|STARTED|Maintenance||2
8640719|NCT03187262|21327222|P1|NOT COMPLETED|Consolidation||5
8640720|NCT03187262|21327222|P1|COMPLETED|Consolidation||2
8640721|NCT03187262|21327222|P1|STARTED|Consolidation||7
8640722|NCT03187262|21327222|P1|NOT COMPLETED|Induction||6
8640723|NCT03187262|21327222|P1|COMPLETED|Induction||7
8640724|NCT03187262|21327222|P1|STARTED|Induction||13
8640725|NCT03134963|21327235|P4|NOT COMPLETED|Overall Study||0
8640726|NCT03134963|21327236|P3|NOT COMPLETED|Overall Study||0
8640727|NCT03134963|21327237|P2|NOT COMPLETED|Overall Study||0
8640728|NCT03134963|21327238|P1|NOT COMPLETED|Overall Study||0
8640729|NCT03134963|21327235|P4|COMPLETED|Overall Study||14
8640730|NCT03134963|21327236|P3|COMPLETED|Overall Study||3
8640731|NCT03134963|21327237|P2|COMPLETED|Overall Study||13
8640732|NCT03134963|21327238|P1|COMPLETED|Overall Study||12
8640733|NCT03134963|21327235|P4|STARTED|Overall Study||14
8640734|NCT03134963|21327236|P3|STARTED|Overall Study||3
8640735|NCT03134963|21327237|P2|STARTED|Overall Study||13
8640736|NCT03134963|21327238|P1|STARTED|Overall Study||12
8640743|NCT03052257|21327281|P2|NOT COMPLETED|Overall Study||3
8640744|NCT03052257|21327282|P1|NOT COMPLETED|Overall Study||5
8640745|NCT03052257|21327281|P2|COMPLETED|Overall Study||97
8640746|NCT03052257|21327282|P1|COMPLETED|Overall Study||95
8640747|NCT03052257|21327281|P2|STARTED|Overall Study||100
8640748|NCT03052257|21327282|P1|STARTED|Overall Study||100
8640749|NCT02937194|21327290|P2|NOT COMPLETED|3-years Followup||78
8640750|NCT02937194|21327291|P1|NOT COMPLETED|3-years Followup||66
8640751|NCT02937194|21327290|P2|COMPLETED|3-years Followup||208
8640752|NCT02937194|21327291|P1|COMPLETED|3-years Followup||228
8640753|NCT02937194|21327290|P2|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
8640754|NCT02937194|21327291|P1|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
8640755|NCT02937194|21327290|P2|NOT COMPLETED|2-years Followup||78
8640756|NCT02937194|21327291|P1|NOT COMPLETED|2-years Followup||78
8640757|NCT02937194|21327290|P2|COMPLETED|2-years Followup||208
8640758|NCT02937194|21327291|P1|COMPLETED|2-years Followup||216
8640759|NCT02937194|21327290|P2|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
8640760|NCT02937194|21327291|P1|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
8640761|NCT02937194|21327290|P2|NOT COMPLETED|1-year Followup||68
8640762|NCT02937194|21327291|P1|NOT COMPLETED|1-year Followup||71
8640763|NCT02937194|21327290|P2|COMPLETED|1-year Followup||218
8640764|NCT02937194|21327291|P1|COMPLETED|1-year Followup||223
8640765|NCT02937194|21327290|P2|STARTED|1-year Followup||286
8640766|NCT02937194|21327291|P1|STARTED|1-year Followup||294
8640767|NCT02927080|21327315|P10|NOT COMPLETED|Overall Study||7
8640768|NCT02927080|21327316|P9|NOT COMPLETED|Overall Study||3
8640769|NCT02927080|21327317|P8|NOT COMPLETED|Overall Study||9
8640770|NCT02927080|21327318|P7|NOT COMPLETED|Overall Study||8
8640771|NCT02927080|21327319|P6|NOT COMPLETED|Overall Study||0
8640772|NCT02927080|21327320|P5|NOT COMPLETED|Overall Study||1
8640773|NCT02927080|21327321|P4|NOT COMPLETED|Overall Study||0
8640774|NCT02927080|21327322|P3|NOT COMPLETED|Overall Study||0
8640775|NCT02927080|21327323|P2|NOT COMPLETED|Overall Study||1
8640776|NCT02927080|21327324|P1|NOT COMPLETED|Overall Study||0
8640777|NCT02927080|21327315|P10|COMPLETED|Overall Study||7
8640778|NCT02927080|21327316|P9|COMPLETED|Overall Study||12
8640779|NCT02927080|21327317|P8|COMPLETED|Overall Study||5
8640780|NCT02927080|21327318|P7|COMPLETED|Overall Study||7
8640781|NCT02927080|21327319|P6|COMPLETED|Overall Study||6
8640782|NCT02927080|21327320|P5|COMPLETED|Overall Study||6
8640783|NCT02927080|21327321|P4|COMPLETED|Overall Study||6
8640784|NCT02927080|21327322|P3|COMPLETED|Overall Study||6
8640785|NCT02927080|21327323|P2|COMPLETED|Overall Study||5
8640786|NCT02927080|21327324|P1|COMPLETED|Overall Study||6
8640787|NCT02927080|21327315|P10|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||12
8640788|NCT02927080|21327316|P9|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
8640789|NCT02927080|21327317|P8|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||13
8640790|NCT02927080|21327318|P7|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
8640791|NCT02927080|21327319|P6|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
8640792|NCT02927080|21327320|P5|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
8640793|NCT02927080|21327321|P4|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
8640794|NCT02927080|21327322|P3|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
8640795|NCT02927080|21327323|P2|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
8640796|NCT02927080|21327324|P1|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
8640797|NCT02927080|21327315|P10|STARTED|Overall Study||14
8640798|NCT02927080|21327316|P9|STARTED|Overall Study||15
8640799|NCT02927080|21327317|P8|STARTED|Overall Study||14
8640800|NCT02927080|21327318|P7|STARTED|Overall Study||15
8640801|NCT02927080|21327319|P6|STARTED|Overall Study||6
8640802|NCT02927080|21327320|P5|STARTED|Overall Study||7
8640803|NCT02927080|21327321|P4|STARTED|Overall Study||6
8640804|NCT02927080|21327322|P3|STARTED|Overall Study||6
8640805|NCT02927080|21327323|P2|STARTED|Overall Study||6
8640806|NCT02927080|21327324|P1|STARTED|Overall Study||6
8640813|NCT02769858|21327427|P1|NOT COMPLETED|Overall Study||2
8640814|NCT02769858|21327427|P1|COMPLETED|Overall Study||8
8640815|NCT02769858|21327427|P1|STARTED|Overall Study||10
8640816|NCT02692391|21327435|P2|NOT COMPLETED|Overall Study||0
8640817|NCT02692391|21327436|P1|NOT COMPLETED|Overall Study||0
8640818|NCT02692391|21327435|P2|COMPLETED|Overall Study||18
8640819|NCT02692391|21327436|P1|COMPLETED|Overall Study||24
8640820|NCT02692391|21327435|P2|STARTED|Overall Study||18
8640821|NCT02692391|21327436|P1|STARTED|Overall Study||24
8640822|NCT02477111|21327448|P1|NOT COMPLETED|Overall Study||11
8640823|NCT02477111|21327448|P1|COMPLETED|Overall Study|All participants who were assessed for one year|139
8640824|NCT02477111|21327448|P1|STARTED|Overall Study||150
8640825|NCT02462876|21327460|P1|NOT COMPLETED|Overall Study||33
8640826|NCT02462876|21327460|P1|COMPLETED|Overall Study||27
8640827|NCT02462876|21327460|P1|STARTED|Overall Study||60
8640828|NCT02459587|21327470|P2|NOT COMPLETED|12-month Follow-up Assessment||27
8640829|NCT02459587|21327471|P1|NOT COMPLETED|12-month Follow-up Assessment||22
8640830|NCT02459587|21327470|P2|COMPLETED|12-month Follow-up Assessment||111
8640831|NCT02459587|21327471|P1|COMPLETED|12-month Follow-up Assessment||127
8640832|NCT02459587|21327470|P2|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|138
8640833|NCT02459587|21327471|P1|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|149
8640834|NCT02459587|21327470|P2|NOT COMPLETED|6-month Follow-up Assessment||25
8640835|NCT02459587|21327471|P1|NOT COMPLETED|6-month Follow-up Assessment||24
8640836|NCT02459587|21327470|P2|COMPLETED|6-month Follow-up Assessment||116
8640837|NCT02459587|21327471|P1|COMPLETED|6-month Follow-up Assessment||128
8640838|NCT02459587|21327470|P2|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|141
8640839|NCT02459587|21327471|P1|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|152
8640840|NCT02459587|21327470|P2|NOT COMPLETED|3-Month Follow-up Assessment||31
8640841|NCT02459587|21327471|P1|NOT COMPLETED|3-Month Follow-up Assessment||32
8640842|NCT02459587|21327470|P2|COMPLETED|3-Month Follow-up Assessment||119
8640843|NCT02459587|21327471|P1|COMPLETED|3-Month Follow-up Assessment||125
8640844|NCT02459587|21327470|P2|STARTED|3-Month Follow-up Assessment||150
8640845|NCT02459587|21327471|P1|STARTED|3-Month Follow-up Assessment||157
8640856|NCT02367456|21327493|P3|NOT COMPLETED|Overall Study||30
8640857|NCT02367456|21327494|P2|NOT COMPLETED|Overall Study||30
8640858|NCT02367456|21327495|P1|NOT COMPLETED|Overall Study||12
8640859|NCT02367456|21327493|P3|COMPLETED|Overall Study||0
8640860|NCT02367456|21327494|P2|COMPLETED|Overall Study||0
8640861|NCT02367456|21327495|P1|COMPLETED|Overall Study||0
8640862|NCT02367456|21327493|P3|STARTED|Overall Study||30
8640863|NCT02367456|21327494|P2|STARTED|Overall Study||30
8640864|NCT02367456|21327495|P1|STARTED|Overall Study||12
8640868|NCT02062593|21327538|P2|NOT COMPLETED|Overall Study||4
8640869|NCT02062593|21327539|P1|NOT COMPLETED|Overall Study||0
8640870|NCT02062593|21327538|P2|COMPLETED|Overall Study||91
8640871|NCT02062593|21327539|P1|COMPLETED|Overall Study||105
8640872|NCT02062593|21327538|P2|STARTED|Overall Study||95
8640873|NCT02062593|21327539|P1|STARTED|Overall Study||105
8640877|NCT01844765|21327551|P2|NOT COMPLETED|Overall Study||15
8640878|NCT01844765|21327552|P1|NOT COMPLETED|Overall Study||15
8640879|NCT01844765|21327551|P2|COMPLETED|Overall Study||10
8640880|NCT01844765|21327552|P1|COMPLETED|Overall Study||19
8640881|NCT01844765|21327551|P2|Untreated|Overall Study||0
8640882|NCT01844765|21327552|P1|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
8640883|NCT01844765|21327551|P2|Treated|Overall Study||25
8640884|NCT01844765|21327552|P1|Treated|Overall Study||33
8640885|NCT01844765|21327551|P2|STARTED|Overall Study||25
8640886|NCT01844765|21327552|P1|STARTED|Overall Study||34
8640893|NCT01692119|21327614|P2|NOT COMPLETED|Overall Study||1
8640894|NCT01692119|21327615|P1|NOT COMPLETED|Overall Study||20
8640895|NCT01692119|21327614|P2|COMPLETED|Overall Study||127
8640896|NCT01692119|21327615|P1|COMPLETED|Overall Study||110
8640897|NCT01692119|21327614|P2|STARTED|Overall Study||128
8640898|NCT01692119|21327615|P1|STARTED|Overall Study||130
8640899|NCT01502813|21327623|P1|NOT COMPLETED|Overall Study||0
8640900|NCT01502813|21327623|P1|COMPLETED|Overall Study||40
8640901|NCT01502813|21327623|P1|STARTED|Overall Study||40
8640902|NCT01390077|21327628|P1|NOT COMPLETED|Overall Study||1
8640903|NCT01390077|21327628|P1|COMPLETED|Overall Study||7
8640904|NCT01390077|21327628|P1|Treatment|Overall Study||7
8640905|NCT01390077|21327628|P1|STARTED|Overall Study||8
8640926|NCT01177735|21327646|P1|NOT COMPLETED|Overall Study||71
8640927|NCT01177735|21327646|P1|COMPLETED|Overall Study||0
8640928|NCT01177735|21327646|P1|STARTED|Overall Study||71
8640929|NCT01022359|21327652|P2|NOT COMPLETED|Overall Study||0
8640930|NCT01022359|21327653|P1|NOT COMPLETED|Overall Study||0
8640931|NCT01022359|21327652|P2|COMPLETED|Overall Study||41
8640932|NCT01022359|21327653|P1|COMPLETED|Overall Study||39
8640933|NCT01022359|21327652|P2|STARTED|Overall Study||41
8640934|NCT01022359|21327653|P1|STARTED|Overall Study||39
8640935|NCT00536601|21327676|P5|NOT COMPLETED|Overall Study||0
8640936|NCT00536601|21327677|P4|NOT COMPLETED|Overall Study||0
8640937|NCT00536601|21327678|P3|NOT COMPLETED|Overall Study||0
8640938|NCT00536601|21327679|P2|NOT COMPLETED|Overall Study||0
8640939|NCT00536601|21327680|P1|NOT COMPLETED|Overall Study||0
8640940|NCT00536601|21327676|P5|COMPLETED|Overall Study||11
8640941|NCT00536601|21327677|P4|COMPLETED|Overall Study||65
8640942|NCT00536601|21327678|P3|COMPLETED|Overall Study||71
8640943|NCT00536601|21327679|P2|COMPLETED|Overall Study||21
8640944|NCT00536601|21327680|P1|COMPLETED|Overall Study||6
8640945|NCT00536601|21327676|P5|STARTED|Overall Study||11
8640946|NCT00536601|21327677|P4|STARTED|Overall Study||65
8640947|NCT00536601|21327678|P3|STARTED|Overall Study||71
8640948|NCT00536601|21327679|P2|STARTED|Overall Study||21
8640949|NCT00536601|21327680|P1|STARTED|Overall Study||6
8640956|NCT04207333|21327722|P2|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
8640957|NCT04207333|21327723|P1|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
8640958|NCT04207333|21327722|P2|COMPLETED|Second Intervention (Single 1-Day Visit)||3
8640959|NCT04207333|21327723|P1|COMPLETED|Second Intervention (Single 1-Day Visit)||3
8640960|NCT04207333|21327722|P2|STARTED|Second Intervention (Single 1-Day Visit)||3
8640961|NCT04207333|21327723|P1|STARTED|Second Intervention (Single 1-Day Visit)||3
8640962|NCT04207333|21327722|P2|NOT COMPLETED|Washout (2-7 Days)||0
8640963|NCT04207333|21327723|P1|NOT COMPLETED|Washout (2-7 Days)||0
8640964|NCT04207333|21327722|P2|COMPLETED|Washout (2-7 Days)||3
8640965|NCT04207333|21327723|P1|COMPLETED|Washout (2-7 Days)||3
8640966|NCT04207333|21327722|P2|STARTED|Washout (2-7 Days)||3
8640967|NCT04207333|21327723|P1|STARTED|Washout (2-7 Days)||3
8640968|NCT04207333|21327722|P2|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
8640969|NCT04207333|21327723|P1|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
8640970|NCT04207333|21327722|P2|COMPLETED|First Intervention (Single 1-Day Visit)||3
8640971|NCT04207333|21327723|P1|COMPLETED|First Intervention (Single 1-Day Visit)||3
8640972|NCT04207333|21327722|P2|STARTED|First Intervention (Single 1-Day Visit)||3
8640973|NCT04207333|21327723|P1|STARTED|First Intervention (Single 1-Day Visit)||3
8640974|NCT04037969|21327743|P2|NOT COMPLETED|Overall Study||0
8640975|NCT04037969|21327744|P1|NOT COMPLETED|Overall Study||0
8640976|NCT04037969|21327743|P2|COMPLETED|Overall Study||10
8640977|NCT04037969|21327744|P1|COMPLETED|Overall Study||10
8640978|NCT04037969|21327743|P2|STARTED|Overall Study||10
8640979|NCT04037969|21327744|P1|STARTED|Overall Study||10
8640998|NCT03686969|21327789|P2|NOT COMPLETED|Overall Study||0
8640999|NCT03686969|21327790|P1|NOT COMPLETED|Overall Study||1
8641000|NCT03686969|21327789|P2|COMPLETED|Overall Study||0
8641001|NCT03686969|21327790|P1|COMPLETED|Overall Study||0
8641002|NCT03686969|21327789|P2|STARTED|Overall Study||0
8641003|NCT03686969|21327790|P1|STARTED|Overall Study||1
8641010|NCT03576183|21327999|P2|NOT COMPLETED|Overall Study||1
8641011|NCT03576183|21328000|P1|NOT COMPLETED|Overall Study||2
8641012|NCT03576183|21327999|P2|COMPLETED|Overall Study||16
8641013|NCT03576183|21328000|P1|COMPLETED|Overall Study||15
8641014|NCT03576183|21327999|P2|STARTED|Overall Study||17
8641015|NCT03576183|21328000|P1|STARTED|Overall Study||17
8641058|NCT03229759|21328147|P1|NOT COMPLETED|Overall Study||30
8641059|NCT03229759|21328147|P1|COMPLETED|Overall Study||69
8641060|NCT03229759|21328147|P1|Treated With Saline Control|Overall Study||46
8641061|NCT03229759|21328147|P1|Treated With Vehicle Control|Overall Study||47
8641062|NCT03229759|21328147|P1|Treated With Investigational Product|Overall Study||45
8641063|NCT03229759|21328147|P1|Participants Treated|Overall Study||69
8641064|NCT03229759|21328147|P1|STARTED|Overall Study||99
8641065|NCT03224299|21328153|P2|NOT COMPLETED|Overall Study||0
8641066|NCT03224299|21328154|P1|NOT COMPLETED|Overall Study||0
8641067|NCT03224299|21328153|P2|COMPLETED|Overall Study||424
8641068|NCT03224299|21328154|P1|COMPLETED|Overall Study||131
8641069|NCT03224299|21328153|P2|Treated With NC|Overall Study||106
8641070|NCT03224299|21328154|P1|Treated With NC|Overall Study||65
8641071|NCT03224299|21328153|P2|Treated With AC|Overall Study||110
8641072|NCT03224299|21328154|P1|Treated With AC|Overall Study||66
8641073|NCT03224299|21328153|P2|Treated With IP#2|Overall Study||107
8641074|NCT03224299|21328154|P1|Treated With IP#2|Overall Study||66
8641075|NCT03224299|21328153|P2|Treated With IP#1|Overall Study||101
8641076|NCT03224299|21328154|P1|Treated With IP#1|Overall Study||65
8641077|NCT03224299|21328153|P2|STARTED|Overall Study||424
8641078|NCT03224299|21328154|P1|STARTED|Overall Study||131
8641079|NCT03203447|21328170|P2|NOT COMPLETED|Overall Study||163
8641080|NCT03203447|21328171|P1|NOT COMPLETED|Overall Study||162
8641081|NCT03203447|21328170|P2|COMPLETED|Overall Study||0
8641082|NCT03203447|21328171|P1|COMPLETED|Overall Study||0
8641083|NCT03203447|21328170|P2|STARTED|Overall Study|One patient was randomized to the Control arm, but did not receive study drug.|163
8641084|NCT03203447|21328171|P1|STARTED|Overall Study|Two patients were randomized to the Active arm, but did not receive study drug.|162
8641097|NCT02987829|21328235|P6|NOT COMPLETED|Overall Study||0
8641098|NCT02987829|21328236|P5|NOT COMPLETED|Overall Study||0
8641099|NCT02987829|21328237|P4|NOT COMPLETED|Overall Study||0
8641100|NCT02987829|21328238|P3|NOT COMPLETED|Overall Study||0
8641101|NCT02987829|21328239|P2|NOT COMPLETED|Overall Study||0
8641102|NCT02987829|21328240|P1|NOT COMPLETED|Overall Study||0
8641103|NCT02987829|21328235|P6|COMPLETED|Overall Study||10
8641104|NCT02987829|21328236|P5|COMPLETED|Overall Study||51
8641105|NCT02987829|21328237|P4|COMPLETED|Overall Study||7
8641106|NCT02987829|21328238|P3|COMPLETED|Overall Study||2
8641107|NCT02987829|21328239|P2|COMPLETED|Overall Study||1
8641108|NCT02987829|21328240|P1|COMPLETED|Overall Study||1
8641109|NCT02987829|21328235|P6|STARTED|Overall Study||10
8641110|NCT02987829|21328236|P5|STARTED|Overall Study||51
8641111|NCT02987829|21328237|P4|STARTED|Overall Study||7
8641112|NCT02987829|21328238|P3|STARTED|Overall Study||2
8641113|NCT02987829|21328239|P2|STARTED|Overall Study||1
8641114|NCT02987829|21328240|P1|STARTED|Overall Study||1
8641115|NCT02636868|21328287|P3|NOT COMPLETED|Overall Study||2
8641116|NCT02636868|21328288|P2|NOT COMPLETED|Overall Study||1
8641117|NCT02636868|21328289|P1|NOT COMPLETED|Overall Study||0
8641118|NCT02636868|21328287|P3|COMPLETED|Overall Study||70
8641119|NCT02636868|21328288|P2|COMPLETED|Overall Study||75
8641120|NCT02636868|21328289|P1|COMPLETED|Overall Study||73
8641121|NCT02636868|21328287|P3|STARTED|Overall Study||72
8641122|NCT02636868|21328288|P2|STARTED|Overall Study||76
8641123|NCT02636868|21328289|P1|STARTED|Overall Study||73
8641124|NCT02569801|21328314|P2|NOT COMPLETED|Overall Study||35
8641125|NCT02569801|21328315|P1|NOT COMPLETED|Overall Study||36
8641126|NCT02569801|21328314|P2|COMPLETED|Overall Study||0
8641127|NCT02569801|21328315|P1|COMPLETED|Overall Study||0
8641128|NCT02569801|21328314|P2|Received Treatment|Overall Study||35
8641129|NCT02569801|21328315|P1|Received Treatment|Overall Study||35
8641130|NCT02569801|21328314|P2|STARTED|Overall Study||35
8641131|NCT02569801|21328315|P1|STARTED|Overall Study||36
8641132|NCT02536794|21328334|P1|NOT COMPLETED|Follow up for 3 Years or Death||0
8641133|NCT02536794|21328334|P1|COMPLETED|Follow up for 3 Years or Death||29
8641134|NCT02536794|21328334|P1|STARTED|Follow up for 3 Years or Death|one patient did not go into follow up as treatment was discontinued due to a protocol violation|29
8641135|NCT02536794|21328334|P1|NOT COMPLETED|Continued Treatment After 1st Response||8
8641136|NCT02536794|21328334|P1|COMPLETED|Continued Treatment After 1st Response||16
8641137|NCT02536794|21328334|P1|Went on to Start Cycle 3|Continued Treatment After 1st Response||16
8641138|NCT02536794|21328334|P1|STARTED|Continued Treatment After 1st Response||24
8641139|NCT02536794|21328334|P1|NOT COMPLETED|Reached 1st Response Assessment||6
8641140|NCT02536794|21328334|P1|COMPLETED|Reached 1st Response Assessment||24
8641141|NCT02536794|21328334|P1|Reached First Response|Reached 1st Response Assessment||24
8641142|NCT02536794|21328334|P1|Attempted Second Cycle|Reached 1st Response Assessment||24
8641143|NCT02536794|21328334|P1|Attempted First Cycle|Reached 1st Response Assessment||30
8641144|NCT02536794|21328334|P1|Started Treatment|Reached 1st Response Assessment||30
8641145|NCT02536794|21328334|P1|STARTED|Reached 1st Response Assessment||30
8641146|NCT02525263|21328343|P1|NOT COMPLETED|Overall Study||0
8641147|NCT02525263|21328343|P1|COMPLETED|Overall Study|The trial was completed when the patient reached the specified endpoint of starting hemodialysis.|1
8641148|NCT02525263|21328343|P1|STARTED|Overall Study|The single patient in this trial was enrolled on 18 July 2016.|1
8641149|NCT02281409|21328356|P4|NOT COMPLETED|Overall Study||0
8641150|NCT02281409|21328357|P3|NOT COMPLETED|Overall Study||0
8641151|NCT02281409|21328358|P2|NOT COMPLETED|Overall Study||0
8641152|NCT02281409|21328359|P1|NOT COMPLETED|Overall Study||0
8641153|NCT02281409|21328356|P4|COMPLETED|Overall Study||6
8641154|NCT02281409|21328357|P3|COMPLETED|Overall Study||5
8641155|NCT02281409|21328358|P2|COMPLETED|Overall Study||3
8641156|NCT02281409|21328359|P1|COMPLETED|Overall Study||3
8641157|NCT02281409|21328356|P4|STARTED|Overall Study||6
8641158|NCT02281409|21328357|P3|STARTED|Overall Study||5
8641159|NCT02281409|21328358|P2|STARTED|Overall Study||3
8641160|NCT02281409|21328359|P1|STARTED|Overall Study||3
8641161|NCT02169830|21328373|P3|NOT COMPLETED|Third Intervention (8 Weeks)||0
8641162|NCT02169830|21328374|P2|NOT COMPLETED|Third Intervention (8 Weeks)||2
8641163|NCT02169830|21328375|P1|NOT COMPLETED|Third Intervention (8 Weeks)||0
8641164|NCT02169830|21328373|P3|COMPLETED|Third Intervention (8 Weeks)||0
8641165|NCT02169830|21328374|P2|COMPLETED|Third Intervention (8 Weeks)||2
8641166|NCT02169830|21328375|P1|COMPLETED|Third Intervention (8 Weeks)||0
8641167|NCT02169830|21328373|P3|STARTED|Third Intervention (8 Weeks)||0
8641168|NCT02169830|21328374|P2|STARTED|Third Intervention (8 Weeks)|These four subjects were randomized to Diet first Topiramate second, and Nortriptyline third. No subjects from this group were weaned and moved to Nortriptyline.|4
8641169|NCT02169830|21328375|P1|STARTED|Third Intervention (8 Weeks)||0
8641170|NCT02169830|21328373|P3|NOT COMPLETED|Second Intervention (8 Weeks)||0
8641171|NCT02169830|21328374|P2|NOT COMPLETED|Second Intervention (8 Weeks)||5
8641172|NCT02169830|21328375|P1|NOT COMPLETED|Second Intervention (8 Weeks)||3
8641173|NCT02169830|21328373|P3|COMPLETED|Second Intervention (8 Weeks)||0
8641174|NCT02169830|21328374|P2|COMPLETED|Second Intervention (8 Weeks)||0
8641175|NCT02169830|21328375|P1|COMPLETED|Second Intervention (8 Weeks)||9
8641176|NCT02169830|21328373|P3|STARTED|Second Intervention (8 Weeks)||0
8641177|NCT02169830|21328374|P2|STARTED|Second Intervention (8 Weeks)||5
8641178|NCT02169830|21328375|P1|STARTED|Second Intervention (8 Weeks)||12
8641179|NCT02169830|21328373|P3|NOT COMPLETED|Diet Intervention (4 Weeks)||1
8641180|NCT02169830|21328374|P2|NOT COMPLETED|Diet Intervention (4 Weeks)||0
8641181|NCT02169830|21328375|P1|NOT COMPLETED|Diet Intervention (4 Weeks)||0
8641182|NCT02169830|21328373|P3|COMPLETED|Diet Intervention (4 Weeks)||32
8641183|NCT02169830|21328374|P2|COMPLETED|Diet Intervention (4 Weeks)||0
8641184|NCT02169830|21328375|P1|COMPLETED|Diet Intervention (4 Weeks)||0
8641185|NCT02169830|21328373|P3|STARTED|Diet Intervention (4 Weeks)||33
8641186|NCT02169830|21328374|P2|STARTED|Diet Intervention (4 Weeks)||0
8641187|NCT02169830|21328375|P1|STARTED|Diet Intervention (4 Weeks)||0
8641188|NCT02057666|21328385|P2|NOT COMPLETED|Open-Label Treatment Period||6
8641189|NCT02057666|21328386|P1|NOT COMPLETED|Open-Label Treatment Period||0
8641190|NCT02057666|21328385|P2|COMPLETED|Open-Label Treatment Period||0
8641191|NCT02057666|21328386|P1|COMPLETED|Open-Label Treatment Period||0
8641192|NCT02057666|21328385|P2|STARTED|Open-Label Treatment Period||6
8641193|NCT02057666|21328386|P1|STARTED|Open-Label Treatment Period||0
8641194|NCT02057666|21328385|P2|NOT COMPLETED|Double Blind Treatment Period||44
8641195|NCT02057666|21328386|P1|NOT COMPLETED|Double Blind Treatment Period||96
8641196|NCT02057666|21328385|P2|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|6
8641197|NCT02057666|21328386|P1|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|0
8641198|NCT02057666|21328385|P2|STARTED|Double Blind Treatment Period||50
8641199|NCT02057666|21328386|P1|STARTED|Double Blind Treatment Period||96
8641203|NCT01846988|21328409|P3|NOT COMPLETED|Intervention #2 - 4 Weeks||0
8641204|NCT01846988|21328410|P2|NOT COMPLETED|Intervention #2 - 4 Weeks||0
8641205|NCT01846988|21328411|P1|NOT COMPLETED|Intervention #2 - 4 Weeks||0
8641206|NCT01846988|21328409|P3|COMPLETED|Intervention #2 - 4 Weeks||5
8641207|NCT01846988|21328410|P2|COMPLETED|Intervention #2 - 4 Weeks||5
8641208|NCT01846988|21328411|P1|COMPLETED|Intervention #2 - 4 Weeks||0
8641209|NCT01846988|21328409|P3|STARTED|Intervention #2 - 4 Weeks||5
8641210|NCT01846988|21328410|P2|STARTED|Intervention #2 - 4 Weeks||5
8641211|NCT01846988|21328411|P1|STARTED|Intervention #2 - 4 Weeks||0
8641212|NCT01846988|21328409|P3|NOT COMPLETED|Intervention #1 - 4 Weeks||0
8641213|NCT01846988|21328410|P2|NOT COMPLETED|Intervention #1 - 4 Weeks||0
8641214|NCT01846988|21328411|P1|NOT COMPLETED|Intervention #1 - 4 Weeks||0
8641215|NCT01846988|21328409|P3|COMPLETED|Intervention #1 - 4 Weeks||5
8641216|NCT01846988|21328410|P2|COMPLETED|Intervention #1 - 4 Weeks||5
8641217|NCT01846988|21328411|P1|COMPLETED|Intervention #1 - 4 Weeks||0
8641218|NCT01846988|21328409|P3|STARTED|Intervention #1 - 4 Weeks||5
8641219|NCT01846988|21328410|P2|STARTED|Intervention #1 - 4 Weeks|Only 10 of 15 participants completing Comparison period started periods 1 & 2|5
8641220|NCT01846988|21328411|P1|STARTED|Intervention #1 - 4 Weeks||0
8641221|NCT01846988|21328409|P3|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
8641222|NCT01846988|21328410|P2|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
8641223|NCT01846988|21328411|P1|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
8641224|NCT01846988|21328409|P3|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
8641225|NCT01846988|21328410|P2|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
8641226|NCT01846988|21328411|P1|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||15
8641227|NCT01846988|21328409|P3|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
8641228|NCT01846988|21328410|P2|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
8641229|NCT01846988|21328411|P1|STARTED|APAP Pressurize Comparison (4-8 Weeks)||15
8641230|NCT01763684|21328430|P2|NOT COMPLETED|Overall Study||133
8641231|NCT01763684|21328431|P1|NOT COMPLETED|Overall Study||133
8641232|NCT01763684|21328430|P2|COMPLETED|Overall Study||0
8641233|NCT01763684|21328431|P1|COMPLETED|Overall Study||0
8641234|NCT01763684|21328430|P2|Completed Surgery|Overall Study||127
8641235|NCT01763684|21328431|P1|Completed Surgery|Overall Study||126
8641236|NCT01763684|21328430|P2|STARTED|Overall Study||133
8641237|NCT01763684|21328431|P1|STARTED|Overall Study||133
8641273|NCT01125293|21328494|P6|NOT COMPLETED|Overall Study||23
8641274|NCT01125293|21328495|P5|NOT COMPLETED|Overall Study||10
8641275|NCT01125293|21328496|P4|NOT COMPLETED|Overall Study||3
8641276|NCT01125293|21328497|P3|NOT COMPLETED|Overall Study||4
8641277|NCT01125293|21328498|P2|NOT COMPLETED|Overall Study||3
8641278|NCT01125293|21328499|P1|NOT COMPLETED|Overall Study||3
8641279|NCT01125293|21328494|P6|COMPLETED|Overall Study||0
8641280|NCT01125293|21328495|P5|COMPLETED|Overall Study||0
8641281|NCT01125293|21328496|P4|COMPLETED|Overall Study||0
8641282|NCT01125293|21328497|P3|COMPLETED|Overall Study||0
8641283|NCT01125293|21328498|P2|COMPLETED|Overall Study||0
8641284|NCT01125293|21328499|P1|COMPLETED|Overall Study||0
8641285|NCT01125293|21328494|P6|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase II cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
8641286|NCT01125293|21328495|P5|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase I dose expansion cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
8641287|NCT01125293|21328496|P4|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
8641288|NCT01125293|21328497|P3|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
8641289|NCT01125293|21328498|P2|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
8641290|NCT01125293|21328499|P1|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
8641291|NCT01125293|21328494|P6|STARTED|Overall Study||23
8641292|NCT01125293|21328495|P5|STARTED|Overall Study|Per protocol, a 10 patient expansion cohort is used to confirm the MTD determined in Stage B .|10
8641293|NCT01125293|21328496|P4|STARTED|Overall Study||3
8641294|NCT01125293|21328497|P3|STARTED|Overall Study||4
8641295|NCT01125293|21328498|P2|STARTED|Overall Study||3
8641296|NCT01125293|21328499|P1|STARTED|Overall Study||3
8641303|NCT00841763|21328721|P4|NOT COMPLETED|Overall Study||3
8641304|NCT00841763|21328722|P3|NOT COMPLETED|Overall Study||8
8641305|NCT00841763|21328723|P2|NOT COMPLETED|Overall Study||57
8641306|NCT00841763|21328724|P1|NOT COMPLETED|Overall Study||162
8641307|NCT00841763|21328721|P4|COMPLETED|Overall Study||53
8641308|NCT00841763|21328722|P3|COMPLETED|Overall Study||211
8641309|NCT00841763|21328723|P2|COMPLETED|Overall Study||624
8641310|NCT00841763|21328724|P1|COMPLETED|Overall Study||2529
8641311|NCT00841763|21328721|P4|STARTED|Overall Study||56
8641312|NCT00841763|21328722|P3|STARTED|Overall Study||219
8641313|NCT00841763|21328723|P2|STARTED|Overall Study||681
8641314|NCT00841763|21328724|P1|STARTED|Overall Study||2691
8641315|NCT00794508|21328792|P1|NOT COMPLETED|Overall Study||0
8641316|NCT00794508|21328792|P1|COMPLETED|Overall Study||10
8641317|NCT00794508|21328792|P1|STARTED|Overall Study||10
8641318|NCT04401579|21328800|P2|NOT COMPLETED|Overall Study||110
8641319|NCT04401579|21328801|P1|NOT COMPLETED|Overall Study||84
8641320|NCT04401579|21328800|P2|COMPLETED|Overall Study||408
8641321|NCT04401579|21328801|P1|COMPLETED|Overall Study||431
8641322|NCT04401579|21328800|P2|Treated|Overall Study||509
8641323|NCT04401579|21328801|P1|Treated|Overall Study||507
8641324|NCT04401579|21328800|P2|STARTED|Overall Study||518
8641325|NCT04401579|21328801|P1|STARTED|Overall Study||515
8641326|NCT04142242|21328895|P6|NOT COMPLETED|Overall Study||1
8641327|NCT04142242|21328896|P5|NOT COMPLETED|Overall Study||0
8641328|NCT04142242|21328897|P4|NOT COMPLETED|Overall Study||39
8641329|NCT04142242|21328898|P3|NOT COMPLETED|Overall Study||31
8641330|NCT04142242|21328899|P2|NOT COMPLETED|Overall Study||1
8641331|NCT04142242|21328900|P1|NOT COMPLETED|Overall Study||1
8641332|NCT04142242|21328895|P6|COMPLETED|Overall Study||59
8641333|NCT04142242|21328896|P5|COMPLETED|Overall Study||26
8641334|NCT04142242|21328897|P4|COMPLETED|Overall Study||0
8641335|NCT04142242|21328898|P3|COMPLETED|Overall Study||0
8641336|NCT04142242|21328899|P2|COMPLETED|Overall Study||175
8641337|NCT04142242|21328900|P1|COMPLETED|Overall Study||138
8641338|NCT04142242|21328895|P6|Safety Analysis Set (SAfAS)|Overall Study||0
8641339|NCT04142242|21328896|P5|Safety Analysis Set (SAfAS)|Overall Study||0
8641340|NCT04142242|21328897|P4|Safety Analysis Set (SAfAS)|Overall Study||0
8641341|NCT04142242|21328898|P3|Safety Analysis Set (SAfAS)|Overall Study||0
8641342|NCT04142242|21328899|P2|Safety Analysis Set (SAfAS)|Overall Study|14 Menomune-primed participants were erroneously assigned by Investigator to Group 2 but per planned analysis they were counted in Group 1 for safety analysis.|162
8641343|NCT04142242|21328900|P1|Safety Analysis Set (SAfAS)|Overall Study|1 MenACYW Conjugate vaccine-primed participant was erroneously assigned by Investigator to Group 1 but per planned analysis was counted in Group 2 for safety analysis.|151
8641344|NCT04142242|21328895|P6|Full Analysis Set (FAS)|Overall Study||59
8641345|NCT04142242|21328896|P5|Full Analysis Set (FAS)|Overall Study||26
8641346|NCT04142242|21328897|P4|Full Analysis Set (FAS)|Overall Study||39
8641347|NCT04142242|21328898|P3|Full Analysis Set (FAS)|Overall Study||31
8641348|NCT04142242|21328899|P2|Full Analysis Set (FAS)|Overall Study||175
8641349|NCT04142242|21328900|P1|Full Analysis Set (FAS)|Overall Study||138
8641350|NCT04142242|21328895|P6|Vaccinated|Overall Study||0
8641351|NCT04142242|21328896|P5|Vaccinated|Overall Study||0
8641352|NCT04142242|21328897|P4|Vaccinated|Overall Study||0
8641353|NCT04142242|21328898|P3|Vaccinated|Overall Study||0
8641354|NCT04142242|21328899|P2|Vaccinated|Overall Study||175
8641355|NCT04142242|21328900|P1|Vaccinated|Overall Study||138
8641356|NCT04142242|21328895|P6|STARTED|Overall Study||60
8641357|NCT04142242|21328896|P5|STARTED|Overall Study||26
8641358|NCT04142242|21328897|P4|STARTED|Overall Study||39
8641359|NCT04142242|21328898|P3|STARTED|Overall Study||31
8641360|NCT04142242|21328899|P2|STARTED|Overall Study||176
8641361|NCT04142242|21328900|P1|STARTED|Overall Study||139
8641362|NCT03950622|21328922|P2|NOT COMPLETED|Overall Study||7
8641363|NCT03950622|21328923|P1|NOT COMPLETED|Overall Study||8
8641364|NCT03950622|21328922|P2|COMPLETED|Overall Study||594
8641365|NCT03950622|21328923|P1|COMPLETED|Overall Study||596
8641366|NCT03950622|21328922|P2|Vaccinated|Overall Study||600
8641367|NCT03950622|21328923|P1|Vaccinated|Overall Study||602
8641368|NCT03950622|21328922|P2|STARTED|Overall Study||601
8641369|NCT03950622|21328923|P1|STARTED|Overall Study||604
8641370|NCT03880474|21328953|P2|NOT COMPLETED|Overall Study||20
8641371|NCT03880474|21328954|P1|NOT COMPLETED|Overall Study||23
8641372|NCT03880474|21328953|P2|COMPLETED|Overall Study||1055
8641373|NCT03880474|21328954|P1|COMPLETED|Overall Study||1054
8641374|NCT03880474|21328953|P2|STARTED|Overall Study||1075
8641375|NCT03880474|21328954|P1|STARTED|Overall Study||1077
8641376|NCT03674112|21328974|P2|NOT COMPLETED|Overall Study||80
8641377|NCT03674112|21328975|P1|NOT COMPLETED|Overall Study||80
8641378|NCT03674112|21328974|P2|COMPLETED|Overall Study||0
8641379|NCT03674112|21328975|P1|COMPLETED|Overall Study||0
8641380|NCT03674112|21328974|P2|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
8641381|NCT03674112|21328975|P1|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
8641382|NCT03674112|21328974|P2|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||36
8641383|NCT03674112|21328975|P1|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||34
8641384|NCT03674112|21328974|P2|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
8641385|NCT03674112|21328975|P1|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
8641386|NCT03674112|21328974|P2|STARTED|Overall Study||80
8641387|NCT03674112|21328975|P1|STARTED|Overall Study||80
8641388|NCT03655054|21329046|P1|NOT COMPLETED|Overall Study||1
8641389|NCT03655054|21329046|P1|COMPLETED|Overall Study||22
8641390|NCT03655054|21329046|P1|STARTED|Overall Study||23
8641397|NCT03571555|21329066|P2|NOT COMPLETED|Overall Study||68
8641398|NCT03571555|21329067|P1|NOT COMPLETED|Overall Study||75
8641399|NCT03571555|21329066|P2|COMPLETED|Overall Study||195
8641400|NCT03571555|21329067|P1|COMPLETED|Overall Study||177
8641401|NCT03571555|21329066|P2|STARTED|Overall Study||263
8641402|NCT03571555|21329067|P1|STARTED|Overall Study||252
8641403|NCT03444155|21329075|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
8641404|NCT03444155|21329076|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8641405|NCT03444155|21329075|P2|COMPLETED|Second Intervention (6 Weeks)||15
8641406|NCT03444155|21329076|P1|COMPLETED|Second Intervention (6 Weeks)||14
8641407|NCT03444155|21329075|P2|STARTED|Second Intervention (6 Weeks)||15
8641408|NCT03444155|21329076|P1|STARTED|Second Intervention (6 Weeks)||14
8641409|NCT03444155|21329075|P2|NOT COMPLETED|Washout (2 Weeks)||0
8641410|NCT03444155|21329076|P1|NOT COMPLETED|Washout (2 Weeks)||0
8641411|NCT03444155|21329075|P2|COMPLETED|Washout (2 Weeks)||15
8641412|NCT03444155|21329076|P1|COMPLETED|Washout (2 Weeks)||14
8641413|NCT03444155|21329075|P2|STARTED|Washout (2 Weeks)||15
8641414|NCT03444155|21329076|P1|STARTED|Washout (2 Weeks)||14
8641415|NCT03444155|21329075|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
8641416|NCT03444155|21329076|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
8641417|NCT03444155|21329075|P2|COMPLETED|First Intervention (6 Weeks)||15
8641418|NCT03444155|21329076|P1|COMPLETED|First Intervention (6 Weeks)||14
8641419|NCT03444155|21329075|P2|STARTED|First Intervention (6 Weeks)||15
8641420|NCT03444155|21329076|P1|STARTED|First Intervention (6 Weeks)||15
8641421|NCT03442777|21329103|P3|NOT COMPLETED|Overall Study||7
8641422|NCT03442777|21329104|P2|NOT COMPLETED|Overall Study||13
8641423|NCT03442777|21329105|P1|NOT COMPLETED|Overall Study||8
8641424|NCT03442777|21329103|P3|COMPLETED|Overall Study||539
8641425|NCT03442777|21329104|P2|COMPLETED|Overall Study||532
8641426|NCT03442777|21329105|P1|COMPLETED|Overall Study||534
8641427|NCT03442777|21329103|P3|STARTED|Overall Study|No participants received dressings|546
8641428|NCT03442777|21329104|P2|STARTED|Overall Study|One participant received one Allevyn® Life dressing (wrong brand by mistake), besides 13 Mepilex® Border on sacrum, (0.2%) All participants received at least 1 dressing|545
8641429|NCT03442777|21329105|P1|STARTED|Overall Study|All participants received at least 1 dressing|542
8641430|NCT03317444|21329119|P2|NOT COMPLETED|Overall Study||4
8641431|NCT03317444|21329120|P1|NOT COMPLETED|Overall Study||5
8641432|NCT03317444|21329119|P2|COMPLETED|Overall Study||89
8641433|NCT03317444|21329120|P1|COMPLETED|Overall Study||119
8641434|NCT03317444|21329119|P2|STARTED|Overall Study||93
8641435|NCT03317444|21329120|P1|STARTED|Overall Study||124
8641436|NCT03312595|21329128|P1|NOT COMPLETED|Overall Study||6
8641437|NCT03312595|21329128|P1|COMPLETED|Overall Study||24
8641438|NCT03312595|21329128|P1|STARTED|Overall Study||30
8641439|NCT03296163|21329136|P2|NOT COMPLETED|Monotherapy||146
8641440|NCT03296163|21329137|P1|NOT COMPLETED|Monotherapy||139
8641441|NCT03296163|21329136|P2|COMPLETED|Monotherapy||74
8641442|NCT03296163|21329137|P1|COMPLETED|Monotherapy||68
8641443|NCT03296163|21329136|P2|STARTED|Monotherapy||220
8641444|NCT03296163|21329137|P1|STARTED|Monotherapy||207
8641445|NCT03296163|21329136|P2|NOT COMPLETED|Combination Therapy||92
8641446|NCT03296163|21329137|P1|NOT COMPLETED|Combination Therapy||108
8641447|NCT03296163|21329136|P2|COMPLETED|Combination Therapy||220
8641448|NCT03296163|21329137|P1|COMPLETED|Combination Therapy||207
8641449|NCT03296163|21329136|P2|STARTED|Combination Therapy||312
8641450|NCT03296163|21329137|P1|STARTED|Combination Therapy||315
8641459|NCT03263442|21329186|P2|NOT COMPLETED|1-month Follow-Up||0
8641460|NCT03263442|21329187|P1|NOT COMPLETED|1-month Follow-Up||1
8641461|NCT03263442|21329186|P2|COMPLETED|1-month Follow-Up||33
8641462|NCT03263442|21329187|P1|COMPLETED|1-month Follow-Up||27
8641463|NCT03263442|21329186|P2|STARTED|1-month Follow-Up||33
8641464|NCT03263442|21329187|P1|STARTED|1-month Follow-Up||28
8641465|NCT03263442|21329186|P2|NOT COMPLETED|Inpatient Phase||1
8641466|NCT03263442|21329187|P1|NOT COMPLETED|Inpatient Phase||2
8641467|NCT03263442|21329186|P2|COMPLETED|Inpatient Phase||33
8641468|NCT03263442|21329187|P1|COMPLETED|Inpatient Phase||28
8641469|NCT03263442|21329186|P2|STARTED|Inpatient Phase||34
8641470|NCT03263442|21329187|P1|STARTED|Inpatient Phase||30
8641471|NCT03259308|21329210|P3|NOT COMPLETED|Overall Study||7
8641472|NCT03259308|21329211|P2|NOT COMPLETED|Overall Study||8
8641473|NCT03259308|21329212|P1|NOT COMPLETED|Overall Study||7
8641474|NCT03259308|21329210|P3|COMPLETED|Overall Study||105
8641475|NCT03259308|21329211|P2|COMPLETED|Overall Study||103
8641476|NCT03259308|21329212|P1|COMPLETED|Overall Study||49
8641477|NCT03259308|21329210|P3|STARTED|Overall Study||112
8641478|NCT03259308|21329211|P2|STARTED|Overall Study||111
8641479|NCT03259308|21329212|P1|STARTED|Overall Study||56
8641510|NCT03072186|21329344|P1|NOT COMPLETED|Overall Study||6
8641511|NCT03072186|21329344|P1|COMPLETED|Overall Study||17
8641512|NCT03072186|21329344|P1|STARTED|Overall Study||23
8641513|NCT03010462|21329350|P2|NOT COMPLETED|Overall Study||1
8641514|NCT03010462|21329351|P1|NOT COMPLETED|Overall Study||3
8641515|NCT03010462|21329350|P2|COMPLETED|Overall Study|1 subject withdrew consent prior to baseline visit|28
8641516|NCT03010462|21329351|P1|COMPLETED|Overall Study|1 subject withdrew consent before baseline visit. 2 subjects completed treatment but were lost during follow-up|28
8641517|NCT03010462|21329350|P2|STARTED|Overall Study||29
8641518|NCT03010462|21329351|P1|STARTED|Overall Study||31
8641519|NCT02948829|21329365|P1|NOT COMPLETED|Overall Study||200
8641520|NCT02948829|21329365|P1|COMPLETED|Overall Study||0
8641521|NCT02948829|21329365|P1|STARTED|Overall Study||200
8641522|NCT02726542|21329399|P2|NOT COMPLETED|Overall Study||1
8641523|NCT02726542|21329400|P1|NOT COMPLETED|Overall Study||3
8641524|NCT02726542|21329399|P2|COMPLETED|Overall Study||10
8641525|NCT02726542|21329400|P1|COMPLETED|Overall Study||10
8641526|NCT02726542|21329399|P2|STARTED|Overall Study||11
8641527|NCT02726542|21329400|P1|STARTED|Overall Study||13
8641528|NCT02661217|21329416|P2|NOT COMPLETED|Overall Study||83
8641529|NCT02661217|21329417|P1|NOT COMPLETED|Overall Study||75
8641530|NCT02661217|21329416|P2|COMPLETED|Overall Study||419
8641531|NCT02661217|21329417|P1|COMPLETED|Overall Study||425
8641532|NCT02661217|21329416|P2|Completed 10 Weeks Treatment Epoch|Overall Study||455
8641533|NCT02661217|21329417|P1|Completed 10 Weeks Treatment Epoch|Overall Study||460
8641534|NCT02661217|21329416|P2|Started 10 Weeks Treatment Epoch|Overall Study||501
8641535|NCT02661217|21329417|P1|Started 10 Weeks Treatment Epoch|Overall Study||497
8641536|NCT02661217|21329416|P2|STARTED|Overall Study||502
8641537|NCT02661217|21329417|P1|STARTED|Overall Study||500
8641562|NCT02501811|21329526|P4|NOT COMPLETED|Overall Study||7
8641563|NCT02501811|21329527|P3|NOT COMPLETED|Overall Study||6
8641564|NCT02501811|21329528|P2|NOT COMPLETED|Overall Study||6
8641565|NCT02501811|21329529|P1|NOT COMPLETED|Overall Study||4
8641566|NCT02501811|21329526|P4|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|25
8641567|NCT02501811|21329527|P3|COMPLETED|Overall Study||25
8641568|NCT02501811|21329528|P2|COMPLETED|Overall Study||23
8641569|NCT02501811|21329529|P1|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|29
8641570|NCT02501811|21329526|P4|STARTED|Overall Study||32
8641571|NCT02501811|21329527|P3|STARTED|Overall Study||31
8641572|NCT02501811|21329528|P2|STARTED|Overall Study||29
8641573|NCT02501811|21329529|P1|STARTED|Overall Study||33
8641582|NCT02363998|21329679|P1|NOT COMPLETED|Overall Study||118
8641583|NCT02363998|21329679|P1|COMPLETED|Overall Study|A subject was defined as completed if at least one dose was taken on Day 7.|168
8641584|NCT02363998|21329679|P1|STARTED|Overall Study||286
8641585|NCT02140970|21329757|P2|NOT COMPLETED|Overall Study||3
8641586|NCT02140970|21329758|P1|NOT COMPLETED|Overall Study||2
8641587|NCT02140970|21329757|P2|COMPLETED|Overall Study||22
8641588|NCT02140970|21329758|P1|COMPLETED|Overall Study||22
8641589|NCT02140970|21329757|P2|Analyzed|Overall Study||22
8641590|NCT02140970|21329758|P1|Analyzed|Overall Study||22
8641591|NCT02140970|21329757|P2|Received Intervention|Overall Study||25
8641592|NCT02140970|21329758|P1|Received Intervention|Overall Study||23
8641593|NCT02140970|21329757|P2|STARTED|Overall Study||25
8641594|NCT02140970|21329758|P1|STARTED|Overall Study||24
8641595|NCT01893359|21329773|P3|NOT COMPLETED|Overall Study||0
8641596|NCT01893359|21329774|P2|NOT COMPLETED|Overall Study||0
8641597|NCT01893359|21329775|P1|NOT COMPLETED|Overall Study||0
8641598|NCT01893359|21329773|P3|COMPLETED|Overall Study||0
8641599|NCT01893359|21329774|P2|COMPLETED|Overall Study||2
8641600|NCT01893359|21329775|P1|COMPLETED|Overall Study||0
8641601|NCT01893359|21329773|P3|STARTED|Overall Study||0
8641602|NCT01893359|21329774|P2|STARTED|Overall Study||2
8641603|NCT01893359|21329775|P1|STARTED|Overall Study||0
8641604|NCT01818492|21329786|P1|NOT COMPLETED|Overall Study||10
8641605|NCT01818492|21329786|P1|COMPLETED|Overall Study||35
8641606|NCT01818492|21329786|P1|STARTED|Overall Study||45
8641607|NCT01530997|21329801|P1|NOT COMPLETED|Overall Study||2
8641608|NCT01530997|21329801|P1|COMPLETED|Overall Study||43
8641609|NCT01530997|21329801|P1|STARTED|Overall Study||45
8641610|NCT00908648|21329823|P2|NOT COMPLETED|Overall Study||0
8641611|NCT00908648|21329824|P1|NOT COMPLETED|Overall Study||0
8641612|NCT00908648|21329823|P2|COMPLETED|Overall Study||103
8641613|NCT00908648|21329824|P1|COMPLETED|Overall Study||108
8641614|NCT00908648|21329823|P2|STARTED|Overall Study||103
8641615|NCT00908648|21329824|P1|STARTED|Overall Study||108
8641616|NCT00674661|21329832|P2|NOT COMPLETED|Overall Study||15
8641617|NCT00674661|21329833|P1|NOT COMPLETED|Overall Study||11
8641618|NCT00674661|21329832|P2|COMPLETED|Overall Study||48
8641619|NCT00674661|21329833|P1|COMPLETED|Overall Study||56
8641620|NCT00674661|21329832|P2|STARTED|Overall Study||63
8641621|NCT00674661|21329833|P1|STARTED|Overall Study||67
8641622|NCT00647699|21329841|P2|NOT COMPLETED|Overall Study||12
8641623|NCT00647699|21329842|P1|NOT COMPLETED|Overall Study||8
8641624|NCT00647699|21329841|P2|COMPLETED|Overall Study||62
8641625|NCT00647699|21329842|P1|COMPLETED|Overall Study||65
8641626|NCT00647699|21329841|P2|STARTED|Overall Study||74
8641627|NCT00647699|21329842|P1|STARTED|Overall Study||73
8641628|NCT00646451|21329848|P2|NOT COMPLETED|Overall Study||0
8641629|NCT00646451|21329849|P1|NOT COMPLETED|Overall Study||4
8641630|NCT00646451|21329848|P2|COMPLETED|Overall Study||10
8641631|NCT00646451|21329849|P1|COMPLETED|Overall Study||6
8641632|NCT00646451|21329848|P2|STARTED|Overall Study||10
8641633|NCT00646451|21329849|P1|STARTED|Overall Study||10
8641634|NCT04628221|21329857|P1|NOT COMPLETED|Overall Study||0
8641635|NCT04628221|21329857|P1|COMPLETED|Overall Study||40
8641636|NCT04628221|21329857|P1|STARTED|Overall Study||40
8641637|NCT03944707|21329872|P2|NOT COMPLETED|Overall Study||10
8641638|NCT03944707|21329873|P1|NOT COMPLETED|Overall Study||12
8641639|NCT03944707|21329872|P2|COMPLETED|Overall Study||19
8641640|NCT03944707|21329873|P1|COMPLETED|Overall Study||35
8641641|NCT03944707|21329872|P2|PD Analysis Set|Overall Study||29
8641642|NCT03944707|21329873|P1|PD Analysis Set|Overall Study||47
8641643|NCT03944707|21329872|P2|PK Analysis Set|Overall Study||0
8641644|NCT03944707|21329873|P1|PK Analysis Set|Overall Study||33
8641645|NCT03944707|21329872|P2|STARTED|Overall Study||29
8641646|NCT03944707|21329873|P1|STARTED|Overall Study||47
8641647|NCT03875118|21329895|P2|NOT COMPLETED|Overall Study||4
8641648|NCT03875118|21329896|P1|NOT COMPLETED|Overall Study||4
8641649|NCT03875118|21329895|P2|COMPLETED|Overall Study||30
8641650|NCT03875118|21329896|P1|COMPLETED|Overall Study||30
8641651|NCT03875118|21329895|P2|STARTED|Overall Study||34
8641652|NCT03875118|21329896|P1|STARTED|Overall Study||34
8641653|NCT03862027|21329904|P1|NOT COMPLETED|Overall Study||0
8641654|NCT03862027|21329904|P1|COMPLETED|Overall Study||1
8641655|NCT03862027|21329904|P1|STARTED|Overall Study||1
8641656|NCT03775681|21329910|P1|NOT COMPLETED|Overall Study||3
8641657|NCT03775681|21329910|P1|COMPLETED|Overall Study||30
8641658|NCT03775681|21329910|P1|STARTED|Overall Study||33
8641673|NCT03708367|21329962|P2|NOT COMPLETED|Overall Study||1
8641674|NCT03708367|21329963|P1|NOT COMPLETED|Overall Study||1
8641675|NCT03708367|21329962|P2|COMPLETED|Overall Study||57
8641676|NCT03708367|21329963|P1|COMPLETED|Overall Study||58
8641677|NCT03708367|21329962|P2|STARTED|Overall Study||58
8641678|NCT03708367|21329963|P1|STARTED|Overall Study||59
8641679|NCT03688282|21329980|P1|NOT COMPLETED|Active Treatment for 30 Minutes||0
8641680|NCT03688282|21329980|P1|COMPLETED|Active Treatment for 30 Minutes||17
8641681|NCT03688282|21329980|P1|STARTED|Active Treatment for 30 Minutes||17
8641682|NCT03688282|21329980|P1|NOT COMPLETED|Washout (7 Days)||0
8641683|NCT03688282|21329980|P1|COMPLETED|Washout (7 Days)||17
8641684|NCT03688282|21329980|P1|STARTED|Washout (7 Days)||17
8641685|NCT03688282|21329980|P1|NOT COMPLETED|Sham Treatment for 30 Minutes||1
8641686|NCT03688282|21329980|P1|COMPLETED|Sham Treatment for 30 Minutes||17
8641687|NCT03688282|21329980|P1|STARTED|Sham Treatment for 30 Minutes||18
8641688|NCT03653208|21329995|P9|NOT COMPLETED|Overall Study||1
8641689|NCT03653208|21329996|P8|NOT COMPLETED|Overall Study||1
8641690|NCT03653208|21329997|P7|NOT COMPLETED|Overall Study||0
8641691|NCT03653208|21329998|P6|NOT COMPLETED|Overall Study||0
8641692|NCT03653208|21329999|P5|NOT COMPLETED|Overall Study||1
8641693|NCT03653208|21330000|P4|NOT COMPLETED|Overall Study||0
8641694|NCT03653208|21330001|P3|NOT COMPLETED|Overall Study||0
8641695|NCT03653208|21330002|P2|NOT COMPLETED|Overall Study||0
8641696|NCT03653208|21330003|P1|NOT COMPLETED|Overall Study||0
8641697|NCT03653208|21329995|P9|COMPLETED|Overall Study||13
8641698|NCT03653208|21329996|P8|COMPLETED|Overall Study||5
8641699|NCT03653208|21329997|P7|COMPLETED|Overall Study||6
8641700|NCT03653208|21329998|P6|COMPLETED|Overall Study||6
8641701|NCT03653208|21329999|P5|COMPLETED|Overall Study||5
8641702|NCT03653208|21330000|P4|COMPLETED|Overall Study||6
8641703|NCT03653208|21330001|P3|COMPLETED|Overall Study||6
8641704|NCT03653208|21330002|P2|COMPLETED|Overall Study||3
8641705|NCT03653208|21330003|P1|COMPLETED|Overall Study||3
8641706|NCT03653208|21329995|P9|STARTED|Overall Study||14
8641707|NCT03653208|21329996|P8|STARTED|Overall Study||6
8641708|NCT03653208|21329997|P7|STARTED|Overall Study||6
8641709|NCT03653208|21329998|P6|STARTED|Overall Study||6
8641710|NCT03653208|21329999|P5|STARTED|Overall Study||6
8641711|NCT03653208|21330000|P4|STARTED|Overall Study||6
8641712|NCT03653208|21330001|P3|STARTED|Overall Study||6
8641713|NCT03653208|21330002|P2|STARTED|Overall Study||3
8641714|NCT03653208|21330003|P1|STARTED|Overall Study||3
8641715|NCT03426137|21330042|P3|NOT COMPLETED|Overall Study||0
8641716|NCT03426137|21330043|P2|NOT COMPLETED|Overall Study||0
8641717|NCT03426137|21330044|P1|NOT COMPLETED|Overall Study||0
8641718|NCT03426137|21330042|P3|COMPLETED|Overall Study||0
8641719|NCT03426137|21330043|P2|COMPLETED|Overall Study||0
8641720|NCT03426137|21330044|P1|COMPLETED|Overall Study||0
8641721|NCT03426137|21330042|P3|STARTED|Overall Study||0
8641722|NCT03426137|21330043|P2|STARTED|Overall Study||0
8641723|NCT03426137|21330044|P1|STARTED|Overall Study||0
8641724|NCT03340428|21330054|P2|NOT COMPLETED|Overall Study||0
8641725|NCT03340428|21330055|P1|NOT COMPLETED|Overall Study||1
8641726|NCT03340428|21330054|P2|COMPLETED|Overall Study||59
8641727|NCT03340428|21330055|P1|COMPLETED|Overall Study||116
8641728|NCT03340428|21330054|P2|STARTED|Overall Study||59
8641729|NCT03340428|21330055|P1|STARTED|Overall Study||117
8641730|NCT03323749|21330063|P2|NOT COMPLETED|Open-Label Period||103
8641731|NCT03323749|21330064|P1|NOT COMPLETED|Open-Label Period||93
8641732|NCT03323749|21330063|P2|COMPLETED|Open-Label Period||0
8641733|NCT03323749|21330064|P1|COMPLETED|Open-Label Period||0
8641734|NCT03323749|21330063|P2|STARTED|Open-Label Period||103
8641735|NCT03323749|21330064|P1|STARTED|Open-Label Period||93
8641736|NCT03323749|21330063|P2|NOT COMPLETED|Double-blind Period||6
8641737|NCT03323749|21330064|P1|NOT COMPLETED|Double-blind Period||7
8641738|NCT03323749|21330063|P2|COMPLETED|Double-blind Period||103
8641739|NCT03323749|21330064|P1|COMPLETED|Double-blind Period||102
8641740|NCT03323749|21330063|P2|STARTED|Double-blind Period||109
8641741|NCT03323749|21330064|P1|STARTED|Double-blind Period||109
8641742|NCT03302780|21330082|P2|NOT COMPLETED|Overall Study||0
8641743|NCT03302780|21330083|P1|NOT COMPLETED|Overall Study||0
8641744|NCT03302780|21330082|P2|COMPLETED|Overall Study||3
8641745|NCT03302780|21330083|P1|COMPLETED|Overall Study||3
8641746|NCT03302780|21330082|P2|STARTED|Overall Study||3
8641747|NCT03302780|21330083|P1|STARTED|Overall Study||3
8641765|NCT03281304|21330147|P2|NOT COMPLETED|Overall Study||12
8641766|NCT03281304|21330148|P1|NOT COMPLETED|Overall Study||13
8641767|NCT03281304|21330147|P2|COMPLETED|Overall Study||58
8641768|NCT03281304|21330148|P1|COMPLETED|Overall Study||57
8641769|NCT03281304|21330147|P2|STARTED|Overall Study||70
8641770|NCT03281304|21330148|P1|STARTED|Overall Study||70
8641771|NCT03123328|21330190|P1|NOT COMPLETED|Overall Study||29
8641772|NCT03123328|21330190|P1|COMPLETED|Overall Study||351
8641773|NCT03123328|21330190|P1|STARTED|Overall Study||380
8641774|NCT03080142|21330196|P2|NOT COMPLETED|Overall Study||0
8641775|NCT03080142|21330197|P1|NOT COMPLETED|Overall Study||0
8641776|NCT03080142|21330196|P2|COMPLETED|Overall Study||44
8641777|NCT03080142|21330197|P1|COMPLETED|Overall Study||42
8641778|NCT03080142|21330196|P2|STARTED|Overall Study||44
8641779|NCT03080142|21330197|P1|STARTED|Overall Study||42
8641792|NCT03051672|21330244|P1|NOT COMPLETED|Overall Study||0
8641793|NCT03051672|21330244|P1|COMPLETED|Overall Study||8
8641794|NCT03051672|21330244|P1|Began Treatment|Overall Study||8
8641795|NCT03051672|21330244|P1|STARTED|Overall Study||8
8641796|NCT03040674|21330251|P1|NOT COMPLETED|Overall Study||248
8641797|NCT03040674|21330251|P1|COMPLETED|Overall Study||241
8641798|NCT03040674|21330251|P1|Participants Completing 6 Month Survey|Overall Study||241
8641799|NCT03040674|21330251|P1|Participants Completing 3 Month Survey|Overall Study||351
8641800|NCT03040674|21330251|P1|STARTED|Overall Study||489
8641810|NCT03029585|21330275|P2|NOT COMPLETED|Overall Study||1
8641811|NCT03029585|21330276|P1|NOT COMPLETED|Overall Study||2
8641812|NCT03029585|21330275|P2|COMPLETED|Overall Study||2
8641813|NCT03029585|21330276|P1|COMPLETED|Overall Study||5
8641814|NCT03029585|21330275|P2|STARTED|Overall Study||3
8641815|NCT03029585|21330276|P1|STARTED|Overall Study||7
8641816|NCT02998476|21330288|P2|NOT COMPLETED|Overall Study||5
8641817|NCT02998476|21330289|P1|NOT COMPLETED|Overall Study||55
8641818|NCT02998476|21330288|P2|COMPLETED|Overall Study||0
8641819|NCT02998476|21330289|P1|COMPLETED|Overall Study||0
8641820|NCT02998476|21330288|P2|STARTED|Overall Study||5
8641821|NCT02998476|21330289|P1|STARTED|Overall Study||55
8641822|NCT02959177|21330300|P3|NOT COMPLETED|Follow-up Post Treatment Phase||2
8641823|NCT02959177|21330301|P2|NOT COMPLETED|Follow-up Post Treatment Phase||1
8641824|NCT02959177|21330302|P1|NOT COMPLETED|Follow-up Post Treatment Phase||1
8641825|NCT02959177|21330300|P3|COMPLETED|Follow-up Post Treatment Phase||98
8641826|NCT02959177|21330301|P2|COMPLETED|Follow-up Post Treatment Phase||51
8641827|NCT02959177|21330302|P1|COMPLETED|Follow-up Post Treatment Phase||51
8641828|NCT02959177|21330300|P3|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|100
8641829|NCT02959177|21330301|P2|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
8641830|NCT02959177|21330302|P1|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
8641831|NCT02959177|21330300|P3|NOT COMPLETED|Double-Blind Treatment Phase||5
8641832|NCT02959177|21330301|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
8641833|NCT02959177|21330302|P1|NOT COMPLETED|Double-Blind Treatment Phase||11
8641834|NCT02959177|21330300|P3|COMPLETED|Double-Blind Treatment Phase||225
8641835|NCT02959177|21330301|P2|COMPLETED|Double-Blind Treatment Phase||111
8641836|NCT02959177|21330302|P1|COMPLETED|Double-Blind Treatment Phase||104
8641837|NCT02959177|21330300|P3|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230
8641838|NCT02959177|21330301|P2|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114
8641839|NCT02959177|21330302|P1|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115
8641840|NCT02959177|21330300|P3|STARTED|Double-Blind Treatment Phase||230
8641841|NCT02959177|21330301|P2|STARTED|Double-Blind Treatment Phase||114
8641842|NCT02959177|21330302|P1|STARTED|Double-Blind Treatment Phase||115
8641846|NCT02903823|21330371|P1|NOT COMPLETED|Overall Study||7
8641847|NCT02903823|21330371|P1|COMPLETED|Overall Study||20
8641848|NCT02903823|21330371|P1|STARTED|Overall Study|First subject enrollment|27
8641849|NCT02902913|21330376|P1|NOT COMPLETED|Overall Study||0
8641850|NCT02902913|21330376|P1|COMPLETED|Overall Study||9
8641851|NCT02902913|21330376|P1|Ibuprofen (400mg)|Overall Study||9
8641852|NCT02902913|21330376|P1|Washout (7 Days)|Overall Study||9
8641853|NCT02902913|21330376|P1|Third Intervention (1 Day)|Overall Study||9
8641854|NCT02902913|21330376|P1|Washout (7 Days)|Overall Study||9
8641855|NCT02902913|21330376|P1|Second Intervention (1 Day)|Overall Study||9
8641856|NCT02902913|21330376|P1|Washout (7 Days)|Overall Study||9
8641857|NCT02902913|21330376|P1|First Intervention (1 Day)|Overall Study||9
8641858|NCT02902913|21330376|P1|STARTED|Overall Study||9
8641874|NCT02749227|21330415|P1|NOT COMPLETED|Overall Study||0
8641875|NCT02749227|21330415|P1|COMPLETED|Overall Study||4
8641876|NCT02749227|21330415|P1|STARTED|Overall Study||4
8641889|NCT02621463|21330451|P1|NOT COMPLETED|Overall Study||0
8641890|NCT02621463|21330451|P1|COMPLETED|Overall Study||29
8641891|NCT02621463|21330451|P1|STARTED|Overall Study||29
8641898|NCT02573779|21330478|P2|NOT COMPLETED|Overall Study||0
8641899|NCT02573779|21330479|P1|NOT COMPLETED|Overall Study||0
8641900|NCT02573779|21330478|P2|COMPLETED|Overall Study||43
8641901|NCT02573779|21330479|P1|COMPLETED|Overall Study||74
8641902|NCT02573779|21330478|P2|STARTED|Overall Study||43
8641903|NCT02573779|21330479|P1|STARTED|Overall Study||74
8641904|NCT02522884|21330501|P1|NOT COMPLETED|Overall Study||18
8641905|NCT02522884|21330501|P1|COMPLETED|Overall Study|Completed 12-month follow-up.|195
8641906|NCT02522884|21330501|P1|STARTED|Overall Study|Intent to Treat (ITT) population.|213
8641907|NCT02457520|21330506|P1|NOT COMPLETED|Post-treatment Period||48
8641908|NCT02457520|21330506|P1|COMPLETED|Post-treatment Period||119
8641909|NCT02457520|21330506|P1|STARTED|Post-treatment Period||167
8641910|NCT02457520|21330506|P1|NOT COMPLETED|Active Treatment Phase||34
8641911|NCT02457520|21330506|P1|COMPLETED|Active Treatment Phase||167
8641912|NCT02457520|21330506|P1|STARTED|Active Treatment Phase|All subjects received treatment according to the same regimen.|201
8641913|NCT02433977|21330547|P1|NOT COMPLETED|Overall Study||0
8641914|NCT02433977|21330547|P1|COMPLETED|Overall Study||6
8641915|NCT02433977|21330547|P1|STARTED|Overall Study||6
8641922|NCT02228408|21330590|P2|NOT COMPLETED|Overall Study||0
8641923|NCT02228408|21330591|P1|NOT COMPLETED|Overall Study||0
8641924|NCT02228408|21330590|P2|COMPLETED|Overall Study||10
8641925|NCT02228408|21330591|P1|COMPLETED|Overall Study||7
8641926|NCT02228408|21330590|P2|STARTED|Overall Study||10
8641927|NCT02228408|21330591|P1|STARTED|Overall Study||7
8641928|NCT02212379|21330609|P1|NOT COMPLETED|From Week 48 to Week 96||4
8641929|NCT02212379|21330609|P1|COMPLETED|From Week 48 to Week 96||152
8641930|NCT02212379|21330609|P1|STARTED|From Week 48 to Week 96||156
8641931|NCT02212379|21330609|P1|NOT COMPLETED|From Baseline to Week 48||9
8641932|NCT02212379|21330609|P1|COMPLETED|From Baseline to Week 48||156
8641933|NCT02212379|21330609|P1|STARTED|From Baseline to Week 48||165
8641981|NCT02144701|21330815|P2|NOT COMPLETED|Overall Study||3
8641982|NCT02144701|21330816|P1|NOT COMPLETED|Overall Study||9
8641983|NCT02144701|21330815|P2|COMPLETED|Overall Study||8
8641984|NCT02144701|21330816|P1|COMPLETED|Overall Study||13
8641985|NCT02144701|21330815|P2|STARTED|Overall Study||11
8641986|NCT02144701|21330816|P1|STARTED|Overall Study||22
8641998|NCT02073565|21330859|P2|NOT COMPLETED|Cohort C||4
8641999|NCT02073565|21330860|P1|NOT COMPLETED|Cohort C||0
8642000|NCT02073565|21330859|P2|COMPLETED|Cohort C||211
8642001|NCT02073565|21330860|P1|COMPLETED|Cohort C||217
8642002|NCT02073565|21330859|P2|STARTED|Cohort C||215
8642003|NCT02073565|21330860|P1|STARTED|Cohort C||217
8642004|NCT02073565|21330859|P2|NOT COMPLETED|Cohort B||2
8642005|NCT02073565|21330860|P1|NOT COMPLETED|Cohort B||1
8642006|NCT02073565|21330859|P2|COMPLETED|Cohort B||54
8642007|NCT02073565|21330860|P1|COMPLETED|Cohort B||53
8642008|NCT02073565|21330859|P2|STARTED|Cohort B||56
8642009|NCT02073565|21330860|P1|STARTED|Cohort B||54
8642010|NCT02073565|21330859|P2|NOT COMPLETED|Cohort A||0
8642011|NCT02073565|21330860|P1|NOT COMPLETED|Cohort A||1
8642012|NCT02073565|21330859|P2|COMPLETED|Cohort A||14
8642013|NCT02073565|21330860|P1|COMPLETED|Cohort A||15
8642014|NCT02073565|21330859|P2|STARTED|Cohort A||14
8642015|NCT02073565|21330860|P1|STARTED|Cohort A||16
8642016|NCT02073565|21330859|P2|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
8642017|NCT02073565|21330860|P1|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
8642018|NCT02073565|21330859|P2|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
8642019|NCT02073565|21330860|P1|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
8642020|NCT02073565|21330859|P2|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
8642021|NCT02073565|21330860|P1|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
8642139|NCT01999335|21331009|P5|NOT COMPLETED|Overall Study||2
8642140|NCT01999335|21331010|P4|NOT COMPLETED|Overall Study||0
8642141|NCT01999335|21331011|P3|NOT COMPLETED|Overall Study||0
8642142|NCT01999335|21331012|P2|NOT COMPLETED|Overall Study||0
8642143|NCT01999335|21331013|P1|NOT COMPLETED|Overall Study||0
8642144|NCT01999335|21331009|P5|COMPLETED|Overall Study||10
8642145|NCT01999335|21331010|P4|COMPLETED|Overall Study||10
8642146|NCT01999335|21331011|P3|COMPLETED|Overall Study||7
8642147|NCT01999335|21331012|P2|COMPLETED|Overall Study||1
8642148|NCT01999335|21331013|P1|COMPLETED|Overall Study||3
8642149|NCT01999335|21331009|P5|Received Study Treatment|Overall Study||10
8642150|NCT01999335|21331010|P4|Received Study Treatment|Overall Study||10
8642151|NCT01999335|21331011|P3|Received Study Treatment|Overall Study||7
8642152|NCT01999335|21331012|P2|Received Study Treatment|Overall Study||1
8642153|NCT01999335|21331013|P1|Received Study Treatment|Overall Study||3
8642154|NCT01999335|21331009|P5|STARTED|Overall Study||12
8642155|NCT01999335|21331010|P4|STARTED|Overall Study||10
8642156|NCT01999335|21331011|P3|STARTED|Overall Study||7
8642157|NCT01999335|21331012|P2|STARTED|Overall Study||1
8642158|NCT01999335|21331013|P1|STARTED|Overall Study||3
8642165|NCT01892501|21331076|P1|NOT COMPLETED|Overall Study||28
8642166|NCT01892501|21331076|P1|COMPLETED|Overall Study||47
8642167|NCT01892501|21331076|P1|Group B : Biopsy Not Surgically Possible|Overall Study||3
8642168|NCT01892501|21331076|P1|Group A : Biopsy Surgically Possible|Overall Study||72
8642169|NCT01892501|21331076|P1|STARTED|Overall Study||75
8642170|NCT01865747|21331086|P2|NOT COMPLETED|Primary Intent to Treat (PITT)||152
8642171|NCT01865747|21331087|P1|NOT COMPLETED|Primary Intent to Treat (PITT)||131
8642172|NCT01865747|21331086|P2|COMPLETED|Primary Intent to Treat (PITT)||36
8642173|NCT01865747|21331087|P1|COMPLETED|Primary Intent to Treat (PITT)||56
8642174|NCT01865747|21331086|P2|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
8642175|NCT01865747|21331087|P1|STARTED|Primary Intent to Treat (PITT)||187
8642176|NCT01865747|21331086|P2|NOT COMPLETED|Overall Study (ITT)||255
8642177|NCT01865747|21331087|P1|NOT COMPLETED|Overall Study (ITT)||198
8642178|NCT01865747|21331086|P2|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
8642179|NCT01865747|21331087|P1|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
8642180|NCT01865747|21331086|P2|STARTED|Overall Study (ITT)||328
8642181|NCT01865747|21331087|P1|STARTED|Overall Study (ITT)||330
8642182|NCT01847755|21331097|P1|NOT COMPLETED|Overall Study||5
8642183|NCT01847755|21331097|P1|COMPLETED|Overall Study||13
8642184|NCT01847755|21331097|P1|STARTED|Overall Study||18
8642233|NCT01741480|21331148|P2|NOT COMPLETED|Overall Study||0
8642234|NCT01741480|21331149|P1|NOT COMPLETED|Overall Study||0
8642235|NCT01741480|21331148|P2|COMPLETED|Overall Study||286
8642236|NCT01741480|21331149|P1|COMPLETED|Overall Study||285
8642237|NCT01741480|21331148|P2|STARTED|Overall Study||286
8642238|NCT01741480|21331149|P1|STARTED|Overall Study||285
8642239|NCT01691820|21331157|P2|NOT COMPLETED|Overall Study||37
8642240|NCT01691820|21331158|P1|NOT COMPLETED|Overall Study||26
8642241|NCT01691820|21331157|P2|COMPLETED|Overall Study||115
8642242|NCT01691820|21331158|P1|COMPLETED|Overall Study||184
8642243|NCT01691820|21331157|P2|STARTED|Overall Study||152
8642244|NCT01691820|21331158|P1|STARTED|Overall Study||210
8642245|NCT01566721|21331194|P2|NOT COMPLETED|Safety Follow-up||207
8642246|NCT01566721|21331195|P1|NOT COMPLETED|Safety Follow-up||547
8642247|NCT01566721|21331194|P2|COMPLETED|Safety Follow-up||501
8642248|NCT01566721|21331195|P1|COMPLETED|Safety Follow-up||1318
8642249|NCT01566721|21331194|P2|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|708
8642250|NCT01566721|21331195|P1|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|1865
8642251|NCT01566721|21331194|P2|NOT COMPLETED|Treatment Period||58
8642252|NCT01566721|21331195|P1|NOT COMPLETED|Treatment Period||197
8642253|NCT01566721|21331194|P2|COMPLETED|Treatment Period||652
8642254|NCT01566721|21331195|P1|COMPLETED|Treatment Period||1670
8642255|NCT01566721|21331194|P2|STARTED|Treatment Period||710
8642256|NCT01566721|21331195|P1|STARTED|Treatment Period||1867
8642257|NCT01497496|21331226|P1|NOT COMPLETED|Overall Study||0
8642258|NCT01497496|21331226|P1|COMPLETED|Overall Study||29
8642259|NCT01497496|21331226|P1|STARTED|Overall Study||29
8642260|NCT01400893|21331234|P2|NOT COMPLETED|Overall Study||27
8642261|NCT01400893|21331235|P1|NOT COMPLETED|Overall Study||27
8642262|NCT01400893|21331234|P2|COMPLETED|Overall Study||38
8642263|NCT01400893|21331235|P1|COMPLETED|Overall Study||42
8642264|NCT01400893|21331234|P2|STARTED|Overall Study||65
8642265|NCT01400893|21331235|P1|STARTED|Overall Study||69
8642281|NCT00942877|21331289|P2|NOT COMPLETED|Overall Study||4
8642282|NCT00942877|21331290|P1|NOT COMPLETED|Overall Study||45
8642283|NCT00942877|21331289|P2|COMPLETED|Overall Study||3
8642284|NCT00942877|21331290|P1|COMPLETED|Overall Study||1
8642285|NCT00942877|21331289|P2|STARTED|Overall Study||7
8642286|NCT00942877|21331290|P1|STARTED|Overall Study||46
8642287|NCT00879060|21331302|P2|NOT COMPLETED|Overall Study||0
8642288|NCT00879060|21331303|P1|NOT COMPLETED|Overall Study||0
8642289|NCT00879060|21331302|P2|COMPLETED|Overall Study||27
8642290|NCT00879060|21331303|P1|COMPLETED|Overall Study||26
8642291|NCT00879060|21331302|P2|STARTED|Overall Study||27
8642292|NCT00879060|21331303|P1|STARTED|Overall Study||26
8642293|NCT00866307|21331323|P3|NOT COMPLETED|Consolidation/Maintenance||16
8642294|NCT00866307|21331324|P2|NOT COMPLETED|Consolidation/Maintenance||9
8642295|NCT00866307|21331325|P1|NOT COMPLETED|Consolidation/Maintenance||0
8642296|NCT00866307|21331323|P3|COMPLETED|Consolidation/Maintenance||14
8642297|NCT00866307|21331324|P2|COMPLETED|Consolidation/Maintenance||45
8642298|NCT00866307|21331325|P1|COMPLETED|Consolidation/Maintenance||0
8642299|NCT00866307|21331323|P3|STARTED|Consolidation/Maintenance||30
8642300|NCT00866307|21331324|P2|STARTED|Consolidation/Maintenance||54
8642301|NCT00866307|21331325|P1|STARTED|Consolidation/Maintenance||0
8642302|NCT00866307|21331323|P3|NOT COMPLETED|Induction||0
8642303|NCT00866307|21331324|P2|NOT COMPLETED|Induction||0
8642304|NCT00866307|21331325|P1|NOT COMPLETED|Induction||20
8642305|NCT00866307|21331323|P3|COMPLETED|Induction||0
8642306|NCT00866307|21331324|P2|COMPLETED|Induction||0
8642307|NCT00866307|21331325|P1|COMPLETED|Induction||84
8642308|NCT00866307|21331323|P3|STARTED|Induction||0
8642309|NCT00866307|21331324|P2|STARTED|Induction||0
8642310|NCT00866307|21331325|P1|STARTED|Induction||104
8642311|NCT00853125|21331332|P1|NOT COMPLETED|Overall Study||1
8642312|NCT00853125|21331332|P1|COMPLETED|Overall Study||9
8642313|NCT00853125|21331332|P1|STARTED|Overall Study||10
8642314|NCT00842764|21331337|P1|NOT COMPLETED|Overall Study||2
8642315|NCT00842764|21331337|P1|COMPLETED|Overall Study||5
8642316|NCT00842764|21331337|P1|STARTED|Overall Study||7
8642317|NCT00671034|21331344|P3|NOT COMPLETED|Overall Study||24
8642318|NCT00671034|21331345|P2|NOT COMPLETED|Overall Study||20
8642319|NCT00671034|21331346|P1|NOT COMPLETED|Overall Study||39
8642320|NCT00671034|21331344|P3|COMPLETED|Overall Study||31
8642321|NCT00671034|21331345|P2|COMPLETED|Overall Study||22
8642322|NCT00671034|21331346|P1|COMPLETED|Overall Study||30
8642323|NCT00671034|21331344|P3|STARTED|Overall Study||55
8642324|NCT00671034|21331345|P2|STARTED|Overall Study||42
8642325|NCT00671034|21331346|P1|STARTED|Overall Study||69
8642414|NCT00479687|21331432|P3|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||9
8642415|NCT00479687|21331433|P2|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
8642416|NCT00479687|21331434|P1|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
8642417|NCT00479687|21331432|P3|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||215
8642418|NCT00479687|21331433|P2|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
8642419|NCT00479687|21331434|P1|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
8642420|NCT00479687|21331432|P3|STARTED|Ph 2: Open Label, Single (Supartz) Arm|Four did not continue to Ph2; 224 received at least 1 inj. and 28 received no trt. (only follow-up)|224
8642421|NCT00479687|21331433|P2|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
8642422|NCT00479687|21331434|P1|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
8642423|NCT00479687|21331432|P3|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
8642424|NCT00479687|21331433|P2|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||19
8642425|NCT00479687|21331434|P1|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||25
8642426|NCT00479687|21331432|P3|COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
8642427|NCT00479687|21331433|P2|COMPLETED|Ph 1: Blinded, Randomized, Controlled||131
8642428|NCT00479687|21331434|P1|COMPLETED|Ph 1: Blinded, Randomized, Controlled||125
8642429|NCT00479687|21331432|P3|STARTED|Ph 1: Blinded, Randomized, Controlled||0
8642430|NCT00479687|21331433|P2|STARTED|Ph 1: Blinded, Randomized, Controlled||150
8642431|NCT00479687|21331434|P1|STARTED|Ph 1: Blinded, Randomized, Controlled||150
8642432|NCT00261807|21331441|P1|NOT COMPLETED|Overall Study||7
8642433|NCT00261807|21331441|P1|COMPLETED|Overall Study||18
8642434|NCT00261807|21331441|P1|STARTED|Overall Study||25
8642435|NCT00228423|21331449|P2|NOT COMPLETED|Overall Study||12
8642436|NCT00228423|21331450|P1|NOT COMPLETED|Overall Study||10
8642437|NCT00228423|21331449|P2|COMPLETED|Overall Study||45
8642438|NCT00228423|21331450|P1|COMPLETED|Overall Study||46
8642439|NCT00228423|21331449|P2|STARTED|Overall Study||57
8642440|NCT00228423|21331450|P1|STARTED|Overall Study||56
8642441|NCT00078754|21331465|P3|NOT COMPLETED|Overall Study||15
8642442|NCT00078754|21331466|P2|NOT COMPLETED|Overall Study||19
8642443|NCT00078754|21331467|P1|NOT COMPLETED|Overall Study||15
8642444|NCT00078754|21331465|P3|COMPLETED|Overall Study||16
8642445|NCT00078754|21331466|P2|COMPLETED|Overall Study||11
8642446|NCT00078754|21331467|P1|COMPLETED|Overall Study||14
8642447|NCT00078754|21331465|P3|STARTED|Overall Study||31
8642448|NCT00078754|21331466|P2|STARTED|Overall Study||30
8642449|NCT00078754|21331467|P1|STARTED|Overall Study||29
8642450|NCT00075725|21331490|P12|NOT COMPLETED|Overall Study||18
8642451|NCT00075725|21331491|P11|NOT COMPLETED|Overall Study||9
8642452|NCT00075725|21331492|P10|NOT COMPLETED|Overall Study||18
8642453|NCT00075725|21331493|P9|NOT COMPLETED|Overall Study||117
8642454|NCT00075725|21331494|P8|NOT COMPLETED|Overall Study||295
8642455|NCT00075725|21331495|P7|NOT COMPLETED|Overall Study||75
8642456|NCT00075725|21331496|P6|NOT COMPLETED|Overall Study||313
8642457|NCT00075725|21331497|P5|NOT COMPLETED|Overall Study||66
8642458|NCT00075725|21331498|P4|NOT COMPLETED|Overall Study||78
8642459|NCT00075725|21331499|P3|NOT COMPLETED|Overall Study||121
8642460|NCT00075725|21331500|P2|NOT COMPLETED|Overall Study||49
8642461|NCT00075725|21331501|P1|NOT COMPLETED|Overall Study||74
8642462|NCT00075725|21331490|P12|COMPLETED|Overall Study||10
8642463|NCT00075725|21331491|P11|COMPLETED|Overall Study||3
8642464|NCT00075725|21331492|P10|COMPLETED|Overall Study||16
8642465|NCT00075725|21331493|P9|COMPLETED|Overall Study||185
8642466|NCT00075725|21331494|P8|COMPLETED|Overall Study||401
8642467|NCT00075725|21331495|P7|COMPLETED|Overall Study||171
8642468|NCT00075725|21331496|P6|COMPLETED|Overall Study||397
8642469|NCT00075725|21331497|P5|COMPLETED|Overall Study||166
8642470|NCT00075725|21331498|P4|COMPLETED|Overall Study||168
8642471|NCT00075725|21331499|P3|COMPLETED|Overall Study||175
8642472|NCT00075725|21331500|P2|COMPLETED|Overall Study||57
8642473|NCT00075725|21331501|P1|COMPLETED|Overall Study||172
8642474|NCT00075725|21331490|P12|STARTED|Overall Study||28
8642475|NCT00075725|21331491|P11|STARTED|Overall Study||12
8642476|NCT00075725|21331492|P10|STARTED|Overall Study||34
8642477|NCT00075725|21331493|P9|STARTED|Overall Study||302
8642478|NCT00075725|21331494|P8|STARTED|Overall Study||696
8642479|NCT00075725|21331495|P7|STARTED|Overall Study||246
8642480|NCT00075725|21331496|P6|STARTED|Overall Study||710
8642481|NCT00075725|21331497|P5|STARTED|Overall Study||232
8642482|NCT00075725|21331498|P4|STARTED|Overall Study||246
8642483|NCT00075725|21331499|P3|STARTED|Overall Study||296
8642484|NCT00075725|21331500|P2|STARTED|Overall Study||106
8642485|NCT00075725|21331501|P1|STARTED|Overall Study||246
8642486|NCT00003508|21331590|P1|NOT COMPLETED|Overall Study||5
8642487|NCT00003508|21331590|P1|COMPLETED|Overall Study||3
8642488|NCT00003508|21331590|P1|STARTED|Overall Study||8
8642498|NCT04274075|21331613|P6|NOT COMPLETED|Overall Study||0
8642499|NCT04274075|21331614|P5|NOT COMPLETED|Overall Study||0
8642500|NCT04274075|21331615|P4|NOT COMPLETED|Overall Study||0
8642501|NCT04274075|21331616|P3|NOT COMPLETED|Overall Study||0
8642502|NCT04274075|21331617|P2|NOT COMPLETED|Overall Study||0
8642503|NCT04274075|21331618|P1|NOT COMPLETED|Overall Study||0
8642504|NCT04274075|21331613|P6|COMPLETED|Overall Study||3
8642505|NCT04274075|21331614|P5|COMPLETED|Overall Study||3
8642506|NCT04274075|21331615|P4|COMPLETED|Overall Study||3
8642507|NCT04274075|21331616|P3|COMPLETED|Overall Study||3
8642508|NCT04274075|21331617|P2|COMPLETED|Overall Study||3
8642509|NCT04274075|21331618|P1|COMPLETED|Overall Study||3
8642510|NCT04274075|21331613|P6|Completed Follow-up Visit|Overall Study||3
8642511|NCT04274075|21331614|P5|Completed Follow-up Visit|Overall Study||3
8642512|NCT04274075|21331615|P4|Completed Follow-up Visit|Overall Study||3
8642513|NCT04274075|21331616|P3|Completed Follow-up Visit|Overall Study||3
8642514|NCT04274075|21331617|P2|Completed Follow-up Visit|Overall Study||3
8642515|NCT04274075|21331618|P1|Completed Follow-up Visit|Overall Study||3
8642516|NCT04274075|21331613|P6|Completed Treatment Period 3 (9 Days)|Overall Study||3
8642517|NCT04274075|21331614|P5|Completed Treatment Period 3 (9 Days)|Overall Study||3
8642518|NCT04274075|21331615|P4|Completed Treatment Period 3 (9 Days)|Overall Study||3
8642519|NCT04274075|21331616|P3|Completed Treatment Period 3 (9 Days)|Overall Study||3
8642520|NCT04274075|21331617|P2|Completed Treatment Period 3 (9 Days)|Overall Study||3
8642521|NCT04274075|21331618|P1|Completed Treatment Period 3 (9 Days)|Overall Study||3
8642522|NCT04274075|21331613|P6|Completed Treatment Period 2 (9 Days)|Overall Study||3
8642523|NCT04274075|21331614|P5|Completed Treatment Period 2 (9 Days)|Overall Study||3
8642524|NCT04274075|21331615|P4|Completed Treatment Period 2 (9 Days)|Overall Study||3
8642525|NCT04274075|21331616|P3|Completed Treatment Period 2 (9 Days)|Overall Study||3
8642526|NCT04274075|21331617|P2|Completed Treatment Period 2 (9 Days)|Overall Study||3
8642527|NCT04274075|21331618|P1|Completed Treatment Period 2 (9 Days)|Overall Study||3
8642528|NCT04274075|21331613|P6|Completed Treatment Period 1 (9 Days)|Overall Study||3
8642529|NCT04274075|21331614|P5|Completed Treatment Period 1 (9 Days)|Overall Study||3
8642530|NCT04274075|21331615|P4|Completed Treatment Period 1 (9 Days)|Overall Study||3
8642531|NCT04274075|21331616|P3|Completed Treatment Period 1 (9 Days)|Overall Study||3
8642532|NCT04274075|21331617|P2|Completed Treatment Period 1 (9 Days)|Overall Study||3
8642533|NCT04274075|21331618|P1|Completed Treatment Period 1 (9 Days)|Overall Study||3
8642534|NCT04274075|21331613|P6|STARTED|Overall Study||3
8642535|NCT04274075|21331614|P5|STARTED|Overall Study||3
8642536|NCT04274075|21331615|P4|STARTED|Overall Study||3
8642537|NCT04274075|21331616|P3|STARTED|Overall Study||3
8642538|NCT04274075|21331617|P2|STARTED|Overall Study||3
8642539|NCT04274075|21331618|P1|STARTED|Overall Study||3
8642549|NCT04153409|21331734|P2|NOT COMPLETED|Overall Study||2
8642550|NCT04153409|21331735|P1|NOT COMPLETED|Overall Study||2
8642551|NCT04153409|21331734|P2|COMPLETED|Overall Study||9
8642552|NCT04153409|21331735|P1|COMPLETED|Overall Study||8
8642553|NCT04153409|21331734|P2|STARTED|Overall Study||11
8642554|NCT04153409|21331735|P1|STARTED|Overall Study||10
8642555|NCT04044352|21331747|P1|NOT COMPLETED|Overall Study||11
8642556|NCT04044352|21331747|P1|COMPLETED|Overall Study||65
8642557|NCT04044352|21331747|P1|STARTED|Overall Study||76
8642558|NCT03945981|21331792|P1|NOT COMPLETED|Overall Study||131
8642559|NCT03945981|21331792|P1|COMPLETED|Overall Study||0
8642560|NCT03945981|21331792|P1|STARTED|Overall Study||131
8642561|NCT03861936|21331813|P3|NOT COMPLETED|Overall Study||10
8642562|NCT03861936|21331814|P2|NOT COMPLETED|Overall Study||10
8642563|NCT03861936|21331815|P1|NOT COMPLETED|Overall Study||14
8642564|NCT03861936|21331813|P3|COMPLETED|Overall Study||39
8642565|NCT03861936|21331814|P2|COMPLETED|Overall Study||43
8642566|NCT03861936|21331815|P1|COMPLETED|Overall Study||34
8642567|NCT03861936|21331813|P3|STARTED|Overall Study||49
8642568|NCT03861936|21331814|P2|STARTED|Overall Study||53
8642569|NCT03861936|21331815|P1|STARTED|Overall Study||48
8642575|NCT03501550|21331877|P1|NOT COMPLETED|Overall Study||0
8642576|NCT03501550|21331877|P1|COMPLETED|Overall Study||12
8642577|NCT03501550|21331877|P1|STARTED|Overall Study||12
8642578|NCT03378921|21331885|P2|NOT COMPLETED|Overall Study||0
8642579|NCT03378921|21331886|P1|NOT COMPLETED|Overall Study||0
8642580|NCT03378921|21331885|P2|COMPLETED|Overall Study||13
8642581|NCT03378921|21331886|P1|COMPLETED|Overall Study||13
8642582|NCT03378921|21331885|P2|STARTED|Overall Study||13
8642583|NCT03378921|21331886|P1|STARTED|Overall Study||13
8642584|NCT03349567|21331896|P2|NOT COMPLETED|Overall Study||0
8642585|NCT03349567|21331897|P1|NOT COMPLETED|Overall Study||0
8642586|NCT03349567|21331896|P2|COMPLETED|Overall Study||2
8642587|NCT03349567|21331897|P1|COMPLETED|Overall Study||2
8642588|NCT03349567|21331896|P2|STARTED|Overall Study||2
8642589|NCT03349567|21331897|P1|STARTED|Overall Study||2
8642590|NCT03329404|21331919|P2|NOT COMPLETED|Overall Study||4
8642591|NCT03329404|21331920|P1|NOT COMPLETED|Overall Study||1
8642592|NCT03329404|21331919|P2|COMPLETED|Overall Study||1
8642593|NCT03329404|21331920|P1|COMPLETED|Overall Study||3
8642594|NCT03329404|21331919|P2|STARTED|Overall Study||5
8642595|NCT03329404|21331920|P1|STARTED|Overall Study||4
8642596|NCT03323736|21331929|P3|NOT COMPLETED|Overall Study||2
8642597|NCT03323736|21331930|P2|NOT COMPLETED|Overall Study||12
8642598|NCT03323736|21331931|P1|NOT COMPLETED|Overall Study||19
8642599|NCT03323736|21331929|P3|COMPLETED|Overall Study||68
8642600|NCT03323736|21331930|P2|COMPLETED|Overall Study||47
8642601|NCT03323736|21331931|P1|COMPLETED|Overall Study||222
8642602|NCT03323736|21331929|P3|Treated|Overall Study||68
8642603|NCT03323736|21331930|P2|Treated|Overall Study||47
8642604|NCT03323736|21331931|P1|Treated|Overall Study||222
8642605|NCT03323736|21331929|P3|STARTED|Overall Study||70
8642606|NCT03323736|21331930|P2|STARTED|Overall Study||59
8642607|NCT03323736|21331931|P1|STARTED|Overall Study||241
8642608|NCT03172884|21331946|P4|NOT COMPLETED|Overall Study||0
8642609|NCT03172884|21331947|P3|NOT COMPLETED|Overall Study||0
8642610|NCT03172884|21331948|P2|NOT COMPLETED|Overall Study||0
8642611|NCT03172884|21331949|P1|NOT COMPLETED|Overall Study||0
8642612|NCT03172884|21331946|P4|COMPLETED|Overall Study||8
8642613|NCT03172884|21331947|P3|COMPLETED|Overall Study||8
8642614|NCT03172884|21331948|P2|COMPLETED|Overall Study||6
8642615|NCT03172884|21331949|P1|COMPLETED|Overall Study||8
8642616|NCT03172884|21331946|P4|STARTED|Overall Study||8
8642617|NCT03172884|21331947|P3|STARTED|Overall Study||8
8642618|NCT03172884|21331948|P2|STARTED|Overall Study||6
8642619|NCT03172884|21331949|P1|STARTED|Overall Study||8
8642620|NCT03154710|21331985|P2|NOT COMPLETED|Overall Study||5
8642621|NCT03154710|21331986|P1|NOT COMPLETED|Overall Study||7
8642622|NCT03154710|21331985|P2|COMPLETED|Overall Study||20
8642623|NCT03154710|21331986|P1|COMPLETED|Overall Study||20
8642624|NCT03154710|21331985|P2|STARTED|Overall Study||25
8642625|NCT03154710|21331986|P1|STARTED|Overall Study||27
8642626|NCT02995915|21331994|P2|NOT COMPLETED|Overall Study||0
8642627|NCT02995915|21331995|P1|NOT COMPLETED|Overall Study||0
8642628|NCT02995915|21331994|P2|COMPLETED|Overall Study||15
8642629|NCT02995915|21331995|P1|COMPLETED|Overall Study||30
8642630|NCT02995915|21331994|P2|STARTED|Overall Study||15
8642631|NCT02995915|21331995|P1|STARTED|Overall Study||30
8642662|NCT02659540|21332098|P2|NOT COMPLETED|Overall Study||8
8642663|NCT02659540|21332099|P1|NOT COMPLETED|Overall Study||6
8642664|NCT02659540|21332098|P2|COMPLETED|Overall Study||2
8642665|NCT02659540|21332099|P1|COMPLETED|Overall Study||4
8642666|NCT02659540|21332098|P2|STARTED|Overall Study||10
8642667|NCT02659540|21332099|P1|STARTED|Overall Study||10
8642668|NCT02658994|21332122|P3|NOT COMPLETED|36 Month Follow up||117
8642669|NCT02658994|21332123|P2|NOT COMPLETED|36 Month Follow up||77
8642670|NCT02658994|21332124|P1|NOT COMPLETED|36 Month Follow up||71
8642671|NCT02658994|21332122|P3|COMPLETED|36 Month Follow up||467
8642672|NCT02658994|21332123|P2|COMPLETED|36 Month Follow up||206
8642673|NCT02658994|21332124|P1|COMPLETED|36 Month Follow up||216
8642674|NCT02658994|21332122|P3|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|584
8642675|NCT02658994|21332123|P2|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|283
8642676|NCT02658994|21332124|P1|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|287
8642677|NCT02658994|21332122|P3|NOT COMPLETED|24 Month Follow up||111
8642678|NCT02658994|21332123|P2|NOT COMPLETED|24 Month Follow up||73
8642679|NCT02658994|21332124|P1|NOT COMPLETED|24 Month Follow up||67
8642680|NCT02658994|21332122|P3|COMPLETED|24 Month Follow up||473
8642681|NCT02658994|21332123|P2|COMPLETED|24 Month Follow up||210
8642682|NCT02658994|21332124|P1|COMPLETED|24 Month Follow up||220
8642683|NCT02658994|21332122|P3|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|584
8642684|NCT02658994|21332123|P2|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|283
8642685|NCT02658994|21332124|P1|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|287
8642686|NCT02658994|21332122|P3|NOT COMPLETED|12 Month Follow up||95
8642687|NCT02658994|21332123|P2|NOT COMPLETED|12 Month Follow up||60
8642688|NCT02658994|21332124|P1|NOT COMPLETED|12 Month Follow up||59
8642689|NCT02658994|21332122|P3|COMPLETED|12 Month Follow up||489
8642690|NCT02658994|21332123|P2|COMPLETED|12 Month Follow up||223
8642691|NCT02658994|21332124|P1|COMPLETED|12 Month Follow up||228
8642692|NCT02658994|21332122|P3|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|584
8642693|NCT02658994|21332123|P2|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|283
8642694|NCT02658994|21332124|P1|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|287
8642695|NCT02658994|21332122|P3|NOT COMPLETED|6 Month Follow up||113
8642696|NCT02658994|21332123|P2|NOT COMPLETED|6 Month Follow up||53
8642697|NCT02658994|21332124|P1|NOT COMPLETED|6 Month Follow up||59
8642698|NCT02658994|21332122|P3|COMPLETED|6 Month Follow up||471
8642699|NCT02658994|21332123|P2|COMPLETED|6 Month Follow up||230
8642700|NCT02658994|21332124|P1|COMPLETED|6 Month Follow up||228
8642701|NCT02658994|21332122|P3|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|584
8642702|NCT02658994|21332123|P2|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|283
8642703|NCT02658994|21332124|P1|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|287
8642704|NCT02658994|21332122|P3|NOT COMPLETED|3 Month Follow up||133
8642705|NCT02658994|21332123|P2|NOT COMPLETED|3 Month Follow up||60
8642706|NCT02658994|21332124|P1|NOT COMPLETED|3 Month Follow up||66
8642707|NCT02658994|21332122|P3|COMPLETED|3 Month Follow up||451
8642708|NCT02658994|21332123|P2|COMPLETED|3 Month Follow up||223
8642709|NCT02658994|21332124|P1|COMPLETED|3 Month Follow up||221
8642710|NCT02658994|21332122|P3|STARTED|3 Month Follow up||584
8642711|NCT02658994|21332123|P2|STARTED|3 Month Follow up||283
8642712|NCT02658994|21332124|P1|STARTED|3 Month Follow up||287
8642713|NCT02658994|21332122|P3|NOT COMPLETED|Enrollment||0
8642714|NCT02658994|21332123|P2|NOT COMPLETED|Enrollment||0
8642715|NCT02658994|21332124|P1|NOT COMPLETED|Enrollment||0
8642716|NCT02658994|21332122|P3|COMPLETED|Enrollment||584
8642717|NCT02658994|21332123|P2|COMPLETED|Enrollment||283
8642718|NCT02658994|21332124|P1|COMPLETED|Enrollment||287
8642719|NCT02658994|21332122|P3|STARTED|Enrollment||584
8642720|NCT02658994|21332123|P2|STARTED|Enrollment||283
8642721|NCT02658994|21332124|P1|STARTED|Enrollment||287
8642722|NCT02651116|21332149|P2|NOT COMPLETED|Overall Study||1
8642723|NCT02651116|21332150|P1|NOT COMPLETED|Overall Study||1
8642724|NCT02651116|21332149|P2|COMPLETED|Overall Study||62
8642725|NCT02651116|21332150|P1|COMPLETED|Overall Study||67
8642726|NCT02651116|21332149|P2|Treated|Overall Study||63
8642727|NCT02651116|21332150|P1|Treated|Overall Study||68
8642728|NCT02651116|21332149|P2|STARTED|Overall Study||63
8642729|NCT02651116|21332150|P1|STARTED|Overall Study||68
8642742|NCT02556775|21332248|P4|NOT COMPLETED|Overall Study||0
8642743|NCT02556775|21332249|P3|NOT COMPLETED|Overall Study||1
8642744|NCT02556775|21332250|P2|NOT COMPLETED|Overall Study||0
8642745|NCT02556775|21332251|P1|NOT COMPLETED|Overall Study||2
8642746|NCT02556775|21332248|P4|COMPLETED|Overall Study||2
8642747|NCT02556775|21332249|P3|COMPLETED|Overall Study||4
8642748|NCT02556775|21332250|P2|COMPLETED|Overall Study||2
8642749|NCT02556775|21332251|P1|COMPLETED|Overall Study||5
8642750|NCT02556775|21332248|P4|STARTED|Overall Study||2
8642751|NCT02556775|21332249|P3|STARTED|Overall Study||5
8642752|NCT02556775|21332250|P2|STARTED|Overall Study||2
8642753|NCT02556775|21332251|P1|STARTED|Overall Study||7
8642754|NCT02354534|21332285|P4|NOT COMPLETED|Overall Study||0
8642755|NCT02354534|21332286|P3|NOT COMPLETED|Overall Study||1
8642756|NCT02354534|21332287|P2|NOT COMPLETED|Overall Study||0
8642757|NCT02354534|21332288|P1|NOT COMPLETED|Overall Study||0
8642758|NCT02354534|21332285|P4|COMPLETED|Overall Study||8
8642759|NCT02354534|21332286|P3|COMPLETED|Overall Study||9
8642760|NCT02354534|21332287|P2|COMPLETED|Overall Study||9
8642761|NCT02354534|21332288|P1|COMPLETED|Overall Study||3
8642762|NCT02354534|21332285|P4|STARTED|Overall Study||8
8642763|NCT02354534|21332286|P3|STARTED|Overall Study||10
8642764|NCT02354534|21332287|P2|STARTED|Overall Study||9
8642765|NCT02354534|21332288|P1|STARTED|Overall Study||3
8642766|NCT02342327|21332308|P2|NOT COMPLETED|Overall Study||22
8642767|NCT02342327|21332309|P1|NOT COMPLETED|Overall Study||21
8642768|NCT02342327|21332308|P2|COMPLETED|Overall Study||40
8642769|NCT02342327|21332309|P1|COMPLETED|Overall Study||39
8642770|NCT02342327|21332308|P2|Completed Quit Day Visit|Overall Study||53
8642771|NCT02342327|21332309|P1|Completed Quit Day Visit|Overall Study||54
8642772|NCT02342327|21332308|P2|STARTED|Overall Study||62
8642773|NCT02342327|21332309|P1|STARTED|Overall Study||60
8642774|NCT02317432|21332319|P2|NOT COMPLETED|Overall Study||6
8642775|NCT02317432|21332320|P1|NOT COMPLETED|Overall Study||31
8642776|NCT02317432|21332319|P2|COMPLETED|Overall Study||148
8642777|NCT02317432|21332320|P1|COMPLETED|Overall Study||122
8642778|NCT02317432|21332319|P2|Completed Enhanced Usual Care|Overall Study||148
8642779|NCT02317432|21332320|P1|Completed Enhanced Usual Care|Overall Study|Participants in CBT + InVEST exercise did not receive Enhanced Usual Care.|0
8642780|NCT02317432|21332319|P2|Completed CBT + InVEST Exercise|Overall Study|Participants in Enhanced Usual Care did not receive either CBT or InVEST sessions.|0
8642781|NCT02317432|21332320|P1|Completed CBT + InVEST Exercise|Overall Study||122
8642782|NCT02317432|21332319|P2|Completed InVEST|Overall Study|Participants in Enhanced Usual Care did not receive InVEST sessions.|0
8642783|NCT02317432|21332320|P1|Completed InVEST|Overall Study||63
8642784|NCT02317432|21332319|P2|Completed CBT|Overall Study|Participants in Enhanced Usual Care did not receive CBT sessions.|0
8642785|NCT02317432|21332320|P1|Completed CBT|Overall Study||118
8642786|NCT02317432|21332319|P2|STARTED|Overall Study||154
8642787|NCT02317432|21332320|P1|STARTED|Overall Study||153
8642788|NCT02103153|21332336|P1|NOT COMPLETED|Overall Study||17
8642789|NCT02103153|21332336|P1|COMPLETED|Overall Study||27
8642790|NCT02103153|21332336|P1|STARTED|Overall Study||44
8642801|NCT01324518|21332370|P3|NOT COMPLETED|Overall Study||1
8642802|NCT01324518|21332371|P2|NOT COMPLETED|Overall Study||3
8642803|NCT01324518|21332372|P1|NOT COMPLETED|Overall Study||5
8642804|NCT01324518|21332370|P3|COMPLETED|Overall Study||33
8642805|NCT01324518|21332371|P2|COMPLETED|Overall Study||30
8642806|NCT01324518|21332372|P1|COMPLETED|Overall Study||28
8642807|NCT01324518|21332370|P3|STARTED|Overall Study||34
8642808|NCT01324518|21332371|P2|STARTED|Overall Study||33
8642809|NCT01324518|21332372|P1|STARTED|Overall Study||33
8642810|NCT01185366|21332409|P2|NOT COMPLETED|Crossover to Second Line Therapy||10
8642811|NCT01185366|21332410|P1|NOT COMPLETED|Crossover to Second Line Therapy||14
8642812|NCT01185366|21332409|P2|COMPLETED|Crossover to Second Line Therapy||23
8642813|NCT01185366|21332410|P1|COMPLETED|Crossover to Second Line Therapy||21
8642814|NCT01185366|21332409|P2|Received Crossover Drug|Crossover to Second Line Therapy||23
8642815|NCT01185366|21332410|P1|Received Crossover Drug|Crossover to Second Line Therapy||21
8642816|NCT01185366|21332409|P2|STARTED|Crossover to Second Line Therapy||33
8642817|NCT01185366|21332410|P1|STARTED|Crossover to Second Line Therapy||35
8642818|NCT01185366|21332409|P2|NOT COMPLETED|First Line Therapy||1
8642819|NCT01185366|21332410|P1|NOT COMPLETED|First Line Therapy||3
8642820|NCT01185366|21332409|P2|COMPLETED|First Line Therapy||33
8642821|NCT01185366|21332410|P1|COMPLETED|First Line Therapy||35
8642822|NCT01185366|21332409|P2|Received 1st Drug|First Line Therapy||33
8642823|NCT01185366|21332410|P1|Received 1st Drug|First Line Therapy||36
8642824|NCT01185366|21332409|P2|STARTED|First Line Therapy||34
8642825|NCT01185366|21332410|P1|STARTED|First Line Therapy||38
8642826|NCT01167595|21332426|P2|NOT COMPLETED|Overall Study||0
8642827|NCT01167595|21332427|P1|NOT COMPLETED|Overall Study||0
8642828|NCT01167595|21332426|P2|COMPLETED|Overall Study||537
8642829|NCT01167595|21332427|P1|COMPLETED|Overall Study||522
8642830|NCT01167595|21332426|P2|STARTED|Overall Study||537
8642831|NCT01167595|21332427|P1|STARTED|Overall Study||522
8642832|NCT04458818|21332441|P1|NOT COMPLETED|Overall Study||0
8642833|NCT04458818|21332441|P1|COMPLETED|Overall Study|Jan 30 2021|39
8642834|NCT04458818|21332441|P1|STARTED|Overall Study|May 01 2020|39
8642835|NCT03920670|21332449|P2|NOT COMPLETED|Overall Study||2
8642836|NCT03920670|21332450|P1|NOT COMPLETED|Overall Study||3
8642837|NCT03920670|21332449|P2|COMPLETED|Overall Study||58
8642838|NCT03920670|21332450|P1|COMPLETED|Overall Study||57
8642839|NCT03920670|21332449|P2|STARTED|Overall Study||60
8642840|NCT03920670|21332450|P1|STARTED|Overall Study||60
8642841|NCT03792477|21332461|P5|NOT COMPLETED|Overall Study||1
8642842|NCT03792477|21332462|P4|NOT COMPLETED|Overall Study||1
8642843|NCT03792477|21332463|P3|NOT COMPLETED|Overall Study||2
8642844|NCT03792477|21332464|P2|NOT COMPLETED|Overall Study||0
8642845|NCT03792477|21332465|P1|NOT COMPLETED|Overall Study||0
8642846|NCT03792477|21332461|P5|COMPLETED|Overall Study||19
8642847|NCT03792477|21332462|P4|COMPLETED|Overall Study||20
8642848|NCT03792477|21332463|P3|COMPLETED|Overall Study||19
8642849|NCT03792477|21332464|P2|COMPLETED|Overall Study||6
8642850|NCT03792477|21332465|P1|COMPLETED|Overall Study||6
8642851|NCT03792477|21332461|P5|STARTED|Overall Study||20
8642852|NCT03792477|21332462|P4|STARTED|Overall Study||21
8642853|NCT03792477|21332463|P3|STARTED|Overall Study||21
8642854|NCT03792477|21332464|P2|STARTED|Overall Study||6
8642855|NCT03792477|21332465|P1|STARTED|Overall Study||6
8642856|NCT03720652|21332483|P2|NOT COMPLETED|Overall Study||11
8642857|NCT03720652|21332484|P1|NOT COMPLETED|Overall Study||2
8642858|NCT03720652|21332483|P2|COMPLETED|Overall Study||16
8642859|NCT03720652|21332484|P1|COMPLETED|Overall Study||10
8642860|NCT03720652|21332483|P2|6-Month Follow Up Interview|Overall Study||16
8642861|NCT03720652|21332484|P1|6-Month Follow Up Interview|Overall Study||10
8642862|NCT03720652|21332483|P2|3-Month Follow Up Interview|Overall Study||19
8642863|NCT03720652|21332484|P1|3-Month Follow Up Interview|Overall Study||10
8642864|NCT03720652|21332483|P2|Complete Intervention|Overall Study||20
8642865|NCT03720652|21332484|P1|Complete Intervention|Overall Study||10
8642866|NCT03720652|21332483|P2|Start Intervention|Overall Study||21
8642867|NCT03720652|21332484|P1|Start Intervention|Overall Study||11
8642868|NCT03720652|21332483|P2|Baseline Interview|Overall Study||22
8642869|NCT03720652|21332484|P1|Baseline Interview|Overall Study||12
8642870|NCT03720652|21332483|P2|STARTED|Overall Study||27
8642871|NCT03720652|21332484|P1|STARTED|Overall Study||12
8642872|NCT03600740|21332530|P1|NOT COMPLETED|Overall Study||1
8642873|NCT03600740|21332530|P1|COMPLETED|Overall Study||0
8642874|NCT03600740|21332530|P1|STARTED|Overall Study||1
8642875|NCT03559517|21332537|P3|NOT COMPLETED|Overall Study||0
8642876|NCT03559517|21332538|P2|NOT COMPLETED|Overall Study||0
8642877|NCT03559517|21332539|P1|NOT COMPLETED|Overall Study||1
8642878|NCT03559517|21332537|P3|COMPLETED|Overall Study||12
8642879|NCT03559517|21332538|P2|COMPLETED|Overall Study||9
8642880|NCT03559517|21332539|P1|COMPLETED|Overall Study||7
8642881|NCT03559517|21332537|P3|STARTED|Overall Study||12
8642882|NCT03559517|21332538|P2|STARTED|Overall Study||9
8642883|NCT03559517|21332539|P1|STARTED|Overall Study||8
8642884|NCT03529162|21332600|P2|NOT COMPLETED|Overall Study||2
8642885|NCT03529162|21332601|P1|NOT COMPLETED|Overall Study||2
8642886|NCT03529162|21332600|P2|COMPLETED|Overall Study||0
8642887|NCT03529162|21332601|P1|COMPLETED|Overall Study||0
8642888|NCT03529162|21332600|P2|STARTED|Overall Study||2
8642889|NCT03529162|21332601|P1|STARTED|Overall Study||2
8642890|NCT03448068|21332617|P2|NOT COMPLETED|Overall Study||0
8642891|NCT03448068|21332618|P1|NOT COMPLETED|Overall Study||0
8642892|NCT03448068|21332617|P2|COMPLETED|Overall Study||17
8642893|NCT03448068|21332618|P1|COMPLETED|Overall Study||17
8642894|NCT03448068|21332617|P2|STARTED|Overall Study||17
8642895|NCT03448068|21332618|P1|STARTED|Overall Study||17
8642896|NCT03440944|21332640|P2|NOT COMPLETED|Overall Study||1
8642897|NCT03440944|21332641|P1|NOT COMPLETED|Overall Study||1
8642898|NCT03440944|21332640|P2|COMPLETED|Overall Study||8
8642899|NCT03440944|21332641|P1|COMPLETED|Overall Study||8
8642900|NCT03440944|21332640|P2|STARTED|Overall Study||9
8642901|NCT03440944|21332641|P1|STARTED|Overall Study||9
8642902|NCT03437512|21332657|P2|NOT COMPLETED|Completed Study Follow up||1
8642903|NCT03437512|21332658|P1|NOT COMPLETED|Completed Study Follow up||2
8642904|NCT03437512|21332657|P2|COMPLETED|Completed Study Follow up||10
8642905|NCT03437512|21332658|P1|COMPLETED|Completed Study Follow up||10
8642906|NCT03437512|21332657|P2|STARTED|Completed Study Follow up||11
8642907|NCT03437512|21332658|P1|STARTED|Completed Study Follow up||12
8642908|NCT03437512|21332657|P2|NOT COMPLETED|Received Final tDCS Session||0
8642909|NCT03437512|21332658|P1|NOT COMPLETED|Received Final tDCS Session||0
8642910|NCT03437512|21332657|P2|COMPLETED|Received Final tDCS Session||11
8642911|NCT03437512|21332658|P1|COMPLETED|Received Final tDCS Session||12
8642912|NCT03437512|21332657|P2|STARTED|Received Final tDCS Session||11
8642913|NCT03437512|21332658|P1|STARTED|Received Final tDCS Session||12
8642914|NCT03437512|21332657|P2|NOT COMPLETED|Received First tDCS Session||0
8642915|NCT03437512|21332658|P1|NOT COMPLETED|Received First tDCS Session||0
8642916|NCT03437512|21332657|P2|COMPLETED|Received First tDCS Session||11
8642917|NCT03437512|21332658|P1|COMPLETED|Received First tDCS Session||12
8642918|NCT03437512|21332657|P2|STARTED|Received First tDCS Session||11
8642919|NCT03437512|21332658|P1|STARTED|Received First tDCS Session||12
8642920|NCT03437512|21332657|P2|NOT COMPLETED|Randomized||2
8642921|NCT03437512|21332658|P1|NOT COMPLETED|Randomized||0
8642922|NCT03437512|21332657|P2|COMPLETED|Randomized||11
8642923|NCT03437512|21332658|P1|COMPLETED|Randomized||12
8642924|NCT03437512|21332657|P2|STARTED|Randomized||13
8642925|NCT03437512|21332658|P1|STARTED|Randomized||12
8642926|NCT03424239|21332668|P1|NOT COMPLETED|Overall Study||2
8642927|NCT03424239|21332668|P1|COMPLETED|Overall Study||4
8642928|NCT03424239|21332668|P1|24 Week Post-op|Overall Study||4
8642929|NCT03424239|21332668|P1|12 Week Post-op|Overall Study||4
8642930|NCT03424239|21332668|P1|2 Week Post-op|Overall Study||4
8642931|NCT03424239|21332668|P1|Baseline/Zoledronic Acid Administration|Overall Study||4
8642932|NCT03424239|21332668|P1|STARTED|Overall Study||6
8642957|NCT03373110|21332739|P3|NOT COMPLETED|Overall Study||44
8642958|NCT03373110|21332740|P2|NOT COMPLETED|Overall Study||84
8642959|NCT03373110|21332741|P1|NOT COMPLETED|Overall Study||91
8642960|NCT03373110|21332739|P3|COMPLETED|Overall Study||28
8642961|NCT03373110|21332740|P2|COMPLETED|Overall Study||61
8642962|NCT03373110|21332741|P1|COMPLETED|Overall Study||53
8642963|NCT03373110|21332739|P3|STARTED|Overall Study||72
8642964|NCT03373110|21332740|P2|STARTED|Overall Study||145
8642965|NCT03373110|21332741|P1|STARTED|Overall Study||144
8642966|NCT03015194|21332788|P1|NOT COMPLETED|Overall Study||12
8642967|NCT03015194|21332788|P1|COMPLETED|Overall Study||18
8642968|NCT03015194|21332788|P1|STARTED|Overall Study||30
8642969|NCT02879578|21332796|P3|NOT COMPLETED|Overall Study||32
8642970|NCT02879578|21332797|P2|NOT COMPLETED|Overall Study||9
8642971|NCT02879578|21332798|P1|NOT COMPLETED|Overall Study||10
8642972|NCT02879578|21332796|P3|COMPLETED|Overall Study||49
8642973|NCT02879578|21332797|P2|COMPLETED|Overall Study||32
8642974|NCT02879578|21332798|P1|COMPLETED|Overall Study||23
8642975|NCT02879578|21332796|P3|Safety Analysis Set|Overall Study||79
8642976|NCT02879578|21332797|P2|Safety Analysis Set|Overall Study||40
8642977|NCT02879578|21332798|P1|Safety Analysis Set|Overall Study||33
8642978|NCT02879578|21332796|P3|STARTED|Overall Study||81
8642979|NCT02879578|21332797|P2|STARTED|Overall Study||41
8642980|NCT02879578|21332798|P1|STARTED|Overall Study||33
8642990|NCT02425306|21332829|P4|NOT COMPLETED|Overall Study||14
8642991|NCT02425306|21332830|P3|NOT COMPLETED|Overall Study||1
8642992|NCT02425306|21332831|P2|NOT COMPLETED|Overall Study||1
8642993|NCT02425306|21332832|P1|NOT COMPLETED|Overall Study||0
8642994|NCT02425306|21332829|P4|COMPLETED|Overall Study||18
8642995|NCT02425306|21332830|P3|COMPLETED|Overall Study||5
8642996|NCT02425306|21332831|P2|COMPLETED|Overall Study||6
8642997|NCT02425306|21332832|P1|COMPLETED|Overall Study||3
8642998|NCT02425306|21332829|P4|STARTED|Overall Study||32
8642999|NCT02425306|21332830|P3|STARTED|Overall Study||6
8643000|NCT02425306|21332831|P2|STARTED|Overall Study||7
8643001|NCT02425306|21332832|P1|STARTED|Overall Study||3
8643008|NCT01977547|21332869|P2|NOT COMPLETED|Overall Study||37
8643009|NCT01977547|21332870|P1|NOT COMPLETED|Overall Study||40
8643010|NCT01977547|21332869|P2|COMPLETED|Overall Study||733
8643011|NCT01977547|21332870|P1|COMPLETED|Overall Study||728
8643012|NCT01977547|21332869|P2|STARTED|Overall Study||770
8643013|NCT01977547|21332870|P1|STARTED|Overall Study||768
8643024|NCT01824082|21332907|P2|NOT COMPLETED|Optional Crossover Treatment||0
8643025|NCT01824082|21332908|P1|NOT COMPLETED|Optional Crossover Treatment||0
8643026|NCT01824082|21332907|P2|COMPLETED|Optional Crossover Treatment||25
8643027|NCT01824082|21332908|P1|COMPLETED|Optional Crossover Treatment||40
8643028|NCT01824082|21332907|P2|STARTED|Optional Crossover Treatment||25
8643029|NCT01824082|21332908|P1|STARTED|Optional Crossover Treatment||40
8643030|NCT01824082|21332907|P2|NOT COMPLETED|Initial Treatment||0
8643031|NCT01824082|21332908|P1|NOT COMPLETED|Initial Treatment||0
8643032|NCT01824082|21332907|P2|COMPLETED|Initial Treatment||73
8643033|NCT01824082|21332908|P1|COMPLETED|Initial Treatment||71
8643034|NCT01824082|21332907|P2|STARTED|Initial Treatment||73
8643035|NCT01824082|21332908|P1|STARTED|Initial Treatment||71
8643036|NCT01566695|21332968|P2|NOT COMPLETED|Overall Study||99
8643037|NCT01566695|21332969|P1|NOT COMPLETED|Overall Study||95
8643038|NCT01566695|21332968|P2|COMPLETED|Overall Study||10
8643039|NCT01566695|21332969|P1|COMPLETED|Overall Study||12
8643040|NCT01566695|21332968|P2|STARTED|Overall Study||109
8643041|NCT01566695|21332969|P1|STARTED|Overall Study||107
8643042|NCT01550562|21333071|P1|NOT COMPLETED|Third Intervention, 4 - 5 Days||0
8643043|NCT01550562|21333071|P1|COMPLETED|Third Intervention, 4 - 5 Days||1
8643044|NCT01550562|21333071|P1|STARTED|Third Intervention, 4 - 5 Days||1
8643045|NCT01550562|21333071|P1|NOT COMPLETED|Second Intervention, 4 - 5 Days||0
8643046|NCT01550562|21333071|P1|COMPLETED|Second Intervention, 4 - 5 Days||1
8643047|NCT01550562|21333071|P1|STARTED|Second Intervention, 4 - 5 Days||1
8643048|NCT01550562|21333071|P1|NOT COMPLETED|First Intervention, 4 - 5 Days||0
8643049|NCT01550562|21333071|P1|COMPLETED|First Intervention, 4 - 5 Days||1
8643050|NCT01550562|21333071|P1|STARTED|First Intervention, 4 - 5 Days||1
8643054|NCT01196936|21333090|P2|NOT COMPLETED|Overall Study||17
8643055|NCT01196936|21333091|P1|NOT COMPLETED|Overall Study||11
8643056|NCT01196936|21333090|P2|COMPLETED|Overall Study||21
8643057|NCT01196936|21333091|P1|COMPLETED|Overall Study||23
8643058|NCT01196936|21333090|P2|Year One Post Treatment|Overall Study||28
8643059|NCT01196936|21333091|P1|Year One Post Treatment|Overall Study||27
8643060|NCT01196936|21333090|P2|STARTED|Overall Study||38
8643061|NCT01196936|21333091|P1|STARTED|Overall Study||34
8643091|NCT00723125|21333182|P2|NOT COMPLETED|Overall Study||6
8643092|NCT00723125|21333183|P1|NOT COMPLETED|Overall Study||18
8643093|NCT00723125|21333182|P2|COMPLETED|Overall Study||21
8643094|NCT00723125|21333183|P1|COMPLETED|Overall Study||15
8643095|NCT00723125|21333182|P2|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
8643096|NCT00723125|21333183|P1|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
8643097|NCT00390325|21333197|P2|NOT COMPLETED|Overall Study||0
8643098|NCT00390325|21333198|P1|NOT COMPLETED|Overall Study||0
8643099|NCT00390325|21333197|P2|COMPLETED|Overall Study||16
8643100|NCT00390325|21333198|P1|COMPLETED|Overall Study||5
8643101|NCT00390325|21333197|P2|STARTED|Overall Study||16
8643102|NCT00390325|21333198|P1|STARTED|Overall Study||5
8643143|NCT04490239|21333235|P1|NOT COMPLETED|2000 U Chronic (Daily, 14 Days)||0
8643144|NCT04490239|21333235|P1|COMPLETED|2000 U Chronic (Daily, 14 Days)||6
8643145|NCT04490239|21333235|P1|STARTED|2000 U Chronic (Daily, 14 Days)||6
8643146|NCT04490239|21333235|P1|NOT COMPLETED|2000 U Acute (One Dose, Day 3)||0
8643147|NCT04490239|21333235|P1|COMPLETED|2000 U Acute (One Dose, Day 3)||6
8643148|NCT04490239|21333235|P1|STARTED|2000 U Acute (One Dose, Day 3)||6
8643149|NCT04490239|21333235|P1|NOT COMPLETED|1000 U Acute (One Dose, Day 1)||0
8643150|NCT04490239|21333235|P1|COMPLETED|1000 U Acute (One Dose, Day 1)||6
8643151|NCT04490239|21333235|P1|STARTED|1000 U Acute (One Dose, Day 1)||6
8643200|NCT03802994|21333788|P5|NOT COMPLETED|Overall Study||2
8643201|NCT03802994|21333789|P4|NOT COMPLETED|Overall Study||2
8643202|NCT03802994|21333790|P3|NOT COMPLETED|Overall Study||3
8643203|NCT03802994|21333791|P2|NOT COMPLETED|Overall Study||2
8643204|NCT03802994|21333792|P1|NOT COMPLETED|Overall Study||0
8643205|NCT03802994|21333788|P5|COMPLETED|Overall Study||8
8643206|NCT03802994|21333789|P4|COMPLETED|Overall Study||9
8643207|NCT03802994|21333790|P3|COMPLETED|Overall Study||12
8643208|NCT03802994|21333791|P2|COMPLETED|Overall Study||10
8643209|NCT03802994|21333792|P1|COMPLETED|Overall Study||9
8643210|NCT03802994|21333788|P5|STARTED|Overall Study||10
8643211|NCT03802994|21333789|P4|STARTED|Overall Study||11
8643212|NCT03802994|21333790|P3|STARTED|Overall Study||15
8643213|NCT03802994|21333791|P2|STARTED|Overall Study||12
8643214|NCT03802994|21333792|P1|STARTED|Overall Study||9
8643215|NCT03747497|21333821|P2|NOT COMPLETED|Overall Study||10
8643216|NCT03747497|21333822|P1|NOT COMPLETED|Overall Study||25
8643217|NCT03747497|21333821|P2|COMPLETED|Overall Study||55
8643218|NCT03747497|21333822|P1|COMPLETED|Overall Study||106
8643219|NCT03747497|21333821|P2|STARTED|Overall Study||65
8643220|NCT03747497|21333822|P1|STARTED|Overall Study||131
8643227|NCT03405363|21333915|P2|NOT COMPLETED|Overall Study||0
8643228|NCT03405363|21333916|P1|NOT COMPLETED|Overall Study||0
8643229|NCT03405363|21333915|P2|COMPLETED|Overall Study||51167
8643230|NCT03405363|21333916|P1|COMPLETED|Overall Study||14239
8643231|NCT03405363|21333915|P2|STARTED|Overall Study||51167
8643232|NCT03405363|21333916|P1|STARTED|Overall Study||14239
8643278|NCT03299244|21333969|P2|NOT COMPLETED|Overall Study||38
8643279|NCT03299244|21333970|P1|NOT COMPLETED|Overall Study||47
8643280|NCT03299244|21333969|P2|COMPLETED|Overall Study||282
8643281|NCT03299244|21333970|P1|COMPLETED|Overall Study||270
8643282|NCT03299244|21333969|P2|Received Treatment|Overall Study||318
8643283|NCT03299244|21333970|P1|Received Treatment|Overall Study||315
8643284|NCT03299244|21333969|P2|STARTED|Overall Study||320
8643285|NCT03299244|21333970|P1|STARTED|Overall Study||317
8643292|NCT02957305|21334020|P2|NOT COMPLETED|Overall Study||0
8643293|NCT02957305|21334021|P1|NOT COMPLETED|Overall Study||0
8643294|NCT02957305|21334020|P2|COMPLETED|Overall Study||105
8643295|NCT02957305|21334021|P1|COMPLETED|Overall Study||106
8643296|NCT02957305|21334020|P2|STARTED|Overall Study||105
8643297|NCT02957305|21334021|P1|STARTED|Overall Study||106
8643298|NCT02955329|21334031|P1|NOT COMPLETED|Combined Cannabis and Tobacco Arm||0
8643299|NCT02955329|21334031|P1|COMPLETED|Combined Cannabis and Tobacco Arm||8
8643300|NCT02955329|21334031|P1|STARTED|Combined Cannabis and Tobacco Arm||8
8643301|NCT02955329|21334031|P1|NOT COMPLETED|Cannabis Arm||0
8643302|NCT02955329|21334031|P1|COMPLETED|Cannabis Arm||8
8643303|NCT02955329|21334031|P1|STARTED|Cannabis Arm||8
8643304|NCT02955329|21334031|P1|NOT COMPLETED|Tobacco Arm||0
8643305|NCT02955329|21334031|P1|COMPLETED|Tobacco Arm||8
8643306|NCT02955329|21334031|P1|STARTED|Tobacco Arm||8
8643307|NCT02888106|21334075|P6|NOT COMPLETED|Overall Study||1
8643308|NCT02888106|21334076|P5|NOT COMPLETED|Overall Study||1
8643309|NCT02888106|21334077|P4|NOT COMPLETED|Overall Study||2
8643310|NCT02888106|21334078|P3|NOT COMPLETED|Overall Study||0
8643311|NCT02888106|21334079|P2|NOT COMPLETED|Overall Study||2
8643312|NCT02888106|21334080|P1|NOT COMPLETED|Overall Study||5
8643313|NCT02888106|21334075|P6|COMPLETED|Overall Study||14
8643314|NCT02888106|21334076|P5|COMPLETED|Overall Study||14
8643315|NCT02888106|21334077|P4|COMPLETED|Overall Study||13
8643316|NCT02888106|21334078|P3|COMPLETED|Overall Study||15
8643317|NCT02888106|21334079|P2|COMPLETED|Overall Study||13
8643318|NCT02888106|21334080|P1|COMPLETED|Overall Study||10
8643319|NCT02888106|21334075|P6|STARTED|Overall Study||15
8643320|NCT02888106|21334076|P5|STARTED|Overall Study||15
8643321|NCT02888106|21334077|P4|STARTED|Overall Study||15
8643322|NCT02888106|21334078|P3|STARTED|Overall Study||15
8643323|NCT02888106|21334079|P2|STARTED|Overall Study||15
8643324|NCT02888106|21334080|P1|STARTED|Overall Study||15
8643325|NCT02860988|21334168|P2|NOT COMPLETED|Overall Study||106
8643326|NCT02860988|21334169|P1|NOT COMPLETED|Overall Study||84
8643327|NCT02860988|21334168|P2|COMPLETED|Overall Study||94
8643328|NCT02860988|21334169|P1|COMPLETED|Overall Study||117
8643329|NCT02860988|21334168|P2|STARTED|Overall Study||200
8643330|NCT02860988|21334169|P1|STARTED|Overall Study||201
8643337|NCT02760407|21334202|P4|NOT COMPLETED|Overall Study||36
8643338|NCT02760407|21334203|P3|NOT COMPLETED|Overall Study||50
8643339|NCT02760407|21334204|P2|NOT COMPLETED|Overall Study||43
8643340|NCT02760407|21334205|P1|NOT COMPLETED|Overall Study||36
8643341|NCT02760407|21334202|P4|COMPLETED|Overall Study||207
8643342|NCT02760407|21334203|P3|COMPLETED|Overall Study||412
8643343|NCT02760407|21334204|P2|COMPLETED|Overall Study||421
8643344|NCT02760407|21334205|P1|COMPLETED|Overall Study||443
8643345|NCT02760407|21334202|P4|STARTED|Overall Study||243
8643346|NCT02760407|21334203|P3|STARTED|Overall Study||462
8643347|NCT02760407|21334204|P2|STARTED|Overall Study||464
8643348|NCT02760407|21334205|P1|STARTED|Overall Study||479
8643349|NCT02581384|21334239|P2|NOT COMPLETED|Overall Study||0
8643350|NCT02581384|21334240|P1|NOT COMPLETED|Overall Study||0
8643351|NCT02581384|21334239|P2|COMPLETED|Overall Study||2
8643352|NCT02581384|21334240|P1|COMPLETED|Overall Study||3
8643353|NCT02581384|21334239|P2|STARTED|Overall Study||2
8643354|NCT02581384|21334240|P1|STARTED|Overall Study||3
8643355|NCT02574455|21334253|P2|NOT COMPLETED|Overall Study||228
8643356|NCT02574455|21334254|P1|NOT COMPLETED|Overall Study||185
8643357|NCT02574455|21334253|P2|COMPLETED|Overall Study||34
8643358|NCT02574455|21334254|P1|COMPLETED|Overall Study||82
8643359|NCT02574455|21334253|P2|Enrolled and Treated|Overall Study||224
8643360|NCT02574455|21334254|P1|Enrolled and Treated|Overall Study||258
8643361|NCT02574455|21334253|P2|STARTED|Overall Study||262
8643362|NCT02574455|21334254|P1|STARTED|Overall Study||267
8643363|NCT02530541|21334282|P6|NOT COMPLETED|Overall Study||5
8643364|NCT02530541|21334283|P5|NOT COMPLETED|Overall Study||5
8643365|NCT02530541|21334284|P4|NOT COMPLETED|Overall Study||6
8643366|NCT02530541|21334285|P3|NOT COMPLETED|Overall Study||8
8643367|NCT02530541|21334286|P2|NOT COMPLETED|Overall Study||8
8643368|NCT02530541|21334287|P1|NOT COMPLETED|Overall Study||7
8643369|NCT02530541|21334282|P6|COMPLETED|Overall Study||14
8643370|NCT02530541|21334283|P5|COMPLETED|Overall Study||15
8643371|NCT02530541|21334284|P4|COMPLETED|Overall Study||15
8643372|NCT02530541|21334285|P3|COMPLETED|Overall Study||14
8643373|NCT02530541|21334286|P2|COMPLETED|Overall Study||15
8643374|NCT02530541|21334287|P1|COMPLETED|Overall Study||14
8643375|NCT02530541|21334282|P6|STARTED|Overall Study||19
8643376|NCT02530541|21334283|P5|STARTED|Overall Study||20
8643377|NCT02530541|21334284|P4|STARTED|Overall Study||21
8643378|NCT02530541|21334285|P3|STARTED|Overall Study||22
8643379|NCT02530541|21334286|P2|STARTED|Overall Study||23
8643380|NCT02530541|21334287|P1|STARTED|Overall Study||21
8643381|NCT02530528|21334296|P8|NOT COMPLETED|Overall Study||2
8643382|NCT02530528|21334297|P7|NOT COMPLETED|Overall Study||2
8643383|NCT02530528|21334298|P6|NOT COMPLETED|Overall Study||1
8643384|NCT02530528|21334299|P5|NOT COMPLETED|Overall Study||1
8643385|NCT02530528|21334300|P4|NOT COMPLETED|Overall Study||2
8643386|NCT02530528|21334301|P3|NOT COMPLETED|Overall Study||2
8643387|NCT02530528|21334302|P2|NOT COMPLETED|Overall Study||1
8643388|NCT02530528|21334303|P1|NOT COMPLETED|Overall Study||1
8643389|NCT02530528|21334296|P8|COMPLETED|Overall Study||12
8643390|NCT02530528|21334297|P7|COMPLETED|Overall Study|14 participants received comparator CHG.|12
8643391|NCT02530528|21334298|P6|COMPLETED|Overall Study||12
8643392|NCT02530528|21334299|P5|COMPLETED|Overall Study|13 participants received CHG cloth|12
8643393|NCT02530528|21334300|P4|COMPLETED|Overall Study||12
8643394|NCT02530528|21334301|P3|COMPLETED|Overall Study|14 participants received CHG cloth|12
8643395|NCT02530528|21334302|P2|COMPLETED|Overall Study||12
8643396|NCT02530528|21334303|P1|COMPLETED|Overall Study|13 participants received CHG Cloth|12
8643397|NCT02530528|21334296|P8|STARTED|Overall Study||14
8643398|NCT02530528|21334297|P7|STARTED|Overall Study||14
8643399|NCT02530528|21334298|P6|STARTED|Overall Study||13
8643400|NCT02530528|21334299|P5|STARTED|Overall Study||13
8643401|NCT02530528|21334300|P4|STARTED|Overall Study||14
8643402|NCT02530528|21334301|P3|STARTED|Overall Study||14
8643403|NCT02530528|21334302|P2|STARTED|Overall Study||13
8643404|NCT02530528|21334303|P1|STARTED|Overall Study||13
8643411|NCT02291601|21334328|P3|NOT COMPLETED|Groin||177
8643412|NCT02291601|21334329|P2|NOT COMPLETED|Groin||30
8643413|NCT02291601|21334330|P1|NOT COMPLETED|Groin||183
8643414|NCT02291601|21334328|P3|COMPLETED|Groin|515 participants received Comparator CHG|338
8643415|NCT02291601|21334329|P2|COMPLETED|Groin|93 participants received vehicle|63
8643416|NCT02291601|21334330|P1|COMPLETED|Groin|520 participants received CHG cloth|337
8643417|NCT02291601|21334328|P3|STARTED|Groin||515
8643418|NCT02291601|21334329|P2|STARTED|Groin||93
8643419|NCT02291601|21334330|P1|STARTED|Groin||520
8643420|NCT02291601|21334328|P3|NOT COMPLETED|Abdomen||339
8643421|NCT02291601|21334329|P2|NOT COMPLETED|Abdomen||54
8643422|NCT02291601|21334330|P1|NOT COMPLETED|Abdomen||333
8643423|NCT02291601|21334328|P3|COMPLETED|Abdomen|642 participants received comparator CHG|303
8643424|NCT02291601|21334329|P2|COMPLETED|Abdomen|108 participants received vehicle|54
8643425|NCT02291601|21334330|P1|COMPLETED|Abdomen|638 participants received CHG cloth|305
8643426|NCT02291601|21334328|P3|STARTED|Abdomen||642
8643427|NCT02291601|21334329|P2|STARTED|Abdomen||108
8643428|NCT02291601|21334330|P1|STARTED|Abdomen||638
8643429|NCT02100631|21334344|P3|NOT COMPLETED|Overall Study||0
8643430|NCT02100631|21334345|P2|NOT COMPLETED|Overall Study||4
8643431|NCT02100631|21334346|P1|NOT COMPLETED|Overall Study||7
8643432|NCT02100631|21334344|P3|COMPLETED|Overall Study||2688
8643433|NCT02100631|21334345|P2|COMPLETED|Overall Study||95
8643434|NCT02100631|21334346|P1|COMPLETED|Overall Study||292
8643435|NCT02100631|21334344|P3|STARTED|Overall Study||2688
8643436|NCT02100631|21334345|P2|STARTED|Overall Study||99
8643437|NCT02100631|21334346|P1|STARTED|Overall Study||299
8643441|NCT01849822|21334372|P1|NOT COMPLETED|Overall Study||0
8643442|NCT01849822|21334372|P1|COMPLETED|Overall Study||1
8643443|NCT01849822|21334372|P1|STARTED|Overall Study||1
8643444|NCT01794117|21334381|P4|NOT COMPLETED|Overall Study||0
8643445|NCT01794117|21334382|P3|NOT COMPLETED|Overall Study||0
8643446|NCT01794117|21334383|P2|NOT COMPLETED|Overall Study||3
8643447|NCT01794117|21334384|P1|NOT COMPLETED|Overall Study||1
8643448|NCT01794117|21334381|P4|COMPLETED|Overall Study||12
8643449|NCT01794117|21334382|P3|COMPLETED|Overall Study||2
8643450|NCT01794117|21334383|P2|COMPLETED|Overall Study||0
8643451|NCT01794117|21334384|P1|COMPLETED|Overall Study||0
8643452|NCT01794117|21334381|P4|STARTED|Overall Study||12
8643453|NCT01794117|21334382|P3|STARTED|Overall Study||2
8643454|NCT01794117|21334383|P2|STARTED|Overall Study||3
8643455|NCT01794117|21334384|P1|STARTED|Overall Study||1
8643456|NCT01748994|21334398|P2|NOT COMPLETED|Overall Study||6
8643457|NCT01748994|21334399|P1|NOT COMPLETED|Overall Study||8
8643458|NCT01748994|21334398|P2|COMPLETED|Overall Study||26
8643459|NCT01748994|21334399|P1|COMPLETED|Overall Study||23
8643460|NCT01748994|21334398|P2|STARTED|Overall Study||32
8643461|NCT01748994|21334399|P1|STARTED|Overall Study||31
8643462|NCT01607905|21334418|P7|NOT COMPLETED|Overall Study||47
8643463|NCT01607905|21334419|P6|NOT COMPLETED|Overall Study||15
8643464|NCT01607905|21334420|P5|NOT COMPLETED|Overall Study||7
8643465|NCT01607905|21334421|P4|NOT COMPLETED|Overall Study||21
8643466|NCT01607905|21334422|P3|NOT COMPLETED|Overall Study||21
8643467|NCT01607905|21334423|P2|NOT COMPLETED|Overall Study||20
8643468|NCT01607905|21334424|P1|NOT COMPLETED|Overall Study||60
8643469|NCT01607905|21334418|P7|COMPLETED|Overall Study||0
8643470|NCT01607905|21334419|P6|COMPLETED|Overall Study||0
8643471|NCT01607905|21334420|P5|COMPLETED|Overall Study||0
8643472|NCT01607905|21334421|P4|COMPLETED|Overall Study||0
8643473|NCT01607905|21334422|P3|COMPLETED|Overall Study||0
8643474|NCT01607905|21334423|P2|COMPLETED|Overall Study||0
8643475|NCT01607905|21334424|P1|COMPLETED|Overall Study||0
8643476|NCT01607905|21334418|P7|High Dose (>= 55 mg/m^2)|Overall Study||18
8643477|NCT01607905|21334419|P6|High Dose (>= 55 mg/m^2)|Overall Study||10
8643478|NCT01607905|21334420|P5|High Dose (>= 55 mg/m^2)|Overall Study||0
8643479|NCT01607905|21334421|P4|High Dose (>= 55 mg/m^2)|Overall Study||13
8643480|NCT01607905|21334422|P3|High Dose (>= 55 mg/m^2)|Overall Study||3
8643481|NCT01607905|21334423|P2|High Dose (>= 55 mg/m^2)|Overall Study||4
8643482|NCT01607905|21334424|P1|High Dose (>= 55 mg/m^2)|Overall Study||16
8643483|NCT01607905|21334418|P7|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||21
8643484|NCT01607905|21334419|P6|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||3
8643485|NCT01607905|21334420|P5|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||6
8643486|NCT01607905|21334421|P4|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||8
8643487|NCT01607905|21334422|P3|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||15
8643488|NCT01607905|21334423|P2|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||11
8643489|NCT01607905|21334424|P1|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||27
8643490|NCT01607905|21334418|P7|Low Dose (<30 mg/m^2)|Overall Study||8
8643491|NCT01607905|21334419|P6|Low Dose (<30 mg/m^2)|Overall Study||2
8643492|NCT01607905|21334420|P5|Low Dose (<30 mg/m^2)|Overall Study||0
8643493|NCT01607905|21334421|P4|Low Dose (<30 mg/m^2)|Overall Study||0
8643494|NCT01607905|21334422|P3|Low Dose (<30 mg/m^2)|Overall Study||3
8643495|NCT01607905|21334423|P2|Low Dose (<30 mg/m^2)|Overall Study||5
8643496|NCT01607905|21334424|P1|Low Dose (<30 mg/m^2)|Overall Study||16
8643497|NCT01607905|21334418|P7|Received Study Drug|Overall Study||47
8643498|NCT01607905|21334419|P6|Received Study Drug|Overall Study||15
8643499|NCT01607905|21334420|P5|Received Study Drug|Overall Study||6
8643500|NCT01607905|21334421|P4|Received Study Drug|Overall Study||21
8643501|NCT01607905|21334422|P3|Received Study Drug|Overall Study||21
8643502|NCT01607905|21334423|P2|Received Study Drug|Overall Study||20
8643503|NCT01607905|21334424|P1|Received Study Drug|Overall Study||59
8643504|NCT01607905|21334418|P7|STARTED|Overall Study||47
8643505|NCT01607905|21334419|P6|STARTED|Overall Study||15
8643506|NCT01607905|21334420|P5|STARTED|Overall Study||7
8643507|NCT01607905|21334421|P4|STARTED|Overall Study||21
8643508|NCT01607905|21334422|P3|STARTED|Overall Study||21
8643509|NCT01607905|21334423|P2|STARTED|Overall Study||20
8643510|NCT01607905|21334424|P1|STARTED|Overall Study||60
8643511|NCT00917150|21334634|P4|NOT COMPLETED|Overall Study||34
8643512|NCT00917150|21334635|P3|NOT COMPLETED|Overall Study||42
8643513|NCT00917150|21334636|P2|NOT COMPLETED|Overall Study||37
8643514|NCT00917150|21334637|P1|NOT COMPLETED|Overall Study||37
8643515|NCT00917150|21334634|P4|COMPLETED|Overall Study||156
8643516|NCT00917150|21334635|P3|COMPLETED|Overall Study||149
8643517|NCT00917150|21334636|P2|COMPLETED|Overall Study||161
8643518|NCT00917150|21334637|P1|COMPLETED|Overall Study||155
8643519|NCT00917150|21334634|P4|STARTED|Overall Study||190
8643520|NCT00917150|21334635|P3|STARTED|Overall Study||191
8643521|NCT00917150|21334636|P2|STARTED|Overall Study||198
8643522|NCT00917150|21334637|P1|STARTED|Overall Study||192
8643523|NCT00784693|21334657|P2|NOT COMPLETED|Overall Study||6
8643524|NCT00784693|21334658|P1|NOT COMPLETED|Overall Study||3
8643525|NCT00784693|21334657|P2|COMPLETED|Overall Study||19
8643526|NCT00784693|21334658|P1|COMPLETED|Overall Study||20
8643527|NCT00784693|21334657|P2|Treated|Overall Study||25
8643528|NCT00784693|21334658|P1|Treated|Overall Study||22
8643529|NCT00784693|21334657|P2|STARTED|Overall Study||25
8643530|NCT00784693|21334658|P1|STARTED|Overall Study||23
8643531|NCT00773747|21334703|P2|NOT COMPLETED|Overall Study||296
8643532|NCT00773747|21334704|P1|NOT COMPLETED|Overall Study||297
8643533|NCT00773747|21334703|P2|COMPLETED|Overall Study||24
8643534|NCT00773747|21334704|P1|COMPLETED|Overall Study||20
8643535|NCT00773747|21334703|P2|Treated|Overall Study||320
8643536|NCT00773747|21334704|P1|Treated|Overall Study||315
8643537|NCT00773747|21334703|P2|STARTED|Overall Study||320
8643538|NCT00773747|21334704|P1|STARTED|Overall Study||317
8643539|NCT00572455|21334732|P14|NOT COMPLETED|Stage II (28 Days)||2
8643540|NCT00572455|21334733|P13|NOT COMPLETED|Stage II (28 Days)||5
8643541|NCT00572455|21334734|P12|NOT COMPLETED|Stage II (28 Days)||4
8643542|NCT00572455|21334735|P11|NOT COMPLETED|Stage II (28 Days)||5
8643543|NCT00572455|21334736|P10|NOT COMPLETED|Stage II (28 Days)||3
8643544|NCT00572455|21334737|P9|NOT COMPLETED|Stage II (28 Days)||3
8643545|NCT00572455|21334738|P8|NOT COMPLETED|Stage II (28 Days)||1
8643546|NCT00572455|21334739|P7|NOT COMPLETED|Stage II (28 Days)||0
8643547|NCT00572455|21334740|P6|NOT COMPLETED|Stage II (28 Days)||0
8643548|NCT00572455|21334741|P5|NOT COMPLETED|Stage II (28 Days)||0
8643549|NCT00572455|21334742|P4|NOT COMPLETED|Stage II (28 Days)||0
8643550|NCT00572455|21334743|P3|NOT COMPLETED|Stage II (28 Days)||0
8643551|NCT00572455|21334744|P2|NOT COMPLETED|Stage II (28 Days)||0
8643552|NCT00572455|21334745|P1|NOT COMPLETED|Stage II (28 Days)||0
8643553|NCT00572455|21334732|P14|COMPLETED|Stage II (28 Days)||34
8643554|NCT00572455|21334733|P13|COMPLETED|Stage II (28 Days)||31
8643555|NCT00572455|21334734|P12|COMPLETED|Stage II (28 Days)||32
8643556|NCT00572455|21334735|P11|COMPLETED|Stage II (28 Days)||31
8643557|NCT00572455|21334736|P10|COMPLETED|Stage II (28 Days)||33
8643558|NCT00572455|21334737|P9|COMPLETED|Stage II (28 Days)||33
8643559|NCT00572455|21334738|P8|COMPLETED|Stage II (28 Days)||34
8643560|NCT00572455|21334739|P7|COMPLETED|Stage II (28 Days)||0
8643561|NCT00572455|21334740|P6|COMPLETED|Stage II (28 Days)||0
8643562|NCT00572455|21334741|P5|COMPLETED|Stage II (28 Days)||0
8643563|NCT00572455|21334742|P4|COMPLETED|Stage II (28 Days)||0
8643564|NCT00572455|21334743|P3|COMPLETED|Stage II (28 Days)||0
8643565|NCT00572455|21334744|P2|COMPLETED|Stage II (28 Days)||0
8643566|NCT00572455|21334745|P1|COMPLETED|Stage II (28 Days)||0
8643567|NCT00572455|21334732|P14|Treated|Stage II (28 Days)||35
8643568|NCT00572455|21334733|P13|Treated|Stage II (28 Days)||36
8643569|NCT00572455|21334734|P12|Treated|Stage II (28 Days)||36
8643570|NCT00572455|21334735|P11|Treated|Stage II (28 Days)||36
8643571|NCT00572455|21334736|P10|Treated|Stage II (28 Days)||36
8643572|NCT00572455|21334737|P9|Treated|Stage II (28 Days)||36
8643573|NCT00572455|21334738|P8|Treated|Stage II (28 Days)||35
8643574|NCT00572455|21334739|P7|Treated|Stage II (28 Days)||0
8643575|NCT00572455|21334740|P6|Treated|Stage II (28 Days)||0
8643576|NCT00572455|21334741|P5|Treated|Stage II (28 Days)||0
8643577|NCT00572455|21334742|P4|Treated|Stage II (28 Days)||0
8643578|NCT00572455|21334743|P3|Treated|Stage II (28 Days)||0
8643579|NCT00572455|21334744|P2|Treated|Stage II (28 Days)||0
8643580|NCT00572455|21334745|P1|Treated|Stage II (28 Days)||0
8643581|NCT00572455|21334732|P14|STARTED|Stage II (28 Days)||36
8643582|NCT00572455|21334733|P13|STARTED|Stage II (28 Days)||36
8643583|NCT00572455|21334734|P12|STARTED|Stage II (28 Days)||36
8643584|NCT00572455|21334735|P11|STARTED|Stage II (28 Days)||36
8643585|NCT00572455|21334736|P10|STARTED|Stage II (28 Days)||36
8643586|NCT00572455|21334737|P9|STARTED|Stage II (28 Days)||36
8643587|NCT00572455|21334738|P8|STARTED|Stage II (28 Days)||35
8643588|NCT00572455|21334739|P7|STARTED|Stage II (28 Days)||0
8643589|NCT00572455|21334740|P6|STARTED|Stage II (28 Days)||0
8643590|NCT00572455|21334741|P5|STARTED|Stage II (28 Days)||0
8643591|NCT00572455|21334742|P4|STARTED|Stage II (28 Days)||0
8643592|NCT00572455|21334743|P3|STARTED|Stage II (28 Days)||0
8643593|NCT00572455|21334744|P2|STARTED|Stage II (28 Days)||0
8643594|NCT00572455|21334745|P1|STARTED|Stage II (28 Days)||0
8643595|NCT00572455|21334732|P14|NOT COMPLETED|Stage I (14 Days)||0
8643596|NCT00572455|21334733|P13|NOT COMPLETED|Stage I (14 Days)||0
8643597|NCT00572455|21334734|P12|NOT COMPLETED|Stage I (14 Days)||0
8643598|NCT00572455|21334735|P11|NOT COMPLETED|Stage I (14 Days)||0
8643599|NCT00572455|21334736|P10|NOT COMPLETED|Stage I (14 Days)||0
8643600|NCT00572455|21334737|P9|NOT COMPLETED|Stage I (14 Days)||0
8643601|NCT00572455|21334738|P8|NOT COMPLETED|Stage I (14 Days)||0
8643602|NCT00572455|21334739|P7|NOT COMPLETED|Stage I (14 Days)||0
8643603|NCT00572455|21334740|P6|NOT COMPLETED|Stage I (14 Days)||3
8643604|NCT00572455|21334741|P5|NOT COMPLETED|Stage I (14 Days)||1
8643605|NCT00572455|21334742|P4|NOT COMPLETED|Stage I (14 Days)||0
8643606|NCT00572455|21334743|P3|NOT COMPLETED|Stage I (14 Days)||0
8643607|NCT00572455|21334744|P2|NOT COMPLETED|Stage I (14 Days)||0
8643608|NCT00572455|21334745|P1|NOT COMPLETED|Stage I (14 Days)||0
8643609|NCT00572455|21334732|P14|COMPLETED|Stage I (14 Days)||0
8643610|NCT00572455|21334733|P13|COMPLETED|Stage I (14 Days)||0
8643611|NCT00572455|21334734|P12|COMPLETED|Stage I (14 Days)||0
8643612|NCT00572455|21334735|P11|COMPLETED|Stage I (14 Days)||0
8643613|NCT00572455|21334736|P10|COMPLETED|Stage I (14 Days)||0
8643614|NCT00572455|21334737|P9|COMPLETED|Stage I (14 Days)||0
8643615|NCT00572455|21334738|P8|COMPLETED|Stage I (14 Days)||0
8643616|NCT00572455|21334739|P7|COMPLETED|Stage I (14 Days)||12
8643617|NCT00572455|21334740|P6|COMPLETED|Stage I (14 Days)||6
8643618|NCT00572455|21334741|P5|COMPLETED|Stage I (14 Days)||8
8643619|NCT00572455|21334742|P4|COMPLETED|Stage I (14 Days)||10
8643620|NCT00572455|21334743|P3|COMPLETED|Stage I (14 Days)||9
8643621|NCT00572455|21334744|P2|COMPLETED|Stage I (14 Days)||9
8643622|NCT00572455|21334745|P1|COMPLETED|Stage I (14 Days)||9
8643623|NCT00572455|21334732|P14|STARTED|Stage I (14 Days)||0
8643624|NCT00572455|21334733|P13|STARTED|Stage I (14 Days)||0
8643625|NCT00572455|21334734|P12|STARTED|Stage I (14 Days)||0
8643626|NCT00572455|21334735|P11|STARTED|Stage I (14 Days)||0
8643627|NCT00572455|21334736|P10|STARTED|Stage I (14 Days)||0
8643628|NCT00572455|21334737|P9|STARTED|Stage I (14 Days)||0
8643629|NCT00572455|21334738|P8|STARTED|Stage I (14 Days)||0
8643630|NCT00572455|21334739|P7|STARTED|Stage I (14 Days)||12
8643631|NCT00572455|21334740|P6|STARTED|Stage I (14 Days)||9
8643632|NCT00572455|21334741|P5|STARTED|Stage I (14 Days)||9
8643633|NCT00572455|21334742|P4|STARTED|Stage I (14 Days)||10
8643634|NCT00572455|21334743|P3|STARTED|Stage I (14 Days)||9
8643635|NCT00572455|21334744|P2|STARTED|Stage I (14 Days)||9
8643636|NCT00572455|21334745|P1|STARTED|Stage I (14 Days)||9
8643637|NCT00317356|21334835|P4|NOT COMPLETED|Overall Study||3
8643638|NCT00317356|21334836|P3|NOT COMPLETED|Overall Study||1
8643639|NCT00317356|21334837|P2|NOT COMPLETED|Overall Study||2
8643640|NCT00317356|21334838|P1|NOT COMPLETED|Overall Study||1
8643641|NCT00317356|21334835|P4|COMPLETED|Overall Study||8
8643642|NCT00317356|21334836|P3|COMPLETED|Overall Study||9
8643643|NCT00317356|21334837|P2|COMPLETED|Overall Study||9
8643644|NCT00317356|21334838|P1|COMPLETED|Overall Study||10
8643645|NCT00317356|21334835|P4|STARTED|Overall Study||11
8643646|NCT00317356|21334836|P3|STARTED|Overall Study||10
8643647|NCT00317356|21334837|P2|STARTED|Overall Study||11
8643648|NCT00317356|21334838|P1|STARTED|Overall Study||11
8643649|NCT04396639|21334876|P1|NOT COMPLETED|Overall Study||2
8643650|NCT04396639|21334876|P1|COMPLETED|Overall Study||48
8643651|NCT04396639|21334876|P1|Completed Follow up|Overall Study||48
8643652|NCT04396639|21334876|P1|STARTED|Overall Study||50
8643674|NCT04332614|21334914|P6|NOT COMPLETED|~1 Month After Study Launch||19
8643675|NCT04332614|21334915|P5|NOT COMPLETED|~1 Month After Study Launch||20
8643676|NCT04332614|21334916|P4|NOT COMPLETED|~1 Month After Study Launch||24
8643677|NCT04332614|21334917|P3|NOT COMPLETED|~1 Month After Study Launch||30
8643678|NCT04332614|21334918|P2|NOT COMPLETED|~1 Month After Study Launch||22
8643679|NCT04332614|21334919|P1|NOT COMPLETED|~1 Month After Study Launch||22
8643680|NCT04332614|21334914|P6|COMPLETED|~1 Month After Study Launch||2096
8643681|NCT04332614|21334915|P5|COMPLETED|~1 Month After Study Launch||2107
8643682|NCT04332614|21334916|P4|COMPLETED|~1 Month After Study Launch||2107
8643683|NCT04332614|21334917|P3|COMPLETED|~1 Month After Study Launch||2094
8643684|NCT04332614|21334918|P2|COMPLETED|~1 Month After Study Launch||2107
8643685|NCT04332614|21334919|P1|COMPLETED|~1 Month After Study Launch||2095
8643686|NCT04332614|21334914|P6|STARTED|~1 Month After Study Launch||2115
8643687|NCT04332614|21334915|P5|STARTED|~1 Month After Study Launch||2127
8643688|NCT04332614|21334916|P4|STARTED|~1 Month After Study Launch||2131
8643689|NCT04332614|21334917|P3|STARTED|~1 Month After Study Launch||2124
8643690|NCT04332614|21334918|P2|STARTED|~1 Month After Study Launch||2129
8643691|NCT04332614|21334919|P1|STARTED|~1 Month After Study Launch||2117
8643692|NCT04332614|21334914|P6|NOT COMPLETED|~1 Week After Study Launch||234
8643693|NCT04332614|21334915|P5|NOT COMPLETED|~1 Week After Study Launch||223
8643694|NCT04332614|21334916|P4|NOT COMPLETED|~1 Week After Study Launch||219
8643695|NCT04332614|21334917|P3|NOT COMPLETED|~1 Week After Study Launch||226
8643696|NCT04332614|21334918|P2|NOT COMPLETED|~1 Week After Study Launch||221
8643697|NCT04332614|21334919|P1|NOT COMPLETED|~1 Week After Study Launch||233
8643698|NCT04332614|21334914|P6|COMPLETED|~1 Week After Study Launch||2115
8643699|NCT04332614|21334915|P5|COMPLETED|~1 Week After Study Launch||2127
8643700|NCT04332614|21334916|P4|COMPLETED|~1 Week After Study Launch||2131
8643701|NCT04332614|21334917|P3|COMPLETED|~1 Week After Study Launch||2124
8643702|NCT04332614|21334918|P2|COMPLETED|~1 Week After Study Launch||2129
8643703|NCT04332614|21334919|P1|COMPLETED|~1 Week After Study Launch||2117
8643704|NCT04332614|21334914|P6|Data in EHR|~1 Week After Study Launch||2249
8643705|NCT04332614|21334915|P5|Data in EHR|~1 Week After Study Launch||2251
8643706|NCT04332614|21334916|P4|Data in EHR|~1 Week After Study Launch||2254
8643707|NCT04332614|21334917|P3|Data in EHR|~1 Week After Study Launch||2251
8643708|NCT04332614|21334918|P2|Data in EHR|~1 Week After Study Launch||2273
8643709|NCT04332614|21334919|P1|Data in EHR|~1 Week After Study Launch||2245
8643710|NCT04332614|21334914|P6|STARTED|~1 Week After Study Launch||2349
8643711|NCT04332614|21334915|P5|STARTED|~1 Week After Study Launch||2350
8643712|NCT04332614|21334916|P4|STARTED|~1 Week After Study Launch||2350
8643713|NCT04332614|21334917|P3|STARTED|~1 Week After Study Launch||2350
8643714|NCT04332614|21334918|P2|STARTED|~1 Week After Study Launch||2350
8643715|NCT04332614|21334919|P1|STARTED|~1 Week After Study Launch||2350
8643716|NCT04287036|21334969|P2|NOT COMPLETED|Period 2||0
8643717|NCT04287036|21334970|P1|NOT COMPLETED|Period 2||0
8643718|NCT04287036|21334969|P2|COMPLETED|Period 2||12
8643719|NCT04287036|21334970|P1|COMPLETED|Period 2||13
8643720|NCT04287036|21334969|P2|STARTED|Period 2||12
8643721|NCT04287036|21334970|P1|STARTED|Period 2||13
8643722|NCT04287036|21334969|P2|NOT COMPLETED|Period 1||0
8643723|NCT04287036|21334970|P1|NOT COMPLETED|Period 1||0
8643724|NCT04287036|21334969|P2|COMPLETED|Period 1||12
8643725|NCT04287036|21334970|P1|COMPLETED|Period 1||13
8643726|NCT04287036|21334969|P2|STARTED|Period 1||12
8643727|NCT04287036|21334970|P1|STARTED|Period 1||13
8643728|NCT04081610|21334984|P2|NOT COMPLETED|Overall Study||0
8643729|NCT04081610|21334985|P1|NOT COMPLETED|Overall Study||0
8643730|NCT04081610|21334984|P2|COMPLETED|Overall Study||18
8643731|NCT04081610|21334985|P1|COMPLETED|Overall Study||16
8643732|NCT04081610|21334984|P2|STARTED|Overall Study||18
8643733|NCT04081610|21334985|P1|STARTED|Overall Study||16
8643734|NCT04075279|21335003|P1|NOT COMPLETED|Overall Study||0
8643735|NCT04075279|21335003|P1|COMPLETED|Overall Study||19
8643736|NCT04075279|21335003|P1|STARTED|Overall Study||19
8643737|NCT03682705|21335024|P6|NOT COMPLETED|Overall Study||2
8643738|NCT03682705|21335025|P5|NOT COMPLETED|Overall Study||6
8643739|NCT03682705|21335026|P4|NOT COMPLETED|Overall Study||5
8643740|NCT03682705|21335027|P3|NOT COMPLETED|Overall Study||3
8643741|NCT03682705|21335028|P2|NOT COMPLETED|Overall Study||4
8643742|NCT03682705|21335029|P1|NOT COMPLETED|Overall Study||2
8643743|NCT03682705|21335024|P6|COMPLETED|Overall Study||38
8643744|NCT03682705|21335025|P5|COMPLETED|Overall Study||35
8643745|NCT03682705|21335026|P4|COMPLETED|Overall Study||34
8643746|NCT03682705|21335027|P3|COMPLETED|Overall Study||38
8643747|NCT03682705|21335028|P2|COMPLETED|Overall Study||58
8643748|NCT03682705|21335029|P1|COMPLETED|Overall Study||17
8643749|NCT03682705|21335024|P6|STARTED|Overall Study||40
8643750|NCT03682705|21335025|P5|STARTED|Overall Study||41
8643751|NCT03682705|21335026|P4|STARTED|Overall Study||39
8643752|NCT03682705|21335027|P3|STARTED|Overall Study||41
8643753|NCT03682705|21335028|P2|STARTED|Overall Study||62
8643754|NCT03682705|21335029|P1|STARTED|Overall Study||19
8643755|NCT03663816|21335169|P1|NOT COMPLETED|Overall Study||0
8643756|NCT03663816|21335169|P1|COMPLETED|Overall Study||15
8643757|NCT03663816|21335169|P1|STARTED|Overall Study||15
8643758|NCT03635424|21335175|P1|NOT COMPLETED|Overall Study||3
8643759|NCT03635424|21335175|P1|COMPLETED|Overall Study||147
8643760|NCT03635424|21335175|P1|STARTED|Overall Study||150
8643881|NCT03371732|21335571|P2|NOT COMPLETED|Overall Study||7
8643882|NCT03371732|21335572|P1|NOT COMPLETED|Overall Study||12
8643883|NCT03371732|21335571|P2|COMPLETED|Overall Study||46
8643884|NCT03371732|21335572|P1|COMPLETED|Overall Study||39
8643885|NCT03371732|21335571|P2|STARTED|Overall Study||53
8643886|NCT03371732|21335572|P1|STARTED|Overall Study||51
8643887|NCT03342963|21335630|P4|NOT COMPLETED|Overall Study||0
8643888|NCT03342963|21335631|P3|NOT COMPLETED|Overall Study||0
8643889|NCT03342963|21335632|P2|NOT COMPLETED|Overall Study||2
8643890|NCT03342963|21335633|P1|NOT COMPLETED|Overall Study||2
8643891|NCT03342963|21335630|P4|COMPLETED|Overall Study||10
8643892|NCT03342963|21335631|P3|COMPLETED|Overall Study||10
8643893|NCT03342963|21335632|P2|COMPLETED|Overall Study||25
8643894|NCT03342963|21335633|P1|COMPLETED|Overall Study||25
8643895|NCT03342963|21335630|P4|STARTED|Overall Study||10
8643896|NCT03342963|21335631|P3|STARTED|Overall Study||10
8643897|NCT03342963|21335632|P2|STARTED|Overall Study||27
8643898|NCT03342963|21335633|P1|STARTED|Overall Study||27
8643902|NCT03078075|21335656|P5|NOT COMPLETED|Overall Study||31
8643903|NCT03078075|21335657|P4|NOT COMPLETED|Overall Study||1
8643904|NCT03078075|21335658|P3|NOT COMPLETED|Overall Study||40
8643905|NCT03078075|21335659|P2|NOT COMPLETED|Overall Study||11
8643906|NCT03078075|21335660|P1|NOT COMPLETED|Overall Study||5
8643907|NCT03078075|21335656|P5|COMPLETED|Overall Study||78
8643908|NCT03078075|21335657|P4|COMPLETED|Overall Study||9
8643909|NCT03078075|21335658|P3|COMPLETED|Overall Study||19
8643910|NCT03078075|21335659|P2|COMPLETED|Overall Study||103
8643911|NCT03078075|21335660|P1|COMPLETED|Overall Study||106
8643912|NCT03078075|21335656|P5|STARTED|Overall Study||109
8643913|NCT03078075|21335657|P4|STARTED|Overall Study||10
8643914|NCT03078075|21335658|P3|STARTED|Overall Study||59
8643915|NCT03078075|21335659|P2|STARTED|Overall Study||114
8643916|NCT03078075|21335660|P1|STARTED|Overall Study||111
8643917|NCT02986074|21335742|P4|NOT COMPLETED|Follow up Period||3
8643918|NCT02986074|21335743|P3|NOT COMPLETED|Follow up Period||1
8643919|NCT02986074|21335744|P2|NOT COMPLETED|Follow up Period||0
8643920|NCT02986074|21335745|P1|NOT COMPLETED|Follow up Period||0
8643921|NCT02986074|21335742|P4|COMPLETED|Follow up Period||19
8643922|NCT02986074|21335743|P3|COMPLETED|Follow up Period||20
8643923|NCT02986074|21335744|P2|COMPLETED|Follow up Period||0
8643924|NCT02986074|21335745|P1|COMPLETED|Follow up Period||0
8643925|NCT02986074|21335742|P4|6 Month Follow up|Follow up Period||20
8643926|NCT02986074|21335743|P3|6 Month Follow up|Follow up Period||21
8643927|NCT02986074|21335744|P2|6 Month Follow up|Follow up Period||0
8643928|NCT02986074|21335745|P1|6 Month Follow up|Follow up Period||0
8643929|NCT02986074|21335742|P4|3 Month Follow up|Follow up Period||21
8643930|NCT02986074|21335743|P3|3 Month Follow up|Follow up Period||21
8643931|NCT02986074|21335744|P2|3 Month Follow up|Follow up Period||0
8643932|NCT02986074|21335745|P1|3 Month Follow up|Follow up Period||0
8643933|NCT02986074|21335742|P4|STARTED|Follow up Period||22
8643934|NCT02986074|21335743|P3|STARTED|Follow up Period||21
8643935|NCT02986074|21335744|P2|STARTED|Follow up Period||0
8643936|NCT02986074|21335745|P1|STARTED|Follow up Period||0
8643937|NCT02986074|21335742|P4|NOT COMPLETED|Second Trial Period||0
8643938|NCT02986074|21335743|P3|NOT COMPLETED|Second Trial Period||0
8643939|NCT02986074|21335744|P2|NOT COMPLETED|Second Trial Period||0
8643940|NCT02986074|21335745|P1|NOT COMPLETED|Second Trial Period||0
8643941|NCT02986074|21335742|P4|COMPLETED|Second Trial Period||0
8643942|NCT02986074|21335743|P3|COMPLETED|Second Trial Period||0
8643943|NCT02986074|21335744|P2|COMPLETED|Second Trial Period||29
8643944|NCT02986074|21335745|P1|COMPLETED|Second Trial Period||25
8643945|NCT02986074|21335742|P4|STARTED|Second Trial Period||0
8643946|NCT02986074|21335743|P3|STARTED|Second Trial Period||0
8643947|NCT02986074|21335744|P2|STARTED|Second Trial Period||29
8643948|NCT02986074|21335745|P1|STARTED|Second Trial Period||25
8643949|NCT02986074|21335742|P4|NOT COMPLETED|First Trial Period||0
8643950|NCT02986074|21335743|P3|NOT COMPLETED|First Trial Period||0
8643951|NCT02986074|21335744|P2|NOT COMPLETED|First Trial Period||0
8643952|NCT02986074|21335745|P1|NOT COMPLETED|First Trial Period||1
8643953|NCT02986074|21335742|P4|COMPLETED|First Trial Period||0
8643954|NCT02986074|21335743|P3|COMPLETED|First Trial Period||0
8643955|NCT02986074|21335744|P2|COMPLETED|First Trial Period||29
8643956|NCT02986074|21335745|P1|COMPLETED|First Trial Period||25
8643957|NCT02986074|21335742|P4|STARTED|First Trial Period||0
8643958|NCT02986074|21335743|P3|STARTED|First Trial Period||0
8643959|NCT02986074|21335744|P2|STARTED|First Trial Period||29
8643960|NCT02986074|21335745|P1|STARTED|First Trial Period||26
8643961|NCT02968758|21335780|P2|NOT COMPLETED|Overall Study||0
8643962|NCT02968758|21335781|P1|NOT COMPLETED|Overall Study||0
8643963|NCT02968758|21335780|P2|COMPLETED|Overall Study||1664
8643964|NCT02968758|21335781|P1|COMPLETED|Overall Study||797
8643965|NCT02968758|21335780|P2|STARTED|Overall Study||1664
8643966|NCT02968758|21335781|P1|STARTED|Overall Study||797
8643975|NCT02849626|21335813|P2|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||3
8643976|NCT02849626|21335814|P1|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||11
8643977|NCT02849626|21335813|P2|COMPLETED|Extension Phase A (up to 29 Weeks)||17
8643978|NCT02849626|21335814|P1|COMPLETED|Extension Phase A (up to 29 Weeks)||105
8643979|NCT02849626|21335813|P2|STARTED|Extension Phase A (up to 29 Weeks)||20
8643980|NCT02849626|21335814|P1|STARTED|Extension Phase A (up to 29 Weeks)||116
8643981|NCT02849626|21335813|P2|NOT COMPLETED|Core Phase (up to 23 Weeks)||7
8643982|NCT02849626|21335814|P1|NOT COMPLETED|Core Phase (up to 23 Weeks)||27
8643983|NCT02849626|21335813|P2|COMPLETED|Core Phase (up to 23 Weeks)||24
8643984|NCT02849626|21335814|P1|COMPLETED|Core Phase (up to 23 Weeks)||122
8643985|NCT02849626|21335813|P2|STARTED|Core Phase (up to 23 Weeks)||31
8643986|NCT02849626|21335814|P1|STARTED|Core Phase (up to 23 Weeks)||149
8643987|NCT02819323|21335877|P3|NOT COMPLETED|Overall Study||1
8643988|NCT02819323|21335878|P2|NOT COMPLETED|Overall Study||2
8643989|NCT02819323|21335879|P1|NOT COMPLETED|Overall Study||5
8643990|NCT02819323|21335877|P3|COMPLETED|Overall Study||31
8643991|NCT02819323|21335878|P2|COMPLETED|Overall Study||26
8643992|NCT02819323|21335879|P1|COMPLETED|Overall Study||26
8643993|NCT02819323|21335877|P3|STARTED|Overall Study||32
8643994|NCT02819323|21335878|P2|STARTED|Overall Study||28
8643995|NCT02819323|21335879|P1|STARTED|Overall Study||31
8643996|NCT02791893|21335889|P2|NOT COMPLETED|Open Label Phase||2
8643997|NCT02791893|21335890|P1|NOT COMPLETED|Open Label Phase||3
8643998|NCT02791893|21335889|P2|COMPLETED|Open Label Phase||8
8643999|NCT02791893|21335890|P1|COMPLETED|Open Label Phase||7
8644000|NCT02791893|21335889|P2|STARTED|Open Label Phase||10
8644001|NCT02791893|21335890|P1|STARTED|Open Label Phase||10
8644002|NCT02791893|21335889|P2|NOT COMPLETED|Blinded Phase||4
8644003|NCT02791893|21335890|P1|NOT COMPLETED|Blinded Phase||3
8644004|NCT02791893|21335889|P2|COMPLETED|Blinded Phase||10
8644005|NCT02791893|21335890|P1|COMPLETED|Blinded Phase||10
8644006|NCT02791893|21335889|P2|STARTED|Blinded Phase||14
8644007|NCT02791893|21335890|P1|STARTED|Blinded Phase||13
8644008|NCT02771210|21335907|P2|NOT COMPLETED|Period 2||3
8644009|NCT02771210|21335908|P1|NOT COMPLETED|Period 2||2
8644010|NCT02771210|21335907|P2|COMPLETED|Period 2||81
8644011|NCT02771210|21335908|P1|COMPLETED|Period 2||89
8644012|NCT02771210|21335907|P2|STARTED|Period 2||84
8644013|NCT02771210|21335908|P1|STARTED|Period 2||91
8644014|NCT02771210|21335907|P2|NOT COMPLETED|Period 1||18
8644015|NCT02771210|21335908|P1|NOT COMPLETED|Period 1||11
8644016|NCT02771210|21335907|P2|COMPLETED|Period 1||84
8644017|NCT02771210|21335908|P1|COMPLETED|Period 1||91
8644018|NCT02771210|21335907|P2|STARTED|Period 1||102
8644019|NCT02771210|21335908|P1|STARTED|Period 1||102
8644020|NCT02718157|21335934|P1|NOT COMPLETED|Overall Study||162
8644021|NCT02718157|21335934|P1|COMPLETED|Overall Study||609
8644022|NCT02718157|21335934|P1|STARTED|Overall Study||771
8644023|NCT02697773|21335944|P3|NOT COMPLETED|Overall Study||40
8644024|NCT02697773|21335945|P2|NOT COMPLETED|Overall Study||38
8644025|NCT02697773|21335946|P1|NOT COMPLETED|Overall Study||38
8644026|NCT02697773|21335944|P3|COMPLETED|Overall Study||193
8644027|NCT02697773|21335945|P2|COMPLETED|Overall Study||194
8644028|NCT02697773|21335946|P1|COMPLETED|Overall Study||195
8644029|NCT02697773|21335944|P3|Treated|Overall Study||233
8644030|NCT02697773|21335945|P2|Treated|Overall Study||231
8644031|NCT02697773|21335946|P1|Treated|Overall Study||232
8644032|NCT02697773|21335944|P3|STARTED|Overall Study||233
8644033|NCT02697773|21335945|P2|STARTED|Overall Study||232
8644034|NCT02697773|21335946|P1|STARTED|Overall Study||233
8644035|NCT02683187|21336125|P1|NOT COMPLETED|Overall Study||8
8644036|NCT02683187|21336125|P1|COMPLETED|Overall Study||32
8644037|NCT02683187|21336125|P1|STARTED|Overall Study||40
8644038|NCT02668185|21336133|P2|NOT COMPLETED|Moitoring Period (2 Weeks)||0
8644039|NCT02668185|21336134|P1|NOT COMPLETED|Moitoring Period (2 Weeks)||0
8644040|NCT02668185|21336133|P2|COMPLETED|Moitoring Period (2 Weeks)||12
8644041|NCT02668185|21336134|P1|COMPLETED|Moitoring Period (2 Weeks)||16
8644042|NCT02668185|21336133|P2|STARTED|Moitoring Period (2 Weeks)||12
8644043|NCT02668185|21336134|P1|STARTED|Moitoring Period (2 Weeks)||16
8644044|NCT02668185|21336133|P2|NOT COMPLETED|Second Intervention (4 Weeks)||3
8644045|NCT02668185|21336134|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
8644046|NCT02668185|21336133|P2|COMPLETED|Second Intervention (4 Weeks)||12
8644047|NCT02668185|21336134|P1|COMPLETED|Second Intervention (4 Weeks)||16
8644048|NCT02668185|21336133|P2|STARTED|Second Intervention (4 Weeks)||15
8644049|NCT02668185|21336134|P1|STARTED|Second Intervention (4 Weeks)||17
8644050|NCT02668185|21336133|P2|NOT COMPLETED|Washout Period (2 Weeks)||2
8644051|NCT02668185|21336134|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
8644052|NCT02668185|21336133|P2|COMPLETED|Washout Period (2 Weeks)||15
8644053|NCT02668185|21336134|P1|COMPLETED|Washout Period (2 Weeks)||17
8644054|NCT02668185|21336133|P2|STARTED|Washout Period (2 Weeks)||17
8644055|NCT02668185|21336134|P1|STARTED|Washout Period (2 Weeks)||18
8644056|NCT02668185|21336133|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
8644057|NCT02668185|21336134|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
8644058|NCT02668185|21336133|P2|COMPLETED|First Intervention (4 Weeks)||17
8644059|NCT02668185|21336134|P1|COMPLETED|First Intervention (4 Weeks)||18
8644060|NCT02668185|21336133|P2|STARTED|First Intervention (4 Weeks)||17
8644061|NCT02668185|21336134|P1|STARTED|First Intervention (4 Weeks)||20
8644062|NCT02668185|21336133|P2|NOT COMPLETED|Baseline Period (2 Weeks)||0
8644063|NCT02668185|21336134|P1|NOT COMPLETED|Baseline Period (2 Weeks)||0
8644064|NCT02668185|21336133|P2|COMPLETED|Baseline Period (2 Weeks)||17
8644065|NCT02668185|21336134|P1|COMPLETED|Baseline Period (2 Weeks)||20
8644066|NCT02668185|21336133|P2|STARTED|Baseline Period (2 Weeks)||17
8644067|NCT02668185|21336134|P1|STARTED|Baseline Period (2 Weeks)||20
8644125|NCT02563067|21336205|P3|NOT COMPLETED|Overall Study||20
8644126|NCT02563067|21336206|P2|NOT COMPLETED|Overall Study||26
8644127|NCT02563067|21336207|P1|NOT COMPLETED|Overall Study||19
8644128|NCT02563067|21336205|P3|COMPLETED|Overall Study||267
8644129|NCT02563067|21336206|P2|COMPLETED|Overall Study||268
8644130|NCT02563067|21336207|P1|COMPLETED|Overall Study||277
8644131|NCT02563067|21336205|P3|FAS/SAF: Overall Population|Overall Study||287
8644132|NCT02563067|21336206|P2|FAS/SAF: Overall Population|Overall Study||293
8644133|NCT02563067|21336207|P1|FAS/SAF: Overall Population|Overall Study||296
8644134|NCT02563067|21336205|P3|FAS/SAF: High Eosinophils Subpopulation|Overall Study||193
8644135|NCT02563067|21336206|P2|FAS/SAF: High Eosinophils Subpopulation|Overall Study||196
8644136|NCT02563067|21336207|P1|FAS/SAF: High Eosinophils Subpopulation|Overall Study||198
8644137|NCT02563067|21336205|P3|STARTED|Overall Study||287
8644138|NCT02563067|21336206|P2|STARTED|Overall Study||294
8644139|NCT02563067|21336207|P1|STARTED|Overall Study||296
8644161|NCT02453191|21336313|P1|NOT COMPLETED|Overall Study||1
8644162|NCT02453191|21336313|P1|COMPLETED|Overall Study||29
8644163|NCT02453191|21336313|P1|STARTED|Overall Study||30
8644164|NCT02357836|21336321|P1|NOT COMPLETED|Overall Study||0
8644165|NCT02357836|21336321|P1|COMPLETED|Overall Study||13
8644166|NCT02357836|21336321|P1|STARTED|Overall Study||13
8644167|NCT02340949|21336342|P2|NOT COMPLETED|Overall Study||4
8644168|NCT02340949|21336343|P1|NOT COMPLETED|Overall Study||16
8644169|NCT02340949|21336342|P2|COMPLETED|Overall Study||61
8644170|NCT02340949|21336343|P1|COMPLETED|Overall Study||99
8644171|NCT02340949|21336342|P2|STARTED|Overall Study||65
8644172|NCT02340949|21336343|P1|STARTED|Overall Study||115
8644173|NCT02318329|21336369|P10|NOT COMPLETED|Overall Study||52
8644174|NCT02318329|21336370|P9|NOT COMPLETED|Overall Study||6
8644175|NCT02318329|21336371|P8|NOT COMPLETED|Overall Study||1
8644176|NCT02318329|21336372|P7|NOT COMPLETED|Overall Study||1
8644177|NCT02318329|21336373|P6|NOT COMPLETED|Overall Study||3
8644178|NCT02318329|21336374|P5|NOT COMPLETED|Overall Study||3
8644179|NCT02318329|21336375|P4|NOT COMPLETED|Overall Study||3
8644180|NCT02318329|21336376|P3|NOT COMPLETED|Overall Study||3
8644181|NCT02318329|21336377|P2|NOT COMPLETED|Overall Study||4
8644182|NCT02318329|21336378|P1|NOT COMPLETED|Overall Study||3
8644183|NCT02318329|21336369|P10|COMPLETED|Overall Study||0
8644184|NCT02318329|21336370|P9|COMPLETED|Overall Study||0
8644185|NCT02318329|21336371|P8|COMPLETED|Overall Study||0
8644186|NCT02318329|21336372|P7|COMPLETED|Overall Study||0
8644187|NCT02318329|21336373|P6|COMPLETED|Overall Study||0
8644188|NCT02318329|21336374|P5|COMPLETED|Overall Study||0
8644189|NCT02318329|21336375|P4|COMPLETED|Overall Study||0
8644190|NCT02318329|21336376|P3|COMPLETED|Overall Study||0
8644191|NCT02318329|21336377|P2|COMPLETED|Overall Study||0
8644192|NCT02318329|21336378|P1|COMPLETED|Overall Study||0
8644193|NCT02318329|21336369|P10|STARTED|Overall Study||52
8644194|NCT02318329|21336370|P9|STARTED|Overall Study||6
8644195|NCT02318329|21336371|P8|STARTED|Overall Study||1
8644196|NCT02318329|21336372|P7|STARTED|Overall Study||1
8644197|NCT02318329|21336373|P6|STARTED|Overall Study||3
8644198|NCT02318329|21336374|P5|STARTED|Overall Study||3
8644199|NCT02318329|21336375|P4|STARTED|Overall Study||3
8644200|NCT02318329|21336376|P3|STARTED|Overall Study||3
8644201|NCT02318329|21336377|P2|STARTED|Overall Study||4
8644202|NCT02318329|21336378|P1|STARTED|Overall Study||3
8644227|NCT02101788|21336502|P2|NOT COMPLETED|Overall Study||14
8644228|NCT02101788|21336503|P1|NOT COMPLETED|Overall Study||10
8644229|NCT02101788|21336502|P2|COMPLETED|Overall Study||116
8644230|NCT02101788|21336503|P1|COMPLETED|Overall Study||120
8644231|NCT02101788|21336502|P2|Crossover From Arm A to Arm B|Overall Study||0
8644232|NCT02101788|21336503|P1|Crossover From Arm A to Arm B|Overall Study||88
8644233|NCT02101788|21336502|P2|STARTED|Overall Study||130
8644234|NCT02101788|21336503|P1|STARTED|Overall Study||130
8644238|NCT02022111|21336529|P2|NOT COMPLETED|Overall Study||15
8644239|NCT02022111|21336530|P1|NOT COMPLETED|Overall Study||10
8644240|NCT02022111|21336529|P2|COMPLETED|Overall Study||193
8644241|NCT02022111|21336530|P1|COMPLETED|Overall Study||186
8644242|NCT02022111|21336529|P2|STARTED|Overall Study||208
8644243|NCT02022111|21336530|P1|STARTED|Overall Study||196
8644244|NCT02013037|21336560|P1|NOT COMPLETED|Overall Study||16
8644245|NCT02013037|21336560|P1|COMPLETED|Overall Study||20
8644246|NCT02013037|21336560|P1|STARTED|Overall Study||36
8644273|NCT01835626|21336623|P1|NOT COMPLETED|Overall Study||7
8644274|NCT01835626|21336623|P1|COMPLETED|Overall Study||17
8644275|NCT01835626|21336623|P1|STARTED|Overall Study||24
8644276|NCT01835145|21336636|P2|NOT COMPLETED|Overall Study||0
8644277|NCT01835145|21336637|P1|NOT COMPLETED|Overall Study||1
8644278|NCT01835145|21336636|P2|COMPLETED|Overall Study||15
8644279|NCT01835145|21336637|P1|COMPLETED|Overall Study||31
8644280|NCT01835145|21336636|P2|STARTED|Overall Study||15
8644281|NCT01835145|21336637|P1|STARTED|Overall Study||32
8644343|NCT01363128|21336727|P1|NOT COMPLETED|Overall Study||0
8644344|NCT01363128|21336727|P1|COMPLETED|Overall Study||69
8644345|NCT01363128|21336727|P1|STARTED|Overall Study||69
8644346|NCT01292252|21336735|P2|NOT COMPLETED|Overall Study||1
8644347|NCT01292252|21336736|P1|NOT COMPLETED|Overall Study||0
8644348|NCT01292252|21336735|P2|COMPLETED|Overall Study||14
8644349|NCT01292252|21336736|P1|COMPLETED|Overall Study||21
8644350|NCT01292252|21336735|P2|STARTED|Overall Study||15
8644351|NCT01292252|21336736|P1|STARTED|Overall Study||21
8644364|NCT01098240|21336782|P3|NOT COMPLETED|Double-Blind Phase||22
8644365|NCT01098240|21336783|P2|NOT COMPLETED|Double-Blind Phase||17
8644366|NCT01098240|21336784|P1|NOT COMPLETED|Double-Blind Phase||0
8644367|NCT01098240|21336782|P3|COMPLETED|Double-Blind Phase||63
8644368|NCT01098240|21336783|P2|COMPLETED|Double-Blind Phase||60
8644369|NCT01098240|21336784|P1|COMPLETED|Double-Blind Phase||0
8644370|NCT01098240|21336782|P3|STARTED|Double-Blind Phase||85
8644371|NCT01098240|21336783|P2|STARTED|Double-Blind Phase||77
8644372|NCT01098240|21336784|P1|STARTED|Double-Blind Phase||0
8644373|NCT01098240|21336782|P3|NOT COMPLETED|Open-Label Phase||0
8644374|NCT01098240|21336783|P2|NOT COMPLETED|Open-Label Phase||0
8644375|NCT01098240|21336784|P1|NOT COMPLETED|Open-Label Phase||135
8644376|NCT01098240|21336782|P3|COMPLETED|Open-Label Phase||0
8644377|NCT01098240|21336783|P2|COMPLETED|Open-Label Phase||0
8644378|NCT01098240|21336784|P1|COMPLETED|Open-Label Phase||162
8644379|NCT01098240|21336782|P3|STARTED|Open-Label Phase||0
8644380|NCT01098240|21336783|P2|STARTED|Open-Label Phase||0
8644381|NCT01098240|21336784|P1|STARTED|Open-Label Phase||297
8644418|NCT01033643|21336848|P6|NOT COMPLETED|Overall Study||1
8644419|NCT01033643|21336849|P5|NOT COMPLETED|Overall Study||0
8644420|NCT01033643|21336850|P4|NOT COMPLETED|Overall Study||0
8644421|NCT01033643|21336851|P3|NOT COMPLETED|Overall Study||0
8644422|NCT01033643|21336852|P2|NOT COMPLETED|Overall Study||3
8644423|NCT01033643|21336853|P1|NOT COMPLETED|Overall Study||0
8644424|NCT01033643|21336848|P6|COMPLETED|Overall Study||7
8644425|NCT01033643|21336849|P5|COMPLETED|Overall Study||0
8644426|NCT01033643|21336850|P4|COMPLETED|Overall Study||4
8644427|NCT01033643|21336851|P3|COMPLETED|Overall Study||6
8644428|NCT01033643|21336852|P2|COMPLETED|Overall Study||3
8644429|NCT01033643|21336853|P1|COMPLETED|Overall Study||6
8644430|NCT01033643|21336848|P6|STARTED|Overall Study||8
8644431|NCT01033643|21336849|P5|STARTED|Overall Study||0
8644432|NCT01033643|21336850|P4|STARTED|Overall Study||4
8644433|NCT01033643|21336851|P3|STARTED|Overall Study||6
8644434|NCT01033643|21336852|P2|STARTED|Overall Study||6
8644435|NCT01033643|21336853|P1|STARTED|Overall Study||6
8644436|NCT00934089|21336987|P2|NOT COMPLETED|Second Intervention Period (14 Days)||0
8644437|NCT00934089|21336988|P1|NOT COMPLETED|Second Intervention Period (14 Days)||0
8644438|NCT00934089|21336987|P2|COMPLETED|Second Intervention Period (14 Days)||16
8644439|NCT00934089|21336988|P1|COMPLETED|Second Intervention Period (14 Days)||13
8644440|NCT00934089|21336987|P2|STARTED|Second Intervention Period (14 Days)||16
8644441|NCT00934089|21336988|P1|STARTED|Second Intervention Period (14 Days)||13
8644442|NCT00934089|21336987|P2|NOT COMPLETED|Washout Period (28 Days)||0
8644443|NCT00934089|21336988|P1|NOT COMPLETED|Washout Period (28 Days)||0
8644444|NCT00934089|21336987|P2|COMPLETED|Washout Period (28 Days)||16
8644445|NCT00934089|21336988|P1|COMPLETED|Washout Period (28 Days)||13
8644446|NCT00934089|21336987|P2|STARTED|Washout Period (28 Days)||16
8644447|NCT00934089|21336988|P1|STARTED|Washout Period (28 Days)||13
8644448|NCT00934089|21336987|P2|NOT COMPLETED|First Intervention Period (14 Days)||0
8644449|NCT00934089|21336988|P1|NOT COMPLETED|First Intervention Period (14 Days)||2
8644450|NCT00934089|21336987|P2|COMPLETED|First Intervention Period (14 Days)||16
8644451|NCT00934089|21336988|P1|COMPLETED|First Intervention Period (14 Days)||13
8644452|NCT00934089|21336987|P2|Treated|First Intervention Period (14 Days)||16
8644453|NCT00934089|21336988|P1|Treated|First Intervention Period (14 Days)||14
8644454|NCT00934089|21336987|P2|STARTED|First Intervention Period (14 Days)||16
8644455|NCT00934089|21336988|P1|STARTED|First Intervention Period (14 Days)||15
8644456|NCT00411684|21337052|P1|NOT COMPLETED|Overall Study||292
8644457|NCT00411684|21337052|P1|COMPLETED|Overall Study||1241
8644458|NCT00411684|21337052|P1|STARTED|Overall Study||1533
8644489|NCT00059202|21337121|P2|NOT COMPLETED|Overall Study||15
8644490|NCT00059202|21337122|P1|NOT COMPLETED|Overall Study||6
8644491|NCT00059202|21337121|P2|COMPLETED|Overall Study||59
8644492|NCT00059202|21337122|P1|COMPLETED|Overall Study||70
8644493|NCT00059202|21337121|P2|STARTED|Overall Study||74
8644494|NCT00059202|21337122|P1|STARTED|Overall Study||76
8644495|NCT04195594|21337158|P1|NOT COMPLETED|Overall Study||3
8644496|NCT04195594|21337158|P1|COMPLETED|Overall Study||11
8644497|NCT04195594|21337158|P1|STARTED|Overall Study||14
8644501|NCT03798366|21337251|P2|NOT COMPLETED|Overall Study||1
8644502|NCT03798366|21337252|P1|NOT COMPLETED|Overall Study||0
8644503|NCT03798366|21337251|P2|COMPLETED|Overall Study||11
8644504|NCT03798366|21337252|P1|COMPLETED|Overall Study||21
8644505|NCT03798366|21337251|P2|STARTED|Overall Study||12
8644506|NCT03798366|21337252|P1|STARTED|Overall Study||21
8644507|NCT03717506|21337269|P3|NOT COMPLETED|Overall Study||27
8644508|NCT03717506|21337270|P2|NOT COMPLETED|Overall Study||50
8644509|NCT03717506|21337271|P1|NOT COMPLETED|Overall Study||49
8644510|NCT03717506|21337269|P3|COMPLETED|Overall Study||222
8644511|NCT03717506|21337270|P2|COMPLETED|Overall Study||441
8644512|NCT03717506|21337271|P1|COMPLETED|Overall Study||447
8644513|NCT03717506|21337269|P3|STARTED|Overall Study||249
8644514|NCT03717506|21337270|P2|STARTED|Overall Study||491
8644515|NCT03717506|21337271|P1|STARTED|Overall Study||496
8644516|NCT03631433|21337290|P2|NOT COMPLETED|Overall Study||0
8644517|NCT03631433|21337291|P1|NOT COMPLETED|Overall Study||0
8644518|NCT03631433|21337290|P2|COMPLETED|Overall Study||53
8644519|NCT03631433|21337291|P1|COMPLETED|Overall Study||49
8644520|NCT03631433|21337290|P2|STARTED|Overall Study||53
8644521|NCT03631433|21337291|P1|STARTED|Overall Study||49
8644522|NCT03623334|21337302|P3|NOT COMPLETED|Overall Study||0
8644523|NCT03623334|21337303|P2|NOT COMPLETED|Overall Study||0
8644524|NCT03623334|21337304|P1|NOT COMPLETED|Overall Study||0
8644525|NCT03623334|21337302|P3|COMPLETED|Overall Study||19
8644526|NCT03623334|21337303|P2|COMPLETED|Overall Study||21
8644527|NCT03623334|21337304|P1|COMPLETED|Overall Study||15
8644528|NCT03623334|21337302|P3|STARTED|Overall Study||19
8644529|NCT03623334|21337303|P2|STARTED|Overall Study||21
8644530|NCT03623334|21337304|P1|STARTED|Overall Study||15
8644531|NCT03443024|21337337|P4|NOT COMPLETED|Overall Study||32
8644532|NCT03443024|21337338|P3|NOT COMPLETED|Overall Study||19
8644533|NCT03443024|21337339|P2|NOT COMPLETED|Overall Study||31
8644534|NCT03443024|21337340|P1|NOT COMPLETED|Overall Study||21
8644535|NCT03443024|21337337|P4|COMPLETED|Overall Study||20
8644536|NCT03443024|21337338|P3|COMPLETED|Overall Study||56
8644537|NCT03443024|21337339|P2|COMPLETED|Overall Study||49
8644538|NCT03443024|21337340|P1|COMPLETED|Overall Study||52
8644539|NCT03443024|21337337|P4|Received at Least One Dose of Study Drug|Overall Study||52
8644540|NCT03443024|21337338|P3|Received at Least One Dose of Study Drug|Overall Study||75
8644541|NCT03443024|21337339|P2|Received at Least One Dose of Study Drug|Overall Study||80
8644542|NCT03443024|21337340|P1|Received at Least One Dose of Study Drug|Overall Study||73
8644543|NCT03443024|21337337|P4|STARTED|Overall Study||52
8644544|NCT03443024|21337338|P3|STARTED|Overall Study||75
8644545|NCT03443024|21337339|P2|STARTED|Overall Study||80
8644546|NCT03443024|21337340|P1|STARTED|Overall Study||73
8644547|NCT03338686|21337397|P3|NOT COMPLETED|Overall Study||0
8644548|NCT03338686|21337398|P2|NOT COMPLETED|Overall Study||0
8644549|NCT03338686|21337399|P1|NOT COMPLETED|Overall Study||0
8644550|NCT03338686|21337397|P3|COMPLETED|Overall Study||7
8644551|NCT03338686|21337398|P2|COMPLETED|Overall Study||5
8644552|NCT03338686|21337399|P1|COMPLETED|Overall Study||2
8644553|NCT03338686|21337397|P3|STARTED|Overall Study|12 FGG implant sites and 7 CTG implant sites for this Arm/Group|7
8644554|NCT03338686|21337398|P2|STARTED|Overall Study||5
8644555|NCT03338686|21337399|P1|STARTED|Overall Study||2
8644556|NCT03302767|21337410|P1|NOT COMPLETED|Overall Study||0
8644557|NCT03302767|21337410|P1|COMPLETED|Overall Study||29
8644558|NCT03302767|21337410|P1|STARTED|Overall Study||29
8644559|NCT03216226|21337420|P2|NOT COMPLETED|Overall Study||5
8644560|NCT03216226|21337421|P1|NOT COMPLETED|Overall Study||5
8644561|NCT03216226|21337420|P2|COMPLETED|Overall Study||50
8644562|NCT03216226|21337421|P1|COMPLETED|Overall Study||52
8644563|NCT03216226|21337420|P2|Randomized and Treated|Overall Study||54
8644564|NCT03216226|21337421|P1|Randomized and Treated|Overall Study||57
8644565|NCT03216226|21337420|P2|STARTED|Overall Study||55
8644566|NCT03216226|21337421|P1|STARTED|Overall Study||57
8644567|NCT03182829|21337461|P2|NOT COMPLETED|Overall Study||15
8644568|NCT03182829|21337462|P1|NOT COMPLETED|Overall Study||16
8644569|NCT03182829|21337461|P2|COMPLETED|Overall Study||429
8644570|NCT03182829|21337462|P1|COMPLETED|Overall Study||451
8644571|NCT03182829|21337461|P2|STARTED|Overall Study||444
8644572|NCT03182829|21337462|P1|STARTED|Overall Study||467
8644582|NCT02994654|21337485|P1|NOT COMPLETED|Overall Study||1
8644583|NCT02994654|21337485|P1|COMPLETED|Overall Study||11
8644584|NCT02994654|21337485|P1|STARTED|Overall Study||12
8644585|NCT02966834|21337498|P6|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
8644586|NCT02966834|21337499|P5|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
8644587|NCT02966834|21337500|P4|NOT COMPLETED|Follow-up (Up to 4 Weeks)||5
8644588|NCT02966834|21337501|P3|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
8644589|NCT02966834|21337502|P2|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
8644590|NCT02966834|21337503|P1|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
8644591|NCT02966834|21337498|P6|COMPLETED|Follow-up (Up to 4 Weeks)||21
8644592|NCT02966834|21337499|P5|COMPLETED|Follow-up (Up to 4 Weeks)||22
8644593|NCT02966834|21337500|P4|COMPLETED|Follow-up (Up to 4 Weeks)||22
8644594|NCT02966834|21337501|P3|COMPLETED|Follow-up (Up to 4 Weeks)||22
8644595|NCT02966834|21337502|P2|COMPLETED|Follow-up (Up to 4 Weeks)||16
8644596|NCT02966834|21337503|P1|COMPLETED|Follow-up (Up to 4 Weeks)||35
8644597|NCT02966834|21337498|P6|STARTED|Follow-up (Up to 4 Weeks)|5 participants discontinued study treatment in Main study period and directly entered follow-up|22
8644598|NCT02966834|21337499|P5|STARTED|Follow-up (Up to 4 Weeks)|1 participant who completed main study period directly entered follow-up in this arm|22
8644599|NCT02966834|21337500|P4|STARTED|Follow-up (Up to 4 Weeks)|8 participants discontinued study treatment in Main Study period and directly entered follow-up.|27
8644600|NCT02966834|21337501|P3|STARTED|Follow-up (Up to 4 Weeks)|4 participants discontinued study treatment in Main study period and directly entered follow-up.|23
8644601|NCT02966834|21337502|P2|STARTED|Follow-up (Up to 4 Weeks)||16
8644602|NCT02966834|21337503|P1|STARTED|Follow-up (Up to 4 Weeks)||35
8644603|NCT02966834|21337498|P6|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
8644604|NCT02966834|21337499|P5|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
8644605|NCT02966834|21337500|P4|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
8644606|NCT02966834|21337501|P3|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
8644607|NCT02966834|21337502|P2|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
8644608|NCT02966834|21337503|P1|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
8644609|NCT02966834|21337498|P6|COMPLETED|Final Study Period (Up to 4 Weeks)||17
8644610|NCT02966834|21337499|P5|COMPLETED|Final Study Period (Up to 4 Weeks)||21
8644611|NCT02966834|21337500|P4|COMPLETED|Final Study Period (Up to 4 Weeks)||19
8644612|NCT02966834|21337501|P3|COMPLETED|Final Study Period (Up to 4 Weeks)||19
8644613|NCT02966834|21337502|P2|COMPLETED|Final Study Period (Up to 4 Weeks)||16
8644614|NCT02966834|21337503|P1|COMPLETED|Final Study Period (Up to 4 Weeks)||35
8644615|NCT02966834|21337498|P6|STARTED|Final Study Period (Up to 4 Weeks)||17
8644616|NCT02966834|21337499|P5|STARTED|Final Study Period (Up to 4 Weeks)|One participant did not enter Final Study Period.|21
8644617|NCT02966834|21337500|P4|STARTED|Final Study Period (Up to 4 Weeks)||19
8644618|NCT02966834|21337501|P3|STARTED|Final Study Period (Up to 4 Weeks)||19
8644619|NCT02966834|21337502|P2|STARTED|Final Study Period (Up to 4 Weeks)||16
8644620|NCT02966834|21337503|P1|STARTED|Final Study Period (Up to 4 Weeks)||35
8644621|NCT02966834|21337498|P6|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||5
8644622|NCT02966834|21337499|P5|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
8644623|NCT02966834|21337500|P4|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||8
8644624|NCT02966834|21337501|P3|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||4
8644625|NCT02966834|21337502|P2|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||0
8644626|NCT02966834|21337503|P1|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
8644627|NCT02966834|21337498|P6|COMPLETED|Main Study Period (Up to 12 Weeks)||17
8644628|NCT02966834|21337499|P5|COMPLETED|Main Study Period (Up to 12 Weeks)||22
8644629|NCT02966834|21337500|P4|COMPLETED|Main Study Period (Up to 12 Weeks)||19
8644630|NCT02966834|21337501|P3|COMPLETED|Main Study Period (Up to 12 Weeks)||19
8644631|NCT02966834|21337502|P2|COMPLETED|Main Study Period (Up to 12 Weeks)||16
8644632|NCT02966834|21337503|P1|COMPLETED|Main Study Period (Up to 12 Weeks)||35
8644633|NCT02966834|21337498|P6|STARTED|Main Study Period (Up to 12 Weeks)||22
8644634|NCT02966834|21337499|P5|STARTED|Main Study Period (Up to 12 Weeks)||23
8644635|NCT02966834|21337500|P4|STARTED|Main Study Period (Up to 12 Weeks)||27
8644636|NCT02966834|21337501|P3|STARTED|Main Study Period (Up to 12 Weeks)||23
8644637|NCT02966834|21337502|P2|STARTED|Main Study Period (Up to 12 Weeks)||16
8644638|NCT02966834|21337503|P1|STARTED|Main Study Period (Up to 12 Weeks)||36
8644651|NCT02931565|21337757|P2|NOT COMPLETED|Overall Study||0
8644652|NCT02931565|21337758|P1|NOT COMPLETED|Overall Study||0
8644653|NCT02931565|21337757|P2|COMPLETED|Overall Study||7
8644654|NCT02931565|21337758|P1|COMPLETED|Overall Study||2
8644655|NCT02931565|21337757|P2|STARTED|Overall Study||7
8644656|NCT02931565|21337758|P1|STARTED|Overall Study||2
8644665|NCT02771990|21337798|P2|NOT COMPLETED|Overall Study||0
8644666|NCT02771990|21337799|P1|NOT COMPLETED|Overall Study||0
8644667|NCT02771990|21337798|P2|COMPLETED|Overall Study||10
8644668|NCT02771990|21337799|P1|COMPLETED|Overall Study||11
8644669|NCT02771990|21337798|P2|STARTED|Overall Study||10
8644670|NCT02771990|21337799|P1|STARTED|Overall Study||11
8644671|NCT02763579|21337809|P2|NOT COMPLETED|Overall Study||202
8644672|NCT02763579|21337810|P1|NOT COMPLETED|Overall Study||201
8644673|NCT02763579|21337809|P2|COMPLETED|Overall Study||0
8644674|NCT02763579|21337810|P1|COMPLETED|Overall Study||0
8644675|NCT02763579|21337809|P2|STARTED|Overall Study||202
8644676|NCT02763579|21337810|P1|STARTED|Overall Study||201
8644677|NCT02746809|21337818|P1|NOT COMPLETED|Baseline-6 Months||5
8644678|NCT02746809|21337818|P1|COMPLETED|Baseline-6 Months||54
8644679|NCT02746809|21337818|P1|STARTED|Baseline-6 Months||59
8644680|NCT02746809|21337818|P1|NOT COMPLETED|Baseline- 30 Days||1
8644681|NCT02746809|21337818|P1|COMPLETED|Baseline- 30 Days||59
8644682|NCT02746809|21337818|P1|STARTED|Baseline- 30 Days||60
8644683|NCT02738853|21337836|P1|NOT COMPLETED|30 Days- 6 Months||2
8644684|NCT02738853|21337836|P1|COMPLETED|30 Days- 6 Months||57
8644685|NCT02738853|21337836|P1|STARTED|30 Days- 6 Months||59
8644686|NCT02738853|21337836|P1|NOT COMPLETED|Baseline -30 Days||1
8644687|NCT02738853|21337836|P1|COMPLETED|Baseline -30 Days||59
8644688|NCT02738853|21337836|P1|STARTED|Baseline -30 Days||60
8644697|NCT02659943|21337888|P7|NOT COMPLETED|Overall Study||6
8644698|NCT02659943|21337889|P6|NOT COMPLETED|Overall Study||5
8644699|NCT02659943|21337890|P5|NOT COMPLETED|Overall Study||2
8644700|NCT02659943|21337891|P4|NOT COMPLETED|Overall Study||3
8644701|NCT02659943|21337892|P3|NOT COMPLETED|Overall Study||1
8644702|NCT02659943|21337893|P2|NOT COMPLETED|Overall Study||2
8644703|NCT02659943|21337894|P1|NOT COMPLETED|Overall Study||1
8644704|NCT02659943|21337888|P7|COMPLETED|Overall Study||0
8644705|NCT02659943|21337889|P6|COMPLETED|Overall Study||4
8644706|NCT02659943|21337890|P5|COMPLETED|Overall Study||0
8644707|NCT02659943|21337891|P4|COMPLETED|Overall Study||1
8644708|NCT02659943|21337892|P3|COMPLETED|Overall Study||0
8644709|NCT02659943|21337893|P2|COMPLETED|Overall Study||0
8644710|NCT02659943|21337894|P1|COMPLETED|Overall Study||2
8644711|NCT02659943|21337888|P7|STARTED|Overall Study||6
8644712|NCT02659943|21337889|P6|STARTED|Overall Study||9
8644713|NCT02659943|21337890|P5|STARTED|Overall Study||2
8644714|NCT02659943|21337891|P4|STARTED|Overall Study||4
8644715|NCT02659943|21337892|P3|STARTED|Overall Study||1
8644716|NCT02659943|21337893|P2|STARTED|Overall Study||2
8644717|NCT02659943|21337894|P1|STARTED|Overall Study||3
8644718|NCT02601105|21337959|P1|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 12||2
8644719|NCT02601105|21337959|P1|COMPLETED|Placebo Cream; Centella Asiatica Week 12||13
8644720|NCT02601105|21337959|P1|STARTED|Placebo Cream; Centella Asiatica Week 12||15
8644721|NCT02601105|21337959|P1|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 6||0
8644722|NCT02601105|21337959|P1|COMPLETED|Placebo Cream; Centella Asiatica Week 6||15
8644723|NCT02601105|21337959|P1|STARTED|Placebo Cream; Centella Asiatica Week 6||15
8644724|NCT02601105|21337959|P1|NOT COMPLETED|Placebo Cream; Centella Asiatica Bsln.||0
8644725|NCT02601105|21337959|P1|COMPLETED|Placebo Cream; Centella Asiatica Bsln.||15
8644726|NCT02601105|21337959|P1|STARTED|Placebo Cream; Centella Asiatica Bsln.||15
8644727|NCT02519491|21337969|P2|NOT COMPLETED|Overall Study||0
8644728|NCT02519491|21337970|P1|NOT COMPLETED|Overall Study||0
8644729|NCT02519491|21337969|P2|COMPLETED|Overall Study||219
8644730|NCT02519491|21337970|P1|COMPLETED|Overall Study||219
8644731|NCT02519491|21337969|P2|STARTED|Overall Study||219
8644732|NCT02519491|21337970|P1|STARTED|Overall Study||219
8644745|NCT02188459|21337996|P2|NOT COMPLETED|Overall Study||7
8644746|NCT02188459|21337997|P1|NOT COMPLETED|Overall Study||3
8644747|NCT02188459|21337996|P2|COMPLETED|Overall Study||58
8644748|NCT02188459|21337997|P1|COMPLETED|Overall Study||61
8644749|NCT02188459|21337996|P2|STARTED|Overall Study||65
8644750|NCT02188459|21337997|P1|STARTED|Overall Study||64
8644751|NCT02004236|21338018|P3|NOT COMPLETED|Overall Study||16
8644752|NCT02004236|21338019|P2|NOT COMPLETED|Overall Study||0
8644753|NCT02004236|21338020|P1|NOT COMPLETED|Overall Study||0
8644754|NCT02004236|21338018|P3|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
8644755|NCT02004236|21338019|P2|COMPLETED|Overall Study||75
8644756|NCT02004236|21338020|P1|COMPLETED|Overall Study||75
8644757|NCT02004236|21338018|P3|STARTED|Overall Study||75
8644758|NCT02004236|21338019|P2|STARTED|Overall Study||75
8644759|NCT02004236|21338020|P1|STARTED|Overall Study||75
8644792|NCT01825512|21338131|P2|NOT COMPLETED|Treatment||27
8644793|NCT01825512|21338132|P1|NOT COMPLETED|Treatment||53
8644794|NCT01825512|21338131|P2|COMPLETED|Treatment||170
8644795|NCT01825512|21338132|P1|COMPLETED|Treatment||140
8644796|NCT01825512|21338131|P2|STARTED|Treatment||197
8644797|NCT01825512|21338132|P1|STARTED|Treatment||193
8644798|NCT01825512|21338131|P2|NOT COMPLETED|Baseline||2
8644799|NCT01825512|21338132|P1|NOT COMPLETED|Baseline||1
8644800|NCT01825512|21338131|P2|COMPLETED|Baseline||197
8644801|NCT01825512|21338132|P1|COMPLETED|Baseline||193
8644802|NCT01825512|21338131|P2|STARTED|Baseline||199
8644803|NCT01825512|21338132|P1|STARTED|Baseline||194
8644804|NCT01788150|21338146|P2|NOT COMPLETED|Overall Study||3
8644805|NCT01788150|21338147|P1|NOT COMPLETED|Overall Study||13
8644806|NCT01788150|21338146|P2|COMPLETED|Overall Study||48
8644807|NCT01788150|21338147|P1|COMPLETED|Overall Study||95
8644808|NCT01788150|21338146|P2|STARTED|Overall Study||51
8644809|NCT01788150|21338147|P1|STARTED|Overall Study||108
8644810|NCT01784523|21338175|P2|NOT COMPLETED|Overall Study||4
8644811|NCT01784523|21338176|P1|NOT COMPLETED|Overall Study||7
8644812|NCT01784523|21338175|P2|COMPLETED|Overall Study||0
8644813|NCT01784523|21338176|P1|COMPLETED|Overall Study||0
8644814|NCT01784523|21338175|P2|STARTED|Overall Study||4
8644815|NCT01784523|21338176|P1|STARTED|Overall Study||7
8644825|NCT01586910|21338208|P2|NOT COMPLETED|Overall Study||71
8644826|NCT01586910|21338209|P1|NOT COMPLETED|Overall Study||15
8644827|NCT01586910|21338208|P2|COMPLETED|Overall Study||796
8644828|NCT01586910|21338209|P1|COMPLETED|Overall Study||864
8644829|NCT01586910|21338208|P2|STARTED|Overall Study||867
8644830|NCT01586910|21338209|P1|STARTED|Overall Study||879
8644831|NCT01531374|21338265|P3|NOT COMPLETED|Overall Study||283
8644832|NCT01531374|21338266|P2|NOT COMPLETED|Overall Study||142
8644833|NCT01531374|21338267|P1|NOT COMPLETED|Overall Study||364
8644834|NCT01531374|21338265|P3|COMPLETED|Overall Study||836
8644835|NCT01531374|21338266|P2|COMPLETED|Overall Study||231
8644836|NCT01531374|21338267|P1|COMPLETED|Overall Study||921
8644837|NCT01531374|21338265|P3|STARTED|Overall Study||1119
8644838|NCT01531374|21338266|P2|STARTED|Overall Study||373
8644839|NCT01531374|21338267|P1|STARTED|Overall Study||1285
8644840|NCT01525082|21338329|P1|NOT COMPLETED|Overall Study||1
8644841|NCT01525082|21338329|P1|COMPLETED|Overall Study||19
8644842|NCT01525082|21338329|P1|STARTED|Overall Study||20
8644843|NCT01240902|21338344|P4|NOT COMPLETED|Overall Study||165
8644844|NCT01240902|21338345|P3|NOT COMPLETED|Overall Study||100
8644845|NCT01240902|21338346|P2|NOT COMPLETED|Overall Study||79
8644846|NCT01240902|21338347|P1|NOT COMPLETED|Overall Study||211
8644847|NCT01240902|21338344|P4|COMPLETED|Overall Study||237
8644848|NCT01240902|21338345|P3|COMPLETED|Overall Study||295
8644849|NCT01240902|21338346|P2|COMPLETED|Overall Study||77
8644850|NCT01240902|21338347|P1|COMPLETED|Overall Study||289
8644851|NCT01240902|21338344|P4|STARTED|Overall Study||402
8644852|NCT01240902|21338345|P3|STARTED|Overall Study||395
8644853|NCT01240902|21338346|P2|STARTED|Overall Study||156
8644854|NCT01240902|21338347|P1|STARTED|Overall Study||500
8644917|NCT00982072|21338556|P2|NOT COMPLETED|Overall Study||2
8644918|NCT00982072|21338557|P1|NOT COMPLETED|Overall Study||0
8644919|NCT00982072|21338556|P2|COMPLETED|Overall Study||25
8644920|NCT00982072|21338557|P1|COMPLETED|Overall Study||25
8644921|NCT00982072|21338556|P2|STARTED|Overall Study||27
8644922|NCT00982072|21338557|P1|STARTED|Overall Study||25
8644932|NCT00951496|21338596|P3|NOT COMPLETED|Overall Study||13
8644933|NCT00951496|21338597|P2|NOT COMPLETED|Overall Study||8
8644934|NCT00951496|21338598|P1|NOT COMPLETED|Overall Study||10
8644935|NCT00951496|21338596|P3|COMPLETED|Overall Study||508
8644936|NCT00951496|21338597|P2|COMPLETED|Overall Study||510
8644937|NCT00951496|21338598|P1|COMPLETED|Overall Study||511
8644938|NCT00951496|21338596|P3|STARTED|Overall Study||521
8644939|NCT00951496|21338597|P2|STARTED|Overall Study||518
8644940|NCT00951496|21338598|P1|STARTED|Overall Study||521
8644953|NCT00570661|21338671|P1|NOT COMPLETED|Overall Study||7
8644954|NCT00570661|21338671|P1|COMPLETED|Overall Study||10
8644955|NCT00570661|21338671|P1|STARTED|Overall Study||17
8644956|NCT00464646|21338716|P2|NOT COMPLETED|Overall Study||0
8644957|NCT00464646|21338717|P1|NOT COMPLETED|Overall Study||0
8644958|NCT00464646|21338716|P2|COMPLETED|Overall Study||29
8644959|NCT00464646|21338717|P1|COMPLETED|Overall Study||76
8644960|NCT00464646|21338716|P2|STARTED|Overall Study||29
8644961|NCT00464646|21338717|P1|STARTED|Overall Study||76
8644962|NCT00224887|21338737|P2|NOT COMPLETED|Overall Study||6
8644963|NCT00224887|21338738|P1|NOT COMPLETED|Overall Study||6
8644964|NCT00224887|21338737|P2|COMPLETED|Overall Study||147
8644965|NCT00224887|21338738|P1|COMPLETED|Overall Study||148
8644966|NCT00224887|21338737|P2|STARTED|Overall Study||153
8644967|NCT00224887|21338738|P1|STARTED|Overall Study||154
8644968|NCT04625426|21338747|P3|NOT COMPLETED|Overall Study||12
8644969|NCT04625426|21338748|P2|NOT COMPLETED|Overall Study||25
8644970|NCT04625426|21338749|P1|NOT COMPLETED|Overall Study||14
8644971|NCT04625426|21338747|P3|COMPLETED|Overall Study||12
8644972|NCT04625426|21338748|P2|COMPLETED|Overall Study||12
8644973|NCT04625426|21338749|P1|COMPLETED|Overall Study||9
8644974|NCT04625426|21338747|P3|STARTED|Overall Study||24
8644975|NCT04625426|21338748|P2|STARTED|Overall Study||37
8644976|NCT04625426|21338749|P1|STARTED|Overall Study||23
8644993|NCT03877237|21338852|P2|NOT COMPLETED|Overall Study||6
8644994|NCT03877237|21338853|P1|NOT COMPLETED|Overall Study||5
8644995|NCT03877237|21338852|P2|COMPLETED|Overall Study||151
8644996|NCT03877237|21338853|P1|COMPLETED|Overall Study||151
8644997|NCT03877237|21338852|P2|Treated|Overall Study||157
8644998|NCT03877237|21338853|P1|Treated|Overall Study||156
8644999|NCT03877237|21338852|P2|STARTED|Overall Study||157
8645000|NCT03877237|21338853|P1|STARTED|Overall Study||156
8645001|NCT03605680|21338869|P4|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||35
8645002|NCT03605680|21338870|P3|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||39
8645003|NCT03605680|21338871|P2|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||44
8645004|NCT03605680|21338872|P1|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||0
8645005|NCT03605680|21338869|P4|COMPLETED|Double-blind Treatment Period (6 Weeks)||121
8645006|NCT03605680|21338870|P3|COMPLETED|Double-blind Treatment Period (6 Weeks)||117
8645007|NCT03605680|21338871|P2|COMPLETED|Double-blind Treatment Period (6 Weeks)||110
8645008|NCT03605680|21338872|P1|COMPLETED|Double-blind Treatment Period (6 Weeks)||0
8645009|NCT03605680|21338869|P4|STARTED|Double-blind Treatment Period (6 Weeks)||156
8645010|NCT03605680|21338870|P3|STARTED|Double-blind Treatment Period (6 Weeks)||156
8645011|NCT03605680|21338871|P2|STARTED|Double-blind Treatment Period (6 Weeks)||154
8645012|NCT03605680|21338872|P1|STARTED|Double-blind Treatment Period (6 Weeks)||0
8645013|NCT03605680|21338869|P4|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
8645014|NCT03605680|21338870|P3|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
8645015|NCT03605680|21338871|P2|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
8645016|NCT03605680|21338872|P1|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||138
8645017|NCT03605680|21338869|P4|COMPLETED|SB Placebo Run-in Period (1 Week)||0
8645018|NCT03605680|21338870|P3|COMPLETED|SB Placebo Run-in Period (1 Week)||0
8645019|NCT03605680|21338871|P2|COMPLETED|SB Placebo Run-in Period (1 Week)||0
8645020|NCT03605680|21338872|P1|COMPLETED|SB Placebo Run-in Period (1 Week)||466
8645021|NCT03605680|21338869|P4|Treated|SB Placebo Run-in Period (1 Week)||0
8645022|NCT03605680|21338870|P3|Treated|SB Placebo Run-in Period (1 Week)||0
8645023|NCT03605680|21338871|P2|Treated|SB Placebo Run-in Period (1 Week)||0
8645024|NCT03605680|21338872|P1|Treated|SB Placebo Run-in Period (1 Week)||584
8645025|NCT03605680|21338869|P4|STARTED|SB Placebo Run-in Period (1 Week)||0
8645026|NCT03605680|21338870|P3|STARTED|SB Placebo Run-in Period (1 Week)||0
8645027|NCT03605680|21338871|P2|STARTED|SB Placebo Run-in Period (1 Week)||0
8645028|NCT03605680|21338872|P1|STARTED|SB Placebo Run-in Period (1 Week)||604
8645029|NCT03569397|21338886|P2|NOT COMPLETED|Overall Study||0
8645030|NCT03569397|21338887|P1|NOT COMPLETED|Overall Study||0
8645031|NCT03569397|21338886|P2|COMPLETED|Overall Study||28
8645032|NCT03569397|21338887|P1|COMPLETED|Overall Study||29
8645033|NCT03569397|21338886|P2|STARTED|Overall Study||28
8645034|NCT03569397|21338887|P1|STARTED|Overall Study||29
8645035|NCT03544333|21338894|P2|NOT COMPLETED|Overall Study||0
8645036|NCT03544333|21338895|P1|NOT COMPLETED|Overall Study||1
8645037|NCT03544333|21338894|P2|COMPLETED|Overall Study||2
8645038|NCT03544333|21338895|P1|COMPLETED|Overall Study||2
8645039|NCT03544333|21338894|P2|STARTED|Overall Study||2
8645040|NCT03544333|21338895|P1|STARTED|Overall Study||3
8645041|NCT03390426|21338903|P2|NOT COMPLETED|Overall Study||1
8645042|NCT03390426|21338904|P1|NOT COMPLETED|Overall Study||0
8645043|NCT03390426|21338903|P2|COMPLETED|Overall Study||15
8645044|NCT03390426|21338904|P1|COMPLETED|Overall Study||15
8645045|NCT03390426|21338903|P2|STARTED|Overall Study||16
8645046|NCT03390426|21338904|P1|STARTED|Overall Study||15
8645047|NCT03330002|21338916|P1|NOT COMPLETED|Overall Study||22
8645048|NCT03330002|21338916|P1|COMPLETED|Overall Study|Subjects that received the MANTA VCD and completed 30 day follow-up visit|478
8645049|NCT03330002|21338916|P1|STARTED|Overall Study|Subjects that received the MANTA VCD|500
8645050|NCT03161158|21338924|P2|NOT COMPLETED|Overall Study||6
8645051|NCT03161158|21338925|P1|NOT COMPLETED|Overall Study||9
8645052|NCT03161158|21338924|P2|COMPLETED|Overall Study||13
8645053|NCT03161158|21338925|P1|COMPLETED|Overall Study||9
8645054|NCT03161158|21338924|P2|STARTED|Overall Study||19
8645055|NCT03161158|21338925|P1|STARTED|Overall Study||18
8645056|NCT03061097|21338935|P2|NOT COMPLETED|Overall Study||3
8645057|NCT03061097|21338936|P1|NOT COMPLETED|Overall Study||0
8645058|NCT03061097|21338935|P2|COMPLETED|Overall Study||0
8645059|NCT03061097|21338936|P1|COMPLETED|Overall Study||4
8645060|NCT03061097|21338935|P2|STARTED|Overall Study||3
8645061|NCT03061097|21338936|P1|STARTED|Overall Study||4
8645062|NCT03018223|21338948|P1|NOT COMPLETED|Overall Study||0
8645063|NCT03018223|21338948|P1|COMPLETED|Overall Study||32
8645064|NCT03018223|21338948|P1|STARTED|Overall Study||32
8645065|NCT02918877|21338957|P2|NOT COMPLETED|Overall Study||3
8645066|NCT02918877|21338958|P1|NOT COMPLETED|Overall Study||6
8645067|NCT02918877|21338957|P2|COMPLETED|Overall Study||22
8645068|NCT02918877|21338958|P1|COMPLETED|Overall Study||18
8645069|NCT02918877|21338957|P2|STARTED|Overall Study||25
8645070|NCT02918877|21338958|P1|STARTED|Overall Study||24
8645071|NCT02872142|21338976|P1|NOT COMPLETED|Overall Study||6
8645072|NCT02872142|21338976|P1|COMPLETED|Overall Study||6
8645073|NCT02872142|21338976|P1|STARTED|Overall Study||12
8645074|NCT02872103|21338998|P2|NOT COMPLETED|Cycle 2-4||1
8645075|NCT02872103|21338999|P1|NOT COMPLETED|Cycle 2-4||2
8645076|NCT02872103|21338998|P2|COMPLETED|Cycle 2-4||37
8645077|NCT02872103|21338999|P1|COMPLETED|Cycle 2-4||81
8645078|NCT02872103|21338998|P2|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38
8645079|NCT02872103|21338999|P1|STARTED|Cycle 2-4||83
8645080|NCT02872103|21338998|P2|NOT COMPLETED|Cycle 1||1
8645081|NCT02872103|21338999|P1|NOT COMPLETED|Cycle 1||0
8645082|NCT02872103|21338998|P2|COMPLETED|Cycle 1||38
8645083|NCT02872103|21338999|P1|COMPLETED|Cycle 1||83
8645084|NCT02872103|21338998|P2|STARTED|Cycle 1||39
8645085|NCT02872103|21338999|P1|STARTED|Cycle 1||83
8645086|NCT02762513|21339023|P1|NOT COMPLETED|Overall Study||0
8645087|NCT02762513|21339023|P1|COMPLETED|Overall Study||28
8645088|NCT02762513|21339023|P1|STARTED|Overall Study||28
8645089|NCT02732847|21339033|P2|NOT COMPLETED|Overall Study||42
8645090|NCT02732847|21339034|P1|NOT COMPLETED|Overall Study||42
8645091|NCT02732847|21339033|P2|COMPLETED|Overall Study||32
8645092|NCT02732847|21339034|P1|COMPLETED|Overall Study||33
8645093|NCT02732847|21339033|P2|STARTED|Overall Study||74
8645094|NCT02732847|21339034|P1|STARTED|Overall Study||75
8645095|NCT02732119|21339045|P5|NOT COMPLETED|Phase II||33
8645096|NCT02732119|21339046|P4|NOT COMPLETED|Phase II||46
8645097|NCT02732119|21339047|P3|NOT COMPLETED|Phase II||0
8645098|NCT02732119|21339048|P2|NOT COMPLETED|Phase II||0
8645099|NCT02732119|21339049|P1|NOT COMPLETED|Phase II||0
8645100|NCT02732119|21339045|P5|COMPLETED|Phase II||0
8645101|NCT02732119|21339046|P4|COMPLETED|Phase II||0
8645102|NCT02732119|21339047|P3|COMPLETED|Phase II||0
8645103|NCT02732119|21339048|P2|COMPLETED|Phase II||0
8645104|NCT02732119|21339049|P1|COMPLETED|Phase II||0
8645105|NCT02732119|21339045|P5|Protocol Analysis Set|Phase II||32
8645106|NCT02732119|21339046|P4|Protocol Analysis Set|Phase II||46
8645107|NCT02732119|21339047|P3|Protocol Analysis Set|Phase II||0
8645108|NCT02732119|21339048|P2|Protocol Analysis Set|Phase II||0
8645109|NCT02732119|21339049|P1|Protocol Analysis Set|Phase II||0
8645110|NCT02732119|21339045|P5|STARTED|Phase II||33
8645111|NCT02732119|21339046|P4|STARTED|Phase II||46
8645112|NCT02732119|21339047|P3|STARTED|Phase II||0
8645113|NCT02732119|21339048|P2|STARTED|Phase II||0
8645114|NCT02732119|21339049|P1|STARTED|Phase II||0
8645115|NCT02732119|21339045|P5|NOT COMPLETED|Phase I||0
8645116|NCT02732119|21339046|P4|NOT COMPLETED|Phase I||0
8645117|NCT02732119|21339047|P3|NOT COMPLETED|Phase I||7
8645118|NCT02732119|21339048|P2|NOT COMPLETED|Phase I||10
8645119|NCT02732119|21339049|P1|NOT COMPLETED|Phase I||8
8645120|NCT02732119|21339045|P5|COMPLETED|Phase I||0
8645121|NCT02732119|21339046|P4|COMPLETED|Phase I||0
8645122|NCT02732119|21339047|P3|COMPLETED|Phase I||0
8645123|NCT02732119|21339048|P2|COMPLETED|Phase I||0
8645124|NCT02732119|21339049|P1|COMPLETED|Phase I||0
8645125|NCT02732119|21339045|P5|STARTED|Phase I||0
8645126|NCT02732119|21339046|P4|STARTED|Phase I||0
8645127|NCT02732119|21339047|P3|STARTED|Phase I||7
8645128|NCT02732119|21339048|P2|STARTED|Phase I||10
8645129|NCT02732119|21339049|P1|STARTED|Phase I||8
8645130|NCT02721017|21339084|P2|NOT COMPLETED|Participant Follow Up||0
8645131|NCT02721017|21339085|P1|NOT COMPLETED|Participant Follow Up||0
8645132|NCT02721017|21339084|P2|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
8645133|NCT02721017|21339085|P1|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
8645134|NCT02721017|21339084|P2|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
8645135|NCT02721017|21339085|P1|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
8645136|NCT02721017|21339084|P2|NOT COMPLETED|Hospital Stay||0
8645137|NCT02721017|21339085|P1|NOT COMPLETED|Hospital Stay||0
8645138|NCT02721017|21339084|P2|COMPLETED|Hospital Stay|Removal occurs prior to Hospital Discharge.|10
8645139|NCT02721017|21339085|P1|COMPLETED|Hospital Stay|Completed during the course of surgery.|10
8645140|NCT02721017|21339084|P2|STARTED|Hospital Stay|Thoracic Epidural placed on Date of Surgery (DOS).|10
8645141|NCT02721017|21339085|P1|STARTED|Hospital Stay|Intraoperative Application of Cryoanalgesia started on Date of Surgery (DOS).|10
8645142|NCT02646618|21339099|P2|NOT COMPLETED|Overall Study||14
8645143|NCT02646618|21339100|P1|NOT COMPLETED|Overall Study||10
8645144|NCT02646618|21339099|P2|COMPLETED|Overall Study||148
8645145|NCT02646618|21339100|P1|COMPLETED|Overall Study||157
8645146|NCT02646618|21339099|P2|6 Month Follow-up|Overall Study||150
8645147|NCT02646618|21339100|P1|6 Month Follow-up|Overall Study||152
8645148|NCT02646618|21339099|P2|STARTED|Overall Study||162
8645149|NCT02646618|21339100|P1|STARTED|Overall Study||167
8645150|NCT02315170|21339202|P2|NOT COMPLETED|Overall Study||0
8645151|NCT02315170|21339203|P1|NOT COMPLETED|Overall Study||0
8645152|NCT02315170|21339202|P2|COMPLETED|Overall Study||50
8645153|NCT02315170|21339203|P1|COMPLETED|Overall Study||50
8645154|NCT02315170|21339202|P2|STARTED|Overall Study||50
8645155|NCT02315170|21339203|P1|STARTED|Overall Study||50
8645156|NCT02250326|21339212|P3|NOT COMPLETED|Follow-Up Period||38
8645157|NCT02250326|21339213|P2|NOT COMPLETED|Follow-Up Period||30
8645158|NCT02250326|21339214|P1|NOT COMPLETED|Follow-Up Period||49
8645159|NCT02250326|21339212|P3|COMPLETED|Follow-Up Period||26
8645160|NCT02250326|21339213|P2|COMPLETED|Follow-Up Period||13
8645161|NCT02250326|21339214|P1|COMPLETED|Follow-Up Period||18
8645162|NCT02250326|21339212|P3|STARTED|Follow-Up Period||64
8645163|NCT02250326|21339213|P2|STARTED|Follow-Up Period||43
8645164|NCT02250326|21339214|P1|STARTED|Follow-Up Period||67
8645165|NCT02250326|21339212|P3|NOT COMPLETED|Treatment Period||77
8645166|NCT02250326|21339213|P2|NOT COMPLETED|Treatment Period||64
8645167|NCT02250326|21339214|P1|NOT COMPLETED|Treatment Period||81
8645168|NCT02250326|21339212|P3|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
8645169|NCT02250326|21339213|P2|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
8645170|NCT02250326|21339214|P1|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
8645171|NCT02250326|21339212|P3|Treated Population|Treatment Period||79
8645172|NCT02250326|21339213|P2|Treated Population|Treatment Period||78
8645173|NCT02250326|21339214|P1|Treated Population|Treatment Period||79
8645174|NCT02250326|21339212|P3|STARTED|Treatment Period||80
8645175|NCT02250326|21339213|P2|STARTED|Treatment Period||79
8645176|NCT02250326|21339214|P1|STARTED|Treatment Period||81
8645177|NCT02191618|21339245|P1|NOT COMPLETED|Overall Study||7
8645178|NCT02191618|21339245|P1|COMPLETED|Overall Study||143
8645179|NCT02191618|21339245|P1|STARTED|Overall Study||150
8645180|NCT02173379|21339252|P2|NOT COMPLETED|Overall Study||77
8645181|NCT02173379|21339253|P1|NOT COMPLETED|Overall Study||91
8645182|NCT02173379|21339252|P2|COMPLETED|Overall Study||1231
8645183|NCT02173379|21339253|P1|COMPLETED|Overall Study||1205
8645184|NCT02173379|21339252|P2|STARTED|Overall Study||1308
8645185|NCT02173379|21339253|P1|STARTED|Overall Study||1296
8645186|NCT01822366|21339501|P4|NOT COMPLETED|Overall Study||22
8645187|NCT01822366|21339502|P3|NOT COMPLETED|Overall Study||5
8645188|NCT01822366|21339503|P2|NOT COMPLETED|Overall Study||22
8645189|NCT01822366|21339504|P1|NOT COMPLETED|Overall Study||5
8645190|NCT01822366|21339501|P4|COMPLETED|Overall Study||298
8645191|NCT01822366|21339502|P3|COMPLETED|Overall Study||315
8645192|NCT01822366|21339503|P2|COMPLETED|Overall Study||298
8645193|NCT01822366|21339504|P1|COMPLETED|Overall Study||315
8645194|NCT01822366|21339501|P4|STARTED|Overall Study||320
8645195|NCT01822366|21339502|P3|STARTED|Overall Study||320
8645196|NCT01822366|21339503|P2|STARTED|Overall Study||320
8645197|NCT01822366|21339504|P1|STARTED|Overall Study||320
8645198|NCT01660256|21339567|P3|NOT COMPLETED|Overall Study||4
8645199|NCT01660256|21339568|P2|NOT COMPLETED|Overall Study||0
8645200|NCT01660256|21339569|P1|NOT COMPLETED|Overall Study||5
8645201|NCT01660256|21339567|P3|COMPLETED|Overall Study||38
8645202|NCT01660256|21339568|P2|COMPLETED|Overall Study||83
8645203|NCT01660256|21339569|P1|COMPLETED|Overall Study||79
8645204|NCT01660256|21339567|P3|STARTED|Overall Study||42
8645205|NCT01660256|21339568|P2|STARTED|Overall Study||83
8645206|NCT01660256|21339569|P1|STARTED|Overall Study||84
8645216|NCT01504438|21339604|P2|NOT COMPLETED|Overall Study||25
8645217|NCT01504438|21339605|P1|NOT COMPLETED|Overall Study||26
8645218|NCT01504438|21339604|P2|COMPLETED|Overall Study||25
8645219|NCT01504438|21339605|P1|COMPLETED|Overall Study||22
8645220|NCT01504438|21339604|P2|STARTED|Overall Study||50
8645221|NCT01504438|21339605|P1|STARTED|Overall Study||48
8645222|NCT01381692|21339623|P6|NOT COMPLETED|Overall Study||0
8645223|NCT01381692|21339624|P5|NOT COMPLETED|Overall Study||0
8645224|NCT01381692|21339625|P4|NOT COMPLETED|Overall Study||0
8645225|NCT01381692|21339626|P3|NOT COMPLETED|Overall Study||0
8645226|NCT01381692|21339627|P2|NOT COMPLETED|Overall Study||0
8645227|NCT01381692|21339628|P1|NOT COMPLETED|Overall Study||1
8645228|NCT01381692|21339623|P6|COMPLETED|Overall Study||0
8645229|NCT01381692|21339624|P5|COMPLETED|Overall Study||0
8645230|NCT01381692|21339625|P4|COMPLETED|Overall Study||0
8645231|NCT01381692|21339626|P3|COMPLETED|Overall Study||0
8645232|NCT01381692|21339627|P2|COMPLETED|Overall Study||2
8645233|NCT01381692|21339628|P1|COMPLETED|Overall Study||6
8645234|NCT01381692|21339623|P6|STARTED|Overall Study||0
8645235|NCT01381692|21339624|P5|STARTED|Overall Study||0
8645236|NCT01381692|21339625|P4|STARTED|Overall Study||0
8645237|NCT01381692|21339626|P3|STARTED|Overall Study||0
8645238|NCT01381692|21339627|P2|STARTED|Overall Study||2
8645239|NCT01381692|21339628|P1|STARTED|Overall Study||7
8645240|NCT01320085|21339653|P3|NOT COMPLETED|Overall Study||25
8645241|NCT01320085|21339654|P2|NOT COMPLETED|Overall Study||117
8645242|NCT01320085|21339655|P1|NOT COMPLETED|Overall Study||41
8645243|NCT01320085|21339653|P3|COMPLETED|Overall Study||0
8645244|NCT01320085|21339654|P2|COMPLETED|Overall Study||0
8645245|NCT01320085|21339655|P1|COMPLETED|Overall Study||0
8645246|NCT01320085|21339653|P3|STARTED|Overall Study||25
8645247|NCT01320085|21339654|P2|STARTED|Overall Study||117
8645248|NCT01320085|21339655|P1|STARTED|Overall Study||41
8645249|NCT01276860|21339752|P2|NOT COMPLETED|Overall Study||0
8645250|NCT01276860|21339753|P1|NOT COMPLETED|Overall Study||0
8645251|NCT01276860|21339752|P2|COMPLETED|Overall Study||2
8645252|NCT01276860|21339753|P1|COMPLETED|Overall Study||5
8645253|NCT01276860|21339752|P2|STARTED|Overall Study||2
8645254|NCT01276860|21339753|P1|STARTED|Overall Study||5
8645255|NCT01252732|21339763|P2|NOT COMPLETED|Overall Study||64
8645256|NCT01252732|21339764|P1|NOT COMPLETED|Overall Study||54
8645257|NCT01252732|21339763|P2|COMPLETED|Overall Study||446
8645258|NCT01252732|21339764|P1|COMPLETED|Overall Study||455
8645259|NCT01252732|21339763|P2|Modified Intent to Treat Population|Overall Study||502
8645260|NCT01252732|21339764|P1|Modified Intent to Treat Population|Overall Study||503
8645261|NCT01252732|21339763|P2|STARTED|Overall Study|Randomized|510
8645262|NCT01252732|21339764|P1|STARTED|Overall Study|Randomized|509
8645263|NCT01238120|21339778|P4|NOT COMPLETED|Overall Study||6
8645264|NCT01238120|21339779|P3|NOT COMPLETED|Overall Study||4
8645265|NCT01238120|21339780|P2|NOT COMPLETED|Overall Study||1
8645266|NCT01238120|21339781|P1|NOT COMPLETED|Overall Study||8
8645267|NCT01238120|21339778|P4|COMPLETED|Overall Study||18
8645268|NCT01238120|21339779|P3|COMPLETED|Overall Study||21
8645269|NCT01238120|21339780|P2|COMPLETED|Overall Study||22
8645270|NCT01238120|21339781|P1|COMPLETED|Overall Study||17
8645271|NCT01238120|21339778|P4|Received Intervention and Completed Baseline Assessments|Overall Study||21
8645272|NCT01238120|21339779|P3|Received Intervention and Completed Baseline Assessments|Overall Study||22
8645273|NCT01238120|21339780|P2|Received Intervention and Completed Baseline Assessments|Overall Study||22
8645274|NCT01238120|21339781|P1|Received Intervention and Completed Baseline Assessments|Overall Study||21
8645275|NCT01238120|21339778|P4|STARTED|Overall Study||24
8645276|NCT01238120|21339779|P3|STARTED|Overall Study||25
8645277|NCT01238120|21339780|P2|STARTED|Overall Study||23
8645278|NCT01238120|21339781|P1|STARTED|Overall Study||25
8645279|NCT01089725|21339800|P5|NOT COMPLETED|Overall Study||80
8645280|NCT01089725|21339801|P4|NOT COMPLETED|Overall Study||79
8645281|NCT01089725|21339802|P3|NOT COMPLETED|Overall Study||61
8645282|NCT01089725|21339803|P2|NOT COMPLETED|Overall Study||68
8645283|NCT01089725|21339804|P1|NOT COMPLETED|Overall Study||66
8645284|NCT01089725|21339800|P5|COMPLETED|Overall Study||6
8645285|NCT01089725|21339801|P4|COMPLETED|Overall Study||8
8645286|NCT01089725|21339802|P3|COMPLETED|Overall Study||4
8645287|NCT01089725|21339803|P2|COMPLETED|Overall Study||7
8645288|NCT01089725|21339804|P1|COMPLETED|Overall Study||6
8645289|NCT01089725|21339800|P5|Treated|Overall Study||84
8645290|NCT01089725|21339801|P4|Treated|Overall Study||86
8645291|NCT01089725|21339802|P3|Treated|Overall Study||63
8645292|NCT01089725|21339803|P2|Treated|Overall Study||74
8645293|NCT01089725|21339804|P1|Treated|Overall Study||72
8645294|NCT01089725|21339800|P5|STARTED|Overall Study||86
8645295|NCT01089725|21339801|P4|STARTED|Overall Study||87
8645296|NCT01089725|21339802|P3|STARTED|Overall Study||65
8645297|NCT01089725|21339803|P2|STARTED|Overall Study||75
8645298|NCT01089725|21339804|P1|STARTED|Overall Study||72
8645299|NCT01016561|21339969|P1|NOT COMPLETED|Overall Study||0
8645300|NCT01016561|21339969|P1|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
8645301|NCT01016561|21339969|P1|STARTED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
8645314|NCT00321555|21340010|P1|NOT COMPLETED|Overall Study||6
8645315|NCT00321555|21340010|P1|COMPLETED|Overall Study||9
8645316|NCT00321555|21340010|P1|STARTED|Overall Study||15
8645320|NCT00123123|21340052|P3|NOT COMPLETED|Overall Study||0
8645321|NCT00123123|21340053|P2|NOT COMPLETED|Overall Study||0
8645322|NCT00123123|21340054|P1|NOT COMPLETED|Overall Study||0
8645323|NCT00123123|21340052|P3|COMPLETED|Overall Study||58
8645324|NCT00123123|21340053|P2|COMPLETED|Overall Study||58
8645325|NCT00123123|21340054|P1|COMPLETED|Overall Study||59
8645326|NCT00123123|21340052|P3|STARTED|Overall Study||58
8645327|NCT00123123|21340053|P2|STARTED|Overall Study||58
8645328|NCT00123123|21340054|P1|STARTED|Overall Study||59
8645335|NCT04544566|21340086|P6|NOT COMPLETED|Overall Study||0
8645336|NCT04544566|21340087|P5|NOT COMPLETED|Overall Study||0
8645337|NCT04544566|21340088|P4|NOT COMPLETED|Overall Study||0
8645338|NCT04544566|21340089|P3|NOT COMPLETED|Overall Study||0
8645339|NCT04544566|21340090|P2|NOT COMPLETED|Overall Study||0
8645340|NCT04544566|21340091|P1|NOT COMPLETED|Overall Study||0
8645341|NCT04544566|21340086|P6|COMPLETED|Overall Study||2
8645342|NCT04544566|21340087|P5|COMPLETED|Overall Study||2
8645343|NCT04544566|21340088|P4|COMPLETED|Overall Study||2
8645344|NCT04544566|21340089|P3|COMPLETED|Overall Study||2
8645345|NCT04544566|21340090|P2|COMPLETED|Overall Study||2
8645346|NCT04544566|21340091|P1|COMPLETED|Overall Study||2
8645347|NCT04544566|21340086|P6|STARTED|Overall Study||2
8645348|NCT04544566|21340087|P5|STARTED|Overall Study||2
8645349|NCT04544566|21340088|P4|STARTED|Overall Study||2
8645350|NCT04544566|21340089|P3|STARTED|Overall Study||2
8645351|NCT04544566|21340090|P2|STARTED|Overall Study||2
8645352|NCT04544566|21340091|P1|STARTED|Overall Study||2
8645353|NCT04486235|21340122|P2|NOT COMPLETED|Overall Study||0
8645354|NCT04486235|21340123|P1|NOT COMPLETED|Overall Study||2
8645355|NCT04486235|21340122|P2|COMPLETED|Overall Study||30
8645356|NCT04486235|21340123|P1|COMPLETED|Overall Study||30
8645357|NCT04486235|21340122|P2|Analysis|Overall Study||30
8645358|NCT04486235|21340123|P1|Analysis|Overall Study||30
8645359|NCT04486235|21340122|P2|STARTED|Overall Study||30
8645360|NCT04486235|21340123|P1|STARTED|Overall Study||32
8645370|NCT03755661|21340150|P2|NOT COMPLETED|Overall Study||0
8645371|NCT03755661|21340151|P1|NOT COMPLETED|Overall Study||1
8645372|NCT03755661|21340150|P2|COMPLETED|Overall Study||12
8645373|NCT03755661|21340151|P1|COMPLETED|Overall Study||11
8645374|NCT03755661|21340150|P2|STARTED|Overall Study||12
8645375|NCT03755661|21340151|P1|STARTED|Overall Study||12
8645376|NCT03647475|21340165|P1|NOT COMPLETED|Overall Study||677
8645377|NCT03647475|21340165|P1|COMPLETED|Overall Study||75
8645378|NCT03647475|21340165|P1|NCT03344653- Included in One Month Clear Analysis Population|Overall Study||905
8645379|NCT03647475|21340165|P1|NCT03647475 - Included in One Month Clear Analysis Population|Overall Study||601
8645380|NCT03647475|21340165|P1|STARTED|Overall Study||752
8645389|NCT03518658|21340202|P2|NOT COMPLETED|Overall Study||0
8645390|NCT03518658|21340203|P1|NOT COMPLETED|Overall Study||51
8645391|NCT03518658|21340202|P2|COMPLETED|Overall Study||128607
8645392|NCT03518658|21340203|P1|COMPLETED|Overall Study|Number of patients completing annual survey|206
8645393|NCT03518658|21340202|P2|STARTED|Overall Study||128607
8645394|NCT03518658|21340203|P1|STARTED|Overall Study|Number of patients completing device pairing survey|257
8645395|NCT03276637|21340211|P1|NOT COMPLETED|Overall Study||24
8645396|NCT03276637|21340211|P1|COMPLETED|Overall Study||69
8645397|NCT03276637|21340211|P1|Completed Post Survey|Overall Study||69
8645398|NCT03276637|21340211|P1|Underwent Sequencing|Overall Study||75
8645399|NCT03276637|21340211|P1|Completed Pre Survey|Overall Study||93
8645400|NCT03276637|21340211|P1|STARTED|Overall Study||93
8645401|NCT03221595|21340221|P2|NOT COMPLETED|Overall Study||0
8645402|NCT03221595|21340222|P1|NOT COMPLETED|Overall Study||0
8645403|NCT03221595|21340221|P2|COMPLETED|Overall Study||59
8645404|NCT03221595|21340222|P1|COMPLETED|Overall Study||51
8645405|NCT03221595|21340221|P2|STARTED|Overall Study||59
8645406|NCT03221595|21340222|P1|STARTED|Overall Study||51
8645407|NCT02969499|21340242|P1|NOT COMPLETED|Overall Study||0
8645408|NCT02969499|21340242|P1|COMPLETED|Overall Study||33
8645409|NCT02969499|21340242|P1|STARTED|Overall Study||33
8645410|NCT02959437|21340254|P4|NOT COMPLETED|Overall Study||0
8645411|NCT02959437|21340255|P3|NOT COMPLETED|Overall Study||0
8645412|NCT02959437|21340256|P2|NOT COMPLETED|Overall Study||8
8645413|NCT02959437|21340257|P1|NOT COMPLETED|Overall Study||62
8645414|NCT02959437|21340254|P4|COMPLETED|Overall Study||0
8645415|NCT02959437|21340255|P3|COMPLETED|Overall Study||0
8645416|NCT02959437|21340256|P2|COMPLETED|Overall Study||0
8645417|NCT02959437|21340257|P1|COMPLETED|Overall Study||0
8645418|NCT02959437|21340254|P4|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
8645419|NCT02959437|21340255|P3|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
8645420|NCT02959437|21340256|P2|STARTED|Overall Study||8
8645421|NCT02959437|21340257|P1|STARTED|Overall Study||62
8645431|NCT02727699|21340295|P2|NOT COMPLETED|Overall Study||5
8645432|NCT02727699|21340296|P1|NOT COMPLETED|Overall Study||9
8645433|NCT02727699|21340295|P2|COMPLETED|Overall Study||89
8645434|NCT02727699|21340296|P1|COMPLETED|Overall Study||82
8645435|NCT02727699|21340295|P2|STARTED|Overall Study||94
8645436|NCT02727699|21340296|P1|STARTED|Overall Study||91
8645437|NCT02721251|21340317|P3|NOT COMPLETED|Overall Study||11
8645438|NCT02721251|21340318|P2|NOT COMPLETED|Overall Study||9
8645439|NCT02721251|21340319|P1|NOT COMPLETED|Overall Study||10
8645440|NCT02721251|21340317|P3|COMPLETED|Overall Study||6
8645441|NCT02721251|21340318|P2|COMPLETED|Overall Study||7
8645442|NCT02721251|21340319|P1|COMPLETED|Overall Study||4
8645443|NCT02721251|21340317|P3|STARTED|Overall Study||17
8645444|NCT02721251|21340318|P2|STARTED|Overall Study||16
8645445|NCT02721251|21340319|P1|STARTED|Overall Study||14
8645446|NCT02574078|21340361|P13|NOT COMPLETED|Treatment Period||13
8645447|NCT02574078|21340362|P12|NOT COMPLETED|Treatment Period||47
8645448|NCT02574078|21340363|P11|NOT COMPLETED|Treatment Period||45
8645449|NCT02574078|21340364|P10|NOT COMPLETED|Treatment Period||17
8645450|NCT02574078|21340365|P9|NOT COMPLETED|Treatment Period||24
8645451|NCT02574078|21340366|P8|NOT COMPLETED|Treatment Period||12
8645452|NCT02574078|21340367|P7|NOT COMPLETED|Treatment Period||12
8645453|NCT02574078|21340368|P6|NOT COMPLETED|Treatment Period||33
8645454|NCT02574078|21340369|P5|NOT COMPLETED|Treatment Period||31
8645455|NCT02574078|21340370|P4|NOT COMPLETED|Treatment Period||28
8645456|NCT02574078|21340371|P3|NOT COMPLETED|Treatment Period||9
8645457|NCT02574078|21340372|P2|NOT COMPLETED|Treatment Period||6
8645458|NCT02574078|21340373|P1|NOT COMPLETED|Treatment Period||10
8645459|NCT02574078|21340361|P13|COMPLETED|Treatment Period||0
8645460|NCT02574078|21340362|P12|COMPLETED|Treatment Period||8
8645461|NCT02574078|21340363|P11|COMPLETED|Treatment Period||4
8645462|NCT02574078|21340364|P10|COMPLETED|Treatment Period||9
8645463|NCT02574078|21340365|P9|COMPLETED|Treatment Period||1
8645464|NCT02574078|21340366|P8|COMPLETED|Treatment Period||2
8645465|NCT02574078|21340367|P7|COMPLETED|Treatment Period||2
8645466|NCT02574078|21340368|P6|COMPLETED|Treatment Period||1
8645467|NCT02574078|21340369|P5|COMPLETED|Treatment Period||3
8645468|NCT02574078|21340370|P4|COMPLETED|Treatment Period||7
8645469|NCT02574078|21340371|P3|COMPLETED|Treatment Period||0
8645470|NCT02574078|21340372|P2|COMPLETED|Treatment Period||0
8645471|NCT02574078|21340373|P1|COMPLETED|Treatment Period||3
8645472|NCT02574078|21340361|P13|STARTED|Treatment Period||13
8645473|NCT02574078|21340362|P12|STARTED|Treatment Period||55
8645474|NCT02574078|21340363|P11|STARTED|Treatment Period||49
8645475|NCT02574078|21340364|P10|STARTED|Treatment Period||26
8645476|NCT02574078|21340365|P9|STARTED|Treatment Period||25
8645477|NCT02574078|21340366|P8|STARTED|Treatment Period||14
8645478|NCT02574078|21340367|P7|STARTED|Treatment Period||14
8645479|NCT02574078|21340368|P6|STARTED|Treatment Period||34
8645480|NCT02574078|21340369|P5|STARTED|Treatment Period||34
8645481|NCT02574078|21340370|P4|STARTED|Treatment Period||35
8645482|NCT02574078|21340371|P3|STARTED|Treatment Period||9
8645483|NCT02574078|21340372|P2|STARTED|Treatment Period||6
8645484|NCT02574078|21340373|P1|STARTED|Treatment Period||13
8645485|NCT02574078|21340361|P13|NOT COMPLETED|Pre-Treatment Period||0
8645486|NCT02574078|21340362|P12|NOT COMPLETED|Pre-Treatment Period||1
8645487|NCT02574078|21340363|P11|NOT COMPLETED|Pre-Treatment Period||4
8645488|NCT02574078|21340364|P10|NOT COMPLETED|Pre-Treatment Period||0
8645489|NCT02574078|21340365|P9|NOT COMPLETED|Pre-Treatment Period||1
8645490|NCT02574078|21340366|P8|NOT COMPLETED|Pre-Treatment Period||3
8645491|NCT02574078|21340367|P7|NOT COMPLETED|Pre-Treatment Period||4
8645492|NCT02574078|21340368|P6|NOT COMPLETED|Pre-Treatment Period||1
8645493|NCT02574078|21340369|P5|NOT COMPLETED|Pre-Treatment Period||0
8645494|NCT02574078|21340370|P4|NOT COMPLETED|Pre-Treatment Period||0
8645495|NCT02574078|21340371|P3|NOT COMPLETED|Pre-Treatment Period||0
8645496|NCT02574078|21340372|P2|NOT COMPLETED|Pre-Treatment Period||0
8645497|NCT02574078|21340373|P1|NOT COMPLETED|Pre-Treatment Period||0
8645498|NCT02574078|21340361|P13|COMPLETED|Pre-Treatment Period||13
8645499|NCT02574078|21340362|P12|COMPLETED|Pre-Treatment Period||55
8645500|NCT02574078|21340363|P11|COMPLETED|Pre-Treatment Period||49
8645501|NCT02574078|21340364|P10|COMPLETED|Pre-Treatment Period||26
8645502|NCT02574078|21340365|P9|COMPLETED|Pre-Treatment Period||25
8645503|NCT02574078|21340366|P8|COMPLETED|Pre-Treatment Period||14
8645504|NCT02574078|21340367|P7|COMPLETED|Pre-Treatment Period||14
8645505|NCT02574078|21340368|P6|COMPLETED|Pre-Treatment Period||34
8645506|NCT02574078|21340369|P5|COMPLETED|Pre-Treatment Period||34
8645507|NCT02574078|21340370|P4|COMPLETED|Pre-Treatment Period||35
8645508|NCT02574078|21340371|P3|COMPLETED|Pre-Treatment Period||9
8645509|NCT02574078|21340372|P2|COMPLETED|Pre-Treatment Period||6
8645510|NCT02574078|21340373|P1|COMPLETED|Pre-Treatment Period||13
8645511|NCT02574078|21340361|P13|STARTED|Pre-Treatment Period||13
8645512|NCT02574078|21340362|P12|STARTED|Pre-Treatment Period||56
8645513|NCT02574078|21340363|P11|STARTED|Pre-Treatment Period||53
8645514|NCT02574078|21340364|P10|STARTED|Pre-Treatment Period||26
8645515|NCT02574078|21340365|P9|STARTED|Pre-Treatment Period||26
8645516|NCT02574078|21340366|P8|STARTED|Pre-Treatment Period||17
8645517|NCT02574078|21340367|P7|STARTED|Pre-Treatment Period||18
8645518|NCT02574078|21340368|P6|STARTED|Pre-Treatment Period||35
8645519|NCT02574078|21340369|P5|STARTED|Pre-Treatment Period||34
8645520|NCT02574078|21340370|P4|STARTED|Pre-Treatment Period||35
8645521|NCT02574078|21340371|P3|STARTED|Pre-Treatment Period||9
8645522|NCT02574078|21340372|P2|STARTED|Pre-Treatment Period||6
8645523|NCT02574078|21340373|P1|STARTED|Pre-Treatment Period||13
8645524|NCT02572167|21340442|P3|NOT COMPLETED|Overall Study||31
8645525|NCT02572167|21340443|P2|NOT COMPLETED|Overall Study||56
8645526|NCT02572167|21340444|P1|NOT COMPLETED|Overall Study||6
8645527|NCT02572167|21340442|P3|COMPLETED|Overall Study||0
8645528|NCT02572167|21340443|P2|COMPLETED|Overall Study||0
8645529|NCT02572167|21340444|P1|COMPLETED|Overall Study||0
8645530|NCT02572167|21340442|P3|STARTED|Overall Study||31
8645531|NCT02572167|21340443|P2|STARTED|Overall Study||56
8645532|NCT02572167|21340444|P1|STARTED|Overall Study||6
8645533|NCT02566902|21340460|P2|NOT COMPLETED|Overall Study||1
8645534|NCT02566902|21340461|P1|NOT COMPLETED|Overall Study||2
8645535|NCT02566902|21340460|P2|COMPLETED|Overall Study||57
8645536|NCT02566902|21340461|P1|COMPLETED|Overall Study||58
8645537|NCT02566902|21340460|P2|STARTED|Overall Study||58
8645538|NCT02566902|21340461|P1|STARTED|Overall Study||60
8645539|NCT02562898|21340485|P2|NOT COMPLETED|Overall Study||0
8645540|NCT02562898|21340486|P1|NOT COMPLETED|Overall Study||0
8645541|NCT02562898|21340485|P2|COMPLETED|Overall Study||8
8645542|NCT02562898|21340486|P1|COMPLETED|Overall Study||10
8645543|NCT02562898|21340485|P2|STARTED|Overall Study||8
8645544|NCT02562898|21340486|P1|STARTED|Overall Study||10
8645545|NCT02544113|21340504|P2|NOT COMPLETED|Overall Study||4
8645546|NCT02544113|21340505|P1|NOT COMPLETED|Overall Study||3
8645547|NCT02544113|21340504|P2|COMPLETED|Overall Study||51
8645548|NCT02544113|21340505|P1|COMPLETED|Overall Study||52
8645549|NCT02544113|21340504|P2|STARTED|Overall Study||55
8645550|NCT02544113|21340505|P1|STARTED|Overall Study||55
8645551|NCT02513719|21340515|P1|NOT COMPLETED|At 5 Years Clinical Follow-up||19
8645552|NCT02513719|21340515|P1|COMPLETED|At 5 Years Clinical Follow-up||254
8645553|NCT02513719|21340515|P1|STARTED|At 5 Years Clinical Follow-up||273
8645554|NCT02513719|21340515|P1|NOT COMPLETED|At 4 Years Clinical Follow-up||16
8645555|NCT02513719|21340515|P1|COMPLETED|At 4 Years Clinical Follow-up||273
8645556|NCT02513719|21340515|P1|STARTED|At 4 Years Clinical Follow-up||289
8645557|NCT02513719|21340515|P1|NOT COMPLETED|At 3 Years Clinical Follow-up||11
8645558|NCT02513719|21340515|P1|COMPLETED|At 3 Years Clinical Follow-up||289
8645559|NCT02513719|21340515|P1|STARTED|At 3 Years Clinical Follow-up||300
8645560|NCT02513719|21340515|P1|NOT COMPLETED|At 2 Years Clinical Follow-up||5
8645561|NCT02513719|21340515|P1|COMPLETED|At 2 Years Clinical Follow-up||300
8645562|NCT02513719|21340515|P1|STARTED|At 2 Years Clinical Follow-up||305
8645563|NCT02513719|21340515|P1|NOT COMPLETED|At 1 Year Clinical Follow-up||7
8645564|NCT02513719|21340515|P1|COMPLETED|At 1 Year Clinical Follow-up||305
8645565|NCT02513719|21340515|P1|STARTED|At 1 Year Clinical Follow-up||312
8645566|NCT02513719|21340515|P1|NOT COMPLETED|At 8 Months Clinical Follow-up||0
8645567|NCT02513719|21340515|P1|COMPLETED|At 8 Months Clinical Follow-up||312
8645568|NCT02513719|21340515|P1|STARTED|At 8 Months Clinical Follow-up||312
8645569|NCT02510794|21340619|P4|NOT COMPLETED|Overall Study||5
8645570|NCT02510794|21340620|P3|NOT COMPLETED|Overall Study||7
8645571|NCT02510794|21340621|P2|NOT COMPLETED|Overall Study||6
8645572|NCT02510794|21340622|P1|NOT COMPLETED|Overall Study||8
8645573|NCT02510794|21340619|P4|COMPLETED|Overall Study||36
8645574|NCT02510794|21340620|P3|COMPLETED|Overall Study||56
8645575|NCT02510794|21340621|P2|COMPLETED|Overall Study||56
8645576|NCT02510794|21340622|P1|COMPLETED|Overall Study||51
8645577|NCT02510794|21340619|P4|STARTED|Overall Study||41
8645578|NCT02510794|21340620|P3|STARTED|Overall Study||63
8645579|NCT02510794|21340621|P2|STARTED|Overall Study||62
8645580|NCT02510794|21340622|P1|STARTED|Overall Study||59
8645605|NCT02414932|21340753|P2|NOT COMPLETED|Overall Study||3
8645606|NCT02414932|21340754|P1|NOT COMPLETED|Overall Study||3
8645607|NCT02414932|21340753|P2|COMPLETED|Overall Study||0
8645608|NCT02414932|21340754|P1|COMPLETED|Overall Study||0
8645609|NCT02414932|21340753|P2|STARTED|Overall Study||3
8645610|NCT02414932|21340754|P1|STARTED|Overall Study||3
8645619|NCT02155647|21340812|P2|NOT COMPLETED|Overall Study||52
8645620|NCT02155647|21340813|P1|NOT COMPLETED|Overall Study||41
8645621|NCT02155647|21340812|P2|COMPLETED|Overall Study||64
8645622|NCT02155647|21340813|P1|COMPLETED|Overall Study||47
8645623|NCT02155647|21340812|P2|STARTED|Overall Study||116
8645624|NCT02155647|21340813|P1|STARTED|Overall Study||88
8645625|NCT01976741|21340849|P10|NOT COMPLETED|Overall Study||4
8645626|NCT01976741|21340850|P9|NOT COMPLETED|Overall Study||1
8645627|NCT01976741|21340851|P8|NOT COMPLETED|Overall Study||12
8645628|NCT01976741|21340852|P7|NOT COMPLETED|Overall Study||4
8645629|NCT01976741|21340853|P6|NOT COMPLETED|Overall Study||0
8645630|NCT01976741|21340854|P5|NOT COMPLETED|Overall Study||0
8645631|NCT01976741|21340855|P4|NOT COMPLETED|Overall Study||1
8645632|NCT01976741|21340856|P3|NOT COMPLETED|Overall Study||3
8645633|NCT01976741|21340857|P2|NOT COMPLETED|Overall Study||0
8645634|NCT01976741|21340858|P1|NOT COMPLETED|Overall Study||1
8645635|NCT01976741|21340849|P10|COMPLETED|Overall Study||36
8645636|NCT01976741|21340850|P9|COMPLETED|Overall Study||7
8645637|NCT01976741|21340851|P8|COMPLETED|Overall Study||62
8645638|NCT01976741|21340852|P7|COMPLETED|Overall Study||19
8645639|NCT01976741|21340853|P6|COMPLETED|Overall Study||4
8645640|NCT01976741|21340854|P5|COMPLETED|Overall Study||4
8645641|NCT01976741|21340855|P4|COMPLETED|Overall Study||2
8645642|NCT01976741|21340856|P3|COMPLETED|Overall Study||1
8645643|NCT01976741|21340857|P2|COMPLETED|Overall Study||4
8645644|NCT01976741|21340858|P1|COMPLETED|Overall Study||3
8645645|NCT01976741|21340849|P10|STARTED|Overall Study||40
8645646|NCT01976741|21340850|P9|STARTED|Overall Study||8
8645647|NCT01976741|21340851|P8|STARTED|Overall Study||74
8645648|NCT01976741|21340852|P7|STARTED|Overall Study||23
8645649|NCT01976741|21340853|P6|STARTED|Overall Study||4
8645650|NCT01976741|21340854|P5|STARTED|Overall Study||4
8645651|NCT01976741|21340855|P4|STARTED|Overall Study||3
8645652|NCT01976741|21340856|P3|STARTED|Overall Study||4
8645653|NCT01976741|21340857|P2|STARTED|Overall Study||4
8645654|NCT01976741|21340858|P1|STARTED|Overall Study||4
8645655|NCT01908426|21341163|P2|NOT COMPLETED|Overall Study||211
8645656|NCT01908426|21341164|P1|NOT COMPLETED|Overall Study||397
8645657|NCT01908426|21341163|P2|COMPLETED|Overall Study||26
8645658|NCT01908426|21341164|P1|COMPLETED|Overall Study||73
8645659|NCT01908426|21341163|P2|STARTED|Overall Study||237
8645660|NCT01908426|21341164|P1|STARTED|Overall Study||470
8645661|NCT01827943|21341174|P1|NOT COMPLETED|Overall Study||9
8645662|NCT01827943|21341174|P1|COMPLETED|Overall Study||45
8645663|NCT01827943|21341174|P1|Safety Population|Overall Study||53
8645664|NCT01827943|21341174|P1|STARTED|Overall Study||54
8645665|NCT01473524|21341183|P6|NOT COMPLETED|LTSE Phase||21
8645666|NCT01473524|21341184|P5|NOT COMPLETED|LTSE Phase||17
8645667|NCT01473524|21341185|P4|NOT COMPLETED|LTSE Phase||9
8645668|NCT01473524|21341186|P3|NOT COMPLETED|LTSE Phase||0
8645669|NCT01473524|21341187|P2|NOT COMPLETED|LTSE Phase||0
8645670|NCT01473524|21341188|P1|NOT COMPLETED|LTSE Phase||0
8645671|NCT01473524|21341183|P6|COMPLETED|LTSE Phase||45
8645672|NCT01473524|21341184|P5|COMPLETED|LTSE Phase||47
8645673|NCT01473524|21341185|P4|COMPLETED|LTSE Phase||54
8645674|NCT01473524|21341186|P3|COMPLETED|LTSE Phase||0
8645675|NCT01473524|21341187|P2|COMPLETED|LTSE Phase||0
8645676|NCT01473524|21341188|P1|COMPLETED|LTSE Phase||0
8645677|NCT01473524|21341183|P6|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||66
8645678|NCT01473524|21341184|P5|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||64
8645679|NCT01473524|21341185|P4|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||63
8645680|NCT01473524|21341186|P3|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
8645681|NCT01473524|21341187|P2|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
8645682|NCT01473524|21341188|P1|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
8645683|NCT01473524|21341183|P6|STARTED|LTSE Phase|Four participants in the double-blind placebo group did not enroll in the LTSE phase.|66
8645684|NCT01473524|21341184|P5|STARTED|LTSE Phase||64
8645685|NCT01473524|21341185|P4|STARTED|LTSE Phase|One participant in the double-blind OCA 5-10 mg group did not enroll in the LTSE phase.|63
8645686|NCT01473524|21341186|P3|STARTED|LTSE Phase||0
8645687|NCT01473524|21341187|P2|STARTED|LTSE Phase||0
8645688|NCT01473524|21341188|P1|STARTED|LTSE Phase||0
8645689|NCT01473524|21341183|P6|NOT COMPLETED|DB Phase||0
8645690|NCT01473524|21341184|P5|NOT COMPLETED|DB Phase||0
8645691|NCT01473524|21341185|P4|NOT COMPLETED|DB Phase||0
8645692|NCT01473524|21341186|P3|NOT COMPLETED|DB Phase||3
8645693|NCT01473524|21341187|P2|NOT COMPLETED|DB Phase||9
8645694|NCT01473524|21341188|P1|NOT COMPLETED|DB Phase||7
8645695|NCT01473524|21341183|P6|COMPLETED|DB Phase||0
8645696|NCT01473524|21341184|P5|COMPLETED|DB Phase||0
8645697|NCT01473524|21341185|P4|COMPLETED|DB Phase||0
8645698|NCT01473524|21341186|P3|COMPLETED|DB Phase||70
8645699|NCT01473524|21341187|P2|COMPLETED|DB Phase||64
8645700|NCT01473524|21341188|P1|COMPLETED|DB Phase||64
8645701|NCT01473524|21341183|P6|Received at Least 1 Dose of Study Drug|DB Phase||0
8645702|NCT01473524|21341184|P5|Received at Least 1 Dose of Study Drug|DB Phase||0
8645703|NCT01473524|21341185|P4|Received at Least 1 Dose of Study Drug|DB Phase||0
8645704|NCT01473524|21341186|P3|Received at Least 1 Dose of Study Drug|DB Phase||73
8645705|NCT01473524|21341187|P2|Received at Least 1 Dose of Study Drug|DB Phase||73
8645706|NCT01473524|21341188|P1|Received at Least 1 Dose of Study Drug|DB Phase||70
8645707|NCT01473524|21341183|P6|STARTED|DB Phase||0
8645708|NCT01473524|21341184|P5|STARTED|DB Phase||0
8645709|NCT01473524|21341185|P4|STARTED|DB Phase||0
8645710|NCT01473524|21341186|P3|STARTED|DB Phase||73
8645711|NCT01473524|21341187|P2|STARTED|DB Phase||73
8645712|NCT01473524|21341188|P1|STARTED|DB Phase||71
8645713|NCT01231906|21341237|P2|NOT COMPLETED|Overall Study||101
8645714|NCT01231906|21341238|P1|NOT COMPLETED|Overall Study||121
8645715|NCT01231906|21341237|P2|COMPLETED|Overall Study||222
8645716|NCT01231906|21341238|P1|COMPLETED|Overall Study||198
8645717|NCT01231906|21341237|P2|Received Therapy|Overall Study||318
8645718|NCT01231906|21341238|P1|Received Therapy|Overall Study||308
8645719|NCT01231906|21341237|P2|STARTED|Overall Study||323
8645720|NCT01231906|21341238|P1|STARTED|Overall Study||319
8645721|NCT01216202|21341246|P2|NOT COMPLETED|Overall Study||2
8645722|NCT01216202|21341247|P1|NOT COMPLETED|Overall Study||22
8645723|NCT01216202|21341246|P2|COMPLETED|Overall Study||75
8645724|NCT01216202|21341247|P1|COMPLETED|Overall Study||79
8645725|NCT01216202|21341246|P2|Analysed After RT|Overall Study||0
8645726|NCT01216202|21341247|P1|Analysed After RT|Overall Study||79
8645727|NCT01216202|21341246|P2|Analysed at Baseline|Overall Study||75
8645728|NCT01216202|21341247|P1|Analysed at Baseline|Overall Study||93
8645729|NCT01216202|21341246|P2|STARTED|Overall Study||77
8645730|NCT01216202|21341247|P1|STARTED|Overall Study||101
8645743|NCT00748033|21341286|P2|NOT COMPLETED|Overall Study||1
8645744|NCT00748033|21341287|P1|NOT COMPLETED|Overall Study||0
8645745|NCT00748033|21341286|P2|COMPLETED|Overall Study|One subject participated only in 2 arms due to an adverse event.|12
8645746|NCT00748033|21341287|P1|COMPLETED|Overall Study||12
8645747|NCT00748033|21341286|P2|STARTED|Overall Study||13
8645748|NCT00748033|21341287|P1|STARTED|Overall Study||12
8645749|NCT00507728|21341311|P3|NOT COMPLETED|From 3 Months to 6 Months||9
8645750|NCT00507728|21341312|P2|NOT COMPLETED|From 3 Months to 6 Months||10
8645751|NCT00507728|21341313|P1|NOT COMPLETED|From 3 Months to 6 Months||6
8645752|NCT00507728|21341311|P3|COMPLETED|From 3 Months to 6 Months||61
8645753|NCT00507728|21341312|P2|COMPLETED|From 3 Months to 6 Months||65
8645754|NCT00507728|21341313|P1|COMPLETED|From 3 Months to 6 Months||54
8645755|NCT00507728|21341311|P3|STARTED|From 3 Months to 6 Months||70
8645756|NCT00507728|21341312|P2|STARTED|From 3 Months to 6 Months||75
8645757|NCT00507728|21341313|P1|STARTED|From 3 Months to 6 Months||60
8645758|NCT00507728|21341311|P3|NOT COMPLETED|Randomization to Month 3||20
8645759|NCT00507728|21341312|P2|NOT COMPLETED|Randomization to Month 3||14
8645760|NCT00507728|21341313|P1|NOT COMPLETED|Randomization to Month 3||15
8645761|NCT00507728|21341311|P3|COMPLETED|Randomization to Month 3||70
8645762|NCT00507728|21341312|P2|COMPLETED|Randomization to Month 3||75
8645763|NCT00507728|21341313|P1|COMPLETED|Randomization to Month 3||60
8645764|NCT00507728|21341311|P3|STARTED|Randomization to Month 3||90
8645765|NCT00507728|21341312|P2|STARTED|Randomization to Month 3||89
8645766|NCT00507728|21341313|P1|STARTED|Randomization to Month 3||75
8645767|NCT00003042|21341383|P2|NOT COMPLETED|Overall Study||0
8645768|NCT00003042|21341384|P1|NOT COMPLETED|Overall Study||0
8645769|NCT00003042|21341383|P2|COMPLETED|Overall Study||27
8645770|NCT00003042|21341384|P1|COMPLETED|Overall Study||14
8645771|NCT00003042|21341383|P2|STARTED|Overall Study||27
8645772|NCT00003042|21341384|P1|STARTED|Overall Study||14
8645773|NCT04342130|21341392|P1|NOT COMPLETED|Overall Study||0
8645774|NCT04342130|21341392|P1|COMPLETED|Overall Study||10
8645775|NCT04342130|21341392|P1|STARTED|Overall Study||10
8645776|NCT04247061|21341399|P1|NOT COMPLETED|Overall Study||9
8645777|NCT04247061|21341399|P1|COMPLETED|Overall Study||4
8645778|NCT04247061|21341399|P1|STARTED|Overall Study|13 Subjects completed the required pre-dental appointment study activities and were scheduled to attend the dental clinic|13
8645779|NCT04027439|21341415|P16|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645780|NCT04027439|21341416|P15|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645781|NCT04027439|21341417|P14|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645782|NCT04027439|21341418|P13|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645783|NCT04027439|21341419|P12|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645784|NCT04027439|21341420|P11|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645785|NCT04027439|21341421|P10|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645786|NCT04027439|21341422|P9|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645787|NCT04027439|21341423|P8|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||2
8645788|NCT04027439|21341424|P7|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645789|NCT04027439|21341425|P6|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645790|NCT04027439|21341426|P5|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645791|NCT04027439|21341427|P4|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645792|NCT04027439|21341428|P3|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645793|NCT04027439|21341429|P2|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645794|NCT04027439|21341430|P1|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645795|NCT04027439|21341415|P16|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
8645796|NCT04027439|21341416|P15|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
8645797|NCT04027439|21341417|P14|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
8645798|NCT04027439|21341418|P13|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
8645799|NCT04027439|21341419|P12|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
8645800|NCT04027439|21341420|P11|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
8645801|NCT04027439|21341421|P10|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
8645802|NCT04027439|21341422|P9|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
8645803|NCT04027439|21341423|P8|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day|1 patient discontinued in part b/period 2 and another in part b/period 3.|1
8645804|NCT04027439|21341424|P7|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
8645805|NCT04027439|21341425|P6|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645806|NCT04027439|21341426|P5|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645807|NCT04027439|21341427|P4|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645808|NCT04027439|21341428|P3|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645809|NCT04027439|21341429|P2|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645810|NCT04027439|21341430|P1|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645811|NCT04027439|21341415|P16|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
8645812|NCT04027439|21341416|P15|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
8645813|NCT04027439|21341417|P14|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
8645814|NCT04027439|21341418|P13|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
8645815|NCT04027439|21341419|P12|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
8645816|NCT04027439|21341420|P11|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
8645817|NCT04027439|21341421|P10|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
8645818|NCT04027439|21341422|P9|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
8645819|NCT04027439|21341423|P8|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
8645820|NCT04027439|21341424|P7|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
8645821|NCT04027439|21341425|P6|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645822|NCT04027439|21341426|P5|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645823|NCT04027439|21341427|P4|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645824|NCT04027439|21341428|P3|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645825|NCT04027439|21341429|P2|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645826|NCT04027439|21341430|P1|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
8645827|NCT04027439|21341415|P16|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645828|NCT04027439|21341416|P15|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645829|NCT04027439|21341417|P14|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645830|NCT04027439|21341418|P13|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645831|NCT04027439|21341419|P12|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645832|NCT04027439|21341420|P11|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645833|NCT04027439|21341421|P10|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645834|NCT04027439|21341422|P9|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645835|NCT04027439|21341423|P8|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645836|NCT04027439|21341424|P7|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645837|NCT04027439|21341425|P6|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645838|NCT04027439|21341426|P5|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645839|NCT04027439|21341427|P4|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645840|NCT04027439|21341428|P3|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645841|NCT04027439|21341429|P2|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645842|NCT04027439|21341430|P1|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
8645843|NCT04027439|21341415|P16|COMPLETED|Part A (R, PC, PG) Single Dose||0
8645844|NCT04027439|21341416|P15|COMPLETED|Part A (R, PC, PG) Single Dose||0
8645845|NCT04027439|21341417|P14|COMPLETED|Part A (R, PC, PG) Single Dose||0
8645846|NCT04027439|21341418|P13|COMPLETED|Part A (R, PC, PG) Single Dose||0
8645847|NCT04027439|21341419|P12|COMPLETED|Part A (R, PC, PG) Single Dose||0
8645848|NCT04027439|21341420|P11|COMPLETED|Part A (R, PC, PG) Single Dose||0
8645849|NCT04027439|21341421|P10|COMPLETED|Part A (R, PC, PG) Single Dose||0
8645850|NCT04027439|21341422|P9|COMPLETED|Part A (R, PC, PG) Single Dose||0
8645851|NCT04027439|21341423|P8|COMPLETED|Part A (R, PC, PG) Single Dose||0
8645852|NCT04027439|21341424|P7|COMPLETED|Part A (R, PC, PG) Single Dose||0
8645853|NCT04027439|21341425|P6|COMPLETED|Part A (R, PC, PG) Single Dose||6
8645854|NCT04027439|21341426|P5|COMPLETED|Part A (R, PC, PG) Single Dose||6
8645855|NCT04027439|21341427|P4|COMPLETED|Part A (R, PC, PG) Single Dose||6
8645856|NCT04027439|21341428|P3|COMPLETED|Part A (R, PC, PG) Single Dose||7
8645857|NCT04027439|21341429|P2|COMPLETED|Part A (R, PC, PG) Single Dose||6
8645858|NCT04027439|21341430|P1|COMPLETED|Part A (R, PC, PG) Single Dose||6
8645859|NCT04027439|21341415|P16|STARTED|Part A (R, PC, PG) Single Dose||0
8645860|NCT04027439|21341416|P15|STARTED|Part A (R, PC, PG) Single Dose||0
8645861|NCT04027439|21341417|P14|STARTED|Part A (R, PC, PG) Single Dose||0
8645862|NCT04027439|21341418|P13|STARTED|Part A (R, PC, PG) Single Dose||0
8645863|NCT04027439|21341419|P12|STARTED|Part A (R, PC, PG) Single Dose||0
8645864|NCT04027439|21341420|P11|STARTED|Part A (R, PC, PG) Single Dose||0
8645865|NCT04027439|21341421|P10|STARTED|Part A (R, PC, PG) Single Dose||0
8645866|NCT04027439|21341422|P9|STARTED|Part A (R, PC, PG) Single Dose||0
8645867|NCT04027439|21341423|P8|STARTED|Part A (R, PC, PG) Single Dose||0
8645868|NCT04027439|21341424|P7|STARTED|Part A (R, PC, PG) Single Dose||0
8645869|NCT04027439|21341425|P6|STARTED|Part A (R, PC, PG) Single Dose||6
8645870|NCT04027439|21341426|P5|STARTED|Part A (R, PC, PG) Single Dose||6
8645871|NCT04027439|21341427|P4|STARTED|Part A (R, PC, PG) Single Dose||6
8645872|NCT04027439|21341428|P3|STARTED|Part A (R, PC, PG) Single Dose||7
8645873|NCT04027439|21341429|P2|STARTED|Part A (R, PC, PG) Single Dose||6
8645874|NCT04027439|21341430|P1|STARTED|Part A (R, PC, PG) Single Dose||6
8645875|NCT03948386|21341530|P3|NOT COMPLETED|Overall Study||3
8645876|NCT03948386|21341531|P2|NOT COMPLETED|Overall Study||1
8645877|NCT03948386|21341532|P1|NOT COMPLETED|Overall Study||1
8645878|NCT03948386|21341530|P3|COMPLETED|Overall Study||50
8645879|NCT03948386|21341531|P2|COMPLETED|Overall Study||53
8645880|NCT03948386|21341532|P1|COMPLETED|Overall Study||51
8645881|NCT03948386|21341530|P3|STARTED|Overall Study||53
8645882|NCT03948386|21341531|P2|STARTED|Overall Study||54
8645883|NCT03948386|21341532|P1|STARTED|Overall Study||52
8645884|NCT03881007|21341557|P2|NOT COMPLETED|Last 3 Months||45
8645885|NCT03881007|21341558|P1|NOT COMPLETED|Last 3 Months||44
8645886|NCT03881007|21341557|P2|COMPLETED|Last 3 Months||74
8645887|NCT03881007|21341558|P1|COMPLETED|Last 3 Months||77
8645888|NCT03881007|21341557|P2|STARTED|Last 3 Months||119
8645889|NCT03881007|21341558|P1|STARTED|Last 3 Months||121
8645890|NCT03881007|21341557|P2|NOT COMPLETED|First 3 Months||52
8645891|NCT03881007|21341558|P1|NOT COMPLETED|First 3 Months||51
8645892|NCT03881007|21341557|P2|COMPLETED|First 3 Months||119
8645893|NCT03881007|21341558|P1|COMPLETED|First 3 Months||121
8645894|NCT03881007|21341557|P2|STARTED|First 3 Months||171
8645895|NCT03881007|21341558|P1|STARTED|First 3 Months||172
8645896|NCT03801473|21341578|P2|NOT COMPLETED|Overall Study||2
8645897|NCT03801473|21341579|P1|NOT COMPLETED|Overall Study||3
8645898|NCT03801473|21341578|P2|COMPLETED|Overall Study||19
8645899|NCT03801473|21341579|P1|COMPLETED|Overall Study||18
8645900|NCT03801473|21341578|P2|STARTED|Overall Study||21
8645901|NCT03801473|21341579|P1|STARTED|Overall Study||21
8645908|NCT03573817|21341652|P2|NOT COMPLETED|Overall Study||4
8645909|NCT03573817|21341653|P1|NOT COMPLETED|Overall Study||1
8645910|NCT03573817|21341652|P2|COMPLETED|Overall Study||55
8645911|NCT03573817|21341653|P1|COMPLETED|Overall Study||62
8645912|NCT03573817|21341652|P2|Randomized and Treated With Study Drug|Overall Study||59
8645913|NCT03573817|21341653|P1|Randomized and Treated With Study Drug|Overall Study||63
8645914|NCT03573817|21341652|P2|STARTED|Overall Study||59
8645915|NCT03573817|21341653|P1|STARTED|Overall Study||63
8645949|NCT03275389|21341783|P10|NOT COMPLETED|Overall Study||18
8645950|NCT03275389|21341784|P9|NOT COMPLETED|Overall Study||15
8645951|NCT03275389|21341785|P8|NOT COMPLETED|Overall Study||18
8645952|NCT03275389|21341786|P7|NOT COMPLETED|Overall Study||25
8645953|NCT03275389|21341787|P6|NOT COMPLETED|Overall Study||18
8645954|NCT03275389|21341788|P5|NOT COMPLETED|Overall Study||16
8645955|NCT03275389|21341789|P4|NOT COMPLETED|Overall Study||22
8645956|NCT03275389|21341790|P3|NOT COMPLETED|Overall Study||23
8645957|NCT03275389|21341791|P2|NOT COMPLETED|Overall Study||16
8645958|NCT03275389|21341792|P1|NOT COMPLETED|Overall Study||11
8645959|NCT03275389|21341783|P10|COMPLETED|Overall Study||29
8645960|NCT03275389|21341784|P9|COMPLETED|Overall Study||31
8645961|NCT03275389|21341785|P8|COMPLETED|Overall Study||30
8645962|NCT03275389|21341786|P7|COMPLETED|Overall Study||22
8645963|NCT03275389|21341787|P6|COMPLETED|Overall Study||29
8645964|NCT03275389|21341788|P5|COMPLETED|Overall Study||32
8645965|NCT03275389|21341789|P4|COMPLETED|Overall Study||25
8645966|NCT03275389|21341790|P3|COMPLETED|Overall Study||24
8645967|NCT03275389|21341791|P2|COMPLETED|Overall Study||30
8645968|NCT03275389|21341792|P1|COMPLETED|Overall Study||34
8645969|NCT03275389|21341783|P10|STARTED|Overall Study||47
8645970|NCT03275389|21341784|P9|STARTED|Overall Study||46
8645971|NCT03275389|21341785|P8|STARTED|Overall Study||48
8645972|NCT03275389|21341786|P7|STARTED|Overall Study||47
8645973|NCT03275389|21341787|P6|STARTED|Overall Study||47
8645974|NCT03275389|21341788|P5|STARTED|Overall Study||48
8645975|NCT03275389|21341789|P4|STARTED|Overall Study||47
8645976|NCT03275389|21341790|P3|STARTED|Overall Study||47
8645977|NCT03275389|21341791|P2|STARTED|Overall Study||46
8645978|NCT03275389|21341792|P1|STARTED|Overall Study||45
8645991|NCT03252431|21342438|P2|NOT COMPLETED|Overall Study||9
8645992|NCT03252431|21342439|P1|NOT COMPLETED|Overall Study||11
8645993|NCT03252431|21342438|P2|COMPLETED|Overall Study||187
8645994|NCT03252431|21342439|P1|COMPLETED|Overall Study||186
8645995|NCT03252431|21342438|P2|STARTED|Overall Study||196
8645996|NCT03252431|21342439|P1|STARTED|Overall Study||197
8645997|NCT03202511|21342457|P2|NOT COMPLETED|Overall Study||0
8645998|NCT03202511|21342458|P1|NOT COMPLETED|Overall Study||1
8645999|NCT03202511|21342457|P2|COMPLETED|Overall Study||7
8646000|NCT03202511|21342458|P1|COMPLETED|Overall Study||7
8646001|NCT03202511|21342457|P2|STARTED|Overall Study||7
8646002|NCT03202511|21342458|P1|STARTED|Overall Study||8
8646003|NCT03167359|21342466|P1|NOT COMPLETED|Overall Study||2
8646004|NCT03167359|21342466|P1|COMPLETED|Overall Study||72
8646005|NCT03167359|21342466|P1|STARTED|Overall Study||74
8646006|NCT03165058|21342491|P2|NOT COMPLETED|Overall Study||0
8646007|NCT03165058|21342492|P1|NOT COMPLETED|Overall Study||0
8646008|NCT03165058|21342491|P2|COMPLETED|Overall Study||11
8646009|NCT03165058|21342492|P1|COMPLETED|Overall Study||21
8646010|NCT03165058|21342491|P2|STARTED|Overall Study||11
8646011|NCT03165058|21342492|P1|STARTED|Overall Study||21
8646012|NCT03095456|21342501|P2|NOT COMPLETED|Overall Study||8
8646013|NCT03095456|21342502|P1|NOT COMPLETED|Overall Study||4
8646014|NCT03095456|21342501|P2|COMPLETED|Overall Study||96
8646015|NCT03095456|21342502|P1|COMPLETED|Overall Study||99
8646016|NCT03095456|21342501|P2|STARTED|Overall Study||104
8646017|NCT03095456|21342502|P1|STARTED|Overall Study||103
8646024|NCT03064113|21342547|P4|NOT COMPLETED|Washout (7 Days)||0
8646025|NCT03064113|21342548|P3|NOT COMPLETED|Washout (7 Days)||0
8646026|NCT03064113|21342549|P2|NOT COMPLETED|Washout (7 Days)||0
8646027|NCT03064113|21342550|P1|NOT COMPLETED|Washout (7 Days)||0
8646028|NCT03064113|21342547|P4|COMPLETED|Washout (7 Days)||8
8646029|NCT03064113|21342548|P3|COMPLETED|Washout (7 Days)||8
8646030|NCT03064113|21342549|P2|COMPLETED|Washout (7 Days)||8
8646031|NCT03064113|21342550|P1|COMPLETED|Washout (7 Days)||8
8646032|NCT03064113|21342547|P4|STARTED|Washout (7 Days)||8
8646033|NCT03064113|21342548|P3|STARTED|Washout (7 Days)||8
8646034|NCT03064113|21342549|P2|STARTED|Washout (7 Days)||8
8646035|NCT03064113|21342550|P1|STARTED|Washout (7 Days)||8
8646036|NCT03064113|21342547|P4|NOT COMPLETED|Intervention 4 (2 Days)||0
8646037|NCT03064113|21342548|P3|NOT COMPLETED|Intervention 4 (2 Days)||0
8646038|NCT03064113|21342549|P2|NOT COMPLETED|Intervention 4 (2 Days)||0
8646039|NCT03064113|21342550|P1|NOT COMPLETED|Intervention 4 (2 Days)||0
8646040|NCT03064113|21342547|P4|COMPLETED|Intervention 4 (2 Days)||8
8646041|NCT03064113|21342548|P3|COMPLETED|Intervention 4 (2 Days)||8
8646042|NCT03064113|21342549|P2|COMPLETED|Intervention 4 (2 Days)||8
8646043|NCT03064113|21342550|P1|COMPLETED|Intervention 4 (2 Days)||8
8646044|NCT03064113|21342547|P4|STARTED|Intervention 4 (2 Days)||8
8646045|NCT03064113|21342548|P3|STARTED|Intervention 4 (2 Days)||8
8646046|NCT03064113|21342549|P2|STARTED|Intervention 4 (2 Days)||8
8646047|NCT03064113|21342550|P1|STARTED|Intervention 4 (2 Days)||8
8646048|NCT03064113|21342547|P4|NOT COMPLETED|Washout (7 Days)||0
8646049|NCT03064113|21342548|P3|NOT COMPLETED|Washout (7 Days)||0
8646050|NCT03064113|21342549|P2|NOT COMPLETED|Washout (7 Days)||0
8646051|NCT03064113|21342550|P1|NOT COMPLETED|Washout (7 Days)||0
8646052|NCT03064113|21342547|P4|COMPLETED|Washout (7 Days)||8
8646053|NCT03064113|21342548|P3|COMPLETED|Washout (7 Days)||8
8646054|NCT03064113|21342549|P2|COMPLETED|Washout (7 Days)||8
8646055|NCT03064113|21342550|P1|COMPLETED|Washout (7 Days)||8
8646056|NCT03064113|21342547|P4|STARTED|Washout (7 Days)||8
8646057|NCT03064113|21342548|P3|STARTED|Washout (7 Days)||8
8646058|NCT03064113|21342549|P2|STARTED|Washout (7 Days)||8
8646059|NCT03064113|21342550|P1|STARTED|Washout (7 Days)||8
8646060|NCT03064113|21342547|P4|NOT COMPLETED|Intervention 3 (2 Days)||0
8646061|NCT03064113|21342548|P3|NOT COMPLETED|Intervention 3 (2 Days)||0
8646062|NCT03064113|21342549|P2|NOT COMPLETED|Intervention 3 (2 Days)||0
8646063|NCT03064113|21342550|P1|NOT COMPLETED|Intervention 3 (2 Days)||0
8646064|NCT03064113|21342547|P4|COMPLETED|Intervention 3 (2 Days)||8
8646065|NCT03064113|21342548|P3|COMPLETED|Intervention 3 (2 Days)||8
8646066|NCT03064113|21342549|P2|COMPLETED|Intervention 3 (2 Days)||8
8646067|NCT03064113|21342550|P1|COMPLETED|Intervention 3 (2 Days)||8
8646068|NCT03064113|21342547|P4|STARTED|Intervention 3 (2 Days)||8
8646069|NCT03064113|21342548|P3|STARTED|Intervention 3 (2 Days)||8
8646070|NCT03064113|21342549|P2|STARTED|Intervention 3 (2 Days)||8
8646071|NCT03064113|21342550|P1|STARTED|Intervention 3 (2 Days)||8
8646072|NCT03064113|21342547|P4|NOT COMPLETED|Washout (7 Days)||0
8646073|NCT03064113|21342548|P3|NOT COMPLETED|Washout (7 Days)||0
8646074|NCT03064113|21342549|P2|NOT COMPLETED|Washout (7 Days)||0
8646075|NCT03064113|21342550|P1|NOT COMPLETED|Washout (7 Days)||0
8646076|NCT03064113|21342547|P4|COMPLETED|Washout (7 Days)||8
8646077|NCT03064113|21342548|P3|COMPLETED|Washout (7 Days)||8
8646078|NCT03064113|21342549|P2|COMPLETED|Washout (7 Days)||8
8646079|NCT03064113|21342550|P1|COMPLETED|Washout (7 Days)||8
8646080|NCT03064113|21342547|P4|STARTED|Washout (7 Days)||8
8646081|NCT03064113|21342548|P3|STARTED|Washout (7 Days)||8
8646082|NCT03064113|21342549|P2|STARTED|Washout (7 Days)||8
8646083|NCT03064113|21342550|P1|STARTED|Washout (7 Days)||8
8646084|NCT03064113|21342547|P4|NOT COMPLETED|Intervention 2 (2 Days)||0
8646085|NCT03064113|21342548|P3|NOT COMPLETED|Intervention 2 (2 Days)||0
8646086|NCT03064113|21342549|P2|NOT COMPLETED|Intervention 2 (2 Days)||0
8646087|NCT03064113|21342550|P1|NOT COMPLETED|Intervention 2 (2 Days)||0
8646088|NCT03064113|21342547|P4|COMPLETED|Intervention 2 (2 Days)||8
8646089|NCT03064113|21342548|P3|COMPLETED|Intervention 2 (2 Days)||8
8646090|NCT03064113|21342549|P2|COMPLETED|Intervention 2 (2 Days)||8
8646091|NCT03064113|21342550|P1|COMPLETED|Intervention 2 (2 Days)||8
8646092|NCT03064113|21342547|P4|STARTED|Intervention 2 (2 Days)||8
8646093|NCT03064113|21342548|P3|STARTED|Intervention 2 (2 Days)||8
8646094|NCT03064113|21342549|P2|STARTED|Intervention 2 (2 Days)||8
8646095|NCT03064113|21342550|P1|STARTED|Intervention 2 (2 Days)||8
8646096|NCT03064113|21342547|P4|NOT COMPLETED|Washout (7 Days)||0
8646097|NCT03064113|21342548|P3|NOT COMPLETED|Washout (7 Days)||0
8646098|NCT03064113|21342549|P2|NOT COMPLETED|Washout (7 Days)||0
8646099|NCT03064113|21342550|P1|NOT COMPLETED|Washout (7 Days)||0
8646100|NCT03064113|21342547|P4|COMPLETED|Washout (7 Days)||8
8646101|NCT03064113|21342548|P3|COMPLETED|Washout (7 Days)||8
8646102|NCT03064113|21342549|P2|COMPLETED|Washout (7 Days)||8
8646103|NCT03064113|21342550|P1|COMPLETED|Washout (7 Days)||8
8646104|NCT03064113|21342547|P4|STARTED|Washout (7 Days)||8
8646105|NCT03064113|21342548|P3|STARTED|Washout (7 Days)||8
8646106|NCT03064113|21342549|P2|STARTED|Washout (7 Days)||8
8646107|NCT03064113|21342550|P1|STARTED|Washout (7 Days)||8
8646108|NCT03064113|21342547|P4|NOT COMPLETED|Intervention 1 (2 Days)||0
8646109|NCT03064113|21342548|P3|NOT COMPLETED|Intervention 1 (2 Days)||0
8646110|NCT03064113|21342549|P2|NOT COMPLETED|Intervention 1 (2 Days)||0
8646111|NCT03064113|21342550|P1|NOT COMPLETED|Intervention 1 (2 Days)||0
8646112|NCT03064113|21342547|P4|COMPLETED|Intervention 1 (2 Days)||8
8646113|NCT03064113|21342548|P3|COMPLETED|Intervention 1 (2 Days)||8
8646114|NCT03064113|21342549|P2|COMPLETED|Intervention 1 (2 Days)||8
8646115|NCT03064113|21342550|P1|COMPLETED|Intervention 1 (2 Days)||8
8646116|NCT03064113|21342547|P4|STARTED|Intervention 1 (2 Days)||8
8646117|NCT03064113|21342548|P3|STARTED|Intervention 1 (2 Days)||8
8646118|NCT03064113|21342549|P2|STARTED|Intervention 1 (2 Days)||8
8646119|NCT03064113|21342550|P1|STARTED|Intervention 1 (2 Days)||8
8646120|NCT03031496|21342584|P2|NOT COMPLETED|Period 2||0
8646121|NCT03031496|21342585|P1|NOT COMPLETED|Period 2||0
8646122|NCT03031496|21342584|P2|COMPLETED|Period 2||19
8646123|NCT03031496|21342585|P1|COMPLETED|Period 2||19
8646124|NCT03031496|21342584|P2|STARTED|Period 2||19
8646125|NCT03031496|21342585|P1|STARTED|Period 2||19
8646126|NCT03031496|21342584|P2|NOT COMPLETED|Period 1||2
8646127|NCT03031496|21342585|P1|NOT COMPLETED|Period 1||2
8646128|NCT03031496|21342584|P2|COMPLETED|Period 1||19
8646129|NCT03031496|21342585|P1|COMPLETED|Period 1||19
8646130|NCT03031496|21342584|P2|STARTED|Period 1||21
8646131|NCT03031496|21342585|P1|STARTED|Period 1||21
8646132|NCT03019055|21342625|P4|NOT COMPLETED|Overall Study||0
8646133|NCT03019055|21342626|P3|NOT COMPLETED|Overall Study||0
8646134|NCT03019055|21342627|P2|NOT COMPLETED|Overall Study||0
8646135|NCT03019055|21342628|P1|NOT COMPLETED|Overall Study||0
8646136|NCT03019055|21342625|P4|COMPLETED|Overall Study||20
8646137|NCT03019055|21342626|P3|COMPLETED|Overall Study||3
8646138|NCT03019055|21342627|P2|COMPLETED|Overall Study||3
8646139|NCT03019055|21342628|P1|COMPLETED|Overall Study||0
8646140|NCT03019055|21342625|P4|STARTED|Overall Study||20
8646141|NCT03019055|21342626|P3|STARTED|Overall Study||3
8646142|NCT03019055|21342627|P2|STARTED|Overall Study||3
8646143|NCT03019055|21342628|P1|STARTED|Overall Study||0
8646144|NCT02957682|21342640|P2|NOT COMPLETED|Overall Study||169
8646145|NCT02957682|21342641|P1|NOT COMPLETED|Overall Study||198
8646146|NCT02957682|21342640|P2|COMPLETED|Overall Study||919
8646147|NCT02957682|21342641|P1|COMPLETED|Overall Study||890
8646148|NCT02957682|21342640|P2|Randomized and Treated|Overall Study||1086
8646149|NCT02957682|21342641|P1|Randomized and Treated|Overall Study||1085
8646150|NCT02957682|21342640|P2|STARTED|Overall Study||1088
8646151|NCT02957682|21342641|P1|STARTED|Overall Study||1088
8646158|NCT02841033|21342686|P1|NOT COMPLETED|Overall Study||0
8646159|NCT02841033|21342686|P1|COMPLETED|Overall Study||22
8646160|NCT02841033|21342686|P1|STARTED|Overall Study||22
8646161|NCT02740517|21342696|P3|NOT COMPLETED|Overall Study||0
8646162|NCT02740517|21342697|P2|NOT COMPLETED|Overall Study||0
8646163|NCT02740517|21342698|P1|NOT COMPLETED|Overall Study||0
8646164|NCT02740517|21342696|P3|COMPLETED|Overall Study||18
8646165|NCT02740517|21342697|P2|COMPLETED|Overall Study||11
8646166|NCT02740517|21342698|P1|COMPLETED|Overall Study||19
8646167|NCT02740517|21342696|P3|STARTED|Overall Study||18
8646168|NCT02740517|21342697|P2|STARTED|Overall Study||11
8646169|NCT02740517|21342698|P1|STARTED|Overall Study||19
8646170|NCT02565914|21342709|P1|NOT COMPLETED|Overall Study||93
8646171|NCT02565914|21342709|P1|COMPLETED|Overall Study||951
8646172|NCT02565914|21342709|P1|Safety Set|Overall Study||1042
8646173|NCT02565914|21342709|P1|STARTED|Overall Study||1044
8646174|NCT02518139|21342746|P3|NOT COMPLETED|Overall Study||94
8646175|NCT02518139|21342747|P2|NOT COMPLETED|Overall Study||144
8646176|NCT02518139|21342748|P1|NOT COMPLETED|Overall Study||145
8646177|NCT02518139|21342746|P3|COMPLETED|Overall Study||262
8646178|NCT02518139|21342747|P2|COMPLETED|Overall Study||191
8646179|NCT02518139|21342748|P1|COMPLETED|Overall Study||219
8646180|NCT02518139|21342746|P3|STARTED|Overall Study||356
8646181|NCT02518139|21342747|P2|STARTED|Overall Study||335
8646182|NCT02518139|21342748|P1|STARTED|Overall Study||364
8646183|NCT02512510|21342759|P3|NOT COMPLETED|Overall Study||52
8646184|NCT02512510|21342760|P2|NOT COMPLETED|Overall Study||35
8646185|NCT02512510|21342761|P1|NOT COMPLETED|Overall Study||42
8646186|NCT02512510|21342759|P3|COMPLETED|Overall Study||157
8646187|NCT02512510|21342760|P2|COMPLETED|Overall Study||162
8646188|NCT02512510|21342761|P1|COMPLETED|Overall Study||163
8646189|NCT02512510|21342759|P3|STARTED|Overall Study||209
8646190|NCT02512510|21342760|P2|STARTED|Overall Study||197
8646191|NCT02512510|21342761|P1|STARTED|Overall Study||205
8646195|NCT02459080|21342796|P3|NOT COMPLETED|Overall Study||58
8646196|NCT02459080|21342797|P2|NOT COMPLETED|Overall Study||40
8646197|NCT02459080|21342798|P1|NOT COMPLETED|Overall Study||44
8646198|NCT02459080|21342796|P3|COMPLETED|Overall Study||151
8646199|NCT02459080|21342797|P2|COMPLETED|Overall Study||158
8646200|NCT02459080|21342798|P1|COMPLETED|Overall Study||168
8646201|NCT02459080|21342796|P3|STARTED|Overall Study||209
8646202|NCT02459080|21342797|P2|STARTED|Overall Study||198
8646203|NCT02459080|21342798|P1|STARTED|Overall Study||212
8646204|NCT02436265|21342823|P2|NOT COMPLETED|Overall Study||0
8646205|NCT02436265|21342824|P1|NOT COMPLETED|Overall Study||0
8646206|NCT02436265|21342823|P2|COMPLETED|Overall Study||4
8646207|NCT02436265|21342824|P1|COMPLETED|Overall Study||3
8646208|NCT02436265|21342823|P2|STARTED|Overall Study||4
8646209|NCT02436265|21342824|P1|STARTED|Overall Study||3
8646210|NCT02237157|21342830|P4|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
8646211|NCT02237157|21342831|P3|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
8646212|NCT02237157|21342832|P2|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
8646213|NCT02237157|21342833|P1|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
8646214|NCT02237157|21342830|P4|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||8
8646215|NCT02237157|21342831|P3|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
8646216|NCT02237157|21342832|P2|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
8646217|NCT02237157|21342833|P1|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
8646218|NCT02237157|21342830|P4|STARTED|Gemcitabine, Local Delivery (Dose 4)||8
8646219|NCT02237157|21342831|P3|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
8646220|NCT02237157|21342832|P2|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
8646221|NCT02237157|21342833|P1|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
8646222|NCT02237157|21342830|P4|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
8646223|NCT02237157|21342831|P3|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
8646224|NCT02237157|21342832|P2|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
8646225|NCT02237157|21342833|P1|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
8646226|NCT02237157|21342830|P4|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
8646227|NCT02237157|21342831|P3|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||11
8646228|NCT02237157|21342832|P2|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
8646229|NCT02237157|21342833|P1|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
8646230|NCT02237157|21342830|P4|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
8646231|NCT02237157|21342831|P3|STARTED|Gemcitabine, Local Delivery (Dose 3)||11
8646232|NCT02237157|21342832|P2|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
8646233|NCT02237157|21342833|P1|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
8646234|NCT02237157|21342830|P4|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
8646235|NCT02237157|21342831|P3|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
8646236|NCT02237157|21342832|P2|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
8646237|NCT02237157|21342833|P1|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
8646238|NCT02237157|21342830|P4|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
8646239|NCT02237157|21342831|P3|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
8646240|NCT02237157|21342832|P2|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||15
8646241|NCT02237157|21342833|P1|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
8646242|NCT02237157|21342830|P4|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
8646243|NCT02237157|21342831|P3|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
8646244|NCT02237157|21342832|P2|STARTED|Gemcitabine, Local Delivery (Dose 2)||15
8646245|NCT02237157|21342833|P1|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
8646246|NCT02237157|21342830|P4|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
8646247|NCT02237157|21342831|P3|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
8646248|NCT02237157|21342832|P2|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
8646249|NCT02237157|21342833|P1|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||4
8646250|NCT02237157|21342830|P4|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
8646251|NCT02237157|21342831|P3|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
8646252|NCT02237157|21342832|P2|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
8646253|NCT02237157|21342833|P1|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||16
8646254|NCT02237157|21342830|P4|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
8646255|NCT02237157|21342831|P3|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
8646256|NCT02237157|21342832|P2|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
8646257|NCT02237157|21342833|P1|STARTED|Gemcitabine, Local Delivery (Dose 1)||20
8646258|NCT02152085|21342842|P2|NOT COMPLETED|Overall Study||1
8646259|NCT02152085|21342843|P1|NOT COMPLETED|Overall Study||1
8646260|NCT02152085|21342842|P2|COMPLETED|Overall Study||14
8646261|NCT02152085|21342843|P1|COMPLETED|Overall Study||13
8646262|NCT02152085|21342842|P2|STARTED|Overall Study||15
8646263|NCT02152085|21342843|P1|STARTED|Overall Study||14
8646264|NCT02109172|21342853|P6|NOT COMPLETED|Overall Study||1
8646265|NCT02109172|21342854|P5|NOT COMPLETED|Overall Study||1
8646266|NCT02109172|21342855|P4|NOT COMPLETED|Overall Study||1
8646267|NCT02109172|21342856|P3|NOT COMPLETED|Overall Study||1
8646268|NCT02109172|21342857|P2|NOT COMPLETED|Overall Study||0
8646269|NCT02109172|21342858|P1|NOT COMPLETED|Overall Study||1
8646270|NCT02109172|21342853|P6|COMPLETED|Overall Study||10
8646271|NCT02109172|21342854|P5|COMPLETED|Overall Study||9
8646272|NCT02109172|21342855|P4|COMPLETED|Overall Study||10
8646273|NCT02109172|21342856|P3|COMPLETED|Overall Study||9
8646274|NCT02109172|21342857|P2|COMPLETED|Overall Study||11
8646275|NCT02109172|21342858|P1|COMPLETED|Overall Study||10
8646276|NCT02109172|21342853|P6|STARTED|Overall Study||11
8646277|NCT02109172|21342854|P5|STARTED|Overall Study||10
8646278|NCT02109172|21342855|P4|STARTED|Overall Study||11
8646279|NCT02109172|21342856|P3|STARTED|Overall Study||10
8646280|NCT02109172|21342857|P2|STARTED|Overall Study||11
8646281|NCT02109172|21342858|P1|STARTED|Overall Study||11
8646282|NCT02080364|21342870|P4|NOT COMPLETED|Treatment Period||224
8646283|NCT02080364|21342871|P3|NOT COMPLETED|Treatment Period||237
8646284|NCT02080364|21342872|P2|NOT COMPLETED|Treatment Period||49
8646285|NCT02080364|21342873|P1|NOT COMPLETED|Treatment Period||47
8646286|NCT02080364|21342870|P4|COMPLETED|Treatment Period||4
8646287|NCT02080364|21342871|P3|COMPLETED|Treatment Period||9
8646288|NCT02080364|21342872|P2|COMPLETED|Treatment Period||157
8646289|NCT02080364|21342873|P1|COMPLETED|Treatment Period||148
8646290|NCT02080364|21342870|P4|STARTED|Treatment Period||228
8646291|NCT02080364|21342871|P3|STARTED|Treatment Period||246
8646292|NCT02080364|21342872|P2|STARTED|Treatment Period||206
8646293|NCT02080364|21342873|P1|STARTED|Treatment Period||195
8646294|NCT02080364|21342870|P4|NOT COMPLETED|Baseline Period||0
8646295|NCT02080364|21342871|P3|NOT COMPLETED|Baseline Period||1
8646296|NCT02080364|21342872|P2|NOT COMPLETED|Baseline Period||2
8646297|NCT02080364|21342873|P1|NOT COMPLETED|Baseline Period||2
8646298|NCT02080364|21342870|P4|COMPLETED|Baseline Period||228
8646299|NCT02080364|21342871|P3|COMPLETED|Baseline Period||246
8646300|NCT02080364|21342872|P2|COMPLETED|Baseline Period||206
8646301|NCT02080364|21342873|P1|COMPLETED|Baseline Period||195
8646302|NCT02080364|21342870|P4|STARTED|Baseline Period||228
8646303|NCT02080364|21342871|P3|STARTED|Baseline Period||247
8646304|NCT02080364|21342872|P2|STARTED|Baseline Period||208
8646305|NCT02080364|21342873|P1|STARTED|Baseline Period||197
8646306|NCT02040792|21342918|P5|NOT COMPLETED|Overall Study||7
8646307|NCT02040792|21342919|P4|NOT COMPLETED|Overall Study||7
8646308|NCT02040792|21342920|P3|NOT COMPLETED|Overall Study||3
8646309|NCT02040792|21342921|P2|NOT COMPLETED|Overall Study||3
8646310|NCT02040792|21342922|P1|NOT COMPLETED|Overall Study||6
8646311|NCT02040792|21342918|P5|COMPLETED|Overall Study||67
8646312|NCT02040792|21342919|P4|COMPLETED|Overall Study||64
8646313|NCT02040792|21342920|P3|COMPLETED|Overall Study||68
8646314|NCT02040792|21342921|P2|COMPLETED|Overall Study||65
8646315|NCT02040792|21342922|P1|COMPLETED|Overall Study||64
8646316|NCT02040792|21342918|P5|STARTED|Overall Study||74
8646317|NCT02040792|21342919|P4|STARTED|Overall Study||71
8646318|NCT02040792|21342920|P3|STARTED|Overall Study||71
8646319|NCT02040792|21342921|P2|STARTED|Overall Study||68
8646320|NCT02040792|21342922|P1|STARTED|Overall Study||70
8646321|NCT01847274|21342938|P4|NOT COMPLETED|Overall Study||104
8646322|NCT01847274|21342939|P3|NOT COMPLETED|Overall Study||188
8646323|NCT01847274|21342940|P2|NOT COMPLETED|Overall Study||61
8646324|NCT01847274|21342941|P1|NOT COMPLETED|Overall Study||91
8646325|NCT01847274|21342938|P4|COMPLETED|Overall Study||12
8646326|NCT01847274|21342939|P3|COMPLETED|Overall Study||46
8646327|NCT01847274|21342940|P2|COMPLETED|Overall Study||4
8646328|NCT01847274|21342941|P1|COMPLETED|Overall Study||47
8646329|NCT01847274|21342938|P4|STARTED|Overall Study||116
8646330|NCT01847274|21342939|P3|STARTED|Overall Study||234
8646331|NCT01847274|21342940|P2|STARTED|Overall Study||65
8646332|NCT01847274|21342941|P1|STARTED|Overall Study||138
8646333|NCT01828112|21342997|P2|NOT COMPLETED|Overall Study||108
8646334|NCT01828112|21342998|P1|NOT COMPLETED|Overall Study||82
8646335|NCT01828112|21342997|P2|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
8646336|NCT01828112|21342998|P1|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
8646337|NCT01828112|21342997|P2|Treated|Overall Study||113
8646338|NCT01828112|21342998|P1|Treated|Overall Study||115
8646339|NCT01828112|21342997|P2|Untreated|Overall Study||3
8646340|NCT01828112|21342998|P1|Untreated|Overall Study||0
8646341|NCT01828112|21342997|P2|Untreated Patients|Overall Study|untreated = did not receive study drug|3
8646342|NCT01828112|21342998|P1|Untreated Patients|Overall Study||0
8646343|NCT01828112|21342997|P2|Discontinued From Study|Overall Study||10
8646344|NCT01828112|21342998|P1|Discontinued From Study|Overall Study||14
8646345|NCT01828112|21342997|P2|Entered Survival Follow-up Phase|Overall Study||19
8646346|NCT01828112|21342998|P1|Entered Survival Follow-up Phase|Overall Study||61
8646347|NCT01828112|21342997|P2|Entered Post-treatment Follow-up Phase|Overall Study||5
8646348|NCT01828112|21342998|P1|Entered Post-treatment Follow-up Phase|Overall Study||7
8646349|NCT01828112|21342997|P2|Entered Extension Treatment Phase|Overall Study||74
8646350|NCT01828112|21342998|P1|Entered Extension Treatment Phase|Overall Study||0
8646351|NCT01828112|21342997|P2|STARTED|Overall Study||116
8646352|NCT01828112|21342998|P1|STARTED|Overall Study||115
8646353|NCT01704404|21343004|P6|NOT COMPLETED|Overall Study||0
8646354|NCT01704404|21343005|P5|NOT COMPLETED|Overall Study||1
8646355|NCT01704404|21343006|P4|NOT COMPLETED|Overall Study||3
8646356|NCT01704404|21343007|P3|NOT COMPLETED|Overall Study||1
8646357|NCT01704404|21343008|P2|NOT COMPLETED|Overall Study||1
8646358|NCT01704404|21343009|P1|NOT COMPLETED|Overall Study||1
8646359|NCT01704404|21343004|P6|COMPLETED|Overall Study||9
8646360|NCT01704404|21343005|P5|COMPLETED|Overall Study||10
8646361|NCT01704404|21343006|P4|COMPLETED|Overall Study||8
8646362|NCT01704404|21343007|P3|COMPLETED|Overall Study||9
8646363|NCT01704404|21343008|P2|COMPLETED|Overall Study||9
8646364|NCT01704404|21343009|P1|COMPLETED|Overall Study||10
8646365|NCT01704404|21343004|P6|STARTED|Overall Study||9
8646366|NCT01704404|21343005|P5|STARTED|Overall Study||11
8646367|NCT01704404|21343006|P4|STARTED|Overall Study||11
8646368|NCT01704404|21343007|P3|STARTED|Overall Study||10
8646369|NCT01704404|21343008|P2|STARTED|Overall Study||10
8646370|NCT01704404|21343009|P1|STARTED|Overall Study||11
8646371|NCT01701193|21343047|P4|NOT COMPLETED|Overall Study||2
8646372|NCT01701193|21343048|P3|NOT COMPLETED|Overall Study||1
8646373|NCT01701193|21343049|P2|NOT COMPLETED|Overall Study||2
8646374|NCT01701193|21343050|P1|NOT COMPLETED|Overall Study||3
8646375|NCT01701193|21343047|P4|COMPLETED|Overall Study||3
8646376|NCT01701193|21343048|P3|COMPLETED|Overall Study||4
8646377|NCT01701193|21343049|P2|COMPLETED|Overall Study||17
8646378|NCT01701193|21343050|P1|COMPLETED|Overall Study||15
8646379|NCT01701193|21343047|P4|STARTED|Overall Study||5
8646380|NCT01701193|21343048|P3|STARTED|Overall Study||5
8646381|NCT01701193|21343049|P2|STARTED|Overall Study||19
8646382|NCT01701193|21343050|P1|STARTED|Overall Study||18
8646393|NCT01625013|21343073|P1|NOT COMPLETED|Overall Study||3
8646394|NCT01625013|21343073|P1|COMPLETED|Overall Study||48
8646395|NCT01625013|21343073|P1|STARTED|Overall Study||51
8646402|NCT00904813|21343096|P5|NOT COMPLETED|Overall Study||0
8646403|NCT00904813|21343097|P4|NOT COMPLETED|Overall Study||0
8646404|NCT00904813|21343098|P3|NOT COMPLETED|Overall Study||0
8646405|NCT00904813|21343099|P2|NOT COMPLETED|Overall Study||0
8646406|NCT00904813|21343100|P1|NOT COMPLETED|Overall Study||0
8646407|NCT00904813|21343096|P5|COMPLETED|Overall Study||227
8646408|NCT00904813|21343097|P4|COMPLETED|Overall Study||228
8646409|NCT00904813|21343098|P3|COMPLETED|Overall Study||128
8646410|NCT00904813|21343099|P2|COMPLETED|Overall Study||128
8646411|NCT00904813|21343100|P1|COMPLETED|Overall Study||129
8646412|NCT00904813|21343096|P5|STARTED|Overall Study||227
8646413|NCT00904813|21343097|P4|STARTED|Overall Study||228
8646414|NCT00904813|21343098|P3|STARTED|Overall Study||128
8646415|NCT00904813|21343099|P2|STARTED|Overall Study||128
8646416|NCT00904813|21343100|P1|STARTED|Overall Study||129
8646417|NCT00783367|21343125|P2|NOT COMPLETED|Overall Study||0
8646418|NCT00783367|21343126|P1|NOT COMPLETED|Overall Study||0
8646419|NCT00783367|21343125|P2|COMPLETED|Overall Study||23
8646420|NCT00783367|21343126|P1|COMPLETED|Overall Study||27
8646421|NCT00783367|21343125|P2|STARTED|Overall Study||23
8646422|NCT00783367|21343126|P1|STARTED|Overall Study||27
8646435|NCT04155047|21343165|P2|NOT COMPLETED|Overall Study||0
8646436|NCT04155047|21343166|P1|NOT COMPLETED|Overall Study||2
8646437|NCT04155047|21343165|P2|COMPLETED|Overall Study||11
8646438|NCT04155047|21343166|P1|COMPLETED|Overall Study||9
8646439|NCT04155047|21343165|P2|STARTED|Overall Study||11
8646440|NCT04155047|21343166|P1|STARTED|Overall Study||11
8646441|NCT04029961|21343174|P2|NOT COMPLETED|Overall Study||1
8646442|NCT04029961|21343175|P1|NOT COMPLETED|Overall Study||1
8646443|NCT04029961|21343174|P2|COMPLETED|Overall Study||12
8646444|NCT04029961|21343175|P1|COMPLETED|Overall Study||12
8646445|NCT04029961|21343174|P2|STARTED|Overall Study||13
8646446|NCT04029961|21343175|P1|STARTED|Overall Study||13
8646447|NCT03797872|21343191|P2|NOT COMPLETED|Overall Study||0
8646448|NCT03797872|21343192|P1|NOT COMPLETED|Overall Study||1
8646449|NCT03797872|21343191|P2|COMPLETED|Overall Study||0
8646450|NCT03797872|21343192|P1|COMPLETED|Overall Study||0
8646451|NCT03797872|21343191|P2|STARTED|Overall Study||0
8646452|NCT03797872|21343192|P1|STARTED|Overall Study||1
8646453|NCT03784300|21343210|P6|NOT COMPLETED|Overall Study||0
8646454|NCT03784300|21343211|P5|NOT COMPLETED|Overall Study||0
8646455|NCT03784300|21343212|P4|NOT COMPLETED|Overall Study||0
8646456|NCT03784300|21343213|P3|NOT COMPLETED|Overall Study||0
8646457|NCT03784300|21343214|P2|NOT COMPLETED|Overall Study||0
8646458|NCT03784300|21343215|P1|NOT COMPLETED|Overall Study||0
8646459|NCT03784300|21343210|P6|COMPLETED|Overall Study||2
8646460|NCT03784300|21343211|P5|COMPLETED|Overall Study||6
8646461|NCT03784300|21343212|P4|COMPLETED|Overall Study||2
8646462|NCT03784300|21343213|P3|COMPLETED|Overall Study||6
8646463|NCT03784300|21343214|P2|COMPLETED|Overall Study||2
8646464|NCT03784300|21343215|P1|COMPLETED|Overall Study||6
8646465|NCT03784300|21343210|P6|STARTED|Overall Study||2
8646466|NCT03784300|21343211|P5|STARTED|Overall Study||6
8646467|NCT03784300|21343212|P4|STARTED|Overall Study||2
8646468|NCT03784300|21343213|P3|STARTED|Overall Study||6
8646469|NCT03784300|21343214|P2|STARTED|Overall Study||2
8646470|NCT03784300|21343215|P1|STARTED|Overall Study||6
8646483|NCT03546621|21343344|P4|NOT COMPLETED|Overall Study||3
8646484|NCT03546621|21343345|P3|NOT COMPLETED|Overall Study||2
8646485|NCT03546621|21343346|P2|NOT COMPLETED|Overall Study||3
8646486|NCT03546621|21343347|P1|NOT COMPLETED|Overall Study||0
8646487|NCT03546621|21343344|P4|COMPLETED|Overall Study||25
8646488|NCT03546621|21343345|P3|COMPLETED|Overall Study||28
8646489|NCT03546621|21343346|P2|COMPLETED|Overall Study||29
8646490|NCT03546621|21343347|P1|COMPLETED|Overall Study||28
8646491|NCT03546621|21343344|P4|STARTED|Overall Study|2 patients from Tenofovir only group withdrew from the study before treatment.|28
8646492|NCT03546621|21343345|P3|STARTED|Overall Study||30
8646493|NCT03546621|21343346|P2|STARTED|Overall Study||32
8646494|NCT03546621|21343347|P1|STARTED|Overall Study||28
8646495|NCT03510663|21343397|P8|NOT COMPLETED|Overall Study||0
8646496|NCT03510663|21343398|P7|NOT COMPLETED|Overall Study||0
8646497|NCT03510663|21343399|P6|NOT COMPLETED|Overall Study||0
8646498|NCT03510663|21343400|P5|NOT COMPLETED|Overall Study||0
8646499|NCT03510663|21343401|P4|NOT COMPLETED|Overall Study||0
8646500|NCT03510663|21343402|P3|NOT COMPLETED|Overall Study||0
8646501|NCT03510663|21343403|P2|NOT COMPLETED|Overall Study||1
8646502|NCT03510663|21343404|P1|NOT COMPLETED|Overall Study||0
8646503|NCT03510663|21343397|P8|COMPLETED|Overall Study||6
8646504|NCT03510663|21343398|P7|COMPLETED|Overall Study||6
8646505|NCT03510663|21343399|P6|COMPLETED|Overall Study||6
8646506|NCT03510663|21343400|P5|COMPLETED|Overall Study||6
8646507|NCT03510663|21343401|P4|COMPLETED|Overall Study||6
8646508|NCT03510663|21343402|P3|COMPLETED|Overall Study||6
8646509|NCT03510663|21343403|P2|COMPLETED|Overall Study||5
8646510|NCT03510663|21343404|P1|COMPLETED|Overall Study||6
8646511|NCT03510663|21343397|P8|STARTED|Overall Study||6
8646512|NCT03510663|21343398|P7|STARTED|Overall Study||6
8646513|NCT03510663|21343399|P6|STARTED|Overall Study||6
8646514|NCT03510663|21343400|P5|STARTED|Overall Study||6
8646515|NCT03510663|21343401|P4|STARTED|Overall Study||6
8646516|NCT03510663|21343402|P3|STARTED|Overall Study||6
8646517|NCT03510663|21343403|P2|STARTED|Overall Study||6
8646518|NCT03510663|21343404|P1|STARTED|Overall Study||6
8646519|NCT03478904|21343414|P1|NOT COMPLETED|Overall Study||0
8646520|NCT03478904|21343414|P1|COMPLETED|Overall Study||1
8646521|NCT03478904|21343414|P1|STARTED|Overall Study||1
8646534|NCT03307785|21343478|P11|NOT COMPLETED|Part I: Up to 24 Months||0
8646535|NCT03307785|21343479|P10|NOT COMPLETED|Part I: Up to 24 Months||0
8646536|NCT03307785|21343480|P9|NOT COMPLETED|Part I: Up to 24 Months||0
8646537|NCT03307785|21343481|P8|NOT COMPLETED|Part I: Up to 24 Months||0
8646538|NCT03307785|21343482|P7|NOT COMPLETED|Part I: Up to 24 Months||0
8646539|NCT03307785|21343483|P6|NOT COMPLETED|Part I: Up to 24 Months||0
8646540|NCT03307785|21343484|P5|NOT COMPLETED|Part I: Up to 24 Months||0
8646541|NCT03307785|21343485|P4|NOT COMPLETED|Part I: Up to 24 Months||0
8646542|NCT03307785|21343486|P3|NOT COMPLETED|Part I: Up to 24 Months||0
8646543|NCT03307785|21343487|P2|NOT COMPLETED|Part I: Up to 24 Months||0
8646544|NCT03307785|21343488|P1|NOT COMPLETED|Part I: Up to 24 Months||0
8646545|NCT03307785|21343478|P11|COMPLETED|Part I: Up to 24 Months||0
8646546|NCT03307785|21343479|P10|COMPLETED|Part I: Up to 24 Months||0
8646547|NCT03307785|21343480|P9|COMPLETED|Part I: Up to 24 Months||0
8646548|NCT03307785|21343481|P8|COMPLETED|Part I: Up to 24 Months||0
8646549|NCT03307785|21343482|P7|COMPLETED|Part I: Up to 24 Months||0
8646550|NCT03307785|21343483|P6|COMPLETED|Part I: Up to 24 Months||0
8646551|NCT03307785|21343484|P5|COMPLETED|Part I: Up to 24 Months||0
8646552|NCT03307785|21343485|P4|COMPLETED|Part I: Up to 24 Months||0
8646553|NCT03307785|21343486|P3|COMPLETED|Part I: Up to 24 Months||0
8646554|NCT03307785|21343487|P2|COMPLETED|Part I: Up to 24 Months||0
8646555|NCT03307785|21343488|P1|COMPLETED|Part I: Up to 24 Months||0
8646556|NCT03307785|21343478|P11|STARTED|Part I: Up to 24 Months||0
8646557|NCT03307785|21343479|P10|STARTED|Part I: Up to 24 Months||0
8646558|NCT03307785|21343480|P9|STARTED|Part I: Up to 24 Months||0
8646559|NCT03307785|21343481|P8|STARTED|Part I: Up to 24 Months||0
8646560|NCT03307785|21343482|P7|STARTED|Part I: Up to 24 Months||0
8646561|NCT03307785|21343483|P6|STARTED|Part I: Up to 24 Months||0
8646562|NCT03307785|21343484|P5|STARTED|Part I: Up to 24 Months||0
8646563|NCT03307785|21343485|P4|STARTED|Part I: Up to 24 Months||0
8646564|NCT03307785|21343486|P3|STARTED|Part I: Up to 24 Months||0
8646565|NCT03307785|21343487|P2|STARTED|Part I: Up to 24 Months||0
8646566|NCT03307785|21343488|P1|STARTED|Part I: Up to 24 Months||0
8646567|NCT03307785|21343478|P11|NOT COMPLETED|Part H: Up to 24 Months||0
8646568|NCT03307785|21343479|P10|NOT COMPLETED|Part H: Up to 24 Months||0
8646569|NCT03307785|21343480|P9|NOT COMPLETED|Part H: Up to 24 Months||0
8646570|NCT03307785|21343481|P8|NOT COMPLETED|Part H: Up to 24 Months||0
8646571|NCT03307785|21343482|P7|NOT COMPLETED|Part H: Up to 24 Months||0
8646572|NCT03307785|21343483|P6|NOT COMPLETED|Part H: Up to 24 Months||0
8646573|NCT03307785|21343484|P5|NOT COMPLETED|Part H: Up to 24 Months||0
8646574|NCT03307785|21343485|P4|NOT COMPLETED|Part H: Up to 24 Months||0
8646575|NCT03307785|21343486|P3|NOT COMPLETED|Part H: Up to 24 Months||0
8646576|NCT03307785|21343487|P2|NOT COMPLETED|Part H: Up to 24 Months||0
8646577|NCT03307785|21343488|P1|NOT COMPLETED|Part H: Up to 24 Months||0
8646578|NCT03307785|21343478|P11|COMPLETED|Part H: Up to 24 Months||0
8646579|NCT03307785|21343479|P10|COMPLETED|Part H: Up to 24 Months||0
8646580|NCT03307785|21343480|P9|COMPLETED|Part H: Up to 24 Months||0
8646581|NCT03307785|21343481|P8|COMPLETED|Part H: Up to 24 Months||0
8646582|NCT03307785|21343482|P7|COMPLETED|Part H: Up to 24 Months||0
8646583|NCT03307785|21343483|P6|COMPLETED|Part H: Up to 24 Months||0
8646584|NCT03307785|21343484|P5|COMPLETED|Part H: Up to 24 Months||0
8646585|NCT03307785|21343485|P4|COMPLETED|Part H: Up to 24 Months||0
8646586|NCT03307785|21343486|P3|COMPLETED|Part H: Up to 24 Months||0
8646587|NCT03307785|21343487|P2|COMPLETED|Part H: Up to 24 Months||0
8646588|NCT03307785|21343488|P1|COMPLETED|Part H: Up to 24 Months||0
8646589|NCT03307785|21343478|P11|STARTED|Part H: Up to 24 Months||0
8646590|NCT03307785|21343479|P10|STARTED|Part H: Up to 24 Months||0
8646591|NCT03307785|21343480|P9|STARTED|Part H: Up to 24 Months||0
8646592|NCT03307785|21343481|P8|STARTED|Part H: Up to 24 Months||0
8646593|NCT03307785|21343482|P7|STARTED|Part H: Up to 24 Months||0
8646594|NCT03307785|21343483|P6|STARTED|Part H: Up to 24 Months||0
8646595|NCT03307785|21343484|P5|STARTED|Part H: Up to 24 Months||0
8646596|NCT03307785|21343485|P4|STARTED|Part H: Up to 24 Months||0
8646597|NCT03307785|21343486|P3|STARTED|Part H: Up to 24 Months||0
8646598|NCT03307785|21343487|P2|STARTED|Part H: Up to 24 Months||0
8646599|NCT03307785|21343488|P1|STARTED|Part H: Up to 24 Months||0
8646600|NCT03307785|21343478|P11|NOT COMPLETED|Part G: Up to 24 Months||0
8646601|NCT03307785|21343479|P10|NOT COMPLETED|Part G: Up to 24 Months||0
8646602|NCT03307785|21343480|P9|NOT COMPLETED|Part G: Up to 24 Months||0
8646603|NCT03307785|21343481|P8|NOT COMPLETED|Part G: Up to 24 Months||0
8646604|NCT03307785|21343482|P7|NOT COMPLETED|Part G: Up to 24 Months||0
8646605|NCT03307785|21343483|P6|NOT COMPLETED|Part G: Up to 24 Months||0
8646606|NCT03307785|21343484|P5|NOT COMPLETED|Part G: Up to 24 Months||0
8646607|NCT03307785|21343485|P4|NOT COMPLETED|Part G: Up to 24 Months||0
8646608|NCT03307785|21343486|P3|NOT COMPLETED|Part G: Up to 24 Months||0
8646609|NCT03307785|21343487|P2|NOT COMPLETED|Part G: Up to 24 Months||0
8646610|NCT03307785|21343488|P1|NOT COMPLETED|Part G: Up to 24 Months||0
8646611|NCT03307785|21343478|P11|COMPLETED|Part G: Up to 24 Months||0
8646612|NCT03307785|21343479|P10|COMPLETED|Part G: Up to 24 Months||0
8646613|NCT03307785|21343480|P9|COMPLETED|Part G: Up to 24 Months||0
8646614|NCT03307785|21343481|P8|COMPLETED|Part G: Up to 24 Months||0
8646615|NCT03307785|21343482|P7|COMPLETED|Part G: Up to 24 Months||0
8646616|NCT03307785|21343483|P6|COMPLETED|Part G: Up to 24 Months||0
8646617|NCT03307785|21343484|P5|COMPLETED|Part G: Up to 24 Months||0
8646618|NCT03307785|21343485|P4|COMPLETED|Part G: Up to 24 Months||0
8646619|NCT03307785|21343486|P3|COMPLETED|Part G: Up to 24 Months||0
8646620|NCT03307785|21343487|P2|COMPLETED|Part G: Up to 24 Months||0
8646621|NCT03307785|21343488|P1|COMPLETED|Part G: Up to 24 Months||0
8646622|NCT03307785|21343478|P11|STARTED|Part G: Up to 24 Months||0
8646623|NCT03307785|21343479|P10|STARTED|Part G: Up to 24 Months||0
8646624|NCT03307785|21343480|P9|STARTED|Part G: Up to 24 Months||0
8646625|NCT03307785|21343481|P8|STARTED|Part G: Up to 24 Months||0
8646626|NCT03307785|21343482|P7|STARTED|Part G: Up to 24 Months||0
8646627|NCT03307785|21343483|P6|STARTED|Part G: Up to 24 Months||0
8646628|NCT03307785|21343484|P5|STARTED|Part G: Up to 24 Months||0
8646629|NCT03307785|21343485|P4|STARTED|Part G: Up to 24 Months||0
8646630|NCT03307785|21343486|P3|STARTED|Part G: Up to 24 Months||0
8646631|NCT03307785|21343487|P2|STARTED|Part G: Up to 24 Months||0
8646632|NCT03307785|21343488|P1|STARTED|Part G: Up to 24 Months||0
8646633|NCT03307785|21343478|P11|NOT COMPLETED|Part F: Up to 3.5 Months||0
8646634|NCT03307785|21343479|P10|NOT COMPLETED|Part F: Up to 3.5 Months||0
8646635|NCT03307785|21343480|P9|NOT COMPLETED|Part F: Up to 3.5 Months||0
8646636|NCT03307785|21343481|P8|NOT COMPLETED|Part F: Up to 3.5 Months||1
8646637|NCT03307785|21343482|P7|NOT COMPLETED|Part F: Up to 3.5 Months||0
8646638|NCT03307785|21343483|P6|NOT COMPLETED|Part F: Up to 3.5 Months||0
8646639|NCT03307785|21343484|P5|NOT COMPLETED|Part F: Up to 3.5 Months||0
8646640|NCT03307785|21343485|P4|NOT COMPLETED|Part F: Up to 3.5 Months||0
8646641|NCT03307785|21343486|P3|NOT COMPLETED|Part F: Up to 3.5 Months||0
8646642|NCT03307785|21343487|P2|NOT COMPLETED|Part F: Up to 3.5 Months||0
8646643|NCT03307785|21343488|P1|NOT COMPLETED|Part F: Up to 3.5 Months||0
8646644|NCT03307785|21343478|P11|COMPLETED|Part F: Up to 3.5 Months||0
8646645|NCT03307785|21343479|P10|COMPLETED|Part F: Up to 3.5 Months||0
8646646|NCT03307785|21343480|P9|COMPLETED|Part F: Up to 3.5 Months||0
8646647|NCT03307785|21343481|P8|COMPLETED|Part F: Up to 3.5 Months||0
8646648|NCT03307785|21343482|P7|COMPLETED|Part F: Up to 3.5 Months||0
8646649|NCT03307785|21343483|P6|COMPLETED|Part F: Up to 3.5 Months||0
8646650|NCT03307785|21343484|P5|COMPLETED|Part F: Up to 3.5 Months||0
8646651|NCT03307785|21343485|P4|COMPLETED|Part F: Up to 3.5 Months||0
8646652|NCT03307785|21343486|P3|COMPLETED|Part F: Up to 3.5 Months||0
8646653|NCT03307785|21343487|P2|COMPLETED|Part F: Up to 3.5 Months||0
8646654|NCT03307785|21343488|P1|COMPLETED|Part F: Up to 3.5 Months||0
8646655|NCT03307785|21343478|P11|STARTED|Part F: Up to 3.5 Months||0
8646656|NCT03307785|21343479|P10|STARTED|Part F: Up to 3.5 Months||0
8646657|NCT03307785|21343480|P9|STARTED|Part F: Up to 3.5 Months||0
8646658|NCT03307785|21343481|P8|STARTED|Part F: Up to 3.5 Months||1
8646659|NCT03307785|21343482|P7|STARTED|Part F: Up to 3.5 Months||0
8646660|NCT03307785|21343483|P6|STARTED|Part F: Up to 3.5 Months||0
8646661|NCT03307785|21343484|P5|STARTED|Part F: Up to 3.5 Months||0
8646662|NCT03307785|21343485|P4|STARTED|Part F: Up to 3.5 Months||0
8646663|NCT03307785|21343486|P3|STARTED|Part F: Up to 3.5 Months||0
8646664|NCT03307785|21343487|P2|STARTED|Part F: Up to 3.5 Months||0
8646665|NCT03307785|21343488|P1|STARTED|Part F: Up to 3.5 Months||0
8646666|NCT03307785|21343478|P11|NOT COMPLETED|Part E: Up to 4.4 Months||0
8646667|NCT03307785|21343479|P10|NOT COMPLETED|Part E: Up to 4.4 Months||0
8646668|NCT03307785|21343480|P9|NOT COMPLETED|Part E: Up to 4.4 Months||0
8646669|NCT03307785|21343481|P8|NOT COMPLETED|Part E: Up to 4.4 Months||0
8646670|NCT03307785|21343482|P7|NOT COMPLETED|Part E: Up to 4.4 Months||2
8646671|NCT03307785|21343483|P6|NOT COMPLETED|Part E: Up to 4.4 Months||0
8646672|NCT03307785|21343484|P5|NOT COMPLETED|Part E: Up to 4.4 Months||0
8646673|NCT03307785|21343485|P4|NOT COMPLETED|Part E: Up to 4.4 Months||0
8646674|NCT03307785|21343486|P3|NOT COMPLETED|Part E: Up to 4.4 Months||0
8646675|NCT03307785|21343487|P2|NOT COMPLETED|Part E: Up to 4.4 Months||0
8646676|NCT03307785|21343488|P1|NOT COMPLETED|Part E: Up to 4.4 Months||0
8646677|NCT03307785|21343478|P11|COMPLETED|Part E: Up to 4.4 Months||0
8646678|NCT03307785|21343479|P10|COMPLETED|Part E: Up to 4.4 Months||0
8646679|NCT03307785|21343480|P9|COMPLETED|Part E: Up to 4.4 Months||0
8646680|NCT03307785|21343481|P8|COMPLETED|Part E: Up to 4.4 Months||0
8646681|NCT03307785|21343482|P7|COMPLETED|Part E: Up to 4.4 Months||0
8646682|NCT03307785|21343483|P6|COMPLETED|Part E: Up to 4.4 Months||0
8646683|NCT03307785|21343484|P5|COMPLETED|Part E: Up to 4.4 Months||0
8646684|NCT03307785|21343485|P4|COMPLETED|Part E: Up to 4.4 Months||0
8646685|NCT03307785|21343486|P3|COMPLETED|Part E: Up to 4.4 Months||0
8646686|NCT03307785|21343487|P2|COMPLETED|Part E: Up to 4.4 Months||0
8646687|NCT03307785|21343488|P1|COMPLETED|Part E: Up to 4.4 Months||0
8646688|NCT03307785|21343478|P11|STARTED|Part E: Up to 4.4 Months||0
8646689|NCT03307785|21343479|P10|STARTED|Part E: Up to 4.4 Months||0
8646690|NCT03307785|21343480|P9|STARTED|Part E: Up to 4.4 Months||0
8646691|NCT03307785|21343481|P8|STARTED|Part E: Up to 4.4 Months||0
8646692|NCT03307785|21343482|P7|STARTED|Part E: Up to 4.4 Months||2
8646693|NCT03307785|21343483|P6|STARTED|Part E: Up to 4.4 Months||0
8646694|NCT03307785|21343484|P5|STARTED|Part E: Up to 4.4 Months||0
8646695|NCT03307785|21343485|P4|STARTED|Part E: Up to 4.4 Months||0
8646696|NCT03307785|21343486|P3|STARTED|Part E: Up to 4.4 Months||0
8646697|NCT03307785|21343487|P2|STARTED|Part E: Up to 4.4 Months||0
8646698|NCT03307785|21343488|P1|STARTED|Part E: Up to 4.4 Months||0
8646699|NCT03307785|21343478|P11|NOT COMPLETED|Part D: Up to 9.5 Months||0
8646700|NCT03307785|21343479|P10|NOT COMPLETED|Part D: Up to 9.5 Months||0
8646701|NCT03307785|21343480|P9|NOT COMPLETED|Part D: Up to 9.5 Months||0
8646702|NCT03307785|21343481|P8|NOT COMPLETED|Part D: Up to 9.5 Months||0
8646703|NCT03307785|21343482|P7|NOT COMPLETED|Part D: Up to 9.5 Months||0
8646704|NCT03307785|21343483|P6|NOT COMPLETED|Part D: Up to 9.5 Months||3
8646705|NCT03307785|21343484|P5|NOT COMPLETED|Part D: Up to 9.5 Months||0
8646706|NCT03307785|21343485|P4|NOT COMPLETED|Part D: Up to 9.5 Months||0
8646707|NCT03307785|21343486|P3|NOT COMPLETED|Part D: Up to 9.5 Months||0
8646708|NCT03307785|21343487|P2|NOT COMPLETED|Part D: Up to 9.5 Months||0
8646709|NCT03307785|21343488|P1|NOT COMPLETED|Part D: Up to 9.5 Months||0
8646710|NCT03307785|21343478|P11|COMPLETED|Part D: Up to 9.5 Months||0
8646711|NCT03307785|21343479|P10|COMPLETED|Part D: Up to 9.5 Months||0
8646712|NCT03307785|21343480|P9|COMPLETED|Part D: Up to 9.5 Months||0
8646713|NCT03307785|21343481|P8|COMPLETED|Part D: Up to 9.5 Months||0
8646714|NCT03307785|21343482|P7|COMPLETED|Part D: Up to 9.5 Months||0
8646715|NCT03307785|21343483|P6|COMPLETED|Part D: Up to 9.5 Months||3
8646716|NCT03307785|21343484|P5|COMPLETED|Part D: Up to 9.5 Months||0
8646717|NCT03307785|21343485|P4|COMPLETED|Part D: Up to 9.5 Months||0
8646718|NCT03307785|21343486|P3|COMPLETED|Part D: Up to 9.5 Months||0
8646719|NCT03307785|21343487|P2|COMPLETED|Part D: Up to 9.5 Months||0
8646720|NCT03307785|21343488|P1|COMPLETED|Part D: Up to 9.5 Months||0
8646721|NCT03307785|21343478|P11|STARTED|Part D: Up to 9.5 Months||0
8646722|NCT03307785|21343479|P10|STARTED|Part D: Up to 9.5 Months||0
8646723|NCT03307785|21343480|P9|STARTED|Part D: Up to 9.5 Months||0
8646724|NCT03307785|21343481|P8|STARTED|Part D: Up to 9.5 Months||0
8646725|NCT03307785|21343482|P7|STARTED|Part D: Up to 9.5 Months||0
8646726|NCT03307785|21343483|P6|STARTED|Part D: Up to 9.5 Months||6
8646727|NCT03307785|21343484|P5|STARTED|Part D: Up to 9.5 Months||0
8646728|NCT03307785|21343485|P4|STARTED|Part D: Up to 9.5 Months||0
8646729|NCT03307785|21343486|P3|STARTED|Part D: Up to 9.5 Months||0
8646730|NCT03307785|21343487|P2|STARTED|Part D: Up to 9.5 Months||0
8646731|NCT03307785|21343488|P1|STARTED|Part D: Up to 9.5 Months||0
8646732|NCT03307785|21343478|P11|NOT COMPLETED|Part C: Up to 22.5 Months||0
8646733|NCT03307785|21343479|P10|NOT COMPLETED|Part C: Up to 22.5 Months||0
8646734|NCT03307785|21343480|P9|NOT COMPLETED|Part C: Up to 22.5 Months||0
8646735|NCT03307785|21343481|P8|NOT COMPLETED|Part C: Up to 22.5 Months||0
8646736|NCT03307785|21343482|P7|NOT COMPLETED|Part C: Up to 22.5 Months||0
8646737|NCT03307785|21343483|P6|NOT COMPLETED|Part C: Up to 22.5 Months||0
8646738|NCT03307785|21343484|P5|NOT COMPLETED|Part C: Up to 22.5 Months||7
8646739|NCT03307785|21343485|P4|NOT COMPLETED|Part C: Up to 22.5 Months||6
8646740|NCT03307785|21343486|P3|NOT COMPLETED|Part C: Up to 22.5 Months||0
8646741|NCT03307785|21343487|P2|NOT COMPLETED|Part C: Up to 22.5 Months||0
8646742|NCT03307785|21343488|P1|NOT COMPLETED|Part C: Up to 22.5 Months||0
8646743|NCT03307785|21343478|P11|COMPLETED|Part C: Up to 22.5 Months||0
8646744|NCT03307785|21343479|P10|COMPLETED|Part C: Up to 22.5 Months||0
8646745|NCT03307785|21343480|P9|COMPLETED|Part C: Up to 22.5 Months||0
8646746|NCT03307785|21343481|P8|COMPLETED|Part C: Up to 22.5 Months||0
8646747|NCT03307785|21343482|P7|COMPLETED|Part C: Up to 22.5 Months||0
8646748|NCT03307785|21343483|P6|COMPLETED|Part C: Up to 22.5 Months||0
8646749|NCT03307785|21343484|P5|COMPLETED|Part C: Up to 22.5 Months||0
8646750|NCT03307785|21343485|P4|COMPLETED|Part C: Up to 22.5 Months||0
8646751|NCT03307785|21343486|P3|COMPLETED|Part C: Up to 22.5 Months||0
8646752|NCT03307785|21343487|P2|COMPLETED|Part C: Up to 22.5 Months||0
8646753|NCT03307785|21343488|P1|COMPLETED|Part C: Up to 22.5 Months||0
8646754|NCT03307785|21343478|P11|STARTED|Part C: Up to 22.5 Months||0
8646755|NCT03307785|21343479|P10|STARTED|Part C: Up to 22.5 Months||0
8646756|NCT03307785|21343480|P9|STARTED|Part C: Up to 22.5 Months||0
8646757|NCT03307785|21343481|P8|STARTED|Part C: Up to 22.5 Months||0
8646758|NCT03307785|21343482|P7|STARTED|Part C: Up to 22.5 Months||0
8646759|NCT03307785|21343483|P6|STARTED|Part C: Up to 22.5 Months||0
8646760|NCT03307785|21343484|P5|STARTED|Part C: Up to 22.5 Months||7
8646761|NCT03307785|21343485|P4|STARTED|Part C: Up to 22.5 Months||6
8646762|NCT03307785|21343486|P3|STARTED|Part C: Up to 22.5 Months||0
8646763|NCT03307785|21343487|P2|STARTED|Part C: Up to 22.5 Months||0
8646764|NCT03307785|21343488|P1|STARTED|Part C: Up to 22.5 Months||0
8646765|NCT03307785|21343478|P11|NOT COMPLETED|Part B: Up to 28.5 Months||0
8646766|NCT03307785|21343479|P10|NOT COMPLETED|Part B: Up to 28.5 Months||0
8646767|NCT03307785|21343480|P9|NOT COMPLETED|Part B: Up to 28.5 Months||0
8646768|NCT03307785|21343481|P8|NOT COMPLETED|Part B: Up to 28.5 Months||0
8646769|NCT03307785|21343482|P7|NOT COMPLETED|Part B: Up to 28.5 Months||0
8646770|NCT03307785|21343483|P6|NOT COMPLETED|Part B: Up to 28.5 Months||0
8646771|NCT03307785|21343484|P5|NOT COMPLETED|Part B: Up to 28.5 Months||0
8646772|NCT03307785|21343485|P4|NOT COMPLETED|Part B: Up to 28.5 Months||0
8646773|NCT03307785|21343486|P3|NOT COMPLETED|Part B: Up to 28.5 Months||14
8646774|NCT03307785|21343487|P2|NOT COMPLETED|Part B: Up to 28.5 Months||0
8646775|NCT03307785|21343488|P1|NOT COMPLETED|Part B: Up to 28.5 Months||0
8646776|NCT03307785|21343478|P11|COMPLETED|Part B: Up to 28.5 Months||0
8646777|NCT03307785|21343479|P10|COMPLETED|Part B: Up to 28.5 Months||0
8646778|NCT03307785|21343480|P9|COMPLETED|Part B: Up to 28.5 Months||0
8646779|NCT03307785|21343481|P8|COMPLETED|Part B: Up to 28.5 Months||0
8646780|NCT03307785|21343482|P7|COMPLETED|Part B: Up to 28.5 Months||0
8646781|NCT03307785|21343483|P6|COMPLETED|Part B: Up to 28.5 Months||0
8646782|NCT03307785|21343484|P5|COMPLETED|Part B: Up to 28.5 Months||0
8646783|NCT03307785|21343485|P4|COMPLETED|Part B: Up to 28.5 Months||0
8646784|NCT03307785|21343486|P3|COMPLETED|Part B: Up to 28.5 Months||0
8646785|NCT03307785|21343487|P2|COMPLETED|Part B: Up to 28.5 Months||0
8646786|NCT03307785|21343488|P1|COMPLETED|Part B: Up to 28.5 Months||0
8646787|NCT03307785|21343478|P11|STARTED|Part B: Up to 28.5 Months||0
8646788|NCT03307785|21343479|P10|STARTED|Part B: Up to 28.5 Months||0
8646789|NCT03307785|21343480|P9|STARTED|Part B: Up to 28.5 Months||0
8646790|NCT03307785|21343481|P8|STARTED|Part B: Up to 28.5 Months||0
8646791|NCT03307785|21343482|P7|STARTED|Part B: Up to 28.5 Months||0
8646792|NCT03307785|21343483|P6|STARTED|Part B: Up to 28.5 Months||0
8646793|NCT03307785|21343484|P5|STARTED|Part B: Up to 28.5 Months||0
8646794|NCT03307785|21343485|P4|STARTED|Part B: Up to 28.5 Months||0
8646795|NCT03307785|21343486|P3|STARTED|Part B: Up to 28.5 Months||14
8646796|NCT03307785|21343487|P2|STARTED|Part B: Up to 28.5 Months||0
8646797|NCT03307785|21343488|P1|STARTED|Part B: Up to 28.5 Months||0
8646798|NCT03307785|21343478|P11|NOT COMPLETED|Part A: Up to 28.5 Months||0
8646799|NCT03307785|21343479|P10|NOT COMPLETED|Part A: Up to 28.5 Months||0
8646800|NCT03307785|21343480|P9|NOT COMPLETED|Part A: Up to 28.5 Months||0
8646801|NCT03307785|21343481|P8|NOT COMPLETED|Part A: Up to 28.5 Months||0
8646802|NCT03307785|21343482|P7|NOT COMPLETED|Part A: Up to 28.5 Months||0
8646803|NCT03307785|21343483|P6|NOT COMPLETED|Part A: Up to 28.5 Months||0
8646804|NCT03307785|21343484|P5|NOT COMPLETED|Part A: Up to 28.5 Months||0
8646805|NCT03307785|21343485|P4|NOT COMPLETED|Part A: Up to 28.5 Months||0
8646806|NCT03307785|21343486|P3|NOT COMPLETED|Part A: Up to 28.5 Months||0
8646807|NCT03307785|21343487|P2|NOT COMPLETED|Part A: Up to 28.5 Months||6
8646808|NCT03307785|21343488|P1|NOT COMPLETED|Part A: Up to 28.5 Months||16
8646809|NCT03307785|21343478|P11|COMPLETED|Part A: Up to 28.5 Months||0
8646810|NCT03307785|21343479|P10|COMPLETED|Part A: Up to 28.5 Months||0
8646811|NCT03307785|21343480|P9|COMPLETED|Part A: Up to 28.5 Months||0
8646812|NCT03307785|21343481|P8|COMPLETED|Part A: Up to 28.5 Months||0
8646813|NCT03307785|21343482|P7|COMPLETED|Part A: Up to 28.5 Months||0
8646814|NCT03307785|21343483|P6|COMPLETED|Part A: Up to 28.5 Months||0
8646815|NCT03307785|21343484|P5|COMPLETED|Part A: Up to 28.5 Months||0
8646816|NCT03307785|21343485|P4|COMPLETED|Part A: Up to 28.5 Months||0
8646817|NCT03307785|21343486|P3|COMPLETED|Part A: Up to 28.5 Months||0
8646818|NCT03307785|21343487|P2|COMPLETED|Part A: Up to 28.5 Months||0
8646819|NCT03307785|21343488|P1|COMPLETED|Part A: Up to 28.5 Months||0
8646820|NCT03307785|21343478|P11|STARTED|Part A: Up to 28.5 Months||0
8646821|NCT03307785|21343479|P10|STARTED|Part A: Up to 28.5 Months||0
8646822|NCT03307785|21343480|P9|STARTED|Part A: Up to 28.5 Months||0
8646823|NCT03307785|21343481|P8|STARTED|Part A: Up to 28.5 Months||0
8646824|NCT03307785|21343482|P7|STARTED|Part A: Up to 28.5 Months||0
8646825|NCT03307785|21343483|P6|STARTED|Part A: Up to 28.5 Months||0
8646826|NCT03307785|21343484|P5|STARTED|Part A: Up to 28.5 Months||0
8646827|NCT03307785|21343485|P4|STARTED|Part A: Up to 28.5 Months||0
8646828|NCT03307785|21343486|P3|STARTED|Part A: Up to 28.5 Months||0
8646829|NCT03307785|21343487|P2|STARTED|Part A: Up to 28.5 Months||6
8646830|NCT03307785|21343488|P1|STARTED|Part A: Up to 28.5 Months||16
8646850|NCT03073005|21343872|P4|NOT COMPLETED|Overall Study||13
8646851|NCT03073005|21343873|P3|NOT COMPLETED|Overall Study||12
8646852|NCT03073005|21343874|P2|NOT COMPLETED|Overall Study||12
8646853|NCT03073005|21343875|P1|NOT COMPLETED|Overall Study||8
8646854|NCT03073005|21343872|P4|COMPLETED|Overall Study||24
8646855|NCT03073005|21343873|P3|COMPLETED|Overall Study|24 pairs (24 patients plus their caregivers)|24
8646856|NCT03073005|21343874|P2|COMPLETED|Overall Study||25
8646857|NCT03073005|21343875|P1|COMPLETED|Overall Study|25 pairs (25 patients plus their caregivers)|25
8646858|NCT03073005|21343872|P4|Received Initial Training|Overall Study||33
8646859|NCT03073005|21343873|P3|Received Initial Training|Overall Study|33 pairs (33 patients plus their caregivers)|33
8646860|NCT03073005|21343874|P2|Received Initial Training|Overall Study||29
8646861|NCT03073005|21343875|P1|Received Initial Training|Overall Study|29 pairs (29 patients plus their caregivers)|29
8646862|NCT03073005|21343872|P4|STARTED|Overall Study||37
8646863|NCT03073005|21343873|P3|STARTED|Overall Study||36
8646864|NCT03073005|21343874|P2|STARTED|Overall Study||37
8646865|NCT03073005|21343875|P1|STARTED|Overall Study||33
8646884|NCT02527512|21343963|P2|NOT COMPLETED|Overall Study||6
8646885|NCT02527512|21343964|P1|NOT COMPLETED|Overall Study||8
8646886|NCT02527512|21343963|P2|COMPLETED|Overall Study||76
8646887|NCT02527512|21343964|P1|COMPLETED|Overall Study||77
8646888|NCT02527512|21343963|P2|STARTED|Overall Study||82
8646889|NCT02527512|21343964|P1|STARTED|Overall Study||85
8646902|NCT02413320|21344092|P2|NOT COMPLETED|Overall Study||0
8646903|NCT02413320|21344093|P1|NOT COMPLETED|Overall Study||1
8646904|NCT02413320|21344092|P2|COMPLETED|Overall Study||52
8646905|NCT02413320|21344093|P1|COMPLETED|Overall Study||48
8646906|NCT02413320|21344092|P2|STARTED|Overall Study||52
8646907|NCT02413320|21344093|P1|STARTED|Overall Study||49
8646908|NCT02410837|21344101|P1|NOT COMPLETED|Overall Study||488
8646909|NCT02410837|21344101|P1|COMPLETED|Overall Study||900
8646910|NCT02410837|21344101|P1|24-Month|Overall Study||900
8646911|NCT02410837|21344101|P1|12-Month|Overall Study||1121
8646912|NCT02410837|21344101|P1|1-Month|Overall Study||1374
8646913|NCT02410837|21344101|P1|Procedure|Overall Study||1388
8646914|NCT02410837|21344101|P1|STARTED|Overall Study||1388
8646927|NCT02178956|21344136|P2|NOT COMPLETED|Overall Study||78
8646928|NCT02178956|21344137|P1|NOT COMPLETED|Overall Study||71
8646929|NCT02178956|21344136|P2|COMPLETED|Overall Study||279
8646930|NCT02178956|21344137|P1|COMPLETED|Overall Study||286
8646931|NCT02178956|21344136|P2|STARTED|Overall Study||357
8646932|NCT02178956|21344137|P1|STARTED|Overall Study||357
8646951|NCT02037256|21344254|P2|NOT COMPLETED|Overall Study||3
8646952|NCT02037256|21344255|P1|NOT COMPLETED|Overall Study||0
8646953|NCT02037256|21344254|P2|COMPLETED|Overall Study||17
8646954|NCT02037256|21344255|P1|COMPLETED|Overall Study||3
8646955|NCT02037256|21344254|P2|STARTED|Overall Study||20
8646956|NCT02037256|21344255|P1|STARTED|Overall Study||3
8646967|NCT01485614|21344296|P4|NOT COMPLETED|Weeks 20-54||0
8646968|NCT01485614|21344297|P3|NOT COMPLETED|Weeks 20-54||2
8646969|NCT01485614|21344298|P2|NOT COMPLETED|Weeks 20-54||8
8646970|NCT01485614|21344299|P1|NOT COMPLETED|Weeks 20-54||11
8646971|NCT01485614|21344296|P4|COMPLETED|Weeks 20-54||5
8646972|NCT01485614|21344297|P3|COMPLETED|Weeks 20-54||6
8646973|NCT01485614|21344298|P2|COMPLETED|Weeks 20-54||78
8646974|NCT01485614|21344299|P1|COMPLETED|Weeks 20-54||74
8646975|NCT01485614|21344296|P4|STARTED|Weeks 20-54||5
8646976|NCT01485614|21344297|P3|STARTED|Weeks 20-54||8
8646977|NCT01485614|21344298|P2|STARTED|Weeks 20-54||86
8646978|NCT01485614|21344299|P1|STARTED|Weeks 20-54||85
8646979|NCT01485614|21344296|P4|NOT COMPLETED|Weeks 0-20||0
8646980|NCT01485614|21344297|P3|NOT COMPLETED|Weeks 0-20||1
8646981|NCT01485614|21344298|P2|NOT COMPLETED|Weeks 0-20||4
8646982|NCT01485614|21344299|P1|NOT COMPLETED|Weeks 0-20||10
8646983|NCT01485614|21344296|P4|COMPLETED|Weeks 0-20||5
8646984|NCT01485614|21344297|P3|COMPLETED|Weeks 0-20||8
8646985|NCT01485614|21344298|P2|COMPLETED|Weeks 0-20||86
8646986|NCT01485614|21344299|P1|COMPLETED|Weeks 0-20||85
8646987|NCT01485614|21344296|P4|Treated|Weeks 0-20||5
8646988|NCT01485614|21344297|P3|Treated|Weeks 0-20||9
8646989|NCT01485614|21344298|P2|Treated|Weeks 0-20||90
8646990|NCT01485614|21344299|P1|Treated|Weeks 0-20||95
8646991|NCT01485614|21344296|P4|STARTED|Weeks 0-20||5
8646992|NCT01485614|21344297|P3|STARTED|Weeks 0-20||9
8646993|NCT01485614|21344298|P2|STARTED|Weeks 0-20||90
8646994|NCT01485614|21344299|P1|STARTED|Weeks 0-20||95
8646995|NCT01485614|21344296|P4|NOT COMPLETED|Randomization||0
8646996|NCT01485614|21344297|P3|NOT COMPLETED|Randomization||0
8646997|NCT01485614|21344298|P2|NOT COMPLETED|Randomization||0
8646998|NCT01485614|21344299|P1|NOT COMPLETED|Randomization||1
8646999|NCT01485614|21344296|P4|COMPLETED|Randomization||5
8647000|NCT01485614|21344297|P3|COMPLETED|Randomization||9
8647001|NCT01485614|21344298|P2|COMPLETED|Randomization||90
8647002|NCT01485614|21344299|P1|COMPLETED|Randomization||95
8647003|NCT01485614|21344296|P4|STARTED|Randomization||5
8647004|NCT01485614|21344297|P3|STARTED|Randomization||9
8647005|NCT01485614|21344298|P2|STARTED|Randomization||90
8647006|NCT01485614|21344299|P1|STARTED|Randomization||96
8647007|NCT01204905|21344655|P1|NOT COMPLETED|Overall Study||2
8647008|NCT01204905|21344655|P1|COMPLETED|Overall Study||5
8647009|NCT01204905|21344655|P1|STARTED|Overall Study||7
8647018|NCT01027949|21344701|P1|NOT COMPLETED|Overall Study||686
8647019|NCT01027949|21344701|P1|COMPLETED|Overall Study||208
8647020|NCT01027949|21344701|P1|STARTED|Overall Study||894
8647021|NCT00809783|21344708|P3|NOT COMPLETED|Overall Study||790
8647022|NCT00809783|21344709|P2|NOT COMPLETED|Overall Study||832
8647023|NCT00809783|21344710|P1|NOT COMPLETED|Overall Study||525
8647024|NCT00809783|21344708|P3|COMPLETED|Overall Study||0
8647025|NCT00809783|21344709|P2|COMPLETED|Overall Study||0
8647026|NCT00809783|21344710|P1|COMPLETED|Overall Study||0
8647027|NCT00809783|21344708|P3|Treated|Overall Study||788
8647028|NCT00809783|21344709|P2|Treated|Overall Study||832
8647029|NCT00809783|21344710|P1|Treated|Overall Study||522
8647030|NCT00809783|21344708|P3|STARTED|Overall Study||790
8647031|NCT00809783|21344709|P2|STARTED|Overall Study||832
8647032|NCT00809783|21344710|P1|STARTED|Overall Study||525
8647033|NCT00777491|21344780|P2|NOT COMPLETED|Overall Study||2
8647034|NCT00777491|21344781|P1|NOT COMPLETED|Overall Study||2
8647035|NCT00777491|21344780|P2|COMPLETED|Overall Study||33
8647036|NCT00777491|21344781|P1|COMPLETED|Overall Study||33
8647037|NCT00777491|21344780|P2|Has 3 Year AUASI Data|Overall Study||6
8647038|NCT00777491|21344781|P1|Has 3 Year AUASI Data|Overall Study||6
8647039|NCT00777491|21344780|P2|Has Adverse Event Data (Late)|Overall Study||31
8647040|NCT00777491|21344781|P1|Has Adverse Event Data (Late)|Overall Study||32
8647041|NCT00777491|21344780|P2|Has Adverse Event Data (Treatment)|Overall Study||33
8647042|NCT00777491|21344781|P1|Has Adverse Event Data (Treatment)|Overall Study||33
8647043|NCT00777491|21344780|P2|Started Adjuvant Therapy|Overall Study||31
8647044|NCT00777491|21344781|P1|Started Adjuvant Therapy|Overall Study||32
8647045|NCT00777491|21344780|P2|Started Consolidation Therapy|Overall Study||25
8647046|NCT00777491|21344781|P1|Started Consolidation Therapy|Overall Study||29
8647047|NCT00777491|21344780|P2|Started Induction Therapy|Overall Study||33
8647048|NCT00777491|21344781|P1|Started Induction Therapy|Overall Study||33
8647049|NCT00777491|21344780|P2|Has 3-year Efficacy Data|Overall Study||25
8647050|NCT00777491|21344781|P1|Has 3-year Efficacy Data|Overall Study||27
8647051|NCT00777491|21344780|P2|Eligible|Overall Study||33
8647052|NCT00777491|21344781|P1|Eligible|Overall Study||33
8647053|NCT00777491|21344780|P2|STARTED|Overall Study||35
8647054|NCT00777491|21344781|P1|STARTED|Overall Study||35
8647079|NCT04345653|21344830|P1|NOT COMPLETED|Overall Study||2
8647080|NCT04345653|21344830|P1|COMPLETED|Overall Study||46
8647081|NCT04345653|21344830|P1|STARTED|Overall Study||48
8647094|NCT04249336|21344886|P4|NOT COMPLETED|Overall Study||3
8647095|NCT04249336|21344887|P3|NOT COMPLETED|Overall Study||3
8647096|NCT04249336|21344888|P2|NOT COMPLETED|Overall Study||3
8647097|NCT04249336|21344889|P1|NOT COMPLETED|Overall Study||3
8647098|NCT04249336|21344886|P4|COMPLETED|Overall Study||32
8647099|NCT04249336|21344887|P3|COMPLETED|Overall Study||32
8647100|NCT04249336|21344888|P2|COMPLETED|Overall Study||32
8647101|NCT04249336|21344889|P1|COMPLETED|Overall Study||32
8647102|NCT04249336|21344886|P4|Per Protocol Population Week 4|Overall Study||34
8647103|NCT04249336|21344887|P3|Per Protocol Population Week 4|Overall Study||33
8647104|NCT04249336|21344888|P2|Per Protocol Population Week 4|Overall Study||35
8647105|NCT04249336|21344889|P1|Per Protocol Population Week 4|Overall Study||33
8647106|NCT04249336|21344886|P4|Per Protocol Population Day 3|Overall Study||32
8647107|NCT04249336|21344887|P3|Per Protocol Population Day 3|Overall Study||32
8647108|NCT04249336|21344888|P2|Per Protocol Population Day 3|Overall Study||32
8647109|NCT04249336|21344889|P1|Per Protocol Population Day 3|Overall Study||32
8647110|NCT04249336|21344886|P4|STARTED|Overall Study||35
8647111|NCT04249336|21344887|P3|STARTED|Overall Study||35
8647112|NCT04249336|21344888|P2|STARTED|Overall Study||35
8647113|NCT04249336|21344889|P1|STARTED|Overall Study||35
8647114|NCT04114058|21344909|P2|NOT COMPLETED|Overall Study||0
8647115|NCT04114058|21344910|P1|NOT COMPLETED|Overall Study||0
8647116|NCT04114058|21344909|P2|COMPLETED|Overall Study||17
8647117|NCT04114058|21344910|P1|COMPLETED|Overall Study||20
8647118|NCT04114058|21344909|P2|STARTED|Overall Study||17
8647119|NCT04114058|21344910|P1|STARTED|Overall Study||20
8647120|NCT04089982|21344922|P2|NOT COMPLETED|Overall Study||0
8647121|NCT04089982|21344923|P1|NOT COMPLETED|Overall Study||0
8647122|NCT04089982|21344922|P2|COMPLETED|Overall Study||5
8647123|NCT04089982|21344923|P1|COMPLETED|Overall Study||6
8647124|NCT04089982|21344922|P2|STARTED|Overall Study||5
8647125|NCT04089982|21344923|P1|STARTED|Overall Study||6
8647156|NCT04074941|21344986|P2|NOT COMPLETED|Overall Study||0
8647157|NCT04074941|21344987|P1|NOT COMPLETED|Overall Study||0
8647158|NCT04074941|21344986|P2|COMPLETED|Overall Study||9
8647159|NCT04074941|21344987|P1|COMPLETED|Overall Study||11
8647160|NCT04074941|21344986|P2|STARTED|Overall Study||9
8647161|NCT04074941|21344987|P1|STARTED|Overall Study||11
8647162|NCT04050371|21344999|P2|NOT COMPLETED|Overall Study||0
8647163|NCT04050371|21345000|P1|NOT COMPLETED|Overall Study||1
8647164|NCT04050371|21344999|P2|COMPLETED|Overall Study||24
8647165|NCT04050371|21345000|P1|COMPLETED|Overall Study||23
8647166|NCT04050371|21344999|P2|STARTED|Overall Study||24
8647167|NCT04050371|21345000|P1|STARTED|Overall Study||24
8647168|NCT03966924|21345010|P1|NOT COMPLETED|Overall Study||0
8647169|NCT03966924|21345010|P1|COMPLETED|Overall Study||2
8647170|NCT03966924|21345010|P1|STARTED|Overall Study||2
8647171|NCT03960957|21345018|P2|NOT COMPLETED|Overall Study||6
8647172|NCT03960957|21345019|P1|NOT COMPLETED|Overall Study||8
8647173|NCT03960957|21345018|P2|COMPLETED|Overall Study||71
8647174|NCT03960957|21345019|P1|COMPLETED|Overall Study||216
8647175|NCT03960957|21345018|P2|STARTED|Overall Study||77
8647176|NCT03960957|21345019|P1|STARTED|Overall Study||224
8647177|NCT03910439|21345025|P1|NOT COMPLETED|Overall Study||0
8647178|NCT03910439|21345025|P1|COMPLETED|Overall Study||4
8647179|NCT03910439|21345025|P1|STARTED|Overall Study||4
8647180|NCT03875508|21345041|P1|NOT COMPLETED|Overall Study||12
8647181|NCT03875508|21345041|P1|COMPLETED|Overall Study||96
8647182|NCT03875508|21345041|P1|STARTED|Overall Study||108
8647183|NCT03836989|21345054|P2|NOT COMPLETED|Overall Study||0
8647184|NCT03836989|21345055|P1|NOT COMPLETED|Overall Study||0
8647185|NCT03836989|21345054|P2|COMPLETED|Overall Study||0
8647186|NCT03836989|21345055|P1|COMPLETED|Overall Study||4
8647187|NCT03836989|21345054|P2|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||0
8647188|NCT03836989|21345055|P1|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||1
8647189|NCT03836989|21345054|P2|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||0
8647190|NCT03836989|21345055|P1|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||1
8647191|NCT03836989|21345054|P2|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||0
8647192|NCT03836989|21345055|P1|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||1
8647193|NCT03836989|21345054|P2|Subjects > 60 Years Old With Complete Paralysis|Overall Study||0
8647194|NCT03836989|21345055|P1|Subjects > 60 Years Old With Complete Paralysis|Overall Study||1
8647195|NCT03836989|21345054|P2|STARTED|Overall Study||0
8647196|NCT03836989|21345055|P1|STARTED|Overall Study||4
8647197|NCT03781726|21345081|P1|NOT COMPLETED|Overall Study||2
8647198|NCT03781726|21345081|P1|COMPLETED|Overall Study||28
8647199|NCT03781726|21345081|P1|STARTED|Overall Study||30
8647200|NCT03781336|21345089|P2|NOT COMPLETED|Overall Study||2
8647201|NCT03781336|21345090|P1|NOT COMPLETED|Overall Study||2
8647202|NCT03781336|21345089|P2|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|35
8647203|NCT03781336|21345090|P1|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|43
8647204|NCT03781336|21345089|P2|STARTED|Overall Study||37
8647205|NCT03781336|21345090|P1|STARTED|Overall Study||45
8647206|NCT03762681|21345118|P8|NOT COMPLETED|Part 2a||1
8647207|NCT03762681|21345119|P7|NOT COMPLETED|Part 2a||0
8647208|NCT03762681|21345120|P6|NOT COMPLETED|Part 2a||0
8647209|NCT03762681|21345121|P5|NOT COMPLETED|Part 2a||0
8647210|NCT03762681|21345122|P4|NOT COMPLETED|Part 2a||0
8647211|NCT03762681|21345123|P3|NOT COMPLETED|Part 2a||0
8647212|NCT03762681|21345124|P2|NOT COMPLETED|Part 2a||0
8647213|NCT03762681|21345125|P1|NOT COMPLETED|Part 2a||0
8647214|NCT03762681|21345118|P8|COMPLETED|Part 2a||4
8647215|NCT03762681|21345119|P7|COMPLETED|Part 2a||8
8647216|NCT03762681|21345120|P6|COMPLETED|Part 2a||2
8647217|NCT03762681|21345121|P5|COMPLETED|Part 2a||0
8647218|NCT03762681|21345122|P4|COMPLETED|Part 2a||0
8647219|NCT03762681|21345123|P3|COMPLETED|Part 2a||0
8647220|NCT03762681|21345124|P2|COMPLETED|Part 2a||0
8647221|NCT03762681|21345125|P1|COMPLETED|Part 2a||0
8647222|NCT03762681|21345118|P8|STARTED|Part 2a||5
8647223|NCT03762681|21345119|P7|STARTED|Part 2a||8
8647224|NCT03762681|21345120|P6|STARTED|Part 2a||2
8647225|NCT03762681|21345121|P5|STARTED|Part 2a||0
8647226|NCT03762681|21345122|P4|STARTED|Part 2a||0
8647227|NCT03762681|21345123|P3|STARTED|Part 2a||0
8647228|NCT03762681|21345124|P2|STARTED|Part 2a||0
8647229|NCT03762681|21345125|P1|STARTED|Part 2a||0
8647230|NCT03762681|21345118|P8|NOT COMPLETED|Part 1||0
8647231|NCT03762681|21345119|P7|NOT COMPLETED|Part 1||0
8647232|NCT03762681|21345120|P6|NOT COMPLETED|Part 1||0
8647233|NCT03762681|21345121|P5|NOT COMPLETED|Part 1||0
8647234|NCT03762681|21345122|P4|NOT COMPLETED|Part 1||1
8647235|NCT03762681|21345123|P3|NOT COMPLETED|Part 1||0
8647236|NCT03762681|21345124|P2|NOT COMPLETED|Part 1||0
8647237|NCT03762681|21345125|P1|NOT COMPLETED|Part 1||0
8647238|NCT03762681|21345118|P8|COMPLETED|Part 1||0
8647239|NCT03762681|21345119|P7|COMPLETED|Part 1||0
8647240|NCT03762681|21345120|P6|COMPLETED|Part 1||0
8647241|NCT03762681|21345121|P5|COMPLETED|Part 1||8
8647242|NCT03762681|21345122|P4|COMPLETED|Part 1||7
8647243|NCT03762681|21345123|P3|COMPLETED|Part 1||8
8647244|NCT03762681|21345124|P2|COMPLETED|Part 1||8
8647245|NCT03762681|21345125|P1|COMPLETED|Part 1||8
8647246|NCT03762681|21345118|P8|STARTED|Part 1||0
8647247|NCT03762681|21345119|P7|STARTED|Part 1||0
8647248|NCT03762681|21345120|P6|STARTED|Part 1||0
8647249|NCT03762681|21345121|P5|STARTED|Part 1||8
8647250|NCT03762681|21345122|P4|STARTED|Part 1||8
8647251|NCT03762681|21345123|P3|STARTED|Part 1||8
8647252|NCT03762681|21345124|P2|STARTED|Part 1||8
8647253|NCT03762681|21345125|P1|STARTED|Part 1||8
8647254|NCT03701074|21345231|P2|NOT COMPLETED|Overall Study||0
8647255|NCT03701074|21345232|P1|NOT COMPLETED|Overall Study||1
8647256|NCT03701074|21345231|P2|COMPLETED|Overall Study||0
8647257|NCT03701074|21345232|P1|COMPLETED|Overall Study|Treatment was withdrawn after the 10th dose of oral medication (acetaminophen), on day 3 of treatment, as the infant developed mild abdominal distension which was as per the study protocol|0
8647258|NCT03701074|21345231|P2|STARTED|Overall Study||0
8647259|NCT03701074|21345232|P1|STARTED|Overall Study||1
8647260|NCT03692676|21345242|P4|NOT COMPLETED|Overall Study||3586
8647261|NCT03692676|21345243|P3|NOT COMPLETED|Overall Study||38344
8647262|NCT03692676|21345244|P2|NOT COMPLETED|Overall Study||47438
8647263|NCT03692676|21345245|P1|NOT COMPLETED|Overall Study||9425
8647264|NCT03692676|21345242|P4|COMPLETED|Overall Study||1561
8647265|NCT03692676|21345243|P3|COMPLETED|Overall Study||11135
8647266|NCT03692676|21345244|P2|COMPLETED|Overall Study||3704
8647267|NCT03692676|21345245|P1|COMPLETED|Overall Study||940
8647268|NCT03692676|21345242|P4|STARTED|Overall Study||5147
8647269|NCT03692676|21345243|P3|STARTED|Overall Study||49479
8647270|NCT03692676|21345244|P2|STARTED|Overall Study||51142
8647271|NCT03692676|21345245|P1|STARTED|Overall Study||10365
8647272|NCT03646305|21345263|P4|NOT COMPLETED|Overall Study||2
8647273|NCT03646305|21345264|P3|NOT COMPLETED|Overall Study||2
8647274|NCT03646305|21345265|P2|NOT COMPLETED|Overall Study||2
8647275|NCT03646305|21345266|P1|NOT COMPLETED|Overall Study||5
8647276|NCT03646305|21345263|P4|COMPLETED|Overall Study||31
8647277|NCT03646305|21345264|P3|COMPLETED|Overall Study||31
8647278|NCT03646305|21345265|P2|COMPLETED|Overall Study||33
8647279|NCT03646305|21345266|P1|COMPLETED|Overall Study||27
8647280|NCT03646305|21345263|P4|No Treatment Recieved|Overall Study||1
8647281|NCT03646305|21345264|P3|No Treatment Recieved|Overall Study||1
8647282|NCT03646305|21345265|P2|No Treatment Recieved|Overall Study||0
8647283|NCT03646305|21345266|P1|No Treatment Recieved|Overall Study||1
8647284|NCT03646305|21345263|P4|Received Treatment|Overall Study||32
8647285|NCT03646305|21345264|P3|Received Treatment|Overall Study||32
8647286|NCT03646305|21345265|P2|Received Treatment|Overall Study||35
8647287|NCT03646305|21345266|P1|Received Treatment|Overall Study||31
8647288|NCT03646305|21345263|P4|STARTED|Overall Study||33
8647289|NCT03646305|21345264|P3|STARTED|Overall Study||33
8647290|NCT03646305|21345265|P2|STARTED|Overall Study||35
8647291|NCT03646305|21345266|P1|STARTED|Overall Study||32
8647292|NCT03632954|21345336|P1|NOT COMPLETED|Overall Study||34
8647293|NCT03632954|21345336|P1|COMPLETED|Overall Study||3
8647294|NCT03632954|21345336|P1|STARTED|Overall Study||37
8647311|NCT03571516|21345420|P2|NOT COMPLETED|Overall Study||1
8647312|NCT03571516|21345421|P1|NOT COMPLETED|Overall Study||1
8647313|NCT03571516|21345420|P2|COMPLETED|Overall Study||4
8647314|NCT03571516|21345421|P1|COMPLETED|Overall Study||4
8647315|NCT03571516|21345420|P2|STARTED|Overall Study||5
8647316|NCT03571516|21345421|P1|STARTED|Overall Study||5
8647317|NCT03566823|21345472|P3|NOT COMPLETED|Overall Study||2
8647318|NCT03566823|21345473|P2|NOT COMPLETED|Overall Study||3
8647319|NCT03566823|21345474|P1|NOT COMPLETED|Overall Study||2
8647320|NCT03566823|21345472|P3|COMPLETED|Overall Study||11
8647321|NCT03566823|21345473|P2|COMPLETED|Overall Study||12
8647322|NCT03566823|21345474|P1|COMPLETED|Overall Study||4
8647323|NCT03566823|21345472|P3|STARTED|Overall Study||13
8647324|NCT03566823|21345473|P2|STARTED|Overall Study||15
8647325|NCT03566823|21345474|P1|STARTED|Overall Study||6
8647326|NCT03484273|21345533|P1|NOT COMPLETED|Overall Study||2
8647327|NCT03484273|21345533|P1|COMPLETED|Overall Study|This was a crossover trial. A total of 30 participants completed all 4 arms.|30
8647328|NCT03484273|21345533|P1|STARTED|Overall Study|This was a crossover trial. A total of 32 participants were enrolled in this study.|32
8647329|NCT03478930|21345569|P2|NOT COMPLETED|Overall Study||9
8647330|NCT03478930|21345570|P1|NOT COMPLETED|Overall Study||9
8647331|NCT03478930|21345569|P2|COMPLETED|Overall Study||114
8647332|NCT03478930|21345570|P1|COMPLETED|Overall Study||117
8647333|NCT03478930|21345569|P2|STARTED|Overall Study||123
8647334|NCT03478930|21345570|P1|STARTED|Overall Study||126
8647335|NCT03476239|21345608|P1|NOT COMPLETED|Overall Study||106
8647336|NCT03476239|21345608|P1|COMPLETED|Overall Study||0
8647337|NCT03476239|21345608|P1|Interim Analysis Set|Overall Study||90
8647338|NCT03476239|21345608|P1|Enrolled Before 21 February 2019|Overall Study||91
8647339|NCT03476239|21345608|P1|STARTED|Overall Study||106
8647346|NCT03428100|21345640|P4|NOT COMPLETED|Overall Study||7
8647347|NCT03428100|21345641|P3|NOT COMPLETED|Overall Study||12
8647348|NCT03428100|21345642|P2|NOT COMPLETED|Overall Study||13
8647349|NCT03428100|21345643|P1|NOT COMPLETED|Overall Study||21
8647350|NCT03428100|21345640|P4|COMPLETED|Overall Study||85
8647351|NCT03428100|21345641|P3|COMPLETED|Overall Study||173
8647352|NCT03428100|21345642|P2|COMPLETED|Overall Study||80
8647353|NCT03428100|21345643|P1|COMPLETED|Overall Study||72
8647354|NCT03428100|21345640|P4|Received at Least One Dose of Study Drug|Overall Study||92
8647355|NCT03428100|21345641|P3|Received at Least One Dose of Study Drug|Overall Study||184
8647356|NCT03428100|21345642|P2|Received at Least One Dose of Study Drug|Overall Study||93
8647357|NCT03428100|21345643|P1|Received at Least One Dose of Study Drug|Overall Study||93
8647358|NCT03428100|21345640|P4|STARTED|Overall Study||92
8647359|NCT03428100|21345641|P3|STARTED|Overall Study||185
8647360|NCT03428100|21345642|P2|STARTED|Overall Study||93
8647361|NCT03428100|21345643|P1|STARTED|Overall Study||93
8647362|NCT03421197|21345762|P4|NOT COMPLETED|Overall Study||45
8647363|NCT03421197|21345763|P3|NOT COMPLETED|Overall Study||51
8647364|NCT03421197|21345764|P2|NOT COMPLETED|Overall Study||39
8647365|NCT03421197|21345765|P1|NOT COMPLETED|Overall Study||38
8647366|NCT03421197|21345762|P4|COMPLETED|Overall Study||62
8647367|NCT03421197|21345763|P3|COMPLETED|Overall Study||56
8647368|NCT03421197|21345764|P2|COMPLETED|Overall Study||68
8647369|NCT03421197|21345765|P1|COMPLETED|Overall Study||67
8647370|NCT03421197|21345762|P4|STARTED|Overall Study||107
8647371|NCT03421197|21345763|P3|STARTED|Overall Study||107
8647372|NCT03421197|21345764|P2|STARTED|Overall Study||107
8647373|NCT03421197|21345765|P1|STARTED|Overall Study||105
8647374|NCT03394768|21345779|P1|NOT COMPLETED|Overall Study||0
8647375|NCT03394768|21345779|P1|COMPLETED|Overall Study||26
8647376|NCT03394768|21345779|P1|STARTED|Overall Study||26
8647395|NCT03370302|21345802|P6|NOT COMPLETED|Dose Expansion Phase||0
8647396|NCT03370302|21345803|P5|NOT COMPLETED|Dose Expansion Phase||0
8647397|NCT03370302|21345804|P4|NOT COMPLETED|Dose Expansion Phase||6
8647398|NCT03370302|21345805|P3|NOT COMPLETED|Dose Expansion Phase||0
8647399|NCT03370302|21345806|P2|NOT COMPLETED|Dose Expansion Phase||0
8647400|NCT03370302|21345807|P1|NOT COMPLETED|Dose Expansion Phase||0
8647401|NCT03370302|21345802|P6|COMPLETED|Dose Expansion Phase||0
8647402|NCT03370302|21345803|P5|COMPLETED|Dose Expansion Phase||0
8647403|NCT03370302|21345804|P4|COMPLETED|Dose Expansion Phase||0
8647404|NCT03370302|21345805|P3|COMPLETED|Dose Expansion Phase||0
8647405|NCT03370302|21345806|P2|COMPLETED|Dose Expansion Phase||0
8647406|NCT03370302|21345807|P1|COMPLETED|Dose Expansion Phase||0
8647407|NCT03370302|21345802|P6|STARTED|Dose Expansion Phase||0
8647408|NCT03370302|21345803|P5|STARTED|Dose Expansion Phase||0
8647409|NCT03370302|21345804|P4|STARTED|Dose Expansion Phase||6
8647410|NCT03370302|21345805|P3|STARTED|Dose Expansion Phase||0
8647411|NCT03370302|21345806|P2|STARTED|Dose Expansion Phase||0
8647412|NCT03370302|21345807|P1|STARTED|Dose Expansion Phase||0
8647413|NCT03370302|21345802|P6|NOT COMPLETED|Dose Escalation Phase||3
8647414|NCT03370302|21345803|P5|NOT COMPLETED|Dose Escalation Phase||3
8647415|NCT03370302|21345804|P4|NOT COMPLETED|Dose Escalation Phase||0
8647416|NCT03370302|21345805|P3|NOT COMPLETED|Dose Escalation Phase||7
8647417|NCT03370302|21345806|P2|NOT COMPLETED|Dose Escalation Phase||6
8647418|NCT03370302|21345807|P1|NOT COMPLETED|Dose Escalation Phase||3
8647419|NCT03370302|21345802|P6|COMPLETED|Dose Escalation Phase||0
8647420|NCT03370302|21345803|P5|COMPLETED|Dose Escalation Phase||0
8647421|NCT03370302|21345804|P4|COMPLETED|Dose Escalation Phase||0
8647422|NCT03370302|21345805|P3|COMPLETED|Dose Escalation Phase||0
8647423|NCT03370302|21345806|P2|COMPLETED|Dose Escalation Phase||0
8647424|NCT03370302|21345807|P1|COMPLETED|Dose Escalation Phase||0
8647425|NCT03370302|21345802|P6|STARTED|Dose Escalation Phase||3
8647426|NCT03370302|21345803|P5|STARTED|Dose Escalation Phase||3
8647427|NCT03370302|21345804|P4|STARTED|Dose Escalation Phase||0
8647428|NCT03370302|21345805|P3|STARTED|Dose Escalation Phase||7
8647429|NCT03370302|21345806|P2|STARTED|Dose Escalation Phase||6
8647430|NCT03370302|21345807|P1|STARTED|Dose Escalation Phase||3
8647431|NCT03353753|21345906|P2|NOT COMPLETED|Overall Study||9
8647432|NCT03353753|21345907|P1|NOT COMPLETED|Overall Study||39
8647433|NCT03353753|21345906|P2|COMPLETED|Overall Study||35
8647434|NCT03353753|21345907|P1|COMPLETED|Overall Study||46
8647435|NCT03353753|21345906|P2|STARTED|Overall Study|1 patient was randomized but not dosed|44
8647436|NCT03353753|21345907|P1|STARTED|Overall Study||85
8647437|NCT03351478|21345928|P3|NOT COMPLETED|Overall Study||7
8647438|NCT03351478|21345929|P2|NOT COMPLETED|Overall Study||17
8647439|NCT03351478|21345930|P1|NOT COMPLETED|Overall Study||14
8647440|NCT03351478|21345928|P3|COMPLETED|Overall Study||147
8647441|NCT03351478|21345929|P2|COMPLETED|Overall Study||292
8647442|NCT03351478|21345930|P1|COMPLETED|Overall Study||293
8647443|NCT03351478|21345928|P3|STARTED|Overall Study||154
8647444|NCT03351478|21345929|P2|STARTED|Overall Study||309
8647445|NCT03351478|21345930|P1|STARTED|Overall Study||307
8647446|NCT03332771|21345963|P4|NOT COMPLETED|Overall Study||48
8647447|NCT03332771|21345964|P3|NOT COMPLETED|Overall Study||32
8647448|NCT03332771|21345965|P2|NOT COMPLETED|Overall Study||51
8647449|NCT03332771|21345966|P1|NOT COMPLETED|Overall Study||34
8647450|NCT03332771|21345963|P4|COMPLETED|Overall Study||270
8647451|NCT03332771|21345964|P3|COMPLETED|Overall Study||128
8647452|NCT03332771|21345965|P2|COMPLETED|Overall Study||266
8647453|NCT03332771|21345966|P1|COMPLETED|Overall Study||125
8647454|NCT03332771|21345963|P4|STARTED|Overall Study||318
8647455|NCT03332771|21345964|P3|STARTED|Overall Study||160
8647456|NCT03332771|21345965|P2|STARTED|Overall Study||317
8647457|NCT03332771|21345966|P1|STARTED|Overall Study||159
8647458|NCT03330041|21346004|P1|NOT COMPLETED|Overall Study||2
8647459|NCT03330041|21346004|P1|COMPLETED|Overall Study||48
8647460|NCT03330041|21346004|P1|STARTED|Overall Study||50
8647461|NCT03292653|21346017|P3|NOT COMPLETED|Overall Study||1
8647462|NCT03292653|21346018|P2|NOT COMPLETED|Overall Study||0
8647463|NCT03292653|21346019|P1|NOT COMPLETED|Overall Study||1
8647464|NCT03292653|21346017|P3|COMPLETED|Overall Study||10
8647465|NCT03292653|21346018|P2|COMPLETED|Overall Study||10
8647466|NCT03292653|21346019|P1|COMPLETED|Overall Study||10
8647467|NCT03292653|21346017|P3|STARTED|Overall Study||11
8647468|NCT03292653|21346018|P2|STARTED|Overall Study||10
8647469|NCT03292653|21346019|P1|STARTED|Overall Study||11
8647470|NCT03286543|21346050|P3|NOT COMPLETED|Study Enrollment||7
8647471|NCT03286543|21346051|P2|NOT COMPLETED|Study Enrollment||6
8647472|NCT03286543|21346052|P1|NOT COMPLETED|Study Enrollment||0
8647473|NCT03286543|21346050|P3|COMPLETED|Study Enrollment||16
8647474|NCT03286543|21346051|P2|COMPLETED|Study Enrollment||12
8647475|NCT03286543|21346052|P1|COMPLETED|Study Enrollment||0
8647476|NCT03286543|21346050|P3|Per Protocol Set|Study Enrollment||16
8647477|NCT03286543|21346051|P2|Per Protocol Set|Study Enrollment||7
8647478|NCT03286543|21346052|P1|Per Protocol Set|Study Enrollment||0
8647479|NCT03286543|21346050|P3|Intent to Treat Set|Study Enrollment||19
8647480|NCT03286543|21346051|P2|Intent to Treat Set|Study Enrollment||18
8647481|NCT03286543|21346052|P1|Intent to Treat Set|Study Enrollment||0
8647482|NCT03286543|21346050|P3|STARTED|Study Enrollment||23
8647483|NCT03286543|21346051|P2|STARTED|Study Enrollment||18
8647484|NCT03286543|21346052|P1|STARTED|Study Enrollment||0
8647485|NCT03286543|21346050|P3|NOT COMPLETED|Consented||0
8647486|NCT03286543|21346051|P2|NOT COMPLETED|Consented||0
8647487|NCT03286543|21346052|P1|NOT COMPLETED|Consented||19
8647488|NCT03286543|21346050|P3|COMPLETED|Consented||0
8647489|NCT03286543|21346051|P2|COMPLETED|Consented||0
8647490|NCT03286543|21346052|P1|COMPLETED|Consented||28
8647491|NCT03286543|21346050|P3|Per Protocol Set|Consented||0
8647492|NCT03286543|21346051|P2|Per Protocol Set|Consented||0
8647493|NCT03286543|21346052|P1|Per Protocol Set|Consented||23
8647494|NCT03286543|21346050|P3|Intent to Treat Set|Consented||0
8647495|NCT03286543|21346051|P2|Intent to Treat Set|Consented||0
8647496|NCT03286543|21346052|P1|Intent to Treat Set|Consented||37
8647497|NCT03286543|21346050|P3|Enrolled|Consented||0
8647498|NCT03286543|21346051|P2|Enrolled|Consented||0
8647499|NCT03286543|21346052|P1|Enrolled|Consented||41
8647500|NCT03286543|21346050|P3|Randomized|Consented||0
8647501|NCT03286543|21346051|P2|Randomized|Consented||0
8647502|NCT03286543|21346052|P1|Randomized|Consented||45
8647503|NCT03286543|21346050|P3|STARTED|Consented||0
8647504|NCT03286543|21346051|P2|STARTED|Consented||0
8647505|NCT03286543|21346052|P1|STARTED|Consented||47
8647506|NCT03285594|21346096|P3|NOT COMPLETED|Overall Study||37
8647507|NCT03285594|21346097|P2|NOT COMPLETED|Overall Study||11
8647508|NCT03285594|21346098|P1|NOT COMPLETED|Overall Study||15
8647509|NCT03285594|21346096|P3|COMPLETED|Overall Study||249
8647510|NCT03285594|21346097|P2|COMPLETED|Overall Study||130
8647511|NCT03285594|21346098|P1|COMPLETED|Overall Study||129
8647512|NCT03285594|21346096|P3|Treated|Overall Study||285
8647513|NCT03285594|21346097|P2|Treated|Overall Study||141
8647514|NCT03285594|21346098|P1|Treated|Overall Study||144
8647515|NCT03285594|21346096|P3|STARTED|Overall Study||286
8647516|NCT03285594|21346097|P2|STARTED|Overall Study||141
8647517|NCT03285594|21346098|P1|STARTED|Overall Study||144
8647518|NCT03275766|21346134|P4|NOT COMPLETED|Overall Study||6
8647519|NCT03275766|21346135|P3|NOT COMPLETED|Overall Study||4
8647520|NCT03275766|21346136|P2|NOT COMPLETED|Overall Study||7
8647521|NCT03275766|21346137|P1|NOT COMPLETED|Overall Study||5
8647522|NCT03275766|21346134|P4|COMPLETED|Overall Study||4
8647523|NCT03275766|21346135|P3|COMPLETED|Overall Study||7
8647524|NCT03275766|21346136|P2|COMPLETED|Overall Study||5
8647525|NCT03275766|21346137|P1|COMPLETED|Overall Study||7
8647526|NCT03275766|21346134|P4|Received Intervention|Overall Study||9
8647527|NCT03275766|21346135|P3|Received Intervention|Overall Study||10
8647528|NCT03275766|21346136|P2|Received Intervention|Overall Study||11
8647529|NCT03275766|21346137|P1|Received Intervention|Overall Study||9
8647530|NCT03275766|21346134|P4|STARTED|Overall Study||10
8647531|NCT03275766|21346135|P3|STARTED|Overall Study||11
8647532|NCT03275766|21346136|P2|STARTED|Overall Study||12
8647533|NCT03275766|21346137|P1|STARTED|Overall Study||12
8647534|NCT03264066|21346153|P6|NOT COMPLETED|Overall Study||3
8647535|NCT03264066|21346154|P5|NOT COMPLETED|Overall Study||7
8647536|NCT03264066|21346155|P4|NOT COMPLETED|Overall Study||20
8647537|NCT03264066|21346156|P3|NOT COMPLETED|Overall Study||17
8647538|NCT03264066|21346157|P2|NOT COMPLETED|Overall Study||20
8647539|NCT03264066|21346158|P1|NOT COMPLETED|Overall Study||20
8647540|NCT03264066|21346153|P6|COMPLETED|Overall Study||0
8647541|NCT03264066|21346154|P5|COMPLETED|Overall Study||0
8647542|NCT03264066|21346155|P4|COMPLETED|Overall Study||0
8647543|NCT03264066|21346156|P3|COMPLETED|Overall Study||0
8647544|NCT03264066|21346157|P2|COMPLETED|Overall Study||0
8647545|NCT03264066|21346158|P1|COMPLETED|Overall Study||0
8647546|NCT03264066|21346153|P6|STARTED|Overall Study||3
8647547|NCT03264066|21346154|P5|STARTED|Overall Study||7
8647548|NCT03264066|21346155|P4|STARTED|Overall Study||20
8647549|NCT03264066|21346156|P3|STARTED|Overall Study||17
8647550|NCT03264066|21346157|P2|STARTED|Overall Study||20
8647551|NCT03264066|21346158|P1|STARTED|Overall Study||20
8647552|NCT03222141|21346212|P1|NOT COMPLETED|Overall Study||18
8647553|NCT03222141|21346212|P1|COMPLETED|Overall Study||565
8647554|NCT03222141|21346212|P1|STARTED|Overall Study||583
8647555|NCT03214406|21346220|P2|NOT COMPLETED|Overall Study||15
8647556|NCT03214406|21346221|P1|NOT COMPLETED|Overall Study||10
8647557|NCT03214406|21346220|P2|COMPLETED|Overall Study||78
8647558|NCT03214406|21346221|P1|COMPLETED|Overall Study||78
8647559|NCT03214406|21346220|P2|STARTED|Overall Study||93
8647560|NCT03214406|21346221|P1|STARTED|Overall Study||88
8647561|NCT03193398|21346233|P2|NOT COMPLETED|Overall Study||16
8647562|NCT03193398|21346234|P1|NOT COMPLETED|Overall Study||15
8647563|NCT03193398|21346233|P2|COMPLETED|Overall Study||35
8647564|NCT03193398|21346234|P1|COMPLETED|Overall Study||38
8647565|NCT03193398|21346233|P2|STARTED|Overall Study||51
8647566|NCT03193398|21346234|P1|STARTED|Overall Study||53
8647567|NCT03177512|21346252|P2|NOT COMPLETED|Overall Study||3
8647568|NCT03177512|21346253|P1|NOT COMPLETED|Overall Study||9
8647569|NCT03177512|21346252|P2|COMPLETED|Overall Study||18
8647570|NCT03177512|21346253|P1|COMPLETED|Overall Study||31
8647571|NCT03177512|21346252|P2|STARTED|Overall Study||21
8647572|NCT03177512|21346253|P1|STARTED|Overall Study||40
8647573|NCT03143894|21346273|P2|NOT COMPLETED|Second Intervention (5 Days)||1
8647574|NCT03143894|21346274|P1|NOT COMPLETED|Second Intervention (5 Days)||0
8647575|NCT03143894|21346273|P2|COMPLETED|Second Intervention (5 Days)||3
8647576|NCT03143894|21346274|P1|COMPLETED|Second Intervention (5 Days)||3
8647577|NCT03143894|21346273|P2|STARTED|Second Intervention (5 Days)||4
8647578|NCT03143894|21346274|P1|STARTED|Second Intervention (5 Days)||3
8647579|NCT03143894|21346273|P2|NOT COMPLETED|Washout (4 Weeks)||0
8647580|NCT03143894|21346274|P1|NOT COMPLETED|Washout (4 Weeks)||0
8647581|NCT03143894|21346273|P2|COMPLETED|Washout (4 Weeks)||4
8647582|NCT03143894|21346274|P1|COMPLETED|Washout (4 Weeks)||3
8647583|NCT03143894|21346273|P2|STARTED|Washout (4 Weeks)||4
8647584|NCT03143894|21346274|P1|STARTED|Washout (4 Weeks)||3
8647585|NCT03143894|21346273|P2|NOT COMPLETED|First Intervention (5 Days)||0
8647586|NCT03143894|21346274|P1|NOT COMPLETED|First Intervention (5 Days)||0
8647587|NCT03143894|21346273|P2|COMPLETED|First Intervention (5 Days)||4
8647588|NCT03143894|21346274|P1|COMPLETED|First Intervention (5 Days)||3
8647589|NCT03143894|21346273|P2|STARTED|First Intervention (5 Days)||4
8647590|NCT03143894|21346274|P1|STARTED|First Intervention (5 Days)||3
8647591|NCT03113955|21346284|P1|NOT COMPLETED|Overall Study||17
8647592|NCT03113955|21346284|P1|COMPLETED|Overall Study||92
8647593|NCT03113955|21346284|P1|STARTED|Overall Study||109
8647594|NCT03111732|21346295|P1|NOT COMPLETED|Overall Study||5
8647595|NCT03111732|21346295|P1|COMPLETED|Overall Study||6
8647596|NCT03111732|21346295|P1|STARTED|Overall Study||11
8647600|NCT03093350|21346322|P1|NOT COMPLETED|Overall Study||2
8647601|NCT03093350|21346322|P1|COMPLETED|Overall Study||10
8647602|NCT03093350|21346322|P1|Started Treatment|Overall Study||10
8647603|NCT03093350|21346322|P1|STARTED|Overall Study||12
8647604|NCT03071263|21346330|P2|NOT COMPLETED|Overall Study||7
8647605|NCT03071263|21346331|P1|NOT COMPLETED|Overall Study||3
8647606|NCT03071263|21346330|P2|COMPLETED|Overall Study||141
8647607|NCT03071263|21346331|P1|COMPLETED|Overall Study||144
8647608|NCT03071263|21346330|P2|STARTED|Overall Study||148
8647609|NCT03071263|21346331|P1|STARTED|Overall Study||147
8647610|NCT03066830|21346357|P2|NOT COMPLETED|Overall Study||22
8647611|NCT03066830|21346358|P1|NOT COMPLETED|Overall Study||33
8647612|NCT03066830|21346357|P2|COMPLETED|Overall Study||231
8647613|NCT03066830|21346358|P1|COMPLETED|Overall Study||221
8647614|NCT03066830|21346357|P2|STARTED|Overall Study||253
8647615|NCT03066830|21346358|P1|STARTED|Overall Study||254
8647631|NCT02926950|21346426|P2|NOT COMPLETED|Overall Study||48
8647632|NCT02926950|21346427|P1|NOT COMPLETED|Overall Study||49
8647633|NCT02926950|21346426|P2|COMPLETED|Overall Study||211
8647634|NCT02926950|21346427|P1|COMPLETED|Overall Study||210
8647635|NCT02926950|21346426|P2|STARTED|Overall Study||259
8647636|NCT02926950|21346427|P1|STARTED|Overall Study||259
8647637|NCT02901899|21346449|P1|NOT COMPLETED|Follow up||16
8647638|NCT02901899|21346449|P1|COMPLETED|Follow up||27
8647639|NCT02901899|21346449|P1|STARTED|Follow up|All patients who receive at least one dose of study drug go into the follow up period.|43
8647640|NCT02901899|21346449|P1|NOT COMPLETED|Continued Treatment After 1st Response||16
8647641|NCT02901899|21346449|P1|COMPLETED|Continued Treatment After 1st Response||21
8647642|NCT02901899|21346449|P1|Went on to Start Cycle 3|Continued Treatment After 1st Response||21
8647643|NCT02901899|21346449|P1|STARTED|Continued Treatment After 1st Response||37
8647644|NCT02901899|21346449|P1|NOT COMPLETED|Reached 1st Response Assessment||8
8647645|NCT02901899|21346449|P1|COMPLETED|Reached 1st Response Assessment||37
8647646|NCT02901899|21346449|P1|Attempted 2 Cycles of Treatment/Reached First Response|Reached 1st Response Assessment||37
8647647|NCT02901899|21346449|P1|Started Treatment|Reached 1st Response Assessment||43
8647648|NCT02901899|21346449|P1|Registered|Reached 1st Response Assessment||45
8647649|NCT02901899|21346449|P1|STARTED|Reached 1st Response Assessment||45
8647650|NCT02859324|21346458|P3|NOT COMPLETED|Overall Study||5
8647651|NCT02859324|21346459|P2|NOT COMPLETED|Overall Study||9
8647652|NCT02859324|21346460|P1|NOT COMPLETED|Overall Study||7
8647653|NCT02859324|21346458|P3|COMPLETED|Overall Study||0
8647654|NCT02859324|21346459|P2|COMPLETED|Overall Study||0
8647655|NCT02859324|21346460|P1|COMPLETED|Overall Study||0
8647656|NCT02859324|21346458|P3|STARTED|Overall Study||5
8647657|NCT02859324|21346459|P2|STARTED|Overall Study||9
8647658|NCT02859324|21346460|P1|STARTED|Overall Study||7
8647659|NCT02848833|21346504|P1|NOT COMPLETED|Overall Study||137
8647660|NCT02848833|21346504|P1|COMPLETED|Overall Study||3231
8647661|NCT02848833|21346504|P1|STARTED|Overall Study||3368
8647662|NCT02792231|21346522|P2|NOT COMPLETED|Overall Study||85
8647663|NCT02792231|21346523|P1|NOT COMPLETED|Overall Study||84
8647664|NCT02792231|21346522|P2|COMPLETED|Overall Study||389
8647665|NCT02792231|21346523|P1|COMPLETED|Overall Study||397
8647666|NCT02792231|21346522|P2|Off Study Drug at Interim Cut Off|Overall Study||19
8647667|NCT02792231|21346523|P1|Off Study Drug at Interim Cut Off|Overall Study||14
8647668|NCT02792231|21346522|P2|On Study Drug at Interim Cut Off|Overall Study||370
8647669|NCT02792231|21346523|P1|On Study Drug at Interim Cut Off|Overall Study||383
8647670|NCT02792231|21346522|P2|STARTED|Overall Study||474
8647671|NCT02792231|21346523|P1|STARTED|Overall Study||481
8647682|NCT02791945|21346568|P2|NOT COMPLETED|Overall Study||2
8647683|NCT02791945|21346569|P1|NOT COMPLETED|Overall Study||2
8647684|NCT02791945|21346568|P2|COMPLETED|Overall Study||14
8647685|NCT02791945|21346569|P1|COMPLETED|Overall Study||12
8647686|NCT02791945|21346568|P2|STARTED|Overall Study||16
8647687|NCT02791945|21346569|P1|STARTED|Overall Study||14
8647688|NCT02751359|21346579|P1|NOT COMPLETED|Overall Study||1
8647689|NCT02751359|21346579|P1|COMPLETED|Overall Study||17
8647690|NCT02751359|21346579|P1|STARTED|Overall Study||18
8647691|NCT02744898|21346593|P1|NOT COMPLETED|Overall Study||4
8647692|NCT02744898|21346593|P1|COMPLETED|Overall Study||19
8647693|NCT02744898|21346593|P1|STARTED|Overall Study||23
8647694|NCT02715076|21346603|P6|NOT COMPLETED|Overall Study||0
8647695|NCT02715076|21346604|P5|NOT COMPLETED|Overall Study||0
8647696|NCT02715076|21346605|P4|NOT COMPLETED|Overall Study||0
8647697|NCT02715076|21346606|P3|NOT COMPLETED|Overall Study||0
8647698|NCT02715076|21346607|P2|NOT COMPLETED|Overall Study||0
8647699|NCT02715076|21346608|P1|NOT COMPLETED|Overall Study||0
8647700|NCT02715076|21346603|P6|COMPLETED|Overall Study||48
8647701|NCT02715076|21346604|P5|COMPLETED|Overall Study||47
8647702|NCT02715076|21346605|P4|COMPLETED|Overall Study||50
8647703|NCT02715076|21346606|P3|COMPLETED|Overall Study||49
8647704|NCT02715076|21346607|P2|COMPLETED|Overall Study||50
8647705|NCT02715076|21346608|P1|COMPLETED|Overall Study||48
8647706|NCT02715076|21346603|P6|STARTED|Overall Study||48
8647707|NCT02715076|21346604|P5|STARTED|Overall Study||47
8647708|NCT02715076|21346605|P4|STARTED|Overall Study||50
8647709|NCT02715076|21346606|P3|STARTED|Overall Study||49
8647710|NCT02715076|21346607|P2|STARTED|Overall Study||50
8647711|NCT02715076|21346608|P1|STARTED|Overall Study||48
8647712|NCT02712424|21346624|P2|NOT COMPLETED|Overall Study||32
8647713|NCT02712424|21346625|P1|NOT COMPLETED|Overall Study||34
8647714|NCT02712424|21346624|P2|COMPLETED|Overall Study||278
8647715|NCT02712424|21346625|P1|COMPLETED|Overall Study||281
8647716|NCT02712424|21346624|P2|STARTED|Overall Study||310
8647717|NCT02712424|21346625|P1|STARTED|Overall Study||315
8647718|NCT02694744|21346635|P2|NOT COMPLETED|Overall Study||5
8647719|NCT02694744|21346636|P1|NOT COMPLETED|Overall Study||6
8647720|NCT02694744|21346635|P2|COMPLETED|Overall Study||52
8647721|NCT02694744|21346636|P1|COMPLETED|Overall Study||51
8647722|NCT02694744|21346635|P2|ITT|Overall Study||55
8647723|NCT02694744|21346636|P1|ITT|Overall Study||57
8647724|NCT02694744|21346635|P2|Safety Population|Overall Study||56
8647725|NCT02694744|21346636|P1|Safety Population|Overall Study||57
8647726|NCT02694744|21346635|P2|STARTED|Overall Study||57
8647727|NCT02694744|21346636|P1|STARTED|Overall Study||57
8647728|NCT02677324|21346644|P1|NOT COMPLETED|Overall Study||12
8647729|NCT02677324|21346644|P1|COMPLETED|Overall Study||21
8647730|NCT02677324|21346644|P1|STARTED|Overall Study||33
8647731|NCT02660827|21346659|P1|NOT COMPLETED|2-6 Years Old Age Group||1
8647732|NCT02660827|21346659|P1|COMPLETED|2-6 Years Old Age Group||45
8647733|NCT02660827|21346659|P1|STARTED|2-6 Years Old Age Group||46
8647734|NCT02660827|21346659|P1|NOT COMPLETED|7-13 Years Old Age Group||0
8647735|NCT02660827|21346659|P1|COMPLETED|7-13 Years Old Age Group||105
8647736|NCT02660827|21346659|P1|STARTED|7-13 Years Old Age Group||105
8647737|NCT02597062|21346676|P1|NOT COMPLETED|Overall Study||1
8647738|NCT02597062|21346676|P1|COMPLETED|Overall Study||75
8647739|NCT02597062|21346676|P1|STARTED|Overall Study||76
8647740|NCT02586727|21346684|P2|NOT COMPLETED|Overall Study||0
8647741|NCT02586727|21346685|P1|NOT COMPLETED|Overall Study||1
8647742|NCT02586727|21346684|P2|COMPLETED|Overall Study||20
8647743|NCT02586727|21346685|P1|COMPLETED|Overall Study||19
8647744|NCT02586727|21346684|P2|STARTED|Overall Study||20
8647745|NCT02586727|21346685|P1|STARTED|Overall Study||20
8647746|NCT02503540|21346693|P1|NOT COMPLETED|Overall Study||3
8647747|NCT02503540|21346693|P1|COMPLETED|Overall Study||28
8647748|NCT02503540|21346693|P1|STARTED|Overall Study||31
8647755|NCT02475369|21346721|P2|NOT COMPLETED|Treatment Period #2 (10 Days)||0
8647756|NCT02475369|21346722|P1|NOT COMPLETED|Treatment Period #2 (10 Days)||0
8647757|NCT02475369|21346721|P2|COMPLETED|Treatment Period #2 (10 Days)||9
8647758|NCT02475369|21346722|P1|COMPLETED|Treatment Period #2 (10 Days)||3
8647759|NCT02475369|21346721|P2|STARTED|Treatment Period #2 (10 Days)||9
8647760|NCT02475369|21346722|P1|STARTED|Treatment Period #2 (10 Days)||3
8647761|NCT02475369|21346721|P2|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
8647762|NCT02475369|21346722|P1|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
8647763|NCT02475369|21346721|P2|COMPLETED|Run-in Washout Period #2 (7 Days)||9
8647764|NCT02475369|21346722|P1|COMPLETED|Run-in Washout Period #2 (7 Days)||3
8647765|NCT02475369|21346721|P2|STARTED|Run-in Washout Period #2 (7 Days)||9
8647766|NCT02475369|21346722|P1|STARTED|Run-in Washout Period #2 (7 Days)||3
8647767|NCT02475369|21346721|P2|NOT COMPLETED|Treatment Period #1 (10 Days)||0
8647768|NCT02475369|21346722|P1|NOT COMPLETED|Treatment Period #1 (10 Days)||0
8647769|NCT02475369|21346721|P2|COMPLETED|Treatment Period #1 (10 Days)||9
8647770|NCT02475369|21346722|P1|COMPLETED|Treatment Period #1 (10 Days)||3
8647771|NCT02475369|21346721|P2|STARTED|Treatment Period #1 (10 Days)||9
8647772|NCT02475369|21346722|P1|STARTED|Treatment Period #1 (10 Days)||3
8647773|NCT02475369|21346721|P2|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||2
8647774|NCT02475369|21346722|P1|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||7
8647775|NCT02475369|21346721|P2|COMPLETED|Run-in Washout Period #1 (7 Days)||9
8647776|NCT02475369|21346722|P1|COMPLETED|Run-in Washout Period #1 (7 Days)||3
8647777|NCT02475369|21346721|P2|STARTED|Run-in Washout Period #1 (7 Days)||11
8647778|NCT02475369|21346722|P1|STARTED|Run-in Washout Period #1 (7 Days)||10
8647779|NCT02453334|21346735|P2|NOT COMPLETED|Overall Study||40
8647780|NCT02453334|21346736|P1|NOT COMPLETED|Overall Study||41
8647781|NCT02453334|21346735|P2|COMPLETED|Overall Study||82
8647782|NCT02453334|21346736|P1|COMPLETED|Overall Study||81
8647783|NCT02453334|21346735|P2|STARTED|Overall Study||122
8647784|NCT02453334|21346736|P1|STARTED|Overall Study||122
8647873|NCT02407054|21347033|P3|NOT COMPLETED|Overall Study||7
8647874|NCT02407054|21347034|P2|NOT COMPLETED|Overall Study||18
8647875|NCT02407054|21347035|P1|NOT COMPLETED|Overall Study||7
8647876|NCT02407054|21347033|P3|COMPLETED|Overall Study||57
8647877|NCT02407054|21347034|P2|COMPLETED|Overall Study||47
8647878|NCT02407054|21347035|P1|COMPLETED|Overall Study||6
8647879|NCT02407054|21347033|P3|Received at Least One Dose of Study Drug|Overall Study||64
8647880|NCT02407054|21347034|P2|Received at Least One Dose of Study Drug|Overall Study||65
8647881|NCT02407054|21347035|P1|Received at Least One Dose of Study Drug|Overall Study||13
8647882|NCT02407054|21347033|P3|STARTED|Overall Study||64
8647883|NCT02407054|21347034|P2|STARTED|Overall Study||65
8647884|NCT02407054|21347035|P1|STARTED|Overall Study||13
8647885|NCT02370056|21347052|P2|NOT COMPLETED|Overall Study||0
8647886|NCT02370056|21347053|P1|NOT COMPLETED|Overall Study||0
8647887|NCT02370056|21347052|P2|COMPLETED|Overall Study||26
8647888|NCT02370056|21347053|P1|COMPLETED|Overall Study||27
8647889|NCT02370056|21347052|P2|STARTED|Overall Study||26
8647890|NCT02370056|21347053|P1|STARTED|Overall Study||27
8647891|NCT02366403|21347063|P2|NOT COMPLETED|Overall Study||15
8647892|NCT02366403|21347064|P1|NOT COMPLETED|Overall Study||11
8647893|NCT02366403|21347063|P2|COMPLETED|Overall Study||29
8647894|NCT02366403|21347064|P1|COMPLETED|Overall Study||30
8647895|NCT02366403|21347063|P2|STARTED|Overall Study||44
8647896|NCT02366403|21347064|P1|STARTED|Overall Study||41
8647897|NCT02360280|21347074|P2|NOT COMPLETED|Overall Study||1
8647898|NCT02360280|21347075|P1|NOT COMPLETED|Overall Study||3
8647899|NCT02360280|21347074|P2|COMPLETED|Overall Study||29
8647900|NCT02360280|21347075|P1|COMPLETED|Overall Study||25
8647901|NCT02360280|21347074|P2|STARTED|Overall Study||30
8647902|NCT02360280|21347075|P1|STARTED|Overall Study||28
8647903|NCT02326974|21347087|P1|NOT COMPLETED|Overall Study||7
8647904|NCT02326974|21347087|P1|COMPLETED|Overall Study||157
8647905|NCT02326974|21347087|P1|Treated|Overall Study||163
8647906|NCT02326974|21347087|P1|STARTED|Overall Study||164
8647907|NCT02323113|21347106|P8|NOT COMPLETED|Overall Study||0
8647908|NCT02323113|21347107|P7|NOT COMPLETED|Overall Study||6
8647909|NCT02323113|21347108|P6|NOT COMPLETED|Overall Study||8
8647910|NCT02323113|21347109|P5|NOT COMPLETED|Overall Study||9
8647911|NCT02323113|21347110|P4|NOT COMPLETED|Overall Study||5
8647912|NCT02323113|21347111|P3|NOT COMPLETED|Overall Study||4
8647913|NCT02323113|21347112|P2|NOT COMPLETED|Overall Study||7
8647914|NCT02323113|21347113|P1|NOT COMPLETED|Overall Study||4
8647915|NCT02323113|21347106|P8|COMPLETED|Overall Study||0
8647916|NCT02323113|21347107|P7|COMPLETED|Overall Study||0
8647917|NCT02323113|21347108|P6|COMPLETED|Overall Study||0
8647918|NCT02323113|21347109|P5|COMPLETED|Overall Study||0
8647919|NCT02323113|21347110|P4|COMPLETED|Overall Study||0
8647920|NCT02323113|21347111|P3|COMPLETED|Overall Study||0
8647921|NCT02323113|21347112|P2|COMPLETED|Overall Study||0
8647922|NCT02323113|21347113|P1|COMPLETED|Overall Study||0
8647923|NCT02323113|21347106|P8|STARTED|Overall Study||0
8647924|NCT02323113|21347107|P7|STARTED|Overall Study||6
8647925|NCT02323113|21347108|P6|STARTED|Overall Study||8
8647926|NCT02323113|21347109|P5|STARTED|Overall Study||9
8647927|NCT02323113|21347110|P4|STARTED|Overall Study||5
8647928|NCT02323113|21347111|P3|STARTED|Overall Study||4
8647929|NCT02323113|21347112|P2|STARTED|Overall Study||7
8647930|NCT02323113|21347113|P1|STARTED|Overall Study||4
8647931|NCT02303990|21347200|P1|NOT COMPLETED|Overall Study||0
8647932|NCT02303990|21347200|P1|COMPLETED|Overall Study||59
8647933|NCT02303990|21347200|P1|STARTED|Overall Study||59
8647934|NCT02274038|21347204|P1|NOT COMPLETED|Overall Study||1
8647935|NCT02274038|21347204|P1|COMPLETED|Overall Study||2
8647936|NCT02274038|21347204|P1|STARTED|Overall Study||3
8647937|NCT02220855|21347212|P1|NOT COMPLETED|Overall Study||14
8647938|NCT02220855|21347212|P1|COMPLETED|Overall Study||0
8647939|NCT02220855|21347212|P1|STARTED|Overall Study||14
8647975|NCT02101060|21347357|P2|NOT COMPLETED|Overall Study||4
8647976|NCT02101060|21347358|P1|NOT COMPLETED|Overall Study||5
8647977|NCT02101060|21347357|P2|COMPLETED|Overall Study||12
8647978|NCT02101060|21347358|P1|COMPLETED|Overall Study||12
8647979|NCT02101060|21347357|P2|STARTED|Overall Study||16
8647980|NCT02101060|21347358|P1|STARTED|Overall Study||17
8647981|NCT02097732|21347370|P2|NOT COMPLETED|Overall Study||0
8647982|NCT02097732|21347371|P1|NOT COMPLETED|Overall Study||0
8647983|NCT02097732|21347370|P2|COMPLETED|Overall Study||3
8647984|NCT02097732|21347371|P1|COMPLETED|Overall Study||1
8647985|NCT02097732|21347370|P2|STARTED|Overall Study||3
8647986|NCT02097732|21347371|P1|STARTED|Overall Study||1
8647987|NCT02097485|21347386|P2|NOT COMPLETED|Overall Study||0
8647988|NCT02097485|21347387|P1|NOT COMPLETED|Overall Study||0
8647989|NCT02097485|21347386|P2|COMPLETED|Overall Study||25
8647990|NCT02097485|21347387|P1|COMPLETED|Overall Study||25
8647991|NCT02097485|21347386|P2|STARTED|Overall Study||25
8647992|NCT02097485|21347387|P1|STARTED|Overall Study||25
8648001|NCT02033317|21347428|P1|NOT COMPLETED|Overall Study||0
8648002|NCT02033317|21347428|P1|COMPLETED|Overall Study||6
8648003|NCT02033317|21347428|P1|STARTED|Overall Study||6
8648004|NCT02015520|21347437|P4|NOT COMPLETED|Overall Study||4
8648005|NCT02015520|21347438|P3|NOT COMPLETED|Overall Study||7
8648006|NCT02015520|21347439|P2|NOT COMPLETED|Overall Study||4
8648007|NCT02015520|21347440|P1|NOT COMPLETED|Overall Study||5
8648008|NCT02015520|21347437|P4|COMPLETED|Overall Study||36
8648009|NCT02015520|21347438|P3|COMPLETED|Overall Study||35
8648010|NCT02015520|21347439|P2|COMPLETED|Overall Study||17
8648011|NCT02015520|21347440|P1|COMPLETED|Overall Study||35
8648012|NCT02015520|21347437|P4|STARTED|Overall Study||40
8648013|NCT02015520|21347438|P3|STARTED|Overall Study||42
8648014|NCT02015520|21347439|P2|STARTED|Overall Study||21
8648015|NCT02015520|21347440|P1|STARTED|Overall Study||40
8648016|NCT02007512|21347482|P4|NOT COMPLETED|Open Label Treatment Period||12
8648017|NCT02007512|21347483|P3|NOT COMPLETED|Open Label Treatment Period||0
8648018|NCT02007512|21347484|P2|NOT COMPLETED|Open Label Treatment Period||21
8648019|NCT02007512|21347485|P1|NOT COMPLETED|Open Label Treatment Period||0
8648020|NCT02007512|21347482|P4|COMPLETED|Open Label Treatment Period||0
8648021|NCT02007512|21347483|P3|COMPLETED|Open Label Treatment Period||0
8648022|NCT02007512|21347484|P2|COMPLETED|Open Label Treatment Period||0
8648023|NCT02007512|21347485|P1|COMPLETED|Open Label Treatment Period||0
8648024|NCT02007512|21347482|P4|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
8648025|NCT02007512|21347483|P3|STARTED|Open Label Treatment Period||0
8648026|NCT02007512|21347484|P2|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
8648027|NCT02007512|21347485|P1|STARTED|Open Label Treatment Period||0
8648028|NCT02007512|21347482|P4|NOT COMPLETED|Double Blind Treatment Period||60
8648029|NCT02007512|21347483|P3|NOT COMPLETED|Double Blind Treatment Period||60
8648030|NCT02007512|21347484|P2|NOT COMPLETED|Double Blind Treatment Period||64
8648031|NCT02007512|21347485|P1|NOT COMPLETED|Double Blind Treatment Period||63
8648032|NCT02007512|21347482|P4|COMPLETED|Double Blind Treatment Period||0
8648033|NCT02007512|21347483|P3|COMPLETED|Double Blind Treatment Period||0
8648034|NCT02007512|21347484|P2|COMPLETED|Double Blind Treatment Period||0
8648035|NCT02007512|21347485|P1|COMPLETED|Double Blind Treatment Period||0
8648036|NCT02007512|21347482|P4|Treated|Double Blind Treatment Period||60
8648037|NCT02007512|21347483|P3|Treated|Double Blind Treatment Period||60
8648038|NCT02007512|21347484|P2|Treated|Double Blind Treatment Period||63
8648039|NCT02007512|21347485|P1|Treated|Double Blind Treatment Period||62
8648040|NCT02007512|21347482|P4|STARTED|Double Blind Treatment Period||60
8648041|NCT02007512|21347483|P3|STARTED|Double Blind Treatment Period||60
8648042|NCT02007512|21347484|P2|STARTED|Double Blind Treatment Period||64
8648043|NCT02007512|21347485|P1|STARTED|Double Blind Treatment Period||63
8648044|NCT01960257|21347555|P3|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
8648045|NCT01960257|21347556|P2|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
8648046|NCT01960257|21347557|P1|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
8648047|NCT01960257|21347555|P3|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
8648048|NCT01960257|21347556|P2|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
8648049|NCT01960257|21347557|P1|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
8648050|NCT01960257|21347555|P3|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
8648051|NCT01960257|21347556|P2|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
8648052|NCT01960257|21347557|P1|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
8648053|NCT01960257|21347555|P3|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
8648054|NCT01960257|21347556|P2|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
8648055|NCT01960257|21347557|P1|NOT COMPLETED|Stage 1 (1-3 Weeks)||16
8648056|NCT01960257|21347555|P3|COMPLETED|Stage 1 (1-3 Weeks)||0
8648057|NCT01960257|21347556|P2|COMPLETED|Stage 1 (1-3 Weeks)||0
8648058|NCT01960257|21347557|P1|COMPLETED|Stage 1 (1-3 Weeks)||61
8648059|NCT01960257|21347555|P3|STARTED|Stage 1 (1-3 Weeks)||0
8648060|NCT01960257|21347556|P2|STARTED|Stage 1 (1-3 Weeks)||0
8648061|NCT01960257|21347557|P1|STARTED|Stage 1 (1-3 Weeks)||77
8648070|NCT01853774|21347578|P2|NOT COMPLETED|Overall Study||28
8648071|NCT01853774|21347579|P1|NOT COMPLETED|Overall Study||46
8648072|NCT01853774|21347578|P2|COMPLETED|Overall Study||134
8648073|NCT01853774|21347579|P1|COMPLETED|Overall Study||211
8648074|NCT01853774|21347578|P2|STARTED|Overall Study||162
8648075|NCT01853774|21347579|P1|STARTED|Overall Study||257
8648076|NCT01824290|21347589|P2|NOT COMPLETED|Overall Study||2
8648077|NCT01824290|21347590|P1|NOT COMPLETED|Overall Study||3
8648078|NCT01824290|21347589|P2|COMPLETED|Overall Study||15
8648079|NCT01824290|21347590|P1|COMPLETED|Overall Study||15
8648080|NCT01824290|21347589|P2|Received 40 mg|Overall Study||13
8648081|NCT01824290|21347590|P1|Received 40 mg|Overall Study||0
8648082|NCT01824290|21347589|P2|Received 20 mg|Overall Study||4
8648083|NCT01824290|21347590|P1|Received 20 mg|Overall Study||0
8648084|NCT01824290|21347589|P2|Received at Least One Dose of Study Drug|Overall Study||17
8648085|NCT01824290|21347590|P1|Received at Least One Dose of Study Drug|Overall Study||18
8648086|NCT01824290|21347589|P2|STARTED|Overall Study||17
8648087|NCT01824290|21347590|P1|STARTED|Overall Study||18
8648088|NCT01757405|21347604|P2|NOT COMPLETED|Overall Study||2
8648089|NCT01757405|21347605|P1|NOT COMPLETED|Overall Study||1
8648090|NCT01757405|21347604|P2|COMPLETED|Overall Study||18
8648091|NCT01757405|21347605|P1|COMPLETED|Overall Study||17
8648092|NCT01757405|21347604|P2|STARTED|Overall Study||20
8648093|NCT01757405|21347605|P1|STARTED|Overall Study||18
8648094|NCT01716208|21347621|P1|NOT COMPLETED|Overall Study||0
8648095|NCT01716208|21347621|P1|COMPLETED|Overall Study||12
8648096|NCT01716208|21347621|P1|STARTED|Overall Study||12
8648109|NCT01519453|21347674|P2|NOT COMPLETED|Overall Study||36
8648110|NCT01519453|21347675|P1|NOT COMPLETED|Overall Study||52
8648111|NCT01519453|21347674|P2|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 326 individuals|163
8648112|NCT01519453|21347675|P1|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 294 individuals|147
8648113|NCT01519453|21347674|P2|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 332 individuals|166
8648114|NCT01519453|21347675|P1|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 318 individuals|159
8648115|NCT01519453|21347674|P2|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 350 individuals|175
8648116|NCT01519453|21347675|P1|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 306 individuals|153
8648117|NCT01519453|21347674|P2|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 362 individuals|181
8648118|NCT01519453|21347675|P1|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 320 individuals|160
8648119|NCT01519453|21347674|P2|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
8648120|NCT01519453|21347675|P1|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
8648121|NCT01403064|21347689|P4|NOT COMPLETED|Overall Study||3
8648122|NCT01403064|21347690|P3|NOT COMPLETED|Overall Study||4
8648123|NCT01403064|21347691|P2|NOT COMPLETED|Overall Study||0
8648124|NCT01403064|21347692|P1|NOT COMPLETED|Overall Study||1
8648125|NCT01403064|21347689|P4|COMPLETED|Overall Study||19
8648126|NCT01403064|21347690|P3|COMPLETED|Overall Study||19
8648127|NCT01403064|21347691|P2|COMPLETED|Overall Study||7
8648128|NCT01403064|21347692|P1|COMPLETED|Overall Study||23
8648129|NCT01403064|21347689|P4|STARTED|Overall Study||22
8648130|NCT01403064|21347690|P3|STARTED|Overall Study||23
8648131|NCT01403064|21347691|P2|STARTED|Overall Study||7
8648132|NCT01403064|21347692|P1|STARTED|Overall Study||24
8648133|NCT01334086|21347753|P1|NOT COMPLETED|Overall Study||0
8648134|NCT01334086|21347753|P1|COMPLETED|Overall Study||41
8648135|NCT01334086|21347753|P1|STARTED|Overall Study||41
8648136|NCT01271504|21347765|P4|NOT COMPLETED|Overall Study||43
8648137|NCT01271504|21347766|P3|NOT COMPLETED|Overall Study||44
8648138|NCT01271504|21347767|P2|NOT COMPLETED|Overall Study||8
8648139|NCT01271504|21347768|P1|NOT COMPLETED|Overall Study||7
8648140|NCT01271504|21347765|P4|COMPLETED|Overall Study||0
8648141|NCT01271504|21347766|P3|COMPLETED|Overall Study||0
8648142|NCT01271504|21347767|P2|COMPLETED|Overall Study||0
8648143|NCT01271504|21347768|P1|COMPLETED|Overall Study||0
8648144|NCT01271504|21347765|P4|Treated|Overall Study||42
8648145|NCT01271504|21347766|P3|Treated|Overall Study||42
8648146|NCT01271504|21347767|P2|Treated|Overall Study||7
8648147|NCT01271504|21347768|P1|Treated|Overall Study||7
8648148|NCT01271504|21347765|P4|STARTED|Overall Study||43
8648149|NCT01271504|21347766|P3|STARTED|Overall Study||44
8648150|NCT01271504|21347767|P2|STARTED|Overall Study||8
8648151|NCT01271504|21347768|P1|STARTED|Overall Study||7
8648152|NCT01257568|21347820|P1|NOT COMPLETED|Overall Study||33
8648153|NCT01257568|21347820|P1|COMPLETED|Overall Study||7
8648154|NCT01257568|21347820|P1|STARTED|Overall Study||40
8648155|NCT01255670|21347834|P2|NOT COMPLETED|Overall Study||20
8648156|NCT01255670|21347835|P1|NOT COMPLETED|Overall Study||26
8648157|NCT01255670|21347834|P2|COMPLETED|Overall Study||80
8648158|NCT01255670|21347835|P1|COMPLETED|Overall Study||74
8648159|NCT01255670|21347834|P2|STARTED|Overall Study||100
8648160|NCT01255670|21347835|P1|STARTED|Overall Study||100
8648161|NCT01251588|21347845|P2|NOT COMPLETED|Overall Study||4
8648162|NCT01251588|21347846|P1|NOT COMPLETED|Overall Study||0
8648163|NCT01251588|21347845|P2|COMPLETED|Overall Study||59
8648164|NCT01251588|21347846|P1|COMPLETED|Overall Study||65
8648165|NCT01251588|21347845|P2|STARTED|Overall Study||63
8648166|NCT01251588|21347846|P1|STARTED|Overall Study||65
8648167|NCT01130597|21347878|P1|NOT COMPLETED|Overall Study||7
8648168|NCT01130597|21347878|P1|COMPLETED|Overall Study||56
8648169|NCT01130597|21347878|P1|STARTED|Overall Study||63
8648170|NCT01116648|21347915|P15|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648171|NCT01116648|21347916|P14|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648172|NCT01116648|21347917|P13|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648173|NCT01116648|21347918|P12|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648174|NCT01116648|21347919|P11|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648175|NCT01116648|21347920|P10|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648176|NCT01116648|21347921|P9|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648177|NCT01116648|21347922|P8|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648178|NCT01116648|21347923|P7|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648179|NCT01116648|21347924|P6|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648180|NCT01116648|21347925|P5|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648181|NCT01116648|21347926|P4|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648182|NCT01116648|21347927|P3|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648183|NCT01116648|21347928|P2|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648184|NCT01116648|21347929|P1|NOT COMPLETED|Phase 1-T PKCed Expansion||0
8648185|NCT01116648|21347915|P15|COMPLETED|Phase 1-T PKCed Expansion||7
8648186|NCT01116648|21347916|P14|COMPLETED|Phase 1-T PKCed Expansion||0
8648187|NCT01116648|21347917|P13|COMPLETED|Phase 1-T PKCed Expansion||0
8648188|NCT01116648|21347918|P12|COMPLETED|Phase 1-T PKCed Expansion||0
8648189|NCT01116648|21347919|P11|COMPLETED|Phase 1-T PKCed Expansion||0
8648190|NCT01116648|21347920|P10|COMPLETED|Phase 1-T PKCed Expansion||0
8648191|NCT01116648|21347921|P9|COMPLETED|Phase 1-T PKCed Expansion||0
8648192|NCT01116648|21347922|P8|COMPLETED|Phase 1-T PKCed Expansion||0
8648193|NCT01116648|21347923|P7|COMPLETED|Phase 1-T PKCed Expansion||0
8648194|NCT01116648|21347924|P6|COMPLETED|Phase 1-T PKCed Expansion||0
8648195|NCT01116648|21347925|P5|COMPLETED|Phase 1-T PKCed Expansion||0
8648196|NCT01116648|21347926|P4|COMPLETED|Phase 1-T PKCed Expansion||0
8648197|NCT01116648|21347927|P3|COMPLETED|Phase 1-T PKCed Expansion||0
8648198|NCT01116648|21347928|P2|COMPLETED|Phase 1-T PKCed Expansion||0
8648199|NCT01116648|21347929|P1|COMPLETED|Phase 1-T PKCed Expansion||0
8648200|NCT01116648|21347915|P15|STARTED|Phase 1-T PKCed Expansion||7
8648201|NCT01116648|21347916|P14|STARTED|Phase 1-T PKCed Expansion||0
8648202|NCT01116648|21347917|P13|STARTED|Phase 1-T PKCed Expansion||0
8648203|NCT01116648|21347918|P12|STARTED|Phase 1-T PKCed Expansion||0
8648204|NCT01116648|21347919|P11|STARTED|Phase 1-T PKCed Expansion||0
8648205|NCT01116648|21347920|P10|STARTED|Phase 1-T PKCed Expansion||0
8648206|NCT01116648|21347921|P9|STARTED|Phase 1-T PKCed Expansion||0
8648207|NCT01116648|21347922|P8|STARTED|Phase 1-T PKCed Expansion||0
8648208|NCT01116648|21347923|P7|STARTED|Phase 1-T PKCed Expansion||0
8648209|NCT01116648|21347924|P6|STARTED|Phase 1-T PKCed Expansion||0
8648210|NCT01116648|21347925|P5|STARTED|Phase 1-T PKCed Expansion||0
8648211|NCT01116648|21347926|P4|STARTED|Phase 1-T PKCed Expansion||0
8648212|NCT01116648|21347927|P3|STARTED|Phase 1-T PKCed Expansion||0
8648213|NCT01116648|21347928|P2|STARTED|Phase 1-T PKCed Expansion||0
8648214|NCT01116648|21347929|P1|STARTED|Phase 1-T PKCed Expansion||0
8648215|NCT01116648|21347915|P15|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648216|NCT01116648|21347916|P14|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648217|NCT01116648|21347917|P13|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648218|NCT01116648|21347918|P12|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648219|NCT01116648|21347919|P11|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648220|NCT01116648|21347920|P10|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648221|NCT01116648|21347921|P9|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648222|NCT01116648|21347922|P8|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648223|NCT01116648|21347923|P7|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648224|NCT01116648|21347924|P6|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648225|NCT01116648|21347925|P5|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648226|NCT01116648|21347926|P4|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648227|NCT01116648|21347927|P3|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648228|NCT01116648|21347928|P2|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648229|NCT01116648|21347929|P1|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
8648230|NCT01116648|21347915|P15|COMPLETED|Phase 1-T PKOlap Expansion||0
8648231|NCT01116648|21347916|P14|COMPLETED|Phase 1-T PKOlap Expansion||6
8648232|NCT01116648|21347917|P13|COMPLETED|Phase 1-T PKOlap Expansion||0
8648233|NCT01116648|21347918|P12|COMPLETED|Phase 1-T PKOlap Expansion||0
8648234|NCT01116648|21347919|P11|COMPLETED|Phase 1-T PKOlap Expansion||0
8648235|NCT01116648|21347920|P10|COMPLETED|Phase 1-T PKOlap Expansion||0
8648236|NCT01116648|21347921|P9|COMPLETED|Phase 1-T PKOlap Expansion||0
8648237|NCT01116648|21347922|P8|COMPLETED|Phase 1-T PKOlap Expansion||0
8648238|NCT01116648|21347923|P7|COMPLETED|Phase 1-T PKOlap Expansion||0
8648239|NCT01116648|21347924|P6|COMPLETED|Phase 1-T PKOlap Expansion||0
8648240|NCT01116648|21347925|P5|COMPLETED|Phase 1-T PKOlap Expansion||0
8648241|NCT01116648|21347926|P4|COMPLETED|Phase 1-T PKOlap Expansion||0
8648242|NCT01116648|21347927|P3|COMPLETED|Phase 1-T PKOlap Expansion||0
8648243|NCT01116648|21347928|P2|COMPLETED|Phase 1-T PKOlap Expansion||0
8648244|NCT01116648|21347929|P1|COMPLETED|Phase 1-T PKOlap Expansion||0
8648245|NCT01116648|21347915|P15|STARTED|Phase 1-T PKOlap Expansion||0
8648246|NCT01116648|21347916|P14|STARTED|Phase 1-T PKOlap Expansion||6
8648247|NCT01116648|21347917|P13|STARTED|Phase 1-T PKOlap Expansion||0
8648248|NCT01116648|21347918|P12|STARTED|Phase 1-T PKOlap Expansion||0
8648249|NCT01116648|21347919|P11|STARTED|Phase 1-T PKOlap Expansion||0
8648250|NCT01116648|21347920|P10|STARTED|Phase 1-T PKOlap Expansion||0
8648251|NCT01116648|21347921|P9|STARTED|Phase 1-T PKOlap Expansion||0
8648252|NCT01116648|21347922|P8|STARTED|Phase 1-T PKOlap Expansion||0
8648253|NCT01116648|21347923|P7|STARTED|Phase 1-T PKOlap Expansion||0
8648254|NCT01116648|21347924|P6|STARTED|Phase 1-T PKOlap Expansion||0
8648255|NCT01116648|21347925|P5|STARTED|Phase 1-T PKOlap Expansion||0
8648256|NCT01116648|21347926|P4|STARTED|Phase 1-T PKOlap Expansion||0
8648257|NCT01116648|21347927|P3|STARTED|Phase 1-T PKOlap Expansion||0
8648258|NCT01116648|21347928|P2|STARTED|Phase 1-T PKOlap Expansion||0
8648259|NCT01116648|21347929|P1|STARTED|Phase 1-T PKOlap Expansion||0
8648260|NCT01116648|21347915|P15|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648261|NCT01116648|21347916|P14|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648262|NCT01116648|21347917|P13|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648263|NCT01116648|21347918|P12|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648264|NCT01116648|21347919|P11|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648265|NCT01116648|21347920|P10|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648266|NCT01116648|21347921|P9|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648267|NCT01116648|21347922|P8|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648268|NCT01116648|21347923|P7|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648269|NCT01116648|21347924|P6|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648270|NCT01116648|21347925|P5|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648271|NCT01116648|21347926|P4|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648272|NCT01116648|21347927|P3|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648273|NCT01116648|21347928|P2|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648274|NCT01116648|21347929|P1|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
8648275|NCT01116648|21347915|P15|COMPLETED|Phase 1-T Dose Level 2-TB||0
8648276|NCT01116648|21347916|P14|COMPLETED|Phase 1-T Dose Level 2-TB||0
8648277|NCT01116648|21347917|P13|COMPLETED|Phase 1-T Dose Level 2-TB||6
8648278|NCT01116648|21347918|P12|COMPLETED|Phase 1-T Dose Level 2-TB||0
8648279|NCT01116648|21347919|P11|COMPLETED|Phase 1-T Dose Level 2-TB||0
8648280|NCT01116648|21347920|P10|COMPLETED|Phase 1-T Dose Level 2-TB||0
8648281|NCT01116648|21347921|P9|COMPLETED|Phase 1-T Dose Level 2-TB||0
8648282|NCT01116648|21347922|P8|COMPLETED|Phase 1-T Dose Level 2-TB||0
8648283|NCT01116648|21347923|P7|COMPLETED|Phase 1-T Dose Level 2-TB||0
8648284|NCT01116648|21347924|P6|COMPLETED|Phase 1-T Dose Level 2-TB||0
8648285|NCT01116648|21347925|P5|COMPLETED|Phase 1-T Dose Level 2-TB||0
8648286|NCT01116648|21347926|P4|COMPLETED|Phase 1-T Dose Level 2-TB||0
8648287|NCT01116648|21347927|P3|COMPLETED|Phase 1-T Dose Level 2-TB||0
8648288|NCT01116648|21347928|P2|COMPLETED|Phase 1-T Dose Level 2-TB||0
8648289|NCT01116648|21347929|P1|COMPLETED|Phase 1-T Dose Level 2-TB||0
8648290|NCT01116648|21347915|P15|STARTED|Phase 1-T Dose Level 2-TB||0
8648291|NCT01116648|21347916|P14|STARTED|Phase 1-T Dose Level 2-TB||0
8648292|NCT01116648|21347917|P13|STARTED|Phase 1-T Dose Level 2-TB||6
8648293|NCT01116648|21347918|P12|STARTED|Phase 1-T Dose Level 2-TB||0
8648294|NCT01116648|21347919|P11|STARTED|Phase 1-T Dose Level 2-TB||0
8648295|NCT01116648|21347920|P10|STARTED|Phase 1-T Dose Level 2-TB||0
8648296|NCT01116648|21347921|P9|STARTED|Phase 1-T Dose Level 2-TB||0
8648297|NCT01116648|21347922|P8|STARTED|Phase 1-T Dose Level 2-TB||0
8648298|NCT01116648|21347923|P7|STARTED|Phase 1-T Dose Level 2-TB||0
8648299|NCT01116648|21347924|P6|STARTED|Phase 1-T Dose Level 2-TB||0
8648300|NCT01116648|21347925|P5|STARTED|Phase 1-T Dose Level 2-TB||0
8648301|NCT01116648|21347926|P4|STARTED|Phase 1-T Dose Level 2-TB||0
8648302|NCT01116648|21347927|P3|STARTED|Phase 1-T Dose Level 2-TB||0
8648303|NCT01116648|21347928|P2|STARTED|Phase 1-T Dose Level 2-TB||0
8648304|NCT01116648|21347929|P1|STARTED|Phase 1-T Dose Level 2-TB||0
8648305|NCT01116648|21347915|P15|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648306|NCT01116648|21347916|P14|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648307|NCT01116648|21347917|P13|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648308|NCT01116648|21347918|P12|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648309|NCT01116648|21347919|P11|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648310|NCT01116648|21347920|P10|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648311|NCT01116648|21347921|P9|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648312|NCT01116648|21347922|P8|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648313|NCT01116648|21347923|P7|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648314|NCT01116648|21347924|P6|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648315|NCT01116648|21347925|P5|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648316|NCT01116648|21347926|P4|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648317|NCT01116648|21347927|P3|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648318|NCT01116648|21347928|P2|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648319|NCT01116648|21347929|P1|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
8648320|NCT01116648|21347915|P15|COMPLETED|Phase 1-T Dose Level 1-TB||0
8648321|NCT01116648|21347916|P14|COMPLETED|Phase 1-T Dose Level 1-TB||0
8648322|NCT01116648|21347917|P13|COMPLETED|Phase 1-T Dose Level 1-TB||0
8648323|NCT01116648|21347918|P12|COMPLETED|Phase 1-T Dose Level 1-TB||3
8648324|NCT01116648|21347919|P11|COMPLETED|Phase 1-T Dose Level 1-TB||0
8648325|NCT01116648|21347920|P10|COMPLETED|Phase 1-T Dose Level 1-TB||0
8648326|NCT01116648|21347921|P9|COMPLETED|Phase 1-T Dose Level 1-TB||0
8648327|NCT01116648|21347922|P8|COMPLETED|Phase 1-T Dose Level 1-TB||0
8648328|NCT01116648|21347923|P7|COMPLETED|Phase 1-T Dose Level 1-TB||0
8648329|NCT01116648|21347924|P6|COMPLETED|Phase 1-T Dose Level 1-TB||0
8648330|NCT01116648|21347925|P5|COMPLETED|Phase 1-T Dose Level 1-TB||0
8648331|NCT01116648|21347926|P4|COMPLETED|Phase 1-T Dose Level 1-TB||0
8648332|NCT01116648|21347927|P3|COMPLETED|Phase 1-T Dose Level 1-TB||0
8648333|NCT01116648|21347928|P2|COMPLETED|Phase 1-T Dose Level 1-TB||0
8648334|NCT01116648|21347929|P1|COMPLETED|Phase 1-T Dose Level 1-TB||0
8648335|NCT01116648|21347915|P15|STARTED|Phase 1-T Dose Level 1-TB||0
8648336|NCT01116648|21347916|P14|STARTED|Phase 1-T Dose Level 1-TB||0
8648337|NCT01116648|21347917|P13|STARTED|Phase 1-T Dose Level 1-TB||0
8648338|NCT01116648|21347918|P12|STARTED|Phase 1-T Dose Level 1-TB||3
8648339|NCT01116648|21347919|P11|STARTED|Phase 1-T Dose Level 1-TB||0
8648340|NCT01116648|21347920|P10|STARTED|Phase 1-T Dose Level 1-TB||0
8648341|NCT01116648|21347921|P9|STARTED|Phase 1-T Dose Level 1-TB||0
8648342|NCT01116648|21347922|P8|STARTED|Phase 1-T Dose Level 1-TB||0
8648343|NCT01116648|21347923|P7|STARTED|Phase 1-T Dose Level 1-TB||0
8648344|NCT01116648|21347924|P6|STARTED|Phase 1-T Dose Level 1-TB||0
8648345|NCT01116648|21347925|P5|STARTED|Phase 1-T Dose Level 1-TB||0
8648346|NCT01116648|21347926|P4|STARTED|Phase 1-T Dose Level 1-TB||0
8648347|NCT01116648|21347927|P3|STARTED|Phase 1-T Dose Level 1-TB||0
8648348|NCT01116648|21347928|P2|STARTED|Phase 1-T Dose Level 1-TB||0
8648349|NCT01116648|21347929|P1|STARTED|Phase 1-T Dose Level 1-TB||0
8648350|NCT01116648|21347915|P15|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648351|NCT01116648|21347916|P14|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648352|NCT01116648|21347917|P13|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648353|NCT01116648|21347918|P12|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648354|NCT01116648|21347919|P11|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648355|NCT01116648|21347920|P10|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648356|NCT01116648|21347921|P9|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648357|NCT01116648|21347922|P8|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648358|NCT01116648|21347923|P7|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648359|NCT01116648|21347924|P6|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648360|NCT01116648|21347925|P5|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648361|NCT01116648|21347926|P4|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648362|NCT01116648|21347927|P3|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648363|NCT01116648|21347928|P2|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648364|NCT01116648|21347929|P1|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
8648365|NCT01116648|21347915|P15|COMPLETED|Phase 1-T Dose Level 0-TB||0
8648366|NCT01116648|21347916|P14|COMPLETED|Phase 1-T Dose Level 0-TB||0
8648367|NCT01116648|21347917|P13|COMPLETED|Phase 1-T Dose Level 0-TB||0
8648368|NCT01116648|21347918|P12|COMPLETED|Phase 1-T Dose Level 0-TB||0
8648369|NCT01116648|21347919|P11|COMPLETED|Phase 1-T Dose Level 0-TB||3
8648370|NCT01116648|21347920|P10|COMPLETED|Phase 1-T Dose Level 0-TB||0
8648371|NCT01116648|21347921|P9|COMPLETED|Phase 1-T Dose Level 0-TB||0
8648372|NCT01116648|21347922|P8|COMPLETED|Phase 1-T Dose Level 0-TB||0
8648373|NCT01116648|21347923|P7|COMPLETED|Phase 1-T Dose Level 0-TB||0
8648374|NCT01116648|21347924|P6|COMPLETED|Phase 1-T Dose Level 0-TB||0
8648375|NCT01116648|21347925|P5|COMPLETED|Phase 1-T Dose Level 0-TB||0
8648376|NCT01116648|21347926|P4|COMPLETED|Phase 1-T Dose Level 0-TB||0
8648377|NCT01116648|21347927|P3|COMPLETED|Phase 1-T Dose Level 0-TB||0
8648378|NCT01116648|21347928|P2|COMPLETED|Phase 1-T Dose Level 0-TB||0
8648379|NCT01116648|21347929|P1|COMPLETED|Phase 1-T Dose Level 0-TB||0
8648380|NCT01116648|21347915|P15|STARTED|Phase 1-T Dose Level 0-TB||0
8648381|NCT01116648|21347916|P14|STARTED|Phase 1-T Dose Level 0-TB||0
8648382|NCT01116648|21347917|P13|STARTED|Phase 1-T Dose Level 0-TB||0
8648383|NCT01116648|21347918|P12|STARTED|Phase 1-T Dose Level 0-TB||0
8648384|NCT01116648|21347919|P11|STARTED|Phase 1-T Dose Level 0-TB||3
8648385|NCT01116648|21347920|P10|STARTED|Phase 1-T Dose Level 0-TB||0
8648386|NCT01116648|21347921|P9|STARTED|Phase 1-T Dose Level 0-TB||0
8648387|NCT01116648|21347922|P8|STARTED|Phase 1-T Dose Level 0-TB||0
8648388|NCT01116648|21347923|P7|STARTED|Phase 1-T Dose Level 0-TB||0
8648389|NCT01116648|21347924|P6|STARTED|Phase 1-T Dose Level 0-TB||0
8648390|NCT01116648|21347925|P5|STARTED|Phase 1-T Dose Level 0-TB||0
8648391|NCT01116648|21347926|P4|STARTED|Phase 1-T Dose Level 0-TB||0
8648392|NCT01116648|21347927|P3|STARTED|Phase 1-T Dose Level 0-TB||0
8648393|NCT01116648|21347928|P2|STARTED|Phase 1-T Dose Level 0-TB||0
8648394|NCT01116648|21347929|P1|STARTED|Phase 1-T Dose Level 0-TB||0
8648395|NCT01116648|21347915|P15|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648396|NCT01116648|21347916|P14|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648397|NCT01116648|21347917|P13|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648398|NCT01116648|21347918|P12|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648399|NCT01116648|21347919|P11|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648400|NCT01116648|21347920|P10|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648401|NCT01116648|21347921|P9|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648402|NCT01116648|21347922|P8|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648403|NCT01116648|21347923|P7|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648404|NCT01116648|21347924|P6|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648405|NCT01116648|21347925|P5|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648406|NCT01116648|21347926|P4|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648407|NCT01116648|21347927|P3|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648408|NCT01116648|21347928|P2|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648409|NCT01116648|21347929|P1|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
8648410|NCT01116648|21347915|P15|COMPLETED|Phase 1-T Dose Level 2-TA||0
8648411|NCT01116648|21347916|P14|COMPLETED|Phase 1-T Dose Level 2-TA||0
8648412|NCT01116648|21347917|P13|COMPLETED|Phase 1-T Dose Level 2-TA||0
8648413|NCT01116648|21347918|P12|COMPLETED|Phase 1-T Dose Level 2-TA||0
8648414|NCT01116648|21347919|P11|COMPLETED|Phase 1-T Dose Level 2-TA||0
8648415|NCT01116648|21347920|P10|COMPLETED|Phase 1-T Dose Level 2-TA||3
8648416|NCT01116648|21347921|P9|COMPLETED|Phase 1-T Dose Level 2-TA||0
8648417|NCT01116648|21347922|P8|COMPLETED|Phase 1-T Dose Level 2-TA||0
8648418|NCT01116648|21347923|P7|COMPLETED|Phase 1-T Dose Level 2-TA||0
8648419|NCT01116648|21347924|P6|COMPLETED|Phase 1-T Dose Level 2-TA||0
8648420|NCT01116648|21347925|P5|COMPLETED|Phase 1-T Dose Level 2-TA||0
8648421|NCT01116648|21347926|P4|COMPLETED|Phase 1-T Dose Level 2-TA||0
8648422|NCT01116648|21347927|P3|COMPLETED|Phase 1-T Dose Level 2-TA||0
8648423|NCT01116648|21347928|P2|COMPLETED|Phase 1-T Dose Level 2-TA||0
8648424|NCT01116648|21347929|P1|COMPLETED|Phase 1-T Dose Level 2-TA||0
8648425|NCT01116648|21347915|P15|STARTED|Phase 1-T Dose Level 2-TA||0
8648426|NCT01116648|21347916|P14|STARTED|Phase 1-T Dose Level 2-TA||0
8648427|NCT01116648|21347917|P13|STARTED|Phase 1-T Dose Level 2-TA||0
8648428|NCT01116648|21347918|P12|STARTED|Phase 1-T Dose Level 2-TA||0
8648429|NCT01116648|21347919|P11|STARTED|Phase 1-T Dose Level 2-TA||0
8648430|NCT01116648|21347920|P10|STARTED|Phase 1-T Dose Level 2-TA||3
8648431|NCT01116648|21347921|P9|STARTED|Phase 1-T Dose Level 2-TA||0
8648432|NCT01116648|21347922|P8|STARTED|Phase 1-T Dose Level 2-TA||0
8648433|NCT01116648|21347923|P7|STARTED|Phase 1-T Dose Level 2-TA||0
8648434|NCT01116648|21347924|P6|STARTED|Phase 1-T Dose Level 2-TA||0
8648435|NCT01116648|21347925|P5|STARTED|Phase 1-T Dose Level 2-TA||0
8648436|NCT01116648|21347926|P4|STARTED|Phase 1-T Dose Level 2-TA||0
8648437|NCT01116648|21347927|P3|STARTED|Phase 1-T Dose Level 2-TA||0
8648438|NCT01116648|21347928|P2|STARTED|Phase 1-T Dose Level 2-TA||0
8648439|NCT01116648|21347929|P1|STARTED|Phase 1-T Dose Level 2-TA||0
8648440|NCT01116648|21347915|P15|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648441|NCT01116648|21347916|P14|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648442|NCT01116648|21347917|P13|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648443|NCT01116648|21347918|P12|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648444|NCT01116648|21347919|P11|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648445|NCT01116648|21347920|P10|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648446|NCT01116648|21347921|P9|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648447|NCT01116648|21347922|P8|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648448|NCT01116648|21347923|P7|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648449|NCT01116648|21347924|P6|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648450|NCT01116648|21347925|P5|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648451|NCT01116648|21347926|P4|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648452|NCT01116648|21347927|P3|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648453|NCT01116648|21347928|P2|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648454|NCT01116648|21347929|P1|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
8648455|NCT01116648|21347915|P15|COMPLETED|Phase 1-T Dose Level 1-TA||0
8648456|NCT01116648|21347916|P14|COMPLETED|Phase 1-T Dose Level 1-TA||0
8648457|NCT01116648|21347917|P13|COMPLETED|Phase 1-T Dose Level 1-TA||0
8648458|NCT01116648|21347918|P12|COMPLETED|Phase 1-T Dose Level 1-TA||0
8648459|NCT01116648|21347919|P11|COMPLETED|Phase 1-T Dose Level 1-TA||0
8648460|NCT01116648|21347920|P10|COMPLETED|Phase 1-T Dose Level 1-TA||0
8648461|NCT01116648|21347921|P9|COMPLETED|Phase 1-T Dose Level 1-TA||6
8648462|NCT01116648|21347922|P8|COMPLETED|Phase 1-T Dose Level 1-TA||0
8648463|NCT01116648|21347923|P7|COMPLETED|Phase 1-T Dose Level 1-TA||0
8648464|NCT01116648|21347924|P6|COMPLETED|Phase 1-T Dose Level 1-TA||0
8648465|NCT01116648|21347925|P5|COMPLETED|Phase 1-T Dose Level 1-TA||0
8648466|NCT01116648|21347926|P4|COMPLETED|Phase 1-T Dose Level 1-TA||0
8648467|NCT01116648|21347927|P3|COMPLETED|Phase 1-T Dose Level 1-TA||0
8648468|NCT01116648|21347928|P2|COMPLETED|Phase 1-T Dose Level 1-TA||0
8648469|NCT01116648|21347929|P1|COMPLETED|Phase 1-T Dose Level 1-TA||0
8648470|NCT01116648|21347915|P15|STARTED|Phase 1-T Dose Level 1-TA||0
8648471|NCT01116648|21347916|P14|STARTED|Phase 1-T Dose Level 1-TA||0
8648472|NCT01116648|21347917|P13|STARTED|Phase 1-T Dose Level 1-TA||0
8648473|NCT01116648|21347918|P12|STARTED|Phase 1-T Dose Level 1-TA||0
8648474|NCT01116648|21347919|P11|STARTED|Phase 1-T Dose Level 1-TA||0
8648475|NCT01116648|21347920|P10|STARTED|Phase 1-T Dose Level 1-TA||0
8648476|NCT01116648|21347921|P9|STARTED|Phase 1-T Dose Level 1-TA||6
8648477|NCT01116648|21347922|P8|STARTED|Phase 1-T Dose Level 1-TA||0
8648478|NCT01116648|21347923|P7|STARTED|Phase 1-T Dose Level 1-TA||0
8648479|NCT01116648|21347924|P6|STARTED|Phase 1-T Dose Level 1-TA||0
8648480|NCT01116648|21347925|P5|STARTED|Phase 1-T Dose Level 1-TA||0
8648481|NCT01116648|21347926|P4|STARTED|Phase 1-T Dose Level 1-TA||0
8648482|NCT01116648|21347927|P3|STARTED|Phase 1-T Dose Level 1-TA||0
8648483|NCT01116648|21347928|P2|STARTED|Phase 1-T Dose Level 1-TA||0
8648484|NCT01116648|21347929|P1|STARTED|Phase 1-T Dose Level 1-TA||0
8648485|NCT01116648|21347915|P15|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648486|NCT01116648|21347916|P14|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648487|NCT01116648|21347917|P13|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648488|NCT01116648|21347918|P12|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648489|NCT01116648|21347919|P11|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648490|NCT01116648|21347920|P10|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648491|NCT01116648|21347921|P9|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648492|NCT01116648|21347922|P8|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648493|NCT01116648|21347923|P7|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648494|NCT01116648|21347924|P6|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648495|NCT01116648|21347925|P5|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648496|NCT01116648|21347926|P4|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648497|NCT01116648|21347927|P3|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648498|NCT01116648|21347928|P2|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648499|NCT01116648|21347929|P1|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
8648500|NCT01116648|21347915|P15|COMPLETED|Phase 1-T Dose Level 0-TA||0
8648501|NCT01116648|21347916|P14|COMPLETED|Phase 1-T Dose Level 0-TA||0
8648502|NCT01116648|21347917|P13|COMPLETED|Phase 1-T Dose Level 0-TA||0
8648503|NCT01116648|21347918|P12|COMPLETED|Phase 1-T Dose Level 0-TA||0
8648504|NCT01116648|21347919|P11|COMPLETED|Phase 1-T Dose Level 0-TA||0
8648505|NCT01116648|21347920|P10|COMPLETED|Phase 1-T Dose Level 0-TA||0
8648506|NCT01116648|21347921|P9|COMPLETED|Phase 1-T Dose Level 0-TA||0
8648507|NCT01116648|21347922|P8|COMPLETED|Phase 1-T Dose Level 0-TA||3
8648508|NCT01116648|21347923|P7|COMPLETED|Phase 1-T Dose Level 0-TA||0
8648509|NCT01116648|21347924|P6|COMPLETED|Phase 1-T Dose Level 0-TA||0
8648510|NCT01116648|21347925|P5|COMPLETED|Phase 1-T Dose Level 0-TA||0
8648511|NCT01116648|21347926|P4|COMPLETED|Phase 1-T Dose Level 0-TA||0
8648512|NCT01116648|21347927|P3|COMPLETED|Phase 1-T Dose Level 0-TA||0
8648513|NCT01116648|21347928|P2|COMPLETED|Phase 1-T Dose Level 0-TA||0
8648514|NCT01116648|21347929|P1|COMPLETED|Phase 1-T Dose Level 0-TA||0
8648515|NCT01116648|21347915|P15|STARTED|Phase 1-T Dose Level 0-TA||0
8648516|NCT01116648|21347916|P14|STARTED|Phase 1-T Dose Level 0-TA||0
8648517|NCT01116648|21347917|P13|STARTED|Phase 1-T Dose Level 0-TA||0
8648518|NCT01116648|21347918|P12|STARTED|Phase 1-T Dose Level 0-TA||0
8648519|NCT01116648|21347919|P11|STARTED|Phase 1-T Dose Level 0-TA||0
8648520|NCT01116648|21347920|P10|STARTED|Phase 1-T Dose Level 0-TA||0
8648521|NCT01116648|21347921|P9|STARTED|Phase 1-T Dose Level 0-TA||0
8648522|NCT01116648|21347922|P8|STARTED|Phase 1-T Dose Level 0-TA||3
8648523|NCT01116648|21347923|P7|STARTED|Phase 1-T Dose Level 0-TA||0
8648524|NCT01116648|21347924|P6|STARTED|Phase 1-T Dose Level 0-TA||0
8648525|NCT01116648|21347925|P5|STARTED|Phase 1-T Dose Level 0-TA||0
8648526|NCT01116648|21347926|P4|STARTED|Phase 1-T Dose Level 0-TA||0
8648527|NCT01116648|21347927|P3|STARTED|Phase 1-T Dose Level 0-TA||0
8648528|NCT01116648|21347928|P2|STARTED|Phase 1-T Dose Level 0-TA||0
8648529|NCT01116648|21347929|P1|STARTED|Phase 1-T Dose Level 0-TA||0
8648530|NCT01116648|21347915|P15|NOT COMPLETED|Phase 2||0
8648531|NCT01116648|21347916|P14|NOT COMPLETED|Phase 2||0
8648532|NCT01116648|21347917|P13|NOT COMPLETED|Phase 2||0
8648533|NCT01116648|21347918|P12|NOT COMPLETED|Phase 2||0
8648534|NCT01116648|21347919|P11|NOT COMPLETED|Phase 2||0
8648535|NCT01116648|21347920|P10|NOT COMPLETED|Phase 2||0
8648536|NCT01116648|21347921|P9|NOT COMPLETED|Phase 2||0
8648537|NCT01116648|21347922|P8|NOT COMPLETED|Phase 2||0
8648538|NCT01116648|21347923|P7|NOT COMPLETED|Phase 2||0
8648539|NCT01116648|21347924|P6|NOT COMPLETED|Phase 2||0
8648540|NCT01116648|21347925|P5|NOT COMPLETED|Phase 2||0
8648541|NCT01116648|21347926|P4|NOT COMPLETED|Phase 2||0
8648542|NCT01116648|21347927|P3|NOT COMPLETED|Phase 2||0
8648543|NCT01116648|21347928|P2|NOT COMPLETED|Phase 2||0
8648544|NCT01116648|21347929|P1|NOT COMPLETED|Phase 2||0
8648545|NCT01116648|21347915|P15|COMPLETED|Phase 2||0
8648546|NCT01116648|21347916|P14|COMPLETED|Phase 2||0
8648547|NCT01116648|21347917|P13|COMPLETED|Phase 2||0
8648548|NCT01116648|21347918|P12|COMPLETED|Phase 2||0
8648549|NCT01116648|21347919|P11|COMPLETED|Phase 2||0
8648550|NCT01116648|21347920|P10|COMPLETED|Phase 2||0
8648551|NCT01116648|21347921|P9|COMPLETED|Phase 2||0
8648552|NCT01116648|21347922|P8|COMPLETED|Phase 2||0
8648553|NCT01116648|21347923|P7|COMPLETED|Phase 2||44
8648554|NCT01116648|21347924|P6|COMPLETED|Phase 2||46
8648555|NCT01116648|21347925|P5|COMPLETED|Phase 2||0
8648556|NCT01116648|21347926|P4|COMPLETED|Phase 2||0
8648557|NCT01116648|21347927|P3|COMPLETED|Phase 2||0
8648558|NCT01116648|21347928|P2|COMPLETED|Phase 2||0
8648559|NCT01116648|21347929|P1|COMPLETED|Phase 2||0
8648560|NCT01116648|21347915|P15|STARTED|Phase 2||0
8648561|NCT01116648|21347916|P14|STARTED|Phase 2||0
8648562|NCT01116648|21347917|P13|STARTED|Phase 2||0
8648563|NCT01116648|21347918|P12|STARTED|Phase 2||0
8648564|NCT01116648|21347919|P11|STARTED|Phase 2||0
8648565|NCT01116648|21347920|P10|STARTED|Phase 2||0
8648566|NCT01116648|21347921|P9|STARTED|Phase 2||0
8648567|NCT01116648|21347922|P8|STARTED|Phase 2||0
8648568|NCT01116648|21347923|P7|STARTED|Phase 2||44
8648569|NCT01116648|21347924|P6|STARTED|Phase 2||46
8648570|NCT01116648|21347925|P5|STARTED|Phase 2||0
8648571|NCT01116648|21347926|P4|STARTED|Phase 2||0
8648572|NCT01116648|21347927|P3|STARTED|Phase 2||0
8648573|NCT01116648|21347928|P2|STARTED|Phase 2||0
8648574|NCT01116648|21347929|P1|STARTED|Phase 2||0
8648575|NCT01116648|21347915|P15|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648576|NCT01116648|21347916|P14|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648577|NCT01116648|21347917|P13|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648578|NCT01116648|21347918|P12|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648579|NCT01116648|21347919|P11|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648580|NCT01116648|21347920|P10|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648581|NCT01116648|21347921|P9|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648582|NCT01116648|21347922|P8|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648583|NCT01116648|21347923|P7|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648584|NCT01116648|21347924|P6|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648585|NCT01116648|21347925|P5|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648586|NCT01116648|21347926|P4|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648587|NCT01116648|21347927|P3|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648588|NCT01116648|21347928|P2|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648589|NCT01116648|21347929|P1|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
8648590|NCT01116648|21347915|P15|COMPLETED|Expansion at Maximum Tolerated Dose||0
8648591|NCT01116648|21347916|P14|COMPLETED|Expansion at Maximum Tolerated Dose||0
8648592|NCT01116648|21347917|P13|COMPLETED|Expansion at Maximum Tolerated Dose||0
8648593|NCT01116648|21347918|P12|COMPLETED|Expansion at Maximum Tolerated Dose||0
8648594|NCT01116648|21347919|P11|COMPLETED|Expansion at Maximum Tolerated Dose||0
8648595|NCT01116648|21347920|P10|COMPLETED|Expansion at Maximum Tolerated Dose||0
8648596|NCT01116648|21347921|P9|COMPLETED|Expansion at Maximum Tolerated Dose||0
8648597|NCT01116648|21347922|P8|COMPLETED|Expansion at Maximum Tolerated Dose||0
8648598|NCT01116648|21347923|P7|COMPLETED|Expansion at Maximum Tolerated Dose||0
8648599|NCT01116648|21347924|P6|COMPLETED|Expansion at Maximum Tolerated Dose||0
8648600|NCT01116648|21347925|P5|COMPLETED|Expansion at Maximum Tolerated Dose||9
8648601|NCT01116648|21347926|P4|COMPLETED|Expansion at Maximum Tolerated Dose||0
8648602|NCT01116648|21347927|P3|COMPLETED|Expansion at Maximum Tolerated Dose||0
8648603|NCT01116648|21347928|P2|COMPLETED|Expansion at Maximum Tolerated Dose||0
8648604|NCT01116648|21347929|P1|COMPLETED|Expansion at Maximum Tolerated Dose||0
8648605|NCT01116648|21347915|P15|STARTED|Expansion at Maximum Tolerated Dose||0
8648606|NCT01116648|21347916|P14|STARTED|Expansion at Maximum Tolerated Dose||0
8648607|NCT01116648|21347917|P13|STARTED|Expansion at Maximum Tolerated Dose||0
8648608|NCT01116648|21347918|P12|STARTED|Expansion at Maximum Tolerated Dose||0
8648609|NCT01116648|21347919|P11|STARTED|Expansion at Maximum Tolerated Dose||0
8648610|NCT01116648|21347920|P10|STARTED|Expansion at Maximum Tolerated Dose||0
8648611|NCT01116648|21347921|P9|STARTED|Expansion at Maximum Tolerated Dose||0
8648612|NCT01116648|21347922|P8|STARTED|Expansion at Maximum Tolerated Dose||0
8648613|NCT01116648|21347923|P7|STARTED|Expansion at Maximum Tolerated Dose||0
8648614|NCT01116648|21347924|P6|STARTED|Expansion at Maximum Tolerated Dose||0
8648615|NCT01116648|21347925|P5|STARTED|Expansion at Maximum Tolerated Dose||9
8648616|NCT01116648|21347926|P4|STARTED|Expansion at Maximum Tolerated Dose||0
8648617|NCT01116648|21347927|P3|STARTED|Expansion at Maximum Tolerated Dose||0
8648618|NCT01116648|21347928|P2|STARTED|Expansion at Maximum Tolerated Dose||0
8648619|NCT01116648|21347929|P1|STARTED|Expansion at Maximum Tolerated Dose||0
8648620|NCT01116648|21347915|P15|NOT COMPLETED|Phase 1 Dose Level 3||0
8648621|NCT01116648|21347916|P14|NOT COMPLETED|Phase 1 Dose Level 3||0
8648622|NCT01116648|21347917|P13|NOT COMPLETED|Phase 1 Dose Level 3||0
8648623|NCT01116648|21347918|P12|NOT COMPLETED|Phase 1 Dose Level 3||0
8648624|NCT01116648|21347919|P11|NOT COMPLETED|Phase 1 Dose Level 3||0
8648625|NCT01116648|21347920|P10|NOT COMPLETED|Phase 1 Dose Level 3||0
8648626|NCT01116648|21347921|P9|NOT COMPLETED|Phase 1 Dose Level 3||0
8648627|NCT01116648|21347922|P8|NOT COMPLETED|Phase 1 Dose Level 3||0
8648628|NCT01116648|21347923|P7|NOT COMPLETED|Phase 1 Dose Level 3||0
8648629|NCT01116648|21347924|P6|NOT COMPLETED|Phase 1 Dose Level 3||0
8648630|NCT01116648|21347925|P5|NOT COMPLETED|Phase 1 Dose Level 3||0
8648631|NCT01116648|21347926|P4|NOT COMPLETED|Phase 1 Dose Level 3||2
8648632|NCT01116648|21347927|P3|NOT COMPLETED|Phase 1 Dose Level 3||0
8648633|NCT01116648|21347928|P2|NOT COMPLETED|Phase 1 Dose Level 3||0
8648634|NCT01116648|21347929|P1|NOT COMPLETED|Phase 1 Dose Level 3||0
8648635|NCT01116648|21347915|P15|COMPLETED|Phase 1 Dose Level 3||0
8648636|NCT01116648|21347916|P14|COMPLETED|Phase 1 Dose Level 3||0
8648637|NCT01116648|21347917|P13|COMPLETED|Phase 1 Dose Level 3||0
8648638|NCT01116648|21347918|P12|COMPLETED|Phase 1 Dose Level 3||0
8648639|NCT01116648|21347919|P11|COMPLETED|Phase 1 Dose Level 3||0
8648640|NCT01116648|21347920|P10|COMPLETED|Phase 1 Dose Level 3||0
8648641|NCT01116648|21347921|P9|COMPLETED|Phase 1 Dose Level 3||0
8648642|NCT01116648|21347922|P8|COMPLETED|Phase 1 Dose Level 3||0
8648643|NCT01116648|21347923|P7|COMPLETED|Phase 1 Dose Level 3||0
8648644|NCT01116648|21347924|P6|COMPLETED|Phase 1 Dose Level 3||0
8648645|NCT01116648|21347925|P5|COMPLETED|Phase 1 Dose Level 3||0
8648646|NCT01116648|21347926|P4|COMPLETED|Phase 1 Dose Level 3||4
8648647|NCT01116648|21347927|P3|COMPLETED|Phase 1 Dose Level 3||0
8648648|NCT01116648|21347928|P2|COMPLETED|Phase 1 Dose Level 3||0
8648649|NCT01116648|21347929|P1|COMPLETED|Phase 1 Dose Level 3||0
8648650|NCT01116648|21347915|P15|STARTED|Phase 1 Dose Level 3||0
8648651|NCT01116648|21347916|P14|STARTED|Phase 1 Dose Level 3||0
8648652|NCT01116648|21347917|P13|STARTED|Phase 1 Dose Level 3||0
8648653|NCT01116648|21347918|P12|STARTED|Phase 1 Dose Level 3||0
8648654|NCT01116648|21347919|P11|STARTED|Phase 1 Dose Level 3||0
8648655|NCT01116648|21347920|P10|STARTED|Phase 1 Dose Level 3||0
8648656|NCT01116648|21347921|P9|STARTED|Phase 1 Dose Level 3||0
8648657|NCT01116648|21347922|P8|STARTED|Phase 1 Dose Level 3||0
8648658|NCT01116648|21347923|P7|STARTED|Phase 1 Dose Level 3||0
8648659|NCT01116648|21347924|P6|STARTED|Phase 1 Dose Level 3||0
8648660|NCT01116648|21347925|P5|STARTED|Phase 1 Dose Level 3||0
8648661|NCT01116648|21347926|P4|STARTED|Phase 1 Dose Level 3||6
8648662|NCT01116648|21347927|P3|STARTED|Phase 1 Dose Level 3||0
8648663|NCT01116648|21347928|P2|STARTED|Phase 1 Dose Level 3||0
8648664|NCT01116648|21347929|P1|STARTED|Phase 1 Dose Level 3||0
8648665|NCT01116648|21347915|P15|NOT COMPLETED|Phase 1 Dose Level 2||0
8648666|NCT01116648|21347916|P14|NOT COMPLETED|Phase 1 Dose Level 2||0
8648667|NCT01116648|21347917|P13|NOT COMPLETED|Phase 1 Dose Level 2||0
8648668|NCT01116648|21347918|P12|NOT COMPLETED|Phase 1 Dose Level 2||0
8648669|NCT01116648|21347919|P11|NOT COMPLETED|Phase 1 Dose Level 2||0
8648670|NCT01116648|21347920|P10|NOT COMPLETED|Phase 1 Dose Level 2||0
8648671|NCT01116648|21347921|P9|NOT COMPLETED|Phase 1 Dose Level 2||0
8648672|NCT01116648|21347922|P8|NOT COMPLETED|Phase 1 Dose Level 2||0
8648673|NCT01116648|21347923|P7|NOT COMPLETED|Phase 1 Dose Level 2||0
8648674|NCT01116648|21347924|P6|NOT COMPLETED|Phase 1 Dose Level 2||0
8648675|NCT01116648|21347925|P5|NOT COMPLETED|Phase 1 Dose Level 2||0
8648676|NCT01116648|21347926|P4|NOT COMPLETED|Phase 1 Dose Level 2||0
8648677|NCT01116648|21347927|P3|NOT COMPLETED|Phase 1 Dose Level 2||0
8648678|NCT01116648|21347928|P2|NOT COMPLETED|Phase 1 Dose Level 2||0
8648679|NCT01116648|21347929|P1|NOT COMPLETED|Phase 1 Dose Level 2||0
8648680|NCT01116648|21347915|P15|COMPLETED|Phase 1 Dose Level 2||0
8648681|NCT01116648|21347916|P14|COMPLETED|Phase 1 Dose Level 2||0
8648682|NCT01116648|21347917|P13|COMPLETED|Phase 1 Dose Level 2||0
8648683|NCT01116648|21347918|P12|COMPLETED|Phase 1 Dose Level 2||0
8648684|NCT01116648|21347919|P11|COMPLETED|Phase 1 Dose Level 2||0
8648685|NCT01116648|21347920|P10|COMPLETED|Phase 1 Dose Level 2||0
8648686|NCT01116648|21347921|P9|COMPLETED|Phase 1 Dose Level 2||0
8648687|NCT01116648|21347922|P8|COMPLETED|Phase 1 Dose Level 2||0
8648688|NCT01116648|21347923|P7|COMPLETED|Phase 1 Dose Level 2||0
8648689|NCT01116648|21347924|P6|COMPLETED|Phase 1 Dose Level 2||0
8648690|NCT01116648|21347925|P5|COMPLETED|Phase 1 Dose Level 2||0
8648691|NCT01116648|21347926|P4|COMPLETED|Phase 1 Dose Level 2||0
8648692|NCT01116648|21347927|P3|COMPLETED|Phase 1 Dose Level 2||7
8648693|NCT01116648|21347928|P2|COMPLETED|Phase 1 Dose Level 2||0
8648694|NCT01116648|21347929|P1|COMPLETED|Phase 1 Dose Level 2||0
8648695|NCT01116648|21347915|P15|STARTED|Phase 1 Dose Level 2||0
8648696|NCT01116648|21347916|P14|STARTED|Phase 1 Dose Level 2||0
8648697|NCT01116648|21347917|P13|STARTED|Phase 1 Dose Level 2||0
8648698|NCT01116648|21347918|P12|STARTED|Phase 1 Dose Level 2||0
8648699|NCT01116648|21347919|P11|STARTED|Phase 1 Dose Level 2||0
8648700|NCT01116648|21347920|P10|STARTED|Phase 1 Dose Level 2||0
8648701|NCT01116648|21347921|P9|STARTED|Phase 1 Dose Level 2||0
8648702|NCT01116648|21347922|P8|STARTED|Phase 1 Dose Level 2||0
8648703|NCT01116648|21347923|P7|STARTED|Phase 1 Dose Level 2||0
8648704|NCT01116648|21347924|P6|STARTED|Phase 1 Dose Level 2||0
8648705|NCT01116648|21347925|P5|STARTED|Phase 1 Dose Level 2||0
8648706|NCT01116648|21347926|P4|STARTED|Phase 1 Dose Level 2||0
8648707|NCT01116648|21347927|P3|STARTED|Phase 1 Dose Level 2||7
8648708|NCT01116648|21347928|P2|STARTED|Phase 1 Dose Level 2||0
8648709|NCT01116648|21347929|P1|STARTED|Phase 1 Dose Level 2||0
8648710|NCT01116648|21347915|P15|NOT COMPLETED|Phase 1 Dose Level 1||0
8648711|NCT01116648|21347916|P14|NOT COMPLETED|Phase 1 Dose Level 1||0
8648712|NCT01116648|21347917|P13|NOT COMPLETED|Phase 1 Dose Level 1||0
8648713|NCT01116648|21347918|P12|NOT COMPLETED|Phase 1 Dose Level 1||0
8648714|NCT01116648|21347919|P11|NOT COMPLETED|Phase 1 Dose Level 1||0
8648715|NCT01116648|21347920|P10|NOT COMPLETED|Phase 1 Dose Level 1||0
8648716|NCT01116648|21347921|P9|NOT COMPLETED|Phase 1 Dose Level 1||0
8648717|NCT01116648|21347922|P8|NOT COMPLETED|Phase 1 Dose Level 1||0
8648718|NCT01116648|21347923|P7|NOT COMPLETED|Phase 1 Dose Level 1||0
8648719|NCT01116648|21347924|P6|NOT COMPLETED|Phase 1 Dose Level 1||0
8648720|NCT01116648|21347925|P5|NOT COMPLETED|Phase 1 Dose Level 1||0
8648721|NCT01116648|21347926|P4|NOT COMPLETED|Phase 1 Dose Level 1||0
8648722|NCT01116648|21347927|P3|NOT COMPLETED|Phase 1 Dose Level 1||0
8648723|NCT01116648|21347928|P2|NOT COMPLETED|Phase 1 Dose Level 1||0
8648724|NCT01116648|21347929|P1|NOT COMPLETED|Phase 1 Dose Level 1||0
8648725|NCT01116648|21347915|P15|COMPLETED|Phase 1 Dose Level 1||0
8648726|NCT01116648|21347916|P14|COMPLETED|Phase 1 Dose Level 1||0
8648727|NCT01116648|21347917|P13|COMPLETED|Phase 1 Dose Level 1||0
8648728|NCT01116648|21347918|P12|COMPLETED|Phase 1 Dose Level 1||0
8648729|NCT01116648|21347919|P11|COMPLETED|Phase 1 Dose Level 1||0
8648730|NCT01116648|21347920|P10|COMPLETED|Phase 1 Dose Level 1||0
8648731|NCT01116648|21347921|P9|COMPLETED|Phase 1 Dose Level 1||0
8648732|NCT01116648|21347922|P8|COMPLETED|Phase 1 Dose Level 1||0
8648733|NCT01116648|21347923|P7|COMPLETED|Phase 1 Dose Level 1||0
8648734|NCT01116648|21347924|P6|COMPLETED|Phase 1 Dose Level 1||0
8648735|NCT01116648|21347925|P5|COMPLETED|Phase 1 Dose Level 1||0
8648736|NCT01116648|21347926|P4|COMPLETED|Phase 1 Dose Level 1||0
8648737|NCT01116648|21347927|P3|COMPLETED|Phase 1 Dose Level 1||0
8648738|NCT01116648|21347928|P2|COMPLETED|Phase 1 Dose Level 1||3
8648739|NCT01116648|21347929|P1|COMPLETED|Phase 1 Dose Level 1||0
8648740|NCT01116648|21347915|P15|STARTED|Phase 1 Dose Level 1||0
8648741|NCT01116648|21347916|P14|STARTED|Phase 1 Dose Level 1||0
8648742|NCT01116648|21347917|P13|STARTED|Phase 1 Dose Level 1||0
8648743|NCT01116648|21347918|P12|STARTED|Phase 1 Dose Level 1||0
8648744|NCT01116648|21347919|P11|STARTED|Phase 1 Dose Level 1||0
8648745|NCT01116648|21347920|P10|STARTED|Phase 1 Dose Level 1||0
8648746|NCT01116648|21347921|P9|STARTED|Phase 1 Dose Level 1||0
8648747|NCT01116648|21347922|P8|STARTED|Phase 1 Dose Level 1||0
8648748|NCT01116648|21347923|P7|STARTED|Phase 1 Dose Level 1||0
8648749|NCT01116648|21347924|P6|STARTED|Phase 1 Dose Level 1||0
8648750|NCT01116648|21347925|P5|STARTED|Phase 1 Dose Level 1||0
8648751|NCT01116648|21347926|P4|STARTED|Phase 1 Dose Level 1||0
8648752|NCT01116648|21347927|P3|STARTED|Phase 1 Dose Level 1||0
8648753|NCT01116648|21347928|P2|STARTED|Phase 1 Dose Level 1||3
8648754|NCT01116648|21347929|P1|STARTED|Phase 1 Dose Level 1||0
8648755|NCT01116648|21347915|P15|NOT COMPLETED|Phase 1 Dose Level 0||0
8648756|NCT01116648|21347916|P14|NOT COMPLETED|Phase 1 Dose Level 0||0
8648757|NCT01116648|21347917|P13|NOT COMPLETED|Phase 1 Dose Level 0||0
8648758|NCT01116648|21347918|P12|NOT COMPLETED|Phase 1 Dose Level 0||0
8648759|NCT01116648|21347919|P11|NOT COMPLETED|Phase 1 Dose Level 0||0
8648760|NCT01116648|21347920|P10|NOT COMPLETED|Phase 1 Dose Level 0||0
8648761|NCT01116648|21347921|P9|NOT COMPLETED|Phase 1 Dose Level 0||0
8648762|NCT01116648|21347922|P8|NOT COMPLETED|Phase 1 Dose Level 0||0
8648763|NCT01116648|21347923|P7|NOT COMPLETED|Phase 1 Dose Level 0||0
8648764|NCT01116648|21347924|P6|NOT COMPLETED|Phase 1 Dose Level 0||0
8648765|NCT01116648|21347925|P5|NOT COMPLETED|Phase 1 Dose Level 0||0
8648766|NCT01116648|21347926|P4|NOT COMPLETED|Phase 1 Dose Level 0||0
8648767|NCT01116648|21347927|P3|NOT COMPLETED|Phase 1 Dose Level 0||0
8648768|NCT01116648|21347928|P2|NOT COMPLETED|Phase 1 Dose Level 0||0
8648769|NCT01116648|21347929|P1|NOT COMPLETED|Phase 1 Dose Level 0||0
8648770|NCT01116648|21347915|P15|COMPLETED|Phase 1 Dose Level 0||0
8648771|NCT01116648|21347916|P14|COMPLETED|Phase 1 Dose Level 0||0
8648772|NCT01116648|21347917|P13|COMPLETED|Phase 1 Dose Level 0||0
8648773|NCT01116648|21347918|P12|COMPLETED|Phase 1 Dose Level 0||0
8648774|NCT01116648|21347919|P11|COMPLETED|Phase 1 Dose Level 0||0
8648775|NCT01116648|21347920|P10|COMPLETED|Phase 1 Dose Level 0||0
8648776|NCT01116648|21347921|P9|COMPLETED|Phase 1 Dose Level 0||0
8648777|NCT01116648|21347922|P8|COMPLETED|Phase 1 Dose Level 0||0
8648778|NCT01116648|21347923|P7|COMPLETED|Phase 1 Dose Level 0||0
8648779|NCT01116648|21347924|P6|COMPLETED|Phase 1 Dose Level 0||0
8648780|NCT01116648|21347925|P5|COMPLETED|Phase 1 Dose Level 0||0
8648781|NCT01116648|21347926|P4|COMPLETED|Phase 1 Dose Level 0||0
8648782|NCT01116648|21347927|P3|COMPLETED|Phase 1 Dose Level 0||0
8648783|NCT01116648|21347928|P2|COMPLETED|Phase 1 Dose Level 0||0
8648784|NCT01116648|21347929|P1|COMPLETED|Phase 1 Dose Level 0||3
8648785|NCT01116648|21347915|P15|STARTED|Phase 1 Dose Level 0||0
8648786|NCT01116648|21347916|P14|STARTED|Phase 1 Dose Level 0||0
8648787|NCT01116648|21347917|P13|STARTED|Phase 1 Dose Level 0||0
8648788|NCT01116648|21347918|P12|STARTED|Phase 1 Dose Level 0||0
8648789|NCT01116648|21347919|P11|STARTED|Phase 1 Dose Level 0||0
8648790|NCT01116648|21347920|P10|STARTED|Phase 1 Dose Level 0||0
8648791|NCT01116648|21347921|P9|STARTED|Phase 1 Dose Level 0||0
8648792|NCT01116648|21347922|P8|STARTED|Phase 1 Dose Level 0||0
8648793|NCT01116648|21347923|P7|STARTED|Phase 1 Dose Level 0||0
8648794|NCT01116648|21347924|P6|STARTED|Phase 1 Dose Level 0||0
8648795|NCT01116648|21347925|P5|STARTED|Phase 1 Dose Level 0||0
8648796|NCT01116648|21347926|P4|STARTED|Phase 1 Dose Level 0||0
8648797|NCT01116648|21347927|P3|STARTED|Phase 1 Dose Level 0||0
8648798|NCT01116648|21347928|P2|STARTED|Phase 1 Dose Level 0||0
8648799|NCT01116648|21347929|P1|STARTED|Phase 1 Dose Level 0||3
8648800|NCT01077024|21347956|P2|NOT COMPLETED|Overall Study||28
8648801|NCT01077024|21347957|P1|NOT COMPLETED|Overall Study||31
8648802|NCT01077024|21347956|P2|COMPLETED|Overall Study||243
8648803|NCT01077024|21347957|P1|COMPLETED|Overall Study||236
8648804|NCT01077024|21347956|P2|STARTED|Overall Study||271
8648805|NCT01077024|21347957|P1|STARTED|Overall Study||267
8648806|NCT01053013|21347977|P2|NOT COMPLETED|Overall Study||0
8648807|NCT01053013|21347978|P1|NOT COMPLETED|Overall Study||0
8648808|NCT01053013|21347977|P2|COMPLETED|Overall Study||34
8648809|NCT01053013|21347978|P1|COMPLETED|Overall Study||24
8648810|NCT01053013|21347977|P2|STARTED|Overall Study||34
8648811|NCT01053013|21347978|P1|STARTED|Overall Study||24
8648812|NCT01018979|21348173|P2|NOT COMPLETED|Overall Study||10
8648813|NCT01018979|21348174|P1|NOT COMPLETED|Overall Study||3
8648814|NCT01018979|21348173|P2|COMPLETED|Overall Study||3
8648815|NCT01018979|21348174|P1|COMPLETED|Overall Study||4
8648816|NCT01018979|21348173|P2|Received at Least One Dose|Overall Study||12
8648817|NCT01018979|21348174|P1|Received at Least One Dose|Overall Study||7
8648818|NCT01018979|21348173|P2|STARTED|Overall Study|A total of 20 subjects were randomized.|13
8648819|NCT01018979|21348174|P1|STARTED|Overall Study||7
8648820|NCT00792467|21348204|P1|NOT COMPLETED|Overall Study||22
8648821|NCT00792467|21348204|P1|COMPLETED|Overall Study||2
8648822|NCT00792467|21348204|P1|STARTED|Overall Study||24
8648832|NCT00728884|21348242|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
8648833|NCT00728884|21348242|P1|COMPLETED|Two Year Post Placement Follow-up||145
8648834|NCT00728884|21348242|P1|STARTED|Two Year Post Placement Follow-up||145
8648835|NCT00728884|21348242|P1|NOT COMPLETED|One Year Post Placement Follow-up||4
8648836|NCT00728884|21348242|P1|COMPLETED|One Year Post Placement Follow-up||145
8648837|NCT00728884|21348242|P1|STARTED|One Year Post Placement Follow-up||149
8648838|NCT00728884|21348242|P1|NOT COMPLETED|Permanent Prosthesis Placement||13
8648839|NCT00728884|21348242|P1|COMPLETED|Permanent Prosthesis Placement||149
8648840|NCT00728884|21348242|P1|STARTED|Permanent Prosthesis Placement||162
8648841|NCT00728884|21348242|P1|NOT COMPLETED|Implant Placement Surgery||0
8648842|NCT00728884|21348242|P1|COMPLETED|Implant Placement Surgery||162
8648843|NCT00728884|21348242|P1|STARTED|Implant Placement Surgery||162
8648844|NCT00725049|21348248|P2|NOT COMPLETED|Overall Study||0
8648845|NCT00725049|21348249|P1|NOT COMPLETED|Overall Study||0
8648846|NCT00725049|21348248|P2|COMPLETED|Overall Study||20
8648847|NCT00725049|21348249|P1|COMPLETED|Overall Study||17
8648848|NCT00725049|21348248|P2|STARTED|Overall Study||20
8648849|NCT00725049|21348249|P1|STARTED|Overall Study||17
8648850|NCT00719576|21348257|P2|NOT COMPLETED|Overall Study||5
8648851|NCT00719576|21348258|P1|NOT COMPLETED|Overall Study||2
8648852|NCT00719576|21348257|P2|COMPLETED|Overall Study||67
8648853|NCT00719576|21348258|P1|COMPLETED|Overall Study||70
8648854|NCT00719576|21348257|P2|STARTED|Overall Study||72
8648855|NCT00719576|21348258|P1|STARTED|Overall Study||72
8648862|NCT00569530|21348325|P2|NOT COMPLETED|Overall Study||0
8648863|NCT00569530|21348326|P1|NOT COMPLETED|Overall Study||0
8648864|NCT00569530|21348325|P2|COMPLETED|Overall Study||42
8648865|NCT00569530|21348326|P1|COMPLETED|Overall Study||43
8648866|NCT00569530|21348325|P2|STARTED|Overall Study||42
8648867|NCT00569530|21348326|P1|STARTED|Overall Study||43
8648885|NCT00499174|21348431|P2|NOT COMPLETED|Overall Study||9
8648886|NCT00499174|21348432|P1|NOT COMPLETED|Overall Study||78
8648887|NCT00499174|21348431|P2|COMPLETED|Overall Study||93
8648888|NCT00499174|21348432|P1|COMPLETED|Overall Study||0
8648889|NCT00499174|21348431|P2|STARTED|Overall Study||102
8648890|NCT00499174|21348432|P1|STARTED|Overall Study||78
8648891|NCT00426517|21348444|P4|NOT COMPLETED|Overall Study||0
8648892|NCT00426517|21348445|P3|NOT COMPLETED|Overall Study||0
8648893|NCT00426517|21348446|P2|NOT COMPLETED|Overall Study||0
8648894|NCT00426517|21348447|P1|NOT COMPLETED|Overall Study||0
8648895|NCT00426517|21348444|P4|COMPLETED|Overall Study||2
8648896|NCT00426517|21348445|P3|COMPLETED|Overall Study||3
8648897|NCT00426517|21348446|P2|COMPLETED|Overall Study||36
8648898|NCT00426517|21348447|P1|COMPLETED|Overall Study||7
8648899|NCT00426517|21348444|P4|STARTED|Overall Study||2
8648900|NCT00426517|21348445|P3|STARTED|Overall Study||3
8648901|NCT00426517|21348446|P2|STARTED|Overall Study||36
8648902|NCT00426517|21348447|P1|STARTED|Overall Study||7
8648911|NCT00256217|21348500|P1|NOT COMPLETED|Overall Study||8
8648912|NCT00256217|21348500|P1|COMPLETED|Overall Study||34
8648913|NCT00256217|21348500|P1|STARTED|Overall Study||42
8648923|NCT04688346|21348530|P2|NOT COMPLETED|Overall Study||0
8648924|NCT04688346|21348531|P1|NOT COMPLETED|Overall Study||0
8648925|NCT04688346|21348530|P2|COMPLETED|Overall Study||7
8648926|NCT04688346|21348531|P1|COMPLETED|Overall Study||6
8648927|NCT04688346|21348530|P2|Second Intervention|Overall Study||7
8648928|NCT04688346|21348531|P1|Second Intervention|Overall Study||6
8648929|NCT04688346|21348530|P2|First Intervention|Overall Study||7
8648930|NCT04688346|21348531|P1|First Intervention|Overall Study||6
8648931|NCT04688346|21348530|P2|STARTED|Overall Study||7
8648932|NCT04688346|21348531|P1|STARTED|Overall Study||6
8648933|NCT04577183|21348541|P1|NOT COMPLETED|Overall Study||6
8648934|NCT04577183|21348541|P1|COMPLETED|Overall Study||7
8648935|NCT04577183|21348541|P1|STARTED|Overall Study||13
8648936|NCT04399980|21348547|P2|NOT COMPLETED|Overall Study||0
8648937|NCT04399980|21348548|P1|NOT COMPLETED|Overall Study||0
8648938|NCT04399980|21348547|P2|COMPLETED|Overall Study||19
8648939|NCT04399980|21348548|P1|COMPLETED|Overall Study||21
8648940|NCT04399980|21348547|P2|STARTED|Overall Study||19
8648941|NCT04399980|21348548|P1|STARTED|Overall Study||21
8648942|NCT04338074|21348560|P2|NOT COMPLETED|Overall Study||0
8648943|NCT04338074|21348561|P1|NOT COMPLETED|Overall Study||0
8648944|NCT04338074|21348560|P2|COMPLETED|Overall Study||2
8648945|NCT04338074|21348561|P1|COMPLETED|Overall Study||3
8648946|NCT04338074|21348560|P2|STARTED|Overall Study||2
8648947|NCT04338074|21348561|P1|STARTED|Overall Study||3
8648948|NCT04327388|21348570|P3|NOT COMPLETED|Overall Study||11
8648949|NCT04327388|21348571|P2|NOT COMPLETED|Overall Study||20
8648950|NCT04327388|21348572|P1|NOT COMPLETED|Overall Study||20
8648951|NCT04327388|21348570|P3|COMPLETED|Overall Study||75
8648952|NCT04327388|21348571|P2|COMPLETED|Overall Study||153
8648953|NCT04327388|21348572|P1|COMPLETED|Overall Study||141
8648954|NCT04327388|21348570|P3|Participants Who Received Second Dose|Overall Study||5
8648955|NCT04327388|21348571|P2|Participants Who Received Second Dose|Overall Study||11
8648956|NCT04327388|21348572|P1|Participants Who Received Second Dose|Overall Study||13
8648957|NCT04327388|21348570|P3|Treated|Overall Study||84
8648958|NCT04327388|21348571|P2|Treated|Overall Study||173
8648959|NCT04327388|21348572|P1|Treated|Overall Study||159
8648960|NCT04327388|21348570|P3|STARTED|Overall Study||86
8648961|NCT04327388|21348571|P2|STARTED|Overall Study||173
8648962|NCT04327388|21348572|P1|STARTED|Overall Study||161
8648963|NCT04308668|21348663|P2|NOT COMPLETED|Overall Study||42
8648964|NCT04308668|21348664|P1|NOT COMPLETED|Overall Study||36
8648965|NCT04308668|21348663|P2|COMPLETED|Overall Study||612
8648966|NCT04308668|21348664|P1|COMPLETED|Overall Study||622
8648967|NCT04308668|21348663|P2|STARTED|Overall Study||654
8648968|NCT04308668|21348664|P1|STARTED|Overall Study||658
8648969|NCT04178720|21348688|P2|NOT COMPLETED|Overall Study||2
8648970|NCT04178720|21348689|P1|NOT COMPLETED|Overall Study||1
8648971|NCT04178720|21348688|P2|COMPLETED|Overall Study||38
8648972|NCT04178720|21348689|P1|COMPLETED|Overall Study||77
8648973|NCT04178720|21348688|P2|STARTED|Overall Study||40
8648974|NCT04178720|21348689|P1|STARTED|Overall Study||78
8648975|NCT04055519|21348698|P2|NOT COMPLETED|Second Wear Period (30 Days)||0
8648976|NCT04055519|21348699|P1|NOT COMPLETED|Second Wear Period (30 Days)||0
8648977|NCT04055519|21348698|P2|COMPLETED|Second Wear Period (30 Days)||20
8648978|NCT04055519|21348699|P1|COMPLETED|Second Wear Period (30 Days)||16
8648979|NCT04055519|21348698|P2|STARTED|Second Wear Period (30 Days)||20
8648980|NCT04055519|21348699|P1|STARTED|Second Wear Period (30 Days)||16
8648981|NCT04055519|21348698|P2|NOT COMPLETED|First Wear Period (30 Days)||0
8648982|NCT04055519|21348699|P1|NOT COMPLETED|First Wear Period (30 Days)||0
8648983|NCT04055519|21348698|P2|COMPLETED|First Wear Period (30 Days)||20
8648984|NCT04055519|21348699|P1|COMPLETED|First Wear Period (30 Days)||16
8648985|NCT04055519|21348698|P2|STARTED|First Wear Period (30 Days)||20
8648986|NCT04055519|21348699|P1|STARTED|First Wear Period (30 Days)||16
8648987|NCT03929367|21348708|P1|NOT COMPLETED|Overall Study||0
8648988|NCT03929367|21348708|P1|COMPLETED|Overall Study||11
8648989|NCT03929367|21348708|P1|STARTED|Overall Study||11
8648990|NCT03844321|21348750|P2|NOT COMPLETED|Overall Study||1659
8648991|NCT03844321|21348751|P1|NOT COMPLETED|Overall Study||1641
8648992|NCT03844321|21348750|P2|COMPLETED|Overall Study||533
8648993|NCT03844321|21348751|P1|COMPLETED|Overall Study||579
8648994|NCT03844321|21348750|P2|STARTED|Overall Study||2192
8648995|NCT03844321|21348751|P1|STARTED|Overall Study||2220
8648996|NCT03683719|21348798|P5|NOT COMPLETED|Overall Study||14
8648997|NCT03683719|21348799|P4|NOT COMPLETED|Overall Study||7
8648998|NCT03683719|21348800|P3|NOT COMPLETED|Overall Study||8
8648999|NCT03683719|21348801|P2|NOT COMPLETED|Overall Study||13
8649000|NCT03683719|21348802|P1|NOT COMPLETED|Overall Study||12
8649001|NCT03683719|21348798|P5|COMPLETED|Overall Study||36
8649002|NCT03683719|21348799|P4|COMPLETED|Overall Study||46
8649003|NCT03683719|21348800|P3|COMPLETED|Overall Study||44
8649004|NCT03683719|21348801|P2|COMPLETED|Overall Study||38
8649005|NCT03683719|21348802|P1|COMPLETED|Overall Study||40
8649006|NCT03683719|21348798|P5|STARTED|Overall Study||50
8649007|NCT03683719|21348799|P4|STARTED|Overall Study||53
8649008|NCT03683719|21348800|P3|STARTED|Overall Study||52
8649009|NCT03683719|21348801|P2|STARTED|Overall Study||51
8649010|NCT03683719|21348802|P1|STARTED|Overall Study||52
8649017|NCT03557931|21348836|P3|NOT COMPLETED|Overall Study||13
8649018|NCT03557931|21348837|P2|NOT COMPLETED|Overall Study||19
8649019|NCT03557931|21348838|P1|NOT COMPLETED|Overall Study||31
8649020|NCT03557931|21348836|P3|COMPLETED|Overall Study||55
8649021|NCT03557931|21348837|P2|COMPLETED|Overall Study||46
8649022|NCT03557931|21348838|P1|COMPLETED|Overall Study||69
8649023|NCT03557931|21348836|P3|STARTED|Overall Study||68
8649024|NCT03557931|21348837|P2|STARTED|Overall Study||65
8649025|NCT03557931|21348838|P1|STARTED|Overall Study||100
8649026|NCT03447730|21348869|P3|NOT COMPLETED|Overall Study||0
8649027|NCT03447730|21348870|P2|NOT COMPLETED|Overall Study||2
8649028|NCT03447730|21348871|P1|NOT COMPLETED|Overall Study||0
8649029|NCT03447730|21348869|P3|COMPLETED|Overall Study||8
8649030|NCT03447730|21348870|P2|COMPLETED|Overall Study||7
8649031|NCT03447730|21348871|P1|COMPLETED|Overall Study||6
8649032|NCT03447730|21348869|P3|STARTED|Overall Study||8
8649033|NCT03447730|21348870|P2|STARTED|Overall Study||9
8649034|NCT03447730|21348871|P1|STARTED|Overall Study||6
8649035|NCT03422172|21348885|P1|NOT COMPLETED|Long Term Follow-up Phase(Upto Week 89)||0
8649036|NCT03422172|21348885|P1|COMPLETED|Long Term Follow-up Phase(Upto Week 89)||43
8649037|NCT03422172|21348885|P1|STARTED|Long Term Follow-up Phase(Upto Week 89)||43
8649038|NCT03422172|21348885|P1|NOT COMPLETED|Injection Phase (Week 5 to Week 41)||4
8649039|NCT03422172|21348885|P1|COMPLETED|Injection Phase (Week 5 to Week 41)||43
8649040|NCT03422172|21348885|P1|STARTED|Injection Phase (Week 5 to Week 41)||47
8649041|NCT03422172|21348885|P1|NOT COMPLETED|Washout (7 Days)||0
8649042|NCT03422172|21348885|P1|COMPLETED|Washout (7 Days)||47
8649043|NCT03422172|21348885|P1|STARTED|Washout (7 Days)||47
8649044|NCT03422172|21348885|P1|NOT COMPLETED|Oral lead-in Phase (4 Weeks)||1
8649045|NCT03422172|21348885|P1|COMPLETED|Oral lead-in Phase (4 Weeks)||47
8649046|NCT03422172|21348885|P1|STARTED|Oral lead-in Phase (4 Weeks)||48
8649047|NCT03382834|21348930|P2|NOT COMPLETED|Overall Study||1
8649048|NCT03382834|21348931|P1|NOT COMPLETED|Overall Study||1
8649049|NCT03382834|21348930|P2|COMPLETED|Overall Study||9
8649050|NCT03382834|21348931|P1|COMPLETED|Overall Study||20
8649051|NCT03382834|21348930|P2|STARTED|Overall Study||10
8649052|NCT03382834|21348931|P1|STARTED|Overall Study||21
8649053|NCT03285542|21348945|P2|NOT COMPLETED|Overall Study||0
8649054|NCT03285542|21348946|P1|NOT COMPLETED|Overall Study||0
8649055|NCT03285542|21348945|P2|COMPLETED|Overall Study||30
8649056|NCT03285542|21348946|P1|COMPLETED|Overall Study||30
8649057|NCT03285542|21348945|P2|STARTED|Overall Study||30
8649058|NCT03285542|21348946|P1|STARTED|Overall Study||30
8649059|NCT03235154|21348956|P1|NOT COMPLETED|Overall Study||4
8649060|NCT03235154|21348956|P1|COMPLETED|Overall Study||7
8649061|NCT03235154|21348956|P1|12-wk Post-treatment HCV RNA Measured|Overall Study||7
8649062|NCT03235154|21348956|P1|Completed Epclusa. Treatment|Overall Study||8
8649063|NCT03235154|21348956|P1|STARTED|Overall Study||11
8649067|NCT03173560|21348968|P2|NOT COMPLETED|Overall Study||117
8649068|NCT03173560|21348969|P1|NOT COMPLETED|Overall Study||105
8649069|NCT03173560|21348968|P2|COMPLETED|Overall Study||54
8649070|NCT03173560|21348969|P1|COMPLETED|Overall Study||67
8649071|NCT03173560|21348968|P2|Safety Set|Overall Study||168
8649072|NCT03173560|21348969|P1|Safety Set|Overall Study||173
8649073|NCT03173560|21348968|P2|Treated Participants|Overall Study||169
8649074|NCT03173560|21348969|P1|Treated Participants|Overall Study||172
8649075|NCT03173560|21348968|P2|STARTED|Overall Study||171
8649076|NCT03173560|21348969|P1|STARTED|Overall Study||172
8649077|NCT03170661|21348999|P2|NOT COMPLETED|Overall Study||0
8649078|NCT03170661|21349000|P1|NOT COMPLETED|Overall Study||0
8649079|NCT03170661|21348999|P2|COMPLETED|Overall Study||49
8649080|NCT03170661|21349000|P1|COMPLETED|Overall Study||49
8649081|NCT03170661|21348999|P2|STARTED|Overall Study||49
8649082|NCT03170661|21349000|P1|STARTED|Overall Study||49
8649083|NCT03126786|21349018|P2|NOT COMPLETED|Overall Study||2
8649084|NCT03126786|21349019|P1|NOT COMPLETED|Overall Study||6
8649085|NCT03126786|21349018|P2|COMPLETED|Overall Study||33
8649086|NCT03126786|21349019|P1|COMPLETED|Overall Study||30
8649087|NCT03126786|21349018|P2|STARTED|Overall Study||35
8649088|NCT03126786|21349019|P1|STARTED|Overall Study||36
8649089|NCT03112473|21349031|P4|NOT COMPLETED|Overall Study||0
8649090|NCT03112473|21349032|P3|NOT COMPLETED|Overall Study||0
8649091|NCT03112473|21349033|P2|NOT COMPLETED|Overall Study||0
8649092|NCT03112473|21349034|P1|NOT COMPLETED|Overall Study||0
8649093|NCT03112473|21349031|P4|COMPLETED|Overall Study||30
8649094|NCT03112473|21349032|P3|COMPLETED|Overall Study||30
8649095|NCT03112473|21349033|P2|COMPLETED|Overall Study||30
8649096|NCT03112473|21349034|P1|COMPLETED|Overall Study||30
8649097|NCT03112473|21349031|P4|STARTED|Overall Study||30
8649098|NCT03112473|21349032|P3|STARTED|Overall Study||30
8649099|NCT03112473|21349033|P2|STARTED|Overall Study||30
8649100|NCT03112473|21349034|P1|STARTED|Overall Study||30
8649101|NCT02975700|21349072|P1|NOT COMPLETED|Overall Study||6
8649102|NCT02975700|21349072|P1|COMPLETED|Overall Study||0
8649103|NCT02975700|21349072|P1|STARTED|Overall Study||6
8649104|NCT02949024|21349092|P2|NOT COMPLETED|Overall Study||1
8649105|NCT02949024|21349093|P1|NOT COMPLETED|Overall Study||0
8649106|NCT02949024|21349092|P2|COMPLETED|Overall Study||9
8649107|NCT02949024|21349093|P1|COMPLETED|Overall Study||10
8649108|NCT02949024|21349092|P2|STARTED|Overall Study||10
8649109|NCT02949024|21349093|P1|STARTED|Overall Study||10
8649110|NCT02873936|21349110|P3|NOT COMPLETED|Overall Study||32
8649111|NCT02873936|21349111|P2|NOT COMPLETED|Overall Study||23
8649112|NCT02873936|21349112|P1|NOT COMPLETED|Overall Study||13
8649113|NCT02873936|21349110|P3|COMPLETED|Overall Study||116
8649114|NCT02873936|21349111|P2|COMPLETED|Overall Study||130
8649115|NCT02873936|21349112|P1|COMPLETED|Overall Study||135
8649116|NCT02873936|21349110|P3|STARTED|Overall Study||148
8649117|NCT02873936|21349111|P2|STARTED|Overall Study||153
8649118|NCT02873936|21349112|P1|STARTED|Overall Study||148
8649119|NCT02810392|21349242|P2|NOT COMPLETED|Overall Study||1
8649120|NCT02810392|21349243|P1|NOT COMPLETED|Overall Study||1
8649121|NCT02810392|21349242|P2|COMPLETED|Overall Study||9
8649122|NCT02810392|21349243|P1|COMPLETED|Overall Study||8
8649123|NCT02810392|21349242|P2|STARTED|Overall Study||10
8649124|NCT02810392|21349243|P1|STARTED|Overall Study||9
8649125|NCT02722304|21349282|P5|NOT COMPLETED|Overall Study||2
8649126|NCT02722304|21349283|P4|NOT COMPLETED|Overall Study||2
8649127|NCT02722304|21349284|P3|NOT COMPLETED|Overall Study||2
8649128|NCT02722304|21349285|P2|NOT COMPLETED|Overall Study||0
8649129|NCT02722304|21349286|P1|NOT COMPLETED|Overall Study||1
8649130|NCT02722304|21349282|P5|COMPLETED|Overall Study||0
8649131|NCT02722304|21349283|P4|COMPLETED|Overall Study||0
8649132|NCT02722304|21349284|P3|COMPLETED|Overall Study||0
8649133|NCT02722304|21349285|P2|COMPLETED|Overall Study||0
8649134|NCT02722304|21349286|P1|COMPLETED|Overall Study||0
8649135|NCT02722304|21349282|P5|Treated|Overall Study||2
8649136|NCT02722304|21349283|P4|Treated|Overall Study||1
8649137|NCT02722304|21349284|P3|Treated|Overall Study||1
8649138|NCT02722304|21349285|P2|Treated|Overall Study||0
8649139|NCT02722304|21349286|P1|Treated|Overall Study||1
8649140|NCT02722304|21349282|P5|STARTED|Overall Study||2
8649141|NCT02722304|21349283|P4|STARTED|Overall Study||2
8649142|NCT02722304|21349284|P3|STARTED|Overall Study||2
8649143|NCT02722304|21349285|P2|STARTED|Overall Study||0
8649144|NCT02722304|21349286|P1|STARTED|Overall Study||1
8649145|NCT02624739|21349338|P2|NOT COMPLETED|Overall Study||0
8649146|NCT02624739|21349339|P1|NOT COMPLETED|Overall Study||0
8649147|NCT02624739|21349338|P2|COMPLETED|Overall Study||0
8649148|NCT02624739|21349339|P1|COMPLETED|Overall Study||0
8649149|NCT02624739|21349338|P2|STARTED|Overall Study||0
8649150|NCT02624739|21349339|P1|STARTED|Overall Study||0
8649151|NCT02607280|21349363|P2|NOT COMPLETED|Overall Study||1
8649152|NCT02607280|21349364|P1|NOT COMPLETED|Overall Study||4
8649153|NCT02607280|21349363|P2|COMPLETED|Overall Study||4
8649154|NCT02607280|21349364|P1|COMPLETED|Overall Study||26
8649155|NCT02607280|21349363|P2|Received Study Drug|Overall Study||5
8649156|NCT02607280|21349364|P1|Received Study Drug|Overall Study||30
8649157|NCT02607280|21349363|P2|STARTED|Overall Study||5
8649158|NCT02607280|21349364|P1|STARTED|Overall Study||30
8649159|NCT02597101|21349372|P2|NOT COMPLETED|Overall Study||0
8649160|NCT02597101|21349373|P1|NOT COMPLETED|Overall Study||0
8649161|NCT02597101|21349372|P2|COMPLETED|Overall Study||5
8649162|NCT02597101|21349373|P1|COMPLETED|Overall Study||4
8649163|NCT02597101|21349372|P2|STARTED|Overall Study||5
8649164|NCT02597101|21349373|P1|STARTED|Overall Study||4
8649165|NCT02583269|21349400|P5|NOT COMPLETED|Overall Study||0
8649166|NCT02583269|21349401|P4|NOT COMPLETED|Overall Study||0
8649167|NCT02583269|21349402|P3|NOT COMPLETED|Overall Study||0
8649168|NCT02583269|21349403|P2|NOT COMPLETED|Overall Study||0
8649169|NCT02583269|21349404|P1|NOT COMPLETED|Overall Study||1
8649170|NCT02583269|21349400|P5|COMPLETED|Overall Study||6
8649171|NCT02583269|21349401|P4|COMPLETED|Overall Study||5
8649172|NCT02583269|21349402|P3|COMPLETED|Overall Study||3
8649173|NCT02583269|21349403|P2|COMPLETED|Overall Study||7
8649174|NCT02583269|21349404|P1|COMPLETED|Overall Study||2
8649175|NCT02583269|21349400|P5|STARTED|Overall Study||6
8649176|NCT02583269|21349401|P4|STARTED|Overall Study||5
8649177|NCT02583269|21349402|P3|STARTED|Overall Study||3
8649178|NCT02583269|21349403|P2|STARTED|Overall Study||7
8649179|NCT02583269|21349404|P1|STARTED|Overall Study||3
8649180|NCT02564471|21349439|P4|NOT COMPLETED|Overall Study||0
8649181|NCT02564471|21349440|P3|NOT COMPLETED|Overall Study||3
8649182|NCT02564471|21349441|P2|NOT COMPLETED|Overall Study||3
8649183|NCT02564471|21349442|P1|NOT COMPLETED|Overall Study||3
8649184|NCT02564471|21349439|P4|COMPLETED|Overall Study||25
8649185|NCT02564471|21349440|P3|COMPLETED|Overall Study||24
8649186|NCT02564471|21349441|P2|COMPLETED|Overall Study||23
8649187|NCT02564471|21349442|P1|COMPLETED|Overall Study||22
8649188|NCT02564471|21349439|P4|STARTED|Overall Study||25
8649189|NCT02564471|21349440|P3|STARTED|Overall Study||27
8649190|NCT02564471|21349441|P2|STARTED|Overall Study||26
8649191|NCT02564471|21349442|P1|STARTED|Overall Study||25
8649396|NCT02513732|21349625|P1|NOT COMPLETED|Overall Study||22
8649397|NCT02513732|21349625|P1|COMPLETED|Overall Study||78
8649398|NCT02513732|21349625|P1|STARTED|Overall Study||100
8649405|NCT02500602|21349774|P2|NOT COMPLETED|Follow Up Phase||22
8649406|NCT02500602|21349775|P1|NOT COMPLETED|Follow Up Phase||15
8649407|NCT02500602|21349774|P2|COMPLETED|Follow Up Phase||47
8649408|NCT02500602|21349775|P1|COMPLETED|Follow Up Phase||53
8649409|NCT02500602|21349774|P2|STARTED|Follow Up Phase||69
8649410|NCT02500602|21349775|P1|STARTED|Follow Up Phase||68
8649411|NCT02500602|21349774|P2|NOT COMPLETED|Treatment Phase||1
8649412|NCT02500602|21349775|P1|NOT COMPLETED|Treatment Phase||6
8649413|NCT02500602|21349774|P2|COMPLETED|Treatment Phase||69
8649414|NCT02500602|21349775|P1|COMPLETED|Treatment Phase||68
8649415|NCT02500602|21349774|P2|STARTED|Treatment Phase||70
8649416|NCT02500602|21349775|P1|STARTED|Treatment Phase||74
8649417|NCT02429934|21349787|P2|NOT COMPLETED|Overall Study||3
8649418|NCT02429934|21349788|P1|NOT COMPLETED|Overall Study||4
8649419|NCT02429934|21349787|P2|COMPLETED|Overall Study||10
8649420|NCT02429934|21349788|P1|COMPLETED|Overall Study||11
8649421|NCT02429934|21349787|P2|STARTED|Overall Study||13
8649422|NCT02429934|21349788|P1|STARTED|Overall Study||15
8649437|NCT02353832|21349852|P1|NOT COMPLETED|Overall Study||0
8649438|NCT02353832|21349852|P1|COMPLETED|Overall Study||44
8649439|NCT02353832|21349852|P1|STARTED|Overall Study||44
8649461|NCT02083354|21349894|P1|NOT COMPLETED|Overall Study||41
8649462|NCT02083354|21349894|P1|COMPLETED|Overall Study||36
8649463|NCT02083354|21349894|P1|STARTED|Overall Study||77
8649464|NCT02021318|21349900|P2|NOT COMPLETED|Overall Study||63
8649465|NCT02021318|21349901|P1|NOT COMPLETED|Overall Study||73
8649466|NCT02021318|21349900|P2|COMPLETED|Overall Study||230
8649467|NCT02021318|21349901|P1|COMPLETED|Overall Study||250
8649468|NCT02021318|21349900|P2|STARTED|Overall Study||293
8649469|NCT02021318|21349901|P1|STARTED|Overall Study||323
8649470|NCT02018458|21350027|P1|NOT COMPLETED|Overall Study||4
8649471|NCT02018458|21350027|P1|COMPLETED|Overall Study||6
8649472|NCT02018458|21350027|P1|STARTED|Overall Study||10
8649505|NCT01798056|21350088|P2|NOT COMPLETED|Overall Study||25
8649506|NCT01798056|21350089|P1|NOT COMPLETED|Overall Study||27
8649507|NCT01798056|21350088|P2|COMPLETED|Overall Study||90
8649508|NCT01798056|21350089|P1|COMPLETED|Overall Study||90
8649509|NCT01798056|21350088|P2|STARTED|Overall Study||115
8649510|NCT01798056|21350089|P1|STARTED|Overall Study||117
8649511|NCT01693562|21350146|P23|NOT COMPLETED|Expansion Phase||10
8649512|NCT01693562|21350147|P22|NOT COMPLETED|Expansion Phase||62
8649513|NCT01693562|21350148|P21|NOT COMPLETED|Expansion Phase||21
8649514|NCT01693562|21350149|P20|NOT COMPLETED|Expansion Phase||20
8649515|NCT01693562|21350150|P19|NOT COMPLETED|Expansion Phase||47
8649516|NCT01693562|21350151|P18|NOT COMPLETED|Expansion Phase||20
8649517|NCT01693562|21350152|P17|NOT COMPLETED|Expansion Phase||197
8649518|NCT01693562|21350153|P16|NOT COMPLETED|Expansion Phase||31
8649519|NCT01693562|21350154|P15|NOT COMPLETED|Expansion Phase||40
8649520|NCT01693562|21350155|P14|NOT COMPLETED|Expansion Phase||51
8649521|NCT01693562|21350156|P13|NOT COMPLETED|Expansion Phase||23
8649522|NCT01693562|21350157|P12|NOT COMPLETED|Expansion Phase||21
8649523|NCT01693562|21350158|P11|NOT COMPLETED|Expansion Phase||40
8649524|NCT01693562|21350159|P10|NOT COMPLETED|Expansion Phase||300
8649525|NCT01693562|21350160|P9|NOT COMPLETED|Expansion Phase||22
8649526|NCT01693562|21350161|P8|NOT COMPLETED|Expansion Phase||62
8649527|NCT01693562|21350162|P7|NOT COMPLETED|Expansion Phase||0
8649528|NCT01693562|21350163|P6|NOT COMPLETED|Expansion Phase||0
8649529|NCT01693562|21350164|P5|NOT COMPLETED|Expansion Phase||0
8649530|NCT01693562|21350165|P4|NOT COMPLETED|Expansion Phase||0
8649531|NCT01693562|21350166|P3|NOT COMPLETED|Expansion Phase||0
8649532|NCT01693562|21350167|P2|NOT COMPLETED|Expansion Phase||0
8649533|NCT01693562|21350168|P1|NOT COMPLETED|Expansion Phase||0
8649534|NCT01693562|21350146|P23|COMPLETED|Expansion Phase||0
8649535|NCT01693562|21350147|P22|COMPLETED|Expansion Phase||0
8649536|NCT01693562|21350148|P21|COMPLETED|Expansion Phase||0
8649537|NCT01693562|21350149|P20|COMPLETED|Expansion Phase||0
8649538|NCT01693562|21350150|P19|COMPLETED|Expansion Phase||0
8649539|NCT01693562|21350151|P18|COMPLETED|Expansion Phase||0
8649540|NCT01693562|21350152|P17|COMPLETED|Expansion Phase||4
8649541|NCT01693562|21350153|P16|COMPLETED|Expansion Phase||0
8649542|NCT01693562|21350154|P15|COMPLETED|Expansion Phase||0
8649543|NCT01693562|21350155|P14|COMPLETED|Expansion Phase||0
8649544|NCT01693562|21350156|P13|COMPLETED|Expansion Phase||1
8649545|NCT01693562|21350157|P12|COMPLETED|Expansion Phase||0
8649546|NCT01693562|21350158|P11|COMPLETED|Expansion Phase||0
8649547|NCT01693562|21350159|P10|COMPLETED|Expansion Phase||4
8649548|NCT01693562|21350160|P9|COMPLETED|Expansion Phase||0
8649549|NCT01693562|21350161|P8|COMPLETED|Expansion Phase||0
8649550|NCT01693562|21350162|P7|COMPLETED|Expansion Phase||0
8649551|NCT01693562|21350163|P6|COMPLETED|Expansion Phase||0
8649552|NCT01693562|21350164|P5|COMPLETED|Expansion Phase||0
8649553|NCT01693562|21350165|P4|COMPLETED|Expansion Phase||0
8649554|NCT01693562|21350166|P3|COMPLETED|Expansion Phase||0
8649555|NCT01693562|21350167|P2|COMPLETED|Expansion Phase||0
8649556|NCT01693562|21350168|P1|COMPLETED|Expansion Phase||0
8649557|NCT01693562|21350146|P23|STARTED|Expansion Phase||10
8649558|NCT01693562|21350147|P22|STARTED|Expansion Phase||62
8649559|NCT01693562|21350148|P21|STARTED|Expansion Phase||21
8649560|NCT01693562|21350149|P20|STARTED|Expansion Phase||20
8649561|NCT01693562|21350150|P19|STARTED|Expansion Phase||47
8649562|NCT01693562|21350151|P18|STARTED|Expansion Phase||20
8649563|NCT01693562|21350152|P17|STARTED|Expansion Phase||201
8649564|NCT01693562|21350153|P16|STARTED|Expansion Phase||31
8649565|NCT01693562|21350154|P15|STARTED|Expansion Phase||40
8649566|NCT01693562|21350155|P14|STARTED|Expansion Phase||51
8649567|NCT01693562|21350156|P13|STARTED|Expansion Phase||24
8649568|NCT01693562|21350157|P12|STARTED|Expansion Phase||21
8649569|NCT01693562|21350158|P11|STARTED|Expansion Phase||40
8649570|NCT01693562|21350159|P10|STARTED|Expansion Phase|2 eligible NSCLC participants from dose-escalation were added to the dose expansion summaries.|304
8649571|NCT01693562|21350160|P9|STARTED|Expansion Phase||22
8649572|NCT01693562|21350161|P8|STARTED|Expansion Phase||62
8649573|NCT01693562|21350162|P7|STARTED|Expansion Phase||0
8649574|NCT01693562|21350163|P6|STARTED|Expansion Phase||0
8649575|NCT01693562|21350164|P5|STARTED|Expansion Phase||0
8649576|NCT01693562|21350165|P4|STARTED|Expansion Phase||0
8649577|NCT01693562|21350166|P3|STARTED|Expansion Phase||0
8649578|NCT01693562|21350167|P2|STARTED|Expansion Phase||0
8649579|NCT01693562|21350168|P1|STARTED|Expansion Phase||0
8649580|NCT01693562|21350146|P23|NOT COMPLETED|Exploration Phase||0
8649581|NCT01693562|21350147|P22|NOT COMPLETED|Exploration Phase||0
8649582|NCT01693562|21350148|P21|NOT COMPLETED|Exploration Phase||0
8649583|NCT01693562|21350149|P20|NOT COMPLETED|Exploration Phase||0
8649584|NCT01693562|21350150|P19|NOT COMPLETED|Exploration Phase||0
8649585|NCT01693562|21350151|P18|NOT COMPLETED|Exploration Phase||0
8649586|NCT01693562|21350152|P17|NOT COMPLETED|Exploration Phase||0
8649587|NCT01693562|21350153|P16|NOT COMPLETED|Exploration Phase||0
8649588|NCT01693562|21350154|P15|NOT COMPLETED|Exploration Phase||0
8649589|NCT01693562|21350155|P14|NOT COMPLETED|Exploration Phase||0
8649590|NCT01693562|21350156|P13|NOT COMPLETED|Exploration Phase||0
8649591|NCT01693562|21350157|P12|NOT COMPLETED|Exploration Phase||0
8649592|NCT01693562|21350158|P11|NOT COMPLETED|Exploration Phase||0
8649593|NCT01693562|21350159|P10|NOT COMPLETED|Exploration Phase||0
8649594|NCT01693562|21350160|P9|NOT COMPLETED|Exploration Phase||0
8649595|NCT01693562|21350161|P8|NOT COMPLETED|Exploration Phase||0
8649596|NCT01693562|21350162|P7|NOT COMPLETED|Exploration Phase||21
8649597|NCT01693562|21350163|P6|NOT COMPLETED|Exploration Phase||0
8649598|NCT01693562|21350164|P5|NOT COMPLETED|Exploration Phase||0
8649599|NCT01693562|21350165|P4|NOT COMPLETED|Exploration Phase||0
8649600|NCT01693562|21350166|P3|NOT COMPLETED|Exploration Phase||0
8649601|NCT01693562|21350167|P2|NOT COMPLETED|Exploration Phase||0
8649602|NCT01693562|21350168|P1|NOT COMPLETED|Exploration Phase||0
8649603|NCT01693562|21350146|P23|COMPLETED|Exploration Phase||0
8649604|NCT01693562|21350147|P22|COMPLETED|Exploration Phase||0
8649605|NCT01693562|21350148|P21|COMPLETED|Exploration Phase||0
8649606|NCT01693562|21350149|P20|COMPLETED|Exploration Phase||0
8649607|NCT01693562|21350150|P19|COMPLETED|Exploration Phase||0
8649608|NCT01693562|21350151|P18|COMPLETED|Exploration Phase||0
8649609|NCT01693562|21350152|P17|COMPLETED|Exploration Phase||0
8649610|NCT01693562|21350153|P16|COMPLETED|Exploration Phase||0
8649611|NCT01693562|21350154|P15|COMPLETED|Exploration Phase||0
8649612|NCT01693562|21350155|P14|COMPLETED|Exploration Phase||0
8649613|NCT01693562|21350156|P13|COMPLETED|Exploration Phase||0
8649614|NCT01693562|21350157|P12|COMPLETED|Exploration Phase||0
8649615|NCT01693562|21350158|P11|COMPLETED|Exploration Phase||0
8649616|NCT01693562|21350159|P10|COMPLETED|Exploration Phase||0
8649617|NCT01693562|21350160|P9|COMPLETED|Exploration Phase||0
8649618|NCT01693562|21350161|P8|COMPLETED|Exploration Phase||0
8649619|NCT01693562|21350162|P7|COMPLETED|Exploration Phase||0
8649620|NCT01693562|21350163|P6|COMPLETED|Exploration Phase||0
8649621|NCT01693562|21350164|P5|COMPLETED|Exploration Phase||0
8649622|NCT01693562|21350165|P4|COMPLETED|Exploration Phase||0
8649623|NCT01693562|21350166|P3|COMPLETED|Exploration Phase||0
8649624|NCT01693562|21350167|P2|COMPLETED|Exploration Phase||0
8649625|NCT01693562|21350168|P1|COMPLETED|Exploration Phase||0
8649626|NCT01693562|21350146|P23|STARTED|Exploration Phase||0
8649627|NCT01693562|21350147|P22|STARTED|Exploration Phase||0
8649628|NCT01693562|21350148|P21|STARTED|Exploration Phase||0
8649629|NCT01693562|21350149|P20|STARTED|Exploration Phase||0
8649630|NCT01693562|21350150|P19|STARTED|Exploration Phase||0
8649631|NCT01693562|21350151|P18|STARTED|Exploration Phase||0
8649632|NCT01693562|21350152|P17|STARTED|Exploration Phase||0
8649633|NCT01693562|21350153|P16|STARTED|Exploration Phase||0
8649634|NCT01693562|21350154|P15|STARTED|Exploration Phase||0
8649635|NCT01693562|21350155|P14|STARTED|Exploration Phase||0
8649636|NCT01693562|21350156|P13|STARTED|Exploration Phase||0
8649637|NCT01693562|21350157|P12|STARTED|Exploration Phase||0
8649638|NCT01693562|21350158|P11|STARTED|Exploration Phase||0
8649639|NCT01693562|21350159|P10|STARTED|Exploration Phase||0
8649640|NCT01693562|21350160|P9|STARTED|Exploration Phase||0
8649641|NCT01693562|21350161|P8|STARTED|Exploration Phase||0
8649642|NCT01693562|21350162|P7|STARTED|Exploration Phase||21
8649643|NCT01693562|21350163|P6|STARTED|Exploration Phase||0
8649644|NCT01693562|21350164|P5|STARTED|Exploration Phase||0
8649645|NCT01693562|21350165|P4|STARTED|Exploration Phase||0
8649646|NCT01693562|21350166|P3|STARTED|Exploration Phase||0
8649647|NCT01693562|21350167|P2|STARTED|Exploration Phase||0
8649648|NCT01693562|21350168|P1|STARTED|Exploration Phase||0
8649649|NCT01693562|21350146|P23|NOT COMPLETED|Escalation Phase||0
8649650|NCT01693562|21350147|P22|NOT COMPLETED|Escalation Phase||0
8649651|NCT01693562|21350148|P21|NOT COMPLETED|Escalation Phase||0
8649652|NCT01693562|21350149|P20|NOT COMPLETED|Escalation Phase||0
8649653|NCT01693562|21350150|P19|NOT COMPLETED|Escalation Phase||0
8649654|NCT01693562|21350151|P18|NOT COMPLETED|Escalation Phase||0
8649655|NCT01693562|21350152|P17|NOT COMPLETED|Escalation Phase||0
8649656|NCT01693562|21350153|P16|NOT COMPLETED|Escalation Phase||0
8649657|NCT01693562|21350154|P15|NOT COMPLETED|Escalation Phase||0
8649658|NCT01693562|21350155|P14|NOT COMPLETED|Escalation Phase||0
8649659|NCT01693562|21350156|P13|NOT COMPLETED|Escalation Phase||0
8649660|NCT01693562|21350157|P12|NOT COMPLETED|Escalation Phase||0
8649661|NCT01693562|21350158|P11|NOT COMPLETED|Escalation Phase||0
8649662|NCT01693562|21350159|P10|NOT COMPLETED|Escalation Phase||0
8649663|NCT01693562|21350160|P9|NOT COMPLETED|Escalation Phase||0
8649664|NCT01693562|21350161|P8|NOT COMPLETED|Escalation Phase||0
8649665|NCT01693562|21350162|P7|NOT COMPLETED|Escalation Phase||0
8649666|NCT01693562|21350163|P6|NOT COMPLETED|Escalation Phase||7
8649667|NCT01693562|21350164|P5|NOT COMPLETED|Escalation Phase||6
8649668|NCT01693562|21350165|P4|NOT COMPLETED|Escalation Phase||3
8649669|NCT01693562|21350166|P3|NOT COMPLETED|Escalation Phase||3
8649670|NCT01693562|21350167|P2|NOT COMPLETED|Escalation Phase||4
8649671|NCT01693562|21350168|P1|NOT COMPLETED|Escalation Phase||4
8649672|NCT01693562|21350146|P23|COMPLETED|Escalation Phase||0
8649673|NCT01693562|21350147|P22|COMPLETED|Escalation Phase||0
8649674|NCT01693562|21350148|P21|COMPLETED|Escalation Phase||0
8649675|NCT01693562|21350149|P20|COMPLETED|Escalation Phase||0
8649676|NCT01693562|21350150|P19|COMPLETED|Escalation Phase||0
8649677|NCT01693562|21350151|P18|COMPLETED|Escalation Phase||0
8649678|NCT01693562|21350152|P17|COMPLETED|Escalation Phase||0
8649679|NCT01693562|21350153|P16|COMPLETED|Escalation Phase||0
8649680|NCT01693562|21350154|P15|COMPLETED|Escalation Phase||0
8649681|NCT01693562|21350155|P14|COMPLETED|Escalation Phase||0
8649682|NCT01693562|21350156|P13|COMPLETED|Escalation Phase||0
8649683|NCT01693562|21350157|P12|COMPLETED|Escalation Phase||0
8649684|NCT01693562|21350158|P11|COMPLETED|Escalation Phase||0
8649685|NCT01693562|21350159|P10|COMPLETED|Escalation Phase||0
8649686|NCT01693562|21350160|P9|COMPLETED|Escalation Phase||0
8649687|NCT01693562|21350161|P8|COMPLETED|Escalation Phase||0
8649688|NCT01693562|21350162|P7|COMPLETED|Escalation Phase||0
8649689|NCT01693562|21350163|P6|COMPLETED|Escalation Phase||0
8649690|NCT01693562|21350164|P5|COMPLETED|Escalation Phase||0
8649691|NCT01693562|21350165|P4|COMPLETED|Escalation Phase||0
8649692|NCT01693562|21350166|P3|COMPLETED|Escalation Phase||0
8649693|NCT01693562|21350167|P2|COMPLETED|Escalation Phase||0
8649694|NCT01693562|21350168|P1|COMPLETED|Escalation Phase||0
8649695|NCT01693562|21350146|P23|STARTED|Escalation Phase||0
8649696|NCT01693562|21350147|P22|STARTED|Escalation Phase||0
8649697|NCT01693562|21350148|P21|STARTED|Escalation Phase||0
8649698|NCT01693562|21350149|P20|STARTED|Escalation Phase||0
8649699|NCT01693562|21350150|P19|STARTED|Escalation Phase||0
8649700|NCT01693562|21350151|P18|STARTED|Escalation Phase||0
8649701|NCT01693562|21350152|P17|STARTED|Escalation Phase||0
8649702|NCT01693562|21350153|P16|STARTED|Escalation Phase||0
8649703|NCT01693562|21350154|P15|STARTED|Escalation Phase||0
8649704|NCT01693562|21350155|P14|STARTED|Escalation Phase||0
8649705|NCT01693562|21350156|P13|STARTED|Escalation Phase||0
8649706|NCT01693562|21350157|P12|STARTED|Escalation Phase||0
8649707|NCT01693562|21350158|P11|STARTED|Escalation Phase||0
8649708|NCT01693562|21350159|P10|STARTED|Escalation Phase||0
8649709|NCT01693562|21350160|P9|STARTED|Escalation Phase||0
8649710|NCT01693562|21350161|P8|STARTED|Escalation Phase||0
8649711|NCT01693562|21350162|P7|STARTED|Escalation Phase||0
8649712|NCT01693562|21350163|P6|STARTED|Escalation Phase||7
8649713|NCT01693562|21350164|P5|STARTED|Escalation Phase||6
8649714|NCT01693562|21350165|P4|STARTED|Escalation Phase||3
8649715|NCT01693562|21350166|P3|STARTED|Escalation Phase||3
8649716|NCT01693562|21350167|P2|STARTED|Escalation Phase||4
8649717|NCT01693562|21350168|P1|STARTED|Escalation Phase||4
8649718|NCT01669343|21350382|P1|NOT COMPLETED|Part B: Patients With BMI>=25||17
8649719|NCT01669343|21350382|P1|COMPLETED|Part B: Patients With BMI>=25||31
8649720|NCT01669343|21350382|P1|STARTED|Part B: Patients With BMI>=25||48
8649721|NCT01669343|21350382|P1|NOT COMPLETED|Part A: All Patients||9
8649722|NCT01669343|21350382|P1|COMPLETED|Part A: All Patients||112
8649723|NCT01669343|21350382|P1|STARTED|Part A: All Patients||121
8649757|NCT01522417|21350689|P3|NOT COMPLETED|Overall Study||0
8649758|NCT01522417|21350690|P2|NOT COMPLETED|Overall Study||0
8649759|NCT01522417|21350691|P1|NOT COMPLETED|Overall Study||0
8649760|NCT01522417|21350689|P3|COMPLETED|Overall Study|Randomization into the long tirofiban arm was completed on 1 February 2018.|124
8649761|NCT01522417|21350690|P2|COMPLETED|Overall Study||202
8649762|NCT01522417|21350691|P1|COMPLETED|Overall Study||209
8649763|NCT01522417|21350689|P3|STARTED|Overall Study|Randomization into the long tirofiban arm was initiated on 14 June 2013.|124
8649764|NCT01522417|21350690|P2|STARTED|Overall Study||202
8649765|NCT01522417|21350691|P1|STARTED|Overall Study||209
8649800|NCT01258075|21350759|P2|NOT COMPLETED|Overall Study||23
8649801|NCT01258075|21350760|P1|NOT COMPLETED|Overall Study||42
8649802|NCT01258075|21350759|P2|COMPLETED|Overall Study||72
8649803|NCT01258075|21350760|P1|COMPLETED|Overall Study||99
8649804|NCT01258075|21350759|P2|STARTED|Overall Study||95
8649805|NCT01258075|21350760|P1|STARTED|Overall Study||141
8649806|NCT01199068|21350781|P3|NOT COMPLETED|Overall Study||9
8649807|NCT01199068|21350782|P2|NOT COMPLETED|Overall Study||3
8649808|NCT01199068|21350783|P1|NOT COMPLETED|Overall Study||3
8649809|NCT01199068|21350781|P3|COMPLETED|Overall Study||0
8649810|NCT01199068|21350782|P2|COMPLETED|Overall Study||0
8649811|NCT01199068|21350783|P1|COMPLETED|Overall Study||0
8649812|NCT01199068|21350781|P3|Received Treatment|Overall Study||8
8649813|NCT01199068|21350782|P2|Received Treatment|Overall Study||3
8649814|NCT01199068|21350783|P1|Received Treatment|Overall Study||3
8649815|NCT01199068|21350781|P3|STARTED|Overall Study||9
8649816|NCT01199068|21350782|P2|STARTED|Overall Study||3
8649817|NCT01199068|21350783|P1|STARTED|Overall Study||3
8649818|NCT01178294|21350814|P1|NOT COMPLETED|Overall Study||11
8649819|NCT01178294|21350814|P1|COMPLETED|Overall Study||18
8649820|NCT01178294|21350814|P1|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
8649821|NCT01130896|21350835|P1|NOT COMPLETED|Overall Study||0
8649822|NCT01130896|21350835|P1|COMPLETED|Overall Study||1509
8649823|NCT01130896|21350835|P1|STARTED|Overall Study||1509
8649824|NCT01022580|21350843|P2|NOT COMPLETED|Overall Study||22
8649825|NCT01022580|21350844|P1|NOT COMPLETED|Overall Study||18
8649826|NCT01022580|21350843|P2|COMPLETED|Overall Study|Survived to discharge.|237
8649827|NCT01022580|21350844|P1|COMPLETED|Overall Study|Survived to discharge|234
8649828|NCT01022580|21350843|P2|STARTED|Overall Study||259
8649829|NCT01022580|21350844|P1|STARTED|Overall Study||252
8649830|NCT00994890|21350861|P3|NOT COMPLETED|Overall Study||226
8649831|NCT00994890|21350862|P2|NOT COMPLETED|Overall Study||222
8649832|NCT00994890|21350863|P1|NOT COMPLETED|Overall Study||231
8649833|NCT00994890|21350861|P3|COMPLETED|Overall Study||0
8649834|NCT00994890|21350862|P2|COMPLETED|Overall Study||0
8649835|NCT00994890|21350863|P1|COMPLETED|Overall Study||0
8649836|NCT00994890|21350861|P3|Treated|Overall Study||226
8649837|NCT00994890|21350862|P2|Treated|Overall Study||222
8649838|NCT00994890|21350863|P1|Treated|Overall Study||230
8649839|NCT00994890|21350861|P3|STARTED|Overall Study||226
8649840|NCT00994890|21350862|P2|STARTED|Overall Study||222
8649841|NCT00994890|21350863|P1|STARTED|Overall Study||231
8649845|NCT00928421|21351001|P1|NOT COMPLETED|Overall Study||0
8649846|NCT00928421|21351001|P1|COMPLETED|Overall Study||16
8649847|NCT00928421|21351001|P1|Treated With Study Drug|Overall Study||16
8649848|NCT00928421|21351001|P1|STARTED|Overall Study||16
8649849|NCT00830063|21351009|P4|NOT COMPLETED|Overall Study||195
8649850|NCT00830063|21351010|P3|NOT COMPLETED|Overall Study||198
8649851|NCT00830063|21351011|P2|NOT COMPLETED|Overall Study||192
8649852|NCT00830063|21351012|P1|NOT COMPLETED|Overall Study||200
8649853|NCT00830063|21351009|P4|COMPLETED|Overall Study||13
8649854|NCT00830063|21351010|P3|COMPLETED|Overall Study||10
8649855|NCT00830063|21351011|P2|COMPLETED|Overall Study||16
8649856|NCT00830063|21351012|P1|COMPLETED|Overall Study||8
8649857|NCT00830063|21351009|P4|Treated|Overall Study||206
8649858|NCT00830063|21351010|P3|Treated|Overall Study||208
8649859|NCT00830063|21351011|P2|Treated|Overall Study||206
8649860|NCT00830063|21351012|P1|Treated|Overall Study||208
8649861|NCT00830063|21351009|P4|STARTED|Overall Study||208
8649862|NCT00830063|21351010|P3|STARTED|Overall Study||208
8649863|NCT00830063|21351011|P2|STARTED|Overall Study||208
8649864|NCT00830063|21351012|P1|STARTED|Overall Study||208
8649865|NCT00826514|21351174|P2|NOT COMPLETED|Overall Study||5
8649866|NCT00826514|21351175|P1|NOT COMPLETED|Overall Study||3
8649867|NCT00826514|21351174|P2|COMPLETED|Overall Study||27
8649868|NCT00826514|21351175|P1|COMPLETED|Overall Study||27
8649869|NCT00826514|21351174|P2|STARTED|Overall Study||32
8649870|NCT00826514|21351175|P1|STARTED|Overall Study||30
8649871|NCT00720941|21351224|P2|NOT COMPLETED|Overall Study||415
8649872|NCT00720941|21351225|P1|NOT COMPLETED|Overall Study||413
8649873|NCT00720941|21351224|P2|COMPLETED|Overall Study||138
8649874|NCT00720941|21351225|P1|COMPLETED|Overall Study||144
8649875|NCT00720941|21351224|P2|Ongoing|Overall Study||23
8649876|NCT00720941|21351225|P1|Ongoing|Overall Study||34
8649877|NCT00720941|21351224|P2|STARTED|Overall Study||553
8649878|NCT00720941|21351225|P1|STARTED|Overall Study||557
8649879|NCT00601484|21351267|P2|NOT COMPLETED|Overall Study||8
8649880|NCT00601484|21351268|P1|NOT COMPLETED|Overall Study||5
8649881|NCT00601484|21351267|P2|COMPLETED|Overall Study||23
8649882|NCT00601484|21351268|P1|COMPLETED|Overall Study||29
8649883|NCT00601484|21351267|P2|Treated|Overall Study||30
8649884|NCT00601484|21351268|P1|Treated|Overall Study||34
8649885|NCT00601484|21351267|P2|STARTED|Overall Study||31
8649886|NCT00601484|21351268|P1|STARTED|Overall Study||34
8649887|NCT00567580|21351365|P3|NOT COMPLETED|Overall Study||24
8649888|NCT00567580|21351366|P2|NOT COMPLETED|Overall Study||24
8649889|NCT00567580|21351367|P1|NOT COMPLETED|Overall Study||28
8649890|NCT00567580|21351365|P3|COMPLETED|Overall Study||574
8649891|NCT00567580|21351366|P2|COMPLETED|Overall Study||578
8649892|NCT00567580|21351367|P1|COMPLETED|Overall Study||564
8649893|NCT00567580|21351365|P3|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
8649894|NCT00567580|21351366|P2|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
8649895|NCT00567580|21351367|P1|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||547
8649896|NCT00567580|21351365|P3|Eligible|Overall Study||574
8649897|NCT00567580|21351366|P2|Eligible|Overall Study||578
8649898|NCT00567580|21351367|P1|Eligible|Overall Study||564
8649899|NCT00567580|21351365|P3|STARTED|Overall Study||598
8649900|NCT00567580|21351366|P2|STARTED|Overall Study||602
8649901|NCT00567580|21351367|P1|STARTED|Overall Study||592
8649902|NCT00533429|21351401|P2|NOT COMPLETED|Overall Study||16
8649903|NCT00533429|21351402|P1|NOT COMPLETED|Overall Study||19
8649904|NCT00533429|21351401|P2|COMPLETED|Overall Study||4
8649905|NCT00533429|21351402|P1|COMPLETED|Overall Study||1
8649906|NCT00533429|21351401|P2|Entered Maintenance|Overall Study||10
8649907|NCT00533429|21351402|P1|Entered Maintenance|Overall Study||8
8649908|NCT00533429|21351401|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
8649909|NCT00533429|21351402|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
8649910|NCT00533429|21351401|P2|STARTED|Overall Study||20
8649911|NCT00533429|21351402|P1|STARTED|Overall Study||20
8649912|NCT00511862|21351421|P3|NOT COMPLETED|Overall Study||0
8649913|NCT00511862|21351422|P2|NOT COMPLETED|Overall Study||0
8649914|NCT00511862|21351423|P1|NOT COMPLETED|Overall Study||0
8649915|NCT00511862|21351421|P3|COMPLETED|Overall Study||47
8649916|NCT00511862|21351422|P2|COMPLETED|Overall Study||43
8649917|NCT00511862|21351423|P1|COMPLETED|Overall Study||61
8649918|NCT00511862|21351421|P3|STARTED|Overall Study||47
8649919|NCT00511862|21351422|P2|STARTED|Overall Study||43
8649920|NCT00511862|21351423|P1|STARTED|Overall Study||61
8649921|NCT00452413|21351437|P3|NOT COMPLETED|Overall Study||49
8649922|NCT00452413|21351438|P2|NOT COMPLETED|Overall Study||12
8649923|NCT00452413|21351439|P1|NOT COMPLETED|Overall Study||4
8649924|NCT00452413|21351437|P3|COMPLETED|Overall Study||0
8649925|NCT00452413|21351438|P2|COMPLETED|Overall Study||0
8649926|NCT00452413|21351439|P1|COMPLETED|Overall Study||0
8649927|NCT00452413|21351437|P3|Received at Least 1 Dose of Study Drug|Overall Study||49
8649928|NCT00452413|21351438|P2|Received at Least 1 Dose of Study Drug|Overall Study||12
8649929|NCT00452413|21351439|P1|Received at Least 1 Dose of Study Drug|Overall Study||4
8649930|NCT00452413|21351437|P3|STARTED|Overall Study||49
8649931|NCT00452413|21351438|P2|STARTED|Overall Study||12
8649932|NCT00452413|21351439|P1|STARTED|Overall Study||4
8649933|NCT00396006|21351458|P1|NOT COMPLETED|Overall Study||0
8649934|NCT00396006|21351458|P1|COMPLETED|Overall Study||13
8649935|NCT00396006|21351458|P1|STARTED|Overall Study||13
8649942|NCT00308750|21351491|P3|NOT COMPLETED|Overall Study||49
8649943|NCT00308750|21351492|P2|NOT COMPLETED|Overall Study||40
8649944|NCT00308750|21351493|P1|NOT COMPLETED|Overall Study||72
8649945|NCT00308750|21351491|P3|COMPLETED|Overall Study||23
8649946|NCT00308750|21351492|P2|COMPLETED|Overall Study||34
8649947|NCT00308750|21351493|P1|COMPLETED|Overall Study||0
8649948|NCT00308750|21351491|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
8649949|NCT00308750|21351492|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
8649950|NCT00308750|21351493|P1|Received at Least 1 Dose of Study Drug|Overall Study||67
8649951|NCT00308750|21351491|P3|STARTED|Overall Study||72
8649952|NCT00308750|21351492|P2|STARTED|Overall Study||74
8649953|NCT00308750|21351493|P1|STARTED|Overall Study||72
8649954|NCT00293423|21351530|P2|NOT COMPLETED|Vaccination Treatment Period||3
8649955|NCT00293423|21351531|P1|NOT COMPLETED|Vaccination Treatment Period||0
8649956|NCT00293423|21351530|P2|COMPLETED|Vaccination Treatment Period||38
8649957|NCT00293423|21351531|P1|COMPLETED|Vaccination Treatment Period||12
8649958|NCT00293423|21351530|P2|STARTED|Vaccination Treatment Period||41
8649959|NCT00293423|21351531|P1|STARTED|Vaccination Treatment Period||12
8649960|NCT00293423|21351530|P2|NOT COMPLETED|Surgical Resection||27
8649961|NCT00293423|21351531|P1|NOT COMPLETED|Surgical Resection||16
8649962|NCT00293423|21351530|P2|COMPLETED|Surgical Resection||41
8649963|NCT00293423|21351531|P1|COMPLETED|Surgical Resection||12
8649964|NCT00293423|21351530|P2|STARTED|Surgical Resection||68
8649965|NCT00293423|21351531|P1|STARTED|Surgical Resection||28
8649966|NCT00242385|21351546|P2|NOT COMPLETED|Period 2||0
8649967|NCT00242385|21351547|P1|NOT COMPLETED|Period 2||0
8649968|NCT00242385|21351546|P2|COMPLETED|Period 2||11
8649969|NCT00242385|21351547|P1|COMPLETED|Period 2||14
8649970|NCT00242385|21351546|P2|STARTED|Period 2||11
8649971|NCT00242385|21351547|P1|STARTED|Period 2||14
8649972|NCT00242385|21351546|P2|NOT COMPLETED|Period 1||0
8649973|NCT00242385|21351547|P1|NOT COMPLETED|Period 1||0
8649974|NCT00242385|21351546|P2|COMPLETED|Period 1||11
8649975|NCT00242385|21351547|P1|COMPLETED|Period 1||14
8649976|NCT00242385|21351546|P2|STARTED|Period 1||11
8649977|NCT00242385|21351547|P1|STARTED|Period 1||14
8649978|NCT04079127|21351571|P1|NOT COMPLETED|Overall Study||61
8649979|NCT04079127|21351571|P1|COMPLETED|Overall Study|89 hips have completed the study, and all 10 year data of 81 were available for analysis.|89
8649980|NCT04079127|21351571|P1|STARTED|Overall Study|hips (in 141 patients)|150
8649981|NCT03716076|21351579|P2|NOT COMPLETED|Overall Study||6
8649982|NCT03716076|21351580|P1|NOT COMPLETED|Overall Study||3
8649983|NCT03716076|21351579|P2|COMPLETED|Overall Study||19
8649984|NCT03716076|21351580|P1|COMPLETED|Overall Study||22
8649985|NCT03716076|21351579|P2|STARTED|Overall Study||25
8649986|NCT03716076|21351580|P1|STARTED|Overall Study||25
8650005|NCT03657264|21351629|P4|NOT COMPLETED|Overall Study||0
8650006|NCT03657264|21351630|P3|NOT COMPLETED|Overall Study||0
8650007|NCT03657264|21351631|P2|NOT COMPLETED|Overall Study||0
8650008|NCT03657264|21351632|P1|NOT COMPLETED|Overall Study||0
8650009|NCT03657264|21351629|P4|COMPLETED|Overall Study||12
8650010|NCT03657264|21351630|P3|COMPLETED|Overall Study||12
8650011|NCT03657264|21351631|P2|COMPLETED|Overall Study||12
8650012|NCT03657264|21351632|P1|COMPLETED|Overall Study||12
8650013|NCT03657264|21351629|P4|STARTED|Overall Study||12
8650014|NCT03657264|21351630|P3|STARTED|Overall Study||12
8650015|NCT03657264|21351631|P2|STARTED|Overall Study||12
8650016|NCT03657264|21351632|P1|STARTED|Overall Study||12
8650017|NCT03603106|21351656|P11|NOT COMPLETED|Overall Study||0
8650018|NCT03603106|21351657|P10|NOT COMPLETED|Overall Study||0
8650019|NCT03603106|21351658|P9|NOT COMPLETED|Overall Study||0
8650020|NCT03603106|21351659|P8|NOT COMPLETED|Overall Study||0
8650021|NCT03603106|21351660|P7|NOT COMPLETED|Overall Study||0
8650022|NCT03603106|21351661|P6|NOT COMPLETED|Overall Study||0
8650023|NCT03603106|21351662|P5|NOT COMPLETED|Overall Study||0
8650024|NCT03603106|21351663|P4|NOT COMPLETED|Overall Study||0
8650025|NCT03603106|21351664|P3|NOT COMPLETED|Overall Study||0
8650026|NCT03603106|21351665|P2|NOT COMPLETED|Overall Study||0
8650027|NCT03603106|21351666|P1|NOT COMPLETED|Overall Study||0
8650028|NCT03603106|21351656|P11|COMPLETED|Overall Study||3
8650029|NCT03603106|21351657|P10|COMPLETED|Overall Study||3
8650030|NCT03603106|21351658|P9|COMPLETED|Overall Study||3
8650031|NCT03603106|21351659|P8|COMPLETED|Overall Study||3
8650032|NCT03603106|21351660|P7|COMPLETED|Overall Study||18
8650033|NCT03603106|21351661|P6|COMPLETED|Overall Study||6
8650034|NCT03603106|21351662|P5|COMPLETED|Overall Study||6
8650035|NCT03603106|21351663|P4|COMPLETED|Overall Study||6
8650036|NCT03603106|21351664|P3|COMPLETED|Overall Study||6
8650037|NCT03603106|21351665|P2|COMPLETED|Overall Study||6
8650038|NCT03603106|21351666|P1|COMPLETED|Overall Study||6
8650039|NCT03603106|21351656|P11|STARTED|Overall Study||3
8650040|NCT03603106|21351657|P10|STARTED|Overall Study||3
8650041|NCT03603106|21351658|P9|STARTED|Overall Study||3
8650042|NCT03603106|21351659|P8|STARTED|Overall Study||3
8650043|NCT03603106|21351660|P7|STARTED|Overall Study||18
8650044|NCT03603106|21351661|P6|STARTED|Overall Study||6
8650045|NCT03603106|21351662|P5|STARTED|Overall Study||6
8650046|NCT03603106|21351663|P4|STARTED|Overall Study||6
8650047|NCT03603106|21351664|P3|STARTED|Overall Study||6
8650048|NCT03603106|21351665|P2|STARTED|Overall Study||6
8650049|NCT03603106|21351666|P1|STARTED|Overall Study||6
8650050|NCT03529773|21351759|P40|NOT COMPLETED|Overall Study||2
8650051|NCT03529773|21351760|P39|NOT COMPLETED|Overall Study||0
8650052|NCT03529773|21351761|P38|NOT COMPLETED|Overall Study||1
8650053|NCT03529773|21351762|P37|NOT COMPLETED|Overall Study||1
8650054|NCT03529773|21351763|P36|NOT COMPLETED|Overall Study||3
8650055|NCT03529773|21351764|P35|NOT COMPLETED|Overall Study||4
8650056|NCT03529773|21351765|P34|NOT COMPLETED|Overall Study||2
8650057|NCT03529773|21351766|P33|NOT COMPLETED|Overall Study||0
8650058|NCT03529773|21351767|P32|NOT COMPLETED|Overall Study||0
8650059|NCT03529773|21351768|P31|NOT COMPLETED|Overall Study||3
8650060|NCT03529773|21351769|P30|NOT COMPLETED|Overall Study||0
8650061|NCT03529773|21351770|P29|NOT COMPLETED|Overall Study||1
8650062|NCT03529773|21351771|P28|NOT COMPLETED|Overall Study||1
8650063|NCT03529773|21351772|P27|NOT COMPLETED|Overall Study||8
8650064|NCT03529773|21351773|P26|NOT COMPLETED|Overall Study||10
8650065|NCT03529773|21351774|P25|NOT COMPLETED|Overall Study||7
8650066|NCT03529773|21351775|P24|NOT COMPLETED|Overall Study||5
8650067|NCT03529773|21351776|P23|NOT COMPLETED|Overall Study||5
8650068|NCT03529773|21351777|P22|NOT COMPLETED|Overall Study||5
8650069|NCT03529773|21351778|P21|NOT COMPLETED|Overall Study||7
8650070|NCT03529773|21351779|P20|NOT COMPLETED|Overall Study||4
8650071|NCT03529773|21351780|P19|NOT COMPLETED|Overall Study||4
8650072|NCT03529773|21351781|P18|NOT COMPLETED|Overall Study||5
8650073|NCT03529773|21351782|P17|NOT COMPLETED|Overall Study||1
8650074|NCT03529773|21351783|P16|NOT COMPLETED|Overall Study||4
8650075|NCT03529773|21351784|P15|NOT COMPLETED|Overall Study||6
8650076|NCT03529773|21351785|P14|NOT COMPLETED|Overall Study||1
8650077|NCT03529773|21351786|P13|NOT COMPLETED|Overall Study||2
8650078|NCT03529773|21351787|P12|NOT COMPLETED|Overall Study||0
8650079|NCT03529773|21351788|P11|NOT COMPLETED|Overall Study||1
8650080|NCT03529773|21351789|P10|NOT COMPLETED|Overall Study||1
8650081|NCT03529773|21351790|P9|NOT COMPLETED|Overall Study||0
8650082|NCT03529773|21351791|P8|NOT COMPLETED|Overall Study||1
8650083|NCT03529773|21351792|P7|NOT COMPLETED|Overall Study||0
8650084|NCT03529773|21351793|P6|NOT COMPLETED|Overall Study||1
8650085|NCT03529773|21351794|P5|NOT COMPLETED|Overall Study||1
8650086|NCT03529773|21351795|P4|NOT COMPLETED|Overall Study||0
8650087|NCT03529773|21351796|P3|NOT COMPLETED|Overall Study||1
8650088|NCT03529773|21351797|P2|NOT COMPLETED|Overall Study||0
8650089|NCT03529773|21351798|P1|NOT COMPLETED|Overall Study||0
8650090|NCT03529773|21351759|P40|COMPLETED|Overall Study||39
8650091|NCT03529773|21351760|P39|COMPLETED|Overall Study||43
8650092|NCT03529773|21351761|P38|COMPLETED|Overall Study||41
8650093|NCT03529773|21351762|P37|COMPLETED|Overall Study||40
8650094|NCT03529773|21351763|P36|COMPLETED|Overall Study||37
8650095|NCT03529773|21351764|P35|COMPLETED|Overall Study||37
8650096|NCT03529773|21351765|P34|COMPLETED|Overall Study||39
8650097|NCT03529773|21351766|P33|COMPLETED|Overall Study||40
8650098|NCT03529773|21351767|P32|COMPLETED|Overall Study||40
8650099|NCT03529773|21351768|P31|COMPLETED|Overall Study||39
8650100|NCT03529773|21351769|P30|COMPLETED|Overall Study||40
8650101|NCT03529773|21351770|P29|COMPLETED|Overall Study||40
8650102|NCT03529773|21351771|P28|COMPLETED|Overall Study||39
8650103|NCT03529773|21351772|P27|COMPLETED|Overall Study||33
8650104|NCT03529773|21351773|P26|COMPLETED|Overall Study||31
8650105|NCT03529773|21351774|P25|COMPLETED|Overall Study||34
8650106|NCT03529773|21351775|P24|COMPLETED|Overall Study||36
8650107|NCT03529773|21351776|P23|COMPLETED|Overall Study||36
8650108|NCT03529773|21351777|P22|COMPLETED|Overall Study||36
8650109|NCT03529773|21351778|P21|COMPLETED|Overall Study||34
8650110|NCT03529773|21351779|P20|COMPLETED|Overall Study||37
8650111|NCT03529773|21351780|P19|COMPLETED|Overall Study||37
8650112|NCT03529773|21351781|P18|COMPLETED|Overall Study||35
8650113|NCT03529773|21351782|P17|COMPLETED|Overall Study||40
8650114|NCT03529773|21351783|P16|COMPLETED|Overall Study||38
8650115|NCT03529773|21351784|P15|COMPLETED|Overall Study||35
8650116|NCT03529773|21351785|P14|COMPLETED|Overall Study||11
8650117|NCT03529773|21351786|P13|COMPLETED|Overall Study||10
8650118|NCT03529773|21351787|P12|COMPLETED|Overall Study||12
8650119|NCT03529773|21351788|P11|COMPLETED|Overall Study||11
8650120|NCT03529773|21351789|P10|COMPLETED|Overall Study||11
8650121|NCT03529773|21351790|P9|COMPLETED|Overall Study||12
8650122|NCT03529773|21351791|P8|COMPLETED|Overall Study||11
8650123|NCT03529773|21351792|P7|COMPLETED|Overall Study||12
8650124|NCT03529773|21351793|P6|COMPLETED|Overall Study||11
8650125|NCT03529773|21351794|P5|COMPLETED|Overall Study||11
8650126|NCT03529773|21351795|P4|COMPLETED|Overall Study||12
8650127|NCT03529773|21351796|P3|COMPLETED|Overall Study||11
8650128|NCT03529773|21351797|P2|COMPLETED|Overall Study||12
8650129|NCT03529773|21351798|P1|COMPLETED|Overall Study||12
8650130|NCT03529773|21351759|P40|STARTED|Overall Study||41
8650131|NCT03529773|21351760|P39|STARTED|Overall Study||43
8650132|NCT03529773|21351761|P38|STARTED|Overall Study||42
8650133|NCT03529773|21351762|P37|STARTED|Overall Study||41
8650134|NCT03529773|21351763|P36|STARTED|Overall Study||40
8650135|NCT03529773|21351764|P35|STARTED|Overall Study||41
8650136|NCT03529773|21351765|P34|STARTED|Overall Study||41
8650137|NCT03529773|21351766|P33|STARTED|Overall Study||40
8650138|NCT03529773|21351767|P32|STARTED|Overall Study||40
8650139|NCT03529773|21351768|P31|STARTED|Overall Study||42
8650140|NCT03529773|21351769|P30|STARTED|Overall Study||40
8650141|NCT03529773|21351770|P29|STARTED|Overall Study||41
8650142|NCT03529773|21351771|P28|STARTED|Overall Study||40
8650143|NCT03529773|21351772|P27|STARTED|Overall Study||41
8650144|NCT03529773|21351773|P26|STARTED|Overall Study||41
8650145|NCT03529773|21351774|P25|STARTED|Overall Study||41
8650146|NCT03529773|21351775|P24|STARTED|Overall Study||41
8650147|NCT03529773|21351776|P23|STARTED|Overall Study||41
8650148|NCT03529773|21351777|P22|STARTED|Overall Study||41
8650149|NCT03529773|21351778|P21|STARTED|Overall Study||41
8650150|NCT03529773|21351779|P20|STARTED|Overall Study||41
8650151|NCT03529773|21351780|P19|STARTED|Overall Study||41
8650152|NCT03529773|21351781|P18|STARTED|Overall Study||40
8650153|NCT03529773|21351782|P17|STARTED|Overall Study||41
8650154|NCT03529773|21351783|P16|STARTED|Overall Study||42
8650155|NCT03529773|21351784|P15|STARTED|Overall Study||41
8650156|NCT03529773|21351785|P14|STARTED|Overall Study||12
8650157|NCT03529773|21351786|P13|STARTED|Overall Study||12
8650158|NCT03529773|21351787|P12|STARTED|Overall Study||12
8650159|NCT03529773|21351788|P11|STARTED|Overall Study||12
8650160|NCT03529773|21351789|P10|STARTED|Overall Study||12
8650161|NCT03529773|21351790|P9|STARTED|Overall Study||12
8650162|NCT03529773|21351791|P8|STARTED|Overall Study||12
8650163|NCT03529773|21351792|P7|STARTED|Overall Study||12
8650164|NCT03529773|21351793|P6|STARTED|Overall Study||12
8650165|NCT03529773|21351794|P5|STARTED|Overall Study||12
8650166|NCT03529773|21351795|P4|STARTED|Overall Study||12
8650167|NCT03529773|21351796|P3|STARTED|Overall Study||12
8650168|NCT03529773|21351797|P2|STARTED|Overall Study||12
8650169|NCT03529773|21351798|P1|STARTED|Overall Study||12
8650170|NCT03465722|21352094|P2|NOT COMPLETED|End of Study||236
8650171|NCT03465722|21352095|P1|NOT COMPLETED|End of Study||240
8650172|NCT03465722|21352094|P2|COMPLETED|End of Study||0
8650173|NCT03465722|21352095|P1|COMPLETED|End of Study||0
8650174|NCT03465722|21352094|P2|STARTED|End of Study||236
8650175|NCT03465722|21352095|P1|STARTED|End of Study||240
8650176|NCT03465722|21352094|P2|NOT COMPLETED|End of Treatment||236
8650177|NCT03465722|21352095|P1|NOT COMPLETED|End of Treatment||240
8650178|NCT03465722|21352094|P2|COMPLETED|End of Treatment||0
8650179|NCT03465722|21352095|P1|COMPLETED|End of Treatment||0
8650180|NCT03465722|21352094|P2|STARTED|End of Treatment||236
8650181|NCT03465722|21352095|P1|STARTED|End of Treatment||240
8650182|NCT03404609|21352107|P1|NOT COMPLETED|Overall Study||0
8650183|NCT03404609|21352107|P1|COMPLETED|Overall Study||7
8650184|NCT03404609|21352107|P1|STARTED|Overall Study||7
8650185|NCT03350542|21352111|P1|NOT COMPLETED|Overall Study||4
8650186|NCT03350542|21352111|P1|COMPLETED|Overall Study||96
8650187|NCT03350542|21352111|P1|Death With no 12-month F/U|Overall Study||4
8650188|NCT03350542|21352111|P1|Completed 12-Month Clinical F/U|Overall Study||96
8650189|NCT03350542|21352111|P1|STARTED|Overall Study||100
8650202|NCT03291288|21352159|P2|NOT COMPLETED|Pexidartinib Only||2
8650203|NCT03291288|21352160|P1|NOT COMPLETED|Pexidartinib Only||0
8650204|NCT03291288|21352159|P2|COMPLETED|Pexidartinib Only||24
8650205|NCT03291288|21352160|P1|COMPLETED|Pexidartinib Only||0
8650206|NCT03291288|21352159|P2|STARTED|Pexidartinib Only||26
8650207|NCT03291288|21352160|P1|STARTED|Pexidartinib Only|This is a crossover trial; participants who completed Part 1 continued to Part 2.|0
8650208|NCT03291288|21352159|P2|NOT COMPLETED|Drug-drug Interaction Phase||0
8650209|NCT03291288|21352160|P1|NOT COMPLETED|Drug-drug Interaction Phase||6
8650210|NCT03291288|21352159|P2|COMPLETED|Drug-drug Interaction Phase||0
8650211|NCT03291288|21352160|P1|COMPLETED|Drug-drug Interaction Phase||26
8650212|NCT03291288|21352159|P2|STARTED|Drug-drug Interaction Phase||0
8650213|NCT03291288|21352160|P1|STARTED|Drug-drug Interaction Phase||32
8650214|NCT03278613|21352204|P2|NOT COMPLETED|Overall Study||1
8650215|NCT03278613|21352205|P1|NOT COMPLETED|Overall Study||3
8650216|NCT03278613|21352204|P2|COMPLETED|Overall Study||54
8650217|NCT03278613|21352205|P1|COMPLETED|Overall Study||108
8650218|NCT03278613|21352204|P2|STARTED|Overall Study||55
8650219|NCT03278613|21352205|P1|STARTED|Overall Study||111
8650220|NCT03219892|21352323|P2|NOT COMPLETED|Overall Study||0
8650221|NCT03219892|21352324|P1|NOT COMPLETED|Overall Study||0
8650222|NCT03219892|21352323|P2|COMPLETED|Overall Study||10
8650223|NCT03219892|21352324|P1|COMPLETED|Overall Study||20
8650224|NCT03219892|21352323|P2|STARTED|Overall Study||10
8650225|NCT03219892|21352324|P1|STARTED|Overall Study||20
8650226|NCT03201562|21352341|P3|NOT COMPLETED|Overall Study||4
8650227|NCT03201562|21352342|P2|NOT COMPLETED|Overall Study||1
8650228|NCT03201562|21352343|P1|NOT COMPLETED|Overall Study||0
8650229|NCT03201562|21352341|P3|COMPLETED|Overall Study||16
8650230|NCT03201562|21352342|P2|COMPLETED|Overall Study||19
8650231|NCT03201562|21352343|P1|COMPLETED|Overall Study||18
8650232|NCT03201562|21352341|P3|STARTED|Overall Study||20
8650233|NCT03201562|21352342|P2|STARTED|Overall Study||20
8650234|NCT03201562|21352343|P1|STARTED|Overall Study||18
8650235|NCT03195660|21352351|P1|NOT COMPLETED|Overall Study||2
8650236|NCT03195660|21352351|P1|COMPLETED|Overall Study||0
8650237|NCT03195660|21352351|P1|STARTED|Overall Study||2
8650238|NCT03185546|21352366|P8|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
8650239|NCT03185546|21352367|P7|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
8650240|NCT03185546|21352368|P6|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
8650241|NCT03185546|21352369|P5|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
8650242|NCT03185546|21352370|P4|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
8650243|NCT03185546|21352371|P3|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
8650244|NCT03185546|21352372|P2|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
8650245|NCT03185546|21352373|P1|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
8650246|NCT03185546|21352366|P8|COMPLETED|Week 12 Through Day 30 Follow up||2
8650247|NCT03185546|21352367|P7|COMPLETED|Week 12 Through Day 30 Follow up||3
8650248|NCT03185546|21352368|P6|COMPLETED|Week 12 Through Day 30 Follow up||4
8650249|NCT03185546|21352369|P5|COMPLETED|Week 12 Through Day 30 Follow up||5
8650250|NCT03185546|21352370|P4|COMPLETED|Week 12 Through Day 30 Follow up||3
8650251|NCT03185546|21352371|P3|COMPLETED|Week 12 Through Day 30 Follow up||4
8650252|NCT03185546|21352372|P2|COMPLETED|Week 12 Through Day 30 Follow up||7
8650253|NCT03185546|21352373|P1|COMPLETED|Week 12 Through Day 30 Follow up||2
8650254|NCT03185546|21352366|P8|STARTED|Week 12 Through Day 30 Follow up||2
8650255|NCT03185546|21352367|P7|STARTED|Week 12 Through Day 30 Follow up||4
8650256|NCT03185546|21352368|P6|STARTED|Week 12 Through Day 30 Follow up||4
8650257|NCT03185546|21352369|P5|STARTED|Week 12 Through Day 30 Follow up||5
8650258|NCT03185546|21352370|P4|STARTED|Week 12 Through Day 30 Follow up||4
8650259|NCT03185546|21352371|P3|STARTED|Week 12 Through Day 30 Follow up||4
8650260|NCT03185546|21352372|P2|STARTED|Week 12 Through Day 30 Follow up||7
8650261|NCT03185546|21352373|P1|STARTED|Week 12 Through Day 30 Follow up||2
8650262|NCT03185546|21352366|P8|NOT COMPLETED|Baseline Through Week 12||3
8650263|NCT03185546|21352367|P7|NOT COMPLETED|Baseline Through Week 12||3
8650264|NCT03185546|21352368|P6|NOT COMPLETED|Baseline Through Week 12||2
8650265|NCT03185546|21352369|P5|NOT COMPLETED|Baseline Through Week 12||1
8650266|NCT03185546|21352370|P4|NOT COMPLETED|Baseline Through Week 12||1
8650267|NCT03185546|21352371|P3|NOT COMPLETED|Baseline Through Week 12||1
8650268|NCT03185546|21352372|P2|NOT COMPLETED|Baseline Through Week 12||3
8650269|NCT03185546|21352373|P1|NOT COMPLETED|Baseline Through Week 12||4
8650270|NCT03185546|21352366|P8|COMPLETED|Baseline Through Week 12||2
8650271|NCT03185546|21352367|P7|COMPLETED|Baseline Through Week 12||4
8650272|NCT03185546|21352368|P6|COMPLETED|Baseline Through Week 12||4
8650273|NCT03185546|21352369|P5|COMPLETED|Baseline Through Week 12||5
8650274|NCT03185546|21352370|P4|COMPLETED|Baseline Through Week 12||4
8650275|NCT03185546|21352371|P3|COMPLETED|Baseline Through Week 12||4
8650276|NCT03185546|21352372|P2|COMPLETED|Baseline Through Week 12||7
8650277|NCT03185546|21352373|P1|COMPLETED|Baseline Through Week 12||2
8650278|NCT03185546|21352366|P8|STARTED|Baseline Through Week 12||5
8650279|NCT03185546|21352367|P7|STARTED|Baseline Through Week 12||7
8650280|NCT03185546|21352368|P6|STARTED|Baseline Through Week 12||6
8650281|NCT03185546|21352369|P5|STARTED|Baseline Through Week 12||6
8650282|NCT03185546|21352370|P4|STARTED|Baseline Through Week 12||5
8650283|NCT03185546|21352371|P3|STARTED|Baseline Through Week 12||5
8650284|NCT03185546|21352372|P2|STARTED|Baseline Through Week 12||10
8650285|NCT03185546|21352373|P1|STARTED|Baseline Through Week 12||6
8650301|NCT03008369|21352474|P1|NOT COMPLETED|Overall Study||0
8650302|NCT03008369|21352474|P1|COMPLETED|Overall Study||3
8650303|NCT03008369|21352474|P1|STARTED|Overall Study||3
8650304|NCT02953860|21352482|P1|NOT COMPLETED|Overall Study||0
8650305|NCT02953860|21352482|P1|COMPLETED|Overall Study||32
8650306|NCT02953860|21352482|P1|STARTED|Overall Study||32
8650307|NCT02913222|21352490|P2|NOT COMPLETED|Overall Study||2
8650308|NCT02913222|21352491|P1|NOT COMPLETED|Overall Study||1
8650309|NCT02913222|21352490|P2|COMPLETED|Overall Study||21
8650310|NCT02913222|21352491|P1|COMPLETED|Overall Study||22
8650311|NCT02913222|21352490|P2|STARTED|Overall Study||23
8650312|NCT02913222|21352491|P1|STARTED|Overall Study||23
8650313|NCT02857283|21352515|P2|NOT COMPLETED|Second Exposure||0
8650314|NCT02857283|21352516|P1|NOT COMPLETED|Second Exposure||0
8650315|NCT02857283|21352515|P2|COMPLETED|Second Exposure||7
8650316|NCT02857283|21352516|P1|COMPLETED|Second Exposure||7
8650317|NCT02857283|21352515|P2|STARTED|Second Exposure||7
8650318|NCT02857283|21352516|P1|STARTED|Second Exposure||7
8650319|NCT02857283|21352515|P2|NOT COMPLETED|Washout (2 Weeks)||0
8650320|NCT02857283|21352516|P1|NOT COMPLETED|Washout (2 Weeks)||0
8650321|NCT02857283|21352515|P2|COMPLETED|Washout (2 Weeks)||7
8650322|NCT02857283|21352516|P1|COMPLETED|Washout (2 Weeks)||7
8650323|NCT02857283|21352515|P2|STARTED|Washout (2 Weeks)||7
8650324|NCT02857283|21352516|P1|STARTED|Washout (2 Weeks)||7
8650325|NCT02857283|21352515|P2|NOT COMPLETED|First Exposure||0
8650326|NCT02857283|21352516|P1|NOT COMPLETED|First Exposure||1
8650327|NCT02857283|21352515|P2|COMPLETED|First Exposure||7
8650328|NCT02857283|21352516|P1|COMPLETED|First Exposure||7
8650329|NCT02857283|21352515|P2|STARTED|First Exposure||7
8650330|NCT02857283|21352516|P1|STARTED|First Exposure||8
8650337|NCT02756910|21352559|P1|NOT COMPLETED|Overall Study||0
8650338|NCT02756910|21352559|P1|COMPLETED|Overall Study||80
8650339|NCT02756910|21352559|P1|STARTED|Overall Study||80
8650349|NCT02674061|21352584|P2|NOT COMPLETED|Overall Study||91
8650350|NCT02674061|21352585|P1|NOT COMPLETED|Overall Study||285
8650351|NCT02674061|21352584|P2|COMPLETED|Overall Study||0
8650352|NCT02674061|21352585|P1|COMPLETED|Overall Study||0
8650353|NCT02674061|21352584|P2|STARTED|Overall Study||91
8650354|NCT02674061|21352585|P1|STARTED|Overall Study||285
8650391|NCT02278471|21352822|P2|NOT COMPLETED|Overall Study||20
8650392|NCT02278471|21352823|P1|NOT COMPLETED|Overall Study||8
8650393|NCT02278471|21352822|P2|COMPLETED|Overall Study||128
8650394|NCT02278471|21352823|P1|COMPLETED|Overall Study||147
8650395|NCT02278471|21352822|P2|STARTED|Overall Study||148
8650396|NCT02278471|21352823|P1|STARTED|Overall Study||155
8650397|NCT02206061|21352848|P3|NOT COMPLETED|Overall Study||21
8650398|NCT02206061|21352849|P2|NOT COMPLETED|Overall Study||14
8650399|NCT02206061|21352850|P1|NOT COMPLETED|Overall Study||18
8650400|NCT02206061|21352848|P3|COMPLETED|Overall Study||118
8650401|NCT02206061|21352849|P2|COMPLETED|Overall Study||128
8650402|NCT02206061|21352850|P1|COMPLETED|Overall Study||131
8650403|NCT02206061|21352848|P3|STARTED|Overall Study||139
8650404|NCT02206061|21352849|P2|STARTED|Overall Study||142
8650405|NCT02206061|21352850|P1|STARTED|Overall Study||149
8650406|NCT02186015|21352860|P2|NOT COMPLETED|Overall Study||0
8650407|NCT02186015|21352861|P1|NOT COMPLETED|Overall Study||1
8650408|NCT02186015|21352860|P2|COMPLETED|Overall Study||31
8650409|NCT02186015|21352861|P1|COMPLETED|Overall Study||10
8650410|NCT02186015|21352860|P2|STARTED|Overall Study||31
8650411|NCT02186015|21352861|P1|STARTED|Overall Study||11
8650412|NCT02166333|21352885|P6|NOT COMPLETED|Stage 2||59
8650413|NCT02166333|21352886|P5|NOT COMPLETED|Stage 2||57
8650414|NCT02166333|21352887|P4|NOT COMPLETED|Stage 2||9
8650415|NCT02166333|21352888|P3|NOT COMPLETED|Stage 2||75
8650416|NCT02166333|21352889|P2|NOT COMPLETED|Stage 2||6
8650417|NCT02166333|21352890|P1|NOT COMPLETED|Stage 2||207
8650418|NCT02166333|21352885|P6|COMPLETED|Stage 2||4
8650419|NCT02166333|21352886|P5|COMPLETED|Stage 2||2
8650420|NCT02166333|21352887|P4|COMPLETED|Stage 2||73
8650421|NCT02166333|21352888|P3|COMPLETED|Stage 2||47
8650422|NCT02166333|21352889|P2|COMPLETED|Stage 2||71
8650423|NCT02166333|21352890|P1|COMPLETED|Stage 2||35
8650424|NCT02166333|21352885|P6|STARTED|Stage 2||63
8650425|NCT02166333|21352886|P5|STARTED|Stage 2||59
8650426|NCT02166333|21352887|P4|STARTED|Stage 2||82
8650427|NCT02166333|21352888|P3|STARTED|Stage 2||122
8650428|NCT02166333|21352889|P2|STARTED|Stage 2||77
8650429|NCT02166333|21352890|P1|STARTED|Stage 2||242
8650430|NCT02166333|21352885|P6|NOT COMPLETED|Stage 1||6
8650431|NCT02166333|21352886|P5|NOT COMPLETED|Stage 1||9
8650432|NCT02166333|21352887|P4|NOT COMPLETED|Stage 1||0
8650433|NCT02166333|21352888|P3|NOT COMPLETED|Stage 1||8
8650434|NCT02166333|21352889|P2|NOT COMPLETED|Stage 1||0
8650435|NCT02166333|21352890|P1|NOT COMPLETED|Stage 1||20
8650436|NCT02166333|21352885|P6|COMPLETED|Stage 1||63
8650437|NCT02166333|21352886|P5|COMPLETED|Stage 1||59
8650438|NCT02166333|21352887|P4|COMPLETED|Stage 1||0
8650439|NCT02166333|21352888|P3|COMPLETED|Stage 1||122
8650440|NCT02166333|21352889|P2|COMPLETED|Stage 1||0
8650441|NCT02166333|21352890|P1|COMPLETED|Stage 1||242
8650442|NCT02166333|21352885|P6|STARTED|Stage 1|Randomization to 4000 IU/d was stopped in March 2018 as part of planned dose-finding|69
8650443|NCT02166333|21352886|P5|STARTED|Stage 1|Randomization to 2000 IU/d was stopped in February 2018 as part of planned dose-finding|68
8650444|NCT02166333|21352887|P4|STARTED|Stage 1||0
8650445|NCT02166333|21352888|P3|STARTED|Stage 1||130
8650446|NCT02166333|21352889|P2|STARTED|Stage 1||0
8650447|NCT02166333|21352890|P1|STARTED|Stage 1||262
8650448|NCT02075515|21352905|P3|NOT COMPLETED|Overall Study||8
8650449|NCT02075515|21352906|P2|NOT COMPLETED|Overall Study||5
8650450|NCT02075515|21352907|P1|NOT COMPLETED|Overall Study||4
8650451|NCT02075515|21352905|P3|COMPLETED|Overall Study||208
8650452|NCT02075515|21352906|P2|COMPLETED|Overall Study||212
8650453|NCT02075515|21352907|P1|COMPLETED|Overall Study||214
8650454|NCT02075515|21352905|P3|STARTED|Overall Study||216
8650455|NCT02075515|21352906|P2|STARTED|Overall Study||217
8650456|NCT02075515|21352907|P1|STARTED|Overall Study||218
8650457|NCT02045836|21352944|P2|NOT COMPLETED|Overall Study||14
8650458|NCT02045836|21352945|P1|NOT COMPLETED|Overall Study||9
8650459|NCT02045836|21352944|P2|COMPLETED|Overall Study||419
8650460|NCT02045836|21352945|P1|COMPLETED|Overall Study||423
8650461|NCT02045836|21352944|P2|STARTED|Overall Study||433
8650462|NCT02045836|21352945|P1|STARTED|Overall Study||432
8650463|NCT01891994|21352976|P1|NOT COMPLETED|Overall Study||0
8650464|NCT01891994|21352976|P1|COMPLETED|Overall Study||40
8650465|NCT01891994|21352976|P1|STARTED|Overall Study||40
8650472|NCT01861054|21353008|P2|NOT COMPLETED|Overall Study||0
8650473|NCT01861054|21353009|P1|NOT COMPLETED|Overall Study||0
8650474|NCT01861054|21353008|P2|COMPLETED|Overall Study||2
8650475|NCT01861054|21353009|P1|COMPLETED|Overall Study||18
8650476|NCT01861054|21353008|P2|PK Population|Overall Study||2
8650477|NCT01861054|21353009|P1|PK Population|Overall Study||4
8650478|NCT01861054|21353008|P2|Safety Population|Overall Study||2
8650479|NCT01861054|21353009|P1|Safety Population|Overall Study||18
8650480|NCT01861054|21353008|P2|STARTED|Overall Study||2
8650481|NCT01861054|21353009|P1|STARTED|Overall Study||18
8650488|NCT01726673|21353055|P2|NOT COMPLETED|Overall Study||3
8650489|NCT01726673|21353056|P1|NOT COMPLETED|Overall Study||6
8650490|NCT01726673|21353055|P2|COMPLETED|Overall Study||21
8650491|NCT01726673|21353056|P1|COMPLETED|Overall Study||24
8650492|NCT01726673|21353055|P2|STARTED|Overall Study||24
8650493|NCT01726673|21353056|P1|STARTED|Overall Study||30
8650494|NCT01540071|21353066|P1|NOT COMPLETED|Overall Study||0
8650495|NCT01540071|21353066|P1|COMPLETED|Overall Study||38
8650496|NCT01540071|21353066|P1|STARTED|Overall Study||38
8650497|NCT01503229|21353074|P1|NOT COMPLETED|Overall Study||1
8650498|NCT01503229|21353074|P1|COMPLETED|Overall Study||29
8650499|NCT01503229|21353074|P1|STARTED|Overall Study||30
8650500|NCT01434511|21353078|P1|NOT COMPLETED|Overall Study||0
8650501|NCT01434511|21353078|P1|COMPLETED|Overall Study||1
8650502|NCT01434511|21353078|P1|STARTED|Overall Study||1
8650503|NCT01419665|21353097|P2|NOT COMPLETED|Open Label Phase||1
8650504|NCT01419665|21353098|P1|NOT COMPLETED|Open Label Phase||1
8650505|NCT01419665|21353097|P2|COMPLETED|Open Label Phase||38
8650506|NCT01419665|21353098|P1|COMPLETED|Open Label Phase||43
8650507|NCT01419665|21353097|P2|STARTED|Open Label Phase||39
8650508|NCT01419665|21353098|P1|STARTED|Open Label Phase||44
8650509|NCT01419665|21353097|P2|NOT COMPLETED|Maintenance Treatment and/or Follow up||102
8650510|NCT01419665|21353098|P1|NOT COMPLETED|Maintenance Treatment and/or Follow up||122
8650511|NCT01419665|21353097|P2|COMPLETED|Maintenance Treatment and/or Follow up||150
8650512|NCT01419665|21353098|P1|COMPLETED|Maintenance Treatment and/or Follow up||132
8650513|NCT01419665|21353097|P2|STARTED|Maintenance Treatment and/or Follow up||252
8650514|NCT01419665|21353098|P1|STARTED|Maintenance Treatment and/or Follow up||254
8650515|NCT01419665|21353097|P2|NOT COMPLETED|Combination Treatment||41
8650516|NCT01419665|21353098|P1|NOT COMPLETED|Combination Treatment||38
8650517|NCT01419665|21353097|P2|COMPLETED|Combination Treatment||274
8650518|NCT01419665|21353098|P1|COMPLETED|Combination Treatment||274
8650519|NCT01419665|21353097|P2|STARTED|Combination Treatment||315
8650520|NCT01419665|21353098|P1|STARTED|Combination Treatment||312
8650521|NCT01412879|21353126|P3|NOT COMPLETED|Consolidation Therapy||0
8650522|NCT01412879|21353127|P2|NOT COMPLETED|Consolidation Therapy||0
8650523|NCT01412879|21353128|P1|NOT COMPLETED|Consolidation Therapy||0
8650524|NCT01412879|21353126|P3|COMPLETED|Consolidation Therapy||26
8650525|NCT01412879|21353127|P2|COMPLETED|Consolidation Therapy||0
8650526|NCT01412879|21353128|P1|COMPLETED|Consolidation Therapy||0
8650527|NCT01412879|21353126|P3|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
8650528|NCT01412879|21353127|P2|STARTED|Consolidation Therapy||0
8650529|NCT01412879|21353128|P1|STARTED|Consolidation Therapy||0
8650530|NCT01412879|21353126|P3|NOT COMPLETED|Initial Registration (Induction Therapy)||0
8650531|NCT01412879|21353127|P2|NOT COMPLETED|Initial Registration (Induction Therapy)||8
8650532|NCT01412879|21353128|P1|NOT COMPLETED|Initial Registration (Induction Therapy)||13
8650533|NCT01412879|21353126|P3|COMPLETED|Initial Registration (Induction Therapy)||0
8650534|NCT01412879|21353127|P2|COMPLETED|Initial Registration (Induction Therapy)||27
8650535|NCT01412879|21353128|P1|COMPLETED|Initial Registration (Induction Therapy)||5
8650536|NCT01412879|21353126|P3|Treatment Started|Initial Registration (Induction Therapy)||0
8650537|NCT01412879|21353127|P2|Treatment Started|Initial Registration (Induction Therapy)||35
8650538|NCT01412879|21353128|P1|Treatment Started|Initial Registration (Induction Therapy)||17
8650539|NCT01412879|21353126|P3|STARTED|Initial Registration (Induction Therapy)||0
8650540|NCT01412879|21353127|P2|STARTED|Initial Registration (Induction Therapy)||35
8650541|NCT01412879|21353128|P1|STARTED|Initial Registration (Induction Therapy)||18
8650542|NCT01303068|21353144|P2|NOT COMPLETED|Overall Study||0
8650543|NCT01303068|21353145|P1|NOT COMPLETED|Overall Study||0
8650544|NCT01303068|21353144|P2|COMPLETED|Overall Study||6
8650545|NCT01303068|21353145|P1|COMPLETED|Overall Study||6
8650546|NCT01303068|21353144|P2|STARTED|Overall Study||6
8650547|NCT01303068|21353145|P1|STARTED|Overall Study||6
8650578|NCT01177787|21353183|P1|NOT COMPLETED|Cryolipolysis on Thigh||14
8650579|NCT01177787|21353183|P1|COMPLETED|Cryolipolysis on Thigh||14
8650580|NCT01177787|21353183|P1|STARTED|Cryolipolysis on Thigh||28
8650581|NCT01177787|21353183|P1|NOT COMPLETED|Clinical Efficacy of Cryolipolysis||0
8650582|NCT01177787|21353183|P1|COMPLETED|Clinical Efficacy of Cryolipolysis||28
8650583|NCT01177787|21353183|P1|STARTED|Clinical Efficacy of Cryolipolysis||28
8650584|NCT01100502|21353199|P2|NOT COMPLETED|Overall Study||94
8650585|NCT01100502|21353200|P1|NOT COMPLETED|Overall Study||76
8650586|NCT01100502|21353199|P2|COMPLETED|Overall Study|Completed due to study closure by sponsor|70
8650587|NCT01100502|21353200|P1|COMPLETED|Overall Study|Completed due to study closure by sponsor|89
8650588|NCT01100502|21353199|P2|STARTED|Overall Study||164
8650589|NCT01100502|21353200|P1|STARTED|Overall Study||165
8650596|NCT00985621|21353275|P4|NOT COMPLETED|Overall Study||137
8650597|NCT00985621|21353276|P3|NOT COMPLETED|Overall Study||123
8650598|NCT00985621|21353277|P2|NOT COMPLETED|Overall Study||131
8650599|NCT00985621|21353278|P1|NOT COMPLETED|Overall Study||114
8650600|NCT00985621|21353275|P4|COMPLETED|Overall Study||22
8650601|NCT00985621|21353276|P3|COMPLETED|Overall Study||29
8650602|NCT00985621|21353277|P2|COMPLETED|Overall Study||30
8650603|NCT00985621|21353278|P1|COMPLETED|Overall Study||28
8650604|NCT00985621|21353275|P4|Treated|Overall Study||158
8650605|NCT00985621|21353276|P3|Treated|Overall Study||150
8650606|NCT00985621|21353277|P2|Treated|Overall Study||161
8650607|NCT00985621|21353278|P1|Treated|Overall Study||141
8650608|NCT00985621|21353275|P4|STARTED|Overall Study||159
8650609|NCT00985621|21353276|P3|STARTED|Overall Study||152
8650610|NCT00985621|21353277|P2|STARTED|Overall Study||161
8650611|NCT00985621|21353278|P1|STARTED|Overall Study||142
8650612|NCT00624442|21353473|P5|NOT COMPLETED|Overall Study||2
8650613|NCT00624442|21353474|P4|NOT COMPLETED|Overall Study||0
8650614|NCT00624442|21353475|P3|NOT COMPLETED|Overall Study||2
8650615|NCT00624442|21353476|P2|NOT COMPLETED|Overall Study||1
8650616|NCT00624442|21353477|P1|NOT COMPLETED|Overall Study||0
8650617|NCT00624442|21353473|P5|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
8650618|NCT00624442|21353474|P4|COMPLETED|Overall Study||8
8650619|NCT00624442|21353475|P3|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
8650620|NCT00624442|21353476|P2|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
8650621|NCT00624442|21353477|P1|COMPLETED|Overall Study||8
8650622|NCT00624442|21353473|P5|STARTED|Overall Study||10
8650623|NCT00624442|21353474|P4|STARTED|Overall Study||8
8650624|NCT00624442|21353475|P3|STARTED|Overall Study||10
8650625|NCT00624442|21353476|P2|STARTED|Overall Study||9
8650626|NCT00624442|21353477|P1|STARTED|Overall Study||8
8650627|NCT00199888|21353529|P1|NOT COMPLETED|Overall Study||1
8650628|NCT00199888|21353529|P1|COMPLETED|Overall Study||25
8650629|NCT00199888|21353529|P1|STARTED|Overall Study||26
8650630|NCT00003487|21353536|P1|NOT COMPLETED|Overall Study||2
8650631|NCT00003487|21353536|P1|COMPLETED|Overall Study||6
8650632|NCT00003487|21353536|P1|STARTED|Overall Study||8
8650633|NCT04748341|21353542|P2|NOT COMPLETED|Overall Study||1
8650634|NCT04748341|21353543|P1|NOT COMPLETED|Overall Study||1
8650635|NCT04748341|21353542|P2|COMPLETED|Overall Study||30
8650636|NCT04748341|21353543|P1|COMPLETED|Overall Study||30
8650637|NCT04748341|21353542|P2|STARTED|Overall Study||31
8650638|NCT04748341|21353543|P1|STARTED|Overall Study||31
8650639|NCT04736069|21353555|P2|NOT COMPLETED|Overall Study||8
8650640|NCT04736069|21353556|P1|NOT COMPLETED|Overall Study||0
8650641|NCT04736069|21353555|P2|COMPLETED|Overall Study||22
8650642|NCT04736069|21353556|P1|COMPLETED|Overall Study||30
8650643|NCT04736069|21353555|P2|STARTED|Overall Study||30
8650644|NCT04736069|21353556|P1|STARTED|Overall Study||30
8650645|NCT04560374|21353572|P2|NOT COMPLETED|Overall Study||0
8650646|NCT04560374|21353573|P1|NOT COMPLETED|Overall Study||0
8650647|NCT04560374|21353572|P2|COMPLETED|Overall Study||50
8650648|NCT04560374|21353573|P1|COMPLETED|Overall Study||50
8650649|NCT04560374|21353572|P2|STARTED|Overall Study||50
8650650|NCT04560374|21353573|P1|STARTED|Overall Study||50
8650651|NCT04347564|21353581|P1|NOT COMPLETED|Overall Study||0
8650652|NCT04347564|21353581|P1|COMPLETED|Overall Study||45
8650653|NCT04347564|21353581|P1|STARTED|Overall Study||45
8650654|NCT04335552|21353592|P4|NOT COMPLETED|Overall Study||0
8650655|NCT04335552|21353593|P3|NOT COMPLETED|Overall Study||0
8650656|NCT04335552|21353594|P2|NOT COMPLETED|Overall Study||0
8650657|NCT04335552|21353595|P1|NOT COMPLETED|Overall Study||1
8650658|NCT04335552|21353592|P4|COMPLETED|Overall Study||2
8650659|NCT04335552|21353593|P3|COMPLETED|Overall Study||3
8650660|NCT04335552|21353594|P2|COMPLETED|Overall Study||4
8650661|NCT04335552|21353595|P1|COMPLETED|Overall Study||1
8650662|NCT04335552|21353592|P4|STARTED|Overall Study||2
8650663|NCT04335552|21353593|P3|STARTED|Overall Study||3
8650664|NCT04335552|21353594|P2|STARTED|Overall Study||4
8650665|NCT04335552|21353595|P1|STARTED|Overall Study||2
8650666|NCT04073186|21353633|P1|NOT COMPLETED|Second Wearing Cycle||1
8650667|NCT04073186|21353633|P1|COMPLETED|Second Wearing Cycle||79
8650668|NCT04073186|21353633|P1|STARTED|Second Wearing Cycle||80
8650669|NCT04073186|21353633|P1|NOT COMPLETED|First Wearing Cycle||6
8650670|NCT04073186|21353633|P1|COMPLETED|First Wearing Cycle||80
8650671|NCT04073186|21353633|P1|STARTED|First Wearing Cycle||86
8650672|NCT04069715|21353644|P2|NOT COMPLETED|Overall Study||5
8650673|NCT04069715|21353645|P1|NOT COMPLETED|Overall Study||5
8650674|NCT04069715|21353644|P2|COMPLETED|Overall Study||43
8650675|NCT04069715|21353645|P1|COMPLETED|Overall Study||42
8650676|NCT04069715|21353644|P2|STARTED|Overall Study||48
8650677|NCT04069715|21353645|P1|STARTED|Overall Study||47
8650678|NCT04037865|21353673|P1|NOT COMPLETED|Overall Study||0
8650679|NCT04037865|21353673|P1|COMPLETED|Overall Study||8
8650680|NCT04037865|21353673|P1|STARTED|Overall Study||8
8650681|NCT04028960|21353685|P2|NOT COMPLETED|Overall Study||0
8650682|NCT04028960|21353686|P1|NOT COMPLETED|Overall Study||0
8650683|NCT04028960|21353685|P2|COMPLETED|Overall Study||2
8650684|NCT04028960|21353686|P1|COMPLETED|Overall Study||2
8650685|NCT04028960|21353685|P2|STARTED|Overall Study||2
8650686|NCT04028960|21353686|P1|STARTED|Overall Study||2
8650690|NCT03909178|21353725|P2|NOT COMPLETED|Overall Study||5
8650691|NCT03909178|21353726|P1|NOT COMPLETED|Overall Study||4
8650692|NCT03909178|21353725|P2|COMPLETED|Overall Study||39
8650693|NCT03909178|21353726|P1|COMPLETED|Overall Study||42
8650694|NCT03909178|21353725|P2|STARTED|Overall Study||44
8650695|NCT03909178|21353726|P1|STARTED|Overall Study||46
8650696|NCT03881059|21353745|P3|NOT COMPLETED|Overall Study||8
8650697|NCT03881059|21353746|P2|NOT COMPLETED|Overall Study||7
8650698|NCT03881059|21353747|P1|NOT COMPLETED|Overall Study||8
8650699|NCT03881059|21353745|P3|COMPLETED|Overall Study||59
8650700|NCT03881059|21353746|P2|COMPLETED|Overall Study||63
8650701|NCT03881059|21353747|P1|COMPLETED|Overall Study||58
8650702|NCT03881059|21353745|P3|STARTED|Overall Study||67
8650703|NCT03881059|21353746|P2|STARTED|Overall Study||70
8650704|NCT03881059|21353747|P1|STARTED|Overall Study||66
8650723|NCT03783962|21353905|P2|NOT COMPLETED|Overall Study||7
8650724|NCT03783962|21353906|P1|NOT COMPLETED|Overall Study||3
8650725|NCT03783962|21353905|P2|COMPLETED|Overall Study||21
8650726|NCT03783962|21353906|P1|COMPLETED|Overall Study||25
8650727|NCT03783962|21353905|P2|STARTED|Overall Study||28
8650728|NCT03783962|21353906|P1|STARTED|Overall Study||28
8650729|NCT03748992|21353932|P1|NOT COMPLETED|Overall Study||0
8650730|NCT03748992|21353932|P1|COMPLETED|Overall Study||10
8650731|NCT03748992|21353932|P1|STARTED|Overall Study||10
8650732|NCT03721172|21353940|P3|NOT COMPLETED|Apremilast Extension Phase||66
8650733|NCT03721172|21353941|P2|NOT COMPLETED|Apremilast Extension Phase||0
8650734|NCT03721172|21353942|P1|NOT COMPLETED|Apremilast Extension Phase||0
8650735|NCT03721172|21353940|P3|COMPLETED|Apremilast Extension Phase||437
8650736|NCT03721172|21353941|P2|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
8650737|NCT03721172|21353942|P1|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
8650738|NCT03721172|21353940|P3|Received at Least 1 Dose|Apremilast Extension Phase||503
8650739|NCT03721172|21353941|P2|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
8650740|NCT03721172|21353942|P1|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
8650741|NCT03721172|21353940|P3|STARTED|Apremilast Extension Phase|1 participant did not enter the extension phase due to physician decision.|503
8650742|NCT03721172|21353941|P2|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
8650743|NCT03721172|21353942|P1|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
8650744|NCT03721172|21353940|P3|NOT COMPLETED|Placebo-controlled Phase||0
8650745|NCT03721172|21353941|P2|NOT COMPLETED|Placebo-controlled Phase||39
8650746|NCT03721172|21353942|P1|NOT COMPLETED|Placebo-controlled Phase||52
8650747|NCT03721172|21353940|P3|COMPLETED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
8650748|NCT03721172|21353941|P2|COMPLETED|Placebo-controlled Phase||258
8650749|NCT03721172|21353942|P1|COMPLETED|Placebo-controlled Phase||246
8650750|NCT03721172|21353940|P3|Received at Least 1 Dose of Treatment|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
8650751|NCT03721172|21353941|P2|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
8650752|NCT03721172|21353942|P1|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
8650753|NCT03721172|21353940|P3|STARTED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
8650754|NCT03721172|21353941|P2|STARTED|Placebo-controlled Phase||297
8650755|NCT03721172|21353942|P1|STARTED|Placebo-controlled Phase||298
8650756|NCT03682120|21353970|P4|NOT COMPLETED|Overall Study||2
8650757|NCT03682120|21353971|P3|NOT COMPLETED|Overall Study||8
8650758|NCT03682120|21353972|P2|NOT COMPLETED|Overall Study||8
8650759|NCT03682120|21353973|P1|NOT COMPLETED|Overall Study||13
8650760|NCT03682120|21353970|P4|COMPLETED|Overall Study||55
8650761|NCT03682120|21353971|P3|COMPLETED|Overall Study||97
8650762|NCT03682120|21353972|P2|COMPLETED|Overall Study||97
8650763|NCT03682120|21353973|P1|COMPLETED|Overall Study||92
8650764|NCT03682120|21353970|P4|STARTED|Overall Study||57
8650765|NCT03682120|21353971|P3|STARTED|Overall Study||105
8650766|NCT03682120|21353972|P2|STARTED|Overall Study||105
8650767|NCT03682120|21353973|P1|STARTED|Overall Study||105
8650777|NCT03622619|21354176|P2|NOT COMPLETED|Overall Study||2
8650778|NCT03622619|21354177|P1|NOT COMPLETED|Overall Study||2
8650779|NCT03622619|21354176|P2|COMPLETED|Overall Study||21
8650780|NCT03622619|21354177|P1|COMPLETED|Overall Study||21
8650781|NCT03622619|21354176|P2|STARTED|Overall Study||23
8650782|NCT03622619|21354177|P1|STARTED|Overall Study||23
8650783|NCT03575897|21354191|P2|NOT COMPLETED|Overall Study||13
8650784|NCT03575897|21354192|P1|NOT COMPLETED|Overall Study||12
8650785|NCT03575897|21354191|P2|COMPLETED|Overall Study||12
8650786|NCT03575897|21354192|P1|COMPLETED|Overall Study||13
8650787|NCT03575897|21354191|P2|STARTED|Overall Study||25
8650788|NCT03575897|21354192|P1|STARTED|Overall Study||25
8650789|NCT03559530|21354208|P2|NOT COMPLETED|Overall Study||0
8650790|NCT03559530|21354209|P1|NOT COMPLETED|Overall Study||91
8650791|NCT03559530|21354208|P2|COMPLETED|Overall Study||65
8650792|NCT03559530|21354209|P1|COMPLETED|Overall Study||106
8650793|NCT03559530|21354208|P2|STARTED|Overall Study||65
8650794|NCT03559530|21354209|P1|STARTED|Overall Study||197
8650795|NCT03489941|21354214|P3|NOT COMPLETED|Overall Study||0
8650796|NCT03489941|21354215|P2|NOT COMPLETED|Overall Study||0
8650797|NCT03489941|21354216|P1|NOT COMPLETED|Overall Study||0
8650798|NCT03489941|21354214|P3|COMPLETED|Overall Study||27
8650799|NCT03489941|21354215|P2|COMPLETED|Overall Study||52
8650800|NCT03489941|21354216|P1|COMPLETED|Overall Study||51
8650801|NCT03489941|21354214|P3|STARTED|Overall Study||27
8650802|NCT03489941|21354215|P2|STARTED|Overall Study||52
8650803|NCT03489941|21354216|P1|STARTED|Overall Study||51
8650804|NCT03480932|21354228|P3|NOT COMPLETED|Overall Study||5
8650805|NCT03480932|21354229|P2|NOT COMPLETED|Overall Study||5
8650806|NCT03480932|21354230|P1|NOT COMPLETED|Overall Study||3
8650807|NCT03480932|21354228|P3|COMPLETED|Overall Study||45
8650808|NCT03480932|21354229|P2|COMPLETED|Overall Study||45
8650809|NCT03480932|21354230|P1|COMPLETED|Overall Study||47
8650810|NCT03480932|21354228|P3|STARTED|Overall Study||50
8650811|NCT03480932|21354229|P2|STARTED|Overall Study||50
8650812|NCT03480932|21354230|P1|STARTED|Overall Study||50
8650813|NCT03426267|21354246|P2|NOT COMPLETED|Overall Study||72
8650814|NCT03426267|21354247|P1|NOT COMPLETED|Overall Study||21
8650815|NCT03426267|21354246|P2|COMPLETED|Overall Study||90
8650816|NCT03426267|21354247|P1|COMPLETED|Overall Study||142
8650817|NCT03426267|21354246|P2|Modified Intent-to-Treat Population|Overall Study||144
8650818|NCT03426267|21354247|P1|Modified Intent-to-Treat Population|Overall Study||154
8650819|NCT03426267|21354246|P2|STARTED|Overall Study||162
8650820|NCT03426267|21354247|P1|STARTED|Overall Study||163
8650827|NCT03399786|21354264|P4|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
8650828|NCT03399786|21354265|P3|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
8650829|NCT03399786|21354266|P2|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
8650830|NCT03399786|21354267|P1|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
8650831|NCT03399786|21354264|P4|COMPLETED|Open-label Treatment Period (OLTP)||43
8650832|NCT03399786|21354265|P3|COMPLETED|Open-label Treatment Period (OLTP)||19
8650833|NCT03399786|21354266|P2|COMPLETED|Open-label Treatment Period (OLTP)||0
8650834|NCT03399786|21354267|P1|COMPLETED|Open-label Treatment Period (OLTP)||0
8650835|NCT03399786|21354264|P4|STARTED|Open-label Treatment Period (OLTP)||44
8650836|NCT03399786|21354265|P3|STARTED|Open-label Treatment Period (OLTP)|One participant from the placebo group received evinacumab during the DBTP|20
8650837|NCT03399786|21354266|P2|STARTED|Open-label Treatment Period (OLTP)||0
8650838|NCT03399786|21354267|P1|STARTED|Open-label Treatment Period (OLTP)||0
8650839|NCT03399786|21354264|P4|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
8650840|NCT03399786|21354265|P3|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
8650841|NCT03399786|21354266|P2|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
8650842|NCT03399786|21354267|P1|NOT COMPLETED|Double-blind Treatment Period (DBTP)||1
8650843|NCT03399786|21354264|P4|COMPLETED|Double-blind Treatment Period (DBTP)||0
8650844|NCT03399786|21354265|P3|COMPLETED|Double-blind Treatment Period (DBTP)||0
8650845|NCT03399786|21354266|P2|COMPLETED|Double-blind Treatment Period (DBTP)||43
8650846|NCT03399786|21354267|P1|COMPLETED|Double-blind Treatment Period (DBTP)||21
8650847|NCT03399786|21354264|P4|STARTED|Double-blind Treatment Period (DBTP)||0
8650848|NCT03399786|21354265|P3|STARTED|Double-blind Treatment Period (DBTP)||0
8650849|NCT03399786|21354266|P2|STARTED|Double-blind Treatment Period (DBTP)||43
8650850|NCT03399786|21354267|P1|STARTED|Double-blind Treatment Period (DBTP)||22
8650851|NCT03394924|21354310|P3|NOT COMPLETED|Overall Study||0
8650852|NCT03394924|21354311|P2|NOT COMPLETED|Overall Study||6
8650853|NCT03394924|21354312|P1|NOT COMPLETED|Overall Study||3
8650854|NCT03394924|21354310|P3|COMPLETED|Overall Study||9
8650855|NCT03394924|21354311|P2|COMPLETED|Overall Study||22
8650856|NCT03394924|21354312|P1|COMPLETED|Overall Study||28
8650857|NCT03394924|21354310|P3|STARTED|Overall Study||9
8650858|NCT03394924|21354311|P2|STARTED|Overall Study||28
8650859|NCT03394924|21354312|P1|STARTED|Overall Study||31
8650902|NCT03382925|21354419|P2|NOT COMPLETED|Overall Study||0
8650903|NCT03382925|21354420|P1|NOT COMPLETED|Overall Study||0
8650904|NCT03382925|21354419|P2|COMPLETED|Overall Study||6
8650905|NCT03382925|21354420|P1|COMPLETED|Overall Study||10
8650906|NCT03382925|21354419|P2|STARTED|Overall Study||6
8650907|NCT03382925|21354420|P1|STARTED|Overall Study||10
8650914|NCT03290768|21354453|P1|NOT COMPLETED|Overall Study||165
8650915|NCT03290768|21354453|P1|COMPLETED|Overall Study||193
8650916|NCT03290768|21354453|P1|STARTED|Overall Study||358
8650917|NCT03270943|21354466|P2|NOT COMPLETED|Randomized (Willingness to be)||1
8650918|NCT03270943|21354467|P1|NOT COMPLETED|Randomized (Willingness to be)||0
8650919|NCT03270943|21354466|P2|COMPLETED|Randomized (Willingness to be)||31
8650920|NCT03270943|21354467|P1|COMPLETED|Randomized (Willingness to be)||30
8650921|NCT03270943|21354466|P2|STARTED|Randomized (Willingness to be)||32
8650922|NCT03270943|21354467|P1|STARTED|Randomized (Willingness to be)||30
8650923|NCT03270943|21354466|P2|NOT COMPLETED|Intervention Refinement||3
8650924|NCT03270943|21354467|P1|NOT COMPLETED|Intervention Refinement||0
8650925|NCT03270943|21354466|P2|COMPLETED|Intervention Refinement||6
8650926|NCT03270943|21354467|P1|COMPLETED|Intervention Refinement||6
8650927|NCT03270943|21354466|P2|STARTED|Intervention Refinement||9
8650928|NCT03270943|21354467|P1|STARTED|Intervention Refinement||6
8650929|NCT03228680|21354487|P2|NOT COMPLETED|Overall Study||35
8650930|NCT03228680|21354488|P1|NOT COMPLETED|Overall Study||23
8650931|NCT03228680|21354487|P2|COMPLETED|Overall Study||143
8650932|NCT03228680|21354488|P1|COMPLETED|Overall Study||147
8650933|NCT03228680|21354487|P2|STARTED|Overall Study||178
8650934|NCT03228680|21354488|P1|STARTED|Overall Study||170
8650935|NCT03133676|21354577|P9|NOT COMPLETED|Overall Study||0
8650936|NCT03133676|21354578|P8|NOT COMPLETED|Overall Study||0
8650937|NCT03133676|21354579|P7|NOT COMPLETED|Overall Study||0
8650938|NCT03133676|21354580|P6|NOT COMPLETED|Overall Study||0
8650939|NCT03133676|21354581|P5|NOT COMPLETED|Overall Study||0
8650940|NCT03133676|21354582|P4|NOT COMPLETED|Overall Study||0
8650941|NCT03133676|21354583|P3|NOT COMPLETED|Overall Study||0
8650942|NCT03133676|21354584|P2|NOT COMPLETED|Overall Study||0
8650943|NCT03133676|21354585|P1|NOT COMPLETED|Overall Study||0
8650944|NCT03133676|21354577|P9|COMPLETED|Overall Study||9
8650945|NCT03133676|21354578|P8|COMPLETED|Overall Study||9
8650946|NCT03133676|21354579|P7|COMPLETED|Overall Study||9
8650947|NCT03133676|21354580|P6|COMPLETED|Overall Study||9
8650948|NCT03133676|21354581|P5|COMPLETED|Overall Study||6
8650949|NCT03133676|21354582|P4|COMPLETED|Overall Study||6
8650950|NCT03133676|21354583|P3|COMPLETED|Overall Study||3
8650951|NCT03133676|21354584|P2|COMPLETED|Overall Study||3
8650952|NCT03133676|21354585|P1|COMPLETED|Overall Study||6
8650953|NCT03133676|21354577|P9|STARTED|Overall Study||9
8650954|NCT03133676|21354578|P8|STARTED|Overall Study||9
8650955|NCT03133676|21354579|P7|STARTED|Overall Study||9
8650956|NCT03133676|21354580|P6|STARTED|Overall Study||9
8650957|NCT03133676|21354581|P5|STARTED|Overall Study||6
8650958|NCT03133676|21354582|P4|STARTED|Overall Study||6
8650959|NCT03133676|21354583|P3|STARTED|Overall Study||3
8650960|NCT03133676|21354584|P2|STARTED|Overall Study||3
8650961|NCT03133676|21354585|P1|STARTED|Overall Study||6
8650992|NCT03075761|21354812|P2|NOT COMPLETED|Overall Study||6
8650993|NCT03075761|21354813|P1|NOT COMPLETED|Overall Study||1
8650994|NCT03075761|21354812|P2|COMPLETED|Overall Study||6
8650995|NCT03075761|21354813|P1|COMPLETED|Overall Study||10
8650996|NCT03075761|21354812|P2|STARTED|Overall Study||12
8650997|NCT03075761|21354813|P1|STARTED|Overall Study||11
8650998|NCT03057977|21354841|P2|NOT COMPLETED|Discontinuation From Trial||22
8650999|NCT03057977|21354842|P1|NOT COMPLETED|Discontinuation From Trial||20
8651000|NCT03057977|21354841|P2|COMPLETED|Discontinuation From Trial||1841
8651001|NCT03057977|21354842|P1|COMPLETED|Discontinuation From Trial||1847
8651002|NCT03057977|21354841|P2|Treated|Discontinuation From Trial||1863
8651003|NCT03057977|21354842|P1|Treated|Discontinuation From Trial||1863
8651004|NCT03057977|21354841|P2|STARTED|Discontinuation From Trial||1863
8651005|NCT03057977|21354842|P1|STARTED|Discontinuation From Trial||1867
8651006|NCT03057977|21354841|P2|NOT COMPLETED|Discontinuation From Treatment||482
8651007|NCT03057977|21354842|P1|NOT COMPLETED|Discontinuation From Treatment||515
8651008|NCT03057977|21354841|P2|COMPLETED|Discontinuation From Treatment||1381
8651009|NCT03057977|21354842|P1|COMPLETED|Discontinuation From Treatment||1352
8651010|NCT03057977|21354841|P2|Treated|Discontinuation From Treatment||1863
8651011|NCT03057977|21354842|P1|Treated|Discontinuation From Treatment||1863
8651012|NCT03057977|21354841|P2|STARTED|Discontinuation From Treatment||1863
8651013|NCT03057977|21354842|P1|STARTED|Discontinuation From Treatment||1867
8651014|NCT03020160|21354868|P2|NOT COMPLETED|Overall Study||41
8651015|NCT03020160|21354869|P1|NOT COMPLETED|Overall Study||7
8651016|NCT03020160|21354868|P2|COMPLETED|Overall Study||0
8651017|NCT03020160|21354869|P1|COMPLETED|Overall Study||0
8651018|NCT03020160|21354868|P2|Completed 24 Weeks in the Study|Overall Study||41
8651019|NCT03020160|21354869|P1|Completed 24 Weeks in the Study|Overall Study||7
8651020|NCT03020160|21354868|P2|STARTED|Overall Study||41
8651021|NCT03020160|21354869|P1|STARTED|Overall Study||7
8651040|NCT03001557|21354944|P8|NOT COMPLETED|Extension Phase||6
8651041|NCT03001557|21354945|P7|NOT COMPLETED|Extension Phase||14
8651042|NCT03001557|21354946|P6|NOT COMPLETED|Extension Phase||5
8651043|NCT03001557|21354947|P5|NOT COMPLETED|Extension Phase||0
8651044|NCT03001557|21354948|P4|NOT COMPLETED|Extension Phase||0
8651045|NCT03001557|21354949|P3|NOT COMPLETED|Extension Phase||0
8651046|NCT03001557|21354950|P2|NOT COMPLETED|Extension Phase||0
8651047|NCT03001557|21354951|P1|NOT COMPLETED|Extension Phase||0
8651048|NCT03001557|21354944|P8|COMPLETED|Extension Phase||0
8651049|NCT03001557|21354945|P7|COMPLETED|Extension Phase||0
8651050|NCT03001557|21354946|P6|COMPLETED|Extension Phase||0
8651051|NCT03001557|21354947|P5|COMPLETED|Extension Phase||0
8651052|NCT03001557|21354948|P4|COMPLETED|Extension Phase||0
8651053|NCT03001557|21354949|P3|COMPLETED|Extension Phase||0
8651054|NCT03001557|21354950|P2|COMPLETED|Extension Phase||0
8651055|NCT03001557|21354951|P1|COMPLETED|Extension Phase||0
8651056|NCT03001557|21354944|P8|STARTED|Extension Phase||6
8651057|NCT03001557|21354945|P7|STARTED|Extension Phase||14
8651058|NCT03001557|21354946|P6|STARTED|Extension Phase||5
8651059|NCT03001557|21354947|P5|STARTED|Extension Phase||0
8651060|NCT03001557|21354948|P4|STARTED|Extension Phase||0
8651061|NCT03001557|21354949|P3|STARTED|Extension Phase||0
8651062|NCT03001557|21354950|P2|STARTED|Extension Phase||0
8651063|NCT03001557|21354951|P1|STARTED|Extension Phase||0
8651064|NCT03001557|21354944|P8|NOT COMPLETED|Core Phase||0
8651065|NCT03001557|21354945|P7|NOT COMPLETED|Core Phase||0
8651066|NCT03001557|21354946|P6|NOT COMPLETED|Core Phase||0
8651067|NCT03001557|21354947|P5|NOT COMPLETED|Core Phase||0
8651068|NCT03001557|21354948|P4|NOT COMPLETED|Core Phase||0
8651069|NCT03001557|21354949|P3|NOT COMPLETED|Core Phase||1
8651070|NCT03001557|21354950|P2|NOT COMPLETED|Core Phase||0
8651071|NCT03001557|21354951|P1|NOT COMPLETED|Core Phase||0
8651072|NCT03001557|21354944|P8|COMPLETED|Core Phase||0
8651073|NCT03001557|21354945|P7|COMPLETED|Core Phase||0
8651074|NCT03001557|21354946|P6|COMPLETED|Core Phase||0
8651075|NCT03001557|21354947|P5|COMPLETED|Core Phase||12
8651076|NCT03001557|21354948|P4|COMPLETED|Core Phase||13
8651077|NCT03001557|21354949|P3|COMPLETED|Core Phase||13
8651078|NCT03001557|21354950|P2|COMPLETED|Core Phase||12
8651079|NCT03001557|21354951|P1|COMPLETED|Core Phase||12
8651080|NCT03001557|21354944|P8|Treated|Core Phase||0
8651081|NCT03001557|21354945|P7|Treated|Core Phase||0
8651082|NCT03001557|21354946|P6|Treated|Core Phase||0
8651083|NCT03001557|21354947|P5|Treated|Core Phase||12
8651084|NCT03001557|21354948|P4|Treated|Core Phase||13
8651085|NCT03001557|21354949|P3|Treated|Core Phase||13
8651086|NCT03001557|21354950|P2|Treated|Core Phase||12
8651087|NCT03001557|21354951|P1|Treated|Core Phase||12
8651088|NCT03001557|21354944|P8|STARTED|Core Phase||0
8651089|NCT03001557|21354945|P7|STARTED|Core Phase||0
8651090|NCT03001557|21354946|P6|STARTED|Core Phase||0
8651091|NCT03001557|21354947|P5|STARTED|Core Phase||12
8651092|NCT03001557|21354948|P4|STARTED|Core Phase||13
8651093|NCT03001557|21354949|P3|STARTED|Core Phase||14
8651094|NCT03001557|21354950|P2|STARTED|Core Phase||12
8651095|NCT03001557|21354951|P1|STARTED|Core Phase||12
8651096|NCT02953678|21355227|P1|NOT COMPLETED|Overall Study||60
8651097|NCT02953678|21355227|P1|COMPLETED|Overall Study||11
8651098|NCT02953678|21355227|P1|Participants Continuing in Study|Overall Study||19
8651099|NCT02953678|21355227|P1|Participants Discontinued From Study|Overall Study||41
8651100|NCT02953678|21355227|P1|STARTED|Overall Study||71
8651101|NCT02927301|21355236|P1|NOT COMPLETED|Overall Study||10
8651102|NCT02927301|21355236|P1|COMPLETED|Overall Study||171
8651103|NCT02927301|21355236|P1|STARTED|Overall Study||181
8651104|NCT02925143|21355242|P1|NOT COMPLETED|Overall Study||0
8651105|NCT02925143|21355242|P1|COMPLETED|Overall Study||6525
8651106|NCT02925143|21355242|P1|Participants Receiving Non-depolarizing Neuromuscular Blocking Agent (NMBA)|Overall Study||3426
8651107|NCT02925143|21355242|P1|Participants Receiving Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine)|Overall Study||3099
8651108|NCT02925143|21355242|P1|STARTED|Overall Study||6525
8651109|NCT02917278|21355254|P2|NOT COMPLETED|Overall Study||0
8651110|NCT02917278|21355255|P1|NOT COMPLETED|Overall Study||1
8651111|NCT02917278|21355254|P2|COMPLETED|Overall Study||9
8651112|NCT02917278|21355255|P1|COMPLETED|Overall Study||9
8651113|NCT02917278|21355254|P2|STARTED|Overall Study||9
8651114|NCT02917278|21355255|P1|STARTED|Overall Study||10
8651115|NCT02907177|21355295|P2|NOT COMPLETED|Overall Study||68
8651116|NCT02907177|21355296|P1|NOT COMPLETED|Overall Study||68
8651117|NCT02907177|21355295|P2|COMPLETED|Overall Study||0
8651118|NCT02907177|21355296|P1|COMPLETED|Overall Study||0
8651119|NCT02907177|21355295|P2|Randomized Analysis Set|Overall Study||68
8651120|NCT02907177|21355296|P1|Randomized Analysis Set|Overall Study||68
8651121|NCT02907177|21355295|P2|Treated|Overall Study||68
8651122|NCT02907177|21355296|P1|Treated|Overall Study||67
8651123|NCT02907177|21355295|P2|STARTED|Overall Study||68
8651124|NCT02907177|21355296|P1|STARTED|Overall Study||68
8651128|NCT02791763|21355316|P3|NOT COMPLETED|Overall Study||13
8651129|NCT02791763|21355317|P2|NOT COMPLETED|Overall Study||37
8651130|NCT02791763|21355318|P1|NOT COMPLETED|Overall Study||38
8651131|NCT02791763|21355316|P3|COMPLETED|Overall Study||43
8651132|NCT02791763|21355317|P2|COMPLETED|Overall Study||113
8651133|NCT02791763|21355318|P1|COMPLETED|Overall Study||111
8651134|NCT02791763|21355316|P3|STARTED|Overall Study||56
8651135|NCT02791763|21355317|P2|STARTED|Overall Study||150
8651136|NCT02791763|21355318|P1|STARTED|Overall Study||149
8651137|NCT02700165|21355435|P1|NOT COMPLETED|Overall Study||0
8651138|NCT02700165|21355435|P1|COMPLETED|Overall Study||14
8651139|NCT02700165|21355435|P1|STARTED|Overall Study||14
8651140|NCT02693743|21355444|P2|NOT COMPLETED|Overall Study||0
8651141|NCT02693743|21355445|P1|NOT COMPLETED|Overall Study||1
8651142|NCT02693743|21355444|P2|COMPLETED|Overall Study||0
8651143|NCT02693743|21355445|P1|COMPLETED|Overall Study||0
8651144|NCT02693743|21355444|P2|STARTED|Overall Study||0
8651145|NCT02693743|21355445|P1|STARTED|Overall Study||1
8651191|NCT02559115|21355589|P1|NOT COMPLETED|Overall Study||3
8651192|NCT02559115|21355589|P1|COMPLETED|Overall Study||16
8651193|NCT02559115|21355589|P1|STARTED|Overall Study||19
8651194|NCT02530905|21355595|P3|NOT COMPLETED|Open Label Extension Period (132 Weeks)||1
8651195|NCT02530905|21355596|P2|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
8651196|NCT02530905|21355597|P1|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
8651197|NCT02530905|21355595|P3|COMPLETED|Open Label Extension Period (132 Weeks)||11
8651198|NCT02530905|21355596|P2|COMPLETED|Open Label Extension Period (132 Weeks)||0
8651199|NCT02530905|21355597|P1|COMPLETED|Open Label Extension Period (132 Weeks)||0
8651200|NCT02530905|21355595|P3|STARTED|Open Label Extension Period (132 Weeks)|All participants from the double-blind period amenable to exon 45 skipping were enrolled to open-label extension period.|12
8651201|NCT02530905|21355596|P2|STARTED|Open Label Extension Period (132 Weeks)||0
8651202|NCT02530905|21355597|P1|STARTED|Open Label Extension Period (132 Weeks)||0
8651203|NCT02530905|21355595|P3|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
8651204|NCT02530905|21355596|P2|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
8651205|NCT02530905|21355597|P1|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
8651206|NCT02530905|21355595|P3|COMPLETED|Double-Blind Period (12 Weeks)||0
8651207|NCT02530905|21355596|P2|COMPLETED|Double-Blind Period (12 Weeks)||8
8651208|NCT02530905|21355597|P1|COMPLETED|Double-Blind Period (12 Weeks)||4
8651209|NCT02530905|21355595|P3|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
8651210|NCT02530905|21355596|P2|Received 30 mg/kg|Double-Blind Period (12 Weeks)||8
8651211|NCT02530905|21355597|P1|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
8651212|NCT02530905|21355595|P3|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
8651213|NCT02530905|21355596|P2|Received 20 mg/kg|Double-Blind Period (12 Weeks)||8
8651214|NCT02530905|21355597|P1|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
8651215|NCT02530905|21355595|P3|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
8651216|NCT02530905|21355596|P2|Received 10 mg/kg|Double-Blind Period (12 Weeks)||8
8651217|NCT02530905|21355597|P1|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
8651218|NCT02530905|21355595|P3|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
8651219|NCT02530905|21355596|P2|Received 4 mg/kg|Double-Blind Period (12 Weeks)||8
8651220|NCT02530905|21355597|P1|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
8651221|NCT02530905|21355595|P3|STARTED|Double-Blind Period (12 Weeks)||0
8651222|NCT02530905|21355596|P2|STARTED|Double-Blind Period (12 Weeks)||8
8651223|NCT02530905|21355597|P1|STARTED|Double-Blind Period (12 Weeks)||4
8651224|NCT02528357|21355703|P19|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
8651225|NCT02528357|21355704|P18|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
8651226|NCT02528357|21355705|P17|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
8651227|NCT02528357|21355706|P16|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651228|NCT02528357|21355707|P15|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651229|NCT02528357|21355708|P14|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651230|NCT02528357|21355709|P13|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651231|NCT02528357|21355710|P12|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651232|NCT02528357|21355711|P11|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651233|NCT02528357|21355712|P10|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651234|NCT02528357|21355713|P9|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651235|NCT02528357|21355714|P8|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651236|NCT02528357|21355715|P7|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651237|NCT02528357|21355716|P6|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651238|NCT02528357|21355717|P5|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651239|NCT02528357|21355718|P4|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651240|NCT02528357|21355719|P3|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651241|NCT02528357|21355720|P2|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651242|NCT02528357|21355721|P1|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651243|NCT02528357|21355703|P19|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||2
8651244|NCT02528357|21355704|P18|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
8651245|NCT02528357|21355705|P17|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||6
8651246|NCT02528357|21355706|P16|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651247|NCT02528357|21355707|P15|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651248|NCT02528357|21355708|P14|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651249|NCT02528357|21355709|P13|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651250|NCT02528357|21355710|P12|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651251|NCT02528357|21355711|P11|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651252|NCT02528357|21355712|P10|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651253|NCT02528357|21355713|P9|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651254|NCT02528357|21355714|P8|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651255|NCT02528357|21355715|P7|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651256|NCT02528357|21355716|P6|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651257|NCT02528357|21355717|P5|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651258|NCT02528357|21355718|P4|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651259|NCT02528357|21355719|P3|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651260|NCT02528357|21355720|P2|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651261|NCT02528357|21355721|P1|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651262|NCT02528357|21355703|P19|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||5
8651263|NCT02528357|21355704|P18|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||8
8651264|NCT02528357|21355705|P17|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||9
8651265|NCT02528357|21355706|P16|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651266|NCT02528357|21355707|P15|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651267|NCT02528357|21355708|P14|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651268|NCT02528357|21355709|P13|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651269|NCT02528357|21355710|P12|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651270|NCT02528357|21355711|P11|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651271|NCT02528357|21355712|P10|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651272|NCT02528357|21355713|P9|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651273|NCT02528357|21355714|P8|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651274|NCT02528357|21355715|P7|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651275|NCT02528357|21355716|P6|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651276|NCT02528357|21355717|P5|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651277|NCT02528357|21355718|P4|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651278|NCT02528357|21355719|P3|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651279|NCT02528357|21355720|P2|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651280|NCT02528357|21355721|P1|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
8651281|NCT02528357|21355703|P19|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651282|NCT02528357|21355704|P18|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651283|NCT02528357|21355705|P17|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651284|NCT02528357|21355706|P16|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651285|NCT02528357|21355707|P15|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
8651286|NCT02528357|21355708|P14|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
8651287|NCT02528357|21355709|P13|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
8651288|NCT02528357|21355710|P12|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
8651289|NCT02528357|21355711|P11|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
8651290|NCT02528357|21355712|P10|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
8651291|NCT02528357|21355713|P9|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
8651292|NCT02528357|21355714|P8|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651293|NCT02528357|21355715|P7|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651294|NCT02528357|21355716|P6|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651295|NCT02528357|21355717|P5|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651296|NCT02528357|21355718|P4|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651297|NCT02528357|21355719|P3|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651298|NCT02528357|21355720|P2|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651299|NCT02528357|21355721|P1|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651300|NCT02528357|21355703|P19|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651301|NCT02528357|21355704|P18|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651302|NCT02528357|21355705|P17|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651303|NCT02528357|21355706|P16|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
8651304|NCT02528357|21355707|P15|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
8651305|NCT02528357|21355708|P14|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
8651306|NCT02528357|21355709|P13|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
8651307|NCT02528357|21355710|P12|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
8651308|NCT02528357|21355711|P11|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
8651309|NCT02528357|21355712|P10|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
8651310|NCT02528357|21355713|P9|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
8651311|NCT02528357|21355714|P8|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651312|NCT02528357|21355715|P7|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651313|NCT02528357|21355716|P6|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651314|NCT02528357|21355717|P5|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651315|NCT02528357|21355718|P4|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651316|NCT02528357|21355719|P3|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651317|NCT02528357|21355720|P2|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651318|NCT02528357|21355721|P1|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651319|NCT02528357|21355703|P19|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651320|NCT02528357|21355704|P18|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651321|NCT02528357|21355705|P17|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651322|NCT02528357|21355706|P16|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
8651323|NCT02528357|21355707|P15|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
8651324|NCT02528357|21355708|P14|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
8651325|NCT02528357|21355709|P13|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||14
8651326|NCT02528357|21355710|P12|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
8651327|NCT02528357|21355711|P11|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||10
8651328|NCT02528357|21355712|P10|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
8651329|NCT02528357|21355713|P9|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
8651330|NCT02528357|21355714|P8|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651331|NCT02528357|21355715|P7|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651332|NCT02528357|21355716|P6|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651333|NCT02528357|21355717|P5|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651334|NCT02528357|21355718|P4|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651335|NCT02528357|21355719|P3|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651336|NCT02528357|21355720|P2|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651337|NCT02528357|21355721|P1|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
8651338|NCT02528357|21355703|P19|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651339|NCT02528357|21355704|P18|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651340|NCT02528357|21355705|P17|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651341|NCT02528357|21355706|P16|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651342|NCT02528357|21355707|P15|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651343|NCT02528357|21355708|P14|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651344|NCT02528357|21355709|P13|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651345|NCT02528357|21355710|P12|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651346|NCT02528357|21355711|P11|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651347|NCT02528357|21355712|P10|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651348|NCT02528357|21355713|P9|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651349|NCT02528357|21355714|P8|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
8651350|NCT02528357|21355715|P7|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
8651351|NCT02528357|21355716|P6|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
8651352|NCT02528357|21355717|P5|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||4
8651353|NCT02528357|21355718|P4|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
8651354|NCT02528357|21355719|P3|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
8651355|NCT02528357|21355720|P2|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
8651356|NCT02528357|21355721|P1|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651357|NCT02528357|21355703|P19|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651358|NCT02528357|21355704|P18|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651359|NCT02528357|21355705|P17|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651360|NCT02528357|21355706|P16|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651361|NCT02528357|21355707|P15|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651362|NCT02528357|21355708|P14|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651363|NCT02528357|21355709|P13|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651364|NCT02528357|21355710|P12|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651365|NCT02528357|21355711|P11|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651366|NCT02528357|21355712|P10|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651367|NCT02528357|21355713|P9|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651368|NCT02528357|21355714|P8|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
8651369|NCT02528357|21355715|P7|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||5
8651370|NCT02528357|21355716|P6|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
8651371|NCT02528357|21355717|P5|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
8651372|NCT02528357|21355718|P4|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||9
8651373|NCT02528357|21355719|P3|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
8651374|NCT02528357|21355720|P2|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651375|NCT02528357|21355721|P1|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
8651376|NCT02528357|21355703|P19|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651377|NCT02528357|21355704|P18|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651378|NCT02528357|21355705|P17|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651379|NCT02528357|21355706|P16|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651380|NCT02528357|21355707|P15|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651381|NCT02528357|21355708|P14|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651382|NCT02528357|21355709|P13|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651383|NCT02528357|21355710|P12|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651384|NCT02528357|21355711|P11|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651385|NCT02528357|21355712|P10|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651386|NCT02528357|21355713|P9|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
8651387|NCT02528357|21355714|P8|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
8651388|NCT02528357|21355715|P7|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||7
8651389|NCT02528357|21355716|P6|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
8651390|NCT02528357|21355717|P5|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
8651391|NCT02528357|21355718|P4|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
8651392|NCT02528357|21355719|P3|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||8
8651393|NCT02528357|21355720|P2|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
8651394|NCT02528357|21355721|P1|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
8651395|NCT02514252|21356101|P1|NOT COMPLETED|Overall Study||0
8651396|NCT02514252|21356101|P1|COMPLETED|Overall Study||6
8651397|NCT02514252|21356101|P1|STARTED|Overall Study||6
8651430|NCT02500550|21356180|P1|NOT COMPLETED|Overall Study||7
8651431|NCT02500550|21356180|P1|COMPLETED|Overall Study||8
8651432|NCT02500550|21356180|P1|STARTED|Overall Study||15
8651433|NCT02481505|21356195|P3|NOT COMPLETED|Overall Study||0
8651434|NCT02481505|21356196|P2|NOT COMPLETED|Overall Study||0
8651435|NCT02481505|21356197|P1|NOT COMPLETED|Overall Study||0
8651436|NCT02481505|21356195|P3|COMPLETED|Overall Study||15
8651437|NCT02481505|21356196|P2|COMPLETED|Overall Study||15
8651438|NCT02481505|21356197|P1|COMPLETED|Overall Study||15
8651439|NCT02481505|21356195|P3|STARTED|Overall Study||15
8651440|NCT02481505|21356196|P2|STARTED|Overall Study||15
8651441|NCT02481505|21356197|P1|STARTED|Overall Study||15
8651456|NCT02410954|21356337|P2|NOT COMPLETED|Overall Study||0
8651457|NCT02410954|21356338|P1|NOT COMPLETED|Overall Study||14
8651458|NCT02410954|21356337|P2|COMPLETED|Overall Study||0
8651459|NCT02410954|21356338|P1|COMPLETED|Overall Study||0
8651460|NCT02410954|21356337|P2|STARTED|Overall Study||0
8651461|NCT02410954|21356338|P1|STARTED|Overall Study||14
8651462|NCT02384993|21356346|P2|NOT COMPLETED|Overall Study||1
8651463|NCT02384993|21356347|P1|NOT COMPLETED|Overall Study||0
8651464|NCT02384993|21356346|P2|COMPLETED|Overall Study||11
8651465|NCT02384993|21356347|P1|COMPLETED|Overall Study||12
8651466|NCT02384993|21356346|P2|STARTED|Overall Study||12
8651467|NCT02384993|21356347|P1|STARTED|Overall Study||12
8651480|NCT02217332|21356419|P1|NOT COMPLETED|Overall Study||7
8651481|NCT02217332|21356419|P1|COMPLETED|Overall Study|Subjects who continued to optional open-label treatment|13
8651482|NCT02217332|21356419|P1|STARTED|Overall Study|Safety Population|20
8651483|NCT02201251|21356432|P2|NOT COMPLETED|Overall Study||3
8651484|NCT02201251|21356433|P1|NOT COMPLETED|Overall Study||4
8651485|NCT02201251|21356432|P2|COMPLETED|Overall Study||32
8651486|NCT02201251|21356433|P1|COMPLETED|Overall Study||24
8651487|NCT02201251|21356432|P2|STARTED|Overall Study||35
8651488|NCT02201251|21356433|P1|STARTED|Overall Study||28
8651489|NCT02158091|21356472|P3|NOT COMPLETED|Overall Study||0
8651490|NCT02158091|21356473|P2|NOT COMPLETED|Overall Study||1
8651491|NCT02158091|21356474|P1|NOT COMPLETED|Overall Study||2
8651492|NCT02158091|21356472|P3|COMPLETED|Overall Study||20
8651493|NCT02158091|21356473|P2|COMPLETED|Overall Study||5
8651494|NCT02158091|21356474|P1|COMPLETED|Overall Study||4
8651495|NCT02158091|21356472|P3|STARTED|Overall Study||20
8651496|NCT02158091|21356473|P2|STARTED|Overall Study||6
8651497|NCT02158091|21356474|P1|STARTED|Overall Study||6
8651498|NCT02141672|21356485|P3|NOT COMPLETED|Overall Study||18
8651499|NCT02141672|21356486|P2|NOT COMPLETED|Overall Study||8
8651500|NCT02141672|21356487|P1|NOT COMPLETED|Overall Study||16
8651501|NCT02141672|21356485|P3|COMPLETED|Overall Study||70
8651502|NCT02141672|21356486|P2|COMPLETED|Overall Study||80
8651503|NCT02141672|21356487|P1|COMPLETED|Overall Study||73
8651504|NCT02141672|21356485|P3|STARTED|Overall Study||88
8651505|NCT02141672|21356486|P2|STARTED|Overall Study||88
8651506|NCT02141672|21356487|P1|STARTED|Overall Study||89
8651507|NCT02130557|21356545|P2|NOT COMPLETED|Overall Study||37
8651508|NCT02130557|21356546|P1|NOT COMPLETED|Overall Study||36
8651509|NCT02130557|21356545|P2|COMPLETED|Overall Study||231
8651510|NCT02130557|21356546|P1|COMPLETED|Overall Study||232
8651511|NCT02130557|21356545|P2|mITT Population|Overall Study||241
8651512|NCT02130557|21356546|P1|mITT Population|Overall Study||246
8651513|NCT02130557|21356545|P2|Treated|Overall Study||265
8651514|NCT02130557|21356546|P1|Treated|Overall Study||268
8651515|NCT02130557|21356545|P2|STARTED|Overall Study||268
8651516|NCT02130557|21356546|P1|STARTED|Overall Study||268
8651517|NCT02086175|21356578|P1|NOT COMPLETED|Overall Study||0
8651518|NCT02086175|21356578|P1|COMPLETED|Overall Study||25
8651519|NCT02086175|21356578|P1|STARTED|Overall Study||25
8651520|NCT01935791|21356584|P9|NOT COMPLETED|Period 2||0
8651521|NCT01935791|21356585|P8|NOT COMPLETED|Period 2||0
8651522|NCT01935791|21356586|P7|NOT COMPLETED|Period 2||0
8651523|NCT01935791|21356587|P6|NOT COMPLETED|Period 2||0
8651524|NCT01935791|21356588|P5|NOT COMPLETED|Period 2||0
8651525|NCT01935791|21356589|P4|NOT COMPLETED|Period 2||0
8651526|NCT01935791|21356590|P3|NOT COMPLETED|Period 2||0
8651527|NCT01935791|21356591|P2|NOT COMPLETED|Period 2||0
8651528|NCT01935791|21356592|P1|NOT COMPLETED|Period 2||0
8651529|NCT01935791|21356584|P9|COMPLETED|Period 2||1
8651530|NCT01935791|21356585|P8|COMPLETED|Period 2||3
8651531|NCT01935791|21356586|P7|COMPLETED|Period 2||1
8651532|NCT01935791|21356587|P6|COMPLETED|Period 2||1
8651533|NCT01935791|21356588|P5|COMPLETED|Period 2||3
8651534|NCT01935791|21356589|P4|COMPLETED|Period 2||2
8651535|NCT01935791|21356590|P3|COMPLETED|Period 2||0
8651536|NCT01935791|21356591|P2|COMPLETED|Period 2||0
8651537|NCT01935791|21356592|P1|COMPLETED|Period 2||0
8651538|NCT01935791|21356584|P9|STARTED|Period 2||1
8651539|NCT01935791|21356585|P8|STARTED|Period 2||3
8651540|NCT01935791|21356586|P7|STARTED|Period 2||1
8651541|NCT01935791|21356587|P6|STARTED|Period 2||1
8651542|NCT01935791|21356588|P5|STARTED|Period 2||3
8651543|NCT01935791|21356589|P4|STARTED|Period 2||2
8651544|NCT01935791|21356590|P3|STARTED|Period 2||0
8651545|NCT01935791|21356591|P2|STARTED|Period 2||0
8651546|NCT01935791|21356592|P1|STARTED|Period 2||0
8651547|NCT01935791|21356584|P9|NOT COMPLETED|Period 1||0
8651548|NCT01935791|21356585|P8|NOT COMPLETED|Period 1||0
8651549|NCT01935791|21356586|P7|NOT COMPLETED|Period 1||0
8651550|NCT01935791|21356587|P6|NOT COMPLETED|Period 1||0
8651551|NCT01935791|21356588|P5|NOT COMPLETED|Period 1||0
8651552|NCT01935791|21356589|P4|NOT COMPLETED|Period 1||0
8651553|NCT01935791|21356590|P3|NOT COMPLETED|Period 1||0
8651554|NCT01935791|21356591|P2|NOT COMPLETED|Period 1||0
8651555|NCT01935791|21356592|P1|NOT COMPLETED|Period 1||0
8651556|NCT01935791|21356584|P9|COMPLETED|Period 1||0
8651557|NCT01935791|21356585|P8|COMPLETED|Period 1||0
8651558|NCT01935791|21356586|P7|COMPLETED|Period 1||0
8651559|NCT01935791|21356587|P6|COMPLETED|Period 1||0
8651560|NCT01935791|21356588|P5|COMPLETED|Period 1||0
8651561|NCT01935791|21356589|P4|COMPLETED|Period 1||0
8651562|NCT01935791|21356590|P3|COMPLETED|Period 1||3
8651563|NCT01935791|21356591|P2|COMPLETED|Period 1||4
8651564|NCT01935791|21356592|P1|COMPLETED|Period 1||4
8651565|NCT01935791|21356584|P9|STARTED|Period 1||0
8651566|NCT01935791|21356585|P8|STARTED|Period 1||0
8651567|NCT01935791|21356586|P7|STARTED|Period 1||0
8651568|NCT01935791|21356587|P6|STARTED|Period 1||0
8651569|NCT01935791|21356588|P5|STARTED|Period 1||0
8651570|NCT01935791|21356589|P4|STARTED|Period 1||0
8651571|NCT01935791|21356590|P3|STARTED|Period 1||3
8651572|NCT01935791|21356591|P2|STARTED|Period 1||4
8651573|NCT01935791|21356592|P1|STARTED|Period 1||4
8651574|NCT01880554|21356606|P1|NOT COMPLETED|Overall Study||16
8651575|NCT01880554|21356606|P1|COMPLETED|Overall Study|Patients eligible and assessable according to two-stage Simon's design (primary outcome)|52
8651576|NCT01880554|21356606|P1|Population Eligible and Assessable|Overall Study||54
8651577|NCT01880554|21356606|P1|Population Eligible|Overall Study||58
8651578|NCT01880554|21356606|P1|STARTED|Overall Study|Patients enrolled in the study|68
8651588|NCT01849770|21356642|P3|NOT COMPLETED|Overall Study||1
8651589|NCT01849770|21356643|P2|NOT COMPLETED|Overall Study||4
8651590|NCT01849770|21356644|P1|NOT COMPLETED|Overall Study||0
8651591|NCT01849770|21356642|P3|COMPLETED|Overall Study||19
8651592|NCT01849770|21356643|P2|COMPLETED|Overall Study||15
8651593|NCT01849770|21356644|P1|COMPLETED|Overall Study||20
8651594|NCT01849770|21356642|P3|STARTED|Overall Study||20
8651595|NCT01849770|21356643|P2|STARTED|Overall Study||19
8651596|NCT01849770|21356644|P1|STARTED|Overall Study||20
8651605|NCT01816945|21356701|P2|NOT COMPLETED|Overall Study||5
8651606|NCT01816945|21356702|P1|NOT COMPLETED|Overall Study||2
8651607|NCT01816945|21356701|P2|COMPLETED|Overall Study||19
8651608|NCT01816945|21356702|P1|COMPLETED|Overall Study||21
8651609|NCT01816945|21356701|P2|STARTED|Overall Study||24
8651610|NCT01816945|21356702|P1|STARTED|Overall Study||23
8651611|NCT01814007|21356716|P1|NOT COMPLETED|Overall Study||1
8651612|NCT01814007|21356716|P1|COMPLETED|Overall Study||34
8651613|NCT01814007|21356716|P1|STARTED|Overall Study||35
8651614|NCT01808547|21356728|P2|NOT COMPLETED|Overall Study||46
8651615|NCT01808547|21356729|P1|NOT COMPLETED|Overall Study||37
8651616|NCT01808547|21356728|P2|COMPLETED|Overall Study||48
8651617|NCT01808547|21356729|P1|COMPLETED|Overall Study||137
8651618|NCT01808547|21356728|P2|mITT Population|Overall Study||85
8651619|NCT01808547|21356729|P1|mITT Population|Overall Study||168
8651620|NCT01808547|21356728|P2|Safety Population|Overall Study||85
8651621|NCT01808547|21356729|P1|Safety Population|Overall Study||170
8651622|NCT01808547|21356728|P2|STARTED|Overall Study||94
8651623|NCT01808547|21356729|P1|STARTED|Overall Study||174
8651624|NCT01807117|21356735|P1|NOT COMPLETED|Overall Study||3
8651625|NCT01807117|21356735|P1|COMPLETED|Overall Study||12
8651626|NCT01807117|21356735|P1|STARTED|Overall Study||15
8651671|NCT01761266|21356845|P2|NOT COMPLETED|Overall Study||476
8651672|NCT01761266|21356846|P1|NOT COMPLETED|Overall Study||478
8651673|NCT01761266|21356845|P2|COMPLETED|Overall Study||0
8651674|NCT01761266|21356846|P1|COMPLETED|Overall Study||0
8651675|NCT01761266|21356845|P2|Treated|Overall Study||475
8651676|NCT01761266|21356846|P1|Treated|Overall Study||476
8651677|NCT01761266|21356845|P2|STARTED|Overall Study||476
8651678|NCT01761266|21356846|P1|STARTED|Overall Study||478
8651679|NCT01727414|21356874|P2|NOT COMPLETED|Overall Study||0
8651680|NCT01727414|21356875|P1|NOT COMPLETED|Overall Study||3
8651681|NCT01727414|21356874|P2|COMPLETED|Overall Study||45
8651682|NCT01727414|21356875|P1|COMPLETED|Overall Study||123
8651683|NCT01727414|21356874|P2|STARTED|Overall Study||45
8651684|NCT01727414|21356875|P1|STARTED|Overall Study||126
8651685|NCT01576952|21356883|P2|NOT COMPLETED|Overall Study||55
8651686|NCT01576952|21356884|P1|NOT COMPLETED|Overall Study||41
8651687|NCT01576952|21356883|P2|COMPLETED|Overall Study||33
8651688|NCT01576952|21356884|P1|COMPLETED|Overall Study||139
8651689|NCT01576952|21356883|P2|mITT Population|Overall Study||85
8651690|NCT01576952|21356884|P1|mITT Population|Overall Study||168
8651691|NCT01576952|21356883|P2|Safety Population|Overall Study||85
8651692|NCT01576952|21356884|P1|Safety Population|Overall Study||169
8651693|NCT01576952|21356883|P2|STARTED|Overall Study||88
8651694|NCT01576952|21356884|P1|STARTED|Overall Study||180
8651695|NCT01559935|21356890|P1|NOT COMPLETED|Maintenance Phase||54
8651696|NCT01559935|21356890|P1|COMPLETED|Maintenance Phase||0
8651697|NCT01559935|21356890|P1|STARTED|Maintenance Phase||54
8651698|NCT01559935|21356890|P1|NOT COMPLETED|BiRD Phase||4
8651699|NCT01559935|21356890|P1|COMPLETED|BiRD Phase||54
8651700|NCT01559935|21356890|P1|STARTED|BiRD Phase||58
8651701|NCT01559935|21356890|P1|NOT COMPLETED|Car Phase||14
8651702|NCT01559935|21356890|P1|COMPLETED|Car Phase||58
8651703|NCT01559935|21356890|P1|STARTED|Car Phase||72
8651710|NCT01387464|21356911|P2|NOT COMPLETED|Overall Study||1
8651711|NCT01387464|21356912|P1|NOT COMPLETED|Overall Study||1
8651712|NCT01387464|21356911|P2|COMPLETED|Overall Study||29
8651713|NCT01387464|21356912|P1|COMPLETED|Overall Study||29
8651714|NCT01387464|21356911|P2|Per-Protocol Population|Overall Study||29
8651715|NCT01387464|21356912|P1|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
8651716|NCT01387464|21356911|P2|Safety Population|Overall Study||29
8651717|NCT01387464|21356912|P1|Safety Population|Overall Study||30
8651718|NCT01387464|21356911|P2|STARTED|Overall Study||30
8651719|NCT01387464|21356912|P1|STARTED|Overall Study||30
8651720|NCT01286272|21356920|P2|NOT COMPLETED|Overall Study||3
8651721|NCT01286272|21356921|P1|NOT COMPLETED|Overall Study||1
8651722|NCT01286272|21356920|P2|COMPLETED|Overall Study||62
8651723|NCT01286272|21356921|P1|COMPLETED|Overall Study||66
8651724|NCT01286272|21356920|P2|STARTED|Overall Study||65
8651725|NCT01286272|21356921|P1|STARTED|Overall Study||67
8651726|NCT01234766|21356931|P1|NOT COMPLETED|Overall Study||4
8651727|NCT01234766|21356931|P1|COMPLETED|Overall Study||35
8651728|NCT01234766|21356931|P1|STARTED|Overall Study||39
8651819|NCT01190878|21357028|P4|NOT COMPLETED|Overall Study||20
8651820|NCT01190878|21357029|P3|NOT COMPLETED|Overall Study||5
8651821|NCT01190878|21357030|P2|NOT COMPLETED|Overall Study||3
8651822|NCT01190878|21357031|P1|NOT COMPLETED|Overall Study||3
8651823|NCT01190878|21357028|P4|COMPLETED|Overall Study||22
8651824|NCT01190878|21357029|P3|COMPLETED|Overall Study||37
8651825|NCT01190878|21357030|P2|COMPLETED|Overall Study||42
8651826|NCT01190878|21357031|P1|COMPLETED|Overall Study||37
8651827|NCT01190878|21357028|P4|STARTED|Overall Study||42
8651828|NCT01190878|21357029|P3|STARTED|Overall Study||42
8651829|NCT01190878|21357030|P2|STARTED|Overall Study||45
8651830|NCT01190878|21357031|P1|STARTED|Overall Study||40
8651831|NCT01169337|21357044|P3|NOT COMPLETED|Overall Study||6
8651832|NCT01169337|21357045|P2|NOT COMPLETED|Overall Study||90
8651833|NCT01169337|21357046|P1|NOT COMPLETED|Overall Study||44
8651834|NCT01169337|21357044|P3|COMPLETED|Overall Study||86
8651835|NCT01169337|21357045|P2|COMPLETED|Overall Study||0
8651836|NCT01169337|21357046|P1|COMPLETED|Overall Study||0
8651837|NCT01169337|21357044|P3|Received Treatment/Observation|Overall Study||86
8651838|NCT01169337|21357045|P2|Received Treatment/Observation|Overall Study||88
8651839|NCT01169337|21357046|P1|Received Treatment/Observation|Overall Study||44
8651840|NCT01169337|21357044|P3|STARTED|Overall Study||92
8651841|NCT01169337|21357045|P2|STARTED|Overall Study||90
8651842|NCT01169337|21357046|P1|STARTED|Overall Study||44
8651846|NCT01135394|21357067|P1|NOT COMPLETED|Study Treatment||4
8651847|NCT01135394|21357067|P1|COMPLETED|Study Treatment||62
8651848|NCT01135394|21357067|P1|STARTED|Study Treatment||66
8651849|NCT01135394|21357067|P1|NOT COMPLETED|Baseline Assessment||15
8651850|NCT01135394|21357067|P1|COMPLETED|Baseline Assessment||66
8651851|NCT01135394|21357067|P1|STARTED|Baseline Assessment||81
8651852|NCT01135394|21357067|P1|NOT COMPLETED|Screening||33
8651853|NCT01135394|21357067|P1|COMPLETED|Screening||81
8651854|NCT01135394|21357067|P1|STARTED|Screening||114
8651855|NCT01076231|21357071|P1|NOT COMPLETED|Overall Study||34
8651856|NCT01076231|21357071|P1|COMPLETED|Overall Study||0
8651857|NCT01076231|21357071|P1|STARTED|Overall Study||34
8651886|NCT01054144|21357195|P1|NOT COMPLETED|Overall Study||2
8651887|NCT01054144|21357195|P1|COMPLETED|Overall Study||25
8651888|NCT01054144|21357195|P1|STARTED|Overall Study||27
8651892|NCT01004718|21357209|P1|NOT COMPLETED|Overall Study||0
8651893|NCT01004718|21357209|P1|COMPLETED|Overall Study||10
8651894|NCT01004718|21357209|P1|STARTED|Overall Study||10
8651913|NCT00863304|21357260|P4|NOT COMPLETED|Overall Study||191
8651914|NCT00863304|21357261|P3|NOT COMPLETED|Overall Study||187
8651915|NCT00863304|21357262|P2|NOT COMPLETED|Overall Study||185
8651916|NCT00863304|21357263|P1|NOT COMPLETED|Overall Study||194
8651917|NCT00863304|21357260|P4|COMPLETED|Overall Study||21
8651918|NCT00863304|21357261|P3|COMPLETED|Overall Study||26
8651919|NCT00863304|21357262|P2|COMPLETED|Overall Study||27
8651920|NCT00863304|21357263|P1|COMPLETED|Overall Study||18
8651921|NCT00863304|21357260|P4|Treated|Overall Study||211
8651922|NCT00863304|21357261|P3|Treated|Overall Study||209
8651923|NCT00863304|21357262|P2|Treated|Overall Study||211
8651924|NCT00863304|21357263|P1|Treated|Overall Study||209
8651925|NCT00863304|21357260|P4|STARTED|Overall Study||212
8651926|NCT00863304|21357261|P3|STARTED|Overall Study||213
8651927|NCT00863304|21357262|P2|STARTED|Overall Study||212
8651928|NCT00863304|21357263|P1|STARTED|Overall Study||212
8651929|NCT00799981|21357411|P6|NOT COMPLETED|Overall Study||0
8651930|NCT00799981|21357412|P5|NOT COMPLETED|Overall Study||0
8651931|NCT00799981|21357413|P4|NOT COMPLETED|Overall Study||0
8651932|NCT00799981|21357414|P3|NOT COMPLETED|Overall Study||0
8651933|NCT00799981|21357415|P2|NOT COMPLETED|Overall Study||0
8651934|NCT00799981|21357416|P1|NOT COMPLETED|Overall Study||0
8651935|NCT00799981|21357411|P6|COMPLETED|Overall Study||10
8651936|NCT00799981|21357412|P5|COMPLETED|Overall Study||11
8651937|NCT00799981|21357413|P4|COMPLETED|Overall Study||10
8651938|NCT00799981|21357414|P3|COMPLETED|Overall Study||10
8651939|NCT00799981|21357415|P2|COMPLETED|Overall Study||9
8651940|NCT00799981|21357416|P1|COMPLETED|Overall Study||10
8651941|NCT00799981|21357411|P6|STARTED|Overall Study||10
8651942|NCT00799981|21357412|P5|STARTED|Overall Study||11
8651943|NCT00799981|21357413|P4|STARTED|Overall Study||10
8651944|NCT00799981|21357414|P3|STARTED|Overall Study||10
8651945|NCT00799981|21357415|P2|STARTED|Overall Study||9
8651946|NCT00799981|21357416|P1|STARTED|Overall Study||10
8651947|NCT00731731|21357434|P3|NOT COMPLETED|Overall Study||3
8651948|NCT00731731|21357435|P2|NOT COMPLETED|Overall Study||0
8651949|NCT00731731|21357436|P1|NOT COMPLETED|Overall Study||0
8651950|NCT00731731|21357434|P3|COMPLETED|Overall Study||107
8651951|NCT00731731|21357435|P2|COMPLETED|Overall Study||3
8651952|NCT00731731|21357436|P1|COMPLETED|Overall Study||12
8651953|NCT00731731|21357434|P3|STARTED|Overall Study||110
8651954|NCT00731731|21357435|P2|STARTED|Overall Study||3
8651955|NCT00731731|21357436|P1|STARTED|Overall Study||12
8651972|NCT00546156|21357483|P2|NOT COMPLETED|Overall Study||1
8651973|NCT00546156|21357484|P1|NOT COMPLETED|Overall Study||14
8651974|NCT00546156|21357483|P2|COMPLETED|Overall Study||19
8651975|NCT00546156|21357484|P1|COMPLETED|Overall Study||70
8651976|NCT00546156|21357483|P2|STARTED|Overall Study||20
8651977|NCT00546156|21357484|P1|STARTED|Overall Study||84
8651978|NCT00532844|21357493|P2|NOT COMPLETED|Treatment Period - Day 15 to Day 28||0
8651979|NCT00532844|21357494|P1|NOT COMPLETED|Treatment Period - Day 15 to Day 28||4
8651980|NCT00532844|21357493|P2|COMPLETED|Treatment Period - Day 15 to Day 28||23
8651981|NCT00532844|21357494|P1|COMPLETED|Treatment Period - Day 15 to Day 28||20
8651982|NCT00532844|21357493|P2|STARTED|Treatment Period - Day 15 to Day 28||23
8651983|NCT00532844|21357494|P1|STARTED|Treatment Period - Day 15 to Day 28||24
8651984|NCT00532844|21357493|P2|NOT COMPLETED|Washout (1 Day)||0
8651985|NCT00532844|21357494|P1|NOT COMPLETED|Washout (1 Day)||0
8651986|NCT00532844|21357493|P2|COMPLETED|Washout (1 Day)||23
8651987|NCT00532844|21357494|P1|COMPLETED|Washout (1 Day)||24
8651988|NCT00532844|21357493|P2|STARTED|Washout (1 Day)||23
8651989|NCT00532844|21357494|P1|STARTED|Washout (1 Day)||24
8651990|NCT00532844|21357493|P2|NOT COMPLETED|Treatment Period - Day 1 to Day 14||1
8651991|NCT00532844|21357494|P1|NOT COMPLETED|Treatment Period - Day 1 to Day 14||0
8651992|NCT00532844|21357493|P2|COMPLETED|Treatment Period - Day 1 to Day 14||23
8651993|NCT00532844|21357494|P1|COMPLETED|Treatment Period - Day 1 to Day 14||24
8651994|NCT00532844|21357493|P2|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
8651995|NCT00532844|21357494|P1|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
8652023|NCT00210106|21357540|P1|NOT COMPLETED|Overall Study||14
8652024|NCT00210106|21357540|P1|COMPLETED|Overall Study||38
8652025|NCT00210106|21357540|P1|Safety Population|Overall Study||49
8652026|NCT00210106|21357540|P1|STARTED|Overall Study||52
8652050|NCT04415489|21357604|P2|NOT COMPLETED|Overall Study||0
8652051|NCT04415489|21357605|P1|NOT COMPLETED|Overall Study||0
8652052|NCT04415489|21357604|P2|COMPLETED|Overall Study||50
8652053|NCT04415489|21357605|P1|COMPLETED|Overall Study||50
8652054|NCT04415489|21357604|P2|STARTED|Overall Study||50
8652055|NCT04415489|21357605|P1|STARTED|Overall Study||50
8652077|NCT04309617|21357647|P1|NOT COMPLETED|Overall Study||0
8652078|NCT04309617|21357647|P1|COMPLETED|Overall Study||618
8652079|NCT04309617|21357647|P1|Modified High Risk of Recurrence|Overall Study||136
8652080|NCT04309617|21357647|P1|STARTED|Overall Study||618
8652081|NCT04018924|21357670|P1|NOT COMPLETED|Overall Study||6
8652082|NCT04018924|21357670|P1|COMPLETED|Overall Study||84
8652083|NCT04018924|21357670|P1|EmoLED Intervention|Overall Study||90
8652084|NCT04018924|21357670|P1|Standard Of Care Intervention|Overall Study||90
8652085|NCT04018924|21357670|P1|STARTED|Overall Study|The total number of participants is 90 and the patient is control of themselves.|90
8652086|NCT03756129|21357685|P6|NOT COMPLETED|Overall Study||5
8652087|NCT03756129|21357686|P5|NOT COMPLETED|Overall Study||1
8652088|NCT03756129|21357687|P4|NOT COMPLETED|Overall Study||3
8652089|NCT03756129|21357688|P3|NOT COMPLETED|Overall Study||3
8652090|NCT03756129|21357689|P2|NOT COMPLETED|Overall Study||2
8652091|NCT03756129|21357690|P1|NOT COMPLETED|Overall Study||3
8652092|NCT03756129|21357685|P6|COMPLETED|Overall Study||15
8652093|NCT03756129|21357686|P5|COMPLETED|Overall Study||9
8652094|NCT03756129|21357687|P4|COMPLETED|Overall Study||6
8652095|NCT03756129|21357688|P3|COMPLETED|Overall Study||7
8652096|NCT03756129|21357689|P2|COMPLETED|Overall Study||8
8652097|NCT03756129|21357690|P1|COMPLETED|Overall Study||8
8652098|NCT03756129|21357685|P6|STARTED|Overall Study||20
8652099|NCT03756129|21357686|P5|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|10
8652100|NCT03756129|21357687|P4|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|9
8652101|NCT03756129|21357688|P3|STARTED|Overall Study||10
8652102|NCT03756129|21357689|P2|STARTED|Overall Study||10
8652103|NCT03756129|21357690|P1|STARTED|Overall Study||11
8652107|NCT03688711|21357796|P2|NOT COMPLETED|Overall Study||1
8652108|NCT03688711|21357797|P1|NOT COMPLETED|Overall Study||0
8652109|NCT03688711|21357796|P2|COMPLETED|Overall Study||10
8652110|NCT03688711|21357797|P1|COMPLETED|Overall Study||34
8652111|NCT03688711|21357796|P2|STARTED|Overall Study||11
8652112|NCT03688711|21357797|P1|STARTED|Overall Study||34
8652113|NCT03687970|21357823|P2|NOT COMPLETED|Overall Study||0
8652114|NCT03687970|21357824|P1|NOT COMPLETED|Overall Study||2
8652115|NCT03687970|21357823|P2|COMPLETED|Overall Study||20
8652116|NCT03687970|21357824|P1|COMPLETED|Overall Study||20
8652117|NCT03687970|21357823|P2|STARTED|Overall Study||20
8652118|NCT03687970|21357824|P1|STARTED|Overall Study||22
8652119|NCT03680521|21357836|P2|NOT COMPLETED|Overall Study||11
8652120|NCT03680521|21357837|P1|NOT COMPLETED|Overall Study||7
8652121|NCT03680521|21357836|P2|COMPLETED|Overall Study||2
8652122|NCT03680521|21357837|P1|COMPLETED|Overall Study||0
8652123|NCT03680521|21357836|P2|STARTED|Overall Study||13
8652124|NCT03680521|21357837|P1|STARTED|Overall Study||7
8652125|NCT03655405|21357854|P2|NOT COMPLETED|Overall Study||5
8652126|NCT03655405|21357855|P1|NOT COMPLETED|Overall Study||5
8652127|NCT03655405|21357854|P2|COMPLETED|Overall Study||25
8652128|NCT03655405|21357855|P1|COMPLETED|Overall Study||27
8652129|NCT03655405|21357854|P2|STARTED|Overall Study||30
8652130|NCT03655405|21357855|P1|STARTED|Overall Study||32
8652131|NCT03635957|21357887|P1|NOT COMPLETED|Pegloticase + IMM Period||3
8652132|NCT03635957|21357887|P1|COMPLETED|Pegloticase + IMM Period||11
8652133|NCT03635957|21357887|P1|Had 6-Month Follow-up|Pegloticase + IMM Period||6
8652134|NCT03635957|21357887|P1|Had 3-Month Follow-up|Pegloticase + IMM Period||7
8652135|NCT03635957|21357887|P1|Discontinued Study Treatment Early|Pegloticase + IMM Period||5
8652136|NCT03635957|21357887|P1|Completed Study at 52 Weeks-Amendment 2|Pegloticase + IMM Period||10
8652137|NCT03635957|21357887|P1|Completed Study at 24 Weeks-Amendment 1|Pegloticase + IMM Period||1
8652138|NCT03635957|21357887|P1|STARTED|Pegloticase + IMM Period||14
8652139|NCT03635957|21357887|P1|NOT COMPLETED|Run-In Period||1
8652140|NCT03635957|21357887|P1|COMPLETED|Run-In Period||14
8652141|NCT03635957|21357887|P1|STARTED|Run-In Period||15
8652142|NCT03610165|21357900|P2|NOT COMPLETED|Overall Study||1
8652143|NCT03610165|21357901|P1|NOT COMPLETED|Overall Study||0
8652144|NCT03610165|21357900|P2|COMPLETED|Overall Study||105
8652145|NCT03610165|21357901|P1|COMPLETED|Overall Study||108
8652146|NCT03610165|21357900|P2|STARTED|Overall Study||106
8652147|NCT03610165|21357901|P1|STARTED|Overall Study||108
8652148|NCT03600376|21357925|P2|NOT COMPLETED|Overall Study||6
8652149|NCT03600376|21357926|P1|NOT COMPLETED|Overall Study||2
8652150|NCT03600376|21357925|P2|COMPLETED|Overall Study||2
8652151|NCT03600376|21357926|P1|COMPLETED|Overall Study||7
8652152|NCT03600376|21357925|P2|STARTED|Overall Study||8
8652153|NCT03600376|21357926|P1|STARTED|Overall Study||9
8652154|NCT03481816|21357936|P2|NOT COMPLETED|Dose Expansion||12
8652155|NCT03481816|21357937|P1|NOT COMPLETED|Dose Expansion||0
8652156|NCT03481816|21357936|P2|COMPLETED|Dose Expansion||0
8652157|NCT03481816|21357937|P1|COMPLETED|Dose Expansion||0
8652158|NCT03481816|21357936|P2|STARTED|Dose Expansion||12
8652159|NCT03481816|21357937|P1|STARTED|Dose Expansion||0
8652160|NCT03481816|21357936|P2|NOT COMPLETED|Starting Dose||0
8652161|NCT03481816|21357937|P1|NOT COMPLETED|Starting Dose||1
8652162|NCT03481816|21357936|P2|COMPLETED|Starting Dose||0
8652163|NCT03481816|21357937|P1|COMPLETED|Starting Dose||5
8652164|NCT03481816|21357936|P2|STARTED|Starting Dose||0
8652165|NCT03481816|21357937|P1|STARTED|Starting Dose||6
8652166|NCT03457727|21357962|P4|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
8652167|NCT03457727|21357963|P3|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
8652168|NCT03457727|21357964|P2|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
8652169|NCT03457727|21357965|P1|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
8652170|NCT03457727|21357962|P4|COMPLETED|Part 2, Period 4 (1 Day)||0
8652171|NCT03457727|21357963|P3|COMPLETED|Part 2, Period 4 (1 Day)||12
8652172|NCT03457727|21357964|P2|COMPLETED|Part 2, Period 4 (1 Day)||0
8652173|NCT03457727|21357965|P1|COMPLETED|Part 2, Period 4 (1 Day)||0
8652174|NCT03457727|21357962|P4|STARTED|Part 2, Period 4 (1 Day)||0
8652175|NCT03457727|21357963|P3|STARTED|Part 2, Period 4 (1 Day)||12
8652176|NCT03457727|21357964|P2|STARTED|Part 2, Period 4 (1 Day)||0
8652177|NCT03457727|21357965|P1|STARTED|Part 2, Period 4 (1 Day)||0
8652178|NCT03457727|21357962|P4|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
8652179|NCT03457727|21357963|P3|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
8652180|NCT03457727|21357964|P2|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
8652181|NCT03457727|21357965|P1|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
8652182|NCT03457727|21357962|P4|COMPLETED|Part 2, Washout Period 3 (5 Days)||11
8652183|NCT03457727|21357963|P3|COMPLETED|Part 2, Washout Period 3 (5 Days)||12
8652184|NCT03457727|21357964|P2|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
8652185|NCT03457727|21357965|P1|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
8652186|NCT03457727|21357962|P4|STARTED|Part 2, Washout Period 3 (5 Days)||11
8652187|NCT03457727|21357963|P3|STARTED|Part 2, Washout Period 3 (5 Days)||12
8652188|NCT03457727|21357964|P2|STARTED|Part 2, Washout Period 3 (5 Days)||0
8652189|NCT03457727|21357965|P1|STARTED|Part 2, Washout Period 3 (5 Days)||0
8652190|NCT03457727|21357962|P4|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
8652191|NCT03457727|21357963|P3|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
8652192|NCT03457727|21357964|P2|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
8652193|NCT03457727|21357965|P1|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
8652194|NCT03457727|21357962|P4|COMPLETED|Part 2, Period 3 (1 Day)||11
8652195|NCT03457727|21357963|P3|COMPLETED|Part 2, Period 3 (1 Day)||12
8652196|NCT03457727|21357964|P2|COMPLETED|Part 2, Period 3 (1 Day)||0
8652197|NCT03457727|21357965|P1|COMPLETED|Part 2, Period 3 (1 Day)||0
8652198|NCT03457727|21357962|P4|STARTED|Part 2, Period 3 (1 Day)||11
8652199|NCT03457727|21357963|P3|STARTED|Part 2, Period 3 (1 Day)||12
8652200|NCT03457727|21357964|P2|STARTED|Part 2, Period 3 (1 Day)||0
8652201|NCT03457727|21357965|P1|STARTED|Part 2, Period 3 (1 Day)||0
8652202|NCT03457727|21357962|P4|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
8652203|NCT03457727|21357963|P3|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
8652204|NCT03457727|21357964|P2|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
8652205|NCT03457727|21357965|P1|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
8652206|NCT03457727|21357962|P4|COMPLETED|Part 2, Washout Period 2 (5 Days)||11
8652207|NCT03457727|21357963|P3|COMPLETED|Part 2, Washout Period 2 (5 Days)||12
8652208|NCT03457727|21357964|P2|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
8652209|NCT03457727|21357965|P1|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
8652210|NCT03457727|21357962|P4|STARTED|Part 2, Washout Period 2 (5 Days)||11
8652211|NCT03457727|21357963|P3|STARTED|Part 2, Washout Period 2 (5 Days)||12
8652212|NCT03457727|21357964|P2|STARTED|Part 2, Washout Period 2 (5 Days)||0
8652213|NCT03457727|21357965|P1|STARTED|Part 2, Washout Period 2 (5 Days)||0
8652214|NCT03457727|21357962|P4|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8652215|NCT03457727|21357963|P3|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8652216|NCT03457727|21357964|P2|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8652217|NCT03457727|21357965|P1|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
8652218|NCT03457727|21357962|P4|COMPLETED|Part 2, Period 2 (1 Day)||11
8652219|NCT03457727|21357963|P3|COMPLETED|Part 2, Period 2 (1 Day)||12
8652220|NCT03457727|21357964|P2|COMPLETED|Part 2, Period 2 (1 Day)||0
8652221|NCT03457727|21357965|P1|COMPLETED|Part 2, Period 2 (1 Day)||0
8652222|NCT03457727|21357962|P4|STARTED|Part 2, Period 2 (1 Day)||11
8652223|NCT03457727|21357963|P3|STARTED|Part 2, Period 2 (1 Day)||12
8652224|NCT03457727|21357964|P2|STARTED|Part 2, Period 2 (1 Day)||0
8652225|NCT03457727|21357965|P1|STARTED|Part 2, Period 2 (1 Day)||0
8652226|NCT03457727|21357962|P4|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1
8652227|NCT03457727|21357963|P3|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
8652228|NCT03457727|21357964|P2|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
8652229|NCT03457727|21357965|P1|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
8652230|NCT03457727|21357962|P4|COMPLETED|Part 2, Washout Period 1 (5 Days)||11
8652231|NCT03457727|21357963|P3|COMPLETED|Part 2, Washout Period 1 (5 Days)||12
8652232|NCT03457727|21357964|P2|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
8652233|NCT03457727|21357965|P1|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
8652234|NCT03457727|21357962|P4|STARTED|Part 2, Washout Period 1 (5 Days)||12
8652235|NCT03457727|21357963|P3|STARTED|Part 2, Washout Period 1 (5 Days)||12
8652236|NCT03457727|21357964|P2|STARTED|Part 2, Washout Period 1 (5 Days)||0
8652237|NCT03457727|21357965|P1|STARTED|Part 2, Washout Period 1 (5 Days)||0
8652238|NCT03457727|21357962|P4|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8652239|NCT03457727|21357963|P3|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8652240|NCT03457727|21357964|P2|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8652241|NCT03457727|21357965|P1|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
8652242|NCT03457727|21357962|P4|COMPLETED|Part 2, Period 1 (1 Day)||12
8652243|NCT03457727|21357963|P3|COMPLETED|Part 2, Period 1 (1 Day)||12
8652244|NCT03457727|21357964|P2|COMPLETED|Part 2, Period 1 (1 Day)||0
8652245|NCT03457727|21357965|P1|COMPLETED|Part 2, Period 1 (1 Day)||0
8652246|NCT03457727|21357962|P4|STARTED|Part 2, Period 1 (1 Day)||12
8652247|NCT03457727|21357963|P3|STARTED|Part 2, Period 1 (1 Day)||12
8652248|NCT03457727|21357964|P2|STARTED|Part 2, Period 1 (1 Day)||0
8652249|NCT03457727|21357965|P1|STARTED|Part 2, Period 1 (1 Day)||0
8652250|NCT03457727|21357962|P4|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
8652251|NCT03457727|21357963|P3|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
8652252|NCT03457727|21357964|P2|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
8652253|NCT03457727|21357965|P1|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
8652254|NCT03457727|21357962|P4|COMPLETED|Part 1, Period 4 (1 Day)||0
8652255|NCT03457727|21357963|P3|COMPLETED|Part 1, Period 4 (1 Day)||0
8652256|NCT03457727|21357964|P2|COMPLETED|Part 1, Period 4 (1 Day)||8
8652257|NCT03457727|21357965|P1|COMPLETED|Part 1, Period 4 (1 Day)||8
8652258|NCT03457727|21357962|P4|STARTED|Part 1, Period 4 (1 Day)||0
8652259|NCT03457727|21357963|P3|STARTED|Part 1, Period 4 (1 Day)||0
8652260|NCT03457727|21357964|P2|STARTED|Part 1, Period 4 (1 Day)||8
8652261|NCT03457727|21357965|P1|STARTED|Part 1, Period 4 (1 Day)||8
8652262|NCT03457727|21357962|P4|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
8652263|NCT03457727|21357963|P3|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
8652264|NCT03457727|21357964|P2|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
8652265|NCT03457727|21357965|P1|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
8652266|NCT03457727|21357962|P4|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
8652267|NCT03457727|21357963|P3|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
8652268|NCT03457727|21357964|P2|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
8652269|NCT03457727|21357965|P1|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
8652270|NCT03457727|21357962|P4|STARTED|Part 1, Washout Period 3 (5 Days)||0
8652271|NCT03457727|21357963|P3|STARTED|Part 1, Washout Period 3 (5 Days)||0
8652272|NCT03457727|21357964|P2|STARTED|Part 1, Washout Period 3 (5 Days)||8
8652273|NCT03457727|21357965|P1|STARTED|Part 1, Washout Period 3 (5 Days)||8
8652274|NCT03457727|21357962|P4|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
8652275|NCT03457727|21357963|P3|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
8652276|NCT03457727|21357964|P2|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
8652277|NCT03457727|21357965|P1|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
8652278|NCT03457727|21357962|P4|COMPLETED|Part 1, Period 3 (1 Day)||0
8652279|NCT03457727|21357963|P3|COMPLETED|Part 1, Period 3 (1 Day)||0
8652280|NCT03457727|21357964|P2|COMPLETED|Part 1, Period 3 (1 Day)||8
8652281|NCT03457727|21357965|P1|COMPLETED|Part 1, Period 3 (1 Day)||8
8652282|NCT03457727|21357962|P4|STARTED|Part 1, Period 3 (1 Day)||0
8652283|NCT03457727|21357963|P3|STARTED|Part 1, Period 3 (1 Day)||0
8652284|NCT03457727|21357964|P2|STARTED|Part 1, Period 3 (1 Day)||8
8652285|NCT03457727|21357965|P1|STARTED|Part 1, Period 3 (1 Day)||8
8652286|NCT03457727|21357962|P4|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
8652287|NCT03457727|21357963|P3|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
8652288|NCT03457727|21357964|P2|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
8652289|NCT03457727|21357965|P1|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
8652290|NCT03457727|21357962|P4|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
8652291|NCT03457727|21357963|P3|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
8652292|NCT03457727|21357964|P2|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
8652293|NCT03457727|21357965|P1|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
8652294|NCT03457727|21357962|P4|STARTED|Part 1, Washout Period 2 (5 Days)||0
8652295|NCT03457727|21357963|P3|STARTED|Part 1, Washout Period 2 (5 Days)||0
8652296|NCT03457727|21357964|P2|STARTED|Part 1, Washout Period 2 (5 Days)||8
8652297|NCT03457727|21357965|P1|STARTED|Part 1, Washout Period 2 (5 Days)||8
8652298|NCT03457727|21357962|P4|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8652299|NCT03457727|21357963|P3|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8652300|NCT03457727|21357964|P2|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8652301|NCT03457727|21357965|P1|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
8652302|NCT03457727|21357962|P4|COMPLETED|Part 1, Period 2 (1 Day)||0
8652303|NCT03457727|21357963|P3|COMPLETED|Part 1, Period 2 (1 Day)||0
8652304|NCT03457727|21357964|P2|COMPLETED|Part 1, Period 2 (1 Day)||8
8652305|NCT03457727|21357965|P1|COMPLETED|Part 1, Period 2 (1 Day)||8
8652306|NCT03457727|21357962|P4|STARTED|Part 1, Period 2 (1 Day)||0
8652307|NCT03457727|21357963|P3|STARTED|Part 1, Period 2 (1 Day)||0
8652308|NCT03457727|21357964|P2|STARTED|Part 1, Period 2 (1 Day)||8
8652309|NCT03457727|21357965|P1|STARTED|Part 1, Period 2 (1 Day)||8
8652310|NCT03457727|21357962|P4|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
8652311|NCT03457727|21357963|P3|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
8652312|NCT03457727|21357964|P2|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
8652313|NCT03457727|21357965|P1|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
8652314|NCT03457727|21357962|P4|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
8652315|NCT03457727|21357963|P3|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
8652316|NCT03457727|21357964|P2|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
8652317|NCT03457727|21357965|P1|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
8652318|NCT03457727|21357962|P4|STARTED|Part 1, Washout Period 1 (5 Days)||0
8652319|NCT03457727|21357963|P3|STARTED|Part 1, Washout Period 1 (5 Days)||0
8652320|NCT03457727|21357964|P2|STARTED|Part 1, Washout Period 1 (5 Days)||8
8652321|NCT03457727|21357965|P1|STARTED|Part 1, Washout Period 1 (5 Days)||8
8652322|NCT03457727|21357962|P4|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
8652323|NCT03457727|21357963|P3|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
8652324|NCT03457727|21357964|P2|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
8652325|NCT03457727|21357965|P1|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
8652326|NCT03457727|21357962|P4|COMPLETED|Part 1, Period 1 (1 Day)||0
8652327|NCT03457727|21357963|P3|COMPLETED|Part 1, Period 1 (1 Day)||0
8652328|NCT03457727|21357964|P2|COMPLETED|Part 1, Period 1 (1 Day)||8
8652329|NCT03457727|21357965|P1|COMPLETED|Part 1, Period 1 (1 Day)||8
8652330|NCT03457727|21357962|P4|STARTED|Part 1, Period 1 (1 Day)||0
8652331|NCT03457727|21357963|P3|STARTED|Part 1, Period 1 (1 Day)||0
8652332|NCT03457727|21357964|P2|STARTED|Part 1, Period 1 (1 Day)||8
8652333|NCT03457727|21357965|P1|STARTED|Part 1, Period 1 (1 Day)||8
8652334|NCT03441581|21358164|P2|NOT COMPLETED|Overall Study||0
8652335|NCT03441581|21358165|P1|NOT COMPLETED|Overall Study||0
8652336|NCT03441581|21358164|P2|COMPLETED|Overall Study||12
8652337|NCT03441581|21358165|P1|COMPLETED|Overall Study||12
8652338|NCT03441581|21358164|P2|STARTED|Overall Study||12
8652339|NCT03441581|21358165|P1|STARTED|Overall Study||12
8652340|NCT03422250|21358211|P4|NOT COMPLETED|Follow-up||2
8652341|NCT03422250|21358212|P3|NOT COMPLETED|Follow-up||0
8652342|NCT03422250|21358213|P2|NOT COMPLETED|Follow-up||0
8652343|NCT03422250|21358214|P1|NOT COMPLETED|Follow-up||0
8652344|NCT03422250|21358211|P4|COMPLETED|Follow-up||8
8652345|NCT03422250|21358212|P3|COMPLETED|Follow-up||10
8652346|NCT03422250|21358213|P2|COMPLETED|Follow-up||10
8652347|NCT03422250|21358214|P1|COMPLETED|Follow-up||10
8652348|NCT03422250|21358211|P4|STARTED|Follow-up||10
8652349|NCT03422250|21358212|P3|STARTED|Follow-up||10
8652350|NCT03422250|21358213|P2|STARTED|Follow-up||10
8652351|NCT03422250|21358214|P1|STARTED|Follow-up||10
8652352|NCT03422250|21358211|P4|NOT COMPLETED|Intervention||1
8652353|NCT03422250|21358212|P3|NOT COMPLETED|Intervention||2
8652354|NCT03422250|21358213|P2|NOT COMPLETED|Intervention||1
8652355|NCT03422250|21358214|P1|NOT COMPLETED|Intervention||1
8652356|NCT03422250|21358211|P4|COMPLETED|Intervention||10
8652357|NCT03422250|21358212|P3|COMPLETED|Intervention||10
8652358|NCT03422250|21358213|P2|COMPLETED|Intervention||10
8652359|NCT03422250|21358214|P1|COMPLETED|Intervention||10
8652360|NCT03422250|21358211|P4|STARTED|Intervention||11
8652361|NCT03422250|21358212|P3|STARTED|Intervention||12
8652362|NCT03422250|21358213|P2|STARTED|Intervention||11
8652363|NCT03422250|21358214|P1|STARTED|Intervention||11
8652364|NCT03361423|21358268|P2|NOT COMPLETED|Overall Study||23
8652365|NCT03361423|21358269|P1|NOT COMPLETED|Overall Study||27
8652366|NCT03361423|21358268|P2|COMPLETED|Overall Study||103
8652367|NCT03361423|21358269|P1|COMPLETED|Overall Study||99
8652368|NCT03361423|21358268|P2|STARTED|Overall Study||126
8652369|NCT03361423|21358269|P1|STARTED|Overall Study||126
8652370|NCT03311724|21358293|P4|NOT COMPLETED|Overall Study||1
8652371|NCT03311724|21358294|P3|NOT COMPLETED|Overall Study||2
8652372|NCT03311724|21358295|P2|NOT COMPLETED|Overall Study||1
8652373|NCT03311724|21358296|P1|NOT COMPLETED|Overall Study||3
8652374|NCT03311724|21358293|P4|COMPLETED|Overall Study||27
8652375|NCT03311724|21358294|P3|COMPLETED|Overall Study||26
8652376|NCT03311724|21358295|P2|COMPLETED|Overall Study||28
8652377|NCT03311724|21358296|P1|COMPLETED|Overall Study||23
8652378|NCT03311724|21358293|P4|Completed Treatment|Overall Study||26
8652379|NCT03311724|21358294|P3|Completed Treatment|Overall Study||22
8652380|NCT03311724|21358295|P2|Completed Treatment|Overall Study||27
8652381|NCT03311724|21358296|P1|Completed Treatment|Overall Study||20
8652382|NCT03311724|21358293|P4|Received At Least One Dose of Study Drug|Overall Study||28
8652383|NCT03311724|21358294|P3|Received At Least One Dose of Study Drug|Overall Study||28
8652384|NCT03311724|21358295|P2|Received At Least One Dose of Study Drug|Overall Study||29
8652385|NCT03311724|21358296|P1|Received At Least One Dose of Study Drug|Overall Study||26
8652386|NCT03311724|21358293|P4|STARTED|Overall Study||28
8652387|NCT03311724|21358294|P3|STARTED|Overall Study||28
8652388|NCT03311724|21358295|P2|STARTED|Overall Study||29
8652389|NCT03311724|21358296|P1|STARTED|Overall Study||26
8652390|NCT03214198|21358333|P1|NOT COMPLETED|Overall Study||36
8652391|NCT03214198|21358333|P1|COMPLETED|Overall Study||1268
8652392|NCT03214198|21358333|P1|STARTED|Overall Study||1304
8652393|NCT03197389|21358347|P6|NOT COMPLETED|Overall Study||0
8652394|NCT03197389|21358348|P5|NOT COMPLETED|Overall Study||0
8652395|NCT03197389|21358349|P4|NOT COMPLETED|Overall Study||0
8652396|NCT03197389|21358350|P3|NOT COMPLETED|Overall Study||0
8652397|NCT03197389|21358351|P2|NOT COMPLETED|Overall Study||0
8652398|NCT03197389|21358352|P1|NOT COMPLETED|Overall Study||0
8652399|NCT03197389|21358347|P6|COMPLETED|Overall Study||5
8652400|NCT03197389|21358348|P5|COMPLETED|Overall Study||1
8652401|NCT03197389|21358349|P4|COMPLETED|Overall Study||9
8652402|NCT03197389|21358350|P3|COMPLETED|Overall Study||18
8652403|NCT03197389|21358351|P2|COMPLETED|Overall Study||5
8652404|NCT03197389|21358352|P1|COMPLETED|Overall Study||16
8652405|NCT03197389|21358347|P6|STARTED|Overall Study||5
8652406|NCT03197389|21358348|P5|STARTED|Overall Study||1
8652407|NCT03197389|21358349|P4|STARTED|Overall Study||9
8652408|NCT03197389|21358350|P3|STARTED|Overall Study||18
8652409|NCT03197389|21358351|P2|STARTED|Overall Study||5
8652410|NCT03197389|21358352|P1|STARTED|Overall Study||16
8652411|NCT03180619|21358369|P3|NOT COMPLETED|Overall Study||28
8652412|NCT03180619|21358370|P2|NOT COMPLETED|Overall Study||15
8652413|NCT03180619|21358371|P1|NOT COMPLETED|Overall Study||73
8652414|NCT03180619|21358369|P3|COMPLETED|Overall Study||3
8652415|NCT03180619|21358370|P2|COMPLETED|Overall Study||0
8652416|NCT03180619|21358371|P1|COMPLETED|Overall Study||5
8652417|NCT03180619|21358369|P3|STARTED|Overall Study||31
8652418|NCT03180619|21358370|P2|STARTED|Overall Study||15
8652419|NCT03180619|21358371|P1|STARTED|Overall Study||78
8652438|NCT03104725|21358487|P2|NOT COMPLETED|Overall Study||0
8652439|NCT03104725|21358488|P1|NOT COMPLETED|Overall Study||0
8652440|NCT03104725|21358487|P2|COMPLETED|Overall Study||4
8652441|NCT03104725|21358488|P1|COMPLETED|Overall Study||2
8652442|NCT03104725|21358487|P2|STARTED|Overall Study||4
8652443|NCT03104725|21358488|P1|STARTED|Overall Study||2
8652444|NCT03096847|21358501|P3|NOT COMPLETED|Overall Study||138
8652445|NCT03096847|21358502|P2|NOT COMPLETED|Overall Study||20
8652446|NCT03096847|21358503|P1|NOT COMPLETED|Overall Study||219
8652447|NCT03096847|21358501|P3|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|19
8652448|NCT03096847|21358502|P2|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|6
8652449|NCT03096847|21358503|P1|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|100
8652450|NCT03096847|21358501|P3|Full Analysis Set|Overall Study||154
8652451|NCT03096847|21358502|P2|Full Analysis Set|Overall Study||26
8652452|NCT03096847|21358503|P1|Full Analysis Set|Overall Study||307
8652453|NCT03096847|21358501|P3|STARTED|Overall Study||157
8652454|NCT03096847|21358502|P2|STARTED|Overall Study||26
8652455|NCT03096847|21358503|P1|STARTED|Overall Study||319
8652456|NCT03075501|21358553|P2|NOT COMPLETED|Overall Study||9
8652457|NCT03075501|21358554|P1|NOT COMPLETED|Overall Study||15
8652458|NCT03075501|21358553|P2|COMPLETED|Overall Study||35
8652459|NCT03075501|21358554|P1|COMPLETED|Overall Study||74
8652460|NCT03075501|21358553|P2|STARTED|Overall Study||44
8652461|NCT03075501|21358554|P1|STARTED|Overall Study||89
8652462|NCT03033108|21358565|P3|NOT COMPLETED|Overall Study||0
8652463|NCT03033108|21358566|P2|NOT COMPLETED|Overall Study||1
8652464|NCT03033108|21358567|P1|NOT COMPLETED|Overall Study||0
8652465|NCT03033108|21358565|P3|COMPLETED|Overall Study||7
8652466|NCT03033108|21358566|P2|COMPLETED|Overall Study||8
8652467|NCT03033108|21358567|P1|COMPLETED|Overall Study||7
8652468|NCT03033108|21358565|P3|STARTED|Overall Study||7
8652469|NCT03033108|21358566|P2|STARTED|Overall Study||9
8652470|NCT03033108|21358567|P1|STARTED|Overall Study||7
8652477|NCT02980692|21358636|P5|NOT COMPLETED|Overall Study||11
8652478|NCT02980692|21358637|P4|NOT COMPLETED|Overall Study||9
8652479|NCT02980692|21358638|P3|NOT COMPLETED|Overall Study||12
8652480|NCT02980692|21358639|P2|NOT COMPLETED|Overall Study||6
8652481|NCT02980692|21358640|P1|NOT COMPLETED|Overall Study||9
8652482|NCT02980692|21358636|P5|COMPLETED|Overall Study||68
8652483|NCT02980692|21358637|P4|COMPLETED|Overall Study||69
8652484|NCT02980692|21358638|P3|COMPLETED|Overall Study||65
8652485|NCT02980692|21358639|P2|COMPLETED|Overall Study||73
8652486|NCT02980692|21358640|P1|COMPLETED|Overall Study||69
8652487|NCT02980692|21358636|P5|STARTED|Overall Study||79
8652488|NCT02980692|21358637|P4|STARTED|Overall Study||78
8652489|NCT02980692|21358638|P3|STARTED|Overall Study||77
8652490|NCT02980692|21358639|P2|STARTED|Overall Study||79
8652491|NCT02980692|21358640|P1|STARTED|Overall Study||78
8652498|NCT02957136|21358738|P2|NOT COMPLETED|Overall Study||1
8652499|NCT02957136|21358739|P1|NOT COMPLETED|Overall Study||2
8652500|NCT02957136|21358738|P2|COMPLETED|Overall Study||98
8652501|NCT02957136|21358739|P1|COMPLETED|Overall Study||93
8652502|NCT02957136|21358738|P2|STARTED|Overall Study||99
8652503|NCT02957136|21358739|P1|STARTED|Overall Study||95
8652504|NCT02936206|21358763|P2|NOT COMPLETED|Overall Study||0
8652505|NCT02936206|21358764|P1|NOT COMPLETED|Overall Study||0
8652506|NCT02936206|21358763|P2|COMPLETED|Overall Study||2
8652507|NCT02936206|21358764|P1|COMPLETED|Overall Study||0
8652508|NCT02936206|21358763|P2|STARTED|Overall Study||2
8652509|NCT02936206|21358764|P1|STARTED|Overall Study||0
8652510|NCT02911285|21358784|P2|NOT COMPLETED|Overall Study||5
8652511|NCT02911285|21358785|P1|NOT COMPLETED|Overall Study||9
8652512|NCT02911285|21358784|P2|COMPLETED|Overall Study||36
8652513|NCT02911285|21358785|P1|COMPLETED|Overall Study||40
8652514|NCT02911285|21358784|P2|STARTED|Overall Study||41
8652515|NCT02911285|21358785|P1|STARTED|Overall Study||49
8652528|NCT02830074|21358820|P2|NOT COMPLETED|Overall Study||0
8652529|NCT02830074|21358821|P1|NOT COMPLETED|Overall Study||0
8652530|NCT02830074|21358820|P2|COMPLETED|Overall Study||31
8652531|NCT02830074|21358821|P1|COMPLETED|Overall Study||32
8652532|NCT02830074|21358820|P2|STARTED|Overall Study||31
8652533|NCT02830074|21358821|P1|STARTED|Overall Study||32
8652534|NCT02781610|21358845|P4|NOT COMPLETED|Overall Study||29
8652535|NCT02781610|21358846|P3|NOT COMPLETED|Overall Study||17
8652536|NCT02781610|21358847|P2|NOT COMPLETED|Overall Study||7
8652537|NCT02781610|21358848|P1|NOT COMPLETED|Overall Study||6
8652538|NCT02781610|21358845|P4|COMPLETED|Overall Study||323
8652539|NCT02781610|21358846|P3|COMPLETED|Overall Study||336
8652540|NCT02781610|21358847|P2|COMPLETED|Overall Study||130
8652541|NCT02781610|21358848|P1|COMPLETED|Overall Study||134
8652542|NCT02781610|21358845|P4|STARTED|Overall Study||352
8652543|NCT02781610|21358846|P3|STARTED|Overall Study||353
8652544|NCT02781610|21358847|P2|STARTED|Overall Study||137
8652545|NCT02781610|21358848|P1|STARTED|Overall Study||140
8652546|NCT02767531|21358866|P2|NOT COMPLETED|Period 4||0
8652547|NCT02767531|21358867|P1|NOT COMPLETED|Period 4||0
8652548|NCT02767531|21358866|P2|COMPLETED|Period 4||1
8652549|NCT02767531|21358867|P1|COMPLETED|Period 4||1
8652550|NCT02767531|21358866|P2|STARTED|Period 4|Orlistat Therapy|1
8652551|NCT02767531|21358867|P1|STARTED|Period 4|Off Orlistat|1
8652552|NCT02767531|21358866|P2|NOT COMPLETED|Period 3||0
8652553|NCT02767531|21358867|P1|NOT COMPLETED|Period 3||0
8652554|NCT02767531|21358866|P2|COMPLETED|Period 3||1
8652555|NCT02767531|21358867|P1|COMPLETED|Period 3||1
8652556|NCT02767531|21358866|P2|STARTED|Period 3|Off Orlistat|1
8652557|NCT02767531|21358867|P1|STARTED|Period 3|Orlistat Therapy|1
8652558|NCT02767531|21358866|P2|NOT COMPLETED|Period 2||0
8652559|NCT02767531|21358867|P1|NOT COMPLETED|Period 2||0
8652560|NCT02767531|21358866|P2|COMPLETED|Period 2||1
8652561|NCT02767531|21358867|P1|COMPLETED|Period 2||1
8652562|NCT02767531|21358866|P2|STARTED|Period 2|Orlistat Therapy|1
8652563|NCT02767531|21358867|P1|STARTED|Period 2|Off Orlistat|1
8652564|NCT02767531|21358866|P2|NOT COMPLETED|Period 1||0
8652565|NCT02767531|21358867|P1|NOT COMPLETED|Period 1||0
8652566|NCT02767531|21358866|P2|COMPLETED|Period 1||1
8652567|NCT02767531|21358867|P1|COMPLETED|Period 1||1
8652568|NCT02767531|21358866|P2|STARTED|Period 1|Off Orlistat|1
8652569|NCT02767531|21358867|P1|STARTED|Period 1|Orlistat therapy|1
8652570|NCT02753400|21358875|P2|NOT COMPLETED|Overall Study||1
8652571|NCT02753400|21358876|P1|NOT COMPLETED|Overall Study||5
8652572|NCT02753400|21358875|P2|COMPLETED|Overall Study||11
8652573|NCT02753400|21358876|P1|COMPLETED|Overall Study||7
8652574|NCT02753400|21358875|P2|STARTED|Overall Study||12
8652575|NCT02753400|21358876|P1|STARTED|Overall Study||12
8652576|NCT02669017|21358891|P9|NOT COMPLETED|Overall Study||25
8652577|NCT02669017|21358892|P8|NOT COMPLETED|Overall Study||62
8652578|NCT02669017|21358893|P7|NOT COMPLETED|Overall Study||11
8652579|NCT02669017|21358894|P6|NOT COMPLETED|Overall Study||19
8652580|NCT02669017|21358895|P5|NOT COMPLETED|Overall Study||12
8652581|NCT02669017|21358896|P4|NOT COMPLETED|Overall Study||4
8652582|NCT02669017|21358897|P3|NOT COMPLETED|Overall Study||2
8652583|NCT02669017|21358898|P2|NOT COMPLETED|Overall Study||2
8652584|NCT02669017|21358899|P1|NOT COMPLETED|Overall Study||1
8652585|NCT02669017|21358891|P9|COMPLETED|Overall Study||11
8652586|NCT02669017|21358892|P8|COMPLETED|Overall Study||7
8652587|NCT02669017|21358893|P7|COMPLETED|Overall Study||8
8652588|NCT02669017|21358894|P6|COMPLETED|Overall Study||7
8652589|NCT02669017|21358895|P5|COMPLETED|Overall Study||4
8652590|NCT02669017|21358896|P4|COMPLETED|Overall Study||1
8652591|NCT02669017|21358897|P3|COMPLETED|Overall Study||2
8652592|NCT02669017|21358898|P2|COMPLETED|Overall Study||2
8652593|NCT02669017|21358899|P1|COMPLETED|Overall Study||3
8652594|NCT02669017|21358891|P9|STARTED|Overall Study||36
8652595|NCT02669017|21358892|P8|STARTED|Overall Study||69
8652596|NCT02669017|21358893|P7|STARTED|Overall Study||19
8652597|NCT02669017|21358894|P6|STARTED|Overall Study||26
8652598|NCT02669017|21358895|P5|STARTED|Overall Study||16
8652599|NCT02669017|21358896|P4|STARTED|Overall Study||5
8652600|NCT02669017|21358897|P3|STARTED|Overall Study||4
8652601|NCT02669017|21358898|P2|STARTED|Overall Study||4
8652602|NCT02669017|21358899|P1|STARTED|Overall Study||4
8652603|NCT02639182|21359023|P2|NOT COMPLETED|Overall Study||66
8652604|NCT02639182|21359024|P1|NOT COMPLETED|Overall Study||67
8652605|NCT02639182|21359023|P2|COMPLETED|Overall Study||0
8652606|NCT02639182|21359024|P1|COMPLETED|Overall Study||0
8652607|NCT02639182|21359023|P2|Treated|Overall Study||65
8652608|NCT02639182|21359024|P1|Treated|Overall Study||66
8652609|NCT02639182|21359023|P2|STARTED|Overall Study||66
8652610|NCT02639182|21359024|P1|STARTED|Overall Study||67
8652611|NCT02621424|21359059|P2|NOT COMPLETED|Overall Study||2
8652612|NCT02621424|21359060|P1|NOT COMPLETED|Overall Study||1
8652613|NCT02621424|21359059|P2|COMPLETED|Overall Study||16
8652614|NCT02621424|21359060|P1|COMPLETED|Overall Study||13
8652615|NCT02621424|21359059|P2|STARTED|Overall Study||18
8652616|NCT02621424|21359060|P1|STARTED|Overall Study||14
8652617|NCT02569892|21359078|P2|NOT COMPLETED|Overall Study||1
8652618|NCT02569892|21359079|P1|NOT COMPLETED|Overall Study||0
8652619|NCT02569892|21359078|P2|COMPLETED|Overall Study||8
8652620|NCT02569892|21359079|P1|COMPLETED|Overall Study||10
8652621|NCT02569892|21359078|P2|STARTED|Overall Study||9
8652622|NCT02569892|21359079|P1|STARTED|Overall Study||10
8652623|NCT02536339|21359089|P1|NOT COMPLETED|Overall Study||31
8652624|NCT02536339|21359089|P1|COMPLETED|Overall Study||9
8652625|NCT02536339|21359089|P1|Received at Least One Dose of Study Drug|Overall Study||39
8652626|NCT02536339|21359089|P1|STARTED|Overall Study||40
8652627|NCT02485717|21359116|P3|NOT COMPLETED|Overall Study||1
8652628|NCT02485717|21359117|P2|NOT COMPLETED|Overall Study||2
8652629|NCT02485717|21359118|P1|NOT COMPLETED|Overall Study||6
8652630|NCT02485717|21359116|P3|COMPLETED|Overall Study||19
8652631|NCT02485717|21359117|P2|COMPLETED|Overall Study||127
8652632|NCT02485717|21359118|P1|COMPLETED|Overall Study||136
8652633|NCT02485717|21359116|P3|STARTED|Overall Study||20
8652634|NCT02485717|21359117|P2|STARTED|Overall Study||129
8652635|NCT02485717|21359118|P1|STARTED|Overall Study||142
8652636|NCT02438722|21359133|P2|NOT COMPLETED|Overall Study||85
8652637|NCT02438722|21359134|P1|NOT COMPLETED|Overall Study||83
8652638|NCT02438722|21359133|P2|COMPLETED|Overall Study||0
8652639|NCT02438722|21359134|P1|COMPLETED|Overall Study||0
8652640|NCT02438722|21359133|P2|Participants Evaluable for Adverse Events|Overall Study||85
8652641|NCT02438722|21359134|P1|Participants Evaluable for Adverse Events|Overall Study||78
8652642|NCT02438722|21359133|P2|STARTED|Overall Study||85
8652643|NCT02438722|21359134|P1|STARTED|Overall Study||83
8652650|NCT02408315|21359200|P2|NOT COMPLETED|Overall Study||0
8652651|NCT02408315|21359201|P1|NOT COMPLETED|Overall Study||0
8652652|NCT02408315|21359200|P2|COMPLETED|Overall Study||152
8652653|NCT02408315|21359201|P1|COMPLETED|Overall Study||148
8652654|NCT02408315|21359200|P2|STARTED|Overall Study||152
8652655|NCT02408315|21359201|P1|STARTED|Overall Study||148
8652656|NCT02283268|21359223|P1|NOT COMPLETED|Overall Study||1
8652657|NCT02283268|21359223|P1|COMPLETED|Overall Study||14
8652658|NCT02283268|21359223|P1|STARTED|Overall Study||15
8652659|NCT02178358|21359287|P3|NOT COMPLETED|Overall Study||4
8652660|NCT02178358|21359288|P2|NOT COMPLETED|Overall Study||3
8652661|NCT02178358|21359289|P1|NOT COMPLETED|Overall Study||0
8652662|NCT02178358|21359287|P3|COMPLETED|Overall Study||34
8652663|NCT02178358|21359288|P2|COMPLETED|Overall Study||71
8652664|NCT02178358|21359289|P1|COMPLETED|Overall Study||20
8652665|NCT02178358|21359287|P3|Received at Least 1 Dose of Study Drug|Overall Study||38
8652666|NCT02178358|21359288|P2|Received at Least 1 Dose of Study Drug|Overall Study||74
8652667|NCT02178358|21359289|P1|Received at Least 1 Dose of Study Drug|Overall Study||20
8652668|NCT02178358|21359287|P3|STARTED|Overall Study||38
8652669|NCT02178358|21359288|P2|STARTED|Overall Study||74
8652670|NCT02178358|21359289|P1|STARTED|Overall Study||20
8652671|NCT02170051|21359316|P2|NOT COMPLETED|Overall Study||13
8652672|NCT02170051|21359317|P1|NOT COMPLETED|Overall Study||11
8652673|NCT02170051|21359316|P2|COMPLETED|Overall Study||16
8652674|NCT02170051|21359317|P1|COMPLETED|Overall Study||15
8652675|NCT02170051|21359316|P2|Tested at Post-treatment|Overall Study||16
8652676|NCT02170051|21359317|P1|Tested at Post-treatment|Overall Study||15
8652677|NCT02170051|21359316|P2|Tested at Mid-point|Overall Study||18
8652678|NCT02170051|21359317|P1|Tested at Mid-point|Overall Study||13
8652679|NCT02170051|21359316|P2|STARTED|Overall Study||29
8652680|NCT02170051|21359317|P1|STARTED|Overall Study||26
8652681|NCT02135653|21359339|P2|NOT COMPLETED|Overall Study||5
8652682|NCT02135653|21359340|P1|NOT COMPLETED|Overall Study||13
8652683|NCT02135653|21359339|P2|COMPLETED|Overall Study||28
8652684|NCT02135653|21359340|P1|COMPLETED|Overall Study||22
8652685|NCT02135653|21359339|P2|STARTED|Overall Study||33
8652686|NCT02135653|21359340|P1|STARTED|Overall Study||35
8652687|NCT02128763|21359362|P2|NOT COMPLETED|Overall Study||16
8652688|NCT02128763|21359363|P1|NOT COMPLETED|Overall Study||20
8652689|NCT02128763|21359362|P2|COMPLETED|Overall Study||170
8652690|NCT02128763|21359363|P1|COMPLETED|Overall Study||329
8652691|NCT02128763|21359362|P2|STARTED|Overall Study||186
8652692|NCT02128763|21359363|P1|STARTED|Overall Study||349
8652693|NCT02122783|21359407|P2|NOT COMPLETED|Overall Study||1
8652694|NCT02122783|21359408|P1|NOT COMPLETED|Overall Study||0
8652695|NCT02122783|21359407|P2|COMPLETED|Overall Study||2
8652696|NCT02122783|21359408|P1|COMPLETED|Overall Study||2
8652697|NCT02122783|21359407|P2|STARTED|Overall Study||3
8652698|NCT02122783|21359408|P1|STARTED|Overall Study||2
8652707|NCT01944423|21359476|P2|NOT COMPLETED|Overall Study||9
8652708|NCT01944423|21359477|P1|NOT COMPLETED|Overall Study||8
8652709|NCT01944423|21359476|P2|COMPLETED|Overall Study|6-month follow-up|17
8652710|NCT01944423|21359477|P1|COMPLETED|Overall Study|6-month follow-up|19
8652711|NCT01944423|21359476|P2|4-month Follow-up|Overall Study||16
8652712|NCT01944423|21359477|P1|4-month Follow-up|Overall Study||19
8652713|NCT01944423|21359476|P2|1-month Follow-up|Overall Study||19
8652714|NCT01944423|21359477|P1|1-month Follow-up|Overall Study||22
8652715|NCT01944423|21359476|P2|End of Treatment|Overall Study||20
8652716|NCT01944423|21359477|P1|End of Treatment|Overall Study||21
8652717|NCT01944423|21359476|P2|STARTED|Overall Study||26
8652718|NCT01944423|21359477|P1|STARTED|Overall Study||27
8652719|NCT01943851|21359505|P18|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||1
8652720|NCT01943851|21359506|P17|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||3
8652721|NCT01943851|21359507|P16|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||6
8652722|NCT01943851|21359508|P15|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652723|NCT01943851|21359509|P14|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652724|NCT01943851|21359510|P13|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652725|NCT01943851|21359511|P12|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652726|NCT01943851|21359512|P11|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652727|NCT01943851|21359513|P10|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652728|NCT01943851|21359514|P9|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652729|NCT01943851|21359515|P8|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652730|NCT01943851|21359516|P7|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652731|NCT01943851|21359517|P6|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652732|NCT01943851|21359518|P5|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652733|NCT01943851|21359519|P4|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652734|NCT01943851|21359520|P3|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652735|NCT01943851|21359521|P2|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652736|NCT01943851|21359522|P1|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652737|NCT01943851|21359505|P18|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652738|NCT01943851|21359506|P17|COMPLETED|Part 2 (Up to 36.4 Weeks)||13
8652739|NCT01943851|21359507|P16|COMPLETED|Part 2 (Up to 36.4 Weeks)||1
8652740|NCT01943851|21359508|P15|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652741|NCT01943851|21359509|P14|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652742|NCT01943851|21359510|P13|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652743|NCT01943851|21359511|P12|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652744|NCT01943851|21359512|P11|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652745|NCT01943851|21359513|P10|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652746|NCT01943851|21359514|P9|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652747|NCT01943851|21359515|P8|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652748|NCT01943851|21359516|P7|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652749|NCT01943851|21359517|P6|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652750|NCT01943851|21359518|P5|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652751|NCT01943851|21359519|P4|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652752|NCT01943851|21359520|P3|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652753|NCT01943851|21359521|P2|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652754|NCT01943851|21359522|P1|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
8652755|NCT01943851|21359505|P18|STARTED|Part 2 (Up to 36.4 Weeks)||1
8652756|NCT01943851|21359506|P17|STARTED|Part 2 (Up to 36.4 Weeks)||16
8652757|NCT01943851|21359507|P16|STARTED|Part 2 (Up to 36.4 Weeks)||7
8652758|NCT01943851|21359508|P15|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652759|NCT01943851|21359509|P14|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652760|NCT01943851|21359510|P13|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652761|NCT01943851|21359511|P12|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652762|NCT01943851|21359512|P11|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652763|NCT01943851|21359513|P10|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652764|NCT01943851|21359514|P9|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652765|NCT01943851|21359515|P8|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652766|NCT01943851|21359516|P7|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652767|NCT01943851|21359517|P6|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652768|NCT01943851|21359518|P5|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652769|NCT01943851|21359519|P4|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652770|NCT01943851|21359520|P3|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652771|NCT01943851|21359521|P2|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652772|NCT01943851|21359522|P1|STARTED|Part 2 (Up to 36.4 Weeks)||0
8652773|NCT01943851|21359505|P18|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652774|NCT01943851|21359506|P17|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652775|NCT01943851|21359507|P16|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652776|NCT01943851|21359508|P15|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652777|NCT01943851|21359509|P14|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8652778|NCT01943851|21359510|P13|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652779|NCT01943851|21359511|P12|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652780|NCT01943851|21359512|P11|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652781|NCT01943851|21359513|P10|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652782|NCT01943851|21359514|P9|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8652783|NCT01943851|21359515|P8|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||2
8652784|NCT01943851|21359516|P7|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8652785|NCT01943851|21359517|P6|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652786|NCT01943851|21359518|P5|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8652787|NCT01943851|21359519|P4|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8652788|NCT01943851|21359520|P3|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652789|NCT01943851|21359521|P2|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652790|NCT01943851|21359522|P1|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652791|NCT01943851|21359505|P18|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652792|NCT01943851|21359506|P17|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652793|NCT01943851|21359507|P16|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652794|NCT01943851|21359508|P15|COMPLETED|Part 1 (Up to 86.9 Weeks)||6
8652795|NCT01943851|21359509|P14|COMPLETED|Part 1 (Up to 86.9 Weeks)||15
8652796|NCT01943851|21359510|P13|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
8652797|NCT01943851|21359511|P12|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
8652798|NCT01943851|21359512|P11|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8652799|NCT01943851|21359513|P10|COMPLETED|Part 1 (Up to 86.9 Weeks)||8
8652800|NCT01943851|21359514|P9|COMPLETED|Part 1 (Up to 86.9 Weeks)||2
8652801|NCT01943851|21359515|P8|COMPLETED|Part 1 (Up to 86.9 Weeks)||16
8652802|NCT01943851|21359516|P7|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
8652803|NCT01943851|21359517|P6|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
8652804|NCT01943851|21359518|P5|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
8652805|NCT01943851|21359519|P4|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
8652806|NCT01943851|21359520|P3|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8652807|NCT01943851|21359521|P2|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8652808|NCT01943851|21359522|P1|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
8652809|NCT01943851|21359505|P18|STARTED|Part 1 (Up to 86.9 Weeks)||0
8652810|NCT01943851|21359506|P17|STARTED|Part 1 (Up to 86.9 Weeks)||0
8652811|NCT01943851|21359507|P16|STARTED|Part 1 (Up to 86.9 Weeks)||0
8652812|NCT01943851|21359508|P15|STARTED|Part 1 (Up to 86.9 Weeks)||6
8652813|NCT01943851|21359509|P14|STARTED|Part 1 (Up to 86.9 Weeks)||16
8652814|NCT01943851|21359510|P13|STARTED|Part 1 (Up to 86.9 Weeks)||7
8652815|NCT01943851|21359511|P12|STARTED|Part 1 (Up to 86.9 Weeks)||7
8652816|NCT01943851|21359512|P11|STARTED|Part 1 (Up to 86.9 Weeks)||1
8652817|NCT01943851|21359513|P10|STARTED|Part 1 (Up to 86.9 Weeks)||8
8652818|NCT01943851|21359514|P9|STARTED|Part 1 (Up to 86.9 Weeks)||3
8652819|NCT01943851|21359515|P8|STARTED|Part 1 (Up to 86.9 Weeks)||18
8652820|NCT01943851|21359516|P7|STARTED|Part 1 (Up to 86.9 Weeks)||8
8652821|NCT01943851|21359517|P6|STARTED|Part 1 (Up to 86.9 Weeks)||4
8652822|NCT01943851|21359518|P5|STARTED|Part 1 (Up to 86.9 Weeks)||1
8652823|NCT01943851|21359519|P4|STARTED|Part 1 (Up to 86.9 Weeks)||5
8652824|NCT01943851|21359520|P3|STARTED|Part 1 (Up to 86.9 Weeks)||1
8652825|NCT01943851|21359521|P2|STARTED|Part 1 (Up to 86.9 Weeks)||1
8652826|NCT01943851|21359522|P1|STARTED|Part 1 (Up to 86.9 Weeks)||1
8652827|NCT01936857|21360158|P2|NOT COMPLETED|Overall Study||25
8652828|NCT01936857|21360159|P1|NOT COMPLETED|Overall Study||34
8652829|NCT01936857|21360158|P2|COMPLETED|Overall Study||115
8652830|NCT01936857|21360159|P1|COMPLETED|Overall Study||107
8652831|NCT01936857|21360158|P2|STARTED|Overall Study||140
8652832|NCT01936857|21360159|P1|STARTED|Overall Study||141
8652841|NCT01854359|21360194|P2|NOT COMPLETED|Overall Study||8
8652842|NCT01854359|21360195|P1|NOT COMPLETED|Overall Study||5
8652843|NCT01854359|21360194|P2|COMPLETED|Overall Study||22
8652844|NCT01854359|21360195|P1|COMPLETED|Overall Study||26
8652845|NCT01854359|21360194|P2|STARTED|Overall Study||30
8652846|NCT01854359|21360195|P1|STARTED|Overall Study||31
8652847|NCT01757535|21360223|P2|NOT COMPLETED|Overall Study||208
8652848|NCT01757535|21360224|P1|NOT COMPLETED|Overall Study||193
8652849|NCT01757535|21360223|P2|COMPLETED|Overall Study||26
8652850|NCT01757535|21360224|P1|COMPLETED|Overall Study||45
8652851|NCT01757535|21360223|P2|Received Treatment|Overall Study||233
8652852|NCT01757535|21360224|P1|Received Treatment|Overall Study||236
8652853|NCT01757535|21360223|P2|STARTED|Overall Study||234
8652854|NCT01757535|21360224|P1|STARTED|Overall Study||238
8652855|NCT01754493|21360254|P1|NOT COMPLETED|Overall Study||7
8652856|NCT01754493|21360254|P1|COMPLETED|Overall Study||10
8652857|NCT01754493|21360254|P1|STARTED|Overall Study||17
8652858|NCT01736579|21360264|P2|NOT COMPLETED|Overall Study||2
8652859|NCT01736579|21360265|P1|NOT COMPLETED|Overall Study||2
8652860|NCT01736579|21360264|P2|COMPLETED|Overall Study||0
8652861|NCT01736579|21360265|P1|COMPLETED|Overall Study||0
8652862|NCT01736579|21360264|P2|STARTED|Overall Study||2
8652863|NCT01736579|21360265|P1|STARTED|Overall Study||2
8652864|NCT01728805|21360301|P3|NOT COMPLETED|Crossover Period||0
8652865|NCT01728805|21360302|P2|NOT COMPLETED|Crossover Period||0
8652866|NCT01728805|21360303|P1|NOT COMPLETED|Crossover Period||0
8652867|NCT01728805|21360301|P3|COMPLETED|Crossover Period||136
8652868|NCT01728805|21360302|P2|COMPLETED|Crossover Period||0
8652869|NCT01728805|21360303|P1|COMPLETED|Crossover Period||0
8652870|NCT01728805|21360301|P3|STARTED|Crossover Period||136
8652871|NCT01728805|21360302|P2|STARTED|Crossover Period||0
8652872|NCT01728805|21360303|P1|STARTED|Crossover Period||0
8652873|NCT01728805|21360301|P3|NOT COMPLETED|Randomization Period||0
8652874|NCT01728805|21360302|P2|NOT COMPLETED|Randomization Period||0
8652875|NCT01728805|21360303|P1|NOT COMPLETED|Randomization Period||0
8652876|NCT01728805|21360301|P3|COMPLETED|Randomization Period||0
8652877|NCT01728805|21360302|P2|COMPLETED|Randomization Period||186
8652878|NCT01728805|21360303|P1|COMPLETED|Randomization Period||186
8652879|NCT01728805|21360301|P3|STARTED|Randomization Period||0
8652880|NCT01728805|21360302|P2|STARTED|Randomization Period||186
8652881|NCT01728805|21360303|P1|STARTED|Randomization Period||186
8652882|NCT01722331|21360319|P7|NOT COMPLETED|Part 3||2
8652883|NCT01722331|21360320|P6|NOT COMPLETED|Part 3||3
8652884|NCT01722331|21360321|P5|NOT COMPLETED|Part 3||0
8652885|NCT01722331|21360322|P4|NOT COMPLETED|Part 3||1
8652886|NCT01722331|21360323|P3|NOT COMPLETED|Part 3||0
8652887|NCT01722331|21360324|P2|NOT COMPLETED|Part 3||17
8652888|NCT01722331|21360325|P1|NOT COMPLETED|Part 3||15
8652889|NCT01722331|21360319|P7|COMPLETED|Part 3||65
8652890|NCT01722331|21360320|P6|COMPLETED|Part 3||59
8652891|NCT01722331|21360321|P5|COMPLETED|Part 3||0
8652892|NCT01722331|21360322|P4|COMPLETED|Part 3||18
8652893|NCT01722331|21360323|P3|COMPLETED|Part 3||0
8652894|NCT01722331|21360324|P2|COMPLETED|Part 3||232
8652895|NCT01722331|21360325|P1|COMPLETED|Part 3||264
8652896|NCT01722331|21360319|P7|STARTED|Part 3||67
8652897|NCT01722331|21360320|P6|STARTED|Part 3||62
8652898|NCT01722331|21360321|P5|STARTED|Part 3||0
8652899|NCT01722331|21360322|P4|STARTED|Part 3||19
8652900|NCT01722331|21360323|P3|STARTED|Part 3||0
8652901|NCT01722331|21360324|P2|STARTED|Part 3||249
8652902|NCT01722331|21360325|P1|STARTED|Part 3||279
8652903|NCT01722331|21360319|P7|NOT COMPLETED|Part 2||7
8652904|NCT01722331|21360320|P6|NOT COMPLETED|Part 2||10
8652905|NCT01722331|21360321|P5|NOT COMPLETED|Part 2||0
8652906|NCT01722331|21360322|P4|NOT COMPLETED|Part 2||0
8652907|NCT01722331|21360323|P3|NOT COMPLETED|Part 2||31
8652908|NCT01722331|21360324|P2|NOT COMPLETED|Part 2||0
8652909|NCT01722331|21360325|P1|NOT COMPLETED|Part 2||19
8652910|NCT01722331|21360319|P7|COMPLETED|Part 2||67
8652911|NCT01722331|21360320|P6|COMPLETED|Part 2||62
8652912|NCT01722331|21360321|P5|COMPLETED|Part 2||0
8652913|NCT01722331|21360322|P4|COMPLETED|Part 2||19
8652914|NCT01722331|21360323|P3|COMPLETED|Part 2||0
8652915|NCT01722331|21360324|P2|COMPLETED|Part 2||249
8652916|NCT01722331|21360325|P1|COMPLETED|Part 2||279
8652917|NCT01722331|21360319|P7|STARTED|Part 2||74
8652918|NCT01722331|21360320|P6|STARTED|Part 2||72
8652919|NCT01722331|21360321|P5|STARTED|Part 2||0
8652920|NCT01722331|21360322|P4|STARTED|Part 2||19
8652921|NCT01722331|21360323|P3|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
8652922|NCT01722331|21360324|P2|STARTED|Part 2||249
8652923|NCT01722331|21360325|P1|STARTED|Part 2||298
8652924|NCT01722331|21360319|P7|NOT COMPLETED|Part 1||0
8652925|NCT01722331|21360320|P6|NOT COMPLETED|Part 1||0
8652926|NCT01722331|21360321|P5|NOT COMPLETED|Part 1||9
8652927|NCT01722331|21360322|P4|NOT COMPLETED|Part 1||0
8652928|NCT01722331|21360323|P3|NOT COMPLETED|Part 1||9
8652929|NCT01722331|21360324|P2|NOT COMPLETED|Part 1||0
8652930|NCT01722331|21360325|P1|NOT COMPLETED|Part 1||10
8652931|NCT01722331|21360319|P7|COMPLETED|Part 1||74
8652932|NCT01722331|21360320|P6|COMPLETED|Part 1||72
8652933|NCT01722331|21360321|P5|COMPLETED|Part 1||0
8652934|NCT01722331|21360322|P4|COMPLETED|Part 1||19
8652935|NCT01722331|21360323|P3|COMPLETED|Part 1||32
8652936|NCT01722331|21360324|P2|COMPLETED|Part 1||249
8652937|NCT01722331|21360325|P1|COMPLETED|Part 1||298
8652938|NCT01722331|21360319|P7|STARTED|Part 1||74
8652939|NCT01722331|21360320|P6|STARTED|Part 1||72
8652940|NCT01722331|21360321|P5|STARTED|Part 1||9
8652941|NCT01722331|21360322|P4|STARTED|Part 1||19
8652942|NCT01722331|21360323|P3|STARTED|Part 1||41
8652943|NCT01722331|21360324|P2|STARTED|Part 1||249
8652944|NCT01722331|21360325|P1|STARTED|Part 1||308
8652954|NCT01647516|21360395|P6|NOT COMPLETED|Open-Label Period||56
8652955|NCT01647516|21360396|P5|NOT COMPLETED|Open-Label Period||51
8652956|NCT01647516|21360397|P4|NOT COMPLETED|Open-Label Period||49
8652957|NCT01647516|21360398|P3|NOT COMPLETED|Open-Label Period||0
8652958|NCT01647516|21360399|P2|NOT COMPLETED|Open-Label Period||0
8652959|NCT01647516|21360400|P1|NOT COMPLETED|Open-Label Period||0
8652960|NCT01647516|21360395|P6|COMPLETED|Open-Label Period||3
8652961|NCT01647516|21360396|P5|COMPLETED|Open-Label Period||5
8652962|NCT01647516|21360397|P4|COMPLETED|Open-Label Period||6
8652963|NCT01647516|21360398|P3|COMPLETED|Open-Label Period||0
8652964|NCT01647516|21360399|P2|COMPLETED|Open-Label Period||0
8652965|NCT01647516|21360400|P1|COMPLETED|Open-Label Period||0
8652966|NCT01647516|21360395|P6|STARTED|Open-Label Period|"The participants were:
~non-responders at Week 8,completed the MP or had disease relapse during MP"|59
8652967|NCT01647516|21360396|P5|STARTED|Open-Label Period|"The participants were:
~non-responders at Week 8,completed the MP or had disease relapse during MP"|56
8652968|NCT01647516|21360397|P4|STARTED|Open-Label Period|"The participants were:
~non-responders at Week 8,completed the MP or had disease relapse during MP"|55
8652969|NCT01647516|21360398|P3|STARTED|Open-Label Period||0
8652970|NCT01647516|21360399|P2|STARTED|Open-Label Period||0
8652971|NCT01647516|21360400|P1|STARTED|Open-Label Period||0
8652972|NCT01647516|21360395|P6|NOT COMPLETED|Maintenance Period (MP)||0
8652973|NCT01647516|21360396|P5|NOT COMPLETED|Maintenance Period (MP)||0
8652974|NCT01647516|21360397|P4|NOT COMPLETED|Maintenance Period (MP)||0
8652975|NCT01647516|21360398|P3|NOT COMPLETED|Maintenance Period (MP)||2
8652976|NCT01647516|21360399|P2|NOT COMPLETED|Maintenance Period (MP)||6
8652977|NCT01647516|21360400|P1|NOT COMPLETED|Maintenance Period (MP)||4
8652978|NCT01647516|21360395|P6|COMPLETED|Maintenance Period (MP)||0
8652979|NCT01647516|21360396|P5|COMPLETED|Maintenance Period (MP)||0
8652980|NCT01647516|21360397|P4|COMPLETED|Maintenance Period (MP)||0
8652981|NCT01647516|21360398|P3|COMPLETED|Maintenance Period (MP)||40
8652982|NCT01647516|21360399|P2|COMPLETED|Maintenance Period (MP)||30
8652983|NCT01647516|21360400|P1|COMPLETED|Maintenance Period (MP)||21
8652984|NCT01647516|21360395|P6|STARTED|Maintenance Period (MP)||0
8652985|NCT01647516|21360396|P5|STARTED|Maintenance Period (MP)||0
8652986|NCT01647516|21360397|P4|STARTED|Maintenance Period (MP)||0
8652987|NCT01647516|21360398|P3|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|42
8652988|NCT01647516|21360399|P2|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|36
8652989|NCT01647516|21360400|P1|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|25
8652990|NCT01647516|21360395|P6|NOT COMPLETED|Induction Period (IP)||0
8652991|NCT01647516|21360396|P5|NOT COMPLETED|Induction Period (IP)||0
8652992|NCT01647516|21360397|P4|NOT COMPLETED|Induction Period (IP)||0
8652993|NCT01647516|21360398|P3|NOT COMPLETED|Induction Period (IP)||4
8652994|NCT01647516|21360399|P2|NOT COMPLETED|Induction Period (IP)||3
8652995|NCT01647516|21360400|P1|NOT COMPLETED|Induction Period (IP)||6
8652996|NCT01647516|21360395|P6|COMPLETED|Induction Period (IP)||0
8652997|NCT01647516|21360396|P5|COMPLETED|Induction Period (IP)||0
8652998|NCT01647516|21360397|P4|COMPLETED|Induction Period (IP)||0
8652999|NCT01647516|21360398|P3|COMPLETED|Induction Period (IP)||63
8653000|NCT01647516|21360399|P2|COMPLETED|Induction Period (IP)||63
8653001|NCT01647516|21360400|P1|COMPLETED|Induction Period (IP)||60
8653002|NCT01647516|21360395|P6|Received Study Drug|Induction Period (IP)||0
8653003|NCT01647516|21360396|P5|Received Study Drug|Induction Period (IP)||0
8653004|NCT01647516|21360397|P4|Received Study Drug|Induction Period (IP)||0
8653005|NCT01647516|21360398|P3|Received Study Drug|Induction Period (IP)||67
8653006|NCT01647516|21360399|P2|Received Study Drug|Induction Period (IP)||65
8653007|NCT01647516|21360400|P1|Received Study Drug|Induction Period (IP)||65
8653008|NCT01647516|21360395|P6|STARTED|Induction Period (IP)||0
8653009|NCT01647516|21360396|P5|STARTED|Induction Period (IP)||0
8653010|NCT01647516|21360397|P4|STARTED|Induction Period (IP)||0
8653011|NCT01647516|21360398|P3|STARTED|Induction Period (IP)||67
8653012|NCT01647516|21360399|P2|STARTED|Induction Period (IP)||66
8653013|NCT01647516|21360400|P1|STARTED|Induction Period (IP)||66
8653014|NCT01524887|21360442|P3|NOT COMPLETED|Overall Study||86
8653015|NCT01524887|21360443|P2|NOT COMPLETED|Overall Study||90
8653016|NCT01524887|21360444|P1|NOT COMPLETED|Overall Study||85
8653017|NCT01524887|21360442|P3|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
8653018|NCT01524887|21360443|P2|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
8653019|NCT01524887|21360444|P1|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
8653020|NCT01524887|21360442|P3|Received Treatment|Overall Study||83
8653021|NCT01524887|21360443|P2|Received Treatment|Overall Study||85
8653022|NCT01524887|21360444|P1|Received Treatment|Overall Study||83
8653023|NCT01524887|21360442|P3|STARTED|Overall Study||86
8653024|NCT01524887|21360443|P2|STARTED|Overall Study||90
8653025|NCT01524887|21360444|P1|STARTED|Overall Study||85
8653026|NCT01507896|21360488|P1|NOT COMPLETED|Overall Study||2
8653027|NCT01507896|21360488|P1|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
8653115|NCT00985426|21360758|P2|COMPLETED|Overall Study||219
8653028|NCT01507896|21360488|P1|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
8653029|NCT01485796|21360529|P1|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
8653030|NCT01485796|21360529|P1|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
8653031|NCT01485796|21360529|P1|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
8653032|NCT01485796|21360529|P1|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
8653033|NCT01485796|21360529|P1|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
8653034|NCT01485796|21360529|P1|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
8653035|NCT01485796|21360529|P1|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
8653036|NCT01485796|21360529|P1|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
8653037|NCT01485796|21360529|P1|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
8653038|NCT01485796|21360529|P1|STARTED|Overall Trial (Incl. Safety Follow-up)||37
8653039|NCT01485796|21360529|P1|NOT COMPLETED|Period 2: Epoch 2||35
8653040|NCT01485796|21360529|P1|COMPLETED|Period 2: Epoch 2||1
8653041|NCT01485796|21360529|P1|Treated in Epoch 2|Period 2: Epoch 2||36
8653042|NCT01485796|21360529|P1|STARTED|Period 2: Epoch 2||36
8653043|NCT01485796|21360529|P1|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
8653044|NCT01485796|21360529|P1|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
8653045|NCT01485796|21360529|P1|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
8653046|NCT01485796|21360529|P1|STARTED|Period 1: Epoch 1 (Ramp-up)||37
8653047|NCT01463007|21360551|P1|NOT COMPLETED|Overall Study||1
8653048|NCT01463007|21360551|P1|COMPLETED|Overall Study||40
8653049|NCT01463007|21360551|P1|STARTED|Overall Study||41
8653050|NCT01459614|21360559|P2|NOT COMPLETED|Overall Study||0
8653051|NCT01459614|21360560|P1|NOT COMPLETED|Overall Study||1
8653052|NCT01459614|21360559|P2|COMPLETED|Overall Study||10
8653053|NCT01459614|21360560|P1|COMPLETED|Overall Study||28
8653054|NCT01459614|21360559|P2|STARTED|Overall Study||10
8653055|NCT01459614|21360560|P1|STARTED|Overall Study||29
8653056|NCT01410227|21360572|P4|NOT COMPLETED|Overall Study||1
8653057|NCT01410227|21360573|P3|NOT COMPLETED|Overall Study||2
8653058|NCT01410227|21360574|P2|NOT COMPLETED|Overall Study||0
8653059|NCT01410227|21360575|P1|NOT COMPLETED|Overall Study||4
8653060|NCT01410227|21360572|P4|COMPLETED|Overall Study||5
8653061|NCT01410227|21360573|P3|COMPLETED|Overall Study||13
8653062|NCT01410227|21360574|P2|COMPLETED|Overall Study||8
8653063|NCT01410227|21360575|P1|COMPLETED|Overall Study||4
8653064|NCT01410227|21360572|P4|STARTED|Overall Study||6
8653065|NCT01410227|21360573|P3|STARTED|Overall Study||15
8653066|NCT01410227|21360574|P2|STARTED|Overall Study||8
8653067|NCT01410227|21360575|P1|STARTED|Overall Study||8
8653068|NCT01217827|21360647|P2|NOT COMPLETED|Overall Study||0
8653069|NCT01217827|21360648|P1|NOT COMPLETED|Overall Study||0
8653070|NCT01217827|21360647|P2|COMPLETED|Overall Study||43
8653071|NCT01217827|21360648|P1|COMPLETED|Overall Study||46
8653072|NCT01217827|21360647|P2|STARTED|Overall Study||43
8653073|NCT01217827|21360648|P1|STARTED|Overall Study||46
8653074|NCT01201850|21360654|P1|NOT COMPLETED|Overall Study||4
8653075|NCT01201850|21360654|P1|COMPLETED|Overall Study||3
8653076|NCT01201850|21360654|P1|STARTED|Overall Study||7
8653077|NCT01185028|21360662|P1|NOT COMPLETED|Overall Study||4
8653078|NCT01185028|21360662|P1|COMPLETED|Overall Study||4
8653079|NCT01185028|21360662|P1|STARTED|Overall Study||8
8653080|NCT01175213|21360671|P2|NOT COMPLETED|Safety Follow-up||0
8653081|NCT01175213|21360672|P1|NOT COMPLETED|Safety Follow-up||1
8653082|NCT01175213|21360671|P2|COMPLETED|Safety Follow-up||3
8653083|NCT01175213|21360672|P1|COMPLETED|Safety Follow-up||47
8653084|NCT01175213|21360671|P2|STARTED|Safety Follow-up||3
8653085|NCT01175213|21360672|P1|STARTED|Safety Follow-up||48
8653086|NCT01175213|21360671|P2|NOT COMPLETED|IGSC, 10%/rHuPH20||0
8653087|NCT01175213|21360672|P1|NOT COMPLETED|IGSC, 10%/rHuPH20||15
8653088|NCT01175213|21360671|P2|COMPLETED|IGSC, 10%/rHuPH20||3
8653089|NCT01175213|21360672|P1|COMPLETED|IGSC, 10%/rHuPH20||48
8653090|NCT01175213|21360671|P2|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
8653091|NCT01175213|21360672|P1|STARTED|IGSC, 10%/rHuPH20||63
8653098|NCT00988429|21360743|P3|NOT COMPLETED|Overall Study||69
8653099|NCT00988429|21360744|P2|NOT COMPLETED|Overall Study||43
8653100|NCT00988429|21360745|P1|NOT COMPLETED|Overall Study||37
8653101|NCT00988429|21360743|P3|COMPLETED|Overall Study||142
8653102|NCT00988429|21360744|P2|COMPLETED|Overall Study||173
8653103|NCT00988429|21360745|P1|COMPLETED|Overall Study||189
8653104|NCT00988429|21360743|P3|Intention-to-treat (ITT) Population|Overall Study||205
8653105|NCT00988429|21360744|P2|Intention-to-treat (ITT) Population|Overall Study||215
8653106|NCT00988429|21360745|P1|Intention-to-treat (ITT) Population|Overall Study||220
8653107|NCT00988429|21360743|P3|Safety Population|Overall Study||210
8653108|NCT00988429|21360744|P2|Safety Population|Overall Study||216
8653109|NCT00988429|21360745|P1|Safety Population|Overall Study||224
8653110|NCT00988429|21360743|P3|STARTED|Overall Study||211
8653111|NCT00988429|21360744|P2|STARTED|Overall Study||216
8653112|NCT00988429|21360745|P1|STARTED|Overall Study||226
8653113|NCT00985426|21360758|P2|NOT COMPLETED|Overall Study||44
8653114|NCT00985426|21360759|P1|NOT COMPLETED|Overall Study||43
8653116|NCT00985426|21360759|P1|COMPLETED|Overall Study||215
8653117|NCT00985426|21360758|P2|STARTED|Overall Study||263
8653118|NCT00985426|21360759|P1|STARTED|Overall Study||258
8653125|NCT00922974|21360795|P2|NOT COMPLETED|Phase III Component||6
8653126|NCT00922974|21360796|P1|NOT COMPLETED|Phase III Component||8
8653127|NCT00922974|21360795|P2|COMPLETED|Phase III Component||130
8653128|NCT00922974|21360796|P1|COMPLETED|Phase III Component||209
8653129|NCT00922974|21360795|P2|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||100
8653130|NCT00922974|21360796|P1|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||152
8653131|NCT00922974|21360795|P2|Eligible, Treated, Adverse Event Data|Phase III Component||83
8653132|NCT00922974|21360796|P1|Eligible, Treated, Adverse Event Data|Phase III Component||148
8653133|NCT00922974|21360795|P2|Eligible With Adverse Event Data|Phase III Component||117
8653134|NCT00922974|21360796|P1|Eligible With Adverse Event Data|Phase III Component||202
8653135|NCT00922974|21360795|P2|Eligible With 3 mo. FACT-G Data|Phase III Component||58
8653136|NCT00922974|21360796|P1|Eligible With 3 mo. FACT-G Data|Phase III Component||87
8653137|NCT00922974|21360795|P2|Eligible With 3 mo. NRPS Data|Phase III Component||76
8653138|NCT00922974|21360796|P1|Eligible With 3 mo. NRPS Data|Phase III Component||139
8653139|NCT00922974|21360795|P2|Eligible|Phase III Component||130
8653140|NCT00922974|21360796|P1|Eligible|Phase III Component||209
8653141|NCT00922974|21360795|P2|STARTED|Phase III Component||136
8653142|NCT00922974|21360796|P1|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217
8653143|NCT00922974|21360795|P2|NOT COMPLETED|Phase II Component||0
8653144|NCT00922974|21360796|P1|NOT COMPLETED|Phase II Component||7
8653145|NCT00922974|21360795|P2|COMPLETED|Phase II Component||0
8653146|NCT00922974|21360796|P1|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39
8653147|NCT00922974|21360795|P2|Eligible, Treated, Adverse Event Data|Phase II Component||0
8653148|NCT00922974|21360796|P1|Eligible, Treated, Adverse Event Data|Phase II Component||34
8653149|NCT00922974|21360795|P2|Eligible and Started Treatment|Phase II Component||0
8653150|NCT00922974|21360796|P1|Eligible and Started Treatment|Phase II Component||39
8653151|NCT00922974|21360795|P2|Eligible|Phase II Component||0
8653152|NCT00922974|21360796|P1|Eligible|Phase II Component||44
8653153|NCT00922974|21360795|P2|STARTED|Phase II Component||0
8653154|NCT00922974|21360796|P1|STARTED|Phase II Component||46
8653155|NCT00921115|21360822|P1|NOT COMPLETED|Overall Study||0
8653156|NCT00921115|21360822|P1|COMPLETED|Overall Study||42
8653157|NCT00921115|21360822|P1|STARTED|Overall Study||42
8653158|NCT00916032|21360826|P2|NOT COMPLETED|Overall Study||0
8653159|NCT00916032|21360827|P1|NOT COMPLETED|Overall Study||0
8653160|NCT00916032|21360826|P2|COMPLETED|Overall Study||11
8653161|NCT00916032|21360827|P1|COMPLETED|Overall Study||12
8653162|NCT00916032|21360826|P2|STARTED|Overall Study||11
8653163|NCT00916032|21360827|P1|STARTED|Overall Study||12
8653164|NCT00854087|21360869|P2|NOT COMPLETED|Overall Study||19
8653165|NCT00854087|21360870|P1|NOT COMPLETED|Overall Study||19
8653166|NCT00854087|21360869|P2|COMPLETED|Overall Study||40
8653167|NCT00854087|21360870|P1|COMPLETED|Overall Study||40
8653168|NCT00854087|21360869|P2|STARTED|Overall Study||59
8653169|NCT00854087|21360870|P1|STARTED|Overall Study||59
8653170|NCT00851721|21360880|P2|NOT COMPLETED|Overall Study||1
8653171|NCT00851721|21360881|P1|NOT COMPLETED|Overall Study||2
8653172|NCT00851721|21360880|P2|COMPLETED|Overall Study||16
8653173|NCT00851721|21360881|P1|COMPLETED|Overall Study||17
8653174|NCT00851721|21360880|P2|STARTED|Overall Study||17
8653175|NCT00851721|21360881|P1|STARTED|Overall Study||19
8653176|NCT00818662|21360973|P4|NOT COMPLETED|Overall Study||16
8653177|NCT00818662|21360974|P3|NOT COMPLETED|Overall Study||9
8653178|NCT00818662|21360975|P2|NOT COMPLETED|Overall Study||33
8653179|NCT00818662|21360976|P1|NOT COMPLETED|Overall Study||23
8653180|NCT00818662|21360973|P4|COMPLETED|Overall Study||47
8653181|NCT00818662|21360974|P3|COMPLETED|Overall Study||49
8653182|NCT00818662|21360975|P2|COMPLETED|Overall Study||102
8653183|NCT00818662|21360976|P1|COMPLETED|Overall Study||104
8653184|NCT00818662|21360973|P4|STARTED|Overall Study||63
8653185|NCT00818662|21360974|P3|STARTED|Overall Study||58
8653186|NCT00818662|21360975|P2|STARTED|Overall Study||135
8653187|NCT00818662|21360976|P1|STARTED|Overall Study||127
8653188|NCT00814320|21361064|P2|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
8653189|NCT00814320|21361065|P1|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
8653190|NCT00814320|21361064|P2|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
8653191|NCT00814320|21361065|P1|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
8653192|NCT00814320|21361064|P2|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
8653193|NCT00814320|21361065|P1|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
8653194|NCT00814320|21361064|P2|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
8653195|NCT00814320|21361065|P1|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
8653196|NCT00814320|21361064|P2|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
8653197|NCT00814320|21361065|P1|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
8653198|NCT00814320|21361064|P2|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
8653199|NCT00814320|21361065|P1|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
8653200|NCT00814320|21361064|P2|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
8653201|NCT00814320|21361065|P1|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
8653202|NCT00814320|21361064|P2|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
8653203|NCT00814320|21361065|P1|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
8653204|NCT00814320|21361064|P2|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
8653205|NCT00814320|21361065|P1|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
8653206|NCT00814320|21361064|P2|NOT COMPLETED|Epoch 1 (IV Treatment)||2
8653207|NCT00814320|21361065|P1|NOT COMPLETED|Epoch 1 (IV Treatment)||1
8653208|NCT00814320|21361064|P2|COMPLETED|Epoch 1 (IV Treatment)||71
8653209|NCT00814320|21361065|P1|COMPLETED|Epoch 1 (IV Treatment)||13
8653210|NCT00814320|21361064|P2|STARTED|Epoch 1 (IV Treatment)||73
8653211|NCT00814320|21361065|P1|STARTED|Epoch 1 (IV Treatment)||14
8653212|NCT00666406|21361193|P2|NOT COMPLETED|Second PK Infusion||0
8653213|NCT00666406|21361194|P1|NOT COMPLETED|Second PK Infusion||0
8653214|NCT00666406|21361193|P2|COMPLETED|Second PK Infusion||3
8653215|NCT00666406|21361194|P1|COMPLETED|Second PK Infusion||6
8653216|NCT00666406|21361193|P2|STARTED|Second PK Infusion||3
8653217|NCT00666406|21361194|P1|STARTED|Second PK Infusion||6
8653218|NCT00666406|21361193|P2|NOT COMPLETED|First PK Infusion||0
8653219|NCT00666406|21361194|P1|NOT COMPLETED|First PK Infusion||0
8653220|NCT00666406|21361193|P2|COMPLETED|First PK Infusion||3
8653221|NCT00666406|21361194|P1|COMPLETED|First PK Infusion||6
8653222|NCT00666406|21361193|P2|STARTED|First PK Infusion||3
8653223|NCT00666406|21361194|P1|STARTED|First PK Infusion||6
8653224|NCT00666263|21361269|P2|NOT COMPLETED|End of Study Visit||0
8653225|NCT00666263|21361270|P1|NOT COMPLETED|End of Study Visit||0
8653226|NCT00666263|21361269|P2|COMPLETED|End of Study Visit||22
8653227|NCT00666263|21361270|P1|COMPLETED|End of Study Visit||22
8653228|NCT00666263|21361269|P2|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
8653229|NCT00666263|21361270|P1|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
8653230|NCT00666263|21361269|P2|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
8653231|NCT00666263|21361270|P1|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
8653232|NCT00666263|21361269|P2|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
8653233|NCT00666263|21361270|P1|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
8653234|NCT00666263|21361269|P2|STARTED|Study Part 5 (Stabilization Phase 3)||21
8653235|NCT00666263|21361270|P1|STARTED|Study Part 5 (Stabilization Phase 3)||21
8653236|NCT00666263|21361269|P2|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
8653237|NCT00666263|21361270|P1|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
8653238|NCT00666263|21361269|P2|COMPLETED|Study Part 4 (Cross-over Period 2)||21
8653239|NCT00666263|21361270|P1|COMPLETED|Study Part 4 (Cross-over Period 2)||21
8653240|NCT00666263|21361269|P2|STARTED|Study Part 4 (Cross-over Period 2)||21
8653241|NCT00666263|21361270|P1|STARTED|Study Part 4 (Cross-over Period 2)||22
8653242|NCT00666263|21361269|P2|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
8653243|NCT00666263|21361270|P1|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
8653244|NCT00666263|21361269|P2|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
8653245|NCT00666263|21361270|P1|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
8653246|NCT00666263|21361269|P2|STARTED|Study Part 3 (Stabilization Phase 2)||21
8653247|NCT00666263|21361270|P1|STARTED|Study Part 3 (Stabilization Phase 2)||22
8653248|NCT00666263|21361269|P2|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
8653249|NCT00666263|21361270|P1|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
8653250|NCT00666263|21361269|P2|COMPLETED|Study Part 2 (Cross-over Period 1)||21
8653251|NCT00666263|21361270|P1|COMPLETED|Study Part 2 (Cross-over Period 1)||22
8653252|NCT00666263|21361269|P2|STARTED|Study Part 2 (Cross-over Period 1)||21
8653253|NCT00666263|21361270|P1|STARTED|Study Part 2 (Cross-over Period 1)||22
8653254|NCT00666263|21361269|P2|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
8653255|NCT00666263|21361270|P1|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
8653256|NCT00666263|21361269|P2|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
8653257|NCT00666263|21361270|P1|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
8653258|NCT00666263|21361269|P2|STARTED|Study Part 1 (Stabilization Phase 1)||22
8653259|NCT00666263|21361270|P1|STARTED|Study Part 1 (Stabilization Phase 1)||22
8653260|NCT00582205|21361412|P1|NOT COMPLETED|Overall Study||10
8653261|NCT00582205|21361412|P1|COMPLETED|Overall Study||11
8653262|NCT00582205|21361412|P1|STARTED|Overall Study||21
8653263|NCT00579553|21361419|P2|NOT COMPLETED|Overall Study||13
8653264|NCT00579553|21361420|P1|NOT COMPLETED|Overall Study||16
8653265|NCT00579553|21361419|P2|COMPLETED|Overall Study||79
8653266|NCT00579553|21361420|P1|COMPLETED|Overall Study||66
8653267|NCT00579553|21361419|P2|STARTED|Overall Study||92
8653268|NCT00579553|21361420|P1|STARTED|Overall Study||82
8653269|NCT00564278|21361434|P2|NOT COMPLETED|Overall Study||42
8653270|NCT00564278|21361435|P1|NOT COMPLETED|Overall Study||47
8653271|NCT00564278|21361434|P2|COMPLETED|Overall Study||56
8653272|NCT00564278|21361435|P1|COMPLETED|Overall Study||50
8653273|NCT00564278|21361434|P2|STARTED|Overall Study||98
8653274|NCT00564278|21361435|P1|STARTED|Overall Study||97
8653275|NCT00546871|21361451|P2|NOT COMPLETED|Study Extension Period||1
8653276|NCT00546871|21361452|P1|NOT COMPLETED|Study Extension Period||1
8653277|NCT00546871|21361451|P2|COMPLETED|Study Extension Period||25
8653278|NCT00546871|21361452|P1|COMPLETED|Study Extension Period||9
8653279|NCT00546871|21361451|P2|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
8653280|NCT00546871|21361452|P1|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
8653281|NCT00546871|21361451|P2|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
8653282|NCT00546871|21361452|P1|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
8653283|NCT00546871|21361451|P2|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
8653284|NCT00546871|21361452|P1|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
8653285|NCT00546871|21361451|P2|STARTED|Part 3b - SC IGIV 12 Weeks||32
8653286|NCT00546871|21361452|P1|STARTED|Part 3b - SC IGIV 12 Weeks||12
8653287|NCT00546871|21361451|P2|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
8653288|NCT00546871|21361452|P1|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
8653289|NCT00546871|21361451|P2|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
8653290|NCT00546871|21361452|P1|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
8653291|NCT00546871|21361451|P2|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
8653292|NCT00546871|21361452|P1|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
8653293|NCT00546871|21361451|P2|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
8653294|NCT00546871|21361452|P1|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
8653295|NCT00546871|21361451|P2|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
8653296|NCT00546871|21361452|P1|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
8653297|NCT00546871|21361451|P2|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
8653298|NCT00546871|21361452|P1|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
8653299|NCT00546871|21361451|P2|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
8653300|NCT00546871|21361452|P1|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
8653301|NCT00546871|21361451|P2|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
8653302|NCT00546871|21361452|P1|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
8653303|NCT00546871|21361451|P2|STARTED|Part 1 - IV Infusions of IGIV, PK||35
8653304|NCT00546871|21361452|P1|STARTED|Part 1 - IV Infusions of IGIV, PK||14
8653305|NCT00529958|21361558|P3|NOT COMPLETED|5-Year Follow-up||1
8653306|NCT00529958|21361559|P2|NOT COMPLETED|5-Year Follow-up||3
8653307|NCT00529958|21361560|P1|NOT COMPLETED|5-Year Follow-up||3
8653308|NCT00529958|21361558|P3|COMPLETED|5-Year Follow-up||107
8653309|NCT00529958|21361559|P2|COMPLETED|5-Year Follow-up||105
8653310|NCT00529958|21361560|P1|COMPLETED|5-Year Follow-up||103
8653311|NCT00529958|21361558|P3|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108
8653312|NCT00529958|21361559|P2|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108
8653313|NCT00529958|21361560|P1|STARTED|5-Year Follow-up||106
8653314|NCT00529958|21361558|P3|NOT COMPLETED|2-Year Follow-up||2
8653315|NCT00529958|21361559|P2|NOT COMPLETED|2-Year Follow-up||2
8653316|NCT00529958|21361560|P1|NOT COMPLETED|2-Year Follow-up||4
8653317|NCT00529958|21361558|P3|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108
8653318|NCT00529958|21361559|P2|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108
8653319|NCT00529958|21361560|P1|COMPLETED|2-Year Follow-up||106
8653320|NCT00529958|21361558|P3|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110
8653321|NCT00529958|21361559|P2|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110
8653322|NCT00529958|21361560|P1|STARTED|2-Year Follow-up||110
8653323|NCT00357656|21361603|P2|NOT COMPLETED|Overall Study||3
8653324|NCT00357656|21361604|P1|NOT COMPLETED|Overall Study||0
8653325|NCT00357656|21361603|P2|COMPLETED|Overall Study||29
8653326|NCT00357656|21361604|P1|COMPLETED|Overall Study||31
8653327|NCT00357656|21361603|P2|STARTED|Overall Study||32
8653328|NCT00357656|21361604|P1|STARTED|Overall Study||31
8653356|NCT00243386|21361696|P3|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
8653357|NCT00243386|21361697|P2|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
8653358|NCT00243386|21361698|P1|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
8653359|NCT00243386|21361696|P3|COMPLETED|PK-Driven or Standard Prophylaxis||32
8653360|NCT00243386|21361697|P2|COMPLETED|PK-Driven or Standard Prophylaxis||31
8653361|NCT00243386|21361698|P1|COMPLETED|PK-Driven or Standard Prophylaxis||0
8653362|NCT00243386|21361696|P3|STARTED|PK-Driven or Standard Prophylaxis||32
8653363|NCT00243386|21361697|P2|STARTED|PK-Driven or Standard Prophylaxis||34
8653364|NCT00243386|21361698|P1|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8653365|NCT00243386|21361696|P3|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
8653366|NCT00243386|21361697|P2|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
8653367|NCT00243386|21361698|P1|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
8653368|NCT00243386|21361696|P3|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
8653369|NCT00243386|21361697|P2|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
8653370|NCT00243386|21361698|P1|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
8653371|NCT00243386|21361696|P3|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8653372|NCT00243386|21361697|P2|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8653373|NCT00243386|21361698|P1|STARTED|End of Part 1, But Prior to Prophylaxis||69
8653374|NCT00243386|21361696|P3|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
8653375|NCT00243386|21361697|P2|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
8653376|NCT00243386|21361698|P1|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
8653377|NCT00243386|21361696|P3|COMPLETED|On-Demand Regimen (Study Part 1)||0
8653378|NCT00243386|21361697|P2|COMPLETED|On-Demand Regimen (Study Part 1)||0
8653379|NCT00243386|21361698|P1|COMPLETED|On-Demand Regimen (Study Part 1)||69
8653380|NCT00243386|21361696|P3|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8653381|NCT00243386|21361697|P2|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
8653382|NCT00243386|21361698|P1|STARTED|On-Demand Regimen (Study Part 1)||73
8653383|NCT00236938|21361765|P2|NOT COMPLETED|Overall Study||20
8653384|NCT00236938|21361766|P1|NOT COMPLETED|Overall Study||13
8653385|NCT00236938|21361765|P2|COMPLETED|Overall Study||26
8653386|NCT00236938|21361766|P1|COMPLETED|Overall Study||62
8653387|NCT00236938|21361765|P2|STARTED|Overall Study||46
8653388|NCT00236938|21361766|P1|STARTED|Overall Study||75
8653404|NCT03907072|21361837|P3|NOT COMPLETED|Overall Study||2
8653405|NCT03907072|21361838|P2|NOT COMPLETED|Overall Study||2
8653406|NCT03907072|21361839|P1|NOT COMPLETED|Overall Study||2
8653407|NCT03907072|21361837|P3|COMPLETED|Overall Study||0
8653408|NCT03907072|21361838|P2|COMPLETED|Overall Study||0
8653409|NCT03907072|21361839|P1|COMPLETED|Overall Study||0
8653410|NCT03907072|21361837|P3|STARTED|Overall Study||2
8653411|NCT03907072|21361838|P2|STARTED|Overall Study||2
8653412|NCT03907072|21361839|P1|STARTED|Overall Study||2
8653413|NCT03875859|21361874|P1|NOT COMPLETED|Overall Study||0
8653414|NCT03875859|21361874|P1|COMPLETED|Overall Study||4
8653415|NCT03875859|21361874|P1|STARTED|Overall Study||4
8653416|NCT03841331|21361882|P2|NOT COMPLETED|Overall Study||10
8653417|NCT03841331|21361883|P1|NOT COMPLETED|Overall Study||9
8653418|NCT03841331|21361882|P2|COMPLETED|Overall Study||106
8653419|NCT03841331|21361883|P1|COMPLETED|Overall Study||108
8653420|NCT03841331|21361882|P2|STARTED|Overall Study||116
8653421|NCT03841331|21361883|P1|STARTED|Overall Study||117
8653422|NCT03710590|21361905|P2|NOT COMPLETED|Overall Study||8
8653423|NCT03710590|21361906|P1|NOT COMPLETED|Overall Study||10
8653424|NCT03710590|21361905|P2|COMPLETED|Overall Study||15
8653425|NCT03710590|21361906|P1|COMPLETED|Overall Study||12
8653426|NCT03710590|21361905|P2|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||15
8653427|NCT03710590|21361906|P1|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||12
8653428|NCT03710590|21361905|P2|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||15
8653429|NCT03710590|21361906|P1|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||12
8653430|NCT03710590|21361905|P2|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||15
8653431|NCT03710590|21361906|P1|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||12
8653432|NCT03710590|21361905|P2|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||15
8653433|NCT03710590|21361906|P1|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||12
8653434|NCT03710590|21361905|P2|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||15
8653435|NCT03710590|21361906|P1|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||12
8653436|NCT03710590|21361905|P2|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||15
8653437|NCT03710590|21361906|P1|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||12
8653438|NCT03710590|21361905|P2|STARTED|Overall Study||23
8653439|NCT03710590|21361906|P1|STARTED|Overall Study||22
8653440|NCT03710187|21361920|P2|NOT COMPLETED|Overall Study||0
8653441|NCT03710187|21361921|P1|NOT COMPLETED|Overall Study||0
8653442|NCT03710187|21361920|P2|COMPLETED|Overall Study||43
8653443|NCT03710187|21361921|P1|COMPLETED|Overall Study||41
8653444|NCT03710187|21361920|P2|STARTED|Overall Study||43
8653445|NCT03710187|21361921|P1|STARTED|Overall Study||41
8653446|NCT03677401|21361929|P2|NOT COMPLETED|Overall Study||18
8653447|NCT03677401|21361930|P1|NOT COMPLETED|Overall Study||10
8653448|NCT03677401|21361929|P2|COMPLETED|Overall Study||129
8653449|NCT03677401|21361930|P1|COMPLETED|Overall Study||138
8653450|NCT03677401|21361929|P2|STARTED|Overall Study||147
8653451|NCT03677401|21361930|P1|STARTED|Overall Study||148
8653452|NCT03546816|21361956|P2|NOT COMPLETED|Overall Study||19
8653453|NCT03546816|21361957|P1|NOT COMPLETED|Overall Study||21
8653454|NCT03546816|21361956|P2|COMPLETED|Overall Study||124
8653455|NCT03546816|21361957|P1|COMPLETED|Overall Study||121
8653456|NCT03546816|21361956|P2|STARTED|Overall Study||143
8653457|NCT03546816|21361957|P1|STARTED|Overall Study||142
8653458|NCT03542266|21361981|P1|NOT COMPLETED|Post-treatment Follow-up Phase||15
8653459|NCT03542266|21361981|P1|COMPLETED|Post-treatment Follow-up Phase||0
8653460|NCT03542266|21361981|P1|STARTED|Post-treatment Follow-up Phase|Three subjects did not enter follow-up: 1 had PD at EOT, 2 withdrew consent|15
8653461|NCT03542266|21361981|P1|NOT COMPLETED|Treatment Phase||3
8653462|NCT03542266|21361981|P1|COMPLETED|Treatment Phase||18
8653463|NCT03542266|21361981|P1|STARTED|Treatment Phase||21
8653464|NCT03540160|21361985|P1|NOT COMPLETED|Overall Study||379
8653465|NCT03540160|21361985|P1|COMPLETED|Overall Study||179
8653466|NCT03540160|21361985|P1|STARTED|Overall Study||558
8653467|NCT03470493|21361989|P1|NOT COMPLETED|Overall Study||0
8653468|NCT03470493|21361989|P1|COMPLETED|Overall Study||130
8653469|NCT03470493|21361989|P1|Met Primary Endpoint|Overall Study||80
8653470|NCT03470493|21361989|P1|STARTED|Overall Study||130
8653471|NCT03387267|21361996|P1|NOT COMPLETED|Overall Study||14
8653472|NCT03387267|21361996|P1|COMPLETED|Overall Study||438
8653473|NCT03387267|21361996|P1|STARTED|Overall Study||452
8653474|NCT03365154|21362005|P1|NOT COMPLETED|Overall Study||0
8653475|NCT03365154|21362005|P1|COMPLETED|Overall Study||10
8653476|NCT03365154|21362005|P1|STARTED|Overall Study||10
8653477|NCT03343639|21362014|P2|NOT COMPLETED|Overall Study||12
8653478|NCT03343639|21362015|P1|NOT COMPLETED|Overall Study||14
8653479|NCT03343639|21362014|P2|COMPLETED|Overall Study||90
8653480|NCT03343639|21362015|P1|COMPLETED|Overall Study||88
8653481|NCT03343639|21362014|P2|STARTED|Overall Study||102
8653482|NCT03343639|21362015|P1|STARTED|Overall Study||102
8653483|NCT03282591|21362029|P2|NOT COMPLETED|Overall Study||4
8653484|NCT03282591|21362030|P1|NOT COMPLETED|Overall Study||4
8653485|NCT03282591|21362029|P2|COMPLETED|Overall Study||89
8653486|NCT03282591|21362030|P1|COMPLETED|Overall Study||88
8653487|NCT03282591|21362029|P2|STARTED|Overall Study||93
8653488|NCT03282591|21362030|P1|STARTED|Overall Study||92
8653489|NCT03038399|21362048|P4|NOT COMPLETED|Overall Study||2
8653490|NCT03038399|21362049|P3|NOT COMPLETED|Overall Study||1
8653491|NCT03038399|21362050|P2|NOT COMPLETED|Overall Study||1
8653492|NCT03038399|21362051|P1|NOT COMPLETED|Overall Study||1
8653493|NCT03038399|21362048|P4|COMPLETED|Overall Study|Subjects escalated from lower dose groups|9
8653494|NCT03038399|21362049|P3|COMPLETED|Overall Study||11
8653495|NCT03038399|21362050|P2|COMPLETED|Overall Study||11
8653496|NCT03038399|21362051|P1|COMPLETED|Overall Study||10
8653497|NCT03038399|21362048|P4|STARTED|Overall Study||11
8653498|NCT03038399|21362049|P3|STARTED|Overall Study||12
8653499|NCT03038399|21362050|P2|STARTED|Overall Study||12
8653500|NCT03038399|21362051|P1|STARTED|Overall Study||11
8653501|NCT03017508|21362070|P2|NOT COMPLETED|Overall Study||0
8653502|NCT03017508|21362071|P1|NOT COMPLETED|Overall Study||0
8653503|NCT03017508|21362070|P2|COMPLETED|Overall Study||10
8653504|NCT03017508|21362071|P1|COMPLETED|Overall Study||12
8653505|NCT03017508|21362070|P2|Second Intervention (1 Day)|Overall Study||10
8653506|NCT03017508|21362071|P1|Second Intervention (1 Day)|Overall Study||12
8653507|NCT03017508|21362070|P2|Washout (2-10 Days)|Overall Study||10
8653508|NCT03017508|21362071|P1|Washout (2-10 Days)|Overall Study||12
8653509|NCT03017508|21362070|P2|First Intervention (1 Day)|Overall Study||10
8653510|NCT03017508|21362071|P1|First Intervention (1 Day)|Overall Study||12
8653511|NCT03017508|21362070|P2|STARTED|Overall Study||10
8653512|NCT03017508|21362071|P1|STARTED|Overall Study||12
8653513|NCT03006887|21362077|P1|NOT COMPLETED|Overall Study||1
8653514|NCT03006887|21362077|P1|COMPLETED|Overall Study||5
8653515|NCT03006887|21362077|P1|STARTED|Overall Study||6
8653516|NCT02975206|21362106|P3|NOT COMPLETED|Overall Study||17
8653517|NCT02975206|21362107|P2|NOT COMPLETED|Overall Study||17
8653518|NCT02975206|21362108|P1|NOT COMPLETED|Overall Study||27
8653519|NCT02975206|21362106|P3|COMPLETED|Overall Study||145
8653520|NCT02975206|21362107|P2|COMPLETED|Overall Study||144
8653521|NCT02975206|21362108|P1|COMPLETED|Overall Study||134
8653522|NCT02975206|21362106|P3|STARTED|Overall Study||162
8653523|NCT02975206|21362107|P2|STARTED|Overall Study||161
8653524|NCT02975206|21362108|P1|STARTED|Overall Study||161
8653525|NCT02966184|21362124|P2|NOT COMPLETED|Overall Study||8
8653526|NCT02966184|21362125|P1|NOT COMPLETED|Overall Study||0
8653527|NCT02966184|21362124|P2|COMPLETED|Overall Study||0
8653528|NCT02966184|21362125|P1|COMPLETED|Overall Study||0
8653529|NCT02966184|21362124|P2|STARTED|Overall Study||8
8653530|NCT02966184|21362125|P1|STARTED|Overall Study||0
8653563|NCT02853305|21362359|P3|NOT COMPLETED|Overall Study||352
8653564|NCT02853305|21362360|P2|NOT COMPLETED|Overall Study||307
8653565|NCT02853305|21362361|P1|NOT COMPLETED|Overall Study||351
8653566|NCT02853305|21362359|P3|COMPLETED|Overall Study||0
8653567|NCT02853305|21362360|P2|COMPLETED|Overall Study||0
8653568|NCT02853305|21362361|P1|COMPLETED|Overall Study||0
8653569|NCT02853305|21362359|P3|Treated|Overall Study||342
8653570|NCT02853305|21362360|P2|Treated|Overall Study||302
8653571|NCT02853305|21362361|P1|Treated|Overall Study|Includes 2 participants randomized to Pembrolizumab alone|349
8653572|NCT02853305|21362359|P3|STARTED|Overall Study||352
8653573|NCT02853305|21362360|P2|STARTED|Overall Study||307
8653574|NCT02853305|21362361|P1|STARTED|Overall Study||351
8653575|NCT02790437|21362428|P2|NOT COMPLETED|Overall Study||0
8653576|NCT02790437|21362429|P1|NOT COMPLETED|Overall Study||3
8653577|NCT02790437|21362428|P2|COMPLETED|Overall Study||3
8653578|NCT02790437|21362429|P1|COMPLETED|Overall Study||13
8653579|NCT02790437|21362428|P2|STARTED|Overall Study||3
8653580|NCT02790437|21362429|P1|STARTED|Overall Study||16
8653584|NCT02693717|21362462|P1|NOT COMPLETED|Overall Study||0
8653585|NCT02693717|21362462|P1|COMPLETED|Overall Study||7
8653586|NCT02693717|21362462|P1|STARTED|Overall Study||7
8653596|NCT02342015|21362554|P1|NOT COMPLETED|Overall Study||0
8653597|NCT02342015|21362554|P1|COMPLETED|Overall Study||20
8653598|NCT02342015|21362554|P1|STARTED|Overall Study||20
8653599|NCT02260531|21362562|P3|NOT COMPLETED|Overall Study||0
8653600|NCT02260531|21362563|P2|NOT COMPLETED|Overall Study||0
8653601|NCT02260531|21362564|P1|NOT COMPLETED|Overall Study||0
8653602|NCT02260531|21362562|P3|COMPLETED|Overall Study||8
8653603|NCT02260531|21362563|P2|COMPLETED|Overall Study||7
8653604|NCT02260531|21362564|P1|COMPLETED|Overall Study||21
8653605|NCT02260531|21362562|P3|STARTED|Overall Study||8
8653606|NCT02260531|21362563|P2|STARTED|Overall Study||7
8653607|NCT02260531|21362564|P1|STARTED|Overall Study||21
8653608|NCT02196324|21362595|P2|NOT COMPLETED|Overall Study||8
8653609|NCT02196324|21362596|P1|NOT COMPLETED|Overall Study||15
8653610|NCT02196324|21362595|P2|COMPLETED|Overall Study||57
8653611|NCT02196324|21362596|P1|COMPLETED|Overall Study||48
8653612|NCT02196324|21362595|P2|STARTED|Overall Study||65
8653613|NCT02196324|21362596|P1|STARTED|Overall Study||63
8653614|NCT02078284|21362639|P5|NOT COMPLETED|Overall Study||0
8653615|NCT02078284|21362640|P4|NOT COMPLETED|Overall Study||0
8653616|NCT02078284|21362641|P3|NOT COMPLETED|Overall Study||0
8653617|NCT02078284|21362642|P2|NOT COMPLETED|Overall Study||0
8653618|NCT02078284|21362643|P1|NOT COMPLETED|Overall Study||0
8653619|NCT02078284|21362639|P5|COMPLETED|Overall Study||4
8653620|NCT02078284|21362640|P4|COMPLETED|Overall Study||6
8653621|NCT02078284|21362641|P3|COMPLETED|Overall Study||6
8653622|NCT02078284|21362642|P2|COMPLETED|Overall Study||7
8653623|NCT02078284|21362643|P1|COMPLETED|Overall Study||5
8653624|NCT02078284|21362639|P5|STARTED|Overall Study||4
8653625|NCT02078284|21362640|P4|STARTED|Overall Study||6
8653626|NCT02078284|21362641|P3|STARTED|Overall Study||6
8653627|NCT02078284|21362642|P2|STARTED|Overall Study||7
8653628|NCT02078284|21362643|P1|STARTED|Overall Study||5
8653629|NCT01917968|21362677|P2|NOT COMPLETED|Overall Study||84
8653630|NCT01917968|21362678|P1|NOT COMPLETED|Overall Study||54
8653631|NCT01917968|21362677|P2|COMPLETED|Overall Study||401
8653632|NCT01917968|21362678|P1|COMPLETED|Overall Study||171
8653633|NCT01917968|21362677|P2|STARTED|Overall Study||485
8653634|NCT01917968|21362678|P1|STARTED|Overall Study||225
8653665|NCT01736475|21362758|P2|NOT COMPLETED|Overall Study||0
8653666|NCT01736475|21362759|P1|NOT COMPLETED|Overall Study||12
8653667|NCT01736475|21362758|P2|COMPLETED|Overall Study||17
8653668|NCT01736475|21362759|P1|COMPLETED|Overall Study||109
8653669|NCT01736475|21362758|P2|STARTED|Overall Study||17
8653670|NCT01736475|21362759|P1|STARTED|Overall Study||121
8653671|NCT01488994|21362814|P2|NOT COMPLETED|Overall Study||1
8653672|NCT01488994|21362815|P1|NOT COMPLETED|Overall Study||0
8653673|NCT01488994|21362814|P2|COMPLETED|Overall Study||11
8653674|NCT01488994|21362815|P1|COMPLETED|Overall Study||11
8653675|NCT01488994|21362814|P2|STARTED|Overall Study||12
8653676|NCT01488994|21362815|P1|STARTED|Overall Study||11
8653677|NCT01286779|21362902|P1|NOT COMPLETED|Overall Study||19
8653678|NCT01286779|21362902|P1|COMPLETED|Overall Study||96
8653679|NCT01286779|21362902|P1|STARTED|Overall Study||115
8653680|NCT01174446|21362952|P4|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
8653681|NCT01174446|21362953|P3|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
8653682|NCT01174446|21362954|P2|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
8653683|NCT01174446|21362955|P1|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
8653684|NCT01174446|21362952|P4|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
8653685|NCT01174446|21362953|P3|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
8653686|NCT01174446|21362954|P2|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
8653687|NCT01174446|21362955|P1|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
8653688|NCT01174446|21362952|P4|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
8653689|NCT01174446|21362953|P3|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
8653690|NCT01174446|21362954|P2|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
8653691|NCT01174446|21362955|P1|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
8653692|NCT01174446|21362952|P4|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
8653693|NCT01174446|21362953|P3|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
8653694|NCT01174446|21362954|P2|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
8653695|NCT01174446|21362955|P1|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
8653696|NCT01174446|21362952|P4|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
8653697|NCT01174446|21362953|P3|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
8653698|NCT01174446|21362954|P2|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
8653699|NCT01174446|21362955|P1|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
8653700|NCT01174446|21362952|P4|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
8653701|NCT01174446|21362953|P3|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
8653702|NCT01174446|21362954|P2|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
8653703|NCT01174446|21362955|P1|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
8653704|NCT01174446|21362952|P4|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8653705|NCT01174446|21362953|P3|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8653706|NCT01174446|21362954|P2|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8653707|NCT01174446|21362955|P1|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8653708|NCT01174446|21362952|P4|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8653709|NCT01174446|21362953|P3|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
8653710|NCT01174446|21362954|P2|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
8653711|NCT01174446|21362955|P1|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
8653712|NCT01174446|21362952|P4|STARTED|Part 1 -Pharmacokinetic Crossover||0
8653713|NCT01174446|21362953|P3|STARTED|Part 1 -Pharmacokinetic Crossover||0
8653714|NCT01174446|21362954|P2|STARTED|Part 1 -Pharmacokinetic Crossover||14
8653715|NCT01174446|21362955|P1|STARTED|Part 1 -Pharmacokinetic Crossover||14
8653716|NCT01131325|21363142|P1|NOT COMPLETED|Overall Study||3
8653717|NCT01131325|21363142|P1|COMPLETED|Overall Study||0
8653718|NCT01131325|21363142|P1|STARTED|Overall Study||3
8653719|NCT00457626|21363152|P1|NOT COMPLETED|Overall Study||6
8653720|NCT00457626|21363152|P1|COMPLETED|Overall Study||60
8653721|NCT00457626|21363152|P1|STARTED|Overall Study||66
8653722|NCT00382070|21363160|P2|NOT COMPLETED|Overall Study||30
8653723|NCT00382070|21363161|P1|NOT COMPLETED|Overall Study||33
8653724|NCT00382070|21363160|P2|COMPLETED|Overall Study||1953
8653725|NCT00382070|21363161|P1|COMPLETED|Overall Study||1950
8653726|NCT00382070|21363160|P2|STARTED|Overall Study||1983
8653727|NCT00382070|21363161|P1|STARTED|Overall Study||1983
8653728|NCT04525157|21363177|P1|NOT COMPLETED|Overall Study||3
8653729|NCT04525157|21363177|P1|COMPLETED|Overall Study||15
8653730|NCT04525157|21363177|P1|STARTED|Overall Study||18
8653731|NCT04407507|21363183|P2|NOT COMPLETED|Overall Study||1
8653732|NCT04407507|21363184|P1|NOT COMPLETED|Overall Study||0
8653733|NCT04407507|21363183|P2|COMPLETED|Overall Study||32
8653734|NCT04407507|21363184|P1|COMPLETED|Overall Study||33
8653735|NCT04407507|21363183|P2|STARTED|Overall Study||33
8653736|NCT04407507|21363184|P1|STARTED|Overall Study||33
8653737|NCT04331899|21363196|P2|NOT COMPLETED|Overall Study||45
8653738|NCT04331899|21363197|P1|NOT COMPLETED|Overall Study||44
8653739|NCT04331899|21363196|P2|COMPLETED|Overall Study||15
8653740|NCT04331899|21363197|P1|COMPLETED|Overall Study||16
8653741|NCT04331899|21363196|P2|Completed the Trial Portion of the Study|Overall Study||58
8653742|NCT04331899|21363197|P1|Completed the Trial Portion of the Study|Overall Study||58
8653743|NCT04331899|21363196|P2|STARTED|Overall Study||60
8653744|NCT04331899|21363197|P1|STARTED|Overall Study||60
8653745|NCT03935126|21363211|P1|NOT COMPLETED|Overall Study||3
8653746|NCT03935126|21363211|P1|COMPLETED|Overall Study||0
8653747|NCT03935126|21363211|P1|STARTED|Overall Study||3
8653748|NCT03642717|21363225|P1|NOT COMPLETED|Overall Study||38
8653749|NCT03642717|21363225|P1|COMPLETED|Overall Study||620
8653750|NCT03642717|21363225|P1|STARTED|Overall Study||658
8653751|NCT03635320|21363243|P2|NOT COMPLETED|Overall Study||8
8653752|NCT03635320|21363244|P1|NOT COMPLETED|Overall Study||12
8653753|NCT03635320|21363243|P2|COMPLETED|Overall Study||86
8653754|NCT03635320|21363244|P1|COMPLETED|Overall Study||82
8653755|NCT03635320|21363243|P2|PPS|Overall Study|6 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject didn't undergo the evaluation or laboratory examination required by the clinical trial, 1 subject violated the inclusion/exclusion criteria and 1 subject used the device beyond the scope of the specifications, which were excluded from the PPS.|83
8653756|NCT03635320|21363244|P1|PPS|Overall Study|11 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject had a risk of unblinding, which was excluded from the PPS.|81
8653757|NCT03635320|21363243|P2|FAS|Overall Study|2 subjects were not implant the device|92
8653758|NCT03635320|21363244|P1|FAS|Overall Study|1 subject was not implanted the device|93
8653759|NCT03635320|21363243|P2|STARTED|Overall Study||94
8653760|NCT03635320|21363244|P1|STARTED|Overall Study||94
8653761|NCT03595215|21363250|P1|NOT COMPLETED|Overall Study||8
8653762|NCT03595215|21363250|P1|COMPLETED|Overall Study||10
8653763|NCT03595215|21363250|P1|STARTED|Overall Study||18
8653764|NCT03461965|21363258|P2|NOT COMPLETED|Overall Study||0
8653765|NCT03461965|21363259|P1|NOT COMPLETED|Overall Study||0
8653766|NCT03461965|21363258|P2|COMPLETED|Overall Study||40
8653767|NCT03461965|21363259|P1|COMPLETED|Overall Study||42
8653768|NCT03461965|21363258|P2|STARTED|Overall Study||40
8653769|NCT03461965|21363259|P1|STARTED|Overall Study||42
8653770|NCT03412604|21363273|P1|NOT COMPLETED|Overall Study||1
8653771|NCT03412604|21363273|P1|COMPLETED|Overall Study||4
8653772|NCT03412604|21363273|P1|STARTED|Overall Study||5
8653773|NCT03352245|21363283|P2|NOT COMPLETED|Overall Study||1
8653774|NCT03352245|21363284|P1|NOT COMPLETED|Overall Study||0
8653775|NCT03352245|21363283|P2|COMPLETED|Overall Study||19
8653776|NCT03352245|21363284|P1|COMPLETED|Overall Study||20
8653777|NCT03352245|21363283|P2|STARTED|Overall Study||20
8653778|NCT03352245|21363284|P1|STARTED|Overall Study||20
8653779|NCT03327220|21363342|P2|NOT COMPLETED|Overall Study||4
8653780|NCT03327220|21363343|P1|NOT COMPLETED|Overall Study||5
8653781|NCT03327220|21363342|P2|COMPLETED|Overall Study||58
8653782|NCT03327220|21363343|P1|COMPLETED|Overall Study||57
8653783|NCT03327220|21363342|P2|Safety Population: Received Study Treatment|Overall Study||60
8653784|NCT03327220|21363343|P1|Safety Population: Received Study Treatment|Overall Study||59
8653785|NCT03327220|21363342|P2|STARTED|Overall Study||62
8653786|NCT03327220|21363343|P1|STARTED|Overall Study||62
8653787|NCT03292809|21363357|P2|NOT COMPLETED|Overall Study||3
8653788|NCT03292809|21363358|P1|NOT COMPLETED|Overall Study||7
8653789|NCT03292809|21363357|P2|COMPLETED|Overall Study||163
8653790|NCT03292809|21363358|P1|COMPLETED|Overall Study||155
8653791|NCT03292809|21363357|P2|STARTED|Overall Study||166
8653792|NCT03292809|21363358|P1|STARTED|Overall Study||162
8653793|NCT03160287|21363366|P1|NOT COMPLETED|Overall Study||2
8653794|NCT03160287|21363366|P1|COMPLETED|Overall Study||22
8653795|NCT03160287|21363366|P1|STARTED|Overall Study||24
8653796|NCT03150589|21363376|P2|NOT COMPLETED|Overall Study||27
8653797|NCT03150589|21363377|P1|NOT COMPLETED|Overall Study||44
8653798|NCT03150589|21363376|P2|COMPLETED|Overall Study||327
8653799|NCT03150589|21363377|P1|COMPLETED|Overall Study||307
8653800|NCT03150589|21363376|P2|STARTED|Overall Study||354
8653801|NCT03150589|21363377|P1|STARTED|Overall Study||351
8653802|NCT02918968|21363387|P2|NOT COMPLETED|2nd Line AAT||12
8653803|NCT02918968|21363388|P1|NOT COMPLETED|2nd Line AAT||25
8653804|NCT02918968|21363387|P2|COMPLETED|2nd Line AAT||73
8653805|NCT02918968|21363388|P1|COMPLETED|2nd Line AAT||23
8653806|NCT02918968|21363387|P2|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|85
8653807|NCT02918968|21363388|P1|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|48
8653808|NCT02918968|21363387|P2|NOT COMPLETED|1st Line AAT||11
8653809|NCT02918968|21363388|P1|NOT COMPLETED|1st Line AAT||29
8653810|NCT02918968|21363387|P2|COMPLETED|1st Line AAT||93
8653811|NCT02918968|21363388|P1|COMPLETED|1st Line AAT||73
8653812|NCT02918968|21363387|P2|Maintained 1st Line AAT Without Progression|1st Line AAT||8
8653813|NCT02918968|21363388|P1|Maintained 1st Line AAT Without Progression|1st Line AAT||25
8653814|NCT02918968|21363387|P2|STARTED|1st Line AAT||104
8653815|NCT02918968|21363388|P1|STARTED|1st Line AAT||102
8653822|NCT02485704|21363420|P2|NOT COMPLETED|Overall Study||8
8653823|NCT02485704|21363421|P1|NOT COMPLETED|Overall Study||5
8653824|NCT02485704|21363420|P2|COMPLETED|Overall Study||118
8653825|NCT02485704|21363421|P1|COMPLETED|Overall Study||149
8653826|NCT02485704|21363420|P2|STARTED|Overall Study||126
8653827|NCT02485704|21363421|P1|STARTED|Overall Study||154
8653828|NCT02432287|21363429|P2|NOT COMPLETED|Second Intervention||0
8653829|NCT02432287|21363430|P1|NOT COMPLETED|Second Intervention||0
8653830|NCT02432287|21363429|P2|COMPLETED|Second Intervention||7
8653831|NCT02432287|21363430|P1|COMPLETED|Second Intervention||7
8653832|NCT02432287|21363429|P2|STARTED|Second Intervention||7
8653833|NCT02432287|21363430|P1|STARTED|Second Intervention||7
8653834|NCT02432287|21363429|P2|NOT COMPLETED|Washout Period||0
8653835|NCT02432287|21363430|P1|NOT COMPLETED|Washout Period||0
8653836|NCT02432287|21363429|P2|COMPLETED|Washout Period||7
8653837|NCT02432287|21363430|P1|COMPLETED|Washout Period||7
8653838|NCT02432287|21363429|P2|STARTED|Washout Period||7
8653839|NCT02432287|21363430|P1|STARTED|Washout Period||7
8653840|NCT02432287|21363429|P2|NOT COMPLETED|First Intervention||1
8653841|NCT02432287|21363430|P1|NOT COMPLETED|First Intervention||0
8653842|NCT02432287|21363429|P2|COMPLETED|First Intervention||7
8653843|NCT02432287|21363430|P1|COMPLETED|First Intervention||8
8653844|NCT02432287|21363429|P2|STARTED|First Intervention||8
8653845|NCT02432287|21363430|P1|STARTED|First Intervention||8
8653846|NCT02412228|21363438|P1|NOT COMPLETED|Overall Study||0
8653847|NCT02412228|21363438|P1|COMPLETED|Overall Study||12
8653848|NCT02412228|21363438|P1|STARTED|Overall Study||12
8653849|NCT02222896|21363443|P3|NOT COMPLETED|Groin||40
8653850|NCT02222896|21363444|P2|NOT COMPLETED|Groin||9
8653851|NCT02222896|21363445|P1|NOT COMPLETED|Groin||43
8653852|NCT02222896|21363443|P3|COMPLETED|Groin||210
8653853|NCT02222896|21363444|P2|COMPLETED|Groin||39
8653854|NCT02222896|21363445|P1|COMPLETED|Groin||211
8653855|NCT02222896|21363443|P3|STARTED|Groin||250
8653856|NCT02222896|21363444|P2|STARTED|Groin||48
8653857|NCT02222896|21363445|P1|STARTED|Groin||254
8653858|NCT02222896|21363443|P3|NOT COMPLETED|Abdomen||32
8653859|NCT02222896|21363444|P2|NOT COMPLETED|Abdomen||10
8653860|NCT02222896|21363445|P1|NOT COMPLETED|Abdomen||34
8653861|NCT02222896|21363443|P3|COMPLETED|Abdomen||221
8653862|NCT02222896|21363444|P2|COMPLETED|Abdomen||38
8653863|NCT02222896|21363445|P1|COMPLETED|Abdomen||219
8653864|NCT02222896|21363443|P3|STARTED|Abdomen||253
8653865|NCT02222896|21363444|P2|STARTED|Abdomen||48
8653866|NCT02222896|21363445|P1|STARTED|Abdomen||253
8653867|NCT02056288|21363458|P2|NOT COMPLETED|48-Hour Post-Discharge Data||20
8653868|NCT02056288|21363459|P1|NOT COMPLETED|48-Hour Post-Discharge Data||14
8653869|NCT02056288|21363458|P2|COMPLETED|48-Hour Post-Discharge Data||18
8653870|NCT02056288|21363459|P1|COMPLETED|48-Hour Post-Discharge Data||21
8653871|NCT02056288|21363458|P2|STARTED|48-Hour Post-Discharge Data||38
8653872|NCT02056288|21363459|P1|STARTED|48-Hour Post-Discharge Data||35
8653873|NCT02056288|21363458|P2|NOT COMPLETED|In-Hospital Data||0
8653874|NCT02056288|21363459|P1|NOT COMPLETED|In-Hospital Data||5
8653875|NCT02056288|21363458|P2|COMPLETED|In-Hospital Data||38
8653876|NCT02056288|21363459|P1|COMPLETED|In-Hospital Data||35
8653877|NCT02056288|21363458|P2|STARTED|In-Hospital Data||38
8653878|NCT02056288|21363459|P1|STARTED|In-Hospital Data||40
8653879|NCT01889862|21363475|P5|NOT COMPLETED|Part 4 (Up to 274 Weeks)||30
8653880|NCT01889862|21363476|P4|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
8653881|NCT01889862|21363477|P3|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
8653882|NCT01889862|21363478|P2|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
8653883|NCT01889862|21363479|P1|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
8653884|NCT01889862|21363475|P5|COMPLETED|Part 4 (Up to 274 Weeks)||172
8653885|NCT01889862|21363476|P4|COMPLETED|Part 4 (Up to 274 Weeks)||0
8653886|NCT01889862|21363477|P3|COMPLETED|Part 4 (Up to 274 Weeks)||0
8653887|NCT01889862|21363478|P2|COMPLETED|Part 4 (Up to 274 Weeks)||0
8653888|NCT01889862|21363479|P1|COMPLETED|Part 4 (Up to 274 Weeks)||0
8653889|NCT01889862|21363475|P5|STARTED|Part 4 (Up to 274 Weeks)|Total of 202 subjects from 165-301, Part 1, 2, 3 entered Part 4 to receive dose of up to 60mg/kg.|202
8653890|NCT01889862|21363476|P4|STARTED|Part 4 (Up to 274 Weeks)||0
8653891|NCT01889862|21363477|P3|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
8653892|NCT01889862|21363478|P2|STARTED|Part 4 (Up to 274 Weeks)||0
8653893|NCT01889862|21363479|P1|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
8653894|NCT01889862|21363475|P5|NOT COMPLETED|Part 3A/B (6 Week)||0
8653895|NCT01889862|21363476|P4|NOT COMPLETED|Part 3A/B (6 Week)||0
8653896|NCT01889862|21363477|P3|NOT COMPLETED|Part 3A/B (6 Week)||0
8653897|NCT01889862|21363478|P2|NOT COMPLETED|Part 3A/B (6 Week)||0
8653898|NCT01889862|21363479|P1|NOT COMPLETED|Part 3A/B (6 Week)||0
8653899|NCT01889862|21363475|P5|COMPLETED|Part 3A/B (6 Week)||0
8653900|NCT01889862|21363476|P4|COMPLETED|Part 3A/B (6 Week)||0
8653901|NCT01889862|21363477|P3|COMPLETED|Part 3A/B (6 Week)||41
8653902|NCT01889862|21363478|P2|COMPLETED|Part 3A/B (6 Week)||0
8653903|NCT01889862|21363479|P1|COMPLETED|Part 3A/B (6 Week)||48
8653904|NCT01889862|21363475|P5|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
8653905|NCT01889862|21363476|P4|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
8653906|NCT01889862|21363477|P3|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||26
8653907|NCT01889862|21363478|P2|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
8653908|NCT01889862|21363479|P1|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||34
8653909|NCT01889862|21363475|P5|STARTED|Part 3A/B (6 Week)||0
8653910|NCT01889862|21363476|P4|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|0
8653911|NCT01889862|21363477|P3|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|41
8653912|NCT01889862|21363478|P2|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|0
8653913|NCT01889862|21363479|P1|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|48
8653914|NCT01889862|21363475|P5|NOT COMPLETED|Part 2 (8 Weeks)||0
8653915|NCT01889862|21363476|P4|NOT COMPLETED|Part 2 (8 Weeks)||0
8653916|NCT01889862|21363477|P3|NOT COMPLETED|Part 2 (8 Weeks)||1
8653917|NCT01889862|21363478|P2|NOT COMPLETED|Part 2 (8 Weeks)||0
8653918|NCT01889862|21363479|P1|NOT COMPLETED|Part 2 (8 Weeks)||0
8653919|NCT01889862|21363475|P5|COMPLETED|Part 2 (8 Weeks)||0
8653920|NCT01889862|21363476|P4|COMPLETED|Part 2 (8 Weeks)||14
8653921|NCT01889862|21363477|P3|COMPLETED|Part 2 (8 Weeks)||31
8653922|NCT01889862|21363478|P2|COMPLETED|Part 2 (8 Weeks)||15
8653923|NCT01889862|21363479|P1|COMPLETED|Part 2 (8 Weeks)||34
8653924|NCT01889862|21363475|P5|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||0
8653925|NCT01889862|21363476|P4|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
8653926|NCT01889862|21363477|P3|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
8653927|NCT01889862|21363478|P2|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
8653928|NCT01889862|21363479|P1|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
8653929|NCT01889862|21363475|P5|STARTED|Part 2 (8 Weeks)||0
8653930|NCT01889862|21363476|P4|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|14
8653931|NCT01889862|21363477|P3|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|32
8653932|NCT01889862|21363478|P2|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|15
8653933|NCT01889862|21363479|P1|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|34
8653934|NCT01889862|21363475|P5|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
8653935|NCT01889862|21363476|P4|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
8653936|NCT01889862|21363477|P3|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
8653937|NCT01889862|21363478|P2|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
8653938|NCT01889862|21363479|P1|NOT COMPLETED|Part 1 (Up to 13 Weeks)||12
8653939|NCT01889862|21363475|P5|COMPLETED|Part 1 (Up to 13 Weeks)||0
8653940|NCT01889862|21363476|P4|COMPLETED|Part 1 (Up to 13 Weeks)||0
8653941|NCT01889862|21363477|P3|COMPLETED|Part 1 (Up to 13 Weeks)||78
8653942|NCT01889862|21363478|P2|COMPLETED|Part 1 (Up to 13 Weeks)||0
8653943|NCT01889862|21363479|P1|COMPLETED|Part 1 (Up to 13 Weeks)|Out of 164, total 12 subjects have not completed Part 1.|74
8653944|NCT01889862|21363475|P5|STARTED|Part 1 (Up to 13 Weeks)||0
8653945|NCT01889862|21363476|P4|STARTED|Part 1 (Up to 13 Weeks)||0
8653946|NCT01889862|21363477|P3|STARTED|Part 1 (Up to 13 Weeks)||78
8653947|NCT01889862|21363478|P2|STARTED|Part 1 (Up to 13 Weeks)||0
8653948|NCT01889862|21363479|P1|STARTED|Part 1 (Up to 13 Weeks)||86
8653949|NCT01629381|21363522|P2|NOT COMPLETED|Overall Study||5
8653950|NCT01629381|21363523|P1|NOT COMPLETED|Overall Study||2
8653951|NCT01629381|21363522|P2|COMPLETED|Overall Study||114
8653952|NCT01629381|21363523|P1|COMPLETED|Overall Study||120
8653953|NCT01629381|21363522|P2|STARTED|Overall Study||119
8653954|NCT01629381|21363523|P1|STARTED|Overall Study||122
8653955|NCT01311648|21363538|P2|NOT COMPLETED|Extension Study||11
8653956|NCT01311648|21363539|P1|NOT COMPLETED|Extension Study||1
8653957|NCT01311648|21363538|P2|COMPLETED|Extension Study||25
8653958|NCT01311648|21363539|P1|COMPLETED|Extension Study||45
8653959|NCT01311648|21363538|P2|STARTED|Extension Study||36
8653960|NCT01311648|21363539|P1|STARTED|Extension Study||46
8653961|NCT01311648|21363538|P2|NOT COMPLETED|Main Study||21
8653962|NCT01311648|21363539|P1|NOT COMPLETED|Main Study||0
8653963|NCT01311648|21363538|P2|COMPLETED|Main Study||22
8653964|NCT01311648|21363539|P1|COMPLETED|Main Study||51
8653965|NCT01311648|21363538|P2|Started 6-12 Years|Main Study||0
8653966|NCT01311648|21363539|P1|Started 6-12 Years|Main Study||26
8653967|NCT01311648|21363538|P2|Started 0-<6 Years|Main Study||43
8653968|NCT01311648|21363539|P1|Started 0-<6 Years|Main Study||25
8653969|NCT01311648|21363538|P2|STARTED|Main Study||43
8653970|NCT01311648|21363539|P1|STARTED|Main Study||51
8653971|NCT01207492|21363586|P1|NOT COMPLETED|Overall Study||15
8653972|NCT01207492|21363586|P1|COMPLETED|Overall Study||2
8653973|NCT01207492|21363586|P1|STARTED|Overall Study||17
8653974|NCT00832780|21363592|P1|NOT COMPLETED|Overall Study||25
8653975|NCT00832780|21363592|P1|COMPLETED|Overall Study||19
8653976|NCT00832780|21363592|P1|STARTED|Overall Study||44
8653980|NCT00392015|21363612|P6|NOT COMPLETED|Overall Study||0
8653981|NCT00392015|21363613|P5|NOT COMPLETED|Overall Study||3
8653982|NCT00392015|21363614|P4|NOT COMPLETED|Overall Study||1
8653983|NCT00392015|21363615|P3|NOT COMPLETED|Overall Study||4
8653984|NCT00392015|21363616|P2|NOT COMPLETED|Overall Study||0
8653985|NCT00392015|21363617|P1|NOT COMPLETED|Overall Study||2
8653986|NCT00392015|21363612|P6|COMPLETED|Overall Study||6
8653987|NCT00392015|21363613|P5|COMPLETED|Overall Study||12
8653988|NCT00392015|21363614|P4|COMPLETED|Overall Study||5
8653989|NCT00392015|21363615|P3|COMPLETED|Overall Study||16
8653990|NCT00392015|21363616|P2|COMPLETED|Overall Study||6
8653991|NCT00392015|21363617|P1|COMPLETED|Overall Study||4
8653992|NCT00392015|21363612|P6|STARTED|Overall Study||6
8653993|NCT00392015|21363613|P5|STARTED|Overall Study||15
8653994|NCT00392015|21363614|P4|STARTED|Overall Study||6
8653995|NCT00392015|21363615|P3|STARTED|Overall Study||20
8653996|NCT00392015|21363616|P2|STARTED|Overall Study||6
8653997|NCT00392015|21363617|P1|STARTED|Overall Study||6
8653998|NCT04138043|21363645|P2|NOT COMPLETED|Overall Study||1
8653999|NCT04138043|21363646|P1|NOT COMPLETED|Overall Study||0
8654000|NCT04138043|21363645|P2|COMPLETED|Overall Study||6
8654001|NCT04138043|21363646|P1|COMPLETED|Overall Study||2
8654002|NCT04138043|21363645|P2|STARTED|Overall Study||7
8654003|NCT04138043|21363646|P1|STARTED|Overall Study||2
8654016|NCT03792191|21363717|P2|NOT COMPLETED|Overall Study||0
8654017|NCT03792191|21363718|P1|NOT COMPLETED|Overall Study||0
8654018|NCT03792191|21363717|P2|COMPLETED|Overall Study||140
8654019|NCT03792191|21363718|P1|COMPLETED|Overall Study||140
8654020|NCT03792191|21363717|P2|STARTED|Overall Study||140
8654021|NCT03792191|21363718|P1|STARTED|Overall Study||140
8654031|NCT03506724|21363760|P2|NOT COMPLETED|Overall Study||0
8654032|NCT03506724|21363761|P1|NOT COMPLETED|Overall Study||0
8654033|NCT03506724|21363760|P2|COMPLETED|Overall Study||55
8654034|NCT03506724|21363761|P1|COMPLETED|Overall Study||54
8654035|NCT03506724|21363760|P2|STARTED|Overall Study||55
8654036|NCT03506724|21363761|P1|STARTED|Overall Study||54
8654037|NCT03487718|21363775|P2|NOT COMPLETED|Overall Study||4
8654038|NCT03487718|21363776|P1|NOT COMPLETED|Overall Study||1
8654039|NCT03487718|21363775|P2|COMPLETED|Overall Study||11
8654040|NCT03487718|21363776|P1|COMPLETED|Overall Study||11
8654041|NCT03487718|21363775|P2|STARTED|Overall Study||15
8654042|NCT03487718|21363776|P1|STARTED|Overall Study||12
8654046|NCT03427268|21363796|P1|NOT COMPLETED|Overall Study||32
8654047|NCT03427268|21363796|P1|COMPLETED|Overall Study||0
8654048|NCT03427268|21363796|P1|STARTED|Overall Study||32
8654049|NCT03381196|21363805|P2|NOT COMPLETED|Overall Study||19
8654050|NCT03381196|21363806|P1|NOT COMPLETED|Overall Study||16
8654051|NCT03381196|21363805|P2|COMPLETED|Overall Study||258
8654052|NCT03381196|21363806|P1|COMPLETED|Overall Study||260
8654053|NCT03381196|21363805|P2|Treated|Overall Study||271
8654054|NCT03381196|21363806|P1|Treated|Overall Study||273
8654055|NCT03381196|21363805|P2|STARTED|Overall Study||277
8654056|NCT03381196|21363806|P1|STARTED|Overall Study||276
8654057|NCT03333057|21363830|P3|NOT COMPLETED|Overall Study||3
8654058|NCT03333057|21363831|P2|NOT COMPLETED|Overall Study||4
8654059|NCT03333057|21363832|P1|NOT COMPLETED|Overall Study||6
8654060|NCT03333057|21363830|P3|COMPLETED|Overall Study||108
8654061|NCT03333057|21363831|P2|COMPLETED|Overall Study||110
8654062|NCT03333057|21363832|P1|COMPLETED|Overall Study||105
8654063|NCT03333057|21363830|P3|STARTED|Overall Study||111
8654064|NCT03333057|21363831|P2|STARTED|Overall Study||114
8654065|NCT03333057|21363832|P1|STARTED|Overall Study||111
8654066|NCT03328325|21363840|P1|NOT COMPLETED|Overall Study||11
8654067|NCT03328325|21363840|P1|COMPLETED|Overall Study||141
8654068|NCT03328325|21363840|P1|STARTED|Overall Study||152
8654069|NCT03298984|21363853|P4|NOT COMPLETED|Overall Study||15
8654070|NCT03298984|21363854|P3|NOT COMPLETED|Overall Study||2
8654071|NCT03298984|21363855|P2|NOT COMPLETED|Overall Study||1
8654072|NCT03298984|21363856|P1|NOT COMPLETED|Overall Study||1
8654073|NCT03298984|21363853|P4|COMPLETED|Overall Study||8
8654074|NCT03298984|21363854|P3|COMPLETED|Overall Study||1
8654075|NCT03298984|21363855|P2|COMPLETED|Overall Study||2
8654076|NCT03298984|21363856|P1|COMPLETED|Overall Study||2
8654077|NCT03298984|21363853|P4|STARTED|Overall Study||23
8654078|NCT03298984|21363854|P3|STARTED|Overall Study||3
8654079|NCT03298984|21363855|P2|STARTED|Overall Study||3
8654080|NCT03298984|21363856|P1|STARTED|Overall Study||3
8654081|NCT03110770|21363881|P5|NOT COMPLETED|Overall Study||123
8654082|NCT03110770|21363882|P4|NOT COMPLETED|Overall Study||133
8654083|NCT03110770|21363883|P3|NOT COMPLETED|Overall Study||2
8654084|NCT03110770|21363884|P2|NOT COMPLETED|Overall Study||0
8654085|NCT03110770|21363885|P1|NOT COMPLETED|Overall Study||6
8654086|NCT03110770|21363881|P5|COMPLETED|Overall Study||1045
8654087|NCT03110770|21363882|P4|COMPLETED|Overall Study||1037
8654088|NCT03110770|21363883|P3|COMPLETED|Overall Study||28
8654089|NCT03110770|21363884|P2|COMPLETED|Overall Study||30
8654090|NCT03110770|21363885|P1|COMPLETED|Overall Study||24
8654091|NCT03110770|21363881|P5|Received Third Product Administration|Overall Study||1107
8654092|NCT03110770|21363882|P4|Received Third Product Administration|Overall Study||1107
8654093|NCT03110770|21363883|P3|Received Third Product Administration|Overall Study||28
8654094|NCT03110770|21363884|P2|Received Third Product Administration|Overall Study||27
8654095|NCT03110770|21363885|P1|Received Third Product Administration|Overall Study||29
8654096|NCT03110770|21363881|P5|Received Second Product Administration|Overall Study||1127
8654097|NCT03110770|21363882|P4|Received Second Product Administration|Overall Study||1126
8654098|NCT03110770|21363883|P3|Received Second Product Administration|Overall Study||29
8654099|NCT03110770|21363884|P2|Received Second Product Administration|Overall Study||29
8654100|NCT03110770|21363885|P1|Received Second Product Administration|Overall Study||30
8654101|NCT03110770|21363881|P5|Received First Product Administration|Overall Study||1161
8654102|NCT03110770|21363882|P4|Received First Product Administration|Overall Study||1162
8654103|NCT03110770|21363883|P3|Received First Product Administration|Overall Study||30
8654104|NCT03110770|21363884|P2|Received First Product Administration|Overall Study||30
8654105|NCT03110770|21363885|P1|Received First Product Administration|Overall Study||30
8654106|NCT03110770|21363881|P5|STARTED|Overall Study||1168
8654107|NCT03110770|21363882|P4|STARTED|Overall Study||1170
8654108|NCT03110770|21363883|P3|STARTED|Overall Study||30
8654109|NCT03110770|21363884|P2|STARTED|Overall Study||30
8654110|NCT03110770|21363885|P1|STARTED|Overall Study||30
8654111|NCT03092219|21363934|P2|NOT COMPLETED|Overall Study||4
8654112|NCT03092219|21363935|P1|NOT COMPLETED|Overall Study||7
8654113|NCT03092219|21363934|P2|COMPLETED|Overall Study||48
8654114|NCT03092219|21363935|P1|COMPLETED|Overall Study||143
8654115|NCT03092219|21363934|P2|Pooled SAFT Population|Overall Study|2 subjects did not receive treatment at Visit 1b.|50
8654116|NCT03092219|21363935|P1|Pooled SAFT Population|Overall Study||150
8654117|NCT03092219|21363934|P2|Primary Analysis Endpoint|Overall Study||51
8654118|NCT03092219|21363935|P1|Primary Analysis Endpoint|Overall Study||150
8654119|NCT03092219|21363934|P2|Baseline / ITT Population|Overall Study|Subject randomized to No Treatment group but received treatment at Visit 1.|51
8654120|NCT03092219|21363935|P1|Baseline / ITT Population|Overall Study||150
8654121|NCT03092219|21363934|P2|STARTED|Overall Study||52
8654122|NCT03092219|21363935|P1|STARTED|Overall Study||150
8654123|NCT03042767|21363978|P2|NOT COMPLETED|Overall Study||2
8654124|NCT03042767|21363979|P1|NOT COMPLETED|Overall Study||1
8654125|NCT03042767|21363978|P2|COMPLETED|Overall Study||11
8654126|NCT03042767|21363979|P1|COMPLETED|Overall Study||11
8654127|NCT03042767|21363978|P2|STARTED|Overall Study||13
8654128|NCT03042767|21363979|P1|STARTED|Overall Study||12
8654129|NCT03041025|21364018|P3|NOT COMPLETED|Overall Study||2
8654130|NCT03041025|21364019|P2|NOT COMPLETED|Overall Study||0
8654131|NCT03041025|21364020|P1|NOT COMPLETED|Overall Study||1
8654132|NCT03041025|21364018|P3|COMPLETED|Overall Study||22
8654133|NCT03041025|21364019|P2|COMPLETED|Overall Study||3
8654134|NCT03041025|21364020|P1|COMPLETED|Overall Study||7
8654135|NCT03041025|21364018|P3|STARTED|Overall Study||24
8654136|NCT03041025|21364019|P2|STARTED|Overall Study||3
8654137|NCT03041025|21364020|P1|STARTED|Overall Study||8
8654141|NCT02863354|21364120|P2|NOT COMPLETED|Year 2||2
8654142|NCT02863354|21364121|P1|NOT COMPLETED|Year 2||2
8654143|NCT02863354|21364120|P2|COMPLETED|Year 2||16
8654144|NCT02863354|21364121|P1|COMPLETED|Year 2||17
8654145|NCT02863354|21364120|P2|STARTED|Year 2||18
8654146|NCT02863354|21364121|P1|STARTED|Year 2||19
8654147|NCT02863354|21364120|P2|NOT COMPLETED|Year 1||2
8654148|NCT02863354|21364121|P1|NOT COMPLETED|Year 1||4
8654149|NCT02863354|21364120|P2|COMPLETED|Year 1||18
8654150|NCT02863354|21364121|P1|COMPLETED|Year 1||19
8654151|NCT02863354|21364120|P2|STARTED|Year 1||20
8654152|NCT02863354|21364121|P1|STARTED|Year 1||23
8654153|NCT02798627|21364151|P2|NOT COMPLETED|Overall Study||0
8654154|NCT02798627|21364152|P1|NOT COMPLETED|Overall Study||0
8654155|NCT02798627|21364151|P2|COMPLETED|Overall Study||28
8654156|NCT02798627|21364152|P1|COMPLETED|Overall Study||27
8654157|NCT02798627|21364151|P2|STARTED|Overall Study||28
8654158|NCT02798627|21364152|P1|STARTED|Overall Study||27
8654162|NCT02692586|21364175|P1|NOT COMPLETED|Overall Study||3
8654163|NCT02692586|21364175|P1|COMPLETED|Overall Study||103
8654164|NCT02692586|21364175|P1|STARTED|Overall Study||106
8654165|NCT02669264|21364187|P7|NOT COMPLETED|Overall Study||5
8654166|NCT02669264|21364188|P6|NOT COMPLETED|Overall Study||6
8654167|NCT02669264|21364189|P5|NOT COMPLETED|Overall Study||5
8654168|NCT02669264|21364190|P4|NOT COMPLETED|Overall Study||3
8654169|NCT02669264|21364191|P3|NOT COMPLETED|Overall Study||3
8654170|NCT02669264|21364192|P2|NOT COMPLETED|Overall Study||6
8654171|NCT02669264|21364193|P1|NOT COMPLETED|Overall Study||5
8654172|NCT02669264|21364187|P7|COMPLETED|Overall Study||0
8654173|NCT02669264|21364188|P6|COMPLETED|Overall Study||0
8654174|NCT02669264|21364189|P5|COMPLETED|Overall Study||0
8654175|NCT02669264|21364190|P4|COMPLETED|Overall Study||1
8654176|NCT02669264|21364191|P3|COMPLETED|Overall Study||0
8654177|NCT02669264|21364192|P2|COMPLETED|Overall Study||1
8654178|NCT02669264|21364193|P1|COMPLETED|Overall Study||0
8654179|NCT02669264|21364187|P7|STARTED|Overall Study||5
8654180|NCT02669264|21364188|P6|STARTED|Overall Study||6
8654181|NCT02669264|21364189|P5|STARTED|Overall Study||5
8654182|NCT02669264|21364190|P4|STARTED|Overall Study||4
8654183|NCT02669264|21364191|P3|STARTED|Overall Study||3
8654184|NCT02669264|21364192|P2|STARTED|Overall Study||7
8654185|NCT02669264|21364193|P1|STARTED|Overall Study||5
8654186|NCT02596971|21364340|P3|NOT COMPLETED|Overall Study||9
8654187|NCT02596971|21364341|P2|NOT COMPLETED|Overall Study||2
8654188|NCT02596971|21364342|P1|NOT COMPLETED|Overall Study||10
8654189|NCT02596971|21364340|P3|COMPLETED|Overall Study||33
8654190|NCT02596971|21364341|P2|COMPLETED|Overall Study||5
8654191|NCT02596971|21364342|P1|COMPLETED|Overall Study||32
8654192|NCT02596971|21364340|P3|STARTED|Overall Study||42
8654193|NCT02596971|21364341|P2|STARTED|Overall Study||7
8654194|NCT02596971|21364342|P1|STARTED|Overall Study||42
8654195|NCT02544451|21364382|P4|NOT COMPLETED|Treatment Period 2 (168 Weeks)||10
8654196|NCT02544451|21364383|P3|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
8654197|NCT02544451|21364384|P2|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
8654198|NCT02544451|21364385|P1|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
8654199|NCT02544451|21364382|P4|COMPLETED|Treatment Period 2 (168 Weeks)||0
8654200|NCT02544451|21364383|P3|COMPLETED|Treatment Period 2 (168 Weeks)||0
8654201|NCT02544451|21364384|P2|COMPLETED|Treatment Period 2 (168 Weeks)||0
8654202|NCT02544451|21364385|P1|COMPLETED|Treatment Period 2 (168 Weeks)||0
8654203|NCT02544451|21364382|P4|STARTED|Treatment Period 2 (168 Weeks)||10
8654204|NCT02544451|21364383|P3|STARTED|Treatment Period 2 (168 Weeks)||0
8654205|NCT02544451|21364384|P2|STARTED|Treatment Period 2 (168 Weeks)||0
8654206|NCT02544451|21364385|P1|STARTED|Treatment Period 2 (168 Weeks)||0
8654207|NCT02544451|21364382|P4|NOT COMPLETED|Treatment Period 1 (96 Weeks)||0
8654208|NCT02544451|21364383|P3|NOT COMPLETED|Treatment Period 1 (96 Weeks)||1
8654209|NCT02544451|21364384|P2|NOT COMPLETED|Treatment Period 1 (96 Weeks)||12
8654210|NCT02544451|21364385|P1|NOT COMPLETED|Treatment Period 1 (96 Weeks)||14
8654211|NCT02544451|21364382|P4|COMPLETED|Treatment Period 1 (96 Weeks)||0
8654212|NCT02544451|21364383|P3|COMPLETED|Treatment Period 1 (96 Weeks)||5
8654213|NCT02544451|21364384|P2|COMPLETED|Treatment Period 1 (96 Weeks)||84
8654214|NCT02544451|21364385|P1|COMPLETED|Treatment Period 1 (96 Weeks)||129
8654215|NCT02544451|21364382|P4|STARTED|Treatment Period 1 (96 Weeks)||0
8654216|NCT02544451|21364383|P3|STARTED|Treatment Period 1 (96 Weeks)||6
8654217|NCT02544451|21364384|P2|STARTED|Treatment Period 1 (96 Weeks)||96
8654218|NCT02544451|21364385|P1|STARTED|Treatment Period 1 (96 Weeks)||143
8654219|NCT02357810|21364430|P1|NOT COMPLETED|Follow-up at Treatment Discontinuation||18
8654220|NCT02357810|21364430|P1|COMPLETED|Follow-up at Treatment Discontinuation||133
8654221|NCT02357810|21364430|P1|STARTED|Follow-up at Treatment Discontinuation|All patients that receive at least one dose of study treatment go into follow up phase of the study.|151
8654222|NCT02357810|21364430|P1|NOT COMPLETED|12 Week Response and Further Treatment||22
8654223|NCT02357810|21364430|P1|COMPLETED|12 Week Response and Further Treatment||73
8654224|NCT02357810|21364430|P1|Went on to be Treated After Response|12 Week Response and Further Treatment||73
8654225|NCT02357810|21364430|P1|Assessed for 12 Week Response|12 Week Response and Further Treatment||95
8654226|NCT02357810|21364430|P1|STARTED|12 Week Response and Further Treatment||95
8654227|NCT02357810|21364430|P1|NOT COMPLETED|Reached 12 Weeks Response||56
8654228|NCT02357810|21364430|P1|COMPLETED|Reached 12 Weeks Response||95
8654229|NCT02357810|21364430|P1|Reached 12 Weeks/3 Cycles|Reached 12 Weeks Response||95
8654230|NCT02357810|21364430|P1|Reached 6 Week Response|Reached 12 Weeks Response||129
8654231|NCT02357810|21364430|P1|Completed 4 Weeks/1 Cycle|Reached 12 Weeks Response||151
8654232|NCT02357810|21364430|P1|STARTED|Reached 12 Weeks Response||151
8654233|NCT02357810|21364430|P1|NOT COMPLETED|Registered and Started Treatment||27
8654234|NCT02357810|21364430|P1|COMPLETED|Registered and Started Treatment||151
8654235|NCT02357810|21364430|P1|Initiated Treatment on Study|Registered and Started Treatment||151
8654236|NCT02357810|21364430|P1|Registered to Study|Registered and Started Treatment||152
8654237|NCT02357810|21364430|P1|Signed Consent|Registered and Started Treatment||178
8654238|NCT02357810|21364430|P1|STARTED|Registered and Started Treatment||178
8654239|NCT02255604|21364445|P3|NOT COMPLETED|Overall Study||3
8654240|NCT02255604|21364446|P2|NOT COMPLETED|Overall Study||1
8654241|NCT02255604|21364447|P1|NOT COMPLETED|Overall Study||2
8654242|NCT02255604|21364445|P3|COMPLETED|Overall Study||9
8654243|NCT02255604|21364446|P2|COMPLETED|Overall Study||11
8654244|NCT02255604|21364447|P1|COMPLETED|Overall Study||10
8654245|NCT02255604|21364445|P3|STARTED|Overall Study||12
8654246|NCT02255604|21364446|P2|STARTED|Overall Study||12
8654247|NCT02255604|21364447|P1|STARTED|Overall Study||12
8654248|NCT02210091|21364463|P2|NOT COMPLETED|Overall Study||2
8654249|NCT02210091|21364464|P1|NOT COMPLETED|Overall Study||0
8654250|NCT02210091|21364463|P2|COMPLETED|Overall Study||32
8654251|NCT02210091|21364464|P1|COMPLETED|Overall Study||32
8654252|NCT02210091|21364463|P2|STARTED|Overall Study||34
8654253|NCT02210091|21364464|P1|STARTED|Overall Study||32
8654254|NCT02155829|21364538|P2|NOT COMPLETED|Overall Study||3
8654255|NCT02155829|21364539|P1|NOT COMPLETED|Overall Study||6
8654256|NCT02155829|21364538|P2|COMPLETED|Overall Study||35
8654257|NCT02155829|21364539|P1|COMPLETED|Overall Study||31
8654258|NCT02155829|21364538|P2|STARTED|Overall Study||38
8654259|NCT02155829|21364539|P1|STARTED|Overall Study||37
8654260|NCT02110069|21364559|P2|NOT COMPLETED|Overall Study||0
8654261|NCT02110069|21364560|P1|NOT COMPLETED|Overall Study||2
8654262|NCT02110069|21364559|P2|COMPLETED|Overall Study|1 subject was takend off protocol treatment at 10 months of maintenance for disease response.|2
8654263|NCT02110069|21364560|P1|COMPLETED|Overall Study|subject was switched to sirolimus at maintenance course 7 for failure on Vincristine|0
8654264|NCT02110069|21364559|P2|STARTED|Overall Study||2
8654265|NCT02110069|21364560|P1|STARTED|Overall Study||2
8654266|NCT02059512|21364579|P3|NOT COMPLETED|Overall Study||14
8654267|NCT02059512|21364580|P2|NOT COMPLETED|Overall Study||9
8654268|NCT02059512|21364581|P1|NOT COMPLETED|Overall Study||9
8654269|NCT02059512|21364579|P3|COMPLETED|Overall Study||23
8654270|NCT02059512|21364580|P2|COMPLETED|Overall Study||25
8654271|NCT02059512|21364581|P1|COMPLETED|Overall Study||37
8654272|NCT02059512|21364579|P3|STARTED|Overall Study||37
8654273|NCT02059512|21364580|P2|STARTED|Overall Study||34
8654274|NCT02059512|21364581|P1|STARTED|Overall Study||46
8654275|NCT01945593|21364687|P4|NOT COMPLETED|Overall Study||20
8654276|NCT01945593|21364688|P3|NOT COMPLETED|Overall Study||3
8654277|NCT01945593|21364689|P2|NOT COMPLETED|Overall Study||8
8654278|NCT01945593|21364690|P1|NOT COMPLETED|Overall Study||0
8654279|NCT01945593|21364687|P4|COMPLETED|Overall Study||105
8654280|NCT01945593|21364688|P3|COMPLETED|Overall Study||23
8654281|NCT01945593|21364689|P2|COMPLETED|Overall Study||56
8654282|NCT01945593|21364690|P1|COMPLETED|Overall Study||3
8654283|NCT01945593|21364687|P4|STARTED|Overall Study||125
8654284|NCT01945593|21364688|P3|STARTED|Overall Study||26
8654285|NCT01945593|21364689|P2|STARTED|Overall Study||64
8654286|NCT01945593|21364690|P1|STARTED|Overall Study||3
8654287|NCT01913405|21364770|P1|NOT COMPLETED|Overall Study||2
8654288|NCT01913405|21364770|P1|COMPLETED|Overall Study||20
8654289|NCT01913405|21364770|P1|STARTED|Overall Study||22
8654290|NCT01854775|21364827|P3|NOT COMPLETED|Extension Phase||18
8654291|NCT01854775|21364828|P2|NOT COMPLETED|Extension Phase||47
8654292|NCT01854775|21364829|P1|NOT COMPLETED|Extension Phase||39
8654293|NCT01854775|21364827|P3|COMPLETED|Extension Phase||0
8654294|NCT01854775|21364828|P2|COMPLETED|Extension Phase||3
8654295|NCT01854775|21364829|P1|COMPLETED|Extension Phase||9
8654296|NCT01854775|21364827|P3|STARTED|Extension Phase||18
8654297|NCT01854775|21364828|P2|STARTED|Extension Phase||50
8654298|NCT01854775|21364829|P1|STARTED|Extension Phase||48
8654299|NCT01854775|21364827|P3|NOT COMPLETED|Treatment Phase (48 Weeks)||9
8654300|NCT01854775|21364828|P2|NOT COMPLETED|Treatment Phase (48 Weeks)||1
8654301|NCT01854775|21364829|P1|NOT COMPLETED|Treatment Phase (48 Weeks)||2
8654302|NCT01854775|21364827|P3|COMPLETED|Treatment Phase (48 Weeks)||18
8654303|NCT01854775|21364828|P2|COMPLETED|Treatment Phase (48 Weeks)||51
8654304|NCT01854775|21364829|P1|COMPLETED|Treatment Phase (48 Weeks)||48
8654305|NCT01854775|21364827|P3|STARTED|Treatment Phase (48 Weeks)||27
8654306|NCT01854775|21364828|P2|STARTED|Treatment Phase (48 Weeks)||52
8654307|NCT01854775|21364829|P1|STARTED|Treatment Phase (48 Weeks)||50
8654308|NCT01727336|21364906|P6|NOT COMPLETED|Part 2 Blinded||0
8654309|NCT01727336|21364907|P5|NOT COMPLETED|Part 2 Blinded||0
8654310|NCT01727336|21364908|P4|NOT COMPLETED|Part 2 Blinded||0
8654311|NCT01727336|21364909|P3|NOT COMPLETED|Part 2 Blinded||0
8654312|NCT01727336|21364910|P2|NOT COMPLETED|Part 2 Blinded||0
8654313|NCT01727336|21364911|P1|NOT COMPLETED|Part 2 Blinded||0
8654314|NCT01727336|21364906|P6|COMPLETED|Part 2 Blinded||68
8654315|NCT01727336|21364907|P5|COMPLETED|Part 2 Blinded||63
8654316|NCT01727336|21364908|P4|COMPLETED|Part 2 Blinded||0
8654317|NCT01727336|21364909|P3|COMPLETED|Part 2 Blinded||0
8654318|NCT01727336|21364910|P2|COMPLETED|Part 2 Blinded||0
8654319|NCT01727336|21364911|P1|COMPLETED|Part 2 Blinded||0
8654320|NCT01727336|21364906|P6|STARTED|Part 2 Blinded||68
8654321|NCT01727336|21364907|P5|STARTED|Part 2 Blinded||63
8654322|NCT01727336|21364908|P4|STARTED|Part 2 Blinded||0
8654323|NCT01727336|21364909|P3|STARTED|Part 2 Blinded||0
8654324|NCT01727336|21364910|P2|STARTED|Part 2 Blinded||0
8654325|NCT01727336|21364911|P1|STARTED|Part 2 Blinded||0
8654326|NCT01727336|21364906|P6|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
8654327|NCT01727336|21364907|P5|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
8654328|NCT01727336|21364908|P4|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
8654329|NCT01727336|21364909|P3|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
8654330|NCT01727336|21364910|P2|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
8654331|NCT01727336|21364911|P1|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
8654332|NCT01727336|21364906|P6|COMPLETED|Part 1 Dalantercept Dose Escalation||0
8654333|NCT01727336|21364907|P5|COMPLETED|Part 1 Dalantercept Dose Escalation||0
8654334|NCT01727336|21364908|P4|COMPLETED|Part 1 Dalantercept Dose Escalation||0
8654335|NCT01727336|21364909|P3|COMPLETED|Part 1 Dalantercept Dose Escalation||14
8654336|NCT01727336|21364910|P2|COMPLETED|Part 1 Dalantercept Dose Escalation||9
8654337|NCT01727336|21364911|P1|COMPLETED|Part 1 Dalantercept Dose Escalation||6
8654338|NCT01727336|21364906|P6|STARTED|Part 1 Dalantercept Dose Escalation||0
8654339|NCT01727336|21364907|P5|STARTED|Part 1 Dalantercept Dose Escalation||0
8654340|NCT01727336|21364908|P4|STARTED|Part 1 Dalantercept Dose Escalation||0
8654341|NCT01727336|21364909|P3|STARTED|Part 1 Dalantercept Dose Escalation||14
8654342|NCT01727336|21364910|P2|STARTED|Part 1 Dalantercept Dose Escalation||9
8654343|NCT01727336|21364911|P1|STARTED|Part 1 Dalantercept Dose Escalation||6
8654344|NCT01668667|21364941|P4|NOT COMPLETED|Overall Study||23
8654345|NCT01668667|21364942|P3|NOT COMPLETED|Overall Study||31
8654346|NCT01668667|21364943|P2|NOT COMPLETED|Overall Study||26
8654347|NCT01668667|21364944|P1|NOT COMPLETED|Overall Study||31
8654348|NCT01668667|21364941|P4|COMPLETED|Overall Study||102
8654349|NCT01668667|21364942|P3|COMPLETED|Overall Study||94
8654350|NCT01668667|21364943|P2|COMPLETED|Overall Study||99
8654351|NCT01668667|21364944|P1|COMPLETED|Overall Study||95
8654352|NCT01668667|21364941|P4|STARTED|Overall Study||125
8654353|NCT01668667|21364942|P3|STARTED|Overall Study||125
8654354|NCT01668667|21364943|P2|STARTED|Overall Study||125
8654355|NCT01668667|21364944|P1|STARTED|Overall Study||126
8654356|NCT01543152|21364971|P5|NOT COMPLETED|Overall Study||0
8654357|NCT01543152|21364972|P4|NOT COMPLETED|Overall Study||0
8654358|NCT01543152|21364973|P3|NOT COMPLETED|Overall Study||0
8654359|NCT01543152|21364974|P2|NOT COMPLETED|Overall Study||2
8654360|NCT01543152|21364975|P1|NOT COMPLETED|Overall Study||0
8654361|NCT01543152|21364971|P5|COMPLETED|Overall Study||3
8654362|NCT01543152|21364972|P4|COMPLETED|Overall Study||3
8654363|NCT01543152|21364973|P3|COMPLETED|Overall Study||11
8654364|NCT01543152|21364974|P2|COMPLETED|Overall Study||4
8654365|NCT01543152|21364975|P1|COMPLETED|Overall Study||3
8654366|NCT01543152|21364971|P5|STARTED|Overall Study||3
8654367|NCT01543152|21364972|P4|STARTED|Overall Study||3
8654368|NCT01543152|21364973|P3|STARTED|Overall Study||11
8654369|NCT01543152|21364974|P2|STARTED|Overall Study||6
8654370|NCT01543152|21364975|P1|STARTED|Overall Study||3
8654371|NCT01376700|21365002|P1|NOT COMPLETED|Overall Study||16
8654372|NCT01376700|21365002|P1|COMPLETED|Overall Study||3
8654373|NCT01376700|21365002|P1|STARTED|Overall Study||19
8654374|NCT00952822|21365018|P4|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
8654375|NCT00952822|21365019|P3|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
8654376|NCT00952822|21365020|P2|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
8654377|NCT00952822|21365021|P1|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
8654378|NCT00952822|21365018|P4|COMPLETED|2nd Pharmacokinetic Evaluation||4
8654379|NCT00952822|21365019|P3|COMPLETED|2nd Pharmacokinetic Evaluation||10
8654380|NCT00952822|21365020|P2|COMPLETED|2nd Pharmacokinetic Evaluation||17
8654381|NCT00952822|21365021|P1|COMPLETED|2nd Pharmacokinetic Evaluation||9
8654382|NCT00952822|21365018|P4|STARTED|2nd Pharmacokinetic Evaluation||4
8654383|NCT00952822|21365019|P3|STARTED|2nd Pharmacokinetic Evaluation||11
8654384|NCT00952822|21365020|P2|STARTED|2nd Pharmacokinetic Evaluation||17
8654385|NCT00952822|21365021|P1|STARTED|2nd Pharmacokinetic Evaluation||9
8654386|NCT00952822|21365018|P4|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
8654387|NCT00952822|21365019|P3|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
8654388|NCT00952822|21365020|P2|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
8654389|NCT00952822|21365021|P1|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
8654390|NCT00952822|21365018|P4|COMPLETED|1st Pharmacokinetic Evaluation||4
8654391|NCT00952822|21365019|P3|COMPLETED|1st Pharmacokinetic Evaluation||11
8654392|NCT00952822|21365020|P2|COMPLETED|1st Pharmacokinetic Evaluation||17
8654393|NCT00952822|21365021|P1|COMPLETED|1st Pharmacokinetic Evaluation||9
8654394|NCT00952822|21365018|P4|STARTED|1st Pharmacokinetic Evaluation||4
8654395|NCT00952822|21365019|P3|STARTED|1st Pharmacokinetic Evaluation||11
8654396|NCT00952822|21365020|P2|STARTED|1st Pharmacokinetic Evaluation||18
8654397|NCT00952822|21365021|P1|STARTED|1st Pharmacokinetic Evaluation||9
8654398|NCT00880685|21365051|P1|NOT COMPLETED|Memantine 30mg||0
8654399|NCT00880685|21365051|P1|COMPLETED|Memantine 30mg||9
8654400|NCT00880685|21365051|P1|STARTED|Memantine 30mg||9
8654401|NCT00880685|21365051|P1|NOT COMPLETED|Memantine 20mg||1
8654402|NCT00880685|21365051|P1|COMPLETED|Memantine 20mg||9
8654403|NCT00880685|21365051|P1|STARTED|Memantine 20mg||10
8654404|NCT00880685|21365051|P1|NOT COMPLETED|Memantine 10mg||2
8654405|NCT00880685|21365051|P1|COMPLETED|Memantine 10mg||10
8654406|NCT00880685|21365051|P1|STARTED|Memantine 10mg||12
8654410|NCT00565851|21365076|P8|NOT COMPLETED|Chemotherapy Assignment||3
8654411|NCT00565851|21365077|P7|NOT COMPLETED|Chemotherapy Assignment||0
8654412|NCT00565851|21365078|P6|NOT COMPLETED|Chemotherapy Assignment||3
8654413|NCT00565851|21365079|P5|NOT COMPLETED|Chemotherapy Assignment||0
8654414|NCT00565851|21365080|P4|NOT COMPLETED|Chemotherapy Assignment||36
8654415|NCT00565851|21365081|P3|NOT COMPLETED|Chemotherapy Assignment||3
8654416|NCT00565851|21365082|P2|NOT COMPLETED|Chemotherapy Assignment||23
8654417|NCT00565851|21365083|P1|NOT COMPLETED|Chemotherapy Assignment||9
8654418|NCT00565851|21365076|P8|COMPLETED|Chemotherapy Assignment||34
8654419|NCT00565851|21365077|P7|COMPLETED|Chemotherapy Assignment||5
8654420|NCT00565851|21365078|P6|COMPLETED|Chemotherapy Assignment||31
8654421|NCT00565851|21365079|P5|COMPLETED|Chemotherapy Assignment||6
8654422|NCT00565851|21365080|P4|COMPLETED|Chemotherapy Assignment||129
8654423|NCT00565851|21365081|P3|COMPLETED|Chemotherapy Assignment||30
8654424|NCT00565851|21365082|P2|COMPLETED|Chemotherapy Assignment||433
8654425|NCT00565851|21365083|P1|COMPLETED|Chemotherapy Assignment||307
8654426|NCT00565851|21365076|P8|Pre-specified Chemo|Chemotherapy Assignment||37
8654427|NCT00565851|21365077|P7|Pre-specified Chemo|Chemotherapy Assignment||5
8654428|NCT00565851|21365078|P6|Pre-specified Chemo|Chemotherapy Assignment||34
8654429|NCT00565851|21365079|P5|Pre-specified Chemo|Chemotherapy Assignment||6
8654430|NCT00565851|21365080|P4|Pre-specified Chemo|Chemotherapy Assignment||139
8654431|NCT00565851|21365081|P3|Pre-specified Chemo|Chemotherapy Assignment||6
8654432|NCT00565851|21365082|P2|Pre-specified Chemo|Chemotherapy Assignment||145
8654433|NCT00565851|21365083|P1|Pre-specified Chemo|Chemotherapy Assignment||6
8654434|NCT00565851|21365076|P8|Randomized to Chemo|Chemotherapy Assignment||0
8654435|NCT00565851|21365077|P7|Randomized to Chemo|Chemotherapy Assignment||0
8654436|NCT00565851|21365078|P6|Randomized to Chemo|Chemotherapy Assignment||0
8654437|NCT00565851|21365079|P5|Randomized to Chemo|Chemotherapy Assignment||0
8654438|NCT00565851|21365080|P4|Randomized to Chemo|Chemotherapy Assignment||26
8654439|NCT00565851|21365081|P3|Randomized to Chemo|Chemotherapy Assignment||27
8654440|NCT00565851|21365082|P2|Randomized to Chemo|Chemotherapy Assignment||311
8654441|NCT00565851|21365083|P1|Randomized to Chemo|Chemotherapy Assignment||310
8654442|NCT00565851|21365076|P8|STARTED|Chemotherapy Assignment||37
8654443|NCT00565851|21365077|P7|STARTED|Chemotherapy Assignment||5
8654444|NCT00565851|21365078|P6|STARTED|Chemotherapy Assignment||34
8654445|NCT00565851|21365079|P5|STARTED|Chemotherapy Assignment||6
8654446|NCT00565851|21365080|P4|STARTED|Chemotherapy Assignment||165
8654447|NCT00565851|21365081|P3|STARTED|Chemotherapy Assignment||33
8654448|NCT00565851|21365082|P2|STARTED|Chemotherapy Assignment||456
8654449|NCT00565851|21365083|P1|STARTED|Chemotherapy Assignment||316
8654450|NCT00565851|21365076|P8|NOT COMPLETED|Surgical Assignment||2
8654451|NCT00565851|21365077|P7|NOT COMPLETED|Surgical Assignment||0
8654452|NCT00565851|21365078|P6|NOT COMPLETED|Surgical Assignment||0
8654453|NCT00565851|21365079|P5|NOT COMPLETED|Surgical Assignment||0
8654454|NCT00565851|21365080|P4|NOT COMPLETED|Surgical Assignment||11
8654455|NCT00565851|21365081|P3|NOT COMPLETED|Surgical Assignment||2
8654456|NCT00565851|21365082|P2|NOT COMPLETED|Surgical Assignment||2
8654457|NCT00565851|21365083|P1|NOT COMPLETED|Surgical Assignment||3
8654458|NCT00565851|21365076|P8|COMPLETED|Surgical Assignment||35
8654459|NCT00565851|21365077|P7|COMPLETED|Surgical Assignment||5
8654460|NCT00565851|21365078|P6|COMPLETED|Surgical Assignment||34
8654461|NCT00565851|21365079|P5|COMPLETED|Surgical Assignment||6
8654462|NCT00565851|21365080|P4|COMPLETED|Surgical Assignment||154
8654463|NCT00565851|21365081|P3|COMPLETED|Surgical Assignment||31
8654464|NCT00565851|21365082|P2|COMPLETED|Surgical Assignment||454
8654465|NCT00565851|21365083|P1|COMPLETED|Surgical Assignment||313
8654466|NCT00565851|21365076|P8|Not Surgical Candidate|Surgical Assignment||0
8654467|NCT00565851|21365077|P7|Not Surgical Candidate|Surgical Assignment||0
8654468|NCT00565851|21365078|P6|Not Surgical Candidate|Surgical Assignment||0
8654469|NCT00565851|21365079|P5|Not Surgical Candidate|Surgical Assignment||0
8654470|NCT00565851|21365080|P4|Not Surgical Candidate|Surgical Assignment||0
8654471|NCT00565851|21365081|P3|Not Surgical Candidate|Surgical Assignment||0
8654472|NCT00565851|21365082|P2|Not Surgical Candidate|Surgical Assignment||284
8654473|NCT00565851|21365083|P1|Not Surgical Candidate|Surgical Assignment||283
8654474|NCT00565851|21365076|P8|Randomized - no Surgery|Surgical Assignment||0
8654475|NCT00565851|21365077|P7|Randomized - no Surgery|Surgical Assignment||0
8654476|NCT00565851|21365078|P6|Randomized - no Surgery|Surgical Assignment||34
8654477|NCT00565851|21365079|P5|Randomized - no Surgery|Surgical Assignment||6
8654478|NCT00565851|21365080|P4|Randomized - no Surgery|Surgical Assignment||0
8654479|NCT00565851|21365081|P3|Randomized - no Surgery|Surgical Assignment||0
8654480|NCT00565851|21365082|P2|Randomized - no Surgery|Surgical Assignment||172
8654481|NCT00565851|21365083|P1|Randomized - no Surgery|Surgical Assignment||33
8654482|NCT00565851|21365076|P8|Randomized - Yes Surgery|Surgical Assignment||37
8654483|NCT00565851|21365077|P7|Randomized - Yes Surgery|Surgical Assignment||5
8654484|NCT00565851|21365078|P6|Randomized - Yes Surgery|Surgical Assignment||0
8654485|NCT00565851|21365079|P5|Randomized - Yes Surgery|Surgical Assignment||0
8654486|NCT00565851|21365080|P4|Randomized - Yes Surgery|Surgical Assignment||165
8654487|NCT00565851|21365081|P3|Randomized - Yes Surgery|Surgical Assignment||33
8654488|NCT00565851|21365082|P2|Randomized - Yes Surgery|Surgical Assignment||0
8654489|NCT00565851|21365083|P1|Randomized - Yes Surgery|Surgical Assignment||0
8654490|NCT00565851|21365076|P8|STARTED|Surgical Assignment||37
8654491|NCT00565851|21365077|P7|STARTED|Surgical Assignment||5
8654492|NCT00565851|21365078|P6|STARTED|Surgical Assignment||34
8654493|NCT00565851|21365079|P5|STARTED|Surgical Assignment||6
8654494|NCT00565851|21365080|P4|STARTED|Surgical Assignment||165
8654495|NCT00565851|21365081|P3|STARTED|Surgical Assignment||33
8654496|NCT00565851|21365082|P2|STARTED|Surgical Assignment||456
8654497|NCT00565851|21365083|P1|STARTED|Surgical Assignment||316
8654498|NCT00538733|21365117|P1|NOT COMPLETED|Overall Study||12
8654499|NCT00538733|21365117|P1|COMPLETED|Overall Study||14
8654500|NCT00538733|21365117|P1|Removed to Pursue Alternative Theray|Overall Study||2
8654501|NCT00538733|21365117|P1|Removed to Pursue a Stem Cell Transplant|Overall Study||11
8654502|NCT00538733|21365117|P1|Removed Due to Progression of Disease|Overall Study||1
8654503|NCT00538733|21365117|P1|STARTED|Overall Study||26
8654504|NCT00489827|21365126|P2|NOT COMPLETED|Overall Study||2
8654505|NCT00489827|21365127|P1|NOT COMPLETED|Overall Study||2
8654506|NCT00489827|21365126|P2|COMPLETED|Overall Study||433
8654507|NCT00489827|21365127|P1|COMPLETED|Overall Study||428
8654508|NCT00489827|21365126|P2|STARTED|Overall Study||435
8654509|NCT00489827|21365127|P1|STARTED|Overall Study||430
8654510|NCT00157157|21365149|P1|NOT COMPLETED|Overall Study||11
8654511|NCT00157157|21365149|P1|COMPLETED|Overall Study||44
8654512|NCT00157157|21365149|P1|STARTED|Overall Study||55
8654513|NCT04821245|21365172|P1|NOT COMPLETED|Overall Study||9
8654514|NCT04821245|21365172|P1|COMPLETED|Overall Study||27
8654515|NCT04821245|21365172|P1|STARTED|Overall Study||36
8654516|NCT04732338|21365180|P2|NOT COMPLETED|Overall Study||3
8654517|NCT04732338|21365181|P1|NOT COMPLETED|Overall Study||3
8654518|NCT04732338|21365180|P2|COMPLETED|Overall Study||10
8654519|NCT04732338|21365181|P1|COMPLETED|Overall Study||10
8654520|NCT04732338|21365180|P2|STARTED|Overall Study||13
8654521|NCT04732338|21365181|P1|STARTED|Overall Study||13
8654522|NCT04634903|21365192|P3|NOT COMPLETED|Overall Study||160
8654523|NCT04634903|21365193|P2|NOT COMPLETED|Overall Study||89
8654524|NCT04634903|21365194|P1|NOT COMPLETED|Overall Study||149
8654525|NCT04634903|21365192|P3|COMPLETED|Overall Study||653
8654526|NCT04634903|21365193|P2|COMPLETED|Overall Study||732
8654527|NCT04634903|21365194|P1|COMPLETED|Overall Study||669
8654528|NCT04634903|21365192|P3|STARTED|Overall Study||813
8654529|NCT04634903|21365193|P2|STARTED|Overall Study||821
8654530|NCT04634903|21365194|P1|STARTED|Overall Study||818
8654531|NCT04021771|21365213|P2|NOT COMPLETED|Overall Study||0
8654532|NCT04021771|21365214|P1|NOT COMPLETED|Overall Study||0
8654533|NCT04021771|21365213|P2|COMPLETED|Overall Study||54
8654534|NCT04021771|21365214|P1|COMPLETED|Overall Study||55
8654535|NCT04021771|21365213|P2|STARTED|Overall Study||54
8654536|NCT04021771|21365214|P1|STARTED|Overall Study||55
8654537|NCT03822416|21365226|P2|NOT COMPLETED|Overall Study||1
8654538|NCT03822416|21365227|P1|NOT COMPLETED|Overall Study||1
8654539|NCT03822416|21365226|P2|COMPLETED|Overall Study||18
8654540|NCT03822416|21365227|P1|COMPLETED|Overall Study||18
8654541|NCT03822416|21365226|P2|STARTED|Overall Study||19
8654542|NCT03822416|21365227|P1|STARTED|Overall Study||19
8654543|NCT03819634|21365237|P1|NOT COMPLETED|Overall Study||2
8654544|NCT03819634|21365237|P1|COMPLETED|Overall Study||22
8654545|NCT03819634|21365237|P1|STARTED|Overall Study||24
8654549|NCT03662789|21365249|P2|NOT COMPLETED|Overall Study||7
8654550|NCT03662789|21365250|P1|NOT COMPLETED|Overall Study||5
8654551|NCT03662789|21365249|P2|COMPLETED|Overall Study|Follow-up at 6 months|43
8654552|NCT03662789|21365250|P1|COMPLETED|Overall Study|Follow-up at 6 months|47
8654553|NCT03662789|21365249|P2|STARTED|Overall Study|Baseline|50
8654554|NCT03662789|21365250|P1|STARTED|Overall Study|Baseline|52
8654555|NCT03633929|21365268|P1|NOT COMPLETED|Overall Study||4
8654556|NCT03633929|21365268|P1|COMPLETED|Overall Study||15
8654557|NCT03633929|21365268|P1|STARTED|Overall Study||19
8654558|NCT03454412|21365276|P1|NOT COMPLETED|Final Assesment||0
8654559|NCT03454412|21365276|P1|COMPLETED|Final Assesment||32
8654560|NCT03454412|21365276|P1|STARTED|Final Assesment||32
8654561|NCT03454412|21365276|P1|NOT COMPLETED|Treatment Course||0
8654562|NCT03454412|21365276|P1|COMPLETED|Treatment Course||32
8654563|NCT03454412|21365276|P1|STARTED|Treatment Course||32
8654564|NCT03454412|21365276|P1|NOT COMPLETED|Baseline Assesment||12
8654565|NCT03454412|21365276|P1|COMPLETED|Baseline Assesment||32
8654566|NCT03454412|21365276|P1|STARTED|Baseline Assesment||44
8654567|NCT03338010|21365288|P2|NOT COMPLETED|Overall Study||18
8654568|NCT03338010|21365289|P1|NOT COMPLETED|Overall Study||23
8654569|NCT03338010|21365288|P2|COMPLETED|Overall Study||159
8654570|NCT03338010|21365289|P1|COMPLETED|Overall Study||336
8654571|NCT03338010|21365288|P2|Received at Least One Dose of Study Drug|Overall Study||177
8654572|NCT03338010|21365289|P1|Received at Least One Dose of Study Drug|Overall Study||359
8654573|NCT03338010|21365288|P2|STARTED|Overall Study||177
8654574|NCT03338010|21365289|P1|STARTED|Overall Study||359
8654575|NCT03027557|21365320|P3|NOT COMPLETED|Overall Study||0
8654576|NCT03027557|21365321|P2|NOT COMPLETED|Overall Study||0
8654577|NCT03027557|21365322|P1|NOT COMPLETED|Overall Study||1
8654578|NCT03027557|21365320|P3|COMPLETED|Overall Study||15
8654579|NCT03027557|21365321|P2|COMPLETED|Overall Study||16
8654580|NCT03027557|21365322|P1|COMPLETED|Overall Study||14
8654581|NCT03027557|21365320|P3|STARTED|Overall Study||15
8654582|NCT03027557|21365321|P2|STARTED|Overall Study||16
8654583|NCT03027557|21365322|P1|STARTED|Overall Study||15
8654584|NCT02974010|21365427|P4|NOT COMPLETED|Overall Study||0
8654585|NCT02974010|21365428|P3|NOT COMPLETED|Overall Study||2
8654586|NCT02974010|21365429|P2|NOT COMPLETED|Overall Study||3
8654587|NCT02974010|21365430|P1|NOT COMPLETED|Overall Study||6
8654588|NCT02974010|21365427|P4|COMPLETED|Overall Study||1
8654589|NCT02974010|21365428|P3|COMPLETED|Overall Study||2
8654590|NCT02974010|21365429|P2|COMPLETED|Overall Study||2
8654591|NCT02974010|21365430|P1|COMPLETED|Overall Study||6
8654592|NCT02974010|21365427|P4|STARTED|Overall Study||1
8654593|NCT02974010|21365428|P3|STARTED|Overall Study||4
8654594|NCT02974010|21365429|P2|STARTED|Overall Study||5
8654595|NCT02974010|21365430|P1|STARTED|Overall Study||12
8654596|NCT02879383|21365444|P4|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
8654597|NCT02879383|21365445|P3|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
8654598|NCT02879383|21365446|P2|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
8654599|NCT02879383|21365447|P1|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
8654600|NCT02879383|21365444|P4|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
8654601|NCT02879383|21365445|P3|COMPLETED|Second 24 Weeks (Crossover for Sham)||4
8654602|NCT02879383|21365446|P2|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
8654603|NCT02879383|21365447|P1|COMPLETED|Second 24 Weeks (Crossover for Sham)||33
8654604|NCT02879383|21365444|P4|STARTED|Second 24 Weeks (Crossover for Sham)||0
8654605|NCT02879383|21365445|P3|STARTED|Second 24 Weeks (Crossover for Sham)||4
8654606|NCT02879383|21365446|P2|STARTED|Second 24 Weeks (Crossover for Sham)||0
8654607|NCT02879383|21365447|P1|STARTED|Second 24 Weeks (Crossover for Sham)||33
8654608|NCT02879383|21365444|P4|NOT COMPLETED|First 24 Weeks||0
8654609|NCT02879383|21365445|P3|NOT COMPLETED|First 24 Weeks||0
8654610|NCT02879383|21365446|P2|NOT COMPLETED|First 24 Weeks||1
8654611|NCT02879383|21365447|P1|NOT COMPLETED|First 24 Weeks||0
8654612|NCT02879383|21365444|P4|COMPLETED|First 24 Weeks||16
8654613|NCT02879383|21365445|P3|COMPLETED|First 24 Weeks||17
8654614|NCT02879383|21365446|P2|COMPLETED|First 24 Weeks||36
8654615|NCT02879383|21365447|P1|COMPLETED|First 24 Weeks||39
8654616|NCT02879383|21365444|P4|STARTED|First 24 Weeks||16
8654617|NCT02879383|21365445|P3|STARTED|First 24 Weeks||17
8654618|NCT02879383|21365446|P2|STARTED|First 24 Weeks||37
8654619|NCT02879383|21365447|P1|STARTED|First 24 Weeks||39
8654620|NCT02852330|21365463|P1|NOT COMPLETED|Overall Study||0
8654621|NCT02852330|21365463|P1|COMPLETED|Overall Study||20
8654622|NCT02852330|21365463|P1|STARTED|Overall Study||20
8654623|NCT02813421|21365469|P2|NOT COMPLETED|Overall Study||3
8654624|NCT02813421|21365470|P1|NOT COMPLETED|Overall Study||2
8654625|NCT02813421|21365469|P2|COMPLETED|Overall Study||3
8654626|NCT02813421|21365470|P1|COMPLETED|Overall Study||3
8654627|NCT02813421|21365469|P2|STARTED|Overall Study||6
8654628|NCT02813421|21365470|P1|STARTED|Overall Study||5
8654629|NCT02781844|21365504|P8|NOT COMPLETED|Treatment Period 2||0
8654630|NCT02781844|21365505|P7|NOT COMPLETED|Treatment Period 2||0
8654631|NCT02781844|21365506|P6|NOT COMPLETED|Treatment Period 2||0
8654632|NCT02781844|21365507|P5|NOT COMPLETED|Treatment Period 2||0
8654633|NCT02781844|21365508|P4|NOT COMPLETED|Treatment Period 2||0
8654634|NCT02781844|21365509|P3|NOT COMPLETED|Treatment Period 2||0
8654635|NCT02781844|21365510|P2|NOT COMPLETED|Treatment Period 2||0
8654636|NCT02781844|21365511|P1|NOT COMPLETED|Treatment Period 2||0
8654637|NCT02781844|21365504|P8|COMPLETED|Treatment Period 2||4
8654638|NCT02781844|21365505|P7|COMPLETED|Treatment Period 2||4
8654639|NCT02781844|21365506|P6|COMPLETED|Treatment Period 2||4
8654640|NCT02781844|21365507|P5|COMPLETED|Treatment Period 2||4
8654641|NCT02781844|21365508|P4|COMPLETED|Treatment Period 2||4
8654642|NCT02781844|21365509|P3|COMPLETED|Treatment Period 2||4
8654643|NCT02781844|21365510|P2|COMPLETED|Treatment Period 2||4
8654644|NCT02781844|21365511|P1|COMPLETED|Treatment Period 2||5
8654645|NCT02781844|21365504|P8|STARTED|Treatment Period 2||4
8654646|NCT02781844|21365505|P7|STARTED|Treatment Period 2||4
8654647|NCT02781844|21365506|P6|STARTED|Treatment Period 2||4
8654648|NCT02781844|21365507|P5|STARTED|Treatment Period 2||4
8654649|NCT02781844|21365508|P4|STARTED|Treatment Period 2||4
8654650|NCT02781844|21365509|P3|STARTED|Treatment Period 2||4
8654651|NCT02781844|21365510|P2|STARTED|Treatment Period 2||4
8654652|NCT02781844|21365511|P1|STARTED|Treatment Period 2||5
8654653|NCT02781844|21365504|P8|NOT COMPLETED|Treatment Period 1||0
8654654|NCT02781844|21365505|P7|NOT COMPLETED|Treatment Period 1||0
8654655|NCT02781844|21365506|P6|NOT COMPLETED|Treatment Period 1||1
8654656|NCT02781844|21365507|P5|NOT COMPLETED|Treatment Period 1||0
8654657|NCT02781844|21365508|P4|NOT COMPLETED|Treatment Period 1||0
8654658|NCT02781844|21365509|P3|NOT COMPLETED|Treatment Period 1||0
8654659|NCT02781844|21365510|P2|NOT COMPLETED|Treatment Period 1||0
8654660|NCT02781844|21365511|P1|NOT COMPLETED|Treatment Period 1||0
8654661|NCT02781844|21365504|P8|COMPLETED|Treatment Period 1||4
8654662|NCT02781844|21365505|P7|COMPLETED|Treatment Period 1||4
8654663|NCT02781844|21365506|P6|COMPLETED|Treatment Period 1||4
8654664|NCT02781844|21365507|P5|COMPLETED|Treatment Period 1||4
8654665|NCT02781844|21365508|P4|COMPLETED|Treatment Period 1||4
8654666|NCT02781844|21365509|P3|COMPLETED|Treatment Period 1||4
8654667|NCT02781844|21365510|P2|COMPLETED|Treatment Period 1||4
8654668|NCT02781844|21365511|P1|COMPLETED|Treatment Period 1||5
8654669|NCT02781844|21365504|P8|STARTED|Treatment Period 1||4
8654670|NCT02781844|21365505|P7|STARTED|Treatment Period 1||4
8654671|NCT02781844|21365506|P6|STARTED|Treatment Period 1||5
8654672|NCT02781844|21365507|P5|STARTED|Treatment Period 1||4
8654673|NCT02781844|21365508|P4|STARTED|Treatment Period 1||4
8654674|NCT02781844|21365509|P3|STARTED|Treatment Period 1||4
8654675|NCT02781844|21365510|P2|STARTED|Treatment Period 1||4
8654676|NCT02781844|21365511|P1|STARTED|Treatment Period 1||5
8654677|NCT02716194|21365644|P3|NOT COMPLETED|Period 2 - BAX 826||0
8654678|NCT02716194|21365645|P2|NOT COMPLETED|Period 2 - BAX 826||0
8654679|NCT02716194|21365646|P1|NOT COMPLETED|Period 2 - BAX 826||0
8654680|NCT02716194|21365644|P3|COMPLETED|Period 2 - BAX 826||13
8654681|NCT02716194|21365645|P2|COMPLETED|Period 2 - BAX 826||15
8654682|NCT02716194|21365646|P1|COMPLETED|Period 2 - BAX 826||10
8654683|NCT02716194|21365644|P3|STARTED|Period 2 - BAX 826||13
8654684|NCT02716194|21365645|P2|STARTED|Period 2 - BAX 826||15
8654685|NCT02716194|21365646|P1|STARTED|Period 2 - BAX 826||10
8654686|NCT02716194|21365644|P3|NOT COMPLETED|Period 1 - ADVATE||0
8654687|NCT02716194|21365645|P2|NOT COMPLETED|Period 1 - ADVATE||1
8654688|NCT02716194|21365646|P1|NOT COMPLETED|Period 1 - ADVATE||1
8654689|NCT02716194|21365644|P3|COMPLETED|Period 1 - ADVATE||13
8654690|NCT02716194|21365645|P2|COMPLETED|Period 1 - ADVATE||15
8654691|NCT02716194|21365646|P1|COMPLETED|Period 1 - ADVATE||10
8654692|NCT02716194|21365644|P3|STARTED|Period 1 - ADVATE||13
8654693|NCT02716194|21365645|P2|STARTED|Period 1 - ADVATE||16
8654694|NCT02716194|21365646|P1|STARTED|Period 1 - ADVATE||11
8654695|NCT02714569|21365735|P11|NOT COMPLETED|Part B (Overall)||0
8654696|NCT02714569|21365736|P10|NOT COMPLETED|Part B (Overall)||2
8654697|NCT02714569|21365737|P9|NOT COMPLETED|Part B (Overall)||0
8654698|NCT02714569|21365738|P8|NOT COMPLETED|Part B (Overall)||1
8654699|NCT02714569|21365739|P7|NOT COMPLETED|Part B (Overall)||1
8654700|NCT02714569|21365740|P6|NOT COMPLETED|Part B (Overall)||0
8654701|NCT02714569|21365741|P5|NOT COMPLETED|Part B (Overall)||0
8654702|NCT02714569|21365742|P4|NOT COMPLETED|Part B (Overall)||0
8654703|NCT02714569|21365743|P3|NOT COMPLETED|Part B (Overall)||0
8654704|NCT02714569|21365744|P2|NOT COMPLETED|Part B (Overall)||0
8654705|NCT02714569|21365745|P1|NOT COMPLETED|Part B (Overall)||0
8654706|NCT02714569|21365735|P11|COMPLETED|Part B (Overall)||8
8654707|NCT02714569|21365736|P10|COMPLETED|Part B (Overall)||6
8654708|NCT02714569|21365737|P9|COMPLETED|Part B (Overall)||8
8654709|NCT02714569|21365738|P8|COMPLETED|Part B (Overall)||7
8654710|NCT02714569|21365739|P7|COMPLETED|Part B (Overall)||7
8654711|NCT02714569|21365740|P6|COMPLETED|Part B (Overall)||0
8654712|NCT02714569|21365741|P5|COMPLETED|Part B (Overall)||0
8654713|NCT02714569|21365742|P4|COMPLETED|Part B (Overall)||0
8654714|NCT02714569|21365743|P3|COMPLETED|Part B (Overall)||0
8654715|NCT02714569|21365744|P2|COMPLETED|Part B (Overall)||0
8654716|NCT02714569|21365745|P1|COMPLETED|Part B (Overall)||0
8654717|NCT02714569|21365735|P11|STARTED|Part B (Overall)|Part B participants randomized to receive placebo instead of LY3202328 + atorvastatin/simvastatin.|8
8654718|NCT02714569|21365736|P10|STARTED|Part B (Overall)|Part B participants randomized to receive 300 mg of LY3202328 + atorvastatin/simvastatin.|8
8654719|NCT02714569|21365737|P9|STARTED|Part B (Overall)|Part B participants randomized to receive 100 mg of LY3202328 + atorvastatin/simvastatin.|8
8654720|NCT02714569|21365738|P8|STARTED|Part B (Overall)|Part B participants randomized to receive 20 mg of LY3202328 + atorvastatin/simvastatin.|8
8654721|NCT02714569|21365739|P7|STARTED|Part B (Overall)|Part B participants randomized to receive 5 mg of LY3202328 + atorvastatin/simvastatin.|8
8654722|NCT02714569|21365740|P6|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
8654723|NCT02714569|21365741|P5|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
8654724|NCT02714569|21365742|P4|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
8654725|NCT02714569|21365743|P3|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
8654726|NCT02714569|21365744|P2|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
8654727|NCT02714569|21365745|P1|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
8654728|NCT02714569|21365735|P11|NOT COMPLETED|Part A Fourth Intervention||0
8654729|NCT02714569|21365736|P10|NOT COMPLETED|Part A Fourth Intervention||0
8654730|NCT02714569|21365737|P9|NOT COMPLETED|Part A Fourth Intervention||0
8654731|NCT02714569|21365738|P8|NOT COMPLETED|Part A Fourth Intervention||0
8654732|NCT02714569|21365739|P7|NOT COMPLETED|Part A Fourth Intervention||0
8654733|NCT02714569|21365740|P6|NOT COMPLETED|Part A Fourth Intervention||1
8654734|NCT02714569|21365741|P5|NOT COMPLETED|Part A Fourth Intervention||0
8654735|NCT02714569|21365742|P4|NOT COMPLETED|Part A Fourth Intervention||0
8654736|NCT02714569|21365743|P3|NOT COMPLETED|Part A Fourth Intervention||0
8654737|NCT02714569|21365744|P2|NOT COMPLETED|Part A Fourth Intervention||0
8654738|NCT02714569|21365745|P1|NOT COMPLETED|Part A Fourth Intervention||1
8654739|NCT02714569|21365735|P11|COMPLETED|Part A Fourth Intervention||0
8654740|NCT02714569|21365736|P10|COMPLETED|Part A Fourth Intervention||0
8654741|NCT02714569|21365737|P9|COMPLETED|Part A Fourth Intervention||0
8654742|NCT02714569|21365738|P8|COMPLETED|Part A Fourth Intervention||0
8654743|NCT02714569|21365739|P7|COMPLETED|Part A Fourth Intervention||0
8654744|NCT02714569|21365740|P6|COMPLETED|Part A Fourth Intervention||2
8654745|NCT02714569|21365741|P5|COMPLETED|Part A Fourth Intervention||3
8654746|NCT02714569|21365742|P4|COMPLETED|Part A Fourth Intervention||2
8654747|NCT02714569|21365743|P3|COMPLETED|Part A Fourth Intervention||3
8654748|NCT02714569|21365744|P2|COMPLETED|Part A Fourth Intervention||2
8654749|NCT02714569|21365745|P1|COMPLETED|Part A Fourth Intervention||3
8654750|NCT02714569|21365735|P11|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
8654751|NCT02714569|21365736|P10|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
8654752|NCT02714569|21365737|P9|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
8654753|NCT02714569|21365738|P8|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
8654754|NCT02714569|21365739|P7|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
8654755|NCT02714569|21365740|P6|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
8654756|NCT02714569|21365741|P5|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
8654757|NCT02714569|21365742|P4|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
8654758|NCT02714569|21365743|P3|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
8654916|NCT02585960|21365871|P3|COMPLETED|PK/Safety Assessment Period||0
8654759|NCT02714569|21365744|P2|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
8654760|NCT02714569|21365745|P1|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
8654761|NCT02714569|21365735|P11|STARTED|Part A Fourth Intervention||0
8654762|NCT02714569|21365736|P10|STARTED|Part A Fourth Intervention||0
8654763|NCT02714569|21365737|P9|STARTED|Part A Fourth Intervention||0
8654764|NCT02714569|21365738|P8|STARTED|Part A Fourth Intervention||0
8654765|NCT02714569|21365739|P7|STARTED|Part A Fourth Intervention||0
8654766|NCT02714569|21365740|P6|STARTED|Part A Fourth Intervention||3
8654767|NCT02714569|21365741|P5|STARTED|Part A Fourth Intervention||3
8654768|NCT02714569|21365742|P4|STARTED|Part A Fourth Intervention||2
8654769|NCT02714569|21365743|P3|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|3
8654770|NCT02714569|21365744|P2|STARTED|Part A Fourth Intervention||2
8654771|NCT02714569|21365745|P1|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|4
8654772|NCT02714569|21365735|P11|NOT COMPLETED|Part A Third Intervention||0
8654773|NCT02714569|21365736|P10|NOT COMPLETED|Part A Third Intervention||0
8654774|NCT02714569|21365737|P9|NOT COMPLETED|Part A Third Intervention||0
8654775|NCT02714569|21365738|P8|NOT COMPLETED|Part A Third Intervention||0
8654776|NCT02714569|21365739|P7|NOT COMPLETED|Part A Third Intervention||0
8654777|NCT02714569|21365740|P6|NOT COMPLETED|Part A Third Intervention||0
8654778|NCT02714569|21365741|P5|NOT COMPLETED|Part A Third Intervention||0
8654779|NCT02714569|21365742|P4|NOT COMPLETED|Part A Third Intervention||1
8654780|NCT02714569|21365743|P3|NOT COMPLETED|Part A Third Intervention||1
8654781|NCT02714569|21365744|P2|NOT COMPLETED|Part A Third Intervention||0
8654782|NCT02714569|21365745|P1|NOT COMPLETED|Part A Third Intervention||0
8654783|NCT02714569|21365735|P11|COMPLETED|Part A Third Intervention||0
8654784|NCT02714569|21365736|P10|COMPLETED|Part A Third Intervention||0
8654785|NCT02714569|21365737|P9|COMPLETED|Part A Third Intervention||0
8654786|NCT02714569|21365738|P8|COMPLETED|Part A Third Intervention||0
8654787|NCT02714569|21365739|P7|COMPLETED|Part A Third Intervention||0
8654788|NCT02714569|21365740|P6|COMPLETED|Part A Third Intervention||3
8654789|NCT02714569|21365741|P5|COMPLETED|Part A Third Intervention||3
8654790|NCT02714569|21365742|P4|COMPLETED|Part A Third Intervention||2
8654791|NCT02714569|21365743|P3|COMPLETED|Part A Third Intervention||2
8654792|NCT02714569|21365744|P2|COMPLETED|Part A Third Intervention||2
8654793|NCT02714569|21365745|P1|COMPLETED|Part A Third Intervention||3
8654794|NCT02714569|21365735|P11|Received at Least One Dose of Study Drug|Part A Third Intervention||0
8654795|NCT02714569|21365736|P10|Received at Least One Dose of Study Drug|Part A Third Intervention||0
8654796|NCT02714569|21365737|P9|Received at Least One Dose of Study Drug|Part A Third Intervention||0
8654797|NCT02714569|21365738|P8|Received at Least One Dose of Study Drug|Part A Third Intervention||0
8654798|NCT02714569|21365739|P7|Received at Least One Dose of Study Drug|Part A Third Intervention||0
8654799|NCT02714569|21365740|P6|Received at Least One Dose of Study Drug|Part A Third Intervention||3
8654800|NCT02714569|21365741|P5|Received at Least One Dose of Study Drug|Part A Third Intervention||3
8654801|NCT02714569|21365742|P4|Received at Least One Dose of Study Drug|Part A Third Intervention||2
8654802|NCT02714569|21365743|P3|Received at Least One Dose of Study Drug|Part A Third Intervention||2
8654803|NCT02714569|21365744|P2|Received at Least One Dose of Study Drug|Part A Third Intervention||2
8654804|NCT02714569|21365745|P1|Received at Least One Dose of Study Drug|Part A Third Intervention||3
8654805|NCT02714569|21365735|P11|STARTED|Part A Third Intervention||0
8654806|NCT02714569|21365736|P10|STARTED|Part A Third Intervention||0
8654807|NCT02714569|21365737|P9|STARTED|Part A Third Intervention||0
8654808|NCT02714569|21365738|P8|STARTED|Part A Third Intervention||0
8654809|NCT02714569|21365739|P7|STARTED|Part A Third Intervention||0
8654810|NCT02714569|21365740|P6|STARTED|Part A Third Intervention||3
8654811|NCT02714569|21365741|P5|STARTED|Part A Third Intervention||3
8654812|NCT02714569|21365742|P4|STARTED|Part A Third Intervention||3
8654813|NCT02714569|21365743|P3|STARTED|Part A Third Intervention||3
8654814|NCT02714569|21365744|P2|STARTED|Part A Third Intervention||2
8654815|NCT02714569|21365745|P1|STARTED|Part A Third Intervention||3
8654816|NCT02714569|21365735|P11|NOT COMPLETED|Part A Second Intervention||0
8654817|NCT02714569|21365736|P10|NOT COMPLETED|Part A Second Intervention||0
8654818|NCT02714569|21365737|P9|NOT COMPLETED|Part A Second Intervention||0
8654819|NCT02714569|21365738|P8|NOT COMPLETED|Part A Second Intervention||0
8654820|NCT02714569|21365739|P7|NOT COMPLETED|Part A Second Intervention||0
8654821|NCT02714569|21365740|P6|NOT COMPLETED|Part A Second Intervention||0
8654822|NCT02714569|21365741|P5|NOT COMPLETED|Part A Second Intervention||0
8654823|NCT02714569|21365742|P4|NOT COMPLETED|Part A Second Intervention||0
8654824|NCT02714569|21365743|P3|NOT COMPLETED|Part A Second Intervention||0
8654825|NCT02714569|21365744|P2|NOT COMPLETED|Part A Second Intervention||1
8654826|NCT02714569|21365745|P1|NOT COMPLETED|Part A Second Intervention||0
8654827|NCT02714569|21365735|P11|COMPLETED|Part A Second Intervention||0
8654828|NCT02714569|21365736|P10|COMPLETED|Part A Second Intervention||0
8654829|NCT02714569|21365737|P9|COMPLETED|Part A Second Intervention||0
8654830|NCT02714569|21365738|P8|COMPLETED|Part A Second Intervention||0
8654831|NCT02714569|21365739|P7|COMPLETED|Part A Second Intervention||0
8654832|NCT02714569|21365740|P6|COMPLETED|Part A Second Intervention||3
8654833|NCT02714569|21365741|P5|COMPLETED|Part A Second Intervention||3
8654834|NCT02714569|21365742|P4|COMPLETED|Part A Second Intervention||3
8654835|NCT02714569|21365743|P3|COMPLETED|Part A Second Intervention||3
8654836|NCT02714569|21365744|P2|COMPLETED|Part A Second Intervention||2
8654837|NCT02714569|21365745|P1|COMPLETED|Part A Second Intervention||3
8654838|NCT02714569|21365735|P11|Received at Least One Dose of Study Drug|Part A Second Intervention||0
8654839|NCT02714569|21365736|P10|Received at Least One Dose of Study Drug|Part A Second Intervention||0
8654840|NCT02714569|21365737|P9|Received at Least One Dose of Study Drug|Part A Second Intervention||0
8654841|NCT02714569|21365738|P8|Received at Least One Dose of Study Drug|Part A Second Intervention||0
8654842|NCT02714569|21365739|P7|Received at Least One Dose of Study Drug|Part A Second Intervention||0
8654843|NCT02714569|21365740|P6|Received at Least One Dose of Study Drug|Part A Second Intervention||3
8654844|NCT02714569|21365741|P5|Received at Least One Dose of Study Drug|Part A Second Intervention||3
8654845|NCT02714569|21365742|P4|Received at Least One Dose of Study Drug|Part A Second Intervention||3
8654846|NCT02714569|21365743|P3|Received at Least One Dose of Study Drug|Part A Second Intervention||3
8654847|NCT02714569|21365744|P2|Received at Least One Dose of Study Drug|Part A Second Intervention||2
8654848|NCT02714569|21365745|P1|Received at Least One Dose of Study Drug|Part A Second Intervention||3
8654849|NCT02714569|21365735|P11|STARTED|Part A Second Intervention||0
8654850|NCT02714569|21365736|P10|STARTED|Part A Second Intervention||0
8654851|NCT02714569|21365737|P9|STARTED|Part A Second Intervention||0
8654852|NCT02714569|21365738|P8|STARTED|Part A Second Intervention||0
8654853|NCT02714569|21365739|P7|STARTED|Part A Second Intervention||0
8654854|NCT02714569|21365740|P6|STARTED|Part A Second Intervention||3
8654855|NCT02714569|21365741|P5|STARTED|Part A Second Intervention||3
8654856|NCT02714569|21365742|P4|STARTED|Part A Second Intervention||3
8654857|NCT02714569|21365743|P3|STARTED|Part A Second Intervention||3
8654858|NCT02714569|21365744|P2|STARTED|Part A Second Intervention||3
8654859|NCT02714569|21365745|P1|STARTED|Part A Second Intervention||3
8654860|NCT02714569|21365735|P11|NOT COMPLETED|Part A First Intervention||0
8654861|NCT02714569|21365736|P10|NOT COMPLETED|Part A First Intervention||0
8654862|NCT02714569|21365737|P9|NOT COMPLETED|Part A First Intervention||0
8654863|NCT02714569|21365738|P8|NOT COMPLETED|Part A First Intervention||0
8654864|NCT02714569|21365739|P7|NOT COMPLETED|Part A First Intervention||0
8654865|NCT02714569|21365740|P6|NOT COMPLETED|Part A First Intervention||0
8654866|NCT02714569|21365741|P5|NOT COMPLETED|Part A First Intervention||0
8654867|NCT02714569|21365742|P4|NOT COMPLETED|Part A First Intervention||0
8654868|NCT02714569|21365743|P3|NOT COMPLETED|Part A First Intervention||0
8654869|NCT02714569|21365744|P2|NOT COMPLETED|Part A First Intervention||0
8654870|NCT02714569|21365745|P1|NOT COMPLETED|Part A First Intervention||0
8654871|NCT02714569|21365735|P11|COMPLETED|Part A First Intervention||0
8654872|NCT02714569|21365736|P10|COMPLETED|Part A First Intervention||0
8654873|NCT02714569|21365737|P9|COMPLETED|Part A First Intervention||0
8654874|NCT02714569|21365738|P8|COMPLETED|Part A First Intervention||0
8654875|NCT02714569|21365739|P7|COMPLETED|Part A First Intervention||0
8654876|NCT02714569|21365740|P6|COMPLETED|Part A First Intervention||3
8654877|NCT02714569|21365741|P5|COMPLETED|Part A First Intervention||3
8654878|NCT02714569|21365742|P4|COMPLETED|Part A First Intervention||3
8654879|NCT02714569|21365743|P3|COMPLETED|Part A First Intervention||3
8654880|NCT02714569|21365744|P2|COMPLETED|Part A First Intervention||3
8654881|NCT02714569|21365745|P1|COMPLETED|Part A First Intervention||3
8654882|NCT02714569|21365735|P11|Received at Least One Dose of Study Drug|Part A First Intervention||0
8654883|NCT02714569|21365736|P10|Received at Least One Dose of Study Drug|Part A First Intervention||0
8654884|NCT02714569|21365737|P9|Received at Least One Dose of Study Drug|Part A First Intervention||0
8654885|NCT02714569|21365738|P8|Received at Least One Dose of Study Drug|Part A First Intervention||0
8654886|NCT02714569|21365739|P7|Received at Least One Dose of Study Drug|Part A First Intervention||0
8654887|NCT02714569|21365740|P6|Received at Least One Dose of Study Drug|Part A First Intervention||3
8654888|NCT02714569|21365741|P5|Received at Least One Dose of Study Drug|Part A First Intervention||3
8654889|NCT02714569|21365742|P4|Received at Least One Dose of Study Drug|Part A First Intervention||3
8654890|NCT02714569|21365743|P3|Received at Least One Dose of Study Drug|Part A First Intervention||3
8654891|NCT02714569|21365744|P2|Received at Least One Dose of Study Drug|Part A First Intervention||3
8654892|NCT02714569|21365745|P1|Received at Least One Dose of Study Drug|Part A First Intervention||3
8654893|NCT02714569|21365735|P11|STARTED|Part A First Intervention||0
8654894|NCT02714569|21365736|P10|STARTED|Part A First Intervention||0
8654895|NCT02714569|21365737|P9|STARTED|Part A First Intervention||0
8654896|NCT02714569|21365738|P8|STARTED|Part A First Intervention||0
8654897|NCT02714569|21365739|P7|STARTED|Part A First Intervention||0
8654898|NCT02714569|21365740|P6|STARTED|Part A First Intervention||3
8654899|NCT02714569|21365741|P5|STARTED|Part A First Intervention||3
8654900|NCT02714569|21365742|P4|STARTED|Part A First Intervention||3
8654901|NCT02714569|21365743|P3|STARTED|Part A First Intervention||3
8654902|NCT02714569|21365744|P2|STARTED|Part A First Intervention||3
8654903|NCT02714569|21365745|P1|STARTED|Part A First Intervention||3
8654904|NCT02585960|21365871|P3|NOT COMPLETED|Prophylactic Treatment Period||0
8654905|NCT02585960|21365872|P2|NOT COMPLETED|Prophylactic Treatment Period||5
8654906|NCT02585960|21365873|P1|NOT COMPLETED|Prophylactic Treatment Period||0
8654907|NCT02585960|21365871|P3|COMPLETED|Prophylactic Treatment Period||0
8654908|NCT02585960|21365872|P2|COMPLETED|Prophylactic Treatment Period||43
8654909|NCT02585960|21365873|P1|COMPLETED|Prophylactic Treatment Period||52
8654910|NCT02585960|21365871|P3|STARTED|Prophylactic Treatment Period||0
8654911|NCT02585960|21365872|P2|STARTED|Prophylactic Treatment Period||48
8654912|NCT02585960|21365873|P1|STARTED|Prophylactic Treatment Period||52
8654913|NCT02585960|21365871|P3|NOT COMPLETED|PK/Safety Assessment Period||6
8654914|NCT02585960|21365872|P2|NOT COMPLETED|PK/Safety Assessment Period||10
8654915|NCT02585960|21365873|P1|NOT COMPLETED|PK/Safety Assessment Period||5
8654917|NCT02585960|21365872|P2|COMPLETED|PK/Safety Assessment Period||48
8654918|NCT02585960|21365873|P1|COMPLETED|PK/Safety Assessment Period||52
8654919|NCT02585960|21365871|P3|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0
8654920|NCT02585960|21365872|P2|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48
8654921|NCT02585960|21365873|P1|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52
8654922|NCT02585960|21365871|P3|Completed 1st 6 Month Period|PK/Safety Assessment Period||0
8654923|NCT02585960|21365872|P2|Completed 1st 6 Month Period|PK/Safety Assessment Period||53
8654924|NCT02585960|21365873|P1|Completed 1st 6 Month Period|PK/Safety Assessment Period||57
8654925|NCT02585960|21365871|P3|STARTED|PK/Safety Assessment Period||6
8654926|NCT02585960|21365872|P2|STARTED|PK/Safety Assessment Period||58
8654927|NCT02585960|21365873|P1|STARTED|PK/Safety Assessment Period||57
8654928|NCT02454153|21365943|P2|NOT COMPLETED|Overall Study||0
8654929|NCT02454153|21365944|P1|NOT COMPLETED|Overall Study||0
8654930|NCT02454153|21365943|P2|COMPLETED|Overall Study||92
8654931|NCT02454153|21365944|P1|COMPLETED|Overall Study||92
8654932|NCT02454153|21365943|P2|STARTED|Overall Study||92
8654933|NCT02454153|21365944|P1|STARTED|Overall Study||92
8654934|NCT02448810|21365976|P8|NOT COMPLETED|Overall Study||8
8654935|NCT02448810|21365977|P7|NOT COMPLETED|Overall Study||18
8654936|NCT02448810|21365978|P6|NOT COMPLETED|Overall Study||16
8654937|NCT02448810|21365979|P5|NOT COMPLETED|Overall Study||31
8654938|NCT02448810|21365980|P4|NOT COMPLETED|Overall Study||3
8654939|NCT02448810|21365981|P3|NOT COMPLETED|Overall Study||3
8654940|NCT02448810|21365982|P2|NOT COMPLETED|Overall Study||3
8654941|NCT02448810|21365983|P1|NOT COMPLETED|Overall Study||3
8654942|NCT02448810|21365976|P8|COMPLETED|Overall Study||0
8654943|NCT02448810|21365977|P7|COMPLETED|Overall Study||0
8654944|NCT02448810|21365978|P6|COMPLETED|Overall Study||0
8654945|NCT02448810|21365979|P5|COMPLETED|Overall Study||0
8654946|NCT02448810|21365980|P4|COMPLETED|Overall Study||0
8654947|NCT02448810|21365981|P3|COMPLETED|Overall Study||0
8654948|NCT02448810|21365982|P2|COMPLETED|Overall Study||0
8654949|NCT02448810|21365983|P1|COMPLETED|Overall Study||0
8654950|NCT02448810|21365976|P8|Treated|Overall Study||7
8654951|NCT02448810|21365977|P7|Treated|Overall Study||18
8654952|NCT02448810|21365978|P6|Treated|Overall Study||13
8654953|NCT02448810|21365979|P5|Treated|Overall Study||29
8654954|NCT02448810|21365980|P4|Treated|Overall Study||3
8654955|NCT02448810|21365981|P3|Treated|Overall Study||3
8654956|NCT02448810|21365982|P2|Treated|Overall Study||3
8654957|NCT02448810|21365983|P1|Treated|Overall Study||3
8654958|NCT02448810|21365976|P8|STARTED|Overall Study||8
8654959|NCT02448810|21365977|P7|STARTED|Overall Study||18
8654960|NCT02448810|21365978|P6|STARTED|Overall Study||16
8654961|NCT02448810|21365979|P5|STARTED|Overall Study||31
8654962|NCT02448810|21365980|P4|STARTED|Overall Study||3
8654963|NCT02448810|21365981|P3|STARTED|Overall Study||3
8654964|NCT02448810|21365982|P2|STARTED|Overall Study||3
8654965|NCT02448810|21365983|P1|STARTED|Overall Study||3
8654984|NCT02366195|21366067|P1|NOT COMPLETED|Overall Study||112
8654985|NCT02366195|21366067|P1|COMPLETED|Overall Study||0
8654986|NCT02366195|21366067|P1|Received Study Drug|Overall Study||111
8654987|NCT02366195|21366067|P1|STARTED|Overall Study||112
8654991|NCT02272842|21366091|P2|NOT COMPLETED|Overall Study||10
8654992|NCT02272842|21366092|P1|NOT COMPLETED|Overall Study||16
8654993|NCT02272842|21366091|P2|COMPLETED|Overall Study||290
8654994|NCT02272842|21366092|P1|COMPLETED|Overall Study||284
8654995|NCT02272842|21366091|P2|STARTED|Overall Study||300
8654996|NCT02272842|21366092|P1|STARTED|Overall Study||300
8654997|NCT02031146|21366106|P7|NOT COMPLETED|Overall Study||5
8654998|NCT02031146|21366107|P6|NOT COMPLETED|Overall Study||4
8654999|NCT02031146|21366108|P5|NOT COMPLETED|Overall Study||26
8655000|NCT02031146|21366109|P4|NOT COMPLETED|Overall Study||100
8655001|NCT02031146|21366110|P3|NOT COMPLETED|Overall Study||0
8655002|NCT02031146|21366111|P2|NOT COMPLETED|Overall Study||0
8655003|NCT02031146|21366112|P1|NOT COMPLETED|Overall Study||0
8655004|NCT02031146|21366106|P7|COMPLETED|Overall Study||0
8655005|NCT02031146|21366107|P6|COMPLETED|Overall Study||0
8655006|NCT02031146|21366108|P5|COMPLETED|Overall Study||16
8655007|NCT02031146|21366109|P4|COMPLETED|Overall Study||48
8655008|NCT02031146|21366110|P3|COMPLETED|Overall Study||18
8655009|NCT02031146|21366111|P2|COMPLETED|Overall Study||3
8655010|NCT02031146|21366112|P1|COMPLETED|Overall Study||11
8655011|NCT02031146|21366106|P7|Considered in Analysis|Overall Study||0
8655012|NCT02031146|21366107|P6|Considered in Analysis|Overall Study||0
8655013|NCT02031146|21366108|P5|Considered in Analysis|Overall Study||16
8655014|NCT02031146|21366109|P4|Considered in Analysis|Overall Study||48
8655015|NCT02031146|21366110|P3|Considered in Analysis|Overall Study||18
8655016|NCT02031146|21366111|P2|Considered in Analysis|Overall Study||3
8655017|NCT02031146|21366112|P1|Considered in Analysis|Overall Study||11
8655018|NCT02031146|21366106|P7|STARTED|Overall Study||5
8655019|NCT02031146|21366107|P6|STARTED|Overall Study||4
8655020|NCT02031146|21366108|P5|STARTED|Overall Study||42
8655021|NCT02031146|21366109|P4|STARTED|Overall Study||148
8655022|NCT02031146|21366110|P3|STARTED|Overall Study||18
8655023|NCT02031146|21366111|P2|STARTED|Overall Study||3
8655024|NCT02031146|21366112|P1|STARTED|Overall Study||11
8655025|NCT01987908|21366122|P3|NOT COMPLETED|Post-Treatment Observation Period||0
8655026|NCT01987908|21366123|P2|NOT COMPLETED|Post-Treatment Observation Period||3
8655027|NCT01987908|21366124|P1|NOT COMPLETED|Post-Treatment Observation Period||0
8655028|NCT01987908|21366122|P3|COMPLETED|Post-Treatment Observation Period||2
8655029|NCT01987908|21366123|P2|COMPLETED|Post-Treatment Observation Period||7
8655030|NCT01987908|21366124|P1|COMPLETED|Post-Treatment Observation Period||0
8655031|NCT01987908|21366122|P3|STARTED|Post-Treatment Observation Period||2
8655032|NCT01987908|21366123|P2|STARTED|Post-Treatment Observation Period||10
8655033|NCT01987908|21366124|P1|STARTED|Post-Treatment Observation Period||0
8655034|NCT01987908|21366122|P3|NOT COMPLETED|Treatment Period||1
8655035|NCT01987908|21366123|P2|NOT COMPLETED|Treatment Period||1
8655036|NCT01987908|21366124|P1|NOT COMPLETED|Treatment Period||0
8655037|NCT01987908|21366122|P3|COMPLETED|Treatment Period||2
8655038|NCT01987908|21366123|P2|COMPLETED|Treatment Period||10
8655039|NCT01987908|21366124|P1|COMPLETED|Treatment Period||0
8655040|NCT01987908|21366122|P3|STARTED|Treatment Period||3
8655041|NCT01987908|21366123|P2|STARTED|Treatment Period||11
8655042|NCT01987908|21366124|P1|STARTED|Treatment Period||0
8655043|NCT01987908|21366122|P3|NOT COMPLETED|Placebo Lead-in Period||0
8655044|NCT01987908|21366123|P2|NOT COMPLETED|Placebo Lead-in Period||0
8655045|NCT01987908|21366124|P1|NOT COMPLETED|Placebo Lead-in Period||9
8655046|NCT01987908|21366122|P3|COMPLETED|Placebo Lead-in Period||0
8655047|NCT01987908|21366123|P2|COMPLETED|Placebo Lead-in Period||0
8655048|NCT01987908|21366124|P1|COMPLETED|Placebo Lead-in Period||14
8655049|NCT01987908|21366122|P3|STARTED|Placebo Lead-in Period||0
8655050|NCT01987908|21366123|P2|STARTED|Placebo Lead-in Period||0
8655051|NCT01987908|21366124|P1|STARTED|Placebo Lead-in Period||23
8655052|NCT01820260|21366219|P14|NOT COMPLETED|Phase 2 (Part 2)||0
8655053|NCT01820260|21366220|P13|NOT COMPLETED|Phase 2 (Part 2)||0
8655054|NCT01820260|21366221|P12|NOT COMPLETED|Phase 2 (Part 2)||0
8655055|NCT01820260|21366222|P11|NOT COMPLETED|Phase 2 (Part 2)||0
8655056|NCT01820260|21366223|P10|NOT COMPLETED|Phase 2 (Part 2)||1
8655057|NCT01820260|21366224|P9|NOT COMPLETED|Phase 2 (Part 2)||0
8655058|NCT01820260|21366225|P8|NOT COMPLETED|Phase 2 (Part 2)||0
8655059|NCT01820260|21366226|P7|NOT COMPLETED|Phase 2 (Part 2)||0
8655060|NCT01820260|21366227|P6|NOT COMPLETED|Phase 2 (Part 2)||0
8655061|NCT01820260|21366228|P5|NOT COMPLETED|Phase 2 (Part 2)||0
8655062|NCT01820260|21366229|P4|NOT COMPLETED|Phase 2 (Part 2)||0
8655063|NCT01820260|21366230|P3|NOT COMPLETED|Phase 2 (Part 2)||0
8655064|NCT01820260|21366231|P2|NOT COMPLETED|Phase 2 (Part 2)||0
8655065|NCT01820260|21366232|P1|NOT COMPLETED|Phase 2 (Part 2)||0
8655066|NCT01820260|21366219|P14|COMPLETED|Phase 2 (Part 2)||31
8655067|NCT01820260|21366220|P13|COMPLETED|Phase 2 (Part 2)||31
8655068|NCT01820260|21366221|P12|COMPLETED|Phase 2 (Part 2)||64
8655069|NCT01820260|21366222|P11|COMPLETED|Phase 2 (Part 2)||61
8655070|NCT01820260|21366223|P10|COMPLETED|Phase 2 (Part 2)||61
8655071|NCT01820260|21366224|P9|COMPLETED|Phase 2 (Part 2)||64
8655072|NCT01820260|21366225|P8|COMPLETED|Phase 2 (Part 2)||0
8655073|NCT01820260|21366226|P7|COMPLETED|Phase 2 (Part 2)||0
8655074|NCT01820260|21366227|P6|COMPLETED|Phase 2 (Part 2)||0
8655075|NCT01820260|21366228|P5|COMPLETED|Phase 2 (Part 2)||0
8655076|NCT01820260|21366229|P4|COMPLETED|Phase 2 (Part 2)||0
8655077|NCT01820260|21366230|P3|COMPLETED|Phase 2 (Part 2)||0
8655078|NCT01820260|21366231|P2|COMPLETED|Phase 2 (Part 2)||0
8655079|NCT01820260|21366232|P1|COMPLETED|Phase 2 (Part 2)||0
8655080|NCT01820260|21366219|P14|STARTED|Phase 2 (Part 2)||31
8655081|NCT01820260|21366220|P13|STARTED|Phase 2 (Part 2)||31
8655082|NCT01820260|21366221|P12|STARTED|Phase 2 (Part 2)||64
8655083|NCT01820260|21366222|P11|STARTED|Phase 2 (Part 2)||61
8655084|NCT01820260|21366223|P10|STARTED|Phase 2 (Part 2)||62
8655085|NCT01820260|21366224|P9|STARTED|Phase 2 (Part 2)||64
8655086|NCT01820260|21366225|P8|STARTED|Phase 2 (Part 2)||0
8655087|NCT01820260|21366226|P7|STARTED|Phase 2 (Part 2)||0
8655088|NCT01820260|21366227|P6|STARTED|Phase 2 (Part 2)||0
8655089|NCT01820260|21366228|P5|STARTED|Phase 2 (Part 2)||0
8655090|NCT01820260|21366229|P4|STARTED|Phase 2 (Part 2)||0
8655091|NCT01820260|21366230|P3|STARTED|Phase 2 (Part 2)||0
8655092|NCT01820260|21366231|P2|STARTED|Phase 2 (Part 2)||0
8655093|NCT01820260|21366232|P1|STARTED|Phase 2 (Part 2)||0
8655094|NCT01820260|21366219|P14|NOT COMPLETED|Phase 1 (Part 1)||0
8655095|NCT01820260|21366220|P13|NOT COMPLETED|Phase 1 (Part 1)||0
8655096|NCT01820260|21366221|P12|NOT COMPLETED|Phase 1 (Part 1)||0
8655097|NCT01820260|21366222|P11|NOT COMPLETED|Phase 1 (Part 1)||0
8655098|NCT01820260|21366223|P10|NOT COMPLETED|Phase 1 (Part 1)||0
8655099|NCT01820260|21366224|P9|NOT COMPLETED|Phase 1 (Part 1)||0
8655100|NCT01820260|21366225|P8|NOT COMPLETED|Phase 1 (Part 1)||0
8655101|NCT01820260|21366226|P7|NOT COMPLETED|Phase 1 (Part 1)||1
8655102|NCT01820260|21366227|P6|NOT COMPLETED|Phase 1 (Part 1)||0
8655103|NCT01820260|21366228|P5|NOT COMPLETED|Phase 1 (Part 1)||0
8655104|NCT01820260|21366229|P4|NOT COMPLETED|Phase 1 (Part 1)||0
8655105|NCT01820260|21366230|P3|NOT COMPLETED|Phase 1 (Part 1)||0
8655106|NCT01820260|21366231|P2|NOT COMPLETED|Phase 1 (Part 1)||0
8655107|NCT01820260|21366232|P1|NOT COMPLETED|Phase 1 (Part 1)||0
8655108|NCT01820260|21366219|P14|COMPLETED|Phase 1 (Part 1)||0
8655109|NCT01820260|21366220|P13|COMPLETED|Phase 1 (Part 1)||0
8655110|NCT01820260|21366221|P12|COMPLETED|Phase 1 (Part 1)||0
8655111|NCT01820260|21366222|P11|COMPLETED|Phase 1 (Part 1)||0
8655112|NCT01820260|21366223|P10|COMPLETED|Phase 1 (Part 1)||0
8655113|NCT01820260|21366224|P9|COMPLETED|Phase 1 (Part 1)||0
8655114|NCT01820260|21366225|P8|COMPLETED|Phase 1 (Part 1)||11
8655115|NCT01820260|21366226|P7|COMPLETED|Phase 1 (Part 1)||11
8655116|NCT01820260|21366227|P6|COMPLETED|Phase 1 (Part 1)||10
8655117|NCT01820260|21366228|P5|COMPLETED|Phase 1 (Part 1)||12
8655118|NCT01820260|21366229|P4|COMPLETED|Phase 1 (Part 1)||12
8655119|NCT01820260|21366230|P3|COMPLETED|Phase 1 (Part 1)||10
8655120|NCT01820260|21366231|P2|COMPLETED|Phase 1 (Part 1)||12
8655121|NCT01820260|21366232|P1|COMPLETED|Phase 1 (Part 1)||3
8655122|NCT01820260|21366219|P14|STARTED|Phase 1 (Part 1)||0
8655123|NCT01820260|21366220|P13|STARTED|Phase 1 (Part 1)||0
8655124|NCT01820260|21366221|P12|STARTED|Phase 1 (Part 1)||0
8655125|NCT01820260|21366222|P11|STARTED|Phase 1 (Part 1)||0
8655126|NCT01820260|21366223|P10|STARTED|Phase 1 (Part 1)||0
8655127|NCT01820260|21366224|P9|STARTED|Phase 1 (Part 1)||0
8655128|NCT01820260|21366225|P8|STARTED|Phase 1 (Part 1)||11
8655129|NCT01820260|21366226|P7|STARTED|Phase 1 (Part 1)||12
8655130|NCT01820260|21366227|P6|STARTED|Phase 1 (Part 1)||10
8655131|NCT01820260|21366228|P5|STARTED|Phase 1 (Part 1)||12
8655132|NCT01820260|21366229|P4|STARTED|Phase 1 (Part 1)||12
8655133|NCT01820260|21366230|P3|STARTED|Phase 1 (Part 1)||10
8655134|NCT01820260|21366231|P2|STARTED|Phase 1 (Part 1)||12
8655135|NCT01820260|21366232|P1|STARTED|Phase 1 (Part 1)||3
8655136|NCT01696032|21366278|P4|NOT COMPLETED|Overall Study||22
8655137|NCT01696032|21366279|P3|NOT COMPLETED|Overall Study||51
8655138|NCT01696032|21366280|P2|NOT COMPLETED|Overall Study||6
8655139|NCT01696032|21366281|P1|NOT COMPLETED|Overall Study||14
8655140|NCT01696032|21366278|P4|COMPLETED|Overall Study||27
8655141|NCT01696032|21366279|P3|COMPLETED|Overall Study||0
8655142|NCT01696032|21366280|P2|COMPLETED|Overall Study||0
8655143|NCT01696032|21366281|P1|COMPLETED|Overall Study||0
8655144|NCT01696032|21366278|P4|STARTED|Overall Study||49
8655145|NCT01696032|21366279|P3|STARTED|Overall Study||51
8655146|NCT01696032|21366280|P2|STARTED|Overall Study||6
8655147|NCT01696032|21366281|P1|STARTED|Overall Study||14
8655148|NCT01651351|21366330|P2|NOT COMPLETED|Overall Study||0
8655149|NCT01651351|21366331|P1|NOT COMPLETED|Overall Study||0
8655150|NCT01651351|21366330|P2|COMPLETED|Overall Study||15
8655151|NCT01651351|21366331|P1|COMPLETED|Overall Study||15
8655152|NCT01651351|21366330|P2|STARTED|Overall Study||15
8655153|NCT01651351|21366331|P1|STARTED|Overall Study||15
8655154|NCT01622010|21366350|P2|NOT COMPLETED|Overall Study||4
8655155|NCT01622010|21366351|P1|NOT COMPLETED|Overall Study||6
8655156|NCT01622010|21366350|P2|COMPLETED|Overall Study||8
8655157|NCT01622010|21366351|P1|COMPLETED|Overall Study||12
8655158|NCT01622010|21366350|P2|STARTED|Overall Study||12
8655159|NCT01622010|21366351|P1|STARTED|Overall Study||18
8655160|NCT01598922|21366365|P2|NOT COMPLETED|Overall Study||10
8655161|NCT01598922|21366366|P1|NOT COMPLETED|Overall Study||3
8655162|NCT01598922|21366365|P2|COMPLETED|Overall Study||30
8655163|NCT01598922|21366366|P1|COMPLETED|Overall Study||34
8655164|NCT01598922|21366365|P2|STARTED|Overall Study||40
8655165|NCT01598922|21366366|P1|STARTED|Overall Study||37
8655169|NCT01380899|21366399|P3|NOT COMPLETED|Overall Study||0
8655170|NCT01380899|21366400|P2|NOT COMPLETED|Overall Study||0
8655171|NCT01380899|21366401|P1|NOT COMPLETED|Overall Study||0
8655172|NCT01380899|21366399|P3|COMPLETED|Overall Study||20
8655173|NCT01380899|21366400|P2|COMPLETED|Overall Study||33
8655174|NCT01380899|21366401|P1|COMPLETED|Overall Study||34
8655175|NCT01380899|21366399|P3|STARTED|Overall Study||20
8655176|NCT01380899|21366400|P2|STARTED|Overall Study||33
8655177|NCT01380899|21366401|P1|STARTED|Overall Study||34
8655178|NCT01297309|21366409|P1|NOT COMPLETED|Overall Study||14
8655179|NCT01297309|21366409|P1|COMPLETED|Overall Study||37
8655180|NCT01297309|21366409|P1|Started Extension Period|Overall Study||46
8655181|NCT01297309|21366409|P1|Treated|Overall Study||49
8655182|NCT01297309|21366409|P1|STARTED|Overall Study||51
8655186|NCT01220128|21366437|P7|NOT COMPLETED|Overall Study||5
8655187|NCT01220128|21366438|P6|NOT COMPLETED|Overall Study||0
8655188|NCT01220128|21366439|P5|NOT COMPLETED|Overall Study||0
8655189|NCT01220128|21366440|P4|NOT COMPLETED|Overall Study||0
8655190|NCT01220128|21366441|P3|NOT COMPLETED|Overall Study||3
8655191|NCT01220128|21366442|P2|NOT COMPLETED|Overall Study||1
8655192|NCT01220128|21366443|P1|NOT COMPLETED|Overall Study||4
8655193|NCT01220128|21366437|P7|COMPLETED|Overall Study||3
8655194|NCT01220128|21366438|P6|COMPLETED|Overall Study||4
8655195|NCT01220128|21366439|P5|COMPLETED|Overall Study||11
8655196|NCT01220128|21366440|P4|COMPLETED|Overall Study||6
8655197|NCT01220128|21366441|P3|COMPLETED|Overall Study||6
8655198|NCT01220128|21366442|P2|COMPLETED|Overall Study||6
8655199|NCT01220128|21366443|P1|COMPLETED|Overall Study||11
8655200|NCT01220128|21366437|P7|STARTED|Overall Study||8
8655201|NCT01220128|21366438|P6|STARTED|Overall Study||4
8655202|NCT01220128|21366439|P5|STARTED|Overall Study||11
8655203|NCT01220128|21366440|P4|STARTED|Overall Study||6
8655204|NCT01220128|21366441|P3|STARTED|Overall Study||9
8655205|NCT01220128|21366442|P2|STARTED|Overall Study||7
8655206|NCT01220128|21366443|P1|STARTED|Overall Study||15
8655213|NCT00981149|21366663|P2|NOT COMPLETED|Overall Study||3
8655214|NCT00981149|21366664|P1|NOT COMPLETED|Overall Study||2
8655215|NCT00981149|21366663|P2|COMPLETED|Overall Study||9
8655216|NCT00981149|21366664|P1|COMPLETED|Overall Study||10
8655217|NCT00981149|21366663|P2|STARTED|Overall Study||12
8655218|NCT00981149|21366664|P1|STARTED|Overall Study||12
8655219|NCT00971945|21366672|P1|NOT COMPLETED|Overall Study||6
8655220|NCT00971945|21366672|P1|COMPLETED|Overall Study||0
8655221|NCT00971945|21366672|P1|STARTED|Overall Study||6
8655222|NCT00943722|21366684|P5|NOT COMPLETED|Overall Study||22
8655223|NCT00943722|21366685|P4|NOT COMPLETED|Overall Study||22
8655224|NCT00943722|21366686|P3|NOT COMPLETED|Overall Study||13
8655225|NCT00943722|21366687|P2|NOT COMPLETED|Overall Study||22
8655226|NCT00943722|21366688|P1|NOT COMPLETED|Overall Study||25
8655227|NCT00943722|21366684|P5|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
8655228|NCT00943722|21366685|P4|COMPLETED|Overall Study||647
8655229|NCT00943722|21366686|P3|COMPLETED|Overall Study||631
8655230|NCT00943722|21366687|P2|COMPLETED|Overall Study||621
8655231|NCT00943722|21366688|P1|COMPLETED|Overall Study||623
8655232|NCT00943722|21366684|P5|Vaccination 3|Overall Study||455
8655233|NCT00943722|21366685|P4|Vaccination 3|Overall Study||653
8655234|NCT00943722|21366686|P3|Vaccination 3|Overall Study||637
8655235|NCT00943722|21366687|P2|Vaccination 3|Overall Study||627
8655236|NCT00943722|21366688|P1|Vaccination 3|Overall Study||635
8655237|NCT00943722|21366684|P5|Vaccination 2|Overall Study||462
8655238|NCT00943722|21366685|P4|Vaccination 2|Overall Study||658
8655239|NCT00943722|21366686|P3|Vaccination 2|Overall Study||638
8655240|NCT00943722|21366687|P2|Vaccination 2|Overall Study||633
8655241|NCT00943722|21366688|P1|Vaccination 2|Overall Study||637
8655242|NCT00943722|21366684|P5|Vaccination 1|Overall Study||468
8655243|NCT00943722|21366685|P4|Vaccination 1|Overall Study||666
8655244|NCT00943722|21366686|P3|Vaccination 1|Overall Study||644
8655245|NCT00943722|21366687|P2|Vaccination 1|Overall Study||642
8655246|NCT00943722|21366688|P1|Vaccination 1|Overall Study||646
8655247|NCT00943722|21366684|P5|STARTED|Overall Study||470
8655248|NCT00943722|21366685|P4|STARTED|Overall Study||669
8655249|NCT00943722|21366686|P3|STARTED|Overall Study||644
8655250|NCT00943722|21366687|P2|STARTED|Overall Study||643
8655251|NCT00943722|21366688|P1|STARTED|Overall Study||648
8655255|NCT00702052|21366725|P1|NOT COMPLETED|Overall Study||58
8655256|NCT00702052|21366725|P1|COMPLETED|Overall Study||0
8655257|NCT00702052|21366725|P1|STARTED|Overall Study||58
8655278|NCT00408005|21366749|P8|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14
8655279|NCT00408005|21366750|P7|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28
8655280|NCT00408005|21366751|P6|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101
8655281|NCT00408005|21366752|P5|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132
8655282|NCT00408005|21366753|P4|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44
8655283|NCT00408005|21366754|P3|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85
8655442|NCT04401202|21366816|P1|COMPLETED|Overall Study||86
8655284|NCT00408005|21366755|P2|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
8655285|NCT00408005|21366756|P1|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
8655286|NCT00408005|21366749|P8|COMPLETED|Post Induction Therapy by Tx Assignment||48
8655287|NCT00408005|21366750|P7|COMPLETED|Post Induction Therapy by Tx Assignment||115
8655288|NCT00408005|21366751|P6|COMPLETED|Post Induction Therapy by Tx Assignment||118
8655289|NCT00408005|21366752|P5|COMPLETED|Post Induction Therapy by Tx Assignment||319
8655290|NCT00408005|21366753|P4|COMPLETED|Post Induction Therapy by Tx Assignment||103
8655291|NCT00408005|21366754|P3|COMPLETED|Post Induction Therapy by Tx Assignment||287
8655292|NCT00408005|21366755|P2|COMPLETED|Post Induction Therapy by Tx Assignment||0
8655293|NCT00408005|21366756|P1|COMPLETED|Post Induction Therapy by Tx Assignment||0
8655294|NCT00408005|21366749|P8|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2
8655295|NCT00408005|21366750|P7|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
8655296|NCT00408005|21366751|P6|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
8655297|NCT00408005|21366752|P5|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
8655298|NCT00408005|21366753|P4|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
8655299|NCT00408005|21366754|P3|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
8655300|NCT00408005|21366755|P2|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
8655301|NCT00408005|21366756|P1|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
8655302|NCT00408005|21366749|P8|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60
8655303|NCT00408005|21366750|P7|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61
8655304|NCT00408005|21366751|P6|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
8655305|NCT00408005|21366752|P5|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
8655306|NCT00408005|21366753|P4|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
8655307|NCT00408005|21366754|P3|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
8655308|NCT00408005|21366755|P2|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
8655309|NCT00408005|21366756|P1|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
8655310|NCT00408005|21366749|P8|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
8655311|NCT00408005|21366750|P7|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82
8655312|NCT00408005|21366751|P6|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
8655313|NCT00408005|21366752|P5|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
8655314|NCT00408005|21366753|P4|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
8655315|NCT00408005|21366754|P3|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
8655316|NCT00408005|21366755|P2|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
8655317|NCT00408005|21366756|P1|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
8655318|NCT00408005|21366749|P8|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
8655319|NCT00408005|21366750|P7|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
8655320|NCT00408005|21366751|P6|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43
8655321|NCT00408005|21366752|P5|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
8655322|NCT00408005|21366753|P4|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
8655323|NCT00408005|21366754|P3|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
8655324|NCT00408005|21366755|P2|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
8655325|NCT00408005|21366756|P1|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
8655326|NCT00408005|21366749|P8|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
8655327|NCT00408005|21366750|P7|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
8655328|NCT00408005|21366751|P6|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31
8655329|NCT00408005|21366752|P5|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84
8655330|NCT00408005|21366753|P4|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
8655331|NCT00408005|21366754|P3|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
8655332|NCT00408005|21366755|P2|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
8655333|NCT00408005|21366756|P1|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
8655334|NCT00408005|21366749|P8|High Risk|Post Induction Therapy by Tx Assignment||0
8655335|NCT00408005|21366750|P7|High Risk|Post Induction Therapy by Tx Assignment||0
8655336|NCT00408005|21366751|P6|High Risk|Post Induction Therapy by Tx Assignment||52
8655337|NCT00408005|21366752|P5|High Risk|Post Induction Therapy by Tx Assignment||55
8655338|NCT00408005|21366753|P4|High Risk|Post Induction Therapy by Tx Assignment||52
8655339|NCT00408005|21366754|P3|High Risk|Post Induction Therapy by Tx Assignment||56
8655340|NCT00408005|21366755|P2|High Risk|Post Induction Therapy by Tx Assignment||0
8655341|NCT00408005|21366756|P1|High Risk|Post Induction Therapy by Tx Assignment||0
8655342|NCT00408005|21366749|P8|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
8655343|NCT00408005|21366750|P7|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
8655344|NCT00408005|21366751|P6|Intermediate Risk|Post Induction Therapy by Tx Assignment||93
8655345|NCT00408005|21366752|P5|Intermediate Risk|Post Induction Therapy by Tx Assignment||257
8655346|NCT00408005|21366753|P4|Intermediate Risk|Post Induction Therapy by Tx Assignment||95
8655347|NCT00408005|21366754|P3|Intermediate Risk|Post Induction Therapy by Tx Assignment||99
8655348|NCT00408005|21366755|P2|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
8655349|NCT00408005|21366756|P1|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
8655350|NCT00408005|21366749|P8|Low Risk|Post Induction Therapy by Tx Assignment||0
8655351|NCT00408005|21366750|P7|Low Risk|Post Induction Therapy by Tx Assignment||0
8655443|NCT04401202|21366815|P2|STARTED|Overall Study||91
8655352|NCT00408005|21366751|P6|Low Risk|Post Induction Therapy by Tx Assignment||0
8655353|NCT00408005|21366752|P5|Low Risk|Post Induction Therapy by Tx Assignment||55
8655354|NCT00408005|21366753|P4|Low Risk|Post Induction Therapy by Tx Assignment||0
8655355|NCT00408005|21366754|P3|Low Risk|Post Induction Therapy by Tx Assignment||217
8655356|NCT00408005|21366755|P2|Low Risk|Post Induction Therapy by Tx Assignment||0
8655357|NCT00408005|21366756|P1|Low Risk|Post Induction Therapy by Tx Assignment||0
8655358|NCT00408005|21366749|P8|STARTED|Post Induction Therapy by Tx Assignment||62
8655359|NCT00408005|21366750|P7|STARTED|Post Induction Therapy by Tx Assignment||143
8655360|NCT00408005|21366751|P6|STARTED|Post Induction Therapy by Tx Assignment||219
8655361|NCT00408005|21366752|P5|STARTED|Post Induction Therapy by Tx Assignment||451
8655362|NCT00408005|21366753|P4|STARTED|Post Induction Therapy by Tx Assignment||147
8655363|NCT00408005|21366754|P3|STARTED|Post Induction Therapy by Tx Assignment||372
8655364|NCT00408005|21366755|P2|STARTED|Post Induction Therapy by Tx Assignment||0
8655365|NCT00408005|21366756|P1|STARTED|Post Induction Therapy by Tx Assignment||0
8655366|NCT00408005|21366749|P8|NOT COMPLETED|Induction||0
8655367|NCT00408005|21366750|P7|NOT COMPLETED|Induction||0
8655368|NCT00408005|21366751|P6|NOT COMPLETED|Induction||0
8655369|NCT00408005|21366752|P5|NOT COMPLETED|Induction||0
8655370|NCT00408005|21366753|P4|NOT COMPLETED|Induction||0
8655371|NCT00408005|21366754|P3|NOT COMPLETED|Induction||0
8655372|NCT00408005|21366755|P2|NOT COMPLETED|Induction||94
8655373|NCT00408005|21366756|P1|NOT COMPLETED|Induction||407
8655374|NCT00408005|21366749|P8|COMPLETED|Induction||0
8655375|NCT00408005|21366750|P7|COMPLETED|Induction||0
8655376|NCT00408005|21366751|P6|COMPLETED|Induction||0
8655377|NCT00408005|21366752|P5|COMPLETED|Induction||0
8655378|NCT00408005|21366753|P4|COMPLETED|Induction||0
8655379|NCT00408005|21366754|P3|COMPLETED|Induction||0
8655380|NCT00408005|21366755|P2|COMPLETED|Induction||205
8655381|NCT00408005|21366756|P1|COMPLETED|Induction||1189
8655382|NCT00408005|21366749|P8|STARTED|Induction||0
8655383|NCT00408005|21366750|P7|STARTED|Induction||0
8655384|NCT00408005|21366751|P6|STARTED|Induction||0
8655385|NCT00408005|21366752|P5|STARTED|Induction||0
8655386|NCT00408005|21366753|P4|STARTED|Induction||0
8655387|NCT00408005|21366754|P3|STARTED|Induction||0
8655388|NCT00408005|21366755|P2|STARTED|Induction||299
8655389|NCT00408005|21366756|P1|STARTED|Induction||1596
8655430|NCT04725500|21366803|P1|NOT COMPLETED|2 Week Take Home||5
8655431|NCT04725500|21366803|P1|COMPLETED|2 Week Take Home||10
8655432|NCT04725500|21366803|P1|STARTED|2 Week Take Home||15
8655433|NCT04725500|21366803|P1|NOT COMPLETED|Overnight Polysomnography (PSG)||0
8655434|NCT04725500|21366803|P1|COMPLETED|Overnight Polysomnography (PSG)||15
8655435|NCT04725500|21366803|P1|STARTED|Overnight Polysomnography (PSG)||15
8655436|NCT04725500|21366803|P1|NOT COMPLETED|Screening||27
8655437|NCT04725500|21366803|P1|COMPLETED|Screening||15
8655438|NCT04725500|21366803|P1|STARTED|Screening||42
8655439|NCT04401202|21366815|P2|NOT COMPLETED|Overall Study||4
8655440|NCT04401202|21366816|P1|NOT COMPLETED|Overall Study||6
8655441|NCT04401202|21366815|P2|COMPLETED|Overall Study||87
8655444|NCT04401202|21366816|P1|STARTED|Overall Study||92
8655445|NCT04340557|21366832|P2|NOT COMPLETED|Overall Study||2
8655446|NCT04340557|21366833|P1|NOT COMPLETED|Overall Study||1
8655447|NCT04340557|21366832|P2|COMPLETED|Overall Study||13
8655448|NCT04340557|21366833|P1|COMPLETED|Overall Study||15
8655449|NCT04340557|21366832|P2|STARTED|Overall Study||15
8655450|NCT04340557|21366833|P1|STARTED|Overall Study||16
8655451|NCT04290676|21366847|P1|NOT COMPLETED|Overall Study||0
8655452|NCT04290676|21366847|P1|COMPLETED|Overall Study||527
8655453|NCT04290676|21366847|P1|STARTED|Overall Study||527
8655454|NCT04107493|21366851|P2|NOT COMPLETED|Second Intervention||0
8655455|NCT04107493|21366852|P1|NOT COMPLETED|Second Intervention||0
8655456|NCT04107493|21366851|P2|COMPLETED|Second Intervention||17
8655457|NCT04107493|21366852|P1|COMPLETED|Second Intervention||16
8655458|NCT04107493|21366851|P2|STARTED|Second Intervention||17
8655459|NCT04107493|21366852|P1|STARTED|Second Intervention||16
8655460|NCT04107493|21366851|P2|NOT COMPLETED|Washout (One Hour)||0
8655461|NCT04107493|21366852|P1|NOT COMPLETED|Washout (One Hour)||0
8655462|NCT04107493|21366851|P2|COMPLETED|Washout (One Hour)||17
8655463|NCT04107493|21366852|P1|COMPLETED|Washout (One Hour)||16
8655464|NCT04107493|21366851|P2|STARTED|Washout (One Hour)||17
8655465|NCT04107493|21366852|P1|STARTED|Washout (One Hour)||16
8655466|NCT04107493|21366851|P2|NOT COMPLETED|First Intervention (1 Hour)||0
8655467|NCT04107493|21366852|P1|NOT COMPLETED|First Intervention (1 Hour)||0
8655468|NCT04107493|21366851|P2|COMPLETED|First Intervention (1 Hour)||17
8655469|NCT04107493|21366852|P1|COMPLETED|First Intervention (1 Hour)||16
8655470|NCT04107493|21366851|P2|STARTED|First Intervention (1 Hour)||17
8655471|NCT04107493|21366852|P1|STARTED|First Intervention (1 Hour)||16
8655475|NCT03702166|21366869|P1|NOT COMPLETED|Overall Study||2
8655476|NCT03702166|21366869|P1|COMPLETED|Overall Study||8
8655477|NCT03702166|21366869|P1|STARTED|Overall Study||10
8655478|NCT03532308|21366880|P2|NOT COMPLETED|Overall Study||1
8655479|NCT03532308|21366881|P1|NOT COMPLETED|Overall Study||0
8655480|NCT03532308|21366880|P2|COMPLETED|Overall Study||8
8655481|NCT03532308|21366881|P1|COMPLETED|Overall Study||10
8655482|NCT03532308|21366880|P2|Completed Assessments|Overall Study||7
8655483|NCT03532308|21366881|P1|Completed Assessments|Overall Study||9
8655484|NCT03532308|21366880|P2|STARTED|Overall Study||9
8655485|NCT03532308|21366881|P1|STARTED|Overall Study||10
8655486|NCT03248492|21366902|P5|NOT COMPLETED|Overall Study||4
8655487|NCT03248492|21366903|P4|NOT COMPLETED|Overall Study||130
8655488|NCT03248492|21366904|P3|NOT COMPLETED|Overall Study||21
8655489|NCT03248492|21366905|P2|NOT COMPLETED|Overall Study||48
8655490|NCT03248492|21366906|P1|NOT COMPLETED|Overall Study||50
8655491|NCT03248492|21366902|P5|COMPLETED|Overall Study||0
8655492|NCT03248492|21366903|P4|COMPLETED|Overall Study||0
8655493|NCT03248492|21366904|P3|COMPLETED|Overall Study||0
8655494|NCT03248492|21366905|P2|COMPLETED|Overall Study||0
8655495|NCT03248492|21366906|P1|COMPLETED|Overall Study||0
8655496|NCT03248492|21366902|P5|STARTED|Overall Study||4
8655497|NCT03248492|21366903|P4|STARTED|Overall Study||130
8655498|NCT03248492|21366904|P3|STARTED|Overall Study||21
8655499|NCT03248492|21366905|P2|STARTED|Overall Study||48
8655500|NCT03248492|21366906|P1|STARTED|Overall Study||50
8655501|NCT03222349|21366944|P2|NOT COMPLETED|Overall Study||7
8655502|NCT03222349|21366945|P1|NOT COMPLETED|Overall Study||8
8655503|NCT03222349|21366944|P2|COMPLETED|Overall Study||6
8655504|NCT03222349|21366945|P1|COMPLETED|Overall Study||3
8655505|NCT03222349|21366944|P2|STARTED|Overall Study||13
8655506|NCT03222349|21366945|P1|STARTED|Overall Study||11
8655507|NCT03123614|21366971|P2|NOT COMPLETED|Overall Study||0
8655508|NCT03123614|21366972|P1|NOT COMPLETED|Overall Study||0
8655509|NCT03123614|21366971|P2|COMPLETED|Overall Study||74
8655510|NCT03123614|21366972|P1|COMPLETED|Overall Study||57
8655511|NCT03123614|21366971|P2|STARTED|Overall Study||74
8655512|NCT03123614|21366972|P1|STARTED|Overall Study||57
8655513|NCT02888665|21366987|P3|NOT COMPLETED|Overall Study||0
8655514|NCT02888665|21366988|P2|NOT COMPLETED|Overall Study||0
8655515|NCT02888665|21366989|P1|NOT COMPLETED|Overall Study||0
8655516|NCT02888665|21366987|P3|COMPLETED|Overall Study||31
8655517|NCT02888665|21366988|P2|COMPLETED|Overall Study||3
8655518|NCT02888665|21366989|P1|COMPLETED|Overall Study||3
8655519|NCT02888665|21366987|P3|STARTED|Overall Study||31
8655520|NCT02888665|21366988|P2|STARTED|Overall Study||3
8655521|NCT02888665|21366989|P1|STARTED|Overall Study||3
8655522|NCT02811913|21367001|P1|NOT COMPLETED|Overall Study||4
8655523|NCT02811913|21367001|P1|COMPLETED|Overall Study||16
8655524|NCT02811913|21367001|P1|STARTED|Overall Study||20
8655525|NCT02716818|21367014|P2|NOT COMPLETED|Overall Study||2
8655526|NCT02716818|21367015|P1|NOT COMPLETED|Overall Study||3
8655527|NCT02716818|21367014|P2|COMPLETED|Overall Study||59
8655528|NCT02716818|21367015|P1|COMPLETED|Overall Study||58
8655529|NCT02716818|21367014|P2|STARTED|Overall Study||61
8655530|NCT02716818|21367015|P1|STARTED|Overall Study||61
8655557|NCT02650856|21367079|P2|NOT COMPLETED|Overall Study||0
8655558|NCT02650856|21367080|P1|NOT COMPLETED|Overall Study||0
8655559|NCT02650856|21367079|P2|COMPLETED|Overall Study||21
8655560|NCT02650856|21367080|P1|COMPLETED|Overall Study||19
8655561|NCT02650856|21367079|P2|72 Hours|Overall Study||21
8655562|NCT02650856|21367080|P1|72 Hours|Overall Study||19
8655563|NCT02650856|21367079|P2|48 Hours|Overall Study||21
8655564|NCT02650856|21367080|P1|48 Hours|Overall Study||19
8655565|NCT02650856|21367079|P2|24 Hours|Overall Study||21
8655566|NCT02650856|21367080|P1|24 Hours|Overall Study||19
8655567|NCT02650856|21367079|P2|Baseline|Overall Study||21
8655568|NCT02650856|21367080|P1|Baseline|Overall Study||19
8655569|NCT02650856|21367079|P2|STARTED|Overall Study||21
8655570|NCT02650856|21367080|P1|STARTED|Overall Study||19
8655571|NCT02574637|21367095|P10|NOT COMPLETED|Open-label (OL) Period||1
8655572|NCT02574637|21367096|P9|NOT COMPLETED|Open-label (OL) Period||2
8655573|NCT02574637|21367097|P8|NOT COMPLETED|Open-label (OL) Period||1
8655574|NCT02574637|21367098|P7|NOT COMPLETED|Open-label (OL) Period||2
8655575|NCT02574637|21367099|P6|NOT COMPLETED|Open-label (OL) Period||2
8655576|NCT02574637|21367100|P5|NOT COMPLETED|Open-label (OL) Period||0
8655577|NCT02574637|21367101|P4|NOT COMPLETED|Open-label (OL) Period||0
8655578|NCT02574637|21367102|P3|NOT COMPLETED|Open-label (OL) Period||0
8655579|NCT02574637|21367103|P2|NOT COMPLETED|Open-label (OL) Period||0
8655580|NCT02574637|21367104|P1|NOT COMPLETED|Open-label (OL) Period||0
8655581|NCT02574637|21367095|P10|COMPLETED|Open-label (OL) Period||0
8655582|NCT02574637|21367096|P9|COMPLETED|Open-label (OL) Period||1
8655583|NCT02574637|21367097|P8|COMPLETED|Open-label (OL) Period||1
8655584|NCT02574637|21367098|P7|COMPLETED|Open-label (OL) Period||1
8655585|NCT02574637|21367099|P6|COMPLETED|Open-label (OL) Period||0
8655586|NCT02574637|21367100|P5|COMPLETED|Open-label (OL) Period||0
8655587|NCT02574637|21367101|P4|COMPLETED|Open-label (OL) Period||0
8655588|NCT02574637|21367102|P3|COMPLETED|Open-label (OL) Period||0
8655589|NCT02574637|21367103|P2|COMPLETED|Open-label (OL) Period||0
8655590|NCT02574637|21367104|P1|COMPLETED|Open-label (OL) Period||0
8655591|NCT02574637|21367095|P10|STARTED|Open-label (OL) Period||1
8655592|NCT02574637|21367096|P9|STARTED|Open-label (OL) Period||3
8655593|NCT02574637|21367097|P8|STARTED|Open-label (OL) Period||2
8655594|NCT02574637|21367098|P7|STARTED|Open-label (OL) Period||3
8655595|NCT02574637|21367099|P6|STARTED|Open-label (OL) Period||2
8655596|NCT02574637|21367100|P5|STARTED|Open-label (OL) Period||0
8655597|NCT02574637|21367101|P4|STARTED|Open-label (OL) Period||0
8655598|NCT02574637|21367102|P3|STARTED|Open-label (OL) Period||0
8655599|NCT02574637|21367103|P2|STARTED|Open-label (OL) Period||0
8655600|NCT02574637|21367104|P1|STARTED|Open-label (OL) Period||0
8655601|NCT02574637|21367095|P10|NOT COMPLETED|Double-blind Period||0
8655602|NCT02574637|21367096|P9|NOT COMPLETED|Double-blind Period||0
8655603|NCT02574637|21367097|P8|NOT COMPLETED|Double-blind Period||0
8655604|NCT02574637|21367098|P7|NOT COMPLETED|Double-blind Period||0
8655605|NCT02574637|21367099|P6|NOT COMPLETED|Double-blind Period||0
8655606|NCT02574637|21367100|P5|NOT COMPLETED|Double-blind Period||2
8655607|NCT02574637|21367101|P4|NOT COMPLETED|Double-blind Period||4
8655608|NCT02574637|21367102|P3|NOT COMPLETED|Double-blind Period||7
8655609|NCT02574637|21367103|P2|NOT COMPLETED|Double-blind Period||1
8655610|NCT02574637|21367104|P1|NOT COMPLETED|Double-blind Period||3
8655611|NCT02574637|21367095|P10|COMPLETED|Double-blind Period||0
8655612|NCT02574637|21367096|P9|COMPLETED|Double-blind Period||0
8655613|NCT02574637|21367097|P8|COMPLETED|Double-blind Period||0
8655614|NCT02574637|21367098|P7|COMPLETED|Double-blind Period||0
8655615|NCT02574637|21367099|P6|COMPLETED|Double-blind Period||0
8655616|NCT02574637|21367100|P5|COMPLETED|Double-blind Period||1
8655617|NCT02574637|21367101|P4|COMPLETED|Double-blind Period||3
8655618|NCT02574637|21367102|P3|COMPLETED|Double-blind Period||2
8655619|NCT02574637|21367103|P2|COMPLETED|Double-blind Period||4
8655620|NCT02574637|21367104|P1|COMPLETED|Double-blind Period||2
8655621|NCT02574637|21367095|P10|STARTED|Double-blind Period||0
8655622|NCT02574637|21367096|P9|STARTED|Double-blind Period||0
8655623|NCT02574637|21367097|P8|STARTED|Double-blind Period||0
8655624|NCT02574637|21367098|P7|STARTED|Double-blind Period||0
8655625|NCT02574637|21367099|P6|STARTED|Double-blind Period||0
8655626|NCT02574637|21367100|P5|STARTED|Double-blind Period||3
8655627|NCT02574637|21367101|P4|STARTED|Double-blind Period||7
8655628|NCT02574637|21367102|P3|STARTED|Double-blind Period||9
8655629|NCT02574637|21367103|P2|STARTED|Double-blind Period||5
8655630|NCT02574637|21367104|P1|STARTED|Double-blind Period||5
8655637|NCT02538510|21367247|P2|NOT COMPLETED|Overall Study||0
8655638|NCT02538510|21367248|P1|NOT COMPLETED|Overall Study||0
8655639|NCT02538510|21367247|P2|COMPLETED|Overall Study||25
8655640|NCT02538510|21367248|P1|COMPLETED|Overall Study||25
8655641|NCT02538510|21367247|P2|STARTED|Overall Study||25
8655642|NCT02538510|21367248|P1|STARTED|Overall Study||25
8655643|NCT02530619|21367258|P1|NOT COMPLETED|Follow-up Period (6 Months)||11
8655644|NCT02530619|21367258|P1|COMPLETED|Follow-up Period (6 Months)||10
8655645|NCT02530619|21367258|P1|STARTED|Follow-up Period (6 Months)|Patients who received at least one dose of study drug go into follow-up.|21
8655646|NCT02530619|21367258|P1|NOT COMPLETED|Continued Treatment Cycle 7+||0
8655647|NCT02530619|21367258|P1|COMPLETED|Continued Treatment Cycle 7+||14
8655648|NCT02530619|21367258|P1|STARTED|Continued Treatment Cycle 7+||14
8655649|NCT02530619|21367258|P1|NOT COMPLETED|Continued Treatment Cycles 2 Through 6||10
8655650|NCT02530619|21367258|P1|COMPLETED|Continued Treatment Cycles 2 Through 6||14
8655651|NCT02530619|21367258|P1|STARTED|Continued Treatment Cycles 2 Through 6||24
8655652|NCT02530619|21367258|P1|NOT COMPLETED|Completed 1st Cycle of Treatment||0
8655653|NCT02530619|21367258|P1|COMPLETED|Completed 1st Cycle of Treatment||24
8655654|NCT02530619|21367258|P1|STARTED|Completed 1st Cycle of Treatment||24
8655655|NCT02530619|21367258|P1|NOT COMPLETED|Registered for Study||2
8655656|NCT02530619|21367258|P1|COMPLETED|Registered for Study||24
8655657|NCT02530619|21367258|P1|Received 1st Dose of Alisertib|Registered for Study||24
8655658|NCT02530619|21367258|P1|Registered|Registered for Study||26
8655659|NCT02530619|21367258|P1|STARTED|Registered for Study||26
8655660|NCT02502097|21367266|P4|NOT COMPLETED|Period 2||0
8655661|NCT02502097|21367267|P3|NOT COMPLETED|Period 2||1
8655662|NCT02502097|21367268|P2|NOT COMPLETED|Period 2||0
8655663|NCT02502097|21367269|P1|NOT COMPLETED|Period 2||0
8655664|NCT02502097|21367266|P4|COMPLETED|Period 2||21
8655665|NCT02502097|21367267|P3|COMPLETED|Period 2||19
8655666|NCT02502097|21367268|P2|COMPLETED|Period 2||2
8655667|NCT02502097|21367269|P1|COMPLETED|Period 2||4
8655668|NCT02502097|21367266|P4|STARTED|Period 2||21
8655669|NCT02502097|21367267|P3|STARTED|Period 2||20
8655670|NCT02502097|21367268|P2|STARTED|Period 2||2
8655671|NCT02502097|21367269|P1|STARTED|Period 2||4
8655672|NCT02502097|21367266|P4|NOT COMPLETED|Wash Out Period||1
8655673|NCT02502097|21367267|P3|NOT COMPLETED|Wash Out Period||1
8655674|NCT02502097|21367268|P2|NOT COMPLETED|Wash Out Period||1
8655675|NCT02502097|21367269|P1|NOT COMPLETED|Wash Out Period||0
8655676|NCT02502097|21367266|P4|COMPLETED|Wash Out Period||21
8655677|NCT02502097|21367267|P3|COMPLETED|Wash Out Period||20
8655678|NCT02502097|21367268|P2|COMPLETED|Wash Out Period||2
8655679|NCT02502097|21367269|P1|COMPLETED|Wash Out Period||4
8655680|NCT02502097|21367266|P4|STARTED|Wash Out Period||22
8655681|NCT02502097|21367267|P3|STARTED|Wash Out Period||21
8655682|NCT02502097|21367268|P2|STARTED|Wash Out Period||3
8655683|NCT02502097|21367269|P1|STARTED|Wash Out Period||4
8655684|NCT02502097|21367266|P4|NOT COMPLETED|Period 1||0
8655685|NCT02502097|21367267|P3|NOT COMPLETED|Period 1||1
8655686|NCT02502097|21367268|P2|NOT COMPLETED|Period 1||0
8655687|NCT02502097|21367269|P1|NOT COMPLETED|Period 1||0
8655688|NCT02502097|21367266|P4|COMPLETED|Period 1||22
8655689|NCT02502097|21367267|P3|COMPLETED|Period 1||21
8655690|NCT02502097|21367268|P2|COMPLETED|Period 1||3
8655691|NCT02502097|21367269|P1|COMPLETED|Period 1||4
8655692|NCT02502097|21367266|P4|STARTED|Period 1||22
8655693|NCT02502097|21367267|P3|STARTED|Period 1||22
8655694|NCT02502097|21367268|P2|STARTED|Period 1||3
8655695|NCT02502097|21367269|P1|STARTED|Period 1||4
8655696|NCT02397096|21367348|P2|NOT COMPLETED|Study Extensions||202
8655697|NCT02397096|21367349|P1|NOT COMPLETED|Study Extensions||399
8655698|NCT02397096|21367348|P2|COMPLETED|Study Extensions|The extension study is ongoing.|0
8655699|NCT02397096|21367349|P1|COMPLETED|Study Extensions|The extension study is ongoing.|0
8655700|NCT02397096|21367348|P2|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202
8655701|NCT02397096|21367349|P1|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399
8655702|NCT02397096|21367348|P2|NOT COMPLETED|Week 24 to Week 48||7
8655703|NCT02397096|21367349|P1|NOT COMPLETED|Week 24 to Week 48||20
8655704|NCT02397096|21367348|P2|COMPLETED|Week 24 to Week 48||202
8655705|NCT02397096|21367349|P1|COMPLETED|Week 24 to Week 48||407
8655706|NCT02397096|21367348|P2|STARTED|Week 24 to Week 48||209
8655707|NCT02397096|21367349|P1|STARTED|Week 24 to Week 48||427
8655708|NCT02397096|21367348|P2|NOT COMPLETED|Day 1 to Week 24||14
8655709|NCT02397096|21367349|P1|NOT COMPLETED|Day 1 to Week 24||20
8655710|NCT02397096|21367348|P2|COMPLETED|Day 1 to Week 24||209
8655711|NCT02397096|21367349|P1|COMPLETED|Day 1 to Week 24||427
8655712|NCT02397096|21367348|P2|STARTED|Day 1 to Week 24||223
8655713|NCT02397096|21367349|P1|STARTED|Day 1 to Week 24||447
8655714|NCT02395991|21367379|P1|NOT COMPLETED|Overall Study||1
8655715|NCT02395991|21367379|P1|COMPLETED|Overall Study||59
8655716|NCT02395991|21367379|P1|STARTED|Overall Study||60
8655717|NCT02351349|21367387|P2|NOT COMPLETED|Overall Study||3
8655718|NCT02351349|21367388|P1|NOT COMPLETED|Overall Study||2
8655719|NCT02351349|21367387|P2|COMPLETED|Overall Study||5
8655720|NCT02351349|21367388|P1|COMPLETED|Overall Study||4
8655721|NCT02351349|21367387|P2|STARTED|Overall Study||8
8655722|NCT02351349|21367388|P1|STARTED|Overall Study||6
8655731|NCT02291289|21367463|P12|NOT COMPLETED|Maintenance Treatment Phase||16
8655732|NCT02291289|21367464|P11|NOT COMPLETED|Maintenance Treatment Phase||31
8655733|NCT02291289|21367465|P10|NOT COMPLETED|Maintenance Treatment Phase||0
8655734|NCT02291289|21367466|P9|NOT COMPLETED|Maintenance Treatment Phase||2
8655735|NCT02291289|21367467|P8|NOT COMPLETED|Maintenance Treatment Phase||2
8655736|NCT02291289|21367468|P7|NOT COMPLETED|Maintenance Treatment Phase||0
8655737|NCT02291289|21367469|P6|NOT COMPLETED|Maintenance Treatment Phase||129
8655738|NCT02291289|21367470|P5|NOT COMPLETED|Maintenance Treatment Phase||252
8655739|NCT02291289|21367471|P4|NOT COMPLETED|Maintenance Treatment Phase||0
8655740|NCT02291289|21367472|P3|NOT COMPLETED|Maintenance Treatment Phase||16
8655741|NCT02291289|21367473|P2|NOT COMPLETED|Maintenance Treatment Phase||24
8655742|NCT02291289|21367474|P1|NOT COMPLETED|Maintenance Treatment Phase||0
8655743|NCT02291289|21367463|P12|COMPLETED|Maintenance Treatment Phase||18
8655744|NCT02291289|21367464|P11|COMPLETED|Maintenance Treatment Phase||34
8655745|NCT02291289|21367465|P10|COMPLETED|Maintenance Treatment Phase||0
8655746|NCT02291289|21367466|P9|COMPLETED|Maintenance Treatment Phase||0
8655747|NCT02291289|21367467|P8|COMPLETED|Maintenance Treatment Phase||1
8655748|NCT02291289|21367468|P7|COMPLETED|Maintenance Treatment Phase||0
8655749|NCT02291289|21367469|P6|COMPLETED|Maintenance Treatment Phase||19
8655750|NCT02291289|21367470|P5|COMPLETED|Maintenance Treatment Phase||45
8655751|NCT02291289|21367471|P4|COMPLETED|Maintenance Treatment Phase||0
8655752|NCT02291289|21367472|P3|COMPLETED|Maintenance Treatment Phase||4
8655753|NCT02291289|21367473|P2|COMPLETED|Maintenance Treatment Phase||16
8655754|NCT02291289|21367474|P1|COMPLETED|Maintenance Treatment Phase||0
8655755|NCT02291289|21367463|P12|Dosed|Maintenance Treatment Phase||34
8655756|NCT02291289|21367464|P11|Dosed|Maintenance Treatment Phase||64
8655757|NCT02291289|21367465|P10|Dosed|Maintenance Treatment Phase||0
8655758|NCT02291289|21367466|P9|Dosed|Maintenance Treatment Phase||2
8655759|NCT02291289|21367467|P8|Dosed|Maintenance Treatment Phase||3
8655760|NCT02291289|21367468|P7|Dosed|Maintenance Treatment Phase||0
8655761|NCT02291289|21367469|P6|Dosed|Maintenance Treatment Phase||143
8655762|NCT02291289|21367470|P5|Dosed|Maintenance Treatment Phase||293
8655763|NCT02291289|21367471|P4|Dosed|Maintenance Treatment Phase||0
8655764|NCT02291289|21367472|P3|Dosed|Maintenance Treatment Phase||18
8655765|NCT02291289|21367473|P2|Dosed|Maintenance Treatment Phase||40
8655766|NCT02291289|21367474|P1|Dosed|Maintenance Treatment Phase||0
8655767|NCT02291289|21367463|P12|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|34
8655768|NCT02291289|21367464|P11|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|65
8655769|NCT02291289|21367465|P10|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
8655770|NCT02291289|21367466|P9|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|2
8655771|NCT02291289|21367467|P8|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|3
8655772|NCT02291289|21367468|P7|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
8655773|NCT02291289|21367469|P6|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|148
8655774|NCT02291289|21367470|P5|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|297
8655775|NCT02291289|21367471|P4|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
8655776|NCT02291289|21367472|P3|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|20
8655777|NCT02291289|21367473|P2|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|40
8655778|NCT02291289|21367474|P1|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
8655779|NCT02291289|21367463|P12|NOT COMPLETED|Induction Treatment||0
8655780|NCT02291289|21367464|P11|NOT COMPLETED|Induction Treatment||0
8655781|NCT02291289|21367465|P10|NOT COMPLETED|Induction Treatment||1
8655782|NCT02291289|21367466|P9|NOT COMPLETED|Induction Treatment||0
8655783|NCT02291289|21367467|P8|NOT COMPLETED|Induction Treatment||0
8655784|NCT02291289|21367468|P7|NOT COMPLETED|Induction Treatment||0
8655785|NCT02291289|21367469|P6|NOT COMPLETED|Induction Treatment||0
8655786|NCT02291289|21367470|P5|NOT COMPLETED|Induction Treatment||0
8655787|NCT02291289|21367471|P4|NOT COMPLETED|Induction Treatment||9
8655788|NCT02291289|21367472|P3|NOT COMPLETED|Induction Treatment||0
8655789|NCT02291289|21367473|P2|NOT COMPLETED|Induction Treatment||0
8655790|NCT02291289|21367474|P1|NOT COMPLETED|Induction Treatment||2
8655791|NCT02291289|21367463|P12|COMPLETED|Induction Treatment||0
8655792|NCT02291289|21367464|P11|COMPLETED|Induction Treatment||0
8655793|NCT02291289|21367465|P10|COMPLETED|Induction Treatment||98
8655794|NCT02291289|21367466|P9|COMPLETED|Induction Treatment||0
8655795|NCT02291289|21367467|P8|COMPLETED|Induction Treatment||0
8655796|NCT02291289|21367468|P7|COMPLETED|Induction Treatment||5
8655797|NCT02291289|21367469|P6|COMPLETED|Induction Treatment||0
8655798|NCT02291289|21367470|P5|COMPLETED|Induction Treatment||0
8655799|NCT02291289|21367471|P4|COMPLETED|Induction Treatment||436
8655800|NCT02291289|21367472|P3|COMPLETED|Induction Treatment||0
8655801|NCT02291289|21367473|P2|COMPLETED|Induction Treatment||0
8655802|NCT02291289|21367474|P1|COMPLETED|Induction Treatment||58
8655803|NCT02291289|21367463|P12|STARTED|Induction Treatment||0
8655804|NCT02291289|21367464|P11|STARTED|Induction Treatment||0
8655805|NCT02291289|21367465|P10|STARTED|Induction Treatment||99
8655806|NCT02291289|21367466|P9|STARTED|Induction Treatment||0
8655807|NCT02291289|21367467|P8|STARTED|Induction Treatment||0
8655808|NCT02291289|21367468|P7|STARTED|Induction Treatment||5
8655809|NCT02291289|21367469|P6|STARTED|Induction Treatment||0
8655810|NCT02291289|21367470|P5|STARTED|Induction Treatment||0
8655811|NCT02291289|21367471|P4|STARTED|Induction Treatment||445
8655812|NCT02291289|21367472|P3|STARTED|Induction Treatment||0
8655813|NCT02291289|21367473|P2|STARTED|Induction Treatment||0
8655814|NCT02291289|21367474|P1|STARTED|Induction Treatment||60
8655815|NCT02281084|21367540|P4|NOT COMPLETED|Overall Study||5
8655816|NCT02281084|21367541|P3|NOT COMPLETED|Overall Study||4
8655817|NCT02281084|21367542|P2|NOT COMPLETED|Overall Study||18
8655818|NCT02281084|21367543|P1|NOT COMPLETED|Overall Study||22
8655819|NCT02281084|21367540|P4|COMPLETED|Overall Study||0
8655820|NCT02281084|21367541|P3|COMPLETED|Overall Study||2
8655821|NCT02281084|21367542|P2|COMPLETED|Overall Study||4
8655822|NCT02281084|21367543|P1|COMPLETED|Overall Study||10
8655823|NCT02281084|21367540|P4|STARTED|Overall Study||5
8655824|NCT02281084|21367541|P3|STARTED|Overall Study||6
8655825|NCT02281084|21367542|P2|STARTED|Overall Study||22
8655826|NCT02281084|21367543|P1|STARTED|Overall Study||32
8655852|NCT02020967|21367655|P1|NOT COMPLETED|Overall Study||51
8655853|NCT02020967|21367655|P1|COMPLETED|Overall Study||316
8655854|NCT02020967|21367655|P1|Examined Participants|Overall Study||329
8655855|NCT02020967|21367655|P1|STARTED|Overall Study||367
8655856|NCT01989221|21367665|P1|NOT COMPLETED|Overall Study||0
8655857|NCT01989221|21367665|P1|COMPLETED|Overall Study||14
8655858|NCT01989221|21367665|P1|STARTED|Overall Study||14
8655859|NCT01968213|21367672|P2|NOT COMPLETED|Overall Study||9
8655860|NCT01968213|21367673|P1|NOT COMPLETED|Overall Study||90
8655861|NCT01968213|21367672|P2|COMPLETED|Overall Study||180
8655862|NCT01968213|21367673|P1|COMPLETED|Overall Study||285
8655863|NCT01968213|21367672|P2|STARTED|Overall Study||189
8655864|NCT01968213|21367673|P1|STARTED|Overall Study||375
8655871|NCT01938001|21367695|P2|NOT COMPLETED|Overall Study||47
8655872|NCT01938001|21367696|P1|NOT COMPLETED|Overall Study||43
8655873|NCT01938001|21367695|P2|COMPLETED|Overall Study||133
8655874|NCT01938001|21367696|P1|COMPLETED|Overall Study||135
8655875|NCT01938001|21367695|P2|Completed Treatment|Overall Study||110
8655876|NCT01938001|21367696|P1|Completed Treatment|Overall Study||124
8655877|NCT01938001|21367695|P2|Participants Received Treatment|Overall Study||180
8655878|NCT01938001|21367696|P1|Participants Received Treatment|Overall Study||176
8655879|NCT01938001|21367695|P2|STARTED|Overall Study||180
8655880|NCT01938001|21367696|P1|STARTED|Overall Study||178
8655889|NCT01862614|21367739|P2|NOT COMPLETED|Second Appointment.||0
8655890|NCT01862614|21367740|P1|NOT COMPLETED|Second Appointment.||0
8655891|NCT01862614|21367739|P2|COMPLETED|Second Appointment.||40
8655892|NCT01862614|21367740|P1|COMPLETED|Second Appointment.||40
8655893|NCT01862614|21367739|P2|STARTED|Second Appointment.|Received articaine at second appointment.|40
8655894|NCT01862614|21367740|P1|STARTED|Second Appointment.|Received buffered articaine at second appointment.|40
8655895|NCT01862614|21367739|P2|NOT COMPLETED|2 Week Washout Period.||0
8655896|NCT01862614|21367740|P1|NOT COMPLETED|2 Week Washout Period.||0
8655897|NCT01862614|21367739|P2|COMPLETED|2 Week Washout Period.||40
8655898|NCT01862614|21367740|P1|COMPLETED|2 Week Washout Period.||40
8655899|NCT01862614|21367739|P2|STARTED|2 Week Washout Period.||40
8655900|NCT01862614|21367740|P1|STARTED|2 Week Washout Period.||40
8655901|NCT01862614|21367739|P2|NOT COMPLETED|First Appointment.||0
8655902|NCT01862614|21367740|P1|NOT COMPLETED|First Appointment.||0
8655903|NCT01862614|21367739|P2|COMPLETED|First Appointment.||40
8655904|NCT01862614|21367740|P1|COMPLETED|First Appointment.||40
8655905|NCT01862614|21367739|P2|STARTED|First Appointment.|Received buffered articaine at first appointment.|40
8655906|NCT01862614|21367740|P1|STARTED|First Appointment.|Received articaine injection at first appointment.|40
8655915|NCT01714726|21367769|P4|NOT COMPLETED|Open-Label Period||28
8655916|NCT01714726|21367770|P3|NOT COMPLETED|Open-Label Period||19
8655917|NCT01714726|21367771|P2|NOT COMPLETED|Open-Label Period||0
8655918|NCT01714726|21367772|P1|NOT COMPLETED|Open-Label Period||0
8655919|NCT01714726|21367769|P4|COMPLETED|Open-Label Period||24
8655920|NCT01714726|21367770|P3|COMPLETED|Open-Label Period||33
8655921|NCT01714726|21367771|P2|COMPLETED|Open-Label Period||0
8655922|NCT01714726|21367772|P1|COMPLETED|Open-Label Period||0
8655923|NCT01714726|21367769|P4|STARTED|Open-Label Period||52
8655924|NCT01714726|21367770|P3|STARTED|Open-Label Period||52
8655925|NCT01714726|21367771|P2|STARTED|Open-Label Period||0
8655926|NCT01714726|21367772|P1|STARTED|Open-Label Period||0
8655927|NCT01714726|21367769|P4|NOT COMPLETED|Double-Blinded Induction Period||0
8655928|NCT01714726|21367770|P3|NOT COMPLETED|Double-Blinded Induction Period||0
8655929|NCT01714726|21367771|P2|NOT COMPLETED|Double-Blinded Induction Period||7
8655930|NCT01714726|21367772|P1|NOT COMPLETED|Double-Blinded Induction Period||8
8655931|NCT01714726|21367769|P4|COMPLETED|Double-Blinded Induction Period||0
8655932|NCT01714726|21367770|P3|COMPLETED|Double-Blinded Induction Period||0
8655933|NCT01714726|21367771|P2|COMPLETED|Double-Blinded Induction Period||52
8655934|NCT01714726|21367772|P1|COMPLETED|Double-Blinded Induction Period||52
8655935|NCT01714726|21367769|P4|STARTED|Double-Blinded Induction Period||0
8655936|NCT01714726|21367770|P3|STARTED|Double-Blinded Induction Period||0
8655937|NCT01714726|21367771|P2|STARTED|Double-Blinded Induction Period||59
8655938|NCT01714726|21367772|P1|STARTED|Double-Blinded Induction Period||60
8655958|NCT01407354|21367907|P2|NOT COMPLETED|Second Intervention||2
8655959|NCT01407354|21367908|P1|NOT COMPLETED|Second Intervention||0
8655960|NCT01407354|21367907|P2|COMPLETED|Second Intervention||13
8655961|NCT01407354|21367908|P1|COMPLETED|Second Intervention||18
8655962|NCT01407354|21367907|P2|STARTED|Second Intervention||15
8655963|NCT01407354|21367908|P1|STARTED|Second Intervention||18
8655964|NCT01407354|21367907|P2|NOT COMPLETED|First Intervention||2
8655965|NCT01407354|21367908|P1|NOT COMPLETED|First Intervention||2
8655966|NCT01407354|21367907|P2|COMPLETED|First Intervention||15
8655967|NCT01407354|21367908|P1|COMPLETED|First Intervention||18
8655968|NCT01407354|21367907|P2|STARTED|First Intervention||17
8655969|NCT01407354|21367908|P1|STARTED|First Intervention||20
8655970|NCT01027754|21367918|P2|NOT COMPLETED|Overall Study||8
8655971|NCT01027754|21367919|P1|NOT COMPLETED|Overall Study||2
8655972|NCT01027754|21367918|P2|COMPLETED|Overall Study||47
8655973|NCT01027754|21367919|P1|COMPLETED|Overall Study||55
8655974|NCT01027754|21367918|P2|STARTED|Overall Study||55
8655975|NCT01027754|21367919|P1|STARTED|Overall Study||57
8655976|NCT01000636|21367953|P1|NOT COMPLETED|Overall Study||2
8655977|NCT01000636|21367953|P1|COMPLETED|Overall Study||7
8655978|NCT01000636|21367953|P1|STARTED|Overall Study||9
8655979|NCT00740129|21367958|P1|NOT COMPLETED|Overall Study||0
8655980|NCT00740129|21367958|P1|COMPLETED|Overall Study||6
8655981|NCT00740129|21367958|P1|STARTED|Overall Study||6
8655982|NCT00622505|21367967|P2|NOT COMPLETED|Overall Study||23
8655983|NCT00622505|21367968|P1|NOT COMPLETED|Overall Study||29
8655984|NCT00622505|21367967|P2|COMPLETED|Overall Study||19
8655985|NCT00622505|21367968|P1|COMPLETED|Overall Study||50
8655986|NCT00622505|21367967|P2|STARTED|Overall Study||42
8655987|NCT00622505|21367968|P1|STARTED|Overall Study||79
8655988|NCT00580333|21367992|P1|NOT COMPLETED|Overall Study||0
8655989|NCT00580333|21367992|P1|COMPLETED|Overall Study||51
8655990|NCT00580333|21367992|P1|STARTED|Overall Study||51
8655991|NCT00571519|21368006|P7|NOT COMPLETED|Overall Study||24
8655992|NCT00571519|21368007|P6|NOT COMPLETED|Overall Study||10
8655993|NCT00571519|21368008|P5|NOT COMPLETED|Overall Study||9
8655994|NCT00571519|21368009|P4|NOT COMPLETED|Overall Study||27
8655995|NCT00571519|21368010|P3|NOT COMPLETED|Overall Study||12
8655996|NCT00571519|21368011|P2|NOT COMPLETED|Overall Study||9
8655997|NCT00571519|21368012|P1|NOT COMPLETED|Overall Study||3
8655998|NCT00571519|21368006|P7|COMPLETED|Overall Study||0
8655999|NCT00571519|21368007|P6|COMPLETED|Overall Study||0
8656000|NCT00571519|21368008|P5|COMPLETED|Overall Study||0
8656001|NCT00571519|21368009|P4|COMPLETED|Overall Study||0
8656002|NCT00571519|21368010|P3|COMPLETED|Overall Study||0
8656003|NCT00571519|21368011|P2|COMPLETED|Overall Study||0
8656004|NCT00571519|21368012|P1|COMPLETED|Overall Study||0
8656005|NCT00571519|21368006|P7|STARTED|Overall Study||24
8656006|NCT00571519|21368007|P6|STARTED|Overall Study||10
8656007|NCT00571519|21368008|P5|STARTED|Overall Study||9
8656008|NCT00571519|21368009|P4|STARTED|Overall Study||27
8656009|NCT00571519|21368010|P3|STARTED|Overall Study||12
8656010|NCT00571519|21368011|P2|STARTED|Overall Study||9
8656011|NCT00571519|21368012|P1|STARTED|Overall Study||3
8656012|NCT00542191|21368126|P1|NOT COMPLETED|Overall Study||3
8656013|NCT00542191|21368126|P1|COMPLETED|Overall Study||18
8656014|NCT00542191|21368126|P1|STARTED|Overall Study||21
8656015|NCT00313144|21368130|P1|NOT COMPLETED|Overall Study||110
8656016|NCT00313144|21368130|P1|COMPLETED|Overall Study||17
8656017|NCT00313144|21368130|P1|STARTED|Overall Study||127
8656018|NCT00288080|21368216|P2|NOT COMPLETED|Overall Study||23
8656019|NCT00288080|21368217|P1|NOT COMPLETED|Overall Study||26
8656020|NCT00288080|21368216|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
8656021|NCT00288080|21368217|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
8656022|NCT00288080|21368216|P2|STARTED|Overall Study||305
8656023|NCT00288080|21368217|P1|STARTED|Overall Study||307
8656045|NCT03980522|21368300|P5|NOT COMPLETED|Extension Period||0
8656046|NCT03980522|21368301|P4|NOT COMPLETED|Extension Period||0
8656047|NCT03980522|21368302|P3|NOT COMPLETED|Extension Period||0
8656048|NCT03980522|21368303|P2|NOT COMPLETED|Extension Period||0
8656049|NCT03980522|21368304|P1|NOT COMPLETED|Extension Period||0
8656050|NCT03980522|21368300|P5|COMPLETED|Extension Period||3
8656051|NCT03980522|21368301|P4|COMPLETED|Extension Period||1
8656052|NCT03980522|21368302|P3|COMPLETED|Extension Period||5
8656053|NCT03980522|21368303|P2|COMPLETED|Extension Period||3
8656054|NCT03980522|21368304|P1|COMPLETED|Extension Period||12
8656055|NCT03980522|21368300|P5|STARTED|Extension Period||3
8656056|NCT03980522|21368301|P4|STARTED|Extension Period||1
8656057|NCT03980522|21368302|P3|STARTED|Extension Period|1 participant did not sign the optional Extension Period consent form.|5
8656058|NCT03980522|21368303|P2|STARTED|Extension Period||3
8656059|NCT03980522|21368304|P1|STARTED|Extension Period||12
8656060|NCT03980522|21368300|P5|NOT COMPLETED|Treatment Period||0
8656061|NCT03980522|21368301|P4|NOT COMPLETED|Treatment Period||0
8656062|NCT03980522|21368302|P3|NOT COMPLETED|Treatment Period||0
8656063|NCT03980522|21368303|P2|NOT COMPLETED|Treatment Period||0
8656064|NCT03980522|21368304|P1|NOT COMPLETED|Treatment Period||1
8656065|NCT03980522|21368300|P5|COMPLETED|Treatment Period||3
8656066|NCT03980522|21368301|P4|COMPLETED|Treatment Period||1
8656067|NCT03980522|21368302|P3|COMPLETED|Treatment Period||6
8656068|NCT03980522|21368303|P2|COMPLETED|Treatment Period||3
8656069|NCT03980522|21368304|P1|COMPLETED|Treatment Period||12
8656070|NCT03980522|21368300|P5|STARTED|Treatment Period||3
8656071|NCT03980522|21368301|P4|STARTED|Treatment Period||1
8656072|NCT03980522|21368302|P3|STARTED|Treatment Period||6
8656073|NCT03980522|21368303|P2|STARTED|Treatment Period||3
8656074|NCT03980522|21368304|P1|STARTED|Treatment Period||13
8656075|NCT03865407|21368329|P2|NOT COMPLETED|Overall Study||0
8656076|NCT03865407|21368330|P1|NOT COMPLETED|Overall Study||3
8656077|NCT03865407|21368329|P2|COMPLETED|Overall Study||7
8656078|NCT03865407|21368330|P1|COMPLETED|Overall Study||7
8656079|NCT03865407|21368329|P2|STARTED|Overall Study||7
8656080|NCT03865407|21368330|P1|STARTED|Overall Study||10
8656081|NCT03816709|21368346|P1|NOT COMPLETED|Overall Study||0
8656082|NCT03816709|21368346|P1|COMPLETED|Overall Study||25
8656083|NCT03816709|21368346|P1|STARTED|Overall Study||25
8656090|NCT03699124|21368372|P3|NOT COMPLETED|Overall Study||40
8656091|NCT03699124|21368373|P2|NOT COMPLETED|Overall Study||40
8656092|NCT03699124|21368374|P1|NOT COMPLETED|Overall Study||45
8656093|NCT03699124|21368372|P3|COMPLETED|Overall Study||337
8656094|NCT03699124|21368373|P2|COMPLETED|Overall Study||335
8656095|NCT03699124|21368374|P1|COMPLETED|Overall Study||332
8656096|NCT03699124|21368372|P3|STARTED|Overall Study||377
8656097|NCT03699124|21368373|P2|STARTED|Overall Study||375
8656098|NCT03699124|21368374|P1|STARTED|Overall Study||377
8656099|NCT03511053|21368418|P1|NOT COMPLETED|Overall Study||1
8656100|NCT03511053|21368418|P1|COMPLETED|Overall Study||10
8656101|NCT03511053|21368418|P1|STARTED|Overall Study||11
8656102|NCT03379662|21368426|P2|NOT COMPLETED|Overall Study||0
8656103|NCT03379662|21368427|P1|NOT COMPLETED|Overall Study||0
8656104|NCT03379662|21368426|P2|COMPLETED|Overall Study||19
8656105|NCT03379662|21368427|P1|COMPLETED|Overall Study||21
8656106|NCT03379662|21368426|P2|STARTED|Overall Study||19
8656107|NCT03379662|21368427|P1|STARTED|Overall Study||21
8656108|NCT03364036|21368433|P1|NOT COMPLETED|Overall Study||6
8656109|NCT03364036|21368433|P1|COMPLETED|Overall Study||264
8656110|NCT03364036|21368433|P1|Full Analysis Set (FAS)|Overall Study||270
8656111|NCT03364036|21368433|P1|STARTED|Overall Study||270
8656124|NCT03280264|21368564|P1|NOT COMPLETED|Overall Study||3
8656125|NCT03280264|21368564|P1|COMPLETED|Overall Study||15
8656126|NCT03280264|21368564|P1|STARTED|Overall Study||18
8656127|NCT03055936|21368576|P4|NOT COMPLETED|Overall Study||1
8656128|NCT03055936|21368577|P3|NOT COMPLETED|Overall Study||2
8656129|NCT03055936|21368578|P2|NOT COMPLETED|Overall Study||1
8656130|NCT03055936|21368579|P1|NOT COMPLETED|Overall Study||2
8656131|NCT03055936|21368576|P4|COMPLETED|Overall Study||13
8656132|NCT03055936|21368577|P3|COMPLETED|Overall Study||12
8656133|NCT03055936|21368578|P2|COMPLETED|Overall Study||13
8656134|NCT03055936|21368579|P1|COMPLETED|Overall Study||12
8656135|NCT03055936|21368576|P4|STARTED|Overall Study||14
8656136|NCT03055936|21368577|P3|STARTED|Overall Study||14
8656137|NCT03055936|21368578|P2|STARTED|Overall Study||14
8656138|NCT03055936|21368579|P1|STARTED|Overall Study||14
8656139|NCT02975349|21368650|P6|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
8656140|NCT02975349|21368651|P5|NOT COMPLETED|Blinded Extension Period (24 Weeks)||2
8656141|NCT02975349|21368652|P4|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
8656142|NCT02975349|21368653|P3|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
8656143|NCT02975349|21368654|P2|NOT COMPLETED|Blinded Extension Period (24 Weeks)||7
8656144|NCT02975349|21368655|P1|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
8656145|NCT02975349|21368650|P6|COMPLETED|Blinded Extension Period (24 Weeks)||52
8656146|NCT02975349|21368651|P5|COMPLETED|Blinded Extension Period (24 Weeks)||46
8656147|NCT02975349|21368652|P4|COMPLETED|Blinded Extension Period (24 Weeks)||44
8656148|NCT02975349|21368653|P3|COMPLETED|Blinded Extension Period (24 Weeks)||43
8656149|NCT02975349|21368654|P2|COMPLETED|Blinded Extension Period (24 Weeks)||42
8656150|NCT02975349|21368655|P1|COMPLETED|Blinded Extension Period (24 Weeks)||0
8656151|NCT02975349|21368650|P6|STARTED|Blinded Extension Period (24 Weeks)||52
8656152|NCT02975349|21368651|P5|STARTED|Blinded Extension Period (24 Weeks)||48
8656153|NCT02975349|21368652|P4|STARTED|Blinded Extension Period (24 Weeks)||48
8656154|NCT02975349|21368653|P3|STARTED|Blinded Extension Period (24 Weeks)||47
8656155|NCT02975349|21368654|P2|STARTED|Blinded Extension Period (24 Weeks)||49
8656156|NCT02975349|21368655|P1|STARTED|Blinded Extension Period (24 Weeks)||0
8656157|NCT02975349|21368650|P6|NOT COMPLETED|Active Treatment Period (24 Weeks)||2
8656158|NCT02975349|21368651|P5|NOT COMPLETED|Active Treatment Period (24 Weeks)||6
8656159|NCT02975349|21368652|P4|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
8656160|NCT02975349|21368653|P3|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
8656161|NCT02975349|21368654|P2|NOT COMPLETED|Active Treatment Period (24 Weeks)||0
8656162|NCT02975349|21368655|P1|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
8656163|NCT02975349|21368650|P6|COMPLETED|Active Treatment Period (24 Weeks)||52
8656164|NCT02975349|21368651|P5|COMPLETED|Active Treatment Period (24 Weeks)||48
8656165|NCT02975349|21368652|P4|COMPLETED|Active Treatment Period (24 Weeks)||48
8656166|NCT02975349|21368653|P3|COMPLETED|Active Treatment Period (24 Weeks)||47
8656167|NCT02975349|21368654|P2|COMPLETED|Active Treatment Period (24 Weeks)||0
8656168|NCT02975349|21368655|P1|COMPLETED|Active Treatment Period (24 Weeks)||49
8656169|NCT02975349|21368650|P6|STARTED|Active Treatment Period (24 Weeks)||54
8656170|NCT02975349|21368651|P5|STARTED|Active Treatment Period (24 Weeks)||54
8656171|NCT02975349|21368652|P4|STARTED|Active Treatment Period (24 Weeks)||53
8656172|NCT02975349|21368653|P3|STARTED|Active Treatment Period (24 Weeks)||52
8656173|NCT02975349|21368654|P2|STARTED|Active Treatment Period (24 Weeks)||0
8656174|NCT02975349|21368655|P1|STARTED|Active Treatment Period (24 Weeks)||54
8656175|NCT02965378|21368788|P2|NOT COMPLETED|Overall Study||9
8656176|NCT02965378|21368789|P1|NOT COMPLETED|Overall Study||25
8656177|NCT02965378|21368788|P2|COMPLETED|Overall Study||0
8656178|NCT02965378|21368789|P1|COMPLETED|Overall Study||0
8656179|NCT02965378|21368788|P2|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||2
8656180|NCT02965378|21368789|P1|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||0
8656181|NCT02965378|21368788|P2|STARTED|Overall Study||9
8656182|NCT02965378|21368789|P1|STARTED|Overall Study||25
8656183|NCT02910037|21368798|P1|NOT COMPLETED|Overall Study||10
8656184|NCT02910037|21368798|P1|COMPLETED|Overall Study||204
8656185|NCT02910037|21368798|P1|STARTED|Overall Study||214
8656192|NCT02785939|21368838|P2|NOT COMPLETED|Overall Study||10
8656193|NCT02785939|21368839|P1|NOT COMPLETED|Overall Study||31
8656194|NCT02785939|21368838|P2|COMPLETED|Overall Study||0
8656195|NCT02785939|21368839|P1|COMPLETED|Overall Study||0
8656196|NCT02785939|21368838|P2|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||1
8656197|NCT02785939|21368839|P1|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||0
8656198|NCT02785939|21368838|P2|STARTED|Overall Study||10
8656199|NCT02785939|21368839|P1|STARTED|Overall Study||31
8656200|NCT02769481|21368850|P2|NOT COMPLETED|Overall Study||36
8656201|NCT02769481|21368851|P1|NOT COMPLETED|Overall Study||33
8656202|NCT02769481|21368850|P2|COMPLETED|Overall Study||177
8656203|NCT02769481|21368851|P1|COMPLETED|Overall Study||180
8656204|NCT02769481|21368850|P2|Study Complete at Week 60|Overall Study||192
8656205|NCT02769481|21368851|P1|Study Complete at Week 60|Overall Study||193
8656206|NCT02769481|21368850|P2|STARTED|Overall Study||213
8656207|NCT02769481|21368851|P1|STARTED|Overall Study||213
8656208|NCT02658487|21368865|P1|NOT COMPLETED|Overall Study||16
8656209|NCT02658487|21368865|P1|COMPLETED|Overall Study||26
8656210|NCT02658487|21368865|P1|STARTED|Overall Study||42
8656251|NCT02188303|21369071|P8|NOT COMPLETED|Overall Study||6
8656252|NCT02188303|21369072|P7|NOT COMPLETED|Overall Study||2
8656253|NCT02188303|21369073|P6|NOT COMPLETED|Overall Study||2
8656254|NCT02188303|21369074|P5|NOT COMPLETED|Overall Study||0
8656255|NCT02188303|21369075|P4|NOT COMPLETED|Overall Study||0
8656256|NCT02188303|21369076|P3|NOT COMPLETED|Overall Study||0
8656257|NCT02188303|21369077|P2|NOT COMPLETED|Overall Study||0
8656258|NCT02188303|21369078|P1|NOT COMPLETED|Overall Study||0
8656259|NCT02188303|21369071|P8|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
8656260|NCT02188303|21369072|P7|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
8656261|NCT02188303|21369073|P6|COMPLETED|Overall Study||10
8656262|NCT02188303|21369074|P5|COMPLETED|Overall Study||4
8656263|NCT02188303|21369075|P4|COMPLETED|Overall Study||6
8656264|NCT02188303|21369076|P3|COMPLETED|Overall Study||6
8656265|NCT02188303|21369077|P2|COMPLETED|Overall Study||6
8656266|NCT02188303|21369078|P1|COMPLETED|Overall Study||6
8656267|NCT02188303|21369071|P8|STARTED|Overall Study||6
8656268|NCT02188303|21369072|P7|STARTED|Overall Study||2
8656269|NCT02188303|21369073|P6|STARTED|Overall Study||12
8656270|NCT02188303|21369074|P5|STARTED|Overall Study||4
8656271|NCT02188303|21369075|P4|STARTED|Overall Study||6
8656272|NCT02188303|21369076|P3|STARTED|Overall Study||6
8656273|NCT02188303|21369077|P2|STARTED|Overall Study||6
8656274|NCT02188303|21369078|P1|STARTED|Overall Study||6
8656275|NCT02119819|21369112|P6|NOT COMPLETED|Overall Study||15
8656276|NCT02119819|21369113|P5|NOT COMPLETED|Overall Study||7
8656277|NCT02119819|21369114|P4|NOT COMPLETED|Overall Study||7
8656278|NCT02119819|21369115|P3|NOT COMPLETED|Overall Study||4
8656279|NCT02119819|21369116|P2|NOT COMPLETED|Overall Study||5
8656280|NCT02119819|21369117|P1|NOT COMPLETED|Overall Study||9
8656281|NCT02119819|21369112|P6|COMPLETED|Overall Study||56
8656282|NCT02119819|21369113|P5|COMPLETED|Overall Study||62
8656283|NCT02119819|21369114|P4|COMPLETED|Overall Study||63
8656284|NCT02119819|21369115|P3|COMPLETED|Overall Study||69
8656285|NCT02119819|21369116|P2|COMPLETED|Overall Study||66
8656286|NCT02119819|21369117|P1|COMPLETED|Overall Study||57
8656287|NCT02119819|21369112|P6|STARTED|Overall Study||71
8656288|NCT02119819|21369113|P5|STARTED|Overall Study||69
8656289|NCT02119819|21369114|P4|STARTED|Overall Study||70
8656290|NCT02119819|21369115|P3|STARTED|Overall Study||73
8656291|NCT02119819|21369116|P2|STARTED|Overall Study||71
8656292|NCT02119819|21369117|P1|STARTED|Overall Study||66
8656317|NCT02093923|21369250|P5|NOT COMPLETED|Overall Study||0
8656318|NCT02093923|21369251|P4|NOT COMPLETED|Overall Study||2
8656319|NCT02093923|21369252|P3|NOT COMPLETED|Overall Study||0
8656320|NCT02093923|21369253|P2|NOT COMPLETED|Overall Study||0
8656321|NCT02093923|21369254|P1|NOT COMPLETED|Overall Study||0
8656322|NCT02093923|21369250|P5|COMPLETED|Overall Study||13
8656323|NCT02093923|21369251|P4|COMPLETED|Overall Study||10
8656324|NCT02093923|21369252|P3|COMPLETED|Overall Study||5
8656325|NCT02093923|21369253|P2|COMPLETED|Overall Study||4
8656326|NCT02093923|21369254|P1|COMPLETED|Overall Study||4
8656327|NCT02093923|21369250|P5|Treated - 2 Doses:|Overall Study||13
8656328|NCT02093923|21369251|P4|Treated - 2 Doses:|Overall Study||10
8656329|NCT02093923|21369252|P3|Treated - 2 Doses:|Overall Study||5
8656330|NCT02093923|21369253|P2|Treated - 2 Doses:|Overall Study||4
8656331|NCT02093923|21369254|P1|Treated - 2 Doses:|Overall Study||4
8656332|NCT02093923|21369250|P5|Treated - 1 Dose Only:|Overall Study||0
8656333|NCT02093923|21369251|P4|Treated - 1 Dose Only:|Overall Study||1
8656334|NCT02093923|21369252|P3|Treated - 1 Dose Only:|Overall Study||0
8656335|NCT02093923|21369253|P2|Treated - 1 Dose Only:|Overall Study||0
8656336|NCT02093923|21369254|P1|Treated - 1 Dose Only:|Overall Study||0
8656337|NCT02093923|21369250|P5|Total Treated|Overall Study||13
8656338|NCT02093923|21369251|P4|Total Treated|Overall Study||11
8656339|NCT02093923|21369252|P3|Total Treated|Overall Study||5
8656340|NCT02093923|21369253|P2|Total Treated|Overall Study||4
8656341|NCT02093923|21369254|P1|Total Treated|Overall Study||4
8656342|NCT02093923|21369250|P5|STARTED|Overall Study||13
8656343|NCT02093923|21369251|P4|STARTED|Overall Study||12
8656344|NCT02093923|21369252|P3|STARTED|Overall Study||5
8656345|NCT02093923|21369253|P2|STARTED|Overall Study||4
8656346|NCT02093923|21369254|P1|STARTED|Overall Study||4
8656378|NCT01790984|21369361|P4|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
8656379|NCT01790984|21369362|P3|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
8656380|NCT01790984|21369363|P2|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
8656381|NCT01790984|21369364|P1|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
8656382|NCT01790984|21369361|P4|COMPLETED|Second Dietary Intervention (12 Weeks)||7
8656383|NCT01790984|21369362|P3|COMPLETED|Second Dietary Intervention (12 Weeks)||6
8656384|NCT01790984|21369363|P2|COMPLETED|Second Dietary Intervention (12 Weeks)||7
8656385|NCT01790984|21369364|P1|COMPLETED|Second Dietary Intervention (12 Weeks)||5
8656386|NCT01790984|21369361|P4|STARTED|Second Dietary Intervention (12 Weeks)||7
8656387|NCT01790984|21369362|P3|STARTED|Second Dietary Intervention (12 Weeks)||6
8656388|NCT01790984|21369363|P2|STARTED|Second Dietary Intervention (12 Weeks)||7
8656389|NCT01790984|21369364|P1|STARTED|Second Dietary Intervention (12 Weeks)||5
8656390|NCT01790984|21369361|P4|NOT COMPLETED|Wash-out (4 Weeks)||0
8656391|NCT01790984|21369362|P3|NOT COMPLETED|Wash-out (4 Weeks)||0
8656392|NCT01790984|21369363|P2|NOT COMPLETED|Wash-out (4 Weeks)||0
8656393|NCT01790984|21369364|P1|NOT COMPLETED|Wash-out (4 Weeks)||0
8656394|NCT01790984|21369361|P4|COMPLETED|Wash-out (4 Weeks)||7
8656395|NCT01790984|21369362|P3|COMPLETED|Wash-out (4 Weeks)||6
8656396|NCT01790984|21369363|P2|COMPLETED|Wash-out (4 Weeks)||7
8656397|NCT01790984|21369364|P1|COMPLETED|Wash-out (4 Weeks)||5
8656398|NCT01790984|21369361|P4|STARTED|Wash-out (4 Weeks)||7
8656399|NCT01790984|21369362|P3|STARTED|Wash-out (4 Weeks)||6
8656400|NCT01790984|21369363|P2|STARTED|Wash-out (4 Weeks)||7
8656401|NCT01790984|21369364|P1|STARTED|Wash-out (4 Weeks)||5
8656402|NCT01790984|21369361|P4|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
8656403|NCT01790984|21369362|P3|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
8656404|NCT01790984|21369363|P2|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
8656405|NCT01790984|21369364|P1|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
8656406|NCT01790984|21369361|P4|COMPLETED|First Dietary Intervention (12 Weeks)||7
8656407|NCT01790984|21369362|P3|COMPLETED|First Dietary Intervention (12 Weeks)||6
8656408|NCT01790984|21369363|P2|COMPLETED|First Dietary Intervention (12 Weeks)||7
8656409|NCT01790984|21369364|P1|COMPLETED|First Dietary Intervention (12 Weeks)||5
8656410|NCT01790984|21369361|P4|STARTED|First Dietary Intervention (12 Weeks)||7
8656411|NCT01790984|21369362|P3|STARTED|First Dietary Intervention (12 Weeks)||6
8656412|NCT01790984|21369363|P2|STARTED|First Dietary Intervention (12 Weeks)||8
8656413|NCT01790984|21369364|P1|STARTED|First Dietary Intervention (12 Weeks)||6
8656417|NCT01705080|21369406|P3|NOT COMPLETED|Overall Study||16
8656418|NCT01705080|21369407|P2|NOT COMPLETED|Overall Study||52
8656419|NCT01705080|21369408|P1|NOT COMPLETED|Overall Study||75
8656420|NCT01705080|21369406|P3|COMPLETED|Overall Study||12
8656421|NCT01705080|21369407|P2|COMPLETED|Overall Study||49
8656422|NCT01705080|21369408|P1|COMPLETED|Overall Study||72
8656423|NCT01705080|21369406|P3|Discharge Following Renal Artery Ablation Procedure|Overall Study||28
8656424|NCT01705080|21369407|P2|Discharge Following Renal Artery Ablation Procedure|Overall Study|Reason Not Completed: Withdrawal by Subject=1|100
8656425|NCT01705080|21369408|P1|Discharge Following Renal Artery Ablation Procedure|Overall Study||147
8656426|NCT01705080|21369406|P3|Renal Artery Ablation Procedure|Overall Study||28
8656427|NCT01705080|21369407|P2|Renal Artery Ablation Procedure|Overall Study||101
8656428|NCT01705080|21369408|P1|Renal Artery Ablation Procedure|Overall Study||147
8656429|NCT01705080|21369406|P3|STARTED|Overall Study||28
8656430|NCT01705080|21369407|P2|STARTED|Overall Study||101
8656431|NCT01705080|21369408|P1|STARTED|Overall Study||147
8656435|NCT01274338|21369526|P6|NOT COMPLETED|Overall Study||0
8656436|NCT01274338|21369527|P5|NOT COMPLETED|Overall Study||1
8656437|NCT01274338|21369528|P4|NOT COMPLETED|Overall Study||1
8656438|NCT01274338|21369529|P3|NOT COMPLETED|Overall Study||325
8656439|NCT01274338|21369530|P2|NOT COMPLETED|Overall Study||454
8656440|NCT01274338|21369531|P1|NOT COMPLETED|Overall Study||403
8656441|NCT01274338|21369526|P6|COMPLETED|Overall Study||1
8656442|NCT01274338|21369527|P5|COMPLETED|Overall Study||0
8656443|NCT01274338|21369528|P4|COMPLETED|Overall Study||0
8656444|NCT01274338|21369529|P3|COMPLETED|Overall Study||198
8656445|NCT01274338|21369530|P2|COMPLETED|Overall Study||182
8656446|NCT01274338|21369531|P1|COMPLETED|Overall Study||108
8656447|NCT01274338|21369526|P6|Data Available for FACIT-D Analysis|Overall Study||0
8656448|NCT01274338|21369527|P5|Data Available for FACIT-D Analysis|Overall Study||0
8656449|NCT01274338|21369528|P4|Data Available for FACIT-D Analysis|Overall Study||0
8656450|NCT01274338|21369529|P3|Data Available for FACIT-D Analysis|Overall Study||97
8656451|NCT01274338|21369530|P2|Data Available for FACIT-D Analysis|Overall Study||114
8656452|NCT01274338|21369531|P1|Data Available for FACIT-D Analysis|Overall Study||109
8656453|NCT01274338|21369526|P6|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
8656454|NCT01274338|21369527|P5|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
8656455|NCT01274338|21369528|P4|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
8656456|NCT01274338|21369529|P3|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||97
8656457|NCT01274338|21369530|P2|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||114
8656458|NCT01274338|21369531|P1|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||110
8656459|NCT01274338|21369526|P6|Received Treatment|Overall Study||1
8656460|NCT01274338|21369527|P5|Received Treatment|Overall Study||1
8656461|NCT01274338|21369528|P4|Received Treatment|Overall Study||1
8656462|NCT01274338|21369529|P3|Received Treatment|Overall Study||516
8656463|NCT01274338|21369530|P2|Received Treatment|Overall Study||520
8656464|NCT01274338|21369531|P1|Received Treatment|Overall Study||503
8656465|NCT01274338|21369526|P6|STARTED|Overall Study||1
8656466|NCT01274338|21369527|P5|STARTED|Overall Study||1
8656467|NCT01274338|21369528|P4|STARTED|Overall Study||1
8656468|NCT01274338|21369529|P3|STARTED|Overall Study||523
8656469|NCT01274338|21369530|P2|STARTED|Overall Study||636
8656470|NCT01274338|21369531|P1|STARTED|Overall Study||511
8656489|NCT00974350|21369591|P3|NOT COMPLETED|Overall Study||1
8656490|NCT00974350|21369592|P2|NOT COMPLETED|Overall Study||0
8656491|NCT00974350|21369593|P1|NOT COMPLETED|Overall Study||3
8656492|NCT00974350|21369591|P3|COMPLETED|Overall Study||31
8656493|NCT00974350|21369592|P2|COMPLETED|Overall Study||47
8656494|NCT00974350|21369593|P1|COMPLETED|Overall Study||42
8656495|NCT00974350|21369591|P3|STARTED|Overall Study||32
8656496|NCT00974350|21369592|P2|STARTED|Overall Study||47
8656497|NCT00974350|21369593|P1|STARTED|Overall Study||45
8656498|NCT00799812|21369616|P1|NOT COMPLETED|Overall Study||0
8656499|NCT00799812|21369616|P1|COMPLETED|Overall Study||335
8656500|NCT00799812|21369616|P1|Sterile Water Swabstick (Sequential)|Overall Study||126
8656501|NCT00799812|21369616|P1|Sterile Water Swab (3 @ Once)|Overall Study||132
8656502|NCT00799812|21369616|P1|Hibiclens|Overall Study||133
8656503|NCT00799812|21369616|P1|CHG Swabstick Sequential|Overall Study||138
8656504|NCT00799812|21369616|P1|CHG Swabstick (3 @ Once)|Overall Study||139
8656505|NCT00799812|21369616|P1|STARTED|Overall Study||335
8656506|NCT04189081|21369631|P3|NOT COMPLETED|Overall Study||1
8656507|NCT04189081|21369632|P2|NOT COMPLETED|Overall Study||0
8656508|NCT04189081|21369633|P1|NOT COMPLETED|Overall Study||1
8656509|NCT04189081|21369631|P3|COMPLETED|Overall Study||45
8656510|NCT04189081|21369632|P2|COMPLETED|Overall Study||45
8656511|NCT04189081|21369633|P1|COMPLETED|Overall Study||45
8656512|NCT04189081|21369631|P3|STARTED|Overall Study||46
8656513|NCT04189081|21369632|P2|STARTED|Overall Study||45
8656514|NCT04189081|21369633|P1|STARTED|Overall Study||46
8656515|NCT04035694|21369646|P2|NOT COMPLETED|Overall Study||0
8656516|NCT04035694|21369647|P1|NOT COMPLETED|Overall Study||0
8656517|NCT04035694|21369646|P2|COMPLETED|Overall Study||216
8656518|NCT04035694|21369647|P1|COMPLETED|Overall Study||374
8656519|NCT04035694|21369646|P2|STARTED|Overall Study||216
8656520|NCT04035694|21369647|P1|STARTED|Overall Study||374
8656524|NCT03859739|21369785|P4|NOT COMPLETED|Overall Study||0
8656525|NCT03859739|21369786|P3|NOT COMPLETED|Overall Study||0
8656526|NCT03859739|21369787|P2|NOT COMPLETED|Overall Study||0
8656527|NCT03859739|21369788|P1|NOT COMPLETED|Overall Study||0
8656528|NCT03859739|21369785|P4|COMPLETED|Overall Study||4
8656529|NCT03859739|21369786|P3|COMPLETED|Overall Study||6
8656530|NCT03859739|21369787|P2|COMPLETED|Overall Study||6
8656531|NCT03859739|21369788|P1|COMPLETED|Overall Study||5
8656532|NCT03859739|21369785|P4|STARTED|Overall Study||4
8656533|NCT03859739|21369786|P3|STARTED|Overall Study||6
8656534|NCT03859739|21369787|P2|STARTED|Overall Study||6
8656535|NCT03859739|21369788|P1|STARTED|Overall Study||5
8656536|NCT03838198|21369844|P4|NOT COMPLETED|3 Month Follow up Period||4
8656537|NCT03838198|21369845|P3|NOT COMPLETED|3 Month Follow up Period||3
8656538|NCT03838198|21369846|P2|NOT COMPLETED|3 Month Follow up Period||3
8656539|NCT03838198|21369847|P1|NOT COMPLETED|3 Month Follow up Period||3
8656540|NCT03838198|21369844|P4|COMPLETED|3 Month Follow up Period||18
8656541|NCT03838198|21369845|P3|COMPLETED|3 Month Follow up Period||14
8656542|NCT03838198|21369846|P2|COMPLETED|3 Month Follow up Period||19
8656543|NCT03838198|21369847|P1|COMPLETED|3 Month Follow up Period||15
8656544|NCT03838198|21369844|P4|Adolescent Survey Completed|3 Month Follow up Period||21
8656545|NCT03838198|21369845|P3|Adolescent Survey Completed|3 Month Follow up Period||15
8656546|NCT03838198|21369846|P2|Adolescent Survey Completed|3 Month Follow up Period||21
8656547|NCT03838198|21369847|P1|Adolescent Survey Completed|3 Month Follow up Period||16
8656548|NCT03838198|21369844|P4|STARTED|3 Month Follow up Period||22
8656549|NCT03838198|21369845|P3|STARTED|3 Month Follow up Period||17
8656550|NCT03838198|21369846|P2|STARTED|3 Month Follow up Period||22
8656551|NCT03838198|21369847|P1|STARTED|3 Month Follow up Period||18
8656552|NCT03838198|21369844|P4|NOT COMPLETED|1 Month Follow up Period||1
8656553|NCT03838198|21369845|P3|NOT COMPLETED|1 Month Follow up Period||1
8656554|NCT03838198|21369846|P2|NOT COMPLETED|1 Month Follow up Period||0
8656555|NCT03838198|21369847|P1|NOT COMPLETED|1 Month Follow up Period||2
8656556|NCT03838198|21369844|P4|COMPLETED|1 Month Follow up Period||21
8656557|NCT03838198|21369845|P3|COMPLETED|1 Month Follow up Period||16
8656558|NCT03838198|21369846|P2|COMPLETED|1 Month Follow up Period||22
8656559|NCT03838198|21369847|P1|COMPLETED|1 Month Follow up Period||16
8656560|NCT03838198|21369844|P4|Adolescent Surveys Completed|1 Month Follow up Period||22
8656561|NCT03838198|21369845|P3|Adolescent Surveys Completed|1 Month Follow up Period||16
8656562|NCT03838198|21369846|P2|Adolescent Surveys Completed|1 Month Follow up Period||22
8656563|NCT03838198|21369847|P1|Adolescent Surveys Completed|1 Month Follow up Period||16
8656564|NCT03838198|21369844|P4|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
8656565|NCT03838198|21369845|P3|STARTED|1 Month Follow up Period||17
8656566|NCT03838198|21369846|P2|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
8656567|NCT03838198|21369847|P1|STARTED|1 Month Follow up Period||18
8656568|NCT03838198|21369844|P4|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
8656569|NCT03838198|21369845|P3|NOT COMPLETED|Phase 2: Added Booster Call or Not||1
8656570|NCT03838198|21369846|P2|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
8656571|NCT03838198|21369847|P1|NOT COMPLETED|Phase 2: Added Booster Call or Not||0
8656572|NCT03838198|21369844|P4|COMPLETED|Phase 2: Added Booster Call or Not||0
8656573|NCT03838198|21369845|P3|COMPLETED|Phase 2: Added Booster Call or Not|Of the 17 who completed the safety plan, only 15 had both parent and adolescent completing the call; 1 had parent only; 1 was unable to be reached.|17
8656574|NCT03838198|21369846|P2|COMPLETED|Phase 2: Added Booster Call or Not||0
8656575|NCT03838198|21369847|P1|COMPLETED|Phase 2: Added Booster Call or Not|All 18 completed the safety plan; but only 14 had both parent and adolescent completing the call; 1 had parent only; 1 had adolescent only; 2 were unable to be reached.|18
8656576|NCT03838198|21369844|P4|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with no added booster call in Phase 2|22
8656577|NCT03838198|21369845|P3|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with added booster call.|18
8656578|NCT03838198|21369846|P2|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with no added booster call.|22
8656579|NCT03838198|21369847|P1|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with added booster call.|18
8656580|NCT03838198|21369844|P4|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
8656581|NCT03838198|21369845|P3|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
8656582|NCT03838198|21369846|P2|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
8656583|NCT03838198|21369847|P1|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
8656584|NCT03838198|21369844|P4|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
8656585|NCT03838198|21369845|P3|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
8656586|NCT03838198|21369846|P2|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
8656587|NCT03838198|21369847|P1|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
8656588|NCT03838198|21369844|P4|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
8656589|NCT03838198|21369845|P3|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
8656590|NCT03838198|21369846|P2|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
8656591|NCT03838198|21369847|P1|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
8656592|NCT03630302|21369866|P1|NOT COMPLETED|Data Post Analyses||2
8656593|NCT03630302|21369866|P1|COMPLETED|Data Post Analyses||5
8656594|NCT03630302|21369866|P1|STARTED|Data Post Analyses||7
8656595|NCT03630302|21369866|P1|NOT COMPLETED|3 Month Visit||2
8656596|NCT03630302|21369866|P1|COMPLETED|3 Month Visit||7
8656597|NCT03630302|21369866|P1|STARTED|3 Month Visit||9
8656598|NCT03630302|21369866|P1|NOT COMPLETED|Surgery||1
8656599|NCT03630302|21369866|P1|COMPLETED|Surgery||9
8656600|NCT03630302|21369866|P1|STARTED|Surgery||10
8656601|NCT03575975|21369874|P3|NOT COMPLETED|Overall Study||0
8656602|NCT03575975|21369875|P2|NOT COMPLETED|Overall Study||0
8656603|NCT03575975|21369876|P1|NOT COMPLETED|Overall Study||1
8656604|NCT03575975|21369874|P3|COMPLETED|Overall Study||0
8656605|NCT03575975|21369875|P2|COMPLETED|Overall Study||5
8656606|NCT03575975|21369876|P1|COMPLETED|Overall Study||3
8656607|NCT03575975|21369874|P3|STARTED|Overall Study||0
8656608|NCT03575975|21369875|P2|STARTED|Overall Study||5
8656609|NCT03575975|21369876|P1|STARTED|Overall Study||4
8656623|NCT03359850|21369915|P2|NOT COMPLETED|Extension Phase (Up to 28 Months)||6
8656624|NCT03359850|21369916|P1|NOT COMPLETED|Extension Phase (Up to 28 Months)||8
8656625|NCT03359850|21369915|P2|COMPLETED|Extension Phase (Up to 28 Months)||1
8656626|NCT03359850|21369916|P1|COMPLETED|Extension Phase (Up to 28 Months)||0
8656627|NCT03359850|21369915|P2|STARTED|Extension Phase (Up to 28 Months)||7
8656628|NCT03359850|21369916|P1|STARTED|Extension Phase (Up to 28 Months)||8
8656629|NCT03359850|21369915|P2|NOT COMPLETED|PK Phase (Up to Day 8)||1
8656630|NCT03359850|21369916|P1|NOT COMPLETED|PK Phase (Up to Day 8)||1
8656631|NCT03359850|21369915|P2|COMPLETED|PK Phase (Up to Day 8)||7
8656632|NCT03359850|21369916|P1|COMPLETED|PK Phase (Up to Day 8)||8
8656633|NCT03359850|21369915|P2|STARTED|PK Phase (Up to Day 8)||8
8656634|NCT03359850|21369916|P1|STARTED|PK Phase (Up to Day 8)||9
8656635|NCT03176784|21369990|P4|NOT COMPLETED|Overall Study||70
8656636|NCT03176784|21369991|P3|NOT COMPLETED|Overall Study||113
8656637|NCT03176784|21369992|P2|NOT COMPLETED|Overall Study||113
8656638|NCT03176784|21369993|P1|NOT COMPLETED|Overall Study||105
8656639|NCT03176784|21369990|P4|COMPLETED|Overall Study||241
8656640|NCT03176784|21369991|P3|COMPLETED|Overall Study||198
8656641|NCT03176784|21369992|P2|COMPLETED|Overall Study||202
8656642|NCT03176784|21369993|P1|COMPLETED|Overall Study||209
8656643|NCT03176784|21369990|P4|STARTED|Overall Study||311
8656644|NCT03176784|21369991|P3|STARTED|Overall Study||311
8656645|NCT03176784|21369992|P2|STARTED|Overall Study||315
8656646|NCT03176784|21369993|P1|STARTED|Overall Study||314
8656647|NCT03167411|21370017|P2|NOT COMPLETED|Overall Study||1
8656648|NCT03167411|21370018|P1|NOT COMPLETED|Overall Study||0
8656649|NCT03167411|21370017|P2|COMPLETED|Overall Study||9
8656650|NCT03167411|21370018|P1|COMPLETED|Overall Study||10
8656651|NCT03167411|21370017|P2|STARTED|Overall Study||10
8656652|NCT03167411|21370018|P1|STARTED|Overall Study||10
8656653|NCT03152084|21370034|P2|NOT COMPLETED|Overall Study||0
8656654|NCT03152084|21370035|P1|NOT COMPLETED|Overall Study||0
8656655|NCT03152084|21370034|P2|COMPLETED|Overall Study||7
8656656|NCT03152084|21370035|P1|COMPLETED|Overall Study||17
8656657|NCT03152084|21370034|P2|STARTED|Overall Study||7
8656658|NCT03152084|21370035|P1|STARTED|Overall Study||17
8656659|NCT03128008|21370073|P1|NOT COMPLETED|Overall Study||9
8656660|NCT03128008|21370073|P1|COMPLETED|Overall Study|9 participants are in follow up|1
8656661|NCT03128008|21370073|P1|STARTED|Overall Study||10
8656662|NCT03122535|21370081|P2|NOT COMPLETED|Overall Study||73
8656663|NCT03122535|21370082|P1|NOT COMPLETED|Overall Study||73
8656664|NCT03122535|21370081|P2|COMPLETED|Overall Study||42
8656665|NCT03122535|21370082|P1|COMPLETED|Overall Study||42
8656666|NCT03122535|21370081|P2|12 Months|Overall Study||42
8656667|NCT03122535|21370082|P1|12 Months|Overall Study||42
8656668|NCT03122535|21370081|P2|3 Months|Overall Study||92
8656669|NCT03122535|21370082|P1|3 Months|Overall Study||92
8656670|NCT03122535|21370081|P2|STARTED|Overall Study||115
8656671|NCT03122535|21370082|P1|STARTED|Overall Study||115
8656684|NCT02963441|21370111|P1|NOT COMPLETED|Overall Study||81
8656685|NCT02963441|21370111|P1|COMPLETED|Overall Study||819
8656686|NCT02963441|21370111|P1|STARTED|Overall Study||900
8656687|NCT02928952|21370121|P2|NOT COMPLETED|Overall Study||7
8656688|NCT02928952|21370122|P1|NOT COMPLETED|Overall Study||10
8656689|NCT02928952|21370121|P2|COMPLETED|Overall Study||60
8656690|NCT02928952|21370122|P1|COMPLETED|Overall Study||55
8656691|NCT02928952|21370121|P2|STARTED|Overall Study||67
8656692|NCT02928952|21370122|P1|STARTED|Overall Study||65
8656699|NCT02812160|21370177|P2|NOT COMPLETED|Overall Study||0
8656700|NCT02812160|21370178|P1|NOT COMPLETED|Overall Study||0
8656701|NCT02812160|21370177|P2|COMPLETED|Overall Study||101
8656702|NCT02812160|21370178|P1|COMPLETED|Overall Study||187
8656703|NCT02812160|21370177|P2|STARTED|Overall Study||101
8656704|NCT02812160|21370178|P1|STARTED|Overall Study||187
8656705|NCT02637232|21370184|P1|NOT COMPLETED|Overall Study||55
8656706|NCT02637232|21370184|P1|COMPLETED|Overall Study||246
8656707|NCT02637232|21370184|P1|STARTED|Overall Study||301
8656708|NCT02595398|21370190|P2|NOT COMPLETED|Overall Study||1
8656709|NCT02595398|21370191|P1|NOT COMPLETED|Overall Study||4
8656710|NCT02595398|21370190|P2|COMPLETED|Overall Study||63
8656711|NCT02595398|21370191|P1|COMPLETED|Overall Study||92
8656712|NCT02595398|21370190|P2|Safety Population|Overall Study||64
8656713|NCT02595398|21370191|P1|Safety Population|Overall Study||96
8656714|NCT02595398|21370190|P2|Intention-to-Treat (ITT) Population|Overall Study||64
8656715|NCT02595398|21370191|P1|Intention-to-Treat (ITT) Population|Overall Study||96
8656716|NCT02595398|21370190|P2|STARTED|Overall Study||64
8656717|NCT02595398|21370191|P1|STARTED|Overall Study||96
8656718|NCT02529137|21370201|P1|NOT COMPLETED|Overall Study||8
8656719|NCT02529137|21370201|P1|COMPLETED|Overall Study||1992
8656720|NCT02529137|21370201|P1|STARTED|Overall Study||2000
8656721|NCT02525471|21370206|P1|NOT COMPLETED|Overall Study||11
8656722|NCT02525471|21370206|P1|COMPLETED|Overall Study||13
8656723|NCT02525471|21370206|P1|Randomized/Treated|Overall Study||16
8656724|NCT02525471|21370206|P1|STARTED|Overall Study||24
8656725|NCT02296112|21370216|P1|NOT COMPLETED|Overall Study||9
8656726|NCT02296112|21370216|P1|COMPLETED|Overall Study||0
8656727|NCT02296112|21370216|P1|STARTED|Overall Study||9
8656728|NCT02216071|21370231|P2|NOT COMPLETED|Overall Study||12
8656729|NCT02216071|21370232|P1|NOT COMPLETED|Overall Study||15
8656730|NCT02216071|21370231|P2|COMPLETED|Overall Study||233
8656731|NCT02216071|21370232|P1|COMPLETED|Overall Study||239
8656732|NCT02216071|21370231|P2|STARTED|Overall Study||245
8656733|NCT02216071|21370232|P1|STARTED|Overall Study||254
8656737|NCT02022735|21370249|P1|NOT COMPLETED|Overall Study||0
8656738|NCT02022735|21370249|P1|COMPLETED|Overall Study||22
8656739|NCT02022735|21370249|P1|STARTED|Overall Study||22
8656746|NCT01931709|21370282|P1|NOT COMPLETED|Overall Study||0
8656747|NCT01931709|21370282|P1|COMPLETED|Overall Study||35
8656748|NCT01931709|21370282|P1|STARTED|Overall Study||35
8656749|NCT01831076|21370294|P2|NOT COMPLETED|Overall Study||1
8656750|NCT01831076|21370295|P1|NOT COMPLETED|Overall Study||1
8656751|NCT01831076|21370294|P2|COMPLETED|Overall Study||4
8656752|NCT01831076|21370295|P1|COMPLETED|Overall Study||30
8656753|NCT01831076|21370294|P2|STARTED|Overall Study||5
8656754|NCT01831076|21370295|P1|STARTED|Overall Study||31
8656755|NCT01681121|21370303|P2|NOT COMPLETED|Overall Study||11
8656756|NCT01681121|21370304|P1|NOT COMPLETED|Overall Study||8
8656757|NCT01681121|21370303|P2|COMPLETED|Overall Study||38
8656758|NCT01681121|21370304|P1|COMPLETED|Overall Study||36
8656759|NCT01681121|21370303|P2|STARTED|Overall Study||49
8656760|NCT01681121|21370304|P1|STARTED|Overall Study||44
8656761|NCT01591733|21370328|P1|NOT COMPLETED|Overall Study||0
8656762|NCT01591733|21370328|P1|COMPLETED|Overall Study||48
8656763|NCT01591733|21370328|P1|STARTED|Overall Study||48
8656770|NCT01297465|21370347|P2|NOT COMPLETED|Overall Study||10
8656771|NCT01297465|21370348|P1|NOT COMPLETED|Overall Study||8
8656772|NCT01297465|21370347|P2|COMPLETED|Overall Study||93
8656773|NCT01297465|21370348|P1|COMPLETED|Overall Study||91
8656774|NCT01297465|21370347|P2|STARTED|Overall Study||103
8656775|NCT01297465|21370348|P1|STARTED|Overall Study||99
8656776|NCT01049919|21370382|P2|NOT COMPLETED|Overall Study||17
8656777|NCT01049919|21370383|P1|NOT COMPLETED|Overall Study||52
8656778|NCT01049919|21370382|P2|COMPLETED|Overall Study|Incl. 11 participants that received crossover treatment after completing 52 week primary follow up.|19
8656779|NCT01049919|21370383|P1|COMPLETED|Overall Study||65
8656780|NCT01049919|21370382|P2|STARTED|Overall Study|One participant is counted in both treatment groups due to one leg being randomized to each group.|36
8656781|NCT01049919|21370383|P1|STARTED|Overall Study||117
8656782|NCT00948194|21370399|P2|NOT COMPLETED|Overall Study||0
8656783|NCT00948194|21370400|P1|NOT COMPLETED|Overall Study||1
8656784|NCT00948194|21370399|P2|COMPLETED|Overall Study||7
8656785|NCT00948194|21370400|P1|COMPLETED|Overall Study||5
8656786|NCT00948194|21370399|P2|STARTED|Overall Study||7
8656787|NCT00948194|21370400|P1|STARTED|Overall Study||6
8656788|NCT00787189|21370412|P2|NOT COMPLETED|Overall Study||2
8656789|NCT00787189|21370413|P1|NOT COMPLETED|Overall Study||2
8656790|NCT00787189|21370412|P2|COMPLETED|Overall Study|To study end point.|30
8656791|NCT00787189|21370413|P1|COMPLETED|Overall Study|To study end point.|30
8656792|NCT00787189|21370412|P2|STARTED|Overall Study||32
8656793|NCT00787189|21370413|P1|STARTED|Overall Study||32
8656794|NCT00738101|21370419|P1|NOT COMPLETED|Overall Study||7
8656795|NCT00738101|21370419|P1|COMPLETED|Overall Study|7 exclusions. 5 primary liver or unrelated disease, 1 died before Omegaven, 1 repeat enrollment|286
8656796|NCT00738101|21370419|P1|STARTED|Overall Study||293
8656797|NCT00568321|21370434|P3|NOT COMPLETED|Overall Study||9
8656798|NCT00568321|21370435|P2|NOT COMPLETED|Overall Study||5
8656799|NCT00568321|21370436|P1|NOT COMPLETED|Overall Study||13
8656800|NCT00568321|21370434|P3|COMPLETED|Overall Study||24
8656801|NCT00568321|21370435|P2|COMPLETED|Overall Study||28
8656802|NCT00568321|21370436|P1|COMPLETED|Overall Study||20
8656803|NCT00568321|21370434|P3|Treated|Overall Study||32
8656804|NCT00568321|21370435|P2|Treated|Overall Study||33
8656805|NCT00568321|21370436|P1|Treated|Overall Study||31
8656806|NCT00568321|21370434|P3|STARTED|Overall Study||33
8656807|NCT00568321|21370435|P2|STARTED|Overall Study||33
8656808|NCT00568321|21370436|P1|STARTED|Overall Study||33
8657223|NCT04431908|21371901|P2|NOT COMPLETED|Overall Study||0
8657224|NCT04431908|21371902|P1|NOT COMPLETED|Overall Study||0
8657225|NCT04431908|21371901|P2|COMPLETED|Overall Study||278
8657226|NCT04431908|21371902|P1|COMPLETED|Overall Study||1042
8657227|NCT04431908|21371901|P2|STARTED|Overall Study||278
8657228|NCT04431908|21371902|P1|STARTED|Overall Study||1042
8657229|NCT04384523|21371916|P6|NOT COMPLETED|Overall Study||1
8657230|NCT04384523|21371917|P5|NOT COMPLETED|Overall Study||0
8657231|NCT04384523|21371918|P4|NOT COMPLETED|Overall Study||0
8657232|NCT04384523|21371919|P3|NOT COMPLETED|Overall Study||0
8657233|NCT04384523|21371920|P2|NOT COMPLETED|Overall Study||1
8657234|NCT04384523|21371921|P1|NOT COMPLETED|Overall Study||1
8657235|NCT04384523|21371916|P6|COMPLETED|Overall Study||5
8657236|NCT04384523|21371917|P5|COMPLETED|Overall Study||7
8657237|NCT04384523|21371918|P4|COMPLETED|Overall Study||6
8657238|NCT04384523|21371919|P3|COMPLETED|Overall Study||6
8657239|NCT04384523|21371920|P2|COMPLETED|Overall Study||5
8657240|NCT04384523|21371921|P1|COMPLETED|Overall Study||9
8657241|NCT04384523|21371916|P6|STARTED|Overall Study||6
8657242|NCT04384523|21371917|P5|STARTED|Overall Study||7
8657243|NCT04384523|21371918|P4|STARTED|Overall Study||6
8657244|NCT04384523|21371919|P3|STARTED|Overall Study||6
8657245|NCT04384523|21371920|P2|STARTED|Overall Study||6
8657246|NCT04384523|21371921|P1|STARTED|Overall Study||10
8657247|NCT04362137|21371943|P2|NOT COMPLETED|Overall Study||6
8657248|NCT04362137|21371944|P1|NOT COMPLETED|Overall Study||18
8657249|NCT04362137|21371943|P2|COMPLETED|Overall Study||139
8657250|NCT04362137|21371944|P1|COMPLETED|Overall Study||269
8657251|NCT04362137|21371943|P2|Safety Set|Overall Study||143
8657252|NCT04362137|21371944|P1|Safety Set|Overall Study||281
8657253|NCT04362137|21371943|P2|STARTED|Overall Study||145
8657254|NCT04362137|21371944|P1|STARTED|Overall Study||287
8657255|NCT04268316|21371981|P3|NOT COMPLETED|Overall Study||0
8657256|NCT04268316|21371982|P2|NOT COMPLETED|Overall Study||1
8657257|NCT04268316|21371983|P1|NOT COMPLETED|Overall Study||2
8657258|NCT04268316|21371981|P3|COMPLETED|Overall Study||4
8657259|NCT04268316|21371982|P2|COMPLETED|Overall Study||3
8657260|NCT04268316|21371983|P1|COMPLETED|Overall Study||3
8657261|NCT04268316|21371981|P3|STARTED|Overall Study||4
8657262|NCT04268316|21371982|P2|STARTED|Overall Study||4
8657263|NCT04268316|21371983|P1|STARTED|Overall Study||5
8657264|NCT04079803|21372003|P3|NOT COMPLETED|Overall Study||0
8657265|NCT04079803|21372004|P2|NOT COMPLETED|Overall Study||1
8657266|NCT04079803|21372005|P1|NOT COMPLETED|Overall Study||0
8657267|NCT04079803|21372003|P3|COMPLETED|Overall Study||21
8657268|NCT04079803|21372004|P2|COMPLETED|Overall Study||20
8657269|NCT04079803|21372005|P1|COMPLETED|Overall Study||22
8657270|NCT04079803|21372003|P3|STARTED|Overall Study||21
8657271|NCT04079803|21372004|P2|STARTED|Overall Study||21
8657272|NCT04079803|21372005|P1|STARTED|Overall Study||22
8657273|NCT04071301|21372040|P1|NOT COMPLETED|Overall Study||7
8657274|NCT04071301|21372040|P1|COMPLETED|Overall Study||8
8657275|NCT04071301|21372040|P1|STARTED|Overall Study||15
8657276|NCT03964649|21372054|P10|NOT COMPLETED|Overall Study||0
8657277|NCT03964649|21372055|P9|NOT COMPLETED|Overall Study||0
8657278|NCT03964649|21372056|P8|NOT COMPLETED|Overall Study||0
8657279|NCT03964649|21372057|P7|NOT COMPLETED|Overall Study||0
8657280|NCT03964649|21372058|P6|NOT COMPLETED|Overall Study||0
8657281|NCT03964649|21372059|P5|NOT COMPLETED|Overall Study||0
8657282|NCT03964649|21372060|P4|NOT COMPLETED|Overall Study||0
8657283|NCT03964649|21372061|P3|NOT COMPLETED|Overall Study||0
8657284|NCT03964649|21372062|P2|NOT COMPLETED|Overall Study||0
8657285|NCT03964649|21372063|P1|NOT COMPLETED|Overall Study||0
8657286|NCT03964649|21372054|P10|COMPLETED|Overall Study||533
8657287|NCT03964649|21372055|P9|COMPLETED|Overall Study||204
8657288|NCT03964649|21372056|P8|COMPLETED|Overall Study||325
8657289|NCT03964649|21372057|P7|COMPLETED|Overall Study||376
8657290|NCT03964649|21372058|P6|COMPLETED|Overall Study||349
8657291|NCT03964649|21372059|P5|COMPLETED|Overall Study||1948
8657292|NCT03964649|21372060|P4|COMPLETED|Overall Study||192
8657293|NCT03964649|21372061|P3|COMPLETED|Overall Study||2728
8657294|NCT03964649|21372062|P2|COMPLETED|Overall Study||304
8657295|NCT03964649|21372063|P1|COMPLETED|Overall Study||349
8657296|NCT03964649|21372054|P10|STARTED|Overall Study||533
8657297|NCT03964649|21372055|P9|STARTED|Overall Study||204
8657298|NCT03964649|21372056|P8|STARTED|Overall Study||325
8657299|NCT03964649|21372057|P7|STARTED|Overall Study||376
8657300|NCT03964649|21372058|P6|STARTED|Overall Study||349
8657301|NCT03964649|21372059|P5|STARTED|Overall Study||1948
8657302|NCT03964649|21372060|P4|STARTED|Overall Study||192
8657303|NCT03964649|21372061|P3|STARTED|Overall Study||2728
8657304|NCT03964649|21372062|P2|STARTED|Overall Study||304
8657305|NCT03964649|21372063|P1|STARTED|Overall Study||349
8657306|NCT03943290|21372554|P9|NOT COMPLETED|Overall Study||8
8657307|NCT03943290|21372555|P8|NOT COMPLETED|Overall Study||8
8657308|NCT03943290|21372556|P7|NOT COMPLETED|Overall Study||6
8657309|NCT03943290|21372557|P6|NOT COMPLETED|Overall Study||6
8657310|NCT03943290|21372558|P5|NOT COMPLETED|Overall Study||7
8657311|NCT03943290|21372559|P4|NOT COMPLETED|Overall Study||6
8657312|NCT03943290|21372560|P3|NOT COMPLETED|Overall Study||13
8657313|NCT03943290|21372561|P2|NOT COMPLETED|Overall Study||1
8657314|NCT03943290|21372562|P1|NOT COMPLETED|Overall Study||7
8657315|NCT03943290|21372554|P9|COMPLETED|Overall Study||0
8657316|NCT03943290|21372555|P8|COMPLETED|Overall Study||0
8657317|NCT03943290|21372556|P7|COMPLETED|Overall Study||0
8657318|NCT03943290|21372557|P6|COMPLETED|Overall Study||0
8657319|NCT03943290|21372558|P5|COMPLETED|Overall Study||0
8657320|NCT03943290|21372559|P4|COMPLETED|Overall Study||0
8657321|NCT03943290|21372560|P3|COMPLETED|Overall Study||0
8657322|NCT03943290|21372561|P2|COMPLETED|Overall Study||0
8657323|NCT03943290|21372562|P1|COMPLETED|Overall Study||0
8657324|NCT03943290|21372554|P9|STARTED|Overall Study||8
8657325|NCT03943290|21372555|P8|STARTED|Overall Study||8
8657326|NCT03943290|21372556|P7|STARTED|Overall Study||6
8657327|NCT03943290|21372557|P6|STARTED|Overall Study||6
8657328|NCT03943290|21372558|P5|STARTED|Overall Study||7
8657329|NCT03943290|21372559|P4|STARTED|Overall Study||6
8657330|NCT03943290|21372560|P3|STARTED|Overall Study||13
8657331|NCT03943290|21372561|P2|STARTED|Overall Study||1
8657332|NCT03943290|21372562|P1|STARTED|Overall Study||7
8657333|NCT03781479|21372642|P3|NOT COMPLETED|Overall Study||1
8657334|NCT03781479|21372643|P2|NOT COMPLETED|Overall Study||0
8657335|NCT03781479|21372644|P1|NOT COMPLETED|Overall Study||0
8657336|NCT03781479|21372642|P3|COMPLETED|Overall Study||0
8657337|NCT03781479|21372643|P2|COMPLETED|Overall Study||6
8657338|NCT03781479|21372644|P1|COMPLETED|Overall Study||6
8657339|NCT03781479|21372642|P3|STARTED|Overall Study||1
8657340|NCT03781479|21372643|P2|STARTED|Overall Study||6
8657341|NCT03781479|21372644|P1|STARTED|Overall Study||6
8657342|NCT03722576|21372650|P1|NOT COMPLETED|Overall Study||7
8657343|NCT03722576|21372650|P1|COMPLETED|Overall Study||11
8657344|NCT03722576|21372650|P1|STARTED|Overall Study||18
8657345|NCT03666858|21372658|P2|NOT COMPLETED|Cohort 2||1
8657346|NCT03666858|21372659|P1|NOT COMPLETED|Cohort 2||0
8657347|NCT03666858|21372658|P2|COMPLETED|Cohort 2||137
8657348|NCT03666858|21372659|P1|COMPLETED|Cohort 2||0
8657349|NCT03666858|21372658|P2|STARTED|Cohort 2|Cohort 1 participants with pain intensity at 0,120minutes after Neosaldina/0 pain before 120minutes.|138
8657350|NCT03666858|21372659|P1|STARTED|Cohort 2||0
8657351|NCT03666858|21372658|P2|NOT COMPLETED|Cohort 1||0
8657352|NCT03666858|21372659|P1|NOT COMPLETED|Cohort 1||1
8657353|NCT03666858|21372658|P2|COMPLETED|Cohort 1||0
8657354|NCT03666858|21372659|P1|COMPLETED|Cohort 1||215
8657355|NCT03666858|21372658|P2|STARTED|Cohort 1||0
8657356|NCT03666858|21372659|P1|STARTED|Cohort 1|All participants with TTH who had reported at least one headache and Neosaldina intake.|216
8657357|NCT03583606|21372678|P3|NOT COMPLETED|Overall Study||0
8657358|NCT03583606|21372679|P2|NOT COMPLETED|Overall Study||1
8657359|NCT03583606|21372680|P1|NOT COMPLETED|Overall Study||1
8657360|NCT03583606|21372678|P3|COMPLETED|Overall Study||19
8657361|NCT03583606|21372679|P2|COMPLETED|Overall Study||19
8657362|NCT03583606|21372680|P1|COMPLETED|Overall Study||21
8657363|NCT03583606|21372678|P3|STARTED|Overall Study||19
8657364|NCT03583606|21372679|P2|STARTED|Overall Study||20
8657365|NCT03583606|21372680|P1|STARTED|Overall Study||22
8657366|NCT03568539|21372783|P2|NOT COMPLETED|Overall Study||0
8657367|NCT03568539|21372784|P1|NOT COMPLETED|Overall Study||0
8657368|NCT03568539|21372783|P2|COMPLETED|Overall Study||36
8657369|NCT03568539|21372784|P1|COMPLETED|Overall Study||3
8657370|NCT03568539|21372783|P2|STARTED|Overall Study||36
8657371|NCT03568539|21372784|P1|STARTED|Overall Study||3
8657372|NCT03493854|21372802|P2|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||17
8657373|NCT03493854|21372803|P1|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||19
8657374|NCT03493854|21372802|P2|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
8657375|NCT03493854|21372803|P1|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
8657376|NCT03493854|21372802|P2|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|17
8657377|NCT03493854|21372803|P1|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|19
8657378|NCT03493854|21372802|P2|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||234
8657379|NCT03493854|21372803|P1|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||242
8657380|NCT03493854|21372802|P2|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
8657381|NCT03493854|21372803|P1|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
8657382|NCT03493854|21372802|P2|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||234
8657383|NCT03493854|21372803|P1|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||239
8657384|NCT03493854|21372802|P2|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||234
8657385|NCT03493854|21372803|P1|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||242
8657386|NCT03493854|21372802|P2|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||14
8657387|NCT03493854|21372803|P1|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||10
8657388|NCT03493854|21372802|P2|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||234
8657389|NCT03493854|21372803|P1|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||242
8657390|NCT03493854|21372802|P2|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||248
8657391|NCT03493854|21372803|P1|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||252
8657392|NCT03493854|21372802|P2|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|248
8657393|NCT03493854|21372803|P1|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|252
8657394|NCT03325881|21372823|P2|NOT COMPLETED|Overall Study||3
8657395|NCT03325881|21372824|P1|NOT COMPLETED|Overall Study||3
8657396|NCT03325881|21372823|P2|COMPLETED|Overall Study||42
8657397|NCT03325881|21372824|P1|COMPLETED|Overall Study||41
8657398|NCT03325881|21372823|P2|Treated|Overall Study||45
8657399|NCT03325881|21372824|P1|Treated|Overall Study||43
8657400|NCT03325881|21372823|P2|STARTED|Overall Study||45
8657401|NCT03325881|21372824|P1|STARTED|Overall Study||44
8657410|NCT03294317|21372979|P1|NOT COMPLETED|Overall Study||20
8657411|NCT03294317|21372979|P1|COMPLETED|Overall Study||50
8657412|NCT03294317|21372979|P1|Subjects With Available CT|Overall Study||51
8657413|NCT03294317|21372979|P1|Implanted With Lead at HIS Bundle|Overall Study||61
8657414|NCT03294317|21372979|P1|STARTED|Overall Study||70
8657424|NCT03242148|21373029|P1|NOT COMPLETED|Overall Study||0
8657425|NCT03242148|21373029|P1|COMPLETED|Overall Study||38
8657426|NCT03242148|21373029|P1|STARTED|Overall Study||38
8657445|NCT03195465|21373062|P1|NOT COMPLETED|Overall Study||0
8657446|NCT03195465|21373062|P1|COMPLETED|Overall Study||0
8657447|NCT03195465|21373062|P1|STARTED|Overall Study||0
8657464|NCT03083847|21373146|P10|NOT COMPLETED|Main||0
8657465|NCT03083847|21373147|P9|NOT COMPLETED|Main||0
8657466|NCT03083847|21373148|P8|NOT COMPLETED|Main||4
8657467|NCT03083847|21373149|P7|NOT COMPLETED|Main||1
8657468|NCT03083847|21373150|P6|NOT COMPLETED|Main||1
8657469|NCT03083847|21373151|P5|NOT COMPLETED|Main||0
8657470|NCT03083847|21373152|P4|NOT COMPLETED|Main||0
8657471|NCT03083847|21373153|P3|NOT COMPLETED|Main||0
8657472|NCT03083847|21373154|P2|NOT COMPLETED|Main||0
8657473|NCT03083847|21373155|P1|NOT COMPLETED|Main||0
8657474|NCT03083847|21373146|P10|COMPLETED|Main||8
8657475|NCT03083847|21373147|P9|COMPLETED|Main||4
8657476|NCT03083847|21373148|P8|COMPLETED|Main||6
8657477|NCT03083847|21373149|P7|COMPLETED|Main||9
8657478|NCT03083847|21373150|P6|COMPLETED|Main||8
8657479|NCT03083847|21373151|P5|COMPLETED|Main||0
8657480|NCT03083847|21373152|P4|COMPLETED|Main||0
8657481|NCT03083847|21373153|P3|COMPLETED|Main||0
8657482|NCT03083847|21373154|P2|COMPLETED|Main||0
8657483|NCT03083847|21373155|P1|COMPLETED|Main||0
8657484|NCT03083847|21373146|P10|STARTED|Main||8
8657485|NCT03083847|21373147|P9|STARTED|Main||4
8657486|NCT03083847|21373148|P8|STARTED|Main||10
8657487|NCT03083847|21373149|P7|STARTED|Main||10
8657488|NCT03083847|21373150|P6|STARTED|Main||9
8657489|NCT03083847|21373151|P5|STARTED|Main||0
8657490|NCT03083847|21373152|P4|STARTED|Main||0
8657491|NCT03083847|21373153|P3|STARTED|Main||0
8657492|NCT03083847|21373154|P2|STARTED|Main||0
8657493|NCT03083847|21373155|P1|STARTED|Main||0
8657494|NCT03083847|21373146|P10|NOT COMPLETED|Pilot 1d & 5b||0
8657495|NCT03083847|21373147|P9|NOT COMPLETED|Pilot 1d & 5b||0
8657496|NCT03083847|21373148|P8|NOT COMPLETED|Pilot 1d & 5b||0
8657497|NCT03083847|21373149|P7|NOT COMPLETED|Pilot 1d & 5b||0
8657498|NCT03083847|21373150|P6|NOT COMPLETED|Pilot 1d & 5b||0
8657499|NCT03083847|21373151|P5|NOT COMPLETED|Pilot 1d & 5b||0
8657500|NCT03083847|21373152|P4|NOT COMPLETED|Pilot 1d & 5b||0
8657501|NCT03083847|21373153|P3|NOT COMPLETED|Pilot 1d & 5b||0
8657502|NCT03083847|21373154|P2|NOT COMPLETED|Pilot 1d & 5b||0
8657503|NCT03083847|21373155|P1|NOT COMPLETED|Pilot 1d & 5b||0
8657504|NCT03083847|21373146|P10|COMPLETED|Pilot 1d & 5b||0
8657505|NCT03083847|21373147|P9|COMPLETED|Pilot 1d & 5b||0
8657506|NCT03083847|21373148|P8|COMPLETED|Pilot 1d & 5b||0
8657507|NCT03083847|21373149|P7|COMPLETED|Pilot 1d & 5b||0
8657508|NCT03083847|21373150|P6|COMPLETED|Pilot 1d & 5b||0
8657509|NCT03083847|21373151|P5|COMPLETED|Pilot 1d & 5b||4
8657510|NCT03083847|21373152|P4|COMPLETED|Pilot 1d & 5b||4
8657511|NCT03083847|21373153|P3|COMPLETED|Pilot 1d & 5b||0
8657512|NCT03083847|21373154|P2|COMPLETED|Pilot 1d & 5b||0
8657513|NCT03083847|21373155|P1|COMPLETED|Pilot 1d & 5b||0
8657514|NCT03083847|21373146|P10|STARTED|Pilot 1d & 5b||0
8657515|NCT03083847|21373147|P9|STARTED|Pilot 1d & 5b||0
8657516|NCT03083847|21373148|P8|STARTED|Pilot 1d & 5b||0
8657517|NCT03083847|21373149|P7|STARTED|Pilot 1d & 5b||0
8657518|NCT03083847|21373150|P6|STARTED|Pilot 1d & 5b||0
8657519|NCT03083847|21373151|P5|STARTED|Pilot 1d & 5b||4
8657520|NCT03083847|21373152|P4|STARTED|Pilot 1d & 5b||4
8657521|NCT03083847|21373153|P3|STARTED|Pilot 1d & 5b||0
8657522|NCT03083847|21373154|P2|STARTED|Pilot 1d & 5b||0
8657523|NCT03083847|21373155|P1|STARTED|Pilot 1d & 5b||0
8657524|NCT03083847|21373146|P10|NOT COMPLETED|Pilot Ib & 5a||0
8657525|NCT03083847|21373147|P9|NOT COMPLETED|Pilot Ib & 5a||0
8657526|NCT03083847|21373148|P8|NOT COMPLETED|Pilot Ib & 5a||0
8657527|NCT03083847|21373149|P7|NOT COMPLETED|Pilot Ib & 5a||0
8657528|NCT03083847|21373150|P6|NOT COMPLETED|Pilot Ib & 5a||0
8657529|NCT03083847|21373151|P5|NOT COMPLETED|Pilot Ib & 5a||0
8657530|NCT03083847|21373152|P4|NOT COMPLETED|Pilot Ib & 5a||0
8657531|NCT03083847|21373153|P3|NOT COMPLETED|Pilot Ib & 5a||0
8657532|NCT03083847|21373154|P2|NOT COMPLETED|Pilot Ib & 5a||0
8657533|NCT03083847|21373155|P1|NOT COMPLETED|Pilot Ib & 5a||0
8657534|NCT03083847|21373146|P10|COMPLETED|Pilot Ib & 5a||0
8657535|NCT03083847|21373147|P9|COMPLETED|Pilot Ib & 5a||0
8657536|NCT03083847|21373148|P8|COMPLETED|Pilot Ib & 5a||0
8657537|NCT03083847|21373149|P7|COMPLETED|Pilot Ib & 5a||0
8657538|NCT03083847|21373150|P6|COMPLETED|Pilot Ib & 5a||0
8657539|NCT03083847|21373151|P5|COMPLETED|Pilot Ib & 5a||0
8657540|NCT03083847|21373152|P4|COMPLETED|Pilot Ib & 5a||0
8657541|NCT03083847|21373153|P3|COMPLETED|Pilot Ib & 5a||2
8657542|NCT03083847|21373154|P2|COMPLETED|Pilot Ib & 5a||2
8657543|NCT03083847|21373155|P1|COMPLETED|Pilot Ib & 5a||0
8657544|NCT03083847|21373146|P10|STARTED|Pilot Ib & 5a||0
8657545|NCT03083847|21373147|P9|STARTED|Pilot Ib & 5a||0
8657546|NCT03083847|21373148|P8|STARTED|Pilot Ib & 5a||0
8657547|NCT03083847|21373149|P7|STARTED|Pilot Ib & 5a||0
8657548|NCT03083847|21373150|P6|STARTED|Pilot Ib & 5a||0
8657549|NCT03083847|21373151|P5|STARTED|Pilot Ib & 5a||0
8657550|NCT03083847|21373152|P4|STARTED|Pilot Ib & 5a||0
8657551|NCT03083847|21373153|P3|STARTED|Pilot Ib & 5a||2
8657552|NCT03083847|21373154|P2|STARTED|Pilot Ib & 5a||2
8657553|NCT03083847|21373155|P1|STARTED|Pilot Ib & 5a||0
8657554|NCT03083847|21373146|P10|NOT COMPLETED|Pilot 1a||0
8657555|NCT03083847|21373147|P9|NOT COMPLETED|Pilot 1a||0
8657556|NCT03083847|21373148|P8|NOT COMPLETED|Pilot 1a||0
8657557|NCT03083847|21373149|P7|NOT COMPLETED|Pilot 1a||0
8657558|NCT03083847|21373150|P6|NOT COMPLETED|Pilot 1a||0
8657559|NCT03083847|21373151|P5|NOT COMPLETED|Pilot 1a||0
8657560|NCT03083847|21373152|P4|NOT COMPLETED|Pilot 1a||0
8657561|NCT03083847|21373153|P3|NOT COMPLETED|Pilot 1a||0
8657562|NCT03083847|21373154|P2|NOT COMPLETED|Pilot 1a||0
8657563|NCT03083847|21373155|P1|NOT COMPLETED|Pilot 1a||0
8657564|NCT03083847|21373146|P10|COMPLETED|Pilot 1a||0
8657565|NCT03083847|21373147|P9|COMPLETED|Pilot 1a||0
8657566|NCT03083847|21373148|P8|COMPLETED|Pilot 1a||0
8657567|NCT03083847|21373149|P7|COMPLETED|Pilot 1a||0
8657568|NCT03083847|21373150|P6|COMPLETED|Pilot 1a||0
8657569|NCT03083847|21373151|P5|COMPLETED|Pilot 1a||0
8657570|NCT03083847|21373152|P4|COMPLETED|Pilot 1a||0
8657571|NCT03083847|21373153|P3|COMPLETED|Pilot 1a||0
8657572|NCT03083847|21373154|P2|COMPLETED|Pilot 1a||0
8657573|NCT03083847|21373155|P1|COMPLETED|Pilot 1a||2
8657574|NCT03083847|21373146|P10|STARTED|Pilot 1a||0
8657575|NCT03083847|21373147|P9|STARTED|Pilot 1a||0
8657576|NCT03083847|21373148|P8|STARTED|Pilot 1a||0
8657577|NCT03083847|21373149|P7|STARTED|Pilot 1a||0
8657578|NCT03083847|21373150|P6|STARTED|Pilot 1a||0
8657579|NCT03083847|21373151|P5|STARTED|Pilot 1a||0
8657580|NCT03083847|21373152|P4|STARTED|Pilot 1a||0
8657581|NCT03083847|21373153|P3|STARTED|Pilot 1a||0
8657582|NCT03083847|21373154|P2|STARTED|Pilot 1a||0
8657583|NCT03083847|21373155|P1|STARTED|Pilot 1a||2
8657587|NCT03053102|21373267|P1|NOT COMPLETED|Study Part 2: 84-Day Treatment||2
8657588|NCT03053102|21373267|P1|COMPLETED|Study Part 2: 84-Day Treatment||8
8657589|NCT03053102|21373267|P1|STARTED|Study Part 2: 84-Day Treatment||10
8657590|NCT03053102|21373267|P1|NOT COMPLETED|Study Part 1: 28-Day Treatment||0
8657591|NCT03053102|21373267|P1|COMPLETED|Study Part 1: 28-Day Treatment||10
8657592|NCT03053102|21373267|P1|Received at Least 1 Dose of Study Drug|Study Part 1: 28-Day Treatment||10
8657593|NCT03053102|21373267|P1|STARTED|Study Part 1: 28-Day Treatment||10
8657594|NCT03039023|21373284|P5|NOT COMPLETED|Overall Study||0
8657595|NCT03039023|21373285|P4|NOT COMPLETED|Overall Study||2
8657596|NCT03039023|21373286|P3|NOT COMPLETED|Overall Study||1
8657597|NCT03039023|21373287|P2|NOT COMPLETED|Overall Study||0
8657598|NCT03039023|21373288|P1|NOT COMPLETED|Overall Study||1
8657599|NCT03039023|21373284|P5|COMPLETED|Overall Study||10
8657600|NCT03039023|21373285|P4|COMPLETED|Overall Study||18
8657601|NCT03039023|21373286|P3|COMPLETED|Overall Study||16
8657602|NCT03039023|21373287|P2|COMPLETED|Overall Study||20
8657603|NCT03039023|21373288|P1|COMPLETED|Overall Study||18
8657604|NCT03039023|21373284|P5|STARTED|Overall Study||10
8657605|NCT03039023|21373285|P4|STARTED|Overall Study||20
8657606|NCT03039023|21373286|P3|STARTED|Overall Study||17
8657607|NCT03039023|21373287|P2|STARTED|Overall Study||20
8657608|NCT03039023|21373288|P1|STARTED|Overall Study||19
8657609|NCT03018249|21373347|P2|NOT COMPLETED|Overall Study||2
8657610|NCT03018249|21373348|P1|NOT COMPLETED|Overall Study||2
8657611|NCT03018249|21373347|P2|COMPLETED|Overall Study||23
8657612|NCT03018249|21373348|P1|COMPLETED|Overall Study||23
8657613|NCT03018249|21373347|P2|STARTED|Overall Study||25
8657614|NCT03018249|21373348|P1|STARTED|Overall Study||25
8657615|NCT02979522|21373362|P2|NOT COMPLETED|Period 2: Phase 2||0
8657616|NCT02979522|21373363|P1|NOT COMPLETED|Period 2: Phase 2||0
8657617|NCT02979522|21373362|P2|COMPLETED|Period 2: Phase 2||59
8657618|NCT02979522|21373363|P1|COMPLETED|Period 2: Phase 2||0
8657619|NCT02979522|21373362|P2|STARTED|Period 2: Phase 2|Participants treated in Phase 1 entered Phase 2 along with additional participants enrolled in Phase 2.|59
8657620|NCT02979522|21373363|P1|STARTED|Period 2: Phase 2||0
8657621|NCT02979522|21373362|P2|NOT COMPLETED|Period 1: Phase 1||0
8657622|NCT02979522|21373363|P1|NOT COMPLETED|Period 1: Phase 1||0
8657623|NCT02979522|21373362|P2|COMPLETED|Period 1: Phase 1||0
8657624|NCT02979522|21373363|P1|COMPLETED|Period 1: Phase 1||8
8657625|NCT02979522|21373362|P2|STARTED|Period 1: Phase 1||0
8657626|NCT02979522|21373363|P1|STARTED|Period 1: Phase 1||8
8657627|NCT02952001|21373377|P2|NOT COMPLETED|Overall Study||3
8657628|NCT02952001|21373378|P1|NOT COMPLETED|Overall Study||14
8657629|NCT02952001|21373377|P2|COMPLETED|Overall Study||2
8657630|NCT02952001|21373378|P1|COMPLETED|Overall Study||14
8657631|NCT02952001|21373377|P2|STARTED|Overall Study||5
8657632|NCT02952001|21373378|P1|STARTED|Overall Study||28
8657633|NCT02941523|21373392|P2|NOT COMPLETED|Carboplatin Combination Therapy||4
8657634|NCT02941523|21373393|P1|NOT COMPLETED|Carboplatin Combination Therapy||5
8657635|NCT02941523|21373392|P2|COMPLETED|Carboplatin Combination Therapy||6
8657636|NCT02941523|21373393|P1|COMPLETED|Carboplatin Combination Therapy||3
8657637|NCT02941523|21373392|P2|STARTED|Carboplatin Combination Therapy|7 continued to combination therapy; 3 started combination therapy only|10
8657638|NCT02941523|21373393|P1|STARTED|Carboplatin Combination Therapy|All continued to combination therapy|8
8657639|NCT02941523|21373392|P2|NOT COMPLETED|Monotherapy||1
8657640|NCT02941523|21373393|P1|NOT COMPLETED|Monotherapy||0
8657641|NCT02941523|21373392|P2|COMPLETED|Monotherapy||7
8657642|NCT02941523|21373393|P1|COMPLETED|Monotherapy||8
8657643|NCT02941523|21373392|P2|STARTED|Monotherapy||8
8657644|NCT02941523|21373393|P1|STARTED|Monotherapy|8 received NOX66 400 mg monotherapy and combination therapy with carboplatin.|8
8657645|NCT02916056|21373415|P1|NOT COMPLETED|Overall Study||297
8657646|NCT02916056|21373415|P1|COMPLETED|Overall Study||0
8657647|NCT02916056|21373415|P1|STARTED|Overall Study||297
8657648|NCT02886728|21373423|P4|NOT COMPLETED|Overall Study||87
8657649|NCT02886728|21373424|P3|NOT COMPLETED|Overall Study||36
8657650|NCT02886728|21373425|P2|NOT COMPLETED|Overall Study||32
8657651|NCT02886728|21373426|P1|NOT COMPLETED|Overall Study||72
8657652|NCT02886728|21373423|P4|COMPLETED|Overall Study||331
8657653|NCT02886728|21373424|P3|COMPLETED|Overall Study||174
8657654|NCT02886728|21373425|P2|COMPLETED|Overall Study||175
8657655|NCT02886728|21373426|P1|COMPLETED|Overall Study||345
8657656|NCT02886728|21373423|P4|STARTED|Overall Study||418
8657657|NCT02886728|21373424|P3|STARTED|Overall Study||210
8657658|NCT02886728|21373425|P2|STARTED|Overall Study||207
8657659|NCT02886728|21373426|P1|STARTED|Overall Study||417
8657660|NCT02865720|21373606|P2|NOT COMPLETED|Overall Study||0
8657661|NCT02865720|21373607|P1|NOT COMPLETED|Overall Study||0
8657662|NCT02865720|21373606|P2|COMPLETED|Overall Study||8
8657663|NCT02865720|21373607|P1|COMPLETED|Overall Study||0
8657664|NCT02865720|21373606|P2|STARTED|Overall Study||8
8657665|NCT02865720|21373607|P1|STARTED|Overall Study||0
8657666|NCT02795767|21373633|P3|NOT COMPLETED|Overall Study||0
8657667|NCT02795767|21373634|P2|NOT COMPLETED|Overall Study||0
8657668|NCT02795767|21373635|P1|NOT COMPLETED|Overall Study||1
8657669|NCT02795767|21373633|P3|COMPLETED|Overall Study||10
8657670|NCT02795767|21373634|P2|COMPLETED|Overall Study||10
8657671|NCT02795767|21373635|P1|COMPLETED|Overall Study||67
8657672|NCT02795767|21373633|P3|Completed 52 Weeks in Study|Overall Study||9
8657673|NCT02795767|21373634|P2|Completed 52 Weeks in Study|Overall Study||10
8657674|NCT02795767|21373635|P1|Completed 52 Weeks in Study|Overall Study||67
8657675|NCT02795767|21373633|P3|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
8657676|NCT02795767|21373634|P2|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
8657677|NCT02795767|21373635|P1|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
8657678|NCT02795767|21373633|P3|Received at Least One Dose of Emicizumab|Overall Study||10
8657679|NCT02795767|21373634|P2|Received at Least One Dose of Emicizumab|Overall Study||10
8657680|NCT02795767|21373635|P1|Received at Least One Dose of Emicizumab|Overall Study||68
8657681|NCT02795767|21373633|P3|STARTED|Overall Study||10
8657682|NCT02795767|21373634|P2|STARTED|Overall Study||10
8657683|NCT02795767|21373635|P1|STARTED|Overall Study||68
8657684|NCT02768558|21373786|P2|NOT COMPLETED|Overall Study||0
8657685|NCT02768558|21373787|P1|NOT COMPLETED|Overall Study||0
8657686|NCT02768558|21373786|P2|COMPLETED|Overall Study||5
8657687|NCT02768558|21373787|P1|COMPLETED|Overall Study||3
8657688|NCT02768558|21373786|P2|Eligible|Overall Study||5
8657689|NCT02768558|21373787|P1|Eligible|Overall Study||3
8657690|NCT02768558|21373786|P2|STARTED|Overall Study||5
8657691|NCT02768558|21373787|P1|STARTED|Overall Study||3
8657692|NCT02747875|21373805|P2|NOT COMPLETED|Overall Study||1
8657693|NCT02747875|21373806|P1|NOT COMPLETED|Overall Study||1
8657694|NCT02747875|21373805|P2|COMPLETED|Overall Study||13
8657695|NCT02747875|21373806|P1|COMPLETED|Overall Study||11
8657696|NCT02747875|21373805|P2|STARTED|Overall Study||14
8657697|NCT02747875|21373806|P1|STARTED|Overall Study||12
8657698|NCT02743078|21373814|P1|NOT COMPLETED|Overall Study||0
8657699|NCT02743078|21373814|P1|COMPLETED|Overall Study||3
8657700|NCT02743078|21373814|P1|Eligible With Six-month Follow-up Data|Overall Study||3
8657701|NCT02743078|21373814|P1|Eligible Populaton|Overall Study||3
8657702|NCT02743078|21373814|P1|STARTED|Overall Study||3
8657703|NCT02654860|21373826|P4|NOT COMPLETED|Second Part||0
8657704|NCT02654860|21373827|P3|NOT COMPLETED|Second Part||0
8657705|NCT02654860|21373828|P2|NOT COMPLETED|Second Part||0
8657706|NCT02654860|21373829|P1|NOT COMPLETED|Second Part||0
8657707|NCT02654860|21373826|P4|COMPLETED|Second Part||15
8657708|NCT02654860|21373827|P3|COMPLETED|Second Part||15
8657709|NCT02654860|21373828|P2|COMPLETED|Second Part||15
8657710|NCT02654860|21373829|P1|COMPLETED|Second Part||15
8657711|NCT02654860|21373826|P4|STARTED|Second Part||15
8657712|NCT02654860|21373827|P3|STARTED|Second Part||15
8657713|NCT02654860|21373828|P2|STARTED|Second Part||15
8657714|NCT02654860|21373829|P1|STARTED|Second Part||15
8657715|NCT02654860|21373826|P4|NOT COMPLETED|First Part||0
8657716|NCT02654860|21373827|P3|NOT COMPLETED|First Part||0
8657717|NCT02654860|21373828|P2|NOT COMPLETED|First Part||0
8657718|NCT02654860|21373829|P1|NOT COMPLETED|First Part||0
8657719|NCT02654860|21373826|P4|COMPLETED|First Part||0
8657720|NCT02654860|21373827|P3|COMPLETED|First Part||3
8657721|NCT02654860|21373828|P2|COMPLETED|First Part||3
8657722|NCT02654860|21373829|P1|COMPLETED|First Part||3
8657723|NCT02654860|21373826|P4|STARTED|First Part||0
8657724|NCT02654860|21373827|P3|STARTED|First Part||3
8657725|NCT02654860|21373828|P2|STARTED|First Part||3
8657726|NCT02654860|21373829|P1|STARTED|First Part||3
8657727|NCT02600923|21373890|P1|NOT COMPLETED|Overall Study||131
8657728|NCT02600923|21373890|P1|COMPLETED|Overall Study||0
8657729|NCT02600923|21373890|P1|Treated|Overall Study||130
8657730|NCT02600923|21373890|P1|STARTED|Overall Study||131
8657731|NCT02586805|21373902|P4|NOT COMPLETED|Overall Study||2
8657732|NCT02586805|21373903|P3|NOT COMPLETED|Overall Study||3
8657733|NCT02586805|21373904|P2|NOT COMPLETED|Overall Study||1
8657734|NCT02586805|21373905|P1|NOT COMPLETED|Overall Study||6
8657735|NCT02586805|21373902|P4|COMPLETED|Overall Study||25
8657736|NCT02586805|21373903|P3|COMPLETED|Overall Study||26
8657737|NCT02586805|21373904|P2|COMPLETED|Overall Study||27
8657738|NCT02586805|21373905|P1|COMPLETED|Overall Study||35
8657739|NCT02586805|21373902|P4|STARTED|Overall Study||27
8657740|NCT02586805|21373903|P3|STARTED|Overall Study||29
8657741|NCT02586805|21373904|P2|STARTED|Overall Study||28
8657742|NCT02586805|21373905|P1|STARTED|Overall Study||41
8657743|NCT02552212|21373929|P3|NOT COMPLETED|SFE Period (Week 52 - 156)||37
8657744|NCT02552212|21373930|P2|NOT COMPLETED|SFE Period (Week 52 - 156)||0
8657745|NCT02552212|21373931|P1|NOT COMPLETED|SFE Period (Week 52 - 156)||0
8657746|NCT02552212|21373929|P3|COMPLETED|SFE Period (Week 52 - 156)||206
8657747|NCT02552212|21373930|P2|COMPLETED|SFE Period (Week 52 - 156)||0
8657748|NCT02552212|21373931|P1|COMPLETED|SFE Period (Week 52 - 156)||0
8657749|NCT02552212|21373929|P3|STARTED|SFE Period (Week 52 - 156)|123 subjects from Placebo arm and 120 subjects from CZP 200 mg Q2W arm|243
8657750|NCT02552212|21373930|P2|STARTED|SFE Period (Week 52 - 156)||0
8657751|NCT02552212|21373931|P1|STARTED|SFE Period (Week 52 - 156)||0
8657752|NCT02552212|21373929|P3|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||0
8657753|NCT02552212|21373930|P2|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||17
8657754|NCT02552212|21373931|P1|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||15
8657755|NCT02552212|21373929|P3|COMPLETED|Double-Blind Period (Week 0 - 52)||0
8657756|NCT02552212|21373930|P2|COMPLETED|Double-Blind Period (Week 0 - 52)||142
8657757|NCT02552212|21373931|P1|COMPLETED|Double-Blind Period (Week 0 - 52)||143
8657758|NCT02552212|21373929|P3|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||0
8657759|NCT02552212|21373930|P2|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||22
8657760|NCT02552212|21373931|P1|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||20
8657761|NCT02552212|21373929|P3|Received OL CZP|Double-Blind Period (Week 0 - 52)||0
8657762|NCT02552212|21373930|P2|Received OL CZP|Double-Blind Period (Week 0 - 52)||20
8657763|NCT02552212|21373931|P1|Received OL CZP|Double-Blind Period (Week 0 - 52)||96
8657764|NCT02552212|21373929|P3|STARTED|Double-Blind Period (Week 0 - 52)||0
8657765|NCT02552212|21373930|P2|STARTED|Double-Blind Period (Week 0 - 52)||159
8657766|NCT02552212|21373931|P1|STARTED|Double-Blind Period (Week 0 - 52)||158
8657767|NCT02522494|21374011|P2|NOT COMPLETED|Overall Study||5
8657768|NCT02522494|21374012|P1|NOT COMPLETED|Overall Study||14
8657769|NCT02522494|21374011|P2|COMPLETED|Overall Study||46
8657770|NCT02522494|21374012|P1|COMPLETED|Overall Study||37
8657771|NCT02522494|21374011|P2|4-Week Follow Up|Overall Study||46
8657772|NCT02522494|21374012|P1|4-Week Follow Up|Overall Study||37
8657773|NCT02522494|21374011|P2|Post-CVT Visit Interview|Overall Study||48
8657774|NCT02522494|21374012|P1|Post-CVT Visit Interview|Overall Study||37
8657775|NCT02522494|21374011|P2|STARTED|Overall Study||51
8657776|NCT02522494|21374012|P1|STARTED|Overall Study||51
8657777|NCT02467166|21374040|P1|NOT COMPLETED|Overall Study||0
8657778|NCT02467166|21374040|P1|COMPLETED|Overall Study||36
8657779|NCT02467166|21374040|P1|STARTED|Overall Study||36
8657780|NCT02426476|21374046|P2|NOT COMPLETED|Overall Study||17
8657781|NCT02426476|21374047|P1|NOT COMPLETED|Overall Study||19
8657782|NCT02426476|21374046|P2|COMPLETED|Overall Study||39
8657783|NCT02426476|21374047|P1|COMPLETED|Overall Study||38
8657784|NCT02426476|21374046|P2|STARTED|Overall Study||56
8657785|NCT02426476|21374047|P1|STARTED|Overall Study||57
8657786|NCT02370238|21374059|P2|NOT COMPLETED|Overall Study||45
8657787|NCT02370238|21374060|P1|NOT COMPLETED|Overall Study||47
8657788|NCT02370238|21374059|P2|COMPLETED|Overall Study||16
8657789|NCT02370238|21374060|P1|COMPLETED|Overall Study||15
8657790|NCT02370238|21374059|P2|Responsable-evaluable Population|Overall Study||54
8657791|NCT02370238|21374060|P1|Responsable-evaluable Population|Overall Study||57
8657792|NCT02370238|21374059|P2|Safety Population|Overall Study||60
8657793|NCT02370238|21374060|P1|Safety Population|Overall Study||61
8657794|NCT02370238|21374059|P2|ITT Population|Overall Study||61
8657795|NCT02370238|21374060|P1|ITT Population|Overall Study||62
8657796|NCT02370238|21374059|P2|STARTED|Overall Study||61
8657797|NCT02370238|21374060|P1|STARTED|Overall Study||62
8657804|NCT02360215|21374103|P2|NOT COMPLETED|Overall Study||0
8657805|NCT02360215|21374104|P1|NOT COMPLETED|Overall Study||0
8657806|NCT02360215|21374103|P2|COMPLETED|Overall Study||261
8657807|NCT02360215|21374104|P1|COMPLETED|Overall Study||257
8657808|NCT02360215|21374103|P2|EQ-5D-5L VAS at 12 Months|Overall Study||48
8657809|NCT02360215|21374104|P1|EQ-5D-5L VAS at 12 Months|Overall Study||57
8657810|NCT02360215|21374103|P2|EQ-5D-5L VAS at 6 Months|Overall Study||69
8657811|NCT02360215|21374104|P1|EQ-5D-5L VAS at 6 Months|Overall Study||76
8657812|NCT02360215|21374103|P2|EQ-5D-5L VAS at 4 Months|Overall Study||193
8657813|NCT02360215|21374104|P1|EQ-5D-5L VAS at 4 Months|Overall Study||104
8657814|NCT02360215|21374103|P2|EQ-5D-5L VAS at 2 Months|Overall Study||123
8657815|NCT02360215|21374104|P1|EQ-5D-5L VAS at 2 Months|Overall Study||139
8657816|NCT02360215|21374103|P2|EQ-5D-5L Index at 12 Months|Overall Study||45
8657817|NCT02360215|21374104|P1|EQ-5D-5L Index at 12 Months|Overall Study||56
8657818|NCT02360215|21374103|P2|EQ-5D-5L Index at 6 Months|Overall Study||70
8657819|NCT02360215|21374104|P1|EQ-5D-5L Index at 6 Months|Overall Study||79
8657820|NCT02360215|21374103|P2|EQ-5D-5L Index at 4 Months|Overall Study||96
8657821|NCT02360215|21374104|P1|EQ-5D-5L Index at 4 Months|Overall Study||110
8657822|NCT02360215|21374103|P2|EQ-5D-5L Index at 2 Months|Overall Study||125
8657823|NCT02360215|21374104|P1|EQ-5D-5L Index at 2 Months|Overall Study||142
8657824|NCT02360215|21374103|P2|Clinical Trial Battery Composite Score|Overall Study||259
8657825|NCT02360215|21374104|P1|Clinical Trial Battery Composite Score|Overall Study||255
8657826|NCT02360215|21374103|P2|Controlled Oral Word Association (COWA)|Overall Study||261
8657827|NCT02360215|21374104|P1|Controlled Oral Word Association (COWA)|Overall Study||257
8657828|NCT02360215|21374103|P2|TMT Part B|Overall Study||257
8657829|NCT02360215|21374104|P1|TMT Part B|Overall Study||250
8657830|NCT02360215|21374103|P2|Trail Making Test (TMT) Part A|Overall Study||260
8657831|NCT02360215|21374104|P1|Trail Making Test (TMT) Part A|Overall Study||256
8657832|NCT02360215|21374103|P2|HVLT-R Recognition|Overall Study||259
8657833|NCT02360215|21374104|P1|HVLT-R Recognition|Overall Study||255
8657834|NCT02360215|21374103|P2|HVLT-R Delayed Recall|Overall Study||259
8657835|NCT02360215|21374104|P1|HVLT-R Delayed Recall|Overall Study||256
8657836|NCT02360215|21374103|P2|HVLT-R Total Recall|Overall Study||259
8657837|NCT02360215|21374104|P1|HVLT-R Total Recall|Overall Study||256
8657838|NCT02360215|21374103|P2|MDASI-BT Neurologic Factor Score|Overall Study||251
8657839|NCT02360215|21374104|P1|MDASI-BT Neurologic Factor Score|Overall Study||249
8657840|NCT02360215|21374103|P2|MDASI-BT Cognitive Factor Score|Overall Study||251
8657841|NCT02360215|21374104|P1|MDASI-BT Cognitive Factor Score|Overall Study||249
8657842|NCT02360215|21374103|P2|MDASI-BT Intererence Score|Overall Study||251
8657843|NCT02360215|21374104|P1|MDASI-BT Intererence Score|Overall Study||248
8657844|NCT02360215|21374103|P2|MDASI-BT Symptom Score|Overall Study||251
8657845|NCT02360215|21374104|P1|MDASI-BT Symptom Score|Overall Study||249
8657846|NCT02360215|21374103|P2|Started Protocol Treatment|Overall Study||223
8657847|NCT02360215|21374104|P1|Started Protocol Treatment|Overall Study||232
8657848|NCT02360215|21374103|P2|All Randomized Participants|Overall Study||261
8657849|NCT02360215|21374104|P1|All Randomized Participants|Overall Study||257
8657850|NCT02360215|21374103|P2|STARTED|Overall Study||261
8657851|NCT02360215|21374104|P1|STARTED|Overall Study||257
8657852|NCT02357134|21374158|P4|NOT COMPLETED|Overall Study||0
8657853|NCT02357134|21374159|P3|NOT COMPLETED|Overall Study||0
8657854|NCT02357134|21374160|P2|NOT COMPLETED|Overall Study||0
8657855|NCT02357134|21374161|P1|NOT COMPLETED|Overall Study||1
8657856|NCT02357134|21374158|P4|COMPLETED|Overall Study||11
8657857|NCT02357134|21374159|P3|COMPLETED|Overall Study||12
8657858|NCT02357134|21374160|P2|COMPLETED|Overall Study||11
8657859|NCT02357134|21374161|P1|COMPLETED|Overall Study||10
8657860|NCT02357134|21374158|P4|STARTED|Overall Study||11
8657861|NCT02357134|21374159|P3|STARTED|Overall Study||12
8657862|NCT02357134|21374160|P2|STARTED|Overall Study||11
8657863|NCT02357134|21374161|P1|STARTED|Overall Study||11
8657864|NCT02335450|21374187|P1|NOT COMPLETED|Overall Study||1
8657865|NCT02335450|21374187|P1|COMPLETED|Overall Study||4
8657866|NCT02335450|21374187|P1|STARTED|Overall Study||5
8657873|NCT02285114|21374215|P3|NOT COMPLETED|Overall Study||3
8657874|NCT02285114|21374216|P2|NOT COMPLETED|Overall Study||7
8657875|NCT02285114|21374217|P1|NOT COMPLETED|Overall Study||22
8657876|NCT02285114|21374215|P3|COMPLETED|Overall Study||0
8657877|NCT02285114|21374216|P2|COMPLETED|Overall Study||2
8657878|NCT02285114|21374217|P1|COMPLETED|Overall Study||7
8657879|NCT02285114|21374215|P3|STARTED|Overall Study||3
8657880|NCT02285114|21374216|P2|STARTED|Overall Study||9
8657881|NCT02285114|21374217|P1|STARTED|Overall Study||29
8657890|NCT02236988|21374299|P4|NOT COMPLETED|Overall Study||3
8657891|NCT02236988|21374300|P3|NOT COMPLETED|Overall Study||0
8657892|NCT02236988|21374301|P2|NOT COMPLETED|Overall Study||0
8657893|NCT02236988|21374302|P1|NOT COMPLETED|Overall Study||0
8657894|NCT02236988|21374299|P4|COMPLETED|Overall Study||27
8657895|NCT02236988|21374300|P3|COMPLETED|Overall Study||18
8657896|NCT02236988|21374301|P2|COMPLETED|Overall Study||16
8657897|NCT02236988|21374302|P1|COMPLETED|Overall Study||16
8657898|NCT02236988|21374299|P4|STARTED|Overall Study||30
8657899|NCT02236988|21374300|P3|STARTED|Overall Study||18
8657900|NCT02236988|21374301|P2|STARTED|Overall Study||16
8657901|NCT02236988|21374302|P1|STARTED|Overall Study||16
8657902|NCT02227446|21374479|P2|NOT COMPLETED|Overall Study||34
8657903|NCT02227446|21374480|P1|NOT COMPLETED|Overall Study||22
8657904|NCT02227446|21374479|P2|COMPLETED|Overall Study||481
8657905|NCT02227446|21374480|P1|COMPLETED|Overall Study||499
8657906|NCT02227446|21374479|P2|STARTED|Overall Study||515
8657907|NCT02227446|21374480|P1|STARTED|Overall Study||521
8657908|NCT02125461|21374488|P2|NOT COMPLETED|Overall Study||129
8657909|NCT02125461|21374489|P1|NOT COMPLETED|Overall Study||203
8657910|NCT02125461|21374488|P2|COMPLETED|Overall Study||108
8657911|NCT02125461|21374489|P1|COMPLETED|Overall Study||273
8657912|NCT02125461|21374488|P2|Completed 12 Months of Treatment|Overall Study||82
8657913|NCT02125461|21374489|P1|Completed 12 Months of Treatment|Overall Study||232
8657914|NCT02125461|21374488|P2|Safety Analysis Set|Overall Study||234
8657915|NCT02125461|21374489|P1|Safety Analysis Set|Overall Study||475
8657916|NCT02125461|21374488|P2|Receieved Treatment|Overall Study||236
8657917|NCT02125461|21374489|P1|Receieved Treatment|Overall Study||473
8657918|NCT02125461|21374488|P2|Full Analysis Set (FAS)|Overall Study||237
8657919|NCT02125461|21374489|P1|Full Analysis Set (FAS)|Overall Study||476
8657920|NCT02125461|21374488|P2|STARTED|Overall Study||237
8657921|NCT02125461|21374489|P1|STARTED|Overall Study||476
8657922|NCT02118337|21374527|P9|NOT COMPLETED|Overall Study||21
8657923|NCT02118337|21374528|P8|NOT COMPLETED|Overall Study||42
8657924|NCT02118337|21374529|P7|NOT COMPLETED|Overall Study||4
8657925|NCT02118337|21374530|P6|NOT COMPLETED|Overall Study||6
8657926|NCT02118337|21374531|P5|NOT COMPLETED|Overall Study||9
8657927|NCT02118337|21374532|P4|NOT COMPLETED|Overall Study||3
8657928|NCT02118337|21374533|P3|NOT COMPLETED|Overall Study||3
8657929|NCT02118337|21374534|P2|NOT COMPLETED|Overall Study||5
8657930|NCT02118337|21374535|P1|NOT COMPLETED|Overall Study||4
8657931|NCT02118337|21374527|P9|COMPLETED|Overall Study||0
8657932|NCT02118337|21374528|P8|COMPLETED|Overall Study||0
8657933|NCT02118337|21374529|P7|COMPLETED|Overall Study||0
8657934|NCT02118337|21374530|P6|COMPLETED|Overall Study||0
8657935|NCT02118337|21374531|P5|COMPLETED|Overall Study||0
8657936|NCT02118337|21374532|P4|COMPLETED|Overall Study||0
8657937|NCT02118337|21374533|P3|COMPLETED|Overall Study||0
8657938|NCT02118337|21374534|P2|COMPLETED|Overall Study||0
8657939|NCT02118337|21374535|P1|COMPLETED|Overall Study||0
8657940|NCT02118337|21374527|P9|STARTED|Overall Study||21
8657941|NCT02118337|21374528|P8|STARTED|Overall Study||42
8657942|NCT02118337|21374529|P7|STARTED|Overall Study||4
8657943|NCT02118337|21374530|P6|STARTED|Overall Study||6
8657944|NCT02118337|21374531|P5|STARTED|Overall Study||9
8657945|NCT02118337|21374532|P4|STARTED|Overall Study||3
8657946|NCT02118337|21374533|P3|STARTED|Overall Study||3
8657947|NCT02118337|21374534|P2|STARTED|Overall Study||5
8657948|NCT02118337|21374535|P1|STARTED|Overall Study||4
8657949|NCT02110732|21374692|P2|NOT COMPLETED|Overall Study||3
8657950|NCT02110732|21374693|P1|NOT COMPLETED|Overall Study||6
8657951|NCT02110732|21374692|P2|COMPLETED|Overall Study||17
8657952|NCT02110732|21374693|P1|COMPLETED|Overall Study||14
8657953|NCT02110732|21374692|P2|STARTED|Overall Study||20
8657954|NCT02110732|21374693|P1|STARTED|Overall Study||20
8657955|NCT02100969|21374703|P1|NOT COMPLETED|Overall Study||1
8657956|NCT02100969|21374703|P1|COMPLETED|Overall Study||22
8657957|NCT02100969|21374703|P1|STARTED|Overall Study||23
8657958|NCT01994538|21374717|P2|NOT COMPLETED|Overall Study||0
8657959|NCT01994538|21374718|P1|NOT COMPLETED|Overall Study||0
8657960|NCT01994538|21374717|P2|COMPLETED|Overall Study||136
8657961|NCT01994538|21374718|P1|COMPLETED|Overall Study||136
8657962|NCT01994538|21374717|P2|STARTED|Overall Study||136
8657963|NCT01994538|21374718|P1|STARTED|Overall Study||136
8657970|NCT01898884|21374775|P9|NOT COMPLETED|Multiple Dose Period||1
8657971|NCT01898884|21374776|P8|NOT COMPLETED|Multiple Dose Period||0
8657972|NCT01898884|21374777|P7|NOT COMPLETED|Multiple Dose Period||1
8657973|NCT01898884|21374778|P6|NOT COMPLETED|Multiple Dose Period||0
8657974|NCT01898884|21374779|P5|NOT COMPLETED|Multiple Dose Period||0
8657975|NCT01898884|21374780|P4|NOT COMPLETED|Multiple Dose Period||0
8657976|NCT01898884|21374781|P3|NOT COMPLETED|Multiple Dose Period||0
8657977|NCT01898884|21374782|P2|NOT COMPLETED|Multiple Dose Period||0
8657978|NCT01898884|21374783|P1|NOT COMPLETED|Multiple Dose Period||0
8657979|NCT01898884|21374775|P9|COMPLETED|Multiple Dose Period||5
8657980|NCT01898884|21374776|P8|COMPLETED|Multiple Dose Period||6
8657981|NCT01898884|21374777|P7|COMPLETED|Multiple Dose Period||5
8657982|NCT01898884|21374778|P6|COMPLETED|Multiple Dose Period||6
8657983|NCT01898884|21374779|P5|COMPLETED|Multiple Dose Period||0
8657984|NCT01898884|21374780|P4|COMPLETED|Multiple Dose Period||0
8657985|NCT01898884|21374781|P3|COMPLETED|Multiple Dose Period||0
8657986|NCT01898884|21374782|P2|COMPLETED|Multiple Dose Period||0
8657987|NCT01898884|21374783|P1|COMPLETED|Multiple Dose Period||0
8657988|NCT01898884|21374775|P9|Treated|Multiple Dose Period||5
8657989|NCT01898884|21374776|P8|Treated|Multiple Dose Period||6
8657990|NCT01898884|21374777|P7|Treated|Multiple Dose Period||6
8657991|NCT01898884|21374778|P6|Treated|Multiple Dose Period||6
8657992|NCT01898884|21374779|P5|Treated|Multiple Dose Period||0
8657993|NCT01898884|21374780|P4|Treated|Multiple Dose Period||0
8657994|NCT01898884|21374781|P3|Treated|Multiple Dose Period||0
8657995|NCT01898884|21374782|P2|Treated|Multiple Dose Period||0
8657996|NCT01898884|21374783|P1|Treated|Multiple Dose Period||0
8657997|NCT01898884|21374775|P9|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
8657998|NCT01898884|21374776|P8|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
8657999|NCT01898884|21374777|P7|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
8658000|NCT01898884|21374778|P6|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
8658001|NCT01898884|21374779|P5|STARTED|Multiple Dose Period||0
8658002|NCT01898884|21374780|P4|STARTED|Multiple Dose Period||0
8658003|NCT01898884|21374781|P3|STARTED|Multiple Dose Period||0
8658004|NCT01898884|21374782|P2|STARTED|Multiple Dose Period||0
8658005|NCT01898884|21374783|P1|STARTED|Multiple Dose Period||0
8658006|NCT01898884|21374775|P9|NOT COMPLETED|Single Dose Period||0
8658007|NCT01898884|21374776|P8|NOT COMPLETED|Single Dose Period||0
8658008|NCT01898884|21374777|P7|NOT COMPLETED|Single Dose Period||0
8658009|NCT01898884|21374778|P6|NOT COMPLETED|Single Dose Period||0
8658010|NCT01898884|21374779|P5|NOT COMPLETED|Single Dose Period||0
8658011|NCT01898884|21374780|P4|NOT COMPLETED|Single Dose Period||0
8658012|NCT01898884|21374781|P3|NOT COMPLETED|Single Dose Period||0
8658013|NCT01898884|21374782|P2|NOT COMPLETED|Single Dose Period||0
8658014|NCT01898884|21374783|P1|NOT COMPLETED|Single Dose Period||0
8658015|NCT01898884|21374775|P9|COMPLETED|Single Dose Period||0
8658016|NCT01898884|21374776|P8|COMPLETED|Single Dose Period||0
8658017|NCT01898884|21374777|P7|COMPLETED|Single Dose Period||0
8658018|NCT01898884|21374778|P6|COMPLETED|Single Dose Period||0
8658019|NCT01898884|21374779|P5|COMPLETED|Single Dose Period||6
8658020|NCT01898884|21374780|P4|COMPLETED|Single Dose Period||6
8658021|NCT01898884|21374781|P3|COMPLETED|Single Dose Period||6
8658022|NCT01898884|21374782|P2|COMPLETED|Single Dose Period||6
8658023|NCT01898884|21374783|P1|COMPLETED|Single Dose Period||8
8658024|NCT01898884|21374775|P9|STARTED|Single Dose Period||0
8658025|NCT01898884|21374776|P8|STARTED|Single Dose Period||0
8658026|NCT01898884|21374777|P7|STARTED|Single Dose Period||0
8658027|NCT01898884|21374778|P6|STARTED|Single Dose Period||0
8658028|NCT01898884|21374779|P5|STARTED|Single Dose Period||6
8658029|NCT01898884|21374780|P4|STARTED|Single Dose Period||6
8658030|NCT01898884|21374781|P3|STARTED|Single Dose Period||6
8658031|NCT01898884|21374782|P2|STARTED|Single Dose Period||6
8658032|NCT01898884|21374783|P1|STARTED|Single Dose Period||8
8658033|NCT01754350|21374935|P2|NOT COMPLETED|Overall Study||3
8658034|NCT01754350|21374936|P1|NOT COMPLETED|Overall Study||5
8658035|NCT01754350|21374935|P2|COMPLETED|Overall Study||22
8658036|NCT01754350|21374936|P1|COMPLETED|Overall Study||20
8658037|NCT01754350|21374935|P2|STARTED|Overall Study||25
8658038|NCT01754350|21374936|P1|STARTED|Overall Study||25
8658039|NCT01655693|21374945|P3|NOT COMPLETED|Overall Study||130
8658040|NCT01655693|21374946|P2|NOT COMPLETED|Overall Study||126
8658041|NCT01655693|21374947|P1|NOT COMPLETED|Overall Study||126
8658042|NCT01655693|21374945|P3|COMPLETED|Overall Study||4
8658043|NCT01655693|21374946|P2|COMPLETED|Overall Study||7
8658044|NCT01655693|21374947|P1|COMPLETED|Overall Study||4
8658045|NCT01655693|21374945|P3|STARTED|Overall Study||134
8658046|NCT01655693|21374946|P2|STARTED|Overall Study||133
8658047|NCT01655693|21374947|P1|STARTED|Overall Study||130
8658048|NCT01649869|21374983|P2|NOT COMPLETED|Overall Study||1
8658049|NCT01649869|21374984|P1|NOT COMPLETED|Overall Study||2
8658050|NCT01649869|21374983|P2|COMPLETED|Overall Study||16
8658051|NCT01649869|21374984|P1|COMPLETED|Overall Study||16
8658052|NCT01649869|21374983|P2|STARTED|Overall Study||17
8658053|NCT01649869|21374984|P1|STARTED|Overall Study||18
8658054|NCT01611974|21375033|P3|NOT COMPLETED|Overall Study||16
8658055|NCT01611974|21375034|P2|NOT COMPLETED|Overall Study||15
8658056|NCT01611974|21375035|P1|NOT COMPLETED|Overall Study||15
8658057|NCT01611974|21375033|P3|COMPLETED|Overall Study||24
8658058|NCT01611974|21375034|P2|COMPLETED|Overall Study||25
8658059|NCT01611974|21375035|P1|COMPLETED|Overall Study||25
8658060|NCT01611974|21375033|P3|STARTED|Overall Study||40
8658061|NCT01611974|21375034|P2|STARTED|Overall Study||40
8658062|NCT01611974|21375035|P1|STARTED|Overall Study||40
8658063|NCT01492101|21375072|P2|NOT COMPLETED|Overall Study||342
8658064|NCT01492101|21375073|P1|NOT COMPLETED|Overall Study||337
8658065|NCT01492101|21375072|P2|COMPLETED|Overall Study||81
8658066|NCT01492101|21375073|P1|COMPLETED|Overall Study||92
8658067|NCT01492101|21375072|P2|STARTED|Overall Study||423
8658068|NCT01492101|21375073|P1|STARTED|Overall Study||429
8658069|NCT01409915|21375102|P2|NOT COMPLETED|Overall Study||3
8658070|NCT01409915|21375103|P1|NOT COMPLETED|Overall Study||1
8658071|NCT01409915|21375102|P2|COMPLETED|Overall Study||20
8658072|NCT01409915|21375103|P1|COMPLETED|Overall Study||20
8658073|NCT01409915|21375102|P2|STARTED|Overall Study||23
8658074|NCT01409915|21375103|P1|STARTED|Overall Study||21
8658159|NCT01069705|21375221|P1|NOT COMPLETED|Overall Study||3
8658160|NCT01069705|21375221|P1|COMPLETED|Overall Study||46
8658161|NCT01069705|21375221|P1|STARTED|Overall Study||49
8658162|NCT01052012|21375242|P6|NOT COMPLETED|Overall Study||10
8658163|NCT01052012|21375243|P5|NOT COMPLETED|Overall Study||16
8658164|NCT01052012|21375244|P4|NOT COMPLETED|Overall Study||1
8658165|NCT01052012|21375245|P3|NOT COMPLETED|Overall Study||0
8658166|NCT01052012|21375246|P2|NOT COMPLETED|Overall Study||6
8658167|NCT01052012|21375247|P1|NOT COMPLETED|Overall Study||4
8658168|NCT01052012|21375242|P6|COMPLETED|Overall Study||76
8658169|NCT01052012|21375243|P5|COMPLETED|Overall Study||124
8658170|NCT01052012|21375244|P4|COMPLETED|Overall Study||19
8658171|NCT01052012|21375245|P3|COMPLETED|Overall Study||30
8658172|NCT01052012|21375246|P2|COMPLETED|Overall Study||17
8658173|NCT01052012|21375247|P1|COMPLETED|Overall Study||28
8658174|NCT01052012|21375242|P6|STARTED|Overall Study||86
8658175|NCT01052012|21375243|P5|STARTED|Overall Study||140
8658176|NCT01052012|21375244|P4|STARTED|Overall Study||20
8658177|NCT01052012|21375245|P3|STARTED|Overall Study||30
8658178|NCT01052012|21375246|P2|STARTED|Overall Study||23
8658179|NCT01052012|21375247|P1|STARTED|Overall Study||32
8658180|NCT01032850|21375309|P1|NOT COMPLETED|Overall Study||2
8658181|NCT01032850|21375309|P1|COMPLETED|Overall Study||13
8658182|NCT01032850|21375309|P1|STARTED|Overall Study||15
8658183|NCT00993226|21375319|P3|NOT COMPLETED|Overall Study||0
8658184|NCT00993226|21375320|P2|NOT COMPLETED|Overall Study||1
8658185|NCT00993226|21375321|P1|NOT COMPLETED|Overall Study||1
8658186|NCT00993226|21375319|P3|COMPLETED|Overall Study||27
8658187|NCT00993226|21375320|P2|COMPLETED|Overall Study||26
8658188|NCT00993226|21375321|P1|COMPLETED|Overall Study||60
8658189|NCT00993226|21375319|P3|STARTED|Overall Study||27
8658190|NCT00993226|21375320|P2|STARTED|Overall Study||27
8658191|NCT00993226|21375321|P1|STARTED|Overall Study||61
8658192|NCT00982930|21375338|P1|NOT COMPLETED|Overall Study||4
8658193|NCT00982930|21375338|P1|COMPLETED|Overall Study||51
8658194|NCT00982930|21375338|P1|STARTED|Overall Study||55
8658195|NCT00868439|21375358|P2|NOT COMPLETED|Overall Study||9
8658196|NCT00868439|21375359|P1|NOT COMPLETED|Overall Study||8
8658197|NCT00868439|21375358|P2|COMPLETED|Overall Study||40
8658198|NCT00868439|21375359|P1|COMPLETED|Overall Study||48
8658199|NCT00868439|21375358|P2|STARTED|Overall Study||49
8658200|NCT00868439|21375359|P1|STARTED|Overall Study||56
8658201|NCT00818363|21375377|P2|NOT COMPLETED|Overall Study||1
8658202|NCT00818363|21375378|P1|NOT COMPLETED|Overall Study||0
8658203|NCT00818363|21375377|P2|COMPLETED|Overall Study||19
8658204|NCT00818363|21375378|P1|COMPLETED|Overall Study||40
8658205|NCT00818363|21375377|P2|STARTED|Overall Study||20
8658206|NCT00818363|21375378|P1|STARTED|Overall Study||40
8658207|NCT00817635|21375401|P5|NOT COMPLETED|Overall Study||8
8658208|NCT00817635|21375402|P4|NOT COMPLETED|Overall Study||5
8658209|NCT00817635|21375403|P3|NOT COMPLETED|Overall Study||3
8658210|NCT00817635|21375404|P2|NOT COMPLETED|Overall Study||4
8658211|NCT00817635|21375405|P1|NOT COMPLETED|Overall Study||9
8658212|NCT00817635|21375401|P5|COMPLETED|Overall Study||25
8658213|NCT00817635|21375402|P4|COMPLETED|Overall Study||28
8658214|NCT00817635|21375403|P3|COMPLETED|Overall Study||28
8658215|NCT00817635|21375404|P2|COMPLETED|Overall Study||22
8658216|NCT00817635|21375405|P1|COMPLETED|Overall Study||23
8658217|NCT00817635|21375401|P5|STARTED|Overall Study||33
8658218|NCT00817635|21375402|P4|STARTED|Overall Study||33
8658219|NCT00817635|21375403|P3|STARTED|Overall Study||31
8658220|NCT00817635|21375404|P2|STARTED|Overall Study||26
8658221|NCT00817635|21375405|P1|STARTED|Overall Study||32
8658222|NCT00817414|21375483|P5|NOT COMPLETED|Overall Study||2
8658223|NCT00817414|21375484|P4|NOT COMPLETED|Overall Study||12
8658224|NCT00817414|21375485|P3|NOT COMPLETED|Overall Study||4
8658225|NCT00817414|21375486|P2|NOT COMPLETED|Overall Study||3
8658226|NCT00817414|21375487|P1|NOT COMPLETED|Overall Study||2
8658227|NCT00817414|21375483|P5|COMPLETED|Overall Study||11
8658228|NCT00817414|21375484|P4|COMPLETED|Overall Study||1
8658229|NCT00817414|21375485|P3|COMPLETED|Overall Study||9
8658230|NCT00817414|21375486|P2|COMPLETED|Overall Study||9
8658231|NCT00817414|21375487|P1|COMPLETED|Overall Study||10
8658232|NCT00817414|21375483|P5|STARTED|Overall Study||13
8658233|NCT00817414|21375484|P4|STARTED|Overall Study||13
8658234|NCT00817414|21375485|P3|STARTED|Overall Study||13
8658235|NCT00817414|21375486|P2|STARTED|Overall Study||12
8658236|NCT00817414|21375487|P1|STARTED|Overall Study||12
8658237|NCT00554515|21375539|P1|NOT COMPLETED|Overall Study||118
8658238|NCT00554515|21375539|P1|COMPLETED|Overall Study||5
8658239|NCT00554515|21375539|P1|Treated|Overall Study||120
8658240|NCT00554515|21375539|P1|STARTED|Overall Study||123
8658241|NCT00305006|21375570|P2|NOT COMPLETED|Overall Study||1
8658242|NCT00305006|21375571|P1|NOT COMPLETED|Overall Study||1
8658243|NCT00305006|21375570|P2|COMPLETED|Overall Study||21
8658244|NCT00305006|21375571|P1|COMPLETED|Overall Study||21
8658245|NCT00305006|21375570|P2|STARTED|Overall Study||22
8658246|NCT00305006|21375571|P1|STARTED|Overall Study||22
8658247|NCT00202644|21375581|P2|NOT COMPLETED|Overall Study||27
8658248|NCT00202644|21375582|P1|NOT COMPLETED|Overall Study||35
8658249|NCT00202644|21375581|P2|COMPLETED|Overall Study||43
8658250|NCT00202644|21375582|P1|COMPLETED|Overall Study||41
8658251|NCT00202644|21375581|P2|STARTED|Overall Study||70
8658252|NCT00202644|21375582|P1|STARTED|Overall Study|One participant not randomized but treated.|76
8658253|NCT00172185|21375610|P4|NOT COMPLETED|Overall Study||4
8658254|NCT00172185|21375611|P3|NOT COMPLETED|Overall Study||5
8658255|NCT00172185|21375612|P2|NOT COMPLETED|Overall Study||2
8658256|NCT00172185|21375613|P1|NOT COMPLETED|Overall Study||0
8658257|NCT00172185|21375610|P4|COMPLETED|Overall Study||23
8658258|NCT00172185|21375611|P3|COMPLETED|Overall Study||20
8658259|NCT00172185|21375612|P2|COMPLETED|Overall Study||5
8658260|NCT00172185|21375613|P1|COMPLETED|Overall Study||6
8658261|NCT00172185|21375610|P4|STARTED|Overall Study||27
8658262|NCT00172185|21375611|P3|STARTED|Overall Study||25
8658263|NCT00172185|21375612|P2|STARTED|Overall Study||7
8658264|NCT00172185|21375613|P1|STARTED|Overall Study||6
8658265|NCT00171951|21375627|P1|NOT COMPLETED|Overall Study||16
8658266|NCT00171951|21375627|P1|COMPLETED|Overall Study||3
8658267|NCT00171951|21375627|P1|STARTED|Overall Study||19
8658268|NCT00171730|21375639|P1|NOT COMPLETED|Overall Study||15
8658269|NCT00171730|21375639|P1|COMPLETED|Overall Study||15
8658270|NCT00171730|21375639|P1|STARTED|Overall Study||30
8658280|NCT00114530|21375679|P2|NOT COMPLETED|Overall Study||20
8658281|NCT00114530|21375680|P1|NOT COMPLETED|Overall Study||9
8658282|NCT00114530|21375679|P2|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|19
8658283|NCT00114530|21375680|P1|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|27
8658284|NCT00114530|21375679|P2|STARTED|Overall Study||39
8658285|NCT00114530|21375680|P1|STARTED|Overall Study||36
8658286|NCT04512703|21375787|P2|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
8658287|NCT04512703|21375788|P1|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
8658288|NCT04512703|21375787|P2|COMPLETED|Between 7th and 90th Day of Device Wear||45
8658289|NCT04512703|21375788|P1|COMPLETED|Between 7th and 90th Day of Device Wear||6
8658290|NCT04512703|21375787|P2|Wore Front Position Device|Between 7th and 90th Day of Device Wear||22
8658291|NCT04512703|21375788|P1|Wore Front Position Device|Between 7th and 90th Day of Device Wear||3
8658292|NCT04512703|21375787|P2|Wore Side Position Device|Between 7th and 90th Day of Device Wear||23
8658293|NCT04512703|21375788|P1|Wore Side Position Device|Between 7th and 90th Day of Device Wear||3
8658294|NCT04512703|21375787|P2|STARTED|Between 7th and 90th Day of Device Wear||45
8658295|NCT04512703|21375788|P1|STARTED|Between 7th and 90th Day of Device Wear||6
8658296|NCT04512703|21375787|P2|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
8658297|NCT04512703|21375788|P1|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
8658298|NCT04512703|21375787|P2|COMPLETED|Within 7 Days From Start of Device Wear||45
8658299|NCT04512703|21375788|P1|COMPLETED|Within 7 Days From Start of Device Wear||6
8658300|NCT04512703|21375787|P2|Wore Side Position|Within 7 Days From Start of Device Wear||45
8658301|NCT04512703|21375788|P1|Wore Side Position|Within 7 Days From Start of Device Wear||6
8658302|NCT04512703|21375787|P2|Wore Front Position|Within 7 Days From Start of Device Wear||45
8658303|NCT04512703|21375788|P1|Wore Front Position|Within 7 Days From Start of Device Wear||6
8658304|NCT04512703|21375787|P2|STARTED|Within 7 Days From Start of Device Wear||45
8658305|NCT04512703|21375788|P1|STARTED|Within 7 Days From Start of Device Wear||6
8658306|NCT04046250|21375817|P2|NOT COMPLETED|Overall Study||4
8658307|NCT04046250|21375818|P1|NOT COMPLETED|Overall Study||3
8658308|NCT04046250|21375817|P2|COMPLETED|Overall Study|Four Methotrexate + TK-12260 Placebo Treatments|7
8658309|NCT04046250|21375818|P1|COMPLETED|Overall Study|Four Methotrexate + TK-112690 Treatments|8
8658310|NCT04046250|21375817|P2|STARTED|Overall Study||11
8658311|NCT04046250|21375818|P1|STARTED|Overall Study||11
8658312|NCT03888755|21375826|P1|NOT COMPLETED|Overall Study||0
8658313|NCT03888755|21375826|P1|COMPLETED|Overall Study||8
8658314|NCT03888755|21375826|P1|STARTED|Overall Study||8
8658315|NCT03878108|21375849|P2|NOT COMPLETED|Overall Study||0
8658316|NCT03878108|21375850|P1|NOT COMPLETED|Overall Study||1
8658317|NCT03878108|21375849|P2|COMPLETED|Overall Study||10
8658318|NCT03878108|21375850|P1|COMPLETED|Overall Study||10
8658319|NCT03878108|21375849|P2|Completed First Phase|Overall Study||10
8658320|NCT03878108|21375850|P1|Completed First Phase|Overall Study||10
8658321|NCT03878108|21375849|P2|STARTED|Overall Study||10
8658322|NCT03878108|21375850|P1|STARTED|Overall Study||11
8658323|NCT03853551|21375872|P1|NOT COMPLETED|Overall Study||9
8658324|NCT03853551|21375872|P1|COMPLETED|Overall Study||51
8658325|NCT03853551|21375872|P1|STARTED|Overall Study||60
8658326|NCT03605212|21375881|P5|NOT COMPLETED|Treatment Period||1
8658327|NCT03605212|21375882|P4|NOT COMPLETED|Treatment Period||0
8658328|NCT03605212|21375883|P3|NOT COMPLETED|Treatment Period||0
8658329|NCT03605212|21375884|P2|NOT COMPLETED|Treatment Period||0
8658330|NCT03605212|21375885|P1|NOT COMPLETED|Treatment Period||1
8658331|NCT03605212|21375881|P5|COMPLETED|Treatment Period||23
8658332|NCT03605212|21375882|P4|COMPLETED|Treatment Period||0
8658333|NCT03605212|21375883|P3|COMPLETED|Treatment Period||3
8658334|NCT03605212|21375884|P2|COMPLETED|Treatment Period||0
8658335|NCT03605212|21375885|P1|COMPLETED|Treatment Period||2
8658336|NCT03605212|21375881|P5|STARTED|Treatment Period||24
8658337|NCT03605212|21375882|P4|STARTED|Treatment Period||0
8658338|NCT03605212|21375883|P3|STARTED|Treatment Period||3
8658339|NCT03605212|21375884|P2|STARTED|Treatment Period||0
8658340|NCT03605212|21375885|P1|STARTED|Treatment Period||3
8658341|NCT03605212|21375881|P5|NOT COMPLETED|Baseline Period||0
8658342|NCT03605212|21375882|P4|NOT COMPLETED|Baseline Period||0
8658343|NCT03605212|21375883|P3|NOT COMPLETED|Baseline Period||0
8658344|NCT03605212|21375884|P2|NOT COMPLETED|Baseline Period||0
8658345|NCT03605212|21375885|P1|NOT COMPLETED|Baseline Period||0
8658346|NCT03605212|21375881|P5|COMPLETED|Baseline Period||24
8658347|NCT03605212|21375882|P4|COMPLETED|Baseline Period||0
8658348|NCT03605212|21375883|P3|COMPLETED|Baseline Period||3
8658349|NCT03605212|21375884|P2|COMPLETED|Baseline Period||0
8658350|NCT03605212|21375885|P1|COMPLETED|Baseline Period||3
8658351|NCT03605212|21375881|P5|STARTED|Baseline Period||24
8658352|NCT03605212|21375882|P4|STARTED|Baseline Period||0
8658353|NCT03605212|21375883|P3|STARTED|Baseline Period||3
8658354|NCT03605212|21375884|P2|STARTED|Baseline Period||0
8658355|NCT03605212|21375885|P1|STARTED|Baseline Period||3
8658356|NCT03585712|21375952|P3|NOT COMPLETED|Treatment Periods 2 and 3||3
8658357|NCT03585712|21375953|P2|NOT COMPLETED|Treatment Periods 2 and 3||3
8658358|NCT03585712|21375954|P1|NOT COMPLETED|Treatment Periods 2 and 3||0
8658359|NCT03585712|21375952|P3|COMPLETED|Treatment Periods 2 and 3||22
8658360|NCT03585712|21375953|P2|COMPLETED|Treatment Periods 2 and 3||23
8658361|NCT03585712|21375954|P1|COMPLETED|Treatment Periods 2 and 3||0
8658362|NCT03585712|21375952|P3|STARTED|Treatment Periods 2 and 3||25
8658363|NCT03585712|21375953|P2|STARTED|Treatment Periods 2 and 3||26
8658364|NCT03585712|21375954|P1|STARTED|Treatment Periods 2 and 3|Subjects having completed Treatment Period 1 randomized in Arm A or Arm B|0
8658365|NCT03585712|21375952|P3|NOT COMPLETED|Treatment Period 1||0
8658366|NCT03585712|21375953|P2|NOT COMPLETED|Treatment Period 1||0
8658367|NCT03585712|21375954|P1|NOT COMPLETED|Treatment Period 1||1
8658368|NCT03585712|21375952|P3|COMPLETED|Treatment Period 1||0
8658369|NCT03585712|21375953|P2|COMPLETED|Treatment Period 1||0
8658370|NCT03585712|21375954|P1|COMPLETED|Treatment Period 1||51
8658371|NCT03585712|21375952|P3|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
8658372|NCT03585712|21375953|P2|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
8658373|NCT03585712|21375954|P1|STARTED|Treatment Period 1||52
8658374|NCT03557658|21375978|P2|NOT COMPLETED|Overall Study||0
8658375|NCT03557658|21375979|P1|NOT COMPLETED|Overall Study||0
8658376|NCT03557658|21375978|P2|COMPLETED|Overall Study||8
8658377|NCT03557658|21375979|P1|COMPLETED|Overall Study||8
8658378|NCT03557658|21375978|P2|STARTED|Overall Study||8
8658379|NCT03557658|21375979|P1|STARTED|Overall Study||8
8658380|NCT03401671|21375995|P2|NOT COMPLETED|Overall Study||0
8658381|NCT03401671|21375996|P1|NOT COMPLETED|Overall Study||0
8658382|NCT03401671|21375995|P2|COMPLETED|Overall Study||16
8658383|NCT03401671|21375996|P1|COMPLETED|Overall Study||16
8658384|NCT03401671|21375995|P2|STARTED|Overall Study||16
8658385|NCT03401671|21375996|P1|STARTED|Overall Study||16
8658392|NCT03325894|21376087|P2|NOT COMPLETED|Overall Study||77
8658393|NCT03325894|21376088|P1|NOT COMPLETED|Overall Study||64
8658394|NCT03325894|21376087|P2|COMPLETED|Overall Study||0
8658395|NCT03325894|21376088|P1|COMPLETED|Overall Study||0
8658396|NCT03325894|21376087|P2|STARTED|Overall Study||77
8658397|NCT03325894|21376088|P1|STARTED|Overall Study||64
8658398|NCT03271528|21376156|P2|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
8658399|NCT03271528|21376157|P1|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
8658400|NCT03271528|21376156|P2|COMPLETED|Alcohol Self-Administration Trial 2||11
8658401|NCT03271528|21376157|P1|COMPLETED|Alcohol Self-Administration Trial 2||8
8658402|NCT03271528|21376156|P2|STARTED|Alcohol Self-Administration Trial 2||11
8658403|NCT03271528|21376157|P1|STARTED|Alcohol Self-Administration Trial 2||8
8658404|NCT03271528|21376156|P2|NOT COMPLETED|Medication Dispense/Exposure Period 2||0
8658405|NCT03271528|21376157|P1|NOT COMPLETED|Medication Dispense/Exposure Period 2||1
8658406|NCT03271528|21376156|P2|COMPLETED|Medication Dispense/Exposure Period 2||11
8658407|NCT03271528|21376157|P1|COMPLETED|Medication Dispense/Exposure Period 2||8
8658408|NCT03271528|21376156|P2|STARTED|Medication Dispense/Exposure Period 2||11
8658409|NCT03271528|21376157|P1|STARTED|Medication Dispense/Exposure Period 2||9
8658410|NCT03271528|21376156|P2|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||1
8658411|NCT03271528|21376157|P1|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||2
8658412|NCT03271528|21376156|P2|COMPLETED|Alcohol Trial 1, Washout Period 1||11
8658413|NCT03271528|21376157|P1|COMPLETED|Alcohol Trial 1, Washout Period 1||9
8658414|NCT03271528|21376156|P2|STARTED|Alcohol Trial 1, Washout Period 1||12
8658415|NCT03271528|21376157|P1|STARTED|Alcohol Trial 1, Washout Period 1||11
8658416|NCT03271528|21376156|P2|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
8658417|NCT03271528|21376157|P1|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
8658418|NCT03271528|21376156|P2|COMPLETED|Medication Dispense/Exposure Period 1||12
8658419|NCT03271528|21376157|P1|COMPLETED|Medication Dispense/Exposure Period 1||11
8658420|NCT03271528|21376156|P2|STARTED|Medication Dispense/Exposure Period 1||14
8658421|NCT03271528|21376157|P1|STARTED|Medication Dispense/Exposure Period 1||13
8658435|NCT03065647|21376236|P2|NOT COMPLETED|Overall Study||0
8658436|NCT03065647|21376237|P1|NOT COMPLETED|Overall Study||0
8658437|NCT03065647|21376236|P2|COMPLETED|Overall Study||12
8658438|NCT03065647|21376237|P1|COMPLETED|Overall Study||3
8658439|NCT03065647|21376236|P2|STARTED|Overall Study||12
8658440|NCT03065647|21376237|P1|STARTED|Overall Study||3
8658441|NCT03038438|21376245|P1|NOT COMPLETED|Overall Study||4
8658442|NCT03038438|21376245|P1|COMPLETED|Overall Study||196
8658443|NCT03038438|21376245|P1|12-Month Follow-up|Overall Study||191
8658444|NCT03038438|21376245|P1|6-Month Follow-up|Overall Study||193
8658445|NCT03038438|21376245|P1|30-Day Follow-Up|Overall Study||198
8658446|NCT03038438|21376245|P1|STARTED|Overall Study||200
8658447|NCT03029247|21376267|P2|NOT COMPLETED|Follow-up Period (14 Days)||0
8658448|NCT03029247|21376268|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
8658449|NCT03029247|21376267|P2|COMPLETED|Follow-up Period (14 Days)||36
8658450|NCT03029247|21376268|P1|COMPLETED|Follow-up Period (14 Days)||32
8658451|NCT03029247|21376267|P2|STARTED|Follow-up Period (14 Days)||36
8658452|NCT03029247|21376268|P1|STARTED|Follow-up Period (14 Days)||32
8658453|NCT03029247|21376267|P2|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
8658454|NCT03029247|21376268|P1|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
8658455|NCT03029247|21376267|P2|COMPLETED|Acute Challenge 2 (Day 57)||36
8658456|NCT03029247|21376268|P1|COMPLETED|Acute Challenge 2 (Day 57)||32
8658457|NCT03029247|21376267|P2|STARTED|Acute Challenge 2 (Day 57)||36
8658458|NCT03029247|21376268|P1|STARTED|Acute Challenge 2 (Day 57)||32
8658459|NCT03029247|21376267|P2|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||7
8658460|NCT03029247|21376268|P1|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||13
8658461|NCT03029247|21376267|P2|COMPLETED|Hgb Maintenance Phase (8 Weeks)||36
8658462|NCT03029247|21376268|P1|COMPLETED|Hgb Maintenance Phase (8 Weeks)||32
8658463|NCT03029247|21376267|P2|STARTED|Hgb Maintenance Phase (8 Weeks)||43
8658464|NCT03029247|21376268|P1|STARTED|Hgb Maintenance Phase (8 Weeks)||45
8658465|NCT03029247|21376267|P2|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
8658466|NCT03029247|21376268|P1|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
8658467|NCT03029247|21376267|P2|COMPLETED|Acute Challenge 1 (Day 1)||43
8658468|NCT03029247|21376268|P1|COMPLETED|Acute Challenge 1 (Day 1)||45
8658469|NCT03029247|21376267|P2|STARTED|Acute Challenge 1 (Day 1)||43
8658470|NCT03029247|21376268|P1|STARTED|Acute Challenge 1 (Day 1)||45
8658471|NCT02937545|21376377|P4|NOT COMPLETED|Overall Study||7
8658472|NCT02937545|21376378|P3|NOT COMPLETED|Overall Study||6
8658473|NCT02937545|21376379|P2|NOT COMPLETED|Overall Study||2
8658474|NCT02937545|21376380|P1|NOT COMPLETED|Overall Study||2
8658475|NCT02937545|21376377|P4|COMPLETED|Overall Study||14
8658476|NCT02937545|21376378|P3|COMPLETED|Overall Study||9
8658477|NCT02937545|21376379|P2|COMPLETED|Overall Study||83
8658478|NCT02937545|21376380|P1|COMPLETED|Overall Study||67
8658479|NCT02937545|21376377|P4|STARTED|Overall Study||21
8658480|NCT02937545|21376378|P3|STARTED|Overall Study||15
8658481|NCT02937545|21376379|P2|STARTED|Overall Study||85
8658482|NCT02937545|21376380|P1|STARTED|Overall Study||69
8658483|NCT02928848|21376408|P2|NOT COMPLETED|Arm 2||0
8658484|NCT02928848|21376409|P1|NOT COMPLETED|Arm 2||1
8658485|NCT02928848|21376408|P2|COMPLETED|Arm 2||6
8658486|NCT02928848|21376409|P1|COMPLETED|Arm 2||8
8658487|NCT02928848|21376408|P2|STARTED|Arm 2||6
8658488|NCT02928848|21376409|P1|STARTED|Arm 2||9
8658489|NCT02928848|21376408|P2|NOT COMPLETED|Arm 1||1
8658490|NCT02928848|21376409|P1|NOT COMPLETED|Arm 1||0
8658491|NCT02928848|21376408|P2|COMPLETED|Arm 1||6
8658492|NCT02928848|21376409|P1|COMPLETED|Arm 1||9
8658493|NCT02928848|21376408|P2|STARTED|Arm 1||7
8658494|NCT02928848|21376409|P1|STARTED|Arm 1||9
8658495|NCT02775240|21376417|P1|NOT COMPLETED|Overall Study||1
8658496|NCT02775240|21376417|P1|COMPLETED|Overall Study||17
8658497|NCT02775240|21376417|P1|Started Treatment B|Overall Study||17
8658498|NCT02775240|21376417|P1|Started Treatment A|Overall Study||18
8658499|NCT02775240|21376417|P1|STARTED|Overall Study||18
8658500|NCT02772302|21376482|P2|NOT COMPLETED|Overall Study||0
8658501|NCT02772302|21376483|P1|NOT COMPLETED|Overall Study||0
8658502|NCT02772302|21376482|P2|COMPLETED|Overall Study||10
8658503|NCT02772302|21376483|P1|COMPLETED|Overall Study||10
8658504|NCT02772302|21376482|P2|STARTED|Overall Study||10
8658505|NCT02772302|21376483|P1|STARTED|Overall Study||10
8658512|NCT02663687|21376513|P5|NOT COMPLETED|Overall Study||0
8658513|NCT02663687|21376514|P4|NOT COMPLETED|Overall Study||0
8658514|NCT02663687|21376515|P3|NOT COMPLETED|Overall Study||1
8658515|NCT02663687|21376516|P2|NOT COMPLETED|Overall Study||0
8658516|NCT02663687|21376517|P1|NOT COMPLETED|Overall Study||2
8658517|NCT02663687|21376513|P5|COMPLETED|Overall Study||9
8658518|NCT02663687|21376514|P4|COMPLETED|Overall Study||9
8658519|NCT02663687|21376515|P3|COMPLETED|Overall Study||8
8658520|NCT02663687|21376516|P2|COMPLETED|Overall Study||9
8658521|NCT02663687|21376517|P1|COMPLETED|Overall Study||10
8658522|NCT02663687|21376513|P5|Treatment Period 2 (SC)|Overall Study||9
8658523|NCT02663687|21376514|P4|Treatment Period 2 (SC)|Overall Study||9
8658524|NCT02663687|21376515|P3|Treatment Period 2 (SC)|Overall Study||8
8658525|NCT02663687|21376516|P2|Treatment Period 2 (SC)|Overall Study||9
8658526|NCT02663687|21376517|P1|Treatment Period 2 (SC)|Overall Study||10
8658527|NCT02663687|21376513|P5|Treatment Period 1 (IV)|Overall Study||9
8658528|NCT02663687|21376514|P4|Treatment Period 1 (IV)|Overall Study||9
8658529|NCT02663687|21376515|P3|Treatment Period 1 (IV)|Overall Study||9
8658530|NCT02663687|21376516|P2|Treatment Period 1 (IV)|Overall Study||9
8658531|NCT02663687|21376517|P1|Treatment Period 1 (IV)|Overall Study||12
8658532|NCT02663687|21376513|P5|STARTED|Overall Study||9
8658533|NCT02663687|21376514|P4|STARTED|Overall Study||9
8658534|NCT02663687|21376515|P3|STARTED|Overall Study||9
8658535|NCT02663687|21376516|P2|STARTED|Overall Study||9
8658536|NCT02663687|21376517|P1|STARTED|Overall Study||12
8658537|NCT02604407|21376572|P3|NOT COMPLETED|Overall Study||16
8658538|NCT02604407|21376573|P2|NOT COMPLETED|Overall Study||12
8658539|NCT02604407|21376574|P1|NOT COMPLETED|Overall Study||11
8658540|NCT02604407|21376572|P3|COMPLETED|Overall Study||76
8658541|NCT02604407|21376573|P2|COMPLETED|Overall Study||80
8658542|NCT02604407|21376574|P1|COMPLETED|Overall Study||80
8658543|NCT02604407|21376572|P3|TREATED|Overall Study||90
8658544|NCT02604407|21376573|P2|TREATED|Overall Study||92
8658545|NCT02604407|21376574|P1|TREATED|Overall Study||89
8658546|NCT02604407|21376572|P3|STARTED|Overall Study||92
8658547|NCT02604407|21376573|P2|STARTED|Overall Study||92
8658548|NCT02604407|21376574|P1|STARTED|Overall Study||91
8658549|NCT02549092|21376587|P2|NOT COMPLETED|Extension/Transition Period||9
8658550|NCT02549092|21376588|P1|NOT COMPLETED|Extension/Transition Period||5
8658551|NCT02549092|21376587|P2|COMPLETED|Extension/Transition Period||5
8658552|NCT02549092|21376588|P1|COMPLETED|Extension/Transition Period||5
8658553|NCT02549092|21376587|P2|STARTED|Extension/Transition Period||14
8658554|NCT02549092|21376588|P1|STARTED|Extension/Transition Period||10
8658555|NCT02549092|21376587|P2|NOT COMPLETED|Treatment Period||7
8658556|NCT02549092|21376588|P1|NOT COMPLETED|Treatment Period||3
8658557|NCT02549092|21376587|P2|COMPLETED|Treatment Period||38
8658558|NCT02549092|21376588|P1|COMPLETED|Treatment Period||41
8658559|NCT02549092|21376587|P2|STARTED|Treatment Period||45
8658560|NCT02549092|21376588|P1|STARTED|Treatment Period||44
8658561|NCT02466425|21376620|P2|NOT COMPLETED|Overall Study||16
8658562|NCT02466425|21376621|P1|NOT COMPLETED|Overall Study||14
8658563|NCT02466425|21376620|P2|COMPLETED|Overall Study||116
8658564|NCT02466425|21376621|P1|COMPLETED|Overall Study||118
8658565|NCT02466425|21376620|P2|Treated|Overall Study||132
8658566|NCT02466425|21376621|P1|Treated|Overall Study||131
8658567|NCT02466425|21376620|P2|STARTED|Overall Study||132
8658568|NCT02466425|21376621|P1|STARTED|Overall Study||132
8658569|NCT02440425|21376629|P1|NOT COMPLETED|Overall Study||5
8658570|NCT02440425|21376629|P1|COMPLETED|Overall Study||37
8658571|NCT02440425|21376629|P1|STARTED|Overall Study||42
8658572|NCT02125292|21376638|P6|NOT COMPLETED|Third Intervention (1 Hour)||0
8658573|NCT02125292|21376639|P5|NOT COMPLETED|Third Intervention (1 Hour)||0
8658574|NCT02125292|21376640|P4|NOT COMPLETED|Third Intervention (1 Hour)||0
8658575|NCT02125292|21376641|P3|NOT COMPLETED|Third Intervention (1 Hour)||0
8658576|NCT02125292|21376642|P2|NOT COMPLETED|Third Intervention (1 Hour)||0
8658577|NCT02125292|21376643|P1|NOT COMPLETED|Third Intervention (1 Hour)||0
8658578|NCT02125292|21376638|P6|COMPLETED|Third Intervention (1 Hour)||3
8658579|NCT02125292|21376639|P5|COMPLETED|Third Intervention (1 Hour)||3
8658580|NCT02125292|21376640|P4|COMPLETED|Third Intervention (1 Hour)||3
8658581|NCT02125292|21376641|P3|COMPLETED|Third Intervention (1 Hour)||3
8658582|NCT02125292|21376642|P2|COMPLETED|Third Intervention (1 Hour)||3
8658583|NCT02125292|21376643|P1|COMPLETED|Third Intervention (1 Hour)||3
8658584|NCT02125292|21376638|P6|STARTED|Third Intervention (1 Hour)||3
8658585|NCT02125292|21376639|P5|STARTED|Third Intervention (1 Hour)||3
8658586|NCT02125292|21376640|P4|STARTED|Third Intervention (1 Hour)||3
8658587|NCT02125292|21376641|P3|STARTED|Third Intervention (1 Hour)||3
8658588|NCT02125292|21376642|P2|STARTED|Third Intervention (1 Hour)||3
8658589|NCT02125292|21376643|P1|STARTED|Third Intervention (1 Hour)||3
8658590|NCT02125292|21376638|P6|NOT COMPLETED|Washout (2 Hours)||0
8658591|NCT02125292|21376639|P5|NOT COMPLETED|Washout (2 Hours)||0
8658592|NCT02125292|21376640|P4|NOT COMPLETED|Washout (2 Hours)||0
8658593|NCT02125292|21376641|P3|NOT COMPLETED|Washout (2 Hours)||0
8658594|NCT02125292|21376642|P2|NOT COMPLETED|Washout (2 Hours)||0
8658595|NCT02125292|21376643|P1|NOT COMPLETED|Washout (2 Hours)||0
8658596|NCT02125292|21376638|P6|COMPLETED|Washout (2 Hours)||3
8658597|NCT02125292|21376639|P5|COMPLETED|Washout (2 Hours)||3
8658598|NCT02125292|21376640|P4|COMPLETED|Washout (2 Hours)||3
8658599|NCT02125292|21376641|P3|COMPLETED|Washout (2 Hours)||3
8658600|NCT02125292|21376642|P2|COMPLETED|Washout (2 Hours)||3
8658601|NCT02125292|21376643|P1|COMPLETED|Washout (2 Hours)||3
8658602|NCT02125292|21376638|P6|STARTED|Washout (2 Hours)||3
8658603|NCT02125292|21376639|P5|STARTED|Washout (2 Hours)||3
8658604|NCT02125292|21376640|P4|STARTED|Washout (2 Hours)||3
8658605|NCT02125292|21376641|P3|STARTED|Washout (2 Hours)||3
8658606|NCT02125292|21376642|P2|STARTED|Washout (2 Hours)||3
8658607|NCT02125292|21376643|P1|STARTED|Washout (2 Hours)||3
8658608|NCT02125292|21376638|P6|NOT COMPLETED|Second Intervention (1 Hour)||0
8658609|NCT02125292|21376639|P5|NOT COMPLETED|Second Intervention (1 Hour)||0
8658610|NCT02125292|21376640|P4|NOT COMPLETED|Second Intervention (1 Hour)||0
8658611|NCT02125292|21376641|P3|NOT COMPLETED|Second Intervention (1 Hour)||0
8658612|NCT02125292|21376642|P2|NOT COMPLETED|Second Intervention (1 Hour)||0
8658613|NCT02125292|21376643|P1|NOT COMPLETED|Second Intervention (1 Hour)||0
8658614|NCT02125292|21376638|P6|COMPLETED|Second Intervention (1 Hour)||3
8658615|NCT02125292|21376639|P5|COMPLETED|Second Intervention (1 Hour)||3
8658616|NCT02125292|21376640|P4|COMPLETED|Second Intervention (1 Hour)||3
8658617|NCT02125292|21376641|P3|COMPLETED|Second Intervention (1 Hour)||3
8658618|NCT02125292|21376642|P2|COMPLETED|Second Intervention (1 Hour)||3
8658619|NCT02125292|21376643|P1|COMPLETED|Second Intervention (1 Hour)||3
8658620|NCT02125292|21376638|P6|STARTED|Second Intervention (1 Hour)||3
8658621|NCT02125292|21376639|P5|STARTED|Second Intervention (1 Hour)||3
8658622|NCT02125292|21376640|P4|STARTED|Second Intervention (1 Hour)||3
8658623|NCT02125292|21376641|P3|STARTED|Second Intervention (1 Hour)||3
8658624|NCT02125292|21376642|P2|STARTED|Second Intervention (1 Hour)||3
8658625|NCT02125292|21376643|P1|STARTED|Second Intervention (1 Hour)||3
8658626|NCT02125292|21376638|P6|NOT COMPLETED|Washout (2 Hours)||0
8658627|NCT02125292|21376639|P5|NOT COMPLETED|Washout (2 Hours)||0
8658628|NCT02125292|21376640|P4|NOT COMPLETED|Washout (2 Hours)||0
8658629|NCT02125292|21376641|P3|NOT COMPLETED|Washout (2 Hours)||0
8658630|NCT02125292|21376642|P2|NOT COMPLETED|Washout (2 Hours)||0
8658631|NCT02125292|21376643|P1|NOT COMPLETED|Washout (2 Hours)||0
8658632|NCT02125292|21376638|P6|COMPLETED|Washout (2 Hours)||3
8658633|NCT02125292|21376639|P5|COMPLETED|Washout (2 Hours)||3
8658634|NCT02125292|21376640|P4|COMPLETED|Washout (2 Hours)||3
8658635|NCT02125292|21376641|P3|COMPLETED|Washout (2 Hours)||3
8658636|NCT02125292|21376642|P2|COMPLETED|Washout (2 Hours)||3
8658637|NCT02125292|21376643|P1|COMPLETED|Washout (2 Hours)||3
8658638|NCT02125292|21376638|P6|STARTED|Washout (2 Hours)||3
8658639|NCT02125292|21376639|P5|STARTED|Washout (2 Hours)||3
8658640|NCT02125292|21376640|P4|STARTED|Washout (2 Hours)||3
8658641|NCT02125292|21376641|P3|STARTED|Washout (2 Hours)||3
8658642|NCT02125292|21376642|P2|STARTED|Washout (2 Hours)||3
8658643|NCT02125292|21376643|P1|STARTED|Washout (2 Hours)||3
8658644|NCT02125292|21376638|P6|NOT COMPLETED|First Intervention (1 Hour)||0
8658645|NCT02125292|21376639|P5|NOT COMPLETED|First Intervention (1 Hour)||0
8658646|NCT02125292|21376640|P4|NOT COMPLETED|First Intervention (1 Hour)||0
8658647|NCT02125292|21376641|P3|NOT COMPLETED|First Intervention (1 Hour)||0
8658648|NCT02125292|21376642|P2|NOT COMPLETED|First Intervention (1 Hour)||0
8658649|NCT02125292|21376643|P1|NOT COMPLETED|First Intervention (1 Hour)||0
8658650|NCT02125292|21376638|P6|COMPLETED|First Intervention (1 Hour)||3
8658651|NCT02125292|21376639|P5|COMPLETED|First Intervention (1 Hour)||3
8658652|NCT02125292|21376640|P4|COMPLETED|First Intervention (1 Hour)||3
8658653|NCT02125292|21376641|P3|COMPLETED|First Intervention (1 Hour)||3
8658654|NCT02125292|21376642|P2|COMPLETED|First Intervention (1 Hour)||3
8658655|NCT02125292|21376643|P1|COMPLETED|First Intervention (1 Hour)||3
8658656|NCT02125292|21376638|P6|STARTED|First Intervention (1 Hour)||3
8658657|NCT02125292|21376639|P5|STARTED|First Intervention (1 Hour)||3
8658658|NCT02125292|21376640|P4|STARTED|First Intervention (1 Hour)||3
8658659|NCT02125292|21376641|P3|STARTED|First Intervention (1 Hour)||3
8658660|NCT02125292|21376642|P2|STARTED|First Intervention (1 Hour)||3
8658661|NCT02125292|21376643|P1|STARTED|First Intervention (1 Hour)||3
8658662|NCT02120781|21376666|P2|NOT COMPLETED|Overall Study||1
8658663|NCT02120781|21376667|P1|NOT COMPLETED|Overall Study||4
8658664|NCT02120781|21376666|P2|COMPLETED|Overall Study||5
8658665|NCT02120781|21376667|P1|COMPLETED|Overall Study||11
8658666|NCT02120781|21376666|P2|STARTED|Overall Study||6
8658667|NCT02120781|21376667|P1|STARTED|Overall Study||15
8658668|NCT02088697|21376689|P2|NOT COMPLETED|Period II||0
8658669|NCT02088697|21376690|P1|NOT COMPLETED|Period II||0
8658670|NCT02088697|21376689|P2|COMPLETED|Period II||21
8658671|NCT02088697|21376690|P1|COMPLETED|Period II||23
8658672|NCT02088697|21376689|P2|STARTED|Period II||21
8658673|NCT02088697|21376690|P1|STARTED|Period II||23
8658674|NCT02088697|21376689|P2|NOT COMPLETED|Wash-out Period (at Least 10 Days)||0
8658675|NCT02088697|21376690|P1|NOT COMPLETED|Wash-out Period (at Least 10 Days)||1
8658676|NCT02088697|21376689|P2|COMPLETED|Wash-out Period (at Least 10 Days)||21
8658677|NCT02088697|21376690|P1|COMPLETED|Wash-out Period (at Least 10 Days)||23
8658678|NCT02088697|21376689|P2|STARTED|Wash-out Period (at Least 10 Days)||21
8658679|NCT02088697|21376690|P1|STARTED|Wash-out Period (at Least 10 Days)||24
8658680|NCT02088697|21376689|P2|NOT COMPLETED|Period I||4
8658681|NCT02088697|21376690|P1|NOT COMPLETED|Period I||1
8658682|NCT02088697|21376689|P2|COMPLETED|Period I||21
8658683|NCT02088697|21376690|P1|COMPLETED|Period I||24
8658684|NCT02088697|21376689|P2|STARTED|Period I||25
8658685|NCT02088697|21376690|P1|STARTED|Period I||25
8658686|NCT02052141|21376700|P2|NOT COMPLETED|Intervention Period 2||0
8658687|NCT02052141|21376701|P1|NOT COMPLETED|Intervention Period 2||0
8658688|NCT02052141|21376700|P2|COMPLETED|Intervention Period 2||7
8658689|NCT02052141|21376701|P1|COMPLETED|Intervention Period 2||5
8658690|NCT02052141|21376700|P2|STARTED|Intervention Period 2||7
8658691|NCT02052141|21376701|P1|STARTED|Intervention Period 2||5
8658692|NCT02052141|21376700|P2|NOT COMPLETED|Intervention Period 1||0
8658693|NCT02052141|21376701|P1|NOT COMPLETED|Intervention Period 1||0
8658694|NCT02052141|21376700|P2|COMPLETED|Intervention Period 1||7
8658695|NCT02052141|21376701|P1|COMPLETED|Intervention Period 1||5
8658696|NCT02052141|21376700|P2|STARTED|Intervention Period 1||7
8658697|NCT02052141|21376701|P1|STARTED|Intervention Period 1||5
8658698|NCT02045264|21376723|P1|NOT COMPLETED|Overall Study||0
8658699|NCT02045264|21376723|P1|COMPLETED|Overall Study||12
8658700|NCT02045264|21376723|P1|STARTED|Overall Study||12
8658701|NCT01894477|21376740|P2|NOT COMPLETED|Overall Study||2
8658702|NCT01894477|21376741|P1|NOT COMPLETED|Overall Study||0
8658703|NCT01894477|21376740|P2|COMPLETED|Overall Study||65
8658704|NCT01894477|21376741|P1|COMPLETED|Overall Study||35
8658705|NCT01894477|21376740|P2|STARTED|Overall Study||67
8658706|NCT01894477|21376741|P1|STARTED|Overall Study||35
8658707|NCT01890785|21376755|P6|NOT COMPLETED|Third Intervention||0
8658708|NCT01890785|21376756|P5|NOT COMPLETED|Third Intervention||0
8658709|NCT01890785|21376757|P4|NOT COMPLETED|Third Intervention||0
8658710|NCT01890785|21376758|P3|NOT COMPLETED|Third Intervention||0
8658711|NCT01890785|21376759|P2|NOT COMPLETED|Third Intervention||1
8658712|NCT01890785|21376760|P1|NOT COMPLETED|Third Intervention||0
8658713|NCT01890785|21376755|P6|COMPLETED|Third Intervention||5
8658714|NCT01890785|21376756|P5|COMPLETED|Third Intervention||5
8658715|NCT01890785|21376757|P4|COMPLETED|Third Intervention||5
8658716|NCT01890785|21376758|P3|COMPLETED|Third Intervention||5
8658717|NCT01890785|21376759|P2|COMPLETED|Third Intervention||4
8658718|NCT01890785|21376760|P1|COMPLETED|Third Intervention||5
8658719|NCT01890785|21376755|P6|STARTED|Third Intervention||5
8658720|NCT01890785|21376756|P5|STARTED|Third Intervention||5
8658721|NCT01890785|21376757|P4|STARTED|Third Intervention||5
8658722|NCT01890785|21376758|P3|STARTED|Third Intervention||5
8658723|NCT01890785|21376759|P2|STARTED|Third Intervention||5
8658724|NCT01890785|21376760|P1|STARTED|Third Intervention||5
8658725|NCT01890785|21376755|P6|NOT COMPLETED|Second Intervention||0
8658726|NCT01890785|21376756|P5|NOT COMPLETED|Second Intervention||0
8658727|NCT01890785|21376757|P4|NOT COMPLETED|Second Intervention||0
8658728|NCT01890785|21376758|P3|NOT COMPLETED|Second Intervention||0
8658729|NCT01890785|21376759|P2|NOT COMPLETED|Second Intervention||0
8658730|NCT01890785|21376760|P1|NOT COMPLETED|Second Intervention||0
8658731|NCT01890785|21376755|P6|COMPLETED|Second Intervention||5
8658732|NCT01890785|21376756|P5|COMPLETED|Second Intervention||5
8658733|NCT01890785|21376757|P4|COMPLETED|Second Intervention||5
8658734|NCT01890785|21376758|P3|COMPLETED|Second Intervention||5
8658735|NCT01890785|21376759|P2|COMPLETED|Second Intervention||5
8658736|NCT01890785|21376760|P1|COMPLETED|Second Intervention||5
8658737|NCT01890785|21376755|P6|STARTED|Second Intervention||5
8658738|NCT01890785|21376756|P5|STARTED|Second Intervention||5
8658739|NCT01890785|21376757|P4|STARTED|Second Intervention||5
8658740|NCT01890785|21376758|P3|STARTED|Second Intervention||5
8658741|NCT01890785|21376759|P2|STARTED|Second Intervention||5
8658742|NCT01890785|21376760|P1|STARTED|Second Intervention||5
8658743|NCT01890785|21376755|P6|NOT COMPLETED|First Intervention||0
8658744|NCT01890785|21376756|P5|NOT COMPLETED|First Intervention||0
8658745|NCT01890785|21376757|P4|NOT COMPLETED|First Intervention||0
8658746|NCT01890785|21376758|P3|NOT COMPLETED|First Intervention||0
8658747|NCT01890785|21376759|P2|NOT COMPLETED|First Intervention||0
8658748|NCT01890785|21376760|P1|NOT COMPLETED|First Intervention||0
8658749|NCT01890785|21376755|P6|COMPLETED|First Intervention||5
8658750|NCT01890785|21376756|P5|COMPLETED|First Intervention||5
8658751|NCT01890785|21376757|P4|COMPLETED|First Intervention||5
8658752|NCT01890785|21376758|P3|COMPLETED|First Intervention||5
8658753|NCT01890785|21376759|P2|COMPLETED|First Intervention||5
8658754|NCT01890785|21376760|P1|COMPLETED|First Intervention||5
8658755|NCT01890785|21376755|P6|STARTED|First Intervention||5
8658756|NCT01890785|21376756|P5|STARTED|First Intervention||5
8658757|NCT01890785|21376757|P4|STARTED|First Intervention||5
8658758|NCT01890785|21376758|P3|STARTED|First Intervention||5
8658759|NCT01890785|21376759|P2|STARTED|First Intervention||5
8658760|NCT01890785|21376760|P1|STARTED|First Intervention||5
8658771|NCT01810939|21376792|P3|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
8658772|NCT01810939|21376793|P2|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
8658773|NCT01810939|21376794|P1|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
8658774|NCT01810939|21376792|P3|COMPLETED|Part B Placebo-Controlled Withdrawal||30
8658775|NCT01810939|21376793|P2|COMPLETED|Part B Placebo-Controlled Withdrawal||45
8658776|NCT01810939|21376794|P1|COMPLETED|Part B Placebo-Controlled Withdrawal||0
8658777|NCT01810939|21376792|P3|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
8658778|NCT01810939|21376793|P2|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
8658779|NCT01810939|21376794|P1|STARTED|Part B Placebo-Controlled Withdrawal||0
8658780|NCT01810939|21376792|P3|NOT COMPLETED|Part A Treatment Period||0
8658781|NCT01810939|21376793|P2|NOT COMPLETED|Part A Treatment Period||0
8658782|NCT01810939|21376794|P1|NOT COMPLETED|Part A Treatment Period||24
8658783|NCT01810939|21376792|P3|COMPLETED|Part A Treatment Period||0
8658784|NCT01810939|21376793|P2|COMPLETED|Part A Treatment Period||0
8658785|NCT01810939|21376794|P1|COMPLETED|Part A Treatment Period||219
8658786|NCT01810939|21376792|P3|STARTED|Part A Treatment Period||0
8658787|NCT01810939|21376793|P2|STARTED|Part A Treatment Period||0
8658788|NCT01810939|21376794|P1|STARTED|Part A Treatment Period||243
8658789|NCT01771809|21376809|P2|NOT COMPLETED|Overall Study||83
8658790|NCT01771809|21376810|P1|NOT COMPLETED|Overall Study||71
8658791|NCT01771809|21376809|P2|COMPLETED|Overall Study||83
8658792|NCT01771809|21376810|P1|COMPLETED|Overall Study||93
8658793|NCT01771809|21376809|P2|STARTED|Overall Study||166
8658794|NCT01771809|21376810|P1|STARTED|Overall Study||164
8658795|NCT01756157|21376824|P2|NOT COMPLETED|Second Intervention Period||0
8658796|NCT01756157|21376825|P1|NOT COMPLETED|Second Intervention Period||0
8658797|NCT01756157|21376824|P2|COMPLETED|Second Intervention Period||22
8658798|NCT01756157|21376825|P1|COMPLETED|Second Intervention Period||22
8658799|NCT01756157|21376824|P2|STARTED|Second Intervention Period||22
8658800|NCT01756157|21376825|P1|STARTED|Second Intervention Period||22
8658801|NCT01756157|21376824|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8658802|NCT01756157|21376825|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8658803|NCT01756157|21376824|P2|COMPLETED|Washout Period (at Least 7 Days)||22
8658804|NCT01756157|21376825|P1|COMPLETED|Washout Period (at Least 7 Days)||22
8658805|NCT01756157|21376824|P2|STARTED|Washout Period (at Least 7 Days)||22
8658806|NCT01756157|21376825|P1|STARTED|Washout Period (at Least 7 Days)||22
8658807|NCT01756157|21376824|P2|NOT COMPLETED|First Intervention Period||2
8658808|NCT01756157|21376825|P1|NOT COMPLETED|First Intervention Period||1
8658809|NCT01756157|21376824|P2|COMPLETED|First Intervention Period||22
8658810|NCT01756157|21376825|P1|COMPLETED|First Intervention Period||22
8658811|NCT01756157|21376824|P2|STARTED|First Intervention Period||24
8658812|NCT01756157|21376825|P1|STARTED|First Intervention Period||23
8658813|NCT01457339|21376841|P2|NOT COMPLETED|Period 6 (250 mg)||1
8658814|NCT01457339|21376842|P1|NOT COMPLETED|Period 6 (250 mg)||1
8658815|NCT01457339|21376841|P2|COMPLETED|Period 6 (250 mg)||21
8658816|NCT01457339|21376842|P1|COMPLETED|Period 6 (250 mg)||6
8658817|NCT01457339|21376841|P2|STARTED|Period 6 (250 mg)||22
8658818|NCT01457339|21376842|P1|STARTED|Period 6 (250 mg)||7
8658819|NCT01457339|21376841|P2|NOT COMPLETED|Period 5 (200 mg)||1
8658820|NCT01457339|21376842|P1|NOT COMPLETED|Period 5 (200 mg)||0
8658821|NCT01457339|21376841|P2|COMPLETED|Period 5 (200 mg)||22
8658822|NCT01457339|21376842|P1|COMPLETED|Period 5 (200 mg)||7
8658823|NCT01457339|21376841|P2|STARTED|Period 5 (200 mg)||23
8658824|NCT01457339|21376842|P1|STARTED|Period 5 (200 mg)||7
8658825|NCT01457339|21376841|P2|NOT COMPLETED|Period 4 (150 mg)||0
8658826|NCT01457339|21376842|P1|NOT COMPLETED|Period 4 (150 mg)||0
8658827|NCT01457339|21376841|P2|COMPLETED|Period 4 (150 mg)||23
8658828|NCT01457339|21376842|P1|COMPLETED|Period 4 (150 mg)||7
8658829|NCT01457339|21376841|P2|STARTED|Period 4 (150 mg)||23
8658830|NCT01457339|21376842|P1|STARTED|Period 4 (150 mg)||7
8658831|NCT01457339|21376841|P2|NOT COMPLETED|Period 3 (100 mg)||1
8658832|NCT01457339|21376842|P1|NOT COMPLETED|Period 3 (100 mg)||0
8658833|NCT01457339|21376841|P2|COMPLETED|Period 3 (100 mg)||23
8658834|NCT01457339|21376842|P1|COMPLETED|Period 3 (100 mg)||7
8658835|NCT01457339|21376841|P2|STARTED|Period 3 (100 mg)||24
8658836|NCT01457339|21376842|P1|STARTED|Period 3 (100 mg)||7
8658837|NCT01457339|21376841|P2|NOT COMPLETED|Period 2 (70 mg)||0
8658838|NCT01457339|21376842|P1|NOT COMPLETED|Period 2 (70 mg)||0
8658839|NCT01457339|21376841|P2|COMPLETED|Period 2 (70 mg)||24
8658840|NCT01457339|21376842|P1|COMPLETED|Period 2 (70 mg)||7
8658841|NCT01457339|21376841|P2|STARTED|Period 2 (70 mg)||24
8658842|NCT01457339|21376842|P1|STARTED|Period 2 (70 mg)||7
8658843|NCT01457339|21376841|P2|NOT COMPLETED|Period 1 (50 mg)||0
8658844|NCT01457339|21376842|P1|NOT COMPLETED|Period 1 (50 mg)||0
8658845|NCT01457339|21376841|P2|COMPLETED|Period 1 (50 mg)||24
8658846|NCT01457339|21376842|P1|COMPLETED|Period 1 (50 mg)||7
8658847|NCT01457339|21376841|P2|STARTED|Period 1 (50 mg)||24
8658848|NCT01457339|21376842|P1|STARTED|Period 1 (50 mg)||7
8658849|NCT01387594|21377010|P2|NOT COMPLETED|Overall Study||3
8658850|NCT01387594|21377011|P1|NOT COMPLETED|Overall Study||0
8658851|NCT01387594|21377010|P2|COMPLETED|Overall Study||36
8658852|NCT01387594|21377011|P1|COMPLETED|Overall Study||10
8658853|NCT01387594|21377010|P2|STARTED|Overall Study||39
8658854|NCT01387594|21377011|P1|STARTED|Overall Study||10
8658855|NCT01371747|21377029|P6|NOT COMPLETED|Overall Study||14
8658856|NCT01371747|21377030|P5|NOT COMPLETED|Overall Study||7
8658857|NCT01371747|21377031|P4|NOT COMPLETED|Overall Study||9
8658858|NCT01371747|21377032|P3|NOT COMPLETED|Overall Study||24
8658859|NCT01371747|21377033|P2|NOT COMPLETED|Overall Study||23
8658860|NCT01371747|21377034|P1|NOT COMPLETED|Overall Study||18
8658861|NCT01371747|21377029|P6|COMPLETED|Overall Study||16
8658862|NCT01371747|21377030|P5|COMPLETED|Overall Study||21
8658863|NCT01371747|21377031|P4|COMPLETED|Overall Study||17
8658864|NCT01371747|21377032|P3|COMPLETED|Overall Study||50
8658865|NCT01371747|21377033|P2|COMPLETED|Overall Study||51
8658866|NCT01371747|21377034|P1|COMPLETED|Overall Study||56
8658867|NCT01371747|21377029|P6|STARTED|Overall Study||30
8658868|NCT01371747|21377030|P5|STARTED|Overall Study||28
8658869|NCT01371747|21377031|P4|STARTED|Overall Study||26
8658870|NCT01371747|21377032|P3|STARTED|Overall Study||74
8658871|NCT01371747|21377033|P2|STARTED|Overall Study||74
8658872|NCT01371747|21377034|P1|STARTED|Overall Study||74
8658873|NCT01298492|21377096|P1|NOT COMPLETED|Overall Study||119
8658874|NCT01298492|21377096|P1|COMPLETED|Overall Study||149
8658875|NCT01298492|21377096|P1|STARTED|Overall Study||268
8658876|NCT01276509|21377106|P4|NOT COMPLETED|Overall Study||5
8658877|NCT01276509|21377107|P3|NOT COMPLETED|Overall Study||5
8658878|NCT01276509|21377108|P2|NOT COMPLETED|Overall Study||12
8658879|NCT01276509|21377109|P1|NOT COMPLETED|Overall Study||13
8658880|NCT01276509|21377106|P4|COMPLETED|Overall Study||58
8658881|NCT01276509|21377107|P3|COMPLETED|Overall Study||63
8658882|NCT01276509|21377108|P2|COMPLETED|Overall Study||53
8658883|NCT01276509|21377109|P1|COMPLETED|Overall Study||53
8658884|NCT01276509|21377106|P4|STARTED|Overall Study||63
8658885|NCT01276509|21377107|P3|STARTED|Overall Study||68
8658886|NCT01276509|21377108|P2|STARTED|Overall Study||65
8658887|NCT01276509|21377109|P1|STARTED|Overall Study||66
8658888|NCT01147536|21377160|P1|NOT COMPLETED|Overall Study||3
8658889|NCT01147536|21377160|P1|COMPLETED|Overall Study||9
8658890|NCT01147536|21377160|P1|Received at Least 1 Dose of Study Drug|Overall Study||12
8658891|NCT01147536|21377160|P1|STARTED|Overall Study||12
8658892|NCT01095510|21377167|P4|NOT COMPLETED|Overall Study||0
8658893|NCT01095510|21377168|P3|NOT COMPLETED|Overall Study||0
8658894|NCT01095510|21377169|P2|NOT COMPLETED|Overall Study||0
8658895|NCT01095510|21377170|P1|NOT COMPLETED|Overall Study||0
8658896|NCT01095510|21377167|P4|COMPLETED|Overall Study||3
8658897|NCT01095510|21377168|P3|COMPLETED|Overall Study||3
8658898|NCT01095510|21377169|P2|COMPLETED|Overall Study||0
8658899|NCT01095510|21377170|P1|COMPLETED|Overall Study||3
8658900|NCT01095510|21377167|P4|STARTED|Overall Study||3
8658901|NCT01095510|21377168|P3|STARTED|Overall Study||3
8658902|NCT01095510|21377169|P2|STARTED|Overall Study||0
8658903|NCT01095510|21377170|P1|STARTED|Overall Study||3
8658904|NCT00798967|21377189|P2|NOT COMPLETED|Overall Study||4
8658905|NCT00798967|21377190|P1|NOT COMPLETED|Overall Study||4
8658906|NCT00798967|21377189|P2|COMPLETED|Overall Study||39
8658907|NCT00798967|21377190|P1|COMPLETED|Overall Study||39
8658908|NCT00798967|21377189|P2|Discontinued During Dosing Period|Overall Study||4
8658909|NCT00798967|21377190|P1|Discontinued During Dosing Period|Overall Study||4
8658910|NCT00798967|21377189|P2|STARTED|Overall Study||43
8658911|NCT00798967|21377190|P1|STARTED|Overall Study||43
8658915|NCT00732615|21377214|P2|NOT COMPLETED|Overall Study||5
8658916|NCT00732615|21377215|P1|NOT COMPLETED|Overall Study||7
8658917|NCT00732615|21377214|P2|COMPLETED|Overall Study||79
8658918|NCT00732615|21377215|P1|COMPLETED|Overall Study||33
8658919|NCT00732615|21377214|P2|STARTED|Overall Study||84
8658920|NCT00732615|21377215|P1|STARTED|Overall Study||40
8658930|NCT00508274|21377303|P1|NOT COMPLETED|Overall Study||2
8658931|NCT00508274|21377303|P1|COMPLETED|Overall Study||50
8658932|NCT00508274|21377303|P1|STARTED|Overall Study||52
8658933|NCT00458783|21377314|P2|NOT COMPLETED|Overall Study||1220
8658934|NCT00458783|21377315|P1|NOT COMPLETED|Overall Study||1228
8658935|NCT00458783|21377314|P2|COMPLETED|Overall Study||701
8658936|NCT00458783|21377315|P1|COMPLETED|Overall Study||686
8658937|NCT00458783|21377314|P2|STARTED|Overall Study||1921
8658938|NCT00458783|21377315|P1|STARTED|Overall Study||1914
8658939|NCT00187226|21377351|P6|NOT COMPLETED|Overall Study||0
8658940|NCT00187226|21377352|P5|NOT COMPLETED|Overall Study||0
8658941|NCT00187226|21377353|P4|NOT COMPLETED|Overall Study||0
8658942|NCT00187226|21377354|P3|NOT COMPLETED|Overall Study||0
8658943|NCT00187226|21377355|P2|NOT COMPLETED|Overall Study||0
8658944|NCT00187226|21377356|P1|NOT COMPLETED|Overall Study||0
8658945|NCT00187226|21377351|P6|COMPLETED|Overall Study||1
8658946|NCT00187226|21377352|P5|COMPLETED|Overall Study||34
8658947|NCT00187226|21377353|P4|COMPLETED|Overall Study||2
8658948|NCT00187226|21377354|P3|COMPLETED|Overall Study||28
8658949|NCT00187226|21377355|P2|COMPLETED|Overall Study||49
8658950|NCT00187226|21377356|P1|COMPLETED|Overall Study||88
8658951|NCT00187226|21377351|P6|STARTED|Overall Study||1
8658952|NCT00187226|21377352|P5|STARTED|Overall Study||34
8658953|NCT00187226|21377353|P4|STARTED|Overall Study||2
8658954|NCT00187226|21377354|P3|STARTED|Overall Study||28
8658955|NCT00187226|21377355|P2|STARTED|Overall Study||49
8658956|NCT00187226|21377356|P1|STARTED|Overall Study||88
8658960|NCT04059094|21377385|P5|NOT COMPLETED|Overall Study||1
8658961|NCT04059094|21377386|P4|NOT COMPLETED|Overall Study||0
8658962|NCT04059094|21377387|P3|NOT COMPLETED|Overall Study||0
8658963|NCT04059094|21377388|P2|NOT COMPLETED|Overall Study||2
8658964|NCT04059094|21377389|P1|NOT COMPLETED|Overall Study||0
8658965|NCT04059094|21377385|P5|COMPLETED|Overall Study||17
8658966|NCT04059094|21377386|P4|COMPLETED|Overall Study||5
8658967|NCT04059094|21377387|P3|COMPLETED|Overall Study||5
8658968|NCT04059094|21377388|P2|COMPLETED|Overall Study||4
8658969|NCT04059094|21377389|P1|COMPLETED|Overall Study||18
8658970|NCT04059094|21377385|P5|STARTED|Overall Study||18
8658971|NCT04059094|21377386|P4|STARTED|Overall Study||5
8658972|NCT04059094|21377387|P3|STARTED|Overall Study||5
8658973|NCT04059094|21377388|P2|STARTED|Overall Study||6
8658974|NCT04059094|21377389|P1|STARTED|Overall Study||18
8658975|NCT04057248|21377441|P1|NOT COMPLETED|Overall Study||2
8658976|NCT04057248|21377441|P1|COMPLETED|Overall Study||12
8658977|NCT04057248|21377441|P1|STARTED|Overall Study||14
8658978|NCT03979820|21377452|P4|NOT COMPLETED|Overall Study||10
8658979|NCT03979820|21377453|P3|NOT COMPLETED|Overall Study||1
8658980|NCT03979820|21377454|P2|NOT COMPLETED|Overall Study||0
8658981|NCT03979820|21377455|P1|NOT COMPLETED|Overall Study||6
8658982|NCT03979820|21377452|P4|COMPLETED|Overall Study||0
8658983|NCT03979820|21377453|P3|COMPLETED|Overall Study||15
8658984|NCT03979820|21377454|P2|COMPLETED|Overall Study||14
8658985|NCT03979820|21377455|P1|COMPLETED|Overall Study||7
8658986|NCT03979820|21377452|P4|STARTED|Overall Study||10
8658987|NCT03979820|21377453|P3|STARTED|Overall Study||16
8658988|NCT03979820|21377454|P2|STARTED|Overall Study||14
8658989|NCT03979820|21377455|P1|STARTED|Overall Study||13
8658996|NCT03878160|21377490|P3|NOT COMPLETED|Overall Study||1
8658997|NCT03878160|21377491|P2|NOT COMPLETED|Overall Study||1
8658998|NCT03878160|21377492|P1|NOT COMPLETED|Overall Study||2
8658999|NCT03878160|21377490|P3|COMPLETED|Overall Study||10
8659000|NCT03878160|21377491|P2|COMPLETED|Overall Study||8
8659001|NCT03878160|21377492|P1|COMPLETED|Overall Study||5
8659002|NCT03878160|21377490|P3|STARTED|Overall Study||11
8659003|NCT03878160|21377491|P2|STARTED|Overall Study||9
8659004|NCT03878160|21377492|P1|STARTED|Overall Study||7
8659005|NCT03830892|21377541|P2|NOT COMPLETED|Overall Study||6
8659006|NCT03830892|21377542|P1|NOT COMPLETED|Overall Study||6
8659007|NCT03830892|21377541|P2|COMPLETED|Overall Study||17
8659008|NCT03830892|21377542|P1|COMPLETED|Overall Study||19
8659009|NCT03830892|21377541|P2|Own Brand|Overall Study||17
8659010|NCT03830892|21377542|P1|Own Brand|Overall Study||19
8659011|NCT03830892|21377541|P2|30 Watts, 30 mg Nicotine|Overall Study||17
8659012|NCT03830892|21377542|P1|30 Watts, 30 mg Nicotine|Overall Study||19
8659013|NCT03830892|21377541|P2|30 Watts, 10 mg Nicotine|Overall Study||17
8659014|NCT03830892|21377542|P1|30 Watts, 10 mg Nicotine|Overall Study||19
8659015|NCT03830892|21377541|P2|15 Watts, 30 mg Nicotine|Overall Study||17
8659016|NCT03830892|21377542|P1|15 Watts, 30 mg Nicotine|Overall Study||19
8659017|NCT03830892|21377541|P2|15 Watts, 10 mg Nicotine|Overall Study||17
8659018|NCT03830892|21377542|P1|15 Watts, 10 mg Nicotine|Overall Study||19
8659019|NCT03830892|21377541|P2|STARTED|Overall Study||23
8659020|NCT03830892|21377542|P1|STARTED|Overall Study||25
8659021|NCT03796676|21377555|P3|NOT COMPLETED|Overall Study||3
8659022|NCT03796676|21377556|P2|NOT COMPLETED|Overall Study||3
8659023|NCT03796676|21377557|P1|NOT COMPLETED|Overall Study||6
8659024|NCT03796676|21377555|P3|COMPLETED|Overall Study||91
8659025|NCT03796676|21377556|P2|COMPLETED|Overall Study||92
8659026|NCT03796676|21377557|P1|COMPLETED|Overall Study||90
8659027|NCT03796676|21377555|P3|STARTED|Overall Study||94
8659028|NCT03796676|21377556|P2|STARTED|Overall Study||95
8659029|NCT03796676|21377557|P1|STARTED|Overall Study||96
8659030|NCT03728348|21377686|P1|NOT COMPLETED|Overall Study||141
8659031|NCT03728348|21377686|P1|COMPLETED|Overall Study||842
8659032|NCT03728348|21377686|P1|Colonoscopy Excluded|Overall Study||19
8659033|NCT03728348|21377686|P1|Multi-target DNA Test Excluded|Overall Study||15
8659034|NCT03728348|21377686|P1|Did Not Complete Study Procedures|Overall Study||107
8659035|NCT03728348|21377686|P1|STARTED|Overall Study||983
8659036|NCT03676972|21377690|P1|NOT COMPLETED|Overall Study||2
8659037|NCT03676972|21377690|P1|COMPLETED|Overall Study||58
8659038|NCT03676972|21377690|P1|STARTED|Overall Study||60
8659070|NCT03302091|21377794|P2|NOT COMPLETED|Overall Study||0
8659071|NCT03302091|21377795|P1|NOT COMPLETED|Overall Study||0
8659072|NCT03302091|21377794|P2|COMPLETED|Overall Study||10
8659073|NCT03302091|21377795|P1|COMPLETED|Overall Study||10
8659074|NCT03302091|21377794|P2|STARTED|Overall Study||10
8659075|NCT03302091|21377795|P1|STARTED|Overall Study||10
8659076|NCT03238963|21377813|P2|NOT COMPLETED|Overall Study||2
8659077|NCT03238963|21377814|P1|NOT COMPLETED|Overall Study||5
8659078|NCT03238963|21377813|P2|COMPLETED|Overall Study||37
8659079|NCT03238963|21377814|P1|COMPLETED|Overall Study||35
8659080|NCT03238963|21377813|P2|STARTED|Overall Study||39
8659081|NCT03238963|21377814|P1|STARTED|Overall Study||40
8659082|NCT03159455|21377830|P6|NOT COMPLETED|Overall Study||1
8659083|NCT03159455|21377831|P5|NOT COMPLETED|Overall Study||0
8659084|NCT03159455|21377832|P4|NOT COMPLETED|Overall Study||0
8659085|NCT03159455|21377833|P3|NOT COMPLETED|Overall Study||0
8659086|NCT03159455|21377834|P2|NOT COMPLETED|Overall Study||0
8659087|NCT03159455|21377835|P1|NOT COMPLETED|Overall Study||0
8659088|NCT03159455|21377830|P6|COMPLETED|Overall Study||8
8659089|NCT03159455|21377831|P5|COMPLETED|Overall Study||3
8659090|NCT03159455|21377832|P4|COMPLETED|Overall Study||9
8659091|NCT03159455|21377833|P3|COMPLETED|Overall Study||9
8659092|NCT03159455|21377834|P2|COMPLETED|Overall Study||9
8659093|NCT03159455|21377835|P1|COMPLETED|Overall Study||9
8659094|NCT03159455|21377830|P6|STARTED|Overall Study||9
8659095|NCT03159455|21377831|P5|STARTED|Overall Study||3
8659096|NCT03159455|21377832|P4|STARTED|Overall Study||9
8659097|NCT03159455|21377833|P3|STARTED|Overall Study||9
8659098|NCT03159455|21377834|P2|STARTED|Overall Study||9
8659099|NCT03159455|21377835|P1|STARTED|Overall Study||9
8659106|NCT03023397|21377883|P3|NOT COMPLETED|Main Study||0
8659107|NCT03023397|21377884|P2|NOT COMPLETED|Main Study||0
8659108|NCT03023397|21377885|P1|NOT COMPLETED|Main Study||0
8659109|NCT03023397|21377883|P3|COMPLETED|Main Study||1
8659110|NCT03023397|21377884|P2|COMPLETED|Main Study||3
8659111|NCT03023397|21377885|P1|COMPLETED|Main Study||6
8659112|NCT03023397|21377883|P3|STARTED|Main Study||1
8659113|NCT03023397|21377884|P2|STARTED|Main Study||3
8659114|NCT03023397|21377885|P1|STARTED|Main Study||6
8659115|NCT03023397|21377883|P3|NOT COMPLETED|Run-In||0
8659116|NCT03023397|21377884|P2|NOT COMPLETED|Run-In||0
8659117|NCT03023397|21377885|P1|NOT COMPLETED|Run-In||2
8659118|NCT03023397|21377883|P3|COMPLETED|Run-In||1
8659119|NCT03023397|21377884|P2|COMPLETED|Run-In||3
8659120|NCT03023397|21377885|P1|COMPLETED|Run-In||6
8659121|NCT03023397|21377883|P3|STARTED|Run-In||1
8659122|NCT03023397|21377884|P2|STARTED|Run-In||3
8659123|NCT03023397|21377885|P1|STARTED|Run-In||8
8659130|NCT02650284|21377922|P2|NOT COMPLETED|Overall Study||4
8659131|NCT02650284|21377923|P1|NOT COMPLETED|Overall Study||3
8659132|NCT02650284|21377922|P2|COMPLETED|Overall Study||5
8659133|NCT02650284|21377923|P1|COMPLETED|Overall Study||5
8659134|NCT02650284|21377922|P2|STARTED|Overall Study||9
8659135|NCT02650284|21377923|P1|STARTED|Overall Study||8
8659136|NCT02554474|21377943|P2|NOT COMPLETED|Overall Study||2
8659137|NCT02554474|21377944|P1|NOT COMPLETED|Overall Study||3
8659138|NCT02554474|21377943|P2|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|57
8659139|NCT02554474|21377944|P1|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|56
8659140|NCT02554474|21377943|P2|STARTED|Overall Study||59
8659141|NCT02554474|21377944|P1|STARTED|Overall Study||59
8659142|NCT02458638|21377966|P1|NOT COMPLETED|Overall Study||459
8659143|NCT02458638|21377966|P1|COMPLETED|Overall Study||15
8659144|NCT02458638|21377966|P1|STARTED|Overall Study||474
8659145|NCT02400905|21377986|P1|NOT COMPLETED|Overall Study||63
8659146|NCT02400905|21377986|P1|COMPLETED|Overall Study||208
8659147|NCT02400905|21377986|P1|36 Months-Follow-up|Overall Study||208
8659148|NCT02400905|21377986|P1|24-Months Follow-up|Overall Study||225
8659149|NCT02400905|21377986|P1|12-Months Follow-up|Overall Study||256
8659150|NCT02400905|21377986|P1|30-Days Follow-up|Overall Study||268
8659151|NCT02400905|21377986|P1|STARTED|Overall Study||271
8659152|NCT02246478|21378005|P4|NOT COMPLETED|Multiple-dose Phase||1
8659153|NCT02246478|21378006|P3|NOT COMPLETED|Multiple-dose Phase||0
8659154|NCT02246478|21378007|P2|NOT COMPLETED|Multiple-dose Phase||0
8659155|NCT02246478|21378008|P1|NOT COMPLETED|Multiple-dose Phase||1
8659156|NCT02246478|21378005|P4|COMPLETED|Multiple-dose Phase||4
8659157|NCT02246478|21378006|P3|COMPLETED|Multiple-dose Phase||5
8659158|NCT02246478|21378007|P2|COMPLETED|Multiple-dose Phase||5
8659159|NCT02246478|21378008|P1|COMPLETED|Multiple-dose Phase||5
8659160|NCT02246478|21378005|P4|STARTED|Multiple-dose Phase||5
8659161|NCT02246478|21378006|P3|STARTED|Multiple-dose Phase||5
8659162|NCT02246478|21378007|P2|STARTED|Multiple-dose Phase||5
8659163|NCT02246478|21378008|P1|STARTED|Multiple-dose Phase||6
8659164|NCT02246478|21378005|P4|NOT COMPLETED|Single-dose Phase||0
8659165|NCT02246478|21378006|P3|NOT COMPLETED|Single-dose Phase||0
8659166|NCT02246478|21378007|P2|NOT COMPLETED|Single-dose Phase||0
8659167|NCT02246478|21378008|P1|NOT COMPLETED|Single-dose Phase||0
8659168|NCT02246478|21378005|P4|COMPLETED|Single-dose Phase||5
8659169|NCT02246478|21378006|P3|COMPLETED|Single-dose Phase||5
8659170|NCT02246478|21378007|P2|COMPLETED|Single-dose Phase||5
8659171|NCT02246478|21378008|P1|COMPLETED|Single-dose Phase||6
8659172|NCT02246478|21378005|P4|STARTED|Single-dose Phase||5
8659173|NCT02246478|21378006|P3|STARTED|Single-dose Phase||5
8659174|NCT02246478|21378007|P2|STARTED|Single-dose Phase||5
8659175|NCT02246478|21378008|P1|STARTED|Single-dose Phase||6
8659176|NCT02085980|21378032|P1|NOT COMPLETED|Overall Study||3
8659177|NCT02085980|21378032|P1|COMPLETED|Overall Study||27
8659178|NCT02085980|21378032|P1|STARTED|Overall Study||30
8659179|NCT02063984|21378038|P2|NOT COMPLETED|Overall Study||5
8659180|NCT02063984|21378039|P1|NOT COMPLETED|Overall Study||6
8659181|NCT02063984|21378038|P2|COMPLETED|Overall Study||25
8659182|NCT02063984|21378039|P1|COMPLETED|Overall Study||23
8659183|NCT02063984|21378038|P2|STARTED|Overall Study||30
8659184|NCT02063984|21378039|P1|STARTED|Overall Study||29
8659185|NCT02021955|21378062|P2|NOT COMPLETED|Step 30||0
8659186|NCT02021955|21378063|P1|NOT COMPLETED|Step 30||0
8659187|NCT02021955|21378062|P2|COMPLETED|Step 30||277
8659188|NCT02021955|21378063|P1|COMPLETED|Step 30||0
8659189|NCT02021955|21378062|P2|STARTED|Step 30|Provider attrition=0; Provider addition=1; Patient discharges=11|277
8659190|NCT02021955|21378063|P1|STARTED|Step 30|Provider attrition=0; Provider addition=0; Patient discharges=0|0
8659191|NCT02021955|21378062|P2|NOT COMPLETED|Step 29||0
8659192|NCT02021955|21378063|P1|NOT COMPLETED|Step 29||0
8659193|NCT02021955|21378062|P2|COMPLETED|Step 29||266
8659194|NCT02021955|21378063|P1|COMPLETED|Step 29||10
8659195|NCT02021955|21378062|P2|STARTED|Step 29|Provider attrition=1; Provider addition=2; Patient discharges=8|266
8659196|NCT02021955|21378063|P1|STARTED|Step 29|Provider attrition=0; Provider addition=0; Patient discharges=0|10
8659197|NCT02021955|21378062|P2|NOT COMPLETED|Step 28||0
8659198|NCT02021955|21378063|P1|NOT COMPLETED|Step 28||0
8659199|NCT02021955|21378062|P2|COMPLETED|Step 28||256
8659200|NCT02021955|21378063|P1|COMPLETED|Step 28||15
8659201|NCT02021955|21378062|P2|STARTED|Step 28|Provider attrition=3; Provider addition=6; Patient discharges=6|256
8659202|NCT02021955|21378063|P1|STARTED|Step 28|Provider attrition=0; Provider addition=2; Patient discharges=0|15
8659203|NCT02021955|21378062|P2|NOT COMPLETED|Step 27||0
8659204|NCT02021955|21378063|P1|NOT COMPLETED|Step 27||0
8659205|NCT02021955|21378062|P2|COMPLETED|Step 27||243
8659206|NCT02021955|21378063|P1|COMPLETED|Step 27||25
8659207|NCT02021955|21378062|P2|STARTED|Step 27|Provider attrition=1; Provider addition=4; Patient discharges=4|243
8659208|NCT02021955|21378063|P1|STARTED|Step 27|Provider attrition=1; Provider addition=1; Patient discharges=0|25
8659209|NCT02021955|21378062|P2|NOT COMPLETED|Step 26||0
8659210|NCT02021955|21378063|P1|NOT COMPLETED|Step 26||0
8659211|NCT02021955|21378062|P2|COMPLETED|Step 26||215
8659212|NCT02021955|21378063|P1|COMPLETED|Step 26||30
8659213|NCT02021955|21378062|P2|STARTED|Step 26|Provider attrition=0; Provider addition=23; Patient discharges=9|215
8659214|NCT02021955|21378063|P1|STARTED|Step 26|Provider attrition=0; Provider addition=0; Patient discharges=2|30
8659215|NCT02021955|21378062|P2|NOT COMPLETED|Step 25||0
8659216|NCT02021955|21378063|P1|NOT COMPLETED|Step 25||0
8659217|NCT02021955|21378062|P2|COMPLETED|Step 25||208
8659218|NCT02021955|21378063|P1|COMPLETED|Step 25||37
8659219|NCT02021955|21378062|P2|STARTED|Step 25|Provider attrition=1; Provider addition=0; Patient discharges=5|208
8659220|NCT02021955|21378063|P1|STARTED|Step 25|Provider attrition=0; Provider addition=1; Patient discharges=0|37
8659221|NCT02021955|21378062|P2|NOT COMPLETED|Step 24||0
8659222|NCT02021955|21378063|P1|NOT COMPLETED|Step 24||0
8659223|NCT02021955|21378062|P2|COMPLETED|Step 24||183
8659224|NCT02021955|21378063|P1|COMPLETED|Step 24||62
8659225|NCT02021955|21378062|P2|STARTED|Step 24|Provider attrition=1; Provider addition=1; Patient discharges=8|183
8659226|NCT02021955|21378063|P1|STARTED|Step 24|Provider attrition=0; Provider addition=0; Patient discharges=4|62
8659227|NCT02021955|21378062|P2|NOT COMPLETED|Step 23||0
8659228|NCT02021955|21378063|P1|NOT COMPLETED|Step 23||0
8659229|NCT02021955|21378062|P2|COMPLETED|Step 23||175
8659230|NCT02021955|21378063|P1|COMPLETED|Step 23||69
8659231|NCT02021955|21378062|P2|STARTED|Step 23|Provider attrition=0; Provider addition=0; Patient discharges=7|175
8659232|NCT02021955|21378063|P1|STARTED|Step 23|Provider attrition=0; Provider addition=1; Patient discharges=3|69
8659233|NCT02021955|21378062|P2|NOT COMPLETED|Step 22||0
8659234|NCT02021955|21378063|P1|NOT COMPLETED|Step 22||0
8659235|NCT02021955|21378062|P2|COMPLETED|Step 22||152
8659236|NCT02021955|21378063|P1|COMPLETED|Step 22||89
8659237|NCT02021955|21378062|P2|STARTED|Step 22|Provider attrition=0; Provider addition=3; Patient discharges=8|152
8659238|NCT02021955|21378063|P1|STARTED|Step 22|Provider attrition=0; Provider addition=0; Patient discharges=8|89
8659239|NCT02021955|21378062|P2|NOT COMPLETED|Step 21||0
8659240|NCT02021955|21378063|P1|NOT COMPLETED|Step 21||0
8659241|NCT02021955|21378062|P2|COMPLETED|Step 21||134
8659242|NCT02021955|21378063|P1|COMPLETED|Step 21||88
8659243|NCT02021955|21378062|P2|STARTED|Step 21|Provider attrition=0; Provider addition=12; Patient discharges=9|134
8659244|NCT02021955|21378063|P1|STARTED|Step 21|Provider attrition=0; Provider addition=7; Patient discharges=1|88
8659245|NCT02021955|21378062|P2|NOT COMPLETED|Step 20||0
8659246|NCT02021955|21378063|P1|NOT COMPLETED|Step 20||0
8659247|NCT02021955|21378062|P2|COMPLETED|Step 20||128
8659248|NCT02021955|21378063|P1|COMPLETED|Step 20||92
8659249|NCT02021955|21378062|P2|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|128
8659250|NCT02021955|21378063|P1|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|92
8659251|NCT02021955|21378062|P2|NOT COMPLETED|Step 19||0
8659252|NCT02021955|21378063|P1|NOT COMPLETED|Step 19||0
8659253|NCT02021955|21378062|P2|COMPLETED|Step 19||126
8659254|NCT02021955|21378063|P1|COMPLETED|Step 19||94
8659255|NCT02021955|21378062|P2|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=9|126
8659256|NCT02021955|21378063|P1|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=5|94
8659257|NCT02021955|21378062|P2|NOT COMPLETED|Step 18||0
8659258|NCT02021955|21378063|P1|NOT COMPLETED|Step 18||0
8659259|NCT02021955|21378062|P2|COMPLETED|Step 18||124
8659260|NCT02021955|21378063|P1|COMPLETED|Step 18||96
8659261|NCT02021955|21378062|P2|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=7|124
8659262|NCT02021955|21378063|P1|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=6|96
8659263|NCT02021955|21378062|P2|NOT COMPLETED|Step 17||0
8659264|NCT02021955|21378063|P1|NOT COMPLETED|Step 17||0
8659265|NCT02021955|21378062|P2|COMPLETED|Step 17||121
8659266|NCT02021955|21378063|P1|COMPLETED|Step 17||99
8659267|NCT02021955|21378062|P2|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=3|121
8659268|NCT02021955|21378063|P1|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=8|99
8659269|NCT02021955|21378062|P2|NOT COMPLETED|Step 16||0
8659270|NCT02021955|21378063|P1|NOT COMPLETED|Step 16||0
8659271|NCT02021955|21378062|P2|COMPLETED|Step 16||114
8659272|NCT02021955|21378063|P1|COMPLETED|Step 16||103
8659273|NCT02021955|21378062|P2|STARTED|Step 16|Provider attrition=0; Provider addition=3; Patient discharges=3|114
8659274|NCT02021955|21378063|P1|STARTED|Step 16|Provider attrition=0; Provider addition=0; Patient discharges=2|103
8659275|NCT02021955|21378062|P2|NOT COMPLETED|Step 15||0
8659276|NCT02021955|21378063|P1|NOT COMPLETED|Step 15||0
8659277|NCT02021955|21378062|P2|COMPLETED|Step 15||102
8659278|NCT02021955|21378063|P1|COMPLETED|Step 15||110
8659279|NCT02021955|21378062|P2|STARTED|Step 15|Provider attrition=0; Provider addition=5; Patient discharges=5|102
8659280|NCT02021955|21378063|P1|STARTED|Step 15|Provider attrition=0; Provider addition=0; Patient discharges=4|110
8659281|NCT02021955|21378062|P2|NOT COMPLETED|Step 14||0
8659282|NCT02021955|21378063|P1|NOT COMPLETED|Step 14||0
8659283|NCT02021955|21378062|P2|COMPLETED|Step 14||95
8659284|NCT02021955|21378063|P1|COMPLETED|Step 14||105
8659285|NCT02021955|21378062|P2|STARTED|Step 14|Provider attrition=7; Provider addition=11; Patient discharges=3|95
8659286|NCT02021955|21378063|P1|STARTED|Step 14|Provider attrition=1; Provider addition=9; Patient discharges=7|105
8659287|NCT02021955|21378062|P2|NOT COMPLETED|Step 13||0
8659288|NCT02021955|21378063|P1|NOT COMPLETED|Step 13||0
8659289|NCT02021955|21378062|P2|COMPLETED|Step 13||96
8659290|NCT02021955|21378063|P1|COMPLETED|Step 13||118
8659291|NCT02021955|21378062|P2|STARTED|Step 13|Provider attrition=4; Provider addition=0; Patient discharges=5|96
8659292|NCT02021955|21378063|P1|STARTED|Step 13|Provider attrition=10; Provider addition=0; Patient discharges=4|118
8659293|NCT02021955|21378062|P2|NOT COMPLETED|Step 12||0
8659294|NCT02021955|21378063|P1|NOT COMPLETED|Step 12||0
8659295|NCT02021955|21378062|P2|COMPLETED|Step 12||90
8659296|NCT02021955|21378063|P1|COMPLETED|Step 12||123
8659297|NCT02021955|21378062|P2|STARTED|Step 12|Provider attrition=0; Provider addition=2; Patient discharges=1|90
8659298|NCT02021955|21378063|P1|STARTED|Step 12|Provider attrition=1; Provider addition=0; Patient discharges=3|123
8659299|NCT02021955|21378062|P2|NOT COMPLETED|Step 11||0
8659300|NCT02021955|21378063|P1|NOT COMPLETED|Step 11||0
8659301|NCT02021955|21378062|P2|COMPLETED|Step 11||88
8659302|NCT02021955|21378063|P1|COMPLETED|Step 11||126
8659303|NCT02021955|21378062|P2|STARTED|Step 11|Provider attrition=2; Provider addition=2; Patient discharges=7|88
8659304|NCT02021955|21378063|P1|STARTED|Step 11|Provider attrition=1; Provider addition=0; Patient discharges=11|126
8659305|NCT02021955|21378062|P2|NOT COMPLETED|Step 10||0
8659306|NCT02021955|21378063|P1|NOT COMPLETED|Step 10||0
8659307|NCT02021955|21378062|P2|COMPLETED|Step 10||79
8659308|NCT02021955|21378063|P1|COMPLETED|Step 10||135
8659309|NCT02021955|21378062|P2|STARTED|Step 10|Provider attrition=1; Provider addition=0; Patient discharges=5|79
8659310|NCT02021955|21378063|P1|STARTED|Step 10|Provider attrition=0; Provider addition=1; Patient discharges: 8|135
8659311|NCT02021955|21378062|P2|NOT COMPLETED|Step 9||0
8659312|NCT02021955|21378063|P1|NOT COMPLETED|Step 9||0
8659313|NCT02021955|21378062|P2|COMPLETED|Step 9||77
8659314|NCT02021955|21378063|P1|COMPLETED|Step 9||139
8659315|NCT02021955|21378062|P2|STARTED|Step 9|Provider attrition=1; Provider addition=0; Patient discharges=8|77
8659316|NCT02021955|21378063|P1|STARTED|Step 9|Provider attrition=2; Provider addition=1; Patient discharges=9|139
8659317|NCT02021955|21378062|P2|NOT COMPLETED|Step 8||0
8659318|NCT02021955|21378063|P1|NOT COMPLETED|Step 8||0
8659319|NCT02021955|21378062|P2|COMPLETED|Step 8||73
8659320|NCT02021955|21378063|P1|COMPLETED|Step 8||144
8659321|NCT02021955|21378062|P2|STARTED|Step 8|Provider attrition=0; Provider addition=0; Patient discharges=11|73
8659322|NCT02021955|21378063|P1|STARTED|Step 8|Provider attrition=1; Provider addition=0; Patient discharges=9|144
8659323|NCT02021955|21378062|P2|NOT COMPLETED|Step 7||0
8659324|NCT02021955|21378063|P1|NOT COMPLETED|Step 7||0
8659325|NCT02021955|21378062|P2|COMPLETED|Step 7||57
8659326|NCT02021955|21378063|P1|COMPLETED|Step 7||157
8659327|NCT02021955|21378062|P2|STARTED|Step 7|Provider attrition=0; Provider addition=1; Patient discharges=2|57
8659328|NCT02021955|21378063|P1|STARTED|Step 7|Provider attrition=0; Provider addition=2; Patient discharges=13|157
8659329|NCT02021955|21378062|P2|NOT COMPLETED|Step 6||0
8659330|NCT02021955|21378063|P1|NOT COMPLETED|Step 6||0
8659331|NCT02021955|21378062|P2|COMPLETED|Step 6||53
8659332|NCT02021955|21378063|P1|COMPLETED|Step 6||158
8659333|NCT02021955|21378062|P2|STARTED|Step 6|Provider attrition=0; Provider addition=1; Patient discharges=1|53
8659334|NCT02021955|21378063|P1|STARTED|Step 6|Provider attrition=0; Provider addition=2; Patient discharges=6|158
8659335|NCT02021955|21378062|P2|NOT COMPLETED|Step 5||0
8659336|NCT02021955|21378063|P1|NOT COMPLETED|Step 5||0
8659337|NCT02021955|21378062|P2|COMPLETED|Step 5||40
8659338|NCT02021955|21378063|P1|COMPLETED|Step 5||174
8659339|NCT02021955|21378062|P2|STARTED|Step 5|Provider attrition=0; Provider addition=0; Patient discharges=2|40
8659340|NCT02021955|21378063|P1|STARTED|Step 5|Provider attrition=3; Provider addition=0; Patient discharges=11|174
8659341|NCT02021955|21378062|P2|NOT COMPLETED|Step 4||0
8659342|NCT02021955|21378063|P1|NOT COMPLETED|Step 4||0
8659343|NCT02021955|21378062|P2|COMPLETED|Step 4||37
8659344|NCT02021955|21378063|P1|COMPLETED|Step 4||173
8659345|NCT02021955|21378062|P2|STARTED|Step 4|Provider attrition=0; Provider addition=1; Patient discharges=0|37
8659346|NCT02021955|21378063|P1|STARTED|Step 4|Provider attrition=0; Provider addition=3; Patient discharges: 13|173
8659347|NCT02021955|21378062|P2|NOT COMPLETED|Step 3||0
8659348|NCT02021955|21378063|P1|NOT COMPLETED|Step 3||0
8659349|NCT02021955|21378062|P2|COMPLETED|Step 3||30
8659350|NCT02021955|21378063|P1|COMPLETED|Step 3||175
8659351|NCT02021955|21378062|P2|STARTED|Step 3|Provider attrition=0; Provider addition=3; Patient discharges=3|30
8659352|NCT02021955|21378063|P1|STARTED|Step 3|Provider attrition=2; Provider addition=4; Patient discharges=5|175
8659353|NCT02021955|21378062|P2|NOT COMPLETED|Step 2||0
8659354|NCT02021955|21378063|P1|NOT COMPLETED|Step 2||0
8659355|NCT02021955|21378062|P2|COMPLETED|Step 2||21
8659356|NCT02021955|21378063|P1|COMPLETED|Step 2||165
8659357|NCT02021955|21378062|P2|STARTED|Step 2|Provider attrition=2; Provider addition=5; Patient discharges=2|21
8659358|NCT02021955|21378063|P1|STARTED|Step 2|Provider attrition=5; Provider addition=21; Patient discharges=12|165
8659359|NCT02021955|21378062|P2|NOT COMPLETED|Step 1||0
8659360|NCT02021955|21378063|P1|NOT COMPLETED|Step 1||0
8659361|NCT02021955|21378062|P2|COMPLETED|Step 1||18
8659362|NCT02021955|21378063|P1|COMPLETED|Step 1||193
8659363|NCT02021955|21378062|P2|STARTED|Step 1|Provider attrition=7; Provider addition=0; Patient discharges: 0|18
8659364|NCT02021955|21378063|P1|STARTED|Step 1|Provider attrition=20; Provider addition=2; Patient discharges=14|193
8659365|NCT02021955|21378062|P2|NOT COMPLETED|Step 0||0
8659366|NCT02021955|21378063|P1|NOT COMPLETED|Step 0||0
8659367|NCT02021955|21378062|P2|COMPLETED|Step 0||0
8659368|NCT02021955|21378063|P1|COMPLETED|Step 0||210
8659369|NCT02021955|21378062|P2|STARTED|Step 0|Provider attrition=0; Provider addition=0; Patient discharges=0|0
8659370|NCT02021955|21378063|P1|STARTED|Step 0|Provider attrition=2; Provider addition=3; Patient discharges=14|210
8659371|NCT01744093|21378075|P2|NOT COMPLETED|Overall Study||1
8659372|NCT01744093|21378076|P1|NOT COMPLETED|Overall Study||6
8659373|NCT01744093|21378075|P2|COMPLETED|Overall Study||8
8659374|NCT01744093|21378076|P1|COMPLETED|Overall Study||12
8659375|NCT01744093|21378075|P2|STARTED|Overall Study||9
8659376|NCT01744093|21378076|P1|STARTED|Overall Study||18
8659377|NCT00931892|21378086|P2|NOT COMPLETED|Completed Endoscopies||1
8659378|NCT00931892|21378087|P1|NOT COMPLETED|Completed Endoscopies||0
8659379|NCT00931892|21378086|P2|COMPLETED|Completed Endoscopies||9
8659380|NCT00931892|21378087|P1|COMPLETED|Completed Endoscopies||10
8659381|NCT00931892|21378086|P2|Third Endoscopy|Completed Endoscopies||9
8659382|NCT00931892|21378087|P1|Third Endoscopy|Completed Endoscopies||10
8659383|NCT00931892|21378086|P2|Second Endoscopy|Completed Endoscopies||10
8659384|NCT00931892|21378087|P1|Second Endoscopy|Completed Endoscopies||10
8659385|NCT00931892|21378086|P2|First Endoscopy|Completed Endoscopies||10
8659386|NCT00931892|21378087|P1|First Endoscopy|Completed Endoscopies||10
8659387|NCT00931892|21378086|P2|STARTED|Completed Endoscopies||10
8659388|NCT00931892|21378087|P1|STARTED|Completed Endoscopies||10
8659389|NCT00931892|21378086|P2|NOT COMPLETED|Completed Gluten Challenge||0
8659390|NCT00931892|21378087|P1|NOT COMPLETED|Completed Gluten Challenge||0
8659391|NCT00931892|21378086|P2|COMPLETED|Completed Gluten Challenge||10
8659392|NCT00931892|21378087|P1|COMPLETED|Completed Gluten Challenge||10
8659393|NCT00931892|21378086|P2|STARTED|Completed Gluten Challenge||10
8659394|NCT00931892|21378087|P1|STARTED|Completed Gluten Challenge||10
8659395|NCT00813358|21378163|P1|NOT COMPLETED|Overall Study||69
8659396|NCT00813358|21378163|P1|COMPLETED|Overall Study||46
8659397|NCT00813358|21378163|P1|STARTED|Overall Study||115
8659401|NCT00233389|21378179|P2|NOT COMPLETED|Overall Study||16
8659402|NCT00233389|21378180|P1|NOT COMPLETED|Overall Study||18
8659403|NCT00233389|21378179|P2|COMPLETED|Overall Study||131
8659404|NCT00233389|21378180|P1|COMPLETED|Overall Study||136
8659405|NCT00233389|21378179|P2|STARTED|Overall Study||147
8659406|NCT00233389|21378180|P1|STARTED|Overall Study||154
8659407|NCT00233363|21378188|P2|NOT COMPLETED|Overall Study||5
8659408|NCT00233363|21378189|P1|NOT COMPLETED|Overall Study||3
8659409|NCT00233363|21378188|P2|COMPLETED|Overall Study||46
8659410|NCT00233363|21378189|P1|COMPLETED|Overall Study||50
8659411|NCT00233363|21378188|P2|STARTED|Overall Study||51
8659412|NCT00233363|21378189|P1|STARTED|Overall Study||53
8659413|NCT04430634|21378203|P8|NOT COMPLETED|Overall Study||0
8659414|NCT04430634|21378204|P7|NOT COMPLETED|Overall Study||1
8659415|NCT04430634|21378205|P6|NOT COMPLETED|Overall Study||0
8659416|NCT04430634|21378206|P5|NOT COMPLETED|Overall Study||0
8659417|NCT04430634|21378207|P4|NOT COMPLETED|Overall Study||1
8659418|NCT04430634|21378208|P3|NOT COMPLETED|Overall Study||0
8659419|NCT04430634|21378209|P2|NOT COMPLETED|Overall Study||0
8659420|NCT04430634|21378210|P1|NOT COMPLETED|Overall Study||0
8659421|NCT04430634|21378203|P8|COMPLETED|Overall Study||5
8659422|NCT04430634|21378204|P7|COMPLETED|Overall Study||4
8659423|NCT04430634|21378205|P6|COMPLETED|Overall Study||5
8659424|NCT04430634|21378206|P5|COMPLETED|Overall Study||5
8659425|NCT04430634|21378207|P4|COMPLETED|Overall Study||4
8659426|NCT04430634|21378208|P3|COMPLETED|Overall Study||5
8659427|NCT04430634|21378209|P2|COMPLETED|Overall Study||5
8659428|NCT04430634|21378210|P1|COMPLETED|Overall Study||5
8659429|NCT04430634|21378203|P8|STARTED|Overall Study||5
8659430|NCT04430634|21378204|P7|STARTED|Overall Study||5
8659431|NCT04430634|21378205|P6|STARTED|Overall Study||5
8659432|NCT04430634|21378206|P5|STARTED|Overall Study||5
8659433|NCT04430634|21378207|P4|STARTED|Overall Study||5
8659434|NCT04430634|21378208|P3|STARTED|Overall Study||5
8659435|NCT04430634|21378209|P2|STARTED|Overall Study||5
8659436|NCT04430634|21378210|P1|STARTED|Overall Study||5
8659437|NCT04429932|21378251|P8|NOT COMPLETED|Overall Study||0
8659438|NCT04429932|21378252|P7|NOT COMPLETED|Overall Study||0
8659439|NCT04429932|21378253|P6|NOT COMPLETED|Overall Study||0
8659440|NCT04429932|21378254|P5|NOT COMPLETED|Overall Study||0
8659441|NCT04429932|21378255|P4|NOT COMPLETED|Overall Study||3
8659442|NCT04429932|21378256|P3|NOT COMPLETED|Overall Study||0
8659443|NCT04429932|21378257|P2|NOT COMPLETED|Overall Study||0
8659444|NCT04429932|21378258|P1|NOT COMPLETED|Overall Study||1
8659445|NCT04429932|21378251|P8|COMPLETED|Overall Study||5
8659446|NCT04429932|21378252|P7|COMPLETED|Overall Study||5
8659447|NCT04429932|21378253|P6|COMPLETED|Overall Study||5
8659448|NCT04429932|21378254|P5|COMPLETED|Overall Study||5
8659449|NCT04429932|21378255|P4|COMPLETED|Overall Study||2
8659450|NCT04429932|21378256|P3|COMPLETED|Overall Study||5
8659451|NCT04429932|21378257|P2|COMPLETED|Overall Study||5
8659452|NCT04429932|21378258|P1|COMPLETED|Overall Study||3
8659453|NCT04429932|21378251|P8|STARTED|Overall Study||5
8659454|NCT04429932|21378252|P7|STARTED|Overall Study||5
8659455|NCT04429932|21378253|P6|STARTED|Overall Study||5
8659456|NCT04429932|21378254|P5|STARTED|Overall Study||5
8659457|NCT04429932|21378255|P4|STARTED|Overall Study||5
8659458|NCT04429932|21378256|P3|STARTED|Overall Study||5
8659459|NCT04429932|21378257|P2|STARTED|Overall Study||5
8659460|NCT04429932|21378258|P1|STARTED|Overall Study||4
8659467|NCT04161131|21378328|P1|NOT COMPLETED|Overall Study||6
8659468|NCT04161131|21378328|P1|COMPLETED|Overall Study||22
8659469|NCT04161131|21378328|P1|Received Intervention|Overall Study||22
8659470|NCT04161131|21378328|P1|Completed Baseline Surveys|Overall Study||27
8659471|NCT04161131|21378328|P1|STARTED|Overall Study||28
8659472|NCT04098172|21378347|P1|NOT COMPLETED|Overall Study||0
8659473|NCT04098172|21378347|P1|COMPLETED|Overall Study||39
8659474|NCT04098172|21378347|P1|STARTED|Overall Study||39
8659475|NCT03977155|21378355|P3|NOT COMPLETED|Overall Study||2
8659476|NCT03977155|21378356|P2|NOT COMPLETED|Overall Study||2
8659477|NCT03977155|21378357|P1|NOT COMPLETED|Overall Study||5
8659478|NCT03977155|21378355|P3|COMPLETED|Overall Study||40
8659479|NCT03977155|21378356|P2|COMPLETED|Overall Study||46
8659480|NCT03977155|21378357|P1|COMPLETED|Overall Study||38
8659481|NCT03977155|21378355|P3|STARTED|Overall Study||42
8659482|NCT03977155|21378356|P2|STARTED|Overall Study||48
8659483|NCT03977155|21378357|P1|STARTED|Overall Study||43
8659484|NCT03966911|21378399|P2|NOT COMPLETED|Overall Study||16
8659485|NCT03966911|21378400|P1|NOT COMPLETED|Overall Study||9
8659486|NCT03966911|21378399|P2|COMPLETED|Overall Study||126
8659487|NCT03966911|21378400|P1|COMPLETED|Overall Study||160
8659488|NCT03966911|21378399|P2|STARTED|Overall Study||142
8659489|NCT03966911|21378400|P1|STARTED|Overall Study||169
8659490|NCT03828487|21378408|P1|NOT COMPLETED|Overall Study||1
8659491|NCT03828487|21378408|P1|COMPLETED|Overall Study||7
8659492|NCT03828487|21378408|P1|STARTED|Overall Study||8
8659493|NCT03781037|21378412|P1|NOT COMPLETED|Overall Study||0
8659494|NCT03781037|21378412|P1|COMPLETED|Overall Study||18
8659495|NCT03781037|21378412|P1|STARTED|Overall Study||18
8659496|NCT03771963|21378423|P1|NOT COMPLETED|Overall Study||32
8659497|NCT03771963|21378423|P1|COMPLETED|Overall Study||168
8659498|NCT03771963|21378423|P1|STARTED|Overall Study||200
8659502|NCT03546647|21378446|P2|NOT COMPLETED|Overall Study||0
8659503|NCT03546647|21378447|P1|NOT COMPLETED|Overall Study||1
8659504|NCT03546647|21378446|P2|COMPLETED|Overall Study||17
8659505|NCT03546647|21378447|P1|COMPLETED|Overall Study||17
8659506|NCT03546647|21378446|P2|STARTED|Overall Study|34|17
8659507|NCT03546647|21378447|P1|STARTED|Overall Study||18
8659508|NCT03508830|21378455|P2|NOT COMPLETED|Overall Study||6
8659509|NCT03508830|21378456|P1|NOT COMPLETED|Overall Study||5
8659510|NCT03508830|21378455|P2|COMPLETED|Overall Study||39
8659511|NCT03508830|21378456|P1|COMPLETED|Overall Study||41
8659512|NCT03508830|21378455|P2|STARTED|Overall Study||45
8659513|NCT03508830|21378456|P1|STARTED|Overall Study||46
8659514|NCT03504852|21378471|P3|NOT COMPLETED|Overall Study||3
8659515|NCT03504852|21378472|P2|NOT COMPLETED|Overall Study||18
8659516|NCT03504852|21378473|P1|NOT COMPLETED|Overall Study||17
8659517|NCT03504852|21378471|P3|COMPLETED|Overall Study||28
8659518|NCT03504852|21378472|P2|COMPLETED|Overall Study||117
8659519|NCT03504852|21378473|P1|COMPLETED|Overall Study||148
8659520|NCT03504852|21378471|P3|STARTED|Overall Study||31
8659521|NCT03504852|21378472|P2|STARTED|Overall Study||135
8659522|NCT03504852|21378473|P1|STARTED|Overall Study||165
8659523|NCT03480022|21378488|P2|NOT COMPLETED|Overall Study||4
8659524|NCT03480022|21378489|P1|NOT COMPLETED|Overall Study||11
8659525|NCT03480022|21378488|P2|COMPLETED|Overall Study||23
8659526|NCT03480022|21378489|P1|COMPLETED|Overall Study||44
8659527|NCT03480022|21378488|P2|STARTED|Overall Study||27
8659528|NCT03480022|21378489|P1|STARTED|Overall Study||55
8659529|NCT03475992|21378554|P3|NOT COMPLETED|Overall Study||0
8659530|NCT03475992|21378555|P2|NOT COMPLETED|Overall Study||0
8659531|NCT03475992|21378556|P1|NOT COMPLETED|Overall Study||0
8659532|NCT03475992|21378554|P3|COMPLETED|Overall Study||5
8659533|NCT03475992|21378555|P2|COMPLETED|Overall Study||9
8659534|NCT03475992|21378556|P1|COMPLETED|Overall Study||11
8659535|NCT03475992|21378554|P3|STARTED|Overall Study||5
8659536|NCT03475992|21378555|P2|STARTED|Overall Study||9
8659537|NCT03475992|21378556|P1|STARTED|Overall Study||11
8659583|NCT03350503|21378614|P1|NOT COMPLETED|Overall Study||5
8659584|NCT03350503|21378614|P1|COMPLETED|Overall Study||116
8659585|NCT03350503|21378614|P1|STARTED|Overall Study||121
8659586|NCT03338998|21378620|P2|NOT COMPLETED|Safety Follow-Up Period||1
8659587|NCT03338998|21378621|P1|NOT COMPLETED|Safety Follow-Up Period||2
8659588|NCT03338998|21378620|P2|COMPLETED|Safety Follow-Up Period||12
8659589|NCT03338998|21378621|P1|COMPLETED|Safety Follow-Up Period||14
8659590|NCT03338998|21378620|P2|STARTED|Safety Follow-Up Period||13
8659591|NCT03338998|21378621|P1|STARTED|Safety Follow-Up Period||16
8659592|NCT03338998|21378620|P2|NOT COMPLETED|Treatment Period||3
8659593|NCT03338998|21378621|P1|NOT COMPLETED|Treatment Period||8
8659594|NCT03338998|21378620|P2|COMPLETED|Treatment Period||10
8659595|NCT03338998|21378621|P1|COMPLETED|Treatment Period||8
8659596|NCT03338998|21378620|P2|STARTED|Treatment Period||13
8659597|NCT03338998|21378621|P1|STARTED|Treatment Period||16
8659598|NCT03338894|21378628|P1|NOT COMPLETED|Overall Study||10
8659599|NCT03338894|21378628|P1|COMPLETED|Overall Study||56
8659600|NCT03338894|21378628|P1|STARTED|Overall Study||66
8659601|NCT03327402|21378633|P1|NOT COMPLETED|Overall Study||2
8659602|NCT03327402|21378633|P1|COMPLETED|Overall Study||22
8659603|NCT03327402|21378633|P1|Sparse PK Sampling Group|Overall Study||12
8659604|NCT03327402|21378633|P1|Rich PK Sampling Group|Overall Study||12
8659605|NCT03327402|21378633|P1|STARTED|Overall Study||24
8659606|NCT03260205|21378671|P5|NOT COMPLETED|Overall Study||14
8659607|NCT03260205|21378672|P4|NOT COMPLETED|Overall Study||7
8659608|NCT03260205|21378673|P3|NOT COMPLETED|Overall Study||11
8659609|NCT03260205|21378674|P2|NOT COMPLETED|Overall Study||8
8659610|NCT03260205|21378675|P1|NOT COMPLETED|Overall Study||9
8659611|NCT03260205|21378671|P5|COMPLETED|Overall Study||25
8659612|NCT03260205|21378672|P4|COMPLETED|Overall Study||30
8659613|NCT03260205|21378673|P3|COMPLETED|Overall Study||26
8659614|NCT03260205|21378674|P2|COMPLETED|Overall Study||32
8659615|NCT03260205|21378675|P1|COMPLETED|Overall Study||37
8659616|NCT03260205|21378671|P5|Received Treatment|Overall Study||38
8659617|NCT03260205|21378672|P4|Received Treatment|Overall Study||34
8659618|NCT03260205|21378673|P3|Received Treatment|Overall Study||35
8659619|NCT03260205|21378674|P2|Received Treatment|Overall Study||39
8659620|NCT03260205|21378675|P1|Received Treatment|Overall Study||45
8659621|NCT03260205|21378671|P5|STARTED|Overall Study||39
8659622|NCT03260205|21378672|P4|STARTED|Overall Study||37
8659623|NCT03260205|21378673|P3|STARTED|Overall Study||37
8659624|NCT03260205|21378674|P2|STARTED|Overall Study||40
8659625|NCT03260205|21378675|P1|STARTED|Overall Study||46
8659626|NCT03221387|21378736|P1|NOT COMPLETED|Overall Study||2
8659627|NCT03221387|21378736|P1|COMPLETED|Overall Study||28
8659628|NCT03221387|21378736|P1|STARTED|Overall Study||30
8659641|NCT03180528|21378773|P1|NOT COMPLETED|Overall Study||3
8659642|NCT03180528|21378773|P1|COMPLETED|Overall Study||27
8659643|NCT03180528|21378773|P1|STARTED|Overall Study||30
8659644|NCT03150108|21378782|P2|NOT COMPLETED|Overall Study||0
8659645|NCT03150108|21378783|P1|NOT COMPLETED|Overall Study||0
8659646|NCT03150108|21378782|P2|COMPLETED|Overall Study||12
8659647|NCT03150108|21378783|P1|COMPLETED|Overall Study||12
8659648|NCT03150108|21378782|P2|STARTED|Overall Study||12
8659649|NCT03150108|21378783|P1|STARTED|Overall Study||12
8659650|NCT03141281|21378877|P4|NOT COMPLETED|Overall Study||11
8659651|NCT03141281|21378878|P3|NOT COMPLETED|Overall Study||14
8659652|NCT03141281|21378879|P2|NOT COMPLETED|Overall Study||21
8659653|NCT03141281|21378880|P1|NOT COMPLETED|Overall Study||12
8659654|NCT03141281|21378877|P4|COMPLETED|Overall Study||47
8659655|NCT03141281|21378878|P3|COMPLETED|Overall Study||42
8659656|NCT03141281|21378879|P2|COMPLETED|Overall Study||38
8659657|NCT03141281|21378880|P1|COMPLETED|Overall Study||45
8659658|NCT03141281|21378877|P4|Post-Test|Overall Study||56
8659659|NCT03141281|21378878|P3|Post-Test|Overall Study||50
8659660|NCT03141281|21378879|P2|Post-Test|Overall Study||47
8659661|NCT03141281|21378880|P1|Post-Test|Overall Study||50
8659662|NCT03141281|21378877|P4|STARTED|Overall Study||58
8659663|NCT03141281|21378878|P3|STARTED|Overall Study||56
8659664|NCT03141281|21378879|P2|STARTED|Overall Study||59
8659665|NCT03141281|21378880|P1|STARTED|Overall Study||57
8659666|NCT03131167|21379027|P13|NOT COMPLETED|Overall Study||0
8659667|NCT03131167|21379028|P12|NOT COMPLETED|Overall Study||0
8659668|NCT03131167|21379029|P11|NOT COMPLETED|Overall Study||0
8659669|NCT03131167|21379030|P10|NOT COMPLETED|Overall Study||0
8659670|NCT03131167|21379031|P9|NOT COMPLETED|Overall Study||0
8659671|NCT03131167|21379032|P8|NOT COMPLETED|Overall Study||0
8659672|NCT03131167|21379033|P7|NOT COMPLETED|Overall Study||0
8659673|NCT03131167|21379034|P6|NOT COMPLETED|Overall Study||1
8659674|NCT03131167|21379035|P5|NOT COMPLETED|Overall Study||0
8659675|NCT03131167|21379036|P4|NOT COMPLETED|Overall Study||0
8659676|NCT03131167|21379037|P3|NOT COMPLETED|Overall Study||0
8659677|NCT03131167|21379038|P2|NOT COMPLETED|Overall Study||0
8659678|NCT03131167|21379039|P1|NOT COMPLETED|Overall Study||0
8659679|NCT03131167|21379027|P13|COMPLETED|Overall Study||5
8659680|NCT03131167|21379028|P12|COMPLETED|Overall Study||5
8659681|NCT03131167|21379029|P11|COMPLETED|Overall Study||4
8659682|NCT03131167|21379030|P10|COMPLETED|Overall Study||5
8659683|NCT03131167|21379031|P9|COMPLETED|Overall Study||2
8659684|NCT03131167|21379032|P8|COMPLETED|Overall Study||5
8659685|NCT03131167|21379033|P7|COMPLETED|Overall Study||5
8659686|NCT03131167|21379034|P6|COMPLETED|Overall Study||4
8659687|NCT03131167|21379035|P5|COMPLETED|Overall Study||6
8659688|NCT03131167|21379036|P4|COMPLETED|Overall Study||5
8659689|NCT03131167|21379037|P3|COMPLETED|Overall Study||5
8659690|NCT03131167|21379038|P2|COMPLETED|Overall Study||5
8659691|NCT03131167|21379039|P1|COMPLETED|Overall Study||6
8659692|NCT03131167|21379027|P13|STARTED|Overall Study||5
8659693|NCT03131167|21379028|P12|STARTED|Overall Study||5
8659694|NCT03131167|21379029|P11|STARTED|Overall Study||4
8659695|NCT03131167|21379030|P10|STARTED|Overall Study||5
8659696|NCT03131167|21379031|P9|STARTED|Overall Study||2
8659697|NCT03131167|21379032|P8|STARTED|Overall Study||5
8659698|NCT03131167|21379033|P7|STARTED|Overall Study||5
8659699|NCT03131167|21379034|P6|STARTED|Overall Study||5
8659700|NCT03131167|21379035|P5|STARTED|Overall Study||6
8659701|NCT03131167|21379036|P4|STARTED|Overall Study||5
8659702|NCT03131167|21379037|P3|STARTED|Overall Study||5
8659703|NCT03131167|21379038|P2|STARTED|Overall Study||5
8659704|NCT03131167|21379039|P1|STARTED|Overall Study||6
8659705|NCT03085017|21379082|P2|NOT COMPLETED|Overall Study||3
8659706|NCT03085017|21379083|P1|NOT COMPLETED|Overall Study||0
8659707|NCT03085017|21379082|P2|COMPLETED|Overall Study||24
8659708|NCT03085017|21379083|P1|COMPLETED|Overall Study||30
8659709|NCT03085017|21379082|P2|STARTED|Overall Study||27
8659710|NCT03085017|21379083|P1|STARTED|Overall Study||30
8659711|NCT02999191|21379110|P3|NOT COMPLETED|Treatment Period 3 [1 Day]||0
8659712|NCT02999191|21379111|P2|NOT COMPLETED|Treatment Period 3 [1 Day]||0
8659713|NCT02999191|21379112|P1|NOT COMPLETED|Treatment Period 3 [1 Day]||0
8659714|NCT02999191|21379110|P3|COMPLETED|Treatment Period 3 [1 Day]||6
8659715|NCT02999191|21379111|P2|COMPLETED|Treatment Period 3 [1 Day]||6
8659716|NCT02999191|21379112|P1|COMPLETED|Treatment Period 3 [1 Day]||6
8659717|NCT02999191|21379110|P3|STARTED|Treatment Period 3 [1 Day]||6
8659718|NCT02999191|21379111|P2|STARTED|Treatment Period 3 [1 Day]||6
8659719|NCT02999191|21379112|P1|STARTED|Treatment Period 3 [1 Day]||6
8659720|NCT02999191|21379110|P3|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
8659721|NCT02999191|21379111|P2|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
8659722|NCT02999191|21379112|P1|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
8659723|NCT02999191|21379110|P3|COMPLETED|Wash-out Period 2 [21 Days]||6
8659724|NCT02999191|21379111|P2|COMPLETED|Wash-out Period 2 [21 Days]||5
8659725|NCT02999191|21379112|P1|COMPLETED|Wash-out Period 2 [21 Days]||6
8659726|NCT02999191|21379110|P3|STARTED|Wash-out Period 2 [21 Days]||6
8659727|NCT02999191|21379111|P2|STARTED|Wash-out Period 2 [21 Days]||5
8659728|NCT02999191|21379112|P1|STARTED|Wash-out Period 2 [21 Days]||6
8659729|NCT02999191|21379110|P3|NOT COMPLETED|Treatment Period 2 [1 Day]||0
8659730|NCT02999191|21379111|P2|NOT COMPLETED|Treatment Period 2 [1 Day]||0
8659731|NCT02999191|21379112|P1|NOT COMPLETED|Treatment Period 2 [1 Day]||0
8659732|NCT02999191|21379110|P3|COMPLETED|Treatment Period 2 [1 Day]||6
8659733|NCT02999191|21379111|P2|COMPLETED|Treatment Period 2 [1 Day]||5
8659734|NCT02999191|21379112|P1|COMPLETED|Treatment Period 2 [1 Day]||6
8659735|NCT02999191|21379110|P3|STARTED|Treatment Period 2 [1 Day]||6
8659736|NCT02999191|21379111|P2|STARTED|Treatment Period 2 [1 Day]||5
8659737|NCT02999191|21379112|P1|STARTED|Treatment Period 2 [1 Day]||6
8659738|NCT02999191|21379110|P3|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
8659739|NCT02999191|21379111|P2|NOT COMPLETED|Wash-out Period 1 [21 Days]||1
8659740|NCT02999191|21379112|P1|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
8659741|NCT02999191|21379110|P3|COMPLETED|Wash-out Period 1 [21 Days]||6
8659742|NCT02999191|21379111|P2|COMPLETED|Wash-out Period 1 [21 Days]||5
8659743|NCT02999191|21379112|P1|COMPLETED|Wash-out Period 1 [21 Days]||6
8659744|NCT02999191|21379110|P3|STARTED|Wash-out Period 1 [21 Days]||6
8659745|NCT02999191|21379111|P2|STARTED|Wash-out Period 1 [21 Days]||6
8659746|NCT02999191|21379112|P1|STARTED|Wash-out Period 1 [21 Days]||6
8659747|NCT02999191|21379110|P3|NOT COMPLETED|Treatment Period 1 [1 Day]||0
8659748|NCT02999191|21379111|P2|NOT COMPLETED|Treatment Period 1 [1 Day]||0
8659749|NCT02999191|21379112|P1|NOT COMPLETED|Treatment Period 1 [1 Day]||0
8659750|NCT02999191|21379110|P3|COMPLETED|Treatment Period 1 [1 Day]||6
8659751|NCT02999191|21379111|P2|COMPLETED|Treatment Period 1 [1 Day]||6
8659752|NCT02999191|21379112|P1|COMPLETED|Treatment Period 1 [1 Day]||6
8659753|NCT02999191|21379110|P3|STARTED|Treatment Period 1 [1 Day]||6
8659754|NCT02999191|21379111|P2|STARTED|Treatment Period 1 [1 Day]||6
8659755|NCT02999191|21379112|P1|STARTED|Treatment Period 1 [1 Day]||6
8659756|NCT02943460|21379126|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||2
8659757|NCT02943460|21379127|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||7
8659758|NCT02943460|21379128|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||5
8659759|NCT02943460|21379126|P3|COMPLETED|Open Label Extension (OLE) Phase||8
8659760|NCT02943460|21379127|P2|COMPLETED|Open Label Extension (OLE) Phase||11
8659761|NCT02943460|21379128|P1|COMPLETED|Open Label Extension (OLE) Phase||14
8659762|NCT02943460|21379126|P3|STARTED|Open Label Extension (OLE) Phase||10
8659763|NCT02943460|21379127|P2|STARTED|Open Label Extension (OLE) Phase|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18
8659764|NCT02943460|21379128|P1|STARTED|Open Label Extension (OLE) Phase||19
8659765|NCT02943460|21379126|P3|NOT COMPLETED|Blinded Study Phase||0
8659766|NCT02943460|21379127|P2|NOT COMPLETED|Blinded Study Phase||1
8659767|NCT02943460|21379128|P1|NOT COMPLETED|Blinded Study Phase||3
8659768|NCT02943460|21379126|P3|COMPLETED|Blinded Study Phase||10
8659769|NCT02943460|21379127|P2|COMPLETED|Blinded Study Phase||19
8659770|NCT02943460|21379128|P1|COMPLETED|Blinded Study Phase||19
8659771|NCT02943460|21379126|P3|STARTED|Blinded Study Phase||10
8659772|NCT02943460|21379127|P2|STARTED|Blinded Study Phase||20
8659773|NCT02943460|21379128|P1|STARTED|Blinded Study Phase||22
8659774|NCT02905435|21379143|P1|NOT COMPLETED|Overall Study||7
8659775|NCT02905435|21379143|P1|COMPLETED|Overall Study||7
8659776|NCT02905435|21379143|P1|STARTED|Overall Study||14
8659777|NCT02901275|21379162|P1|NOT COMPLETED|Overall Study||0
8659778|NCT02901275|21379162|P1|COMPLETED|Overall Study||29
8659779|NCT02901275|21379162|P1|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 10mg|Overall Study||29
8659780|NCT02901275|21379162|P1|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 5mg|Overall Study||29
8659781|NCT02901275|21379162|P1|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 2.5mg|Overall Study||29
8659782|NCT02901275|21379162|P1|Hydromorphone (Oral) 4mg + Placebo|Overall Study||29
8659783|NCT02901275|21379162|P1|Placebo + Placebo|Overall Study||29
8659784|NCT02901275|21379162|P1|STARTED|Overall Study||29
8659785|NCT02862548|21379186|P2|NOT COMPLETED|Open-Label Extension Phase||24
8659786|NCT02862548|21379187|P1|NOT COMPLETED|Open-Label Extension Phase||26
8659787|NCT02862548|21379186|P2|COMPLETED|Open-Label Extension Phase||0
8659788|NCT02862548|21379187|P1|COMPLETED|Open-Label Extension Phase||0
8659789|NCT02862548|21379186|P2|STARTED|Open-Label Extension Phase||24
8659790|NCT02862548|21379187|P1|STARTED|Open-Label Extension Phase||26
8659791|NCT02862548|21379186|P2|NOT COMPLETED|Open-Label Phase||1
8659792|NCT02862548|21379187|P1|NOT COMPLETED|Open-Label Phase||0
8659793|NCT02862548|21379186|P2|COMPLETED|Open-Label Phase||24
8659794|NCT02862548|21379187|P1|COMPLETED|Open-Label Phase||26
8659795|NCT02862548|21379186|P2|STARTED|Open-Label Phase||25
8659796|NCT02862548|21379187|P1|STARTED|Open-Label Phase||26
8659797|NCT02861586|21379219|P8|NOT COMPLETED|Overall Study||0
8659798|NCT02861586|21379220|P7|NOT COMPLETED|Overall Study||1
8659799|NCT02861586|21379221|P6|NOT COMPLETED|Overall Study||5
8659800|NCT02861586|21379222|P5|NOT COMPLETED|Overall Study||0
8659801|NCT02861586|21379223|P4|NOT COMPLETED|Overall Study||0
8659802|NCT02861586|21379224|P3|NOT COMPLETED|Overall Study||1
8659803|NCT02861586|21379225|P2|NOT COMPLETED|Overall Study||3
8659804|NCT02861586|21379226|P1|NOT COMPLETED|Overall Study||4
8659805|NCT02861586|21379219|P8|COMPLETED|Overall Study||16
8659806|NCT02861586|21379220|P7|COMPLETED|Overall Study||17
8659807|NCT02861586|21379221|P6|COMPLETED|Overall Study||45
8659808|NCT02861586|21379222|P5|COMPLETED|Overall Study||47
8659809|NCT02861586|21379223|P4|COMPLETED|Overall Study||16
8659810|NCT02861586|21379224|P3|COMPLETED|Overall Study||46
8659811|NCT02861586|21379225|P2|COMPLETED|Overall Study||15
8659812|NCT02861586|21379226|P1|COMPLETED|Overall Study||47
8659813|NCT02861586|21379219|P8|STARTED|Overall Study||16
8659814|NCT02861586|21379220|P7|STARTED|Overall Study||18
8659815|NCT02861586|21379221|P6|STARTED|Overall Study||50
8659816|NCT02861586|21379222|P5|STARTED|Overall Study||47
8659817|NCT02861586|21379223|P4|STARTED|Overall Study||16
8659818|NCT02861586|21379224|P3|STARTED|Overall Study||47
8659819|NCT02861586|21379225|P2|STARTED|Overall Study||18
8659820|NCT02861586|21379226|P1|STARTED|Overall Study||51
8659821|NCT02842242|21379302|P2|NOT COMPLETED|Overall Study||0
8659822|NCT02842242|21379303|P1|NOT COMPLETED|Overall Study||1
8659823|NCT02842242|21379302|P2|COMPLETED|Overall Study||10
8659824|NCT02842242|21379303|P1|COMPLETED|Overall Study||10
8659825|NCT02842242|21379302|P2|STARTED|Overall Study||10
8659826|NCT02842242|21379303|P1|STARTED|Overall Study||11
8659827|NCT02741596|21379327|P2|NOT COMPLETED|Overall Study||78
8659828|NCT02741596|21379328|P1|NOT COMPLETED|Overall Study||78
8659829|NCT02741596|21379327|P2|COMPLETED|Overall Study||25
8659830|NCT02741596|21379328|P1|COMPLETED|Overall Study||31
8659831|NCT02741596|21379327|P2|STARTED|Overall Study||103
8659832|NCT02741596|21379328|P1|STARTED|Overall Study||109
8659833|NCT02733627|21379348|P4|NOT COMPLETED|Overall Study||0
8659834|NCT02733627|21379349|P3|NOT COMPLETED|Overall Study||2
8659835|NCT02733627|21379350|P2|NOT COMPLETED|Overall Study||1
8659836|NCT02733627|21379351|P1|NOT COMPLETED|Overall Study||0
8659837|NCT02733627|21379348|P4|COMPLETED|Overall Study||9
8659838|NCT02733627|21379349|P3|COMPLETED|Overall Study||7
8659839|NCT02733627|21379350|P2|COMPLETED|Overall Study||8
8659840|NCT02733627|21379351|P1|COMPLETED|Overall Study||9
8659841|NCT02733627|21379348|P4|STARTED|Overall Study||9
8659842|NCT02733627|21379349|P3|STARTED|Overall Study||9
8659843|NCT02733627|21379350|P2|STARTED|Overall Study||9
8659844|NCT02733627|21379351|P1|STARTED|Overall Study||9
8659863|NCT02674685|21379390|P1|NOT COMPLETED|Overall Study||4
8659864|NCT02674685|21379390|P1|COMPLETED|Overall Study||233
8659865|NCT02674685|21379390|P1|STARTED|Overall Study||237
8659866|NCT02605837|21379406|P2|NOT COMPLETED|Overall Study||11
8659867|NCT02605837|21379407|P1|NOT COMPLETED|Overall Study||11
8659868|NCT02605837|21379406|P2|COMPLETED|Overall Study||202
8659869|NCT02605837|21379407|P1|COMPLETED|Overall Study||94
8659870|NCT02605837|21379406|P2|STARTED|Overall Study||213
8659871|NCT02605837|21379407|P1|STARTED|Overall Study||105
8659872|NCT02584959|21379447|P3|NOT COMPLETED|Period 2||2
8659873|NCT02584959|21379448|P2|NOT COMPLETED|Period 2||1
8659874|NCT02584959|21379449|P1|NOT COMPLETED|Period 2||6
8659875|NCT02584959|21379447|P3|COMPLETED|Period 2||13
8659876|NCT02584959|21379448|P2|COMPLETED|Period 2||24
8659877|NCT02584959|21379449|P1|COMPLETED|Period 2||22
8659878|NCT02584959|21379447|P3|STARTED|Period 2||15
8659879|NCT02584959|21379448|P2|STARTED|Period 2||25
8659880|NCT02584959|21379449|P1|STARTED|Period 2||28
8659881|NCT02584959|21379447|P3|NOT COMPLETED|Period 1||0
8659882|NCT02584959|21379448|P2|NOT COMPLETED|Period 1||4
8659883|NCT02584959|21379449|P1|NOT COMPLETED|Period 1||3
8659884|NCT02584959|21379447|P3|COMPLETED|Period 1||15
8659885|NCT02584959|21379448|P2|COMPLETED|Period 1||25
8659886|NCT02584959|21379449|P1|COMPLETED|Period 1||28
8659887|NCT02584959|21379447|P3|STARTED|Period 1||15
8659888|NCT02584959|21379448|P2|STARTED|Period 1||29
8659889|NCT02584959|21379449|P1|STARTED|Period 1||31
8659890|NCT02567227|21379506|P2|NOT COMPLETED|12 Months||34
8659891|NCT02567227|21379507|P1|NOT COMPLETED|12 Months||31
8659892|NCT02567227|21379506|P2|COMPLETED|12 Months||93
8659893|NCT02567227|21379507|P1|COMPLETED|12 Months||82
8659894|NCT02567227|21379506|P2|STARTED|12 Months||127
8659895|NCT02567227|21379507|P1|STARTED|12 Months||113
8659896|NCT02567227|21379506|P2|NOT COMPLETED|6 Month||40
8659897|NCT02567227|21379507|P1|NOT COMPLETED|6 Month||45
8659898|NCT02567227|21379506|P2|COMPLETED|6 Month||127
8659899|NCT02567227|21379507|P1|COMPLETED|6 Month||113
8659900|NCT02567227|21379506|P2|STARTED|6 Month||167
8659901|NCT02567227|21379507|P1|STARTED|6 Month||158
8659902|NCT02567227|21379506|P2|NOT COMPLETED|9 Weeks||24
8659903|NCT02567227|21379507|P1|NOT COMPLETED|9 Weeks||34
8659904|NCT02567227|21379506|P2|COMPLETED|9 Weeks||167
8659905|NCT02567227|21379507|P1|COMPLETED|9 Weeks||158
8659906|NCT02567227|21379506|P2|STARTED|9 Weeks||191
8659907|NCT02567227|21379507|P1|STARTED|9 Weeks||192
8659920|NCT02473614|21379596|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
8659921|NCT02473614|21379597|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
8659922|NCT02473614|21379596|P2|COMPLETED|Second Intervention (3 Weeks)||5
8659923|NCT02473614|21379597|P1|COMPLETED|Second Intervention (3 Weeks)||5
8659924|NCT02473614|21379596|P2|STARTED|Second Intervention (3 Weeks)||5
8659925|NCT02473614|21379597|P1|STARTED|Second Intervention (3 Weeks)||5
8659926|NCT02473614|21379596|P2|NOT COMPLETED|Wash Out Period (3 Weeks)||0
8659927|NCT02473614|21379597|P1|NOT COMPLETED|Wash Out Period (3 Weeks)||0
8659928|NCT02473614|21379596|P2|COMPLETED|Wash Out Period (3 Weeks)||5
8659929|NCT02473614|21379597|P1|COMPLETED|Wash Out Period (3 Weeks)||5
8659930|NCT02473614|21379596|P2|STARTED|Wash Out Period (3 Weeks)||5
8659931|NCT02473614|21379597|P1|STARTED|Wash Out Period (3 Weeks)||5
8659932|NCT02473614|21379596|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
8659933|NCT02473614|21379597|P1|NOT COMPLETED|First Intervention (3 Weeks)||1
8659934|NCT02473614|21379596|P2|COMPLETED|First Intervention (3 Weeks)||5
8659935|NCT02473614|21379597|P1|COMPLETED|First Intervention (3 Weeks)||5
8659936|NCT02473614|21379596|P2|STARTED|First Intervention (3 Weeks)||5
8659937|NCT02473614|21379597|P1|STARTED|First Intervention (3 Weeks)||6
8659938|NCT02420223|21379607|P2|NOT COMPLETED|Overall Study||2
8659939|NCT02420223|21379608|P1|NOT COMPLETED|Overall Study||1
8659940|NCT02420223|21379607|P2|COMPLETED|Overall Study||11
8659941|NCT02420223|21379608|P1|COMPLETED|Overall Study||11
8659942|NCT02420223|21379607|P2|STARTED|Overall Study||13
8659943|NCT02420223|21379608|P1|STARTED|Overall Study||12
8659944|NCT02402166|21379626|P1|NOT COMPLETED|Overall Study||5
8659945|NCT02402166|21379626|P1|COMPLETED|Overall Study||19
8659946|NCT02402166|21379626|P1|STARTED|Overall Study||24
8659947|NCT02317042|21379647|P2|NOT COMPLETED|Overall Study||0
8659948|NCT02317042|21379648|P1|NOT COMPLETED|Overall Study||0
8659949|NCT02317042|21379647|P2|COMPLETED|Overall Study||14
8659950|NCT02317042|21379648|P1|COMPLETED|Overall Study||11
8659951|NCT02317042|21379647|P2|STARTED|Overall Study||14
8659952|NCT02317042|21379648|P1|STARTED|Overall Study||11
8659953|NCT02310100|21379686|P1|NOT COMPLETED|Overall Study||18
8659954|NCT02310100|21379686|P1|COMPLETED|Overall Study||160
8659955|NCT02310100|21379686|P1|STARTED|Overall Study|First enrollment|178
8659967|NCT02251548|21379756|P1|NOT COMPLETED|Overall Study||85
8659968|NCT02251548|21379756|P1|COMPLETED|Overall Study||0
8659969|NCT02251548|21379756|P1|STARTED|Overall Study||85
8659970|NCT02181556|21379762|P1|NOT COMPLETED|Overall Study||1
8659971|NCT02181556|21379762|P1|COMPLETED|Overall Study||40
8659972|NCT02181556|21379762|P1|STARTED|Overall Study||41
8659973|NCT02096588|21379770|P2|NOT COMPLETED|Overall Study||1
8659974|NCT02096588|21379771|P1|NOT COMPLETED|Overall Study||2
8659975|NCT02096588|21379770|P2|COMPLETED|Overall Study||15
8659976|NCT02096588|21379771|P1|COMPLETED|Overall Study||13
8659977|NCT02096588|21379770|P2|STARTED|Overall Study||16
8659978|NCT02096588|21379771|P1|STARTED|Overall Study||15
8659979|NCT02060526|21379782|P3|NOT COMPLETED|Overall Study||0
8659980|NCT02060526|21379783|P2|NOT COMPLETED|Overall Study||0
8659981|NCT02060526|21379784|P1|NOT COMPLETED|Overall Study||0
8659982|NCT02060526|21379782|P3|COMPLETED|Overall Study||7
8659983|NCT02060526|21379783|P2|COMPLETED|Overall Study||7
8659984|NCT02060526|21379784|P1|COMPLETED|Overall Study||7
8659985|NCT02060526|21379782|P3|STARTED|Overall Study||7
8659986|NCT02060526|21379783|P2|STARTED|Overall Study||7
8659987|NCT02060526|21379784|P1|STARTED|Overall Study||7
8659988|NCT02009332|21379826|P6|NOT COMPLETED|Phase 2 (Weeks 206-252)||1
8659989|NCT02009332|21379827|P5|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
8659990|NCT02009332|21379828|P4|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
8659991|NCT02009332|21379829|P3|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
8659992|NCT02009332|21379830|P2|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
8659993|NCT02009332|21379831|P1|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
8659994|NCT02009332|21379826|P6|COMPLETED|Phase 2 (Weeks 206-252)|Phase 2 stopped due to lack of efficacy.|5
8659995|NCT02009332|21379827|P5|COMPLETED|Phase 2 (Weeks 206-252)||0
8659996|NCT02009332|21379828|P4|COMPLETED|Phase 2 (Weeks 206-252)||0
8659997|NCT02009332|21379829|P3|COMPLETED|Phase 2 (Weeks 206-252)||0
8659998|NCT02009332|21379830|P2|COMPLETED|Phase 2 (Weeks 206-252)||0
8659999|NCT02009332|21379831|P1|COMPLETED|Phase 2 (Weeks 206-252)||0
8660000|NCT02009332|21379826|P6|STARTED|Phase 2 (Weeks 206-252)||6
8660001|NCT02009332|21379827|P5|STARTED|Phase 2 (Weeks 206-252)||0
8660002|NCT02009332|21379828|P4|STARTED|Phase 2 (Weeks 206-252)||0
8660003|NCT02009332|21379829|P3|STARTED|Phase 2 (Weeks 206-252)||0
8660004|NCT02009332|21379830|P2|STARTED|Phase 2 (Weeks 206-252)||0
8660005|NCT02009332|21379831|P1|STARTED|Phase 2 (Weeks 206-252)||0
8660006|NCT02009332|21379826|P6|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660007|NCT02009332|21379827|P5|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||1
8660008|NCT02009332|21379828|P4|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660009|NCT02009332|21379829|P3|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660010|NCT02009332|21379830|P2|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660011|NCT02009332|21379831|P1|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660012|NCT02009332|21379826|P6|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660013|NCT02009332|21379827|P5|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)|Cohort 4 completed 6-week treatment.|3
8660014|NCT02009332|21379828|P4|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660015|NCT02009332|21379829|P3|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660016|NCT02009332|21379830|P2|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660017|NCT02009332|21379831|P1|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660018|NCT02009332|21379826|P6|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660019|NCT02009332|21379827|P5|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||4
8660020|NCT02009332|21379828|P4|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660021|NCT02009332|21379829|P3|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660022|NCT02009332|21379830|P2|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660023|NCT02009332|21379831|P1|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
8660024|NCT02009332|21379826|P6|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660025|NCT02009332|21379827|P5|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660026|NCT02009332|21379828|P4|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660027|NCT02009332|21379829|P3|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660028|NCT02009332|21379830|P2|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660029|NCT02009332|21379831|P1|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660030|NCT02009332|21379826|P6|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660031|NCT02009332|21379827|P5|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660032|NCT02009332|21379828|P4|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)|Cohort 3 completed 6-week treatment.|3
8660033|NCT02009332|21379829|P3|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660034|NCT02009332|21379830|P2|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660035|NCT02009332|21379831|P1|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660036|NCT02009332|21379826|P6|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660037|NCT02009332|21379827|P5|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660038|NCT02009332|21379828|P4|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||3
8660039|NCT02009332|21379829|P3|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660040|NCT02009332|21379830|P2|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660041|NCT02009332|21379831|P1|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
8660042|NCT02009332|21379826|P6|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8660043|NCT02009332|21379827|P5|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8660044|NCT02009332|21379828|P4|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8660045|NCT02009332|21379829|P3|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8660046|NCT02009332|21379830|P2|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
8660047|NCT02009332|21379831|P1|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8660048|NCT02009332|21379826|P6|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8660049|NCT02009332|21379827|P5|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8660050|NCT02009332|21379828|P4|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8660051|NCT02009332|21379829|P3|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2b stopped due to lack of enrollment.|1
8660052|NCT02009332|21379830|P2|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2 completed 6-week treatment.|3
8660053|NCT02009332|21379831|P1|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8660054|NCT02009332|21379826|P6|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8660055|NCT02009332|21379827|P5|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8660056|NCT02009332|21379828|P4|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8660057|NCT02009332|21379829|P3|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
8660058|NCT02009332|21379830|P2|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||4
8660059|NCT02009332|21379831|P1|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
8660060|NCT02009332|21379826|P6|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660061|NCT02009332|21379827|P5|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660062|NCT02009332|21379828|P4|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660063|NCT02009332|21379829|P3|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660064|NCT02009332|21379830|P2|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660065|NCT02009332|21379831|P1|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660066|NCT02009332|21379826|P6|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660067|NCT02009332|21379827|P5|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660068|NCT02009332|21379828|P4|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660069|NCT02009332|21379829|P3|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660070|NCT02009332|21379830|P2|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660071|NCT02009332|21379831|P1|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)|Cohort 1 completed 6-week treatment.|3
8660072|NCT02009332|21379826|P6|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660073|NCT02009332|21379827|P5|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660074|NCT02009332|21379828|P4|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660075|NCT02009332|21379829|P3|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660076|NCT02009332|21379830|P2|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
8660077|NCT02009332|21379831|P1|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||3
8660078|NCT01921166|21379852|P2|NOT COMPLETED|Overall Study||0
8660079|NCT01921166|21379853|P1|NOT COMPLETED|Overall Study||0
8660080|NCT01921166|21379852|P2|COMPLETED|Overall Study||15
8660081|NCT01921166|21379853|P1|COMPLETED|Overall Study||8
8660082|NCT01921166|21379852|P2|STARTED|Overall Study||15
8660083|NCT01921166|21379853|P1|STARTED|Overall Study||8
8660084|NCT01919801|21379863|P2|NOT COMPLETED|Overall Study||3
8660085|NCT01919801|21379864|P1|NOT COMPLETED|Overall Study||1
8660086|NCT01919801|21379863|P2|COMPLETED|Overall Study||57
8660087|NCT01919801|21379864|P1|COMPLETED|Overall Study||60
8660088|NCT01919801|21379863|P2|STARTED|Overall Study||60
8660089|NCT01919801|21379864|P1|STARTED|Overall Study||61
8660093|NCT01806584|21379893|P2|NOT COMPLETED|Overall Study||18
8660094|NCT01806584|21379894|P1|NOT COMPLETED|Overall Study||14
8660095|NCT01806584|21379893|P2|COMPLETED|Overall Study||0
8660096|NCT01806584|21379894|P1|COMPLETED|Overall Study||0
8660097|NCT01806584|21379893|P2|STARTED|Overall Study||18
8660098|NCT01806584|21379894|P1|STARTED|Overall Study||14
8660099|NCT01806545|21379908|P2|NOT COMPLETED|Overall Study||5
8660100|NCT01806545|21379909|P1|NOT COMPLETED|Overall Study||6
8660101|NCT01806545|21379908|P2|COMPLETED|Overall Study||30
8660102|NCT01806545|21379909|P1|COMPLETED|Overall Study||23
8660103|NCT01806545|21379908|P2|STARTED|Overall Study||35
8660104|NCT01806545|21379909|P1|STARTED|Overall Study||29
8660108|NCT01739933|21379938|P2|NOT COMPLETED|Overall Study||107
8660109|NCT01739933|21379939|P1|NOT COMPLETED|Overall Study||106
8660110|NCT01739933|21379938|P2|COMPLETED|Overall Study|91% of those eligible (alive and who did not withdraw)|101
8660111|NCT01739933|21379939|P1|COMPLETED|Overall Study|97% of those eligible (alive and who did not withdraw)|108
8660112|NCT01739933|21379938|P2|Discharged From Hospital and Eligible for Follow-up|Overall Study||147
8660113|NCT01739933|21379939|P1|Discharged From Hospital and Eligible for Follow-up|Overall Study||140
8660114|NCT01739933|21379938|P2|STARTED|Overall Study|Underwent randomization and received study drug|208
8660115|NCT01739933|21379939|P1|STARTED|Overall Study|Underwent randomization and received study drug|214
8660116|NCT01718483|21379953|P2|NOT COMPLETED|Overall Study||34
8660117|NCT01718483|21379954|P1|NOT COMPLETED|Overall Study||34
8660118|NCT01718483|21379953|P2|COMPLETED|Overall Study||158
8660119|NCT01718483|21379954|P1|COMPLETED|Overall Study||157
8660120|NCT01718483|21379953|P2|Treated|Overall Study||192
8660121|NCT01718483|21379954|P1|Treated|Overall Study||187
8660122|NCT01718483|21379953|P2|STARTED|Overall Study||192
8660123|NCT01718483|21379954|P1|STARTED|Overall Study||191
8660124|NCT01667406|21380008|P10|NOT COMPLETED|Overall Study||0
8660125|NCT01667406|21380009|P9|NOT COMPLETED|Overall Study||0
8660126|NCT01667406|21380010|P8|NOT COMPLETED|Overall Study||0
8660127|NCT01667406|21380011|P7|NOT COMPLETED|Overall Study||0
8660128|NCT01667406|21380012|P6|NOT COMPLETED|Overall Study||0
8660129|NCT01667406|21380013|P5|NOT COMPLETED|Overall Study||0
8660130|NCT01667406|21380014|P4|NOT COMPLETED|Overall Study||0
8660131|NCT01667406|21380015|P3|NOT COMPLETED|Overall Study||0
8660132|NCT01667406|21380016|P2|NOT COMPLETED|Overall Study||0
8660133|NCT01667406|21380017|P1|NOT COMPLETED|Overall Study||0
8660134|NCT01667406|21380008|P10|COMPLETED|Overall Study||31
8660135|NCT01667406|21380009|P9|COMPLETED|Overall Study||31
8660136|NCT01667406|21380010|P8|COMPLETED|Overall Study||20
8660137|NCT01667406|21380011|P7|COMPLETED|Overall Study||15
8660138|NCT01667406|21380012|P6|COMPLETED|Overall Study||20
8660139|NCT01667406|21380013|P5|COMPLETED|Overall Study||5
8660140|NCT01667406|21380014|P4|COMPLETED|Overall Study||24
8660141|NCT01667406|21380015|P3|COMPLETED|Overall Study||24
8660142|NCT01667406|21380016|P2|COMPLETED|Overall Study||3
8660143|NCT01667406|21380017|P1|COMPLETED|Overall Study||2
8660144|NCT01667406|21380008|P10|STARTED|Overall Study||31
8660145|NCT01667406|21380009|P9|STARTED|Overall Study||31
8660146|NCT01667406|21380010|P8|STARTED|Overall Study||20
8660147|NCT01667406|21380011|P7|STARTED|Overall Study||15
8660148|NCT01667406|21380012|P6|STARTED|Overall Study||20
8660149|NCT01667406|21380013|P5|STARTED|Overall Study||5
8660150|NCT01667406|21380014|P4|STARTED|Overall Study||24
8660151|NCT01667406|21380015|P3|STARTED|Overall Study||24
8660152|NCT01667406|21380016|P2|STARTED|Overall Study||3
8660153|NCT01667406|21380017|P1|STARTED|Overall Study||2
8660154|NCT01642212|21380091|P5|NOT COMPLETED|Open-label Extension||8
8660155|NCT01642212|21380092|P4|NOT COMPLETED|Open-label Extension||10
8660156|NCT01642212|21380093|P3|NOT COMPLETED|Open-label Extension||0
8660157|NCT01642212|21380094|P2|NOT COMPLETED|Open-label Extension||0
8660158|NCT01642212|21380095|P1|NOT COMPLETED|Open-label Extension||0
8660159|NCT01642212|21380091|P5|COMPLETED|Open-label Extension||37
8660160|NCT01642212|21380092|P4|COMPLETED|Open-label Extension||27
8660161|NCT01642212|21380093|P3|COMPLETED|Open-label Extension||0
8660162|NCT01642212|21380094|P2|COMPLETED|Open-label Extension||0
8660163|NCT01642212|21380095|P1|COMPLETED|Open-label Extension||0
8660164|NCT01642212|21380091|P5|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
8660165|NCT01642212|21380092|P4|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
8660166|NCT01642212|21380093|P3|STARTED|Open-label Extension||0
8660167|NCT01642212|21380094|P2|STARTED|Open-label Extension||0
8660168|NCT01642212|21380095|P1|STARTED|Open-label Extension||0
8660169|NCT01642212|21380091|P5|NOT COMPLETED|Double-blind Treatment||0
8660170|NCT01642212|21380092|P4|NOT COMPLETED|Double-blind Treatment||0
8660171|NCT01642212|21380093|P3|NOT COMPLETED|Double-blind Treatment||2
8660172|NCT01642212|21380094|P2|NOT COMPLETED|Double-blind Treatment||3
8660173|NCT01642212|21380095|P1|NOT COMPLETED|Double-blind Treatment||0
8660174|NCT01642212|21380091|P5|COMPLETED|Double-blind Treatment||0
8660175|NCT01642212|21380092|P4|COMPLETED|Double-blind Treatment||0
8660176|NCT01642212|21380093|P3|COMPLETED|Double-blind Treatment||49
8660177|NCT01642212|21380094|P2|COMPLETED|Double-blind Treatment||39
8660178|NCT01642212|21380095|P1|COMPLETED|Double-blind Treatment||0
8660179|NCT01642212|21380091|P5|STARTED|Double-blind Treatment||0
8660180|NCT01642212|21380092|P4|STARTED|Double-blind Treatment||0
8660181|NCT01642212|21380093|P3|STARTED|Double-blind Treatment||51
8660182|NCT01642212|21380094|P2|STARTED|Double-blind Treatment||42
8660183|NCT01642212|21380095|P1|STARTED|Double-blind Treatment||0
8660184|NCT01642212|21380091|P5|NOT COMPLETED|Single-blind Baseline||0
8660185|NCT01642212|21380092|P4|NOT COMPLETED|Single-blind Baseline||0
8660186|NCT01642212|21380093|P3|NOT COMPLETED|Single-blind Baseline||0
8660187|NCT01642212|21380094|P2|NOT COMPLETED|Single-blind Baseline||0
8660188|NCT01642212|21380095|P1|NOT COMPLETED|Single-blind Baseline||26
8660189|NCT01642212|21380091|P5|COMPLETED|Single-blind Baseline||0
8660190|NCT01642212|21380092|P4|COMPLETED|Single-blind Baseline||0
8660191|NCT01642212|21380093|P3|COMPLETED|Single-blind Baseline||0
8660192|NCT01642212|21380094|P2|COMPLETED|Single-blind Baseline||0
8660193|NCT01642212|21380095|P1|COMPLETED|Single-blind Baseline||93
8660194|NCT01642212|21380091|P5|STARTED|Single-blind Baseline||0
8660195|NCT01642212|21380092|P4|STARTED|Single-blind Baseline||0
8660196|NCT01642212|21380093|P3|STARTED|Single-blind Baseline||0
8660197|NCT01642212|21380094|P2|STARTED|Single-blind Baseline||0
8660198|NCT01642212|21380095|P1|STARTED|Single-blind Baseline||119
8660199|NCT01624506|21380145|P2|NOT COMPLETED|Overall Study||17
8660200|NCT01624506|21380146|P1|NOT COMPLETED|Overall Study||65
8660201|NCT01624506|21380145|P2|COMPLETED|Overall Study||213
8660202|NCT01624506|21380146|P1|COMPLETED|Overall Study||465
8660203|NCT01624506|21380145|P2|STARTED|Overall Study||230
8660204|NCT01624506|21380146|P1|STARTED|Overall Study||530
8660205|NCT01564485|21380154|P2|NOT COMPLETED|Overall Study||23
8660206|NCT01564485|21380155|P1|NOT COMPLETED|Overall Study||8
8660207|NCT01564485|21380154|P2|COMPLETED|Overall Study||78
8660208|NCT01564485|21380155|P1|COMPLETED|Overall Study||84
8660209|NCT01564485|21380154|P2|STARTED|Overall Study||101
8660210|NCT01564485|21380155|P1|STARTED|Overall Study||92
8660211|NCT01552915|21380164|P3|NOT COMPLETED|Overall Study||27
8660212|NCT01552915|21380165|P2|NOT COMPLETED|Overall Study||29
8660213|NCT01552915|21380166|P1|NOT COMPLETED|Overall Study||23
8660214|NCT01552915|21380164|P3|COMPLETED|Overall Study||157
8660215|NCT01552915|21380165|P2|COMPLETED|Overall Study||155
8660216|NCT01552915|21380166|P1|COMPLETED|Overall Study||68
8660217|NCT01552915|21380164|P3|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
8660218|NCT01552915|21380165|P2|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
8660219|NCT01552915|21380166|P1|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
8660220|NCT01540474|21380190|P4|NOT COMPLETED|Malaria Challenge||1
8660221|NCT01540474|21380191|P3|NOT COMPLETED|Malaria Challenge||0
8660222|NCT01540474|21380192|P2|NOT COMPLETED|Malaria Challenge||0
8660223|NCT01540474|21380193|P1|NOT COMPLETED|Malaria Challenge||0
8660224|NCT01540474|21380190|P4|COMPLETED|Malaria Challenge||5
8660225|NCT01540474|21380191|P3|COMPLETED|Malaria Challenge||10
8660226|NCT01540474|21380192|P2|COMPLETED|Malaria Challenge||9
8660227|NCT01540474|21380193|P1|COMPLETED|Malaria Challenge||10
8660228|NCT01540474|21380190|P4|STARTED|Malaria Challenge||6
8660229|NCT01540474|21380191|P3|STARTED|Malaria Challenge||10
8660230|NCT01540474|21380192|P2|STARTED|Malaria Challenge||9
8660231|NCT01540474|21380193|P1|STARTED|Malaria Challenge||10
8660232|NCT01540474|21380190|P4|NOT COMPLETED|Vaccination Period||0
8660233|NCT01540474|21380191|P3|NOT COMPLETED|Vaccination Period||0
8660234|NCT01540474|21380192|P2|NOT COMPLETED|Vaccination Period||1
8660235|NCT01540474|21380193|P1|NOT COMPLETED|Vaccination Period||0
8660236|NCT01540474|21380190|P4|COMPLETED|Vaccination Period||0
8660237|NCT01540474|21380191|P3|COMPLETED|Vaccination Period||10
8660238|NCT01540474|21380192|P2|COMPLETED|Vaccination Period||9
8660239|NCT01540474|21380193|P1|COMPLETED|Vaccination Period||10
8660240|NCT01540474|21380190|P4|STARTED|Vaccination Period||0
8660241|NCT01540474|21380191|P3|STARTED|Vaccination Period||10
8660242|NCT01540474|21380192|P2|STARTED|Vaccination Period||10
8660243|NCT01540474|21380193|P1|STARTED|Vaccination Period||10
8660244|NCT01518946|21380221|P3|NOT COMPLETED|Randomized Phase (Second Intervention)||0
8660245|NCT01518946|21380222|P2|NOT COMPLETED|Randomized Phase (Second Intervention)||0
8660246|NCT01518946|21380223|P1|NOT COMPLETED|Randomized Phase (Second Intervention)||0
8660247|NCT01518946|21380221|P3|COMPLETED|Randomized Phase (Second Intervention)||10
8660248|NCT01518946|21380222|P2|COMPLETED|Randomized Phase (Second Intervention)||9
8660249|NCT01518946|21380223|P1|COMPLETED|Randomized Phase (Second Intervention)||0
8660250|NCT01518946|21380221|P3|STARTED|Randomized Phase (Second Intervention)||10
8660251|NCT01518946|21380222|P2|STARTED|Randomized Phase (Second Intervention)||9
8660252|NCT01518946|21380223|P1|STARTED|Randomized Phase (Second Intervention)||0
8660253|NCT01518946|21380221|P3|NOT COMPLETED|Randomized Phase (First Intervention)||0
8660254|NCT01518946|21380222|P2|NOT COMPLETED|Randomized Phase (First Intervention)||1
8660255|NCT01518946|21380223|P1|NOT COMPLETED|Randomized Phase (First Intervention)||0
8660256|NCT01518946|21380221|P3|COMPLETED|Randomized Phase (First Intervention)||10
8660257|NCT01518946|21380222|P2|COMPLETED|Randomized Phase (First Intervention)||9
8660258|NCT01518946|21380223|P1|COMPLETED|Randomized Phase (First Intervention)||0
8660259|NCT01518946|21380221|P3|STARTED|Randomized Phase (First Intervention)||10
8660260|NCT01518946|21380222|P2|STARTED|Randomized Phase (First Intervention)||10
8660261|NCT01518946|21380223|P1|STARTED|Randomized Phase (First Intervention)||0
8660262|NCT01518946|21380221|P3|NOT COMPLETED|Open-label Phase||0
8660263|NCT01518946|21380222|P2|NOT COMPLETED|Open-label Phase||0
8660264|NCT01518946|21380223|P1|NOT COMPLETED|Open-label Phase||4
8660265|NCT01518946|21380221|P3|COMPLETED|Open-label Phase||0
8660266|NCT01518946|21380222|P2|COMPLETED|Open-label Phase||0
8660267|NCT01518946|21380223|P1|COMPLETED|Open-label Phase||20
8660268|NCT01518946|21380221|P3|STARTED|Open-label Phase||0
8660269|NCT01518946|21380222|P2|STARTED|Open-label Phase||0
8660270|NCT01518946|21380223|P1|STARTED|Open-label Phase||24
8660271|NCT01483144|21380233|P3|NOT COMPLETED|Overall Study||15
8660272|NCT01483144|21380234|P2|NOT COMPLETED|Overall Study||13
8660273|NCT01483144|21380235|P1|NOT COMPLETED|Overall Study||15
8660274|NCT01483144|21380233|P3|COMPLETED|Overall Study||43
8660275|NCT01483144|21380234|P2|COMPLETED|Overall Study||44
8660276|NCT01483144|21380235|P1|COMPLETED|Overall Study||41
8660277|NCT01483144|21380233|P3|STARTED|Overall Study||58
8660278|NCT01483144|21380234|P2|STARTED|Overall Study||57
8660279|NCT01483144|21380235|P1|STARTED|Overall Study||56
8660280|NCT01467427|21380251|P2|NOT COMPLETED|Overall Study||13
8660281|NCT01467427|21380252|P1|NOT COMPLETED|Overall Study||12
8660282|NCT01467427|21380251|P2|COMPLETED|Overall Study||0
8660283|NCT01467427|21380252|P1|COMPLETED|Overall Study||0
8660284|NCT01467427|21380251|P2|Completed Main Phase|Overall Study||13
8660285|NCT01467427|21380252|P1|Completed Main Phase|Overall Study||11
8660286|NCT01467427|21380251|P2|STARTED|Overall Study||13
8660287|NCT01467427|21380252|P1|STARTED|Overall Study||12
8660288|NCT01458366|21380275|P5|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||1
8660289|NCT01458366|21380276|P4|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8660290|NCT01458366|21380277|P3|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8660291|NCT01458366|21380278|P2|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8660292|NCT01458366|21380279|P1|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8660293|NCT01458366|21380275|P5|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||26
8660294|NCT01458366|21380276|P4|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8660295|NCT01458366|21380277|P3|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8660296|NCT01458366|21380278|P2|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8660297|NCT01458366|21380279|P1|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
8660298|NCT01458366|21380275|P5|STARTED|Period 5: Maximum Tolerated Dose (MTD)||27
8660299|NCT01458366|21380276|P4|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
8660300|NCT01458366|21380277|P3|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
8660301|NCT01458366|21380278|P2|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
8660302|NCT01458366|21380279|P1|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
8660303|NCT01458366|21380275|P5|NOT COMPLETED|Period 4: 120mg/m^2||0
8660304|NCT01458366|21380276|P4|NOT COMPLETED|Period 4: 120mg/m^2||0
8660305|NCT01458366|21380277|P3|NOT COMPLETED|Period 4: 120mg/m^2||0
8660306|NCT01458366|21380278|P2|NOT COMPLETED|Period 4: 120mg/m^2||0
8660307|NCT01458366|21380279|P1|NOT COMPLETED|Period 4: 120mg/m^2||0
8660308|NCT01458366|21380275|P5|COMPLETED|Period 4: 120mg/m^2||0
8660309|NCT01458366|21380276|P4|COMPLETED|Period 4: 120mg/m^2||3
8660310|NCT01458366|21380277|P3|COMPLETED|Period 4: 120mg/m^2||0
8660311|NCT01458366|21380278|P2|COMPLETED|Period 4: 120mg/m^2||0
8660312|NCT01458366|21380279|P1|COMPLETED|Period 4: 120mg/m^2||0
8660313|NCT01458366|21380275|P5|STARTED|Period 4: 120mg/m^2||0
8660314|NCT01458366|21380276|P4|STARTED|Period 4: 120mg/m^2||3
8660315|NCT01458366|21380277|P3|STARTED|Period 4: 120mg/m^2||0
8660316|NCT01458366|21380278|P2|STARTED|Period 4: 120mg/m^2||0
8660317|NCT01458366|21380279|P1|STARTED|Period 4: 120mg/m^2||0
8660318|NCT01458366|21380275|P5|NOT COMPLETED|Period 3: 90mg/m^2||0
8660319|NCT01458366|21380276|P4|NOT COMPLETED|Period 3: 90mg/m^2||0
8660320|NCT01458366|21380277|P3|NOT COMPLETED|Period 3: 90mg/m^2||0
8660321|NCT01458366|21380278|P2|NOT COMPLETED|Period 3: 90mg/m^2||0
8660322|NCT01458366|21380279|P1|NOT COMPLETED|Period 3: 90mg/m^2||0
8660323|NCT01458366|21380275|P5|COMPLETED|Period 3: 90mg/m^2||0
8660324|NCT01458366|21380276|P4|COMPLETED|Period 3: 90mg/m^2||0
8660325|NCT01458366|21380277|P3|COMPLETED|Period 3: 90mg/m^2||3
8660326|NCT01458366|21380278|P2|COMPLETED|Period 3: 90mg/m^2||0
8660327|NCT01458366|21380279|P1|COMPLETED|Period 3: 90mg/m^2||0
8660328|NCT01458366|21380275|P5|STARTED|Period 3: 90mg/m^2||0
8660329|NCT01458366|21380276|P4|STARTED|Period 3: 90mg/m^2||0
8660330|NCT01458366|21380277|P3|STARTED|Period 3: 90mg/m^2||3
8660331|NCT01458366|21380278|P2|STARTED|Period 3: 90mg/m^2||0
8660332|NCT01458366|21380279|P1|STARTED|Period 3: 90mg/m^2||0
8660333|NCT01458366|21380275|P5|NOT COMPLETED|Period 2: 50mg/m^2||0
8660334|NCT01458366|21380276|P4|NOT COMPLETED|Period 2: 50mg/m^2||0
8660335|NCT01458366|21380277|P3|NOT COMPLETED|Period 2: 50mg/m^2||0
8660336|NCT01458366|21380278|P2|NOT COMPLETED|Period 2: 50mg/m^2||0
8660337|NCT01458366|21380279|P1|NOT COMPLETED|Period 2: 50mg/m^2||0
8660338|NCT01458366|21380275|P5|COMPLETED|Period 2: 50mg/m^2||0
8660339|NCT01458366|21380276|P4|COMPLETED|Period 2: 50mg/m^2||0
8660340|NCT01458366|21380277|P3|COMPLETED|Period 2: 50mg/m^2||0
8660341|NCT01458366|21380278|P2|COMPLETED|Period 2: 50mg/m^2||0
8660342|NCT01458366|21380279|P1|COMPLETED|Period 2: 50mg/m^2||0
8660343|NCT01458366|21380275|P5|STARTED|Period 2: 50mg/m^2||0
8660344|NCT01458366|21380276|P4|STARTED|Period 2: 50mg/m^2||0
8660345|NCT01458366|21380277|P3|STARTED|Period 2: 50mg/m^2||0
8660346|NCT01458366|21380278|P2|STARTED|Period 2: 50mg/m^2||0
8660347|NCT01458366|21380279|P1|STARTED|Period 2: 50mg/m^2||0
8660348|NCT01458366|21380275|P5|NOT COMPLETED|Period 1: 70mg/m^2||0
8660349|NCT01458366|21380276|P4|NOT COMPLETED|Period 1: 70mg/m^2||0
8660350|NCT01458366|21380277|P3|NOT COMPLETED|Period 1: 70mg/m^2||0
8660351|NCT01458366|21380278|P2|NOT COMPLETED|Period 1: 70mg/m^2||0
8660352|NCT01458366|21380279|P1|NOT COMPLETED|Period 1: 70mg/m^2||2
8660353|NCT01458366|21380275|P5|COMPLETED|Period 1: 70mg/m^2||0
8660354|NCT01458366|21380276|P4|COMPLETED|Period 1: 70mg/m^2||0
8660355|NCT01458366|21380277|P3|COMPLETED|Period 1: 70mg/m^2||0
8660356|NCT01458366|21380278|P2|COMPLETED|Period 1: 70mg/m^2||0
8660357|NCT01458366|21380279|P1|COMPLETED|Period 1: 70mg/m^2||3
8660358|NCT01458366|21380275|P5|STARTED|Period 1: 70mg/m^2||0
8660359|NCT01458366|21380276|P4|STARTED|Period 1: 70mg/m^2||0
8660360|NCT01458366|21380277|P3|STARTED|Period 1: 70mg/m^2||0
8660361|NCT01458366|21380278|P2|STARTED|Period 1: 70mg/m^2||0
8660362|NCT01458366|21380279|P1|STARTED|Period 1: 70mg/m^2||5
8660363|NCT01433991|21380298|P4|NOT COMPLETED|Treatment Phase (Combination Agent)||6
8660364|NCT01433991|21380299|P3|NOT COMPLETED|Treatment Phase (Combination Agent)||6
8660365|NCT01433991|21380300|P2|NOT COMPLETED|Treatment Phase (Combination Agent)||1
8660366|NCT01433991|21380301|P1|NOT COMPLETED|Treatment Phase (Combination Agent)||2
8660367|NCT01433991|21380298|P4|COMPLETED|Treatment Phase (Combination Agent)||2
8660368|NCT01433991|21380299|P3|COMPLETED|Treatment Phase (Combination Agent)||8
8660369|NCT01433991|21380300|P2|COMPLETED|Treatment Phase (Combination Agent)||2
8660370|NCT01433991|21380301|P1|COMPLETED|Treatment Phase (Combination Agent)||1
8660371|NCT01433991|21380298|P4|STARTED|Treatment Phase (Combination Agent)||8
8660372|NCT01433991|21380299|P3|STARTED|Treatment Phase (Combination Agent)||14
8660373|NCT01433991|21380300|P2|STARTED|Treatment Phase (Combination Agent)||3
8660374|NCT01433991|21380301|P1|STARTED|Treatment Phase (Combination Agent)||3
8660375|NCT01433991|21380298|P4|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
8660376|NCT01433991|21380299|P3|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
8660377|NCT01433991|21380300|P2|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
8660378|NCT01433991|21380301|P1|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||2
8660379|NCT01433991|21380298|P4|COMPLETED|Pretreatment Phase (Single Agent Run-in)||8
8660380|NCT01433991|21380299|P3|COMPLETED|Pretreatment Phase (Single Agent Run-in)||14
8660381|NCT01433991|21380300|P2|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
8660382|NCT01433991|21380301|P1|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
8660383|NCT01433991|21380298|P4|STARTED|Pretreatment Phase (Single Agent Run-in)||8
8660384|NCT01433991|21380299|P3|STARTED|Pretreatment Phase (Single Agent Run-in)||14
8660385|NCT01433991|21380300|P2|STARTED|Pretreatment Phase (Single Agent Run-in)||3
8660386|NCT01433991|21380301|P1|STARTED|Pretreatment Phase (Single Agent Run-in)||5
8660387|NCT01386658|21380443|P2|NOT COMPLETED|Icatibant Exposure 3||0
8660388|NCT01386658|21380444|P1|NOT COMPLETED|Icatibant Exposure 3||0
8660389|NCT01386658|21380443|P2|COMPLETED|Icatibant Exposure 3||9
8660390|NCT01386658|21380444|P1|COMPLETED|Icatibant Exposure 3||0
8660391|NCT01386658|21380443|P2|STARTED|Icatibant Exposure 3||9
8660392|NCT01386658|21380444|P1|STARTED|Icatibant Exposure 3||0
8660393|NCT01386658|21380443|P2|NOT COMPLETED|Icatibant Exposure 2||0
8660394|NCT01386658|21380444|P1|NOT COMPLETED|Icatibant Exposure 2||0
8660395|NCT01386658|21380443|P2|COMPLETED|Icatibant Exposure 2||9
8660396|NCT01386658|21380444|P1|COMPLETED|Icatibant Exposure 2||0
8660397|NCT01386658|21380443|P2|STARTED|Icatibant Exposure 2||9
8660398|NCT01386658|21380444|P1|STARTED|Icatibant Exposure 2||0
8660399|NCT01386658|21380443|P2|NOT COMPLETED|Initial Icatibant Exposure||12
8660400|NCT01386658|21380444|P1|NOT COMPLETED|Initial Icatibant Exposure||0
8660401|NCT01386658|21380443|P2|COMPLETED|Initial Icatibant Exposure||9
8660402|NCT01386658|21380444|P1|COMPLETED|Initial Icatibant Exposure||11
8660403|NCT01386658|21380443|P2|STARTED|Initial Icatibant Exposure||21
8660404|NCT01386658|21380444|P1|STARTED|Initial Icatibant Exposure||11
8660405|NCT01375959|21380509|P2|NOT COMPLETED|Second Intervention (6 Weeks)||3
8660406|NCT01375959|21380510|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
8660407|NCT01375959|21380509|P2|COMPLETED|Second Intervention (6 Weeks)||15
8660408|NCT01375959|21380510|P1|COMPLETED|Second Intervention (6 Weeks)||15
8660409|NCT01375959|21380509|P2|STARTED|Second Intervention (6 Weeks)||18
8660410|NCT01375959|21380510|P1|STARTED|Second Intervention (6 Weeks)||15
8660411|NCT01375959|21380509|P2|NOT COMPLETED|Wash-Out (3 Weeks)||0
8660412|NCT01375959|21380510|P1|NOT COMPLETED|Wash-Out (3 Weeks)||0
8660413|NCT01375959|21380509|P2|COMPLETED|Wash-Out (3 Weeks)||18
8660414|NCT01375959|21380510|P1|COMPLETED|Wash-Out (3 Weeks)||15
8660415|NCT01375959|21380509|P2|STARTED|Wash-Out (3 Weeks)||18
8660416|NCT01375959|21380510|P1|STARTED|Wash-Out (3 Weeks)||15
8660417|NCT01375959|21380509|P2|NOT COMPLETED|First Intervention (6 Weeks)||3
8660418|NCT01375959|21380510|P1|NOT COMPLETED|First Intervention (6 Weeks)||2
8660419|NCT01375959|21380509|P2|COMPLETED|First Intervention (6 Weeks)|Three participants were withdrawn due to adverse events.|18
8660420|NCT01375959|21380510|P1|COMPLETED|First Intervention (6 Weeks)|Two participants were withdrawn due to adverse events.|15
8660421|NCT01375959|21380509|P2|Received Invertention|First Intervention (6 Weeks)||21
8660422|NCT01375959|21380510|P1|Received Invertention|First Intervention (6 Weeks)||17
8660423|NCT01375959|21380509|P2|STARTED|First Intervention (6 Weeks)||21
8660424|NCT01375959|21380510|P1|STARTED|First Intervention (6 Weeks)||17
8660425|NCT01298141|21380516|P1|NOT COMPLETED|Overall Study||31
8660426|NCT01298141|21380516|P1|COMPLETED|Overall Study||140
8660427|NCT01298141|21380516|P1|Treated|Overall Study||167
8660428|NCT01298141|21380516|P1|STARTED|Overall Study||171
8660429|NCT01281189|21380528|P2|NOT COMPLETED|Overall Study||143
8660430|NCT01281189|21380529|P1|NOT COMPLETED|Overall Study||147
8660431|NCT01281189|21380528|P2|COMPLETED|Overall Study||331
8660432|NCT01281189|21380529|P1|COMPLETED|Overall Study||321
8660433|NCT01281189|21380528|P2|STARTED|Overall Study||474
8660434|NCT01281189|21380529|P1|STARTED|Overall Study||468
8660435|NCT01190930|21380547|P10|NOT COMPLETED|Maintenance||37
8660436|NCT01190930|21380548|P9|NOT COMPLETED|Maintenance||46
8660437|NCT01190930|21380549|P8|NOT COMPLETED|Maintenance||46
8660438|NCT01190930|21380550|P7|NOT COMPLETED|Maintenance||26
8660439|NCT01190930|21380551|P6|NOT COMPLETED|Maintenance||12
8660440|NCT01190930|21380552|P5|NOT COMPLETED|Maintenance||9
8660441|NCT01190930|21380553|P4|NOT COMPLETED|Maintenance||40
8660442|NCT01190930|21380554|P3|NOT COMPLETED|Maintenance||0
8660443|NCT01190930|21380555|P2|NOT COMPLETED|Maintenance||10
8660444|NCT01190930|21380556|P1|NOT COMPLETED|Maintenance||0
8660445|NCT01190930|21380547|P10|COMPLETED|Maintenance||555
8660446|NCT01190930|21380548|P9|COMPLETED|Maintenance||540
8660447|NCT01190930|21380549|P8|COMPLETED|Maintenance||540
8660448|NCT01190930|21380550|P7|COMPLETED|Maintenance||574
8660449|NCT01190930|21380551|P6|COMPLETED|Maintenance||284
8660450|NCT01190930|21380552|P5|COMPLETED|Maintenance||287
8660451|NCT01190930|21380553|P4|COMPLETED|Maintenance||167
8660452|NCT01190930|21380554|P3|COMPLETED|Maintenance||0
8660453|NCT01190930|21380555|P2|COMPLETED|Maintenance||27
8660454|NCT01190930|21380556|P1|COMPLETED|Maintenance||0
8660455|NCT01190930|21380547|P10|STARTED|Maintenance||592
8660456|NCT01190930|21380548|P9|STARTED|Maintenance||586
8660457|NCT01190930|21380549|P8|STARTED|Maintenance||586
8660458|NCT01190930|21380550|P7|STARTED|Maintenance||600
8660459|NCT01190930|21380551|P6|STARTED|Maintenance||296
8660460|NCT01190930|21380552|P5|STARTED|Maintenance||296
8660461|NCT01190930|21380553|P4|STARTED|Maintenance||207
8660462|NCT01190930|21380554|P3|STARTED|Maintenance||0
8660463|NCT01190930|21380555|P2|STARTED|Maintenance||37
8660464|NCT01190930|21380556|P1|STARTED|Maintenance||0
8660465|NCT01190930|21380547|P10|NOT COMPLETED|Post Induction Pre-Maintenance||0
8660466|NCT01190930|21380548|P9|NOT COMPLETED|Post Induction Pre-Maintenance||0
8660467|NCT01190930|21380549|P8|NOT COMPLETED|Post Induction Pre-Maintenance||0
8660468|NCT01190930|21380550|P7|NOT COMPLETED|Post Induction Pre-Maintenance||0
8660469|NCT01190930|21380551|P6|NOT COMPLETED|Post Induction Pre-Maintenance||6
8660470|NCT01190930|21380552|P5|NOT COMPLETED|Post Induction Pre-Maintenance||5
8660471|NCT01190930|21380553|P4|NOT COMPLETED|Post Induction Pre-Maintenance||17
8660472|NCT01190930|21380554|P3|NOT COMPLETED|Post Induction Pre-Maintenance||758
8660473|NCT01190930|21380555|P2|NOT COMPLETED|Post Induction Pre-Maintenance||6
8660474|NCT01190930|21380556|P1|NOT COMPLETED|Post Induction Pre-Maintenance||0
8660475|NCT01190930|21380547|P10|COMPLETED|Post Induction Pre-Maintenance||0
8660476|NCT01190930|21380548|P9|COMPLETED|Post Induction Pre-Maintenance||0
8660477|NCT01190930|21380549|P8|COMPLETED|Post Induction Pre-Maintenance||0
8660478|NCT01190930|21380550|P7|COMPLETED|Post Induction Pre-Maintenance||0
8660479|NCT01190930|21380551|P6|COMPLETED|Post Induction Pre-Maintenance||296
8660480|NCT01190930|21380552|P5|COMPLETED|Post Induction Pre-Maintenance||296
8660481|NCT01190930|21380553|P4|COMPLETED|Post Induction Pre-Maintenance||207
8660482|NCT01190930|21380554|P3|COMPLETED|Post Induction Pre-Maintenance||2364
8660483|NCT01190930|21380555|P2|COMPLETED|Post Induction Pre-Maintenance||37
8660484|NCT01190930|21380556|P1|COMPLETED|Post Induction Pre-Maintenance||0
8660485|NCT01190930|21380547|P10|STARTED|Post Induction Pre-Maintenance||0
8660486|NCT01190930|21380548|P9|STARTED|Post Induction Pre-Maintenance||0
8660487|NCT01190930|21380549|P8|STARTED|Post Induction Pre-Maintenance||0
8660488|NCT01190930|21380550|P7|STARTED|Post Induction Pre-Maintenance||0
8660489|NCT01190930|21380551|P6|STARTED|Post Induction Pre-Maintenance||302
8660490|NCT01190930|21380552|P5|STARTED|Post Induction Pre-Maintenance||301
8660491|NCT01190930|21380553|P4|STARTED|Post Induction Pre-Maintenance||224
8660492|NCT01190930|21380554|P3|STARTED|Post Induction Pre-Maintenance||3122
8660493|NCT01190930|21380555|P2|STARTED|Post Induction Pre-Maintenance||43
8660494|NCT01190930|21380556|P1|STARTED|Post Induction Pre-Maintenance||0
8660495|NCT01190930|21380547|P10|NOT COMPLETED|Induction||0
8660496|NCT01190930|21380548|P9|NOT COMPLETED|Induction||0
8660497|NCT01190930|21380549|P8|NOT COMPLETED|Induction||0
8660498|NCT01190930|21380550|P7|NOT COMPLETED|Induction||0
8660499|NCT01190930|21380551|P6|NOT COMPLETED|Induction||0
8660500|NCT01190930|21380552|P5|NOT COMPLETED|Induction||0
8660501|NCT01190930|21380553|P4|NOT COMPLETED|Induction||0
8660502|NCT01190930|21380554|P3|NOT COMPLETED|Induction||0
8660503|NCT01190930|21380555|P2|NOT COMPLETED|Induction||9
8660504|NCT01190930|21380556|P1|NOT COMPLETED|Induction||5349
8660505|NCT01190930|21380547|P10|COMPLETED|Induction||0
8660506|NCT01190930|21380548|P9|COMPLETED|Induction||0
8660507|NCT01190930|21380549|P8|COMPLETED|Induction||0
8660508|NCT01190930|21380550|P7|COMPLETED|Induction||0
8660509|NCT01190930|21380551|P6|COMPLETED|Induction||0
8660510|NCT01190930|21380552|P5|COMPLETED|Induction||0
8660511|NCT01190930|21380553|P4|COMPLETED|Induction||0
8660512|NCT01190930|21380554|P3|COMPLETED|Induction||0
8660513|NCT01190930|21380555|P2|COMPLETED|Induction||43
8660514|NCT01190930|21380556|P1|COMPLETED|Induction||3949
8660515|NCT01190930|21380547|P10|STARTED|Induction||0
8660516|NCT01190930|21380548|P9|STARTED|Induction||0
8660517|NCT01190930|21380549|P8|STARTED|Induction||0
8660518|NCT01190930|21380550|P7|STARTED|Induction||0
8660519|NCT01190930|21380551|P6|STARTED|Induction||0
8660520|NCT01190930|21380552|P5|STARTED|Induction||0
8660521|NCT01190930|21380553|P4|STARTED|Induction||0
8660522|NCT01190930|21380554|P3|STARTED|Induction||0
8660523|NCT01190930|21380555|P2|STARTED|Induction||52
8660524|NCT01190930|21380556|P1|STARTED|Induction||9298
8660525|NCT01136668|21380636|P2|NOT COMPLETED|Overall Study||0
8660526|NCT01136668|21380637|P1|NOT COMPLETED|Overall Study||0
8660527|NCT01136668|21380636|P2|COMPLETED|Overall Study||6
8660528|NCT01136668|21380637|P1|COMPLETED|Overall Study||7
8660529|NCT01136668|21380636|P2|STARTED|Overall Study||6
8660530|NCT01136668|21380637|P1|STARTED|Overall Study||7
8660531|NCT01124643|21380643|P1|NOT COMPLETED|Overall Study||1
8660532|NCT01124643|21380643|P1|COMPLETED|Overall Study||34
8660533|NCT01124643|21380643|P1|STARTED|Overall Study||35
8660534|NCT01059526|21380657|P2|NOT COMPLETED|Overall Study||22
8660535|NCT01059526|21380658|P1|NOT COMPLETED|Overall Study||30
8660536|NCT01059526|21380657|P2|COMPLETED|Overall Study||18
8660537|NCT01059526|21380658|P1|COMPLETED|Overall Study||11
8660538|NCT01059526|21380657|P2|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
8660539|NCT01059526|21380658|P1|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
8660540|NCT01059526|21380657|P2|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
8660541|NCT01059526|21380658|P1|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
8660542|NCT01032603|21380668|P2|NOT COMPLETED|Overall Study||19
8660543|NCT01032603|21380669|P1|NOT COMPLETED|Overall Study||15
8660544|NCT01032603|21380668|P2|COMPLETED|Overall Study||77
8660545|NCT01032603|21380669|P1|COMPLETED|Overall Study||86
8660546|NCT01032603|21380668|P2|STARTED|Overall Study||96
8660547|NCT01032603|21380669|P1|STARTED|Overall Study||101
8660548|NCT00997984|21380728|P3|NOT COMPLETED|Overall Study||26
8660549|NCT00997984|21380729|P2|NOT COMPLETED|Overall Study||34
8660550|NCT00997984|21380730|P1|NOT COMPLETED|Overall Study||37
8660551|NCT00997984|21380728|P3|COMPLETED|Overall Study||88
8660552|NCT00997984|21380729|P2|COMPLETED|Overall Study||79
8660553|NCT00997984|21380730|P1|COMPLETED|Overall Study||76
8660554|NCT00997984|21380728|P3|STARTED|Overall Study||114
8660555|NCT00997984|21380729|P2|STARTED|Overall Study||113
8660556|NCT00997984|21380730|P1|STARTED|Overall Study||113
8660557|NCT00985725|21380798|P2|NOT COMPLETED|Overall Study||13
8660558|NCT00985725|21380799|P1|NOT COMPLETED|Overall Study||11
8660559|NCT00985725|21380798|P2|COMPLETED|Overall Study||59
8660560|NCT00985725|21380799|P1|COMPLETED|Overall Study||60
8660561|NCT00985725|21380798|P2|STARTED|Overall Study||72
8660562|NCT00985725|21380799|P1|STARTED|Overall Study||71
8660563|NCT00882921|21380833|P1|NOT COMPLETED|Overall Study||11
8660564|NCT00882921|21380833|P1|COMPLETED|Overall Study||15
8660565|NCT00882921|21380833|P1|STARTED|Overall Study||26
8660578|NCT00681811|21380887|P2|NOT COMPLETED|Overall Study||4
8660579|NCT00681811|21380888|P1|NOT COMPLETED|Overall Study||3
8660580|NCT00681811|21380887|P2|COMPLETED|Overall Study||1
8660581|NCT00681811|21380888|P1|COMPLETED|Overall Study||3
8660582|NCT00681811|21380887|P2|STARTED|Overall Study||5
8660583|NCT00681811|21380888|P1|STARTED|Overall Study||6
8660584|NCT00667719|21380916|P1|NOT COMPLETED|Overall Study||71
8660585|NCT00667719|21380916|P1|COMPLETED|Overall Study||493
8660586|NCT00667719|21380916|P1|STARTED|Overall Study||564
8660587|NCT00616759|21380931|P2|NOT COMPLETED|Overall Study||2
8660588|NCT00616759|21380932|P1|NOT COMPLETED|Overall Study||3
8660589|NCT00616759|21380931|P2|COMPLETED|Overall Study||8
8660590|NCT00616759|21380932|P1|COMPLETED|Overall Study||7
8660591|NCT00616759|21380931|P2|STARTED|Overall Study||10
8660592|NCT00616759|21380932|P1|STARTED|Overall Study||10
8660593|NCT00607386|21380938|P1|NOT COMPLETED|Overall Study||1
8660594|NCT00607386|21380938|P1|COMPLETED|Overall Study||27
8660595|NCT00607386|21380938|P1|STARTED|Overall Study||28
8660605|NCT00553631|21380970|P2|NOT COMPLETED|Overall Study||1
8660606|NCT00553631|21380971|P1|NOT COMPLETED|Overall Study||1
8660607|NCT00553631|21380970|P2|COMPLETED|Overall Study||16
8660608|NCT00553631|21380971|P1|COMPLETED|Overall Study||16
8660609|NCT00553631|21380970|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|17
8660610|NCT00553631|21380971|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|17
8660611|NCT00462709|21380991|P1|NOT COMPLETED|Overall Study||67
8660612|NCT00462709|21380991|P1|COMPLETED|Overall Study||79
8660613|NCT00462709|21380991|P1|STARTED|Overall Study||146
8660614|NCT00457015|21381000|P2|NOT COMPLETED|Overall Study||1
8660615|NCT00457015|21381001|P1|NOT COMPLETED|Overall Study||0
8660616|NCT00457015|21381000|P2|COMPLETED|Overall Study||47
8660617|NCT00457015|21381001|P1|COMPLETED|Overall Study||48
8660618|NCT00457015|21381000|P2|STARTED|Overall Study||48
8660619|NCT00457015|21381001|P1|STARTED|Overall Study||48
8660620|NCT00456508|21381015|P1|NOT COMPLETED|Overall Study||0
8660621|NCT00456508|21381015|P1|COMPLETED|Overall Study||147
8660622|NCT00456508|21381015|P1|STARTED|Overall Study||147
8660623|NCT00450450|21381023|P2|NOT COMPLETED|Overall Study||3
8660624|NCT00450450|21381024|P1|NOT COMPLETED|Overall Study||5
8660625|NCT00450450|21381023|P2|COMPLETED|Overall Study||11
8660626|NCT00450450|21381024|P1|COMPLETED|Overall Study||8
8660627|NCT00450450|21381023|P2|STARTED|Overall Study||14
8660628|NCT00450450|21381024|P1|STARTED|Overall Study||13
8660632|NCT00438815|21381053|P1|NOT COMPLETED|Overall Study||70
8660633|NCT00438815|21381053|P1|COMPLETED|Overall Study||43
8660634|NCT00438815|21381053|P1|STARTED|Overall Study||113
8660635|NCT00414765|21381065|P2|NOT COMPLETED|Overall Study||11
8660636|NCT00414765|21381066|P1|NOT COMPLETED|Overall Study||6
8660637|NCT00414765|21381065|P2|COMPLETED|Overall Study||8
8660638|NCT00414765|21381066|P1|COMPLETED|Overall Study||1
8660639|NCT00414765|21381065|P2|Completed Cycle 2|Overall Study||16
8660640|NCT00414765|21381066|P1|Completed Cycle 2|Overall Study||4
8660641|NCT00414765|21381065|P2|Completed Cycle 1|Overall Study||19
8660642|NCT00414765|21381066|P1|Completed Cycle 1|Overall Study||7
8660643|NCT00414765|21381065|P2|Completed Study|Overall Study||18
8660644|NCT00414765|21381066|P1|Completed Study|Overall Study||7
8660645|NCT00414765|21381065|P2|STARTED|Overall Study||19
8660646|NCT00414765|21381066|P1|STARTED|Overall Study||7
8660659|NCT00336024|21381116|P2|NOT COMPLETED|Overall Study||19
8660660|NCT00336024|21381117|P1|NOT COMPLETED|Overall Study||20
8660661|NCT00336024|21381116|P2|COMPLETED|Overall Study||26
8660662|NCT00336024|21381117|P1|COMPLETED|Overall Study||26
8660663|NCT00336024|21381116|P2|STARTED|Overall Study||45
8660664|NCT00336024|21381117|P1|STARTED|Overall Study||46
8660665|NCT00297882|21381153|P2|NOT COMPLETED|Day 28||23
8660666|NCT00297882|21381154|P1|NOT COMPLETED|Day 28||16
8660667|NCT00297882|21381153|P2|COMPLETED|Day 28||540
8660668|NCT00297882|21381154|P1|COMPLETED|Day 28||176
8660669|NCT00297882|21381153|P2|STARTED|Day 28||563
8660670|NCT00297882|21381154|P1|STARTED|Day 28||192
8660671|NCT00297882|21381153|P2|NOT COMPLETED|Day 14||49
8660672|NCT00297882|21381154|P1|NOT COMPLETED|Day 14||12
8660673|NCT00297882|21381153|P2|COMPLETED|Day 14||563
8660674|NCT00297882|21381154|P1|COMPLETED|Day 14||192
8660675|NCT00297882|21381153|P2|STARTED|Day 14||612
8660676|NCT00297882|21381154|P1|STARTED|Day 14||204
8660677|NCT00291447|21381166|P4|NOT COMPLETED|Overall Study||0
8660678|NCT00291447|21381167|P3|NOT COMPLETED|Overall Study||0
8660679|NCT00291447|21381168|P2|NOT COMPLETED|Overall Study||0
8660680|NCT00291447|21381169|P1|NOT COMPLETED|Overall Study||0
8660681|NCT00291447|21381166|P4|COMPLETED|Overall Study||2
8660682|NCT00291447|21381167|P3|COMPLETED|Overall Study||2
8660683|NCT00291447|21381168|P2|COMPLETED|Overall Study||2
8660684|NCT00291447|21381169|P1|COMPLETED|Overall Study||2
8660685|NCT00291447|21381166|P4|STARTED|Overall Study||2
8660686|NCT00291447|21381167|P3|STARTED|Overall Study||2
8660687|NCT00291447|21381168|P2|STARTED|Overall Study||2
8660688|NCT00291447|21381169|P1|STARTED|Overall Study||2
8660689|NCT00243230|21381218|P4|NOT COMPLETED|Open Label Period||85
8660690|NCT00243230|21381219|P3|NOT COMPLETED|Open Label Period||0
8660691|NCT00243230|21381220|P2|NOT COMPLETED|Open Label Period||0
8660692|NCT00243230|21381221|P1|NOT COMPLETED|Open Label Period||0
8660693|NCT00243230|21381218|P4|COMPLETED|Open Label Period||0
8660694|NCT00243230|21381219|P3|COMPLETED|Open Label Period||0
8660695|NCT00243230|21381220|P2|COMPLETED|Open Label Period||0
8660696|NCT00243230|21381221|P1|COMPLETED|Open Label Period||0
8660697|NCT00243230|21381218|P4|STARTED|Open Label Period||85
8660698|NCT00243230|21381219|P3|STARTED|Open Label Period||0
8660699|NCT00243230|21381220|P2|STARTED|Open Label Period||0
8660700|NCT00243230|21381221|P1|STARTED|Open Label Period||0
8660701|NCT00243230|21381218|P4|NOT COMPLETED|Double-Blind Period||0
8660702|NCT00243230|21381219|P3|NOT COMPLETED|Double-Blind Period||19
8660703|NCT00243230|21381220|P2|NOT COMPLETED|Double-Blind Period||5
8660704|NCT00243230|21381221|P1|NOT COMPLETED|Double-Blind Period||6
8660705|NCT00243230|21381218|P4|COMPLETED|Double-Blind Period||0
8660706|NCT00243230|21381219|P3|COMPLETED|Double-Blind Period||18
8660707|NCT00243230|21381220|P2|COMPLETED|Double-Blind Period||35
8660708|NCT00243230|21381221|P1|COMPLETED|Double-Blind Period||33
8660709|NCT00243230|21381218|P4|Treated|Double-Blind Period||0
8660710|NCT00243230|21381219|P3|Treated|Double-Blind Period||35
8660711|NCT00243230|21381220|P2|Treated|Double-Blind Period||40
8660712|NCT00243230|21381221|P1|Treated|Double-Blind Period||39
8660713|NCT00243230|21381218|P4|STARTED|Double-Blind Period||0
8660714|NCT00243230|21381219|P3|STARTED|Double-Blind Period||37
8660715|NCT00243230|21381220|P2|STARTED|Double-Blind Period||40
8660716|NCT00243230|21381221|P1|STARTED|Double-Blind Period||39
8660717|NCT00104676|21381298|P2|NOT COMPLETED|Overall Study||14
8660718|NCT00104676|21381299|P1|NOT COMPLETED|Overall Study||7
8660719|NCT00104676|21381298|P2|COMPLETED|Overall Study||91
8660720|NCT00104676|21381299|P1|COMPLETED|Overall Study||91
8660721|NCT00104676|21381298|P2|STARTED|Overall Study||105
8660722|NCT00104676|21381299|P1|STARTED|Overall Study||98
8660723|NCT04511520|21381310|P3|NOT COMPLETED|Overall Study||0
8660724|NCT04511520|21381311|P2|NOT COMPLETED|Overall Study||0
8660725|NCT04511520|21381312|P1|NOT COMPLETED|Overall Study||0
8660726|NCT04511520|21381310|P3|COMPLETED|Overall Study||24
8660727|NCT04511520|21381311|P2|COMPLETED|Overall Study||24
8660728|NCT04511520|21381312|P1|COMPLETED|Overall Study||24
8660729|NCT04511520|21381310|P3|STARTED|Overall Study||24
8660730|NCT04511520|21381311|P2|STARTED|Overall Study||24
8660731|NCT04511520|21381312|P1|STARTED|Overall Study||24
8660732|NCT04189848|21381326|P4|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8660733|NCT04189848|21381327|P3|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8660734|NCT04189848|21381328|P2|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8660735|NCT04189848|21381329|P1|NOT COMPLETED|Treatment Period 2 (Day 1)||0
8660736|NCT04189848|21381326|P4|COMPLETED|Treatment Period 2 (Day 1)||27
8660737|NCT04189848|21381327|P3|COMPLETED|Treatment Period 2 (Day 1)||25
8660738|NCT04189848|21381328|P2|COMPLETED|Treatment Period 2 (Day 1)||26
8660739|NCT04189848|21381329|P1|COMPLETED|Treatment Period 2 (Day 1)||26
8660740|NCT04189848|21381326|P4|STARTED|Treatment Period 2 (Day 1)||27
8660741|NCT04189848|21381327|P3|STARTED|Treatment Period 2 (Day 1)||25
8660742|NCT04189848|21381328|P2|STARTED|Treatment Period 2 (Day 1)||26
8660743|NCT04189848|21381329|P1|STARTED|Treatment Period 2 (Day 1)||26
8660744|NCT04189848|21381326|P4|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8660745|NCT04189848|21381327|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8660746|NCT04189848|21381328|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8660747|NCT04189848|21381329|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8660748|NCT04189848|21381326|P4|COMPLETED|Treatment Period 1 (Day 1)||27
8660749|NCT04189848|21381327|P3|COMPLETED|Treatment Period 1 (Day 1)||25
8660750|NCT04189848|21381328|P2|COMPLETED|Treatment Period 1 (Day 1)||26
8660751|NCT04189848|21381329|P1|COMPLETED|Treatment Period 1 (Day 1)||26
8660752|NCT04189848|21381326|P4|STARTED|Treatment Period 1 (Day 1)||27
8660753|NCT04189848|21381327|P3|STARTED|Treatment Period 1 (Day 1)||25
8660754|NCT04189848|21381328|P2|STARTED|Treatment Period 1 (Day 1)||26
8660755|NCT04189848|21381329|P1|STARTED|Treatment Period 1 (Day 1)||26
8660756|NCT03896633|21381336|P2|NOT COMPLETED|Overall Study||10
8660757|NCT03896633|21381337|P1|NOT COMPLETED|Overall Study||9
8660758|NCT03896633|21381336|P2|COMPLETED|Overall Study||306
8660759|NCT03896633|21381337|P1|COMPLETED|Overall Study||312
8660760|NCT03896633|21381336|P2|STARTED|Overall Study||316
8660761|NCT03896633|21381337|P1|STARTED|Overall Study||321
8660762|NCT03831854|21381347|P2|NOT COMPLETED|Overall Study||0
8660763|NCT03831854|21381348|P1|NOT COMPLETED|Overall Study||0
8660764|NCT03831854|21381347|P2|COMPLETED|Overall Study||23
8660765|NCT03831854|21381348|P1|COMPLETED|Overall Study||23
8660766|NCT03831854|21381347|P2|STARTED|Overall Study||23
8660767|NCT03831854|21381348|P1|STARTED|Overall Study||23
8660768|NCT03771352|21381370|P1|NOT COMPLETED|Overall Study||4
8660769|NCT03771352|21381370|P1|COMPLETED|Overall Study|The fellow eye of one subject was not implanted per the discretion of the investigator.|51
8660770|NCT03771352|21381370|P1|STARTED|Overall Study||55
8660771|NCT03717012|21381378|P2|NOT COMPLETED|Overall Study||6
8660772|NCT03717012|21381379|P1|NOT COMPLETED|Overall Study||1
8660773|NCT03717012|21381378|P2|COMPLETED|Overall Study||4
8660774|NCT03717012|21381379|P1|COMPLETED|Overall Study||8
8660775|NCT03717012|21381378|P2|STARTED|Overall Study||10
8660776|NCT03717012|21381379|P1|STARTED|Overall Study||9
8660777|NCT03530098|21381411|P2|NOT COMPLETED|Overall Study||0
8660778|NCT03530098|21381412|P1|NOT COMPLETED|Overall Study||0
8660779|NCT03530098|21381411|P2|COMPLETED|Overall Study||964
8660780|NCT03530098|21381412|P1|COMPLETED|Overall Study||939
8660781|NCT03530098|21381411|P2|Primary Analysis Set|Overall Study||792
8660782|NCT03530098|21381412|P1|Primary Analysis Set|Overall Study||739
8660783|NCT03530098|21381411|P2|Ground-truth Labeled|Overall Study||794
8660784|NCT03530098|21381412|P1|Ground-truth Labeled|Overall Study||741
8660785|NCT03530098|21381411|P2|STARTED|Overall Study||964
8660786|NCT03530098|21381412|P1|STARTED|Overall Study||939
8660787|NCT03408483|21381422|P2|NOT COMPLETED|Overall Study||3
8660788|NCT03408483|21381423|P1|NOT COMPLETED|Overall Study||6
8660789|NCT03408483|21381422|P2|COMPLETED|Overall Study||35
8660790|NCT03408483|21381423|P1|COMPLETED|Overall Study||36
8660791|NCT03408483|21381422|P2|STARTED|Overall Study||38
8660792|NCT03408483|21381423|P1|STARTED|Overall Study||42
8660793|NCT03317288|21381449|P1|NOT COMPLETED|Overall Study||0
8660794|NCT03317288|21381449|P1|COMPLETED|Overall Study||15
8660795|NCT03317288|21381449|P1|STARTED|Overall Study||15
8660796|NCT03256344|21381484|P2|NOT COMPLETED|Overall Study||25
8660797|NCT03256344|21381485|P1|NOT COMPLETED|Overall Study||11
8660798|NCT03256344|21381484|P2|COMPLETED|Overall Study||0
8660799|NCT03256344|21381485|P1|COMPLETED|Overall Study||0
8660800|NCT03256344|21381484|P2|Received Atezolizumab|Overall Study||24
8660801|NCT03256344|21381485|P1|Received Atezolizumab|Overall Study||10
8660802|NCT03256344|21381484|P2|Received Talimogene Laherparepvec|Overall Study||23
8660803|NCT03256344|21381485|P1|Received Talimogene Laherparepvec|Overall Study||8
8660804|NCT03256344|21381484|P2|STARTED|Overall Study||25
8660805|NCT03256344|21381485|P1|STARTED|Overall Study||11
8660809|NCT03175731|21381517|P2|NOT COMPLETED|Overall Study||5
8660810|NCT03175731|21381518|P1|NOT COMPLETED|Overall Study||7
8660811|NCT03175731|21381517|P2|COMPLETED|Overall Study||48
8660812|NCT03175731|21381518|P1|COMPLETED|Overall Study||46
8660813|NCT03175731|21381517|P2|STARTED|Overall Study||53
8660814|NCT03175731|21381518|P1|STARTED|Overall Study||53
8660833|NCT03092089|21381545|P1|NOT COMPLETED|Overall Study||0
8660834|NCT03092089|21381545|P1|COMPLETED|Overall Study||15
8660835|NCT03092089|21381545|P1|STARTED|Overall Study||15
8660836|NCT03004924|21381560|P3|NOT COMPLETED|Overall Study||28
8660837|NCT03004924|21381561|P2|NOT COMPLETED|Overall Study||14
8660838|NCT03004924|21381562|P1|NOT COMPLETED|Overall Study||27
8660839|NCT03004924|21381560|P3|COMPLETED|Overall Study||293
8660840|NCT03004924|21381561|P2|COMPLETED|Overall Study||94
8660841|NCT03004924|21381562|P1|COMPLETED|Overall Study||297
8660842|NCT03004924|21381560|P3|STARTED|Overall Study||321
8660843|NCT03004924|21381561|P2|STARTED|Overall Study||108
8660844|NCT03004924|21381562|P1|STARTED|Overall Study||324
8660845|NCT02998554|21381614|P2|NOT COMPLETED|Overall Study||11
8660846|NCT02998554|21381615|P1|NOT COMPLETED|Overall Study||11
8660847|NCT02998554|21381614|P2|COMPLETED|Overall Study||66
8660848|NCT02998554|21381615|P1|COMPLETED|Overall Study||68
8660849|NCT02998554|21381614|P2|STARTED|Overall Study||77
8660850|NCT02998554|21381615|P1|STARTED|Overall Study||79
8660851|NCT02939105|21381643|P1|NOT COMPLETED|Overall Study||0
8660852|NCT02939105|21381643|P1|COMPLETED|Overall Study||15
8660853|NCT02939105|21381643|P1|STARTED|Overall Study||15
8660854|NCT02927639|21381650|P2|NOT COMPLETED|Overall Study||69
8660855|NCT02927639|21381651|P1|NOT COMPLETED|Overall Study||73
8660856|NCT02927639|21381650|P2|COMPLETED|Overall Study||13
8660857|NCT02927639|21381651|P1|COMPLETED|Overall Study||10
8660858|NCT02927639|21381650|P2|STARTED|Overall Study|1 subj was inadvertently enrolled in another interventional study just before enrolling so removed.|82
8660859|NCT02927639|21381651|P1|STARTED|Overall Study||83
8660860|NCT02915016|21381665|P8|NOT COMPLETED|Overall Study||4
8660861|NCT02915016|21381666|P7|NOT COMPLETED|Overall Study||12
8660862|NCT02915016|21381667|P6|NOT COMPLETED|Overall Study||6
8660863|NCT02915016|21381668|P5|NOT COMPLETED|Overall Study||7
8660864|NCT02915016|21381669|P4|NOT COMPLETED|Overall Study||4
8660865|NCT02915016|21381670|P3|NOT COMPLETED|Overall Study||8
8660866|NCT02915016|21381671|P2|NOT COMPLETED|Overall Study||3
8660867|NCT02915016|21381672|P1|NOT COMPLETED|Overall Study||7
8660868|NCT02915016|21381665|P8|COMPLETED|Overall Study||20
8660869|NCT02915016|21381666|P7|COMPLETED|Overall Study||38
8660870|NCT02915016|21381667|P6|COMPLETED|Overall Study||44
8660871|NCT02915016|21381668|P5|COMPLETED|Overall Study||43
8660872|NCT02915016|21381669|P4|COMPLETED|Overall Study||26
8660873|NCT02915016|21381670|P3|COMPLETED|Overall Study||42
8660874|NCT02915016|21381671|P2|COMPLETED|Overall Study||47
8660875|NCT02915016|21381672|P1|COMPLETED|Overall Study||23
8660876|NCT02915016|21381665|P8|Month 6.5 Immunogenicity Timepoint|Overall Study||21
8660877|NCT02915016|21381666|P7|Month 6.5 Immunogenicity Timepoint|Overall Study||42
8660878|NCT02915016|21381667|P6|Month 6.5 Immunogenicity Timepoint|Overall Study||42
8660879|NCT02915016|21381668|P5|Month 6.5 Immunogenicity Timepoint|Overall Study||43
8660880|NCT02915016|21381669|P4|Month 6.5 Immunogenicity Timepoint|Overall Study||26
8660881|NCT02915016|21381670|P3|Month 6.5 Immunogenicity Timepoint|Overall Study||46
8660882|NCT02915016|21381671|P2|Month 6.5 Immunogenicity Timepoint|Overall Study||49
8660883|NCT02915016|21381672|P1|Month 6.5 Immunogenicity Timepoint|Overall Study||23
8660884|NCT02915016|21381665|P8|STARTED|Overall Study||24
8660885|NCT02915016|21381666|P7|STARTED|Overall Study||50
8660886|NCT02915016|21381667|P6|STARTED|Overall Study||50
8660887|NCT02915016|21381668|P5|STARTED|Overall Study||50
8660888|NCT02915016|21381669|P4|STARTED|Overall Study||30
8660889|NCT02915016|21381670|P3|STARTED|Overall Study||50
8660890|NCT02915016|21381671|P2|STARTED|Overall Study||50
8660891|NCT02915016|21381672|P1|STARTED|Overall Study||30
8660892|NCT02889796|21381886|P6|NOT COMPLETED|Overall Study||72
8660893|NCT02889796|21381887|P5|NOT COMPLETED|Overall Study||6
8660894|NCT02889796|21381888|P4|NOT COMPLETED|Overall Study||9
8660895|NCT02889796|21381889|P3|NOT COMPLETED|Overall Study||44
8660896|NCT02889796|21381890|P2|NOT COMPLETED|Overall Study||58
8660897|NCT02889796|21381891|P1|NOT COMPLETED|Overall Study||53
8660898|NCT02889796|21381886|P6|COMPLETED|Overall Study|Completed 24 weeks of placebo treatment and not rerandomized to Filgotinib 200 mg or 100 mg groups|24
8660899|NCT02889796|21381887|P5|COMPLETED|Overall Study||185
8660900|NCT02889796|21381888|P4|COMPLETED|Overall Study||181
8660901|NCT02889796|21381889|P3|COMPLETED|Overall Study||281
8660902|NCT02889796|21381890|P2|COMPLETED|Overall Study||422
8660903|NCT02889796|21381891|P1|COMPLETED|Overall Study||424
8660904|NCT02889796|21381886|P6|STARTED|Overall Study||96
8660905|NCT02889796|21381887|P5|STARTED|Overall Study||191
8660906|NCT02889796|21381888|P4|STARTED|Overall Study||190
8660907|NCT02889796|21381889|P3|STARTED|Overall Study||325
8660908|NCT02889796|21381890|P2|STARTED|Overall Study||480
8660909|NCT02889796|21381891|P1|STARTED|Overall Study||477
8660910|NCT02864394|21382258|P2|NOT COMPLETED|Overall Study||212
8660911|NCT02864394|21382259|P1|NOT COMPLETED|Overall Study||213
8660912|NCT02864394|21382258|P2|COMPLETED|Overall Study||0
8660913|NCT02864394|21382259|P1|COMPLETED|Overall Study||0
8660914|NCT02864394|21382258|P2|Treated|Overall Study||198
8660915|NCT02864394|21382259|P1|Treated|Overall Study||213
8660916|NCT02864394|21382258|P2|STARTED|Overall Study||212
8660917|NCT02864394|21382259|P1|STARTED|Overall Study||213
8660918|NCT02861014|21382283|P1|NOT COMPLETED|Overall Study||39
8660919|NCT02861014|21382283|P1|COMPLETED|Overall Study||641
8660920|NCT02861014|21382283|P1|STARTED|Overall Study||680
8660921|NCT02835690|21382316|P3|NOT COMPLETED|Overall Study||15
8660922|NCT02835690|21382317|P2|NOT COMPLETED|Overall Study||15
8660923|NCT02835690|21382318|P1|NOT COMPLETED|Overall Study||14
8660924|NCT02835690|21382316|P3|COMPLETED|Overall Study||0
8660925|NCT02835690|21382317|P2|COMPLETED|Overall Study||0
8660926|NCT02835690|21382318|P1|COMPLETED|Overall Study||0
8660927|NCT02835690|21382316|P3|Treated|Overall Study||15
8660928|NCT02835690|21382317|P2|Treated|Overall Study||13
8660929|NCT02835690|21382318|P1|Treated|Overall Study||14
8660930|NCT02835690|21382316|P3|STARTED|Overall Study||15
8660931|NCT02835690|21382317|P2|STARTED|Overall Study||15
8660932|NCT02835690|21382318|P1|STARTED|Overall Study||14
8660933|NCT02810340|21382374|P3|NOT COMPLETED|Overall Study||1
8660934|NCT02810340|21382375|P2|NOT COMPLETED|Overall Study||1
8660935|NCT02810340|21382376|P1|NOT COMPLETED|Overall Study||1
8660936|NCT02810340|21382374|P3|COMPLETED|Overall Study||19
8660937|NCT02810340|21382375|P2|COMPLETED|Overall Study||19
8660938|NCT02810340|21382376|P1|COMPLETED|Overall Study||19
8660939|NCT02810340|21382374|P3|STARTED|Overall Study||20
8660940|NCT02810340|21382375|P2|STARTED|Overall Study||20
8660941|NCT02810340|21382376|P1|STARTED|Overall Study||20
8660942|NCT02710669|21382408|P3|NOT COMPLETED|Overall Study||2
8660943|NCT02710669|21382409|P2|NOT COMPLETED|Overall Study||11
8660944|NCT02710669|21382410|P1|NOT COMPLETED|Overall Study||14
8660945|NCT02710669|21382408|P3|COMPLETED|Overall Study||19
8660946|NCT02710669|21382409|P2|COMPLETED|Overall Study||75
8660947|NCT02710669|21382410|P1|COMPLETED|Overall Study||71
8660948|NCT02710669|21382408|P3|STARTED|Overall Study||21
8660949|NCT02710669|21382409|P2|STARTED|Overall Study||86
8660950|NCT02710669|21382410|P1|STARTED|Overall Study||85
8660951|NCT02682381|21382427|P3|NOT COMPLETED|Overall Study||0
8660952|NCT02682381|21382428|P2|NOT COMPLETED|Overall Study||0
8660953|NCT02682381|21382429|P1|NOT COMPLETED|Overall Study||0
8660954|NCT02682381|21382427|P3|COMPLETED|Overall Study||9
8660955|NCT02682381|21382428|P2|COMPLETED|Overall Study||26
8660956|NCT02682381|21382429|P1|COMPLETED|Overall Study||24
8660957|NCT02682381|21382427|P3|STARTED|Overall Study||9
8660958|NCT02682381|21382428|P2|STARTED|Overall Study||26
8660959|NCT02682381|21382429|P1|STARTED|Overall Study||24
8660960|NCT02671032|21382494|P1|NOT COMPLETED|Overall Study||0
8660961|NCT02671032|21382494|P1|COMPLETED|Overall Study||12
8660962|NCT02671032|21382494|P1|STARTED|Overall Study||12
8660963|NCT02631538|21382506|P4|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
8660964|NCT02631538|21382507|P3|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
8660965|NCT02631538|21382508|P2|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
8660966|NCT02631538|21382509|P1|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
8660967|NCT02631538|21382506|P4|COMPLETED|General Follow-up (GFU) (Up to Week 68)||16
8660968|NCT02631538|21382507|P3|COMPLETED|General Follow-up (GFU) (Up to Week 68)||19
8660969|NCT02631538|21382508|P2|COMPLETED|General Follow-up (GFU) (Up to Week 68)||17
8660970|NCT02631538|21382509|P1|COMPLETED|General Follow-up (GFU) (Up to Week 68)||8
8660971|NCT02631538|21382506|P4|STARTED|General Follow-up (GFU) (Up to Week 68)||17
8660972|NCT02631538|21382507|P3|STARTED|General Follow-up (GFU) (Up to Week 68)||19
8660973|NCT02631538|21382508|P2|STARTED|General Follow-up (GFU) (Up to Week 68)||17
8660974|NCT02631538|21382509|P1|STARTED|General Follow-up (GFU) (Up to Week 68)||9
8660975|NCT02631538|21382506|P4|NOT COMPLETED|Treatment Period (Up to Week 52)||8
8660976|NCT02631538|21382507|P3|NOT COMPLETED|Treatment Period (Up to Week 52)||5
8660977|NCT02631538|21382508|P2|NOT COMPLETED|Treatment Period (Up to Week 52)||7
8660978|NCT02631538|21382509|P1|NOT COMPLETED|Treatment Period (Up to Week 52)||4
8660979|NCT02631538|21382506|P4|COMPLETED|Treatment Period (Up to Week 52)||17
8660980|NCT02631538|21382507|P3|COMPLETED|Treatment Period (Up to Week 52)||19
8660981|NCT02631538|21382508|P2|COMPLETED|Treatment Period (Up to Week 52)||17
8660982|NCT02631538|21382509|P1|COMPLETED|Treatment Period (Up to Week 52)||9
8660983|NCT02631538|21382506|P4|STARTED|Treatment Period (Up to Week 52)||25
8660984|NCT02631538|21382507|P3|STARTED|Treatment Period (Up to Week 52)||24
8660985|NCT02631538|21382508|P2|STARTED|Treatment Period (Up to Week 52)||24
8660986|NCT02631538|21382509|P1|STARTED|Treatment Period (Up to Week 52)||13
8660987|NCT02612194|21382542|P3|NOT COMPLETED|Overall Study||2
8660988|NCT02612194|21382543|P2|NOT COMPLETED|Overall Study||0
8660989|NCT02612194|21382544|P1|NOT COMPLETED|Overall Study||6
8660990|NCT02612194|21382542|P3|COMPLETED|Overall Study||0
8660991|NCT02612194|21382543|P2|COMPLETED|Overall Study||0
8660992|NCT02612194|21382544|P1|COMPLETED|Overall Study||0
8660993|NCT02612194|21382542|P3|STARTED|Overall Study||2
8660994|NCT02612194|21382543|P2|STARTED|Overall Study||0
8660995|NCT02612194|21382544|P1|STARTED|Overall Study||6
8660999|NCT02530242|21382565|P2|NOT COMPLETED|Overall Study||1
8661000|NCT02530242|21382566|P1|NOT COMPLETED|Overall Study||0
8661001|NCT02530242|21382565|P2|COMPLETED|Overall Study||15
8661002|NCT02530242|21382566|P1|COMPLETED|Overall Study||16
8661003|NCT02530242|21382565|P2|STARTED|Overall Study||16
8661004|NCT02530242|21382566|P1|STARTED|Overall Study||16
8661093|NCT02340819|21382824|P1|NOT COMPLETED|Overall Study||4
8661094|NCT02340819|21382824|P1|COMPLETED|Overall Study||7
8661095|NCT02340819|21382824|P1|Completed Stage 4|Overall Study||7
8661096|NCT02340819|21382824|P1|Started Stage 4|Overall Study||7
8661097|NCT02340819|21382824|P1|Completed Stage 3|Overall Study||7
8661098|NCT02340819|21382824|P1|Started Stage 3|Overall Study||8
8661099|NCT02340819|21382824|P1|Completed Stage 2|Overall Study||9
8661100|NCT02340819|21382824|P1|Started Stage 2|Overall Study||11
8661101|NCT02340819|21382824|P1|STARTED|Overall Study||11
8661102|NCT02271594|21382853|P2|NOT COMPLETED|Overall Study||12
8661103|NCT02271594|21382854|P1|NOT COMPLETED|Overall Study||19
8661104|NCT02271594|21382853|P2|COMPLETED|Overall Study|Study closed down|0
8661105|NCT02271594|21382854|P1|COMPLETED|Overall Study|Study closed down|0
8661106|NCT02271594|21382853|P2|STARTED|Overall Study||12
8661107|NCT02271594|21382854|P1|STARTED|Overall Study||19
8661108|NCT02268500|21382870|P2|NOT COMPLETED|Overall Study||0
8661109|NCT02268500|21382871|P1|NOT COMPLETED|Overall Study||0
8661110|NCT02268500|21382870|P2|COMPLETED|Overall Study||24
8661111|NCT02268500|21382871|P1|COMPLETED|Overall Study||24
8661112|NCT02268500|21382870|P2|STARTED|Overall Study||24
8661113|NCT02268500|21382871|P1|STARTED|Overall Study||24
8661123|NCT02159872|21382905|P1|NOT COMPLETED|Overall Study||0
8661124|NCT02159872|21382905|P1|COMPLETED|Overall Study||48
8661125|NCT02159872|21382905|P1|STARTED|Overall Study||48
8661126|NCT02093663|21382910|P5|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11
8661127|NCT02093663|21382911|P4|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10
8661128|NCT02093663|21382912|P3|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8661129|NCT02093663|21382913|P2|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8661130|NCT02093663|21382914|P1|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8661131|NCT02093663|21382910|P5|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34
8661132|NCT02093663|21382911|P4|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32
8661133|NCT02093663|21382912|P3|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8661134|NCT02093663|21382913|P2|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8661135|NCT02093663|21382914|P1|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
8661136|NCT02093663|21382910|P5|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
8661137|NCT02093663|21382911|P4|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
8661138|NCT02093663|21382912|P3|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
8661139|NCT02093663|21382913|P2|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
8661140|NCT02093663|21382914|P1|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
8661141|NCT02093663|21382910|P5|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15
8661142|NCT02093663|21382911|P4|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12
8661143|NCT02093663|21382912|P3|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
8661144|NCT02093663|21382913|P2|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
8661145|NCT02093663|21382914|P1|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
8661146|NCT02093663|21382910|P5|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
8661147|NCT02093663|21382911|P4|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
8661148|NCT02093663|21382912|P3|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
8661149|NCT02093663|21382913|P2|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
8661150|NCT02093663|21382914|P1|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
8661151|NCT02093663|21382910|P5|STARTED|Double Blind Maintenance Phase(26 Weeks)||45
8661152|NCT02093663|21382911|P4|STARTED|Double Blind Maintenance Phase(26 Weeks)||42
8661153|NCT02093663|21382912|P3|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
8661154|NCT02093663|21382913|P2|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
8661155|NCT02093663|21382914|P1|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
8661156|NCT02093663|21382910|P5|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
8661157|NCT02093663|21382911|P4|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
8661158|NCT02093663|21382912|P3|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6
8661159|NCT02093663|21382913|P2|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
8661160|NCT02093663|21382914|P1|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
8661161|NCT02093663|21382910|P5|COMPLETED|Open Label Acute Phase (8 Weeks)||0
8661162|NCT02093663|21382911|P4|COMPLETED|Open Label Acute Phase (8 Weeks)||0
8661163|NCT02093663|21382912|P3|COMPLETED|Open Label Acute Phase (8 Weeks)||12
8661164|NCT02093663|21382913|P2|COMPLETED|Open Label Acute Phase (8 Weeks)||0
8661165|NCT02093663|21382914|P1|COMPLETED|Open Label Acute Phase (8 Weeks)||0
8661166|NCT02093663|21382910|P5|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
8661167|NCT02093663|21382911|P4|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
8661168|NCT02093663|21382912|P3|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18
8661169|NCT02093663|21382913|P2|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
8661170|NCT02093663|21382914|P1|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
8661171|NCT02093663|21382910|P5|STARTED|Open Label Acute Phase (8 Weeks)||0
8661172|NCT02093663|21382911|P4|STARTED|Open Label Acute Phase (8 Weeks)||0
8661173|NCT02093663|21382912|P3|STARTED|Open Label Acute Phase (8 Weeks)||18
8661174|NCT02093663|21382913|P2|STARTED|Open Label Acute Phase (8 Weeks)||0
8661175|NCT02093663|21382914|P1|STARTED|Open Label Acute Phase (8 Weeks)||0
8661176|NCT02093663|21382910|P5|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8661177|NCT02093663|21382911|P4|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8661178|NCT02093663|21382912|P3|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8661179|NCT02093663|21382913|P2|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4
8661180|NCT02093663|21382914|P1|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8
8661181|NCT02093663|21382910|P5|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8661182|NCT02093663|21382911|P4|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8661183|NCT02093663|21382912|P3|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
8661184|NCT02093663|21382913|P2|COMPLETED|Double Blind Acute Phase (8 Weeks)||22
8661185|NCT02093663|21382914|P1|COMPLETED|Double Blind Acute Phase (8 Weeks)||19
8661186|NCT02093663|21382910|P5|STARTED|Double Blind Acute Phase (8 Weeks)||0
8661187|NCT02093663|21382911|P4|STARTED|Double Blind Acute Phase (8 Weeks)||0
8661188|NCT02093663|21382912|P3|STARTED|Double Blind Acute Phase (8 Weeks)||0
8661189|NCT02093663|21382913|P2|STARTED|Double Blind Acute Phase (8 Weeks)||26
8661190|NCT02093663|21382914|P1|STARTED|Double Blind Acute Phase (8 Weeks)||27
8661191|NCT01983228|21382943|P2|NOT COMPLETED|Overall Study||62
8661192|NCT01983228|21382944|P1|NOT COMPLETED|Overall Study||38
8661193|NCT01983228|21382943|P2|COMPLETED|Overall Study||189
8661194|NCT01983228|21382944|P1|COMPLETED|Overall Study||211
8661195|NCT01983228|21382943|P2|STARTED|Overall Study||251
8661196|NCT01983228|21382944|P1|STARTED|Overall Study||249
8661203|NCT01968707|21382987|P8|NOT COMPLETED|Overall Study||35
8661204|NCT01968707|21382988|P7|NOT COMPLETED|Overall Study||34
8661205|NCT01968707|21382989|P6|NOT COMPLETED|Overall Study||11
8661206|NCT01968707|21382990|P5|NOT COMPLETED|Overall Study||36
8661207|NCT01968707|21382991|P4|NOT COMPLETED|Overall Study||44
8661208|NCT01968707|21382992|P3|NOT COMPLETED|Overall Study||41
8661209|NCT01968707|21382993|P2|NOT COMPLETED|Overall Study||12
8661210|NCT01968707|21382994|P1|NOT COMPLETED|Overall Study||49
8661211|NCT01968707|21382987|P8|COMPLETED|Overall Study||203
8661212|NCT01968707|21382988|P7|COMPLETED|Overall Study||204
8661213|NCT01968707|21382989|P6|COMPLETED|Overall Study||59
8661214|NCT01968707|21382990|P5|COMPLETED|Overall Study||200
8661215|NCT01968707|21382991|P4|COMPLETED|Overall Study||201
8661216|NCT01968707|21382992|P3|COMPLETED|Overall Study||205
8661217|NCT01968707|21382993|P2|COMPLETED|Overall Study||62
8661218|NCT01968707|21382994|P1|COMPLETED|Overall Study||198
8661219|NCT01968707|21382987|P8|STARTED|Overall Study||238
8661220|NCT01968707|21382988|P7|STARTED|Overall Study||238
8661221|NCT01968707|21382989|P6|STARTED|Overall Study||70
8661222|NCT01968707|21382990|P5|STARTED|Overall Study||236
8661223|NCT01968707|21382991|P4|STARTED|Overall Study||245
8661224|NCT01968707|21382992|P3|STARTED|Overall Study||246
8661225|NCT01968707|21382993|P2|STARTED|Overall Study||74
8661226|NCT01968707|21382994|P1|STARTED|Overall Study||247
8661227|NCT01952080|21383064|P4|NOT COMPLETED|Overall Study||1
8661228|NCT01952080|21383065|P3|NOT COMPLETED|Overall Study||0
8661229|NCT01952080|21383066|P2|NOT COMPLETED|Overall Study||1
8661230|NCT01952080|21383067|P1|NOT COMPLETED|Overall Study||0
8661231|NCT01952080|21383064|P4|COMPLETED|Overall Study||14
8661232|NCT01952080|21383065|P3|COMPLETED|Overall Study||14
8661233|NCT01952080|21383066|P2|COMPLETED|Overall Study||7
8661234|NCT01952080|21383067|P1|COMPLETED|Overall Study||5
8661235|NCT01952080|21383064|P4|Treated|Overall Study||15
8661236|NCT01952080|21383065|P3|Treated|Overall Study||14
8661237|NCT01952080|21383066|P2|Treated|Overall Study||8
8661238|NCT01952080|21383067|P1|Treated|Overall Study||5
8661239|NCT01952080|21383064|P4|STARTED|Overall Study||15
8661240|NCT01952080|21383065|P3|STARTED|Overall Study||14
8661241|NCT01952080|21383066|P2|STARTED|Overall Study||8
8661242|NCT01952080|21383067|P1|STARTED|Overall Study||5
8661243|NCT01861002|21383113|P1|NOT COMPLETED|Overall Study||1
8661244|NCT01861002|21383113|P1|COMPLETED|Overall Study||14
8661245|NCT01861002|21383113|P1|STARTED|Overall Study||15
8661254|NCT01722604|21383144|P2|NOT COMPLETED|Overall Study||9
8661255|NCT01722604|21383145|P1|NOT COMPLETED|Overall Study||6
8661256|NCT01722604|21383144|P2|COMPLETED|Overall Study||120
8661257|NCT01722604|21383145|P1|COMPLETED|Overall Study||123
8661258|NCT01722604|21383144|P2|STARTED|Overall Study||129
8661259|NCT01722604|21383145|P1|STARTED|Overall Study||129
8661260|NCT01665144|21383155|P2|NOT COMPLETED|Overall Study||122
8661261|NCT01665144|21383156|P1|NOT COMPLETED|Overall Study||202
8661262|NCT01665144|21383155|P2|COMPLETED|Overall Study||424
8661263|NCT01665144|21383156|P1|COMPLETED|Overall Study||903
8661264|NCT01665144|21383155|P2|Full Analysis Set|Overall Study||546
8661265|NCT01665144|21383156|P1|Full Analysis Set|Overall Study||1099
8661266|NCT01665144|21383155|P2|Safety Set|Overall Study||546
8661267|NCT01665144|21383156|P1|Safety Set|Overall Study||1099
8661268|NCT01665144|21383155|P2|STARTED|Overall Study||546
8661269|NCT01665144|21383156|P1|STARTED|Overall Study||1105
8661270|NCT01657019|21383162|P1|NOT COMPLETED|Overall Study||235
8661271|NCT01657019|21383162|P1|COMPLETED|Overall Study||369
8661272|NCT01657019|21383162|P1|STARTED|Overall Study||604
8661273|NCT01619085|21383174|P1|NOT COMPLETED|Overall Study||369
8661274|NCT01619085|21383174|P1|COMPLETED|Overall Study|Total 341 patients did not complete the trial.|366
8661275|NCT01619085|21383174|P1|STARTED|Overall Study|27 patients were ongoing on trial at database lock. 1 patient was not treated with trial drugs.|735
8661276|NCT01601860|21383180|P2|NOT COMPLETED|Overall Study||9
8661277|NCT01601860|21383181|P1|NOT COMPLETED|Overall Study||21
8661278|NCT01601860|21383180|P2|COMPLETED|Overall Study||31
8661279|NCT01601860|21383181|P1|COMPLETED|Overall Study||19
8661280|NCT01601860|21383180|P2|STARTED|Overall Study||40
8661281|NCT01601860|21383181|P1|STARTED|Overall Study||40
8661282|NCT01561963|21383207|P1|NOT COMPLETED|Overall Study||1
8661283|NCT01561963|21383207|P1|COMPLETED|Overall Study||20
8661284|NCT01561963|21383207|P1|Received Period 3 Treatment|Overall Study||20
8661285|NCT01561963|21383207|P1|Received Period 2 Treatment|Overall Study||20
8661286|NCT01561963|21383207|P1|Received Period 1 Treatment|Overall Study||21
8661287|NCT01561963|21383207|P1|STARTED|Overall Study||21
8661288|NCT01552928|21383238|P4|NOT COMPLETED|Period 4||0
8661289|NCT01552928|21383239|P3|NOT COMPLETED|Period 4||0
8661290|NCT01552928|21383240|P2|NOT COMPLETED|Period 4||0
8661291|NCT01552928|21383241|P1|NOT COMPLETED|Period 4||0
8661292|NCT01552928|21383238|P4|COMPLETED|Period 4||16
8661293|NCT01552928|21383239|P3|COMPLETED|Period 4||14
8661294|NCT01552928|21383240|P2|COMPLETED|Period 4||15
8661295|NCT01552928|21383241|P1|COMPLETED|Period 4||14
8661296|NCT01552928|21383238|P4|STARTED|Period 4||16
8661297|NCT01552928|21383239|P3|STARTED|Period 4||14
8661298|NCT01552928|21383240|P2|STARTED|Period 4||15
8661299|NCT01552928|21383241|P1|STARTED|Period 4||14
8661300|NCT01552928|21383238|P4|NOT COMPLETED|Period 3||0
8661301|NCT01552928|21383239|P3|NOT COMPLETED|Period 3||1
8661302|NCT01552928|21383240|P2|NOT COMPLETED|Period 3||0
8661303|NCT01552928|21383241|P1|NOT COMPLETED|Period 3||0
8661304|NCT01552928|21383238|P4|COMPLETED|Period 3||16
8661305|NCT01552928|21383239|P3|COMPLETED|Period 3||14
8661306|NCT01552928|21383240|P2|COMPLETED|Period 3||15
8661307|NCT01552928|21383241|P1|COMPLETED|Period 3||14
8661308|NCT01552928|21383238|P4|STARTED|Period 3||16
8661309|NCT01552928|21383239|P3|STARTED|Period 3||15
8661310|NCT01552928|21383240|P2|STARTED|Period 3||15
8661311|NCT01552928|21383241|P1|STARTED|Period 3||14
8661312|NCT01552928|21383238|P4|NOT COMPLETED|Period 2||0
8661313|NCT01552928|21383239|P3|NOT COMPLETED|Period 2||0
8661314|NCT01552928|21383240|P2|NOT COMPLETED|Period 2||0
8661315|NCT01552928|21383241|P1|NOT COMPLETED|Period 2||0
8661316|NCT01552928|21383238|P4|COMPLETED|Period 2||16
8661317|NCT01552928|21383239|P3|COMPLETED|Period 2||15
8661318|NCT01552928|21383240|P2|COMPLETED|Period 2||15
8661319|NCT01552928|21383241|P1|COMPLETED|Period 2||14
8661320|NCT01552928|21383238|P4|STARTED|Period 2||16
8661321|NCT01552928|21383239|P3|STARTED|Period 2||15
8661322|NCT01552928|21383240|P2|STARTED|Period 2||15
8661323|NCT01552928|21383241|P1|STARTED|Period 2||14
8661324|NCT01552928|21383238|P4|NOT COMPLETED|Period 1||0
8661325|NCT01552928|21383239|P3|NOT COMPLETED|Period 1||0
8661326|NCT01552928|21383240|P2|NOT COMPLETED|Period 1||0
8661327|NCT01552928|21383241|P1|NOT COMPLETED|Period 1||0
8661328|NCT01552928|21383238|P4|COMPLETED|Period 1||16
8661329|NCT01552928|21383239|P3|COMPLETED|Period 1||15
8661330|NCT01552928|21383240|P2|COMPLETED|Period 1||15
8661331|NCT01552928|21383241|P1|COMPLETED|Period 1||14
8661332|NCT01552928|21383238|P4|STARTED|Period 1||16
8661333|NCT01552928|21383239|P3|STARTED|Period 1||15
8661334|NCT01552928|21383240|P2|STARTED|Period 1||15
8661335|NCT01552928|21383241|P1|STARTED|Period 1||14
8661336|NCT01515865|21383285|P3|NOT COMPLETED|Part C (Randomized)||0
8661337|NCT01515865|21383286|P2|NOT COMPLETED|Part C (Randomized)||0
8661338|NCT01515865|21383287|P1|NOT COMPLETED|Part C (Randomized)||0
8661339|NCT01515865|21383285|P3|COMPLETED|Part C (Randomized)||34
8661340|NCT01515865|21383286|P2|COMPLETED|Part C (Randomized)||33
8661341|NCT01515865|21383287|P1|COMPLETED|Part C (Randomized)||0
8661342|NCT01515865|21383285|P3|STARTED|Part C (Randomized)||34
8661343|NCT01515865|21383286|P2|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
8661344|NCT01515865|21383287|P1|STARTED|Part C (Randomized)||0
8661345|NCT01515865|21383285|P3|NOT COMPLETED|Part B (Open-label)||0
8661346|NCT01515865|21383286|P2|NOT COMPLETED|Part B (Open-label)||0
8661347|NCT01515865|21383287|P1|NOT COMPLETED|Part B (Open-label)||2
8661348|NCT01515865|21383285|P3|COMPLETED|Part B (Open-label)||0
8661349|NCT01515865|21383286|P2|COMPLETED|Part B (Open-label)||0
8661350|NCT01515865|21383287|P1|COMPLETED|Part B (Open-label)||69
8661351|NCT01515865|21383285|P3|STARTED|Part B (Open-label)||0
8661352|NCT01515865|21383286|P2|STARTED|Part B (Open-label)||0
8661353|NCT01515865|21383287|P1|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
8661354|NCT01515865|21383285|P3|NOT COMPLETED|Part A (Open-label)||0
8661355|NCT01515865|21383286|P2|NOT COMPLETED|Part A (Open-label)||0
8661356|NCT01515865|21383287|P1|NOT COMPLETED|Part A (Open-label)||3
8661357|NCT01515865|21383285|P3|COMPLETED|Part A (Open-label)||0
8661358|NCT01515865|21383286|P2|COMPLETED|Part A (Open-label)||0
8661359|NCT01515865|21383287|P1|COMPLETED|Part A (Open-label)||95
8661360|NCT01515865|21383285|P3|STARTED|Part A (Open-label)||0
8661361|NCT01515865|21383286|P2|STARTED|Part A (Open-label)||0
8661362|NCT01515865|21383287|P1|STARTED|Part A (Open-label)||98
8661363|NCT01500109|21383298|P3|NOT COMPLETED|Overall Study||0
8661364|NCT01500109|21383299|P2|NOT COMPLETED|Overall Study||0
8661365|NCT01500109|21383300|P1|NOT COMPLETED|Overall Study||0
8661366|NCT01500109|21383298|P3|COMPLETED|Overall Study||0
8661367|NCT01500109|21383299|P2|COMPLETED|Overall Study||0
8661368|NCT01500109|21383300|P1|COMPLETED|Overall Study||0
8661369|NCT01500109|21383298|P3|STARTED|Overall Study||0
8661370|NCT01500109|21383299|P2|STARTED|Overall Study||0
8661371|NCT01500109|21383300|P1|STARTED|Overall Study||0
8661372|NCT01472939|21383312|P4|NOT COMPLETED|Overall Study||20
8661373|NCT01472939|21383313|P3|NOT COMPLETED|Overall Study||11
8661374|NCT01472939|21383314|P2|NOT COMPLETED|Overall Study||14
8661375|NCT01472939|21383315|P1|NOT COMPLETED|Overall Study||20
8661376|NCT01472939|21383312|P4|COMPLETED|Overall Study||99
8661377|NCT01472939|21383313|P3|COMPLETED|Overall Study||108
8661378|NCT01472939|21383314|P2|COMPLETED|Overall Study||105
8661379|NCT01472939|21383315|P1|COMPLETED|Overall Study||103
8661380|NCT01472939|21383312|P4|STARTED|Overall Study||119
8661381|NCT01472939|21383313|P3|STARTED|Overall Study||119
8661382|NCT01472939|21383314|P2|STARTED|Overall Study||119
8661383|NCT01472939|21383315|P1|STARTED|Overall Study||123
8661384|NCT01467661|21383342|P1|NOT COMPLETED|Overall Study||21
8661385|NCT01467661|21383342|P1|COMPLETED|Overall Study||32
8661386|NCT01467661|21383342|P1|Started Post Marketing Trial|Overall Study||33
8661387|NCT01467661|21383342|P1|Started SPD422-309 (NCT01467661)|Overall Study||41
8661388|NCT01467661|21383342|P1|Completed SPD422-308 (NCT01214915)|Overall Study||42
8661389|NCT01467661|21383342|P1|STARTED|Overall Study||53
8661390|NCT01449240|21383359|P1|NOT COMPLETED|Overall Study||0
8661391|NCT01449240|21383359|P1|COMPLETED|Overall Study||10
8661392|NCT01449240|21383359|P1|STARTED|Overall Study||10
8661393|NCT01442688|21383366|P2|NOT COMPLETED|Second Intervention||0
8661394|NCT01442688|21383367|P1|NOT COMPLETED|Second Intervention||1
8661395|NCT01442688|21383366|P2|COMPLETED|Second Intervention||31
8661396|NCT01442688|21383367|P1|COMPLETED|Second Intervention||28
8661397|NCT01442688|21383366|P2|STARTED|Second Intervention||31
8661398|NCT01442688|21383367|P1|STARTED|Second Intervention||29
8661399|NCT01442688|21383366|P2|NOT COMPLETED|First Intervention||0
8661400|NCT01442688|21383367|P1|NOT COMPLETED|First Intervention||2
8661401|NCT01442688|21383366|P2|COMPLETED|First Intervention||31
8661402|NCT01442688|21383367|P1|COMPLETED|First Intervention||29
8661403|NCT01442688|21383366|P2|STARTED|First Intervention||31
8661404|NCT01442688|21383367|P1|STARTED|First Intervention||31
8661405|NCT01436162|21383377|P3|NOT COMPLETED|Randomized Phase||25
8661406|NCT01436162|21383378|P2|NOT COMPLETED|Randomized Phase||31
8661407|NCT01436162|21383379|P1|NOT COMPLETED|Randomized Phase||44
8661408|NCT01436162|21383377|P3|COMPLETED|Randomized Phase||189
8661409|NCT01436162|21383378|P2|COMPLETED|Randomized Phase||181
8661410|NCT01436162|21383379|P1|COMPLETED|Randomized Phase||353
8661411|NCT01436162|21383377|P3|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
8661412|NCT01436162|21383378|P2|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
8661413|NCT01436162|21383379|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
8661414|NCT01436162|21383377|P3|NOT COMPLETED|Single-blind Lead-in Phase||0
8661415|NCT01436162|21383378|P2|NOT COMPLETED|Single-blind Lead-in Phase||0
8661416|NCT01436162|21383379|P1|NOT COMPLETED|Single-blind Lead-in Phase||282
8661417|NCT01436162|21383377|P3|COMPLETED|Single-blind Lead-in Phase||0
8661418|NCT01436162|21383378|P2|COMPLETED|Single-blind Lead-in Phase||0
8661419|NCT01436162|21383379|P1|COMPLETED|Single-blind Lead-in Phase||823
8661420|NCT01436162|21383377|P3|STARTED|Single-blind Lead-in Phase||0
8661421|NCT01436162|21383378|P2|STARTED|Single-blind Lead-in Phase||0
8661422|NCT01436162|21383379|P1|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
8661423|NCT01436149|21383413|P3|NOT COMPLETED|Randomized Phase||42
8661424|NCT01436149|21383414|P2|NOT COMPLETED|Randomized Phase||38
8661425|NCT01436149|21383415|P1|NOT COMPLETED|Randomized Phase||77
8661426|NCT01436149|21383413|P3|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
8661427|NCT01436149|21383414|P2|COMPLETED|Randomized Phase||164
8661428|NCT01436149|21383415|P1|COMPLETED|Randomized Phase||415
8661429|NCT01436149|21383413|P3|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
8661430|NCT01436149|21383414|P2|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
8661431|NCT01436149|21383415|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
8661432|NCT01436149|21383413|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
8661433|NCT01436149|21383414|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
8661434|NCT01436149|21383415|P1|NOT COMPLETED|Antidepressant Lead-in Phase||366
8661435|NCT01436149|21383413|P3|COMPLETED|Antidepressant Lead-in Phase||0
8661436|NCT01436149|21383414|P2|COMPLETED|Antidepressant Lead-in Phase||0
8661437|NCT01436149|21383415|P1|COMPLETED|Antidepressant Lead-in Phase||896
8661438|NCT01436149|21383413|P3|STARTED|Antidepressant Lead-in Phase||0
8661439|NCT01436149|21383414|P2|STARTED|Antidepressant Lead-in Phase||0
8661440|NCT01436149|21383415|P1|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
8661441|NCT01435759|21383448|P6|NOT COMPLETED|Double-blind Phase||9
8661442|NCT01435759|21383449|P5|NOT COMPLETED|Double-blind Phase||9
8661443|NCT01435759|21383450|P4|NOT COMPLETED|Double-blind Phase||9
8661444|NCT01435759|21383451|P3|NOT COMPLETED|Double-blind Phase||7
8661445|NCT01435759|21383452|P2|NOT COMPLETED|Double-blind Phase||7
8661446|NCT01435759|21383453|P1|NOT COMPLETED|Double-blind Phase||66
8661447|NCT01435759|21383448|P6|COMPLETED|Double-blind Phase||71
8661448|NCT01435759|21383449|P5|COMPLETED|Double-blind Phase||69
8661449|NCT01435759|21383450|P4|COMPLETED|Double-blind Phase||69
8661450|NCT01435759|21383451|P3|COMPLETED|Double-blind Phase||71
8661451|NCT01435759|21383452|P2|COMPLETED|Double-blind Phase||71
8661452|NCT01435759|21383453|P1|COMPLETED|Double-blind Phase||397
8661453|NCT01435759|21383448|P6|STARTED|Double-blind Phase||80
8661454|NCT01435759|21383449|P5|STARTED|Double-blind Phase||78
8661455|NCT01435759|21383450|P4|STARTED|Double-blind Phase|Two subjects were not dosed.|78
8661456|NCT01435759|21383451|P3|STARTED|Double-blind Phase|One subject was not dosed.|78
8661457|NCT01435759|21383452|P2|STARTED|Double-blind Phase||78
8661458|NCT01435759|21383453|P1|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
8661459|NCT01435759|21383448|P6|NOT COMPLETED|Antidepressant Lead-in Phase||0
8661460|NCT01435759|21383449|P5|NOT COMPLETED|Antidepressant Lead-in Phase||0
8661461|NCT01435759|21383450|P4|NOT COMPLETED|Antidepressant Lead-in Phase||0
8661462|NCT01435759|21383451|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
8661463|NCT01435759|21383452|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
8661464|NCT01435759|21383453|P1|NOT COMPLETED|Antidepressant Lead-in Phase||342
8661465|NCT01435759|21383448|P6|COMPLETED|Antidepressant Lead-in Phase||0
8661466|NCT01435759|21383449|P5|COMPLETED|Antidepressant Lead-in Phase||0
8661467|NCT01435759|21383450|P4|COMPLETED|Antidepressant Lead-in Phase||0
8661468|NCT01435759|21383451|P3|COMPLETED|Antidepressant Lead-in Phase||0
8661469|NCT01435759|21383452|P2|COMPLETED|Antidepressant Lead-in Phase||0
8661470|NCT01435759|21383453|P1|COMPLETED|Antidepressant Lead-in Phase||855
8661471|NCT01435759|21383448|P6|STARTED|Antidepressant Lead-in Phase||0
8661472|NCT01435759|21383449|P5|STARTED|Antidepressant Lead-in Phase||0
8661473|NCT01435759|21383450|P4|STARTED|Antidepressant Lead-in Phase||0
8661474|NCT01435759|21383451|P3|STARTED|Antidepressant Lead-in Phase||0
8661475|NCT01435759|21383452|P2|STARTED|Antidepressant Lead-in Phase||0
8661476|NCT01435759|21383453|P1|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
8661477|NCT01418365|21383482|P2|NOT COMPLETED|Second Intervention||1
8661478|NCT01418365|21383483|P1|NOT COMPLETED|Second Intervention||0
8661479|NCT01418365|21383482|P2|COMPLETED|Second Intervention||13
8661480|NCT01418365|21383483|P1|COMPLETED|Second Intervention||14
8661481|NCT01418365|21383482|P2|STARTED|Second Intervention||14
8661482|NCT01418365|21383483|P1|STARTED|Second Intervention||14
8661483|NCT01418365|21383482|P2|NOT COMPLETED|First Intervention||1
8661484|NCT01418365|21383483|P1|NOT COMPLETED|First Intervention||1
8661485|NCT01418365|21383482|P2|COMPLETED|First Intervention||14
8661486|NCT01418365|21383483|P1|COMPLETED|First Intervention||14
8661487|NCT01418365|21383482|P2|STARTED|First Intervention||15
8661488|NCT01418365|21383483|P1|STARTED|First Intervention||15
8661489|NCT01402947|21383493|P2|NOT COMPLETED|Second Intervention||0
8661490|NCT01402947|21383494|P1|NOT COMPLETED|Second Intervention||0
8661491|NCT01402947|21383493|P2|COMPLETED|Second Intervention||14
8661492|NCT01402947|21383494|P1|COMPLETED|Second Intervention||15
8661493|NCT01402947|21383493|P2|STARTED|Second Intervention||14
8661494|NCT01402947|21383494|P1|STARTED|Second Intervention||15
8661495|NCT01402947|21383493|P2|NOT COMPLETED|First Intervention||1
8661496|NCT01402947|21383494|P1|NOT COMPLETED|First Intervention||0
8661497|NCT01402947|21383493|P2|COMPLETED|First Intervention||14
8661498|NCT01402947|21383494|P1|COMPLETED|First Intervention||15
8661499|NCT01402947|21383493|P2|STARTED|First Intervention||15
8661500|NCT01402947|21383494|P1|STARTED|First Intervention||15
8661501|NCT01363492|21383502|P1|NOT COMPLETED|Overall Study||0
8661502|NCT01363492|21383502|P1|COMPLETED|Overall Study||14
8661503|NCT01363492|21383502|P1|STARTED|Overall Study||14
8661504|NCT01351753|21383521|P6|NOT COMPLETED|Overall Study||1
8661505|NCT01351753|21383522|P5|NOT COMPLETED|Overall Study||7
8661506|NCT01351753|21383523|P4|NOT COMPLETED|Overall Study||0
8661507|NCT01351753|21383524|P3|NOT COMPLETED|Overall Study||7
8661508|NCT01351753|21383525|P2|NOT COMPLETED|Overall Study||7
8661509|NCT01351753|21383526|P1|NOT COMPLETED|Overall Study||7
8661510|NCT01351753|21383521|P6|COMPLETED|Overall Study||22
8661511|NCT01351753|21383522|P5|COMPLETED|Overall Study||14
8661512|NCT01351753|21383523|P4|COMPLETED|Overall Study||21
8661513|NCT01351753|21383524|P3|COMPLETED|Overall Study||14
8661514|NCT01351753|21383525|P2|COMPLETED|Overall Study||13
8661515|NCT01351753|21383526|P1|COMPLETED|Overall Study||15
8661516|NCT01351753|21383521|P6|STARTED|Overall Study||23
8661517|NCT01351753|21383522|P5|STARTED|Overall Study||21
8661518|NCT01351753|21383523|P4|STARTED|Overall Study||21
8661519|NCT01351753|21383524|P3|STARTED|Overall Study||21
8661520|NCT01351753|21383525|P2|STARTED|Overall Study||20
8661521|NCT01351753|21383526|P1|STARTED|Overall Study||22
8661522|NCT01214915|21383558|P1|NOT COMPLETED|Overall Study||11
8661523|NCT01214915|21383558|P1|COMPLETED|Overall Study||42
8661524|NCT01214915|21383558|P1|STARTED|Overall Study||53
8661525|NCT01183234|21383568|P2|NOT COMPLETED|Second Intervention||0
8661526|NCT01183234|21383569|P1|NOT COMPLETED|Second Intervention||0
8661527|NCT01183234|21383568|P2|COMPLETED|Second Intervention||14
8661528|NCT01183234|21383569|P1|COMPLETED|Second Intervention||13
8661529|NCT01183234|21383568|P2|STARTED|Second Intervention||14
8661530|NCT01183234|21383569|P1|STARTED|Second Intervention||13
8661531|NCT01183234|21383568|P2|NOT COMPLETED|Washout||0
8661532|NCT01183234|21383569|P1|NOT COMPLETED|Washout||0
8661533|NCT01183234|21383568|P2|COMPLETED|Washout||14
8661534|NCT01183234|21383569|P1|COMPLETED|Washout||13
8661535|NCT01183234|21383568|P2|STARTED|Washout||14
8661536|NCT01183234|21383569|P1|STARTED|Washout||13
8661537|NCT01183234|21383568|P2|NOT COMPLETED|First Intervention||0
8661538|NCT01183234|21383569|P1|NOT COMPLETED|First Intervention||1
8661539|NCT01183234|21383568|P2|COMPLETED|First Intervention||14
8661540|NCT01183234|21383569|P1|COMPLETED|First Intervention||13
8661541|NCT01183234|21383568|P2|STARTED|First Intervention||14
8661542|NCT01183234|21383569|P1|STARTED|First Intervention||14
8661543|NCT01166984|21383584|P5|NOT COMPLETED|Overall Study||0
8661544|NCT01166984|21383585|P4|NOT COMPLETED|Overall Study||0
8661545|NCT01166984|21383586|P3|NOT COMPLETED|Overall Study||0
8661546|NCT01166984|21383587|P2|NOT COMPLETED|Overall Study||0
8661547|NCT01166984|21383588|P1|NOT COMPLETED|Overall Study||0
8661548|NCT01166984|21383584|P5|COMPLETED|Overall Study||5
8661549|NCT01166984|21383585|P4|COMPLETED|Overall Study||5
8661550|NCT01166984|21383586|P3|COMPLETED|Overall Study||5
8661551|NCT01166984|21383587|P2|COMPLETED|Overall Study||5
8661552|NCT01166984|21383588|P1|COMPLETED|Overall Study||5
8661553|NCT01166984|21383584|P5|STARTED|Overall Study||5
8661554|NCT01166984|21383585|P4|STARTED|Overall Study||5
8661555|NCT01166984|21383586|P3|STARTED|Overall Study||5
8661556|NCT01166984|21383587|P2|STARTED|Overall Study||5
8661557|NCT01166984|21383588|P1|STARTED|Overall Study||5
8661558|NCT01128179|21383625|P2|NOT COMPLETED|Overall Study||0
8661559|NCT01128179|21383626|P1|NOT COMPLETED|Overall Study||2
8661560|NCT01128179|21383625|P2|COMPLETED|Overall Study||12
8661561|NCT01128179|21383626|P1|COMPLETED|Overall Study||21
8661562|NCT01128179|21383625|P2|STARTED|Overall Study||12
8661563|NCT01128179|21383626|P1|STARTED|Overall Study||23
8661564|NCT01124149|21383644|P1|NOT COMPLETED|Maintenance Phase||96
8661565|NCT01124149|21383644|P1|COMPLETED|Maintenance Phase||373
8661566|NCT01124149|21383644|P1|STARTED|Maintenance Phase||469
8661567|NCT01124149|21383644|P1|NOT COMPLETED|Acute Phase||83
8661568|NCT01124149|21383644|P1|COMPLETED|Acute Phase||639
8661569|NCT01124149|21383644|P1|STARTED|Acute Phase||722
8661570|NCT01101022|21383662|P2|NOT COMPLETED|Overall Study||27
8661571|NCT01101022|21383663|P1|NOT COMPLETED|Overall Study||17
8661572|NCT01101022|21383662|P2|COMPLETED|Overall Study||53
8661573|NCT01101022|21383663|P1|COMPLETED|Overall Study||62
8661574|NCT01101022|21383662|P2|STARTED|Overall Study||80
8661575|NCT01101022|21383663|P1|STARTED|Overall Study||79
8661576|NCT00993798|21383700|P5|NOT COMPLETED|Overall Study||0
8661577|NCT00993798|21383701|P4|NOT COMPLETED|Overall Study||0
8661578|NCT00993798|21383702|P3|NOT COMPLETED|Overall Study||0
8661579|NCT00993798|21383703|P2|NOT COMPLETED|Overall Study||0
8661580|NCT00993798|21383704|P1|NOT COMPLETED|Overall Study||0
8661581|NCT00993798|21383700|P5|COMPLETED|Overall Study||0
8661582|NCT00993798|21383701|P4|COMPLETED|Overall Study||0
8661583|NCT00993798|21383702|P3|COMPLETED|Overall Study||29
8661584|NCT00993798|21383703|P2|COMPLETED|Overall Study||25
8661585|NCT00993798|21383704|P1|COMPLETED|Overall Study||53
8661586|NCT00993798|21383700|P5|STARTED|Overall Study||0
8661587|NCT00993798|21383701|P4|STARTED|Overall Study||0
8661588|NCT00993798|21383702|P3|STARTED|Overall Study||29
8661589|NCT00993798|21383703|P2|STARTED|Overall Study||25
8661590|NCT00993798|21383704|P1|STARTED|Overall Study||53
8661603|NCT00922272|21383755|P2|NOT COMPLETED|Double-blind Phase||6
8661604|NCT00922272|21383756|P1|NOT COMPLETED|Double-blind Phase||7
8661605|NCT00922272|21383755|P2|COMPLETED|Double-blind Phase||29
8661606|NCT00922272|21383756|P1|COMPLETED|Double-blind Phase||27
8661607|NCT00922272|21383755|P2|STARTED|Double-blind Phase||35
8661608|NCT00922272|21383756|P1|STARTED|Double-blind Phase||34
8661609|NCT00922272|21383755|P2|NOT COMPLETED|Open-label Phase||0
8661610|NCT00922272|21383756|P1|NOT COMPLETED|Open-label Phase||23
8661611|NCT00922272|21383755|P2|COMPLETED|Open-label Phase||0
8661612|NCT00922272|21383756|P1|COMPLETED|Open-label Phase||69
8661613|NCT00922272|21383755|P2|STARTED|Open-label Phase||0
8661614|NCT00922272|21383756|P1|STARTED|Open-label Phase||92
8661615|NCT00890916|21383812|P1|NOT COMPLETED|"Rehab - NP Off"||0
8661616|NCT00890916|21383812|P1|COMPLETED|"Rehab - NP Off"||10
8661617|NCT00890916|21383812|P1|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
8661618|NCT00890916|21383812|P1|STARTED|"Rehab - NP Off"||10
8661619|NCT00890916|21383812|P1|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
8661620|NCT00890916|21383812|P1|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
8661621|NCT00890916|21383812|P1|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
8661622|NCT00890916|21383812|P1|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
8661629|NCT00864851|21383836|P3|NOT COMPLETED|Overall Study||0
8661630|NCT00864851|21383837|P2|NOT COMPLETED|Overall Study||1
8661631|NCT00864851|21383838|P1|NOT COMPLETED|Overall Study||3
8661632|NCT00864851|21383836|P3|COMPLETED|Overall Study||5
8661633|NCT00864851|21383837|P2|COMPLETED|Overall Study||18
8661634|NCT00864851|21383838|P1|COMPLETED|Overall Study||17
8661635|NCT00864851|21383836|P3|STARTED|Overall Study||5
8661636|NCT00864851|21383837|P2|STARTED|Overall Study||19
8661637|NCT00864851|21383838|P1|STARTED|Overall Study||20
8661638|NCT00784654|21383872|P3|NOT COMPLETED|Randomized Withdrawal Period||63
8661639|NCT00784654|21383873|P2|NOT COMPLETED|Randomized Withdrawal Period||18
8661640|NCT00784654|21383874|P1|NOT COMPLETED|Randomized Withdrawal Period||0
8661641|NCT00784654|21383872|P3|COMPLETED|Randomized Withdrawal Period||16
8661642|NCT00784654|21383873|P2|COMPLETED|Randomized Withdrawal Period||60
8661643|NCT00784654|21383874|P1|COMPLETED|Randomized Withdrawal Period||0
8661644|NCT00784654|21383872|P3|STARTED|Randomized Withdrawal Period||79
8661645|NCT00784654|21383873|P2|STARTED|Randomized Withdrawal Period||78
8661646|NCT00784654|21383874|P1|STARTED|Randomized Withdrawal Period||0
8661647|NCT00784654|21383872|P3|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
8661648|NCT00784654|21383873|P2|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
8661649|NCT00784654|21383874|P1|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
8661650|NCT00784654|21383872|P3|COMPLETED|Open-Label Period (Non-Randomized)||0
8661651|NCT00784654|21383873|P2|COMPLETED|Open-Label Period (Non-Randomized)||0
8661652|NCT00784654|21383874|P1|COMPLETED|Open-Label Period (Non-Randomized)||165
8661653|NCT00784654|21383872|P3|STARTED|Open-Label Period (Non-Randomized)||0
8661654|NCT00784654|21383873|P2|STARTED|Open-Label Period (Non-Randomized)||0
8661655|NCT00784654|21383874|P1|STARTED|Open-Label Period (Non-Randomized)||276
8661656|NCT00776555|21383908|P2|NOT COMPLETED|Overall Study||0
8661657|NCT00776555|21383909|P1|NOT COMPLETED|Overall Study||3
8661658|NCT00776555|21383908|P2|COMPLETED|Overall Study||0
8661659|NCT00776555|21383909|P1|COMPLETED|Overall Study||0
8661660|NCT00776555|21383908|P2|STARTED|Overall Study||0
8661661|NCT00776555|21383909|P1|STARTED|Overall Study||3
8661662|NCT00762307|21383923|P4|NOT COMPLETED|Overall Study||1
8661663|NCT00762307|21383924|P3|NOT COMPLETED|Overall Study||0
8661664|NCT00762307|21383925|P2|NOT COMPLETED|Overall Study||0
8661665|NCT00762307|21383926|P1|NOT COMPLETED|Overall Study||2
8661666|NCT00762307|21383923|P4|COMPLETED|Overall Study||9
8661667|NCT00762307|21383924|P3|COMPLETED|Overall Study||11
8661668|NCT00762307|21383925|P2|COMPLETED|Overall Study||11
8661669|NCT00762307|21383926|P1|COMPLETED|Overall Study||26
8661670|NCT00762307|21383923|P4|STARTED|Overall Study||10
8661671|NCT00762307|21383924|P3|STARTED|Overall Study||11
8661672|NCT00762307|21383925|P2|STARTED|Overall Study||11
8661673|NCT00762307|21383926|P1|STARTED|Overall Study||28
8661674|NCT00697515|21383947|P2|NOT COMPLETED|Second Intervention (Crossover Period)||1
8661675|NCT00697515|21383948|P1|NOT COMPLETED|Second Intervention (Crossover Period)||1
8661676|NCT00697515|21383947|P2|COMPLETED|Second Intervention (Crossover Period)||51
8661677|NCT00697515|21383948|P1|COMPLETED|Second Intervention (Crossover Period)||52
8661678|NCT00697515|21383947|P2|STARTED|Second Intervention (Crossover Period)||52
8661679|NCT00697515|21383948|P1|STARTED|Second Intervention (Crossover Period)||53
8661680|NCT00697515|21383947|P2|NOT COMPLETED|First Intervention (Crossover Period)||12
8661681|NCT00697515|21383948|P1|NOT COMPLETED|First Intervention (Crossover Period)||10
8661682|NCT00697515|21383947|P2|COMPLETED|First Intervention (Crossover Period)||52
8661683|NCT00697515|21383948|P1|COMPLETED|First Intervention (Crossover Period)||53
8661684|NCT00697515|21383947|P2|STARTED|First Intervention (Crossover Period)||64
8661685|NCT00697515|21383948|P1|STARTED|First Intervention (Crossover Period)||63
8661686|NCT00697515|21383947|P2|NOT COMPLETED|Dose Optimization Period||0
8661687|NCT00697515|21383948|P1|NOT COMPLETED|Dose Optimization Period||15
8661688|NCT00697515|21383947|P2|COMPLETED|Dose Optimization Period||0
8661689|NCT00697515|21383948|P1|COMPLETED|Dose Optimization Period||127
8661690|NCT00697515|21383947|P2|STARTED|Dose Optimization Period||0
8661691|NCT00697515|21383948|P1|STARTED|Dose Optimization Period||142
8661692|NCT00688909|21383976|P1|NOT COMPLETED|Overall Study||33
8661693|NCT00688909|21383976|P1|COMPLETED|Overall Study||228
8661694|NCT00688909|21383976|P1|STARTED|Overall Study||261
8661695|NCT00567502|21383989|P4|NOT COMPLETED|Overall Study||87
8661696|NCT00567502|21383990|P3|NOT COMPLETED|Overall Study||908
8661697|NCT00567502|21383991|P2|NOT COMPLETED|Overall Study||33
8661698|NCT00567502|21383992|P1|NOT COMPLETED|Overall Study||241
8661699|NCT00567502|21383989|P4|COMPLETED|Overall Study||23
8661700|NCT00567502|21383990|P3|COMPLETED|Overall Study||1758
8661701|NCT00567502|21383991|P2|COMPLETED|Overall Study||108
8661702|NCT00567502|21383992|P1|COMPLETED|Overall Study||563
8661703|NCT00567502|21383989|P4|Initiated Treatment|Overall Study||38
8661704|NCT00567502|21383990|P3|Initiated Treatment|Overall Study||2666
8661705|NCT00567502|21383991|P2|Initiated Treatment|Overall Study||141
8661706|NCT00567502|21383992|P1|Initiated Treatment|Overall Study||804
8661707|NCT00567502|21383989|P4|STARTED|Overall Study||110
8661708|NCT00567502|21383990|P3|STARTED|Overall Study||2666
8661709|NCT00567502|21383991|P2|STARTED|Overall Study||141
8661710|NCT00567502|21383992|P1|STARTED|Overall Study||804
8661711|NCT00554788|21384030|P3|NOT COMPLETED|Overall Study||14
8661712|NCT00554788|21384031|P2|NOT COMPLETED|Overall Study||6
8661713|NCT00554788|21384032|P1|NOT COMPLETED|Overall Study||7
8661714|NCT00554788|21384030|P3|COMPLETED|Overall Study||7
8661715|NCT00554788|21384031|P2|COMPLETED|Overall Study||12
8661716|NCT00554788|21384032|P1|COMPLETED|Overall Study||14
8661717|NCT00554788|21384030|P3|STARTED|Overall Study||21
8661718|NCT00554788|21384031|P2|STARTED|Overall Study||18
8661719|NCT00554788|21384032|P1|STARTED|Overall Study||21
8661720|NCT00500656|21384048|P4|NOT COMPLETED|Open Label Extension (OLE) Phase||2
8661721|NCT00500656|21384049|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||1
8661722|NCT00500656|21384050|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||12
8661723|NCT00500656|21384051|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||7
8661724|NCT00500656|21384048|P4|COMPLETED|Open Label Extension (OLE) Phase||6
8661725|NCT00500656|21384049|P3|COMPLETED|Open Label Extension (OLE) Phase||1
8661726|NCT00500656|21384050|P2|COMPLETED|Open Label Extension (OLE) Phase||9
8661727|NCT00500656|21384051|P1|COMPLETED|Open Label Extension (OLE) Phase||16
8661728|NCT00500656|21384048|P4|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
8661729|NCT00500656|21384049|P3|STARTED|Open Label Extension (OLE) Phase||2
8661730|NCT00500656|21384050|P2|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
8661731|NCT00500656|21384051|P1|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
8661732|NCT00500656|21384048|P4|NOT COMPLETED|Controlled Phase||8
8661733|NCT00500656|21384049|P3|NOT COMPLETED|Controlled Phase||1
8661734|NCT00500656|21384050|P2|NOT COMPLETED|Controlled Phase||10
8661735|NCT00500656|21384051|P1|NOT COMPLETED|Controlled Phase||10
8661736|NCT00500656|21384048|P4|COMPLETED|Controlled Phase||0
8661737|NCT00500656|21384049|P3|COMPLETED|Controlled Phase||2
8661738|NCT00500656|21384050|P2|COMPLETED|Controlled Phase||28
8661739|NCT00500656|21384051|P1|COMPLETED|Controlled Phase||26
8661740|NCT00500656|21384048|P4|STARTED|Controlled Phase||8
8661741|NCT00500656|21384049|P3|STARTED|Controlled Phase||3
8661742|NCT00500656|21384050|P2|STARTED|Controlled Phase||38
8661743|NCT00500656|21384051|P1|STARTED|Controlled Phase||36
8661744|NCT00343642|21384066|P3|NOT COMPLETED|Overall Study||7
8661745|NCT00343642|21384067|P2|NOT COMPLETED|Overall Study||8
8661746|NCT00343642|21384068|P1|NOT COMPLETED|Overall Study||9
8661747|NCT00343642|21384066|P3|COMPLETED|Overall Study||9
8661748|NCT00343642|21384067|P2|COMPLETED|Overall Study||11
8661749|NCT00343642|21384068|P1|COMPLETED|Overall Study||10
8661750|NCT00343642|21384066|P3|3-6 Months Complete or Flare|Overall Study||2
8661751|NCT00343642|21384067|P2|3-6 Months Complete or Flare|Overall Study||2
8661752|NCT00343642|21384068|P1|3-6 Months Complete or Flare|Overall Study||4
8661753|NCT00343642|21384066|P3|Upto 3 Months Complete or Flare|Overall Study||1
8661754|NCT00343642|21384067|P2|Upto 3 Months Complete or Flare|Overall Study||0
8661755|NCT00343642|21384068|P1|Upto 3 Months Complete or Flare|Overall Study||2
8661756|NCT00343642|21384066|P3|STARTED|Overall Study||16
8661757|NCT00343642|21384067|P2|STARTED|Overall Study||19
8661758|NCT00343642|21384068|P1|STARTED|Overall Study||19
8661759|NCT00320931|21384085|P1|NOT COMPLETED|Overall Study||0
8661760|NCT00320931|21384085|P1|COMPLETED|Overall Study||30
8661761|NCT00320931|21384085|P1|STARTED|Overall Study||30
8661762|NCT00097695|21384093|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
8661763|NCT00097695|21384094|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
8661764|NCT00097695|21384095|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
8661765|NCT00097695|21384096|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
8661766|NCT00097695|21384093|P4|COMPLETED|The Open Label Extension (OLE) Phase||15
8661767|NCT00097695|21384094|P3|COMPLETED|The Open Label Extension (OLE) Phase||1
8661768|NCT00097695|21384095|P2|COMPLETED|The Open Label Extension (OLE) Phase||11
8661769|NCT00097695|21384096|P1|COMPLETED|The Open Label Extension (OLE) Phase||10
8661770|NCT00097695|21384093|P4|STARTED|The Open Label Extension (OLE) Phase||20
8661771|NCT00097695|21384094|P3|STARTED|The Open Label Extension (OLE) Phase||3
8661772|NCT00097695|21384095|P2|STARTED|The Open Label Extension (OLE) Phase||26
8661773|NCT00097695|21384096|P1|STARTED|The Open Label Extension (OLE) Phase||23
8661774|NCT00097695|21384093|P4|NOT COMPLETED|The Controlled Phase||20
8661775|NCT00097695|21384094|P3|NOT COMPLETED|The Controlled Phase||5
8661776|NCT00097695|21384095|P2|NOT COMPLETED|The Controlled Phase||3
8661777|NCT00097695|21384096|P1|NOT COMPLETED|The Controlled Phase||4
8661778|NCT00097695|21384093|P4|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
8661779|NCT00097695|21384094|P3|COMPLETED|The Controlled Phase||3
8661780|NCT00097695|21384095|P2|COMPLETED|The Controlled Phase||26
8661781|NCT00097695|21384096|P1|COMPLETED|The Controlled Phase||23
8661782|NCT00097695|21384093|P4|STARTED|The Controlled Phase||20
8661783|NCT00097695|21384094|P3|STARTED|The Controlled Phase||8
8661784|NCT00097695|21384095|P2|STARTED|The Controlled Phase||29
8661785|NCT00097695|21384096|P1|STARTED|The Controlled Phase||27
8661786|NCT00081458|21384113|P3|NOT COMPLETED|Overall Study||4
8661787|NCT00081458|21384114|P2|NOT COMPLETED|Overall Study||8
8661788|NCT00081458|21384115|P1|NOT COMPLETED|Overall Study||1
8661789|NCT00081458|21384113|P3|COMPLETED|Overall Study||29
8661790|NCT00081458|21384114|P2|COMPLETED|Overall Study||27
8661791|NCT00081458|21384115|P1|COMPLETED|Overall Study||15
8661792|NCT00081458|21384113|P3|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
8661793|NCT00081458|21384114|P2|Received Treatment|Overall Study||35
8661794|NCT00081458|21384115|P1|Received Treatment|Overall Study||16
8661795|NCT00081458|21384113|P3|STARTED|Overall Study||33
8661796|NCT00081458|21384114|P2|STARTED|Overall Study||35
8661797|NCT00081458|21384115|P1|STARTED|Overall Study||16
8661798|NCT00003511|21384126|P1|NOT COMPLETED|Overall Study||4
8661799|NCT00003511|21384126|P1|COMPLETED|Overall Study||1
8661800|NCT00003511|21384126|P1|STARTED|Overall Study||5
8661807|NCT03897634|21384167|P1|NOT COMPLETED|Overall Study||0
8661808|NCT03897634|21384167|P1|COMPLETED|Overall Study||22
8661809|NCT03897634|21384167|P1|STARTED|Overall Study||22
8661810|NCT03868059|21384173|P1|NOT COMPLETED|Overall Study||12
8661811|NCT03868059|21384173|P1|COMPLETED|Overall Study||126
8661812|NCT03868059|21384173|P1|STARTED|Overall Study||138
8661813|NCT03863496|21384202|P1|NOT COMPLETED|Overall Study||0
8661814|NCT03863496|21384202|P1|COMPLETED|Overall Study||71
8661815|NCT03863496|21384202|P1|STARTED|Overall Study||71
8661816|NCT03848949|21384222|P2|NOT COMPLETED|Overall Study||7
8661817|NCT03848949|21384223|P1|NOT COMPLETED|Overall Study||5
8661818|NCT03848949|21384222|P2|COMPLETED|Overall Study||46
8661819|NCT03848949|21384223|P1|COMPLETED|Overall Study||49
8661820|NCT03848949|21384222|P2|STARTED|Overall Study||53
8661821|NCT03848949|21384223|P1|STARTED|Overall Study||54
8661822|NCT03722524|21384231|P1|NOT COMPLETED|Overall Study||99
8661823|NCT03722524|21384231|P1|COMPLETED|Overall Study||1148
8661824|NCT03722524|21384231|P1|STARTED|Overall Study||1247
8661825|NCT03700892|21384241|P3|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
8661826|NCT03700892|21384242|P2|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||1
8661827|NCT03700892|21384243|P1|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
8661828|NCT03700892|21384241|P3|COMPLETED|Second Intervention (Single 1-Day Visit)||0
8661829|NCT03700892|21384242|P2|COMPLETED|Second Intervention (Single 1-Day Visit)||3
8661830|NCT03700892|21384243|P1|COMPLETED|Second Intervention (Single 1-Day Visit)||1
8661831|NCT03700892|21384241|P3|Received Intervention|Second Intervention (Single 1-Day Visit)||0
8661832|NCT03700892|21384242|P2|Received Intervention|Second Intervention (Single 1-Day Visit)||3
8661833|NCT03700892|21384243|P1|Received Intervention|Second Intervention (Single 1-Day Visit)||1
8661834|NCT03700892|21384241|P3|STARTED|Second Intervention (Single 1-Day Visit)||0
8661835|NCT03700892|21384242|P2|STARTED|Second Intervention (Single 1-Day Visit)||4
8661836|NCT03700892|21384243|P1|STARTED|Second Intervention (Single 1-Day Visit)||1
8661837|NCT03700892|21384241|P3|NOT COMPLETED|Washout (2-3 Weeks)||0
8661838|NCT03700892|21384242|P2|NOT COMPLETED|Washout (2-3 Weeks)||0
8661839|NCT03700892|21384243|P1|NOT COMPLETED|Washout (2-3 Weeks)||0
8661840|NCT03700892|21384241|P3|COMPLETED|Washout (2-3 Weeks)||0
8661841|NCT03700892|21384242|P2|COMPLETED|Washout (2-3 Weeks)||4
8661842|NCT03700892|21384243|P1|COMPLETED|Washout (2-3 Weeks)||1
8661843|NCT03700892|21384241|P3|STARTED|Washout (2-3 Weeks)||0
8661844|NCT03700892|21384242|P2|STARTED|Washout (2-3 Weeks)||4
8661845|NCT03700892|21384243|P1|STARTED|Washout (2-3 Weeks)||1
8661846|NCT03700892|21384241|P3|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
8661847|NCT03700892|21384242|P2|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
8661848|NCT03700892|21384243|P1|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
8661849|NCT03700892|21384241|P3|COMPLETED|First Intervention (Single 1-Day Visit)||0
8661850|NCT03700892|21384242|P2|COMPLETED|First Intervention (Single 1-Day Visit)||4
8661851|NCT03700892|21384243|P1|COMPLETED|First Intervention (Single 1-Day Visit)||1
8661852|NCT03700892|21384241|P3|STARTED|First Intervention (Single 1-Day Visit)||0
8661853|NCT03700892|21384242|P2|STARTED|First Intervention (Single 1-Day Visit)||4
8661854|NCT03700892|21384243|P1|STARTED|First Intervention (Single 1-Day Visit)||1
8661855|NCT03700892|21384241|P3|NOT COMPLETED|Baseline||0
8661856|NCT03700892|21384242|P2|NOT COMPLETED|Baseline||0
8661857|NCT03700892|21384243|P1|NOT COMPLETED|Baseline||0
8661858|NCT03700892|21384241|P3|COMPLETED|Baseline||4
8661859|NCT03700892|21384242|P2|COMPLETED|Baseline||0
8661860|NCT03700892|21384243|P1|COMPLETED|Baseline||15
8661861|NCT03700892|21384241|P3|STARTED|Baseline||4
8661862|NCT03700892|21384242|P2|STARTED|Baseline||0
8661863|NCT03700892|21384243|P1|STARTED|Baseline||15
8661864|NCT03670030|21384256|P1|NOT COMPLETED|Overall Study||0
8661865|NCT03670030|21384256|P1|COMPLETED|Overall Study||5
8661866|NCT03670030|21384256|P1|STARTED|Overall Study||5
8661867|NCT03591406|21384263|P2|NOT COMPLETED|Overall Study||9
8661868|NCT03591406|21384264|P1|NOT COMPLETED|Overall Study||7
8661869|NCT03591406|21384263|P2|COMPLETED|Overall Study||174
8661870|NCT03591406|21384264|P1|COMPLETED|Overall Study||181
8661871|NCT03591406|21384263|P2|STARTED|Overall Study||183
8661872|NCT03591406|21384264|P1|STARTED|Overall Study||188
8661879|NCT03396952|21384323|P1|NOT COMPLETED|Overall Study||0
8661880|NCT03396952|21384323|P1|COMPLETED|Overall Study||27
8661881|NCT03396952|21384323|P1|STARTED|Overall Study||27
8661882|NCT03384966|21384332|P3|NOT COMPLETED|Follow-up Period||0
8661883|NCT03384966|21384333|P2|NOT COMPLETED|Follow-up Period||0
8661884|NCT03384966|21384334|P1|NOT COMPLETED|Follow-up Period||1
8661885|NCT03384966|21384332|P3|COMPLETED|Follow-up Period||116
8661886|NCT03384966|21384333|P2|COMPLETED|Follow-up Period||115
8661887|NCT03384966|21384334|P1|COMPLETED|Follow-up Period||113
8661888|NCT03384966|21384332|P3|STARTED|Follow-up Period||116
8661889|NCT03384966|21384333|P2|STARTED|Follow-up Period||115
8661890|NCT03384966|21384334|P1|STARTED|Follow-up Period||114
8661891|NCT03384966|21384332|P3|NOT COMPLETED|Treatment Period||0
8661892|NCT03384966|21384333|P2|NOT COMPLETED|Treatment Period||0
8661893|NCT03384966|21384334|P1|NOT COMPLETED|Treatment Period||0
8661894|NCT03384966|21384332|P3|COMPLETED|Treatment Period||116
8661895|NCT03384966|21384333|P2|COMPLETED|Treatment Period||115
8661896|NCT03384966|21384334|P1|COMPLETED|Treatment Period||114
8661897|NCT03384966|21384332|P3|Pharmacokinetic Analysis Set|Treatment Period||0
8661898|NCT03384966|21384333|P2|Pharmacokinetic Analysis Set|Treatment Period||115
8661899|NCT03384966|21384334|P1|Pharmacokinetic Analysis Set|Treatment Period||111
8661900|NCT03384966|21384332|P3|Safety Analysis Set|Treatment Period||116
8661901|NCT03384966|21384333|P2|Safety Analysis Set|Treatment Period||115
8661902|NCT03384966|21384334|P1|Safety Analysis Set|Treatment Period||114
8661903|NCT03384966|21384332|P3|Per-protocol Analysis Set|Treatment Period||93
8661904|NCT03384966|21384333|P2|Per-protocol Analysis Set|Treatment Period||90
8661905|NCT03384966|21384334|P1|Per-protocol Analysis Set|Treatment Period||96
8661906|NCT03384966|21384332|P3|Abdomen Administration|Treatment Period||58
8661907|NCT03384966|21384333|P2|Abdomen Administration|Treatment Period||58
8661908|NCT03384966|21384334|P1|Abdomen Administration|Treatment Period||57
8661909|NCT03384966|21384332|P3|Thigh Administration|Treatment Period||58
8661910|NCT03384966|21384333|P2|Thigh Administration|Treatment Period||57
8661911|NCT03384966|21384334|P1|Thigh Administration|Treatment Period||57
8661912|NCT03384966|21384332|P3|STARTED|Treatment Period||116
8661913|NCT03384966|21384333|P2|STARTED|Treatment Period||115
8661914|NCT03384966|21384334|P1|STARTED|Treatment Period||114
8661915|NCT03384966|21384332|P3|NOT COMPLETED|Randomized at End of Screening Period||0
8661916|NCT03384966|21384333|P2|NOT COMPLETED|Randomized at End of Screening Period||0
8661917|NCT03384966|21384334|P1|NOT COMPLETED|Randomized at End of Screening Period||1
8661918|NCT03384966|21384332|P3|COMPLETED|Randomized at End of Screening Period||116
8661919|NCT03384966|21384333|P2|COMPLETED|Randomized at End of Screening Period||115
8661920|NCT03384966|21384334|P1|COMPLETED|Randomized at End of Screening Period||114
8661921|NCT03384966|21384332|P3|STARTED|Randomized at End of Screening Period||116
8661922|NCT03384966|21384333|P2|STARTED|Randomized at End of Screening Period||115
8661923|NCT03384966|21384334|P1|STARTED|Randomized at End of Screening Period||115
8661924|NCT03378635|21384372|P3|NOT COMPLETED|Overall Study||0
8661925|NCT03378635|21384373|P2|NOT COMPLETED|Overall Study||0
8661926|NCT03378635|21384374|P1|NOT COMPLETED|Overall Study||2
8661927|NCT03378635|21384372|P3|COMPLETED|Overall Study||43
8661928|NCT03378635|21384373|P2|COMPLETED|Overall Study||43
8661929|NCT03378635|21384374|P1|COMPLETED|Overall Study||82
8661930|NCT03378635|21384372|P3|Randomized and Exposed to Treatment|Overall Study||43
8661931|NCT03378635|21384373|P2|Randomized and Exposed to Treatment|Overall Study||43
8661932|NCT03378635|21384374|P1|Randomized and Exposed to Treatment|Overall Study||82
8661933|NCT03378635|21384372|P3|STARTED|Overall Study||43
8661934|NCT03378635|21384373|P2|STARTED|Overall Study||43
8661935|NCT03378635|21384374|P1|STARTED|Overall Study||84
8661936|NCT03342001|21384410|P1|NOT COMPLETED|Overall Study||2
8661937|NCT03342001|21384410|P1|COMPLETED|Overall Study||9
8661938|NCT03342001|21384410|P1|STARTED|Overall Study||11
8661939|NCT03298880|21384414|P1|NOT COMPLETED|Overall Study||0
8661940|NCT03298880|21384414|P1|COMPLETED|Overall Study||75
8661941|NCT03298880|21384414|P1|STARTED|Overall Study||75
8661942|NCT03231943|21384432|P13|NOT COMPLETED|Part 2||0
8661943|NCT03231943|21384433|P12|NOT COMPLETED|Part 2||1
8661944|NCT03231943|21384434|P11|NOT COMPLETED|Part 2||1
8661945|NCT03231943|21384435|P10|NOT COMPLETED|Part 2||0
8661946|NCT03231943|21384436|P9|NOT COMPLETED|Part 2||0
8661947|NCT03231943|21384437|P8|NOT COMPLETED|Part 2||0
8661948|NCT03231943|21384438|P7|NOT COMPLETED|Part 2||0
8661949|NCT03231943|21384439|P6|NOT COMPLETED|Part 2||0
8661950|NCT03231943|21384440|P5|NOT COMPLETED|Part 2||0
8661951|NCT03231943|21384441|P4|NOT COMPLETED|Part 2||0
8661952|NCT03231943|21384442|P3|NOT COMPLETED|Part 2||0
8661953|NCT03231943|21384443|P2|NOT COMPLETED|Part 2||0
8661954|NCT03231943|21384444|P1|NOT COMPLETED|Part 2||0
8661955|NCT03231943|21384432|P13|COMPLETED|Part 2||14
8661956|NCT03231943|21384433|P12|COMPLETED|Part 2||6
8661957|NCT03231943|21384434|P11|COMPLETED|Part 2||24
8661958|NCT03231943|21384435|P10|COMPLETED|Part 2||6
8661959|NCT03231943|21384436|P9|COMPLETED|Part 2||6
8661960|NCT03231943|21384437|P8|COMPLETED|Part 2||0
8661961|NCT03231943|21384438|P7|COMPLETED|Part 2||0
8661962|NCT03231943|21384439|P6|COMPLETED|Part 2||0
8661963|NCT03231943|21384440|P5|COMPLETED|Part 2||0
8661964|NCT03231943|21384441|P4|COMPLETED|Part 2||0
8661965|NCT03231943|21384442|P3|COMPLETED|Part 2||0
8661966|NCT03231943|21384443|P2|COMPLETED|Part 2||0
8661967|NCT03231943|21384444|P1|COMPLETED|Part 2||0
8661968|NCT03231943|21384432|P13|STARTED|Part 2||14
8661969|NCT03231943|21384433|P12|STARTED|Part 2||7
8661970|NCT03231943|21384434|P11|STARTED|Part 2||25
8661971|NCT03231943|21384435|P10|STARTED|Part 2||6
8661972|NCT03231943|21384436|P9|STARTED|Part 2||6
8661973|NCT03231943|21384437|P8|STARTED|Part 2||0
8661974|NCT03231943|21384438|P7|STARTED|Part 2||0
8661975|NCT03231943|21384439|P6|STARTED|Part 2||0
8661976|NCT03231943|21384440|P5|STARTED|Part 2||0
8661977|NCT03231943|21384441|P4|STARTED|Part 2||0
8661978|NCT03231943|21384442|P3|STARTED|Part 2||0
8661979|NCT03231943|21384443|P2|STARTED|Part 2||0
8661980|NCT03231943|21384444|P1|STARTED|Part 2||0
8661981|NCT03231943|21384432|P13|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661982|NCT03231943|21384433|P12|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661983|NCT03231943|21384434|P11|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661984|NCT03231943|21384435|P10|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661985|NCT03231943|21384436|P9|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661986|NCT03231943|21384437|P8|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661987|NCT03231943|21384438|P7|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661988|NCT03231943|21384439|P6|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661989|NCT03231943|21384440|P5|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661990|NCT03231943|21384441|P4|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661991|NCT03231943|21384442|P3|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661992|NCT03231943|21384443|P2|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661993|NCT03231943|21384444|P1|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661994|NCT03231943|21384432|P13|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661995|NCT03231943|21384433|P12|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661996|NCT03231943|21384434|P11|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661997|NCT03231943|21384435|P10|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661998|NCT03231943|21384436|P9|COMPLETED|Part 1 Period 4 (up to Day 60)||0
8661999|NCT03231943|21384437|P8|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8662000|NCT03231943|21384438|P7|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8662001|NCT03231943|21384439|P6|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8662002|NCT03231943|21384440|P5|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8662003|NCT03231943|21384441|P4|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8662004|NCT03231943|21384442|P3|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8662005|NCT03231943|21384443|P2|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8662006|NCT03231943|21384444|P1|COMPLETED|Part 1 Period 4 (up to Day 60)||2
8662007|NCT03231943|21384432|P13|STARTED|Part 1 Period 4 (up to Day 60)||0
8662008|NCT03231943|21384433|P12|STARTED|Part 1 Period 4 (up to Day 60)||0
8662009|NCT03231943|21384434|P11|STARTED|Part 1 Period 4 (up to Day 60)||0
8662010|NCT03231943|21384435|P10|STARTED|Part 1 Period 4 (up to Day 60)||0
8662011|NCT03231943|21384436|P9|STARTED|Part 1 Period 4 (up to Day 60)||0
8662012|NCT03231943|21384437|P8|STARTED|Part 1 Period 4 (up to Day 60)||2
8662013|NCT03231943|21384438|P7|STARTED|Part 1 Period 4 (up to Day 60)||2
8662014|NCT03231943|21384439|P6|STARTED|Part 1 Period 4 (up to Day 60)||2
8662015|NCT03231943|21384440|P5|STARTED|Part 1 Period 4 (up to Day 60)||2
8662016|NCT03231943|21384441|P4|STARTED|Part 1 Period 4 (up to Day 60)||2
8662017|NCT03231943|21384442|P3|STARTED|Part 1 Period 4 (up to Day 60)||2
8662018|NCT03231943|21384443|P2|STARTED|Part 1 Period 4 (up to Day 60)||2
8662019|NCT03231943|21384444|P1|STARTED|Part 1 Period 4 (up to Day 60)||2
8662020|NCT03231943|21384432|P13|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662021|NCT03231943|21384433|P12|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662022|NCT03231943|21384434|P11|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662023|NCT03231943|21384435|P10|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662024|NCT03231943|21384436|P9|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662025|NCT03231943|21384437|P8|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662026|NCT03231943|21384438|P7|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662027|NCT03231943|21384439|P6|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662028|NCT03231943|21384440|P5|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662029|NCT03231943|21384441|P4|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662030|NCT03231943|21384442|P3|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662031|NCT03231943|21384443|P2|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662032|NCT03231943|21384444|P1|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1
8662033|NCT03231943|21384432|P13|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662034|NCT03231943|21384433|P12|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662035|NCT03231943|21384434|P11|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662036|NCT03231943|21384435|P10|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662037|NCT03231943|21384436|P9|COMPLETED|Part 1, Period 3 (up to Day 45)||0
8662038|NCT03231943|21384437|P8|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8662039|NCT03231943|21384438|P7|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8662040|NCT03231943|21384439|P6|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8662041|NCT03231943|21384440|P5|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8662042|NCT03231943|21384441|P4|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8662043|NCT03231943|21384442|P3|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8662044|NCT03231943|21384443|P2|COMPLETED|Part 1, Period 3 (up to Day 45)||2
8662045|NCT03231943|21384444|P1|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1
8662046|NCT03231943|21384432|P13|STARTED|Part 1, Period 3 (up to Day 45)||0
8662047|NCT03231943|21384433|P12|STARTED|Part 1, Period 3 (up to Day 45)||0
8662048|NCT03231943|21384434|P11|STARTED|Part 1, Period 3 (up to Day 45)||0
8662049|NCT03231943|21384435|P10|STARTED|Part 1, Period 3 (up to Day 45)||0
8662050|NCT03231943|21384436|P9|STARTED|Part 1, Period 3 (up to Day 45)||0
8662051|NCT03231943|21384437|P8|STARTED|Part 1, Period 3 (up to Day 45)||2
8662052|NCT03231943|21384438|P7|STARTED|Part 1, Period 3 (up to Day 45)||2
8662053|NCT03231943|21384439|P6|STARTED|Part 1, Period 3 (up to Day 45)||2
8662054|NCT03231943|21384440|P5|STARTED|Part 1, Period 3 (up to Day 45)||2
8662055|NCT03231943|21384441|P4|STARTED|Part 1, Period 3 (up to Day 45)||2
8662056|NCT03231943|21384442|P3|STARTED|Part 1, Period 3 (up to Day 45)||2
8662057|NCT03231943|21384443|P2|STARTED|Part 1, Period 3 (up to Day 45)||2
8662058|NCT03231943|21384444|P1|STARTED|Part 1, Period 3 (up to Day 45)||2
8662059|NCT03231943|21384432|P13|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662060|NCT03231943|21384433|P12|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662061|NCT03231943|21384434|P11|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662062|NCT03231943|21384435|P10|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662063|NCT03231943|21384436|P9|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662064|NCT03231943|21384437|P8|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662065|NCT03231943|21384438|P7|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662066|NCT03231943|21384439|P6|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662067|NCT03231943|21384440|P5|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662068|NCT03231943|21384441|P4|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662069|NCT03231943|21384442|P3|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1
8662070|NCT03231943|21384443|P2|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2
8662071|NCT03231943|21384444|P1|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662072|NCT03231943|21384432|P13|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662073|NCT03231943|21384433|P12|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662074|NCT03231943|21384434|P11|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662075|NCT03231943|21384435|P10|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662076|NCT03231943|21384436|P9|COMPLETED|Part 1, Period 2 (up to Day 30)||0
8662077|NCT03231943|21384437|P8|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8662078|NCT03231943|21384438|P7|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8662079|NCT03231943|21384439|P6|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8662080|NCT03231943|21384440|P5|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8662081|NCT03231943|21384441|P4|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8662082|NCT03231943|21384442|P3|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1
8662083|NCT03231943|21384443|P2|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0
8662084|NCT03231943|21384444|P1|COMPLETED|Part 1, Period 2 (up to Day 30)||2
8662085|NCT03231943|21384432|P13|STARTED|Part 1, Period 2 (up to Day 30)||0
8662086|NCT03231943|21384433|P12|STARTED|Part 1, Period 2 (up to Day 30)||0
8662087|NCT03231943|21384434|P11|STARTED|Part 1, Period 2 (up to Day 30)||0
8662088|NCT03231943|21384435|P10|STARTED|Part 1, Period 2 (up to Day 30)||0
8662089|NCT03231943|21384436|P9|STARTED|Part 1, Period 2 (up to Day 30)||0
8662090|NCT03231943|21384437|P8|STARTED|Part 1, Period 2 (up to Day 30)||2
8662091|NCT03231943|21384438|P7|STARTED|Part 1, Period 2 (up to Day 30)||2
8662092|NCT03231943|21384439|P6|STARTED|Part 1, Period 2 (up to Day 30)||2
8662093|NCT03231943|21384440|P5|STARTED|Part 1, Period 2 (up to Day 30)||2
8662094|NCT03231943|21384441|P4|STARTED|Part 1, Period 2 (up to Day 30)||2
8662095|NCT03231943|21384442|P3|STARTED|Part 1, Period 2 (up to Day 30)||2
8662096|NCT03231943|21384443|P2|STARTED|Part 1, Period 2 (up to Day 30)||2
8662097|NCT03231943|21384444|P1|STARTED|Part 1, Period 2 (up to Day 30)||2
8662098|NCT03231943|21384432|P13|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662099|NCT03231943|21384433|P12|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662100|NCT03231943|21384434|P11|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662101|NCT03231943|21384435|P10|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662102|NCT03231943|21384436|P9|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662103|NCT03231943|21384437|P8|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662104|NCT03231943|21384438|P7|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662105|NCT03231943|21384439|P6|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662106|NCT03231943|21384440|P5|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662107|NCT03231943|21384441|P4|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662108|NCT03231943|21384442|P3|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662109|NCT03231943|21384443|P2|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662110|NCT03231943|21384444|P1|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662111|NCT03231943|21384432|P13|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662112|NCT03231943|21384433|P12|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662113|NCT03231943|21384434|P11|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662114|NCT03231943|21384435|P10|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662115|NCT03231943|21384436|P9|COMPLETED|Part 1, Period 1 (up to Day 15)||0
8662116|NCT03231943|21384437|P8|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8662117|NCT03231943|21384438|P7|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8662118|NCT03231943|21384439|P6|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8662119|NCT03231943|21384440|P5|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8662120|NCT03231943|21384441|P4|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8662121|NCT03231943|21384442|P3|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8662122|NCT03231943|21384443|P2|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8662123|NCT03231943|21384444|P1|COMPLETED|Part 1, Period 1 (up to Day 15)||2
8662124|NCT03231943|21384432|P13|STARTED|Part 1, Period 1 (up to Day 15)||0
8662125|NCT03231943|21384433|P12|STARTED|Part 1, Period 1 (up to Day 15)||0
8662126|NCT03231943|21384434|P11|STARTED|Part 1, Period 1 (up to Day 15)||0
8662127|NCT03231943|21384435|P10|STARTED|Part 1, Period 1 (up to Day 15)||0
8662128|NCT03231943|21384436|P9|STARTED|Part 1, Period 1 (up to Day 15)||0
8662129|NCT03231943|21384437|P8|STARTED|Part 1, Period 1 (up to Day 15)||2
8662130|NCT03231943|21384438|P7|STARTED|Part 1, Period 1 (up to Day 15)||2
8662131|NCT03231943|21384439|P6|STARTED|Part 1, Period 1 (up to Day 15)||2
8662132|NCT03231943|21384440|P5|STARTED|Part 1, Period 1 (up to Day 15)||2
8662133|NCT03231943|21384441|P4|STARTED|Part 1, Period 1 (up to Day 15)||2
8662134|NCT03231943|21384442|P3|STARTED|Part 1, Period 1 (up to Day 15)||2
8662135|NCT03231943|21384443|P2|STARTED|Part 1, Period 1 (up to Day 15)||2
8662136|NCT03231943|21384444|P1|STARTED|Part 1, Period 1 (up to Day 15)||2
8662143|NCT03128411|21384917|P1|NOT COMPLETED|Long Term Follow-up Phase||19
8662144|NCT03128411|21384917|P1|COMPLETED|Long Term Follow-up Phase||0
8662145|NCT03128411|21384917|P1|STARTED|Long Term Follow-up Phase|"Participants who discontinued treatment phase, entered this phase, except those were Ongoing."|19
8662146|NCT03128411|21384917|P1|NOT COMPLETED|Treatment Phase||60
8662147|NCT03128411|21384917|P1|COMPLETED|Treatment Phase||0
8662148|NCT03128411|21384917|P1|Received Treatment|Treatment Phase||60
8662149|NCT03128411|21384917|P1|STARTED|Treatment Phase||60
8662150|NCT03066778|21384958|P2|NOT COMPLETED|Overall Study||225
8662151|NCT03066778|21384959|P1|NOT COMPLETED|Overall Study||228
8662152|NCT03066778|21384958|P2|COMPLETED|Overall Study||0
8662153|NCT03066778|21384959|P1|COMPLETED|Overall Study||0
8662154|NCT03066778|21384958|P2|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
8662155|NCT03066778|21384959|P1|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
8662156|NCT03066778|21384958|P2|STARTED|Overall Study||225
8662157|NCT03066778|21384959|P1|STARTED|Overall Study||228
8662158|NCT03016598|21384987|P2|NOT COMPLETED|Overall Study||2
8662159|NCT03016598|21384988|P1|NOT COMPLETED|Overall Study||0
8662160|NCT03016598|21384987|P2|COMPLETED|Overall Study||20
8662161|NCT03016598|21384988|P1|COMPLETED|Overall Study||18
8662162|NCT03016598|21384987|P2|STARTED|Overall Study||22
8662163|NCT03016598|21384988|P1|STARTED|Overall Study||18
8662170|NCT02993731|21385039|P2|NOT COMPLETED|Overall Study||105
8662171|NCT02993731|21385040|P1|NOT COMPLETED|Overall Study||101
8662172|NCT02993731|21385039|P2|COMPLETED|Overall Study||464
8662173|NCT02993731|21385040|P1|COMPLETED|Overall Study||464
8662174|NCT02993731|21385039|P2|STARTED|Overall Study||569
8662175|NCT02993731|21385040|P1|STARTED|Overall Study||565
8662176|NCT02970812|21385066|P2|NOT COMPLETED|Overall Study||2
8662177|NCT02970812|21385067|P1|NOT COMPLETED|Overall Study||8
8662178|NCT02970812|21385066|P2|COMPLETED|Overall Study||28
8662179|NCT02970812|21385067|P1|COMPLETED|Overall Study||22
8662180|NCT02970812|21385066|P2|STARTED|Overall Study||30
8662181|NCT02970812|21385067|P1|STARTED|Overall Study||30
8662182|NCT02951052|21385075|P2|NOT COMPLETED|Overall Study||18
8662183|NCT02951052|21385076|P1|NOT COMPLETED|Overall Study||27
8662184|NCT02951052|21385075|P2|COMPLETED|Overall Study||290
8662185|NCT02951052|21385076|P1|COMPLETED|Overall Study||281
8662186|NCT02951052|21385075|P2|STARTED|Overall Study||308
8662187|NCT02951052|21385076|P1|STARTED|Overall Study||308
8662188|NCT02940223|21385242|P2|NOT COMPLETED|Overall Study||0
8662189|NCT02940223|21385243|P1|NOT COMPLETED|Overall Study||2
8662190|NCT02940223|21385242|P2|COMPLETED|Overall Study||0
8662191|NCT02940223|21385243|P1|COMPLETED|Overall Study||0
8662192|NCT02940223|21385242|P2|STARTED|Overall Study||0
8662193|NCT02940223|21385243|P1|STARTED|Overall Study||2
8662200|NCT02885350|21385272|P4|NOT COMPLETED|Overall Study||0
8662201|NCT02885350|21385273|P3|NOT COMPLETED|Overall Study||0
8662202|NCT02885350|21385274|P2|NOT COMPLETED|Overall Study||0
8662203|NCT02885350|21385275|P1|NOT COMPLETED|Overall Study||0
8662204|NCT02885350|21385272|P4|COMPLETED|Overall Study||20
8662205|NCT02885350|21385273|P3|COMPLETED|Overall Study||20
8662206|NCT02885350|21385274|P2|COMPLETED|Overall Study||20
8662207|NCT02885350|21385275|P1|COMPLETED|Overall Study||20
8662208|NCT02885350|21385272|P4|STARTED|Overall Study||20
8662209|NCT02885350|21385273|P3|STARTED|Overall Study||20
8662210|NCT02885350|21385274|P2|STARTED|Overall Study||20
8662211|NCT02885350|21385275|P1|STARTED|Overall Study||20
8662218|NCT02820298|21385304|P2|NOT COMPLETED|Overall Study||2
8662219|NCT02820298|21385305|P1|NOT COMPLETED|Overall Study||1
8662220|NCT02820298|21385304|P2|COMPLETED|Overall Study||10
8662221|NCT02820298|21385305|P1|COMPLETED|Overall Study||12
8662222|NCT02820298|21385304|P2|STARTED|Overall Study||12
8662223|NCT02820298|21385305|P1|STARTED|Overall Study||13
8662224|NCT02738840|21385319|P1|NOT COMPLETED|Overall Study||8
8662225|NCT02738840|21385319|P1|COMPLETED|Overall Study||48
8662226|NCT02738840|21385319|P1|STARTED|Overall Study||56
8662233|NCT02669121|21385348|P2|NOT COMPLETED|Overall Study||282
8662234|NCT02669121|21385349|P1|NOT COMPLETED|Overall Study||290
8662235|NCT02669121|21385348|P2|COMPLETED|Overall Study||2089
8662236|NCT02669121|21385349|P1|COMPLETED|Overall Study||2087
8662237|NCT02669121|21385348|P2|Treated (Safety Analysis Set)|Overall Study||2355
8662238|NCT02669121|21385349|P1|Treated (Safety Analysis Set)|Overall Study||2357
8662239|NCT02669121|21385348|P2|STARTED|Overall Study||2371
8662240|NCT02669121|21385349|P1|STARTED|Overall Study||2377
8662241|NCT02663895|21385361|P1|NOT COMPLETED|Overall Study||7
8662242|NCT02663895|21385361|P1|COMPLETED|Overall Study||5
8662243|NCT02663895|21385361|P1|STARTED|Overall Study||12
8662244|NCT02613169|21385378|P2|NOT COMPLETED|Overall Study||17
8662245|NCT02613169|21385379|P1|NOT COMPLETED|Overall Study||18
8662246|NCT02613169|21385378|P2|COMPLETED|Overall Study||133
8662247|NCT02613169|21385379|P1|COMPLETED|Overall Study||132
8662248|NCT02613169|21385378|P2|STARTED|Overall Study||150
8662249|NCT02613169|21385379|P1|STARTED|Overall Study||150
8662250|NCT02545868|21385394|P3|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
8662251|NCT02545868|21385395|P2|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
8662252|NCT02545868|21385396|P1|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
8662253|NCT02545868|21385394|P3|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
8662254|NCT02545868|21385395|P2|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
8662255|NCT02545868|21385396|P1|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
8662256|NCT02545868|21385394|P3|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
8662257|NCT02545868|21385395|P2|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
8662258|NCT02545868|21385396|P1|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
8662259|NCT02545868|21385394|P3|NOT COMPLETED|Immunization Study Period (ISP)||0
8662260|NCT02545868|21385395|P2|NOT COMPLETED|Immunization Study Period (ISP)||0
8662261|NCT02545868|21385396|P1|NOT COMPLETED|Immunization Study Period (ISP)||0
8662262|NCT02545868|21385394|P3|COMPLETED|Immunization Study Period (ISP)||34
8662263|NCT02545868|21385395|P2|COMPLETED|Immunization Study Period (ISP)||35
8662264|NCT02545868|21385396|P1|COMPLETED|Immunization Study Period (ISP)||33
8662265|NCT02545868|21385394|P3|STARTED|Immunization Study Period (ISP)||34
8662266|NCT02545868|21385395|P2|STARTED|Immunization Study Period (ISP)||35
8662267|NCT02545868|21385396|P1|STARTED|Immunization Study Period (ISP)||33
8662268|NCT02538523|21385469|P2|NOT COMPLETED|Overall Study||0
8662269|NCT02538523|21385470|P1|NOT COMPLETED|Overall Study||0
8662270|NCT02538523|21385469|P2|COMPLETED|Overall Study||29
8662271|NCT02538523|21385470|P1|COMPLETED|Overall Study||29
8662272|NCT02538523|21385469|P2|STARTED|Overall Study||29
8662273|NCT02538523|21385470|P1|STARTED|Overall Study||29
8662274|NCT02424253|21385480|P2|NOT COMPLETED|Overall Study||9
8662275|NCT02424253|21385481|P1|NOT COMPLETED|Overall Study||11
8662276|NCT02424253|21385480|P2|COMPLETED|Overall Study||24
8662277|NCT02424253|21385481|P1|COMPLETED|Overall Study||54
8662278|NCT02424253|21385480|P2|STARTED|Overall Study||33
8662279|NCT02424253|21385481|P1|STARTED|Overall Study||65
8662280|NCT02412631|21385491|P2|NOT COMPLETED|Overall Study||24
8662281|NCT02412631|21385492|P1|NOT COMPLETED|Overall Study||26
8662282|NCT02412631|21385491|P2|COMPLETED|Overall Study||16
8662283|NCT02412631|21385492|P1|COMPLETED|Overall Study||18
8662284|NCT02412631|21385491|P2|STARTED|Overall Study||40
8662285|NCT02412631|21385492|P1|STARTED|Overall Study||44
8662286|NCT02389946|21385508|P2|NOT COMPLETED|Overall Study||15
8662287|NCT02389946|21385509|P1|NOT COMPLETED|Overall Study||24
8662288|NCT02389946|21385508|P2|COMPLETED|Overall Study||435
8662289|NCT02389946|21385509|P1|COMPLETED|Overall Study||860
8662290|NCT02389946|21385508|P2|STARTED|Overall Study||450
8662291|NCT02389946|21385509|P1|STARTED|Overall Study||884
8662292|NCT02349633|21385535|P14|NOT COMPLETED|Overall Study||0
8662293|NCT02349633|21385536|P13|NOT COMPLETED|Overall Study||0
8662294|NCT02349633|21385537|P12|NOT COMPLETED|Overall Study||0
8662295|NCT02349633|21385538|P11|NOT COMPLETED|Overall Study||0
8662296|NCT02349633|21385539|P10|NOT COMPLETED|Overall Study||5
8662297|NCT02349633|21385540|P9|NOT COMPLETED|Overall Study||2
8662298|NCT02349633|21385541|P8|NOT COMPLETED|Overall Study||16
8662299|NCT02349633|21385542|P7|NOT COMPLETED|Overall Study||1
8662300|NCT02349633|21385543|P6|NOT COMPLETED|Overall Study||1
8662301|NCT02349633|21385544|P5|NOT COMPLETED|Overall Study||2
8662302|NCT02349633|21385545|P4|NOT COMPLETED|Overall Study||2
8662303|NCT02349633|21385546|P3|NOT COMPLETED|Overall Study||0
8662304|NCT02349633|21385547|P2|NOT COMPLETED|Overall Study||1
8662305|NCT02349633|21385548|P1|NOT COMPLETED|Overall Study||0
8662306|NCT02349633|21385535|P14|COMPLETED|Overall Study||0
8662307|NCT02349633|21385536|P13|COMPLETED|Overall Study||0
8662308|NCT02349633|21385537|P12|COMPLETED|Overall Study||0
8662309|NCT02349633|21385538|P11|COMPLETED|Overall Study||0
8662310|NCT02349633|21385539|P10|COMPLETED|Overall Study||0
8662311|NCT02349633|21385540|P9|COMPLETED|Overall Study||3
8662312|NCT02349633|21385541|P8|COMPLETED|Overall Study||13
8662313|NCT02349633|21385542|P7|COMPLETED|Overall Study||3
8662314|NCT02349633|21385543|P6|COMPLETED|Overall Study||3
8662315|NCT02349633|21385544|P5|COMPLETED|Overall Study||1
8662316|NCT02349633|21385545|P4|COMPLETED|Overall Study||2
8662317|NCT02349633|21385546|P3|COMPLETED|Overall Study||4
8662318|NCT02349633|21385547|P2|COMPLETED|Overall Study||2
8662319|NCT02349633|21385548|P1|COMPLETED|Overall Study||4
8662320|NCT02349633|21385535|P14|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
8662321|NCT02349633|21385536|P13|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
8662322|NCT02349633|21385537|P12|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
8662323|NCT02349633|21385538|P11|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
8662324|NCT02349633|21385539|P10|STARTED|Overall Study||5
8662325|NCT02349633|21385540|P9|STARTED|Overall Study||5
8662326|NCT02349633|21385541|P8|STARTED|Overall Study||29
8662327|NCT02349633|21385542|P7|STARTED|Overall Study||4
8662328|NCT02349633|21385543|P6|STARTED|Overall Study||4
8662329|NCT02349633|21385544|P5|STARTED|Overall Study||3
8662330|NCT02349633|21385545|P4|STARTED|Overall Study||4
8662331|NCT02349633|21385546|P3|STARTED|Overall Study||4
8662332|NCT02349633|21385547|P2|STARTED|Overall Study||3
8662333|NCT02349633|21385548|P1|STARTED|Overall Study||4
8662334|NCT02336282|21385855|P1|NOT COMPLETED|Overall Study||5
8662335|NCT02336282|21385855|P1|COMPLETED|Overall Study||28
8662336|NCT02336282|21385855|P1|STARTED|Overall Study||33
8662337|NCT02120157|21385881|P2|NOT COMPLETED|Overall Study||2
8662338|NCT02120157|21385882|P1|NOT COMPLETED|Overall Study||6
8662339|NCT02120157|21385881|P2|COMPLETED|Overall Study||11
8662340|NCT02120157|21385882|P1|COMPLETED|Overall Study||13
8662341|NCT02120157|21385881|P2|Undergoing Follow-up|Overall Study||8
8662342|NCT02120157|21385882|P1|Undergoing Follow-up|Overall Study||7
8662343|NCT02120157|21385881|P2|Completed 180 Days|Overall Study||3
8662344|NCT02120157|21385882|P1|Completed 180 Days|Overall Study||5
8662345|NCT02120157|21385881|P2|STARTED|Overall Study||13
8662346|NCT02120157|21385882|P1|STARTED|Overall Study||19
8662347|NCT02104557|21385890|P1|NOT COMPLETED|Overall Study||177
8662348|NCT02104557|21385890|P1|COMPLETED|Overall Study||185
8662349|NCT02104557|21385890|P1|Safety Population|Overall Study||337
8662350|NCT02104557|21385890|P1|STARTED|Overall Study||362
8662351|NCT02031978|21385903|P1|NOT COMPLETED|Overall Study||0
8662352|NCT02031978|21385903|P1|COMPLETED|Overall Study||4367
8662353|NCT02031978|21385903|P1|STARTED|Overall Study||4367
8662354|NCT01995175|21385907|P1|NOT COMPLETED|Overall Study||253
8662355|NCT01995175|21385907|P1|COMPLETED|Overall Study||2148
8662356|NCT01995175|21385907|P1|STARTED|Overall Study||2401
8662357|NCT01985542|21385924|P2|NOT COMPLETED|Overall Study||6
8662358|NCT01985542|21385925|P1|NOT COMPLETED|Overall Study||4
8662359|NCT01985542|21385924|P2|COMPLETED|Overall Study||3
8662360|NCT01985542|21385925|P1|COMPLETED|Overall Study||3
8662361|NCT01985542|21385924|P2|STARTED|Overall Study||9
8662362|NCT01985542|21385925|P1|STARTED|Overall Study||7
8662363|NCT01831544|21385933|P1|NOT COMPLETED|Overall Study||3
8662364|NCT01831544|21385933|P1|COMPLETED|Overall Study||8
8662365|NCT01831544|21385933|P1|STARTED|Overall Study||11
8662366|NCT01807000|21385950|P1|NOT COMPLETED|Overall Study||0
8662367|NCT01807000|21385950|P1|COMPLETED|Overall Study||6
8662368|NCT01807000|21385950|P1|STARTED|Overall Study||6
8662369|NCT01786876|21385969|P1|NOT COMPLETED|Overall Study||0
8662370|NCT01786876|21385969|P1|COMPLETED|Overall Study||6
8662371|NCT01786876|21385969|P1|STARTED|Overall Study||6
8662412|NCT01716455|21386067|P6|NOT COMPLETED|Overall Study||0
8662413|NCT01716455|21386068|P5|NOT COMPLETED|Overall Study||0
8662414|NCT01716455|21386069|P4|NOT COMPLETED|Overall Study||0
8662415|NCT01716455|21386070|P3|NOT COMPLETED|Overall Study||0
8662416|NCT01716455|21386071|P2|NOT COMPLETED|Overall Study||0
8662417|NCT01716455|21386072|P1|NOT COMPLETED|Overall Study||0
8662418|NCT01716455|21386067|P6|COMPLETED|Overall Study||8
8662419|NCT01716455|21386068|P5|COMPLETED|Overall Study||26
8662420|NCT01716455|21386069|P4|COMPLETED|Overall Study||8
8662421|NCT01716455|21386070|P3|COMPLETED|Overall Study||8
8662422|NCT01716455|21386071|P2|COMPLETED|Overall Study||8
8662423|NCT01716455|21386072|P1|COMPLETED|Overall Study||8
8662424|NCT01716455|21386067|P6|STARTED|Overall Study||8
8662425|NCT01716455|21386068|P5|STARTED|Overall Study||26
8662426|NCT01716455|21386069|P4|STARTED|Overall Study||8
8662427|NCT01716455|21386070|P3|STARTED|Overall Study||8
8662428|NCT01716455|21386071|P2|STARTED|Overall Study||8
8662429|NCT01716455|21386072|P1|STARTED|Overall Study||8
8662454|NCT01698905|21386112|P1|NOT COMPLETED|Overall Study||11
8662455|NCT01698905|21386112|P1|COMPLETED|Overall Study||152
8662456|NCT01698905|21386112|P1|NTCT-P Phase Phase|Overall Study||6
8662457|NCT01698905|21386112|P1|NTRI-2 Phase|Overall Study||1
8662458|NCT01698905|21386112|P1|TFR-2 Phase|Overall Study||2
8662459|NCT01698905|21386112|P1|NTCT Phase|Overall Study||26
8662460|NCT01698905|21386112|P1|NTRI Phase|Overall Study||51
8662461|NCT01698905|21386112|P1|TFR Phase|Overall Study||126
8662462|NCT01698905|21386112|P1|Still on Study Phase|Overall Study||0
8662463|NCT01698905|21386112|P1|STARTED|Overall Study||163
8662464|NCT01696279|21386123|P4|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8
8662465|NCT01696279|21386124|P3|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8662466|NCT01696279|21386125|P2|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8662467|NCT01696279|21386126|P1|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8662468|NCT01696279|21386123|P4|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34
8662469|NCT01696279|21386124|P3|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8662470|NCT01696279|21386125|P2|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8662471|NCT01696279|21386126|P1|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
8662472|NCT01696279|21386123|P4|STARTED|Part 3: Lanthanum Carbonate (6 Months)|34 participants from Part 2a and 8 participants from Part 2b continued to Part 3|42
8662473|NCT01696279|21386124|P3|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
8662474|NCT01696279|21386125|P2|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
8662475|NCT01696279|21386126|P1|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
8662476|NCT01696279|21386123|P4|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662477|NCT01696279|21386124|P3|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1
8662478|NCT01696279|21386125|P2|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662479|NCT01696279|21386126|P1|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662480|NCT01696279|21386123|P4|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662481|NCT01696279|21386124|P3|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8
8662482|NCT01696279|21386125|P2|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662483|NCT01696279|21386126|P1|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662484|NCT01696279|21386123|P4|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662485|NCT01696279|21386124|P3|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9
8662486|NCT01696279|21386125|P2|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662487|NCT01696279|21386126|P1|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662488|NCT01696279|21386123|P4|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662489|NCT01696279|21386124|P3|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662490|NCT01696279|21386125|P2|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662491|NCT01696279|21386126|P1|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662492|NCT01696279|21386123|P4|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662493|NCT01696279|21386124|P3|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
8662494|NCT01696279|21386125|P2|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662495|NCT01696279|21386126|P1|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662496|NCT01696279|21386123|P4|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662497|NCT01696279|21386124|P3|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
8662498|NCT01696279|21386125|P2|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662499|NCT01696279|21386126|P1|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662500|NCT01696279|21386123|P4|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662501|NCT01696279|21386124|P3|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)|9 new participants were enrolled in Part 2b|9
8662502|NCT01696279|21386125|P2|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662503|NCT01696279|21386126|P1|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
8662504|NCT01696279|21386123|P4|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8662505|NCT01696279|21386124|P3|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8662506|NCT01696279|21386125|P2|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19
8662507|NCT01696279|21386126|P1|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8662508|NCT01696279|21386123|P4|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8662509|NCT01696279|21386124|P3|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8662510|NCT01696279|21386125|P2|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34
8662511|NCT01696279|21386126|P1|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
8662512|NCT01696279|21386123|P4|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
8662513|NCT01696279|21386124|P3|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
8662514|NCT01696279|21386125|P2|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34
8662515|NCT01696279|21386126|P1|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
8662516|NCT01696279|21386123|P4|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
8662517|NCT01696279|21386124|P3|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
8662518|NCT01696279|21386125|P2|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25
8662519|NCT01696279|21386126|P1|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
8662520|NCT01696279|21386123|P4|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
8662521|NCT01696279|21386124|P3|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
8662522|NCT01696279|21386125|P2|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17
8662523|NCT01696279|21386126|P1|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
8662524|NCT01696279|21386123|P4|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
8662525|NCT01696279|21386124|P3|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
8662526|NCT01696279|21386125|P2|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53
8662527|NCT01696279|21386126|P1|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
8662528|NCT01696279|21386123|P4|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
8662529|NCT01696279|21386124|P3|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
8662530|NCT01696279|21386125|P2|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37
8662531|NCT01696279|21386126|P1|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
8662532|NCT01696279|21386123|P4|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
8662533|NCT01696279|21386124|P3|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
8662534|NCT01696279|21386125|P2|STARTED|Part 2a: Calcium Carbonate + Lanthanum|19 participants enrolled from Part 1 and 34 new participants enrolled in Part 2a|53
8662535|NCT01696279|21386126|P1|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
8662536|NCT01696279|21386123|P4|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8662537|NCT01696279|21386124|P3|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8662538|NCT01696279|21386125|P2|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8662539|NCT01696279|21386126|P1|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1
8662540|NCT01696279|21386123|P4|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8662541|NCT01696279|21386124|P3|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8662542|NCT01696279|21386125|P2|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
8662543|NCT01696279|21386126|P1|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19
8662544|NCT01696279|21386123|P4|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
8662545|NCT01696279|21386124|P3|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
8662546|NCT01696279|21386125|P2|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
8662547|NCT01696279|21386126|P1|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19
8662548|NCT01696279|21386123|P4|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
8662549|NCT01696279|21386124|P3|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
8662550|NCT01696279|21386125|P2|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
8662551|NCT01696279|21386126|P1|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20
8662552|NCT01696279|21386123|P4|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
8662553|NCT01696279|21386124|P3|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
8662554|NCT01696279|21386125|P2|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
8662555|NCT01696279|21386126|P1|STARTED|Part 1: Single Dose Lanthanum Carbonate||20
8662556|NCT01568255|21386162|P2|NOT COMPLETED|Overall Study||0
8662557|NCT01568255|21386163|P1|NOT COMPLETED|Overall Study||0
8662558|NCT01568255|21386162|P2|COMPLETED|Overall Study||6
8662559|NCT01568255|21386163|P1|COMPLETED|Overall Study||5
8662560|NCT01568255|21386162|P2|STARTED|Overall Study||6
8662561|NCT01568255|21386163|P1|STARTED|Overall Study||5
8662562|NCT01560403|21386185|P2|NOT COMPLETED|Overall Study||1
8662563|NCT01560403|21386186|P1|NOT COMPLETED|Overall Study||0
8662564|NCT01560403|21386185|P2|COMPLETED|Overall Study||8
8662565|NCT01560403|21386186|P1|COMPLETED|Overall Study||5
8662566|NCT01560403|21386185|P2|STARTED|Overall Study||9
8662567|NCT01560403|21386186|P1|STARTED|Overall Study||5
8662568|NCT01552902|21386195|P3|NOT COMPLETED|Overall Study||33
8662569|NCT01552902|21386196|P2|NOT COMPLETED|Overall Study||37
8662570|NCT01552902|21386197|P1|NOT COMPLETED|Overall Study||13
8662571|NCT01552902|21386195|P3|COMPLETED|Overall Study||186
8662572|NCT01552902|21386196|P2|COMPLETED|Overall Study||181
8662573|NCT01552902|21386197|P1|COMPLETED|Overall Study||97
8662574|NCT01552902|21386195|P3|STARTED|Overall Study||219
8662575|NCT01552902|21386196|P2|STARTED|Overall Study||218
8662576|NCT01552902|21386197|P1|STARTED|Overall Study||110
8662577|NCT01529268|21386219|P2|NOT COMPLETED|Overall Study||3
8662578|NCT01529268|21386220|P1|NOT COMPLETED|Overall Study||12
8662579|NCT01529268|21386219|P2|COMPLETED|Overall Study||78
8662580|NCT01529268|21386220|P1|COMPLETED|Overall Study||76
8662581|NCT01529268|21386219|P2|Completed 52-week Biopsy|Overall Study||75
8662582|NCT01529268|21386220|P1|Completed 52-week Biopsy|Overall Study||71
8662583|NCT01529268|21386219|P2|STARTED|Overall Study||81
8662584|NCT01529268|21386220|P1|STARTED|Overall Study||88
8662585|NCT01474486|21386274|P1|NOT COMPLETED|Overall Study||8
8662586|NCT01474486|21386274|P1|COMPLETED|Overall Study||20
8662587|NCT01474486|21386274|P1|Treated|Overall Study||22
8662588|NCT01474486|21386274|P1|STARTED|Overall Study||28
8662589|NCT01470469|21386287|P2|NOT COMPLETED|Overall Study||24
8662590|NCT01470469|21386288|P1|NOT COMPLETED|Overall Study||10
8662591|NCT01470469|21386287|P2|COMPLETED|Overall Study||38
8662592|NCT01470469|21386288|P1|COMPLETED|Overall Study||11
8662593|NCT01470469|21386287|P2|STARTED|Overall Study||62
8662594|NCT01470469|21386288|P1|STARTED|Overall Study||21
8662595|NCT01415349|21386306|P2|NOT COMPLETED|Treatment Period 2||0
8662596|NCT01415349|21386307|P1|NOT COMPLETED|Treatment Period 2||0
8662597|NCT01415349|21386306|P2|COMPLETED|Treatment Period 2||19
8662598|NCT01415349|21386307|P1|COMPLETED|Treatment Period 2||21
8662599|NCT01415349|21386306|P2|STARTED|Treatment Period 2||19
8662600|NCT01415349|21386307|P1|STARTED|Treatment Period 2||21
8662601|NCT01415349|21386306|P2|NOT COMPLETED|Treatment Period 1||2
8662602|NCT01415349|21386307|P1|NOT COMPLETED|Treatment Period 1||0
8662603|NCT01415349|21386306|P2|COMPLETED|Treatment Period 1||19
8662604|NCT01415349|21386307|P1|COMPLETED|Treatment Period 1||21
8662605|NCT01415349|21386306|P2|STARTED|Treatment Period 1||21
8662606|NCT01415349|21386307|P1|STARTED|Treatment Period 1||21
8662607|NCT01370863|21386317|P2|NOT COMPLETED|Overall Study||3
8662608|NCT01370863|21386318|P1|NOT COMPLETED|Overall Study||2
8662609|NCT01370863|21386317|P2|COMPLETED|Overall Study||30
8662610|NCT01370863|21386318|P1|COMPLETED|Overall Study||32
8662611|NCT01370863|21386317|P2|STARTED|Overall Study||33
8662612|NCT01370863|21386318|P1|STARTED|Overall Study||34
8662613|NCT01330381|21386330|P3|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
8662614|NCT01330381|21386331|P2|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
8662615|NCT01330381|21386332|P1|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
8662616|NCT01330381|21386330|P3|COMPLETED|Open-label Treatment Period (16 Weeks)||81
8662617|NCT01330381|21386331|P2|COMPLETED|Open-label Treatment Period (16 Weeks)||0
8662618|NCT01330381|21386332|P1|COMPLETED|Open-label Treatment Period (16 Weeks)||88
8662619|NCT01330381|21386330|P3|STARTED|Open-label Treatment Period (16 Weeks)||99
8662620|NCT01330381|21386331|P2|STARTED|Open-label Treatment Period (16 Weeks)||0
8662621|NCT01330381|21386332|P1|STARTED|Open-label Treatment Period (16 Weeks)||98
8662622|NCT01330381|21386330|P3|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
8662623|NCT01330381|21386331|P2|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
8662624|NCT01330381|21386332|P1|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
8662625|NCT01330381|21386330|P3|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
8662626|NCT01330381|21386331|P2|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
8662627|NCT01330381|21386332|P1|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
8662628|NCT01330381|21386330|P3|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
8662629|NCT01330381|21386331|P2|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
8662630|NCT01330381|21386332|P1|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
8662631|NCT01330381|21386330|P3|STARTED|Double-blind Treatment Period (8 Weeks)||0
8662632|NCT01330381|21386331|P2|STARTED|Double-blind Treatment Period (8 Weeks)||108
8662633|NCT01330381|21386332|P1|STARTED|Double-blind Treatment Period (8 Weeks)||107
8662634|NCT01328756|21386376|P1|NOT COMPLETED|Overall Study||123
8662635|NCT01328756|21386376|P1|COMPLETED|Overall Study||191
8662636|NCT01328756|21386376|P1|STARTED|Overall Study||314
8662637|NCT01291173|21386397|P4|NOT COMPLETED|Overall Study||13
8662638|NCT01291173|21386398|P3|NOT COMPLETED|Overall Study||13
8662639|NCT01291173|21386399|P2|NOT COMPLETED|Overall Study||15
8662640|NCT01291173|21386400|P1|NOT COMPLETED|Overall Study||17
8662641|NCT01291173|21386397|P4|COMPLETED|Overall Study||52
8662642|NCT01291173|21386398|P3|COMPLETED|Overall Study||52
8662643|NCT01291173|21386399|P2|COMPLETED|Overall Study||51
8662644|NCT01291173|21386400|P1|COMPLETED|Overall Study||47
8662645|NCT01291173|21386397|P4|STARTED|Overall Study||65
8662646|NCT01291173|21386398|P3|STARTED|Overall Study||65
8662647|NCT01291173|21386399|P2|STARTED|Overall Study||66
8662648|NCT01291173|21386400|P1|STARTED|Overall Study||64
8662649|NCT01259726|21386466|P4|NOT COMPLETED|Overall Study||5
8662650|NCT01259726|21386467|P3|NOT COMPLETED|Overall Study||4
8662651|NCT01259726|21386468|P2|NOT COMPLETED|Overall Study||4
8662652|NCT01259726|21386469|P1|NOT COMPLETED|Overall Study||5
8662653|NCT01259726|21386466|P4|COMPLETED|Overall Study||36
8662654|NCT01259726|21386467|P3|COMPLETED|Overall Study||39
8662655|NCT01259726|21386468|P2|COMPLETED|Overall Study||37
8662656|NCT01259726|21386469|P1|COMPLETED|Overall Study||38
8662657|NCT01259726|21386466|P4|Treated|Overall Study||39
8662658|NCT01259726|21386467|P3|Treated|Overall Study||41
8662659|NCT01259726|21386468|P2|Treated|Overall Study||37
8662660|NCT01259726|21386469|P1|Treated|Overall Study||40
8662661|NCT01259726|21386466|P4|STARTED|Overall Study||41
8662662|NCT01259726|21386467|P3|STARTED|Overall Study||43
8662663|NCT01259726|21386468|P2|STARTED|Overall Study||41
8662664|NCT01259726|21386469|P1|STARTED|Overall Study||43
8662665|NCT01188681|21386503|P4|NOT COMPLETED|Overall Study||1
8662666|NCT01188681|21386504|P3|NOT COMPLETED|Overall Study||1
8662667|NCT01188681|21386505|P2|NOT COMPLETED|Overall Study||0
8662668|NCT01188681|21386506|P1|NOT COMPLETED|Overall Study||0
8662669|NCT01188681|21386503|P4|COMPLETED|Overall Study||33
8662670|NCT01188681|21386504|P3|COMPLETED|Overall Study||32
8662671|NCT01188681|21386505|P2|COMPLETED|Overall Study||6
8662672|NCT01188681|21386506|P1|COMPLETED|Overall Study||6
8662673|NCT01188681|21386503|P4|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
8662674|NCT01188681|21386504|P3|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
8662675|NCT01188681|21386505|P2|STARTED|Overall Study||6
8662676|NCT01188681|21386506|P1|STARTED|Overall Study||6
8662677|NCT01186419|21386522|P2|NOT COMPLETED|Overall Study||9
8662678|NCT01186419|21386523|P1|NOT COMPLETED|Overall Study||7
8662679|NCT01186419|21386522|P2|COMPLETED|Overall Study||18
8662680|NCT01186419|21386523|P1|COMPLETED|Overall Study||17
8662681|NCT01186419|21386522|P2|STARTED|Overall Study||27
8662682|NCT01186419|21386523|P1|STARTED|Overall Study||24
8662683|NCT01169844|21386532|P2|NOT COMPLETED|Overall Study||1
8662684|NCT01169844|21386533|P1|NOT COMPLETED|Overall Study||5
8662685|NCT01169844|21386532|P2|COMPLETED|Overall Study||8
8662686|NCT01169844|21386533|P1|COMPLETED|Overall Study||14
8662687|NCT01169844|21386532|P2|STARTED|Overall Study||9
8662688|NCT01169844|21386533|P1|STARTED|Overall Study||19
8662689|NCT01147926|21386545|P2|NOT COMPLETED|Overall Study||29
8662690|NCT01147926|21386546|P1|NOT COMPLETED|Overall Study||27
8662691|NCT01147926|21386545|P2|COMPLETED|Overall Study||158
8662692|NCT01147926|21386546|P1|COMPLETED|Overall Study||160
8662693|NCT01147926|21386545|P2|STARTED|Overall Study||187
8662694|NCT01147926|21386546|P1|STARTED|Overall Study||187
8662695|NCT01116739|21386580|P2|NOT COMPLETED|Overall Study||136
8662696|NCT01116739|21386581|P1|NOT COMPLETED|Overall Study||130
8662697|NCT01116739|21386580|P2|COMPLETED|Overall Study||868
8662698|NCT01116739|21386581|P1|COMPLETED|Overall Study||926
8662699|NCT01116739|21386580|P2|STARTED|Overall Study||1004
8662700|NCT01116739|21386581|P1|STARTED|Overall Study||1056
8662701|NCT01048905|21386601|P1|NOT COMPLETED|Overall Study||1
8662702|NCT01048905|21386601|P1|COMPLETED|Overall Study||12
8662703|NCT01048905|21386601|P1|STARTED|Overall Study||13
8662704|NCT00905515|21386613|P3|NOT COMPLETED|Overall Study||2
8662705|NCT00905515|21386614|P2|NOT COMPLETED|Overall Study||0
8662706|NCT00905515|21386615|P1|NOT COMPLETED|Overall Study||2
8662707|NCT00905515|21386613|P3|COMPLETED|Overall Study||20
8662708|NCT00905515|21386614|P2|COMPLETED|Overall Study||20
8662709|NCT00905515|21386615|P1|COMPLETED|Overall Study||19
8662710|NCT00905515|21386613|P3|STARTED|Overall Study||22
8662711|NCT00905515|21386614|P2|STARTED|Overall Study||20
8662712|NCT00905515|21386615|P1|STARTED|Overall Study||21
8662713|NCT00895622|21386632|P3|NOT COMPLETED|Overall Study||4
8662714|NCT00895622|21386633|P2|NOT COMPLETED|Overall Study||4
8662715|NCT00895622|21386634|P1|NOT COMPLETED|Overall Study||5
8662716|NCT00895622|21386632|P3|COMPLETED|Overall Study||53
8662717|NCT00895622|21386633|P2|COMPLETED|Overall Study||52
8662718|NCT00895622|21386634|P1|COMPLETED|Overall Study||60
8662719|NCT00895622|21386632|P3|STARTED|Overall Study||57
8662720|NCT00895622|21386633|P2|STARTED|Overall Study||56
8662721|NCT00895622|21386634|P1|STARTED|Overall Study||65
8662722|NCT00770601|21386667|P1|NOT COMPLETED|Overall Study||1
8662723|NCT00770601|21386667|P1|COMPLETED|Overall Study||6
8662724|NCT00770601|21386667|P1|STARTED|Overall Study||7
8662725|NCT00640133|21386673|P2|NOT COMPLETED|Open Label Phase (Month 4-12)||0
8662726|NCT00640133|21386674|P1|NOT COMPLETED|Open Label Phase (Month 4-12)||3
8662727|NCT00640133|21386673|P2|COMPLETED|Open Label Phase (Month 4-12)||0
8662728|NCT00640133|21386674|P1|COMPLETED|Open Label Phase (Month 4-12)||24
8662729|NCT00640133|21386673|P2|STARTED|Open Label Phase (Month 4-12)||0
8662730|NCT00640133|21386674|P1|STARTED|Open Label Phase (Month 4-12)||27
8662731|NCT00640133|21386673|P2|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
8662732|NCT00640133|21386674|P1|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
8662733|NCT00640133|21386673|P2|COMPLETED|Randomization Phase (Baseline-Month 3)||12
8662734|NCT00640133|21386674|P1|COMPLETED|Randomization Phase (Baseline-Month 3)||15
8662735|NCT00640133|21386673|P2|STARTED|Randomization Phase (Baseline-Month 3)||12
8662736|NCT00640133|21386674|P1|STARTED|Randomization Phase (Baseline-Month 3)||15
8662737|NCT00635427|21386699|P5|NOT COMPLETED|Overall Study||8
8662738|NCT00635427|21386700|P4|NOT COMPLETED|Overall Study||9
8662739|NCT00635427|21386701|P3|NOT COMPLETED|Overall Study||11
8662740|NCT00635427|21386702|P2|NOT COMPLETED|Overall Study||6
8662741|NCT00635427|21386703|P1|NOT COMPLETED|Overall Study||12
8662742|NCT00635427|21386699|P5|COMPLETED|Overall Study||30
8662743|NCT00635427|21386700|P4|COMPLETED|Overall Study||7
8662744|NCT00635427|21386701|P3|COMPLETED|Overall Study||5
8662745|NCT00635427|21386702|P2|COMPLETED|Overall Study||6
8662746|NCT00635427|21386703|P1|COMPLETED|Overall Study||1
8662747|NCT00635427|21386699|P5|STARTED|Overall Study||38
8662748|NCT00635427|21386700|P4|STARTED|Overall Study||16
8662749|NCT00635427|21386701|P3|STARTED|Overall Study||16
8662750|NCT00635427|21386702|P2|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
8662751|NCT00635427|21386703|P1|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
8662752|NCT00630747|21386723|P1|NOT COMPLETED|Overall Study||9
8662753|NCT00630747|21386723|P1|COMPLETED|Overall Study||85
8662754|NCT00630747|21386723|P1|Participants Treated in Phase I of Study|Overall Study||94
8662755|NCT00630747|21386723|P1|STARTED|Overall Study||94
8662756|NCT00478647|21386732|P1|NOT COMPLETED|Overall Study||2
8662757|NCT00478647|21386732|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
8662758|NCT00478647|21386732|P1|STARTED|Overall Study||40
8662762|NCT00289536|21386751|P3|NOT COMPLETED|Period 3||1
8662763|NCT00289536|21386752|P2|NOT COMPLETED|Period 3||0
8662764|NCT00289536|21386753|P1|NOT COMPLETED|Period 3||0
8662765|NCT00289536|21386751|P3|COMPLETED|Period 3||9
8662766|NCT00289536|21386752|P2|COMPLETED|Period 3||9
8662767|NCT00289536|21386753|P1|COMPLETED|Period 3||7
8662768|NCT00289536|21386751|P3|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
8662769|NCT00289536|21386752|P2|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
8662770|NCT00289536|21386753|P1|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
8662771|NCT00289536|21386751|P3|NOT COMPLETED|Period 2||0
8662772|NCT00289536|21386752|P2|NOT COMPLETED|Period 2||0
8662773|NCT00289536|21386753|P1|NOT COMPLETED|Period 2||0
8662774|NCT00289536|21386751|P3|COMPLETED|Period 2||7
8662775|NCT00289536|21386752|P2|COMPLETED|Period 2||9
8662776|NCT00289536|21386753|P1|COMPLETED|Period 2||10
8662777|NCT00289536|21386751|P3|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
8662778|NCT00289536|21386752|P2|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
8662779|NCT00289536|21386753|P1|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
8662780|NCT00289536|21386751|P3|NOT COMPLETED|Period 1||0
8662781|NCT00289536|21386752|P2|NOT COMPLETED|Period 1||0
8662782|NCT00289536|21386753|P1|NOT COMPLETED|Period 1||0
8662783|NCT00289536|21386751|P3|COMPLETED|Period 1||9
8662784|NCT00289536|21386752|P2|COMPLETED|Period 1||8
8662785|NCT00289536|21386753|P1|COMPLETED|Period 1||9
8662786|NCT00289536|21386751|P3|STARTED|Period 1||9
8662787|NCT00289536|21386752|P2|STARTED|Period 1||8
8662788|NCT00289536|21386753|P1|STARTED|Period 1||9
8662789|NCT00152009|21386796|P4|NOT COMPLETED|Overall Study||33
8662790|NCT00152009|21386797|P3|NOT COMPLETED|Overall Study||37
8662791|NCT00152009|21386798|P2|NOT COMPLETED|Overall Study||31
8662792|NCT00152009|21386799|P1|NOT COMPLETED|Overall Study||29
8662793|NCT00152009|21386796|P4|COMPLETED|Overall Study||53
8662794|NCT00152009|21386797|P3|COMPLETED|Overall Study||49
8662795|NCT00152009|21386798|P2|COMPLETED|Overall Study||55
8662796|NCT00152009|21386799|P1|COMPLETED|Overall Study||58
8662797|NCT00152009|21386796|P4|STARTED|Overall Study||86
8662798|NCT00152009|21386797|P3|STARTED|Overall Study||86
8662799|NCT00152009|21386798|P2|STARTED|Overall Study||86
8662800|NCT00152009|21386799|P1|STARTED|Overall Study||87
8662801|NCT00151996|21386831|P2|NOT COMPLETED|Overall Study||7
8662802|NCT00151996|21386832|P1|NOT COMPLETED|Overall Study||5
8662803|NCT00151996|21386831|P2|COMPLETED|Overall Study||26
8662804|NCT00151996|21386832|P1|COMPLETED|Overall Study||37
8662805|NCT00151996|21386831|P2|STARTED|Overall Study||33
8662806|NCT00151996|21386832|P1|STARTED|Overall Study||42
8662807|NCT00150618|21386851|P5|NOT COMPLETED|Overall Study||25
8662808|NCT00150618|21386852|P4|NOT COMPLETED|Overall Study||26
8662809|NCT00150618|21386853|P3|NOT COMPLETED|Overall Study||27
8662810|NCT00150618|21386854|P2|NOT COMPLETED|Overall Study||18
8662811|NCT00150618|21386855|P1|NOT COMPLETED|Overall Study||17
8662812|NCT00150618|21386851|P5|COMPLETED|Overall Study||41
8662813|NCT00150618|21386852|P4|COMPLETED|Overall Study||40
8662814|NCT00150618|21386853|P3|COMPLETED|Overall Study||38
8662815|NCT00150618|21386854|P2|COMPLETED|Overall Study||47
8662816|NCT00150618|21386855|P1|COMPLETED|Overall Study||45
8662817|NCT00150618|21386851|P5|STARTED|Overall Study||66
8662818|NCT00150618|21386852|P4|STARTED|Overall Study||66
8662819|NCT00150618|21386853|P3|STARTED|Overall Study||65
8662820|NCT00150618|21386854|P2|STARTED|Overall Study||65
8662821|NCT00150618|21386855|P1|STARTED|Overall Study||62
8662822|NCT00150592|21386889|P2|NOT COMPLETED|Overall Study||3
8662823|NCT00150592|21386890|P1|NOT COMPLETED|Overall Study||7
8662824|NCT00150592|21386889|P2|COMPLETED|Overall Study||54
8662825|NCT00150592|21386890|P1|COMPLETED|Overall Study||114
8662826|NCT00150592|21386889|P2|STARTED|Overall Study||57
8662827|NCT00150592|21386890|P1|STARTED|Overall Study||121
8662828|NCT00118040|21386913|P3|NOT COMPLETED|Overall Study||6
8662829|NCT00118040|21386914|P2|NOT COMPLETED|Overall Study||2
8662830|NCT00118040|21386915|P1|NOT COMPLETED|Overall Study||1
8662831|NCT00118040|21386913|P3|COMPLETED|Overall Study||14
8662832|NCT00118040|21386914|P2|COMPLETED|Overall Study||18
8662833|NCT00118040|21386915|P1|COMPLETED|Overall Study||19
8662834|NCT00118040|21386913|P3|STARTED|Overall Study||20
8662835|NCT00118040|21386914|P2|STARTED|Overall Study||20
8662836|NCT00118040|21386915|P1|STARTED|Overall Study||20
8662837|NCT00069641|21386979|P3|NOT COMPLETED|Overall Study||1
8662838|NCT00069641|21386980|P2|NOT COMPLETED|Overall Study||0
8662839|NCT00069641|21386981|P1|NOT COMPLETED|Overall Study||1
8662840|NCT00069641|21386979|P3|COMPLETED|Overall Study||31
8662841|NCT00069641|21386980|P2|COMPLETED|Overall Study||32
8662842|NCT00069641|21386981|P1|COMPLETED|Overall Study||31
8662843|NCT00069641|21386979|P3|STARTED|Overall Study||32
8662844|NCT00069641|21386980|P2|STARTED|Overall Study||32
8662845|NCT00069641|21386981|P1|STARTED|Overall Study||32
8662846|NCT04697888|21387006|P1|NOT COMPLETED|Overall Study||0
8662847|NCT04697888|21387006|P1|COMPLETED|Overall Study||2
8662848|NCT04697888|21387006|P1|STARTED|Overall Study||2
8662855|NCT04333199|21387024|P3|NOT COMPLETED|Emailed Patients||318
8662856|NCT04333199|21387025|P2|NOT COMPLETED|Emailed Patients||272
8662857|NCT04333199|21387026|P1|NOT COMPLETED|Emailed Patients||0
8662858|NCT04333199|21387024|P3|COMPLETED|Emailed Patients||1351
8662859|NCT04333199|21387025|P2|COMPLETED|Emailed Patients||1399
8662860|NCT04333199|21387026|P1|COMPLETED|Emailed Patients|Patients in this group were not emailed|0
8662861|NCT04333199|21387024|P3|Valid Email Address|Emailed Patients||1441
8662862|NCT04333199|21387025|P2|Valid Email Address|Emailed Patients||1495
8662863|NCT04333199|21387026|P1|Valid Email Address|Emailed Patients|Patients in this group were not emailed|0
8662864|NCT04333199|21387024|P3|STARTED|Emailed Patients||1669
8662865|NCT04333199|21387025|P2|STARTED|Emailed Patients||1671
8662866|NCT04333199|21387026|P1|STARTED|Emailed Patients|Patients in this group were not emailed|0
8662867|NCT04333199|21387024|P3|NOT COMPLETED|Evaluated Patients||2
8662868|NCT04333199|21387025|P2|NOT COMPLETED|Evaluated Patients||1
8662869|NCT04333199|21387026|P1|NOT COMPLETED|Evaluated Patients||0
8662870|NCT04333199|21387024|P3|COMPLETED|Evaluated Patients||1669
8662871|NCT04333199|21387025|P2|COMPLETED|Evaluated Patients||1671
8662872|NCT04333199|21387026|P1|COMPLETED|Evaluated Patients||1669
8662873|NCT04333199|21387024|P3|STARTED|Evaluated Patients||1671
8662874|NCT04333199|21387025|P2|STARTED|Evaluated Patients||1672
8662875|NCT04333199|21387026|P1|STARTED|Evaluated Patients||1669
8662876|NCT04195581|21387043|P1|NOT COMPLETED|Fanfilcon A With Refine One Step||2
8662877|NCT04195581|21387043|P1|COMPLETED|Fanfilcon A With Refine One Step||27
8662878|NCT04195581|21387043|P1|STARTED|Fanfilcon A With Refine One Step||29
8662879|NCT04195581|21387043|P1|NOT COMPLETED|Fanfilcon A With Hy-Care||3
8662880|NCT04195581|21387043|P1|COMPLETED|Fanfilcon A With Hy-Care||25
8662881|NCT04195581|21387043|P1|STARTED|Fanfilcon A With Hy-Care||28
8662882|NCT04195581|21387043|P1|NOT COMPLETED|Fanfilcon A With All in One Light||1
8662883|NCT04195581|21387043|P1|COMPLETED|Fanfilcon A With All in One Light||27
8662884|NCT04195581|21387043|P1|STARTED|Fanfilcon A With All in One Light||28
8662885|NCT04195581|21387043|P1|NOT COMPLETED|Comfilcon A With Refine One Step||1
8662886|NCT04195581|21387043|P1|COMPLETED|Comfilcon A With Refine One Step||24
8662887|NCT04195581|21387043|P1|STARTED|Comfilcon A With Refine One Step||25
8662888|NCT04195581|21387043|P1|NOT COMPLETED|Comfilcon A With Hy-Care||5
8662889|NCT04195581|21387043|P1|COMPLETED|Comfilcon A With Hy-Care||25
8662890|NCT04195581|21387043|P1|STARTED|Comfilcon A With Hy-Care||30
8662891|NCT04195581|21387043|P1|NOT COMPLETED|Comfilcon A With All in One Light||4
8662892|NCT04195581|21387043|P1|COMPLETED|Comfilcon A With All in One Light||24
8662893|NCT04195581|21387043|P1|STARTED|Comfilcon A With All in One Light||28
8662894|NCT04005586|21387117|P1|NOT COMPLETED|Overall Study||0
8662895|NCT04005586|21387117|P1|COMPLETED|Overall Study||25
8662896|NCT04005586|21387117|P1|STARTED|Overall Study||25
8662897|NCT03988842|21387123|P1|NOT COMPLETED|Overall Study||1
8662898|NCT03988842|21387123|P1|COMPLETED|Overall Study||3
8662899|NCT03988842|21387123|P1|STARTED|Overall Study||4
8662900|NCT03962738|21387142|P4|NOT COMPLETED|Overall Study||1
8662901|NCT03962738|21387143|P3|NOT COMPLETED|Overall Study||2
8662902|NCT03962738|21387144|P2|NOT COMPLETED|Overall Study||0
8662903|NCT03962738|21387145|P1|NOT COMPLETED|Overall Study||7
8662904|NCT03962738|21387142|P4|COMPLETED|Overall Study||217
8662905|NCT03962738|21387143|P3|COMPLETED|Overall Study||259
8662906|NCT03962738|21387144|P2|COMPLETED|Overall Study||109
8662907|NCT03962738|21387145|P1|COMPLETED|Overall Study||251
8662908|NCT03962738|21387142|P4|Received At Least One Dose of Study Drug|Overall Study||182
8662909|NCT03962738|21387143|P3|Received At Least One Dose of Study Drug|Overall Study||208
8662910|NCT03962738|21387144|P2|Received At Least One Dose of Study Drug|Overall Study||87
8662911|NCT03962738|21387145|P1|Received At Least One Dose of Study Drug|Overall Study||214
8662912|NCT03962738|21387142|P4|STARTED|Overall Study||218
8662913|NCT03962738|21387143|P3|STARTED|Overall Study||261
8662914|NCT03962738|21387144|P2|STARTED|Overall Study||109
8662915|NCT03962738|21387145|P1|STARTED|Overall Study||258
8662916|NCT03943160|21387225|P1|NOT COMPLETED|Overall Study||0
8662917|NCT03943160|21387225|P1|COMPLETED|Overall Study||50
8662918|NCT03943160|21387225|P1|STARTED|Overall Study||50
8662919|NCT03786718|21387230|P1|NOT COMPLETED|Overall Study||7
8662920|NCT03786718|21387230|P1|COMPLETED|Overall Study||60
8662921|NCT03786718|21387230|P1|STARTED|Overall Study||67
8662922|NCT03734601|21387245|P1|NOT COMPLETED|Overall Study||0
8662923|NCT03734601|21387245|P1|COMPLETED|Overall Study||22
8662924|NCT03734601|21387245|P1|STARTED|Overall Study||22
8662928|NCT03615066|21387263|P3|NOT COMPLETED|Overall Study||4
8662929|NCT03615066|21387264|P2|NOT COMPLETED|Overall Study||8
8662930|NCT03615066|21387265|P1|NOT COMPLETED|Overall Study||9
8662931|NCT03615066|21387263|P3|COMPLETED|Overall Study||9
8662932|NCT03615066|21387264|P2|COMPLETED|Overall Study||20
8662933|NCT03615066|21387265|P1|COMPLETED|Overall Study||17
8662934|NCT03615066|21387263|P3|STARTED|Overall Study||13
8662935|NCT03615066|21387264|P2|STARTED|Overall Study||28
8662936|NCT03615066|21387265|P1|STARTED|Overall Study||26
8662940|NCT03482635|21387364|P4|NOT COMPLETED|Overall Study||8
8662941|NCT03482635|21387365|P3|NOT COMPLETED|Overall Study||1
8662942|NCT03482635|21387366|P2|NOT COMPLETED|Overall Study||3
8662943|NCT03482635|21387367|P1|NOT COMPLETED|Overall Study||5
8662944|NCT03482635|21387364|P4|COMPLETED|Overall Study||20
8662945|NCT03482635|21387365|P3|COMPLETED|Overall Study||22
8662946|NCT03482635|21387366|P2|COMPLETED|Overall Study||21
8662947|NCT03482635|21387367|P1|COMPLETED|Overall Study||18
8662948|NCT03482635|21387364|P4|Treated|Overall Study||27
8662949|NCT03482635|21387365|P3|Treated|Overall Study||23
8662950|NCT03482635|21387366|P2|Treated|Overall Study||24
8662951|NCT03482635|21387367|P1|Treated|Overall Study||23
8662952|NCT03482635|21387364|P4|STARTED|Overall Study||28
8662953|NCT03482635|21387365|P3|STARTED|Overall Study||23
8662954|NCT03482635|21387366|P2|STARTED|Overall Study||24
8662955|NCT03482635|21387367|P1|STARTED|Overall Study||23
8663008|NCT03273153|21387430|P2|NOT COMPLETED|Overall Study||222
8663009|NCT03273153|21387431|P1|NOT COMPLETED|Overall Study||224
8663010|NCT03273153|21387430|P2|COMPLETED|Overall Study||0
8663011|NCT03273153|21387431|P1|COMPLETED|Overall Study||0
8663012|NCT03273153|21387430|P2|STARTED|Overall Study||222
8663013|NCT03273153|21387431|P1|STARTED|Overall Study||224
8663014|NCT03223649|21387453|P2|NOT COMPLETED|Overall Study||6
8663015|NCT03223649|21387454|P1|NOT COMPLETED|Overall Study||10
8663016|NCT03223649|21387453|P2|COMPLETED|Overall Study||51
8663017|NCT03223649|21387454|P1|COMPLETED|Overall Study||42
8663018|NCT03223649|21387453|P2|STARTED|Overall Study||57
8663019|NCT03223649|21387454|P1|STARTED|Overall Study||52
8663020|NCT03192137|21387480|P2|NOT COMPLETED|Overall Study||58
8663021|NCT03192137|21387481|P1|NOT COMPLETED|Overall Study||50
8663022|NCT03192137|21387480|P2|COMPLETED|Overall Study||29
8663023|NCT03192137|21387481|P1|COMPLETED|Overall Study||123
8663024|NCT03192137|21387480|P2|STARTED|Overall Study||87
8663025|NCT03192137|21387481|P1|STARTED|Overall Study||173
8663026|NCT03191799|21387489|P1|NOT COMPLETED|Overall Study||9
8663027|NCT03191799|21387489|P1|COMPLETED|Overall Study||186
8663028|NCT03191799|21387489|P1|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
8663029|NCT03191799|21387489|P1|Received at Least One Dose of Emicizumab|Overall Study||193
8663030|NCT03191799|21387489|P1|STARTED|Overall Study||195
8663031|NCT03147690|21387540|P1|NOT COMPLETED|Overall Study||3
8663032|NCT03147690|21387540|P1|COMPLETED|Overall Study||71
8663033|NCT03147690|21387540|P1|STARTED|Overall Study||74
8663034|NCT03137693|21387562|P1|NOT COMPLETED|Overall Study||0
8663035|NCT03137693|21387562|P1|COMPLETED|Overall Study||20
8663036|NCT03137693|21387562|P1|STARTED|Overall Study||20
8663037|NCT03122860|21387572|P6|NOT COMPLETED|Overall Study||12
8663038|NCT03122860|21387573|P5|NOT COMPLETED|Overall Study||15
8663039|NCT03122860|21387574|P4|NOT COMPLETED|Overall Study||11
8663040|NCT03122860|21387575|P3|NOT COMPLETED|Overall Study||12
8663041|NCT03122860|21387576|P2|NOT COMPLETED|Overall Study||5
8663042|NCT03122860|21387577|P1|NOT COMPLETED|Overall Study||10
8663043|NCT03122860|21387572|P6|COMPLETED|Overall Study||105
8663044|NCT03122860|21387573|P5|COMPLETED|Overall Study||102
8663045|NCT03122860|21387574|P4|COMPLETED|Overall Study||105
8663046|NCT03122860|21387575|P3|COMPLETED|Overall Study||105
8663047|NCT03122860|21387576|P2|COMPLETED|Overall Study||111
8663048|NCT03122860|21387577|P1|COMPLETED|Overall Study||107
8663049|NCT03122860|21387572|P6|Full Analysis Set|Overall Study||117
8663050|NCT03122860|21387573|P5|Full Analysis Set|Overall Study||116
8663051|NCT03122860|21387574|P4|Full Analysis Set|Overall Study||116
8663052|NCT03122860|21387575|P3|Full Analysis Set|Overall Study||115
8663053|NCT03122860|21387576|P2|Full Analysis Set|Overall Study||115
8663054|NCT03122860|21387577|P1|Full Analysis Set|Overall Study||116
8663055|NCT03122860|21387572|P6|STARTED|Overall Study||117
8663056|NCT03122860|21387573|P5|STARTED|Overall Study||117
8663057|NCT03122860|21387574|P4|STARTED|Overall Study||116
8663058|NCT03122860|21387575|P3|STARTED|Overall Study||117
8663059|NCT03122860|21387576|P2|STARTED|Overall Study||116
8663060|NCT03122860|21387577|P1|STARTED|Overall Study||117
8663061|NCT03073200|21387643|P3|NOT COMPLETED|Overall Study||30
8663062|NCT03073200|21387644|P2|NOT COMPLETED|Overall Study||115
8663063|NCT03073200|21387645|P1|NOT COMPLETED|Overall Study||55
8663064|NCT03073200|21387643|P3|COMPLETED|Overall Study||0
8663065|NCT03073200|21387644|P2|COMPLETED|Overall Study||0
8663066|NCT03073200|21387645|P1|COMPLETED|Overall Study||1
8663067|NCT03073200|21387643|P3|Pts in Etanercept Approved Countries|Overall Study||30
8663068|NCT03073200|21387644|P2|Pts in Etanercept Approved Countries|Overall Study||38
8663069|NCT03073200|21387645|P1|Pts in Etanercept Approved Countries|Overall Study||19
8663070|NCT03073200|21387643|P3|STARTED|Overall Study||30
8663071|NCT03073200|21387644|P2|STARTED|Overall Study||115
8663072|NCT03073200|21387645|P1|STARTED|Overall Study||56
8663073|NCT03072953|21387681|P1|NOT COMPLETED|Overall Study||0
8663074|NCT03072953|21387681|P1|COMPLETED|Overall Study||2
8663075|NCT03072953|21387681|P1|STARTED|Overall Study||2
8663076|NCT03011034|21387693|P2|NOT COMPLETED|Overall Study||0
8663077|NCT03011034|21387694|P1|NOT COMPLETED|Overall Study||1
8663078|NCT03011034|21387693|P2|COMPLETED|Overall Study||33
8663079|NCT03011034|21387694|P1|COMPLETED|Overall Study||0
8663080|NCT03011034|21387693|P2|STARTED|Overall Study||33
8663081|NCT03011034|21387694|P1|STARTED|Overall Study||1
8663082|NCT02983552|21387726|P4|NOT COMPLETED|Overall Study||0
8663083|NCT02983552|21387727|P3|NOT COMPLETED|Overall Study||0
8663084|NCT02983552|21387728|P2|NOT COMPLETED|Overall Study||2
8663085|NCT02983552|21387729|P1|NOT COMPLETED|Overall Study||0
8663086|NCT02983552|21387726|P4|COMPLETED|Overall Study||90
8663087|NCT02983552|21387727|P3|COMPLETED|Overall Study||92
8663088|NCT02983552|21387728|P2|COMPLETED|Overall Study||67
8663089|NCT02983552|21387729|P1|COMPLETED|Overall Study||69
8663090|NCT02983552|21387726|P4|16 Week Visit|Overall Study||72
8663091|NCT02983552|21387727|P3|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
8663092|NCT02983552|21387728|P2|16 Week Visit|Overall Study||66
8663093|NCT02983552|21387729|P1|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
8663094|NCT02983552|21387726|P4|8 Week Visit|Overall Study||84
8663095|NCT02983552|21387727|P3|8 Week Visit|Overall Study||85
8663096|NCT02983552|21387728|P2|8 Week Visit|Overall Study||68
8663097|NCT02983552|21387729|P1|8 Week Visit|Overall Study||67
8663098|NCT02983552|21387726|P4|4 Week Visit|Overall Study||84
8663099|NCT02983552|21387727|P3|4 Week Visit|Overall Study||85
8663100|NCT02983552|21387728|P2|4 Week Visit|Overall Study||67
8663101|NCT02983552|21387729|P1|4 Week Visit|Overall Study||69
8663102|NCT02983552|21387726|P4|STARTED|Overall Study||90
8663103|NCT02983552|21387727|P3|STARTED|Overall Study||92
8663104|NCT02983552|21387728|P2|STARTED|Overall Study||69
8663105|NCT02983552|21387729|P1|STARTED|Overall Study||69
8663106|NCT02938520|21387873|P2|NOT COMPLETED|Overall Study||283
8663107|NCT02938520|21387874|P1|NOT COMPLETED|Overall Study||283
8663108|NCT02938520|21387873|P2|COMPLETED|Overall Study||0
8663109|NCT02938520|21387874|P1|COMPLETED|Overall Study||0
8663110|NCT02938520|21387873|P2|STARTED|Overall Study||283
8663111|NCT02938520|21387874|P1|STARTED|Overall Study||283
8663112|NCT02920476|21387999|P1|NOT COMPLETED|Overall Study||1
8663113|NCT02920476|21387999|P1|COMPLETED|Overall Study||3
8663114|NCT02920476|21387999|P1|STARTED|Overall Study||4
8663115|NCT02901548|21388004|P1|NOT COMPLETED|Overall Study||4
8663116|NCT02901548|21388004|P1|COMPLETED|Overall Study||13
8663117|NCT02901548|21388004|P1|STARTED|Overall Study||17
8663118|NCT02889900|21388008|P1|NOT COMPLETED|Overall Study||57
8663119|NCT02889900|21388008|P1|COMPLETED|Overall Study|Patients ongoing in study at primary analysis data cut off (DCO)|5
8663120|NCT02889900|21388008|P1|Received Treatment|Overall Study||60
8663121|NCT02889900|21388008|P1|STARTED|Overall Study||62
8663134|NCT02871128|21388080|P3|NOT COMPLETED|Overall Study||1
8663135|NCT02871128|21388081|P2|NOT COMPLETED|Overall Study||1
8663136|NCT02871128|21388082|P1|NOT COMPLETED|Overall Study||0
8663137|NCT02871128|21388080|P3|COMPLETED|Overall Study||15
8663138|NCT02871128|21388081|P2|COMPLETED|Overall Study||19
8663139|NCT02871128|21388082|P1|COMPLETED|Overall Study||20
8663140|NCT02871128|21388080|P3|STARTED|Overall Study||16
8663141|NCT02871128|21388081|P2|STARTED|Overall Study||20
8663142|NCT02871128|21388082|P1|STARTED|Overall Study||20
8663143|NCT02831764|21388095|P2|NOT COMPLETED|Overall Study||359
8663144|NCT02831764|21388096|P1|NOT COMPLETED|Overall Study||360
8663145|NCT02831764|21388095|P2|COMPLETED|Overall Study||0
8663146|NCT02831764|21388096|P1|COMPLETED|Overall Study||0
8663147|NCT02831764|21388095|P2|STARTED|Overall Study||359
8663148|NCT02831764|21388096|P1|STARTED|Overall Study||360
8663149|NCT02831673|21388160|P2|NOT COMPLETED|Overall Study||358
8663150|NCT02831673|21388161|P1|NOT COMPLETED|Overall Study||356
8663151|NCT02831673|21388160|P2|COMPLETED|Overall Study||0
8663152|NCT02831673|21388161|P1|COMPLETED|Overall Study||0
8663153|NCT02831673|21388160|P2|STARTED|Overall Study||358
8663154|NCT02831673|21388161|P1|STARTED|Overall Study||356
8663155|NCT02821104|21388223|P1|NOT COMPLETED|Overall Study||0
8663156|NCT02821104|21388223|P1|COMPLETED|Overall Study||77
8663157|NCT02821104|21388223|P1|STARTED|Overall Study||77
8663158|NCT02783911|21388239|P2|NOT COMPLETED|Overall Study||32
8663159|NCT02783911|21388240|P1|NOT COMPLETED|Overall Study||3
8663160|NCT02783911|21388239|P2|COMPLETED|Overall Study||14
8663161|NCT02783911|21388240|P1|COMPLETED|Overall Study||8
8663162|NCT02783911|21388239|P2|STARTED|Overall Study||46
8663163|NCT02783911|21388240|P1|STARTED|Overall Study||11
8663164|NCT02763566|21388250|P4|NOT COMPLETED|Overall Study||14
8663165|NCT02763566|21388251|P3|NOT COMPLETED|Overall Study||54
8663166|NCT02763566|21388252|P2|NOT COMPLETED|Overall Study||39
8663167|NCT02763566|21388253|P1|NOT COMPLETED|Overall Study||118
8663168|NCT02763566|21388250|P4|COMPLETED|Overall Study||39
8663169|NCT02763566|21388251|P3|COMPLETED|Overall Study||50
8663170|NCT02763566|21388252|P2|COMPLETED|Overall Study||60
8663171|NCT02763566|21388253|P1|COMPLETED|Overall Study||89
8663172|NCT02763566|21388250|P4|STARTED|Overall Study||53
8663173|NCT02763566|21388251|P3|STARTED|Overall Study||104
8663174|NCT02763566|21388252|P2|STARTED|Overall Study||99
8663175|NCT02763566|21388253|P1|STARTED|Overall Study||207
8663176|NCT02657889|21388285|P4|NOT COMPLETED|Overall Study||55
8663177|NCT02657889|21388286|P3|NOT COMPLETED|Overall Study||53
8663178|NCT02657889|21388287|P2|NOT COMPLETED|Overall Study||7
8663179|NCT02657889|21388288|P1|NOT COMPLETED|Overall Study||7
8663180|NCT02657889|21388285|P4|COMPLETED|Overall Study||0
8663181|NCT02657889|21388286|P3|COMPLETED|Overall Study||0
8663182|NCT02657889|21388287|P2|COMPLETED|Overall Study||0
8663183|NCT02657889|21388288|P1|COMPLETED|Overall Study||0
8663184|NCT02657889|21388285|P4|STARTED|Overall Study||55
8663185|NCT02657889|21388286|P3|STARTED|Overall Study||53
8663186|NCT02657889|21388287|P2|STARTED|Overall Study||7
8663187|NCT02657889|21388288|P1|STARTED|Overall Study||7
8663188|NCT02652949|21388306|P1|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||35
8663189|NCT02652949|21388306|P1|COMPLETED|24-Month Follow-up Secondary Endpoint||52
8663190|NCT02652949|21388306|P1|STARTED|24-Month Follow-up Secondary Endpoint||87
8663191|NCT02652949|21388306|P1|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
8663192|NCT02652949|21388306|P1|COMPLETED|12-Month Follow-up Secondary Endpoint||87
8663193|NCT02652949|21388306|P1|STARTED|12-Month Follow-up Secondary Endpoint||91
8663194|NCT02652949|21388306|P1|NOT COMPLETED|6-Month Follow-up Secondary Endpoint||8
8663195|NCT02652949|21388306|P1|COMPLETED|6-Month Follow-up Secondary Endpoint||91
8663196|NCT02652949|21388306|P1|STARTED|6-Month Follow-up Secondary Endpoint|Note that 6-month follow up is not mandatory for OUS subjects.|99
8663197|NCT02652949|21388306|P1|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
8663198|NCT02652949|21388306|P1|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
8663199|NCT02652949|21388306|P1|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
8663200|NCT02652949|21388306|P1|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
8663201|NCT02652949|21388306|P1|COMPLETED|30-Day Follow-up for Primary Endpoint||86
8663202|NCT02652949|21388306|P1|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
8663203|NCT02649218|21388317|P1|NOT COMPLETED|Overall Study||25
8663204|NCT02649218|21388317|P1|COMPLETED|Overall Study||201
8663205|NCT02649218|21388317|P1|STARTED|Overall Study||226
8663206|NCT02625324|21388324|P1|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||35
8663207|NCT02625324|21388324|P1|COMPLETED|24-Month Follow-up Secondary Endpoint||52
8663208|NCT02625324|21388324|P1|STARTED|24-Month Follow-up Secondary Endpoint||87
8663209|NCT02625324|21388324|P1|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
8663210|NCT02625324|21388324|P1|COMPLETED|12-Month Follow-up Secondary Endpoint||87
8663211|NCT02625324|21388324|P1|STARTED|12-Month Follow-up Secondary Endpoint||91
8663212|NCT02625324|21388324|P1|NOT COMPLETED|6-Month Follow-up Subject Accountability||8
8663213|NCT02625324|21388324|P1|COMPLETED|6-Month Follow-up Subject Accountability||91
8663214|NCT02625324|21388324|P1|STARTED|6-Month Follow-up Subject Accountability|Note that 6-month follow up is not mandatory for OUS subjects|99
8663215|NCT02625324|21388324|P1|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
8663216|NCT02625324|21388324|P1|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
8663217|NCT02625324|21388324|P1|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
8663218|NCT02625324|21388324|P1|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
8663219|NCT02625324|21388324|P1|COMPLETED|30-Day Follow-up for Primary Endpoint||86
8663220|NCT02625324|21388324|P1|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
8663230|NCT02588664|21388361|P2|NOT COMPLETED|Overall Study||1045
8663231|NCT02588664|21388362|P1|NOT COMPLETED|Overall Study||1361
8663232|NCT02588664|21388361|P2|COMPLETED|Overall Study||1644
8663233|NCT02588664|21388362|P1|COMPLETED|Overall Study||1832
8663234|NCT02588664|21388361|P2|STARTED|Overall Study||2689
8663235|NCT02588664|21388362|P1|STARTED|Overall Study||3193
8663236|NCT02540954|21388422|P2|NOT COMPLETED|Overall Study||14
8663237|NCT02540954|21388423|P1|NOT COMPLETED|Overall Study||19
8663238|NCT02540954|21388422|P2|COMPLETED|Overall Study|Completed treatment|154
8663239|NCT02540954|21388423|P1|COMPLETED|Overall Study|Completed treatment|149
8663240|NCT02540954|21388422|P2|Post-baseline BCVA Assessment|Overall Study|FAS|167
8663241|NCT02540954|21388423|P1|Post-baseline BCVA Assessment|Overall Study|FAS|165
8663242|NCT02540954|21388422|P2|Treated|Overall Study||168
8663243|NCT02540954|21388423|P1|Treated|Overall Study||167
8663244|NCT02540954|21388422|P2|STARTED|Overall Study||168
8663245|NCT02540954|21388423|P1|STARTED|Overall Study||168
8663246|NCT02533674|21388451|P8|NOT COMPLETED|Dose Level VIII||6
8663247|NCT02533674|21388452|P7|NOT COMPLETED|Dose Level VIII||0
8663248|NCT02533674|21388453|P6|NOT COMPLETED|Dose Level VIII||0
8663249|NCT02533674|21388454|P5|NOT COMPLETED|Dose Level VIII||0
8663250|NCT02533674|21388455|P4|NOT COMPLETED|Dose Level VIII||0
8663251|NCT02533674|21388456|P3|NOT COMPLETED|Dose Level VIII||0
8663252|NCT02533674|21388457|P2|NOT COMPLETED|Dose Level VIII||0
8663253|NCT02533674|21388458|P1|NOT COMPLETED|Dose Level VIII||0
8663254|NCT02533674|21388451|P8|COMPLETED|Dose Level VIII||0
8663255|NCT02533674|21388452|P7|COMPLETED|Dose Level VIII||0
8663256|NCT02533674|21388453|P6|COMPLETED|Dose Level VIII||0
8663257|NCT02533674|21388454|P5|COMPLETED|Dose Level VIII||0
8663258|NCT02533674|21388455|P4|COMPLETED|Dose Level VIII||0
8663259|NCT02533674|21388456|P3|COMPLETED|Dose Level VIII||0
8663260|NCT02533674|21388457|P2|COMPLETED|Dose Level VIII||0
8663261|NCT02533674|21388458|P1|COMPLETED|Dose Level VIII||0
8663262|NCT02533674|21388451|P8|STARTED|Dose Level VIII||6
8663263|NCT02533674|21388452|P7|STARTED|Dose Level VIII||0
8663264|NCT02533674|21388453|P6|STARTED|Dose Level VIII||0
8663265|NCT02533674|21388454|P5|STARTED|Dose Level VIII||0
8663266|NCT02533674|21388455|P4|STARTED|Dose Level VIII||0
8663267|NCT02533674|21388456|P3|STARTED|Dose Level VIII||0
8663268|NCT02533674|21388457|P2|STARTED|Dose Level VIII||0
8663269|NCT02533674|21388458|P1|STARTED|Dose Level VIII||0
8663270|NCT02533674|21388451|P8|NOT COMPLETED|Dose Level VII||0
8663271|NCT02533674|21388452|P7|NOT COMPLETED|Dose Level VII||16
8663272|NCT02533674|21388453|P6|NOT COMPLETED|Dose Level VII||0
8663273|NCT02533674|21388454|P5|NOT COMPLETED|Dose Level VII||0
8663274|NCT02533674|21388455|P4|NOT COMPLETED|Dose Level VII||0
8663275|NCT02533674|21388456|P3|NOT COMPLETED|Dose Level VII||0
8663276|NCT02533674|21388457|P2|NOT COMPLETED|Dose Level VII||0
8663277|NCT02533674|21388458|P1|NOT COMPLETED|Dose Level VII||0
8663278|NCT02533674|21388451|P8|COMPLETED|Dose Level VII||0
8663279|NCT02533674|21388452|P7|COMPLETED|Dose Level VII||0
8663280|NCT02533674|21388453|P6|COMPLETED|Dose Level VII||0
8663281|NCT02533674|21388454|P5|COMPLETED|Dose Level VII||0
8663282|NCT02533674|21388455|P4|COMPLETED|Dose Level VII||0
8663283|NCT02533674|21388456|P3|COMPLETED|Dose Level VII||0
8663284|NCT02533674|21388457|P2|COMPLETED|Dose Level VII||0
8663285|NCT02533674|21388458|P1|COMPLETED|Dose Level VII||0
8663286|NCT02533674|21388451|P8|STARTED|Dose Level VII||0
8663287|NCT02533674|21388452|P7|STARTED|Dose Level VII||16
8663288|NCT02533674|21388453|P6|STARTED|Dose Level VII||0
8663289|NCT02533674|21388454|P5|STARTED|Dose Level VII||0
8663290|NCT02533674|21388455|P4|STARTED|Dose Level VII||0
8663291|NCT02533674|21388456|P3|STARTED|Dose Level VII||0
8663292|NCT02533674|21388457|P2|STARTED|Dose Level VII||0
8663293|NCT02533674|21388458|P1|STARTED|Dose Level VII||0
8663294|NCT02533674|21388451|P8|NOT COMPLETED|Dose Level VI||0
8663295|NCT02533674|21388452|P7|NOT COMPLETED|Dose Level VI||0
8663296|NCT02533674|21388453|P6|NOT COMPLETED|Dose Level VI||9
8663297|NCT02533674|21388454|P5|NOT COMPLETED|Dose Level VI||0
8663298|NCT02533674|21388455|P4|NOT COMPLETED|Dose Level VI||0
8663299|NCT02533674|21388456|P3|NOT COMPLETED|Dose Level VI||0
8663300|NCT02533674|21388457|P2|NOT COMPLETED|Dose Level VI||0
8663301|NCT02533674|21388458|P1|NOT COMPLETED|Dose Level VI||0
8663302|NCT02533674|21388451|P8|COMPLETED|Dose Level VI||0
8663303|NCT02533674|21388452|P7|COMPLETED|Dose Level VI||0
8663304|NCT02533674|21388453|P6|COMPLETED|Dose Level VI||0
8663305|NCT02533674|21388454|P5|COMPLETED|Dose Level VI||0
8663306|NCT02533674|21388455|P4|COMPLETED|Dose Level VI||0
8663307|NCT02533674|21388456|P3|COMPLETED|Dose Level VI||0
8663308|NCT02533674|21388457|P2|COMPLETED|Dose Level VI||0
8663309|NCT02533674|21388458|P1|COMPLETED|Dose Level VI||0
8663310|NCT02533674|21388451|P8|STARTED|Dose Level VI||0
8663311|NCT02533674|21388452|P7|STARTED|Dose Level VI||0
8663312|NCT02533674|21388453|P6|STARTED|Dose Level VI||9
8663313|NCT02533674|21388454|P5|STARTED|Dose Level VI||0
8663314|NCT02533674|21388455|P4|STARTED|Dose Level VI||0
8663315|NCT02533674|21388456|P3|STARTED|Dose Level VI||0
8663316|NCT02533674|21388457|P2|STARTED|Dose Level VI||0
8663317|NCT02533674|21388458|P1|STARTED|Dose Level VI||0
8663318|NCT02533674|21388451|P8|NOT COMPLETED|Dose Level V||0
8663319|NCT02533674|21388452|P7|NOT COMPLETED|Dose Level V||0
8663320|NCT02533674|21388453|P6|NOT COMPLETED|Dose Level V||0
8663321|NCT02533674|21388454|P5|NOT COMPLETED|Dose Level V||5
8663322|NCT02533674|21388455|P4|NOT COMPLETED|Dose Level V||0
8663323|NCT02533674|21388456|P3|NOT COMPLETED|Dose Level V||0
8663324|NCT02533674|21388457|P2|NOT COMPLETED|Dose Level V||0
8663325|NCT02533674|21388458|P1|NOT COMPLETED|Dose Level V||0
8663326|NCT02533674|21388451|P8|COMPLETED|Dose Level V||0
8663327|NCT02533674|21388452|P7|COMPLETED|Dose Level V||0
8663328|NCT02533674|21388453|P6|COMPLETED|Dose Level V||0
8663329|NCT02533674|21388454|P5|COMPLETED|Dose Level V||0
8663330|NCT02533674|21388455|P4|COMPLETED|Dose Level V||0
8663331|NCT02533674|21388456|P3|COMPLETED|Dose Level V||0
8663332|NCT02533674|21388457|P2|COMPLETED|Dose Level V||0
8663333|NCT02533674|21388458|P1|COMPLETED|Dose Level V||0
8663334|NCT02533674|21388451|P8|STARTED|Dose Level V||0
8663335|NCT02533674|21388452|P7|STARTED|Dose Level V||0
8663336|NCT02533674|21388453|P6|STARTED|Dose Level V||0
8663337|NCT02533674|21388454|P5|STARTED|Dose Level V||5
8663338|NCT02533674|21388455|P4|STARTED|Dose Level V||0
8663339|NCT02533674|21388456|P3|STARTED|Dose Level V||0
8663340|NCT02533674|21388457|P2|STARTED|Dose Level V||0
8663341|NCT02533674|21388458|P1|STARTED|Dose Level V||0
8663342|NCT02533674|21388451|P8|NOT COMPLETED|Dose Level IV||0
8663343|NCT02533674|21388452|P7|NOT COMPLETED|Dose Level IV||0
8663344|NCT02533674|21388453|P6|NOT COMPLETED|Dose Level IV||0
8663345|NCT02533674|21388454|P5|NOT COMPLETED|Dose Level IV||0
8663346|NCT02533674|21388455|P4|NOT COMPLETED|Dose Level IV||5
8663347|NCT02533674|21388456|P3|NOT COMPLETED|Dose Level IV||0
8663348|NCT02533674|21388457|P2|NOT COMPLETED|Dose Level IV||0
8663349|NCT02533674|21388458|P1|NOT COMPLETED|Dose Level IV||0
8663350|NCT02533674|21388451|P8|COMPLETED|Dose Level IV||0
8663351|NCT02533674|21388452|P7|COMPLETED|Dose Level IV||0
8663352|NCT02533674|21388453|P6|COMPLETED|Dose Level IV||0
8663353|NCT02533674|21388454|P5|COMPLETED|Dose Level IV||0
8663354|NCT02533674|21388455|P4|COMPLETED|Dose Level IV||0
8663355|NCT02533674|21388456|P3|COMPLETED|Dose Level IV||0
8663356|NCT02533674|21388457|P2|COMPLETED|Dose Level IV||0
8663357|NCT02533674|21388458|P1|COMPLETED|Dose Level IV||0
8663358|NCT02533674|21388451|P8|STARTED|Dose Level IV||0
8663359|NCT02533674|21388452|P7|STARTED|Dose Level IV||0
8663360|NCT02533674|21388453|P6|STARTED|Dose Level IV||0
8663361|NCT02533674|21388454|P5|STARTED|Dose Level IV||0
8663362|NCT02533674|21388455|P4|STARTED|Dose Level IV||5
8663363|NCT02533674|21388456|P3|STARTED|Dose Level IV||0
8663364|NCT02533674|21388457|P2|STARTED|Dose Level IV||0
8663365|NCT02533674|21388458|P1|STARTED|Dose Level IV||0
8663366|NCT02533674|21388451|P8|NOT COMPLETED|Dose Level III||0
8663367|NCT02533674|21388452|P7|NOT COMPLETED|Dose Level III||0
8663368|NCT02533674|21388453|P6|NOT COMPLETED|Dose Level III||0
8663369|NCT02533674|21388454|P5|NOT COMPLETED|Dose Level III||0
8663370|NCT02533674|21388455|P4|NOT COMPLETED|Dose Level III||0
8663371|NCT02533674|21388456|P3|NOT COMPLETED|Dose Level III||4
8663372|NCT02533674|21388457|P2|NOT COMPLETED|Dose Level III||0
8663373|NCT02533674|21388458|P1|NOT COMPLETED|Dose Level III||0
8663374|NCT02533674|21388451|P8|COMPLETED|Dose Level III||0
8663375|NCT02533674|21388452|P7|COMPLETED|Dose Level III||0
8663376|NCT02533674|21388453|P6|COMPLETED|Dose Level III||0
8663377|NCT02533674|21388454|P5|COMPLETED|Dose Level III||0
8663378|NCT02533674|21388455|P4|COMPLETED|Dose Level III||0
8663379|NCT02533674|21388456|P3|COMPLETED|Dose Level III||0
8663380|NCT02533674|21388457|P2|COMPLETED|Dose Level III||0
8663381|NCT02533674|21388458|P1|COMPLETED|Dose Level III||0
8663382|NCT02533674|21388451|P8|STARTED|Dose Level III||0
8663383|NCT02533674|21388452|P7|STARTED|Dose Level III||0
8663384|NCT02533674|21388453|P6|STARTED|Dose Level III||0
8663385|NCT02533674|21388454|P5|STARTED|Dose Level III||0
8663386|NCT02533674|21388455|P4|STARTED|Dose Level III||0
8663387|NCT02533674|21388456|P3|STARTED|Dose Level III||4
8663388|NCT02533674|21388457|P2|STARTED|Dose Level III||0
8663389|NCT02533674|21388458|P1|STARTED|Dose Level III||0
8663390|NCT02533674|21388451|P8|NOT COMPLETED|Dose Level II||0
8663391|NCT02533674|21388452|P7|NOT COMPLETED|Dose Level II||0
8663392|NCT02533674|21388453|P6|NOT COMPLETED|Dose Level II||0
8663393|NCT02533674|21388454|P5|NOT COMPLETED|Dose Level II||0
8663394|NCT02533674|21388455|P4|NOT COMPLETED|Dose Level II||0
8663395|NCT02533674|21388456|P3|NOT COMPLETED|Dose Level II||0
8663396|NCT02533674|21388457|P2|NOT COMPLETED|Dose Level II||7
8663397|NCT02533674|21388458|P1|NOT COMPLETED|Dose Level II||0
8663398|NCT02533674|21388451|P8|COMPLETED|Dose Level II||0
8663399|NCT02533674|21388452|P7|COMPLETED|Dose Level II||0
8663400|NCT02533674|21388453|P6|COMPLETED|Dose Level II||0
8663401|NCT02533674|21388454|P5|COMPLETED|Dose Level II||0
8663402|NCT02533674|21388455|P4|COMPLETED|Dose Level II||0
8663403|NCT02533674|21388456|P3|COMPLETED|Dose Level II||0
8663404|NCT02533674|21388457|P2|COMPLETED|Dose Level II||0
8663405|NCT02533674|21388458|P1|COMPLETED|Dose Level II||0
8663406|NCT02533674|21388451|P8|STARTED|Dose Level II||0
8663407|NCT02533674|21388452|P7|STARTED|Dose Level II||0
8663408|NCT02533674|21388453|P6|STARTED|Dose Level II||0
8663409|NCT02533674|21388454|P5|STARTED|Dose Level II||0
8663410|NCT02533674|21388455|P4|STARTED|Dose Level II||0
8663411|NCT02533674|21388456|P3|STARTED|Dose Level II||0
8663412|NCT02533674|21388457|P2|STARTED|Dose Level II||7
8663413|NCT02533674|21388458|P1|STARTED|Dose Level II||0
8663414|NCT02533674|21388451|P8|NOT COMPLETED|Dose Level I||0
8663415|NCT02533674|21388452|P7|NOT COMPLETED|Dose Level I||0
8663416|NCT02533674|21388453|P6|NOT COMPLETED|Dose Level I||0
8663417|NCT02533674|21388454|P5|NOT COMPLETED|Dose Level I||0
8663418|NCT02533674|21388455|P4|NOT COMPLETED|Dose Level I||0
8663419|NCT02533674|21388456|P3|NOT COMPLETED|Dose Level I||0
8663420|NCT02533674|21388457|P2|NOT COMPLETED|Dose Level I||0
8663421|NCT02533674|21388458|P1|NOT COMPLETED|Dose Level I||5
8663422|NCT02533674|21388451|P8|COMPLETED|Dose Level I||0
8663423|NCT02533674|21388452|P7|COMPLETED|Dose Level I||0
8663424|NCT02533674|21388453|P6|COMPLETED|Dose Level I||0
8663425|NCT02533674|21388454|P5|COMPLETED|Dose Level I||0
8663426|NCT02533674|21388455|P4|COMPLETED|Dose Level I||0
8663427|NCT02533674|21388456|P3|COMPLETED|Dose Level I||0
8663428|NCT02533674|21388457|P2|COMPLETED|Dose Level I||0
8663429|NCT02533674|21388458|P1|COMPLETED|Dose Level I||0
8663430|NCT02533674|21388451|P8|STARTED|Dose Level I||0
8663431|NCT02533674|21388452|P7|STARTED|Dose Level I||0
8663432|NCT02533674|21388453|P6|STARTED|Dose Level I||0
8663433|NCT02533674|21388454|P5|STARTED|Dose Level I||0
8663434|NCT02533674|21388455|P4|STARTED|Dose Level I||0
8663435|NCT02533674|21388456|P3|STARTED|Dose Level I||0
8663436|NCT02533674|21388457|P2|STARTED|Dose Level I||0
8663437|NCT02533674|21388458|P1|STARTED|Dose Level I||5
8663438|NCT02533180|21388486|P2|NOT COMPLETED|Overall Study||47
8663439|NCT02533180|21388487|P1|NOT COMPLETED|Overall Study||39
8663440|NCT02533180|21388486|P2|COMPLETED|Overall Study||14
8663441|NCT02533180|21388487|P1|COMPLETED|Overall Study||0
8663442|NCT02533180|21388486|P2|STARTED|Overall Study||61
8663443|NCT02533180|21388487|P1|STARTED|Overall Study||39
8663444|NCT02522481|21388492|P1|NOT COMPLETED|Overall Study||3
8663445|NCT02522481|21388492|P1|COMPLETED|Overall Study||172
8663446|NCT02522481|21388492|P1|STARTED|Overall Study||175
8663447|NCT02520310|21388503|P1|NOT COMPLETED|AT 4 Year Clinical Follow-up||2
8663448|NCT02520310|21388503|P1|COMPLETED|AT 4 Year Clinical Follow-up||22
8663449|NCT02520310|21388503|P1|STARTED|AT 4 Year Clinical Follow-up||24
8663450|NCT02520310|21388503|P1|NOT COMPLETED|AT 3 Year Clinical Follow-up||4
8663451|NCT02520310|21388503|P1|COMPLETED|AT 3 Year Clinical Follow-up||24
8663452|NCT02520310|21388503|P1|STARTED|AT 3 Year Clinical Follow-up||28
8663453|NCT02520310|21388503|P1|NOT COMPLETED|At 2 Year Clinical Follow-up||0
8663454|NCT02520310|21388503|P1|COMPLETED|At 2 Year Clinical Follow-up||28
8663455|NCT02520310|21388503|P1|STARTED|At 2 Year Clinical Follow-up||28
8663456|NCT02520310|21388503|P1|NOT COMPLETED|At 1 Year Clinical Follow-up||1
8663457|NCT02520310|21388503|P1|COMPLETED|At 1 Year Clinical Follow-up||28
8663458|NCT02520310|21388503|P1|STARTED|At 1 Year Clinical Follow-up||29
8663459|NCT02520310|21388503|P1|NOT COMPLETED|At 6 Months Clinical Follow-up||1
8663460|NCT02520310|21388503|P1|COMPLETED|At 6 Months Clinical Follow-up||29
8663461|NCT02520310|21388503|P1|STARTED|At 6 Months Clinical Follow-up||30
8663462|NCT02520310|21388503|P1|NOT COMPLETED|At 30 Days Clinical Follow-up||0
8663463|NCT02520310|21388503|P1|COMPLETED|At 30 Days Clinical Follow-up||30
8663464|NCT02520310|21388503|P1|STARTED|At 30 Days Clinical Follow-up||30
8663465|NCT02518191|21388695|P2|NOT COMPLETED|Overall Study||9
8663466|NCT02518191|21388696|P1|NOT COMPLETED|Overall Study||6
8663467|NCT02518191|21388695|P2|COMPLETED|Overall Study||165
8663468|NCT02518191|21388696|P1|COMPLETED|Overall Study||165
8663469|NCT02518191|21388695|P2|STARTED|Overall Study||174
8663470|NCT02518191|21388696|P1|STARTED|Overall Study||171
8663471|NCT02516332|21388707|P3|NOT COMPLETED|Overall Study||2
8663472|NCT02516332|21388708|P2|NOT COMPLETED|Overall Study||1
8663473|NCT02516332|21388709|P1|NOT COMPLETED|Overall Study||2
8663474|NCT02516332|21388707|P3|COMPLETED|Overall Study||21
8663475|NCT02516332|21388708|P2|COMPLETED|Overall Study||52
8663476|NCT02516332|21388709|P1|COMPLETED|Overall Study||50
8663477|NCT02516332|21388707|P3|STARTED|Overall Study||23
8663478|NCT02516332|21388708|P2|STARTED|Overall Study||53
8663479|NCT02516332|21388709|P1|STARTED|Overall Study||52
8663480|NCT02510040|21388738|P3|NOT COMPLETED|Overall Study||1
8663481|NCT02510040|21388739|P2|NOT COMPLETED|Overall Study||3
8663482|NCT02510040|21388740|P1|NOT COMPLETED|Overall Study||18
8663483|NCT02510040|21388738|P3|COMPLETED|Overall Study||21
8663484|NCT02510040|21388739|P2|COMPLETED|Overall Study||111
8663485|NCT02510040|21388740|P1|COMPLETED|Overall Study||63
8663486|NCT02510040|21388738|P3|STARTED|Overall Study||22
8663487|NCT02510040|21388739|P2|STARTED|Overall Study||114
8663488|NCT02510040|21388740|P1|STARTED|Overall Study||81
8663489|NCT02507297|21388754|P2|NOT COMPLETED|Overall Study||1
8663490|NCT02507297|21388755|P1|NOT COMPLETED|Overall Study||1
8663491|NCT02507297|21388754|P2|COMPLETED|Overall Study||12
8663492|NCT02507297|21388755|P1|COMPLETED|Overall Study||15
8663493|NCT02507297|21388754|P2|STARTED|Overall Study||13
8663494|NCT02507297|21388755|P1|STARTED|Overall Study||16
8663495|NCT02499081|21388769|P1|NOT COMPLETED|Overall Study||19
8663496|NCT02499081|21388769|P1|COMPLETED|Overall Study||1
8663497|NCT02499081|21388769|P1|STARTED|Overall Study||20
8663501|NCT02425644|21388780|P2|NOT COMPLETED|Overall Study||71
8663502|NCT02425644|21388781|P1|NOT COMPLETED|Overall Study||77
8663503|NCT02425644|21388780|P2|COMPLETED|Overall Study||495
8663504|NCT02425644|21388781|P1|COMPLETED|Overall Study||490
8663505|NCT02425644|21388780|P2|Treated|Overall Study||566
8663506|NCT02425644|21388781|P1|Treated|Overall Study||565
8663507|NCT02425644|21388780|P2|STARTED|Overall Study||566
8663508|NCT02425644|21388781|P1|STARTED|Overall Study||567
8663547|NCT02371369|21388835|P2|NOT COMPLETED|Part 2||4
8663548|NCT02371369|21388836|P1|NOT COMPLETED|Part 2||9
8663549|NCT02371369|21388835|P2|COMPLETED|Part 2||26
8663550|NCT02371369|21388836|P1|COMPLETED|Part 2||39
8663551|NCT02371369|21388835|P2|STARTED|Part 2|N=30; Only participants who were eligible to receive treatment in Part 2.|30
8663552|NCT02371369|21388836|P1|STARTED|Part 2|N=48; Only participants who were eligible to receive treatment in Part 2.|48
8663553|NCT02371369|21388835|P2|NOT COMPLETED|Part 1||11
8663554|NCT02371369|21388836|P1|NOT COMPLETED|Part 1||9
8663555|NCT02371369|21388835|P2|COMPLETED|Part 1||48
8663556|NCT02371369|21388836|P1|COMPLETED|Part 1||52
8663557|NCT02371369|21388835|P2|STARTED|Part 1||59
8663558|NCT02371369|21388836|P1|STARTED|Part 1||61
8663559|NCT02352948|21388890|P6|NOT COMPLETED|Overall Study||49
8663560|NCT02352948|21388891|P5|NOT COMPLETED|Overall Study||88
8663561|NCT02352948|21388892|P4|NOT COMPLETED|Overall Study||99
8663562|NCT02352948|21388893|P3|NOT COMPLETED|Overall Study||129
8663563|NCT02352948|21388894|P2|NOT COMPLETED|Overall Study||59
8663564|NCT02352948|21388895|P1|NOT COMPLETED|Overall Study||49
8663565|NCT02352948|21388890|P6|COMPLETED|Overall Study||11
8663566|NCT02352948|21388891|P5|COMPLETED|Overall Study||29
8663567|NCT02352948|21388892|P4|COMPLETED|Overall Study||19
8663568|NCT02352948|21388893|P3|COMPLETED|Overall Study||45
8663569|NCT02352948|21388894|P2|COMPLETED|Overall Study||5
8663570|NCT02352948|21388895|P1|COMPLETED|Overall Study||13
8663571|NCT02352948|21388890|P6|Completed Study Treatment|Overall Study||4
8663572|NCT02352948|21388891|P5|Completed Study Treatment|Overall Study||23
8663573|NCT02352948|21388892|P4|Completed Study Treatment|Overall Study||0
8663574|NCT02352948|21388893|P3|Completed Study Treatment|Overall Study||36
8663575|NCT02352948|21388894|P2|Completed Study Treatment|Overall Study||0
8663576|NCT02352948|21388895|P1|Completed Study Treatment|Overall Study||15
8663577|NCT02352948|21388890|P6|Received Treatment|Overall Study||60
8663578|NCT02352948|21388891|P5|Received Treatment|Overall Study||117
8663579|NCT02352948|21388892|P4|Received Treatment|Overall Study||110
8663580|NCT02352948|21388893|P3|Received Treatment|Overall Study||173
8663581|NCT02352948|21388894|P2|Received Treatment|Overall Study||63
8663582|NCT02352948|21388895|P1|Received Treatment|Overall Study||62
8663583|NCT02352948|21388890|P6|STARTED|Overall Study||60
8663584|NCT02352948|21388891|P5|STARTED|Overall Study||117
8663585|NCT02352948|21388892|P4|STARTED|Overall Study||118
8663586|NCT02352948|21388893|P3|STARTED|Overall Study||174
8663587|NCT02352948|21388894|P2|STARTED|Overall Study||64
8663588|NCT02352948|21388895|P1|STARTED|Overall Study||62
8663589|NCT02350816|21388955|P4|NOT COMPLETED|Overall Study||0
8663590|NCT02350816|21388956|P3|NOT COMPLETED|Overall Study||0
8663591|NCT02350816|21388957|P2|NOT COMPLETED|Overall Study||0
8663592|NCT02350816|21388958|P1|NOT COMPLETED|Overall Study||0
8663593|NCT02350816|21388955|P4|COMPLETED|Overall Study||2
8663594|NCT02350816|21388956|P3|COMPLETED|Overall Study||2
8663595|NCT02350816|21388957|P2|COMPLETED|Overall Study||6
8663596|NCT02350816|21388958|P1|COMPLETED|Overall Study||7
8663597|NCT02350816|21388955|P4|STARTED|Overall Study||2
8663598|NCT02350816|21388956|P3|STARTED|Overall Study||2
8663599|NCT02350816|21388957|P2|STARTED|Overall Study||6
8663600|NCT02350816|21388958|P1|STARTED|Overall Study||7
8663619|NCT02284516|21389029|P2|NOT COMPLETED|Overall Study||36
8663620|NCT02284516|21389030|P1|NOT COMPLETED|Overall Study||38
8663621|NCT02284516|21389029|P2|COMPLETED|Overall Study||319
8663622|NCT02284516|21389030|P1|COMPLETED|Overall Study||318
8663623|NCT02284516|21389029|P2|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
8663624|NCT02284516|21389030|P1|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
8663625|NCT02284516|21389029|P2|STARTED|Overall Study||355
8663626|NCT02284516|21389030|P1|STARTED|Overall Study||356
8663627|NCT02246621|21389040|P2|NOT COMPLETED|Overall Study||135
8663628|NCT02246621|21389041|P1|NOT COMPLETED|Overall Study||265
8663629|NCT02246621|21389040|P2|COMPLETED|Overall Study||30
8663630|NCT02246621|21389041|P1|COMPLETED|Overall Study||63
8663631|NCT02246621|21389040|P2|Received At Least One Dose of Study Drug|Overall Study||161
8663632|NCT02246621|21389041|P1|Received At Least One Dose of Study Drug|Overall Study||327
8663633|NCT02246621|21389040|P2|STARTED|Overall Study||165
8663634|NCT02246621|21389041|P1|STARTED|Overall Study||328
8663635|NCT02228681|21389069|P2|NOT COMPLETED|Overall Study||0
8663636|NCT02228681|21389070|P1|NOT COMPLETED|Overall Study||0
8663637|NCT02228681|21389069|P2|COMPLETED|Overall Study||37
8663638|NCT02228681|21389070|P1|COMPLETED|Overall Study||37
8663639|NCT02228681|21389069|P2|STARTED|Overall Study||37
8663640|NCT02228681|21389070|P1|STARTED|Overall Study||37
8663641|NCT02207569|21389082|P1|NOT COMPLETED|6 Months - 1 Year||9
8663642|NCT02207569|21389082|P1|COMPLETED|6 Months - 1 Year||213
8663643|NCT02207569|21389082|P1|STARTED|6 Months - 1 Year||222
8663644|NCT02207569|21389082|P1|NOT COMPLETED|30 Days to 6 Months||11
8663645|NCT02207569|21389082|P1|COMPLETED|30 Days to 6 Months||222
8663646|NCT02207569|21389082|P1|STARTED|30 Days to 6 Months||233
8663647|NCT02207569|21389082|P1|NOT COMPLETED|Implant to 30 Days||4
8663648|NCT02207569|21389082|P1|COMPLETED|Implant to 30 Days||233
8663649|NCT02207569|21389082|P1|STARTED|Implant to 30 Days||237
8663650|NCT02207569|21389082|P1|NOT COMPLETED|Enrolled to Implant||4
8663651|NCT02207569|21389082|P1|COMPLETED|Enrolled to Implant|237 actual implants|237
8663652|NCT02207569|21389082|P1|STARTED|Enrolled to Implant|241 entered procedure room for implant|241
8663653|NCT02202434|21389104|P4|NOT COMPLETED|Overall Study||37
8663654|NCT02202434|21389105|P3|NOT COMPLETED|Overall Study||15
8663655|NCT02202434|21389106|P2|NOT COMPLETED|Overall Study||69
8663656|NCT02202434|21389107|P1|NOT COMPLETED|Overall Study||109
8663657|NCT02202434|21389104|P4|COMPLETED|Overall Study||258
8663658|NCT02202434|21389105|P3|COMPLETED|Overall Study||87
8663659|NCT02202434|21389106|P2|COMPLETED|Overall Study||236
8663660|NCT02202434|21389107|P1|COMPLETED|Overall Study||498
8663661|NCT02202434|21389104|P4|STARTED|Overall Study||295
8663662|NCT02202434|21389105|P3|STARTED|Overall Study||102
8663663|NCT02202434|21389106|P2|STARTED|Overall Study||305
8663664|NCT02202434|21389107|P1|STARTED|Overall Study||607
8663679|NCT02101034|21389251|P5|NOT COMPLETED|Overall Study||0
8663680|NCT02101034|21389252|P4|NOT COMPLETED|Overall Study||0
8663681|NCT02101034|21389253|P3|NOT COMPLETED|Overall Study||1
8663682|NCT02101034|21389254|P2|NOT COMPLETED|Overall Study||0
8663683|NCT02101034|21389255|P1|NOT COMPLETED|Overall Study||0
8663684|NCT02101034|21389251|P5|COMPLETED|Overall Study||24
8663685|NCT02101034|21389252|P4|COMPLETED|Overall Study||32
8663686|NCT02101034|21389253|P3|COMPLETED|Overall Study||30
8663687|NCT02101034|21389254|P2|COMPLETED|Overall Study||6
8663688|NCT02101034|21389255|P1|COMPLETED|Overall Study||3
8663689|NCT02101034|21389251|P5|STARTED|Overall Study||24
8663690|NCT02101034|21389252|P4|STARTED|Overall Study||32
8663691|NCT02101034|21389253|P3|STARTED|Overall Study||31
8663692|NCT02101034|21389254|P2|STARTED|Overall Study||6
8663693|NCT02101034|21389255|P1|STARTED|Overall Study||3
8663694|NCT02099864|21389281|P1|NOT COMPLETED|Overall Study||0
8663695|NCT02099864|21389281|P1|COMPLETED|Overall Study||36
8663696|NCT02099864|21389281|P1|STARTED|Overall Study||36
8663697|NCT02055118|21389307|P3|NOT COMPLETED|Overall Study||0
8663698|NCT02055118|21389308|P2|NOT COMPLETED|Overall Study||2
8663699|NCT02055118|21389309|P1|NOT COMPLETED|Overall Study||0
8663700|NCT02055118|21389307|P3|COMPLETED|Overall Study||9
8663701|NCT02055118|21389308|P2|COMPLETED|Overall Study||32
8663702|NCT02055118|21389309|P1|COMPLETED|Overall Study||15
8663703|NCT02055118|21389307|P3|STARTED|Overall Study||9
8663704|NCT02055118|21389308|P2|STARTED|Overall Study||34
8663705|NCT02055118|21389309|P1|STARTED|Overall Study||15
8663706|NCT02031302|21389368|P2|NOT COMPLETED|Overall Study||0
8663707|NCT02031302|21389369|P1|NOT COMPLETED|Overall Study||164
8663708|NCT02031302|21389368|P2|COMPLETED|Overall Study||50
8663709|NCT02031302|21389369|P1|COMPLETED|Overall Study||850
8663710|NCT02031302|21389368|P2|STARTED|Overall Study||50
8663711|NCT02031302|21389369|P1|STARTED|Overall Study||1014
8663712|NCT01970176|21389389|P2|NOT COMPLETED|Overall Study||0
8663713|NCT01970176|21389390|P1|NOT COMPLETED|Overall Study||0
8663714|NCT01970176|21389389|P2|COMPLETED|Overall Study||6
8663715|NCT01970176|21389390|P1|COMPLETED|Overall Study||14
8663716|NCT01970176|21389389|P2|STARTED|Overall Study||6
8663717|NCT01970176|21389390|P1|STARTED|Overall Study||14
8663718|NCT01936870|21389400|P1|NOT COMPLETED|Overall Study||189
8663719|NCT01936870|21389400|P1|COMPLETED|Overall Study||2303
8663720|NCT01936870|21389400|P1|STARTED|Overall Study||2492
8663721|NCT01915095|21389421|P5|NOT COMPLETED|Overall Study||6
8663722|NCT01915095|21389422|P4|NOT COMPLETED|Overall Study||4
8663723|NCT01915095|21389423|P3|NOT COMPLETED|Overall Study||0
8663724|NCT01915095|21389424|P2|NOT COMPLETED|Overall Study||0
8663725|NCT01915095|21389425|P1|NOT COMPLETED|Overall Study||0
8663726|NCT01915095|21389421|P5|COMPLETED|Overall Study||3
8663727|NCT01915095|21389422|P4|COMPLETED|Overall Study||4
8663728|NCT01915095|21389423|P3|COMPLETED|Overall Study||5
8663729|NCT01915095|21389424|P2|COMPLETED|Overall Study||10
8663730|NCT01915095|21389425|P1|COMPLETED|Overall Study||10
8663731|NCT01915095|21389421|P5|Control|Overall Study||0
8663732|NCT01915095|21389422|P4|Control|Overall Study||0
8663733|NCT01915095|21389423|P3|Control|Overall Study||0
8663734|NCT01915095|21389424|P2|Control|Overall Study||5
8663735|NCT01915095|21389425|P1|Control|Overall Study||5
8663736|NCT01915095|21389421|P5|SCI|Overall Study||9
8663737|NCT01915095|21389422|P4|SCI|Overall Study||8
8663738|NCT01915095|21389423|P3|SCI|Overall Study||5
8663739|NCT01915095|21389424|P2|SCI|Overall Study||5
8663740|NCT01915095|21389425|P1|SCI|Overall Study||5
8663741|NCT01915095|21389421|P5|STARTED|Overall Study||9
8663742|NCT01915095|21389422|P4|STARTED|Overall Study||8
8663743|NCT01915095|21389423|P3|STARTED|Overall Study||5
8663744|NCT01915095|21389424|P2|STARTED|Overall Study||10
8663745|NCT01915095|21389425|P1|STARTED|Overall Study||10
8663881|NCT01808573|21389501|P2|NOT COMPLETED|Overall Study||314
8663882|NCT01808573|21389502|P1|NOT COMPLETED|Overall Study||307
8663883|NCT01808573|21389501|P2|COMPLETED|Overall Study||0
8663884|NCT01808573|21389502|P1|COMPLETED|Overall Study||0
8663885|NCT01808573|21389501|P2|Received Treatment|Overall Study||311
8663886|NCT01808573|21389502|P1|Received Treatment|Overall Study||303
8663887|NCT01808573|21389501|P2|STARTED|Overall Study||314
8663888|NCT01808573|21389502|P1|STARTED|Overall Study||307
8663889|NCT01789281|21389522|P2|NOT COMPLETED|Overall Study||10
8663890|NCT01789281|21389523|P1|NOT COMPLETED|Overall Study||22
8663891|NCT01789281|21389522|P2|COMPLETED|Overall Study||2
8663892|NCT01789281|21389523|P1|COMPLETED|Overall Study||0
8663893|NCT01789281|21389522|P2|STARTED|Overall Study||12
8663894|NCT01789281|21389523|P1|STARTED|Overall Study||22
8663895|NCT01705977|21389534|P2|NOT COMPLETED|Overall Study||260
8663896|NCT01705977|21389535|P1|NOT COMPLETED|Overall Study||273
8663897|NCT01705977|21389534|P2|COMPLETED|Overall Study||1741
8663898|NCT01705977|21389535|P1|COMPLETED|Overall Study||1729
8663899|NCT01705977|21389534|P2|STARTED|Overall Study||2001
8663900|NCT01705977|21389535|P1|STARTED|Overall Study||2002
8663901|NCT01685216|21389553|P1|NOT COMPLETED|Overall Study||1
8663902|NCT01685216|21389553|P1|COMPLETED|Overall Study||6
8663903|NCT01685216|21389553|P1|STARTED|Overall Study||7
8663904|NCT01680965|21389567|P4|NOT COMPLETED|Overall Study||6
8663905|NCT01680965|21389568|P3|NOT COMPLETED|Overall Study||0
8663906|NCT01680965|21389569|P2|NOT COMPLETED|Overall Study||0
8663907|NCT01680965|21389570|P1|NOT COMPLETED|Overall Study||0
8663908|NCT01680965|21389567|P4|COMPLETED|Overall Study||26
8663909|NCT01680965|21389568|P3|COMPLETED|Overall Study||6
8663910|NCT01680965|21389569|P2|COMPLETED|Overall Study||3
8663911|NCT01680965|21389570|P1|COMPLETED|Overall Study||3
8663912|NCT01680965|21389567|P4|STARTED|Overall Study||32
8663913|NCT01680965|21389568|P3|STARTED|Overall Study||6
8663914|NCT01680965|21389569|P2|STARTED|Overall Study||3
8663915|NCT01680965|21389570|P1|STARTED|Overall Study||3
8663916|NCT01636206|21389581|P2|NOT COMPLETED|Overall Study||51
8663917|NCT01636206|21389582|P1|NOT COMPLETED|Overall Study||19
8663918|NCT01636206|21389581|P2|COMPLETED|Overall Study||170
8663919|NCT01636206|21389582|P1|COMPLETED|Overall Study||92
8663920|NCT01636206|21389581|P2|STARTED|Overall Study||221
8663921|NCT01636206|21389582|P1|STARTED|Overall Study||111
8663922|NCT01625286|21389595|P7|NOT COMPLETED|Overall Study||56
8663923|NCT01625286|21389596|P6|NOT COMPLETED|Overall Study||54
8663924|NCT01625286|21389597|P5|NOT COMPLETED|Overall Study||6
8663925|NCT01625286|21389598|P4|NOT COMPLETED|Overall Study||7
8663926|NCT01625286|21389599|P3|NOT COMPLETED|Overall Study||5
8663927|NCT01625286|21389600|P2|NOT COMPLETED|Overall Study||8
8663928|NCT01625286|21389601|P1|NOT COMPLETED|Overall Study||12
8663929|NCT01625286|21389595|P7|COMPLETED|Overall Study||0
8663930|NCT01625286|21389596|P6|COMPLETED|Overall Study||0
8663931|NCT01625286|21389597|P5|COMPLETED|Overall Study||0
8663932|NCT01625286|21389598|P4|COMPLETED|Overall Study||0
8663933|NCT01625286|21389599|P3|COMPLETED|Overall Study||0
8663934|NCT01625286|21389600|P2|COMPLETED|Overall Study||0
8663935|NCT01625286|21389601|P1|COMPLETED|Overall Study||0
8663936|NCT01625286|21389595|P7|Did Not Receive AZD5363/Placebo Trt|Overall Study||1
8663937|NCT01625286|21389596|P6|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8663938|NCT01625286|21389597|P5|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8663939|NCT01625286|21389598|P4|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8663940|NCT01625286|21389599|P3|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8663941|NCT01625286|21389600|P2|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8663942|NCT01625286|21389601|P1|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
8663943|NCT01625286|21389595|P7|Received AZD5363/Placebo Treatment|Overall Study||55
8663944|NCT01625286|21389596|P6|Received AZD5363/Placebo Treatment|Overall Study||54
8663945|NCT01625286|21389597|P5|Received AZD5363/Placebo Treatment|Overall Study||6
8663946|NCT01625286|21389598|P4|Received AZD5363/Placebo Treatment|Overall Study||7
8663947|NCT01625286|21389599|P3|Received AZD5363/Placebo Treatment|Overall Study||5
8663948|NCT01625286|21389600|P2|Received AZD5363/Placebo Treatment|Overall Study||8
8663949|NCT01625286|21389601|P1|Received AZD5363/Placebo Treatment|Overall Study||12
8663950|NCT01625286|21389595|P7|STARTED|Overall Study||56
8663951|NCT01625286|21389596|P6|STARTED|Overall Study||54
8663952|NCT01625286|21389597|P5|STARTED|Overall Study||6
8663953|NCT01625286|21389598|P4|STARTED|Overall Study||7
8663954|NCT01625286|21389599|P3|STARTED|Overall Study||5
8663955|NCT01625286|21389600|P2|STARTED|Overall Study||8
8663956|NCT01625286|21389601|P1|STARTED|Overall Study||12
8663957|NCT01620255|21389685|P5|NOT COMPLETED|Overall Study||6
8663958|NCT01620255|21389686|P4|NOT COMPLETED|Overall Study||3
8663959|NCT01620255|21389687|P3|NOT COMPLETED|Overall Study||2
8663960|NCT01620255|21389688|P2|NOT COMPLETED|Overall Study||6
8663961|NCT01620255|21389689|P1|NOT COMPLETED|Overall Study||4
8663962|NCT01620255|21389685|P5|COMPLETED|Overall Study||64
8663963|NCT01620255|21389686|P4|COMPLETED|Overall Study||70
8663964|NCT01620255|21389687|P3|COMPLETED|Overall Study||68
8663965|NCT01620255|21389688|P2|COMPLETED|Overall Study||65
8663966|NCT01620255|21389689|P1|COMPLETED|Overall Study||69
8663967|NCT01620255|21389685|P5|Treated|Overall Study||70
8663968|NCT01620255|21389686|P4|Treated|Overall Study||73
8663969|NCT01620255|21389687|P3|Treated|Overall Study||70
8663970|NCT01620255|21389688|P2|Treated|Overall Study||71
8663971|NCT01620255|21389689|P1|Treated|Overall Study||73
8663972|NCT01620255|21389685|P5|STARTED|Overall Study||70
8663973|NCT01620255|21389686|P4|STARTED|Overall Study||73
8663974|NCT01620255|21389687|P3|STARTED|Overall Study||70
8663975|NCT01620255|21389688|P2|STARTED|Overall Study||71
8663976|NCT01620255|21389689|P1|STARTED|Overall Study||73
8663986|NCT01554618|21389775|P2|NOT COMPLETED|Open-Label Extension Period||5
8663987|NCT01554618|21389776|P1|NOT COMPLETED|Open-Label Extension Period||3
8663988|NCT01554618|21389775|P2|COMPLETED|Open-Label Extension Period||18
8663989|NCT01554618|21389776|P1|COMPLETED|Open-Label Extension Period||46
8663990|NCT01554618|21389775|P2|STARTED|Open-Label Extension Period||23
8663991|NCT01554618|21389776|P1|STARTED|Open-Label Extension Period|1 patient who was noncompliant with study medication did not enter the open-label extension period|49
8663992|NCT01554618|21389775|P2|NOT COMPLETED|Controlled Assessment Period||1
8663993|NCT01554618|21389776|P1|NOT COMPLETED|Controlled Assessment Period||8
8663994|NCT01554618|21389775|P2|COMPLETED|Controlled Assessment Period||23
8663995|NCT01554618|21389776|P1|COMPLETED|Controlled Assessment Period||50
8663996|NCT01554618|21389775|P2|STARTED|Controlled Assessment Period||24
8663997|NCT01554618|21389776|P1|STARTED|Controlled Assessment Period||58
8663998|NCT01554618|21389775|P2|NOT COMPLETED|Randomized Through Start of Treatment||0
8663999|NCT01554618|21389776|P1|NOT COMPLETED|Randomized Through Start of Treatment||1
8664000|NCT01554618|21389775|P2|COMPLETED|Randomized Through Start of Treatment||24
8664001|NCT01554618|21389776|P1|COMPLETED|Randomized Through Start of Treatment||58
8664002|NCT01554618|21389775|P2|STARTED|Randomized Through Start of Treatment||24
8664003|NCT01554618|21389776|P1|STARTED|Randomized Through Start of Treatment||59
8664004|NCT01536392|21389828|P2|NOT COMPLETED|Overall Study||15
8664005|NCT01536392|21389829|P1|NOT COMPLETED|Overall Study||13
8664006|NCT01536392|21389828|P2|COMPLETED|Overall Study||19
8664007|NCT01536392|21389829|P1|COMPLETED|Overall Study||28
8664008|NCT01536392|21389828|P2|STARTED|Overall Study||34
8664009|NCT01536392|21389829|P1|STARTED|Overall Study||41
8664010|NCT01474200|21389839|P2|NOT COMPLETED|Overall Study||30
8664011|NCT01474200|21389840|P1|NOT COMPLETED|Overall Study||29
8664012|NCT01474200|21389839|P2|COMPLETED|Overall Study||84
8664013|NCT01474200|21389840|P1|COMPLETED|Overall Study||81
8664014|NCT01474200|21389839|P2|STARTED|Overall Study||114
8664015|NCT01474200|21389840|P1|STARTED|Overall Study||110
8664016|NCT01455181|21389890|P1|NOT COMPLETED|Overall Study||0
8664017|NCT01455181|21389890|P1|COMPLETED|Overall Study||24
8664018|NCT01455181|21389890|P1|STARTED|Overall Study||24
8664019|NCT01424228|21389900|P2|NOT COMPLETED|Overall Study||47
8664020|NCT01424228|21389901|P1|NOT COMPLETED|Overall Study||56
8664021|NCT01424228|21389900|P2|COMPLETED|Overall Study||135
8664022|NCT01424228|21389901|P1|COMPLETED|Overall Study||126
8664023|NCT01424228|21389900|P2|STARTED|Overall Study||182
8664024|NCT01424228|21389901|P1|STARTED|Overall Study||182
8664025|NCT01421498|21389941|P2|NOT COMPLETED|Overall Study||11
8664026|NCT01421498|21389942|P1|NOT COMPLETED|Overall Study||12
8664027|NCT01421498|21389941|P2|COMPLETED|Overall Study||284
8664028|NCT01421498|21389942|P1|COMPLETED|Overall Study||281
8664029|NCT01421498|21389941|P2|STARTED|Overall Study||295
8664030|NCT01421498|21389942|P1|STARTED|Overall Study||293
8664031|NCT01410890|21389952|P2|NOT COMPLETED|Overall Study||1
8664032|NCT01410890|21389953|P1|NOT COMPLETED|Overall Study||0
8664033|NCT01410890|21389952|P2|COMPLETED|Overall Study||10
8664034|NCT01410890|21389953|P1|COMPLETED|Overall Study||10
8664035|NCT01410890|21389952|P2|Treated|Overall Study||10
8664036|NCT01410890|21389953|P1|Treated|Overall Study||10
8664037|NCT01410890|21389952|P2|STARTED|Overall Study||11
8664038|NCT01410890|21389953|P1|STARTED|Overall Study||10
8664039|NCT01343823|21389989|P4|NOT COMPLETED|Overall Study||1
8664040|NCT01343823|21389990|P3|NOT COMPLETED|Overall Study||0
8664041|NCT01343823|21389991|P2|NOT COMPLETED|Overall Study||0
8664042|NCT01343823|21389992|P1|NOT COMPLETED|Overall Study||2
8664043|NCT01343823|21389989|P4|COMPLETED|Overall Study||19
8664044|NCT01343823|21389990|P3|COMPLETED|Overall Study||19
8664045|NCT01343823|21389991|P2|COMPLETED|Overall Study||20
8664046|NCT01343823|21389992|P1|COMPLETED|Overall Study||18
8664047|NCT01343823|21389989|P4|STARTED|Overall Study||20
8664048|NCT01343823|21389990|P3|STARTED|Overall Study||19
8664049|NCT01343823|21389991|P2|STARTED|Overall Study||20
8664050|NCT01343823|21389992|P1|STARTED|Overall Study||20
8664051|NCT01321073|21390006|P1|NOT COMPLETED|Overall Study||7
8664052|NCT01321073|21390006|P1|COMPLETED|Overall Study||57
8664053|NCT01321073|21390006|P1|STARTED|Overall Study||64
8664054|NCT01314118|21390010|P1|NOT COMPLETED|Overall Study||131
8664055|NCT01314118|21390010|P1|COMPLETED|Overall Study||0
8664056|NCT01314118|21390010|P1|STARTED|Overall Study||131
8664057|NCT01268527|21390019|P2|NOT COMPLETED|Overall Study||0
8664058|NCT01268527|21390020|P1|NOT COMPLETED|Overall Study||0
8664059|NCT01268527|21390019|P2|COMPLETED|Overall Study||15
8664060|NCT01268527|21390020|P1|COMPLETED|Overall Study||15
8664061|NCT01268527|21390019|P2|STARTED|Overall Study||15
8664062|NCT01268527|21390020|P1|STARTED|Overall Study||15
8664063|NCT01268098|21390080|P2|NOT COMPLETED|Overall Study||0
8664064|NCT01268098|21390081|P1|NOT COMPLETED|Overall Study||1
8664065|NCT01268098|21390080|P2|COMPLETED|Overall Study||23
8664066|NCT01268098|21390081|P1|COMPLETED|Overall Study||18
8664067|NCT01268098|21390080|P2|STARTED|Overall Study||23
8664068|NCT01268098|21390081|P1|STARTED|Overall Study||19
8664099|NCT01147302|21390121|P2|NOT COMPLETED|Overall Study||0
8664100|NCT01147302|21390122|P1|NOT COMPLETED|Overall Study||0
8664101|NCT01147302|21390121|P2|COMPLETED|Overall Study||9
8664102|NCT01147302|21390122|P1|COMPLETED|Overall Study||9
8664103|NCT01147302|21390121|P2|STARTED|Overall Study||9
8664104|NCT01147302|21390122|P1|STARTED|Overall Study||9
8664105|NCT01117051|21390154|P2|NOT COMPLETED|Overall Study||11
8664106|NCT01117051|21390155|P1|NOT COMPLETED|Overall Study||13
8664107|NCT01117051|21390154|P2|COMPLETED|Overall Study||77
8664108|NCT01117051|21390155|P1|COMPLETED|Overall Study||73
8664109|NCT01117051|21390154|P2|STARTED|Overall Study||88
8664110|NCT01117051|21390155|P1|STARTED|Overall Study||86
8664111|NCT01106430|21390165|P2|NOT COMPLETED|Overall Study||33
8664112|NCT01106430|21390166|P1|NOT COMPLETED|Overall Study||33
8664113|NCT01106430|21390165|P2|COMPLETED|Overall Study||101
8664114|NCT01106430|21390166|P1|COMPLETED|Overall Study||100
8664115|NCT01106430|21390165|P2|STARTED|Overall Study||134
8664116|NCT01106430|21390166|P1|STARTED|Overall Study||133
8664117|NCT01047306|21390188|P2|NOT COMPLETED|Overall Study||0
8664118|NCT01047306|21390189|P1|NOT COMPLETED|Overall Study||3
8664119|NCT01047306|21390188|P2|COMPLETED|Overall Study||6
8664120|NCT01047306|21390189|P1|COMPLETED|Overall Study||16
8664121|NCT01047306|21390188|P2|Discontinued From the Study|Overall Study||0
8664122|NCT01047306|21390189|P1|Discontinued From the Study|Overall Study||3
8664123|NCT01047306|21390188|P2|STARTED|Overall Study||6
8664124|NCT01047306|21390189|P1|STARTED|Overall Study||19
8664125|NCT01045057|21390263|P1|NOT COMPLETED|Overall Study||0
8664126|NCT01045057|21390263|P1|COMPLETED|Overall Study||27
8664127|NCT01045057|21390263|P1|STARTED|Overall Study||27
8664128|NCT01006265|21390274|P4|NOT COMPLETED|Overall Study||5
8664129|NCT01006265|21390275|P3|NOT COMPLETED|Overall Study||9
8664130|NCT01006265|21390276|P2|NOT COMPLETED|Overall Study||9
8664131|NCT01006265|21390277|P1|NOT COMPLETED|Overall Study||6
8664132|NCT01006265|21390274|P4|COMPLETED|Overall Study||116
8664133|NCT01006265|21390275|P3|COMPLETED|Overall Study||99
8664134|NCT01006265|21390276|P2|COMPLETED|Overall Study||107
8664135|NCT01006265|21390277|P1|COMPLETED|Overall Study||113
8664136|NCT01006265|21390274|P4|Treated|Overall Study||121
8664137|NCT01006265|21390275|P3|Treated|Overall Study||108
8664138|NCT01006265|21390276|P2|Treated|Overall Study||114
8664139|NCT01006265|21390277|P1|Treated|Overall Study||119
8664140|NCT01006265|21390274|P4|STARTED|Overall Study||121
8664141|NCT01006265|21390275|P3|STARTED|Overall Study||108
8664142|NCT01006265|21390276|P2|STARTED|Overall Study||116
8664143|NCT01006265|21390277|P1|STARTED|Overall Study||119
8664144|NCT01005888|21390299|P2|NOT COMPLETED|Second Intervention||1
8664145|NCT01005888|21390300|P1|NOT COMPLETED|Second Intervention||1
8664146|NCT01005888|21390299|P2|COMPLETED|Second Intervention||10
8664147|NCT01005888|21390300|P1|COMPLETED|Second Intervention||10
8664148|NCT01005888|21390299|P2|STARTED|Second Intervention||11
8664149|NCT01005888|21390300|P1|STARTED|Second Intervention||11
8664150|NCT01005888|21390299|P2|NOT COMPLETED|First Intervention||1
8664151|NCT01005888|21390300|P1|NOT COMPLETED|First Intervention||1
8664152|NCT01005888|21390299|P2|COMPLETED|First Intervention||11
8664153|NCT01005888|21390300|P1|COMPLETED|First Intervention||11
8664154|NCT01005888|21390299|P2|STARTED|First Intervention||12
8664155|NCT01005888|21390300|P1|STARTED|First Intervention||12
8664156|NCT00997204|21390322|P2|NOT COMPLETED|Self-administration Phase||1
8664157|NCT00997204|21390323|P1|NOT COMPLETED|Self-administration Phase||0
8664158|NCT00997204|21390322|P2|COMPLETED|Self-administration Phase||77
8664159|NCT00997204|21390323|P1|COMPLETED|Self-administration Phase||19
8664160|NCT00997204|21390322|P2|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
8664161|NCT00997204|21390323|P1|STARTED|Self-administration Phase||19
8664162|NCT00997204|21390322|P2|NOT COMPLETED|Naive Treatment Phase||79
8664163|NCT00997204|21390323|P1|NOT COMPLETED|Naive Treatment Phase||6
8664164|NCT00997204|21390322|P2|COMPLETED|Naive Treatment Phase||0
8664165|NCT00997204|21390323|P1|COMPLETED|Naive Treatment Phase||19
8664166|NCT00997204|21390322|P2|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
8664167|NCT00997204|21390323|P1|STARTED|Naive Treatment Phase||25
8664168|NCT00946192|21390337|P3|NOT COMPLETED|Overall Study||12
8664169|NCT00946192|21390338|P2|NOT COMPLETED|Overall Study||18
8664170|NCT00946192|21390339|P1|NOT COMPLETED|Overall Study||18
8664171|NCT00946192|21390337|P3|COMPLETED|Overall Study||26
8664172|NCT00946192|21390338|P2|COMPLETED|Overall Study||22
8664173|NCT00946192|21390339|P1|COMPLETED|Overall Study||25
8664174|NCT00946192|21390337|P3|STARTED|Overall Study||38
8664175|NCT00946192|21390338|P2|STARTED|Overall Study||40
8664176|NCT00946192|21390339|P1|STARTED|Overall Study||43
8664177|NCT00932438|21390352|P2|NOT COMPLETED|Overall Study||0
8664178|NCT00932438|21390353|P1|NOT COMPLETED|Overall Study||1
8664179|NCT00932438|21390352|P2|COMPLETED|Overall Study||30
8664180|NCT00932438|21390353|P1|COMPLETED|Overall Study||39
8664181|NCT00932438|21390352|P2|STARTED|Overall Study||30
8664182|NCT00932438|21390353|P1|STARTED|Overall Study||40
8664183|NCT00930644|21390361|P1|NOT COMPLETED|Overall Study||23
8664184|NCT00930644|21390361|P1|COMPLETED|Overall Study||65
8664185|NCT00930644|21390361|P1|STARTED|Overall Study||88
8664186|NCT00912093|21390379|P5|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
8664187|NCT00912093|21390380|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
8664188|NCT00912093|21390381|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
8664189|NCT00912093|21390382|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
8664190|NCT00912093|21390383|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
8664191|NCT00912093|21390379|P5|COMPLETED|The Open Label Extension (OLE) Phase||4
8664192|NCT00912093|21390380|P4|COMPLETED|The Open Label Extension (OLE) Phase||2
8664193|NCT00912093|21390381|P3|COMPLETED|The Open Label Extension (OLE) Phase||3
8664194|NCT00912093|21390382|P2|COMPLETED|The Open Label Extension (OLE) Phase||35
8664195|NCT00912093|21390383|P1|COMPLETED|The Open Label Extension (OLE) Phase||38
8664196|NCT00912093|21390379|P5|STARTED|The Open Label Extension (OLE) Phase||4
8664197|NCT00912093|21390380|P4|STARTED|The Open Label Extension (OLE) Phase||2
8664198|NCT00912093|21390381|P3|STARTED|The Open Label Extension (OLE) Phase||3
8664199|NCT00912093|21390382|P2|STARTED|The Open Label Extension (OLE) Phase||35
8664200|NCT00912093|21390383|P1|STARTED|The Open Label Extension (OLE) Phase||38
8664201|NCT00912093|21390379|P5|NOT COMPLETED|The Controlled Phase||1
8664202|NCT00912093|21390380|P4|NOT COMPLETED|The Controlled Phase||0
8664203|NCT00912093|21390381|P3|NOT COMPLETED|The Controlled Phase||0
8664204|NCT00912093|21390382|P2|NOT COMPLETED|The Controlled Phase||2
8664205|NCT00912093|21390383|P1|NOT COMPLETED|The Controlled Phase||0
8664206|NCT00912093|21390379|P5|COMPLETED|The Controlled Phase||4
8664207|NCT00912093|21390380|P4|COMPLETED|The Controlled Phase||2
8664208|NCT00912093|21390381|P3|COMPLETED|The Controlled Phase||3
8664209|NCT00912093|21390382|P2|COMPLETED|The Controlled Phase||43
8664210|NCT00912093|21390383|P1|COMPLETED|The Controlled Phase||43
8664211|NCT00912093|21390379|P5|STARTED|The Controlled Phase||5
8664212|NCT00912093|21390380|P4|STARTED|The Controlled Phase||2
8664213|NCT00912093|21390381|P3|STARTED|The Controlled Phase||3
8664214|NCT00912093|21390382|P2|STARTED|The Controlled Phase||45
8664215|NCT00912093|21390383|P1|STARTED|The Controlled Phase||43
8664216|NCT00882687|21390403|P4|NOT COMPLETED|Overall Study||2
8664217|NCT00882687|21390404|P3|NOT COMPLETED|Overall Study||3
8664218|NCT00882687|21390405|P2|NOT COMPLETED|Overall Study||2
8664219|NCT00882687|21390406|P1|NOT COMPLETED|Overall Study||2
8664220|NCT00882687|21390403|P4|COMPLETED|Overall Study||13
8664221|NCT00882687|21390404|P3|COMPLETED|Overall Study||12
8664222|NCT00882687|21390405|P2|COMPLETED|Overall Study||13
8664223|NCT00882687|21390406|P1|COMPLETED|Overall Study||13
8664224|NCT00882687|21390403|P4|STARTED|Overall Study||15
8664225|NCT00882687|21390404|P3|STARTED|Overall Study||15
8664226|NCT00882687|21390405|P2|STARTED|Overall Study||15
8664227|NCT00882687|21390406|P1|STARTED|Overall Study||15
8664228|NCT00880750|21390438|P2|NOT COMPLETED|Second Intervention||2
8664229|NCT00880750|21390439|P1|NOT COMPLETED|Second Intervention||4
8664230|NCT00880750|21390438|P2|COMPLETED|Second Intervention||30
8664231|NCT00880750|21390439|P1|COMPLETED|Second Intervention||26
8664232|NCT00880750|21390438|P2|STARTED|Second Intervention||32
8664233|NCT00880750|21390439|P1|STARTED|Second Intervention||30
8664234|NCT00880750|21390438|P2|NOT COMPLETED|Washout Period||0
8664235|NCT00880750|21390439|P1|NOT COMPLETED|Washout Period||0
8664236|NCT00880750|21390438|P2|COMPLETED|Washout Period||32
8664237|NCT00880750|21390439|P1|COMPLETED|Washout Period||30
8664238|NCT00880750|21390438|P2|STARTED|Washout Period||32
8664239|NCT00880750|21390439|P1|STARTED|Washout Period||30
8664240|NCT00880750|21390438|P2|NOT COMPLETED|First Intervention||1
8664241|NCT00880750|21390439|P1|NOT COMPLETED|First Intervention||9
8664242|NCT00880750|21390438|P2|COMPLETED|First Intervention||32
8664243|NCT00880750|21390439|P1|COMPLETED|First Intervention||30
8664244|NCT00880750|21390438|P2|STARTED|First Intervention||33
8664245|NCT00880750|21390439|P1|STARTED|First Intervention||39
8664246|NCT00878709|21390455|P2|NOT COMPLETED|Overall Study||237
8664247|NCT00878709|21390456|P1|NOT COMPLETED|Overall Study||325
8664248|NCT00878709|21390455|P2|COMPLETED|Overall Study||1183
8664249|NCT00878709|21390456|P1|COMPLETED|Overall Study||1095
8664250|NCT00878709|21390455|P2|STARTED|Overall Study||1420
8664251|NCT00878709|21390456|P1|STARTED|Overall Study||1420
8664252|NCT00847912|21390496|P2|NOT COMPLETED|Overall Study||13
8664253|NCT00847912|21390497|P1|NOT COMPLETED|Overall Study||9
8664254|NCT00847912|21390496|P2|COMPLETED|Overall Study||464
8664255|NCT00847912|21390497|P1|COMPLETED|Overall Study||468
8664256|NCT00847912|21390496|P2|STARTED|Overall Study||477
8664257|NCT00847912|21390497|P1|STARTED|Overall Study||477
8664258|NCT00762073|21390509|P4|NOT COMPLETED|Overall Study||3
8664259|NCT00762073|21390510|P3|NOT COMPLETED|Overall Study||2
8664260|NCT00762073|21390511|P2|NOT COMPLETED|Overall Study||4
8664261|NCT00762073|21390512|P1|NOT COMPLETED|Overall Study||4
8664262|NCT00762073|21390509|P4|COMPLETED|Overall Study||17
8664263|NCT00762073|21390510|P3|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
8664264|NCT00762073|21390511|P2|COMPLETED|Overall Study||17
8664265|NCT00762073|21390512|P1|COMPLETED|Overall Study||17
8664266|NCT00762073|21390509|P4|STARTED|Overall Study||20
8664267|NCT00762073|21390510|P3|STARTED|Overall Study||20
8664268|NCT00762073|21390511|P2|STARTED|Overall Study||21
8664269|NCT00762073|21390512|P1|STARTED|Overall Study||21
8664270|NCT00663871|21390576|P2|NOT COMPLETED|Overall Study||7
8664271|NCT00663871|21390577|P1|NOT COMPLETED|Overall Study||10
8664272|NCT00663871|21390576|P2|COMPLETED|Overall Study||131
8664273|NCT00663871|21390577|P1|COMPLETED|Overall Study||124
8664274|NCT00663871|21390576|P2|STARTED|Overall Study||138
8664275|NCT00663871|21390577|P1|STARTED|Overall Study||134
8664276|NCT00593840|21390621|P1|NOT COMPLETED|Overall Study||1
8664277|NCT00593840|21390621|P1|COMPLETED|Overall Study||72
8664278|NCT00593840|21390621|P1|STARTED|Overall Study||73
8664279|NCT00545103|21390635|P4|NOT COMPLETED|Overall Study||70
8664280|NCT00545103|21390636|P3|NOT COMPLETED|Overall Study||76
8664281|NCT00545103|21390637|P2|NOT COMPLETED|Overall Study||78
8664282|NCT00545103|21390638|P1|NOT COMPLETED|Overall Study||75
8664283|NCT00545103|21390635|P4|COMPLETED|Overall Study||76
8664284|NCT00545103|21390636|P3|COMPLETED|Overall Study||74
8664285|NCT00545103|21390637|P2|COMPLETED|Overall Study||70
8664286|NCT00545103|21390638|P1|COMPLETED|Overall Study||73
8664287|NCT00545103|21390635|P4|STARTED|Overall Study||146
8664288|NCT00545103|21390636|P3|STARTED|Overall Study||150
8664289|NCT00545103|21390637|P2|STARTED|Overall Study||148
8664290|NCT00545103|21390638|P1|STARTED|Overall Study||148
8664291|NCT00497796|21390674|P2|NOT COMPLETED|Overall Study||59
8664292|NCT00497796|21390675|P1|NOT COMPLETED|Overall Study||85
8664293|NCT00497796|21390674|P2|COMPLETED|Overall Study||101
8664294|NCT00497796|21390675|P1|COMPLETED|Overall Study||62
8664295|NCT00497796|21390674|P2|STARTED|Overall Study||160
8664296|NCT00497796|21390675|P1|STARTED|Overall Study||147
8664297|NCT00441545|21390703|P2|NOT COMPLETED|Second Intervention||7
8664298|NCT00441545|21390704|P1|NOT COMPLETED|Second Intervention||12
8664299|NCT00441545|21390703|P2|COMPLETED|Second Intervention||68
8664300|NCT00441545|21390704|P1|COMPLETED|Second Intervention||65
8664301|NCT00441545|21390703|P2|STARTED|Second Intervention||75
8664302|NCT00441545|21390704|P1|STARTED|Second Intervention||77
8664303|NCT00441545|21390703|P2|NOT COMPLETED|Washout||0
8664304|NCT00441545|21390704|P1|NOT COMPLETED|Washout||0
8664305|NCT00441545|21390703|P2|COMPLETED|Washout||75
8664306|NCT00441545|21390704|P1|COMPLETED|Washout||77
8664307|NCT00441545|21390703|P2|STARTED|Washout||75
8664308|NCT00441545|21390704|P1|STARTED|Washout||77
8664309|NCT00441545|21390703|P2|NOT COMPLETED|First Intervention||12
8664310|NCT00441545|21390704|P1|NOT COMPLETED|First Intervention||18
8664311|NCT00441545|21390703|P2|COMPLETED|First Intervention||75
8664312|NCT00441545|21390704|P1|COMPLETED|First Intervention||77
8664313|NCT00441545|21390703|P2|STARTED|First Intervention||87
8664314|NCT00441545|21390704|P1|STARTED|First Intervention||95
8664315|NCT00411645|21390718|P2|NOT COMPLETED|Overall Study||164
8664316|NCT00411645|21390719|P1|NOT COMPLETED|Overall Study||81
8664317|NCT00411645|21390718|P2|COMPLETED|Overall Study||290
8664318|NCT00411645|21390719|P1|COMPLETED|Overall Study||146
8664319|NCT00411645|21390718|P2|STARTED|Overall Study||454
8664320|NCT00411645|21390719|P1|STARTED|Overall Study||227
8664321|NCT00399308|21390746|P3|NOT COMPLETED|Overall Study||1
8664322|NCT00399308|21390747|P2|NOT COMPLETED|Overall Study||0
8664323|NCT00399308|21390748|P1|NOT COMPLETED|Overall Study||0
8664324|NCT00399308|21390746|P3|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
8664325|NCT00399308|21390747|P2|COMPLETED|Overall Study||15
8664326|NCT00399308|21390748|P1|COMPLETED|Overall Study||13
8664327|NCT00399308|21390746|P3|STARTED|Overall Study||12
8664328|NCT00399308|21390747|P2|STARTED|Overall Study||15
8664329|NCT00399308|21390748|P1|STARTED|Overall Study||13
8664330|NCT00289211|21390768|P3|NOT COMPLETED|Overall Study||10
8664331|NCT00289211|21390769|P2|NOT COMPLETED|Overall Study||1
8664332|NCT00289211|21390770|P1|NOT COMPLETED|Overall Study||0
8664333|NCT00289211|21390768|P3|COMPLETED|Overall Study||2
8664334|NCT00289211|21390769|P2|COMPLETED|Overall Study||34
8664335|NCT00289211|21390770|P1|COMPLETED|Overall Study||36
8664336|NCT00289211|21390768|P3|STARTED|Overall Study||12
8664337|NCT00289211|21390769|P2|STARTED|Overall Study||35
8664338|NCT00289211|21390770|P1|STARTED|Overall Study||36
8664339|NCT00281658|21390788|P3|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
8664340|NCT00281658|21390789|P2|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
8664341|NCT00281658|21390790|P1|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
8664342|NCT00281658|21390788|P3|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
8664343|NCT00281658|21390789|P2|COMPLETED|Open-label Monotherapy Extension Phase||0
8664344|NCT00281658|21390790|P1|COMPLETED|Open-label Monotherapy Extension Phase||0
8664345|NCT00281658|21390788|P3|STARTED|Open-label Monotherapy Extension Phase||149
8664346|NCT00281658|21390789|P2|STARTED|Open-label Monotherapy Extension Phase||0
8664347|NCT00281658|21390790|P1|STARTED|Open-label Monotherapy Extension Phase||0
8664348|NCT00281658|21390788|P3|NOT COMPLETED|Double-blind, Randomized Phase||0
8664349|NCT00281658|21390789|P2|NOT COMPLETED|Double-blind, Randomized Phase||54
8664350|NCT00281658|21390790|P1|NOT COMPLETED|Double-blind, Randomized Phase||137
8664351|NCT00281658|21390788|P3|COMPLETED|Double-blind, Randomized Phase||0
8664352|NCT00281658|21390789|P2|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
8664353|NCT00281658|21390790|P1|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
8664354|NCT00281658|21390788|P3|STARTED|Double-blind, Randomized Phase||0
8664355|NCT00281658|21390789|P2|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
8664356|NCT00281658|21390790|P1|STARTED|Double-blind, Randomized Phase||222
8664357|NCT00262080|21390810|P3|NOT COMPLETED|Repeat Dose Treatment Period||5
8664358|NCT00262080|21390811|P2|NOT COMPLETED|Repeat Dose Treatment Period||1
8664359|NCT00262080|21390812|P1|NOT COMPLETED|Repeat Dose Treatment Period||4
8664360|NCT00262080|21390810|P3|COMPLETED|Repeat Dose Treatment Period||14
8664361|NCT00262080|21390811|P2|COMPLETED|Repeat Dose Treatment Period||25
8664362|NCT00262080|21390812|P1|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
8664363|NCT00262080|21390810|P3|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
8664364|NCT00262080|21390811|P2|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
8664365|NCT00262080|21390812|P1|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
8664366|NCT00262080|21390810|P3|NOT COMPLETED|Double Blind Treatment Period||0
8664367|NCT00262080|21390811|P2|NOT COMPLETED|Double Blind Treatment Period||0
8664368|NCT00262080|21390812|P1|NOT COMPLETED|Double Blind Treatment Period||1
8664369|NCT00262080|21390810|P3|COMPLETED|Double Blind Treatment Period||0
8664370|NCT00262080|21390811|P2|COMPLETED|Double Blind Treatment Period||36
8664371|NCT00262080|21390812|P1|COMPLETED|Double Blind Treatment Period||35
8664372|NCT00262080|21390810|P3|STARTED|Double Blind Treatment Period||0
8664373|NCT00262080|21390811|P2|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
8664374|NCT00262080|21390812|P1|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
8664457|NCT03864900|21390994|P2|STARTED|Overall Study||36
8664375|NCT00046475|21390830|P3|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
8664376|NCT00046475|21390831|P2|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
8664377|NCT00046475|21390832|P1|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
8664378|NCT00046475|21390830|P3|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
8664379|NCT00046475|21390831|P2|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
8664380|NCT00046475|21390832|P1|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
8664381|NCT00046475|21390830|P3|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
8664382|NCT00046475|21390831|P2|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
8664383|NCT00046475|21390832|P1|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
8664384|NCT00046475|21390830|P3|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
8664385|NCT00046475|21390831|P2|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
8664386|NCT00046475|21390832|P1|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
8664387|NCT00046475|21390830|P3|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
8664388|NCT00046475|21390831|P2|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
8664389|NCT00046475|21390832|P1|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
8664390|NCT00046475|21390830|P3|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
8664391|NCT00046475|21390831|P2|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
8664392|NCT00046475|21390832|P1|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
8664393|NCT00046475|21390830|P3|NOT COMPLETED|Titration (1 Week)||0
8664394|NCT00046475|21390831|P2|NOT COMPLETED|Titration (1 Week)||0
8664395|NCT00046475|21390832|P1|NOT COMPLETED|Titration (1 Week)||0
8664396|NCT00046475|21390830|P3|COMPLETED|Titration (1 Week)||0
8664397|NCT00046475|21390831|P2|COMPLETED|Titration (1 Week)||0
8664398|NCT00046475|21390832|P1|COMPLETED|Titration (1 Week)||136
8664399|NCT00046475|21390830|P3|STARTED|Titration (1 Week)||0
8664400|NCT00046475|21390831|P2|STARTED|Titration (1 Week)||0
8664401|NCT00046475|21390832|P1|STARTED|Titration (1 Week)||136
8664402|NCT00046475|21390830|P3|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8664403|NCT00046475|21390831|P2|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8664404|NCT00046475|21390832|P1|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
8664405|NCT00046475|21390830|P3|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8664406|NCT00046475|21390831|P2|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
8664407|NCT00046475|21390832|P1|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
8664408|NCT00046475|21390830|P3|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
8664409|NCT00046475|21390831|P2|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
8664410|NCT00046475|21390832|P1|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
8664411|NCT00031694|21390868|P1|NOT COMPLETED|Overall Study||19
8664412|NCT00031694|21390868|P1|COMPLETED|Overall Study||0
8664413|NCT00031694|21390868|P1|STARTED|Overall Study||19
8664414|NCT04475588|21390876|P2|NOT COMPLETED|Overall Study||0
8664415|NCT04475588|21390877|P1|NOT COMPLETED|Overall Study||2
8664416|NCT04475588|21390876|P2|COMPLETED|Overall Study||10
8664417|NCT04475588|21390877|P1|COMPLETED|Overall Study||20
8664418|NCT04475588|21390876|P2|STARTED|Overall Study||10
8664419|NCT04475588|21390877|P1|STARTED|Overall Study|Stated in protocol apriori, patient not completing 1st infusion were not evaluable & were replaced.|22
8664420|NCT04321980|21390913|P2|NOT COMPLETED|Overall Study||0
8664421|NCT04321980|21390914|P1|NOT COMPLETED|Overall Study||0
8664422|NCT04321980|21390913|P2|COMPLETED|Overall Study||4
8664423|NCT04321980|21390914|P1|COMPLETED|Overall Study||4
8664424|NCT04321980|21390913|P2|STARTED|Overall Study||4
8664425|NCT04321980|21390914|P1|STARTED|Overall Study||4
8664426|NCT04227119|21390930|P1|NOT COMPLETED|Overall Study||0
8664427|NCT04227119|21390930|P1|COMPLETED|Overall Study||11
8664428|NCT04227119|21390930|P1|STARTED|Overall Study||11
8664429|NCT03926039|21390942|P2|NOT COMPLETED|Overall Study||1
8664430|NCT03926039|21390943|P1|NOT COMPLETED|Overall Study||0
8664431|NCT03926039|21390942|P2|COMPLETED|Overall Study||34
8664432|NCT03926039|21390943|P1|COMPLETED|Overall Study||35
8664433|NCT03926039|21390942|P2|STARTED|Overall Study||35
8664434|NCT03926039|21390943|P1|STARTED|Overall Study||35
8664435|NCT03865953|21390957|P2|NOT COMPLETED|Second Intervention (4 Weeks)||2
8664436|NCT03865953|21390958|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8664437|NCT03865953|21390957|P2|COMPLETED|Second Intervention (4 Weeks)||25
8664438|NCT03865953|21390958|P1|COMPLETED|Second Intervention (4 Weeks)||23
8664439|NCT03865953|21390957|P2|STARTED|Second Intervention (4 Weeks)||27
8664440|NCT03865953|21390958|P1|STARTED|Second Intervention (4 Weeks)||23
8664441|NCT03865953|21390957|P2|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
8664442|NCT03865953|21390958|P1|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
8664443|NCT03865953|21390957|P2|COMPLETED|Washout/Baseline Period (3 Weeks)||27
8664444|NCT03865953|21390958|P1|COMPLETED|Washout/Baseline Period (3 Weeks)||23
8664445|NCT03865953|21390957|P2|STARTED|Washout/Baseline Period (3 Weeks)||27
8664446|NCT03865953|21390958|P1|STARTED|Washout/Baseline Period (3 Weeks)||23
8664447|NCT03865953|21390957|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
8664448|NCT03865953|21390958|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
8664449|NCT03865953|21390957|P2|COMPLETED|First Intervention (4 Weeks)||27
8664450|NCT03865953|21390958|P1|COMPLETED|First Intervention (4 Weeks)||23
8664451|NCT03865953|21390957|P2|STARTED|First Intervention (4 Weeks)||28
8664452|NCT03865953|21390958|P1|STARTED|First Intervention (4 Weeks)||25
8664453|NCT03864900|21390994|P2|NOT COMPLETED|Overall Study||6
8664454|NCT03864900|21390995|P1|NOT COMPLETED|Overall Study||3
8664455|NCT03864900|21390994|P2|COMPLETED|Overall Study||30
8664456|NCT03864900|21390995|P1|COMPLETED|Overall Study||33
8664458|NCT03864900|21390995|P1|STARTED|Overall Study||36
8664459|NCT03862482|21391004|P3|NOT COMPLETED|Overall Study||0
8664460|NCT03862482|21391005|P2|NOT COMPLETED|Overall Study||0
8664461|NCT03862482|21391006|P1|NOT COMPLETED|Overall Study||0
8664462|NCT03862482|21391004|P3|COMPLETED|Overall Study|Twelve B, six SW, and 12 SC implant units were placed on a rotating basis at the five sites for a total of 30 implant units|6
8664463|NCT03862482|21391005|P2|COMPLETED|Overall Study|Eight B, 16 SW, and 16 SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, two implant units (one B, one SW) were removed from all future analyses due to technical issues with radiographs|8
8664464|NCT03862482|21391006|P1|COMPLETED|Overall Study|Sixteen B, 16 SW, and eight SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, one implant unit (SW) had fractured and was subsequently excluded from all future analyses|8
8664465|NCT03862482|21391004|P3|STARTED|Overall Study|Six participants (thirty implant units) were randomly allocated to Configuration 3 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|6
8664466|NCT03862482|21391005|P2|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 2 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
8664467|NCT03862482|21391006|P1|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 1 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
8664468|NCT03856255|21391018|P1|NOT COMPLETED|Overall Study||0
8664469|NCT03856255|21391018|P1|COMPLETED|Overall Study||23
8664470|NCT03856255|21391018|P1|STARTED|Overall Study||23
8664471|NCT03782701|21391026|P1|NOT COMPLETED|Overall Study||0
8664472|NCT03782701|21391026|P1|COMPLETED|Overall Study||43
8664473|NCT03782701|21391026|P1|Saline Solution|Overall Study||43
8664474|NCT03782701|21391026|P1|Lumify|Overall Study||43
8664475|NCT03782701|21391026|P1|STARTED|Overall Study||43
8664476|NCT03739684|21391038|P1|NOT COMPLETED|Overall Study||13
8664477|NCT03739684|21391038|P1|COMPLETED|Overall Study||195
8664478|NCT03739684|21391038|P1|STARTED|Overall Study||208
8664479|NCT03710161|21391049|P2|NOT COMPLETED|Overall Study||2
8664480|NCT03710161|21391050|P1|NOT COMPLETED|Overall Study||3
8664481|NCT03710161|21391049|P2|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
8664482|NCT03710161|21391050|P1|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
8664483|NCT03710161|21391049|P2|STARTED|Overall Study||2
8664484|NCT03710161|21391050|P1|STARTED|Overall Study||3
8664485|NCT03706469|21391066|P4|NOT COMPLETED|Overall Study||0
8664486|NCT03706469|21391067|P3|NOT COMPLETED|Overall Study||0
8664487|NCT03706469|21391068|P2|NOT COMPLETED|Overall Study||0
8664488|NCT03706469|21391069|P1|NOT COMPLETED|Overall Study||0
8664489|NCT03706469|21391066|P4|COMPLETED|Overall Study||4
8664490|NCT03706469|21391067|P3|COMPLETED|Overall Study||4
8664491|NCT03706469|21391068|P2|COMPLETED|Overall Study||4
8664492|NCT03706469|21391069|P1|COMPLETED|Overall Study||4
8664493|NCT03706469|21391066|P4|STARTED|Overall Study||4
8664494|NCT03706469|21391067|P3|STARTED|Overall Study||4
8664495|NCT03706469|21391068|P2|STARTED|Overall Study||4
8664496|NCT03706469|21391069|P1|STARTED|Overall Study||4
8664497|NCT03687684|21391105|P9|NOT COMPLETED|Overall Study||0
8664498|NCT03687684|21391106|P8|NOT COMPLETED|Overall Study||0
8664499|NCT03687684|21391107|P7|NOT COMPLETED|Overall Study||0
8664500|NCT03687684|21391108|P6|NOT COMPLETED|Overall Study||0
8664501|NCT03687684|21391109|P5|NOT COMPLETED|Overall Study||0
8664502|NCT03687684|21391110|P4|NOT COMPLETED|Overall Study||0
8664503|NCT03687684|21391111|P3|NOT COMPLETED|Overall Study||0
8664504|NCT03687684|21391112|P2|NOT COMPLETED|Overall Study||0
8664505|NCT03687684|21391113|P1|NOT COMPLETED|Overall Study||0
8664506|NCT03687684|21391105|P9|COMPLETED|Overall Study||6
8664507|NCT03687684|21391106|P8|COMPLETED|Overall Study||2
8664508|NCT03687684|21391107|P7|COMPLETED|Overall Study||6
8664509|NCT03687684|21391108|P6|COMPLETED|Overall Study||6
8664510|NCT03687684|21391109|P5|COMPLETED|Overall Study||6
8664511|NCT03687684|21391110|P4|COMPLETED|Overall Study||6
8664512|NCT03687684|21391111|P3|COMPLETED|Overall Study||2
8664513|NCT03687684|21391112|P2|COMPLETED|Overall Study||2
8664514|NCT03687684|21391113|P1|COMPLETED|Overall Study||4
8664515|NCT03687684|21391105|P9|STARTED|Overall Study||6
8664516|NCT03687684|21391106|P8|STARTED|Overall Study||2
8664517|NCT03687684|21391107|P7|STARTED|Overall Study||6
8664518|NCT03687684|21391108|P6|STARTED|Overall Study||6
8664519|NCT03687684|21391109|P5|STARTED|Overall Study||6
8664520|NCT03687684|21391110|P4|STARTED|Overall Study||6
8664521|NCT03687684|21391111|P3|STARTED|Overall Study||2
8664522|NCT03687684|21391112|P2|STARTED|Overall Study||2
8664523|NCT03687684|21391113|P1|STARTED|Overall Study||4
8664524|NCT03628924|21391204|P7|NOT COMPLETED|Active Treatment Period (Week 16-48)||11
8664525|NCT03628924|21391205|P6|NOT COMPLETED|Active Treatment Period (Week 16-48)||13
8664526|NCT03628924|21391206|P5|NOT COMPLETED|Active Treatment Period (Week 16-48)||4
8664527|NCT03628924|21391207|P4|NOT COMPLETED|Active Treatment Period (Week 16-48)||8
8664528|NCT03628924|21391208|P3|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
8664529|NCT03628924|21391209|P2|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
8664530|NCT03628924|21391210|P1|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
8664531|NCT03628924|21391204|P7|COMPLETED|Active Treatment Period (Week 16-48)||46
8664532|NCT03628924|21391205|P6|COMPLETED|Active Treatment Period (Week 16-48)||43
8664533|NCT03628924|21391206|P5|COMPLETED|Active Treatment Period (Week 16-48)||24
8664534|NCT03628924|21391207|P4|COMPLETED|Active Treatment Period (Week 16-48)||20
8664535|NCT03628924|21391208|P3|COMPLETED|Active Treatment Period (Week 16-48)||0
8664536|NCT03628924|21391209|P2|COMPLETED|Active Treatment Period (Week 16-48)||0
8664537|NCT03628924|21391210|P1|COMPLETED|Active Treatment Period (Week 16-48)||0
8664538|NCT03628924|21391204|P7|STARTED|Active Treatment Period (Week 16-48)||57
8664539|NCT03628924|21391205|P6|STARTED|Active Treatment Period (Week 16-48)||56
8664540|NCT03628924|21391206|P5|STARTED|Active Treatment Period (Week 16-48)||28
8664541|NCT03628924|21391207|P4|STARTED|Active Treatment Period (Week 16-48)||28
8664542|NCT03628924|21391208|P3|STARTED|Active Treatment Period (Week 16-48)||0
8664543|NCT03628924|21391209|P2|STARTED|Active Treatment Period (Week 16-48)||0
8664544|NCT03628924|21391210|P1|STARTED|Active Treatment Period (Week 16-48)||0
8664545|NCT03628924|21391204|P7|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8664546|NCT03628924|21391205|P6|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8664547|NCT03628924|21391206|P5|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8664548|NCT03628924|21391207|P4|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8664549|NCT03628924|21391208|P3|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
8664550|NCT03628924|21391209|P2|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
8664551|NCT03628924|21391210|P1|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||6
8664552|NCT03628924|21391204|P7|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8664553|NCT03628924|21391205|P6|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8664554|NCT03628924|21391206|P5|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8664555|NCT03628924|21391207|P4|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
8664556|NCT03628924|21391208|P3|COMPLETED|Placebo Controlled Period (Week 0 - 16)||57
8664557|NCT03628924|21391209|P2|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
8664558|NCT03628924|21391210|P1|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
8664559|NCT03628924|21391204|P7|STARTED|Placebo Controlled Period (Week 0 - 16)||0
8664560|NCT03628924|21391205|P6|STARTED|Placebo Controlled Period (Week 0 - 16)||0
8664561|NCT03628924|21391206|P5|STARTED|Placebo Controlled Period (Week 0 - 16)||0
8664562|NCT03628924|21391207|P4|STARTED|Placebo Controlled Period (Week 0 - 16)||0
8664563|NCT03628924|21391208|P3|STARTED|Placebo Controlled Period (Week 0 - 16)||60
8664564|NCT03628924|21391209|P2|STARTED|Placebo Controlled Period (Week 0 - 16)||59
8664565|NCT03628924|21391210|P1|STARTED|Placebo Controlled Period (Week 0 - 16)||62
8664566|NCT03602339|21391285|P1|NOT COMPLETED|Overall Study||15
8664567|NCT03602339|21391285|P1|COMPLETED|Overall Study||142
8664568|NCT03602339|21391285|P1|Started Period 2 (Gadobutrol)|Overall Study||142
8664569|NCT03602339|21391285|P1|Completed Period 1 (Gadoterate)|Overall Study||155
8664570|NCT03602339|21391285|P1|STARTED|Overall Study||157
8664571|NCT03600194|21391312|P3|NOT COMPLETED|In Lab Phase||0
8664572|NCT03600194|21391313|P2|NOT COMPLETED|In Lab Phase||0
8664573|NCT03600194|21391314|P1|NOT COMPLETED|In Lab Phase||0
8664574|NCT03600194|21391312|P3|COMPLETED|In Lab Phase||6
8664575|NCT03600194|21391313|P2|COMPLETED|In Lab Phase||5
8664576|NCT03600194|21391314|P1|COMPLETED|In Lab Phase||0
8664577|NCT03600194|21391312|P3|STARTED|In Lab Phase||6
8664578|NCT03600194|21391313|P2|STARTED|In Lab Phase||5
8664579|NCT03600194|21391314|P1|STARTED|In Lab Phase||0
8664580|NCT03600194|21391312|P3|NOT COMPLETED|Screening||0
8664581|NCT03600194|21391313|P2|NOT COMPLETED|Screening||0
8664582|NCT03600194|21391314|P1|NOT COMPLETED|Screening||27
8664583|NCT03600194|21391312|P3|COMPLETED|Screening||0
8664584|NCT03600194|21391313|P2|COMPLETED|Screening||0
8664585|NCT03600194|21391314|P1|COMPLETED|Screening||11
8664586|NCT03600194|21391312|P3|STARTED|Screening||0
8664587|NCT03600194|21391313|P2|STARTED|Screening||0
8664588|NCT03600194|21391314|P1|STARTED|Screening||38
8664589|NCT03480685|21391333|P1|NOT COMPLETED|Overall Study||0
8664590|NCT03480685|21391333|P1|COMPLETED|Overall Study||12
8664591|NCT03480685|21391333|P1|STARTED|Overall Study||12
8664592|NCT03389893|21391355|P4|NOT COMPLETED|Open Label Extension and Follow-Up||12
8664593|NCT03389893|21391356|P3|NOT COMPLETED|Open Label Extension and Follow-Up||25
8664594|NCT03389893|21391357|P2|NOT COMPLETED|Open Label Extension and Follow-Up||0
8664595|NCT03389893|21391358|P1|NOT COMPLETED|Open Label Extension and Follow-Up||0
8664596|NCT03389893|21391355|P4|COMPLETED|Open Label Extension and Follow-Up||14
8664597|NCT03389893|21391356|P3|COMPLETED|Open Label Extension and Follow-Up||20
8664598|NCT03389893|21391357|P2|COMPLETED|Open Label Extension and Follow-Up||0
8664599|NCT03389893|21391358|P1|COMPLETED|Open Label Extension and Follow-Up||0
8664600|NCT03389893|21391355|P4|STARTED|Open Label Extension and Follow-Up||26
8664601|NCT03389893|21391356|P3|STARTED|Open Label Extension and Follow-Up||45
8664602|NCT03389893|21391357|P2|STARTED|Open Label Extension and Follow-Up||0
8664603|NCT03389893|21391358|P1|STARTED|Open Label Extension and Follow-Up||0
8664604|NCT03389893|21391355|P4|NOT COMPLETED|Randomized Double Blind Period||0
8664605|NCT03389893|21391356|P3|NOT COMPLETED|Randomized Double Blind Period||0
8664606|NCT03389893|21391357|P2|NOT COMPLETED|Randomized Double Blind Period||0
8664607|NCT03389893|21391358|P1|NOT COMPLETED|Randomized Double Blind Period||1
8664608|NCT03389893|21391355|P4|COMPLETED|Randomized Double Blind Period||0
8664609|NCT03389893|21391356|P3|COMPLETED|Randomized Double Blind Period||0
8664610|NCT03389893|21391357|P2|COMPLETED|Randomized Double Blind Period||26
8664611|NCT03389893|21391358|P1|COMPLETED|Randomized Double Blind Period||45
8664612|NCT03389893|21391355|P4|STARTED|Randomized Double Blind Period||0
8664613|NCT03389893|21391356|P3|STARTED|Randomized Double Blind Period||0
8664614|NCT03389893|21391357|P2|STARTED|Randomized Double Blind Period||26
8664615|NCT03389893|21391358|P1|STARTED|Randomized Double Blind Period||46
8664616|NCT03383692|21391366|P2|NOT COMPLETED|Overall Study||4
8664617|NCT03383692|21391367|P1|NOT COMPLETED|Overall Study||6
8664618|NCT03383692|21391366|P2|COMPLETED|Overall Study||19
8664619|NCT03383692|21391367|P1|COMPLETED|Overall Study||11
8664620|NCT03383692|21391366|P2|STARTED|Overall Study||23
8664621|NCT03383692|21391367|P1|STARTED|Overall Study||17
8664628|NCT03306277|21391407|P1|NOT COMPLETED|Overall Study||3
8664629|NCT03306277|21391407|P1|COMPLETED|Overall Study||19
8664630|NCT03306277|21391407|P1|STARTED|Overall Study||22
8664631|NCT03300570|21391416|P2|NOT COMPLETED|Overall Study||1
8664632|NCT03300570|21391417|P1|NOT COMPLETED|Overall Study||2
8664633|NCT03300570|21391416|P2|COMPLETED|Overall Study||13
8664634|NCT03300570|21391417|P1|COMPLETED|Overall Study||11
8664635|NCT03300570|21391416|P2|STARTED|Overall Study||14
8664636|NCT03300570|21391417|P1|STARTED|Overall Study||13
8664652|NCT03259334|21391478|P3|NOT COMPLETED|Overall Study||13
8664653|NCT03259334|21391479|P2|NOT COMPLETED|Overall Study||17
8664654|NCT03259334|21391480|P1|NOT COMPLETED|Overall Study||10
8664655|NCT03259334|21391478|P3|COMPLETED|Overall Study||138
8664656|NCT03259334|21391479|P2|COMPLETED|Overall Study||136
8664657|NCT03259334|21391480|P1|COMPLETED|Overall Study||66
8664658|NCT03259334|21391478|P3|Treated|Overall Study||151
8664659|NCT03259334|21391479|P2|Treated|Overall Study||151
8664660|NCT03259334|21391480|P1|Treated|Overall Study||76
8664661|NCT03259334|21391478|P3|STARTED|Overall Study||151
8664662|NCT03259334|21391479|P2|STARTED|Overall Study||153
8664663|NCT03259334|21391480|P1|STARTED|Overall Study||76
8664664|NCT03232749|21391557|P1|NOT COMPLETED|Overall Study||4
8664665|NCT03232749|21391557|P1|COMPLETED|Overall Study||21
8664666|NCT03232749|21391557|P1|STARTED|Overall Study||25
8664667|NCT03224325|21391570|P7|NOT COMPLETED|Overall Study||1
8664668|NCT03224325|21391571|P6|NOT COMPLETED|Overall Study||0
8664669|NCT03224325|21391572|P5|NOT COMPLETED|Overall Study||0
8664670|NCT03224325|21391573|P4|NOT COMPLETED|Overall Study||1
8664671|NCT03224325|21391574|P3|NOT COMPLETED|Overall Study||0
8664672|NCT03224325|21391575|P2|NOT COMPLETED|Overall Study||0
8664673|NCT03224325|21391576|P1|NOT COMPLETED|Overall Study||1
8664674|NCT03224325|21391570|P7|COMPLETED|Overall Study||6
8664675|NCT03224325|21391571|P6|COMPLETED|Overall Study||6
8664676|NCT03224325|21391572|P5|COMPLETED|Overall Study||6
8664677|NCT03224325|21391573|P4|COMPLETED|Overall Study||5
8664678|NCT03224325|21391574|P3|COMPLETED|Overall Study||6
8664679|NCT03224325|21391575|P2|COMPLETED|Overall Study||6
8664680|NCT03224325|21391576|P1|COMPLETED|Overall Study||12
8664681|NCT03224325|21391570|P7|STARTED|Overall Study||7
8664682|NCT03224325|21391571|P6|STARTED|Overall Study||6
8664683|NCT03224325|21391572|P5|STARTED|Overall Study||6
8664684|NCT03224325|21391573|P4|STARTED|Overall Study||6
8664685|NCT03224325|21391574|P3|STARTED|Overall Study||6
8664686|NCT03224325|21391575|P2|STARTED|Overall Study||6
8664687|NCT03224325|21391576|P1|STARTED|Overall Study||13
8664688|NCT03214588|21391640|P3|NOT COMPLETED|Overall Study||2
8664689|NCT03214588|21391641|P2|NOT COMPLETED|Overall Study||1
8664690|NCT03214588|21391642|P1|NOT COMPLETED|Overall Study||1
8664691|NCT03214588|21391640|P3|COMPLETED|Overall Study||24
8664692|NCT03214588|21391641|P2|COMPLETED|Overall Study||13
8664693|NCT03214588|21391642|P1|COMPLETED|Overall Study||26
8664694|NCT03214588|21391640|P3|STARTED|Overall Study||26
8664695|NCT03214588|21391641|P2|STARTED|Overall Study||14
8664696|NCT03214588|21391642|P1|STARTED|Overall Study||27
8664703|NCT03188991|21391722|P4|NOT COMPLETED|Overall Study||1
8664704|NCT03188991|21391723|P3|NOT COMPLETED|Overall Study||0
8664705|NCT03188991|21391724|P2|NOT COMPLETED|Overall Study||0
8664706|NCT03188991|21391725|P1|NOT COMPLETED|Overall Study||0
8664707|NCT03188991|21391722|P4|COMPLETED|Overall Study||10
8664708|NCT03188991|21391723|P3|COMPLETED|Overall Study||3
8664709|NCT03188991|21391724|P2|COMPLETED|Overall Study||3
8664710|NCT03188991|21391725|P1|COMPLETED|Overall Study||3
8664711|NCT03188991|21391722|P4|STARTED|Overall Study||11
8664712|NCT03188991|21391723|P3|STARTED|Overall Study||3
8664713|NCT03188991|21391724|P2|STARTED|Overall Study||3
8664714|NCT03188991|21391725|P1|STARTED|Overall Study||3
8664715|NCT03151395|21391739|P1|NOT COMPLETED|Overall Study||15
8664716|NCT03151395|21391739|P1|COMPLETED|Overall Study||182
8664717|NCT03151395|21391739|P1|STARTED|Overall Study||197
8664718|NCT03131960|21391764|P2|NOT COMPLETED|Overall Study||1
8664719|NCT03131960|21391765|P1|NOT COMPLETED|Overall Study||0
8664720|NCT03131960|21391764|P2|COMPLETED|Overall Study||54
8664721|NCT03131960|21391765|P1|COMPLETED|Overall Study||53
8664722|NCT03131960|21391764|P2|STARTED|Overall Study|1 discontinued treatment due to adverse event and inability to tolerate rehabilitation.|55
8664723|NCT03131960|21391765|P1|STARTED|Overall Study|1 participant missed the day one visit (V5) but remained in the study and returned for the day 90 assessment (V7).|53
8664724|NCT03111628|21391777|P1|NOT COMPLETED|Overall Study||0
8664725|NCT03111628|21391777|P1|COMPLETED|Overall Study||18
8664726|NCT03111628|21391777|P1|STARTED|Overall Study||18
8664727|NCT03101293|21391784|P2|NOT COMPLETED|Intervention Period 2||0
8664728|NCT03101293|21391785|P1|NOT COMPLETED|Intervention Period 2||0
8664729|NCT03101293|21391784|P2|COMPLETED|Intervention Period 2||8
8664730|NCT03101293|21391785|P1|COMPLETED|Intervention Period 2||6
8664731|NCT03101293|21391784|P2|STARTED|Intervention Period 2||8
8664732|NCT03101293|21391785|P1|STARTED|Intervention Period 2||6
8664733|NCT03101293|21391784|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
8664734|NCT03101293|21391785|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||1
8664735|NCT03101293|21391784|P2|COMPLETED|Washout Period (at Least 7 Days)||8
8664736|NCT03101293|21391785|P1|COMPLETED|Washout Period (at Least 7 Days)||6
8664737|NCT03101293|21391784|P2|STARTED|Washout Period (at Least 7 Days)||8
8664738|NCT03101293|21391785|P1|STARTED|Washout Period (at Least 7 Days)||7
8664739|NCT03101293|21391784|P2|NOT COMPLETED|Intervention Period 1||0
8664740|NCT03101293|21391785|P1|NOT COMPLETED|Intervention Period 1||0
8664741|NCT03101293|21391784|P2|COMPLETED|Intervention Period 1||8
8664742|NCT03101293|21391785|P1|COMPLETED|Intervention Period 1||7
8664743|NCT03101293|21391784|P2|STARTED|Intervention Period 1||8
8664744|NCT03101293|21391785|P1|STARTED|Intervention Period 1||7
8664749|NCT03019796|21391807|P2|NOT COMPLETED|Third Intervention Drug Test||0
8664750|NCT03019796|21391808|P1|NOT COMPLETED|Third Intervention Drug Test||0
8664751|NCT03019796|21391807|P2|COMPLETED|Third Intervention Drug Test||19
8664752|NCT03019796|21391808|P1|COMPLETED|Third Intervention Drug Test||19
8664753|NCT03019796|21391807|P2|STARTED|Third Intervention Drug Test||19
8664754|NCT03019796|21391808|P1|STARTED|Third Intervention Drug Test||19
8664755|NCT03019796|21391807|P2|NOT COMPLETED|Second Intervention Training (4 Months)||1
8664756|NCT03019796|21391808|P1|NOT COMPLETED|Second Intervention Training (4 Months)||1
8664757|NCT03019796|21391807|P2|COMPLETED|Second Intervention Training (4 Months)||19
8664758|NCT03019796|21391808|P1|COMPLETED|Second Intervention Training (4 Months)||19
8664759|NCT03019796|21391807|P2|STARTED|Second Intervention Training (4 Months)||20
8664760|NCT03019796|21391808|P1|STARTED|Second Intervention Training (4 Months)||20
8664761|NCT03019796|21391807|P2|NOT COMPLETED|First Intervention Drug Tests||0
8664762|NCT03019796|21391808|P1|NOT COMPLETED|First Intervention Drug Tests||0
8664763|NCT03019796|21391807|P2|COMPLETED|First Intervention Drug Tests||20
8664764|NCT03019796|21391808|P1|COMPLETED|First Intervention Drug Tests||20
8664765|NCT03019796|21391807|P2|STARTED|First Intervention Drug Tests||20
8664766|NCT03019796|21391808|P1|STARTED|First Intervention Drug Tests||20
8664767|NCT02998541|21391827|P3|NOT COMPLETED|Overall Study||6
8664768|NCT02998541|21391828|P2|NOT COMPLETED|Overall Study||9
8664769|NCT02998541|21391829|P1|NOT COMPLETED|Overall Study||8
8664770|NCT02998541|21391827|P3|COMPLETED|Overall Study||37
8664771|NCT02998541|21391828|P2|COMPLETED|Overall Study||81
8664772|NCT02998541|21391829|P1|COMPLETED|Overall Study||78
8664773|NCT02998541|21391827|P3|STARTED|Overall Study||43
8664774|NCT02998541|21391828|P2|STARTED|Overall Study||90
8664775|NCT02998541|21391829|P1|STARTED|Overall Study||86
8664776|NCT02992899|21391884|P2|NOT COMPLETED|Overall Study||3
8664777|NCT02992899|21391885|P1|NOT COMPLETED|Overall Study||2
8664778|NCT02992899|21391884|P2|COMPLETED|Overall Study||26
8664779|NCT02992899|21391885|P1|COMPLETED|Overall Study||25
8664780|NCT02992899|21391884|P2|STARTED|Overall Study||29
8664781|NCT02992899|21391885|P1|STARTED|Overall Study||27
8664782|NCT02949362|21391937|P4|NOT COMPLETED|Prospective Period||4
8664783|NCT02949362|21391938|P3|NOT COMPLETED|Prospective Period||1
8664784|NCT02949362|21391939|P2|NOT COMPLETED|Prospective Period||0
8664785|NCT02949362|21391940|P1|NOT COMPLETED|Prospective Period||0
8664786|NCT02949362|21391937|P4|COMPLETED|Prospective Period||15
8664787|NCT02949362|21391938|P3|COMPLETED|Prospective Period||4
8664788|NCT02949362|21391939|P2|COMPLETED|Prospective Period||0
8664789|NCT02949362|21391940|P1|COMPLETED|Prospective Period||0
8664790|NCT02949362|21391937|P4|STARTED|Prospective Period|Participants were enrolled from retrospective period.|19
8664791|NCT02949362|21391938|P3|STARTED|Prospective Period|Participants were enrolled from retrospective period.|5
8664792|NCT02949362|21391939|P2|STARTED|Prospective Period||0
8664793|NCT02949362|21391940|P1|STARTED|Prospective Period||0
8664794|NCT02949362|21391937|P4|NOT COMPLETED|Retrospective Period||0
8664795|NCT02949362|21391938|P3|NOT COMPLETED|Retrospective Period||0
8664796|NCT02949362|21391939|P2|NOT COMPLETED|Retrospective Period||1
8664797|NCT02949362|21391940|P1|NOT COMPLETED|Retrospective Period||4
8664798|NCT02949362|21391937|P4|COMPLETED|Retrospective Period||0
8664799|NCT02949362|21391938|P3|COMPLETED|Retrospective Period||0
8664800|NCT02949362|21391939|P2|COMPLETED|Retrospective Period||4
8664801|NCT02949362|21391940|P1|COMPLETED|Retrospective Period||20
8664802|NCT02949362|21391937|P4|STARTED|Retrospective Period||0
8664803|NCT02949362|21391938|P3|STARTED|Retrospective Period||0
8664804|NCT02949362|21391939|P2|STARTED|Retrospective Period||5
8664805|NCT02949362|21391940|P1|STARTED|Retrospective Period||24
8664806|NCT02919475|21392003|P5|NOT COMPLETED|Overall Study||4
8664807|NCT02919475|21392004|P4|NOT COMPLETED|Overall Study||13
8664808|NCT02919475|21392005|P3|NOT COMPLETED|Overall Study||5
8664809|NCT02919475|21392006|P2|NOT COMPLETED|Overall Study||8
8664810|NCT02919475|21392007|P1|NOT COMPLETED|Overall Study||6
8664811|NCT02919475|21392003|P5|COMPLETED|Overall Study||48
8664812|NCT02919475|21392004|P4|COMPLETED|Overall Study||38
8664813|NCT02919475|21392005|P3|COMPLETED|Overall Study||47
8664814|NCT02919475|21392006|P2|COMPLETED|Overall Study||44
8664815|NCT02919475|21392007|P1|COMPLETED|Overall Study||46
8664816|NCT02919475|21392003|P5|Started Dosing|Overall Study||52
8664817|NCT02919475|21392004|P4|Started Dosing|Overall Study||51
8664818|NCT02919475|21392005|P3|Started Dosing|Overall Study||52
8664819|NCT02919475|21392006|P2|Started Dosing|Overall Study||52
8664820|NCT02919475|21392007|P1|Started Dosing|Overall Study||51
8664821|NCT02919475|21392003|P5|STARTED|Overall Study||52
8664822|NCT02919475|21392004|P4|STARTED|Overall Study||51
8664823|NCT02919475|21392005|P3|STARTED|Overall Study||52
8664824|NCT02919475|21392006|P2|STARTED|Overall Study||52
8664825|NCT02919475|21392007|P1|STARTED|Overall Study||52
8664826|NCT02899195|21392063|P1|NOT COMPLETED|Maintenance Durvalumab||34
8664827|NCT02899195|21392063|P1|COMPLETED|Maintenance Durvalumab||10
8664828|NCT02899195|21392063|P1|STARTED|Maintenance Durvalumab||44
8664829|NCT02899195|21392063|P1|NOT COMPLETED|Concurrent Durvalumab||11
8664830|NCT02899195|21392063|P1|COMPLETED|Concurrent Durvalumab||44
8664831|NCT02899195|21392063|P1|STARTED|Concurrent Durvalumab||55
8664832|NCT02850601|21392073|P2|NOT COMPLETED|Overall Study||0
8664833|NCT02850601|21392074|P1|NOT COMPLETED|Overall Study||0
8664834|NCT02850601|21392073|P2|COMPLETED|Overall Study||12
8664835|NCT02850601|21392074|P1|COMPLETED|Overall Study||12
8664836|NCT02850601|21392073|P2|STARTED|Overall Study||12
8664837|NCT02850601|21392074|P1|STARTED|Overall Study||12
8664838|NCT02786537|21392086|P6|NOT COMPLETED|As Treated||7
8664839|NCT02786537|21392087|P5|NOT COMPLETED|As Treated||12
8664840|NCT02786537|21392088|P4|NOT COMPLETED|As Treated||35
8664841|NCT02786537|21392089|P3|NOT COMPLETED|As Treated||0
8664842|NCT02786537|21392090|P2|NOT COMPLETED|As Treated||62
8664843|NCT02786537|21392091|P1|NOT COMPLETED|As Treated||6
8664844|NCT02786537|21392086|P6|COMPLETED|As Treated||40
8664845|NCT02786537|21392087|P5|COMPLETED|As Treated||87
8664846|NCT02786537|21392088|P4|COMPLETED|As Treated||359
8664847|NCT02786537|21392089|P3|COMPLETED|As Treated||15
8664848|NCT02786537|21392090|P2|COMPLETED|As Treated||602
8664849|NCT02786537|21392091|P1|COMPLETED|As Treated||50
8664850|NCT02786537|21392086|P6|STARTED|As Treated||47
8664851|NCT02786537|21392087|P5|STARTED|As Treated||99
8664852|NCT02786537|21392088|P4|STARTED|As Treated||394
8664853|NCT02786537|21392089|P3|STARTED|As Treated||15
8664854|NCT02786537|21392090|P2|STARTED|As Treated||664
8664855|NCT02786537|21392091|P1|STARTED|As Treated||56
8664856|NCT02786537|21392086|P6|NOT COMPLETED|As Randomized||7
8664857|NCT02786537|21392087|P5|NOT COMPLETED|As Randomized||12
8664858|NCT02786537|21392088|P4|NOT COMPLETED|As Randomized||35
8664859|NCT02786537|21392089|P3|NOT COMPLETED|As Randomized||0
8664860|NCT02786537|21392090|P2|NOT COMPLETED|As Randomized||62
8664861|NCT02786537|21392091|P1|NOT COMPLETED|As Randomized||6
8664862|NCT02786537|21392086|P6|COMPLETED|As Randomized||41
8664863|NCT02786537|21392087|P5|COMPLETED|As Randomized||87
8664864|NCT02786537|21392088|P4|COMPLETED|As Randomized||378
8664865|NCT02786537|21392089|P3|COMPLETED|As Randomized||15
8664866|NCT02786537|21392090|P2|COMPLETED|As Randomized||582
8664867|NCT02786537|21392091|P1|COMPLETED|As Randomized||50
8664868|NCT02786537|21392086|P6|STARTED|As Randomized||48
8664869|NCT02786537|21392087|P5|STARTED|As Randomized||99
8664870|NCT02786537|21392088|P4|STARTED|As Randomized||413
8664871|NCT02786537|21392089|P3|STARTED|As Randomized||15
8664872|NCT02786537|21392090|P2|STARTED|As Randomized||644
8664873|NCT02786537|21392091|P1|STARTED|As Randomized||56
8664874|NCT02716987|21392226|P6|NOT COMPLETED|Overall Study||1
8664875|NCT02716987|21392227|P5|NOT COMPLETED|Overall Study||1
8664876|NCT02716987|21392228|P4|NOT COMPLETED|Overall Study||0
8664877|NCT02716987|21392229|P3|NOT COMPLETED|Overall Study||1
8664878|NCT02716987|21392230|P2|NOT COMPLETED|Overall Study||0
8664879|NCT02716987|21392231|P1|NOT COMPLETED|Overall Study||0
8664880|NCT02716987|21392226|P6|COMPLETED|Overall Study||0
8664881|NCT02716987|21392227|P5|COMPLETED|Overall Study||5
8664882|NCT02716987|21392228|P4|COMPLETED|Overall Study||2
8664883|NCT02716987|21392229|P3|COMPLETED|Overall Study||4
8664884|NCT02716987|21392230|P2|COMPLETED|Overall Study||2
8664885|NCT02716987|21392231|P1|COMPLETED|Overall Study||4
8664886|NCT02716987|21392226|P6|STARTED|Overall Study||1
8664887|NCT02716987|21392227|P5|STARTED|Overall Study||6
8664888|NCT02716987|21392228|P4|STARTED|Overall Study||2
8664889|NCT02716987|21392229|P3|STARTED|Overall Study||5
8664890|NCT02716987|21392230|P2|STARTED|Overall Study||2
8664891|NCT02716987|21392231|P1|STARTED|Overall Study||4
8664892|NCT02714153|21392295|P1|NOT COMPLETED|Overall Study||1
8664893|NCT02714153|21392295|P1|COMPLETED|Overall Study||22
8664894|NCT02714153|21392295|P1|STARTED|Overall Study||23
8664898|NCT02691013|21392321|P2|NOT COMPLETED|Overall Study||0
8664899|NCT02691013|21392322|P1|NOT COMPLETED|Overall Study||3
8664900|NCT02691013|21392321|P2|COMPLETED|Overall Study||59
8664901|NCT02691013|21392322|P1|COMPLETED|Overall Study||58
8664902|NCT02691013|21392321|P2|STARTED|Overall Study||59
8664903|NCT02691013|21392322|P1|STARTED|Overall Study||61
8664912|NCT02592447|21392449|P2|NOT COMPLETED|Overall Study||1
8664913|NCT02592447|21392450|P1|NOT COMPLETED|Overall Study||2
8664914|NCT02592447|21392449|P2|COMPLETED|Overall Study||14
8664915|NCT02592447|21392450|P1|COMPLETED|Overall Study||27
8664916|NCT02592447|21392449|P2|STARTED|Overall Study||15
8664917|NCT02592447|21392450|P1|STARTED|Overall Study||29
8664921|NCT02566759|21392481|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664922|NCT02566759|21392482|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664923|NCT02566759|21392483|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664924|NCT02566759|21392484|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664925|NCT02566759|21392485|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664926|NCT02566759|21392486|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664927|NCT02566759|21392487|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664928|NCT02566759|21392488|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664929|NCT02566759|21392489|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664930|NCT02566759|21392490|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664931|NCT02566759|21392491|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664932|NCT02566759|21392492|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664933|NCT02566759|21392493|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664934|NCT02566759|21392494|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664935|NCT02566759|21392495|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664936|NCT02566759|21392496|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664937|NCT02566759|21392497|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664938|NCT02566759|21392481|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
8664939|NCT02566759|21392482|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
8664940|NCT02566759|21392483|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
8664941|NCT02566759|21392484|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664942|NCT02566759|21392485|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664943|NCT02566759|21392486|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664944|NCT02566759|21392487|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664945|NCT02566759|21392488|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664946|NCT02566759|21392489|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664947|NCT02566759|21392490|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664948|NCT02566759|21392491|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664949|NCT02566759|21392492|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664950|NCT02566759|21392493|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664951|NCT02566759|21392494|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664952|NCT02566759|21392495|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664953|NCT02566759|21392496|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664954|NCT02566759|21392497|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8664955|NCT02566759|21392481|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||7
8664956|NCT02566759|21392482|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8664957|NCT02566759|21392483|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8664958|NCT02566759|21392484|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8664959|NCT02566759|21392485|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8664960|NCT02566759|21392486|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8664961|NCT02566759|21392487|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8664962|NCT02566759|21392488|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8664963|NCT02566759|21392489|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8664964|NCT02566759|21392490|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8664965|NCT02566759|21392491|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8664966|NCT02566759|21392492|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8664967|NCT02566759|21392493|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8664968|NCT02566759|21392494|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8664969|NCT02566759|21392495|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8664970|NCT02566759|21392496|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8664971|NCT02566759|21392497|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8664972|NCT02566759|21392481|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664973|NCT02566759|21392482|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664974|NCT02566759|21392483|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664975|NCT02566759|21392484|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664976|NCT02566759|21392485|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664977|NCT02566759|21392486|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664978|NCT02566759|21392487|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664979|NCT02566759|21392488|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664980|NCT02566759|21392489|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664981|NCT02566759|21392490|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664982|NCT02566759|21392491|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664983|NCT02566759|21392492|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664984|NCT02566759|21392493|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664985|NCT02566759|21392494|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664986|NCT02566759|21392495|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664987|NCT02566759|21392496|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664988|NCT02566759|21392497|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664989|NCT02566759|21392481|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
8664990|NCT02566759|21392482|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8664991|NCT02566759|21392483|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8664992|NCT02566759|21392484|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664993|NCT02566759|21392485|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664994|NCT02566759|21392486|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664995|NCT02566759|21392487|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664996|NCT02566759|21392488|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664997|NCT02566759|21392489|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664998|NCT02566759|21392490|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8664999|NCT02566759|21392491|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665000|NCT02566759|21392492|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665001|NCT02566759|21392493|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665002|NCT02566759|21392494|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665003|NCT02566759|21392495|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665004|NCT02566759|21392496|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665005|NCT02566759|21392497|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665006|NCT02566759|21392481|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||7
8665007|NCT02566759|21392482|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8665008|NCT02566759|21392483|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8665009|NCT02566759|21392484|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665010|NCT02566759|21392485|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665011|NCT02566759|21392486|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665012|NCT02566759|21392487|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665013|NCT02566759|21392488|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665014|NCT02566759|21392489|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665015|NCT02566759|21392490|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665016|NCT02566759|21392491|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665017|NCT02566759|21392492|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665018|NCT02566759|21392493|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665019|NCT02566759|21392494|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665020|NCT02566759|21392495|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665021|NCT02566759|21392496|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665022|NCT02566759|21392497|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665023|NCT02566759|21392481|P17|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
8665024|NCT02566759|21392482|P16|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665025|NCT02566759|21392483|P15|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665026|NCT02566759|21392484|P14|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665027|NCT02566759|21392485|P13|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665028|NCT02566759|21392486|P12|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665029|NCT02566759|21392487|P11|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665030|NCT02566759|21392488|P10|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665031|NCT02566759|21392489|P9|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665032|NCT02566759|21392490|P8|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665033|NCT02566759|21392491|P7|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665034|NCT02566759|21392492|P6|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665035|NCT02566759|21392493|P5|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665036|NCT02566759|21392494|P4|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665037|NCT02566759|21392495|P3|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665038|NCT02566759|21392496|P2|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665039|NCT02566759|21392497|P1|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665040|NCT02566759|21392481|P17|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
8665041|NCT02566759|21392482|P16|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
8665042|NCT02566759|21392483|P15|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
8665043|NCT02566759|21392484|P14|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665044|NCT02566759|21392485|P13|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665045|NCT02566759|21392486|P12|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665046|NCT02566759|21392487|P11|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665047|NCT02566759|21392488|P10|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665048|NCT02566759|21392489|P9|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665049|NCT02566759|21392490|P8|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665050|NCT02566759|21392491|P7|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665051|NCT02566759|21392492|P6|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665052|NCT02566759|21392493|P5|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665053|NCT02566759|21392494|P4|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665054|NCT02566759|21392495|P3|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665055|NCT02566759|21392496|P2|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665056|NCT02566759|21392497|P1|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
8665057|NCT02566759|21392481|P17|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8665058|NCT02566759|21392482|P16|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8665059|NCT02566759|21392483|P15|STARTED|Crossover Treatment (Part 4: 1 Day)||8
8665060|NCT02566759|21392484|P14|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8665061|NCT02566759|21392485|P13|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8665062|NCT02566759|21392486|P12|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8665063|NCT02566759|21392487|P11|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8665064|NCT02566759|21392488|P10|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8665065|NCT02566759|21392489|P9|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8665066|NCT02566759|21392490|P8|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8665067|NCT02566759|21392491|P7|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8665068|NCT02566759|21392492|P6|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8665069|NCT02566759|21392493|P5|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8665070|NCT02566759|21392494|P4|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8665071|NCT02566759|21392495|P3|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8665072|NCT02566759|21392496|P2|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8665073|NCT02566759|21392497|P1|STARTED|Crossover Treatment (Part 4: 1 Day)||0
8665074|NCT02566759|21392481|P17|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665075|NCT02566759|21392482|P16|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665076|NCT02566759|21392483|P15|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665077|NCT02566759|21392484|P14|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665078|NCT02566759|21392485|P13|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665079|NCT02566759|21392486|P12|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665080|NCT02566759|21392487|P11|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665081|NCT02566759|21392488|P10|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665082|NCT02566759|21392489|P9|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665083|NCT02566759|21392490|P8|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665084|NCT02566759|21392491|P7|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665085|NCT02566759|21392492|P6|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665086|NCT02566759|21392493|P5|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665087|NCT02566759|21392494|P4|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665088|NCT02566759|21392495|P3|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665089|NCT02566759|21392496|P2|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665090|NCT02566759|21392497|P1|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665091|NCT02566759|21392481|P17|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8665092|NCT02566759|21392482|P16|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8665093|NCT02566759|21392483|P15|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
8665094|NCT02566759|21392484|P14|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665095|NCT02566759|21392485|P13|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665096|NCT02566759|21392486|P12|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665097|NCT02566759|21392487|P11|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665098|NCT02566759|21392488|P10|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665099|NCT02566759|21392489|P9|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665100|NCT02566759|21392490|P8|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665101|NCT02566759|21392491|P7|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665102|NCT02566759|21392492|P6|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665103|NCT02566759|21392493|P5|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665104|NCT02566759|21392494|P4|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665105|NCT02566759|21392495|P3|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665106|NCT02566759|21392496|P2|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665107|NCT02566759|21392497|P1|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
8665108|NCT02566759|21392481|P17|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8665109|NCT02566759|21392482|P16|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8665110|NCT02566759|21392483|P15|STARTED|Washout Crossover Period (Part 4:5 Days)||8
8665111|NCT02566759|21392484|P14|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665112|NCT02566759|21392485|P13|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665113|NCT02566759|21392486|P12|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665114|NCT02566759|21392487|P11|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665115|NCT02566759|21392488|P10|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665116|NCT02566759|21392489|P9|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665117|NCT02566759|21392490|P8|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665118|NCT02566759|21392491|P7|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665119|NCT02566759|21392492|P6|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665120|NCT02566759|21392493|P5|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665121|NCT02566759|21392494|P4|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665122|NCT02566759|21392495|P3|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665123|NCT02566759|21392496|P2|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665124|NCT02566759|21392497|P1|STARTED|Washout Crossover Period (Part 4:5 Days)||0
8665125|NCT02566759|21392481|P17|NOT COMPLETED|All Parts||0
8665126|NCT02566759|21392482|P16|NOT COMPLETED|All Parts||0
8665127|NCT02566759|21392483|P15|NOT COMPLETED|All Parts||0
8665128|NCT02566759|21392484|P14|NOT COMPLETED|All Parts||5
8665129|NCT02566759|21392485|P13|NOT COMPLETED|All Parts||1
8665130|NCT02566759|21392486|P12|NOT COMPLETED|All Parts||0
8665131|NCT02566759|21392487|P11|NOT COMPLETED|All Parts||0
8665132|NCT02566759|21392488|P10|NOT COMPLETED|All Parts||0
8665133|NCT02566759|21392489|P9|NOT COMPLETED|All Parts||0
8665134|NCT02566759|21392490|P8|NOT COMPLETED|All Parts||0
8665135|NCT02566759|21392491|P7|NOT COMPLETED|All Parts||0
8665136|NCT02566759|21392492|P6|NOT COMPLETED|All Parts||0
8665137|NCT02566759|21392493|P5|NOT COMPLETED|All Parts||0
8665138|NCT02566759|21392494|P4|NOT COMPLETED|All Parts||0
8665139|NCT02566759|21392495|P3|NOT COMPLETED|All Parts||0
8665140|NCT02566759|21392496|P2|NOT COMPLETED|All Parts||1
8665141|NCT02566759|21392497|P1|NOT COMPLETED|All Parts||0
8665142|NCT02566759|21392481|P17|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
8665143|NCT02566759|21392482|P16|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
8665144|NCT02566759|21392483|P15|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
8665145|NCT02566759|21392484|P14|COMPLETED|All Parts||0
8665146|NCT02566759|21392485|P13|COMPLETED|All Parts||0
8665147|NCT02566759|21392486|P12|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8665148|NCT02566759|21392487|P11|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8665149|NCT02566759|21392488|P10|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8665150|NCT02566759|21392489|P9|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8665151|NCT02566759|21392490|P8|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
8665152|NCT02566759|21392491|P7|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8665153|NCT02566759|21392492|P6|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8665154|NCT02566759|21392493|P5|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8665155|NCT02566759|21392494|P4|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8665156|NCT02566759|21392495|P3|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
8665157|NCT02566759|21392496|P2|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
8665158|NCT02566759|21392497|P1|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
8665159|NCT02566759|21392481|P17|STARTED|All Parts||8
8665160|NCT02566759|21392482|P16|STARTED|All Parts||8
8665161|NCT02566759|21392483|P15|STARTED|All Parts||8
8665162|NCT02566759|21392484|P14|STARTED|All Parts||5
8665163|NCT02566759|21392485|P13|STARTED|All Parts||1
8665164|NCT02566759|21392486|P12|STARTED|All Parts||6
8665165|NCT02566759|21392487|P11|STARTED|All Parts||6
8665166|NCT02566759|21392488|P10|STARTED|All Parts||6
8665167|NCT02566759|21392489|P9|STARTED|All Parts||6
8665168|NCT02566759|21392490|P8|STARTED|All Parts||8
8665169|NCT02566759|21392491|P7|STARTED|All Parts||6
8665170|NCT02566759|21392492|P6|STARTED|All Parts||6
8665171|NCT02566759|21392493|P5|STARTED|All Parts||6
8665172|NCT02566759|21392494|P4|STARTED|All Parts||6
8665173|NCT02566759|21392495|P3|STARTED|All Parts||6
8665174|NCT02566759|21392496|P2|STARTED|All Parts||6
8665175|NCT02566759|21392497|P1|STARTED|All Parts||12
8665176|NCT02546986|21392650|P2|NOT COMPLETED|Survival Follow-Up Phase||35
8665177|NCT02546986|21392651|P1|NOT COMPLETED|Survival Follow-Up Phase||36
8665178|NCT02546986|21392650|P2|COMPLETED|Survival Follow-Up Phase||0
8665179|NCT02546986|21392651|P1|COMPLETED|Survival Follow-Up Phase||0
8665180|NCT02546986|21392650|P2|STARTED|Survival Follow-Up Phase||35
8665181|NCT02546986|21392651|P1|STARTED|Survival Follow-Up Phase||36
8665182|NCT02546986|21392650|P2|NOT COMPLETED|Treatment Period||49
8665183|NCT02546986|21392651|P1|NOT COMPLETED|Treatment Period||51
8665184|NCT02546986|21392650|P2|COMPLETED|Treatment Period||0
8665185|NCT02546986|21392651|P1|COMPLETED|Treatment Period||0
8665186|NCT02546986|21392650|P2|STARTED|Treatment Period||49
8665187|NCT02546986|21392651|P1|STARTED|Treatment Period||51
8665188|NCT02524730|21392674|P1|NOT COMPLETED|Overall Study||46
8665189|NCT02524730|21392674|P1|COMPLETED|Overall Study||159
8665190|NCT02524730|21392674|P1|STARTED|Overall Study||205
8665191|NCT02467270|21392686|P3|NOT COMPLETED|Overall Study||94
8665192|NCT02467270|21392687|P2|NOT COMPLETED|Overall Study||95
8665193|NCT02467270|21392688|P1|NOT COMPLETED|Overall Study||94
8665194|NCT02467270|21392686|P3|COMPLETED|Overall Study||0
8665195|NCT02467270|21392687|P2|COMPLETED|Overall Study||0
8665196|NCT02467270|21392688|P1|COMPLETED|Overall Study||0
8665197|NCT02467270|21392686|P3|Treated (Safety Population)|Overall Study||94
8665198|NCT02467270|21392687|P2|Treated (Safety Population)|Overall Study||94
8665199|NCT02467270|21392688|P1|Treated (Safety Population)|Overall Study||94
8665200|NCT02467270|21392686|P3|STARTED|Overall Study||94
8665201|NCT02467270|21392687|P2|STARTED|Overall Study||95
8665202|NCT02467270|21392688|P1|STARTED|Overall Study||94
8665203|NCT02458469|21392738|P6|NOT COMPLETED|Third Intervention (2 Weeks)||0
8665204|NCT02458469|21392739|P5|NOT COMPLETED|Third Intervention (2 Weeks)||0
8665205|NCT02458469|21392740|P4|NOT COMPLETED|Third Intervention (2 Weeks)||0
8665206|NCT02458469|21392741|P3|NOT COMPLETED|Third Intervention (2 Weeks)||0
8665207|NCT02458469|21392742|P2|NOT COMPLETED|Third Intervention (2 Weeks)||0
8665208|NCT02458469|21392743|P1|NOT COMPLETED|Third Intervention (2 Weeks)||0
8665209|NCT02458469|21392738|P6|COMPLETED|Third Intervention (2 Weeks)||1
8665210|NCT02458469|21392739|P5|COMPLETED|Third Intervention (2 Weeks)||1
8665211|NCT02458469|21392740|P4|COMPLETED|Third Intervention (2 Weeks)||0
8665212|NCT02458469|21392741|P3|COMPLETED|Third Intervention (2 Weeks)||2
8665213|NCT02458469|21392742|P2|COMPLETED|Third Intervention (2 Weeks)||2
8665214|NCT02458469|21392743|P1|COMPLETED|Third Intervention (2 Weeks)||2
8665215|NCT02458469|21392738|P6|STARTED|Third Intervention (2 Weeks)||1
8665216|NCT02458469|21392739|P5|STARTED|Third Intervention (2 Weeks)||1
8665217|NCT02458469|21392740|P4|STARTED|Third Intervention (2 Weeks)||0
8665218|NCT02458469|21392741|P3|STARTED|Third Intervention (2 Weeks)||2
8665219|NCT02458469|21392742|P2|STARTED|Third Intervention (2 Weeks)||2
8665220|NCT02458469|21392743|P1|STARTED|Third Intervention (2 Weeks)||2
8665221|NCT02458469|21392738|P6|NOT COMPLETED|Second Washout (2 Weeks)||0
8665222|NCT02458469|21392739|P5|NOT COMPLETED|Second Washout (2 Weeks)||0
8665223|NCT02458469|21392740|P4|NOT COMPLETED|Second Washout (2 Weeks)||0
8665224|NCT02458469|21392741|P3|NOT COMPLETED|Second Washout (2 Weeks)||0
8665225|NCT02458469|21392742|P2|NOT COMPLETED|Second Washout (2 Weeks)||0
8665226|NCT02458469|21392743|P1|NOT COMPLETED|Second Washout (2 Weeks)||0
8665227|NCT02458469|21392738|P6|COMPLETED|Second Washout (2 Weeks)||1
8665228|NCT02458469|21392739|P5|COMPLETED|Second Washout (2 Weeks)||1
8665229|NCT02458469|21392740|P4|COMPLETED|Second Washout (2 Weeks)||0
8665230|NCT02458469|21392741|P3|COMPLETED|Second Washout (2 Weeks)||2
8665231|NCT02458469|21392742|P2|COMPLETED|Second Washout (2 Weeks)||2
8665232|NCT02458469|21392743|P1|COMPLETED|Second Washout (2 Weeks)||2
8665233|NCT02458469|21392738|P6|STARTED|Second Washout (2 Weeks)||1
8665234|NCT02458469|21392739|P5|STARTED|Second Washout (2 Weeks)||1
8665235|NCT02458469|21392740|P4|STARTED|Second Washout (2 Weeks)||0
8665236|NCT02458469|21392741|P3|STARTED|Second Washout (2 Weeks)||2
8665237|NCT02458469|21392742|P2|STARTED|Second Washout (2 Weeks)||2
8665238|NCT02458469|21392743|P1|STARTED|Second Washout (2 Weeks)||2
8665239|NCT02458469|21392738|P6|NOT COMPLETED|Second Intervention (2 Weeks)||1
8665240|NCT02458469|21392739|P5|NOT COMPLETED|Second Intervention (2 Weeks)||0
8665241|NCT02458469|21392740|P4|NOT COMPLETED|Second Intervention (2 Weeks)||0
8665242|NCT02458469|21392741|P3|NOT COMPLETED|Second Intervention (2 Weeks)||0
8665243|NCT02458469|21392742|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8665244|NCT02458469|21392743|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8665245|NCT02458469|21392738|P6|COMPLETED|Second Intervention (2 Weeks)||1
8665246|NCT02458469|21392739|P5|COMPLETED|Second Intervention (2 Weeks)||1
8665247|NCT02458469|21392740|P4|COMPLETED|Second Intervention (2 Weeks)||0
8665248|NCT02458469|21392741|P3|COMPLETED|Second Intervention (2 Weeks)||2
8665249|NCT02458469|21392742|P2|COMPLETED|Second Intervention (2 Weeks)||2
8665250|NCT02458469|21392743|P1|COMPLETED|Second Intervention (2 Weeks)||2
8665251|NCT02458469|21392738|P6|STARTED|Second Intervention (2 Weeks)||2
8665252|NCT02458469|21392739|P5|STARTED|Second Intervention (2 Weeks)||1
8665253|NCT02458469|21392740|P4|STARTED|Second Intervention (2 Weeks)||0
8665254|NCT02458469|21392741|P3|STARTED|Second Intervention (2 Weeks)||2
8665255|NCT02458469|21392742|P2|STARTED|Second Intervention (2 Weeks)||2
8665256|NCT02458469|21392743|P1|STARTED|Second Intervention (2 Weeks)||2
8665257|NCT02458469|21392738|P6|NOT COMPLETED|First Washout (2 Weeks)||0
8665258|NCT02458469|21392739|P5|NOT COMPLETED|First Washout (2 Weeks)||0
8665259|NCT02458469|21392740|P4|NOT COMPLETED|First Washout (2 Weeks)||0
8665260|NCT02458469|21392741|P3|NOT COMPLETED|First Washout (2 Weeks)||0
8665261|NCT02458469|21392742|P2|NOT COMPLETED|First Washout (2 Weeks)||0
8665262|NCT02458469|21392743|P1|NOT COMPLETED|First Washout (2 Weeks)||0
8665263|NCT02458469|21392738|P6|COMPLETED|First Washout (2 Weeks)||2
8665264|NCT02458469|21392739|P5|COMPLETED|First Washout (2 Weeks)||1
8665265|NCT02458469|21392740|P4|COMPLETED|First Washout (2 Weeks)||0
8665266|NCT02458469|21392741|P3|COMPLETED|First Washout (2 Weeks)||2
8665267|NCT02458469|21392742|P2|COMPLETED|First Washout (2 Weeks)||2
8665268|NCT02458469|21392743|P1|COMPLETED|First Washout (2 Weeks)||2
8665269|NCT02458469|21392738|P6|STARTED|First Washout (2 Weeks)||2
8665270|NCT02458469|21392739|P5|STARTED|First Washout (2 Weeks)||1
8665271|NCT02458469|21392740|P4|STARTED|First Washout (2 Weeks)||0
8665272|NCT02458469|21392741|P3|STARTED|First Washout (2 Weeks)||2
8665273|NCT02458469|21392742|P2|STARTED|First Washout (2 Weeks)||2
8665274|NCT02458469|21392743|P1|STARTED|First Washout (2 Weeks)||2
8665275|NCT02458469|21392738|P6|NOT COMPLETED|First Intervention (2 Weeks)||0
8665276|NCT02458469|21392739|P5|NOT COMPLETED|First Intervention (2 Weeks)||0
8665277|NCT02458469|21392740|P4|NOT COMPLETED|First Intervention (2 Weeks)||0
8665278|NCT02458469|21392741|P3|NOT COMPLETED|First Intervention (2 Weeks)||1
8665279|NCT02458469|21392742|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
8665280|NCT02458469|21392743|P1|NOT COMPLETED|First Intervention (2 Weeks)||1
8665281|NCT02458469|21392738|P6|COMPLETED|First Intervention (2 Weeks)||2
8665282|NCT02458469|21392739|P5|COMPLETED|First Intervention (2 Weeks)||1
8665283|NCT02458469|21392740|P4|COMPLETED|First Intervention (2 Weeks)||0
8665284|NCT02458469|21392741|P3|COMPLETED|First Intervention (2 Weeks)||2
8665285|NCT02458469|21392742|P2|COMPLETED|First Intervention (2 Weeks)||2
8665286|NCT02458469|21392743|P1|COMPLETED|First Intervention (2 Weeks)||2
8665287|NCT02458469|21392738|P6|STARTED|First Intervention (2 Weeks)||2
8665288|NCT02458469|21392739|P5|STARTED|First Intervention (2 Weeks)||1
8665289|NCT02458469|21392740|P4|STARTED|First Intervention (2 Weeks)||0
8665290|NCT02458469|21392741|P3|STARTED|First Intervention (2 Weeks)||3
8665291|NCT02458469|21392742|P2|STARTED|First Intervention (2 Weeks)||2
8665292|NCT02458469|21392743|P1|STARTED|First Intervention (2 Weeks)||3
8665301|NCT02407457|21392765|P2|NOT COMPLETED|5-year||63
8665302|NCT02407457|21392766|P1|NOT COMPLETED|5-year||71
8665303|NCT02407457|21392765|P2|COMPLETED|5-year||0
8665304|NCT02407457|21392766|P1|COMPLETED|5-year|Due to the time frame of the study - subjects have not passed 5-year.|0
8665305|NCT02407457|21392765|P2|STARTED|5-year||63
8665306|NCT02407457|21392766|P1|STARTED|5-year||71
8665307|NCT02407457|21392765|P2|NOT COMPLETED|4-year||77
8665308|NCT02407457|21392766|P1|NOT COMPLETED|4-year||86
8665309|NCT02407457|21392765|P2|COMPLETED|4-year||63
8665310|NCT02407457|21392766|P1|COMPLETED|4-year||71
8665311|NCT02407457|21392765|P2|STARTED|4-year||140
8665312|NCT02407457|21392766|P1|STARTED|4-year||157
8665313|NCT02407457|21392765|P2|NOT COMPLETED|3-year||42
8665314|NCT02407457|21392766|P1|NOT COMPLETED|3-year||48
8665315|NCT02407457|21392765|P2|COMPLETED|3-year||140
8665316|NCT02407457|21392766|P1|COMPLETED|3-year||157
8665317|NCT02407457|21392765|P2|STARTED|3-year||182
8665318|NCT02407457|21392766|P1|STARTED|3-year||205
8665319|NCT02407457|21392765|P2|NOT COMPLETED|2-year||14
8665320|NCT02407457|21392766|P1|NOT COMPLETED|2-year||15
8665321|NCT02407457|21392765|P2|COMPLETED|2-year||182
8665322|NCT02407457|21392766|P1|COMPLETED|2-year||205
8665323|NCT02407457|21392765|P2|STARTED|2-year||196
8665324|NCT02407457|21392766|P1|STARTED|2-year||220
8665325|NCT02407457|21392765|P2|NOT COMPLETED|1 Year||24
8665326|NCT02407457|21392766|P1|NOT COMPLETED|1 Year||15
8665327|NCT02407457|21392765|P2|COMPLETED|1 Year||196
8665328|NCT02407457|21392766|P1|COMPLETED|1 Year||220
8665329|NCT02407457|21392765|P2|STARTED|1 Year||220
8665330|NCT02407457|21392766|P1|STARTED|1 Year||235
8665343|NCT02255422|21392816|P7|NOT COMPLETED|Overall Study||2
8665344|NCT02255422|21392817|P6|NOT COMPLETED|Overall Study||0
8665345|NCT02255422|21392818|P5|NOT COMPLETED|Overall Study||0
8665346|NCT02255422|21392819|P4|NOT COMPLETED|Overall Study||0
8665347|NCT02255422|21392820|P3|NOT COMPLETED|Overall Study||1
8665348|NCT02255422|21392821|P2|NOT COMPLETED|Overall Study||0
8665349|NCT02255422|21392822|P1|NOT COMPLETED|Overall Study||0
8665350|NCT02255422|21392816|P7|COMPLETED|Overall Study||8
8665351|NCT02255422|21392817|P6|COMPLETED|Overall Study||6
8665352|NCT02255422|21392818|P5|COMPLETED|Overall Study||6
8665353|NCT02255422|21392819|P4|COMPLETED|Overall Study||6
8665354|NCT02255422|21392820|P3|COMPLETED|Overall Study||5
8665355|NCT02255422|21392821|P2|COMPLETED|Overall Study||6
8665356|NCT02255422|21392822|P1|COMPLETED|Overall Study||13
8665357|NCT02255422|21392816|P7|STARTED|Overall Study||10
8665358|NCT02255422|21392817|P6|STARTED|Overall Study||6
8665359|NCT02255422|21392818|P5|STARTED|Overall Study||6
8665360|NCT02255422|21392819|P4|STARTED|Overall Study||6
8665361|NCT02255422|21392820|P3|STARTED|Overall Study||6
8665362|NCT02255422|21392821|P2|STARTED|Overall Study||6
8665363|NCT02255422|21392822|P1|STARTED|Overall Study||13
8665364|NCT02218164|21392845|P1|NOT COMPLETED|Overall Study||0
8665365|NCT02218164|21392845|P1|COMPLETED|Overall Study||8
8665366|NCT02218164|21392845|P1|STARTED|Overall Study||8
8665367|NCT02164240|21392852|P3|NOT COMPLETED|Overall Study||0
8665368|NCT02164240|21392853|P2|NOT COMPLETED|Overall Study||0
8665369|NCT02164240|21392854|P1|NOT COMPLETED|Overall Study||0
8665370|NCT02164240|21392852|P3|COMPLETED|Overall Study||4
8665371|NCT02164240|21392853|P2|COMPLETED|Overall Study||5
8665372|NCT02164240|21392854|P1|COMPLETED|Overall Study||4
8665373|NCT02164240|21392852|P3|STARTED|Overall Study||4
8665374|NCT02164240|21392853|P2|STARTED|Overall Study||5
8665375|NCT02164240|21392854|P1|STARTED|Overall Study||4
8665376|NCT02142738|21392866|P2|NOT COMPLETED|Overall Study||151
8665377|NCT02142738|21392867|P1|NOT COMPLETED|Overall Study||154
8665378|NCT02142738|21392866|P2|COMPLETED|Overall Study||0
8665379|NCT02142738|21392867|P1|COMPLETED|Overall Study||0
8665380|NCT02142738|21392866|P2|Treated|Overall Study||150
8665381|NCT02142738|21392867|P1|Treated|Overall Study||154
8665382|NCT02142738|21392866|P2|STARTED|Overall Study||151
8665383|NCT02142738|21392867|P1|STARTED|Overall Study||154
8665384|NCT02122952|21392879|P2|NOT COMPLETED|Overall Study||0
8665385|NCT02122952|21392880|P1|NOT COMPLETED|Overall Study||0
8665386|NCT02122952|21392879|P2|COMPLETED|Overall Study||12
8665387|NCT02122952|21392880|P1|COMPLETED|Overall Study||3
8665388|NCT02122952|21392879|P2|STARTED|Overall Study||12
8665389|NCT02122952|21392880|P1|STARTED|Overall Study||3
8665404|NCT02050919|21392901|P1|NOT COMPLETED|Overall Study||0
8665405|NCT02050919|21392901|P1|COMPLETED|Overall Study||20
8665406|NCT02050919|21392901|P1|STARTED|Overall Study||20
8665415|NCT02041533|21392942|P2|NOT COMPLETED|Overall Study||258
8665416|NCT02041533|21392943|P1|NOT COMPLETED|Overall Study||228
8665417|NCT02041533|21392942|P2|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
8665418|NCT02041533|21392943|P1|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
8665419|NCT02041533|21392942|P2|Began Treatment|Overall Study||263
8665420|NCT02041533|21392943|P1|Began Treatment|Overall Study||267
8665421|NCT02041533|21392942|P2|STARTED|Overall Study||270
8665422|NCT02041533|21392943|P1|STARTED|Overall Study||271
8665423|NCT02009163|21392963|P3|NOT COMPLETED|Randomized-withdrawal Period||35
8665424|NCT02009163|21392964|P2|NOT COMPLETED|Randomized-withdrawal Period||88
8665425|NCT02009163|21392965|P1|NOT COMPLETED|Randomized-withdrawal Period||0
8665426|NCT02009163|21392963|P3|COMPLETED|Randomized-withdrawal Period||102
8665427|NCT02009163|21392964|P2|COMPLETED|Randomized-withdrawal Period||50
8665428|NCT02009163|21392965|P1|COMPLETED|Randomized-withdrawal Period||0
8665429|NCT02009163|21392963|P3|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
8665430|NCT02009163|21392964|P2|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
8665431|NCT02009163|21392965|P1|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
8665432|NCT02009163|21392963|P3|NOT COMPLETED|Open-label Period (Non-randomized)||0
8665433|NCT02009163|21392964|P2|NOT COMPLETED|Open-label Period (Non-randomized)||0
8665434|NCT02009163|21392965|P1|NOT COMPLETED|Open-label Period (Non-randomized)||143
8665435|NCT02009163|21392963|P3|COMPLETED|Open-label Period (Non-randomized)||0
8665436|NCT02009163|21392964|P2|COMPLETED|Open-label Period (Non-randomized)||0
8665437|NCT02009163|21392965|P1|COMPLETED|Open-label Period (Non-randomized)||275
8665438|NCT02009163|21392963|P3|STARTED|Open-label Period (Non-randomized)||0
8665439|NCT02009163|21392964|P2|STARTED|Open-label Period (Non-randomized)||0
8665440|NCT02009163|21392965|P1|STARTED|Open-label Period (Non-randomized)||418
8665441|NCT01960075|21393001|P3|NOT COMPLETED|Overall Study||7
8665442|NCT01960075|21393002|P2|NOT COMPLETED|Overall Study||3
8665443|NCT01960075|21393003|P1|NOT COMPLETED|Overall Study||8
8665444|NCT01960075|21393001|P3|COMPLETED|Overall Study||173
8665445|NCT01960075|21393002|P2|COMPLETED|Overall Study||146
8665446|NCT01960075|21393003|P1|COMPLETED|Overall Study||141
8665447|NCT01960075|21393001|P3|STARTED|Overall Study||180
8665448|NCT01960075|21393002|P2|STARTED|Overall Study||149
8665449|NCT01960075|21393003|P1|STARTED|Overall Study||149
8665450|NCT01933932|21393061|P2|NOT COMPLETED|Overall Study||178
8665451|NCT01933932|21393062|P1|NOT COMPLETED|Overall Study||184
8665452|NCT01933932|21393061|P2|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
8665453|NCT01933932|21393062|P1|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
8665454|NCT01933932|21393061|P2|STARTED|Overall Study||256
8665455|NCT01933932|21393062|P1|STARTED|Overall Study||254
8665456|NCT01894672|21393078|P1|NOT COMPLETED|Overall Study||0
8665457|NCT01894672|21393078|P1|COMPLETED|Overall Study||7
8665458|NCT01894672|21393078|P1|STARTED|Overall Study||7
8665491|NCT01842841|21393149|P1|NOT COMPLETED|Overall Study||0
8665492|NCT01842841|21393149|P1|COMPLETED|Overall Study||5
8665493|NCT01842841|21393149|P1|STARTED|Overall Study||5
8665494|NCT01842646|21393168|P1|NOT COMPLETED|Overall Study||0
8665495|NCT01842646|21393168|P1|COMPLETED|Overall Study||35
8665496|NCT01842646|21393168|P1|STARTED|Overall Study||35
8665497|NCT01768845|21393176|P1|NOT COMPLETED|Overall Study||23
8665498|NCT01768845|21393176|P1|COMPLETED|Overall Study||11
8665499|NCT01768845|21393176|P1|STARTED|Overall Study||34
8665500|NCT01750281|21393184|P3|NOT COMPLETED|Overall Study||84
8665501|NCT01750281|21393185|P2|NOT COMPLETED|Overall Study||85
8665502|NCT01750281|21393186|P1|NOT COMPLETED|Overall Study||43
8665503|NCT01750281|21393184|P3|COMPLETED|Overall Study||0
8665504|NCT01750281|21393185|P2|COMPLETED|Overall Study||0
8665505|NCT01750281|21393186|P1|COMPLETED|Overall Study||0
8665506|NCT01750281|21393184|P3|Did Not Receive Treatment|Overall Study||0
8665507|NCT01750281|21393185|P2|Did Not Receive Treatment|Overall Study||1
8665508|NCT01750281|21393186|P1|Did Not Receive Treatment|Overall Study||0
8665509|NCT01750281|21393184|P3|Received Treatment|Overall Study||84
8665510|NCT01750281|21393185|P2|Received Treatment|Overall Study||84
8665511|NCT01750281|21393186|P1|Received Treatment|Overall Study||43
8665512|NCT01750281|21393184|P3|STARTED|Overall Study||84
8665513|NCT01750281|21393185|P2|STARTED|Overall Study||85
8665514|NCT01750281|21393186|P1|STARTED|Overall Study||43
8665515|NCT01661881|21393197|P1|NOT COMPLETED|Overall Study||1
8665516|NCT01661881|21393197|P1|COMPLETED|Overall Study||22
8665517|NCT01661881|21393197|P1|STARTED|Overall Study||23
8665518|NCT01651195|21393207|P4|NOT COMPLETED|Overall Study||108
8665519|NCT01651195|21393208|P3|NOT COMPLETED|Overall Study||83
8665520|NCT01651195|21393209|P2|NOT COMPLETED|Overall Study||211
8665521|NCT01651195|21393210|P1|NOT COMPLETED|Overall Study||221
8665522|NCT01651195|21393207|P4|COMPLETED|Overall Study||103
8665523|NCT01651195|21393208|P3|COMPLETED|Overall Study||121
8665524|NCT01651195|21393209|P2|COMPLETED|Overall Study||73
8665525|NCT01651195|21393210|P1|COMPLETED|Overall Study||63
8665526|NCT01651195|21393207|P4|STARTED|Overall Study||211
8665527|NCT01651195|21393208|P3|STARTED|Overall Study||204
8665528|NCT01651195|21393209|P2|STARTED|Overall Study||284
8665529|NCT01651195|21393210|P1|STARTED|Overall Study||284
8665530|NCT01650558|21393235|P3|NOT COMPLETED|Overall Study||75
8665531|NCT01650558|21393236|P2|NOT COMPLETED|Overall Study||92
8665532|NCT01650558|21393237|P1|NOT COMPLETED|Overall Study||83
8665533|NCT01650558|21393235|P3|COMPLETED|Overall Study||424
8665534|NCT01650558|21393236|P2|COMPLETED|Overall Study||408
8665535|NCT01650558|21393237|P1|COMPLETED|Overall Study||417
8665536|NCT01650558|21393235|P3|STARTED|Overall Study||499
8665537|NCT01650558|21393236|P2|STARTED|Overall Study||500
8665538|NCT01650558|21393237|P1|STARTED|Overall Study||500
8665542|NCT01582477|21393276|P2|NOT COMPLETED|Overall Study||0
8665543|NCT01582477|21393277|P1|NOT COMPLETED|Overall Study||0
8665544|NCT01582477|21393276|P2|COMPLETED|Overall Study||12
8665545|NCT01582477|21393277|P1|COMPLETED|Overall Study||12
8665546|NCT01582477|21393276|P2|STARTED|Overall Study||12
8665547|NCT01582477|21393277|P1|STARTED|Overall Study||12
8665548|NCT01510028|21393297|P4|NOT COMPLETED|Overall Study||0
8665549|NCT01510028|21393298|P3|NOT COMPLETED|Overall Study||0
8665550|NCT01510028|21393299|P2|NOT COMPLETED|Overall Study||0
8665551|NCT01510028|21393300|P1|NOT COMPLETED|Overall Study||1
8665552|NCT01510028|21393297|P4|COMPLETED|Overall Study||6
8665553|NCT01510028|21393298|P3|COMPLETED|Overall Study||6
8665554|NCT01510028|21393299|P2|COMPLETED|Overall Study||6
8665555|NCT01510028|21393300|P1|COMPLETED|Overall Study||5
8665556|NCT01510028|21393297|P4|STARTED|Overall Study||6
8665557|NCT01510028|21393298|P3|STARTED|Overall Study||6
8665558|NCT01510028|21393299|P2|STARTED|Overall Study||6
8665559|NCT01510028|21393300|P1|STARTED|Overall Study||6
8665560|NCT01468311|21393414|P1|NOT COMPLETED|Overall Study||2
8665561|NCT01468311|21393414|P1|COMPLETED|Overall Study||4
8665562|NCT01468311|21393414|P1|STARTED|Overall Study||6
8665563|NCT01436175|21393424|P1|NOT COMPLETED|Overall Study||1270
8665564|NCT01436175|21393424|P1|COMPLETED|Overall Study||300
8665565|NCT01436175|21393424|P1|STARTED|Overall Study||1570
8665566|NCT01363908|21393451|P2|NOT COMPLETED|Chronic Dosing (CD) Phase||6
8665567|NCT01363908|21393452|P1|NOT COMPLETED|Chronic Dosing (CD) Phase||10
8665568|NCT01363908|21393451|P2|COMPLETED|Chronic Dosing (CD) Phase||10
8665569|NCT01363908|21393452|P1|COMPLETED|Chronic Dosing (CD) Phase||3
8665570|NCT01363908|21393451|P2|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
8665571|NCT01363908|21393452|P1|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
8665572|NCT01363908|21393451|P2|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
8665573|NCT01363908|21393452|P1|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
8665574|NCT01363908|21393451|P2|COMPLETED|Pharmacokinetic (PK) Phase||8
8665575|NCT01363908|21393452|P1|COMPLETED|Pharmacokinetic (PK) Phase||8
8665576|NCT01363908|21393451|P2|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
8665577|NCT01363908|21393452|P1|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
8665578|NCT01363908|21393451|P2|NOT COMPLETED|Screening/Enrollment||0
8665579|NCT01363908|21393452|P1|NOT COMPLETED|Screening/Enrollment||1
8665580|NCT01363908|21393451|P2|COMPLETED|Screening/Enrollment||16
8665581|NCT01363908|21393452|P1|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
8665582|NCT01363908|21393451|P2|STARTED|Screening/Enrollment||16
8665583|NCT01363908|21393452|P1|STARTED|Screening/Enrollment||14
8665584|NCT01353495|21393484|P2|NOT COMPLETED|Overall Study||0
8665585|NCT01353495|21393485|P1|NOT COMPLETED|Overall Study||0
8665586|NCT01353495|21393484|P2|COMPLETED|Overall Study||20
8665587|NCT01353495|21393485|P1|COMPLETED|Overall Study||19
8665588|NCT01353495|21393484|P2|STARTED|Overall Study||20
8665589|NCT01353495|21393485|P1|STARTED|Overall Study||19
8665590|NCT01299727|21393494|P3|NOT COMPLETED|Overall Study||4
8665591|NCT01299727|21393495|P2|NOT COMPLETED|Overall Study||4
8665592|NCT01299727|21393496|P1|NOT COMPLETED|Overall Study||4
8665593|NCT01299727|21393494|P3|COMPLETED|Overall Study||0
8665594|NCT01299727|21393495|P2|COMPLETED|Overall Study||0
8665595|NCT01299727|21393496|P1|COMPLETED|Overall Study||0
8665596|NCT01299727|21393494|P3|STARTED|Overall Study||4
8665597|NCT01299727|21393495|P2|STARTED|Overall Study||4
8665598|NCT01299727|21393496|P1|STARTED|Overall Study||4
8665605|NCT01235338|21393563|P2|NOT COMPLETED|Overall Study||5
8665606|NCT01235338|21393564|P1|NOT COMPLETED|Overall Study||11
8665607|NCT01235338|21393563|P2|COMPLETED|Overall Study||33
8665608|NCT01235338|21393564|P1|COMPLETED|Overall Study||31
8665609|NCT01235338|21393563|P2|STARTED|Overall Study||38
8665610|NCT01235338|21393564|P1|STARTED|Overall Study||42
8665686|NCT01192347|21393648|P1|NOT COMPLETED|Overall Study||12
8665687|NCT01192347|21393648|P1|COMPLETED|Overall Study||163
8665688|NCT01192347|21393648|P1|STARTED|Overall Study||175
8665689|NCT01168219|21393669|P1|NOT COMPLETED|Overall Study||5
8665690|NCT01168219|21393669|P1|COMPLETED|Overall Study||63
8665691|NCT01168219|21393669|P1|STARTED|Overall Study||68
8665692|NCT01155778|21393678|P3|NOT COMPLETED|Overall Study||0
8665693|NCT01155778|21393679|P2|NOT COMPLETED|Overall Study||0
8665694|NCT01155778|21393680|P1|NOT COMPLETED|Overall Study||0
8665695|NCT01155778|21393678|P3|COMPLETED|Overall Study||4
8665696|NCT01155778|21393679|P2|COMPLETED|Overall Study||4
8665697|NCT01155778|21393680|P1|COMPLETED|Overall Study||4
8665698|NCT01155778|21393678|P3|STARTED|Overall Study||4
8665699|NCT01155778|21393679|P2|STARTED|Overall Study||4
8665700|NCT01155778|21393680|P1|STARTED|Overall Study||4
8665701|NCT01147822|21393762|P2|NOT COMPLETED|Overall Study||179
8665702|NCT01147822|21393763|P1|NOT COMPLETED|Overall Study||188
8665703|NCT01147822|21393762|P2|COMPLETED|Overall Study||0
8665704|NCT01147822|21393763|P1|COMPLETED|Overall Study||0
8665705|NCT01147822|21393762|P2|Not Completed/Ongoing|Overall Study||102
8665706|NCT01147822|21393763|P1|Not Completed/Ongoing|Overall Study||111
8665707|NCT01147822|21393762|P2|STARTED|Overall Study||179
8665708|NCT01147822|21393763|P1|STARTED|Overall Study||188
8665709|NCT01132807|21393777|P3|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
8665710|NCT01132807|21393778|P2|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
8665711|NCT01132807|21393779|P1|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
8665712|NCT01132807|21393777|P3|COMPLETED|Post-Cycle 2 PET Assessment||14
8665713|NCT01132807|21393778|P2|COMPLETED|Post-Cycle 2 PET Assessment||135
8665714|NCT01132807|21393779|P1|COMPLETED|Post-Cycle 2 PET Assessment||0
8665715|NCT01132807|21393777|P3|STARTED|Post-Cycle 2 PET Assessment||14
8665716|NCT01132807|21393778|P2|STARTED|Post-Cycle 2 PET Assessment||135
8665717|NCT01132807|21393779|P1|STARTED|Post-Cycle 2 PET Assessment||0
8665718|NCT01132807|21393777|P3|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
8665719|NCT01132807|21393778|P2|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
8665720|NCT01132807|21393779|P1|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||15
8665721|NCT01132807|21393777|P3|COMPLETED|Initial ABVD Treatment (2 Cycles)||14
8665722|NCT01132807|21393778|P2|COMPLETED|Initial ABVD Treatment (2 Cycles)||135
8665723|NCT01132807|21393779|P1|COMPLETED|Initial ABVD Treatment (2 Cycles)||0
8665724|NCT01132807|21393777|P3|STARTED|Initial ABVD Treatment (2 Cycles)||14
8665725|NCT01132807|21393778|P2|STARTED|Initial ABVD Treatment (2 Cycles)||135
8665726|NCT01132807|21393779|P1|STARTED|Initial ABVD Treatment (2 Cycles)||15
8665727|NCT01130844|21393792|P3|NOT COMPLETED|Overall Study||0
8665728|NCT01130844|21393793|P2|NOT COMPLETED|Overall Study||0
8665729|NCT01130844|21393794|P1|NOT COMPLETED|Overall Study||0
8665730|NCT01130844|21393792|P3|COMPLETED|Overall Study||9
8665731|NCT01130844|21393793|P2|COMPLETED|Overall Study||22
8665732|NCT01130844|21393794|P1|COMPLETED|Overall Study||21
8665733|NCT01130844|21393792|P3|STARTED|Overall Study||9
8665734|NCT01130844|21393793|P2|STARTED|Overall Study||22
8665735|NCT01130844|21393794|P1|STARTED|Overall Study||21
8665736|NCT01096784|21393834|P2|NOT COMPLETED|Overall Study||14
8665737|NCT01096784|21393835|P1|NOT COMPLETED|Overall Study||15
8665738|NCT01096784|21393834|P2|COMPLETED|Overall Study||46
8665739|NCT01096784|21393835|P1|COMPLETED|Overall Study||46
8665740|NCT01096784|21393834|P2|STARTED|Overall Study||60
8665741|NCT01096784|21393835|P1|STARTED|Overall Study||61
8665742|NCT01096680|21393872|P5|NOT COMPLETED|Overall Study||0
8665743|NCT01096680|21393873|P4|NOT COMPLETED|Overall Study||0
8665744|NCT01096680|21393874|P3|NOT COMPLETED|Overall Study||0
8665745|NCT01096680|21393875|P2|NOT COMPLETED|Overall Study||0
8665746|NCT01096680|21393876|P1|NOT COMPLETED|Overall Study||0
8665747|NCT01096680|21393872|P5|COMPLETED|Overall Study||27
8665748|NCT01096680|21393873|P4|COMPLETED|Overall Study||27
8665749|NCT01096680|21393874|P3|COMPLETED|Overall Study||27
8665750|NCT01096680|21393875|P2|COMPLETED|Overall Study||27
8665751|NCT01096680|21393876|P1|COMPLETED|Overall Study||27
8665752|NCT01096680|21393872|P5|STARTED|Overall Study||27
8665753|NCT01096680|21393873|P4|STARTED|Overall Study||27
8665754|NCT01096680|21393874|P3|STARTED|Overall Study||27
8665755|NCT01096680|21393875|P2|STARTED|Overall Study||27
8665756|NCT01096680|21393876|P1|STARTED|Overall Study||27
8665757|NCT01081145|21393908|P2|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
8665758|NCT01081145|21393909|P1|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
8665759|NCT01081145|21393908|P2|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
8665760|NCT01081145|21393909|P1|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
8665761|NCT01081145|21393908|P2|STARTED|Double-Blind Randomized-Withdrawal Phase||159
8665762|NCT01081145|21393909|P1|STARTED|Double-Blind Randomized-Withdrawal Phase||157
8665763|NCT01081145|21393908|P2|NOT COMPLETED|Open-Label Phase||0
8665764|NCT01081145|21393909|P1|NOT COMPLETED|Open-Label Phase||212
8665765|NCT01081145|21393908|P2|COMPLETED|Open-Label Phase||0
8665766|NCT01081145|21393909|P1|COMPLETED|Open-Label Phase||316
8665767|NCT01081145|21393908|P2|STARTED|Open-Label Phase||0
8665768|NCT01081145|21393909|P1|STARTED|Open-Label Phase||528
8665781|NCT01010750|21393973|P6|NOT COMPLETED|Third Intervention||0
8665782|NCT01010750|21393974|P5|NOT COMPLETED|Third Intervention||0
8665783|NCT01010750|21393975|P4|NOT COMPLETED|Third Intervention||0
8665784|NCT01010750|21393976|P3|NOT COMPLETED|Third Intervention||0
8665785|NCT01010750|21393977|P2|NOT COMPLETED|Third Intervention||0
8665786|NCT01010750|21393978|P1|NOT COMPLETED|Third Intervention||0
8665787|NCT01010750|21393973|P6|COMPLETED|Third Intervention||3
8665788|NCT01010750|21393974|P5|COMPLETED|Third Intervention||2
8665789|NCT01010750|21393975|P4|COMPLETED|Third Intervention||3
8665790|NCT01010750|21393976|P3|COMPLETED|Third Intervention||3
8665791|NCT01010750|21393977|P2|COMPLETED|Third Intervention||3
8665792|NCT01010750|21393978|P1|COMPLETED|Third Intervention||3
8665793|NCT01010750|21393973|P6|STARTED|Third Intervention||3
8665794|NCT01010750|21393974|P5|STARTED|Third Intervention||2
8665795|NCT01010750|21393975|P4|STARTED|Third Intervention||3
8665796|NCT01010750|21393976|P3|STARTED|Third Intervention||3
8665797|NCT01010750|21393977|P2|STARTED|Third Intervention||3
8665798|NCT01010750|21393978|P1|STARTED|Third Intervention||3
8665799|NCT01010750|21393973|P6|NOT COMPLETED|Second Intervention||0
8665800|NCT01010750|21393974|P5|NOT COMPLETED|Second Intervention||0
8665801|NCT01010750|21393975|P4|NOT COMPLETED|Second Intervention||0
8665802|NCT01010750|21393976|P3|NOT COMPLETED|Second Intervention||0
8665803|NCT01010750|21393977|P2|NOT COMPLETED|Second Intervention||1
8665804|NCT01010750|21393978|P1|NOT COMPLETED|Second Intervention||0
8665805|NCT01010750|21393973|P6|COMPLETED|Second Intervention||3
8665806|NCT01010750|21393974|P5|COMPLETED|Second Intervention||2
8665807|NCT01010750|21393975|P4|COMPLETED|Second Intervention||3
8665808|NCT01010750|21393976|P3|COMPLETED|Second Intervention||3
8665809|NCT01010750|21393977|P2|COMPLETED|Second Intervention||3
8665810|NCT01010750|21393978|P1|COMPLETED|Second Intervention||3
8665811|NCT01010750|21393973|P6|STARTED|Second Intervention||3
8665812|NCT01010750|21393974|P5|STARTED|Second Intervention||2
8665813|NCT01010750|21393975|P4|STARTED|Second Intervention||3
8665814|NCT01010750|21393976|P3|STARTED|Second Intervention||3
8665815|NCT01010750|21393977|P2|STARTED|Second Intervention||4
8665816|NCT01010750|21393978|P1|STARTED|Second Intervention||3
8665817|NCT01010750|21393973|P6|NOT COMPLETED|First Intervention||0
8665818|NCT01010750|21393974|P5|NOT COMPLETED|First Intervention||0
8665819|NCT01010750|21393975|P4|NOT COMPLETED|First Intervention||0
8665820|NCT01010750|21393976|P3|NOT COMPLETED|First Intervention||0
8665821|NCT01010750|21393977|P2|NOT COMPLETED|First Intervention||0
8665822|NCT01010750|21393978|P1|NOT COMPLETED|First Intervention||0
8665823|NCT01010750|21393973|P6|COMPLETED|First Intervention||3
8665824|NCT01010750|21393974|P5|COMPLETED|First Intervention||2
8665825|NCT01010750|21393975|P4|COMPLETED|First Intervention||3
8665826|NCT01010750|21393976|P3|COMPLETED|First Intervention||3
8665827|NCT01010750|21393977|P2|COMPLETED|First Intervention||4
8665828|NCT01010750|21393978|P1|COMPLETED|First Intervention||3
8665829|NCT01010750|21393973|P6|STARTED|First Intervention||3
8665830|NCT01010750|21393974|P5|STARTED|First Intervention||2
8665831|NCT01010750|21393975|P4|STARTED|First Intervention||3
8665832|NCT01010750|21393976|P3|STARTED|First Intervention||3
8665833|NCT01010750|21393977|P2|STARTED|First Intervention||4
8665834|NCT01010750|21393978|P1|STARTED|First Intervention||3
8665835|NCT00988013|21394005|P4|NOT COMPLETED|Overall Study||0
8665836|NCT00988013|21394006|P3|NOT COMPLETED|Overall Study||0
8665837|NCT00988013|21394007|P2|NOT COMPLETED|Overall Study||0
8665838|NCT00988013|21394008|P1|NOT COMPLETED|Overall Study||0
8665839|NCT00988013|21394005|P4|COMPLETED|Overall Study||2
8665840|NCT00988013|21394006|P3|COMPLETED|Overall Study||6
8665841|NCT00988013|21394007|P2|COMPLETED|Overall Study||3
8665842|NCT00988013|21394008|P1|COMPLETED|Overall Study||3
8665843|NCT00988013|21394005|P4|STARTED|Overall Study||2
8665844|NCT00988013|21394006|P3|STARTED|Overall Study||6
8665845|NCT00988013|21394007|P2|STARTED|Overall Study||3
8665846|NCT00988013|21394008|P1|STARTED|Overall Study||3
8665847|NCT00967343|21394026|P1|NOT COMPLETED|Overall Study||38
8665848|NCT00967343|21394026|P1|COMPLETED|Overall Study||2
8665849|NCT00967343|21394026|P1|STARTED|Overall Study||40
8665850|NCT00937794|21394036|P1|NOT COMPLETED|Overall Study||0
8665851|NCT00937794|21394036|P1|COMPLETED|Overall Study||33
8665852|NCT00937794|21394036|P1|STARTED|Overall Study||33
8665853|NCT00920816|21394045|P4|NOT COMPLETED|Overall Study||69
8665854|NCT00920816|21394046|P3|NOT COMPLETED|Overall Study||135
8665855|NCT00920816|21394047|P2|NOT COMPLETED|Overall Study||96
8665856|NCT00920816|21394048|P1|NOT COMPLETED|Overall Study||192
8665857|NCT00920816|21394045|P4|COMPLETED|Overall Study||0
8665858|NCT00920816|21394046|P3|COMPLETED|Overall Study||0
8665859|NCT00920816|21394047|P2|COMPLETED|Overall Study||0
8665860|NCT00920816|21394048|P1|COMPLETED|Overall Study||0
8665861|NCT00920816|21394045|P4|Treated|Overall Study||69
8665862|NCT00920816|21394046|P3|Treated|Overall Study||135
8665863|NCT00920816|21394047|P2|Treated|Overall Study||96
8665864|NCT00920816|21394048|P1|Treated|Overall Study||189
8665865|NCT00920816|21394045|P4|STARTED|Overall Study||69
8665866|NCT00920816|21394046|P3|STARTED|Overall Study||135
8665867|NCT00920816|21394047|P2|STARTED|Overall Study||96
8665868|NCT00920816|21394048|P1|STARTED|Overall Study||192
8665869|NCT00919867|21394092|P6|NOT COMPLETED|Third Intervention||0
8665870|NCT00919867|21394093|P5|NOT COMPLETED|Third Intervention||0
8665871|NCT00919867|21394094|P4|NOT COMPLETED|Third Intervention||0
8665872|NCT00919867|21394095|P3|NOT COMPLETED|Third Intervention||0
8665873|NCT00919867|21394096|P2|NOT COMPLETED|Third Intervention||0
8665874|NCT00919867|21394097|P1|NOT COMPLETED|Third Intervention||0
8665875|NCT00919867|21394092|P6|COMPLETED|Third Intervention||6
8665876|NCT00919867|21394093|P5|COMPLETED|Third Intervention||7
8665877|NCT00919867|21394094|P4|COMPLETED|Third Intervention||7
8665878|NCT00919867|21394095|P3|COMPLETED|Third Intervention||6
8665879|NCT00919867|21394096|P2|COMPLETED|Third Intervention||7
8665880|NCT00919867|21394097|P1|COMPLETED|Third Intervention||7
8665881|NCT00919867|21394092|P6|STARTED|Third Intervention||6
8665882|NCT00919867|21394093|P5|STARTED|Third Intervention||7
8665883|NCT00919867|21394094|P4|STARTED|Third Intervention||7
8665884|NCT00919867|21394095|P3|STARTED|Third Intervention||6
8665885|NCT00919867|21394096|P2|STARTED|Third Intervention||7
8665886|NCT00919867|21394097|P1|STARTED|Third Intervention||7
8665887|NCT00919867|21394092|P6|NOT COMPLETED|Washout||0
8665888|NCT00919867|21394093|P5|NOT COMPLETED|Washout||0
8665889|NCT00919867|21394094|P4|NOT COMPLETED|Washout||0
8665890|NCT00919867|21394095|P3|NOT COMPLETED|Washout||0
8665891|NCT00919867|21394096|P2|NOT COMPLETED|Washout||0
8665892|NCT00919867|21394097|P1|NOT COMPLETED|Washout||0
8665893|NCT00919867|21394092|P6|COMPLETED|Washout||6
8665894|NCT00919867|21394093|P5|COMPLETED|Washout||7
8665895|NCT00919867|21394094|P4|COMPLETED|Washout||7
8665896|NCT00919867|21394095|P3|COMPLETED|Washout||6
8665897|NCT00919867|21394096|P2|COMPLETED|Washout||7
8665898|NCT00919867|21394097|P1|COMPLETED|Washout||7
8665899|NCT00919867|21394092|P6|STARTED|Washout||6
8665900|NCT00919867|21394093|P5|STARTED|Washout||7
8665901|NCT00919867|21394094|P4|STARTED|Washout||7
8665902|NCT00919867|21394095|P3|STARTED|Washout||6
8665903|NCT00919867|21394096|P2|STARTED|Washout||7
8665904|NCT00919867|21394097|P1|STARTED|Washout||7
8665905|NCT00919867|21394092|P6|NOT COMPLETED|Second Intervention||0
8665906|NCT00919867|21394093|P5|NOT COMPLETED|Second Intervention||0
8665907|NCT00919867|21394094|P4|NOT COMPLETED|Second Intervention||0
8665908|NCT00919867|21394095|P3|NOT COMPLETED|Second Intervention||0
8665909|NCT00919867|21394096|P2|NOT COMPLETED|Second Intervention||0
8665910|NCT00919867|21394097|P1|NOT COMPLETED|Second Intervention||0
8665911|NCT00919867|21394092|P6|COMPLETED|Second Intervention||6
8665912|NCT00919867|21394093|P5|COMPLETED|Second Intervention||7
8665913|NCT00919867|21394094|P4|COMPLETED|Second Intervention||7
8665914|NCT00919867|21394095|P3|COMPLETED|Second Intervention||6
8665915|NCT00919867|21394096|P2|COMPLETED|Second Intervention||7
8665916|NCT00919867|21394097|P1|COMPLETED|Second Intervention||7
8665917|NCT00919867|21394092|P6|STARTED|Second Intervention||6
8665918|NCT00919867|21394093|P5|STARTED|Second Intervention||7
8665919|NCT00919867|21394094|P4|STARTED|Second Intervention||7
8665920|NCT00919867|21394095|P3|STARTED|Second Intervention||6
8665921|NCT00919867|21394096|P2|STARTED|Second Intervention||7
8665922|NCT00919867|21394097|P1|STARTED|Second Intervention||7
8665923|NCT00919867|21394092|P6|NOT COMPLETED|Washout||0
8665924|NCT00919867|21394093|P5|NOT COMPLETED|Washout||0
8665925|NCT00919867|21394094|P4|NOT COMPLETED|Washout||0
8665926|NCT00919867|21394095|P3|NOT COMPLETED|Washout||0
8665927|NCT00919867|21394096|P2|NOT COMPLETED|Washout||0
8665928|NCT00919867|21394097|P1|NOT COMPLETED|Washout||0
8665929|NCT00919867|21394092|P6|COMPLETED|Washout||6
8665930|NCT00919867|21394093|P5|COMPLETED|Washout||7
8665931|NCT00919867|21394094|P4|COMPLETED|Washout||7
8665932|NCT00919867|21394095|P3|COMPLETED|Washout||6
8665933|NCT00919867|21394096|P2|COMPLETED|Washout||7
8665934|NCT00919867|21394097|P1|COMPLETED|Washout||7
8665935|NCT00919867|21394092|P6|STARTED|Washout||6
8665936|NCT00919867|21394093|P5|STARTED|Washout||7
8665937|NCT00919867|21394094|P4|STARTED|Washout||7
8665938|NCT00919867|21394095|P3|STARTED|Washout||6
8665939|NCT00919867|21394096|P2|STARTED|Washout||7
8665940|NCT00919867|21394097|P1|STARTED|Washout||7
8665941|NCT00919867|21394092|P6|NOT COMPLETED|First Intervention||1
8665942|NCT00919867|21394093|P5|NOT COMPLETED|First Intervention||0
8665943|NCT00919867|21394094|P4|NOT COMPLETED|First Intervention||0
8665944|NCT00919867|21394095|P3|NOT COMPLETED|First Intervention||1
8665945|NCT00919867|21394096|P2|NOT COMPLETED|First Intervention||0
8665946|NCT00919867|21394097|P1|NOT COMPLETED|First Intervention||0
8665947|NCT00919867|21394092|P6|COMPLETED|First Intervention||6
8665948|NCT00919867|21394093|P5|COMPLETED|First Intervention||7
8665949|NCT00919867|21394094|P4|COMPLETED|First Intervention||7
8665950|NCT00919867|21394095|P3|COMPLETED|First Intervention||6
8665951|NCT00919867|21394096|P2|COMPLETED|First Intervention||7
8665952|NCT00919867|21394097|P1|COMPLETED|First Intervention||7
8665953|NCT00919867|21394092|P6|STARTED|First Intervention||7
8665954|NCT00919867|21394093|P5|STARTED|First Intervention||7
8665955|NCT00919867|21394094|P4|STARTED|First Intervention||7
8665956|NCT00919867|21394095|P3|STARTED|First Intervention||7
8665957|NCT00919867|21394096|P2|STARTED|First Intervention||7
8665958|NCT00919867|21394097|P1|STARTED|First Intervention||7
8665959|NCT00905424|21394120|P2|NOT COMPLETED|Overall Study||9
8665960|NCT00905424|21394121|P1|NOT COMPLETED|Overall Study||11
8665961|NCT00905424|21394120|P2|COMPLETED|Overall Study||79
8665962|NCT00905424|21394121|P1|COMPLETED|Overall Study||78
8665963|NCT00905424|21394120|P2|STARTED|Overall Study||88
8665964|NCT00905424|21394121|P1|STARTED|Overall Study||89
8665965|NCT00901576|21394167|P6|NOT COMPLETED|Third Intervention||0
8665966|NCT00901576|21394168|P5|NOT COMPLETED|Third Intervention||0
8665967|NCT00901576|21394169|P4|NOT COMPLETED|Third Intervention||0
8665968|NCT00901576|21394170|P3|NOT COMPLETED|Third Intervention||0
8665969|NCT00901576|21394171|P2|NOT COMPLETED|Third Intervention||0
8665970|NCT00901576|21394172|P1|NOT COMPLETED|Third Intervention||0
8665971|NCT00901576|21394167|P6|COMPLETED|Third Intervention||5
8665972|NCT00901576|21394168|P5|COMPLETED|Third Intervention||6
8665973|NCT00901576|21394169|P4|COMPLETED|Third Intervention||5
8665974|NCT00901576|21394170|P3|COMPLETED|Third Intervention||7
8665975|NCT00901576|21394171|P2|COMPLETED|Third Intervention||7
8665976|NCT00901576|21394172|P1|COMPLETED|Third Intervention||5
8665977|NCT00901576|21394167|P6|STARTED|Third Intervention||5
8665978|NCT00901576|21394168|P5|STARTED|Third Intervention||6
8665979|NCT00901576|21394169|P4|STARTED|Third Intervention||5
8665980|NCT00901576|21394170|P3|STARTED|Third Intervention||7
8665981|NCT00901576|21394171|P2|STARTED|Third Intervention||7
8665982|NCT00901576|21394172|P1|STARTED|Third Intervention||5
8665983|NCT00901576|21394167|P6|NOT COMPLETED|Washout||0
8665984|NCT00901576|21394168|P5|NOT COMPLETED|Washout||0
8665985|NCT00901576|21394169|P4|NOT COMPLETED|Washout||0
8665986|NCT00901576|21394170|P3|NOT COMPLETED|Washout||0
8665987|NCT00901576|21394171|P2|NOT COMPLETED|Washout||0
8665988|NCT00901576|21394172|P1|NOT COMPLETED|Washout||0
8665989|NCT00901576|21394167|P6|COMPLETED|Washout||5
8665990|NCT00901576|21394168|P5|COMPLETED|Washout||6
8665991|NCT00901576|21394169|P4|COMPLETED|Washout||5
8665992|NCT00901576|21394170|P3|COMPLETED|Washout||7
8665993|NCT00901576|21394171|P2|COMPLETED|Washout||7
8665994|NCT00901576|21394172|P1|COMPLETED|Washout||5
8665995|NCT00901576|21394167|P6|STARTED|Washout||5
8665996|NCT00901576|21394168|P5|STARTED|Washout||6
8665997|NCT00901576|21394169|P4|STARTED|Washout||5
8665998|NCT00901576|21394170|P3|STARTED|Washout||7
8665999|NCT00901576|21394171|P2|STARTED|Washout||7
8666000|NCT00901576|21394172|P1|STARTED|Washout||5
8666001|NCT00901576|21394167|P6|NOT COMPLETED|Second Intervention||1
8666002|NCT00901576|21394168|P5|NOT COMPLETED|Second Intervention||0
8666003|NCT00901576|21394169|P4|NOT COMPLETED|Second Intervention||1
8666004|NCT00901576|21394170|P3|NOT COMPLETED|Second Intervention||0
8666005|NCT00901576|21394171|P2|NOT COMPLETED|Second Intervention||0
8666006|NCT00901576|21394172|P1|NOT COMPLETED|Second Intervention||1
8666007|NCT00901576|21394167|P6|COMPLETED|Second Intervention||5
8666008|NCT00901576|21394168|P5|COMPLETED|Second Intervention||6
8666009|NCT00901576|21394169|P4|COMPLETED|Second Intervention||5
8666010|NCT00901576|21394170|P3|COMPLETED|Second Intervention||7
8666011|NCT00901576|21394171|P2|COMPLETED|Second Intervention||7
8666012|NCT00901576|21394172|P1|COMPLETED|Second Intervention||5
8666013|NCT00901576|21394167|P6|STARTED|Second Intervention||6
8666014|NCT00901576|21394168|P5|STARTED|Second Intervention||6
8666015|NCT00901576|21394169|P4|STARTED|Second Intervention||6
8666016|NCT00901576|21394170|P3|STARTED|Second Intervention||7
8666017|NCT00901576|21394171|P2|STARTED|Second Intervention||7
8666018|NCT00901576|21394172|P1|STARTED|Second Intervention||6
8666019|NCT00901576|21394167|P6|NOT COMPLETED|Washout||0
8666020|NCT00901576|21394168|P5|NOT COMPLETED|Washout||0
8666021|NCT00901576|21394169|P4|NOT COMPLETED|Washout||0
8666022|NCT00901576|21394170|P3|NOT COMPLETED|Washout||0
8666023|NCT00901576|21394171|P2|NOT COMPLETED|Washout||0
8666024|NCT00901576|21394172|P1|NOT COMPLETED|Washout||0
8666025|NCT00901576|21394167|P6|COMPLETED|Washout||6
8666026|NCT00901576|21394168|P5|COMPLETED|Washout||6
8666027|NCT00901576|21394169|P4|COMPLETED|Washout||6
8666028|NCT00901576|21394170|P3|COMPLETED|Washout||7
8666029|NCT00901576|21394171|P2|COMPLETED|Washout||7
8666030|NCT00901576|21394172|P1|COMPLETED|Washout||6
8666031|NCT00901576|21394167|P6|STARTED|Washout||6
8666032|NCT00901576|21394168|P5|STARTED|Washout||6
8666033|NCT00901576|21394169|P4|STARTED|Washout||6
8666034|NCT00901576|21394170|P3|STARTED|Washout||7
8666035|NCT00901576|21394171|P2|STARTED|Washout||7
8666036|NCT00901576|21394172|P1|STARTED|Washout||6
8666037|NCT00901576|21394167|P6|NOT COMPLETED|First Intervention||0
8666038|NCT00901576|21394168|P5|NOT COMPLETED|First Intervention||0
8666039|NCT00901576|21394169|P4|NOT COMPLETED|First Intervention||0
8666040|NCT00901576|21394170|P3|NOT COMPLETED|First Intervention||0
8666041|NCT00901576|21394171|P2|NOT COMPLETED|First Intervention||0
8666042|NCT00901576|21394172|P1|NOT COMPLETED|First Intervention||0
8666043|NCT00901576|21394167|P6|COMPLETED|First Intervention||6
8666044|NCT00901576|21394168|P5|COMPLETED|First Intervention||6
8666045|NCT00901576|21394169|P4|COMPLETED|First Intervention||6
8666046|NCT00901576|21394170|P3|COMPLETED|First Intervention||7
8666047|NCT00901576|21394171|P2|COMPLETED|First Intervention||7
8666048|NCT00901576|21394172|P1|COMPLETED|First Intervention||6
8666049|NCT00901576|21394167|P6|STARTED|First Intervention||6
8666050|NCT00901576|21394168|P5|STARTED|First Intervention||6
8666051|NCT00901576|21394169|P4|STARTED|First Intervention||6
8666052|NCT00901576|21394170|P3|STARTED|First Intervention||7
8666053|NCT00901576|21394171|P2|STARTED|First Intervention||7
8666054|NCT00901576|21394172|P1|STARTED|First Intervention||6
8666067|NCT00764868|21394296|P1|NOT COMPLETED|Overall Study||113
8666068|NCT00764868|21394296|P1|COMPLETED|Overall Study||156
8666069|NCT00764868|21394296|P1|STARTED|Overall Study||269
8666070|NCT00763971|21394305|P3|NOT COMPLETED|Overall Study||69
8666071|NCT00763971|21394306|P2|NOT COMPLETED|Overall Study||38
8666072|NCT00763971|21394307|P1|NOT COMPLETED|Overall Study||33
8666073|NCT00763971|21394305|P3|COMPLETED|Overall Study||42
8666074|NCT00763971|21394306|P2|COMPLETED|Overall Study||74
8666075|NCT00763971|21394307|P1|COMPLETED|Overall Study||80
8666076|NCT00763971|21394305|P3|STARTED|Overall Study||111
8666077|NCT00763971|21394306|P2|STARTED|Overall Study||112
8666078|NCT00763971|21394307|P1|STARTED|Overall Study||113
8666079|NCT00746733|21394336|P2|NOT COMPLETED|Fourth Intervention||0
8666080|NCT00746733|21394337|P1|NOT COMPLETED|Fourth Intervention||0
8666081|NCT00746733|21394336|P2|COMPLETED|Fourth Intervention||11
8666082|NCT00746733|21394337|P1|COMPLETED|Fourth Intervention||10
8666083|NCT00746733|21394336|P2|STARTED|Fourth Intervention||11
8666084|NCT00746733|21394337|P1|STARTED|Fourth Intervention||10
8666085|NCT00746733|21394336|P2|NOT COMPLETED|Third Intervention||1
8666086|NCT00746733|21394337|P1|NOT COMPLETED|Third Intervention||1
8666087|NCT00746733|21394336|P2|COMPLETED|Third Intervention||11
8666088|NCT00746733|21394337|P1|COMPLETED|Third Intervention||10
8666089|NCT00746733|21394336|P2|STARTED|Third Intervention||12
8666090|NCT00746733|21394337|P1|STARTED|Third Intervention||11
8666091|NCT00746733|21394336|P2|NOT COMPLETED|Second Intervention||0
8666092|NCT00746733|21394337|P1|NOT COMPLETED|Second Intervention||1
8666093|NCT00746733|21394336|P2|COMPLETED|Second Intervention||12
8666094|NCT00746733|21394337|P1|COMPLETED|Second Intervention||11
8666095|NCT00746733|21394336|P2|STARTED|Second Intervention||12
8666096|NCT00746733|21394337|P1|STARTED|Second Intervention||12
8666097|NCT00746733|21394336|P2|NOT COMPLETED|First Intervention||0
8666098|NCT00746733|21394337|P1|NOT COMPLETED|First Intervention||0
8666099|NCT00746733|21394336|P2|COMPLETED|First Intervention||12
8666100|NCT00746733|21394337|P1|COMPLETED|First Intervention||12
8666101|NCT00746733|21394336|P2|STARTED|First Intervention||12
8666102|NCT00746733|21394337|P1|STARTED|First Intervention||12
8666103|NCT00735371|21394401|P4|NOT COMPLETED|Overall Study||10
8666104|NCT00735371|21394402|P3|NOT COMPLETED|Overall Study||11
8666105|NCT00735371|21394403|P2|NOT COMPLETED|Overall Study||13
8666106|NCT00735371|21394404|P1|NOT COMPLETED|Overall Study||15
8666107|NCT00735371|21394401|P4|COMPLETED|Overall Study||69
8666108|NCT00735371|21394402|P3|COMPLETED|Overall Study||67
8666109|NCT00735371|21394403|P2|COMPLETED|Overall Study||66
8666110|NCT00735371|21394404|P1|COMPLETED|Overall Study||63
8666111|NCT00735371|21394401|P4|STARTED|Overall Study||79
8666112|NCT00735371|21394402|P3|STARTED|Overall Study||78
8666113|NCT00735371|21394403|P2|STARTED|Overall Study||79
8666114|NCT00735371|21394404|P1|STARTED|Overall Study||78
8666115|NCT00734578|21394425|P3|NOT COMPLETED|Overall Study||25
8666116|NCT00734578|21394426|P2|NOT COMPLETED|Overall Study||25
8666117|NCT00734578|21394427|P1|NOT COMPLETED|Overall Study||33
8666118|NCT00734578|21394425|P3|COMPLETED|Overall Study||129
8666119|NCT00734578|21394426|P2|COMPLETED|Overall Study||128
8666120|NCT00734578|21394427|P1|COMPLETED|Overall Study||121
8666121|NCT00734578|21394425|P3|STARTED|Overall Study||154
8666122|NCT00734578|21394426|P2|STARTED|Overall Study||153
8666123|NCT00734578|21394427|P1|STARTED|Overall Study||154
8666124|NCT00679783|21394466|P7|NOT COMPLETED|Overall Study||1
8666125|NCT00679783|21394467|P6|NOT COMPLETED|Overall Study||0
8666126|NCT00679783|21394468|P5|NOT COMPLETED|Overall Study||1
8666127|NCT00679783|21394469|P4|NOT COMPLETED|Overall Study||20
8666128|NCT00679783|21394470|P3|NOT COMPLETED|Overall Study||1
8666129|NCT00679783|21394471|P2|NOT COMPLETED|Overall Study||3
8666130|NCT00679783|21394472|P1|NOT COMPLETED|Overall Study||2
8666131|NCT00679783|21394466|P7|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
8666132|NCT00679783|21394467|P6|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
8666133|NCT00679783|21394468|P5|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
8666134|NCT00679783|21394469|P4|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
8666135|NCT00679783|21394470|P3|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
8666136|NCT00679783|21394471|P2|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
8666137|NCT00679783|21394472|P1|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
8666138|NCT00679783|21394466|P7|STARTED|Overall Study|Gave Informed consent and passed screening|16
8666139|NCT00679783|21394467|P6|STARTED|Overall Study|Gave Informed consent and passed screening|5
8666140|NCT00679783|21394468|P5|STARTED|Overall Study|Gave Informed consent and passed screening|5
8666141|NCT00679783|21394469|P4|STARTED|Overall Study|Gave Informed consent and passed screening|45
8666142|NCT00679783|21394470|P3|STARTED|Overall Study|Gave Informed consent and passed screening|3
8666143|NCT00679783|21394471|P2|STARTED|Overall Study|Gave Informed consent and passed screening|13
8666144|NCT00679783|21394472|P1|STARTED|Overall Study|Gave Informed consent and passed screening|4
8666145|NCT00672984|21394526|P3|NOT COMPLETED|Third Intervention||1
8666146|NCT00672984|21394527|P2|NOT COMPLETED|Third Intervention||0
8666147|NCT00672984|21394528|P1|NOT COMPLETED|Third Intervention||1
8666148|NCT00672984|21394526|P3|COMPLETED|Third Intervention||23
8666149|NCT00672984|21394527|P2|COMPLETED|Third Intervention||17
8666150|NCT00672984|21394528|P1|COMPLETED|Third Intervention||21
8666151|NCT00672984|21394526|P3|STARTED|Third Intervention||24
8666152|NCT00672984|21394527|P2|STARTED|Third Intervention||17
8666153|NCT00672984|21394528|P1|STARTED|Third Intervention||22
8666154|NCT00672984|21394526|P3|NOT COMPLETED|Second Intervention||1
8666155|NCT00672984|21394527|P2|NOT COMPLETED|Second Intervention||6
8666156|NCT00672984|21394528|P1|NOT COMPLETED|Second Intervention||0
8666157|NCT00672984|21394526|P3|COMPLETED|Second Intervention||24
8666158|NCT00672984|21394527|P2|COMPLETED|Second Intervention||17
8666159|NCT00672984|21394528|P1|COMPLETED|Second Intervention||22
8666160|NCT00672984|21394526|P3|STARTED|Second Intervention||25
8666161|NCT00672984|21394527|P2|STARTED|Second Intervention||23
8666162|NCT00672984|21394528|P1|STARTED|Second Intervention||22
8666163|NCT00672984|21394526|P3|NOT COMPLETED|First Intervention||2
8666164|NCT00672984|21394527|P2|NOT COMPLETED|First Intervention||2
8666165|NCT00672984|21394528|P1|NOT COMPLETED|First Intervention||9
8666166|NCT00672984|21394526|P3|COMPLETED|First Intervention||25
8666167|NCT00672984|21394527|P2|COMPLETED|First Intervention||23
8666168|NCT00672984|21394528|P1|COMPLETED|First Intervention||22
8666169|NCT00672984|21394526|P3|STARTED|First Intervention||27
8666170|NCT00672984|21394527|P2|STARTED|First Intervention||25
8666171|NCT00672984|21394528|P1|STARTED|First Intervention||31
8666172|NCT00633139|21394580|P3|NOT COMPLETED|Overall Study||1
8666173|NCT00633139|21394581|P2|NOT COMPLETED|Overall Study||1
8666174|NCT00633139|21394582|P1|NOT COMPLETED|Overall Study||0
8666175|NCT00633139|21394580|P3|COMPLETED|Overall Study||3
8666176|NCT00633139|21394581|P2|COMPLETED|Overall Study||4
8666177|NCT00633139|21394582|P1|COMPLETED|Overall Study||4
8666178|NCT00633139|21394580|P3|STARTED|Overall Study||4
8666179|NCT00633139|21394581|P2|STARTED|Overall Study||5
8666180|NCT00633139|21394582|P1|STARTED|Overall Study||4
8666189|NCT00585650|21394615|P2|NOT COMPLETED|Overall Study||0
8666190|NCT00585650|21394616|P1|NOT COMPLETED|Overall Study||0
8666191|NCT00585650|21394615|P2|COMPLETED|Overall Study||12
8666192|NCT00585650|21394616|P1|COMPLETED|Overall Study||8
8666193|NCT00585650|21394615|P2|STARTED|Overall Study||12
8666194|NCT00585650|21394616|P1|STARTED|Overall Study||8
8666195|NCT00555880|21394624|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8666196|NCT00555880|21394625|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
8666197|NCT00555880|21394624|P2|COMPLETED|Treatment Period 2 (1 Day)||11
8666198|NCT00555880|21394625|P1|COMPLETED|Treatment Period 2 (1 Day)||13
8666199|NCT00555880|21394624|P2|STARTED|Treatment Period 2 (1 Day)||11
8666200|NCT00555880|21394625|P1|STARTED|Treatment Period 2 (1 Day)||13
8666201|NCT00555880|21394624|P2|NOT COMPLETED|Washout (1 Day)||0
8666202|NCT00555880|21394625|P1|NOT COMPLETED|Washout (1 Day)||0
8666203|NCT00555880|21394624|P2|COMPLETED|Washout (1 Day)||11
8666204|NCT00555880|21394625|P1|COMPLETED|Washout (1 Day)||13
8666205|NCT00555880|21394624|P2|STARTED|Washout (1 Day)||11
8666206|NCT00555880|21394625|P1|STARTED|Washout (1 Day)||13
8666207|NCT00555880|21394624|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8666208|NCT00555880|21394625|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
8666209|NCT00555880|21394624|P2|COMPLETED|Treatment Period 1 (1 Day)||11
8666210|NCT00555880|21394625|P1|COMPLETED|Treatment Period 1 (1 Day)||13
8666211|NCT00555880|21394624|P2|STARTED|Treatment Period 1 (1 Day)||11
8666212|NCT00555880|21394625|P1|STARTED|Treatment Period 1 (1 Day)||13
8666213|NCT00545740|21394666|P4|NOT COMPLETED|Overall Study||71
8666214|NCT00545740|21394667|P3|NOT COMPLETED|Overall Study||96
8666215|NCT00545740|21394668|P2|NOT COMPLETED|Overall Study||83
8666216|NCT00545740|21394669|P1|NOT COMPLETED|Overall Study||75
8666217|NCT00545740|21394666|P4|COMPLETED|Overall Study||78
8666218|NCT00545740|21394667|P3|COMPLETED|Overall Study||55
8666219|NCT00545740|21394668|P2|COMPLETED|Overall Study||62
8666220|NCT00545740|21394669|P1|COMPLETED|Overall Study||70
8666221|NCT00545740|21394666|P4|STARTED|Overall Study||149
8666222|NCT00545740|21394667|P3|STARTED|Overall Study||151
8666223|NCT00545740|21394668|P2|STARTED|Overall Study||145
8666224|NCT00545740|21394669|P1|STARTED|Overall Study||145
8666225|NCT00500149|21394703|P2|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
8666226|NCT00500149|21394704|P1|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
8666227|NCT00500149|21394703|P2|COMPLETED|Second Intervention (Cross-over Phase)||57
8666228|NCT00500149|21394704|P1|COMPLETED|Second Intervention (Cross-over Phase)||54
8666229|NCT00500149|21394703|P2|STARTED|Second Intervention (Cross-over Phase)||57
8666230|NCT00500149|21394704|P1|STARTED|Second Intervention (Cross-over Phase)||56
8666231|NCT00500149|21394703|P2|NOT COMPLETED|First Intervention (Cross-over Phase)||2
8666232|NCT00500149|21394704|P1|NOT COMPLETED|First Intervention (Cross-over Phase)||2
8666233|NCT00500149|21394703|P2|COMPLETED|First Intervention (Cross-over Phase)||57
8666234|NCT00500149|21394704|P1|COMPLETED|First Intervention (Cross-over Phase)||56
8666235|NCT00500149|21394703|P2|STARTED|First Intervention (Cross-over Phase)||59
8666236|NCT00500149|21394704|P1|STARTED|First Intervention (Cross-over Phase)||58
8666237|NCT00500149|21394703|P2|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
8666238|NCT00500149|21394704|P1|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
8666239|NCT00500149|21394703|P2|COMPLETED|Enrolled (Dose-optimization Phase)||0
8666240|NCT00500149|21394704|P1|COMPLETED|Enrolled (Dose-optimization Phase)||117
8666241|NCT00500149|21394703|P2|STARTED|Enrolled (Dose-optimization Phase)||0
8666242|NCT00500149|21394704|P1|STARTED|Enrolled (Dose-optimization Phase)||129
8666243|NCT00450333|21394716|P4|NOT COMPLETED|Overall Study||28
8666244|NCT00450333|21394717|P3|NOT COMPLETED|Overall Study||25
8666245|NCT00450333|21394718|P2|NOT COMPLETED|Overall Study||63
8666246|NCT00450333|21394719|P1|NOT COMPLETED|Overall Study||54
8666247|NCT00450333|21394716|P4|COMPLETED|Overall Study||74
8666248|NCT00450333|21394717|P3|COMPLETED|Overall Study||75
8666249|NCT00450333|21394718|P2|COMPLETED|Overall Study||44
8666250|NCT00450333|21394719|P1|COMPLETED|Overall Study||44
8666251|NCT00450333|21394716|P4|STARTED|Overall Study||102
8666252|NCT00450333|21394717|P3|STARTED|Overall Study||100
8666253|NCT00450333|21394718|P2|STARTED|Overall Study||107
8666254|NCT00450333|21394719|P1|STARTED|Overall Study||98
8666255|NCT00447694|21394737|P1|NOT COMPLETED|Overall Study||6
8666256|NCT00447694|21394737|P1|COMPLETED|Overall Study||22
8666257|NCT00447694|21394737|P1|STARTED|Overall Study||28
8666258|NCT00446849|21394744|P1|NOT COMPLETED|Maintenance Phase||70
8666259|NCT00446849|21394744|P1|COMPLETED|Maintenance Phase||138
8666260|NCT00446849|21394744|P1|STARTED|Maintenance Phase||208
8666261|NCT00446849|21394744|P1|NOT COMPLETED|Acute Phase||82
8666262|NCT00446849|21394744|P1|COMPLETED|Acute Phase||56
8666263|NCT00446849|21394744|P1|STARTED|Acute Phase||138
8666264|NCT00367835|21394756|P2|NOT COMPLETED|Overall Study||31
8666265|NCT00367835|21394757|P1|NOT COMPLETED|Overall Study||29
8666266|NCT00367835|21394756|P2|COMPLETED|Overall Study||48
8666267|NCT00367835|21394757|P1|COMPLETED|Overall Study||109
8666268|NCT00367835|21394756|P2|STARTED|Overall Study||79
8666269|NCT00367835|21394757|P1|STARTED|Overall Study||138
8666270|NCT00334958|21394785|P2|NOT COMPLETED|Overall Study||24
8666271|NCT00334958|21394786|P1|NOT COMPLETED|Overall Study||37
8666272|NCT00334958|21394785|P2|COMPLETED|Overall Study||156
8666273|NCT00334958|21394786|P1|COMPLETED|Overall Study||139
8666274|NCT00334958|21394785|P2|STARTED|Overall Study|1 participant withdrawn prior to study drug dosing due to not obtaining labs|180
8666275|NCT00334958|21394786|P1|STARTED|Overall Study||176
8666282|NCT00151892|21394817|P2|NOT COMPLETED|Overall Study||83
8666283|NCT00151892|21394818|P1|NOT COMPLETED|Overall Study||76
8666284|NCT00151892|21394817|P2|COMPLETED|Overall Study||330
8666285|NCT00151892|21394818|P1|COMPLETED|Overall Study||340
8666286|NCT00151892|21394817|P2|STARTED|Overall Study||413
8666287|NCT00151892|21394818|P1|STARTED|Overall Study||416
8666288|NCT00103285|21394832|P8|NOT COMPLETED|Response Assignment||120
8666289|NCT00103285|21394833|P7|NOT COMPLETED|Response Assignment||49
8666290|NCT00103285|21394834|P6|NOT COMPLETED|Response Assignment||48
8666291|NCT00103285|21394835|P5|NOT COMPLETED|Response Assignment||84
8666292|NCT00103285|21394836|P4|NOT COMPLETED|Response Assignment||62
8666293|NCT00103285|21394837|P3|NOT COMPLETED|Response Assignment||84
8666294|NCT00103285|21394838|P2|NOT COMPLETED|Response Assignment||132
8666295|NCT00103285|21394839|P1|NOT COMPLETED|Response Assignment||0
8666296|NCT00103285|21394832|P8|COMPLETED|Response Assignment||523
8666297|NCT00103285|21394833|P7|COMPLETED|Response Assignment||199
8666298|NCT00103285|21394834|P6|COMPLETED|Response Assignment||201
8666299|NCT00103285|21394835|P5|COMPLETED|Response Assignment||425
8666300|NCT00103285|21394836|P4|COMPLETED|Response Assignment||441
8666301|NCT00103285|21394837|P3|COMPLETED|Response Assignment||853
8666302|NCT00103285|21394838|P2|COMPLETED|Response Assignment||807
8666303|NCT00103285|21394839|P1|COMPLETED|Response Assignment||0
8666304|NCT00103285|21394832|P8|STARTED|Response Assignment||643
8666305|NCT00103285|21394833|P7|STARTED|Response Assignment||248
8666306|NCT00103285|21394834|P6|STARTED|Response Assignment||249
8666307|NCT00103285|21394835|P5|STARTED|Response Assignment||509
8666308|NCT00103285|21394836|P4|STARTED|Response Assignment||503
8666309|NCT00103285|21394837|P3|STARTED|Response Assignment||937
8666310|NCT00103285|21394838|P2|STARTED|Response Assignment||939
8666311|NCT00103285|21394839|P1|STARTED|Response Assignment||0
8666312|NCT00103285|21394832|P8|NOT COMPLETED|Induction||0
8666313|NCT00103285|21394833|P7|NOT COMPLETED|Induction||0
8666314|NCT00103285|21394834|P6|NOT COMPLETED|Induction||0
8666315|NCT00103285|21394835|P5|NOT COMPLETED|Induction||0
8666316|NCT00103285|21394836|P4|NOT COMPLETED|Induction||0
8666317|NCT00103285|21394837|P3|NOT COMPLETED|Induction||0
8666318|NCT00103285|21394838|P2|NOT COMPLETED|Induction||0
8666319|NCT00103285|21394839|P1|NOT COMPLETED|Induction||1349
8666320|NCT00103285|21394832|P8|COMPLETED|Induction||0
8666321|NCT00103285|21394833|P7|COMPLETED|Induction||0
8666322|NCT00103285|21394834|P6|COMPLETED|Induction||0
8666323|NCT00103285|21394835|P5|COMPLETED|Induction||0
8666324|NCT00103285|21394836|P4|COMPLETED|Induction||0
8666325|NCT00103285|21394837|P3|COMPLETED|Induction||0
8666326|NCT00103285|21394838|P2|COMPLETED|Induction||0
8666327|NCT00103285|21394839|P1|COMPLETED|Induction||4028
8666328|NCT00103285|21394832|P8|STARTED|Induction||0
8666329|NCT00103285|21394833|P7|STARTED|Induction||0
8666330|NCT00103285|21394834|P6|STARTED|Induction||0
8666331|NCT00103285|21394835|P5|STARTED|Induction||0
8666332|NCT00103285|21394836|P4|STARTED|Induction||0
8666333|NCT00103285|21394837|P3|STARTED|Induction||0
8666334|NCT00103285|21394838|P2|STARTED|Induction||0
8666335|NCT00103285|21394839|P1|STARTED|Induction||5377
8666336|NCT00004124|21394868|P2|NOT COMPLETED|Overall Study||20
8666337|NCT00004124|21394869|P1|NOT COMPLETED|Overall Study||12
8666338|NCT00004124|21394868|P2|COMPLETED|Overall Study||460
8666339|NCT00004124|21394869|P1|COMPLETED|Overall Study||469
8666340|NCT00004124|21394868|P2|STARTED|Overall Study||480
8666341|NCT00004124|21394869|P1|STARTED|Overall Study||481
8666342|NCT04799782|21394883|P2|NOT COMPLETED|Second Intervention||0
8666343|NCT04799782|21394884|P1|NOT COMPLETED|Second Intervention||0
8666344|NCT04799782|21394883|P2|COMPLETED|Second Intervention||4
8666345|NCT04799782|21394884|P1|COMPLETED|Second Intervention||6
8666346|NCT04799782|21394883|P2|STARTED|Second Intervention||4
8666347|NCT04799782|21394884|P1|STARTED|Second Intervention||6
8666348|NCT04799782|21394883|P2|NOT COMPLETED|Washout||3
8666349|NCT04799782|21394884|P1|NOT COMPLETED|Washout||2
8666350|NCT04799782|21394883|P2|COMPLETED|Washout||4
8666351|NCT04799782|21394884|P1|COMPLETED|Washout||6
8666352|NCT04799782|21394883|P2|STARTED|Washout||7
8666353|NCT04799782|21394884|P1|STARTED|Washout||8
8666354|NCT04799782|21394883|P2|NOT COMPLETED|First Intervention||0
8666355|NCT04799782|21394884|P1|NOT COMPLETED|First Intervention||0
8666356|NCT04799782|21394883|P2|COMPLETED|First Intervention||7
8666357|NCT04799782|21394884|P1|COMPLETED|First Intervention||8
8666358|NCT04799782|21394883|P2|STARTED|First Intervention||7
8666359|NCT04799782|21394884|P1|STARTED|First Intervention||8
8666360|NCT04085289|21394895|P3|NOT COMPLETED|Overall Study||1
8666361|NCT04085289|21394896|P2|NOT COMPLETED|Overall Study||0
8666362|NCT04085289|21394897|P1|NOT COMPLETED|Overall Study||0
8666363|NCT04085289|21394895|P3|COMPLETED|Overall Study||11
8666364|NCT04085289|21394896|P2|COMPLETED|Overall Study||12
8666365|NCT04085289|21394897|P1|COMPLETED|Overall Study||6
8666366|NCT04085289|21394895|P3|Received at Least One Dose of Study Drug|Overall Study||12
8666367|NCT04085289|21394896|P2|Received at Least One Dose of Study Drug|Overall Study||12
8666368|NCT04085289|21394897|P1|Received at Least One Dose of Study Drug|Overall Study||6
8666369|NCT04085289|21394895|P3|STARTED|Overall Study||12
8666370|NCT04085289|21394896|P2|STARTED|Overall Study||12
8666371|NCT04085289|21394897|P1|STARTED|Overall Study||6
8666372|NCT03866434|21394906|P1|NOT COMPLETED|Overall Study||0
8666373|NCT03866434|21394906|P1|COMPLETED|Overall Study||20
8666374|NCT03866434|21394906|P1|STARTED|Overall Study||20
8666375|NCT03851094|21394924|P2|NOT COMPLETED|Overall Study||4
8666376|NCT03851094|21394925|P1|NOT COMPLETED|Overall Study||0
8666377|NCT03851094|21394924|P2|COMPLETED|Overall Study||51
8666378|NCT03851094|21394925|P1|COMPLETED|Overall Study||111
8666379|NCT03851094|21394924|P2|STARTED|Overall Study||55
8666380|NCT03851094|21394925|P1|STARTED|Overall Study||111
8666381|NCT03850509|21394939|P2|NOT COMPLETED|Overall Study||1
8666382|NCT03850509|21394940|P1|NOT COMPLETED|Overall Study||2
8666383|NCT03850509|21394939|P2|COMPLETED|Overall Study||0
8666384|NCT03850509|21394940|P1|COMPLETED|Overall Study||0
8666385|NCT03850509|21394939|P2|STARTED|Overall Study||1
8666386|NCT03850509|21394940|P1|STARTED|Overall Study||2
8666387|NCT03849690|21394960|P1|NOT COMPLETED|Period 2 (6 Days)||0
8666388|NCT03849690|21394960|P1|COMPLETED|Period 2 (6 Days)||12
8666389|NCT03849690|21394960|P1|STARTED|Period 2 (6 Days)||12
8666390|NCT03849690|21394960|P1|NOT COMPLETED|Washout Period (at Least 4 Days)||0
8666391|NCT03849690|21394960|P1|COMPLETED|Washout Period (at Least 4 Days)||12
8666392|NCT03849690|21394960|P1|STARTED|Washout Period (at Least 4 Days)||12
8666393|NCT03849690|21394960|P1|NOT COMPLETED|Period 1 (3 Days)||0
8666394|NCT03849690|21394960|P1|COMPLETED|Period 1 (3 Days)||12
8666395|NCT03849690|21394960|P1|STARTED|Period 1 (3 Days)||12
8666396|NCT03700320|21394985|P2|NOT COMPLETED|Overall Study||173
8666397|NCT03700320|21394986|P1|NOT COMPLETED|Overall Study||62
8666398|NCT03700320|21394985|P2|COMPLETED|Overall Study||373
8666399|NCT03700320|21394986|P1|COMPLETED|Overall Study||136
8666400|NCT03700320|21394985|P2|Entered Safety Follow-up|Overall Study||472
8666401|NCT03700320|21394986|P1|Entered Safety Follow-up|Overall Study||159
8666402|NCT03700320|21394985|P2|Safety Population; Received Treatment|Overall Study||543
8666403|NCT03700320|21394986|P1|Safety Population; Received Treatment|Overall Study||196
8666404|NCT03700320|21394985|P2|STARTED|Overall Study||546
8666405|NCT03700320|21394986|P1|STARTED|Overall Study||198
8666406|NCT03694197|21395000|P1|NOT COMPLETED|Overall Study||1385
8666407|NCT03694197|21395000|P1|COMPLETED|Overall Study||0
8666408|NCT03694197|21395000|P1|STARTED|Overall Study||1385
8666409|NCT03597529|21395038|P2|NOT COMPLETED|Overall Study||18
8666410|NCT03597529|21395039|P1|NOT COMPLETED|Overall Study||20
8666411|NCT03597529|21395038|P2|COMPLETED|Overall Study||24
8666412|NCT03597529|21395039|P1|COMPLETED|Overall Study||22
8666413|NCT03597529|21395038|P2|Follow-up|Overall Study||24
8666414|NCT03597529|21395039|P1|Follow-up|Overall Study||22
8666415|NCT03597529|21395038|P2|STARTED|Overall Study||42
8666416|NCT03597529|21395039|P1|STARTED|Overall Study||42
8666417|NCT03532009|21395047|P2|NOT COMPLETED|Overall Study||4
8666418|NCT03532009|21395048|P1|NOT COMPLETED|Overall Study||2
8666419|NCT03532009|21395047|P2|COMPLETED|Overall Study||86
8666420|NCT03532009|21395048|P1|COMPLETED|Overall Study||90
8666421|NCT03532009|21395047|P2|Received Treatment|Overall Study||90
8666422|NCT03532009|21395048|P1|Received Treatment|Overall Study||91
8666423|NCT03532009|21395047|P2|STARTED|Overall Study||90
8666424|NCT03532009|21395048|P1|STARTED|Overall Study||92
8666437|NCT03511378|21395085|P2|NOT COMPLETED|Overall Study||2
8666438|NCT03511378|21395086|P1|NOT COMPLETED|Overall Study||3
8666439|NCT03511378|21395085|P2|COMPLETED|Overall Study||66
8666440|NCT03511378|21395086|P1|COMPLETED|Overall Study||67
8666441|NCT03511378|21395085|P2|STARTED|Overall Study||68
8666442|NCT03511378|21395086|P1|STARTED|Overall Study||70
8666443|NCT03406377|21395100|P2|NOT COMPLETED|Overall Study||21
8666444|NCT03406377|21395101|P1|NOT COMPLETED|Overall Study||16
8666445|NCT03406377|21395100|P2|COMPLETED|Overall Study||51
8666446|NCT03406377|21395101|P1|COMPLETED|Overall Study||25
8666447|NCT03406377|21395100|P2|STARTED|Overall Study||72
8666448|NCT03406377|21395101|P1|STARTED|Overall Study||41
8666449|NCT03303079|21395116|P3|NOT COMPLETED|Overall Study||12
8666450|NCT03303079|21395117|P2|NOT COMPLETED|Overall Study||11
8666451|NCT03303079|21395118|P1|NOT COMPLETED|Overall Study||7
8666452|NCT03303079|21395116|P3|COMPLETED|Overall Study||179
8666453|NCT03303079|21395117|P2|COMPLETED|Overall Study||180
8666454|NCT03303079|21395118|P1|COMPLETED|Overall Study||182
8666455|NCT03303079|21395116|P3|STARTED|Overall Study||191
8666456|NCT03303079|21395117|P2|STARTED|Overall Study||191
8666457|NCT03303079|21395118|P1|STARTED|Overall Study||189
8666458|NCT03230175|21395141|P1|NOT COMPLETED|Overall Study||2
8666459|NCT03230175|21395141|P1|COMPLETED|Overall Study||30
8666460|NCT03230175|21395141|P1|STARTED|Overall Study||32
8666484|NCT03084796|21395176|P6|NOT COMPLETED|Overall Study||7
8666485|NCT03084796|21395177|P5|NOT COMPLETED|Overall Study||11
8666486|NCT03084796|21395178|P4|NOT COMPLETED|Overall Study||4
8666487|NCT03084796|21395179|P3|NOT COMPLETED|Overall Study||12
8666488|NCT03084796|21395180|P2|NOT COMPLETED|Overall Study||10
8666489|NCT03084796|21395181|P1|NOT COMPLETED|Overall Study||7
8666490|NCT03084796|21395176|P6|COMPLETED|Overall Study||116
8666491|NCT03084796|21395177|P5|COMPLETED|Overall Study||110
8666492|NCT03084796|21395178|P4|COMPLETED|Overall Study||119
8666493|NCT03084796|21395179|P3|COMPLETED|Overall Study||110
8666494|NCT03084796|21395180|P2|COMPLETED|Overall Study||113
8666495|NCT03084796|21395181|P1|COMPLETED|Overall Study||114
8666496|NCT03084796|21395176|P6|STARTED|Overall Study||123
8666497|NCT03084796|21395177|P5|STARTED|Overall Study||121
8666498|NCT03084796|21395178|P4|STARTED|Overall Study||123
8666499|NCT03084796|21395179|P3|STARTED|Overall Study||122
8666500|NCT03084796|21395180|P2|STARTED|Overall Study||123
8666501|NCT03084796|21395181|P1|STARTED|Overall Study||121
8666505|NCT02936635|21395343|P2|NOT COMPLETED|Overall Study||165
8666506|NCT02936635|21395344|P1|NOT COMPLETED|Overall Study||115
8666507|NCT02936635|21395343|P2|COMPLETED|Overall Study||0
8666508|NCT02936635|21395344|P1|COMPLETED|Overall Study||0
8666509|NCT02936635|21395343|P2|STARTED|Overall Study||165
8666510|NCT02936635|21395344|P1|STARTED|Overall Study||115
8666583|NCT02858492|21395455|P4|NOT COMPLETED|Overall Study||6
8666584|NCT02858492|21395456|P3|NOT COMPLETED|Overall Study||0
8666585|NCT02858492|21395457|P2|NOT COMPLETED|Overall Study||1
8666586|NCT02858492|21395458|P1|NOT COMPLETED|Overall Study||0
8666587|NCT02858492|21395455|P4|COMPLETED|Overall Study||22
8666588|NCT02858492|21395456|P3|COMPLETED|Overall Study||5
8666589|NCT02858492|21395457|P2|COMPLETED|Overall Study||14
8666590|NCT02858492|21395458|P1|COMPLETED|Overall Study||3
8666591|NCT02858492|21395455|P4|STARTED|Overall Study||28
8666592|NCT02858492|21395456|P3|STARTED|Overall Study||5
8666593|NCT02858492|21395457|P2|STARTED|Overall Study||15
8666594|NCT02858492|21395458|P1|STARTED|Overall Study||3
8666595|NCT02826161|21395636|P2|NOT COMPLETED|Overall Study||0
8666596|NCT02826161|21395637|P1|NOT COMPLETED|Overall Study||0
8666597|NCT02826161|21395636|P2|COMPLETED|Overall Study||3
8666598|NCT02826161|21395637|P1|COMPLETED|Overall Study||1
8666599|NCT02826161|21395636|P2|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
8666600|NCT02826161|21395637|P1|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
8666601|NCT02826161|21395636|P2|Discontinued Due to Patient Withdrawal|Overall Study||1
8666602|NCT02826161|21395637|P1|Discontinued Due to Patient Withdrawal|Overall Study||0
8666603|NCT02826161|21395636|P2|Discontinued Due to Death|Overall Study||1
8666604|NCT02826161|21395637|P1|Discontinued Due to Death|Overall Study||0
8666605|NCT02826161|21395636|P2|Discontinued Due to Treatment Related AE|Overall Study||0
8666606|NCT02826161|21395637|P1|Discontinued Due to Treatment Related AE|Overall Study||1
8666607|NCT02826161|21395636|P2|STARTED|Overall Study||3
8666608|NCT02826161|21395637|P1|STARTED|Overall Study||1
8666609|NCT02698215|21395651|P2|NOT COMPLETED|Overall Study||18
8666610|NCT02698215|21395652|P1|NOT COMPLETED|Overall Study||28
8666611|NCT02698215|21395651|P2|COMPLETED|Overall Study||64
8666612|NCT02698215|21395652|P1|COMPLETED|Overall Study||55
8666613|NCT02698215|21395651|P2|STARTED|Overall Study||82
8666614|NCT02698215|21395652|P1|STARTED|Overall Study||83
8666615|NCT02678247|21395662|P2|NOT COMPLETED|Second Intervention (7 Weeks)||2
8666616|NCT02678247|21395663|P1|NOT COMPLETED|Second Intervention (7 Weeks)||4
8666617|NCT02678247|21395662|P2|COMPLETED|Second Intervention (7 Weeks)||9
8666618|NCT02678247|21395663|P1|COMPLETED|Second Intervention (7 Weeks)||10
8666619|NCT02678247|21395662|P2|STARTED|Second Intervention (7 Weeks)||11
8666620|NCT02678247|21395663|P1|STARTED|Second Intervention (7 Weeks)|One subject crossed over despite not completing all data collection time points for the preceding socket.|14
8666621|NCT02678247|21395662|P2|NOT COMPLETED|First Intervention (7 Weeks)||4
8666622|NCT02678247|21395663|P1|NOT COMPLETED|First Intervention (7 Weeks)||2
8666623|NCT02678247|21395662|P2|COMPLETED|First Intervention (7 Weeks)||11
8666624|NCT02678247|21395663|P1|COMPLETED|First Intervention (7 Weeks)||13
8666625|NCT02678247|21395662|P2|STARTED|First Intervention (7 Weeks)||15
8666626|NCT02678247|21395663|P1|STARTED|First Intervention (7 Weeks)||15
8666627|NCT02599402|21395691|P1|NOT COMPLETED|Overall Study||533
8666628|NCT02599402|21395691|P1|COMPLETED|Overall Study||0
8666629|NCT02599402|21395691|P1|STARTED|Overall Study||533
8666630|NCT02417142|21395812|P2|NOT COMPLETED|Overall Study||13
8666631|NCT02417142|21395813|P1|NOT COMPLETED|Overall Study||16
8666632|NCT02417142|21395812|P2|COMPLETED|Overall Study||22
8666633|NCT02417142|21395813|P1|COMPLETED|Overall Study||19
8666634|NCT02417142|21395812|P2|STARTED|Overall Study||35
8666635|NCT02417142|21395813|P1|STARTED|Overall Study||35
8666636|NCT02388906|21395823|P2|NOT COMPLETED|Treatment Period||331
8666637|NCT02388906|21395824|P1|NOT COMPLETED|Treatment Period||177
8666638|NCT02388906|21395823|P2|COMPLETED|Treatment Period||122
8666639|NCT02388906|21395824|P1|COMPLETED|Treatment Period||275
8666640|NCT02388906|21395823|P2|STARTED|Treatment Period||453
8666641|NCT02388906|21395824|P1|STARTED|Treatment Period||452
8666642|NCT02388906|21395823|P2|NOT COMPLETED|Pre-Treatment Period||0
8666643|NCT02388906|21395824|P1|NOT COMPLETED|Pre-Treatment Period||1
8666644|NCT02388906|21395823|P2|COMPLETED|Pre-Treatment Period||453
8666645|NCT02388906|21395824|P1|COMPLETED|Pre-Treatment Period||452
8666646|NCT02388906|21395823|P2|STARTED|Pre-Treatment Period||453
8666647|NCT02388906|21395824|P1|STARTED|Pre-Treatment Period||453
8666648|NCT02357043|21395844|P1|NOT COMPLETED|Overall Study||0
8666649|NCT02357043|21395844|P1|COMPLETED|Overall Study||368
8666650|NCT02357043|21395844|P1|STARTED|Overall Study||368
8666651|NCT02354144|21395850|P2|NOT COMPLETED|Overall Study||77
8666652|NCT02354144|21395851|P1|NOT COMPLETED|Overall Study||79
8666653|NCT02354144|21395850|P2|COMPLETED|Overall Study|Participants completed all 7 study visits.|51
8666654|NCT02354144|21395851|P1|COMPLETED|Overall Study|Participants completed all 7 study visits.|48
8666655|NCT02354144|21395850|P2|STARTED|Overall Study||128
8666656|NCT02354144|21395851|P1|STARTED|Overall Study||127
8666657|NCT02323126|21395863|P2|NOT COMPLETED|Overall Study||30
8666658|NCT02323126|21395864|P1|NOT COMPLETED|Overall Study||16
8666659|NCT02323126|21395863|P2|COMPLETED|Overall Study||0
8666660|NCT02323126|21395864|P1|COMPLETED|Overall Study||0
8666661|NCT02323126|21395863|P2|STARTED|Overall Study||30
8666662|NCT02323126|21395864|P1|STARTED|Overall Study||16
8666663|NCT02275026|21395871|P1|NOT COMPLETED|Overall Study||33
8666664|NCT02275026|21395871|P1|COMPLETED|Overall Study||71
8666665|NCT02275026|21395871|P1|STARTED|Overall Study||104
8666734|NCT02092298|21396076|P1|NOT COMPLETED|Overall Study||0
8666735|NCT02092298|21396076|P1|COMPLETED|Overall Study||19
8666736|NCT02092298|21396076|P1|STARTED|Overall Study||19
8666737|NCT01982955|21396086|P5|NOT COMPLETED|Overall Study||0
8666738|NCT01982955|21396087|P4|NOT COMPLETED|Overall Study||1
8666739|NCT01982955|21396088|P3|NOT COMPLETED|Overall Study||4
8666740|NCT01982955|21396089|P2|NOT COMPLETED|Overall Study||0
8666741|NCT01982955|21396090|P1|NOT COMPLETED|Overall Study||0
8666742|NCT01982955|21396086|P5|COMPLETED|Overall Study||15
8666743|NCT01982955|21396087|P4|COMPLETED|Overall Study||23
8666744|NCT01982955|21396088|P3|COMPLETED|Overall Study||27
8666745|NCT01982955|21396089|P2|COMPLETED|Overall Study||12
8666746|NCT01982955|21396090|P1|COMPLETED|Overall Study||6
8666747|NCT01982955|21396086|P5|Treated|Overall Study||15
8666748|NCT01982955|21396087|P4|Treated|Overall Study||23
8666749|NCT01982955|21396088|P3|Treated|Overall Study||31
8666750|NCT01982955|21396089|P2|Treated|Overall Study||12
8666751|NCT01982955|21396090|P1|Treated|Overall Study||6
8666752|NCT01982955|21396086|P5|STARTED|Overall Study||15
8666753|NCT01982955|21396087|P4|STARTED|Overall Study||24
8666754|NCT01982955|21396088|P3|STARTED|Overall Study||31
8666755|NCT01982955|21396089|P2|STARTED|Overall Study||12
8666756|NCT01982955|21396090|P1|STARTED|Overall Study||6
8666781|NCT01707108|21396281|P1|NOT COMPLETED|Overall Study||0
8666782|NCT01707108|21396281|P1|COMPLETED|Overall Study||60
8666783|NCT01707108|21396281|P1|1 Year|Overall Study||60
8666784|NCT01707108|21396281|P1|STARTED|Overall Study||60
8666785|NCT01614067|21396288|P2|NOT COMPLETED|Overall Study||15
8666786|NCT01614067|21396289|P1|NOT COMPLETED|Overall Study||15
8666787|NCT01614067|21396288|P2|COMPLETED|Overall Study||0
8666788|NCT01614067|21396289|P1|COMPLETED|Overall Study||0
8666789|NCT01614067|21396288|P2|STARTED|Overall Study||15
8666790|NCT01614067|21396289|P1|STARTED|Overall Study||15
8666791|NCT01445730|21396307|P1|NOT COMPLETED|Overall Study||11
8666792|NCT01445730|21396307|P1|COMPLETED|Overall Study||71
8666793|NCT01445730|21396307|P1|STARTED|Overall Study||82
8666794|NCT01079663|21396319|P2|NOT COMPLETED|Overall Study||4
8666795|NCT01079663|21396320|P1|NOT COMPLETED|Overall Study||0
8666796|NCT01079663|21396319|P2|COMPLETED|Overall Study||26
8666797|NCT01079663|21396320|P1|COMPLETED|Overall Study||30
8666798|NCT01079663|21396319|P2|STARTED|Overall Study||30
8666799|NCT01079663|21396320|P1|STARTED|Overall Study||30
8666800|NCT00925704|21396336|P6|NOT COMPLETED|Third Intervention||1
8666801|NCT00925704|21396337|P5|NOT COMPLETED|Third Intervention||0
8666802|NCT00925704|21396338|P4|NOT COMPLETED|Third Intervention||0
8666803|NCT00925704|21396339|P3|NOT COMPLETED|Third Intervention||0
8666804|NCT00925704|21396340|P2|NOT COMPLETED|Third Intervention||0
8666805|NCT00925704|21396341|P1|NOT COMPLETED|Third Intervention||0
8666806|NCT00925704|21396336|P6|COMPLETED|Third Intervention||6
8666807|NCT00925704|21396337|P5|COMPLETED|Third Intervention||5
8666808|NCT00925704|21396338|P4|COMPLETED|Third Intervention||6
8666809|NCT00925704|21396339|P3|COMPLETED|Third Intervention||7
8666810|NCT00925704|21396340|P2|COMPLETED|Third Intervention||7
8666811|NCT00925704|21396341|P1|COMPLETED|Third Intervention||5
8666812|NCT00925704|21396336|P6|STARTED|Third Intervention||7
8666813|NCT00925704|21396337|P5|STARTED|Third Intervention||5
8666814|NCT00925704|21396338|P4|STARTED|Third Intervention||6
8666815|NCT00925704|21396339|P3|STARTED|Third Intervention||7
8666816|NCT00925704|21396340|P2|STARTED|Third Intervention||7
8666817|NCT00925704|21396341|P1|STARTED|Third Intervention||5
8666818|NCT00925704|21396336|P6|NOT COMPLETED|Washout||0
8666819|NCT00925704|21396337|P5|NOT COMPLETED|Washout||0
8666820|NCT00925704|21396338|P4|NOT COMPLETED|Washout||0
8666821|NCT00925704|21396339|P3|NOT COMPLETED|Washout||0
8666822|NCT00925704|21396340|P2|NOT COMPLETED|Washout||0
8666823|NCT00925704|21396341|P1|NOT COMPLETED|Washout||0
8666824|NCT00925704|21396336|P6|COMPLETED|Washout||7
8666825|NCT00925704|21396337|P5|COMPLETED|Washout||5
8666826|NCT00925704|21396338|P4|COMPLETED|Washout||6
8666827|NCT00925704|21396339|P3|COMPLETED|Washout||7
8666828|NCT00925704|21396340|P2|COMPLETED|Washout||7
8666829|NCT00925704|21396341|P1|COMPLETED|Washout||5
8666830|NCT00925704|21396336|P6|STARTED|Washout||7
8666831|NCT00925704|21396337|P5|STARTED|Washout||5
8666832|NCT00925704|21396338|P4|STARTED|Washout||6
8666833|NCT00925704|21396339|P3|STARTED|Washout||7
8666834|NCT00925704|21396340|P2|STARTED|Washout||7
8666835|NCT00925704|21396341|P1|STARTED|Washout||5
8666836|NCT00925704|21396336|P6|NOT COMPLETED|Second Intervention||0
8666837|NCT00925704|21396337|P5|NOT COMPLETED|Second Intervention||1
8666838|NCT00925704|21396338|P4|NOT COMPLETED|Second Intervention||0
8666839|NCT00925704|21396339|P3|NOT COMPLETED|Second Intervention||0
8666840|NCT00925704|21396340|P2|NOT COMPLETED|Second Intervention||0
8666841|NCT00925704|21396341|P1|NOT COMPLETED|Second Intervention||1
8666842|NCT00925704|21396336|P6|COMPLETED|Second Intervention||7
8666843|NCT00925704|21396337|P5|COMPLETED|Second Intervention||5
8666844|NCT00925704|21396338|P4|COMPLETED|Second Intervention||6
8666845|NCT00925704|21396339|P3|COMPLETED|Second Intervention||7
8666846|NCT00925704|21396340|P2|COMPLETED|Second Intervention||7
8666847|NCT00925704|21396341|P1|COMPLETED|Second Intervention||5
8666848|NCT00925704|21396336|P6|STARTED|Second Intervention||7
8666849|NCT00925704|21396337|P5|STARTED|Second Intervention||6
8666850|NCT00925704|21396338|P4|STARTED|Second Intervention||6
8666851|NCT00925704|21396339|P3|STARTED|Second Intervention||7
8666852|NCT00925704|21396340|P2|STARTED|Second Intervention||7
8666853|NCT00925704|21396341|P1|STARTED|Second Intervention||6
8666854|NCT00925704|21396336|P6|NOT COMPLETED|Washout||0
8666855|NCT00925704|21396337|P5|NOT COMPLETED|Washout||0
8666856|NCT00925704|21396338|P4|NOT COMPLETED|Washout||0
8666857|NCT00925704|21396339|P3|NOT COMPLETED|Washout||0
8666858|NCT00925704|21396340|P2|NOT COMPLETED|Washout||0
8666859|NCT00925704|21396341|P1|NOT COMPLETED|Washout||0
8666860|NCT00925704|21396336|P6|COMPLETED|Washout||7
8666861|NCT00925704|21396337|P5|COMPLETED|Washout||6
8666862|NCT00925704|21396338|P4|COMPLETED|Washout||6
8666863|NCT00925704|21396339|P3|COMPLETED|Washout||7
8666864|NCT00925704|21396340|P2|COMPLETED|Washout||7
8666865|NCT00925704|21396341|P1|COMPLETED|Washout||6
8666866|NCT00925704|21396336|P6|STARTED|Washout||7
8666867|NCT00925704|21396337|P5|STARTED|Washout||6
8666868|NCT00925704|21396338|P4|STARTED|Washout||6
8666869|NCT00925704|21396339|P3|STARTED|Washout||7
8666870|NCT00925704|21396340|P2|STARTED|Washout||7
8666871|NCT00925704|21396341|P1|STARTED|Washout||6
8666872|NCT00925704|21396336|P6|NOT COMPLETED|First Intervention||0
8666873|NCT00925704|21396337|P5|NOT COMPLETED|First Intervention||1
8666874|NCT00925704|21396338|P4|NOT COMPLETED|First Intervention||1
8666875|NCT00925704|21396339|P3|NOT COMPLETED|First Intervention||0
8666876|NCT00925704|21396340|P2|NOT COMPLETED|First Intervention||0
8666877|NCT00925704|21396341|P1|NOT COMPLETED|First Intervention||0
8666878|NCT00925704|21396336|P6|COMPLETED|First Intervention||7
8666879|NCT00925704|21396337|P5|COMPLETED|First Intervention||6
8666880|NCT00925704|21396338|P4|COMPLETED|First Intervention||6
8666881|NCT00925704|21396339|P3|COMPLETED|First Intervention||7
8666882|NCT00925704|21396340|P2|COMPLETED|First Intervention||7
8666883|NCT00925704|21396341|P1|COMPLETED|First Intervention||6
8666884|NCT00925704|21396336|P6|STARTED|First Intervention||7
8666885|NCT00925704|21396337|P5|STARTED|First Intervention||7
8666886|NCT00925704|21396338|P4|STARTED|First Intervention||7
8666887|NCT00925704|21396339|P3|STARTED|First Intervention||7
8666888|NCT00925704|21396340|P2|STARTED|First Intervention||7
8666889|NCT00925704|21396341|P1|STARTED|First Intervention||6
8666890|NCT00875017|21396358|P6|NOT COMPLETED|Fourth Intervention||1
8666891|NCT00875017|21396359|P5|NOT COMPLETED|Fourth Intervention||0
8666892|NCT00875017|21396360|P4|NOT COMPLETED|Fourth Intervention||0
8666893|NCT00875017|21396361|P3|NOT COMPLETED|Fourth Intervention||0
8666894|NCT00875017|21396362|P2|NOT COMPLETED|Fourth Intervention||0
8666895|NCT00875017|21396363|P1|NOT COMPLETED|Fourth Intervention||0
8666896|NCT00875017|21396358|P6|COMPLETED|Fourth Intervention||4
8666897|NCT00875017|21396359|P5|COMPLETED|Fourth Intervention||3
8666898|NCT00875017|21396360|P4|COMPLETED|Fourth Intervention||4
8666899|NCT00875017|21396361|P3|COMPLETED|Fourth Intervention||2
8666900|NCT00875017|21396362|P2|COMPLETED|Fourth Intervention||3
8666901|NCT00875017|21396363|P1|COMPLETED|Fourth Intervention||3
8666902|NCT00875017|21396358|P6|STARTED|Fourth Intervention||5
8666903|NCT00875017|21396359|P5|STARTED|Fourth Intervention||3
8666904|NCT00875017|21396360|P4|STARTED|Fourth Intervention||4
8666905|NCT00875017|21396361|P3|STARTED|Fourth Intervention||2
8666906|NCT00875017|21396362|P2|STARTED|Fourth Intervention||3
8666907|NCT00875017|21396363|P1|STARTED|Fourth Intervention||3
8666908|NCT00875017|21396358|P6|NOT COMPLETED|Washout||0
8666909|NCT00875017|21396359|P5|NOT COMPLETED|Washout||1
8666910|NCT00875017|21396360|P4|NOT COMPLETED|Washout||0
8666911|NCT00875017|21396361|P3|NOT COMPLETED|Washout||0
8666912|NCT00875017|21396362|P2|NOT COMPLETED|Washout||0
8666913|NCT00875017|21396363|P1|NOT COMPLETED|Washout||0
8666914|NCT00875017|21396358|P6|COMPLETED|Washout||5
8666915|NCT00875017|21396359|P5|COMPLETED|Washout||3
8666916|NCT00875017|21396360|P4|COMPLETED|Washout||4
8666917|NCT00875017|21396361|P3|COMPLETED|Washout||2
8666918|NCT00875017|21396362|P2|COMPLETED|Washout||3
8666919|NCT00875017|21396363|P1|COMPLETED|Washout||3
8666920|NCT00875017|21396358|P6|STARTED|Washout||5
8666921|NCT00875017|21396359|P5|STARTED|Washout||4
8666922|NCT00875017|21396360|P4|STARTED|Washout||4
8666923|NCT00875017|21396361|P3|STARTED|Washout||2
8666924|NCT00875017|21396362|P2|STARTED|Washout||3
8666925|NCT00875017|21396363|P1|STARTED|Washout||3
8666926|NCT00875017|21396358|P6|NOT COMPLETED|Third Intervention||0
8666927|NCT00875017|21396359|P5|NOT COMPLETED|Third Intervention||0
8666928|NCT00875017|21396360|P4|NOT COMPLETED|Third Intervention||0
8666929|NCT00875017|21396361|P3|NOT COMPLETED|Third Intervention||1
8666930|NCT00875017|21396362|P2|NOT COMPLETED|Third Intervention||1
8666931|NCT00875017|21396363|P1|NOT COMPLETED|Third Intervention||0
8666932|NCT00875017|21396358|P6|COMPLETED|Third Intervention||5
8666933|NCT00875017|21396359|P5|COMPLETED|Third Intervention||4
8666934|NCT00875017|21396360|P4|COMPLETED|Third Intervention||4
8666935|NCT00875017|21396361|P3|COMPLETED|Third Intervention||2
8666936|NCT00875017|21396362|P2|COMPLETED|Third Intervention||3
8666937|NCT00875017|21396363|P1|COMPLETED|Third Intervention||3
8666938|NCT00875017|21396358|P6|STARTED|Third Intervention||5
8666939|NCT00875017|21396359|P5|STARTED|Third Intervention||4
8666940|NCT00875017|21396360|P4|STARTED|Third Intervention||4
8666941|NCT00875017|21396361|P3|STARTED|Third Intervention||3
8666942|NCT00875017|21396362|P2|STARTED|Third Intervention||4
8666943|NCT00875017|21396363|P1|STARTED|Third Intervention||3
8666944|NCT00875017|21396358|P6|NOT COMPLETED|Washout||0
8666945|NCT00875017|21396359|P5|NOT COMPLETED|Washout||0
8666946|NCT00875017|21396360|P4|NOT COMPLETED|Washout||0
8666947|NCT00875017|21396361|P3|NOT COMPLETED|Washout||0
8666948|NCT00875017|21396362|P2|NOT COMPLETED|Washout||1
8666949|NCT00875017|21396363|P1|NOT COMPLETED|Washout||0
8666950|NCT00875017|21396358|P6|COMPLETED|Washout||5
8666951|NCT00875017|21396359|P5|COMPLETED|Washout||4
8666952|NCT00875017|21396360|P4|COMPLETED|Washout||4
8666953|NCT00875017|21396361|P3|COMPLETED|Washout||3
8666954|NCT00875017|21396362|P2|COMPLETED|Washout||4
8666955|NCT00875017|21396363|P1|COMPLETED|Washout||3
8666956|NCT00875017|21396358|P6|STARTED|Washout||5
8666957|NCT00875017|21396359|P5|STARTED|Washout||4
8666958|NCT00875017|21396360|P4|STARTED|Washout||4
8666959|NCT00875017|21396361|P3|STARTED|Washout||3
8666960|NCT00875017|21396362|P2|STARTED|Washout||5
8666961|NCT00875017|21396363|P1|STARTED|Washout||3
8666962|NCT00875017|21396358|P6|NOT COMPLETED|Second Intervention||0
8666963|NCT00875017|21396359|P5|NOT COMPLETED|Second Intervention||0
8666964|NCT00875017|21396360|P4|NOT COMPLETED|Second Intervention||1
8666965|NCT00875017|21396361|P3|NOT COMPLETED|Second Intervention||0
8666966|NCT00875017|21396362|P2|NOT COMPLETED|Second Intervention||0
8666967|NCT00875017|21396363|P1|NOT COMPLETED|Second Intervention||0
8666968|NCT00875017|21396358|P6|COMPLETED|Second Intervention||5
8666969|NCT00875017|21396359|P5|COMPLETED|Second Intervention||4
8666970|NCT00875017|21396360|P4|COMPLETED|Second Intervention||4
8666971|NCT00875017|21396361|P3|COMPLETED|Second Intervention||3
8666972|NCT00875017|21396362|P2|COMPLETED|Second Intervention||5
8666973|NCT00875017|21396363|P1|COMPLETED|Second Intervention||3
8666974|NCT00875017|21396358|P6|STARTED|Second Intervention||5
8666975|NCT00875017|21396359|P5|STARTED|Second Intervention||4
8666976|NCT00875017|21396360|P4|STARTED|Second Intervention||5
8666977|NCT00875017|21396361|P3|STARTED|Second Intervention||3
8666978|NCT00875017|21396362|P2|STARTED|Second Intervention||5
8666979|NCT00875017|21396363|P1|STARTED|Second Intervention||3
8666980|NCT00875017|21396358|P6|NOT COMPLETED|Washout||0
8666981|NCT00875017|21396359|P5|NOT COMPLETED|Washout||0
8666982|NCT00875017|21396360|P4|NOT COMPLETED|Washout||0
8666983|NCT00875017|21396361|P3|NOT COMPLETED|Washout||1
8666984|NCT00875017|21396362|P2|NOT COMPLETED|Washout||0
8666985|NCT00875017|21396363|P1|NOT COMPLETED|Washout||0
8666986|NCT00875017|21396358|P6|COMPLETED|Washout||5
8666987|NCT00875017|21396359|P5|COMPLETED|Washout||4
8666988|NCT00875017|21396360|P4|COMPLETED|Washout||5
8666989|NCT00875017|21396361|P3|COMPLETED|Washout||3
8666990|NCT00875017|21396362|P2|COMPLETED|Washout||5
8666991|NCT00875017|21396363|P1|COMPLETED|Washout||3
8666992|NCT00875017|21396358|P6|STARTED|Washout||5
8666993|NCT00875017|21396359|P5|STARTED|Washout||4
8666994|NCT00875017|21396360|P4|STARTED|Washout||5
8666995|NCT00875017|21396361|P3|STARTED|Washout||4
8666996|NCT00875017|21396362|P2|STARTED|Washout||5
8666997|NCT00875017|21396363|P1|STARTED|Washout||3
8666998|NCT00875017|21396358|P6|NOT COMPLETED|First Intervention||0
8666999|NCT00875017|21396359|P5|NOT COMPLETED|First Intervention||1
8667000|NCT00875017|21396360|P4|NOT COMPLETED|First Intervention||1
8667001|NCT00875017|21396361|P3|NOT COMPLETED|First Intervention||1
8667002|NCT00875017|21396362|P2|NOT COMPLETED|First Intervention||0
8667003|NCT00875017|21396363|P1|NOT COMPLETED|First Intervention||2
8667004|NCT00875017|21396358|P6|COMPLETED|First Intervention||5
8667005|NCT00875017|21396359|P5|COMPLETED|First Intervention||4
8667006|NCT00875017|21396360|P4|COMPLETED|First Intervention||5
8667007|NCT00875017|21396361|P3|COMPLETED|First Intervention||4
8667008|NCT00875017|21396362|P2|COMPLETED|First Intervention||5
8667009|NCT00875017|21396363|P1|COMPLETED|First Intervention||3
8667010|NCT00875017|21396358|P6|STARTED|First Intervention||5
8667011|NCT00875017|21396359|P5|STARTED|First Intervention||5
8667012|NCT00875017|21396360|P4|STARTED|First Intervention||6
8667013|NCT00875017|21396361|P3|STARTED|First Intervention||5
8667014|NCT00875017|21396362|P2|STARTED|First Intervention||5
8667015|NCT00875017|21396363|P1|STARTED|First Intervention||5
8667016|NCT00843726|21396379|P2|NOT COMPLETED|Overall Study||1
8667017|NCT00843726|21396380|P1|NOT COMPLETED|Overall Study||1
8667018|NCT00843726|21396379|P2|COMPLETED|Overall Study||48
8667019|NCT00843726|21396380|P1|COMPLETED|Overall Study||48
8667020|NCT00843726|21396379|P2|STARTED|Overall Study||49
8667021|NCT00843726|21396380|P1|STARTED|Overall Study||49
8667022|NCT04446429|21396392|P2|NOT COMPLETED|Overall Study||0
8667023|NCT04446429|21396393|P1|NOT COMPLETED|Overall Study||6
8667024|NCT04446429|21396392|P2|COMPLETED|Overall Study||134
8667025|NCT04446429|21396393|P1|COMPLETED|Overall Study|In placebo group, 6 patients were lost to follow-up but were included in intention-to-treat analysis.|128
8667026|NCT04446429|21396392|P2|STARTED|Overall Study||134
8667027|NCT04446429|21396393|P1|STARTED|Overall Study||134
8667028|NCT04132336|21396406|P7|NOT COMPLETED|Overall Study||0
8667029|NCT04132336|21396407|P6|NOT COMPLETED|Overall Study||0
8667030|NCT04132336|21396408|P5|NOT COMPLETED|Overall Study||0
8667031|NCT04132336|21396409|P4|NOT COMPLETED|Overall Study||0
8667032|NCT04132336|21396410|P3|NOT COMPLETED|Overall Study||0
8667033|NCT04132336|21396411|P2|NOT COMPLETED|Overall Study||1
8667034|NCT04132336|21396412|P1|NOT COMPLETED|Overall Study||0
8667035|NCT04132336|21396406|P7|COMPLETED|Overall Study||17
8667036|NCT04132336|21396407|P6|COMPLETED|Overall Study||16
8667037|NCT04132336|21396408|P5|COMPLETED|Overall Study||32
8667038|NCT04132336|21396409|P4|COMPLETED|Overall Study||32
8667039|NCT04132336|21396410|P3|COMPLETED|Overall Study||32
8667040|NCT04132336|21396411|P2|COMPLETED|Overall Study||31
8667041|NCT04132336|21396412|P1|COMPLETED|Overall Study||32
8667042|NCT04132336|21396406|P7|STARTED|Overall Study||17
8667043|NCT04132336|21396407|P6|STARTED|Overall Study||16
8667044|NCT04132336|21396408|P5|STARTED|Overall Study||32
8667045|NCT04132336|21396409|P4|STARTED|Overall Study||32
8667046|NCT04132336|21396410|P3|STARTED|Overall Study||32
8667047|NCT04132336|21396411|P2|STARTED|Overall Study||32
8667048|NCT04132336|21396412|P1|STARTED|Overall Study||32
8667049|NCT04087395|21396505|P1|NOT COMPLETED|Overall Study||0
8667050|NCT04087395|21396505|P1|COMPLETED|Overall Study||30
8667051|NCT04087395|21396505|P1|STARTED|Overall Study||30
8667052|NCT04069585|21396511|P1|NOT COMPLETED|Overall Study||0
8667053|NCT04069585|21396511|P1|COMPLETED|Overall Study||30
8667054|NCT04069585|21396511|P1|STARTED|Overall Study||30
8667055|NCT03824704|21396517|P1|NOT COMPLETED|Overall Study||1
8667056|NCT03824704|21396517|P1|COMPLETED|Overall Study||0
8667057|NCT03824704|21396517|P1|STARTED|Overall Study||1
8667058|NCT03768726|21396527|P2|NOT COMPLETED|Follow-Up||3
8667059|NCT03768726|21396528|P1|NOT COMPLETED|Follow-Up||6
8667060|NCT03768726|21396527|P2|COMPLETED|Follow-Up||9
8667061|NCT03768726|21396528|P1|COMPLETED|Follow-Up||2
8667062|NCT03768726|21396527|P2|Received Treatment|Follow-Up||12
8667063|NCT03768726|21396528|P1|Received Treatment|Follow-Up||8
8667064|NCT03768726|21396527|P2|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|12
8667065|NCT03768726|21396528|P1|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|8
8667066|NCT03768726|21396527|P2|NOT COMPLETED|Treatment Phase||3
8667067|NCT03768726|21396528|P1|NOT COMPLETED|Treatment Phase||8
8667068|NCT03768726|21396527|P2|COMPLETED|Treatment Phase||10
8667069|NCT03768726|21396528|P1|COMPLETED|Treatment Phase||2
8667070|NCT03768726|21396527|P2|STARTED|Treatment Phase||13
8667071|NCT03768726|21396528|P1|STARTED|Treatment Phase||10
8667072|NCT03731182|21396572|P2|NOT COMPLETED|Overall Study||0
8667073|NCT03731182|21396573|P1|NOT COMPLETED|Overall Study||5
8667074|NCT03731182|21396572|P2|COMPLETED|Overall Study||34
8667075|NCT03731182|21396573|P1|COMPLETED|Overall Study||65
8667076|NCT03731182|21396572|P2|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||34
8667077|NCT03731182|21396573|P1|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||69
8667078|NCT03731182|21396572|P2|STARTED|Overall Study||34
8667079|NCT03731182|21396573|P1|STARTED|Overall Study||70
8667080|NCT03727347|21396591|P1|NOT COMPLETED|Overall Study||3
8667081|NCT03727347|21396591|P1|COMPLETED|Overall Study||47
8667082|NCT03727347|21396591|P1|52-week Evaluation|Overall Study||47
8667083|NCT03727347|21396591|P1|26-week Evaluation|Overall Study||48
8667084|NCT03727347|21396591|P1|12-week Primary Endpoint Evaluation|Overall Study||50
8667085|NCT03727347|21396591|P1|4-week Evaluation|Overall Study||50
8667086|NCT03727347|21396591|P1|2-week Evaluation|Overall Study||50
8667087|NCT03727347|21396591|P1|STARTED|Overall Study||50
8667112|NCT03515681|21396653|P2|NOT COMPLETED|Overall Study||45
8667113|NCT03515681|21396654|P1|NOT COMPLETED|Overall Study||33
8667114|NCT03515681|21396653|P2|COMPLETED|Overall Study||25
8667115|NCT03515681|21396654|P1|COMPLETED|Overall Study||37
8667116|NCT03515681|21396653|P2|Completed at 6 Months|Overall Study||62
8667117|NCT03515681|21396654|P1|Completed at 6 Months|Overall Study||61
8667118|NCT03515681|21396653|P2|Randomized|Overall Study||70
8667119|NCT03515681|21396654|P1|Randomized|Overall Study||70
8667120|NCT03515681|21396653|P2|STARTED|Overall Study||70
8667121|NCT03515681|21396654|P1|STARTED|Overall Study||70
8667122|NCT03451773|21396674|P2|NOT COMPLETED|Overall Study||6
8667123|NCT03451773|21396675|P1|NOT COMPLETED|Overall Study||1
8667124|NCT03451773|21396674|P2|COMPLETED|Overall Study||0
8667125|NCT03451773|21396675|P1|COMPLETED|Overall Study||0
8667126|NCT03451773|21396674|P2|STARTED|Overall Study||6
8667127|NCT03451773|21396675|P1|STARTED|Overall Study||1
8667128|NCT03449134|21396700|P3|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
8667129|NCT03449134|21396701|P2|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
8667130|NCT03449134|21396702|P1|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
8667131|NCT03449134|21396700|P3|COMPLETED|12-Week Off-Treatment Durability Period||13
8667132|NCT03449134|21396701|P2|COMPLETED|12-Week Off-Treatment Durability Period||18
8667133|NCT03449134|21396702|P1|COMPLETED|12-Week Off-Treatment Durability Period||10
8667134|NCT03449134|21396700|P3|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|13
8667135|NCT03449134|21396701|P2|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|18
8667136|NCT03449134|21396702|P1|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|10
8667137|NCT03449134|21396700|P3|NOT COMPLETED|52-Week Treatment Period||60
8667138|NCT03449134|21396701|P2|NOT COMPLETED|52-Week Treatment Period||44
8667139|NCT03449134|21396702|P1|NOT COMPLETED|52-Week Treatment Period||45
8667140|NCT03449134|21396700|P3|COMPLETED|52-Week Treatment Period||184
8667141|NCT03449134|21396701|P2|COMPLETED|52-Week Treatment Period||200
8667142|NCT03449134|21396702|P1|COMPLETED|52-Week Treatment Period||199
8667143|NCT03449134|21396700|P3|Treated|52-Week Treatment Period||243
8667144|NCT03449134|21396701|P2|Treated|52-Week Treatment Period||244
8667145|NCT03449134|21396702|P1|Treated|52-Week Treatment Period||243
8667146|NCT03449134|21396700|P3|STARTED|52-Week Treatment Period||244
8667147|NCT03449134|21396701|P2|STARTED|52-Week Treatment Period||244
8667148|NCT03449134|21396702|P1|STARTED|52-Week Treatment Period||244
8667149|NCT03403231|21396753|P16|NOT COMPLETED|Overall Study||0
8667150|NCT03403231|21396754|P15|NOT COMPLETED|Overall Study||0
8667151|NCT03403231|21396755|P14|NOT COMPLETED|Overall Study||0
8667152|NCT03403231|21396756|P13|NOT COMPLETED|Overall Study||0
8667153|NCT03403231|21396757|P12|NOT COMPLETED|Overall Study||0
8667154|NCT03403231|21396758|P11|NOT COMPLETED|Overall Study||0
8667155|NCT03403231|21396759|P10|NOT COMPLETED|Overall Study||0
8667156|NCT03403231|21396760|P9|NOT COMPLETED|Overall Study||0
8667157|NCT03403231|21396761|P8|NOT COMPLETED|Overall Study||0
8667158|NCT03403231|21396762|P7|NOT COMPLETED|Overall Study||0
8667159|NCT03403231|21396763|P6|NOT COMPLETED|Overall Study||0
8667160|NCT03403231|21396764|P5|NOT COMPLETED|Overall Study||0
8667161|NCT03403231|21396765|P4|NOT COMPLETED|Overall Study||0
8667162|NCT03403231|21396766|P3|NOT COMPLETED|Overall Study||0
8667163|NCT03403231|21396767|P2|NOT COMPLETED|Overall Study||0
8667164|NCT03403231|21396768|P1|NOT COMPLETED|Overall Study||0
8667165|NCT03403231|21396753|P16|COMPLETED|Overall Study||9
8667166|NCT03403231|21396754|P15|COMPLETED|Overall Study||9
8667167|NCT03403231|21396755|P14|COMPLETED|Overall Study||9
8667168|NCT03403231|21396756|P13|COMPLETED|Overall Study||9
8667169|NCT03403231|21396757|P12|COMPLETED|Overall Study||9
8667170|NCT03403231|21396758|P11|COMPLETED|Overall Study||9
8667171|NCT03403231|21396759|P10|COMPLETED|Overall Study||9
8667172|NCT03403231|21396760|P9|COMPLETED|Overall Study||9
8667173|NCT03403231|21396761|P8|COMPLETED|Overall Study||9
8667174|NCT03403231|21396762|P7|COMPLETED|Overall Study||9
8667175|NCT03403231|21396763|P6|COMPLETED|Overall Study||9
8667176|NCT03403231|21396764|P5|COMPLETED|Overall Study||9
8667177|NCT03403231|21396765|P4|COMPLETED|Overall Study||9
8667178|NCT03403231|21396766|P3|COMPLETED|Overall Study||9
8667179|NCT03403231|21396767|P2|COMPLETED|Overall Study||9
8667180|NCT03403231|21396768|P1|COMPLETED|Overall Study||9
8667181|NCT03403231|21396753|P16|STARTED|Overall Study||9
8667182|NCT03403231|21396754|P15|STARTED|Overall Study||9
8667183|NCT03403231|21396755|P14|STARTED|Overall Study||9
8667184|NCT03403231|21396756|P13|STARTED|Overall Study||9
8667185|NCT03403231|21396757|P12|STARTED|Overall Study||9
8667186|NCT03403231|21396758|P11|STARTED|Overall Study||9
8667187|NCT03403231|21396759|P10|STARTED|Overall Study||9
8667188|NCT03403231|21396760|P9|STARTED|Overall Study||9
8667189|NCT03403231|21396761|P8|STARTED|Overall Study||9
8667190|NCT03403231|21396762|P7|STARTED|Overall Study||9
8667191|NCT03403231|21396763|P6|STARTED|Overall Study||9
8667192|NCT03403231|21396764|P5|STARTED|Overall Study||9
8667193|NCT03403231|21396765|P4|STARTED|Overall Study||9
8667194|NCT03403231|21396766|P3|STARTED|Overall Study||9
8667195|NCT03403231|21396767|P2|STARTED|Overall Study||9
8667196|NCT03403231|21396768|P1|STARTED|Overall Study||9
8667197|NCT03364738|21396930|P1|NOT COMPLETED|Overall Study||8
8667198|NCT03364738|21396930|P1|COMPLETED|Overall Study||14
8667199|NCT03364738|21396930|P1|STARTED|Overall Study||22
8667200|NCT03287947|21396954|P1|NOT COMPLETED|Overall Study||0
8667201|NCT03287947|21396954|P1|COMPLETED|Overall Study|All subjects enrolled discontinued treatment and are now off study.|5
8667202|NCT03287947|21396954|P1|STARTED|Overall Study|Five subjects were enrolled to the study.|5
8667203|NCT03186781|21396967|P6|NOT COMPLETED|Overall Study||0
8667204|NCT03186781|21396968|P5|NOT COMPLETED|Overall Study||3
8667205|NCT03186781|21396969|P4|NOT COMPLETED|Overall Study||0
8667206|NCT03186781|21396970|P3|NOT COMPLETED|Overall Study||1
8667207|NCT03186781|21396971|P2|NOT COMPLETED|Overall Study||0
8667208|NCT03186781|21396972|P1|NOT COMPLETED|Overall Study||0
8667209|NCT03186781|21396967|P6|COMPLETED|Overall Study||10
8667210|NCT03186781|21396968|P5|COMPLETED|Overall Study||7
8667211|NCT03186781|21396969|P4|COMPLETED|Overall Study||10
8667212|NCT03186781|21396970|P3|COMPLETED|Overall Study||9
8667213|NCT03186781|21396971|P2|COMPLETED|Overall Study||5
8667214|NCT03186781|21396972|P1|COMPLETED|Overall Study||5
8667215|NCT03186781|21396967|P6|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
8667216|NCT03186781|21396968|P5|Received All Product Administrations|Overall Study|2nd dose not given due to subject decision to withdraw (n=2)|8
8667217|NCT03186781|21396969|P4|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
8667218|NCT03186781|21396970|P3|Received All Product Administrations|Overall Study|2nd dose not given due to unrelated intercurrent illness (n=1) and lost to follow up (n=1)|8
8667219|NCT03186781|21396971|P2|Received All Product Administrations|Overall Study||5
8667220|NCT03186781|21396972|P1|Received All Product Administrations|Overall Study||5
8667221|NCT03186781|21396967|P6|Received First Product Administration|Overall Study||10
8667222|NCT03186781|21396968|P5|Received First Product Administration|Overall Study||10
8667223|NCT03186781|21396969|P4|Received First Product Administration|Overall Study||10
8667224|NCT03186781|21396970|P3|Received First Product Administration|Overall Study||10
8667225|NCT03186781|21396971|P2|Received First Product Administration|Overall Study||5
8667226|NCT03186781|21396972|P1|Received First Product Administration|Overall Study||5
8667227|NCT03186781|21396967|P6|STARTED|Overall Study||10
8667228|NCT03186781|21396968|P5|STARTED|Overall Study||10
8667229|NCT03186781|21396969|P4|STARTED|Overall Study||10
8667230|NCT03186781|21396970|P3|STARTED|Overall Study||10
8667231|NCT03186781|21396971|P2|STARTED|Overall Study||5
8667232|NCT03186781|21396972|P1|STARTED|Overall Study||5
8667233|NCT03156270|21397038|P1|NOT COMPLETED|Overall Study||2
8667234|NCT03156270|21397038|P1|COMPLETED|Overall Study||18
8667235|NCT03156270|21397038|P1|STARTED|Overall Study||20
8667242|NCT03021499|21397095|P2|NOT COMPLETED|Overall Study||31
8667243|NCT03021499|21397096|P1|NOT COMPLETED|Overall Study||16
8667244|NCT03021499|21397095|P2|COMPLETED|Overall Study||147
8667245|NCT03021499|21397096|P1|COMPLETED|Overall Study||163
8667246|NCT03021499|21397095|P2|Week 52|Overall Study||147
8667247|NCT03021499|21397096|P1|Week 52|Overall Study||162
8667248|NCT03021499|21397095|P2|Week 24|Overall Study||162
8667249|NCT03021499|21397096|P1|Week 24|Overall Study||167
8667250|NCT03021499|21397095|P2|STARTED|Overall Study||178
8667251|NCT03021499|21397096|P1|STARTED|Overall Study||179
8667252|NCT02958527|21397128|P1|NOT COMPLETED|Overall Study||12
8667253|NCT02958527|21397128|P1|COMPLETED|Overall Study||1396
8667254|NCT02958527|21397128|P1|STARTED|Overall Study||1408
8667255|NCT02948426|21397147|P4|NOT COMPLETED|Overall Study||0
8667256|NCT02948426|21397148|P3|NOT COMPLETED|Overall Study||0
8667257|NCT02948426|21397149|P2|NOT COMPLETED|Overall Study||0
8667258|NCT02948426|21397150|P1|NOT COMPLETED|Overall Study||0
8667259|NCT02948426|21397147|P4|COMPLETED|Overall Study||6
8667260|NCT02948426|21397148|P3|COMPLETED|Overall Study||3
8667261|NCT02948426|21397149|P2|COMPLETED|Overall Study||6
8667262|NCT02948426|21397150|P1|COMPLETED|Overall Study||3
8667263|NCT02948426|21397147|P4|STARTED|Overall Study||6
8667264|NCT02948426|21397148|P3|STARTED|Overall Study||3
8667265|NCT02948426|21397149|P2|STARTED|Overall Study||6
8667266|NCT02948426|21397150|P1|STARTED|Overall Study||3
8667276|NCT02778932|21397213|P2|NOT COMPLETED|Overall Study||0
8667277|NCT02778932|21397214|P1|NOT COMPLETED|Overall Study||0
8667278|NCT02778932|21397213|P2|COMPLETED|Overall Study||74
8667279|NCT02778932|21397214|P1|COMPLETED|Overall Study||74
8667280|NCT02778932|21397213|P2|STARTED|Overall Study||74
8667281|NCT02778932|21397214|P1|STARTED|Overall Study||74
8667282|NCT02684136|21397222|P2|NOT COMPLETED|Second Intervention (9 Nights)||0
8667283|NCT02684136|21397223|P1|NOT COMPLETED|Second Intervention (9 Nights)||0
8667284|NCT02684136|21397222|P2|COMPLETED|Second Intervention (9 Nights)||5
8667285|NCT02684136|21397223|P1|COMPLETED|Second Intervention (9 Nights)||5
8667286|NCT02684136|21397222|P2|STARTED|Second Intervention (9 Nights)||5
8667287|NCT02684136|21397223|P1|STARTED|Second Intervention (9 Nights)||5
8667288|NCT02684136|21397222|P2|NOT COMPLETED|Washout (7 Days)||0
8667289|NCT02684136|21397223|P1|NOT COMPLETED|Washout (7 Days)||0
8667290|NCT02684136|21397222|P2|COMPLETED|Washout (7 Days)||5
8667291|NCT02684136|21397223|P1|COMPLETED|Washout (7 Days)||5
8667292|NCT02684136|21397222|P2|STARTED|Washout (7 Days)||5
8667293|NCT02684136|21397223|P1|STARTED|Washout (7 Days)||5
8667294|NCT02684136|21397222|P2|NOT COMPLETED|First Intervention (9 Nights)||0
8667295|NCT02684136|21397223|P1|NOT COMPLETED|First Intervention (9 Nights)||0
8667296|NCT02684136|21397222|P2|COMPLETED|First Intervention (9 Nights)||5
8667297|NCT02684136|21397223|P1|COMPLETED|First Intervention (9 Nights)||5
8667298|NCT02684136|21397222|P2|STARTED|First Intervention (9 Nights)||5
8667299|NCT02684136|21397223|P1|STARTED|First Intervention (9 Nights)||5
8667318|NCT02588586|21397308|P1|NOT COMPLETED|Overall Study||2
8667319|NCT02588586|21397308|P1|COMPLETED|Overall Study||15
8667320|NCT02588586|21397308|P1|STARTED|Overall Study||17
8667327|NCT02459964|21397333|P3|NOT COMPLETED|Overall Study||2
8667328|NCT02459964|21397334|P2|NOT COMPLETED|Overall Study||0
8667329|NCT02459964|21397335|P1|NOT COMPLETED|Overall Study||0
8667330|NCT02459964|21397333|P3|COMPLETED|Overall Study||0
8667331|NCT02459964|21397334|P2|COMPLETED|Overall Study||40
8667332|NCT02459964|21397335|P1|COMPLETED|Overall Study||42
8667333|NCT02459964|21397333|P3|STARTED|Overall Study||2
8667334|NCT02459964|21397334|P2|STARTED|Overall Study||40
8667335|NCT02459964|21397335|P1|STARTED|Overall Study||42
8667354|NCT02372136|21397383|P2|NOT COMPLETED|Overall Study||1
8667355|NCT02372136|21397384|P1|NOT COMPLETED|Overall Study||3
8667356|NCT02372136|21397383|P2|COMPLETED|Overall Study||57
8667357|NCT02372136|21397384|P1|COMPLETED|Overall Study||59
8667358|NCT02372136|21397383|P2|STARTED|Overall Study||58
8667359|NCT02372136|21397384|P1|STARTED|Overall Study||62
8667360|NCT02371850|21397398|P1|NOT COMPLETED|Overall Study||0
8667361|NCT02371850|21397398|P1|COMPLETED|Overall Study||10
8667362|NCT02371850|21397398|P1|STARTED|Overall Study||10
8667366|NCT02328105|21397420|P1|NOT COMPLETED|Overall Study||11
8667367|NCT02328105|21397420|P1|COMPLETED|Overall Study||0
8667368|NCT02328105|21397420|P1|STARTED|Overall Study||11
8667369|NCT02243020|21397431|P2|NOT COMPLETED|Overall Study||0
8667370|NCT02243020|21397432|P1|NOT COMPLETED|Overall Study||0
8667371|NCT02243020|21397431|P2|COMPLETED|Overall Study||9
8667372|NCT02243020|21397432|P1|COMPLETED|Overall Study||8
8667373|NCT02243020|21397431|P2|STARTED|Overall Study||9
8667374|NCT02243020|21397432|P1|STARTED|Overall Study||8
8667375|NCT02197234|21397440|P1|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
8667376|NCT02197234|21397440|P1|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
8667377|NCT02197234|21397440|P1|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
8667378|NCT02197234|21397440|P1|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
8667379|NCT02197234|21397440|P1|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
8667380|NCT02197234|21397440|P1|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
8667381|NCT02197234|21397440|P1|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
8667382|NCT02197234|21397440|P1|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
8667383|NCT02197234|21397440|P1|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
8667384|NCT02197234|21397440|P1|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
8667385|NCT02197234|21397440|P1|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
8667386|NCT02197234|21397440|P1|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
8667387|NCT02163733|21397461|P3|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
8667388|NCT02163733|21397462|P2|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
8667389|NCT02163733|21397463|P1|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
8667390|NCT02163733|21397461|P3|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
8667391|NCT02163733|21397462|P2|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
8667392|NCT02163733|21397463|P1|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
8667393|NCT02163733|21397461|P3|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
8667394|NCT02163733|21397462|P2|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
8667395|NCT02163733|21397463|P1|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
8667396|NCT02163733|21397461|P3|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
8667397|NCT02163733|21397462|P2|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
8667398|NCT02163733|21397463|P1|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
8667399|NCT02163733|21397461|P3|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
8667400|NCT02163733|21397462|P2|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
8667401|NCT02163733|21397463|P1|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
8667402|NCT02163733|21397461|P3|STARTED|Part A: Day 10-15 (2nd Intervention)||0
8667403|NCT02163733|21397462|P2|STARTED|Part A: Day 10-15 (2nd Intervention)||20
8667404|NCT02163733|21397463|P1|STARTED|Part A: Day 10-15 (2nd Intervention)||18
8667405|NCT02163733|21397461|P3|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
8667406|NCT02163733|21397462|P2|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
8667407|NCT02163733|21397463|P1|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
8667408|NCT02163733|21397461|P3|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
8667409|NCT02163733|21397462|P2|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
8667410|NCT02163733|21397463|P1|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
8667411|NCT02163733|21397461|P3|STARTED|Part A: Day 1-9 (1st Intervention)||0
8667412|NCT02163733|21397462|P2|STARTED|Part A: Day 1-9 (1st Intervention)||20
8667413|NCT02163733|21397463|P1|STARTED|Part A: Day 1-9 (1st Intervention)||18
8667414|NCT02157883|21397498|P1|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
8667415|NCT02157883|21397498|P1|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
8667416|NCT02157883|21397498|P1|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
8667417|NCT02157883|21397498|P1|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
8667418|NCT02157883|21397498|P1|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
8667419|NCT02157883|21397498|P1|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
8667420|NCT02157883|21397498|P1|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
8667421|NCT02157883|21397498|P1|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
8667422|NCT02157883|21397498|P1|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
8667423|NCT02121002|21397530|P3|NOT COMPLETED|Overall Study||10
8667424|NCT02121002|21397531|P2|NOT COMPLETED|Overall Study||4
8667425|NCT02121002|21397532|P1|NOT COMPLETED|Overall Study||7
8667426|NCT02121002|21397530|P3|COMPLETED|Overall Study||381
8667427|NCT02121002|21397531|P2|COMPLETED|Overall Study||389
8667428|NCT02121002|21397532|P1|COMPLETED|Overall Study||385
8667429|NCT02121002|21397530|P3|STARTED|Overall Study||391
8667430|NCT02121002|21397531|P2|STARTED|Overall Study||393
8667431|NCT02121002|21397532|P1|STARTED|Overall Study||392
8667432|NCT02103218|21397544|P4|NOT COMPLETED|Overall Study||7
8667433|NCT02103218|21397545|P3|NOT COMPLETED|Overall Study||4
8667434|NCT02103218|21397546|P2|NOT COMPLETED|Overall Study||8
8667435|NCT02103218|21397547|P1|NOT COMPLETED|Overall Study||5
8667436|NCT02103218|21397544|P4|COMPLETED|Overall Study||47
8667437|NCT02103218|21397545|P3|COMPLETED|Overall Study||44
8667438|NCT02103218|21397546|P2|COMPLETED|Overall Study||51
8667439|NCT02103218|21397547|P1|COMPLETED|Overall Study||46
8667440|NCT02103218|21397544|P4|STARTED|Overall Study||54
8667441|NCT02103218|21397545|P3|STARTED|Overall Study||48
8667442|NCT02103218|21397546|P2|STARTED|Overall Study||59
8667443|NCT02103218|21397547|P1|STARTED|Overall Study||51
8667444|NCT02075047|21397593|P2|NOT COMPLETED|Follow up Phase (5 Weeks)||13
8667445|NCT02075047|21397594|P1|NOT COMPLETED|Follow up Phase (5 Weeks)||26
8667446|NCT02075047|21397593|P2|COMPLETED|Follow up Phase (5 Weeks)||72
8667447|NCT02075047|21397594|P1|COMPLETED|Follow up Phase (5 Weeks)||60
8667448|NCT02075047|21397593|P2|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|85
8667449|NCT02075047|21397594|P1|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|86
8667450|NCT02075047|21397593|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||10
8667451|NCT02075047|21397594|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||23
8667452|NCT02075047|21397593|P2|COMPLETED|Treatment Phase (4 Weeks)||75
8667453|NCT02075047|21397594|P1|COMPLETED|Treatment Phase (4 Weeks)||63
8667454|NCT02075047|21397593|P2|STARTED|Treatment Phase (4 Weeks)||85
8667455|NCT02075047|21397594|P1|STARTED|Treatment Phase (4 Weeks)||86
8667464|NCT02062008|21397661|P1|NOT COMPLETED|Overall Study||0
8667465|NCT02062008|21397661|P1|COMPLETED|Overall Study||2
8667466|NCT02062008|21397661|P1|STARTED|Overall Study||2
8667467|NCT02032810|21397667|P2|NOT COMPLETED|Overall Study||0
8667468|NCT02032810|21397668|P1|NOT COMPLETED|Overall Study||0
8667469|NCT02032810|21397667|P2|COMPLETED|Overall Study||11
8667470|NCT02032810|21397668|P1|COMPLETED|Overall Study||6
8667471|NCT02032810|21397667|P2|STARTED|Overall Study||11
8667472|NCT02032810|21397668|P1|STARTED|Overall Study||6
8667473|NCT01780662|21397682|P3|NOT COMPLETED|Overall Study||10
8667474|NCT01780662|21397683|P2|NOT COMPLETED|Overall Study||6
8667475|NCT01780662|21397684|P1|NOT COMPLETED|Overall Study||1
8667476|NCT01780662|21397682|P3|COMPLETED|Overall Study||20
8667477|NCT01780662|21397683|P2|COMPLETED|Overall Study||7
8667478|NCT01780662|21397684|P1|COMPLETED|Overall Study||2
8667479|NCT01780662|21397682|P3|STARTED|Overall Study||30
8667480|NCT01780662|21397683|P2|STARTED|Overall Study||13
8667481|NCT01780662|21397684|P1|STARTED|Overall Study||3
8667482|NCT01771055|21397700|P2|NOT COMPLETED|Overall Study||0
8667483|NCT01771055|21397701|P1|NOT COMPLETED|Overall Study||0
8667484|NCT01771055|21397700|P2|COMPLETED|Overall Study||3
8667485|NCT01771055|21397701|P1|COMPLETED|Overall Study||4
8667486|NCT01771055|21397700|P2|STARTED|Overall Study||3
8667487|NCT01771055|21397701|P1|STARTED|Overall Study||4
8667535|NCT01527162|21397947|P2|NOT COMPLETED|Overall Study||0
8667536|NCT01527162|21397948|P1|NOT COMPLETED|Overall Study||0
8667537|NCT01527162|21397947|P2|COMPLETED|Overall Study||5
8667538|NCT01527162|21397948|P1|COMPLETED|Overall Study||6
8667539|NCT01527162|21397947|P2|STARTED|Overall Study||5
8667540|NCT01527162|21397948|P1|STARTED|Overall Study||6
8667541|NCT01509612|21397961|P3|NOT COMPLETED|Overall Study||0
8667542|NCT01509612|21397962|P2|NOT COMPLETED|Overall Study||0
8667543|NCT01509612|21397963|P1|NOT COMPLETED|Overall Study||0
8667544|NCT01509612|21397961|P3|COMPLETED|Overall Study||52
8667545|NCT01509612|21397962|P2|COMPLETED|Overall Study||51
8667546|NCT01509612|21397963|P1|COMPLETED|Overall Study||47
8667547|NCT01509612|21397961|P3|STARTED|Overall Study||52
8667548|NCT01509612|21397962|P2|STARTED|Overall Study||51
8667549|NCT01509612|21397963|P1|STARTED|Overall Study||47
8667550|NCT01500694|21397976|P2|NOT COMPLETED|Overall Study||29
8667551|NCT01500694|21397977|P1|NOT COMPLETED|Overall Study||52
8667552|NCT01500694|21397976|P2|COMPLETED|Overall Study||54
8667553|NCT01500694|21397977|P1|COMPLETED|Overall Study||79
8667554|NCT01500694|21397976|P2|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
8667555|NCT01500694|21397977|P1|STARTED|Overall Study||131
8667567|NCT01349959|21398031|P1|NOT COMPLETED|Overall Study||7
8667568|NCT01349959|21398031|P1|COMPLETED|Overall Study||33
8667569|NCT01349959|21398031|P1|STARTED|Overall Study||40
8667570|NCT01338415|21398044|P3|NOT COMPLETED|Exceptional Use Treatment Period||6
8667571|NCT01338415|21398045|P2|NOT COMPLETED|Exceptional Use Treatment Period||0
8667572|NCT01338415|21398046|P1|NOT COMPLETED|Exceptional Use Treatment Period||0
8667573|NCT01338415|21398044|P3|COMPLETED|Exceptional Use Treatment Period||4
8667574|NCT01338415|21398045|P2|COMPLETED|Exceptional Use Treatment Period||0
8667575|NCT01338415|21398046|P1|COMPLETED|Exceptional Use Treatment Period||0
8667576|NCT01338415|21398044|P3|STARTED|Exceptional Use Treatment Period||10
8667577|NCT01338415|21398045|P2|STARTED|Exceptional Use Treatment Period||0
8667578|NCT01338415|21398046|P1|STARTED|Exceptional Use Treatment Period||0
8667579|NCT01338415|21398044|P3|NOT COMPLETED|Core + Extension||0
8667580|NCT01338415|21398045|P2|NOT COMPLETED|Core + Extension||9
8667581|NCT01338415|21398046|P1|NOT COMPLETED|Core + Extension||10
8667582|NCT01338415|21398044|P3|COMPLETED|Core + Extension||0
8667583|NCT01338415|21398045|P2|COMPLETED|Core + Extension||22
8667584|NCT01338415|21398046|P1|COMPLETED|Core + Extension||23
8667585|NCT01338415|21398044|P3|Enrolled in FUTURE 3 Extension|Core + Extension||0
8667586|NCT01338415|21398045|P2|Enrolled in FUTURE 3 Extension|Core + Extension||27
8667587|NCT01338415|21398046|P1|Enrolled in FUTURE 3 Extension|Core + Extension||31
8667588|NCT01338415|21398044|P3|STARTED|Core + Extension||0
8667589|NCT01338415|21398045|P2|STARTED|Core + Extension||31
8667590|NCT01338415|21398046|P1|STARTED|Core + Extension||33
8667591|NCT01256398|21398076|P1|NOT COMPLETED|Overall Study||1
8667592|NCT01256398|21398076|P1|COMPLETED|Overall Study||65
8667593|NCT01256398|21398076|P1|STARTED|Overall Study||66
8667597|NCT01211483|21398088|P4|NOT COMPLETED|Phase 2||71
8667598|NCT01211483|21398089|P3|NOT COMPLETED|Phase 2||72
8667599|NCT01211483|21398090|P2|NOT COMPLETED|Phase 2||72
8667600|NCT01211483|21398091|P1|NOT COMPLETED|Phase 2||0
8667601|NCT01211483|21398088|P4|COMPLETED|Phase 2||0
8667602|NCT01211483|21398089|P3|COMPLETED|Phase 2||0
8667603|NCT01211483|21398090|P2|COMPLETED|Phase 2||0
8667604|NCT01211483|21398091|P1|COMPLETED|Phase 2||0
8667605|NCT01211483|21398088|P4|STARTED|Phase 2|Participants entered only at Period 2.|71
8667606|NCT01211483|21398089|P3|STARTED|Phase 2|Participants entered only at Period 2.|72
8667607|NCT01211483|21398090|P2|STARTED|Phase 2|Participants entered only at Period 2.|72
8667608|NCT01211483|21398091|P1|STARTED|Phase 2||0
8667609|NCT01211483|21398088|P4|NOT COMPLETED|Phase 1b||0
8667610|NCT01211483|21398089|P3|NOT COMPLETED|Phase 1b||0
8667611|NCT01211483|21398090|P2|NOT COMPLETED|Phase 1b||0
8667612|NCT01211483|21398091|P1|NOT COMPLETED|Phase 1b||7
8667613|NCT01211483|21398088|P4|COMPLETED|Phase 1b||0
8667614|NCT01211483|21398089|P3|COMPLETED|Phase 1b||0
8667615|NCT01211483|21398090|P2|COMPLETED|Phase 1b||0
8667616|NCT01211483|21398091|P1|COMPLETED|Phase 1b||0
8667617|NCT01211483|21398088|P4|STARTED|Phase 1b||0
8667618|NCT01211483|21398089|P3|STARTED|Phase 1b||0
8667619|NCT01211483|21398090|P2|STARTED|Phase 1b||0
8667620|NCT01211483|21398091|P1|STARTED|Phase 1b||7
8667621|NCT01189266|21398138|P3|NOT COMPLETED|Overall Study||65
8667622|NCT01189266|21398139|P2|NOT COMPLETED|Overall Study||6
8667623|NCT01189266|21398140|P1|NOT COMPLETED|Overall Study||6
8667624|NCT01189266|21398138|P3|COMPLETED|Overall Study||2
8667625|NCT01189266|21398139|P2|COMPLETED|Overall Study||0
8667626|NCT01189266|21398140|P1|COMPLETED|Overall Study||0
8667627|NCT01189266|21398138|P3|STARTED|Overall Study||67
8667628|NCT01189266|21398139|P2|STARTED|Overall Study||6
8667629|NCT01189266|21398140|P1|STARTED|Overall Study||6
8667630|NCT01187095|21398169|P2|NOT COMPLETED|Overall Study||34
8667631|NCT01187095|21398170|P1|NOT COMPLETED|Overall Study||45
8667632|NCT01187095|21398169|P2|COMPLETED|Overall Study||108
8667633|NCT01187095|21398170|P1|COMPLETED|Overall Study||108
8667634|NCT01187095|21398169|P2|STARTED|Overall Study||142
8667635|NCT01187095|21398170|P1|STARTED|Overall Study||153
8667636|NCT01081951|21398180|P2|NOT COMPLETED|Overall Study||55
8667637|NCT01081951|21398181|P1|NOT COMPLETED|Overall Study||56
8667638|NCT01081951|21398180|P2|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
8667639|NCT01081951|21398181|P1|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
8667640|NCT01081951|21398180|P2|Ongoing Study Treatment at Data Cut-off|Overall Study||0
8667641|NCT01081951|21398181|P1|Ongoing Study Treatment at Data Cut-off|Overall Study||11
8667642|NCT01081951|21398180|P2|Entered Maintenance Phase|Overall Study||55
8667643|NCT01081951|21398181|P1|Entered Maintenance Phase|Overall Study||66
8667644|NCT01081951|21398180|P2|Received Study Treatment|Overall Study||75
8667645|NCT01081951|21398181|P1|Received Study Treatment|Overall Study||81
8667646|NCT01081951|21398180|P2|STARTED|Overall Study||81
8667647|NCT01081951|21398181|P1|STARTED|Overall Study||81
8667648|NCT01078662|21398196|P5|NOT COMPLETED|Overall Study||11
8667649|NCT01078662|21398197|P4|NOT COMPLETED|Overall Study||7
8667650|NCT01078662|21398198|P3|NOT COMPLETED|Overall Study||21
8667651|NCT01078662|21398199|P2|NOT COMPLETED|Overall Study||168
8667652|NCT01078662|21398200|P1|NOT COMPLETED|Overall Study||58
8667653|NCT01078662|21398196|P5|COMPLETED|Overall Study||1
8667654|NCT01078662|21398197|P4|COMPLETED|Overall Study||1
8667655|NCT01078662|21398198|P3|COMPLETED|Overall Study||2
8667656|NCT01078662|21398199|P2|COMPLETED|Overall Study||25
8667657|NCT01078662|21398200|P1|COMPLETED|Overall Study||4
8667658|NCT01078662|21398196|P5|STARTED|Overall Study||12
8667659|NCT01078662|21398197|P4|STARTED|Overall Study||8
8667660|NCT01078662|21398198|P3|STARTED|Overall Study||23
8667661|NCT01078662|21398199|P2|STARTED|Overall Study||193
8667662|NCT01078662|21398200|P1|STARTED|Overall Study||62
8667691|NCT01029704|21398365|P9|NOT COMPLETED|Overall Study||1
8667692|NCT01029704|21398366|P8|NOT COMPLETED|Overall Study||6
8667693|NCT01029704|21398367|P7|NOT COMPLETED|Overall Study||4
8667694|NCT01029704|21398368|P6|NOT COMPLETED|Overall Study||4
8667695|NCT01029704|21398369|P5|NOT COMPLETED|Overall Study||5
8667696|NCT01029704|21398370|P4|NOT COMPLETED|Overall Study||0
8667697|NCT01029704|21398371|P3|NOT COMPLETED|Overall Study||0
8667698|NCT01029704|21398372|P2|NOT COMPLETED|Overall Study||0
8667699|NCT01029704|21398373|P1|NOT COMPLETED|Overall Study||0
8667700|NCT01029704|21398365|P9|COMPLETED|Overall Study||25
8667701|NCT01029704|21398366|P8|COMPLETED|Overall Study||22
8667702|NCT01029704|21398367|P7|COMPLETED|Overall Study||19
8667703|NCT01029704|21398368|P6|COMPLETED|Overall Study||20
8667704|NCT01029704|21398369|P5|COMPLETED|Overall Study||23
8667705|NCT01029704|21398370|P4|COMPLETED|Overall Study||5
8667706|NCT01029704|21398371|P3|COMPLETED|Overall Study||5
8667707|NCT01029704|21398372|P2|COMPLETED|Overall Study||5
8667708|NCT01029704|21398373|P1|COMPLETED|Overall Study||5
8667709|NCT01029704|21398365|P9|STARTED|Overall Study||26
8667710|NCT01029704|21398366|P8|STARTED|Overall Study||28
8667711|NCT01029704|21398367|P7|STARTED|Overall Study||23
8667712|NCT01029704|21398368|P6|STARTED|Overall Study||24
8667713|NCT01029704|21398369|P5|STARTED|Overall Study||28
8667714|NCT01029704|21398370|P4|STARTED|Overall Study||5
8667715|NCT01029704|21398371|P3|STARTED|Overall Study||5
8667716|NCT01029704|21398372|P2|STARTED|Overall Study||5
8667717|NCT01029704|21398373|P1|STARTED|Overall Study||5
8667718|NCT00669669|21398417|P1|NOT COMPLETED|Overall Study||1
8667719|NCT00669669|21398417|P1|COMPLETED|Overall Study||11
8667720|NCT00669669|21398417|P1|STARTED|Overall Study||12
8667733|NCT00520533|21398496|P1|NOT COMPLETED|Overall Study||4
8667734|NCT00520533|21398496|P1|COMPLETED|Overall Study||4
8667735|NCT00520533|21398496|P1|STARTED|Overall Study||8
8667736|NCT00494234|21398514|P2|NOT COMPLETED|Overall Study||10
8667737|NCT00494234|21398515|P1|NOT COMPLETED|Overall Study||15
8667738|NCT00494234|21398514|P2|COMPLETED|Overall Study||17
8667739|NCT00494234|21398515|P1|COMPLETED|Overall Study||12
8667740|NCT00494234|21398514|P2|STARTED|Overall Study||27
8667741|NCT00494234|21398515|P1|STARTED|Overall Study||27
8667742|NCT00378534|21398533|P2|NOT COMPLETED|Overall Study||0
8667743|NCT00378534|21398534|P1|NOT COMPLETED|Overall Study||3
8667744|NCT00378534|21398533|P2|COMPLETED|Overall Study||58
8667745|NCT00378534|21398534|P1|COMPLETED|Overall Study||55
8667746|NCT00378534|21398533|P2|STARTED|Overall Study||58
8667747|NCT00378534|21398534|P1|STARTED|Overall Study||58
8667751|NCT00099437|21398551|P2|NOT COMPLETED|Overall Study||349
8667752|NCT00099437|21398552|P1|NOT COMPLETED|Overall Study||366
8667753|NCT00099437|21398551|P2|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
8667754|NCT00099437|21398552|P1|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
8667755|NCT00099437|21398551|P2|STARTED|Overall Study|randomised patients|362
8667756|NCT00099437|21398552|P1|STARTED|Overall Study|randomised patients|374
8667766|NCT04381481|21398597|P12|NOT COMPLETED|Overall Study||15
8667767|NCT04381481|21398598|P11|NOT COMPLETED|Overall Study||9
8667768|NCT04381481|21398599|P10|NOT COMPLETED|Overall Study||10
8667769|NCT04381481|21398600|P9|NOT COMPLETED|Overall Study||19
8667770|NCT04381481|21398601|P8|NOT COMPLETED|Overall Study||16
8667771|NCT04381481|21398602|P7|NOT COMPLETED|Overall Study||10
8667772|NCT04381481|21398603|P6|NOT COMPLETED|Overall Study||15
8667773|NCT04381481|21398604|P5|NOT COMPLETED|Overall Study||8
8667774|NCT04381481|21398605|P4|NOT COMPLETED|Overall Study||14
8667775|NCT04381481|21398606|P3|NOT COMPLETED|Overall Study||9
8667776|NCT04381481|21398607|P2|NOT COMPLETED|Overall Study||15
8667777|NCT04381481|21398608|P1|NOT COMPLETED|Overall Study||15
8667778|NCT04381481|21398597|P12|COMPLETED|Overall Study||173
8667779|NCT04381481|21398598|P11|COMPLETED|Overall Study||183
8667780|NCT04381481|21398599|P10|COMPLETED|Overall Study||188
8667781|NCT04381481|21398600|P9|COMPLETED|Overall Study||195
8667782|NCT04381481|21398601|P8|COMPLETED|Overall Study||177
8667783|NCT04381481|21398602|P7|COMPLETED|Overall Study||184
8667784|NCT04381481|21398603|P6|COMPLETED|Overall Study||180
8667785|NCT04381481|21398604|P5|COMPLETED|Overall Study||191
8667786|NCT04381481|21398605|P4|COMPLETED|Overall Study||183
8667787|NCT04381481|21398606|P3|COMPLETED|Overall Study||190
8667788|NCT04381481|21398607|P2|COMPLETED|Overall Study||190
8667789|NCT04381481|21398608|P1|COMPLETED|Overall Study||185
8667790|NCT04381481|21398597|P12|STARTED|Overall Study||188
8667791|NCT04381481|21398598|P11|STARTED|Overall Study||192
8667792|NCT04381481|21398599|P10|STARTED|Overall Study||198
8667793|NCT04381481|21398600|P9|STARTED|Overall Study||214
8667794|NCT04381481|21398601|P8|STARTED|Overall Study||193
8667795|NCT04381481|21398602|P7|STARTED|Overall Study||194
8667796|NCT04381481|21398603|P6|STARTED|Overall Study||195
8667797|NCT04381481|21398604|P5|STARTED|Overall Study||199
8667798|NCT04381481|21398605|P4|STARTED|Overall Study||197
8667799|NCT04381481|21398606|P3|STARTED|Overall Study||199
8667800|NCT04381481|21398607|P2|STARTED|Overall Study||205
8667801|NCT04381481|21398608|P1|STARTED|Overall Study||200
8667984|NCT03687125|21398991|P2|NOT COMPLETED|Overall Study||1
8667985|NCT03687125|21398992|P1|NOT COMPLETED|Overall Study||3
8667986|NCT03687125|21398991|P2|COMPLETED|Overall Study||2
8667987|NCT03687125|21398992|P1|COMPLETED|Overall Study||0
8667988|NCT03687125|21398991|P2|STARTED|Overall Study||3
8667989|NCT03687125|21398992|P1|STARTED|Overall Study||3
8667990|NCT03650387|21399030|P1|NOT COMPLETED|Overall Study||34
8667991|NCT03650387|21399030|P1|COMPLETED|Overall Study||173
8667992|NCT03650387|21399030|P1|STARTED|Overall Study||207
8668008|NCT03527160|21399106|P1|NOT COMPLETED|Overall Study||21
8668009|NCT03527160|21399106|P1|COMPLETED|Overall Study||113
8668010|NCT03527160|21399106|P1|STARTED|Overall Study||134
8668011|NCT03472469|21399113|P2|NOT COMPLETED|Overall Study||0
8668012|NCT03472469|21399114|P1|NOT COMPLETED|Overall Study||0
8668013|NCT03472469|21399113|P2|COMPLETED|Overall Study||774
8668014|NCT03472469|21399114|P1|COMPLETED|Overall Study||787
8668015|NCT03472469|21399113|P2|STARTED|Overall Study||774
8668016|NCT03472469|21399114|P1|STARTED|Overall Study||787
8668021|NCT03332212|21399156|P4|NOT COMPLETED|Overall Study||1
8668022|NCT03332212|21399157|P3|NOT COMPLETED|Overall Study||0
8668023|NCT03332212|21399158|P2|NOT COMPLETED|Overall Study||2
8668024|NCT03332212|21399159|P1|NOT COMPLETED|Overall Study||1
8668025|NCT03332212|21399156|P4|COMPLETED|Overall Study||17
8668026|NCT03332212|21399157|P3|COMPLETED|Overall Study||17
8668027|NCT03332212|21399158|P2|COMPLETED|Overall Study||16
8668028|NCT03332212|21399159|P1|COMPLETED|Overall Study||18
8668029|NCT03332212|21399156|P4|Treated|Overall Study||18
8668030|NCT03332212|21399157|P3|Treated|Overall Study||17
8668031|NCT03332212|21399158|P2|Treated|Overall Study||17
8668032|NCT03332212|21399159|P1|Treated|Overall Study||19
8668033|NCT03332212|21399156|P4|STARTED|Overall Study||18
8668034|NCT03332212|21399157|P3|STARTED|Overall Study||17
8668035|NCT03332212|21399158|P2|STARTED|Overall Study||18
8668036|NCT03332212|21399159|P1|STARTED|Overall Study||19
8668037|NCT03276975|21399169|P2|NOT COMPLETED|Overall Study||0
8668038|NCT03276975|21399170|P1|NOT COMPLETED|Overall Study||1
8668039|NCT03276975|21399169|P2|COMPLETED|Overall Study||7
8668040|NCT03276975|21399170|P1|COMPLETED|Overall Study||7
8668041|NCT03276975|21399169|P2|Crossover At 2 Months|Overall Study||7
8668042|NCT03276975|21399170|P1|Crossover At 2 Months|Overall Study||0
8668043|NCT03276975|21399169|P2|STARTED|Overall Study||7
8668044|NCT03276975|21399170|P1|STARTED|Overall Study||8
8668054|NCT03187730|21399227|P2|NOT COMPLETED|Overall Study||48
8668055|NCT03187730|21399228|P1|NOT COMPLETED|Overall Study||79
8668056|NCT03187730|21399227|P2|COMPLETED|Overall Study||154
8668057|NCT03187730|21399228|P1|COMPLETED|Overall Study||129
8668058|NCT03187730|21399227|P2|STARTED|Overall Study||202
8668059|NCT03187730|21399228|P1|STARTED|Overall Study||208
8668201|NCT02937454|21399441|P2|NOT COMPLETED|Overall Study||128
8668202|NCT02937454|21399442|P1|NOT COMPLETED|Overall Study||140
8668203|NCT02937454|21399441|P2|COMPLETED|Overall Study||437
8668204|NCT02937454|21399442|P1|COMPLETED|Overall Study||427
8668205|NCT02937454|21399441|P2|Started Treatment|Overall Study||551
8668206|NCT02937454|21399442|P1|Started Treatment|Overall Study||559
8668207|NCT02937454|21399441|P2|STARTED|Overall Study||565
8668208|NCT02937454|21399442|P1|STARTED|Overall Study||567
8668245|NCT02777333|21399525|P2|NOT COMPLETED|Overall Study||2
8668246|NCT02777333|21399526|P1|NOT COMPLETED|Overall Study||0
8668247|NCT02777333|21399525|P2|COMPLETED|Overall Study||13
8668248|NCT02777333|21399526|P1|COMPLETED|Overall Study||15
8668249|NCT02777333|21399525|P2|STARTED|Overall Study||15
8668250|NCT02777333|21399526|P1|STARTED|Overall Study||15
8668251|NCT02772783|21399550|P2|NOT COMPLETED|Experimental Condition 2, 1 Day||0
8668252|NCT02772783|21399551|P1|NOT COMPLETED|Experimental Condition 2, 1 Day||0
8668253|NCT02772783|21399550|P2|COMPLETED|Experimental Condition 2, 1 Day||7
8668254|NCT02772783|21399551|P1|COMPLETED|Experimental Condition 2, 1 Day||8
8668255|NCT02772783|21399550|P2|STARTED|Experimental Condition 2, 1 Day||7
8668256|NCT02772783|21399551|P1|STARTED|Experimental Condition 2, 1 Day||8
8668257|NCT02772783|21399550|P2|NOT COMPLETED|Wash-out, 1 Week||0
8668258|NCT02772783|21399551|P1|NOT COMPLETED|Wash-out, 1 Week||0
8668259|NCT02772783|21399550|P2|COMPLETED|Wash-out, 1 Week||7
8668260|NCT02772783|21399551|P1|COMPLETED|Wash-out, 1 Week||8
8668261|NCT02772783|21399550|P2|STARTED|Wash-out, 1 Week||7
8668262|NCT02772783|21399551|P1|STARTED|Wash-out, 1 Week||8
8668263|NCT02772783|21399550|P2|NOT COMPLETED|Comparison Condition, 1 Day||0
8668264|NCT02772783|21399551|P1|NOT COMPLETED|Comparison Condition, 1 Day||0
8668265|NCT02772783|21399550|P2|COMPLETED|Comparison Condition, 1 Day||7
8668266|NCT02772783|21399551|P1|COMPLETED|Comparison Condition, 1 Day||8
8668267|NCT02772783|21399550|P2|STARTED|Comparison Condition, 1 Day||7
8668268|NCT02772783|21399551|P1|STARTED|Comparison Condition, 1 Day||8
8668269|NCT02772783|21399550|P2|NOT COMPLETED|Wash-out, 1 Week||0
8668270|NCT02772783|21399551|P1|NOT COMPLETED|Wash-out, 1 Week||0
8668271|NCT02772783|21399550|P2|COMPLETED|Wash-out, 1 Week||7
8668272|NCT02772783|21399551|P1|COMPLETED|Wash-out, 1 Week||8
8668273|NCT02772783|21399550|P2|STARTED|Wash-out, 1 Week||7
8668274|NCT02772783|21399551|P1|STARTED|Wash-out, 1 Week||8
8668275|NCT02772783|21399550|P2|NOT COMPLETED|Experimental Condition 1, 1 Day||0
8668276|NCT02772783|21399551|P1|NOT COMPLETED|Experimental Condition 1, 1 Day||0
8668277|NCT02772783|21399550|P2|COMPLETED|Experimental Condition 1, 1 Day||7
8668278|NCT02772783|21399551|P1|COMPLETED|Experimental Condition 1, 1 Day||8
8668279|NCT02772783|21399550|P2|STARTED|Experimental Condition 1, 1 Day||7
8668280|NCT02772783|21399551|P1|STARTED|Experimental Condition 1, 1 Day||8
8668308|NCT02593539|21399641|P1|NOT COMPLETED|Overall Study||1
8668309|NCT02593539|21399641|P1|COMPLETED|Overall Study||4
8668310|NCT02593539|21399641|P1|STARTED|Overall Study||5
8668329|NCT02391337|21399713|P2|NOT COMPLETED|12 Months Follow-up||3
8668330|NCT02391337|21399714|P1|NOT COMPLETED|12 Months Follow-up||2
8668331|NCT02391337|21399713|P2|COMPLETED|12 Months Follow-up||73
8668332|NCT02391337|21399714|P1|COMPLETED|12 Months Follow-up||72
8668333|NCT02391337|21399713|P2|STARTED|12 Months Follow-up||76
8668334|NCT02391337|21399714|P1|STARTED|12 Months Follow-up||74
8668335|NCT02391337|21399713|P2|NOT COMPLETED|6 Months Follow-up||5
8668336|NCT02391337|21399714|P1|NOT COMPLETED|6 Months Follow-up||6
8668337|NCT02391337|21399713|P2|COMPLETED|6 Months Follow-up||76
8668338|NCT02391337|21399714|P1|COMPLETED|6 Months Follow-up||74
8668339|NCT02391337|21399713|P2|STARTED|6 Months Follow-up||81
8668340|NCT02391337|21399714|P1|STARTED|6 Months Follow-up||80
8668341|NCT02391337|21399713|P2|NOT COMPLETED|Baseline||0
8668342|NCT02391337|21399714|P1|NOT COMPLETED|Baseline||0
8668343|NCT02391337|21399713|P2|COMPLETED|Baseline||81
8668344|NCT02391337|21399714|P1|COMPLETED|Baseline||80
8668345|NCT02391337|21399713|P2|STARTED|Baseline||81
8668346|NCT02391337|21399714|P1|STARTED|Baseline||80
8668368|NCT02184195|21399810|P2|NOT COMPLETED|Overall Study||35
8668369|NCT02184195|21399811|P1|NOT COMPLETED|Overall Study||43
8668370|NCT02184195|21399810|P2|COMPLETED|Overall Study||27
8668371|NCT02184195|21399811|P1|COMPLETED|Overall Study||49
8668372|NCT02184195|21399810|P2|STARTED|Overall Study||62
8668373|NCT02184195|21399811|P1|STARTED|Overall Study||92
8668407|NCT01823835|21399919|P15|NOT COMPLETED|Overall Study||6
8668408|NCT01823835|21399920|P14|NOT COMPLETED|Overall Study||4
8668409|NCT01823835|21399921|P13|NOT COMPLETED|Overall Study||19
8668410|NCT01823835|21399922|P12|NOT COMPLETED|Overall Study||53
8668411|NCT01823835|21399923|P11|NOT COMPLETED|Overall Study||10
8668412|NCT01823835|21399924|P10|NOT COMPLETED|Overall Study||19
8668413|NCT01823835|21399925|P9|NOT COMPLETED|Overall Study||3
8668414|NCT01823835|21399926|P8|NOT COMPLETED|Overall Study||3
8668415|NCT01823835|21399927|P7|NOT COMPLETED|Overall Study||6
8668416|NCT01823835|21399928|P6|NOT COMPLETED|Overall Study||6
8668417|NCT01823835|21399929|P5|NOT COMPLETED|Overall Study||6
8668418|NCT01823835|21399930|P4|NOT COMPLETED|Overall Study||6
8668419|NCT01823835|21399931|P3|NOT COMPLETED|Overall Study||4
8668420|NCT01823835|21399932|P2|NOT COMPLETED|Overall Study||4
8668421|NCT01823835|21399933|P1|NOT COMPLETED|Overall Study||3
8668422|NCT01823835|21399919|P15|COMPLETED|Overall Study||0
8668423|NCT01823835|21399920|P14|COMPLETED|Overall Study||0
8668424|NCT01823835|21399921|P13|COMPLETED|Overall Study||0
8668425|NCT01823835|21399922|P12|COMPLETED|Overall Study||0
8668426|NCT01823835|21399923|P11|COMPLETED|Overall Study||0
8668427|NCT01823835|21399924|P10|COMPLETED|Overall Study||0
8668428|NCT01823835|21399925|P9|COMPLETED|Overall Study||0
8668429|NCT01823835|21399926|P8|COMPLETED|Overall Study||0
8668430|NCT01823835|21399927|P7|COMPLETED|Overall Study||0
8668431|NCT01823835|21399928|P6|COMPLETED|Overall Study||0
8668432|NCT01823835|21399929|P5|COMPLETED|Overall Study||0
8668433|NCT01823835|21399930|P4|COMPLETED|Overall Study||0
8668434|NCT01823835|21399931|P3|COMPLETED|Overall Study||0
8668435|NCT01823835|21399932|P2|COMPLETED|Overall Study||0
8668436|NCT01823835|21399933|P1|COMPLETED|Overall Study||0
8668437|NCT01823835|21399919|P15|STARTED|Overall Study||6
8668438|NCT01823835|21399920|P14|STARTED|Overall Study||4
8668439|NCT01823835|21399921|P13|STARTED|Overall Study||19
8668440|NCT01823835|21399922|P12|STARTED|Overall Study||53
8668441|NCT01823835|21399923|P11|STARTED|Overall Study||10
8668442|NCT01823835|21399924|P10|STARTED|Overall Study||19
8668443|NCT01823835|21399925|P9|STARTED|Overall Study||3
8668444|NCT01823835|21399926|P8|STARTED|Overall Study||3
8668445|NCT01823835|21399927|P7|STARTED|Overall Study||6
8668446|NCT01823835|21399928|P6|STARTED|Overall Study||6
8668447|NCT01823835|21399929|P5|STARTED|Overall Study||6
8668448|NCT01823835|21399930|P4|STARTED|Overall Study||6
8668449|NCT01823835|21399931|P3|STARTED|Overall Study||4
8668450|NCT01823835|21399932|P2|STARTED|Overall Study||4
8668451|NCT01823835|21399933|P1|STARTED|Overall Study||3
8668726|NCT01562041|21400183|P1|NOT COMPLETED|Overall Study||0
8668727|NCT01562041|21400183|P1|COMPLETED|Overall Study||14
8668728|NCT01562041|21400183|P1|STARTED|Overall Study||14
8668741|NCT00562978|21400244|P2|NOT COMPLETED|Overall Study||11
8668742|NCT00562978|21400245|P1|NOT COMPLETED|Overall Study||1
8668743|NCT00562978|21400244|P2|COMPLETED|Overall Study||37
8668744|NCT00562978|21400245|P1|COMPLETED|Overall Study||5
8668745|NCT00562978|21400244|P2|STARTED|Overall Study||48
8668746|NCT00562978|21400245|P1|STARTED|Overall Study||6
8668747|NCT00545129|21400259|P2|NOT COMPLETED|Overall Study||24
8668748|NCT00545129|21400260|P1|NOT COMPLETED|Overall Study||17
8668749|NCT00545129|21400259|P2|COMPLETED|Overall Study||6
8668750|NCT00545129|21400260|P1|COMPLETED|Overall Study||12
8668751|NCT00545129|21400259|P2|STARTED|Overall Study||30
8668752|NCT00545129|21400260|P1|STARTED|Overall Study||29
8668798|NCT04292535|21400406|P14|NOT COMPLETED|Overall Study||2
8668799|NCT04292535|21400407|P13|NOT COMPLETED|Overall Study||1
8668800|NCT04292535|21400408|P12|NOT COMPLETED|Overall Study||1
8668801|NCT04292535|21400409|P11|NOT COMPLETED|Overall Study||0
8668802|NCT04292535|21400410|P10|NOT COMPLETED|Overall Study||0
8668803|NCT04292535|21400411|P9|NOT COMPLETED|Overall Study||0
8668804|NCT04292535|21400412|P8|NOT COMPLETED|Overall Study||2
8668805|NCT04292535|21400413|P7|NOT COMPLETED|Overall Study||0
8668806|NCT04292535|21400414|P6|NOT COMPLETED|Overall Study||0
8668807|NCT04292535|21400415|P5|NOT COMPLETED|Overall Study||0
8668808|NCT04292535|21400416|P4|NOT COMPLETED|Overall Study||0
8668809|NCT04292535|21400417|P3|NOT COMPLETED|Overall Study||0
8668810|NCT04292535|21400418|P2|NOT COMPLETED|Overall Study||0
8668811|NCT04292535|21400419|P1|NOT COMPLETED|Overall Study||0
8668812|NCT04292535|21400406|P14|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1) Condition stopped due to Report of Dizziness (n = 1)|7
8668813|NCT04292535|21400407|P13|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
8668814|NCT04292535|21400408|P12|COMPLETED|Overall Study||6
8668815|NCT04292535|21400409|P11|COMPLETED|Overall Study||7
8668816|NCT04292535|21400410|P10|COMPLETED|Overall Study||8
8668817|NCT04292535|21400411|P9|COMPLETED|Overall Study||8
8668818|NCT04292535|21400412|P8|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
8668819|NCT04292535|21400413|P7|COMPLETED|Overall Study||8
8668820|NCT04292535|21400414|P6|COMPLETED|Overall Study||9
8668821|NCT04292535|21400415|P5|COMPLETED|Overall Study||8
8668822|NCT04292535|21400416|P4|COMPLETED|Overall Study||8
8668823|NCT04292535|21400417|P3|COMPLETED|Overall Study||9
8668824|NCT04292535|21400418|P2|COMPLETED|Overall Study||8
8668825|NCT04292535|21400419|P1|COMPLETED|Overall Study||8
8668826|NCT04292535|21400406|P14|STARTED|Overall Study||9
8668827|NCT04292535|21400407|P13|STARTED|Overall Study||9
8668828|NCT04292535|21400408|P12|STARTED|Overall Study||7
8668829|NCT04292535|21400409|P11|STARTED|Overall Study||7
8668830|NCT04292535|21400410|P10|STARTED|Overall Study||8
8668831|NCT04292535|21400411|P9|STARTED|Overall Study||8
8668832|NCT04292535|21400412|P8|STARTED|Overall Study||10
8668833|NCT04292535|21400413|P7|STARTED|Overall Study||8
8668834|NCT04292535|21400414|P6|STARTED|Overall Study||9
8668835|NCT04292535|21400415|P5|STARTED|Overall Study||8
8668836|NCT04292535|21400416|P4|STARTED|Overall Study||8
8668837|NCT04292535|21400417|P3|STARTED|Overall Study||9
8668838|NCT04292535|21400418|P2|STARTED|Overall Study||8
8668839|NCT04292535|21400419|P1|STARTED|Overall Study||8
8668840|NCT04271605|21400575|P1|NOT COMPLETED|Overall Study||5
8668841|NCT04271605|21400575|P1|COMPLETED|Overall Study||0
8668842|NCT04271605|21400575|P1|STARTED|Overall Study|Baseline questionnaire and examination were done after enrollment.|5
8668843|NCT04126343|21400588|P6|NOT COMPLETED|Overall Study||4
8668844|NCT04126343|21400589|P5|NOT COMPLETED|Overall Study||3
8668845|NCT04126343|21400590|P4|NOT COMPLETED|Overall Study||4
8668846|NCT04126343|21400591|P3|NOT COMPLETED|Overall Study||3
8668847|NCT04126343|21400592|P2|NOT COMPLETED|Overall Study||4
8668848|NCT04126343|21400593|P1|NOT COMPLETED|Overall Study||3
8668849|NCT04126343|21400588|P6|COMPLETED|Overall Study||5
8668850|NCT04126343|21400589|P5|COMPLETED|Overall Study||6
8668851|NCT04126343|21400590|P4|COMPLETED|Overall Study||5
8668852|NCT04126343|21400591|P3|COMPLETED|Overall Study||6
8668853|NCT04126343|21400592|P2|COMPLETED|Overall Study||5
8668854|NCT04126343|21400593|P1|COMPLETED|Overall Study||6
8668855|NCT04126343|21400588|P6|Completed Moxifloxacin Period|Overall Study||9
8668856|NCT04126343|21400589|P5|Completed Moxifloxacin Period|Overall Study||9
8668857|NCT04126343|21400590|P4|Completed Moxifloxacin Period|Overall Study||9
8668858|NCT04126343|21400591|P3|Completed Moxifloxacin Period|Overall Study||7
8668859|NCT04126343|21400592|P2|Completed Moxifloxacin Period|Overall Study||9
8668860|NCT04126343|21400593|P1|Completed Moxifloxacin Period|Overall Study||8
8668861|NCT04126343|21400588|P6|Completed Placebo Period|Overall Study||9
8668862|NCT04126343|21400589|P5|Completed Placebo Period|Overall Study||7
8668863|NCT04126343|21400590|P4|Completed Placebo Period|Overall Study||9
8668864|NCT04126343|21400591|P3|Completed Placebo Period|Overall Study||9
8668865|NCT04126343|21400592|P2|Completed Placebo Period|Overall Study||7
8668866|NCT04126343|21400593|P1|Completed Placebo Period|Overall Study||9
8668867|NCT04126343|21400588|P6|Completed Padsevonil Period|Overall Study||8
8668868|NCT04126343|21400589|P5|Completed Padsevonil Period|Overall Study||9
8668869|NCT04126343|21400590|P4|Completed Padsevonil Period|Overall Study||7
8668870|NCT04126343|21400591|P3|Completed Padsevonil Period|Overall Study||9
8668871|NCT04126343|21400592|P2|Completed Padsevonil Period|Overall Study||9
8668872|NCT04126343|21400593|P1|Completed Padsevonil Period|Overall Study||9
8668873|NCT04126343|21400588|P6|STARTED|Overall Study||9
8668874|NCT04126343|21400589|P5|STARTED|Overall Study||9
8668875|NCT04126343|21400590|P4|STARTED|Overall Study||9
8668876|NCT04126343|21400591|P3|STARTED|Overall Study||9
8668877|NCT04126343|21400592|P2|STARTED|Overall Study||9
8668878|NCT04126343|21400593|P1|STARTED|Overall Study||9
8668903|NCT04039919|21400689|P5|NOT COMPLETED|Treatment Period 6||0
8668904|NCT04039919|21400690|P4|NOT COMPLETED|Treatment Period 6||0
8668905|NCT04039919|21400691|P3|NOT COMPLETED|Treatment Period 6||0
8668906|NCT04039919|21400692|P2|NOT COMPLETED|Treatment Period 6||0
8668907|NCT04039919|21400693|P1|NOT COMPLETED|Treatment Period 6||0
8668908|NCT04039919|21400689|P5|COMPLETED|Treatment Period 6||0
8668909|NCT04039919|21400690|P4|COMPLETED|Treatment Period 6||6
8668910|NCT04039919|21400691|P3|COMPLETED|Treatment Period 6||5
8668911|NCT04039919|21400692|P2|COMPLETED|Treatment Period 6||6
8668912|NCT04039919|21400693|P1|COMPLETED|Treatment Period 6||5
8668913|NCT04039919|21400689|P5|STARTED|Treatment Period 6||0
8668914|NCT04039919|21400690|P4|STARTED|Treatment Period 6||6
8668915|NCT04039919|21400691|P3|STARTED|Treatment Period 6||5
8668916|NCT04039919|21400692|P2|STARTED|Treatment Period 6||6
8668917|NCT04039919|21400693|P1|STARTED|Treatment Period 6||5
8668918|NCT04039919|21400689|P5|NOT COMPLETED|Treatment Period 5||0
8668919|NCT04039919|21400690|P4|NOT COMPLETED|Treatment Period 5||0
8668920|NCT04039919|21400691|P3|NOT COMPLETED|Treatment Period 5||0
8668921|NCT04039919|21400692|P2|NOT COMPLETED|Treatment Period 5||0
8668922|NCT04039919|21400693|P1|NOT COMPLETED|Treatment Period 5||1
8668923|NCT04039919|21400689|P5|COMPLETED|Treatment Period 5||0
8668924|NCT04039919|21400690|P4|COMPLETED|Treatment Period 5||6
8668925|NCT04039919|21400691|P3|COMPLETED|Treatment Period 5||5
8668926|NCT04039919|21400692|P2|COMPLETED|Treatment Period 5||6
8668927|NCT04039919|21400693|P1|COMPLETED|Treatment Period 5||5
8668928|NCT04039919|21400689|P5|STARTED|Treatment Period 5||0
8668929|NCT04039919|21400690|P4|STARTED|Treatment Period 5||6
8668930|NCT04039919|21400691|P3|STARTED|Treatment Period 5||5
8668931|NCT04039919|21400692|P2|STARTED|Treatment Period 5||6
8668932|NCT04039919|21400693|P1|STARTED|Treatment Period 5||6
8668933|NCT04039919|21400689|P5|NOT COMPLETED|Treatment Period 4||0
8668934|NCT04039919|21400690|P4|NOT COMPLETED|Treatment Period 4||0
8668935|NCT04039919|21400691|P3|NOT COMPLETED|Treatment Period 4||0
8668936|NCT04039919|21400692|P2|NOT COMPLETED|Treatment Period 4||0
8668937|NCT04039919|21400693|P1|NOT COMPLETED|Treatment Period 4||0
8668938|NCT04039919|21400689|P5|COMPLETED|Treatment Period 4||0
8668939|NCT04039919|21400690|P4|COMPLETED|Treatment Period 4||6
8668940|NCT04039919|21400691|P3|COMPLETED|Treatment Period 4||5
8668941|NCT04039919|21400692|P2|COMPLETED|Treatment Period 4||6
8668942|NCT04039919|21400693|P1|COMPLETED|Treatment Period 4||6
8668943|NCT04039919|21400689|P5|STARTED|Treatment Period 4||0
8668944|NCT04039919|21400690|P4|STARTED|Treatment Period 4||6
8668945|NCT04039919|21400691|P3|STARTED|Treatment Period 4||5
8668946|NCT04039919|21400692|P2|STARTED|Treatment Period 4||6
8668947|NCT04039919|21400693|P1|STARTED|Treatment Period 4||6
8668948|NCT04039919|21400689|P5|NOT COMPLETED|Treatment Period 3||0
8668949|NCT04039919|21400690|P4|NOT COMPLETED|Treatment Period 3||0
8668950|NCT04039919|21400691|P3|NOT COMPLETED|Treatment Period 3||0
8668951|NCT04039919|21400692|P2|NOT COMPLETED|Treatment Period 3||0
8668952|NCT04039919|21400693|P1|NOT COMPLETED|Treatment Period 3||0
8668953|NCT04039919|21400689|P5|COMPLETED|Treatment Period 3||0
8668954|NCT04039919|21400690|P4|COMPLETED|Treatment Period 3||6
8668955|NCT04039919|21400691|P3|COMPLETED|Treatment Period 3||5
8668956|NCT04039919|21400692|P2|COMPLETED|Treatment Period 3||6
8668957|NCT04039919|21400693|P1|COMPLETED|Treatment Period 3||6
8668958|NCT04039919|21400689|P5|STARTED|Treatment Period 3||0
8668959|NCT04039919|21400690|P4|STARTED|Treatment Period 3||6
8668960|NCT04039919|21400691|P3|STARTED|Treatment Period 3||5
8668961|NCT04039919|21400692|P2|STARTED|Treatment Period 3||6
8668962|NCT04039919|21400693|P1|STARTED|Treatment Period 3||6
8668963|NCT04039919|21400689|P5|NOT COMPLETED|Treatment Period 2||0
8668964|NCT04039919|21400690|P4|NOT COMPLETED|Treatment Period 2||0
8668965|NCT04039919|21400691|P3|NOT COMPLETED|Treatment Period 2||0
8668966|NCT04039919|21400692|P2|NOT COMPLETED|Treatment Period 2||0
8668967|NCT04039919|21400693|P1|NOT COMPLETED|Treatment Period 2||0
8668968|NCT04039919|21400689|P5|COMPLETED|Treatment Period 2||0
8668969|NCT04039919|21400690|P4|COMPLETED|Treatment Period 2||6
8668970|NCT04039919|21400691|P3|COMPLETED|Treatment Period 2||5
8668971|NCT04039919|21400692|P2|COMPLETED|Treatment Period 2||6
8668972|NCT04039919|21400693|P1|COMPLETED|Treatment Period 2||6
8668973|NCT04039919|21400689|P5|STARTED|Treatment Period 2||0
8668974|NCT04039919|21400690|P4|STARTED|Treatment Period 2||6
8668975|NCT04039919|21400691|P3|STARTED|Treatment Period 2||5
8668976|NCT04039919|21400692|P2|STARTED|Treatment Period 2||6
8668977|NCT04039919|21400693|P1|STARTED|Treatment Period 2||6
8668978|NCT04039919|21400689|P5|NOT COMPLETED|Treatment Period 1||16
8668979|NCT04039919|21400690|P4|NOT COMPLETED|Treatment Period 1||0
8668980|NCT04039919|21400691|P3|NOT COMPLETED|Treatment Period 1||0
8668981|NCT04039919|21400692|P2|NOT COMPLETED|Treatment Period 1||0
8668982|NCT04039919|21400693|P1|NOT COMPLETED|Treatment Period 1||1
8668983|NCT04039919|21400689|P5|COMPLETED|Treatment Period 1||0
8668984|NCT04039919|21400690|P4|COMPLETED|Treatment Period 1||6
8668985|NCT04039919|21400691|P3|COMPLETED|Treatment Period 1||5
8668986|NCT04039919|21400692|P2|COMPLETED|Treatment Period 1||6
8668987|NCT04039919|21400693|P1|COMPLETED|Treatment Period 1||6
8668988|NCT04039919|21400689|P5|STARTED|Treatment Period 1||16
8668989|NCT04039919|21400690|P4|STARTED|Treatment Period 1||6
8668990|NCT04039919|21400691|P3|STARTED|Treatment Period 1||5
8668991|NCT04039919|21400692|P2|STARTED|Treatment Period 1||6
8668992|NCT04039919|21400693|P1|STARTED|Treatment Period 1||7
8668993|NCT03954743|21400769|P2|NOT COMPLETED|Overall Study||17
8668994|NCT03954743|21400770|P1|NOT COMPLETED|Overall Study||24
8668995|NCT03954743|21400769|P2|COMPLETED|Overall Study||657
8668996|NCT03954743|21400770|P1|COMPLETED|Overall Study||653
8668997|NCT03954743|21400769|P2|STARTED|Overall Study||674
8668998|NCT03954743|21400770|P1|STARTED|Overall Study||677
8668999|NCT03931330|21400782|P1|NOT COMPLETED|Overall Study||1
8669000|NCT03931330|21400782|P1|COMPLETED|Overall Study||7
8669001|NCT03931330|21400782|P1|4 Weeks of Neuromodulation|Overall Study|at 4 weeks of neuromodulation|7
8669002|NCT03931330|21400782|P1|STARTED|Overall Study||8
8669009|NCT03799198|21400803|P2|NOT COMPLETED|Overall Study||9
8669010|NCT03799198|21400804|P1|NOT COMPLETED|Overall Study||4
8669011|NCT03799198|21400803|P2|COMPLETED|Overall Study||91
8669012|NCT03799198|21400804|P1|COMPLETED|Overall Study||96
8669013|NCT03799198|21400803|P2|Full Analysis Set (FAS)|Overall Study||100
8669014|NCT03799198|21400804|P1|Full Analysis Set (FAS)|Overall Study||100
8669015|NCT03799198|21400803|P2|STARTED|Overall Study||100
8669016|NCT03799198|21400804|P1|STARTED|Overall Study||100
8669017|NCT03763929|21400840|P2|NOT COMPLETED|Overall Study||0
8669018|NCT03763929|21400841|P1|NOT COMPLETED|Overall Study||0
8669019|NCT03763929|21400840|P2|COMPLETED|Overall Study||4
8669020|NCT03763929|21400841|P1|COMPLETED|Overall Study||2
8669021|NCT03763929|21400840|P2|STARTED|Overall Study||4
8669022|NCT03763929|21400841|P1|STARTED|Overall Study||2
8669023|NCT03742427|21400847|P1|NOT COMPLETED|Overall Study||0
8669024|NCT03742427|21400847|P1|COMPLETED|Overall Study||50
8669025|NCT03742427|21400847|P1|STARTED|Overall Study||50
8669035|NCT03595176|21400883|P2|NOT COMPLETED|Overall Study||3
8669036|NCT03595176|21400884|P1|NOT COMPLETED|Overall Study||0
8669037|NCT03595176|21400883|P2|COMPLETED|Overall Study||381
8669038|NCT03595176|21400884|P1|COMPLETED|Overall Study||47
8669039|NCT03595176|21400883|P2|STARTED|Overall Study||384
8669040|NCT03595176|21400884|P1|STARTED|Overall Study||47
8669047|NCT03425799|21400912|P2|NOT COMPLETED|Overall Study||0
8669048|NCT03425799|21400913|P1|NOT COMPLETED|Overall Study||0
8669049|NCT03425799|21400912|P2|COMPLETED|Overall Study|Study terminated due to low recruitment|0
8669050|NCT03425799|21400913|P1|COMPLETED|Overall Study|Study terminated due to low recruitment|0
8669051|NCT03425799|21400912|P2|STARTED|Overall Study|Study terminated due to low recruitment|0
8669052|NCT03425799|21400913|P1|STARTED|Overall Study|Study terminated due to low recruitment|0
8669053|NCT03395353|21400927|P1|NOT COMPLETED|Overall Study||87
8669054|NCT03395353|21400927|P1|COMPLETED|Overall Study||64
8669055|NCT03395353|21400927|P1|Received At Least 1 Dose of Study Drug|Overall Study||150
8669056|NCT03395353|21400927|P1|STARTED|Overall Study||151
8669057|NCT03325556|21400937|P3|NOT COMPLETED|Double-blind Period||77
8669058|NCT03325556|21400938|P2|NOT COMPLETED|Double-blind Period||61
8669059|NCT03325556|21400939|P1|NOT COMPLETED|Double-blind Period||0
8669060|NCT03325556|21400937|P3|COMPLETED|Double-blind Period||35
8669061|NCT03325556|21400938|P2|COMPLETED|Double-blind Period||44
8669062|NCT03325556|21400939|P1|COMPLETED|Double-blind Period||0
8669063|NCT03325556|21400937|P3|STARTED|Double-blind Period||112
8669064|NCT03325556|21400938|P2|STARTED|Double-blind Period||105
8669065|NCT03325556|21400939|P1|STARTED|Double-blind Period||0
8669066|NCT03325556|21400937|P3|NOT COMPLETED|Open-label Period||0
8669067|NCT03325556|21400938|P2|NOT COMPLETED|Open-label Period||0
8669068|NCT03325556|21400939|P1|NOT COMPLETED|Open-label Period||175
8669069|NCT03325556|21400937|P3|COMPLETED|Open-label Period||0
8669070|NCT03325556|21400938|P2|COMPLETED|Open-label Period||0
8669071|NCT03325556|21400939|P1|COMPLETED|Open-label Period||217
8669072|NCT03325556|21400937|P3|STARTED|Open-label Period||0
8669073|NCT03325556|21400938|P2|STARTED|Open-label Period||0
8669074|NCT03325556|21400939|P1|STARTED|Open-label Period||392
8669075|NCT03247517|21400951|P3|NOT COMPLETED|Overall Study||14
8669076|NCT03247517|21400952|P2|NOT COMPLETED|Overall Study||20
8669077|NCT03247517|21400953|P1|NOT COMPLETED|Overall Study||8
8669078|NCT03247517|21400951|P3|COMPLETED|Overall Study||92
8669079|NCT03247517|21400952|P2|COMPLETED|Overall Study||78
8669080|NCT03247517|21400953|P1|COMPLETED|Overall Study||96
8669081|NCT03247517|21400951|P3|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received 200mg/day SPN-812 during the trial|106
8669082|NCT03247517|21400952|P2|STARTED|Overall Study||98
8669083|NCT03247517|21400953|P1|STARTED|Overall Study||104
8669183|NCT03098420|21401098|P3|NOT COMPLETED|Overall Study||0
8669184|NCT03098420|21401099|P2|NOT COMPLETED|Overall Study||0
8669185|NCT03098420|21401100|P1|NOT COMPLETED|Overall Study||0
8669186|NCT03098420|21401098|P3|COMPLETED|Overall Study||13
8669187|NCT03098420|21401099|P2|COMPLETED|Overall Study||9
8669188|NCT03098420|21401100|P1|COMPLETED|Overall Study||7
8669189|NCT03098420|21401098|P3|STARTED|Overall Study||13
8669190|NCT03098420|21401099|P2|STARTED|Overall Study||9
8669191|NCT03098420|21401100|P1|STARTED|Overall Study||7
8669192|NCT03065400|21401114|P1|NOT COMPLETED|Overall Study||10
8669193|NCT03065400|21401114|P1|COMPLETED|Overall Study||0
8669194|NCT03065400|21401114|P1|STARTED|Overall Study||10
8669195|NCT03064152|21401121|P2|NOT COMPLETED|Overall Study||0
8669196|NCT03064152|21401122|P1|NOT COMPLETED|Overall Study||0
8669197|NCT03064152|21401121|P2|COMPLETED|Overall Study||23
8669198|NCT03064152|21401122|P1|COMPLETED|Overall Study||26
8669199|NCT03064152|21401121|P2|STARTED|Overall Study||23
8669200|NCT03064152|21401122|P1|STARTED|Overall Study||26
8669201|NCT03050307|21401138|P2|NOT COMPLETED|Overall Study||9
8669202|NCT03050307|21401139|P1|NOT COMPLETED|Overall Study||8
8669203|NCT03050307|21401138|P2|COMPLETED|Overall Study||110
8669204|NCT03050307|21401139|P1|COMPLETED|Overall Study||107
8669205|NCT03050307|21401138|P2|STARTED|Overall Study||119
8669206|NCT03050307|21401139|P1|STARTED|Overall Study||115
8669207|NCT03043872|21401154|P3|NOT COMPLETED|Overall Study||238
8669208|NCT03043872|21401155|P2|NOT COMPLETED|Overall Study||212
8669209|NCT03043872|21401156|P1|NOT COMPLETED|Overall Study||212
8669210|NCT03043872|21401154|P3|COMPLETED|Overall Study||31
8669211|NCT03043872|21401155|P2|COMPLETED|Overall Study||56
8669212|NCT03043872|21401156|P1|COMPLETED|Overall Study||56
8669213|NCT03043872|21401154|P3|Received Treatment|Overall Study||266
8669214|NCT03043872|21401155|P2|Received Treatment|Overall Study||265
8669215|NCT03043872|21401156|P1|Received Treatment|Overall Study||266
8669216|NCT03043872|21401154|P3|STARTED|Overall Study||269
8669217|NCT03043872|21401155|P2|STARTED|Overall Study||268
8669218|NCT03043872|21401156|P1|STARTED|Overall Study||268
8669219|NCT03035318|21401204|P5|NOT COMPLETED|Overall Study||7
8669220|NCT03035318|21401205|P4|NOT COMPLETED|Overall Study||2
8669221|NCT03035318|21401206|P3|NOT COMPLETED|Overall Study||4
8669222|NCT03035318|21401207|P2|NOT COMPLETED|Overall Study||4
8669223|NCT03035318|21401208|P1|NOT COMPLETED|Overall Study||2
8669224|NCT03035318|21401204|P5|COMPLETED|Overall Study||20
8669225|NCT03035318|21401205|P4|COMPLETED|Overall Study||23
8669226|NCT03035318|21401206|P3|COMPLETED|Overall Study||21
8669227|NCT03035318|21401207|P2|COMPLETED|Overall Study||21
8669228|NCT03035318|21401208|P1|COMPLETED|Overall Study||22
8669229|NCT03035318|21401204|P5|STARTED|Overall Study||27
8669230|NCT03035318|21401205|P4|STARTED|Overall Study||25
8669231|NCT03035318|21401206|P3|STARTED|Overall Study||25
8669232|NCT03035318|21401207|P2|STARTED|Overall Study||25
8669233|NCT03035318|21401208|P1|STARTED|Overall Study||24
8669234|NCT02960438|21401234|P4|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
8669235|NCT02960438|21401235|P3|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||14
8669236|NCT02960438|21401236|P2|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||9
8669237|NCT02960438|21401237|P1|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
8669238|NCT02960438|21401234|P4|COMPLETED|Extension Phase (Open-label): 80 Weeks||35
8669239|NCT02960438|21401235|P3|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
8669240|NCT02960438|21401236|P2|COMPLETED|Extension Phase (Open-label): 80 Weeks||17
8669241|NCT02960438|21401237|P1|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
8669242|NCT02960438|21401234|P4|STARTED|Extension Phase (Open-label): 80 Weeks||46
8669243|NCT02960438|21401235|P3|STARTED|Extension Phase (Open-label): 80 Weeks||50
8669244|NCT02960438|21401236|P2|STARTED|Extension Phase (Open-label): 80 Weeks||26
8669245|NCT02960438|21401237|P1|STARTED|Extension Phase (Open-label): 80 Weeks||47
8669246|NCT02960438|21401234|P4|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
8669247|NCT02960438|21401235|P3|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||4
8669248|NCT02960438|21401236|P2|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||3
8669249|NCT02960438|21401237|P1|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
8669250|NCT02960438|21401234|P4|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||46
8669251|NCT02960438|21401235|P3|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||50
8669252|NCT02960438|21401236|P2|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||26
8669253|NCT02960438|21401237|P1|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||47
8669254|NCT02960438|21401234|P4|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
8669255|NCT02960438|21401235|P3|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
8669256|NCT02960438|21401236|P2|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||28
8669257|NCT02960438|21401237|P1|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
8669258|NCT02960438|21401234|P4|STARTED|Treatment Phase (Double-blind): 24 Weeks||55
8669259|NCT02960438|21401235|P3|STARTED|Treatment Phase (Double-blind): 24 Weeks||54
8669260|NCT02960438|21401236|P2|STARTED|Treatment Phase (Double-blind): 24 Weeks||29
8669261|NCT02960438|21401237|P1|STARTED|Treatment Phase (Double-blind): 24 Weeks||56
8669262|NCT02930824|21401411|P4|NOT COMPLETED|Overall Study||7
8669263|NCT02930824|21401412|P3|NOT COMPLETED|Overall Study||10
8669264|NCT02930824|21401413|P2|NOT COMPLETED|Overall Study||6
8669265|NCT02930824|21401414|P1|NOT COMPLETED|Overall Study||6
8669266|NCT02930824|21401411|P4|COMPLETED|Overall Study||23
8669267|NCT02930824|21401412|P3|COMPLETED|Overall Study||20
8669268|NCT02930824|21401413|P2|COMPLETED|Overall Study||57
8669269|NCT02930824|21401414|P1|COMPLETED|Overall Study||56
8669270|NCT02930824|21401411|P4|STARTED|Overall Study||30
8669271|NCT02930824|21401412|P3|STARTED|Overall Study||30
8669272|NCT02930824|21401413|P2|STARTED|Overall Study||63
8669273|NCT02930824|21401414|P1|STARTED|Overall Study||62
8669274|NCT02928055|21401443|P3|NOT COMPLETED|Overall Study||2
8669275|NCT02928055|21401444|P2|NOT COMPLETED|Overall Study||2
8669276|NCT02928055|21401445|P1|NOT COMPLETED|Overall Study||3
8669277|NCT02928055|21401443|P3|COMPLETED|Overall Study||5
8669278|NCT02928055|21401444|P2|COMPLETED|Overall Study||6
8669279|NCT02928055|21401445|P1|COMPLETED|Overall Study||5
8669280|NCT02928055|21401443|P3|3 Month Follow up|Overall Study||5
8669281|NCT02928055|21401444|P2|3 Month Follow up|Overall Study||6
8669282|NCT02928055|21401445|P1|3 Month Follow up|Overall Study||5
8669283|NCT02928055|21401443|P3|2 Month Follow up|Overall Study||5
8669284|NCT02928055|21401444|P2|2 Month Follow up|Overall Study||7
8669285|NCT02928055|21401445|P1|2 Month Follow up|Overall Study||6
8669286|NCT02928055|21401443|P3|1 Month Follow up|Overall Study||6
8669287|NCT02928055|21401444|P2|1 Month Follow up|Overall Study||7
8669288|NCT02928055|21401445|P1|1 Month Follow up|Overall Study||7
8669289|NCT02928055|21401443|P3|End of Treatment|Overall Study||6
8669290|NCT02928055|21401444|P2|End of Treatment|Overall Study||8
8669291|NCT02928055|21401445|P1|End of Treatment|Overall Study||8
8669292|NCT02928055|21401443|P3|STARTED|Overall Study||7
8669293|NCT02928055|21401444|P2|STARTED|Overall Study||8
8669294|NCT02928055|21401445|P1|STARTED|Overall Study||8
8669295|NCT02926937|21401456|P3|NOT COMPLETED|Overall Study||11
8669296|NCT02926937|21401457|P2|NOT COMPLETED|Overall Study||15
8669297|NCT02926937|21401458|P1|NOT COMPLETED|Overall Study||19
8669298|NCT02926937|21401456|P3|COMPLETED|Overall Study||96
8669299|NCT02926937|21401457|P2|COMPLETED|Overall Study||127
8669300|NCT02926937|21401458|P1|COMPLETED|Overall Study||131
8669301|NCT02926937|21401456|P3|STARTED|Overall Study||107
8669302|NCT02926937|21401457|P2|STARTED|Overall Study||142
8669303|NCT02926937|21401458|P1|STARTED|Overall Study||150
8669304|NCT02917031|21401494|P3|NOT COMPLETED|Overall Study||15
8669305|NCT02917031|21401495|P2|NOT COMPLETED|Overall Study||13
8669306|NCT02917031|21401496|P1|NOT COMPLETED|Overall Study||18
8669307|NCT02917031|21401494|P3|COMPLETED|Overall Study||105
8669308|NCT02917031|21401495|P2|COMPLETED|Overall Study||102
8669309|NCT02917031|21401496|P1|COMPLETED|Overall Study||94
8669310|NCT02917031|21401494|P3|STARTED|Overall Study||120
8669311|NCT02917031|21401495|P2|STARTED|Overall Study||115
8669312|NCT02917031|21401496|P1|STARTED|Overall Study||112
8669313|NCT02757326|21401517|P3|NOT COMPLETED|Overall Study||0
8669314|NCT02757326|21401518|P2|NOT COMPLETED|Overall Study||0
8669315|NCT02757326|21401519|P1|NOT COMPLETED|Overall Study||0
8669316|NCT02757326|21401517|P3|COMPLETED|Overall Study||6
8669317|NCT02757326|21401518|P2|COMPLETED|Overall Study||4
8669318|NCT02757326|21401519|P1|COMPLETED|Overall Study||3
8669319|NCT02757326|21401517|P3|STARTED|Overall Study||6
8669320|NCT02757326|21401518|P2|STARTED|Overall Study||4
8669321|NCT02757326|21401519|P1|STARTED|Overall Study||3
8669322|NCT02703779|21401536|P2|NOT COMPLETED|Overall Study||0
8669323|NCT02703779|21401537|P1|NOT COMPLETED|Overall Study||0
8669324|NCT02703779|21401536|P2|COMPLETED|Overall Study||50
8669325|NCT02703779|21401537|P1|COMPLETED|Overall Study||51
8669326|NCT02703779|21401536|P2|STARTED|Overall Study||50
8669327|NCT02703779|21401537|P1|STARTED|Overall Study||51
8669328|NCT02663622|21401551|P4|NOT COMPLETED|Overall Study||15
8669329|NCT02663622|21401552|P3|NOT COMPLETED|Overall Study||1
8669330|NCT02663622|21401553|P2|NOT COMPLETED|Overall Study||1
8669331|NCT02663622|21401554|P1|NOT COMPLETED|Overall Study||3
8669332|NCT02663622|21401551|P4|COMPLETED|Overall Study||11
8669333|NCT02663622|21401552|P3|COMPLETED|Overall Study||5
8669334|NCT02663622|21401553|P2|COMPLETED|Overall Study||5
8669335|NCT02663622|21401554|P1|COMPLETED|Overall Study||3
8669336|NCT02663622|21401551|P4|STARTED|Overall Study||26
8669337|NCT02663622|21401552|P3|STARTED|Overall Study||6
8669338|NCT02663622|21401553|P2|STARTED|Overall Study||6
8669339|NCT02663622|21401554|P1|STARTED|Overall Study||6
8669340|NCT02561273|21401583|P2|NOT COMPLETED|Overall Study||0
8669341|NCT02561273|21401584|P1|NOT COMPLETED|Overall Study||1
8669342|NCT02561273|21401583|P2|COMPLETED|Overall Study||4
8669343|NCT02561273|21401584|P1|COMPLETED|Overall Study||39
8669344|NCT02561273|21401583|P2|STARTED|Overall Study||4
8669345|NCT02561273|21401584|P1|STARTED|Overall Study||40
8669361|NCT02476968|21401633|P3|NOT COMPLETED|Overall Study||2
8669362|NCT02476968|21401634|P2|NOT COMPLETED|Overall Study||15
8669363|NCT02476968|21401635|P1|NOT COMPLETED|Overall Study||74
8669364|NCT02476968|21401633|P3|COMPLETED|Overall Study||1
8669365|NCT02476968|21401634|P2|COMPLETED|Overall Study||18
8669366|NCT02476968|21401635|P1|COMPLETED|Overall Study||71
8669367|NCT02476968|21401633|P3|Received Treatment|Overall Study||2
8669368|NCT02476968|21401634|P2|Received Treatment|Overall Study||32
8669369|NCT02476968|21401635|P1|Received Treatment|Overall Study||143
8669370|NCT02476968|21401633|P3|STARTED|Overall Study||3
8669371|NCT02476968|21401634|P2|STARTED|Overall Study||33
8669372|NCT02476968|21401635|P1|STARTED|Overall Study||145
8669373|NCT02435680|21401663|P3|NOT COMPLETED|Overall Study||16
8669374|NCT02435680|21401664|P2|NOT COMPLETED|Overall Study||13
8669375|NCT02435680|21401665|P1|NOT COMPLETED|Overall Study||21
8669376|NCT02435680|21401663|P3|COMPLETED|Overall Study||0
8669377|NCT02435680|21401664|P2|COMPLETED|Overall Study||0
8669378|NCT02435680|21401665|P1|COMPLETED|Overall Study||0
8669379|NCT02435680|21401663|P3|STARTED|Overall Study||16
8669380|NCT02435680|21401664|P2|STARTED|Overall Study||13
8669381|NCT02435680|21401665|P1|STARTED|Overall Study||21
8669397|NCT02286843|21401750|P1|NOT COMPLETED|Overall Study||6
8669398|NCT02286843|21401750|P1|COMPLETED|Overall Study||43
8669399|NCT02286843|21401750|P1|STARTED|Overall Study||49
8669400|NCT02233530|21401754|P1|NOT COMPLETED|Overall Study||0
8669401|NCT02233530|21401754|P1|COMPLETED|Overall Study||8
8669402|NCT02233530|21401754|P1|STARTED|Overall Study||8
8669403|NCT02227667|21401765|P1|NOT COMPLETED|Overall Study||0
8669404|NCT02227667|21401765|P1|COMPLETED|Overall Study||16
8669405|NCT02227667|21401765|P1|STARTED|Overall Study||16
8669406|NCT02047604|21401776|P6|NOT COMPLETED|Overall Study||1
8669407|NCT02047604|21401777|P5|NOT COMPLETED|Overall Study||1
8669408|NCT02047604|21401778|P4|NOT COMPLETED|Overall Study||0
8669409|NCT02047604|21401779|P3|NOT COMPLETED|Overall Study||0
8669410|NCT02047604|21401780|P2|NOT COMPLETED|Overall Study||0
8669411|NCT02047604|21401781|P1|NOT COMPLETED|Overall Study||0
8669412|NCT02047604|21401776|P6|COMPLETED|Overall Study||9
8669413|NCT02047604|21401777|P5|COMPLETED|Overall Study||5
8669414|NCT02047604|21401778|P4|COMPLETED|Overall Study||6
8669415|NCT02047604|21401779|P3|COMPLETED|Overall Study||6
8669416|NCT02047604|21401780|P2|COMPLETED|Overall Study||7
8669417|NCT02047604|21401781|P1|COMPLETED|Overall Study||6
8669418|NCT02047604|21401776|P6|STARTED|Overall Study||10
8669419|NCT02047604|21401777|P5|STARTED|Overall Study||6
8669420|NCT02047604|21401778|P4|STARTED|Overall Study||6
8669421|NCT02047604|21401779|P3|STARTED|Overall Study||6
8669422|NCT02047604|21401780|P2|STARTED|Overall Study||7
8669423|NCT02047604|21401781|P1|STARTED|Overall Study||6
8669424|NCT02043899|21401819|P1|NOT COMPLETED|Overall Study||27
8669425|NCT02043899|21401819|P1|COMPLETED|Overall Study||9
8669426|NCT02043899|21401819|P1|Underwent [124I]mIBG PET/CT Imaging|Overall Study||9
8669427|NCT02043899|21401819|P1|Underwent Routine [123I]mIBG Planar and SPECT/CT Imaging|Overall Study||32
8669428|NCT02043899|21401819|P1|STARTED|Overall Study||36
8669435|NCT01982448|21401850|P2|NOT COMPLETED|Definitive Breast Surgery||0
8669436|NCT01982448|21401851|P1|NOT COMPLETED|Definitive Breast Surgery||0
8669437|NCT01982448|21401850|P2|COMPLETED|Definitive Breast Surgery||67
8669438|NCT01982448|21401851|P1|COMPLETED|Definitive Breast Surgery||72
8669439|NCT01982448|21401850|P2|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||48
8669440|NCT01982448|21401851|P1|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||56
8669441|NCT01982448|21401850|P2|STARTED|Definitive Breast Surgery||67
8669442|NCT01982448|21401851|P1|STARTED|Definitive Breast Surgery||72
8669443|NCT01982448|21401850|P2|NOT COMPLETED|Preoperative Chemotherapy||5
8669444|NCT01982448|21401851|P1|NOT COMPLETED|Preoperative Chemotherapy||3
8669445|NCT01982448|21401850|P2|COMPLETED|Preoperative Chemotherapy||67
8669446|NCT01982448|21401851|P1|COMPLETED|Preoperative Chemotherapy||72
8669447|NCT01982448|21401850|P2|Evaluable for Safety|Preoperative Chemotherapy||68
8669448|NCT01982448|21401851|P1|Evaluable for Safety|Preoperative Chemotherapy||72
8669449|NCT01982448|21401850|P2|Eligible & Treated|Preoperative Chemotherapy||70
8669450|NCT01982448|21401851|P1|Eligible & Treated|Preoperative Chemotherapy||72
8669451|NCT01982448|21401850|P2|STARTED|Preoperative Chemotherapy||72
8669452|NCT01982448|21401851|P1|STARTED|Preoperative Chemotherapy||75
8669453|NCT01944046|21401871|P2|NOT COMPLETED|Open Label Eligible and Consented||8
8669454|NCT01944046|21401872|P1|NOT COMPLETED|Open Label Eligible and Consented||14
8669455|NCT01944046|21401871|P2|COMPLETED|Open Label Eligible and Consented||116
8669456|NCT01944046|21401872|P1|COMPLETED|Open Label Eligible and Consented||110
8669457|NCT01944046|21401871|P2|STARTED|Open Label Eligible and Consented||124
8669458|NCT01944046|21401872|P1|STARTED|Open Label Eligible and Consented||124
8669459|NCT01944046|21401871|P2|NOT COMPLETED|Randomized to DB||19
8669460|NCT01944046|21401872|P1|NOT COMPLETED|Randomized to DB||21
8669461|NCT01944046|21401871|P2|COMPLETED|Randomized to DB||125
8669462|NCT01944046|21401872|P1|COMPLETED|Randomized to DB||125
8669463|NCT01944046|21401871|P2|STARTED|Randomized to DB||144
8669464|NCT01944046|21401872|P1|STARTED|Randomized to DB||146
8669465|NCT01905241|21401910|P1|NOT COMPLETED|Overall Study||0
8669466|NCT01905241|21401910|P1|COMPLETED|Overall Study||20
8669467|NCT01905241|21401910|P1|STARTED|Overall Study||20
8669468|NCT01776307|21401920|P3|NOT COMPLETED|Overall Study||1
8669469|NCT01776307|21401921|P2|NOT COMPLETED|Overall Study||0
8669470|NCT01776307|21401922|P1|NOT COMPLETED|Overall Study||0
8669471|NCT01776307|21401920|P3|COMPLETED|Overall Study||75
8669472|NCT01776307|21401921|P2|COMPLETED|Overall Study||75
8669473|NCT01776307|21401922|P1|COMPLETED|Overall Study||49
8669474|NCT01776307|21401920|P3|STARTED|Overall Study||76
8669475|NCT01776307|21401921|P2|STARTED|Overall Study||75
8669476|NCT01776307|21401922|P1|STARTED|Overall Study||49
8669477|NCT01749215|21401974|P2|NOT COMPLETED|Overall Study||26
8669478|NCT01749215|21401975|P1|NOT COMPLETED|Overall Study||25
8669479|NCT01749215|21401974|P2|COMPLETED|Overall Study||53
8669480|NCT01749215|21401975|P1|COMPLETED|Overall Study||47
8669481|NCT01749215|21401974|P2|STARTED|Overall Study||79
8669482|NCT01749215|21401975|P1|STARTED|Overall Study||72
8669483|NCT01706458|21401991|P2|NOT COMPLETED|Overall Study||4
8669484|NCT01706458|21401992|P1|NOT COMPLETED|Overall Study||3
8669485|NCT01706458|21401991|P2|COMPLETED|Overall Study||5
8669486|NCT01706458|21401992|P1|COMPLETED|Overall Study||6
8669487|NCT01706458|21401991|P2|STARTED|Overall Study||9
8669488|NCT01706458|21401992|P1|STARTED|Overall Study||9
8669489|NCT01682811|21402023|P7|NOT COMPLETED|Part 2 Dose Level 3||0
8669490|NCT01682811|21402024|P6|NOT COMPLETED|Part 2 Dose Level 3||0
8669491|NCT01682811|21402025|P5|NOT COMPLETED|Part 2 Dose Level 3||0
8669492|NCT01682811|21402026|P4|NOT COMPLETED|Part 2 Dose Level 3||0
8669493|NCT01682811|21402027|P3|NOT COMPLETED|Part 2 Dose Level 3||0
8669494|NCT01682811|21402028|P2|NOT COMPLETED|Part 2 Dose Level 3||0
8669495|NCT01682811|21402029|P1|NOT COMPLETED|Part 2 Dose Level 3||0
8669496|NCT01682811|21402023|P7|COMPLETED|Part 2 Dose Level 3||0
8669497|NCT01682811|21402024|P6|COMPLETED|Part 2 Dose Level 3||0
8669498|NCT01682811|21402025|P5|COMPLETED|Part 2 Dose Level 3||0
8669499|NCT01682811|21402026|P4|COMPLETED|Part 2 Dose Level 3||0
8669500|NCT01682811|21402027|P3|COMPLETED|Part 2 Dose Level 3||0
8669501|NCT01682811|21402028|P2|COMPLETED|Part 2 Dose Level 3||0
8669502|NCT01682811|21402029|P1|COMPLETED|Part 2 Dose Level 3||0
8669503|NCT01682811|21402023|P7|Treated|Part 2 Dose Level 3||0
8669504|NCT01682811|21402024|P6|Treated|Part 2 Dose Level 3||0
8669505|NCT01682811|21402025|P5|Treated|Part 2 Dose Level 3||0
8669506|NCT01682811|21402026|P4|Treated|Part 2 Dose Level 3||0
8669507|NCT01682811|21402027|P3|Treated|Part 2 Dose Level 3||0
8669508|NCT01682811|21402028|P2|Treated|Part 2 Dose Level 3||0
8669509|NCT01682811|21402029|P1|Treated|Part 2 Dose Level 3||0
8669510|NCT01682811|21402023|P7|Control|Part 2 Dose Level 3||0
8669511|NCT01682811|21402024|P6|Control|Part 2 Dose Level 3||0
8669512|NCT01682811|21402025|P5|Control|Part 2 Dose Level 3||0
8669513|NCT01682811|21402026|P4|Control|Part 2 Dose Level 3||0
8669514|NCT01682811|21402027|P3|Control|Part 2 Dose Level 3||0
8669515|NCT01682811|21402028|P2|Control|Part 2 Dose Level 3||0
8669516|NCT01682811|21402029|P1|Control|Part 2 Dose Level 3||0
8669517|NCT01682811|21402023|P7|STARTED|Part 2 Dose Level 3||0
8669518|NCT01682811|21402024|P6|STARTED|Part 2 Dose Level 3||0
8669519|NCT01682811|21402025|P5|STARTED|Part 2 Dose Level 3||0
8669520|NCT01682811|21402026|P4|STARTED|Part 2 Dose Level 3||0
8669521|NCT01682811|21402027|P3|STARTED|Part 2 Dose Level 3||0
8669522|NCT01682811|21402028|P2|STARTED|Part 2 Dose Level 3||0
8669523|NCT01682811|21402029|P1|STARTED|Part 2 Dose Level 3||0
8669524|NCT01682811|21402023|P7|NOT COMPLETED|Part 2 Dose Level 2||0
8669525|NCT01682811|21402024|P6|NOT COMPLETED|Part 2 Dose Level 2||3
8669526|NCT01682811|21402025|P5|NOT COMPLETED|Part 2 Dose Level 2||0
8669527|NCT01682811|21402026|P4|NOT COMPLETED|Part 2 Dose Level 2||0
8669528|NCT01682811|21402027|P3|NOT COMPLETED|Part 2 Dose Level 2||0
8669529|NCT01682811|21402028|P2|NOT COMPLETED|Part 2 Dose Level 2||0
8669530|NCT01682811|21402029|P1|NOT COMPLETED|Part 2 Dose Level 2||0
8669531|NCT01682811|21402023|P7|COMPLETED|Part 2 Dose Level 2||0
8669532|NCT01682811|21402024|P6|COMPLETED|Part 2 Dose Level 2||0
8669533|NCT01682811|21402025|P5|COMPLETED|Part 2 Dose Level 2||0
8669534|NCT01682811|21402026|P4|COMPLETED|Part 2 Dose Level 2||0
8669535|NCT01682811|21402027|P3|COMPLETED|Part 2 Dose Level 2||0
8669536|NCT01682811|21402028|P2|COMPLETED|Part 2 Dose Level 2||0
8669537|NCT01682811|21402029|P1|COMPLETED|Part 2 Dose Level 2||0
8669538|NCT01682811|21402023|P7|Treated|Part 2 Dose Level 2||0
8669539|NCT01682811|21402024|P6|Treated|Part 2 Dose Level 2||3
8669540|NCT01682811|21402025|P5|Treated|Part 2 Dose Level 2||0
8669541|NCT01682811|21402026|P4|Treated|Part 2 Dose Level 2||0
8669542|NCT01682811|21402027|P3|Treated|Part 2 Dose Level 2||0
8669543|NCT01682811|21402028|P2|Treated|Part 2 Dose Level 2||0
8669544|NCT01682811|21402029|P1|Treated|Part 2 Dose Level 2||0
8669545|NCT01682811|21402023|P7|Control|Part 2 Dose Level 2||0
8669546|NCT01682811|21402024|P6|Control|Part 2 Dose Level 2||3
8669547|NCT01682811|21402025|P5|Control|Part 2 Dose Level 2||0
8669548|NCT01682811|21402026|P4|Control|Part 2 Dose Level 2||0
8669549|NCT01682811|21402027|P3|Control|Part 2 Dose Level 2||0
8669550|NCT01682811|21402028|P2|Control|Part 2 Dose Level 2||0
8669551|NCT01682811|21402029|P1|Control|Part 2 Dose Level 2||0
8669552|NCT01682811|21402023|P7|STARTED|Part 2 Dose Level 2||0
8669553|NCT01682811|21402024|P6|STARTED|Part 2 Dose Level 2||3
8669554|NCT01682811|21402025|P5|STARTED|Part 2 Dose Level 2||0
8669555|NCT01682811|21402026|P4|STARTED|Part 2 Dose Level 2||0
8669556|NCT01682811|21402027|P3|STARTED|Part 2 Dose Level 2||0
8669557|NCT01682811|21402028|P2|STARTED|Part 2 Dose Level 2||0
8669558|NCT01682811|21402029|P1|STARTED|Part 2 Dose Level 2||0
8669559|NCT01682811|21402023|P7|NOT COMPLETED|Part 2 Dose Level 1||0
8669560|NCT01682811|21402024|P6|NOT COMPLETED|Part 2 Dose Level 1||0
8669561|NCT01682811|21402025|P5|NOT COMPLETED|Part 2 Dose Level 1||11
8669562|NCT01682811|21402026|P4|NOT COMPLETED|Part 2 Dose Level 1||0
8669563|NCT01682811|21402027|P3|NOT COMPLETED|Part 2 Dose Level 1||0
8669564|NCT01682811|21402028|P2|NOT COMPLETED|Part 2 Dose Level 1||0
8669565|NCT01682811|21402029|P1|NOT COMPLETED|Part 2 Dose Level 1||0
8669566|NCT01682811|21402023|P7|COMPLETED|Part 2 Dose Level 1||0
8669567|NCT01682811|21402024|P6|COMPLETED|Part 2 Dose Level 1||0
8669568|NCT01682811|21402025|P5|COMPLETED|Part 2 Dose Level 1||0
8669569|NCT01682811|21402026|P4|COMPLETED|Part 2 Dose Level 1||0
8669570|NCT01682811|21402027|P3|COMPLETED|Part 2 Dose Level 1||0
8669571|NCT01682811|21402028|P2|COMPLETED|Part 2 Dose Level 1||0
8669572|NCT01682811|21402029|P1|COMPLETED|Part 2 Dose Level 1||0
8669573|NCT01682811|21402023|P7|Treated|Part 2 Dose Level 1||0
8669574|NCT01682811|21402024|P6|Treated|Part 2 Dose Level 1||0
8669575|NCT01682811|21402025|P5|Treated|Part 2 Dose Level 1||10
8669576|NCT01682811|21402026|P4|Treated|Part 2 Dose Level 1||0
8669577|NCT01682811|21402027|P3|Treated|Part 2 Dose Level 1||0
8669578|NCT01682811|21402028|P2|Treated|Part 2 Dose Level 1||0
8669579|NCT01682811|21402029|P1|Treated|Part 2 Dose Level 1||0
8669580|NCT01682811|21402023|P7|Control|Part 2 Dose Level 1||0
8669581|NCT01682811|21402024|P6|Control|Part 2 Dose Level 1||0
8669582|NCT01682811|21402025|P5|Control|Part 2 Dose Level 1||10
8669583|NCT01682811|21402026|P4|Control|Part 2 Dose Level 1||0
8669584|NCT01682811|21402027|P3|Control|Part 2 Dose Level 1||0
8669585|NCT01682811|21402028|P2|Control|Part 2 Dose Level 1||0
8669586|NCT01682811|21402029|P1|Control|Part 2 Dose Level 1||0
8669587|NCT01682811|21402023|P7|STARTED|Part 2 Dose Level 1||0
8669588|NCT01682811|21402024|P6|STARTED|Part 2 Dose Level 1||0
8669589|NCT01682811|21402025|P5|STARTED|Part 2 Dose Level 1||11
8669590|NCT01682811|21402026|P4|STARTED|Part 2 Dose Level 1||0
8669591|NCT01682811|21402027|P3|STARTED|Part 2 Dose Level 1||0
8669592|NCT01682811|21402028|P2|STARTED|Part 2 Dose Level 1||0
8669593|NCT01682811|21402029|P1|STARTED|Part 2 Dose Level 1||0
8669594|NCT01682811|21402023|P7|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8669595|NCT01682811|21402024|P6|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8669596|NCT01682811|21402025|P5|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8669597|NCT01682811|21402026|P4|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8669598|NCT01682811|21402027|P3|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8669599|NCT01682811|21402028|P2|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8669600|NCT01682811|21402029|P1|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8669601|NCT01682811|21402023|P7|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8669602|NCT01682811|21402024|P6|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8669603|NCT01682811|21402025|P5|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8669604|NCT01682811|21402026|P4|COMPLETED|Part 1 Levulan Paint Twice Microneedling||2
8669605|NCT01682811|21402027|P3|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8669606|NCT01682811|21402028|P2|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8669607|NCT01682811|21402029|P1|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
8669608|NCT01682811|21402023|P7|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
8669609|NCT01682811|21402024|P6|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
8669610|NCT01682811|21402025|P5|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
8669611|NCT01682811|21402026|P4|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||2
8669612|NCT01682811|21402027|P3|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
8669613|NCT01682811|21402028|P2|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
8669614|NCT01682811|21402029|P1|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
8669615|NCT01682811|21402023|P7|Control|Part 1 Levulan Paint Twice Microneedling||0
8669616|NCT01682811|21402024|P6|Control|Part 1 Levulan Paint Twice Microneedling||0
8669617|NCT01682811|21402025|P5|Control|Part 1 Levulan Paint Twice Microneedling||0
8669618|NCT01682811|21402026|P4|Control|Part 1 Levulan Paint Twice Microneedling||2
8669619|NCT01682811|21402027|P3|Control|Part 1 Levulan Paint Twice Microneedling||0
8669620|NCT01682811|21402028|P2|Control|Part 1 Levulan Paint Twice Microneedling||0
8669621|NCT01682811|21402029|P1|Control|Part 1 Levulan Paint Twice Microneedling||0
8669622|NCT01682811|21402023|P7|STARTED|Part 1 Levulan Paint Twice Microneedling||0
8669623|NCT01682811|21402024|P6|STARTED|Part 1 Levulan Paint Twice Microneedling||0
8669624|NCT01682811|21402025|P5|STARTED|Part 1 Levulan Paint Twice Microneedling||0
8669625|NCT01682811|21402026|P4|STARTED|Part 1 Levulan Paint Twice Microneedling||2
8669626|NCT01682811|21402027|P3|STARTED|Part 1 Levulan Paint Twice Microneedling||0
8669627|NCT01682811|21402028|P2|STARTED|Part 1 Levulan Paint Twice Microneedling||0
8669628|NCT01682811|21402029|P1|STARTED|Part 1 Levulan Paint Twice Microneedling||0
8669629|NCT01682811|21402023|P7|NOT COMPLETED|Part 1 Levulan Painted Twice||0
8669630|NCT01682811|21402024|P6|NOT COMPLETED|Part 1 Levulan Painted Twice||0
8669631|NCT01682811|21402025|P5|NOT COMPLETED|Part 1 Levulan Painted Twice||0
8669632|NCT01682811|21402026|P4|NOT COMPLETED|Part 1 Levulan Painted Twice||0
8669633|NCT01682811|21402027|P3|NOT COMPLETED|Part 1 Levulan Painted Twice||0
8669634|NCT01682811|21402028|P2|NOT COMPLETED|Part 1 Levulan Painted Twice||0
8669635|NCT01682811|21402029|P1|NOT COMPLETED|Part 1 Levulan Painted Twice||0
8669636|NCT01682811|21402023|P7|COMPLETED|Part 1 Levulan Painted Twice||0
8669637|NCT01682811|21402024|P6|COMPLETED|Part 1 Levulan Painted Twice||0
8669638|NCT01682811|21402025|P5|COMPLETED|Part 1 Levulan Painted Twice||0
8669639|NCT01682811|21402026|P4|COMPLETED|Part 1 Levulan Painted Twice||0
8669640|NCT01682811|21402027|P3|COMPLETED|Part 1 Levulan Painted Twice||2
8669641|NCT01682811|21402028|P2|COMPLETED|Part 1 Levulan Painted Twice||0
8669642|NCT01682811|21402029|P1|COMPLETED|Part 1 Levulan Painted Twice||0
8669643|NCT01682811|21402023|P7|Treated 24 Hours|Part 1 Levulan Painted Twice||0
8669644|NCT01682811|21402024|P6|Treated 24 Hours|Part 1 Levulan Painted Twice||0
8669645|NCT01682811|21402025|P5|Treated 24 Hours|Part 1 Levulan Painted Twice||0
8669646|NCT01682811|21402026|P4|Treated 24 Hours|Part 1 Levulan Painted Twice||0
8669647|NCT01682811|21402027|P3|Treated 24 Hours|Part 1 Levulan Painted Twice||2
8669648|NCT01682811|21402028|P2|Treated 24 Hours|Part 1 Levulan Painted Twice||0
8669649|NCT01682811|21402029|P1|Treated 24 Hours|Part 1 Levulan Painted Twice||0
8669650|NCT01682811|21402023|P7|Control|Part 1 Levulan Painted Twice||0
8669651|NCT01682811|21402024|P6|Control|Part 1 Levulan Painted Twice||0
8669652|NCT01682811|21402025|P5|Control|Part 1 Levulan Painted Twice||0
8669653|NCT01682811|21402026|P4|Control|Part 1 Levulan Painted Twice||0
8669654|NCT01682811|21402027|P3|Control|Part 1 Levulan Painted Twice||2
8669655|NCT01682811|21402028|P2|Control|Part 1 Levulan Painted Twice||0
8669656|NCT01682811|21402029|P1|Control|Part 1 Levulan Painted Twice||0
8669657|NCT01682811|21402023|P7|STARTED|Part 1 Levulan Painted Twice||0
8669658|NCT01682811|21402024|P6|STARTED|Part 1 Levulan Painted Twice||0
8669659|NCT01682811|21402025|P5|STARTED|Part 1 Levulan Painted Twice||0
8669660|NCT01682811|21402026|P4|STARTED|Part 1 Levulan Painted Twice||0
8669661|NCT01682811|21402027|P3|STARTED|Part 1 Levulan Painted Twice||2
8669662|NCT01682811|21402028|P2|STARTED|Part 1 Levulan Painted Twice||0
8669663|NCT01682811|21402029|P1|STARTED|Part 1 Levulan Painted Twice||0
8669664|NCT01682811|21402023|P7|NOT COMPLETED|Part 1 Levulan Painting||0
8669665|NCT01682811|21402024|P6|NOT COMPLETED|Part 1 Levulan Painting||0
8669666|NCT01682811|21402025|P5|NOT COMPLETED|Part 1 Levulan Painting||0
8669667|NCT01682811|21402026|P4|NOT COMPLETED|Part 1 Levulan Painting||0
8669668|NCT01682811|21402027|P3|NOT COMPLETED|Part 1 Levulan Painting||0
8669669|NCT01682811|21402028|P2|NOT COMPLETED|Part 1 Levulan Painting||0
8669670|NCT01682811|21402029|P1|NOT COMPLETED|Part 1 Levulan Painting||0
8669671|NCT01682811|21402023|P7|COMPLETED|Part 1 Levulan Painting||0
8669672|NCT01682811|21402024|P6|COMPLETED|Part 1 Levulan Painting||0
8669673|NCT01682811|21402025|P5|COMPLETED|Part 1 Levulan Painting||0
8669674|NCT01682811|21402026|P4|COMPLETED|Part 1 Levulan Painting||0
8669675|NCT01682811|21402027|P3|COMPLETED|Part 1 Levulan Painting||0
8669676|NCT01682811|21402028|P2|COMPLETED|Part 1 Levulan Painting||1
8669677|NCT01682811|21402029|P1|COMPLETED|Part 1 Levulan Painting||0
8669678|NCT01682811|21402023|P7|Treated 24 Hours|Part 1 Levulan Painting||0
8669679|NCT01682811|21402024|P6|Treated 24 Hours|Part 1 Levulan Painting||0
8669680|NCT01682811|21402025|P5|Treated 24 Hours|Part 1 Levulan Painting||0
8669681|NCT01682811|21402026|P4|Treated 24 Hours|Part 1 Levulan Painting||0
8669682|NCT01682811|21402027|P3|Treated 24 Hours|Part 1 Levulan Painting||0
8669683|NCT01682811|21402028|P2|Treated 24 Hours|Part 1 Levulan Painting||1
8669684|NCT01682811|21402029|P1|Treated 24 Hours|Part 1 Levulan Painting||0
8669685|NCT01682811|21402023|P7|Treated 3 Hours|Part 1 Levulan Painting||0
8669686|NCT01682811|21402024|P6|Treated 3 Hours|Part 1 Levulan Painting||0
8669687|NCT01682811|21402025|P5|Treated 3 Hours|Part 1 Levulan Painting||0
8669688|NCT01682811|21402026|P4|Treated 3 Hours|Part 1 Levulan Painting||0
8669689|NCT01682811|21402027|P3|Treated 3 Hours|Part 1 Levulan Painting||0
8669690|NCT01682811|21402028|P2|Treated 3 Hours|Part 1 Levulan Painting||1
8669691|NCT01682811|21402029|P1|Treated 3 Hours|Part 1 Levulan Painting||0
8669692|NCT01682811|21402023|P7|Control|Part 1 Levulan Painting||0
8669693|NCT01682811|21402024|P6|Control|Part 1 Levulan Painting||0
8669694|NCT01682811|21402025|P5|Control|Part 1 Levulan Painting||0
8669695|NCT01682811|21402026|P4|Control|Part 1 Levulan Painting||0
8669696|NCT01682811|21402027|P3|Control|Part 1 Levulan Painting||0
8669697|NCT01682811|21402028|P2|Control|Part 1 Levulan Painting||1
8669698|NCT01682811|21402029|P1|Control|Part 1 Levulan Painting||0
8669699|NCT01682811|21402023|P7|STARTED|Part 1 Levulan Painting||0
8669700|NCT01682811|21402024|P6|STARTED|Part 1 Levulan Painting||0
8669701|NCT01682811|21402025|P5|STARTED|Part 1 Levulan Painting||0
8669702|NCT01682811|21402026|P4|STARTED|Part 1 Levulan Painting||0
8669703|NCT01682811|21402027|P3|STARTED|Part 1 Levulan Painting||0
8669704|NCT01682811|21402028|P2|STARTED|Part 1 Levulan Painting||1
8669705|NCT01682811|21402029|P1|STARTED|Part 1 Levulan Painting||0
8669706|NCT01682811|21402023|P7|NOT COMPLETED|Part 1 Levulan Injection||0
8669707|NCT01682811|21402024|P6|NOT COMPLETED|Part 1 Levulan Injection||0
8669708|NCT01682811|21402025|P5|NOT COMPLETED|Part 1 Levulan Injection||0
8669709|NCT01682811|21402026|P4|NOT COMPLETED|Part 1 Levulan Injection||0
8669710|NCT01682811|21402027|P3|NOT COMPLETED|Part 1 Levulan Injection||0
8669711|NCT01682811|21402028|P2|NOT COMPLETED|Part 1 Levulan Injection||0
8669712|NCT01682811|21402029|P1|NOT COMPLETED|Part 1 Levulan Injection||0
8669713|NCT01682811|21402023|P7|COMPLETED|Part 1 Levulan Injection||0
8669714|NCT01682811|21402024|P6|COMPLETED|Part 1 Levulan Injection||0
8669715|NCT01682811|21402025|P5|COMPLETED|Part 1 Levulan Injection||0
8669716|NCT01682811|21402026|P4|COMPLETED|Part 1 Levulan Injection||0
8669717|NCT01682811|21402027|P3|COMPLETED|Part 1 Levulan Injection||0
8669718|NCT01682811|21402028|P2|COMPLETED|Part 1 Levulan Injection||0
8669719|NCT01682811|21402029|P1|COMPLETED|Part 1 Levulan Injection||1
8669720|NCT01682811|21402023|P7|Treated 24 Hours|Part 1 Levulan Injection||0
8669721|NCT01682811|21402024|P6|Treated 24 Hours|Part 1 Levulan Injection||0
8669722|NCT01682811|21402025|P5|Treated 24 Hours|Part 1 Levulan Injection||0
8669723|NCT01682811|21402026|P4|Treated 24 Hours|Part 1 Levulan Injection||0
8669724|NCT01682811|21402027|P3|Treated 24 Hours|Part 1 Levulan Injection||0
8669725|NCT01682811|21402028|P2|Treated 24 Hours|Part 1 Levulan Injection||0
8669726|NCT01682811|21402029|P1|Treated 24 Hours|Part 1 Levulan Injection||1
8669727|NCT01682811|21402023|P7|Treated 3 Hours|Part 1 Levulan Injection||0
8669728|NCT01682811|21402024|P6|Treated 3 Hours|Part 1 Levulan Injection||0
8669729|NCT01682811|21402025|P5|Treated 3 Hours|Part 1 Levulan Injection||0
8669730|NCT01682811|21402026|P4|Treated 3 Hours|Part 1 Levulan Injection||0
8669731|NCT01682811|21402027|P3|Treated 3 Hours|Part 1 Levulan Injection||0
8669732|NCT01682811|21402028|P2|Treated 3 Hours|Part 1 Levulan Injection||0
8669733|NCT01682811|21402029|P1|Treated 3 Hours|Part 1 Levulan Injection||1
8669734|NCT01682811|21402023|P7|Control|Part 1 Levulan Injection||0
8669735|NCT01682811|21402024|P6|Control|Part 1 Levulan Injection||0
8669736|NCT01682811|21402025|P5|Control|Part 1 Levulan Injection||0
8669737|NCT01682811|21402026|P4|Control|Part 1 Levulan Injection||0
8669738|NCT01682811|21402027|P3|Control|Part 1 Levulan Injection||0
8669739|NCT01682811|21402028|P2|Control|Part 1 Levulan Injection||0
8669740|NCT01682811|21402029|P1|Control|Part 1 Levulan Injection||1
8669741|NCT01682811|21402023|P7|STARTED|Part 1 Levulan Injection||0
8669742|NCT01682811|21402024|P6|STARTED|Part 1 Levulan Injection||0
8669743|NCT01682811|21402025|P5|STARTED|Part 1 Levulan Injection||0
8669744|NCT01682811|21402026|P4|STARTED|Part 1 Levulan Injection||0
8669745|NCT01682811|21402027|P3|STARTED|Part 1 Levulan Injection||0
8669746|NCT01682811|21402028|P2|STARTED|Part 1 Levulan Injection||0
8669747|NCT01682811|21402029|P1|STARTED|Part 1 Levulan Injection||1
8669748|NCT01551030|21402057|P1|NOT COMPLETED|Overall Study||0
8669749|NCT01551030|21402057|P1|COMPLETED|Overall Study||19
8669750|NCT01551030|21402057|P1|STARTED|Overall Study||19
8669751|NCT01392469|21402064|P1|NOT COMPLETED|Overall Study||4
8669752|NCT01392469|21402064|P1|COMPLETED|Overall Study||17
8669753|NCT01392469|21402064|P1|STARTED|Overall Study||21
8669754|NCT01389232|21402089|P1|NOT COMPLETED|Overall Study||19
8669755|NCT01389232|21402089|P1|COMPLETED|Overall Study||81
8669756|NCT01389232|21402089|P1|STARTED|Overall Study||100
8669757|NCT00901485|21402105|P2|NOT COMPLETED|Overall Study||4
8669758|NCT00901485|21402106|P1|NOT COMPLETED|Overall Study||1
8669759|NCT00901485|21402105|P2|COMPLETED|Overall Study||9
8669760|NCT00901485|21402106|P1|COMPLETED|Overall Study||9
8669761|NCT00901485|21402105|P2|STARTED|Overall Study||13
8669762|NCT00901485|21402106|P1|STARTED|Overall Study||10
8669763|NCT00890045|21402140|P2|NOT COMPLETED|Overall Study||10
8669764|NCT00890045|21402141|P1|NOT COMPLETED|Overall Study||5
8669765|NCT00890045|21402140|P2|COMPLETED|Overall Study||42
8669766|NCT00890045|21402141|P1|COMPLETED|Overall Study||15
8669767|NCT00890045|21402140|P2|STARTED|Overall Study|Of the 52 subjects randomized to the HeRO Graft, two implants were abandoned.|52
8669768|NCT00890045|21402141|P1|STARTED|Overall Study||20
8669769|NCT00667862|21402155|P1|NOT COMPLETED|Overall Study||35
8669770|NCT00667862|21402155|P1|COMPLETED|Overall Study||0
8669771|NCT00667862|21402155|P1|STARTED|Overall Study||35
8669772|NCT00418301|21402166|P1|NOT COMPLETED|Overall Study||3
8669773|NCT00418301|21402166|P1|COMPLETED|Overall Study||12
8669774|NCT00418301|21402166|P1|STARTED|Overall Study||15
8669775|NCT00205868|21402171|P1|NOT COMPLETED|Overall Study||0
8669776|NCT00205868|21402171|P1|COMPLETED|Overall Study||304
8669777|NCT00205868|21402171|P1|STARTED|Overall Study||304
8669784|NCT04449263|21402192|P2|NOT COMPLETED|Third Intervention||0
8669785|NCT04449263|21402193|P1|NOT COMPLETED|Third Intervention||0
8669786|NCT04449263|21402192|P2|COMPLETED|Third Intervention||30
8669787|NCT04449263|21402193|P1|COMPLETED|Third Intervention||29
8669788|NCT04449263|21402192|P2|STARTED|Third Intervention||30
8669789|NCT04449263|21402193|P1|STARTED|Third Intervention||29
8669790|NCT04449263|21402192|P2|NOT COMPLETED|Second Intervention||0
8669791|NCT04449263|21402193|P1|NOT COMPLETED|Second Intervention||0
8669792|NCT04449263|21402192|P2|COMPLETED|Second Intervention||30
8669793|NCT04449263|21402193|P1|COMPLETED|Second Intervention||29
8669794|NCT04449263|21402192|P2|STARTED|Second Intervention||30
8669795|NCT04449263|21402193|P1|STARTED|Second Intervention||29
8669796|NCT04449263|21402192|P2|NOT COMPLETED|First Intervention||0
8669797|NCT04449263|21402193|P1|NOT COMPLETED|First Intervention||0
8669798|NCT04449263|21402192|P2|COMPLETED|First Intervention||30
8669799|NCT04449263|21402193|P1|COMPLETED|First Intervention||29
8669800|NCT04449263|21402192|P2|STARTED|First Intervention||30
8669801|NCT04449263|21402193|P1|STARTED|First Intervention||29
8669802|NCT04332081|21402203|P2|NOT COMPLETED|Overall Study||0
8669803|NCT04332081|21402204|P1|NOT COMPLETED|Overall Study||0
8669804|NCT04332081|21402203|P2|COMPLETED|Overall Study||60
8669805|NCT04332081|21402204|P1|COMPLETED|Overall Study||20
8669806|NCT04332081|21402203|P2|STARTED|Overall Study||60
8669807|NCT04332081|21402204|P1|STARTED|Overall Study||20
8669808|NCT04223635|21402214|P2|NOT COMPLETED|Overall Study||0
8669809|NCT04223635|21402215|P1|NOT COMPLETED|Overall Study||0
8669810|NCT04223635|21402214|P2|COMPLETED|Overall Study||8
8669811|NCT04223635|21402215|P1|COMPLETED|Overall Study||8
8669812|NCT04223635|21402214|P2|STARTED|Overall Study||8
8669813|NCT04223635|21402215|P1|STARTED|Overall Study||8
8669832|NCT03930264|21402288|P2|NOT COMPLETED|Overall Study||1
8669833|NCT03930264|21402289|P1|NOT COMPLETED|Overall Study||0
8669834|NCT03930264|21402288|P2|COMPLETED|Overall Study||14
8669835|NCT03930264|21402289|P1|COMPLETED|Overall Study||15
8669836|NCT03930264|21402288|P2|STARTED|Overall Study||15
8669837|NCT03930264|21402289|P1|STARTED|Overall Study||15
8669838|NCT03927209|21402301|P2|NOT COMPLETED|Overall Study||0
8669839|NCT03927209|21402302|P1|NOT COMPLETED|Overall Study||0
8669840|NCT03927209|21402301|P2|COMPLETED|Overall Study||5
8669841|NCT03927209|21402302|P1|COMPLETED|Overall Study||5
8669842|NCT03927209|21402301|P2|STARTED|Overall Study||5
8669843|NCT03927209|21402302|P1|STARTED|Overall Study||5
8669868|NCT03493607|21402374|P1|NOT COMPLETED|Overall Study||0
8669869|NCT03493607|21402374|P1|COMPLETED|Overall Study||6
8669870|NCT03493607|21402374|P1|STARTED|Overall Study||6
8669871|NCT03440723|21402380|P2|NOT COMPLETED|Overall Study||0
8669872|NCT03440723|21402381|P1|NOT COMPLETED|Overall Study||0
8669873|NCT03440723|21402380|P2|COMPLETED|Overall Study||21
8669874|NCT03440723|21402381|P1|COMPLETED|Overall Study||21
8669875|NCT03440723|21402380|P2|STARTED|Overall Study||21
8669876|NCT03440723|21402381|P1|STARTED|Overall Study||21
8669877|NCT03410056|21402394|P7|NOT COMPLETED|Overall Study||0
8669878|NCT03410056|21402395|P6|NOT COMPLETED|Overall Study||0
8669879|NCT03410056|21402396|P5|NOT COMPLETED|Overall Study||0
8669880|NCT03410056|21402397|P4|NOT COMPLETED|Overall Study||5
8669881|NCT03410056|21402398|P3|NOT COMPLETED|Overall Study||8
8669882|NCT03410056|21402399|P2|NOT COMPLETED|Overall Study||2
8669883|NCT03410056|21402400|P1|NOT COMPLETED|Overall Study||0
8669884|NCT03410056|21402394|P7|COMPLETED|Overall Study||0
8669885|NCT03410056|21402395|P6|COMPLETED|Overall Study||0
8669886|NCT03410056|21402396|P5|COMPLETED|Overall Study||0
8669887|NCT03410056|21402397|P4|COMPLETED|Overall Study||6
8669888|NCT03410056|21402398|P3|COMPLETED|Overall Study||3
8669889|NCT03410056|21402399|P2|COMPLETED|Overall Study||4
8669890|NCT03410056|21402400|P1|COMPLETED|Overall Study||8
8669891|NCT03410056|21402394|P7|Received Treatment|Overall Study||0
8669892|NCT03410056|21402395|P6|Received Treatment|Overall Study||0
8669893|NCT03410056|21402396|P5|Received Treatment|Overall Study||0
8669894|NCT03410056|21402397|P4|Received Treatment|Overall Study||11
8669895|NCT03410056|21402398|P3|Received Treatment|Overall Study||11
8669896|NCT03410056|21402399|P2|Received Treatment|Overall Study||6
8669897|NCT03410056|21402400|P1|Received Treatment|Overall Study||8
8669898|NCT03410056|21402394|P7|STARTED|Overall Study||0
8669899|NCT03410056|21402395|P6|STARTED|Overall Study||0
8669900|NCT03410056|21402396|P5|STARTED|Overall Study||0
8669901|NCT03410056|21402397|P4|STARTED|Overall Study||11
8669902|NCT03410056|21402398|P3|STARTED|Overall Study||11
8669903|NCT03410056|21402399|P2|STARTED|Overall Study||6
8669904|NCT03410056|21402400|P1|STARTED|Overall Study||8
8669905|NCT03382509|21402466|P2|NOT COMPLETED|Overall Study||0
8669906|NCT03382509|21402467|P1|NOT COMPLETED|Overall Study||0
8669907|NCT03382509|21402466|P2|COMPLETED|Overall Study||8
8669908|NCT03382509|21402467|P1|COMPLETED|Overall Study||8
8669909|NCT03382509|21402466|P2|STARTED|Overall Study||8
8669910|NCT03382509|21402467|P1|STARTED|Overall Study||8
8669923|NCT03273257|21402516|P2|NOT COMPLETED|Overall Study||4
8669924|NCT03273257|21402517|P1|NOT COMPLETED|Overall Study||4
8669925|NCT03273257|21402516|P2|COMPLETED|Overall Study||3
8669926|NCT03273257|21402517|P1|COMPLETED|Overall Study||3
8669927|NCT03273257|21402516|P2|Underwent PEA|Overall Study||5
8669928|NCT03273257|21402517|P1|Underwent PEA|Overall Study||6
8669929|NCT03273257|21402516|P2|Started Treatment|Overall Study|Only 6 patients from the placebo group started treatment because 1 patient died after randomization (= study start), but before initiating treatment|6
8669930|NCT03273257|21402517|P1|Started Treatment|Overall Study||7
8669931|NCT03273257|21402516|P2|STARTED|Overall Study||7
8669932|NCT03273257|21402517|P1|STARTED|Overall Study||7
8669933|NCT03219866|21402543|P2|NOT COMPLETED|Overall Study||0
8669934|NCT03219866|21402544|P1|NOT COMPLETED|Overall Study||0
8669935|NCT03219866|21402543|P2|COMPLETED|Overall Study||19
8669936|NCT03219866|21402544|P1|COMPLETED|Overall Study||21
8669937|NCT03219866|21402543|P2|STARTED|Overall Study||19
8669938|NCT03219866|21402544|P1|STARTED|Overall Study||21
8669939|NCT03190213|21402566|P1|NOT COMPLETED|Overall Study||0
8669940|NCT03190213|21402566|P1|COMPLETED|Overall Study||6
8669941|NCT03190213|21402566|P1|STARTED|Overall Study||6
8669950|NCT03115112|21402609|P2|NOT COMPLETED|Overall Study||5
8669951|NCT03115112|21402610|P1|NOT COMPLETED|Overall Study||12
8669952|NCT03115112|21402609|P2|COMPLETED|Overall Study||189
8669953|NCT03115112|21402610|P1|COMPLETED|Overall Study||180
8669954|NCT03115112|21402609|P2|Intention-to-treat|Overall Study||193
8669955|NCT03115112|21402610|P1|Intention-to-treat|Overall Study||191
8669956|NCT03115112|21402609|P2|STARTED|Overall Study||194
8669957|NCT03115112|21402610|P1|STARTED|Overall Study||192
8669958|NCT03040154|21402624|P2|NOT COMPLETED|Overall Study||0
8669959|NCT03040154|21402625|P1|NOT COMPLETED|Overall Study||0
8669960|NCT03040154|21402624|P2|COMPLETED|Overall Study||105
8669961|NCT03040154|21402625|P1|COMPLETED|Overall Study||110
8669962|NCT03040154|21402624|P2|STARTED|Overall Study||105
8669963|NCT03040154|21402625|P1|STARTED|Overall Study||110
8669964|NCT03029234|21402631|P1|NOT COMPLETED|Overall Study||67
8669965|NCT03029234|21402631|P1|COMPLETED|Overall Study||59
8669966|NCT03029234|21402631|P1|Received Carfilzomib|Overall Study||123
8669967|NCT03029234|21402631|P1|STARTED|Overall Study||126
8669968|NCT02970942|21402660|P4|NOT COMPLETED|Overall Study||3
8669969|NCT02970942|21402661|P3|NOT COMPLETED|Overall Study||5
8669970|NCT02970942|21402662|P2|NOT COMPLETED|Overall Study||6
8669971|NCT02970942|21402663|P1|NOT COMPLETED|Overall Study||4
8669972|NCT02970942|21402660|P4|COMPLETED|Overall Study||77
8669973|NCT02970942|21402661|P3|COMPLETED|Overall Study||77
8669974|NCT02970942|21402662|P2|COMPLETED|Overall Study||72
8669975|NCT02970942|21402663|P1|COMPLETED|Overall Study||76
8669976|NCT02970942|21402660|P4|Exposed|Overall Study||80
8669977|NCT02970942|21402661|P3|Exposed|Overall Study||81
8669978|NCT02970942|21402662|P2|Exposed|Overall Study||78
8669979|NCT02970942|21402663|P1|Exposed|Overall Study||80
8669980|NCT02970942|21402660|P4|Safety Analysis Set|Overall Study||80
8669981|NCT02970942|21402661|P3|Safety Analysis Set|Overall Study||81
8669982|NCT02970942|21402662|P2|Safety Analysis Set|Overall Study||78
8669983|NCT02970942|21402663|P1|Safety Analysis Set|Overall Study||80
8669984|NCT02970942|21402660|P4|Full Analysis Set|Overall Study||80
8669985|NCT02970942|21402661|P3|Full Analysis Set|Overall Study||82
8669986|NCT02970942|21402662|P2|Full Analysis Set|Overall Study||78
8669987|NCT02970942|21402663|P1|Full Analysis Set|Overall Study||80
8669988|NCT02970942|21402660|P4|STARTED|Overall Study||80
8669989|NCT02970942|21402661|P3|STARTED|Overall Study||82
8669990|NCT02970942|21402662|P2|STARTED|Overall Study||78
8669991|NCT02970942|21402663|P1|STARTED|Overall Study||80
8669992|NCT02959944|21403019|P2|NOT COMPLETED|Overall Study||76
8669993|NCT02959944|21403020|P1|NOT COMPLETED|Overall Study||74
8669994|NCT02959944|21403019|P2|COMPLETED|Overall Study||22
8669995|NCT02959944|21403020|P1|COMPLETED|Overall Study||21
8669996|NCT02959944|21403019|P2|Completed Treatment Phase, In Study Follow-Up|Overall Study||43
8669997|NCT02959944|21403020|P1|Completed Treatment Phase, In Study Follow-Up|Overall Study||33
8669998|NCT02959944|21403019|P2|In Treatment Phase|Overall Study||33
8669999|NCT02959944|21403020|P1|In Treatment Phase|Overall Study||41
8670000|NCT02959944|21403019|P2|Received at Least 1 Dose of Study Drug|Overall Study||96
8670001|NCT02959944|21403020|P1|Received at Least 1 Dose of Study Drug|Overall Study||94
8670002|NCT02959944|21403019|P2|STARTED|Overall Study||98
8670003|NCT02959944|21403020|P1|STARTED|Overall Study||95
8670004|NCT02952586|21403044|P2|NOT COMPLETED|LT Follow-up (up to Approx. 40 Months)||201
8670005|NCT02952586|21403045|P1|NOT COMPLETED|LT Follow-up (up to Approx. 40 Months)||209
8670006|NCT02952586|21403044|P2|COMPLETED|LT Follow-up (up to Approx. 40 Months)||0
8670007|NCT02952586|21403045|P1|COMPLETED|LT Follow-up (up to Approx. 40 Months)||0
8670008|NCT02952586|21403044|P2|STARTED|LT Follow-up (up to Approx. 40 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase|201
8670009|NCT02952586|21403045|P1|STARTED|LT Follow-up (up to Approx. 40 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase|209
8670010|NCT02952586|21403044|P2|NOT COMPLETED|Follow-Up Phase (90 Days)||57
8670011|NCT02952586|21403045|P1|NOT COMPLETED|Follow-Up Phase (90 Days)||59
8670012|NCT02952586|21403044|P2|COMPLETED|Follow-Up Phase (90 Days)||179
8670013|NCT02952586|21403045|P1|COMPLETED|Follow-Up Phase (90 Days)||172
8670014|NCT02952586|21403044|P2|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase|236
8670015|NCT02952586|21403045|P1|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase|231
8670016|NCT02952586|21403044|P2|NOT COMPLETED|Maintenance Phase (12 Months)||167
8670017|NCT02952586|21403045|P1|NOT COMPLETED|Maintenance Phase (12 Months)||184
8670018|NCT02952586|21403044|P2|COMPLETED|Maintenance Phase (12 Months)||137
8670019|NCT02952586|21403045|P1|COMPLETED|Maintenance Phase (12 Months)||107
8670020|NCT02952586|21403044|P2|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase|304
8670021|NCT02952586|21403045|P1|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase|291
8670022|NCT02952586|21403044|P2|NOT COMPLETED|CRT for IMRT (63 Days)||20
8670023|NCT02952586|21403045|P1|NOT COMPLETED|CRT for IMRT (63 Days)||23
8670024|NCT02952586|21403044|P2|COMPLETED|CRT for IMRT (63 Days)||320
8670025|NCT02952586|21403045|P1|COMPLETED|CRT for IMRT (63 Days)||322
8670026|NCT02952586|21403044|P2|STARTED|CRT for IMRT (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
8670027|NCT02952586|21403045|P1|STARTED|CRT for IMRT (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
8670028|NCT02952586|21403044|P2|NOT COMPLETED|CRT for Cisplatin (63 Days)||104
8670029|NCT02952586|21403045|P1|NOT COMPLETED|CRT for Cisplatin (63 Days)||111
8670030|NCT02952586|21403044|P2|COMPLETED|CRT for Cisplatin (63 Days)||236
8670031|NCT02952586|21403045|P1|COMPLETED|CRT for Cisplatin (63 Days)||234
8670032|NCT02952586|21403044|P2|STARTED|CRT for Cisplatin (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
8670033|NCT02952586|21403045|P1|STARTED|CRT for Cisplatin (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
8670034|NCT02952586|21403044|P2|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||27
8670035|NCT02952586|21403045|P1|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||33
8670036|NCT02952586|21403044|P2|COMPLETED|CRT for Avelumab or Placebo (63 Days)||313
8670037|NCT02952586|21403045|P1|COMPLETED|CRT for Avelumab or Placebo (63 Days)||312
8670038|NCT02952586|21403044|P2|STARTED|CRT for Avelumab or Placebo (63 Days)|All participants who did not withdraw from study after Lead-In phase, entered into CRT phase|340
8670039|NCT02952586|21403045|P1|STARTED|CRT for Avelumab or Placebo (63 Days)||345
8670040|NCT02952586|21403044|P2|NOT COMPLETED|Lead-In Phase (7 Days)||4
8670041|NCT02952586|21403045|P1|NOT COMPLETED|Lead-In Phase (7 Days)||5
8670042|NCT02952586|21403044|P2|COMPLETED|Lead-In Phase (7 Days)||343
8670043|NCT02952586|21403045|P1|COMPLETED|Lead-In Phase (7 Days)||345
8670044|NCT02952586|21403044|P2|Treated|Lead-In Phase (7 Days)||344
8670045|NCT02952586|21403045|P1|Treated|Lead-In Phase (7 Days)||348
8670046|NCT02952586|21403044|P2|STARTED|Lead-In Phase (7 Days)||347
8670047|NCT02952586|21403045|P1|STARTED|Lead-In Phase (7 Days)||350
8670048|NCT02925455|21403085|P2|NOT COMPLETED|Overall Study||0
8670049|NCT02925455|21403086|P1|NOT COMPLETED|Overall Study||2
8670050|NCT02925455|21403085|P2|COMPLETED|Overall Study||6
8670051|NCT02925455|21403086|P1|COMPLETED|Overall Study||7
8670052|NCT02925455|21403085|P2|STARTED|Overall Study||6
8670053|NCT02925455|21403086|P1|STARTED|Overall Study||9
8670126|NCT02904512|21403195|P2|NOT COMPLETED|Overall Study||0
8670127|NCT02904512|21403196|P1|NOT COMPLETED|Overall Study||3
8670128|NCT02904512|21403195|P2|COMPLETED|Overall Study||7
8670129|NCT02904512|21403196|P1|COMPLETED|Overall Study||6
8670130|NCT02904512|21403195|P2|STARTED|Overall Study||7
8670131|NCT02904512|21403196|P1|STARTED|Overall Study||9
8670132|NCT02743494|21403208|P2|NOT COMPLETED|Treatment Period||241
8670133|NCT02743494|21403209|P1|NOT COMPLETED|Treatment Period||501
8670134|NCT02743494|21403208|P2|COMPLETED|Treatment Period||19
8670135|NCT02743494|21403209|P1|COMPLETED|Treatment Period||31
8670136|NCT02743494|21403208|P2|STARTED|Treatment Period||260
8670137|NCT02743494|21403209|P1|STARTED|Treatment Period||532
8670138|NCT02743494|21403208|P2|NOT COMPLETED|Pre-treatment Period||2
8670139|NCT02743494|21403209|P1|NOT COMPLETED|Pre-treatment Period||0
8670140|NCT02743494|21403208|P2|COMPLETED|Pre-treatment Period||260
8670141|NCT02743494|21403209|P1|COMPLETED|Pre-treatment Period||532
8670142|NCT02743494|21403208|P2|STARTED|Pre-treatment Period||262
8670143|NCT02743494|21403209|P1|STARTED|Pre-treatment Period||532
8670144|NCT02727192|21403217|P3|NOT COMPLETED|Overall Study||0
8670145|NCT02727192|21403218|P2|NOT COMPLETED|Overall Study||0
8670146|NCT02727192|21403219|P1|NOT COMPLETED|Overall Study||1
8670147|NCT02727192|21403217|P3|COMPLETED|Overall Study||1
8670148|NCT02727192|21403218|P2|COMPLETED|Overall Study||54
8670149|NCT02727192|21403219|P1|COMPLETED|Overall Study||53
8670150|NCT02727192|21403217|P3|STARTED|Overall Study||1
8670151|NCT02727192|21403218|P2|STARTED|Overall Study||54
8670152|NCT02727192|21403219|P1|STARTED|Overall Study||54
8670153|NCT02701400|21403248|P2|NOT COMPLETED|Overall Study||0
8670154|NCT02701400|21403249|P1|NOT COMPLETED|Overall Study||0
8670155|NCT02701400|21403248|P2|COMPLETED|Overall Study||9
8670156|NCT02701400|21403249|P1|COMPLETED|Overall Study||9
8670157|NCT02701400|21403248|P2|STARTED|Overall Study||9
8670158|NCT02701400|21403249|P1|STARTED|Overall Study||9
8670159|NCT02647645|21403264|P2|NOT COMPLETED|Overall Study||1
8670160|NCT02647645|21403265|P1|NOT COMPLETED|Overall Study||2
8670161|NCT02647645|21403264|P2|COMPLETED|Overall Study||9
8670162|NCT02647645|21403265|P1|COMPLETED|Overall Study||9
8670163|NCT02647645|21403264|P2|STARTED|Overall Study||10
8670164|NCT02647645|21403265|P1|STARTED|Overall Study||11
8670264|NCT02455557|21403480|P1|NOT COMPLETED|Overall Study||2
8670265|NCT02455557|21403480|P1|COMPLETED|Overall Study||64
8670266|NCT02455557|21403480|P1|STARTED|Overall Study||66
8670267|NCT02439749|21403488|P2|NOT COMPLETED|Overall Study||37
8670268|NCT02439749|21403489|P1|NOT COMPLETED|Overall Study||29
8670269|NCT02439749|21403488|P2|COMPLETED|Overall Study||147
8670270|NCT02439749|21403489|P1|COMPLETED|Overall Study||153
8670271|NCT02439749|21403488|P2|STARTED|Overall Study||184
8670272|NCT02439749|21403489|P1|STARTED|Overall Study||182
8670273|NCT02426125|21403555|P2|NOT COMPLETED|Overall Study||26
8670274|NCT02426125|21403556|P1|NOT COMPLETED|Overall Study||29
8670275|NCT02426125|21403555|P2|COMPLETED|Overall Study||241
8670276|NCT02426125|21403556|P1|COMPLETED|Overall Study||234
8670277|NCT02426125|21403555|P2|First Randomized Participants|Overall Study||221
8670278|NCT02426125|21403556|P1|First Randomized Participants|Overall Study||216
8670279|NCT02426125|21403555|P2|Received at Least One Dose of Study Drug|Overall Study||265
8670280|NCT02426125|21403556|P1|Received at Least One Dose of Study Drug|Overall Study||258
8670281|NCT02426125|21403555|P2|STARTED|Overall Study||267
8670282|NCT02426125|21403556|P1|STARTED|Overall Study||263
8670283|NCT02410629|21403582|P2|NOT COMPLETED|Overall Study||3
8670284|NCT02410629|21403583|P1|NOT COMPLETED|Overall Study||3
8670285|NCT02410629|21403582|P2|COMPLETED|Overall Study|6 subjects from the conventional hand exercise group were crossed over to music glove group.|6
8670286|NCT02410629|21403583|P1|COMPLETED|Overall Study|5 subjects from the music glove group were crossed over to conventional hand exercise group.|5
8670287|NCT02410629|21403582|P2|STARTED|Overall Study||9
8670288|NCT02410629|21403583|P1|STARTED|Overall Study||8
8670289|NCT02367820|21403599|P1|NOT COMPLETED|Overall Study||236
8670290|NCT02367820|21403599|P1|COMPLETED|Overall Study||402
8670291|NCT02367820|21403599|P1|STARTED|Overall Study||638
8670298|NCT02337530|21403647|P3|NOT COMPLETED|Overall Study||0
8670299|NCT02337530|21403648|P2|NOT COMPLETED|Overall Study||0
8670300|NCT02337530|21403649|P1|NOT COMPLETED|Overall Study||0
8670301|NCT02337530|21403647|P3|COMPLETED|Overall Study||21
8670302|NCT02337530|21403648|P2|COMPLETED|Overall Study||21
8670303|NCT02337530|21403649|P1|COMPLETED|Overall Study||20
8670304|NCT02337530|21403647|P3|STARTED|Overall Study||21
8670305|NCT02337530|21403648|P2|STARTED|Overall Study||21
8670306|NCT02337530|21403649|P1|STARTED|Overall Study||20
8670307|NCT02288156|21403664|P4|NOT COMPLETED|Overall Study||2
8670308|NCT02288156|21403665|P3|NOT COMPLETED|Overall Study||2
8670309|NCT02288156|21403666|P2|NOT COMPLETED|Overall Study||4
8670310|NCT02288156|21403667|P1|NOT COMPLETED|Overall Study||4
8670311|NCT02288156|21403664|P4|COMPLETED|Overall Study||18
8670312|NCT02288156|21403665|P3|COMPLETED|Overall Study||18
8670313|NCT02288156|21403666|P2|COMPLETED|Overall Study||16
8670314|NCT02288156|21403667|P1|COMPLETED|Overall Study||16
8670315|NCT02288156|21403664|P4|STARTED|Overall Study||20
8670316|NCT02288156|21403665|P3|STARTED|Overall Study||20
8670317|NCT02288156|21403666|P2|STARTED|Overall Study||20
8670318|NCT02288156|21403667|P1|STARTED|Overall Study||20
8670319|NCT02227199|21403700|P3|NOT COMPLETED|Overall Study||4
8670320|NCT02227199|21403701|P2|NOT COMPLETED|Overall Study||0
8670321|NCT02227199|21403702|P1|NOT COMPLETED|Overall Study||0
8670322|NCT02227199|21403700|P3|COMPLETED|Overall Study||35
8670323|NCT02227199|21403701|P2|COMPLETED|Overall Study||3
8670324|NCT02227199|21403702|P1|COMPLETED|Overall Study||3
8670325|NCT02227199|21403700|P3|STARTED|Overall Study||39
8670326|NCT02227199|21403701|P2|STARTED|Overall Study||3
8670327|NCT02227199|21403702|P1|STARTED|Overall Study||3
8670328|NCT02155712|21403719|P2|NOT COMPLETED|Secondary Objectives||134
8670329|NCT02155712|21403720|P1|NOT COMPLETED|Secondary Objectives||319
8670330|NCT02155712|21403719|P2|COMPLETED|Secondary Objectives||0
8670331|NCT02155712|21403720|P1|COMPLETED|Secondary Objectives||0
8670332|NCT02155712|21403719|P2|STARTED|Secondary Objectives|This period will be updated when posting secondary objective results.|134
8670333|NCT02155712|21403720|P1|STARTED|Secondary Objectives||319
8670334|NCT02155712|21403719|P2|NOT COMPLETED|Primary Objective||0
8670335|NCT02155712|21403720|P1|NOT COMPLETED|Primary Objective||60
8670336|NCT02155712|21403719|P2|COMPLETED|Primary Objective||0
8670337|NCT02155712|21403720|P1|COMPLETED|Primary Objective||259
8670338|NCT02155712|21403719|P2|STARTED|Primary Objective|Cohort 2 isn't included in primary obj analysis|0
8670339|NCT02155712|21403720|P1|STARTED|Primary Objective||319
8670340|NCT02137239|21403728|P2|NOT COMPLETED|Overall Study||6
8670341|NCT02137239|21403729|P1|NOT COMPLETED|Overall Study||3
8670342|NCT02137239|21403728|P2|COMPLETED|Overall Study||26
8670343|NCT02137239|21403729|P1|COMPLETED|Overall Study||23
8670344|NCT02137239|21403728|P2|STARTED|Overall Study||32
8670345|NCT02137239|21403729|P1|STARTED|Overall Study||26
8670346|NCT02128230|21403789|P1|NOT COMPLETED|Overall Study||19
8670347|NCT02128230|21403789|P1|COMPLETED|Overall Study||1
8670348|NCT02128230|21403789|P1|STARTED|Overall Study||20
8670355|NCT02008396|21403820|P2|NOT COMPLETED|Overall Study||1
8670356|NCT02008396|21403821|P1|NOT COMPLETED|Overall Study||0
8670357|NCT02008396|21403820|P2|COMPLETED|Overall Study||7
8670358|NCT02008396|21403821|P1|COMPLETED|Overall Study||4
8670359|NCT02008396|21403820|P2|STARTED|Overall Study||8
8670360|NCT02008396|21403821|P1|STARTED|Overall Study||4
8670367|NCT01969708|21403844|P2|NOT COMPLETED|Overall Study||9
8670368|NCT01969708|21403845|P1|NOT COMPLETED|Overall Study||5
8670369|NCT01969708|21403844|P2|COMPLETED|Overall Study||173
8670370|NCT01969708|21403845|P1|COMPLETED|Overall Study||175
8670371|NCT01969708|21403844|P2|STARTED|Overall Study||182
8670372|NCT01969708|21403845|P1|STARTED|Overall Study||180
8670373|NCT01936948|21403865|P4|NOT COMPLETED|Overall Study||3
8670374|NCT01936948|21403866|P3|NOT COMPLETED|Overall Study||3
8670375|NCT01936948|21403867|P2|NOT COMPLETED|Overall Study||3
8670376|NCT01936948|21403868|P1|NOT COMPLETED|Overall Study||0
8670377|NCT01936948|21403865|P4|COMPLETED|Overall Study||230
8670378|NCT01936948|21403866|P3|COMPLETED|Overall Study||234
8670379|NCT01936948|21403867|P2|COMPLETED|Overall Study||228
8670380|NCT01936948|21403868|P1|COMPLETED|Overall Study||227
8670381|NCT01936948|21403865|P4|Crossover|Overall Study||25
8670382|NCT01936948|21403866|P3|Crossover|Overall Study||22
8670383|NCT01936948|21403867|P2|Crossover|Overall Study||27
8670384|NCT01936948|21403868|P1|Crossover|Overall Study||31
8670385|NCT01936948|21403865|P4|STARTED|Overall Study||233
8670386|NCT01936948|21403866|P3|STARTED|Overall Study||237
8670387|NCT01936948|21403867|P2|STARTED|Overall Study||231
8670388|NCT01936948|21403868|P1|STARTED|Overall Study||227
8670389|NCT01860976|21403880|P2|NOT COMPLETED|Long Term Extension||107
8670390|NCT01860976|21403881|P1|NOT COMPLETED|Long Term Extension||113
8670391|NCT01860976|21403880|P2|COMPLETED|Long Term Extension||8
8670392|NCT01860976|21403881|P1|COMPLETED|Long Term Extension||0
8670393|NCT01860976|21403880|P2|STARTED|Long Term Extension||115
8670394|NCT01860976|21403881|P1|STARTED|Long Term Extension||113
8670395|NCT01860976|21403880|P2|NOT COMPLETED|Open-Label||64
8670396|NCT01860976|21403881|P1|NOT COMPLETED|Open-Label||74
8670397|NCT01860976|21403880|P2|COMPLETED|Open-Label||121
8670398|NCT01860976|21403881|P1|COMPLETED|Open-Label||123
8670399|NCT01860976|21403880|P2|STARTED|Open-Label||185
8670400|NCT01860976|21403881|P1|STARTED|Open-Label||197
8670401|NCT01860976|21403880|P2|NOT COMPLETED|Blinded Treatment||113
8670402|NCT01860976|21403881|P1|NOT COMPLETED|Blinded Treatment||88
8670403|NCT01860976|21403880|P2|COMPLETED|Blinded Treatment||98
8670404|NCT01860976|21403881|P1|COMPLETED|Blinded Treatment||125
8670405|NCT01860976|21403880|P2|STARTED|Blinded Treatment||211
8670406|NCT01860976|21403881|P1|STARTED|Blinded Treatment||213
8670407|NCT01840579|21403913|P10|NOT COMPLETED|Overall Study||3
8670408|NCT01840579|21403914|P9|NOT COMPLETED|Overall Study||3
8670409|NCT01840579|21403915|P8|NOT COMPLETED|Overall Study||3
8670410|NCT01840579|21403916|P7|NOT COMPLETED|Overall Study||2
8670411|NCT01840579|21403917|P6|NOT COMPLETED|Overall Study||4
8670412|NCT01840579|21403918|P5|NOT COMPLETED|Overall Study||4
8670413|NCT01840579|21403919|P4|NOT COMPLETED|Overall Study||3
8670414|NCT01840579|21403920|P3|NOT COMPLETED|Overall Study||2
8670415|NCT01840579|21403921|P2|NOT COMPLETED|Overall Study||7
8670416|NCT01840579|21403922|P1|NOT COMPLETED|Overall Study||3
8670417|NCT01840579|21403913|P10|COMPLETED|Overall Study||0
8670418|NCT01840579|21403914|P9|COMPLETED|Overall Study||3
8670419|NCT01840579|21403915|P8|COMPLETED|Overall Study||3
8670420|NCT01840579|21403916|P7|COMPLETED|Overall Study||4
8670421|NCT01840579|21403917|P6|COMPLETED|Overall Study||2
8670422|NCT01840579|21403918|P5|COMPLETED|Overall Study||4
8670423|NCT01840579|21403919|P4|COMPLETED|Overall Study||3
8670424|NCT01840579|21403920|P3|COMPLETED|Overall Study||4
8670425|NCT01840579|21403921|P2|COMPLETED|Overall Study||0
8670426|NCT01840579|21403922|P1|COMPLETED|Overall Study||0
8670427|NCT01840579|21403913|P10|STARTED|Overall Study||3
8670428|NCT01840579|21403914|P9|STARTED|Overall Study||6
8670429|NCT01840579|21403915|P8|STARTED|Overall Study||6
8670430|NCT01840579|21403916|P7|STARTED|Overall Study||6
8670431|NCT01840579|21403917|P6|STARTED|Overall Study||6
8670432|NCT01840579|21403918|P5|STARTED|Overall Study||8
8670433|NCT01840579|21403919|P4|STARTED|Overall Study||6
8670434|NCT01840579|21403920|P3|STARTED|Overall Study||6
8670435|NCT01840579|21403921|P2|STARTED|Overall Study||7
8670436|NCT01840579|21403922|P1|STARTED|Overall Study||3
8670437|NCT01818739|21404119|P1|NOT COMPLETED|Overall Study||0
8670438|NCT01818739|21404119|P1|COMPLETED|Overall Study||204
8670439|NCT01818739|21404119|P1|STARTED|Overall Study||204
8670440|NCT01817075|21404126|P2|NOT COMPLETED|Overall Study||35
8670441|NCT01817075|21404127|P1|NOT COMPLETED|Overall Study||47
8670442|NCT01817075|21404126|P2|COMPLETED|Overall Study||54
8670443|NCT01817075|21404127|P1|COMPLETED|Overall Study||41
8670444|NCT01817075|21404126|P2|STARTED|Overall Study||89
8670445|NCT01817075|21404127|P1|STARTED|Overall Study||88
8670446|NCT01787383|21404141|P2|NOT COMPLETED|Overall Study||22
8670447|NCT01787383|21404142|P1|NOT COMPLETED|Overall Study||9
8670448|NCT01787383|21404141|P2|COMPLETED|Overall Study||76
8670449|NCT01787383|21404142|P1|COMPLETED|Overall Study||92
8670450|NCT01787383|21404141|P2|STARTED|Overall Study||98
8670451|NCT01787383|21404142|P1|STARTED|Overall Study||101
8670464|NCT01760993|21404187|P1|NOT COMPLETED|Overall Study||0
8670465|NCT01760993|21404187|P1|COMPLETED|Overall Study||0
8670466|NCT01760993|21404187|P1|STARTED|Overall Study||0
8670467|NCT01760889|21404207|P3|NOT COMPLETED|Overall Study||0
8670468|NCT01760889|21404208|P2|NOT COMPLETED|Overall Study||0
8670469|NCT01760889|21404209|P1|NOT COMPLETED|Overall Study||0
8670470|NCT01760889|21404207|P3|COMPLETED|Overall Study||0
8670471|NCT01760889|21404208|P2|COMPLETED|Overall Study||0
8670472|NCT01760889|21404209|P1|COMPLETED|Overall Study||0
8670473|NCT01760889|21404207|P3|STARTED|Overall Study||0
8670474|NCT01760889|21404208|P2|STARTED|Overall Study||0
8670475|NCT01760889|21404209|P1|STARTED|Overall Study||0
8670476|NCT01738698|21404260|P4|NOT COMPLETED|Overall Study||0
8670477|NCT01738698|21404261|P3|NOT COMPLETED|Overall Study||0
8670478|NCT01738698|21404262|P2|NOT COMPLETED|Overall Study||0
8670479|NCT01738698|21404263|P1|NOT COMPLETED|Overall Study||0
8670480|NCT01738698|21404260|P4|COMPLETED|Overall Study||0
8670481|NCT01738698|21404261|P3|COMPLETED|Overall Study||0
8670482|NCT01738698|21404262|P2|COMPLETED|Overall Study||0
8670483|NCT01738698|21404263|P1|COMPLETED|Overall Study||0
8670484|NCT01738698|21404260|P4|STARTED|Overall Study||0
8670485|NCT01738698|21404261|P3|STARTED|Overall Study||0
8670486|NCT01738698|21404262|P2|STARTED|Overall Study||0
8670487|NCT01738698|21404263|P1|STARTED|Overall Study||0
8670488|NCT01057433|21404329|P1|NOT COMPLETED|Overall Study||1
8670489|NCT01057433|21404329|P1|COMPLETED|Overall Study||23
8670490|NCT01057433|21404329|P1|STARTED|Overall Study||24
8670491|NCT00914628|21404335|P2|NOT COMPLETED|Overall Study||28
8670492|NCT00914628|21404336|P1|NOT COMPLETED|Overall Study||64
8670493|NCT00914628|21404335|P2|COMPLETED|Overall Study|Early termination of the Study|0
8670494|NCT00914628|21404336|P1|COMPLETED|Overall Study|Early termination of the Study|0
8670495|NCT00914628|21404335|P2|STARTED|Overall Study|Referred to all randomized patient|28
8670496|NCT00914628|21404336|P1|STARTED|Overall Study|Referred to all randomized patient|64
8670497|NCT00877487|21404364|P2|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
8670498|NCT00877487|21404365|P1|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
8670499|NCT00877487|21404364|P2|COMPLETED|Double-blind Randomized Withdrawal Phase||13
8670500|NCT00877487|21404365|P1|COMPLETED|Double-blind Randomized Withdrawal Phase||50
8670501|NCT00877487|21404364|P2|STARTED|Double-blind Randomized Withdrawal Phase||60
8670502|NCT00877487|21404365|P1|STARTED|Double-blind Randomized Withdrawal Phase||56
8670503|NCT00877487|21404364|P2|NOT COMPLETED|Open-label Treatment Phase||0
8670504|NCT00877487|21404365|P1|NOT COMPLETED|Open-label Treatment Phase||7
8670505|NCT00877487|21404364|P2|COMPLETED|Open-label Treatment Phase||0
8670506|NCT00877487|21404365|P1|COMPLETED|Open-label Treatment Phase||116
8670507|NCT00877487|21404364|P2|STARTED|Open-label Treatment Phase||0
8670508|NCT00877487|21404365|P1|STARTED|Open-label Treatment Phase||123
8670509|NCT00860574|21404375|P1|NOT COMPLETED|Overall Study||3
8670510|NCT00860574|21404375|P1|COMPLETED|Overall Study||93
8670511|NCT00860574|21404375|P1|STARTED|Overall Study||96
8670512|NCT00570765|21404389|P4|NOT COMPLETED|LTSE Phase||12
8670513|NCT00570765|21404390|P3|NOT COMPLETED|LTSE Phase||0
8670514|NCT00570765|21404391|P2|NOT COMPLETED|LTSE Phase||0
8670515|NCT00570765|21404392|P1|NOT COMPLETED|LTSE Phase||0
8670516|NCT00570765|21404389|P4|COMPLETED|LTSE Phase||16
8670517|NCT00570765|21404390|P3|COMPLETED|LTSE Phase||0
8670518|NCT00570765|21404391|P2|COMPLETED|LTSE Phase||0
8670519|NCT00570765|21404392|P1|COMPLETED|LTSE Phase||0
8670520|NCT00570765|21404389|P4|Safety Population|LTSE Phase||28
8670521|NCT00570765|21404390|P3|Safety Population|LTSE Phase||0
8670522|NCT00570765|21404391|P2|Safety Population|LTSE Phase||0
8670523|NCT00570765|21404392|P1|Safety Population|LTSE Phase||0
8670524|NCT00570765|21404389|P4|Received at Least 1 Dose of Study Drug|LTSE Phase||28
8670525|NCT00570765|21404390|P3|Received at Least 1 Dose of Study Drug|LTSE Phase||0
8670526|NCT00570765|21404391|P2|Received at Least 1 Dose of Study Drug|LTSE Phase||0
8670527|NCT00570765|21404392|P1|Received at Least 1 Dose of Study Drug|LTSE Phase||0
8670528|NCT00570765|21404389|P4|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|28
8670529|NCT00570765|21404390|P3|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
8670530|NCT00570765|21404391|P2|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
8670531|NCT00570765|21404392|P1|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
8670532|NCT00570765|21404389|P4|NOT COMPLETED|DB Phase||0
8670533|NCT00570765|21404390|P3|NOT COMPLETED|DB Phase||1
8670534|NCT00570765|21404391|P2|NOT COMPLETED|DB Phase||7
8670535|NCT00570765|21404392|P1|NOT COMPLETED|DB Phase||4
8670536|NCT00570765|21404389|P4|COMPLETED|DB Phase||0
8670537|NCT00570765|21404390|P3|COMPLETED|DB Phase||23
8670538|NCT00570765|21404391|P2|COMPLETED|DB Phase||9
8670539|NCT00570765|21404392|P1|COMPLETED|DB Phase||16
8670540|NCT00570765|21404389|P4|Safety Population|DB Phase||0
8670541|NCT00570765|21404390|P3|Safety Population|DB Phase||23
8670542|NCT00570765|21404391|P2|Safety Population|DB Phase||16
8670543|NCT00570765|21404392|P1|Safety Population|DB Phase||20
8670544|NCT00570765|21404389|P4|Received at Least 1 Dose of Study Drug|DB Phase||0
8670545|NCT00570765|21404390|P3|Received at Least 1 Dose of Study Drug|DB Phase||23
8670546|NCT00570765|21404391|P2|Received at Least 1 Dose of Study Drug|DB Phase||16
8670547|NCT00570765|21404392|P1|Received at Least 1 Dose of Study Drug|DB Phase||20
8670548|NCT00570765|21404389|P4|STARTED|DB Phase||0
8670549|NCT00570765|21404390|P3|STARTED|DB Phase||24
8670550|NCT00570765|21404391|P2|STARTED|DB Phase||16
8670551|NCT00570765|21404392|P1|STARTED|DB Phase||20
8670552|NCT00500071|21404423|P1|NOT COMPLETED|30-day Safety Follow-up||17
8670553|NCT00500071|21404423|P1|COMPLETED|30-day Safety Follow-up||278
8670554|NCT00500071|21404423|P1|STARTED|30-day Safety Follow-up||295
8670555|NCT00500071|21404423|P1|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
8670556|NCT00500071|21404423|P1|COMPLETED|Dose-optimization and Maintenance Phase||295
8670557|NCT00500071|21404423|P1|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
8670558|NCT00500071|21404423|P1|NOT COMPLETED|Screening and Washout Phase||1
8670559|NCT00500071|21404423|P1|COMPLETED|Screening and Washout Phase||317
8670560|NCT00500071|21404423|P1|STARTED|Screening and Washout Phase||318
8670561|NCT00487695|21404432|P2|NOT COMPLETED|Second Procedure||3
8670562|NCT00487695|21404433|P1|NOT COMPLETED|Second Procedure||1
8670563|NCT00487695|21404432|P2|COMPLETED|Second Procedure||20
8670564|NCT00487695|21404433|P1|COMPLETED|Second Procedure||19
8670565|NCT00487695|21404432|P2|STARTED|Second Procedure||23
8670566|NCT00487695|21404433|P1|STARTED|Second Procedure||20
8670567|NCT00487695|21404432|P2|NOT COMPLETED|First Procedure||0
8670568|NCT00487695|21404433|P1|NOT COMPLETED|First Procedure||3
8670569|NCT00487695|21404432|P2|COMPLETED|First Procedure||23
8670570|NCT00487695|21404433|P1|COMPLETED|First Procedure||20
8670571|NCT00487695|21404432|P2|STARTED|First Procedure||23
8670572|NCT00487695|21404433|P1|STARTED|First Procedure||23
8670573|NCT00391625|21404449|P1|NOT COMPLETED|Month 84||0
8670574|NCT00391625|21404449|P1|COMPLETED|Month 84||8
8670575|NCT00391625|21404449|P1|STARTED|Month 84||8
8670576|NCT00391625|21404449|P1|NOT COMPLETED|Month 50||1
8670577|NCT00391625|21404449|P1|COMPLETED|Month 50||8
8670578|NCT00391625|21404449|P1|STARTED|Month 50||9
8670579|NCT00391625|21404449|P1|NOT COMPLETED|Month 14||1
8670580|NCT00391625|21404449|P1|COMPLETED|Month 14||9
8670581|NCT00391625|21404449|P1|STARTED|Month 14||10
8670582|NCT00391625|21404449|P1|NOT COMPLETED|Baseline||0
8670583|NCT00391625|21404449|P1|COMPLETED|Baseline||10
8670584|NCT00391625|21404449|P1|STARTED|Baseline||10
8670591|NCT04668352|21404506|P2|NOT COMPLETED|Overall Study||2
8670592|NCT04668352|21404507|P1|NOT COMPLETED|Overall Study||1
8670593|NCT04668352|21404506|P2|COMPLETED|Overall Study||511
8670594|NCT04668352|21404507|P1|COMPLETED|Overall Study||510
8670595|NCT04668352|21404506|P2|STARTED|Overall Study||513
8670596|NCT04668352|21404507|P1|STARTED|Overall Study||511
8670597|NCT04492397|21404513|P2|NOT COMPLETED|Second Intervention||0
8670598|NCT04492397|21404514|P1|NOT COMPLETED|Second Intervention||0
8670599|NCT04492397|21404513|P2|COMPLETED|Second Intervention||18
8670600|NCT04492397|21404514|P1|COMPLETED|Second Intervention||17
8670601|NCT04492397|21404513|P2|STARTED|Second Intervention||18
8670602|NCT04492397|21404514|P1|STARTED|Second Intervention||17
8670603|NCT04492397|21404513|P2|NOT COMPLETED|First Intervention||0
8670604|NCT04492397|21404514|P1|NOT COMPLETED|First Intervention||0
8670605|NCT04492397|21404513|P2|COMPLETED|First Intervention||18
8670606|NCT04492397|21404514|P1|COMPLETED|First Intervention||17
8670607|NCT04492397|21404513|P2|STARTED|First Intervention||18
8670608|NCT04492397|21404514|P1|STARTED|First Intervention||17
8670609|NCT04452435|21404534|P2|NOT COMPLETED|Follow-up||1
8670610|NCT04452435|21404535|P1|NOT COMPLETED|Follow-up||0
8670611|NCT04452435|21404534|P2|COMPLETED|Follow-up||42
8670612|NCT04452435|21404535|P1|COMPLETED|Follow-up||45
8670613|NCT04452435|21404534|P2|STARTED|Follow-up||43
8670614|NCT04452435|21404535|P1|STARTED|Follow-up||45
8670615|NCT04452435|21404534|P2|NOT COMPLETED|Treatment Period||12
8670616|NCT04452435|21404535|P1|NOT COMPLETED|Treatment Period||6
8670617|NCT04452435|21404534|P2|COMPLETED|Treatment Period||43
8670618|NCT04452435|21404535|P1|COMPLETED|Treatment Period||45
8670619|NCT04452435|21404534|P2|STARTED|Treatment Period||55
8670620|NCT04452435|21404535|P1|STARTED|Treatment Period||51
8670621|NCT04452435|21404534|P2|NOT COMPLETED|Screening||0
8670622|NCT04452435|21404535|P1|NOT COMPLETED|Screening||0
8670623|NCT04452435|21404534|P2|COMPLETED|Screening||55
8670624|NCT04452435|21404535|P1|COMPLETED|Screening||51
8670625|NCT04452435|21404534|P2|STARTED|Screening||55
8670626|NCT04452435|21404535|P1|STARTED|Screening||51
8670627|NCT03999944|21404566|P2|NOT COMPLETED|Second Sleep Night||4
8670628|NCT03999944|21404567|P1|NOT COMPLETED|Second Sleep Night||0
8670629|NCT03999944|21404566|P2|COMPLETED|Second Sleep Night||20
8670630|NCT03999944|21404567|P1|COMPLETED|Second Sleep Night||22
8670631|NCT03999944|21404566|P2|STARTED|Second Sleep Night||24
8670632|NCT03999944|21404567|P1|STARTED|Second Sleep Night||22
8670633|NCT03999944|21404566|P2|NOT COMPLETED|First Sleep Night||2
8670634|NCT03999944|21404567|P1|NOT COMPLETED|First Sleep Night||4
8670635|NCT03999944|21404566|P2|COMPLETED|First Sleep Night||24
8670636|NCT03999944|21404567|P1|COMPLETED|First Sleep Night||22
8670637|NCT03999944|21404566|P2|STARTED|First Sleep Night||26
8670638|NCT03999944|21404567|P1|STARTED|First Sleep Night||26
8670639|NCT03959189|21404577|P2|NOT COMPLETED|Overall Study||0
8670640|NCT03959189|21404578|P1|NOT COMPLETED|Overall Study||0
8670641|NCT03959189|21404577|P2|COMPLETED|Overall Study||5
8670642|NCT03959189|21404578|P1|COMPLETED|Overall Study||7
8670643|NCT03959189|21404577|P2|STARTED|Overall Study||5
8670644|NCT03959189|21404578|P1|STARTED|Overall Study||7
8670645|NCT03954444|21404605|P3|NOT COMPLETED|Overall Study||17
8670646|NCT03954444|21404606|P2|NOT COMPLETED|Overall Study||16
8670647|NCT03954444|21404607|P1|NOT COMPLETED|Overall Study||13
8670648|NCT03954444|21404605|P3|COMPLETED|Overall Study||327
8670649|NCT03954444|21404606|P2|COMPLETED|Overall Study||366
8670650|NCT03954444|21404607|P1|COMPLETED|Overall Study||366
8670651|NCT03954444|21404605|P3|STARTED|Overall Study||344
8670652|NCT03954444|21404606|P2|STARTED|Overall Study||382
8670653|NCT03954444|21404607|P1|STARTED|Overall Study||379
8670654|NCT03847389|21404618|P3|NOT COMPLETED|Overall Study||0
8670655|NCT03847389|21404619|P2|NOT COMPLETED|Overall Study||0
8670656|NCT03847389|21404620|P1|NOT COMPLETED|Overall Study||0
8670657|NCT03847389|21404618|P3|COMPLETED|Overall Study||0
8670658|NCT03847389|21404619|P2|COMPLETED|Overall Study||0
8670659|NCT03847389|21404620|P1|COMPLETED|Overall Study||8
8670660|NCT03847389|21404618|P3|STARTED|Overall Study|Start of Cohort 3 can only happen if less than or equal to 40% of subjects in Cohort 2 had HPA axis suppression.|0
8670661|NCT03847389|21404619|P2|STARTED|Overall Study|Start of Cohort 2 can only happen if less than or equal to 40% of subjects in Cohort 1 had HPA axis suppression.|0
8670662|NCT03847389|21404620|P1|STARTED|Overall Study||8
8670663|NCT03738163|21404634|P1|NOT COMPLETED|Overall Study||7
8670664|NCT03738163|21404634|P1|COMPLETED|Overall Study||114
8670665|NCT03738163|21404634|P1|STARTED|Overall Study||121
8670666|NCT03680742|21404645|P1|NOT COMPLETED|Overall Study||2
8670667|NCT03680742|21404645|P1|COMPLETED|Overall Study||32
8670668|NCT03680742|21404645|P1|STARTED|Overall Study||34
8670669|NCT03483675|21404652|P2|NOT COMPLETED|Overall Study||0
8670670|NCT03483675|21404653|P1|NOT COMPLETED|Overall Study||0
8670671|NCT03483675|21404652|P2|COMPLETED|Overall Study||8
8670672|NCT03483675|21404653|P1|COMPLETED|Overall Study||9
8670673|NCT03483675|21404652|P2|STARTED|Overall Study||8
8670674|NCT03483675|21404653|P1|STARTED|Overall Study||9
8670675|NCT03392935|21404675|P1|NOT COMPLETED|Overall Study||2
8670676|NCT03392935|21404675|P1|COMPLETED|Overall Study||35
8670677|NCT03392935|21404675|P1|STARTED|Overall Study||37
8670678|NCT03380000|21404682|P2|NOT COMPLETED|Second Intervention (1day)||0
8670679|NCT03380000|21404683|P1|NOT COMPLETED|Second Intervention (1day)||0
8670680|NCT03380000|21404682|P2|COMPLETED|Second Intervention (1day)||8
8670681|NCT03380000|21404683|P1|COMPLETED|Second Intervention (1day)||8
8670682|NCT03380000|21404682|P2|STARTED|Second Intervention (1day)||8
8670683|NCT03380000|21404683|P1|STARTED|Second Intervention (1day)||8
8670684|NCT03380000|21404682|P2|NOT COMPLETED|Washout (>7days)||0
8670685|NCT03380000|21404683|P1|NOT COMPLETED|Washout (>7days)||0
8670686|NCT03380000|21404682|P2|COMPLETED|Washout (>7days)||8
8670687|NCT03380000|21404683|P1|COMPLETED|Washout (>7days)||8
8670688|NCT03380000|21404682|P2|STARTED|Washout (>7days)||8
8670689|NCT03380000|21404683|P1|STARTED|Washout (>7days)||8
8670690|NCT03380000|21404682|P2|NOT COMPLETED|First Intervention (1day)||0
8670691|NCT03380000|21404683|P1|NOT COMPLETED|First Intervention (1day)||0
8670692|NCT03380000|21404682|P2|COMPLETED|First Intervention (1day)||8
8670693|NCT03380000|21404683|P1|COMPLETED|First Intervention (1day)||8
8670694|NCT03380000|21404682|P2|STARTED|First Intervention (1day)||8
8670695|NCT03380000|21404683|P1|STARTED|First Intervention (1day)||8
8670696|NCT03377556|21404693|P1|NOT COMPLETED|Overall Study||47
8670697|NCT03377556|21404693|P1|COMPLETED|Overall Study||0
8670698|NCT03377556|21404693|P1|Primary Analysis Population (HRRD-positive Per MDVN Criteria)|Overall Study||24
8670699|NCT03377556|21404693|P1|STARTED|Overall Study||47
8670700|NCT03204526|21404705|P1|NOT COMPLETED|Overall Study||0
8670701|NCT03204526|21404705|P1|COMPLETED|Overall Study||15
8670702|NCT03204526|21404705|P1|STARTED|Overall Study||15
8670703|NCT03197935|21404714|P2|NOT COMPLETED|Overall Study||165
8670704|NCT03197935|21404715|P1|NOT COMPLETED|Overall Study||168
8670705|NCT03197935|21404714|P2|COMPLETED|Overall Study||0
8670706|NCT03197935|21404715|P1|COMPLETED|Overall Study||0
8670707|NCT03197935|21404714|P2|STARTED|Overall Study||165
8670708|NCT03197935|21404715|P1|STARTED|Overall Study||168
8670709|NCT03150875|21404728|P2|NOT COMPLETED|Overall Study||145
8670710|NCT03150875|21404729|P1|NOT COMPLETED|Overall Study||145
8670711|NCT03150875|21404728|P2|COMPLETED|Overall Study||0
8670712|NCT03150875|21404729|P1|COMPLETED|Overall Study||0
8670713|NCT03150875|21404728|P2|Crossover to Certain Treatment|Overall Study||0
8670714|NCT03150875|21404729|P1|Crossover to Certain Treatment|Overall Study||0
8670715|NCT03150875|21404728|P2|Treated|Overall Study||130
8670716|NCT03150875|21404729|P1|Treated|Overall Study||144
8670717|NCT03150875|21404728|P2|STARTED|Overall Study||145
8670718|NCT03150875|21404729|P1|STARTED|Overall Study||145
8670719|NCT03101514|21404743|P1|NOT COMPLETED|Overall Study||7
8670720|NCT03101514|21404743|P1|COMPLETED|Overall Study||46
8670721|NCT03101514|21404743|P1|STARTED|Overall Study||53
8670722|NCT03097315|21404752|P1|NOT COMPLETED|Overall Study||1
8670723|NCT03097315|21404752|P1|COMPLETED|Overall Study||37
8670724|NCT03097315|21404752|P1|Safety Population|Overall Study||38
8670725|NCT03097315|21404752|P1|Intention-to-Treat Population|Overall Study||38
8670726|NCT03097315|21404752|P1|STARTED|Overall Study||38
8670727|NCT02997085|21404763|P3|NOT COMPLETED|Overall Study||0
8670728|NCT02997085|21404764|P2|NOT COMPLETED|Overall Study||0
8670729|NCT02997085|21404765|P1|NOT COMPLETED|Overall Study||0
8670730|NCT02997085|21404763|P3|COMPLETED|Overall Study||34
8670731|NCT02997085|21404764|P2|COMPLETED|Overall Study||35
8670732|NCT02997085|21404765|P1|COMPLETED|Overall Study||34
8670733|NCT02997085|21404763|P3|STARTED|Overall Study||34
8670734|NCT02997085|21404764|P2|STARTED|Overall Study||35
8670735|NCT02997085|21404765|P1|STARTED|Overall Study||34
8670736|NCT02836236|21404786|P2|NOT COMPLETED|Overall Study||50
8670737|NCT02836236|21404787|P1|NOT COMPLETED|Overall Study||105
8670738|NCT02836236|21404786|P2|COMPLETED|Overall Study||0
8670739|NCT02836236|21404787|P1|COMPLETED|Overall Study||0
8670740|NCT02836236|21404786|P2|STARTED|Overall Study||50
8670741|NCT02836236|21404787|P1|STARTED|Overall Study||105
8670742|NCT02770820|21404801|P1|NOT COMPLETED|Overall Study||3
8670743|NCT02770820|21404801|P1|COMPLETED|Overall Study||4
8670744|NCT02770820|21404801|P1|STARTED|Overall Study||7
8670745|NCT02749201|21404807|P1|NOT COMPLETED|Overall Study||0
8670746|NCT02749201|21404807|P1|COMPLETED|Overall Study||10
8670747|NCT02749201|21404807|P1|STARTED|Overall Study||10
8670774|NCT02675231|21404860|P3|NOT COMPLETED|Overall Study||26
8670775|NCT02675231|21404861|P2|NOT COMPLETED|Overall Study||36
8670776|NCT02675231|21404862|P1|NOT COMPLETED|Overall Study||26
8670777|NCT02675231|21404860|P3|COMPLETED|Overall Study||53
8670778|NCT02675231|21404861|P2|COMPLETED|Overall Study||43
8670779|NCT02675231|21404862|P1|COMPLETED|Overall Study||53
8670780|NCT02675231|21404860|P3|Received at Least One Dose of Drug|Overall Study||72
8670781|NCT02675231|21404861|P2|Received at Least One Dose of Drug|Overall Study||77
8670782|NCT02675231|21404862|P1|Received at Least One Dose of Drug|Overall Study||78
8670783|NCT02675231|21404860|P3|STARTED|Overall Study||79
8670784|NCT02675231|21404861|P2|STARTED|Overall Study||79
8670785|NCT02675231|21404862|P1|STARTED|Overall Study||79
8670786|NCT02608463|21404899|P4|NOT COMPLETED|Overall Study||0
8670787|NCT02608463|21404900|P3|NOT COMPLETED|Overall Study||0
8670788|NCT02608463|21404901|P2|NOT COMPLETED|Overall Study||0
8670789|NCT02608463|21404902|P1|NOT COMPLETED|Overall Study||0
8670790|NCT02608463|21404899|P4|COMPLETED|Overall Study||0
8670791|NCT02608463|21404900|P3|COMPLETED|Overall Study||0
8670792|NCT02608463|21404901|P2|COMPLETED|Overall Study||5
8670793|NCT02608463|21404902|P1|COMPLETED|Overall Study||10
8670794|NCT02608463|21404899|P4|STARTED|Overall Study|No study participants were enrolled in Part B.|0
8670795|NCT02608463|21404900|P3|STARTED|Overall Study||0
8670796|NCT02608463|21404901|P2|STARTED|Overall Study||5
8670797|NCT02608463|21404902|P1|STARTED|Overall Study||10
8670798|NCT02564900|21404925|P15|NOT COMPLETED|Dose Expansion||23
8670799|NCT02564900|21404926|P14|NOT COMPLETED|Dose Expansion||20
8670800|NCT02564900|21404927|P13|NOT COMPLETED|Dose Expansion||18
8670801|NCT02564900|21404928|P12|NOT COMPLETED|Dose Expansion||24
8670802|NCT02564900|21404929|P11|NOT COMPLETED|Dose Expansion||16
8670803|NCT02564900|21404930|P10|NOT COMPLETED|Dose Expansion||31
8670804|NCT02564900|21404931|P9|NOT COMPLETED|Dose Expansion||20
8670805|NCT02564900|21404932|P8|NOT COMPLETED|Dose Expansion||64
8670806|NCT02564900|21404933|P7|NOT COMPLETED|Dose Expansion||49
8670807|NCT02564900|21404934|P6|NOT COMPLETED|Dose Expansion||0
8670808|NCT02564900|21404935|P5|NOT COMPLETED|Dose Expansion||0
8670809|NCT02564900|21404936|P4|NOT COMPLETED|Dose Expansion||0
8670810|NCT02564900|21404937|P3|NOT COMPLETED|Dose Expansion||0
8670811|NCT02564900|21404938|P2|NOT COMPLETED|Dose Expansion||0
8670812|NCT02564900|21404939|P1|NOT COMPLETED|Dose Expansion||0
8670813|NCT02564900|21404925|P15|COMPLETED|Dose Expansion||0
8670814|NCT02564900|21404926|P14|COMPLETED|Dose Expansion||0
8670815|NCT02564900|21404927|P13|COMPLETED|Dose Expansion||0
8670816|NCT02564900|21404928|P12|COMPLETED|Dose Expansion||0
8670817|NCT02564900|21404929|P11|COMPLETED|Dose Expansion||0
8670818|NCT02564900|21404930|P10|COMPLETED|Dose Expansion||0
8670819|NCT02564900|21404931|P9|COMPLETED|Dose Expansion||0
8670820|NCT02564900|21404932|P8|COMPLETED|Dose Expansion||0
8670821|NCT02564900|21404933|P7|COMPLETED|Dose Expansion||0
8670822|NCT02564900|21404934|P6|COMPLETED|Dose Expansion||0
8670823|NCT02564900|21404935|P5|COMPLETED|Dose Expansion||0
8670824|NCT02564900|21404936|P4|COMPLETED|Dose Expansion||0
8670825|NCT02564900|21404937|P3|COMPLETED|Dose Expansion||0
8670826|NCT02564900|21404938|P2|COMPLETED|Dose Expansion||0
8670827|NCT02564900|21404939|P1|COMPLETED|Dose Expansion||0
8670828|NCT02564900|21404925|P15|Enrolled, But Not Dosed|Dose Expansion||1
8670829|NCT02564900|21404926|P14|Enrolled, But Not Dosed|Dose Expansion||0
8670830|NCT02564900|21404927|P13|Enrolled, But Not Dosed|Dose Expansion||0
8670831|NCT02564900|21404928|P12|Enrolled, But Not Dosed|Dose Expansion||0
8670832|NCT02564900|21404929|P11|Enrolled, But Not Dosed|Dose Expansion||0
8670833|NCT02564900|21404930|P10|Enrolled, But Not Dosed|Dose Expansion||0
8670834|NCT02564900|21404931|P9|Enrolled, But Not Dosed|Dose Expansion||0
8670835|NCT02564900|21404932|P8|Enrolled, But Not Dosed|Dose Expansion||1
8670836|NCT02564900|21404933|P7|Enrolled, But Not Dosed|Dose Expansion||1
8670837|NCT02564900|21404934|P6|Enrolled, But Not Dosed|Dose Expansion||0
8670838|NCT02564900|21404935|P5|Enrolled, But Not Dosed|Dose Expansion||0
8670839|NCT02564900|21404936|P4|Enrolled, But Not Dosed|Dose Expansion||0
8670840|NCT02564900|21404937|P3|Enrolled, But Not Dosed|Dose Expansion||0
8670841|NCT02564900|21404938|P2|Enrolled, But Not Dosed|Dose Expansion||0
8670842|NCT02564900|21404939|P1|Enrolled, But Not Dosed|Dose Expansion||0
8670843|NCT02564900|21404925|P15|STARTED|Dose Expansion||23
8670844|NCT02564900|21404926|P14|STARTED|Dose Expansion||20
8670845|NCT02564900|21404927|P13|STARTED|Dose Expansion||18
8670846|NCT02564900|21404928|P12|STARTED|Dose Expansion||24
8670847|NCT02564900|21404929|P11|STARTED|Dose Expansion||16
8670848|NCT02564900|21404930|P10|STARTED|Dose Expansion||31
8670849|NCT02564900|21404931|P9|STARTED|Dose Expansion||20
8670850|NCT02564900|21404932|P8|STARTED|Dose Expansion||64
8670851|NCT02564900|21404933|P7|STARTED|Dose Expansion||49
8670852|NCT02564900|21404934|P6|STARTED|Dose Expansion||0
8670853|NCT02564900|21404935|P5|STARTED|Dose Expansion||0
8670854|NCT02564900|21404936|P4|STARTED|Dose Expansion||0
8670855|NCT02564900|21404937|P3|STARTED|Dose Expansion||0
8670856|NCT02564900|21404938|P2|STARTED|Dose Expansion||0
8670857|NCT02564900|21404939|P1|STARTED|Dose Expansion||0
8670858|NCT02564900|21404925|P15|NOT COMPLETED|Dose Escalation||0
8670859|NCT02564900|21404926|P14|NOT COMPLETED|Dose Escalation||0
8670860|NCT02564900|21404927|P13|NOT COMPLETED|Dose Escalation||0
8670861|NCT02564900|21404928|P12|NOT COMPLETED|Dose Escalation||0
8670862|NCT02564900|21404929|P11|NOT COMPLETED|Dose Escalation||0
8670863|NCT02564900|21404930|P10|NOT COMPLETED|Dose Escalation||0
8670864|NCT02564900|21404931|P9|NOT COMPLETED|Dose Escalation||0
8670865|NCT02564900|21404932|P8|NOT COMPLETED|Dose Escalation||0
8670866|NCT02564900|21404933|P7|NOT COMPLETED|Dose Escalation||0
8670867|NCT02564900|21404934|P6|NOT COMPLETED|Dose Escalation||6
8670868|NCT02564900|21404935|P5|NOT COMPLETED|Dose Escalation||6
8670869|NCT02564900|21404936|P4|NOT COMPLETED|Dose Escalation||6
8670870|NCT02564900|21404937|P3|NOT COMPLETED|Dose Escalation||3
8670871|NCT02564900|21404938|P2|NOT COMPLETED|Dose Escalation||3
8670872|NCT02564900|21404939|P1|NOT COMPLETED|Dose Escalation||3
8670873|NCT02564900|21404925|P15|COMPLETED|Dose Escalation||0
8670874|NCT02564900|21404926|P14|COMPLETED|Dose Escalation||0
8670875|NCT02564900|21404927|P13|COMPLETED|Dose Escalation||0
8670876|NCT02564900|21404928|P12|COMPLETED|Dose Escalation||0
8670877|NCT02564900|21404929|P11|COMPLETED|Dose Escalation||0
8670878|NCT02564900|21404930|P10|COMPLETED|Dose Escalation||0
8670879|NCT02564900|21404931|P9|COMPLETED|Dose Escalation||0
8670880|NCT02564900|21404932|P8|COMPLETED|Dose Escalation||0
8670881|NCT02564900|21404933|P7|COMPLETED|Dose Escalation||0
8670882|NCT02564900|21404934|P6|COMPLETED|Dose Escalation||0
8670883|NCT02564900|21404935|P5|COMPLETED|Dose Escalation||0
8670884|NCT02564900|21404936|P4|COMPLETED|Dose Escalation||0
8670885|NCT02564900|21404937|P3|COMPLETED|Dose Escalation||0
8670886|NCT02564900|21404938|P2|COMPLETED|Dose Escalation||0
8670887|NCT02564900|21404939|P1|COMPLETED|Dose Escalation||0
8670888|NCT02564900|21404925|P15|STARTED|Dose Escalation||0
8670889|NCT02564900|21404926|P14|STARTED|Dose Escalation||0
8670890|NCT02564900|21404927|P13|STARTED|Dose Escalation||0
8670891|NCT02564900|21404928|P12|STARTED|Dose Escalation||0
8670892|NCT02564900|21404929|P11|STARTED|Dose Escalation||0
8670893|NCT02564900|21404930|P10|STARTED|Dose Escalation||0
8670894|NCT02564900|21404931|P9|STARTED|Dose Escalation||0
8670895|NCT02564900|21404932|P8|STARTED|Dose Escalation||0
8670896|NCT02564900|21404933|P7|STARTED|Dose Escalation||0
8670897|NCT02564900|21404934|P6|STARTED|Dose Escalation||6
8670898|NCT02564900|21404935|P5|STARTED|Dose Escalation||6
8670899|NCT02564900|21404936|P4|STARTED|Dose Escalation||6
8670900|NCT02564900|21404937|P3|STARTED|Dose Escalation||3
8670901|NCT02564900|21404938|P2|STARTED|Dose Escalation||3
8670902|NCT02564900|21404939|P1|STARTED|Dose Escalation||3
8670903|NCT02556736|21405104|P1|NOT COMPLETED|Overall Study||0
8670904|NCT02556736|21405104|P1|COMPLETED|Overall Study||14
8670905|NCT02556736|21405104|P1|STARTED|Overall Study||14
8670915|NCT02450331|21405142|P2|NOT COMPLETED|Overall Study||406
8670916|NCT02450331|21405143|P1|NOT COMPLETED|Overall Study||403
8670917|NCT02450331|21405142|P2|COMPLETED|Overall Study||0
8670918|NCT02450331|21405143|P1|COMPLETED|Overall Study||0
8670919|NCT02450331|21405142|P2|STARTED|Overall Study||406
8670920|NCT02450331|21405143|P1|STARTED|Overall Study||403
8670931|NCT02430480|21405173|P1|NOT COMPLETED|Overall Study||3
8670932|NCT02430480|21405173|P1|COMPLETED|Overall Study||36
8670933|NCT02430480|21405173|P1|STARTED|Overall Study||39
8670946|NCT02080403|21405215|P2|NOT COMPLETED|Overall Study||12
8670947|NCT02080403|21405216|P1|NOT COMPLETED|Overall Study||15
8670948|NCT02080403|21405215|P2|COMPLETED|Overall Study||132
8670949|NCT02080403|21405216|P1|COMPLETED|Overall Study||131
8670950|NCT02080403|21405215|P2|STARTED|Overall Study||144
8670951|NCT02080403|21405216|P1|STARTED|Overall Study||146
8670952|NCT02004288|21405230|P2|NOT COMPLETED|Overall Study||1
8670953|NCT02004288|21405231|P1|NOT COMPLETED|Overall Study||1
8670954|NCT02004288|21405230|P2|COMPLETED|Overall Study||15
8670955|NCT02004288|21405231|P1|COMPLETED|Overall Study||14
8670956|NCT02004288|21405230|P2|STARTED|Overall Study||16
8670957|NCT02004288|21405231|P1|STARTED|Overall Study||15
8670958|NCT01940341|21405241|P2|NOT COMPLETED|Open-label Extension Phase||1
8670959|NCT01940341|21405242|P1|NOT COMPLETED|Open-label Extension Phase||4
8670960|NCT01940341|21405241|P2|COMPLETED|Open-label Extension Phase||0
8670961|NCT01940341|21405242|P1|COMPLETED|Open-label Extension Phase||0
8670962|NCT01940341|21405241|P2|STARTED|Open-label Extension Phase||1
8670963|NCT01940341|21405242|P1|STARTED|Open-label Extension Phase||4
8670964|NCT01940341|21405241|P2|NOT COMPLETED|Double-Blind Phase||140
8670965|NCT01940341|21405242|P1|NOT COMPLETED|Double-Blind Phase||281
8670966|NCT01940341|21405241|P2|COMPLETED|Double-Blind Phase||1
8670967|NCT01940341|21405242|P1|COMPLETED|Double-Blind Phase||4
8670968|NCT01940341|21405241|P2|STARTED|Double-Blind Phase||141
8670969|NCT01940341|21405242|P1|STARTED|Double-Blind Phase||285
8670970|NCT01902953|21405256|P1|NOT COMPLETED|Overall Study||0
8670971|NCT01902953|21405256|P1|COMPLETED|Overall Study||16
8670972|NCT01902953|21405256|P1|STARTED|Overall Study||16
8671019|NCT01743729|21405329|P2|NOT COMPLETED|Overall Study||12
8671020|NCT01743729|21405330|P1|NOT COMPLETED|Overall Study||37
8671021|NCT01743729|21405329|P2|COMPLETED|Overall Study||348
8671022|NCT01743729|21405330|P1|COMPLETED|Overall Study||321
8671023|NCT01743729|21405329|P2|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
8671024|NCT01743729|21405330|P1|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
8671025|NCT01719380|21405348|P10|NOT COMPLETED|Overall Study||51
8671026|NCT01719380|21405349|P9|NOT COMPLETED|Overall Study||50
8671027|NCT01719380|21405350|P8|NOT COMPLETED|Overall Study||7
8671028|NCT01719380|21405351|P7|NOT COMPLETED|Overall Study||10
8671029|NCT01719380|21405352|P6|NOT COMPLETED|Overall Study||8
8671030|NCT01719380|21405353|P5|NOT COMPLETED|Overall Study||3
8671031|NCT01719380|21405354|P4|NOT COMPLETED|Overall Study||8
8671032|NCT01719380|21405355|P3|NOT COMPLETED|Overall Study||9
8671033|NCT01719380|21405356|P2|NOT COMPLETED|Overall Study||7
8671034|NCT01719380|21405357|P1|NOT COMPLETED|Overall Study||2
8671035|NCT01719380|21405348|P10|COMPLETED|Overall Study||1
8671036|NCT01719380|21405349|P9|COMPLETED|Overall Study||0
8671037|NCT01719380|21405350|P8|COMPLETED|Overall Study||0
8671038|NCT01719380|21405351|P7|COMPLETED|Overall Study||0
8671039|NCT01719380|21405352|P6|COMPLETED|Overall Study||0
8671040|NCT01719380|21405353|P5|COMPLETED|Overall Study||0
8671041|NCT01719380|21405354|P4|COMPLETED|Overall Study||0
8671042|NCT01719380|21405355|P3|COMPLETED|Overall Study||0
8671043|NCT01719380|21405356|P2|COMPLETED|Overall Study||0
8671044|NCT01719380|21405357|P1|COMPLETED|Overall Study||0
8671045|NCT01719380|21405348|P10|STARTED|Overall Study||52
8671046|NCT01719380|21405349|P9|STARTED|Overall Study||50
8671047|NCT01719380|21405350|P8|STARTED|Overall Study||7
8671048|NCT01719380|21405351|P7|STARTED|Overall Study||10
8671049|NCT01719380|21405352|P6|STARTED|Overall Study||8
8671050|NCT01719380|21405353|P5|STARTED|Overall Study||3
8671051|NCT01719380|21405354|P4|STARTED|Overall Study||8
8671052|NCT01719380|21405355|P3|STARTED|Overall Study||9
8671053|NCT01719380|21405356|P2|STARTED|Overall Study||7
8671054|NCT01719380|21405357|P1|STARTED|Overall Study||2
8671055|NCT01716039|21405577|P3|NOT COMPLETED|Overall Study||2
8671056|NCT01716039|21405578|P2|NOT COMPLETED|Overall Study||2
8671057|NCT01716039|21405579|P1|NOT COMPLETED|Overall Study||1
8671058|NCT01716039|21405577|P3|COMPLETED|Overall Study||8
8671059|NCT01716039|21405578|P2|COMPLETED|Overall Study||6
8671060|NCT01716039|21405579|P1|COMPLETED|Overall Study||3
8671061|NCT01716039|21405577|P3|STARTED|Overall Study||10
8671062|NCT01716039|21405578|P2|STARTED|Overall Study||8
8671063|NCT01716039|21405579|P1|STARTED|Overall Study||4
8671064|NCT01715571|21405590|P1|NOT COMPLETED|Overall Study||8
8671065|NCT01715571|21405590|P1|COMPLETED|Overall Study||3
8671066|NCT01715571|21405590|P1|STARTED|Overall Study||11
8671067|NCT01708954|21405604|P3|NOT COMPLETED|Step 2||0
8671068|NCT01708954|21405605|P2|NOT COMPLETED|Step 2||7
8671069|NCT01708954|21405606|P1|NOT COMPLETED|Step 2||13
8671070|NCT01708954|21405604|P3|COMPLETED|Step 2||0
8671071|NCT01708954|21405605|P2|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
8671072|NCT01708954|21405606|P1|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
8671073|NCT01708954|21405604|P3|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
8671074|NCT01708954|21405605|P2|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
8671075|NCT01708954|21405606|P1|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
8671076|NCT01708954|21405604|P3|NOT COMPLETED|Step 1||43
8671077|NCT01708954|21405605|P2|NOT COMPLETED|Step 1||40
8671078|NCT01708954|21405606|P1|NOT COMPLETED|Step 1||42
8671079|NCT01708954|21405604|P3|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
8671080|NCT01708954|21405605|P2|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
8671081|NCT01708954|21405606|P1|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
8671082|NCT01708954|21405604|P3|Patients With MET Status Data Available|Step 1||24
8671083|NCT01708954|21405605|P2|Patients With MET Status Data Available|Step 1||32
8671084|NCT01708954|21405606|P1|Patients With MET Status Data Available|Step 1||30
8671085|NCT01708954|21405604|P3|Eligible and Treated|Step 1||35
8671086|NCT01708954|21405605|P2|Eligible and Treated|Step 1||38
8671087|NCT01708954|21405606|P1|Eligible and Treated|Step 1||38
8671088|NCT01708954|21405604|P3|Started Protocol Therapy|Step 1||39
8671089|NCT01708954|21405605|P2|Started Protocol Therapy|Step 1||40
8671090|NCT01708954|21405606|P1|Started Protocol Therapy|Step 1||40
8671091|NCT01708954|21405604|P3|STARTED|Step 1||43
8671092|NCT01708954|21405605|P2|STARTED|Step 1||40
8671093|NCT01708954|21405606|P1|STARTED|Step 1||42
8671110|NCT01643408|21405648|P1|NOT COMPLETED|Overall Study||14
8671111|NCT01643408|21405648|P1|COMPLETED|Overall Study||16
8671112|NCT01643408|21405648|P1|STARTED|Overall Study||30
8671113|NCT01590433|21405658|P2|NOT COMPLETED|Overall Study||22
8671114|NCT01590433|21405659|P1|NOT COMPLETED|Overall Study||52
8671115|NCT01590433|21405658|P2|COMPLETED|Overall Study||33
8671116|NCT01590433|21405659|P1|COMPLETED|Overall Study||75
8671117|NCT01590433|21405658|P2|STARTED|Overall Study||55
8671118|NCT01590433|21405659|P1|STARTED|Overall Study||127
8671119|NCT01332968|21405667|P8|NOT COMPLETED|Follow-Up Period||531
8671120|NCT01332968|21405668|P7|NOT COMPLETED|Follow-Up Period||542
8671121|NCT01332968|21405669|P6|NOT COMPLETED|Follow-Up Period||0
8671122|NCT01332968|21405670|P5|NOT COMPLETED|Follow-Up Period||0
8671123|NCT01332968|21405671|P4|NOT COMPLETED|Follow-Up Period||0
8671124|NCT01332968|21405672|P3|NOT COMPLETED|Follow-Up Period||0
8671125|NCT01332968|21405673|P2|NOT COMPLETED|Follow-Up Period||0
8671126|NCT01332968|21405674|P1|NOT COMPLETED|Follow-Up Period||0
8671127|NCT01332968|21405667|P8|COMPLETED|Follow-Up Period||0
8671128|NCT01332968|21405668|P7|COMPLETED|Follow-Up Period||0
8671129|NCT01332968|21405669|P6|COMPLETED|Follow-Up Period||0
8671130|NCT01332968|21405670|P5|COMPLETED|Follow-Up Period||0
8671131|NCT01332968|21405671|P4|COMPLETED|Follow-Up Period||0
8671132|NCT01332968|21405672|P3|COMPLETED|Follow-Up Period||0
8671133|NCT01332968|21405673|P2|COMPLETED|Follow-Up Period||0
8671134|NCT01332968|21405674|P1|COMPLETED|Follow-Up Period||0
8671135|NCT01332968|21405667|P8|STARTED|Follow-Up Period||531
8671136|NCT01332968|21405668|P7|STARTED|Follow-Up Period||542
8671137|NCT01332968|21405669|P6|STARTED|Follow-Up Period||0
8671138|NCT01332968|21405670|P5|STARTED|Follow-Up Period||0
8671139|NCT01332968|21405671|P4|STARTED|Follow-Up Period||0
8671140|NCT01332968|21405672|P3|STARTED|Follow-Up Period||0
8671141|NCT01332968|21405673|P2|STARTED|Follow-Up Period||0
8671142|NCT01332968|21405674|P1|STARTED|Follow-Up Period||0
8671143|NCT01332968|21405667|P8|NOT COMPLETED|Maintenance/Observation Period||0
8671144|NCT01332968|21405668|P7|NOT COMPLETED|Maintenance/Observation Period||0
8671145|NCT01332968|21405669|P6|NOT COMPLETED|Maintenance/Observation Period||9
8671146|NCT01332968|21405670|P5|NOT COMPLETED|Maintenance/Observation Period||10
8671147|NCT01332968|21405671|P4|NOT COMPLETED|Maintenance/Observation Period||207
8671148|NCT01332968|21405672|P3|NOT COMPLETED|Maintenance/Observation Period||213
8671149|NCT01332968|21405673|P2|NOT COMPLETED|Maintenance/Observation Period||0
8671150|NCT01332968|21405674|P1|NOT COMPLETED|Maintenance/Observation Period||0
8671151|NCT01332968|21405667|P8|COMPLETED|Maintenance/Observation Period||0
8671152|NCT01332968|21405668|P7|COMPLETED|Maintenance/Observation Period||0
8671153|NCT01332968|21405669|P6|COMPLETED|Maintenance/Observation Period||2
8671154|NCT01332968|21405670|P5|COMPLETED|Maintenance/Observation Period||2
8671155|NCT01332968|21405671|P4|COMPLETED|Maintenance/Observation Period||417
8671156|NCT01332968|21405672|P3|COMPLETED|Maintenance/Observation Period||399
8671157|NCT01332968|21405673|P2|COMPLETED|Maintenance/Observation Period||0
8671158|NCT01332968|21405674|P1|COMPLETED|Maintenance/Observation Period||0
8671159|NCT01332968|21405667|P8|STARTED|Maintenance/Observation Period||0
8671160|NCT01332968|21405668|P7|STARTED|Maintenance/Observation Period||0
8671161|NCT01332968|21405669|P6|STARTED|Maintenance/Observation Period||11
8671162|NCT01332968|21405670|P5|STARTED|Maintenance/Observation Period||12
8671163|NCT01332968|21405671|P4|STARTED|Maintenance/Observation Period||624
8671164|NCT01332968|21405672|P3|STARTED|Maintenance/Observation Period||612
8671165|NCT01332968|21405673|P2|STARTED|Maintenance/Observation Period||0
8671166|NCT01332968|21405674|P1|STARTED|Maintenance/Observation Period||0
8671167|NCT01332968|21405667|P8|NOT COMPLETED|Induction Period||0
8671168|NCT01332968|21405668|P7|NOT COMPLETED|Induction Period||0
8671169|NCT01332968|21405669|P6|NOT COMPLETED|Induction Period||0
8671170|NCT01332968|21405670|P5|NOT COMPLETED|Induction Period||0
8671171|NCT01332968|21405671|P4|NOT COMPLETED|Induction Period||0
8671172|NCT01332968|21405672|P3|NOT COMPLETED|Induction Period||0
8671173|NCT01332968|21405673|P2|NOT COMPLETED|Induction Period||56
8671174|NCT01332968|21405674|P1|NOT COMPLETED|Induction Period||58
8671175|NCT01332968|21405667|P8|COMPLETED|Induction Period||0
8671176|NCT01332968|21405668|P7|COMPLETED|Induction Period||0
8671177|NCT01332968|21405669|P6|COMPLETED|Induction Period||0
8671178|NCT01332968|21405670|P5|COMPLETED|Induction Period||0
8671179|NCT01332968|21405671|P4|COMPLETED|Induction Period||0
8671180|NCT01332968|21405672|P3|COMPLETED|Induction Period||0
8671181|NCT01332968|21405673|P2|COMPLETED|Induction Period||646
8671182|NCT01332968|21405674|P1|COMPLETED|Induction Period||641
8671183|NCT01332968|21405667|P8|STARTED|Induction Period||0
8671184|NCT01332968|21405668|P7|STARTED|Induction Period||0
8671185|NCT01332968|21405669|P6|STARTED|Induction Period||0
8671186|NCT01332968|21405670|P5|STARTED|Induction Period||0
8671187|NCT01332968|21405671|P4|STARTED|Induction Period||0
8671188|NCT01332968|21405672|P3|STARTED|Induction Period||0
8671189|NCT01332968|21405673|P2|STARTED|Induction Period||702
8671190|NCT01332968|21405674|P1|STARTED|Induction Period||699
8671191|NCT01318356|21405741|P3|NOT COMPLETED|Overall Study||2
8671192|NCT01318356|21405742|P2|NOT COMPLETED|Overall Study||3
8671193|NCT01318356|21405743|P1|NOT COMPLETED|Overall Study||8
8671194|NCT01318356|21405741|P3|COMPLETED|Overall Study||50
8671195|NCT01318356|21405742|P2|COMPLETED|Overall Study||49
8671196|NCT01318356|21405743|P1|COMPLETED|Overall Study||43
8671197|NCT01318356|21405741|P3|STARTED|Overall Study||52
8671198|NCT01318356|21405742|P2|STARTED|Overall Study||52
8671199|NCT01318356|21405743|P1|STARTED|Overall Study||51
8671206|NCT01275300|21405778|P2|NOT COMPLETED|Phase 2: Open-label 6days)||0
8671207|NCT01275300|21405779|P1|NOT COMPLETED|Phase 2: Open-label 6days)||0
8671208|NCT01275300|21405778|P2|COMPLETED|Phase 2: Open-label 6days)||4
8671209|NCT01275300|21405779|P1|COMPLETED|Phase 2: Open-label 6days)||5
8671210|NCT01275300|21405778|P2|STARTED|Phase 2: Open-label 6days)||4
8671211|NCT01275300|21405779|P1|STARTED|Phase 2: Open-label 6days)||5
8671212|NCT01275300|21405778|P2|NOT COMPLETED|Washout (14 Days)||0
8671213|NCT01275300|21405779|P1|NOT COMPLETED|Washout (14 Days)||0
8671214|NCT01275300|21405778|P2|COMPLETED|Washout (14 Days)||4
8671215|NCT01275300|21405779|P1|COMPLETED|Washout (14 Days)||5
8671216|NCT01275300|21405778|P2|STARTED|Washout (14 Days)||4
8671217|NCT01275300|21405779|P1|STARTED|Washout (14 Days)||5
8671218|NCT01275300|21405778|P2|NOT COMPLETED|2nd Intervention(5 Days)||0
8671219|NCT01275300|21405779|P1|NOT COMPLETED|2nd Intervention(5 Days)||0
8671220|NCT01275300|21405778|P2|COMPLETED|2nd Intervention(5 Days)||4
8671221|NCT01275300|21405779|P1|COMPLETED|2nd Intervention(5 Days)||5
8671222|NCT01275300|21405778|P2|STARTED|2nd Intervention(5 Days)||4
8671223|NCT01275300|21405779|P1|STARTED|2nd Intervention(5 Days)||5
8671224|NCT01275300|21405778|P2|NOT COMPLETED|Washout (14 Days)||0
8671225|NCT01275300|21405779|P1|NOT COMPLETED|Washout (14 Days)||0
8671226|NCT01275300|21405778|P2|COMPLETED|Washout (14 Days)||4
8671227|NCT01275300|21405779|P1|COMPLETED|Washout (14 Days)||5
8671228|NCT01275300|21405778|P2|STARTED|Washout (14 Days)||4
8671229|NCT01275300|21405779|P1|STARTED|Washout (14 Days)||5
8671230|NCT01275300|21405778|P2|NOT COMPLETED|1st Intervention (5 Days)||0
8671231|NCT01275300|21405779|P1|NOT COMPLETED|1st Intervention (5 Days)||0
8671232|NCT01275300|21405778|P2|COMPLETED|1st Intervention (5 Days)||4
8671233|NCT01275300|21405779|P1|COMPLETED|1st Intervention (5 Days)||5
8671234|NCT01275300|21405778|P2|STARTED|1st Intervention (5 Days)||4
8671235|NCT01275300|21405779|P1|STARTED|1st Intervention (5 Days)||5
8671236|NCT01251861|21405787|P2|NOT COMPLETED|Overall Study||28
8671237|NCT01251861|21405788|P1|NOT COMPLETED|Overall Study||18
8671238|NCT01251861|21405787|P2|COMPLETED|Overall Study||26
8671239|NCT01251861|21405788|P1|COMPLETED|Overall Study||36
8671240|NCT01251861|21405787|P2|Pts With PSA Response|Overall Study||36
8671241|NCT01251861|21405788|P1|Pts With PSA Response|Overall Study||44
8671242|NCT01251861|21405787|P2|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47
8671243|NCT01251861|21405788|P1|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49
8671244|NCT01251861|21405787|P2|Pts Who Received Protocol Therapy|Overall Study||53
8671245|NCT01251861|21405788|P1|Pts Who Received Protocol Therapy|Overall Study||50
8671246|NCT01251861|21405787|P2|STARTED|Overall Study||54
8671247|NCT01251861|21405788|P1|STARTED|Overall Study||54
8671248|NCT01238211|21405814|P1|NOT COMPLETED|Overall Study||58
8671249|NCT01238211|21405814|P1|COMPLETED|Overall Study||3
8671250|NCT01238211|21405814|P1|STARTED|Overall Study||61
8671251|NCT01145495|21405818|P1|NOT COMPLETED|Overall Study||12
8671252|NCT01145495|21405818|P1|COMPLETED|Overall Study||51
8671253|NCT01145495|21405818|P1|STARTED|Overall Study||63
8671254|NCT01142388|21405824|P2|NOT COMPLETED|Overall Study||47
8671255|NCT01142388|21405825|P1|NOT COMPLETED|Overall Study||47
8671256|NCT01142388|21405824|P2|COMPLETED|Overall Study||0
8671257|NCT01142388|21405825|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
8671258|NCT01142388|21405824|P2|Treated|Overall Study||44
8671259|NCT01142388|21405825|P1|Treated|Overall Study||40
8671260|NCT01142388|21405824|P2|Eligible|Overall Study||44
8671261|NCT01142388|21405825|P1|Eligible|Overall Study||43
8671262|NCT01142388|21405824|P2|STARTED|Overall Study||47
8671263|NCT01142388|21405825|P1|STARTED|Overall Study||47
8671274|NCT00914966|21405848|P1|NOT COMPLETED|Step 3: 2500 Units||0
8671275|NCT00914966|21405848|P1|COMPLETED|Step 3: 2500 Units||12
8671276|NCT00914966|21405848|P1|STARTED|Step 3: 2500 Units||12
8671277|NCT00914966|21405848|P1|NOT COMPLETED|Step 2: 2000 Units||1
8671278|NCT00914966|21405848|P1|COMPLETED|Step 2: 2000 Units||12
8671279|NCT00914966|21405848|P1|STARTED|Step 2: 2000 Units||13
8671280|NCT00914966|21405848|P1|NOT COMPLETED|Step 1: 1500 Units||2
8671281|NCT00914966|21405848|P1|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
8671282|NCT00914966|21405848|P1|STARTED|Step 1: 1500 Units||20
8671335|NCT00577317|21405918|P2|NOT COMPLETED|Overall Study||2
8671336|NCT00577317|21405919|P1|NOT COMPLETED|Overall Study||0
8671337|NCT00577317|21405918|P2|COMPLETED|Overall Study||0
8671338|NCT00577317|21405919|P1|COMPLETED|Overall Study||0
8671339|NCT00577317|21405918|P2|STARTED|Overall Study||2
8671340|NCT00577317|21405919|P1|STARTED|Overall Study||0
8671371|NCT00135226|21405983|P4|NOT COMPLETED|Overall Study||36
8671372|NCT00135226|21405984|P3|NOT COMPLETED|Overall Study||34
8671373|NCT00135226|21405985|P2|NOT COMPLETED|Overall Study||35
8671374|NCT00135226|21405986|P1|NOT COMPLETED|Overall Study||34
8671375|NCT00135226|21405983|P4|COMPLETED|Overall Study||3834
8671376|NCT00135226|21405984|P3|COMPLETED|Overall Study||3836
8671377|NCT00135226|21405985|P2|COMPLETED|Overall Study||3835
8671378|NCT00135226|21405986|P1|COMPLETED|Overall Study||3836
8671379|NCT00135226|21405983|P4|STARTED|Overall Study||3870
8671380|NCT00135226|21405984|P3|STARTED|Overall Study||3870
8671381|NCT00135226|21405985|P2|STARTED|Overall Study||3870
8671382|NCT00135226|21405986|P1|STARTED|Overall Study||3870
8671383|NCT00114101|21406080|P2|NOT COMPLETED|Overall Study||0
8671384|NCT00114101|21406081|P1|NOT COMPLETED|Overall Study||0
8671385|NCT00114101|21406080|P2|COMPLETED|Overall Study||229
8671386|NCT00114101|21406081|P1|COMPLETED|Overall Study||231
8671387|NCT00114101|21406080|P2|STARTED|Overall Study||229
8671388|NCT00114101|21406081|P1|STARTED|Overall Study||231
8671409|NCT04728802|21406128|P2|NOT COMPLETED|Overall Study||36
8671410|NCT04728802|21406129|P1|NOT COMPLETED|Overall Study||29
8671411|NCT04728802|21406128|P2|COMPLETED|Overall Study||292
8671412|NCT04728802|21406129|P1|COMPLETED|Overall Study||288
8671413|NCT04728802|21406128|P2|STARTED|Overall Study||328
8671414|NCT04728802|21406129|P1|STARTED|Overall Study||317
8671415|NCT04646291|21406144|P3|NOT COMPLETED|Overall Study||0
8671416|NCT04646291|21406145|P2|NOT COMPLETED|Overall Study||0
8671417|NCT04646291|21406146|P1|NOT COMPLETED|Overall Study||0
8671418|NCT04646291|21406144|P3|COMPLETED|Overall Study||8
8671419|NCT04646291|21406145|P2|COMPLETED|Overall Study||70
8671420|NCT04646291|21406146|P1|COMPLETED|Overall Study||272
8671421|NCT04646291|21406144|P3|STARTED|Overall Study||8
8671422|NCT04646291|21406145|P2|STARTED|Overall Study||70
8671423|NCT04646291|21406146|P1|STARTED|Overall Study||272
8671424|NCT04131517|21406199|P2|NOT COMPLETED|Overall Study||0
8671425|NCT04131517|21406200|P1|NOT COMPLETED|Overall Study||0
8671426|NCT04131517|21406199|P2|COMPLETED|Overall Study||7
8671427|NCT04131517|21406200|P1|COMPLETED|Overall Study||7
8671428|NCT04131517|21406199|P2|STARTED|Overall Study||7
8671429|NCT04131517|21406200|P1|STARTED|Overall Study||7
8671430|NCT04086693|21406243|P2|NOT COMPLETED|Overall Study||4
8671431|NCT04086693|21406244|P1|NOT COMPLETED|Overall Study||1
8671432|NCT04086693|21406243|P2|COMPLETED|Overall Study||171
8671433|NCT04086693|21406244|P1|COMPLETED|Overall Study||174
8671434|NCT04086693|21406243|P2|STARTED|Overall Study||175
8671435|NCT04086693|21406244|P1|STARTED|Overall Study||175
8671436|NCT03681405|21406256|P2|NOT COMPLETED|Overall Study||0
8671437|NCT03681405|21406257|P1|NOT COMPLETED|Overall Study||1
8671438|NCT03681405|21406256|P2|COMPLETED|Overall Study||17
8671439|NCT03681405|21406257|P1|COMPLETED|Overall Study||13
8671440|NCT03681405|21406256|P2|STARTED|Overall Study||17
8671441|NCT03681405|21406257|P1|STARTED|Overall Study||14
8671442|NCT03584100|21406279|P1|NOT COMPLETED|Overall Study||0
8671443|NCT03584100|21406279|P1|COMPLETED|Overall Study||12
8671444|NCT03584100|21406279|P1|STARTED|Overall Study||12
8671445|NCT03496545|21406288|P2|NOT COMPLETED|Overall Study||2
8671446|NCT03496545|21406289|P1|NOT COMPLETED|Overall Study||1
8671447|NCT03496545|21406288|P2|COMPLETED|Overall Study||24
8671448|NCT03496545|21406289|P1|COMPLETED|Overall Study||20
8671449|NCT03496545|21406288|P2|STARTED|Overall Study||26
8671450|NCT03496545|21406289|P1|STARTED|Overall Study||21
8671451|NCT03477279|21406306|P5|NOT COMPLETED|Overall Study||1
8671452|NCT03477279|21406307|P4|NOT COMPLETED|Overall Study||32
8671453|NCT03477279|21406308|P3|NOT COMPLETED|Overall Study||0
8671454|NCT03477279|21406309|P2|NOT COMPLETED|Overall Study||48
8671455|NCT03477279|21406310|P1|NOT COMPLETED|Overall Study||47
8671456|NCT03477279|21406306|P5|COMPLETED|Overall Study||349
8671457|NCT03477279|21406307|P4|COMPLETED|Overall Study||136
8671458|NCT03477279|21406308|P3|COMPLETED|Overall Study||98
8671459|NCT03477279|21406309|P2|COMPLETED|Overall Study||202
8671460|NCT03477279|21406310|P1|COMPLETED|Overall Study||203
8671461|NCT03477279|21406306|P5|STARTED|Overall Study||350
8671462|NCT03477279|21406307|P4|STARTED|Overall Study||168
8671463|NCT03477279|21406308|P3|STARTED|Overall Study||98
8671464|NCT03477279|21406309|P2|STARTED|Overall Study||250
8671465|NCT03477279|21406310|P1|STARTED|Overall Study||250
8671466|NCT03446885|21406333|P2|NOT COMPLETED|Overall Study||0
8671467|NCT03446885|21406334|P1|NOT COMPLETED|Overall Study||2
8671468|NCT03446885|21406333|P2|COMPLETED|Overall Study||10
8671469|NCT03446885|21406334|P1|COMPLETED|Overall Study||10
8671470|NCT03446885|21406333|P2|STARTED|Overall Study||10
8671471|NCT03446885|21406334|P1|STARTED|Overall Study||12
8671472|NCT03428230|21406350|P4|NOT COMPLETED|Overall Study||0
8671473|NCT03428230|21406351|P3|NOT COMPLETED|Overall Study||0
8671474|NCT03428230|21406352|P2|NOT COMPLETED|Overall Study||0
8671475|NCT03428230|21406353|P1|NOT COMPLETED|Overall Study||0
8671476|NCT03428230|21406350|P4|COMPLETED|Overall Study||15
8671477|NCT03428230|21406351|P3|COMPLETED|Overall Study||15
8671478|NCT03428230|21406352|P2|COMPLETED|Overall Study||15
8671479|NCT03428230|21406353|P1|COMPLETED|Overall Study||15
8671480|NCT03428230|21406350|P4|STARTED|Overall Study||15
8671481|NCT03428230|21406351|P3|STARTED|Overall Study||15
8671482|NCT03428230|21406352|P2|STARTED|Overall Study||15
8671483|NCT03428230|21406353|P1|STARTED|Overall Study||15
8671484|NCT03408808|21406453|P2|NOT COMPLETED|Overall Study||1
8671485|NCT03408808|21406454|P1|NOT COMPLETED|Overall Study||0
8671486|NCT03408808|21406453|P2|COMPLETED|Overall Study||8
8671487|NCT03408808|21406454|P1|COMPLETED|Overall Study||8
8671488|NCT03408808|21406453|P2|STARTED|Overall Study||9
8671489|NCT03408808|21406454|P1|STARTED|Overall Study||8
8671490|NCT03368196|21406466|P1|NOT COMPLETED|Overall Study||0
8671491|NCT03368196|21406466|P1|COMPLETED|Overall Study||12
8671492|NCT03368196|21406466|P1|STARTED|Overall Study||12
8671493|NCT03323853|21406479|P2|NOT COMPLETED|Overall Study||0
8671494|NCT03323853|21406480|P1|NOT COMPLETED|Overall Study||0
8671495|NCT03323853|21406479|P2|COMPLETED|Overall Study||238
8671496|NCT03323853|21406480|P1|COMPLETED|Overall Study||213
8671497|NCT03323853|21406479|P2|STARTED|Overall Study||238
8671498|NCT03323853|21406480|P1|STARTED|Overall Study||213
8671546|NCT02622321|21406637|P4|NOT COMPLETED|Overall Study||0
8671547|NCT02622321|21406638|P3|NOT COMPLETED|Overall Study||1
8671548|NCT02622321|21406639|P2|NOT COMPLETED|Overall Study||0
8671549|NCT02622321|21406640|P1|NOT COMPLETED|Overall Study||3
8671550|NCT02622321|21406637|P4|COMPLETED|Overall Study||11
8671551|NCT02622321|21406638|P3|COMPLETED|Overall Study||48
8671552|NCT02622321|21406639|P2|COMPLETED|Overall Study||18
8671553|NCT02622321|21406640|P1|COMPLETED|Overall Study||32
8671554|NCT02622321|21406637|P4|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
8671555|NCT02622321|21406638|P3|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
8671556|NCT02622321|21406639|P2|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
8671557|NCT02622321|21406640|P1|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
8671558|NCT02622321|21406637|P4|Completed 24 Weeks in the Study|Overall Study||11
8671559|NCT02622321|21406638|P3|Completed 24 Weeks in the Study|Overall Study||49
8671560|NCT02622321|21406639|P2|Completed 24 Weeks in the Study|Overall Study|After 24 weeks, all 18 participants in Arm B switched to receive emicizumab prophylaxis.|18
8671561|NCT02622321|21406640|P1|Completed 24 Weeks in the Study|Overall Study||31
8671562|NCT02622321|21406637|P4|Received at Least One Dose of Treatment|Overall Study||11
8671563|NCT02622321|21406638|P3|Received at Least One Dose of Treatment|Overall Study||49
8671564|NCT02622321|21406639|P2|Received at Least One Dose of Treatment|Overall Study||18
8671565|NCT02622321|21406640|P1|Received at Least One Dose of Treatment|Overall Study|1 participant withdrew prior to study Day 1.|34
8671566|NCT02622321|21406637|P4|STARTED|Overall Study||11
8671567|NCT02622321|21406638|P3|STARTED|Overall Study||49
8671568|NCT02622321|21406639|P2|STARTED|Overall Study||18
8671569|NCT02622321|21406640|P1|STARTED|Overall Study||35
8671570|NCT02511236|21406720|P2|NOT COMPLETED|Overall Study||45
8671571|NCT02511236|21406721|P1|NOT COMPLETED|Overall Study||40
8671572|NCT02511236|21406720|P2|COMPLETED|Overall Study||146
8671573|NCT02511236|21406721|P1|COMPLETED|Overall Study||125
8671574|NCT02511236|21406720|P2|STARTED|Overall Study||191
8671575|NCT02511236|21406721|P1|STARTED|Overall Study||165
8671576|NCT02488109|21406733|P2|NOT COMPLETED|12-month Follow-Up||7
8671577|NCT02488109|21406734|P1|NOT COMPLETED|12-month Follow-Up||4
8671578|NCT02488109|21406733|P2|COMPLETED|12-month Follow-Up||44
8671579|NCT02488109|21406734|P1|COMPLETED|12-month Follow-Up||56
8671580|NCT02488109|21406733|P2|Included in mITT Analysis|12-month Follow-Up||51
8671581|NCT02488109|21406734|P1|Included in mITT Analysis|12-month Follow-Up||60
8671582|NCT02488109|21406733|P2|STARTED|12-month Follow-Up||51
8671583|NCT02488109|21406734|P1|STARTED|12-month Follow-Up||60
8671584|NCT02488109|21406733|P2|NOT COMPLETED|Treatment in Hospital||5
8671585|NCT02488109|21406734|P1|NOT COMPLETED|Treatment in Hospital||0
8671586|NCT02488109|21406733|P2|COMPLETED|Treatment in Hospital||51
8671587|NCT02488109|21406734|P1|COMPLETED|Treatment in Hospital||60
8671588|NCT02488109|21406733|P2|Included in mITT Analysis|Treatment in Hospital||51
8671589|NCT02488109|21406734|P1|Included in mITT Analysis|Treatment in Hospital||60
8671590|NCT02488109|21406733|P2|Received Treatment|Treatment in Hospital||51
8671591|NCT02488109|21406734|P1|Received Treatment|Treatment in Hospital||60
8671592|NCT02488109|21406733|P2|STARTED|Treatment in Hospital||56
8671593|NCT02488109|21406734|P1|STARTED|Treatment in Hospital||60
8671594|NCT02424968|21406744|P1|NOT COMPLETED|Overall Study||0
8671595|NCT02424968|21406744|P1|COMPLETED|Overall Study||18
8671596|NCT02424968|21406744|P1|STARTED|Overall Study||18
8671597|NCT02417870|21406755|P1|NOT COMPLETED|Overall Study||2
8671598|NCT02417870|21406755|P1|COMPLETED|Overall Study||0
8671599|NCT02417870|21406755|P1|STARTED|Overall Study||2
8671600|NCT02374918|21406763|P4|NOT COMPLETED|Overall Study||2
8671601|NCT02374918|21406764|P3|NOT COMPLETED|Overall Study||4
8671602|NCT02374918|21406765|P2|NOT COMPLETED|Overall Study||1
8671603|NCT02374918|21406766|P1|NOT COMPLETED|Overall Study||3
8671604|NCT02374918|21406763|P4|COMPLETED|Overall Study||18
8671605|NCT02374918|21406764|P3|COMPLETED|Overall Study||18
8671606|NCT02374918|21406765|P2|COMPLETED|Overall Study||17
8671607|NCT02374918|21406766|P1|COMPLETED|Overall Study||14
8671608|NCT02374918|21406763|P4|STARTED|Overall Study||20
8671609|NCT02374918|21406764|P3|STARTED|Overall Study||22
8671610|NCT02374918|21406765|P2|STARTED|Overall Study||18
8671611|NCT02374918|21406766|P1|STARTED|Overall Study||17
8671612|NCT02259231|21406799|P7|NOT COMPLETED|Overall Study||5
8671613|NCT02259231|21406800|P6|NOT COMPLETED|Overall Study||6
8671614|NCT02259231|21406801|P5|NOT COMPLETED|Overall Study||6
8671615|NCT02259231|21406802|P4|NOT COMPLETED|Overall Study||6
8671616|NCT02259231|21406803|P3|NOT COMPLETED|Overall Study||6
8671617|NCT02259231|21406804|P2|NOT COMPLETED|Overall Study||6
8671618|NCT02259231|21406805|P1|NOT COMPLETED|Overall Study||6
8671619|NCT02259231|21406799|P7|COMPLETED|Overall Study||0
8671620|NCT02259231|21406800|P6|COMPLETED|Overall Study||0
8671621|NCT02259231|21406801|P5|COMPLETED|Overall Study||0
8671622|NCT02259231|21406802|P4|COMPLETED|Overall Study||0
8671623|NCT02259231|21406803|P3|COMPLETED|Overall Study||0
8671624|NCT02259231|21406804|P2|COMPLETED|Overall Study||0
8671625|NCT02259231|21406805|P1|COMPLETED|Overall Study||0
8671626|NCT02259231|21406799|P7|STARTED|Overall Study||5
8671627|NCT02259231|21406800|P6|STARTED|Overall Study||6
8671628|NCT02259231|21406801|P5|STARTED|Overall Study||6
8671629|NCT02259231|21406802|P4|STARTED|Overall Study||6
8671630|NCT02259231|21406803|P3|STARTED|Overall Study||6
8671631|NCT02259231|21406804|P2|STARTED|Overall Study||6
8671632|NCT02259231|21406805|P1|STARTED|Overall Study||6
8671633|NCT02196038|21406823|P2|NOT COMPLETED|Overall Study||22
8671634|NCT02196038|21406824|P1|NOT COMPLETED|Overall Study||17
8671635|NCT02196038|21406823|P2|COMPLETED|Overall Study||153
8671636|NCT02196038|21406824|P1|COMPLETED|Overall Study||157
8671637|NCT02196038|21406823|P2|STARTED|Overall Study||175
8671638|NCT02196038|21406824|P1|STARTED|Overall Study||174
8671639|NCT02177123|21406832|P1|NOT COMPLETED|Overall Study||24
8671640|NCT02177123|21406832|P1|COMPLETED|Overall Study||83
8671641|NCT02177123|21406832|P1|STARTED|Overall Study||107
8671642|NCT02000622|21406841|P2|NOT COMPLETED|Overall Study||80
8671643|NCT02000622|21406842|P1|NOT COMPLETED|Overall Study||169
8671644|NCT02000622|21406841|P2|COMPLETED|Overall Study||17
8671645|NCT02000622|21406842|P1|COMPLETED|Overall Study||36
8671646|NCT02000622|21406841|P2|STARTED|Overall Study||97
8671647|NCT02000622|21406842|P1|STARTED|Overall Study||205
8671648|NCT01989169|21406872|P2|NOT COMPLETED|Period 2||1
8671649|NCT01989169|21406873|P1|NOT COMPLETED|Period 2||0
8671650|NCT01989169|21406872|P2|COMPLETED|Period 2||14
8671651|NCT01989169|21406873|P1|COMPLETED|Period 2||15
8671652|NCT01989169|21406872|P2|STARTED|Period 2||15
8671653|NCT01989169|21406873|P1|STARTED|Period 2||15
8671654|NCT01989169|21406872|P2|NOT COMPLETED|Period 1||0
8671655|NCT01989169|21406873|P1|NOT COMPLETED|Period 1||0
8671656|NCT01989169|21406872|P2|COMPLETED|Period 1||15
8671657|NCT01989169|21406873|P1|COMPLETED|Period 1||15
8671658|NCT01989169|21406872|P2|STARTED|Period 1||15
8671659|NCT01989169|21406873|P1|STARTED|Period 1||15
8671660|NCT01979185|21406885|P2|NOT COMPLETED|Period 2||1
8671661|NCT01979185|21406886|P1|NOT COMPLETED|Period 2||0
8671662|NCT01979185|21406885|P2|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
8671663|NCT01979185|21406886|P1|COMPLETED|Period 2||15
8671664|NCT01979185|21406885|P2|STARTED|Period 2||15
8671665|NCT01979185|21406886|P1|STARTED|Period 2||15
8671666|NCT01979185|21406885|P2|NOT COMPLETED|Period 1||0
8671667|NCT01979185|21406886|P1|NOT COMPLETED|Period 1||0
8671668|NCT01979185|21406885|P2|COMPLETED|Period 1||15
8671669|NCT01979185|21406886|P1|COMPLETED|Period 1||15
8671670|NCT01979185|21406885|P2|STARTED|Period 1||15
8671671|NCT01979185|21406886|P1|STARTED|Period 1||15
8671672|NCT01928446|21406898|P2|NOT COMPLETED|Overall Study||139
8671673|NCT01928446|21406899|P1|NOT COMPLETED|Overall Study||111
8671674|NCT01928446|21406898|P2|COMPLETED|Overall Study|23 subjects stopped study drug but continued with followup|125
8671675|NCT01928446|21406899|P1|COMPLETED|Overall Study|39 subjects stopped study drug but continued with followup|144
8671676|NCT01928446|21406898|P2|STARTED|Overall Study||264
8671677|NCT01928446|21406899|P1|STARTED|Overall Study||255
8671678|NCT01905553|21406911|P2|NOT COMPLETED|Period 2||0
8671679|NCT01905553|21406912|P1|NOT COMPLETED|Period 2||1
8671680|NCT01905553|21406911|P2|COMPLETED|Period 2||4
8671681|NCT01905553|21406912|P1|COMPLETED|Period 2||4
8671682|NCT01905553|21406911|P2|STARTED|Period 2||4
8671683|NCT01905553|21406912|P1|STARTED|Period 2||5
8671684|NCT01905553|21406911|P2|NOT COMPLETED|Period 1||0
8671685|NCT01905553|21406912|P1|NOT COMPLETED|Period 1||0
8671686|NCT01905553|21406911|P2|COMPLETED|Period 1||4
8671687|NCT01905553|21406912|P1|COMPLETED|Period 1||5
8671688|NCT01905553|21406911|P2|STARTED|Period 1||4
8671689|NCT01905553|21406912|P1|STARTED|Period 1||5
8671690|NCT01824446|21406922|P1|NOT COMPLETED|Overall Study||0
8671691|NCT01824446|21406922|P1|COMPLETED|Overall Study||6
8671692|NCT01824446|21406922|P1|STARTED|Overall Study||6
8671693|NCT01734512|21406945|P1|NOT COMPLETED|Overall Study||0
8671694|NCT01734512|21406945|P1|COMPLETED|Overall Study||65
8671695|NCT01734512|21406945|P1|STARTED|Overall Study||65
8671696|NCT01699789|21406951|P2|NOT COMPLETED|Overall Study||126
8671697|NCT01699789|21406952|P1|NOT COMPLETED|Overall Study||102
8671698|NCT01699789|21406951|P2|COMPLETED|Overall Study|Clients in 46 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|514
8671699|NCT01699789|21406952|P1|COMPLETED|Overall Study|Clients in 44 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|504
8671700|NCT01699789|21406951|P2|4-Year Follow-up|Overall Study||140
8671701|NCT01699789|21406952|P1|4-Year Follow-up|Overall Study||143
8671702|NCT01699789|21406951|P2|3-Year Follow-up|Overall Study||307
8671703|NCT01699789|21406952|P1|3-Year Follow-up|Overall Study||293
8671704|NCT01699789|21406951|P2|12-Month Follow-Up|Overall Study||369
8671705|NCT01699789|21406952|P1|12-Month Follow-Up|Overall Study||364
8671706|NCT01699789|21406951|P2|6-Month Follow-Up|Overall Study||379
8671707|NCT01699789|21406952|P1|6-Month Follow-Up|Overall Study||380
8671708|NCT01699789|21406951|P2|Baseline|Overall Study||489
8671709|NCT01699789|21406952|P1|Baseline|Overall Study||492
8671710|NCT01699789|21406951|P2|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
8671711|NCT01699789|21406952|P1|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
8671712|NCT01687218|21407066|P6|NOT COMPLETED|Overall Study||0
8671713|NCT01687218|21407067|P5|NOT COMPLETED|Overall Study||1
8671714|NCT01687218|21407068|P4|NOT COMPLETED|Overall Study||2
8671715|NCT01687218|21407069|P3|NOT COMPLETED|Overall Study||1
8671716|NCT01687218|21407070|P2|NOT COMPLETED|Overall Study||3
8671717|NCT01687218|21407071|P1|NOT COMPLETED|Overall Study||3
8671718|NCT01687218|21407066|P6|COMPLETED|Overall Study||32
8671719|NCT01687218|21407067|P5|COMPLETED|Overall Study||32
8671720|NCT01687218|21407068|P4|COMPLETED|Overall Study||32
8671721|NCT01687218|21407069|P3|COMPLETED|Overall Study||30
8671722|NCT01687218|21407070|P2|COMPLETED|Overall Study||29
8671723|NCT01687218|21407071|P1|COMPLETED|Overall Study||30
8671724|NCT01687218|21407066|P6|STARTED|Overall Study||32
8671725|NCT01687218|21407067|P5|STARTED|Overall Study||33
8671726|NCT01687218|21407068|P4|STARTED|Overall Study||34
8671727|NCT01687218|21407069|P3|STARTED|Overall Study||31
8671728|NCT01687218|21407070|P2|STARTED|Overall Study||32
8671729|NCT01687218|21407071|P1|STARTED|Overall Study||33
8671730|NCT01563237|21407112|P2|NOT COMPLETED|Overall Study||0
8671731|NCT01563237|21407113|P1|NOT COMPLETED|Overall Study||10
8671732|NCT01563237|21407112|P2|COMPLETED|Overall Study||5
8671733|NCT01563237|21407113|P1|COMPLETED|Overall Study||54
8671734|NCT01563237|21407112|P2|STARTED|Overall Study||5
8671735|NCT01563237|21407113|P1|STARTED|Overall Study||64
8671736|NCT01486784|21407124|P6|NOT COMPLETED|Overall Study||3
8671737|NCT01486784|21407125|P5|NOT COMPLETED|Overall Study||2
8671738|NCT01486784|21407126|P4|NOT COMPLETED|Overall Study||0
8671739|NCT01486784|21407127|P3|NOT COMPLETED|Overall Study||1
8671740|NCT01486784|21407128|P2|NOT COMPLETED|Overall Study||0
8671741|NCT01486784|21407129|P1|NOT COMPLETED|Overall Study||0
8671742|NCT01486784|21407124|P6|COMPLETED|Overall Study||2
8671743|NCT01486784|21407125|P5|COMPLETED|Overall Study||3
8671744|NCT01486784|21407126|P4|COMPLETED|Overall Study||1
8671745|NCT01486784|21407127|P3|COMPLETED|Overall Study||5
8671746|NCT01486784|21407128|P2|COMPLETED|Overall Study||7
8671747|NCT01486784|21407129|P1|COMPLETED|Overall Study||3
8671748|NCT01486784|21407124|P6|Received Treatment|Overall Study||2
8671749|NCT01486784|21407125|P5|Received Treatment|Overall Study||3
8671750|NCT01486784|21407126|P4|Received Treatment|Overall Study||1
8671751|NCT01486784|21407127|P3|Received Treatment|Overall Study||5
8671752|NCT01486784|21407128|P2|Received Treatment|Overall Study||7
8671753|NCT01486784|21407129|P1|Received Treatment|Overall Study||3
8671754|NCT01486784|21407124|P6|Completed Cycle 1|Overall Study||2
8671755|NCT01486784|21407125|P5|Completed Cycle 1|Overall Study||3
8671756|NCT01486784|21407126|P4|Completed Cycle 1|Overall Study||1
8671757|NCT01486784|21407127|P3|Completed Cycle 1|Overall Study||3
8671758|NCT01486784|21407128|P2|Completed Cycle 1|Overall Study||6
8671759|NCT01486784|21407129|P1|Completed Cycle 1|Overall Study||2
8671760|NCT01486784|21407124|P6|STARTED|Overall Study||5
8671761|NCT01486784|21407125|P5|STARTED|Overall Study||5
8671762|NCT01486784|21407126|P4|STARTED|Overall Study||1
8671763|NCT01486784|21407127|P3|STARTED|Overall Study||6
8671764|NCT01486784|21407128|P2|STARTED|Overall Study||7
8671765|NCT01486784|21407129|P1|STARTED|Overall Study||3
8671766|NCT01434290|21407151|P2|NOT COMPLETED|Overall Study||7
8671767|NCT01434290|21407152|P1|NOT COMPLETED|Overall Study||8
8671768|NCT01434290|21407151|P2|COMPLETED|Overall Study|Eligible subjects included in analysis|121
8671769|NCT01434290|21407152|P1|COMPLETED|Overall Study|Eligible subjects included in analysis|119
8671770|NCT01434290|21407151|P2|STARTED|Overall Study||128
8671771|NCT01434290|21407152|P1|STARTED|Overall Study||127
8671783|NCT01109940|21407207|P4|NOT COMPLETED|Overall Study||0
8671784|NCT01109940|21407208|P3|NOT COMPLETED|Overall Study||1
8671785|NCT01109940|21407209|P2|NOT COMPLETED|Overall Study||2
8671786|NCT01109940|21407210|P1|NOT COMPLETED|Overall Study||8
8671787|NCT01109940|21407207|P4|COMPLETED|Overall Study||3
8671788|NCT01109940|21407208|P3|COMPLETED|Overall Study||6
8671789|NCT01109940|21407209|P2|COMPLETED|Overall Study||6
8671790|NCT01109940|21407210|P1|COMPLETED|Overall Study||13
8671791|NCT01109940|21407207|P4|STARTED|Overall Study||3
8671792|NCT01109940|21407208|P3|STARTED|Overall Study||7
8671793|NCT01109940|21407209|P2|STARTED|Overall Study||8
8671794|NCT01109940|21407210|P1|STARTED|Overall Study||21
8671795|NCT00809354|21407246|P10|NOT COMPLETED|Overall Study||226
8671796|NCT00809354|21407247|P9|NOT COMPLETED|Overall Study||228
8671797|NCT00809354|21407248|P8|NOT COMPLETED|Overall Study||238
8671798|NCT00809354|21407249|P7|NOT COMPLETED|Overall Study||223
8671799|NCT00809354|21407250|P6|NOT COMPLETED|Overall Study||225
8671800|NCT00809354|21407251|P5|NOT COMPLETED|Overall Study||256
8671801|NCT00809354|21407252|P4|NOT COMPLETED|Overall Study||256
8671802|NCT00809354|21407253|P3|NOT COMPLETED|Overall Study||254
8671803|NCT00809354|21407254|P2|NOT COMPLETED|Overall Study||258
8671804|NCT00809354|21407255|P1|NOT COMPLETED|Overall Study||255
8671805|NCT00809354|21407246|P10|COMPLETED|Overall Study||31
8671806|NCT00809354|21407247|P9|COMPLETED|Overall Study||28
8671807|NCT00809354|21407248|P8|COMPLETED|Overall Study||19
8671808|NCT00809354|21407249|P7|COMPLETED|Overall Study||32
8671809|NCT00809354|21407250|P6|COMPLETED|Overall Study||31
8671810|NCT00809354|21407251|P5|COMPLETED|Overall Study||32
8671811|NCT00809354|21407252|P4|COMPLETED|Overall Study||32
8671812|NCT00809354|21407253|P3|COMPLETED|Overall Study||32
8671813|NCT00809354|21407254|P2|COMPLETED|Overall Study||31
8671814|NCT00809354|21407255|P1|COMPLETED|Overall Study||33
8671815|NCT00809354|21407246|P10|Treated|Overall Study||256
8671816|NCT00809354|21407247|P9|Treated|Overall Study||254
8671817|NCT00809354|21407248|P8|Treated|Overall Study||256
8671818|NCT00809354|21407249|P7|Treated|Overall Study||254
8671819|NCT00809354|21407250|P6|Treated|Overall Study||256
8671820|NCT00809354|21407251|P5|Treated|Overall Study||283
8671821|NCT00809354|21407252|P4|Treated|Overall Study||288
8671822|NCT00809354|21407253|P3|Treated|Overall Study||280
8671823|NCT00809354|21407254|P2|Treated|Overall Study||288
8671824|NCT00809354|21407255|P1|Treated|Overall Study||285
8671825|NCT00809354|21407246|P10|STARTED|Overall Study||257
8671826|NCT00809354|21407247|P9|STARTED|Overall Study||256
8671827|NCT00809354|21407248|P8|STARTED|Overall Study||257
8671828|NCT00809354|21407249|P7|STARTED|Overall Study||255
8671829|NCT00809354|21407250|P6|STARTED|Overall Study||256
8671830|NCT00809354|21407251|P5|STARTED|Overall Study||288
8671831|NCT00809354|21407252|P4|STARTED|Overall Study||288
8671832|NCT00809354|21407253|P3|STARTED|Overall Study||286
8671833|NCT00809354|21407254|P2|STARTED|Overall Study||289
8671834|NCT00809354|21407255|P1|STARTED|Overall Study||288
8671847|NCT00117507|21407746|P1|NOT COMPLETED|Overall Study||15
8671848|NCT00117507|21407746|P1|COMPLETED|Overall Study||9
8671849|NCT00117507|21407746|P1|STARTED|Overall Study||24
8671856|NCT04411667|21407778|P2|NOT COMPLETED|Overall Study||0
8671857|NCT04411667|21407779|P1|NOT COMPLETED|Overall Study||1
8671858|NCT04411667|21407778|P2|COMPLETED|Overall Study||17
8671859|NCT04411667|21407779|P1|COMPLETED|Overall Study||16
8671860|NCT04411667|21407778|P2|STARTED|Overall Study||17
8671861|NCT04411667|21407779|P1|STARTED|Overall Study||17
8671862|NCT04392362|21407791|P2|NOT COMPLETED|Overall Study||0
8671863|NCT04392362|21407792|P1|NOT COMPLETED|Overall Study||0
8671864|NCT04392362|21407791|P2|COMPLETED|Overall Study||7
8671865|NCT04392362|21407792|P1|COMPLETED|Overall Study||23
8671866|NCT04392362|21407791|P2|STARTED|Overall Study||7
8671867|NCT04392362|21407792|P1|STARTED|Overall Study||23
8671868|NCT04317313|21407800|P2|NOT COMPLETED|Overall Study||0
8671869|NCT04317313|21407801|P1|NOT COMPLETED|Overall Study||0
8671870|NCT04317313|21407800|P2|COMPLETED|Overall Study||62
8671871|NCT04317313|21407801|P1|COMPLETED|Overall Study||100
8671872|NCT04317313|21407800|P2|STARTED|Overall Study||62
8671873|NCT04317313|21407801|P1|STARTED|Overall Study||100
8671874|NCT04151628|21407811|P2|NOT COMPLETED|Overall Study||0
8671875|NCT04151628|21407812|P1|NOT COMPLETED|Overall Study||0
8671876|NCT04151628|21407811|P2|COMPLETED|Overall Study||64
8671877|NCT04151628|21407812|P1|COMPLETED|Overall Study||8
8671878|NCT04151628|21407811|P2|STARTED|Overall Study||64
8671879|NCT04151628|21407812|P1|STARTED|Overall Study||8
8671880|NCT04054765|21407820|P2|NOT COMPLETED|6-month Follow up||32
8671881|NCT04054765|21407821|P1|NOT COMPLETED|6-month Follow up||32
8671882|NCT04054765|21407820|P2|COMPLETED|6-month Follow up||91
8671883|NCT04054765|21407821|P1|COMPLETED|6-month Follow up||110
8671884|NCT04054765|21407820|P2|STARTED|6-month Follow up||123
8671885|NCT04054765|21407821|P1|STARTED|6-month Follow up||142
8671886|NCT04054765|21407820|P2|NOT COMPLETED|3-month Follow up||3
8671887|NCT04054765|21407821|P1|NOT COMPLETED|3-month Follow up||0
8671888|NCT04054765|21407820|P2|COMPLETED|3-month Follow up||123
8671889|NCT04054765|21407821|P1|COMPLETED|3-month Follow up||142
8671890|NCT04054765|21407820|P2|STARTED|3-month Follow up||126
8671891|NCT04054765|21407821|P1|STARTED|3-month Follow up||142
8671892|NCT04054765|21407820|P2|NOT COMPLETED|Post-Gameplay / 1-week Follow up||3
8671893|NCT04054765|21407821|P1|NOT COMPLETED|Post-Gameplay / 1-week Follow up||8
8671894|NCT04054765|21407820|P2|COMPLETED|Post-Gameplay / 1-week Follow up||126
8671895|NCT04054765|21407821|P1|COMPLETED|Post-Gameplay / 1-week Follow up||142
8671896|NCT04054765|21407820|P2|STARTED|Post-Gameplay / 1-week Follow up||129
8671897|NCT04054765|21407821|P1|STARTED|Post-Gameplay / 1-week Follow up||150
8671898|NCT04054765|21407820|P2|NOT COMPLETED|Baseline||3
8671899|NCT04054765|21407821|P1|NOT COMPLETED|Baseline||5
8671900|NCT04054765|21407820|P2|COMPLETED|Baseline||129
8671901|NCT04054765|21407821|P1|COMPLETED|Baseline||150
8671902|NCT04054765|21407820|P2|STARTED|Baseline||132
8671903|NCT04054765|21407821|P1|STARTED|Baseline||155
8671904|NCT03569748|21407871|P2|NOT COMPLETED|Overall Study||9
8671905|NCT03569748|21407872|P1|NOT COMPLETED|Overall Study||0
8671906|NCT03569748|21407871|P2|COMPLETED|Overall Study||101
8671907|NCT03569748|21407872|P1|COMPLETED|Overall Study||110
8671908|NCT03569748|21407871|P2|STARTED|Overall Study||110
8671909|NCT03569748|21407872|P1|STARTED|Overall Study||110
8671910|NCT03472885|21407888|P1|NOT COMPLETED|Overall Study||1
8671911|NCT03472885|21407888|P1|COMPLETED|Overall Study||11
8671912|NCT03472885|21407888|P1|Efficacy Population: Received Study Drug for at Least 4 Weeks|Overall Study||11
8671913|NCT03472885|21407888|P1|Safety Population: Received at Least 1 Dose of Study Drug|Overall Study||12
8671914|NCT03472885|21407888|P1|STARTED|Overall Study||12
8671927|NCT03386344|21407916|P3|NOT COMPLETED|Overall Study||116
8671928|NCT03386344|21407917|P2|NOT COMPLETED|Overall Study||116
8671929|NCT03386344|21407918|P1|NOT COMPLETED|Overall Study||117
8671930|NCT03386344|21407916|P3|COMPLETED|Overall Study||9
8671931|NCT03386344|21407917|P2|COMPLETED|Overall Study||9
8671932|NCT03386344|21407918|P1|COMPLETED|Overall Study||9
8671933|NCT03386344|21407916|P3|STARTED|Overall Study||125
8671934|NCT03386344|21407917|P2|STARTED|Overall Study||125
8671935|NCT03386344|21407918|P1|STARTED|Overall Study||126
8671936|NCT03364309|21407953|P19|NOT COMPLETED|Post-Treatment Followup Period||2
8671937|NCT03364309|21407954|P18|NOT COMPLETED|Post-Treatment Followup Period||31
8671938|NCT03364309|21407955|P17|NOT COMPLETED|Post-Treatment Followup Period||5
8671939|NCT03364309|21407956|P16|NOT COMPLETED|Post-Treatment Followup Period||0
8671940|NCT03364309|21407957|P15|NOT COMPLETED|Post-Treatment Followup Period||0
8671941|NCT03364309|21407958|P14|NOT COMPLETED|Post-Treatment Followup Period||0
8671942|NCT03364309|21407959|P13|NOT COMPLETED|Post-Treatment Followup Period||0
8671943|NCT03364309|21407960|P12|NOT COMPLETED|Post-Treatment Followup Period||0
8671944|NCT03364309|21407961|P11|NOT COMPLETED|Post-Treatment Followup Period||0
8671945|NCT03364309|21407962|P10|NOT COMPLETED|Post-Treatment Followup Period||0
8671946|NCT03364309|21407963|P9|NOT COMPLETED|Post-Treatment Followup Period||0
8671947|NCT03364309|21407964|P8|NOT COMPLETED|Post-Treatment Followup Period||0
8671948|NCT03364309|21407965|P7|NOT COMPLETED|Post-Treatment Followup Period||0
8671949|NCT03364309|21407966|P6|NOT COMPLETED|Post-Treatment Followup Period||0
8671950|NCT03364309|21407967|P5|NOT COMPLETED|Post-Treatment Followup Period||0
8671951|NCT03364309|21407968|P4|NOT COMPLETED|Post-Treatment Followup Period||0
8671952|NCT03364309|21407969|P3|NOT COMPLETED|Post-Treatment Followup Period||0
8671953|NCT03364309|21407970|P2|NOT COMPLETED|Post-Treatment Followup Period||0
8671954|NCT03364309|21407971|P1|NOT COMPLETED|Post-Treatment Followup Period||0
8671955|NCT03364309|21407953|P19|COMPLETED|Post-Treatment Followup Period||0
8671956|NCT03364309|21407954|P18|COMPLETED|Post-Treatment Followup Period||344
8671957|NCT03364309|21407955|P17|COMPLETED|Post-Treatment Followup Period||6
8671958|NCT03364309|21407956|P16|COMPLETED|Post-Treatment Followup Period||0
8671959|NCT03364309|21407957|P15|COMPLETED|Post-Treatment Followup Period||0
8671960|NCT03364309|21407958|P14|COMPLETED|Post-Treatment Followup Period||0
8671961|NCT03364309|21407959|P13|COMPLETED|Post-Treatment Followup Period||0
8671962|NCT03364309|21407960|P12|COMPLETED|Post-Treatment Followup Period||0
8671963|NCT03364309|21407961|P11|COMPLETED|Post-Treatment Followup Period||0
8671964|NCT03364309|21407962|P10|COMPLETED|Post-Treatment Followup Period||0
8671965|NCT03364309|21407963|P9|COMPLETED|Post-Treatment Followup Period||0
8671966|NCT03364309|21407964|P8|COMPLETED|Post-Treatment Followup Period||0
8671967|NCT03364309|21407965|P7|COMPLETED|Post-Treatment Followup Period||0
8671968|NCT03364309|21407966|P6|COMPLETED|Post-Treatment Followup Period||0
8671969|NCT03364309|21407967|P5|COMPLETED|Post-Treatment Followup Period||0
8671970|NCT03364309|21407968|P4|COMPLETED|Post-Treatment Followup Period||0
8671971|NCT03364309|21407969|P3|COMPLETED|Post-Treatment Followup Period||0
8671972|NCT03364309|21407970|P2|COMPLETED|Post-Treatment Followup Period||0
8671973|NCT03364309|21407971|P1|COMPLETED|Post-Treatment Followup Period||0
8671974|NCT03364309|21407953|P19|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|2
8671975|NCT03364309|21407954|P18|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|375
8671976|NCT03364309|21407955|P17|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|11
8671977|NCT03364309|21407956|P16|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
8672207|NCT03327571|21408043|P1|Participants Were Counted in Both Groups|Group 2: RRHL||0
8671978|NCT03364309|21407957|P15|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
8671979|NCT03364309|21407958|P14|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
8671980|NCT03364309|21407959|P13|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
8671981|NCT03364309|21407960|P12|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
8671982|NCT03364309|21407961|P11|STARTED|Post-Treatment Followup Period||0
8671983|NCT03364309|21407962|P10|STARTED|Post-Treatment Followup Period||0
8671984|NCT03364309|21407963|P9|STARTED|Post-Treatment Followup Period||0
8671985|NCT03364309|21407964|P8|STARTED|Post-Treatment Followup Period||0
8671986|NCT03364309|21407965|P7|STARTED|Post-Treatment Followup Period||0
8671987|NCT03364309|21407966|P6|STARTED|Post-Treatment Followup Period||0
8671988|NCT03364309|21407967|P5|STARTED|Post-Treatment Followup Period||0
8671989|NCT03364309|21407968|P4|STARTED|Post-Treatment Followup Period||0
8671990|NCT03364309|21407969|P3|STARTED|Post-Treatment Followup Period||0
8671991|NCT03364309|21407970|P2|STARTED|Post-Treatment Followup Period||0
8671992|NCT03364309|21407971|P1|STARTED|Post-Treatment Followup Period||0
8671993|NCT03364309|21407953|P19|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8671994|NCT03364309|21407954|P18|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8671995|NCT03364309|21407955|P17|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8671996|NCT03364309|21407956|P16|NOT COMPLETED|Re-treatment (Maintenance) Period||2
8671997|NCT03364309|21407957|P15|NOT COMPLETED|Re-treatment (Maintenance) Period||2
8671998|NCT03364309|21407958|P14|NOT COMPLETED|Re-treatment (Maintenance) Period||1
8671999|NCT03364309|21407959|P13|NOT COMPLETED|Re-treatment (Maintenance) Period||1
8672000|NCT03364309|21407960|P12|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8672001|NCT03364309|21407961|P11|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8672002|NCT03364309|21407962|P10|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8672003|NCT03364309|21407963|P9|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8672004|NCT03364309|21407964|P8|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8672005|NCT03364309|21407965|P7|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8672006|NCT03364309|21407966|P6|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8672007|NCT03364309|21407967|P5|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8672008|NCT03364309|21407968|P4|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8672009|NCT03364309|21407969|P3|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8672010|NCT03364309|21407970|P2|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8672011|NCT03364309|21407971|P1|NOT COMPLETED|Re-treatment (Maintenance) Period||0
8672012|NCT03364309|21407953|P19|COMPLETED|Re-treatment (Maintenance) Period||0
8672013|NCT03364309|21407954|P18|COMPLETED|Re-treatment (Maintenance) Period||0
8672014|NCT03364309|21407955|P17|COMPLETED|Re-treatment (Maintenance) Period||0
8672015|NCT03364309|21407956|P16|COMPLETED|Re-treatment (Maintenance) Period||8
8672016|NCT03364309|21407957|P15|COMPLETED|Re-treatment (Maintenance) Period||43
8672017|NCT03364309|21407958|P14|COMPLETED|Re-treatment (Maintenance) Period||6
8672018|NCT03364309|21407959|P13|COMPLETED|Re-treatment (Maintenance) Period||42
8672019|NCT03364309|21407960|P12|COMPLETED|Re-treatment (Maintenance) Period||2
8672020|NCT03364309|21407961|P11|COMPLETED|Re-treatment (Maintenance) Period||0
8672021|NCT03364309|21407962|P10|COMPLETED|Re-treatment (Maintenance) Period||0
8672022|NCT03364309|21407963|P9|COMPLETED|Re-treatment (Maintenance) Period||0
8672023|NCT03364309|21407964|P8|COMPLETED|Re-treatment (Maintenance) Period||0
8672024|NCT03364309|21407965|P7|COMPLETED|Re-treatment (Maintenance) Period||0
8672025|NCT03364309|21407966|P6|COMPLETED|Re-treatment (Maintenance) Period||0
8672026|NCT03364309|21407967|P5|COMPLETED|Re-treatment (Maintenance) Period||0
8672027|NCT03364309|21407968|P4|COMPLETED|Re-treatment (Maintenance) Period||0
8672028|NCT03364309|21407969|P3|COMPLETED|Re-treatment (Maintenance) Period||0
8672029|NCT03364309|21407970|P2|COMPLETED|Re-treatment (Maintenance) Period||0
8672030|NCT03364309|21407971|P1|COMPLETED|Re-treatment (Maintenance) Period||0
8672031|NCT03364309|21407953|P19|STARTED|Re-treatment (Maintenance) Period||0
8672032|NCT03364309|21407954|P18|STARTED|Re-treatment (Maintenance) Period||0
8672033|NCT03364309|21407955|P17|STARTED|Re-treatment (Maintenance) Period||0
8672034|NCT03364309|21407956|P16|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|10
8672035|NCT03364309|21407957|P15|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|45
8672036|NCT03364309|21407958|P14|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|7
8672037|NCT03364309|21407959|P13|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|43
8672038|NCT03364309|21407960|P12|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|2
8672039|NCT03364309|21407961|P11|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
8672040|NCT03364309|21407962|P10|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
8672041|NCT03364309|21407963|P9|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
8672042|NCT03364309|21407964|P8|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
8672043|NCT03364309|21407965|P7|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
8672044|NCT03364309|21407966|P6|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
8672045|NCT03364309|21407967|P5|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
8672301|NCT03031938|21408387|P1|STARTED|Overall Study||2
8672046|NCT03364309|21407968|P4|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
8672047|NCT03364309|21407969|P3|STARTED|Re-treatment (Maintenance) Period||0
8672048|NCT03364309|21407970|P2|STARTED|Re-treatment (Maintenance) Period||0
8672049|NCT03364309|21407971|P1|STARTED|Re-treatment (Maintenance) Period||0
8672050|NCT03364309|21407953|P19|NOT COMPLETED|Maintenance Period||0
8672051|NCT03364309|21407954|P18|NOT COMPLETED|Maintenance Period||0
8672052|NCT03364309|21407955|P17|NOT COMPLETED|Maintenance Period||0
8672053|NCT03364309|21407956|P16|NOT COMPLETED|Maintenance Period||0
8672054|NCT03364309|21407957|P15|NOT COMPLETED|Maintenance Period||0
8672055|NCT03364309|21407958|P14|NOT COMPLETED|Maintenance Period||0
8672056|NCT03364309|21407959|P13|NOT COMPLETED|Maintenance Period||0
8672057|NCT03364309|21407960|P12|NOT COMPLETED|Maintenance Period||0
8672058|NCT03364309|21407961|P11|NOT COMPLETED|Maintenance Period||6
8672059|NCT03364309|21407962|P10|NOT COMPLETED|Maintenance Period||4
8672060|NCT03364309|21407963|P9|NOT COMPLETED|Maintenance Period||6
8672061|NCT03364309|21407964|P8|NOT COMPLETED|Maintenance Period||2
8672062|NCT03364309|21407965|P7|NOT COMPLETED|Maintenance Period||16
8672063|NCT03364309|21407966|P6|NOT COMPLETED|Maintenance Period||46
8672064|NCT03364309|21407967|P5|NOT COMPLETED|Maintenance Period||12
8672065|NCT03364309|21407968|P4|NOT COMPLETED|Maintenance Period||44
8672066|NCT03364309|21407969|P3|NOT COMPLETED|Maintenance Period||0
8672067|NCT03364309|21407970|P2|NOT COMPLETED|Maintenance Period||0
8672068|NCT03364309|21407971|P1|NOT COMPLETED|Maintenance Period||0
8672069|NCT03364309|21407953|P19|COMPLETED|Maintenance Period||0
8672070|NCT03364309|21407954|P18|COMPLETED|Maintenance Period||0
8672071|NCT03364309|21407955|P17|COMPLETED|Maintenance Period||0
8672072|NCT03364309|21407956|P16|COMPLETED|Maintenance Period||0
8672073|NCT03364309|21407957|P15|COMPLETED|Maintenance Period||0
8672074|NCT03364309|21407958|P14|COMPLETED|Maintenance Period||0
8672075|NCT03364309|21407959|P13|COMPLETED|Maintenance Period||0
8672076|NCT03364309|21407960|P12|COMPLETED|Maintenance Period||0
8672077|NCT03364309|21407961|P11|COMPLETED|Maintenance Period||17
8672078|NCT03364309|21407962|P10|COMPLETED|Maintenance Period||27
8672079|NCT03364309|21407963|P9|COMPLETED|Maintenance Period||73
8672080|NCT03364309|21407964|P8|COMPLETED|Maintenance Period||1
8672081|NCT03364309|21407965|P7|COMPLETED|Maintenance Period||84
8672082|NCT03364309|21407966|P6|COMPLETED|Maintenance Period||4
8672083|NCT03364309|21407967|P5|COMPLETED|Maintenance Period||80
8672084|NCT03364309|21407968|P4|COMPLETED|Maintenance Period||3
8672085|NCT03364309|21407969|P3|COMPLETED|Maintenance Period||0
8672086|NCT03364309|21407970|P2|COMPLETED|Maintenance Period||0
8672087|NCT03364309|21407971|P1|COMPLETED|Maintenance Period||0
8672088|NCT03364309|21407953|P19|Received at Least One Dose of Study Drug|Maintenance Period||0
8672089|NCT03364309|21407954|P18|Received at Least One Dose of Study Drug|Maintenance Period||0
8672090|NCT03364309|21407955|P17|Received at Least One Dose of Study Drug|Maintenance Period||0
8672091|NCT03364309|21407956|P16|Received at Least One Dose of Study Drug|Maintenance Period||0
8672092|NCT03364309|21407957|P15|Received at Least One Dose of Study Drug|Maintenance Period||0
8672093|NCT03364309|21407958|P14|Received at Least One Dose of Study Drug|Maintenance Period||0
8672094|NCT03364309|21407959|P13|Received at Least One Dose of Study Drug|Maintenance Period||0
8672095|NCT03364309|21407960|P12|Received at Least One Dose of Study Drug|Maintenance Period||0
8672096|NCT03364309|21407961|P11|Received at Least One Dose of Study Drug|Maintenance Period||23
8672097|NCT03364309|21407962|P10|Received at Least One Dose of Study Drug|Maintenance Period||31
8672098|NCT03364309|21407963|P9|Received at Least One Dose of Study Drug|Maintenance Period||79
8672099|NCT03364309|21407964|P8|Received at Least One Dose of Study Drug|Maintenance Period||3
8672100|NCT03364309|21407965|P7|Received at Least One Dose of Study Drug|Maintenance Period||100
8672101|NCT03364309|21407966|P6|Received at Least One Dose of Study Drug|Maintenance Period||50
8672102|NCT03364309|21407967|P5|Received at Least One Dose of Study Drug|Maintenance Period||92
8672103|NCT03364309|21407968|P4|Received at Least One Dose of Study Drug|Maintenance Period||47
8672104|NCT03364309|21407969|P3|Received at Least One Dose of Study Drug|Maintenance Period||0
8672105|NCT03364309|21407970|P2|Received at Least One Dose of Study Drug|Maintenance Period||0
8672106|NCT03364309|21407971|P1|Received at Least One Dose of Study Drug|Maintenance Period||0
8672107|NCT03364309|21407953|P19|STARTED|Maintenance Period||0
8672108|NCT03364309|21407954|P18|STARTED|Maintenance Period||0
8672109|NCT03364309|21407955|P17|STARTED|Maintenance Period||0
8672110|NCT03364309|21407956|P16|STARTED|Maintenance Period||0
8672111|NCT03364309|21407957|P15|STARTED|Maintenance Period||0
8672112|NCT03364309|21407958|P14|STARTED|Maintenance Period||0
8672113|NCT03364309|21407959|P13|STARTED|Maintenance Period||0
8672114|NCT03364309|21407960|P12|STARTED|Maintenance Period||0
8672115|NCT03364309|21407961|P11|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|23
8672116|NCT03364309|21407962|P10|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|31
8672117|NCT03364309|21407963|P9|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|79
8672118|NCT03364309|21407964|P8|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|3
8672119|NCT03364309|21407965|P7|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|100
8672120|NCT03364309|21407966|P6|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|50
8672121|NCT03364309|21407967|P5|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|92
8672122|NCT03364309|21407968|P4|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|47
8672302|NCT03020615|21408546|P3|NOT COMPLETED|Overall Study||7
8672123|NCT03364309|21407969|P3|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
8672124|NCT03364309|21407970|P2|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
8672125|NCT03364309|21407971|P1|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
8672126|NCT03364309|21407953|P19|NOT COMPLETED|Induction Period||0
8672127|NCT03364309|21407954|P18|NOT COMPLETED|Induction Period||0
8672128|NCT03364309|21407955|P17|NOT COMPLETED|Induction Period||0
8672129|NCT03364309|21407956|P16|NOT COMPLETED|Induction Period||0
8672130|NCT03364309|21407957|P15|NOT COMPLETED|Induction Period||0
8672131|NCT03364309|21407958|P14|NOT COMPLETED|Induction Period||0
8672132|NCT03364309|21407959|P13|NOT COMPLETED|Induction Period||0
8672133|NCT03364309|21407960|P12|NOT COMPLETED|Induction Period||0
8672134|NCT03364309|21407961|P11|NOT COMPLETED|Induction Period||0
8672135|NCT03364309|21407962|P10|NOT COMPLETED|Induction Period||0
8672136|NCT03364309|21407963|P9|NOT COMPLETED|Induction Period||0
8672137|NCT03364309|21407964|P8|NOT COMPLETED|Induction Period||0
8672138|NCT03364309|21407965|P7|NOT COMPLETED|Induction Period||0
8672139|NCT03364309|21407966|P6|NOT COMPLETED|Induction Period||0
8672140|NCT03364309|21407967|P5|NOT COMPLETED|Induction Period||0
8672141|NCT03364309|21407968|P4|NOT COMPLETED|Induction Period||0
8672142|NCT03364309|21407969|P3|NOT COMPLETED|Induction Period||1
8672143|NCT03364309|21407970|P2|NOT COMPLETED|Induction Period||4
8672144|NCT03364309|21407971|P1|NOT COMPLETED|Induction Period||6
8672145|NCT03364309|21407953|P19|COMPLETED|Induction Period||0
8672146|NCT03364309|21407954|P18|COMPLETED|Induction Period||0
8672147|NCT03364309|21407955|P17|COMPLETED|Induction Period||0
8672148|NCT03364309|21407956|P16|COMPLETED|Induction Period||0
8672149|NCT03364309|21407957|P15|COMPLETED|Induction Period||0
8672150|NCT03364309|21407958|P14|COMPLETED|Induction Period||0
8672151|NCT03364309|21407959|P13|COMPLETED|Induction Period||0
8672152|NCT03364309|21407960|P12|COMPLETED|Induction Period||0
8672153|NCT03364309|21407961|P11|COMPLETED|Induction Period||0
8672154|NCT03364309|21407962|P10|COMPLETED|Induction Period||0
8672155|NCT03364309|21407963|P9|COMPLETED|Induction Period||0
8672156|NCT03364309|21407964|P8|COMPLETED|Induction Period||0
8672157|NCT03364309|21407965|P7|COMPLETED|Induction Period||0
8672158|NCT03364309|21407966|P6|COMPLETED|Induction Period||0
8672159|NCT03364309|21407967|P5|COMPLETED|Induction Period||0
8672160|NCT03364309|21407968|P4|COMPLETED|Induction Period||0
8672161|NCT03364309|21407969|P3|COMPLETED|Induction Period||175
8672162|NCT03364309|21407970|P2|COMPLETED|Induction Period||170
8672163|NCT03364309|21407971|P1|COMPLETED|Induction Period||82
8672164|NCT03364309|21407953|P19|Received at Least One Dose of Study Drug|Induction Period||0
8672165|NCT03364309|21407954|P18|Received at Least One Dose of Study Drug|Induction Period||0
8672166|NCT03364309|21407955|P17|Received at Least One Dose of Study Drug|Induction Period||0
8672167|NCT03364309|21407956|P16|Received at Least One Dose of Study Drug|Induction Period||0
8672168|NCT03364309|21407957|P15|Received at Least One Dose of Study Drug|Induction Period||0
8672169|NCT03364309|21407958|P14|Received at Least One Dose of Study Drug|Induction Period||0
8672170|NCT03364309|21407959|P13|Received at Least One Dose of Study Drug|Induction Period||0
8672171|NCT03364309|21407960|P12|Received at Least One Dose of Study Drug|Induction Period||0
8672172|NCT03364309|21407961|P11|Received at Least One Dose of Study Drug|Induction Period||0
8672173|NCT03364309|21407962|P10|Received at Least One Dose of Study Drug|Induction Period||0
8672174|NCT03364309|21407963|P9|Received at Least One Dose of Study Drug|Induction Period||0
8672175|NCT03364309|21407964|P8|Received at Least One Dose of Study Drug|Induction Period||0
8672176|NCT03364309|21407965|P7|Received at Least One Dose of Study Drug|Induction Period||0
8672177|NCT03364309|21407966|P6|Received at Least One Dose of Study Drug|Induction Period||0
8672178|NCT03364309|21407967|P5|Received at Least One Dose of Study Drug|Induction Period||0
8672179|NCT03364309|21407968|P4|Received at Least One Dose of Study Drug|Induction Period||0
8672180|NCT03364309|21407969|P3|Received at Least One Dose of Study Drug|Induction Period||176
8672181|NCT03364309|21407970|P2|Received at Least One Dose of Study Drug|Induction Period||174
8672182|NCT03364309|21407971|P1|Received at Least One Dose of Study Drug|Induction Period||88
8672183|NCT03364309|21407953|P19|STARTED|Induction Period||0
8672184|NCT03364309|21407954|P18|STARTED|Induction Period||0
8672185|NCT03364309|21407955|P17|STARTED|Induction Period||0
8672186|NCT03364309|21407956|P16|STARTED|Induction Period||0
8672187|NCT03364309|21407957|P15|STARTED|Induction Period||0
8672188|NCT03364309|21407958|P14|STARTED|Induction Period||0
8672189|NCT03364309|21407959|P13|STARTED|Induction Period||0
8672190|NCT03364309|21407960|P12|STARTED|Induction Period||0
8672191|NCT03364309|21407961|P11|STARTED|Induction Period||0
8672192|NCT03364309|21407962|P10|STARTED|Induction Period||0
8672193|NCT03364309|21407963|P9|STARTED|Induction Period||0
8672194|NCT03364309|21407964|P8|STARTED|Induction Period||0
8672195|NCT03364309|21407965|P7|STARTED|Induction Period||0
8672196|NCT03364309|21407966|P6|STARTED|Induction Period||0
8672197|NCT03364309|21407967|P5|STARTED|Induction Period||0
8672198|NCT03364309|21407968|P4|STARTED|Induction Period||0
8672199|NCT03364309|21407969|P3|STARTED|Induction Period||176
8672200|NCT03364309|21407970|P2|STARTED|Induction Period||174
8672201|NCT03364309|21407971|P1|STARTED|Induction Period||88
8672202|NCT03327571|21408042|P2|NOT COMPLETED|Group 2: RRHL||0
8672203|NCT03327571|21408043|P1|NOT COMPLETED|Group 2: RRHL||0
8672204|NCT03327571|21408042|P2|COMPLETED|Group 2: RRHL||426
8672205|NCT03327571|21408043|P1|COMPLETED|Group 2: RRHL||0
8672206|NCT03327571|21408042|P2|Participants Were Counted in Both Groups|Group 2: RRHL|Participants who were diagnosed with CHL, and subsequently RRHL between 2010 and 2013.|321
8672208|NCT03327571|21408042|P2|STARTED|Group 2: RRHL|105 RRHL only participants and 321 common participants who had CHL, and subsequently RRHL between 2010-2013.|426
8672209|NCT03327571|21408043|P1|STARTED|Group 2: RRHL||0
8672210|NCT03327571|21408042|P2|NOT COMPLETED|Group 1: cHL||0
8672211|NCT03327571|21408043|P1|NOT COMPLETED|Group 1: cHL||0
8672212|NCT03327571|21408042|P2|COMPLETED|Group 1: cHL||0
8672213|NCT03327571|21408043|P1|COMPLETED|Group 1: cHL||1598
8672214|NCT03327571|21408042|P2|STARTED|Group 1: cHL||0
8672215|NCT03327571|21408043|P1|STARTED|Group 1: cHL||1598
8672233|NCT03242252|21408194|P3|NOT COMPLETED|Overall Study||32
8672234|NCT03242252|21408195|P2|NOT COMPLETED|Overall Study||23
8672235|NCT03242252|21408196|P1|NOT COMPLETED|Overall Study||36
8672236|NCT03242252|21408194|P3|COMPLETED|Overall Study||232
8672237|NCT03242252|21408195|P2|COMPLETED|Overall Study||240
8672238|NCT03242252|21408196|P1|COMPLETED|Overall Study||224
8672239|NCT03242252|21408194|P3|STARTED|Overall Study||264
8672240|NCT03242252|21408195|P2|STARTED|Overall Study||263
8672241|NCT03242252|21408196|P1|STARTED|Overall Study||260
8672242|NCT03242018|21408234|P3|NOT COMPLETED|Overall Study||14
8672243|NCT03242018|21408235|P2|NOT COMPLETED|Overall Study||14
8672244|NCT03242018|21408236|P1|NOT COMPLETED|Overall Study||18
8672245|NCT03242018|21408234|P3|COMPLETED|Overall Study||78
8672246|NCT03242018|21408235|P2|COMPLETED|Overall Study||78
8672247|NCT03242018|21408236|P1|COMPLETED|Overall Study||75
8672248|NCT03242018|21408234|P3|STARTED|Overall Study||92
8672249|NCT03242018|21408235|P2|STARTED|Overall Study||92
8672250|NCT03242018|21408236|P1|STARTED|Overall Study||93
8672263|NCT03069716|21408286|P3|NOT COMPLETED|Randomized Treatment||0
8672264|NCT03069716|21408287|P2|NOT COMPLETED|Randomized Treatment||2
8672265|NCT03069716|21408288|P1|NOT COMPLETED|Randomized Treatment||0
8672266|NCT03069716|21408286|P3|COMPLETED|Randomized Treatment||22
8672267|NCT03069716|21408287|P2|COMPLETED|Randomized Treatment||18
8672268|NCT03069716|21408288|P1|COMPLETED|Randomized Treatment||0
8672269|NCT03069716|21408286|P3|STARTED|Randomized Treatment||22
8672270|NCT03069716|21408287|P2|STARTED|Randomized Treatment||20
8672271|NCT03069716|21408288|P1|STARTED|Randomized Treatment||0
8672272|NCT03069716|21408286|P3|NOT COMPLETED|Run-in Period (2 Weeks)||0
8672273|NCT03069716|21408287|P2|NOT COMPLETED|Run-in Period (2 Weeks)||0
8672274|NCT03069716|21408288|P1|NOT COMPLETED|Run-in Period (2 Weeks)||7
8672275|NCT03069716|21408286|P3|COMPLETED|Run-in Period (2 Weeks)||0
8672276|NCT03069716|21408287|P2|COMPLETED|Run-in Period (2 Weeks)||0
8672277|NCT03069716|21408288|P1|COMPLETED|Run-in Period (2 Weeks)||42
8672278|NCT03069716|21408286|P3|STARTED|Run-in Period (2 Weeks)||0
8672279|NCT03069716|21408287|P2|STARTED|Run-in Period (2 Weeks)||0
8672280|NCT03069716|21408288|P1|STARTED|Run-in Period (2 Weeks)||49
8672281|NCT03049917|21408327|P5|NOT COMPLETED|Overall Study||34
8672282|NCT03049917|21408328|P4|NOT COMPLETED|Overall Study||41
8672283|NCT03049917|21408329|P3|NOT COMPLETED|Overall Study||49
8672284|NCT03049917|21408330|P2|NOT COMPLETED|Overall Study||58
8672285|NCT03049917|21408331|P1|NOT COMPLETED|Overall Study||59
8672286|NCT03049917|21408327|P5|COMPLETED|Overall Study||54
8672287|NCT03049917|21408328|P4|COMPLETED|Overall Study||51
8672288|NCT03049917|21408329|P3|COMPLETED|Overall Study||44
8672289|NCT03049917|21408330|P2|COMPLETED|Overall Study||31
8672290|NCT03049917|21408331|P1|COMPLETED|Overall Study||31
8672291|NCT03049917|21408327|P5|STARTED|Overall Study||88
8672292|NCT03049917|21408328|P4|STARTED|Overall Study||92
8672293|NCT03049917|21408329|P3|STARTED|Overall Study||93
8672294|NCT03049917|21408330|P2|STARTED|Overall Study||89
8672295|NCT03049917|21408331|P1|STARTED|Overall Study||90
8672296|NCT03031938|21408386|P2|NOT COMPLETED|Overall Study||0
8672297|NCT03031938|21408387|P1|NOT COMPLETED|Overall Study||1
8672298|NCT03031938|21408386|P2|COMPLETED|Overall Study||2
8672299|NCT03031938|21408387|P1|COMPLETED|Overall Study||1
8672300|NCT03031938|21408386|P2|STARTED|Overall Study||2
8672303|NCT03020615|21408547|P2|NOT COMPLETED|Overall Study||2
8672304|NCT03020615|21408548|P1|NOT COMPLETED|Overall Study||7
8672305|NCT03020615|21408546|P3|COMPLETED|Overall Study||0
8672306|NCT03020615|21408547|P2|COMPLETED|Overall Study||23
8672307|NCT03020615|21408548|P1|COMPLETED|Overall Study||19
8672308|NCT03020615|21408546|P3|STARTED|Overall Study||7
8672309|NCT03020615|21408547|P2|STARTED|Overall Study||25
8672310|NCT03020615|21408548|P1|STARTED|Overall Study||26
8672311|NCT02968420|21408649|P3|NOT COMPLETED|Overall Study||0
8672312|NCT02968420|21408650|P2|NOT COMPLETED|Overall Study||0
8672313|NCT02968420|21408651|P1|NOT COMPLETED|Overall Study||0
8672314|NCT02968420|21408649|P3|COMPLETED|Overall Study||6
8672315|NCT02968420|21408650|P2|COMPLETED|Overall Study||6
8672316|NCT02968420|21408651|P1|COMPLETED|Overall Study||6
8672317|NCT02968420|21408649|P3|STARTED|Overall Study||6
8672318|NCT02968420|21408650|P2|STARTED|Overall Study||6
8672319|NCT02968420|21408651|P1|STARTED|Overall Study||6
8672320|NCT02968004|21408679|P2|NOT COMPLETED|Overall Study||1
8672321|NCT02968004|21408680|P1|NOT COMPLETED|Overall Study||1
8672322|NCT02968004|21408679|P2|COMPLETED|Overall Study||114
8672323|NCT02968004|21408680|P1|COMPLETED|Overall Study||108
8672324|NCT02968004|21408679|P2|STARTED|Overall Study||115
8672325|NCT02968004|21408680|P1|STARTED|Overall Study||109
8672326|NCT02939781|21408695|P1|NOT COMPLETED|Overall Study||9
8672327|NCT02939781|21408695|P1|COMPLETED|Overall Study||3
8672328|NCT02939781|21408695|P1|STARTED|Overall Study||12
8672329|NCT02751827|21408703|P3|NOT COMPLETED|Overall Study||1
8672330|NCT02751827|21408704|P2|NOT COMPLETED|Overall Study||0
8672331|NCT02751827|21408705|P1|NOT COMPLETED|Overall Study||0
8672332|NCT02751827|21408703|P3|COMPLETED|Overall Study||99
8672333|NCT02751827|21408704|P2|COMPLETED|Overall Study||171
8672334|NCT02751827|21408705|P1|COMPLETED|Overall Study||41
8672335|NCT02751827|21408703|P3|STARTED|Overall Study||100
8672336|NCT02751827|21408704|P2|STARTED|Overall Study||171
8672337|NCT02751827|21408705|P1|STARTED|Overall Study||41
8672338|NCT02694185|21408715|P2|NOT COMPLETED|Overall Study||0
8672339|NCT02694185|21408716|P1|NOT COMPLETED|Overall Study||45
8672340|NCT02694185|21408715|P2|COMPLETED|Overall Study||4793
8672341|NCT02694185|21408716|P1|COMPLETED|Overall Study||431
8672342|NCT02694185|21408715|P2|STARTED|Overall Study||4793
8672343|NCT02694185|21408716|P1|STARTED|Overall Study||476
8672344|NCT02561247|21408726|P1|NOT COMPLETED|Overall Study||6
8672345|NCT02561247|21408726|P1|COMPLETED|Overall Study||17
8672346|NCT02561247|21408726|P1|STARTED|Overall Study||23
8672347|NCT02542150|21408736|P2|NOT COMPLETED|Overall Study||0
8672348|NCT02542150|21408737|P1|NOT COMPLETED|Overall Study||0
8672349|NCT02542150|21408736|P2|COMPLETED|Overall Study||12
8672350|NCT02542150|21408737|P1|COMPLETED|Overall Study||12
8672351|NCT02542150|21408736|P2|Started Intervention|Overall Study||12
8672352|NCT02542150|21408737|P1|Started Intervention|Overall Study||12
8672353|NCT02542150|21408736|P2|Completed Placebo|Overall Study||12
8672354|NCT02542150|21408737|P1|Completed Placebo|Overall Study||12
8672355|NCT02542150|21408736|P2|STARTED|Overall Study||12
8672356|NCT02542150|21408737|P1|STARTED|Overall Study||12
8672393|NCT02272634|21408818|P3|NOT COMPLETED|Overall Study||1
8672394|NCT02272634|21408819|P2|NOT COMPLETED|Overall Study||1
8672395|NCT02272634|21408820|P1|NOT COMPLETED|Overall Study||1
8672396|NCT02272634|21408818|P3|COMPLETED|Overall Study||19
8672397|NCT02272634|21408819|P2|COMPLETED|Overall Study||20
8672398|NCT02272634|21408820|P1|COMPLETED|Overall Study||19
8672399|NCT02272634|21408818|P3|STARTED|Overall Study||20
8672400|NCT02272634|21408819|P2|STARTED|Overall Study||21
8672401|NCT02272634|21408820|P1|STARTED|Overall Study||20
8672402|NCT02255097|21408882|P1|NOT COMPLETED|Overall Study||172
8672403|NCT02255097|21408882|P1|COMPLETED|Overall Study||0
8672404|NCT02255097|21408882|P1|Treated|Overall Study||171
8672405|NCT02255097|21408882|P1|STARTED|Overall Study||172
8672406|NCT02169219|21408903|P1|NOT COMPLETED|Overall Study||6
8672407|NCT02169219|21408903|P1|COMPLETED|Overall Study||14
8672408|NCT02169219|21408903|P1|STARTED|Overall Study||20
8672409|NCT01999946|21408917|P3|NOT COMPLETED|Overall Study||79
8672410|NCT01999946|21408918|P2|NOT COMPLETED|Overall Study||2
8672411|NCT01999946|21408919|P1|NOT COMPLETED|Overall Study||2
8672412|NCT01999946|21408917|P3|COMPLETED|Overall Study||0
8672413|NCT01999946|21408918|P2|COMPLETED|Overall Study||56
8672414|NCT01999946|21408919|P1|COMPLETED|Overall Study||59
8672415|NCT01999946|21408917|P3|STARTED|Overall Study||79
8672416|NCT01999946|21408918|P2|STARTED|Overall Study||58
8672417|NCT01999946|21408919|P1|STARTED|Overall Study||61
8672418|NCT01855412|21408929|P3|NOT COMPLETED|Overall Study||76
8672419|NCT01855412|21408930|P2|NOT COMPLETED|Overall Study||343
8672420|NCT01855412|21408931|P1|NOT COMPLETED|Overall Study||212
8672421|NCT01855412|21408929|P3|COMPLETED|Overall Study||24
8672422|NCT01855412|21408930|P2|COMPLETED|Overall Study||260
8672423|NCT01855412|21408931|P1|COMPLETED|Overall Study||289
8672424|NCT01855412|21408929|P3|STARTED|Overall Study||100
8672425|NCT01855412|21408930|P2|STARTED|Overall Study||603
8672426|NCT01855412|21408931|P1|STARTED|Overall Study||501
8672427|NCT01814332|21408953|P2|NOT COMPLETED|Overall Study||16
8672428|NCT01814332|21408954|P1|NOT COMPLETED|Overall Study||16
8672429|NCT01814332|21408953|P2|COMPLETED|Overall Study||49
8672430|NCT01814332|21408954|P1|COMPLETED|Overall Study||47
8672431|NCT01814332|21408953|P2|STARTED|Overall Study||65
8672432|NCT01814332|21408954|P1|STARTED|Overall Study||63
8672463|NCT01275222|21409008|P6|NOT COMPLETED|Phase ll by Stratum||46
8672464|NCT01275222|21409009|P5|NOT COMPLETED|Phase ll by Stratum||28
8672465|NCT01275222|21409010|P4|NOT COMPLETED|Phase ll by Stratum||0
8672466|NCT01275222|21409011|P3|NOT COMPLETED|Phase ll by Stratum||0
8672467|NCT01275222|21409012|P2|NOT COMPLETED|Phase ll by Stratum||0
8672468|NCT01275222|21409013|P1|NOT COMPLETED|Phase ll by Stratum||0
8672469|NCT01275222|21409008|P6|COMPLETED|Phase ll by Stratum||1
8672470|NCT01275222|21409009|P5|COMPLETED|Phase ll by Stratum||0
8672471|NCT01275222|21409010|P4|COMPLETED|Phase ll by Stratum||0
8672472|NCT01275222|21409011|P3|COMPLETED|Phase ll by Stratum||0
8672473|NCT01275222|21409012|P2|COMPLETED|Phase ll by Stratum||0
8672474|NCT01275222|21409013|P1|COMPLETED|Phase ll by Stratum||0
8672475|NCT01275222|21409008|P6|STARTED|Phase ll by Stratum||47
8672476|NCT01275222|21409009|P5|STARTED|Phase ll by Stratum||28
8672477|NCT01275222|21409010|P4|STARTED|Phase ll by Stratum||0
8672478|NCT01275222|21409011|P3|STARTED|Phase ll by Stratum||0
8672479|NCT01275222|21409012|P2|STARTED|Phase ll by Stratum||0
8672480|NCT01275222|21409013|P1|STARTED|Phase ll by Stratum||0
8672481|NCT01275222|21409008|P6|NOT COMPLETED|Phase l by Treatment||0
8672482|NCT01275222|21409009|P5|NOT COMPLETED|Phase l by Treatment||0
8672483|NCT01275222|21409010|P4|NOT COMPLETED|Phase l by Treatment||11
8672484|NCT01275222|21409011|P3|NOT COMPLETED|Phase l by Treatment||5
8672485|NCT01275222|21409012|P2|NOT COMPLETED|Phase l by Treatment||13
8672486|NCT01275222|21409013|P1|NOT COMPLETED|Phase l by Treatment||13
8672487|NCT01275222|21409008|P6|COMPLETED|Phase l by Treatment||0
8672488|NCT01275222|21409009|P5|COMPLETED|Phase l by Treatment||0
8672489|NCT01275222|21409010|P4|COMPLETED|Phase l by Treatment||0
8672490|NCT01275222|21409011|P3|COMPLETED|Phase l by Treatment||0
8672491|NCT01275222|21409012|P2|COMPLETED|Phase l by Treatment||0
8672492|NCT01275222|21409013|P1|COMPLETED|Phase l by Treatment||0
8672493|NCT01275222|21409008|P6|STARTED|Phase l by Treatment||0
8672494|NCT01275222|21409009|P5|STARTED|Phase l by Treatment||0
8672495|NCT01275222|21409010|P4|STARTED|Phase l by Treatment||11
8672496|NCT01275222|21409011|P3|STARTED|Phase l by Treatment||5
8672497|NCT01275222|21409012|P2|STARTED|Phase l by Treatment||13
8672498|NCT01275222|21409013|P1|STARTED|Phase l by Treatment||13
8672499|NCT00978874|21409069|P1|NOT COMPLETED|Overall Study||0
8672500|NCT00978874|21409069|P1|COMPLETED|Overall Study|The study was terminated and no data are available to be reported|0
8672501|NCT00978874|21409069|P1|STARTED|Overall Study|The study was terminated and no data are available to be reported|0
8672502|NCT00928135|21409075|P2|NOT COMPLETED|Overall Study||0
8672503|NCT00928135|21409076|P1|NOT COMPLETED|Overall Study||1
8672504|NCT00928135|21409075|P2|COMPLETED|Overall Study||30
8672505|NCT00928135|21409076|P1|COMPLETED|Overall Study||29
8672506|NCT00928135|21409075|P2|STARTED|Overall Study||30
8672507|NCT00928135|21409076|P1|STARTED|Overall Study||30
8672508|NCT00878072|21409086|P1|NOT COMPLETED|Overall Study||2
8672509|NCT00878072|21409086|P1|COMPLETED|Overall Study||51
8672510|NCT00878072|21409086|P1|STARTED|Overall Study||53
8672511|NCT00695110|21409106|P1|NOT COMPLETED|Treatment Period 4||1
8672512|NCT00695110|21409106|P1|COMPLETED|Treatment Period 4||24
8672513|NCT00695110|21409106|P1|STARTED|Treatment Period 4||25
8672514|NCT00695110|21409106|P1|NOT COMPLETED|Treatment Period 3||1
8672515|NCT00695110|21409106|P1|COMPLETED|Treatment Period 3||25
8672516|NCT00695110|21409106|P1|STARTED|Treatment Period 3||26
8672517|NCT00695110|21409106|P1|NOT COMPLETED|Treatment Period 2||0
8672518|NCT00695110|21409106|P1|COMPLETED|Treatment Period 2||26
8672519|NCT00695110|21409106|P1|STARTED|Treatment Period 2||26
8672520|NCT00695110|21409106|P1|NOT COMPLETED|Treatment Period 1||3
8672521|NCT00695110|21409106|P1|COMPLETED|Treatment Period 1||26
8672522|NCT00695110|21409106|P1|STARTED|Treatment Period 1||29
8672523|NCT00665392|21409117|P1|NOT COMPLETED|Overall Study||1
8672524|NCT00665392|21409117|P1|COMPLETED|Overall Study||41
8672525|NCT00665392|21409117|P1|STARTED|Overall Study||42
8672526|NCT00664066|21409127|P1|NOT COMPLETED|Overall Study||3
8672527|NCT00664066|21409127|P1|COMPLETED|Overall Study||0
8672528|NCT00664066|21409127|P1|STARTED|Overall Study||3
8672529|NCT00455403|21409133|P2|NOT COMPLETED|Overall Study||6
8672530|NCT00455403|21409134|P1|NOT COMPLETED|Overall Study||3
8672531|NCT00455403|21409133|P2|COMPLETED|Overall Study||51
8672532|NCT00455403|21409134|P1|COMPLETED|Overall Study||56
8672533|NCT00455403|21409133|P2|STARTED|Overall Study||57
8672534|NCT00455403|21409134|P1|STARTED|Overall Study||59
8672535|NCT00418561|21409143|P3|NOT COMPLETED|Overall Study||0
8672536|NCT00418561|21409144|P2|NOT COMPLETED|Overall Study||1
8672537|NCT00418561|21409145|P1|NOT COMPLETED|Overall Study||0
8672538|NCT00418561|21409143|P3|COMPLETED|Overall Study||4
8672539|NCT00418561|21409144|P2|COMPLETED|Overall Study||4
8672540|NCT00418561|21409145|P1|COMPLETED|Overall Study||4
8672541|NCT00418561|21409143|P3|STARTED|Overall Study||4
8672542|NCT00418561|21409144|P2|STARTED|Overall Study||5
8672543|NCT00418561|21409145|P1|STARTED|Overall Study||4
8672544|NCT00171158|21409213|P1|NOT COMPLETED|E2 Extension||7
8672545|NCT00171158|21409213|P1|COMPLETED|E2 Extension||1
8672546|NCT00171158|21409213|P1|STARTED|E2 Extension||8
8672547|NCT00171158|21409213|P1|NOT COMPLETED|Core Study||239
8672548|NCT00171158|21409213|P1|COMPLETED|Core Study||21
8672549|NCT00171158|21409213|P1|STARTED|Core Study||260
8672550|NCT04780919|21409220|P2|NOT COMPLETED|Overall Study||0
8672551|NCT04780919|21409221|P1|NOT COMPLETED|Overall Study||0
8672552|NCT04780919|21409220|P2|COMPLETED|Overall Study||9
8672553|NCT04780919|21409221|P1|COMPLETED|Overall Study||9
8672554|NCT04780919|21409220|P2|STARTED|Overall Study||9
8672555|NCT04780919|21409221|P1|STARTED|Overall Study||9
8672568|NCT03958955|21409295|P1|NOT COMPLETED|Overall Study||1
8672569|NCT03958955|21409295|P1|COMPLETED|Overall Study||26
8672570|NCT03958955|21409295|P1|Lesions Treated With Delgocitinib Cream Vehicle|Overall Study||27
8672571|NCT03958955|21409295|P1|Lesions Treated With Delgocitinib Cream|Overall Study||27
8672572|NCT03958955|21409295|P1|STARTED|Overall Study||27
8672573|NCT03947983|21409314|P2|NOT COMPLETED|Overall Study||6
8672574|NCT03947983|21409315|P1|NOT COMPLETED|Overall Study||5
8672575|NCT03947983|21409314|P2|COMPLETED|Overall Study||13
8672576|NCT03947983|21409315|P1|COMPLETED|Overall Study||14
8672577|NCT03947983|21409314|P2|12 Weeks|Overall Study||17
8672578|NCT03947983|21409315|P1|12 Weeks|Overall Study||15
8672579|NCT03947983|21409314|P2|STARTED|Overall Study||19
8672580|NCT03947983|21409315|P1|STARTED|Overall Study||19
8672581|NCT03607994|21409377|P2|NOT COMPLETED|Overall Study||1
8672582|NCT03607994|21409378|P1|NOT COMPLETED|Overall Study||1
8672583|NCT03607994|21409377|P2|COMPLETED|Overall Study||11
8672584|NCT03607994|21409378|P1|COMPLETED|Overall Study||9
8672585|NCT03607994|21409377|P2|STARTED|Overall Study||12
8672586|NCT03607994|21409378|P1|STARTED|Overall Study||10
8672587|NCT03374683|21409389|P3|NOT COMPLETED|Overall Study||69
8672588|NCT03374683|21409390|P2|NOT COMPLETED|Overall Study||45
8672589|NCT03374683|21409391|P1|NOT COMPLETED|Overall Study||25
8672590|NCT03374683|21409389|P3|COMPLETED|Overall Study||84
8672591|NCT03374683|21409390|P2|COMPLETED|Overall Study||105
8672592|NCT03374683|21409391|P1|COMPLETED|Overall Study||123
8672593|NCT03374683|21409389|P3|1-week Post-intervention|Overall Study||85
8672594|NCT03374683|21409390|P2|1-week Post-intervention|Overall Study||113
8672595|NCT03374683|21409391|P1|1-week Post-intervention|Overall Study||135
8672596|NCT03374683|21409389|P3|STARTED|Overall Study||153
8672597|NCT03374683|21409390|P2|STARTED|Overall Study||150
8672598|NCT03374683|21409391|P1|STARTED|Overall Study||148
8672602|NCT03325010|21409413|P2|NOT COMPLETED|Overall Study||20
8672603|NCT03325010|21409414|P1|NOT COMPLETED|Overall Study||9
8672604|NCT03325010|21409413|P2|COMPLETED|Overall Study||43
8672605|NCT03325010|21409414|P1|COMPLETED|Overall Study||55
8672606|NCT03325010|21409413|P2|Full Analysis Set|Overall Study||58
8672607|NCT03325010|21409414|P1|Full Analysis Set|Overall Study||61
8672608|NCT03325010|21409413|P2|Safety Analysis Set|Overall Study||59
8672609|NCT03325010|21409414|P1|Safety Analysis Set|Overall Study||62
8672610|NCT03325010|21409413|P2|STARTED|Overall Study||63
8672611|NCT03325010|21409414|P1|STARTED|Overall Study||64
8672612|NCT03318861|21409431|P5|NOT COMPLETED|Overall Study||3
8672613|NCT03318861|21409432|P4|NOT COMPLETED|Overall Study||4
8672614|NCT03318861|21409433|P3|NOT COMPLETED|Overall Study||3
8672615|NCT03318861|21409434|P2|NOT COMPLETED|Overall Study||4
8672616|NCT03318861|21409435|P1|NOT COMPLETED|Overall Study||3
8672617|NCT03318861|21409431|P5|COMPLETED|Overall Study||0
8672618|NCT03318861|21409432|P4|COMPLETED|Overall Study||0
8672619|NCT03318861|21409433|P3|COMPLETED|Overall Study||0
8672620|NCT03318861|21409434|P2|COMPLETED|Overall Study||0
8672621|NCT03318861|21409435|P1|COMPLETED|Overall Study||0
8672622|NCT03318861|21409431|P5|STARTED|Overall Study||3
8672623|NCT03318861|21409432|P4|STARTED|Overall Study||4
8672624|NCT03318861|21409433|P3|STARTED|Overall Study||3
8672625|NCT03318861|21409434|P2|STARTED|Overall Study||4
8672626|NCT03318861|21409435|P1|STARTED|Overall Study||3
8672627|NCT03100149|21409484|P3|NOT COMPLETED|Overall Study||2
8672628|NCT03100149|21409485|P2|NOT COMPLETED|Overall Study||4
8672629|NCT03100149|21409486|P1|NOT COMPLETED|Overall Study||0
8672630|NCT03100149|21409484|P3|COMPLETED|Overall Study||104
8672631|NCT03100149|21409485|P2|COMPLETED|Overall Study||101
8672632|NCT03100149|21409486|P1|COMPLETED|Overall Study||105
8672633|NCT03100149|21409484|P3|STARTED|Overall Study||106
8672634|NCT03100149|21409485|P2|STARTED|Overall Study||105
8672635|NCT03100149|21409486|P1|STARTED|Overall Study||105
8672636|NCT03000010|21409523|P2|NOT COMPLETED|Overall Study||0
8672637|NCT03000010|21409524|P1|NOT COMPLETED|Overall Study||0
8672638|NCT03000010|21409523|P2|COMPLETED|Overall Study||20
8672639|NCT03000010|21409524|P1|COMPLETED|Overall Study||21
8672640|NCT03000010|21409523|P2|STARTED|Overall Study||20
8672641|NCT03000010|21409524|P1|STARTED|Overall Study||21
8672642|NCT02994394|21409532|P6|NOT COMPLETED|Period 3 (Days 7 and 8)||0
8672643|NCT02994394|21409533|P5|NOT COMPLETED|Period 3 (Days 7 and 8)||0
8672644|NCT02994394|21409534|P4|NOT COMPLETED|Period 3 (Days 7 and 8)||0
8672645|NCT02994394|21409535|P3|NOT COMPLETED|Period 3 (Days 7 and 8)||0
8672646|NCT02994394|21409536|P2|NOT COMPLETED|Period 3 (Days 7 and 8)||0
8672647|NCT02994394|21409537|P1|NOT COMPLETED|Period 3 (Days 7 and 8)||0
8672648|NCT02994394|21409532|P6|COMPLETED|Period 3 (Days 7 and 8)||14
8672649|NCT02994394|21409533|P5|COMPLETED|Period 3 (Days 7 and 8)||13
8672650|NCT02994394|21409534|P4|COMPLETED|Period 3 (Days 7 and 8)||14
8672651|NCT02994394|21409535|P3|COMPLETED|Period 3 (Days 7 and 8)||13
8672652|NCT02994394|21409536|P2|COMPLETED|Period 3 (Days 7 and 8)||13
8672653|NCT02994394|21409537|P1|COMPLETED|Period 3 (Days 7 and 8)||14
8672654|NCT02994394|21409532|P6|STARTED|Period 3 (Days 7 and 8)||14
8672655|NCT02994394|21409533|P5|STARTED|Period 3 (Days 7 and 8)||13
8672656|NCT02994394|21409534|P4|STARTED|Period 3 (Days 7 and 8)||14
8672657|NCT02994394|21409535|P3|STARTED|Period 3 (Days 7 and 8)||13
8672658|NCT02994394|21409536|P2|STARTED|Period 3 (Days 7 and 8)||13
8672659|NCT02994394|21409537|P1|STARTED|Period 3 (Days 7 and 8)||14
8672660|NCT02994394|21409532|P6|NOT COMPLETED|Period 2 (Days 4 to 6)||0
8672661|NCT02994394|21409533|P5|NOT COMPLETED|Period 2 (Days 4 to 6)||1
8672662|NCT02994394|21409534|P4|NOT COMPLETED|Period 2 (Days 4 to 6)||0
8672663|NCT02994394|21409535|P3|NOT COMPLETED|Period 2 (Days 4 to 6)||0
8672664|NCT02994394|21409536|P2|NOT COMPLETED|Period 2 (Days 4 to 6)||1
8672665|NCT02994394|21409537|P1|NOT COMPLETED|Period 2 (Days 4 to 6)||0
8672666|NCT02994394|21409532|P6|COMPLETED|Period 2 (Days 4 to 6)||14
8672667|NCT02994394|21409533|P5|COMPLETED|Period 2 (Days 4 to 6)||13
8672668|NCT02994394|21409534|P4|COMPLETED|Period 2 (Days 4 to 6)||14
8672669|NCT02994394|21409535|P3|COMPLETED|Period 2 (Days 4 to 6)||13
8672670|NCT02994394|21409536|P2|COMPLETED|Period 2 (Days 4 to 6)||13
8672671|NCT02994394|21409537|P1|COMPLETED|Period 2 (Days 4 to 6)||14
8672672|NCT02994394|21409532|P6|STARTED|Period 2 (Days 4 to 6)||14
8672673|NCT02994394|21409533|P5|STARTED|Period 2 (Days 4 to 6)||14
8672674|NCT02994394|21409534|P4|STARTED|Period 2 (Days 4 to 6)||14
8672675|NCT02994394|21409535|P3|STARTED|Period 2 (Days 4 to 6)||13
8672676|NCT02994394|21409536|P2|STARTED|Period 2 (Days 4 to 6)||14
8672677|NCT02994394|21409537|P1|STARTED|Period 2 (Days 4 to 6)||14
8672678|NCT02994394|21409532|P6|NOT COMPLETED|Period 1 (Days 1 to 3)||0
8672679|NCT02994394|21409533|P5|NOT COMPLETED|Period 1 (Days 1 to 3)||0
8672680|NCT02994394|21409534|P4|NOT COMPLETED|Period 1 (Days 1 to 3)||0
8672681|NCT02994394|21409535|P3|NOT COMPLETED|Period 1 (Days 1 to 3)||1
8672682|NCT02994394|21409536|P2|NOT COMPLETED|Period 1 (Days 1 to 3)||0
8672683|NCT02994394|21409537|P1|NOT COMPLETED|Period 1 (Days 1 to 3)||0
8672684|NCT02994394|21409532|P6|COMPLETED|Period 1 (Days 1 to 3)||14
8672685|NCT02994394|21409533|P5|COMPLETED|Period 1 (Days 1 to 3)||14
8672686|NCT02994394|21409534|P4|COMPLETED|Period 1 (Days 1 to 3)||14
8672687|NCT02994394|21409535|P3|COMPLETED|Period 1 (Days 1 to 3)||13
8672688|NCT02994394|21409536|P2|COMPLETED|Period 1 (Days 1 to 3)||14
8672689|NCT02994394|21409537|P1|COMPLETED|Period 1 (Days 1 to 3)||14
8672690|NCT02994394|21409532|P6|STARTED|Period 1 (Days 1 to 3)||14
8672691|NCT02994394|21409533|P5|STARTED|Period 1 (Days 1 to 3)||14
8672692|NCT02994394|21409534|P4|STARTED|Period 1 (Days 1 to 3)||14
8672693|NCT02994394|21409535|P3|STARTED|Period 1 (Days 1 to 3)||14
8672694|NCT02994394|21409536|P2|STARTED|Period 1 (Days 1 to 3)||14
8672695|NCT02994394|21409537|P1|STARTED|Period 1 (Days 1 to 3)||14
8672696|NCT02981953|21409557|P1|NOT COMPLETED|Overall Study||11
8672697|NCT02981953|21409557|P1|COMPLETED|Overall Study||29
8672698|NCT02981953|21409557|P1|STARTED|Overall Study||40
8672699|NCT02819479|21409588|P1|NOT COMPLETED|Overall Study||2
8672700|NCT02819479|21409588|P1|COMPLETED|Overall Study|2 subjects experienced recurrence of radiation necrosis requiring intervention at approx. month 11.|8
8672701|NCT02819479|21409588|P1|STARTED|Overall Study||10
8672702|NCT02761330|21409599|P6|NOT COMPLETED|Treatment Week 2||0
8672703|NCT02761330|21409600|P5|NOT COMPLETED|Treatment Week 2||0
8672704|NCT02761330|21409601|P4|NOT COMPLETED|Treatment Week 2||0
8672705|NCT02761330|21409602|P3|NOT COMPLETED|Treatment Week 2||0
8672706|NCT02761330|21409603|P2|NOT COMPLETED|Treatment Week 2||0
8672707|NCT02761330|21409604|P1|NOT COMPLETED|Treatment Week 2||0
8672708|NCT02761330|21409599|P6|COMPLETED|Treatment Week 2||1
8672709|NCT02761330|21409600|P5|COMPLETED|Treatment Week 2||1
8672710|NCT02761330|21409601|P4|COMPLETED|Treatment Week 2||1
8672711|NCT02761330|21409602|P3|COMPLETED|Treatment Week 2||2
8672712|NCT02761330|21409603|P2|COMPLETED|Treatment Week 2||3
8672713|NCT02761330|21409604|P1|COMPLETED|Treatment Week 2||2
8672714|NCT02761330|21409599|P6|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to cancellation of treatment.|1
8672715|NCT02761330|21409600|P5|STARTED|Treatment Week 2||1
8672716|NCT02761330|21409601|P4|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to withdraw.|1
8672717|NCT02761330|21409602|P3|STARTED|Treatment Week 2||2
8672718|NCT02761330|21409603|P2|STARTED|Treatment Week 2||3
8672719|NCT02761330|21409604|P1|STARTED|Treatment Week 2||2
8672720|NCT02761330|21409599|P6|NOT COMPLETED|Treatment Week 1||1
8672721|NCT02761330|21409600|P5|NOT COMPLETED|Treatment Week 1||0
8672722|NCT02761330|21409601|P4|NOT COMPLETED|Treatment Week 1||1
8672723|NCT02761330|21409602|P3|NOT COMPLETED|Treatment Week 1||0
8672724|NCT02761330|21409603|P2|NOT COMPLETED|Treatment Week 1||0
8672725|NCT02761330|21409604|P1|NOT COMPLETED|Treatment Week 1||0
8672726|NCT02761330|21409599|P6|COMPLETED|Treatment Week 1||2
8672727|NCT02761330|21409600|P5|COMPLETED|Treatment Week 1||1
8672728|NCT02761330|21409601|P4|COMPLETED|Treatment Week 1||2
8672729|NCT02761330|21409602|P3|COMPLETED|Treatment Week 1||2
8672730|NCT02761330|21409603|P2|COMPLETED|Treatment Week 1||3
8672731|NCT02761330|21409604|P1|COMPLETED|Treatment Week 1||2
8672732|NCT02761330|21409599|P6|STARTED|Treatment Week 1||3
8672733|NCT02761330|21409600|P5|STARTED|Treatment Week 1||1
8672734|NCT02761330|21409601|P4|STARTED|Treatment Week 1||3
8672735|NCT02761330|21409602|P3|STARTED|Treatment Week 1||2
8672736|NCT02761330|21409603|P2|STARTED|Treatment Week 1||3
8672737|NCT02761330|21409604|P1|STARTED|Treatment Week 1||2
8672738|NCT02751931|21409649|P2|NOT COMPLETED|Overall Study||8
8672739|NCT02751931|21409650|P1|NOT COMPLETED|Overall Study||13
8672740|NCT02751931|21409649|P2|COMPLETED|Overall Study||27
8672741|NCT02751931|21409650|P1|COMPLETED|Overall Study||43
8672742|NCT02751931|21409649|P2|Treated|Overall Study||31
8672743|NCT02751931|21409650|P1|Treated|Overall Study||55
8672744|NCT02751931|21409649|P2|STARTED|Overall Study||35
8672745|NCT02751931|21409650|P1|STARTED|Overall Study||56
8672746|NCT02734433|21409724|P2|NOT COMPLETED|Overall Study||8
8672747|NCT02734433|21409725|P1|NOT COMPLETED|Overall Study||2
8672748|NCT02734433|21409724|P2|COMPLETED|Overall Study||0
8672749|NCT02734433|21409725|P1|COMPLETED|Overall Study||1
8672750|NCT02734433|21409724|P2|STARTED|Overall Study||8
8672751|NCT02734433|21409725|P1|STARTED|Overall Study||3
8672752|NCT02715258|21409759|P2|NOT COMPLETED|Overall Study||6
8672753|NCT02715258|21409760|P1|NOT COMPLETED|Overall Study||16
8672754|NCT02715258|21409759|P2|COMPLETED|Overall Study||64
8672755|NCT02715258|21409760|P1|COMPLETED|Overall Study||124
8672756|NCT02715258|21409759|P2|Intent to Treat/Safety Analysis|Overall Study||69
8672757|NCT02715258|21409760|P1|Intent to Treat/Safety Analysis|Overall Study||138
8672758|NCT02715258|21409759|P2|STARTED|Overall Study||70
8672759|NCT02715258|21409760|P1|STARTED|Overall Study||140
8672760|NCT02677701|21409778|P2|NOT COMPLETED|Overall Study||5
8672761|NCT02677701|21409779|P1|NOT COMPLETED|Overall Study||6
8672762|NCT02677701|21409778|P2|COMPLETED|Overall Study||52
8672763|NCT02677701|21409779|P1|COMPLETED|Overall Study||56
8672764|NCT02677701|21409778|P2|Treated|Overall Study||54
8672765|NCT02677701|21409779|P1|Treated|Overall Study||61
8672766|NCT02677701|21409778|P2|STARTED|Overall Study||57
8672767|NCT02677701|21409779|P1|STARTED|Overall Study||62
8672768|NCT02655016|21409795|P2|NOT COMPLETED|Overall Study||90
8672769|NCT02655016|21409796|P1|NOT COMPLETED|Overall Study||55
8672770|NCT02655016|21409795|P2|COMPLETED|Overall Study|177 participants are ongoing in the study.|397
8672771|NCT02655016|21409796|P1|COMPLETED|Overall Study|69 participants are ongoing in the study.|191
8672772|NCT02655016|21409795|P2|Ongoing With Treatment in the Study|Overall Study||177
8672773|NCT02655016|21409796|P1|Ongoing With Treatment in the Study|Overall Study||69
8672774|NCT02655016|21409795|P2|Received Study Treatment|Overall Study|3 participants never received treatment (2 failed screening & 1 withdrew consent before first dose).|484
8672775|NCT02655016|21409796|P1|Received Study Treatment|Overall Study|2 participants never received treatment due to screen failure after randomization.|244
8672776|NCT02655016|21409795|P2|STARTED|Overall Study||487
8672777|NCT02655016|21409796|P1|STARTED|Overall Study||246
8672778|NCT02504268|21409831|P9|NOT COMPLETED|Overall Study||0
8672779|NCT02504268|21409832|P8|NOT COMPLETED|Overall Study||0
8672780|NCT02504268|21409833|P7|NOT COMPLETED|Overall Study||0
8672781|NCT02504268|21409834|P6|NOT COMPLETED|Overall Study||0
8672782|NCT02504268|21409835|P5|NOT COMPLETED|Overall Study||0
8672783|NCT02504268|21409836|P4|NOT COMPLETED|Overall Study||0
8672784|NCT02504268|21409837|P3|NOT COMPLETED|Overall Study||41
8672785|NCT02504268|21409838|P2|NOT COMPLETED|Overall Study||68
8672786|NCT02504268|21409839|P1|NOT COMPLETED|Overall Study||63
8672787|NCT02504268|21409831|P9|COMPLETED|Overall Study||0
8672788|NCT02504268|21409832|P8|COMPLETED|Overall Study||0
8672789|NCT02504268|21409833|P7|COMPLETED|Overall Study||0
8672790|NCT02504268|21409834|P6|COMPLETED|Overall Study||0
8672791|NCT02504268|21409835|P5|COMPLETED|Overall Study||0
8672792|NCT02504268|21409836|P4|COMPLETED|Overall Study||0
8672793|NCT02504268|21409837|P3|COMPLETED|Overall Study||201
8672794|NCT02504268|21409838|P2|COMPLETED|Overall Study||233
8672795|NCT02504268|21409839|P1|COMPLETED|Overall Study||388
8672796|NCT02504268|21409831|P9|Open Label and Open Label Extension Period|Overall Study||120
8672797|NCT02504268|21409832|P8|Open Label and Open Label Extension Period|Overall Study||685
8672798|NCT02504268|21409833|P7|Open Label and Open Label Extension Period|Overall Study||0
8672799|NCT02504268|21409834|P6|Open Label and Open Label Extension Period|Overall Study||0
8672800|NCT02504268|21409835|P5|Open Label and Open Label Extension Period|Overall Study||0
8672801|NCT02504268|21409836|P4|Open Label and Open Label Extension Period|Overall Study||0
8672802|NCT02504268|21409837|P3|Open Label and Open Label Extension Period|Overall Study||0
8672803|NCT02504268|21409838|P2|Open Label and Open Label Extension Period|Overall Study||0
8672804|NCT02504268|21409839|P1|Open Label and Open Label Extension Period|Overall Study||0
8672805|NCT02504268|21409831|P9|Early Escaped De-Escalation to Open Label Period|Overall Study||0
8672806|NCT02504268|21409832|P8|Early Escaped De-Escalation to Open Label Period|Overall Study||0
8672807|NCT02504268|21409833|P7|Early Escaped De-Escalation to Open Label Period|Overall Study||3
8672808|NCT02504268|21409834|P6|Early Escaped De-Escalation to Open Label Period|Overall Study||4
8672809|NCT02504268|21409835|P5|Early Escaped De-Escalation to Open Label Period|Overall Study||5
8672810|NCT02504268|21409836|P4|Early Escaped De-Escalation to Open Label Period|Overall Study||2
8672811|NCT02504268|21409837|P3|Early Escaped De-Escalation to Open Label Period|Overall Study||0
8672812|NCT02504268|21409838|P2|Early Escaped De-Escalation to Open Label Period|Overall Study||0
8672813|NCT02504268|21409839|P1|Early Escaped De-Escalation to Open Label Period|Overall Study||0
8672814|NCT02504268|21409831|P9|De-Escalation to Open Label Extension|Overall Study||0
8672815|NCT02504268|21409832|P8|De-Escalation to Open Label Extension|Overall Study||0
8672816|NCT02504268|21409833|P7|De-Escalation to Open Label Extension|Overall Study||22
8672817|NCT02504268|21409834|P6|De-Escalation to Open Label Extension|Overall Study||32
8672818|NCT02504268|21409835|P5|De-Escalation to Open Label Extension|Overall Study||30
8672819|NCT02504268|21409836|P4|De-Escalation to Open Label Extension|Overall Study||36
8672820|NCT02504268|21409837|P3|De-Escalation to Open Label Extension|Overall Study||0
8672821|NCT02504268|21409838|P2|De-Escalation to Open Label Extension|Overall Study||0
8672822|NCT02504268|21409839|P1|De-Escalation to Open Label Extension|Overall Study||0
8672823|NCT02504268|21409831|P9|Randomized in De-Escalation Period|Overall Study||0
8672824|NCT02504268|21409832|P8|Randomized in De-Escalation Period|Overall Study||0
8672825|NCT02504268|21409833|P7|Randomized in De-Escalation Period|Overall Study||37
8672826|NCT02504268|21409834|P6|Randomized in De-Escalation Period|Overall Study||47
8672827|NCT02504268|21409835|P5|Randomized in De-Escalation Period|Overall Study||50
8672828|NCT02504268|21409836|P4|Randomized in De-Escalation Period|Overall Study||50
8672829|NCT02504268|21409837|P3|Randomized in De-Escalation Period|Overall Study||0
8672830|NCT02504268|21409838|P2|Randomized in De-Escalation Period|Overall Study||0
8672831|NCT02504268|21409839|P1|Randomized in De-Escalation Period|Overall Study||0
8672832|NCT02504268|21409831|P9|Induction to De-Escalation|Overall Study||0
8672833|NCT02504268|21409832|P8|Induction to De-Escalation|Overall Study||0
8672834|NCT02504268|21409833|P7|Induction to De-Escalation|Overall Study||0
8672835|NCT02504268|21409834|P6|Induction to De-Escalation|Overall Study||0
8672836|NCT02504268|21409835|P5|Induction to De-Escalation|Overall Study||0
8672837|NCT02504268|21409836|P4|Induction to De-Escalation|Overall Study||0
8672838|NCT02504268|21409837|P3|Induction to De-Escalation|Overall Study||53
8672839|NCT02504268|21409838|P2|Induction to De-Escalation|Overall Study||37
8672840|NCT02504268|21409839|P1|Induction to De-Escalation|Overall Study||94
8672841|NCT02504268|21409831|P9|Early Escaped to Open Label|Overall Study||0
8672842|NCT02504268|21409832|P8|Early Escaped to Open Label|Overall Study||0
8672843|NCT02504268|21409833|P7|Early Escaped to Open Label|Overall Study||0
8672844|NCT02504268|21409834|P6|Early Escaped to Open Label|Overall Study||0
8672845|NCT02504268|21409835|P5|Early Escaped to Open Label|Overall Study||0
8672846|NCT02504268|21409836|P4|Early Escaped to Open Label|Overall Study||0
8672847|NCT02504268|21409837|P3|Early Escaped to Open Label|Overall Study||8
8672848|NCT02504268|21409838|P2|Early Escaped to Open Label|Overall Study||21
8672849|NCT02504268|21409839|P1|Early Escaped to Open Label|Overall Study||10
8672850|NCT02504268|21409831|P9|Induction to Open Label|Overall Study||0
8672851|NCT02504268|21409832|P8|Induction to Open Label|Overall Study||0
8672852|NCT02504268|21409833|P7|Induction to Open Label|Overall Study||0
8672853|NCT02504268|21409834|P6|Induction to Open Label|Overall Study||0
8672854|NCT02504268|21409835|P5|Induction to Open Label|Overall Study||0
8672855|NCT02504268|21409836|P4|Induction to Open Label|Overall Study||0
8672856|NCT02504268|21409837|P3|Induction to Open Label|Overall Study||147
8672857|NCT02504268|21409838|P2|Induction to Open Label|Overall Study||196
8672858|NCT02504268|21409839|P1|Induction to Open Label|Overall Study||289
8672859|NCT02504268|21409831|P9|STARTED|Overall Study||0
8672860|NCT02504268|21409832|P8|STARTED|Overall Study||0
8672861|NCT02504268|21409833|P7|STARTED|Overall Study||0
8672862|NCT02504268|21409834|P6|STARTED|Overall Study||0
8672863|NCT02504268|21409835|P5|STARTED|Overall Study||0
8672864|NCT02504268|21409836|P4|STARTED|Overall Study||0
8672865|NCT02504268|21409837|P3|STARTED|Overall Study||242
8672866|NCT02504268|21409838|P2|STARTED|Overall Study||301
8672867|NCT02504268|21409839|P1|STARTED|Overall Study||451
8672868|NCT02369900|21409897|P2|NOT COMPLETED|Overall Study||0
8672869|NCT02369900|21409898|P1|NOT COMPLETED|Overall Study||0
8672870|NCT02369900|21409897|P2|COMPLETED|Overall Study||22
8672871|NCT02369900|21409898|P1|COMPLETED|Overall Study||18
8672872|NCT02369900|21409897|P2|STARTED|Overall Study||22
8672873|NCT02369900|21409898|P1|STARTED|Overall Study||18
8672874|NCT02232243|21409927|P3|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8672875|NCT02232243|21409928|P2|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8672876|NCT02232243|21409929|P1|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8672877|NCT02232243|21409927|P3|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3
8672878|NCT02232243|21409928|P2|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8672879|NCT02232243|21409929|P1|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
8672880|NCT02232243|21409927|P3|STARTED|Third Dose(200mg HCQ Twice Daily)||3
8672881|NCT02232243|21409928|P2|STARTED|Third Dose(200mg HCQ Twice Daily)||0
8672882|NCT02232243|21409929|P1|STARTED|Third Dose(200mg HCQ Twice Daily)||0
8672883|NCT02232243|21409927|P3|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
8672884|NCT02232243|21409928|P2|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1
8672885|NCT02232243|21409929|P1|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
8672886|NCT02232243|21409927|P3|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
8672887|NCT02232243|21409928|P2|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3
8672888|NCT02232243|21409929|P1|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
8672889|NCT02232243|21409927|P3|STARTED|Second Dose (400mg HCQ Twice Daily)||0
8672890|NCT02232243|21409928|P2|STARTED|Second Dose (400mg HCQ Twice Daily)||4
8672891|NCT02232243|21409929|P1|STARTED|Second Dose (400mg HCQ Twice Daily)||0
8672892|NCT02232243|21409927|P3|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8672893|NCT02232243|21409928|P2|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8672894|NCT02232243|21409929|P1|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8672895|NCT02232243|21409927|P3|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8672896|NCT02232243|21409928|P2|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
8672897|NCT02232243|21409929|P1|COMPLETED|First Dose (200mg HCQ Twice Daily)||3
8672898|NCT02232243|21409927|P3|STARTED|First Dose (200mg HCQ Twice Daily)||0
8672899|NCT02232243|21409928|P2|STARTED|First Dose (200mg HCQ Twice Daily)||0
8672900|NCT02232243|21409929|P1|STARTED|First Dose (200mg HCQ Twice Daily)||3
8672901|NCT02015390|21409940|P2|NOT COMPLETED|Overall Study||4
8672902|NCT02015390|21409941|P1|NOT COMPLETED|Overall Study||1
8672903|NCT02015390|21409940|P2|COMPLETED|Overall Study||3
8672904|NCT02015390|21409941|P1|COMPLETED|Overall Study||8
8672905|NCT02015390|21409940|P2|STARTED|Overall Study||7
8672906|NCT02015390|21409941|P1|STARTED|Overall Study||9
8672907|NCT01966471|21409963|P2|NOT COMPLETED|Overall Study||113
8672908|NCT01966471|21409964|P1|NOT COMPLETED|Overall Study||103
8672909|NCT01966471|21409963|P2|COMPLETED|Overall Study||815
8672910|NCT01966471|21409964|P1|COMPLETED|Overall Study||815
8672911|NCT01966471|21409963|P2|STARTED|Overall Study||928
8672912|NCT01966471|21409964|P1|STARTED|Overall Study||918
8672913|NCT01848834|21409985|P5|NOT COMPLETED|Overall Study||94
8672914|NCT01848834|21409986|P4|NOT COMPLETED|Overall Study||26
8672915|NCT01848834|21409987|P3|NOT COMPLETED|Overall Study||24
8672916|NCT01848834|21409988|P2|NOT COMPLETED|Overall Study||48
8672917|NCT01848834|21409989|P1|NOT COMPLETED|Overall Study||19
8672918|NCT01848834|21409985|P5|COMPLETED|Overall Study|Completed means two-year treatment completed|38
8672919|NCT01848834|21409986|P4|COMPLETED|Overall Study|Completed means two-year treatment completed|13
8672920|NCT01848834|21409987|P3|COMPLETED|Overall Study|Completed means two-year treatment completed|9
8672921|NCT01848834|21409988|P2|COMPLETED|Overall Study|Completed means two-year treatment completed|13
8672922|NCT01848834|21409989|P1|COMPLETED|Overall Study|Completed means two-year treatment completed|13
8672923|NCT01848834|21409985|P5|Treated|Overall Study||132
8672924|NCT01848834|21409986|P4|Treated|Overall Study||39
8672925|NCT01848834|21409987|P3|Treated|Overall Study||33
8672926|NCT01848834|21409988|P2|Treated|Overall Study||60
8672927|NCT01848834|21409989|P1|Treated|Overall Study||32
8672928|NCT01848834|21409985|P5|STARTED|Overall Study||132
8672929|NCT01848834|21409986|P4|STARTED|Overall Study||39
8672930|NCT01848834|21409987|P3|STARTED|Overall Study||33
8672931|NCT01848834|21409988|P2|STARTED|Overall Study||61
8672932|NCT01848834|21409989|P1|STARTED|Overall Study||32
8672939|NCT01699542|21410041|P2|NOT COMPLETED|Overall Study||0
8672940|NCT01699542|21410042|P1|NOT COMPLETED|Overall Study||0
8672941|NCT01699542|21410041|P2|COMPLETED|Overall Study||9
8672942|NCT01699542|21410042|P1|COMPLETED|Overall Study||9
8672943|NCT01699542|21410041|P2|STARTED|Overall Study||9
8672944|NCT01699542|21410042|P1|STARTED|Overall Study||9
8672945|NCT01699178|21410068|P2|NOT COMPLETED|Overall Study||32
8672946|NCT01699178|21410069|P1|NOT COMPLETED|Overall Study||19
8672947|NCT01699178|21410068|P2|COMPLETED|Overall Study||62
8672948|NCT01699178|21410069|P1|COMPLETED|Overall Study||69
8672949|NCT01699178|21410068|P2|STARTED|Overall Study||94
8672950|NCT01699178|21410069|P1|STARTED|Overall Study||88
8672951|NCT01651403|21410087|P2|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||14
8672952|NCT01651403|21410088|P1|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||21
8672953|NCT01651403|21410087|P2|COMPLETED|Open-Label Phase (Weeks 49/73-192)||11
8672954|NCT01651403|21410088|P1|COMPLETED|Open-Label Phase (Weeks 49/73-192)||35
8672955|NCT01651403|21410087|P2|STARTED|Open-Label Phase (Weeks 49/73-192)||25
8672956|NCT01651403|21410088|P1|STARTED|Open-Label Phase (Weeks 49/73-192)||56
8672957|NCT01651403|21410087|P2|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||5
8672958|NCT01651403|21410088|P1|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
8672959|NCT01651403|21410087|P2|COMPLETED|Double-Blind Period (Through Week 48/72)||25
8672960|NCT01651403|21410088|P1|COMPLETED|Double-Blind Period (Through Week 48/72)||56
8672961|NCT01651403|21410087|P2|STARTED|Double-Blind Period (Through Week 48/72)||30
8672962|NCT01651403|21410088|P1|STARTED|Double-Blind Period (Through Week 48/72)||60
8672963|NCT01614574|21410152|P1|NOT COMPLETED|Overall Study||0
8672964|NCT01614574|21410152|P1|COMPLETED|Overall Study||6
8672965|NCT01614574|21410152|P1|STARTED|Overall Study||6
8672966|NCT01356628|21410166|P1|NOT COMPLETED|Overall Study||0
8672967|NCT01356628|21410166|P1|COMPLETED|Overall Study||23
8672968|NCT01356628|21410166|P1|STARTED|Overall Study||23
8672969|NCT01130831|21410171|P1|NOT COMPLETED|Overall Study||14
8672970|NCT01130831|21410171|P1|COMPLETED|Overall Study||52
8672971|NCT01130831|21410171|P1|STARTED|Overall Study||66
8672975|NCT01099215|21410206|P2|NOT COMPLETED|Overall Study||1
8672976|NCT01099215|21410207|P1|NOT COMPLETED|Overall Study||1
8672977|NCT01099215|21410206|P2|COMPLETED|Overall Study||9
8672978|NCT01099215|21410207|P1|COMPLETED|Overall Study||10
8672979|NCT01099215|21410206|P2|STARTED|Overall Study||10
8672980|NCT01099215|21410207|P1|STARTED|Overall Study||11
8672981|NCT01081132|21410245|P2|NOT COMPLETED|Overall Study||52
8672982|NCT01081132|21410246|P1|NOT COMPLETED|Overall Study||55
8672983|NCT01081132|21410245|P2|COMPLETED|Overall Study||105
8672984|NCT01081132|21410246|P1|COMPLETED|Overall Study||102
8672985|NCT01081132|21410245|P2|STARTED|Overall Study||157
8672986|NCT01081132|21410246|P1|STARTED|Overall Study||157
8672987|NCT01073020|21410288|P4|NOT COMPLETED|Overall Study||2
8672988|NCT01073020|21410289|P3|NOT COMPLETED|Overall Study||3
8672989|NCT01073020|21410290|P2|NOT COMPLETED|Overall Study||5
8672990|NCT01073020|21410291|P1|NOT COMPLETED|Overall Study||7
8672991|NCT01073020|21410288|P4|COMPLETED|Overall Study||19
8672992|NCT01073020|21410289|P3|COMPLETED|Overall Study||19
8672993|NCT01073020|21410290|P2|COMPLETED|Overall Study||17
8672994|NCT01073020|21410291|P1|COMPLETED|Overall Study||16
8672995|NCT01073020|21410288|P4|STARTED|Overall Study||21
8672996|NCT01073020|21410289|P3|STARTED|Overall Study||22
8672997|NCT01073020|21410290|P2|STARTED|Overall Study||22
8672998|NCT01073020|21410291|P1|STARTED|Overall Study||23
8672999|NCT01014624|21410315|P2|NOT COMPLETED|Overall Study||1
8673000|NCT01014624|21410316|P1|NOT COMPLETED|Overall Study||2
8673001|NCT01014624|21410315|P2|COMPLETED|Overall Study||26
8673002|NCT01014624|21410316|P1|COMPLETED|Overall Study||27
8673003|NCT01014624|21410315|P2|STARTED|Overall Study||27
8673004|NCT01014624|21410316|P1|STARTED|Overall Study||29
8673005|NCT00920647|21410340|P4|NOT COMPLETED|Overall Study||0
8673006|NCT00920647|21410341|P3|NOT COMPLETED|Overall Study||0
8673007|NCT00920647|21410342|P2|NOT COMPLETED|Overall Study||0
8673008|NCT00920647|21410343|P1|NOT COMPLETED|Overall Study||0
8673009|NCT00920647|21410340|P4|COMPLETED|Overall Study||4
8673010|NCT00920647|21410341|P3|COMPLETED|Overall Study||4
8673011|NCT00920647|21410342|P2|COMPLETED|Overall Study||4
8673012|NCT00920647|21410343|P1|COMPLETED|Overall Study||4
8673013|NCT00920647|21410340|P4|STARTED|Overall Study||4
8673014|NCT00920647|21410341|P3|STARTED|Overall Study||4
8673015|NCT00920647|21410342|P2|STARTED|Overall Study||4
8673016|NCT00920647|21410343|P1|STARTED|Overall Study||4
8673017|NCT00653263|21410391|P1|NOT COMPLETED|Overall Study||2
8673018|NCT00653263|21410391|P1|COMPLETED|Overall Study||6
8673019|NCT00653263|21410391|P1|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
8673020|NCT04439240|21410397|P1|NOT COMPLETED|Overall Study||52
8673021|NCT04439240|21410397|P1|COMPLETED|Overall Study||0
8673022|NCT04439240|21410397|P1|Reported Adverse Events Data|Overall Study||49
8673023|NCT04439240|21410397|P1|Eligible and Started Protocol Therapy|Overall Study||48
8673024|NCT04439240|21410397|P1|Eligible|Overall Study||49
8673025|NCT04439240|21410397|P1|Started Protocol Therapy|Overall Study||50
8673026|NCT04439240|21410397|P1|STARTED|Overall Study||52
8673027|NCT04409886|21410403|P1|NOT COMPLETED|Overall Study||0
8673028|NCT04409886|21410403|P1|COMPLETED|Overall Study||1
8673029|NCT04409886|21410403|P1|STARTED|Overall Study||1
8673030|NCT04322396|21410409|P2|NOT COMPLETED|Overall Study||0
8673031|NCT04322396|21410410|P1|NOT COMPLETED|Overall Study||0
8673032|NCT04322396|21410409|P2|COMPLETED|Overall Study||61
8673033|NCT04322396|21410410|P1|COMPLETED|Overall Study||56
8673034|NCT04322396|21410409|P2|STARTED|Overall Study||61
8673035|NCT04322396|21410410|P1|STARTED|Overall Study||56
8673036|NCT04160975|21410446|P6|NOT COMPLETED|Overall Study||51
8673037|NCT04160975|21410447|P5|NOT COMPLETED|Overall Study||35
8673038|NCT04160975|21410448|P4|NOT COMPLETED|Overall Study||75
8673039|NCT04160975|21410449|P3|NOT COMPLETED|Overall Study||61
8673040|NCT04160975|21410450|P2|NOT COMPLETED|Overall Study||66
8673041|NCT04160975|21410451|P1|NOT COMPLETED|Overall Study||64
8673042|NCT04160975|21410446|P6|COMPLETED|Overall Study||607
8673043|NCT04160975|21410447|P5|COMPLETED|Overall Study||614
8673044|NCT04160975|21410448|P4|COMPLETED|Overall Study||410
8673045|NCT04160975|21410449|P3|COMPLETED|Overall Study||417
8673046|NCT04160975|21410450|P2|COMPLETED|Overall Study||430
8673047|NCT04160975|21410451|P1|COMPLETED|Overall Study||415
8673048|NCT04160975|21410446|P6|STARTED|Overall Study||658
8673049|NCT04160975|21410447|P5|STARTED|Overall Study||649
8673050|NCT04160975|21410448|P4|STARTED|Overall Study||485
8673051|NCT04160975|21410449|P3|STARTED|Overall Study||478
8673052|NCT04160975|21410450|P2|STARTED|Overall Study||496
8673053|NCT04160975|21410451|P1|STARTED|Overall Study||479
8673054|NCT04084015|21410491|P1|NOT COMPLETED|Overall Study||0
8673055|NCT04084015|21410491|P1|COMPLETED|Overall Study||2
8673056|NCT04084015|21410491|P1|STARTED|Overall Study||2
8673057|NCT04057768|21410502|P1|NOT COMPLETED|Overall Study||0
8673058|NCT04057768|21410502|P1|COMPLETED|Overall Study||10
8673059|NCT04057768|21410502|P1|STARTED|Overall Study||10
8673060|NCT03988049|21410513|P2|NOT COMPLETED|Overall Study||0
8673061|NCT03988049|21410514|P1|NOT COMPLETED|Overall Study||0
8673062|NCT03988049|21410513|P2|COMPLETED|Overall Study||22
8673063|NCT03988049|21410514|P1|COMPLETED|Overall Study||22
8673064|NCT03988049|21410513|P2|STARTED|Overall Study||22
8673065|NCT03988049|21410514|P1|STARTED|Overall Study||22
8673066|NCT03677869|21410520|P1|NOT COMPLETED|Overall Study||1
8673067|NCT03677869|21410520|P1|COMPLETED|Overall Study||34
8673068|NCT03677869|21410520|P1|STARTED|Overall Study||35
8673075|NCT03592745|21410542|P2|NOT COMPLETED|Overall Study||3
8673076|NCT03592745|21410543|P1|NOT COMPLETED|Overall Study||3
8673077|NCT03592745|21410542|P2|COMPLETED|Overall Study||15
8673078|NCT03592745|21410543|P1|COMPLETED|Overall Study||15
8673079|NCT03592745|21410542|P2|STARTED|Overall Study||18
8673080|NCT03592745|21410543|P1|STARTED|Overall Study||18
8673081|NCT03574753|21410551|P1|NOT COMPLETED|Overall Study||23
8673082|NCT03574753|21410551|P1|COMPLETED|Overall Study||0
8673083|NCT03574753|21410551|P1|STARTED|Overall Study||23
8673084|NCT03537261|21410564|P2|NOT COMPLETED|Overall Study||12
8673085|NCT03537261|21410565|P1|NOT COMPLETED|Overall Study||8
8673086|NCT03537261|21410564|P2|COMPLETED|Overall Study||27
8673087|NCT03537261|21410565|P1|COMPLETED|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|33
8673088|NCT03537261|21410564|P2|Completed Baseline Assessment|Overall Study||28
8673089|NCT03537261|21410565|P1|Completed Baseline Assessment|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|35
8673090|NCT03537261|21410564|P2|STARTED|Overall Study||39
8673091|NCT03537261|21410565|P1|STARTED|Overall Study||41
8673107|NCT03463889|21410626|P1|NOT COMPLETED|Overall Study||0
8673108|NCT03463889|21410626|P1|COMPLETED|Overall Study||12
8673109|NCT03463889|21410626|P1|STARTED|Overall Study||12
8673110|NCT03407053|21410636|P2|NOT COMPLETED|Overall Study||0
8673111|NCT03407053|21410637|P1|NOT COMPLETED|Overall Study||0
8673112|NCT03407053|21410636|P2|COMPLETED|Overall Study||10
8673113|NCT03407053|21410637|P1|COMPLETED|Overall Study||10
8673114|NCT03407053|21410636|P2|STARTED|Overall Study||10
8673115|NCT03407053|21410637|P1|STARTED|Overall Study||10
8673155|NCT03342690|21410675|P1|NOT COMPLETED|Overall Study||25
8673156|NCT03342690|21410675|P1|COMPLETED|Overall Study||1139
8673157|NCT03342690|21410675|P1|STARTED|Overall Study||1164
8673158|NCT03309020|21410686|P2|NOT COMPLETED|Overall Study||1
8673159|NCT03309020|21410687|P1|NOT COMPLETED|Overall Study||3
8673160|NCT03309020|21410686|P2|COMPLETED|Overall Study||24
8673161|NCT03309020|21410687|P1|COMPLETED|Overall Study||9
8673162|NCT03309020|21410686|P2|Underwent Cataract Surgery|Overall Study||24
8673163|NCT03309020|21410687|P1|Underwent Cataract Surgery|Overall Study||10
8673164|NCT03309020|21410686|P2|STARTED|Overall Study||25
8673165|NCT03309020|21410687|P1|STARTED|Overall Study||12
8673178|NCT03182725|21410837|P2|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
8673179|NCT03182725|21410838|P1|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
8673180|NCT03182725|21410837|P2|COMPLETED|Treatment Arm 2 (Second Half of Study)||6
8673181|NCT03182725|21410838|P1|COMPLETED|Treatment Arm 2 (Second Half of Study)||16
8673182|NCT03182725|21410837|P2|STARTED|Treatment Arm 2 (Second Half of Study)|One participant withdrew during crossover and therefore did not start Treatment Arm 2.|6
8673183|NCT03182725|21410838|P1|STARTED|Treatment Arm 2 (Second Half of Study)||16
8673184|NCT03182725|21410837|P2|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||3
8673185|NCT03182725|21410838|P1|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||0
8673186|NCT03182725|21410837|P2|COMPLETED|Treatment Arm 1 (First Half of Study)||7
8673187|NCT03182725|21410838|P1|COMPLETED|Treatment Arm 1 (First Half of Study)||16
8673188|NCT03182725|21410837|P2|STARTED|Treatment Arm 1 (First Half of Study)||10
8673189|NCT03182725|21410838|P1|STARTED|Treatment Arm 1 (First Half of Study)||16
8673190|NCT03156621|21410848|P2|NOT COMPLETED|Open-Label Treatment Period (OLTP)||3
8673191|NCT03156621|21410849|P1|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0
8673192|NCT03156621|21410848|P2|COMPLETED|Open-Label Treatment Period (OLTP)||42
8673193|NCT03156621|21410849|P1|COMPLETED|Open-Label Treatment Period (OLTP)||24
8673194|NCT03156621|21410848|P2|STARTED|Open-Label Treatment Period (OLTP)||45
8673195|NCT03156621|21410849|P1|STARTED|Open-Label Treatment Period (OLTP)||24
8673196|NCT03156621|21410848|P2|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
8673197|NCT03156621|21410849|P1|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
8673198|NCT03156621|21410848|P2|COMPLETED|Double-Blind Treatment Period (DBTP)||45
8673199|NCT03156621|21410849|P1|COMPLETED|Double-Blind Treatment Period (DBTP)||24
8673200|NCT03156621|21410848|P2|STARTED|Double-Blind Treatment Period (DBTP)||45
8673201|NCT03156621|21410849|P1|STARTED|Double-Blind Treatment Period (DBTP)||24
8673210|NCT03023813|21411028|P3|NOT COMPLETED|Overall Study||0
8673211|NCT03023813|21411029|P2|NOT COMPLETED|Overall Study||2
8673212|NCT03023813|21411030|P1|NOT COMPLETED|Overall Study||1
8673213|NCT03023813|21411028|P3|COMPLETED|Overall Study||31
8673214|NCT03023813|21411029|P2|COMPLETED|Overall Study||32
8673215|NCT03023813|21411030|P1|COMPLETED|Overall Study||38
8673216|NCT03023813|21411028|P3|STARTED|Overall Study||31
8673217|NCT03023813|21411029|P2|STARTED|Overall Study||34
8673218|NCT03023813|21411030|P1|STARTED|Overall Study||39
8673219|NCT02883400|21411061|P2|NOT COMPLETED|Overall Study||0
8673220|NCT02883400|21411062|P1|NOT COMPLETED|Overall Study||0
8673221|NCT02883400|21411061|P2|COMPLETED|Overall Study||8
8673222|NCT02883400|21411062|P1|COMPLETED|Overall Study||22
8673223|NCT02883400|21411061|P2|STARTED|Overall Study||8
8673224|NCT02883400|21411062|P1|STARTED|Overall Study||22
8673225|NCT02842086|21411070|P2|NOT COMPLETED|Overall Study||493
8673226|NCT02842086|21411071|P1|NOT COMPLETED|Overall Study||544
8673227|NCT02842086|21411070|P2|COMPLETED|Overall Study||2206
8673228|NCT02842086|21411071|P1|COMPLETED|Overall Study||2156
8673229|NCT02842086|21411070|P2|STARTED|Overall Study||2699
8673230|NCT02842086|21411071|P1|STARTED|Overall Study||2700
8673231|NCT02817906|21411109|P2|NOT COMPLETED|Overall Study||5
8673232|NCT02817906|21411110|P1|NOT COMPLETED|Overall Study||16
8673233|NCT02817906|21411109|P2|COMPLETED|Overall Study||84
8673234|NCT02817906|21411110|P1|COMPLETED|Overall Study||70
8673235|NCT02817906|21411109|P2|STARTED|Overall Study|90 patients were randomized but only 89 received study drug. The number completed and discontinued is based on 89 patients that received study drug.|89
8673236|NCT02817906|21411110|P1|STARTED|Overall Study|87 patients were randomized but only 86 received study drug. The number completed and discontinued is based on the 86 patients that received study drug.|86
8673237|NCT02701413|21411120|P2|NOT COMPLETED|Overall Study||11
8673238|NCT02701413|21411121|P1|NOT COMPLETED|Overall Study||7
8673239|NCT02701413|21411120|P2|COMPLETED|Overall Study||22
8673240|NCT02701413|21411121|P1|COMPLETED|Overall Study||26
8673241|NCT02701413|21411120|P2|STARTED|Overall Study||33
8673242|NCT02701413|21411121|P1|STARTED|Overall Study||33
8673279|NCT02513095|21411185|P2|NOT COMPLETED|Overall Study||0
8673280|NCT02513095|21411186|P1|NOT COMPLETED|Overall Study||0
8673281|NCT02513095|21411185|P2|COMPLETED|Overall Study||17
8673282|NCT02513095|21411186|P1|COMPLETED|Overall Study||17
8673283|NCT02513095|21411185|P2|Treatment Phase - Up to 120 Minutes|Overall Study||17
8673284|NCT02513095|21411186|P1|Treatment Phase - Up to 120 Minutes|Overall Study||17
8673285|NCT02513095|21411185|P2|STARTED|Overall Study||17
8673286|NCT02513095|21411186|P1|STARTED|Overall Study||17
8673287|NCT02478489|21411194|P2|NOT COMPLETED|Overall Study||16
8673288|NCT02478489|21411195|P1|NOT COMPLETED|Overall Study||15
8673289|NCT02478489|21411194|P2|COMPLETED|Overall Study||109
8673290|NCT02478489|21411195|P1|COMPLETED|Overall Study||108
8673291|NCT02478489|21411194|P2|STARTED|Overall Study||125
8673292|NCT02478489|21411195|P1|STARTED|Overall Study||123
8673293|NCT02390050|21411207|P4|NOT COMPLETED|Overall Study||7
8673294|NCT02390050|21411208|P3|NOT COMPLETED|Overall Study||4
8673295|NCT02390050|21411209|P2|NOT COMPLETED|Overall Study||5
8673296|NCT02390050|21411210|P1|NOT COMPLETED|Overall Study||7
8673297|NCT02390050|21411207|P4|COMPLETED|Overall Study||69
8673298|NCT02390050|21411208|P3|COMPLETED|Overall Study||68
8673299|NCT02390050|21411209|P2|COMPLETED|Overall Study||67
8673300|NCT02390050|21411210|P1|COMPLETED|Overall Study||65
8673301|NCT02390050|21411207|P4|STARTED|Overall Study||76
8673302|NCT02390050|21411208|P3|STARTED|Overall Study||72
8673303|NCT02390050|21411209|P2|STARTED|Overall Study||72
8673304|NCT02390050|21411210|P1|STARTED|Overall Study||72
8673305|NCT02352090|21411243|P3|NOT COMPLETED|Overall Study||2
8673306|NCT02352090|21411244|P2|NOT COMPLETED|Overall Study||0
8673307|NCT02352090|21411245|P1|NOT COMPLETED|Overall Study||1
8673308|NCT02352090|21411243|P3|COMPLETED|Overall Study||17
8673309|NCT02352090|21411244|P2|COMPLETED|Overall Study||20
8673310|NCT02352090|21411245|P1|COMPLETED|Overall Study||19
8673311|NCT02352090|21411243|P3|STARTED|Overall Study||19
8673312|NCT02352090|21411244|P2|STARTED|Overall Study||20
8673313|NCT02352090|21411245|P1|STARTED|Overall Study||20
8673314|NCT02325414|21411258|P2|NOT COMPLETED|Overall Study||6
8673315|NCT02325414|21411259|P1|NOT COMPLETED|Overall Study||8
8673316|NCT02325414|21411258|P2|COMPLETED|Overall Study||24
8673317|NCT02325414|21411259|P1|COMPLETED|Overall Study||22
8673318|NCT02325414|21411258|P2|STARTED|Overall Study||30
8673319|NCT02325414|21411259|P1|STARTED|Overall Study||30
8673320|NCT02303093|21411271|P1|NOT COMPLETED|Overall Study||0
8673321|NCT02303093|21411271|P1|COMPLETED|Overall Study||344
8673322|NCT02303093|21411271|P1|STARTED|Overall Study||344
8673323|NCT02281955|21411289|P1|NOT COMPLETED|Overall Study||1
8673324|NCT02281955|21411289|P1|COMPLETED|Overall Study||113
8673325|NCT02281955|21411289|P1|STARTED|Overall Study||114
8673326|NCT02181829|21411298|P1|NOT COMPLETED|Overall Study||0
8673327|NCT02181829|21411298|P1|COMPLETED|Overall Study||10
8673328|NCT02181829|21411298|P1|STARTED|Overall Study||10
8673329|NCT02067806|21411304|P1|NOT COMPLETED|Overall Study||7
8673330|NCT02067806|21411304|P1|COMPLETED|Overall Study||387
8673331|NCT02067806|21411304|P1|STARTED|Overall Study||394
8673332|NCT01948739|21411310|P1|NOT COMPLETED|Overall Study||8
8673333|NCT01948739|21411310|P1|COMPLETED|Overall Study||10
8673334|NCT01948739|21411310|P1|Received Intervention|Overall Study||10
8673335|NCT01948739|21411310|P1|STARTED|Overall Study||18
8673336|NCT01928199|21411326|P2|NOT COMPLETED|Overall Study||0
8673337|NCT01928199|21411327|P1|NOT COMPLETED|Overall Study||0
8673338|NCT01928199|21411326|P2|COMPLETED|Overall Study||29
8673339|NCT01928199|21411327|P1|COMPLETED|Overall Study||32
8673340|NCT01928199|21411326|P2|STARTED|Overall Study||29
8673341|NCT01928199|21411327|P1|STARTED|Overall Study||32
8673342|NCT01812759|21411336|P3|NOT COMPLETED|Overall Study||1
8673343|NCT01812759|21411337|P2|NOT COMPLETED|Overall Study||0
8673344|NCT01812759|21411338|P1|NOT COMPLETED|Overall Study||0
8673345|NCT01812759|21411336|P3|COMPLETED|Overall Study||0
8673346|NCT01812759|21411337|P2|COMPLETED|Overall Study||1
8673347|NCT01812759|21411338|P1|COMPLETED|Overall Study||1
8673348|NCT01812759|21411336|P3|STARTED|Overall Study||1
8673349|NCT01812759|21411337|P2|STARTED|Overall Study||1
8673350|NCT01812759|21411338|P1|STARTED|Overall Study||1
8673360|NCT01767857|21411379|P2|NOT COMPLETED|Overall Study||213
8673361|NCT01767857|21411380|P1|NOT COMPLETED|Overall Study||430
8673362|NCT01767857|21411379|P2|COMPLETED|Overall Study||0
8673363|NCT01767857|21411380|P1|COMPLETED|Overall Study||0
8673364|NCT01767857|21411379|P2|Treated|Overall Study||200
8673365|NCT01767857|21411380|P1|Treated|Overall Study||411
8673366|NCT01767857|21411379|P2|STARTED|Overall Study||213
8673367|NCT01767857|21411380|P1|STARTED|Overall Study||430
8673368|NCT01689740|21411401|P3|NOT COMPLETED|Overall Study||0
8673369|NCT01689740|21411402|P2|NOT COMPLETED|Overall Study||0
8673370|NCT01689740|21411403|P1|NOT COMPLETED|Overall Study||0
8673371|NCT01689740|21411401|P3|COMPLETED|Overall Study||5
8673372|NCT01689740|21411402|P2|COMPLETED|Overall Study||3
8673373|NCT01689740|21411403|P1|COMPLETED|Overall Study||2
8673374|NCT01689740|21411401|P3|STARTED|Overall Study||5
8673375|NCT01689740|21411402|P2|STARTED|Overall Study||3
8673376|NCT01689740|21411403|P1|STARTED|Overall Study||2
8673377|NCT01671111|21411443|P1|NOT COMPLETED|Overall Study||30
8673378|NCT01671111|21411443|P1|COMPLETED|Overall Study||0
8673379|NCT01671111|21411443|P1|STARTED|Overall Study||30
8673380|NCT01604941|21411455|P6|NOT COMPLETED|Overall Study||7
8673381|NCT01604941|21411456|P5|NOT COMPLETED|Overall Study||1
8673382|NCT01604941|21411457|P4|NOT COMPLETED|Overall Study||3
8673383|NCT01604941|21411458|P3|NOT COMPLETED|Overall Study||3
8673384|NCT01604941|21411459|P2|NOT COMPLETED|Overall Study||4
8673385|NCT01604941|21411460|P1|NOT COMPLETED|Overall Study||11
8673386|NCT01604941|21411455|P6|COMPLETED|Overall Study||0
8673387|NCT01604941|21411456|P5|COMPLETED|Overall Study||3
8673388|NCT01604941|21411457|P4|COMPLETED|Overall Study||0
8673389|NCT01604941|21411458|P3|COMPLETED|Overall Study||0
8673390|NCT01604941|21411459|P2|COMPLETED|Overall Study||0
8673391|NCT01604941|21411460|P1|COMPLETED|Overall Study||0
8673392|NCT01604941|21411455|P6|STARTED|Overall Study||7
8673393|NCT01604941|21411456|P5|STARTED|Overall Study||4
8673394|NCT01604941|21411457|P4|STARTED|Overall Study||3
8673395|NCT01604941|21411458|P3|STARTED|Overall Study||3
8673396|NCT01604941|21411459|P2|STARTED|Overall Study||4
8673397|NCT01604941|21411460|P1|STARTED|Overall Study||11
8673398|NCT01576783|21411488|P2|NOT COMPLETED|Overall Study||17
8673399|NCT01576783|21411489|P1|NOT COMPLETED|Overall Study||20
8673400|NCT01576783|21411488|P2|COMPLETED|Overall Study||171
8673401|NCT01576783|21411489|P1|COMPLETED|Overall Study||169
8673402|NCT01576783|21411488|P2|STARTED|Overall Study||188
8673403|NCT01576783|21411489|P1|STARTED|Overall Study||189
8673404|NCT01527149|21411531|P1|NOT COMPLETED|Overall Study||2
8673405|NCT01527149|21411531|P1|COMPLETED|Overall Study||35
8673406|NCT01527149|21411531|P1|STARTED|Overall Study||37
8673407|NCT01471093|21411548|P4|NOT COMPLETED|Overall Study||0
8673408|NCT01471093|21411549|P3|NOT COMPLETED|Overall Study||0
8673409|NCT01471093|21411550|P2|NOT COMPLETED|Overall Study||0
8673410|NCT01471093|21411551|P1|NOT COMPLETED|Overall Study||1
8673411|NCT01471093|21411548|P4|COMPLETED|Overall Study||25
8673412|NCT01471093|21411549|P3|COMPLETED|Overall Study||25
8673413|NCT01471093|21411550|P2|COMPLETED|Overall Study||25
8673414|NCT01471093|21411551|P1|COMPLETED|Overall Study||24
8673415|NCT01471093|21411548|P4|STARTED|Overall Study||25
8673416|NCT01471093|21411549|P3|STARTED|Overall Study||25
8673417|NCT01471093|21411550|P2|STARTED|Overall Study||25
8673418|NCT01471093|21411551|P1|STARTED|Overall Study||25
8673419|NCT01218542|21411559|P1|NOT COMPLETED|Overall Study||9
8673420|NCT01218542|21411559|P1|COMPLETED|Overall Study||13
8673421|NCT01218542|21411559|P1|STARTED|Overall Study||22
8673422|NCT01023477|21411569|P2|NOT COMPLETED|Overall Study||0
8673423|NCT01023477|21411570|P1|NOT COMPLETED|Overall Study||0
8673424|NCT01023477|21411569|P2|COMPLETED|Overall Study||5
8673425|NCT01023477|21411570|P1|COMPLETED|Overall Study||7
8673426|NCT01023477|21411569|P2|STARTED|Overall Study||5
8673427|NCT01023477|21411570|P1|STARTED|Overall Study||7
8673446|NCT00681031|21411639|P1|NOT COMPLETED|Overall Study||0
8673447|NCT00681031|21411639|P1|COMPLETED|Overall Study||96
8673448|NCT00681031|21411639|P1|STARTED|Overall Study||96
8673449|NCT00631163|21411643|P1|NOT COMPLETED|Number of Participants in Year 2||5
8673450|NCT00631163|21411643|P1|COMPLETED|Number of Participants in Year 2||52
8673451|NCT00631163|21411643|P1|STARTED|Number of Participants in Year 2||57
8673452|NCT00631163|21411643|P1|NOT COMPLETED|Number of Participants in Year 1||34
8673453|NCT00631163|21411643|P1|COMPLETED|Number of Participants in Year 1||68
8673454|NCT00631163|21411643|P1|STARTED|Number of Participants in Year 1||102
8673455|NCT00430625|21411663|P2|NOT COMPLETED|Overall Study||0
8673456|NCT00430625|21411664|P1|NOT COMPLETED|Overall Study||0
8673457|NCT00430625|21411663|P2|COMPLETED|Overall Study||12
8673458|NCT00430625|21411664|P1|COMPLETED|Overall Study||13
8673459|NCT00430625|21411663|P2|STARTED|Overall Study||12
8673460|NCT00430625|21411664|P1|STARTED|Overall Study||13
8673461|NCT00413634|21411682|P2|NOT COMPLETED|Overall Study||0
8673462|NCT00413634|21411683|P1|NOT COMPLETED|Overall Study||0
8673463|NCT00413634|21411682|P2|COMPLETED|Overall Study||12
8673464|NCT00413634|21411683|P1|COMPLETED|Overall Study||12
8673465|NCT00413634|21411682|P2|STARTED|Overall Study||12
8673466|NCT00413634|21411683|P1|STARTED|Overall Study||12
8673473|NCT00185640|21411734|P1|NOT COMPLETED|Overall Study||145
8673474|NCT00185640|21411734|P1|COMPLETED|Overall Study||158
8673475|NCT00185640|21411734|P1|90 Days Post-transplant|Overall Study||161
8673476|NCT00185640|21411734|P1|Transplanted|Overall Study||296
8673477|NCT00185640|21411734|P1|STARTED|Overall Study||303
8673478|NCT00109707|21411746|P3|NOT COMPLETED|Overall Study||41
8673479|NCT00109707|21411747|P2|NOT COMPLETED|Overall Study||129
8673480|NCT00109707|21411748|P1|NOT COMPLETED|Overall Study||254
8673481|NCT00109707|21411746|P3|COMPLETED|Overall Study||8
8673482|NCT00109707|21411747|P2|COMPLETED|Overall Study||8
8673483|NCT00109707|21411748|P1|COMPLETED|Overall Study||67
8673484|NCT00109707|21411746|P3|Entered Extension Study|Overall Study||15
8673485|NCT00109707|21411747|P2|Entered Extension Study|Overall Study||15
8673486|NCT00109707|21411748|P1|Entered Extension Study|Overall Study||106
8673487|NCT00109707|21411746|P3|STARTED|Overall Study||49
8673488|NCT00109707|21411747|P2|STARTED|Overall Study||137
8673489|NCT00109707|21411748|P1|STARTED|Overall Study||321
8673496|NCT04724538|21411804|P2|NOT COMPLETED|Overall Study||0
8673497|NCT04724538|21411805|P1|NOT COMPLETED|Overall Study||0
8673498|NCT04724538|21411804|P2|COMPLETED|Overall Study||14
8673499|NCT04724538|21411805|P1|COMPLETED|Overall Study||11
8673500|NCT04724538|21411804|P2|STARTED|Overall Study||14
8673501|NCT04724538|21411805|P1|STARTED|Overall Study||11
8673502|NCT04653766|21411834|P5|NOT COMPLETED|Overall Study||0
8673503|NCT04653766|21411835|P4|NOT COMPLETED|Overall Study||0
8673504|NCT04653766|21411836|P3|NOT COMPLETED|Overall Study||0
8673505|NCT04653766|21411837|P2|NOT COMPLETED|Overall Study||0
8673506|NCT04653766|21411838|P1|NOT COMPLETED|Overall Study||0
8673507|NCT04653766|21411834|P5|COMPLETED|Overall Study||8
8673508|NCT04653766|21411835|P4|COMPLETED|Overall Study||6
8673509|NCT04653766|21411836|P3|COMPLETED|Overall Study||6
8673510|NCT04653766|21411837|P2|COMPLETED|Overall Study||6
8673511|NCT04653766|21411838|P1|COMPLETED|Overall Study||6
8673512|NCT04653766|21411834|P5|STARTED|Overall Study||8
8673513|NCT04653766|21411835|P4|STARTED|Overall Study||6
8673514|NCT04653766|21411836|P3|STARTED|Overall Study||6
8673515|NCT04653766|21411837|P2|STARTED|Overall Study||6
8673516|NCT04653766|21411838|P1|STARTED|Overall Study||6
8673517|NCT04530591|21411876|P1|NOT COMPLETED|Overall Study||0
8673518|NCT04530591|21411876|P1|COMPLETED|Overall Study||97
8673519|NCT04530591|21411876|P1|STARTED|Overall Study||97
8673520|NCT04439110|21411881|P1|NOT COMPLETED|Overall Study||38
8673521|NCT04439110|21411881|P1|COMPLETED|Overall Study||0
8673522|NCT04439110|21411881|P1|Eligible|Overall Study||36
8673523|NCT04439110|21411881|P1|STARTED|Overall Study||38
8673524|NCT04370548|21411889|P2|NOT COMPLETED|Overall Study||3
8673525|NCT04370548|21411890|P1|NOT COMPLETED|Overall Study||14
8673526|NCT04370548|21411889|P2|COMPLETED|Overall Study||100
8673527|NCT04370548|21411890|P1|COMPLETED|Overall Study||190
8673528|NCT04370548|21411889|P2|STARTED|Overall Study||103
8673529|NCT04370548|21411890|P1|STARTED|Overall Study||204
8673530|NCT04328467|21411921|P3|NOT COMPLETED|Overall Study||1
8673531|NCT04328467|21411922|P2|NOT COMPLETED|Overall Study||2
8673532|NCT04328467|21411923|P1|NOT COMPLETED|Overall Study||4
8673533|NCT04328467|21411921|P3|COMPLETED|Overall Study||493
8673534|NCT04328467|21411922|P2|COMPLETED|Overall Study||493
8673535|NCT04328467|21411923|P1|COMPLETED|Overall Study||490
8673536|NCT04328467|21411921|P3|STARTED|Overall Study||494
8673537|NCT04328467|21411922|P2|STARTED|Overall Study||495
8673538|NCT04328467|21411923|P1|STARTED|Overall Study||494
8673539|NCT04320615|21411951|P2|NOT COMPLETED|Overall Study||104
8673540|NCT04320615|21411952|P1|NOT COMPLETED|Overall Study||48
8673541|NCT04320615|21411951|P2|COMPLETED|Overall Study||190
8673542|NCT04320615|21411952|P1|COMPLETED|Overall Study||96
8673543|NCT04320615|21411951|P2|STARTED|Overall Study||294
8673544|NCT04320615|21411952|P1|STARTED|Overall Study||144
8673545|NCT04234672|21411986|P1|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0
8673546|NCT04234672|21411986|P1|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6
8673547|NCT04234672|21411986|P1|STARTED|Treatment Period 2(Day9[Day1of Period2])||6
8673548|NCT04234672|21411986|P1|NOT COMPLETED|Washout Period (Day 2 to 8)||0
8673549|NCT04234672|21411986|P1|COMPLETED|Washout Period (Day 2 to 8)||6
8673550|NCT04234672|21411986|P1|STARTED|Washout Period (Day 2 to 8)||6
8673551|NCT04234672|21411986|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
8673552|NCT04234672|21411986|P1|COMPLETED|Treatment Period 1 (Day 1)||6
8673553|NCT04234672|21411986|P1|STARTED|Treatment Period 1 (Day 1)||6
8673554|NCT04228302|21412039|P6|NOT COMPLETED|Overall Study||0
8673555|NCT04228302|21412040|P5|NOT COMPLETED|Overall Study||1
8673556|NCT04228302|21412041|P4|NOT COMPLETED|Overall Study||0
8673557|NCT04228302|21412042|P3|NOT COMPLETED|Overall Study||0
8673558|NCT04228302|21412043|P2|NOT COMPLETED|Overall Study||0
8673559|NCT04228302|21412044|P1|NOT COMPLETED|Overall Study||0
8673560|NCT04228302|21412039|P6|COMPLETED|Overall Study||10
8673561|NCT04228302|21412040|P5|COMPLETED|Overall Study||5
8673562|NCT04228302|21412041|P4|COMPLETED|Overall Study||6
8673563|NCT04228302|21412042|P3|COMPLETED|Overall Study||6
8673564|NCT04228302|21412043|P2|COMPLETED|Overall Study||6
8673565|NCT04228302|21412044|P1|COMPLETED|Overall Study||6
8673566|NCT04228302|21412039|P6|STARTED|Overall Study||10
8673567|NCT04228302|21412040|P5|STARTED|Overall Study||6
8673568|NCT04228302|21412041|P4|STARTED|Overall Study||6
8673569|NCT04228302|21412042|P3|STARTED|Overall Study||6
8673570|NCT04228302|21412043|P2|STARTED|Overall Study||6
8673571|NCT04228302|21412044|P1|STARTED|Overall Study||6
8673572|NCT04167189|21412124|P1|NOT COMPLETED|Overall Study||0
8673573|NCT04167189|21412124|P1|COMPLETED|Overall Study||28
8673574|NCT04167189|21412124|P1|STARTED|Overall Study||28
8673575|NCT04087343|21412130|P2|NOT COMPLETED|Overall Study||0
8673576|NCT04087343|21412131|P1|NOT COMPLETED|Overall Study||0
8673577|NCT04087343|21412130|P2|COMPLETED|Overall Study||5
8673578|NCT04087343|21412131|P1|COMPLETED|Overall Study||4
8673579|NCT04087343|21412130|P2|STARTED|Overall Study||5
8673580|NCT04087343|21412131|P1|STARTED|Overall Study||4
8673581|NCT04081324|21412143|P4|NOT COMPLETED|Overall Study||0
8673582|NCT04081324|21412144|P3|NOT COMPLETED|Overall Study||0
8673583|NCT04081324|21412145|P2|NOT COMPLETED|Overall Study||0
8673584|NCT04081324|21412146|P1|NOT COMPLETED|Overall Study||0
8673585|NCT04081324|21412143|P4|COMPLETED|Overall Study||10
8673586|NCT04081324|21412144|P3|COMPLETED|Overall Study||10
8673587|NCT04081324|21412145|P2|COMPLETED|Overall Study||10
8673588|NCT04081324|21412146|P1|COMPLETED|Overall Study||6
8673589|NCT04081324|21412143|P4|Received At Least One Dose of Study Drug|Overall Study||10
8673590|NCT04081324|21412144|P3|Received At Least One Dose of Study Drug|Overall Study||10
8673591|NCT04081324|21412145|P2|Received At Least One Dose of Study Drug|Overall Study||10
8673592|NCT04081324|21412146|P1|Received At Least One Dose of Study Drug|Overall Study||6
8673593|NCT04081324|21412143|P4|STARTED|Overall Study||10
8673594|NCT04081324|21412144|P3|STARTED|Overall Study||10
8673595|NCT04081324|21412145|P2|STARTED|Overall Study||10
8673596|NCT04081324|21412146|P1|STARTED|Overall Study||6
8673597|NCT04073368|21412168|P4|NOT COMPLETED|Overall Study||2
8673598|NCT04073368|21412169|P3|NOT COMPLETED|Overall Study||3
8673599|NCT04073368|21412170|P2|NOT COMPLETED|Overall Study||8
8673600|NCT04073368|21412171|P1|NOT COMPLETED|Overall Study||12
8673601|NCT04073368|21412168|P4|COMPLETED|Overall Study||13
8673602|NCT04073368|21412169|P3|COMPLETED|Overall Study||26
8673603|NCT04073368|21412170|P2|COMPLETED|Overall Study||18
8673604|NCT04073368|21412171|P1|COMPLETED|Overall Study||20
8673605|NCT04073368|21412168|P4|STARTED|Overall Study||15
8673606|NCT04073368|21412169|P3|STARTED|Overall Study||29
8673607|NCT04073368|21412170|P2|STARTED|Overall Study||26
8673608|NCT04073368|21412171|P1|STARTED|Overall Study||32
8673609|NCT04067011|21412204|P3|NOT COMPLETED|Overall Study||8
8673610|NCT04067011|21412205|P2|NOT COMPLETED|Overall Study||13
8673611|NCT04067011|21412206|P1|NOT COMPLETED|Overall Study||19
8673612|NCT04067011|21412204|P3|COMPLETED|Overall Study||61
8673613|NCT04067011|21412205|P2|COMPLETED|Overall Study||58
8673614|NCT04067011|21412206|P1|COMPLETED|Overall Study||51
8673615|NCT04067011|21412204|P3|STARTED|Overall Study||69
8673616|NCT04067011|21412205|P2|STARTED|Overall Study||71
8673617|NCT04067011|21412206|P1|STARTED|Overall Study||70
8673618|NCT04058353|21412218|P2|NOT COMPLETED|Overall Study||1
8673619|NCT04058353|21412219|P1|NOT COMPLETED|Overall Study||4
8673620|NCT04058353|21412218|P2|COMPLETED|Overall Study||131
8673621|NCT04058353|21412219|P1|COMPLETED|Overall Study||122
8673622|NCT04058353|21412218|P2|STARTED|Overall Study||132
8673623|NCT04058353|21412219|P1|STARTED|Overall Study||126
8673624|NCT04019626|21412239|P6|NOT COMPLETED|Overall Study||1
8673625|NCT04019626|21412240|P5|NOT COMPLETED|Overall Study||6
8673626|NCT04019626|21412241|P4|NOT COMPLETED|Overall Study||7
8673627|NCT04019626|21412242|P3|NOT COMPLETED|Overall Study||8
8673628|NCT04019626|21412243|P2|NOT COMPLETED|Overall Study||10
8673629|NCT04019626|21412244|P1|NOT COMPLETED|Overall Study||6
8673630|NCT04019626|21412239|P6|COMPLETED|Overall Study||20
8673631|NCT04019626|21412240|P5|COMPLETED|Overall Study||38
8673632|NCT04019626|21412241|P4|COMPLETED|Overall Study||39
8673633|NCT04019626|21412242|P3|COMPLETED|Overall Study||37
8673634|NCT04019626|21412243|P2|COMPLETED|Overall Study||32
8673635|NCT04019626|21412244|P1|COMPLETED|Overall Study||36
8673636|NCT04019626|21412239|P6|STARTED|Overall Study||21
8673637|NCT04019626|21412240|P5|STARTED|Overall Study||44
8673638|NCT04019626|21412241|P4|STARTED|Overall Study||46
8673639|NCT04019626|21412242|P3|STARTED|Overall Study||45
8673640|NCT04019626|21412243|P2|STARTED|Overall Study||42
8673641|NCT04019626|21412244|P1|STARTED|Overall Study||42
8673642|NCT04013191|21412295|P2|NOT COMPLETED|Overall Study||0
8673643|NCT04013191|21412296|P1|NOT COMPLETED|Overall Study||1
8673644|NCT04013191|21412295|P2|COMPLETED|Overall Study||18
8673645|NCT04013191|21412296|P1|COMPLETED|Overall Study||9
8673646|NCT04013191|21412295|P2|Completed Period 1B (Multiple Dose)|Overall Study||18
8673647|NCT04013191|21412296|P1|Completed Period 1B (Multiple Dose)|Overall Study||9
8673648|NCT04013191|21412295|P2|Completed Period 1A (Single Dose)|Overall Study||18
8673649|NCT04013191|21412296|P1|Completed Period 1A (Single Dose)|Overall Study||10
8673650|NCT04013191|21412295|P2|STARTED|Overall Study||18
8673651|NCT04013191|21412296|P1|STARTED|Overall Study||10
8673652|NCT04011826|21412322|P1|NOT COMPLETED|Overall Study||0
8673653|NCT04011826|21412322|P1|COMPLETED|Overall Study||45
8673654|NCT04011826|21412322|P1|STARTED|Overall Study||45
8673655|NCT04005391|21412330|P2|NOT COMPLETED|Overall Study||0
8673656|NCT04005391|21412331|P1|NOT COMPLETED|Overall Study||7
8673657|NCT04005391|21412330|P2|COMPLETED|Overall Study||100
8673658|NCT04005391|21412331|P1|COMPLETED|Overall Study||101
8673659|NCT04005391|21412330|P2|STARTED|Overall Study|10/23/18|100
8673660|NCT04005391|21412331|P1|STARTED|Overall Study|10/23/18|108
8673673|NCT03978832|21412378|P1|NOT COMPLETED|Overall Study||54
8673674|NCT03978832|21412378|P1|COMPLETED|Overall Study||15
8673675|NCT03978832|21412378|P1|Treatment Period|Overall Study||23
8673676|NCT03978832|21412378|P1|Stabilization Period|Overall Study||25
8673677|NCT03978832|21412378|P1|STARTED|Overall Study|69 participants signed the ICF and entered screening; 25 met eligibility criteria and were enrolled.|69
8673678|NCT03956550|21412403|P3|NOT COMPLETED|Overall Study||70
8673679|NCT03956550|21412404|P2|NOT COMPLETED|Overall Study||72
8673680|NCT03956550|21412405|P1|NOT COMPLETED|Overall Study||70
8673681|NCT03956550|21412403|P3|COMPLETED|Overall Study||15
8673682|NCT03956550|21412404|P2|COMPLETED|Overall Study||14
8673683|NCT03956550|21412405|P1|COMPLETED|Overall Study||18
8673684|NCT03956550|21412403|P3|STARTED|Overall Study||85
8673685|NCT03956550|21412404|P2|STARTED|Overall Study||86
8673686|NCT03956550|21412405|P1|STARTED|Overall Study||88
8673687|NCT03900728|21412440|P3|NOT COMPLETED|Overall Study||4
8673688|NCT03900728|21412441|P2|NOT COMPLETED|Overall Study||0
8673689|NCT03900728|21412442|P1|NOT COMPLETED|Overall Study||0
8673690|NCT03900728|21412440|P3|COMPLETED|Overall Study||35
8673691|NCT03900728|21412441|P2|COMPLETED|Overall Study||57
8673692|NCT03900728|21412442|P1|COMPLETED|Overall Study||40
8673693|NCT03900728|21412440|P3|STARTED|Overall Study||39
8673694|NCT03900728|21412441|P2|STARTED|Overall Study||57
8673695|NCT03900728|21412442|P1|STARTED|Overall Study||40
8673696|NCT03898063|21412455|P2|NOT COMPLETED|Overall Study||8
8673697|NCT03898063|21412456|P1|NOT COMPLETED|Overall Study||10
8673698|NCT03898063|21412455|P2|COMPLETED|Overall Study||66
8673699|NCT03898063|21412456|P1|COMPLETED|Overall Study||64
8673700|NCT03898063|21412455|P2|STARTED|Overall Study||74
8673701|NCT03898063|21412456|P1|STARTED|Overall Study||74
8673702|NCT03838731|21412468|P2|NOT COMPLETED|Overall Study||1
8673703|NCT03838731|21412469|P1|NOT COMPLETED|Overall Study||1
8673704|NCT03838731|21412468|P2|COMPLETED|Overall Study||28
8673705|NCT03838731|21412469|P1|COMPLETED|Overall Study||26
8673706|NCT03838731|21412468|P2|STARTED|Overall Study||29
8673707|NCT03838731|21412469|P1|STARTED|Overall Study||27
8673714|NCT03779997|21412522|P2|NOT COMPLETED|Overall Study||0
8673715|NCT03779997|21412523|P1|NOT COMPLETED|Overall Study||0
8673716|NCT03779997|21412522|P2|COMPLETED|Overall Study||39
8673717|NCT03779997|21412523|P1|COMPLETED|Overall Study||39
8673718|NCT03779997|21412522|P2|Completed at Least One Visit|Overall Study||39
8673719|NCT03779997|21412523|P1|Completed at Least One Visit|Overall Study||39
8673720|NCT03779997|21412522|P2|STARTED|Overall Study||39
8673721|NCT03779997|21412523|P1|STARTED|Overall Study||39
8673722|NCT03769194|21412551|P4|NOT COMPLETED|Overall Study||3
8673723|NCT03769194|21412552|P3|NOT COMPLETED|Overall Study||4
8673724|NCT03769194|21412553|P2|NOT COMPLETED|Overall Study||10
8673725|NCT03769194|21412554|P1|NOT COMPLETED|Overall Study||1
8673726|NCT03769194|21412551|P4|COMPLETED|Overall Study||121
8673727|NCT03769194|21412552|P3|COMPLETED|Overall Study||201
8673728|NCT03769194|21412553|P2|COMPLETED|Overall Study||204
8673729|NCT03769194|21412554|P1|COMPLETED|Overall Study||28
8673730|NCT03769194|21412551|P4|STARTED|Overall Study||124
8673731|NCT03769194|21412552|P3|STARTED|Overall Study||205
8673732|NCT03769194|21412553|P2|STARTED|Overall Study||214
8673733|NCT03769194|21412554|P1|STARTED|Overall Study||29
8673734|NCT03758157|21412564|P1|NOT COMPLETED|Overall Study||0
8673735|NCT03758157|21412564|P1|COMPLETED|Overall Study||110
8673736|NCT03758157|21412564|P1|STARTED|Overall Study||110
8673737|NCT03748706|21412569|P1|NOT COMPLETED|Overall Study||1
8673738|NCT03748706|21412569|P1|COMPLETED|Overall Study||12
8673739|NCT03748706|21412569|P1|STARTED|Overall Study||13
8673740|NCT03739593|21412583|P3|NOT COMPLETED|Overall Study||8
8673741|NCT03739593|21412584|P2|NOT COMPLETED|Overall Study||6
8673742|NCT03739593|21412585|P1|NOT COMPLETED|Overall Study||3
8673743|NCT03739593|21412583|P3|COMPLETED|Overall Study||14
8673744|NCT03739593|21412584|P2|COMPLETED|Overall Study||16
8673745|NCT03739593|21412585|P1|COMPLETED|Overall Study||2
8673746|NCT03739593|21412583|P3|STARTED|Overall Study||22
8673747|NCT03739593|21412584|P2|STARTED|Overall Study||22
8673748|NCT03739593|21412585|P1|STARTED|Overall Study||5
8673779|NCT03717051|21412926|P2|NOT COMPLETED|Overall Study||0
8673780|NCT03717051|21412927|P1|NOT COMPLETED|Overall Study||0
8673781|NCT03717051|21412926|P2|COMPLETED|Overall Study||482
8673782|NCT03717051|21412927|P1|COMPLETED|Overall Study||352
8673783|NCT03717051|21412926|P2|STARTED|Overall Study||482
8673784|NCT03717051|21412927|P1|STARTED|Overall Study||352
8673785|NCT03695367|21412967|P2|NOT COMPLETED|Overall Study||4
8673786|NCT03695367|21412968|P1|NOT COMPLETED|Overall Study||1
8673787|NCT03695367|21412967|P2|COMPLETED|Overall Study||26
8673788|NCT03695367|21412968|P1|COMPLETED|Overall Study||32
8673789|NCT03695367|21412967|P2|STARTED|Overall Study||30
8673790|NCT03695367|21412968|P1|STARTED|Overall Study||33
8673791|NCT03670810|21412985|P4|NOT COMPLETED|Overall Study||38
8673792|NCT03670810|21412986|P3|NOT COMPLETED|Overall Study||41
8673793|NCT03670810|21412987|P2|NOT COMPLETED|Overall Study||117
8673794|NCT03670810|21412988|P1|NOT COMPLETED|Overall Study||104
8673795|NCT03670810|21412985|P4|COMPLETED|Overall Study||213
8673796|NCT03670810|21412986|P3|COMPLETED|Overall Study||208
8673797|NCT03670810|21412987|P2|COMPLETED|Overall Study||369
8673798|NCT03670810|21412988|P1|COMPLETED|Overall Study||381
8673799|NCT03670810|21412985|P4|Treated at Least One Migraine Attack|Overall Study||251
8673800|NCT03670810|21412986|P3|Treated at Least One Migraine Attack|Overall Study||249
8673801|NCT03670810|21412987|P2|Treated at Least One Migraine Attack|Overall Study||486
8673802|NCT03670810|21412988|P1|Treated at Least One Migraine Attack|Overall Study||485
8673803|NCT03670810|21412985|P4|STARTED|Overall Study||251
8673804|NCT03670810|21412986|P3|STARTED|Overall Study||249
8673805|NCT03670810|21412987|P2|STARTED|Overall Study||486
8673806|NCT03670810|21412988|P1|STARTED|Overall Study||485
8673807|NCT03667053|21413062|P3|NOT COMPLETED|Overall Study||0
8673808|NCT03667053|21413063|P2|NOT COMPLETED|Overall Study||0
8673809|NCT03667053|21413064|P1|NOT COMPLETED|Overall Study||1
8673810|NCT03667053|21413062|P3|COMPLETED|Overall Study||10
8673811|NCT03667053|21413063|P2|COMPLETED|Overall Study||11
8673812|NCT03667053|21413064|P1|COMPLETED|Overall Study||20
8673813|NCT03667053|21413062|P3|Randomized and Treated|Overall Study||10
8673814|NCT03667053|21413063|P2|Randomized and Treated|Overall Study||11
8673815|NCT03667053|21413064|P1|Randomized and Treated|Overall Study||20
8673816|NCT03667053|21413062|P3|STARTED|Overall Study||10
8673817|NCT03667053|21413063|P2|STARTED|Overall Study||11
8673818|NCT03667053|21413064|P1|STARTED|Overall Study||21
8673819|NCT03662750|21413113|P1|NOT COMPLETED|Overall Study||1
8673820|NCT03662750|21413113|P1|COMPLETED|Overall Study||2
8673821|NCT03662750|21413113|P1|STARTED|Overall Study||3
8673822|NCT03654326|21413120|P2|NOT COMPLETED|Overall Study||6
8673823|NCT03654326|21413121|P1|NOT COMPLETED|Overall Study||6
8673824|NCT03654326|21413120|P2|COMPLETED|Overall Study||87
8673825|NCT03654326|21413121|P1|COMPLETED|Overall Study||88
8673826|NCT03654326|21413120|P2|STARTED|Overall Study||93
8673827|NCT03654326|21413121|P1|STARTED|Overall Study||94
8673828|NCT03639779|21413135|P1|NOT COMPLETED|Overall Study||1
8673829|NCT03639779|21413135|P1|COMPLETED|Overall Study||4
8673830|NCT03639779|21413135|P1|Month 3|Overall Study||4
8673831|NCT03639779|21413135|P1|Month 2|Overall Study||4
8673832|NCT03639779|21413135|P1|Month 1|Overall Study||5
8673833|NCT03639779|21413135|P1|Baseline|Overall Study||5
8673834|NCT03639779|21413135|P1|STARTED|Overall Study||5
8673835|NCT03639766|21413145|P1|NOT COMPLETED|Overall Study||0
8673836|NCT03639766|21413145|P1|COMPLETED|Overall Study||3
8673837|NCT03639766|21413145|P1|STARTED|Overall Study||3
8673838|NCT03586167|21413153|P2|NOT COMPLETED|Overall Study||0
8673839|NCT03586167|21413154|P1|NOT COMPLETED|Overall Study||1
8673840|NCT03586167|21413153|P2|COMPLETED|Overall Study||28
8673841|NCT03586167|21413154|P1|COMPLETED|Overall Study||57
8673842|NCT03586167|21413153|P2|STARTED|Overall Study||28
8673843|NCT03586167|21413154|P1|STARTED|Overall Study||58
8673844|NCT03569098|21413163|P3|NOT COMPLETED|Open-Label Treatment Cycle 3||6
8673845|NCT03569098|21413164|P2|NOT COMPLETED|Open-Label Treatment Cycle 3||1
8673846|NCT03569098|21413165|P1|NOT COMPLETED|Open-Label Treatment Cycle 3||0
8673847|NCT03569098|21413163|P3|COMPLETED|Open-Label Treatment Cycle 3||50
8673848|NCT03569098|21413164|P2|COMPLETED|Open-Label Treatment Cycle 3||7
8673849|NCT03569098|21413165|P1|COMPLETED|Open-Label Treatment Cycle 3||0
8673850|NCT03569098|21413163|P3|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 500 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|56
8673851|NCT03569098|21413164|P2|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 300 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|8
8673852|NCT03569098|21413165|P1|STARTED|Open-Label Treatment Cycle 3||0
8673853|NCT03569098|21413163|P3|NOT COMPLETED|Open-Label Treatment Cycle 2||0
8673854|NCT03569098|21413164|P2|NOT COMPLETED|Open-Label Treatment Cycle 2||35
8673855|NCT03569098|21413165|P1|NOT COMPLETED|Open-Label Treatment Cycle 2||0
8673856|NCT03569098|21413163|P3|COMPLETED|Open-Label Treatment Cycle 2||0
8673857|NCT03569098|21413164|P2|COMPLETED|Open-Label Treatment Cycle 2||111
8673858|NCT03569098|21413165|P1|COMPLETED|Open-Label Treatment Cycle 2||0
8673859|NCT03569098|21413163|P3|STARTED|Open-Label Treatment Cycle 2|No participants were treated with Dysport 500 U during the open-label treatment cycle 2.|0
8673860|NCT03569098|21413164|P2|STARTED|Open-Label Treatment Cycle 2|All participants who met retreatment criteria were treated with Dysport 300 U during the open-label treatment cycle 2.|146
8673861|NCT03569098|21413165|P1|STARTED|Open-Label Treatment Cycle 2|No participants were treated with placebo during the open-label treatment cycle 2.|0
8673862|NCT03569098|21413163|P3|NOT COMPLETED|Double-Blind Treatment Cycle 1||11
8673863|NCT03569098|21413164|P2|NOT COMPLETED|Double-Blind Treatment Cycle 1||10
8673864|NCT03569098|21413165|P1|NOT COMPLETED|Double-Blind Treatment Cycle 1||8
8673865|NCT03569098|21413163|P3|COMPLETED|Double-Blind Treatment Cycle 1||49
8673866|NCT03569098|21413164|P2|COMPLETED|Double-Blind Treatment Cycle 1||53
8673867|NCT03569098|21413165|P1|COMPLETED|Double-Blind Treatment Cycle 1||55
8673868|NCT03569098|21413163|P3|Received Study Medication|Double-Blind Treatment Cycle 1||56
8673869|NCT03569098|21413164|P2|Received Study Medication|Double-Blind Treatment Cycle 1||63
8673870|NCT03569098|21413165|P1|Received Study Medication|Double-Blind Treatment Cycle 1||61
8673871|NCT03569098|21413163|P3|STARTED|Double-Blind Treatment Cycle 1||60
8673872|NCT03569098|21413164|P2|STARTED|Double-Blind Treatment Cycle 1||63
8673873|NCT03569098|21413165|P1|STARTED|Double-Blind Treatment Cycle 1||63
8673874|NCT03567616|21413217|P1|NOT COMPLETED|Overall Study||8
8673875|NCT03567616|21413217|P1|COMPLETED|Overall Study||0
8673876|NCT03567616|21413217|P1|STARTED|Overall Study||8
8673877|NCT03557372|21413235|P1|NOT COMPLETED|Overall Study||0
8673878|NCT03557372|21413235|P1|COMPLETED|Overall Study||14
8673879|NCT03557372|21413235|P1|STARTED|Overall Study||14
8673880|NCT03496701|21413239|P1|NOT COMPLETED|Overall Study||0
8673881|NCT03496701|21413239|P1|COMPLETED|Overall Study||77
8673882|NCT03496701|21413239|P1|STARTED|Overall Study||77
8673883|NCT03494816|21413255|P1|NOT COMPLETED|Overall Study||6
8673884|NCT03494816|21413255|P1|COMPLETED|Overall Study||18
8673885|NCT03494816|21413255|P1|STARTED|Overall Study||24
8673886|NCT03485287|21413263|P1|NOT COMPLETED|Overall Study||0
8673887|NCT03485287|21413263|P1|COMPLETED|Overall Study||4
8673888|NCT03485287|21413263|P1|STARTED|Overall Study||4
8673889|NCT03476798|21413272|P1|NOT COMPLETED|Overall Study||5
8673890|NCT03476798|21413272|P1|COMPLETED|Overall Study||28
8673891|NCT03476798|21413272|P1|STARTED|Overall Study||33
8673892|NCT03451084|21413284|P4|NOT COMPLETED|Overall Study||6
8673893|NCT03451084|21413285|P3|NOT COMPLETED|Overall Study||6
8673894|NCT03451084|21413286|P2|NOT COMPLETED|Overall Study||6
8673895|NCT03451084|21413287|P1|NOT COMPLETED|Overall Study||6
8673896|NCT03451084|21413284|P4|COMPLETED|Overall Study||0
8673897|NCT03451084|21413285|P3|COMPLETED|Overall Study||0
8673898|NCT03451084|21413286|P2|COMPLETED|Overall Study||0
8673899|NCT03451084|21413287|P1|COMPLETED|Overall Study||0
8673900|NCT03451084|21413284|P4|STARTED|Overall Study||6
8673901|NCT03451084|21413285|P3|STARTED|Overall Study||6
8673902|NCT03451084|21413286|P2|STARTED|Overall Study||6
8673903|NCT03451084|21413287|P1|STARTED|Overall Study||6
8673907|NCT03417804|21413324|P1|NOT COMPLETED|Overall Study||0
8673908|NCT03417804|21413324|P1|COMPLETED|Overall Study||366
8673909|NCT03417804|21413324|P1|STARTED|Overall Study|at least 360 patients|366
8673927|NCT03390101|21413357|P3|NOT COMPLETED|Weeks 12-54||2
8673928|NCT03390101|21413358|P2|NOT COMPLETED|Weeks 12-54||4
8673929|NCT03390101|21413359|P1|NOT COMPLETED|Weeks 12-54||3
8673930|NCT03390101|21413357|P3|COMPLETED|Weeks 12-54||41
8673931|NCT03390101|21413358|P2|COMPLETED|Weeks 12-54||78
8673932|NCT03390101|21413359|P1|COMPLETED|Weeks 12-54||82
8673933|NCT03390101|21413357|P3|STARTED|Weeks 12-54||43
8673934|NCT03390101|21413358|P2|STARTED|Weeks 12-54||82
8673935|NCT03390101|21413359|P1|STARTED|Weeks 12-54||85
8673936|NCT03390101|21413357|P3|NOT COMPLETED|Weeks 0-12||1
8673937|NCT03390101|21413358|P2|NOT COMPLETED|Weeks 0-12||2
8673938|NCT03390101|21413359|P1|NOT COMPLETED|Weeks 0-12||0
8673939|NCT03390101|21413357|P3|COMPLETED|Weeks 0-12||43
8673940|NCT03390101|21413358|P2|COMPLETED|Weeks 0-12||82
8673941|NCT03390101|21413359|P1|COMPLETED|Weeks 0-12||85
8673942|NCT03390101|21413357|P3|STARTED|Weeks 0-12||44
8673943|NCT03390101|21413358|P2|STARTED|Weeks 0-12||84
8673944|NCT03390101|21413359|P1|STARTED|Weeks 0-12||85
8673945|NCT03379506|21413371|P4|NOT COMPLETED|Overall Study||0
8673946|NCT03379506|21413372|P3|NOT COMPLETED|Overall Study||0
8673947|NCT03379506|21413373|P2|NOT COMPLETED|Overall Study||0
8673948|NCT03379506|21413374|P1|NOT COMPLETED|Overall Study||0
8673949|NCT03379506|21413371|P4|COMPLETED|Overall Study||11
8673950|NCT03379506|21413372|P3|COMPLETED|Overall Study||7
8673951|NCT03379506|21413373|P2|COMPLETED|Overall Study||17
8673952|NCT03379506|21413374|P1|COMPLETED|Overall Study||22
8673953|NCT03379506|21413371|P4|STARTED|Overall Study||11
8673954|NCT03379506|21413372|P3|STARTED|Overall Study||7
8673955|NCT03379506|21413373|P2|STARTED|Overall Study||17
8673956|NCT03379506|21413374|P1|STARTED|Overall Study||22
8673957|NCT03377127|21413426|P2|NOT COMPLETED|Overall Study||0
8673958|NCT03377127|21413427|P1|NOT COMPLETED|Overall Study||0
8673959|NCT03377127|21413426|P2|COMPLETED|Overall Study||44
8673960|NCT03377127|21413427|P1|COMPLETED|Overall Study||42
8673961|NCT03377127|21413426|P2|STARTED|Overall Study||44
8673962|NCT03377127|21413427|P1|STARTED|Overall Study||42
8673969|NCT03366428|21413496|P1|NOT COMPLETED|Overall Study||19
8673970|NCT03366428|21413496|P1|COMPLETED|Overall Study||32
8673971|NCT03366428|21413496|P1|STARTED|Overall Study||51
8673980|NCT03317002|21413529|P3|NOT COMPLETED|Overall Study||1
8673981|NCT03317002|21413530|P2|NOT COMPLETED|Overall Study||1
8673982|NCT03317002|21413531|P1|NOT COMPLETED|Overall Study||2
8673983|NCT03317002|21413529|P3|COMPLETED|Overall Study||51
8673984|NCT03317002|21413530|P2|COMPLETED|Overall Study||24
8673985|NCT03317002|21413531|P1|COMPLETED|Overall Study||50
8673986|NCT03317002|21413529|P3|STARTED|Overall Study||52
8673987|NCT03317002|21413530|P2|STARTED|Overall Study||25
8673988|NCT03317002|21413531|P1|STARTED|Overall Study||52
8673989|NCT03316547|21413570|P2|NOT COMPLETED|Overall Study||13
8673990|NCT03316547|21413571|P1|NOT COMPLETED|Overall Study||18
8673991|NCT03316547|21413570|P2|COMPLETED|Overall Study||18
8673992|NCT03316547|21413571|P1|COMPLETED|Overall Study||21
8673993|NCT03316547|21413570|P2|STARTED|Overall Study||31
8673994|NCT03316547|21413571|P1|STARTED|Overall Study||39
8673995|NCT03308942|21413604|P5|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
8673996|NCT03308942|21413605|P4|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||12
8673997|NCT03308942|21413606|P3|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
8673998|NCT03308942|21413607|P2|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
8673999|NCT03308942|21413608|P1|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
8674000|NCT03308942|21413604|P5|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
8674001|NCT03308942|21413605|P4|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
8674002|NCT03308942|21413606|P3|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
8674003|NCT03308942|21413607|P2|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
8674004|NCT03308942|21413608|P1|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
8674005|NCT03308942|21413604|P5|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
8674006|NCT03308942|21413605|P4|STARTED|Stage 2 (up to a Maximum of 17 Months)||12
8674007|NCT03308942|21413606|P3|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
8674008|NCT03308942|21413607|P2|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
8674009|NCT03308942|21413608|P1|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
8674010|NCT03308942|21413604|P5|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
8674011|NCT03308942|21413605|P4|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
8674012|NCT03308942|21413606|P3|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||3
8674013|NCT03308942|21413607|P2|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||21
8674014|NCT03308942|21413608|P1|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||17
8674015|NCT03308942|21413604|P5|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
8674016|NCT03308942|21413605|P4|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
8674017|NCT03308942|21413606|P3|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
8674018|NCT03308942|21413607|P2|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
8674019|NCT03308942|21413608|P1|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
8674020|NCT03308942|21413604|P5|STARTED|Stage 1 (up to a Maximum of 29 Months)||0
8674021|NCT03308942|21413605|P4|STARTED|Stage 1 (up to a Maximum of 29 Months)||0
8674022|NCT03308942|21413606|P3|STARTED|Stage 1 (up to a Maximum of 29 Months)||3
8674023|NCT03308942|21413607|P2|STARTED|Stage 1 (up to a Maximum of 29 Months)||21
8674024|NCT03308942|21413608|P1|STARTED|Stage 1 (up to a Maximum of 29 Months)||17
8674025|NCT03307837|21413661|P6|NOT COMPLETED|Overall Study||2
8674026|NCT03307837|21413662|P5|NOT COMPLETED|Overall Study||0
8674027|NCT03307837|21413663|P4|NOT COMPLETED|Overall Study||0
8674028|NCT03307837|21413664|P3|NOT COMPLETED|Overall Study||1
8674029|NCT03307837|21413665|P2|NOT COMPLETED|Overall Study||1
8674030|NCT03307837|21413666|P1|NOT COMPLETED|Overall Study||1
8674031|NCT03307837|21413661|P6|COMPLETED|Overall Study||8
8674032|NCT03307837|21413662|P5|COMPLETED|Overall Study||6
8674033|NCT03307837|21413663|P4|COMPLETED|Overall Study||6
8674034|NCT03307837|21413664|P3|COMPLETED|Overall Study||5
8674035|NCT03307837|21413665|P2|COMPLETED|Overall Study||5
8674036|NCT03307837|21413666|P1|COMPLETED|Overall Study||5
8674037|NCT03307837|21413661|P6|STARTED|Overall Study||10
8674038|NCT03307837|21413662|P5|STARTED|Overall Study||6
8674039|NCT03307837|21413663|P4|STARTED|Overall Study||6
8674040|NCT03307837|21413664|P3|STARTED|Overall Study||6
8674041|NCT03307837|21413665|P2|STARTED|Overall Study||6
8674042|NCT03307837|21413666|P1|STARTED|Overall Study||6
8674043|NCT03305653|21413698|P1|NOT COMPLETED|Overall Study||0
8674044|NCT03305653|21413698|P1|COMPLETED|Overall Study||21
8674045|NCT03305653|21413698|P1|STARTED|Overall Study||21
8674046|NCT03296800|21413705|P3|NOT COMPLETED|Overall Study||0
8674047|NCT03296800|21413706|P2|NOT COMPLETED|Overall Study||0
8674048|NCT03296800|21413707|P1|NOT COMPLETED|Overall Study||0
8674049|NCT03296800|21413705|P3|COMPLETED|Overall Study||16
8674050|NCT03296800|21413706|P2|COMPLETED|Overall Study||16
8674051|NCT03296800|21413707|P1|COMPLETED|Overall Study||16
8674052|NCT03296800|21413705|P3|STARTED|Overall Study||16
8674053|NCT03296800|21413706|P2|STARTED|Overall Study||16
8674054|NCT03296800|21413707|P1|STARTED|Overall Study||16
8674055|NCT03296527|21413741|P2|NOT COMPLETED|Overall Study||53
8674056|NCT03296527|21413742|P1|NOT COMPLETED|Overall Study||35
8674057|NCT03296527|21413741|P2|COMPLETED|Overall Study||458
8674058|NCT03296527|21413742|P1|COMPLETED|Overall Study||465
8674059|NCT03296527|21413741|P2|Full Analysis Set|Overall Study||510
8674060|NCT03296527|21413742|P1|Full Analysis Set|Overall Study||499
8674061|NCT03296527|21413741|P2|STARTED|Overall Study||511
8674062|NCT03296527|21413742|P1|STARTED|Overall Study||500
8674069|NCT03292952|21413881|P3|NOT COMPLETED|Double-Blind Treatment Phase||1
8674070|NCT03292952|21413882|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
8674071|NCT03292952|21413883|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
8674072|NCT03292952|21413881|P3|COMPLETED|Double-Blind Treatment Phase||75
8674073|NCT03292952|21413882|P2|COMPLETED|Double-Blind Treatment Phase||74
8674074|NCT03292952|21413883|P1|COMPLETED|Double-Blind Treatment Phase||0
8674075|NCT03292952|21413881|P3|STARTED|Double-Blind Treatment Phase||76
8674076|NCT03292952|21413882|P2|STARTED|Double-Blind Treatment Phase||74
8674077|NCT03292952|21413883|P1|STARTED|Double-Blind Treatment Phase|Subjects were randomized to the double-blind Treatment Phase after Open-Label Dose Optimization|0
8674078|NCT03292952|21413881|P3|NOT COMPLETED|Open-Label Dose Optimization||0
8674079|NCT03292952|21413882|P2|NOT COMPLETED|Open-Label Dose Optimization||0
8674080|NCT03292952|21413883|P1|NOT COMPLETED|Open-Label Dose Optimization||5
8674081|NCT03292952|21413881|P3|COMPLETED|Open-Label Dose Optimization||0
8674082|NCT03292952|21413882|P2|COMPLETED|Open-Label Dose Optimization||0
8674083|NCT03292952|21413883|P1|COMPLETED|Open-Label Dose Optimization||150
8674084|NCT03292952|21413881|P3|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
8674085|NCT03292952|21413882|P2|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
8674086|NCT03292952|21413883|P1|STARTED|Open-Label Dose Optimization||155
8674087|NCT03285646|21413894|P2|NOT COMPLETED|Overall Study||4
8674088|NCT03285646|21413895|P1|NOT COMPLETED|Overall Study||13
8674089|NCT03285646|21413894|P2|COMPLETED|Overall Study||27
8674090|NCT03285646|21413895|P1|COMPLETED|Overall Study||19
8674091|NCT03285646|21413894|P2|STARTED|Overall Study||31
8674092|NCT03285646|21413895|P1|STARTED|Overall Study||32
8674093|NCT03265132|21413928|P2|NOT COMPLETED|Overall Study||6
8674094|NCT03265132|21413929|P1|NOT COMPLETED|Overall Study||0
8674095|NCT03265132|21413928|P2|COMPLETED|Overall Study||0
8674096|NCT03265132|21413929|P1|COMPLETED|Overall Study||6
8674097|NCT03265132|21413928|P2|STARTED|Overall Study|One patient failed disease specific inclusion criteria and was excluded from efficacy analysis|6
8674098|NCT03265132|21413929|P1|STARTED|Overall Study||6
8674099|NCT03265119|21414035|P2|NOT COMPLETED|Overall Study||7
8674100|NCT03265119|21414036|P1|NOT COMPLETED|Overall Study||10
8674101|NCT03265119|21414035|P2|COMPLETED|Overall Study||28
8674102|NCT03265119|21414036|P1|COMPLETED|Overall Study||24
8674103|NCT03265119|21414035|P2|STARTED|Overall Study||35
8674104|NCT03265119|21414036|P1|STARTED|Overall Study||34
8674105|NCT03261973|21414044|P1|NOT COMPLETED|Overall Study||4
8674106|NCT03261973|21414044|P1|COMPLETED|Overall Study||43
8674107|NCT03261973|21414044|P1|STARTED|Overall Study||47
8674108|NCT03259789|21414057|P3|NOT COMPLETED|Overall Study||6
8674109|NCT03259789|21414058|P2|NOT COMPLETED|Overall Study||17
8674110|NCT03259789|21414059|P1|NOT COMPLETED|Overall Study||17
8674111|NCT03259789|21414057|P3|COMPLETED|Overall Study||28
8674112|NCT03259789|21414058|P2|COMPLETED|Overall Study||142
8674113|NCT03259789|21414059|P1|COMPLETED|Overall Study||141
8674114|NCT03259789|21414057|P3|STARTED|Overall Study||34
8674115|NCT03259789|21414058|P2|STARTED|Overall Study||159
8674116|NCT03259789|21414059|P1|STARTED|Overall Study||158
8674117|NCT03247556|21414085|P3|NOT COMPLETED|Overall Study||18
8674118|NCT03247556|21414086|P2|NOT COMPLETED|Overall Study||12
8674119|NCT03247556|21414087|P1|NOT COMPLETED|Overall Study||12
8674120|NCT03247556|21414085|P3|COMPLETED|Overall Study||81
8674121|NCT03247556|21414086|P2|COMPLETED|Overall Study||88
8674122|NCT03247556|21414087|P1|COMPLETED|Overall Study||85
8674123|NCT03247556|21414085|P3|STARTED|Overall Study||99
8674124|NCT03247556|21414086|P2|STARTED|Overall Study||100
8674125|NCT03247556|21414087|P1|STARTED|Overall Study||97
8674126|NCT03247530|21414122|P3|NOT COMPLETED|Overall Study||20
8674127|NCT03247530|21414123|P2|NOT COMPLETED|Overall Study||28
8674128|NCT03247530|21414124|P1|NOT COMPLETED|Overall Study||27
8674129|NCT03247530|21414122|P3|COMPLETED|Overall Study||141
8674130|NCT03247530|21414123|P2|COMPLETED|Overall Study||126
8674131|NCT03247530|21414124|P1|COMPLETED|Overall Study||132
8674132|NCT03247530|21414122|P3|STARTED|Overall Study||161
8674133|NCT03247530|21414123|P2|STARTED|Overall Study||154
8674134|NCT03247530|21414124|P1|STARTED|Overall Study||159
8674135|NCT03246646|21414158|P2|NOT COMPLETED|Overall Study||0
8674136|NCT03246646|21414159|P1|NOT COMPLETED|Overall Study||11
8674137|NCT03246646|21414158|P2|COMPLETED|Overall Study|Follow-up was limited to chart follow-up in CIC services|26
8674138|NCT03246646|21414159|P1|COMPLETED|Overall Study|15 participants completed either 6-month or 12-month follow-up or both.|15
8674139|NCT03246646|21414158|P2|STARTED|Overall Study||26
8674140|NCT03246646|21414159|P1|STARTED|Overall Study||26
8674141|NCT03226457|21414165|P2|NOT COMPLETED|Treatment 2: 6 Weeks||0
8674142|NCT03226457|21414166|P1|NOT COMPLETED|Treatment 2: 6 Weeks||0
8674143|NCT03226457|21414165|P2|COMPLETED|Treatment 2: 6 Weeks||11
8674144|NCT03226457|21414166|P1|COMPLETED|Treatment 2: 6 Weeks||12
8674145|NCT03226457|21414165|P2|STARTED|Treatment 2: 6 Weeks||11
8674146|NCT03226457|21414166|P1|STARTED|Treatment 2: 6 Weeks||12
8674147|NCT03226457|21414165|P2|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
8674148|NCT03226457|21414166|P1|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
8674149|NCT03226457|21414165|P2|COMPLETED|Washout Period: Minimum 2 Weeks||11
8674150|NCT03226457|21414166|P1|COMPLETED|Washout Period: Minimum 2 Weeks||12
8674151|NCT03226457|21414165|P2|STARTED|Washout Period: Minimum 2 Weeks||11
8674152|NCT03226457|21414166|P1|STARTED|Washout Period: Minimum 2 Weeks||12
8674153|NCT03226457|21414165|P2|NOT COMPLETED|Treatment 1: 6 Weeks||0
8674154|NCT03226457|21414166|P1|NOT COMPLETED|Treatment 1: 6 Weeks||0
8674155|NCT03226457|21414165|P2|COMPLETED|Treatment 1: 6 Weeks||11
8674156|NCT03226457|21414166|P1|COMPLETED|Treatment 1: 6 Weeks||12
8674157|NCT03226457|21414165|P2|STARTED|Treatment 1: 6 Weeks||11
8674158|NCT03226457|21414166|P1|STARTED|Treatment 1: 6 Weeks||12
8674159|NCT03216382|21414186|P2|NOT COMPLETED|Overall Study||10
8674160|NCT03216382|21414187|P1|NOT COMPLETED|Overall Study||7
8674161|NCT03216382|21414186|P2|COMPLETED|Overall Study||44
8674162|NCT03216382|21414187|P1|COMPLETED|Overall Study||34
8674163|NCT03216382|21414186|P2|STARTED|Overall Study||54
8674164|NCT03216382|21414187|P1|STARTED|Overall Study||41
8674183|NCT03197038|21414246|P2|NOT COMPLETED|Overall Study||0
8674184|NCT03197038|21414247|P1|NOT COMPLETED|Overall Study||4
8674185|NCT03197038|21414246|P2|COMPLETED|Overall Study||17
8674186|NCT03197038|21414247|P1|COMPLETED|Overall Study||18
8674187|NCT03197038|21414246|P2|STARTED|Overall Study||17
8674188|NCT03197038|21414247|P1|STARTED|Overall Study||22
8674189|NCT03196297|21414283|P1|NOT COMPLETED|Extension Period||3
8674190|NCT03196297|21414283|P1|COMPLETED|Extension Period||29
8674191|NCT03196297|21414283|P1|SAS|Extension Period||32
8674192|NCT03196297|21414283|P1|FAS|Extension Period||32
8674193|NCT03196297|21414283|P1|STARTED|Extension Period||32
8674194|NCT03196297|21414283|P1|NOT COMPLETED|Main Period||4
8674195|NCT03196297|21414283|P1|COMPLETED|Main Period||32
8674196|NCT03196297|21414283|P1|Subject Analysis Set (SAS)|Main Period||36
8674197|NCT03196297|21414283|P1|Full Analysis Set (FAS)|Main Period||36
8674198|NCT03196297|21414283|P1|STARTED|Main Period||36
8674199|NCT03189719|21414379|P2|NOT COMPLETED|Overall Study||376
8674200|NCT03189719|21414380|P1|NOT COMPLETED|Overall Study||373
8674201|NCT03189719|21414379|P2|COMPLETED|Overall Study||0
8674202|NCT03189719|21414380|P1|COMPLETED|Overall Study||0
8674203|NCT03189719|21414379|P2|Treated|Overall Study||370
8674204|NCT03189719|21414380|P1|Treated|Overall Study||370
8674205|NCT03189719|21414379|P2|STARTED|Overall Study||376
8674206|NCT03189719|21414380|P1|STARTED|Overall Study||373
8674207|NCT03158688|21414436|P2|NOT COMPLETED|Overall Study||312
8674208|NCT03158688|21414437|P1|NOT COMPLETED|Overall Study||154
8674209|NCT03158688|21414436|P2|COMPLETED|Overall Study||0
8674210|NCT03158688|21414437|P1|COMPLETED|Overall Study||0
8674211|NCT03158688|21414436|P2|Treated|Overall Study||308
8674212|NCT03158688|21414437|P1|Treated|Overall Study||153
8674213|NCT03158688|21414436|P2|STARTED|Overall Study||312
8674214|NCT03158688|21414437|P1|STARTED|Overall Study||154
8674221|NCT03124121|21414520|P2|NOT COMPLETED|Overall Study||3
8674222|NCT03124121|21414521|P1|NOT COMPLETED|Overall Study||3
8674223|NCT03124121|21414520|P2|COMPLETED|Overall Study||67
8674224|NCT03124121|21414521|P1|COMPLETED|Overall Study||39
8674225|NCT03124121|21414520|P2|STARTED|Overall Study||70
8674226|NCT03124121|21414521|P1|STARTED|Overall Study||42
8674245|NCT03093480|21414558|P1|NOT COMPLETED|Overall Study||0
8674246|NCT03093480|21414558|P1|COMPLETED|Overall Study||16
8674247|NCT03093480|21414558|P1|Follow-up Period|Overall Study||10
8674248|NCT03093480|21414558|P1|Tapering Period|Overall Study||10
8674249|NCT03093480|21414558|P1|STARTED|Overall Study||16
8674250|NCT03092934|21414577|P4|NOT COMPLETED|Overall Study||0
8674251|NCT03092934|21414578|P3|NOT COMPLETED|Overall Study||0
8674252|NCT03092934|21414579|P2|NOT COMPLETED|Overall Study||0
8674253|NCT03092934|21414580|P1|NOT COMPLETED|Overall Study||0
8674254|NCT03092934|21414577|P4|COMPLETED|Overall Study||1
8674255|NCT03092934|21414578|P3|COMPLETED|Overall Study||2
8674256|NCT03092934|21414579|P2|COMPLETED|Overall Study||2
8674257|NCT03092934|21414580|P1|COMPLETED|Overall Study||8
8674258|NCT03092934|21414577|P4|Received at Least One Dose of Study Drug|Overall Study||1
8674259|NCT03092934|21414578|P3|Received at Least One Dose of Study Drug|Overall Study||2
8674260|NCT03092934|21414579|P2|Received at Least One Dose of Study Drug|Overall Study||2
8674261|NCT03092934|21414580|P1|Received at Least One Dose of Study Drug|Overall Study||8
8674262|NCT03092934|21414577|P4|STARTED|Overall Study||1
8674263|NCT03092934|21414578|P3|STARTED|Overall Study||2
8674264|NCT03092934|21414579|P2|STARTED|Overall Study||2
8674265|NCT03092934|21414580|P1|STARTED|Overall Study||8
8674266|NCT03087019|21414609|P2|NOT COMPLETED|Overall Study||0
8674267|NCT03087019|21414610|P1|NOT COMPLETED|Overall Study||1
8674268|NCT03087019|21414609|P2|COMPLETED|Overall Study||10
8674269|NCT03087019|21414610|P1|COMPLETED|Overall Study||10
8674270|NCT03087019|21414609|P2|STARTED|Overall Study||10
8674271|NCT03087019|21414610|P1|STARTED|Overall Study||11
8674272|NCT03086330|21414628|P2|NOT COMPLETED|Overall Study||4
8674273|NCT03086330|21414629|P1|NOT COMPLETED|Overall Study||4
8674274|NCT03086330|21414628|P2|COMPLETED|Overall Study||147
8674275|NCT03086330|21414629|P1|COMPLETED|Overall Study||147
8674276|NCT03086330|21414628|P2|Exposed|Overall Study||151
8674277|NCT03086330|21414629|P1|Exposed|Overall Study||150
8674278|NCT03086330|21414628|P2|STARTED|Overall Study||151
8674279|NCT03086330|21414629|P1|STARTED|Overall Study||151
8674280|NCT03081117|21414751|P2|NOT COMPLETED|Overall Study||3
8674281|NCT03081117|21414752|P1|NOT COMPLETED|Overall Study||4
8674282|NCT03081117|21414751|P2|COMPLETED|Overall Study||8
8674283|NCT03081117|21414752|P1|COMPLETED|Overall Study||6
8674284|NCT03081117|21414751|P2|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||9
8674285|NCT03081117|21414752|P1|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||7
8674286|NCT03081117|21414751|P2|Secondary Measures Collected at Week 24|Overall Study||9
8674287|NCT03081117|21414752|P1|Secondary Measures Collected at Week 24|Overall Study||8
8674288|NCT03081117|21414751|P2|Primary Outcome 1 (SAE)|Overall Study||11
8674289|NCT03081117|21414752|P1|Primary Outcome 1 (SAE)|Overall Study||10
8674290|NCT03081117|21414751|P2|STARTED|Overall Study||11
8674291|NCT03081117|21414752|P1|STARTED|Overall Study||10
8674468|NCT02626156|21415512|P3|COMPLETED|Study Visit 4||24
8674292|NCT03077607|21414786|P2|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2
8674293|NCT03077607|21414787|P1|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3
8674294|NCT03077607|21414786|P2|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
8674295|NCT03077607|21414787|P1|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14
8674296|NCT03077607|21414786|P2|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
8674297|NCT03077607|21414787|P1|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
8674298|NCT03077607|21414786|P2|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
8674299|NCT03077607|21414787|P1|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
8674300|NCT03077607|21414786|P2|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
8674301|NCT03077607|21414787|P1|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
8674302|NCT03077607|21414786|P2|NOT COMPLETED|Period 1 (15 Days)||0
8674303|NCT03077607|21414787|P1|NOT COMPLETED|Period 1 (15 Days)||2
8674304|NCT03077607|21414786|P2|COMPLETED|Period 1 (15 Days)||17
8674305|NCT03077607|21414787|P1|COMPLETED|Period 1 (15 Days)||17
8674306|NCT03077607|21414786|P2|Received Talazoparib|Period 1 (15 Days)||17
8674307|NCT03077607|21414787|P1|Received Talazoparib|Period 1 (15 Days)||19
8674308|NCT03077607|21414786|P2|Treated (With Any Study Drug)|Period 1 (15 Days)||17
8674309|NCT03077607|21414787|P1|Treated (With Any Study Drug)|Period 1 (15 Days)||19
8674310|NCT03077607|21414786|P2|STARTED|Period 1 (15 Days)||17
8674311|NCT03077607|21414787|P1|STARTED|Period 1 (15 Days)||19
8674312|NCT03068715|21414855|P2|NOT COMPLETED|Overall Study||0
8674313|NCT03068715|21414856|P1|NOT COMPLETED|Overall Study||1
8674314|NCT03068715|21414855|P2|COMPLETED|Overall Study||15
8674315|NCT03068715|21414856|P1|COMPLETED|Overall Study||14
8674316|NCT03068715|21414855|P2|STARTED|Overall Study||15
8674317|NCT03068715|21414856|P1|STARTED|Overall Study||15
8674318|NCT03046966|21414880|P2|NOT COMPLETED|Overall Study||0
8674319|NCT03046966|21414881|P1|NOT COMPLETED|Overall Study||0
8674320|NCT03046966|21414880|P2|COMPLETED|Overall Study||51
8674321|NCT03046966|21414881|P1|COMPLETED|Overall Study||51
8674322|NCT03046966|21414880|P2|STARTED|Overall Study||51
8674323|NCT03046966|21414881|P1|STARTED|Overall Study||51
8674324|NCT03036150|21414895|P2|NOT COMPLETED|Overall Study||5
8674325|NCT03036150|21414896|P1|NOT COMPLETED|Overall Study||10
8674326|NCT03036150|21414895|P2|COMPLETED|Overall Study||2147
8674327|NCT03036150|21414896|P1|COMPLETED|Overall Study||2142
8674328|NCT03036150|21414895|P2|STARTED|Overall Study||2152
8674329|NCT03036150|21414896|P1|STARTED|Overall Study||2152
8674336|NCT02951767|21414931|P1|NOT COMPLETED|Overall Study||119
8674337|NCT02951767|21414931|P1|COMPLETED|Overall Study||0
8674338|NCT02951767|21414931|P1|STARTED|Overall Study||119
8674339|NCT02950558|21414950|P2|NOT COMPLETED|Overall Study||0
8674340|NCT02950558|21414951|P1|NOT COMPLETED|Overall Study||2
8674341|NCT02950558|21414950|P2|COMPLETED|Overall Study||6
8674342|NCT02950558|21414951|P1|COMPLETED|Overall Study||6
8674343|NCT02950558|21414950|P2|12 Month Pain Questionnaire|Overall Study||6
8674344|NCT02950558|21414951|P1|12 Month Pain Questionnaire|Overall Study||6
8674345|NCT02950558|21414950|P2|STARTED|Overall Study||6
8674346|NCT02950558|21414951|P1|STARTED|Overall Study||8
8674347|NCT02836873|21414967|P2|NOT COMPLETED|Overall Study||11
8674348|NCT02836873|21414968|P1|NOT COMPLETED|Overall Study||5
8674349|NCT02836873|21414967|P2|COMPLETED|Overall Study||144
8674350|NCT02836873|21414968|P1|COMPLETED|Overall Study||152
8674351|NCT02836873|21414967|P2|STARTED|Overall Study||155
8674352|NCT02836873|21414968|P1|STARTED|Overall Study||157
8674353|NCT02804763|21414986|P4|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
8674354|NCT02804763|21414987|P3|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
8674355|NCT02804763|21414988|P2|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||1
8674356|NCT02804763|21414989|P1|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||6
8674357|NCT02804763|21414986|P4|COMPLETED|Observational Period (Wk 24 to Wk 48)||42
8674358|NCT02804763|21414987|P3|COMPLETED|Observational Period (Wk 24 to Wk 48)||41
8674359|NCT02804763|21414988|P2|COMPLETED|Observational Period (Wk 24 to Wk 48)||43
8674360|NCT02804763|21414989|P1|COMPLETED|Observational Period (Wk 24 to Wk 48)||38
8674361|NCT02804763|21414986|P4|STARTED|Observational Period (Wk 24 to Wk 48)||45
8674362|NCT02804763|21414987|P3|STARTED|Observational Period (Wk 24 to Wk 48)||44
8674363|NCT02804763|21414988|P2|STARTED|Observational Period (Wk 24 to Wk 48)||44
8674364|NCT02804763|21414989|P1|STARTED|Observational Period (Wk 24 to Wk 48)||44
8674365|NCT02804763|21414986|P4|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||2
8674366|NCT02804763|21414987|P3|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
8674367|NCT02804763|21414988|P2|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
8674368|NCT02804763|21414989|P1|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
8674369|NCT02804763|21414986|P4|COMPLETED|Double-Blind Period (Week 1 to Week 24)||45
8674370|NCT02804763|21414987|P3|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
8674371|NCT02804763|21414988|P2|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
8674372|NCT02804763|21414989|P1|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
8674373|NCT02804763|21414986|P4|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||45
8674374|NCT02804763|21414987|P3|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
8674375|NCT02804763|21414988|P2|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
8674376|NCT02804763|21414989|P1|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
8674377|NCT02804763|21414986|P4|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
8674378|NCT02804763|21414987|P3|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
8674379|NCT02804763|21414988|P2|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
8674380|NCT02804763|21414989|P1|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
8674381|NCT02804763|21414986|P4|STARTED|Double-Blind Period (Week 1 to Week 24)||47
8674382|NCT02804763|21414987|P3|STARTED|Double-Blind Period (Week 1 to Week 24)||45
8674383|NCT02804763|21414988|P2|STARTED|Double-Blind Period (Week 1 to Week 24)||45
8674384|NCT02804763|21414989|P1|STARTED|Double-Blind Period (Week 1 to Week 24)||45
8674385|NCT02802735|21415230|P5|NOT COMPLETED|Overall Study||0
8674386|NCT02802735|21415231|P4|NOT COMPLETED|Overall Study||0
8674387|NCT02802735|21415232|P3|NOT COMPLETED|Overall Study||0
8674388|NCT02802735|21415233|P2|NOT COMPLETED|Overall Study||1
8674389|NCT02802735|21415234|P1|NOT COMPLETED|Overall Study||0
8674390|NCT02802735|21415230|P5|COMPLETED|Overall Study||4
8674391|NCT02802735|21415231|P4|COMPLETED|Overall Study||12
8674392|NCT02802735|21415232|P3|COMPLETED|Overall Study||4
8674393|NCT02802735|21415233|P2|COMPLETED|Overall Study||3
8674394|NCT02802735|21415234|P1|COMPLETED|Overall Study||4
8674395|NCT02802735|21415230|P5|STARTED|Overall Study||4
8674396|NCT02802735|21415231|P4|STARTED|Overall Study||12
8674397|NCT02802735|21415232|P3|STARTED|Overall Study||4
8674398|NCT02802735|21415233|P2|STARTED|Overall Study||4
8674399|NCT02802735|21415234|P1|STARTED|Overall Study||4
8674400|NCT02790138|21415278|P2|NOT COMPLETED|Overall Study||19
8674401|NCT02790138|21415279|P1|NOT COMPLETED|Overall Study||21
8674402|NCT02790138|21415278|P2|COMPLETED|Overall Study||32
8674403|NCT02790138|21415279|P1|COMPLETED|Overall Study||30
8674404|NCT02790138|21415278|P2|STARTED|Overall Study||51
8674405|NCT02790138|21415279|P1|STARTED|Overall Study||51
8674406|NCT02701192|21415285|P1|NOT COMPLETED|Overall Study||6
8674407|NCT02701192|21415285|P1|COMPLETED|Overall Study||94
8674408|NCT02701192|21415285|P1|STARTED|Overall Study||100
8674409|NCT02697916|21415303|P2|NOT COMPLETED|Overall Study||708
8674410|NCT02697916|21415304|P1|NOT COMPLETED|Overall Study||578
8674411|NCT02697916|21415303|P2|COMPLETED|Overall Study||6828
8674412|NCT02697916|21415304|P1|COMPLETED|Overall Study||6962
8674413|NCT02697916|21415303|P2|STARTED|Overall Study||7536
8674414|NCT02697916|21415304|P1|STARTED|Overall Study||7540
8674415|NCT02689063|21415326|P4|NOT COMPLETED|Overall Study||0
8674416|NCT02689063|21415327|P3|NOT COMPLETED|Overall Study||3
8674417|NCT02689063|21415328|P2|NOT COMPLETED|Overall Study||2
8674418|NCT02689063|21415329|P1|NOT COMPLETED|Overall Study||0
8674419|NCT02689063|21415326|P4|COMPLETED|Overall Study||50
8674420|NCT02689063|21415327|P3|COMPLETED|Overall Study||73
8674421|NCT02689063|21415328|P2|COMPLETED|Overall Study||73
8674422|NCT02689063|21415329|P1|COMPLETED|Overall Study||75
8674423|NCT02689063|21415326|P4|STARTED|Overall Study||50
8674424|NCT02689063|21415327|P3|STARTED|Overall Study||76
8674425|NCT02689063|21415328|P2|STARTED|Overall Study||75
8674426|NCT02689063|21415329|P1|STARTED|Overall Study||75
8674427|NCT02655354|21415393|P2|NOT COMPLETED|Overall Study||81
8674428|NCT02655354|21415394|P1|NOT COMPLETED|Overall Study||77
8674429|NCT02655354|21415393|P2|COMPLETED|Overall Study||289
8674430|NCT02655354|21415394|P1|COMPLETED|Overall Study||188
8674431|NCT02655354|21415393|P2|STARTED|Overall Study||370
8674432|NCT02655354|21415394|P1|STARTED|Overall Study||265
8674451|NCT02649439|21415471|P2|NOT COMPLETED|Overall Study||28
8674452|NCT02649439|21415472|P1|NOT COMPLETED|Overall Study||27
8674453|NCT02649439|21415471|P2|COMPLETED|Overall Study||12
8674454|NCT02649439|21415472|P1|COMPLETED|Overall Study||13
8674455|NCT02649439|21415471|P2|STARTED|Overall Study||40
8674456|NCT02649439|21415472|P1|STARTED|Overall Study||40
8674457|NCT02631148|21415494|P2|NOT COMPLETED|Overall Study||0
8674458|NCT02631148|21415495|P1|NOT COMPLETED|Overall Study||10
8674459|NCT02631148|21415494|P2|COMPLETED|Overall Study||0
8674460|NCT02631148|21415495|P1|COMPLETED|Overall Study||2
8674461|NCT02631148|21415494|P2|STARTED|Overall Study||0
8674462|NCT02631148|21415495|P1|STARTED|Overall Study||12
8674463|NCT02626156|21415511|P4|NOT COMPLETED|Study Visit 4||5
8674464|NCT02626156|21415512|P3|NOT COMPLETED|Study Visit 4||9
8674465|NCT02626156|21415513|P2|NOT COMPLETED|Study Visit 4||2
8674466|NCT02626156|21415514|P1|NOT COMPLETED|Study Visit 4||3
8674467|NCT02626156|21415511|P4|COMPLETED|Study Visit 4||28
8674469|NCT02626156|21415513|P2|COMPLETED|Study Visit 4||15
8674470|NCT02626156|21415514|P1|COMPLETED|Study Visit 4||12
8674471|NCT02626156|21415511|P4|STARTED|Study Visit 4||33
8674472|NCT02626156|21415512|P3|STARTED|Study Visit 4||33
8674473|NCT02626156|21415513|P2|STARTED|Study Visit 4||17
8674474|NCT02626156|21415514|P1|STARTED|Study Visit 4||15
8674475|NCT02626156|21415511|P4|NOT COMPLETED|Study Visit 3||2
8674476|NCT02626156|21415512|P3|NOT COMPLETED|Study Visit 3||4
8674477|NCT02626156|21415513|P2|NOT COMPLETED|Study Visit 3||5
8674478|NCT02626156|21415514|P1|NOT COMPLETED|Study Visit 3||8
8674479|NCT02626156|21415511|P4|COMPLETED|Study Visit 3||33
8674480|NCT02626156|21415512|P3|COMPLETED|Study Visit 3||33
8674481|NCT02626156|21415513|P2|COMPLETED|Study Visit 3||17
8674482|NCT02626156|21415514|P1|COMPLETED|Study Visit 3||15
8674483|NCT02626156|21415511|P4|STARTED|Study Visit 3||35
8674484|NCT02626156|21415512|P3|STARTED|Study Visit 3||37
8674485|NCT02626156|21415513|P2|STARTED|Study Visit 3||22
8674486|NCT02626156|21415514|P1|STARTED|Study Visit 3||23
8674487|NCT02626156|21415511|P4|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
8674488|NCT02626156|21415512|P3|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
8674489|NCT02626156|21415513|P2|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||7
8674490|NCT02626156|21415514|P1|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||6
8674491|NCT02626156|21415511|P4|COMPLETED|Baseline (Visit 1 to Visit 2)||35
8674492|NCT02626156|21415512|P3|COMPLETED|Baseline (Visit 1 to Visit 2)||37
8674493|NCT02626156|21415513|P2|COMPLETED|Baseline (Visit 1 to Visit 2)||22
8674494|NCT02626156|21415514|P1|COMPLETED|Baseline (Visit 1 to Visit 2)||23
8674495|NCT02626156|21415511|P4|STARTED|Baseline (Visit 1 to Visit 2)||40
8674496|NCT02626156|21415512|P3|STARTED|Baseline (Visit 1 to Visit 2)||42
8674497|NCT02626156|21415513|P2|STARTED|Baseline (Visit 1 to Visit 2)||29
8674498|NCT02626156|21415514|P1|STARTED|Baseline (Visit 1 to Visit 2)||29
8674499|NCT02612779|21415557|P2|NOT COMPLETED|Overall Study||6
8674500|NCT02612779|21415558|P1|NOT COMPLETED|Overall Study||68
8674501|NCT02612779|21415557|P2|COMPLETED|Overall Study||0
8674502|NCT02612779|21415558|P1|COMPLETED|Overall Study||0
8674503|NCT02612779|21415557|P2|STARTED|Overall Study||6
8674504|NCT02612779|21415558|P1|STARTED|Overall Study||68
8674626|NCT02508532|21415890|P8|NOT COMPLETED|Part 2 - Treatment||0
8674559|NCT02593682|21415611|P2|NOT COMPLETED|Overall Study||0
8674560|NCT02593682|21415612|P1|NOT COMPLETED|Overall Study||0
8674561|NCT02593682|21415611|P2|COMPLETED|Overall Study||0
8674562|NCT02593682|21415612|P1|COMPLETED|Overall Study||0
8674563|NCT02593682|21415611|P2|STARTED|Overall Study||0
8674564|NCT02593682|21415612|P1|STARTED|Overall Study||0
8674565|NCT02586064|21415626|P2|NOT COMPLETED|Overall Study||28
8674566|NCT02586064|21415627|P1|NOT COMPLETED|Overall Study||18
8674567|NCT02586064|21415626|P2|COMPLETED|Overall Study||26
8674568|NCT02586064|21415627|P1|COMPLETED|Overall Study||43
8674569|NCT02586064|21415626|P2|STARTED|Overall Study||54
8674570|NCT02586064|21415627|P1|STARTED|Overall Study||61
8674583|NCT02552238|21415704|P1|NOT COMPLETED|Overall Study||4
8674584|NCT02552238|21415704|P1|COMPLETED|Overall Study|Of the 174 subjects enrolled in the study, 2 withdrew consent prior to administration of investigational product and 2 discontinued due to post-dose adverse event. Therefore, 170 subjects completed the study.|170
8674585|NCT02552238|21415704|P1|STARTED|Overall Study||174
8674586|NCT02551718|21415715|P1|NOT COMPLETED|Overall Study||0
8674587|NCT02551718|21415715|P1|COMPLETED|Overall Study||34
8674588|NCT02551718|21415715|P1|STARTED|Overall Study||34
8674589|NCT02534935|21415722|P3|NOT COMPLETED|Overall Study||5
8674590|NCT02534935|21415723|P2|NOT COMPLETED|Overall Study||10
8674591|NCT02534935|21415724|P1|NOT COMPLETED|Overall Study||0
8674592|NCT02534935|21415722|P3|COMPLETED|Overall Study||127
8674593|NCT02534935|21415723|P2|COMPLETED|Overall Study||210
8674594|NCT02534935|21415724|P1|COMPLETED|Overall Study||44
8674595|NCT02534935|21415722|P3|STARTED|Overall Study||132
8674596|NCT02534935|21415723|P2|STARTED|Overall Study||220
8674597|NCT02534935|21415724|P1|STARTED|Overall Study||44
8674598|NCT02508532|21415889|P9|NOT COMPLETED|Part 1 and Part 2 End of Study||217
8674599|NCT02508532|21415890|P8|NOT COMPLETED|Part 1 and Part 2 End of Study||3
8674600|NCT02508532|21415891|P7|NOT COMPLETED|Part 1 and Part 2 End of Study||0
8674601|NCT02508532|21415892|P6|NOT COMPLETED|Part 1 and Part 2 End of Study||0
8674602|NCT02508532|21415893|P5|NOT COMPLETED|Part 1 and Part 2 End of Study||6
8674603|NCT02508532|21415894|P4|NOT COMPLETED|Part 1 and Part 2 End of Study||6
8674604|NCT02508532|21415895|P3|NOT COMPLETED|Part 1 and Part 2 End of Study||6
8674605|NCT02508532|21415896|P2|NOT COMPLETED|Part 1 and Part 2 End of Study||6
8674606|NCT02508532|21415897|P1|NOT COMPLETED|Part 1 and Part 2 End of Study||6
8674607|NCT02508532|21415889|P9|COMPLETED|Part 1 and Part 2 End of Study||0
8674608|NCT02508532|21415890|P8|COMPLETED|Part 1 and Part 2 End of Study||0
8674609|NCT02508532|21415891|P7|COMPLETED|Part 1 and Part 2 End of Study||0
8674610|NCT02508532|21415892|P6|COMPLETED|Part 1 and Part 2 End of Study||0
8674611|NCT02508532|21415893|P5|COMPLETED|Part 1 and Part 2 End of Study||0
8674612|NCT02508532|21415894|P4|COMPLETED|Part 1 and Part 2 End of Study||0
8674613|NCT02508532|21415895|P3|COMPLETED|Part 1 and Part 2 End of Study||0
8674614|NCT02508532|21415896|P2|COMPLETED|Part 1 and Part 2 End of Study||0
8674615|NCT02508532|21415897|P1|COMPLETED|Part 1 and Part 2 End of Study||0
8674616|NCT02508532|21415889|P9|STARTED|Part 1 and Part 2 End of Study|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
8674617|NCT02508532|21415890|P8|STARTED|Part 1 and Part 2 End of Study||3
8674618|NCT02508532|21415891|P7|STARTED|Part 1 and Part 2 End of Study|These 7 patients are included in the 300 or 400 mg QD dose group|0
8674619|NCT02508532|21415892|P6|STARTED|Part 1 and Part 2 End of Study|These 6 patients are included in the 300 or 400 mg QD dose group|0
8674620|NCT02508532|21415893|P5|STARTED|Part 1 and Part 2 End of Study||6
8674621|NCT02508532|21415894|P4|STARTED|Part 1 and Part 2 End of Study||6
8674622|NCT02508532|21415895|P3|STARTED|Part 1 and Part 2 End of Study||6
8674623|NCT02508532|21415896|P2|STARTED|Part 1 and Part 2 End of Study||6
8674624|NCT02508532|21415897|P1|STARTED|Part 1 and Part 2 End of Study||6
8674625|NCT02508532|21415889|P9|NOT COMPLETED|Part 2 - Treatment||217
8674627|NCT02508532|21415891|P7|NOT COMPLETED|Part 2 - Treatment||0
8674628|NCT02508532|21415892|P6|NOT COMPLETED|Part 2 - Treatment||0
8674629|NCT02508532|21415893|P5|NOT COMPLETED|Part 2 - Treatment||0
8674630|NCT02508532|21415894|P4|NOT COMPLETED|Part 2 - Treatment||0
8674631|NCT02508532|21415895|P3|NOT COMPLETED|Part 2 - Treatment||0
8674632|NCT02508532|21415896|P2|NOT COMPLETED|Part 2 - Treatment||0
8674633|NCT02508532|21415897|P1|NOT COMPLETED|Part 2 - Treatment||0
8674634|NCT02508532|21415889|P9|COMPLETED|Part 2 - Treatment||0
8674635|NCT02508532|21415890|P8|COMPLETED|Part 2 - Treatment||0
8674636|NCT02508532|21415891|P7|COMPLETED|Part 2 - Treatment||0
8674637|NCT02508532|21415892|P6|COMPLETED|Part 2 - Treatment||0
8674638|NCT02508532|21415893|P5|COMPLETED|Part 2 - Treatment||0
8674639|NCT02508532|21415894|P4|COMPLETED|Part 2 - Treatment||0
8674640|NCT02508532|21415895|P3|COMPLETED|Part 2 - Treatment||0
8674641|NCT02508532|21415896|P2|COMPLETED|Part 2 - Treatment||0
8674642|NCT02508532|21415897|P1|COMPLETED|Part 2 - Treatment||0
8674643|NCT02508532|21415889|P9|STARTED|Part 2 - Treatment|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
8674644|NCT02508532|21415890|P8|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
8674645|NCT02508532|21415891|P7|STARTED|Part 2 - Treatment|"Part 1 Only:
~7 Patients from this group are included in the 300 or 400 mg QD group."|0
8674646|NCT02508532|21415892|P6|STARTED|Part 2 - Treatment|"Part 1 Only:
~6 Patients from this group are included in the 300 or 400 mg QD group."|0
8674647|NCT02508532|21415893|P5|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
8674648|NCT02508532|21415894|P4|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
8674649|NCT02508532|21415895|P3|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
8674650|NCT02508532|21415896|P2|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
8674651|NCT02508532|21415897|P1|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
8674652|NCT02508532|21415889|P9|NOT COMPLETED|Part 1 - Dose Determining Period||0
8674653|NCT02508532|21415890|P8|NOT COMPLETED|Part 1 - Dose Determining Period||1
8674654|NCT02508532|21415891|P7|NOT COMPLETED|Part 1 - Dose Determining Period||1
8674655|NCT02508532|21415892|P6|NOT COMPLETED|Part 1 - Dose Determining Period||0
8674656|NCT02508532|21415893|P5|NOT COMPLETED|Part 1 - Dose Determining Period||0
8674657|NCT02508532|21415894|P4|NOT COMPLETED|Part 1 - Dose Determining Period||0
8674658|NCT02508532|21415895|P3|NOT COMPLETED|Part 1 - Dose Determining Period||0
8674659|NCT02508532|21415896|P2|NOT COMPLETED|Part 1 - Dose Determining Period||0
8674660|NCT02508532|21415897|P1|NOT COMPLETED|Part 1 - Dose Determining Period||0
8674661|NCT02508532|21415889|P9|COMPLETED|Part 1 - Dose Determining Period||0
8674662|NCT02508532|21415890|P8|COMPLETED|Part 1 - Dose Determining Period||2
8674663|NCT02508532|21415891|P7|COMPLETED|Part 1 - Dose Determining Period||6
8674664|NCT02508532|21415892|P6|COMPLETED|Part 1 - Dose Determining Period||6
8674665|NCT02508532|21415893|P5|COMPLETED|Part 1 - Dose Determining Period||6
8674666|NCT02508532|21415894|P4|COMPLETED|Part 1 - Dose Determining Period||6
8674667|NCT02508532|21415895|P3|COMPLETED|Part 1 - Dose Determining Period||6
8674668|NCT02508532|21415896|P2|COMPLETED|Part 1 - Dose Determining Period||6
8674669|NCT02508532|21415897|P1|COMPLETED|Part 1 - Dose Determining Period||6
8674670|NCT02508532|21415889|P9|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
8674671|NCT02508532|21415890|P8|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
8674672|NCT02508532|21415891|P7|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||7
8674673|NCT02508532|21415892|P6|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||6
8674674|NCT02508532|21415893|P5|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
8674675|NCT02508532|21415894|P4|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
8674676|NCT02508532|21415895|P3|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
8674677|NCT02508532|21415896|P2|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
8674678|NCT02508532|21415897|P1|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
8674679|NCT02508532|21415889|P9|STARTED|Part 1 - Dose Determining Period|This group includes patients enrolled in Part 1 and Part 2 at a starting dose of 300 or 400 mg QD. This group was not used to determine the MTD in Part 1|0
8674680|NCT02508532|21415890|P8|STARTED|Part 1 - Dose Determining Period||3
8674681|NCT02508532|21415891|P7|STARTED|Part 1 - Dose Determining Period||7
8674682|NCT02508532|21415892|P6|STARTED|Part 1 - Dose Determining Period||6
8674683|NCT02508532|21415893|P5|STARTED|Part 1 - Dose Determining Period||6
8674684|NCT02508532|21415894|P4|STARTED|Part 1 - Dose Determining Period||6
8674685|NCT02508532|21415895|P3|STARTED|Part 1 - Dose Determining Period||6
8674686|NCT02508532|21415896|P2|STARTED|Part 1 - Dose Determining Period||6
8674687|NCT02508532|21415897|P1|STARTED|Part 1 - Dose Determining Period||6
8674694|NCT02477839|21415984|P2|NOT COMPLETED|Overall Study||10
8674695|NCT02477839|21415985|P1|NOT COMPLETED|Overall Study||3
8674696|NCT02477839|21415984|P2|COMPLETED|Overall Study||118
8674697|NCT02477839|21415985|P1|COMPLETED|Overall Study||124
8674698|NCT02477839|21415984|P2|Completed Taper After Maintenance|Overall Study||1
8674699|NCT02477839|21415985|P1|Completed Taper After Maintenance|Overall Study||0
8674700|NCT02477839|21415984|P2|Completed Transition Period|Overall Study||117
8674701|NCT02477839|21415985|P1|Completed Transition Period|Overall Study||124
8674702|NCT02477839|21415984|P2|STARTED|Overall Study||128
8674703|NCT02477839|21415985|P1|STARTED|Overall Study||127
8674704|NCT02466126|21416015|P2|NOT COMPLETED|12 Month Assessment||2
8674705|NCT02466126|21416016|P1|NOT COMPLETED|12 Month Assessment||1
8674706|NCT02466126|21416015|P2|COMPLETED|12 Month Assessment||66
8674707|NCT02466126|21416016|P1|COMPLETED|12 Month Assessment||85
8674708|NCT02466126|21416015|P2|STARTED|12 Month Assessment||68
8674709|NCT02466126|21416016|P1|STARTED|12 Month Assessment||86
8674710|NCT02466126|21416015|P2|NOT COMPLETED|8 Month Assessment||3
8674711|NCT02466126|21416016|P1|NOT COMPLETED|8 Month Assessment||7
8674712|NCT02466126|21416015|P2|COMPLETED|8 Month Assessment||68
8674713|NCT02466126|21416016|P1|COMPLETED|8 Month Assessment||86
8674714|NCT02466126|21416015|P2|STARTED|8 Month Assessment||71
8674715|NCT02466126|21416016|P1|STARTED|8 Month Assessment||93
8674716|NCT02466126|21416015|P2|NOT COMPLETED|4 Month Assessment||9
8674717|NCT02466126|21416016|P1|NOT COMPLETED|4 Month Assessment||16
8674718|NCT02466126|21416015|P2|COMPLETED|4 Month Assessment||71
8674719|NCT02466126|21416016|P1|COMPLETED|4 Month Assessment||93
8674720|NCT02466126|21416015|P2|STARTED|4 Month Assessment||80
8674721|NCT02466126|21416016|P1|STARTED|4 Month Assessment||109
8674722|NCT02466126|21416015|P2|NOT COMPLETED|Baseline||0
8674723|NCT02466126|21416016|P1|NOT COMPLETED|Baseline||0
8674724|NCT02466126|21416015|P2|COMPLETED|Baseline||80
8674725|NCT02466126|21416016|P1|COMPLETED|Baseline||109
8674726|NCT02466126|21416015|P2|STARTED|Baseline||80
8674727|NCT02466126|21416016|P1|STARTED|Baseline||109
8674728|NCT02453282|21416029|P3|NOT COMPLETED|Overall Study||372
8674729|NCT02453282|21416030|P2|NOT COMPLETED|Overall Study||372
8674730|NCT02453282|21416031|P1|NOT COMPLETED|Overall Study||374
8674731|NCT02453282|21416029|P3|COMPLETED|Overall Study||0
8674732|NCT02453282|21416030|P2|COMPLETED|Overall Study||0
8674733|NCT02453282|21416031|P1|COMPLETED|Overall Study||0
8674734|NCT02453282|21416029|P3|Received Treatment|Overall Study||352
8674735|NCT02453282|21416030|P2|Received Treatment|Overall Study||371
8674736|NCT02453282|21416031|P1|Received Treatment|Overall Study||369
8674737|NCT02453282|21416029|P3|STARTED|Overall Study||372
8674738|NCT02453282|21416030|P2|STARTED|Overall Study||372
8674739|NCT02453282|21416031|P1|STARTED|Overall Study||374
8674740|NCT02448771|21416110|P1|NOT COMPLETED|Overall Study||36
8674741|NCT02448771|21416110|P1|COMPLETED|Overall Study||0
8674742|NCT02448771|21416110|P1|STARTED|Overall Study||36
8674743|NCT02440568|21416127|P4|NOT COMPLETED|Overall Study||2
8674744|NCT02440568|21416128|P3|NOT COMPLETED|Overall Study||5
8674745|NCT02440568|21416129|P2|NOT COMPLETED|Overall Study||3
8674746|NCT02440568|21416130|P1|NOT COMPLETED|Overall Study||4
8674747|NCT02440568|21416127|P4|COMPLETED|Overall Study||1
8674748|NCT02440568|21416128|P3|COMPLETED|Overall Study||5
8674749|NCT02440568|21416129|P2|COMPLETED|Overall Study||1
8674750|NCT02440568|21416130|P1|COMPLETED|Overall Study||1
8674751|NCT02440568|21416127|P4|STARTED|Overall Study||3
8674752|NCT02440568|21416128|P3|STARTED|Overall Study||10
8674753|NCT02440568|21416129|P2|STARTED|Overall Study||4
8674754|NCT02440568|21416130|P1|STARTED|Overall Study||5
8674755|NCT02428192|21416162|P2|NOT COMPLETED|Overall Study||1
8674756|NCT02428192|21416163|P1|NOT COMPLETED|Overall Study||12
8674757|NCT02428192|21416162|P2|COMPLETED|Overall Study||7
8674758|NCT02428192|21416163|P1|COMPLETED|Overall Study||0
8674759|NCT02428192|21416162|P2|STARTED|Overall Study||8
8674760|NCT02428192|21416163|P1|STARTED|Overall Study||12
8674849|NCT02370498|21416429|P2|NOT COMPLETED|Overall Study||296
8674850|NCT02370498|21416430|P1|NOT COMPLETED|Overall Study||296
8674851|NCT02370498|21416429|P2|COMPLETED|Overall Study||0
8674852|NCT02370498|21416430|P1|COMPLETED|Overall Study||0
8674853|NCT02370498|21416429|P2|PD-L1 Positive Participants|Overall Study||199
8674854|NCT02370498|21416430|P1|PD-L1 Positive Participants|Overall Study||196
8674855|NCT02370498|21416429|P2|Treated|Overall Study||276
8674856|NCT02370498|21416430|P1|Treated|Overall Study||294
8674857|NCT02370498|21416429|P2|STARTED|Overall Study||296
8674858|NCT02370498|21416430|P1|STARTED|Overall Study||296
8674859|NCT02360605|21416484|P2|NOT COMPLETED|Overall Study||18
8674860|NCT02360605|21416485|P1|NOT COMPLETED|Overall Study||11
8674861|NCT02360605|21416484|P2|COMPLETED|Overall Study||291
8674862|NCT02360605|21416485|P1|COMPLETED|Overall Study||300
8674863|NCT02360605|21416484|P2|STARTED|Overall Study||309
8674864|NCT02360605|21416485|P1|STARTED|Overall Study||311
8674865|NCT02318095|21416495|P1|NOT COMPLETED|Overall Study||1
8674866|NCT02318095|21416495|P1|COMPLETED|Overall Study||39
8674867|NCT02318095|21416495|P1|STARTED|Overall Study||40
8674868|NCT02300285|21416504|P2|NOT COMPLETED|Overall Study||0
8674869|NCT02300285|21416505|P1|NOT COMPLETED|Overall Study||0
8674870|NCT02300285|21416504|P2|COMPLETED|Overall Study||3
8674871|NCT02300285|21416505|P1|COMPLETED|Overall Study||3
8674872|NCT02300285|21416504|P2|STARTED|Overall Study||3
8674873|NCT02300285|21416505|P1|STARTED|Overall Study||3
8674874|NCT02298023|21416522|P3|NOT COMPLETED|Overall Study||0
8674875|NCT02298023|21416523|P2|NOT COMPLETED|Overall Study||0
8674876|NCT02298023|21416524|P1|NOT COMPLETED|Overall Study||1
8674877|NCT02298023|21416522|P3|COMPLETED|Overall Study||8
8674878|NCT02298023|21416523|P2|COMPLETED|Overall Study||8
8674879|NCT02298023|21416524|P1|COMPLETED|Overall Study||7
8674880|NCT02298023|21416522|P3|Intervention|Overall Study||8
8674881|NCT02298023|21416523|P2|Intervention|Overall Study||8
8674882|NCT02298023|21416524|P1|Intervention|Overall Study|Withdrawal by participant before intervention.|7
8674883|NCT02298023|21416522|P3|STARTED|Overall Study||8
8674884|NCT02298023|21416523|P2|STARTED|Overall Study||8
8674885|NCT02298023|21416524|P1|STARTED|Overall Study||8
8674892|NCT02276547|21416570|P1|NOT COMPLETED|Overall Study||4
8674893|NCT02276547|21416570|P1|COMPLETED|Overall Study||23
8674894|NCT02276547|21416570|P1|STARTED|Overall Study||27
8674898|NCT02255513|21416583|P2|NOT COMPLETED|Double Blind, Placebo-controlled||0
8674899|NCT02255513|21416584|P1|NOT COMPLETED|Double Blind, Placebo-controlled||0
8674900|NCT02255513|21416583|P2|COMPLETED|Double Blind, Placebo-controlled||21
8674901|NCT02255513|21416584|P1|COMPLETED|Double Blind, Placebo-controlled||22
8674902|NCT02255513|21416583|P2|STARTED|Double Blind, Placebo-controlled||21
8674903|NCT02255513|21416584|P1|STARTED|Double Blind, Placebo-controlled||22
8674904|NCT02255513|21416583|P2|NOT COMPLETED|Open-label, Treatment Optimization||0
8674905|NCT02255513|21416584|P1|NOT COMPLETED|Open-label, Treatment Optimization||0
8674906|NCT02255513|21416583|P2|COMPLETED|Open-label, Treatment Optimization||0
8674907|NCT02255513|21416584|P1|COMPLETED|Open-label, Treatment Optimization||43
8674908|NCT02255513|21416583|P2|STARTED|Open-label, Treatment Optimization||0
8674909|NCT02255513|21416584|P1|STARTED|Open-label, Treatment Optimization||43
8674910|NCT02230527|21416592|P2|NOT COMPLETED|Overall Study||2
8674911|NCT02230527|21416593|P1|NOT COMPLETED|Overall Study||5
8674912|NCT02230527|21416592|P2|COMPLETED|Overall Study||21
8674913|NCT02230527|21416593|P1|COMPLETED|Overall Study||18
8674914|NCT02230527|21416592|P2|STARTED|Overall Study||23
8674915|NCT02230527|21416593|P1|STARTED|Overall Study||23
8674916|NCT02210247|21416604|P5|NOT COMPLETED|Overall Study||0
8674917|NCT02210247|21416605|P4|NOT COMPLETED|Overall Study||0
8674918|NCT02210247|21416606|P3|NOT COMPLETED|Overall Study||0
8674919|NCT02210247|21416607|P2|NOT COMPLETED|Overall Study||0
8674920|NCT02210247|21416608|P1|NOT COMPLETED|Overall Study||0
8674921|NCT02210247|21416604|P5|COMPLETED|Overall Study||12
8674922|NCT02210247|21416605|P4|COMPLETED|Overall Study||12
8674923|NCT02210247|21416606|P3|COMPLETED|Overall Study||12
8674924|NCT02210247|21416607|P2|COMPLETED|Overall Study||12
8674925|NCT02210247|21416608|P1|COMPLETED|Overall Study||12
8674926|NCT02210247|21416604|P5|STARTED|Overall Study||12
8674927|NCT02210247|21416605|P4|STARTED|Overall Study||12
8674928|NCT02210247|21416606|P3|STARTED|Overall Study||12
8674929|NCT02210247|21416607|P2|STARTED|Overall Study||12
8674930|NCT02210247|21416608|P1|STARTED|Overall Study||12
8674939|NCT02149173|21416679|P1|NOT COMPLETED|Overall Study||0
8674940|NCT02149173|21416679|P1|COMPLETED|Overall Study||29
8674941|NCT02149173|21416679|P1|STARTED|Overall Study||29
8674950|NCT02130427|21416710|P1|NOT COMPLETED|Overall Study||30
8674951|NCT02130427|21416710|P1|COMPLETED|Overall Study||44
8674952|NCT02130427|21416710|P1|STARTED|Overall Study||74
8674959|NCT02126969|21416731|P2|NOT COMPLETED|Overall Study||2
8674960|NCT02126969|21416732|P1|NOT COMPLETED|Overall Study||1
8674961|NCT02126969|21416731|P2|COMPLETED|Overall Study||20
8674962|NCT02126969|21416732|P1|COMPLETED|Overall Study||22
8674963|NCT02126969|21416731|P2|STARTED|Overall Study||22
8674964|NCT02126969|21416732|P1|STARTED|Overall Study||23
8674965|NCT02117713|21416742|P1|NOT COMPLETED|Long Term Follow-up Treatment||6
8674966|NCT02117713|21416742|P1|COMPLETED|Long Term Follow-up Treatment||20
8674967|NCT02117713|21416742|P1|STARTED|Long Term Follow-up Treatment||26
8674968|NCT02117713|21416742|P1|NOT COMPLETED|Week 48||8
8674969|NCT02117713|21416742|P1|COMPLETED|Week 48||26
8674970|NCT02117713|21416742|P1|STARTED|Week 48||34
8674971|NCT02115139|21416767|P1|NOT COMPLETED|Overall Study||7
8674972|NCT02115139|21416767|P1|COMPLETED|Overall Study||51
8674973|NCT02115139|21416767|P1|STARTED|Overall Study||58
8674974|NCT02108652|21416777|P1|NOT COMPLETED|Overall Study||310
8674975|NCT02108652|21416777|P1|COMPLETED|Overall Study||0
8674976|NCT02108652|21416777|P1|STARTED|Overall Study||310
8674984|NCT02028884|21416819|P2|NOT COMPLETED|Open-label Extension Period||18
8674985|NCT02028884|21416820|P1|NOT COMPLETED|Open-label Extension Period||24
8674986|NCT02028884|21416819|P2|COMPLETED|Open-label Extension Period||0
8674987|NCT02028884|21416820|P1|COMPLETED|Open-label Extension Period||0
8674988|NCT02028884|21416819|P2|STARTED|Open-label Extension Period||18
8674989|NCT02028884|21416820|P1|STARTED|Open-label Extension Period||24
8674990|NCT02028884|21416819|P2|NOT COMPLETED|Double-blind Period||23
8674991|NCT02028884|21416820|P1|NOT COMPLETED|Double-blind Period||18
8674992|NCT02028884|21416819|P2|COMPLETED|Double-blind Period||18
8674993|NCT02028884|21416820|P1|COMPLETED|Double-blind Period||24
8674994|NCT02028884|21416819|P2|STARTED|Double-blind Period||41
8674995|NCT02028884|21416820|P1|STARTED|Double-blind Period||42
8674996|NCT02023411|21416890|P2|NOT COMPLETED|Overall Study||0
8674997|NCT02023411|21416891|P1|NOT COMPLETED|Overall Study||0
8674998|NCT02023411|21416890|P2|COMPLETED|Overall Study||10
8674999|NCT02023411|21416891|P1|COMPLETED|Overall Study||10
8675000|NCT02023411|21416890|P2|STARTED|Overall Study||10
8675001|NCT02023411|21416891|P1|STARTED|Overall Study||10
8675002|NCT02002182|21416901|P2|NOT COMPLETED|Overall Study||1
8675003|NCT02002182|21416902|P1|NOT COMPLETED|Overall Study||5
8675004|NCT02002182|21416901|P2|COMPLETED|Overall Study||5
8675005|NCT02002182|21416902|P1|COMPLETED|Overall Study||4
8675006|NCT02002182|21416901|P2|STARTED|Overall Study||6
8675007|NCT02002182|21416902|P1|STARTED|Overall Study||9
8675008|NCT01989676|21416914|P2|NOT COMPLETED|Overall Study||138
8675009|NCT01989676|21416915|P1|NOT COMPLETED|Overall Study||118
8675010|NCT01989676|21416914|P2|COMPLETED|Overall Study||217
8675011|NCT01989676|21416915|P1|COMPLETED|Overall Study||234
8675012|NCT01989676|21416914|P2|Treated|Overall Study||353
8675013|NCT01989676|21416915|P1|Treated|Overall Study||349
8675014|NCT01989676|21416914|P2|STARTED|Overall Study||355
8675015|NCT01989676|21416915|P1|STARTED|Overall Study||352
8675016|NCT01975428|21416937|P2|NOT COMPLETED|Overall Study||14
8675017|NCT01975428|21416938|P1|NOT COMPLETED|Overall Study||20
8675018|NCT01975428|21416937|P2|COMPLETED|Overall Study||83
8675019|NCT01975428|21416938|P1|COMPLETED|Overall Study||65
8675020|NCT01975428|21416937|P2|STARTED|Overall Study||97
8675021|NCT01975428|21416938|P1|STARTED|Overall Study||85
8675032|NCT01954056|21416959|P2|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0
8675033|NCT01954056|21416960|P1|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1
8675034|NCT01954056|21416959|P2|COMPLETED|Birth to 22-26 Mos. Corrected GA||6
8675035|NCT01954056|21416960|P1|COMPLETED|Birth to 22-26 Mos. Corrected GA||5
8675036|NCT01954056|21416959|P2|STARTED|Birth to 22-26 Mos. Corrected GA||6
8675037|NCT01954056|21416960|P1|STARTED|Birth to 22-26 Mos. Corrected GA||6
8675038|NCT01954056|21416959|P2|NOT COMPLETED|Birth to 60 Days of Life||0
8675039|NCT01954056|21416960|P1|NOT COMPLETED|Birth to 60 Days of Life||0
8675040|NCT01954056|21416959|P2|COMPLETED|Birth to 60 Days of Life||6
8675041|NCT01954056|21416960|P1|COMPLETED|Birth to 60 Days of Life||6
8675042|NCT01954056|21416959|P2|STARTED|Birth to 60 Days of Life||6
8675043|NCT01954056|21416960|P1|STARTED|Birth to 60 Days of Life||6
8675044|NCT01931995|21417004|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8675045|NCT01931995|21417005|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8675046|NCT01931995|21417004|P2|COMPLETED|Second Intervention (1 Day)||19
8675047|NCT01931995|21417005|P1|COMPLETED|Second Intervention (1 Day)||18
8675048|NCT01931995|21417004|P2|STARTED|Second Intervention (1 Day)||19
8675049|NCT01931995|21417005|P1|STARTED|Second Intervention (1 Day)||18
8675050|NCT01931995|21417004|P2|NOT COMPLETED|Washout (at Least 6 Days)||0
8675051|NCT01931995|21417005|P1|NOT COMPLETED|Washout (at Least 6 Days)||0
8675052|NCT01931995|21417004|P2|COMPLETED|Washout (at Least 6 Days)||18
8675053|NCT01931995|21417005|P1|COMPLETED|Washout (at Least 6 Days)||19
8675054|NCT01931995|21417004|P2|STARTED|Washout (at Least 6 Days)||18
8675055|NCT01931995|21417005|P1|STARTED|Washout (at Least 6 Days)||19
8675056|NCT01931995|21417004|P2|NOT COMPLETED|First Intervention (1 Day)||4
8675057|NCT01931995|21417005|P1|NOT COMPLETED|First Intervention (1 Day)||4
8675058|NCT01931995|21417004|P2|COMPLETED|First Intervention (1 Day)||18
8675059|NCT01931995|21417005|P1|COMPLETED|First Intervention (1 Day)||19
8675060|NCT01931995|21417004|P2|STARTED|First Intervention (1 Day)||22
8675061|NCT01931995|21417005|P1|STARTED|First Intervention (1 Day)||23
8675062|NCT01924533|21417015|P2|NOT COMPLETED|Overall Study||205
8675063|NCT01924533|21417016|P1|NOT COMPLETED|Overall Study||189
8675064|NCT01924533|21417015|P2|COMPLETED|Overall Study||57
8675065|NCT01924533|21417016|P1|COMPLETED|Overall Study||74
8675066|NCT01924533|21417015|P2|STARTED|Overall Study||262
8675067|NCT01924533|21417016|P1|STARTED|Overall Study||263
8675068|NCT01919190|21417046|P2|NOT COMPLETED|Overall Study||0
8675069|NCT01919190|21417047|P1|NOT COMPLETED|Overall Study||3
8675070|NCT01919190|21417046|P2|COMPLETED|Overall Study||34
8675071|NCT01919190|21417047|P1|COMPLETED|Overall Study||30
8675072|NCT01919190|21417046|P2|STARTED|Overall Study|Met eligibility criteria|34
8675073|NCT01919190|21417047|P1|STARTED|Overall Study|Met eligibility criteria|33
8675074|NCT01891643|21417065|P2|NOT COMPLETED|Overall Study||10
8675075|NCT01891643|21417066|P1|NOT COMPLETED|Overall Study||10
8675076|NCT01891643|21417065|P2|COMPLETED|Overall Study||0
8675077|NCT01891643|21417066|P1|COMPLETED|Overall Study||3
8675078|NCT01891643|21417065|P2|STARTED|Overall Study||10
8675079|NCT01891643|21417066|P1|STARTED|Overall Study||13
8675088|NCT01874431|21417111|P8|NOT COMPLETED|Overall Study||4
8675089|NCT01874431|21417112|P7|NOT COMPLETED|Overall Study||8
8675090|NCT01874431|21417113|P6|NOT COMPLETED|Overall Study||11
8675091|NCT01874431|21417114|P5|NOT COMPLETED|Overall Study||8
8675092|NCT01874431|21417115|P4|NOT COMPLETED|Overall Study||7
8675093|NCT01874431|21417116|P3|NOT COMPLETED|Overall Study||10
8675094|NCT01874431|21417117|P2|NOT COMPLETED|Overall Study||5
8675095|NCT01874431|21417118|P1|NOT COMPLETED|Overall Study||6
8675096|NCT01874431|21417111|P8|COMPLETED|Overall Study||90
8675097|NCT01874431|21417112|P7|COMPLETED|Overall Study||112
8675098|NCT01874431|21417113|P6|COMPLETED|Overall Study||114
8675099|NCT01874431|21417114|P5|COMPLETED|Overall Study||90
8675100|NCT01874431|21417115|P4|COMPLETED|Overall Study||91
8675101|NCT01874431|21417116|P3|COMPLETED|Overall Study||90
8675102|NCT01874431|21417117|P2|COMPLETED|Overall Study||87
8675103|NCT01874431|21417118|P1|COMPLETED|Overall Study||90
8675104|NCT01874431|21417111|P8|Participants Received Treatment|Overall Study||94
8675105|NCT01874431|21417112|P7|Participants Received Treatment|Overall Study||119
8675106|NCT01874431|21417113|P6|Participants Received Treatment|Overall Study||125
8675107|NCT01874431|21417114|P5|Participants Received Treatment|Overall Study||98
8675108|NCT01874431|21417115|P4|Participants Received Treatment|Overall Study||97
8675109|NCT01874431|21417116|P3|Participants Received Treatment|Overall Study||100
8675110|NCT01874431|21417117|P2|Participants Received Treatment|Overall Study||92
8675111|NCT01874431|21417118|P1|Participants Received Treatment|Overall Study||96
8675112|NCT01874431|21417111|P8|STARTED|Overall Study||94
8675113|NCT01874431|21417112|P7|STARTED|Overall Study||120
8675114|NCT01874431|21417113|P6|STARTED|Overall Study||125
8675115|NCT01874431|21417114|P5|STARTED|Overall Study||98
8675116|NCT01874431|21417115|P4|STARTED|Overall Study||98
8675117|NCT01874431|21417116|P3|STARTED|Overall Study||100
8675118|NCT01874431|21417117|P2|STARTED|Overall Study||92
8675119|NCT01874431|21417118|P1|STARTED|Overall Study||96
8675155|NCT01807221|21417237|P6|NOT COMPLETED|Overall Study||41
8675156|NCT01807221|21417238|P5|NOT COMPLETED|Overall Study||36
8675157|NCT01807221|21417239|P4|NOT COMPLETED|Overall Study||46
8675158|NCT01807221|21417240|P3|NOT COMPLETED|Overall Study||43
8675159|NCT01807221|21417241|P2|NOT COMPLETED|Overall Study||52
8675160|NCT01807221|21417242|P1|NOT COMPLETED|Overall Study||80
8675161|NCT01807221|21417237|P6|COMPLETED|Overall Study||124
8675162|NCT01807221|21417238|P5|COMPLETED|Overall Study||134
8675163|NCT01807221|21417239|P4|COMPLETED|Overall Study||123
8675164|NCT01807221|21417240|P3|COMPLETED|Overall Study||122
8675165|NCT01807221|21417241|P2|COMPLETED|Overall Study||121
8675166|NCT01807221|21417242|P1|COMPLETED|Overall Study||144
8675167|NCT01807221|21417237|P6|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
8675168|NCT01807221|21417238|P5|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||169
8675169|NCT01807221|21417239|P4|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||167
8675170|NCT01807221|21417240|P3|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
8675171|NCT01807221|21417241|P2|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||172
8675172|NCT01807221|21417242|P1|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||221
8675173|NCT01807221|21417237|P6|STARTED|Overall Study||165
8675174|NCT01807221|21417238|P5|STARTED|Overall Study||170
8675175|NCT01807221|21417239|P4|STARTED|Overall Study||169
8675176|NCT01807221|21417240|P3|STARTED|Overall Study||165
8675177|NCT01807221|21417241|P2|STARTED|Overall Study||173
8675178|NCT01807221|21417242|P1|STARTED|Overall Study||224
8675201|NCT01709981|21417336|P2|NOT COMPLETED|Overall Study||0
8675202|NCT01709981|21417337|P1|NOT COMPLETED|Overall Study||0
8675203|NCT01709981|21417336|P2|COMPLETED|Overall Study||139
8675204|NCT01709981|21417337|P1|COMPLETED|Overall Study||141
8675205|NCT01709981|21417336|P2|STARTED|Overall Study||139
8675206|NCT01709981|21417337|P1|STARTED|Overall Study||141
8675207|NCT01707667|21417353|P2|NOT COMPLETED|Period 2||0
8675208|NCT01707667|21417354|P1|NOT COMPLETED|Period 2||0
8675209|NCT01707667|21417353|P2|COMPLETED|Period 2||6
8675210|NCT01707667|21417354|P1|COMPLETED|Period 2||6
8675211|NCT01707667|21417353|P2|STARTED|Period 2||6
8675212|NCT01707667|21417354|P1|STARTED|Period 2||6
8675213|NCT01707667|21417353|P2|NOT COMPLETED|Period 1||0
8675214|NCT01707667|21417354|P1|NOT COMPLETED|Period 1||1
8675215|NCT01707667|21417353|P2|COMPLETED|Period 1||6
8675216|NCT01707667|21417354|P1|COMPLETED|Period 1||6
8675217|NCT01707667|21417353|P2|STARTED|Period 1||6
8675218|NCT01707667|21417354|P1|STARTED|Period 1||7
8675219|NCT01705964|21417374|P2|NOT COMPLETED|Overall Study||0
8675220|NCT01705964|21417375|P1|NOT COMPLETED|Overall Study||0
8675221|NCT01705964|21417374|P2|COMPLETED|Overall Study||24
8675222|NCT01705964|21417375|P1|COMPLETED|Overall Study||25
8675223|NCT01705964|21417374|P2|STARTED|Overall Study||24
8675224|NCT01705964|21417375|P1|STARTED|Overall Study||25
8675225|NCT01696994|21417391|P2|NOT COMPLETED|Overall Study||8437
8675226|NCT01696994|21417392|P1|NOT COMPLETED|Overall Study||5192
8675227|NCT01696994|21417391|P2|COMPLETED|Overall Study||30668
8675228|NCT01696994|21417392|P1|COMPLETED|Overall Study||33919
8675229|NCT01696994|21417391|P2|STARTED|Overall Study||39105
8675230|NCT01696994|21417392|P1|STARTED|Overall Study||39111
8675231|NCT01696981|21417420|P2|NOT COMPLETED|Overall Study||10374
8675232|NCT01696981|21417421|P1|NOT COMPLETED|Overall Study||1201
8675233|NCT01696981|21417420|P2|COMPLETED|Overall Study||67071
8675234|NCT01696981|21417421|P1|COMPLETED|Overall Study||76254
8675235|NCT01696981|21417420|P2|STARTED|Overall Study||77445
8675236|NCT01696981|21417421|P1|STARTED|Overall Study||77455
8675237|NCT01696968|21417441|P2|NOT COMPLETED|Overall Study||6812
8675238|NCT01696968|21417442|P1|NOT COMPLETED|Overall Study||1201
8675239|NCT01696968|21417441|P2|COMPLETED|Overall Study||70633
8675240|NCT01696968|21417442|P1|COMPLETED|Overall Study||76255
8675241|NCT01696968|21417441|P2|STARTED|Overall Study||77445
8675242|NCT01696968|21417442|P1|STARTED|Overall Study||77456
8675243|NCT01690520|21417464|P2|NOT COMPLETED|Overall Study||47
8675244|NCT01690520|21417465|P1|NOT COMPLETED|Overall Study||51
8675245|NCT01690520|21417464|P2|COMPLETED|Overall Study||35
8675246|NCT01690520|21417465|P1|COMPLETED|Overall Study||27
8675247|NCT01690520|21417464|P2|Modified Intent to Treat (mITT)|Overall Study||80
8675248|NCT01690520|21417465|P1|Modified Intent to Treat (mITT)|Overall Study||78
8675249|NCT01690520|21417464|P2|STARTED|Overall Study||82
8675250|NCT01690520|21417465|P1|STARTED|Overall Study||78
8675257|NCT01555541|21417494|P1|NOT COMPLETED|Autologous Stem Cell Transplantation||0
8675258|NCT01555541|21417494|P1|COMPLETED|Autologous Stem Cell Transplantation||12
8675259|NCT01555541|21417494|P1|STARTED|Autologous Stem Cell Transplantation|7 patients didn't move forward due to non-response/progression on last line of therapy prior to ASCT|12
8675260|NCT01555541|21417494|P1|NOT COMPLETED|OVA Treatment||0
8675261|NCT01555541|21417494|P1|COMPLETED|OVA Treatment||19
8675262|NCT01555541|21417494|P1|STARTED|OVA Treatment||19
8675263|NCT01555541|21417494|P1|NOT COMPLETED|Salvage Response Assessment||0
8675264|NCT01555541|21417494|P1|COMPLETED|Salvage Response Assessment||19
8675265|NCT01555541|21417494|P1|STARTED|Salvage Response Assessment||19
8675266|NCT01541215|21417503|P2|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
8675267|NCT01541215|21417504|P1|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
8675268|NCT01541215|21417503|P2|COMPLETED|Follow up 2 (Weeks 105-156)||0
8675269|NCT01541215|21417504|P1|COMPLETED|Follow up 2 (Weeks 105-156)||48
8675270|NCT01541215|21417503|P2|STARTED|Follow up 2 (Weeks 105-156)||0
8675271|NCT01541215|21417504|P1|STARTED|Follow up 2 (Weeks 105-156)|Subjects who attended safety follow up visit at week 156 were included.|48
8675272|NCT01541215|21417503|P2|NOT COMPLETED|Follow up 1 (Weeks 53-104)||0
8675273|NCT01541215|21417504|P1|NOT COMPLETED|Follow up 1 (Weeks 53-104)||2
8675274|NCT01541215|21417503|P2|COMPLETED|Follow up 1 (Weeks 53-104)||0
8675275|NCT01541215|21417504|P1|COMPLETED|Follow up 1 (Weeks 53-104)||50
8675276|NCT01541215|21417503|P2|STARTED|Follow up 1 (Weeks 53-104)|Follow up was not planned for the subjects who received placebo.|0
8675277|NCT01541215|21417504|P1|STARTED|Follow up 1 (Weeks 53-104)|Subjects who attended safety follow up visit at week 104 were included.|52
8675278|NCT01541215|21417503|P2|NOT COMPLETED|Treatment Period (52 Weeks)||16
8675279|NCT01541215|21417504|P1|NOT COMPLETED|Treatment Period (52 Weeks)||10
8675280|NCT01541215|21417503|P2|COMPLETED|Treatment Period (52 Weeks)||53
8675281|NCT01541215|21417504|P1|COMPLETED|Treatment Period (52 Weeks)||56
8675282|NCT01541215|21417503|P2|Exposed|Treatment Period (52 Weeks)||68
8675283|NCT01541215|21417504|P1|Exposed|Treatment Period (52 Weeks)||66
8675284|NCT01541215|21417503|P2|STARTED|Treatment Period (52 Weeks)||69
8675285|NCT01541215|21417504|P1|STARTED|Treatment Period (52 Weeks)||66
8675286|NCT01520870|21417656|P1|NOT COMPLETED|Overall Study||2
8675287|NCT01520870|21417656|P1|COMPLETED|Overall Study||47
8675288|NCT01520870|21417656|P1|STARTED|Overall Study||49
8675289|NCT01485770|21417668|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
8675290|NCT01485770|21417669|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
8675291|NCT01485770|21417668|P2|COMPLETED|Second Intervention (2 Weeks)||16
8675292|NCT01485770|21417669|P1|COMPLETED|Second Intervention (2 Weeks)||17
8675293|NCT01485770|21417668|P2|STARTED|Second Intervention (2 Weeks)||16
8675294|NCT01485770|21417669|P1|STARTED|Second Intervention (2 Weeks)||17
8675295|NCT01485770|21417668|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
8675296|NCT01485770|21417669|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
8675297|NCT01485770|21417668|P2|COMPLETED|First Intervention (2 Weeks)||16
8675298|NCT01485770|21417669|P1|COMPLETED|First Intervention (2 Weeks)||17
8675299|NCT01485770|21417668|P2|STARTED|First Intervention (2 Weeks)||16
8675300|NCT01485770|21417669|P1|STARTED|First Intervention (2 Weeks)||17
8675301|NCT01471522|21417685|P2|NOT COMPLETED|Overall Study||48
8675302|NCT01471522|21417686|P1|NOT COMPLETED|Overall Study||64
8675303|NCT01471522|21417685|P2|COMPLETED|Overall Study||2543
8675304|NCT01471522|21417686|P1|COMPLETED|Overall Study||2524
8675305|NCT01471522|21417685|P2|STARTED|Overall Study||2591
8675306|NCT01471522|21417686|P1|STARTED|Overall Study||2588
8675307|NCT01468207|21417712|P6|NOT COMPLETED|Treatment Period 2||20
8675308|NCT01468207|21417713|P5|NOT COMPLETED|Treatment Period 2||21
8675309|NCT01468207|21417714|P4|NOT COMPLETED|Treatment Period 2||27
8675310|NCT01468207|21417715|P3|NOT COMPLETED|Treatment Period 2||52
8675311|NCT01468207|21417716|P2|NOT COMPLETED|Treatment Period 2||0
8675312|NCT01468207|21417717|P1|NOT COMPLETED|Treatment Period 2||0
8675313|NCT01468207|21417712|P6|COMPLETED|Treatment Period 2||28
8675314|NCT01468207|21417713|P5|COMPLETED|Treatment Period 2||27
8675315|NCT01468207|21417714|P4|COMPLETED|Treatment Period 2||22
8675316|NCT01468207|21417715|P3|COMPLETED|Treatment Period 2||93
8675317|NCT01468207|21417716|P2|COMPLETED|Treatment Period 2||0
8675318|NCT01468207|21417717|P1|COMPLETED|Treatment Period 2||0
8675319|NCT01468207|21417712|P6|STARTED|Treatment Period 2||48
8675320|NCT01468207|21417713|P5|STARTED|Treatment Period 2||48
8675321|NCT01468207|21417714|P4|STARTED|Treatment Period 2||49
8675322|NCT01468207|21417715|P3|STARTED|Treatment Period 2||145
8675323|NCT01468207|21417716|P2|STARTED|Treatment Period 2||0
8675324|NCT01468207|21417717|P1|STARTED|Treatment Period 2||0
8675325|NCT01468207|21417712|P6|NOT COMPLETED|Treatment Period 1||0
8675326|NCT01468207|21417713|P5|NOT COMPLETED|Treatment Period 1||0
8675327|NCT01468207|21417714|P4|NOT COMPLETED|Treatment Period 1||0
8675328|NCT01468207|21417715|P3|NOT COMPLETED|Treatment Period 1||0
8675329|NCT01468207|21417716|P2|NOT COMPLETED|Treatment Period 1||8
8675330|NCT01468207|21417717|P1|NOT COMPLETED|Treatment Period 1||9
8675331|NCT01468207|21417712|P6|COMPLETED|Treatment Period 1||0
8675332|NCT01468207|21417713|P5|COMPLETED|Treatment Period 1||0
8675333|NCT01468207|21417714|P4|COMPLETED|Treatment Period 1||0
8675334|NCT01468207|21417715|P3|COMPLETED|Treatment Period 1||0
8675335|NCT01468207|21417716|P2|COMPLETED|Treatment Period 1||145
8675336|NCT01468207|21417717|P1|COMPLETED|Treatment Period 1||145
8675337|NCT01468207|21417712|P6|Received Study Drug|Treatment Period 1||0
8675338|NCT01468207|21417713|P5|Received Study Drug|Treatment Period 1||0
8675339|NCT01468207|21417714|P4|Received Study Drug|Treatment Period 1||0
8675340|NCT01468207|21417715|P3|Received Study Drug|Treatment Period 1||0
8675341|NCT01468207|21417716|P2|Received Study Drug|Treatment Period 1||153
8675342|NCT01468207|21417717|P1|Received Study Drug|Treatment Period 1||152
8675343|NCT01468207|21417712|P6|STARTED|Treatment Period 1||0
8675344|NCT01468207|21417713|P5|STARTED|Treatment Period 1||0
8675345|NCT01468207|21417714|P4|STARTED|Treatment Period 1||0
8675346|NCT01468207|21417715|P3|STARTED|Treatment Period 1||0
8675347|NCT01468207|21417716|P2|STARTED|Treatment Period 1||153
8675348|NCT01468207|21417717|P1|STARTED|Treatment Period 1||154
8675361|NCT01445548|21417766|P1|NOT COMPLETED|Overall Study||1
8675362|NCT01445548|21417766|P1|COMPLETED|Overall Study||5
8675363|NCT01445548|21417766|P1|STARTED|Overall Study||6
8675364|NCT01377844|21417790|P2|NOT COMPLETED|Overall Study||35
8675365|NCT01377844|21417791|P1|NOT COMPLETED|Overall Study||36
8675366|NCT01377844|21417790|P2|COMPLETED|Overall Study||108
8675367|NCT01377844|21417791|P1|COMPLETED|Overall Study||109
8675368|NCT01377844|21417790|P2|Safety Population|Overall Study||141
8675369|NCT01377844|21417791|P1|Safety Population|Overall Study||145
8675370|NCT01377844|21417790|P2|STARTED|Overall Study||143
8675371|NCT01377844|21417791|P1|STARTED|Overall Study||145
8675372|NCT01359592|21417807|P4|NOT COMPLETED|PET-Directed Therapy||0
8675373|NCT01359592|21417808|P3|NOT COMPLETED|PET-Directed Therapy||26
8675374|NCT01359592|21417809|P2|NOT COMPLETED|PET-Directed Therapy||0
8675375|NCT01359592|21417810|P1|NOT COMPLETED|PET-Directed Therapy||0
8675376|NCT01359592|21417807|P4|COMPLETED|PET-Directed Therapy||12
8675377|NCT01359592|21417808|P3|COMPLETED|PET-Directed Therapy||111
8675378|NCT01359592|21417809|P2|COMPLETED|PET-Directed Therapy||0
8675379|NCT01359592|21417810|P1|COMPLETED|PET-Directed Therapy||0
8675380|NCT01359592|21417807|P4|Eligible and Evaluable|PET-Directed Therapy||12
8675381|NCT01359592|21417808|P3|Eligible and Evaluable|PET-Directed Therapy||113
8675382|NCT01359592|21417809|P2|Eligible and Evaluable|PET-Directed Therapy||0
8675383|NCT01359592|21417810|P1|Eligible and Evaluable|PET-Directed Therapy||0
8675384|NCT01359592|21417807|P4|STARTED|PET-Directed Therapy||12
8675385|NCT01359592|21417808|P3|STARTED|PET-Directed Therapy||137
8675386|NCT01359592|21417809|P2|STARTED|PET-Directed Therapy||0
8675387|NCT01359592|21417810|P1|STARTED|PET-Directed Therapy||0
8675388|NCT01359592|21417807|P4|NOT COMPLETED|Initial Registration||0
8675389|NCT01359592|21417808|P3|NOT COMPLETED|Initial Registration||0
8675390|NCT01359592|21417809|P2|NOT COMPLETED|Initial Registration||0
8675391|NCT01359592|21417810|P1|NOT COMPLETED|Initial Registration||29
8675392|NCT01359592|21417807|P4|COMPLETED|Initial Registration||0
8675393|NCT01359592|21417808|P3|COMPLETED|Initial Registration||0
8675394|NCT01359592|21417809|P2|COMPLETED|Initial Registration||1
8675395|NCT01359592|21417810|P1|COMPLETED|Initial Registration||129
8675396|NCT01359592|21417807|P4|Eligible and Evaluable|Initial Registration||0
8675397|NCT01359592|21417808|P3|Eligible and Evaluable|Initial Registration||0
8675398|NCT01359592|21417809|P2|Eligible and Evaluable|Initial Registration||1
8675399|NCT01359592|21417810|P1|Eligible and Evaluable|Initial Registration||132
8675400|NCT01359592|21417807|P4|STARTED|Initial Registration||0
8675401|NCT01359592|21417808|P3|STARTED|Initial Registration||0
8675402|NCT01359592|21417809|P2|STARTED|Initial Registration||1
8675403|NCT01359592|21417810|P1|STARTED|Initial Registration||158
8675404|NCT01343043|21417830|P4|NOT COMPLETED|Overall Study||1
8675405|NCT01343043|21417831|P3|NOT COMPLETED|Overall Study||0
8675406|NCT01343043|21417832|P2|NOT COMPLETED|Overall Study||1
8675407|NCT01343043|21417833|P1|NOT COMPLETED|Overall Study||3
8675408|NCT01343043|21417830|P4|COMPLETED|Overall Study||15
8675409|NCT01343043|21417831|P3|COMPLETED|Overall Study||5
8675410|NCT01343043|21417832|P2|COMPLETED|Overall Study||13
8675411|NCT01343043|21417833|P1|COMPLETED|Overall Study||12
8675412|NCT01343043|21417830|P4|Received T-cell Infusion|Overall Study||15
8675413|NCT01343043|21417831|P3|Received T-cell Infusion|Overall Study||5
8675414|NCT01343043|21417832|P2|Received T-cell Infusion|Overall Study||13
8675415|NCT01343043|21417833|P1|Received T-cell Infusion|Overall Study||12
8675416|NCT01343043|21417830|P4|STARTED|Overall Study||16
8675417|NCT01343043|21417831|P3|STARTED|Overall Study||5
8675418|NCT01343043|21417832|P2|STARTED|Overall Study||14
8675419|NCT01343043|21417833|P1|STARTED|Overall Study||15
8675420|NCT01293396|21417895|P3|NOT COMPLETED|Third Intervention||0
8675421|NCT01293396|21417896|P2|NOT COMPLETED|Third Intervention||0
8675422|NCT01293396|21417897|P1|NOT COMPLETED|Third Intervention||0
8675423|NCT01293396|21417895|P3|COMPLETED|Third Intervention||3
8675424|NCT01293396|21417896|P2|COMPLETED|Third Intervention||8
8675425|NCT01293396|21417897|P1|COMPLETED|Third Intervention||9
8675426|NCT01293396|21417895|P3|STARTED|Third Intervention||3
8675427|NCT01293396|21417896|P2|STARTED|Third Intervention||8
8675428|NCT01293396|21417897|P1|STARTED|Third Intervention||9
8675429|NCT01293396|21417895|P3|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
8675430|NCT01293396|21417896|P2|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
8675431|NCT01293396|21417897|P1|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
8675432|NCT01293396|21417895|P3|COMPLETED|Wash Out Period 2 (3 Days)||10
8675433|NCT01293396|21417896|P2|COMPLETED|Wash Out Period 2 (3 Days)||5
8675434|NCT01293396|21417897|P1|COMPLETED|Wash Out Period 2 (3 Days)||5
8675435|NCT01293396|21417895|P3|STARTED|Wash Out Period 2 (3 Days)||10
8675436|NCT01293396|21417896|P2|STARTED|Wash Out Period 2 (3 Days)||5
8675437|NCT01293396|21417897|P1|STARTED|Wash Out Period 2 (3 Days)||5
8675438|NCT01293396|21417895|P3|NOT COMPLETED|Second Intervention||0
8675439|NCT01293396|21417896|P2|NOT COMPLETED|Second Intervention||0
8675440|NCT01293396|21417897|P1|NOT COMPLETED|Second Intervention||0
8675441|NCT01293396|21417895|P3|COMPLETED|Second Intervention||10
8675442|NCT01293396|21417896|P2|COMPLETED|Second Intervention||5
8675443|NCT01293396|21417897|P1|COMPLETED|Second Intervention||5
8675444|NCT01293396|21417895|P3|STARTED|Second Intervention||10
8675445|NCT01293396|21417896|P2|STARTED|Second Intervention||5
8675446|NCT01293396|21417897|P1|STARTED|Second Intervention||5
8675447|NCT01293396|21417895|P3|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
8675448|NCT01293396|21417896|P2|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
8675449|NCT01293396|21417897|P1|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
8675450|NCT01293396|21417895|P3|COMPLETED|Wash Out Period 1 (3 Days)||7
8675451|NCT01293396|21417896|P2|COMPLETED|Wash Out Period 1 (3 Days)||7
8675452|NCT01293396|21417897|P1|COMPLETED|Wash Out Period 1 (3 Days)||6
8675453|NCT01293396|21417895|P3|STARTED|Wash Out Period 1 (3 Days)||7
8675454|NCT01293396|21417896|P2|STARTED|Wash Out Period 1 (3 Days)||7
8675455|NCT01293396|21417897|P1|STARTED|Wash Out Period 1 (3 Days)||6
8675456|NCT01293396|21417895|P3|NOT COMPLETED|First Intervention||0
8675457|NCT01293396|21417896|P2|NOT COMPLETED|First Intervention||0
8675458|NCT01293396|21417897|P1|NOT COMPLETED|First Intervention||0
8675459|NCT01293396|21417895|P3|COMPLETED|First Intervention||7
8675460|NCT01293396|21417896|P2|COMPLETED|First Intervention||7
8675461|NCT01293396|21417897|P1|COMPLETED|First Intervention||6
8675462|NCT01293396|21417895|P3|STARTED|First Intervention||7
8675463|NCT01293396|21417896|P2|STARTED|First Intervention||7
8675464|NCT01293396|21417897|P1|STARTED|First Intervention||6
8675465|NCT01276379|21417922|P1|NOT COMPLETED|Overall Study||40
8675466|NCT01276379|21417922|P1|COMPLETED|Overall Study||181
8675467|NCT01276379|21417922|P1|STARTED|Overall Study||221
8675468|NCT01244490|21417937|P3|NOT COMPLETED|Overall Study||23
8675469|NCT01244490|21417938|P2|NOT COMPLETED|Overall Study||24
8675470|NCT01244490|21417939|P1|NOT COMPLETED|Overall Study||19
8675471|NCT01244490|21417937|P3|COMPLETED|Overall Study||89
8675472|NCT01244490|21417938|P2|COMPLETED|Overall Study||91
8675473|NCT01244490|21417939|P1|COMPLETED|Overall Study||92
8675474|NCT01244490|21417937|P3|STARTED|Overall Study||112
8675475|NCT01244490|21417938|P2|STARTED|Overall Study||115
8675476|NCT01244490|21417939|P1|STARTED|Overall Study||111
8675501|NCT01187017|21418035|P1|NOT COMPLETED|Overall Study||0
8675502|NCT01187017|21418035|P1|COMPLETED|Overall Study||1
8675503|NCT01187017|21418035|P1|STARTED|Overall Study||1
8675504|NCT01138657|21418045|P2|NOT COMPLETED|Overall Study||18
8675505|NCT01138657|21418046|P1|NOT COMPLETED|Overall Study||8
8675506|NCT01138657|21418045|P2|COMPLETED|Overall Study||101
8675507|NCT01138657|21418046|P1|COMPLETED|Overall Study||112
8675508|NCT01138657|21418045|P2|Enrolled in Japan Sub-study|Overall Study||8
8675509|NCT01138657|21418046|P1|Enrolled in Japan Sub-study|Overall Study||8
8675510|NCT01138657|21418045|P2|Enrolled in Main Study|Overall Study||111
8675511|NCT01138657|21418046|P1|Enrolled in Main Study|Overall Study||112
8675512|NCT01138657|21418045|P2|STARTED|Overall Study||119
8675513|NCT01138657|21418046|P1|STARTED|Overall Study||120
8675514|NCT01124838|21418092|P2|NOT COMPLETED|Overall Study||15
8675515|NCT01124838|21418093|P1|NOT COMPLETED|Overall Study||18
8675516|NCT01124838|21418092|P2|COMPLETED|Overall Study||116
8675517|NCT01124838|21418093|P1|COMPLETED|Overall Study||112
8675518|NCT01124838|21418092|P2|Enrolled in Japan Sub-study|Overall Study||16
8675519|NCT01124838|21418093|P1|Enrolled in Japan Sub-study|Overall Study||16
8675520|NCT01124838|21418092|P2|Enrolled in Main Study|Overall Study||115
8675521|NCT01124838|21418093|P1|Enrolled in Main Study|Overall Study||114
8675522|NCT01124838|21418092|P2|STARTED|Overall Study||131
8675523|NCT01124838|21418093|P1|STARTED|Overall Study||130
8675524|NCT01117792|21418137|P1|NOT COMPLETED|Overall Study||4
8675525|NCT01117792|21418137|P1|COMPLETED|Overall Study||51
8675526|NCT01117792|21418137|P1|STARTED|Overall Study||55
8675527|NCT01108666|21418141|P1|NOT COMPLETED|Overall Study||0
8675528|NCT01108666|21418141|P1|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
8675529|NCT01108666|21418141|P1|STARTED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
8675530|NCT01070888|21418150|P2|NOT COMPLETED|Second Intervention (14 Days)||0
8675531|NCT01070888|21418151|P1|NOT COMPLETED|Second Intervention (14 Days)||0
8675532|NCT01070888|21418150|P2|COMPLETED|Second Intervention (14 Days)||2
8675533|NCT01070888|21418151|P1|COMPLETED|Second Intervention (14 Days)||1
8675534|NCT01070888|21418150|P2|STARTED|Second Intervention (14 Days)||2
8675535|NCT01070888|21418151|P1|STARTED|Second Intervention (14 Days)||1
8675536|NCT01070888|21418150|P2|NOT COMPLETED|Washout (14 Days)||0
8675537|NCT01070888|21418151|P1|NOT COMPLETED|Washout (14 Days)||1
8675538|NCT01070888|21418150|P2|COMPLETED|Washout (14 Days)||2
8675539|NCT01070888|21418151|P1|COMPLETED|Washout (14 Days)||1
8675540|NCT01070888|21418150|P2|STARTED|Washout (14 Days)||2
8675541|NCT01070888|21418151|P1|STARTED|Washout (14 Days)||2
8675542|NCT01070888|21418150|P2|NOT COMPLETED|First Intervention (14 Days)||2
8675543|NCT01070888|21418151|P1|NOT COMPLETED|First Intervention (14 Days)||0
8675544|NCT01070888|21418150|P2|COMPLETED|First Intervention (14 Days)||2
8675545|NCT01070888|21418151|P1|COMPLETED|First Intervention (14 Days)||2
8675546|NCT01070888|21418150|P2|STARTED|First Intervention (14 Days)||4
8675547|NCT01070888|21418151|P1|STARTED|First Intervention (14 Days)||2
8675548|NCT01064856|21418159|P4|NOT COMPLETED|Open-label (OL) Period||20
8675549|NCT01064856|21418160|P3|NOT COMPLETED|Open-label (OL) Period||26
8675550|NCT01064856|21418161|P2|NOT COMPLETED|Open-label (OL) Period||0
8675551|NCT01064856|21418162|P1|NOT COMPLETED|Open-label (OL) Period||0
8675552|NCT01064856|21418159|P4|COMPLETED|Open-label (OL) Period||61
8675553|NCT01064856|21418160|P3|COMPLETED|Open-label (OL) Period||56
8675554|NCT01064856|21418161|P2|COMPLETED|Open-label (OL) Period||0
8675555|NCT01064856|21418162|P1|COMPLETED|Open-label (OL) Period||0
8675556|NCT01064856|21418159|P4|STARTED|Open-label (OL) Period||81
8675557|NCT01064856|21418160|P3|STARTED|Open-label (OL) Period||82
8675558|NCT01064856|21418161|P2|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
8675559|NCT01064856|21418162|P1|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
8675560|NCT01064856|21418159|P4|NOT COMPLETED|Double-blind (DB) Period||0
8675561|NCT01064856|21418160|P3|NOT COMPLETED|Double-blind (DB) Period||0
8675562|NCT01064856|21418161|P2|NOT COMPLETED|Double-blind (DB) Period||0
8675563|NCT01064856|21418162|P1|NOT COMPLETED|Double-blind (DB) Period||2
8675564|NCT01064856|21418159|P4|COMPLETED|Double-blind (DB) Period||0
8675565|NCT01064856|21418160|P3|COMPLETED|Double-blind (DB) Period||0
8675566|NCT01064856|21418161|P2|COMPLETED|Double-blind (DB) Period||81
8675567|NCT01064856|21418162|P1|COMPLETED|Double-blind (DB) Period||82
8675568|NCT01064856|21418159|P4|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
8675569|NCT01064856|21418160|P3|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
8675570|NCT01064856|21418161|P2|STARTED|Double-blind (DB) Period||81
8675571|NCT01064856|21418162|P1|STARTED|Double-blind (DB) Period||84
8675572|NCT01030874|21418195|P2|NOT COMPLETED|Overall Study||16
8675573|NCT01030874|21418196|P1|NOT COMPLETED|Overall Study||18
8675574|NCT01030874|21418195|P2|COMPLETED|Overall Study||162
8675575|NCT01030874|21418196|P1|COMPLETED|Overall Study||160
8675576|NCT01030874|21418195|P2|STARTED|Overall Study|1 with impaired decision making capacity|178
8675577|NCT01030874|21418196|P1|STARTED|Overall Study|1 with impaired decision making capacity|178
8675578|NCT01008943|21418204|P1|NOT COMPLETED|Overall Study||1
8675579|NCT01008943|21418204|P1|COMPLETED|Overall Study||15
8675580|NCT01008943|21418204|P1|STARTED|Overall Study||16
8675581|NCT00980018|21418211|P1|NOT COMPLETED|Overall Study||12
8675582|NCT00980018|21418211|P1|COMPLETED|Overall Study||40
8675583|NCT00980018|21418211|P1|STARTED|Overall Study||52
8675593|NCT00927810|21418249|P4|NOT COMPLETED|Overall Study||2
8675594|NCT00927810|21418250|P3|NOT COMPLETED|Overall Study||1
8675595|NCT00927810|21418251|P2|NOT COMPLETED|Overall Study||8
8675596|NCT00927810|21418252|P1|NOT COMPLETED|Overall Study||0
8675597|NCT00927810|21418249|P4|COMPLETED|Overall Study||58
8675598|NCT00927810|21418250|P3|COMPLETED|Overall Study||24
8675599|NCT00927810|21418251|P2|COMPLETED|Overall Study||173
8675600|NCT00927810|21418252|P1|COMPLETED|Overall Study||75
8675601|NCT00927810|21418249|P4|STARTED|Overall Study||60
8675602|NCT00927810|21418250|P3|STARTED|Overall Study||25
8675603|NCT00927810|21418251|P2|STARTED|Overall Study||181
8675604|NCT00927810|21418252|P1|STARTED|Overall Study||75
8675605|NCT00876187|21418284|P5|NOT COMPLETED|Overall Study||271
8675606|NCT00876187|21418285|P4|NOT COMPLETED|Overall Study||275
8675607|NCT00876187|21418286|P3|NOT COMPLETED|Overall Study||279
8675608|NCT00876187|21418287|P2|NOT COMPLETED|Overall Study||215
8675609|NCT00876187|21418288|P1|NOT COMPLETED|Overall Study||210
8675610|NCT00876187|21418284|P5|COMPLETED|Overall Study||27
8675611|NCT00876187|21418285|P4|COMPLETED|Overall Study||22
8675612|NCT00876187|21418286|P3|COMPLETED|Overall Study||19
8675613|NCT00876187|21418287|P2|COMPLETED|Overall Study||18
8675614|NCT00876187|21418288|P1|COMPLETED|Overall Study||23
8675615|NCT00876187|21418284|P5|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|185
8675616|NCT00876187|21418285|P4|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|188
8675617|NCT00876187|21418286|P3|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|193
8675618|NCT00876187|21418287|P2|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|146
8675619|NCT00876187|21418288|P1|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|128
8675620|NCT00876187|21418284|P5|Treated|Overall Study||295
8675621|NCT00876187|21418285|P4|Treated|Overall Study||295
8675622|NCT00876187|21418286|P3|Treated|Overall Study||295
8675623|NCT00876187|21418287|P2|Treated|Overall Study||232
8675624|NCT00876187|21418288|P1|Treated|Overall Study||230
8675625|NCT00876187|21418284|P5|STARTED|Overall Study||298
8675626|NCT00876187|21418285|P4|STARTED|Overall Study||297
8675627|NCT00876187|21418286|P3|STARTED|Overall Study||298
8675628|NCT00876187|21418287|P2|STARTED|Overall Study||233
8675629|NCT00876187|21418288|P1|STARTED|Overall Study||233
8675630|NCT00853645|21418386|P1|NOT COMPLETED|Overall Study||0
8675631|NCT00853645|21418386|P1|COMPLETED|Overall Study||6
8675632|NCT00853645|21418386|P1|STARTED|Overall Study||6
8675633|NCT00847535|21418390|P3|NOT COMPLETED|Overall Study||1
8675634|NCT00847535|21418391|P2|NOT COMPLETED|Overall Study||2
8675635|NCT00847535|21418392|P1|NOT COMPLETED|Overall Study||2
8675636|NCT00847535|21418390|P3|COMPLETED|Overall Study||15
8675637|NCT00847535|21418391|P2|COMPLETED|Overall Study||22
8675638|NCT00847535|21418392|P1|COMPLETED|Overall Study||22
8675639|NCT00847535|21418390|P3|200 Million AMDC|Overall Study||8
8675640|NCT00847535|21418391|P2|200 Million AMDC|Overall Study||0
8675641|NCT00847535|21418392|P1|200 Million AMDC|Overall Study||0
8675642|NCT00847535|21418390|P3|100 Million AMDC|Overall Study||8
8675643|NCT00847535|21418391|P2|100 Million AMDC|Overall Study||8
8675644|NCT00847535|21418392|P1|100 Million AMDC|Overall Study||8
8675645|NCT00847535|21418390|P3|50 Million AMDC|Overall Study||0
8675646|NCT00847535|21418391|P2|50 Million AMDC|Overall Study||8
8675647|NCT00847535|21418392|P1|50 Million AMDC|Overall Study||8
8675648|NCT00847535|21418390|P3|10 Million AMDC|Overall Study||0
8675649|NCT00847535|21418391|P2|10 Million AMDC|Overall Study||8
8675650|NCT00847535|21418392|P1|10 Million AMDC|Overall Study||8
8675651|NCT00847535|21418390|P3|STARTED|Overall Study||16
8675652|NCT00847535|21418391|P2|STARTED|Overall Study||24
8675653|NCT00847535|21418392|P1|STARTED|Overall Study||24
8675654|NCT00792077|21418400|P1|NOT COMPLETED|Overall Study||0
8675655|NCT00792077|21418400|P1|COMPLETED|Overall Study||6
8675656|NCT00792077|21418400|P1|Day 57+/-3 Days|Overall Study||6
8675657|NCT00792077|21418400|P1|Day 43+/-3 Days|Overall Study||6
8675658|NCT00792077|21418400|P1|Day 29+/-3 Days|Overall Study||6
8675659|NCT00792077|21418400|P1|Day 15+/- 3 Days|Overall Study||6
8675660|NCT00792077|21418400|P1|STARTED|Overall Study||6
8675661|NCT00780494|21418407|P1|NOT COMPLETED|Overall Study||0
8675662|NCT00780494|21418407|P1|COMPLETED|Overall Study||35
8675663|NCT00780494|21418407|P1|STARTED|Overall Study||35
8675664|NCT00758524|21418422|P17|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675665|NCT00758524|21418423|P16|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675666|NCT00758524|21418424|P15|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675667|NCT00758524|21418425|P14|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675668|NCT00758524|21418426|P13|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675669|NCT00758524|21418427|P12|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675670|NCT00758524|21418428|P11|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675671|NCT00758524|21418429|P10|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675672|NCT00758524|21418430|P9|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||2
8675673|NCT00758524|21418431|P8|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675674|NCT00758524|21418432|P7|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||1
8675675|NCT00758524|21418433|P6|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675676|NCT00758524|21418434|P5|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675677|NCT00758524|21418435|P4|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675678|NCT00758524|21418436|P3|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675679|NCT00758524|21418437|P2|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675680|NCT00758524|21418438|P1|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675681|NCT00758524|21418422|P17|COMPLETED|Withdrawal Period (Week 8 to Week 9)||66
8675682|NCT00758524|21418423|P16|COMPLETED|Withdrawal Period (Week 8 to Week 9)||36
8675683|NCT00758524|21418424|P15|COMPLETED|Withdrawal Period (Week 8 to Week 9)||39
8675684|NCT00758524|21418425|P14|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
8675685|NCT00758524|21418426|P13|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
8675686|NCT00758524|21418427|P12|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
8675687|NCT00758524|21418428|P11|COMPLETED|Withdrawal Period (Week 8 to Week 9)||41
8675688|NCT00758524|21418429|P10|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
8675689|NCT00758524|21418430|P9|COMPLETED|Withdrawal Period (Week 8 to Week 9)||42
8675690|NCT00758524|21418431|P8|COMPLETED|Withdrawal Period (Week 8 to Week 9)||38
8675691|NCT00758524|21418432|P7|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
8675692|NCT00758524|21418433|P6|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675693|NCT00758524|21418434|P5|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675694|NCT00758524|21418435|P4|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675695|NCT00758524|21418436|P3|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675696|NCT00758524|21418437|P2|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675697|NCT00758524|21418438|P1|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
8675698|NCT00758524|21418422|P17|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set. However, this participant was counted in the Placebo arm (N=67) in the Randomized Withdrawal Set.|67
8675699|NCT00758524|21418423|P16|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
8675700|NCT00758524|21418424|P15|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||39
8675701|NCT00758524|21418425|P14|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||44
8675702|NCT00758524|21418426|P13|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
8675703|NCT00758524|21418427|P12|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
8675704|NCT00758524|21418428|P11|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||41
8675705|NCT00758524|21418429|P10|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||37
8675706|NCT00758524|21418430|P9|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||43
8675707|NCT00758524|21418431|P8|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||38
8675708|NCT00758524|21418432|P7|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
8675709|NCT00758524|21418433|P6|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
8675710|NCT00758524|21418434|P5|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
8675711|NCT00758524|21418435|P4|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
8675712|NCT00758524|21418436|P3|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
8675713|NCT00758524|21418437|P2|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
8675714|NCT00758524|21418438|P1|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
8675715|NCT00758524|21418422|P17|STARTED|Withdrawal Period (Week 8 to Week 9)||66
8675716|NCT00758524|21418423|P16|STARTED|Withdrawal Period (Week 8 to Week 9)||36
8675717|NCT00758524|21418424|P15|STARTED|Withdrawal Period (Week 8 to Week 9)||39
8675718|NCT00758524|21418425|P14|STARTED|Withdrawal Period (Week 8 to Week 9)||45
8675719|NCT00758524|21418426|P13|STARTED|Withdrawal Period (Week 8 to Week 9)||45
8675720|NCT00758524|21418427|P12|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to LCI699 0.5 mg BID in the core period received LCI699 1.0 mg QD and was considered in the LCI699 1.0 mg QD arm in Randomized Withdrawal Safety Set.|37
8675721|NCT00758524|21418428|P11|STARTED|Withdrawal Period (Week 8 to Week 9)||41
8675722|NCT00758524|21418429|P10|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set.|37
8675723|NCT00758524|21418430|P9|STARTED|Withdrawal Period (Week 8 to Week 9)||44
8675724|NCT00758524|21418431|P8|STARTED|Withdrawal Period (Week 8 to Week 9)||38
8675725|NCT00758524|21418432|P7|STARTED|Withdrawal Period (Week 8 to Week 9)||46
8675726|NCT00758524|21418433|P6|STARTED|Withdrawal Period (Week 8 to Week 9)||0
8675727|NCT00758524|21418434|P5|STARTED|Withdrawal Period (Week 8 to Week 9)||0
8675728|NCT00758524|21418435|P4|STARTED|Withdrawal Period (Week 8 to Week 9)||0
8675729|NCT00758524|21418436|P3|STARTED|Withdrawal Period (Week 8 to Week 9)||0
8675730|NCT00758524|21418437|P2|STARTED|Withdrawal Period (Week 8 to Week 9)||0
8675731|NCT00758524|21418438|P1|STARTED|Withdrawal Period (Week 8 to Week 9)||0
8675732|NCT00758524|21418422|P17|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8675733|NCT00758524|21418423|P16|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8675734|NCT00758524|21418424|P15|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8675735|NCT00758524|21418425|P14|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8675736|NCT00758524|21418426|P13|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8675737|NCT00758524|21418427|P12|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8675738|NCT00758524|21418428|P11|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8675739|NCT00758524|21418429|P10|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8675740|NCT00758524|21418430|P9|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8675741|NCT00758524|21418431|P8|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8675742|NCT00758524|21418432|P7|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
8675743|NCT00758524|21418433|P6|NOT COMPLETED|Core Period (Week 0 to Week 8)||10
8675744|NCT00758524|21418434|P5|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
8675745|NCT00758524|21418435|P4|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
8675746|NCT00758524|21418436|P3|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
8675747|NCT00758524|21418437|P2|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
8675748|NCT00758524|21418438|P1|NOT COMPLETED|Core Period (Week 0 to Week 8)||8
8675749|NCT00758524|21418422|P17|COMPLETED|Core Period (Week 0 to Week 8)||0
8675750|NCT00758524|21418423|P16|COMPLETED|Core Period (Week 0 to Week 8)||0
8675751|NCT00758524|21418424|P15|COMPLETED|Core Period (Week 0 to Week 8)||0
8675752|NCT00758524|21418425|P14|COMPLETED|Core Period (Week 0 to Week 8)||0
8675753|NCT00758524|21418426|P13|COMPLETED|Core Period (Week 0 to Week 8)||0
8675754|NCT00758524|21418427|P12|COMPLETED|Core Period (Week 0 to Week 8)||0
8675755|NCT00758524|21418428|P11|COMPLETED|Core Period (Week 0 to Week 8)||0
8675756|NCT00758524|21418429|P10|COMPLETED|Core Period (Week 0 to Week 8)||0
8675757|NCT00758524|21418430|P9|COMPLETED|Core Period (Week 0 to Week 8)||0
8675758|NCT00758524|21418431|P8|COMPLETED|Core Period (Week 0 to Week 8)||0
8675759|NCT00758524|21418432|P7|COMPLETED|Core Period (Week 0 to Week 8)||0
8675760|NCT00758524|21418433|P6|COMPLETED|Core Period (Week 0 to Week 8)||67
8675761|NCT00758524|21418434|P5|COMPLETED|Core Period (Week 0 to Week 8)||75
8675762|NCT00758524|21418435|P4|COMPLETED|Core Period (Week 0 to Week 8)||90
8675763|NCT00758524|21418436|P3|COMPLETED|Core Period (Week 0 to Week 8)||77
8675764|NCT00758524|21418437|P2|COMPLETED|Core Period (Week 0 to Week 8)||81
8675765|NCT00758524|21418438|P1|COMPLETED|Core Period (Week 0 to Week 8)||84
8675766|NCT00758524|21418422|P17|Treated|Core Period (Week 0 to Week 8)||0
8675767|NCT00758524|21418423|P16|Treated|Core Period (Week 0 to Week 8)||0
8675768|NCT00758524|21418424|P15|Treated|Core Period (Week 0 to Week 8)||0
8675769|NCT00758524|21418425|P14|Treated|Core Period (Week 0 to Week 8)||0
8675770|NCT00758524|21418426|P13|Treated|Core Period (Week 0 to Week 8)||0
8675771|NCT00758524|21418427|P12|Treated|Core Period (Week 0 to Week 8)||0
8675772|NCT00758524|21418428|P11|Treated|Core Period (Week 0 to Week 8)||0
8675773|NCT00758524|21418429|P10|Treated|Core Period (Week 0 to Week 8)||0
8675774|NCT00758524|21418430|P9|Treated|Core Period (Week 0 to Week 8)||0
8675775|NCT00758524|21418431|P8|Treated|Core Period (Week 0 to Week 8)||0
8675776|NCT00758524|21418432|P7|Treated|Core Period (Week 0 to Week 8)||0
8675777|NCT00758524|21418433|P6|Treated|Core Period (Week 0 to Week 8)||76
8675778|NCT00758524|21418434|P5|Treated|Core Period (Week 0 to Week 8)||84
8675779|NCT00758524|21418435|P4|Treated|Core Period (Week 0 to Week 8)||97
8675780|NCT00758524|21418436|P3|Treated|Core Period (Week 0 to Week 8)|One participant from LCI699 0.5 mg QD was randomized to LCI699 1.0 mg QD and received LCI699 1.0 mg QD, thus was included in this arm in the Safety Set.|87
8675781|NCT00758524|21418437|P2|Treated|Core Period (Week 0 to Week 8)||87
8675782|NCT00758524|21418438|P1|Treated|Core Period (Week 0 to Week 8)||92
8675783|NCT00758524|21418422|P17|STARTED|Core Period (Week 0 to Week 8)||0
8675784|NCT00758524|21418423|P16|STARTED|Core Period (Week 0 to Week 8)||0
8675785|NCT00758524|21418424|P15|STARTED|Core Period (Week 0 to Week 8)||0
8675786|NCT00758524|21418425|P14|STARTED|Core Period (Week 0 to Week 8)||0
8675787|NCT00758524|21418426|P13|STARTED|Core Period (Week 0 to Week 8)||0
8675788|NCT00758524|21418427|P12|STARTED|Core Period (Week 0 to Week 8)||0
8675789|NCT00758524|21418428|P11|STARTED|Core Period (Week 0 to Week 8)||0
8675790|NCT00758524|21418429|P10|STARTED|Core Period (Week 0 to Week 8)||0
8675791|NCT00758524|21418430|P9|STARTED|Core Period (Week 0 to Week 8)||0
8675792|NCT00758524|21418431|P8|STARTED|Core Period (Week 0 to Week 8)||0
8675793|NCT00758524|21418432|P7|STARTED|Core Period (Week 0 to Week 8)||0
8675794|NCT00758524|21418433|P6|STARTED|Core Period (Week 0 to Week 8)||77
8675795|NCT00758524|21418434|P5|STARTED|Core Period (Week 0 to Week 8)||84
8675796|NCT00758524|21418435|P4|STARTED|Core Period (Week 0 to Week 8)|One participant in this arm group was randomized twice and was excluded from Full Analysis Set.|97
8675797|NCT00758524|21418436|P3|STARTED|Core Period (Week 0 to Week 8)||86
8675798|NCT00758524|21418437|P2|STARTED|Core Period (Week 0 to Week 8)||88
8675799|NCT00758524|21418438|P1|STARTED|Core Period (Week 0 to Week 8)||92
8675800|NCT00753545|21418555|P2|NOT COMPLETED|Overall Study||118
8675801|NCT00753545|21418556|P1|NOT COMPLETED|Overall Study||108
8675802|NCT00753545|21418555|P2|COMPLETED|Overall Study|Patients completing the Study|11
8675803|NCT00753545|21418556|P1|COMPLETED|Overall Study|Patients completing the Study|28
8675804|NCT00753545|21418555|P2|STARTED|Overall Study|Patients randomized|129
8675805|NCT00753545|21418556|P1|STARTED|Overall Study|Patients randomized|136
8675806|NCT00716976|21418594|P2|NOT COMPLETED|Overall Study||9
8675807|NCT00716976|21418595|P1|NOT COMPLETED|Overall Study||20
8675808|NCT00716976|21418594|P2|COMPLETED|Overall Study||57
8675809|NCT00716976|21418595|P1|COMPLETED|Overall Study||45
8675810|NCT00716976|21418594|P2|STARTED|Overall Study||66
8675811|NCT00716976|21418595|P1|STARTED|Overall Study||65
8675812|NCT00613171|21418617|P1|NOT COMPLETED|Overall Study||14
8675813|NCT00613171|21418617|P1|COMPLETED|Overall Study||13
8675814|NCT00613171|21418617|P1|STARTED|Overall Study||27
8675815|NCT00606294|21418625|P2|NOT COMPLETED|Overall Study||0
8675816|NCT00606294|21418626|P1|NOT COMPLETED|Overall Study||36
8675817|NCT00606294|21418625|P2|COMPLETED|Overall Study||19
8675818|NCT00606294|21418626|P1|COMPLETED|Overall Study||161
8675819|NCT00606294|21418625|P2|STARTED|Overall Study||19
8675820|NCT00606294|21418626|P1|STARTED|Overall Study||197
8675821|NCT00581893|21418638|P2|NOT COMPLETED|Second Intervention (1 Month)||2
8675822|NCT00581893|21418639|P1|NOT COMPLETED|Second Intervention (1 Month)||3
8675823|NCT00581893|21418638|P2|COMPLETED|Second Intervention (1 Month)||8
8675824|NCT00581893|21418639|P1|COMPLETED|Second Intervention (1 Month)||7
8675825|NCT00581893|21418638|P2|STARTED|Second Intervention (1 Month)||10
8675826|NCT00581893|21418639|P1|STARTED|Second Intervention (1 Month)||10
8675827|NCT00581893|21418638|P2|NOT COMPLETED|Washout (14 Days)||0
8675828|NCT00581893|21418639|P1|NOT COMPLETED|Washout (14 Days)||0
8675829|NCT00581893|21418638|P2|COMPLETED|Washout (14 Days)||10
8675830|NCT00581893|21418639|P1|COMPLETED|Washout (14 Days)||10
8675831|NCT00581893|21418638|P2|STARTED|Washout (14 Days)||10
8675832|NCT00581893|21418639|P1|STARTED|Washout (14 Days)||10
8675833|NCT00581893|21418638|P2|NOT COMPLETED|First Intervention (1 Month)||0
8675834|NCT00581893|21418639|P1|NOT COMPLETED|First Intervention (1 Month)||0
8675835|NCT00581893|21418638|P2|COMPLETED|First Intervention (1 Month)||10
8675836|NCT00581893|21418639|P1|COMPLETED|First Intervention (1 Month)||10
8675837|NCT00581893|21418638|P2|STARTED|First Intervention (1 Month)||10
8675838|NCT00581893|21418639|P1|STARTED|First Intervention (1 Month)||10
8675839|NCT00573794|21418645|P1|NOT COMPLETED|Overall Study||330
8675840|NCT00573794|21418645|P1|COMPLETED|Overall Study||255
8675841|NCT00573794|21418645|P1|STARTED|Overall Study||585
8675842|NCT00553358|21418676|P3|NOT COMPLETED|Overall Study||88
8675843|NCT00553358|21418677|P2|NOT COMPLETED|Overall Study||96
8675844|NCT00553358|21418678|P1|NOT COMPLETED|Overall Study||79
8675845|NCT00553358|21418676|P3|COMPLETED|Overall Study||61
8675846|NCT00553358|21418677|P2|COMPLETED|Overall Study||58
8675847|NCT00553358|21418678|P1|COMPLETED|Overall Study||73
8675848|NCT00553358|21418676|P3|STARTED|Overall Study||149
8675849|NCT00553358|21418677|P2|STARTED|Overall Study||154
8675850|NCT00553358|21418678|P1|STARTED|Overall Study||152
8675851|NCT00499616|21418753|P4|NOT COMPLETED|Overall Study||57
8675852|NCT00499616|21418754|P3|NOT COMPLETED|Overall Study||36
8675853|NCT00499616|21418755|P2|NOT COMPLETED|Overall Study||28
8675854|NCT00499616|21418756|P1|NOT COMPLETED|Overall Study||15
8675855|NCT00499616|21418753|P4|COMPLETED|Overall Study||0
8675856|NCT00499616|21418754|P3|COMPLETED|Overall Study||53
8675857|NCT00499616|21418755|P2|COMPLETED|Overall Study||114
8675858|NCT00499616|21418756|P1|COMPLETED|Overall Study||161
8675859|NCT00499616|21418753|P4|STARTED|Overall Study||57
8675860|NCT00499616|21418754|P3|STARTED|Overall Study||89
8675861|NCT00499616|21418755|P2|STARTED|Overall Study||142
8675862|NCT00499616|21418756|P1|STARTED|Overall Study||176
8675863|NCT00368836|21418801|P1|NOT COMPLETED|Phase I Pre-op/Post-op||21
8675864|NCT00368836|21418801|P1|COMPLETED|Phase I Pre-op/Post-op||104
8675865|NCT00368836|21418801|P1|STARTED|Phase I Pre-op/Post-op|The phases consisted of unique subjects. Those enrolled in Phase I did not carry over to Phase II.|125
8675866|NCT00368836|21418801|P1|NOT COMPLETED|Phase II||21
8675867|NCT00368836|21418801|P1|COMPLETED|Phase II||329
8675868|NCT00368836|21418801|P1|STARTED|Phase II||350
8675869|NCT00361842|21418810|P2|NOT COMPLETED|Overall Study||34
8675870|NCT00361842|21418811|P1|NOT COMPLETED|Overall Study||27
8675871|NCT00361842|21418810|P2|COMPLETED|Overall Study||1
8675872|NCT00361842|21418811|P1|COMPLETED|Overall Study||1
8675873|NCT00361842|21418810|P2|STARTED|Overall Study||35
8675874|NCT00361842|21418811|P1|STARTED|Overall Study||28
8675881|NCT00147251|21418832|P2|NOT COMPLETED|Follow up||0
8675882|NCT00147251|21418833|P1|NOT COMPLETED|Follow up||0
8675883|NCT00147251|21418832|P2|COMPLETED|Follow up||252
8675884|NCT00147251|21418833|P1|COMPLETED|Follow up||247
8675885|NCT00147251|21418832|P2|STARTED|Follow up||252
8675886|NCT00147251|21418833|P1|STARTED|Follow up||247
8675887|NCT00147251|21418832|P2|NOT COMPLETED|Recruitment and Enrollment||25
8675888|NCT00147251|21418833|P1|NOT COMPLETED|Recruitment and Enrollment||24
8675889|NCT00147251|21418832|P2|COMPLETED|Recruitment and Enrollment||252
8675890|NCT00147251|21418833|P1|COMPLETED|Recruitment and Enrollment||247
8675891|NCT00147251|21418832|P2|STARTED|Recruitment and Enrollment||277
8675892|NCT00147251|21418833|P1|STARTED|Recruitment and Enrollment||271
8675893|NCT00127205|21418844|P3|NOT COMPLETED|Overall Study||612
8675894|NCT00127205|21418845|P2|NOT COMPLETED|Overall Study||973
8675895|NCT00127205|21418846|P1|NOT COMPLETED|Overall Study||829
8675896|NCT00127205|21418844|P3|COMPLETED|Overall Study||955
8675897|NCT00127205|21418845|P2|COMPLETED|Overall Study||1295
8675898|NCT00127205|21418846|P1|COMPLETED|Overall Study||1433
8675899|NCT00127205|21418844|P3|STARTED|Overall Study||1567
8675900|NCT00127205|21418845|P2|STARTED|Overall Study||2268
8675901|NCT00127205|21418846|P1|STARTED|Overall Study||2262
8675902|NCT00002540|21418865|P2|NOT COMPLETED|Overall Study||2464
8675903|NCT00002540|21418866|P1|NOT COMPLETED|Overall Study||801
8675904|NCT00002540|21418865|P2|COMPLETED|Overall Study||35876
8675905|NCT00002540|21418866|P1|COMPLETED|Overall Study||37544
8675906|NCT00002540|21418865|P2|STARTED|Overall Study||38340
8675907|NCT00002540|21418866|P1|STARTED|Overall Study||38345
8675912|NCT04901897|21418900|P3|NOT COMPLETED|Overall Study||2
8675913|NCT04901897|21418901|P2|NOT COMPLETED|Overall Study||2
8675914|NCT04901897|21418902|P1|NOT COMPLETED|Overall Study||5
8675915|NCT04901897|21418900|P3|COMPLETED|Overall Study||203
8675916|NCT04901897|21418901|P2|COMPLETED|Overall Study||200
8675917|NCT04901897|21418902|P1|COMPLETED|Overall Study||393
8675918|NCT04901897|21418900|P3|STARTED|Overall Study||205
8675919|NCT04901897|21418901|P2|STARTED|Overall Study||202
8675920|NCT04901897|21418902|P1|STARTED|Overall Study||398
8675921|NCT04616430|21418919|P3|NOT COMPLETED|Overall Study||30
8675922|NCT04616430|21418920|P2|NOT COMPLETED|Overall Study||28
8675923|NCT04616430|21418921|P1|NOT COMPLETED|Overall Study||7
8675924|NCT04616430|21418919|P3|COMPLETED|Overall Study||0
8675925|NCT04616430|21418920|P2|COMPLETED|Overall Study||2
8675926|NCT04616430|21418921|P1|COMPLETED|Overall Study||23
8675927|NCT04616430|21418919|P3|STARTED|Overall Study||30
8675928|NCT04616430|21418920|P2|STARTED|Overall Study||30
8675929|NCT04616430|21418921|P1|STARTED|Overall Study||30
8675930|NCT04552535|21418931|P2|NOT COMPLETED|Overall Study||0
8675931|NCT04552535|21418932|P1|NOT COMPLETED|Overall Study||0
8675932|NCT04552535|21418931|P2|COMPLETED|Overall Study||101
8675933|NCT04552535|21418932|P1|COMPLETED|Overall Study||99
8675934|NCT04552535|21418931|P2|STARTED|Overall Study||101
8675935|NCT04552535|21418932|P1|STARTED|Overall Study||99
8675936|NCT04551677|21418946|P3|NOT COMPLETED|Overall Study||0
8675937|NCT04551677|21418947|P2|NOT COMPLETED|Overall Study||0
8675938|NCT04551677|21418948|P1|NOT COMPLETED|Overall Study||0
8675939|NCT04551677|21418946|P3|COMPLETED|Overall Study||30
8675940|NCT04551677|21418947|P2|COMPLETED|Overall Study||31
8675941|NCT04551677|21418948|P1|COMPLETED|Overall Study||29
8675942|NCT04551677|21418946|P3|Vaccinated|Overall Study||30
8675943|NCT04551677|21418947|P2|Vaccinated|Overall Study||31
8675944|NCT04551677|21418948|P1|Vaccinated|Overall Study||29
8675945|NCT04551677|21418946|P3|STARTED|Overall Study||30
8675946|NCT04551677|21418947|P2|STARTED|Overall Study||31
8675947|NCT04551677|21418948|P1|STARTED|Overall Study||29
8675948|NCT04547036|21418956|P1|NOT COMPLETED|Overall Study||0
8675949|NCT04547036|21418956|P1|COMPLETED|Overall Study||129
8675950|NCT04547036|21418956|P1|STARTED|Overall Study||129
8675951|NCT04459585|21418960|P1|NOT COMPLETED|Period 2 (Day 5 to Day 12)||0
8675952|NCT04459585|21418960|P1|COMPLETED|Period 2 (Day 5 to Day 12)||20
8675953|NCT04459585|21418960|P1|STARTED|Period 2 (Day 5 to Day 12)||20
8675954|NCT04459585|21418960|P1|NOT COMPLETED|Period 1 (Day 1 to Day 5)||0
8675955|NCT04459585|21418960|P1|COMPLETED|Period 1 (Day 1 to Day 5)||20
8675956|NCT04459585|21418960|P1|STARTED|Period 1 (Day 1 to Day 5)||20
8675957|NCT04456634|21418981|P2|NOT COMPLETED|Overall Study||0
8675958|NCT04456634|21418982|P1|NOT COMPLETED|Overall Study||1
8675959|NCT04456634|21418981|P2|COMPLETED|Overall Study||2
8675960|NCT04456634|21418982|P1|COMPLETED|Overall Study||5
8675961|NCT04456634|21418981|P2|STARTED|Overall Study||2
8675962|NCT04456634|21418982|P1|STARTED|Overall Study||6
8675963|NCT04449341|21418998|P2|NOT COMPLETED|Overall Study||0
8675964|NCT04449341|21418999|P1|NOT COMPLETED|Overall Study||1
8675965|NCT04449341|21418998|P2|COMPLETED|Overall Study||28
8675966|NCT04449341|21418999|P1|COMPLETED|Overall Study||30
8675967|NCT04449341|21418998|P2|STARTED|Overall Study||28
8675968|NCT04449341|21418999|P1|STARTED|Overall Study||31
8675969|NCT04342663|21419009|P2|NOT COMPLETED|Overall Study||19
8675970|NCT04342663|21419010|P1|NOT COMPLETED|Overall Study||18
8675971|NCT04342663|21419009|P2|COMPLETED|Overall Study||53
8675972|NCT04342663|21419010|P1|COMPLETED|Overall Study||62
8675973|NCT04342663|21419009|P2|STARTED|Overall Study||72
8675974|NCT04342663|21419010|P1|STARTED|Overall Study||80
8675975|NCT04289623|21419024|P6|NOT COMPLETED|Wave 2 Emails||0
8675976|NCT04289623|21419025|P5|NOT COMPLETED|Wave 2 Emails||0
8675977|NCT04289623|21419026|P4|NOT COMPLETED|Wave 2 Emails||0
8675978|NCT04289623|21419027|P3|NOT COMPLETED|Wave 2 Emails||0
8675979|NCT04289623|21419028|P2|NOT COMPLETED|Wave 2 Emails||0
8675980|NCT04289623|21419029|P1|NOT COMPLETED|Wave 2 Emails||0
8675981|NCT04289623|21419024|P6|COMPLETED|Wave 2 Emails||0
8675982|NCT04289623|21419025|P5|COMPLETED|Wave 2 Emails||0
8675983|NCT04289623|21419026|P4|COMPLETED|Wave 2 Emails||6117
8675984|NCT04289623|21419027|P3|COMPLETED|Wave 2 Emails||6099
8675985|NCT04289623|21419028|P2|COMPLETED|Wave 2 Emails||0
8675986|NCT04289623|21419029|P1|COMPLETED|Wave 2 Emails||0
8675987|NCT04289623|21419024|P6|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
8675988|NCT04289623|21419025|P5|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
8675989|NCT04289623|21419026|P4|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6117
8675990|NCT04289623|21419027|P3|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6099
8675991|NCT04289623|21419028|P2|STARTED|Wave 2 Emails|Participants were already sent this intervention or the standard email in Wave 1.|0
8675992|NCT04289623|21419029|P1|STARTED|Wave 2 Emails|Participants were already sent this intervention or the loss frame email in Wave 1.|0
8675993|NCT04289623|21419024|P6|NOT COMPLETED|Wave 1 Emails||0
8675994|NCT04289623|21419025|P5|NOT COMPLETED|Wave 1 Emails||0
8675995|NCT04289623|21419026|P4|NOT COMPLETED|Wave 1 Emails||0
8675996|NCT04289623|21419027|P3|NOT COMPLETED|Wave 1 Emails||0
8675997|NCT04289623|21419028|P2|NOT COMPLETED|Wave 1 Emails||257
8675998|NCT04289623|21419029|P1|NOT COMPLETED|Wave 1 Emails||268
8675999|NCT04289623|21419024|P6|COMPLETED|Wave 1 Emails||0
8676000|NCT04289623|21419025|P5|COMPLETED|Wave 1 Emails||0
8676001|NCT04289623|21419026|P4|COMPLETED|Wave 1 Emails||0
8676002|NCT04289623|21419027|P3|COMPLETED|Wave 1 Emails||0
8676003|NCT04289623|21419028|P2|COMPLETED|Wave 1 Emails||6507
8676004|NCT04289623|21419029|P1|COMPLETED|Wave 1 Emails||6514
8676005|NCT04289623|21419024|P6|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
8676006|NCT04289623|21419025|P5|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
8676007|NCT04289623|21419026|P4|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (medical expert) email in Wave 2.|0
8676008|NCT04289623|21419027|P3|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (rank-and-file) email in Wave 2.|0
8676009|NCT04289623|21419028|P2|STARTED|Wave 1 Emails||6764
8676010|NCT04289623|21419029|P1|STARTED|Wave 1 Emails||6782
8676011|NCT04134429|21419049|P1|NOT COMPLETED|Overall Study||1
8676012|NCT04134429|21419049|P1|COMPLETED|Overall Study||19
8676013|NCT04134429|21419049|P1|STARTED|Overall Study||20
8676014|NCT04090242|21419072|P2|NOT COMPLETED|Overall Study||0
8676015|NCT04090242|21419073|P1|NOT COMPLETED|Overall Study||1
8676016|NCT04090242|21419072|P2|COMPLETED|Overall Study||30
8676017|NCT04090242|21419073|P1|COMPLETED|Overall Study||27
8676018|NCT04090242|21419072|P2|STARTED|Overall Study||30
8676019|NCT04090242|21419073|P1|STARTED|Overall Study||28
8676020|NCT04084028|21419107|P4|NOT COMPLETED|Overall Study||0
8676021|NCT04084028|21419108|P3|NOT COMPLETED|Overall Study||0
8676022|NCT04084028|21419109|P2|NOT COMPLETED|Overall Study||0
8676023|NCT04084028|21419110|P1|NOT COMPLETED|Overall Study||0
8676024|NCT04084028|21419107|P4|COMPLETED|Overall Study||10
8676025|NCT04084028|21419108|P3|COMPLETED|Overall Study||9
8676026|NCT04084028|21419109|P2|COMPLETED|Overall Study||16
8676027|NCT04084028|21419110|P1|COMPLETED|Overall Study||18
8676028|NCT04084028|21419107|P4|STARTED|Overall Study||10
8676029|NCT04084028|21419108|P3|STARTED|Overall Study||9
8676030|NCT04084028|21419109|P2|STARTED|Overall Study||16
8676031|NCT04084028|21419110|P1|STARTED|Overall Study||18
8676032|NCT04075409|21419143|P3|NOT COMPLETED|Overall Study||0
8676033|NCT04075409|21419144|P2|NOT COMPLETED|Overall Study||0
8676034|NCT04075409|21419145|P1|NOT COMPLETED|Overall Study||0
8676035|NCT04075409|21419143|P3|COMPLETED|Overall Study||13
8676036|NCT04075409|21419144|P2|COMPLETED|Overall Study||13
8676037|NCT04075409|21419145|P1|COMPLETED|Overall Study||13
8676038|NCT04075409|21419143|P3|STARTED|Overall Study||13
8676039|NCT04075409|21419144|P2|STARTED|Overall Study||13
8676040|NCT04075409|21419145|P1|STARTED|Overall Study||13
8676041|NCT04054375|21419186|P1|NOT COMPLETED|Overall Study||0
8676042|NCT04054375|21419186|P1|COMPLETED|Overall Study|Due to COVID-19, some participants were not able to come to our site to complete all outcome measurements. Our study team worked with individuals to make them feel safe and collect as much data as we possibly could. This is the reason why some outcome metrics have less than 20 data points. All 20 patients completed the study and took the medication for all 24 weeks.|20
8676043|NCT04054375|21419186|P1|STARTED|Overall Study||20
8676044|NCT04030104|21419194|P1|NOT COMPLETED|Overall Study||0
8676045|NCT04030104|21419194|P1|COMPLETED|Overall Study||480
8676046|NCT04030104|21419194|P1|STARTED|Overall Study||480
8676047|NCT04004481|21419205|P1|NOT COMPLETED|Overall Study||3
8676048|NCT04004481|21419205|P1|COMPLETED|Overall Study||47
8676049|NCT04004481|21419205|P1|STARTED|Overall Study||50
8676050|NCT03993288|21419229|P2|NOT COMPLETED|Overall Study||5
8676051|NCT03993288|21419230|P1|NOT COMPLETED|Overall Study||10
8676052|NCT03993288|21419229|P2|COMPLETED|Overall Study||129
8676053|NCT03993288|21419230|P1|COMPLETED|Overall Study||123
8676054|NCT03993288|21419229|P2|Safety Analysis Set|Overall Study||134
8676055|NCT03993288|21419230|P1|Safety Analysis Set|Overall Study||133
8676056|NCT03993288|21419229|P2|Intention-to-treat (ITT) Population|Overall Study||129
8676057|NCT03993288|21419230|P1|Intention-to-treat (ITT) Population|Overall Study||123
8676058|NCT03993288|21419229|P2|STARTED|Overall Study||134
8676059|NCT03993288|21419230|P1|STARTED|Overall Study||133
8676060|NCT03979872|21419250|P4|NOT COMPLETED|Overall Study||4
8676061|NCT03979872|21419251|P3|NOT COMPLETED|Overall Study||6
8676062|NCT03979872|21419252|P2|NOT COMPLETED|Overall Study||8
8676063|NCT03979872|21419253|P1|NOT COMPLETED|Overall Study||3
8676064|NCT03979872|21419250|P4|COMPLETED|Overall Study||19
8676065|NCT03979872|21419251|P3|COMPLETED|Overall Study||18
8676066|NCT03979872|21419252|P2|COMPLETED|Overall Study||15
8676067|NCT03979872|21419253|P1|COMPLETED|Overall Study||19
8676068|NCT03979872|21419250|P4|STARTED|Overall Study||23
8676069|NCT03979872|21419251|P3|STARTED|Overall Study||24
8676070|NCT03979872|21419252|P2|STARTED|Overall Study||23
8676071|NCT03979872|21419253|P1|STARTED|Overall Study||22
8676072|NCT03970733|21419282|P3|NOT COMPLETED|Overall Study||2
8676073|NCT03970733|21419283|P2|NOT COMPLETED|Overall Study||6
8676074|NCT03970733|21419284|P1|NOT COMPLETED|Overall Study||4
8676075|NCT03970733|21419282|P3|COMPLETED|Overall Study||49
8676076|NCT03970733|21419283|P2|COMPLETED|Overall Study||92
8676077|NCT03970733|21419284|P1|COMPLETED|Overall Study||93
8676078|NCT03970733|21419282|P3|STARTED|Overall Study||51
8676079|NCT03970733|21419283|P2|STARTED|Overall Study||98
8676080|NCT03970733|21419284|P1|STARTED|Overall Study||97
8676081|NCT03965351|21419294|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
8676082|NCT03965351|21419295|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
8676083|NCT03965351|21419294|P2|COMPLETED|Second Intervention (4 Weeks)||3
8676084|NCT03965351|21419295|P1|COMPLETED|Second Intervention (4 Weeks)||3
8676085|NCT03965351|21419294|P2|STARTED|Second Intervention (4 Weeks)||4
8676086|NCT03965351|21419295|P1|STARTED|Second Intervention (4 Weeks)||3
8676087|NCT03965351|21419294|P2|NOT COMPLETED|Wash Out Period (4 Weeks)||0
8676088|NCT03965351|21419295|P1|NOT COMPLETED|Wash Out Period (4 Weeks)||0
8676089|NCT03965351|21419294|P2|COMPLETED|Wash Out Period (4 Weeks)||4
8676090|NCT03965351|21419295|P1|COMPLETED|Wash Out Period (4 Weeks)||3
8676091|NCT03965351|21419294|P2|STARTED|Wash Out Period (4 Weeks)||4
8676092|NCT03965351|21419295|P1|STARTED|Wash Out Period (4 Weeks)||3
8676093|NCT03965351|21419294|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
8676094|NCT03965351|21419295|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
8676095|NCT03965351|21419294|P2|COMPLETED|First Intervention (4 Weeks)||4
8676096|NCT03965351|21419295|P1|COMPLETED|First Intervention (4 Weeks)||3
8676097|NCT03965351|21419294|P2|STARTED|First Intervention (4 Weeks)||5
8676098|NCT03965351|21419295|P1|STARTED|First Intervention (4 Weeks)||3
8676099|NCT03944785|21419314|P3|NOT COMPLETED|4 Month Study Optional Extension||23
8676100|NCT03944785|21419315|P2|NOT COMPLETED|4 Month Study Optional Extension||2
8676101|NCT03944785|21419316|P1|NOT COMPLETED|4 Month Study Optional Extension||1
8676102|NCT03944785|21419314|P3|COMPLETED|4 Month Study Optional Extension||41
8676103|NCT03944785|21419315|P2|COMPLETED|4 Month Study Optional Extension||8
8676104|NCT03944785|21419316|P1|COMPLETED|4 Month Study Optional Extension||0
8676105|NCT03944785|21419314|P3|STARTED|4 Month Study Optional Extension||64
8676106|NCT03944785|21419315|P2|STARTED|4 Month Study Optional Extension||10
8676107|NCT03944785|21419316|P1|STARTED|4 Month Study Optional Extension||1
8676108|NCT03944785|21419314|P3|NOT COMPLETED|2 Month Study Completion||5
8676109|NCT03944785|21419315|P2|NOT COMPLETED|2 Month Study Completion||4
8676110|NCT03944785|21419316|P1|NOT COMPLETED|2 Month Study Completion||0
8676111|NCT03944785|21419314|P3|COMPLETED|2 Month Study Completion||123
8676112|NCT03944785|21419315|P2|COMPLETED|2 Month Study Completion||30
8676113|NCT03944785|21419316|P1|COMPLETED|2 Month Study Completion||2
8676114|NCT03944785|21419314|P3|STARTED|2 Month Study Completion||128
8676115|NCT03944785|21419315|P2|STARTED|2 Month Study Completion||34
8676116|NCT03944785|21419316|P1|STARTED|2 Month Study Completion||2
8676117|NCT03938337|21419341|P2|NOT COMPLETED|Overall Study||0
8676118|NCT03938337|21419342|P1|NOT COMPLETED|Overall Study||0
8676119|NCT03938337|21419341|P2|COMPLETED|Overall Study||0
8676120|NCT03938337|21419342|P1|COMPLETED|Overall Study||1
8676121|NCT03938337|21419341|P2|STARTED|Overall Study||0
8676122|NCT03938337|21419342|P1|STARTED|Overall Study||1
8676123|NCT03894813|21419376|P2|NOT COMPLETED|Overall Study||16
8676124|NCT03894813|21419377|P1|NOT COMPLETED|Overall Study||11
8676125|NCT03894813|21419376|P2|COMPLETED|Overall Study||47
8676126|NCT03894813|21419377|P1|COMPLETED|Overall Study||52
8676127|NCT03894813|21419376|P2|STARTED|Overall Study||63
8676128|NCT03894813|21419377|P1|STARTED|Overall Study||63
8676129|NCT03889704|21419391|P1|NOT COMPLETED|Overall Study||1
8676130|NCT03889704|21419391|P1|COMPLETED|Overall Study||1
8676131|NCT03889704|21419391|P1|STARTED|Overall Study||2
8676132|NCT03880227|21419399|P4|NOT COMPLETED|Second Visit||0
8676133|NCT03880227|21419400|P3|NOT COMPLETED|Second Visit||0
8676134|NCT03880227|21419401|P2|NOT COMPLETED|Second Visit||0
8676135|NCT03880227|21419402|P1|NOT COMPLETED|Second Visit||0
8676136|NCT03880227|21419399|P4|COMPLETED|Second Visit||18
8676137|NCT03880227|21419400|P3|COMPLETED|Second Visit||19
8676138|NCT03880227|21419401|P2|COMPLETED|Second Visit||20
8676139|NCT03880227|21419402|P1|COMPLETED|Second Visit||19
8676140|NCT03880227|21419399|P4|STARTED|Second Visit||18
8676141|NCT03880227|21419400|P3|STARTED|Second Visit||19
8676142|NCT03880227|21419401|P2|STARTED|Second Visit||20
8676143|NCT03880227|21419402|P1|STARTED|Second Visit||19
8676144|NCT03880227|21419399|P4|NOT COMPLETED|1 Week Washout/ Delay||0
8676145|NCT03880227|21419400|P3|NOT COMPLETED|1 Week Washout/ Delay||3
8676146|NCT03880227|21419401|P2|NOT COMPLETED|1 Week Washout/ Delay||1
8676147|NCT03880227|21419402|P1|NOT COMPLETED|1 Week Washout/ Delay||0
8676148|NCT03880227|21419399|P4|COMPLETED|1 Week Washout/ Delay||18
8676149|NCT03880227|21419400|P3|COMPLETED|1 Week Washout/ Delay||19
8676150|NCT03880227|21419401|P2|COMPLETED|1 Week Washout/ Delay||20
8676151|NCT03880227|21419402|P1|COMPLETED|1 Week Washout/ Delay||19
8676152|NCT03880227|21419399|P4|STARTED|1 Week Washout/ Delay||18
8676153|NCT03880227|21419400|P3|STARTED|1 Week Washout/ Delay||22
8676154|NCT03880227|21419401|P2|STARTED|1 Week Washout/ Delay||21
8676155|NCT03880227|21419402|P1|STARTED|1 Week Washout/ Delay||19
8676156|NCT03880227|21419399|P4|NOT COMPLETED|First Visit||0
8676157|NCT03880227|21419400|P3|NOT COMPLETED|First Visit||0
8676158|NCT03880227|21419401|P2|NOT COMPLETED|First Visit||0
8676159|NCT03880227|21419402|P1|NOT COMPLETED|First Visit||1
8676160|NCT03880227|21419399|P4|COMPLETED|First Visit||18
8676161|NCT03880227|21419400|P3|COMPLETED|First Visit||22
8676162|NCT03880227|21419401|P2|COMPLETED|First Visit||21
8676163|NCT03880227|21419402|P1|COMPLETED|First Visit||19
8676164|NCT03880227|21419399|P4|STARTED|First Visit||18
8676165|NCT03880227|21419400|P3|STARTED|First Visit||22
8676166|NCT03880227|21419401|P2|STARTED|First Visit||21
8676167|NCT03880227|21419402|P1|STARTED|First Visit||20
8676168|NCT03802227|21419426|P2|NOT COMPLETED|Overall Study||0
8676169|NCT03802227|21419427|P1|NOT COMPLETED|Overall Study||0
8676170|NCT03802227|21419426|P2|COMPLETED|Overall Study||4
8676171|NCT03802227|21419427|P1|COMPLETED|Overall Study||4
8676172|NCT03802227|21419426|P2|STARTED|Overall Study||4
8676173|NCT03802227|21419427|P1|STARTED|Overall Study||4
8676174|NCT03796039|21419443|P2|NOT COMPLETED|Overall Study||5
8676175|NCT03796039|21419444|P1|NOT COMPLETED|Overall Study||9
8676176|NCT03796039|21419443|P2|COMPLETED|Overall Study||42
8676177|NCT03796039|21419444|P1|COMPLETED|Overall Study||41
8676178|NCT03796039|21419443|P2|STARTED|Overall Study||47
8676179|NCT03796039|21419444|P1|STARTED|Overall Study||50
8676180|NCT03784963|21419474|P4|NOT COMPLETED|Overall Study||0
8676181|NCT03784963|21419475|P3|NOT COMPLETED|Overall Study||1
8676182|NCT03784963|21419476|P2|NOT COMPLETED|Overall Study||10
8676183|NCT03784963|21419477|P1|NOT COMPLETED|Overall Study||12
8676184|NCT03784963|21419474|P4|COMPLETED|Overall Study||0
8676185|NCT03784963|21419475|P3|COMPLETED|Overall Study||0
8676186|NCT03784963|21419476|P2|COMPLETED|Overall Study||0
8676187|NCT03784963|21419477|P1|COMPLETED|Overall Study||0
8676188|NCT03784963|21419474|P4|STARTED|Overall Study||0
8676189|NCT03784963|21419475|P3|STARTED|Overall Study||1
8676190|NCT03784963|21419476|P2|STARTED|Overall Study||10
8676191|NCT03784963|21419477|P1|STARTED|Overall Study||12
8676192|NCT03783039|21419505|P2|NOT COMPLETED|Overall Study||1
8676193|NCT03783039|21419506|P1|NOT COMPLETED|Overall Study||2
8676194|NCT03783039|21419505|P2|COMPLETED|Overall Study||114
8676195|NCT03783039|21419506|P1|COMPLETED|Overall Study||117
8676196|NCT03783039|21419505|P2|STARTED|Overall Study||115
8676197|NCT03783039|21419506|P1|STARTED|Overall Study||119
8676198|NCT03777059|21419526|P4|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||9
8676199|NCT03777059|21419527|P3|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||6
8676200|NCT03777059|21419528|P2|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
8676201|NCT03777059|21419529|P1|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
8676202|NCT03777059|21419526|P4|COMPLETED|Follow-Up Period (Weeks 12 to 16)||36
8676203|NCT03777059|21419527|P3|COMPLETED|Follow-Up Period (Weeks 12 to 16)||32
8676204|NCT03777059|21419528|P2|COMPLETED|Follow-Up Period (Weeks 12 to 16)||49
8676205|NCT03777059|21419529|P1|COMPLETED|Follow-Up Period (Weeks 12 to 16)||41
8676206|NCT03777059|21419526|P4|STARTED|Follow-Up Period (Weeks 12 to 16)||45
8676207|NCT03777059|21419527|P3|STARTED|Follow-Up Period (Weeks 12 to 16)||38
8676208|NCT03777059|21419528|P2|STARTED|Follow-Up Period (Weeks 12 to 16)||54
8676209|NCT03777059|21419529|P1|STARTED|Follow-Up Period (Weeks 12 to 16)||46
8676210|NCT03777059|21419526|P4|NOT COMPLETED|DB Treatment Period (Up to Week 12)||31
8676211|NCT03777059|21419527|P3|NOT COMPLETED|DB Treatment Period (Up to Week 12)||23
8676212|NCT03777059|21419528|P2|NOT COMPLETED|DB Treatment Period (Up to Week 12)||29
8676213|NCT03777059|21419529|P1|NOT COMPLETED|DB Treatment Period (Up to Week 12)||22
8676214|NCT03777059|21419526|P4|COMPLETED|DB Treatment Period (Up to Week 12)||204
8676215|NCT03777059|21419527|P3|COMPLETED|DB Treatment Period (Up to Week 12)||207
8676216|NCT03777059|21419528|P2|COMPLETED|DB Treatment Period (Up to Week 12)||193
8676217|NCT03777059|21419529|P1|COMPLETED|DB Treatment Period (Up to Week 12)||201
8676218|NCT03777059|21419526|P4|Treated: Safety Population|DB Treatment Period (Up to Week 12)||231
8676219|NCT03777059|21419527|P3|Treated: Safety Population|DB Treatment Period (Up to Week 12)||228
8676220|NCT03777059|21419528|P2|Treated: Safety Population|DB Treatment Period (Up to Week 12)||221
8676221|NCT03777059|21419529|P1|Treated: Safety Population|DB Treatment Period (Up to Week 12)||222
8676222|NCT03777059|21419526|P4|STARTED|DB Treatment Period (Up to Week 12)||235
8676223|NCT03777059|21419527|P3|STARTED|DB Treatment Period (Up to Week 12)||230
8676224|NCT03777059|21419528|P2|STARTED|DB Treatment Period (Up to Week 12)||222
8676225|NCT03777059|21419529|P1|STARTED|DB Treatment Period (Up to Week 12)||223
8676226|NCT03737110|21419565|P3|NOT COMPLETED|Long-Term Extension (LTE) Period||30
8676227|NCT03737110|21419566|P2|NOT COMPLETED|Long-Term Extension (LTE) Period||29
8676228|NCT03737110|21419567|P1|NOT COMPLETED|Long-Term Extension (LTE) Period||15
8676229|NCT03737110|21419565|P3|COMPLETED|Long-Term Extension (LTE) Period||0
8676230|NCT03737110|21419566|P2|COMPLETED|Long-Term Extension (LTE) Period||0
8676231|NCT03737110|21419567|P1|COMPLETED|Long-Term Extension (LTE) Period||0
8676232|NCT03737110|21419565|P3|STARTED|Long-Term Extension (LTE) Period||30
8676233|NCT03737110|21419566|P2|STARTED|Long-Term Extension (LTE) Period|1 participant withdrew consent prior to entering LTE.|29
8676234|NCT03737110|21419567|P1|STARTED|Long-Term Extension (LTE) Period|Participants who entered the LTE directly from RI after protocol-specified 22 adjudicated pericarditis recurrence events had accrued.|15
8676235|NCT03737110|21419565|P3|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
8676236|NCT03737110|21419566|P2|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
8676237|NCT03737110|21419567|P1|NOT COMPLETED|Randomized Withdrawal (RW) Period||0
8676238|NCT03737110|21419565|P3|COMPLETED|Randomized Withdrawal (RW) Period||30
8676239|NCT03737110|21419566|P2|COMPLETED|Randomized Withdrawal (RW) Period||29
8676240|NCT03737110|21419567|P1|COMPLETED|Randomized Withdrawal (RW) Period||0
8676241|NCT03737110|21419565|P3|STARTED|Randomized Withdrawal (RW) Period||31
8676242|NCT03737110|21419566|P2|STARTED|Randomized Withdrawal (RW) Period||30
8676243|NCT03737110|21419567|P1|STARTED|Randomized Withdrawal (RW) Period||0
8676244|NCT03737110|21419565|P3|NOT COMPLETED|Run-in (RI) Period||0
8676245|NCT03737110|21419566|P2|NOT COMPLETED|Run-in (RI) Period||0
8676246|NCT03737110|21419567|P1|NOT COMPLETED|Run-in (RI) Period||10
8676247|NCT03737110|21419565|P3|COMPLETED|Run-in (RI) Period||0
8676248|NCT03737110|21419566|P2|COMPLETED|Run-in (RI) Period||0
8676249|NCT03737110|21419567|P1|COMPLETED|Run-in (RI) Period||76
8676250|NCT03737110|21419565|P3|Continue Directly to LTE Period|Run-in (RI) Period||0
8676251|NCT03737110|21419566|P2|Continue Directly to LTE Period|Run-in (RI) Period||0
8676252|NCT03737110|21419567|P1|Continue Directly to LTE Period|Run-in (RI) Period||15
8676253|NCT03737110|21419565|P3|Continue to RW Period|Run-in (RI) Period||0
8676254|NCT03737110|21419566|P2|Continue to RW Period|Run-in (RI) Period||0
8676255|NCT03737110|21419567|P1|Continue to RW Period|Run-in (RI) Period||61
8676256|NCT03737110|21419565|P3|STARTED|Run-in (RI) Period||0
8676257|NCT03737110|21419566|P2|STARTED|Run-in (RI) Period||0
8676258|NCT03737110|21419567|P1|STARTED|Run-in (RI) Period||86
8676259|NCT03733483|21419678|P1|NOT COMPLETED|Overall Study||0
8676260|NCT03733483|21419678|P1|COMPLETED|Overall Study||12
8676261|NCT03733483|21419678|P1|STARTED|Overall Study||12
8676262|NCT03725722|21419688|P5|NOT COMPLETED|Overall Study||14
8676263|NCT03725722|21419689|P4|NOT COMPLETED|Overall Study||6
8676264|NCT03725722|21419690|P3|NOT COMPLETED|Overall Study||6
8676265|NCT03725722|21419691|P2|NOT COMPLETED|Overall Study||6
8676266|NCT03725722|21419692|P1|NOT COMPLETED|Overall Study||11
8676267|NCT03725722|21419688|P5|COMPLETED|Overall Study||36
8676268|NCT03725722|21419689|P4|COMPLETED|Overall Study||46
8676269|NCT03725722|21419690|P3|COMPLETED|Overall Study||44
8676270|NCT03725722|21419691|P2|COMPLETED|Overall Study||44
8676271|NCT03725722|21419692|P1|COMPLETED|Overall Study||38
8676272|NCT03725722|21419688|P5|STARTED|Overall Study||50
8676273|NCT03725722|21419689|P4|STARTED|Overall Study||52
8676274|NCT03725722|21419690|P3|STARTED|Overall Study||50
8676275|NCT03725722|21419691|P2|STARTED|Overall Study||50
8676276|NCT03725722|21419692|P1|STARTED|Overall Study||49
8676277|NCT03703791|21419721|P2|NOT COMPLETED|Overall Study||1
8676278|NCT03703791|21419722|P1|NOT COMPLETED|Overall Study||0
8676279|NCT03703791|21419721|P2|COMPLETED|Overall Study||0
8676280|NCT03703791|21419722|P1|COMPLETED|Overall Study||0
8676281|NCT03703791|21419721|P2|STARTED|Overall Study||1
8676282|NCT03703791|21419722|P1|STARTED|Overall Study||0
8676286|NCT03682367|21419735|P2|NOT COMPLETED|Overall Study||4
8676287|NCT03682367|21419736|P1|NOT COMPLETED|Overall Study||2
8676288|NCT03682367|21419735|P2|COMPLETED|Overall Study|Patients withdrawn due to confounding neuropathic pain or exited early from study.|0
8676289|NCT03682367|21419736|P1|COMPLETED|Overall Study|Withdrawn due to non-compliance|2
8676290|NCT03682367|21419735|P2|STARTED|Overall Study||4
8676291|NCT03682367|21419736|P1|STARTED|Overall Study||4
8676292|NCT03672032|21419758|P2|NOT COMPLETED|Overall Study||0
8676293|NCT03672032|21419759|P1|NOT COMPLETED|Overall Study||0
8676294|NCT03672032|21419758|P2|COMPLETED|Overall Study||67
8676295|NCT03672032|21419759|P1|COMPLETED|Overall Study||67
8676296|NCT03672032|21419758|P2|STARTED|Overall Study||67
8676297|NCT03672032|21419759|P1|STARTED|Overall Study||67
8676298|NCT03672006|21419771|P2|NOT COMPLETED|Overall Study||1
8676299|NCT03672006|21419772|P1|NOT COMPLETED|Overall Study||0
8676300|NCT03672006|21419771|P2|COMPLETED|Overall Study||9
8676301|NCT03672006|21419772|P1|COMPLETED|Overall Study||10
8676302|NCT03672006|21419771|P2|STARTED|Overall Study||10
8676303|NCT03672006|21419772|P1|STARTED|Overall Study||10
8676304|NCT03670264|21419789|P3|NOT COMPLETED|Overall Study||0
8676305|NCT03670264|21419790|P2|NOT COMPLETED|Overall Study||0
8676306|NCT03670264|21419791|P1|NOT COMPLETED|Overall Study||0
8676307|NCT03670264|21419789|P3|COMPLETED|Overall Study||5
8676308|NCT03670264|21419790|P2|COMPLETED|Overall Study||5
8676309|NCT03670264|21419791|P1|COMPLETED|Overall Study||5
8676310|NCT03670264|21419789|P3|STARTED|Overall Study||5
8676311|NCT03670264|21419790|P2|STARTED|Overall Study||5
8676312|NCT03670264|21419791|P1|STARTED|Overall Study||5
8676313|NCT03653351|21419801|P2|NOT COMPLETED|Overall Study||2
8676314|NCT03653351|21419802|P1|NOT COMPLETED|Overall Study||1
8676315|NCT03653351|21419801|P2|COMPLETED|Overall Study||10
8676316|NCT03653351|21419802|P1|COMPLETED|Overall Study||13
8676317|NCT03653351|21419801|P2|STARTED|Overall Study||12
8676318|NCT03653351|21419802|P1|STARTED|Overall Study||14
8676319|NCT03648879|21419808|P1|NOT COMPLETED|Overall Study||1
8676320|NCT03648879|21419808|P1|COMPLETED|Overall Study||36
8676321|NCT03648879|21419808|P1|STARTED|Overall Study||37
8676331|NCT03632655|21419846|P2|NOT COMPLETED|Overall Study||16
8676332|NCT03632655|21419847|P1|NOT COMPLETED|Overall Study||22
8676333|NCT03632655|21419846|P2|COMPLETED|Overall Study||0
8676334|NCT03632655|21419847|P1|COMPLETED|Overall Study||0
8676335|NCT03632655|21419846|P2|STARTED|Overall Study||16
8676336|NCT03632655|21419847|P1|STARTED|Overall Study||22
8676337|NCT03611582|21419865|P2|NOT COMPLETED|Overall Study||38
8676338|NCT03611582|21419866|P1|NOT COMPLETED|Overall Study||68
8676339|NCT03611582|21419865|P2|COMPLETED|Overall Study||166
8676340|NCT03611582|21419866|P1|COMPLETED|Overall Study||339
8676341|NCT03611582|21419865|P2|Safety Analysis Set (SAS)|Overall Study||204
8676342|NCT03611582|21419866|P1|Safety Analysis Set (SAS)|Overall Study||407
8676343|NCT03611582|21419865|P2|Full Analysis Set (FAS)|Overall Study||204
8676344|NCT03611582|21419866|P1|Full Analysis Set (FAS)|Overall Study||407
8676345|NCT03611582|21419865|P2|STARTED|Overall Study||204
8676346|NCT03611582|21419866|P1|STARTED|Overall Study||407
8676347|NCT03597139|21419934|P2|NOT COMPLETED|Overall Study||0
8676348|NCT03597139|21419935|P1|NOT COMPLETED|Overall Study||4
8676349|NCT03597139|21419934|P2|COMPLETED|Overall Study||49
8676350|NCT03597139|21419935|P1|COMPLETED|Overall Study||47
8676351|NCT03597139|21419934|P2|STARTED|Overall Study||49
8676352|NCT03597139|21419935|P1|STARTED|Overall Study||51
8676353|NCT03595904|21419965|P2|NOT COMPLETED|Overall Study||5
8676354|NCT03595904|21419966|P1|NOT COMPLETED|Overall Study||10
8676355|NCT03595904|21419965|P2|COMPLETED|Overall Study||34
8676356|NCT03595904|21419966|P1|COMPLETED|Overall Study||29
8676357|NCT03595904|21419965|P2|STARTED|Overall Study||39
8676358|NCT03595904|21419966|P1|STARTED|Overall Study||39
8676359|NCT03595449|21419982|P2|NOT COMPLETED|Overall Study||0
8676360|NCT03595449|21419983|P1|NOT COMPLETED|Overall Study||0
8676361|NCT03595449|21419982|P2|COMPLETED|Overall Study||115
8676362|NCT03595449|21419983|P1|COMPLETED|Overall Study||118
8676363|NCT03595449|21419982|P2|STARTED|Overall Study||115
8676364|NCT03595449|21419983|P1|STARTED|Overall Study||118
8676365|NCT03483506|21419991|P1|NOT COMPLETED|Overall Study||0
8676366|NCT03483506|21419991|P1|COMPLETED|Overall Study||12
8676367|NCT03483506|21419991|P1|STARTED|Overall Study||12
8676368|NCT03480243|21420015|P1|NOT COMPLETED|Erythromycin (Period 3c)||0
8676369|NCT03480243|21420015|P1|COMPLETED|Erythromycin (Period 3c)||26
8676370|NCT03480243|21420015|P1|STARTED|Erythromycin (Period 3c)||26
8676371|NCT03480243|21420015|P1|NOT COMPLETED|Padsevonil and Erythromycin (Period 3b)||1
8676372|NCT03480243|21420015|P1|COMPLETED|Padsevonil and Erythromycin (Period 3b)||26
8676373|NCT03480243|21420015|P1|STARTED|Padsevonil and Erythromycin (Period 3b)||27
8676374|NCT03480243|21420015|P1|NOT COMPLETED|Erythromycin (Period 3a)||0
8676375|NCT03480243|21420015|P1|COMPLETED|Erythromycin (Period 3a)||27
8676376|NCT03480243|21420015|P1|STARTED|Erythromycin (Period 3a)||27
8676377|NCT03480243|21420015|P1|NOT COMPLETED|Padsevonil (Period 2)||1
8676378|NCT03480243|21420015|P1|COMPLETED|Padsevonil (Period 2)||27
8676379|NCT03480243|21420015|P1|STARTED|Padsevonil (Period 2)||28
8676380|NCT03480243|21420015|P1|NOT COMPLETED|Padsevonil (Period 1)||0
8676381|NCT03480243|21420015|P1|COMPLETED|Padsevonil (Period 1)||28
8676382|NCT03480243|21420015|P1|STARTED|Padsevonil (Period 1)||28
8676383|NCT03478956|21420109|P2|NOT COMPLETED|Overall Study||12
8676384|NCT03478956|21420110|P1|NOT COMPLETED|Overall Study||12
8676385|NCT03478956|21420109|P2|COMPLETED|Overall Study||0
8676386|NCT03478956|21420110|P1|COMPLETED|Overall Study||0
8676387|NCT03478956|21420109|P2|Started PML Safety Monitoring Phase|Overall Study||2
8676388|NCT03478956|21420110|P1|Started PML Safety Monitoring Phase|Overall Study||1
8676389|NCT03478956|21420109|P2|Completed OLE Treatment Phase|Overall Study||0
8676390|NCT03478956|21420110|P1|Completed OLE Treatment Phase|Overall Study||0
8676391|NCT03478956|21420109|P2|Started OLE Treatment Phase|Overall Study||10
8676392|NCT03478956|21420110|P1|Started OLE Treatment Phase|Overall Study||11
8676393|NCT03478956|21420109|P2|Completed Randomized Treatment Phase|Overall Study||10
8676394|NCT03478956|21420110|P1|Completed Randomized Treatment Phase|Overall Study||11
8676395|NCT03478956|21420109|P2|Received at Least One Dose of Study Drug|Overall Study||12
8676396|NCT03478956|21420110|P1|Received at Least One Dose of Study Drug|Overall Study||12
8676397|NCT03478956|21420109|P2|STARTED|Overall Study||12
8676398|NCT03478956|21420110|P1|STARTED|Overall Study||12
8676399|NCT03478787|21420138|P2|NOT COMPLETED|Overall Study||13
8676400|NCT03478787|21420139|P1|NOT COMPLETED|Overall Study||29
8676401|NCT03478787|21420138|P2|COMPLETED|Overall Study||151
8676402|NCT03478787|21420139|P1|COMPLETED|Overall Study||134
8676403|NCT03478787|21420138|P2|STARTED|Overall Study||164
8676404|NCT03478787|21420139|P1|STARTED|Overall Study||163
8676405|NCT03459040|21420153|P1|NOT COMPLETED|Overall Study||9
8676406|NCT03459040|21420153|P1|COMPLETED|Overall Study||21
8676407|NCT03459040|21420153|P1|STARTED|Overall Study||30
8676408|NCT03440320|21420169|P2|NOT COMPLETED|Overall Study||1
8676409|NCT03440320|21420170|P1|NOT COMPLETED|Overall Study||0
8676410|NCT03440320|21420169|P2|COMPLETED|Overall Study||13
8676411|NCT03440320|21420170|P1|COMPLETED|Overall Study||18
8676412|NCT03440320|21420169|P2|STARTED|Overall Study||14
8676413|NCT03440320|21420170|P1|STARTED|Overall Study||18
8676414|NCT03435055|21420178|P1|NOT COMPLETED|Received Intervention||3
8676415|NCT03435055|21420178|P1|COMPLETED|Received Intervention||16
8676416|NCT03435055|21420178|P1|STARTED|Received Intervention||19
8676417|NCT03435055|21420178|P1|NOT COMPLETED|Screening||2
8676418|NCT03435055|21420178|P1|COMPLETED|Screening||19
8676419|NCT03435055|21420178|P1|STARTED|Screening||21
8676426|NCT03424265|21420202|P2|NOT COMPLETED|Overall Study||2
8676427|NCT03424265|21420203|P1|NOT COMPLETED|Overall Study||1
8676428|NCT03424265|21420202|P2|COMPLETED|Overall Study||32
8676429|NCT03424265|21420203|P1|COMPLETED|Overall Study||28
8676430|NCT03424265|21420202|P2|STARTED|Overall Study||34
8676431|NCT03424265|21420203|P1|STARTED|Overall Study||29
8676432|NCT03410953|21420209|P1|NOT COMPLETED|Overall Study||0
8676433|NCT03410953|21420209|P1|COMPLETED|Overall Study|67 participants were enrolled in the Clinical Trial and included the analyses|67
8676434|NCT03410953|21420209|P1|STARTED|Overall Study|First patient recruited|67
8676487|NCT03400033|21420250|P2|NOT COMPLETED|Overall Study||2
8676488|NCT03400033|21420251|P1|NOT COMPLETED|Overall Study||1
8676489|NCT03400033|21420250|P2|COMPLETED|Overall Study||135
8676490|NCT03400033|21420251|P1|COMPLETED|Overall Study||269
8676491|NCT03400033|21420250|P2|STARTED|Overall Study||137
8676492|NCT03400033|21420251|P1|STARTED|Overall Study||270
8676493|NCT03392168|21420299|P4|NOT COMPLETED|Period 2: Cohort 2||1
8676494|NCT03392168|21420300|P3|NOT COMPLETED|Period 2: Cohort 2||1
8676495|NCT03392168|21420301|P2|NOT COMPLETED|Period 2: Cohort 2||2
8676496|NCT03392168|21420302|P1|NOT COMPLETED|Period 2: Cohort 2||0
8676497|NCT03392168|21420299|P4|COMPLETED|Period 2: Cohort 2||30
8676498|NCT03392168|21420300|P3|COMPLETED|Period 2: Cohort 2||27
8676499|NCT03392168|21420301|P2|COMPLETED|Period 2: Cohort 2||28
8676500|NCT03392168|21420302|P1|COMPLETED|Period 2: Cohort 2||0
8676501|NCT03392168|21420299|P4|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|31
8676502|NCT03392168|21420300|P3|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|28
8676503|NCT03392168|21420301|P2|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|30
8676504|NCT03392168|21420302|P1|STARTED|Period 2: Cohort 2||0
8676505|NCT03392168|21420299|P4|NOT COMPLETED|Period 1: Cohort 1||0
8676506|NCT03392168|21420300|P3|NOT COMPLETED|Period 1: Cohort 1||0
8676507|NCT03392168|21420301|P2|NOT COMPLETED|Period 1: Cohort 1||0
8676508|NCT03392168|21420302|P1|NOT COMPLETED|Period 1: Cohort 1||0
8676509|NCT03392168|21420299|P4|COMPLETED|Period 1: Cohort 1||0
8676510|NCT03392168|21420300|P3|COMPLETED|Period 1: Cohort 1||0
8676511|NCT03392168|21420301|P2|COMPLETED|Period 1: Cohort 1||0
8676512|NCT03392168|21420302|P1|COMPLETED|Period 1: Cohort 1||8
8676513|NCT03392168|21420299|P4|STARTED|Period 1: Cohort 1||0
8676514|NCT03392168|21420300|P3|STARTED|Period 1: Cohort 1||0
8676515|NCT03392168|21420301|P2|STARTED|Period 1: Cohort 1||0
8676516|NCT03392168|21420302|P1|STARTED|Period 1: Cohort 1||8
8676517|NCT03374358|21420322|P2|NOT COMPLETED|Overall Study||2
8676518|NCT03374358|21420323|P1|NOT COMPLETED|Overall Study||0
8676519|NCT03374358|21420322|P2|COMPLETED|Overall Study||19
8676520|NCT03374358|21420323|P1|COMPLETED|Overall Study||24
8676521|NCT03374358|21420322|P2|STARTED|Overall Study||21
8676522|NCT03374358|21420323|P1|STARTED|Overall Study||24
8676523|NCT03359395|21420345|P2|NOT COMPLETED|Second Intervention B/A||3
8676524|NCT03359395|21420346|P1|NOT COMPLETED|Second Intervention B/A||3
8676525|NCT03359395|21420345|P2|COMPLETED|Second Intervention B/A||44
8676526|NCT03359395|21420346|P1|COMPLETED|Second Intervention B/A||43
8676527|NCT03359395|21420345|P2|STARTED|Second Intervention B/A||47
8676528|NCT03359395|21420346|P1|STARTED|Second Intervention B/A||46
8676529|NCT03359395|21420345|P2|NOT COMPLETED|First Intervention A / B||3
8676530|NCT03359395|21420346|P1|NOT COMPLETED|First Intervention A / B||3
8676531|NCT03359395|21420345|P2|COMPLETED|First Intervention A / B||47
8676532|NCT03359395|21420346|P1|COMPLETED|First Intervention A / B||46
8676533|NCT03359395|21420345|P2|STARTED|First Intervention A / B||50
8676534|NCT03359395|21420346|P1|STARTED|First Intervention A / B||49
8676535|NCT03329846|21420376|P2|NOT COMPLETED|Overall Study||9
8676536|NCT03329846|21420377|P1|NOT COMPLETED|Overall Study||8
8676537|NCT03329846|21420376|P2|COMPLETED|Overall Study||1
8676538|NCT03329846|21420377|P1|COMPLETED|Overall Study||2
8676539|NCT03329846|21420376|P2|STARTED|Overall Study||10
8676540|NCT03329846|21420377|P1|STARTED|Overall Study||10
8676541|NCT03320057|21420383|P2|NOT COMPLETED|Overall Study||17
8676542|NCT03320057|21420384|P1|NOT COMPLETED|Overall Study||6
8676543|NCT03320057|21420383|P2|COMPLETED|Overall Study|This includes pharmacists who completed the endline survey. Only trained pharmacists (n=56) were eligible.|43
8676544|NCT03320057|21420384|P1|COMPLETED|Overall Study||260
8676545|NCT03320057|21420383|P2|Pharmacists Completed Baseline Survey|Overall Study||47
8676546|NCT03320057|21420384|P1|Pharmacists Completed Baseline Survey|Overall Study||0
8676547|NCT03320057|21420383|P2|Received Pharmacist Training|Overall Study||56
8676548|NCT03320057|21420384|P1|Received Pharmacist Training|Overall Study||0
8676549|NCT03320057|21420383|P2|Patient's Clinical Outcome Information Obtained|Overall Study|Clinical outcome data were not collected for pharmacists - this milestone does not apply|0
8676550|NCT03320057|21420384|P1|Patient's Clinical Outcome Information Obtained|Overall Study||262
8676551|NCT03320057|21420383|P2|STARTED|Overall Study|Includes pharmacists at study pharmacies that consented to training on mifepristone dispensing.|60
8676552|NCT03320057|21420384|P1|STARTED|Overall Study||266
8676553|NCT03316170|21420396|P2|NOT COMPLETED|Overall Study||7
8676554|NCT03316170|21420397|P1|NOT COMPLETED|Overall Study||7
8676555|NCT03316170|21420396|P2|COMPLETED|Overall Study||18
8676556|NCT03316170|21420397|P1|COMPLETED|Overall Study||17
8676557|NCT03316170|21420396|P2|STARTED|Overall Study||25
8676558|NCT03316170|21420397|P1|STARTED|Overall Study||24
8676578|NCT03247543|21420471|P3|NOT COMPLETED|Overall Study||23
8676579|NCT03247543|21420472|P2|NOT COMPLETED|Overall Study||19
8676580|NCT03247543|21420473|P1|NOT COMPLETED|Overall Study||17
8676581|NCT03247543|21420471|P3|COMPLETED|Overall Study||78
8676582|NCT03247543|21420472|P2|COMPLETED|Overall Study||88
8676583|NCT03247543|21420473|P1|COMPLETED|Overall Study||85
8676584|NCT03247543|21420471|P3|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received Placebo during the trial.|101
8676585|NCT03247543|21420472|P2|STARTED|Overall Study||107
8676586|NCT03247543|21420473|P1|STARTED|Overall Study||102
8676587|NCT03239106|21420505|P1|NOT COMPLETED|Overall Study||7
8676588|NCT03239106|21420505|P1|COMPLETED|Overall Study||3
8676589|NCT03239106|21420505|P1|STARTED|Overall Study||10
8676590|NCT03231397|21420516|P4|NOT COMPLETED|Overall Study||0
8676591|NCT03231397|21420517|P3|NOT COMPLETED|Overall Study||0
8676592|NCT03231397|21420518|P2|NOT COMPLETED|Overall Study||0
8676593|NCT03231397|21420519|P1|NOT COMPLETED|Overall Study||0
8676594|NCT03231397|21420516|P4|COMPLETED|Overall Study||0
8676595|NCT03231397|21420517|P3|COMPLETED|Overall Study||1
8676596|NCT03231397|21420518|P2|COMPLETED|Overall Study||1
8676597|NCT03231397|21420519|P1|COMPLETED|Overall Study||0
8676598|NCT03231397|21420516|P4|STARTED|Overall Study||0
8676599|NCT03231397|21420517|P3|STARTED|Overall Study||1
8676600|NCT03231397|21420518|P2|STARTED|Overall Study||1
8676601|NCT03231397|21420519|P1|STARTED|Overall Study||0
8676602|NCT03211234|21420540|P3|NOT COMPLETED|Overall Study||3
8676603|NCT03211234|21420541|P2|NOT COMPLETED|Overall Study||1
8676604|NCT03211234|21420542|P1|NOT COMPLETED|Overall Study||1
8676605|NCT03211234|21420540|P3|COMPLETED|Overall Study||25
8676606|NCT03211234|21420541|P2|COMPLETED|Overall Study||30
8676607|NCT03211234|21420542|P1|COMPLETED|Overall Study||16
8676608|NCT03211234|21420540|P3|STARTED|Overall Study||28
8676609|NCT03211234|21420541|P2|STARTED|Overall Study||31
8676610|NCT03211234|21420542|P1|STARTED|Overall Study||17
8676611|NCT03196791|21420552|P2|NOT COMPLETED|Overall Study||5
8676612|NCT03196791|21420553|P1|NOT COMPLETED|Overall Study||10
8676613|NCT03196791|21420552|P2|COMPLETED|Overall Study||93
8676614|NCT03196791|21420553|P1|COMPLETED|Overall Study||88
8676615|NCT03196791|21420552|P2|STARTED|Overall Study||98
8676616|NCT03196791|21420553|P1|STARTED|Overall Study||98
8676617|NCT03174925|21420565|P1|NOT COMPLETED|Overall Study||3
8676618|NCT03174925|21420565|P1|COMPLETED|Overall Study||52
8676619|NCT03174925|21420565|P1|STARTED|Overall Study||55
8676620|NCT03144687|21420571|P2|NOT COMPLETED|Overall Study||10
8676621|NCT03144687|21420572|P1|NOT COMPLETED|Overall Study||13
8676622|NCT03144687|21420571|P2|COMPLETED|Overall Study||0
8676623|NCT03144687|21420572|P1|COMPLETED|Overall Study||0
8676624|NCT03144687|21420571|P2|STARTED|Overall Study||10
8676625|NCT03144687|21420572|P1|STARTED|Overall Study||13
8676626|NCT03137459|21420622|P2|NOT COMPLETED|6-months||17
8676627|NCT03137459|21420623|P1|NOT COMPLETED|6-months||21
8676628|NCT03137459|21420622|P2|COMPLETED|6-months||430
8676629|NCT03137459|21420623|P1|COMPLETED|6-months||413
8676630|NCT03137459|21420622|P2|STARTED|6-months||447
8676631|NCT03137459|21420623|P1|STARTED|6-months||434
8676632|NCT03137459|21420622|P2|NOT COMPLETED|4-month Assessment||46
8676633|NCT03137459|21420623|P1|NOT COMPLETED|4-month Assessment||78
8676634|NCT03137459|21420622|P2|COMPLETED|4-month Assessment||405
8676635|NCT03137459|21420623|P1|COMPLETED|4-month Assessment||364
8676636|NCT03137459|21420622|P2|STARTED|4-month Assessment||451
8676637|NCT03137459|21420623|P1|STARTED|4-month Assessment||442
8676638|NCT03137459|21420622|P2|NOT COMPLETED|2-month Assessment||42
8676639|NCT03137459|21420623|P1|NOT COMPLETED|2-month Assessment||68
8676640|NCT03137459|21420622|P2|COMPLETED|2-month Assessment||412
8676641|NCT03137459|21420623|P1|COMPLETED|2-month Assessment||387
8676642|NCT03137459|21420622|P2|STARTED|2-month Assessment||454
8676643|NCT03137459|21420623|P1|STARTED|2-month Assessment||455
8676644|NCT03126760|21420637|P2|NOT COMPLETED|Overall Study||0
8676645|NCT03126760|21420638|P1|NOT COMPLETED|Overall Study||0
8676646|NCT03126760|21420637|P2|COMPLETED|Overall Study||17
8676647|NCT03126760|21420638|P1|COMPLETED|Overall Study||18
8676648|NCT03126760|21420637|P2|Completed Treatment|Overall Study||17
8676649|NCT03126760|21420638|P1|Completed Treatment|Overall Study|One participant halted treatment for adverse event, but completed the study|17
8676650|NCT03126760|21420637|P2|Modified Intent to Treat (mITT)|Overall Study||17
8676651|NCT03126760|21420638|P1|Modified Intent to Treat (mITT)|Overall Study||18
8676652|NCT03126760|21420637|P2|STARTED|Overall Study||17
8676653|NCT03126760|21420638|P1|STARTED|Overall Study||18
8676654|NCT03124368|21420646|P2|NOT COMPLETED|Overall Study||0
8676655|NCT03124368|21420647|P1|NOT COMPLETED|Overall Study||0
8676656|NCT03124368|21420646|P2|COMPLETED|Overall Study||4
8676657|NCT03124368|21420647|P1|COMPLETED|Overall Study||2
8676658|NCT03124368|21420646|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
8676659|NCT03124368|21420647|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
8676660|NCT03124368|21420646|P2|STARTED|Overall Study||4
8676661|NCT03124368|21420647|P1|STARTED|Overall Study||2
8676662|NCT03122886|21420686|P2|NOT COMPLETED|Overall Study||2
8676663|NCT03122886|21420687|P1|NOT COMPLETED|Overall Study||1
8676664|NCT03122886|21420686|P2|COMPLETED|Overall Study||7
8676665|NCT03122886|21420687|P1|COMPLETED|Overall Study||9
8676666|NCT03122886|21420686|P2|STARTED|Overall Study||9
8676667|NCT03122886|21420687|P1|STARTED|Overall Study||10
8676694|NCT03110562|21420779|P2|NOT COMPLETED|Overall Study||207
8676695|NCT03110562|21420780|P1|NOT COMPLETED|Overall Study||195
8676696|NCT03110562|21420779|P2|COMPLETED|Overall Study||0
8676697|NCT03110562|21420780|P1|COMPLETED|Overall Study||0
8676698|NCT03110562|21420779|P2|Treated|Overall Study||204
8676699|NCT03110562|21420780|P1|Treated|Overall Study||195
8676700|NCT03110562|21420779|P2|STARTED|Overall Study||207
8676701|NCT03110562|21420780|P1|STARTED|Overall Study||195
8676702|NCT03107091|21420786|P1|NOT COMPLETED|Overall Study||1
8676703|NCT03107091|21420786|P1|COMPLETED|Overall Study||5
8676704|NCT03107091|21420786|P1|STARTED|Overall Study||6
8676705|NCT03097588|21420792|P1|NOT COMPLETED|Overall Study||1
8676706|NCT03097588|21420792|P1|COMPLETED|Overall Study||42
8676707|NCT03097588|21420792|P1|STARTED|Overall Study||43
8676708|NCT03082261|21420806|P1|NOT COMPLETED|Overall Study||120
8676709|NCT03082261|21420806|P1|COMPLETED|Overall Study||149
8676710|NCT03082261|21420806|P1|STARTED|Overall Study||269
8676711|NCT03067129|21420886|P4|NOT COMPLETED|Overall Study||24
8676712|NCT03067129|21420887|P3|NOT COMPLETED|Overall Study||27
8676713|NCT03067129|21420888|P2|NOT COMPLETED|Overall Study||28
8676714|NCT03067129|21420889|P1|NOT COMPLETED|Overall Study||45
8676715|NCT03067129|21420886|P4|COMPLETED|Overall Study||0
8676716|NCT03067129|21420887|P3|COMPLETED|Overall Study||0
8676717|NCT03067129|21420888|P2|COMPLETED|Overall Study||1
8676718|NCT03067129|21420889|P1|COMPLETED|Overall Study||2
8676719|NCT03067129|21420886|P4|STARTED|Overall Study||24
8676720|NCT03067129|21420887|P3|STARTED|Overall Study||27
8676721|NCT03067129|21420888|P2|STARTED|Overall Study||29
8676722|NCT03067129|21420889|P1|STARTED|Overall Study||47
8676723|NCT03040024|21420972|P3|NOT COMPLETED|Overall Study||1
8676724|NCT03040024|21420973|P2|NOT COMPLETED|Overall Study||2
8676725|NCT03040024|21420974|P1|NOT COMPLETED|Overall Study||0
8676726|NCT03040024|21420972|P3|COMPLETED|Overall Study||23
8676727|NCT03040024|21420973|P2|COMPLETED|Overall Study||24
8676728|NCT03040024|21420974|P1|COMPLETED|Overall Study||21
8676729|NCT03040024|21420972|P3|STARTED|Overall Study||24
8676730|NCT03040024|21420973|P2|STARTED|Overall Study||26
8676731|NCT03040024|21420974|P1|STARTED|Overall Study||21
8676737|NCT03003130|21421012|P2|NOT COMPLETED|Overall Study||7
8676738|NCT03003130|21421013|P1|NOT COMPLETED|Overall Study||8
8676739|NCT03003130|21421012|P2|COMPLETED|Overall Study||80
8676740|NCT03003130|21421013|P1|COMPLETED|Overall Study||80
8676741|NCT03003130|21421012|P2|STARTED|Overall Study||87
8676742|NCT03003130|21421013|P1|STARTED|Overall Study||88
8676743|NCT02996864|21421021|P2|NOT COMPLETED|Overall Study||14
8676744|NCT02996864|21421022|P1|NOT COMPLETED|Overall Study||8
8676745|NCT02996864|21421021|P2|COMPLETED|Overall Study||136
8676746|NCT02996864|21421022|P1|COMPLETED|Overall Study||142
8676747|NCT02996864|21421021|P2|STARTED|Overall Study||150
8676748|NCT02996864|21421022|P1|STARTED|Overall Study||150
8676749|NCT02989714|21421050|P1|NOT COMPLETED|Overall Study||1
8676750|NCT02989714|21421050|P1|COMPLETED|Overall Study||12
8676751|NCT02989714|21421050|P1|Started Nivolumab|Overall Study||12
8676752|NCT02989714|21421050|P1|STARTED|Overall Study||13
8676753|NCT02982590|21421060|P2|NOT COMPLETED|Overall Study||1
8676754|NCT02982590|21421061|P1|NOT COMPLETED|Overall Study||4
8676755|NCT02982590|21421060|P2|COMPLETED|Overall Study||13
8676756|NCT02982590|21421061|P1|COMPLETED|Overall Study||9
8676757|NCT02982590|21421060|P2|STARTED|Overall Study||14
8676758|NCT02982590|21421061|P1|STARTED|Overall Study||13
8676759|NCT02979925|21421075|P2|NOT COMPLETED|Overall Study||6
8676760|NCT02979925|21421076|P1|NOT COMPLETED|Overall Study||0
8676761|NCT02979925|21421075|P2|COMPLETED|Overall Study||23
8676762|NCT02979925|21421076|P1|COMPLETED|Overall Study||28
8676763|NCT02979925|21421075|P2|STARTED|Overall Study||29
8676764|NCT02979925|21421076|P1|STARTED|Overall Study||28
8676765|NCT02933320|21421090|P4|NOT COMPLETED|Overall Study||0
8676766|NCT02933320|21421091|P3|NOT COMPLETED|Overall Study||0
8676767|NCT02933320|21421092|P2|NOT COMPLETED|Overall Study||0
8676768|NCT02933320|21421093|P1|NOT COMPLETED|Overall Study||0
8676769|NCT02933320|21421090|P4|COMPLETED|Overall Study||0
8676770|NCT02933320|21421091|P3|COMPLETED|Overall Study||0
8676771|NCT02933320|21421092|P2|COMPLETED|Overall Study||1
8676772|NCT02933320|21421093|P1|COMPLETED|Overall Study||13
8676773|NCT02933320|21421090|P4|STARTED|Overall Study|Trial terminated early|0
8676774|NCT02933320|21421091|P3|STARTED|Overall Study|Trial terminated early|0
8676775|NCT02933320|21421092|P2|STARTED|Overall Study||1
8676776|NCT02933320|21421093|P1|STARTED|Overall Study||13
8676777|NCT02925494|21421151|P4|NOT COMPLETED|Post-Treatment Follow-Up Period||50
8676778|NCT02925494|21421152|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||24
8676779|NCT02925494|21421153|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||10
8676780|NCT02925494|21421154|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||14
8676781|NCT02925494|21421151|P4|COMPLETED|Post-Treatment Follow-Up Period||134
8676782|NCT02925494|21421152|P3|COMPLETED|Post-Treatment Follow-Up Period||64
8676783|NCT02925494|21421153|P2|COMPLETED|Post-Treatment Follow-Up Period||37
8676784|NCT02925494|21421154|P1|COMPLETED|Post-Treatment Follow-Up Period||40
8676785|NCT02925494|21421151|P4|STARTED|Post-Treatment Follow-Up Period||184
8676786|NCT02925494|21421152|P3|STARTED|Post-Treatment Follow-Up Period||88
8676787|NCT02925494|21421153|P2|STARTED|Post-Treatment Follow-Up Period||47
8676788|NCT02925494|21421154|P1|STARTED|Post-Treatment Follow-Up Period||54
8676789|NCT02925494|21421151|P4|NOT COMPLETED|Treatment Period||36
8676790|NCT02925494|21421152|P3|NOT COMPLETED|Treatment Period||19
8676791|NCT02925494|21421153|P2|NOT COMPLETED|Treatment Period||15
8676792|NCT02925494|21421154|P1|NOT COMPLETED|Treatment Period||9
8676793|NCT02925494|21421151|P4|COMPLETED|Treatment Period||182
8676794|NCT02925494|21421152|P3|COMPLETED|Treatment Period||79
8676795|NCT02925494|21421153|P2|COMPLETED|Treatment Period||43
8676796|NCT02925494|21421154|P1|COMPLETED|Treatment Period||50
8676797|NCT02925494|21421151|P4|STARTED|Treatment Period||218
8676798|NCT02925494|21421152|P3|STARTED|Treatment Period||98
8676799|NCT02925494|21421153|P2|STARTED|Treatment Period||58
8676800|NCT02925494|21421154|P1|STARTED|Treatment Period||59
8676801|NCT02874742|21421183|P3|NOT COMPLETED|Overall Study||16
8676802|NCT02874742|21421184|P2|NOT COMPLETED|Overall Study||104
8676803|NCT02874742|21421185|P1|NOT COMPLETED|Overall Study||103
8676804|NCT02874742|21421183|P3|COMPLETED|Overall Study||0
8676805|NCT02874742|21421184|P2|COMPLETED|Overall Study||0
8676806|NCT02874742|21421185|P1|COMPLETED|Overall Study||0
8676807|NCT02874742|21421183|P3|Safety|Overall Study||16
8676808|NCT02874742|21421184|P2|Safety|Overall Study||99
8676809|NCT02874742|21421185|P1|Safety|Overall Study||102
8676810|NCT02874742|21421183|P3|STARTED|Overall Study||16
8676811|NCT02874742|21421184|P2|STARTED|Overall Study||104
8676812|NCT02874742|21421185|P1|STARTED|Overall Study||103
8676813|NCT02873195|21421239|P2|NOT COMPLETED|Overall Study||0
8676814|NCT02873195|21421240|P1|NOT COMPLETED|Overall Study||5
8676815|NCT02873195|21421239|P2|COMPLETED|Overall Study||46
8676816|NCT02873195|21421240|P1|COMPLETED|Overall Study||82
8676817|NCT02873195|21421239|P2|Never Began Treatment (Cancel)|Overall Study||0
8676818|NCT02873195|21421240|P1|Never Began Treatment (Cancel)|Overall Study||1
8676819|NCT02873195|21421239|P2|STARTED|Overall Study||46
8676820|NCT02873195|21421240|P1|STARTED|Overall Study||87
8676821|NCT02871492|21421255|P3|NOT COMPLETED|Overall Study||6
8676822|NCT02871492|21421256|P2|NOT COMPLETED|Overall Study||3
8676823|NCT02871492|21421257|P1|NOT COMPLETED|Overall Study||6
8676824|NCT02871492|21421255|P3|COMPLETED|Overall Study||71
8676825|NCT02871492|21421256|P2|COMPLETED|Overall Study||70
8676826|NCT02871492|21421257|P1|COMPLETED|Overall Study||67
8676827|NCT02871492|21421255|P3|STARTED|Overall Study||77
8676828|NCT02871492|21421256|P2|STARTED|Overall Study||73
8676829|NCT02871492|21421257|P1|STARTED|Overall Study||73
8676830|NCT02869334|21421267|P2|NOT COMPLETED|Overall Study||7
8676831|NCT02869334|21421268|P1|NOT COMPLETED|Overall Study||8
8676832|NCT02869334|21421267|P2|COMPLETED|Overall Study||3
8676833|NCT02869334|21421268|P1|COMPLETED|Overall Study||2
8676834|NCT02869334|21421267|P2|STARTED|Overall Study||10
8676835|NCT02869334|21421268|P1|STARTED|Overall Study||10
8676836|NCT02868281|21421284|P2|NOT COMPLETED|Overall Study||44
8676837|NCT02868281|21421285|P1|NOT COMPLETED|Overall Study||43
8676838|NCT02868281|21421284|P2|COMPLETED|Overall Study||234
8676839|NCT02868281|21421285|P1|COMPLETED|Overall Study||209
8676840|NCT02868281|21421284|P2|STARTED|Overall Study||278
8676841|NCT02868281|21421285|P1|STARTED|Overall Study||252
8676842|NCT02829918|21421307|P1|NOT COMPLETED|Overall Study||8
8676843|NCT02829918|21421307|P1|COMPLETED|Overall Study||46
8676844|NCT02829918|21421307|P1|STARTED|Overall Study||54
8676845|NCT02792218|21421314|P2|NOT COMPLETED|Overall Study||86
8676846|NCT02792218|21421315|P1|NOT COMPLETED|Overall Study||49
8676847|NCT02792218|21421314|P2|COMPLETED|Overall Study||376
8676848|NCT02792218|21421315|P1|COMPLETED|Overall Study||416
8676849|NCT02792218|21421314|P2|Off Study Drug at Interim Cut Off|Overall Study||17
8676850|NCT02792218|21421315|P1|Off Study Drug at Interim Cut Off|Overall Study||16
8676851|NCT02792218|21421314|P2|On Study Drug at Interim Cut Off|Overall Study||359
8676852|NCT02792218|21421315|P1|On Study Drug at Interim Cut Off|Overall Study||400
8676853|NCT02792218|21421314|P2|STARTED|Overall Study||462
8676854|NCT02792218|21421315|P1|STARTED|Overall Study||465
8676855|NCT02781480|21421338|P3|NOT COMPLETED|Overall Study||0
8676856|NCT02781480|21421339|P2|NOT COMPLETED|Overall Study||0
8676857|NCT02781480|21421340|P1|NOT COMPLETED|Overall Study||0
8676858|NCT02781480|21421338|P3|COMPLETED|Overall Study||3
8676859|NCT02781480|21421339|P2|COMPLETED|Overall Study||3
8676860|NCT02781480|21421340|P1|COMPLETED|Overall Study||9
8676861|NCT02781480|21421338|P3|STARTED|Overall Study||3
8676862|NCT02781480|21421339|P2|STARTED|Overall Study||3
8676863|NCT02781480|21421340|P1|STARTED|Overall Study||9
8676864|NCT02770170|21421352|P4|NOT COMPLETED|Overall Study||7
8676865|NCT02770170|21421353|P3|NOT COMPLETED|Overall Study||5
8676866|NCT02770170|21421354|P2|NOT COMPLETED|Overall Study||3
8676867|NCT02770170|21421355|P1|NOT COMPLETED|Overall Study||7
8676868|NCT02770170|21421352|P4|COMPLETED|Overall Study||33
8676869|NCT02770170|21421353|P3|COMPLETED|Overall Study||35
8676870|NCT02770170|21421354|P2|COMPLETED|Overall Study||17
8676871|NCT02770170|21421355|P1|COMPLETED|Overall Study||14
8676872|NCT02770170|21421352|P4|STARTED|Overall Study||40
8676873|NCT02770170|21421353|P3|STARTED|Overall Study||40
8676874|NCT02770170|21421354|P2|STARTED|Overall Study||20
8676875|NCT02770170|21421355|P1|STARTED|Overall Study||21
8676879|NCT02740972|21421407|P5|NOT COMPLETED|20-week Open Label Treatment Period||0
8676880|NCT02740972|21421408|P4|NOT COMPLETED|20-week Open Label Treatment Period||0
8676881|NCT02740972|21421409|P3|NOT COMPLETED|20-week Open Label Treatment Period||0
8676882|NCT02740972|21421410|P2|NOT COMPLETED|20-week Open Label Treatment Period||0
8676883|NCT02740972|21421411|P1|NOT COMPLETED|20-week Open Label Treatment Period||0
8676884|NCT02740972|21421407|P5|COMPLETED|20-week Open Label Treatment Period||8
8676885|NCT02740972|21421408|P4|COMPLETED|20-week Open Label Treatment Period||8
8676886|NCT02740972|21421409|P3|COMPLETED|20-week Open Label Treatment Period||0
8676887|NCT02740972|21421410|P2|COMPLETED|20-week Open Label Treatment Period||0
8676888|NCT02740972|21421411|P1|COMPLETED|20-week Open Label Treatment Period||0
8676889|NCT02740972|21421407|P5|STARTED|20-week Open Label Treatment Period||8
8676890|NCT02740972|21421408|P4|STARTED|20-week Open Label Treatment Period||8
8676891|NCT02740972|21421409|P3|STARTED|20-week Open Label Treatment Period||0
8676892|NCT02740972|21421410|P2|STARTED|20-week Open Label Treatment Period||0
8676893|NCT02740972|21421411|P1|STARTED|20-week Open Label Treatment Period||0
8676894|NCT02740972|21421407|P5|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
8676895|NCT02740972|21421408|P4|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
8676896|NCT02740972|21421409|P3|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
8676897|NCT02740972|21421410|P2|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
8676898|NCT02740972|21421411|P1|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
8676899|NCT02740972|21421407|P5|COMPLETED|4-week Double-blinded Placebo-controlled||0
8676900|NCT02740972|21421408|P4|COMPLETED|4-week Double-blinded Placebo-controlled||0
8676901|NCT02740972|21421409|P3|COMPLETED|4-week Double-blinded Placebo-controlled||5
8676902|NCT02740972|21421410|P2|COMPLETED|4-week Double-blinded Placebo-controlled||6
8676903|NCT02740972|21421411|P1|COMPLETED|4-week Double-blinded Placebo-controlled||5
8676904|NCT02740972|21421407|P5|STARTED|4-week Double-blinded Placebo-controlled||0
8676905|NCT02740972|21421408|P4|STARTED|4-week Double-blinded Placebo-controlled||0
8676906|NCT02740972|21421409|P3|STARTED|4-week Double-blinded Placebo-controlled||5
8676907|NCT02740972|21421410|P2|STARTED|4-week Double-blinded Placebo-controlled||6
8676908|NCT02740972|21421411|P1|STARTED|4-week Double-blinded Placebo-controlled||5
8676909|NCT02738138|21421466|P2|NOT COMPLETED|Overall Study||1
8676910|NCT02738138|21421467|P1|NOT COMPLETED|Overall Study||3
8676911|NCT02738138|21421466|P2|COMPLETED|Overall Study||15
8676912|NCT02738138|21421467|P1|COMPLETED|Overall Study||134
8676913|NCT02738138|21421466|P2|STARTED|Overall Study||16
8676914|NCT02738138|21421467|P1|STARTED|Overall Study||137
8676915|NCT02706249|21421476|P2|NOT COMPLETED|Overall Study||1
8676916|NCT02706249|21421477|P1|NOT COMPLETED|Overall Study||2
8676917|NCT02706249|21421476|P2|COMPLETED|Overall Study||24
8676918|NCT02706249|21421477|P1|COMPLETED|Overall Study||23
8676919|NCT02706249|21421476|P2|STARTED|Overall Study||25
8676920|NCT02706249|21421477|P1|STARTED|Overall Study||25
8676921|NCT02702401|21421488|P2|NOT COMPLETED|Overall Study||135
8676922|NCT02702401|21421489|P1|NOT COMPLETED|Overall Study||278
8676923|NCT02702401|21421488|P2|COMPLETED|Overall Study||0
8676924|NCT02702401|21421489|P1|COMPLETED|Overall Study||0
8676925|NCT02702401|21421488|P2|Treated|Overall Study||135
8676926|NCT02702401|21421489|P1|Treated|Overall Study||278
8676927|NCT02702401|21421488|P2|STARTED|Overall Study||135
8676928|NCT02702401|21421489|P1|STARTED|Overall Study||278
8676929|NCT02698189|21421511|P2|NOT COMPLETED|Overall Study||6
8676930|NCT02698189|21421512|P1|NOT COMPLETED|Overall Study||3
8676931|NCT02698189|21421511|P2|COMPLETED|Overall Study||0
8676932|NCT02698189|21421512|P1|COMPLETED|Overall Study||0
8676933|NCT02698189|21421511|P2|STARTED|Overall Study||6
8676934|NCT02698189|21421512|P1|STARTED|Overall Study||3
8676935|NCT02696031|21421542|P3|NOT COMPLETED|Week 52||26
8676936|NCT02696031|21421543|P2|NOT COMPLETED|Week 52||19
8676937|NCT02696031|21421544|P1|NOT COMPLETED|Week 52||29
8676938|NCT02696031|21421542|P3|COMPLETED|Week 52||160
8676939|NCT02696031|21421543|P2|COMPLETED|Week 52||165
8676940|NCT02696031|21421544|P1|COMPLETED|Week 52||156
8676941|NCT02696031|21421542|P3|STARTED|Week 52||186
8676942|NCT02696031|21421543|P2|STARTED|Week 52||184
8676943|NCT02696031|21421544|P1|STARTED|Week 52||185
8676944|NCT02696031|21421542|P3|NOT COMPLETED|Week 24||11
8676945|NCT02696031|21421543|P2|NOT COMPLETED|Week 24||7
8676946|NCT02696031|21421544|P1|NOT COMPLETED|Week 24||10
8676947|NCT02696031|21421542|P3|COMPLETED|Week 24||175
8676948|NCT02696031|21421543|P2|COMPLETED|Week 24||177
8676949|NCT02696031|21421544|P1|COMPLETED|Week 24||175
8676950|NCT02696031|21421542|P3|STARTED|Week 24||186
8676951|NCT02696031|21421543|P2|STARTED|Week 24||184
8676952|NCT02696031|21421544|P1|STARTED|Week 24||185
8676953|NCT02692703|21421556|P1|NOT COMPLETED|Overall Study||2
8676954|NCT02692703|21421556|P1|COMPLETED|Overall Study||98
8676955|NCT02692703|21421556|P1|STARTED|Overall Study||100
8676956|NCT02691494|21421565|P3|NOT COMPLETED|Post-Treatment Follow-Up Period||17
8676957|NCT02691494|21421566|P2|NOT COMPLETED|Post-Treatment Follow-Up Period||7
8676958|NCT02691494|21421567|P1|NOT COMPLETED|Post-Treatment Follow-Up Period||5
8676959|NCT02691494|21421565|P3|COMPLETED|Post-Treatment Follow-Up Period||42
8676960|NCT02691494|21421566|P2|COMPLETED|Post-Treatment Follow-Up Period||18
8676961|NCT02691494|21421567|P1|COMPLETED|Post-Treatment Follow-Up Period||9
8676962|NCT02691494|21421565|P3|STARTED|Post-Treatment Follow-Up Period||59
8676963|NCT02691494|21421566|P2|STARTED|Post-Treatment Follow-Up Period||25
8676964|NCT02691494|21421567|P1|STARTED|Post-Treatment Follow-Up Period||14
8676965|NCT02691494|21421565|P3|NOT COMPLETED|Treatment Period||41
8676966|NCT02691494|21421566|P2|NOT COMPLETED|Treatment Period||26
8676967|NCT02691494|21421567|P1|NOT COMPLETED|Treatment Period||22
8676968|NCT02691494|21421565|P3|COMPLETED|Treatment Period|completed treatment period|148
8676969|NCT02691494|21421566|P2|COMPLETED|Treatment Period|completed treatment period|69
8676970|NCT02691494|21421567|P1|COMPLETED|Treatment Period|completed treatment period|72
8676971|NCT02691494|21421565|P3|STARTED|Treatment Period||189
8676972|NCT02691494|21421566|P2|STARTED|Treatment Period||95
8676973|NCT02691494|21421567|P1|STARTED|Treatment Period||94
8676974|NCT02680314|21421595|P2|NOT COMPLETED|Overall Study||0
8676975|NCT02680314|21421596|P1|NOT COMPLETED|Overall Study||0
8676976|NCT02680314|21421595|P2|COMPLETED|Overall Study||123
8676977|NCT02680314|21421596|P1|COMPLETED|Overall Study||120
8676978|NCT02680314|21421595|P2|STARTED|Overall Study||123
8676979|NCT02680314|21421596|P1|STARTED|Overall Study||120
8676986|NCT02657434|21421643|P2|NOT COMPLETED|Overall Study||292
8676987|NCT02657434|21421644|P1|NOT COMPLETED|Overall Study||286
8676988|NCT02657434|21421643|P2|COMPLETED|Overall Study||0
8676989|NCT02657434|21421644|P1|COMPLETED|Overall Study||0
8676990|NCT02657434|21421643|P2|STARTED|Overall Study||292
8676991|NCT02657434|21421644|P1|STARTED|Overall Study||286
8676992|NCT02642432|21421672|P1|NOT COMPLETED|Overall Study||8
8676993|NCT02642432|21421672|P1|COMPLETED|Overall Study||138
8676994|NCT02642432|21421672|P1|STARTED|Overall Study||146
8676995|NCT02636595|21421678|P1|NOT COMPLETED|Overall Study||2
8676996|NCT02636595|21421678|P1|COMPLETED|Overall Study||119
8676997|NCT02636595|21421678|P1|STARTED|Overall Study||121
8676998|NCT02633501|21421690|P6|NOT COMPLETED|Overall Study||15
8676999|NCT02633501|21421691|P5|NOT COMPLETED|Overall Study||11
8677000|NCT02633501|21421692|P4|NOT COMPLETED|Overall Study||4
8677001|NCT02633501|21421693|P3|NOT COMPLETED|Overall Study||7
8677002|NCT02633501|21421694|P2|NOT COMPLETED|Overall Study||3
8677003|NCT02633501|21421695|P1|NOT COMPLETED|Overall Study||2
8677004|NCT02633501|21421690|P6|COMPLETED|Overall Study||48
8677005|NCT02633501|21421691|P5|COMPLETED|Overall Study||53
8677006|NCT02633501|21421692|P4|COMPLETED|Overall Study||59
8677007|NCT02633501|21421693|P3|COMPLETED|Overall Study||55
8677008|NCT02633501|21421694|P2|COMPLETED|Overall Study||11
8677009|NCT02633501|21421695|P1|COMPLETED|Overall Study||12
8677010|NCT02633501|21421690|P6|STARTED|Overall Study||63
8677011|NCT02633501|21421691|P5|STARTED|Overall Study||64
8677012|NCT02633501|21421692|P4|STARTED|Overall Study||63
8677013|NCT02633501|21421693|P3|STARTED|Overall Study||62
8677014|NCT02633501|21421694|P2|STARTED|Overall Study||14
8677015|NCT02633501|21421695|P1|STARTED|Overall Study||14
8677016|NCT02630316|21421716|P2|NOT COMPLETED|Overall Study||33
8677017|NCT02630316|21421717|P1|NOT COMPLETED|Overall Study||35
8677018|NCT02630316|21421716|P2|COMPLETED|Overall Study||130
8677019|NCT02630316|21421717|P1|COMPLETED|Overall Study||128
8677020|NCT02630316|21421716|P2|STARTED|Overall Study||163
8677021|NCT02630316|21421717|P1|STARTED|Overall Study||163
8677022|NCT02610868|21421731|P1|NOT COMPLETED|MYOBLOC: Treatment Session 4||2
8677023|NCT02610868|21421731|P1|COMPLETED|MYOBLOC: Treatment Session 4||22
8677024|NCT02610868|21421731|P1|STARTED|MYOBLOC: Treatment Session 4||24
8677025|NCT02610868|21421731|P1|NOT COMPLETED|MYOBLOC: Treatment Session 3||7
8677026|NCT02610868|21421731|P1|COMPLETED|MYOBLOC: Treatment Session 3||43
8677027|NCT02610868|21421731|P1|STARTED|MYOBLOC: Treatment Session 3||50
8677028|NCT02610868|21421731|P1|NOT COMPLETED|MYOBLOC: Treatment Session 2||12
8677029|NCT02610868|21421731|P1|COMPLETED|MYOBLOC: Treatment Session 2||165
8677030|NCT02610868|21421731|P1|STARTED|MYOBLOC: Treatment Session 2||177
8677031|NCT02610868|21421731|P1|NOT COMPLETED|MYOBLOC: Treatment Session 1||7
8677032|NCT02610868|21421731|P1|COMPLETED|MYOBLOC: Treatment Session 1||180
8677033|NCT02610868|21421731|P1|STARTED|MYOBLOC: Treatment Session 1||187
8677034|NCT02604017|21421833|P2|NOT COMPLETED|Overall Study||8
8677035|NCT02604017|21421834|P1|NOT COMPLETED|Overall Study||6
8677036|NCT02604017|21421833|P2|COMPLETED|Overall Study||343
8677037|NCT02604017|21421834|P1|COMPLETED|Overall Study||346
8677038|NCT02604017|21421833|P2|STARTED|Overall Study||351
8677039|NCT02604017|21421834|P1|STARTED|Overall Study||352
8677040|NCT02593318|21421861|P2|NOT COMPLETED|Overall Study||1
8677041|NCT02593318|21421862|P1|NOT COMPLETED|Overall Study||1
8677042|NCT02593318|21421861|P2|COMPLETED|Overall Study||15
8677043|NCT02593318|21421862|P1|COMPLETED|Overall Study||15
8677044|NCT02593318|21421861|P2|STARTED|Overall Study||16
8677045|NCT02593318|21421862|P1|STARTED|Overall Study||16
8677046|NCT02586857|21421876|P2|NOT COMPLETED|Overall Study||0
8677047|NCT02586857|21421877|P1|NOT COMPLETED|Overall Study||1
8677048|NCT02586857|21421876|P2|COMPLETED|Overall Study||9
8677049|NCT02586857|21421877|P1|COMPLETED|Overall Study||14
8677050|NCT02586857|21421876|P2|Discontinued Study|Overall Study||9
8677051|NCT02586857|21421877|P1|Discontinued Study|Overall Study||14
8677052|NCT02586857|21421876|P2|Received Study Medication|Overall Study||9
8677053|NCT02586857|21421877|P1|Received Study Medication|Overall Study||15
8677054|NCT02586857|21421876|P2|Enrolled|Overall Study||9
8677055|NCT02586857|21421877|P1|Enrolled|Overall Study||15
8677056|NCT02586857|21421876|P2|STARTED|Overall Study||9
8677057|NCT02586857|21421877|P1|STARTED|Overall Study||15
8677058|NCT02586675|21421883|P1|NOT COMPLETED|Overall Study||0
8677059|NCT02586675|21421883|P1|COMPLETED|Overall Study||7
8677060|NCT02586675|21421883|P1|STARTED|Overall Study||7
8677061|NCT02584140|21421889|P1|NOT COMPLETED|Overall Study||53
8677062|NCT02584140|21421889|P1|COMPLETED|Overall Study||83
8677063|NCT02584140|21421889|P1|STARTED|Overall Study||136
8677064|NCT02574520|21421900|P4|NOT COMPLETED|Overall Study||8
8677065|NCT02574520|21421901|P3|NOT COMPLETED|Overall Study||5
8677066|NCT02574520|21421902|P2|NOT COMPLETED|Overall Study||0
8677067|NCT02574520|21421903|P1|NOT COMPLETED|Overall Study||2
8677068|NCT02574520|21421900|P4|COMPLETED|Overall Study||144
8677069|NCT02574520|21421901|P3|COMPLETED|Overall Study||148
8677070|NCT02574520|21421902|P2|COMPLETED|Overall Study||46
8677071|NCT02574520|21421903|P1|COMPLETED|Overall Study||46
8677072|NCT02574520|21421900|P4|Dosed|Overall Study||148
8677073|NCT02574520|21421901|P3|Dosed|Overall Study||148
8677074|NCT02574520|21421902|P2|Dosed|Overall Study||46
8677075|NCT02574520|21421903|P1|Dosed|Overall Study||46
8677076|NCT02574520|21421900|P4|STARTED|Overall Study||152
8677077|NCT02574520|21421901|P3|STARTED|Overall Study||153
8677078|NCT02574520|21421902|P2|STARTED|Overall Study||46
8677079|NCT02574520|21421903|P1|STARTED|Overall Study||48
8677080|NCT02565511|21421927|P4|NOT COMPLETED|Overall Study||164
8677081|NCT02565511|21421928|P3|NOT COMPLETED|Overall Study||251
8677082|NCT02565511|21421929|P2|NOT COMPLETED|Overall Study||23
8677083|NCT02565511|21421930|P1|NOT COMPLETED|Overall Study||42
8677084|NCT02565511|21421927|P4|COMPLETED|Overall Study||0
8677085|NCT02565511|21421928|P3|COMPLETED|Overall Study||0
8677086|NCT02565511|21421929|P2|COMPLETED|Overall Study||0
8677087|NCT02565511|21421930|P1|COMPLETED|Overall Study||0
8677088|NCT02565511|21421927|P4|3 Patients Were Mis-randomized|Overall Study||1
8677089|NCT02565511|21421928|P3|3 Patients Were Mis-randomized|Overall Study||2
8677090|NCT02565511|21421929|P2|3 Patients Were Mis-randomized|Overall Study||0
8677091|NCT02565511|21421930|P1|3 Patients Were Mis-randomized|Overall Study||0
8677092|NCT02565511|21421927|P4|STARTED|Overall Study||164
8677093|NCT02565511|21421928|P3|STARTED|Overall Study||251
8677094|NCT02565511|21421929|P2|STARTED|Overall Study||23
8677095|NCT02565511|21421930|P1|STARTED|Overall Study||42
8677096|NCT02510001|21422012|P8|NOT COMPLETED|Overall Study||7
8677097|NCT02510001|21422013|P7|NOT COMPLETED|Overall Study||2
8677098|NCT02510001|21422014|P6|NOT COMPLETED|Overall Study||2
8677099|NCT02510001|21422015|P5|NOT COMPLETED|Overall Study||4
8677100|NCT02510001|21422016|P4|NOT COMPLETED|Overall Study||2
8677101|NCT02510001|21422017|P3|NOT COMPLETED|Overall Study||0
8677102|NCT02510001|21422018|P2|NOT COMPLETED|Overall Study||0
8677103|NCT02510001|21422019|P1|NOT COMPLETED|Overall Study||0
8677104|NCT02510001|21422012|P8|COMPLETED|Overall Study||30
8677105|NCT02510001|21422013|P7|COMPLETED|Overall Study||3
8677106|NCT02510001|21422014|P6|COMPLETED|Overall Study||5
8677107|NCT02510001|21422015|P5|COMPLETED|Overall Study||4
8677108|NCT02510001|21422016|P4|COMPLETED|Overall Study||6
8677109|NCT02510001|21422017|P3|COMPLETED|Overall Study||6
8677110|NCT02510001|21422018|P2|COMPLETED|Overall Study||5
8677111|NCT02510001|21422019|P1|COMPLETED|Overall Study||6
8677112|NCT02510001|21422012|P8|STARTED|Overall Study||37
8677113|NCT02510001|21422013|P7|STARTED|Overall Study||5
8677114|NCT02510001|21422014|P6|STARTED|Overall Study||7
8677115|NCT02510001|21422015|P5|STARTED|Overall Study||8
8677116|NCT02510001|21422016|P4|STARTED|Overall Study||8
8677117|NCT02510001|21422017|P3|STARTED|Overall Study||6
8677118|NCT02510001|21422018|P2|STARTED|Overall Study||5
8677119|NCT02510001|21422019|P1|STARTED|Overall Study||6
8677120|NCT02500797|21422102|P8|NOT COMPLETED|Overall Study||0
8677121|NCT02500797|21422103|P7|NOT COMPLETED|Overall Study||0
8677122|NCT02500797|21422104|P6|NOT COMPLETED|Overall Study||1
8677123|NCT02500797|21422105|P5|NOT COMPLETED|Overall Study||1
8677124|NCT02500797|21422106|P4|NOT COMPLETED|Overall Study||0
8677125|NCT02500797|21422107|P3|NOT COMPLETED|Overall Study||0
8677126|NCT02500797|21422108|P2|NOT COMPLETED|Overall Study||0
8677127|NCT02500797|21422109|P1|NOT COMPLETED|Overall Study||1
8677128|NCT02500797|21422102|P8|COMPLETED|Overall Study||11
8677129|NCT02500797|21422103|P7|COMPLETED|Overall Study||10
8677130|NCT02500797|21422104|P6|COMPLETED|Overall Study||14
8677131|NCT02500797|21422105|P5|COMPLETED|Overall Study||13
8677132|NCT02500797|21422106|P4|COMPLETED|Overall Study||14
8677133|NCT02500797|21422107|P3|COMPLETED|Overall Study||15
8677134|NCT02500797|21422108|P2|COMPLETED|Overall Study||42
8677135|NCT02500797|21422109|P1|COMPLETED|Overall Study||42
8677136|NCT02500797|21422102|P8|Arm I Crossover|Overall Study||0
8677137|NCT02500797|21422103|P7|Arm I Crossover|Overall Study||2
8677138|NCT02500797|21422104|P6|Arm I Crossover|Overall Study||0
8677139|NCT02500797|21422105|P5|Arm I Crossover|Overall Study||1
8677140|NCT02500797|21422106|P4|Arm I Crossover|Overall Study||0
8677141|NCT02500797|21422107|P3|Arm I Crossover|Overall Study||6
8677142|NCT02500797|21422108|P2|Arm I Crossover|Overall Study||0
8677143|NCT02500797|21422109|P1|Arm I Crossover|Overall Study||4
8677144|NCT02500797|21422102|P8|STARTED|Overall Study||11
8677145|NCT02500797|21422103|P7|STARTED|Overall Study||10
8677146|NCT02500797|21422104|P6|STARTED|Overall Study||15
8677147|NCT02500797|21422105|P5|STARTED|Overall Study||14
8677148|NCT02500797|21422106|P4|STARTED|Overall Study||14
8677149|NCT02500797|21422107|P3|STARTED|Overall Study||15
8677150|NCT02500797|21422108|P2|STARTED|Overall Study||42
8677151|NCT02500797|21422109|P1|STARTED|Overall Study||43
8677152|NCT02489422|21422169|P2|NOT COMPLETED|Overall Study||0
8677153|NCT02489422|21422170|P1|NOT COMPLETED|Overall Study||0
8677154|NCT02489422|21422169|P2|COMPLETED|Overall Study||21
8677155|NCT02489422|21422170|P1|COMPLETED|Overall Study||23
8677156|NCT02489422|21422169|P2|STARTED|Overall Study||21
8677157|NCT02489422|21422170|P1|STARTED|Overall Study||23
8677158|NCT02487966|21422215|P4|NOT COMPLETED|Overall Study||2
8677159|NCT02487966|21422216|P3|NOT COMPLETED|Overall Study||2
8677160|NCT02487966|21422217|P2|NOT COMPLETED|Overall Study||4
8677161|NCT02487966|21422218|P1|NOT COMPLETED|Overall Study||1
8677162|NCT02487966|21422215|P4|COMPLETED|Overall Study||25
8677163|NCT02487966|21422216|P3|COMPLETED|Overall Study||26
8677164|NCT02487966|21422217|P2|COMPLETED|Overall Study||24
8677165|NCT02487966|21422218|P1|COMPLETED|Overall Study||28
8677166|NCT02487966|21422215|P4|STARTED|Overall Study||27
8677167|NCT02487966|21422216|P3|STARTED|Overall Study||28
8677168|NCT02487966|21422217|P2|STARTED|Overall Study||28
8677169|NCT02487966|21422218|P1|STARTED|Overall Study||29
8677170|NCT02469389|21422238|P2|NOT COMPLETED|Overall Study||8
8677171|NCT02469389|21422239|P1|NOT COMPLETED|Overall Study||16
8677172|NCT02469389|21422238|P2|COMPLETED|Overall Study||44
8677173|NCT02469389|21422239|P1|COMPLETED|Overall Study||37
8677174|NCT02469389|21422238|P2|Completed 24-week Assessment|Overall Study|6 lost to contact or refused|46
8677175|NCT02469389|21422239|P1|Completed 24-week Assessment|Overall Study|16 lost to contact or refused|37
8677176|NCT02469389|21422238|P2|Completed 12-week Assessment|Overall Study|8 lost to contact or refused|44
8677177|NCT02469389|21422239|P1|Completed 12-week Assessment|Overall Study|13 lost to contact or refused|40
8677178|NCT02469389|21422238|P2|STARTED|Overall Study||52
8677179|NCT02469389|21422239|P1|STARTED|Overall Study||53
8677180|NCT02463799|21422269|P2|NOT COMPLETED|Overall Study||0
8677181|NCT02463799|21422270|P1|NOT COMPLETED|Overall Study||0
8677182|NCT02463799|21422269|P2|COMPLETED|Overall Study||16
8677183|NCT02463799|21422270|P1|COMPLETED|Overall Study||16
8677184|NCT02463799|21422269|P2|STARTED|Overall Study||16
8677185|NCT02463799|21422270|P1|STARTED|Overall Study||16
8677192|NCT02448446|21422321|P2|NOT COMPLETED|Overall Study||0
8677193|NCT02448446|21422322|P1|NOT COMPLETED|Overall Study||1
8677194|NCT02448446|21422321|P2|COMPLETED|Overall Study||12
8677195|NCT02448446|21422322|P1|COMPLETED|Overall Study||12
8677196|NCT02448446|21422321|P2|STARTED|Overall Study||12
8677197|NCT02448446|21422322|P1|STARTED|Overall Study||13
8677198|NCT02432235|21422356|P12|NOT COMPLETED|Overall Study||1
8677199|NCT02432235|21422357|P11|NOT COMPLETED|Overall Study||1
8677200|NCT02432235|21422358|P10|NOT COMPLETED|Overall Study||3
8677201|NCT02432235|21422359|P9|NOT COMPLETED|Overall Study||21
8677202|NCT02432235|21422360|P8|NOT COMPLETED|Overall Study||20
8677203|NCT02432235|21422361|P7|NOT COMPLETED|Overall Study||18
8677204|NCT02432235|21422362|P6|NOT COMPLETED|Overall Study||12
8677205|NCT02432235|21422363|P5|NOT COMPLETED|Overall Study||2
8677206|NCT02432235|21422364|P4|NOT COMPLETED|Overall Study||2
8677207|NCT02432235|21422365|P3|NOT COMPLETED|Overall Study||2
8677208|NCT02432235|21422366|P2|NOT COMPLETED|Overall Study||2
8677209|NCT02432235|21422367|P1|NOT COMPLETED|Overall Study||1
8677210|NCT02432235|21422356|P12|COMPLETED|Overall Study||0
8677211|NCT02432235|21422357|P11|COMPLETED|Overall Study||1
8677212|NCT02432235|21422358|P10|COMPLETED|Overall Study||0
8677213|NCT02432235|21422359|P9|COMPLETED|Overall Study||5
8677214|NCT02432235|21422360|P8|COMPLETED|Overall Study||9
8677215|NCT02432235|21422361|P7|COMPLETED|Overall Study||23
8677216|NCT02432235|21422362|P6|COMPLETED|Overall Study||8
8677217|NCT02432235|21422363|P5|COMPLETED|Overall Study||0
8677218|NCT02432235|21422364|P4|COMPLETED|Overall Study||1
8677219|NCT02432235|21422365|P3|COMPLETED|Overall Study||0
8677220|NCT02432235|21422366|P2|COMPLETED|Overall Study||0
8677221|NCT02432235|21422367|P1|COMPLETED|Overall Study||1
8677222|NCT02432235|21422356|P12|STARTED|Overall Study||1
8677223|NCT02432235|21422357|P11|STARTED|Overall Study||2
8677224|NCT02432235|21422358|P10|STARTED|Overall Study||3
8677225|NCT02432235|21422359|P9|STARTED|Overall Study||26
8677226|NCT02432235|21422360|P8|STARTED|Overall Study||29
8677227|NCT02432235|21422361|P7|STARTED|Overall Study||41
8677228|NCT02432235|21422362|P6|STARTED|Overall Study||20
8677229|NCT02432235|21422363|P5|STARTED|Overall Study||2
8677230|NCT02432235|21422364|P4|STARTED|Overall Study||3
8677231|NCT02432235|21422365|P3|STARTED|Overall Study||2
8677232|NCT02432235|21422366|P2|STARTED|Overall Study||2
8677233|NCT02432235|21422367|P1|STARTED|Overall Study||2
8677242|NCT02418949|21422586|P4|NOT COMPLETED|Overall Study||1
8677243|NCT02418949|21422587|P3|NOT COMPLETED|Overall Study||3
8677244|NCT02418949|21422588|P2|NOT COMPLETED|Overall Study||1
8677245|NCT02418949|21422589|P1|NOT COMPLETED|Overall Study||3
8677246|NCT02418949|21422586|P4|COMPLETED|Overall Study||24
8677247|NCT02418949|21422587|P3|COMPLETED|Overall Study||23
8677248|NCT02418949|21422588|P2|COMPLETED|Overall Study||21
8677249|NCT02418949|21422589|P1|COMPLETED|Overall Study||20
8677250|NCT02418949|21422586|P4|STARTED|Overall Study||25
8677251|NCT02418949|21422587|P3|STARTED|Overall Study||26
8677252|NCT02418949|21422588|P2|STARTED|Overall Study||22
8677253|NCT02418949|21422589|P1|STARTED|Overall Study||23
8677254|NCT02393755|21422605|P2|NOT COMPLETED|Overall Study||7
8677255|NCT02393755|21422606|P1|NOT COMPLETED|Overall Study||0
8677256|NCT02393755|21422605|P2|COMPLETED|Overall Study||32
8677257|NCT02393755|21422606|P1|COMPLETED|Overall Study||3
8677258|NCT02393755|21422605|P2|STARTED|Overall Study||39
8677259|NCT02393755|21422606|P1|STARTED|Overall Study||3
8677260|NCT02382588|21422618|P2|NOT COMPLETED|Overall Study||0
8677261|NCT02382588|21422619|P1|NOT COMPLETED|Overall Study||0
8677262|NCT02382588|21422618|P2|COMPLETED|Overall Study||4
8677263|NCT02382588|21422619|P1|COMPLETED|Overall Study||4
8677264|NCT02382588|21422618|P2|STARTED|Overall Study||4
8677265|NCT02382588|21422619|P1|STARTED|Overall Study||4
8677266|NCT02363686|21422625|P1|NOT COMPLETED|Overall Study||35
8677267|NCT02363686|21422625|P1|COMPLETED|Overall Study||213
8677268|NCT02363686|21422625|P1|STARTED|Overall Study||248
8677269|NCT02348203|21422631|P2|NOT COMPLETED|Overall Study||10
8677270|NCT02348203|21422632|P1|NOT COMPLETED|Overall Study||10
8677271|NCT02348203|21422631|P2|COMPLETED|Overall Study||22
8677272|NCT02348203|21422632|P1|COMPLETED|Overall Study||21
8677273|NCT02348203|21422631|P2|STARTED|Overall Study||32
8677274|NCT02348203|21422632|P1|STARTED|Overall Study||31
8677290|NCT02292719|21422670|P6|NOT COMPLETED|Overall Study||0
8677291|NCT02292719|21422671|P5|NOT COMPLETED|Overall Study||1
8677292|NCT02292719|21422672|P4|NOT COMPLETED|Overall Study||1
8677293|NCT02292719|21422673|P3|NOT COMPLETED|Overall Study||1
8677294|NCT02292719|21422674|P2|NOT COMPLETED|Overall Study||0
8677295|NCT02292719|21422675|P1|NOT COMPLETED|Overall Study||0
8677296|NCT02292719|21422670|P6|COMPLETED|Overall Study||10
8677297|NCT02292719|21422671|P5|COMPLETED|Overall Study||20
8677298|NCT02292719|21422672|P4|COMPLETED|Overall Study||8
8677299|NCT02292719|21422673|P3|COMPLETED|Overall Study||9
8677300|NCT02292719|21422674|P2|COMPLETED|Overall Study||11
8677301|NCT02292719|21422675|P1|COMPLETED|Overall Study||9
8677302|NCT02292719|21422670|P6|STARTED|Overall Study||10
8677303|NCT02292719|21422671|P5|STARTED|Overall Study||21
8677304|NCT02292719|21422672|P4|STARTED|Overall Study||9
8677305|NCT02292719|21422673|P3|STARTED|Overall Study||10
8677306|NCT02292719|21422674|P2|STARTED|Overall Study||11
8677307|NCT02292719|21422675|P1|STARTED|Overall Study||9
8677308|NCT02272790|21422707|P6|NOT COMPLETED|Overall Study||0
8677309|NCT02272790|21422708|P5|NOT COMPLETED|Overall Study||0
8677310|NCT02272790|21422709|P4|NOT COMPLETED|Overall Study||0
8677311|NCT02272790|21422710|P3|NOT COMPLETED|Overall Study||0
8677312|NCT02272790|21422711|P2|NOT COMPLETED|Overall Study||1
8677313|NCT02272790|21422712|P1|NOT COMPLETED|Overall Study||0
8677314|NCT02272790|21422707|P6|COMPLETED|Overall Study||6
8677315|NCT02272790|21422708|P5|COMPLETED|Overall Study||6
8677316|NCT02272790|21422709|P4|COMPLETED|Overall Study||12
8677317|NCT02272790|21422710|P3|COMPLETED|Overall Study||23
8677318|NCT02272790|21422711|P2|COMPLETED|Overall Study||38
8677319|NCT02272790|21422712|P1|COMPLETED|Overall Study||9
8677320|NCT02272790|21422707|P6|STARTED|Overall Study||6
8677321|NCT02272790|21422708|P5|STARTED|Overall Study||6
8677322|NCT02272790|21422709|P4|STARTED|Overall Study||12
8677323|NCT02272790|21422710|P3|STARTED|Overall Study||23
8677324|NCT02272790|21422711|P2|STARTED|Overall Study||39
8677325|NCT02272790|21422712|P1|STARTED|Overall Study||9
8677326|NCT02243280|21422857|P11|NOT COMPLETED|Treated||3
8677327|NCT02243280|21422858|P10|NOT COMPLETED|Treated||0
8677328|NCT02243280|21422859|P9|NOT COMPLETED|Treated||1
8677329|NCT02243280|21422860|P8|NOT COMPLETED|Treated||0
8677330|NCT02243280|21422861|P7|NOT COMPLETED|Treated||0
8677331|NCT02243280|21422862|P6|NOT COMPLETED|Treated||0
8677332|NCT02243280|21422863|P5|NOT COMPLETED|Treated||0
8677333|NCT02243280|21422864|P4|NOT COMPLETED|Treated||0
8677334|NCT02243280|21422865|P3|NOT COMPLETED|Treated||0
8677335|NCT02243280|21422866|P2|NOT COMPLETED|Treated||0
8677336|NCT02243280|21422867|P1|NOT COMPLETED|Treated||1
8677337|NCT02243280|21422857|P11|COMPLETED|Treated||31
8677338|NCT02243280|21422858|P10|COMPLETED|Treated||0
8677339|NCT02243280|21422859|P9|COMPLETED|Treated||31
8677340|NCT02243280|21422860|P8|COMPLETED|Treated||0
8677341|NCT02243280|21422861|P7|COMPLETED|Treated||0
8677342|NCT02243280|21422862|P6|COMPLETED|Treated||27
8677343|NCT02243280|21422863|P5|COMPLETED|Treated||0
8677344|NCT02243280|21422864|P4|COMPLETED|Treated||0
8677345|NCT02243280|21422865|P3|COMPLETED|Treated||0
8677346|NCT02243280|21422866|P2|COMPLETED|Treated||39
8677347|NCT02243280|21422867|P1|COMPLETED|Treated||41
8677348|NCT02243280|21422857|P11|Completed Treatment|Treated||33
8677349|NCT02243280|21422858|P10|Completed Treatment|Treated||0
8677350|NCT02243280|21422859|P9|Completed Treatment|Treated||32
8677351|NCT02243280|21422860|P8|Completed Treatment|Treated||0
8677352|NCT02243280|21422861|P7|Completed Treatment|Treated||0
8677353|NCT02243280|21422862|P6|Completed Treatment|Treated||27
8677354|NCT02243280|21422863|P5|Completed Treatment|Treated||0
8677355|NCT02243280|21422864|P4|Completed Treatment|Treated||0
8677356|NCT02243280|21422865|P3|Completed Treatment|Treated||0
8677357|NCT02243280|21422866|P2|Completed Treatment|Treated||38
8677358|NCT02243280|21422867|P1|Completed Treatment|Treated||42
8677359|NCT02243280|21422857|P11|STARTED|Treated||34
8677360|NCT02243280|21422858|P10|STARTED|Treated||0
8677361|NCT02243280|21422859|P9|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
8677362|NCT02243280|21422860|P8|STARTED|Treated||0
8677363|NCT02243280|21422861|P7|STARTED|Treated||0
8677364|NCT02243280|21422862|P6|STARTED|Treated||27
8677365|NCT02243280|21422863|P5|STARTED|Treated||0
8677366|NCT02243280|21422864|P4|STARTED|Treated||0
8677367|NCT02243280|21422865|P3|STARTED|Treated||0
8677368|NCT02243280|21422866|P2|STARTED|Treated||39
8677369|NCT02243280|21422867|P1|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
8677370|NCT02243280|21422857|P11|NOT COMPLETED|Enrolled||0
8677371|NCT02243280|21422858|P10|NOT COMPLETED|Enrolled||0
8677372|NCT02243280|21422859|P9|NOT COMPLETED|Enrolled||0
8677373|NCT02243280|21422860|P8|NOT COMPLETED|Enrolled||0
8677374|NCT02243280|21422861|P7|NOT COMPLETED|Enrolled||0
8677375|NCT02243280|21422862|P6|NOT COMPLETED|Enrolled||0
8677376|NCT02243280|21422863|P5|NOT COMPLETED|Enrolled||0
8677377|NCT02243280|21422864|P4|NOT COMPLETED|Enrolled||0
8677378|NCT02243280|21422865|P3|NOT COMPLETED|Enrolled||0
8677379|NCT02243280|21422866|P2|NOT COMPLETED|Enrolled||0
8677380|NCT02243280|21422867|P1|NOT COMPLETED|Enrolled||0
8677381|NCT02243280|21422857|P11|COMPLETED|Enrolled||34
8677382|NCT02243280|21422858|P10|COMPLETED|Enrolled||0
8677383|NCT02243280|21422859|P9|COMPLETED|Enrolled||34
8677384|NCT02243280|21422860|P8|COMPLETED|Enrolled||0
8677385|NCT02243280|21422861|P7|COMPLETED|Enrolled||0
8677386|NCT02243280|21422862|P6|COMPLETED|Enrolled||27
8677387|NCT02243280|21422863|P5|COMPLETED|Enrolled||0
8677388|NCT02243280|21422864|P4|COMPLETED|Enrolled||0
8677389|NCT02243280|21422865|P3|COMPLETED|Enrolled||0
8677390|NCT02243280|21422866|P2|COMPLETED|Enrolled||39
8677391|NCT02243280|21422867|P1|COMPLETED|Enrolled||40
8677392|NCT02243280|21422857|P11|STARTED|Enrolled||34
8677393|NCT02243280|21422858|P10|STARTED|Enrolled||0
8677394|NCT02243280|21422859|P9|STARTED|Enrolled||34
8677395|NCT02243280|21422860|P8|STARTED|Enrolled||0
8677396|NCT02243280|21422861|P7|STARTED|Enrolled||0
8677397|NCT02243280|21422862|P6|STARTED|Enrolled||27
8677398|NCT02243280|21422863|P5|STARTED|Enrolled||0
8677399|NCT02243280|21422864|P4|STARTED|Enrolled||0
8677400|NCT02243280|21422865|P3|STARTED|Enrolled||0
8677401|NCT02243280|21422866|P2|STARTED|Enrolled||39
8677402|NCT02243280|21422867|P1|STARTED|Enrolled||40
8677403|NCT02219503|21422918|P1|NOT COMPLETED|Overall Study||0
8677404|NCT02219503|21422918|P1|COMPLETED|Overall Study||60
8677405|NCT02219503|21422918|P1|STARTED|Overall Study||60
8677406|NCT02208050|21422926|P2|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
8677407|NCT02208050|21422927|P1|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
8677408|NCT02208050|21422926|P2|COMPLETED|Washout Period 2: 2 Weeks Washout.||28
8677409|NCT02208050|21422927|P1|COMPLETED|Washout Period 2: 2 Weeks Washout.||33
8677410|NCT02208050|21422926|P2|STARTED|Washout Period 2: 2 Weeks Washout.||28
8677411|NCT02208050|21422927|P1|STARTED|Washout Period 2: 2 Weeks Washout.||33
8677412|NCT02208050|21422926|P2|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||0
8677413|NCT02208050|21422927|P1|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||2
8677414|NCT02208050|21422926|P2|COMPLETED|Treatment Period 2: 8 Weeks Treatment||28
8677415|NCT02208050|21422927|P1|COMPLETED|Treatment Period 2: 8 Weeks Treatment||33
8677416|NCT02208050|21422926|P2|STARTED|Treatment Period 2: 8 Weeks Treatment||28
8677417|NCT02208050|21422927|P1|STARTED|Treatment Period 2: 8 Weeks Treatment||35
8677418|NCT02208050|21422926|P2|NOT COMPLETED|Washout Period 1: 2 Weeks||0
8677419|NCT02208050|21422927|P1|NOT COMPLETED|Washout Period 1: 2 Weeks||1
8677420|NCT02208050|21422926|P2|COMPLETED|Washout Period 1: 2 Weeks||28
8677421|NCT02208050|21422927|P1|COMPLETED|Washout Period 1: 2 Weeks||35
8677422|NCT02208050|21422926|P2|STARTED|Washout Period 1: 2 Weeks||28
8677423|NCT02208050|21422927|P1|STARTED|Washout Period 1: 2 Weeks||36
8677424|NCT02208050|21422926|P2|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
8677425|NCT02208050|21422927|P1|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
8677426|NCT02208050|21422926|P2|COMPLETED|Treatment Period 1: 8 Weeks Treatment||28
8677427|NCT02208050|21422927|P1|COMPLETED|Treatment Period 1: 8 Weeks Treatment||36
8677428|NCT02208050|21422926|P2|STARTED|Treatment Period 1: 8 Weeks Treatment||28
8677429|NCT02208050|21422927|P1|STARTED|Treatment Period 1: 8 Weeks Treatment||36
8677430|NCT02208050|21422926|P2|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
8677431|NCT02208050|21422927|P1|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
8677432|NCT02208050|21422926|P2|COMPLETED|Baseline Assessment Period: 2 Weeks||28
8677433|NCT02208050|21422927|P1|COMPLETED|Baseline Assessment Period: 2 Weeks||36
8677434|NCT02208050|21422926|P2|STARTED|Baseline Assessment Period: 2 Weeks||28
8677435|NCT02208050|21422927|P1|STARTED|Baseline Assessment Period: 2 Weeks||36
8677436|NCT02207556|21422949|P2|NOT COMPLETED|Overall Study||5
8677437|NCT02207556|21422950|P1|NOT COMPLETED|Overall Study||2
8677438|NCT02207556|21422949|P2|COMPLETED|Overall Study||20
8677439|NCT02207556|21422950|P1|COMPLETED|Overall Study||5
8677440|NCT02207556|21422949|P2|STARTED|Overall Study||25
8677441|NCT02207556|21422950|P1|STARTED|Overall Study||7
8677454|NCT02197247|21422988|P1|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
8677455|NCT02197247|21422988|P1|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
8677456|NCT02197247|21422988|P1|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
8677457|NCT02197247|21422988|P1|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
8677458|NCT02197247|21422988|P1|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
8677459|NCT02197247|21422988|P1|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
8677460|NCT02197247|21422988|P1|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
8677461|NCT02197247|21422988|P1|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
8677462|NCT02197247|21422988|P1|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
8677463|NCT02197247|21422988|P1|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
8677464|NCT02197247|21422988|P1|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
8677465|NCT02197247|21422988|P1|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
8677466|NCT02177136|21423036|P4|NOT COMPLETED|LTSE Phase||24
8677467|NCT02177136|21423037|P3|NOT COMPLETED|LTSE Phase||0
8677468|NCT02177136|21423038|P2|NOT COMPLETED|LTSE Phase||0
8677469|NCT02177136|21423039|P1|NOT COMPLETED|LTSE Phase||0
8677470|NCT02177136|21423036|P4|COMPLETED|LTSE Phase||35
8677471|NCT02177136|21423037|P3|COMPLETED|LTSE Phase||0
8677472|NCT02177136|21423038|P2|COMPLETED|LTSE Phase||0
8677473|NCT02177136|21423039|P1|COMPLETED|LTSE Phase||0
8677474|NCT02177136|21423036|P4|Received At Least 1 Dose Of Study Drug|LTSE Phase||59
8677475|NCT02177136|21423037|P3|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
8677476|NCT02177136|21423038|P2|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
8677477|NCT02177136|21423039|P1|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
8677478|NCT02177136|21423036|P4|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|59
8677479|NCT02177136|21423037|P3|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
8677480|NCT02177136|21423038|P2|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
8677481|NCT02177136|21423039|P1|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
8677482|NCT02177136|21423036|P4|NOT COMPLETED|DB Phase||0
8677483|NCT02177136|21423037|P3|NOT COMPLETED|DB Phase||4
8677484|NCT02177136|21423038|P2|NOT COMPLETED|DB Phase||5
8677485|NCT02177136|21423039|P1|NOT COMPLETED|DB Phase||7
8677486|NCT02177136|21423036|P4|COMPLETED|DB Phase||0
8677487|NCT02177136|21423037|P3|COMPLETED|DB Phase||21
8677488|NCT02177136|21423038|P2|COMPLETED|DB Phase||21
8677489|NCT02177136|21423039|P1|COMPLETED|DB Phase||19
8677490|NCT02177136|21423036|P4|Received At Least 1 Dose Of Study Drug|DB Phase||0
8677491|NCT02177136|21423037|P3|Received At Least 1 Dose Of Study Drug|DB Phase||25
8677492|NCT02177136|21423038|P2|Received At Least 1 Dose Of Study Drug|DB Phase||26
8677493|NCT02177136|21423039|P1|Received At Least 1 Dose Of Study Drug|DB Phase|One participant randomized to receive 1.5 mg OCA titrating to 3 mg OCA withdrew prior to dosing.|25
8677494|NCT02177136|21423036|P4|STARTED|DB Phase||0
8677495|NCT02177136|21423037|P3|STARTED|DB Phase||25
8677496|NCT02177136|21423038|P2|STARTED|DB Phase||26
8677497|NCT02177136|21423039|P1|STARTED|DB Phase||26
8677498|NCT02164422|21423089|P3|NOT COMPLETED|Overall Study||0
8677499|NCT02164422|21423090|P2|NOT COMPLETED|Overall Study||2
8677500|NCT02164422|21423091|P1|NOT COMPLETED|Overall Study||1
8677501|NCT02164422|21423089|P3|COMPLETED|Overall Study||23
8677502|NCT02164422|21423090|P2|COMPLETED|Overall Study||20
8677503|NCT02164422|21423091|P1|COMPLETED|Overall Study||24
8677504|NCT02164422|21423089|P3|STARTED|Overall Study||23
8677505|NCT02164422|21423090|P2|STARTED|Overall Study||22
8677506|NCT02164422|21423091|P1|STARTED|Overall Study||25
8677507|NCT02152631|21423101|P2|NOT COMPLETED|Overall Study||26
8677508|NCT02152631|21423102|P1|NOT COMPLETED|Overall Study||66
8677509|NCT02152631|21423101|P2|COMPLETED|Overall Study||157
8677510|NCT02152631|21423102|P1|COMPLETED|Overall Study||204
8677511|NCT02152631|21423101|P2|Progressive Disease|Overall Study||137
8677512|NCT02152631|21423102|P1|Progressive Disease|Overall Study||174
8677513|NCT02152631|21423101|P2|Death Due to Any Cause|Overall Study||20
8677514|NCT02152631|21423102|P1|Death Due to Any Cause|Overall Study||30
8677515|NCT02152631|21423101|P2|Off Treatment|Overall Study||172
8677516|NCT02152631|21423102|P1|Off Treatment|Overall Study||246
8677517|NCT02152631|21423101|P2|Received at Least One Dose of Study Drug|Overall Study||175
8677518|NCT02152631|21423102|P1|Received at Least One Dose of Study Drug|Overall Study||265
8677519|NCT02152631|21423101|P2|STARTED|Overall Study||183
8677520|NCT02152631|21423102|P1|STARTED|Overall Study||270
8677521|NCT02152163|21423121|P2|NOT COMPLETED|Overall Study||13
8677522|NCT02152163|21423122|P1|NOT COMPLETED|Overall Study||12
8677523|NCT02152163|21423121|P2|COMPLETED|Overall Study||35
8677524|NCT02152163|21423122|P1|COMPLETED|Overall Study||39
8677525|NCT02152163|21423121|P2|STARTED|Overall Study||48
8677526|NCT02152163|21423122|P1|STARTED|Overall Study||51
8677527|NCT02143713|21423132|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
8677528|NCT02143713|21423133|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
8677529|NCT02143713|21423134|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
8677530|NCT02143713|21423135|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
8677531|NCT02143713|21423132|P4|COMPLETED|Post-treatment Follow-up (12 Months)||95
8677532|NCT02143713|21423133|P3|COMPLETED|Post-treatment Follow-up (12 Months)||96
8677533|NCT02143713|21423134|P2|COMPLETED|Post-treatment Follow-up (12 Months)||81
8677534|NCT02143713|21423135|P1|COMPLETED|Post-treatment Follow-up (12 Months)||73
8677535|NCT02143713|21423132|P4|STARTED|Post-treatment Follow-up (12 Months)||122
8677536|NCT02143713|21423133|P3|STARTED|Post-treatment Follow-up (12 Months)||125
8677537|NCT02143713|21423134|P2|STARTED|Post-treatment Follow-up (12 Months)||105
8677538|NCT02143713|21423135|P1|STARTED|Post-treatment Follow-up (12 Months)||85
8677539|NCT02143713|21423132|P4|NOT COMPLETED|Treatment Period (6 Months)||28
8677540|NCT02143713|21423133|P3|NOT COMPLETED|Treatment Period (6 Months)||22
8677541|NCT02143713|21423134|P2|NOT COMPLETED|Treatment Period (6 Months)||12
8677542|NCT02143713|21423135|P1|NOT COMPLETED|Treatment Period (6 Months)||20
8677543|NCT02143713|21423132|P4|COMPLETED|Treatment Period (6 Months)||112
8677544|NCT02143713|21423133|P3|COMPLETED|Treatment Period (6 Months)||120
8677545|NCT02143713|21423134|P2|COMPLETED|Treatment Period (6 Months)||99
8677546|NCT02143713|21423135|P1|COMPLETED|Treatment Period (6 Months)||82
8677547|NCT02143713|21423132|P4|Received Elagolix|Treatment Period (6 Months)||140
8677548|NCT02143713|21423133|P3|Received Elagolix|Treatment Period (6 Months)||142
8677549|NCT02143713|21423134|P2|Received Elagolix|Treatment Period (6 Months)||111
8677550|NCT02143713|21423135|P1|Received Elagolix|Treatment Period (6 Months)||102
8677551|NCT02143713|21423132|P4|STARTED|Treatment Period (6 Months)||140
8677552|NCT02143713|21423133|P3|STARTED|Treatment Period (6 Months)||142
8677553|NCT02143713|21423134|P2|STARTED|Treatment Period (6 Months)||111
8677554|NCT02143713|21423135|P1|STARTED|Treatment Period (6 Months)||102
8677555|NCT02112526|21423215|P2|NOT COMPLETED|Overall Study||9
8677556|NCT02112526|21423216|P1|NOT COMPLETED|Overall Study||11
8677557|NCT02112526|21423215|P2|COMPLETED|Overall Study||1
8677558|NCT02112526|21423216|P1|COMPLETED|Overall Study||0
8677559|NCT02112526|21423215|P2|Subjects Continuing Study Medication|Overall Study||1
8677560|NCT02112526|21423216|P1|Subjects Continuing Study Medication|Overall Study||0
8677561|NCT02112526|21423215|P2|Discontinued Study|Overall Study||9
8677562|NCT02112526|21423216|P1|Discontinued Study|Overall Study||11
8677563|NCT02112526|21423215|P2|Received Study Medication|Overall Study||10
8677564|NCT02112526|21423216|P1|Received Study Medication|Overall Study||11
8677565|NCT02112526|21423215|P2|Enrolled|Overall Study||10
8677566|NCT02112526|21423216|P1|Enrolled|Overall Study||11
8677567|NCT02112526|21423215|P2|STARTED|Overall Study||10
8677568|NCT02112526|21423216|P1|STARTED|Overall Study||11
8677569|NCT02092987|21423224|P2|NOT COMPLETED|Overall Study||8
8677570|NCT02092987|21423225|P1|NOT COMPLETED|Overall Study||4
8677571|NCT02092987|21423224|P2|COMPLETED|Overall Study||103
8677572|NCT02092987|21423225|P1|COMPLETED|Overall Study||106
8677573|NCT02092987|21423224|P2|STARTED|Overall Study||111
8677574|NCT02092987|21423225|P1|STARTED|Overall Study||110
8677575|NCT02057718|21423247|P2|NOT COMPLETED|Optional Follow-up Treatment Period||8
8677576|NCT02057718|21423248|P1|NOT COMPLETED|Optional Follow-up Treatment Period||2
8677577|NCT02057718|21423247|P2|COMPLETED|Optional Follow-up Treatment Period||8
8677578|NCT02057718|21423248|P1|COMPLETED|Optional Follow-up Treatment Period||4
8677579|NCT02057718|21423247|P2|STARTED|Optional Follow-up Treatment Period||16
8677580|NCT02057718|21423248|P1|STARTED|Optional Follow-up Treatment Period||6
8677581|NCT02057718|21423247|P2|NOT COMPLETED|Completed Study Treatment Through Wk. 72||9
8677582|NCT02057718|21423248|P1|NOT COMPLETED|Completed Study Treatment Through Wk. 72||2
8677583|NCT02057718|21423247|P2|COMPLETED|Completed Study Treatment Through Wk. 72||16
8677584|NCT02057718|21423248|P1|COMPLETED|Completed Study Treatment Through Wk. 72||6
8677585|NCT02057718|21423247|P2|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||16
8677586|NCT02057718|21423248|P1|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||6
8677587|NCT02057718|21423247|P2|STARTED|Completed Study Treatment Through Wk. 72||25
8677588|NCT02057718|21423248|P1|STARTED|Completed Study Treatment Through Wk. 72||8
8677597|NCT02033083|21423306|P2|NOT COMPLETED|Overall Study||1
8677598|NCT02033083|21423307|P1|NOT COMPLETED|Overall Study||1
8677599|NCT02033083|21423306|P2|COMPLETED|Overall Study||89
8677600|NCT02033083|21423307|P1|COMPLETED|Overall Study||89
8677601|NCT02033083|21423306|P2|STARTED|Overall Study||90
8677602|NCT02033083|21423307|P1|STARTED|Overall Study||90
8677606|NCT01995071|21423329|P12|NOT COMPLETED|Overall Study||0
8677607|NCT01995071|21423330|P11|NOT COMPLETED|Overall Study||1
8677608|NCT01995071|21423331|P10|NOT COMPLETED|Overall Study||0
8677609|NCT01995071|21423332|P9|NOT COMPLETED|Overall Study||1
8677610|NCT01995071|21423333|P8|NOT COMPLETED|Overall Study||2
8677611|NCT01995071|21423334|P7|NOT COMPLETED|Overall Study||1
8677612|NCT01995071|21423335|P6|NOT COMPLETED|Overall Study||0
8677613|NCT01995071|21423336|P5|NOT COMPLETED|Overall Study||1
8677614|NCT01995071|21423337|P4|NOT COMPLETED|Overall Study||0
8677615|NCT01995071|21423338|P3|NOT COMPLETED|Overall Study||1
8677616|NCT01995071|21423339|P2|NOT COMPLETED|Overall Study||0
8677617|NCT01995071|21423340|P1|NOT COMPLETED|Overall Study||1
8677618|NCT01995071|21423329|P12|COMPLETED|Overall Study||0
8677619|NCT01995071|21423330|P11|COMPLETED|Overall Study||7
8677620|NCT01995071|21423331|P10|COMPLETED|Overall Study||8
8677621|NCT01995071|21423332|P9|COMPLETED|Overall Study||7
8677622|NCT01995071|21423333|P8|COMPLETED|Overall Study||6
8677623|NCT01995071|21423334|P7|COMPLETED|Overall Study||7
8677624|NCT01995071|21423335|P6|COMPLETED|Overall Study||8
8677625|NCT01995071|21423336|P5|COMPLETED|Overall Study||7
8677626|NCT01995071|21423337|P4|COMPLETED|Overall Study||8
8677627|NCT01995071|21423338|P3|COMPLETED|Overall Study||8
8677628|NCT01995071|21423339|P2|COMPLETED|Overall Study||8
8677629|NCT01995071|21423340|P1|COMPLETED|Overall Study||7
8677630|NCT01995071|21423329|P12|STARTED|Overall Study||0
8677631|NCT01995071|21423330|P11|STARTED|Overall Study||8
8677632|NCT01995071|21423331|P10|STARTED|Overall Study||8
8677633|NCT01995071|21423332|P9|STARTED|Overall Study||8
8677634|NCT01995071|21423333|P8|STARTED|Overall Study||8
8677635|NCT01995071|21423334|P7|STARTED|Overall Study||8
8677636|NCT01995071|21423335|P6|STARTED|Overall Study||8
8677637|NCT01995071|21423336|P5|STARTED|Overall Study||8
8677638|NCT01995071|21423337|P4|STARTED|Overall Study||8
8677639|NCT01995071|21423338|P3|STARTED|Overall Study||9
8677640|NCT01995071|21423339|P2|STARTED|Overall Study||8
8677641|NCT01995071|21423340|P1|STARTED|Overall Study||8
8677642|NCT01994109|21423402|P4|NOT COMPLETED|Open-label Phase (Part B)||42
8677643|NCT01994109|21423403|P3|NOT COMPLETED|Open-label Phase (Part B)||0
8677644|NCT01994109|21423404|P2|NOT COMPLETED|Open-label Phase (Part B)||0
8677645|NCT01994109|21423405|P1|NOT COMPLETED|Open-label Phase (Part B)||0
8677646|NCT01994109|21423402|P4|COMPLETED|Open-label Phase (Part B)||128
8677647|NCT01994109|21423403|P3|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0
8677648|NCT01994109|21423404|P2|COMPLETED|Open-label Phase (Part B)||0
8677649|NCT01994109|21423405|P1|COMPLETED|Open-label Phase (Part B)||0
8677650|NCT01994109|21423402|P4|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170
8677651|NCT01994109|21423403|P3|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0
8677652|NCT01994109|21423404|P2|STARTED|Open-label Phase (Part B)||0
8677653|NCT01994109|21423405|P1|STARTED|Open-label Phase (Part B)||0
8677654|NCT01994109|21423402|P4|NOT COMPLETED|Double-blind Phase (Part A)||0
8677655|NCT01994109|21423403|P3|NOT COMPLETED|Double-blind Phase (Part A)||7
8677656|NCT01994109|21423404|P2|NOT COMPLETED|Double-blind Phase (Part A)||3
8677657|NCT01994109|21423405|P1|NOT COMPLETED|Double-blind Phase (Part A)||1
8677658|NCT01994109|21423402|P4|COMPLETED|Double-blind Phase (Part A)||0
8677659|NCT01994109|21423403|P3|COMPLETED|Double-blind Phase (Part A)||53
8677660|NCT01994109|21423404|P2|COMPLETED|Double-blind Phase (Part A)||61
8677661|NCT01994109|21423405|P1|COMPLETED|Double-blind Phase (Part A)||62
8677662|NCT01994109|21423402|P4|STARTED|Double-blind Phase (Part A)||0
8677663|NCT01994109|21423403|P3|STARTED|Double-blind Phase (Part A)||60
8677664|NCT01994109|21423404|P2|STARTED|Double-blind Phase (Part A)||64
8677665|NCT01994109|21423405|P1|STARTED|Double-blind Phase (Part A)||63
8677693|NCT01939197|21423542|P7|NOT COMPLETED|Overall Study||2
8677694|NCT01939197|21423543|P6|NOT COMPLETED|Overall Study||1
8677695|NCT01939197|21423544|P5|NOT COMPLETED|Overall Study||4
8677696|NCT01939197|21423545|P4|NOT COMPLETED|Overall Study||1
8677697|NCT01939197|21423546|P3|NOT COMPLETED|Overall Study||0
8677698|NCT01939197|21423547|P2|NOT COMPLETED|Overall Study||1
8677699|NCT01939197|21423548|P1|NOT COMPLETED|Overall Study||1
8677700|NCT01939197|21423542|P7|COMPLETED|Overall Study||26
8677701|NCT01939197|21423543|P6|COMPLETED|Overall Study||4
8677702|NCT01939197|21423544|P5|COMPLETED|Overall Study||196
8677703|NCT01939197|21423545|P4|COMPLETED|Overall Study||11
8677704|NCT01939197|21423546|P3|COMPLETED|Overall Study||10
8677705|NCT01939197|21423547|P2|COMPLETED|Overall Study||31
8677706|NCT01939197|21423548|P1|COMPLETED|Overall Study||30
8677707|NCT01939197|21423542|P7|STARTED|Overall Study||28
8677708|NCT01939197|21423543|P6|STARTED|Overall Study||5
8677709|NCT01939197|21423544|P5|STARTED|Overall Study||200
8677710|NCT01939197|21423545|P4|STARTED|Overall Study||12
8677711|NCT01939197|21423546|P3|STARTED|Overall Study||10
8677712|NCT01939197|21423547|P2|STARTED|Overall Study||32
8677713|NCT01939197|21423548|P1|STARTED|Overall Study||31
8677732|NCT01905657|21423769|P3|NOT COMPLETED|Overall Study||328
8677733|NCT01905657|21423770|P2|NOT COMPLETED|Overall Study||346
8677734|NCT01905657|21423771|P1|NOT COMPLETED|Overall Study||345
8677735|NCT01905657|21423769|P3|COMPLETED|Overall Study||15
8677736|NCT01905657|21423770|P2|COMPLETED|Overall Study||0
8677737|NCT01905657|21423771|P1|COMPLETED|Overall Study||0
8677738|NCT01905657|21423769|P3|Treated|Overall Study||309
8677739|NCT01905657|21423770|P2|Treated|Overall Study||343
8677740|NCT01905657|21423771|P1|Treated|Overall Study||339
8677741|NCT01905657|21423769|P3|STARTED|Overall Study||343
8677742|NCT01905657|21423770|P2|STARTED|Overall Study||346
8677743|NCT01905657|21423771|P1|STARTED|Overall Study||345
8677744|NCT01899261|21423794|P1|NOT COMPLETED|Overall Study||0
8677745|NCT01899261|21423794|P1|COMPLETED|Overall Study||20
8677746|NCT01899261|21423794|P1|STARTED|Overall Study||20
8677747|NCT01891344|21423802|P8|NOT COMPLETED|Overall Study||0
8677748|NCT01891344|21423803|P7|NOT COMPLETED|Overall Study||0
8677749|NCT01891344|21423804|P6|NOT COMPLETED|Overall Study||1
8677750|NCT01891344|21423805|P5|NOT COMPLETED|Overall Study||4
8677751|NCT01891344|21423806|P4|NOT COMPLETED|Overall Study||1
8677752|NCT01891344|21423807|P3|NOT COMPLETED|Overall Study||0
8677753|NCT01891344|21423808|P2|NOT COMPLETED|Overall Study||2
8677754|NCT01891344|21423809|P1|NOT COMPLETED|Overall Study||6
8677755|NCT01891344|21423802|P8|COMPLETED|Overall Study||23
8677756|NCT01891344|21423803|P7|COMPLETED|Overall Study||107
8677757|NCT01891344|21423804|P6|COMPLETED|Overall Study||72
8677758|NCT01891344|21423805|P5|COMPLETED|Overall Study||80
8677759|NCT01891344|21423806|P4|COMPLETED|Overall Study||11
8677760|NCT01891344|21423807|P3|COMPLETED|Overall Study||70
8677761|NCT01891344|21423808|P2|COMPLETED|Overall Study||80
8677762|NCT01891344|21423809|P1|COMPLETED|Overall Study||34
8677763|NCT01891344|21423802|P8|STARTED|Overall Study||23
8677764|NCT01891344|21423803|P7|STARTED|Overall Study||107
8677765|NCT01891344|21423804|P6|STARTED|Overall Study||73
8677766|NCT01891344|21423805|P5|STARTED|Overall Study||84
8677767|NCT01891344|21423806|P4|STARTED|Overall Study||12
8677768|NCT01891344|21423807|P3|STARTED|Overall Study||70
8677769|NCT01891344|21423808|P2|STARTED|Overall Study||82
8677770|NCT01891344|21423809|P1|STARTED|Overall Study||40
8677781|NCT01849874|21423868|P2|NOT COMPLETED|Overall Study||102
8677782|NCT01849874|21423869|P1|NOT COMPLETED|Overall Study||201
8677783|NCT01849874|21423868|P2|COMPLETED|Overall Study||0
8677784|NCT01849874|21423869|P1|COMPLETED|Overall Study||0
8677785|NCT01849874|21423868|P2|Treated|Overall Study||94
8677786|NCT01849874|21423869|P1|Treated|Overall Study||200
8677787|NCT01849874|21423868|P2|STARTED|Overall Study||102
8677788|NCT01849874|21423869|P1|STARTED|Overall Study||201
8677789|NCT01833533|21423889|P2|NOT COMPLETED|Overall Study||21
8677790|NCT01833533|21423890|P1|NOT COMPLETED|Overall Study||6
8677791|NCT01833533|21423889|P2|COMPLETED|Overall Study||184
8677792|NCT01833533|21423890|P1|COMPLETED|Overall Study||94
8677793|NCT01833533|21423889|P2|STARTED|Overall Study||205
8677794|NCT01833533|21423890|P1|STARTED|Overall Study||100
8677795|NCT01802411|21423906|P2|NOT COMPLETED|Overall Study||21
8677796|NCT01802411|21423907|P1|NOT COMPLETED|Overall Study||14
8677797|NCT01802411|21423906|P2|COMPLETED|Overall Study||74
8677798|NCT01802411|21423907|P1|COMPLETED|Overall Study||82
8677799|NCT01802411|21423906|P2|STARTED|Overall Study||95
8677800|NCT01802411|21423907|P1|STARTED|Overall Study||96
8677801|NCT01784861|21423923|P6|NOT COMPLETED|Overall Study||1
8677802|NCT01784861|21423924|P5|NOT COMPLETED|Overall Study||1
8677803|NCT01784861|21423925|P4|NOT COMPLETED|Overall Study||5
8677804|NCT01784861|21423926|P3|NOT COMPLETED|Overall Study||1
8677805|NCT01784861|21423927|P2|NOT COMPLETED|Overall Study||0
8677806|NCT01784861|21423928|P1|NOT COMPLETED|Overall Study||0
8677807|NCT01784861|21423923|P6|COMPLETED|Overall Study||1
8677808|NCT01784861|21423924|P5|COMPLETED|Overall Study||2
8677809|NCT01784861|21423925|P4|COMPLETED|Overall Study||3
8677810|NCT01784861|21423926|P3|COMPLETED|Overall Study||3
8677811|NCT01784861|21423927|P2|COMPLETED|Overall Study||3
8677812|NCT01784861|21423928|P1|COMPLETED|Overall Study||3
8677813|NCT01784861|21423923|P6|STARTED|Overall Study||2
8677814|NCT01784861|21423924|P5|STARTED|Overall Study||3
8677815|NCT01784861|21423925|P4|STARTED|Overall Study||8
8677816|NCT01784861|21423926|P3|STARTED|Overall Study||4
8677817|NCT01784861|21423927|P2|STARTED|Overall Study||3
8677818|NCT01784861|21423928|P1|STARTED|Overall Study||3
8677819|NCT01776723|21423985|P5|NOT COMPLETED|Overall Study||0
8677820|NCT01776723|21423986|P4|NOT COMPLETED|Overall Study||0
8677821|NCT01776723|21423987|P3|NOT COMPLETED|Overall Study||0
8677822|NCT01776723|21423988|P2|NOT COMPLETED|Overall Study||0
8677823|NCT01776723|21423989|P1|NOT COMPLETED|Overall Study||0
8677824|NCT01776723|21423985|P5|COMPLETED|Overall Study||30
8677825|NCT01776723|21423986|P4|COMPLETED|Overall Study||5
8677826|NCT01776723|21423987|P3|COMPLETED|Overall Study||5
8677827|NCT01776723|21423988|P2|COMPLETED|Overall Study||4
8677828|NCT01776723|21423989|P1|COMPLETED|Overall Study||6
8677829|NCT01776723|21423985|P5|STARTED|Overall Study||30
8677830|NCT01776723|21423986|P4|STARTED|Overall Study||5
8677831|NCT01776723|21423987|P3|STARTED|Overall Study||5
8677832|NCT01776723|21423988|P2|STARTED|Overall Study||4
8677833|NCT01776723|21423989|P1|STARTED|Overall Study||6
8677834|NCT01767636|21424005|P1|NOT COMPLETED|Overall Study||3
8677835|NCT01767636|21424005|P1|COMPLETED|Overall Study||35
8677836|NCT01767636|21424005|P1|STARTED|Overall Study||38
8677837|NCT01767116|21424015|P2|NOT COMPLETED|Overall Study||2
8677838|NCT01767116|21424016|P1|NOT COMPLETED|Overall Study||2
8677839|NCT01767116|21424015|P2|COMPLETED|Overall Study||207
8677840|NCT01767116|21424016|P1|COMPLETED|Overall Study||208
8677841|NCT01767116|21424015|P2|STARTED|Overall Study||209
8677842|NCT01767116|21424016|P1|STARTED|Overall Study||210
8677843|NCT01760954|21424036|P4|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
8677844|NCT01760954|21424037|P3|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
8677845|NCT01760954|21424038|P2|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
8677846|NCT01760954|21424039|P1|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
8677847|NCT01760954|21424036|P4|COMPLETED|Post-treatment Follow-up (12 Months)||67
8677848|NCT01760954|21424037|P3|COMPLETED|Post-treatment Follow-up (12 Months)||65
8677849|NCT01760954|21424038|P2|COMPLETED|Post-treatment Follow-up (12 Months)||83
8677850|NCT01760954|21424039|P1|COMPLETED|Post-treatment Follow-up (12 Months)||96
8677851|NCT01760954|21424036|P4|STARTED|Post-treatment Follow-up (12 Months)||87
8677852|NCT01760954|21424037|P3|STARTED|Post-treatment Follow-up (12 Months)||86
8677853|NCT01760954|21424038|P2|STARTED|Post-treatment Follow-up (12 Months)||118
8677854|NCT01760954|21424039|P1|STARTED|Post-treatment Follow-up (12 Months)||126
8677855|NCT01760954|21424036|P4|NOT COMPLETED|Treatment Period (6 Months)||26
8677856|NCT01760954|21424037|P3|NOT COMPLETED|Treatment Period (6 Months)||21
8677857|NCT01760954|21424038|P2|NOT COMPLETED|Treatment Period (6 Months)||28
8677858|NCT01760954|21424039|P1|NOT COMPLETED|Treatment Period (6 Months)||33
8677859|NCT01760954|21424036|P4|COMPLETED|Treatment Period (6 Months)||83
8677860|NCT01760954|21424037|P3|COMPLETED|Treatment Period (6 Months)||87
8677861|NCT01760954|21424038|P2|COMPLETED|Treatment Period (6 Months)||110
8677862|NCT01760954|21424039|P1|COMPLETED|Treatment Period (6 Months)||116
8677863|NCT01760954|21424036|P4|STARTED|Treatment Period (6 Months)||109
8677864|NCT01760954|21424037|P3|STARTED|Treatment Period (6 Months)||108
8677865|NCT01760954|21424038|P2|STARTED|Treatment Period (6 Months)||138
8677866|NCT01760954|21424039|P1|STARTED|Treatment Period (6 Months)||149
8677867|NCT01748916|21424117|P6|NOT COMPLETED|Overall Study||0
8677868|NCT01748916|21424118|P5|NOT COMPLETED|Overall Study||0
8677869|NCT01748916|21424119|P4|NOT COMPLETED|Overall Study||0
8677870|NCT01748916|21424120|P3|NOT COMPLETED|Overall Study||0
8677871|NCT01748916|21424121|P2|NOT COMPLETED|Overall Study||0
8677872|NCT01748916|21424122|P1|NOT COMPLETED|Overall Study||0
8677873|NCT01748916|21424117|P6|COMPLETED|Overall Study||3
8677874|NCT01748916|21424118|P5|COMPLETED|Overall Study||3
8677875|NCT01748916|21424119|P4|COMPLETED|Overall Study||3
8677876|NCT01748916|21424120|P3|COMPLETED|Overall Study||2
8677877|NCT01748916|21424121|P2|COMPLETED|Overall Study||3
8677878|NCT01748916|21424122|P1|COMPLETED|Overall Study||2
8677879|NCT01748916|21424117|P6|STARTED|Overall Study||3
8677880|NCT01748916|21424118|P5|STARTED|Overall Study||3
8677881|NCT01748916|21424119|P4|STARTED|Overall Study||3
8677882|NCT01748916|21424120|P3|STARTED|Overall Study||2
8677883|NCT01748916|21424121|P2|STARTED|Overall Study||3
8677884|NCT01748916|21424122|P1|STARTED|Overall Study||2
8677885|NCT01728779|21424130|P1|NOT COMPLETED|Overall Study||1
8677886|NCT01728779|21424130|P1|COMPLETED|Overall Study||37
8677887|NCT01728779|21424130|P1|STARTED|Overall Study||38
8677888|NCT01716585|21424141|P2|NOT COMPLETED|Open-label Treatment||7
8677889|NCT01716585|21424142|P1|NOT COMPLETED|Open-label Treatment||0
8677890|NCT01716585|21424141|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
8677891|NCT01716585|21424142|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
8677892|NCT01716585|21424141|P2|STARTED|Open-label Treatment||157
8677893|NCT01716585|21424142|P1|STARTED|Open-label Treatment|not applicable to this arm|0
8677894|NCT01716585|21424141|P2|NOT COMPLETED|Double-blind Treatment||2
8677895|NCT01716585|21424142|P1|NOT COMPLETED|Double-blind Treatment||13
8677896|NCT01716585|21424141|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
8677897|NCT01716585|21424142|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
8677898|NCT01716585|21424141|P2|Randomized But Not Treated|Double-blind Treatment||1
8677899|NCT01716585|21424142|P1|Randomized But Not Treated|Double-blind Treatment||4
8677900|NCT01716585|21424141|P2|STARTED|Double-blind Treatment||159
8677901|NCT01716585|21424142|P1|STARTED|Double-blind Treatment||477
8677902|NCT01704755|21424156|P2|NOT COMPLETED|Overall Study||7
8677903|NCT01704755|21424157|P1|NOT COMPLETED|Overall Study||12
8677904|NCT01704755|21424156|P2|COMPLETED|Overall Study||165
8677905|NCT01704755|21424157|P1|COMPLETED|Overall Study||196
8677906|NCT01704755|21424156|P2|Completed Study Drug|Overall Study||163
8677907|NCT01704755|21424157|P1|Completed Study Drug|Overall Study||204
8677908|NCT01704755|21424156|P2|STARTED|Overall Study||172
8677909|NCT01704755|21424157|P1|STARTED|Overall Study||208
8677910|NCT01696773|21424171|P2|NOT COMPLETED|Day 28, Second Intervention||0
8677911|NCT01696773|21424172|P1|NOT COMPLETED|Day 28, Second Intervention||0
8677912|NCT01696773|21424171|P2|COMPLETED|Day 28, Second Intervention||6
8677913|NCT01696773|21424172|P1|COMPLETED|Day 28, Second Intervention||5
8677914|NCT01696773|21424171|P2|STARTED|Day 28, Second Intervention||6
8677915|NCT01696773|21424172|P1|STARTED|Day 28, Second Intervention||5
8677916|NCT01696773|21424171|P2|NOT COMPLETED|Days 15-27, Washout||0
8677917|NCT01696773|21424172|P1|NOT COMPLETED|Days 15-27, Washout||1
8677918|NCT01696773|21424171|P2|COMPLETED|Days 15-27, Washout||6
8677919|NCT01696773|21424172|P1|COMPLETED|Days 15-27, Washout||5
8677920|NCT01696773|21424171|P2|STARTED|Days 15-27, Washout||6
8677921|NCT01696773|21424172|P1|STARTED|Days 15-27, Washout||6
8677922|NCT01696773|21424171|P2|NOT COMPLETED|Day 14, First Intervention||0
8677923|NCT01696773|21424172|P1|NOT COMPLETED|Day 14, First Intervention||0
8677924|NCT01696773|21424171|P2|COMPLETED|Day 14, First Intervention||6
8677925|NCT01696773|21424172|P1|COMPLETED|Day 14, First Intervention||6
8677926|NCT01696773|21424171|P2|STARTED|Day 14, First Intervention||6
8677927|NCT01696773|21424172|P1|STARTED|Day 14, First Intervention||6
8677928|NCT01696773|21424171|P2|NOT COMPLETED|Days 1-13, Washout||0
8677929|NCT01696773|21424172|P1|NOT COMPLETED|Days 1-13, Washout||0
8677930|NCT01696773|21424171|P2|COMPLETED|Days 1-13, Washout||6
8677931|NCT01696773|21424172|P1|COMPLETED|Days 1-13, Washout||6
8677932|NCT01696773|21424171|P2|STARTED|Days 1-13, Washout||6
8677933|NCT01696773|21424172|P1|STARTED|Days 1-13, Washout||6
8677934|NCT01687595|21424180|P2|NOT COMPLETED|Overall Study||10
8677935|NCT01687595|21424181|P1|NOT COMPLETED|Overall Study||70
8677936|NCT01687595|21424180|P2|COMPLETED|Overall Study||0
8677937|NCT01687595|21424181|P1|COMPLETED|Overall Study||0
8677938|NCT01687595|21424180|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
8677939|NCT01687595|21424181|P1|Received at Least 1 Dose of Study Drug|Overall Study||70
8677940|NCT01687595|21424180|P2|STARTED|Overall Study||10
8677941|NCT01687595|21424181|P1|STARTED|Overall Study||70
8677942|NCT01674725|21424193|P2|NOT COMPLETED|Overall Study||1
8677943|NCT01674725|21424194|P1|NOT COMPLETED|Overall Study||3
8677944|NCT01674725|21424193|P2|COMPLETED|Overall Study||94
8677945|NCT01674725|21424194|P1|COMPLETED|Overall Study||89
8677946|NCT01674725|21424193|P2|STARTED|Overall Study||95
8677947|NCT01674725|21424194|P1|STARTED|Overall Study||92
8677948|NCT01623167|21424211|P3|NOT COMPLETED|Overall Study||13
8677949|NCT01623167|21424212|P2|NOT COMPLETED|Overall Study||14
8677950|NCT01623167|21424213|P1|NOT COMPLETED|Overall Study||17
8677951|NCT01623167|21424211|P3|COMPLETED|Overall Study||18
8677952|NCT01623167|21424212|P2|COMPLETED|Overall Study||17
8677953|NCT01623167|21424213|P1|COMPLETED|Overall Study||13
8677954|NCT01623167|21424211|P3|STARTED|Overall Study||31
8677955|NCT01623167|21424212|P2|STARTED|Overall Study||31
8677956|NCT01623167|21424213|P1|STARTED|Overall Study||30
8677966|NCT01518699|21424249|P6|NOT COMPLETED|Period 3||0
8677967|NCT01518699|21424250|P5|NOT COMPLETED|Period 3||0
8677968|NCT01518699|21424251|P4|NOT COMPLETED|Period 3||0
8677969|NCT01518699|21424252|P3|NOT COMPLETED|Period 3||0
8677970|NCT01518699|21424253|P2|NOT COMPLETED|Period 3||0
8677971|NCT01518699|21424254|P1|NOT COMPLETED|Period 3||0
8677972|NCT01518699|21424249|P6|COMPLETED|Period 3||9
8677973|NCT01518699|21424250|P5|COMPLETED|Period 3||10
8677974|NCT01518699|21424251|P4|COMPLETED|Period 3||10
8677975|NCT01518699|21424252|P3|COMPLETED|Period 3||9
8677976|NCT01518699|21424253|P2|COMPLETED|Period 3||7
8677977|NCT01518699|21424254|P1|COMPLETED|Period 3||8
8677978|NCT01518699|21424249|P6|STARTED|Period 3||9
8677979|NCT01518699|21424250|P5|STARTED|Period 3||10
8677980|NCT01518699|21424251|P4|STARTED|Period 3||10
8677981|NCT01518699|21424252|P3|STARTED|Period 3||9
8677982|NCT01518699|21424253|P2|STARTED|Period 3||7
8677983|NCT01518699|21424254|P1|STARTED|Period 3||8
8677984|NCT01518699|21424249|P6|NOT COMPLETED|Period 2||0
8677985|NCT01518699|21424250|P5|NOT COMPLETED|Period 2||0
8677986|NCT01518699|21424251|P4|NOT COMPLETED|Period 2||0
8677987|NCT01518699|21424252|P3|NOT COMPLETED|Period 2||0
8677988|NCT01518699|21424253|P2|NOT COMPLETED|Period 2||2
8677989|NCT01518699|21424254|P1|NOT COMPLETED|Period 2||2
8677990|NCT01518699|21424249|P6|COMPLETED|Period 2||9
8677991|NCT01518699|21424250|P5|COMPLETED|Period 2||10
8677992|NCT01518699|21424251|P4|COMPLETED|Period 2||10
8677993|NCT01518699|21424252|P3|COMPLETED|Period 2||9
8677994|NCT01518699|21424253|P2|COMPLETED|Period 2||7
8677995|NCT01518699|21424254|P1|COMPLETED|Period 2||8
8677996|NCT01518699|21424249|P6|STARTED|Period 2||9
8677997|NCT01518699|21424250|P5|STARTED|Period 2||10
8677998|NCT01518699|21424251|P4|STARTED|Period 2||10
8677999|NCT01518699|21424252|P3|STARTED|Period 2||9
8678000|NCT01518699|21424253|P2|STARTED|Period 2||9
8678001|NCT01518699|21424254|P1|STARTED|Period 2||10
8678002|NCT01518699|21424249|P6|NOT COMPLETED|Period 1||0
8678003|NCT01518699|21424250|P5|NOT COMPLETED|Period 1||0
8678004|NCT01518699|21424251|P4|NOT COMPLETED|Period 1||0
8678005|NCT01518699|21424252|P3|NOT COMPLETED|Period 1||0
8678006|NCT01518699|21424253|P2|NOT COMPLETED|Period 1||0
8678007|NCT01518699|21424254|P1|NOT COMPLETED|Period 1||0
8678008|NCT01518699|21424249|P6|COMPLETED|Period 1||9
8678009|NCT01518699|21424250|P5|COMPLETED|Period 1||10
8678010|NCT01518699|21424251|P4|COMPLETED|Period 1||10
8678011|NCT01518699|21424252|P3|COMPLETED|Period 1||9
8678012|NCT01518699|21424253|P2|COMPLETED|Period 1||9
8678013|NCT01518699|21424254|P1|COMPLETED|Period 1||10
8678014|NCT01518699|21424249|P6|STARTED|Period 1||9
8678015|NCT01518699|21424250|P5|STARTED|Period 1||10
8678016|NCT01518699|21424251|P4|STARTED|Period 1||10
8678017|NCT01518699|21424252|P3|STARTED|Period 1||9
8678018|NCT01518699|21424253|P2|STARTED|Period 1||9
8678019|NCT01518699|21424254|P1|STARTED|Period 1||10
8678020|NCT01504841|21424265|P3|NOT COMPLETED|Overall Study||0
8678021|NCT01504841|21424266|P2|NOT COMPLETED|Overall Study||4
8678022|NCT01504841|21424267|P1|NOT COMPLETED|Overall Study||16
8678023|NCT01504841|21424265|P3|COMPLETED|Overall Study||0
8678024|NCT01504841|21424266|P2|COMPLETED|Overall Study||2
8678025|NCT01504841|21424267|P1|COMPLETED|Overall Study||4
8678026|NCT01504841|21424265|P3|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0
8678027|NCT01504841|21424266|P2|STARTED|Overall Study||6
8678028|NCT01504841|21424267|P1|STARTED|Overall Study||20
8678029|NCT01470989|21424302|P2|NOT COMPLETED|Overall Study||186
8678030|NCT01470989|21424303|P1|NOT COMPLETED|Overall Study||148
8678031|NCT01470989|21424302|P2|COMPLETED|Overall Study||43
8678032|NCT01470989|21424303|P1|COMPLETED|Overall Study||79
8678033|NCT01470989|21424302|P2|Entered Extension 3|Overall Study||49
8678034|NCT01470989|21424303|P1|Entered Extension 3|Overall Study||87
8678035|NCT01470989|21424302|P2|Completed Extension 2 Study|Overall Study||117
8678036|NCT01470989|21424303|P1|Completed Extension 2 Study|Overall Study||132
8678037|NCT01470989|21424302|P2|Entered Extension 2 Study|Overall Study||131
8678038|NCT01470989|21424303|P1|Entered Extension 2 Study|Overall Study||141
8678039|NCT01470989|21424302|P2|Completed Extension 1 Study|Overall Study||152
8678040|NCT01470989|21424303|P1|Completed Extension 1 Study|Overall Study||165
8678041|NCT01470989|21424302|P2|Entered Extension 1 Study|Overall Study||161
8678042|NCT01470989|21424303|P1|Entered Extension 1 Study|Overall Study||174
8678043|NCT01470989|21424302|P2|Completed Core Study|Overall Study||208
8678044|NCT01470989|21424303|P1|Completed Core Study|Overall Study||208
8678045|NCT01470989|21424302|P2|STARTED|Overall Study||229
8678046|NCT01470989|21424303|P1|STARTED|Overall Study||227
8678047|NCT01469637|21424315|P2|NOT COMPLETED|Second Intervention||0
8678048|NCT01469637|21424316|P1|NOT COMPLETED|Second Intervention||1
8678049|NCT01469637|21424315|P2|COMPLETED|Second Intervention||21
8678050|NCT01469637|21424316|P1|COMPLETED|Second Intervention||21
8678051|NCT01469637|21424315|P2|STARTED|Second Intervention||21
8678052|NCT01469637|21424316|P1|STARTED|Second Intervention||22
8678053|NCT01469637|21424315|P2|NOT COMPLETED|First Intervention||1
8678054|NCT01469637|21424316|P1|NOT COMPLETED|First Intervention||0
8678055|NCT01469637|21424315|P2|COMPLETED|First Intervention||21
8678056|NCT01469637|21424316|P1|COMPLETED|First Intervention||22
8678057|NCT01469637|21424315|P2|STARTED|First Intervention||22
8678058|NCT01469637|21424316|P1|STARTED|First Intervention||22
8678059|NCT01468233|21424326|P6|NOT COMPLETED|Treatment Period 2||23
8678060|NCT01468233|21424327|P5|NOT COMPLETED|Treatment Period 2||28
8678061|NCT01468233|21424328|P4|NOT COMPLETED|Treatment Period 2||28
8678062|NCT01468233|21424329|P3|NOT COMPLETED|Treatment Period 2||111
8678063|NCT01468233|21424330|P2|NOT COMPLETED|Treatment Period 2||0
8678064|NCT01468233|21424331|P1|NOT COMPLETED|Treatment Period 2||0
8678065|NCT01468233|21424326|P6|COMPLETED|Treatment Period 2||28
8678066|NCT01468233|21424327|P5|COMPLETED|Treatment Period 2||25
8678067|NCT01468233|21424328|P4|COMPLETED|Treatment Period 2||23
8678068|NCT01468233|21424329|P3|COMPLETED|Treatment Period 2||40
8678069|NCT01468233|21424330|P2|COMPLETED|Treatment Period 2||0
8678070|NCT01468233|21424331|P1|COMPLETED|Treatment Period 2||0
8678071|NCT01468233|21424326|P6|STARTED|Treatment Period 2||51
8678072|NCT01468233|21424327|P5|STARTED|Treatment Period 2||53
8678073|NCT01468233|21424328|P4|STARTED|Treatment Period 2||51
8678074|NCT01468233|21424329|P3|STARTED|Treatment Period 2||151
8678075|NCT01468233|21424330|P2|STARTED|Treatment Period 2||0
8678076|NCT01468233|21424331|P1|STARTED|Treatment Period 2||0
8678077|NCT01468233|21424326|P6|NOT COMPLETED|Treatment Period 1||0
8678078|NCT01468233|21424327|P5|NOT COMPLETED|Treatment Period 1||0
8678079|NCT01468233|21424328|P4|NOT COMPLETED|Treatment Period 1||0
8678080|NCT01468233|21424329|P3|NOT COMPLETED|Treatment Period 1||0
8678081|NCT01468233|21424330|P2|NOT COMPLETED|Treatment Period 1||8
8678082|NCT01468233|21424331|P1|NOT COMPLETED|Treatment Period 1||12
8678083|NCT01468233|21424326|P6|COMPLETED|Treatment Period 1||0
8678084|NCT01468233|21424327|P5|COMPLETED|Treatment Period 1||0
8678085|NCT01468233|21424328|P4|COMPLETED|Treatment Period 1||0
8678086|NCT01468233|21424329|P3|COMPLETED|Treatment Period 1||0
8678087|NCT01468233|21424330|P2|COMPLETED|Treatment Period 1||155
8678088|NCT01468233|21424331|P1|COMPLETED|Treatment Period 1||151
8678089|NCT01468233|21424326|P6|STARTED|Treatment Period 1||0
8678090|NCT01468233|21424327|P5|STARTED|Treatment Period 1||0
8678091|NCT01468233|21424328|P4|STARTED|Treatment Period 1||0
8678092|NCT01468233|21424329|P3|STARTED|Treatment Period 1||0
8678093|NCT01468233|21424330|P2|STARTED|Treatment Period 1||163
8678094|NCT01468233|21424331|P1|STARTED|Treatment Period 1||163
8678095|NCT01457118|21424355|P4|NOT COMPLETED|Overall Study||2
8678096|NCT01457118|21424356|P3|NOT COMPLETED|Overall Study||1
8678097|NCT01457118|21424357|P2|NOT COMPLETED|Overall Study||4
8678098|NCT01457118|21424358|P1|NOT COMPLETED|Overall Study||20
8678099|NCT01457118|21424355|P4|COMPLETED|Overall Study||0
8678100|NCT01457118|21424356|P3|COMPLETED|Overall Study||0
8678101|NCT01457118|21424357|P2|COMPLETED|Overall Study||0
8678102|NCT01457118|21424358|P1|COMPLETED|Overall Study||0
8678103|NCT01457118|21424355|P4|STARTED|Overall Study||2
8678104|NCT01457118|21424356|P3|STARTED|Overall Study||1
8678105|NCT01457118|21424357|P2|STARTED|Overall Study||4
8678106|NCT01457118|21424358|P1|STARTED|Overall Study||20
8678107|NCT01441635|21424390|P10|NOT COMPLETED|Overall Study||2
8678108|NCT01441635|21424391|P9|NOT COMPLETED|Overall Study||2
8678109|NCT01441635|21424392|P8|NOT COMPLETED|Overall Study||4
8678110|NCT01441635|21424393|P7|NOT COMPLETED|Overall Study||6
8678111|NCT01441635|21424394|P6|NOT COMPLETED|Overall Study||5
8678112|NCT01441635|21424395|P5|NOT COMPLETED|Overall Study||2
8678113|NCT01441635|21424396|P4|NOT COMPLETED|Overall Study||7
8678114|NCT01441635|21424397|P3|NOT COMPLETED|Overall Study||3
8678115|NCT01441635|21424398|P2|NOT COMPLETED|Overall Study||6
8678116|NCT01441635|21424399|P1|NOT COMPLETED|Overall Study||6
8678117|NCT01441635|21424390|P10|COMPLETED|Overall Study||25
8678118|NCT01441635|21424391|P9|COMPLETED|Overall Study||14
8678119|NCT01441635|21424392|P8|COMPLETED|Overall Study||26
8678120|NCT01441635|21424393|P7|COMPLETED|Overall Study||24
8678121|NCT01441635|21424394|P6|COMPLETED|Overall Study||29
8678122|NCT01441635|21424395|P5|COMPLETED|Overall Study||16
8678123|NCT01441635|21424396|P4|COMPLETED|Overall Study||28
8678124|NCT01441635|21424397|P3|COMPLETED|Overall Study||13
8678125|NCT01441635|21424398|P2|COMPLETED|Overall Study||27
8678126|NCT01441635|21424399|P1|COMPLETED|Overall Study||26
8678127|NCT01441635|21424390|P10|STARTED|Overall Study||27
8678128|NCT01441635|21424391|P9|STARTED|Overall Study||16
8678129|NCT01441635|21424392|P8|STARTED|Overall Study||30
8678130|NCT01441635|21424393|P7|STARTED|Overall Study||30
8678131|NCT01441635|21424394|P6|STARTED|Overall Study||34
8678132|NCT01441635|21424395|P5|STARTED|Overall Study||18
8678133|NCT01441635|21424396|P4|STARTED|Overall Study||35
8678134|NCT01441635|21424397|P3|STARTED|Overall Study||16
8678135|NCT01441635|21424398|P2|STARTED|Overall Study||33
8678136|NCT01441635|21424399|P1|STARTED|Overall Study||32
8678137|NCT01431209|21424613|P2|NOT COMPLETED|Overall Study||1
8678138|NCT01431209|21424614|P1|NOT COMPLETED|Overall Study||4
8678139|NCT01431209|21424613|P2|COMPLETED|Overall Study||12
8678140|NCT01431209|21424614|P1|COMPLETED|Overall Study||43
8678141|NCT01431209|21424613|P2|STARTED|Overall Study||13
8678142|NCT01431209|21424614|P1|STARTED|Overall Study||47
8678143|NCT01424293|21424624|P1|NOT COMPLETED|Overall Study||0
8678144|NCT01424293|21424624|P1|COMPLETED|Overall Study||7
8678145|NCT01424293|21424624|P1|STARTED|Overall Study||7
8678146|NCT01411319|21424628|P1|NOT COMPLETED|Overall Study||1
8678147|NCT01411319|21424628|P1|COMPLETED|Overall Study||24
8678148|NCT01411319|21424628|P1|STARTED|Overall Study||25
8678341|NCT01373489|21424678|P2|NOT COMPLETED|Overall Study||13
8678342|NCT01373489|21424679|P1|NOT COMPLETED|Overall Study||15
8678343|NCT01373489|21424678|P2|COMPLETED|Overall Study||41
8678344|NCT01373489|21424679|P1|COMPLETED|Overall Study||44
8678345|NCT01373489|21424678|P2|STARTED|Overall Study||54
8678346|NCT01373489|21424679|P1|STARTED|Overall Study||59
8678347|NCT01370174|21424689|P4|NOT COMPLETED|Overall Study||9
8678348|NCT01370174|21424690|P3|NOT COMPLETED|Overall Study||12
8678349|NCT01370174|21424691|P2|NOT COMPLETED|Overall Study||11
8678350|NCT01370174|21424692|P1|NOT COMPLETED|Overall Study||7
8678351|NCT01370174|21424689|P4|COMPLETED|Overall Study||17
8678352|NCT01370174|21424690|P3|COMPLETED|Overall Study||13
8678353|NCT01370174|21424691|P2|COMPLETED|Overall Study||15
8678354|NCT01370174|21424692|P1|COMPLETED|Overall Study||18
8678355|NCT01370174|21424689|P4|STARTED|Overall Study||26
8678356|NCT01370174|21424690|P3|STARTED|Overall Study||25
8678357|NCT01370174|21424691|P2|STARTED|Overall Study||26
8678358|NCT01370174|21424692|P1|STARTED|Overall Study||25
8678359|NCT01329341|21424710|P1|NOT COMPLETED|Overall Study||44
8678360|NCT01329341|21424710|P1|COMPLETED|Overall Study||16
8678361|NCT01329341|21424710|P1|STARTED|Overall Study||60
8678362|NCT01301183|21424716|P2|NOT COMPLETED|Overall Study||16
8678363|NCT01301183|21424717|P1|NOT COMPLETED|Overall Study||26
8678364|NCT01301183|21424716|P2|COMPLETED|Overall Study||21
8678365|NCT01301183|21424717|P1|COMPLETED|Overall Study||12
8678366|NCT01301183|21424716|P2|STARTED|Overall Study||37
8678367|NCT01301183|21424717|P1|STARTED|Overall Study||38
8678374|NCT01166282|21424740|P3|NOT COMPLETED|Open-label Period||17
8678375|NCT01166282|21424741|P2|NOT COMPLETED|Open-label Period||0
8678376|NCT01166282|21424742|P1|NOT COMPLETED|Open-label Period||0
8678377|NCT01166282|21424740|P3|COMPLETED|Open-label Period||29
8678378|NCT01166282|21424741|P2|COMPLETED|Open-label Period||0
8678379|NCT01166282|21424742|P1|COMPLETED|Open-label Period||0
8678380|NCT01166282|21424740|P3|STARTED|Open-label Period||46
8678381|NCT01166282|21424741|P2|STARTED|Open-label Period||0
8678382|NCT01166282|21424742|P1|STARTED|Open-label Period||0
8678383|NCT01166282|21424740|P3|NOT COMPLETED|Double-blind Period||0
8678384|NCT01166282|21424741|P2|NOT COMPLETED|Double-blind Period||0
8678385|NCT01166282|21424742|P1|NOT COMPLETED|Double-blind Period||0
8678386|NCT01166282|21424740|P3|COMPLETED|Double-blind Period||0
8678387|NCT01166282|21424741|P2|COMPLETED|Double-blind Period||31
8678388|NCT01166282|21424742|P1|COMPLETED|Double-blind Period||15
8678389|NCT01166282|21424740|P3|STARTED|Double-blind Period||0
8678390|NCT01166282|21424741|P2|STARTED|Double-blind Period||31
8678391|NCT01166282|21424742|P1|STARTED|Double-blind Period||15
8678392|NCT01148225|21424764|P1|NOT COMPLETED|Overall Study||185
8678393|NCT01148225|21424764|P1|COMPLETED|Overall Study||239
8678394|NCT01148225|21424764|P1|STARTED|Overall Study||424
8678395|NCT01095497|21424804|P2|NOT COMPLETED|Subcutaneous CINRYZE||0
8678396|NCT01095497|21424805|P1|NOT COMPLETED|Subcutaneous CINRYZE||1
8678397|NCT01095497|21424804|P2|COMPLETED|Subcutaneous CINRYZE||12
8678398|NCT01095497|21424805|P1|COMPLETED|Subcutaneous CINRYZE||12
8678399|NCT01095497|21424804|P2|STARTED|Subcutaneous CINRYZE||12
8678400|NCT01095497|21424805|P1|STARTED|Subcutaneous CINRYZE||13
8678401|NCT01095497|21424804|P2|NOT COMPLETED|Intravenous CINRYZE||0
8678402|NCT01095497|21424805|P1|NOT COMPLETED|Intravenous CINRYZE||1
8678403|NCT01095497|21424804|P2|COMPLETED|Intravenous CINRYZE||12
8678404|NCT01095497|21424805|P1|COMPLETED|Intravenous CINRYZE||13
8678405|NCT01095497|21424804|P2|STARTED|Intravenous CINRYZE||12
8678406|NCT01095497|21424805|P1|STARTED|Intravenous CINRYZE||14
8678419|NCT01009281|21424859|P1|NOT COMPLETED|Overall Study||7
8678420|NCT01009281|21424859|P1|COMPLETED|Overall Study||0
8678421|NCT01009281|21424859|P1|STARTED|Overall Study||7
8678422|NCT00946712|21424871|P2|NOT COMPLETED|Overall Study||662
8678423|NCT00946712|21424872|P1|NOT COMPLETED|Overall Study||547
8678424|NCT00946712|21424871|P2|COMPLETED|Overall Study||0
8678425|NCT00946712|21424872|P1|COMPLETED|Overall Study||124
8678426|NCT00946712|21424871|P2|STARTED|Overall Study||662
8678427|NCT00946712|21424872|P1|STARTED|Overall Study||671
8678428|NCT00946348|21424888|P2|NOT COMPLETED|Overall Study||0
8678429|NCT00946348|21424889|P1|NOT COMPLETED|Overall Study||0
8678430|NCT00946348|21424888|P2|COMPLETED|Overall Study||6
8678431|NCT00946348|21424889|P1|COMPLETED|Overall Study||6
8678432|NCT00946348|21424888|P2|STARTED|Overall Study||6
8678433|NCT00946348|21424889|P1|STARTED|Overall Study||6
8678434|NCT00943618|21424898|P3|NOT COMPLETED|Overall Study||31
8678435|NCT00943618|21424899|P2|NOT COMPLETED|Overall Study||77
8678436|NCT00943618|21424900|P1|NOT COMPLETED|Overall Study||55
8678437|NCT00943618|21424898|P3|COMPLETED|Overall Study||25
8678438|NCT00943618|21424899|P2|COMPLETED|Overall Study||89
8678439|NCT00943618|21424900|P1|COMPLETED|Overall Study||108
8678440|NCT00943618|21424898|P3|STARTED|Overall Study||56
8678441|NCT00943618|21424899|P2|STARTED|Overall Study||166
8678442|NCT00943618|21424900|P1|STARTED|Overall Study||163
8678449|NCT00929838|21424925|P4|NOT COMPLETED|Overall Study||9
8678450|NCT00929838|21424926|P3|NOT COMPLETED|Overall Study||10
8678451|NCT00929838|21424927|P2|NOT COMPLETED|Overall Study||9
8678452|NCT00929838|21424928|P1|NOT COMPLETED|Overall Study||10
8678453|NCT00929838|21424925|P4|COMPLETED|Overall Study||55
8678454|NCT00929838|21424926|P3|COMPLETED|Overall Study||53
8678455|NCT00929838|21424927|P2|COMPLETED|Overall Study||56
8678456|NCT00929838|21424928|P1|COMPLETED|Overall Study||53
8678457|NCT00929838|21424925|P4|STARTED|Overall Study||64
8678458|NCT00929838|21424926|P3|STARTED|Overall Study||63
8678459|NCT00929838|21424927|P2|STARTED|Overall Study||65
8678460|NCT00929838|21424928|P1|STARTED|Overall Study||63
8678461|NCT00911820|21424940|P2|NOT COMPLETED|Overall Study||43
8678462|NCT00911820|21424941|P1|NOT COMPLETED|Overall Study||45
8678463|NCT00911820|21424940|P2|COMPLETED|Overall Study||0
8678464|NCT00911820|21424941|P1|COMPLETED|Overall Study||0
8678465|NCT00911820|21424940|P2|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
8678466|NCT00911820|21424941|P1|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
8678467|NCT00911820|21424940|P2|STARTED|Overall Study||43
8678468|NCT00911820|21424941|P1|STARTED|Overall Study||45
8678469|NCT00871260|21424955|P1|NOT COMPLETED|Overall Study||0
8678470|NCT00871260|21424955|P1|COMPLETED|Overall Study||20
8678471|NCT00871260|21424955|P1|STARTED|Overall Study||20
8678472|NCT00856375|21424963|P2|NOT COMPLETED|Overall Study||41
8678473|NCT00856375|21424964|P1|NOT COMPLETED|Overall Study||42
8678474|NCT00856375|21424963|P2|COMPLETED|Overall Study||0
8678475|NCT00856375|21424964|P1|COMPLETED|Overall Study||0
8678476|NCT00856375|21424963|P2|STARTED|Overall Study||41
8678477|NCT00856375|21424964|P1|STARTED|Overall Study||42
8678508|NCT00806156|21425010|P2|NOT COMPLETED|Overall Study||139
8678509|NCT00806156|21425011|P1|NOT COMPLETED|Overall Study||39
8678510|NCT00806156|21425010|P2|COMPLETED|Overall Study||0
8678511|NCT00806156|21425011|P1|COMPLETED|Overall Study||0
8678512|NCT00806156|21425010|P2|STARTED|Overall Study||139
8678513|NCT00806156|21425011|P1|STARTED|Overall Study||39
8678523|NCT00689273|21425119|P2|NOT COMPLETED|Overall Study||5
8678524|NCT00689273|21425120|P1|NOT COMPLETED|Overall Study||13
8678525|NCT00689273|21425119|P2|COMPLETED|Overall Study||73
8678526|NCT00689273|21425120|P1|COMPLETED|Overall Study||66
8678527|NCT00689273|21425119|P2|Treated|Overall Study||78
8678528|NCT00689273|21425120|P1|Treated|Overall Study||78
8678529|NCT00689273|21425119|P2|STARTED|Overall Study||78
8678530|NCT00689273|21425120|P1|STARTED|Overall Study||79
8678531|NCT00647296|21425169|P4|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||14
8678532|NCT00647296|21425170|P3|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
8678533|NCT00647296|21425171|P2|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||15
8678534|NCT00647296|21425172|P1|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
8678535|NCT00647296|21425169|P4|COMPLETED|Part 2: 76-week Double-Blind Treatment||30
8678536|NCT00647296|21425170|P3|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
8678537|NCT00647296|21425171|P2|COMPLETED|Part 2: 76-week Double-Blind Treatment||33
8678538|NCT00647296|21425172|P1|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
8678539|NCT00647296|21425169|P4|STARTED|Part 2: 76-week Double-Blind Treatment||44
8678540|NCT00647296|21425170|P3|STARTED|Part 2: 76-week Double-Blind Treatment||0
8678541|NCT00647296|21425171|P2|STARTED|Part 2: 76-week Double-Blind Treatment||48
8678542|NCT00647296|21425172|P1|STARTED|Part 2: 76-week Double-Blind Treatment||0
8678543|NCT00647296|21425169|P4|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
8678544|NCT00647296|21425170|P3|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
8678545|NCT00647296|21425171|P2|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
8678546|NCT00647296|21425172|P1|NOT COMPLETED|Part 2: 4-week Placebo Washout||5
8678547|NCT00647296|21425169|P4|COMPLETED|Part 2: 4-week Placebo Washout||0
8678548|NCT00647296|21425170|P3|COMPLETED|Part 2: 4-week Placebo Washout||0
8678549|NCT00647296|21425171|P2|COMPLETED|Part 2: 4-week Placebo Washout||0
8678550|NCT00647296|21425172|P1|COMPLETED|Part 2: 4-week Placebo Washout||92
8678551|NCT00647296|21425169|P4|STARTED|Part 2: 4-week Placebo Washout||0
8678552|NCT00647296|21425170|P3|STARTED|Part 2: 4-week Placebo Washout||0
8678553|NCT00647296|21425171|P2|STARTED|Part 2: 4-week Placebo Washout||0
8678554|NCT00647296|21425172|P1|STARTED|Part 2: 4-week Placebo Washout||97
8678555|NCT00647296|21425169|P4|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||2
8678556|NCT00647296|21425170|P3|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||0
8678557|NCT00647296|21425171|P2|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
8678558|NCT00647296|21425172|P1|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
8678559|NCT00647296|21425169|P4|COMPLETED|Part 1: 12-week Double-Blind Treatment||24
8678560|NCT00647296|21425170|P3|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
8678561|NCT00647296|21425171|P2|COMPLETED|Part 1: 12-week Double-Blind Treatment||22
8678562|NCT00647296|21425172|P1|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
8678563|NCT00647296|21425169|P4|STARTED|Part 1: 12-week Double-Blind Treatment||26
8678564|NCT00647296|21425170|P3|STARTED|Part 1: 12-week Double-Blind Treatment||26
8678565|NCT00647296|21425171|P2|STARTED|Part 1: 12-week Double-Blind Treatment||23
8678566|NCT00647296|21425172|P1|STARTED|Part 1: 12-week Double-Blind Treatment||27
8678573|NCT00598975|21425242|P2|NOT COMPLETED|Overall Study||6
8678574|NCT00598975|21425243|P1|NOT COMPLETED|Overall Study||12
8678575|NCT00598975|21425242|P2|COMPLETED|Overall Study||0
8678576|NCT00598975|21425243|P1|COMPLETED|Overall Study||0
8678577|NCT00598975|21425242|P2|Completed Cycle 1|Overall Study||6
8678578|NCT00598975|21425243|P1|Completed Cycle 1|Overall Study||12
8678579|NCT00598975|21425242|P2|STARTED|Overall Study||6
8678580|NCT00598975|21425243|P1|STARTED|Overall Study||12
8678581|NCT00584870|21425260|P3|NOT COMPLETED|Overall Study||18
8678582|NCT00584870|21425261|P2|NOT COMPLETED|Overall Study||25
8678583|NCT00584870|21425262|P1|NOT COMPLETED|Overall Study||29
8678584|NCT00584870|21425260|P3|COMPLETED|Overall Study||25
8678585|NCT00584870|21425261|P2|COMPLETED|Overall Study||64
8678586|NCT00584870|21425262|P1|COMPLETED|Overall Study||59
8678587|NCT00584870|21425260|P3|Treated|Overall Study||41
8678588|NCT00584870|21425261|P2|Treated|Overall Study||88
8678589|NCT00584870|21425262|P1|Treated|Overall Study||88
8678590|NCT00584870|21425260|P3|STARTED|Overall Study||43
8678591|NCT00584870|21425261|P2|STARTED|Overall Study||89
8678592|NCT00584870|21425262|P1|STARTED|Overall Study||88
8678601|NCT00557323|21425350|P1|NOT COMPLETED|Overall Study||7
8678602|NCT00557323|21425350|P1|COMPLETED|Overall Study||27
8678603|NCT00557323|21425350|P1|STARTED|Overall Study||34
8678604|NCT00554606|21425355|P1|NOT COMPLETED|Overall Study||85
8678605|NCT00554606|21425355|P1|COMPLETED|Overall Study||30
8678606|NCT00554606|21425355|P1|STARTED|Overall Study||115
8678607|NCT00528437|21425384|P1|NOT COMPLETED|Overall Study||0
8678608|NCT00528437|21425384|P1|COMPLETED|Overall Study||46
8678609|NCT00528437|21425384|P1|STARTED|Overall Study||46
8678610|NCT00514813|21425394|P4|NOT COMPLETED|Overall Study||4
8678611|NCT00514813|21425395|P3|NOT COMPLETED|Overall Study||47
8678612|NCT00514813|21425396|P2|NOT COMPLETED|Overall Study||86
8678613|NCT00514813|21425397|P1|NOT COMPLETED|Overall Study||15
8678614|NCT00514813|21425394|P4|COMPLETED|Overall Study||0
8678615|NCT00514813|21425395|P3|COMPLETED|Overall Study||0
8678616|NCT00514813|21425396|P2|COMPLETED|Overall Study||0
8678617|NCT00514813|21425397|P1|COMPLETED|Overall Study||0
8678618|NCT00514813|21425394|P4|STARTED|Overall Study||4
8678619|NCT00514813|21425395|P3|STARTED|Overall Study||47
8678620|NCT00514813|21425396|P2|STARTED|Overall Study||86
8678621|NCT00514813|21425397|P1|STARTED|Overall Study||15
8678622|NCT00488592|21425415|P1|NOT COMPLETED|Overall Study||3
8678623|NCT00488592|21425415|P1|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
8678624|NCT00488592|21425415|P1|STARTED|Overall Study|10 subjects were accrued|10
8678625|NCT00444535|21425420|P1|NOT COMPLETED|Overall Study||13
8678626|NCT00444535|21425420|P1|COMPLETED|Overall Study||39
8678627|NCT00444535|21425420|P1|STARTED|Overall Study||52
8678655|NCT00367016|21425452|P2|NOT COMPLETED|Overall Study||0
8678656|NCT00367016|21425453|P1|NOT COMPLETED|Overall Study||0
8678657|NCT00367016|21425452|P2|COMPLETED|Overall Study||3
8678658|NCT00367016|21425453|P1|COMPLETED|Overall Study||3
8678659|NCT00367016|21425452|P2|Second Intervention|Overall Study||3
8678660|NCT00367016|21425453|P1|Second Intervention|Overall Study||3
8678661|NCT00367016|21425452|P2|First Intervention|Overall Study||3
8678662|NCT00367016|21425453|P1|First Intervention|Overall Study||3
8678663|NCT00367016|21425452|P2|STARTED|Overall Study||3
8678664|NCT00367016|21425453|P1|STARTED|Overall Study||3
8678665|NCT00348946|21425465|P2|NOT COMPLETED|Overall Study||12
8678666|NCT00348946|21425466|P1|NOT COMPLETED|Overall Study||11
8678667|NCT00348946|21425465|P2|COMPLETED|Overall Study||35
8678668|NCT00348946|21425466|P1|COMPLETED|Overall Study||35
8678669|NCT00348946|21425465|P2|STARTED|Overall Study||47
8678670|NCT00348946|21425466|P1|STARTED|Overall Study||46
8678679|NCT00293202|21425497|P2|NOT COMPLETED|Overall Study||2
8678680|NCT00293202|21425498|P1|NOT COMPLETED|Overall Study||3
8678681|NCT00293202|21425497|P2|COMPLETED|Overall Study||3
8678682|NCT00293202|21425498|P1|COMPLETED|Overall Study||2
8678683|NCT00293202|21425497|P2|STARTED|Overall Study||5
8678684|NCT00293202|21425498|P1|STARTED|Overall Study||5
8678685|NCT00274937|21425508|P1|NOT COMPLETED|Overall Study||20
8678686|NCT00274937|21425508|P1|COMPLETED|Overall Study||91
8678687|NCT00274937|21425508|P1|STARTED|Overall Study||111
8678688|NCT00199797|21425517|P1|NOT COMPLETED|Overall Study||3
8678689|NCT00199797|21425517|P1|COMPLETED|Overall Study||17
8678690|NCT00199797|21425517|P1|STARTED|Overall Study||20
8678691|NCT00070070|21425527|P4|NOT COMPLETED|Overall Study||0
8678692|NCT00070070|21425528|P3|NOT COMPLETED|Overall Study||0
8678693|NCT00070070|21425529|P2|NOT COMPLETED|Overall Study||0
8678694|NCT00070070|21425530|P1|NOT COMPLETED|Overall Study||0
8678695|NCT00070070|21425527|P4|COMPLETED|Overall Study||5
8678696|NCT00070070|21425528|P3|COMPLETED|Overall Study||0
8678697|NCT00070070|21425529|P2|COMPLETED|Overall Study||0
8678698|NCT00070070|21425530|P1|COMPLETED|Overall Study||1
8678699|NCT00070070|21425527|P4|STARTED|Overall Study||5
8678700|NCT00070070|21425528|P3|STARTED|Overall Study||0
8678701|NCT00070070|21425529|P2|STARTED|Overall Study||0
8678702|NCT00070070|21425530|P1|STARTED|Overall Study||1
8678703|NCT00053352|21425554|P2|NOT COMPLETED|Overall Study||10
8678704|NCT00053352|21425555|P1|NOT COMPLETED|Overall Study||21
8678705|NCT00053352|21425554|P2|COMPLETED|Overall Study||102
8678706|NCT00053352|21425555|P1|COMPLETED|Overall Study||169
8678707|NCT00053352|21425554|P2|STARTED|Overall Study||112
8678708|NCT00053352|21425555|P1|STARTED|Overall Study||190
8678709|NCT00001962|21425564|P1|NOT COMPLETED|Overall Study||28
8678710|NCT00001962|21425564|P1|COMPLETED|Overall Study||72
8678711|NCT00001962|21425564|P1|STARTED|Overall Study||100
8678712|NCT04383665|21425570|P6|NOT COMPLETED|Overall Study||0
8678713|NCT04383665|21425571|P5|NOT COMPLETED|Overall Study||0
8678714|NCT04383665|21425572|P4|NOT COMPLETED|Overall Study||0
8678715|NCT04383665|21425573|P3|NOT COMPLETED|Overall Study||0
8678716|NCT04383665|21425574|P2|NOT COMPLETED|Overall Study||0
8678717|NCT04383665|21425575|P1|NOT COMPLETED|Overall Study||0
8678718|NCT04383665|21425570|P6|COMPLETED|Overall Study||2
8678719|NCT04383665|21425571|P5|COMPLETED|Overall Study||2
8678720|NCT04383665|21425572|P4|COMPLETED|Overall Study||2
8678721|NCT04383665|21425573|P3|COMPLETED|Overall Study||2
8678722|NCT04383665|21425574|P2|COMPLETED|Overall Study||2
8678723|NCT04383665|21425575|P1|COMPLETED|Overall Study||2
8678724|NCT04383665|21425570|P6|STARTED|Overall Study||2
8678725|NCT04383665|21425571|P5|STARTED|Overall Study||2
8678726|NCT04383665|21425572|P4|STARTED|Overall Study||2
8678727|NCT04383665|21425573|P3|STARTED|Overall Study||2
8678728|NCT04383665|21425574|P2|STARTED|Overall Study||2
8678729|NCT04383665|21425575|P1|STARTED|Overall Study||2
8678754|NCT04094883|21425623|P1|NOT COMPLETED|Overall Study||1
8678755|NCT04094883|21425623|P1|COMPLETED|Overall Study||10
8678756|NCT04094883|21425623|P1|STARTED|Overall Study||11
8678757|NCT04085341|21425632|P2|NOT COMPLETED|Overall Study||0
8678758|NCT04085341|21425633|P1|NOT COMPLETED|Overall Study||0
8678759|NCT04085341|21425632|P2|COMPLETED|Overall Study||11
8678760|NCT04085341|21425633|P1|COMPLETED|Overall Study||10
8678761|NCT04085341|21425632|P2|STARTED|Overall Study||11
8678762|NCT04085341|21425633|P1|STARTED|Overall Study||10
8678763|NCT03990649|21425647|P3|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||4
8678764|NCT03990649|21425648|P2|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
8678765|NCT03990649|21425649|P1|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
8678766|NCT03990649|21425647|P3|COMPLETED|Part B: OL Extension Period (14 Weeks)||14
8678767|NCT03990649|21425648|P2|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
8678768|NCT03990649|21425649|P1|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
8678769|NCT03990649|21425647|P3|STARTED|Part B: OL Extension Period (14 Weeks)||18
8678770|NCT03990649|21425648|P2|STARTED|Part B: OL Extension Period (14 Weeks)||0
8678771|NCT03990649|21425649|P1|STARTED|Part B: OL Extension Period (14 Weeks)||0
8678772|NCT03990649|21425647|P3|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
8678773|NCT03990649|21425648|P2|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
8678774|NCT03990649|21425649|P1|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
8678775|NCT03990649|21425647|P3|COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
8678776|NCT03990649|21425648|P2|COMPLETED|Part A: DB Treatment Period (15 Weeks)||12
8678777|NCT03990649|21425649|P1|COMPLETED|Part A: DB Treatment Period (15 Weeks)||6
8678778|NCT03990649|21425647|P3|STARTED|Part A: DB Treatment Period (15 Weeks)||0
8678779|NCT03990649|21425648|P2|STARTED|Part A: DB Treatment Period (15 Weeks)||15
8678780|NCT03990649|21425649|P1|STARTED|Part A: DB Treatment Period (15 Weeks)||9
8678781|NCT03987074|21425675|P5|NOT COMPLETED|Overall Study||2
8678782|NCT03987074|21425676|P4|NOT COMPLETED|Overall Study||4
8678783|NCT03987074|21425677|P3|NOT COMPLETED|Overall Study||1
8678784|NCT03987074|21425678|P2|NOT COMPLETED|Overall Study||2
8678785|NCT03987074|21425679|P1|NOT COMPLETED|Overall Study||3
8678786|NCT03987074|21425675|P5|COMPLETED|Overall Study||19
8678787|NCT03987074|21425676|P4|COMPLETED|Overall Study||18
8678788|NCT03987074|21425677|P3|COMPLETED|Overall Study||21
8678789|NCT03987074|21425678|P2|COMPLETED|Overall Study||20
8678790|NCT03987074|21425679|P1|COMPLETED|Overall Study||18
8678791|NCT03987074|21425675|P5|STARTED|Overall Study||21
8678792|NCT03987074|21425676|P4|STARTED|Overall Study||22
8678793|NCT03987074|21425677|P3|STARTED|Overall Study||22
8678794|NCT03987074|21425678|P2|STARTED|Overall Study||22
8678795|NCT03987074|21425679|P1|STARTED|Overall Study||21
8678796|NCT03927846|21425698|P2|NOT COMPLETED|Overall Study||11
8678797|NCT03927846|21425699|P1|NOT COMPLETED|Overall Study||10
8678798|NCT03927846|21425698|P2|COMPLETED|Overall Study||19
8678799|NCT03927846|21425699|P1|COMPLETED|Overall Study||20
8678800|NCT03927846|21425698|P2|STARTED|Overall Study||30
8678801|NCT03927846|21425699|P1|STARTED|Overall Study||30
8678802|NCT03801265|21425715|P2|NOT COMPLETED|Overall Study||0
8678803|NCT03801265|21425716|P1|NOT COMPLETED|Overall Study||0
8678804|NCT03801265|21425715|P2|COMPLETED|Overall Study||23
8678805|NCT03801265|21425716|P1|COMPLETED|Overall Study||23
8678806|NCT03801265|21425715|P2|STARTED|Overall Study||23
8678807|NCT03801265|21425716|P1|STARTED|Overall Study||23
8678808|NCT03704636|21425758|P1|NOT COMPLETED|Overall Study||3
8678809|NCT03704636|21425758|P1|COMPLETED|Overall Study||20
8678810|NCT03704636|21425758|P1|STARTED|Overall Study||23
8678811|NCT03597061|21425764|P2|NOT COMPLETED|Overall Study||1
8678812|NCT03597061|21425765|P1|NOT COMPLETED|Overall Study||1
8678813|NCT03597061|21425764|P2|COMPLETED|Overall Study||16
8678814|NCT03597061|21425765|P1|COMPLETED|Overall Study||16
8678815|NCT03597061|21425764|P2|STARTED|Overall Study||17
8678816|NCT03597061|21425765|P1|STARTED|Overall Study||17
8678817|NCT03557034|21425779|P2|NOT COMPLETED|Overall Study||0
8678818|NCT03557034|21425780|P1|NOT COMPLETED|Overall Study||1
8678819|NCT03557034|21425779|P2|COMPLETED|Overall Study||51
8678820|NCT03557034|21425780|P1|COMPLETED|Overall Study||48
8678821|NCT03557034|21425779|P2|Randomization|Overall Study||51
8678822|NCT03557034|21425780|P1|Randomization|Overall Study||49
8678823|NCT03557034|21425779|P2|STARTED|Overall Study||51
8678824|NCT03557034|21425780|P1|STARTED|Overall Study||49
8678837|NCT03474081|21425833|P2|NOT COMPLETED|Overall Study||13
8678838|NCT03474081|21425834|P1|NOT COMPLETED|Overall Study||17
8678839|NCT03474081|21425833|P2|COMPLETED|Overall Study||387
8678840|NCT03474081|21425834|P1|COMPLETED|Overall Study||383
8678841|NCT03474081|21425833|P2|Received Study Treatment|Overall Study|One randomized participant withdrew consent and never received study treatment.|399
8678842|NCT03474081|21425834|P1|Received Study Treatment|Overall Study||400
8678843|NCT03474081|21425833|P2|STARTED|Overall Study||400
8678844|NCT03474081|21425834|P1|STARTED|Overall Study||400
8678875|NCT03215771|21426004|P1|NOT COMPLETED|Overall Study||3
8678876|NCT03215771|21426004|P1|COMPLETED|Overall Study||13
8678877|NCT03215771|21426004|P1|TBI Subjects|Overall Study||8
8678878|NCT03215771|21426004|P1|Stroke Subjects|Overall Study||8
8678879|NCT03215771|21426004|P1|STARTED|Overall Study||16
8678892|NCT02738775|21426035|P6|NOT COMPLETED|Overall Study||1
8678893|NCT02738775|21426036|P5|NOT COMPLETED|Overall Study||0
8678894|NCT02738775|21426037|P4|NOT COMPLETED|Overall Study||1
8678895|NCT02738775|21426038|P3|NOT COMPLETED|Overall Study||0
8678896|NCT02738775|21426039|P2|NOT COMPLETED|Overall Study||2
8678897|NCT02738775|21426040|P1|NOT COMPLETED|Overall Study||0
8678898|NCT02738775|21426035|P6|COMPLETED|Overall Study||7
8678899|NCT02738775|21426036|P5|COMPLETED|Overall Study||8
8678900|NCT02738775|21426037|P4|COMPLETED|Overall Study||8
8678901|NCT02738775|21426038|P3|COMPLETED|Overall Study||8
8678902|NCT02738775|21426039|P2|COMPLETED|Overall Study||6
8678903|NCT02738775|21426040|P1|COMPLETED|Overall Study||8
8678904|NCT02738775|21426035|P6|Initially Treated With Placebo|Overall Study||0
8678905|NCT02738775|21426036|P5|Initially Treated With Placebo|Overall Study||0
8678906|NCT02738775|21426037|P4|Initially Treated With Placebo|Overall Study||1
8678907|NCT02738775|21426038|P3|Initially Treated With Placebo|Overall Study||0
8678908|NCT02738775|21426039|P2|Initially Treated With Placebo|Overall Study||0
8678909|NCT02738775|21426040|P1|Initially Treated With Placebo|Overall Study||0
8678910|NCT02738775|21426035|P6|STARTED|Overall Study||8
8678911|NCT02738775|21426036|P5|STARTED|Overall Study||8
8678912|NCT02738775|21426037|P4|STARTED|Overall Study||9
8678913|NCT02738775|21426038|P3|STARTED|Overall Study||8
8678914|NCT02738775|21426039|P2|STARTED|Overall Study||8
8678915|NCT02738775|21426040|P1|STARTED|Overall Study||8
8678919|NCT02676778|21426145|P3|NOT COMPLETED|Overall Study||1
8678920|NCT02676778|21426146|P2|NOT COMPLETED|Overall Study||12
8678921|NCT02676778|21426147|P1|NOT COMPLETED|Overall Study||17
8678922|NCT02676778|21426145|P3|COMPLETED|Overall Study||0
8678923|NCT02676778|21426146|P2|COMPLETED|Overall Study||7
8678924|NCT02676778|21426147|P1|COMPLETED|Overall Study||0
8678925|NCT02676778|21426145|P3|STARTED|Overall Study||1
8678926|NCT02676778|21426146|P2|STARTED|Overall Study||19
8678927|NCT02676778|21426147|P1|STARTED|Overall Study||17
8678928|NCT02520011|21426193|P3|NOT COMPLETED|Overall Study||9
8678929|NCT02520011|21426194|P2|NOT COMPLETED|Overall Study||46
8678930|NCT02520011|21426195|P1|NOT COMPLETED|Overall Study||5
8678931|NCT02520011|21426193|P3|COMPLETED|Overall Study||5
8678932|NCT02520011|21426194|P2|COMPLETED|Overall Study||33
8678933|NCT02520011|21426195|P1|COMPLETED|Overall Study||6
8678934|NCT02520011|21426193|P3|Stage 2|Overall Study||4
8678935|NCT02520011|21426194|P2|Stage 2|Overall Study||47
8678936|NCT02520011|21426195|P1|Stage 2|Overall Study||11
8678937|NCT02520011|21426193|P3|Stage 1|Overall Study||10
8678938|NCT02520011|21426194|P2|Stage 1|Overall Study||32
8678939|NCT02520011|21426195|P1|Stage 1|Overall Study||0
8678940|NCT02520011|21426193|P3|STARTED|Overall Study||14
8678941|NCT02520011|21426194|P2|STARTED|Overall Study||79
8678942|NCT02520011|21426195|P1|STARTED|Overall Study||11
8678943|NCT02514070|21426210|P2|NOT COMPLETED|Week 14 to Week 20||2
8678944|NCT02514070|21426211|P1|NOT COMPLETED|Week 14 to Week 20||1
8678945|NCT02514070|21426210|P2|COMPLETED|Week 14 to Week 20||14
8678946|NCT02514070|21426211|P1|COMPLETED|Week 14 to Week 20||16
8678947|NCT02514070|21426210|P2|STARTED|Week 14 to Week 20||16
8678948|NCT02514070|21426211|P1|STARTED|Week 14 to Week 20||17
8678949|NCT02514070|21426210|P2|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
8678950|NCT02514070|21426211|P1|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
8678951|NCT02514070|21426210|P2|COMPLETED|Week 6 to Week 14 - Washout Period||16
8678952|NCT02514070|21426211|P1|COMPLETED|Week 6 to Week 14 - Washout Period||17
8678953|NCT02514070|21426210|P2|STARTED|Week 6 to Week 14 - Washout Period||16
8678954|NCT02514070|21426211|P1|STARTED|Week 6 to Week 14 - Washout Period||17
8678955|NCT02514070|21426210|P2|NOT COMPLETED|Weeks 0 to Week 6||4
8678956|NCT02514070|21426211|P1|NOT COMPLETED|Weeks 0 to Week 6||2
8678957|NCT02514070|21426210|P2|COMPLETED|Weeks 0 to Week 6||16
8678958|NCT02514070|21426211|P1|COMPLETED|Weeks 0 to Week 6||17
8678959|NCT02514070|21426210|P2|STARTED|Weeks 0 to Week 6||20
8678960|NCT02514070|21426211|P1|STARTED|Weeks 0 to Week 6||19
8678961|NCT02385097|21426224|P2|NOT COMPLETED|Overall Study||0
8678962|NCT02385097|21426225|P1|NOT COMPLETED|Overall Study||0
8678963|NCT02385097|21426224|P2|COMPLETED|Overall Study||105
8678964|NCT02385097|21426225|P1|COMPLETED|Overall Study||106
8678965|NCT02385097|21426224|P2|STARTED|Overall Study||105
8678966|NCT02385097|21426225|P1|STARTED|Overall Study||106
8678967|NCT02339155|21426259|P2|NOT COMPLETED|Overall Study||21
8678968|NCT02339155|21426260|P1|NOT COMPLETED|Overall Study||15
8678969|NCT02339155|21426259|P2|COMPLETED|Overall Study||265
8678970|NCT02339155|21426260|P1|COMPLETED|Overall Study||272
8678971|NCT02339155|21426259|P2|Received Study Treatment|Overall Study||280
8678972|NCT02339155|21426260|P1|Received Study Treatment|Overall Study||286
8678973|NCT02339155|21426259|P2|STARTED|Overall Study||286
8678974|NCT02339155|21426260|P1|STARTED|Overall Study||287
8678975|NCT02336165|21426292|P5|NOT COMPLETED|Overall Study||22
8678976|NCT02336165|21426293|P4|NOT COMPLETED|Overall Study||31
8678977|NCT02336165|21426294|P3|NOT COMPLETED|Overall Study||31
8678978|NCT02336165|21426295|P2|NOT COMPLETED|Overall Study||25
8678979|NCT02336165|21426296|P1|NOT COMPLETED|Overall Study||34
8678980|NCT02336165|21426292|P5|COMPLETED|Overall Study||0
8678981|NCT02336165|21426293|P4|COMPLETED|Overall Study||2
8678982|NCT02336165|21426294|P3|COMPLETED|Overall Study||2
8678983|NCT02336165|21426295|P2|COMPLETED|Overall Study||6
8678984|NCT02336165|21426296|P1|COMPLETED|Overall Study||6
8678985|NCT02336165|21426292|P5|STARTED|Overall Study||22
8678986|NCT02336165|21426293|P4|STARTED|Overall Study||33
8678987|NCT02336165|21426294|P3|STARTED|Overall Study||33
8678988|NCT02336165|21426295|P2|STARTED|Overall Study||31
8678989|NCT02336165|21426296|P1|STARTED|Overall Study||40
8678990|NCT02137538|21426340|P2|NOT COMPLETED|Overall Study||14
8678991|NCT02137538|21426341|P1|NOT COMPLETED|Overall Study||16
8678992|NCT02137538|21426340|P2|COMPLETED|Overall Study||26
8678993|NCT02137538|21426341|P1|COMPLETED|Overall Study||23
8678994|NCT02137538|21426340|P2|STARTED|Overall Study||40
8678995|NCT02137538|21426341|P1|STARTED|Overall Study||39
8678996|NCT02094586|21426371|P4|NOT COMPLETED|Overall Study||20
8678997|NCT02094586|21426372|P3|NOT COMPLETED|Overall Study||59
8678998|NCT02094586|21426373|P2|NOT COMPLETED|Overall Study||67
8678999|NCT02094586|21426374|P1|NOT COMPLETED|Overall Study||79
8679000|NCT02094586|21426371|P4|COMPLETED|Overall Study||331
8679001|NCT02094586|21426372|P3|COMPLETED|Overall Study||876
8679002|NCT02094586|21426373|P2|COMPLETED|Overall Study||866
8679003|NCT02094586|21426374|P1|COMPLETED|Overall Study||848
8679004|NCT02094586|21426371|P4|STARTED|Overall Study||351
8679005|NCT02094586|21426372|P3|STARTED|Overall Study||935
8679006|NCT02094586|21426373|P2|STARTED|Overall Study||933
8679007|NCT02094586|21426374|P1|STARTED|Overall Study||927
8679014|NCT02040857|21426457|P1|NOT COMPLETED|Overall Study||60
8679015|NCT02040857|21426457|P1|COMPLETED|Overall Study||102
8679016|NCT02040857|21426457|P1|Treatment Discontinuation Evaluable|Overall Study|Evaluable population excludes participants who discontinue early for reasons unrelated to treatment.|152
8679017|NCT02040857|21426457|P1|STARTED|Overall Study||162
8679018|NCT02040298|21426469|P2|NOT COMPLETED|Second Intervention (2 Months)||0
8679019|NCT02040298|21426470|P1|NOT COMPLETED|Second Intervention (2 Months)||0
8679020|NCT02040298|21426469|P2|COMPLETED|Second Intervention (2 Months)||25
8679021|NCT02040298|21426470|P1|COMPLETED|Second Intervention (2 Months)||25
8679022|NCT02040298|21426469|P2|STARTED|Second Intervention (2 Months)||25
8679023|NCT02040298|21426470|P1|STARTED|Second Intervention (2 Months)||25
8679024|NCT02040298|21426469|P2|NOT COMPLETED|First Intervention (3 Months)||0
8679025|NCT02040298|21426470|P1|NOT COMPLETED|First Intervention (3 Months)||0
8679026|NCT02040298|21426469|P2|COMPLETED|First Intervention (3 Months)||25
8679027|NCT02040298|21426470|P1|COMPLETED|First Intervention (3 Months)||25
8679028|NCT02040298|21426469|P2|STARTED|First Intervention (3 Months)||25
8679029|NCT02040298|21426470|P1|STARTED|First Intervention (3 Months)||25
8679030|NCT02031432|21426482|P1|NOT COMPLETED|Overall Study||38
8679031|NCT02031432|21426482|P1|COMPLETED|Overall Study||38
8679032|NCT02031432|21426482|P1|Completing the Treatment|Overall Study||39
8679033|NCT02031432|21426482|P1|Completing the Titration Phase|Overall Study||67
8679034|NCT02031432|21426482|P1|STARTED|Overall Study||76
8679035|NCT01975831|21426516|P9|NOT COMPLETED|Overall Study||12
8679036|NCT01975831|21426517|P8|NOT COMPLETED|Overall Study||15
8679037|NCT01975831|21426518|P7|NOT COMPLETED|Overall Study||16
8679038|NCT01975831|21426519|P6|NOT COMPLETED|Overall Study||14
8679039|NCT01975831|21426520|P5|NOT COMPLETED|Overall Study||18
8679040|NCT01975831|21426521|P4|NOT COMPLETED|Overall Study||4
8679041|NCT01975831|21426522|P3|NOT COMPLETED|Overall Study||4
8679042|NCT01975831|21426523|P2|NOT COMPLETED|Overall Study||9
8679043|NCT01975831|21426524|P1|NOT COMPLETED|Overall Study||3
8679044|NCT01975831|21426516|P9|COMPLETED|Overall Study||3
8679045|NCT01975831|21426517|P8|COMPLETED|Overall Study||1
8679046|NCT01975831|21426518|P7|COMPLETED|Overall Study||0
8679047|NCT01975831|21426519|P6|COMPLETED|Overall Study||2
8679048|NCT01975831|21426520|P5|COMPLETED|Overall Study||1
8679049|NCT01975831|21426521|P4|COMPLETED|Overall Study||0
8679050|NCT01975831|21426522|P3|COMPLETED|Overall Study||0
8679051|NCT01975831|21426523|P2|COMPLETED|Overall Study||2
8679052|NCT01975831|21426524|P1|COMPLETED|Overall Study||0
8679053|NCT01975831|21426516|P9|STARTED|Overall Study||15
8679054|NCT01975831|21426517|P8|STARTED|Overall Study||16
8679055|NCT01975831|21426518|P7|STARTED|Overall Study||16
8679056|NCT01975831|21426519|P6|STARTED|Overall Study||16
8679057|NCT01975831|21426520|P5|STARTED|Overall Study||19
8679058|NCT01975831|21426521|P4|STARTED|Overall Study||4
8679059|NCT01975831|21426522|P3|STARTED|Overall Study||4
8679060|NCT01975831|21426523|P2|STARTED|Overall Study||11
8679061|NCT01975831|21426524|P1|STARTED|Overall Study||3
8679062|NCT01972308|21426591|P2|NOT COMPLETED|Overall Study||8
8679063|NCT01972308|21426592|P1|NOT COMPLETED|Overall Study||8
8679064|NCT01972308|21426591|P2|COMPLETED|Overall Study||148
8679065|NCT01972308|21426592|P1|COMPLETED|Overall Study||148
8679066|NCT01972308|21426591|P2|STARTED|Overall Study||156
8679067|NCT01972308|21426592|P1|STARTED|Overall Study||156
8679068|NCT01964378|21426610|P2|NOT COMPLETED|Overall Study||21
8679069|NCT01964378|21426611|P1|NOT COMPLETED|Overall Study||25
8679070|NCT01964378|21426610|P2|COMPLETED|Overall Study||45
8679071|NCT01964378|21426611|P1|COMPLETED|Overall Study||41
8679072|NCT01964378|21426610|P2|Participants Treated (Safety Set)|Overall Study|"4 Participants died during treatment, hereof 2 with withdrawal... as primary reason for discont."|61
8679073|NCT01964378|21426611|P1|Participants Treated (Safety Set)|Overall Study||65
8679074|NCT01964378|21426610|P2|STARTED|Overall Study||66
8679075|NCT01964378|21426611|P1|STARTED|Overall Study||66
8679076|NCT01956123|21426645|P4|NOT COMPLETED|COS Cycle 3||2
8679077|NCT01956123|21426646|P3|NOT COMPLETED|COS Cycle 3||6
8679078|NCT01956123|21426647|P2|NOT COMPLETED|COS Cycle 3||0
8679079|NCT01956123|21426648|P1|NOT COMPLETED|COS Cycle 3||0
8679080|NCT01956123|21426645|P4|COMPLETED|COS Cycle 3||91
8679081|NCT01956123|21426646|P3|COMPLETED|COS Cycle 3||89
8679082|NCT01956123|21426647|P2|COMPLETED|COS Cycle 3||0
8679083|NCT01956123|21426648|P1|COMPLETED|COS Cycle 3||0
8679084|NCT01956123|21426645|P4|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
8679085|NCT01956123|21426646|P3|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
8679086|NCT01956123|21426647|P2|STARTED|COS Cycle 3||0
8679087|NCT01956123|21426648|P1|STARTED|COS Cycle 3||0
8679088|NCT01956123|21426645|P4|NOT COMPLETED|COS Cycle 2||0
8679089|NCT01956123|21426646|P3|NOT COMPLETED|COS Cycle 2||0
8679090|NCT01956123|21426647|P2|NOT COMPLETED|COS Cycle 2||7
8679091|NCT01956123|21426648|P1|NOT COMPLETED|COS Cycle 2||14
8679092|NCT01956123|21426645|P4|COMPLETED|COS Cycle 2||0
8679093|NCT01956123|21426646|P3|COMPLETED|COS Cycle 2||0
8679094|NCT01956123|21426647|P2|COMPLETED|COS Cycle 2||254
8679095|NCT01956123|21426648|P1|COMPLETED|COS Cycle 2||238
8679096|NCT01956123|21426645|P4|STARTED|COS Cycle 2||0
8679097|NCT01956123|21426646|P3|STARTED|COS Cycle 2||0
8679098|NCT01956123|21426647|P2|STARTED|COS Cycle 2||261
8679099|NCT01956123|21426648|P1|STARTED|COS Cycle 2||252
8679100|NCT01956110|21426700|P2|NOT COMPLETED|Overall Study||22
8679101|NCT01956110|21426701|P1|NOT COMPLETED|Overall Study||35
8679102|NCT01956110|21426700|P2|COMPLETED|Overall Study||639
8679103|NCT01956110|21426701|P1|COMPLETED|Overall Study||630
8679104|NCT01956110|21426700|P2|STARTED|Overall Study||661
8679105|NCT01956110|21426701|P1|STARTED|Overall Study||665
8679106|NCT01939366|21426756|P5|NOT COMPLETED|Overall Study||18
8679107|NCT01939366|21426757|P4|NOT COMPLETED|Overall Study||17
8679108|NCT01939366|21426758|P3|NOT COMPLETED|Overall Study||38
8679109|NCT01939366|21426759|P2|NOT COMPLETED|Overall Study||23
8679110|NCT01939366|21426760|P1|NOT COMPLETED|Overall Study||14
8679111|NCT01939366|21426756|P5|COMPLETED|Overall Study||48
8679112|NCT01939366|21426757|P4|COMPLETED|Overall Study||51
8679113|NCT01939366|21426758|P3|COMPLETED|Overall Study||27
8679114|NCT01939366|21426759|P2|COMPLETED|Overall Study||41
8679115|NCT01939366|21426760|P1|COMPLETED|Overall Study||52
8679116|NCT01939366|21426756|P5|Per Protocol Set|Overall Study||49
8679117|NCT01939366|21426757|P4|Per Protocol Set|Overall Study||51
8679118|NCT01939366|21426758|P3|Per Protocol Set|Overall Study||50
8679119|NCT01939366|21426759|P2|Per Protocol Set|Overall Study||55
8679120|NCT01939366|21426760|P1|Per Protocol Set|Overall Study||58
8679121|NCT01939366|21426756|P5|Full Analysis Set|Overall Study||62
8679122|NCT01939366|21426757|P4|Full Analysis Set|Overall Study||65
8679123|NCT01939366|21426758|P3|Full Analysis Set|Overall Study||61
8679124|NCT01939366|21426759|P2|Full Analysis Set|Overall Study||60
8679125|NCT01939366|21426760|P1|Full Analysis Set|Overall Study||64
8679126|NCT01939366|21426756|P5|Safety Set|Overall Study||62
8679127|NCT01939366|21426757|P4|Safety Set|Overall Study||65
8679128|NCT01939366|21426758|P3|Safety Set|Overall Study||62
8679129|NCT01939366|21426759|P2|Safety Set|Overall Study||61
8679130|NCT01939366|21426760|P1|Safety Set|Overall Study||64
8679131|NCT01939366|21426756|P5|Allocated Set Excl. Non-compliant Sites|Overall Study||63
8679132|NCT01939366|21426757|P4|Allocated Set Excl. Non-compliant Sites|Overall Study||65
8679133|NCT01939366|21426758|P3|Allocated Set Excl. Non-compliant Sites|Overall Study||63
8679134|NCT01939366|21426759|P2|Allocated Set Excl. Non-compliant Sites|Overall Study||61
8679135|NCT01939366|21426760|P1|Allocated Set Excl. Non-compliant Sites|Overall Study||64
8679136|NCT01939366|21426756|P5|STARTED|Overall Study||66
8679137|NCT01939366|21426757|P4|STARTED|Overall Study||68
8679138|NCT01939366|21426758|P3|STARTED|Overall Study||65
8679139|NCT01939366|21426759|P2|STARTED|Overall Study||64
8679140|NCT01939366|21426760|P1|STARTED|Overall Study||66
8679141|NCT01743989|21426775|P3|NOT COMPLETED|Re-treatment Phase||0
8679142|NCT01743989|21426776|P2|NOT COMPLETED|Re-treatment Phase||9
8679143|NCT01743989|21426777|P1|NOT COMPLETED|Re-treatment Phase||16
8679144|NCT01743989|21426775|P3|COMPLETED|Re-treatment Phase||0
8679145|NCT01743989|21426776|P2|COMPLETED|Re-treatment Phase||46
8679146|NCT01743989|21426777|P1|COMPLETED|Re-treatment Phase||58
8679147|NCT01743989|21426775|P3|STARTED|Re-treatment Phase||0
8679148|NCT01743989|21426776|P2|STARTED|Re-treatment Phase||55
8679149|NCT01743989|21426777|P1|STARTED|Re-treatment Phase||74
8679150|NCT01743989|21426775|P3|NOT COMPLETED|TFR Phase||0
8679151|NCT01743989|21426776|P2|NOT COMPLETED|TFR Phase||68
8679152|NCT01743989|21426777|P1|NOT COMPLETED|TFR Phase||82
8679153|NCT01743989|21426775|P3|COMPLETED|TFR Phase||0
8679154|NCT01743989|21426776|P2|COMPLETED|TFR Phase||36
8679155|NCT01743989|21426777|P1|COMPLETED|TFR Phase||37
8679156|NCT01743989|21426775|P3|STARTED|TFR Phase||0
8679157|NCT01743989|21426776|P2|STARTED|TFR Phase||104
8679158|NCT01743989|21426777|P1|STARTED|TFR Phase||119
8679159|NCT01743989|21426775|P3|NOT COMPLETED|Treatment Phase||381
8679160|NCT01743989|21426776|P2|NOT COMPLETED|Treatment Phase||15
8679161|NCT01743989|21426777|P1|NOT COMPLETED|Treatment Phase||1
8679162|NCT01743989|21426775|P3|COMPLETED|Treatment Phase||0
8679163|NCT01743989|21426776|P2|COMPLETED|Treatment Phase||104
8679164|NCT01743989|21426777|P1|COMPLETED|Treatment Phase||119
8679165|NCT01743989|21426775|P3|Participants Who Signed Informed Consent|Treatment Phase||381
8679166|NCT01743989|21426776|P2|Participants Who Signed Informed Consent|Treatment Phase||118
8679167|NCT01743989|21426777|P1|Participants Who Signed Informed Consent|Treatment Phase||120
8679168|NCT01743989|21426775|P3|STARTED|Treatment Phase||381
8679169|NCT01743989|21426776|P2|STARTED|Treatment Phase||119
8679170|NCT01743989|21426777|P1|STARTED|Treatment Phase||120
8679180|NCT01597388|21426873|P9|NOT COMPLETED|Overall Study||0
8679181|NCT01597388|21426874|P8|NOT COMPLETED|Overall Study||0
8679182|NCT01597388|21426875|P7|NOT COMPLETED|Overall Study||0
8679183|NCT01597388|21426876|P6|NOT COMPLETED|Overall Study||0
8679184|NCT01597388|21426877|P5|NOT COMPLETED|Overall Study||0
8679185|NCT01597388|21426878|P4|NOT COMPLETED|Overall Study||0
8679186|NCT01597388|21426879|P3|NOT COMPLETED|Overall Study||0
8679187|NCT01597388|21426880|P2|NOT COMPLETED|Overall Study||0
8679188|NCT01597388|21426881|P1|NOT COMPLETED|Overall Study||0
8679189|NCT01597388|21426873|P9|COMPLETED|Overall Study||2
8679190|NCT01597388|21426874|P8|COMPLETED|Overall Study||5
8679191|NCT01597388|21426875|P7|COMPLETED|Overall Study||8
8679192|NCT01597388|21426876|P6|COMPLETED|Overall Study||4
8679193|NCT01597388|21426877|P5|COMPLETED|Overall Study||37
8679194|NCT01597388|21426878|P4|COMPLETED|Overall Study||10
8679195|NCT01597388|21426879|P3|COMPLETED|Overall Study||14
8679196|NCT01597388|21426880|P2|COMPLETED|Overall Study||13
8679197|NCT01597388|21426881|P1|COMPLETED|Overall Study||6
8679198|NCT01597388|21426873|P9|STARTED|Overall Study||2
8679199|NCT01597388|21426874|P8|STARTED|Overall Study||5
8679200|NCT01597388|21426875|P7|STARTED|Overall Study||8
8679201|NCT01597388|21426876|P6|STARTED|Overall Study||4
8679202|NCT01597388|21426877|P5|STARTED|Overall Study||37
8679203|NCT01597388|21426878|P4|STARTED|Overall Study||10
8679204|NCT01597388|21426879|P3|STARTED|Overall Study||14
8679205|NCT01597388|21426880|P2|STARTED|Overall Study||13
8679206|NCT01597388|21426881|P1|STARTED|Overall Study||6
8679207|NCT01579162|21427137|P5|NOT COMPLETED|Overall Study||0
8679208|NCT01579162|21427138|P4|NOT COMPLETED|Overall Study||0
8679209|NCT01579162|21427139|P3|NOT COMPLETED|Overall Study||0
8679210|NCT01579162|21427140|P2|NOT COMPLETED|Overall Study||0
8679211|NCT01579162|21427141|P1|NOT COMPLETED|Overall Study||0
8679212|NCT01579162|21427137|P5|COMPLETED|Overall Study||8
8679213|NCT01579162|21427138|P4|COMPLETED|Overall Study||8
8679214|NCT01579162|21427139|P3|COMPLETED|Overall Study||8
8679215|NCT01579162|21427140|P2|COMPLETED|Overall Study||8
8679216|NCT01579162|21427141|P1|COMPLETED|Overall Study||16
8679217|NCT01579162|21427137|P5|STARTED|Overall Study||8
8679218|NCT01579162|21427138|P4|STARTED|Overall Study||8
8679219|NCT01579162|21427139|P3|STARTED|Overall Study||8
8679220|NCT01579162|21427140|P2|STARTED|Overall Study||8
8679221|NCT01579162|21427141|P1|STARTED|Overall Study||16
8679222|NCT01482195|21427154|P1|NOT COMPLETED|Overall Study||0
8679223|NCT01482195|21427154|P1|COMPLETED|Overall Study||6
8679224|NCT01482195|21427154|P1|One Year Results|Overall Study||6
8679225|NCT01482195|21427154|P1|STARTED|Overall Study||6
8679226|NCT01448447|21427169|P2|NOT COMPLETED|Overall Study||0
8679227|NCT01448447|21427170|P1|NOT COMPLETED|Overall Study||0
8679228|NCT01448447|21427169|P2|COMPLETED|Overall Study||0
8679229|NCT01448447|21427170|P1|COMPLETED|Overall Study||20
8679230|NCT01448447|21427169|P2|STARTED|Overall Study||0
8679231|NCT01448447|21427170|P1|STARTED|Overall Study||20
8679232|NCT01394978|21427183|P2|NOT COMPLETED|Overall Study||31
8679233|NCT01394978|21427184|P1|NOT COMPLETED|Overall Study||21
8679234|NCT01394978|21427183|P2|COMPLETED|Overall Study||245
8679235|NCT01394978|21427184|P1|COMPLETED|Overall Study||147
8679236|NCT01394978|21427183|P2|STARTED|Overall Study||276
8679237|NCT01394978|21427184|P1|STARTED|Overall Study||168
8679238|NCT01262898|21427195|P4|NOT COMPLETED|Overall Study||0
8679239|NCT01262898|21427196|P3|NOT COMPLETED|Overall Study||0
8679240|NCT01262898|21427197|P2|NOT COMPLETED|Overall Study||2
8679241|NCT01262898|21427198|P1|NOT COMPLETED|Overall Study||3
8679242|NCT01262898|21427195|P4|COMPLETED|Overall Study||22
8679243|NCT01262898|21427196|P3|COMPLETED|Overall Study||18
8679244|NCT01262898|21427197|P2|COMPLETED|Overall Study||16
8679245|NCT01262898|21427198|P1|COMPLETED|Overall Study||18
8679246|NCT01262898|21427195|P4|STARTED|Overall Study||22
8679247|NCT01262898|21427196|P3|STARTED|Overall Study||18
8679248|NCT01262898|21427197|P2|STARTED|Overall Study||18
8679249|NCT01262898|21427198|P1|STARTED|Overall Study||21
8679250|NCT01208051|21427323|P5|NOT COMPLETED|After Crossover to Cediranib Only||0
8679251|NCT01208051|21427324|P4|NOT COMPLETED|After Crossover to Cediranib Only||0
8679252|NCT01208051|21427325|P3|NOT COMPLETED|After Crossover to Cediranib Only||0
8679253|NCT01208051|21427326|P2|NOT COMPLETED|After Crossover to Cediranib Only||0
8679254|NCT01208051|21427327|P1|NOT COMPLETED|After Crossover to Cediranib Only||0
8679255|NCT01208051|21427323|P5|COMPLETED|After Crossover to Cediranib Only||69
8679256|NCT01208051|21427324|P4|COMPLETED|After Crossover to Cediranib Only||39
8679257|NCT01208051|21427325|P3|COMPLETED|After Crossover to Cediranib Only||0
8679258|NCT01208051|21427326|P2|COMPLETED|After Crossover to Cediranib Only||0
8679259|NCT01208051|21427327|P1|COMPLETED|After Crossover to Cediranib Only||0
8679260|NCT01208051|21427323|P5|STARTED|After Crossover to Cediranib Only|One patient entered while futility analysis was ongoing.|69
8679261|NCT01208051|21427324|P4|STARTED|After Crossover to Cediranib Only||39
8679262|NCT01208051|21427325|P3|STARTED|After Crossover to Cediranib Only||0
8679263|NCT01208051|21427326|P2|STARTED|After Crossover to Cediranib Only||0
8679264|NCT01208051|21427327|P1|STARTED|After Crossover to Cediranib Only||0
8679265|NCT01208051|21427323|P5|NOT COMPLETED|Interim Futility Analysis||0
8679266|NCT01208051|21427324|P4|NOT COMPLETED|Interim Futility Analysis||0
8679267|NCT01208051|21427325|P3|NOT COMPLETED|Interim Futility Analysis||0
8679268|NCT01208051|21427326|P2|NOT COMPLETED|Interim Futility Analysis||0
8679269|NCT01208051|21427327|P1|NOT COMPLETED|Interim Futility Analysis||0
8679270|NCT01208051|21427323|P5|COMPLETED|Interim Futility Analysis||68
8679271|NCT01208051|21427324|P4|COMPLETED|Interim Futility Analysis||39
8679272|NCT01208051|21427325|P3|COMPLETED|Interim Futility Analysis||0
8679273|NCT01208051|21427326|P2|COMPLETED|Interim Futility Analysis||0
8679274|NCT01208051|21427327|P1|COMPLETED|Interim Futility Analysis||0
8679275|NCT01208051|21427323|P5|STARTED|Interim Futility Analysis||68
8679276|NCT01208051|21427324|P4|STARTED|Interim Futility Analysis||39
8679277|NCT01208051|21427325|P3|STARTED|Interim Futility Analysis||0
8679278|NCT01208051|21427326|P2|STARTED|Interim Futility Analysis||0
8679279|NCT01208051|21427327|P1|STARTED|Interim Futility Analysis||0
8679280|NCT01208051|21427323|P5|NOT COMPLETED|Total Enrollment||2
8679281|NCT01208051|21427324|P4|NOT COMPLETED|Total Enrollment||0
8679282|NCT01208051|21427325|P3|NOT COMPLETED|Total Enrollment||1
8679283|NCT01208051|21427326|P2|NOT COMPLETED|Total Enrollment||1
8679284|NCT01208051|21427327|P1|NOT COMPLETED|Total Enrollment||0
8679285|NCT01208051|21427323|P5|COMPLETED|Total Enrollment||69
8679286|NCT01208051|21427324|P4|COMPLETED|Total Enrollment||39
8679287|NCT01208051|21427325|P3|COMPLETED|Total Enrollment||5
8679288|NCT01208051|21427326|P2|COMPLETED|Total Enrollment||6
8679289|NCT01208051|21427327|P1|COMPLETED|Total Enrollment||4
8679290|NCT01208051|21427323|P5|STARTED|Total Enrollment||71
8679291|NCT01208051|21427324|P4|STARTED|Total Enrollment||39
8679292|NCT01208051|21427325|P3|STARTED|Total Enrollment||6
8679293|NCT01208051|21427326|P2|STARTED|Total Enrollment||7
8679294|NCT01208051|21427327|P1|STARTED|Total Enrollment||4
8679323|NCT00504894|21427494|P3|NOT COMPLETED|Overall Study||0
8679324|NCT00504894|21427495|P2|NOT COMPLETED|Overall Study||3
8679325|NCT00504894|21427496|P1|NOT COMPLETED|Overall Study||3
8679326|NCT00504894|21427494|P3|COMPLETED|Overall Study||19
8679327|NCT00504894|21427495|P2|COMPLETED|Overall Study||18
8679328|NCT00504894|21427496|P1|COMPLETED|Overall Study||17
8679329|NCT00504894|21427494|P3|STARTED|Overall Study||19
8679330|NCT00504894|21427495|P2|STARTED|Overall Study||21
8679331|NCT00504894|21427496|P1|STARTED|Overall Study||20
8679332|NCT00451035|21427507|P1|NOT COMPLETED|Overall Study||17
8679333|NCT00451035|21427507|P1|COMPLETED|Overall Study||12
8679334|NCT00451035|21427507|P1|STARTED|Overall Study||29
8679335|NCT00449761|21427524|P1|NOT COMPLETED|Overall Study||18
8679336|NCT00449761|21427524|P1|COMPLETED|Overall Study||9
8679337|NCT00449761|21427524|P1|STARTED|Overall Study||27
8679338|NCT00199836|21427544|P1|NOT COMPLETED|Overall Study||6
8679339|NCT00199836|21427544|P1|COMPLETED|Overall Study||8
8679340|NCT00199836|21427544|P1|STARTED|Overall Study||14
8679341|NCT04440449|21427554|P2|NOT COMPLETED|Overall Study||0
8679342|NCT04440449|21427555|P1|NOT COMPLETED|Overall Study||2
8679343|NCT04440449|21427554|P2|COMPLETED|Overall Study||0
8679344|NCT04440449|21427555|P1|COMPLETED|Overall Study||18
8679345|NCT04440449|21427554|P2|STARTED|Overall Study||0
8679346|NCT04440449|21427555|P1|STARTED|Overall Study||20
8679347|NCT04335812|21427570|P2|NOT COMPLETED|Overall Study||33
8679348|NCT04335812|21427571|P1|NOT COMPLETED|Overall Study||35
8679349|NCT04335812|21427570|P2|COMPLETED|Overall Study||30
8679350|NCT04335812|21427571|P1|COMPLETED|Overall Study||28
8679351|NCT04335812|21427570|P2|STARTED|Overall Study||63
8679352|NCT04335812|21427571|P1|STARTED|Overall Study||63
8679353|NCT04271761|21427593|P1|NOT COMPLETED|Overall Study||0
8679354|NCT04271761|21427593|P1|COMPLETED|Overall Study||14
8679355|NCT04271761|21427593|P1|STARTED|Overall Study||14
8679356|NCT04117607|21427603|P14|NOT COMPLETED|Overall Study||0
8679357|NCT04117607|21427604|P13|NOT COMPLETED|Overall Study||0
8679358|NCT04117607|21427605|P12|NOT COMPLETED|Overall Study||0
8679359|NCT04117607|21427606|P11|NOT COMPLETED|Overall Study||0
8679360|NCT04117607|21427607|P10|NOT COMPLETED|Overall Study||0
8679361|NCT04117607|21427608|P9|NOT COMPLETED|Overall Study||0
8679362|NCT04117607|21427609|P8|NOT COMPLETED|Overall Study||0
8679363|NCT04117607|21427610|P7|NOT COMPLETED|Overall Study||1
8679364|NCT04117607|21427611|P6|NOT COMPLETED|Overall Study||0
8679365|NCT04117607|21427612|P5|NOT COMPLETED|Overall Study||0
8679366|NCT04117607|21427613|P4|NOT COMPLETED|Overall Study||0
8679367|NCT04117607|21427614|P3|NOT COMPLETED|Overall Study||0
8679368|NCT04117607|21427615|P2|NOT COMPLETED|Overall Study||1
8679369|NCT04117607|21427616|P1|NOT COMPLETED|Overall Study||0
8679370|NCT04117607|21427603|P14|COMPLETED|Overall Study||0
8679371|NCT04117607|21427604|P13|COMPLETED|Overall Study||0
8679372|NCT04117607|21427605|P12|COMPLETED|Overall Study||0
8679373|NCT04117607|21427606|P11|COMPLETED|Overall Study||0
8679374|NCT04117607|21427607|P10|COMPLETED|Overall Study||0
8679375|NCT04117607|21427608|P9|COMPLETED|Overall Study||0
8679376|NCT04117607|21427609|P8|COMPLETED|Overall Study||0
8679377|NCT04117607|21427610|P7|COMPLETED|Overall Study||3
8679378|NCT04117607|21427611|P6|COMPLETED|Overall Study||0
8679379|NCT04117607|21427612|P5|COMPLETED|Overall Study||0
8679380|NCT04117607|21427613|P4|COMPLETED|Overall Study||0
8679381|NCT04117607|21427614|P3|COMPLETED|Overall Study||0
8679382|NCT04117607|21427615|P2|COMPLETED|Overall Study||6
8679383|NCT04117607|21427616|P1|COMPLETED|Overall Study||3
8679384|NCT04117607|21427603|P14|Completed All PK Blood Draws|Overall Study||0
8679385|NCT04117607|21427604|P13|Completed All PK Blood Draws|Overall Study||0
8679386|NCT04117607|21427605|P12|Completed All PK Blood Draws|Overall Study||0
8679387|NCT04117607|21427606|P11|Completed All PK Blood Draws|Overall Study||0
8679388|NCT04117607|21427607|P10|Completed All PK Blood Draws|Overall Study||0
8679389|NCT04117607|21427608|P9|Completed All PK Blood Draws|Overall Study||0
8679390|NCT04117607|21427609|P8|Completed All PK Blood Draws|Overall Study||0
8679391|NCT04117607|21427610|P7|Completed All PK Blood Draws|Overall Study||1
8679392|NCT04117607|21427611|P6|Completed All PK Blood Draws|Overall Study||0
8679393|NCT04117607|21427612|P5|Completed All PK Blood Draws|Overall Study||0
8679394|NCT04117607|21427613|P4|Completed All PK Blood Draws|Overall Study||0
8679395|NCT04117607|21427614|P3|Completed All PK Blood Draws|Overall Study||0
8679396|NCT04117607|21427615|P2|Completed All PK Blood Draws|Overall Study||6
8679397|NCT04117607|21427616|P1|Completed All PK Blood Draws|Overall Study||0
8679398|NCT04117607|21427603|P14|Received Study Product|Overall Study||0
8679399|NCT04117607|21427604|P13|Received Study Product|Overall Study||0
8679400|NCT04117607|21427605|P12|Received Study Product|Overall Study||0
8679401|NCT04117607|21427606|P11|Received Study Product|Overall Study||0
8679402|NCT04117607|21427607|P10|Received Study Product|Overall Study||0
8679403|NCT04117607|21427608|P9|Received Study Product|Overall Study||0
8679404|NCT04117607|21427609|P8|Received Study Product|Overall Study||0
8679405|NCT04117607|21427610|P7|Received Study Product|Overall Study||3
8679406|NCT04117607|21427611|P6|Received Study Product|Overall Study||0
8679407|NCT04117607|21427612|P5|Received Study Product|Overall Study||0
8679408|NCT04117607|21427613|P4|Received Study Product|Overall Study||0
8679409|NCT04117607|21427614|P3|Received Study Product|Overall Study||0
8679410|NCT04117607|21427615|P2|Received Study Product|Overall Study||6
8679411|NCT04117607|21427616|P1|Received Study Product|Overall Study||3
8679412|NCT04117607|21427603|P14|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
8679413|NCT04117607|21427604|P13|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
8679414|NCT04117607|21427605|P12|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
8679583|NCT02734979|21428255|P1|COMPLETED|Overall Study||1
8679415|NCT04117607|21427606|P11|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
8679416|NCT04117607|21427607|P10|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
8679417|NCT04117607|21427608|P9|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
8679418|NCT04117607|21427609|P8|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
8679419|NCT04117607|21427610|P7|STARTED|Overall Study||4
8679420|NCT04117607|21427611|P6|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
8679421|NCT04117607|21427612|P5|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
8679422|NCT04117607|21427613|P4|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
8679423|NCT04117607|21427614|P3|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
8679424|NCT04117607|21427615|P2|STARTED|Overall Study||7
8679425|NCT04117607|21427616|P1|STARTED|Overall Study||3
8679426|NCT04072237|21427791|P1|NOT COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||0
8679427|NCT04072237|21427791|P1|COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
8679428|NCT04072237|21427791|P1|STARTED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
8679429|NCT04072237|21427791|P1|NOT COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||0
8679430|NCT04072237|21427791|P1|COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
8679431|NCT04072237|21427791|P1|STARTED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
8679432|NCT04072237|21427791|P1|NOT COMPLETED|Stage 7: MarzAA 120 µg/kg SC||0
8679433|NCT04072237|21427791|P1|COMPLETED|Stage 7: MarzAA 120 µg/kg SC||8
8679434|NCT04072237|21427791|P1|STARTED|Stage 7: MarzAA 120 µg/kg SC||8
8679435|NCT04072237|21427791|P1|NOT COMPLETED|Stage 6: MarzAA 90 µg/kg SC||0
8679436|NCT04072237|21427791|P1|COMPLETED|Stage 6: MarzAA 90 µg/kg SC||8
8679437|NCT04072237|21427791|P1|STARTED|Stage 6: MarzAA 90 µg/kg SC||8
8679438|NCT04072237|21427791|P1|NOT COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||0
8679439|NCT04072237|21427791|P1|COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
8679440|NCT04072237|21427791|P1|STARTED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
8679441|NCT04072237|21427791|P1|NOT COMPLETED|Stage 4: MarzAA 60 µg/kg SC||0
8679442|NCT04072237|21427791|P1|COMPLETED|Stage 4: MarzAA 60 µg/kg SC||8
8679443|NCT04072237|21427791|P1|STARTED|Stage 4: MarzAA 60 µg/kg SC||8
8679444|NCT04072237|21427791|P1|NOT COMPLETED|Stage 3: MarzAA 45 µg/kg SC||0
8679445|NCT04072237|21427791|P1|COMPLETED|Stage 3: MarzAA 45 µg/kg SC||8
8679446|NCT04072237|21427791|P1|STARTED|Stage 3: MarzAA 45 µg/kg SC||8
8679447|NCT04072237|21427791|P1|NOT COMPLETED|Stage 2: MarzAA 30 µg/kg SC||0
8679448|NCT04072237|21427791|P1|COMPLETED|Stage 2: MarzAA 30 µg/kg SC||8
8679449|NCT04072237|21427791|P1|STARTED|Stage 2: MarzAA 30 µg/kg SC||8
8679450|NCT04072237|21427791|P1|NOT COMPLETED|Stage I: MarzAA 18 µg/kg IV||1
8679451|NCT04072237|21427791|P1|COMPLETED|Stage I: MarzAA 18 µg/kg IV||10
8679452|NCT04072237|21427791|P1|STARTED|Stage I: MarzAA 18 µg/kg IV||11
8679453|NCT03802916|21427997|P2|NOT COMPLETED|Overall Study||2
8679454|NCT03802916|21427998|P1|NOT COMPLETED|Overall Study||0
8679455|NCT03802916|21427997|P2|COMPLETED|Overall Study||13
8679456|NCT03802916|21427998|P1|COMPLETED|Overall Study||15
8679457|NCT03802916|21427997|P2|STARTED|Overall Study||15
8679458|NCT03802916|21427998|P1|STARTED|Overall Study||15
8679459|NCT03750695|21428008|P2|NOT COMPLETED|Overall Study||1
8679460|NCT03750695|21428009|P1|NOT COMPLETED|Overall Study||0
8679461|NCT03750695|21428008|P2|COMPLETED|Overall Study||7
8679462|NCT03750695|21428009|P1|COMPLETED|Overall Study||8
8679463|NCT03750695|21428008|P2|STARTED|Overall Study||8
8679464|NCT03750695|21428009|P1|STARTED|Overall Study||8
8679465|NCT03694548|21428022|P3|NOT COMPLETED|Part B Yoga Program||11
8679466|NCT03694548|21428023|P2|NOT COMPLETED|Part B Yoga Program||0
8679467|NCT03694548|21428024|P1|NOT COMPLETED|Part B Yoga Program||0
8679468|NCT03694548|21428022|P3|COMPLETED|Part B Yoga Program||1
8679469|NCT03694548|21428023|P2|COMPLETED|Part B Yoga Program||0
8679470|NCT03694548|21428024|P1|COMPLETED|Part B Yoga Program||0
8679471|NCT03694548|21428022|P3|STARTED|Part B Yoga Program||12
8679472|NCT03694548|21428023|P2|STARTED|Part B Yoga Program||0
8679473|NCT03694548|21428024|P1|STARTED|Part B Yoga Program||0
8679474|NCT03694548|21428022|P3|NOT COMPLETED|Part A Survey||0
8679475|NCT03694548|21428023|P2|NOT COMPLETED|Part A Survey||3
8679476|NCT03694548|21428024|P1|NOT COMPLETED|Part A Survey||3
8679477|NCT03694548|21428022|P3|COMPLETED|Part A Survey||0
8679478|NCT03694548|21428023|P2|COMPLETED|Part A Survey||14
8679479|NCT03694548|21428024|P1|COMPLETED|Part A Survey||15
8679480|NCT03694548|21428022|P3|STARTED|Part A Survey||0
8679481|NCT03694548|21428023|P2|STARTED|Part A Survey||17
8679482|NCT03694548|21428024|P1|STARTED|Part A Survey||18
8679501|NCT03678285|21428062|P1|NOT COMPLETED|Overall Study||4
8679502|NCT03678285|21428062|P1|COMPLETED|Overall Study||38
8679503|NCT03678285|21428062|P1|Started Workout|Overall Study||40
8679504|NCT03678285|21428062|P1|STARTED|Overall Study||42
8679505|NCT03610048|21428072|P1|NOT COMPLETED|Overall Study||161
8679506|NCT03610048|21428072|P1|COMPLETED|Overall Study||14
8679507|NCT03610048|21428072|P1|Completed Treatment|Overall Study||15
8679508|NCT03610048|21428072|P1|STARTED|Overall Study||175
8679509|NCT03512210|21428076|P1|NOT COMPLETED|Overall Study||4
8679510|NCT03512210|21428076|P1|COMPLETED|Overall Study||396
8679511|NCT03512210|21428076|P1|STARTED|Overall Study||400
8679512|NCT03338816|21428086|P2|NOT COMPLETED|Open-Label Extension Period||47
8679513|NCT03338816|21428087|P1|NOT COMPLETED|Open-Label Extension Period||46
8679514|NCT03338816|21428086|P2|COMPLETED|Open-Label Extension Period||0
8679515|NCT03338816|21428087|P1|COMPLETED|Open-Label Extension Period||0
8679516|NCT03338816|21428086|P2|STARTED|Open-Label Extension Period||47
8679517|NCT03338816|21428087|P1|STARTED|Open-Label Extension Period||46
8679518|NCT03338816|21428086|P2|NOT COMPLETED|6-Month Double-blind Period||1
8679519|NCT03338816|21428087|P1|NOT COMPLETED|6-Month Double-blind Period||0
8679520|NCT03338816|21428086|P2|COMPLETED|6-Month Double-blind Period|1 participant discontinued treatment during the 6-month DB period but completed the 6-month DB Visit|47
8679521|NCT03338816|21428087|P1|COMPLETED|6-Month Double-blind Period||46
8679522|NCT03338816|21428086|P2|STARTED|6-Month Double-blind Period||48
8679523|NCT03338816|21428087|P1|STARTED|6-Month Double-blind Period||46
8679524|NCT03303105|21428117|P2|NOT COMPLETED|Overall Study||4
8679525|NCT03303105|21428118|P1|NOT COMPLETED|Overall Study||2
8679526|NCT03303105|21428117|P2|COMPLETED|Overall Study||21
8679527|NCT03303105|21428118|P1|COMPLETED|Overall Study||23
8679528|NCT03303105|21428117|P2|STARTED|Overall Study||25
8679529|NCT03303105|21428118|P1|STARTED|Overall Study||25
8679530|NCT03294850|21428130|P2|NOT COMPLETED|Overall Study||0
8679531|NCT03294850|21428131|P1|NOT COMPLETED|Overall Study||0
8679532|NCT03294850|21428130|P2|COMPLETED|Overall Study||10
8679533|NCT03294850|21428131|P1|COMPLETED|Overall Study||4
8679534|NCT03294850|21428130|P2|STARTED|Overall Study||10
8679535|NCT03294850|21428131|P1|STARTED|Overall Study||4
8679542|NCT03194737|21428156|P2|NOT COMPLETED|Overall Study||0
8679543|NCT03194737|21428157|P1|NOT COMPLETED|Overall Study||5
8679544|NCT03194737|21428156|P2|COMPLETED|Overall Study||49
8679545|NCT03194737|21428157|P1|COMPLETED|Overall Study||47
8679546|NCT03194737|21428156|P2|STARTED|Overall Study||49
8679547|NCT03194737|21428157|P1|STARTED|Overall Study||52
8679548|NCT03178201|21428165|P1|NOT COMPLETED|Overall Study||5
8679549|NCT03178201|21428165|P1|COMPLETED|Overall Study||0
8679550|NCT03178201|21428165|P1|STARTED|Overall Study||5
8679551|NCT03141242|21428176|P2|NOT COMPLETED|Overall Study||0
8679552|NCT03141242|21428177|P1|NOT COMPLETED|Overall Study||0
8679553|NCT03141242|21428176|P2|COMPLETED|Overall Study||55
8679554|NCT03141242|21428177|P1|COMPLETED|Overall Study||55
8679555|NCT03141242|21428176|P2|6 Month Interview|Overall Study||49
8679556|NCT03141242|21428177|P1|6 Month Interview|Overall Study||51
8679557|NCT03141242|21428176|P2|Received Allocated Intervenion|Overall Study||55
8679558|NCT03141242|21428177|P1|Received Allocated Intervenion|Overall Study|11 subjects didn't attend their scheduled group session; all were included in ITT analysis|44
8679559|NCT03141242|21428176|P2|STARTED|Overall Study||55
8679560|NCT03141242|21428177|P1|STARTED|Overall Study||55
8679561|NCT03095118|21428200|P1|NOT COMPLETED|Overall Study||2
8679562|NCT03095118|21428200|P1|COMPLETED|Overall Study||10
8679563|NCT03095118|21428200|P1|STARTED|Overall Study||12
8679570|NCT02867618|21428235|P1|NOT COMPLETED|Overall Study||0
8679571|NCT02867618|21428235|P1|COMPLETED|Overall Study||11
8679572|NCT02867618|21428235|P1|STARTED|Overall Study||11
8679573|NCT02831816|21428240|P1|NOT COMPLETED|Overall Study||0
8679574|NCT02831816|21428240|P1|COMPLETED|Overall Study||640
8679575|NCT02831816|21428240|P1|Vehicle|Overall Study||131
8679576|NCT02831816|21428240|P1|CP|Overall Study||590
8679577|NCT02831816|21428240|P1|ZP|Overall Study||589
8679578|NCT02831816|21428240|P1|STARTED|Overall Study||640
8679579|NCT02783469|21428251|P1|NOT COMPLETED|Overall Study||0
8679580|NCT02783469|21428251|P1|COMPLETED|Overall Study||1915
8679581|NCT02783469|21428251|P1|STARTED|Overall Study||1915
8679582|NCT02734979|21428255|P1|NOT COMPLETED|Overall Study||0
8679584|NCT02734979|21428255|P1|STARTED|Overall Study||1
8679585|NCT02723084|21428272|P2|NOT COMPLETED|Overall Study||1
8679586|NCT02723084|21428273|P1|NOT COMPLETED|Overall Study||4
8679587|NCT02723084|21428272|P2|COMPLETED|Overall Study||45
8679588|NCT02723084|21428273|P1|COMPLETED|Overall Study||86
8679589|NCT02723084|21428272|P2|STARTED|Overall Study||46
8679590|NCT02723084|21428273|P1|STARTED|Overall Study||90
8679591|NCT02707952|21428288|P4|NOT COMPLETED|Overall Study||0
8679592|NCT02707952|21428289|P3|NOT COMPLETED|Overall Study||2
8679593|NCT02707952|21428290|P2|NOT COMPLETED|Overall Study||1
8679594|NCT02707952|21428291|P1|NOT COMPLETED|Overall Study||2
8679595|NCT02707952|21428288|P4|COMPLETED|Overall Study||10
8679596|NCT02707952|21428289|P3|COMPLETED|Overall Study||101
8679597|NCT02707952|21428290|P2|COMPLETED|Overall Study||52
8679598|NCT02707952|21428291|P1|COMPLETED|Overall Study||127
8679599|NCT02707952|21428288|P4|Participants Who Received Study Drug|Overall Study||10
8679600|NCT02707952|21428289|P3|Participants Who Received Study Drug|Overall Study||103
8679601|NCT02707952|21428290|P2|Participants Who Received Study Drug|Overall Study||52
8679602|NCT02707952|21428291|P1|Participants Who Received Study Drug|Overall Study||129
8679603|NCT02707952|21428288|P4|STARTED|Overall Study||10
8679604|NCT02707952|21428289|P3|STARTED|Overall Study||103
8679605|NCT02707952|21428290|P2|STARTED|Overall Study||53
8679606|NCT02707952|21428291|P1|STARTED|Overall Study||129
8679607|NCT02640482|21428312|P2|NOT COMPLETED|Overall Study||0
8679608|NCT02640482|21428313|P1|NOT COMPLETED|Overall Study||3
8679609|NCT02640482|21428312|P2|COMPLETED|Overall Study||100
8679610|NCT02640482|21428313|P1|COMPLETED|Overall Study||199
8679611|NCT02640482|21428312|P2|STARTED|Overall Study||100
8679612|NCT02640482|21428313|P1|STARTED|Overall Study||202
8679625|NCT02573246|21428370|P5|NOT COMPLETED|Overall Study||4
8679626|NCT02573246|21428371|P4|NOT COMPLETED|Overall Study||2
8679627|NCT02573246|21428372|P3|NOT COMPLETED|Overall Study||3
8679628|NCT02573246|21428373|P2|NOT COMPLETED|Overall Study||1
8679629|NCT02573246|21428374|P1|NOT COMPLETED|Overall Study||3
8679630|NCT02573246|21428370|P5|COMPLETED|Overall Study||11
8679631|NCT02573246|21428371|P4|COMPLETED|Overall Study||14
8679632|NCT02573246|21428372|P3|COMPLETED|Overall Study||15
8679633|NCT02573246|21428373|P2|COMPLETED|Overall Study||14
8679634|NCT02573246|21428374|P1|COMPLETED|Overall Study||11
8679635|NCT02573246|21428370|P5|STARTED|Overall Study||15
8679636|NCT02573246|21428371|P4|STARTED|Overall Study||16
8679637|NCT02573246|21428372|P3|STARTED|Overall Study||18
8679638|NCT02573246|21428373|P2|STARTED|Overall Study||15
8679639|NCT02573246|21428374|P1|STARTED|Overall Study||14
8679640|NCT02460666|21428428|P2|NOT COMPLETED|Overall Study||26
8679641|NCT02460666|21428429|P1|NOT COMPLETED|Overall Study||27
8679642|NCT02460666|21428428|P2|COMPLETED|Overall Study||63
8679643|NCT02460666|21428429|P1|COMPLETED|Overall Study||62
8679644|NCT02460666|21428428|P2|STARTED|Overall Study||89
8679645|NCT02460666|21428429|P1|STARTED|Overall Study||89
8679646|NCT02439970|21428445|P2|NOT COMPLETED|Overall Study||3
8679647|NCT02439970|21428446|P1|NOT COMPLETED|Overall Study||2
8679648|NCT02439970|21428445|P2|COMPLETED|Overall Study||0
8679649|NCT02439970|21428446|P1|COMPLETED|Overall Study||0
8679650|NCT02439970|21428445|P2|STARTED|Overall Study||3
8679651|NCT02439970|21428446|P1|STARTED|Overall Study||2
8679652|NCT02439957|21428454|P2|NOT COMPLETED|Overall Study||3
8679653|NCT02439957|21428455|P1|NOT COMPLETED|Overall Study||3
8679654|NCT02439957|21428454|P2|COMPLETED|Overall Study||0
8679655|NCT02439957|21428455|P1|COMPLETED|Overall Study||0
8679656|NCT02439957|21428454|P2|Blinded Treatment Period|Overall Study||2
8679657|NCT02439957|21428455|P1|Blinded Treatment Period|Overall Study||1
8679658|NCT02439957|21428454|P2|STARTED|Overall Study||3
8679659|NCT02439957|21428455|P1|STARTED|Overall Study||3
8679660|NCT02346240|21428465|P24|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||8
8679661|NCT02346240|21428466|P23|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
8679662|NCT02346240|21428467|P22|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||31
8679663|NCT02346240|21428468|P21|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
8679664|NCT02346240|21428469|P20|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
8679665|NCT02346240|21428470|P19|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||17
8679666|NCT02346240|21428471|P18|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
8679667|NCT02346240|21428472|P17|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679668|NCT02346240|21428473|P16|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679669|NCT02346240|21428474|P15|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679670|NCT02346240|21428475|P14|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679671|NCT02346240|21428476|P13|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679672|NCT02346240|21428477|P12|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679673|NCT02346240|21428478|P11|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679674|NCT02346240|21428479|P10|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679675|NCT02346240|21428480|P9|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679676|NCT02346240|21428481|P8|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679677|NCT02346240|21428482|P7|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679678|NCT02346240|21428483|P6|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679679|NCT02346240|21428484|P5|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679680|NCT02346240|21428485|P4|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679681|NCT02346240|21428486|P3|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679682|NCT02346240|21428487|P2|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679683|NCT02346240|21428488|P1|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679684|NCT02346240|21428465|P24|COMPLETED|Open-Label Period (Week 48 to Week 144)||8
8679685|NCT02346240|21428466|P23|COMPLETED|Open-Label Period (Week 48 to Week 144)||27
8679686|NCT02346240|21428467|P22|COMPLETED|Open-Label Period (Week 48 to Week 144)||146
8679687|NCT02346240|21428468|P21|COMPLETED|Open-Label Period (Week 48 to Week 144)||45
8679688|NCT02346240|21428469|P20|COMPLETED|Open-Label Period (Week 48 to Week 144)||34
8679689|NCT02346240|21428470|P19|COMPLETED|Open-Label Period (Week 48 to Week 144)||105
8679690|NCT02346240|21428471|P18|COMPLETED|Open-Label Period (Week 48 to Week 144)||31
8679691|NCT02346240|21428472|P17|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679692|NCT02346240|21428473|P16|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679693|NCT02346240|21428474|P15|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679694|NCT02346240|21428475|P14|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679695|NCT02346240|21428476|P13|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679696|NCT02346240|21428477|P12|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679697|NCT02346240|21428478|P11|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679698|NCT02346240|21428479|P10|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679699|NCT02346240|21428480|P9|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679700|NCT02346240|21428481|P8|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679701|NCT02346240|21428482|P7|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679702|NCT02346240|21428483|P6|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679703|NCT02346240|21428484|P5|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679704|NCT02346240|21428485|P4|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679705|NCT02346240|21428486|P3|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679706|NCT02346240|21428487|P2|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679707|NCT02346240|21428488|P1|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
8679708|NCT02346240|21428465|P24|STARTED|Open-Label Period (Week 48 to Week 144)||16
8679709|NCT02346240|21428466|P23|STARTED|Open-Label Period (Week 48 to Week 144)||34
8679710|NCT02346240|21428467|P22|STARTED|Open-Label Period (Week 48 to Week 144)||177
8679711|NCT02346240|21428468|P21|STARTED|Open-Label Period (Week 48 to Week 144)||48
8679712|NCT02346240|21428469|P20|STARTED|Open-Label Period (Week 48 to Week 144)||41
8679713|NCT02346240|21428470|P19|STARTED|Open-Label Period (Week 48 to Week 144)||122
8679714|NCT02346240|21428471|P18|STARTED|Open-Label Period (Week 48 to Week 144)||34
8679715|NCT02346240|21428472|P17|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679716|NCT02346240|21428473|P16|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679717|NCT02346240|21428474|P15|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679718|NCT02346240|21428475|P14|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679719|NCT02346240|21428476|P13|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679720|NCT02346240|21428477|P12|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679721|NCT02346240|21428478|P11|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679722|NCT02346240|21428479|P10|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679723|NCT02346240|21428480|P9|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679724|NCT02346240|21428481|P8|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679725|NCT02346240|21428482|P7|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679726|NCT02346240|21428483|P6|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679727|NCT02346240|21428484|P5|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679728|NCT02346240|21428485|P4|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679729|NCT02346240|21428486|P3|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679730|NCT02346240|21428487|P2|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679731|NCT02346240|21428488|P1|STARTED|Open-Label Period (Week 48 to Week 144)||0
8679732|NCT02346240|21428465|P24|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679733|NCT02346240|21428466|P23|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679734|NCT02346240|21428467|P22|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679735|NCT02346240|21428468|P21|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679736|NCT02346240|21428469|P20|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679737|NCT02346240|21428470|P19|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679738|NCT02346240|21428471|P18|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679739|NCT02346240|21428472|P17|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
8679740|NCT02346240|21428473|P16|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||14
8679741|NCT02346240|21428474|P15|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||17
8679742|NCT02346240|21428475|P14|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8
8679743|NCT02346240|21428476|P13|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679744|NCT02346240|21428477|P12|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||3
8679745|NCT02346240|21428478|P11|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8679746|NCT02346240|21428479|P10|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
8679747|NCT02346240|21428480|P9|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||4
8679748|NCT02346240|21428481|P8|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8679749|NCT02346240|21428482|P7|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8679750|NCT02346240|21428483|P6|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
8679751|NCT02346240|21428484|P5|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679752|NCT02346240|21428485|P4|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679753|NCT02346240|21428486|P3|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679754|NCT02346240|21428487|P2|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679755|NCT02346240|21428488|P1|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679756|NCT02346240|21428465|P24|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679757|NCT02346240|21428466|P23|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679758|NCT02346240|21428467|P22|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679759|NCT02346240|21428468|P21|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679760|NCT02346240|21428469|P20|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679761|NCT02346240|21428470|P19|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679762|NCT02346240|21428471|P18|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679763|NCT02346240|21428472|P17|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|29
8679764|NCT02346240|21428473|P16|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|35
8679765|NCT02346240|21428474|P15|COMPLETED|Maintenance Period (Week 16 to Week 48)|3 subjects completed the Maintenance Period but did not enter the Open-Label Period.|68
8679766|NCT02346240|21428475|P14|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|45
8679767|NCT02346240|21428476|P13|COMPLETED|Maintenance Period (Week 16 to Week 48)||49
8679768|NCT02346240|21428477|P12|COMPLETED|Maintenance Period (Week 16 to Week 48)||47
8679769|NCT02346240|21428478|P11|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
8679770|NCT02346240|21428479|P10|COMPLETED|Maintenance Period (Week 16 to Week 48)||43
8679771|NCT02346240|21428480|P9|COMPLETED|Maintenance Period (Week 16 to Week 48)||40
8679772|NCT02346240|21428481|P8|COMPLETED|Maintenance Period (Week 16 to Week 48)||20
8679773|NCT02346240|21428482|P7|COMPLETED|Maintenance Period (Week 16 to Week 48)||48
8679774|NCT02346240|21428483|P6|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
8679775|NCT02346240|21428484|P5|COMPLETED|Maintenance Period (Week 16 to Week 48)||2
8679776|NCT02346240|21428485|P4|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679777|NCT02346240|21428486|P3|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679778|NCT02346240|21428487|P2|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679779|NCT02346240|21428488|P1|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
8679780|NCT02346240|21428465|P24|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8679781|NCT02346240|21428466|P23|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8679782|NCT02346240|21428467|P22|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8679783|NCT02346240|21428468|P21|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8679784|NCT02346240|21428469|P20|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8679785|NCT02346240|21428470|P19|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8679786|NCT02346240|21428471|P18|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8679787|NCT02346240|21428472|P17|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||29
8679788|NCT02346240|21428473|P16|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||35
8679789|NCT02346240|21428474|P15|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||68
8679790|NCT02346240|21428475|P14|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||45
8679791|NCT02346240|21428476|P13|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||49
8679792|NCT02346240|21428477|P12|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||47
8679793|NCT02346240|21428478|P11|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
8679794|NCT02346240|21428479|P10|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||43
8679795|NCT02346240|21428480|P9|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||40
8679796|NCT02346240|21428481|P8|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||20
8679797|NCT02346240|21428482|P7|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||48
8679798|NCT02346240|21428483|P6|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
8679799|NCT02346240|21428484|P5|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||2
8679800|NCT02346240|21428485|P4|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8679801|NCT02346240|21428486|P3|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8679802|NCT02346240|21428487|P2|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8679803|NCT02346240|21428488|P1|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
8679804|NCT02346240|21428465|P24|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8679805|NCT02346240|21428466|P23|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8679806|NCT02346240|21428467|P22|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8679807|NCT02346240|21428468|P21|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8679808|NCT02346240|21428469|P20|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8679809|NCT02346240|21428470|P19|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8679810|NCT02346240|21428471|P18|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8679811|NCT02346240|21428472|P17|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||30
8679812|NCT02346240|21428473|P16|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||36
8679813|NCT02346240|21428474|P15|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||71
8679814|NCT02346240|21428475|P14|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||46
8679815|NCT02346240|21428476|P13|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||49
8679816|NCT02346240|21428477|P12|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||47
8679817|NCT02346240|21428478|P11|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
8679818|NCT02346240|21428479|P10|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||43
8679819|NCT02346240|21428480|P9|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||40
8679820|NCT02346240|21428481|P8|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||20
8679821|NCT02346240|21428482|P7|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||48
8679822|NCT02346240|21428483|P6|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
8679823|NCT02346240|21428484|P5|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||2
8679824|NCT02346240|21428485|P4|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8679825|NCT02346240|21428486|P3|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8679826|NCT02346240|21428487|P2|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8679827|NCT02346240|21428488|P1|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
8679828|NCT02346240|21428465|P24|STARTED|Maintenance Period (Week 16 to Week 48)||0
8679829|NCT02346240|21428466|P23|STARTED|Maintenance Period (Week 16 to Week 48)||0
8679830|NCT02346240|21428467|P22|STARTED|Maintenance Period (Week 16 to Week 48)||0
8679831|NCT02346240|21428468|P21|STARTED|Maintenance Period (Week 16 to Week 48)||0
8679832|NCT02346240|21428469|P20|STARTED|Maintenance Period (Week 16 to Week 48)||0
8679833|NCT02346240|21428470|P19|STARTED|Maintenance Period (Week 16 to Week 48)||0
8679834|NCT02346240|21428471|P18|STARTED|Maintenance Period (Week 16 to Week 48)||0
8679835|NCT02346240|21428472|P17|STARTED|Maintenance Period (Week 16 to Week 48)||36
8679836|NCT02346240|21428473|P16|STARTED|Maintenance Period (Week 16 to Week 48)||49
8679837|NCT02346240|21428474|P15|STARTED|Maintenance Period (Week 16 to Week 48)||85
8679838|NCT02346240|21428475|P14|STARTED|Maintenance Period (Week 16 to Week 48)||53
8679839|NCT02346240|21428476|P13|STARTED|Maintenance Period (Week 16 to Week 48)||49
8679840|NCT02346240|21428477|P12|STARTED|Maintenance Period (Week 16 to Week 48)||50
8679841|NCT02346240|21428478|P11|STARTED|Maintenance Period (Week 16 to Week 48)||25
8679842|NCT02346240|21428479|P10|STARTED|Maintenance Period (Week 16 to Week 48)||44
8679843|NCT02346240|21428480|P9|STARTED|Maintenance Period (Week 16 to Week 48)||44
8679844|NCT02346240|21428481|P8|STARTED|Maintenance Period (Week 16 to Week 48)||22
8679845|NCT02346240|21428482|P7|STARTED|Maintenance Period (Week 16 to Week 48)||50
8679846|NCT02346240|21428483|P6|STARTED|Maintenance Period (Week 16 to Week 48)||24
8679847|NCT02346240|21428484|P5|STARTED|Maintenance Period (Week 16 to Week 48)||2
8679848|NCT02346240|21428485|P4|STARTED|Maintenance Period (Week 16 to Week 48)||0
8679849|NCT02346240|21428486|P3|STARTED|Maintenance Period (Week 16 to Week 48)||0
8679850|NCT02346240|21428487|P2|STARTED|Maintenance Period (Week 16 to Week 48)||0
8679851|NCT02346240|21428488|P1|STARTED|Maintenance Period (Week 16 to Week 48)||0
8679852|NCT02346240|21428465|P24|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679853|NCT02346240|21428466|P23|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679854|NCT02346240|21428467|P22|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679855|NCT02346240|21428468|P21|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679856|NCT02346240|21428469|P20|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679857|NCT02346240|21428470|P19|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679858|NCT02346240|21428471|P18|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679859|NCT02346240|21428472|P17|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679860|NCT02346240|21428473|P16|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679861|NCT02346240|21428474|P15|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679862|NCT02346240|21428475|P14|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679863|NCT02346240|21428476|P13|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679864|NCT02346240|21428477|P12|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679865|NCT02346240|21428478|P11|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679866|NCT02346240|21428479|P10|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679867|NCT02346240|21428480|P9|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679868|NCT02346240|21428481|P8|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679869|NCT02346240|21428482|P7|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679870|NCT02346240|21428483|P6|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679871|NCT02346240|21428484|P5|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
8679872|NCT02346240|21428485|P4|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
8679873|NCT02346240|21428486|P3|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
8679874|NCT02346240|21428487|P2|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
8679875|NCT02346240|21428488|P1|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
8679876|NCT02346240|21428465|P24|COMPLETED|Initial Period (Baseline to Week 16)||0
8679877|NCT02346240|21428466|P23|COMPLETED|Initial Period (Baseline to Week 16)||0
8679878|NCT02346240|21428467|P22|COMPLETED|Initial Period (Baseline to Week 16)||0
8679879|NCT02346240|21428468|P21|COMPLETED|Initial Period (Baseline to Week 16)||0
8679880|NCT02346240|21428469|P20|COMPLETED|Initial Period (Baseline to Week 16)||0
8679881|NCT02346240|21428470|P19|COMPLETED|Initial Period (Baseline to Week 16)||0
8679882|NCT02346240|21428471|P18|COMPLETED|Initial Period (Baseline to Week 16)||0
8679883|NCT02346240|21428472|P17|COMPLETED|Initial Period (Baseline to Week 16)||0
8679884|NCT02346240|21428473|P16|COMPLETED|Initial Period (Baseline to Week 16)||0
8679885|NCT02346240|21428474|P15|COMPLETED|Initial Period (Baseline to Week 16)||0
8679886|NCT02346240|21428475|P14|COMPLETED|Initial Period (Baseline to Week 16)||0
8679887|NCT02346240|21428476|P13|COMPLETED|Initial Period (Baseline to Week 16)||0
8679888|NCT02346240|21428477|P12|COMPLETED|Initial Period (Baseline to Week 16)||0
8679889|NCT02346240|21428478|P11|COMPLETED|Initial Period (Baseline to Week 16)||0
8679890|NCT02346240|21428479|P10|COMPLETED|Initial Period (Baseline to Week 16)||0
8679891|NCT02346240|21428480|P9|COMPLETED|Initial Period (Baseline to Week 16)||0
8679892|NCT02346240|21428481|P8|COMPLETED|Initial Period (Baseline to Week 16)||0
8679893|NCT02346240|21428482|P7|COMPLETED|Initial Period (Baseline to Week 16)||0
8679894|NCT02346240|21428483|P6|COMPLETED|Initial Period (Baseline to Week 16)||0
8679895|NCT02346240|21428484|P5|COMPLETED|Initial Period (Baseline to Week 16)||0
8679896|NCT02346240|21428485|P4|COMPLETED|Initial Period (Baseline to Week 16)||160
8679897|NCT02346240|21428486|P3|COMPLETED|Initial Period (Baseline to Week 16)||159
8679898|NCT02346240|21428487|P2|COMPLETED|Initial Period (Baseline to Week 16)||159
8679899|NCT02346240|21428488|P1|COMPLETED|Initial Period (Baseline to Week 16)||55
8679900|NCT02346240|21428465|P24|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679901|NCT02346240|21428466|P23|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679902|NCT02346240|21428467|P22|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679903|NCT02346240|21428468|P21|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679904|NCT02346240|21428469|P20|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679905|NCT02346240|21428470|P19|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679906|NCT02346240|21428471|P18|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679907|NCT02346240|21428472|P17|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679908|NCT02346240|21428473|P16|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679909|NCT02346240|21428474|P15|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679910|NCT02346240|21428475|P14|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679911|NCT02346240|21428476|P13|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679912|NCT02346240|21428477|P12|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679913|NCT02346240|21428478|P11|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679914|NCT02346240|21428479|P10|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679915|NCT02346240|21428480|P9|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679916|NCT02346240|21428481|P8|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679917|NCT02346240|21428482|P7|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679918|NCT02346240|21428483|P6|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679919|NCT02346240|21428484|P5|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
8679920|NCT02346240|21428485|P4|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
8679921|NCT02346240|21428486|P3|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
8679922|NCT02346240|21428487|P2|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
8679923|NCT02346240|21428488|P1|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
8679924|NCT02346240|21428465|P24|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679925|NCT02346240|21428466|P23|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679926|NCT02346240|21428467|P22|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679927|NCT02346240|21428468|P21|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679928|NCT02346240|21428469|P20|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679929|NCT02346240|21428470|P19|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679930|NCT02346240|21428471|P18|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679931|NCT02346240|21428472|P17|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679932|NCT02346240|21428473|P16|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679933|NCT02346240|21428474|P15|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679934|NCT02346240|21428475|P14|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679935|NCT02346240|21428476|P13|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679936|NCT02346240|21428477|P12|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679937|NCT02346240|21428478|P11|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679938|NCT02346240|21428479|P10|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679939|NCT02346240|21428480|P9|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679940|NCT02346240|21428481|P8|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679941|NCT02346240|21428482|P7|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679942|NCT02346240|21428483|P6|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679943|NCT02346240|21428484|P5|Completed Week 16|Initial Period (Baseline to Week 16)||0
8679944|NCT02346240|21428485|P4|Completed Week 16|Initial Period (Baseline to Week 16)||162
8679945|NCT02346240|21428486|P3|Completed Week 16|Initial Period (Baseline to Week 16)||159
8679946|NCT02346240|21428487|P2|Completed Week 16|Initial Period (Baseline to Week 16)||159
8679947|NCT02346240|21428488|P1|Completed Week 16|Initial Period (Baseline to Week 16)||55
8679948|NCT02346240|21428465|P24|STARTED|Initial Period (Baseline to Week 16)||0
8679949|NCT02346240|21428466|P23|STARTED|Initial Period (Baseline to Week 16)||0
8679950|NCT02346240|21428467|P22|STARTED|Initial Period (Baseline to Week 16)||0
8679951|NCT02346240|21428468|P21|STARTED|Initial Period (Baseline to Week 16)||0
8679952|NCT02346240|21428469|P20|STARTED|Initial Period (Baseline to Week 16)||0
8679953|NCT02346240|21428470|P19|STARTED|Initial Period (Baseline to Week 16)||0
8679954|NCT02346240|21428471|P18|STARTED|Initial Period (Baseline to Week 16)||0
8679955|NCT02346240|21428472|P17|STARTED|Initial Period (Baseline to Week 16)||0
8679956|NCT02346240|21428473|P16|STARTED|Initial Period (Baseline to Week 16)||0
8679957|NCT02346240|21428474|P15|STARTED|Initial Period (Baseline to Week 16)||0
8679958|NCT02346240|21428475|P14|STARTED|Initial Period (Baseline to Week 16)||0
8679959|NCT02346240|21428476|P13|STARTED|Initial Period (Baseline to Week 16)||0
8679960|NCT02346240|21428477|P12|STARTED|Initial Period (Baseline to Week 16)||0
8679961|NCT02346240|21428478|P11|STARTED|Initial Period (Baseline to Week 16)||0
8679962|NCT02346240|21428479|P10|STARTED|Initial Period (Baseline to Week 16)||0
8679963|NCT02346240|21428480|P9|STARTED|Initial Period (Baseline to Week 16)||0
8679964|NCT02346240|21428481|P8|STARTED|Initial Period (Baseline to Week 16)||0
8679965|NCT02346240|21428482|P7|STARTED|Initial Period (Baseline to Week 16)||0
8679966|NCT02346240|21428483|P6|STARTED|Initial Period (Baseline to Week 16)||0
8679967|NCT02346240|21428484|P5|STARTED|Initial Period (Baseline to Week 16)||0
8679968|NCT02346240|21428485|P4|STARTED|Initial Period (Baseline to Week 16)||167
8679969|NCT02346240|21428486|P3|STARTED|Initial Period (Baseline to Week 16)||165
8679970|NCT02346240|21428487|P2|STARTED|Initial Period (Baseline to Week 16)||170
8679971|NCT02346240|21428488|P1|STARTED|Initial Period (Baseline to Week 16)||57
8679978|NCT01963793|21428577|P1|NOT COMPLETED|Overall Study||0
8679979|NCT01963793|21428577|P1|COMPLETED|Overall Study||20
8679980|NCT01963793|21428577|P1|STARTED|Overall Study||20
8680001|NCT01776424|21428632|P3|NOT COMPLETED|Overall Study||24
8680002|NCT01776424|21428633|P2|NOT COMPLETED|Overall Study||19
8680003|NCT01776424|21428634|P1|NOT COMPLETED|Overall Study||20
8680004|NCT01776424|21428632|P3|COMPLETED|Overall Study||9102
8680005|NCT01776424|21428633|P2|COMPLETED|Overall Study||9098
8680006|NCT01776424|21428634|P1|COMPLETED|Overall Study||9132
8680007|NCT01776424|21428632|P3|Treated|Overall Study||9107
8680008|NCT01776424|21428633|P2|Treated|Overall Study||9110
8680009|NCT01776424|21428634|P1|Treated|Overall Study||9134
8680010|NCT01776424|21428632|P3|STARTED|Overall Study||9126
8680011|NCT01776424|21428633|P2|STARTED|Overall Study||9117
8680012|NCT01776424|21428634|P1|STARTED|Overall Study||9152
8680013|NCT01736176|21428654|P1|NOT COMPLETED|Overall Study||11
8680014|NCT01736176|21428654|P1|COMPLETED|Overall Study||28
8680015|NCT01736176|21428654|P1|Received LCIG|Overall Study||38
8680016|NCT01736176|21428654|P1|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
8680017|NCT01718509|21428700|P2|NOT COMPLETED|Overall Study||48
8680018|NCT01718509|21428701|P1|NOT COMPLETED|Overall Study||48
8680019|NCT01718509|21428700|P2|COMPLETED|Overall Study||147
8680020|NCT01718509|21428701|P1|COMPLETED|Overall Study||147
8680021|NCT01718509|21428700|P2|STARTED|Overall Study||195
8680022|NCT01718509|21428701|P1|STARTED|Overall Study||195
8680023|NCT01620190|21428745|P1|NOT COMPLETED|Overall Study||0
8680024|NCT01620190|21428745|P1|COMPLETED|Overall Study||26
8680025|NCT01620190|21428745|P1|STARTED|Overall Study||26
8680041|NCT00942305|21428785|P10|NOT COMPLETED|Overall Study||10
8680042|NCT00942305|21428786|P9|NOT COMPLETED|Overall Study||25
8680043|NCT00942305|21428787|P8|NOT COMPLETED|Overall Study||5
8680044|NCT00942305|21428788|P7|NOT COMPLETED|Overall Study||24
8680045|NCT00942305|21428789|P6|NOT COMPLETED|Overall Study||5
8680046|NCT00942305|21428790|P5|NOT COMPLETED|Overall Study||25
8680047|NCT00942305|21428791|P4|NOT COMPLETED|Overall Study||6
8680048|NCT00942305|21428792|P3|NOT COMPLETED|Overall Study||15
8680049|NCT00942305|21428793|P2|NOT COMPLETED|Overall Study||5
8680050|NCT00942305|21428794|P1|NOT COMPLETED|Overall Study||23
8680051|NCT00942305|21428785|P10|COMPLETED|Overall Study||7
8680052|NCT00942305|21428786|P9|COMPLETED|Overall Study||25
8680053|NCT00942305|21428787|P8|COMPLETED|Overall Study||5
8680054|NCT00942305|21428788|P7|COMPLETED|Overall Study||6
8680055|NCT00942305|21428789|P6|COMPLETED|Overall Study||9
8680056|NCT00942305|21428790|P5|COMPLETED|Overall Study||14
8680057|NCT00942305|21428791|P4|COMPLETED|Overall Study||4
8680058|NCT00942305|21428792|P3|COMPLETED|Overall Study||14
8680059|NCT00942305|21428793|P2|COMPLETED|Overall Study||5
8680060|NCT00942305|21428794|P1|COMPLETED|Overall Study||7
8680061|NCT00942305|21428785|P10|STARTED|Overall Study||17
8680062|NCT00942305|21428786|P9|STARTED|Overall Study||50
8680063|NCT00942305|21428787|P8|STARTED|Overall Study||10
8680064|NCT00942305|21428788|P7|STARTED|Overall Study||30
8680065|NCT00942305|21428789|P6|STARTED|Overall Study||14
8680066|NCT00942305|21428790|P5|STARTED|Overall Study||39
8680067|NCT00942305|21428791|P4|STARTED|Overall Study||10
8680068|NCT00942305|21428792|P3|STARTED|Overall Study||29
8680069|NCT00942305|21428793|P2|STARTED|Overall Study||10
8680070|NCT00942305|21428794|P1|STARTED|Overall Study||30
8680851|NCT04698993|21430484|P2|NOT COMPLETED|Overall Study||7
8680852|NCT04698993|21430485|P1|NOT COMPLETED|Overall Study||3
8680853|NCT04698993|21430484|P2|COMPLETED|Overall Study||106
8680854|NCT04698993|21430485|P1|COMPLETED|Overall Study||272
8680855|NCT04698993|21430484|P2|STARTED|Overall Study||113
8680856|NCT04698993|21430485|P1|STARTED|Overall Study||275
8680857|NCT04370834|21430501|P1|NOT COMPLETED|Overall Study||0
8680858|NCT04370834|21430501|P1|COMPLETED|Overall Study||1
8680859|NCT04370834|21430501|P1|STARTED|Overall Study||1
8680860|NCT04124536|21430516|P5|NOT COMPLETED|Overall Study||0
8680861|NCT04124536|21430517|P4|NOT COMPLETED|Overall Study||7
8680862|NCT04124536|21430518|P3|NOT COMPLETED|Overall Study||3
8680863|NCT04124536|21430519|P2|NOT COMPLETED|Overall Study||5
8680864|NCT04124536|21430520|P1|NOT COMPLETED|Overall Study||11
8680865|NCT04124536|21430516|P5|COMPLETED|Overall Study||15
8680866|NCT04124536|21430517|P4|COMPLETED|Overall Study||98
8680867|NCT04124536|21430518|P3|COMPLETED|Overall Study||102
8680868|NCT04124536|21430519|P2|COMPLETED|Overall Study||53
8680869|NCT04124536|21430520|P1|COMPLETED|Overall Study||47
8680870|NCT04124536|21430516|P5|STARTED|Overall Study||15
8680871|NCT04124536|21430517|P4|STARTED|Overall Study||105
8680872|NCT04124536|21430518|P3|STARTED|Overall Study||105
8680873|NCT04124536|21430519|P2|STARTED|Overall Study||58
8680874|NCT04124536|21430520|P1|STARTED|Overall Study||58
8680875|NCT03855059|21430549|P2|NOT COMPLETED|Overall Study||0
8680876|NCT03855059|21430550|P1|NOT COMPLETED|Overall Study||2
8680877|NCT03855059|21430549|P2|COMPLETED|Overall Study||25
8680878|NCT03855059|21430550|P1|COMPLETED|Overall Study||23
8680879|NCT03855059|21430549|P2|STARTED|Overall Study||25
8680880|NCT03855059|21430550|P1|STARTED|Overall Study||25
8680881|NCT03812679|21430556|P1|NOT COMPLETED|Overall Study||8
8680882|NCT03812679|21430556|P1|COMPLETED|Overall Study||14
8680883|NCT03812679|21430556|P1|STARTED|Overall Study||22
8680884|NCT03798717|21430569|P6|NOT COMPLETED|Overall Study||1
8680885|NCT03798717|21430570|P5|NOT COMPLETED|Overall Study||1
8680886|NCT03798717|21430571|P4|NOT COMPLETED|Overall Study||2
8680887|NCT03798717|21430572|P3|NOT COMPLETED|Overall Study||1
8680888|NCT03798717|21430573|P2|NOT COMPLETED|Overall Study||1
8680889|NCT03798717|21430574|P1|NOT COMPLETED|Overall Study||2
8680890|NCT03798717|21430569|P6|COMPLETED|Overall Study||2
8680891|NCT03798717|21430570|P5|COMPLETED|Overall Study||2
8680892|NCT03798717|21430571|P4|COMPLETED|Overall Study||2
8680893|NCT03798717|21430572|P3|COMPLETED|Overall Study||2
8680894|NCT03798717|21430573|P2|COMPLETED|Overall Study||2
8680895|NCT03798717|21430574|P1|COMPLETED|Overall Study||2
8680896|NCT03798717|21430569|P6|STARTED|Overall Study||3
8680897|NCT03798717|21430570|P5|STARTED|Overall Study||3
8680898|NCT03798717|21430571|P4|STARTED|Overall Study||4
8680899|NCT03798717|21430572|P3|STARTED|Overall Study||3
8680900|NCT03798717|21430573|P2|STARTED|Overall Study||3
8680901|NCT03798717|21430574|P1|STARTED|Overall Study||4
8680902|NCT03768206|21430602|P2|NOT COMPLETED|Overall Study||2
8680903|NCT03768206|21430603|P1|NOT COMPLETED|Overall Study||2
8680904|NCT03768206|21430602|P2|COMPLETED|Overall Study||19
8680905|NCT03768206|21430603|P1|COMPLETED|Overall Study||22
8680906|NCT03768206|21430602|P2|STARTED|Overall Study||21
8680907|NCT03768206|21430603|P1|STARTED|Overall Study||24
8680908|NCT03644017|21430612|P1|NOT COMPLETED|Overall Study||7
8680909|NCT03644017|21430612|P1|COMPLETED|Overall Study||39
8680910|NCT03644017|21430612|P1|STARTED|Overall Study||46
8680911|NCT03639857|21430631|P3|NOT COMPLETED|Overall Study||0
8680912|NCT03639857|21430632|P2|NOT COMPLETED|Overall Study||0
8680913|NCT03639857|21430633|P1|NOT COMPLETED|Overall Study||0
8680914|NCT03639857|21430631|P3|COMPLETED|Overall Study||3
8680915|NCT03639857|21430632|P2|COMPLETED|Overall Study||3
8680916|NCT03639857|21430633|P1|COMPLETED|Overall Study||1
8680917|NCT03639857|21430631|P3|STARTED|Overall Study||3
8680918|NCT03639857|21430632|P2|STARTED|Overall Study||3
8680919|NCT03639857|21430633|P1|STARTED|Overall Study||1
8680932|NCT03566550|21430658|P2|NOT COMPLETED|Overall Study||1
8680933|NCT03566550|21430659|P1|NOT COMPLETED|Overall Study||0
8680934|NCT03566550|21430658|P2|COMPLETED|Overall Study||12
8680935|NCT03566550|21430659|P1|COMPLETED|Overall Study||12
8680936|NCT03566550|21430658|P2|STARTED|Overall Study||13
8680937|NCT03566550|21430659|P1|STARTED|Overall Study||12
8680938|NCT03484429|21430675|P2|NOT COMPLETED|Overall Study||0
8680939|NCT03484429|21430676|P1|NOT COMPLETED|Overall Study||3
8680940|NCT03484429|21430675|P2|COMPLETED|Overall Study||8
8680941|NCT03484429|21430676|P1|COMPLETED|Overall Study||5
8680942|NCT03484429|21430675|P2|Postamputation Month 3|Overall Study||7
8680943|NCT03484429|21430676|P1|Postamputation Month 3|Overall Study||5
8680944|NCT03484429|21430675|P2|Postamputation Week 5-8|Overall Study||8
8680945|NCT03484429|21430676|P1|Postamputation Week 5-8|Overall Study||5
8680946|NCT03484429|21430675|P2|Postamputation Week 1-4|Overall Study||8
8680947|NCT03484429|21430676|P1|Postamputation Week 1-4|Overall Study||8
8680948|NCT03484429|21430675|P2|STARTED|Overall Study||8
8680949|NCT03484429|21430676|P1|STARTED|Overall Study||8
8680950|NCT03446612|21430712|P2|NOT COMPLETED|Overall Study||1
8680951|NCT03446612|21430713|P1|NOT COMPLETED|Overall Study||0
8680952|NCT03446612|21430712|P2|COMPLETED|Overall Study||2
8680953|NCT03446612|21430713|P1|COMPLETED|Overall Study||2
8680954|NCT03446612|21430712|P2|STARTED|Overall Study||3
8680955|NCT03446612|21430713|P1|STARTED|Overall Study||2
8680956|NCT03196076|21430814|P3|NOT COMPLETED|Overall Study||0
8680957|NCT03196076|21430815|P2|NOT COMPLETED|Overall Study||0
8680958|NCT03196076|21430816|P1|NOT COMPLETED|Overall Study||0
8680959|NCT03196076|21430814|P3|COMPLETED|Overall Study||0
8680960|NCT03196076|21430815|P2|COMPLETED|Overall Study||20
8680961|NCT03196076|21430816|P1|COMPLETED|Overall Study||5
8680962|NCT03196076|21430814|P3|STARTED|Overall Study||0
8680963|NCT03196076|21430815|P2|STARTED|Overall Study||20
8680964|NCT03196076|21430816|P1|STARTED|Overall Study||5
8680965|NCT03123939|21430824|P1|NOT COMPLETED|Overall Study||41
8680966|NCT03123939|21430824|P1|COMPLETED|Overall Study||33
8680967|NCT03123939|21430824|P1|Safety Set (SAF)|Overall Study||69
8680968|NCT03123939|21430824|P1|Cellular Kinetic Analysis Set (CKAS)|Overall Study||69
8680969|NCT03123939|21430824|P1|Full Analysis Set (FAS)|Overall Study||69
8680970|NCT03123939|21430824|P1|CTL019 Infused|Overall Study||69
8680971|NCT03123939|21430824|P1|STARTED|Overall Study||74
8680972|NCT03112902|21430861|P10|NOT COMPLETED|Overall Study||0
8680973|NCT03112902|21430862|P9|NOT COMPLETED|Overall Study||0
8680974|NCT03112902|21430863|P8|NOT COMPLETED|Overall Study||2
8680975|NCT03112902|21430864|P7|NOT COMPLETED|Overall Study||8
8680976|NCT03112902|21430865|P6|NOT COMPLETED|Overall Study||3
8680977|NCT03112902|21430866|P5|NOT COMPLETED|Overall Study||0
8680978|NCT03112902|21430867|P4|NOT COMPLETED|Overall Study||1
8680979|NCT03112902|21430868|P3|NOT COMPLETED|Overall Study||1
8680980|NCT03112902|21430869|P2|NOT COMPLETED|Overall Study||0
8680981|NCT03112902|21430870|P1|NOT COMPLETED|Overall Study||2
8680982|NCT03112902|21430861|P10|COMPLETED|Overall Study||0
8680983|NCT03112902|21430862|P9|COMPLETED|Overall Study||0
8680984|NCT03112902|21430863|P8|COMPLETED|Overall Study||1
8680985|NCT03112902|21430864|P7|COMPLETED|Overall Study||1
8680986|NCT03112902|21430865|P6|COMPLETED|Overall Study||0
8680987|NCT03112902|21430866|P5|COMPLETED|Overall Study||1
8680988|NCT03112902|21430867|P4|COMPLETED|Overall Study||0
8680989|NCT03112902|21430868|P3|COMPLETED|Overall Study||2
8680990|NCT03112902|21430869|P2|COMPLETED|Overall Study||2
8680991|NCT03112902|21430870|P1|COMPLETED|Overall Study||0
8680992|NCT03112902|21430861|P10|STARTED|Overall Study||0
8680993|NCT03112902|21430862|P9|STARTED|Overall Study||0
8680994|NCT03112902|21430863|P8|STARTED|Overall Study||3
8680995|NCT03112902|21430864|P7|STARTED|Overall Study||9
8680996|NCT03112902|21430865|P6|STARTED|Overall Study||3
8680997|NCT03112902|21430866|P5|STARTED|Overall Study||1
8680998|NCT03112902|21430867|P4|STARTED|Overall Study||1
8680999|NCT03112902|21430868|P3|STARTED|Overall Study||3
8681000|NCT03112902|21430869|P2|STARTED|Overall Study||2
8681001|NCT03112902|21430870|P1|STARTED|Overall Study||2
8681002|NCT03097783|21430892|P2|NOT COMPLETED|Overall Study||6
8681003|NCT03097783|21430893|P1|NOT COMPLETED|Overall Study||9
8681004|NCT03097783|21430892|P2|COMPLETED|Overall Study||31
8681005|NCT03097783|21430893|P1|COMPLETED|Overall Study||123
8681006|NCT03097783|21430892|P2|STARTED|Overall Study||37
8681007|NCT03097783|21430893|P1|STARTED|Overall Study||132
8681008|NCT03058679|21430901|P2|NOT COMPLETED|Week 6 to Week 12||17
8681009|NCT03058679|21430902|P1|NOT COMPLETED|Week 6 to Week 12||20
8681010|NCT03058679|21430901|P2|COMPLETED|Week 6 to Week 12||60
8681011|NCT03058679|21430902|P1|COMPLETED|Week 6 to Week 12||61
8681012|NCT03058679|21430901|P2|STARTED|Week 6 to Week 12||77
8681013|NCT03058679|21430902|P1|STARTED|Week 6 to Week 12||81
8681014|NCT03058679|21430901|P2|NOT COMPLETED|Baseline to Week 6||15
8681015|NCT03058679|21430902|P1|NOT COMPLETED|Baseline to Week 6||18
8681016|NCT03058679|21430901|P2|COMPLETED|Baseline to Week 6||77
8681017|NCT03058679|21430902|P1|COMPLETED|Baseline to Week 6||81
8681018|NCT03058679|21430901|P2|STARTED|Baseline to Week 6|Due to an error 1 participant was randomized with a baseline sCDAI<150. This pt was excluded.|92
8681019|NCT03058679|21430902|P1|STARTED|Baseline to Week 6|3 randomized to SCD withdrew before starting diet;2 randomized pts w/ baseline sCDAI<150 excluded.|99
8681020|NCT02980042|21430916|P2|NOT COMPLETED|Overall Study||0
8681021|NCT02980042|21430917|P1|NOT COMPLETED|Overall Study||7
8681022|NCT02980042|21430916|P2|COMPLETED|Overall Study||100
8681023|NCT02980042|21430917|P1|COMPLETED|Overall Study|All 100 subjects completed their Week 24 infusion. 7 subjects did not complete the 12 month visit.|93
8681024|NCT02980042|21430916|P2|STARTED|Overall Study||100
8681025|NCT02980042|21430917|P1|STARTED|Overall Study||100
8681026|NCT02922634|21431006|P1|NOT COMPLETED|Overall Study||10
8681027|NCT02922634|21431006|P1|COMPLETED|Overall Study||219
8681028|NCT02922634|21431006|P1|STARTED|Overall Study||229
8681101|NCT02873208|21431132|P1|NOT COMPLETED|Overall Study||98
8681102|NCT02873208|21431132|P1|COMPLETED|Overall Study||167
8681103|NCT02873208|21431132|P1|STARTED|Overall Study||265
8681104|NCT02805309|21431139|P3|NOT COMPLETED|Overall Study||3
8681105|NCT02805309|21431140|P2|NOT COMPLETED|Overall Study||4
8681106|NCT02805309|21431141|P1|NOT COMPLETED|Overall Study||2
8681107|NCT02805309|21431139|P3|COMPLETED|Overall Study||16
8681108|NCT02805309|21431140|P2|COMPLETED|Overall Study||13
8681109|NCT02805309|21431141|P1|COMPLETED|Overall Study||16
8681110|NCT02805309|21431139|P3|STARTED|Overall Study||19
8681111|NCT02805309|21431140|P2|STARTED|Overall Study||17
8681112|NCT02805309|21431141|P1|STARTED|Overall Study||18
8681113|NCT02760433|21431181|P5|NOT COMPLETED|Overall Study||10
8681114|NCT02760433|21431182|P4|NOT COMPLETED|Overall Study||2
8681115|NCT02760433|21431183|P3|NOT COMPLETED|Overall Study||1
8681116|NCT02760433|21431184|P2|NOT COMPLETED|Overall Study||10
8681117|NCT02760433|21431185|P1|NOT COMPLETED|Overall Study||27
8681118|NCT02760433|21431181|P5|COMPLETED|Overall Study||1
8681119|NCT02760433|21431182|P4|COMPLETED|Overall Study||30
8681120|NCT02760433|21431183|P3|COMPLETED|Overall Study||25
8681121|NCT02760433|21431184|P2|COMPLETED|Overall Study||128
8681122|NCT02760433|21431185|P1|COMPLETED|Overall Study||134
8681123|NCT02760433|21431181|P5|STARTED|Overall Study||11
8681124|NCT02760433|21431182|P4|STARTED|Overall Study||32
8681125|NCT02760433|21431183|P3|STARTED|Overall Study||26
8681126|NCT02760433|21431184|P2|STARTED|Overall Study||138
8681127|NCT02760433|21431185|P1|STARTED|Overall Study||161
8681134|NCT02646917|21431233|P2|NOT COMPLETED|Overall Study||0
8681135|NCT02646917|21431234|P1|NOT COMPLETED|Overall Study||0
8681136|NCT02646917|21431233|P2|COMPLETED|Overall Study||20
8681137|NCT02646917|21431234|P1|COMPLETED|Overall Study||21
8681138|NCT02646917|21431233|P2|STARTED|Overall Study||20
8681139|NCT02646917|21431234|P1|STARTED|Overall Study||21
8681140|NCT02625974|21431250|P2|NOT COMPLETED|Overall Study||6
8681141|NCT02625974|21431251|P1|NOT COMPLETED|Overall Study||16
8681142|NCT02625974|21431250|P2|COMPLETED|Overall Study||105
8681143|NCT02625974|21431251|P1|COMPLETED|Overall Study||203
8681144|NCT02625974|21431250|P2|Received Treatment|Overall Study||111
8681145|NCT02625974|21431251|P1|Received Treatment|Overall Study||219
8681146|NCT02625974|21431250|P2|STARTED|Overall Study||111
8681147|NCT02625974|21431251|P1|STARTED|Overall Study||219
8681148|NCT02588339|21431359|P1|NOT COMPLETED|Overall Study||3
8681149|NCT02588339|21431359|P1|COMPLETED|Overall Study||39
8681150|NCT02588339|21431359|P1|STARTED|Overall Study||42
8681151|NCT02476994|21431371|P2|NOT COMPLETED|Overall Study||0
8681152|NCT02476994|21431372|P1|NOT COMPLETED|Overall Study||1
8681153|NCT02476994|21431371|P2|COMPLETED|Overall Study||0
8681154|NCT02476994|21431372|P1|COMPLETED|Overall Study||0
8681155|NCT02476994|21431371|P2|STARTED|Overall Study||0
8681156|NCT02476994|21431372|P1|STARTED|Overall Study||1
8681175|NCT01949337|21431438|P2|NOT COMPLETED|Overall Study||0
8681176|NCT01949337|21431439|P1|NOT COMPLETED|Overall Study||0
8681177|NCT01949337|21431438|P2|COMPLETED|Overall Study||654
8681178|NCT01949337|21431439|P1|COMPLETED|Overall Study||657
8681179|NCT01949337|21431438|P2|STARTED|Overall Study||654
8681180|NCT01949337|21431439|P1|STARTED|Overall Study||657
8681181|NCT01769170|21431449|P2|NOT COMPLETED|Overall Study||27
8681182|NCT01769170|21431450|P1|NOT COMPLETED|Overall Study||71
8681183|NCT01769170|21431449|P2|COMPLETED|Overall Study||122
8681184|NCT01769170|21431450|P1|COMPLETED|Overall Study||232
8681185|NCT01769170|21431449|P2|STARTED|Overall Study||149
8681186|NCT01769170|21431450|P1|STARTED|Overall Study||303
8681187|NCT01605097|21431458|P1|NOT COMPLETED|Overall Study||1
8681188|NCT01605097|21431458|P1|COMPLETED|Overall Study||25
8681189|NCT01605097|21431458|P1|STARTED|Overall Study|One patient consented but was ineligible due to lack of lesion visible on mpMRI|26
8681190|NCT01415427|21431468|P4|NOT COMPLETED|Overall Study||56
8681191|NCT01415427|21431469|P3|NOT COMPLETED|Overall Study||58
8681192|NCT01415427|21431470|P2|NOT COMPLETED|Overall Study||29
8681193|NCT01415427|21431471|P1|NOT COMPLETED|Overall Study||29
8681194|NCT01415427|21431468|P4|COMPLETED|Overall Study||0
8681195|NCT01415427|21431469|P3|COMPLETED|Overall Study||1
8681196|NCT01415427|21431470|P2|COMPLETED|Overall Study||0
8681197|NCT01415427|21431471|P1|COMPLETED|Overall Study||0
8681198|NCT01415427|21431468|P4|STARTED|Overall Study||56
8681199|NCT01415427|21431469|P3|STARTED|Overall Study||59
8681200|NCT01415427|21431470|P2|STARTED|Overall Study||29
8681201|NCT01415427|21431471|P1|STARTED|Overall Study||29
8681202|NCT01404312|21431510|P2|NOT COMPLETED|Overall Study||311
8681203|NCT01404312|21431511|P1|NOT COMPLETED|Overall Study||298
8681204|NCT01404312|21431510|P2|COMPLETED|Overall Study||1193
8681205|NCT01404312|21431511|P1|COMPLETED|Overall Study||1198
8681206|NCT01404312|21431510|P2|STARTED|Overall Study||1504
8681207|NCT01404312|21431511|P1|STARTED|Overall Study||1496
8681208|NCT01241344|21431536|P4|NOT COMPLETED|Overall Study||2
8681209|NCT01241344|21431537|P3|NOT COMPLETED|Overall Study||9
8681210|NCT01241344|21431538|P2|NOT COMPLETED|Overall Study||9
8681211|NCT01241344|21431539|P1|NOT COMPLETED|Overall Study||5
8681212|NCT01241344|21431536|P4|COMPLETED|Overall Study||2
8681213|NCT01241344|21431537|P3|COMPLETED|Overall Study||9
8681214|NCT01241344|21431538|P2|COMPLETED|Overall Study||7
8681215|NCT01241344|21431539|P1|COMPLETED|Overall Study||9
8681216|NCT01241344|21431536|P4|Randomized to Open-label|Overall Study||0
8681217|NCT01241344|21431537|P3|Randomized to Open-label|Overall Study||5
8681218|NCT01241344|21431538|P2|Randomized to Open-label|Overall Study||4
8681219|NCT01241344|21431539|P1|Randomized to Open-label|Overall Study||3
8681220|NCT01241344|21431536|P4|STARTED|Overall Study||4
8681221|NCT01241344|21431537|P3|STARTED|Overall Study||18
8681222|NCT01241344|21431538|P2|STARTED|Overall Study||16
8681223|NCT01241344|21431539|P1|STARTED|Overall Study||14
8681224|NCT00879437|21431548|P2|NOT COMPLETED|Overall Study||1
8681225|NCT00879437|21431549|P1|NOT COMPLETED|Overall Study||1
8681226|NCT00879437|21431548|P2|COMPLETED|Overall Study||17
8681227|NCT00879437|21431549|P1|COMPLETED|Overall Study||19
8681228|NCT00879437|21431548|P2|STARTED|Overall Study||18
8681229|NCT00879437|21431549|P1|STARTED|Overall Study||20
8681230|NCT00391430|21431603|P3|NOT COMPLETED|Overall Study||12
8681231|NCT00391430|21431604|P2|NOT COMPLETED|Overall Study||0
8681232|NCT00391430|21431605|P1|NOT COMPLETED|Overall Study||3
8681233|NCT00391430|21431603|P3|COMPLETED|Overall Study||19
8681234|NCT00391430|21431604|P2|COMPLETED|Overall Study||0
8681235|NCT00391430|21431605|P1|COMPLETED|Overall Study||5
8681236|NCT00391430|21431603|P3|STARTED|Overall Study||31
8681237|NCT00391430|21431604|P2|STARTED|Overall Study||0
8681238|NCT00391430|21431605|P1|STARTED|Overall Study||8
8681248|NCT00065260|21431699|P2|NOT COMPLETED|Overall Study||1
8681249|NCT00065260|21431700|P1|NOT COMPLETED|Overall Study||0
8681250|NCT00065260|21431699|P2|COMPLETED|Overall Study||26
8681251|NCT00065260|21431700|P1|COMPLETED|Overall Study||27
8681252|NCT00065260|21431699|P2|STARTED|Overall Study||27
8681253|NCT00065260|21431700|P1|STARTED|Overall Study||27
8681254|NCT04927858|21431714|P1|NOT COMPLETED|Overall Study||0
8681255|NCT04927858|21431714|P1|COMPLETED|Overall Study||460558
8681256|NCT04927858|21431714|P1|Treated With Empagliflozin|Overall Study||16985
8681257|NCT04927858|21431714|P1|STARTED|Overall Study||460558
8681261|NCT04066686|21431728|P2|NOT COMPLETED|Overall Study||0
8681262|NCT04066686|21431729|P1|NOT COMPLETED|Overall Study||2
8681263|NCT04066686|21431728|P2|COMPLETED|Overall Study||13
8681264|NCT04066686|21431729|P1|COMPLETED|Overall Study||12
8681265|NCT04066686|21431728|P2|STARTED|Overall Study||13
8681266|NCT04066686|21431729|P1|STARTED|Overall Study||14
8681267|NCT03586544|21431741|P2|NOT COMPLETED|Second Intervention||1
8681268|NCT03586544|21431742|P1|NOT COMPLETED|Second Intervention||0
8681269|NCT03586544|21431741|P2|COMPLETED|Second Intervention||10
8681270|NCT03586544|21431742|P1|COMPLETED|Second Intervention||6
8681271|NCT03586544|21431741|P2|STARTED|Second Intervention||11
8681272|NCT03586544|21431742|P1|STARTED|Second Intervention||6
8681273|NCT03586544|21431741|P2|NOT COMPLETED|First Intervention||1
8681274|NCT03586544|21431742|P1|NOT COMPLETED|First Intervention||0
8681275|NCT03586544|21431741|P2|COMPLETED|First Intervention||11
8681276|NCT03586544|21431742|P1|COMPLETED|First Intervention||6
8681277|NCT03586544|21431741|P2|STARTED|First Intervention||12
8681278|NCT03586544|21431742|P1|STARTED|First Intervention||6
8681279|NCT03571256|21431751|P3|NOT COMPLETED|Overall Study||4
8681280|NCT03571256|21431752|P2|NOT COMPLETED|Overall Study||3
8681281|NCT03571256|21431753|P1|NOT COMPLETED|Overall Study||6
8681282|NCT03571256|21431751|P3|COMPLETED|Overall Study||48
8681283|NCT03571256|21431752|P2|COMPLETED|Overall Study||51
8681284|NCT03571256|21431753|P1|COMPLETED|Overall Study||46
8681285|NCT03571256|21431751|P3|Modified ITT (mITT) Analysis Set|Overall Study||51
8681286|NCT03571256|21431752|P2|Modified ITT (mITT) Analysis Set|Overall Study||53
8681287|NCT03571256|21431753|P1|Modified ITT (mITT) Analysis Set|Overall Study||49
8681288|NCT03571256|21431751|P3|Safety Analysis Set|Overall Study||51
8681289|NCT03571256|21431752|P2|Safety Analysis Set|Overall Study||54
8681290|NCT03571256|21431753|P1|Safety Analysis Set|Overall Study||52
8681291|NCT03571256|21431751|P3|STARTED|Overall Study||52
8681292|NCT03571256|21431752|P2|STARTED|Overall Study||54
8681293|NCT03571256|21431753|P1|STARTED|Overall Study||52
8681294|NCT03452943|21431782|P2|NOT COMPLETED|Maintenance Period (5 Weeks)||0
8681295|NCT03452943|21431783|P1|NOT COMPLETED|Maintenance Period (5 Weeks)||3
8681296|NCT03452943|21431782|P2|COMPLETED|Maintenance Period (5 Weeks)||56
8681297|NCT03452943|21431783|P1|COMPLETED|Maintenance Period (5 Weeks)||51
8681298|NCT03452943|21431782|P2|STARTED|Maintenance Period (5 Weeks)||56
8681299|NCT03452943|21431783|P1|STARTED|Maintenance Period (5 Weeks)||54
8681300|NCT03452943|21431782|P2|NOT COMPLETED|Titration Period (7 Weeks)||4
8681301|NCT03452943|21431783|P1|NOT COMPLETED|Titration Period (7 Weeks)||5
8681302|NCT03452943|21431782|P2|COMPLETED|Titration Period (7 Weeks)||56
8681303|NCT03452943|21431783|P1|COMPLETED|Titration Period (7 Weeks)||54
8681304|NCT03452943|21431782|P2|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||59
8681305|NCT03452943|21431783|P1|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||58
8681306|NCT03452943|21431782|P2|Safety Analysis Set|Titration Period (7 Weeks)||59
8681307|NCT03452943|21431783|P1|Safety Analysis Set|Titration Period (7 Weeks)||58
8681308|NCT03452943|21431782|P2|STARTED|Titration Period (7 Weeks)||60
8681309|NCT03452943|21431783|P1|STARTED|Titration Period (7 Weeks)||59
8681310|NCT03393000|21431797|P1|NOT COMPLETED|Overall Study||14
8681311|NCT03393000|21431797|P1|COMPLETED|Overall Study|19 subjects treated|5
8681312|NCT03393000|21431797|P1|STARTED|Overall Study|23 subjects screened|19
8681313|NCT03297216|21431803|P2|NOT COMPLETED|Overall Study||5
8681314|NCT03297216|21431804|P1|NOT COMPLETED|Overall Study||3
8681315|NCT03297216|21431803|P2|COMPLETED|Overall Study||396
8681316|NCT03297216|21431804|P1|COMPLETED|Overall Study||396
8681317|NCT03297216|21431803|P2|Infants Born During Study|Overall Study||401
8681318|NCT03297216|21431804|P1|Infants Born During Study|Overall Study||399
8681319|NCT03297216|21431803|P2|Discontinued Intervention|Overall Study||4
8681320|NCT03297216|21431804|P1|Discontinued Intervention|Overall Study||5
8681321|NCT03297216|21431803|P2|STARTED|Overall Study||401
8681322|NCT03297216|21431804|P1|STARTED|Overall Study||399
8681323|NCT03277352|21431838|P1|NOT COMPLETED|Overall Study||10
8681324|NCT03277352|21431838|P1|COMPLETED|Overall Study||0
8681325|NCT03277352|21431838|P1|STARTED|Overall Study||10
8681326|NCT03137303|21431852|P2|NOT COMPLETED|T4: 12-month Follow-up||5
8681327|NCT03137303|21431853|P1|NOT COMPLETED|T4: 12-month Follow-up||7
8681328|NCT03137303|21431852|P2|COMPLETED|T4: 12-month Follow-up||162
8681329|NCT03137303|21431853|P1|COMPLETED|T4: 12-month Follow-up||222
8681330|NCT03137303|21431852|P2|STARTED|T4: 12-month Follow-up||167
8681331|NCT03137303|21431853|P1|STARTED|T4: 12-month Follow-up||229
8681332|NCT03137303|21431852|P2|NOT COMPLETED|T3: 9-month Follow-up||4
8681333|NCT03137303|21431853|P1|NOT COMPLETED|T3: 9-month Follow-up||5
8681334|NCT03137303|21431852|P2|COMPLETED|T3: 9-month Follow-up||163
8681335|NCT03137303|21431853|P1|COMPLETED|T3: 9-month Follow-up||225
8681336|NCT03137303|21431852|P2|STARTED|T3: 9-month Follow-up||167
8681337|NCT03137303|21431853|P1|STARTED|T3: 9-month Follow-up||230
8681338|NCT03137303|21431852|P2|NOT COMPLETED|T2: 6-month Follow-up||5
8681339|NCT03137303|21431853|P1|NOT COMPLETED|T2: 6-month Follow-up||5
8681340|NCT03137303|21431852|P2|COMPLETED|T2: 6-month Follow-up||162
8681341|NCT03137303|21431853|P1|COMPLETED|T2: 6-month Follow-up||225
8681342|NCT03137303|21431852|P2|STARTED|T2: 6-month Follow-up||167
8681343|NCT03137303|21431853|P1|STARTED|T2: 6-month Follow-up||230
8681344|NCT03137303|21431852|P2|NOT COMPLETED|T1: 3-month Follow-up||10
8681345|NCT03137303|21431853|P1|NOT COMPLETED|T1: 3-month Follow-up||6
8681346|NCT03137303|21431852|P2|COMPLETED|T1: 3-month Follow-up||161
8681347|NCT03137303|21431853|P1|COMPLETED|T1: 3-month Follow-up||225
8681348|NCT03137303|21431852|P2|STARTED|T1: 3-month Follow-up||171
8681349|NCT03137303|21431853|P1|STARTED|T1: 3-month Follow-up||231
8681350|NCT03137303|21431852|P2|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
8681351|NCT03137303|21431853|P1|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
8681352|NCT03137303|21431852|P2|COMPLETED|T0: Time of Enrollment - Baseline Visit||171
8681353|NCT03137303|21431853|P1|COMPLETED|T0: Time of Enrollment - Baseline Visit||231
8681354|NCT03137303|21431852|P2|STARTED|T0: Time of Enrollment - Baseline Visit||171
8681355|NCT03137303|21431853|P1|STARTED|T0: Time of Enrollment - Baseline Visit||231
8681356|NCT03129100|21431866|P11|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
8681357|NCT03129100|21431867|P10|NOT COMPLETED|Period 2 (Retreatment Extension Period)||1
8681358|NCT03129100|21431868|P9|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
8681359|NCT03129100|21431869|P8|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
8681360|NCT03129100|21431870|P7|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
8681361|NCT03129100|21431871|P6|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
8681362|NCT03129100|21431872|P5|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
8681363|NCT03129100|21431873|P4|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
8681364|NCT03129100|21431874|P3|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
8681365|NCT03129100|21431875|P2|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
8681366|NCT03129100|21431876|P1|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
8681367|NCT03129100|21431866|P11|COMPLETED|Period 2 (Retreatment Extension Period)||10
8681368|NCT03129100|21431867|P10|COMPLETED|Period 2 (Retreatment Extension Period)||8
8681369|NCT03129100|21431868|P9|COMPLETED|Period 2 (Retreatment Extension Period)||5
8681370|NCT03129100|21431869|P8|COMPLETED|Period 2 (Retreatment Extension Period)||6
8681371|NCT03129100|21431870|P7|COMPLETED|Period 2 (Retreatment Extension Period)||0
8681372|NCT03129100|21431871|P6|COMPLETED|Period 2 (Retreatment Extension Period)||0
8681373|NCT03129100|21431872|P5|COMPLETED|Period 2 (Retreatment Extension Period)||0
8681374|NCT03129100|21431873|P4|COMPLETED|Period 2 (Retreatment Extension Period)||0
8681375|NCT03129100|21431874|P3|COMPLETED|Period 2 (Retreatment Extension Period)||0
8681376|NCT03129100|21431875|P2|COMPLETED|Period 2 (Retreatment Extension Period)||0
8681377|NCT03129100|21431876|P1|COMPLETED|Period 2 (Retreatment Extension Period)||0
8681378|NCT03129100|21431866|P11|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|10
8681379|NCT03129100|21431867|P10|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|9
8681380|NCT03129100|21431868|P9|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|5
8681381|NCT03129100|21431869|P8|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|6
8681382|NCT03129100|21431870|P7|STARTED|Period 2 (Retreatment Extension Period)||0
8681383|NCT03129100|21431871|P6|STARTED|Period 2 (Retreatment Extension Period)||0
8681384|NCT03129100|21431872|P5|STARTED|Period 2 (Retreatment Extension Period)||0
8681385|NCT03129100|21431873|P4|STARTED|Period 2 (Retreatment Extension Period)||0
8681386|NCT03129100|21431874|P3|STARTED|Period 2 (Retreatment Extension Period)||0
8681387|NCT03129100|21431875|P2|STARTED|Period 2 (Retreatment Extension Period)||0
8681388|NCT03129100|21431876|P1|STARTED|Period 2 (Retreatment Extension Period)||0
8681389|NCT03129100|21431866|P11|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
8681390|NCT03129100|21431867|P10|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
8681391|NCT03129100|21431868|P9|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
8681392|NCT03129100|21431869|P8|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
8681393|NCT03129100|21431870|P7|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
8681394|NCT03129100|21431871|P6|NOT COMPLETED|Period2 Extension Period (Group A and B)||9
8681395|NCT03129100|21431872|P5|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
8681396|NCT03129100|21431873|P4|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
8681397|NCT03129100|21431874|P3|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
8681398|NCT03129100|21431875|P2|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
8681399|NCT03129100|21431876|P1|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
8681400|NCT03129100|21431866|P11|COMPLETED|Period2 Extension Period (Group A and B)||0
8681401|NCT03129100|21431867|P10|COMPLETED|Period2 Extension Period (Group A and B)||0
8681402|NCT03129100|21431868|P9|COMPLETED|Period2 Extension Period (Group A and B)||0
8681403|NCT03129100|21431869|P8|COMPLETED|Period2 Extension Period (Group A and B)||0
8681404|NCT03129100|21431870|P7|COMPLETED|Period2 Extension Period (Group A and B)||32
8681405|NCT03129100|21431871|P6|COMPLETED|Period2 Extension Period (Group A and B)||45
8681406|NCT03129100|21431872|P5|COMPLETED|Period2 Extension Period (Group A and B)||42
8681407|NCT03129100|21431873|P4|COMPLETED|Period2 Extension Period (Group A and B)||312
8681408|NCT03129100|21431874|P3|COMPLETED|Period2 Extension Period (Group A and B)||234
8681409|NCT03129100|21431875|P2|COMPLETED|Period2 Extension Period (Group A and B)||0
8681410|NCT03129100|21431876|P1|COMPLETED|Period2 Extension Period (Group A and B)||0
8681411|NCT03129100|21431866|P11|STARTED|Period2 Extension Period (Group A and B)||0
8681412|NCT03129100|21431867|P10|STARTED|Period2 Extension Period (Group A and B)||0
8681413|NCT03129100|21431868|P9|STARTED|Period2 Extension Period (Group A and B)||0
8681414|NCT03129100|21431869|P8|STARTED|Period2 Extension Period (Group A and B)||0
8681415|NCT03129100|21431870|P7|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|53
8681416|NCT03129100|21431871|P6|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|54
8681417|NCT03129100|21431872|P5|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|48
8681418|NCT03129100|21431873|P4|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|318
8681419|NCT03129100|21431874|P3|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|255
8681420|NCT03129100|21431875|P2|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
8681421|NCT03129100|21431876|P1|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
8681422|NCT03129100|21431866|P11|NOT COMPLETED|Lead-In Period (Period 1)||0
8681423|NCT03129100|21431867|P10|NOT COMPLETED|Lead-In Period (Period 1)||0
8681424|NCT03129100|21431868|P9|NOT COMPLETED|Lead-In Period (Period 1)||0
8681425|NCT03129100|21431869|P8|NOT COMPLETED|Lead-In Period (Period 1)||0
8681426|NCT03129100|21431870|P7|NOT COMPLETED|Lead-In Period (Period 1)||0
8681427|NCT03129100|21431871|P6|NOT COMPLETED|Lead-In Period (Period 1)||0
8681428|NCT03129100|21431872|P5|NOT COMPLETED|Lead-In Period (Period 1)||0
8681429|NCT03129100|21431873|P4|NOT COMPLETED|Lead-In Period (Period 1)||0
8681430|NCT03129100|21431874|P3|NOT COMPLETED|Lead-In Period (Period 1)||0
8681431|NCT03129100|21431875|P2|NOT COMPLETED|Lead-In Period (Period 1)||17
8681432|NCT03129100|21431876|P1|NOT COMPLETED|Lead-In Period (Period 1)||15
8681433|NCT03129100|21431866|P11|COMPLETED|Lead-In Period (Period 1)||0
8681434|NCT03129100|21431867|P10|COMPLETED|Lead-In Period (Period 1)||0
8681435|NCT03129100|21431868|P9|COMPLETED|Lead-In Period (Period 1)||0
8681436|NCT03129100|21431869|P8|COMPLETED|Lead-In Period (Period 1)||0
8681437|NCT03129100|21431870|P7|COMPLETED|Lead-In Period (Period 1)||0
8681438|NCT03129100|21431871|P6|COMPLETED|Lead-In Period (Period 1)||0
8681439|NCT03129100|21431872|P5|COMPLETED|Lead-In Period (Period 1)||0
8681440|NCT03129100|21431873|P4|COMPLETED|Lead-In Period (Period 1)||0
8681441|NCT03129100|21431874|P3|COMPLETED|Lead-In Period (Period 1)||0
8681442|NCT03129100|21431875|P2|COMPLETED|Lead-In Period (Period 1)||406
8681443|NCT03129100|21431876|P1|COMPLETED|Lead-In Period (Period 1)||335
8681444|NCT03129100|21431866|P11|STARTED|Lead-In Period (Period 1)||0
8681445|NCT03129100|21431867|P10|STARTED|Lead-In Period (Period 1)||0
8681446|NCT03129100|21431868|P9|STARTED|Lead-In Period (Period 1)||0
8681447|NCT03129100|21431869|P8|STARTED|Lead-In Period (Period 1)||0
8681448|NCT03129100|21431870|P7|STARTED|Lead-In Period (Period 1)||0
8681449|NCT03129100|21431871|P6|STARTED|Lead-In Period (Period 1)||0
8681450|NCT03129100|21431872|P5|STARTED|Lead-In Period (Period 1)||0
8681451|NCT03129100|21431873|P4|STARTED|Lead-In Period (Period 1)||0
8681452|NCT03129100|21431874|P3|STARTED|Lead-In Period (Period 1)||0
8681453|NCT03129100|21431875|P2|STARTED|Lead-In Period (Period 1)||423
8681454|NCT03129100|21431876|P1|STARTED|Lead-In Period (Period 1)||350
8681455|NCT03068455|21431973|P2|NOT COMPLETED|End-of-Study Status||13
8681456|NCT03068455|21431974|P1|NOT COMPLETED|End-of-Study Status||19
8681457|NCT03068455|21431973|P2|COMPLETED|End-of-Study Status||904
8681458|NCT03068455|21431974|P1|COMPLETED|End-of-Study Status||897
8681459|NCT03068455|21431973|P2|STARTED|End-of-Study Status||917
8681460|NCT03068455|21431974|P1|STARTED|End-of-Study Status||916
8681461|NCT03068455|21431973|P2|NOT COMPLETED|Treatment Period||356
8681462|NCT03068455|21431974|P1|NOT COMPLETED|Treatment Period||552
8681463|NCT03068455|21431973|P2|COMPLETED|Treatment Period||561
8681464|NCT03068455|21431974|P1|COMPLETED|Treatment Period||364
8681465|NCT03068455|21431973|P2|STARTED|Treatment Period||917
8681466|NCT03068455|21431974|P1|STARTED|Treatment Period||916
8681467|NCT03068455|21431973|P2|NOT COMPLETED|Pre-treatment Period||7
8681468|NCT03068455|21431974|P1|NOT COMPLETED|Pre-treatment Period||4
8681469|NCT03068455|21431973|P2|COMPLETED|Pre-treatment Period||917
8681470|NCT03068455|21431974|P1|COMPLETED|Pre-treatment Period||916
8681471|NCT03068455|21431973|P2|STARTED|Pre-treatment Period||924
8681472|NCT03068455|21431974|P1|STARTED|Pre-treatment Period||920
8681473|NCT02956044|21431993|P3|NOT COMPLETED|Overall Study||0
8681474|NCT02956044|21431994|P2|NOT COMPLETED|Overall Study||0
8681475|NCT02956044|21431995|P1|NOT COMPLETED|Overall Study||0
8681476|NCT02956044|21431993|P3|COMPLETED|Overall Study||18
8681477|NCT02956044|21431994|P2|COMPLETED|Overall Study||18
8681478|NCT02956044|21431995|P1|COMPLETED|Overall Study||18
8681479|NCT02956044|21431993|P3|STARTED|Overall Study||18
8681480|NCT02956044|21431994|P2|STARTED|Overall Study||18
8681481|NCT02956044|21431995|P1|STARTED|Overall Study||18
8681482|NCT02901080|21432051|P1|NOT COMPLETED|Overall Study||49
8681483|NCT02901080|21432051|P1|COMPLETED|Overall Study||112
8681484|NCT02901080|21432051|P1|STARTED|Overall Study||161
8681485|NCT02804594|21432060|P2|NOT COMPLETED|Overall Study||0
8681486|NCT02804594|21432061|P1|NOT COMPLETED|Overall Study||0
8681487|NCT02804594|21432060|P2|COMPLETED|Overall Study||5
8681488|NCT02804594|21432061|P1|COMPLETED|Overall Study||10
8681489|NCT02804594|21432060|P2|STARTED|Overall Study||5
8681490|NCT02804594|21432061|P1|STARTED|Overall Study||10
8681491|NCT02777554|21432073|P6|NOT COMPLETED|Overall Study||0
8681492|NCT02777554|21432074|P5|NOT COMPLETED|Overall Study||0
8681493|NCT02777554|21432075|P4|NOT COMPLETED|Overall Study||1
8681494|NCT02777554|21432076|P3|NOT COMPLETED|Overall Study||1
8681495|NCT02777554|21432077|P2|NOT COMPLETED|Overall Study||25
8681496|NCT02777554|21432078|P1|NOT COMPLETED|Overall Study||30
8681497|NCT02777554|21432073|P6|COMPLETED|Overall Study||5
8681498|NCT02777554|21432074|P5|COMPLETED|Overall Study||5
8681499|NCT02777554|21432075|P4|COMPLETED|Overall Study||4
8681500|NCT02777554|21432076|P3|COMPLETED|Overall Study||4
8681501|NCT02777554|21432077|P2|COMPLETED|Overall Study||37
8681502|NCT02777554|21432078|P1|COMPLETED|Overall Study||32
8681503|NCT02777554|21432073|P6|STARTED|Overall Study||5
8681504|NCT02777554|21432074|P5|STARTED|Overall Study||5
8681505|NCT02777554|21432075|P4|STARTED|Overall Study||5
8681506|NCT02777554|21432076|P3|STARTED|Overall Study||5
8681507|NCT02777554|21432077|P2|STARTED|Overall Study||62
8681508|NCT02777554|21432078|P1|STARTED|Overall Study||62
8681509|NCT02761993|21432113|P3|NOT COMPLETED|Overall Study||4
8681510|NCT02761993|21432114|P2|NOT COMPLETED|Overall Study||6
8681511|NCT02761993|21432115|P1|NOT COMPLETED|Overall Study||2
8681512|NCT02761993|21432113|P3|COMPLETED|Overall Study||46
8681513|NCT02761993|21432114|P2|COMPLETED|Overall Study||43
8681514|NCT02761993|21432115|P1|COMPLETED|Overall Study||50
8681515|NCT02761993|21432113|P3|STARTED|Overall Study||50
8681516|NCT02761993|21432114|P2|STARTED|Overall Study||49
8681517|NCT02761993|21432115|P1|STARTED|Overall Study||52
8681518|NCT02664909|21432131|P2|NOT COMPLETED|Overall Study||3
8681519|NCT02664909|21432132|P1|NOT COMPLETED|Overall Study||2
8681520|NCT02664909|21432131|P2|COMPLETED|Overall Study||16
8681521|NCT02664909|21432132|P1|COMPLETED|Overall Study||15
8681522|NCT02664909|21432131|P2|STARTED|Overall Study||19
8681523|NCT02664909|21432132|P1|STARTED|Overall Study||17
8681524|NCT02659059|21432152|P2|NOT COMPLETED|Overall Study||32
8681525|NCT02659059|21432153|P1|NOT COMPLETED|Overall Study||200
8681526|NCT02659059|21432152|P2|COMPLETED|Overall Study||4
8681527|NCT02659059|21432153|P1|COMPLETED|Overall Study||88
8681528|NCT02659059|21432152|P2|STARTED|Overall Study||36
8681529|NCT02659059|21432153|P1|STARTED|Overall Study||288
8681530|NCT02650999|21432174|P1|NOT COMPLETED|Overall Study||0
8681531|NCT02650999|21432174|P1|COMPLETED|Overall Study||12
8681532|NCT02650999|21432174|P1|STARTED|Overall Study||12
8681545|NCT02543723|21432230|P2|NOT COMPLETED|Overall Study||0
8681546|NCT02543723|21432231|P1|NOT COMPLETED|Overall Study||0
8681547|NCT02543723|21432230|P2|COMPLETED|Overall Study||63
8681548|NCT02543723|21432231|P1|COMPLETED|Overall Study||65
8681549|NCT02543723|21432230|P2|STARTED|Overall Study||63
8681550|NCT02543723|21432231|P1|STARTED|Overall Study||65
8681551|NCT02528942|21432239|P1|NOT COMPLETED|Overall Study||34
8681552|NCT02528942|21432239|P1|COMPLETED|Overall Study||67
8681553|NCT02528942|21432239|P1|STARTED|Overall Study||101
8681554|NCT02527434|21432247|P3|NOT COMPLETED|Overall Study||20
8681555|NCT02527434|21432248|P2|NOT COMPLETED|Overall Study||11
8681556|NCT02527434|21432249|P1|NOT COMPLETED|Overall Study||28
8681557|NCT02527434|21432247|P3|COMPLETED|Overall Study||0
8681558|NCT02527434|21432248|P2|COMPLETED|Overall Study||1
8681559|NCT02527434|21432249|P1|COMPLETED|Overall Study||4
8681560|NCT02527434|21432247|P3|Started Retreatment Phase (MEDI)|Overall Study||1
8681561|NCT02527434|21432248|P2|Started Retreatment Phase (MEDI)|Overall Study||0
8681562|NCT02527434|21432249|P1|Started Retreatment Phase (MEDI)|Overall Study||4
8681563|NCT02527434|21432247|P3|Started Retreatment Phase (COMBO)|Overall Study||4
8681564|NCT02527434|21432248|P2|Started Retreatment Phase (COMBO)|Overall Study||5
8681565|NCT02527434|21432249|P1|Started Retreatment Phase (COMBO)|Overall Study||7
8681566|NCT02527434|21432247|P3|STARTED|Overall Study||20
8681567|NCT02527434|21432248|P2|STARTED|Overall Study||12
8681568|NCT02527434|21432249|P1|STARTED|Overall Study||32
8681569|NCT02514239|21432317|P10|NOT COMPLETED|Overall Study||3
8681570|NCT02514239|21432318|P9|NOT COMPLETED|Overall Study||8
8681571|NCT02514239|21432319|P8|NOT COMPLETED|Overall Study||3
8681572|NCT02514239|21432320|P7|NOT COMPLETED|Overall Study||4
8681573|NCT02514239|21432321|P6|NOT COMPLETED|Overall Study||4
8681574|NCT02514239|21432322|P5|NOT COMPLETED|Overall Study||3
8681575|NCT02514239|21432323|P4|NOT COMPLETED|Overall Study||3
8681576|NCT02514239|21432324|P3|NOT COMPLETED|Overall Study||2
8681577|NCT02514239|21432325|P2|NOT COMPLETED|Overall Study||4
8681578|NCT02514239|21432326|P1|NOT COMPLETED|Overall Study||5
8681579|NCT02514239|21432317|P10|COMPLETED|Overall Study||0
8681580|NCT02514239|21432318|P9|COMPLETED|Overall Study||2
8681581|NCT02514239|21432319|P8|COMPLETED|Overall Study||0
8681582|NCT02514239|21432320|P7|COMPLETED|Overall Study||0
8681583|NCT02514239|21432321|P6|COMPLETED|Overall Study||1
8681584|NCT02514239|21432322|P5|COMPLETED|Overall Study||0
8681585|NCT02514239|21432323|P4|COMPLETED|Overall Study||0
8681586|NCT02514239|21432324|P3|COMPLETED|Overall Study||1
8681587|NCT02514239|21432325|P2|COMPLETED|Overall Study||0
8681588|NCT02514239|21432326|P1|COMPLETED|Overall Study||0
8681589|NCT02514239|21432317|P10|Treated|Overall Study||3
8681590|NCT02514239|21432318|P9|Treated|Overall Study||10
8681591|NCT02514239|21432319|P8|Treated|Overall Study||3
8681592|NCT02514239|21432320|P7|Treated|Overall Study||4
8681593|NCT02514239|21432321|P6|Treated|Overall Study||5
8681594|NCT02514239|21432322|P5|Treated|Overall Study||3
8681595|NCT02514239|21432323|P4|Treated|Overall Study||3
8681596|NCT02514239|21432324|P3|Treated|Overall Study||3
8681597|NCT02514239|21432325|P2|Treated|Overall Study||3
8681598|NCT02514239|21432326|P1|Treated|Overall Study||5
8681599|NCT02514239|21432317|P10|STARTED|Overall Study||3
8681600|NCT02514239|21432318|P9|STARTED|Overall Study||10
8681601|NCT02514239|21432319|P8|STARTED|Overall Study||3
8681602|NCT02514239|21432320|P7|STARTED|Overall Study||4
8681603|NCT02514239|21432321|P6|STARTED|Overall Study||5
8681604|NCT02514239|21432322|P5|STARTED|Overall Study||3
8681605|NCT02514239|21432323|P4|STARTED|Overall Study||3
8681606|NCT02514239|21432324|P3|STARTED|Overall Study||3
8681607|NCT02514239|21432325|P2|STARTED|Overall Study||4
8681608|NCT02514239|21432326|P1|STARTED|Overall Study||5
8681615|NCT02406651|21432469|P1|NOT COMPLETED|Overall Study||3
8681616|NCT02406651|21432469|P1|COMPLETED|Overall Study||27
8681617|NCT02406651|21432469|P1|STARTED|Overall Study||30
8681618|NCT02395978|21432482|P5|NOT COMPLETED|Overall Study||5
8681619|NCT02395978|21432483|P4|NOT COMPLETED|Overall Study||5
8681620|NCT02395978|21432484|P3|NOT COMPLETED|Overall Study||2
8681621|NCT02395978|21432485|P2|NOT COMPLETED|Overall Study||0
8681622|NCT02395978|21432486|P1|NOT COMPLETED|Overall Study||0
8681623|NCT02395978|21432482|P5|COMPLETED|Overall Study||15
8681624|NCT02395978|21432483|P4|COMPLETED|Overall Study||14
8681625|NCT02395978|21432484|P3|COMPLETED|Overall Study||19
8681626|NCT02395978|21432485|P2|COMPLETED|Overall Study||6
8681627|NCT02395978|21432486|P1|COMPLETED|Overall Study||6
8681628|NCT02395978|21432482|P5|STARTED|Overall Study||20
8681629|NCT02395978|21432483|P4|STARTED|Overall Study||19
8681630|NCT02395978|21432484|P3|STARTED|Overall Study||21
8681631|NCT02395978|21432485|P2|STARTED|Overall Study||6
8681632|NCT02395978|21432486|P1|STARTED|Overall Study||6
8681633|NCT02376010|21432525|P2|NOT COMPLETED|Overall Study||4
8681634|NCT02376010|21432526|P1|NOT COMPLETED|Overall Study||9
8681635|NCT02376010|21432525|P2|COMPLETED|Overall Study||51
8681636|NCT02376010|21432526|P1|COMPLETED|Overall Study||46
8681637|NCT02376010|21432525|P2|STARTED|Overall Study||55
8681638|NCT02376010|21432526|P1|STARTED|Overall Study||55
8681639|NCT02307513|21432536|P2|NOT COMPLETED|Long-term Extension||0
8681640|NCT02307513|21432537|P1|NOT COMPLETED|Long-term Extension||1
8681641|NCT02307513|21432536|P2|COMPLETED|Long-term Extension||0
8681642|NCT02307513|21432537|P1|COMPLETED|Long-term Extension||1
8681643|NCT02307513|21432536|P2|STARTED|Long-term Extension||0
8681644|NCT02307513|21432537|P1|STARTED|Long-term Extension||2
8681645|NCT02307513|21432536|P2|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20
8681646|NCT02307513|21432537|P1|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15
8681647|NCT02307513|21432536|P2|COMPLETED|Active Treatment Phase (Weeks 13-64)||75
8681648|NCT02307513|21432537|P1|COMPLETED|Active Treatment Phase (Weeks 13-64)||68
8681649|NCT02307513|21432536|P2|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95
8681650|NCT02307513|21432537|P1|STARTED|Active Treatment Phase (Weeks 13-64)||83
8681651|NCT02307513|21432536|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8
8681652|NCT02307513|21432537|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20
8681653|NCT02307513|21432536|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96
8681654|NCT02307513|21432537|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83
8681655|NCT02307513|21432536|P2|STARTED|Placebo Controlled Phase (Weeks 0-12)||104
8681656|NCT02307513|21432537|P1|STARTED|Placebo Controlled Phase (Weeks 0-12)||103
8681657|NCT02213926|21432579|P1|NOT COMPLETED|Overall Study||70
8681658|NCT02213926|21432579|P1|COMPLETED|Overall Study||54
8681659|NCT02213926|21432579|P1|STARTED|Overall Study||124
8681660|NCT02207244|21432586|P11|NOT COMPLETED|Open-label Guselkumab: Week 72-264||102
8681661|NCT02207244|21432587|P10|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8681662|NCT02207244|21432588|P9|NOT COMPLETED|Open-label Guselkumab: Week 72-264||38
8681663|NCT02207244|21432589|P8|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8681664|NCT02207244|21432590|P7|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8681665|NCT02207244|21432591|P6|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8681666|NCT02207244|21432592|P5|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8681667|NCT02207244|21432593|P4|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8681668|NCT02207244|21432594|P3|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8681669|NCT02207244|21432595|P2|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8681670|NCT02207244|21432596|P1|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
8681671|NCT02207244|21432586|P11|COMPLETED|Open-label Guselkumab: Week 72-264||554
8681672|NCT02207244|21432587|P10|COMPLETED|Open-label Guselkumab: Week 72-264||0
8681673|NCT02207244|21432588|P9|COMPLETED|Open-label Guselkumab: Week 72-264||173
8681674|NCT02207244|21432589|P8|COMPLETED|Open-label Guselkumab: Week 72-264||0
8681675|NCT02207244|21432590|P7|COMPLETED|Open-label Guselkumab: Week 72-264||0
8681676|NCT02207244|21432591|P6|COMPLETED|Open-label Guselkumab: Week 72-264||0
8681677|NCT02207244|21432592|P5|COMPLETED|Open-label Guselkumab: Week 72-264||0
8681678|NCT02207244|21432593|P4|COMPLETED|Open-label Guselkumab: Week 72-264||0
8681679|NCT02207244|21432594|P3|COMPLETED|Open-label Guselkumab: Week 72-264||0
8681680|NCT02207244|21432595|P2|COMPLETED|Open-label Guselkumab: Week 72-264||0
8681681|NCT02207244|21432596|P1|COMPLETED|Open-label Guselkumab: Week 72-264||0
8681682|NCT02207244|21432586|P11|STARTED|Open-label Guselkumab: Week 72-264||656
8681683|NCT02207244|21432587|P10|STARTED|Open-label Guselkumab: Week 72-264||0
8681684|NCT02207244|21432588|P9|STARTED|Open-label Guselkumab: Week 72-264||211
8681685|NCT02207244|21432589|P8|STARTED|Open-label Guselkumab: Week 72-264||0
8681686|NCT02207244|21432590|P7|STARTED|Open-label Guselkumab: Week 72-264||0
8681687|NCT02207244|21432591|P6|STARTED|Open-label Guselkumab: Week 72-264||0
8681688|NCT02207244|21432592|P5|STARTED|Open-label Guselkumab: Week 72-264||0
8681689|NCT02207244|21432593|P4|STARTED|Open-label Guselkumab: Week 72-264||0
8681690|NCT02207244|21432594|P3|STARTED|Open-label Guselkumab: Week 72-264||0
8681691|NCT02207244|21432595|P2|STARTED|Open-label Guselkumab: Week 72-264||0
8681692|NCT02207244|21432596|P1|STARTED|Open-label Guselkumab: Week 72-264||0
8681693|NCT02207244|21432586|P11|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681694|NCT02207244|21432587|P10|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||8
8681695|NCT02207244|21432588|P9|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||9
8681696|NCT02207244|21432589|P8|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||27
8681697|NCT02207244|21432590|P7|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||14
8681698|NCT02207244|21432591|P6|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681699|NCT02207244|21432592|P5|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681700|NCT02207244|21432593|P4|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681701|NCT02207244|21432594|P3|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681702|NCT02207244|21432595|P2|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681703|NCT02207244|21432596|P1|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681704|NCT02207244|21432586|P11|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681705|NCT02207244|21432587|P10|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681706|NCT02207244|21432588|P9|COMPLETED|Withdrawal and Re-treatment: Week 28-72||211
8681707|NCT02207244|21432589|P8|COMPLETED|Withdrawal and Re-treatment: Week 28-72||443
8681708|NCT02207244|21432590|P7|COMPLETED|Withdrawal and Re-treatment: Week 28-72||213
8681709|NCT02207244|21432591|P6|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681710|NCT02207244|21432592|P5|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681711|NCT02207244|21432593|P4|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681712|NCT02207244|21432594|P3|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681713|NCT02207244|21432595|P2|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681714|NCT02207244|21432596|P1|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
8681715|NCT02207244|21432586|P11|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8681716|NCT02207244|21432587|P10|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8681717|NCT02207244|21432588|P9|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||108
8681718|NCT02207244|21432589|P8|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8681719|NCT02207244|21432590|P7|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||147
8681720|NCT02207244|21432591|P6|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8681721|NCT02207244|21432592|P5|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8681722|NCT02207244|21432593|P4|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8681723|NCT02207244|21432594|P3|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8681724|NCT02207244|21432595|P2|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8681725|NCT02207244|21432596|P1|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
8681726|NCT02207244|21432586|P11|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8681727|NCT02207244|21432587|P10|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8681728|NCT02207244|21432588|P9|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8681729|NCT02207244|21432589|P8|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72|Participants randomized to withdrawal=182 and maintenance= 193|375
8681730|NCT02207244|21432590|P7|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8681731|NCT02207244|21432591|P6|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8681732|NCT02207244|21432592|P5|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8681733|NCT02207244|21432593|P4|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8681734|NCT02207244|21432594|P3|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8681735|NCT02207244|21432595|P2|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8681736|NCT02207244|21432596|P1|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
8681737|NCT02207244|21432586|P11|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8681738|NCT02207244|21432587|P10|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8681739|NCT02207244|21432588|P9|Nonresponders|Withdrawal and Re-treatment: Week 28-72||112
8681740|NCT02207244|21432589|P8|Nonresponders|Withdrawal and Re-treatment: Week 28-72||95
8681741|NCT02207244|21432590|P7|Nonresponders|Withdrawal and Re-treatment: Week 28-72||80
8681742|NCT02207244|21432591|P6|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8681743|NCT02207244|21432592|P5|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8681744|NCT02207244|21432593|P4|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8681745|NCT02207244|21432594|P3|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8681746|NCT02207244|21432595|P2|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8681747|NCT02207244|21432596|P1|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
8681748|NCT02207244|21432586|P11|STARTED|Withdrawal and Re-treatment: Week 28-72||0
8681749|NCT02207244|21432587|P10|STARTED|Withdrawal and Re-treatment: Week 28-72||8
8681750|NCT02207244|21432588|P9|STARTED|Withdrawal and Re-treatment: Week 28-72||220
8681751|NCT02207244|21432589|P8|STARTED|Withdrawal and Re-treatment: Week 28-72||470
8681752|NCT02207244|21432590|P7|STARTED|Withdrawal and Re-treatment: Week 28-72||227
8681753|NCT02207244|21432591|P6|STARTED|Withdrawal and Re-treatment: Week 28-72||0
8681754|NCT02207244|21432592|P5|STARTED|Withdrawal and Re-treatment: Week 28-72||0
8681755|NCT02207244|21432593|P4|STARTED|Withdrawal and Re-treatment: Week 28-72||0
8681756|NCT02207244|21432594|P3|STARTED|Withdrawal and Re-treatment: Week 28-72||0
8681757|NCT02207244|21432595|P2|STARTED|Withdrawal and Re-treatment: Week 28-72||0
8681758|NCT02207244|21432596|P1|STARTED|Withdrawal and Re-treatment: Week 28-72||0
8681759|NCT02207244|21432586|P11|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681760|NCT02207244|21432587|P10|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681761|NCT02207244|21432588|P9|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681762|NCT02207244|21432589|P8|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681763|NCT02207244|21432590|P7|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681764|NCT02207244|21432591|P6|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||9
8681765|NCT02207244|21432592|P5|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||8
8681766|NCT02207244|21432593|P4|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||6
8681767|NCT02207244|21432594|P3|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681768|NCT02207244|21432595|P2|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681769|NCT02207244|21432596|P1|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681770|NCT02207244|21432586|P11|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681771|NCT02207244|21432587|P10|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681772|NCT02207244|21432588|P9|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681773|NCT02207244|21432589|P8|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681774|NCT02207244|21432590|P7|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681775|NCT02207244|21432591|P6|COMPLETED|Placebo Crossover and ACP: Week 16-28||228
8681776|NCT02207244|21432592|P5|COMPLETED|Placebo Crossover and ACP: Week 16-28||470
8681777|NCT02207244|21432593|P4|COMPLETED|Placebo Crossover and ACP: Week 16-28||227
8681778|NCT02207244|21432594|P3|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681779|NCT02207244|21432595|P2|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681780|NCT02207244|21432596|P1|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
8681781|NCT02207244|21432586|P11|STARTED|Placebo Crossover and ACP: Week 16-28||0
8681782|NCT02207244|21432587|P10|STARTED|Placebo Crossover and ACP: Week 16-28||0
8681783|NCT02207244|21432588|P9|STARTED|Placebo Crossover and ACP: Week 16-28||0
8681784|NCT02207244|21432589|P8|STARTED|Placebo Crossover and ACP: Week 16-28||0
8681785|NCT02207244|21432590|P7|STARTED|Placebo Crossover and ACP: Week 16-28||0
8681786|NCT02207244|21432591|P6|STARTED|Placebo Crossover and ACP: Week 16-28||237
8681787|NCT02207244|21432592|P5|STARTED|Placebo Crossover and ACP: Week 16-28||478
8681788|NCT02207244|21432593|P4|STARTED|Placebo Crossover and ACP: Week 16-28||233
8681789|NCT02207244|21432594|P3|STARTED|Placebo Crossover and ACP: Week 16-28||0
8681790|NCT02207244|21432595|P2|STARTED|Placebo Crossover and ACP: Week 16-28||0
8681791|NCT02207244|21432596|P1|STARTED|Placebo Crossover and ACP: Week 16-28||0
8681792|NCT02207244|21432586|P11|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8681793|NCT02207244|21432587|P10|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8681794|NCT02207244|21432588|P9|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8681795|NCT02207244|21432589|P8|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8681796|NCT02207244|21432590|P7|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8681797|NCT02207244|21432591|P6|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8681798|NCT02207244|21432592|P5|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8681799|NCT02207244|21432593|P4|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
8681800|NCT02207244|21432594|P3|NOT COMPLETED|Placebo Controlled Period: Week 0-16||11
8681801|NCT02207244|21432595|P2|NOT COMPLETED|Placebo Controlled Period: Week 0-16||18
8681802|NCT02207244|21432596|P1|NOT COMPLETED|Placebo Controlled Period: Week 0-16||15
8681803|NCT02207244|21432586|P11|COMPLETED|Placebo Controlled Period: Week 0-16||0
8681804|NCT02207244|21432587|P10|COMPLETED|Placebo Controlled Period: Week 0-16||0
8681805|NCT02207244|21432588|P9|COMPLETED|Placebo Controlled Period: Week 0-16||0
8681806|NCT02207244|21432589|P8|COMPLETED|Placebo Controlled Period: Week 0-16||0
8681807|NCT02207244|21432590|P7|COMPLETED|Placebo Controlled Period: Week 0-16||0
8681808|NCT02207244|21432591|P6|COMPLETED|Placebo Controlled Period: Week 0-16||0
8681809|NCT02207244|21432592|P5|COMPLETED|Placebo Controlled Period: Week 0-16||0
8681810|NCT02207244|21432593|P4|COMPLETED|Placebo Controlled Period: Week 0-16||0
8681811|NCT02207244|21432594|P3|COMPLETED|Placebo Controlled Period: Week 0-16||237
8681812|NCT02207244|21432595|P2|COMPLETED|Placebo Controlled Period: Week 0-16||478
8681813|NCT02207244|21432596|P1|COMPLETED|Placebo Controlled Period: Week 0-16||233
8681814|NCT02207244|21432586|P11|Treated|Placebo Controlled Period: Week 0-16||0
8681815|NCT02207244|21432587|P10|Treated|Placebo Controlled Period: Week 0-16||0
8681816|NCT02207244|21432588|P9|Treated|Placebo Controlled Period: Week 0-16||0
8681817|NCT02207244|21432589|P8|Treated|Placebo Controlled Period: Week 0-16||0
8681818|NCT02207244|21432590|P7|Treated|Placebo Controlled Period: Week 0-16||0
8681819|NCT02207244|21432591|P6|Treated|Placebo Controlled Period: Week 0-16||0
8681820|NCT02207244|21432592|P5|Treated|Placebo Controlled Period: Week 0-16||0
8681821|NCT02207244|21432593|P4|Treated|Placebo Controlled Period: Week 0-16||0
8681822|NCT02207244|21432594|P3|Treated|Placebo Controlled Period: Week 0-16||248
8681823|NCT02207244|21432595|P2|Treated|Placebo Controlled Period: Week 0-16||494
8681824|NCT02207244|21432596|P1|Treated|Placebo Controlled Period: Week 0-16||248
8681825|NCT02207244|21432586|P11|STARTED|Placebo Controlled Period: Week 0-16||0
8681826|NCT02207244|21432587|P10|STARTED|Placebo Controlled Period: Week 0-16||0
8681827|NCT02207244|21432588|P9|STARTED|Placebo Controlled Period: Week 0-16||0
8681828|NCT02207244|21432589|P8|STARTED|Placebo Controlled Period: Week 0-16||0
8681829|NCT02207244|21432590|P7|STARTED|Placebo Controlled Period: Week 0-16||0
8681830|NCT02207244|21432591|P6|STARTED|Placebo Controlled Period: Week 0-16||0
8681831|NCT02207244|21432592|P5|STARTED|Placebo Controlled Period: Week 0-16||0
8681832|NCT02207244|21432593|P4|STARTED|Placebo Controlled Period: Week 0-16||0
8681833|NCT02207244|21432594|P3|STARTED|Placebo Controlled Period: Week 0-16||248
8681834|NCT02207244|21432595|P2|STARTED|Placebo Controlled Period: Week 0-16||496
8681835|NCT02207244|21432596|P1|STARTED|Placebo Controlled Period: Week 0-16||248
8681836|NCT02132312|21432650|P2|NOT COMPLETED|Overall Study||3
8681837|NCT02132312|21432651|P1|NOT COMPLETED|Overall Study||6
8681838|NCT02132312|21432650|P2|COMPLETED|Overall Study||38
8681839|NCT02132312|21432651|P1|COMPLETED|Overall Study||31
8681840|NCT02132312|21432650|P2|STARTED|Overall Study||41
8681841|NCT02132312|21432651|P1|STARTED|Overall Study||37
8681842|NCT01972217|21432665|P4|NOT COMPLETED|Part B Double-blind, Randomised Period||47
8681843|NCT01972217|21432666|P3|NOT COMPLETED|Part B Double-blind, Randomised Period||46
8681844|NCT01972217|21432667|P2|NOT COMPLETED|Part B Double-blind, Randomised Period||0
8681845|NCT01972217|21432668|P1|NOT COMPLETED|Part B Double-blind, Randomised Period||0
8681846|NCT01972217|21432665|P4|COMPLETED|Part B Double-blind, Randomised Period||24
8681847|NCT01972217|21432666|P3|COMPLETED|Part B Double-blind, Randomised Period||25
8681848|NCT01972217|21432667|P2|COMPLETED|Part B Double-blind, Randomised Period||0
8681849|NCT01972217|21432668|P1|COMPLETED|Part B Double-blind, Randomised Period||0
8681850|NCT01972217|21432665|P4|Received Abiraterone|Part B Double-blind, Randomised Period||71
8681851|NCT01972217|21432666|P3|Received Abiraterone|Part B Double-blind, Randomised Period||71
8681852|NCT01972217|21432667|P2|Received Abiraterone|Part B Double-blind, Randomised Period||0
8681853|NCT01972217|21432668|P1|Received Abiraterone|Part B Double-blind, Randomised Period||0
8681854|NCT01972217|21432665|P4|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
8681855|NCT01972217|21432666|P3|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
8681856|NCT01972217|21432667|P2|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
8681857|NCT01972217|21432668|P1|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
8681858|NCT01972217|21432665|P4|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
8681859|NCT01972217|21432666|P3|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
8681860|NCT01972217|21432667|P2|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
8681861|NCT01972217|21432668|P1|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
8681862|NCT01972217|21432665|P4|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
8681863|NCT01972217|21432666|P3|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
8681864|NCT01972217|21432667|P2|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
8681865|NCT01972217|21432668|P1|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
8681866|NCT01972217|21432665|P4|COMPLETED|Part A: Open-label Safety Run-in Period||0
8681867|NCT01972217|21432666|P3|COMPLETED|Part A: Open-label Safety Run-in Period||0
8681868|NCT01972217|21432667|P2|COMPLETED|Part A: Open-label Safety Run-in Period||1
8681869|NCT01972217|21432668|P1|COMPLETED|Part A: Open-label Safety Run-in Period||2
8681870|NCT01972217|21432665|P4|STARTED|Part A: Open-label Safety Run-in Period||0
8681871|NCT01972217|21432666|P3|STARTED|Part A: Open-label Safety Run-in Period||0
8681872|NCT01972217|21432667|P2|STARTED|Part A: Open-label Safety Run-in Period||13
8681873|NCT01972217|21432668|P1|STARTED|Part A: Open-label Safety Run-in Period||3
8681874|NCT01877655|21432716|P2|NOT COMPLETED|Overall Study||97
8681875|NCT01877655|21432717|P1|NOT COMPLETED|Overall Study||98
8681876|NCT01877655|21432716|P2|COMPLETED|Overall Study||154
8681877|NCT01877655|21432717|P1|COMPLETED|Overall Study||165
8681878|NCT01877655|21432716|P2|Received Treatment|Overall Study||246
8681879|NCT01877655|21432717|P1|Received Treatment|Overall Study||255
8681880|NCT01877655|21432716|P2|STARTED|Overall Study||251
8681881|NCT01877655|21432717|P1|STARTED|Overall Study||263
8681882|NCT01848041|21432736|P3|NOT COMPLETED|Overall Study||0
8681883|NCT01848041|21432737|P2|NOT COMPLETED|Overall Study||0
8681884|NCT01848041|21432738|P1|NOT COMPLETED|Overall Study||0
8681885|NCT01848041|21432736|P3|COMPLETED|Overall Study||15
8681886|NCT01848041|21432737|P2|COMPLETED|Overall Study||16
8681887|NCT01848041|21432738|P1|COMPLETED|Overall Study||15
8681888|NCT01848041|21432736|P3|STARTED|Overall Study||15
8681889|NCT01848041|21432737|P2|STARTED|Overall Study||16
8681890|NCT01848041|21432738|P1|STARTED|Overall Study||15
8681891|NCT01811875|21432755|P1|NOT COMPLETED|Overall Study||2
8681892|NCT01811875|21432755|P1|COMPLETED|Overall Study||5
8681893|NCT01811875|21432755|P1|STARTED|Overall Study||7
8681894|NCT01684722|21432775|P4|NOT COMPLETED|Overall Study||110
8681895|NCT01684722|21432776|P3|NOT COMPLETED|Overall Study||94
8681896|NCT01684722|21432777|P2|NOT COMPLETED|Overall Study||77
8681897|NCT01684722|21432778|P1|NOT COMPLETED|Overall Study||97
8681898|NCT01684722|21432775|P4|COMPLETED|Overall Study||260
8681899|NCT01684722|21432776|P3|COMPLETED|Overall Study||226
8681900|NCT01684722|21432777|P2|COMPLETED|Overall Study||212
8681901|NCT01684722|21432778|P1|COMPLETED|Overall Study||236
8681902|NCT01684722|21432775|P4|STARTED|Overall Study||370
8681903|NCT01684722|21432776|P3|STARTED|Overall Study||320
8681904|NCT01684722|21432777|P2|STARTED|Overall Study||289
8681905|NCT01684722|21432778|P1|STARTED|Overall Study||333
8681906|NCT00171249|21432804|P7|NOT COMPLETED|Overall Study||2
8681907|NCT00171249|21432805|P6|NOT COMPLETED|Overall Study||43
8681908|NCT00171249|21432806|P5|NOT COMPLETED|Overall Study||3
8681909|NCT00171249|21432807|P4|NOT COMPLETED|Overall Study||152
8681910|NCT00171249|21432808|P3|NOT COMPLETED|Overall Study||5
8681911|NCT00171249|21432809|P2|NOT COMPLETED|Overall Study||5
8681912|NCT00171249|21432810|P1|NOT COMPLETED|Overall Study||76
8681913|NCT00171249|21432804|P7|COMPLETED|Overall Study||0
8681914|NCT00171249|21432805|P6|COMPLETED|Overall Study||0
8681915|NCT00171249|21432806|P5|COMPLETED|Overall Study||0
8681916|NCT00171249|21432807|P4|COMPLETED|Overall Study||6
8681917|NCT00171249|21432808|P3|COMPLETED|Overall Study||0
8681918|NCT00171249|21432809|P2|COMPLETED|Overall Study||0
8681919|NCT00171249|21432810|P1|COMPLETED|Overall Study||1
8681920|NCT00171249|21432804|P7|Completed Part 1|Overall Study||0
8681921|NCT00171249|21432805|P6|Completed Part 1|Overall Study||6
8681922|NCT00171249|21432806|P5|Completed Part 1|Overall Study||2
8681923|NCT00171249|21432807|P4|Completed Part 1|Overall Study||125
8681924|NCT00171249|21432808|P3|Completed Part 1|Overall Study||1
8681925|NCT00171249|21432809|P2|Completed Part 1|Overall Study||0
8681926|NCT00171249|21432810|P1|Completed Part 1|Overall Study||50
8681927|NCT00171249|21432804|P7|STARTED|Overall Study||2
8681928|NCT00171249|21432805|P6|STARTED|Overall Study||43
8681929|NCT00171249|21432806|P5|STARTED|Overall Study||3
8681930|NCT00171249|21432807|P4|STARTED|Overall Study||158
8681931|NCT00171249|21432808|P3|STARTED|Overall Study||5
8681932|NCT00171249|21432809|P2|STARTED|Overall Study||5
8681933|NCT00171249|21432810|P1|STARTED|Overall Study||77
8681934|NCT00171223|21432832|P3|NOT COMPLETED|Overall Study||170
8681935|NCT00171223|21432833|P2|NOT COMPLETED|Overall Study||141
8681936|NCT00171223|21432834|P1|NOT COMPLETED|Overall Study||140
8681937|NCT00171223|21432832|P3|COMPLETED|Overall Study||22
8681938|NCT00171223|21432833|P2|COMPLETED|Overall Study||47
8681939|NCT00171223|21432834|P1|COMPLETED|Overall Study||12
8681940|NCT00171223|21432832|P3|STARTED|Overall Study||192
8681941|NCT00171223|21432833|P2|STARTED|Overall Study||188
8681942|NCT00171223|21432834|P1|STARTED|Overall Study||152
8681946|NCT00082329|21432864|P1|NOT COMPLETED|Overall Study||0
8681947|NCT00082329|21432864|P1|COMPLETED|Overall Study||9
8681948|NCT00082329|21432864|P1|STARTED|Overall Study||9
8681949|NCT04204057|21432870|P1|NOT COMPLETED|Overall Study||0
8681950|NCT04204057|21432870|P1|COMPLETED|Overall Study||21
8681951|NCT04204057|21432870|P1|STARTED|Overall Study||21
8681952|NCT04147611|21432879|P2|NOT COMPLETED|Overall Study||1
8681953|NCT04147611|21432880|P1|NOT COMPLETED|Overall Study||0
8681954|NCT04147611|21432879|P2|COMPLETED|Overall Study||12
8681955|NCT04147611|21432880|P1|COMPLETED|Overall Study||9
8681956|NCT04147611|21432879|P2|STARTED|Overall Study||13
8681957|NCT04147611|21432880|P1|STARTED|Overall Study||9
8681958|NCT03846219|21432889|P3|NOT COMPLETED|Overall Study||5
8681959|NCT03846219|21432890|P2|NOT COMPLETED|Overall Study||4
8681960|NCT03846219|21432891|P1|NOT COMPLETED|Overall Study||3
8681961|NCT03846219|21432889|P3|COMPLETED|Overall Study||64
8681962|NCT03846219|21432890|P2|COMPLETED|Overall Study||65
8681963|NCT03846219|21432891|P1|COMPLETED|Overall Study||69
8681964|NCT03846219|21432889|P3|Patients Treated|Overall Study||69
8681965|NCT03846219|21432890|P2|Patients Treated|Overall Study||69
8681966|NCT03846219|21432891|P1|Patients Treated|Overall Study||71
8681967|NCT03846219|21432889|P3|STARTED|Overall Study||69
8681968|NCT03846219|21432890|P2|STARTED|Overall Study||69
8681969|NCT03846219|21432891|P1|STARTED|Overall Study||72
8681970|NCT03800173|21433070|P5|NOT COMPLETED|Overall Study||1
8681971|NCT03800173|21433071|P4|NOT COMPLETED|Overall Study||0
8681972|NCT03800173|21433072|P3|NOT COMPLETED|Overall Study||0
8681973|NCT03800173|21433073|P2|NOT COMPLETED|Overall Study||0
8681974|NCT03800173|21433074|P1|NOT COMPLETED|Overall Study||0
8681975|NCT03800173|21433070|P5|COMPLETED|Overall Study||5
8681976|NCT03800173|21433071|P4|COMPLETED|Overall Study||6
8681977|NCT03800173|21433072|P3|COMPLETED|Overall Study||6
8681978|NCT03800173|21433073|P2|COMPLETED|Overall Study||6
8681979|NCT03800173|21433074|P1|COMPLETED|Overall Study||8
8681980|NCT03800173|21433070|P5|PK Population|Overall Study||6
8681981|NCT03800173|21433071|P4|PK Population|Overall Study||6
8681982|NCT03800173|21433072|P3|PK Population|Overall Study||6
8681983|NCT03800173|21433073|P2|PK Population|Overall Study||6
8681984|NCT03800173|21433074|P1|PK Population|Overall Study||0
8681985|NCT03800173|21433070|P5|Safety Population|Overall Study||6
8681986|NCT03800173|21433071|P4|Safety Population|Overall Study||6
8681987|NCT03800173|21433072|P3|Safety Population|Overall Study||6
8681988|NCT03800173|21433073|P2|Safety Population|Overall Study||6
8681989|NCT03800173|21433074|P1|Safety Population|Overall Study||8
8681990|NCT03800173|21433070|P5|STARTED|Overall Study||6
8681991|NCT03800173|21433071|P4|STARTED|Overall Study||6
8681992|NCT03800173|21433072|P3|STARTED|Overall Study||6
8681993|NCT03800173|21433073|P2|STARTED|Overall Study||6
8681994|NCT03800173|21433074|P1|STARTED|Overall Study||8
8681995|NCT03668613|21433100|P2|NOT COMPLETED|Overall Study||3
8681996|NCT03668613|21433101|P1|NOT COMPLETED|Overall Study||0
8681997|NCT03668613|21433100|P2|COMPLETED|Overall Study||39
8681998|NCT03668613|21433101|P1|COMPLETED|Overall Study||42
8681999|NCT03668613|21433100|P2|STARTED|Overall Study||42
8682000|NCT03668613|21433101|P1|STARTED|Overall Study||42
8682001|NCT03652675|21433113|P2|NOT COMPLETED|Overall Study||4
8682002|NCT03652675|21433114|P1|NOT COMPLETED|Overall Study||4
8682003|NCT03652675|21433113|P2|COMPLETED|Overall Study||11
8682004|NCT03652675|21433114|P1|COMPLETED|Overall Study||12
8682005|NCT03652675|21433113|P2|STARTED|Overall Study||15
8682006|NCT03652675|21433114|P1|STARTED|Overall Study||16
8682007|NCT03611075|21433143|P9|NOT COMPLETED|Overall Study||0
8682008|NCT03611075|21433144|P8|NOT COMPLETED|Overall Study||0
8682009|NCT03611075|21433145|P7|NOT COMPLETED|Overall Study||2
8682010|NCT03611075|21433146|P6|NOT COMPLETED|Overall Study||0
8682011|NCT03611075|21433147|P5|NOT COMPLETED|Overall Study||0
8682012|NCT03611075|21433148|P4|NOT COMPLETED|Overall Study||4
8682013|NCT03611075|21433149|P3|NOT COMPLETED|Overall Study||2
8682014|NCT03611075|21433150|P2|NOT COMPLETED|Overall Study||2
8682015|NCT03611075|21433151|P1|NOT COMPLETED|Overall Study||1
8682016|NCT03611075|21433143|P9|COMPLETED|Overall Study||17
8682017|NCT03611075|21433144|P8|COMPLETED|Overall Study||17
8682018|NCT03611075|21433145|P7|COMPLETED|Overall Study||13
8682019|NCT03611075|21433146|P6|COMPLETED|Overall Study||18
8682020|NCT03611075|21433147|P5|COMPLETED|Overall Study||13
8682021|NCT03611075|21433148|P4|COMPLETED|Overall Study||13
8682022|NCT03611075|21433149|P3|COMPLETED|Overall Study||14
8682023|NCT03611075|21433150|P2|COMPLETED|Overall Study||13
8682024|NCT03611075|21433151|P1|COMPLETED|Overall Study||15
8682025|NCT03611075|21433143|P9|STARTED|Overall Study||17
8682026|NCT03611075|21433144|P8|STARTED|Overall Study||17
8682027|NCT03611075|21433145|P7|STARTED|Overall Study||15
8682028|NCT03611075|21433146|P6|STARTED|Overall Study||18
8682029|NCT03611075|21433147|P5|STARTED|Overall Study||13
8682030|NCT03611075|21433148|P4|STARTED|Overall Study||17
8682031|NCT03611075|21433149|P3|STARTED|Overall Study||16
8682032|NCT03611075|21433150|P2|STARTED|Overall Study||15
8682033|NCT03611075|21433151|P1|STARTED|Overall Study||16
8682034|NCT03567252|21433282|P2|NOT COMPLETED|Overall Study||0
8682035|NCT03567252|21433283|P1|NOT COMPLETED|Overall Study||0
8682036|NCT03567252|21433282|P2|COMPLETED|Overall Study||19
8682037|NCT03567252|21433283|P1|COMPLETED|Overall Study||48
8682038|NCT03567252|21433282|P2|STARTED|Overall Study||19
8682039|NCT03567252|21433283|P1|STARTED|Overall Study||48
8682046|NCT03334695|21433348|P2|NOT COMPLETED|Overall Study||6
8682047|NCT03334695|21433349|P1|NOT COMPLETED|Overall Study||4
8682048|NCT03334695|21433348|P2|COMPLETED|Overall Study||26
8682049|NCT03334695|21433349|P1|COMPLETED|Overall Study||27
8682050|NCT03334695|21433348|P2|STARTED|Overall Study||32
8682051|NCT03334695|21433349|P1|STARTED|Overall Study||31
8682052|NCT03305809|21433387|P4|NOT COMPLETED|Overall Study||27
8682053|NCT03305809|21433388|P3|NOT COMPLETED|Overall Study||19
8682054|NCT03305809|21433389|P2|NOT COMPLETED|Overall Study||8
8682055|NCT03305809|21433390|P1|NOT COMPLETED|Overall Study||7
8682056|NCT03305809|21433387|P4|COMPLETED|Overall Study||60
8682057|NCT03305809|21433388|P3|COMPLETED|Overall Study||66
8682058|NCT03305809|21433389|P2|COMPLETED|Overall Study||78
8682059|NCT03305809|21433390|P1|COMPLETED|Overall Study||79
8682060|NCT03305809|21433387|P4|Received at Least One Dose of Study Drug|Overall Study||87
8682061|NCT03305809|21433388|P3|Received at Least One Dose of Study Drug|Overall Study||85
8682062|NCT03305809|21433389|P2|Received at Least One Dose of Study Drug|Overall Study||86
8682063|NCT03305809|21433390|P1|Received at Least One Dose of Study Drug|Overall Study||86
8682064|NCT03305809|21433387|P4|STARTED|Overall Study||87
8682065|NCT03305809|21433388|P3|STARTED|Overall Study||85
8682066|NCT03305809|21433389|P2|STARTED|Overall Study||86
8682067|NCT03305809|21433390|P1|STARTED|Overall Study||86
8682068|NCT03277105|21433477|P2|NOT COMPLETED|Overall Study||263
8682069|NCT03277105|21433478|P1|NOT COMPLETED|Overall Study||259
8682070|NCT03277105|21433477|P2|COMPLETED|Overall Study||0
8682071|NCT03277105|21433478|P1|COMPLETED|Overall Study||0
8682072|NCT03277105|21433477|P2|Safety Analysis Set|Overall Study||260
8682073|NCT03277105|21433478|P1|Safety Analysis Set|Overall Study||258
8682074|NCT03277105|21433477|P2|STARTED|Overall Study||263
8682075|NCT03277105|21433478|P1|STARTED|Overall Study||259
8682076|NCT03209882|21433510|P2|NOT COMPLETED|Overall Study||0
8682077|NCT03209882|21433511|P1|NOT COMPLETED|Overall Study||0
8682078|NCT03209882|21433510|P2|COMPLETED|Overall Study||3
8682079|NCT03209882|21433511|P1|COMPLETED|Overall Study||6
8682080|NCT03209882|21433510|P2|STARTED|Overall Study||3
8682081|NCT03209882|21433511|P1|STARTED|Overall Study||6
8682094|NCT03197324|21433537|P2|NOT COMPLETED|Overall Study||1
8682095|NCT03197324|21433538|P1|NOT COMPLETED|Overall Study||0
8682096|NCT03197324|21433537|P2|COMPLETED|Overall Study||9
8682097|NCT03197324|21433538|P1|COMPLETED|Overall Study||10
8682098|NCT03197324|21433537|P2|STARTED|Overall Study||10
8682099|NCT03197324|21433538|P1|STARTED|Overall Study||10
8682100|NCT03144089|21433552|P2|NOT COMPLETED|Overall Study||0
8682101|NCT03144089|21433553|P1|NOT COMPLETED|Overall Study||0
8682102|NCT03144089|21433552|P2|COMPLETED|Overall Study||28
8682103|NCT03144089|21433553|P1|COMPLETED|Overall Study||28
8682104|NCT03144089|21433552|P2|STARTED|Overall Study||28
8682105|NCT03144089|21433553|P1|STARTED|Overall Study||28
8682106|NCT03098550|21433566|P3|NOT COMPLETED|Overall Study||43
8682107|NCT03098550|21433567|P2|NOT COMPLETED|Overall Study||20
8682108|NCT03098550|21433568|P1|NOT COMPLETED|Overall Study||41
8682109|NCT03098550|21433566|P3|COMPLETED|Overall Study||0
8682110|NCT03098550|21433567|P2|COMPLETED|Overall Study||1
8682111|NCT03098550|21433568|P1|COMPLETED|Overall Study||0
8682112|NCT03098550|21433566|P3|STARTED|Overall Study||43
8682113|NCT03098550|21433567|P2|STARTED|Overall Study||21
8682114|NCT03098550|21433568|P1|STARTED|Overall Study||41
8682115|NCT03058991|21433612|P3|NOT COMPLETED|Overall Study||12
8682116|NCT03058991|21433613|P2|NOT COMPLETED|Overall Study||12
8682117|NCT03058991|21433614|P1|NOT COMPLETED|Overall Study||18
8682118|NCT03058991|21433612|P3|COMPLETED|Overall Study||25
8682119|NCT03058991|21433613|P2|COMPLETED|Overall Study||20
8682120|NCT03058991|21433614|P1|COMPLETED|Overall Study||21
8682121|NCT03058991|21433612|P3|1-Week Follow Up|Overall Study||28
8682122|NCT03058991|21433613|P2|1-Week Follow Up|Overall Study||27
8682123|NCT03058991|21433614|P1|1-Week Follow Up|Overall Study||23
8682124|NCT03058991|21433612|P3|STARTED|Overall Study||37
8682125|NCT03058991|21433613|P2|STARTED|Overall Study||32
8682126|NCT03058991|21433614|P1|STARTED|Overall Study||39
8682127|NCT03041467|21433642|P2|NOT COMPLETED|Overall Study||160
8682128|NCT03041467|21433643|P1|NOT COMPLETED|Overall Study||170
8682129|NCT03041467|21433642|P2|COMPLETED|Overall Study||0
8682130|NCT03041467|21433643|P1|COMPLETED|Overall Study||0
8682131|NCT03041467|21433642|P2|STARTED|Overall Study||160
8682132|NCT03041467|21433643|P1|STARTED|Overall Study||170
8682133|NCT03027466|21433677|P4|NOT COMPLETED|Overall Study||1821
8682134|NCT03027466|21433678|P3|NOT COMPLETED|Overall Study||1743
8682135|NCT03027466|21433679|P2|NOT COMPLETED|Overall Study||1819
8682136|NCT03027466|21433680|P1|NOT COMPLETED|Overall Study||1869
8682137|NCT03027466|21433677|P4|COMPLETED|Overall Study||164
8682138|NCT03027466|21433678|P3|COMPLETED|Overall Study||160
8682139|NCT03027466|21433679|P2|COMPLETED|Overall Study||165
8682140|NCT03027466|21433680|P1|COMPLETED|Overall Study||158
8682141|NCT03027466|21433677|P4|STARTED|Overall Study||1985
8682142|NCT03027466|21433678|P3|STARTED|Overall Study||1903
8682143|NCT03027466|21433679|P2|STARTED|Overall Study||1984
8682144|NCT03027466|21433680|P1|STARTED|Overall Study||2027
8682157|NCT02765165|21433734|P7|NOT COMPLETED|Post-treatment Follow-up||1
8682158|NCT02765165|21433735|P6|NOT COMPLETED|Post-treatment Follow-up||3
8682159|NCT02765165|21433736|P5|NOT COMPLETED|Post-treatment Follow-up||3
8682160|NCT02765165|21433737|P4|NOT COMPLETED|Post-treatment Follow-up||3
8682161|NCT02765165|21433738|P3|NOT COMPLETED|Post-treatment Follow-up||3
8682162|NCT02765165|21433739|P2|NOT COMPLETED|Post-treatment Follow-up||3
8682163|NCT02765165|21433740|P1|NOT COMPLETED|Post-treatment Follow-up||1
8682164|NCT02765165|21433734|P7|COMPLETED|Post-treatment Follow-up||0
8682165|NCT02765165|21433735|P6|COMPLETED|Post-treatment Follow-up||0
8682166|NCT02765165|21433736|P5|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
8682167|NCT02765165|21433737|P4|COMPLETED|Post-treatment Follow-up||0
8682168|NCT02765165|21433738|P3|COMPLETED|Post-treatment Follow-up||0
8682169|NCT02765165|21433739|P2|COMPLETED|Post-treatment Follow-up||0
8682170|NCT02765165|21433740|P1|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
8682171|NCT02765165|21433734|P7|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
8682172|NCT02765165|21433735|P6|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
8682173|NCT02765165|21433736|P5|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
8682174|NCT02765165|21433737|P4|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
8682175|NCT02765165|21433738|P3|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
8682176|NCT02765165|21433739|P2|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
8682177|NCT02765165|21433740|P1|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
8682178|NCT02765165|21433734|P7|NOT COMPLETED|Treatment Period||4
8682179|NCT02765165|21433735|P6|NOT COMPLETED|Treatment Period||3
8682180|NCT02765165|21433736|P5|NOT COMPLETED|Treatment Period||6
8682181|NCT02765165|21433737|P4|NOT COMPLETED|Treatment Period||3
8682182|NCT02765165|21433738|P3|NOT COMPLETED|Treatment Period||3
8682183|NCT02765165|21433739|P2|NOT COMPLETED|Treatment Period||4
8682184|NCT02765165|21433740|P1|NOT COMPLETED|Treatment Period||3
8682185|NCT02765165|21433734|P7|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
8682186|NCT02765165|21433735|P6|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
8682187|NCT02765165|21433736|P5|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
8682188|NCT02765165|21433737|P4|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
8682189|NCT02765165|21433738|P3|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
8682190|NCT02765165|21433739|P2|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
8682191|NCT02765165|21433740|P1|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
8682192|NCT02765165|21433734|P7|STARTED|Treatment Period||4
8682193|NCT02765165|21433735|P6|STARTED|Treatment Period||3
8682194|NCT02765165|21433736|P5|STARTED|Treatment Period||6
8682195|NCT02765165|21433737|P4|STARTED|Treatment Period||3
8682196|NCT02765165|21433738|P3|STARTED|Treatment Period||3
8682197|NCT02765165|21433739|P2|STARTED|Treatment Period||4
8682198|NCT02765165|21433740|P1|STARTED|Treatment Period||3
8682199|NCT02725593|21433781|P2|NOT COMPLETED|Long Term Extension||1
8682200|NCT02725593|21433782|P1|NOT COMPLETED|Long Term Extension||1
8682201|NCT02725593|21433781|P2|COMPLETED|Long Term Extension||24
8682202|NCT02725593|21433782|P1|COMPLETED|Long Term Extension||32
8682203|NCT02725593|21433781|P2|STARTED|Long Term Extension||25
8682204|NCT02725593|21433782|P1|STARTED|Long Term Extension|1 participant who completed Period 1 did not enter the long-term extension period.|33
8682205|NCT02725593|21433781|P2|NOT COMPLETED|Blinded Treatment Period||6
8682206|NCT02725593|21433782|P1|NOT COMPLETED|Blinded Treatment Period||5
8682207|NCT02725593|21433781|P2|COMPLETED|Blinded Treatment Period||25
8682208|NCT02725593|21433782|P1|COMPLETED|Blinded Treatment Period||34
8682209|NCT02725593|21433781|P2|Received Treatment|Blinded Treatment Period||31
8682210|NCT02725593|21433782|P1|Received Treatment|Blinded Treatment Period||39
8682211|NCT02725593|21433781|P2|STARTED|Blinded Treatment Period||31
8682212|NCT02725593|21433782|P1|STARTED|Blinded Treatment Period||39
8682222|NCT02562716|21433820|P2|NOT COMPLETED|Overall Study||28
8682223|NCT02562716|21433821|P1|NOT COMPLETED|Overall Study||28
8682224|NCT02562716|21433820|P2|COMPLETED|Overall Study||19
8682225|NCT02562716|21433821|P1|COMPLETED|Overall Study||27
8682226|NCT02562716|21433820|P2|Participants Assessed for AEs|Overall Study||45
8682227|NCT02562716|21433821|P1|Participants Assessed for AEs|Overall Study||53
8682228|NCT02562716|21433820|P2|STARTED|Overall Study||47
8682229|NCT02562716|21433821|P1|STARTED|Overall Study||55
8682230|NCT02520388|21433843|P2|NOT COMPLETED|Overall Study||16
8682231|NCT02520388|21433844|P1|NOT COMPLETED|Overall Study||9
8682232|NCT02520388|21433843|P2|COMPLETED|Overall Study||65
8682233|NCT02520388|21433844|P1|COMPLETED|Overall Study||73
8682234|NCT02520388|21433843|P2|Treated|Overall Study||80
8682235|NCT02520388|21433844|P1|Treated|Overall Study||81
8682236|NCT02520388|21433843|P2|STARTED|Overall Study||81
8682237|NCT02520388|21433844|P1|STARTED|Overall Study||82
8682238|NCT02518230|21433854|P2|NOT COMPLETED|Overall Study||0
8682239|NCT02518230|21433855|P1|NOT COMPLETED|Overall Study||0
8682240|NCT02518230|21433854|P2|COMPLETED|Overall Study||11
8682241|NCT02518230|21433855|P1|COMPLETED|Overall Study||11
8682242|NCT02518230|21433854|P2|STARTED|Overall Study||11
8682243|NCT02518230|21433855|P1|STARTED|Overall Study||11
8682244|NCT02493777|21433864|P2|NOT COMPLETED|Overall Study||1
8682245|NCT02493777|21433865|P1|NOT COMPLETED|Overall Study||0
8682246|NCT02493777|21433864|P2|COMPLETED|Overall Study||53
8682247|NCT02493777|21433865|P1|COMPLETED|Overall Study||65
8682248|NCT02493777|21433864|P2|STARTED|Overall Study||54
8682249|NCT02493777|21433865|P1|STARTED|Overall Study||65
8682250|NCT02454933|21433875|P2|NOT COMPLETED|Overall Study||8
8682251|NCT02454933|21433876|P1|NOT COMPLETED|Overall Study||8
8682252|NCT02454933|21433875|P2|COMPLETED|Overall Study||4
8682253|NCT02454933|21433876|P1|COMPLETED|Overall Study||9
8682254|NCT02454933|21433875|P2|Treatment Group Randomised to|Overall Study||14
8682255|NCT02454933|21433876|P1|Treatment Group Randomised to|Overall Study||15
8682256|NCT02454933|21433875|P2|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
8682257|NCT02454933|21433876|P1|STARTED|Overall Study||17
8682258|NCT02426658|21433881|P1|NOT COMPLETED|Overall Study||3
8682259|NCT02426658|21433881|P1|COMPLETED|Overall Study||13
8682260|NCT02426658|21433881|P1|STARTED|Overall Study||16
8682261|NCT02389998|21433888|P2|NOT COMPLETED|Overall Study||0
8682262|NCT02389998|21433889|P1|NOT COMPLETED|Overall Study||1
8682263|NCT02389998|21433888|P2|COMPLETED|Overall Study||15
8682264|NCT02389998|21433889|P1|COMPLETED|Overall Study||15
8682265|NCT02389998|21433888|P2|STARTED|Overall Study||15
8682266|NCT02389998|21433889|P1|STARTED|Overall Study||16
8682267|NCT02291133|21433899|P1|NOT COMPLETED|Overall Study||1
8682268|NCT02291133|21433899|P1|COMPLETED|Overall Study||24
8682269|NCT02291133|21433899|P1|STARTED|Overall Study||25
8682270|NCT02255656|21433904|P1|NOT COMPLETED|Overall Study||470
8682271|NCT02255656|21433904|P1|COMPLETED|Overall Study||592
8682272|NCT02255656|21433904|P1|STARTED|Overall Study||1062
8682281|NCT02207231|21433992|P4|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||83
8682282|NCT02207231|21433993|P3|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||38
8682283|NCT02207231|21433994|P2|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
8682284|NCT02207231|21433995|P1|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
8682285|NCT02207231|21433992|P4|COMPLETED|Open-label Guselkumab: Week 48 - 264||380
8682286|NCT02207231|21433993|P3|COMPLETED|Open-label Guselkumab: Week 48 - 264||242
8682287|NCT02207231|21433994|P2|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
8682288|NCT02207231|21433995|P1|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
8682289|NCT02207231|21433992|P4|STARTED|Open-label Guselkumab: Week 48 - 264|162 + 301= 463|463
8682290|NCT02207231|21433993|P3|STARTED|Open-label Guselkumab: Week 48 - 264|One participant did not crossover at Week 52 due to adverse event.|280
8682291|NCT02207231|21433994|P2|STARTED|Open-label Guselkumab: Week 48 - 264||0
8682292|NCT02207231|21433995|P1|STARTED|Open-label Guselkumab: Week 48 - 264||0
8682293|NCT02207231|21433992|P4|NOT COMPLETED|Active Controlled Period: Week 16 - 48||0
8682294|NCT02207231|21433993|P3|NOT COMPLETED|Active Controlled Period: Week 16 - 48||43
8682295|NCT02207231|21433994|P2|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
8682296|NCT02207231|21433995|P1|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
8682297|NCT02207231|21433992|P4|COMPLETED|Active Controlled Period: Week 16 - 48||0
8682298|NCT02207231|21433993|P3|COMPLETED|Active Controlled Period: Week 16 - 48||281
8682299|NCT02207231|21433994|P2|COMPLETED|Active Controlled Period: Week 16 - 48||301
8682300|NCT02207231|21433995|P1|COMPLETED|Active Controlled Period: Week 16 - 48||162
8682301|NCT02207231|21433992|P4|STARTED|Active Controlled Period: Week 16 - 48||0
8682302|NCT02207231|21433993|P3|STARTED|Active Controlled Period: Week 16 - 48||324
8682303|NCT02207231|21433994|P2|STARTED|Active Controlled Period: Week 16 - 48||322
8682304|NCT02207231|21433995|P1|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
8682305|NCT02207231|21433992|P4|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8682306|NCT02207231|21433993|P3|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
8682307|NCT02207231|21433994|P2|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
8682308|NCT02207231|21433995|P1|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
8682309|NCT02207231|21433992|P4|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
8682310|NCT02207231|21433993|P3|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
8682311|NCT02207231|21433994|P2|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
8682312|NCT02207231|21433995|P1|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
8682313|NCT02207231|21433992|P4|Treated|Placebo Controlled Period: Week 0 - 16||0
8682314|NCT02207231|21433993|P3|Treated|Placebo Controlled Period: Week 0 - 16||333
8682315|NCT02207231|21433994|P2|Treated|Placebo Controlled Period: Week 0 - 16||329
8682316|NCT02207231|21433995|P1|Treated|Placebo Controlled Period: Week 0 - 16||174
8682317|NCT02207231|21433992|P4|STARTED|Placebo Controlled Period: Week 0 - 16||0
8682318|NCT02207231|21433993|P3|STARTED|Placebo Controlled Period: Week 0 - 16||334
8682319|NCT02207231|21433994|P2|STARTED|Placebo Controlled Period: Week 0 - 16||329
8682320|NCT02207231|21433995|P1|STARTED|Placebo Controlled Period: Week 0 - 16||174
8682321|NCT02195479|21434043|P2|NOT COMPLETED|Overall Study||350
8682322|NCT02195479|21434044|P1|NOT COMPLETED|Overall Study||356
8682323|NCT02195479|21434043|P2|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
8682324|NCT02195479|21434044|P1|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
8682325|NCT02195479|21434043|P2|Treated|Overall Study||346
8682326|NCT02195479|21434044|P1|Treated|Overall Study||354
8682327|NCT02195479|21434043|P2|STARTED|Overall Study||350
8682328|NCT02195479|21434044|P1|STARTED|Overall Study||356
8682329|NCT02171429|21434083|P3|NOT COMPLETED|Overall Study||5
8682330|NCT02171429|21434084|P2|NOT COMPLETED|Overall Study||3
8682331|NCT02171429|21434085|P1|NOT COMPLETED|Overall Study||1
8682332|NCT02171429|21434083|P3|COMPLETED|Overall Study||138
8682333|NCT02171429|21434084|P2|COMPLETED|Overall Study||140
8682334|NCT02171429|21434085|P1|COMPLETED|Overall Study||71
8682335|NCT02171429|21434083|P3|Completed Week 10 Visit|Overall Study||141
8682336|NCT02171429|21434084|P2|Completed Week 10 Visit|Overall Study||141
8682337|NCT02171429|21434085|P1|Completed Week 10 Visit|Overall Study||70
8682338|NCT02171429|21434083|P3|STARTED|Overall Study||143
8682339|NCT02171429|21434084|P2|STARTED|Overall Study||143
8682340|NCT02171429|21434085|P1|STARTED|Overall Study||72
8682341|NCT02163759|21434161|P3|NOT COMPLETED|Overall Study||3
8682342|NCT02163759|21434162|P2|NOT COMPLETED|Overall Study||5
8682343|NCT02163759|21434163|P1|NOT COMPLETED|Overall Study||1
8682344|NCT02163759|21434161|P3|COMPLETED|Overall Study||141
8682345|NCT02163759|21434162|P2|COMPLETED|Overall Study||137
8682346|NCT02163759|21434163|P1|COMPLETED|Overall Study||71
8682347|NCT02163759|21434161|P3|Completed Week 10|Overall Study||143
8682348|NCT02163759|21434162|P2|Completed Week 10|Overall Study||141
8682349|NCT02163759|21434163|P1|Completed Week 10|Overall Study||71
8682350|NCT02163759|21434161|P3|STARTED|Overall Study||144
8682351|NCT02163759|21434162|P2|STARTED|Overall Study||142
8682352|NCT02163759|21434163|P1|STARTED|Overall Study||72
8682353|NCT02036970|21434246|P10|NOT COMPLETED|Part 2: Week 16 Onwards||5
8682354|NCT02036970|21434247|P9|NOT COMPLETED|Part 2: Week 16 Onwards||9
8682355|NCT02036970|21434248|P8|NOT COMPLETED|Part 2: Week 16 Onwards||1
8682356|NCT02036970|21434249|P7|NOT COMPLETED|Part 2: Week 16 Onwards||1
8682357|NCT02036970|21434250|P6|NOT COMPLETED|Part 2: Week 16 Onwards||0
8682358|NCT02036970|21434251|P5|NOT COMPLETED|Part 2: Week 16 Onwards||1
8682359|NCT02036970|21434252|P4|NOT COMPLETED|Part 2: Week 16 Onwards||2
8682360|NCT02036970|21434253|P3|NOT COMPLETED|Part 2: Week 16 Onwards||3
8682361|NCT02036970|21434254|P2|NOT COMPLETED|Part 2: Week 16 Onwards||5
8682362|NCT02036970|21434255|P1|NOT COMPLETED|Part 2: Week 16 Onwards||0
8682363|NCT02036970|21434246|P10|COMPLETED|Part 2: Week 16 Onwards||28
8682364|NCT02036970|21434247|P9|COMPLETED|Part 2: Week 16 Onwards||54
8682365|NCT02036970|21434248|P8|COMPLETED|Part 2: Week 16 Onwards||2
8682366|NCT02036970|21434249|P7|COMPLETED|Part 2: Week 16 Onwards||2
8682367|NCT02036970|21434250|P6|COMPLETED|Part 2: Week 16 Onwards||3
8682368|NCT02036970|21434251|P5|COMPLETED|Part 2: Week 16 Onwards||0
8682369|NCT02036970|21434252|P4|COMPLETED|Part 2: Week 16 Onwards||7
8682370|NCT02036970|21434253|P3|COMPLETED|Part 2: Week 16 Onwards||3
8682371|NCT02036970|21434254|P2|COMPLETED|Part 2: Week 16 Onwards||6
8682372|NCT02036970|21434255|P1|COMPLETED|Part 2: Week 16 Onwards||5
8682373|NCT02036970|21434246|P10|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||8
8682374|NCT02036970|21434247|P9|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||15
8682375|NCT02036970|21434248|P8|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
8682376|NCT02036970|21434249|P7|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
8682377|NCT02036970|21434250|P6|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
8682378|NCT02036970|21434251|P5|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
8682379|NCT02036970|21434252|P4|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
8682380|NCT02036970|21434253|P3|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
8682381|NCT02036970|21434254|P2|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
8682382|NCT02036970|21434255|P1|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
8682383|NCT02036970|21434246|P10|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||1
8682384|NCT02036970|21434247|P9|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||3
8682385|NCT02036970|21434248|P8|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
8682386|NCT02036970|21434249|P7|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
8682387|NCT02036970|21434250|P6|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
8682388|NCT02036970|21434251|P5|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
8682389|NCT02036970|21434252|P4|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
8682390|NCT02036970|21434253|P3|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
8682391|NCT02036970|21434254|P2|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
8682392|NCT02036970|21434255|P1|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
8682393|NCT02036970|21434246|P10|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||2
8682394|NCT02036970|21434247|P9|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||5
8682395|NCT02036970|21434248|P8|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
8682396|NCT02036970|21434249|P7|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
8682397|NCT02036970|21434250|P6|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
8682398|NCT02036970|21434251|P5|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
8682399|NCT02036970|21434252|P4|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
8682400|NCT02036970|21434253|P3|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
8682401|NCT02036970|21434254|P2|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
8682402|NCT02036970|21434255|P1|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
8682403|NCT02036970|21434246|P10|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||7
8682404|NCT02036970|21434247|P9|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||16
8682405|NCT02036970|21434248|P8|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
8682406|NCT02036970|21434249|P7|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
8682407|NCT02036970|21434250|P6|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
8682408|NCT02036970|21434251|P5|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
8682409|NCT02036970|21434252|P4|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
8682410|NCT02036970|21434253|P3|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
8682411|NCT02036970|21434254|P2|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
8682412|NCT02036970|21434255|P1|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
8682413|NCT02036970|21434246|P10|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||7
8682414|NCT02036970|21434247|P9|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||12
8682415|NCT02036970|21434248|P8|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
8682416|NCT02036970|21434249|P7|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
8682417|NCT02036970|21434250|P6|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
8682418|NCT02036970|21434251|P5|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
8682419|NCT02036970|21434252|P4|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
8682420|NCT02036970|21434253|P3|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
8682421|NCT02036970|21434254|P2|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
8682422|NCT02036970|21434255|P1|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
8682423|NCT02036970|21434246|P10|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||8
8682424|NCT02036970|21434247|P9|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||12
8682425|NCT02036970|21434248|P8|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
8682426|NCT02036970|21434249|P7|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
8682427|NCT02036970|21434250|P6|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
8682428|NCT02036970|21434251|P5|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
8682429|NCT02036970|21434252|P4|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
8682430|NCT02036970|21434253|P3|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
8682431|NCT02036970|21434254|P2|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
8682432|NCT02036970|21434255|P1|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
8682433|NCT02036970|21434246|P10|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
8682434|NCT02036970|21434247|P9|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
8682435|NCT02036970|21434248|P8|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||1
8682436|NCT02036970|21434249|P7|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
8682437|NCT02036970|21434250|P6|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||2
8682438|NCT02036970|21434251|P5|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
8682439|NCT02036970|21434252|P4|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||4
8682440|NCT02036970|21434253|P3|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
8682441|NCT02036970|21434254|P2|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||6
8682442|NCT02036970|21434255|P1|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
8682443|NCT02036970|21434246|P10|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
8682444|NCT02036970|21434247|P9|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
8682445|NCT02036970|21434248|P8|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||2
8682446|NCT02036970|21434249|P7|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||3
8682447|NCT02036970|21434250|P6|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
8682448|NCT02036970|21434251|P5|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
8682449|NCT02036970|21434252|P4|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
8682450|NCT02036970|21434253|P3|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||6
8682451|NCT02036970|21434254|P2|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
8682452|NCT02036970|21434255|P1|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
8682453|NCT02036970|21434246|P10|STARTED|Part 2: Week 16 Onwards||33
8682454|NCT02036970|21434247|P9|STARTED|Part 2: Week 16 Onwards|Three patients who completed Part 1 elected not to continue to Part 2.|63
8682455|NCT02036970|21434248|P8|STARTED|Part 2: Week 16 Onwards||3
8682456|NCT02036970|21434249|P7|STARTED|Part 2: Week 16 Onwards||3
8682457|NCT02036970|21434250|P6|STARTED|Part 2: Week 16 Onwards||3
8682458|NCT02036970|21434251|P5|STARTED|Part 2: Week 16 Onwards||1
8682459|NCT02036970|21434252|P4|STARTED|Part 2: Week 16 Onwards||9
8682460|NCT02036970|21434253|P3|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|6
8682461|NCT02036970|21434254|P2|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|11
8682462|NCT02036970|21434255|P1|STARTED|Part 2: Week 16 Onwards||5
8682463|NCT02036970|21434246|P10|NOT COMPLETED|Part 1: Day 1 Through Week 16||5
8682464|NCT02036970|21434247|P9|NOT COMPLETED|Part 1: Day 1 Through Week 16||8
8682465|NCT02036970|21434248|P8|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
8682466|NCT02036970|21434249|P7|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
8682467|NCT02036970|21434250|P6|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
8682468|NCT02036970|21434251|P5|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
8682469|NCT02036970|21434252|P4|NOT COMPLETED|Part 1: Day 1 Through Week 16||3
8682470|NCT02036970|21434253|P3|NOT COMPLETED|Part 1: Day 1 Through Week 16||4
8682471|NCT02036970|21434254|P2|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
8682472|NCT02036970|21434255|P1|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
8682473|NCT02036970|21434246|P10|COMPLETED|Part 1: Day 1 Through Week 16||33
8682474|NCT02036970|21434247|P9|COMPLETED|Part 1: Day 1 Through Week 16||66
8682475|NCT02036970|21434248|P8|COMPLETED|Part 1: Day 1 Through Week 16||3
8682476|NCT02036970|21434249|P7|COMPLETED|Part 1: Day 1 Through Week 16||3
8682477|NCT02036970|21434250|P6|COMPLETED|Part 1: Day 1 Through Week 16||3
8682478|NCT02036970|21434251|P5|COMPLETED|Part 1: Day 1 Through Week 16||1
8682479|NCT02036970|21434252|P4|COMPLETED|Part 1: Day 1 Through Week 16||9
8682480|NCT02036970|21434253|P3|COMPLETED|Part 1: Day 1 Through Week 16||7
8682481|NCT02036970|21434254|P2|COMPLETED|Part 1: Day 1 Through Week 16||12
8682482|NCT02036970|21434255|P1|COMPLETED|Part 1: Day 1 Through Week 16||5
8682483|NCT02036970|21434246|P10|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||1
8682484|NCT02036970|21434247|P9|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||17
8682485|NCT02036970|21434248|P8|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
8682486|NCT02036970|21434249|P7|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
8682487|NCT02036970|21434250|P6|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
8682488|NCT02036970|21434251|P5|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
8682489|NCT02036970|21434252|P4|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
8682490|NCT02036970|21434253|P3|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
8682491|NCT02036970|21434254|P2|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
8682492|NCT02036970|21434255|P1|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
8682493|NCT02036970|21434246|P10|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||1
8682494|NCT02036970|21434247|P9|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||4
8682495|NCT02036970|21434248|P8|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
8682496|NCT02036970|21434249|P7|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
8682497|NCT02036970|21434250|P6|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
8682498|NCT02036970|21434251|P5|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
8682499|NCT02036970|21434252|P4|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
8682500|NCT02036970|21434253|P3|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
8682501|NCT02036970|21434254|P2|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
8682502|NCT02036970|21434255|P1|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
8682503|NCT02036970|21434246|P10|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||2
8682504|NCT02036970|21434247|P9|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||6
8682505|NCT02036970|21434248|P8|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
8682506|NCT02036970|21434249|P7|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
8682507|NCT02036970|21434250|P6|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
8682508|NCT02036970|21434251|P5|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
8682509|NCT02036970|21434252|P4|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
8682510|NCT02036970|21434253|P3|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
8682511|NCT02036970|21434254|P2|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
8682512|NCT02036970|21434255|P1|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
8682513|NCT02036970|21434246|P10|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||8
8682514|NCT02036970|21434247|P9|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||17
8682515|NCT02036970|21434248|P8|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
8682516|NCT02036970|21434249|P7|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
8682517|NCT02036970|21434250|P6|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
8682518|NCT02036970|21434251|P5|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
8682519|NCT02036970|21434252|P4|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
8682520|NCT02036970|21434253|P3|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
8682521|NCT02036970|21434254|P2|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
8682522|NCT02036970|21434255|P1|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
8682523|NCT02036970|21434246|P10|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||9
8682524|NCT02036970|21434247|P9|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||16
8682525|NCT02036970|21434248|P8|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
8682526|NCT02036970|21434249|P7|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
8682527|NCT02036970|21434250|P6|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
8682528|NCT02036970|21434251|P5|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
8682529|NCT02036970|21434252|P4|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
8682530|NCT02036970|21434253|P3|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
8682531|NCT02036970|21434254|P2|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
8682532|NCT02036970|21434255|P1|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
8682533|NCT02036970|21434246|P10|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||8
8682534|NCT02036970|21434247|P9|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||14
8682535|NCT02036970|21434248|P8|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
8682536|NCT02036970|21434249|P7|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
8682537|NCT02036970|21434250|P6|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
8682538|NCT02036970|21434251|P5|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
8682539|NCT02036970|21434252|P4|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
8682540|NCT02036970|21434253|P3|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
8682541|NCT02036970|21434254|P2|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
8682542|NCT02036970|21434255|P1|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
8682543|NCT02036970|21434246|P10|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
8682544|NCT02036970|21434247|P9|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
8682545|NCT02036970|21434248|P8|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
8682546|NCT02036970|21434249|P7|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
8682547|NCT02036970|21434250|P6|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
8682548|NCT02036970|21434251|P5|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
8682549|NCT02036970|21434252|P4|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
8682550|NCT02036970|21434253|P3|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
8682551|NCT02036970|21434254|P2|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
8682552|NCT02036970|21434255|P1|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
8682553|NCT02036970|21434246|P10|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
8682554|NCT02036970|21434247|P9|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
8682555|NCT02036970|21434248|P8|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
8682556|NCT02036970|21434249|P7|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||3
8682557|NCT02036970|21434250|P6|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
8682558|NCT02036970|21434251|P5|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
8682559|NCT02036970|21434252|P4|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
8682560|NCT02036970|21434253|P3|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||11
8682561|NCT02036970|21434254|P2|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
8682562|NCT02036970|21434255|P1|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
8682563|NCT02036970|21434246|P10|STARTED|Part 1: Day 1 Through Week 16||38
8682564|NCT02036970|21434247|P9|STARTED|Part 1: Day 1 Through Week 16||74
8682565|NCT02036970|21434248|P8|STARTED|Part 1: Day 1 Through Week 16||4
8682566|NCT02036970|21434249|P7|STARTED|Part 1: Day 1 Through Week 16||3
8682567|NCT02036970|21434250|P6|STARTED|Part 1: Day 1 Through Week 16||4
8682568|NCT02036970|21434251|P5|STARTED|Part 1: Day 1 Through Week 16||2
8682569|NCT02036970|21434252|P4|STARTED|Part 1: Day 1 Through Week 16||12
8682570|NCT02036970|21434253|P3|STARTED|Part 1: Day 1 Through Week 16||11
8682571|NCT02036970|21434254|P2|STARTED|Part 1: Day 1 Through Week 16||12
8682572|NCT02036970|21434255|P1|STARTED|Part 1: Day 1 Through Week 16||6
8682581|NCT01843374|21434308|P2|NOT COMPLETED|Overall Study||379
8682582|NCT01843374|21434309|P1|NOT COMPLETED|Overall Study||189
8682583|NCT01843374|21434308|P2|COMPLETED|Overall Study||3
8682584|NCT01843374|21434309|P1|COMPLETED|Overall Study||0
8682585|NCT01843374|21434308|P2|RANDOMIZED|Overall Study||382
8682586|NCT01843374|21434309|P1|RANDOMIZED|Overall Study||189
8682587|NCT01843374|21434308|P2|STARTED|Overall Study||382
8682588|NCT01843374|21434309|P1|STARTED|Overall Study||189
8682613|NCT01578239|21434358|P2|NOT COMPLETED|Overall Study||25
8682614|NCT01578239|21434359|P1|NOT COMPLETED|Overall Study||22
8682615|NCT01578239|21434358|P2|COMPLETED|Overall Study||88
8682616|NCT01578239|21434359|P1|COMPLETED|Overall Study||94
8682617|NCT01578239|21434358|P2|Safety Set (SAF)|Overall Study||111
8682618|NCT01578239|21434359|P1|Safety Set (SAF)|Overall Study||112
8682619|NCT01578239|21434358|P2|STARTED|Overall Study||113
8682620|NCT01578239|21434359|P1|STARTED|Overall Study||116
8682621|NCT01217437|21434367|P2|NOT COMPLETED|Overall Study||41
8682622|NCT01217437|21434368|P1|NOT COMPLETED|Overall Study||43
8682623|NCT01217437|21434367|P2|COMPLETED|Overall Study||12
8682624|NCT01217437|21434368|P1|COMPLETED|Overall Study||12
8682625|NCT01217437|21434367|P2|STARTED|Overall Study||53
8682626|NCT01217437|21434368|P1|STARTED|Overall Study||55
8682627|NCT00624910|21434381|P3|NOT COMPLETED|Overall Study||0
8682628|NCT00624910|21434382|P2|NOT COMPLETED|Overall Study||0
8682629|NCT00624910|21434383|P1|NOT COMPLETED|Overall Study||0
8682630|NCT00624910|21434381|P3|COMPLETED|Overall Study||11
8682631|NCT00624910|21434382|P2|COMPLETED|Overall Study||15
8682632|NCT00624910|21434383|P1|COMPLETED|Overall Study||28
8682633|NCT00624910|21434381|P3|STARTED|Overall Study||11
8682634|NCT00624910|21434382|P2|STARTED|Overall Study||15
8682635|NCT00624910|21434383|P1|STARTED|Overall Study||28
8682636|NCT00490139|21434416|P4|NOT COMPLETED|Overall Study||307
8682637|NCT00490139|21434417|P3|NOT COMPLETED|Overall Study||434
8682638|NCT00490139|21434418|P2|NOT COMPLETED|Overall Study||275
8682639|NCT00490139|21434419|P1|NOT COMPLETED|Overall Study||308
8682640|NCT00490139|21434416|P4|COMPLETED|Overall Study||1790
8682641|NCT00490139|21434417|P3|COMPLETED|Overall Study||1666
8682642|NCT00490139|21434418|P2|COMPLETED|Overall Study||1816
8682643|NCT00490139|21434419|P1|COMPLETED|Overall Study||1785
8682644|NCT00490139|21434416|P4|STARTED|Overall Study||2097
8682645|NCT00490139|21434417|P3|STARTED|Overall Study||2100
8682646|NCT00490139|21434418|P2|STARTED|Overall Study||2091
8682647|NCT00490139|21434419|P1|STARTED|Overall Study||2093
8682648|NCT04728594|21434452|P3|NOT COMPLETED|Overall Study||0
8682649|NCT04728594|21434453|P2|NOT COMPLETED|Overall Study||0
8682650|NCT04728594|21434454|P1|NOT COMPLETED|Overall Study||0
8682651|NCT04728594|21434452|P3|COMPLETED|Overall Study||3190
8682652|NCT04728594|21434453|P2|COMPLETED|Overall Study||3198
8682653|NCT04728594|21434454|P1|COMPLETED|Overall Study||3178
8682654|NCT04728594|21434452|P3|STARTED|Overall Study||3190
8682655|NCT04728594|21434453|P2|STARTED|Overall Study||3198
8682656|NCT04728594|21434454|P1|STARTED|Overall Study|The number of participants who were sent a follow up email (delayed, three days after the other two arms) was used to see how many started.|3178
8682657|NCT04599959|21434466|P1|NOT COMPLETED|Overall Study||0
8682658|NCT04599959|21434466|P1|COMPLETED|Overall Study||151
8682659|NCT04599959|21434466|P1|STARTED|Overall Study||151
8682660|NCT04439279|21434472|P1|NOT COMPLETED|Overall Study||35
8682661|NCT04439279|21434472|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerability.|0
8682662|NCT04439279|21434472|P1|Reported Adverse Events Data|Overall Study|Adverse event was not assessed on one patient before discontinuing therapy due to withdraw/refusal|34
8682663|NCT04439279|21434472|P1|Eligible|Overall Study||33
8682664|NCT04439279|21434472|P1|Started Protocol Therapy|Overall Study||35
8682665|NCT04439279|21434472|P1|STARTED|Overall Study||35
8682666|NCT03965754|21434482|P4|NOT COMPLETED|Overall Study||0
8682667|NCT03965754|21434483|P3|NOT COMPLETED|Overall Study||0
8682668|NCT03965754|21434484|P2|NOT COMPLETED|Overall Study||0
8682669|NCT03965754|21434485|P1|NOT COMPLETED|Overall Study||0
8682670|NCT03965754|21434482|P4|COMPLETED|Overall Study||1425
8682671|NCT03965754|21434483|P3|COMPLETED|Overall Study||1425
8682672|NCT03965754|21434484|P2|COMPLETED|Overall Study||1425
8682673|NCT03965754|21434485|P1|COMPLETED|Overall Study||1422
8682674|NCT03965754|21434482|P4|STARTED|Overall Study||1425
8682675|NCT03965754|21434483|P3|STARTED|Overall Study||1425
8682676|NCT03965754|21434484|P2|STARTED|Overall Study||1425
8682677|NCT03965754|21434485|P1|STARTED|Overall Study||1422
8682684|NCT03762200|21434516|P1|NOT COMPLETED|Overall Study||2
8682685|NCT03762200|21434516|P1|COMPLETED|Overall Study||101
8682686|NCT03762200|21434516|P1|STARTED|Overall Study||103
8682687|NCT03618030|21434527|P8|NOT COMPLETED|Overall Study||10
8682688|NCT03618030|21434528|P7|NOT COMPLETED|Overall Study||4
8682689|NCT03618030|21434529|P6|NOT COMPLETED|Overall Study||6
8682690|NCT03618030|21434530|P5|NOT COMPLETED|Overall Study||7
8682691|NCT03618030|21434531|P4|NOT COMPLETED|Overall Study||9
8682692|NCT03618030|21434532|P3|NOT COMPLETED|Overall Study||8
8682693|NCT03618030|21434533|P2|NOT COMPLETED|Overall Study||11
8682694|NCT03618030|21434534|P1|NOT COMPLETED|Overall Study||12
8682695|NCT03618030|21434527|P8|COMPLETED|Overall Study||108
8682696|NCT03618030|21434528|P7|COMPLETED|Overall Study||14
8682697|NCT03618030|21434529|P6|COMPLETED|Overall Study||21
8682698|NCT03618030|21434530|P5|COMPLETED|Overall Study||29
8682699|NCT03618030|21434531|P4|COMPLETED|Overall Study||30
8682700|NCT03618030|21434532|P3|COMPLETED|Overall Study||13
8682701|NCT03618030|21434533|P2|COMPLETED|Overall Study||3
8682702|NCT03618030|21434534|P1|COMPLETED|Overall Study||3
8682703|NCT03618030|21434527|P8|STARTED|Overall Study||118
8682704|NCT03618030|21434528|P7|STARTED|Overall Study||18
8682705|NCT03618030|21434529|P6|STARTED|Overall Study||27
8682706|NCT03618030|21434530|P5|STARTED|Overall Study||36
8682707|NCT03618030|21434531|P4|STARTED|Overall Study||39
8682708|NCT03618030|21434532|P3|STARTED|Overall Study||21
8682709|NCT03618030|21434533|P2|STARTED|Overall Study||14
8682710|NCT03618030|21434534|P1|STARTED|Overall Study||15
8682711|NCT03541317|21434549|P6|NOT COMPLETED|Stage 2 of the Implementation||0
8682712|NCT03541317|21434550|P5|NOT COMPLETED|Stage 2 of the Implementation||0
8682713|NCT03541317|21434551|P4|NOT COMPLETED|Stage 2 of the Implementation||0
8682714|NCT03541317|21434552|P3|NOT COMPLETED|Stage 2 of the Implementation||0
8682715|NCT03541317|21434553|P2|NOT COMPLETED|Stage 2 of the Implementation||0
8682716|NCT03541317|21434554|P1|NOT COMPLETED|Stage 2 of the Implementation||1
8682717|NCT03541317|21434549|P6|COMPLETED|Stage 2 of the Implementation||36
8682718|NCT03541317|21434550|P5|COMPLETED|Stage 2 of the Implementation||43
8682719|NCT03541317|21434551|P4|COMPLETED|Stage 2 of the Implementation||9
8682720|NCT03541317|21434552|P3|COMPLETED|Stage 2 of the Implementation||38
8682721|NCT03541317|21434553|P2|COMPLETED|Stage 2 of the Implementation||37
8682722|NCT03541317|21434554|P1|COMPLETED|Stage 2 of the Implementation||5
8682723|NCT03541317|21434549|P6|STARTED|Stage 2 of the Implementation||36
8682724|NCT03541317|21434550|P5|STARTED|Stage 2 of the Implementation||43
8682725|NCT03541317|21434551|P4|STARTED|Stage 2 of the Implementation||9
8682726|NCT03541317|21434552|P3|STARTED|Stage 2 of the Implementation||38
8682727|NCT03541317|21434553|P2|STARTED|Stage 2 of the Implementation||37
8682728|NCT03541317|21434554|P1|STARTED|Stage 2 of the Implementation||6
8682729|NCT03541317|21434549|P6|NOT COMPLETED|Stage 1 of the Implementation||0
8682730|NCT03541317|21434550|P5|NOT COMPLETED|Stage 1 of the Implementation||0
8682731|NCT03541317|21434551|P4|NOT COMPLETED|Stage 1 of the Implementation||0
8682732|NCT03541317|21434552|P3|NOT COMPLETED|Stage 1 of the Implementation||0
8682733|NCT03541317|21434553|P2|NOT COMPLETED|Stage 1 of the Implementation||0
8682734|NCT03541317|21434554|P1|NOT COMPLETED|Stage 1 of the Implementation||0
8682735|NCT03541317|21434549|P6|COMPLETED|Stage 1 of the Implementation||36
8682736|NCT03541317|21434550|P5|COMPLETED|Stage 1 of the Implementation||43
8682737|NCT03541317|21434551|P4|COMPLETED|Stage 1 of the Implementation||9
8682738|NCT03541317|21434552|P3|COMPLETED|Stage 1 of the Implementation||38
8682739|NCT03541317|21434553|P2|COMPLETED|Stage 1 of the Implementation||37
8682740|NCT03541317|21434554|P1|COMPLETED|Stage 1 of the Implementation||6
8682741|NCT03541317|21434549|P6|STARTED|Stage 1 of the Implementation||36
8682742|NCT03541317|21434550|P5|STARTED|Stage 1 of the Implementation||43
8682743|NCT03541317|21434551|P4|STARTED|Stage 1 of the Implementation||9
8682744|NCT03541317|21434552|P3|STARTED|Stage 1 of the Implementation||38
8682745|NCT03541317|21434553|P2|STARTED|Stage 1 of the Implementation||37
8682746|NCT03541317|21434554|P1|STARTED|Stage 1 of the Implementation||6
8682747|NCT03414047|21434574|P4|NOT COMPLETED|Overall Study||3
8682748|NCT03414047|21434575|P3|NOT COMPLETED|Overall Study||0
8682749|NCT03414047|21434576|P2|NOT COMPLETED|Overall Study||0
8682750|NCT03414047|21434577|P1|NOT COMPLETED|Overall Study||1
8682751|NCT03414047|21434574|P4|COMPLETED|Overall Study||28
8682752|NCT03414047|21434575|P3|COMPLETED|Overall Study||40
8682753|NCT03414047|21434576|P2|COMPLETED|Overall Study||44
8682754|NCT03414047|21434577|P1|COMPLETED|Overall Study||53
8682755|NCT03414047|21434574|P4|STARTED|Overall Study||31
8682756|NCT03414047|21434575|P3|STARTED|Overall Study||40
8682757|NCT03414047|21434576|P2|STARTED|Overall Study||44
8682758|NCT03414047|21434577|P1|STARTED|Overall Study||54
8682759|NCT03388268|21434610|P2|NOT COMPLETED|Overall Study||3
8682760|NCT03388268|21434611|P1|NOT COMPLETED|Overall Study||1
8682761|NCT03388268|21434610|P2|COMPLETED|Overall Study||4
8682762|NCT03388268|21434611|P1|COMPLETED|Overall Study||7
8682763|NCT03388268|21434610|P2|STARTED|Overall Study||7
8682764|NCT03388268|21434611|P1|STARTED|Overall Study||8
8682765|NCT03313076|21434627|P4|NOT COMPLETED|Overall Study||2
8682766|NCT03313076|21434628|P3|NOT COMPLETED|Overall Study||2
8682767|NCT03313076|21434629|P2|NOT COMPLETED|Overall Study||2
8682768|NCT03313076|21434630|P1|NOT COMPLETED|Overall Study||2
8682769|NCT03313076|21434627|P4|COMPLETED|Overall Study||3
8682770|NCT03313076|21434628|P3|COMPLETED|Overall Study||4
8682771|NCT03313076|21434629|P2|COMPLETED|Overall Study||4
8682772|NCT03313076|21434630|P1|COMPLETED|Overall Study||5
8682773|NCT03313076|21434627|P4|STARTED|Overall Study||5
8682774|NCT03313076|21434628|P3|STARTED|Overall Study||6
8682775|NCT03313076|21434629|P2|STARTED|Overall Study||6
8682776|NCT03313076|21434630|P1|STARTED|Overall Study||7
8682777|NCT03236662|21434664|P1|NOT COMPLETED|Overall Study||0
8682778|NCT03236662|21434664|P1|COMPLETED|Overall Study||2
8682779|NCT03236662|21434664|P1|STARTED|Overall Study||2
8682788|NCT02860546|21434698|P1|NOT COMPLETED|Overall Study||18
8682789|NCT02860546|21434698|P1|COMPLETED|Overall Study||0
8682790|NCT02860546|21434698|P1|STARTED|Overall Study||18
8682791|NCT02561221|21434714|P2|NOT COMPLETED|Overall Study||43
8682792|NCT02561221|21434715|P1|NOT COMPLETED|Overall Study||90
8682793|NCT02561221|21434714|P2|COMPLETED|Overall Study||308
8682794|NCT02561221|21434715|P1|COMPLETED|Overall Study||362
8682795|NCT02561221|21434714|P2|Month 18|Overall Study||316
8682796|NCT02561221|21434715|P1|Month 18|Overall Study||357
8682797|NCT02561221|21434714|P2|Month 12|Overall Study||326
8682798|NCT02561221|21434715|P1|Month 12|Overall Study||365
8682799|NCT02561221|21434714|P2|Month 6|Overall Study||340
8682800|NCT02561221|21434715|P1|Month 6|Overall Study||386
8682801|NCT02561221|21434714|P2|STARTED|Overall Study||351
8682802|NCT02561221|21434715|P1|STARTED|Overall Study||452
8682803|NCT02349412|21434769|P2|NOT COMPLETED|Overall Study||7
8682804|NCT02349412|21434770|P1|NOT COMPLETED|Overall Study||7
8682805|NCT02349412|21434769|P2|COMPLETED|Overall Study||196
8682806|NCT02349412|21434770|P1|COMPLETED|Overall Study||195
8682807|NCT02349412|21434769|P2|Completed Week-24 QOL Assessment Measure|Overall Study||80
8682808|NCT02349412|21434770|P1|Completed Week-24 QOL Assessment Measure|Overall Study||68
8682809|NCT02349412|21434769|P2|Completed Week-12 QOL Assessment Measure|Overall Study||101
8682810|NCT02349412|21434770|P1|Completed Week-12 QOL Assessment Measure|Overall Study||92
8682811|NCT02349412|21434769|P2|STARTED|Overall Study||203
8682812|NCT02349412|21434770|P1|STARTED|Overall Study||202
8682813|NCT02130687|21434787|P3|NOT COMPLETED|Crossover Period 3||0
8682814|NCT02130687|21434788|P2|NOT COMPLETED|Crossover Period 3||0
8682815|NCT02130687|21434789|P1|NOT COMPLETED|Crossover Period 3||0
8682816|NCT02130687|21434787|P3|COMPLETED|Crossover Period 3||27
8682817|NCT02130687|21434788|P2|COMPLETED|Crossover Period 3||25
8682818|NCT02130687|21434789|P1|COMPLETED|Crossover Period 3||33
8682819|NCT02130687|21434787|P3|STARTED|Crossover Period 3||27
8682820|NCT02130687|21434788|P2|STARTED|Crossover Period 3||25
8682821|NCT02130687|21434789|P1|STARTED|Crossover Period 3||33
8682822|NCT02130687|21434787|P3|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||2
8682823|NCT02130687|21434788|P2|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||1
8682824|NCT02130687|21434789|P1|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||0
8682825|NCT02130687|21434787|P3|COMPLETED|Drug 1 Only Between Periods 2 and 3||27
8682826|NCT02130687|21434788|P2|COMPLETED|Drug 1 Only Between Periods 2 and 3||25
8682827|NCT02130687|21434789|P1|COMPLETED|Drug 1 Only Between Periods 2 and 3||33
8682828|NCT02130687|21434787|P3|STARTED|Drug 1 Only Between Periods 2 and 3||29
8682829|NCT02130687|21434788|P2|STARTED|Drug 1 Only Between Periods 2 and 3||26
8682830|NCT02130687|21434789|P1|STARTED|Drug 1 Only Between Periods 2 and 3||33
8682831|NCT02130687|21434787|P3|NOT COMPLETED|Crossover Period 2||0
8682832|NCT02130687|21434788|P2|NOT COMPLETED|Crossover Period 2||0
8682833|NCT02130687|21434789|P1|NOT COMPLETED|Crossover Period 2||0
8682834|NCT02130687|21434787|P3|COMPLETED|Crossover Period 2||29
8682835|NCT02130687|21434788|P2|COMPLETED|Crossover Period 2||26
8682836|NCT02130687|21434789|P1|COMPLETED|Crossover Period 2||33
8682837|NCT02130687|21434787|P3|STARTED|Crossover Period 2||29
8682838|NCT02130687|21434788|P2|STARTED|Crossover Period 2||26
8682839|NCT02130687|21434789|P1|STARTED|Crossover Period 2||33
8682840|NCT02130687|21434787|P3|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||1
8682841|NCT02130687|21434788|P2|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||4
8682842|NCT02130687|21434789|P1|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||0
8682843|NCT02130687|21434787|P3|COMPLETED|Drug 1 Only Between Periods 1 and 2||29
8682844|NCT02130687|21434788|P2|COMPLETED|Drug 1 Only Between Periods 1 and 2||26
8682845|NCT02130687|21434789|P1|COMPLETED|Drug 1 Only Between Periods 1 and 2||33
8682846|NCT02130687|21434787|P3|STARTED|Drug 1 Only Between Periods 1 and 2||30
8682847|NCT02130687|21434788|P2|STARTED|Drug 1 Only Between Periods 1 and 2||30
8682848|NCT02130687|21434789|P1|STARTED|Drug 1 Only Between Periods 1 and 2||33
8682849|NCT02130687|21434787|P3|NOT COMPLETED|Crossover Period 1||0
8682850|NCT02130687|21434788|P2|NOT COMPLETED|Crossover Period 1||0
8682851|NCT02130687|21434789|P1|NOT COMPLETED|Crossover Period 1||0
8682852|NCT02130687|21434787|P3|COMPLETED|Crossover Period 1||30
8682853|NCT02130687|21434788|P2|COMPLETED|Crossover Period 1||30
8682854|NCT02130687|21434789|P1|COMPLETED|Crossover Period 1||33
8682855|NCT02130687|21434787|P3|STARTED|Crossover Period 1||30
8682856|NCT02130687|21434788|P2|STARTED|Crossover Period 1||30
8682857|NCT02130687|21434789|P1|STARTED|Crossover Period 1||33
8682858|NCT02130687|21434787|P3|NOT COMPLETED|Drug 1 Only||1
8682859|NCT02130687|21434788|P2|NOT COMPLETED|Drug 1 Only||3
8682860|NCT02130687|21434789|P1|NOT COMPLETED|Drug 1 Only||3
8682861|NCT02130687|21434787|P3|COMPLETED|Drug 1 Only||30
8682862|NCT02130687|21434788|P2|COMPLETED|Drug 1 Only||30
8682863|NCT02130687|21434789|P1|COMPLETED|Drug 1 Only||33
8682864|NCT02130687|21434787|P3|STARTED|Drug 1 Only||31
8682865|NCT02130687|21434788|P2|STARTED|Drug 1 Only||33
8682866|NCT02130687|21434789|P1|STARTED|Drug 1 Only||36
8682867|NCT02130687|21434787|P3|NOT COMPLETED|Washout||4
8682868|NCT02130687|21434788|P2|NOT COMPLETED|Washout||2
8682869|NCT02130687|21434789|P1|NOT COMPLETED|Washout||0
8682870|NCT02130687|21434787|P3|COMPLETED|Washout||31
8682871|NCT02130687|21434788|P2|COMPLETED|Washout||33
8682872|NCT02130687|21434789|P1|COMPLETED|Washout||36
8682873|NCT02130687|21434787|P3|STARTED|Washout||35
8682874|NCT02130687|21434788|P2|STARTED|Washout||35
8682875|NCT02130687|21434789|P1|STARTED|Washout||36
8682876|NCT02068885|21434845|P3|NOT COMPLETED|Overall Study||8
8682877|NCT02068885|21434846|P2|NOT COMPLETED|Overall Study||5
8682878|NCT02068885|21434847|P1|NOT COMPLETED|Overall Study||3
8682879|NCT02068885|21434845|P3|COMPLETED|Overall Study||46
8682880|NCT02068885|21434846|P2|COMPLETED|Overall Study||48
8682881|NCT02068885|21434847|P1|COMPLETED|Overall Study||54
8682882|NCT02068885|21434845|P3|Included in Intention-to-treat Analysis|Overall Study||54
8682883|NCT02068885|21434846|P2|Included in Intention-to-treat Analysis|Overall Study||52
8682884|NCT02068885|21434847|P1|Included in Intention-to-treat Analysis|Overall Study||56
8682885|NCT02068885|21434845|P3|Provided Data at End of Test Phase|Overall Study||46
8682886|NCT02068885|21434846|P2|Provided Data at End of Test Phase|Overall Study||48
8682887|NCT02068885|21434847|P1|Provided Data at End of Test Phase|Overall Study||54
8682888|NCT02068885|21434845|P3|Provided Data at Midpoint Test Phase|Overall Study||48
8682889|NCT02068885|21434846|P2|Provided Data at Midpoint Test Phase|Overall Study||50
8682890|NCT02068885|21434847|P1|Provided Data at Midpoint Test Phase|Overall Study||56
8682891|NCT02068885|21434845|P3|STARTED|Overall Study||54
8682892|NCT02068885|21434846|P2|STARTED|Overall Study||53
8682893|NCT02068885|21434847|P1|STARTED|Overall Study||57
8682894|NCT02061813|21434943|P1|NOT COMPLETED|Overall Study||3
8682895|NCT02061813|21434943|P1|COMPLETED|Overall Study||37
8682896|NCT02061813|21434943|P1|SLS 0.2%|Overall Study||40
8682897|NCT02061813|21434943|P1|Saline 0.9%|Overall Study||40
8682898|NCT02061813|21434943|P1|Vehicle Lotion|Overall Study||40
8682899|NCT02061813|21434943|P1|Abametapir Lotion|Overall Study||40
8682900|NCT02061813|21434943|P1|STARTED|Overall Study||40
8682901|NCT01748825|21434960|P10|NOT COMPLETED|Dose Expansion||5
8682902|NCT01748825|21434961|P9|NOT COMPLETED|Dose Expansion||2
8682903|NCT01748825|21434962|P8|NOT COMPLETED|Dose Expansion||0
8682904|NCT01748825|21434963|P7|NOT COMPLETED|Dose Expansion||0
8682905|NCT01748825|21434964|P6|NOT COMPLETED|Dose Expansion||0
8682906|NCT01748825|21434965|P5|NOT COMPLETED|Dose Expansion||0
8682907|NCT01748825|21434966|P4|NOT COMPLETED|Dose Expansion||0
8682908|NCT01748825|21434967|P3|NOT COMPLETED|Dose Expansion||0
8682909|NCT01748825|21434968|P2|NOT COMPLETED|Dose Expansion||0
8682910|NCT01748825|21434969|P1|NOT COMPLETED|Dose Expansion||0
8682911|NCT01748825|21434960|P10|COMPLETED|Dose Expansion||15
8682912|NCT01748825|21434961|P9|COMPLETED|Dose Expansion||11
8682913|NCT01748825|21434962|P8|COMPLETED|Dose Expansion||0
8682914|NCT01748825|21434963|P7|COMPLETED|Dose Expansion||0
8682915|NCT01748825|21434964|P6|COMPLETED|Dose Expansion||0
8682916|NCT01748825|21434965|P5|COMPLETED|Dose Expansion||0
8682917|NCT01748825|21434966|P4|COMPLETED|Dose Expansion||0
8682918|NCT01748825|21434967|P3|COMPLETED|Dose Expansion||0
8682919|NCT01748825|21434968|P2|COMPLETED|Dose Expansion||0
8682920|NCT01748825|21434969|P1|COMPLETED|Dose Expansion||0
8682921|NCT01748825|21434960|P10|STARTED|Dose Expansion||20
8682922|NCT01748825|21434961|P9|STARTED|Dose Expansion||13
8682923|NCT01748825|21434962|P8|STARTED|Dose Expansion||0
8682924|NCT01748825|21434963|P7|STARTED|Dose Expansion||0
8682925|NCT01748825|21434964|P6|STARTED|Dose Expansion||0
8682926|NCT01748825|21434965|P5|STARTED|Dose Expansion||0
8682927|NCT01748825|21434966|P4|STARTED|Dose Expansion||0
8682928|NCT01748825|21434967|P3|STARTED|Dose Expansion||0
8682929|NCT01748825|21434968|P2|STARTED|Dose Expansion||0
8682930|NCT01748825|21434969|P1|STARTED|Dose Expansion||0
8682931|NCT01748825|21434960|P10|NOT COMPLETED|Dose Escalation||0
8682932|NCT01748825|21434961|P9|NOT COMPLETED|Dose Escalation||0
8682933|NCT01748825|21434962|P8|NOT COMPLETED|Dose Escalation||0
8682934|NCT01748825|21434963|P7|NOT COMPLETED|Dose Escalation||1
8682935|NCT01748825|21434964|P6|NOT COMPLETED|Dose Escalation||2
8682936|NCT01748825|21434965|P5|NOT COMPLETED|Dose Escalation||1
8682937|NCT01748825|21434966|P4|NOT COMPLETED|Dose Escalation||1
8682938|NCT01748825|21434967|P3|NOT COMPLETED|Dose Escalation||0
8682939|NCT01748825|21434968|P2|NOT COMPLETED|Dose Escalation||2
8682940|NCT01748825|21434969|P1|NOT COMPLETED|Dose Escalation||2
8682941|NCT01748825|21434960|P10|COMPLETED|Dose Escalation||0
8682942|NCT01748825|21434961|P9|COMPLETED|Dose Escalation||0
8682943|NCT01748825|21434962|P8|COMPLETED|Dose Escalation||3
8682944|NCT01748825|21434963|P7|COMPLETED|Dose Escalation||2
8682945|NCT01748825|21434964|P6|COMPLETED|Dose Escalation||4
8682946|NCT01748825|21434965|P5|COMPLETED|Dose Escalation||2
8682947|NCT01748825|21434966|P4|COMPLETED|Dose Escalation||2
8682948|NCT01748825|21434967|P3|COMPLETED|Dose Escalation||6
8682949|NCT01748825|21434968|P2|COMPLETED|Dose Escalation||2
8682950|NCT01748825|21434969|P1|COMPLETED|Dose Escalation||4
8682951|NCT01748825|21434960|P10|STARTED|Dose Escalation||0
8682952|NCT01748825|21434961|P9|STARTED|Dose Escalation||0
8682953|NCT01748825|21434962|P8|STARTED|Dose Escalation||3
8682954|NCT01748825|21434963|P7|STARTED|Dose Escalation||3
8682955|NCT01748825|21434964|P6|STARTED|Dose Escalation||6
8682956|NCT01748825|21434965|P5|STARTED|Dose Escalation||3
8682957|NCT01748825|21434966|P4|STARTED|Dose Escalation||3
8682958|NCT01748825|21434967|P3|STARTED|Dose Escalation||6
8682959|NCT01748825|21434968|P2|STARTED|Dose Escalation||4
8682960|NCT01748825|21434969|P1|STARTED|Dose Escalation||6
8682961|NCT01444716|21435026|P1|NOT COMPLETED|Overall Study||0
8682962|NCT01444716|21435026|P1|COMPLETED|Overall Study||34
8682963|NCT01444716|21435026|P1|STARTED|Overall Study||34
8682964|NCT01254227|21435032|P1|NOT COMPLETED|Overall Study||26
8682965|NCT01254227|21435032|P1|COMPLETED|Overall Study||34
8682966|NCT01254227|21435032|P1|Completion of 24 Months|Overall Study||34
8682967|NCT01254227|21435032|P1|Completion of 12 Months|Overall Study||39
8682968|NCT01254227|21435032|P1|STARTED|Overall Study||60
8682969|NCT04502056|21435044|P12|NOT COMPLETED|Overall Study||406
8682970|NCT04502056|21435045|P11|NOT COMPLETED|Overall Study||735
8682971|NCT04502056|21435046|P10|NOT COMPLETED|Overall Study||714
8682972|NCT04502056|21435047|P9|NOT COMPLETED|Overall Study||728
8682973|NCT04502056|21435048|P8|NOT COMPLETED|Overall Study||1440
8682974|NCT04502056|21435049|P7|NOT COMPLETED|Overall Study||1441
8682975|NCT04502056|21435050|P6|NOT COMPLETED|Overall Study||1456
8682976|NCT04502056|21435051|P5|NOT COMPLETED|Overall Study||1418
8682977|NCT04502056|21435052|P4|NOT COMPLETED|Overall Study||1449
8682978|NCT04502056|21435053|P3|NOT COMPLETED|Overall Study||1459
8682979|NCT04502056|21435054|P2|NOT COMPLETED|Overall Study||1442
8682980|NCT04502056|21435055|P1|NOT COMPLETED|Overall Study||1442
8682981|NCT04502056|21435044|P12|COMPLETED|Overall Study||614
8682982|NCT04502056|21435045|P11|COMPLETED|Overall Study||288
8682983|NCT04502056|21435046|P10|COMPLETED|Overall Study||311
8682984|NCT04502056|21435047|P9|COMPLETED|Overall Study||298
8682985|NCT04502056|21435048|P8|COMPLETED|Overall Study||603
8682986|NCT04502056|21435049|P7|COMPLETED|Overall Study||605
8682987|NCT04502056|21435050|P6|COMPLETED|Overall Study||596
8682988|NCT04502056|21435051|P5|COMPLETED|Overall Study||626
8682989|NCT04502056|21435052|P4|COMPLETED|Overall Study||597
8682990|NCT04502056|21435053|P3|COMPLETED|Overall Study||586
8682991|NCT04502056|21435054|P2|COMPLETED|Overall Study||602
8682992|NCT04502056|21435055|P1|COMPLETED|Overall Study||604
8682993|NCT04502056|21435044|P12|Completed the Follow-up Survey|Overall Study||316
8682994|NCT04502056|21435045|P11|Completed the Follow-up Survey|Overall Study||291
8682995|NCT04502056|21435046|P10|Completed the Follow-up Survey|Overall Study||313
8682996|NCT04502056|21435047|P9|Completed the Follow-up Survey|Overall Study||301
8682997|NCT04502056|21435048|P8|Completed the Follow-up Survey|Overall Study||607
8682998|NCT04502056|21435049|P7|Completed the Follow-up Survey|Overall Study||607
8682999|NCT04502056|21435050|P6|Completed the Follow-up Survey|Overall Study||598
8683000|NCT04502056|21435051|P5|Completed the Follow-up Survey|Overall Study||631
8683001|NCT04502056|21435052|P4|Completed the Follow-up Survey|Overall Study||601
8683002|NCT04502056|21435053|P3|Completed the Follow-up Survey|Overall Study||591
8683003|NCT04502056|21435054|P2|Completed the Follow-up Survey|Overall Study||607
8683004|NCT04502056|21435055|P1|Completed the Follow-up Survey|Overall Study||608
8683005|NCT04502056|21435044|P12|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||900
8683006|NCT04502056|21435045|P11|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||928
8683007|NCT04502056|21435046|P10|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||912
8683008|NCT04502056|21435047|P9|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||914
8683009|NCT04502056|21435048|P8|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1844
8683010|NCT04502056|21435049|P7|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1821
8683011|NCT04502056|21435050|P6|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1820
8683012|NCT04502056|21435051|P5|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1792
8683013|NCT04502056|21435052|P4|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1835
8683014|NCT04502056|21435053|P3|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1830
8683015|NCT04502056|21435054|P2|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1828
8683016|NCT04502056|21435055|P1|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1799
8683099|NCT04371419|21435120|P13|STARTED|Overall Study||779
8683017|NCT04502056|21435044|P12|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||928
8683018|NCT04502056|21435045|P11|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||946
8683019|NCT04502056|21435046|P10|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||942
8683020|NCT04502056|21435047|P9|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||947
8683021|NCT04502056|21435048|P8|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1883
8683022|NCT04502056|21435049|P7|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1888
8683023|NCT04502056|21435050|P6|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1877
8683024|NCT04502056|21435051|P5|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1846
8683025|NCT04502056|21435052|P4|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1886
8683026|NCT04502056|21435053|P3|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1879
8683027|NCT04502056|21435054|P2|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1881
8683028|NCT04502056|21435055|P1|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1859
8683029|NCT04502056|21435044|P12|STARTED|Overall Study||1020
8683030|NCT04502056|21435045|P11|STARTED|Overall Study||1023
8683031|NCT04502056|21435046|P10|STARTED|Overall Study||1025
8683032|NCT04502056|21435047|P9|STARTED|Overall Study||1026
8683033|NCT04502056|21435048|P8|STARTED|Overall Study||2043
8683034|NCT04502056|21435049|P7|STARTED|Overall Study||2046
8683035|NCT04502056|21435050|P6|STARTED|Overall Study||2052
8683036|NCT04502056|21435051|P5|STARTED|Overall Study||2044
8683037|NCT04502056|21435052|P4|STARTED|Overall Study||2046
8683038|NCT04502056|21435053|P3|STARTED|Overall Study||2045
8683039|NCT04502056|21435054|P2|STARTED|Overall Study||2044
8683040|NCT04502056|21435055|P1|STARTED|Overall Study||2046
8683041|NCT04450381|21435109|P1|NOT COMPLETED|Overall Study||6
8683042|NCT04450381|21435109|P1|COMPLETED|Overall Study||125
8683043|NCT04450381|21435109|P1|STARTED|Overall Study||131
8683044|NCT04371419|21435116|P17|NOT COMPLETED|Overall Study||167
8683045|NCT04371419|21435117|P16|NOT COMPLETED|Overall Study||156
8683046|NCT04371419|21435118|P15|NOT COMPLETED|Overall Study||155
8683047|NCT04371419|21435119|P14|NOT COMPLETED|Overall Study||126
8683048|NCT04371419|21435120|P13|NOT COMPLETED|Overall Study||146
8683049|NCT04371419|21435121|P12|NOT COMPLETED|Overall Study||128
8683050|NCT04371419|21435122|P11|NOT COMPLETED|Overall Study||156
8683051|NCT04371419|21435123|P10|NOT COMPLETED|Overall Study||159
8683052|NCT04371419|21435124|P9|NOT COMPLETED|Overall Study||130
8683053|NCT04371419|21435125|P8|NOT COMPLETED|Overall Study||130
8683054|NCT04371419|21435126|P7|NOT COMPLETED|Overall Study||144
8683055|NCT04371419|21435127|P6|NOT COMPLETED|Overall Study||134
8683056|NCT04371419|21435128|P5|NOT COMPLETED|Overall Study||133
8683057|NCT04371419|21435129|P4|NOT COMPLETED|Overall Study||147
8683058|NCT04371419|21435130|P3|NOT COMPLETED|Overall Study||141
8683059|NCT04371419|21435131|P2|NOT COMPLETED|Overall Study||155
8683060|NCT04371419|21435132|P1|NOT COMPLETED|Overall Study||143
8683061|NCT04371419|21435116|P17|COMPLETED|Overall Study||1450
8683062|NCT04371419|21435117|P16|COMPLETED|Overall Study||625
8683063|NCT04371419|21435118|P15|COMPLETED|Overall Study||626
8683064|NCT04371419|21435119|P14|COMPLETED|Overall Study||660
8683065|NCT04371419|21435120|P13|COMPLETED|Overall Study||633
8683066|NCT04371419|21435121|P12|COMPLETED|Overall Study||662
8683067|NCT04371419|21435122|P11|COMPLETED|Overall Study||626
8683068|NCT04371419|21435123|P10|COMPLETED|Overall Study||621
8683069|NCT04371419|21435124|P9|COMPLETED|Overall Study||649
8683070|NCT04371419|21435125|P8|COMPLETED|Overall Study||658
8683071|NCT04371419|21435126|P7|COMPLETED|Overall Study||639
8683072|NCT04371419|21435127|P6|COMPLETED|Overall Study||654
8683073|NCT04371419|21435128|P5|COMPLETED|Overall Study||644
8683074|NCT04371419|21435129|P4|COMPLETED|Overall Study||631
8683075|NCT04371419|21435130|P3|COMPLETED|Overall Study||639
8683076|NCT04371419|21435131|P2|COMPLETED|Overall Study||636
8683077|NCT04371419|21435132|P1|COMPLETED|Overall Study||641
8683078|NCT04371419|21435116|P17|Completed the Knowledge Questions|Overall Study||1526
8683079|NCT04371419|21435117|P16|Completed the Knowledge Questions|Overall Study||652
8683080|NCT04371419|21435118|P15|Completed the Knowledge Questions|Overall Study||652
8683081|NCT04371419|21435119|P14|Completed the Knowledge Questions|Overall Study||687
8683082|NCT04371419|21435120|P13|Completed the Knowledge Questions|Overall Study||664
8683083|NCT04371419|21435121|P12|Completed the Knowledge Questions|Overall Study||692
8683084|NCT04371419|21435122|P11|Completed the Knowledge Questions|Overall Study||656
8683085|NCT04371419|21435123|P10|Completed the Knowledge Questions|Overall Study||655
8683086|NCT04371419|21435124|P9|Completed the Knowledge Questions|Overall Study||670
8683087|NCT04371419|21435125|P8|Completed the Knowledge Questions|Overall Study||679
8683088|NCT04371419|21435126|P7|Completed the Knowledge Questions|Overall Study||664
8683089|NCT04371419|21435127|P6|Completed the Knowledge Questions|Overall Study||683
8683090|NCT04371419|21435128|P5|Completed the Knowledge Questions|Overall Study||666
8683091|NCT04371419|21435129|P4|Completed the Knowledge Questions|Overall Study||664
8683092|NCT04371419|21435130|P3|Completed the Knowledge Questions|Overall Study||673
8683093|NCT04371419|21435131|P2|Completed the Knowledge Questions|Overall Study||669
8683094|NCT04371419|21435132|P1|Completed the Knowledge Questions|Overall Study||663
8683095|NCT04371419|21435116|P17|STARTED|Overall Study||1617
8683096|NCT04371419|21435117|P16|STARTED|Overall Study||781
8683097|NCT04371419|21435118|P15|STARTED|Overall Study||781
8683098|NCT04371419|21435119|P14|STARTED|Overall Study||786
8683100|NCT04371419|21435121|P12|STARTED|Overall Study||790
8683101|NCT04371419|21435122|P11|STARTED|Overall Study||782
8683102|NCT04371419|21435123|P10|STARTED|Overall Study||780
8683103|NCT04371419|21435124|P9|STARTED|Overall Study||779
8683104|NCT04371419|21435125|P8|STARTED|Overall Study||788
8683105|NCT04371419|21435126|P7|STARTED|Overall Study||783
8683106|NCT04371419|21435127|P6|STARTED|Overall Study||788
8683107|NCT04371419|21435128|P5|STARTED|Overall Study||777
8683108|NCT04371419|21435129|P4|STARTED|Overall Study||778
8683109|NCT04371419|21435130|P3|STARTED|Overall Study||780
8683110|NCT04371419|21435131|P2|STARTED|Overall Study||791
8683111|NCT04371419|21435132|P1|STARTED|Overall Study||784
8683112|NCT04356937|21435177|P2|NOT COMPLETED|Treatment (mITT Population)||1
8683113|NCT04356937|21435178|P1|NOT COMPLETED|Treatment (mITT Population)||0
8683114|NCT04356937|21435177|P2|COMPLETED|Treatment (mITT Population)||81
8683115|NCT04356937|21435178|P1|COMPLETED|Treatment (mITT Population)||161
8683116|NCT04356937|21435177|P2|STARTED|Treatment (mITT Population)||82
8683117|NCT04356937|21435178|P1|STARTED|Treatment (mITT Population)||161
8683118|NCT04356937|21435177|P2|NOT COMPLETED|Randomization (Safety Population)||0
8683119|NCT04356937|21435178|P1|NOT COMPLETED|Randomization (Safety Population)||0
8683120|NCT04356937|21435177|P2|COMPLETED|Randomization (Safety Population)||82
8683121|NCT04356937|21435178|P1|COMPLETED|Randomization (Safety Population)||161
8683122|NCT04356937|21435177|P2|STARTED|Randomization (Safety Population)||82
8683123|NCT04356937|21435178|P1|STARTED|Randomization (Safety Population)||161
8683130|NCT03738826|21435223|P2|NOT COMPLETED|Overall Study||0
8683131|NCT03738826|21435224|P1|NOT COMPLETED|Overall Study||0
8683132|NCT03738826|21435223|P2|COMPLETED|Overall Study||5
8683133|NCT03738826|21435224|P1|COMPLETED|Overall Study||130
8683134|NCT03738826|21435223|P2|STARTED|Overall Study||5
8683135|NCT03738826|21435224|P1|STARTED|Overall Study||130
8683136|NCT03532776|21435239|P3|NOT COMPLETED|Overall Study||4
8683137|NCT03532776|21435240|P2|NOT COMPLETED|Overall Study||4
8683138|NCT03532776|21435241|P1|NOT COMPLETED|Overall Study||5
8683139|NCT03532776|21435239|P3|COMPLETED|Overall Study||63
8683140|NCT03532776|21435240|P2|COMPLETED|Overall Study||194
8683141|NCT03532776|21435241|P1|COMPLETED|Overall Study||196
8683142|NCT03532776|21435239|P3|STARTED|Overall Study||67
8683143|NCT03532776|21435240|P2|STARTED|Overall Study||198
8683144|NCT03532776|21435241|P1|STARTED|Overall Study||201
8683145|NCT03461146|21435255|P1|NOT COMPLETED|Overall Study||3
8683146|NCT03461146|21435255|P1|COMPLETED|Overall Study||21
8683147|NCT03461146|21435255|P1|STARTED|Overall Study||24
8683148|NCT03382418|21435266|P3|NOT COMPLETED|Overall Study||0
8683149|NCT03382418|21435267|P2|NOT COMPLETED|Overall Study||3
8683150|NCT03382418|21435268|P1|NOT COMPLETED|Overall Study||3
8683151|NCT03382418|21435266|P3|COMPLETED|Overall Study||5
8683152|NCT03382418|21435267|P2|COMPLETED|Overall Study||12
8683153|NCT03382418|21435268|P1|COMPLETED|Overall Study||22
8683154|NCT03382418|21435266|P3|Month 6.5 Immunogenicity Cohort|Overall Study||5
8683155|NCT03382418|21435267|P2|Month 6.5 Immunogenicity Cohort|Overall Study||13
8683156|NCT03382418|21435268|P1|Month 6.5 Immunogenicity Cohort|Overall Study||21
8683157|NCT03382418|21435266|P3|Month .5 Immunogenicity Cohort|Overall Study||5
8683158|NCT03382418|21435267|P2|Month .5 Immunogenicity Cohort|Overall Study||14
8683159|NCT03382418|21435268|P1|Month .5 Immunogenicity Cohort|Overall Study||25
8683160|NCT03382418|21435266|P3|STARTED|Overall Study||5
8683161|NCT03382418|21435267|P2|STARTED|Overall Study||15
8683162|NCT03382418|21435268|P1|STARTED|Overall Study||25
8683163|NCT03372434|21435360|P3|NOT COMPLETED|Overall Study||2
8683164|NCT03372434|21435361|P2|NOT COMPLETED|Overall Study||3
8683165|NCT03372434|21435362|P1|NOT COMPLETED|Overall Study||2
8683166|NCT03372434|21435360|P3|COMPLETED|Overall Study||72
8683167|NCT03372434|21435361|P2|COMPLETED|Overall Study||70
8683168|NCT03372434|21435362|P1|COMPLETED|Overall Study||76
8683169|NCT03372434|21435360|P3|1 Month Follow-up|Overall Study||73
8683170|NCT03372434|21435361|P2|1 Month Follow-up|Overall Study||72
8683171|NCT03372434|21435362|P1|1 Month Follow-up|Overall Study||76
8683172|NCT03372434|21435360|P3|STARTED|Overall Study||74
8683173|NCT03372434|21435361|P2|STARTED|Overall Study||73
8683174|NCT03372434|21435362|P1|STARTED|Overall Study||78
8683175|NCT03363321|21435375|P5|NOT COMPLETED|Overall Study||0
8683176|NCT03363321|21435376|P4|NOT COMPLETED|Overall Study||1
8683177|NCT03363321|21435377|P3|NOT COMPLETED|Overall Study||0
8683178|NCT03363321|21435378|P2|NOT COMPLETED|Overall Study||1
8683179|NCT03363321|21435379|P1|NOT COMPLETED|Overall Study||0
8683180|NCT03363321|21435375|P5|COMPLETED|Overall Study||2
8683181|NCT03363321|21435376|P4|COMPLETED|Overall Study||4
8683182|NCT03363321|21435377|P3|COMPLETED|Overall Study||4
8683183|NCT03363321|21435378|P2|COMPLETED|Overall Study||3
8683184|NCT03363321|21435379|P1|COMPLETED|Overall Study||5
8683185|NCT03363321|21435375|P5|STARTED|Overall Study||2
8683186|NCT03363321|21435376|P4|STARTED|Overall Study||5
8683187|NCT03363321|21435377|P3|STARTED|Overall Study||4
8683188|NCT03363321|21435378|P2|STARTED|Overall Study||4
8683189|NCT03363321|21435379|P1|STARTED|Overall Study||5
8683205|NCT03040427|21435537|P3|NOT COMPLETED|Overall Study||0
8683206|NCT03040427|21435538|P2|NOT COMPLETED|Overall Study||0
8683207|NCT03040427|21435539|P1|NOT COMPLETED|Overall Study||0
8683208|NCT03040427|21435537|P3|COMPLETED|Overall Study||4
8683209|NCT03040427|21435538|P2|COMPLETED|Overall Study||6
8683210|NCT03040427|21435539|P1|COMPLETED|Overall Study||2
8683211|NCT03040427|21435537|P3|STARTED|Overall Study||4
8683212|NCT03040427|21435538|P2|STARTED|Overall Study||6
8683213|NCT03040427|21435539|P1|STARTED|Overall Study||2
8683214|NCT02988986|21435547|P1|NOT COMPLETED|Overall Study||3
8683215|NCT02988986|21435547|P1|COMPLETED|Overall Study||25
8683216|NCT02988986|21435547|P1|STARTED|Overall Study||28
8683217|NCT02930343|21435555|P2|NOT COMPLETED|Overall Study||7
8683218|NCT02930343|21435556|P1|NOT COMPLETED|Overall Study||9
8683219|NCT02930343|21435555|P2|COMPLETED|Overall Study||61
8683220|NCT02930343|21435556|P1|COMPLETED|Overall Study||59
8683221|NCT02930343|21435555|P2|STARTED|Overall Study||68
8683222|NCT02930343|21435556|P1|STARTED|Overall Study||68
8683223|NCT02810964|21435570|P2|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
8683224|NCT02810964|21435571|P1|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
8683225|NCT02810964|21435570|P2|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
8683226|NCT02810964|21435571|P1|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
8683227|NCT02810964|21435570|P2|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
8683228|NCT02810964|21435571|P1|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
8683229|NCT02810964|21435570|P2|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
8683230|NCT02810964|21435571|P1|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
8683231|NCT02810964|21435570|P2|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
8683232|NCT02810964|21435571|P1|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
8683233|NCT02810964|21435570|P2|STARTED|Placebo Run-In Phase (2 Weeks)||32
8683234|NCT02810964|21435571|P1|STARTED|Placebo Run-In Phase (2 Weeks)||32
8683235|NCT02764385|21435593|P2|NOT COMPLETED|Overall Study||0
8683236|NCT02764385|21435594|P1|NOT COMPLETED|Overall Study||0
8683237|NCT02764385|21435593|P2|COMPLETED|Overall Study||6641
8683238|NCT02764385|21435594|P1|COMPLETED|Overall Study||9145
8683239|NCT02764385|21435593|P2|STARTED|Overall Study||6641
8683240|NCT02764385|21435594|P1|STARTED|Overall Study||9145
8683241|NCT02695420|21435606|P4|NOT COMPLETED|Overall Study||0
8683242|NCT02695420|21435607|P3|NOT COMPLETED|Overall Study||0
8683243|NCT02695420|21435608|P2|NOT COMPLETED|Overall Study||1
8683244|NCT02695420|21435609|P1|NOT COMPLETED|Overall Study||0
8683245|NCT02695420|21435606|P4|COMPLETED|Overall Study||20
8683246|NCT02695420|21435607|P3|COMPLETED|Overall Study||19
8683247|NCT02695420|21435608|P2|COMPLETED|Overall Study||20
8683248|NCT02695420|21435609|P1|COMPLETED|Overall Study||21
8683249|NCT02695420|21435606|P4|STARTED|Overall Study||20
8683250|NCT02695420|21435607|P3|STARTED|Overall Study||19
8683251|NCT02695420|21435608|P2|STARTED|Overall Study||21
8683252|NCT02695420|21435609|P1|STARTED|Overall Study||21
8683253|NCT02668692|21435631|P2|NOT COMPLETED|Overall Study||0
8683254|NCT02668692|21435632|P1|NOT COMPLETED|Overall Study||1
8683255|NCT02668692|21435631|P2|COMPLETED|Overall Study||105
8683256|NCT02668692|21435632|P1|COMPLETED|Overall Study||100
8683257|NCT02668692|21435631|P2|STARTED|Overall Study||105
8683258|NCT02668692|21435632|P1|STARTED|Overall Study||101
8683259|NCT02664415|21435644|P2|NOT COMPLETED|Overall Study||0
8683260|NCT02664415|21435645|P1|NOT COMPLETED|Overall Study||1
8683261|NCT02664415|21435644|P2|COMPLETED|Overall Study||5
8683262|NCT02664415|21435645|P1|COMPLETED|Overall Study||13
8683263|NCT02664415|21435644|P2|STARTED|Overall Study||5
8683264|NCT02664415|21435645|P1|STARTED|Overall Study||14
8683265|NCT02627963|21435675|P2|NOT COMPLETED|Overall Study||14
8683266|NCT02627963|21435676|P1|NOT COMPLETED|Overall Study||36
8683267|NCT02627963|21435675|P2|COMPLETED|Overall Study||161
8683268|NCT02627963|21435676|P1|COMPLETED|Overall Study||139
8683269|NCT02627963|21435675|P2|STARTED|Overall Study||175
8683270|NCT02627963|21435676|P1|STARTED|Overall Study||175
8683271|NCT02601001|21435691|P7|NOT COMPLETED|Dosing Period 2||1
8683272|NCT02601001|21435692|P6|NOT COMPLETED|Dosing Period 2||0
8683273|NCT02601001|21435693|P5|NOT COMPLETED|Dosing Period 2||0
8683274|NCT02601001|21435694|P4|NOT COMPLETED|Dosing Period 2||0
8683275|NCT02601001|21435695|P3|NOT COMPLETED|Dosing Period 2||0
8683276|NCT02601001|21435696|P2|NOT COMPLETED|Dosing Period 2||0
8683277|NCT02601001|21435697|P1|NOT COMPLETED|Dosing Period 2||0
8683278|NCT02601001|21435691|P7|COMPLETED|Dosing Period 2||12
8683279|NCT02601001|21435692|P6|COMPLETED|Dosing Period 2||7
8683280|NCT02601001|21435693|P5|COMPLETED|Dosing Period 2||13
8683281|NCT02601001|21435694|P4|COMPLETED|Dosing Period 2||7
8683282|NCT02601001|21435695|P3|COMPLETED|Dosing Period 2||0
8683283|NCT02601001|21435696|P2|COMPLETED|Dosing Period 2||0
8683284|NCT02601001|21435697|P1|COMPLETED|Dosing Period 2||10
8683285|NCT02601001|21435691|P7|STARTED|Dosing Period 2||13
8683286|NCT02601001|21435692|P6|STARTED|Dosing Period 2||7
8683287|NCT02601001|21435693|P5|STARTED|Dosing Period 2||13
8683288|NCT02601001|21435694|P4|STARTED|Dosing Period 2||7
8683289|NCT02601001|21435695|P3|STARTED|Dosing Period 2||0
8683290|NCT02601001|21435696|P2|STARTED|Dosing Period 2||0
8683291|NCT02601001|21435697|P1|STARTED|Dosing Period 2||10
8683292|NCT02601001|21435691|P7|NOT COMPLETED|Dosing Period 1||0
8683293|NCT02601001|21435692|P6|NOT COMPLETED|Dosing Period 1||0
8683294|NCT02601001|21435693|P5|NOT COMPLETED|Dosing Period 1||0
8683295|NCT02601001|21435694|P4|NOT COMPLETED|Dosing Period 1||0
8683296|NCT02601001|21435695|P3|NOT COMPLETED|Dosing Period 1||0
8683297|NCT02601001|21435696|P2|NOT COMPLETED|Dosing Period 1||0
8683298|NCT02601001|21435697|P1|NOT COMPLETED|Dosing Period 1||0
8683299|NCT02601001|21435691|P7|COMPLETED|Dosing Period 1||0
8683300|NCT02601001|21435692|P6|COMPLETED|Dosing Period 1||0
8683301|NCT02601001|21435693|P5|COMPLETED|Dosing Period 1||0
8683302|NCT02601001|21435694|P4|COMPLETED|Dosing Period 1||0
8683303|NCT02601001|21435695|P3|COMPLETED|Dosing Period 1||20
8683304|NCT02601001|21435696|P2|COMPLETED|Dosing Period 1||20
8683305|NCT02601001|21435697|P1|COMPLETED|Dosing Period 1||10
8683306|NCT02601001|21435691|P7|STARTED|Dosing Period 1||0
8683307|NCT02601001|21435692|P6|STARTED|Dosing Period 1||0
8683308|NCT02601001|21435693|P5|STARTED|Dosing Period 1||0
8683309|NCT02601001|21435694|P4|STARTED|Dosing Period 1||0
8683310|NCT02601001|21435695|P3|STARTED|Dosing Period 1||20
8683311|NCT02601001|21435696|P2|STARTED|Dosing Period 1||20
8683312|NCT02601001|21435697|P1|STARTED|Dosing Period 1||10
8683313|NCT02511106|21435759|P2|NOT COMPLETED|Overall Study||323
8683314|NCT02511106|21435760|P1|NOT COMPLETED|Overall Study||331
8683315|NCT02511106|21435759|P2|COMPLETED|Overall Study||20
8683316|NCT02511106|21435760|P1|COMPLETED|Overall Study||8
8683317|NCT02511106|21435759|P2|Received Treatment|Overall Study||343
8683318|NCT02511106|21435760|P1|Received Treatment|Overall Study||337
8683319|NCT02511106|21435759|P2|STARTED|Overall Study||343
8683320|NCT02511106|21435760|P1|STARTED|Overall Study||339
8683327|NCT02468804|21435802|P2|NOT COMPLETED|Overall Study||8
8683328|NCT02468804|21435803|P1|NOT COMPLETED|Overall Study||1
8683329|NCT02468804|21435802|P2|COMPLETED|Overall Study||50
8683330|NCT02468804|21435803|P1|COMPLETED|Overall Study||36
8683331|NCT02468804|21435802|P2|STARTED|Overall Study||58
8683332|NCT02468804|21435803|P1|STARTED|Overall Study||37
8683345|NCT02429856|21435837|P2|NOT COMPLETED|Overall Study||19
8683346|NCT02429856|21435838|P1|NOT COMPLETED|Overall Study||19
8683347|NCT02429856|21435837|P2|COMPLETED|Overall Study||32
8683348|NCT02429856|21435838|P1|COMPLETED|Overall Study||30
8683349|NCT02429856|21435837|P2|STARTED|Overall Study||51
8683350|NCT02429856|21435838|P1|STARTED|Overall Study||49
8683351|NCT02326467|21435854|P1|NOT COMPLETED|Overall Study||1
8683352|NCT02326467|21435854|P1|COMPLETED|Overall Study||9
8683353|NCT02326467|21435854|P1|STARTED|Overall Study||10
8683354|NCT01986140|21435861|P2|NOT COMPLETED|Overall Study||28
8683355|NCT01986140|21435862|P1|NOT COMPLETED|Overall Study||35
8683356|NCT01986140|21435861|P2|COMPLETED|Overall Study||51
8683357|NCT01986140|21435862|P1|COMPLETED|Overall Study||122
8683358|NCT01986140|21435861|P2|STARTED|Overall Study||79
8683359|NCT01986140|21435862|P1|STARTED|Overall Study||157
8683360|NCT01619865|21435868|P1|NOT COMPLETED|Overall Study||4
8683361|NCT01619865|21435868|P1|COMPLETED|Overall Study||219
8683362|NCT01619865|21435868|P1|STARTED|Overall Study||223
8683387|NCT01500252|21435893|P2|NOT COMPLETED|Overall Study||6
8683388|NCT01500252|21435894|P1|NOT COMPLETED|Overall Study||9
8683389|NCT01500252|21435893|P2|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
8683390|NCT01500252|21435894|P1|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
8683391|NCT01500252|21435893|P2|Ten Years|Overall Study||11
8683392|NCT01500252|21435894|P1|Ten Years|Overall Study||12
8683393|NCT01500252|21435893|P2|Five Years|Overall Study||13
8683394|NCT01500252|21435894|P1|Five Years|Overall Study||17
8683395|NCT01500252|21435893|P2|One Years|Overall Study||16
8683396|NCT01500252|21435894|P1|One Years|Overall Study||20
8683397|NCT01500252|21435893|P2|STARTED|Overall Study||17
8683398|NCT01500252|21435894|P1|STARTED|Overall Study||21
8683399|NCT01201863|21435921|P3|NOT COMPLETED|Overall Study||6
8683400|NCT01201863|21435922|P2|NOT COMPLETED|Overall Study||4
8683401|NCT01201863|21435923|P1|NOT COMPLETED|Overall Study||1
8683402|NCT01201863|21435921|P3|COMPLETED|Overall Study||18
8683403|NCT01201863|21435922|P2|COMPLETED|Overall Study||6
8683404|NCT01201863|21435923|P1|COMPLETED|Overall Study||11
8683405|NCT01201863|21435921|P3|STARTED|Overall Study||24
8683406|NCT01201863|21435922|P2|STARTED|Overall Study||10
8683407|NCT01201863|21435923|P1|STARTED|Overall Study||12
8683408|NCT01057381|21435935|P4|NOT COMPLETED|Overall Study||0
8683409|NCT01057381|21435936|P3|NOT COMPLETED|Overall Study||0
8683410|NCT01057381|21435937|P2|NOT COMPLETED|Overall Study||0
8683411|NCT01057381|21435938|P1|NOT COMPLETED|Overall Study||0
8683412|NCT01057381|21435935|P4|COMPLETED|Overall Study||26
8683413|NCT01057381|21435936|P3|COMPLETED|Overall Study||30
8683414|NCT01057381|21435937|P2|COMPLETED|Overall Study||27
8683415|NCT01057381|21435938|P1|COMPLETED|Overall Study||26
8683416|NCT01057381|21435935|P4|STARTED|Overall Study||26
8683417|NCT01057381|21435936|P3|STARTED|Overall Study||30
8683418|NCT01057381|21435937|P2|STARTED|Overall Study||27
8683419|NCT01057381|21435938|P1|STARTED|Overall Study||26
8683420|NCT01041573|21435972|P4|NOT COMPLETED|Overall Study||2
8683421|NCT01041573|21435973|P3|NOT COMPLETED|Overall Study||7
8683422|NCT01041573|21435974|P2|NOT COMPLETED|Overall Study||13
8683423|NCT01041573|21435975|P1|NOT COMPLETED|Overall Study||5
8683424|NCT01041573|21435972|P4|COMPLETED|Overall Study||62
8683425|NCT01041573|21435973|P3|COMPLETED|Overall Study||387
8683426|NCT01041573|21435974|P2|COMPLETED|Overall Study||858
8683427|NCT01041573|21435975|P1|COMPLETED|Overall Study||535
8683428|NCT01041573|21435972|P4|STARTED|Overall Study||64
8683429|NCT01041573|21435973|P3|STARTED|Overall Study||394
8683430|NCT01041573|21435974|P2|STARTED|Overall Study||871
8683431|NCT01041573|21435975|P1|STARTED|Overall Study||540
8683432|NCT00484198|21436009|P4|NOT COMPLETED|Overall Study||172
8683433|NCT00484198|21436010|P3|NOT COMPLETED|Overall Study||151
8683434|NCT00484198|21436011|P2|NOT COMPLETED|Overall Study||66
8683435|NCT00484198|21436012|P1|NOT COMPLETED|Overall Study||41
8683436|NCT00484198|21436009|P4|COMPLETED|Overall Study||579
8683437|NCT00484198|21436010|P3|COMPLETED|Overall Study||599
8683438|NCT00484198|21436011|P2|COMPLETED|Overall Study||208
8683439|NCT00484198|21436012|P1|COMPLETED|Overall Study||96
8683440|NCT00484198|21436009|P4|STARTED|Overall Study||751
8683441|NCT00484198|21436010|P3|STARTED|Overall Study||750
8683442|NCT00484198|21436011|P2|STARTED|Overall Study||274
8683443|NCT00484198|21436012|P1|STARTED|Overall Study||137
8683444|NCT04578457|21436110|P1|NOT COMPLETED|Overall Study||1
8683445|NCT04578457|21436110|P1|COMPLETED|Overall Study||18
8683446|NCT04578457|21436110|P1|STARTED|Overall Study||19
8683447|NCT04570670|21436123|P2|NOT COMPLETED|Overall Study||0
8683448|NCT04570670|21436124|P1|NOT COMPLETED|Overall Study||1
8683449|NCT04570670|21436123|P2|COMPLETED|Overall Study||25
8683450|NCT04570670|21436124|P1|COMPLETED|Overall Study||24
8683451|NCT04570670|21436123|P2|STARTED|Overall Study||25
8683452|NCT04570670|21436124|P1|STARTED|Overall Study||25
8683453|NCT04136444|21436134|P2|NOT COMPLETED|Overall Study||1
8683454|NCT04136444|21436135|P1|NOT COMPLETED|Overall Study||0
8683455|NCT04136444|21436134|P2|COMPLETED|Overall Study||8
8683456|NCT04136444|21436135|P1|COMPLETED|Overall Study|The cohort was not completely recruited, as the study was stopped/terminated due to COVID-19.|3
8683457|NCT04136444|21436134|P2|STARTED|Overall Study||9
8683458|NCT04136444|21436135|P1|STARTED|Overall Study||3
8683459|NCT04041414|21436165|P2|NOT COMPLETED|Overall Study||2
8683460|NCT04041414|21436166|P1|NOT COMPLETED|Overall Study||1
8683461|NCT04041414|21436165|P2|COMPLETED|Overall Study||18
8683462|NCT04041414|21436166|P1|COMPLETED|Overall Study||26
8683463|NCT04041414|21436165|P2|STARTED|Overall Study||20
8683464|NCT04041414|21436166|P1|STARTED|Overall Study||27
8683465|NCT03796728|21436184|P1|NOT COMPLETED|Overall Study||24
8683466|NCT03796728|21436184|P1|COMPLETED|Overall Study||36
8683467|NCT03796728|21436184|P1|STARTED|Overall Study||60
8683468|NCT03657277|21436196|P1|NOT COMPLETED|Overall Study||11
8683469|NCT03657277|21436196|P1|COMPLETED|Overall Study||35
8683470|NCT03657277|21436196|P1|STARTED|Overall Study||46
8683471|NCT03624192|21436203|P2|NOT COMPLETED|Overall Study||1
8683472|NCT03624192|21436204|P1|NOT COMPLETED|Overall Study||1
8683473|NCT03624192|21436203|P2|COMPLETED|Overall Study||2
8683474|NCT03624192|21436204|P1|COMPLETED|Overall Study||2
8683475|NCT03624192|21436203|P2|STARTED|Overall Study||3
8683476|NCT03624192|21436204|P1|STARTED|Overall Study||3
8683477|NCT03595618|21436221|P4|NOT COMPLETED|Overall Study||34
8683478|NCT03595618|21436222|P3|NOT COMPLETED|Overall Study||56
8683479|NCT03595618|21436223|P2|NOT COMPLETED|Overall Study||40
8683480|NCT03595618|21436224|P1|NOT COMPLETED|Overall Study||43
8683481|NCT03595618|21436221|P4|COMPLETED|Overall Study||200
8683482|NCT03595618|21436222|P3|COMPLETED|Overall Study||177
8683483|NCT03595618|21436223|P2|COMPLETED|Overall Study||191
8683484|NCT03595618|21436224|P1|COMPLETED|Overall Study||191
8683485|NCT03595618|21436221|P4|Treated|Overall Study||234
8683486|NCT03595618|21436222|P3|Treated|Overall Study||232
8683487|NCT03595618|21436223|P2|Treated|Overall Study||231
8683488|NCT03595618|21436224|P1|Treated|Overall Study||234
8683489|NCT03595618|21436221|P4|STARTED|Overall Study||234
8683490|NCT03595618|21436222|P3|STARTED|Overall Study||233
8683491|NCT03595618|21436223|P2|STARTED|Overall Study||231
8683492|NCT03595618|21436224|P1|STARTED|Overall Study||234
8683493|NCT03560141|21436283|P2|NOT COMPLETED|Overall Study||0
8683494|NCT03560141|21436284|P1|NOT COMPLETED|Overall Study||0
8683495|NCT03560141|21436283|P2|COMPLETED|Overall Study||5
8683496|NCT03560141|21436284|P1|COMPLETED|Overall Study||6
8683497|NCT03560141|21436283|P2|STARTED|Overall Study||5
8683498|NCT03560141|21436284|P1|STARTED|Overall Study||6
8683499|NCT03457818|21436294|P2|NOT COMPLETED|Overall Study||4
8683500|NCT03457818|21436295|P1|NOT COMPLETED|Overall Study||4
8683501|NCT03457818|21436294|P2|COMPLETED|Overall Study|study terminated|0
8683502|NCT03457818|21436295|P1|COMPLETED|Overall Study|Study terminated|0
8683503|NCT03457818|21436294|P2|STARTED|Overall Study||4
8683504|NCT03457818|21436295|P1|STARTED|Overall Study||4
8683544|NCT03297398|21436332|P3|NOT COMPLETED|Overall Study||15
8683545|NCT03297398|21436333|P2|NOT COMPLETED|Overall Study||17
8683546|NCT03297398|21436334|P1|NOT COMPLETED|Overall Study||8
8683547|NCT03297398|21436332|P3|COMPLETED|Overall Study||23
8683548|NCT03297398|21436333|P2|COMPLETED|Overall Study||23
8683549|NCT03297398|21436334|P1|COMPLETED|Overall Study||28
8683550|NCT03297398|21436332|P3|STARTED|Overall Study||38
8683551|NCT03297398|21436333|P2|STARTED|Overall Study||40
8683552|NCT03297398|21436334|P1|STARTED|Overall Study||36
8683553|NCT03254108|21436365|P5|NOT COMPLETED|Overall Study||3
8683554|NCT03254108|21436366|P4|NOT COMPLETED|Overall Study||1
8683555|NCT03254108|21436367|P3|NOT COMPLETED|Overall Study||0
8683556|NCT03254108|21436368|P2|NOT COMPLETED|Overall Study||2
8683557|NCT03254108|21436369|P1|NOT COMPLETED|Overall Study||0
8683558|NCT03254108|21436365|P5|COMPLETED|Overall Study||9
8683559|NCT03254108|21436366|P4|COMPLETED|Overall Study||11
8683560|NCT03254108|21436367|P3|COMPLETED|Overall Study||12
8683561|NCT03254108|21436368|P2|COMPLETED|Overall Study||10
8683562|NCT03254108|21436369|P1|COMPLETED|Overall Study||13
8683563|NCT03254108|21436365|P5|Received Treatment|Overall Study||12
8683564|NCT03254108|21436366|P4|Received Treatment|Overall Study||11
8683565|NCT03254108|21436367|P3|Received Treatment|Overall Study||12
8683566|NCT03254108|21436368|P2|Received Treatment|Overall Study||12
8683567|NCT03254108|21436369|P1|Received Treatment|Overall Study||13
8683568|NCT03254108|21436365|P5|STARTED|Overall Study||12
8683569|NCT03254108|21436366|P4|STARTED|Overall Study||12
8683570|NCT03254108|21436367|P3|STARTED|Overall Study||12
8683571|NCT03254108|21436368|P2|STARTED|Overall Study||12
8683572|NCT03254108|21436369|P1|STARTED|Overall Study||13
8683573|NCT03248947|21436386|P1|NOT COMPLETED|Overall Study||8
8683574|NCT03248947|21436386|P1|COMPLETED|Overall Study||63
8683575|NCT03248947|21436386|P1|STARTED|Overall Study||71
8683576|NCT03214640|21436403|P4|NOT COMPLETED|Overall Study||4
8683577|NCT03214640|21436404|P3|NOT COMPLETED|Overall Study||1
8683578|NCT03214640|21436405|P2|NOT COMPLETED|Overall Study||2
8683579|NCT03214640|21436406|P1|NOT COMPLETED|Overall Study||1
8683580|NCT03214640|21436403|P4|COMPLETED|Overall Study||30
8683581|NCT03214640|21436404|P3|COMPLETED|Overall Study||30
8683582|NCT03214640|21436405|P2|COMPLETED|Overall Study||30
8683583|NCT03214640|21436406|P1|COMPLETED|Overall Study||30
8683584|NCT03214640|21436403|P4|STARTED|Overall Study||34
8683585|NCT03214640|21436404|P3|STARTED|Overall Study||31
8683586|NCT03214640|21436405|P2|STARTED|Overall Study||32
8683587|NCT03214640|21436406|P1|STARTED|Overall Study||31
8683594|NCT03124459|21436439|P6|NOT COMPLETED|Part 2- Open Label ACE-083||23
8683595|NCT03124459|21436440|P5|NOT COMPLETED|Part 2- Open Label ACE-083||0
8683596|NCT03124459|21436441|P4|NOT COMPLETED|Part 2- Open Label ACE-083||0
8683597|NCT03124459|21436442|P3|NOT COMPLETED|Part 2- Open Label ACE-083||0
8683598|NCT03124459|21436443|P2|NOT COMPLETED|Part 2- Open Label ACE-083||0
8683599|NCT03124459|21436444|P1|NOT COMPLETED|Part 2- Open Label ACE-083||0
8683600|NCT03124459|21436439|P6|COMPLETED|Part 2- Open Label ACE-083||17
8683601|NCT03124459|21436440|P5|COMPLETED|Part 2- Open Label ACE-083||0
8683602|NCT03124459|21436441|P4|COMPLETED|Part 2- Open Label ACE-083||0
8683603|NCT03124459|21436442|P3|COMPLETED|Part 2- Open Label ACE-083||0
8683604|NCT03124459|21436443|P2|COMPLETED|Part 2- Open Label ACE-083||0
8683605|NCT03124459|21436444|P1|COMPLETED|Part 2- Open Label ACE-083||0
8683606|NCT03124459|21436439|P6|STARTED|Part 2- Open Label ACE-083|The open-label portion of Part 2 are the participants that were enrolled in and completed the double-blind placebo-controlled portion of Part 2.|40
8683607|NCT03124459|21436440|P5|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
8683608|NCT03124459|21436441|P4|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
8683609|NCT03124459|21436442|P3|STARTED|Part 2- Open Label ACE-083||0
8683610|NCT03124459|21436443|P2|STARTED|Part 2- Open Label ACE-083||0
8683611|NCT03124459|21436444|P1|STARTED|Part 2- Open Label ACE-083||0
8683612|NCT03124459|21436439|P6|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
8683613|NCT03124459|21436440|P5|NOT COMPLETED|Phase 2- Randomized Doubled-blind||19
8683614|NCT03124459|21436441|P4|NOT COMPLETED|Phase 2- Randomized Doubled-blind||12
8683615|NCT03124459|21436442|P3|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
8683616|NCT03124459|21436443|P2|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
8683617|NCT03124459|21436444|P1|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
8683618|NCT03124459|21436439|P6|COMPLETED|Phase 2- Randomized Doubled-blind||0
8683619|NCT03124459|21436440|P5|COMPLETED|Phase 2- Randomized Doubled-blind||5
8683620|NCT03124459|21436441|P4|COMPLETED|Phase 2- Randomized Doubled-blind||9
8683621|NCT03124459|21436442|P3|COMPLETED|Phase 2- Randomized Doubled-blind||0
8683622|NCT03124459|21436443|P2|COMPLETED|Phase 2- Randomized Doubled-blind||0
8683623|NCT03124459|21436444|P1|COMPLETED|Phase 2- Randomized Doubled-blind||0
8683624|NCT03124459|21436439|P6|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
8683689|NCT02942966|21436578|P1|STARTED|Overall Study|Intent to Treat (ITT) population.|233
8683625|NCT03124459|21436440|P5|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|24
8683626|NCT03124459|21436441|P4|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|21
8683627|NCT03124459|21436442|P3|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
8683628|NCT03124459|21436443|P2|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
8683629|NCT03124459|21436444|P1|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
8683630|NCT03124459|21436439|P6|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
8683631|NCT03124459|21436440|P5|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
8683632|NCT03124459|21436441|P4|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
8683633|NCT03124459|21436442|P3|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
8683634|NCT03124459|21436443|P2|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
8683635|NCT03124459|21436444|P1|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
8683636|NCT03124459|21436439|P6|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
8683637|NCT03124459|21436440|P5|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
8683638|NCT03124459|21436441|P4|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
8683639|NCT03124459|21436442|P3|COMPLETED|Part 1-Open Label Dose Escalation||6
8683640|NCT03124459|21436443|P2|COMPLETED|Part 1-Open Label Dose Escalation||6
8683641|NCT03124459|21436444|P1|COMPLETED|Part 1-Open Label Dose Escalation||6
8683642|NCT03124459|21436439|P6|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
8683643|NCT03124459|21436440|P5|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
8683644|NCT03124459|21436441|P4|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
8683645|NCT03124459|21436442|P3|STARTED|Part 1-Open Label Dose Escalation||6
8683646|NCT03124459|21436443|P2|STARTED|Part 1-Open Label Dose Escalation||6
8683647|NCT03124459|21436444|P1|STARTED|Part 1-Open Label Dose Escalation||6
8683648|NCT03092024|21436477|P2|NOT COMPLETED|Overall Study||0
8683649|NCT03092024|21436478|P1|NOT COMPLETED|Overall Study||0
8683650|NCT03092024|21436477|P2|COMPLETED|Overall Study||16
8683651|NCT03092024|21436478|P1|COMPLETED|Overall Study||24
8683652|NCT03092024|21436477|P2|STARTED|Overall Study||16
8683653|NCT03092024|21436478|P1|STARTED|Overall Study||24
8683654|NCT03072043|21436507|P3|NOT COMPLETED|Overall Study||9
8683655|NCT03072043|21436508|P2|NOT COMPLETED|Overall Study||0
8683656|NCT03072043|21436509|P1|NOT COMPLETED|Overall Study||0
8683657|NCT03072043|21436507|P3|COMPLETED|Overall Study||40
8683658|NCT03072043|21436508|P2|COMPLETED|Overall Study||3
8683659|NCT03072043|21436509|P1|COMPLETED|Overall Study||3
8683660|NCT03072043|21436507|P3|STARTED|Overall Study||49
8683661|NCT03072043|21436508|P2|STARTED|Overall Study||3
8683662|NCT03072043|21436509|P1|STARTED|Overall Study||3
8683663|NCT02964039|21436524|P3|NOT COMPLETED|Overall Study||5
8683664|NCT02964039|21436525|P2|NOT COMPLETED|Overall Study||1
8683665|NCT02964039|21436526|P1|NOT COMPLETED|Overall Study||4
8683666|NCT02964039|21436524|P3|COMPLETED|Overall Study||13
8683667|NCT02964039|21436525|P2|COMPLETED|Overall Study||17
8683668|NCT02964039|21436526|P1|COMPLETED|Overall Study||14
8683669|NCT02964039|21436524|P3|Received Allocated Intervention|Overall Study||14
8683670|NCT02964039|21436525|P2|Received Allocated Intervention|Overall Study||17
8683671|NCT02964039|21436526|P1|Received Allocated Intervention|Overall Study||15
8683672|NCT02964039|21436524|P3|STARTED|Overall Study||18
8683673|NCT02964039|21436525|P2|STARTED|Overall Study||18
8683674|NCT02964039|21436526|P1|STARTED|Overall Study||18
8683675|NCT02953262|21436553|P4|NOT COMPLETED|Overall Study||3
8683676|NCT02953262|21436554|P3|NOT COMPLETED|Overall Study||3
8683677|NCT02953262|21436555|P2|NOT COMPLETED|Overall Study||6
8683678|NCT02953262|21436556|P1|NOT COMPLETED|Overall Study||3
8683679|NCT02953262|21436553|P4|COMPLETED|Overall Study||67
8683680|NCT02953262|21436554|P3|COMPLETED|Overall Study||65
8683681|NCT02953262|21436555|P2|COMPLETED|Overall Study||63
8683682|NCT02953262|21436556|P1|COMPLETED|Overall Study||65
8683683|NCT02953262|21436553|P4|STARTED|Overall Study||70
8683684|NCT02953262|21436554|P3|STARTED|Overall Study||68
8683685|NCT02953262|21436555|P2|STARTED|Overall Study||69
8683686|NCT02953262|21436556|P1|STARTED|Overall Study||68
8683687|NCT02942966|21436578|P1|NOT COMPLETED|Overall Study||28
8683688|NCT02942966|21436578|P1|COMPLETED|Overall Study|Completed 6-month follow-up|205
8683690|NCT02910466|21436585|P1|NOT COMPLETED|Overall Study||39
8683691|NCT02910466|21436585|P1|COMPLETED|Overall Study||0
8683692|NCT02910466|21436585|P1|Treated|Overall Study||36
8683693|NCT02910466|21436585|P1|Safety Set|Overall Study||39
8683694|NCT02910466|21436585|P1|STARTED|Overall Study||39
8683695|NCT02607930|21436616|P2|NOT COMPLETED|Open-Label Extension Phase||254
8683696|NCT02607930|21436617|P1|NOT COMPLETED|Open-Label Extension Phase||252
8683697|NCT02607930|21436616|P2|COMPLETED|Open-Label Extension Phase||0
8683698|NCT02607930|21436617|P1|COMPLETED|Open-Label Extension Phase||0
8683699|NCT02607930|21436616|P2|STARTED|Open-Label Extension Phase|8 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase|254
8683700|NCT02607930|21436617|P1|STARTED|Open-Label Extension Phase|10 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase|252
8683701|NCT02607930|21436616|P2|NOT COMPLETED|Double-Blinded Phase||53
8683702|NCT02607930|21436617|P1|NOT COMPLETED|Double-Blinded Phase||54
8683703|NCT02607930|21436616|P2|COMPLETED|Double-Blinded Phase||262
8683704|NCT02607930|21436617|P1|COMPLETED|Double-Blinded Phase||262
8683705|NCT02607930|21436616|P2|STARTED|Double-Blinded Phase||315
8683706|NCT02607930|21436617|P1|STARTED|Double-Blinded Phase||316
8683707|NCT02366143|21436666|P3|NOT COMPLETED|Overall Study||400
8683708|NCT02366143|21436667|P2|NOT COMPLETED|Overall Study||402
8683709|NCT02366143|21436668|P1|NOT COMPLETED|Overall Study||400
8683710|NCT02366143|21436666|P3|COMPLETED|Overall Study||0
8683711|NCT02366143|21436667|P2|COMPLETED|Overall Study||0
8683712|NCT02366143|21436668|P1|COMPLETED|Overall Study||0
8683713|NCT02366143|21436666|P3|STARTED|Overall Study||400
8683714|NCT02366143|21436667|P2|STARTED|Overall Study||402
8683715|NCT02366143|21436668|P1|STARTED|Overall Study||400
8683716|NCT02363738|21436733|P2|NOT COMPLETED|Overall Study||5
8683717|NCT02363738|21436734|P1|NOT COMPLETED|Overall Study||8
8683718|NCT02363738|21436733|P2|COMPLETED|Overall Study||26
8683719|NCT02363738|21436734|P1|COMPLETED|Overall Study||21
8683720|NCT02363738|21436733|P2|STARTED|Overall Study||31
8683721|NCT02363738|21436734|P1|STARTED|Overall Study||29
8683722|NCT02361762|21436748|P2|NOT COMPLETED|Overall Study||2
8683723|NCT02361762|21436749|P1|NOT COMPLETED|Overall Study||0
8683724|NCT02361762|21436748|P2|COMPLETED|Overall Study||33
8683725|NCT02361762|21436749|P1|COMPLETED|Overall Study||35
8683726|NCT02361762|21436748|P2|STARTED|Overall Study||35
8683727|NCT02361762|21436749|P1|STARTED|Overall Study||35
8683728|NCT02250651|21436782|P3|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||5
8683729|NCT02250651|21436783|P2|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||4
8683730|NCT02250651|21436784|P1|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||9
8683731|NCT02250651|21436782|P3|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||154
8683732|NCT02250651|21436783|P2|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||152
8683733|NCT02250651|21436784|P1|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||138
8683734|NCT02250651|21436782|P3|STARTED|Treatment Period 3 (Week 32 to Week 52)||159
8683735|NCT02250651|21436783|P2|STARTED|Treatment Period 3 (Week 32 to Week 52)||156
8683736|NCT02250651|21436784|P1|STARTED|Treatment Period 3 (Week 32 to Week 52)||147
8683737|NCT02250651|21436782|P3|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||5
8683738|NCT02250651|21436783|P2|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
8683739|NCT02250651|21436784|P1|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
8683740|NCT02250651|21436782|P3|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||160
8683741|NCT02250651|21436783|P2|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||162
8683742|NCT02250651|21436784|P1|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||159
8683743|NCT02250651|21436782|P3|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
8683744|NCT02250651|21436783|P2|STARTED|Treatment Period 2 (Week 16 to Week 31)||168
8683745|NCT02250651|21436784|P1|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
8683746|NCT02250651|21436782|P3|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||11
8683747|NCT02250651|21436783|P2|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||6
8683748|NCT02250651|21436784|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||4
8683749|NCT02250651|21436782|P3|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||165
8683750|NCT02250651|21436783|P2|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||170
8683751|NCT02250651|21436784|P1|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||172
8683752|NCT02250651|21436782|P3|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||173
8683753|NCT02250651|21436783|P2|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||175
8683754|NCT02250651|21436784|P1|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||176
8683755|NCT02250651|21436782|P3|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
8683756|NCT02250651|21436783|P2|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
8683757|NCT02250651|21436784|P1|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
8683758|NCT02133742|21436813|P1|NOT COMPLETED|Period 2:Dose Expansion Phase (1344days)||52
8683759|NCT02133742|21436813|P1|COMPLETED|Period 2:Dose Expansion Phase (1344days)||0
8683760|NCT02133742|21436813|P1|STARTED|Period 2:Dose Expansion Phase (1344days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52
8683761|NCT02133742|21436813|P1|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0
8683762|NCT02133742|21436813|P1|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11
8683763|NCT02133742|21436813|P1|STARTED|Period 1: Dose Finding Phase (6 Months)||11
8683770|NCT01959464|21436877|P2|NOT COMPLETED|Overall Study||0
8683771|NCT01959464|21436878|P1|NOT COMPLETED|Overall Study||1
8683772|NCT01959464|21436877|P2|COMPLETED|Overall Study||10
8683773|NCT01959464|21436878|P1|COMPLETED|Overall Study||9
8683774|NCT01959464|21436877|P2|STARTED|Overall Study||10
8683775|NCT01959464|21436878|P1|STARTED|Overall Study||10
8683782|NCT01750879|21436928|P2|NOT COMPLETED|Overall Study||3
8683783|NCT01750879|21436929|P1|NOT COMPLETED|Overall Study||10
8683784|NCT01750879|21436928|P2|COMPLETED|Overall Study||8
8683785|NCT01750879|21436929|P1|COMPLETED|Overall Study||20
8683786|NCT01750879|21436928|P2|DBPCFC3|Overall Study||0
8683787|NCT01750879|21436929|P1|DBPCFC3|Overall Study||20
8683788|NCT01750879|21436928|P2|DBPCFC2|Overall Study||8
8683789|NCT01750879|21436929|P1|DBPCFC2|Overall Study||20
8683790|NCT01750879|21436928|P2|STARTED|Overall Study||11
8683791|NCT01750879|21436929|P1|STARTED|Overall Study||30
8683792|NCT01729494|21436958|P3|NOT COMPLETED|Overall Study||11
8683793|NCT01729494|21436959|P2|NOT COMPLETED|Overall Study||11
8683794|NCT01729494|21436960|P1|NOT COMPLETED|Overall Study||10
8683795|NCT01729494|21436958|P3|COMPLETED|Overall Study||94
8683796|NCT01729494|21436959|P2|COMPLETED|Overall Study||93
8683797|NCT01729494|21436960|P1|COMPLETED|Overall Study||97
8683798|NCT01729494|21436958|P3|STARTED|Overall Study||105
8683799|NCT01729494|21436959|P2|STARTED|Overall Study||104
8683800|NCT01729494|21436960|P1|STARTED|Overall Study||107
8683801|NCT01222247|21437030|P2|NOT COMPLETED|Overall Study||2
8683802|NCT01222247|21437031|P1|NOT COMPLETED|Overall Study||2
8683803|NCT01222247|21437030|P2|COMPLETED|Overall Study||1400
8683804|NCT01222247|21437031|P1|COMPLETED|Overall Study||1427
8683805|NCT01222247|21437030|P2|Did Not Receive Assigned Medication|Overall Study||5
8683806|NCT01222247|21437031|P1|Did Not Receive Assigned Medication|Overall Study||1
8683807|NCT01222247|21437030|P2|Received 1 Dose|Overall Study||571
8683808|NCT01222247|21437031|P1|Received 1 Dose|Overall Study||568
8683809|NCT01222247|21437030|P2|Received 2 Doses|Overall Study||826
8683810|NCT01222247|21437031|P1|Received 2 Doses|Overall Study||860
8683811|NCT01222247|21437030|P2|STARTED|Overall Study||1402
8683812|NCT01222247|21437031|P1|STARTED|Overall Study||1429
8683822|NCT01063517|21437114|P2|NOT COMPLETED|Overall Study||60
8683823|NCT01063517|21437115|P1|NOT COMPLETED|Overall Study||58
8683824|NCT01063517|21437114|P2|COMPLETED|Overall Study||2
8683825|NCT01063517|21437115|P1|COMPLETED|Overall Study||4
8683826|NCT01063517|21437114|P2|Received Randomised Treatment|Overall Study||62
8683827|NCT01063517|21437115|P1|Received Randomised Treatment|Overall Study||61
8683828|NCT01063517|21437114|P2|STARTED|Overall Study||62
8683829|NCT01063517|21437115|P1|STARTED|Overall Study||62
8683830|NCT00952718|21437155|P2|NOT COMPLETED|Overall Study||6
8683831|NCT00952718|21437156|P1|NOT COMPLETED|Overall Study||6
8683832|NCT00952718|21437155|P2|COMPLETED|Overall Study||13
8683833|NCT00952718|21437156|P1|COMPLETED|Overall Study||13
8683834|NCT00952718|21437155|P2|STARTED|Overall Study||19
8683835|NCT00952718|21437156|P1|STARTED|Overall Study||19
8683836|NCT00777829|21437166|P2|NOT COMPLETED|Overall Study||2
8683837|NCT00777829|21437167|P1|NOT COMPLETED|Overall Study||0
8683838|NCT00777829|21437166|P2|COMPLETED|Overall Study||13
8683839|NCT00777829|21437167|P1|COMPLETED|Overall Study||15
8683840|NCT00777829|21437166|P2|Study Orientation|Overall Study||13
8683841|NCT00777829|21437167|P1|Study Orientation|Overall Study||15
8683842|NCT00777829|21437166|P2|STARTED|Overall Study||15
8683843|NCT00777829|21437167|P1|STARTED|Overall Study||15
8683844|NCT00742027|21437175|P1|NOT COMPLETED|Overall Study||129
8683845|NCT00742027|21437175|P1|COMPLETED|Overall Study||0
8683846|NCT00742027|21437175|P1|STARTED|Overall Study||129
8683847|NCT00441350|21437191|P6|NOT COMPLETED|Phase B: Week 8 to Week 16||2
8683848|NCT00441350|21437192|P5|NOT COMPLETED|Phase B: Week 8 to Week 16||3
8683849|NCT00441350|21437193|P4|NOT COMPLETED|Phase B: Week 8 to Week 16||2
8683850|NCT00441350|21437194|P3|NOT COMPLETED|Phase B: Week 8 to Week 16||1
8683851|NCT00441350|21437195|P2|NOT COMPLETED|Phase B: Week 8 to Week 16||0
8683852|NCT00441350|21437196|P1|NOT COMPLETED|Phase B: Week 8 to Week 16||0
8683853|NCT00441350|21437191|P6|COMPLETED|Phase B: Week 8 to Week 16||186
8683854|NCT00441350|21437192|P5|COMPLETED|Phase B: Week 8 to Week 16||333
8683855|NCT00441350|21437193|P4|COMPLETED|Phase B: Week 8 to Week 16||137
8683856|NCT00441350|21437194|P3|COMPLETED|Phase B: Week 8 to Week 16||128
8683857|NCT00441350|21437195|P2|COMPLETED|Phase B: Week 8 to Week 16||0
8683858|NCT00441350|21437196|P1|COMPLETED|Phase B: Week 8 to Week 16||0
8683859|NCT00441350|21437191|P6|STARTED|Phase B: Week 8 to Week 16||188
8683860|NCT00441350|21437192|P5|STARTED|Phase B: Week 8 to Week 16||336
8683861|NCT00441350|21437193|P4|STARTED|Phase B: Week 8 to Week 16||139
8683862|NCT00441350|21437194|P3|STARTED|Phase B: Week 8 to Week 16||129
8683863|NCT00441350|21437195|P2|STARTED|Phase B: Week 8 to Week 16||0
8683864|NCT00441350|21437196|P1|STARTED|Phase B: Week 8 to Week 16||0
8683865|NCT00441350|21437191|P6|NOT COMPLETED|Phase A: Randomization to Week 8||0
8683866|NCT00441350|21437192|P5|NOT COMPLETED|Phase A: Randomization to Week 8||0
8683867|NCT00441350|21437193|P4|NOT COMPLETED|Phase A: Randomization to Week 8||0
8683868|NCT00441350|21437194|P3|NOT COMPLETED|Phase A: Randomization to Week 8||0
8683869|NCT00441350|21437195|P2|NOT COMPLETED|Phase A: Randomization to Week 8||37
8683870|NCT00441350|21437196|P1|NOT COMPLETED|Phase A: Randomization to Week 8||17
8683871|NCT00441350|21437191|P6|COMPLETED|Phase A: Randomization to Week 8||0
8683872|NCT00441350|21437192|P5|COMPLETED|Phase A: Randomization to Week 8||0
8683873|NCT00441350|21437193|P4|COMPLETED|Phase A: Randomization to Week 8||0
8683874|NCT00441350|21437194|P3|COMPLETED|Phase A: Randomization to Week 8||0
8683875|NCT00441350|21437195|P2|COMPLETED|Phase A: Randomization to Week 8||524
8683876|NCT00441350|21437196|P1|COMPLETED|Phase A: Randomization to Week 8||268
8683877|NCT00441350|21437191|P6|STARTED|Phase A: Randomization to Week 8||0
8683878|NCT00441350|21437192|P5|STARTED|Phase A: Randomization to Week 8||0
8683879|NCT00441350|21437193|P4|STARTED|Phase A: Randomization to Week 8||0
8683880|NCT00441350|21437194|P3|STARTED|Phase A: Randomization to Week 8||0
8683881|NCT00441350|21437195|P2|STARTED|Phase A: Randomization to Week 8||561
8683882|NCT00441350|21437196|P1|STARTED|Phase A: Randomization to Week 8||285
8683883|NCT00359294|21437221|P5|NOT COMPLETED|Overall Study||3
8683884|NCT00359294|21437222|P4|NOT COMPLETED|Overall Study||4
8683885|NCT00359294|21437223|P3|NOT COMPLETED|Overall Study||3
8683886|NCT00359294|21437224|P2|NOT COMPLETED|Overall Study||1
8683887|NCT00359294|21437225|P1|NOT COMPLETED|Overall Study||1
8683888|NCT00359294|21437221|P5|COMPLETED|Overall Study||0
8683889|NCT00359294|21437222|P4|COMPLETED|Overall Study||0
8683890|NCT00359294|21437223|P3|COMPLETED|Overall Study||0
8683891|NCT00359294|21437224|P2|COMPLETED|Overall Study||0
8683892|NCT00359294|21437225|P1|COMPLETED|Overall Study||0
8683893|NCT00359294|21437221|P5|STARTED|Overall Study||3
8683894|NCT00359294|21437222|P4|STARTED|Overall Study||4
8683895|NCT00359294|21437223|P3|STARTED|Overall Study||3
8683896|NCT00359294|21437224|P2|STARTED|Overall Study||1
8683897|NCT00359294|21437225|P1|STARTED|Overall Study||1
8683898|NCT00200902|21437241|P3|NOT COMPLETED|Overall Study||8
8683899|NCT00200902|21437242|P2|NOT COMPLETED|Overall Study||3
8683900|NCT00200902|21437243|P1|NOT COMPLETED|Overall Study||10
8683901|NCT00200902|21437241|P3|COMPLETED|Overall Study||12
8683902|NCT00200902|21437242|P2|COMPLETED|Overall Study||26
8683903|NCT00200902|21437243|P1|COMPLETED|Overall Study||29
8683904|NCT00200902|21437241|P3|STARTED|Overall Study||20
8683905|NCT00200902|21437242|P2|STARTED|Overall Study||29
8683906|NCT00200902|21437243|P1|STARTED|Overall Study||39
8683907|NCT00116142|21437259|P2|NOT COMPLETED|Overall Study||20
8683908|NCT00116142|21437260|P1|NOT COMPLETED|Overall Study||19
8683909|NCT00116142|21437259|P2|COMPLETED|Overall Study||155
8683910|NCT00116142|21437260|P1|COMPLETED|Overall Study||156
8683911|NCT00116142|21437259|P2|Treated|Overall Study||171
8683912|NCT00116142|21437260|P1|Treated|Overall Study||174
8683913|NCT00116142|21437259|P2|STARTED|Overall Study||175
8683914|NCT00116142|21437260|P1|STARTED|Overall Study||175
8683915|NCT03968978|21437276|P2|NOT COMPLETED|Overall Study||0
8683916|NCT03968978|21437277|P1|NOT COMPLETED|Overall Study||1
8683917|NCT03968978|21437276|P2|COMPLETED|Overall Study||105
8683918|NCT03968978|21437277|P1|COMPLETED|Overall Study||110
8683919|NCT03968978|21437276|P2|STARTED|Overall Study||105
8683920|NCT03968978|21437277|P1|STARTED|Overall Study||111
8683921|NCT03869333|21437297|P4|NOT COMPLETED|Overall Study||0
8683922|NCT03869333|21437298|P3|NOT COMPLETED|Overall Study||0
8683923|NCT03869333|21437299|P2|NOT COMPLETED|Overall Study||1
8683924|NCT03869333|21437300|P1|NOT COMPLETED|Overall Study||2
8683925|NCT03869333|21437297|P4|COMPLETED|Overall Study||12
8683926|NCT03869333|21437298|P3|COMPLETED|Overall Study||16
8683927|NCT03869333|21437299|P2|COMPLETED|Overall Study||15
8683928|NCT03869333|21437300|P1|COMPLETED|Overall Study||12
8683929|NCT03869333|21437297|P4|Received Third Dose|Overall Study||11
8683930|NCT03869333|21437298|P3|Received Third Dose|Overall Study||16
8683931|NCT03869333|21437299|P2|Received Third Dose|Overall Study||15
8683932|NCT03869333|21437300|P1|Received Third Dose|Overall Study||13
8683933|NCT03869333|21437297|P4|Received Second Dose|Overall Study||12
8683934|NCT03869333|21437298|P3|Received Second Dose|Overall Study||16
8683935|NCT03869333|21437299|P2|Received Second Dose|Overall Study||15
8683936|NCT03869333|21437300|P1|Received Second Dose|Overall Study||13
8683937|NCT03869333|21437297|P4|Received First Dose|Overall Study||12
8683938|NCT03869333|21437298|P3|Received First Dose|Overall Study||16
8683939|NCT03869333|21437299|P2|Received First Dose|Overall Study||16
8683940|NCT03869333|21437300|P1|Received First Dose|Overall Study||14
8683941|NCT03869333|21437297|P4|STARTED|Overall Study||12
8683942|NCT03869333|21437298|P3|STARTED|Overall Study||16
8683943|NCT03869333|21437299|P2|STARTED|Overall Study||16
8683944|NCT03869333|21437300|P1|STARTED|Overall Study||14
8683945|NCT03820024|21437376|P2|NOT COMPLETED|Overall Study||2
8683946|NCT03820024|21437377|P1|NOT COMPLETED|Overall Study||1
8683947|NCT03820024|21437376|P2|COMPLETED|Overall Study||18
8683948|NCT03820024|21437377|P1|COMPLETED|Overall Study||18
8683949|NCT03820024|21437376|P2|STARTED|Overall Study||20
8683950|NCT03820024|21437377|P1|STARTED|Overall Study||19
8683951|NCT03760796|21437385|P2|NOT COMPLETED|Overall Study||0
8683952|NCT03760796|21437386|P1|NOT COMPLETED|Overall Study||0
8683953|NCT03760796|21437385|P2|COMPLETED|Overall Study||864
8683954|NCT03760796|21437386|P1|COMPLETED|Overall Study||200
8683955|NCT03760796|21437385|P2|STARTED|Overall Study||864
8683956|NCT03760796|21437386|P1|STARTED|Overall Study||200
8683957|NCT03589469|21437414|P1|NOT COMPLETED|Overall Study||145
8683958|NCT03589469|21437414|P1|COMPLETED|Overall Study||0
8683959|NCT03589469|21437414|P1|Received Treatment|Overall Study||145
8683960|NCT03589469|21437414|P1|STARTED|Overall Study||145
8683961|NCT03303092|21437441|P3|NOT COMPLETED|Overall Study||5
8683962|NCT03303092|21437442|P2|NOT COMPLETED|Overall Study||6
8683963|NCT03303092|21437443|P1|NOT COMPLETED|Overall Study||3
8683964|NCT03303092|21437441|P3|COMPLETED|Overall Study||112
8683965|NCT03303092|21437442|P2|COMPLETED|Overall Study||113
8683966|NCT03303092|21437443|P1|COMPLETED|Overall Study||118
8683967|NCT03303092|21437441|P3|STARTED|Overall Study||117
8683968|NCT03303092|21437442|P2|STARTED|Overall Study||119
8683969|NCT03303092|21437443|P1|STARTED|Overall Study||121
8683970|NCT03285308|21437465|P2|NOT COMPLETED|Overall Study||23
8683971|NCT03285308|21437466|P1|NOT COMPLETED|Overall Study||20
8683972|NCT03285308|21437465|P2|COMPLETED|Overall Study||146
8683973|NCT03285308|21437466|P1|COMPLETED|Overall Study||147
8683974|NCT03285308|21437465|P2|Safety Population|Overall Study||163
8683975|NCT03285308|21437466|P1|Safety Population|Overall Study||163
8683976|NCT03285308|21437465|P2|STARTED|Overall Study||169
8683977|NCT03285308|21437466|P1|STARTED|Overall Study||167
8683978|NCT03282123|21437493|P1|NOT COMPLETED|Overall Study||5
8683979|NCT03282123|21437493|P1|COMPLETED|Overall Study||33
8683980|NCT03282123|21437493|P1|STARTED|Overall Study||38
8683981|NCT03165955|21437498|P1|NOT COMPLETED|Treatment||8
8683982|NCT03165955|21437498|P1|COMPLETED|Treatment||20
8683983|NCT03165955|21437498|P1|STARTED|Treatment||28
8683984|NCT03165955|21437498|P1|NOT COMPLETED|Screening/Baseline||3
8683985|NCT03165955|21437498|P1|COMPLETED|Screening/Baseline||28
8683986|NCT03165955|21437498|P1|STARTED|Screening/Baseline||31
8684002|NCT03093246|21437634|P2|NOT COMPLETED|Overall Study||0
8684003|NCT03093246|21437635|P1|NOT COMPLETED|Overall Study||0
8684004|NCT03093246|21437634|P2|COMPLETED|Overall Study||19
8684005|NCT03093246|21437635|P1|COMPLETED|Overall Study||19
8684006|NCT03093246|21437634|P2|STARTED|Overall Study||19
8684007|NCT03093246|21437635|P1|STARTED|Overall Study||19
8684008|NCT03064763|21437645|P1|NOT COMPLETED|Overall Study||18
8684009|NCT03064763|21437645|P1|COMPLETED|Overall Study||0
8684010|NCT03064763|21437645|P1|Received Treatment|Overall Study||18
8684011|NCT03064763|21437645|P1|STARTED|Overall Study||18
8684012|NCT03033511|21437652|P2|NOT COMPLETED|Overall Study||0
8684013|NCT03033511|21437653|P1|NOT COMPLETED|Overall Study||0
8684014|NCT03033511|21437652|P2|COMPLETED|Overall Study||372
8684015|NCT03033511|21437653|P1|COMPLETED|Overall Study||376
8684016|NCT03033511|21437652|P2|STARTED|Overall Study||372
8684017|NCT03033511|21437653|P1|STARTED|Overall Study||376
8684018|NCT02869295|21437668|P5|NOT COMPLETED|Overall Study||1
8684019|NCT02869295|21437669|P4|NOT COMPLETED|Overall Study||6
8684020|NCT02869295|21437670|P3|NOT COMPLETED|Overall Study||6
8684021|NCT02869295|21437671|P2|NOT COMPLETED|Overall Study||11
8684022|NCT02869295|21437672|P1|NOT COMPLETED|Overall Study||4
8684023|NCT02869295|21437668|P5|COMPLETED|Overall Study||0
8684024|NCT02869295|21437669|P4|COMPLETED|Overall Study||0
8684025|NCT02869295|21437670|P3|COMPLETED|Overall Study||0
8684026|NCT02869295|21437671|P2|COMPLETED|Overall Study||0
8684027|NCT02869295|21437672|P1|COMPLETED|Overall Study||0
8684028|NCT02869295|21437668|P5|STARTED|Overall Study||1
8684029|NCT02869295|21437669|P4|STARTED|Overall Study||6
8684030|NCT02869295|21437670|P3|STARTED|Overall Study||6
8684031|NCT02869295|21437671|P2|STARTED|Overall Study||11
8684032|NCT02869295|21437672|P1|STARTED|Overall Study||4
8684033|NCT02855164|21437697|P8|NOT COMPLETED|Part C (Randomized Set)||7
8684034|NCT02855164|21437698|P7|NOT COMPLETED|Part C (Randomized Set)||14
8684035|NCT02855164|21437699|P6|NOT COMPLETED|Part C (Randomized Set)||12
8684036|NCT02855164|21437700|P5|NOT COMPLETED|Part C (Randomized Set)||0
8684037|NCT02855164|21437701|P4|NOT COMPLETED|Part C (Randomized Set)||0
8684038|NCT02855164|21437702|P3|NOT COMPLETED|Part C (Randomized Set)||0
8684039|NCT02855164|21437703|P2|NOT COMPLETED|Part C (Randomized Set)||0
8684040|NCT02855164|21437704|P1|NOT COMPLETED|Part C (Randomized Set)||0
8684041|NCT02855164|21437697|P8|COMPLETED|Part C (Randomized Set)||44
8684042|NCT02855164|21437698|P7|COMPLETED|Part C (Randomized Set)||37
8684043|NCT02855164|21437699|P6|COMPLETED|Part C (Randomized Set)||38
8684044|NCT02855164|21437700|P5|COMPLETED|Part C (Randomized Set)||0
8684045|NCT02855164|21437701|P4|COMPLETED|Part C (Randomized Set)||0
8684046|NCT02855164|21437702|P3|COMPLETED|Part C (Randomized Set)||0
8684047|NCT02855164|21437703|P2|COMPLETED|Part C (Randomized Set)||0
8684048|NCT02855164|21437704|P1|COMPLETED|Part C (Randomized Set)||0
8684049|NCT02855164|21437697|P8|STARTED|Part C (Randomized Set)||51
8684050|NCT02855164|21437698|P7|STARTED|Part C (Randomized Set)||51
8684051|NCT02855164|21437699|P6|STARTED|Part C (Randomized Set)||50
8684052|NCT02855164|21437700|P5|STARTED|Part C (Randomized Set)||0
8684053|NCT02855164|21437701|P4|STARTED|Part C (Randomized Set)||0
8684054|NCT02855164|21437702|P3|STARTED|Part C (Randomized Set)||0
8684055|NCT02855164|21437703|P2|STARTED|Part C (Randomized Set)||0
8684056|NCT02855164|21437704|P1|STARTED|Part C (Randomized Set)||0
8684057|NCT02855164|21437697|P8|NOT COMPLETED|Parts A + B (Randomized Set)||0
8684058|NCT02855164|21437698|P7|NOT COMPLETED|Parts A + B (Randomized Set)||0
8684059|NCT02855164|21437699|P6|NOT COMPLETED|Parts A + B (Randomized Set)||0
8684060|NCT02855164|21437700|P5|NOT COMPLETED|Parts A + B (Randomized Set)||1
8684061|NCT02855164|21437701|P4|NOT COMPLETED|Parts A + B (Randomized Set)||8
8684062|NCT02855164|21437702|P3|NOT COMPLETED|Parts A + B (Randomized Set)||1
8684063|NCT02855164|21437703|P2|NOT COMPLETED|Parts A + B (Randomized Set)||0
8684064|NCT02855164|21437704|P1|NOT COMPLETED|Parts A + B (Randomized Set)||0
8684065|NCT02855164|21437697|P8|COMPLETED|Parts A + B (Randomized Set)||0
8684066|NCT02855164|21437698|P7|COMPLETED|Parts A + B (Randomized Set)||0
8684067|NCT02855164|21437699|P6|COMPLETED|Parts A + B (Randomized Set)||0
8684068|NCT02855164|21437700|P5|COMPLETED|Parts A + B (Randomized Set)||45
8684069|NCT02855164|21437701|P4|COMPLETED|Parts A + B (Randomized Set)||77
8684070|NCT02855164|21437702|P3|COMPLETED|Parts A + B (Randomized Set)||36
8684071|NCT02855164|21437703|P2|COMPLETED|Parts A + B (Randomized Set)||16
8684072|NCT02855164|21437704|P1|COMPLETED|Parts A + B (Randomized Set)||14
8684073|NCT02855164|21437697|P8|STARTED|Parts A + B (Randomized Set)||0
8684074|NCT02855164|21437698|P7|STARTED|Parts A + B (Randomized Set)||0
8684075|NCT02855164|21437699|P6|STARTED|Parts A + B (Randomized Set)||0
8684076|NCT02855164|21437700|P5|STARTED|Parts A + B (Randomized Set)||46
8684077|NCT02855164|21437701|P4|STARTED|Parts A + B (Randomized Set)||85
8684078|NCT02855164|21437702|P3|STARTED|Parts A + B (Randomized Set)||37
8684079|NCT02855164|21437703|P2|STARTED|Parts A + B (Randomized Set)||16
8684080|NCT02855164|21437704|P1|STARTED|Parts A + B (Randomized Set)||14
8684081|NCT02709109|21437863|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
8684082|NCT02709109|21437864|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||3
8684083|NCT02709109|21437865|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||4
8684084|NCT02709109|21437866|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||2
8684085|NCT02709109|21437863|P4|COMPLETED|Treatment Period 2 (28 Days)||24
8684086|NCT02709109|21437864|P3|COMPLETED|Treatment Period 2 (28 Days)||15
8684087|NCT02709109|21437865|P2|COMPLETED|Treatment Period 2 (28 Days)||36
8684088|NCT02709109|21437866|P1|COMPLETED|Treatment Period 2 (28 Days)||41
8684089|NCT02709109|21437863|P4|STARTED|Treatment Period 2 (28 Days)||24
8684090|NCT02709109|21437864|P3|STARTED|Treatment Period 2 (28 Days)||18
8684091|NCT02709109|21437865|P2|STARTED|Treatment Period 2 (28 Days)||40
8684092|NCT02709109|21437866|P1|STARTED|Treatment Period 2 (28 Days)||43
8684093|NCT02709109|21437863|P4|NOT COMPLETED|Washout Period (28 Days)||0
8684094|NCT02709109|21437864|P3|NOT COMPLETED|Washout Period (28 Days)||3
8684095|NCT02709109|21437865|P2|NOT COMPLETED|Washout Period (28 Days)||2
8684096|NCT02709109|21437866|P1|NOT COMPLETED|Washout Period (28 Days)||2
8684097|NCT02709109|21437863|P4|COMPLETED|Washout Period (28 Days)||24
8684098|NCT02709109|21437864|P3|COMPLETED|Washout Period (28 Days)||18
8684099|NCT02709109|21437865|P2|COMPLETED|Washout Period (28 Days)||40
8684100|NCT02709109|21437866|P1|COMPLETED|Washout Period (28 Days)||43
8684101|NCT02709109|21437863|P4|STARTED|Washout Period (28 Days)||24
8684102|NCT02709109|21437864|P3|STARTED|Washout Period (28 Days)||21
8684103|NCT02709109|21437865|P2|STARTED|Washout Period (28 Days)||42
8684104|NCT02709109|21437866|P1|STARTED|Washout Period (28 Days)||45
8684105|NCT02709109|21437863|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
8684106|NCT02709109|21437864|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
8684107|NCT02709109|21437865|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||5
8684108|NCT02709109|21437866|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||4
8684109|NCT02709109|21437863|P4|COMPLETED|Treatment Period 1 (28 Days)||24
8684110|NCT02709109|21437864|P3|COMPLETED|Treatment Period 1 (28 Days)||21
8684111|NCT02709109|21437865|P2|COMPLETED|Treatment Period 1 (28 Days)||42
8684112|NCT02709109|21437866|P1|COMPLETED|Treatment Period 1 (28 Days)||45
8684113|NCT02709109|21437863|P4|STARTED|Treatment Period 1 (28 Days)||24
8684114|NCT02709109|21437864|P3|STARTED|Treatment Period 1 (28 Days)||22
8684115|NCT02709109|21437865|P2|STARTED|Treatment Period 1 (28 Days)||47
8684116|NCT02709109|21437866|P1|STARTED|Treatment Period 1 (28 Days)||49
8684117|NCT02550652|21437886|P2|NOT COMPLETED|Overall Study||21
8684118|NCT02550652|21437887|P1|NOT COMPLETED|Overall Study||21
8684119|NCT02550652|21437886|P2|COMPLETED|Overall Study||41
8684120|NCT02550652|21437887|P1|COMPLETED|Overall Study||42
8684121|NCT02550652|21437886|P2|STARTED|Overall Study||62
8684122|NCT02550652|21437887|P1|STARTED|Overall Study||63
8684123|NCT02420821|21437931|P2|NOT COMPLETED|Overall Study||137
8684124|NCT02420821|21437932|P1|NOT COMPLETED|Overall Study||168
8684125|NCT02420821|21437931|P2|COMPLETED|Overall Study||317
8684126|NCT02420821|21437932|P1|COMPLETED|Overall Study||293
8684127|NCT02420821|21437931|P2|STARTED|Overall Study||454
8684128|NCT02420821|21437932|P1|STARTED|Overall Study||461
8684129|NCT02409368|21438003|P3|NOT COMPLETED|Overall Study||99
8684130|NCT02409368|21438004|P2|NOT COMPLETED|Overall Study||489
8684131|NCT02409368|21438005|P1|NOT COMPLETED|Overall Study||148
8684132|NCT02409368|21438003|P3|COMPLETED|Overall Study||4
8684133|NCT02409368|21438004|P2|COMPLETED|Overall Study||45
8684134|NCT02409368|21438005|P1|COMPLETED|Overall Study||25
8684135|NCT02409368|21438003|P3|STARTED|Overall Study||103
8684136|NCT02409368|21438004|P2|STARTED|Overall Study||534
8684137|NCT02409368|21438005|P1|STARTED|Overall Study||173
8684138|NCT02405325|21438031|P2|NOT COMPLETED|Overall Study||34
8684139|NCT02405325|21438032|P1|NOT COMPLETED|Overall Study||64
8684140|NCT02405325|21438031|P2|COMPLETED|Overall Study||175
8684141|NCT02405325|21438032|P1|COMPLETED|Overall Study||203
8684142|NCT02405325|21438031|P2|STARTED|Overall Study||209
8684143|NCT02405325|21438032|P1|STARTED|Overall Study||267
8684144|NCT02378714|21438042|P4|NOT COMPLETED|Overall Study||32
8684145|NCT02378714|21438043|P3|NOT COMPLETED|Overall Study||30
8684146|NCT02378714|21438044|P2|NOT COMPLETED|Overall Study||39
8684147|NCT02378714|21438045|P1|NOT COMPLETED|Overall Study||29
8684148|NCT02378714|21438042|P4|COMPLETED|Overall Study||51
8684149|NCT02378714|21438043|P3|COMPLETED|Overall Study||51
8684150|NCT02378714|21438044|P2|COMPLETED|Overall Study||29
8684151|NCT02378714|21438045|P1|COMPLETED|Overall Study||39
8684152|NCT02378714|21438042|P4|STARTED|Overall Study||83
8684153|NCT02378714|21438043|P3|STARTED|Overall Study||81
8684154|NCT02378714|21438044|P2|STARTED|Overall Study||68
8684155|NCT02378714|21438045|P1|STARTED|Overall Study||68
8684156|NCT02252042|21438095|P2|NOT COMPLETED|Overall Study||248
8684157|NCT02252042|21438096|P1|NOT COMPLETED|Overall Study||247
8684158|NCT02252042|21438095|P2|COMPLETED|Overall Study||0
8684159|NCT02252042|21438096|P1|COMPLETED|Overall Study||0
8684160|NCT02252042|21438095|P2|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
8684161|NCT02252042|21438096|P1|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
8684162|NCT02252042|21438095|P2|STARTED|Overall Study||248
8684163|NCT02252042|21438096|P1|STARTED|Overall Study||247
8684164|NCT02087423|21438137|P3|NOT COMPLETED|Overall Study||68
8684165|NCT02087423|21438138|P2|NOT COMPLETED|Overall Study||265
8684166|NCT02087423|21438139|P1|NOT COMPLETED|Overall Study||111
8684167|NCT02087423|21438137|P3|COMPLETED|Overall Study||0
8684168|NCT02087423|21438138|P2|COMPLETED|Overall Study||0
8684169|NCT02087423|21438139|P1|COMPLETED|Overall Study||0
8684170|NCT02087423|21438137|P3|Completed 12 Months of Treatment|Overall Study||26
8684171|NCT02087423|21438138|P2|Completed 12 Months of Treatment|Overall Study||60
8684172|NCT02087423|21438139|P1|Completed 12 Months of Treatment|Overall Study||18
8684173|NCT02087423|21438137|P3|STARTED|Overall Study|Treated|68
8684174|NCT02087423|21438138|P2|STARTED|Overall Study|Treated|265
8684175|NCT02087423|21438139|P1|STARTED|Overall Study|Treated|111
8684176|NCT02001064|21438166|P2|NOT COMPLETED|Overall Study||1
8684177|NCT02001064|21438167|P1|NOT COMPLETED|Overall Study||2
8684178|NCT02001064|21438166|P2|COMPLETED|Overall Study||29
8684179|NCT02001064|21438167|P1|COMPLETED|Overall Study||28
8684180|NCT02001064|21438166|P2|STARTED|Overall Study||30
8684181|NCT02001064|21438167|P1|STARTED|Overall Study||30
8684182|NCT01850563|21438179|P2|NOT COMPLETED|Overall Study||0
8684183|NCT01850563|21438180|P1|NOT COMPLETED|Overall Study||18
8684184|NCT01850563|21438179|P2|COMPLETED|Overall Study||19
8684185|NCT01850563|21438180|P1|COMPLETED|Overall Study||4
8684186|NCT01850563|21438179|P2|HBO Treatment Completed|Overall Study||0
8684187|NCT01850563|21438180|P1|HBO Treatment Completed|Overall Study||19
8684188|NCT01850563|21438179|P2|STARTED|Overall Study||19
8684189|NCT01850563|21438180|P1|STARTED|Overall Study||22
8684190|NCT01755091|21438203|P3|NOT COMPLETED|Overall Study||7
8684191|NCT01755091|21438204|P2|NOT COMPLETED|Overall Study||3
8684192|NCT01755091|21438205|P1|NOT COMPLETED|Overall Study||9
8684193|NCT01755091|21438203|P3|COMPLETED|Overall Study||20
8684194|NCT01755091|21438204|P2|COMPLETED|Overall Study||19
8684195|NCT01755091|21438205|P1|COMPLETED|Overall Study||17
8684196|NCT01755091|21438203|P3|STARTED|Overall Study||27
8684197|NCT01755091|21438204|P2|STARTED|Overall Study||22
8684198|NCT01755091|21438205|P1|STARTED|Overall Study||26
8684199|NCT01696929|21438228|P1|NOT COMPLETED|Overall Study||1
8684200|NCT01696929|21438228|P1|COMPLETED|Overall Study||5
8684201|NCT01696929|21438228|P1|STARTED|Overall Study||6
8684202|NCT01618695|21438237|P4|NOT COMPLETED|Extension Phase||97
8684203|NCT01618695|21438238|P3|NOT COMPLETED|Extension Phase||92
8684204|NCT01618695|21438239|P2|NOT COMPLETED|Extension Phase||116
8684205|NCT01618695|21438240|P1|NOT COMPLETED|Extension Phase||95
8684206|NCT01618695|21438237|P4|COMPLETED|Extension Phase||46
8684207|NCT01618695|21438238|P3|COMPLETED|Extension Phase||54
8684208|NCT01618695|21438239|P2|COMPLETED|Extension Phase||40
8684209|NCT01618695|21438240|P1|COMPLETED|Extension Phase||56
8684210|NCT01618695|21438237|P4|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|143
8684211|NCT01618695|21438238|P3|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|146
8684212|NCT01618695|21438239|P2|STARTED|Extension Phase||156
8684213|NCT01618695|21438240|P1|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|151
8684214|NCT01618695|21438237|P4|NOT COMPLETED|Core Phase||36
8684215|NCT01618695|21438238|P3|NOT COMPLETED|Core Phase||30
8684216|NCT01618695|21438239|P2|NOT COMPLETED|Core Phase||20
8684217|NCT01618695|21438240|P1|NOT COMPLETED|Core Phase||25
8684218|NCT01618695|21438237|P4|COMPLETED|Core Phase||144
8684219|NCT01618695|21438238|P3|COMPLETED|Core Phase||147
8684220|NCT01618695|21438239|P2|COMPLETED|Core Phase||156
8684221|NCT01618695|21438240|P1|COMPLETED|Core Phase||152
8684222|NCT01618695|21438237|P4|Treated (Safety Analysis Set)|Core Phase||180
8684223|NCT01618695|21438238|P3|Treated (Safety Analysis Set)|Core Phase||175
8684224|NCT01618695|21438239|P2|Treated (Safety Analysis Set)|Core Phase||176
8684225|NCT01618695|21438240|P1|Treated (Safety Analysis Set)|Core Phase||176
8684226|NCT01618695|21438237|P4|STARTED|Core Phase||180
8684227|NCT01618695|21438238|P3|STARTED|Core Phase||177
8684228|NCT01618695|21438239|P2|STARTED|Core Phase||176
8684229|NCT01618695|21438240|P1|STARTED|Core Phase||177
8684230|NCT01608906|21438263|P1|NOT COMPLETED|Overall Study||39
8684231|NCT01608906|21438263|P1|COMPLETED|Overall Study||113
8684232|NCT01608906|21438263|P1|STARTED|Overall Study||152
8684233|NCT01275365|21438274|P4|NOT COMPLETED|Overall Study||3
8684234|NCT01275365|21438275|P3|NOT COMPLETED|Overall Study||5
8684235|NCT01275365|21438276|P2|NOT COMPLETED|Overall Study||3
8684236|NCT01275365|21438277|P1|NOT COMPLETED|Overall Study||3
8684237|NCT01275365|21438274|P4|COMPLETED|Overall Study||19
8684238|NCT01275365|21438275|P3|COMPLETED|Overall Study||17
8684239|NCT01275365|21438276|P2|COMPLETED|Overall Study||21
8684240|NCT01275365|21438277|P1|COMPLETED|Overall Study||21
8684241|NCT01275365|21438274|P4|STARTED|Overall Study||22
8684242|NCT01275365|21438275|P3|STARTED|Overall Study||22
8684243|NCT01275365|21438276|P2|STARTED|Overall Study||24
8684244|NCT01275365|21438277|P1|STARTED|Overall Study||24
8684245|NCT00925002|21438326|P3|NOT COMPLETED|Overall Study||10
8684246|NCT00925002|21438327|P2|NOT COMPLETED|Overall Study||9
8684247|NCT00925002|21438328|P1|NOT COMPLETED|Overall Study||6
8684248|NCT00925002|21438326|P3|COMPLETED|Overall Study||8
8684249|NCT00925002|21438327|P2|COMPLETED|Overall Study||28
8684250|NCT00925002|21438328|P1|COMPLETED|Overall Study||32
8684251|NCT00925002|21438326|P3|Treated|Overall Study||18
8684252|NCT00925002|21438327|P2|Treated|Overall Study||37
8684253|NCT00925002|21438328|P1|Treated|Overall Study||38
8684254|NCT00925002|21438326|P3|STARTED|Overall Study||18
8684255|NCT00925002|21438327|P2|STARTED|Overall Study||37
8684256|NCT00925002|21438328|P1|STARTED|Overall Study||38
8684257|NCT00860379|21438412|P3|NOT COMPLETED|Overall Study||0
8684258|NCT00860379|21438413|P2|NOT COMPLETED|Overall Study||0
8684259|NCT00860379|21438414|P1|NOT COMPLETED|Overall Study||0
8684260|NCT00860379|21438412|P3|COMPLETED|Overall Study||4
8684261|NCT00860379|21438413|P2|COMPLETED|Overall Study||6
8684262|NCT00860379|21438414|P1|COMPLETED|Overall Study||4
8684263|NCT00860379|21438412|P3|STARTED|Overall Study||4
8684264|NCT00860379|21438413|P2|STARTED|Overall Study||6
8684265|NCT00860379|21438414|P1|STARTED|Overall Study||4
8684266|NCT00378482|21438422|P1|NOT COMPLETED|Overall Study||31
8684267|NCT00378482|21438422|P1|COMPLETED|Overall Study||6
8684268|NCT00378482|21438422|P1|STARTED|Overall Study||37
8684269|NCT00033631|21438433|P2|NOT COMPLETED|Overall Study||15
8684270|NCT00033631|21438434|P1|NOT COMPLETED|Overall Study||18
8684271|NCT00033631|21438433|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
8684272|NCT00033631|21438434|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
8684273|NCT00033631|21438433|P2|STARTED|Overall Study||763
8684274|NCT00033631|21438434|P1|STARTED|Overall Study||769
8684275|NCT04330157|21438456|P1|NOT COMPLETED|Overall Study||7
8684276|NCT04330157|21438456|P1|COMPLETED|Overall Study||43
8684277|NCT04330157|21438456|P1|STARTED|Overall Study||50
8684278|NCT04286412|21438465|P1|NOT COMPLETED|Overall Study||0
8684279|NCT04286412|21438465|P1|COMPLETED|Overall Study||25
8684280|NCT04286412|21438465|P1|STARTED|Overall Study||25
8684281|NCT04202497|21438475|P4|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
8684282|NCT04202497|21438476|P3|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
8684283|NCT04202497|21438477|P2|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
8684284|NCT04202497|21438478|P1|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
8684285|NCT04202497|21438475|P4|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
8684286|NCT04202497|21438476|P3|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
8684287|NCT04202497|21438477|P2|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
8684288|NCT04202497|21438478|P1|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
8684289|NCT04202497|21438475|P4|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
8684290|NCT04202497|21438476|P3|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
8684291|NCT04202497|21438477|P2|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
8684292|NCT04202497|21438478|P1|STARTED|Treatment Period (Day 1 Through Day 2-3)||0
8684293|NCT04202497|21438475|P4|NOT COMPLETED|Baseline Scan (Day-1)||0
8684294|NCT04202497|21438476|P3|NOT COMPLETED|Baseline Scan (Day-1)||0
8684295|NCT04202497|21438477|P2|NOT COMPLETED|Baseline Scan (Day-1)||0
8684296|NCT04202497|21438478|P1|NOT COMPLETED|Baseline Scan (Day-1)||1
8684297|NCT04202497|21438475|P4|COMPLETED|Baseline Scan (Day-1)||0
8684298|NCT04202497|21438476|P3|COMPLETED|Baseline Scan (Day-1)||0
8684299|NCT04202497|21438477|P2|COMPLETED|Baseline Scan (Day-1)||0
8684300|NCT04202497|21438478|P1|COMPLETED|Baseline Scan (Day-1)||6
8684301|NCT04202497|21438475|P4|STARTED|Baseline Scan (Day-1)||0
8684302|NCT04202497|21438476|P3|STARTED|Baseline Scan (Day-1)||0
8684303|NCT04202497|21438477|P2|STARTED|Baseline Scan (Day-1)||0
8684304|NCT04202497|21438478|P1|STARTED|Baseline Scan (Day-1)||7
8684305|NCT04017754|21438521|P2|NOT COMPLETED|Overall Study||0
8684306|NCT04017754|21438522|P1|NOT COMPLETED|Overall Study||0
8684307|NCT04017754|21438521|P2|COMPLETED|Overall Study||185
8684308|NCT04017754|21438522|P1|COMPLETED|Overall Study||267
8684309|NCT04017754|21438521|P2|STARTED|Overall Study||185
8684310|NCT04017754|21438522|P1|STARTED|Overall Study||267
8684317|NCT03811834|21438598|P1|NOT COMPLETED|Period 2 (10 Days)||0
8684318|NCT03811834|21438598|P1|COMPLETED|Period 2 (10 Days)||6
8684319|NCT03811834|21438598|P1|STARTED|Period 2 (10 Days)||6
8684320|NCT03811834|21438598|P1|NOT COMPLETED|Washout Period (9 Days)||0
8684321|NCT03811834|21438598|P1|COMPLETED|Washout Period (9 Days)||6
8684322|NCT03811834|21438598|P1|STARTED|Washout Period (9 Days)||6
8684323|NCT03811834|21438598|P1|NOT COMPLETED|Period 1 ( 7 Days)||1
8684324|NCT03811834|21438598|P1|COMPLETED|Period 1 ( 7 Days)||6
8684325|NCT03811834|21438598|P1|STARTED|Period 1 ( 7 Days)||7
8684332|NCT03738241|21438677|P10|NOT COMPLETED|Overall Study||1
8684333|NCT03738241|21438678|P9|NOT COMPLETED|Overall Study||1
8684334|NCT03738241|21438679|P8|NOT COMPLETED|Overall Study||0
8684335|NCT03738241|21438680|P7|NOT COMPLETED|Overall Study||0
8684336|NCT03738241|21438681|P6|NOT COMPLETED|Overall Study||0
8684337|NCT03738241|21438682|P5|NOT COMPLETED|Overall Study||0
8684338|NCT03738241|21438683|P4|NOT COMPLETED|Overall Study||0
8684339|NCT03738241|21438684|P3|NOT COMPLETED|Overall Study||0
8684340|NCT03738241|21438685|P2|NOT COMPLETED|Overall Study||0
8684341|NCT03738241|21438686|P1|NOT COMPLETED|Overall Study||1
8684342|NCT03738241|21438677|P10|COMPLETED|Overall Study||34
8684343|NCT03738241|21438678|P9|COMPLETED|Overall Study||28
8684344|NCT03738241|21438679|P8|COMPLETED|Overall Study||16
8684345|NCT03738241|21438680|P7|COMPLETED|Overall Study||20
8684346|NCT03738241|21438681|P6|COMPLETED|Overall Study||44
8684347|NCT03738241|21438682|P5|COMPLETED|Overall Study||40
8684348|NCT03738241|21438683|P4|COMPLETED|Overall Study||18
8684349|NCT03738241|21438684|P3|COMPLETED|Overall Study||24
8684350|NCT03738241|21438685|P2|COMPLETED|Overall Study||40
8684351|NCT03738241|21438686|P1|COMPLETED|Overall Study||37
8684352|NCT03738241|21438677|P10|STARTED|Overall Study||35
8684353|NCT03738241|21438678|P9|STARTED|Overall Study||29
8684354|NCT03738241|21438679|P8|STARTED|Overall Study||16
8684355|NCT03738241|21438680|P7|STARTED|Overall Study||20
8684356|NCT03738241|21438681|P6|STARTED|Overall Study||44
8684357|NCT03738241|21438682|P5|STARTED|Overall Study||40
8684358|NCT03738241|21438683|P4|STARTED|Overall Study||18
8684359|NCT03738241|21438684|P3|STARTED|Overall Study||24
8684360|NCT03738241|21438685|P2|STARTED|Overall Study||40
8684361|NCT03738241|21438686|P1|STARTED|Overall Study||38
8684362|NCT03665155|21439001|P3|NOT COMPLETED|Overall Study||0
8684363|NCT03665155|21439002|P2|NOT COMPLETED|Overall Study||0
8684364|NCT03665155|21439003|P1|NOT COMPLETED|Overall Study||0
8684365|NCT03665155|21439001|P3|COMPLETED|Overall Study||1
8684366|NCT03665155|21439002|P2|COMPLETED|Overall Study||7
8684367|NCT03665155|21439003|P1|COMPLETED|Overall Study||3
8684368|NCT03665155|21439001|P3|STARTED|Overall Study||1
8684369|NCT03665155|21439002|P2|STARTED|Overall Study||7
8684370|NCT03665155|21439003|P1|STARTED|Overall Study||3
8684371|NCT03609619|21439011|P2|NOT COMPLETED|Overall Study||6
8684372|NCT03609619|21439012|P1|NOT COMPLETED|Overall Study||10
8684373|NCT03609619|21439011|P2|COMPLETED|Overall Study||49
8684374|NCT03609619|21439012|P1|COMPLETED|Overall Study||44
8684375|NCT03609619|21439011|P2|STARTED|Overall Study||55
8684376|NCT03609619|21439012|P1|STARTED|Overall Study||54
8684377|NCT03556891|21439020|P1|NOT COMPLETED|Overall Study||13
8684378|NCT03556891|21439020|P1|COMPLETED|Overall Study||120
8684379|NCT03556891|21439020|P1|STARTED|Overall Study||133
8684380|NCT03416179|21439031|P4|NOT COMPLETED|Overall Study||162
8684381|NCT03416179|21439032|P3|NOT COMPLETED|Overall Study||163
8684382|NCT03416179|21439033|P2|NOT COMPLETED|Overall Study||203
8684383|NCT03416179|21439034|P1|NOT COMPLETED|Overall Study||201
8684384|NCT03416179|21439031|P4|COMPLETED|Overall Study||0
8684385|NCT03416179|21439032|P3|COMPLETED|Overall Study||0
8684386|NCT03416179|21439033|P2|COMPLETED|Overall Study||0
8684387|NCT03416179|21439034|P1|COMPLETED|Overall Study||0
8684388|NCT03416179|21439031|P4|STARTED|Overall Study||162
8684389|NCT03416179|21439032|P3|STARTED|Overall Study||163
8684390|NCT03416179|21439033|P2|STARTED|Overall Study||203
8684391|NCT03416179|21439034|P1|STARTED|Overall Study||201
8684392|NCT03365791|21439044|P1|NOT COMPLETED|Overall Study||72
8684393|NCT03365791|21439044|P1|COMPLETED|Overall Study||4
8684394|NCT03365791|21439044|P1|Full Analysis Set (FAS)|Overall Study||75
8684395|NCT03365791|21439044|P1|STARTED|Overall Study||76
8684396|NCT03340025|21439059|P2|NOT COMPLETED|Overall Study||2
8684397|NCT03340025|21439060|P1|NOT COMPLETED|Overall Study||2
8684398|NCT03340025|21439059|P2|COMPLETED|Overall Study||7
8684399|NCT03340025|21439060|P1|COMPLETED|Overall Study||9
8684400|NCT03340025|21439059|P2|STARTED|Overall Study||9
8684401|NCT03340025|21439060|P1|STARTED|Overall Study||11
8684402|NCT03299049|21439068|P2|NOT COMPLETED|Overall Study||523
8684403|NCT03299049|21439069|P1|NOT COMPLETED|Overall Study||522
8684404|NCT03299049|21439068|P2|COMPLETED|Overall Study||0
8684405|NCT03299049|21439069|P1|COMPLETED|Overall Study||0
8684406|NCT03299049|21439068|P2|STARTED|Overall Study||523
8684407|NCT03299049|21439069|P1|STARTED|Overall Study||522
8684408|NCT03282682|21439169|P3|NOT COMPLETED|Overall Study||0
8684409|NCT03282682|21439170|P2|NOT COMPLETED|Overall Study||0
8684410|NCT03282682|21439171|P1|NOT COMPLETED|Overall Study||0
8684411|NCT03282682|21439169|P3|COMPLETED|Overall Study||8
8684412|NCT03282682|21439170|P2|COMPLETED|Overall Study||8
8684413|NCT03282682|21439171|P1|COMPLETED|Overall Study||6
8684414|NCT03282682|21439169|P3|STARTED|Overall Study||8
8684415|NCT03282682|21439170|P2|STARTED|Overall Study||8
8684416|NCT03282682|21439171|P1|STARTED|Overall Study||6
8684417|NCT03234374|21439232|P2|NOT COMPLETED|Overall Study||1
8684418|NCT03234374|21439233|P1|NOT COMPLETED|Overall Study||1
8684419|NCT03234374|21439232|P2|COMPLETED|Overall Study||16
8684420|NCT03234374|21439233|P1|COMPLETED|Overall Study||34
8684421|NCT03234374|21439232|P2|STARTED|Overall Study||17
8684422|NCT03234374|21439233|P1|STARTED|Overall Study||35
8684423|NCT03165721|21439256|P3|NOT COMPLETED|Overall Study||0
8684424|NCT03165721|21439257|P2|NOT COMPLETED|Overall Study||0
8684425|NCT03165721|21439258|P1|NOT COMPLETED|Overall Study||4
8684426|NCT03165721|21439256|P3|COMPLETED|Overall Study||1
8684427|NCT03165721|21439257|P2|COMPLETED|Overall Study||1
8684428|NCT03165721|21439258|P1|COMPLETED|Overall Study||3
8684429|NCT03165721|21439256|P3|STARTED|Overall Study||1
8684430|NCT03165721|21439257|P2|STARTED|Overall Study||1
8684431|NCT03165721|21439258|P1|STARTED|Overall Study||7
8684432|NCT03158116|21439284|P1|NOT COMPLETED|Overall Study||0
8684433|NCT03158116|21439284|P1|COMPLETED|Overall Study||5
8684434|NCT03158116|21439284|P1|STARTED|Overall Study||5
8684435|NCT03122223|21439296|P4|NOT COMPLETED|Overall Study||0
8684436|NCT03122223|21439297|P3|NOT COMPLETED|Overall Study||4
8684437|NCT03122223|21439298|P2|NOT COMPLETED|Overall Study||5
8684438|NCT03122223|21439299|P1|NOT COMPLETED|Overall Study||3
8684439|NCT03122223|21439296|P4|COMPLETED|Overall Study||10
8684440|NCT03122223|21439297|P3|COMPLETED|Overall Study||46
8684441|NCT03122223|21439298|P2|COMPLETED|Overall Study||45
8684442|NCT03122223|21439299|P1|COMPLETED|Overall Study||47
8684443|NCT03122223|21439296|P4|Month 12 Immunogenicity Cohort|Overall Study||10
8684444|NCT03122223|21439297|P3|Month 12 Immunogenicity Cohort|Overall Study||46
8684445|NCT03122223|21439298|P2|Month 12 Immunogenicity Cohort|Overall Study||45
8684446|NCT03122223|21439299|P1|Month 12 Immunogenicity Cohort|Overall Study||47
8684447|NCT03122223|21439296|P4|Month 6.5 Immunogenicity Cohort|Overall Study||8
8684448|NCT03122223|21439297|P3|Month 6.5 Immunogenicity Cohort|Overall Study||47
8684449|NCT03122223|21439298|P2|Month 6.5 Immunogenicity Cohort|Overall Study||48
8684450|NCT03122223|21439299|P1|Month 6.5 Immunogenicity Cohort|Overall Study||49
8684451|NCT03122223|21439296|P4|STARTED|Overall Study||10
8684452|NCT03122223|21439297|P3|STARTED|Overall Study||50
8684453|NCT03122223|21439298|P2|STARTED|Overall Study||50
8684454|NCT03122223|21439299|P1|STARTED|Overall Study||50
8684455|NCT03096353|21439355|P2|NOT COMPLETED|Period 2||0
8684456|NCT03096353|21439356|P1|NOT COMPLETED|Period 2||0
8684457|NCT03096353|21439355|P2|COMPLETED|Period 2||12
8684458|NCT03096353|21439356|P1|COMPLETED|Period 2||12
8684459|NCT03096353|21439355|P2|STARTED|Period 2||12
8684460|NCT03096353|21439356|P1|STARTED|Period 2||12
8684461|NCT03096353|21439355|P2|NOT COMPLETED|Period 1||1
8684462|NCT03096353|21439356|P1|NOT COMPLETED|Period 1||3
8684463|NCT03096353|21439355|P2|COMPLETED|Period 1||12
8684464|NCT03096353|21439356|P1|COMPLETED|Period 1||12
8684465|NCT03096353|21439355|P2|STARTED|Period 1||13
8684466|NCT03096353|21439356|P1|STARTED|Period 1||15
8684467|NCT03084471|21439388|P1|NOT COMPLETED|Overall Study||867
8684468|NCT03084471|21439388|P1|COMPLETED|Overall Study||0
8684469|NCT03084471|21439388|P1|STARTED|Overall Study||867
8684482|NCT03038308|21439448|P1|NOT COMPLETED|Overall Study||4
8684483|NCT03038308|21439448|P1|COMPLETED|Overall Study||11
8684484|NCT03038308|21439448|P1|STARTED|Overall Study||15
8684485|NCT03032250|21439455|P2|NOT COMPLETED|Overall Study||0
8684486|NCT03032250|21439456|P1|NOT COMPLETED|Overall Study||0
8684487|NCT03032250|21439455|P2|COMPLETED|Overall Study||18
8684488|NCT03032250|21439456|P1|COMPLETED|Overall Study||17
8684489|NCT03032250|21439455|P2|STARTED|Overall Study||18
8684490|NCT03032250|21439456|P1|STARTED|Overall Study||17
8684491|NCT02966795|21439478|P2|NOT COMPLETED|Overall Study||1
8684492|NCT02966795|21439479|P1|NOT COMPLETED|Overall Study||0
8684493|NCT02966795|21439478|P2|COMPLETED|Overall Study||60
8684494|NCT02966795|21439479|P1|COMPLETED|Overall Study||23
8684495|NCT02966795|21439478|P2|STARTED|Overall Study||61
8684496|NCT02966795|21439479|P1|STARTED|Overall Study||23
8684497|NCT02868229|21439492|P4|NOT COMPLETED|Overall Study||5
8684498|NCT02868229|21439493|P3|NOT COMPLETED|Overall Study||1
8684499|NCT02868229|21439494|P2|NOT COMPLETED|Overall Study||0
8684500|NCT02868229|21439495|P1|NOT COMPLETED|Overall Study||1
8684501|NCT02868229|21439492|P4|COMPLETED|Overall Study||12
8684502|NCT02868229|21439493|P3|COMPLETED|Overall Study||15
8684503|NCT02868229|21439494|P2|COMPLETED|Overall Study||16
8684504|NCT02868229|21439495|P1|COMPLETED|Overall Study||11
8684505|NCT02868229|21439492|P4|Maximum Tolerated Dose (MTD) Population|Overall Study||16
8684506|NCT02868229|21439493|P3|Maximum Tolerated Dose (MTD) Population|Overall Study||16
8684507|NCT02868229|21439494|P2|Maximum Tolerated Dose (MTD) Population|Overall Study||16
8684508|NCT02868229|21439495|P1|Maximum Tolerated Dose (MTD) Population|Overall Study||12
8684509|NCT02868229|21439492|P4|Safety Analysis Population|Overall Study||17
8684510|NCT02868229|21439493|P3|Safety Analysis Population|Overall Study||16
8684511|NCT02868229|21439494|P2|Safety Analysis Population|Overall Study||16
8684512|NCT02868229|21439495|P1|Safety Analysis Population|Overall Study||12
8684513|NCT02868229|21439492|P4|Pharmacokinetic (PK) Population|Overall Study||17
8684514|NCT02868229|21439493|P3|Pharmacokinetic (PK) Population|Overall Study||16
8684515|NCT02868229|21439494|P2|Pharmacokinetic (PK) Population|Overall Study||16
8684516|NCT02868229|21439495|P1|Pharmacokinetic (PK) Population|Overall Study||12
8684517|NCT02868229|21439492|P4|Pharmacodynamic (PD) Population|Overall Study||12
8684518|NCT02868229|21439493|P3|Pharmacodynamic (PD) Population|Overall Study||13
8684519|NCT02868229|21439494|P2|Pharmacodynamic (PD) Population|Overall Study||16
8684520|NCT02868229|21439495|P1|Pharmacodynamic (PD) Population|Overall Study||12
8684521|NCT02868229|21439492|P4|Intent to Treat (ITT) Population|Overall Study||17
8684522|NCT02868229|21439493|P3|Intent to Treat (ITT) Population|Overall Study||16
8684523|NCT02868229|21439494|P2|Intent to Treat (ITT) Population|Overall Study||16
8684524|NCT02868229|21439495|P1|Intent to Treat (ITT) Population|Overall Study||12
8684525|NCT02868229|21439492|P4|STARTED|Overall Study||17
8684526|NCT02868229|21439493|P3|STARTED|Overall Study||16
8684527|NCT02868229|21439494|P2|STARTED|Overall Study||16
8684528|NCT02868229|21439495|P1|STARTED|Overall Study||12
8684529|NCT02835625|21440032|P2|NOT COMPLETED|Overall Study||0
8684530|NCT02835625|21440033|P1|NOT COMPLETED|Overall Study||0
8684531|NCT02835625|21440032|P2|COMPLETED|Overall Study||14719
8684532|NCT02835625|21440033|P1|COMPLETED|Overall Study||14734
8684533|NCT02835625|21440032|P2|STARTED|Overall Study||14719
8684534|NCT02835625|21440033|P1|STARTED|Overall Study||14734
8684535|NCT02810457|21440056|P2|NOT COMPLETED|Overall Study||329
8684536|NCT02810457|21440057|P1|NOT COMPLETED|Overall Study||327
8684537|NCT02810457|21440056|P2|COMPLETED|Overall Study||38
8684538|NCT02810457|21440057|P1|COMPLETED|Overall Study||37
8684539|NCT02810457|21440056|P2|STARTED|Overall Study|366 patients received study treatment|367
8684540|NCT02810457|21440057|P1|STARTED|Overall Study|362 patients received study treatment|364
8684541|NCT02694523|21440079|P7|NOT COMPLETED|Part B||2
8684542|NCT02694523|21440080|P6|NOT COMPLETED|Part B||5
8684543|NCT02694523|21440081|P5|NOT COMPLETED|Part B||4
8684544|NCT02694523|21440082|P4|NOT COMPLETED|Part B||4
8684545|NCT02694523|21440083|P3|NOT COMPLETED|Part B||20
8684546|NCT02694523|21440084|P2|NOT COMPLETED|Part B||0
8684547|NCT02694523|21440085|P1|NOT COMPLETED|Part B||0
8684548|NCT02694523|21440079|P7|COMPLETED|Part B||51
8684549|NCT02694523|21440080|P6|COMPLETED|Part B||51
8684550|NCT02694523|21440081|P5|COMPLETED|Part B||34
8684551|NCT02694523|21440082|P4|COMPLETED|Part B||140
8684552|NCT02694523|21440083|P3|COMPLETED|Part B||274
8684553|NCT02694523|21440084|P2|COMPLETED|Part B||0
8684554|NCT02694523|21440085|P1|COMPLETED|Part B||0
8684555|NCT02694523|21440079|P7|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53
8684556|NCT02694523|21440080|P6|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56
8684557|NCT02694523|21440081|P5|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38
8684558|NCT02694523|21440082|P4|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144
8684559|NCT02694523|21440083|P3|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294
8684560|NCT02694523|21440084|P2|STARTED|Part B||0
8684561|NCT02694523|21440085|P1|STARTED|Part B||0
8684562|NCT02694523|21440079|P7|NOT COMPLETED|Part A||0
8684563|NCT02694523|21440080|P6|NOT COMPLETED|Part A||0
8684564|NCT02694523|21440081|P5|NOT COMPLETED|Part A||0
8684565|NCT02694523|21440082|P4|NOT COMPLETED|Part A||0
8684566|NCT02694523|21440083|P3|NOT COMPLETED|Part A||0
8684567|NCT02694523|21440084|P2|NOT COMPLETED|Part A||7
8684568|NCT02694523|21440085|P1|NOT COMPLETED|Part A||13
8684569|NCT02694523|21440079|P7|COMPLETED|Part A||0
8684570|NCT02694523|21440080|P6|COMPLETED|Part A||0
8684571|NCT02694523|21440081|P5|COMPLETED|Part A||0
8684572|NCT02694523|21440082|P4|COMPLETED|Part A||0
8684573|NCT02694523|21440083|P3|COMPLETED|Part A||0
8684574|NCT02694523|21440084|P2|COMPLETED|Part A||294
8684575|NCT02694523|21440085|P1|COMPLETED|Part A||291
8684576|NCT02694523|21440079|P7|STARTED|Part A||0
8684577|NCT02694523|21440080|P6|STARTED|Part A||0
8684578|NCT02694523|21440081|P5|STARTED|Part A||0
8684579|NCT02694523|21440082|P4|STARTED|Part A||0
8684580|NCT02694523|21440083|P3|STARTED|Part A||0
8684581|NCT02694523|21440084|P2|STARTED|Part A||301
8684582|NCT02694523|21440085|P1|STARTED|Part A||304
8684583|NCT02684370|21440112|P6|NOT COMPLETED|Part B||8
8684584|NCT02684370|21440113|P5|NOT COMPLETED|Part B||5
8684585|NCT02684370|21440114|P4|NOT COMPLETED|Part B||2
8684586|NCT02684370|21440115|P3|NOT COMPLETED|Part B||0
8684587|NCT02684370|21440116|P2|NOT COMPLETED|Part B||0
8684588|NCT02684370|21440117|P1|NOT COMPLETED|Part B||0
8684589|NCT02684370|21440112|P6|COMPLETED|Part B||289
8684590|NCT02684370|21440113|P5|COMPLETED|Part B||94
8684591|NCT02684370|21440114|P4|COMPLETED|Part B||95
8684592|NCT02684370|21440115|P3|COMPLETED|Part B||0
8684593|NCT02684370|21440116|P2|COMPLETED|Part B||0
8684594|NCT02684370|21440117|P1|COMPLETED|Part B||0
8684595|NCT02684370|21440112|P6|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297
8684596|NCT02684370|21440113|P5|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99
8684597|NCT02684370|21440114|P4|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97
8684598|NCT02684370|21440115|P3|STARTED|Part B||0
8684599|NCT02684370|21440116|P2|STARTED|Part B||0
8684600|NCT02684370|21440117|P1|STARTED|Part B||0
8684601|NCT02684370|21440112|P6|NOT COMPLETED|Part A||0
8684602|NCT02684370|21440113|P5|NOT COMPLETED|Part A||0
8684603|NCT02684370|21440114|P4|NOT COMPLETED|Part A||0
8684604|NCT02684370|21440115|P3|NOT COMPLETED|Part A||5
8684605|NCT02684370|21440116|P2|NOT COMPLETED|Part A||1
8684606|NCT02684370|21440117|P1|NOT COMPLETED|Part A||4
8684607|NCT02684370|21440112|P6|COMPLETED|Part A||0
8684608|NCT02684370|21440113|P5|COMPLETED|Part A||0
8684609|NCT02684370|21440114|P4|COMPLETED|Part A||0
8684610|NCT02684370|21440115|P3|COMPLETED|Part A||299
8684611|NCT02684370|21440116|P2|COMPLETED|Part A||99
8684612|NCT02684370|21440117|P1|COMPLETED|Part A||98
8684613|NCT02684370|21440112|P6|STARTED|Part A||0
8684614|NCT02684370|21440113|P5|STARTED|Part A||0
8684615|NCT02684370|21440114|P4|STARTED|Part A||0
8684616|NCT02684370|21440115|P3|STARTED|Part A||304
8684617|NCT02684370|21440116|P2|STARTED|Part A||100
8684618|NCT02684370|21440117|P1|STARTED|Part A||102
8684619|NCT02674568|21440159|P1|NOT COMPLETED|Overall Study||339
8684620|NCT02674568|21440159|P1|COMPLETED|Overall Study||0
8684621|NCT02674568|21440159|P1|DLL3 Positive|Overall Study||287
8684622|NCT02674568|21440159|P1|Delta-like Protein 3 (DLL3) High|Overall Study||238
8684623|NCT02674568|21440159|P1|STARTED|Overall Study|Enrolled and dosed.|339
8684624|NCT02640157|21440185|P3|NOT COMPLETED|Overall Study||10
8684625|NCT02640157|21440186|P2|NOT COMPLETED|Overall Study||5
8684626|NCT02640157|21440187|P1|NOT COMPLETED|Overall Study||13
8684627|NCT02640157|21440185|P3|COMPLETED|Overall Study||147
8684628|NCT02640157|21440186|P2|COMPLETED|Overall Study||111
8684629|NCT02640157|21440187|P1|COMPLETED|Overall Study||220
8684630|NCT02640157|21440185|P3|Discontinued Study Drug|Overall Study||3
8684631|NCT02640157|21440186|P2|Discontinued Study Drug|Overall Study||3
8684632|NCT02640157|21440187|P1|Discontinued Study Drug|Overall Study||8
8684633|NCT02640157|21440185|P3|Completed Study Drug|Overall Study||154
8684634|NCT02640157|21440186|P2|Completed Study Drug|Overall Study||112
8684635|NCT02640157|21440187|P1|Completed Study Drug|Overall Study||225
8684636|NCT02640157|21440185|P3|Received Study Drug|Overall Study||157
8684637|NCT02640157|21440186|P2|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
8684638|NCT02640157|21440187|P1|Received Study Drug|Overall Study||233
8684639|NCT02640157|21440185|P3|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
8684640|NCT02640157|21440186|P2|STARTED|Overall Study||116
8684641|NCT02640157|21440187|P1|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
8684642|NCT02582632|21440204|P1|NOT COMPLETED|Overall Study||1
8684643|NCT02582632|21440204|P1|COMPLETED|Overall Study||165
8684644|NCT02582632|21440204|P1|STARTED|Overall Study||166
8684645|NCT02493751|21440219|P2|NOT COMPLETED|Overall Study||29
8684646|NCT02493751|21440220|P1|NOT COMPLETED|Overall Study||13
8684647|NCT02493751|21440219|P2|COMPLETED|Overall Study|Participants who died were considered as completed.|10
8684648|NCT02493751|21440220|P1|COMPLETED|Overall Study|Participants who died were considered as completed.|3
8684649|NCT02493751|21440219|P2|STARTED|Overall Study||39
8684650|NCT02493751|21440220|P1|STARTED|Overall Study||16
8684651|NCT02435433|21440227|P5|NOT COMPLETED|Overall Study||0
8684652|NCT02435433|21440228|P4|NOT COMPLETED|Overall Study||0
8684653|NCT02435433|21440229|P3|NOT COMPLETED|Overall Study||0
8684654|NCT02435433|21440230|P2|NOT COMPLETED|Overall Study||5
8684655|NCT02435433|21440231|P1|NOT COMPLETED|Overall Study||15
8684656|NCT02435433|21440227|P5|COMPLETED|Overall Study||0
8684657|NCT02435433|21440228|P4|COMPLETED|Overall Study||0
8684658|NCT02435433|21440229|P3|COMPLETED|Overall Study||0
8684659|NCT02435433|21440230|P2|COMPLETED|Overall Study||90
8684660|NCT02435433|21440231|P1|COMPLETED|Overall Study||182
8684661|NCT02435433|21440227|P5|Participants Who Received Study Drug|Overall Study||0
8684662|NCT02435433|21440228|P4|Participants Who Received Study Drug|Overall Study||0
8684663|NCT02435433|21440229|P3|Participants Who Received Study Drug|Overall Study||0
8684664|NCT02435433|21440230|P2|Participants Who Received Study Drug|Overall Study||95
8684665|NCT02435433|21440231|P1|Participants Who Received Study Drug|Overall Study||197
8684666|NCT02435433|21440227|P5|STARTED|Overall Study||0
8684667|NCT02435433|21440228|P4|STARTED|Overall Study||0
8684668|NCT02435433|21440229|P3|STARTED|Overall Study||0
8684669|NCT02435433|21440230|P2|STARTED|Overall Study||95
8684670|NCT02435433|21440231|P1|STARTED|Overall Study||197
8684683|NCT02247401|21440277|P3|NOT COMPLETED|Overall Study||2
8684684|NCT02247401|21440278|P2|NOT COMPLETED|Overall Study||2
8684685|NCT02247401|21440279|P1|NOT COMPLETED|Overall Study||6
8684686|NCT02247401|21440277|P3|COMPLETED|Overall Study||27
8684687|NCT02247401|21440278|P2|COMPLETED|Overall Study||29
8684688|NCT02247401|21440279|P1|COMPLETED|Overall Study||94
8684689|NCT02247401|21440277|P3|STARTED|Overall Study||29
8684690|NCT02247401|21440278|P2|STARTED|Overall Study||31
8684691|NCT02247401|21440279|P1|STARTED|Overall Study||100
8684692|NCT02243293|21440313|P22|NOT COMPLETED|Overall Study||3
8684693|NCT02243293|21440314|P21|NOT COMPLETED|Overall Study||2
8684694|NCT02243293|21440315|P20|NOT COMPLETED|Overall Study||1
8684695|NCT02243293|21440316|P19|NOT COMPLETED|Overall Study||0
8684696|NCT02243293|21440317|P18|NOT COMPLETED|Overall Study||1
8684697|NCT02243293|21440318|P17|NOT COMPLETED|Overall Study||3
8684698|NCT02243293|21440319|P16|NOT COMPLETED|Overall Study||1
8684699|NCT02243293|21440320|P15|NOT COMPLETED|Overall Study||1
8684700|NCT02243293|21440321|P14|NOT COMPLETED|Overall Study||0
8684701|NCT02243293|21440322|P13|NOT COMPLETED|Overall Study||0
8684702|NCT02243293|21440323|P12|NOT COMPLETED|Overall Study||3
8684703|NCT02243293|21440324|P11|NOT COMPLETED|Overall Study||0
8684704|NCT02243293|21440325|P10|NOT COMPLETED|Overall Study||2
8684705|NCT02243293|21440326|P9|NOT COMPLETED|Overall Study||0
8684706|NCT02243293|21440327|P8|NOT COMPLETED|Overall Study||0
8684707|NCT02243293|21440328|P7|NOT COMPLETED|Overall Study||3
8684708|NCT02243293|21440329|P6|NOT COMPLETED|Overall Study||0
8684709|NCT02243293|21440330|P5|NOT COMPLETED|Overall Study||1
8684710|NCT02243293|21440331|P4|NOT COMPLETED|Overall Study||1
8684711|NCT02243293|21440332|P3|NOT COMPLETED|Overall Study||1
8684712|NCT02243293|21440333|P2|NOT COMPLETED|Overall Study||1
8684713|NCT02243293|21440334|P1|NOT COMPLETED|Overall Study||2
8684714|NCT02243293|21440313|P22|COMPLETED|Overall Study||55
8684715|NCT02243293|21440314|P21|COMPLETED|Overall Study||143
8684716|NCT02243293|21440315|P20|COMPLETED|Overall Study||47
8684717|NCT02243293|21440316|P19|COMPLETED|Overall Study||22
8684718|NCT02243293|21440317|P18|COMPLETED|Overall Study||21
8684719|NCT02243293|21440318|P17|COMPLETED|Overall Study||37
8684720|NCT02243293|21440319|P16|COMPLETED|Overall Study||26
8684721|NCT02243293|21440320|P15|COMPLETED|Overall Study||27
8684722|NCT02243293|21440321|P14|COMPLETED|Overall Study||0
8684723|NCT02243293|21440322|P13|COMPLETED|Overall Study||0
8684724|NCT02243293|21440323|P12|COMPLETED|Overall Study||50
8684725|NCT02243293|21440324|P11|COMPLETED|Overall Study||0
8684726|NCT02243293|21440325|P10|COMPLETED|Overall Study||53
8684727|NCT02243293|21440326|P9|COMPLETED|Overall Study||0
8684728|NCT02243293|21440327|P8|COMPLETED|Overall Study||0
8684729|NCT02243293|21440328|P7|COMPLETED|Overall Study||27
8684730|NCT02243293|21440329|P6|COMPLETED|Overall Study||31
8684731|NCT02243293|21440330|P5|COMPLETED|Overall Study||30
8684732|NCT02243293|21440331|P4|COMPLETED|Overall Study||29
8684733|NCT02243293|21440332|P3|COMPLETED|Overall Study||24
8684734|NCT02243293|21440333|P2|COMPLETED|Overall Study||23
8684735|NCT02243293|21440334|P1|COMPLETED|Overall Study||23
8684736|NCT02243293|21440313|P22|STARTED|Overall Study||58
8684737|NCT02243293|21440314|P21|STARTED|Overall Study||145
8684738|NCT02243293|21440315|P20|STARTED|Overall Study||48
8684739|NCT02243293|21440316|P19|STARTED|Overall Study||22
8684740|NCT02243293|21440317|P18|STARTED|Overall Study||22
8684741|NCT02243293|21440318|P17|STARTED|Overall Study||40
8684742|NCT02243293|21440319|P16|STARTED|Overall Study||27
8684743|NCT02243293|21440320|P15|STARTED|Overall Study||28
8684744|NCT02243293|21440321|P14|STARTED|Overall Study||0
8684745|NCT02243293|21440322|P13|STARTED|Overall Study||0
8684746|NCT02243293|21440323|P12|STARTED|Overall Study||53
8684747|NCT02243293|21440324|P11|STARTED|Overall Study||0
8684748|NCT02243293|21440325|P10|STARTED|Overall Study||55
8684749|NCT02243293|21440326|P9|STARTED|Overall Study||0
8684750|NCT02243293|21440327|P8|STARTED|Overall Study||0
8684751|NCT02243293|21440328|P7|STARTED|Overall Study||30
8684752|NCT02243293|21440329|P6|STARTED|Overall Study||31
8684753|NCT02243293|21440330|P5|STARTED|Overall Study||31
8684754|NCT02243293|21440331|P4|STARTED|Overall Study||30
8684755|NCT02243293|21440332|P3|STARTED|Overall Study||25
8684756|NCT02243293|21440333|P2|STARTED|Overall Study||24
8684757|NCT02243293|21440334|P1|STARTED|Overall Study||25
8684758|NCT02091960|21440422|P1|NOT COMPLETED|Overall Study||51
8684759|NCT02091960|21440422|P1|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
8684760|NCT02091960|21440422|P1|Received Treatment|Overall Study||103
8684761|NCT02091960|21440422|P1|STARTED|Overall Study||103
8684762|NCT02076152|21440435|P2|NOT COMPLETED|Overall Study||0
8684763|NCT02076152|21440436|P1|NOT COMPLETED|Overall Study||0
8684764|NCT02076152|21440435|P2|COMPLETED|Overall Study||9
8684765|NCT02076152|21440436|P1|COMPLETED|Overall Study||2
8684766|NCT02076152|21440435|P2|STARTED|Overall Study||9
8684767|NCT02076152|21440436|P1|STARTED|Overall Study||2
8684768|NCT02066389|21440450|P6|NOT COMPLETED|Overall Study||5
8684769|NCT02066389|21440451|P5|NOT COMPLETED|Overall Study||7
8684770|NCT02066389|21440452|P4|NOT COMPLETED|Overall Study||3
8684771|NCT02066389|21440453|P3|NOT COMPLETED|Overall Study||6
8684772|NCT02066389|21440454|P2|NOT COMPLETED|Overall Study||1
8684773|NCT02066389|21440455|P1|NOT COMPLETED|Overall Study||5
8684774|NCT02066389|21440450|P6|COMPLETED|Overall Study||45
8684775|NCT02066389|21440451|P5|COMPLETED|Overall Study||43
8684776|NCT02066389|21440452|P4|COMPLETED|Overall Study||47
8684777|NCT02066389|21440453|P3|COMPLETED|Overall Study||44
8684778|NCT02066389|21440454|P2|COMPLETED|Overall Study||49
8684779|NCT02066389|21440455|P1|COMPLETED|Overall Study||45
8684780|NCT02066389|21440450|P6|Received Study Drug|Overall Study||49
8684781|NCT02066389|21440451|P5|Received Study Drug|Overall Study||50
8684782|NCT02066389|21440452|P4|Received Study Drug|Overall Study||50
8684783|NCT02066389|21440453|P3|Received Study Drug|Overall Study||50
8684784|NCT02066389|21440454|P2|Received Study Drug|Overall Study||50
8684785|NCT02066389|21440455|P1|Received Study Drug|Overall Study||50
8684786|NCT02066389|21440450|P6|STARTED|Overall Study||50
8684787|NCT02066389|21440451|P5|STARTED|Overall Study||50
8684788|NCT02066389|21440452|P4|STARTED|Overall Study||50
8684789|NCT02066389|21440453|P3|STARTED|Overall Study||50
8684790|NCT02066389|21440454|P2|STARTED|Overall Study||50
8684791|NCT02066389|21440455|P1|STARTED|Overall Study||50
8684798|NCT02023112|21440516|P2|NOT COMPLETED|Overall Study||1
8684799|NCT02023112|21440517|P1|NOT COMPLETED|Overall Study||2
8684800|NCT02023112|21440516|P2|COMPLETED|Overall Study||85
8684801|NCT02023112|21440517|P1|COMPLETED|Overall Study||83
8684802|NCT02023112|21440516|P2|STARTED|Overall Study||86
8684803|NCT02023112|21440517|P1|STARTED|Overall Study||85
8684804|NCT01946152|21440539|P4|NOT COMPLETED|Overall Study||8
8684805|NCT01946152|21440540|P3|NOT COMPLETED|Overall Study||6
8684806|NCT01946152|21440541|P2|NOT COMPLETED|Overall Study||3
8684807|NCT01946152|21440542|P1|NOT COMPLETED|Overall Study||1
8684808|NCT01946152|21440539|P4|COMPLETED|Overall Study||0
8684809|NCT01946152|21440540|P3|COMPLETED|Overall Study||0
8684810|NCT01946152|21440541|P2|COMPLETED|Overall Study||0
8684811|NCT01946152|21440542|P1|COMPLETED|Overall Study||2
8684812|NCT01946152|21440539|P4|STARTED|Overall Study||8
8684813|NCT01946152|21440540|P3|STARTED|Overall Study||6
8684814|NCT01946152|21440541|P2|STARTED|Overall Study||3
8684815|NCT01946152|21440542|P1|STARTED|Overall Study||3
8684826|NCT01841736|21440572|P2|NOT COMPLETED|Overall Study||0
8684827|NCT01841736|21440573|P1|NOT COMPLETED|Overall Study||0
8684828|NCT01841736|21440572|P2|COMPLETED|Overall Study||74
8684829|NCT01841736|21440573|P1|COMPLETED|Overall Study||97
8684830|NCT01841736|21440572|P2|Crossover|Overall Study||49
8684831|NCT01841736|21440573|P1|Crossover|Overall Study||0
8684832|NCT01841736|21440572|P2|STARTED|Overall Study||74
8684833|NCT01841736|21440573|P1|STARTED|Overall Study||97
8684834|NCT01774721|21440586|P2|NOT COMPLETED|Overall Study||225
8684835|NCT01774721|21440587|P1|NOT COMPLETED|Overall Study||227
8684836|NCT01774721|21440586|P2|COMPLETED|Overall Study||0
8684837|NCT01774721|21440587|P1|COMPLETED|Overall Study||0
8684838|NCT01774721|21440586|P2|Treated|Overall Study||224
8684839|NCT01774721|21440587|P1|Treated|Overall Study||227
8684840|NCT01774721|21440586|P2|STARTED|Overall Study||225
8684841|NCT01774721|21440587|P1|STARTED|Overall Study||227
8684842|NCT01772472|21440631|P2|NOT COMPLETED|Overall Study||743
8684843|NCT01772472|21440632|P1|NOT COMPLETED|Overall Study||743
8684844|NCT01772472|21440631|P2|COMPLETED|Overall Study||0
8684845|NCT01772472|21440632|P1|COMPLETED|Overall Study||0
8684846|NCT01772472|21440631|P2|STARTED|Overall Study||743
8684847|NCT01772472|21440632|P1|STARTED|Overall Study||743
8684848|NCT01733186|21440646|P2|NOT COMPLETED|Overall Study||0
8684849|NCT01733186|21440647|P1|NOT COMPLETED|Overall Study||0
8684850|NCT01733186|21440646|P2|COMPLETED|Overall Study||6
8684851|NCT01733186|21440647|P1|COMPLETED|Overall Study||6
8684852|NCT01733186|21440646|P2|STARTED|Overall Study||6
8684853|NCT01733186|21440647|P1|STARTED|Overall Study||6
8684854|NCT01685203|21440668|P7|NOT COMPLETED|Overall Study||0
8684855|NCT01685203|21440669|P6|NOT COMPLETED|Overall Study||3
8684856|NCT01685203|21440670|P5|NOT COMPLETED|Overall Study||0
8684857|NCT01685203|21440671|P4|NOT COMPLETED|Overall Study||1
8684858|NCT01685203|21440672|P3|NOT COMPLETED|Overall Study||0
8684859|NCT01685203|21440673|P2|NOT COMPLETED|Overall Study||3
8684860|NCT01685203|21440674|P1|NOT COMPLETED|Overall Study||4
8684861|NCT01685203|21440668|P7|COMPLETED|Overall Study||52
8684862|NCT01685203|21440669|P6|COMPLETED|Overall Study||44
8684863|NCT01685203|21440670|P5|COMPLETED|Overall Study||49
8684864|NCT01685203|21440671|P4|COMPLETED|Overall Study||41
8684865|NCT01685203|21440672|P3|COMPLETED|Overall Study||40
8684866|NCT01685203|21440673|P2|COMPLETED|Overall Study||39
8684867|NCT01685203|21440674|P1|COMPLETED|Overall Study||40
8684868|NCT01685203|21440668|P7|Completed Study Drug|Overall Study||52
8684869|NCT01685203|21440669|P6|Completed Study Drug|Overall Study||43
8684870|NCT01685203|21440670|P5|Completed Study Drug|Overall Study||49
8684871|NCT01685203|21440671|P4|Completed Study Drug|Overall Study||42
8684872|NCT01685203|21440672|P3|Completed Study Drug|Overall Study||39
8684873|NCT01685203|21440673|P2|Completed Study Drug|Overall Study||40
8684874|NCT01685203|21440674|P1|Completed Study Drug|Overall Study||42
8684875|NCT01685203|21440668|P7|STARTED|Overall Study||52
8684876|NCT01685203|21440669|P6|STARTED|Overall Study||47
8684877|NCT01685203|21440670|P5|STARTED|Overall Study||49
8684878|NCT01685203|21440671|P4|STARTED|Overall Study||42
8684879|NCT01685203|21440672|P3|STARTED|Overall Study||40
8684880|NCT01685203|21440673|P2|STARTED|Overall Study||42
8684881|NCT01685203|21440674|P1|STARTED|Overall Study||44
8684882|NCT01651936|21440720|P3|NOT COMPLETED|Extension Study||14
8684883|NCT01651936|21440721|P2|NOT COMPLETED|Extension Study||0
8684884|NCT01651936|21440722|P1|NOT COMPLETED|Extension Study||0
8684885|NCT01651936|21440720|P3|COMPLETED|Extension Study||0
8684886|NCT01651936|21440721|P2|COMPLETED|Extension Study||0
8684887|NCT01651936|21440722|P1|COMPLETED|Extension Study||0
8684888|NCT01651936|21440720|P3|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
8684889|NCT01651936|21440721|P2|STARTED|Extension Study||0
8684890|NCT01651936|21440722|P1|STARTED|Extension Study||0
8684891|NCT01651936|21440720|P3|NOT COMPLETED|Base Study||0
8684892|NCT01651936|21440721|P2|NOT COMPLETED|Base Study||25
8684893|NCT01651936|21440722|P1|NOT COMPLETED|Base Study||27
8684894|NCT01651936|21440720|P3|COMPLETED|Base Study||0
8684895|NCT01651936|21440721|P2|COMPLETED|Base Study||1
8684896|NCT01651936|21440722|P1|COMPLETED|Base Study||3
8684897|NCT01651936|21440720|P3|STARTED|Base Study||0
8684898|NCT01651936|21440721|P2|STARTED|Base Study||26
8684899|NCT01651936|21440722|P1|STARTED|Base Study||30
8684900|NCT01547780|21440746|P4|NOT COMPLETED|Repeat PET Scan||0
8684901|NCT01547780|21440747|P3|NOT COMPLETED|Repeat PET Scan||0
8684902|NCT01547780|21440748|P2|NOT COMPLETED|Repeat PET Scan||0
8684903|NCT01547780|21440749|P1|NOT COMPLETED|Repeat PET Scan||0
8684904|NCT01547780|21440746|P4|COMPLETED|Repeat PET Scan||0
8684905|NCT01547780|21440747|P3|COMPLETED|Repeat PET Scan||0
8684906|NCT01547780|21440748|P2|COMPLETED|Repeat PET Scan||4
8684907|NCT01547780|21440749|P1|COMPLETED|Repeat PET Scan||0
8684908|NCT01547780|21440746|P4|STARTED|Repeat PET Scan||0
8684909|NCT01547780|21440747|P3|STARTED|Repeat PET Scan||0
8684910|NCT01547780|21440748|P2|STARTED|Repeat PET Scan||4
8684911|NCT01547780|21440749|P1|STARTED|Repeat PET Scan||0
8684912|NCT01547780|21440746|P4|NOT COMPLETED|Baseline PET Scan||0
8684913|NCT01547780|21440747|P3|NOT COMPLETED|Baseline PET Scan||2
8684914|NCT01547780|21440748|P2|NOT COMPLETED|Baseline PET Scan||0
8684915|NCT01547780|21440749|P1|NOT COMPLETED|Baseline PET Scan||3
8684916|NCT01547780|21440746|P4|COMPLETED|Baseline PET Scan||19
8684917|NCT01547780|21440747|P3|COMPLETED|Baseline PET Scan||17
8684918|NCT01547780|21440748|P2|COMPLETED|Baseline PET Scan||0
8684919|NCT01547780|21440749|P1|COMPLETED|Baseline PET Scan||9
8684920|NCT01547780|21440746|P4|STARTED|Baseline PET Scan||19
8684921|NCT01547780|21440747|P3|STARTED|Baseline PET Scan||19
8684922|NCT01547780|21440748|P2|STARTED|Baseline PET Scan||0
8684923|NCT01547780|21440749|P1|STARTED|Baseline PET Scan||12
8684924|NCT01506947|21440763|P1|NOT COMPLETED|Overall Study||16
8684925|NCT01506947|21440763|P1|COMPLETED|Overall Study||49
8684926|NCT01506947|21440763|P1|STARTED|Overall Study||65
8684927|NCT01505868|21440784|P5|NOT COMPLETED|Overall Study||0
8684928|NCT01505868|21440785|P4|NOT COMPLETED|Overall Study||0
8684929|NCT01505868|21440786|P3|NOT COMPLETED|Overall Study||0
8684930|NCT01505868|21440787|P2|NOT COMPLETED|Overall Study||0
8684931|NCT01505868|21440788|P1|NOT COMPLETED|Overall Study||1
8684932|NCT01505868|21440784|P5|COMPLETED|Overall Study||81
8684933|NCT01505868|21440785|P4|COMPLETED|Overall Study||79
8684934|NCT01505868|21440786|P3|COMPLETED|Overall Study||3
8684935|NCT01505868|21440787|P2|COMPLETED|Overall Study||3
8684936|NCT01505868|21440788|P1|COMPLETED|Overall Study||3
8684937|NCT01505868|21440784|P5|STARTED|Overall Study||81
8684938|NCT01505868|21440785|P4|STARTED|Overall Study||79
8684939|NCT01505868|21440786|P3|STARTED|Overall Study||3
8684940|NCT01505868|21440787|P2|STARTED|Overall Study||3
8684941|NCT01505868|21440788|P1|STARTED|Overall Study||4
8684942|NCT01411332|21440812|P2|NOT COMPLETED|Overall Study||2
8684943|NCT01411332|21440813|P1|NOT COMPLETED|Overall Study||2
8684944|NCT01411332|21440812|P2|COMPLETED|Overall Study||7
8684945|NCT01411332|21440813|P1|COMPLETED|Overall Study||8
8684946|NCT01411332|21440812|P2|STARTED|Overall Study||9
8684947|NCT01411332|21440813|P1|STARTED|Overall Study||10
8684948|NCT01399372|21440821|P2|NOT COMPLETED|Overall Study||1
8684949|NCT01399372|21440822|P1|NOT COMPLETED|Overall Study||3
8684950|NCT01399372|21440821|P2|COMPLETED|Overall Study||43
8684951|NCT01399372|21440822|P1|COMPLETED|Overall Study||44
8684952|NCT01399372|21440821|P2|Eligible and Started Protocol Treatment|Overall Study||43
8684953|NCT01399372|21440822|P1|Eligible and Started Protocol Treatment|Overall Study||43
8684954|NCT01399372|21440821|P2|Eligible|Overall Study||43
8684955|NCT01399372|21440822|P1|Eligible|Overall Study||44
8684956|NCT01399372|21440821|P2|STARTED|Overall Study||44
8684957|NCT01399372|21440822|P1|STARTED|Overall Study||47
8685150|NCT01352585|21440873|P2|NOT COMPLETED|Overall Study||3
8685151|NCT01352585|21440874|P1|NOT COMPLETED|Overall Study||8
8685152|NCT01352585|21440873|P2|COMPLETED|Overall Study||21
8685153|NCT01352585|21440874|P1|COMPLETED|Overall Study||15
8685154|NCT01352585|21440873|P2|STARTED|Overall Study||24
8685155|NCT01352585|21440874|P1|STARTED|Overall Study||23
8685159|NCT00931762|21440904|P1|NOT COMPLETED|Overall Study||35
8685160|NCT00931762|21440904|P1|COMPLETED|Overall Study||0
8685161|NCT00931762|21440904|P1|STARTED|Overall Study||35
8685192|NCT00805792|21440939|P1|NOT COMPLETED|Overall Study||5
8685193|NCT00805792|21440939|P1|COMPLETED|Overall Study||28
8685194|NCT00805792|21440939|P1|STARTED|Overall Study||33
8685195|NCT00713427|21440947|P1|NOT COMPLETED|Overall Study||4
8685196|NCT00713427|21440947|P1|COMPLETED|Overall Study||66
8685197|NCT00713427|21440947|P1|STARTED|Overall Study||70
8685204|NCT00538915|21440971|P1|NOT COMPLETED|Overall Study||11
8685205|NCT00538915|21440971|P1|COMPLETED|Overall Study||52
8685206|NCT00538915|21440971|P1|STARTED|Overall Study||63
8685207|NCT00473824|21440977|P2|NOT COMPLETED|Overall Study||0
8685208|NCT00473824|21440978|P1|NOT COMPLETED|Overall Study||5
8685209|NCT00473824|21440977|P2|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
8685210|NCT00473824|21440978|P1|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
8685211|NCT00473824|21440977|P2|STARTED|Overall Study||2
8685212|NCT00473824|21440978|P1|STARTED|Overall Study||5
8685213|NCT00429273|21440987|P3|NOT COMPLETED|Overall Study||9
8685214|NCT00429273|21440988|P2|NOT COMPLETED|Overall Study||8
8685215|NCT00429273|21440989|P1|NOT COMPLETED|Overall Study||8
8685216|NCT00429273|21440987|P3|COMPLETED|Overall Study||61
8685217|NCT00429273|21440988|P2|COMPLETED|Overall Study||61
8685218|NCT00429273|21440989|P1|COMPLETED|Overall Study||60
8685219|NCT00429273|21440987|P3|STARTED|Overall Study||70
8685220|NCT00429273|21440988|P2|STARTED|Overall Study||69
8685221|NCT00429273|21440989|P1|STARTED|Overall Study||68
8685222|NCT00293462|21441000|P3|NOT COMPLETED|Overall Study||12
8685223|NCT00293462|21441001|P2|NOT COMPLETED|Overall Study||8
8685224|NCT00293462|21441002|P1|NOT COMPLETED|Overall Study||7
8685225|NCT00293462|21441000|P3|COMPLETED|Overall Study||19
8685226|NCT00293462|21441001|P2|COMPLETED|Overall Study||21
8685227|NCT00293462|21441002|P1|COMPLETED|Overall Study||24
8685228|NCT00293462|21441000|P3|STARTED|Overall Study||31
8685229|NCT00293462|21441001|P2|STARTED|Overall Study||29
8685230|NCT00293462|21441002|P1|STARTED|Overall Study||31
8685231|NCT00179777|21441023|P2|NOT COMPLETED|Overall Study||1465
8685232|NCT00179777|21441024|P1|NOT COMPLETED|Overall Study||1532
8685233|NCT00179777|21441023|P2|COMPLETED|Overall Study||1078
8685234|NCT00179777|21441024|P1|COMPLETED|Overall Study||1081
8685235|NCT00179777|21441023|P2|STARTED|Overall Study||2543
8685236|NCT00179777|21441024|P1|STARTED|Overall Study||2613
8685237|NCT00084084|21441032|P1|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
8685238|NCT00084084|21441032|P1|COMPLETED|Phase 2 (Transition to Replagal AF)||10
8685239|NCT00084084|21441032|P1|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
8685240|NCT00084084|21441032|P1|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
8685241|NCT00084084|21441032|P1|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
8685242|NCT00084084|21441032|P1|STARTED|Phase 1 (Treatment With Replagal RB)||17
8685243|NCT00081328|21441049|P3|NOT COMPLETED|Overall Study||0
8685244|NCT00081328|21441050|P2|NOT COMPLETED|Overall Study||0
8685245|NCT00081328|21441051|P1|NOT COMPLETED|Overall Study||0
8685246|NCT00081328|21441049|P3|COMPLETED|Overall Study||234
8685247|NCT00081328|21441050|P2|COMPLETED|Overall Study||233
8685248|NCT00081328|21441051|P1|COMPLETED|Overall Study||232
8685249|NCT00081328|21441049|P3|STARTED|Overall Study||234
8685250|NCT00081328|21441050|P2|STARTED|Overall Study||233
8685251|NCT00081328|21441051|P1|STARTED|Overall Study||232
8685252|NCT00072384|21441089|P1|NOT COMPLETED|Overall Study||9
8685253|NCT00072384|21441089|P1|COMPLETED|Overall Study||21
8685254|NCT00072384|21441089|P1|STARTED|Overall Study||30
8685255|NCT04898166|21441102|P2|NOT COMPLETED|Overall Study||0
8685256|NCT04898166|21441103|P1|NOT COMPLETED|Overall Study||0
8685257|NCT04898166|21441102|P2|COMPLETED|Overall Study||80
8685258|NCT04898166|21441103|P1|COMPLETED|Overall Study||220
8685259|NCT04898166|21441102|P2|STARTED|Overall Study||80
8685260|NCT04898166|21441103|P1|STARTED|Overall Study||220
8685261|NCT04335136|21441125|P2|NOT COMPLETED|Overall Study||7
8685262|NCT04335136|21441126|P1|NOT COMPLETED|Overall Study||14
8685263|NCT04335136|21441125|P2|COMPLETED|Overall Study||83
8685264|NCT04335136|21441126|P1|COMPLETED|Overall Study||77
8685265|NCT04335136|21441125|P2|Treated|Overall Study||90
8685266|NCT04335136|21441126|P1|Treated|Overall Study||88
8685267|NCT04335136|21441125|P2|STARTED|Overall Study||90
8685268|NCT04335136|21441126|P1|STARTED|Overall Study||91
8685269|NCT04256785|21441166|P2|NOT COMPLETED|Overall Study||25
8685270|NCT04256785|21441167|P1|NOT COMPLETED|Overall Study||28
8685271|NCT04256785|21441166|P2|COMPLETED|Overall Study||31
8685272|NCT04256785|21441167|P1|COMPLETED|Overall Study||26
8685273|NCT04256785|21441166|P2|STARTED|Overall Study||56
8685274|NCT04256785|21441167|P1|STARTED|Overall Study||54
8685275|NCT04023682|21441191|P1|NOT COMPLETED|Overall Study||6
8685276|NCT04023682|21441191|P1|COMPLETED|Overall Study||25
8685277|NCT04023682|21441191|P1|STARTED|Overall Study||31
8685278|NCT03905811|21441203|P2|NOT COMPLETED|Overall Study||0
8685279|NCT03905811|21441204|P1|NOT COMPLETED|Overall Study||2
8685280|NCT03905811|21441203|P2|COMPLETED|Overall Study||5
8685281|NCT03905811|21441204|P1|COMPLETED|Overall Study||6
8685282|NCT03905811|21441203|P2|STARTED|Overall Study||5
8685283|NCT03905811|21441204|P1|STARTED|Overall Study||8
8685284|NCT03850275|21441220|P6|NOT COMPLETED|Overall Study||0
8685285|NCT03850275|21441221|P5|NOT COMPLETED|Overall Study||0
8685286|NCT03850275|21441222|P4|NOT COMPLETED|Overall Study||0
8685287|NCT03850275|21441223|P3|NOT COMPLETED|Overall Study||0
8685288|NCT03850275|21441224|P2|NOT COMPLETED|Overall Study||0
8685289|NCT03850275|21441225|P1|NOT COMPLETED|Overall Study||0
8685290|NCT03850275|21441220|P6|COMPLETED|Overall Study||5
8685291|NCT03850275|21441221|P5|COMPLETED|Overall Study||5
8685292|NCT03850275|21441222|P4|COMPLETED|Overall Study||5
8685293|NCT03850275|21441223|P3|COMPLETED|Overall Study||5
8685294|NCT03850275|21441224|P2|COMPLETED|Overall Study||5
8685295|NCT03850275|21441225|P1|COMPLETED|Overall Study||5
8685296|NCT03850275|21441220|P6|STARTED|Overall Study||5
8685297|NCT03850275|21441221|P5|STARTED|Overall Study||5
8685298|NCT03850275|21441222|P4|STARTED|Overall Study||5
8685299|NCT03850275|21441223|P3|STARTED|Overall Study||5
8685300|NCT03850275|21441224|P2|STARTED|Overall Study||5
8685301|NCT03850275|21441225|P1|STARTED|Overall Study||5
8685302|NCT03806127|21441343|P2|NOT COMPLETED|Overall Study||12
8685303|NCT03806127|21441344|P1|NOT COMPLETED|Overall Study||21
8685304|NCT03806127|21441343|P2|COMPLETED|Overall Study||99
8685305|NCT03806127|21441344|P1|COMPLETED|Overall Study||90
8685306|NCT03806127|21441343|P2|STARTED|Overall Study||111
8685307|NCT03806127|21441344|P1|STARTED|Overall Study||111
8685308|NCT03589807|21441368|P6|NOT COMPLETED|Overall Study||1
8685309|NCT03589807|21441369|P5|NOT COMPLETED|Overall Study||2
8685310|NCT03589807|21441370|P4|NOT COMPLETED|Overall Study||4
8685311|NCT03589807|21441371|P3|NOT COMPLETED|Overall Study||2
8685312|NCT03589807|21441372|P2|NOT COMPLETED|Overall Study||7
8685313|NCT03589807|21441373|P1|NOT COMPLETED|Overall Study||0
8685314|NCT03589807|21441368|P6|COMPLETED|Overall Study||29
8685315|NCT03589807|21441369|P5|COMPLETED|Overall Study||26
8685316|NCT03589807|21441370|P4|COMPLETED|Overall Study||28
8685317|NCT03589807|21441371|P3|COMPLETED|Overall Study||31
8685318|NCT03589807|21441372|P2|COMPLETED|Overall Study||23
8685319|NCT03589807|21441373|P1|COMPLETED|Overall Study||27
8685320|NCT03589807|21441368|P6|STARTED|Overall Study||30
8685321|NCT03589807|21441369|P5|STARTED|Overall Study||28
8685322|NCT03589807|21441370|P4|STARTED|Overall Study||32
8685323|NCT03589807|21441371|P3|STARTED|Overall Study||33
8685324|NCT03589807|21441372|P2|STARTED|Overall Study||30
8685325|NCT03589807|21441373|P1|STARTED|Overall Study||27
8685326|NCT03452033|21441721|P4|NOT COMPLETED|Overall Study||0
8685327|NCT03452033|21441722|P3|NOT COMPLETED|Overall Study||0
8685328|NCT03452033|21441723|P2|NOT COMPLETED|Overall Study||0
8685329|NCT03452033|21441724|P1|NOT COMPLETED|Overall Study||0
8685330|NCT03452033|21441721|P4|COMPLETED|Overall Study||22
8685331|NCT03452033|21441722|P3|COMPLETED|Overall Study||22
8685332|NCT03452033|21441723|P2|COMPLETED|Overall Study||22
8685333|NCT03452033|21441724|P1|COMPLETED|Overall Study||21
8685334|NCT03452033|21441721|P4|STARTED|Overall Study||22
8685335|NCT03452033|21441722|P3|STARTED|Overall Study||22
8685336|NCT03452033|21441723|P2|STARTED|Overall Study||22
8685337|NCT03452033|21441724|P1|STARTED|Overall Study||21
8685392|NCT03178487|21441786|P2|NOT COMPLETED|Overall Study||4
8685393|NCT03178487|21441787|P1|NOT COMPLETED|Overall Study||4
8685394|NCT03178487|21441786|P2|COMPLETED|Overall Study||89
8685395|NCT03178487|21441787|P1|COMPLETED|Overall Study||90
8685396|NCT03178487|21441786|P2|Received Treatment|Overall Study||93
8685397|NCT03178487|21441787|P1|Received Treatment|Overall Study||94
8685398|NCT03178487|21441786|P2|STARTED|Overall Study||93
8685399|NCT03178487|21441787|P1|STARTED|Overall Study||94
8685400|NCT03086343|21441823|P2|NOT COMPLETED|Overall Study||25
8685401|NCT03086343|21441824|P1|NOT COMPLETED|Overall Study||32
8685402|NCT03086343|21441823|P2|COMPLETED|Overall Study||278
8685403|NCT03086343|21441824|P1|COMPLETED|Overall Study||277
8685404|NCT03086343|21441823|P2|STARTED|Overall Study||303
8685405|NCT03086343|21441824|P1|STARTED|Overall Study||309
8685406|NCT03069352|21441836|P2|NOT COMPLETED|Overall Study||40
8685407|NCT03069352|21441837|P1|NOT COMPLETED|Overall Study||12
8685408|NCT03069352|21441836|P2|COMPLETED|Overall Study||103
8685409|NCT03069352|21441837|P1|COMPLETED|Overall Study||56
8685410|NCT03069352|21441836|P2|Received Treatment|Overall Study||142
8685411|NCT03069352|21441837|P1|Received Treatment|Overall Study||68
8685412|NCT03069352|21441836|P2|STARTED|Overall Study||143
8685413|NCT03069352|21441837|P1|STARTED|Overall Study||68
8685414|NCT02855060|21441881|P2|NOT COMPLETED|Overall Study||5
8685415|NCT02855060|21441882|P1|NOT COMPLETED|Overall Study||2
8685416|NCT02855060|21441881|P2|COMPLETED|Overall Study||23
8685417|NCT02855060|21441882|P1|COMPLETED|Overall Study||20
8685418|NCT02855060|21441881|P2|STARTED|Overall Study||28
8685419|NCT02855060|21441882|P1|STARTED|Overall Study||22
8685420|NCT02720523|21441899|P7|NOT COMPLETED|Period 2: Long-term Extension Period||60
8685421|NCT02720523|21441900|P6|NOT COMPLETED|Period 2: Long-term Extension Period||62
8685422|NCT02720523|21441901|P5|NOT COMPLETED|Period 2: Long-term Extension Period||65
8685423|NCT02720523|21441902|P4|NOT COMPLETED|Period 2: Long-term Extension Period||0
8685424|NCT02720523|21441903|P3|NOT COMPLETED|Period 2: Long-term Extension Period||0
8685425|NCT02720523|21441904|P2|NOT COMPLETED|Period 2: Long-term Extension Period||0
8685426|NCT02720523|21441905|P1|NOT COMPLETED|Period 2: Long-term Extension Period||0
8685427|NCT02720523|21441899|P7|COMPLETED|Period 2: Long-term Extension Period||0
8685428|NCT02720523|21441900|P6|COMPLETED|Period 2: Long-term Extension Period||0
8685429|NCT02720523|21441901|P5|COMPLETED|Period 2: Long-term Extension Period||0
8685430|NCT02720523|21441902|P4|COMPLETED|Period 2: Long-term Extension Period||0
8685431|NCT02720523|21441903|P3|COMPLETED|Period 2: Long-term Extension Period||0
8685432|NCT02720523|21441904|P2|COMPLETED|Period 2: Long-term Extension Period||0
8685433|NCT02720523|21441905|P1|COMPLETED|Period 2: Long-term Extension Period||0
8685434|NCT02720523|21441899|P7|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60
8685435|NCT02720523|21441900|P6|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62
8685436|NCT02720523|21441901|P5|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65
8685437|NCT02720523|21441902|P4|STARTED|Period 2: Long-term Extension Period||0
8685438|NCT02720523|21441903|P3|STARTED|Period 2: Long-term Extension Period||0
8685439|NCT02720523|21441904|P2|STARTED|Period 2: Long-term Extension Period||0
8685440|NCT02720523|21441905|P1|STARTED|Period 2: Long-term Extension Period||0
8685441|NCT02720523|21441899|P7|NOT COMPLETED|Period 1: Placebo-controlled Period||0
8685442|NCT02720523|21441900|P6|NOT COMPLETED|Period 1: Placebo-controlled Period||0
8685443|NCT02720523|21441901|P5|NOT COMPLETED|Period 1: Placebo-controlled Period||0
8685444|NCT02720523|21441902|P4|NOT COMPLETED|Period 1: Placebo-controlled Period||6
8685445|NCT02720523|21441903|P3|NOT COMPLETED|Period 1: Placebo-controlled Period||2
8685446|NCT02720523|21441904|P2|NOT COMPLETED|Period 1: Placebo-controlled Period||0
8685447|NCT02720523|21441905|P1|NOT COMPLETED|Period 1: Placebo-controlled Period||2
8685448|NCT02720523|21441899|P7|COMPLETED|Period 1: Placebo-controlled Period||0
8685449|NCT02720523|21441900|P6|COMPLETED|Period 1: Placebo-controlled Period||0
8685450|NCT02720523|21441901|P5|COMPLETED|Period 1: Placebo-controlled Period||0
8685451|NCT02720523|21441902|P4|COMPLETED|Period 1: Placebo-controlled Period||44
8685452|NCT02720523|21441903|P3|COMPLETED|Period 1: Placebo-controlled Period||47
8685453|NCT02720523|21441904|P2|COMPLETED|Period 1: Placebo-controlled Period||49
8685454|NCT02720523|21441905|P1|COMPLETED|Period 1: Placebo-controlled Period||47
8685455|NCT02720523|21441899|P7|STARTED|Period 1: Placebo-controlled Period||0
8685456|NCT02720523|21441900|P6|STARTED|Period 1: Placebo-controlled Period||0
8685457|NCT02720523|21441901|P5|STARTED|Period 1: Placebo-controlled Period||0
8685458|NCT02720523|21441902|P4|STARTED|Period 1: Placebo-controlled Period||50
8685459|NCT02720523|21441903|P3|STARTED|Period 1: Placebo-controlled Period||49
8685460|NCT02720523|21441904|P2|STARTED|Period 1: Placebo-controlled Period||49
8685461|NCT02720523|21441905|P1|STARTED|Period 1: Placebo-controlled Period||49
8685462|NCT02706951|21441965|P3|NOT COMPLETED|Overall Study||10
8685463|NCT02706951|21441966|P2|NOT COMPLETED|Overall Study||16
8685464|NCT02706951|21441967|P1|NOT COMPLETED|Overall Study||14
8685465|NCT02706951|21441965|P3|COMPLETED|Overall Study||205
8685466|NCT02706951|21441966|P2|COMPLETED|Overall Study||201
8685467|NCT02706951|21441967|P1|COMPLETED|Overall Study||202
8685468|NCT02706951|21441965|P3|STARTED|Overall Study||215
8685469|NCT02706951|21441966|P2|STARTED|Overall Study||217
8685470|NCT02706951|21441967|P1|STARTED|Overall Study||216
8685471|NCT02706873|21442003|P4|NOT COMPLETED|Overall Study||33
8685472|NCT02706873|21442004|P3|NOT COMPLETED|Overall Study||27
8685473|NCT02706873|21442005|P2|NOT COMPLETED|Overall Study||4
8685474|NCT02706873|21442006|P1|NOT COMPLETED|Overall Study||47
8685475|NCT02706873|21442003|P4|COMPLETED|Overall Study||282
8685476|NCT02706873|21442004|P3|COMPLETED|Overall Study||290
8685477|NCT02706873|21442005|P2|COMPLETED|Overall Study||51
8685478|NCT02706873|21442006|P1|COMPLETED|Overall Study||268
8685479|NCT02706873|21442003|P4|Japan Sub-study|Overall Study||28
8685480|NCT02706873|21442004|P3|Japan Sub-study|Overall Study||27
8685481|NCT02706873|21442005|P2|Japan Sub-study|Overall Study||55
8685482|NCT02706873|21442006|P1|Japan Sub-study|Overall Study||28
8685483|NCT02706873|21442003|P4|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
8685484|NCT02706873|21442004|P3|Global Analysis Population|Overall Study|Includes 27 participants in the Japan sub-study|317
8685485|NCT02706873|21442005|P2|Global Analysis Population|Overall Study||0
8685486|NCT02706873|21442006|P1|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
8685487|NCT02706873|21442003|P4|Received Study Drug|Overall Study||314
8685488|NCT02706873|21442004|P3|Received Study Drug|Overall Study||317
8685489|NCT02706873|21442005|P2|Received Study Drug|Overall Study||55
8685490|NCT02706873|21442006|P1|Received Study Drug|Overall Study||314
8685491|NCT02706873|21442003|P4|STARTED|Overall Study||315
8685492|NCT02706873|21442004|P3|STARTED|Overall Study||317
8685493|NCT02706873|21442005|P2|STARTED|Overall Study||55
8685494|NCT02706873|21442006|P1|STARTED|Overall Study||315
8685495|NCT02706847|21442106|P4|NOT COMPLETED|Week 12 to Week 24||14
8685496|NCT02706847|21442107|P3|NOT COMPLETED|Week 12 to Week 24||4
8685497|NCT02706847|21442108|P2|NOT COMPLETED|Week 12 to Week 24||2
8685498|NCT02706847|21442109|P1|NOT COMPLETED|Week 12 to Week 24||3
8685499|NCT02706847|21442106|P4|COMPLETED|Week 12 to Week 24||135
8685500|NCT02706847|21442107|P3|COMPLETED|Week 12 to Week 24||153
8685501|NCT02706847|21442108|P2|COMPLETED|Week 12 to Week 24||74
8685502|NCT02706847|21442109|P1|COMPLETED|Week 12 to Week 24||72
8685503|NCT02706847|21442106|P4|Received Study Treatment|Week 12 to Week 24||148
8685504|NCT02706847|21442107|P3|Received Study Treatment|Week 12 to Week 24||156
8685505|NCT02706847|21442108|P2|Received Study Treatment|Week 12 to Week 24||75
8685506|NCT02706847|21442109|P1|Received Study Treatment|Week 12 to Week 24||72
8685507|NCT02706847|21442106|P4|STARTED|Week 12 to Week 24||149
8685508|NCT02706847|21442107|P3|STARTED|Week 12 to Week 24||157
8685509|NCT02706847|21442108|P2|STARTED|Week 12 to Week 24||76
8685510|NCT02706847|21442109|P1|STARTED|Week 12 to Week 24||75
8685511|NCT02706847|21442106|P4|NOT COMPLETED|Day 1 to Week 12||16
8685512|NCT02706847|21442107|P3|NOT COMPLETED|Day 1 to Week 12||8
8685513|NCT02706847|21442108|P2|NOT COMPLETED|Day 1 to Week 12||8
8685514|NCT02706847|21442109|P1|NOT COMPLETED|Day 1 to Week 12||10
8685515|NCT02706847|21442106|P4|COMPLETED|Day 1 to Week 12||149
8685516|NCT02706847|21442107|P3|COMPLETED|Day 1 to Week 12||157
8685517|NCT02706847|21442108|P2|COMPLETED|Day 1 to Week 12||76
8685518|NCT02706847|21442109|P1|COMPLETED|Day 1 to Week 12||75
8685519|NCT02706847|21442106|P4|Received Study Treatment|Day 1 to Week 12||165
8685520|NCT02706847|21442107|P3|Received Study Treatment|Day 1 to Week 12||164
8685521|NCT02706847|21442108|P2|Received Study Treatment|Day 1 to Week 12||84
8685522|NCT02706847|21442109|P1|Received Study Treatment|Day 1 to Week 12||85
8685523|NCT02706847|21442106|P4|STARTED|Day 1 to Week 12||165
8685524|NCT02706847|21442107|P3|STARTED|Day 1 to Week 12||165
8685525|NCT02706847|21442108|P2|STARTED|Day 1 to Week 12||84
8685526|NCT02706847|21442109|P1|STARTED|Day 1 to Week 12||85
8685527|NCT02690714|21442140|P1|NOT COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||2
8685528|NCT02690714|21442140|P1|COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||10
8685529|NCT02690714|21442140|P1|STARTED|Post-Wk 48: Safety Week 48 to EoS Visit|3 subjects from Norway did not go past 48 weeks|12
8685530|NCT02690714|21442140|P1|NOT COMPLETED|Segment 3: Extended Treatment Wks 12-48||0
8685531|NCT02690714|21442140|P1|COMPLETED|Segment 3: Extended Treatment Wks 12-48||15
8685532|NCT02690714|21442140|P1|STARTED|Segment 3: Extended Treatment Wks 12-48||15
8685533|NCT02690714|21442140|P1|NOT COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||0
8685534|NCT02690714|21442140|P1|COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||15
8685535|NCT02690714|21442140|P1|STARTED|Segment 2: Multi-dose Day 0 to Week 12||15
8685536|NCT02690714|21442140|P1|NOT COMPLETED|Segment 1: Single-dose Day -4 to Day 0||0
8685537|NCT02690714|21442140|P1|COMPLETED|Segment 1: Single-dose Day -4 to Day 0|Six participants skipped Segment 1 as they had PK data from Phase 1 study 2002C005G.|9
8685538|NCT02690714|21442140|P1|STARTED|Segment 1: Single-dose Day -4 to Day 0||9
8685539|NCT02675426|21442162|P3|NOT COMPLETED|Overall Study||18
8685540|NCT02675426|21442163|P2|NOT COMPLETED|Overall Study||8
8685541|NCT02675426|21442164|P1|NOT COMPLETED|Overall Study||13
8685542|NCT02675426|21442162|P3|COMPLETED|Overall Study||201
8685543|NCT02675426|21442163|P2|COMPLETED|Overall Study||213
8685544|NCT02675426|21442164|P1|COMPLETED|Overall Study||208
8685545|NCT02675426|21442162|P3|Treated|Overall Study||219
8685546|NCT02675426|21442163|P2|Treated|Overall Study||221
8685547|NCT02675426|21442164|P1|Treated|Overall Study||221
8685548|NCT02675426|21442162|P3|STARTED|Overall Study||219
8685549|NCT02675426|21442163|P2|STARTED|Overall Study||221
8685550|NCT02675426|21442164|P1|STARTED|Overall Study||221
8685551|NCT02470585|21442208|P3|NOT COMPLETED|Overall Study||125
8685552|NCT02470585|21442209|P2|NOT COMPLETED|Overall Study||117
8685553|NCT02470585|21442210|P1|NOT COMPLETED|Overall Study||107
8685554|NCT02470585|21442208|P3|COMPLETED|Overall Study||257
8685555|NCT02470585|21442209|P2|COMPLETED|Overall Study||266
8685556|NCT02470585|21442210|P1|COMPLETED|Overall Study||268
8685557|NCT02470585|21442208|P3|Received Study Drug|Overall Study||377
8685558|NCT02470585|21442209|P2|Received Study Drug|Overall Study||376
8685559|NCT02470585|21442210|P1|Received Study Drug|Overall Study||371
8685560|NCT02470585|21442208|P3|STARTED|Overall Study||382
8685561|NCT02470585|21442209|P2|STARTED|Overall Study||383
8685562|NCT02470585|21442210|P1|STARTED|Overall Study||375
8685563|NCT02427568|21442235|P2|NOT COMPLETED|Overall Study||0
8685564|NCT02427568|21442236|P1|NOT COMPLETED|Overall Study||0
8685565|NCT02427568|21442235|P2|COMPLETED|Overall Study||13
8685566|NCT02427568|21442236|P1|COMPLETED|Overall Study||5
8685567|NCT02427568|21442235|P2|STARTED|Overall Study||13
8685568|NCT02427568|21442236|P1|STARTED|Overall Study||5
8685569|NCT02258074|21442272|P4|NOT COMPLETED|Overall Study||0
8685570|NCT02258074|21442273|P3|NOT COMPLETED|Overall Study||0
8685571|NCT02258074|21442274|P2|NOT COMPLETED|Overall Study||0
8685572|NCT02258074|21442275|P1|NOT COMPLETED|Overall Study||1
8685573|NCT02258074|21442272|P4|COMPLETED|Overall Study||51
8685574|NCT02258074|21442273|P3|COMPLETED|Overall Study||51
8685575|NCT02258074|21442274|P2|COMPLETED|Overall Study||50
8685576|NCT02258074|21442275|P1|COMPLETED|Overall Study||52
8685577|NCT02258074|21442272|P4|STARTED|Overall Study||51
8685578|NCT02258074|21442273|P3|STARTED|Overall Study||51
8685579|NCT02258074|21442274|P2|STARTED|Overall Study||50
8685580|NCT02258074|21442275|P1|STARTED|Overall Study||53
8685581|NCT02061384|21442291|P2|NOT COMPLETED|Overall Study||0
8685582|NCT02061384|21442292|P1|NOT COMPLETED|Overall Study||0
8685583|NCT02061384|21442291|P2|COMPLETED|Overall Study||10
8685584|NCT02061384|21442292|P1|COMPLETED|Overall Study||10
8685585|NCT02061384|21442291|P2|STARTED|Overall Study||10
8685586|NCT02061384|21442292|P1|STARTED|Overall Study||10
8685587|NCT01986348|21442302|P4|NOT COMPLETED|Overall Study||30
8685588|NCT01986348|21442303|P3|NOT COMPLETED|Overall Study||14
8685589|NCT01986348|21442304|P2|NOT COMPLETED|Overall Study||24
8685590|NCT01986348|21442305|P1|NOT COMPLETED|Overall Study||8
8685591|NCT01986348|21442302|P4|COMPLETED|Overall Study||0
8685592|NCT01986348|21442303|P3|COMPLETED|Overall Study||0
8685593|NCT01986348|21442304|P2|COMPLETED|Overall Study||0
8685594|NCT01986348|21442305|P1|COMPLETED|Overall Study||0
8685595|NCT01986348|21442302|P4|STARTED|Overall Study||30
8685596|NCT01986348|21442303|P3|STARTED|Overall Study||14
8685597|NCT01986348|21442304|P2|STARTED|Overall Study||24
8685598|NCT01986348|21442305|P1|STARTED|Overall Study||8
8685605|NCT01715415|21442338|P2|NOT COMPLETED|Open-label Treatment||2
8685606|NCT01715415|21442339|P1|NOT COMPLETED|Open-label Treatment||0
8685607|NCT01715415|21442338|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
8685608|NCT01715415|21442339|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
8685609|NCT01715415|21442338|P2|STARTED|Open-label Treatment||96
8685610|NCT01715415|21442339|P1|STARTED|Open-label Treatment|not applicable to this arm|0
8685611|NCT01715415|21442338|P2|NOT COMPLETED|Double-blind Treatment||2
8685612|NCT01715415|21442339|P1|NOT COMPLETED|Double-blind Treatment||5
8685613|NCT01715415|21442338|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
8685614|NCT01715415|21442339|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
8685615|NCT01715415|21442338|P2|Randomized But Not Treated|Double-blind Treatment||1
8685616|NCT01715415|21442339|P1|Randomized But Not Treated|Double-blind Treatment||0
8685617|NCT01715415|21442338|P2|STARTED|Double-blind Treatment||98
8685618|NCT01715415|21442339|P1|STARTED|Double-blind Treatment||297
8685619|NCT01619839|21442356|P5|NOT COMPLETED|Overall Study||9
8685620|NCT01619839|21442357|P4|NOT COMPLETED|Overall Study||1
8685621|NCT01619839|21442358|P3|NOT COMPLETED|Overall Study||1
8685622|NCT01619839|21442359|P2|NOT COMPLETED|Overall Study||4
8685623|NCT01619839|21442360|P1|NOT COMPLETED|Overall Study||5
8685624|NCT01619839|21442356|P5|COMPLETED|Overall Study||97
8685625|NCT01619839|21442357|P4|COMPLETED|Overall Study||9
8685626|NCT01619839|21442358|P3|COMPLETED|Overall Study||17
8685627|NCT01619839|21442359|P2|COMPLETED|Overall Study||27
8685628|NCT01619839|21442360|P1|COMPLETED|Overall Study||43
8685629|NCT01619839|21442356|P5|STARTED|Overall Study||106
8685630|NCT01619839|21442357|P4|STARTED|Overall Study||10
8685631|NCT01619839|21442358|P3|STARTED|Overall Study||18
8685632|NCT01619839|21442359|P2|STARTED|Overall Study||31
8685633|NCT01619839|21442360|P1|STARTED|Overall Study||48
8685634|NCT01613118|21442375|P4|NOT COMPLETED|Open-label Extension||0
8685635|NCT01613118|21442376|P3|NOT COMPLETED|Open-label Extension||40
8685636|NCT01613118|21442377|P2|NOT COMPLETED|Open-label Extension||42
8685637|NCT01613118|21442378|P1|NOT COMPLETED|Open-label Extension||21
8685638|NCT01613118|21442375|P4|COMPLETED|Open-label Extension||0
8685639|NCT01613118|21442376|P3|COMPLETED|Open-label Extension|OLE ongoing|0
8685640|NCT01613118|21442377|P2|COMPLETED|Open-label Extension|OLE ongoing|0
8685641|NCT01613118|21442378|P1|COMPLETED|Open-label Extension|OLE ongoing|0
8685642|NCT01613118|21442375|P4|STARTED|Open-label Extension||0
8685643|NCT01613118|21442376|P3|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|40
8685644|NCT01613118|21442377|P2|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|42
8685645|NCT01613118|21442378|P1|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|21
8685646|NCT01613118|21442375|P4|NOT COMPLETED|Double-blind||1
8685647|NCT01613118|21442376|P3|NOT COMPLETED|Double-blind||2
8685648|NCT01613118|21442377|P2|NOT COMPLETED|Double-blind||3
8685649|NCT01613118|21442378|P1|NOT COMPLETED|Double-blind||0
8685650|NCT01613118|21442375|P4|COMPLETED|Double-blind||35
8685651|NCT01613118|21442376|P3|COMPLETED|Double-blind||32
8685652|NCT01613118|21442377|P2|COMPLETED|Double-blind||23
8685653|NCT01613118|21442378|P1|COMPLETED|Double-blind||13
8685654|NCT01613118|21442375|P4|STARTED|Double-blind||36
8685655|NCT01613118|21442376|P3|STARTED|Double-blind||34
8685656|NCT01613118|21442377|P2|STARTED|Double-blind||26
8685657|NCT01613118|21442378|P1|STARTED|Double-blind||13
8685658|NCT01545934|21442391|P2|NOT COMPLETED|Overall Study||3
8685659|NCT01545934|21442392|P1|NOT COMPLETED|Overall Study||5
8685660|NCT01545934|21442391|P2|COMPLETED|Overall Study||129
8685661|NCT01545934|21442392|P1|COMPLETED|Overall Study||127
8685662|NCT01545934|21442391|P2|STARTED|Overall Study||132
8685663|NCT01545934|21442392|P1|STARTED|Overall Study||132
8685694|NCT01037985|21442464|P2|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||5
8685695|NCT01037985|21442465|P1|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
8685696|NCT01037985|21442464|P2|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||32
8685697|NCT01037985|21442465|P1|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
8685698|NCT01037985|21442464|P2|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||33
8685699|NCT01037985|21442465|P1|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||0
8685700|NCT01037985|21442464|P2|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who completed Part A of the study and were negative for skin sensitization.|37
8685701|NCT01037985|21442465|P1|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
8685702|NCT01037985|21442464|P2|NOT COMPLETED|Part A: Skin Testing (50 Days)||0
8685703|NCT01037985|21442465|P1|NOT COMPLETED|Part A: Skin Testing (50 Days)||4
8685704|NCT01037985|21442464|P2|COMPLETED|Part A: Skin Testing (50 Days)||0
8685705|NCT01037985|21442465|P1|COMPLETED|Part A: Skin Testing (50 Days)||37
8685706|NCT01037985|21442464|P2|STARTED|Part A: Skin Testing (50 Days)||0
8685707|NCT01037985|21442465|P1|STARTED|Part A: Skin Testing (50 Days)||41
8685708|NCT01037413|21442490|P2|NOT COMPLETED|Part B: Scar Revision||2
8685709|NCT01037413|21442491|P1|NOT COMPLETED|Part B: Scar Revision||0
8685710|NCT01037413|21442490|P2|COMPLETED|Part B: Scar Revision||21
8685711|NCT01037413|21442491|P1|COMPLETED|Part B: Scar Revision||0
8685712|NCT01037413|21442490|P2|Treated|Part B: Scar Revision||22
8685713|NCT01037413|21442491|P1|Treated|Part B: Scar Revision||0
8685714|NCT01037413|21442490|P2|STARTED|Part B: Scar Revision|Participants who completed Part A of the study and were negative for skin sensitization.|23
8685715|NCT01037413|21442491|P1|STARTED|Part B: Scar Revision|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
8685716|NCT01037413|21442490|P2|NOT COMPLETED|Part A: Skin Testing||0
8685717|NCT01037413|21442491|P1|NOT COMPLETED|Part A: Skin Testing||2
8685718|NCT01037413|21442490|P2|COMPLETED|Part A: Skin Testing||0
8685719|NCT01037413|21442491|P1|COMPLETED|Part A: Skin Testing||23
8685720|NCT01037413|21442490|P2|STARTED|Part A: Skin Testing||0
8685721|NCT01037413|21442491|P1|STARTED|Part A: Skin Testing||25
8685722|NCT01035099|21442515|P2|NOT COMPLETED|Overall Study||0
8685723|NCT01035099|21442516|P1|NOT COMPLETED|Overall Study||0
8685724|NCT01035099|21442515|P2|COMPLETED|Overall Study||22
8685725|NCT01035099|21442516|P1|COMPLETED|Overall Study||18
8685726|NCT01035099|21442515|P2|STARTED|Overall Study||22
8685727|NCT01035099|21442516|P1|STARTED|Overall Study||18
8685728|NCT00634803|21442555|P3|NOT COMPLETED|Overall Study||7
8685729|NCT00634803|21442556|P2|NOT COMPLETED|Overall Study||7
8685730|NCT00634803|21442557|P1|NOT COMPLETED|Overall Study||6
8685731|NCT00634803|21442555|P3|COMPLETED|Overall Study||23
8685732|NCT00634803|21442556|P2|COMPLETED|Overall Study||23
8685733|NCT00634803|21442557|P1|COMPLETED|Overall Study||24
8685734|NCT00634803|21442555|P3|Month 3|Overall Study||26
8685735|NCT00634803|21442556|P2|Month 3|Overall Study||23
8685736|NCT00634803|21442557|P1|Month 3|Overall Study||25
8685737|NCT00634803|21442555|P3|Month 2|Overall Study||28
8685738|NCT00634803|21442556|P2|Month 2|Overall Study||26
8685739|NCT00634803|21442557|P1|Month 2|Overall Study||26
8685740|NCT00634803|21442555|P3|Month 1|Overall Study||29
8685741|NCT00634803|21442556|P2|Month 1|Overall Study||29
8685742|NCT00634803|21442557|P1|Month 1|Overall Study||29
8685743|NCT00634803|21442555|P3|STARTED|Overall Study||30
8685744|NCT00634803|21442556|P2|STARTED|Overall Study||30
8685745|NCT00634803|21442557|P1|STARTED|Overall Study||30
8685746|NCT00624234|21442577|P6|NOT COMPLETED|Overall Study||0
8685747|NCT00624234|21442578|P5|NOT COMPLETED|Overall Study||0
8685748|NCT00624234|21442579|P4|NOT COMPLETED|Overall Study||0
8685749|NCT00624234|21442580|P3|NOT COMPLETED|Overall Study||0
8685750|NCT00624234|21442581|P2|NOT COMPLETED|Overall Study||0
8685751|NCT00624234|21442582|P1|NOT COMPLETED|Overall Study||0
8685752|NCT00624234|21442577|P6|COMPLETED|Overall Study||14
8685753|NCT00624234|21442578|P5|COMPLETED|Overall Study||18
8685754|NCT00624234|21442579|P4|COMPLETED|Overall Study||14
8685755|NCT00624234|21442580|P3|COMPLETED|Overall Study||26
8685756|NCT00624234|21442581|P2|COMPLETED|Overall Study||9
8685757|NCT00624234|21442582|P1|COMPLETED|Overall Study||8
8685758|NCT00624234|21442577|P6|STARTED|Overall Study||14
8685759|NCT00624234|21442578|P5|STARTED|Overall Study||18
8685760|NCT00624234|21442579|P4|STARTED|Overall Study||14
8685761|NCT00624234|21442580|P3|STARTED|Overall Study||26
8685762|NCT00624234|21442581|P2|STARTED|Overall Study||9
8685763|NCT00624234|21442582|P1|STARTED|Overall Study||8
8685764|NCT00278915|21442596|P1|NOT COMPLETED|Overall Study||1
8685765|NCT00278915|21442596|P1|COMPLETED|Overall Study||29
8685766|NCT00278915|21442596|P1|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
8685767|NCT04281901|21442631|P2|NOT COMPLETED|Overall Study||1
8685768|NCT04281901|21442632|P1|NOT COMPLETED|Overall Study||1
8685769|NCT04281901|21442631|P2|COMPLETED|Overall Study||11
8685770|NCT04281901|21442632|P1|COMPLETED|Overall Study||11
8685771|NCT04281901|21442631|P2|3. Check-up|Overall Study||11
8685772|NCT04281901|21442632|P1|3. Check-up|Overall Study||11
8685773|NCT04281901|21442631|P2|2. Check-up|Overall Study||11
8685774|NCT04281901|21442632|P1|2. Check-up|Overall Study||11
8685775|NCT04281901|21442631|P2|STARTED|Overall Study||12
8685776|NCT04281901|21442632|P1|STARTED|Overall Study||12
8685777|NCT04235582|21442645|P3|NOT COMPLETED|Overall Study||3
8685778|NCT04235582|21442646|P2|NOT COMPLETED|Overall Study||1
8685779|NCT04235582|21442647|P1|NOT COMPLETED|Overall Study||0
8685780|NCT04235582|21442645|P3|COMPLETED|Overall Study||8
8685781|NCT04235582|21442646|P2|COMPLETED|Overall Study||12
8685782|NCT04235582|21442647|P1|COMPLETED|Overall Study||12
8685783|NCT04235582|21442645|P3|STARTED|Overall Study||11
8685784|NCT04235582|21442646|P2|STARTED|Overall Study||13
8685785|NCT04235582|21442647|P1|STARTED|Overall Study||12
8685786|NCT04115358|21442664|P3|NOT COMPLETED|Overall Study||1
8685787|NCT04115358|21442665|P2|NOT COMPLETED|Overall Study||0
8685788|NCT04115358|21442666|P1|NOT COMPLETED|Overall Study||0
8685789|NCT04115358|21442664|P3|COMPLETED|Overall Study|34 participants 38 teeth for clinical assessment, 26 participants 31 teeth for radiographic assessment.|33
8685790|NCT04115358|21442665|P2|COMPLETED|Overall Study|33 participants 40 teeth for clinical assessment, 26 participants 32 teeth for radiographic assessment.|33
8685791|NCT04115358|21442666|P1|COMPLETED|Overall Study|34 participants 48 teeth for clinical assessment, 28 participants 35 teeth for radiographic assessment.|34
8685792|NCT04115358|21442664|P3|STARTED|Overall Study||34
8685793|NCT04115358|21442665|P2|STARTED|Overall Study||33
8685794|NCT04115358|21442666|P1|STARTED|Overall Study||34
8685795|NCT03979638|21442769|P2|NOT COMPLETED|Period 2||1
8685796|NCT03979638|21442770|P1|NOT COMPLETED|Period 2||1
8685797|NCT03979638|21442769|P2|COMPLETED|Period 2||27
8685798|NCT03979638|21442770|P1|COMPLETED|Period 2||25
8685799|NCT03979638|21442769|P2|STARTED|Period 2||28
8685800|NCT03979638|21442770|P1|STARTED|Period 2||26
8685801|NCT03979638|21442769|P2|NOT COMPLETED|Period 1||7
8685802|NCT03979638|21442770|P1|NOT COMPLETED|Period 1||7
8685803|NCT03979638|21442769|P2|COMPLETED|Period 1||28
8685804|NCT03979638|21442770|P1|COMPLETED|Period 1||26
8685805|NCT03979638|21442769|P2|STARTED|Period 1||35
8685806|NCT03979638|21442770|P1|STARTED|Period 1||33
8685807|NCT03892460|21442803|P2|NOT COMPLETED|Overall Study||5
8685808|NCT03892460|21442804|P1|NOT COMPLETED|Overall Study||12
8685809|NCT03892460|21442803|P2|COMPLETED|Overall Study||19
8685810|NCT03892460|21442804|P1|COMPLETED|Overall Study||18
8685811|NCT03892460|21442803|P2|Randomization|Overall Study||20
8685812|NCT03892460|21442804|P1|Randomization|Overall Study||25
8685813|NCT03892460|21442803|P2|STARTED|Overall Study||24
8685814|NCT03892460|21442804|P1|STARTED|Overall Study||30
8685815|NCT03656692|21442830|P1|NOT COMPLETED|Overall Study||3
8685816|NCT03656692|21442830|P1|COMPLETED|Overall Study||2
8685817|NCT03656692|21442830|P1|STARTED|Overall Study||5
8685818|NCT03645863|21442840|P3|NOT COMPLETED|Overall Study||0
8685819|NCT03645863|21442841|P2|NOT COMPLETED|Overall Study||0
8685820|NCT03645863|21442842|P1|NOT COMPLETED|Overall Study||1
8685821|NCT03645863|21442840|P3|COMPLETED|Overall Study||20
8685822|NCT03645863|21442841|P2|COMPLETED|Overall Study||20
8685823|NCT03645863|21442842|P1|COMPLETED|Overall Study||20
8685824|NCT03645863|21442840|P3|STARTED|Overall Study||20
8685825|NCT03645863|21442841|P2|STARTED|Overall Study||20
8685826|NCT03645863|21442842|P1|STARTED|Overall Study||21
8685827|NCT03550209|21442872|P4|NOT COMPLETED|Overall Study||4
8685828|NCT03550209|21442873|P3|NOT COMPLETED|Overall Study||2
8685829|NCT03550209|21442874|P2|NOT COMPLETED|Overall Study||3
8685830|NCT03550209|21442875|P1|NOT COMPLETED|Overall Study||1
8685831|NCT03550209|21442872|P4|COMPLETED|Overall Study||31
8685832|NCT03550209|21442873|P3|COMPLETED|Overall Study||11
8685833|NCT03550209|21442874|P2|COMPLETED|Overall Study||9
8685834|NCT03550209|21442875|P1|COMPLETED|Overall Study||11
8685835|NCT03550209|21442872|P4|STARTED|Overall Study||35
8685836|NCT03550209|21442873|P3|STARTED|Overall Study||13
8685837|NCT03550209|21442874|P2|STARTED|Overall Study||12
8685838|NCT03550209|21442875|P1|STARTED|Overall Study||12
8685839|NCT03439137|21442895|P2|NOT COMPLETED|Overall Study||26
8685840|NCT03439137|21442896|P1|NOT COMPLETED|Overall Study||42
8685841|NCT03439137|21442895|P2|COMPLETED|Overall Study||135
8685842|NCT03439137|21442896|P1|COMPLETED|Overall Study||120
8685843|NCT03439137|21442895|P2|STARTED|Overall Study||161
8685844|NCT03439137|21442896|P1|STARTED|Overall Study||162
8685845|NCT03402386|21442908|P1|NOT COMPLETED|Overall Study||6
8685846|NCT03402386|21442908|P1|COMPLETED|Overall Study||36
8685847|NCT03402386|21442908|P1|Conversion Group|Overall Study||40
8685848|NCT03402386|21442908|P1|Correction Group|Overall Study||2
8685849|NCT03402386|21442908|P1|STARTED|Overall Study||42
8685850|NCT03384745|21442922|P6|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||2
8685851|NCT03384745|21442923|P5|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
8685852|NCT03384745|21442924|P4|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
8685853|NCT03384745|21442925|P3|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
8685854|NCT03384745|21442926|P2|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||3
8685855|NCT03384745|21442927|P1|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
8685856|NCT03384745|21442922|P6|COMPLETED|Response Assess/Dose Hold (W24-W48)||49
8685857|NCT03384745|21442923|P5|COMPLETED|Response Assess/Dose Hold (W24-W48)||46
8685858|NCT03384745|21442924|P4|COMPLETED|Response Assess/Dose Hold (W24-W48)||43
8685859|NCT03384745|21442925|P3|COMPLETED|Response Assess/Dose Hold (W24-W48)||45
8685860|NCT03384745|21442926|P2|COMPLETED|Response Assess/Dose Hold (W24-W48)||48
8685861|NCT03384745|21442927|P1|COMPLETED|Response Assess/Dose Hold (W24-W48)||51
8685862|NCT03384745|21442922|P6|STARTED|Response Assess/Dose Hold (W24-W48)||51
8685863|NCT03384745|21442923|P5|STARTED|Response Assess/Dose Hold (W24-W48)||47
8685864|NCT03384745|21442924|P4|STARTED|Response Assess/Dose Hold (W24-W48)||47
8685865|NCT03384745|21442925|P3|STARTED|Response Assess/Dose Hold (W24-W48)||49
8685866|NCT03384745|21442926|P2|STARTED|Response Assess/Dose Hold (W24-W48)||51
8685867|NCT03384745|21442927|P1|STARTED|Response Assess/Dose Hold (W24-W48)||52
8685868|NCT03384745|21442922|P6|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
8685869|NCT03384745|21442923|P5|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
8685870|NCT03384745|21442924|P4|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
8685871|NCT03384745|21442925|P3|NOT COMPLETED|Maintenance/Escalation (W12-W24)||1
8685872|NCT03384745|21442926|P2|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
8685873|NCT03384745|21442927|P1|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
8685874|NCT03384745|21442922|P6|COMPLETED|Maintenance/Escalation (W12-W24)||51
8685875|NCT03384745|21442923|P5|COMPLETED|Maintenance/Escalation (W12-W24)||47
8685876|NCT03384745|21442924|P4|COMPLETED|Maintenance/Escalation (W12-W24)||47
8685877|NCT03384745|21442925|P3|COMPLETED|Maintenance/Escalation (W12-W24)||49
8685878|NCT03384745|21442926|P2|COMPLETED|Maintenance/Escalation (W12-W24)||51
8685879|NCT03384745|21442927|P1|COMPLETED|Maintenance/Escalation (W12-W24)||52
8685880|NCT03384745|21442922|P6|STARTED|Maintenance/Escalation (W12-W24)||51
8685881|NCT03384745|21442923|P5|STARTED|Maintenance/Escalation (W12-W24)||49
8685882|NCT03384745|21442924|P4|STARTED|Maintenance/Escalation (W12-W24)||49
8685883|NCT03384745|21442925|P3|STARTED|Maintenance/Escalation (W12-W24)||50
8685884|NCT03384745|21442926|P2|STARTED|Maintenance/Escalation (W12-W24)||51
8685885|NCT03384745|21442927|P1|STARTED|Maintenance/Escalation (W12-W24)||52
8685886|NCT03384745|21442922|P6|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
8685887|NCT03384745|21442923|P5|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
8685888|NCT03384745|21442924|P4|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
8685889|NCT03384745|21442925|P3|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
8685890|NCT03384745|21442926|P2|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||1
8685891|NCT03384745|21442927|P1|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||0
8685892|NCT03384745|21442922|P6|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
8685893|NCT03384745|21442923|P5|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
8685894|NCT03384745|21442924|P4|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
8685895|NCT03384745|21442925|P3|COMPLETED|Placebo Controlled Induction (W0 - W12)||50
8685896|NCT03384745|21442926|P2|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
8685897|NCT03384745|21442927|P1|COMPLETED|Placebo Controlled Induction (W0 - W12)||52
8685898|NCT03384745|21442922|P6|STARTED|Placebo Controlled Induction (W0 - W12)||53
8685899|NCT03384745|21442923|P5|STARTED|Placebo Controlled Induction (W0 - W12)||52
8685900|NCT03384745|21442924|P4|STARTED|Placebo Controlled Induction (W0 - W12)||51
8685901|NCT03384745|21442925|P3|STARTED|Placebo Controlled Induction (W0 - W12)||53
8685902|NCT03384745|21442926|P2|STARTED|Placebo Controlled Induction (W0 - W12)||52
8685903|NCT03384745|21442927|P1|STARTED|Placebo Controlled Induction (W0 - W12)||52
8685904|NCT03329196|21442964|P2|NOT COMPLETED|Overall Study||30
8685905|NCT03329196|21442965|P1|NOT COMPLETED|Overall Study||40
8685906|NCT03329196|21442964|P2|COMPLETED|Overall Study||123
8685907|NCT03329196|21442965|P1|COMPLETED|Overall Study||111
8685908|NCT03329196|21442964|P2|STARTED|Overall Study||153
8685909|NCT03329196|21442965|P1|STARTED|Overall Study||151
8685910|NCT03238417|21442983|P2|NOT COMPLETED|24-month||625
8685911|NCT03238417|21442984|P1|NOT COMPLETED|24-month||295
8685912|NCT03238417|21442983|P2|COMPLETED|24-month||222
8685913|NCT03238417|21442984|P1|COMPLETED|24-month||122
8685914|NCT03238417|21442983|P2|STARTED|24-month|VA Medical Centers|847
8685915|NCT03238417|21442984|P1|STARTED|24-month|VA Medical Centers|417
8685916|NCT03238417|21442983|P2|NOT COMPLETED|12-month||706
8685917|NCT03238417|21442984|P1|NOT COMPLETED|12-month||319
8685918|NCT03238417|21442983|P2|COMPLETED|12-month||205
8685919|NCT03238417|21442984|P1|COMPLETED|12-month||81
8685920|NCT03238417|21442983|P2|STARTED|12-month|VA Medical Centers|911
8685921|NCT03238417|21442984|P1|STARTED|12-month|VA Medical Centers|400
8685922|NCT03238417|21442983|P2|NOT COMPLETED|Baseline||717
8685923|NCT03238417|21442984|P1|NOT COMPLETED|Baseline||389
8685924|NCT03238417|21442983|P2|COMPLETED|Baseline||217
8685925|NCT03238417|21442984|P1|COMPLETED|Baseline|VA Medical Centers|124
8685926|NCT03238417|21442983|P2|STARTED|Baseline|VA Medical Centers|934
8685927|NCT03238417|21442984|P1|STARTED|Baseline|VA Medical Centers|513
8685928|NCT03238417|21442983|P2|NOT COMPLETED|Overall||1988
8685929|NCT03238417|21442984|P1|NOT COMPLETED|Overall||1003
8685930|NCT03238417|21442983|P2|COMPLETED|Overall||644
8685931|NCT03238417|21442984|P1|COMPLETED|Overall||327
8685932|NCT03238417|21442983|P2|STARTED|Overall||2632
8685933|NCT03238417|21442984|P1|STARTED|Overall||1330
8685934|NCT03201003|21443026|P2|NOT COMPLETED|Overall Study||3
8685935|NCT03201003|21443027|P1|NOT COMPLETED|Overall Study||26
8685936|NCT03201003|21443026|P2|COMPLETED|Overall Study||40
8685937|NCT03201003|21443027|P1|COMPLETED|Overall Study||106
8685938|NCT03201003|21443026|P2|STARTED|Overall Study||43
8685939|NCT03201003|21443027|P1|STARTED|Overall Study||132
8685940|NCT03172026|21443041|P2|NOT COMPLETED|Overall Study||0
8685941|NCT03172026|21443042|P1|NOT COMPLETED|Overall Study||2
8685942|NCT03172026|21443041|P2|COMPLETED|Overall Study||0
8685943|NCT03172026|21443042|P1|COMPLETED|Overall Study||0
8685944|NCT03172026|21443041|P2|6 Month Assessment|Overall Study||0
8685945|NCT03172026|21443042|P1|6 Month Assessment|Overall Study||0
8685946|NCT03172026|21443041|P2|8 Week Assessment|Overall Study||0
8685947|NCT03172026|21443042|P1|8 Week Assessment|Overall Study||0
8685948|NCT03172026|21443041|P2|STARTED|Overall Study||0
8685949|NCT03172026|21443042|P1|STARTED|Overall Study||2
8685950|NCT03140254|21443068|P1|NOT COMPLETED|Overall Study||1
8685951|NCT03140254|21443068|P1|COMPLETED|Overall Study||144
8685952|NCT03140254|21443068|P1|Treatment VC - Abdomen|Overall Study||19
8685953|NCT03140254|21443068|P1|Treatment VC - Groin|Overall Study||18
8685954|NCT03140254|21443068|P1|Treatment AC - Abdomen|Overall Study||48
8685955|NCT03140254|21443068|P1|Treatment AC - Groin|Overall Study||51
8685956|NCT03140254|21443068|P1|Treatment IP - Abdomen|Overall Study||48
8685957|NCT03140254|21443068|P1|Treatment IP - Groin|Overall Study||51
8685958|NCT03140254|21443068|P1|STARTED|Overall Study||145
8685959|NCT03096730|21443088|P5|NOT COMPLETED|Overall Study||3
8685960|NCT03096730|21443089|P4|NOT COMPLETED|Overall Study||3
8685961|NCT03096730|21443090|P3|NOT COMPLETED|Overall Study||3
8685962|NCT03096730|21443091|P2|NOT COMPLETED|Overall Study||3
8685963|NCT03096730|21443092|P1|NOT COMPLETED|Overall Study||3
8685964|NCT03096730|21443088|P5|COMPLETED|Overall Study||27
8685965|NCT03096730|21443089|P4|COMPLETED|Overall Study||27
8685966|NCT03096730|21443090|P3|COMPLETED|Overall Study||27
8685967|NCT03096730|21443091|P2|COMPLETED|Overall Study||27
8685968|NCT03096730|21443092|P1|COMPLETED|Overall Study||27
8685969|NCT03096730|21443088|P5|STARTED|Overall Study||30
8685970|NCT03096730|21443089|P4|STARTED|Overall Study||30
8685971|NCT03096730|21443090|P3|STARTED|Overall Study||30
8685972|NCT03096730|21443091|P2|STARTED|Overall Study||30
8685973|NCT03096730|21443092|P1|STARTED|Overall Study||30
8685974|NCT03093870|21443107|P3|NOT COMPLETED|Overall Study||41
8685975|NCT03093870|21443108|P2|NOT COMPLETED|Overall Study||41
8685976|NCT03093870|21443109|P1|NOT COMPLETED|Overall Study||24
8685977|NCT03093870|21443107|P3|COMPLETED|Overall Study||22
8685978|NCT03093870|21443108|P2|COMPLETED|Overall Study||23
8685979|NCT03093870|21443109|P1|COMPLETED|Overall Study||0
8685980|NCT03093870|21443107|P3|STARTED|Overall Study||63
8685981|NCT03093870|21443108|P2|STARTED|Overall Study||64
8685982|NCT03093870|21443109|P1|STARTED|Overall Study||24
8685983|NCT03085797|21443141|P2|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||1
8685984|NCT03085797|21443142|P1|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||0
8685985|NCT03085797|21443141|P2|COMPLETED|No-treatment Follow-up Period (6 Months)||68
8685986|NCT03085797|21443142|P1|COMPLETED|No-treatment Follow-up Period (6 Months)||65
8685987|NCT03085797|21443141|P2|STARTED|No-treatment Follow-up Period (6 Months)|Only 69 Par. continued in FU to check maintenance of response after stopping treatment per protocol|69
8685988|NCT03085797|21443142|P1|STARTED|No-treatment Follow-up Period (6 Months)|Only 65 Par. continued in FU to check maintenance of response after stopping treatment per protocol|65
8685989|NCT03085797|21443141|P2|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
8685990|NCT03085797|21443142|P1|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
8685991|NCT03085797|21443141|P2|COMPLETED|Treatment Period (TP) (52 Weeks)||189
8685992|NCT03085797|21443142|P1|COMPLETED|Treatment Period (TP) (52 Weeks)||184
8685993|NCT03085797|21443141|P2|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||12
8685994|NCT03085797|21443142|P1|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||15
8685995|NCT03085797|21443141|P2|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||1
8685996|NCT03085797|21443142|P1|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||2
8685997|NCT03085797|21443141|P2|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
8685998|NCT03085797|21443142|P1|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
8685999|NCT03085797|21443141|P2|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||0
8686000|NCT03085797|21443142|P1|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||1
8686001|NCT03085797|21443141|P2|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||5
8686002|NCT03085797|21443142|P1|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||11
8686003|NCT03085797|21443141|P2|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
8686004|NCT03085797|21443142|P1|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
8686005|NCT03085797|21443141|P2|Not Completed IP|Treatment Period (TP) (52 Weeks)||23
8686006|NCT03085797|21443142|P1|Not Completed IP|Treatment Period (TP) (52 Weeks)||34
8686007|NCT03085797|21443141|P2|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||183
8686008|NCT03085797|21443142|P1|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||167
8686009|NCT03085797|21443141|P2|STARTED|Treatment Period (TP) (52 Weeks)||206
8686010|NCT03085797|21443142|P1|STARTED|Treatment Period (TP) (52 Weeks)||201
8686011|NCT03063125|21443164|P1|NOT COMPLETED|Overall Study||2
8686012|NCT03063125|21443164|P1|COMPLETED|Overall Study||23
8686013|NCT03063125|21443164|P1|STARTED|Overall Study||25
8686014|NCT03052751|21443173|P6|NOT COMPLETED|Observation Period||0
8686015|NCT03052751|21443174|P5|NOT COMPLETED|Observation Period||1
8686016|NCT03052751|21443175|P4|NOT COMPLETED|Observation Period||0
8686017|NCT03052751|21443176|P3|NOT COMPLETED|Observation Period||0
8686018|NCT03052751|21443177|P2|NOT COMPLETED|Observation Period||0
8686019|NCT03052751|21443178|P1|NOT COMPLETED|Observation Period||0
8686020|NCT03052751|21443173|P6|COMPLETED|Observation Period||10
8686021|NCT03052751|21443174|P5|COMPLETED|Observation Period||9
8686022|NCT03052751|21443175|P4|COMPLETED|Observation Period||11
8686023|NCT03052751|21443176|P3|COMPLETED|Observation Period||11
8686024|NCT03052751|21443177|P2|COMPLETED|Observation Period||21
8686025|NCT03052751|21443178|P1|COMPLETED|Observation Period||22
8686026|NCT03052751|21443173|P6|STARTED|Observation Period||10
8686027|NCT03052751|21443174|P5|STARTED|Observation Period||10
8686028|NCT03052751|21443175|P4|STARTED|Observation Period||11
8686029|NCT03052751|21443176|P3|STARTED|Observation Period||11
8686030|NCT03052751|21443177|P2|STARTED|Observation Period||21
8686031|NCT03052751|21443178|P1|STARTED|Observation Period||22
8686032|NCT03052751|21443173|P6|NOT COMPLETED|Dosing Period 2||0
8686033|NCT03052751|21443174|P5|NOT COMPLETED|Dosing Period 2||0
8686034|NCT03052751|21443175|P4|NOT COMPLETED|Dosing Period 2||0
8686035|NCT03052751|21443176|P3|NOT COMPLETED|Dosing Period 2||3
8686036|NCT03052751|21443177|P2|NOT COMPLETED|Dosing Period 2||0
8686037|NCT03052751|21443178|P1|NOT COMPLETED|Dosing Period 2||0
8686038|NCT03052751|21443173|P6|COMPLETED|Dosing Period 2||10
8686039|NCT03052751|21443174|P5|COMPLETED|Dosing Period 2||10
8686040|NCT03052751|21443175|P4|COMPLETED|Dosing Period 2||11
8686041|NCT03052751|21443176|P3|COMPLETED|Dosing Period 2||8
8686042|NCT03052751|21443177|P2|COMPLETED|Dosing Period 2||0
8686043|NCT03052751|21443178|P1|COMPLETED|Dosing Period 2||0
8686044|NCT03052751|21443173|P6|STARTED|Dosing Period 2||10
8686045|NCT03052751|21443174|P5|STARTED|Dosing Period 2||10
8686046|NCT03052751|21443175|P4|STARTED|Dosing Period 2||11
8686047|NCT03052751|21443176|P3|STARTED|Dosing Period 2||11
8686048|NCT03052751|21443177|P2|STARTED|Dosing Period 2||0
8686049|NCT03052751|21443178|P1|STARTED|Dosing Period 2||0
8686050|NCT03052751|21443173|P6|NOT COMPLETED|Dosing Period 1||0
8686051|NCT03052751|21443174|P5|NOT COMPLETED|Dosing Period 1||0
8686052|NCT03052751|21443175|P4|NOT COMPLETED|Dosing Period 1||0
8686053|NCT03052751|21443176|P3|NOT COMPLETED|Dosing Period 1||0
8686054|NCT03052751|21443177|P2|NOT COMPLETED|Dosing Period 1||1
8686055|NCT03052751|21443178|P1|NOT COMPLETED|Dosing Period 1||0
8686056|NCT03052751|21443173|P6|COMPLETED|Dosing Period 1||0
8686057|NCT03052751|21443174|P5|COMPLETED|Dosing Period 1||0
8686058|NCT03052751|21443175|P4|COMPLETED|Dosing Period 1||0
8686059|NCT03052751|21443176|P3|COMPLETED|Dosing Period 1||0
8686060|NCT03052751|21443177|P2|COMPLETED|Dosing Period 1||20
8686061|NCT03052751|21443178|P1|COMPLETED|Dosing Period 1||22
8686062|NCT03052751|21443173|P6|Completed Period 1 and Started Period 2|Dosing Period 1||0
8686063|NCT03052751|21443174|P5|Completed Period 1 and Started Period 2|Dosing Period 1||0
8686064|NCT03052751|21443175|P4|Completed Period 1 and Started Period 2|Dosing Period 1||0
8686065|NCT03052751|21443176|P3|Completed Period 1 and Started Period 2|Dosing Period 1||0
8686066|NCT03052751|21443177|P2|Completed Period 1 and Started Period 2|Dosing Period 1||20
8686067|NCT03052751|21443178|P1|Completed Period 1 and Started Period 2|Dosing Period 1||22
8686068|NCT03052751|21443173|P6|Completed Period 1|Dosing Period 1||0
8686069|NCT03052751|21443174|P5|Completed Period 1|Dosing Period 1||0
8686070|NCT03052751|21443175|P4|Completed Period 1|Dosing Period 1||0
8686071|NCT03052751|21443176|P3|Completed Period 1|Dosing Period 1||0
8686072|NCT03052751|21443177|P2|Completed Period 1|Dosing Period 1||21
8686073|NCT03052751|21443178|P1|Completed Period 1|Dosing Period 1||22
8686074|NCT03052751|21443173|P6|STARTED|Dosing Period 1||0
8686075|NCT03052751|21443174|P5|STARTED|Dosing Period 1||0
8686076|NCT03052751|21443175|P4|STARTED|Dosing Period 1||0
8686077|NCT03052751|21443176|P3|STARTED|Dosing Period 1||0
8686078|NCT03052751|21443177|P2|STARTED|Dosing Period 1||21
8686079|NCT03052751|21443178|P1|STARTED|Dosing Period 1||22
8686080|NCT03005054|21443192|P1|NOT COMPLETED|Overall Study||0
8686081|NCT03005054|21443192|P1|COMPLETED|Overall Study||3
8686082|NCT03005054|21443192|P1|STARTED|Overall Study||3
8686095|NCT02898077|21443216|P2|NOT COMPLETED|Overall Study||30
8686096|NCT02898077|21443217|P1|NOT COMPLETED|Overall Study||95
8686097|NCT02898077|21443216|P2|COMPLETED|Overall Study||116
8686098|NCT02898077|21443217|P1|COMPLETED|Overall Study||199
8686099|NCT02898077|21443216|P2|Received at Least 1 Dose of Study Drug|Overall Study||145
8686100|NCT02898077|21443217|P1|Received at Least 1 Dose of Study Drug|Overall Study||293
8686101|NCT02898077|21443216|P2|STARTED|Overall Study||146
8686102|NCT02898077|21443217|P1|STARTED|Overall Study||294
8686103|NCT02865811|21443239|P1|NOT COMPLETED|Overall Study||0
8686104|NCT02865811|21443239|P1|COMPLETED|Overall Study||26
8686105|NCT02865811|21443239|P1|STARTED|Overall Study||26
8686106|NCT02841644|21443250|P2|NOT COMPLETED|Overall Study||0
8686107|NCT02841644|21443251|P1|NOT COMPLETED|Overall Study||0
8686108|NCT02841644|21443250|P2|COMPLETED|Overall Study||120
8686109|NCT02841644|21443251|P1|COMPLETED|Overall Study||60
8686110|NCT02841644|21443250|P2|STARTED|Overall Study||120
8686111|NCT02841644|21443251|P1|STARTED|Overall Study||60
8686119|NCT02521870|21443277|P12|NOT COMPLETED|Phase 2: Dose Expansion||30
8686120|NCT02521870|21443278|P11|NOT COMPLETED|Phase 2: Dose Expansion||23
8686121|NCT02521870|21443279|P10|NOT COMPLETED|Phase 2: Dose Expansion||28
8686122|NCT02521870|21443280|P9|NOT COMPLETED|Phase 2: Dose Expansion||22
8686123|NCT02521870|21443281|P8|NOT COMPLETED|Phase 2: Dose Expansion||9
8686124|NCT02521870|21443282|P7|NOT COMPLETED|Phase 2: Dose Expansion||23
8686125|NCT02521870|21443283|P6|NOT COMPLETED|Phase 2: Dose Expansion||25
8686126|NCT02521870|21443284|P5|NOT COMPLETED|Phase 2: Dose Expansion||52
8686127|NCT02521870|21443285|P4|NOT COMPLETED|Phase 2: Dose Expansion||0
8686128|NCT02521870|21443286|P3|NOT COMPLETED|Phase 2: Dose Expansion||0
8686129|NCT02521870|21443287|P2|NOT COMPLETED|Phase 2: Dose Expansion||0
8686130|NCT02521870|21443288|P1|NOT COMPLETED|Phase 2: Dose Expansion||0
8686131|NCT02521870|21443277|P12|COMPLETED|Phase 2: Dose Expansion||0
8686132|NCT02521870|21443278|P11|COMPLETED|Phase 2: Dose Expansion||0
8686133|NCT02521870|21443279|P10|COMPLETED|Phase 2: Dose Expansion||0
8686134|NCT02521870|21443280|P9|COMPLETED|Phase 2: Dose Expansion|4 participants completed pembrolizumab treatment (up to 35 cycles).|2
8686135|NCT02521870|21443281|P8|COMPLETED|Phase 2: Dose Expansion||0
8686136|NCT02521870|21443282|P7|COMPLETED|Phase 2: Dose Expansion||0
8686137|NCT02521870|21443283|P6|COMPLETED|Phase 2: Dose Expansion||0
8686138|NCT02521870|21443284|P5|COMPLETED|Phase 2: Dose Expansion||5
8686139|NCT02521870|21443285|P4|COMPLETED|Phase 2: Dose Expansion||0
8686140|NCT02521870|21443286|P3|COMPLETED|Phase 2: Dose Expansion||0
8686141|NCT02521870|21443287|P2|COMPLETED|Phase 2: Dose Expansion||0
8686142|NCT02521870|21443288|P1|COMPLETED|Phase 2: Dose Expansion||0
8686215|NCT02521870|21443277|P12|STARTED|Phase 1: Dose Escalation||0
8686143|NCT02521870|21443277|P12|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8686144|NCT02521870|21443278|P11|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8686145|NCT02521870|21443279|P10|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8686146|NCT02521870|21443280|P9|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8686147|NCT02521870|21443281|P8|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8686148|NCT02521870|21443282|P7|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8686149|NCT02521870|21443283|P6|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||1
8686150|NCT02521870|21443284|P5|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||7
8686151|NCT02521870|21443285|P4|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8686152|NCT02521870|21443286|P3|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8686153|NCT02521870|21443287|P2|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8686154|NCT02521870|21443288|P1|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
8686155|NCT02521870|21443277|P12|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||11
8686156|NCT02521870|21443278|P11|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||1
8686157|NCT02521870|21443279|P10|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||5
8686158|NCT02521870|21443280|P9|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||9
8686159|NCT02521870|21443281|P8|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||2
8686160|NCT02521870|21443282|P7|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||3
8686161|NCT02521870|21443283|P6|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||7
8686162|NCT02521870|21443284|P5|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||25
8686163|NCT02521870|21443285|P4|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
8686164|NCT02521870|21443286|P3|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
8686165|NCT02521870|21443287|P2|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
8686166|NCT02521870|21443288|P1|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
8686167|NCT02521870|21443277|P12|STARTED|Phase 2: Dose Expansion||30
8686168|NCT02521870|21443278|P11|STARTED|Phase 2: Dose Expansion||23
8686169|NCT02521870|21443279|P10|STARTED|Phase 2: Dose Expansion||28
8686170|NCT02521870|21443280|P9|STARTED|Phase 2: Dose Expansion||24
8686171|NCT02521870|21443281|P8|STARTED|Phase 2: Dose Expansion||9
8686172|NCT02521870|21443282|P7|STARTED|Phase 2: Dose Expansion||23
8686173|NCT02521870|21443283|P6|STARTED|Phase 2: Dose Expansion||25
8686174|NCT02521870|21443284|P5|STARTED|Phase 2: Dose Expansion||57
8686175|NCT02521870|21443285|P4|STARTED|Phase 2: Dose Expansion||0
8686176|NCT02521870|21443286|P3|STARTED|Phase 2: Dose Expansion||0
8686177|NCT02521870|21443287|P2|STARTED|Phase 2: Dose Expansion||0
8686178|NCT02521870|21443288|P1|STARTED|Phase 2: Dose Expansion||0
8686179|NCT02521870|21443277|P12|NOT COMPLETED|Phase 1: Dose Escalation||0
8686180|NCT02521870|21443278|P11|NOT COMPLETED|Phase 1: Dose Escalation||0
8686181|NCT02521870|21443279|P10|NOT COMPLETED|Phase 1: Dose Escalation||0
8686182|NCT02521870|21443280|P9|NOT COMPLETED|Phase 1: Dose Escalation||0
8686183|NCT02521870|21443281|P8|NOT COMPLETED|Phase 1: Dose Escalation||0
8686184|NCT02521870|21443282|P7|NOT COMPLETED|Phase 1: Dose Escalation||0
8686185|NCT02521870|21443283|P6|NOT COMPLETED|Phase 1: Dose Escalation||0
8686186|NCT02521870|21443284|P5|NOT COMPLETED|Phase 1: Dose Escalation||0
8686187|NCT02521870|21443285|P4|NOT COMPLETED|Phase 1: Dose Escalation||6
8686188|NCT02521870|21443286|P3|NOT COMPLETED|Phase 1: Dose Escalation||4
8686189|NCT02521870|21443287|P2|NOT COMPLETED|Phase 1: Dose Escalation||4
8686190|NCT02521870|21443288|P1|NOT COMPLETED|Phase 1: Dose Escalation||5
8686191|NCT02521870|21443277|P12|COMPLETED|Phase 1: Dose Escalation||0
8686192|NCT02521870|21443278|P11|COMPLETED|Phase 1: Dose Escalation||0
8686193|NCT02521870|21443279|P10|COMPLETED|Phase 1: Dose Escalation||0
8686194|NCT02521870|21443280|P9|COMPLETED|Phase 1: Dose Escalation||0
8686195|NCT02521870|21443281|P8|COMPLETED|Phase 1: Dose Escalation||0
8686196|NCT02521870|21443282|P7|COMPLETED|Phase 1: Dose Escalation||0
8686197|NCT02521870|21443283|P6|COMPLETED|Phase 1: Dose Escalation||0
8686198|NCT02521870|21443284|P5|COMPLETED|Phase 1: Dose Escalation||0
8686199|NCT02521870|21443285|P4|COMPLETED|Phase 1: Dose Escalation||0
8686200|NCT02521870|21443286|P3|COMPLETED|Phase 1: Dose Escalation||1
8686201|NCT02521870|21443287|P2|COMPLETED|Phase 1: Dose Escalation||1
8686202|NCT02521870|21443288|P1|COMPLETED|Phase 1: Dose Escalation||1
8686203|NCT02521870|21443277|P12|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8686204|NCT02521870|21443278|P11|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8686205|NCT02521870|21443279|P10|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8686206|NCT02521870|21443280|P9|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8686207|NCT02521870|21443281|P8|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8686208|NCT02521870|21443282|P7|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8686209|NCT02521870|21443283|P6|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8686210|NCT02521870|21443284|P5|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8686211|NCT02521870|21443285|P4|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||1
8686212|NCT02521870|21443286|P3|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
8686213|NCT02521870|21443287|P2|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
8686214|NCT02521870|21443288|P1|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
8686216|NCT02521870|21443278|P11|STARTED|Phase 1: Dose Escalation||0
8686217|NCT02521870|21443279|P10|STARTED|Phase 1: Dose Escalation||0
8686218|NCT02521870|21443280|P9|STARTED|Phase 1: Dose Escalation||0
8686219|NCT02521870|21443281|P8|STARTED|Phase 1: Dose Escalation||0
8686220|NCT02521870|21443282|P7|STARTED|Phase 1: Dose Escalation||0
8686221|NCT02521870|21443283|P6|STARTED|Phase 1: Dose Escalation||0
8686222|NCT02521870|21443284|P5|STARTED|Phase 1: Dose Escalation||0
8686223|NCT02521870|21443285|P4|STARTED|Phase 1: Dose Escalation||6
8686224|NCT02521870|21443286|P3|STARTED|Phase 1: Dose Escalation||5
8686225|NCT02521870|21443287|P2|STARTED|Phase 1: Dose Escalation||5
8686226|NCT02521870|21443288|P1|STARTED|Phase 1: Dose Escalation||6
8686227|NCT02476916|21443352|P2|NOT COMPLETED|Extension Period||18
8686228|NCT02476916|21443353|P1|NOT COMPLETED|Extension Period||18
8686229|NCT02476916|21443352|P2|COMPLETED|Extension Period||0
8686230|NCT02476916|21443353|P1|COMPLETED|Extension Period||0
8686231|NCT02476916|21443352|P2|STARTED|Extension Period||18
8686232|NCT02476916|21443353|P1|STARTED|Extension Period||18
8686233|NCT02476916|21443352|P2|NOT COMPLETED|Core Period||3
8686234|NCT02476916|21443353|P1|NOT COMPLETED|Core Period||6
8686235|NCT02476916|21443352|P2|COMPLETED|Core Period||22
8686236|NCT02476916|21443353|P1|COMPLETED|Core Period||21
8686237|NCT02476916|21443352|P2|STARTED|Core Period||25
8686238|NCT02476916|21443353|P1|STARTED|Core Period||27
8686239|NCT02440789|21443395|P1|NOT COMPLETED|Overall Study||4
8686240|NCT02440789|21443395|P1|COMPLETED|Overall Study||28
8686241|NCT02440789|21443395|P1|Completed 20 Weeks of Sirolimus|Overall Study||16
8686242|NCT02440789|21443395|P1|Initiated Sirolimus|Overall Study||30
8686243|NCT02440789|21443395|P1|STARTED|Overall Study||32
8686244|NCT02393690|21443446|P2|NOT COMPLETED|Overall Study||0
8686245|NCT02393690|21443447|P1|NOT COMPLETED|Overall Study||0
8686246|NCT02393690|21443446|P2|COMPLETED|Overall Study||31
8686247|NCT02393690|21443447|P1|COMPLETED|Overall Study||29
8686248|NCT02393690|21443446|P2|STARTED|Overall Study||31
8686249|NCT02393690|21443447|P1|STARTED|Overall Study||29
8686250|NCT02365480|21443455|P2|NOT COMPLETED|Overall Study||0
8686251|NCT02365480|21443456|P1|NOT COMPLETED|Overall Study||2
8686252|NCT02365480|21443455|P2|COMPLETED|Overall Study||4
8686253|NCT02365480|21443456|P1|COMPLETED|Overall Study||12
8686254|NCT02365480|21443455|P2|STARTED|Overall Study||4
8686255|NCT02365480|21443456|P1|STARTED|Overall Study||14
8686256|NCT02296125|21443476|P4|NOT COMPLETED|Overall Study||62
8686257|NCT02296125|21443477|P3|NOT COMPLETED|Overall Study||56
8686258|NCT02296125|21443478|P2|NOT COMPLETED|Overall Study||264
8686259|NCT02296125|21443479|P1|NOT COMPLETED|Overall Study||218
8686260|NCT02296125|21443476|P4|COMPLETED|Overall Study||3
8686261|NCT02296125|21443477|P3|COMPLETED|Overall Study||15
8686262|NCT02296125|21443478|P2|COMPLETED|Overall Study||13
8686263|NCT02296125|21443479|P1|COMPLETED|Overall Study||61
8686264|NCT02296125|21443476|P4|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65
8686265|NCT02296125|21443477|P3|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|71
8686266|NCT02296125|21443478|P2|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
8686267|NCT02296125|21443479|P1|STARTED|Overall Study||279
8686268|NCT02094261|21443531|P1|NOT COMPLETED|Overall Study||210
8686269|NCT02094261|21443531|P1|COMPLETED|Overall Study||0
8686270|NCT02094261|21443531|P1|STARTED|Overall Study||210
8686271|NCT01969058|21443540|P2|NOT COMPLETED|Overall Study||0
8686272|NCT01969058|21443541|P1|NOT COMPLETED|Overall Study||3
8686273|NCT01969058|21443540|P2|COMPLETED|Overall Study||26
8686274|NCT01969058|21443541|P1|COMPLETED|Overall Study||47
8686275|NCT01969058|21443540|P2|STARTED|Overall Study||26
8686276|NCT01969058|21443541|P1|STARTED|Overall Study||50
8686277|NCT01968356|21443591|P8|NOT COMPLETED|Overall Study||0
8686278|NCT01968356|21443592|P7|NOT COMPLETED|Overall Study||0
8686279|NCT01968356|21443593|P6|NOT COMPLETED|Overall Study||0
8686280|NCT01968356|21443594|P5|NOT COMPLETED|Overall Study||0
8686281|NCT01968356|21443595|P4|NOT COMPLETED|Overall Study||0
8686282|NCT01968356|21443596|P3|NOT COMPLETED|Overall Study||0
8686283|NCT01968356|21443597|P2|NOT COMPLETED|Overall Study||0
8686284|NCT01968356|21443598|P1|NOT COMPLETED|Overall Study||0
8686285|NCT01968356|21443591|P8|COMPLETED|Overall Study||31
8686286|NCT01968356|21443592|P7|COMPLETED|Overall Study||97
8686287|NCT01968356|21443593|P6|COMPLETED|Overall Study||99
8686288|NCT01968356|21443594|P5|COMPLETED|Overall Study||97
8686289|NCT01968356|21443595|P4|COMPLETED|Overall Study||32
8686290|NCT01968356|21443596|P3|COMPLETED|Overall Study||96
8686291|NCT01968356|21443597|P2|COMPLETED|Overall Study||93
8686292|NCT01968356|21443598|P1|COMPLETED|Overall Study||101
8686293|NCT01968356|21443591|P8|STARTED|Overall Study||31
8686294|NCT01968356|21443592|P7|STARTED|Overall Study||97
8686295|NCT01968356|21443593|P6|STARTED|Overall Study||99
8686296|NCT01968356|21443594|P5|STARTED|Overall Study||97
8686297|NCT01968356|21443595|P4|STARTED|Overall Study||32
8686298|NCT01968356|21443596|P3|STARTED|Overall Study||96
8686299|NCT01968356|21443597|P2|STARTED|Overall Study||93
8686300|NCT01968356|21443598|P1|STARTED|Overall Study||101
8686301|NCT01928927|21443666|P2|NOT COMPLETED|Overall Study||1
8686302|NCT01928927|21443667|P1|NOT COMPLETED|Overall Study||2
8686303|NCT01928927|21443666|P2|COMPLETED|Overall Study||14
8686304|NCT01928927|21443667|P1|COMPLETED|Overall Study||27
8686305|NCT01928927|21443666|P2|STARTED|Overall Study||15
8686306|NCT01928927|21443667|P1|STARTED|Overall Study||29
8686307|NCT01828099|21443805|P2|NOT COMPLETED|Overall Study||157
8686308|NCT01828099|21443806|P1|NOT COMPLETED|Overall Study||94
8686309|NCT01828099|21443805|P2|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
8686310|NCT01828099|21443806|P1|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
8686311|NCT01828099|21443805|P2|Discontinued From Study|Overall Study||29
8686312|NCT01828099|21443806|P1|Discontinued From Study|Overall Study||20
8686313|NCT01828099|21443805|P2|Entered Survival Follow-up Phase|Overall Study||31
8686314|NCT01828099|21443806|P1|Entered Survival Follow-up Phase|Overall Study||64
8686315|NCT01828099|21443805|P2|Entered Post-treatment Follow-up Phase|Overall Study||16
8686316|NCT01828099|21443806|P1|Entered Post-treatment Follow-up Phase|Overall Study||10
8686317|NCT01828099|21443805|P2|Entered Extension-treatment Phase|Overall Study||81
8686318|NCT01828099|21443806|P1|Entered Extension-treatment Phase|Overall Study||0
8686319|NCT01828099|21443805|P2|Discontinued From Treatment Phase|Overall Study||157
8686320|NCT01828099|21443806|P1|Discontinued From Treatment Phase|Overall Study||94
8686321|NCT01828099|21443805|P2|Treated|Overall Study||175
8686322|NCT01828099|21443806|P1|Treated|Overall Study|discontinued from treatment phase = Not completed|189
8686323|NCT01828099|21443805|P2|Untreated Patients|Overall Study||12
8686324|NCT01828099|21443806|P1|Untreated Patients|Overall Study||0
8686325|NCT01828099|21443805|P2|STARTED|Overall Study||187
8686326|NCT01828099|21443806|P1|STARTED|Overall Study||189
8686327|NCT01777997|21443812|P1|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
8686328|NCT01777997|21443812|P1|COMPLETED|Weeks 48 to 72/96 on ART||26
8686329|NCT01777997|21443812|P1|STARTED|Weeks 48 to 72/96 on ART||28
8686330|NCT01777997|21443812|P1|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
8686331|NCT01777997|21443812|P1|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
8686332|NCT01777997|21443812|P1|STARTED|Weeks 0 to 24/48 on ART||36
8686333|NCT01777997|21443812|P1|NOT COMPLETED|12 Week lead-in of no ART||2
8686334|NCT01777997|21443812|P1|COMPLETED|12 Week lead-in of no ART||36
8686335|NCT01777997|21443812|P1|STARTED|12 Week lead-in of no ART||38
8686336|NCT01400412|21443826|P2|NOT COMPLETED|Overall Study||17
8686337|NCT01400412|21443827|P1|NOT COMPLETED|Overall Study||10
8686338|NCT01400412|21443826|P2|COMPLETED|Overall Study||115
8686339|NCT01400412|21443827|P1|COMPLETED|Overall Study||120
8686340|NCT01400412|21443826|P2|STARTED|Overall Study||132
8686341|NCT01400412|21443827|P1|STARTED|Overall Study||130
8686348|NCT01351025|21443898|P2|NOT COMPLETED|Week 44 - 48||0
8686349|NCT01351025|21443899|P1|NOT COMPLETED|Week 44 - 48||0
8686350|NCT01351025|21443898|P2|COMPLETED|Week 44 - 48||43
8686351|NCT01351025|21443899|P1|COMPLETED|Week 44 - 48||42
8686352|NCT01351025|21443898|P2|STARTED|Week 44 - 48||43
8686353|NCT01351025|21443899|P1|STARTED|Week 44 - 48||42
8686354|NCT01351025|21443898|P2|NOT COMPLETED|Week 24 - 44||4
8686355|NCT01351025|21443899|P1|NOT COMPLETED|Week 24 - 44||1
8686356|NCT01351025|21443898|P2|COMPLETED|Week 24 - 44||43
8686357|NCT01351025|21443899|P1|COMPLETED|Week 24 - 44||42
8686358|NCT01351025|21443898|P2|STARTED|Week 24 - 44||47
8686359|NCT01351025|21443899|P1|STARTED|Week 24 - 44||43
8686360|NCT01351025|21443898|P2|NOT COMPLETED|Week 20 - 24||0
8686361|NCT01351025|21443899|P1|NOT COMPLETED|Week 20 - 24||0
8686362|NCT01351025|21443898|P2|COMPLETED|Week 20 - 24||47
8686363|NCT01351025|21443899|P1|COMPLETED|Week 20 - 24||43
8686364|NCT01351025|21443898|P2|STARTED|Week 20 - 24||47
8686365|NCT01351025|21443899|P1|STARTED|Week 20 - 24||43
8686366|NCT01351025|21443898|P2|NOT COMPLETED|Week 0 - 20||1
8686367|NCT01351025|21443899|P1|NOT COMPLETED|Week 0 - 20||3
8686368|NCT01351025|21443898|P2|COMPLETED|Week 0 - 20||47
8686369|NCT01351025|21443899|P1|COMPLETED|Week 0 - 20||43
8686370|NCT01351025|21443898|P2|STARTED|Week 0 - 20||48
8686371|NCT01351025|21443899|P1|STARTED|Week 0 - 20||46
8686372|NCT01221857|21443929|P1|NOT COMPLETED|Overall Study||0
8686373|NCT01221857|21443929|P1|COMPLETED|Overall Study||12
8686374|NCT01221857|21443929|P1|STARTED|Overall Study||12
8686375|NCT01054768|21443939|P2|NOT COMPLETED|Overall Study||3
8686376|NCT01054768|21443940|P1|NOT COMPLETED|Overall Study||8
8686377|NCT01054768|21443939|P2|COMPLETED|Overall Study||17
8686378|NCT01054768|21443940|P1|COMPLETED|Overall Study||9
8686379|NCT01054768|21443939|P2|STARTED|Overall Study||20
8686380|NCT01054768|21443940|P1|STARTED|Overall Study||17
8686381|NCT00999518|21443951|P5|NOT COMPLETED|Overall Study||24
8686382|NCT00999518|21443952|P4|NOT COMPLETED|Overall Study||22
8686383|NCT00999518|21443953|P3|NOT COMPLETED|Overall Study||22
8686384|NCT00999518|21443954|P2|NOT COMPLETED|Overall Study||25
8686385|NCT00999518|21443955|P1|NOT COMPLETED|Overall Study||24
8686386|NCT00999518|21443951|P5|COMPLETED|Overall Study||17
8686387|NCT00999518|21443952|P4|COMPLETED|Overall Study||18
8686388|NCT00999518|21443953|P3|COMPLETED|Overall Study||17
8686389|NCT00999518|21443954|P2|COMPLETED|Overall Study||17
8686390|NCT00999518|21443955|P1|COMPLETED|Overall Study||19
8686391|NCT00999518|21443951|P5|Treated|Overall Study||40
8686392|NCT00999518|21443952|P4|Treated|Overall Study||40
8686393|NCT00999518|21443953|P3|Treated|Overall Study||37
8686394|NCT00999518|21443954|P2|Treated|Overall Study||41
8686395|NCT00999518|21443955|P1|Treated|Overall Study||42
8686396|NCT00999518|21443951|P5|STARTED|Overall Study||41
8686397|NCT00999518|21443952|P4|STARTED|Overall Study||40
8686398|NCT00999518|21443953|P3|STARTED|Overall Study||39
8686399|NCT00999518|21443954|P2|STARTED|Overall Study||42
8686400|NCT00999518|21443955|P1|STARTED|Overall Study||43
8686401|NCT00668707|21444143|P2|NOT COMPLETED|Overall Study||180
8686402|NCT00668707|21444144|P1|NOT COMPLETED|Overall Study||199
8686403|NCT00668707|21444143|P2|COMPLETED|Overall Study||173
8686404|NCT00668707|21444144|P1|COMPLETED|Overall Study||157
8686405|NCT00668707|21444143|P2|STARTED|Overall Study||353
8686406|NCT00668707|21444144|P1|STARTED|Overall Study||356
8686417|NCT04313647|21444190|P5|NOT COMPLETED|Overall Study||0
8686418|NCT04313647|21444191|P4|NOT COMPLETED|Overall Study||0
8686419|NCT04313647|21444192|P3|NOT COMPLETED|Overall Study||0
8686420|NCT04313647|21444193|P2|NOT COMPLETED|Overall Study||0
8686421|NCT04313647|21444194|P1|NOT COMPLETED|Overall Study||0
8686422|NCT04313647|21444190|P5|COMPLETED|Overall Study||6
8686423|NCT04313647|21444191|P4|COMPLETED|Overall Study||6
8686424|NCT04313647|21444192|P3|COMPLETED|Overall Study||6
8686425|NCT04313647|21444193|P2|COMPLETED|Overall Study||3
8686426|NCT04313647|21444194|P1|COMPLETED|Overall Study||3
8686427|NCT04313647|21444190|P5|STARTED|Overall Study||6
8686428|NCT04313647|21444191|P4|STARTED|Overall Study||6
8686429|NCT04313647|21444192|P3|STARTED|Overall Study||6
8686430|NCT04313647|21444193|P2|STARTED|Overall Study||3
8686431|NCT04313647|21444194|P1|STARTED|Overall Study||3
8686432|NCT04128319|21444216|P1|NOT COMPLETED|Overall Study||3
8686433|NCT04128319|21444216|P1|COMPLETED|Overall Study||0
8686434|NCT04128319|21444216|P1|Initiated T-Guard Treatment|Overall Study||3
8686435|NCT04128319|21444216|P1|STARTED|Overall Study||3
8686436|NCT03990298|21444246|P1|NOT COMPLETED|Overall Study||0
8686437|NCT03990298|21444246|P1|COMPLETED|Overall Study||16
8686438|NCT03990298|21444246|P1|STARTED|Overall Study||16
8686439|NCT03963401|21444256|P6|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
8686440|NCT03963401|21444257|P5|NOT COMPLETED|Extension Period (Week 17 - Week 52)||6
8686441|NCT03963401|21444258|P4|NOT COMPLETED|Extension Period (Week 17 - Week 52)||1
8686442|NCT03963401|21444259|P3|NOT COMPLETED|Extension Period (Week 17 - Week 52)||4
8686443|NCT03963401|21444260|P2|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
8686444|NCT03963401|21444261|P1|NOT COMPLETED|Extension Period (Week 17 - Week 52)||14
8686445|NCT03963401|21444256|P6|COMPLETED|Extension Period (Week 17 - Week 52)||26
8686446|NCT03963401|21444257|P5|COMPLETED|Extension Period (Week 17 - Week 52)||25
8686447|NCT03963401|21444258|P4|COMPLETED|Extension Period (Week 17 - Week 52)||12
8686448|NCT03963401|21444259|P3|COMPLETED|Extension Period (Week 17 - Week 52)||10
8686449|NCT03963401|21444260|P2|COMPLETED|Extension Period (Week 17 - Week 52)||52
8686450|NCT03963401|21444261|P1|COMPLETED|Extension Period (Week 17 - Week 52)||43
8686451|NCT03963401|21444256|P6|STARTED|Extension Period (Week 17 - Week 52)||31
8686452|NCT03963401|21444257|P5|STARTED|Extension Period (Week 17 - Week 52)||31
8686453|NCT03963401|21444258|P4|STARTED|Extension Period (Week 17 - Week 52)||13
8686454|NCT03963401|21444259|P3|STARTED|Extension Period (Week 17 - Week 52)||14
8686455|NCT03963401|21444260|P2|STARTED|Extension Period (Week 17 - Week 52)||57
8686456|NCT03963401|21444261|P1|STARTED|Extension Period (Week 17 - Week 52)||57
8686457|NCT03963401|21444256|P6|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
8686458|NCT03963401|21444257|P5|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
8686459|NCT03963401|21444258|P4|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
8686460|NCT03963401|21444259|P3|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
8686461|NCT03963401|21444260|P2|NOT COMPLETED|Initial Period (Day 1 - Week 16)||4
8686462|NCT03963401|21444261|P1|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
8686463|NCT03963401|21444256|P6|COMPLETED|Initial Period (Day 1 - Week 16)||31
8686464|NCT03963401|21444257|P5|COMPLETED|Initial Period (Day 1 - Week 16)||31
8686465|NCT03963401|21444258|P4|COMPLETED|Initial Period (Day 1 - Week 16)||13
8686466|NCT03963401|21444259|P3|COMPLETED|Initial Period (Day 1 - Week 16)||14
8686467|NCT03963401|21444260|P2|COMPLETED|Initial Period (Day 1 - Week 16)||57
8686468|NCT03963401|21444261|P1|COMPLETED|Initial Period (Day 1 - Week 16)||57
8686469|NCT03963401|21444256|P6|Treated|Initial Period (Day 1 - Week 16)||33
8686470|NCT03963401|21444257|P5|Treated|Initial Period (Day 1 - Week 16)||34
8686471|NCT03963401|21444258|P4|Treated|Initial Period (Day 1 - Week 16)||15
8686472|NCT03963401|21444259|P3|Treated|Initial Period (Day 1 - Week 16)||16
8686473|NCT03963401|21444260|P2|Treated|Initial Period (Day 1 - Week 16)||60
8686474|NCT03963401|21444261|P1|Treated|Initial Period (Day 1 - Week 16)||60
8686475|NCT03963401|21444256|P6|STARTED|Initial Period (Day 1 - Week 16)||33
8686476|NCT03963401|21444257|P5|STARTED|Initial Period (Day 1 - Week 16)||34
8686477|NCT03963401|21444258|P4|STARTED|Initial Period (Day 1 - Week 16)||15
8686478|NCT03963401|21444259|P3|STARTED|Initial Period (Day 1 - Week 16)||16
8686479|NCT03963401|21444260|P2|STARTED|Initial Period (Day 1 - Week 16)||61
8686480|NCT03963401|21444261|P1|STARTED|Initial Period (Day 1 - Week 16)||60
8686481|NCT03697460|21444445|P1|NOT COMPLETED|Overall Study||3
8686482|NCT03697460|21444445|P1|COMPLETED|Overall Study||9
8686483|NCT03697460|21444445|P1|STARTED|Overall Study||12
8686484|NCT03495869|21444458|P4|NOT COMPLETED|Overall Study||21
8686485|NCT03495869|21444459|P3|NOT COMPLETED|Overall Study||10
8686486|NCT03495869|21444460|P2|NOT COMPLETED|Overall Study||27
8686487|NCT03495869|21444461|P1|NOT COMPLETED|Overall Study||4
8686488|NCT03495869|21444458|P4|COMPLETED|Overall Study||108
8686489|NCT03495869|21444459|P3|COMPLETED|Overall Study||51
8686490|NCT03495869|21444460|P2|COMPLETED|Overall Study||97
8686491|NCT03495869|21444461|P1|COMPLETED|Overall Study||50
8686492|NCT03495869|21444458|P4|STARTED|Overall Study||129
8686493|NCT03495869|21444459|P3|STARTED|Overall Study||61
8686494|NCT03495869|21444460|P2|STARTED|Overall Study||124
8686495|NCT03495869|21444461|P1|STARTED|Overall Study||54
8686496|NCT03464422|21444479|P1|NOT COMPLETED|Overall Study||4
8686497|NCT03464422|21444479|P1|COMPLETED|Overall Study||17
8686498|NCT03464422|21444479|P1|STARTED|Overall Study||21
8686499|NCT02987543|21444499|P4|NOT COMPLETED|Overall Study||48
8686500|NCT02987543|21444500|P3|NOT COMPLETED|Overall Study||94
8686501|NCT02987543|21444501|P2|NOT COMPLETED|Overall Study||83
8686502|NCT02987543|21444502|P1|NOT COMPLETED|Overall Study||162
8686503|NCT02987543|21444499|P4|COMPLETED|Overall Study||0
8686504|NCT02987543|21444500|P3|COMPLETED|Overall Study||0
8686505|NCT02987543|21444501|P2|COMPLETED|Overall Study||0
8686506|NCT02987543|21444502|P1|COMPLETED|Overall Study||0
8686507|NCT02987543|21444499|P4|STARTED|Overall Study||48
8686508|NCT02987543|21444500|P3|STARTED|Overall Study||94
8686509|NCT02987543|21444501|P2|STARTED|Overall Study||83
8686510|NCT02987543|21444502|P1|STARTED|Overall Study||162
8686511|NCT02717546|21444516|P1|NOT COMPLETED|Overall Study||12
8686512|NCT02717546|21444516|P1|COMPLETED|Overall Study||20
8686513|NCT02717546|21444516|P1|STARTED|Overall Study||32
8686514|NCT02687711|21444528|P1|NOT COMPLETED|Overall Study||212
8686515|NCT02687711|21444528|P1|COMPLETED|Overall Study||332
8686516|NCT02687711|21444528|P1|STARTED|Overall Study||544
8686517|NCT02633046|21444565|P1|NOT COMPLETED|Overall Study||27
8686518|NCT02633046|21444565|P1|COMPLETED|Overall Study||36
8686519|NCT02633046|21444565|P1|Safety Population|Overall Study||63
8686520|NCT02633046|21444565|P1|STARTED|Overall Study||63
8686521|NCT02631590|21444569|P1|NOT COMPLETED|Overall Study||0
8686522|NCT02631590|21444569|P1|COMPLETED|Overall Study||24
8686523|NCT02631590|21444569|P1|STARTED|Overall Study||24
8686524|NCT02566239|21444577|P2|NOT COMPLETED|Overall Study||4
8686525|NCT02566239|21444578|P1|NOT COMPLETED|Overall Study||4
8686526|NCT02566239|21444577|P2|COMPLETED|Overall Study||44
8686527|NCT02566239|21444578|P1|COMPLETED|Overall Study||39
8686528|NCT02566239|21444577|P2|STARTED|Overall Study||48
8686529|NCT02566239|21444578|P1|STARTED|Overall Study||43
8686530|NCT02542267|21444584|P1|NOT COMPLETED|Overall Study||77
8686531|NCT02542267|21444584|P1|COMPLETED|Overall Study||31
8686532|NCT02542267|21444584|P1|STARTED|Overall Study||108
8686533|NCT02407236|21444598|P8|NOT COMPLETED|Maintenance Study (44 Weeks)||8
8686534|NCT02407236|21444599|P7|NOT COMPLETED|Maintenance Study (44 Weeks)||9
8686535|NCT02407236|21444600|P6|NOT COMPLETED|Maintenance Study (44 Weeks)||8
8686536|NCT02407236|21444601|P5|NOT COMPLETED|Maintenance Study (44 Weeks)||11
8686537|NCT02407236|21444602|P4|NOT COMPLETED|Maintenance Study (44 Weeks)||10
8686538|NCT02407236|21444603|P3|NOT COMPLETED|Maintenance Study (44 Weeks)||0
8686539|NCT02407236|21444604|P2|NOT COMPLETED|Maintenance Study (44 Weeks)||0
8686540|NCT02407236|21444605|P1|NOT COMPLETED|Maintenance Study (44 Weeks)||0
8686541|NCT02407236|21444598|P8|COMPLETED|Maintenance Study (44 Weeks)||149
8686542|NCT02407236|21444599|P7|COMPLETED|Maintenance Study (44 Weeks)||94
8686543|NCT02407236|21444600|P6|COMPLETED|Maintenance Study (44 Weeks)||168
8686544|NCT02407236|21444601|P5|COMPLETED|Maintenance Study (44 Weeks)||161
8686545|NCT02407236|21444602|P4|COMPLETED|Maintenance Study (44 Weeks)||165
8686546|NCT02407236|21444603|P3|COMPLETED|Maintenance Study (44 Weeks)||0
8686547|NCT02407236|21444604|P2|COMPLETED|Maintenance Study (44 Weeks)||0
8686548|NCT02407236|21444605|P1|COMPLETED|Maintenance Study (44 Weeks)||0
8686549|NCT02407236|21444598|P8|STARTED|Maintenance Study (44 Weeks)||157
8686550|NCT02407236|21444599|P7|STARTED|Maintenance Study (44 Weeks)||103
8686551|NCT02407236|21444600|P6|STARTED|Maintenance Study (44 Weeks)||176
8686552|NCT02407236|21444601|P5|STARTED|Maintenance Study (44 Weeks)||172
8686553|NCT02407236|21444602|P4|STARTED|Maintenance Study (44 Weeks)||175
8686554|NCT02407236|21444603|P3|STARTED|Maintenance Study (44 Weeks)||0
8686555|NCT02407236|21444604|P2|STARTED|Maintenance Study (44 Weeks)||0
8686556|NCT02407236|21444605|P1|STARTED|Maintenance Study (44 Weeks)||0
8686557|NCT02407236|21444598|P8|NOT COMPLETED|Induction Study (8 Weeks)||0
8686558|NCT02407236|21444599|P7|NOT COMPLETED|Induction Study (8 Weeks)||0
8686559|NCT02407236|21444600|P6|NOT COMPLETED|Induction Study (8 Weeks)||0
8686560|NCT02407236|21444601|P5|NOT COMPLETED|Induction Study (8 Weeks)||0
8686561|NCT02407236|21444602|P4|NOT COMPLETED|Induction Study (8 Weeks)||0
8686562|NCT02407236|21444603|P3|NOT COMPLETED|Induction Study (8 Weeks)||15
8686563|NCT02407236|21444604|P2|NOT COMPLETED|Induction Study (8 Weeks)||11
8686564|NCT02407236|21444605|P1|NOT COMPLETED|Induction Study (8 Weeks)||23
8686565|NCT02407236|21444598|P8|COMPLETED|Induction Study (8 Weeks)||0
8686566|NCT02407236|21444599|P7|COMPLETED|Induction Study (8 Weeks)||0
8686567|NCT02407236|21444600|P6|COMPLETED|Induction Study (8 Weeks)||0
8686568|NCT02407236|21444601|P5|COMPLETED|Induction Study (8 Weeks)||0
8686569|NCT02407236|21444602|P4|COMPLETED|Induction Study (8 Weeks)||0
8686570|NCT02407236|21444603|P3|COMPLETED|Induction Study (8 Weeks)||307
8686571|NCT02407236|21444604|P2|COMPLETED|Induction Study (8 Weeks)||309
8686572|NCT02407236|21444605|P1|COMPLETED|Induction Study (8 Weeks)||296
8686573|NCT02407236|21444598|P8|Non-responders at Week 8|Induction Study (8 Weeks)||0
8686574|NCT02407236|21444599|P7|Non-responders at Week 8|Induction Study (8 Weeks)||0
8686575|NCT02407236|21444600|P6|Non-responders at Week 8|Induction Study (8 Weeks)||0
8686576|NCT02407236|21444601|P5|Non-responders at Week 8|Induction Study (8 Weeks)||0
8686577|NCT02407236|21444602|P4|Non-responders at Week 8|Induction Study (8 Weeks)||0
8686578|NCT02407236|21444603|P3|Non-responders at Week 8|Induction Study (8 Weeks)||101
8686579|NCT02407236|21444604|P2|Non-responders at Week 8|Induction Study (8 Weeks)||132
8686580|NCT02407236|21444605|P1|Non-responders at Week 8|Induction Study (8 Weeks)||184
8686581|NCT02407236|21444598|P8|Safety Analysis Set|Induction Study (8 Weeks)||0
8686582|NCT02407236|21444599|P7|Safety Analysis Set|Induction Study (8 Weeks)||0
8686583|NCT02407236|21444600|P6|Safety Analysis Set|Induction Study (8 Weeks)||0
8686584|NCT02407236|21444601|P5|Safety Analysis Set|Induction Study (8 Weeks)||0
8686585|NCT02407236|21444602|P4|Safety Analysis Set|Induction Study (8 Weeks)||0
8686586|NCT02407236|21444603|P3|Safety Analysis Set|Induction Study (8 Weeks)||320
8686587|NCT02407236|21444604|P2|Safety Analysis Set|Induction Study (8 Weeks)|1 participant of ustekinumab 130mg never had drug, 2 participants planned to 6 mg/kg but had 130mg.|321
8686588|NCT02407236|21444605|P1|Safety Analysis Set|Induction Study (8 Weeks)||319
8686589|NCT02407236|21444598|P8|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8686590|NCT02407236|21444599|P7|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8686591|NCT02407236|21444600|P6|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8686592|NCT02407236|21444601|P5|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8686593|NCT02407236|21444602|P4|Completed Safety Follow-up|Induction Study (8 Weeks)||0
8686594|NCT02407236|21444603|P3|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 22 from IW- 16.|32
8686595|NCT02407236|21444604|P2|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 37 from IW- 16.|47
8686596|NCT02407236|21444605|P1|Completed Safety Follow-up|Induction Study (8 Weeks)|17 participants from Induction Week (IW)- 8 and 33 participants from IW- 16.|50
8686597|NCT02407236|21444598|P8|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8686598|NCT02407236|21444599|P7|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8686599|NCT02407236|21444600|P6|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8686600|NCT02407236|21444601|P5|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8686601|NCT02407236|21444602|P4|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
8686602|NCT02407236|21444603|P3|Clinical Response at IS Week 16|Induction Study (8 Weeks)||67
8686603|NCT02407236|21444604|P2|Clinical Response at IS Week 16|Induction Study (8 Weeks)||90
8686604|NCT02407236|21444605|P1|Clinical Response at IS Week 16|Induction Study (8 Weeks)||143
8686605|NCT02407236|21444598|P8|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8686606|NCT02407236|21444599|P7|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8686607|NCT02407236|21444600|P6|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8686608|NCT02407236|21444601|P5|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8686609|NCT02407236|21444602|P4|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
8686610|NCT02407236|21444603|P3|Clinical Response at IS Week 8|Induction Study (8 Weeks)||208
8686611|NCT02407236|21444604|P2|Clinical Response at IS Week 8|Induction Study (8 Weeks)||172
8686612|NCT02407236|21444605|P1|Clinical Response at IS Week 8|Induction Study (8 Weeks)||103
8686613|NCT02407236|21444598|P8|STARTED|Induction Study (8 Weeks)||0
8686614|NCT02407236|21444599|P7|STARTED|Induction Study (8 Weeks)||0
8686615|NCT02407236|21444600|P6|STARTED|Induction Study (8 Weeks)||0
8686616|NCT02407236|21444601|P5|STARTED|Induction Study (8 Weeks)||0
8686617|NCT02407236|21444602|P4|STARTED|Induction Study (8 Weeks)||0
8686618|NCT02407236|21444603|P3|STARTED|Induction Study (8 Weeks)||322
8686619|NCT02407236|21444604|P2|STARTED|Induction Study (8 Weeks)||320
8686620|NCT02407236|21444605|P1|STARTED|Induction Study (8 Weeks)||319
8686621|NCT02186834|21444842|P6|NOT COMPLETED|Treatment at RP2D||1
8686622|NCT02186834|21444843|P5|NOT COMPLETED|Treatment at RP2D||0
8686623|NCT02186834|21444844|P4|NOT COMPLETED|Treatment at RP2D||0
8686624|NCT02186834|21444845|P3|NOT COMPLETED|Treatment at RP2D||0
8686625|NCT02186834|21444846|P2|NOT COMPLETED|Treatment at RP2D||0
8686626|NCT02186834|21444847|P1|NOT COMPLETED|Treatment at RP2D||0
8686627|NCT02186834|21444842|P6|COMPLETED|Treatment at RP2D||13
8686628|NCT02186834|21444843|P5|COMPLETED|Treatment at RP2D||0
8686629|NCT02186834|21444844|P4|COMPLETED|Treatment at RP2D||0
8686630|NCT02186834|21444845|P3|COMPLETED|Treatment at RP2D||0
8686631|NCT02186834|21444846|P2|COMPLETED|Treatment at RP2D||0
8686632|NCT02186834|21444847|P1|COMPLETED|Treatment at RP2D||0
8686633|NCT02186834|21444842|P6|STARTED|Treatment at RP2D||14
8686634|NCT02186834|21444843|P5|STARTED|Treatment at RP2D||0
8686635|NCT02186834|21444844|P4|STARTED|Treatment at RP2D||0
8686636|NCT02186834|21444845|P3|STARTED|Treatment at RP2D||0
8686637|NCT02186834|21444846|P2|STARTED|Treatment at RP2D||0
8686638|NCT02186834|21444847|P1|STARTED|Treatment at RP2D||0
8686639|NCT02186834|21444842|P6|NOT COMPLETED|Dose Escalation||0
8686640|NCT02186834|21444843|P5|NOT COMPLETED|Dose Escalation||0
8686641|NCT02186834|21444844|P4|NOT COMPLETED|Dose Escalation||1
8686642|NCT02186834|21444845|P3|NOT COMPLETED|Dose Escalation||0
8686643|NCT02186834|21444846|P2|NOT COMPLETED|Dose Escalation||0
8686644|NCT02186834|21444847|P1|NOT COMPLETED|Dose Escalation||0
8686645|NCT02186834|21444842|P6|COMPLETED|Dose Escalation||0
8686646|NCT02186834|21444843|P5|COMPLETED|Dose Escalation||4
8686647|NCT02186834|21444844|P4|COMPLETED|Dose Escalation||6
8686648|NCT02186834|21444845|P3|COMPLETED|Dose Escalation||0
8686649|NCT02186834|21444846|P2|COMPLETED|Dose Escalation||3
8686650|NCT02186834|21444847|P1|COMPLETED|Dose Escalation||6
8686651|NCT02186834|21444842|P6|STARTED|Dose Escalation||0
8686652|NCT02186834|21444843|P5|STARTED|Dose Escalation||4
8686653|NCT02186834|21444844|P4|STARTED|Dose Escalation||7
8686654|NCT02186834|21444845|P3|STARTED|Dose Escalation||0
8686655|NCT02186834|21444846|P2|STARTED|Dose Escalation||3
8686656|NCT02186834|21444847|P1|STARTED|Dose Escalation||6
8686657|NCT02151981|21444860|P2|NOT COMPLETED|Overall Study||140
8686658|NCT02151981|21444861|P1|NOT COMPLETED|Overall Study||279
8686659|NCT02151981|21444860|P2|COMPLETED|Overall Study||0
8686660|NCT02151981|21444861|P1|COMPLETED|Overall Study||0
8686661|NCT02151981|21444860|P2|Crossed Over Osimertinib|Overall Study|Patients randomised to chemotherapy were allowed to crossover to Osimertinib after progression|99
8686662|NCT02151981|21444861|P1|Crossed Over Osimertinib|Overall Study||0
8686663|NCT02151981|21444860|P2|Did Not Receive Treatment|Overall Study||4
8686664|NCT02151981|21444861|P1|Did Not Receive Treatment|Overall Study||0
8686665|NCT02151981|21444860|P2|Received Randomised Treatment Only|Overall Study||136
8686666|NCT02151981|21444861|P1|Received Randomised Treatment Only|Overall Study||279
8686667|NCT02151981|21444860|P2|STARTED|Overall Study||140
8686668|NCT02151981|21444861|P1|STARTED|Overall Study||279
8686669|NCT02028221|21444883|P2|NOT COMPLETED|Overall Study||20
8686670|NCT02028221|21444884|P1|NOT COMPLETED|Overall Study||13
8686671|NCT02028221|21444883|P2|COMPLETED|Overall Study||56
8686672|NCT02028221|21444884|P1|COMPLETED|Overall Study||62
8686673|NCT02028221|21444883|P2|STARTED|Overall Study||76
8686674|NCT02028221|21444884|P1|STARTED|Overall Study||75
8686675|NCT01976975|21444894|P2|NOT COMPLETED|Overall Study||12
8686676|NCT01976975|21444895|P1|NOT COMPLETED|Overall Study||147
8686677|NCT01976975|21444894|P2|COMPLETED|Overall Study||32
8686678|NCT01976975|21444895|P1|COMPLETED|Overall Study||79
8686679|NCT01976975|21444894|P2|STARTED|Overall Study||44
8686680|NCT01976975|21444895|P1|STARTED|Overall Study||226
8686681|NCT01953692|21444914|P9|NOT COMPLETED|Overall Study||5
8686682|NCT01953692|21444915|P8|NOT COMPLETED|Overall Study||10
8686683|NCT01953692|21444916|P7|NOT COMPLETED|Overall Study||32
8686684|NCT01953692|21444917|P6|NOT COMPLETED|Overall Study||18
8686685|NCT01953692|21444918|P5|NOT COMPLETED|Overall Study||3
8686686|NCT01953692|21444919|P4|NOT COMPLETED|Overall Study||14
8686687|NCT01953692|21444920|P3|NOT COMPLETED|Overall Study||20
8686688|NCT01953692|21444921|P2|NOT COMPLETED|Overall Study||25
8686689|NCT01953692|21444922|P1|NOT COMPLETED|Overall Study||27
8686690|NCT01953692|21444914|P9|COMPLETED|Overall Study||1
8686691|NCT01953692|21444915|P8|COMPLETED|Overall Study||3
8686692|NCT01953692|21444916|P7|COMPLETED|Overall Study||10
8686693|NCT01953692|21444917|P6|COMPLETED|Overall Study||4
8686694|NCT01953692|21444918|P5|COMPLETED|Overall Study||1
8686695|NCT01953692|21444919|P4|COMPLETED|Overall Study||7
8686696|NCT01953692|21444920|P3|COMPLETED|Overall Study||11
8686697|NCT01953692|21444921|P2|COMPLETED|Overall Study||5
8686698|NCT01953692|21444922|P1|COMPLETED|Overall Study||1
8686699|NCT01953692|21444914|P9|STARTED|Overall Study||6
8686700|NCT01953692|21444915|P8|STARTED|Overall Study||13
8686701|NCT01953692|21444916|P7|STARTED|Overall Study||42
8686702|NCT01953692|21444917|P6|STARTED|Overall Study||22
8686703|NCT01953692|21444918|P5|STARTED|Overall Study||4
8686704|NCT01953692|21444919|P4|STARTED|Overall Study||21
8686705|NCT01953692|21444920|P3|STARTED|Overall Study||31
8686706|NCT01953692|21444921|P2|STARTED|Overall Study||30
8686707|NCT01953692|21444922|P1|STARTED|Overall Study||28
8686714|NCT01743131|21445050|P5|NOT COMPLETED|Overall Study||0
8686715|NCT01743131|21445051|P4|NOT COMPLETED|Overall Study||0
8686716|NCT01743131|21445052|P3|NOT COMPLETED|Overall Study||0
8686717|NCT01743131|21445053|P2|NOT COMPLETED|Overall Study||0
8686718|NCT01743131|21445054|P1|NOT COMPLETED|Overall Study||0
8686719|NCT01743131|21445050|P5|COMPLETED|Overall Study||127
8686720|NCT01743131|21445051|P4|COMPLETED|Overall Study||1
8686721|NCT01743131|21445052|P3|COMPLETED|Overall Study||43
8686722|NCT01743131|21445053|P2|COMPLETED|Overall Study||69
8686723|NCT01743131|21445054|P1|COMPLETED|Overall Study||73
8686724|NCT01743131|21445050|P5|Not Included in Analysis|Overall Study||0
8686725|NCT01743131|21445051|P4|Not Included in Analysis|Overall Study||1
8686726|NCT01743131|21445052|P3|Not Included in Analysis|Overall Study||0
8686727|NCT01743131|21445053|P2|Not Included in Analysis|Overall Study||0
8686728|NCT01743131|21445054|P1|Not Included in Analysis|Overall Study||0
8686729|NCT01743131|21445050|P5|STARTED|Overall Study||127
8686730|NCT01743131|21445051|P4|STARTED|Overall Study||1
8686731|NCT01743131|21445052|P3|STARTED|Overall Study||43
8686732|NCT01743131|21445053|P2|STARTED|Overall Study||69
8686733|NCT01743131|21445054|P1|STARTED|Overall Study||73
8686734|NCT01721772|21445073|P2|NOT COMPLETED|Overall Study||192
8686735|NCT01721772|21445074|P1|NOT COMPLETED|Overall Study||111
8686736|NCT01721772|21445073|P2|COMPLETED|Overall Study|Continuing in treatment period|13
8686737|NCT01721772|21445074|P1|COMPLETED|Overall Study|Continuing in treatment period|95
8686738|NCT01721772|21445073|P2|STARTED|Overall Study||205
8686739|NCT01721772|21445074|P1|STARTED|Overall Study||206
8686740|NCT01701674|21445094|P1|NOT COMPLETED|Overall Study||1
8686741|NCT01701674|21445094|P1|COMPLETED|Overall Study||12
8686742|NCT01701674|21445094|P1|STARTED|Overall Study||13
8686743|NCT01638052|21445103|P2|NOT COMPLETED|Overall Study||0
8686744|NCT01638052|21445104|P1|NOT COMPLETED|Overall Study||0
8686745|NCT01638052|21445103|P2|COMPLETED|Overall Study||28
8686746|NCT01638052|21445104|P1|COMPLETED|Overall Study||28
8686747|NCT01638052|21445103|P2|STARTED|Overall Study||28
8686748|NCT01638052|21445104|P1|STARTED|Overall Study||28
8686749|NCT01269034|21445118|P4|NOT COMPLETED|Overall Study||0
8686750|NCT01269034|21445119|P3|NOT COMPLETED|Overall Study||0
8686751|NCT01269034|21445120|P2|NOT COMPLETED|Overall Study||0
8686752|NCT01269034|21445121|P1|NOT COMPLETED|Overall Study||1
8686753|NCT01269034|21445118|P4|COMPLETED|Overall Study||9
8686754|NCT01269034|21445119|P3|COMPLETED|Overall Study||1
8686755|NCT01269034|21445120|P2|COMPLETED|Overall Study||2
8686756|NCT01269034|21445121|P1|COMPLETED|Overall Study||0
8686757|NCT01269034|21445118|P4|STARTED|Overall Study||9
8686758|NCT01269034|21445119|P3|STARTED|Overall Study||1
8686759|NCT01269034|21445120|P2|STARTED|Overall Study||2
8686760|NCT01269034|21445121|P1|STARTED|Overall Study||1
8686767|NCT00910650|21445152|P1|NOT COMPLETED|Overall Study||2
8686768|NCT00910650|21445152|P1|COMPLETED|Overall Study||12
8686769|NCT00910650|21445152|P1|STARTED|Overall Study||14
8686770|NCT00711555|21445157|P1|NOT COMPLETED|Overall Study||3
8686771|NCT00711555|21445157|P1|COMPLETED|Overall Study||19
8686772|NCT00711555|21445157|P1|STARTED|Overall Study||22
8686773|NCT00449007|21445166|P2|NOT COMPLETED|Overall Study||0
8686774|NCT00449007|21445167|P1|NOT COMPLETED|Overall Study||0
8686775|NCT00449007|21445166|P2|COMPLETED|Overall Study||3
8686776|NCT00449007|21445167|P1|COMPLETED|Overall Study||2
8686777|NCT00449007|21445166|P2|STARTED|Overall Study||3
8686778|NCT00449007|21445167|P1|STARTED|Overall Study||2
8686779|NCT00214136|21445175|P1|NOT COMPLETED|Overall Study||5
8686780|NCT00214136|21445175|P1|COMPLETED|Overall Study||25
8686781|NCT00214136|21445175|P1|STARTED|Overall Study||30
8686782|NCT00145145|21445180|P1|NOT COMPLETED|Overall Study||0
8686783|NCT00145145|21445180|P1|COMPLETED|Overall Study||1
8686784|NCT00145145|21445180|P1|STARTED|Overall Study||1
8686788|NCT04277936|21445192|P1|NOT COMPLETED|Overall Study||0
8686789|NCT04277936|21445192|P1|COMPLETED|Overall Study||1
8686790|NCT04277936|21445192|P1|STARTED|Overall Study||1
8686791|NCT04141930|21445199|P2|NOT COMPLETED|Overall Study||0
8686792|NCT04141930|21445200|P1|NOT COMPLETED|Overall Study||0
8686793|NCT04141930|21445199|P2|COMPLETED|Overall Study||179
8686794|NCT04141930|21445200|P1|COMPLETED|Overall Study||302
8686795|NCT04141930|21445199|P2|STARTED|Overall Study|The 179 individuals that were not eligible to receive the study drug, participated in an observation portion of the study where all study procedures were the same excluding telehealth visit and an antiviral delivery.|179
8686796|NCT04141930|21445200|P1|STARTED|Overall Study||302
8686797|NCT04032171|21445208|P2|NOT COMPLETED|Overall Study||0
8686798|NCT04032171|21445209|P1|NOT COMPLETED|Overall Study||1
8686799|NCT04032171|21445208|P2|COMPLETED|Overall Study||0
8686800|NCT04032171|21445209|P1|COMPLETED|Overall Study||0
8686801|NCT04032171|21445208|P2|STARTED|Overall Study||0
8686802|NCT04032171|21445209|P1|STARTED|Overall Study||1
8686803|NCT04032158|21445263|P2|NOT COMPLETED|Overall Study||1
8686804|NCT04032158|21445264|P1|NOT COMPLETED|Overall Study||2
8686805|NCT04032158|21445263|P2|COMPLETED|Overall Study||0
8686806|NCT04032158|21445264|P1|COMPLETED|Overall Study||0
8686807|NCT04032158|21445263|P2|STARTED|Overall Study||1
8686808|NCT04032158|21445264|P1|STARTED|Overall Study||2
8686809|NCT03832907|21445316|P1|NOT COMPLETED|Overall Study||10
8686810|NCT03832907|21445316|P1|COMPLETED|Overall Study||91
8686811|NCT03832907|21445316|P1|STARTED|Overall Study||101
8686812|NCT03772041|21445371|P2|NOT COMPLETED|Overall Study||10
8686813|NCT03772041|21445372|P1|NOT COMPLETED|Overall Study||14
8686814|NCT03772041|21445371|P2|COMPLETED|Overall Study||135
8686815|NCT03772041|21445372|P1|COMPLETED|Overall Study||135
8686816|NCT03772041|21445371|P2|STARTED|Overall Study||145
8686817|NCT03772041|21445372|P1|STARTED|Overall Study||149
8686818|NCT03762993|21445388|P2|NOT COMPLETED|Overall Study||0
8686819|NCT03762993|21445389|P1|NOT COMPLETED|Overall Study||0
8686820|NCT03762993|21445388|P2|COMPLETED|Overall Study||10
8686821|NCT03762993|21445389|P1|COMPLETED|Overall Study||21
8686822|NCT03762993|21445388|P2|STARTED|Overall Study||10
8686823|NCT03762993|21445389|P1|STARTED|Overall Study||21
8686824|NCT03688685|21445397|P1|NOT COMPLETED|Overall Study||4
8686825|NCT03688685|21445397|P1|COMPLETED|Overall Study||21
8686826|NCT03688685|21445397|P1|STARTED|Overall Study||25
8686827|NCT03634800|21445401|P1|NOT COMPLETED|Overall Study||6
8686828|NCT03634800|21445401|P1|COMPLETED|Overall Study||0
8686829|NCT03634800|21445401|P1|STARTED|Overall Study||6
8686830|NCT03604705|21445407|P1|NOT COMPLETED|Overall Study||1
8686831|NCT03604705|21445407|P1|COMPLETED|Overall Study||20
8686832|NCT03604705|21445407|P1|STARTED|Overall Study||21
8686833|NCT03504917|21445422|P2|NOT COMPLETED|Open Label Extension Treatment Period||97
8686834|NCT03504917|21445423|P1|NOT COMPLETED|Open Label Extension Treatment Period||100
8686835|NCT03504917|21445422|P2|COMPLETED|Open Label Extension Treatment Period||0
8686836|NCT03504917|21445423|P1|COMPLETED|Open Label Extension Treatment Period||0
8686837|NCT03504917|21445422|P2|STARTED|Open Label Extension Treatment Period||97
8686838|NCT03504917|21445423|P1|STARTED|Open Label Extension Treatment Period||100
8686839|NCT03504917|21445422|P2|NOT COMPLETED|Blinded Treatment Period||56
8686840|NCT03504917|21445423|P1|NOT COMPLETED|Blinded Treatment Period||60
8686841|NCT03504917|21445422|P2|COMPLETED|Blinded Treatment Period||102
8686842|NCT03504917|21445423|P1|COMPLETED|Blinded Treatment Period||103
8686843|NCT03504917|21445422|P2|STARTED|Blinded Treatment Period||158
8686844|NCT03504917|21445423|P1|STARTED|Blinded Treatment Period||163
8686845|NCT03428360|21445455|P1|NOT COMPLETED|Overall Study||40
8686846|NCT03428360|21445455|P1|COMPLETED|Overall Study||90
8686847|NCT03428360|21445455|P1|STARTED|Overall Study||130
8686848|NCT03287245|21445471|P4|NOT COMPLETED|Overall Study||1
8686849|NCT03287245|21445472|P3|NOT COMPLETED|Overall Study||6
8686850|NCT03287245|21445473|P2|NOT COMPLETED|Overall Study||5
8686851|NCT03287245|21445474|P1|NOT COMPLETED|Overall Study||15
8686852|NCT03287245|21445471|P4|COMPLETED|Overall Study||0
8686853|NCT03287245|21445472|P3|COMPLETED|Overall Study||0
8686854|NCT03287245|21445473|P2|COMPLETED|Overall Study||0
8686855|NCT03287245|21445474|P1|COMPLETED|Overall Study||0
8686856|NCT03287245|21445471|P4|STARTED|Overall Study||1
8686857|NCT03287245|21445472|P3|STARTED|Overall Study||6
8686858|NCT03287245|21445473|P2|STARTED|Overall Study||5
8686859|NCT03287245|21445474|P1|STARTED|Overall Study||15
8686860|NCT03283371|21445594|P2|NOT COMPLETED|Overall Study||3
8686861|NCT03283371|21445595|P1|NOT COMPLETED|Overall Study||3
8686862|NCT03283371|21445594|P2|COMPLETED|Overall Study||30
8686863|NCT03283371|21445595|P1|COMPLETED|Overall Study||31
8686864|NCT03283371|21445594|P2|Number of Participants Dosed|Overall Study||32
8686865|NCT03283371|21445595|P1|Number of Participants Dosed|Overall Study||34
8686866|NCT03283371|21445594|P2|STARTED|Overall Study||33
8686867|NCT03283371|21445595|P1|STARTED|Overall Study||34
8686868|NCT03248440|21445611|P2|NOT COMPLETED|Overall Study||12
8686869|NCT03248440|21445612|P1|NOT COMPLETED|Overall Study||15
8686870|NCT03248440|21445611|P2|COMPLETED|Overall Study||120
8686871|NCT03248440|21445612|P1|COMPLETED|Overall Study||116
8686872|NCT03248440|21445611|P2|STARTED|Overall Study||132
8686873|NCT03248440|21445612|P1|STARTED|Overall Study||131
8686874|NCT03201900|21445620|P1|NOT COMPLETED|Extension Phase (From Week 63 to 156)||8
8686875|NCT03201900|21445620|P1|COMPLETED|Extension Phase (From Week 63 to 156)||38
8686876|NCT03201900|21445620|P1|STARTED|Extension Phase (From Week 63 to 156)|Eligible participants who completed Treatment Phase and agreed to continue in the Extension Phase.|46
8686877|NCT03201900|21445620|P1|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37
8686878|NCT03201900|21445620|P1|COMPLETED|Treatment Phase (Up to 62 Weeks)||54
8686879|NCT03201900|21445620|P1|Treated|Treatment Phase (Up to 62 Weeks)||89
8686880|NCT03201900|21445620|P1|STARTED|Treatment Phase (Up to 62 Weeks)||91
8686881|NCT03187132|21445634|P2|NOT COMPLETED|Pain Clinic Only, Fully Remote||54
8686882|NCT03187132|21445635|P1|NOT COMPLETED|Pain Clinic Only, Fully Remote||33
8686883|NCT03187132|21445634|P2|COMPLETED|Pain Clinic Only, Fully Remote||64
8686884|NCT03187132|21445635|P1|COMPLETED|Pain Clinic Only, Fully Remote||43
8686885|NCT03187132|21445634|P2|STARTED|Pain Clinic Only, Fully Remote||118
8686886|NCT03187132|21445635|P1|STARTED|Pain Clinic Only, Fully Remote||76
8686887|NCT03187132|21445634|P2|NOT COMPLETED|Inpatient Trauma+Pain Clinic||7
8686888|NCT03187132|21445635|P1|NOT COMPLETED|Inpatient Trauma+Pain Clinic||3
8686889|NCT03187132|21445634|P2|COMPLETED|Inpatient Trauma+Pain Clinic||0
8686890|NCT03187132|21445635|P1|COMPLETED|Inpatient Trauma+Pain Clinic||8
8686891|NCT03187132|21445634|P2|STARTED|Inpatient Trauma+Pain Clinic||7
8686892|NCT03187132|21445635|P1|STARTED|Inpatient Trauma+Pain Clinic||11
8686893|NCT03187132|21445634|P2|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||5
8686894|NCT03187132|21445635|P1|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||1
8686895|NCT03187132|21445634|P2|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||0
8686896|NCT03187132|21445635|P1|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||3
8686897|NCT03187132|21445634|P2|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||5
8686898|NCT03187132|21445635|P1|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||4
8686899|NCT03187132|21445634|P2|NOT COMPLETED|Inpatient Trauma Only||12
8686900|NCT03187132|21445635|P1|NOT COMPLETED|Inpatient Trauma Only||4
8686901|NCT03187132|21445634|P2|COMPLETED|Inpatient Trauma Only||0
8686902|NCT03187132|21445635|P1|COMPLETED|Inpatient Trauma Only||8
8686903|NCT03187132|21445634|P2|STARTED|Inpatient Trauma Only||12
8686904|NCT03187132|21445635|P1|STARTED|Inpatient Trauma Only||12
8686905|NCT03161483|21445653|P4|NOT COMPLETED|Overall Study||8
8686906|NCT03161483|21445654|P3|NOT COMPLETED|Overall Study||20
8686907|NCT03161483|21445655|P2|NOT COMPLETED|Overall Study||3
8686908|NCT03161483|21445656|P1|NOT COMPLETED|Overall Study||10
8686909|NCT03161483|21445653|P4|COMPLETED|Overall Study||73
8686910|NCT03161483|21445654|P3|COMPLETED|Overall Study||62
8686911|NCT03161483|21445655|P2|COMPLETED|Overall Study||39
8686912|NCT03161483|21445656|P1|COMPLETED|Overall Study||73
8686913|NCT03161483|21445653|P4|STARTED|Overall Study||81
8686914|NCT03161483|21445654|P3|STARTED|Overall Study||82
8686915|NCT03161483|21445655|P2|STARTED|Overall Study||42
8686916|NCT03161483|21445656|P1|STARTED|Overall Study||83
8686917|NCT03135262|21445719|P5|NOT COMPLETED|Overall Study||1
8686918|NCT03135262|21445720|P4|NOT COMPLETED|Overall Study||6
8686919|NCT03135262|21445721|P3|NOT COMPLETED|Overall Study||7
8686920|NCT03135262|21445722|P2|NOT COMPLETED|Overall Study||6
8686921|NCT03135262|21445723|P1|NOT COMPLETED|Overall Study||9
8686922|NCT03135262|21445719|P5|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
8687013|NCT02607956|21446048|P1|NOT COMPLETED|Open-Label Extension Phase||254
8686923|NCT03135262|21445720|P4|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
8686924|NCT03135262|21445721|P3|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
8686925|NCT03135262|21445722|P2|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
8686926|NCT03135262|21445723|P1|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
8686927|NCT03135262|21445719|P5|STARTED|Overall Study||1
8686928|NCT03135262|21445720|P4|STARTED|Overall Study||6
8686929|NCT03135262|21445721|P3|STARTED|Overall Study||7
8686930|NCT03135262|21445722|P2|STARTED|Overall Study||6
8686931|NCT03135262|21445723|P1|STARTED|Overall Study||9
8686932|NCT03131453|21445834|P3|NOT COMPLETED|Overall Study||456
8686933|NCT03131453|21445835|P2|NOT COMPLETED|Overall Study||233
8686934|NCT03131453|21445836|P1|NOT COMPLETED|Overall Study||456
8686935|NCT03131453|21445834|P3|COMPLETED|Overall Study||0
8686936|NCT03131453|21445835|P2|COMPLETED|Overall Study||0
8686937|NCT03131453|21445836|P1|COMPLETED|Overall Study||0
8686938|NCT03131453|21445834|P3|Patient Misrandomized|Overall Study||0
8686939|NCT03131453|21445835|P2|Patient Misrandomized|Overall Study||0
8686940|NCT03131453|21445836|P1|Patient Misrandomized|Overall Study||1
8686941|NCT03131453|21445834|P3|STARTED|Overall Study||456
8686942|NCT03131453|21445835|P2|STARTED|Overall Study||233
8686943|NCT03131453|21445836|P1|STARTED|Overall Study||456
8686944|NCT03085914|21445893|P7|NOT COMPLETED|Overall Study||11
8686945|NCT03085914|21445894|P6|NOT COMPLETED|Overall Study||8
8686946|NCT03085914|21445895|P5|NOT COMPLETED|Overall Study||13
8686947|NCT03085914|21445896|P4|NOT COMPLETED|Overall Study||9
8686948|NCT03085914|21445897|P3|NOT COMPLETED|Overall Study||11
8686949|NCT03085914|21445898|P2|NOT COMPLETED|Overall Study||9
8686950|NCT03085914|21445899|P1|NOT COMPLETED|Overall Study||9
8686951|NCT03085914|21445893|P7|COMPLETED|Overall Study||0
8686952|NCT03085914|21445894|P6|COMPLETED|Overall Study||0
8686953|NCT03085914|21445895|P5|COMPLETED|Overall Study||0
8686954|NCT03085914|21445896|P4|COMPLETED|Overall Study||0
8686955|NCT03085914|21445897|P3|COMPLETED|Overall Study||0
8686956|NCT03085914|21445898|P2|COMPLETED|Overall Study||0
8686957|NCT03085914|21445899|P1|COMPLETED|Overall Study||0
8686958|NCT03085914|21445893|P7|STARTED|Overall Study||11
8686959|NCT03085914|21445894|P6|STARTED|Overall Study||8
8686960|NCT03085914|21445895|P5|STARTED|Overall Study||13
8686961|NCT03085914|21445896|P4|STARTED|Overall Study||9
8686962|NCT03085914|21445897|P3|STARTED|Overall Study||11
8686963|NCT03085914|21445898|P2|STARTED|Overall Study||9
8686964|NCT03085914|21445899|P1|STARTED|Overall Study||9
8686965|NCT03019965|21445932|P2|NOT COMPLETED|Overall Study||13
8686966|NCT03019965|21445933|P1|NOT COMPLETED|Overall Study||10
8686967|NCT03019965|21445932|P2|COMPLETED|Overall Study||202
8686968|NCT03019965|21445933|P1|COMPLETED|Overall Study||201
8686969|NCT03019965|21445932|P2|STARTED|Overall Study||215
8686970|NCT03019965|21445933|P1|STARTED|Overall Study||211
8686971|NCT02985021|21445941|P1|NOT COMPLETED|Overall Study||1
8686972|NCT02985021|21445941|P1|COMPLETED|Overall Study||1
8686973|NCT02985021|21445941|P1|STARTED|Overall Study||2
8686977|NCT02792504|21445959|P1|NOT COMPLETED|Overall Study||30
8686978|NCT02792504|21445959|P1|COMPLETED|Overall Study||639
8686979|NCT02792504|21445959|P1|Efficacy Analysis Set|Overall Study||390
8686980|NCT02792504|21445959|P1|Safety Analysis Set|Overall Study||639
8686981|NCT02792504|21445959|P1|STARTED|Overall Study||669
8686982|NCT02769351|21445971|P1|NOT COMPLETED|Overall Study||42
8686983|NCT02769351|21445971|P1|COMPLETED|Overall Study|SP|4
8686984|NCT02769351|21445971|P1|STARTED|Overall Study|SP|46
8686985|NCT02693262|21445979|P2|NOT COMPLETED|Overall Study||0
8686986|NCT02693262|21445980|P1|NOT COMPLETED|Overall Study||0
8686987|NCT02693262|21445979|P2|COMPLETED|Overall Study||5
8686988|NCT02693262|21445980|P1|COMPLETED|Overall Study||4
8686989|NCT02693262|21445979|P2|STARTED|Overall Study||5
8686990|NCT02693262|21445980|P1|STARTED|Overall Study||4
8686994|NCT02641353|21446005|P6|NOT COMPLETED|Overall Study||0
8686995|NCT02641353|21446006|P5|NOT COMPLETED|Overall Study||0
8686996|NCT02641353|21446007|P4|NOT COMPLETED|Overall Study||0
8686997|NCT02641353|21446008|P3|NOT COMPLETED|Overall Study||0
8686998|NCT02641353|21446009|P2|NOT COMPLETED|Overall Study||0
8686999|NCT02641353|21446010|P1|NOT COMPLETED|Overall Study||0
8687000|NCT02641353|21446005|P6|COMPLETED|Overall Study||6
8687001|NCT02641353|21446006|P5|COMPLETED|Overall Study||6
8687002|NCT02641353|21446007|P4|COMPLETED|Overall Study||6
8687003|NCT02641353|21446008|P3|COMPLETED|Overall Study||6
8687004|NCT02641353|21446009|P2|COMPLETED|Overall Study||5
8687005|NCT02641353|21446010|P1|COMPLETED|Overall Study||5
8687006|NCT02641353|21446005|P6|STARTED|Overall Study||6
8687007|NCT02641353|21446006|P5|STARTED|Overall Study||6
8687008|NCT02641353|21446007|P4|STARTED|Overall Study||6
8687009|NCT02641353|21446008|P3|STARTED|Overall Study||6
8687010|NCT02641353|21446009|P2|STARTED|Overall Study||5
8687011|NCT02641353|21446010|P1|STARTED|Overall Study||5
8687012|NCT02607956|21446047|P2|NOT COMPLETED|Open-Label Extension Phase||265
8687014|NCT02607956|21446047|P2|COMPLETED|Open-Label Extension Phase||0
8687015|NCT02607956|21446048|P1|COMPLETED|Open-Label Extension Phase||0
8687016|NCT02607956|21446047|P2|STARTED|Open-Label Extension Phase|12 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase|265
8687017|NCT02607956|21446048|P1|STARTED|Open-Label Extension Phase|12 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase|254
8687018|NCT02607956|21446047|P2|NOT COMPLETED|Double-Blinded Phase||53
8687019|NCT02607956|21446048|P1|NOT COMPLETED|Double-Blinded Phase||61
8687020|NCT02607956|21446047|P2|COMPLETED|Double-Blinded Phase||277
8687021|NCT02607956|21446048|P1|COMPLETED|Double-Blinded Phase||266
8687022|NCT02607956|21446047|P2|STARTED|Double-Blinded Phase||330
8687023|NCT02607956|21446048|P1|STARTED|Double-Blinded Phase||327
8687024|NCT02603432|21446084|P2|NOT COMPLETED|Overall Study||350
8687025|NCT02603432|21446085|P1|NOT COMPLETED|Overall Study||350
8687026|NCT02603432|21446084|P2|COMPLETED|Overall Study||0
8687027|NCT02603432|21446085|P1|COMPLETED|Overall Study||0
8687028|NCT02603432|21446084|P2|STARTED|Overall Study||350
8687029|NCT02603432|21446085|P1|STARTED|Overall Study||350
8687030|NCT02581137|21446133|P1|NOT COMPLETED|Overall Study||4
8687031|NCT02581137|21446133|P1|COMPLETED|Overall Study||22
8687032|NCT02581137|21446133|P1|STARTED|Overall Study||26
8687033|NCT02568072|21446138|P1|NOT COMPLETED|Overall Study||52
8687034|NCT02568072|21446138|P1|COMPLETED|Overall Study||68
8687035|NCT02568072|21446138|P1|STARTED|Overall Study||120
8687036|NCT02487979|21446151|P1|NOT COMPLETED|Overall Study||21
8687037|NCT02487979|21446151|P1|COMPLETED|Overall Study||1
8687038|NCT02487979|21446151|P1|STARTED|Overall Study||22
8687039|NCT02484443|21446161|P1|NOT COMPLETED|Overall Study||32
8687040|NCT02484443|21446161|P1|COMPLETED|Overall Study||9
8687041|NCT02484443|21446161|P1|STARTED|Overall Study||41
8687042|NCT02397278|21446172|P2|NOT COMPLETED|Overall Study||3
8687043|NCT02397278|21446173|P1|NOT COMPLETED|Overall Study||1
8687044|NCT02397278|21446172|P2|COMPLETED|Overall Study||5
8687045|NCT02397278|21446173|P1|COMPLETED|Overall Study||6
8687046|NCT02397278|21446172|P2|STARTED|Overall Study||8
8687047|NCT02397278|21446173|P1|STARTED|Overall Study||7
8687056|NCT02243605|21446244|P2|NOT COMPLETED|Stage 2 - Final Analysis Population||3
8687057|NCT02243605|21446245|P1|NOT COMPLETED|Stage 2 - Final Analysis Population||6
8687058|NCT02243605|21446244|P2|COMPLETED|Stage 2 - Final Analysis Population||42
8687059|NCT02243605|21446245|P1|COMPLETED|Stage 2 - Final Analysis Population||39
8687060|NCT02243605|21446244|P2|STARTED|Stage 2 - Final Analysis Population||45
8687061|NCT02243605|21446245|P1|STARTED|Stage 2 - Final Analysis Population||45
8687062|NCT02243605|21446244|P2|NOT COMPLETED|Stage 1 - Interim Analysis Population||1
8687063|NCT02243605|21446245|P1|NOT COMPLETED|Stage 1 - Interim Analysis Population||2
8687064|NCT02243605|21446244|P2|COMPLETED|Stage 1 - Interim Analysis Population||21
8687065|NCT02243605|21446245|P1|COMPLETED|Stage 1 - Interim Analysis Population||21
8687066|NCT02243605|21446244|P2|STARTED|Stage 1 - Interim Analysis Population||22
8687067|NCT02243605|21446245|P1|STARTED|Stage 1 - Interim Analysis Population||23
8687068|NCT02200445|21446256|P3|NOT COMPLETED|Overall Study||2
8687069|NCT02200445|21446257|P2|NOT COMPLETED|Overall Study||4
8687070|NCT02200445|21446258|P1|NOT COMPLETED|Overall Study||1
8687071|NCT02200445|21446256|P3|COMPLETED|Overall Study||3
8687072|NCT02200445|21446257|P2|COMPLETED|Overall Study||13
8687073|NCT02200445|21446258|P1|COMPLETED|Overall Study||3
8687074|NCT02200445|21446256|P3|STARTED|Overall Study||5
8687075|NCT02200445|21446257|P2|STARTED|Overall Study||17
8687076|NCT02200445|21446258|P1|STARTED|Overall Study||4
8687077|NCT02180867|21446279|P7|NOT COMPLETED|Overall Study||5
8687078|NCT02180867|21446280|P6|NOT COMPLETED|Overall Study||3
8687079|NCT02180867|21446281|P5|NOT COMPLETED|Overall Study||27
8687080|NCT02180867|21446282|P4|NOT COMPLETED|Overall Study||26
8687081|NCT02180867|21446283|P3|NOT COMPLETED|Overall Study||4
8687082|NCT02180867|21446284|P2|NOT COMPLETED|Overall Study||11
8687083|NCT02180867|21446285|P1|NOT COMPLETED|Overall Study||6
8687084|NCT02180867|21446279|P7|COMPLETED|Overall Study||1
8687085|NCT02180867|21446280|P6|COMPLETED|Overall Study||3
8687086|NCT02180867|21446281|P5|COMPLETED|Overall Study||21
8687087|NCT02180867|21446282|P4|COMPLETED|Overall Study||23
8687088|NCT02180867|21446283|P3|COMPLETED|Overall Study||6
8687089|NCT02180867|21446284|P2|COMPLETED|Overall Study||0
8687090|NCT02180867|21446285|P1|COMPLETED|Overall Study||4
8687091|NCT02180867|21446279|P7|Adult Patients|Overall Study||6
8687092|NCT02180867|21446280|P6|Adult Patients|Overall Study||5
8687093|NCT02180867|21446281|P5|Adult Patients|Overall Study||29
8687094|NCT02180867|21446282|P4|Adult Patients|Overall Study||31
8687095|NCT02180867|21446283|P3|Adult Patients|Overall Study||7
8687096|NCT02180867|21446284|P2|Adult Patients|Overall Study||7
8687097|NCT02180867|21446285|P1|Adult Patients|Overall Study||4
8687098|NCT02180867|21446279|P7|Pediatric Patients|Overall Study||0
8687099|NCT02180867|21446280|P6|Pediatric Patients|Overall Study||1
8687100|NCT02180867|21446281|P5|Pediatric Patients|Overall Study||19
8687101|NCT02180867|21446282|P4|Pediatric Patients|Overall Study||18
8687102|NCT02180867|21446283|P3|Pediatric Patients|Overall Study||3
8687103|NCT02180867|21446284|P2|Pediatric Patients|Overall Study||4
8687104|NCT02180867|21446285|P1|Pediatric Patients|Overall Study||6
8687105|NCT02180867|21446279|P7|STARTED|Overall Study||6
8687106|NCT02180867|21446280|P6|STARTED|Overall Study||6
8687107|NCT02180867|21446281|P5|STARTED|Overall Study||48
8687108|NCT02180867|21446282|P4|STARTED|Overall Study||49
8687109|NCT02180867|21446283|P3|STARTED|Overall Study||10
8687110|NCT02180867|21446284|P2|STARTED|Overall Study||11
8687111|NCT02180867|21446285|P1|STARTED|Overall Study||10
8687112|NCT02134925|21446316|P2|NOT COMPLETED|Overall Study||6
8687113|NCT02134925|21446317|P1|NOT COMPLETED|Overall Study||2
8687114|NCT02134925|21446316|P2|COMPLETED|Overall Study||50
8687115|NCT02134925|21446317|P1|COMPLETED|Overall Study||52
8687116|NCT02134925|21446316|P2|Received at Least One Dose of Treatment|Overall Study||50
8687117|NCT02134925|21446317|P1|Received at Least One Dose of Treatment|Overall Study||53
8687118|NCT02134925|21446316|P2|STARTED|Overall Study||56
8687119|NCT02134925|21446317|P1|STARTED|Overall Study||54
8687120|NCT02002884|21446336|P4|NOT COMPLETED|Open-Label Extension Period (OLEX)||50
8687121|NCT02002884|21446337|P3|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
8687122|NCT02002884|21446338|P2|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
8687123|NCT02002884|21446339|P1|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
8687124|NCT02002884|21446336|P4|COMPLETED|Open-Label Extension Period (OLEX)||281
8687125|NCT02002884|21446337|P3|COMPLETED|Open-Label Extension Period (OLEX)||0
8687126|NCT02002884|21446338|P2|COMPLETED|Open-Label Extension Period (OLEX)||0
8687127|NCT02002884|21446339|P1|COMPLETED|Open-Label Extension Period (OLEX)||0
8687128|NCT02002884|21446336|P4|STARTED|Open-Label Extension Period (OLEX)||331
8687129|NCT02002884|21446337|P3|STARTED|Open-Label Extension Period (OLEX)||0
8687130|NCT02002884|21446338|P2|STARTED|Open-Label Extension Period (OLEX)||0
8687131|NCT02002884|21446339|P1|STARTED|Open-Label Extension Period (OLEX)||0
8687132|NCT02002884|21446336|P4|NOT COMPLETED|Main Period (MP)||0
8687133|NCT02002884|21446337|P3|NOT COMPLETED|Main Period (MP)||8
8687134|NCT02002884|21446338|P2|NOT COMPLETED|Main Period (MP)||6
8687135|NCT02002884|21446339|P1|NOT COMPLETED|Main Period (MP)||6
8687136|NCT02002884|21446336|P4|COMPLETED|Main Period (MP)||0
8687137|NCT02002884|21446337|P3|COMPLETED|Main Period (MP)||168
8687138|NCT02002884|21446338|P2|COMPLETED|Main Period (MP)||82
8687139|NCT02002884|21446339|P1|COMPLETED|Main Period (MP)||81
8687140|NCT02002884|21446336|P4|Treated|Main Period (MP)||0
8687141|NCT02002884|21446337|P3|Treated|Main Period (MP)||176
8687142|NCT02002884|21446338|P2|Treated|Main Period (MP)||87
8687143|NCT02002884|21446339|P1|Treated|Main Period (MP)||87
8687144|NCT02002884|21446336|P4|STARTED|Main Period (MP)||0
8687145|NCT02002884|21446337|P3|STARTED|Main Period (MP)||176
8687146|NCT02002884|21446338|P2|STARTED|Main Period (MP)||88
8687147|NCT02002884|21446339|P1|STARTED|Main Period (MP)||87
8687148|NCT01902173|21446404|P6|NOT COMPLETED|Phase II||0
8687149|NCT01902173|21446405|P5|NOT COMPLETED|Phase II||0
8687150|NCT01902173|21446406|P4|NOT COMPLETED|Phase II||0
8687151|NCT01902173|21446407|P3|NOT COMPLETED|Phase II||0
8687152|NCT01902173|21446408|P2|NOT COMPLETED|Phase II||0
8687153|NCT01902173|21446409|P1|NOT COMPLETED|Phase II||0
8687154|NCT01902173|21446404|P6|COMPLETED|Phase II||0
8687155|NCT01902173|21446405|P5|COMPLETED|Phase II||0
8687156|NCT01902173|21446406|P4|COMPLETED|Phase II||0
8687157|NCT01902173|21446407|P3|COMPLETED|Phase II||0
8687158|NCT01902173|21446408|P2|COMPLETED|Phase II||0
8687159|NCT01902173|21446409|P1|COMPLETED|Phase II||0
8687160|NCT01902173|21446404|P6|STARTED|Phase II||0
8687161|NCT01902173|21446405|P5|STARTED|Phase II||0
8687162|NCT01902173|21446406|P4|STARTED|Phase II||0
8687163|NCT01902173|21446407|P3|STARTED|Phase II||0
8687164|NCT01902173|21446408|P2|STARTED|Phase II||0
8687165|NCT01902173|21446409|P1|STARTED|Phase II||0
8687166|NCT01902173|21446404|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||5
8687167|NCT01902173|21446405|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8687168|NCT01902173|21446406|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8687169|NCT01902173|21446407|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8687170|NCT01902173|21446408|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8687171|NCT01902173|21446409|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8687172|NCT01902173|21446404|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8687173|NCT01902173|21446405|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8687174|NCT01902173|21446406|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8687175|NCT01902173|21446407|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8687176|NCT01902173|21446408|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8687177|NCT01902173|21446409|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
8687178|NCT01902173|21446404|P6|STARTED|Phase 1 Triplet Regimen Cohort 4||5
8687179|NCT01902173|21446405|P5|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8687180|NCT01902173|21446406|P4|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8687181|NCT01902173|21446407|P3|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8687182|NCT01902173|21446408|P2|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8687183|NCT01902173|21446409|P1|STARTED|Phase 1 Triplet Regimen Cohort 4||0
8687184|NCT01902173|21446404|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8687185|NCT01902173|21446405|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||3
8687186|NCT01902173|21446406|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8687187|NCT01902173|21446407|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8687188|NCT01902173|21446408|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8687189|NCT01902173|21446409|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8687190|NCT01902173|21446404|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8687191|NCT01902173|21446405|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8687192|NCT01902173|21446406|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8687193|NCT01902173|21446407|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8687194|NCT01902173|21446408|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8687195|NCT01902173|21446409|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
8687196|NCT01902173|21446404|P6|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8687197|NCT01902173|21446405|P5|STARTED|Phase 1 Triplet Regimen Cohort 3||3
8687198|NCT01902173|21446406|P4|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8687199|NCT01902173|21446407|P3|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8687200|NCT01902173|21446408|P2|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8687201|NCT01902173|21446409|P1|STARTED|Phase 1 Triplet Regimen Cohort 3||0
8687202|NCT01902173|21446404|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8687203|NCT01902173|21446405|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8687204|NCT01902173|21446406|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||3
8687205|NCT01902173|21446407|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8687206|NCT01902173|21446408|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8687207|NCT01902173|21446409|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8687208|NCT01902173|21446404|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8687209|NCT01902173|21446405|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8687210|NCT01902173|21446406|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8687211|NCT01902173|21446407|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8687212|NCT01902173|21446408|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8687213|NCT01902173|21446409|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
8687214|NCT01902173|21446404|P6|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8687215|NCT01902173|21446405|P5|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8687216|NCT01902173|21446406|P4|STARTED|Phase 1 Triplet Regimen Cohort 2||3
8687217|NCT01902173|21446407|P3|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8687218|NCT01902173|21446408|P2|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8687219|NCT01902173|21446409|P1|STARTED|Phase 1 Triplet Regimen Cohort 2||0
8687220|NCT01902173|21446404|P6|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8687221|NCT01902173|21446405|P5|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8687222|NCT01902173|21446406|P4|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8687223|NCT01902173|21446407|P3|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||4
8687224|NCT01902173|21446408|P2|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8687225|NCT01902173|21446409|P1|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8687226|NCT01902173|21446404|P6|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8687227|NCT01902173|21446405|P5|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8687228|NCT01902173|21446406|P4|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8687229|NCT01902173|21446407|P3|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8687230|NCT01902173|21446408|P2|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8687231|NCT01902173|21446409|P1|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
8687232|NCT01902173|21446404|P6|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8687233|NCT01902173|21446405|P5|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8687234|NCT01902173|21446406|P4|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8687235|NCT01902173|21446407|P3|STARTED|Phase 1 Triplet Regimen Cohort 1||4
8687236|NCT01902173|21446408|P2|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8687237|NCT01902173|21446409|P1|STARTED|Phase 1 Triplet Regimen Cohort 1||0
8687238|NCT01902173|21446404|P6|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8687239|NCT01902173|21446405|P5|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8687240|NCT01902173|21446406|P4|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8687241|NCT01902173|21446407|P3|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8687242|NCT01902173|21446408|P2|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||9
8687243|NCT01902173|21446409|P1|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8687244|NCT01902173|21446404|P6|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8687245|NCT01902173|21446405|P5|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8687246|NCT01902173|21446406|P4|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8687247|NCT01902173|21446407|P3|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8687248|NCT01902173|21446408|P2|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8687249|NCT01902173|21446409|P1|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
8687250|NCT01902173|21446404|P6|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8687251|NCT01902173|21446405|P5|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8687252|NCT01902173|21446406|P4|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8687253|NCT01902173|21446407|P3|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8687254|NCT01902173|21446408|P2|STARTED|Phase 1 Doublet Regimen Cohort 2||9
8687255|NCT01902173|21446409|P1|STARTED|Phase 1 Doublet Regimen Cohort 2||0
8687256|NCT01902173|21446404|P6|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8687257|NCT01902173|21446405|P5|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8687258|NCT01902173|21446406|P4|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8687259|NCT01902173|21446407|P3|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8687260|NCT01902173|21446408|P2|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8687261|NCT01902173|21446409|P1|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||3
8687262|NCT01902173|21446404|P6|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8687263|NCT01902173|21446405|P5|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8687264|NCT01902173|21446406|P4|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8687265|NCT01902173|21446407|P3|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8687266|NCT01902173|21446408|P2|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8687267|NCT01902173|21446409|P1|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
8687268|NCT01902173|21446404|P6|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8687269|NCT01902173|21446405|P5|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8687270|NCT01902173|21446406|P4|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8687271|NCT01902173|21446407|P3|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8687272|NCT01902173|21446408|P2|STARTED|Phase 1 Doublet Regimen Cohort 1||0
8687273|NCT01902173|21446409|P1|STARTED|Phase 1 Doublet Regimen Cohort 1||3
8687274|NCT01893411|21446429|P3|NOT COMPLETED|Overall Study||9
8687275|NCT01893411|21446430|P2|NOT COMPLETED|Overall Study||7
8687276|NCT01893411|21446431|P1|NOT COMPLETED|Overall Study||17
8687277|NCT01893411|21446429|P3|COMPLETED|Overall Study||69
8687278|NCT01893411|21446430|P2|COMPLETED|Overall Study||70
8687279|NCT01893411|21446431|P1|COMPLETED|Overall Study||139
8687280|NCT01893411|21446429|P3|STARTED|Overall Study||78
8687281|NCT01893411|21446430|P2|STARTED|Overall Study||77
8687282|NCT01893411|21446431|P1|STARTED|Overall Study||156
8687283|NCT01849263|21446493|P1|NOT COMPLETED|Overall Study||0
8687284|NCT01849263|21446493|P1|COMPLETED|Overall Study||40
8687285|NCT01849263|21446493|P1|STARTED|Overall Study||40
8687286|NCT01812668|21446503|P1|NOT COMPLETED|Overall Study||0
8687287|NCT01812668|21446503|P1|COMPLETED|Overall Study||20
8687288|NCT01812668|21446503|P1|STARTED|Overall Study||20
8687289|NCT01702571|21446514|P2|NOT COMPLETED|Overall Study||117
8687290|NCT01702571|21446515|P1|NOT COMPLETED|Overall Study||1509
8687291|NCT01702571|21446514|P2|COMPLETED|Overall Study||65
8687292|NCT01702571|21446515|P1|COMPLETED|Overall Study|For one participant, the site incorrectly answered the question 'Did the participant complete follow-up as per protocol?' It was answered No, however the participant was in survival follow-up and the site should have answered Yes. This participant is wrongly counted in the 'discontinued from study' number.|494
8687293|NCT01702571|21446514|P2|STARTED|Overall Study||182
8687294|NCT01702571|21446515|P1|STARTED|Overall Study||2003
8687295|NCT01524783|21446543|P3|NOT COMPLETED|Open-label Period||6
8687296|NCT01524783|21446544|P2|NOT COMPLETED|Open-label Period||0
8687297|NCT01524783|21446545|P1|NOT COMPLETED|Open-label Period||26
8687298|NCT01524783|21446543|P3|COMPLETED|Open-label Period||0
8687299|NCT01524783|21446544|P2|COMPLETED|Open-label Period||0
8687300|NCT01524783|21446545|P1|COMPLETED|Open-label Period||0
8687301|NCT01524783|21446543|P3|STARTED|Open-label Period||6
8687302|NCT01524783|21446544|P2|STARTED|Open-label Period||0
8687303|NCT01524783|21446545|P1|STARTED|Open-label Period||26
8687304|NCT01524783|21446543|P3|NOT COMPLETED|Blinded Period||0
8687305|NCT01524783|21446544|P2|NOT COMPLETED|Blinded Period||91
8687306|NCT01524783|21446545|P1|NOT COMPLETED|Blinded Period||179
8687307|NCT01524783|21446543|P3|COMPLETED|Blinded Period||0
8687308|NCT01524783|21446544|P2|COMPLETED|Blinded Period||6
8687309|NCT01524783|21446545|P1|COMPLETED|Blinded Period||26
8687310|NCT01524783|21446543|P3|STARTED|Blinded Period||0
8687311|NCT01524783|21446544|P2|STARTED|Blinded Period||97
8687312|NCT01524783|21446545|P1|STARTED|Blinded Period||205
8687313|NCT01465659|21446576|P4|NOT COMPLETED|Completed Follow for 1 Year||4
8687314|NCT01465659|21446577|P3|NOT COMPLETED|Completed Follow for 1 Year||2
8687315|NCT01465659|21446578|P2|NOT COMPLETED|Completed Follow for 1 Year||3
8687316|NCT01465659|21446579|P1|NOT COMPLETED|Completed Follow for 1 Year||6
8687317|NCT01465659|21446576|P4|COMPLETED|Completed Follow for 1 Year||7
8687318|NCT01465659|21446577|P3|COMPLETED|Completed Follow for 1 Year||4
8687319|NCT01465659|21446578|P2|COMPLETED|Completed Follow for 1 Year||1
8687320|NCT01465659|21446579|P1|COMPLETED|Completed Follow for 1 Year||1
8687321|NCT01465659|21446576|P4|STARTED|Completed Follow for 1 Year||11
8687322|NCT01465659|21446577|P3|STARTED|Completed Follow for 1 Year||6
8687323|NCT01465659|21446578|P2|STARTED|Completed Follow for 1 Year||4
8687324|NCT01465659|21446579|P1|STARTED|Completed Follow for 1 Year||7
8687325|NCT01465659|21446576|P4|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
8687326|NCT01465659|21446577|P3|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
8687327|NCT01465659|21446578|P2|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
8687328|NCT01465659|21446579|P1|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
8687329|NCT01465659|21446576|P4|COMPLETED|Went on to Cycle 3 and Beyond||9
8687330|NCT01465659|21446577|P3|COMPLETED|Went on to Cycle 3 and Beyond||4
8687331|NCT01465659|21446578|P2|COMPLETED|Went on to Cycle 3 and Beyond||4
8687332|NCT01465659|21446579|P1|COMPLETED|Went on to Cycle 3 and Beyond||5
8687333|NCT01465659|21446576|P4|STARTED|Went on to Cycle 3 and Beyond||9
8687334|NCT01465659|21446577|P3|STARTED|Went on to Cycle 3 and Beyond||4
8687335|NCT01465659|21446578|P2|STARTED|Went on to Cycle 3 and Beyond||4
8687336|NCT01465659|21446579|P1|STARTED|Went on to Cycle 3 and Beyond||5
8687337|NCT01465659|21446576|P4|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
8687338|NCT01465659|21446577|P3|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
8687339|NCT01465659|21446578|P2|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
8687340|NCT01465659|21446579|P1|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
8687341|NCT01465659|21446576|P4|COMPLETED|Completed 2 Cycles/Reached 1st Response||9
8687342|NCT01465659|21446577|P3|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
8687343|NCT01465659|21446578|P2|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
8687344|NCT01465659|21446579|P1|COMPLETED|Completed 2 Cycles/Reached 1st Response||5
8687345|NCT01465659|21446576|P4|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||10
8687346|NCT01465659|21446577|P3|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
8687347|NCT01465659|21446578|P2|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
8687348|NCT01465659|21446579|P1|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||7
8687349|NCT01465659|21446576|P4|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||10
8687350|NCT01465659|21446577|P3|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||6
8687351|NCT01465659|21446578|P2|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||4
8687352|NCT01465659|21446579|P1|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||7
8687353|NCT01465659|21446576|P4|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||10
8687354|NCT01465659|21446577|P3|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||6
8687355|NCT01465659|21446578|P2|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||4
8687356|NCT01465659|21446579|P1|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||7
8687357|NCT01465659|21446576|P4|STARTED|Completed 2 Cycles/Reached 1st Response||10
8687358|NCT01465659|21446577|P3|STARTED|Completed 2 Cycles/Reached 1st Response||6
8687359|NCT01465659|21446578|P2|STARTED|Completed 2 Cycles/Reached 1st Response||4
8687360|NCT01465659|21446579|P1|STARTED|Completed 2 Cycles/Reached 1st Response||7
8687361|NCT01465659|21446576|P4|NOT COMPLETED|Completed 1 Cycle of Treatment||1
8687362|NCT01465659|21446577|P3|NOT COMPLETED|Completed 1 Cycle of Treatment||0
8687363|NCT01465659|21446578|P2|NOT COMPLETED|Completed 1 Cycle of Treatment||1
8687364|NCT01465659|21446579|P1|NOT COMPLETED|Completed 1 Cycle of Treatment||0
8687365|NCT01465659|21446576|P4|COMPLETED|Completed 1 Cycle of Treatment||10
8687366|NCT01465659|21446577|P3|COMPLETED|Completed 1 Cycle of Treatment||6
8687367|NCT01465659|21446578|P2|COMPLETED|Completed 1 Cycle of Treatment||4
8687368|NCT01465659|21446579|P1|COMPLETED|Completed 1 Cycle of Treatment||7
8687369|NCT01465659|21446576|P4|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||11
8687370|NCT01465659|21446577|P3|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||6
8687371|NCT01465659|21446578|P2|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||4
8687372|NCT01465659|21446579|P1|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||7
8687373|NCT01465659|21446576|P4|STARTED|Completed 1 Cycle of Treatment||11
8687374|NCT01465659|21446577|P3|STARTED|Completed 1 Cycle of Treatment||6
8687375|NCT01465659|21446578|P2|STARTED|Completed 1 Cycle of Treatment||5
8687376|NCT01465659|21446579|P1|STARTED|Completed 1 Cycle of Treatment||7
8687569|NCT01371981|21446639|P6|NOT COMPLETED|Overall Study||14
8687570|NCT01371981|21446640|P5|NOT COMPLETED|Overall Study||32
8687571|NCT01371981|21446641|P4|NOT COMPLETED|Overall Study||21
8687572|NCT01371981|21446642|P3|NOT COMPLETED|Overall Study||6
8687573|NCT01371981|21446643|P2|NOT COMPLETED|Overall Study||192
8687574|NCT01371981|21446644|P1|NOT COMPLETED|Overall Study||184
8687575|NCT01371981|21446639|P6|COMPLETED|Overall Study||368
8687576|NCT01371981|21446640|P5|COMPLETED|Overall Study||15
8687577|NCT01371981|21446641|P4|COMPLETED|Overall Study||12
8687578|NCT01371981|21446642|P3|COMPLETED|Overall Study||6
8687579|NCT01371981|21446643|P2|COMPLETED|Overall Study||399
8687580|NCT01371981|21446644|P1|COMPLETED|Overall Study||396
8687581|NCT01371981|21446639|P6|STARTED|Overall Study||382
8687582|NCT01371981|21446640|P5|STARTED|Overall Study||47
8687583|NCT01371981|21446641|P4|STARTED|Overall Study||33
8687584|NCT01371981|21446642|P3|STARTED|Overall Study||12
8687585|NCT01371981|21446643|P2|STARTED|Overall Study||591
8687586|NCT01371981|21446644|P1|STARTED|Overall Study||580
8687587|NCT01352715|21446703|P2|NOT COMPLETED|Overall Study||46
8687588|NCT01352715|21446704|P1|NOT COMPLETED|Overall Study||45
8687589|NCT01352715|21446703|P2|COMPLETED|Overall Study||209
8687590|NCT01352715|21446704|P1|COMPLETED|Overall Study||215
8687591|NCT01352715|21446703|P2|STARTED|Overall Study||255
8687592|NCT01352715|21446704|P1|STARTED|Overall Study||260
8687593|NCT01267955|21446726|P1|NOT COMPLETED|Stage 2 (6 Months)||6
8687594|NCT01267955|21446726|P1|COMPLETED|Stage 2 (6 Months)||39
8687595|NCT01267955|21446726|P1|STARTED|Stage 2 (6 Months)||45
8687596|NCT01267955|21446726|P1|NOT COMPLETED|Stage 1 (6 Months)||3
8687597|NCT01267955|21446726|P1|COMPLETED|Stage 1 (6 Months)||17
8687598|NCT01267955|21446726|P1|STARTED|Stage 1 (6 Months)||20
8687599|NCT01236560|21446736|P6|NOT COMPLETED|Overall Study||0
8687600|NCT01236560|21446737|P5|NOT COMPLETED|Overall Study||0
8687601|NCT01236560|21446738|P4|NOT COMPLETED|Overall Study||22
8687602|NCT01236560|21446739|P3|NOT COMPLETED|Overall Study||20
8687603|NCT01236560|21446740|P2|NOT COMPLETED|Overall Study||24
8687604|NCT01236560|21446741|P1|NOT COMPLETED|Overall Study||5
8687605|NCT01236560|21446736|P6|COMPLETED|Overall Study||0
8687606|NCT01236560|21446737|P5|COMPLETED|Overall Study||0
8687607|NCT01236560|21446738|P4|COMPLETED|Overall Study||10
8687608|NCT01236560|21446739|P3|COMPLETED|Overall Study||11
8687609|NCT01236560|21446740|P2|COMPLETED|Overall Study||8
8687610|NCT01236560|21446741|P1|COMPLETED|Overall Study||1
8687611|NCT01236560|21446736|P6|STARTED|Overall Study||0
8687612|NCT01236560|21446737|P5|STARTED|Overall Study||0
8687613|NCT01236560|21446738|P4|STARTED|Overall Study||32
8687614|NCT01236560|21446739|P3|STARTED|Overall Study||31
8687615|NCT01236560|21446740|P2|STARTED|Overall Study||32
8687616|NCT01236560|21446741|P1|STARTED|Overall Study||6
8687617|NCT01193842|21446765|P5|NOT COMPLETED|Phase II: Randomized Groups||10
8687618|NCT01193842|21446766|P4|NOT COMPLETED|Phase II: Randomized Groups||12
8687619|NCT01193842|21446767|P3|NOT COMPLETED|Phase II: Randomized Groups||0
8687620|NCT01193842|21446768|P2|NOT COMPLETED|Phase II: Randomized Groups||0
8687621|NCT01193842|21446769|P1|NOT COMPLETED|Phase II: Randomized Groups||0
8687622|NCT01193842|21446765|P5|COMPLETED|Phase II: Randomized Groups||36
8687623|NCT01193842|21446766|P4|COMPLETED|Phase II: Randomized Groups||33
8687624|NCT01193842|21446767|P3|COMPLETED|Phase II: Randomized Groups||0
8687625|NCT01193842|21446768|P2|COMPLETED|Phase II: Randomized Groups||0
8687626|NCT01193842|21446769|P1|COMPLETED|Phase II: Randomized Groups||0
8687627|NCT01193842|21446765|P5|STARTED|Phase II: Randomized Groups||46
8687628|NCT01193842|21446766|P4|STARTED|Phase II: Randomized Groups||45
8687629|NCT01193842|21446767|P3|STARTED|Phase II: Randomized Groups||0
8687630|NCT01193842|21446768|P2|STARTED|Phase II: Randomized Groups||0
8687631|NCT01193842|21446769|P1|STARTED|Phase II: Randomized Groups||0
8687632|NCT01193842|21446765|P5|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
8687633|NCT01193842|21446766|P4|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
8687634|NCT01193842|21446767|P3|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
8687635|NCT01193842|21446768|P2|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
8687636|NCT01193842|21446769|P1|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
8687637|NCT01193842|21446765|P5|COMPLETED|Phase I: VR-CHOP, DL 1||0
8687638|NCT01193842|21446766|P4|COMPLETED|Phase I: VR-CHOP, DL 1||0
8687639|NCT01193842|21446767|P3|COMPLETED|Phase I: VR-CHOP, DL 1||1
8687640|NCT01193842|21446768|P2|COMPLETED|Phase I: VR-CHOP, DL 1||0
8687641|NCT01193842|21446769|P1|COMPLETED|Phase I: VR-CHOP, DL 1||0
8687642|NCT01193842|21446765|P5|STARTED|Phase I: VR-CHOP, DL 1||0
8687643|NCT01193842|21446766|P4|STARTED|Phase I: VR-CHOP, DL 1||0
8687644|NCT01193842|21446767|P3|STARTED|Phase I: VR-CHOP, DL 1||2
8687645|NCT01193842|21446768|P2|STARTED|Phase I: VR-CHOP, DL 1||0
8687646|NCT01193842|21446769|P1|STARTED|Phase I: VR-CHOP, DL 1||0
8687647|NCT01193842|21446765|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8687648|NCT01193842|21446766|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8687649|NCT01193842|21446767|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8687650|NCT01193842|21446768|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8687651|NCT01193842|21446769|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
8687652|NCT01193842|21446765|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8687653|NCT01193842|21446766|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8687654|NCT01193842|21446767|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8687655|NCT01193842|21446768|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8687656|NCT01193842|21446769|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
8687657|NCT01193842|21446765|P5|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8687658|NCT01193842|21446766|P4|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8687659|NCT01193842|21446767|P3|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8687660|NCT01193842|21446768|P2|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
8687661|NCT01193842|21446769|P1|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
8687662|NCT01193842|21446765|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8687663|NCT01193842|21446766|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8687664|NCT01193842|21446767|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8687665|NCT01193842|21446768|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
8687666|NCT01193842|21446769|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8687667|NCT01193842|21446765|P5|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8687668|NCT01193842|21446766|P4|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8687669|NCT01193842|21446767|P3|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8687670|NCT01193842|21446768|P2|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
8687671|NCT01193842|21446769|P1|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
8687672|NCT01193842|21446765|P5|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
8687673|NCT01193842|21446766|P4|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
8687674|NCT01193842|21446767|P3|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
8687675|NCT01193842|21446768|P2|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
8687676|NCT01193842|21446769|P1|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
8687677|NCT01193842|21446765|P5|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8687678|NCT01193842|21446766|P4|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8687679|NCT01193842|21446767|P3|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8687680|NCT01193842|21446768|P2|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8687681|NCT01193842|21446769|P1|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8687682|NCT01193842|21446765|P5|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8687683|NCT01193842|21446766|P4|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8687684|NCT01193842|21446767|P3|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8687685|NCT01193842|21446768|P2|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8687686|NCT01193842|21446769|P1|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
8687687|NCT01193842|21446765|P5|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8687688|NCT01193842|21446766|P4|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8687689|NCT01193842|21446767|P3|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8687690|NCT01193842|21446768|P2|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
8687691|NCT01193842|21446769|P1|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
8687692|NCT01113502|21446807|P5|NOT COMPLETED|Overall Study||0
8687693|NCT01113502|21446808|P4|NOT COMPLETED|Overall Study||3
8687694|NCT01113502|21446809|P3|NOT COMPLETED|Overall Study||4
8687695|NCT01113502|21446810|P2|NOT COMPLETED|Overall Study||0
8687696|NCT01113502|21446811|P1|NOT COMPLETED|Overall Study||1
8687697|NCT01113502|21446807|P5|COMPLETED|Overall Study||21
8687698|NCT01113502|21446808|P4|COMPLETED|Overall Study||6
8687699|NCT01113502|21446809|P3|COMPLETED|Overall Study||3
8687700|NCT01113502|21446810|P2|COMPLETED|Overall Study||3
8687701|NCT01113502|21446811|P1|COMPLETED|Overall Study||3
8687702|NCT01113502|21446807|P5|STARTED|Overall Study||21
8687703|NCT01113502|21446808|P4|STARTED|Overall Study||9
8687704|NCT01113502|21446809|P3|STARTED|Overall Study||7
8687705|NCT01113502|21446810|P2|STARTED|Overall Study||3
8687706|NCT01113502|21446811|P1|STARTED|Overall Study||4
8687743|NCT01005745|21446866|P1|NOT COMPLETED|Overall Study||6
8687744|NCT01005745|21446866|P1|COMPLETED|Overall Study||13
8687745|NCT01005745|21446866|P1|STARTED|Overall Study||19
8687746|NCT00937937|21446871|P1|NOT COMPLETED|Overall Study||72
8687747|NCT00937937|21446871|P1|COMPLETED|Overall Study||0
8687748|NCT00937937|21446871|P1|STARTED|Overall Study||72
8687749|NCT00792948|21446878|P1|NOT COMPLETED|Overall Study||28
8687750|NCT00792948|21446878|P1|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
8687751|NCT00792948|21446878|P1|STARTED|Overall Study|Patients registered to induction/consolidation step|97
8687752|NCT00644228|21446889|P2|NOT COMPLETED|Maintenance||135
8687753|NCT00644228|21446890|P1|NOT COMPLETED|Maintenance||143
8687754|NCT00644228|21446889|P2|COMPLETED|Maintenance||0
8687755|NCT00644228|21446890|P1|COMPLETED|Maintenance||0
8687756|NCT00644228|21446889|P2|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
8687757|NCT00644228|21446890|P1|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
8687758|NCT00644228|21446889|P2|NOT COMPLETED|Induction Therapy||105
8687759|NCT00644228|21446890|P1|NOT COMPLETED|Induction Therapy||83
8687760|NCT00644228|21446889|P2|COMPLETED|Induction Therapy||137
8687761|NCT00644228|21446890|P1|COMPLETED|Induction Therapy||146
8687762|NCT00644228|21446889|P2|STARTED|Induction Therapy||242
8687763|NCT00644228|21446890|P1|STARTED|Induction Therapy||229
8687764|NCT00644228|21446889|P2|NOT COMPLETED|Randomization & Eligibility||22
8687765|NCT00644228|21446890|P1|NOT COMPLETED|Randomization & Eligibility||32
8687766|NCT00644228|21446889|P2|COMPLETED|Randomization & Eligibility||242
8687767|NCT00644228|21446890|P1|COMPLETED|Randomization & Eligibility||229
8687768|NCT00644228|21446889|P2|Eligible and Analyzable|Randomization & Eligibility||242
8687769|NCT00644228|21446890|P1|Eligible and Analyzable|Randomization & Eligibility||229
8687770|NCT00644228|21446889|P2|STARTED|Randomization & Eligibility||264
8687771|NCT00644228|21446890|P1|STARTED|Randomization & Eligibility||261
8687772|NCT00599638|21446904|P4|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
8687773|NCT00599638|21446905|P3|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
8687774|NCT00599638|21446906|P2|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
8687775|NCT00599638|21446907|P1|NOT COMPLETED|Second Intervention Period (2 Weeks)||1
8687776|NCT00599638|21446904|P4|COMPLETED|Second Intervention Period (2 Weeks)||14
8687777|NCT00599638|21446905|P3|COMPLETED|Second Intervention Period (2 Weeks)||17
8687778|NCT00599638|21446906|P2|COMPLETED|Second Intervention Period (2 Weeks)||11
8687779|NCT00599638|21446907|P1|COMPLETED|Second Intervention Period (2 Weeks)||12
8687780|NCT00599638|21446904|P4|STARTED|Second Intervention Period (2 Weeks)||14
8687781|NCT00599638|21446905|P3|STARTED|Second Intervention Period (2 Weeks)||17
8687782|NCT00599638|21446906|P2|STARTED|Second Intervention Period (2 Weeks)||11
8687783|NCT00599638|21446907|P1|STARTED|Second Intervention Period (2 Weeks)||13
8687784|NCT00599638|21446904|P4|NOT COMPLETED|Washout Period (2 Weeks)||3
8687785|NCT00599638|21446905|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
8687786|NCT00599638|21446906|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
8687787|NCT00599638|21446907|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
8687788|NCT00599638|21446904|P4|COMPLETED|Washout Period (2 Weeks)||14
8687789|NCT00599638|21446905|P3|COMPLETED|Washout Period (2 Weeks)||17
8687790|NCT00599638|21446906|P2|COMPLETED|Washout Period (2 Weeks)||11
8687791|NCT00599638|21446907|P1|COMPLETED|Washout Period (2 Weeks)||13
8687792|NCT00599638|21446904|P4|STARTED|Washout Period (2 Weeks)||17
8687793|NCT00599638|21446905|P3|STARTED|Washout Period (2 Weeks)||17
8687794|NCT00599638|21446906|P2|STARTED|Washout Period (2 Weeks)||12
8687795|NCT00599638|21446907|P1|STARTED|Washout Period (2 Weeks)||14
8687796|NCT00599638|21446904|P4|NOT COMPLETED|First Intervention Period (2 Weeks)||5
8687797|NCT00599638|21446905|P3|NOT COMPLETED|First Intervention Period (2 Weeks)||3
8687798|NCT00599638|21446906|P2|NOT COMPLETED|First Intervention Period (2 Weeks)||2
8687799|NCT00599638|21446907|P1|NOT COMPLETED|First Intervention Period (2 Weeks)||2
8687800|NCT00599638|21446904|P4|COMPLETED|First Intervention Period (2 Weeks)||17
8687801|NCT00599638|21446905|P3|COMPLETED|First Intervention Period (2 Weeks)||17
8687802|NCT00599638|21446906|P2|COMPLETED|First Intervention Period (2 Weeks)||12
8687803|NCT00599638|21446907|P1|COMPLETED|First Intervention Period (2 Weeks)||14
8687804|NCT00599638|21446904|P4|Treated|First Intervention Period (2 Weeks)||21
8687805|NCT00599638|21446905|P3|Treated|First Intervention Period (2 Weeks)||20
8687806|NCT00599638|21446906|P2|Treated|First Intervention Period (2 Weeks)||13
8687807|NCT00599638|21446907|P1|Treated|First Intervention Period (2 Weeks)||16
8687808|NCT00599638|21446904|P4|STARTED|First Intervention Period (2 Weeks)||22
8687809|NCT00599638|21446905|P3|STARTED|First Intervention Period (2 Weeks)||20
8687810|NCT00599638|21446906|P2|STARTED|First Intervention Period (2 Weeks)||14
8687811|NCT00599638|21446907|P1|STARTED|First Intervention Period (2 Weeks)||16
8687822|NCT00381641|21446954|P2|NOT COMPLETED|Overall Study||2
8687823|NCT00381641|21446955|P1|NOT COMPLETED|Overall Study||0
8687824|NCT00381641|21446954|P2|COMPLETED|Overall Study||23
8687825|NCT00381641|21446955|P1|COMPLETED|Overall Study||38
8687826|NCT00381641|21446954|P2|STARTED|Overall Study||25
8687827|NCT00381641|21446955|P1|STARTED|Overall Study||38
8687828|NCT00334815|21446969|P2|NOT COMPLETED|Overall Study||10
8687829|NCT00334815|21446970|P1|NOT COMPLETED|Overall Study||7
8687830|NCT00334815|21446969|P2|COMPLETED|Overall Study||3
8687831|NCT00334815|21446970|P1|COMPLETED|Overall Study||9
8687832|NCT00334815|21446969|P2|STARTED|Overall Study||13
8687833|NCT00334815|21446970|P1|STARTED|Overall Study||16
8687866|NCT00265798|21447034|P1|NOT COMPLETED|Overall Study||0
8687867|NCT00265798|21447034|P1|COMPLETED|Overall Study||38
8687868|NCT00265798|21447034|P1|STARTED|Overall Study||38
8687869|NCT00238420|21447042|P2|NOT COMPLETED|Overall Study||1
8687870|NCT00238420|21447043|P1|NOT COMPLETED|Overall Study||1
8687871|NCT00238420|21447042|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
8687872|NCT00238420|21447043|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
8687873|NCT00238420|21447042|P2|STARTED|Overall Study||48
8687874|NCT00238420|21447043|P1|STARTED|Overall Study||22
8687875|NCT00180297|21447059|P2|NOT COMPLETED|Overall Study||41
8687876|NCT00180297|21447060|P1|NOT COMPLETED|Overall Study||46
8687877|NCT00180297|21447059|P2|COMPLETED|Overall Study||67
8687878|NCT00180297|21447060|P1|COMPLETED|Overall Study||61
8687879|NCT00180297|21447059|P2|STARTED|Overall Study||108
8687880|NCT00180297|21447060|P1|STARTED|Overall Study||107
8687881|NCT00095784|21447076|P1|NOT COMPLETED|Overall Study||0
8687882|NCT00095784|21447076|P1|COMPLETED|Overall Study||21
8687883|NCT00095784|21447076|P1|STARTED|Overall Study||21
8687884|NCT00026312|21447101|P2|NOT COMPLETED|Overall Study||269
8687885|NCT00026312|21447102|P1|NOT COMPLETED|Overall Study||34
8687886|NCT00026312|21447101|P2|COMPLETED|Overall Study||1064
8687887|NCT00026312|21447102|P1|COMPLETED|Overall Study||82
8687888|NCT00026312|21447101|P2|STARTED|Overall Study||1333
8687889|NCT00026312|21447102|P1|STARTED|Overall Study||116
8687890|NCT04335929|21447117|P1|NOT COMPLETED|Overall Study||10
8687891|NCT04335929|21447117|P1|COMPLETED|Overall Study||22
8687892|NCT04335929|21447117|P1|STARTED|Overall Study||32
8687893|NCT04223687|21447131|P2|NOT COMPLETED|Overall Study||0
8687894|NCT04223687|21447132|P1|NOT COMPLETED|Overall Study||1
8687895|NCT04223687|21447131|P2|COMPLETED|Overall Study||163
8687896|NCT04223687|21447132|P1|COMPLETED|Overall Study||162
8687897|NCT04223687|21447131|P2|STARTED|Overall Study||163
8687898|NCT04223687|21447132|P1|STARTED|Overall Study||163
8687899|NCT04137783|21447173|P3|NOT COMPLETED|Overall Study||0
8687900|NCT04137783|21447174|P2|NOT COMPLETED|Overall Study||0
8687901|NCT04137783|21447175|P1|NOT COMPLETED|Overall Study||0
8687902|NCT04137783|21447173|P3|COMPLETED|Overall Study||22
8687903|NCT04137783|21447174|P2|COMPLETED|Overall Study||10
8687904|NCT04137783|21447175|P1|COMPLETED|Overall Study||7
8687905|NCT04137783|21447173|P3|STARTED|Overall Study||22
8687906|NCT04137783|21447174|P2|STARTED|Overall Study||10
8687907|NCT04137783|21447175|P1|STARTED|Overall Study||7
8687908|NCT04105218|21447194|P2|NOT COMPLETED|Overall Study||6
8687909|NCT04105218|21447195|P1|NOT COMPLETED|Overall Study||6
8687910|NCT04105218|21447194|P2|COMPLETED|Overall Study||0
8687911|NCT04105218|21447195|P1|COMPLETED|Overall Study||0
8687912|NCT04105218|21447194|P2|Completed Second Condition|Overall Study||0
8687913|NCT04105218|21447195|P1|Completed Second Condition|Overall Study||0
8687914|NCT04105218|21447194|P2|Completed First Condition|Overall Study||1
8687915|NCT04105218|21447195|P1|Completed First Condition|Overall Study||0
8687916|NCT04105218|21447194|P2|STARTED|Overall Study||6
8687917|NCT04105218|21447195|P1|STARTED|Overall Study||6
8687918|NCT03999684|21447217|P1|NOT COMPLETED|Overall Study||0
8687919|NCT03999684|21447217|P1|COMPLETED|Overall Study||18
8687920|NCT03999684|21447217|P1|STARTED|Overall Study||18
8687921|NCT03856944|21447226|P1|NOT COMPLETED|Overall Study||0
8687922|NCT03856944|21447226|P1|COMPLETED|Overall Study||29
8687923|NCT03856944|21447226|P1|STARTED|Overall Study||29
8687924|NCT03729024|21447246|P1|NOT COMPLETED|Overall Study||0
8687925|NCT03729024|21447246|P1|COMPLETED|Overall Study||21
8687926|NCT03729024|21447246|P1|STARTED|Overall Study||21
8687927|NCT03708393|21447250|P1|NOT COMPLETED|Overall Study||0
8687928|NCT03708393|21447250|P1|COMPLETED|Overall Study||155
8687929|NCT03708393|21447250|P1|STARTED|Overall Study||155
8687930|NCT03609658|21447269|P2|NOT COMPLETED|Overall Study||0
8687931|NCT03609658|21447270|P1|NOT COMPLETED|Overall Study||0
8687932|NCT03609658|21447269|P2|COMPLETED|Overall Study||380
8687933|NCT03609658|21447270|P1|COMPLETED|Overall Study||379
8687934|NCT03609658|21447269|P2|STARTED|Overall Study||380
8687935|NCT03609658|21447270|P1|STARTED|Overall Study||379
8687936|NCT03521479|21447294|P4|NOT COMPLETED|Overall Study||0
8687937|NCT03521479|21447295|P3|NOT COMPLETED|Overall Study||0
8687938|NCT03521479|21447296|P2|NOT COMPLETED|Overall Study||0
8687939|NCT03521479|21447297|P1|NOT COMPLETED|Overall Study||0
8687940|NCT03521479|21447294|P4|COMPLETED|Overall Study||10
8687941|NCT03521479|21447295|P3|COMPLETED|Overall Study||10
8687942|NCT03521479|21447296|P2|COMPLETED|Overall Study||10
8687943|NCT03521479|21447297|P1|COMPLETED|Overall Study||10
8687944|NCT03521479|21447294|P4|STARTED|Overall Study||10
8687945|NCT03521479|21447295|P3|STARTED|Overall Study||10
8687946|NCT03521479|21447296|P2|STARTED|Overall Study||10
8687947|NCT03521479|21447297|P1|STARTED|Overall Study||10
8687948|NCT03426345|21447309|P2|NOT COMPLETED|Overall Study||17
8687949|NCT03426345|21447310|P1|NOT COMPLETED|Overall Study||18
8687950|NCT03426345|21447309|P2|COMPLETED|Overall Study||139
8687951|NCT03426345|21447310|P1|COMPLETED|Overall Study||137
8687952|NCT03426345|21447309|P2|Safety Population|Overall Study||155
8687953|NCT03426345|21447310|P1|Safety Population|Overall Study||152
8687954|NCT03426345|21447309|P2|STARTED|Overall Study||156
8687955|NCT03426345|21447310|P1|STARTED|Overall Study||155
8687956|NCT03358290|21447342|P5|NOT COMPLETED|Overall Study||1
8687957|NCT03358290|21447343|P4|NOT COMPLETED|Overall Study||2
8687958|NCT03358290|21447344|P3|NOT COMPLETED|Overall Study||2
8687959|NCT03358290|21447345|P2|NOT COMPLETED|Overall Study||1
8687960|NCT03358290|21447346|P1|NOT COMPLETED|Overall Study||0
8687961|NCT03358290|21447342|P5|COMPLETED|Overall Study||1
8687962|NCT03358290|21447343|P4|COMPLETED|Overall Study||1
8687963|NCT03358290|21447344|P3|COMPLETED|Overall Study||1
8687964|NCT03358290|21447345|P2|COMPLETED|Overall Study||2
8687965|NCT03358290|21447346|P1|COMPLETED|Overall Study||2
8687966|NCT03358290|21447342|P5|STARTED|Overall Study||2
8687967|NCT03358290|21447343|P4|STARTED|Overall Study||3
8687968|NCT03358290|21447344|P3|STARTED|Overall Study||3
8687969|NCT03358290|21447345|P2|STARTED|Overall Study||3
8687970|NCT03358290|21447346|P1|STARTED|Overall Study||2
8687971|NCT03178773|21447424|P2|NOT COMPLETED|Overall Study||40
8687972|NCT03178773|21447425|P1|NOT COMPLETED|Overall Study||39
8687973|NCT03178773|21447424|P2|COMPLETED|Overall Study||40
8687974|NCT03178773|21447425|P1|COMPLETED|Overall Study||47
8687975|NCT03178773|21447424|P2|9month Follow up Phone|Overall Study||51
8687976|NCT03178773|21447425|P1|9month Follow up Phone|Overall Study||36
8687977|NCT03178773|21447424|P2|6month in Person Follow up|Overall Study||46
8687978|NCT03178773|21447425|P1|6month in Person Follow up|Overall Study||54
8687979|NCT03178773|21447424|P2|3month Phone Follow up|Overall Study||51
8687980|NCT03178773|21447425|P1|3month Phone Follow up|Overall Study||49
8687981|NCT03178773|21447424|P2|STARTED|Overall Study||80
8687982|NCT03178773|21447425|P1|STARTED|Overall Study||86
8687983|NCT02973087|21447534|P2|NOT COMPLETED|Overall Study||2
8687984|NCT02973087|21447535|P1|NOT COMPLETED|Overall Study||4
8687985|NCT02973087|21447534|P2|COMPLETED|Overall Study||8
8687986|NCT02973087|21447535|P1|COMPLETED|Overall Study||9
8687987|NCT02973087|21447534|P2|STARTED|Overall Study||10
8687988|NCT02973087|21447535|P1|STARTED|Overall Study||13
8687989|NCT02963974|21447637|P1|NOT COMPLETED|Overall Study||1
8687990|NCT02963974|21447637|P1|COMPLETED|Overall Study||19
8687991|NCT02963974|21447637|P1|STARTED|Overall Study||20
8687992|NCT02913924|21447653|P2|NOT COMPLETED|Overall Study||13
8687993|NCT02913924|21447654|P1|NOT COMPLETED|Overall Study||13
8687994|NCT02913924|21447653|P2|COMPLETED|Overall Study||21
8687995|NCT02913924|21447654|P1|COMPLETED|Overall Study||21
8687996|NCT02913924|21447653|P2|STARTED|Overall Study||34
8687997|NCT02913924|21447654|P1|STARTED|Overall Study||34
8687998|NCT02904954|21447664|P2|NOT COMPLETED|Adjuvant Durvalumab||16
8687999|NCT02904954|21447665|P1|NOT COMPLETED|Adjuvant Durvalumab||21
8688000|NCT02904954|21447664|P2|COMPLETED|Adjuvant Durvalumab||10
8688001|NCT02904954|21447665|P1|COMPLETED|Adjuvant Durvalumab||5
8688002|NCT02904954|21447664|P2|STARTED|Adjuvant Durvalumab||26
8688003|NCT02904954|21447665|P1|STARTED|Adjuvant Durvalumab||26
8688004|NCT02904954|21447664|P2|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
8688005|NCT02904954|21447665|P1|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
8688006|NCT02904954|21447664|P2|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed the first neoadjuvant Durvalumab cycle combined with SBRT. Three subjects did not receive the 2nd cycle. Surgical resection was not performed in 4 participants.|26
8688007|NCT02904954|21447665|P1|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed 2 neoadjuvant cycles. Surgical resection was not performed in 4 participants.|26
8688008|NCT02904954|21447664|P2|STARTED|Neoadjuvant (Preoperative) to Surgery||30
8688009|NCT02904954|21447665|P1|STARTED|Neoadjuvant (Preoperative) to Surgery||30
8688018|NCT02791399|21447694|P2|NOT COMPLETED|Overall Study||15
8688019|NCT02791399|21447695|P1|NOT COMPLETED|Overall Study||13
8688020|NCT02791399|21447694|P2|COMPLETED|Overall Study||135
8688021|NCT02791399|21447695|P1|COMPLETED|Overall Study||123
8688022|NCT02791399|21447694|P2|STARTED|Overall Study||150
8688023|NCT02791399|21447695|P1|STARTED|Overall Study||136
8688024|NCT02694029|21447711|P2|NOT COMPLETED|Overall Study||0
8688025|NCT02694029|21447712|P1|NOT COMPLETED|Overall Study||0
8688026|NCT02694029|21447711|P2|COMPLETED|Overall Study||5
8688027|NCT02694029|21447712|P1|COMPLETED|Overall Study||5
8688028|NCT02694029|21447711|P2|Second Intervention|Overall Study||5
8688029|NCT02694029|21447712|P1|Second Intervention|Overall Study||5
8688030|NCT02694029|21447711|P2|First Intervention|Overall Study||5
8688031|NCT02694029|21447712|P1|First Intervention|Overall Study||5
8688032|NCT02694029|21447711|P2|STARTED|Overall Study||5
8688033|NCT02694029|21447712|P1|STARTED|Overall Study||5
8688034|NCT02490878|21447730|P2|NOT COMPLETED|Overall Study||3
8688035|NCT02490878|21447731|P1|NOT COMPLETED|Overall Study||0
8688036|NCT02490878|21447730|P2|COMPLETED|Overall Study||6
8688037|NCT02490878|21447731|P1|COMPLETED|Overall Study||10
8688038|NCT02490878|21447730|P2|Eligible Participants|Overall Study||8
8688039|NCT02490878|21447731|P1|Eligible Participants|Overall Study||10
8688040|NCT02490878|21447730|P2|STARTED|Overall Study||9
8688041|NCT02490878|21447731|P1|STARTED|Overall Study||10
8688042|NCT02447718|21447753|P2|NOT COMPLETED|Overall Study||0
8688043|NCT02447718|21447754|P1|NOT COMPLETED|Overall Study||12
8688044|NCT02447718|21447753|P2|COMPLETED|Overall Study||78
8688045|NCT02447718|21447754|P1|COMPLETED|Overall Study||66
8688046|NCT02447718|21447753|P2|Received Pneumovax® 23|Overall Study|Do not receive vaccination|0
8688047|NCT02447718|21447754|P1|Received Pneumovax® 23|Overall Study||73
8688048|NCT02447718|21447753|P2|Received Pediacel®|Overall Study|Do not receive vaccination|0
8688049|NCT02447718|21447754|P1|Received Pediacel®|Overall Study||73
8688050|NCT02447718|21447753|P2|Received Prevnar®13|Overall Study|Do not receive vaccination|0
8688051|NCT02447718|21447754|P1|Received Prevnar®13|Overall Study||74
8688052|NCT02447718|21447753|P2|STARTED|Overall Study||78
8688053|NCT02447718|21447754|P1|STARTED|Overall Study||78
8688066|NCT02328807|21447798|P1|NOT COMPLETED|Overall Study||0
8688067|NCT02328807|21447798|P1|COMPLETED|Overall Study||6
8688068|NCT02328807|21447798|P1|STARTED|Overall Study||6
8688069|NCT02210221|21447805|P1|NOT COMPLETED|Overall Study||50
8688070|NCT02210221|21447805|P1|COMPLETED|Overall Study||4509
8688071|NCT02210221|21447805|P1|STARTED|Overall Study||4559
8688078|NCT01958021|21447874|P2|NOT COMPLETED|Overall Study||180
8688079|NCT01958021|21447875|P1|NOT COMPLETED|Overall Study||139
8688080|NCT01958021|21447874|P2|COMPLETED|Overall Study|Completed = Treatment ongoing|154
8688081|NCT01958021|21447875|P1|COMPLETED|Overall Study|Completed = Treatment ongoing|195
8688082|NCT01958021|21447874|P2|Patients Treated|Overall Study||330
8688083|NCT01958021|21447875|P1|Patients Treated|Overall Study||334
8688084|NCT01958021|21447874|P2|Patients Untreated|Overall Study||4
8688085|NCT01958021|21447875|P1|Patients Untreated|Overall Study||0
8688086|NCT01958021|21447874|P2|STARTED|Overall Study||334
8688087|NCT01958021|21447875|P1|STARTED|Overall Study||334
8688116|NCT01620944|21447938|P2|NOT COMPLETED|Overall Study||1
8688117|NCT01620944|21447939|P1|NOT COMPLETED|Overall Study||2
8688118|NCT01620944|21447938|P2|COMPLETED|Overall Study||0
8688119|NCT01620944|21447939|P1|COMPLETED|Overall Study||0
8688120|NCT01620944|21447938|P2|STARTED|Overall Study||1
8688121|NCT01620944|21447939|P1|STARTED|Overall Study||2
8688122|NCT01609790|21447958|P3|NOT COMPLETED|Overall Study||8
8688123|NCT01609790|21447959|P2|NOT COMPLETED|Overall Study||7
8688124|NCT01609790|21447960|P1|NOT COMPLETED|Overall Study||1
8688125|NCT01609790|21447958|P3|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
8688126|NCT01609790|21447959|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
8688127|NCT01609790|21447960|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
8688128|NCT01609790|21447958|P3|STARTED|Overall Study||65
8688129|NCT01609790|21447959|P2|STARTED|Overall Study||65
8688130|NCT01609790|21447960|P1|STARTED|Overall Study||7
8688131|NCT01522976|21447980|P3|NOT COMPLETED|Overall Study||93
8688132|NCT01522976|21447981|P2|NOT COMPLETED|Overall Study||92
8688133|NCT01522976|21447982|P1|NOT COMPLETED|Overall Study||97
8688134|NCT01522976|21447980|P3|COMPLETED|Overall Study||0
8688135|NCT01522976|21447981|P2|COMPLETED|Overall Study||0
8688136|NCT01522976|21447982|P1|COMPLETED|Overall Study||0
8688137|NCT01522976|21447980|P3|STARTED|Overall Study||93
8688138|NCT01522976|21447981|P2|STARTED|Overall Study||92
8688139|NCT01522976|21447982|P1|STARTED|Overall Study||97
8688146|NCT01268683|21448026|P1|NOT COMPLETED|Overall Study||2
8688147|NCT01268683|21448026|P1|COMPLETED|Overall Study||8
8688148|NCT01268683|21448026|P1|STARTED|Overall Study||10
8688149|NCT01236547|21448054|P5|NOT COMPLETED|Overall Study||12
8688150|NCT01236547|21448055|P4|NOT COMPLETED|Overall Study||6
8688151|NCT01236547|21448056|P3|NOT COMPLETED|Overall Study||1
8688152|NCT01236547|21448057|P2|NOT COMPLETED|Overall Study||1
8688153|NCT01236547|21448058|P1|NOT COMPLETED|Overall Study||0
8688154|NCT01236547|21448054|P5|COMPLETED|Overall Study||35
8688155|NCT01236547|21448055|P4|COMPLETED|Overall Study||36
8688156|NCT01236547|21448056|P3|COMPLETED|Overall Study||11
8688157|NCT01236547|21448057|P2|COMPLETED|Overall Study||10
8688158|NCT01236547|21448058|P1|COMPLETED|Overall Study||11
8688159|NCT01236547|21448054|P5|Eligible and Response Assessed|Overall Study||27
8688160|NCT01236547|21448055|P4|Eligible and Response Assessed|Overall Study||23
8688161|NCT01236547|21448056|P3|Eligible and Response Assessed|Overall Study||0
8688162|NCT01236547|21448057|P2|Eligible and Response Assessed|Overall Study||0
8688163|NCT01236547|21448058|P1|Eligible and Response Assessed|Overall Study||0
8688164|NCT01236547|21448054|P5|Eligible and Started Study Treatment|Overall Study||34
8688165|NCT01236547|21448055|P4|Eligible and Started Study Treatment|Overall Study||36
8688166|NCT01236547|21448056|P3|Eligible and Started Study Treatment|Overall Study||11
8688167|NCT01236547|21448057|P2|Eligible and Started Study Treatment|Overall Study||10
8688168|NCT01236547|21448058|P1|Eligible and Started Study Treatment|Overall Study||11
8688169|NCT01236547|21448054|P5|Eligible|Overall Study||35
8688170|NCT01236547|21448055|P4|Eligible|Overall Study||36
8688171|NCT01236547|21448056|P3|Eligible|Overall Study||11
8688172|NCT01236547|21448057|P2|Eligible|Overall Study||10
8688173|NCT01236547|21448058|P1|Eligible|Overall Study||11
8688174|NCT01236547|21448054|P5|STARTED|Overall Study||47
8688175|NCT01236547|21448055|P4|STARTED|Overall Study||42
8688176|NCT01236547|21448056|P3|STARTED|Overall Study||12
8688177|NCT01236547|21448057|P2|STARTED|Overall Study||11
8688178|NCT01236547|21448058|P1|STARTED|Overall Study||11
8688179|NCT01203774|21448079|P2|NOT COMPLETED|Overall Study||0
8688180|NCT01203774|21448080|P1|NOT COMPLETED|Overall Study||0
8688181|NCT01203774|21448079|P2|COMPLETED|Overall Study||10
8688182|NCT01203774|21448080|P1|COMPLETED|Overall Study||21
8688183|NCT01203774|21448079|P2|STARTED|Overall Study||10
8688184|NCT01203774|21448080|P1|STARTED|Overall Study||21
8688203|NCT01150045|21448124|P4|NOT COMPLETED|Overall Study||1
8688204|NCT01150045|21448125|P3|NOT COMPLETED|Overall Study||0
8688205|NCT01150045|21448126|P2|NOT COMPLETED|Overall Study||1
8688206|NCT01150045|21448127|P1|NOT COMPLETED|Overall Study||0
8688207|NCT01150045|21448124|P4|COMPLETED|Overall Study||617
8688208|NCT01150045|21448125|P3|COMPLETED|Overall Study||646
8688209|NCT01150045|21448126|P2|COMPLETED|Overall Study||646
8688210|NCT01150045|21448127|P1|COMPLETED|Overall Study||615
8688211|NCT01150045|21448124|P4|STARTED|Overall Study||618
8688212|NCT01150045|21448125|P3|STARTED|Overall Study||646
8688213|NCT01150045|21448126|P2|STARTED|Overall Study||647
8688214|NCT01150045|21448127|P1|STARTED|Overall Study||615
8688215|NCT01120639|21448141|P4|NOT COMPLETED|Overall Study||0
8688216|NCT01120639|21448142|P3|NOT COMPLETED|Overall Study||0
8688217|NCT01120639|21448143|P2|NOT COMPLETED|Overall Study||0
8688218|NCT01120639|21448144|P1|NOT COMPLETED|Overall Study||0
8688219|NCT01120639|21448141|P4|COMPLETED|Overall Study||12
8688220|NCT01120639|21448142|P3|COMPLETED|Overall Study||6
8688221|NCT01120639|21448143|P2|COMPLETED|Overall Study||6
8688222|NCT01120639|21448144|P1|COMPLETED|Overall Study||6
8688223|NCT01120639|21448141|P4|STARTED|Overall Study||12
8688224|NCT01120639|21448142|P3|STARTED|Overall Study||6
8688225|NCT01120639|21448143|P2|STARTED|Overall Study||6
8688226|NCT01120639|21448144|P1|STARTED|Overall Study||6
8688254|NCT00972478|21448266|P2|NOT COMPLETED|Overall Study||38
8688255|NCT00972478|21448267|P1|NOT COMPLETED|Overall Study||7
8688256|NCT00972478|21448266|P2|COMPLETED|Overall Study||34
8688257|NCT00972478|21448267|P1|COMPLETED|Overall Study||4
8688258|NCT00972478|21448266|P2|Eligible and Began Protocol Therapy|Overall Study||63
8688259|NCT00972478|21448267|P1|Eligible and Began Protocol Therapy|Overall Study||9
8688260|NCT00972478|21448266|P2|STARTED|Overall Study||72
8688261|NCT00972478|21448267|P1|STARTED|Overall Study||11
8688280|NCT00658814|21448313|P2|NOT COMPLETED|Maintenance Therapy||1
8688281|NCT00658814|21448314|P1|NOT COMPLETED|Maintenance Therapy||3
8688282|NCT00658814|21448313|P2|COMPLETED|Maintenance Therapy||7
8688283|NCT00658814|21448314|P1|COMPLETED|Maintenance Therapy||17
8688284|NCT00658814|21448313|P2|Eligible|Maintenance Therapy||8
8688285|NCT00658814|21448314|P1|Eligible|Maintenance Therapy||19
8688286|NCT00658814|21448313|P2|STARTED|Maintenance Therapy||8
8688287|NCT00658814|21448314|P1|STARTED|Maintenance Therapy||20
8688288|NCT00658814|21448313|P2|NOT COMPLETED|Consolidation Therapy||3
8688289|NCT00658814|21448314|P1|NOT COMPLETED|Consolidation Therapy||2
8688290|NCT00658814|21448313|P2|COMPLETED|Consolidation Therapy||10
8688291|NCT00658814|21448314|P1|COMPLETED|Consolidation Therapy||22
8688292|NCT00658814|21448313|P2|Eligible|Consolidation Therapy||11
8688293|NCT00658814|21448314|P1|Eligible|Consolidation Therapy||22
8688294|NCT00658814|21448313|P2|STARTED|Consolidation Therapy||13
8688295|NCT00658814|21448314|P1|STARTED|Consolidation Therapy||24
8688296|NCT00658814|21448313|P2|NOT COMPLETED|Remission Induction Chemotherapy||18
8688297|NCT00658814|21448314|P1|NOT COMPLETED|Remission Induction Chemotherapy||8
8688298|NCT00658814|21448313|P2|COMPLETED|Remission Induction Chemotherapy||41
8688299|NCT00658814|21448314|P1|COMPLETED|Remission Induction Chemotherapy||75
8688300|NCT00658814|21448313|P2|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
8688301|NCT00658814|21448314|P1|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
8688302|NCT00658814|21448313|P2|Eligible|Remission Induction Chemotherapy||57
8688303|NCT00658814|21448314|P1|Eligible|Remission Induction Chemotherapy||82
8688304|NCT00658814|21448313|P2|STARTED|Remission Induction Chemotherapy||59
8688305|NCT00658814|21448314|P1|STARTED|Remission Induction Chemotherapy||83
8688306|NCT00569127|21448330|P2|NOT COMPLETED|Overall Study||213
8688307|NCT00569127|21448331|P1|NOT COMPLETED|Overall Study||214
8688308|NCT00569127|21448330|P2|COMPLETED|Overall Study||0
8688309|NCT00569127|21448331|P1|COMPLETED|Overall Study||0
8688310|NCT00569127|21448330|P2|Eligible|Overall Study||202
8688311|NCT00569127|21448331|P1|Eligible|Overall Study||200
8688312|NCT00569127|21448330|P2|STARTED|Overall Study||213
8688313|NCT00569127|21448331|P1|STARTED|Overall Study||214
8688314|NCT00547729|21448347|P1|NOT COMPLETED|Overall Study||0
8688315|NCT00547729|21448347|P1|COMPLETED|Overall Study||71
8688316|NCT00547729|21448347|P1|STARTED|Overall Study||71
8688337|NCT04883541|21448386|P2|NOT COMPLETED|Overall Study||9
8688338|NCT04883541|21448387|P1|NOT COMPLETED|Overall Study||16
8688339|NCT04883541|21448386|P2|COMPLETED|Overall Study||60
8688340|NCT04883541|21448387|P1|COMPLETED|Overall Study||30
8688341|NCT04883541|21448386|P2|STARTED|Overall Study||69
8688342|NCT04883541|21448387|P1|STARTED|Overall Study||46
8688343|NCT04397445|21448399|P4|NOT COMPLETED|Overall Study||0
8688344|NCT04397445|21448400|P3|NOT COMPLETED|Overall Study||0
8688345|NCT04397445|21448401|P2|NOT COMPLETED|Overall Study||0
8688346|NCT04397445|21448402|P1|NOT COMPLETED|Overall Study||1
8688347|NCT04397445|21448399|P4|COMPLETED|Overall Study||4
8688348|NCT04397445|21448400|P3|COMPLETED|Overall Study||4
8688349|NCT04397445|21448401|P2|COMPLETED|Overall Study||5
8688350|NCT04397445|21448402|P1|COMPLETED|Overall Study||4
8688351|NCT04397445|21448399|P4|STARTED|Overall Study||4
8688352|NCT04397445|21448400|P3|STARTED|Overall Study||4
8688353|NCT04397445|21448401|P2|STARTED|Overall Study||5
8688354|NCT04397445|21448402|P1|STARTED|Overall Study||5
8688355|NCT04337138|21448433|P1|NOT COMPLETED|Overall Study||0
8688356|NCT04337138|21448433|P1|COMPLETED|Overall Study||32
8688357|NCT04337138|21448433|P1|STARTED|Overall Study||32
8688358|NCT04267575|21448442|P1|NOT COMPLETED|Overall Study||0
8688359|NCT04267575|21448442|P1|COMPLETED|Overall Study||20
8688360|NCT04267575|21448442|P1|STARTED|Overall Study||20
8688361|NCT04075812|21448446|P1|NOT COMPLETED|Overall Study||0
8688362|NCT04075812|21448446|P1|COMPLETED|Overall Study||2
8688363|NCT04075812|21448446|P1|STARTED|Overall Study||2
8688364|NCT04023994|21448457|P6|NOT COMPLETED|Overall Study||0
8688365|NCT04023994|21448458|P5|NOT COMPLETED|Overall Study||0
8688366|NCT04023994|21448459|P4|NOT COMPLETED|Overall Study||1
8688367|NCT04023994|21448460|P3|NOT COMPLETED|Overall Study||2
8688368|NCT04023994|21448461|P2|NOT COMPLETED|Overall Study||1
8688369|NCT04023994|21448462|P1|NOT COMPLETED|Overall Study||0
8688370|NCT04023994|21448457|P6|COMPLETED|Overall Study||6
8688371|NCT04023994|21448458|P5|COMPLETED|Overall Study||6
8688372|NCT04023994|21448459|P4|COMPLETED|Overall Study||5
8688373|NCT04023994|21448460|P3|COMPLETED|Overall Study||2
8688374|NCT04023994|21448461|P2|COMPLETED|Overall Study||3
8688375|NCT04023994|21448462|P1|COMPLETED|Overall Study||10
8688376|NCT04023994|21448457|P6|STARTED|Overall Study||6
8688377|NCT04023994|21448458|P5|STARTED|Overall Study||6
8688378|NCT04023994|21448459|P4|STARTED|Overall Study||6
8688379|NCT04023994|21448460|P3|STARTED|Overall Study||4
8688380|NCT04023994|21448461|P2|STARTED|Overall Study||4
8688381|NCT04023994|21448462|P1|STARTED|Overall Study||10
8688382|NCT03995784|21448531|P1|NOT COMPLETED|Overall Study||1
8688383|NCT03995784|21448531|P1|COMPLETED|Overall Study||5
8688384|NCT03995784|21448531|P1|STARTED|Overall Study||6
8688385|NCT03988647|21448552|P1|NOT COMPLETED|Overall Study||0
8688386|NCT03988647|21448552|P1|COMPLETED|Overall Study||1
8688387|NCT03988647|21448552|P1|STARTED|Overall Study||1
8688391|NCT03828539|21448567|P2|NOT COMPLETED|Overall Study||22
8688392|NCT03828539|21448568|P1|NOT COMPLETED|Overall Study||16
8688393|NCT03828539|21448567|P2|COMPLETED|Overall Study||366
8688394|NCT03828539|21448568|P1|COMPLETED|Overall Study||373
8688395|NCT03828539|21448567|P2|Safety Analysis Set (SAF)|Overall Study||388
8688396|NCT03828539|21448568|P1|Safety Analysis Set (SAF)|Overall Study||388
8688397|NCT03828539|21448567|P2|Full Analysis Set (FAS)|Overall Study||388
8688398|NCT03828539|21448568|P1|Full Analysis Set (FAS)|Overall Study||388
8688399|NCT03828539|21448567|P2|STARTED|Overall Study||388
8688400|NCT03828539|21448568|P1|STARTED|Overall Study||389
8688401|NCT03732638|21448582|P2|NOT COMPLETED|Overall Study||61
8688402|NCT03732638|21448583|P1|NOT COMPLETED|Overall Study||54
8688403|NCT03732638|21448582|P2|COMPLETED|Overall Study||310
8688404|NCT03732638|21448583|P1|COMPLETED|Overall Study||316
8688405|NCT03732638|21448582|P2|STARTED|Overall Study||371
8688406|NCT03732638|21448583|P1|STARTED|Overall Study||370
8688407|NCT03610399|21448612|P3|NOT COMPLETED|Overall Study||16
8688408|NCT03610399|21448613|P2|NOT COMPLETED|Overall Study||18
8688409|NCT03610399|21448614|P1|NOT COMPLETED|Overall Study||10
8688410|NCT03610399|21448612|P3|COMPLETED|Overall Study||79
8688411|NCT03610399|21448613|P2|COMPLETED|Overall Study||78
8688412|NCT03610399|21448614|P1|COMPLETED|Overall Study||53
8688413|NCT03610399|21448612|P3|STARTED|Overall Study||95
8688414|NCT03610399|21448613|P2|STARTED|Overall Study||96
8688415|NCT03610399|21448614|P1|STARTED|Overall Study||63
8688416|NCT03410914|21448628|P1|NOT COMPLETED|Overall Study||0
8688417|NCT03410914|21448628|P1|COMPLETED|Overall Study||52
8688418|NCT03410914|21448628|P1|STARTED|Overall Study||52
8688419|NCT03359174|21448636|P1|NOT COMPLETED|Overall Study||1
8688420|NCT03359174|21448636|P1|COMPLETED|Overall Study||1
8688421|NCT03359174|21448636|P1|STARTED|Overall Study||2
8688422|NCT03349710|21448650|P4|NOT COMPLETED|Treatment Period||24
8688423|NCT03349710|21448651|P3|NOT COMPLETED|Treatment Period||27
8688424|NCT03349710|21448652|P2|NOT COMPLETED|Treatment Period||10
8688425|NCT03349710|21448653|P1|NOT COMPLETED|Treatment Period||12
8688426|NCT03349710|21448650|P4|COMPLETED|Treatment Period||0
8688427|NCT03349710|21448651|P3|COMPLETED|Treatment Period||0
8688428|NCT03349710|21448652|P2|COMPLETED|Treatment Period||0
8688429|NCT03349710|21448653|P1|COMPLETED|Treatment Period||0
8688430|NCT03349710|21448650|P4|STARTED|Treatment Period||24
8688431|NCT03349710|21448651|P3|STARTED|Treatment Period||27
8688432|NCT03349710|21448652|P2|STARTED|Treatment Period||10
8688433|NCT03349710|21448653|P1|STARTED|Treatment Period||12
8688434|NCT03349710|21448650|P4|NOT COMPLETED|Randomized||1
8688435|NCT03349710|21448651|P3|NOT COMPLETED|Randomized||0
8688436|NCT03349710|21448652|P2|NOT COMPLETED|Randomized||0
8688437|NCT03349710|21448653|P1|NOT COMPLETED|Randomized||0
8688438|NCT03349710|21448650|P4|COMPLETED|Randomized||24
8688439|NCT03349710|21448651|P3|COMPLETED|Randomized||27
8688440|NCT03349710|21448652|P2|COMPLETED|Randomized||10
8688441|NCT03349710|21448653|P1|COMPLETED|Randomized||12
8688442|NCT03349710|21448650|P4|STARTED|Randomized||25
8688443|NCT03349710|21448651|P3|STARTED|Randomized||27
8688444|NCT03349710|21448652|P2|STARTED|Randomized||10
8688445|NCT03349710|21448653|P1|STARTED|Randomized||12
8688446|NCT03294941|21448701|P2|NOT COMPLETED|Overall Study||2
8688447|NCT03294941|21448702|P1|NOT COMPLETED|Overall Study||0
8688448|NCT03294941|21448701|P2|COMPLETED|Overall Study||11
8688449|NCT03294941|21448702|P1|COMPLETED|Overall Study||4
8688450|NCT03294941|21448701|P2|STARTED|Overall Study||13
8688451|NCT03294941|21448702|P1|STARTED|Overall Study||4
8688452|NCT03232645|21448711|P1|NOT COMPLETED|Overall Study||4
8688453|NCT03232645|21448711|P1|COMPLETED|Overall Study||58
8688454|NCT03232645|21448711|P1|STARTED|Overall Study||62
8688470|NCT03003676|21448795|P1|NOT COMPLETED|Overall Study||14
8688471|NCT03003676|21448795|P1|COMPLETED|Overall Study||7
8688472|NCT03003676|21448795|P1|STARTED|Overall Study||21
8688473|NCT02981368|21448801|P2|NOT COMPLETED|Overall Study||15
8688474|NCT02981368|21448802|P1|NOT COMPLETED|Overall Study||20
8688475|NCT02981368|21448801|P2|COMPLETED|Overall Study||102
8688476|NCT02981368|21448802|P1|COMPLETED|Overall Study||248
8688477|NCT02981368|21448801|P2|STARTED|Overall Study||117
8688478|NCT02981368|21448802|P1|STARTED|Overall Study||268
8688479|NCT02732015|21448854|P2|NOT COMPLETED|Overall Study||1
8688480|NCT02732015|21448855|P1|NOT COMPLETED|Overall Study||0
8688481|NCT02732015|21448854|P2|COMPLETED|Overall Study||26
8688482|NCT02732015|21448855|P1|COMPLETED|Overall Study||9
8688483|NCT02732015|21448854|P2|STARTED|Overall Study||27
8688484|NCT02732015|21448855|P1|STARTED|Overall Study||9
8688485|NCT02722941|21448863|P2|NOT COMPLETED|Overall Study||0
8688486|NCT02722941|21448864|P1|NOT COMPLETED|Overall Study||0
8688487|NCT02722941|21448863|P2|COMPLETED|Overall Study||15
8688488|NCT02722941|21448864|P1|COMPLETED|Overall Study||15
8688489|NCT02722941|21448863|P2|STARTED|Overall Study||15
8688490|NCT02722941|21448864|P1|STARTED|Overall Study||15
8688491|NCT02556606|21448880|P4|NOT COMPLETED|Overall Study||0
8688492|NCT02556606|21448881|P3|NOT COMPLETED|Overall Study||0
8688493|NCT02556606|21448882|P2|NOT COMPLETED|Overall Study||0
8688494|NCT02556606|21448883|P1|NOT COMPLETED|Overall Study||0
8688495|NCT02556606|21448880|P4|COMPLETED|Overall Study||13
8688496|NCT02556606|21448881|P3|COMPLETED|Overall Study||11
8688497|NCT02556606|21448882|P2|COMPLETED|Overall Study||5
8688498|NCT02556606|21448883|P1|COMPLETED|Overall Study||4
8688499|NCT02556606|21448880|P4|STARTED|Overall Study||13
8688500|NCT02556606|21448881|P3|STARTED|Overall Study||11
8688501|NCT02556606|21448882|P2|STARTED|Overall Study||5
8688502|NCT02556606|21448883|P1|STARTED|Overall Study||4
8688503|NCT02523196|21448897|P1|NOT COMPLETED|Overall Study||0
8688504|NCT02523196|21448897|P1|COMPLETED|Overall Study||20
8688505|NCT02523196|21448897|P1|Received HQ Shunt|Overall Study||20
8688506|NCT02523196|21448897|P1|Received HVPG|Overall Study||20
8688507|NCT02523196|21448897|P1|STARTED|Overall Study||20
8688508|NCT02491671|21448931|P2|NOT COMPLETED|Overall Study||13
8688509|NCT02491671|21448932|P1|NOT COMPLETED|Overall Study||11
8688510|NCT02491671|21448931|P2|COMPLETED|Overall Study||118
8688511|NCT02491671|21448932|P1|COMPLETED|Overall Study||118
8688512|NCT02491671|21448931|P2|STARTED|Overall Study||131
8688513|NCT02491671|21448932|P1|STARTED|Overall Study||129
8688514|NCT02425891|21448946|P2|NOT COMPLETED|Overall Study||451
8688515|NCT02425891|21448947|P1|NOT COMPLETED|Overall Study||451
8688516|NCT02425891|21448946|P2|COMPLETED|Overall Study||0
8688517|NCT02425891|21448947|P1|COMPLETED|Overall Study||0
8688518|NCT02425891|21448946|P2|STARTED|Overall Study||451
8688519|NCT02425891|21448947|P1|STARTED|Overall Study||451
8688520|NCT02409342|21448978|P2|NOT COMPLETED|Overall Study||285
8688521|NCT02409342|21448979|P1|NOT COMPLETED|Overall Study||287
8688522|NCT02409342|21448978|P2|COMPLETED|Overall Study||0
8688523|NCT02409342|21448979|P1|COMPLETED|Overall Study||0
8688524|NCT02409342|21448978|P2|STARTED|Overall Study||285
8688525|NCT02409342|21448979|P1|STARTED|Overall Study||287
8688526|NCT02392286|21449026|P2|NOT COMPLETED|Overall Study||2
8688527|NCT02392286|21449027|P1|NOT COMPLETED|Overall Study||3
8688528|NCT02392286|21449026|P2|COMPLETED|Overall Study||6
8688529|NCT02392286|21449027|P1|COMPLETED|Overall Study||4
8688530|NCT02392286|21449026|P2|STARTED|Overall Study||8
8688531|NCT02392286|21449027|P1|STARTED|Overall Study||7
8688532|NCT02367781|21449045|P2|NOT COMPLETED|Overall Study||240
8688533|NCT02367781|21449046|P1|NOT COMPLETED|Overall Study||483
8688534|NCT02367781|21449045|P2|COMPLETED|Overall Study||0
8688535|NCT02367781|21449046|P1|COMPLETED|Overall Study||0
8688536|NCT02367781|21449045|P2|STARTED|Overall Study||240
8688537|NCT02367781|21449046|P1|STARTED|Overall Study||483
8688538|NCT02204579|21449085|P1|NOT COMPLETED|Overall Study||2
8688539|NCT02204579|21449085|P1|COMPLETED|Overall Study||5
8688540|NCT02204579|21449085|P1|Treated|Overall Study||5
8688541|NCT02204579|21449085|P1|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
8688542|NCT02204579|21449085|P1|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
8688543|NCT02204579|21449085|P1|STARTED|Overall Study||7
8688544|NCT02076009|21449139|P2|NOT COMPLETED|Overall Study||286
8688545|NCT02076009|21449140|P1|NOT COMPLETED|Overall Study||283
8688546|NCT02076009|21449139|P2|COMPLETED|Overall Study||0
8688547|NCT02076009|21449140|P1|COMPLETED|Overall Study||0
8688548|NCT02076009|21449139|P2|Treated|Overall Study||283
8688549|NCT02076009|21449140|P1|Treated|Overall Study||281
8688550|NCT02076009|21449139|P2|STARTED|Overall Study||286
8688551|NCT02076009|21449140|P1|STARTED|Overall Study||283
8688552|NCT01988090|21449162|P2|NOT COMPLETED|Complete Study After Start||1
8688553|NCT01988090|21449163|P1|NOT COMPLETED|Complete Study After Start||3
8688554|NCT01988090|21449162|P2|COMPLETED|Complete Study After Start||42
8688555|NCT01988090|21449163|P1|COMPLETED|Complete Study After Start||41
8688556|NCT01988090|21449162|P2|STARTED|Complete Study After Start||43
8688557|NCT01988090|21449163|P1|STARTED|Complete Study After Start||44
8688558|NCT01988090|21449162|P2|NOT COMPLETED|Start Treament After Randomization||4
8688559|NCT01988090|21449163|P1|NOT COMPLETED|Start Treament After Randomization||2
8688560|NCT01988090|21449162|P2|COMPLETED|Start Treament After Randomization||43
8688561|NCT01988090|21449163|P1|COMPLETED|Start Treament After Randomization||44
8688562|NCT01988090|21449162|P2|STARTED|Start Treament After Randomization||47
8688563|NCT01988090|21449163|P1|STARTED|Start Treament After Randomization||46
8688564|NCT01960998|21449175|P2|NOT COMPLETED|Overall Study||11
8688565|NCT01960998|21449176|P1|NOT COMPLETED|Overall Study||11
8688566|NCT01960998|21449175|P2|COMPLETED|Overall Study||85
8688567|NCT01960998|21449176|P1|COMPLETED|Overall Study||90
8688568|NCT01960998|21449175|P2|STARTED|Overall Study||96
8688569|NCT01960998|21449176|P1|STARTED|Overall Study||101
8688570|NCT01735981|21449206|P2|NOT COMPLETED|Crossed Over||0
8688571|NCT01735981|21449207|P1|NOT COMPLETED|Crossed Over||0
8688572|NCT01735981|21449206|P2|COMPLETED|Crossed Over||7
8688573|NCT01735981|21449207|P1|COMPLETED|Crossed Over||11
8688574|NCT01735981|21449206|P2|STARTED|Crossed Over|N=1 lost to cross over before DDR intervention|7
8688575|NCT01735981|21449207|P1|STARTED|Crossed Over||11
8688576|NCT01735981|21449206|P2|NOT COMPLETED|Allocated||3
8688577|NCT01735981|21449207|P1|NOT COMPLETED|Allocated||2
8688578|NCT01735981|21449206|P2|COMPLETED|Allocated||8
8688579|NCT01735981|21449207|P1|COMPLETED|Allocated||11
8688580|NCT01735981|21449206|P2|STARTED|Allocated||11
8688581|NCT01735981|21449207|P1|STARTED|Allocated||13
8688582|NCT00999804|21449243|P2|NOT COMPLETED|Overall Study||5
8688583|NCT00999804|21449244|P1|NOT COMPLETED|Overall Study||21
8688584|NCT00999804|21449243|P2|COMPLETED|Overall Study||38
8688585|NCT00999804|21449244|P1|COMPLETED|Overall Study||64
8688586|NCT00999804|21449243|P2|STARTED|Overall Study||43
8688587|NCT00999804|21449244|P1|STARTED|Overall Study||85
8688588|NCT00926185|21449260|P4|NOT COMPLETED|Overall Study||10
8688589|NCT00926185|21449261|P3|NOT COMPLETED|Overall Study||10
8688590|NCT00926185|21449262|P2|NOT COMPLETED|Overall Study||6
8688591|NCT00926185|21449263|P1|NOT COMPLETED|Overall Study||3
8688592|NCT00926185|21449260|P4|COMPLETED|Overall Study||48
8688593|NCT00926185|21449261|P3|COMPLETED|Overall Study||48
8688594|NCT00926185|21449262|P2|COMPLETED|Overall Study||51
8688595|NCT00926185|21449263|P1|COMPLETED|Overall Study||54
8688596|NCT00926185|21449260|P4|STARTED|Overall Study||58
8688597|NCT00926185|21449261|P3|STARTED|Overall Study||58
8688598|NCT00926185|21449262|P2|STARTED|Overall Study||57
8688599|NCT00926185|21449263|P1|STARTED|Overall Study||57
8688600|NCT00006046|21449282|P5|NOT COMPLETED|Overall Study||0
8688601|NCT00006046|21449283|P4|NOT COMPLETED|Overall Study||0
8688602|NCT00006046|21449284|P3|NOT COMPLETED|Overall Study||0
8688603|NCT00006046|21449285|P2|NOT COMPLETED|Overall Study||0
8688604|NCT00006046|21449286|P1|NOT COMPLETED|Overall Study||5
8688605|NCT00006046|21449282|P5|COMPLETED|Overall Study||0
8688606|NCT00006046|21449283|P4|COMPLETED|Overall Study||0
8688607|NCT00006046|21449284|P3|COMPLETED|Overall Study||0
8688608|NCT00006046|21449285|P2|COMPLETED|Overall Study||0
8688609|NCT00006046|21449286|P1|COMPLETED|Overall Study||2
8688610|NCT00006046|21449282|P5|STARTED|Overall Study||0
8688611|NCT00006046|21449283|P4|STARTED|Overall Study||0
8688612|NCT00006046|21449284|P3|STARTED|Overall Study||0
8688613|NCT00006046|21449285|P2|STARTED|Overall Study||0
8688614|NCT00006046|21449286|P1|STARTED|Overall Study||7
8688621|NCT04851314|21449314|P2|NOT COMPLETED|Overall Study||4
8688622|NCT04851314|21449315|P1|NOT COMPLETED|Overall Study||3
8688623|NCT04851314|21449314|P2|COMPLETED|Overall Study||51
8688624|NCT04851314|21449315|P1|COMPLETED|Overall Study||52
8688625|NCT04851314|21449314|P2|STARTED|Overall Study||55
8688626|NCT04851314|21449315|P1|STARTED|Overall Study||55
8688627|NCT04773028|21449327|P2|NOT COMPLETED|Overall Study||0
8688628|NCT04773028|21449328|P1|NOT COMPLETED|Overall Study||0
8688629|NCT04773028|21449327|P2|COMPLETED|Overall Study||24
8688630|NCT04773028|21449328|P1|COMPLETED|Overall Study||24
8688631|NCT04773028|21449327|P2|STARTED|Overall Study||24
8688632|NCT04773028|21449328|P1|STARTED|Overall Study||24
8688633|NCT04439123|21449334|P1|NOT COMPLETED|Overall Study||35
8688634|NCT04439123|21449334|P1|COMPLETED|Overall Study||0
8688635|NCT04439123|21449334|P1|STARTED|Overall Study|All 35 patients enrolled were eligible and treated in the arm|35
8688636|NCT04288752|21449342|P2|NOT COMPLETED|Overall Study||3
8688637|NCT04288752|21449343|P1|NOT COMPLETED|Overall Study||6
8688638|NCT04288752|21449342|P2|COMPLETED|Overall Study||85
8688639|NCT04288752|21449343|P1|COMPLETED|Overall Study||81
8688640|NCT04288752|21449342|P2|STARTED|Overall Study||88
8688641|NCT04288752|21449343|P1|STARTED|Overall Study|88 Participants were randomized to the VR101 group. However, one randomized participant (AR33) was unable to place the device and was immediately terminated from the study, prior to any post-randomization data collection. Therefore, 87 participants assigned to the VR101 group entered the treatment phase.|87
8688642|NCT04208698|21449354|P5|NOT COMPLETED|Overall Study||0
8688643|NCT04208698|21449355|P4|NOT COMPLETED|Overall Study||0
8688644|NCT04208698|21449356|P3|NOT COMPLETED|Overall Study||0
8688645|NCT04208698|21449357|P2|NOT COMPLETED|Overall Study||0
8688646|NCT04208698|21449358|P1|NOT COMPLETED|Overall Study||2
8688647|NCT04208698|21449354|P5|COMPLETED|Overall Study||0
8688648|NCT04208698|21449355|P4|COMPLETED|Overall Study||0
8688649|NCT04208698|21449356|P3|COMPLETED|Overall Study||0
8688650|NCT04208698|21449357|P2|COMPLETED|Overall Study||0
8688651|NCT04208698|21449358|P1|COMPLETED|Overall Study||0
8688652|NCT04208698|21449354|P5|STARTED|Overall Study||0
8688653|NCT04208698|21449355|P4|STARTED|Overall Study||0
8688654|NCT04208698|21449356|P3|STARTED|Overall Study||0
8688655|NCT04208698|21449357|P2|STARTED|Overall Study||0
8688656|NCT04208698|21449358|P1|STARTED|Overall Study||2
8688657|NCT03694613|21449396|P1|NOT COMPLETED|Overall Study||0
8688658|NCT03694613|21449396|P1|COMPLETED|Overall Study|65 samples were collected and analyzed. at least 3 ml were collected.|65
8688659|NCT03694613|21449396|P1|STARTED|Overall Study||65
8688660|NCT03605745|21449413|P1|NOT COMPLETED|Overall Study||47
8688661|NCT03605745|21449413|P1|COMPLETED|Overall Study||0
8688662|NCT03605745|21449413|P1|24 Months|Overall Study||1
8688663|NCT03605745|21449413|P1|12 Months|Overall Study||40
8688664|NCT03605745|21449413|P1|6 Months|Overall Study||47
8688665|NCT03605745|21449413|P1|3 Months|Overall Study||47
8688666|NCT03605745|21449413|P1|6 Weeks|Overall Study||47
8688667|NCT03605745|21449413|P1|2 Weeks|Overall Study||47
8688668|NCT03605745|21449413|P1|STARTED|Overall Study||47
8688669|NCT03601117|21449422|P2|NOT COMPLETED|Overall Study||1
8688670|NCT03601117|21449423|P1|NOT COMPLETED|Overall Study||3
8688671|NCT03601117|21449422|P2|COMPLETED|Overall Study||1
8688672|NCT03601117|21449423|P1|COMPLETED|Overall Study||17
8688673|NCT03601117|21449422|P2|STARTED|Overall Study||2
8688674|NCT03601117|21449423|P1|STARTED|Overall Study||20
8688687|NCT03404219|21449478|P1|NOT COMPLETED|Overall Study||0
8688688|NCT03404219|21449478|P1|COMPLETED|Overall Study||31
8688689|NCT03404219|21449478|P1|STARTED|Overall Study||31
8688690|NCT03402243|21449487|P3|NOT COMPLETED|Overall Study||2
8688691|NCT03402243|21449488|P2|NOT COMPLETED|Overall Study||3
8688692|NCT03402243|21449489|P1|NOT COMPLETED|Overall Study||3
8688693|NCT03402243|21449487|P3|COMPLETED|Overall Study||14
8688694|NCT03402243|21449488|P2|COMPLETED|Overall Study||12
8688695|NCT03402243|21449489|P1|COMPLETED|Overall Study||13
8688696|NCT03402243|21449487|P3|STARTED|Overall Study||16
8688697|NCT03402243|21449488|P2|STARTED|Overall Study||15
8688698|NCT03402243|21449489|P1|STARTED|Overall Study||16
8688699|NCT03400956|21449506|P3|NOT COMPLETED|Follow-up Period||2
8688700|NCT03400956|21449507|P2|NOT COMPLETED|Follow-up Period||0
8688701|NCT03400956|21449508|P1|NOT COMPLETED|Follow-up Period||0
8688702|NCT03400956|21449506|P3|COMPLETED|Follow-up Period||5
8688703|NCT03400956|21449507|P2|COMPLETED|Follow-up Period||9
8688704|NCT03400956|21449508|P1|COMPLETED|Follow-up Period||6
8688705|NCT03400956|21449506|P3|STARTED|Follow-up Period||7
8688706|NCT03400956|21449507|P2|STARTED|Follow-up Period||9
8688707|NCT03400956|21449508|P1|STARTED|Follow-up Period||6
8688708|NCT03400956|21449506|P3|NOT COMPLETED|Treatment Period 2||4
8688709|NCT03400956|21449507|P2|NOT COMPLETED|Treatment Period 2||3
8688710|NCT03400956|21449508|P1|NOT COMPLETED|Treatment Period 2||4
8688711|NCT03400956|21449506|P3|COMPLETED|Treatment Period 2||5
8688712|NCT03400956|21449507|P2|COMPLETED|Treatment Period 2||7
8688713|NCT03400956|21449508|P1|COMPLETED|Treatment Period 2||5
8688714|NCT03400956|21449506|P3|STARTED|Treatment Period 2||9
8688715|NCT03400956|21449507|P2|STARTED|Treatment Period 2||10
8688716|NCT03400956|21449508|P1|STARTED|Treatment Period 2||9
8688717|NCT03400956|21449506|P3|NOT COMPLETED|Post-treatment Period 1||16
8688718|NCT03400956|21449507|P2|NOT COMPLETED|Post-treatment Period 1||16
8688719|NCT03400956|21449508|P1|NOT COMPLETED|Post-treatment Period 1||22
8688720|NCT03400956|21449506|P3|COMPLETED|Post-treatment Period 1||9
8688721|NCT03400956|21449507|P2|COMPLETED|Post-treatment Period 1||10
8688722|NCT03400956|21449508|P1|COMPLETED|Post-treatment Period 1||9
8688723|NCT03400956|21449506|P3|STARTED|Post-treatment Period 1||25
8688724|NCT03400956|21449507|P2|STARTED|Post-treatment Period 1||26
8688725|NCT03400956|21449508|P1|STARTED|Post-treatment Period 1||31
8688726|NCT03400956|21449506|P3|NOT COMPLETED|Treatment Period 1||9
8688727|NCT03400956|21449507|P2|NOT COMPLETED|Treatment Period 1||8
8688728|NCT03400956|21449508|P1|NOT COMPLETED|Treatment Period 1||4
8688729|NCT03400956|21449506|P3|COMPLETED|Treatment Period 1||25
8688730|NCT03400956|21449507|P2|COMPLETED|Treatment Period 1||26
8688731|NCT03400956|21449508|P1|COMPLETED|Treatment Period 1||31
8688732|NCT03400956|21449506|P3|Treated|Treatment Period 1||30
8688733|NCT03400956|21449507|P2|Treated|Treatment Period 1||30
8688734|NCT03400956|21449508|P1|Treated|Treatment Period 1||31
8688735|NCT03400956|21449506|P3|STARTED|Treatment Period 1||34
8688736|NCT03400956|21449507|P2|STARTED|Treatment Period 1||34
8688737|NCT03400956|21449508|P1|STARTED|Treatment Period 1||35
8688741|NCT03328832|21449545|P2|NOT COMPLETED|Overall Study||1
8688742|NCT03328832|21449546|P1|NOT COMPLETED|Overall Study||0
8688743|NCT03328832|21449545|P2|COMPLETED|Overall Study||34
8688744|NCT03328832|21449546|P1|COMPLETED|Overall Study||35
8688745|NCT03328832|21449545|P2|STARTED|Overall Study||35
8688746|NCT03328832|21449546|P1|STARTED|Overall Study||35
8688747|NCT03244917|21449558|P2|NOT COMPLETED|Overall Study||2
8688748|NCT03244917|21449559|P1|NOT COMPLETED|Overall Study||2
8688749|NCT03244917|21449558|P2|COMPLETED|Overall Study||227
8688750|NCT03244917|21449559|P1|COMPLETED|Overall Study||199
8688751|NCT03244917|21449558|P2|STARTED|Overall Study||229
8688752|NCT03244917|21449559|P1|STARTED|Overall Study||201
8688753|NCT03228420|21449573|P2|NOT COMPLETED|Overall Study||5
8688754|NCT03228420|21449574|P1|NOT COMPLETED|Overall Study||20
8688755|NCT03228420|21449573|P2|COMPLETED|Overall Study||98
8688756|NCT03228420|21449574|P1|COMPLETED|Overall Study||93
8688757|NCT03228420|21449573|P2|Month-3|Overall Study||98
8688758|NCT03228420|21449574|P1|Month-3|Overall Study||93
8688759|NCT03228420|21449573|P2|Month-1|Overall Study||101
8688760|NCT03228420|21449574|P1|Month-1|Overall Study||95
8688761|NCT03228420|21449573|P2|STARTED|Overall Study||103
8688762|NCT03228420|21449574|P1|STARTED|Overall Study||113
8688763|NCT03173547|21449582|P2|NOT COMPLETED|Overall Study||2
8688764|NCT03173547|21449583|P1|NOT COMPLETED|Overall Study||4
8688765|NCT03173547|21449582|P2|COMPLETED|Overall Study||38
8688766|NCT03173547|21449583|P1|COMPLETED|Overall Study||36
8688767|NCT03173547|21449582|P2|STARTED|Overall Study||40
8688768|NCT03173547|21449583|P1|STARTED|Overall Study||40
8688769|NCT03117738|21449593|P2|NOT COMPLETED|Overall Study||5
8688770|NCT03117738|21449594|P1|NOT COMPLETED|Overall Study||4
8688771|NCT03117738|21449593|P2|COMPLETED|Overall Study||5
8688772|NCT03117738|21449594|P1|COMPLETED|Overall Study||7
8688773|NCT03117738|21449593|P2|STARTED|Overall Study||10
8688774|NCT03117738|21449594|P1|STARTED|Overall Study||11
8688775|NCT03107793|21449614|P3|NOT COMPLETED|Maintenance Period (16-48 Week)||28
8688776|NCT03107793|21449615|P2|NOT COMPLETED|Maintenance Period (16-48 Week)||46
8688777|NCT03107793|21449616|P1|NOT COMPLETED|Maintenance Period (16-48 Week)||0
8688778|NCT03107793|21449614|P3|COMPLETED|Maintenance Period (16-48 Week)||193
8688779|NCT03107793|21449615|P2|COMPLETED|Maintenance Period (16-48 Week)||174
8688780|NCT03107793|21449616|P1|COMPLETED|Maintenance Period (16-48 Week)||0
8688781|NCT03107793|21449614|P3|STARTED|Maintenance Period (16-48 Week)||221
8688782|NCT03107793|21449615|P2|STARTED|Maintenance Period (16-48 Week)||220
8688783|NCT03107793|21449616|P1|STARTED|Maintenance Period (16-48 Week)||0
8688784|NCT03107793|21449614|P3|NOT COMPLETED|Induction Period (16 Weeks)||0
8688785|NCT03107793|21449615|P2|NOT COMPLETED|Induction Period (16 Weeks)||0
8688786|NCT03107793|21449616|P1|NOT COMPLETED|Induction Period (16 Weeks)||10
8688787|NCT03107793|21449614|P3|COMPLETED|Induction Period (16 Weeks)||0
8688788|NCT03107793|21449615|P2|COMPLETED|Induction Period (16 Weeks)||0
8688789|NCT03107793|21449616|P1|COMPLETED|Induction Period (16 Weeks)||490
8688790|NCT03107793|21449614|P3|STARTED|Induction Period (16 Weeks)||0
8688791|NCT03107793|21449615|P2|STARTED|Induction Period (16 Weeks)||0
8688792|NCT03107793|21449616|P1|STARTED|Induction Period (16 Weeks)||500
8688793|NCT03101566|21449633|P2|NOT COMPLETED|Overall Study||7
8688794|NCT03101566|21449634|P1|NOT COMPLETED|Overall Study||6
8688795|NCT03101566|21449633|P2|COMPLETED|Overall Study||31
8688796|NCT03101566|21449634|P1|COMPLETED|Overall Study||31
8688797|NCT03101566|21449633|P2|Assessed for Primary and Secondary Progression-free Survival|Overall Study||33
8688798|NCT03101566|21449634|P1|Assessed for Primary and Secondary Progression-free Survival|Overall Study||32
8688799|NCT03101566|21449633|P2|Received at Least One Dose of Protocol Therapy|Overall Study||33
8688800|NCT03101566|21449634|P1|Received at Least One Dose of Protocol Therapy|Overall Study||35
8688801|NCT03101566|21449633|P2|STARTED|Overall Study||38
8688802|NCT03101566|21449634|P1|STARTED|Overall Study||37
8688803|NCT03020966|21449642|P2|NOT COMPLETED|Overall Study||0
8688804|NCT03020966|21449643|P1|NOT COMPLETED|Overall Study||2
8688805|NCT03020966|21449642|P2|COMPLETED|Overall Study||77
8688806|NCT03020966|21449643|P1|COMPLETED|Overall Study||75
8688807|NCT03020966|21449642|P2|STARTED|Overall Study||77
8688808|NCT03020966|21449643|P1|STARTED|Overall Study||77
8688809|NCT02981602|21449658|P5|NOT COMPLETED|Overall Study||0
8688810|NCT02981602|21449659|P4|NOT COMPLETED|Overall Study||1
8688811|NCT02981602|21449660|P3|NOT COMPLETED|Overall Study||0
8688812|NCT02981602|21449661|P2|NOT COMPLETED|Overall Study||0
8688813|NCT02981602|21449662|P1|NOT COMPLETED|Overall Study||0
8688814|NCT02981602|21449658|P5|COMPLETED|Overall Study||2
8688815|NCT02981602|21449659|P4|COMPLETED|Overall Study||4
8688816|NCT02981602|21449660|P3|COMPLETED|Overall Study||6
8688817|NCT02981602|21449661|P2|COMPLETED|Overall Study||12
8688818|NCT02981602|21449662|P1|COMPLETED|Overall Study||6
8688819|NCT02981602|21449658|P5|STARTED|Overall Study||2
8688820|NCT02981602|21449659|P4|STARTED|Overall Study||5
8688821|NCT02981602|21449660|P3|STARTED|Overall Study||6
8688822|NCT02981602|21449661|P2|STARTED|Overall Study||12
8688823|NCT02981602|21449662|P1|STARTED|Overall Study||6
8688824|NCT02847637|21449846|P4|NOT COMPLETED|Overall Study||63
8688825|NCT02847637|21449847|P3|NOT COMPLETED|Overall Study||35
8688826|NCT02847637|21449848|P2|NOT COMPLETED|Overall Study||35
8688827|NCT02847637|21449849|P1|NOT COMPLETED|Overall Study||17
8688828|NCT02847637|21449846|P4|COMPLETED|Overall Study||0
8688829|NCT02847637|21449847|P3|COMPLETED|Overall Study||0
8688830|NCT02847637|21449848|P2|COMPLETED|Overall Study||1
8688831|NCT02847637|21449849|P1|COMPLETED|Overall Study||1
8688832|NCT02847637|21449846|P4|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
8688833|NCT02847637|21449847|P3|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
8688834|NCT02847637|21449848|P2|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
8688835|NCT02847637|21449849|P1|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
8688836|NCT02847637|21449846|P4|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
8688837|NCT02847637|21449847|P3|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
8688838|NCT02847637|21449848|P2|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
8688839|NCT02847637|21449849|P1|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
8688840|NCT02847637|21449846|P4|Completed 24 Weeks on No Prophylaxis|Overall Study||0
8688841|NCT02847637|21449847|P3|Completed 24 Weeks on No Prophylaxis|Overall Study||0
8688842|NCT02847637|21449848|P2|Completed 24 Weeks on No Prophylaxis|Overall Study||0
8688843|NCT02847637|21449849|P1|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
8688844|NCT02847637|21449846|P4|STARTED|Overall Study||63
8688845|NCT02847637|21449847|P3|STARTED|Overall Study||35
8688846|NCT02847637|21449848|P2|STARTED|Overall Study||36
8688847|NCT02847637|21449849|P1|STARTED|Overall Study||18
8688848|NCT02743221|21449963|P2|NOT COMPLETED|Overall Study||60
8688849|NCT02743221|21449964|P1|NOT COMPLETED|Overall Study||56
8688850|NCT02743221|21449963|P2|COMPLETED|Overall Study||17
8688851|NCT02743221|21449964|P1|COMPLETED|Overall Study||21
8688852|NCT02743221|21449963|P2|STARTED|Overall Study||77
8688853|NCT02743221|21449964|P1|STARTED|Overall Study||77
8688854|NCT02711956|21449993|P15|NOT COMPLETED|Overall Study||8
8688855|NCT02711956|21449994|P14|NOT COMPLETED|Overall Study||5
8688856|NCT02711956|21449995|P13|NOT COMPLETED|Overall Study||16
8688857|NCT02711956|21449996|P12|NOT COMPLETED|Overall Study||9
8688858|NCT02711956|21449997|P11|NOT COMPLETED|Overall Study||1
8688859|NCT02711956|21449998|P10|NOT COMPLETED|Overall Study||3
8688860|NCT02711956|21449999|P9|NOT COMPLETED|Overall Study||4
8688861|NCT02711956|21450000|P8|NOT COMPLETED|Overall Study||2
8688862|NCT02711956|21450001|P7|NOT COMPLETED|Overall Study||4
8688863|NCT02711956|21450002|P6|NOT COMPLETED|Overall Study||2
8688864|NCT02711956|21450003|P5|NOT COMPLETED|Overall Study||4
8688865|NCT02711956|21450004|P4|NOT COMPLETED|Overall Study||3
8688866|NCT02711956|21450005|P3|NOT COMPLETED|Overall Study||2
8688867|NCT02711956|21450006|P2|NOT COMPLETED|Overall Study||2
8688868|NCT02711956|21450007|P1|NOT COMPLETED|Overall Study||2
8688869|NCT02711956|21449993|P15|COMPLETED|Overall Study||0
8688870|NCT02711956|21449994|P14|COMPLETED|Overall Study||1
8688871|NCT02711956|21449995|P13|COMPLETED|Overall Study||1
8688872|NCT02711956|21449996|P12|COMPLETED|Overall Study||0
8688873|NCT02711956|21449997|P11|COMPLETED|Overall Study||0
8688874|NCT02711956|21449998|P10|COMPLETED|Overall Study||0
8688875|NCT02711956|21449999|P9|COMPLETED|Overall Study||0
8688876|NCT02711956|21450000|P8|COMPLETED|Overall Study||2
8688877|NCT02711956|21450001|P7|COMPLETED|Overall Study||0
8688878|NCT02711956|21450002|P6|COMPLETED|Overall Study||1
8688879|NCT02711956|21450003|P5|COMPLETED|Overall Study||0
8688880|NCT02711956|21450004|P4|COMPLETED|Overall Study||2
8688881|NCT02711956|21450005|P3|COMPLETED|Overall Study||1
8688882|NCT02711956|21450006|P2|COMPLETED|Overall Study||0
8688883|NCT02711956|21450007|P1|COMPLETED|Overall Study||0
8688884|NCT02711956|21449993|P15|STARTED|Overall Study||8
8688885|NCT02711956|21449994|P14|STARTED|Overall Study||6
8688886|NCT02711956|21449995|P13|STARTED|Overall Study||17
8688887|NCT02711956|21449996|P12|STARTED|Overall Study||9
8688888|NCT02711956|21449997|P11|STARTED|Overall Study||1
8688889|NCT02711956|21449998|P10|STARTED|Overall Study||3
8688890|NCT02711956|21449999|P9|STARTED|Overall Study||4
8688891|NCT02711956|21450000|P8|STARTED|Overall Study||4
8688892|NCT02711956|21450001|P7|STARTED|Overall Study||4
8688893|NCT02711956|21450002|P6|STARTED|Overall Study||3
8688894|NCT02711956|21450003|P5|STARTED|Overall Study||4
8688895|NCT02711956|21450004|P4|STARTED|Overall Study||5
8688896|NCT02711956|21450005|P3|STARTED|Overall Study||3
8688897|NCT02711956|21450006|P2|STARTED|Overall Study||2
8688898|NCT02711956|21450007|P1|STARTED|Overall Study||2
8688899|NCT02708641|21450052|P1|NOT COMPLETED|Overall Study||0
8688900|NCT02708641|21450052|P1|COMPLETED|Overall Study||12
8688901|NCT02708641|21450052|P1|STARTED|Overall Study||12
8688902|NCT02702518|21450062|P2|NOT COMPLETED|Overall Study||4
8688903|NCT02702518|21450063|P1|NOT COMPLETED|Overall Study||3
8688904|NCT02702518|21450062|P2|COMPLETED|Overall Study||25
8688905|NCT02702518|21450063|P1|COMPLETED|Overall Study||26
8688906|NCT02702518|21450062|P2|STARTED|Overall Study||29
8688907|NCT02702518|21450063|P1|STARTED|Overall Study||29
8688908|NCT02700425|21450073|P2|NOT COMPLETED|Overall Study||1
8688909|NCT02700425|21450074|P1|NOT COMPLETED|Overall Study||0
8688910|NCT02700425|21450073|P2|COMPLETED|Overall Study|1 patient withdrew after randomization|19
8688911|NCT02700425|21450074|P1|COMPLETED|Overall Study||21
8688912|NCT02700425|21450073|P2|STARTED|Overall Study||20
8688913|NCT02700425|21450074|P1|STARTED|Overall Study||21
8688914|NCT02691468|21450094|P2|NOT COMPLETED|Overall Study||2
8688915|NCT02691468|21450095|P1|NOT COMPLETED|Overall Study||6
8688916|NCT02691468|21450094|P2|COMPLETED|Overall Study||52
8688917|NCT02691468|21450095|P1|COMPLETED|Overall Study||48
8688918|NCT02691468|21450094|P2|STARTED|Overall Study||54
8688919|NCT02691468|21450095|P1|STARTED|Overall Study||54
8688920|NCT02690558|21450103|P1|NOT COMPLETED|Overall Study||0
8688921|NCT02690558|21450103|P1|COMPLETED|Overall Study||39
8688922|NCT02690558|21450103|P1|STARTED|Overall Study||39
8688923|NCT02674399|21450110|P2|NOT COMPLETED|Overall Study||0
8688924|NCT02674399|21450111|P1|NOT COMPLETED|Overall Study||2
8688925|NCT02674399|21450110|P2|COMPLETED|Overall Study||9
8688926|NCT02674399|21450111|P1|COMPLETED|Overall Study||17
8688927|NCT02674399|21450110|P2|STARTED|Overall Study||9
8688928|NCT02674399|21450111|P1|STARTED|Overall Study||19
8688929|NCT02668003|21450149|P2|NOT COMPLETED|Overall Study||5
8688930|NCT02668003|21450150|P1|NOT COMPLETED|Overall Study||1
8688931|NCT02668003|21450149|P2|COMPLETED|Overall Study||496
8688932|NCT02668003|21450150|P1|COMPLETED|Overall Study||500
8688933|NCT02668003|21450149|P2|STARTED|Overall Study||501
8688934|NCT02668003|21450150|P1|STARTED|Overall Study||501
8688935|NCT02489123|21450216|P1|NOT COMPLETED|Overall Study||0
8688936|NCT02489123|21450216|P1|COMPLETED|Overall Study||8
8688937|NCT02489123|21450216|P1|STARTED|Overall Study||8
8688938|NCT02361307|21450227|P2|NOT COMPLETED|Overall Study||1
8688939|NCT02361307|21450228|P1|NOT COMPLETED|Overall Study||0
8688940|NCT02361307|21450227|P2|COMPLETED|Overall Study||17
8688941|NCT02361307|21450228|P1|COMPLETED|Overall Study||18
8688942|NCT02361307|21450227|P2|STARTED|Overall Study||18
8688943|NCT02361307|21450228|P1|STARTED|Overall Study||18
8688944|NCT02351115|21450239|P5|NOT COMPLETED|Overall Study||0
8688945|NCT02351115|21450240|P4|NOT COMPLETED|Overall Study||0
8688946|NCT02351115|21450241|P3|NOT COMPLETED|Overall Study||0
8688947|NCT02351115|21450242|P2|NOT COMPLETED|Overall Study||0
8688948|NCT02351115|21450243|P1|NOT COMPLETED|Overall Study||0
8688949|NCT02351115|21450239|P5|COMPLETED|Overall Study||1
8688950|NCT02351115|21450240|P4|COMPLETED|Overall Study||1
8688951|NCT02351115|21450241|P3|COMPLETED|Overall Study||1
8688952|NCT02351115|21450242|P2|COMPLETED|Overall Study||1
8688953|NCT02351115|21450243|P1|COMPLETED|Overall Study||1
8688954|NCT02351115|21450239|P5|STARTED|Overall Study||1
8688955|NCT02351115|21450240|P4|STARTED|Overall Study||1
8688956|NCT02351115|21450241|P3|STARTED|Overall Study||1
8688957|NCT02351115|21450242|P2|STARTED|Overall Study||1
8688958|NCT02351115|21450243|P1|STARTED|Overall Study||1
8688959|NCT02343549|21450270|P1|NOT COMPLETED|Overall Study||13
8688960|NCT02343549|21450270|P1|COMPLETED|Overall Study||0
8688961|NCT02343549|21450270|P1|STARTED|Overall Study||13
8688962|NCT02314728|21450282|P2|NOT COMPLETED|Overall Study||1
8688963|NCT02314728|21450283|P1|NOT COMPLETED|Overall Study||1
8688964|NCT02314728|21450282|P2|COMPLETED|Overall Study||112
8688965|NCT02314728|21450283|P1|COMPLETED|Overall Study||116
8688966|NCT02314728|21450282|P2|STARTED|Overall Study||113
8688967|NCT02314728|21450283|P1|STARTED|Overall Study||117
8688968|NCT02278120|21450293|P2|NOT COMPLETED|Overall Study||216
8688969|NCT02278120|21450294|P1|NOT COMPLETED|Overall Study||161
8688970|NCT02278120|21450293|P2|COMPLETED|Overall Study||121
8688971|NCT02278120|21450294|P1|COMPLETED|Overall Study||174
8688972|NCT02278120|21450293|P2|STARTED|Overall Study||337
8688973|NCT02278120|21450294|P1|STARTED|Overall Study||335
8688974|NCT02270736|21450311|P5|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
8688975|NCT02270736|21450312|P4|NOT COMPLETED|OLEX Period (up to 48 Weeks)||25
8688976|NCT02270736|21450313|P3|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
8688977|NCT02270736|21450314|P2|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
8688978|NCT02270736|21450315|P1|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
8688979|NCT02270736|21450311|P5|COMPLETED|OLEX Period (up to 48 Weeks)||33
8688980|NCT02270736|21450312|P4|COMPLETED|OLEX Period (up to 48 Weeks)||189
8688981|NCT02270736|21450313|P3|COMPLETED|OLEX Period (up to 48 Weeks)||0
8688982|NCT02270736|21450314|P2|COMPLETED|OLEX Period (up to 48 Weeks)||0
8688983|NCT02270736|21450315|P1|COMPLETED|OLEX Period (up to 48 Weeks)||0
8688984|NCT02270736|21450311|P5|STARTED|OLEX Period (up to 48 Weeks)|1 participant from MP did not enter OLEX due to adverse event.|33
8688985|NCT02270736|21450312|P4|STARTED|OLEX Period (up to 48 Weeks)|2 participants from MP did not enter OLEX due to withdrawal of consent.|214
8688986|NCT02270736|21450313|P3|STARTED|OLEX Period (up to 48 Weeks)||0
8688987|NCT02270736|21450314|P2|STARTED|OLEX Period (up to 48 Weeks)||0
8688988|NCT02270736|21450315|P1|STARTED|OLEX Period (up to 48 Weeks)||0
8688989|NCT02270736|21450311|P5|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
8688990|NCT02270736|21450312|P4|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
8688991|NCT02270736|21450313|P3|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
8688992|NCT02270736|21450314|P2|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
8688993|NCT02270736|21450315|P1|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
8688994|NCT02270736|21450311|P5|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
8688995|NCT02270736|21450312|P4|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
8688996|NCT02270736|21450313|P3|COMPLETED|Main Period (MP) (up to 16 Weeks)||34
8688997|NCT02270736|21450314|P2|COMPLETED|Main Period (MP) (up to 16 Weeks)||146
8688998|NCT02270736|21450315|P1|COMPLETED|Main Period (MP) (up to 16 Weeks)||70
8688999|NCT02270736|21450311|P5|Treated|Main Period (MP) (up to 16 Weeks)||0
8689000|NCT02270736|21450312|P4|Treated|Main Period (MP) (up to 16 Weeks)||0
8689001|NCT02270736|21450313|P3|Treated|Main Period (MP) (up to 16 Weeks)||35
8689002|NCT02270736|21450314|P2|Treated|Main Period (MP) (up to 16 Weeks)||148
8689003|NCT02270736|21450315|P1|Treated|Main Period (MP) (up to 16 Weeks)||72
8689004|NCT02270736|21450311|P5|STARTED|Main Period (MP) (up to 16 Weeks)||0
8689005|NCT02270736|21450312|P4|STARTED|Main Period (MP) (up to 16 Weeks)||0
8689006|NCT02270736|21450313|P3|STARTED|Main Period (MP) (up to 16 Weeks)||36
8689007|NCT02270736|21450314|P2|STARTED|Main Period (MP) (up to 16 Weeks)||148
8689008|NCT02270736|21450315|P1|STARTED|Main Period (MP) (up to 16 Weeks)||72
8689009|NCT02258256|21450355|P1|NOT COMPLETED|Overall Study||0
8689010|NCT02258256|21450355|P1|COMPLETED|Overall Study||11
8689011|NCT02258256|21450355|P1|STARTED|Overall Study||11
8689012|NCT02171065|21450362|P3|NOT COMPLETED|Overall Study||1
8689013|NCT02171065|21450363|P2|NOT COMPLETED|Overall Study||0
8689014|NCT02171065|21450364|P1|NOT COMPLETED|Overall Study||1
8689015|NCT02171065|21450362|P3|COMPLETED|Overall Study||715
8689016|NCT02171065|21450363|P2|COMPLETED|Overall Study||93
8689017|NCT02171065|21450364|P1|COMPLETED|Overall Study||88
8689018|NCT02171065|21450362|P3|STARTED|Overall Study||716
8689019|NCT02171065|21450363|P2|STARTED|Overall Study||93
8689020|NCT02171065|21450364|P1|STARTED|Overall Study||89
8689021|NCT02041299|21450376|P2|NOT COMPLETED|Overall Study||20
8689022|NCT02041299|21450377|P1|NOT COMPLETED|Overall Study||46
8689023|NCT02041299|21450376|P2|COMPLETED|Overall Study||58
8689024|NCT02041299|21450377|P1|COMPLETED|Overall Study||106
8689025|NCT02041299|21450376|P2|STARTED|Overall Study|Two participants double-enrolled under different subject numbers so were each counted twice.|78
8689026|NCT02041299|21450377|P1|STARTED|Overall Study||152
8689027|NCT01993017|21450392|P3|NOT COMPLETED|Overall Study||79
8689028|NCT01993017|21450393|P2|NOT COMPLETED|Overall Study||90
8689029|NCT01993017|21450394|P1|NOT COMPLETED|Overall Study||106
8689030|NCT01993017|21450392|P3|COMPLETED|Overall Study||421
8689031|NCT01993017|21450393|P2|COMPLETED|Overall Study||411
8689032|NCT01993017|21450394|P1|COMPLETED|Overall Study||393
8689033|NCT01993017|21450392|P3|STARTED|Overall Study||500
8689034|NCT01993017|21450393|P2|STARTED|Overall Study||501
8689035|NCT01993017|21450394|P1|STARTED|Overall Study||499
8689036|NCT01958593|21450410|P2|NOT COMPLETED|Overall Study||0
8689037|NCT01958593|21450411|P1|NOT COMPLETED|Overall Study||0
8689038|NCT01958593|21450410|P2|COMPLETED|Overall Study||4
8689039|NCT01958593|21450411|P1|COMPLETED|Overall Study||2
8689040|NCT01958593|21450410|P2|STARTED|Overall Study||4
8689041|NCT01958593|21450411|P1|STARTED|Overall Study||2
8689042|NCT01683422|21450417|P1|NOT COMPLETED|Overall Study||0
8689043|NCT01683422|21450417|P1|COMPLETED|Overall Study||9
8689044|NCT01683422|21450417|P1|STARTED|Overall Study||9
8689045|NCT01666730|21450421|P1|NOT COMPLETED|Overall Study||50
8689046|NCT01666730|21450421|P1|COMPLETED|Overall Study||0
8689047|NCT01666730|21450421|P1|STARTED|Overall Study||50
8689048|NCT01585831|21450431|P2|NOT COMPLETED|Overall Study||2
8689049|NCT01585831|21450432|P1|NOT COMPLETED|Overall Study||2
8689050|NCT01585831|21450431|P2|COMPLETED|Overall Study||18
8689051|NCT01585831|21450432|P1|COMPLETED|Overall Study||26
8689052|NCT01585831|21450431|P2|STARTED|Overall Study||20
8689053|NCT01585831|21450432|P1|STARTED|Overall Study||28
8689054|NCT01497808|21450460|P4|NOT COMPLETED|Overall Study||0
8689055|NCT01497808|21450461|P3|NOT COMPLETED|Overall Study||0
8689056|NCT01497808|21450462|P2|NOT COMPLETED|Overall Study||0
8689057|NCT01497808|21450463|P1|NOT COMPLETED|Overall Study||0
8689058|NCT01497808|21450460|P4|COMPLETED|Overall Study||6
8689059|NCT01497808|21450461|P3|COMPLETED|Overall Study||6
8689060|NCT01497808|21450462|P2|COMPLETED|Overall Study||4
8689061|NCT01497808|21450463|P1|COMPLETED|Overall Study||6
8689062|NCT01497808|21450460|P4|STARTED|Overall Study||6
8689063|NCT01497808|21450461|P3|STARTED|Overall Study||6
8689064|NCT01497808|21450462|P2|STARTED|Overall Study||4
8689065|NCT01497808|21450463|P1|STARTED|Overall Study||6
8689066|NCT01191541|21450479|P2|NOT COMPLETED|the Randomized Patients||0
8689067|NCT01191541|21450480|P1|NOT COMPLETED|the Randomized Patients||0
8689068|NCT01191541|21450479|P2|COMPLETED|the Randomized Patients||35
8689069|NCT01191541|21450480|P1|COMPLETED|the Randomized Patients||30
8689070|NCT01191541|21450479|P2|STARTED|the Randomized Patients||35
8689071|NCT01191541|21450480|P1|STARTED|the Randomized Patients||30
8689072|NCT01191541|21450479|P2|NOT COMPLETED|All the Patients||0
8689073|NCT01191541|21450480|P1|NOT COMPLETED|All the Patients||0
8689074|NCT01191541|21450479|P2|COMPLETED|All the Patients||35
8689075|NCT01191541|21450480|P1|COMPLETED|All the Patients||30
8689076|NCT01191541|21450479|P2|STARTED|All the Patients||35
8689077|NCT01191541|21450480|P1|STARTED|All the Patients||30
8689078|NCT01146808|21450496|P1|NOT COMPLETED|Overall Study||0
8689079|NCT01146808|21450496|P1|COMPLETED|Overall Study||16
8689080|NCT01146808|21450496|P1|STARTED|Overall Study||16
8689081|NCT01097642|21450504|P2|NOT COMPLETED|Overall Study||0
8689082|NCT01097642|21450505|P1|NOT COMPLETED|Overall Study||0
8689083|NCT01097642|21450504|P2|COMPLETED|Overall Study||25
8689084|NCT01097642|21450505|P1|COMPLETED|Overall Study||15
8689085|NCT01097642|21450504|P2|STARTED|Overall Study||25
8689086|NCT01097642|21450505|P1|STARTED|Overall Study||15
8689087|NCT00887432|21450517|P2|NOT COMPLETED|Overall Study||14
8689088|NCT00887432|21450518|P1|NOT COMPLETED|Overall Study||15
8689089|NCT00887432|21450517|P2|COMPLETED|Overall Study||60
8689090|NCT00887432|21450518|P1|COMPLETED|Overall Study||43
8689091|NCT00887432|21450517|P2|STARTED|Overall Study||74
8689092|NCT00887432|21450518|P1|STARTED|Overall Study||58
8689093|NCT00703820|21450530|P2|NOT COMPLETED|Overall Study||34
8689094|NCT00703820|21450531|P1|NOT COMPLETED|Overall Study||35
8689095|NCT00703820|21450530|P2|COMPLETED|Overall Study||95
8689096|NCT00703820|21450531|P1|COMPLETED|Overall Study||98
8689097|NCT00703820|21450530|P2|STARTED|Overall Study||129
8689098|NCT00703820|21450531|P1|STARTED|Overall Study||133
8689099|NCT00621179|21450546|P4|NOT COMPLETED|Overall Study||1
8689100|NCT00621179|21450547|P3|NOT COMPLETED|Overall Study||1
8689101|NCT00621179|21450548|P2|NOT COMPLETED|Overall Study||0
8689102|NCT00621179|21450549|P1|NOT COMPLETED|Overall Study||0
8689103|NCT00621179|21450546|P4|COMPLETED|Overall Study||9
8689104|NCT00621179|21450547|P3|COMPLETED|Overall Study||6
8689105|NCT00621179|21450548|P2|COMPLETED|Overall Study||8
8689106|NCT00621179|21450549|P1|COMPLETED|Overall Study||12
8689107|NCT00621179|21450546|P4|STARTED|Overall Study||10
8689108|NCT00621179|21450547|P3|STARTED|Overall Study||7
8689109|NCT00621179|21450548|P2|STARTED|Overall Study||8
8689110|NCT00621179|21450549|P1|STARTED|Overall Study||12
8689111|NCT04912297|21450561|P2|NOT COMPLETED|Overall Study||33
8689112|NCT04912297|21450562|P1|NOT COMPLETED|Overall Study||31
8689113|NCT04912297|21450561|P2|COMPLETED|Overall Study||54
8689114|NCT04912297|21450562|P1|COMPLETED|Overall Study||68
8689115|NCT04912297|21450561|P2|STARTED|Overall Study||87
8689116|NCT04912297|21450562|P1|STARTED|Overall Study||99
8689117|NCT04565353|21450588|P20|NOT COMPLETED|Overall Study||46
8689118|NCT04565353|21450589|P19|NOT COMPLETED|Overall Study||43
8689119|NCT04565353|21450590|P18|NOT COMPLETED|Overall Study||48
8689120|NCT04565353|21450591|P17|NOT COMPLETED|Overall Study||42
8689121|NCT04565353|21450592|P16|NOT COMPLETED|Overall Study||49
8689122|NCT04565353|21450593|P15|NOT COMPLETED|Overall Study||37
8689123|NCT04565353|21450594|P14|NOT COMPLETED|Overall Study||50
8689124|NCT04565353|21450595|P13|NOT COMPLETED|Overall Study||52
8689125|NCT04565353|21450596|P12|NOT COMPLETED|Overall Study||41
8689126|NCT04565353|21450597|P11|NOT COMPLETED|Overall Study||49
8689127|NCT04565353|21450598|P10|NOT COMPLETED|Overall Study||43
8689128|NCT04565353|21450599|P9|NOT COMPLETED|Overall Study||66
8689129|NCT04565353|21450600|P8|NOT COMPLETED|Overall Study||39
8689130|NCT04565353|21450601|P7|NOT COMPLETED|Overall Study||54
8689131|NCT04565353|21450602|P6|NOT COMPLETED|Overall Study||53
8689132|NCT04565353|21450603|P5|NOT COMPLETED|Overall Study||41
8689133|NCT04565353|21450604|P4|NOT COMPLETED|Overall Study||42
8689134|NCT04565353|21450605|P3|NOT COMPLETED|Overall Study||39
8689135|NCT04565353|21450606|P2|NOT COMPLETED|Overall Study||49
8689136|NCT04565353|21450607|P1|NOT COMPLETED|Overall Study||0
8689137|NCT04565353|21450588|P20|COMPLETED|Overall Study||3712
8689138|NCT04565353|21450589|P19|COMPLETED|Overall Study||3698
8689139|NCT04565353|21450590|P18|COMPLETED|Overall Study||3696
8689140|NCT04565353|21450591|P17|COMPLETED|Overall Study||3734
8689141|NCT04565353|21450592|P16|COMPLETED|Overall Study||3690
8689142|NCT04565353|21450593|P15|COMPLETED|Overall Study||3736
8689143|NCT04565353|21450594|P14|COMPLETED|Overall Study||3664
8689144|NCT04565353|21450595|P13|COMPLETED|Overall Study||3685
8689145|NCT04565353|21450596|P12|COMPLETED|Overall Study||3710
8689146|NCT04565353|21450597|P11|COMPLETED|Overall Study||3623
8689147|NCT04565353|21450598|P10|COMPLETED|Overall Study||3734
8689148|NCT04565353|21450599|P9|COMPLETED|Overall Study||3662
8689149|NCT04565353|21450600|P8|COMPLETED|Overall Study||3693
8689150|NCT04565353|21450601|P7|COMPLETED|Overall Study||3665
8689151|NCT04565353|21450602|P6|COMPLETED|Overall Study||3716
8689152|NCT04565353|21450603|P5|COMPLETED|Overall Study||3717
8689153|NCT04565353|21450604|P4|COMPLETED|Overall Study||3693
8689154|NCT04565353|21450605|P3|COMPLETED|Overall Study||3670
8689155|NCT04565353|21450606|P2|COMPLETED|Overall Study||3688
8689156|NCT04565353|21450607|P1|COMPLETED|Overall Study||3742
8689157|NCT04565353|21450588|P20|STARTED|Overall Study||3758
8689158|NCT04565353|21450589|P19|STARTED|Overall Study||3741
8689159|NCT04565353|21450590|P18|STARTED|Overall Study||3744
8689160|NCT04565353|21450591|P17|STARTED|Overall Study||3776
8689161|NCT04565353|21450592|P16|STARTED|Overall Study||3739
8689162|NCT04565353|21450593|P15|STARTED|Overall Study||3773
8689163|NCT04565353|21450594|P14|STARTED|Overall Study||3714
8689164|NCT04565353|21450595|P13|STARTED|Overall Study||3737
8689165|NCT04565353|21450596|P12|STARTED|Overall Study||3751
8689166|NCT04565353|21450597|P11|STARTED|Overall Study||3672
8689167|NCT04565353|21450598|P10|STARTED|Overall Study||3777
8689168|NCT04565353|21450599|P9|STARTED|Overall Study||3728
8689169|NCT04565353|21450600|P8|STARTED|Overall Study||3732
8689170|NCT04565353|21450601|P7|STARTED|Overall Study||3719
8689171|NCT04565353|21450602|P6|STARTED|Overall Study||3769
8689172|NCT04565353|21450603|P5|STARTED|Overall Study||3758
8689173|NCT04565353|21450604|P4|STARTED|Overall Study||3735
8689174|NCT04565353|21450605|P3|STARTED|Overall Study||3709
8689175|NCT04565353|21450606|P2|STARTED|Overall Study||3737
8689176|NCT04565353|21450607|P1|STARTED|Overall Study||3742
8689177|NCT04463069|21450671|P2|NOT COMPLETED|Overall Study||23
8689178|NCT04463069|21450672|P1|NOT COMPLETED|Overall Study||2
8689179|NCT04463069|21450671|P2|COMPLETED|Overall Study||22
8689180|NCT04463069|21450672|P1|COMPLETED|Overall Study||39
8689181|NCT04463069|21450671|P2|STARTED|Overall Study||45
8689182|NCT04463069|21450672|P1|STARTED|Overall Study||41
8689183|NCT04463004|21450690|P2|NOT COMPLETED|Overall Study||0
8689184|NCT04463004|21450691|P1|NOT COMPLETED|Overall Study||0
8689185|NCT04463004|21450690|P2|COMPLETED|Overall Study||1
8689186|NCT04463004|21450691|P1|COMPLETED|Overall Study||1
8689187|NCT04463004|21450690|P2|STARTED|Overall Study||1
8689188|NCT04463004|21450691|P1|STARTED|Overall Study||1
8689189|NCT04290039|21450702|P3|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
8689190|NCT04290039|21450703|P2|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
8689191|NCT04290039|21450704|P1|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
8689192|NCT04290039|21450702|P3|COMPLETED|Period 3 (Visit 3; Day 15)||5
8689193|NCT04290039|21450703|P2|COMPLETED|Period 3 (Visit 3; Day 15)||4
8689194|NCT04290039|21450704|P1|COMPLETED|Period 3 (Visit 3; Day 15)||5
8689195|NCT04290039|21450702|P3|STARTED|Period 3 (Visit 3; Day 15)||5
8689196|NCT04290039|21450703|P2|STARTED|Period 3 (Visit 3; Day 15)||4
8689197|NCT04290039|21450704|P1|STARTED|Period 3 (Visit 3; Day 15)||5
8689198|NCT04290039|21450702|P3|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
8689199|NCT04290039|21450703|P2|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
8689200|NCT04290039|21450704|P1|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
8689201|NCT04290039|21450702|P3|COMPLETED|Period 2 (Visit 2; Day 8)||5
8689202|NCT04290039|21450703|P2|COMPLETED|Period 2 (Visit 2; Day 8)||5
8689203|NCT04290039|21450704|P1|COMPLETED|Period 2 (Visit 2; Day 8)||5
8689204|NCT04290039|21450702|P3|STARTED|Period 2 (Visit 2; Day 8)||5
8689205|NCT04290039|21450703|P2|STARTED|Period 2 (Visit 2; Day 8)||5
8689206|NCT04290039|21450704|P1|STARTED|Period 2 (Visit 2; Day 8)||5
8689207|NCT04290039|21450702|P3|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
8689208|NCT04290039|21450703|P2|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
8689209|NCT04290039|21450704|P1|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
8689210|NCT04290039|21450702|P3|COMPLETED|Period 1 (Visit 1; Day 1)||5
8689211|NCT04290039|21450703|P2|COMPLETED|Period 1 (Visit 1; Day 1)||5
8689212|NCT04290039|21450704|P1|COMPLETED|Period 1 (Visit 1; Day 1)||5
8689213|NCT04290039|21450702|P3|STARTED|Period 1 (Visit 1; Day 1)||5
8689214|NCT04290039|21450703|P2|STARTED|Period 1 (Visit 1; Day 1)||5
8689215|NCT04290039|21450704|P1|STARTED|Period 1 (Visit 1; Day 1)||5
8689216|NCT04240678|21450747|P2|NOT COMPLETED|Overall Study||0
8689217|NCT04240678|21450748|P1|NOT COMPLETED|Overall Study||0
8689218|NCT04240678|21450747|P2|COMPLETED|Overall Study||4158
8689219|NCT04240678|21450748|P1|COMPLETED|Overall Study||4141
8689220|NCT04240678|21450747|P2|STARTED|Overall Study||4158
8689221|NCT04240678|21450748|P1|STARTED|Overall Study||4141
8689225|NCT04092907|21450771|P2|NOT COMPLETED|Overall Study||0
8689226|NCT04092907|21450772|P1|NOT COMPLETED|Overall Study||2
8689227|NCT04092907|21450771|P2|COMPLETED|Overall Study||50
8689228|NCT04092907|21450772|P1|COMPLETED|Overall Study||48
8689229|NCT04092907|21450771|P2|STARTED|Overall Study||50
8689230|NCT04092907|21450772|P1|STARTED|Overall Study||50
8689231|NCT04004260|21450782|P2|NOT COMPLETED|Overall Study||32
8689232|NCT04004260|21450783|P1|NOT COMPLETED|Overall Study||42
8689233|NCT04004260|21450782|P2|COMPLETED|Overall Study||47
8689234|NCT04004260|21450783|P1|COMPLETED|Overall Study||37
8689235|NCT04004260|21450782|P2|STARTED|Overall Study||79
8689236|NCT04004260|21450783|P1|STARTED|Overall Study||79
8689237|NCT03763747|21450805|P1|NOT COMPLETED|Overall Study||0
8689238|NCT03763747|21450805|P1|COMPLETED|Overall Study||200
8689239|NCT03763747|21450805|P1|STARTED|Overall Study||200
8689240|NCT03613454|21450817|P2|NOT COMPLETED|Overall Study||1
8689241|NCT03613454|21450818|P1|NOT COMPLETED|Overall Study||1
8689242|NCT03613454|21450817|P2|COMPLETED|Overall Study||23
8689243|NCT03613454|21450818|P1|COMPLETED|Overall Study||23
8689244|NCT03613454|21450817|P2|STARTED|Overall Study||24
8689245|NCT03613454|21450818|P1|STARTED|Overall Study||24
8689246|NCT03599089|21450838|P4|NOT COMPLETED|Overall Study||2
8689247|NCT03599089|21450839|P3|NOT COMPLETED|Overall Study||1
8689248|NCT03599089|21450840|P2|NOT COMPLETED|Overall Study||1
8689249|NCT03599089|21450841|P1|NOT COMPLETED|Overall Study||3
8689250|NCT03599089|21450838|P4|COMPLETED|Overall Study||35
8689251|NCT03599089|21450839|P3|COMPLETED|Overall Study||37
8689252|NCT03599089|21450840|P2|COMPLETED|Overall Study||35
8689253|NCT03599089|21450841|P1|COMPLETED|Overall Study||33
8689254|NCT03599089|21450838|P4|STARTED|Overall Study||37
8689255|NCT03599089|21450839|P3|STARTED|Overall Study||38
8689256|NCT03599089|21450840|P2|STARTED|Overall Study||36
8689257|NCT03599089|21450841|P1|STARTED|Overall Study||36
8689258|NCT03566485|21450861|P2|NOT COMPLETED|Overall Study||7
8689259|NCT03566485|21450862|P1|NOT COMPLETED|Overall Study||5
8689260|NCT03566485|21450861|P2|COMPLETED|Overall Study||0
8689261|NCT03566485|21450862|P1|COMPLETED|Overall Study||0
8689262|NCT03566485|21450861|P2|STARTED|Overall Study|Dose level 1 (Idasanutlin 100mg PO)|7
8689263|NCT03566485|21450862|P1|STARTED|Overall Study||5
8689264|NCT03552757|21450878|P3|NOT COMPLETED|Overall Study||20
8689265|NCT03552757|21450879|P2|NOT COMPLETED|Overall Study||13
8689266|NCT03552757|21450880|P1|NOT COMPLETED|Overall Study||13
8689267|NCT03552757|21450878|P3|COMPLETED|Overall Study||383
8689268|NCT03552757|21450879|P2|COMPLETED|Overall Study||391
8689269|NCT03552757|21450880|P1|COMPLETED|Overall Study||390
8689270|NCT03552757|21450878|P3|Safety Analysis Set (SAS)|Overall Study||402
8689271|NCT03552757|21450879|P2|Safety Analysis Set (SAS)|Overall Study||403
8689272|NCT03552757|21450880|P1|Safety Analysis Set (SAS)|Overall Study||402
8689273|NCT03552757|21450878|P3|Full Analysis Set (FAS)|Overall Study||403
8689274|NCT03552757|21450879|P2|Full Analysis Set (FAS)|Overall Study||404
8689275|NCT03552757|21450880|P1|Full Analysis Set (FAS)|Overall Study||403
8689276|NCT03552757|21450878|P3|Exposed|Overall Study||402
8689277|NCT03552757|21450879|P2|Exposed|Overall Study||403
8689278|NCT03552757|21450880|P1|Exposed|Overall Study||402
8689279|NCT03552757|21450878|P3|STARTED|Overall Study||403
8689280|NCT03552757|21450879|P2|STARTED|Overall Study||404
8689281|NCT03552757|21450880|P1|STARTED|Overall Study||403
8689282|NCT03548935|21450999|P2|NOT COMPLETED|Overall Study||46
8689283|NCT03548935|21451000|P1|NOT COMPLETED|Overall Study||66
8689284|NCT03548935|21450999|P2|COMPLETED|Overall Study||609
8689285|NCT03548935|21451000|P1|COMPLETED|Overall Study||1240
8689286|NCT03548935|21450999|P2|Safety Analysis Set (SAS)|Overall Study||655
8689287|NCT03548935|21451000|P1|Safety Analysis Set (SAS)|Overall Study||1306
8689288|NCT03548935|21450999|P2|Full Analysis Set (FAS)|Overall Study||655
8689289|NCT03548935|21451000|P1|Full Analysis Set (FAS)|Overall Study||1306
8689290|NCT03548935|21450999|P2|STARTED|Overall Study||655
8689291|NCT03548935|21451000|P1|STARTED|Overall Study||1306
8689292|NCT03186378|21451090|P2|NOT COMPLETED|Overall Study||0
8689293|NCT03186378|21451091|P1|NOT COMPLETED|Overall Study||1
8689294|NCT03186378|21451090|P2|COMPLETED|Overall Study||16
8689295|NCT03186378|21451091|P1|COMPLETED|Overall Study||16
8689296|NCT03186378|21451090|P2|STARTED|Overall Study||16
8689297|NCT03186378|21451091|P1|STARTED|Overall Study||17
8689298|NCT03149055|21451108|P1|NOT COMPLETED|Overall Study||4
8689299|NCT03149055|21451108|P1|COMPLETED|Overall Study||95
8689300|NCT03149055|21451108|P1|STARTED|Overall Study||99
8689301|NCT03139604|21451115|P2|NOT COMPLETED|Overall Study||220
8689302|NCT03139604|21451116|P1|NOT COMPLETED|Overall Study||219
8689303|NCT03139604|21451115|P2|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
8689479|NCT01509846|21451812|P5|STARTED|Received Vaccination 3||14
8689304|NCT03139604|21451116|P1|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
8689305|NCT03139604|21451115|P2|STARTED|Overall Study||220
8689306|NCT03139604|21451116|P1|STARTED|Overall Study||219
8689307|NCT03127514|21451158|P2|NOT COMPLETED|Overall Study||22
8689308|NCT03127514|21451159|P1|NOT COMPLETED|Overall Study||10
8689309|NCT03127514|21451158|P2|COMPLETED|Overall Study||67
8689310|NCT03127514|21451159|P1|COMPLETED|Overall Study||38
8689311|NCT03127514|21451158|P2|STARTED|Overall Study||89
8689312|NCT03127514|21451159|P1|STARTED|Overall Study||48
8689313|NCT03118518|21451179|P2|NOT COMPLETED|Overall Study||11
8689314|NCT03118518|21451180|P1|NOT COMPLETED|Overall Study||6
8689315|NCT03118518|21451179|P2|COMPLETED|Overall Study||91
8689316|NCT03118518|21451180|P1|COMPLETED|Overall Study||102
8689317|NCT03118518|21451179|P2|Subject Treated According to Randomization Assignment|Overall Study||99
8689318|NCT03118518|21451180|P1|Subject Treated According to Randomization Assignment|Overall Study||104
8689319|NCT03118518|21451179|P2|STARTED|Overall Study||102
8689320|NCT03118518|21451180|P1|STARTED|Overall Study||108
8689321|NCT03000166|21451192|P2|NOT COMPLETED|Overall Study||3
8689322|NCT03000166|21451193|P1|NOT COMPLETED|Overall Study||0
8689323|NCT03000166|21451192|P2|COMPLETED|Overall Study||19
8689324|NCT03000166|21451193|P1|COMPLETED|Overall Study||25
8689325|NCT03000166|21451192|P2|STARTED|Overall Study||22
8689326|NCT03000166|21451193|P1|STARTED|Overall Study||25
8689327|NCT02828267|21451209|P4|NOT COMPLETED|Overall Study||0
8689328|NCT02828267|21451210|P3|NOT COMPLETED|Overall Study||0
8689329|NCT02828267|21451211|P2|NOT COMPLETED|Overall Study||0
8689330|NCT02828267|21451212|P1|NOT COMPLETED|Overall Study||0
8689331|NCT02828267|21451209|P4|COMPLETED|Overall Study||20
8689332|NCT02828267|21451210|P3|COMPLETED|Overall Study||24
8689333|NCT02828267|21451211|P2|COMPLETED|Overall Study||21
8689334|NCT02828267|21451212|P1|COMPLETED|Overall Study||10
8689335|NCT02828267|21451209|P4|STARTED|Overall Study||20
8689336|NCT02828267|21451210|P3|STARTED|Overall Study||24
8689337|NCT02828267|21451211|P2|STARTED|Overall Study||21
8689338|NCT02828267|21451212|P1|STARTED|Overall Study||10
8689339|NCT02807844|21451242|P10|NOT COMPLETED|Overall Study||20
8689340|NCT02807844|21451243|P9|NOT COMPLETED|Overall Study||21
8689341|NCT02807844|21451244|P8|NOT COMPLETED|Overall Study||20
8689342|NCT02807844|21451245|P7|NOT COMPLETED|Overall Study||20
8689343|NCT02807844|21451246|P6|NOT COMPLETED|Overall Study||11
8689344|NCT02807844|21451247|P5|NOT COMPLETED|Overall Study||6
8689345|NCT02807844|21451248|P4|NOT COMPLETED|Overall Study||13
8689346|NCT02807844|21451249|P3|NOT COMPLETED|Overall Study||12
8689347|NCT02807844|21451250|P2|NOT COMPLETED|Overall Study||12
8689348|NCT02807844|21451251|P1|NOT COMPLETED|Overall Study||6
8689349|NCT02807844|21451242|P10|COMPLETED|Overall Study||0
8689350|NCT02807844|21451243|P9|COMPLETED|Overall Study||0
8689351|NCT02807844|21451244|P8|COMPLETED|Overall Study||0
8689352|NCT02807844|21451245|P7|COMPLETED|Overall Study||0
8689353|NCT02807844|21451246|P6|COMPLETED|Overall Study||0
8689354|NCT02807844|21451247|P5|COMPLETED|Overall Study||0
8689355|NCT02807844|21451248|P4|COMPLETED|Overall Study||0
8689356|NCT02807844|21451249|P3|COMPLETED|Overall Study||0
8689357|NCT02807844|21451250|P2|COMPLETED|Overall Study||0
8689358|NCT02807844|21451251|P1|COMPLETED|Overall Study||0
8689359|NCT02807844|21451242|P10|STARTED|Overall Study||20
8689360|NCT02807844|21451243|P9|STARTED|Overall Study||21
8689361|NCT02807844|21451244|P8|STARTED|Overall Study||20
8689362|NCT02807844|21451245|P7|STARTED|Overall Study||20
8689363|NCT02807844|21451246|P6|STARTED|Overall Study||11
8689364|NCT02807844|21451247|P5|STARTED|Overall Study||6
8689365|NCT02807844|21451248|P4|STARTED|Overall Study||13
8689366|NCT02807844|21451249|P3|STARTED|Overall Study||12
8689367|NCT02807844|21451250|P2|STARTED|Overall Study||12
8689368|NCT02807844|21451251|P1|STARTED|Overall Study||6
8689369|NCT02796625|21451575|P1|NOT COMPLETED|Overall Study||19
8689370|NCT02796625|21451575|P1|COMPLETED|Overall Study||61
8689371|NCT02796625|21451575|P1|STARTED|Overall Study||80
8689372|NCT02777931|21451582|P2|NOT COMPLETED|Overall Study||13
8689373|NCT02777931|21451583|P1|NOT COMPLETED|Overall Study||12
8689374|NCT02777931|21451582|P2|COMPLETED|Overall Study||39
8689375|NCT02777931|21451583|P1|COMPLETED|Overall Study||37
8689376|NCT02777931|21451582|P2|Modified Intent to Treat Population|Overall Study||50
8689377|NCT02777931|21451583|P1|Modified Intent to Treat Population|Overall Study||46
8689378|NCT02777931|21451582|P2|Safety Population|Overall Study||50
8689379|NCT02777931|21451583|P1|Safety Population|Overall Study||47
8689380|NCT02777931|21451582|P2|STARTED|Overall Study||52
8689381|NCT02777931|21451583|P1|STARTED|Overall Study||49
8689382|NCT02741284|21451593|P2|NOT COMPLETED|Overall Study||9
8689383|NCT02741284|21451594|P1|NOT COMPLETED|Overall Study||6
8689384|NCT02741284|21451593|P2|COMPLETED|Overall Study||48
8689385|NCT02741284|21451594|P1|COMPLETED|Overall Study||51
8689386|NCT02741284|21451593|P2|STARTED|Overall Study||57
8689387|NCT02741284|21451594|P1|STARTED|Overall Study||57
8689388|NCT02730234|21451612|P1|NOT COMPLETED|Overall Study||8
8689389|NCT02730234|21451612|P1|COMPLETED|Overall Study|8 Deaths|52
8689390|NCT02730234|21451612|P1|STARTED|Overall Study||60
8689391|NCT02437318|21451633|P2|NOT COMPLETED|Overall Study||242
8689392|NCT02437318|21451634|P1|NOT COMPLETED|Overall Study||229
8689393|NCT02437318|21451633|P2|COMPLETED|Overall Study||46
8689394|NCT02437318|21451634|P1|COMPLETED|Overall Study||55
8689395|NCT02437318|21451633|P2|Untreated (Protocol Deviation)|Overall Study||1
8689396|NCT02437318|21451634|P1|Untreated (Protocol Deviation)|Overall Study||0
8689397|NCT02437318|21451633|P2|End of Treatment (Didn't Complete)|Overall Study||241
8689398|NCT02437318|21451634|P1|End of Treatment (Didn't Complete)|Overall Study||229
8689399|NCT02437318|21451633|P2|STARTED|Overall Study||288
8689400|NCT02437318|21451634|P1|STARTED|Overall Study||284
8689401|NCT02269124|21451642|P2|NOT COMPLETED|Overall Study||2
8689402|NCT02269124|21451643|P1|NOT COMPLETED|Overall Study||1
8689403|NCT02269124|21451642|P2|COMPLETED|Overall Study|Two participants from the Conventional measures + Hearing Aid First arm withdrew from the study prior to the second arm because they did not wish to stop using the hearing aid.|14
8689404|NCT02269124|21451643|P1|COMPLETED|Overall Study|One participant from the Conventional Measures Only First arm did not return any surveys, nor did their parent/guardian or teacher, and were deemed lost to follow-up.|20
8689405|NCT02269124|21451642|P2|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||10
8689406|NCT02269124|21451643|P1|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||14
8689407|NCT02269124|21451642|P2|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||10
8689408|NCT02269124|21451643|P1|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||16
8689409|NCT02269124|21451642|P2|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||8
8689410|NCT02269124|21451643|P1|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||11
8689411|NCT02269124|21451642|P2|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||11
8689412|NCT02269124|21451643|P1|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||17
8689413|NCT02269124|21451642|P2|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||13
8689414|NCT02269124|21451643|P1|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||17
8689415|NCT02269124|21451642|P2|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||14
8689416|NCT02269124|21451643|P1|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||20
8689417|NCT02269124|21451642|P2|STARTED|Overall Study||16
8689418|NCT02269124|21451643|P1|STARTED|Overall Study||21
8689419|NCT02239224|21451661|P4|NOT COMPLETED|Overall Study||1
8689420|NCT02239224|21451662|P3|NOT COMPLETED|Overall Study||3
8689421|NCT02239224|21451663|P2|NOT COMPLETED|Overall Study||0
8689422|NCT02239224|21451664|P1|NOT COMPLETED|Overall Study||0
8689423|NCT02239224|21451661|P4|COMPLETED|Overall Study||4
8689424|NCT02239224|21451662|P3|COMPLETED|Overall Study||3
8689425|NCT02239224|21451663|P2|COMPLETED|Overall Study||6
8689426|NCT02239224|21451664|P1|COMPLETED|Overall Study||3
8689427|NCT02239224|21451661|P4|Received at Least One Dose of Study Drug|Overall Study||5
8689428|NCT02239224|21451662|P3|Received at Least One Dose of Study Drug|Overall Study||6
8689429|NCT02239224|21451663|P2|Received at Least One Dose of Study Drug|Overall Study||6
8689430|NCT02239224|21451664|P1|Received at Least One Dose of Study Drug|Overall Study||3
8689431|NCT02239224|21451661|P4|STARTED|Overall Study||5
8689432|NCT02239224|21451662|P3|STARTED|Overall Study||6
8689433|NCT02239224|21451663|P2|STARTED|Overall Study||6
8689434|NCT02239224|21451664|P1|STARTED|Overall Study||3
8689435|NCT02225223|21451720|P2|NOT COMPLETED|Overall Study||5
8689436|NCT02225223|21451721|P1|NOT COMPLETED|Overall Study||19
8689437|NCT02225223|21451720|P2|COMPLETED|Overall Study||3
8689438|NCT02225223|21451721|P1|COMPLETED|Overall Study||8
8689439|NCT02225223|21451720|P2|STARTED|Overall Study||8
8689440|NCT02225223|21451721|P1|STARTED|Overall Study||27
8689449|NCT01892722|21451752|P2|NOT COMPLETED|Overall Study||20
8689450|NCT01892722|21451753|P1|NOT COMPLETED|Overall Study||7
8689451|NCT01892722|21451752|P2|COMPLETED|Overall Study||88
8689452|NCT01892722|21451753|P1|COMPLETED|Overall Study||100
8689453|NCT01892722|21451752|P2|Full Analysis Set|Overall Study||107
8689454|NCT01892722|21451753|P1|Full Analysis Set|Overall Study||107
8689455|NCT01892722|21451752|P2|STARTED|Overall Study||108
8689456|NCT01892722|21451753|P1|STARTED|Overall Study||107
8689457|NCT01876901|21451761|P2|NOT COMPLETED|Overall Study||7
8689458|NCT01876901|21451762|P1|NOT COMPLETED|Overall Study||17
8689459|NCT01876901|21451761|P2|COMPLETED|Overall Study||52
8689460|NCT01876901|21451762|P1|COMPLETED|Overall Study||48
8689461|NCT01876901|21451761|P2|STARTED|Overall Study||59
8689462|NCT01876901|21451762|P1|STARTED|Overall Study||65
8689463|NCT01602380|21451784|P2|NOT COMPLETED|Overall Study||101
8689464|NCT01602380|21451785|P1|NOT COMPLETED|Overall Study||93
8689465|NCT01602380|21451784|P2|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
8689466|NCT01602380|21451785|P1|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
8689467|NCT01602380|21451784|P2|STARTED|Overall Study||232
8689468|NCT01602380|21451785|P1|STARTED|Overall Study||230
8689469|NCT01509846|21451812|P5|NOT COMPLETED|Received Vaccination 3||0
8689470|NCT01509846|21451813|P4|NOT COMPLETED|Received Vaccination 3||1
8689471|NCT01509846|21451814|P3|NOT COMPLETED|Received Vaccination 3||1
8689472|NCT01509846|21451815|P2|NOT COMPLETED|Received Vaccination 3||1
8689473|NCT01509846|21451816|P1|NOT COMPLETED|Received Vaccination 3||0
8689474|NCT01509846|21451812|P5|COMPLETED|Received Vaccination 3||14
8689475|NCT01509846|21451813|P4|COMPLETED|Received Vaccination 3||19
8689476|NCT01509846|21451814|P3|COMPLETED|Received Vaccination 3||18
8689477|NCT01509846|21451815|P2|COMPLETED|Received Vaccination 3||19
8689478|NCT01509846|21451816|P1|COMPLETED|Received Vaccination 3||0
8689480|NCT01509846|21451813|P4|STARTED|Received Vaccination 3||20
8689481|NCT01509846|21451814|P3|STARTED|Received Vaccination 3||19
8689482|NCT01509846|21451815|P2|STARTED|Received Vaccination 3||20
8689483|NCT01509846|21451816|P1|STARTED|Received Vaccination 3||0
8689484|NCT01509846|21451812|P5|NOT COMPLETED|Received Vaccination 2||3
8689485|NCT01509846|21451813|P4|NOT COMPLETED|Received Vaccination 2||0
8689486|NCT01509846|21451814|P3|NOT COMPLETED|Received Vaccination 2||1
8689487|NCT01509846|21451815|P2|NOT COMPLETED|Received Vaccination 2||0
8689488|NCT01509846|21451816|P1|NOT COMPLETED|Received Vaccination 2||5
8689489|NCT01509846|21451812|P5|COMPLETED|Received Vaccination 2||14
8689490|NCT01509846|21451813|P4|COMPLETED|Received Vaccination 2||20
8689491|NCT01509846|21451814|P3|COMPLETED|Received Vaccination 2||19
8689492|NCT01509846|21451815|P2|COMPLETED|Received Vaccination 2||20
8689493|NCT01509846|21451816|P1|COMPLETED|Received Vaccination 2||0
8689494|NCT01509846|21451812|P5|STARTED|Received Vaccination 2||17
8689495|NCT01509846|21451813|P4|STARTED|Received Vaccination 2||20
8689496|NCT01509846|21451814|P3|STARTED|Received Vaccination 2||20
8689497|NCT01509846|21451815|P2|STARTED|Received Vaccination 2||20
8689498|NCT01509846|21451816|P1|STARTED|Received Vaccination 2||5
8689499|NCT01509846|21451812|P5|NOT COMPLETED|Received Vaccination 1||0
8689500|NCT01509846|21451813|P4|NOT COMPLETED|Received Vaccination 1||0
8689501|NCT01509846|21451814|P3|NOT COMPLETED|Received Vaccination 1||0
8689502|NCT01509846|21451815|P2|NOT COMPLETED|Received Vaccination 1||0
8689503|NCT01509846|21451816|P1|NOT COMPLETED|Received Vaccination 1||0
8689504|NCT01509846|21451812|P5|COMPLETED|Received Vaccination 1||17
8689505|NCT01509846|21451813|P4|COMPLETED|Received Vaccination 1||20
8689506|NCT01509846|21451814|P3|COMPLETED|Received Vaccination 1||20
8689507|NCT01509846|21451815|P2|COMPLETED|Received Vaccination 1||20
8689508|NCT01509846|21451816|P1|COMPLETED|Received Vaccination 1||5
8689509|NCT01509846|21451812|P5|STARTED|Received Vaccination 1||17
8689510|NCT01509846|21451813|P4|STARTED|Received Vaccination 1||20
8689511|NCT01509846|21451814|P3|STARTED|Received Vaccination 1||20
8689512|NCT01509846|21451815|P2|STARTED|Received Vaccination 1||20
8689513|NCT01509846|21451816|P1|STARTED|Received Vaccination 1||5
8689514|NCT00369564|21451886|P2|NOT COMPLETED|Overall Study||23
8689515|NCT00369564|21451887|P1|NOT COMPLETED|Overall Study||43
8689516|NCT00369564|21451886|P2|COMPLETED|Overall Study||100
8689517|NCT00369564|21451887|P1|COMPLETED|Overall Study||84
8689518|NCT00369564|21451886|P2|STARTED|Overall Study||123
8689519|NCT00369564|21451887|P1|STARTED|Overall Study||127
8689520|NCT04845633|21451903|P4|NOT COMPLETED|Overall Study||0
8689521|NCT04845633|21451904|P3|NOT COMPLETED|Overall Study||0
8689522|NCT04845633|21451905|P2|NOT COMPLETED|Overall Study||0
8689523|NCT04845633|21451906|P1|NOT COMPLETED|Overall Study||0
8689524|NCT04845633|21451903|P4|COMPLETED|Overall Study||12
8689525|NCT04845633|21451904|P3|COMPLETED|Overall Study||12
8689526|NCT04845633|21451905|P2|COMPLETED|Overall Study||12
8689527|NCT04845633|21451906|P1|COMPLETED|Overall Study||12
8689528|NCT04845633|21451903|P4|STARTED|Overall Study||12
8689529|NCT04845633|21451904|P3|STARTED|Overall Study||12
8689530|NCT04845633|21451905|P2|STARTED|Overall Study||12
8689531|NCT04845633|21451906|P1|STARTED|Overall Study||12
8689532|NCT04607291|21451928|P1|NOT COMPLETED|Overall Study||0
8689533|NCT04607291|21451928|P1|COMPLETED|Overall Study||183
8689534|NCT04607291|21451928|P1|STARTED|Overall Study||183
8689535|NCT04596085|21451936|P2|NOT COMPLETED|Overall Study||0
8689536|NCT04596085|21451937|P1|NOT COMPLETED|Overall Study||0
8689537|NCT04596085|21451936|P2|COMPLETED|Overall Study||59
8689538|NCT04596085|21451937|P1|COMPLETED|Overall Study||59
8689539|NCT04596085|21451936|P2|STARTED|Overall Study||59
8689540|NCT04596085|21451937|P1|STARTED|Overall Study||59
8689541|NCT04498403|21451963|P2|NOT COMPLETED|Overall Study||10
8689542|NCT04498403|21451964|P1|NOT COMPLETED|Overall Study||30
8689543|NCT04498403|21451963|P2|COMPLETED|Overall Study||0
8689544|NCT04498403|21451964|P1|COMPLETED|Overall Study||0
8689545|NCT04498403|21451963|P2|Completed Follow up|Overall Study||10
8689546|NCT04498403|21451964|P1|Completed Follow up|Overall Study||30
8689547|NCT04498403|21451963|P2|STARTED|Overall Study||10
8689548|NCT04498403|21451964|P1|STARTED|Overall Study||30
8689549|NCT04342897|21451972|P2|NOT COMPLETED|Overall Study||12
8689550|NCT04342897|21451973|P1|NOT COMPLETED|Overall Study||14
8689551|NCT04342897|21451972|P2|COMPLETED|Overall Study||36
8689552|NCT04342897|21451973|P1|COMPLETED|Overall Study||33
8689553|NCT04342897|21451972|P2|Received at Least One Dose of Study Drug|Overall Study||48
8689554|NCT04342897|21451973|P1|Received at Least One Dose of Study Drug|Overall Study||47
8689555|NCT04342897|21451972|P2|STARTED|Overall Study||48
8689556|NCT04342897|21451973|P1|STARTED|Overall Study||47
8689557|NCT04126187|21451991|P1|NOT COMPLETED|Overall Study||0
8689558|NCT04126187|21451991|P1|COMPLETED|Overall Study||30
8689559|NCT04126187|21451991|P1|STARTED|Overall Study||30
8689560|NCT03905694|21452004|P1|NOT COMPLETED|Long-term Extension Period||18
8689561|NCT03905694|21452004|P1|COMPLETED|Long-term Extension Period||0
8689562|NCT03905694|21452004|P1|STARTED|Long-term Extension Period||18
8689563|NCT03905694|21452004|P1|NOT COMPLETED|Primary Analysis Period||0
8689564|NCT03905694|21452004|P1|COMPLETED|Primary Analysis Period||18
8689565|NCT03905694|21452004|P1|STARTED|Primary Analysis Period||18
8689566|NCT03874013|21452010|P2|NOT COMPLETED|Overall Study||1
8689567|NCT03874013|21452011|P1|NOT COMPLETED|Overall Study||0
8689568|NCT03874013|21452010|P2|COMPLETED|Overall Study||21
8689569|NCT03874013|21452011|P1|COMPLETED|Overall Study||22
8689570|NCT03874013|21452010|P2|STARTED|Overall Study||22
8689571|NCT03874013|21452011|P1|STARTED|Overall Study||22
8689572|NCT03838874|21452027|P2|NOT COMPLETED|Overall Study||0
8689573|NCT03838874|21452028|P1|NOT COMPLETED|Overall Study||0
8689574|NCT03838874|21452027|P2|COMPLETED|Overall Study||74
8689575|NCT03838874|21452028|P1|COMPLETED|Overall Study||80
8689576|NCT03838874|21452027|P2|STARTED|Overall Study||74
8689577|NCT03838874|21452028|P1|STARTED|Overall Study||80
8689578|NCT03783130|21452054|P4|NOT COMPLETED|Overall Study||0
8689579|NCT03783130|21452055|P3|NOT COMPLETED|Overall Study||0
8689580|NCT03783130|21452056|P2|NOT COMPLETED|Overall Study||0
8689581|NCT03783130|21452057|P1|NOT COMPLETED|Overall Study||0
8689582|NCT03783130|21452054|P4|COMPLETED|Overall Study||5
8689583|NCT03783130|21452055|P3|COMPLETED|Overall Study||5
8689584|NCT03783130|21452056|P2|COMPLETED|Overall Study||3
8689585|NCT03783130|21452057|P1|COMPLETED|Overall Study||3
8689586|NCT03783130|21452054|P4|Received All Product Administrations|Overall Study||5
8689587|NCT03783130|21452055|P3|Received All Product Administrations|Overall Study||5
8689588|NCT03783130|21452056|P2|Received All Product Administrations|Overall Study||3
8689589|NCT03783130|21452057|P1|Received All Product Administrations|Overall Study||3
8689590|NCT03783130|21452054|P4|STARTED|Overall Study||5
8689591|NCT03783130|21452055|P3|STARTED|Overall Study||5
8689592|NCT03783130|21452056|P2|STARTED|Overall Study||3
8689593|NCT03783130|21452057|P1|STARTED|Overall Study||3
8689594|NCT03761147|21452094|P2|NOT COMPLETED|Overall Study||4
8689595|NCT03761147|21452095|P1|NOT COMPLETED|Overall Study||7
8689596|NCT03761147|21452094|P2|COMPLETED|Overall Study||28
8689597|NCT03761147|21452095|P1|COMPLETED|Overall Study||25
8689598|NCT03761147|21452094|P2|STARTED|Overall Study||32
8689599|NCT03761147|21452095|P1|STARTED|Overall Study||32
8689600|NCT03711578|21452101|P1|NOT COMPLETED|Overall Study||0
8689601|NCT03711578|21452101|P1|COMPLETED|Overall Study||20
8689602|NCT03711578|21452101|P1|STARTED|Overall Study||20
8689609|NCT03431337|21452120|P2|NOT COMPLETED|Overall Study||22
8689610|NCT03431337|21452121|P1|NOT COMPLETED|Overall Study||29
8689611|NCT03431337|21452120|P2|COMPLETED|Overall Study||57
8689612|NCT03431337|21452121|P1|COMPLETED|Overall Study||49
8689613|NCT03431337|21452120|P2|STARTED|Overall Study||79
8689614|NCT03431337|21452121|P1|STARTED|Overall Study||78
8689615|NCT03394885|21452153|P1|NOT COMPLETED|Overall Study||15
8689616|NCT03394885|21452153|P1|COMPLETED|Overall Study||3
8689617|NCT03394885|21452153|P1|STARTED|Overall Study||18
8689618|NCT03253094|21452171|P6|NOT COMPLETED|Overall Study||4
8689619|NCT03253094|21452172|P5|NOT COMPLETED|Overall Study||5
8689620|NCT03253094|21452173|P4|NOT COMPLETED|Overall Study||4
8689621|NCT03253094|21452174|P3|NOT COMPLETED|Overall Study||6
8689622|NCT03253094|21452175|P2|NOT COMPLETED|Overall Study||3
8689623|NCT03253094|21452176|P1|NOT COMPLETED|Overall Study||4
8689624|NCT03253094|21452171|P6|COMPLETED|Overall Study||28
8689625|NCT03253094|21452172|P5|COMPLETED|Overall Study||27
8689626|NCT03253094|21452173|P4|COMPLETED|Overall Study||28
8689627|NCT03253094|21452174|P3|COMPLETED|Overall Study||22
8689628|NCT03253094|21452175|P2|COMPLETED|Overall Study||27
8689629|NCT03253094|21452176|P1|COMPLETED|Overall Study||28
8689630|NCT03253094|21452171|P6|Subjects Discontinued|Overall Study||4
8689631|NCT03253094|21452172|P5|Subjects Discontinued|Overall Study||5
8689632|NCT03253094|21452173|P4|Subjects Discontinued|Overall Study||4
8689633|NCT03253094|21452174|P3|Subjects Discontinued|Overall Study||6
8689634|NCT03253094|21452175|P2|Subjects Discontinued|Overall Study||3
8689635|NCT03253094|21452176|P1|Subjects Discontinued|Overall Study||4
8689636|NCT03253094|21452171|P6|STARTED|Overall Study||32
8689637|NCT03253094|21452172|P5|STARTED|Overall Study||32
8689638|NCT03253094|21452173|P4|STARTED|Overall Study||32
8689639|NCT03253094|21452174|P3|STARTED|Overall Study||28
8689640|NCT03253094|21452175|P2|STARTED|Overall Study||30
8689641|NCT03253094|21452176|P1|STARTED|Overall Study||32
8689645|NCT03136913|21452207|P1|NOT COMPLETED|Overall Study||5
8689646|NCT03136913|21452207|P1|COMPLETED|Overall Study|8 subjects with 8 OFT and 8 CFT sites received implant surgery|8
8689647|NCT03136913|21452207|P1|Subjects Received Both Intervention|Overall Study|10 subjects with 10 OFT and 10 CFT sites received clinical measurement before implant surgery|10
8689648|NCT03136913|21452207|P1|STARTED|Overall Study||13
8689649|NCT03095885|21452216|P1|NOT COMPLETED|Overall Study||0
8689650|NCT03095885|21452216|P1|COMPLETED|Overall Study||22
8689651|NCT03095885|21452216|P1|STARTED|Overall Study||22
8689652|NCT02865434|21452233|P11|NOT COMPLETED|Overall Study||0
8689653|NCT02865434|21452234|P10|NOT COMPLETED|Overall Study||0
8689654|NCT02865434|21452235|P9|NOT COMPLETED|Overall Study||0
8689655|NCT02865434|21452236|P8|NOT COMPLETED|Overall Study||0
8689656|NCT02865434|21452237|P7|NOT COMPLETED|Overall Study||0
8689657|NCT02865434|21452238|P6|NOT COMPLETED|Overall Study||0
8689658|NCT02865434|21452239|P5|NOT COMPLETED|Overall Study||0
8689659|NCT02865434|21452240|P4|NOT COMPLETED|Overall Study||0
8689660|NCT02865434|21452241|P3|NOT COMPLETED|Overall Study||0
8689661|NCT02865434|21452242|P2|NOT COMPLETED|Overall Study||0
8689662|NCT02865434|21452243|P1|NOT COMPLETED|Overall Study||0
8689663|NCT02865434|21452233|P11|COMPLETED|Overall Study||6
8689664|NCT02865434|21452234|P10|COMPLETED|Overall Study||6
8689665|NCT02865434|21452235|P9|COMPLETED|Overall Study||3
8689666|NCT02865434|21452236|P8|COMPLETED|Overall Study||3
8689667|NCT02865434|21452237|P7|COMPLETED|Overall Study||3
8689668|NCT02865434|21452238|P6|COMPLETED|Overall Study||3
8689669|NCT02865434|21452239|P5|COMPLETED|Overall Study||3
8689670|NCT02865434|21452240|P4|COMPLETED|Overall Study||3
8689671|NCT02865434|21452241|P3|COMPLETED|Overall Study||3
8689672|NCT02865434|21452242|P2|COMPLETED|Overall Study||3
8689673|NCT02865434|21452243|P1|COMPLETED|Overall Study||3
8689674|NCT02865434|21452233|P11|STARTED|Overall Study||6
8689675|NCT02865434|21452234|P10|STARTED|Overall Study||6
8689676|NCT02865434|21452235|P9|STARTED|Overall Study||3
8689677|NCT02865434|21452236|P8|STARTED|Overall Study||3
8689678|NCT02865434|21452237|P7|STARTED|Overall Study||3
8689679|NCT02865434|21452238|P6|STARTED|Overall Study||3
8689680|NCT02865434|21452239|P5|STARTED|Overall Study||3
8689681|NCT02865434|21452240|P4|STARTED|Overall Study||3
8689682|NCT02865434|21452241|P3|STARTED|Overall Study||3
8689683|NCT02865434|21452242|P2|STARTED|Overall Study||3
8689684|NCT02865434|21452243|P1|STARTED|Overall Study||3
8689685|NCT02687815|21452403|P2|NOT COMPLETED|Overall Study||8
8689686|NCT02687815|21452404|P1|NOT COMPLETED|Overall Study||4
8689687|NCT02687815|21452403|P2|COMPLETED|Overall Study||88
8689688|NCT02687815|21452404|P1|COMPLETED|Overall Study||92
8689689|NCT02687815|21452403|P2|STARTED|Overall Study||96
8689690|NCT02687815|21452404|P1|STARTED|Overall Study||96
8689691|NCT02610777|21452418|P2|NOT COMPLETED|Overall Study||22
8689692|NCT02610777|21452419|P1|NOT COMPLETED|Overall Study||21
8689693|NCT02610777|21452418|P2|COMPLETED|Overall Study||36
8689694|NCT02610777|21452419|P1|COMPLETED|Overall Study||41
8689695|NCT02610777|21452418|P2|STARTED|Overall Study||58
8689696|NCT02610777|21452419|P1|STARTED|Overall Study||62
8689697|NCT02605967|21452427|P3|NOT COMPLETED|After Cross Over||25
8689698|NCT02605967|21452428|P2|NOT COMPLETED|After Cross Over||0
8689699|NCT02605967|21452429|P1|NOT COMPLETED|After Cross Over||82
8689700|NCT02605967|21452427|P3|COMPLETED|After Cross Over||0
8689701|NCT02605967|21452428|P2|COMPLETED|After Cross Over||0
8689702|NCT02605967|21452429|P1|COMPLETED|After Cross Over||0
8689703|NCT02605967|21452427|P3|STARTED|After Cross Over||25
8689704|NCT02605967|21452428|P2|STARTED|After Cross Over||0
8689705|NCT02605967|21452429|P1|STARTED|After Cross Over||82
8689706|NCT02605967|21452427|P3|NOT COMPLETED|Overall Study : Prior to Cross Over||0
8689707|NCT02605967|21452428|P2|NOT COMPLETED|Overall Study : Prior to Cross Over||40
8689708|NCT02605967|21452429|P1|NOT COMPLETED|Overall Study : Prior to Cross Over||82
8689709|NCT02605967|21452427|P3|COMPLETED|Overall Study : Prior to Cross Over||0
8689710|NCT02605967|21452428|P2|COMPLETED|Overall Study : Prior to Cross Over||0
8689711|NCT02605967|21452429|P1|COMPLETED|Overall Study : Prior to Cross Over||0
8689712|NCT02605967|21452427|P3|STARTED|Overall Study : Prior to Cross Over||0
8689713|NCT02605967|21452428|P2|STARTED|Overall Study : Prior to Cross Over||40
8689714|NCT02605967|21452429|P1|STARTED|Overall Study : Prior to Cross Over||82
8689715|NCT02536846|21452441|P1|NOT COMPLETED|Overall Study||1
8689716|NCT02536846|21452441|P1|COMPLETED|Overall Study||9
8689717|NCT02536846|21452441|P1|STARTED|Overall Study||10
8689718|NCT02294734|21452479|P2|NOT COMPLETED|Overall Study||8
8689719|NCT02294734|21452480|P1|NOT COMPLETED|Overall Study||14
8689720|NCT02294734|21452479|P2|COMPLETED|Overall Study||55
8689721|NCT02294734|21452480|P1|COMPLETED|Overall Study||49
8689722|NCT02294734|21452479|P2|STARTED|Overall Study||63
8689723|NCT02294734|21452480|P1|STARTED|Overall Study||63
8689724|NCT02282020|21452532|P2|NOT COMPLETED|Overall Study||87
8689725|NCT02282020|21452533|P1|NOT COMPLETED|Overall Study||135
8689726|NCT02282020|21452532|P2|COMPLETED|Overall Study||1
8689727|NCT02282020|21452533|P1|COMPLETED|Overall Study||43
8689728|NCT02282020|21452532|P2|Received Treatment|Overall Study||76
8689729|NCT02282020|21452533|P1|Received Treatment|Overall Study||178
8689730|NCT02282020|21452532|P2|STARTED|Overall Study||88
8689731|NCT02282020|21452533|P1|STARTED|Overall Study||178
8689732|NCT02275780|21452580|P2|NOT COMPLETED|Extension Study: up to 192 Weeks||233
8689733|NCT02275780|21452581|P1|NOT COMPLETED|Extension Study: up to 192 Weeks||260
8689734|NCT02275780|21452580|P2|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
8689735|NCT02275780|21452581|P1|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
8689736|NCT02275780|21452580|P2|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
8689737|NCT02275780|21452581|P1|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
8689738|NCT02275780|21452580|P2|NOT COMPLETED|Base Study: 96 Weeks||111
8689739|NCT02275780|21452581|P1|NOT COMPLETED|Base Study: 96 Weeks||93
8689740|NCT02275780|21452580|P2|COMPLETED|Base Study: 96 Weeks||273
8689741|NCT02275780|21452581|P1|COMPLETED|Base Study: 96 Weeks||292
8689742|NCT02275780|21452580|P2|Treated|Base Study: 96 Weeks||383
8689743|NCT02275780|21452581|P1|Treated|Base Study: 96 Weeks||383
8689744|NCT02275780|21452580|P2|STARTED|Base Study: 96 Weeks||384
8689745|NCT02275780|21452581|P1|STARTED|Base Study: 96 Weeks||385
8689746|NCT02261727|21452620|P3|NOT COMPLETED|Overall Study||125
8689747|NCT02261727|21452621|P2|NOT COMPLETED|Overall Study||146
8689748|NCT02261727|21452622|P1|NOT COMPLETED|Overall Study||157
8689749|NCT02261727|21452620|P3|COMPLETED|Overall Study||423
8689750|NCT02261727|21452621|P2|COMPLETED|Overall Study||408
8689751|NCT02261727|21452622|P1|COMPLETED|Overall Study||411
8689752|NCT02261727|21452620|P3|STARTED|Overall Study||548
8689753|NCT02261727|21452621|P2|STARTED|Overall Study||554
8689754|NCT02261727|21452622|P1|STARTED|Overall Study||568
8689755|NCT01818258|21452647|P2|NOT COMPLETED|Overall Study||3
8689756|NCT01818258|21452648|P1|NOT COMPLETED|Overall Study||3
8689757|NCT01818258|21452647|P2|COMPLETED|Overall Study||24
8689758|NCT01818258|21452648|P1|COMPLETED|Overall Study||22
8689759|NCT01818258|21452647|P2|STARTED|Overall Study||27
8689760|NCT01818258|21452648|P1|STARTED|Overall Study||25
8689761|NCT01806688|21452688|P2|NOT COMPLETED|Third Intervention Pita Study||0
8689762|NCT01806688|21452689|P1|NOT COMPLETED|Third Intervention Pita Study||0
8689763|NCT01806688|21452688|P2|COMPLETED|Third Intervention Pita Study||38
8689764|NCT01806688|21452689|P1|COMPLETED|Third Intervention Pita Study||0
8689765|NCT01806688|21452688|P2|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|13
8689766|NCT01806688|21452689|P1|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|0
8689767|NCT01806688|21452688|P2|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|13
8689768|NCT01806688|21452689|P1|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|0
8689769|NCT01806688|21452688|P2|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|12
8689770|NCT01806688|21452689|P1|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|0
8689771|NCT01806688|21452688|P2|STARTED|Third Intervention Pita Study|"Participants received one of the following:
~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|38
8689772|NCT01806688|21452689|P1|STARTED|Third Intervention Pita Study|"Participants received one of the following:
~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|0
8689773|NCT01806688|21452688|P2|NOT COMPLETED|Second Intervention Pita Study||0
8689774|NCT01806688|21452689|P1|NOT COMPLETED|Second Intervention Pita Study||0
8689775|NCT01806688|21452688|P2|COMPLETED|Second Intervention Pita Study||38
8689776|NCT01806688|21452689|P1|COMPLETED|Second Intervention Pita Study||0
8689777|NCT01806688|21452688|P2|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|13
8689778|NCT01806688|21452689|P1|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|0
8689779|NCT01806688|21452688|P2|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|13
8689780|NCT01806688|21452689|P1|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|0
8689781|NCT01806688|21452688|P2|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|12
8689782|NCT01806688|21452689|P1|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|0
8689783|NCT01806688|21452688|P2|STARTED|Second Intervention Pita Study|"Participants received one of the following:
~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread
~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread
~placebo comparator non-caloric control water"|38
8689784|NCT01806688|21452689|P1|STARTED|Second Intervention Pita Study|"Participants received one of the following:
~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread
~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread
~placebo comparator non-caloric control water"|0
8689785|NCT01806688|21452688|P2|NOT COMPLETED|First Intervention Pita Study||0
8689786|NCT01806688|21452689|P1|NOT COMPLETED|First Intervention Pita Study||0
8689787|NCT01806688|21452688|P2|COMPLETED|First Intervention Pita Study||38
8689788|NCT01806688|21452689|P1|COMPLETED|First Intervention Pita Study||0
8689789|NCT01806688|21452688|P2|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|12
8689790|NCT01806688|21452689|P1|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|0
8689791|NCT01806688|21452688|P2|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|12
8689792|NCT01806688|21452689|P1|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|0
8689793|NCT01806688|21452688|P2|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|14
8689794|NCT01806688|21452689|P1|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|0
8689917|NCT01143181|21453136|P1|NOT COMPLETED|Overall Study||16
8689918|NCT01143181|21453133|P4|COMPLETED|Overall Study||17
8689919|NCT01143181|21453134|P3|COMPLETED|Overall Study||58
8689795|NCT01806688|21452688|P2|STARTED|First Intervention Pita Study|"Participants received one of the following:
~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread
~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread
~placebo comparator non-caloric control water"|38
8689796|NCT01806688|21452689|P1|STARTED|First Intervention Pita Study|"Participants received one of the following:
~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread
~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread
~placebo comparator non-caloric control water"|0
8689797|NCT01806688|21452688|P2|NOT COMPLETED|Third Intervention Seed Study||0
8689798|NCT01806688|21452689|P1|NOT COMPLETED|Third Intervention Seed Study||0
8689799|NCT01806688|21452688|P2|COMPLETED|Third Intervention Seed Study||0
8689800|NCT01806688|21452689|P1|COMPLETED|Third Intervention Seed Study||38
8689801|NCT01806688|21452688|P2|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|0
8689802|NCT01806688|21452689|P1|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|14
8689803|NCT01806688|21452688|P2|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|0
8689804|NCT01806688|21452689|P1|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|12
8689805|NCT01806688|21452688|P2|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|0
8689806|NCT01806688|21452689|P1|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|12
8689807|NCT01806688|21452688|P2|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:
~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats
~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts
~placebo comparator non-caloric control water"|0
8689808|NCT01806688|21452689|P1|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:
~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats
~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts
~placebo comparator non-caloric control water"|38
8689809|NCT01806688|21452688|P2|NOT COMPLETED|Second Intervention Seed Study||0
8689810|NCT01806688|21452689|P1|NOT COMPLETED|Second Intervention Seed Study||0
8689811|NCT01806688|21452688|P2|COMPLETED|Second Intervention Seed Study||0
8689812|NCT01806688|21452689|P1|COMPLETED|Second Intervention Seed Study||38
8689813|NCT01806688|21452688|P2|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|0
8689814|NCT01806688|21452689|P1|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|12
8689815|NCT01806688|21452688|P2|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|0
8689816|NCT01806688|21452689|P1|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|13
8689817|NCT01806688|21452688|P2|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|0
8689818|NCT01806688|21452689|P1|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|13
8689819|NCT01806688|21452688|P2|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:
~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats
~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts
~placebo comparator non-caloric control #1, water"|0
8689820|NCT01806688|21452689|P1|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:
~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats
~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts
~placebo comparator non-caloric control #1, water"|38
8689821|NCT01806688|21452688|P2|NOT COMPLETED|First Intervention Seed Study||0
8689822|NCT01806688|21452689|P1|NOT COMPLETED|First Intervention Seed Study||0
8689823|NCT01806688|21452688|P2|COMPLETED|First Intervention Seed Study||0
8689824|NCT01806688|21452689|P1|COMPLETED|First Intervention Seed Study||38
8689825|NCT01806688|21452688|P2|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|0
8689826|NCT01806688|21452689|P1|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|12
8689827|NCT01806688|21452688|P2|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|0
8689828|NCT01806688|21452689|P1|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|13
8689829|NCT01806688|21452688|P2|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|0
8689830|NCT01806688|21452689|P1|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|13
8689920|NCT01143181|21453135|P2|COMPLETED|Overall Study||22
8689921|NCT01143181|21453136|P1|COMPLETED|Overall Study||14
8689831|NCT01806688|21452688|P2|STARTED|First Intervention Seed Study|"Participants received one of the following:
~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats
~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts
~placebo comparator non-caloric control water"|0
8689832|NCT01806688|21452689|P1|STARTED|First Intervention Seed Study|"Participants received one of the following:
~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats
~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts
~placebo comparator non-caloric control water"|38
8689833|NCT01786512|21452710|P11|NOT COMPLETED|Overall Study||12
8689834|NCT01786512|21452711|P10|NOT COMPLETED|Overall Study||5
8689835|NCT01786512|21452712|P9|NOT COMPLETED|Overall Study||4
8689836|NCT01786512|21452713|P8|NOT COMPLETED|Overall Study||0
8689837|NCT01786512|21452714|P7|NOT COMPLETED|Overall Study||1
8689838|NCT01786512|21452715|P6|NOT COMPLETED|Overall Study||0
8689839|NCT01786512|21452716|P5|NOT COMPLETED|Overall Study||0
8689840|NCT01786512|21452717|P4|NOT COMPLETED|Overall Study||0
8689841|NCT01786512|21452718|P3|NOT COMPLETED|Overall Study||0
8689842|NCT01786512|21452719|P2|NOT COMPLETED|Overall Study||1
8689843|NCT01786512|21452720|P1|NOT COMPLETED|Overall Study||0
8689844|NCT01786512|21452710|P11|COMPLETED|Overall Study||137
8689845|NCT01786512|21452711|P10|COMPLETED|Overall Study||145
8689846|NCT01786512|21452712|P9|COMPLETED|Overall Study||145
8689847|NCT01786512|21452713|P8|COMPLETED|Overall Study||14
8689848|NCT01786512|21452714|P7|COMPLETED|Overall Study||11
8689849|NCT01786512|21452715|P6|COMPLETED|Overall Study||11
8689850|NCT01786512|21452716|P5|COMPLETED|Overall Study||10
8689851|NCT01786512|21452717|P4|COMPLETED|Overall Study||13
8689852|NCT01786512|21452718|P3|COMPLETED|Overall Study||14
8689853|NCT01786512|21452719|P2|COMPLETED|Overall Study||10
8689854|NCT01786512|21452720|P1|COMPLETED|Overall Study||11
8689855|NCT01786512|21452710|P11|Received Study Treatment|Overall Study||146
8689856|NCT01786512|21452711|P10|Received Study Treatment|Overall Study||150
8689857|NCT01786512|21452712|P9|Received Study Treatment|Overall Study||149
8689858|NCT01786512|21452713|P8|Received Study Treatment|Overall Study||14
8689859|NCT01786512|21452714|P7|Received Study Treatment|Overall Study||11
8689860|NCT01786512|21452715|P6|Received Study Treatment|Overall Study||11
8689861|NCT01786512|21452716|P5|Received Study Treatment|Overall Study||10
8689862|NCT01786512|21452717|P4|Received Study Treatment|Overall Study||13
8689863|NCT01786512|21452718|P3|Received Study Treatment|Overall Study||14
8689864|NCT01786512|21452719|P2|Received Study Treatment|Overall Study||10
8689865|NCT01786512|21452720|P1|Received Study Treatment|Overall Study||11
8689866|NCT01786512|21452710|P11|STARTED|Overall Study||149
8689867|NCT01786512|21452711|P10|STARTED|Overall Study||150
8689868|NCT01786512|21452712|P9|STARTED|Overall Study||149
8689869|NCT01786512|21452713|P8|STARTED|Overall Study||14
8689870|NCT01786512|21452714|P7|STARTED|Overall Study||12
8689871|NCT01786512|21452715|P6|STARTED|Overall Study||11
8689872|NCT01786512|21452716|P5|STARTED|Overall Study||10
8689873|NCT01786512|21452717|P4|STARTED|Overall Study||13
8689874|NCT01786512|21452718|P3|STARTED|Overall Study||14
8689875|NCT01786512|21452719|P2|STARTED|Overall Study||11
8689876|NCT01786512|21452720|P1|STARTED|Overall Study||11
8689877|NCT01660451|21452793|P3|NOT COMPLETED|Overall Study||105
8689878|NCT01660451|21452794|P2|NOT COMPLETED|Overall Study||17
8689879|NCT01660451|21452795|P1|NOT COMPLETED|Overall Study||17
8689880|NCT01660451|21452793|P3|COMPLETED|Overall Study||37
8689881|NCT01660451|21452794|P2|COMPLETED|Overall Study||34
8689882|NCT01660451|21452795|P1|COMPLETED|Overall Study||16
8689883|NCT01660451|21452793|P3|STARTED|Overall Study||142
8689884|NCT01660451|21452794|P2|STARTED|Overall Study||51
8689885|NCT01660451|21452795|P1|STARTED|Overall Study||33
8689886|NCT01649180|21452823|P1|NOT COMPLETED|Overall Study||0
8689887|NCT01649180|21452823|P1|COMPLETED|Overall Study||3
8689888|NCT01649180|21452823|P1|STARTED|Overall Study||3
8689889|NCT01631552|21452835|P4|NOT COMPLETED|Overall Study||0
8689890|NCT01631552|21452836|P3|NOT COMPLETED|Overall Study||0
8689891|NCT01631552|21452837|P2|NOT COMPLETED|Overall Study||20
8689892|NCT01631552|21452838|P1|NOT COMPLETED|Overall Study||2
8689893|NCT01631552|21452835|P4|COMPLETED|Overall Study||3
8689894|NCT01631552|21452836|P3|COMPLETED|Overall Study||9
8689895|NCT01631552|21452837|P2|COMPLETED|Overall Study||400
8689896|NCT01631552|21452838|P1|COMPLETED|Overall Study||81
8689897|NCT01631552|21452835|P4|Enrolled and Treated|Overall Study||3
8689898|NCT01631552|21452836|P3|Enrolled and Treated|Overall Study||9
8689899|NCT01631552|21452837|P2|Enrolled and Treated|Overall Study||402
8689900|NCT01631552|21452838|P1|Enrolled and Treated|Overall Study||81
8689901|NCT01631552|21452835|P4|STARTED|Overall Study||3
8689902|NCT01631552|21452836|P3|STARTED|Overall Study||9
8689903|NCT01631552|21452837|P2|STARTED|Overall Study||420
8689904|NCT01631552|21452838|P1|STARTED|Overall Study||83
8689905|NCT01562444|21452882|P3|NOT COMPLETED|Overall Study||7
8689906|NCT01562444|21452883|P2|NOT COMPLETED|Overall Study||2
8689907|NCT01562444|21452884|P1|NOT COMPLETED|Overall Study||5
8689908|NCT01562444|21452882|P3|COMPLETED|Overall Study||99
8689909|NCT01562444|21452883|P2|COMPLETED|Overall Study||49
8689910|NCT01562444|21452884|P1|COMPLETED|Overall Study||43
8689911|NCT01562444|21452882|P3|STARTED|Overall Study||106
8689912|NCT01562444|21452883|P2|STARTED|Overall Study||51
8689913|NCT01562444|21452884|P1|STARTED|Overall Study||48
8689914|NCT01143181|21453133|P4|NOT COMPLETED|Overall Study||23
8689915|NCT01143181|21453134|P3|NOT COMPLETED|Overall Study||44
8689916|NCT01143181|21453135|P2|NOT COMPLETED|Overall Study||16
8689922|NCT01143181|21453133|P4|STARTED|Overall Study||40
8689923|NCT01143181|21453134|P3|STARTED|Overall Study||102
8689924|NCT01143181|21453135|P2|STARTED|Overall Study||38
8689925|NCT01143181|21453136|P1|STARTED|Overall Study||30
8689926|NCT01065454|21453150|P4|NOT COMPLETED|Follow up||44
8689927|NCT01065454|21453151|P3|NOT COMPLETED|Follow up||17
8689928|NCT01065454|21453152|P2|NOT COMPLETED|Follow up||24
8689929|NCT01065454|21453153|P1|NOT COMPLETED|Follow up||39
8689930|NCT01065454|21453150|P4|COMPLETED|Follow up||13
8689931|NCT01065454|21453151|P3|COMPLETED|Follow up||6
8689932|NCT01065454|21453152|P2|COMPLETED|Follow up||4
8689933|NCT01065454|21453153|P1|COMPLETED|Follow up||15
8689934|NCT01065454|21453150|P4|Entering Follow-up|Follow up||51
8689935|NCT01065454|21453151|P3|Entering Follow-up|Follow up||23
8689936|NCT01065454|21453152|P2|Entering Follow-up|Follow up||27
8689937|NCT01065454|21453153|P1|Entering Follow-up|Follow up||49
8689938|NCT01065454|21453150|P4|STARTED|Follow up||57
8689939|NCT01065454|21453151|P3|STARTED|Follow up||23
8689940|NCT01065454|21453152|P2|STARTED|Follow up||28
8689941|NCT01065454|21453153|P1|STARTED|Follow up||54
8689942|NCT01065454|21453150|P4|NOT COMPLETED|Treatment||12
8689943|NCT01065454|21453151|P3|NOT COMPLETED|Treatment||9
8689944|NCT01065454|21453152|P2|NOT COMPLETED|Treatment||5
8689945|NCT01065454|21453153|P1|NOT COMPLETED|Treatment||13
8689946|NCT01065454|21453150|P4|COMPLETED|Treatment||57
8689947|NCT01065454|21453151|P3|COMPLETED|Treatment||23
8689948|NCT01065454|21453152|P2|COMPLETED|Treatment||28
8689949|NCT01065454|21453153|P1|COMPLETED|Treatment||54
8689950|NCT01065454|21453150|P4|STARTED|Treatment||69
8689951|NCT01065454|21453151|P3|STARTED|Treatment||32
8689952|NCT01065454|21453152|P2|STARTED|Treatment||33
8689953|NCT01065454|21453153|P1|STARTED|Treatment||67
8689954|NCT00901199|21453263|P1|NOT COMPLETED|Overall Study||4
8689955|NCT00901199|21453263|P1|COMPLETED|Overall Study||18
8689956|NCT00901199|21453263|P1|STARTED|Overall Study||22
8689957|NCT00311168|21453270|P2|NOT COMPLETED|Second Intervention||4
8689958|NCT00311168|21453271|P1|NOT COMPLETED|Second Intervention||10
8689959|NCT00311168|21453270|P2|COMPLETED|Second Intervention||58
8689960|NCT00311168|21453271|P1|COMPLETED|Second Intervention||49
8689961|NCT00311168|21453270|P2|STARTED|Second Intervention||62
8689962|NCT00311168|21453271|P1|STARTED|Second Intervention||59
8689963|NCT00311168|21453270|P2|NOT COMPLETED|First Intervention||6
8689964|NCT00311168|21453271|P1|NOT COMPLETED|First Intervention||7
8689965|NCT00311168|21453270|P2|COMPLETED|First Intervention||62
8689966|NCT00311168|21453271|P1|COMPLETED|First Intervention||59
8689967|NCT00311168|21453270|P2|STARTED|First Intervention||68
8689968|NCT00311168|21453271|P1|STARTED|First Intervention||66
8689969|NCT00006099|21453293|P2|NOT COMPLETED|Overall Study||0
8689970|NCT00006099|21453294|P1|NOT COMPLETED|Overall Study||0
8689971|NCT00006099|21453293|P2|COMPLETED|Overall Study||0
8689972|NCT00006099|21453294|P1|COMPLETED|Overall Study||1
8689973|NCT00006099|21453293|P2|STARTED|Overall Study||0
8689974|NCT00006099|21453294|P1|STARTED|Overall Study||1
8689975|NCT04314037|21453302|P2|NOT COMPLETED|Treatment Period 4||0
8689976|NCT04314037|21453303|P1|NOT COMPLETED|Treatment Period 4||0
8689977|NCT04314037|21453302|P2|COMPLETED|Treatment Period 4||17
8689978|NCT04314037|21453303|P1|COMPLETED|Treatment Period 4||16
8689979|NCT04314037|21453302|P2|STARTED|Treatment Period 4||17
8689980|NCT04314037|21453303|P1|STARTED|Treatment Period 4||16
8689981|NCT04314037|21453302|P2|NOT COMPLETED|Treatment Period 3||1
8689982|NCT04314037|21453303|P1|NOT COMPLETED|Treatment Period 3||1
8689983|NCT04314037|21453302|P2|COMPLETED|Treatment Period 3||17
8689984|NCT04314037|21453303|P1|COMPLETED|Treatment Period 3||16
8689985|NCT04314037|21453302|P2|STARTED|Treatment Period 3||18
8689986|NCT04314037|21453303|P1|STARTED|Treatment Period 3||17
8689987|NCT04314037|21453302|P2|NOT COMPLETED|Treatment Period 2||0
8689988|NCT04314037|21453303|P1|NOT COMPLETED|Treatment Period 2||1
8689989|NCT04314037|21453302|P2|COMPLETED|Treatment Period 2||18
8689990|NCT04314037|21453303|P1|COMPLETED|Treatment Period 2||17
8689991|NCT04314037|21453302|P2|STARTED|Treatment Period 2||18
8689992|NCT04314037|21453303|P1|STARTED|Treatment Period 2||18
8689993|NCT04314037|21453302|P2|NOT COMPLETED|Treatment Period 1||0
8689994|NCT04314037|21453303|P1|NOT COMPLETED|Treatment Period 1||0
8689995|NCT04314037|21453302|P2|COMPLETED|Treatment Period 1||18
8689996|NCT04314037|21453303|P1|COMPLETED|Treatment Period 1||18
8689997|NCT04314037|21453302|P2|STARTED|Treatment Period 1||18
8689998|NCT04314037|21453303|P1|STARTED|Treatment Period 1||18
8689999|NCT04086472|21453378|P5|NOT COMPLETED|Overall Study||2
8690000|NCT04086472|21453379|P4|NOT COMPLETED|Overall Study||3
8690001|NCT04086472|21453380|P3|NOT COMPLETED|Overall Study||2
8690002|NCT04086472|21453381|P2|NOT COMPLETED|Overall Study||2
8690003|NCT04086472|21453382|P1|NOT COMPLETED|Overall Study||4
8690004|NCT04086472|21453378|P5|COMPLETED|Overall Study||14
8690005|NCT04086472|21453379|P4|COMPLETED|Overall Study||13
8690006|NCT04086472|21453380|P3|COMPLETED|Overall Study||14
8690007|NCT04086472|21453381|P2|COMPLETED|Overall Study||14
8690008|NCT04086472|21453382|P1|COMPLETED|Overall Study||12
8690009|NCT04086472|21453378|P5|Not Inoculated|Overall Study||1
8690010|NCT04086472|21453379|P4|Not Inoculated|Overall Study||3
8690011|NCT04086472|21453380|P3|Not Inoculated|Overall Study||2
8690012|NCT04086472|21453381|P2|Not Inoculated|Overall Study||2
8690013|NCT04086472|21453382|P1|Not Inoculated|Overall Study||2
8690014|NCT04086472|21453378|P5|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||15
8690015|NCT04086472|21453379|P4|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||13
8690016|NCT04086472|21453380|P3|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
8690017|NCT04086472|21453381|P2|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
8690018|NCT04086472|21453382|P1|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
8690019|NCT04086472|21453378|P5|Received MK-1654 or Placebo|Overall Study||16
8690020|NCT04086472|21453379|P4|Received MK-1654 or Placebo|Overall Study||16
8690021|NCT04086472|21453380|P3|Received MK-1654 or Placebo|Overall Study||16
8690022|NCT04086472|21453381|P2|Received MK-1654 or Placebo|Overall Study||16
8690023|NCT04086472|21453382|P1|Received MK-1654 or Placebo|Overall Study||16
8690024|NCT04086472|21453378|P5|STARTED|Overall Study||16
8690025|NCT04086472|21453379|P4|STARTED|Overall Study||16
8690026|NCT04086472|21453380|P3|STARTED|Overall Study||16
8690027|NCT04086472|21453381|P2|STARTED|Overall Study||16
8690028|NCT04086472|21453382|P1|STARTED|Overall Study||16
8690029|NCT04006795|21453418|P1|NOT COMPLETED|Challenge Phase||0
8690030|NCT04006795|21453418|P1|COMPLETED|Challenge Phase||37
8690031|NCT04006795|21453418|P1|STARTED|Challenge Phase||37
8690032|NCT04006795|21453418|P1|NOT COMPLETED|Rest Phase||0
8690033|NCT04006795|21453418|P1|COMPLETED|Rest Phase||37
8690034|NCT04006795|21453418|P1|STARTED|Rest Phase||37
8690035|NCT04006795|21453418|P1|NOT COMPLETED|Induction Phase||0
8690036|NCT04006795|21453418|P1|COMPLETED|Induction Phase||37
8690037|NCT04006795|21453418|P1|STARTED|Induction Phase||37
8690038|NCT03976752|21453443|P2|NOT COMPLETED|Overall Study||9
8690039|NCT03976752|21453444|P1|NOT COMPLETED|Overall Study||1
8690040|NCT03976752|21453443|P2|COMPLETED|Overall Study||28
8690041|NCT03976752|21453444|P1|COMPLETED|Overall Study||3
8690042|NCT03976752|21453443|P2|Completed Study Arm D|Overall Study||4
8690043|NCT03976752|21453444|P1|Completed Study Arm D|Overall Study||0
8690044|NCT03976752|21453443|P2|Started Study Arm D|Overall Study||6
8690045|NCT03976752|21453444|P1|Started Study Arm D|Overall Study||0
8690046|NCT03976752|21453443|P2|Completed Study Arm C|Overall Study||8
8690047|NCT03976752|21453444|P1|Completed Study Arm C|Overall Study||0
8690048|NCT03976752|21453443|P2|Started Study Arm C|Overall Study||11
8690049|NCT03976752|21453444|P1|Started Study Arm C|Overall Study||0
8690050|NCT03976752|21453443|P2|Completed Study Arm B|Overall Study||8
8690051|NCT03976752|21453444|P1|Completed Study Arm B|Overall Study||0
8690052|NCT03976752|21453443|P2|Started Study Arm B|Overall Study||8
8690053|NCT03976752|21453444|P1|Started Study Arm B|Overall Study||0
8690054|NCT03976752|21453443|P2|Completed Study Arm A|Overall Study||8
8690055|NCT03976752|21453444|P1|Completed Study Arm A|Overall Study||0
8690056|NCT03976752|21453443|P2|Started Study Arm A|Overall Study||14
8690057|NCT03976752|21453444|P1|Started Study Arm A|Overall Study||0
8690058|NCT03976752|21453443|P2|STARTED|Overall Study||37
8690059|NCT03976752|21453444|P1|STARTED|Overall Study||4
8690060|NCT03942042|21453493|P2|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
8690061|NCT03942042|21453494|P1|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
8690062|NCT03942042|21453493|P2|COMPLETED|Maintenance Dosing Period (8 Weeks)||4
8690063|NCT03942042|21453494|P1|COMPLETED|Maintenance Dosing Period (8 Weeks)||2
8690064|NCT03942042|21453493|P2|STARTED|Maintenance Dosing Period (8 Weeks)||4
8690065|NCT03942042|21453494|P1|STARTED|Maintenance Dosing Period (8 Weeks)|Only participants with GIS ≥2 at Week 12 and based on investigators' discretion continued to maintenance dosing period.|2
8690066|NCT03942042|21453493|P2|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
8690067|NCT03942042|21453494|P1|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
8690068|NCT03942042|21453493|P2|COMPLETED|Induction Dosing Period (12 Weeks)||4
8690069|NCT03942042|21453494|P1|COMPLETED|Induction Dosing Period (12 Weeks)||6
8690070|NCT03942042|21453493|P2|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||4
8690071|NCT03942042|21453494|P1|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||2
8690072|NCT03942042|21453493|P2|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||0
8690073|NCT03942042|21453494|P1|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||4
8690074|NCT03942042|21453493|P2|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||5
8690075|NCT03942042|21453494|P1|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||7
8690076|NCT03942042|21453493|P2|STARTED|Induction Dosing Period (12 Weeks)||5
8690077|NCT03942042|21453494|P1|STARTED|Induction Dosing Period (12 Weeks)||7
8690078|NCT03775915|21453527|P2|NOT COMPLETED|Overall Study||0
8690079|NCT03775915|21453528|P1|NOT COMPLETED|Overall Study||0
8690080|NCT03775915|21453527|P2|COMPLETED|Overall Study||12
8690081|NCT03775915|21453528|P1|COMPLETED|Overall Study||12
8690082|NCT03775915|21453527|P2|STARTED|Overall Study||12
8690083|NCT03775915|21453528|P1|STARTED|Overall Study||12
8690084|NCT03722030|21453548|P2|NOT COMPLETED|Overall Study||0
8690085|NCT03722030|21453549|P1|NOT COMPLETED|Overall Study||1
8690086|NCT03722030|21453548|P2|COMPLETED|Overall Study||20
8690087|NCT03722030|21453549|P1|COMPLETED|Overall Study||19
8690088|NCT03722030|21453548|P2|STARTED|Overall Study||20
8690089|NCT03722030|21453549|P1|STARTED|Overall Study||20
8690090|NCT03674177|21453619|P4|NOT COMPLETED|Overall Study||2
8690091|NCT03674177|21453620|P3|NOT COMPLETED|Overall Study||0
8690092|NCT03674177|21453621|P2|NOT COMPLETED|Overall Study||1
8690093|NCT03674177|21453622|P1|NOT COMPLETED|Overall Study||2
8690094|NCT03674177|21453619|P4|COMPLETED|Overall Study||124
8690095|NCT03674177|21453620|P3|COMPLETED|Overall Study||126
8690096|NCT03674177|21453621|P2|COMPLETED|Overall Study||125
8690097|NCT03674177|21453622|P1|COMPLETED|Overall Study||122
8690098|NCT03674177|21453619|P4|STARTED|Overall Study||126
8690099|NCT03674177|21453620|P3|STARTED|Overall Study||126
8690100|NCT03674177|21453621|P2|STARTED|Overall Study||126
8690101|NCT03674177|21453622|P1|STARTED|Overall Study||124
8690102|NCT03627065|21453688|P1|NOT COMPLETED|Overall Study||3
8690103|NCT03627065|21453688|P1|COMPLETED|Overall Study||7
8690104|NCT03627065|21453688|P1|STARTED|Overall Study||10
8690105|NCT03588910|21453711|P2|NOT COMPLETED|Overall Study||15
8690106|NCT03588910|21453712|P1|NOT COMPLETED|Overall Study||13
8690107|NCT03588910|21453711|P2|COMPLETED|Overall Study||45
8690108|NCT03588910|21453712|P1|COMPLETED|Overall Study||47
8690109|NCT03588910|21453711|P2|Post Op Day 1 Survey|Overall Study||47
8690110|NCT03588910|21453712|P1|Post Op Day 1 Survey|Overall Study||52
8690111|NCT03588910|21453711|P2|STARTED|Overall Study||60
8690112|NCT03588910|21453712|P1|STARTED|Overall Study||60
8690113|NCT03438045|21453726|P1|NOT COMPLETED|Overall Study||0
8690114|NCT03438045|21453726|P1|COMPLETED|Overall Study||75
8690115|NCT03438045|21453726|P1|STARTED|Overall Study||75
8690116|NCT03402230|21453733|P2|NOT COMPLETED|Overall Study||1
8690117|NCT03402230|21453734|P1|NOT COMPLETED|Overall Study||0
8690118|NCT03402230|21453733|P2|COMPLETED|Overall Study||23
8690119|NCT03402230|21453734|P1|COMPLETED|Overall Study||25
8690120|NCT03402230|21453733|P2|STARTED|Overall Study||24
8690121|NCT03402230|21453734|P1|STARTED|Overall Study||25
8690122|NCT03320850|21453750|P10|NOT COMPLETED|Overall Study||9
8690123|NCT03320850|21453751|P9|NOT COMPLETED|Overall Study||10
8690124|NCT03320850|21453752|P8|NOT COMPLETED|Overall Study||7
8690125|NCT03320850|21453753|P7|NOT COMPLETED|Overall Study||7
8690126|NCT03320850|21453754|P6|NOT COMPLETED|Overall Study||9
8690127|NCT03320850|21453755|P5|NOT COMPLETED|Overall Study||2
8690128|NCT03320850|21453756|P4|NOT COMPLETED|Overall Study||1
8690129|NCT03320850|21453757|P3|NOT COMPLETED|Overall Study||0
8690130|NCT03320850|21453758|P2|NOT COMPLETED|Overall Study||0
8690131|NCT03320850|21453759|P1|NOT COMPLETED|Overall Study||0
8690132|NCT03320850|21453750|P10|COMPLETED|Overall Study||50
8690133|NCT03320850|21453751|P9|COMPLETED|Overall Study||50
8690134|NCT03320850|21453752|P8|COMPLETED|Overall Study||53
8690135|NCT03320850|21453753|P7|COMPLETED|Overall Study||50
8690136|NCT03320850|21453754|P6|COMPLETED|Overall Study||49
8690137|NCT03320850|21453755|P5|COMPLETED|Overall Study||17
8690138|NCT03320850|21453756|P4|COMPLETED|Overall Study||21
8690139|NCT03320850|21453757|P3|COMPLETED|Overall Study||18
8690140|NCT03320850|21453758|P2|COMPLETED|Overall Study||12
8690141|NCT03320850|21453759|P1|COMPLETED|Overall Study||18
8690142|NCT03320850|21453750|P10|Safety Population|Overall Study||58
8690143|NCT03320850|21453751|P9|Safety Population|Overall Study||60
8690144|NCT03320850|21453752|P8|Safety Population|Overall Study||60
8690145|NCT03320850|21453753|P7|Safety Population|Overall Study||57
8690146|NCT03320850|21453754|P6|Safety Population|Overall Study||57
8690147|NCT03320850|21453755|P5|Safety Population|Overall Study||19
8690148|NCT03320850|21453756|P4|Safety Population|Overall Study||22
8690149|NCT03320850|21453757|P3|Safety Population|Overall Study||18
8690150|NCT03320850|21453758|P2|Safety Population|Overall Study||12
8690151|NCT03320850|21453759|P1|Safety Population|Overall Study||18
8690152|NCT03320850|21453750|P10|STARTED|Overall Study||59
8690153|NCT03320850|21453751|P9|STARTED|Overall Study||60
8690154|NCT03320850|21453752|P8|STARTED|Overall Study||60
8690155|NCT03320850|21453753|P7|STARTED|Overall Study||57
8690156|NCT03320850|21453754|P6|STARTED|Overall Study||58
8690157|NCT03320850|21453755|P5|STARTED|Overall Study||19
8690158|NCT03320850|21453756|P4|STARTED|Overall Study||22
8690159|NCT03320850|21453757|P3|STARTED|Overall Study||18
8690160|NCT03320850|21453758|P2|STARTED|Overall Study||12
8690161|NCT03320850|21453759|P1|STARTED|Overall Study||18
8690162|NCT03304054|21453799|P6|NOT COMPLETED|Overall Study||6
8690163|NCT03304054|21453800|P5|NOT COMPLETED|Overall Study||17
8690164|NCT03304054|21453801|P4|NOT COMPLETED|Overall Study||0
8690165|NCT03304054|21453802|P3|NOT COMPLETED|Overall Study||1
8690166|NCT03304054|21453803|P2|NOT COMPLETED|Overall Study||0
8690167|NCT03304054|21453804|P1|NOT COMPLETED|Overall Study||0
8690168|NCT03304054|21453799|P6|COMPLETED|Overall Study||0
8690169|NCT03304054|21453800|P5|COMPLETED|Overall Study||0
8690170|NCT03304054|21453801|P4|COMPLETED|Overall Study||8
8690171|NCT03304054|21453802|P3|COMPLETED|Overall Study||27
8690172|NCT03304054|21453803|P2|COMPLETED|Overall Study||7
8690173|NCT03304054|21453804|P1|COMPLETED|Overall Study||27
8690174|NCT03304054|21453799|P6|STARTED|Overall Study||6
8690175|NCT03304054|21453800|P5|STARTED|Overall Study||17
8690176|NCT03304054|21453801|P4|STARTED|Overall Study||8
8690177|NCT03304054|21453802|P3|STARTED|Overall Study||28
8690178|NCT03304054|21453803|P2|STARTED|Overall Study||7
8690179|NCT03304054|21453804|P1|STARTED|Overall Study||27
8690180|NCT03266172|21453820|P3|NOT COMPLETED|Part C Period 6(2 Days)||0
8690181|NCT03266172|21453821|P2|NOT COMPLETED|Part C Period 6(2 Days)||0
8690182|NCT03266172|21453822|P1|NOT COMPLETED|Part C Period 6(2 Days)||0
8690183|NCT03266172|21453820|P3|COMPLETED|Part C Period 6(2 Days)||14
8690184|NCT03266172|21453821|P2|COMPLETED|Part C Period 6(2 Days)||0
8690185|NCT03266172|21453822|P1|COMPLETED|Part C Period 6(2 Days)||0
8690186|NCT03266172|21453820|P3|STARTED|Part C Period 6(2 Days)||14
8690187|NCT03266172|21453821|P2|STARTED|Part C Period 6(2 Days)||0
8690188|NCT03266172|21453822|P1|STARTED|Part C Period 6(2 Days)||0
8690189|NCT03266172|21453820|P3|NOT COMPLETED|Part C Washout Period (7 Days)||1
8690190|NCT03266172|21453821|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
8690191|NCT03266172|21453822|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
8690192|NCT03266172|21453820|P3|COMPLETED|Part C Washout Period (7 Days)||14
8690193|NCT03266172|21453821|P2|COMPLETED|Part C Washout Period (7 Days)||0
8690194|NCT03266172|21453822|P1|COMPLETED|Part C Washout Period (7 Days)||0
8690195|NCT03266172|21453820|P3|STARTED|Part C Washout Period (7 Days)||15
8690196|NCT03266172|21453821|P2|STARTED|Part C Washout Period (7 Days)||0
8690197|NCT03266172|21453822|P1|STARTED|Part C Washout Period (7 Days)||0
8690198|NCT03266172|21453820|P3|NOT COMPLETED|Part C Period 5(2 Days)||0
8690199|NCT03266172|21453821|P2|NOT COMPLETED|Part C Period 5(2 Days)||0
8690200|NCT03266172|21453822|P1|NOT COMPLETED|Part C Period 5(2 Days)||0
8690201|NCT03266172|21453820|P3|COMPLETED|Part C Period 5(2 Days)||15
8690202|NCT03266172|21453821|P2|COMPLETED|Part C Period 5(2 Days)||0
8690203|NCT03266172|21453822|P1|COMPLETED|Part C Period 5(2 Days)||0
8690204|NCT03266172|21453820|P3|STARTED|Part C Period 5(2 Days)||15
8690205|NCT03266172|21453821|P2|STARTED|Part C Period 5(2 Days)||0
8690206|NCT03266172|21453822|P1|STARTED|Part C Period 5(2 Days)||0
8690207|NCT03266172|21453820|P3|NOT COMPLETED|Part C Washout Period (7 Days)||1
8690208|NCT03266172|21453821|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
8690209|NCT03266172|21453822|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
8690210|NCT03266172|21453820|P3|COMPLETED|Part C Washout Period (7 Days)||15
8690211|NCT03266172|21453821|P2|COMPLETED|Part C Washout Period (7 Days)||0
8690212|NCT03266172|21453822|P1|COMPLETED|Part C Washout Period (7 Days)||0
8690213|NCT03266172|21453820|P3|STARTED|Part C Washout Period (7 Days)||16
8690214|NCT03266172|21453821|P2|STARTED|Part C Washout Period (7 Days)||0
8690215|NCT03266172|21453822|P1|STARTED|Part C Washout Period (7 Days)||0
8690216|NCT03266172|21453820|P3|NOT COMPLETED|Part C Period 4(2 Days)||0
8690217|NCT03266172|21453821|P2|NOT COMPLETED|Part C Period 4(2 Days)||0
8690218|NCT03266172|21453822|P1|NOT COMPLETED|Part C Period 4(2 Days)||0
8690219|NCT03266172|21453820|P3|COMPLETED|Part C Period 4(2 Days)||16
8690220|NCT03266172|21453821|P2|COMPLETED|Part C Period 4(2 Days)||0
8690221|NCT03266172|21453822|P1|COMPLETED|Part C Period 4(2 Days)||0
8690222|NCT03266172|21453820|P3|STARTED|Part C Period 4(2 Days)||16
8690223|NCT03266172|21453821|P2|STARTED|Part C Period 4(2 Days)||0
8690224|NCT03266172|21453822|P1|STARTED|Part C Period 4(2 Days)||0
8690225|NCT03266172|21453820|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
8690226|NCT03266172|21453821|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
8690227|NCT03266172|21453822|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
8690228|NCT03266172|21453820|P3|COMPLETED|Part C Washout Period (7 Days)||16
8690229|NCT03266172|21453821|P2|COMPLETED|Part C Washout Period (7 Days)||0
8690230|NCT03266172|21453822|P1|COMPLETED|Part C Washout Period (7 Days)||0
8690231|NCT03266172|21453820|P3|STARTED|Part C Washout Period (7 Days)||16
8690232|NCT03266172|21453821|P2|STARTED|Part C Washout Period (7 Days)||0
8690233|NCT03266172|21453822|P1|STARTED|Part C Washout Period (7 Days)||0
8690234|NCT03266172|21453820|P3|NOT COMPLETED|Part C Period 3(2 Days)||0
8690235|NCT03266172|21453821|P2|NOT COMPLETED|Part C Period 3(2 Days)||0
8690236|NCT03266172|21453822|P1|NOT COMPLETED|Part C Period 3(2 Days)||0
8690237|NCT03266172|21453820|P3|COMPLETED|Part C Period 3(2 Days)||16
8690238|NCT03266172|21453821|P2|COMPLETED|Part C Period 3(2 Days)||0
8690239|NCT03266172|21453822|P1|COMPLETED|Part C Period 3(2 Days)||0
8690240|NCT03266172|21453820|P3|STARTED|Part C Period 3(2 Days)|1 replacement participant enrolled|16
8690241|NCT03266172|21453821|P2|STARTED|Part C Period 3(2 Days)||0
8690242|NCT03266172|21453822|P1|STARTED|Part C Period 3(2 Days)||0
8690243|NCT03266172|21453820|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
8690244|NCT03266172|21453821|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
8690245|NCT03266172|21453822|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
8690246|NCT03266172|21453820|P3|COMPLETED|Part C Washout Period (7 Days)||15
8690247|NCT03266172|21453821|P2|COMPLETED|Part C Washout Period (7 Days)||0
8690248|NCT03266172|21453822|P1|COMPLETED|Part C Washout Period (7 Days)||0
8690249|NCT03266172|21453820|P3|STARTED|Part C Washout Period (7 Days)||15
8690250|NCT03266172|21453821|P2|STARTED|Part C Washout Period (7 Days)||0
8690251|NCT03266172|21453822|P1|STARTED|Part C Washout Period (7 Days)||0
8690252|NCT03266172|21453820|P3|NOT COMPLETED|Part C Period 2(2 Days)||0
8690253|NCT03266172|21453821|P2|NOT COMPLETED|Part C Period 2(2 Days)||0
8690254|NCT03266172|21453822|P1|NOT COMPLETED|Part C Period 2(2 Days)||0
8690255|NCT03266172|21453820|P3|COMPLETED|Part C Period 2(2 Days)||15
8690256|NCT03266172|21453821|P2|COMPLETED|Part C Period 2(2 Days)||0
8690257|NCT03266172|21453822|P1|COMPLETED|Part C Period 2(2 Days)||0
8690258|NCT03266172|21453820|P3|STARTED|Part C Period 2(2 Days)||15
8690259|NCT03266172|21453821|P2|STARTED|Part C Period 2(2 Days)||0
8690260|NCT03266172|21453822|P1|STARTED|Part C Period 2(2 Days)||0
8690261|NCT03266172|21453820|P3|NOT COMPLETED|Part C Washout Period (7 Days)||0
8690262|NCT03266172|21453821|P2|NOT COMPLETED|Part C Washout Period (7 Days)||0
8690263|NCT03266172|21453822|P1|NOT COMPLETED|Part C Washout Period (7 Days)||0
8690264|NCT03266172|21453820|P3|COMPLETED|Part C Washout Period (7 Days)||15
8690265|NCT03266172|21453821|P2|COMPLETED|Part C Washout Period (7 Days)||0
8690266|NCT03266172|21453822|P1|COMPLETED|Part C Washout Period (7 Days)||0
8690267|NCT03266172|21453820|P3|STARTED|Part C Washout Period (7 Days)||15
8690268|NCT03266172|21453821|P2|STARTED|Part C Washout Period (7 Days)||0
8690269|NCT03266172|21453822|P1|STARTED|Part C Washout Period (7 Days)||0
8690270|NCT03266172|21453820|P3|NOT COMPLETED|Part C: Period 1(2 Days)||0
8690271|NCT03266172|21453821|P2|NOT COMPLETED|Part C: Period 1(2 Days)||0
8690272|NCT03266172|21453822|P1|NOT COMPLETED|Part C: Period 1(2 Days)||0
8690273|NCT03266172|21453820|P3|COMPLETED|Part C: Period 1(2 Days)||15
8690274|NCT03266172|21453821|P2|COMPLETED|Part C: Period 1(2 Days)||0
8690275|NCT03266172|21453822|P1|COMPLETED|Part C: Period 1(2 Days)||0
8690276|NCT03266172|21453820|P3|STARTED|Part C: Period 1(2 Days)|New participants were enrolled in Part C of study|15
8690277|NCT03266172|21453821|P2|STARTED|Part C: Period 1(2 Days)|Participants from Part B did not enter Part C|0
8690278|NCT03266172|21453822|P1|STARTED|Part C: Period 1(2 Days)||0
8690279|NCT03266172|21453820|P3|NOT COMPLETED|Part B: Period 3 (4 Days)||0
8690280|NCT03266172|21453821|P2|NOT COMPLETED|Part B: Period 3 (4 Days)||0
8690281|NCT03266172|21453822|P1|NOT COMPLETED|Part B: Period 3 (4 Days)||0
8690282|NCT03266172|21453820|P3|COMPLETED|Part B: Period 3 (4 Days)||0
8690283|NCT03266172|21453821|P2|COMPLETED|Part B: Period 3 (4 Days)||6
8690284|NCT03266172|21453822|P1|COMPLETED|Part B: Period 3 (4 Days)||0
8690285|NCT03266172|21453820|P3|STARTED|Part B: Period 3 (4 Days)||0
8690286|NCT03266172|21453821|P2|STARTED|Part B: Period 3 (4 Days)|Two participants completed Washout Period but withdrew before the start of Period 3.|6
8690287|NCT03266172|21453822|P1|STARTED|Part B: Period 3 (4 Days)||0
8690288|NCT03266172|21453820|P3|NOT COMPLETED|Part B: Washout (7 Days)||0
8690289|NCT03266172|21453821|P2|NOT COMPLETED|Part B: Washout (7 Days)||2
8690290|NCT03266172|21453822|P1|NOT COMPLETED|Part B: Washout (7 Days)||0
8690291|NCT03266172|21453820|P3|COMPLETED|Part B: Washout (7 Days)||0
8690292|NCT03266172|21453821|P2|COMPLETED|Part B: Washout (7 Days)||8
8690293|NCT03266172|21453822|P1|COMPLETED|Part B: Washout (7 Days)||0
8690294|NCT03266172|21453820|P3|STARTED|Part B: Washout (7 Days)||0
8690295|NCT03266172|21453821|P2|STARTED|Part B: Washout (7 Days)||10
8690296|NCT03266172|21453822|P1|STARTED|Part B: Washout (7 Days)||0
8690297|NCT03266172|21453820|P3|NOT COMPLETED|Part B: Period 2 (4 Days)||0
8690298|NCT03266172|21453821|P2|NOT COMPLETED|Part B: Period 2 (4 Days)||0
8690299|NCT03266172|21453822|P1|NOT COMPLETED|Part B: Period 2 (4 Days)||0
8690300|NCT03266172|21453820|P3|COMPLETED|Part B: Period 2 (4 Days)||0
8690301|NCT03266172|21453821|P2|COMPLETED|Part B: Period 2 (4 Days)||10
8690302|NCT03266172|21453822|P1|COMPLETED|Part B: Period 2 (4 Days)||0
8690303|NCT03266172|21453820|P3|STARTED|Part B: Period 2 (4 Days)||0
8690304|NCT03266172|21453821|P2|STARTED|Part B: Period 2 (4 Days)||10
8690305|NCT03266172|21453822|P1|STARTED|Part B: Period 2 (4 Days)||0
8690306|NCT03266172|21453820|P3|NOT COMPLETED|Part B: Washout (7 Days)||0
8690307|NCT03266172|21453821|P2|NOT COMPLETED|Part B: Washout (7 Days)||0
8690308|NCT03266172|21453822|P1|NOT COMPLETED|Part B: Washout (7 Days)||0
8690309|NCT03266172|21453820|P3|COMPLETED|Part B: Washout (7 Days)||0
8690310|NCT03266172|21453821|P2|COMPLETED|Part B: Washout (7 Days)||10
8690311|NCT03266172|21453822|P1|COMPLETED|Part B: Washout (7 Days)||0
8690312|NCT03266172|21453820|P3|STARTED|Part B: Washout (7 Days)||0
8690313|NCT03266172|21453821|P2|STARTED|Part B: Washout (7 Days)||10
8690314|NCT03266172|21453822|P1|STARTED|Part B: Washout (7 Days)||0
8690315|NCT03266172|21453820|P3|NOT COMPLETED|Part B: Period 1 (4 Days)||0
8690316|NCT03266172|21453821|P2|NOT COMPLETED|Part B: Period 1 (4 Days)||0
8690317|NCT03266172|21453822|P1|NOT COMPLETED|Part B: Period 1 (4 Days)||0
8690318|NCT03266172|21453820|P3|COMPLETED|Part B: Period 1 (4 Days)||0
8690319|NCT03266172|21453821|P2|COMPLETED|Part B: Period 1 (4 Days)||10
8690320|NCT03266172|21453822|P1|COMPLETED|Part B: Period 1 (4 Days)||0
8690321|NCT03266172|21453820|P3|STARTED|Part B: Period 1 (4 Days)||0
8690322|NCT03266172|21453821|P2|STARTED|Part B: Period 1 (4 Days)|New participants were enrolled in Part B of study|10
8690323|NCT03266172|21453822|P1|STARTED|Part B: Period 1 (4 Days)|Participants from Part A did not enter Part B|0
8690324|NCT03266172|21453820|P3|NOT COMPLETED|Part A: Period 4 (2 Days)||0
8690325|NCT03266172|21453821|P2|NOT COMPLETED|Part A: Period 4 (2 Days)||0
8690326|NCT03266172|21453822|P1|NOT COMPLETED|Part A: Period 4 (2 Days)||0
8690327|NCT03266172|21453820|P3|COMPLETED|Part A: Period 4 (2 Days)||0
8690328|NCT03266172|21453821|P2|COMPLETED|Part A: Period 4 (2 Days)||0
8690329|NCT03266172|21453822|P1|COMPLETED|Part A: Period 4 (2 Days)||16
8690330|NCT03266172|21453820|P3|STARTED|Part A: Period 4 (2 Days)||0
8690331|NCT03266172|21453821|P2|STARTED|Part A: Period 4 (2 Days)||0
8690332|NCT03266172|21453822|P1|STARTED|Part A: Period 4 (2 Days)||16
8690333|NCT03266172|21453820|P3|NOT COMPLETED|Part A: Washout (7 Days)||0
8690334|NCT03266172|21453821|P2|NOT COMPLETED|Part A: Washout (7 Days)||0
8690335|NCT03266172|21453822|P1|NOT COMPLETED|Part A: Washout (7 Days)||0
8690336|NCT03266172|21453820|P3|COMPLETED|Part A: Washout (7 Days)||0
8690337|NCT03266172|21453821|P2|COMPLETED|Part A: Washout (7 Days)||0
8690338|NCT03266172|21453822|P1|COMPLETED|Part A: Washout (7 Days)||16
8690339|NCT03266172|21453820|P3|STARTED|Part A: Washout (7 Days)||0
8690340|NCT03266172|21453821|P2|STARTED|Part A: Washout (7 Days)||0
8690341|NCT03266172|21453822|P1|STARTED|Part A: Washout (7 Days)||16
8690342|NCT03266172|21453820|P3|NOT COMPLETED|Part A: Period 3 (2 Days)||0
8690343|NCT03266172|21453821|P2|NOT COMPLETED|Part A: Period 3 (2 Days)||0
8690344|NCT03266172|21453822|P1|NOT COMPLETED|Part A: Period 3 (2 Days)||0
8690345|NCT03266172|21453820|P3|COMPLETED|Part A: Period 3 (2 Days)||0
8690346|NCT03266172|21453821|P2|COMPLETED|Part A: Period 3 (2 Days)||0
8690347|NCT03266172|21453822|P1|COMPLETED|Part A: Period 3 (2 Days)||16
8690348|NCT03266172|21453820|P3|STARTED|Part A: Period 3 (2 Days)||0
8690349|NCT03266172|21453821|P2|STARTED|Part A: Period 3 (2 Days)||0
8690350|NCT03266172|21453822|P1|STARTED|Part A: Period 3 (2 Days)|3 replacement participants were enrolled|16
8690351|NCT03266172|21453820|P3|NOT COMPLETED|Part A: Washout (7 Days)||0
8690352|NCT03266172|21453821|P2|NOT COMPLETED|Part A: Washout (7 Days)||0
8690353|NCT03266172|21453822|P1|NOT COMPLETED|Part A: Washout (7 Days)||0
8690354|NCT03266172|21453820|P3|COMPLETED|Part A: Washout (7 Days)||0
8690355|NCT03266172|21453821|P2|COMPLETED|Part A: Washout (7 Days)||0
8690356|NCT03266172|21453822|P1|COMPLETED|Part A: Washout (7 Days)||13
8690357|NCT03266172|21453820|P3|STARTED|Part A: Washout (7 Days)||0
8690358|NCT03266172|21453821|P2|STARTED|Part A: Washout (7 Days)||0
8690359|NCT03266172|21453822|P1|STARTED|Part A: Washout (7 Days)||13
8690360|NCT03266172|21453820|P3|NOT COMPLETED|Part A: Period 2 (2 Days)||0
8690361|NCT03266172|21453821|P2|NOT COMPLETED|Part A: Period 2 (2 Days)||0
8690362|NCT03266172|21453822|P1|NOT COMPLETED|Part A: Period 2 (2 Days)||0
8690363|NCT03266172|21453820|P3|COMPLETED|Part A: Period 2 (2 Days)||0
8690364|NCT03266172|21453821|P2|COMPLETED|Part A: Period 2 (2 Days)||0
8690365|NCT03266172|21453822|P1|COMPLETED|Part A: Period 2 (2 Days)||13
8690366|NCT03266172|21453820|P3|STARTED|Part A: Period 2 (2 Days)||0
8690367|NCT03266172|21453821|P2|STARTED|Part A: Period 2 (2 Days)||0
8690368|NCT03266172|21453822|P1|STARTED|Part A: Period 2 (2 Days)||13
8690369|NCT03266172|21453820|P3|NOT COMPLETED|Part A: Washout Period (7 Days)||0
8690370|NCT03266172|21453821|P2|NOT COMPLETED|Part A: Washout Period (7 Days)||0
8690371|NCT03266172|21453822|P1|NOT COMPLETED|Part A: Washout Period (7 Days)||2
8690372|NCT03266172|21453820|P3|COMPLETED|Part A: Washout Period (7 Days)||0
8690373|NCT03266172|21453821|P2|COMPLETED|Part A: Washout Period (7 Days)||0
8690374|NCT03266172|21453822|P1|COMPLETED|Part A: Washout Period (7 Days)||13
8690375|NCT03266172|21453820|P3|STARTED|Part A: Washout Period (7 Days)||0
8690376|NCT03266172|21453821|P2|STARTED|Part A: Washout Period (7 Days)||0
8690377|NCT03266172|21453822|P1|STARTED|Part A: Washout Period (7 Days)||15
8690378|NCT03266172|21453820|P3|NOT COMPLETED|Part A: Period 1(2 Days)||0
8690379|NCT03266172|21453821|P2|NOT COMPLETED|Part A: Period 1(2 Days)||0
8690380|NCT03266172|21453822|P1|NOT COMPLETED|Part A: Period 1(2 Days)||1
8690381|NCT03266172|21453820|P3|COMPLETED|Part A: Period 1(2 Days)||0
8690382|NCT03266172|21453821|P2|COMPLETED|Part A: Period 1(2 Days)||0
8690383|NCT03266172|21453822|P1|COMPLETED|Part A: Period 1(2 Days)||15
8690384|NCT03266172|21453820|P3|STARTED|Part A: Period 1(2 Days)||0
8690385|NCT03266172|21453821|P2|STARTED|Part A: Period 1(2 Days)||0
8690386|NCT03266172|21453822|P1|STARTED|Part A: Period 1(2 Days)||16
8690387|NCT03209050|21454067|P1|NOT COMPLETED|Overall Study||3
8690388|NCT03209050|21454067|P1|COMPLETED|Overall Study||27
8690389|NCT03209050|21454067|P1|STARTED|Overall Study||30
8690390|NCT02908490|21454074|P2|NOT COMPLETED|Overall Study||2
8690391|NCT02908490|21454075|P1|NOT COMPLETED|Overall Study||2
8690392|NCT02908490|21454074|P2|COMPLETED|Overall Study||11
8690393|NCT02908490|21454075|P1|COMPLETED|Overall Study||10
8690394|NCT02908490|21454074|P2|STARTED|Overall Study||13
8690395|NCT02908490|21454075|P1|STARTED|Overall Study||12
8690396|NCT02614261|21454112|P3|NOT COMPLETED|Overall Study||11
8690397|NCT02614261|21454113|P2|NOT COMPLETED|Overall Study||15
8690398|NCT02614261|21454114|P1|NOT COMPLETED|Overall Study||49
8690399|NCT02614261|21454112|P3|COMPLETED|Overall Study||266
8690400|NCT02614261|21454113|P2|COMPLETED|Overall Study||263
8690401|NCT02614261|21454114|P1|COMPLETED|Overall Study||509
8690402|NCT02614261|21454112|P3|Received at Least One Dose of Study Drug|Overall Study||277
8690403|NCT02614261|21454113|P2|Received at Least One Dose of Study Drug|Overall Study||278
8690404|NCT02614261|21454114|P1|Received at Least One Dose of Study Drug|Overall Study||558
8690405|NCT02614261|21454112|P3|STARTED|Overall Study||277
8690406|NCT02614261|21454113|P2|STARTED|Overall Study||278
8690407|NCT02614261|21454114|P1|STARTED|Overall Study||558
8690408|NCT02578732|21454151|P1|NOT COMPLETED|Overall Study||0
8690409|NCT02578732|21454151|P1|COMPLETED|Overall Study||28
8690410|NCT02578732|21454151|P1|STARTED|Overall Study||28
8690411|NCT02528500|21454155|P1|NOT COMPLETED|Overall Study||0
8690412|NCT02528500|21454155|P1|COMPLETED|Overall Study||10
8690413|NCT02528500|21454155|P1|STARTED|Overall Study||10
8690426|NCT02489045|21454192|P1|NOT COMPLETED|Follow-up||10
8690427|NCT02489045|21454192|P1|COMPLETED|Follow-up||11
8690428|NCT02489045|21454192|P1|STARTED|Follow-up|"Only subjects with portal hypertension in overall study were eligible to progress to follow-up"|21
8690429|NCT02489045|21454192|P1|NOT COMPLETED|Overall Study||53
8690430|NCT02489045|21454192|P1|COMPLETED|Overall Study||125
8690431|NCT02489045|21454192|P1|STARTED|Overall Study||178
8690432|NCT02452762|21454200|P2|NOT COMPLETED|Overall Study||3
8690433|NCT02452762|21454201|P1|NOT COMPLETED|Overall Study||5
8690434|NCT02452762|21454200|P2|COMPLETED|Overall Study||19
8690435|NCT02452762|21454201|P1|COMPLETED|Overall Study||40
8690436|NCT02452762|21454200|P2|STARTED|Overall Study||22
8690437|NCT02452762|21454201|P1|STARTED|Overall Study||45
8690438|NCT02452476|21454218|P2|NOT COMPLETED|Overall Study||10
8690439|NCT02452476|21454219|P1|NOT COMPLETED|Overall Study||11
8690440|NCT02452476|21454218|P2|COMPLETED|Overall Study||49
8690441|NCT02452476|21454219|P1|COMPLETED|Overall Study||53
8690442|NCT02452476|21454218|P2|STARTED|Overall Study||59
8690443|NCT02452476|21454219|P1|STARTED|Overall Study||64
8690444|NCT02450539|21454241|P2|NOT COMPLETED|Overall Study||7
8690445|NCT02450539|21454242|P1|NOT COMPLETED|Overall Study||16
8690446|NCT02450539|21454241|P2|COMPLETED|Overall Study||46
8690447|NCT02450539|21454242|P1|COMPLETED|Overall Study||90
8690448|NCT02450539|21454241|P2|Received at Least One Dose of Study Drug|Overall Study||52
8690449|NCT02450539|21454242|P1|Received at Least One Dose of Study Drug|Overall Study||106
8690450|NCT02450539|21454241|P2|STARTED|Overall Study||53
8690451|NCT02450539|21454242|P1|STARTED|Overall Study||106
8690452|NCT02422615|21454266|P2|NOT COMPLETED|Overall Study||166
8690453|NCT02422615|21454267|P1|NOT COMPLETED|Overall Study||280
8690454|NCT02422615|21454266|P2|COMPLETED|Overall Study||76
8690455|NCT02422615|21454267|P1|COMPLETED|Overall Study||204
8690456|NCT02422615|21454266|P2|Untreated|Overall Study||1
8690457|NCT02422615|21454267|P1|Untreated|Overall Study||1
8690458|NCT02422615|21454266|P2|STARTED|Overall Study||242
8690459|NCT02422615|21454267|P1|STARTED|Overall Study||484
8690460|NCT02368886|21454277|P4|NOT COMPLETED|Overall Study||4
8690461|NCT02368886|21454278|P3|NOT COMPLETED|Overall Study||1
8690462|NCT02368886|21454279|P2|NOT COMPLETED|Overall Study||1
8690463|NCT02368886|21454280|P1|NOT COMPLETED|Overall Study||1
8690464|NCT02368886|21454277|P4|COMPLETED|Overall Study||29
8690465|NCT02368886|21454278|P3|COMPLETED|Overall Study||33
8690466|NCT02368886|21454279|P2|COMPLETED|Overall Study||26
8690467|NCT02368886|21454280|P1|COMPLETED|Overall Study||28
8690468|NCT02368886|21454277|P4|STARTED|Overall Study||33
8690469|NCT02368886|21454278|P3|STARTED|Overall Study||34
8690470|NCT02368886|21454279|P2|STARTED|Overall Study||27
8690471|NCT02368886|21454280|P1|STARTED|Overall Study||29
8690472|NCT02291302|21454302|P4|NOT COMPLETED|Overall Study||0
8690473|NCT02291302|21454303|P3|NOT COMPLETED|Overall Study||0
8690474|NCT02291302|21454304|P2|NOT COMPLETED|Overall Study||0
8690475|NCT02291302|21454305|P1|NOT COMPLETED|Overall Study||0
8690476|NCT02291302|21454302|P4|COMPLETED|Overall Study||59
8690477|NCT02291302|21454303|P3|COMPLETED|Overall Study||59
8690478|NCT02291302|21454304|P2|COMPLETED|Overall Study||59
8690479|NCT02291302|21454305|P1|COMPLETED|Overall Study||59
8690480|NCT02291302|21454302|P4|STARTED|Overall Study||59
8690481|NCT02291302|21454303|P3|STARTED|Overall Study||59
8690482|NCT02291302|21454304|P2|STARTED|Overall Study||59
8690483|NCT02291302|21454305|P1|STARTED|Overall Study||59
8690484|NCT02136069|21454329|P2|NOT COMPLETED|Overall Study||28
8690485|NCT02136069|21454330|P1|NOT COMPLETED|Overall Study||34
8690486|NCT02136069|21454329|P2|COMPLETED|Overall Study||170
8690487|NCT02136069|21454330|P1|COMPLETED|Overall Study||165
8690488|NCT02136069|21454329|P2|STARTED|Overall Study||198
8690489|NCT02136069|21454330|P1|STARTED|Overall Study||199
8690490|NCT02108964|21454384|P8|NOT COMPLETED|Overall Study||12
8690491|NCT02108964|21454385|P7|NOT COMPLETED|Overall Study||11
8690492|NCT02108964|21454386|P6|NOT COMPLETED|Overall Study||5
8690493|NCT02108964|21454387|P5|NOT COMPLETED|Overall Study||25
8690494|NCT02108964|21454388|P4|NOT COMPLETED|Overall Study||6
8690495|NCT02108964|21454389|P3|NOT COMPLETED|Overall Study||65
8690496|NCT02108964|21454390|P2|NOT COMPLETED|Overall Study||32
8690497|NCT02108964|21454391|P1|NOT COMPLETED|Overall Study||14
8690498|NCT02108964|21454384|P8|COMPLETED|Overall Study||33
8690499|NCT02108964|21454385|P7|COMPLETED|Overall Study||0
8690500|NCT02108964|21454386|P6|COMPLETED|Overall Study||0
8690501|NCT02108964|21454387|P5|COMPLETED|Overall Study||3
8690502|NCT02108964|21454388|P4|COMPLETED|Overall Study||2
8690503|NCT02108964|21454389|P3|COMPLETED|Overall Study||8
8690504|NCT02108964|21454390|P2|COMPLETED|Overall Study||6
8690505|NCT02108964|21454391|P1|COMPLETED|Overall Study||3
8690506|NCT02108964|21454384|P8|STARTED|Overall Study||45
8690507|NCT02108964|21454385|P7|STARTED|Overall Study||11
8690508|NCT02108964|21454386|P6|STARTED|Overall Study||5
8690509|NCT02108964|21454387|P5|STARTED|Overall Study||28
8690510|NCT02108964|21454388|P4|STARTED|Overall Study||8
8690511|NCT02108964|21454389|P3|STARTED|Overall Study||73
8690512|NCT02108964|21454390|P2|STARTED|Overall Study||38
8690513|NCT02108964|21454391|P1|STARTED|Overall Study||17
8690514|NCT02106065|21454413|P3|NOT COMPLETED|Overall Study||10
8690515|NCT02106065|21454414|P2|NOT COMPLETED|Overall Study||3
8690516|NCT02106065|21454415|P1|NOT COMPLETED|Overall Study||3
8690517|NCT02106065|21454413|P3|COMPLETED|Overall Study||5
8690518|NCT02106065|21454414|P2|COMPLETED|Overall Study||8
8690519|NCT02106065|21454415|P1|COMPLETED|Overall Study||3
8690520|NCT02106065|21454413|P3|6 Month Completion|Overall Study||5
8690521|NCT02106065|21454414|P2|6 Month Completion|Overall Study||8
8690522|NCT02106065|21454415|P1|6 Month Completion|Overall Study||3
8690523|NCT02106065|21454413|P3|STARTED|Overall Study||15
8690524|NCT02106065|21454414|P2|STARTED|Overall Study||11
8690525|NCT02106065|21454415|P1|STARTED|Overall Study||6
8690526|NCT02100696|21454438|P6|NOT COMPLETED|Maintenance Phase||5
8690527|NCT02100696|21454439|P5|NOT COMPLETED|Maintenance Phase||9
8690528|NCT02100696|21454440|P4|NOT COMPLETED|Maintenance Phase||1
8690529|NCT02100696|21454441|P3|NOT COMPLETED|Maintenance Phase||0
8690530|NCT02100696|21454442|P2|NOT COMPLETED|Maintenance Phase||0
8690531|NCT02100696|21454443|P1|NOT COMPLETED|Maintenance Phase||0
8690532|NCT02100696|21454438|P6|COMPLETED|Maintenance Phase||112
8690533|NCT02100696|21454439|P5|COMPLETED|Maintenance Phase||106
8690534|NCT02100696|21454440|P4|COMPLETED|Maintenance Phase||26
8690535|NCT02100696|21454441|P3|COMPLETED|Maintenance Phase||0
8690536|NCT02100696|21454442|P2|COMPLETED|Maintenance Phase||0
8690537|NCT02100696|21454443|P1|COMPLETED|Maintenance Phase||0
8690538|NCT02100696|21454438|P6|STARTED|Maintenance Phase||117
8690539|NCT02100696|21454439|P5|STARTED|Maintenance Phase||115
8690540|NCT02100696|21454440|P4|STARTED|Maintenance Phase||27
8690541|NCT02100696|21454441|P3|STARTED|Maintenance Phase||0
8690542|NCT02100696|21454442|P2|STARTED|Maintenance Phase||0
8690543|NCT02100696|21454443|P1|STARTED|Maintenance Phase||0
8690544|NCT02100696|21454438|P6|NOT COMPLETED|Induction Phase||0
8690545|NCT02100696|21454439|P5|NOT COMPLETED|Induction Phase||0
8690546|NCT02100696|21454440|P4|NOT COMPLETED|Induction Phase||0
8690547|NCT02100696|21454441|P3|NOT COMPLETED|Induction Phase||26
8690548|NCT02100696|21454442|P2|NOT COMPLETED|Induction Phase||5
8690549|NCT02100696|21454443|P1|NOT COMPLETED|Induction Phase||15
8690550|NCT02100696|21454438|P6|COMPLETED|Induction Phase||0
8690551|NCT02100696|21454439|P5|COMPLETED|Induction Phase||0
8690552|NCT02100696|21454440|P4|COMPLETED|Induction Phase||0
8690553|NCT02100696|21454441|P3|COMPLETED|Induction Phase||358
8690554|NCT02100696|21454442|P2|COMPLETED|Induction Phase||90
8690555|NCT02100696|21454443|P1|COMPLETED|Induction Phase||115
8690556|NCT02100696|21454438|P6|STARTED|Induction Phase||0
8690557|NCT02100696|21454439|P5|STARTED|Induction Phase||0
8690558|NCT02100696|21454440|P4|STARTED|Induction Phase||0
8690559|NCT02100696|21454441|P3|STARTED|Induction Phase||384
8690560|NCT02100696|21454442|P2|STARTED|Induction Phase||95
8690561|NCT02100696|21454443|P1|STARTED|Induction Phase||130
8690562|NCT02087306|21454549|P3|NOT COMPLETED|Overall Study||27
8690563|NCT02087306|21454550|P2|NOT COMPLETED|Overall Study||64
8690564|NCT02087306|21454551|P1|NOT COMPLETED|Overall Study||36
8690565|NCT02087306|21454549|P3|COMPLETED|Overall Study||16
8690566|NCT02087306|21454550|P2|COMPLETED|Overall Study||29
8690567|NCT02087306|21454551|P1|COMPLETED|Overall Study||29
8690568|NCT02087306|21454549|P3|STARTED|Overall Study||43
8690569|NCT02087306|21454550|P2|STARTED|Overall Study||93
8690570|NCT02087306|21454551|P1|STARTED|Overall Study||65
8690571|NCT02080221|21454564|P1|NOT COMPLETED|Overall Study||2
8690572|NCT02080221|21454564|P1|COMPLETED|Overall Study||48
8690573|NCT02080221|21454564|P1|STARTED|Overall Study||50
8690574|NCT02005471|21454571|P2|NOT COMPLETED|Overall Study||194
8690575|NCT02005471|21454572|P1|NOT COMPLETED|Overall Study||195
8690576|NCT02005471|21454571|P2|COMPLETED|Overall Study||0
8690577|NCT02005471|21454572|P1|COMPLETED|Overall Study||0
8690578|NCT02005471|21454571|P2|Treated|Overall Study||194
8690579|NCT02005471|21454572|P1|Treated|Overall Study||188
8690580|NCT02005471|21454571|P2|STARTED|Overall Study||194
8690581|NCT02005471|21454572|P1|STARTED|Overall Study||195
8690612|NCT01783938|21454657|P2|NOT COMPLETED|Overall Study||61
8690613|NCT01783938|21454658|P1|NOT COMPLETED|Overall Study||57
8690614|NCT01783938|21454657|P2|COMPLETED|Overall Study||9
8690615|NCT01783938|21454658|P1|COMPLETED|Overall Study||11
8690616|NCT01783938|21454657|P2|STARTED|Overall Study||70
8690617|NCT01783938|21454658|P1|STARTED|Overall Study||68
8690630|NCT01708941|21454744|P4|NOT COMPLETED|Overall Study||18
8690631|NCT01708941|21454745|P3|NOT COMPLETED|Overall Study||19
8690632|NCT01708941|21454746|P2|NOT COMPLETED|Overall Study||18
8690633|NCT01708941|21454747|P1|NOT COMPLETED|Overall Study||18
8690634|NCT01708941|21454744|P4|COMPLETED|Overall Study||4
8690635|NCT01708941|21454745|P3|COMPLETED|Overall Study||3
8690636|NCT01708941|21454746|P2|COMPLETED|Overall Study||5
8690637|NCT01708941|21454747|P1|COMPLETED|Overall Study||3
8690638|NCT01708941|21454744|P4|Eligible and Started Treatment|Overall Study||22
8690639|NCT01708941|21454745|P3|Eligible and Started Treatment|Overall Study||19
8690640|NCT01708941|21454746|P2|Eligible and Started Treatment|Overall Study||22
8690641|NCT01708941|21454747|P1|Eligible and Started Treatment|Overall Study||18
8690642|NCT01708941|21454744|P4|STARTED|Overall Study||22
8690643|NCT01708941|21454745|P3|STARTED|Overall Study||22
8690644|NCT01708941|21454746|P2|STARTED|Overall Study||23
8690645|NCT01708941|21454747|P1|STARTED|Overall Study||21
8690649|NCT01547000|21454773|P2|NOT COMPLETED|Overall Study||0
8690650|NCT01547000|21454774|P1|NOT COMPLETED|Overall Study||0
8690651|NCT01547000|21454773|P2|COMPLETED|Overall Study||16
8690652|NCT01547000|21454774|P1|COMPLETED|Overall Study||18
8690653|NCT01547000|21454773|P2|STARTED|Overall Study||16
8690654|NCT01547000|21454774|P1|STARTED|Overall Study||18
8690655|NCT01494922|21454780|P1|NOT COMPLETED|Overall Study||1
8690656|NCT01494922|21454780|P1|COMPLETED|Overall Study||13
8690657|NCT01494922|21454780|P1|STARTED|Overall Study||14
8690658|NCT01386385|21454798|P8|NOT COMPLETED|Phase II: Consolidation Therapy||2
8690659|NCT01386385|21454799|P7|NOT COMPLETED|Phase II: Consolidation Therapy||5
8690660|NCT01386385|21454800|P6|NOT COMPLETED|Phase II: Consolidation Therapy||0
8690661|NCT01386385|21454801|P5|NOT COMPLETED|Phase II: Consolidation Therapy||0
8690662|NCT01386385|21454802|P4|NOT COMPLETED|Phase II: Consolidation Therapy||0
8690663|NCT01386385|21454803|P3|NOT COMPLETED|Phase II: Consolidation Therapy||0
8690664|NCT01386385|21454804|P2|NOT COMPLETED|Phase II: Consolidation Therapy||0
8690665|NCT01386385|21454805|P1|NOT COMPLETED|Phase II: Consolidation Therapy||0
8690666|NCT01386385|21454798|P8|COMPLETED|Phase II: Consolidation Therapy||8
8690667|NCT01386385|21454799|P7|COMPLETED|Phase II: Consolidation Therapy||8
8690668|NCT01386385|21454800|P6|COMPLETED|Phase II: Consolidation Therapy||0
8690669|NCT01386385|21454801|P5|COMPLETED|Phase II: Consolidation Therapy||0
8690670|NCT01386385|21454802|P4|COMPLETED|Phase II: Consolidation Therapy||0
8690671|NCT01386385|21454803|P3|COMPLETED|Phase II: Consolidation Therapy||0
8690672|NCT01386385|21454804|P2|COMPLETED|Phase II: Consolidation Therapy||0
8690673|NCT01386385|21454805|P1|COMPLETED|Phase II: Consolidation Therapy||0
8690674|NCT01386385|21454798|P8|STARTED|Phase II: Consolidation Therapy||10
8690675|NCT01386385|21454799|P7|STARTED|Phase II: Consolidation Therapy||13
8690676|NCT01386385|21454800|P6|STARTED|Phase II: Consolidation Therapy||0
8690677|NCT01386385|21454801|P5|STARTED|Phase II: Consolidation Therapy||0
8690678|NCT01386385|21454802|P4|STARTED|Phase II: Consolidation Therapy||0
8690679|NCT01386385|21454803|P3|STARTED|Phase II: Consolidation Therapy||0
8690680|NCT01386385|21454804|P2|STARTED|Phase II: Consolidation Therapy||0
8690681|NCT01386385|21454805|P1|STARTED|Phase II: Consolidation Therapy||0
8690682|NCT01386385|21454798|P8|NOT COMPLETED|Phase II Concurrent CRT||3
8690683|NCT01386385|21454799|P7|NOT COMPLETED|Phase II Concurrent CRT||6
8690684|NCT01386385|21454800|P6|NOT COMPLETED|Phase II Concurrent CRT||0
8690685|NCT01386385|21454801|P5|NOT COMPLETED|Phase II Concurrent CRT||0
8690686|NCT01386385|21454802|P4|NOT COMPLETED|Phase II Concurrent CRT||0
8690687|NCT01386385|21454803|P3|NOT COMPLETED|Phase II Concurrent CRT||0
8690688|NCT01386385|21454804|P2|NOT COMPLETED|Phase II Concurrent CRT||0
8690689|NCT01386385|21454805|P1|NOT COMPLETED|Phase II Concurrent CRT||0
8690690|NCT01386385|21454798|P8|COMPLETED|Phase II Concurrent CRT||10
8690691|NCT01386385|21454799|P7|COMPLETED|Phase II Concurrent CRT||12
8690692|NCT01386385|21454800|P6|COMPLETED|Phase II Concurrent CRT||0
8690693|NCT01386385|21454801|P5|COMPLETED|Phase II Concurrent CRT||0
8690694|NCT01386385|21454802|P4|COMPLETED|Phase II Concurrent CRT||0
8690695|NCT01386385|21454803|P3|COMPLETED|Phase II Concurrent CRT||0
8690696|NCT01386385|21454804|P2|COMPLETED|Phase II Concurrent CRT||0
8690697|NCT01386385|21454805|P1|COMPLETED|Phase II Concurrent CRT||0
8690698|NCT01386385|21454798|P8|STARTED|Phase II Concurrent CRT||13
8690699|NCT01386385|21454799|P7|STARTED|Phase II Concurrent CRT||18
8690700|NCT01386385|21454800|P6|STARTED|Phase II Concurrent CRT||0
8690701|NCT01386385|21454801|P5|STARTED|Phase II Concurrent CRT||0
8690702|NCT01386385|21454802|P4|STARTED|Phase II Concurrent CRT||0
8690703|NCT01386385|21454803|P3|STARTED|Phase II Concurrent CRT||0
8690704|NCT01386385|21454804|P2|STARTED|Phase II Concurrent CRT||0
8690705|NCT01386385|21454805|P1|STARTED|Phase II Concurrent CRT||0
8690706|NCT01386385|21454798|P8|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690707|NCT01386385|21454799|P7|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690708|NCT01386385|21454800|P6|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690709|NCT01386385|21454801|P5|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690710|NCT01386385|21454802|P4|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690711|NCT01386385|21454803|P3|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690712|NCT01386385|21454804|P2|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690713|NCT01386385|21454805|P1|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690714|NCT01386385|21454798|P8|COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690715|NCT01386385|21454799|P7|COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690716|NCT01386385|21454800|P6|COMPLETED|Phase I 120mg: Consolidation Therapy||5
8690717|NCT01386385|21454801|P5|COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690718|NCT01386385|21454802|P4|COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690719|NCT01386385|21454803|P3|COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690720|NCT01386385|21454804|P2|COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690721|NCT01386385|21454805|P1|COMPLETED|Phase I 120mg: Consolidation Therapy||0
8690722|NCT01386385|21454798|P8|STARTED|Phase I 120mg: Consolidation Therapy||0
8690723|NCT01386385|21454799|P7|STARTED|Phase I 120mg: Consolidation Therapy||0
8690724|NCT01386385|21454800|P6|STARTED|Phase I 120mg: Consolidation Therapy||5
8690725|NCT01386385|21454801|P5|STARTED|Phase I 120mg: Consolidation Therapy||0
8690726|NCT01386385|21454802|P4|STARTED|Phase I 120mg: Consolidation Therapy||0
8690727|NCT01386385|21454803|P3|STARTED|Phase I 120mg: Consolidation Therapy||0
8690728|NCT01386385|21454804|P2|STARTED|Phase I 120mg: Consolidation Therapy||0
8690729|NCT01386385|21454805|P1|STARTED|Phase I 120mg: Consolidation Therapy||0
8690730|NCT01386385|21454798|P8|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
8690731|NCT01386385|21454799|P7|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
8690732|NCT01386385|21454800|P6|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
8690733|NCT01386385|21454801|P5|NOT COMPLETED|Phase I 120mg: Concurrent CRT||1
8690734|NCT01386385|21454802|P4|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
8690735|NCT01386385|21454803|P3|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
8690736|NCT01386385|21454804|P2|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
8690737|NCT01386385|21454805|P1|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
8690738|NCT01386385|21454798|P8|COMPLETED|Phase I 120mg: Concurrent CRT||0
8690739|NCT01386385|21454799|P7|COMPLETED|Phase I 120mg: Concurrent CRT||0
8690740|NCT01386385|21454800|P6|COMPLETED|Phase I 120mg: Concurrent CRT||0
8690741|NCT01386385|21454801|P5|COMPLETED|Phase I 120mg: Concurrent CRT||5
8690742|NCT01386385|21454802|P4|COMPLETED|Phase I 120mg: Concurrent CRT||0
8690743|NCT01386385|21454803|P3|COMPLETED|Phase I 120mg: Concurrent CRT||0
8690744|NCT01386385|21454804|P2|COMPLETED|Phase I 120mg: Concurrent CRT||0
8690745|NCT01386385|21454805|P1|COMPLETED|Phase I 120mg: Concurrent CRT||0
8690746|NCT01386385|21454798|P8|STARTED|Phase I 120mg: Concurrent CRT||0
8690747|NCT01386385|21454799|P7|STARTED|Phase I 120mg: Concurrent CRT||0
8690748|NCT01386385|21454800|P6|STARTED|Phase I 120mg: Concurrent CRT||0
8690749|NCT01386385|21454801|P5|STARTED|Phase I 120mg: Concurrent CRT||6
8690750|NCT01386385|21454802|P4|STARTED|Phase I 120mg: Concurrent CRT||0
8690751|NCT01386385|21454803|P3|STARTED|Phase I 120mg: Concurrent CRT||0
8690752|NCT01386385|21454804|P2|STARTED|Phase I 120mg: Concurrent CRT||0
8690753|NCT01386385|21454805|P1|STARTED|Phase I 120mg: Concurrent CRT||0
8690754|NCT01386385|21454798|P8|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690755|NCT01386385|21454799|P7|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690756|NCT01386385|21454800|P6|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690757|NCT01386385|21454801|P5|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690758|NCT01386385|21454802|P4|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690759|NCT01386385|21454803|P3|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690760|NCT01386385|21454804|P2|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690761|NCT01386385|21454805|P1|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690762|NCT01386385|21454798|P8|COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690763|NCT01386385|21454799|P7|COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690764|NCT01386385|21454800|P6|COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690765|NCT01386385|21454801|P5|COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690766|NCT01386385|21454802|P4|COMPLETED|Phase I 80mg: Consolidation Therapy||5
8690767|NCT01386385|21454803|P3|COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690768|NCT01386385|21454804|P2|COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690769|NCT01386385|21454805|P1|COMPLETED|Phase I 80mg: Consolidation Therapy||0
8690770|NCT01386385|21454798|P8|STARTED|Phase I 80mg: Consolidation Therapy||0
8690771|NCT01386385|21454799|P7|STARTED|Phase I 80mg: Consolidation Therapy||0
8690772|NCT01386385|21454800|P6|STARTED|Phase I 80mg: Consolidation Therapy||0
8690773|NCT01386385|21454801|P5|STARTED|Phase I 80mg: Consolidation Therapy||0
8690774|NCT01386385|21454802|P4|STARTED|Phase I 80mg: Consolidation Therapy||5
8690775|NCT01386385|21454803|P3|STARTED|Phase I 80mg: Consolidation Therapy||0
8690776|NCT01386385|21454804|P2|STARTED|Phase I 80mg: Consolidation Therapy||0
8690777|NCT01386385|21454805|P1|STARTED|Phase I 80mg: Consolidation Therapy||0
8690778|NCT01386385|21454798|P8|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
8690779|NCT01386385|21454799|P7|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
8690780|NCT01386385|21454800|P6|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
8690781|NCT01386385|21454801|P5|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
8690782|NCT01386385|21454802|P4|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
8690783|NCT01386385|21454803|P3|NOT COMPLETED|Phase I 80mg: Concurrent CRT||2
8690784|NCT01386385|21454804|P2|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
8690785|NCT01386385|21454805|P1|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
8690786|NCT01386385|21454798|P8|COMPLETED|Phase I 80mg: Concurrent CRT||0
8690787|NCT01386385|21454799|P7|COMPLETED|Phase I 80mg: Concurrent CRT||0
8690788|NCT01386385|21454800|P6|COMPLETED|Phase I 80mg: Concurrent CRT||0
8690789|NCT01386385|21454801|P5|COMPLETED|Phase I 80mg: Concurrent CRT||0
8690790|NCT01386385|21454802|P4|COMPLETED|Phase I 80mg: Concurrent CRT||0
8690791|NCT01386385|21454803|P3|COMPLETED|Phase I 80mg: Concurrent CRT||5
8690792|NCT01386385|21454804|P2|COMPLETED|Phase I 80mg: Concurrent CRT||0
8690793|NCT01386385|21454805|P1|COMPLETED|Phase I 80mg: Concurrent CRT||0
8690794|NCT01386385|21454798|P8|STARTED|Phase I 80mg: Concurrent CRT||0
8690795|NCT01386385|21454799|P7|STARTED|Phase I 80mg: Concurrent CRT||0
8690796|NCT01386385|21454800|P6|STARTED|Phase I 80mg: Concurrent CRT||0
8690797|NCT01386385|21454801|P5|STARTED|Phase I 80mg: Concurrent CRT||0
8690798|NCT01386385|21454802|P4|STARTED|Phase I 80mg: Concurrent CRT||0
8690799|NCT01386385|21454803|P3|STARTED|Phase I 80mg: Concurrent CRT||7
8690800|NCT01386385|21454804|P2|STARTED|Phase I 80mg: Concurrent CRT||0
8690801|NCT01386385|21454805|P1|STARTED|Phase I 80mg: Concurrent CRT||0
8690802|NCT01386385|21454798|P8|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690803|NCT01386385|21454799|P7|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690804|NCT01386385|21454800|P6|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690805|NCT01386385|21454801|P5|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690806|NCT01386385|21454802|P4|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690807|NCT01386385|21454803|P3|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690808|NCT01386385|21454804|P2|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690809|NCT01386385|21454805|P1|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690810|NCT01386385|21454798|P8|COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690811|NCT01386385|21454799|P7|COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690812|NCT01386385|21454800|P6|COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690813|NCT01386385|21454801|P5|COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690814|NCT01386385|21454802|P4|COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690815|NCT01386385|21454803|P3|COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690816|NCT01386385|21454804|P2|COMPLETED|Phase I 40mg: Consolidation Therapy||4
8690817|NCT01386385|21454805|P1|COMPLETED|Phase I 40mg: Consolidation Therapy||0
8690818|NCT01386385|21454798|P8|STARTED|Phase I 40mg: Consolidation Therapy||0
8690819|NCT01386385|21454799|P7|STARTED|Phase I 40mg: Consolidation Therapy||0
8690820|NCT01386385|21454800|P6|STARTED|Phase I 40mg: Consolidation Therapy||0
8690821|NCT01386385|21454801|P5|STARTED|Phase I 40mg: Consolidation Therapy||0
8690822|NCT01386385|21454802|P4|STARTED|Phase I 40mg: Consolidation Therapy||0
8690823|NCT01386385|21454803|P3|STARTED|Phase I 40mg: Consolidation Therapy||0
8690824|NCT01386385|21454804|P2|STARTED|Phase I 40mg: Consolidation Therapy||4
8690825|NCT01386385|21454805|P1|STARTED|Phase I 40mg: Consolidation Therapy||0
8690826|NCT01386385|21454798|P8|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
8690827|NCT01386385|21454799|P7|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
8690828|NCT01386385|21454800|P6|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
8690829|NCT01386385|21454801|P5|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
8690830|NCT01386385|21454802|P4|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
8690831|NCT01386385|21454803|P3|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
8690832|NCT01386385|21454804|P2|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
8690833|NCT01386385|21454805|P1|NOT COMPLETED|Phase I 40mg: Concurrent CRT||2
8690834|NCT01386385|21454798|P8|COMPLETED|Phase I 40mg: Concurrent CRT||0
8690835|NCT01386385|21454799|P7|COMPLETED|Phase I 40mg: Concurrent CRT||0
8690836|NCT01386385|21454800|P6|COMPLETED|Phase I 40mg: Concurrent CRT||0
8690837|NCT01386385|21454801|P5|COMPLETED|Phase I 40mg: Concurrent CRT||0
8690838|NCT01386385|21454802|P4|COMPLETED|Phase I 40mg: Concurrent CRT||0
8690839|NCT01386385|21454803|P3|COMPLETED|Phase I 40mg: Concurrent CRT||0
8690840|NCT01386385|21454804|P2|COMPLETED|Phase I 40mg: Concurrent CRT||0
8690841|NCT01386385|21454805|P1|COMPLETED|Phase I 40mg: Concurrent CRT||6
8690842|NCT01386385|21454798|P8|STARTED|Phase I 40mg: Concurrent CRT||0
8690843|NCT01386385|21454799|P7|STARTED|Phase I 40mg: Concurrent CRT||0
8690844|NCT01386385|21454800|P6|STARTED|Phase I 40mg: Concurrent CRT||0
8690845|NCT01386385|21454801|P5|STARTED|Phase I 40mg: Concurrent CRT||0
8690846|NCT01386385|21454802|P4|STARTED|Phase I 40mg: Concurrent CRT||0
8690847|NCT01386385|21454803|P3|STARTED|Phase I 40mg: Concurrent CRT||0
8690848|NCT01386385|21454804|P2|STARTED|Phase I 40mg: Concurrent CRT||0
8690849|NCT01386385|21454805|P1|STARTED|Phase I 40mg: Concurrent CRT||8
8690850|NCT01381718|21454832|P2|NOT COMPLETED|Overall Study||13
8690851|NCT01381718|21454833|P1|NOT COMPLETED|Overall Study||5
8690852|NCT01381718|21454832|P2|COMPLETED|Overall Study||43
8690853|NCT01381718|21454833|P1|COMPLETED|Overall Study||51
8690854|NCT01381718|21454832|P2|STARTED|Overall Study||56
8690855|NCT01381718|21454833|P1|STARTED|Overall Study||56
8690856|NCT01147107|21454847|P2|NOT COMPLETED|Overall Study||1
8690857|NCT01147107|21454848|P1|NOT COMPLETED|Overall Study||6
8690858|NCT01147107|21454847|P2|COMPLETED|Overall Study||40
8690859|NCT01147107|21454848|P1|COMPLETED|Overall Study||33
8690860|NCT01147107|21454847|P2|STARTED|Overall Study||41
8690861|NCT01147107|21454848|P1|STARTED|Overall Study||39
8690862|NCT01064648|21454857|P4|NOT COMPLETED|Phase II||48
8690863|NCT01064648|21454858|P3|NOT COMPLETED|Phase II||49
8690864|NCT01064648|21454859|P2|NOT COMPLETED|Phase II||0
8690865|NCT01064648|21454860|P1|NOT COMPLETED|Phase II||0
8690866|NCT01064648|21454857|P4|COMPLETED|Phase II||0
8690867|NCT01064648|21454858|P3|COMPLETED|Phase II||0
8690868|NCT01064648|21454859|P2|COMPLETED|Phase II||0
8690869|NCT01064648|21454860|P1|COMPLETED|Phase II||0
8690870|NCT01064648|21454857|P4|STARTED|Phase II||48
8690871|NCT01064648|21454858|P3|STARTED|Phase II||49
8690872|NCT01064648|21454859|P2|STARTED|Phase II||0
8690873|NCT01064648|21454860|P1|STARTED|Phase II||0
8690874|NCT01064648|21454857|P4|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
8690875|NCT01064648|21454858|P3|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
8690876|NCT01064648|21454859|P2|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13
8690877|NCT01064648|21454860|P1|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
8690878|NCT01064648|21454857|P4|COMPLETED|Phase I Cohort 2: Dose Level 2||0
8690879|NCT01064648|21454858|P3|COMPLETED|Phase I Cohort 2: Dose Level 2||0
8690880|NCT01064648|21454859|P2|COMPLETED|Phase I Cohort 2: Dose Level 2||0
8690881|NCT01064648|21454860|P1|COMPLETED|Phase I Cohort 2: Dose Level 2||0
8690882|NCT01064648|21454857|P4|STARTED|Phase I Cohort 2: Dose Level 2||0
8690883|NCT01064648|21454858|P3|STARTED|Phase I Cohort 2: Dose Level 2||0
8690884|NCT01064648|21454859|P2|STARTED|Phase I Cohort 2: Dose Level 2||13
8690885|NCT01064648|21454860|P1|STARTED|Phase I Cohort 2: Dose Level 2||0
8690886|NCT01064648|21454857|P4|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
8690887|NCT01064648|21454858|P3|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
8690888|NCT01064648|21454859|P2|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
8690889|NCT01064648|21454860|P1|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7
8690890|NCT01064648|21454857|P4|COMPLETED|Phase I Cohort1: Dose Level 1||0
8690891|NCT01064648|21454858|P3|COMPLETED|Phase I Cohort1: Dose Level 1||0
8690892|NCT01064648|21454859|P2|COMPLETED|Phase I Cohort1: Dose Level 1||0
8690893|NCT01064648|21454860|P1|COMPLETED|Phase I Cohort1: Dose Level 1||0
8690894|NCT01064648|21454857|P4|STARTED|Phase I Cohort1: Dose Level 1||0
8690895|NCT01064648|21454858|P3|STARTED|Phase I Cohort1: Dose Level 1||0
8690896|NCT01064648|21454859|P2|STARTED|Phase I Cohort1: Dose Level 1||0
8690897|NCT01064648|21454860|P1|STARTED|Phase I Cohort1: Dose Level 1||7
8690898|NCT00960752|21454886|P3|NOT COMPLETED|Overall Study||2
8690899|NCT00960752|21454887|P2|NOT COMPLETED|Overall Study||0
8690900|NCT00960752|21454888|P1|NOT COMPLETED|Overall Study||0
8690901|NCT00960752|21454886|P3|COMPLETED|Overall Study||17
8690902|NCT00960752|21454887|P2|COMPLETED|Overall Study||13
8690903|NCT00960752|21454888|P1|COMPLETED|Overall Study||13
8690904|NCT00960752|21454886|P3|STARTED|Overall Study||19
8690905|NCT00960752|21454887|P2|STARTED|Overall Study||13
8690906|NCT00960752|21454888|P1|STARTED|Overall Study||13
8690907|NCT00919503|21454901|P2|NOT COMPLETED|Overall Study||0
8690908|NCT00919503|21454902|P1|NOT COMPLETED|Overall Study||0
8690909|NCT00919503|21454901|P2|COMPLETED|Overall Study||14
8690910|NCT00919503|21454902|P1|COMPLETED|Overall Study||84
8690911|NCT00919503|21454901|P2|STARTED|Overall Study||14
8690912|NCT00919503|21454902|P1|STARTED|Overall Study||84
8690913|NCT00860028|21454928|P2|NOT COMPLETED|Smoking Cessation Phase||2
8690914|NCT00860028|21454929|P1|NOT COMPLETED|Smoking Cessation Phase||0
8690915|NCT00860028|21454928|P2|COMPLETED|Smoking Cessation Phase||12
8690916|NCT00860028|21454929|P1|COMPLETED|Smoking Cessation Phase||13
8690917|NCT00860028|21454928|P2|STARTED|Smoking Cessation Phase||14
8690918|NCT00860028|21454929|P1|STARTED|Smoking Cessation Phase||13
8690919|NCT00860028|21454928|P2|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
8690920|NCT00860028|21454929|P1|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
8690921|NCT00860028|21454928|P2|COMPLETED|Placebo Controlled Pretreatment Period||14
8690922|NCT00860028|21454929|P1|COMPLETED|Placebo Controlled Pretreatment Period||13
8690923|NCT00860028|21454928|P2|STARTED|Placebo Controlled Pretreatment Period||15
8690924|NCT00860028|21454929|P1|STARTED|Placebo Controlled Pretreatment Period||15
8690925|NCT00743574|21454939|P1|NOT COMPLETED|Overall Study||24
8690926|NCT00743574|21454939|P1|COMPLETED|Overall Study||12
8690927|NCT00743574|21454939|P1|Dropped Out After Initiating Trial|Overall Study||3
8690928|NCT00743574|21454939|P1|Further Exclusions|Overall Study||8
8690929|NCT00743574|21454939|P1|Dropped Out Before Eligibility Testing|Overall Study||13
8690930|NCT00743574|21454939|P1|STARTED|Overall Study||36
8690931|NCT00731588|21454950|P2|NOT COMPLETED|Overall Study||42
8690932|NCT00731588|21454951|P1|NOT COMPLETED|Overall Study||0
8690933|NCT00731588|21454950|P2|COMPLETED|Overall Study||53
8690934|NCT00731588|21454951|P1|COMPLETED|Overall Study||9
8690935|NCT00731588|21454950|P2|STARTED|Overall Study||95
8690936|NCT00731588|21454951|P1|STARTED|Overall Study||9
8690937|NCT00602459|21454967|P4|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
8690938|NCT00602459|21454968|P3|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
8690939|NCT00602459|21454969|P2|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
8690940|NCT00602459|21454970|P1|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
8690941|NCT00602459|21454967|P4|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
8690942|NCT00602459|21454968|P3|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
8690943|NCT00602459|21454969|P2|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
8690944|NCT00602459|21454970|P1|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
8690945|NCT00602459|21454967|P4|STARTED|Re-assignment After Del(11q22.3) Testing||31
8690946|NCT00602459|21454968|P3|STARTED|Re-assignment After Del(11q22.3) Testing||137
8690947|NCT00602459|21454969|P2|STARTED|Re-assignment After Del(11q22.3) Testing||109
8690948|NCT00602459|21454970|P1|STARTED|Re-assignment After Del(11q22.3) Testing||123
8690949|NCT00602459|21454967|P4|NOT COMPLETED|Initial Registration/Randomization||0
8690950|NCT00602459|21454968|P3|NOT COMPLETED|Initial Registration/Randomization||3
8690951|NCT00602459|21454969|P2|NOT COMPLETED|Initial Registration/Randomization||10
8690952|NCT00602459|21454970|P1|NOT COMPLETED|Initial Registration/Randomization||5
8690953|NCT00602459|21454967|P4|COMPLETED|Initial Registration/Randomization||0
8690954|NCT00602459|21454968|P3|COMPLETED|Initial Registration/Randomization||137
8690955|NCT00602459|21454969|P2|COMPLETED|Initial Registration/Randomization||130
8690956|NCT00602459|21454970|P1|COMPLETED|Initial Registration/Randomization||133
8690957|NCT00602459|21454967|P4|STARTED|Initial Registration/Randomization||0
8690958|NCT00602459|21454968|P3|STARTED|Initial Registration/Randomization||140
8690959|NCT00602459|21454969|P2|STARTED|Initial Registration/Randomization||140
8690960|NCT00602459|21454970|P1|STARTED|Initial Registration/Randomization||138
8690961|NCT00378508|21454993|P2|NOT COMPLETED|Overall Study||3
8690962|NCT00378508|21454994|P1|NOT COMPLETED|Overall Study||2
8690963|NCT00378508|21454993|P2|COMPLETED|Overall Study||31
8690964|NCT00378508|21454994|P1|COMPLETED|Overall Study||27
8690965|NCT00378508|21454993|P2|Received Intervention/Placebo|Overall Study||31
8690966|NCT00378508|21454994|P1|Received Intervention/Placebo|Overall Study||28
8690967|NCT00378508|21454993|P2|Randomized|Overall Study||34
8690968|NCT00378508|21454994|P1|Randomized|Overall Study||29
8690969|NCT00378508|21454993|P2|STARTED|Overall Study||34
8690970|NCT00378508|21454994|P1|STARTED|Overall Study||29
8690971|NCT00335829|21455010|P1|NOT COMPLETED|Overall Study||3
8690972|NCT00335829|21455010|P1|COMPLETED|Overall Study||23
8690973|NCT00335829|21455010|P1|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
8690974|NCT00335829|21455010|P1|Received Bevacizumab|Overall Study||26
8690975|NCT00335829|21455010|P1|STARTED|Overall Study||26
8690976|NCT00149734|21455024|P2|NOT COMPLETED|Overall Study||0
8690977|NCT00149734|21455025|P1|NOT COMPLETED|Overall Study||0
8690978|NCT00149734|21455024|P2|COMPLETED|Overall Study||4
8690979|NCT00149734|21455025|P1|COMPLETED|Overall Study||4
8690980|NCT00149734|21455024|P2|Started Intervention 2|Overall Study||4
8690981|NCT00149734|21455025|P1|Started Intervention 2|Overall Study||4
8690982|NCT00149734|21455024|P2|STARTED|Overall Study||4
8690983|NCT00149734|21455025|P1|STARTED|Overall Study||4
8690984|NCT00064844|21455035|P2|NOT COMPLETED|Overall Study||19
8690985|NCT00064844|21455036|P1|NOT COMPLETED|Overall Study||8
8690986|NCT00064844|21455035|P2|COMPLETED|Overall Study||32
8690987|NCT00064844|21455036|P1|COMPLETED|Overall Study||37
8690988|NCT00064844|21455035|P2|12 Month Follow-up|Overall Study||32
8690989|NCT00064844|21455036|P1|12 Month Follow-up|Overall Study||37
8690990|NCT00064844|21455035|P2|6 Month Follow-up|Overall Study||40
8690991|NCT00064844|21455036|P1|6 Month Follow-up|Overall Study||39
8690992|NCT00064844|21455035|P2|3 Month Follow-up|Overall Study||47
8690993|NCT00064844|21455036|P1|3 Month Follow-up|Overall Study||40
8690994|NCT00064844|21455035|P2|2 Week Follow-up|Overall Study||51
8690995|NCT00064844|21455036|P1|2 Week Follow-up|Overall Study||45
8690996|NCT00064844|21455035|P2|STARTED|Overall Study||51
8690997|NCT00064844|21455036|P1|STARTED|Overall Study||45
8690998|NCT00003816|21455049|P5|NOT COMPLETED|Overall Study||0
8690999|NCT00003816|21455050|P4|NOT COMPLETED|Overall Study||0
8691000|NCT00003816|21455051|P3|NOT COMPLETED|Overall Study||0
8691001|NCT00003816|21455052|P2|NOT COMPLETED|Overall Study||0
8691002|NCT00003816|21455053|P1|NOT COMPLETED|Overall Study||0
8691003|NCT00003816|21455049|P5|COMPLETED|Overall Study||15
8691004|NCT00003816|21455050|P4|COMPLETED|Overall Study||23
8691005|NCT00003816|21455051|P3|COMPLETED|Overall Study||199
8691006|NCT00003816|21455052|P2|COMPLETED|Overall Study||69
8691007|NCT00003816|21455053|P1|COMPLETED|Overall Study||55
8691008|NCT00003816|21455049|P5|STARTED|Overall Study||15
8691009|NCT00003816|21455050|P4|STARTED|Overall Study||23
8691010|NCT00003816|21455051|P3|STARTED|Overall Study||199
8691011|NCT00003816|21455052|P2|STARTED|Overall Study||69
8691012|NCT00003816|21455053|P1|STARTED|Overall Study||55
8691013|NCT04673214|21455082|P2|NOT COMPLETED|Overall Study||1
8691014|NCT04673214|21455083|P1|NOT COMPLETED|Overall Study||2
8691015|NCT04673214|21455082|P2|COMPLETED|Overall Study||46
8691016|NCT04673214|21455083|P1|COMPLETED|Overall Study||65
8691017|NCT04673214|21455082|P2|Lost to Follow up|Overall Study|This patient was stopped being followed up in the first days of his follow-up by video call. He presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; With the follow-up criteria of the protocol, the patient was informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patient is searched, registering death.|1
8691018|NCT04673214|21455083|P1|Lost to Follow up|Overall Study|These patients were discontinued, given in the first days of their follow-up by video call, they presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; Following the protocol's follow-up criteria, patients were informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patients is searched, registering their death.|2
8691019|NCT04673214|21455082|P2|STARTED|Overall Study||47
8691020|NCT04673214|21455083|P1|STARTED|Overall Study||67
8691021|NCT04362813|21455097|P2|NOT COMPLETED|Overall Study||25
8691022|NCT04362813|21455098|P1|NOT COMPLETED|Overall Study||18
8691023|NCT04362813|21455097|P2|COMPLETED|Overall Study||202
8691024|NCT04362813|21455098|P1|COMPLETED|Overall Study||209
8691025|NCT04362813|21455097|P2|Completed Day 29|Overall Study||206
8691026|NCT04362813|21455098|P1|Completed Day 29|Overall Study||211
8691027|NCT04362813|21455097|P2|Safety Set|Overall Study||223
8691028|NCT04362813|21455098|P1|Safety Set|Overall Study||225
8691029|NCT04362813|21455097|P2|STARTED|Overall Study||227
8691030|NCT04362813|21455098|P1|STARTED|Overall Study||227
8691039|NCT04040933|21455135|P1|NOT COMPLETED|Overall Study||3
8691040|NCT04040933|21455135|P1|COMPLETED|Overall Study||33
8691041|NCT04040933|21455135|P1|Treated|Overall Study||36
8691042|NCT04040933|21455135|P1|STARTED|Overall Study||36
8691043|NCT04026308|21455220|P2|NOT COMPLETED|Overall Study||0
8691044|NCT04026308|21455221|P1|NOT COMPLETED|Overall Study||0
8691045|NCT04026308|21455220|P2|COMPLETED|Overall Study||16
8691046|NCT04026308|21455221|P1|COMPLETED|Overall Study||14
8691047|NCT04026308|21455220|P2|STARTED|Overall Study||16
8691048|NCT04026308|21455221|P1|STARTED|Overall Study||14
8691049|NCT03847233|21455231|P1|NOT COMPLETED|6 Month After Index Procedure||1
8691050|NCT03847233|21455231|P1|COMPLETED|6 Month After Index Procedure||30
8691051|NCT03847233|21455231|P1|STARTED|6 Month After Index Procedure||31
8691052|NCT03847233|21455231|P1|NOT COMPLETED|Index Procedure||0
8691053|NCT03847233|21455231|P1|COMPLETED|Index Procedure||31
8691054|NCT03847233|21455231|P1|STARTED|Index Procedure||31
8691055|NCT03839212|21455247|P1|NOT COMPLETED|Overall Study||4
8691056|NCT03839212|21455247|P1|COMPLETED|Overall Study||14
8691057|NCT03839212|21455247|P1|STARTED|Overall Study||18
8691067|NCT03827564|21455306|P2|NOT COMPLETED|Overall Study||0
8691068|NCT03827564|21455307|P1|NOT COMPLETED|Overall Study||1
8691069|NCT03827564|21455306|P2|COMPLETED|Overall Study||5
8691070|NCT03827564|21455307|P1|COMPLETED|Overall Study||8
8691071|NCT03827564|21455306|P2|STARTED|Overall Study||5
8691072|NCT03827564|21455307|P1|STARTED|Overall Study||9
8691073|NCT03681184|21455315|P2|NOT COMPLETED|Open-Label Extension Period||1
8691074|NCT03681184|21455316|P1|NOT COMPLETED|Open-Label Extension Period||1
8691075|NCT03681184|21455315|P2|COMPLETED|Open-Label Extension Period||0
8691076|NCT03681184|21455316|P1|COMPLETED|Open-Label Extension Period||0
8691077|NCT03681184|21455315|P2|STARTED|Open-Label Extension Period||1
8691078|NCT03681184|21455316|P1|STARTED|Open-Label Extension Period||1
8691079|NCT03681184|21455315|P2|NOT COMPLETED|3-Month Blinded Extension Period||23
8691080|NCT03681184|21455316|P1|NOT COMPLETED|3-Month Blinded Extension Period||12
8691081|NCT03681184|21455315|P2|COMPLETED|3-Month Blinded Extension Period||1
8691082|NCT03681184|21455316|P1|COMPLETED|3-Month Blinded Extension Period||1
8691083|NCT03681184|21455315|P2|STARTED|3-Month Blinded Extension Period|1 participant discontinued study drug and entered safety follow up after the DB period.|24
8691084|NCT03681184|21455316|P1|STARTED|3-Month Blinded Extension Period||13
8691085|NCT03681184|21455315|P2|NOT COMPLETED|6-Month Double-Blind Period||1
8691086|NCT03681184|21455316|P1|NOT COMPLETED|6-Month Double-Blind Period||0
8691087|NCT03681184|21455315|P2|COMPLETED|6-Month Double-Blind Period||25
8691088|NCT03681184|21455316|P1|COMPLETED|6-Month Double-Blind Period||13
8691089|NCT03681184|21455315|P2|STARTED|6-Month Double-Blind Period||26
8691090|NCT03681184|21455316|P1|STARTED|6-Month Double-Blind Period||13
8691091|NCT03637699|21455342|P2|NOT COMPLETED|Overall Study||1
8691092|NCT03637699|21455343|P1|NOT COMPLETED|Overall Study||1
8691093|NCT03637699|21455342|P2|COMPLETED|Overall Study||14
8691094|NCT03637699|21455343|P1|COMPLETED|Overall Study||14
8691095|NCT03637699|21455342|P2|STARTED|Overall Study||15
8691096|NCT03637699|21455343|P1|STARTED|Overall Study||15
8691097|NCT03597789|21455367|P1|NOT COMPLETED|Overall Study||35
8691098|NCT03597789|21455367|P1|COMPLETED|Overall Study||10
8691099|NCT03597789|21455367|P1|STARTED|Overall Study||45
8691112|NCT03475316|21455448|P2|NOT COMPLETED|9 Months||4
8691113|NCT03475316|21455449|P1|NOT COMPLETED|9 Months||3
8691114|NCT03475316|21455448|P2|COMPLETED|9 Months||4
8691115|NCT03475316|21455449|P1|COMPLETED|9 Months||5
8691116|NCT03475316|21455448|P2|STARTED|9 Months||8
8691117|NCT03475316|21455449|P1|STARTED|9 Months||8
8691118|NCT03475316|21455448|P2|NOT COMPLETED|6 Month Intervention||4
8691119|NCT03475316|21455449|P1|NOT COMPLETED|6 Month Intervention||5
8691120|NCT03475316|21455448|P2|COMPLETED|6 Month Intervention||8
8691121|NCT03475316|21455449|P1|COMPLETED|6 Month Intervention||8
8691122|NCT03475316|21455448|P2|STARTED|6 Month Intervention||12
8691123|NCT03475316|21455449|P1|STARTED|6 Month Intervention||13
8691124|NCT03086460|21455467|P1|NOT COMPLETED|Treatment F||0
8691125|NCT03086460|21455467|P1|COMPLETED|Treatment F||41
8691126|NCT03086460|21455467|P1|STARTED|Treatment F||41
8691127|NCT03086460|21455467|P1|NOT COMPLETED|Treatment E||4
8691128|NCT03086460|21455467|P1|COMPLETED|Treatment E||36
8691129|NCT03086460|21455467|P1|STARTED|Treatment E||40
8691130|NCT03086460|21455467|P1|NOT COMPLETED|Treatment D||0
8691131|NCT03086460|21455467|P1|COMPLETED|Treatment D||40
8691132|NCT03086460|21455467|P1|STARTED|Treatment D||40
8691133|NCT03086460|21455467|P1|NOT COMPLETED|Treatment C||2
8691134|NCT03086460|21455467|P1|COMPLETED|Treatment C||35
8691135|NCT03086460|21455467|P1|STARTED|Treatment C||37
8691136|NCT03086460|21455467|P1|NOT COMPLETED|Treatment B||0
8691137|NCT03086460|21455467|P1|COMPLETED|Treatment B||35
8691138|NCT03086460|21455467|P1|STARTED|Treatment B||35
8691139|NCT03086460|21455467|P1|NOT COMPLETED|Treatment A||4
8691140|NCT03086460|21455467|P1|COMPLETED|Treatment A||35
8691141|NCT03086460|21455467|P1|STARTED|Treatment A||39
8691142|NCT03086460|21455467|P1|NOT COMPLETED|Study Participants||9
8691143|NCT03086460|21455467|P1|COMPLETED|Study Participants||58
8691144|NCT03086460|21455467|P1|Treatment F|Study Participants||41
8691145|NCT03086460|21455467|P1|Treatment E|Study Participants||40
8691146|NCT03086460|21455467|P1|Treatment D|Study Participants||40
8691147|NCT03086460|21455467|P1|Treatment C|Study Participants||37
8691148|NCT03086460|21455467|P1|Treatment B|Study Participants||35
8691149|NCT03086460|21455467|P1|Treatment A|Study Participants||39
8691150|NCT03086460|21455467|P1|STARTED|Study Participants||67
8691151|NCT02762565|21455619|P1|NOT COMPLETED|Overall Study||11
8691152|NCT02762565|21455619|P1|COMPLETED|Overall Study||78
8691153|NCT02762565|21455619|P1|STARTED|Overall Study||89
8691166|NCT02561455|21455654|P4|NOT COMPLETED|Overall Study||1
8691167|NCT02561455|21455655|P3|NOT COMPLETED|Overall Study||3
8691168|NCT02561455|21455656|P2|NOT COMPLETED|Overall Study||2
8691169|NCT02561455|21455657|P1|NOT COMPLETED|Overall Study||2
8691170|NCT02561455|21455654|P4|COMPLETED|Overall Study||0
8691171|NCT02561455|21455655|P3|COMPLETED|Overall Study||0
8691172|NCT02561455|21455656|P2|COMPLETED|Overall Study||1
8691173|NCT02561455|21455657|P1|COMPLETED|Overall Study||0
8691174|NCT02561455|21455654|P4|STARTED|Overall Study||1
8691175|NCT02561455|21455655|P3|STARTED|Overall Study||3
8691176|NCT02561455|21455656|P2|STARTED|Overall Study||3
8691177|NCT02561455|21455657|P1|STARTED|Overall Study||2
8691184|NCT02471144|21455690|P11|NOT COMPLETED|Extension Period (Week 52 to Week 236)||4
8691185|NCT02471144|21455691|P10|NOT COMPLETED|Extension Period (Week 52 to Week 236)||7
8691186|NCT02471144|21455692|P9|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8691187|NCT02471144|21455693|P8|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8691188|NCT02471144|21455694|P7|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8691189|NCT02471144|21455695|P6|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8691190|NCT02471144|21455696|P5|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8691191|NCT02471144|21455697|P4|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8691192|NCT02471144|21455698|P3|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8691193|NCT02471144|21455699|P2|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8691194|NCT02471144|21455700|P1|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
8691195|NCT02471144|21455690|P11|COMPLETED|Extension Period (Week 52 to Week 236)||49
8691196|NCT02471144|21455691|P10|COMPLETED|Extension Period (Week 52 to Week 236)||46
8691197|NCT02471144|21455692|P9|COMPLETED|Extension Period (Week 52 to Week 236)||0
8691198|NCT02471144|21455693|P8|COMPLETED|Extension Period (Week 52 to Week 236)||0
8691199|NCT02471144|21455694|P7|COMPLETED|Extension Period (Week 52 to Week 236)||0
8691200|NCT02471144|21455695|P6|COMPLETED|Extension Period (Week 52 to Week 236)||0
8691201|NCT02471144|21455696|P5|COMPLETED|Extension Period (Week 52 to Week 236)||0
8691202|NCT02471144|21455697|P4|COMPLETED|Extension Period (Week 52 to Week 236)||0
8691203|NCT02471144|21455698|P3|COMPLETED|Extension Period (Week 52 to Week 236)||0
8691204|NCT02471144|21455699|P2|COMPLETED|Extension Period (Week 52 to Week 236)||0
8691205|NCT02471144|21455700|P1|COMPLETED|Extension Period (Week 52 to Week 236)||0
8691206|NCT02471144|21455690|P11|STARTED|Extension Period (Week 52 to Week 236)||53
8691207|NCT02471144|21455691|P10|STARTED|Extension Period (Week 52 to Week 236)||53
8691208|NCT02471144|21455692|P9|STARTED|Extension Period (Week 52 to Week 236)||0
8691209|NCT02471144|21455693|P8|STARTED|Extension Period (Week 52 to Week 236)||0
8691210|NCT02471144|21455694|P7|STARTED|Extension Period (Week 52 to Week 236)||0
8691211|NCT02471144|21455695|P6|STARTED|Extension Period (Week 52 to Week 236)||0
8691212|NCT02471144|21455696|P5|STARTED|Extension Period (Week 52 to Week 236)||0
8691213|NCT02471144|21455697|P4|STARTED|Extension Period (Week 52 to Week 236)||0
8691214|NCT02471144|21455698|P3|STARTED|Extension Period (Week 52 to Week 236)||0
8691215|NCT02471144|21455699|P2|STARTED|Extension Period (Week 52 to Week 236)||0
8691216|NCT02471144|21455700|P1|STARTED|Extension Period (Week 52 to Week 236)||0
8691217|NCT02471144|21455690|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8691218|NCT02471144|21455691|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8691219|NCT02471144|21455692|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||6
8691220|NCT02471144|21455693|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||2
8691221|NCT02471144|21455694|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
8691222|NCT02471144|21455695|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
8691223|NCT02471144|21455696|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
8691224|NCT02471144|21455697|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8691225|NCT02471144|21455698|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8691226|NCT02471144|21455699|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8691227|NCT02471144|21455700|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8691228|NCT02471144|21455690|P11|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8691229|NCT02471144|21455691|P10|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8691230|NCT02471144|21455692|P9|COMPLETED|Maintenance Period (Week 12 to Week 52)||34
8691231|NCT02471144|21455693|P8|COMPLETED|Maintenance Period (Week 12 to Week 52)||16
8691232|NCT02471144|21455694|P7|COMPLETED|Maintenance Period (Week 12 to Week 52)||15
8691233|NCT02471144|21455695|P6|COMPLETED|Maintenance Period (Week 12 to Week 52)||37
8691234|NCT02471144|21455696|P5|COMPLETED|Maintenance Period (Week 12 to Week 52)||38
8691235|NCT02471144|21455697|P4|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8691236|NCT02471144|21455698|P3|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8691237|NCT02471144|21455699|P2|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8691238|NCT02471144|21455700|P1|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
8691239|NCT02471144|21455690|P11|STARTED|Maintenance Period (Week 12 to Week 52)||0
8691240|NCT02471144|21455691|P10|STARTED|Maintenance Period (Week 12 to Week 52)||0
8691241|NCT02471144|21455692|P9|STARTED|Maintenance Period (Week 12 to Week 52)||40
8691242|NCT02471144|21455693|P8|STARTED|Maintenance Period (Week 12 to Week 52)||18
8691243|NCT02471144|21455694|P7|STARTED|Maintenance Period (Week 12 to Week 52)||16
8691244|NCT02471144|21455695|P6|STARTED|Maintenance Period (Week 12 to Week 52)||38
8691245|NCT02471144|21455696|P5|STARTED|Maintenance Period (Week 12 to Week 52)||39
8691246|NCT02471144|21455697|P4|STARTED|Maintenance Period (Week 12 to Week 52)||0
8691247|NCT02471144|21455698|P3|STARTED|Maintenance Period (Week 12 to Week 52)||0
8691248|NCT02471144|21455699|P2|STARTED|Maintenance Period (Week 12 to Week 52)||0
8691249|NCT02471144|21455700|P1|STARTED|Maintenance Period (Week 12 to Week 52)||0
8691250|NCT02471144|21455690|P11|NOT COMPLETED|Induction Period (Up to Week 12)||0
8691251|NCT02471144|21455691|P10|NOT COMPLETED|Induction Period (Up to Week 12)||0
8691252|NCT02471144|21455692|P9|NOT COMPLETED|Induction Period (Up to Week 12)||0
8691253|NCT02471144|21455693|P8|NOT COMPLETED|Induction Period (Up to Week 12)||0
8691254|NCT02471144|21455694|P7|NOT COMPLETED|Induction Period (Up to Week 12)||0
8691255|NCT02471144|21455695|P6|NOT COMPLETED|Induction Period (Up to Week 12)||0
8691256|NCT02471144|21455696|P5|NOT COMPLETED|Induction Period (Up to Week 12)||0
8691257|NCT02471144|21455697|P4|NOT COMPLETED|Induction Period (Up to Week 12)||1
8691258|NCT02471144|21455698|P3|NOT COMPLETED|Induction Period (Up to Week 12)||2
8691259|NCT02471144|21455699|P2|NOT COMPLETED|Induction Period (Up to Week 12)||2
8691260|NCT02471144|21455700|P1|NOT COMPLETED|Induction Period (Up to Week 12)||1
8691261|NCT02471144|21455690|P11|COMPLETED|Induction Period (Up to Week 12)||0
8691262|NCT02471144|21455691|P10|COMPLETED|Induction Period (Up to Week 12)||0
8691263|NCT02471144|21455692|P9|COMPLETED|Induction Period (Up to Week 12)||0
8691264|NCT02471144|21455693|P8|COMPLETED|Induction Period (Up to Week 12)||0
8691265|NCT02471144|21455694|P7|COMPLETED|Induction Period (Up to Week 12)||0
8691266|NCT02471144|21455695|P6|COMPLETED|Induction Period (Up to Week 12)||0
8691267|NCT02471144|21455696|P5|COMPLETED|Induction Period (Up to Week 12)||0
8691268|NCT02471144|21455697|P4|COMPLETED|Induction Period (Up to Week 12)||40
8691269|NCT02471144|21455698|P3|COMPLETED|Induction Period (Up to Week 12)||39
8691270|NCT02471144|21455699|P2|COMPLETED|Induction Period (Up to Week 12)||38
8691271|NCT02471144|21455700|P1|COMPLETED|Induction Period (Up to Week 12)||39
8691272|NCT02471144|21455690|P11|STARTED|Induction Period (Up to Week 12)||0
8691273|NCT02471144|21455691|P10|STARTED|Induction Period (Up to Week 12)||0
8691274|NCT02471144|21455692|P9|STARTED|Induction Period (Up to Week 12)||0
8691275|NCT02471144|21455693|P8|STARTED|Induction Period (Up to Week 12)||0
8691276|NCT02471144|21455694|P7|STARTED|Induction Period (Up to Week 12)||0
8691277|NCT02471144|21455695|P6|STARTED|Induction Period (Up to Week 12)||0
8691278|NCT02471144|21455696|P5|STARTED|Induction Period (Up to Week 12)||0
8691279|NCT02471144|21455697|P4|STARTED|Induction Period (Up to Week 12)||41
8691280|NCT02471144|21455698|P3|STARTED|Induction Period (Up to Week 12)||41
8691281|NCT02471144|21455699|P2|STARTED|Induction Period (Up to Week 12)||40
8691282|NCT02471144|21455700|P1|STARTED|Induction Period (Up to Week 12)||40
8691283|NCT02370511|21455780|P3|NOT COMPLETED|Overall Study||1
8691284|NCT02370511|21455781|P2|NOT COMPLETED|Overall Study||11
8691285|NCT02370511|21455782|P1|NOT COMPLETED|Overall Study||12
8691286|NCT02370511|21455780|P3|COMPLETED|Overall Study||29
8691287|NCT02370511|21455781|P2|COMPLETED|Overall Study||19
8691288|NCT02370511|21455782|P1|COMPLETED|Overall Study||19
8691289|NCT02370511|21455780|P3|STARTED|Overall Study||30
8691290|NCT02370511|21455781|P2|STARTED|Overall Study||30
8691291|NCT02370511|21455782|P1|STARTED|Overall Study||31
8691298|NCT02129348|21455818|P2|NOT COMPLETED|Overall Study||10
8691299|NCT02129348|21455819|P1|NOT COMPLETED|Overall Study||9
8691300|NCT02129348|21455818|P2|COMPLETED|Overall Study||29
8691301|NCT02129348|21455819|P1|COMPLETED|Overall Study||29
8691302|NCT02129348|21455818|P2|STARTED|Overall Study||39
8691303|NCT02129348|21455819|P1|STARTED|Overall Study||38
8691304|NCT02092181|21455845|P2|NOT COMPLETED|Overall Study||1
8691305|NCT02092181|21455846|P1|NOT COMPLETED|Overall Study||3
8691306|NCT02092181|21455845|P2|COMPLETED|Overall Study||14
8691307|NCT02092181|21455846|P1|COMPLETED|Overall Study||12
8691308|NCT02092181|21455845|P2|STARTED|Overall Study||15
8691309|NCT02092181|21455846|P1|STARTED|Overall Study||15
8691310|NCT02043678|21455866|P2|NOT COMPLETED|Overall Study||405
8691311|NCT02043678|21455867|P1|NOT COMPLETED|Overall Study||401
8691312|NCT02043678|21455866|P2|COMPLETED|Overall Study||0
8691313|NCT02043678|21455867|P1|COMPLETED|Overall Study||0
8691314|NCT02043678|21455866|P2|Treated|Overall Study||396
8691315|NCT02043678|21455867|P1|Treated|Overall Study||390
8691316|NCT02043678|21455866|P2|STARTED|Overall Study||405
8691317|NCT02043678|21455867|P1|STARTED|Overall Study||401
8691318|NCT01901055|21455901|P2|NOT COMPLETED|Week 36||5
8691319|NCT01901055|21455902|P1|NOT COMPLETED|Week 36||0
8691320|NCT01901055|21455901|P2|COMPLETED|Week 36||15
8691321|NCT01901055|21455902|P1|COMPLETED|Week 36||30
8691322|NCT01901055|21455901|P2|STARTED|Week 36||20
8691323|NCT01901055|21455902|P1|STARTED|Week 36||30
8691324|NCT01901055|21455901|P2|NOT COMPLETED|Week 24||19
8691325|NCT01901055|21455902|P1|NOT COMPLETED|Week 24||14
8691326|NCT01901055|21455901|P2|COMPLETED|Week 24||20
8691327|NCT01901055|21455902|P1|COMPLETED|Week 24||30
8691328|NCT01901055|21455901|P2|STARTED|Week 24||39
8691329|NCT01901055|21455902|P1|STARTED|Week 24||44
8691330|NCT01901055|21455901|P2|NOT COMPLETED|Week 12 Assessment||4
8691331|NCT01901055|21455902|P1|NOT COMPLETED|Week 12 Assessment||1
8691332|NCT01901055|21455901|P2|COMPLETED|Week 12 Assessment||39
8691333|NCT01901055|21455902|P1|COMPLETED|Week 12 Assessment||44
8691334|NCT01901055|21455901|P2|STARTED|Week 12 Assessment||43
8691335|NCT01901055|21455902|P1|STARTED|Week 12 Assessment||45
8691336|NCT01901055|21455901|P2|NOT COMPLETED|Started Protocol to Week 6||4
8691337|NCT01901055|21455902|P1|NOT COMPLETED|Started Protocol to Week 6||3
8691338|NCT01901055|21455901|P2|COMPLETED|Started Protocol to Week 6||43
8691339|NCT01901055|21455902|P1|COMPLETED|Started Protocol to Week 6||45
8691340|NCT01901055|21455901|P2|STARTED|Started Protocol to Week 6||47
8691341|NCT01901055|21455902|P1|STARTED|Started Protocol to Week 6||48
8691342|NCT01901055|21455901|P2|NOT COMPLETED|Randomization But Not Titrated||2
8691343|NCT01901055|21455902|P1|NOT COMPLETED|Randomization But Not Titrated||1
8691344|NCT01901055|21455901|P2|COMPLETED|Randomization But Not Titrated||47
8691345|NCT01901055|21455902|P1|COMPLETED|Randomization But Not Titrated||48
8691346|NCT01901055|21455901|P2|STARTED|Randomization But Not Titrated||49
8691347|NCT01901055|21455902|P1|STARTED|Randomization But Not Titrated||49
8691348|NCT01828073|21455931|P2|NOT COMPLETED|Overall Study||2
8691349|NCT01828073|21455932|P1|NOT COMPLETED|Overall Study||1
8691350|NCT01828073|21455931|P2|COMPLETED|Overall Study||16
8691351|NCT01828073|21455932|P1|COMPLETED|Overall Study||21
8691352|NCT01828073|21455931|P2|STARTED|Overall Study||18
8691353|NCT01828073|21455932|P1|STARTED|Overall Study||22
8691354|NCT01793610|21455955|P3|NOT COMPLETED|Overall Study||1
8691355|NCT01793610|21455956|P2|NOT COMPLETED|Overall Study||0
8691356|NCT01793610|21455957|P1|NOT COMPLETED|Overall Study||1
8691357|NCT01793610|21455955|P3|COMPLETED|Overall Study||12
8691358|NCT01793610|21455956|P2|COMPLETED|Overall Study||9
8691359|NCT01793610|21455957|P1|COMPLETED|Overall Study||5
8691360|NCT01793610|21455955|P3|STARTED|Overall Study||13
8691361|NCT01793610|21455956|P2|STARTED|Overall Study||9
8691362|NCT01793610|21455957|P1|STARTED|Overall Study||6
8691363|NCT01720524|21455985|P2|NOT COMPLETED|Part B||9
8691364|NCT01720524|21455986|P1|NOT COMPLETED|Part B||5
8691365|NCT01720524|21455985|P2|COMPLETED|Part B||17
8691366|NCT01720524|21455986|P1|COMPLETED|Part B||22
8691367|NCT01720524|21455985|P2|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|26
8691368|NCT01720524|21455986|P1|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|27
8691369|NCT01720524|21455985|P2|NOT COMPLETED|Part A||12
8691370|NCT01720524|21455986|P1|NOT COMPLETED|Part A||7
8691371|NCT01720524|21455985|P2|COMPLETED|Part A||18
8691372|NCT01720524|21455986|P1|COMPLETED|Part A||22
8691373|NCT01720524|21455985|P2|STARTED|Part A||30
8691374|NCT01720524|21455986|P1|STARTED|Part A||29
8691375|NCT00931944|21456053|P1|NOT COMPLETED|Overall Study||55
8691376|NCT00931944|21456053|P1|COMPLETED|Overall Study||19
8691377|NCT00931944|21456053|P1|STARTED|Overall Study||74
8691378|NCT00875342|21456072|P2|NOT COMPLETED|Overall Study||5
8691379|NCT00875342|21456073|P1|NOT COMPLETED|Overall Study||4
8691380|NCT00875342|21456072|P2|COMPLETED|Overall Study||16
8691381|NCT00875342|21456073|P1|COMPLETED|Overall Study||16
8691382|NCT00875342|21456072|P2|STARTED|Overall Study||21
8691383|NCT00875342|21456073|P1|STARTED|Overall Study||20
8691384|NCT00793598|21456084|P8|NOT COMPLETED|Overall Study||1
8691385|NCT00793598|21456085|P7|NOT COMPLETED|Overall Study||0
8691386|NCT00793598|21456086|P6|NOT COMPLETED|Overall Study||1
8691387|NCT00793598|21456087|P5|NOT COMPLETED|Overall Study||0
8691388|NCT00793598|21456088|P4|NOT COMPLETED|Overall Study||0
8691389|NCT00793598|21456089|P3|NOT COMPLETED|Overall Study||0
8691390|NCT00793598|21456090|P2|NOT COMPLETED|Overall Study||1
8691391|NCT00793598|21456091|P1|NOT COMPLETED|Overall Study||0
8691392|NCT00793598|21456084|P8|COMPLETED|Overall Study||3
8691393|NCT00793598|21456085|P7|COMPLETED|Overall Study||4
8691394|NCT00793598|21456086|P6|COMPLETED|Overall Study||7
8691395|NCT00793598|21456087|P5|COMPLETED|Overall Study||8
8691396|NCT00793598|21456088|P4|COMPLETED|Overall Study||2
8691397|NCT00793598|21456089|P3|COMPLETED|Overall Study||1
8691398|NCT00793598|21456090|P2|COMPLETED|Overall Study||0
8691399|NCT00793598|21456091|P1|COMPLETED|Overall Study||1
8691400|NCT00793598|21456084|P8|STARTED|Overall Study||4
8691401|NCT00793598|21456085|P7|STARTED|Overall Study||4
8691402|NCT00793598|21456086|P6|STARTED|Overall Study||8
8691403|NCT00793598|21456087|P5|STARTED|Overall Study||8
8691404|NCT00793598|21456088|P4|STARTED|Overall Study||2
8691405|NCT00793598|21456089|P3|STARTED|Overall Study||1
8691406|NCT00793598|21456090|P2|STARTED|Overall Study||1
8691407|NCT00793598|21456091|P1|STARTED|Overall Study||1
8691414|NCT00110266|21456146|P1|NOT COMPLETED|Overall Study||78
8691415|NCT00110266|21456146|P1|COMPLETED|Overall Study||95
8691416|NCT00110266|21456146|P1|STARTED|Overall Study||173
8691417|NCT02831998|21456162|P1|NOT COMPLETED|Overall Study||0
8691418|NCT02831998|21456162|P1|COMPLETED|Overall Study||440
8691419|NCT02831998|21456162|P1|Vehicle|Overall Study||80
8691420|NCT02831998|21456162|P1|CP|Overall Study||400
8691421|NCT02831998|21456162|P1|ZP|Overall Study||400
8691422|NCT02831998|21456162|P1|STARTED|Overall Study||440
8691423|NCT01633398|21456175|P2|NOT COMPLETED|Overall Study||0
8691424|NCT01633398|21456176|P1|NOT COMPLETED|Overall Study||0
8691425|NCT01633398|21456175|P2|COMPLETED|Overall Study||1550
8691426|NCT01633398|21456176|P1|COMPLETED|Overall Study||4779
8691427|NCT01633398|21456175|P2|STARTED|Overall Study||1550
8691428|NCT01633398|21456176|P1|STARTED|Overall Study||4779
8691429|NCT04633642|21456186|P2|NOT COMPLETED|Overall Study||2
8691430|NCT04633642|21456187|P1|NOT COMPLETED|Overall Study||1
8691431|NCT04633642|21456186|P2|COMPLETED|Overall Study|22 participants|22
8691432|NCT04633642|21456187|P1|COMPLETED|Overall Study|26 participants|26
8691433|NCT04633642|21456186|P2|STARTED|Overall Study|24 participants|24
8691434|NCT04633642|21456187|P1|STARTED|Overall Study|27 participants|27
8691435|NCT04590027|21456205|P2|NOT COMPLETED|Overall Study||17
8691436|NCT04590027|21456206|P1|NOT COMPLETED|Overall Study||17
8691437|NCT04590027|21456205|P2|COMPLETED|Overall Study||22
8691438|NCT04590027|21456206|P1|COMPLETED|Overall Study||30
8691439|NCT04590027|21456205|P2|STARTED|Overall Study||39
8691440|NCT04590027|21456206|P1|STARTED|Overall Study||47
8691441|NCT04147455|21456218|P2|NOT COMPLETED|Overall Study||23
8691442|NCT04147455|21456219|P1|NOT COMPLETED|Overall Study||35
8691443|NCT04147455|21456218|P2|COMPLETED|Overall Study||374
8691444|NCT04147455|21456219|P1|COMPLETED|Overall Study||361
8691445|NCT04147455|21456218|P2|STARTED|Overall Study||397
8691446|NCT04147455|21456219|P1|STARTED|Overall Study||396
8691447|NCT03799952|21456233|P2|NOT COMPLETED|Overall Study||2
8691448|NCT03799952|21456234|P1|NOT COMPLETED|Overall Study||1
8691449|NCT03799952|21456233|P2|COMPLETED|Overall Study||29
8691450|NCT03799952|21456234|P1|COMPLETED|Overall Study||30
8691451|NCT03799952|21456233|P2|STARTED|Overall Study||31
8691452|NCT03799952|21456234|P1|STARTED|Overall Study||31
8691453|NCT03770091|21456261|P3|NOT COMPLETED|Overall Study||0
8691454|NCT03770091|21456262|P2|NOT COMPLETED|Overall Study||0
8691455|NCT03770091|21456263|P1|NOT COMPLETED|Overall Study||0
8691456|NCT03770091|21456261|P3|COMPLETED|Overall Study||12
8691457|NCT03770091|21456262|P2|COMPLETED|Overall Study||13
8691458|NCT03770091|21456263|P1|COMPLETED|Overall Study||15
8691459|NCT03770091|21456261|P3|STARTED|Overall Study||12
8691460|NCT03770091|21456262|P2|STARTED|Overall Study||13
8691461|NCT03770091|21456263|P1|STARTED|Overall Study||15
8691462|NCT03630120|21456287|P4|NOT COMPLETED|Overall Study||1
8691463|NCT03630120|21456288|P3|NOT COMPLETED|Overall Study||1
8691464|NCT03630120|21456289|P2|NOT COMPLETED|Overall Study||1
8691465|NCT03630120|21456290|P1|NOT COMPLETED|Overall Study||0
8691466|NCT03630120|21456287|P4|COMPLETED|Overall Study||0
8691467|NCT03630120|21456288|P3|COMPLETED|Overall Study||0
8691468|NCT03630120|21456289|P2|COMPLETED|Overall Study||1
8691469|NCT03630120|21456290|P1|COMPLETED|Overall Study||2
8691470|NCT03630120|21456287|P4|STARTED|Overall Study||1
8691471|NCT03630120|21456288|P3|STARTED|Overall Study||1
8691472|NCT03630120|21456289|P2|STARTED|Overall Study||2
8691473|NCT03630120|21456290|P1|STARTED|Overall Study||2
8691474|NCT04034121|21456320|P1|NOT COMPLETED|Brazil Cohort||0
8691475|NCT04034121|21456320|P1|COMPLETED|Brazil Cohort||20
8691476|NCT04034121|21456320|P1|STARTED|Brazil Cohort|The Brazil Cohort enrolled 20 patients|20
8691477|NCT04034121|21456320|P1|NOT COMPLETED|European Cohort||0
8691478|NCT04034121|21456320|P1|COMPLETED|European Cohort||30
8691479|NCT04034121|21456320|P1|STARTED|European Cohort|The European Cohort enrolled 30 patients|30
8691480|NCT04029519|21456328|P1|NOT COMPLETED|Overall Study||5
8691481|NCT04029519|21456328|P1|COMPLETED|Overall Study||79
8691482|NCT04029519|21456328|P1|STARTED|Overall Study||84
8691483|NCT03676725|21456342|P6|NOT COMPLETED|Overall Study||0
8691484|NCT03676725|21456343|P5|NOT COMPLETED|Overall Study||0
8691485|NCT03676725|21456344|P4|NOT COMPLETED|Overall Study||0
8691486|NCT03676725|21456345|P3|NOT COMPLETED|Overall Study||0
8691487|NCT03676725|21456346|P2|NOT COMPLETED|Overall Study||0
8691488|NCT03676725|21456347|P1|NOT COMPLETED|Overall Study||0
8691489|NCT03676725|21456342|P6|COMPLETED|Overall Study||11
8691490|NCT03676725|21456343|P5|COMPLETED|Overall Study||15
8691491|NCT03676725|21456344|P4|COMPLETED|Overall Study||5
8691492|NCT03676725|21456345|P3|COMPLETED|Overall Study||22
8691493|NCT03676725|21456346|P2|COMPLETED|Overall Study||14
8691494|NCT03676725|21456347|P1|COMPLETED|Overall Study||23
8691495|NCT03676725|21456342|P6|STARTED|Overall Study||11
8691496|NCT03676725|21456343|P5|STARTED|Overall Study||15
8691497|NCT03676725|21456344|P4|STARTED|Overall Study||5
8691498|NCT03676725|21456345|P3|STARTED|Overall Study||22
8691499|NCT03676725|21456346|P2|STARTED|Overall Study||14
8691500|NCT03676725|21456347|P1|STARTED|Overall Study||23
8691501|NCT03591146|21456361|P5|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
8691502|NCT03591146|21456362|P4|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
8691503|NCT03591146|21456363|P3|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
8691504|NCT03591146|21456364|P2|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
8691505|NCT03591146|21456365|P1|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
8691506|NCT03591146|21456361|P5|COMPLETED|TLC590 475mg and Naropin 150mg||4
8691507|NCT03591146|21456362|P4|COMPLETED|TLC590 475mg and Naropin 150mg||12
8691508|NCT03591146|21456363|P3|COMPLETED|TLC590 475mg and Naropin 150mg||0
8691509|NCT03591146|21456364|P2|COMPLETED|TLC590 475mg and Naropin 150mg||0
8691510|NCT03591146|21456365|P1|COMPLETED|TLC590 475mg and Naropin 150mg||0
8691511|NCT03591146|21456361|P5|STARTED|TLC590 475mg and Naropin 150mg||4
8691512|NCT03591146|21456362|P4|STARTED|TLC590 475mg and Naropin 150mg||12
8691513|NCT03591146|21456363|P3|STARTED|TLC590 475mg and Naropin 150mg||0
8691514|NCT03591146|21456364|P2|STARTED|TLC590 475mg and Naropin 150mg||0
8691515|NCT03591146|21456365|P1|STARTED|TLC590 475mg and Naropin 150mg||0
8691516|NCT03591146|21456361|P5|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
8691517|NCT03591146|21456362|P4|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
8691518|NCT03591146|21456363|P3|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
8691519|NCT03591146|21456364|P2|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
8691520|NCT03591146|21456365|P1|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
8691521|NCT03591146|21456361|P5|COMPLETED|TLC590 570mg and Naropin 150mg||3
8691522|NCT03591146|21456362|P4|COMPLETED|TLC590 570mg and Naropin 150mg||0
8691523|NCT03591146|21456363|P3|COMPLETED|TLC590 570mg and Naropin 150mg||11
8691524|NCT03591146|21456364|P2|COMPLETED|TLC590 570mg and Naropin 150mg||0
8691525|NCT03591146|21456365|P1|COMPLETED|TLC590 570mg and Naropin 150mg||0
8691526|NCT03591146|21456361|P5|STARTED|TLC590 570mg and Naropin 150mg||4
8691527|NCT03591146|21456362|P4|STARTED|TLC590 570mg and Naropin 150mg||0
8691528|NCT03591146|21456363|P3|STARTED|TLC590 570mg and Naropin 150mg||12
8691529|NCT03591146|21456364|P2|STARTED|TLC590 570mg and Naropin 150mg||0
8691530|NCT03591146|21456365|P1|STARTED|TLC590 570mg and Naropin 150mg||0
8691531|NCT03591146|21456361|P5|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
8691532|NCT03591146|21456362|P4|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
8691533|NCT03591146|21456363|P3|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
8691534|NCT03591146|21456364|P2|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
8691535|NCT03591146|21456365|P1|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
8691536|NCT03591146|21456361|P5|COMPLETED|TLC590 380mg and Naropin 150mg||4
8691537|NCT03591146|21456362|P4|COMPLETED|TLC590 380mg and Naropin 150mg||0
8691538|NCT03591146|21456363|P3|COMPLETED|TLC590 380mg and Naropin 150mg||0
8691539|NCT03591146|21456364|P2|COMPLETED|TLC590 380mg and Naropin 150mg||11
8691540|NCT03591146|21456365|P1|COMPLETED|TLC590 380mg and Naropin 150mg||0
8691541|NCT03591146|21456361|P5|STARTED|TLC590 380mg and Naropin 150mg||5
8691542|NCT03591146|21456362|P4|STARTED|TLC590 380mg and Naropin 150mg||0
8691543|NCT03591146|21456363|P3|STARTED|TLC590 380mg and Naropin 150mg||0
8691544|NCT03591146|21456364|P2|STARTED|TLC590 380mg and Naropin 150mg||12
8691545|NCT03591146|21456365|P1|STARTED|TLC590 380mg and Naropin 150mg||0
8691546|NCT03591146|21456361|P5|NOT COMPLETED|TLC590 190mg and Naropin 150mg||1
8691547|NCT03591146|21456362|P4|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
8691548|NCT03591146|21456363|P3|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
8691549|NCT03591146|21456364|P2|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
8691550|NCT03591146|21456365|P1|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
8691551|NCT03591146|21456361|P5|COMPLETED|TLC590 190mg and Naropin 150mg||3
8691552|NCT03591146|21456362|P4|COMPLETED|TLC590 190mg and Naropin 150mg||0
8691553|NCT03591146|21456363|P3|COMPLETED|TLC590 190mg and Naropin 150mg||0
8691554|NCT03591146|21456364|P2|COMPLETED|TLC590 190mg and Naropin 150mg||0
8691555|NCT03591146|21456365|P1|COMPLETED|TLC590 190mg and Naropin 150mg||12
8691556|NCT03591146|21456361|P5|STARTED|TLC590 190mg and Naropin 150mg||4
8691557|NCT03591146|21456362|P4|STARTED|TLC590 190mg and Naropin 150mg||0
8691558|NCT03591146|21456363|P3|STARTED|TLC590 190mg and Naropin 150mg||0
8691559|NCT03591146|21456364|P2|STARTED|TLC590 190mg and Naropin 150mg||0
8691560|NCT03591146|21456365|P1|STARTED|TLC590 190mg and Naropin 150mg||12
8691561|NCT03426228|21456379|P2|NOT COMPLETED|Overall Study||33
8691562|NCT03426228|21456380|P1|NOT COMPLETED|Overall Study||41
8691563|NCT03426228|21456379|P2|COMPLETED|Overall Study||158
8691564|NCT03426228|21456380|P1|COMPLETED|Overall Study||117
8691565|NCT03426228|21456379|P2|STARTED|Overall Study||191
8691566|NCT03426228|21456380|P1|STARTED|Overall Study||158
8691567|NCT03444961|21456390|P1|NOT COMPLETED|Overall Study||0
8691568|NCT03444961|21456390|P1|COMPLETED|Overall Study||4
8691569|NCT03444961|21456390|P1|STARTED|Overall Study||4
8691570|NCT03345407|21456413|P7|NOT COMPLETED|Overall Study||45
8691571|NCT03345407|21456414|P6|NOT COMPLETED|Overall Study||16
8691572|NCT03345407|21456415|P5|NOT COMPLETED|Overall Study||15
8691573|NCT03345407|21456416|P4|NOT COMPLETED|Overall Study||11
8691574|NCT03345407|21456417|P3|NOT COMPLETED|Overall Study||12
8691575|NCT03345407|21456418|P2|NOT COMPLETED|Overall Study||3
8691576|NCT03345407|21456419|P1|NOT COMPLETED|Overall Study||32
8691577|NCT03345407|21456413|P7|COMPLETED|Overall Study||233
8691578|NCT03345407|21456414|P6|COMPLETED|Overall Study||73
8691579|NCT03345407|21456415|P5|COMPLETED|Overall Study||75
8691580|NCT03345407|21456416|P4|COMPLETED|Overall Study||81
8691581|NCT03345407|21456417|P3|COMPLETED|Overall Study||79
8691582|NCT03345407|21456418|P2|COMPLETED|Overall Study||19
8691583|NCT03345407|21456419|P1|COMPLETED|Overall Study||244
8691584|NCT03345407|21456413|P7|STARTED|Overall Study||278
8691585|NCT03345407|21456414|P6|STARTED|Overall Study||89
8691586|NCT03345407|21456415|P5|STARTED|Overall Study||90
8691587|NCT03345407|21456416|P4|STARTED|Overall Study||92
8691588|NCT03345407|21456417|P3|STARTED|Overall Study||91
8691589|NCT03345407|21456418|P2|STARTED|Overall Study||22
8691590|NCT03345407|21456419|P1|STARTED|Overall Study||276
8691591|NCT03338569|21456606|P2|NOT COMPLETED|Overall Study||5
8691592|NCT03338569|21456607|P1|NOT COMPLETED|Overall Study||8
8691593|NCT03338569|21456606|P2|COMPLETED|Overall Study||56
8691594|NCT03338569|21456607|P1|COMPLETED|Overall Study||56
8691595|NCT03338569|21456606|P2|STARTED|Overall Study||61
8691596|NCT03338569|21456607|P1|STARTED|Overall Study||64
8691597|NCT03332498|21456638|P3|NOT COMPLETED|Overall Study||2
8691598|NCT03332498|21456639|P2|NOT COMPLETED|Overall Study||0
8691599|NCT03332498|21456640|P1|NOT COMPLETED|Overall Study||0
8691600|NCT03332498|21456638|P3|COMPLETED|Overall Study||30
8691601|NCT03332498|21456639|P2|COMPLETED|Overall Study||4
8691602|NCT03332498|21456640|P1|COMPLETED|Overall Study||4
8691603|NCT03332498|21456638|P3|STARTED|Overall Study||32
8691604|NCT03332498|21456639|P2|STARTED|Overall Study||4
8691605|NCT03332498|21456640|P1|STARTED|Overall Study||4
8691606|NCT03289481|21456649|P2|NOT COMPLETED|Overall Study||2
8691607|NCT03289481|21456650|P1|NOT COMPLETED|Overall Study||2
8691608|NCT03289481|21456649|P2|COMPLETED|Overall Study||5
8691609|NCT03289481|21456650|P1|COMPLETED|Overall Study||4
8691610|NCT03289481|21456649|P2|STARTED|Overall Study||7
8691611|NCT03289481|21456650|P1|STARTED|Overall Study||6
8691612|NCT03210259|21456664|P3|NOT COMPLETED|48-Week Randomized Responder Period||29
8691613|NCT03210259|21456665|P2|NOT COMPLETED|48-Week Randomized Responder Period||11
8691614|NCT03210259|21456666|P1|NOT COMPLETED|48-Week Randomized Responder Period||0
8691615|NCT03210259|21456664|P3|COMPLETED|48-Week Randomized Responder Period||91
8691616|NCT03210259|21456665|P2|COMPLETED|48-Week Randomized Responder Period||107
8691617|NCT03210259|21456666|P1|COMPLETED|48-Week Randomized Responder Period||0
8691618|NCT03210259|21456664|P3|STARTED|48-Week Randomized Responder Period||120
8691619|NCT03210259|21456665|P2|STARTED|48-Week Randomized Responder Period||118
8691620|NCT03210259|21456666|P1|STARTED|48-Week Randomized Responder Period||0
8691621|NCT03210259|21456664|P3|NOT COMPLETED|12-Week Run-in Period||0
8691622|NCT03210259|21456665|P2|NOT COMPLETED|12-Week Run-in Period||0
8691623|NCT03210259|21456666|P1|NOT COMPLETED|12-Week Run-in Period||21
8691624|NCT03210259|21456664|P3|COMPLETED|12-Week Run-in Period||120
8691625|NCT03210259|21456665|P2|COMPLETED|12-Week Run-in Period||118
8691626|NCT03210259|21456666|P1|COMPLETED|12-Week Run-in Period||0
8691627|NCT03210259|21456664|P3|STARTED|12-Week Run-in Period||120
8691628|NCT03210259|21456665|P2|STARTED|12-Week Run-in Period||118
8691629|NCT03210259|21456666|P1|STARTED|12-Week Run-in Period||21
8691630|NCT03146741|21456693|P1|NOT COMPLETED|Overall Study||10
8691631|NCT03146741|21456693|P1|COMPLETED|Overall Study||10
8691632|NCT03146741|21456693|P1|STARTED|Overall Study||20
8691633|NCT03142438|21456698|P1|NOT COMPLETED|Overall Study||0
8691634|NCT03142438|21456698|P1|COMPLETED|Overall Study||57
8691635|NCT03142438|21456698|P1|STARTED|Overall Study||57
8691636|NCT02926833|21456711|P4|NOT COMPLETED|Overall Study||23
8691637|NCT02926833|21456712|P3|NOT COMPLETED|Overall Study||7
8691638|NCT02926833|21456713|P2|NOT COMPLETED|Overall Study||4
8691639|NCT02926833|21456714|P1|NOT COMPLETED|Overall Study||3
8691640|NCT02926833|21456711|P4|COMPLETED|Overall Study||0
8691641|NCT02926833|21456712|P3|COMPLETED|Overall Study||0
8691642|NCT02926833|21456713|P2|COMPLETED|Overall Study||0
8691643|NCT02926833|21456714|P1|COMPLETED|Overall Study||0
8691644|NCT02926833|21456711|P4|STARTED|Overall Study||23
8691645|NCT02926833|21456712|P3|STARTED|Overall Study||7
8691646|NCT02926833|21456713|P2|STARTED|Overall Study||4
8691647|NCT02926833|21456714|P1|STARTED|Overall Study||3
8691648|NCT03124069|21456768|P1|NOT COMPLETED|Overall Study||0
8691649|NCT03124069|21456768|P1|COMPLETED|Overall Study||37
8691650|NCT03124069|21456768|P1|STARTED|Overall Study||37
8691651|NCT02908841|21456780|P2|NOT COMPLETED|Overall Study||0
8691652|NCT02908841|21456781|P1|NOT COMPLETED|Overall Study||4
8691653|NCT02908841|21456780|P2|COMPLETED|Overall Study||12
8691654|NCT02908841|21456781|P1|COMPLETED|Overall Study||6
8691655|NCT02908841|21456780|P2|STARTED|Overall Study||12
8691656|NCT02908841|21456781|P1|STARTED|Overall Study||10
8691657|NCT02879994|21456797|P1|NOT COMPLETED|Overall Study||11
8691658|NCT02879994|21456797|P1|COMPLETED|Overall Study||0
8691659|NCT02879994|21456797|P1|STARTED|Overall Study||11
8691660|NCT02849418|21456805|P6|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8691661|NCT02849418|21456806|P5|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8691662|NCT02849418|21456807|P4|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8691663|NCT02849418|21456808|P3|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8691664|NCT02849418|21456809|P2|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8691665|NCT02849418|21456810|P1|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8691666|NCT02849418|21456805|P6|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3
8691667|NCT02849418|21456806|P5|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5
8691668|NCT02849418|21456807|P4|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8691669|NCT02849418|21456808|P3|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8691670|NCT02849418|21456809|P2|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8691671|NCT02849418|21456810|P1|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
8691672|NCT02849418|21456805|P6|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3
8691673|NCT02849418|21456806|P5|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5
8691674|NCT02849418|21456807|P4|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
8691675|NCT02849418|21456808|P3|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
8691676|NCT02849418|21456809|P2|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
8691677|NCT02849418|21456810|P1|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
8691678|NCT02849418|21456805|P6|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8691679|NCT02849418|21456806|P5|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8691680|NCT02849418|21456807|P4|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8691681|NCT02849418|21456808|P3|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8691682|NCT02849418|21456809|P2|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8691683|NCT02849418|21456810|P1|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8691684|NCT02849418|21456805|P6|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8691685|NCT02849418|21456806|P5|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8691686|NCT02849418|21456807|P4|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6
8691687|NCT02849418|21456808|P3|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10
8691688|NCT02849418|21456809|P2|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8691689|NCT02849418|21456810|P1|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
8691690|NCT02849418|21456805|P6|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
8691691|NCT02849418|21456806|P5|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
8691692|NCT02849418|21456807|P4|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6
8691693|NCT02849418|21456808|P3|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10
8691694|NCT02849418|21456809|P2|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
8691695|NCT02849418|21456810|P1|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
8691696|NCT02849418|21456805|P6|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8691697|NCT02849418|21456806|P5|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8691698|NCT02849418|21456807|P4|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8691699|NCT02849418|21456808|P3|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8691700|NCT02849418|21456809|P2|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8691701|NCT02849418|21456810|P1|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
8691702|NCT02849418|21456805|P6|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8691703|NCT02849418|21456806|P5|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8691704|NCT02849418|21456807|P4|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8691705|NCT02849418|21456808|P3|COMPLETED|Double-blinded (Up to 48 Weeks)||0
8691706|NCT02849418|21456809|P2|COMPLETED|Double-blinded (Up to 48 Weeks)||11
8691707|NCT02849418|21456810|P1|COMPLETED|Double-blinded (Up to 48 Weeks)||10
8691708|NCT02849418|21456805|P6|STARTED|Double-blinded (Up to 48 Weeks)||0
8691709|NCT02849418|21456806|P5|STARTED|Double-blinded (Up to 48 Weeks)||0
8691710|NCT02849418|21456807|P4|STARTED|Double-blinded (Up to 48 Weeks)||0
8691711|NCT02849418|21456808|P3|STARTED|Double-blinded (Up to 48 Weeks)||0
8691712|NCT02849418|21456809|P2|STARTED|Double-blinded (Up to 48 Weeks)||11
8691713|NCT02849418|21456810|P1|STARTED|Double-blinded (Up to 48 Weeks)||10
8691714|NCT02665975|21456960|P2|NOT COMPLETED|Overall Study||9
8691715|NCT02665975|21456961|P1|NOT COMPLETED|Overall Study||9
8691716|NCT02665975|21456960|P2|COMPLETED|Overall Study||37
8691717|NCT02665975|21456961|P1|COMPLETED|Overall Study||37
8691718|NCT02665975|21456960|P2|STARTED|Overall Study||46
8691719|NCT02665975|21456961|P1|STARTED|Overall Study||46
8691720|NCT03005106|21456983|P1|NOT COMPLETED|Overall Study||20
8691721|NCT03005106|21456983|P1|COMPLETED|Overall Study||51
8691722|NCT03005106|21456983|P1|Completed Month 12 Visit|Overall Study||51
8691723|NCT03005106|21456983|P1|Completed Month 3 Visit|Overall Study||64
8691724|NCT03005106|21456983|P1|STARTED|Overall Study||71
8691725|NCT02558296|21456992|P2|NOT COMPLETED|Completed the Study||85
8691726|NCT02558296|21456993|P1|NOT COMPLETED|Completed the Study||146
8691727|NCT02558296|21456992|P2|COMPLETED|Completed the Study||482
8691728|NCT02558296|21456993|P1|COMPLETED|Completed the Study||987
8691729|NCT02558296|21456992|P2|STARTED|Completed the Study||567
8691730|NCT02558296|21456993|P1|STARTED|Completed the Study||1133
8691731|NCT02558296|21456992|P2|NOT COMPLETED|Completed the Study Through Week 24||25
8691732|NCT02558296|21456993|P1|NOT COMPLETED|Completed the Study Through Week 24||44
8691733|NCT02558296|21456992|P2|COMPLETED|Completed the Study Through Week 24||542
8691734|NCT02558296|21456993|P1|COMPLETED|Completed the Study Through Week 24||1089
8691735|NCT02558296|21456992|P2|STARTED|Completed the Study Through Week 24||567
8691736|NCT02558296|21456993|P1|STARTED|Completed the Study Through Week 24||1133
8691737|NCT02447497|21457025|P4|NOT COMPLETED|Overall Study||2
8691738|NCT02447497|21457026|P3|NOT COMPLETED|Overall Study||2
8691739|NCT02447497|21457027|P2|NOT COMPLETED|Overall Study||6
8691740|NCT02447497|21457028|P1|NOT COMPLETED|Overall Study||6
8691741|NCT02447497|21457025|P4|COMPLETED|Overall Study||21
8691742|NCT02447497|21457026|P3|COMPLETED|Overall Study||21
8691743|NCT02447497|21457027|P2|COMPLETED|Overall Study||19
8691744|NCT02447497|21457028|P1|COMPLETED|Overall Study||19
8691745|NCT02447497|21457025|P4|STARTED|Overall Study||23
8691746|NCT02447497|21457026|P3|STARTED|Overall Study||23
8691747|NCT02447497|21457027|P2|STARTED|Overall Study||25
8691748|NCT02447497|21457028|P1|STARTED|Overall Study||25
8691749|NCT02370810|21457048|P2|NOT COMPLETED|Overall Study||19
8691750|NCT02370810|21457049|P1|NOT COMPLETED|Overall Study||23
8691751|NCT02370810|21457048|P2|COMPLETED|Overall Study||54
8691752|NCT02370810|21457049|P1|COMPLETED|Overall Study||50
8691753|NCT02370810|21457048|P2|STARTED|Overall Study||73
8691754|NCT02370810|21457049|P1|STARTED|Overall Study||73
8691761|NCT01874353|21457100|P4|NOT COMPLETED|Overall Study||7
8691762|NCT01874353|21457101|P3|NOT COMPLETED|Overall Study||15
8691763|NCT01874353|21457102|P2|NOT COMPLETED|Overall Study||73
8691764|NCT01874353|21457103|P1|NOT COMPLETED|Overall Study||127
8691765|NCT01874353|21457100|P4|COMPLETED|Overall Study||3
8691766|NCT01874353|21457101|P3|COMPLETED|Overall Study||7
8691767|NCT01874353|21457102|P2|COMPLETED|Overall Study||26
8691768|NCT01874353|21457103|P1|COMPLETED|Overall Study||69
8691769|NCT01874353|21457100|P4|STARTED|Overall Study||10
8691770|NCT01874353|21457101|P3|STARTED|Overall Study||22
8691771|NCT01874353|21457102|P2|STARTED|Overall Study||99
8691772|NCT01874353|21457103|P1|STARTED|Overall Study||196
8691773|NCT02302157|21457147|P5|NOT COMPLETED|Overall Study||0
8691774|NCT02302157|21457148|P4|NOT COMPLETED|Overall Study||0
8691775|NCT02302157|21457149|P3|NOT COMPLETED|Overall Study||0
8691776|NCT02302157|21457150|P2|NOT COMPLETED|Overall Study||0
8691777|NCT02302157|21457151|P1|NOT COMPLETED|Overall Study||0
8691778|NCT02302157|21457147|P5|COMPLETED|Overall Study||4
8691779|NCT02302157|21457148|P4|COMPLETED|Overall Study||6
8691780|NCT02302157|21457149|P3|COMPLETED|Overall Study||6
8691781|NCT02302157|21457150|P2|COMPLETED|Overall Study||6
8691782|NCT02302157|21457151|P1|COMPLETED|Overall Study||3
8691783|NCT02302157|21457147|P5|STARTED|Overall Study||4
8691784|NCT02302157|21457148|P4|STARTED|Overall Study||6
8691785|NCT02302157|21457149|P3|STARTED|Overall Study||6
8691786|NCT02302157|21457150|P2|STARTED|Overall Study||6
8691787|NCT02302157|21457151|P1|STARTED|Overall Study||3
8691788|NCT02279524|21457171|P3|NOT COMPLETED|Overall Study||7
8691789|NCT02279524|21457172|P2|NOT COMPLETED|Overall Study||11
8691790|NCT02279524|21457173|P1|NOT COMPLETED|Overall Study||10
8691791|NCT02279524|21457171|P3|COMPLETED|Overall Study||41
8691792|NCT02279524|21457172|P2|COMPLETED|Overall Study||90
8691793|NCT02279524|21457173|P1|COMPLETED|Overall Study||88
8691794|NCT02279524|21457171|P3|STARTED|Overall Study||48
8691795|NCT02279524|21457172|P2|STARTED|Overall Study||101
8691796|NCT02279524|21457173|P1|STARTED|Overall Study||98
8691797|NCT02160782|21457202|P5|NOT COMPLETED|Long-term Extension Period: Maralixibat||9
8691798|NCT02160782|21457203|P4|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
8691799|NCT02160782|21457204|P3|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
8691800|NCT02160782|21457205|P2|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
8691801|NCT02160782|21457206|P1|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
8691802|NCT02160782|21457202|P5|COMPLETED|Long-term Extension Period: Maralixibat||14
8691803|NCT02160782|21457203|P4|COMPLETED|Long-term Extension Period: Maralixibat||0
8691804|NCT02160782|21457204|P3|COMPLETED|Long-term Extension Period: Maralixibat||0
8691805|NCT02160782|21457205|P2|COMPLETED|Long-term Extension Period: Maralixibat||0
8691806|NCT02160782|21457206|P1|COMPLETED|Long-term Extension Period: Maralixibat||0
8691807|NCT02160782|21457202|P5|STARTED|Long-term Extension Period: Maralixibat||23
8691808|NCT02160782|21457203|P4|STARTED|Long-term Extension Period: Maralixibat||0
8691809|NCT02160782|21457204|P3|STARTED|Long-term Extension Period: Maralixibat||0
8691810|NCT02160782|21457205|P2|STARTED|Long-term Extension Period: Maralixibat||0
8691811|NCT02160782|21457206|P1|STARTED|Long-term Extension Period: Maralixibat||0
8691812|NCT02160782|21457202|P5|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
8691813|NCT02160782|21457203|P4|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||6
8691814|NCT02160782|21457204|P3|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
8691815|NCT02160782|21457205|P2|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
8691816|NCT02160782|21457206|P1|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
8691817|NCT02160782|21457202|P5|COMPLETED|After Randomized Withdrawal: Maralixibat||0
8691818|NCT02160782|21457203|P4|COMPLETED|After Randomized Withdrawal: Maralixibat||23
8691819|NCT02160782|21457204|P3|COMPLETED|After Randomized Withdrawal: Maralixibat||0
8691820|NCT02160782|21457205|P2|COMPLETED|After Randomized Withdrawal: Maralixibat||0
8691821|NCT02160782|21457206|P1|COMPLETED|After Randomized Withdrawal: Maralixibat||0
8691822|NCT02160782|21457202|P5|STARTED|After Randomized Withdrawal: Maralixibat||0
8691823|NCT02160782|21457203|P4|STARTED|After Randomized Withdrawal: Maralixibat||29
8691824|NCT02160782|21457204|P3|STARTED|After Randomized Withdrawal: Maralixibat||0
8691825|NCT02160782|21457205|P2|STARTED|After Randomized Withdrawal: Maralixibat||0
8691826|NCT02160782|21457206|P1|STARTED|After Randomized Withdrawal: Maralixibat||0
8691827|NCT02160782|21457202|P5|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8691828|NCT02160782|21457203|P4|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8691829|NCT02160782|21457204|P3|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8691830|NCT02160782|21457205|P2|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8691921|NCT02065245|21457533|P2|STARTED|Infusion 4||2
8691831|NCT02160782|21457206|P1|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8691832|NCT02160782|21457202|P5|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8691833|NCT02160782|21457203|P4|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8691834|NCT02160782|21457204|P3|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||16
8691835|NCT02160782|21457205|P2|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||13
8691836|NCT02160782|21457206|P1|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
8691837|NCT02160782|21457202|P5|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
8691838|NCT02160782|21457203|P4|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
8691839|NCT02160782|21457204|P3|STARTED|Randomized Withdrawal Period- Pbo vs MRX||16
8691840|NCT02160782|21457205|P2|STARTED|Randomized Withdrawal Period- Pbo vs MRX||13
8691841|NCT02160782|21457206|P1|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
8691842|NCT02160782|21457202|P5|NOT COMPLETED|Open-label Period: Maralixibat||0
8691843|NCT02160782|21457203|P4|NOT COMPLETED|Open-label Period: Maralixibat||0
8691844|NCT02160782|21457204|P3|NOT COMPLETED|Open-label Period: Maralixibat||0
8691845|NCT02160782|21457205|P2|NOT COMPLETED|Open-label Period: Maralixibat||0
8691846|NCT02160782|21457206|P1|NOT COMPLETED|Open-label Period: Maralixibat||2
8691847|NCT02160782|21457202|P5|COMPLETED|Open-label Period: Maralixibat||0
8691848|NCT02160782|21457203|P4|COMPLETED|Open-label Period: Maralixibat||0
8691849|NCT02160782|21457204|P3|COMPLETED|Open-label Period: Maralixibat||0
8691850|NCT02160782|21457205|P2|COMPLETED|Open-label Period: Maralixibat||0
8691851|NCT02160782|21457206|P1|COMPLETED|Open-label Period: Maralixibat||29
8691852|NCT02160782|21457202|P5|STARTED|Open-label Period: Maralixibat||0
8691853|NCT02160782|21457203|P4|STARTED|Open-label Period: Maralixibat||0
8691854|NCT02160782|21457204|P3|STARTED|Open-label Period: Maralixibat||0
8691855|NCT02160782|21457205|P2|STARTED|Open-label Period: Maralixibat||0
8691856|NCT02160782|21457206|P1|STARTED|Open-label Period: Maralixibat||31
8691857|NCT02129426|21457244|P2|NOT COMPLETED|Overall Study||13
8691858|NCT02129426|21457245|P1|NOT COMPLETED|Overall Study||7
8691859|NCT02129426|21457244|P2|COMPLETED|Overall Study||0
8691860|NCT02129426|21457245|P1|COMPLETED|Overall Study||0
8691861|NCT02129426|21457244|P2|STARTED|Overall Study||13
8691862|NCT02129426|21457245|P1|STARTED|Overall Study||7
8691863|NCT02124772|21457270|P13|NOT COMPLETED|Overall Study||2
8691864|NCT02124772|21457271|P12|NOT COMPLETED|Overall Study||6
8691865|NCT02124772|21457272|P11|NOT COMPLETED|Overall Study||2
8691866|NCT02124772|21457273|P10|NOT COMPLETED|Overall Study||7
8691867|NCT02124772|21457274|P9|NOT COMPLETED|Overall Study||1
8691868|NCT02124772|21457275|P8|NOT COMPLETED|Overall Study||9
8691869|NCT02124772|21457276|P7|NOT COMPLETED|Overall Study||8
8691870|NCT02124772|21457277|P6|NOT COMPLETED|Overall Study||8
8691871|NCT02124772|21457278|P5|NOT COMPLETED|Overall Study||9
8691872|NCT02124772|21457279|P4|NOT COMPLETED|Overall Study||13
8691873|NCT02124772|21457280|P3|NOT COMPLETED|Overall Study||6
8691874|NCT02124772|21457281|P2|NOT COMPLETED|Overall Study||14
8691875|NCT02124772|21457282|P1|NOT COMPLETED|Overall Study||3
8691876|NCT02124772|21457270|P13|COMPLETED|Overall Study||8
8691877|NCT02124772|21457271|P12|COMPLETED|Overall Study||14
8691878|NCT02124772|21457272|P11|COMPLETED|Overall Study||4
8691879|NCT02124772|21457273|P10|COMPLETED|Overall Study||2
8691880|NCT02124772|21457274|P9|COMPLETED|Overall Study||2
8691881|NCT02124772|21457275|P8|COMPLETED|Overall Study||1
8691882|NCT02124772|21457276|P7|COMPLETED|Overall Study||2
8691883|NCT02124772|21457277|P6|COMPLETED|Overall Study||2
8691884|NCT02124772|21457278|P5|COMPLETED|Overall Study||2
8691885|NCT02124772|21457279|P4|COMPLETED|Overall Study||3
8691886|NCT02124772|21457280|P3|COMPLETED|Overall Study||6
8691887|NCT02124772|21457281|P2|COMPLETED|Overall Study||5
8691888|NCT02124772|21457282|P1|COMPLETED|Overall Study||0
8691889|NCT02124772|21457270|P13|STARTED|Overall Study||10
8691890|NCT02124772|21457271|P12|STARTED|Overall Study||20
8691891|NCT02124772|21457272|P11|STARTED|Overall Study||6
8691892|NCT02124772|21457273|P10|STARTED|Overall Study||9
8691893|NCT02124772|21457274|P9|STARTED|Overall Study||3
8691894|NCT02124772|21457275|P8|STARTED|Overall Study||10
8691895|NCT02124772|21457276|P7|STARTED|Overall Study||10
8691896|NCT02124772|21457277|P6|STARTED|Overall Study||10
8691897|NCT02124772|21457278|P5|STARTED|Overall Study||11
8691898|NCT02124772|21457279|P4|STARTED|Overall Study||16
8691899|NCT02124772|21457280|P3|STARTED|Overall Study||12
8691900|NCT02124772|21457281|P2|STARTED|Overall Study||19
8691901|NCT02124772|21457282|P1|STARTED|Overall Study||3
8691902|NCT02065245|21457528|P7|NOT COMPLETED|Infusion 4||0
8691903|NCT02065245|21457529|P6|NOT COMPLETED|Infusion 4||0
8691904|NCT02065245|21457530|P5|NOT COMPLETED|Infusion 4||0
8691905|NCT02065245|21457531|P4|NOT COMPLETED|Infusion 4||0
8691906|NCT02065245|21457532|P3|NOT COMPLETED|Infusion 4||0
8691907|NCT02065245|21457533|P2|NOT COMPLETED|Infusion 4||0
8691908|NCT02065245|21457534|P1|NOT COMPLETED|Infusion 4||0
8691909|NCT02065245|21457528|P7|COMPLETED|Infusion 4||0
8691910|NCT02065245|21457529|P6|COMPLETED|Infusion 4||0
8691911|NCT02065245|21457530|P5|COMPLETED|Infusion 4||0
8691912|NCT02065245|21457531|P4|COMPLETED|Infusion 4||0
8691913|NCT02065245|21457532|P3|COMPLETED|Infusion 4||1
8691914|NCT02065245|21457533|P2|COMPLETED|Infusion 4||2
8691915|NCT02065245|21457534|P1|COMPLETED|Infusion 4||1
8691916|NCT02065245|21457528|P7|STARTED|Infusion 4||0
8691917|NCT02065245|21457529|P6|STARTED|Infusion 4||0
8691918|NCT02065245|21457530|P5|STARTED|Infusion 4||0
8691919|NCT02065245|21457531|P4|STARTED|Infusion 4||0
8691920|NCT02065245|21457532|P3|STARTED|Infusion 4||1
8691922|NCT02065245|21457534|P1|STARTED|Infusion 4||1
8691923|NCT02065245|21457528|P7|NOT COMPLETED|Infusion 3||0
8691924|NCT02065245|21457529|P6|NOT COMPLETED|Infusion 3||0
8691925|NCT02065245|21457530|P5|NOT COMPLETED|Infusion 3||0
8691926|NCT02065245|21457531|P4|NOT COMPLETED|Infusion 3||0
8691927|NCT02065245|21457532|P3|NOT COMPLETED|Infusion 3||0
8691928|NCT02065245|21457533|P2|NOT COMPLETED|Infusion 3||1
8691929|NCT02065245|21457534|P1|NOT COMPLETED|Infusion 3||1
8691930|NCT02065245|21457528|P7|COMPLETED|Infusion 3||0
8691931|NCT02065245|21457529|P6|COMPLETED|Infusion 3||0
8691932|NCT02065245|21457530|P5|COMPLETED|Infusion 3||0
8691933|NCT02065245|21457531|P4|COMPLETED|Infusion 3||0
8691934|NCT02065245|21457532|P3|COMPLETED|Infusion 3||1
8691935|NCT02065245|21457533|P2|COMPLETED|Infusion 3||4
8691936|NCT02065245|21457534|P1|COMPLETED|Infusion 3||2
8691937|NCT02065245|21457528|P7|STARTED|Infusion 3||0
8691938|NCT02065245|21457529|P6|STARTED|Infusion 3||0
8691939|NCT02065245|21457530|P5|STARTED|Infusion 3||0
8691940|NCT02065245|21457531|P4|STARTED|Infusion 3||0
8691941|NCT02065245|21457532|P3|STARTED|Infusion 3||1
8691942|NCT02065245|21457533|P2|STARTED|Infusion 3||5
8691943|NCT02065245|21457534|P1|STARTED|Infusion 3||3
8691944|NCT02065245|21457528|P7|NOT COMPLETED|Infusion 2||1
8691945|NCT02065245|21457529|P6|NOT COMPLETED|Infusion 2||0
8691946|NCT02065245|21457530|P5|NOT COMPLETED|Infusion 2||0
8691947|NCT02065245|21457531|P4|NOT COMPLETED|Infusion 2||0
8691948|NCT02065245|21457532|P3|NOT COMPLETED|Infusion 2||0
8691949|NCT02065245|21457533|P2|NOT COMPLETED|Infusion 2||0
8691950|NCT02065245|21457534|P1|NOT COMPLETED|Infusion 2||0
8691951|NCT02065245|21457528|P7|COMPLETED|Infusion 2||11
8691952|NCT02065245|21457529|P6|COMPLETED|Infusion 2||6
8691953|NCT02065245|21457530|P5|COMPLETED|Infusion 2||0
8691954|NCT02065245|21457531|P4|COMPLETED|Infusion 2||0
8691955|NCT02065245|21457532|P3|COMPLETED|Infusion 2||2
8691956|NCT02065245|21457533|P2|COMPLETED|Infusion 2||5
8691957|NCT02065245|21457534|P1|COMPLETED|Infusion 2||5
8691958|NCT02065245|21457528|P7|STARTED|Infusion 2||12
8691959|NCT02065245|21457529|P6|STARTED|Infusion 2||6
8691960|NCT02065245|21457530|P5|STARTED|Infusion 2||0
8691961|NCT02065245|21457531|P4|STARTED|Infusion 2||0
8691962|NCT02065245|21457532|P3|STARTED|Infusion 2||2
8691963|NCT02065245|21457533|P2|STARTED|Infusion 2||5
8691964|NCT02065245|21457534|P1|STARTED|Infusion 2||5
8691965|NCT02065245|21457528|P7|NOT COMPLETED|Infusion 1||1
8691966|NCT02065245|21457529|P6|NOT COMPLETED|Infusion 1||0
8691967|NCT02065245|21457530|P5|NOT COMPLETED|Infusion 1||1
8691968|NCT02065245|21457531|P4|NOT COMPLETED|Infusion 1||0
8691969|NCT02065245|21457532|P3|NOT COMPLETED|Infusion 1||1
8691970|NCT02065245|21457533|P2|NOT COMPLETED|Infusion 1||0
8691971|NCT02065245|21457534|P1|NOT COMPLETED|Infusion 1||0
8691972|NCT02065245|21457528|P7|COMPLETED|Infusion 1||19
8691973|NCT02065245|21457529|P6|COMPLETED|Infusion 1||10
8691974|NCT02065245|21457530|P5|COMPLETED|Infusion 1||9
8691975|NCT02065245|21457531|P4|COMPLETED|Infusion 1||10
8691976|NCT02065245|21457532|P3|COMPLETED|Infusion 1||4
8691977|NCT02065245|21457533|P2|COMPLETED|Infusion 1||5
8691978|NCT02065245|21457534|P1|COMPLETED|Infusion 1||5
8691979|NCT02065245|21457528|P7|STARTED|Infusion 1||20
8691980|NCT02065245|21457529|P6|STARTED|Infusion 1||10
8691981|NCT02065245|21457530|P5|STARTED|Infusion 1||10
8691982|NCT02065245|21457531|P4|STARTED|Infusion 1||10
8691983|NCT02065245|21457532|P3|STARTED|Infusion 1||5
8691984|NCT02065245|21457533|P2|STARTED|Infusion 1||5
8691985|NCT02065245|21457534|P1|STARTED|Infusion 1||5
8691986|NCT01276184|21457552|P2|NOT COMPLETED|Overall Study||0
8691987|NCT01276184|21457553|P1|NOT COMPLETED|Overall Study||0
8691988|NCT01276184|21457552|P2|COMPLETED|Overall Study||9
8691989|NCT01276184|21457553|P1|COMPLETED|Overall Study||13
8691990|NCT01276184|21457552|P2|STARTED|Overall Study||9
8691991|NCT01276184|21457553|P1|STARTED|Overall Study||13
8691992|NCT00772330|21457559|P1|NOT COMPLETED|Overall Study||3
8691993|NCT00772330|21457559|P1|COMPLETED|Overall Study||20
8691994|NCT00772330|21457559|P1|STARTED|Overall Study||23
8691995|NCT00445068|21457569|P1|NOT COMPLETED|Overall Study||36
8691996|NCT00445068|21457569|P1|COMPLETED|Overall Study||2
8691997|NCT00445068|21457569|P1|STARTED|Overall Study||38
8691998|NCT00367003|21457584|P1|NOT COMPLETED|Overall Study||9
8691999|NCT00367003|21457584|P1|COMPLETED|Overall Study||28
8692000|NCT00367003|21457584|P1|STARTED|Overall Study||37
8692001|NCT00140855|21457588|P1|NOT COMPLETED|Overall Study||2
8692002|NCT00140855|21457588|P1|COMPLETED|Overall Study||4
8692003|NCT00140855|21457588|P1|STARTED|Overall Study||6
8692004|NCT01467063|21457594|P2|NOT COMPLETED|Overall Study||0
8692005|NCT01467063|21457595|P1|NOT COMPLETED|Overall Study||1
8692006|NCT01467063|21457594|P2|COMPLETED|Overall Study||7
8692007|NCT01467063|21457595|P1|COMPLETED|Overall Study||5
8692008|NCT01467063|21457594|P2|STARTED|Overall Study||7
8692009|NCT01467063|21457595|P1|STARTED|Overall Study||6
8692010|NCT04392219|21457621|P18|NOT COMPLETED|Overall Study||0
8692011|NCT04392219|21457622|P17|NOT COMPLETED|Overall Study||0
8692012|NCT04392219|21457623|P16|NOT COMPLETED|Overall Study||0
8692013|NCT04392219|21457624|P15|NOT COMPLETED|Overall Study||0
8692014|NCT04392219|21457625|P14|NOT COMPLETED|Overall Study||0
8692015|NCT04392219|21457626|P13|NOT COMPLETED|Overall Study||0
8692016|NCT04392219|21457627|P12|NOT COMPLETED|Overall Study||0
8692017|NCT04392219|21457628|P11|NOT COMPLETED|Overall Study||0
8692018|NCT04392219|21457629|P10|NOT COMPLETED|Overall Study||0
8692019|NCT04392219|21457630|P9|NOT COMPLETED|Overall Study||0
8692020|NCT04392219|21457631|P8|NOT COMPLETED|Overall Study||0
8692021|NCT04392219|21457632|P7|NOT COMPLETED|Overall Study||0
8692022|NCT04392219|21457633|P6|NOT COMPLETED|Overall Study||0
8692023|NCT04392219|21457634|P5|NOT COMPLETED|Overall Study||0
8692024|NCT04392219|21457635|P4|NOT COMPLETED|Overall Study||0
8692025|NCT04392219|21457636|P3|NOT COMPLETED|Overall Study||0
8692026|NCT04392219|21457637|P2|NOT COMPLETED|Overall Study||0
8692027|NCT04392219|21457638|P1|NOT COMPLETED|Overall Study||0
8692028|NCT04392219|21457621|P18|COMPLETED|Overall Study||6
8692029|NCT04392219|21457622|P17|COMPLETED|Overall Study||6
8692030|NCT04392219|21457623|P16|COMPLETED|Overall Study||6
8692031|NCT04392219|21457624|P15|COMPLETED|Overall Study||6
8692032|NCT04392219|21457625|P14|COMPLETED|Overall Study||6
8692033|NCT04392219|21457626|P13|COMPLETED|Overall Study||6
8692034|NCT04392219|21457627|P12|COMPLETED|Overall Study||6
8692035|NCT04392219|21457628|P11|COMPLETED|Overall Study||14
8692036|NCT04392219|21457629|P10|COMPLETED|Overall Study||10
8692037|NCT04392219|21457630|P9|COMPLETED|Overall Study||6
8692038|NCT04392219|21457631|P8|COMPLETED|Overall Study||6
8692039|NCT04392219|21457632|P7|COMPLETED|Overall Study||6
8692040|NCT04392219|21457633|P6|COMPLETED|Overall Study||6
8692041|NCT04392219|21457634|P5|COMPLETED|Overall Study||6
8692042|NCT04392219|21457635|P4|COMPLETED|Overall Study||6
8692043|NCT04392219|21457636|P3|COMPLETED|Overall Study||6
8692044|NCT04392219|21457637|P2|COMPLETED|Overall Study||6
8692045|NCT04392219|21457638|P1|COMPLETED|Overall Study||16
8692046|NCT04392219|21457621|P18|STARTED|Overall Study||6
8692047|NCT04392219|21457622|P17|STARTED|Overall Study||6
8692048|NCT04392219|21457623|P16|STARTED|Overall Study||6
8692049|NCT04392219|21457624|P15|STARTED|Overall Study||6
8692050|NCT04392219|21457625|P14|STARTED|Overall Study||6
8692051|NCT04392219|21457626|P13|STARTED|Overall Study||6
8692052|NCT04392219|21457627|P12|STARTED|Overall Study||6
8692053|NCT04392219|21457628|P11|STARTED|Overall Study||14
8692054|NCT04392219|21457629|P10|STARTED|Overall Study||10
8692055|NCT04392219|21457630|P9|STARTED|Overall Study||6
8692056|NCT04392219|21457631|P8|STARTED|Overall Study||6
8692057|NCT04392219|21457632|P7|STARTED|Overall Study||6
8692058|NCT04392219|21457633|P6|STARTED|Overall Study||6
8692059|NCT04392219|21457634|P5|STARTED|Overall Study||6
8692060|NCT04392219|21457635|P4|STARTED|Overall Study||6
8692061|NCT04392219|21457636|P3|STARTED|Overall Study||6
8692062|NCT04392219|21457637|P2|STARTED|Overall Study||6
8692063|NCT04392219|21457638|P1|STARTED|Overall Study||16
8692064|NCT03987932|21457679|P3|NOT COMPLETED|Overall Study||2
8692065|NCT03987932|21457680|P2|NOT COMPLETED|Overall Study||1
8692066|NCT03987932|21457681|P1|NOT COMPLETED|Overall Study||2
8692067|NCT03987932|21457679|P3|COMPLETED|Overall Study||2
8692068|NCT03987932|21457680|P2|COMPLETED|Overall Study||2
8692069|NCT03987932|21457681|P1|COMPLETED|Overall Study||2
8692070|NCT03987932|21457679|P3|6 Months|Overall Study||2
8692071|NCT03987932|21457680|P2|6 Months|Overall Study||2
8692072|NCT03987932|21457681|P1|6 Months|Overall Study||2
8692073|NCT03987932|21457679|P3|3 Months|Overall Study||3
8692074|NCT03987932|21457680|P2|3 Months|Overall Study||2
8692075|NCT03987932|21457681|P1|3 Months|Overall Study||4
8692076|NCT03987932|21457679|P3|1 Month|Overall Study||3
8692077|NCT03987932|21457680|P2|1 Month|Overall Study||2
8692078|NCT03987932|21457681|P1|1 Month|Overall Study||4
8692079|NCT03987932|21457679|P3|STARTED|Overall Study||4
8692080|NCT03987932|21457680|P2|STARTED|Overall Study||3
8692081|NCT03987932|21457681|P1|STARTED|Overall Study||4
8692082|NCT04063371|21457716|P3|NOT COMPLETED|Overall Study||0
8692083|NCT04063371|21457717|P2|NOT COMPLETED|Overall Study||0
8692084|NCT04063371|21457718|P1|NOT COMPLETED|Overall Study||0
8692085|NCT04063371|21457716|P3|COMPLETED|Overall Study||100
8692086|NCT04063371|21457717|P2|COMPLETED|Overall Study||100
8692087|NCT04063371|21457718|P1|COMPLETED|Overall Study||100
8692088|NCT04063371|21457716|P3|STARTED|Overall Study||100
8692089|NCT04063371|21457717|P2|STARTED|Overall Study||100
8692090|NCT04063371|21457718|P1|STARTED|Overall Study||100
8692091|NCT03823391|21457742|P2|NOT COMPLETED|Period 2: Weeks 12 to Week 24||1
8692092|NCT03823391|21457743|P1|NOT COMPLETED|Period 2: Weeks 12 to Week 24||2
8692093|NCT03823391|21457742|P2|COMPLETED|Period 2: Weeks 12 to Week 24||30
8692094|NCT03823391|21457743|P1|COMPLETED|Period 2: Weeks 12 to Week 24||15
8692095|NCT03823391|21457742|P2|STARTED|Period 2: Weeks 12 to Week 24||31
8692096|NCT03823391|21457743|P1|STARTED|Period 2: Weeks 12 to Week 24||17
8692097|NCT03823391|21457742|P2|NOT COMPLETED|Period 1: Week 1 to Week 12||0
8692098|NCT03823391|21457743|P1|NOT COMPLETED|Period 1: Week 1 to Week 12||0
8692099|NCT03823391|21457742|P2|COMPLETED|Period 1: Week 1 to Week 12||31
8692100|NCT03823391|21457743|P1|COMPLETED|Period 1: Week 1 to Week 12||17
8692101|NCT03823391|21457742|P2|STARTED|Period 1: Week 1 to Week 12||31
8692102|NCT03823391|21457743|P1|STARTED|Period 1: Week 1 to Week 12||17
8692103|NCT03756285|21457763|P2|NOT COMPLETED|Overall Study||5
8692104|NCT03756285|21457764|P1|NOT COMPLETED|Overall Study||3
8692105|NCT03756285|21457763|P2|COMPLETED|Overall Study||9
8692106|NCT03756285|21457764|P1|COMPLETED|Overall Study||24
8692107|NCT03756285|21457763|P2|STARTED|Overall Study||14
8692108|NCT03756285|21457764|P1|STARTED|Overall Study||27
8692109|NCT03723070|21457774|P1|NOT COMPLETED|Overall Study||9
8692110|NCT03723070|21457774|P1|COMPLETED|Overall Study||79
8692111|NCT03723070|21457774|P1|STARTED|Overall Study||88
8692112|NCT03634813|21457784|P2|NOT COMPLETED|Overall Study||0
8692113|NCT03634813|21457785|P1|NOT COMPLETED|Overall Study||0
8692114|NCT03634813|21457784|P2|COMPLETED|Overall Study||51
8692115|NCT03634813|21457785|P1|COMPLETED|Overall Study||49
8692116|NCT03634813|21457784|P2|STARTED|Overall Study||51
8692117|NCT03634813|21457785|P1|STARTED|Overall Study||49
8692121|NCT03461211|21457814|P2|NOT COMPLETED|Overall Study||2
8692122|NCT03461211|21457815|P1|NOT COMPLETED|Overall Study||1
8692123|NCT03461211|21457814|P2|COMPLETED|Overall Study||12
8692124|NCT03461211|21457815|P1|COMPLETED|Overall Study||36
8692125|NCT03461211|21457814|P2|Relapsed During Follow-Up Period of OPTIC|Overall Study||9
8692126|NCT03461211|21457815|P1|Relapsed During Follow-Up Period of OPTIC|Overall Study||1
8692127|NCT03461211|21457814|P2|Proptosis Non-Responders in OPTIC|Overall Study||5
8692128|NCT03461211|21457815|P1|Proptosis Non-Responders in OPTIC|Overall Study||36
8692129|NCT03461211|21457814|P2|STARTED|Overall Study||14
8692130|NCT03461211|21457815|P1|STARTED|Overall Study||37
8692131|NCT03460652|21457831|P1|NOT COMPLETED|Overall Study||127
8692132|NCT03460652|21457831|P1|COMPLETED|Overall Study||155
8692133|NCT03460652|21457831|P1|Entered Treatment Phase|Overall Study||238
8692134|NCT03460652|21457831|P1|STARTED|Overall Study||282
8692135|NCT03338296|21457840|P2|NOT COMPLETED|Overall Study||108
8692136|NCT03338296|21457841|P1|NOT COMPLETED|Overall Study||103
8692137|NCT03338296|21457840|P2|COMPLETED|Overall Study||31
8692138|NCT03338296|21457841|P1|COMPLETED|Overall Study||36
8692139|NCT03338296|21457840|P2|Safety Analysis Set|Overall Study||136
8692140|NCT03338296|21457841|P1|Safety Analysis Set|Overall Study||139
8692141|NCT03338296|21457840|P2|STARTED|Overall Study||139
8692142|NCT03338296|21457841|P1|STARTED|Overall Study||139
8692143|NCT03333941|21457893|P1|NOT COMPLETED|Overall Study||13
8692144|NCT03333941|21457893|P1|COMPLETED|Overall Study||63
8692145|NCT03333941|21457893|P1|STARTED|Overall Study||76
8692146|NCT03304184|21457899|P2|NOT COMPLETED|Overall Study||2
8692147|NCT03304184|21457900|P1|NOT COMPLETED|Overall Study||1
8692148|NCT03304184|21457899|P2|COMPLETED|Overall Study||7
8692149|NCT03304184|21457900|P1|COMPLETED|Overall Study||14
8692150|NCT03304184|21457899|P2|STARTED|Overall Study||9
8692151|NCT03304184|21457900|P1|STARTED|Overall Study||15
8692152|NCT03300336|21457912|P2|NOT COMPLETED|Overall Study||0
8692153|NCT03300336|21457913|P1|NOT COMPLETED|Overall Study||0
8692154|NCT03300336|21457912|P2|COMPLETED|Overall Study||6952
8692155|NCT03300336|21457913|P1|COMPLETED|Overall Study||7348
8692156|NCT03300336|21457912|P2|STARTED|Overall Study||6952
8692157|NCT03300336|21457913|P1|STARTED|Overall Study||7348
8692158|NCT03291379|21457941|P1|NOT COMPLETED|Overall Study||0
8692159|NCT03291379|21457941|P1|COMPLETED|Overall Study||8
8692160|NCT03291379|21457941|P1|STARTED|Overall Study||8
8692161|NCT03101111|21457955|P2|NOT COMPLETED|Overall Study||1
8692162|NCT03101111|21457956|P1|NOT COMPLETED|Overall Study||3
8692163|NCT03101111|21457955|P2|COMPLETED|Overall Study|End of Study Visit|7
8692164|NCT03101111|21457956|P1|COMPLETED|Overall Study|End of Study Visit|23
8692165|NCT03101111|21457955|P2|STARTED|Overall Study|First subject signed ICF (MMR group)|8
8692166|NCT03101111|21457956|P1|STARTED|Overall Study|First subject signed ICF (MV-CHIK group)|26
8692167|NCT03026283|21457970|P8|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692168|NCT03026283|21457971|P7|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692169|NCT03026283|21457972|P6|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692170|NCT03026283|21457973|P5|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692171|NCT03026283|21457974|P4|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692172|NCT03026283|21457975|P3|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692173|NCT03026283|21457976|P2|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692174|NCT03026283|21457977|P1|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692175|NCT03026283|21457970|P8|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692176|NCT03026283|21457971|P7|COMPLETED|Optimal Care/ICA Diagnostic Cath||21
8692177|NCT03026283|21457972|P6|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692178|NCT03026283|21457973|P5|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692179|NCT03026283|21457974|P4|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692180|NCT03026283|21457975|P3|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692181|NCT03026283|21457976|P2|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692182|NCT03026283|21457977|P1|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
8692183|NCT03026283|21457970|P8|STARTED|Optimal Care/ICA Diagnostic Cath||0
8692184|NCT03026283|21457971|P7|STARTED|Optimal Care/ICA Diagnostic Cath||21
8692185|NCT03026283|21457972|P6|STARTED|Optimal Care/ICA Diagnostic Cath||0
8692186|NCT03026283|21457973|P5|STARTED|Optimal Care/ICA Diagnostic Cath||0
8692187|NCT03026283|21457974|P4|STARTED|Optimal Care/ICA Diagnostic Cath||0
8692188|NCT03026283|21457975|P3|STARTED|Optimal Care/ICA Diagnostic Cath||0
8692189|NCT03026283|21457976|P2|STARTED|Optimal Care/ICA Diagnostic Cath||0
8692190|NCT03026283|21457977|P1|STARTED|Optimal Care/ICA Diagnostic Cath||0
8692191|NCT03026283|21457970|P8|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
8692192|NCT03026283|21457971|P7|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
8692193|NCT03026283|21457972|P6|NOT COMPLETED|Optimal Care/Stress Test/ICA||28
8692194|NCT03026283|21457973|P5|NOT COMPLETED|Optimal Care/Stress Test/ICA||38
8692195|NCT03026283|21457974|P4|NOT COMPLETED|Optimal Care/Stress Test/ICA||20
8692196|NCT03026283|21457975|P3|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
8692197|NCT03026283|21457976|P2|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
8692198|NCT03026283|21457977|P1|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
8692199|NCT03026283|21457970|P8|COMPLETED|Optimal Care/Stress Test/ICA||0
8692200|NCT03026283|21457971|P7|COMPLETED|Optimal Care/Stress Test/ICA||0
8692201|NCT03026283|21457972|P6|COMPLETED|Optimal Care/Stress Test/ICA||73
8692202|NCT03026283|21457973|P5|COMPLETED|Optimal Care/Stress Test/ICA||14
8692203|NCT03026283|21457974|P4|COMPLETED|Optimal Care/Stress Test/ICA||108
8692204|NCT03026283|21457975|P3|COMPLETED|Optimal Care/Stress Test/ICA||0
8692205|NCT03026283|21457976|P2|COMPLETED|Optimal Care/Stress Test/ICA||0
8692206|NCT03026283|21457977|P1|COMPLETED|Optimal Care/Stress Test/ICA||0
8692207|NCT03026283|21457970|P8|STARTED|Optimal Care/Stress Test/ICA||0
8692208|NCT03026283|21457971|P7|STARTED|Optimal Care/Stress Test/ICA||0
8692209|NCT03026283|21457972|P6|STARTED|Optimal Care/Stress Test/ICA||101
8692210|NCT03026283|21457973|P5|STARTED|Optimal Care/Stress Test/ICA||52
8692211|NCT03026283|21457974|P4|STARTED|Optimal Care/Stress Test/ICA||128
8692212|NCT03026283|21457975|P3|STARTED|Optimal Care/Stress Test/ICA||0
8692213|NCT03026283|21457976|P2|STARTED|Optimal Care/Stress Test/ICA||0
8692214|NCT03026283|21457977|P1|STARTED|Optimal Care/Stress Test/ICA||0
8692215|NCT03026283|21457970|P8|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8692216|NCT03026283|21457971|P7|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8692217|NCT03026283|21457972|P6|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8692218|NCT03026283|21457973|P5|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8692219|NCT03026283|21457974|P4|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8692220|NCT03026283|21457975|P3|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||15
8692221|NCT03026283|21457976|P2|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||3
8692222|NCT03026283|21457977|P1|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8692223|NCT03026283|21457970|P8|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8692224|NCT03026283|21457971|P7|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8692225|NCT03026283|21457972|P6|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8692226|NCT03026283|21457973|P5|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8692227|NCT03026283|21457974|P4|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8692228|NCT03026283|21457975|P3|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||265
8692229|NCT03026283|21457976|P2|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||286
8692230|NCT03026283|21457977|P1|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
8692231|NCT03026283|21457970|P8|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
8692232|NCT03026283|21457971|P7|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
8692233|NCT03026283|21457972|P6|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
8692234|NCT03026283|21457973|P5|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
8692235|NCT03026283|21457974|P4|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
8692236|NCT03026283|21457975|P3|STARTED|Optimal Medical Care/FFR-CT Diagnosis||280
8692237|NCT03026283|21457976|P2|STARTED|Optimal Medical Care/FFR-CT Diagnosis||289
8692238|NCT03026283|21457977|P1|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
8692239|NCT03026283|21457970|P8|NOT COMPLETED|CCTA Diagnosis||0
8692240|NCT03026283|21457971|P7|NOT COMPLETED|CCTA Diagnosis||0
8692241|NCT03026283|21457972|P6|NOT COMPLETED|CCTA Diagnosis||0
8692242|NCT03026283|21457973|P5|NOT COMPLETED|CCTA Diagnosis||0
8692243|NCT03026283|21457974|P4|NOT COMPLETED|CCTA Diagnosis||0
8692244|NCT03026283|21457975|P3|NOT COMPLETED|CCTA Diagnosis||0
8692245|NCT03026283|21457976|P2|NOT COMPLETED|CCTA Diagnosis||0
8692246|NCT03026283|21457977|P1|NOT COMPLETED|CCTA Diagnosis||14
8692247|NCT03026283|21457970|P8|COMPLETED|CCTA Diagnosis||0
8692248|NCT03026283|21457971|P7|COMPLETED|CCTA Diagnosis||0
8692249|NCT03026283|21457972|P6|COMPLETED|CCTA Diagnosis||0
8692250|NCT03026283|21457973|P5|COMPLETED|CCTA Diagnosis||0
8692251|NCT03026283|21457974|P4|COMPLETED|CCTA Diagnosis||0
8692252|NCT03026283|21457975|P3|COMPLETED|CCTA Diagnosis||0
8692253|NCT03026283|21457976|P2|COMPLETED|CCTA Diagnosis||0
8692254|NCT03026283|21457977|P1|COMPLETED|CCTA Diagnosis||572
8692255|NCT03026283|21457970|P8|STARTED|CCTA Diagnosis||0
8692256|NCT03026283|21457971|P7|STARTED|CCTA Diagnosis||0
8692257|NCT03026283|21457972|P6|STARTED|CCTA Diagnosis||0
8692258|NCT03026283|21457973|P5|STARTED|CCTA Diagnosis||0
8692259|NCT03026283|21457974|P4|STARTED|CCTA Diagnosis||0
8692260|NCT03026283|21457975|P3|STARTED|CCTA Diagnosis||0
8692261|NCT03026283|21457976|P2|STARTED|CCTA Diagnosis||0
8692262|NCT03026283|21457977|P1|STARTED|CCTA Diagnosis||586
8692263|NCT03018925|21457992|P1|NOT COMPLETED|Overall Study||0
8692264|NCT03018925|21457992|P1|COMPLETED|Overall Study||15
8692265|NCT03018925|21457992|P1|STARTED|Overall Study||15
8692266|NCT02886494|21458019|P2|NOT COMPLETED|Overall Study||4
8692267|NCT02886494|21458020|P1|NOT COMPLETED|Overall Study||17
8692268|NCT02886494|21458019|P2|COMPLETED|Overall Study||16
8692269|NCT02886494|21458020|P1|COMPLETED|Overall Study||43
8692270|NCT02886494|21458019|P2|STARTED|Overall Study||20
8692271|NCT02886494|21458020|P1|STARTED|Overall Study||60
8692272|NCT02690168|21458048|P1|NOT COMPLETED|Overall Study||0
8692273|NCT02690168|21458048|P1|COMPLETED|Overall Study||6
8692274|NCT02690168|21458048|P1|STARTED|Overall Study||6
8692275|NCT02876172|21458058|P2|NOT COMPLETED|Overall Study||0
8692276|NCT02876172|21458059|P1|NOT COMPLETED|Overall Study||0
8692277|NCT02876172|21458058|P2|COMPLETED|Overall Study||6
8692278|NCT02876172|21458059|P1|COMPLETED|Overall Study||6
8692279|NCT02876172|21458058|P2|STARTED|Overall Study||6
8692280|NCT02876172|21458059|P1|STARTED|Overall Study||6
8692284|NCT02540993|21458156|P2|NOT COMPLETED|Overall Study||36
8692285|NCT02540993|21458157|P1|NOT COMPLETED|Overall Study||42
8692286|NCT02540993|21458156|P2|COMPLETED|Overall Study||2832
8692287|NCT02540993|21458157|P1|COMPLETED|Overall Study||2824
8692288|NCT02540993|21458156|P2|Treated|Overall Study||2831
8692289|NCT02540993|21458157|P1|Treated|Overall Study||2827
8692290|NCT02540993|21458156|P2|Included in FAS|Overall Study||2841
8692291|NCT02540993|21458157|P1|Included in FAS|Overall Study||2833
8692292|NCT02540993|21458156|P2|STARTED|Overall Study||2868
8692293|NCT02540993|21458157|P1|STARTED|Overall Study||2866
8692294|NCT02159521|21458173|P1|NOT COMPLETED|Overall Study||18
8692295|NCT02159521|21458173|P1|COMPLETED|Overall Study||63
8692296|NCT02159521|21458173|P1|Received EkoSonic® Treatment|Overall Study||78
8692297|NCT02159521|21458173|P1|STARTED|Overall Study|4 participants had both limbs treated.|81
8692298|NCT02511678|21458194|P1|NOT COMPLETED|Overall Study||36
8692299|NCT02511678|21458194|P1|COMPLETED|Overall Study||37
8692300|NCT02511678|21458194|P1|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65
8692301|NCT02511678|21458194|P1|Participants Discontinued Pre-Treatment|Overall Study||7
8692302|NCT02511678|21458194|P1|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66
8692303|NCT02511678|21458194|P1|STARTED|Overall Study||73
8692304|NCT02508207|21458209|P2|NOT COMPLETED|Overall Study||0
8692305|NCT02508207|21458210|P1|NOT COMPLETED|Overall Study||0
8692306|NCT02508207|21458209|P2|COMPLETED|Overall Study||27
8692307|NCT02508207|21458210|P1|COMPLETED|Overall Study||7
8692308|NCT02508207|21458209|P2|STARTED|Overall Study||27
8692309|NCT02508207|21458210|P1|STARTED|Overall Study||7
8692310|NCT02499380|21458224|P1|NOT COMPLETED|Overall Study||3
8692311|NCT02499380|21458224|P1|COMPLETED|Overall Study||17
8692312|NCT02499380|21458224|P1|STARTED|Overall Study||20
8692313|NCT02396758|21458233|P4|NOT COMPLETED|Overall Study||5
8692314|NCT02396758|21458234|P3|NOT COMPLETED|Overall Study||4
8692315|NCT02396758|21458235|P2|NOT COMPLETED|Overall Study||6
8692316|NCT02396758|21458236|P1|NOT COMPLETED|Overall Study||12
8692317|NCT02396758|21458233|P4|COMPLETED|Overall Study||13
8692318|NCT02396758|21458234|P3|COMPLETED|Overall Study||34
8692319|NCT02396758|21458235|P2|COMPLETED|Overall Study||31
8692320|NCT02396758|21458236|P1|COMPLETED|Overall Study||26
8692321|NCT02396758|21458233|P4|STARTED|Overall Study||18
8692322|NCT02396758|21458234|P3|STARTED|Overall Study||38
8692323|NCT02396758|21458235|P2|STARTED|Overall Study||37
8692324|NCT02396758|21458236|P1|STARTED|Overall Study||38
8692325|NCT02337517|21458350|P1|NOT COMPLETED|Overall Study||0
8692326|NCT02337517|21458350|P1|COMPLETED|Overall Study||6
8692327|NCT02337517|21458350|P1|STARTED|Overall Study||6
8692328|NCT02200614|21458363|P2|NOT COMPLETED|Open Label||23
8692329|NCT02200614|21458364|P1|NOT COMPLETED|Open Label||125
8692330|NCT02200614|21458363|P2|COMPLETED|Open Label||147
8692331|NCT02200614|21458364|P1|COMPLETED|Open Label||466
8692332|NCT02200614|21458363|P2|STARTED|Open Label|Not all participants from treatment period entered follow-up|170
8692333|NCT02200614|21458364|P1|STARTED|Open Label|Not all participants from treatment period entered follow-up|591
8692334|NCT02200614|21458363|P2|NOT COMPLETED|Double Blind Treatment||384
8692335|NCT02200614|21458364|P1|NOT COMPLETED|Double Blind Treatment||364
8692336|NCT02200614|21458363|P2|COMPLETED|Double Blind Treatment||170
8692337|NCT02200614|21458364|P1|COMPLETED|Double Blind Treatment||591
8692338|NCT02200614|21458363|P2|STARTED|Double Blind Treatment||554
8692339|NCT02200614|21458364|P1|STARTED|Double Blind Treatment||955
8692340|NCT01945775|21458388|P2|NOT COMPLETED|Overall Study||144
8692341|NCT01945775|21458389|P1|NOT COMPLETED|Overall Study||287
8692342|NCT01945775|21458388|P2|COMPLETED|Overall Study||0
8692343|NCT01945775|21458389|P1|COMPLETED|Overall Study||0
8692344|NCT01945775|21458388|P2|Treated|Overall Study||126
8692345|NCT01945775|21458389|P1|Treated|Overall Study||286
8692346|NCT01945775|21458388|P2|STARTED|Overall Study||144
8692347|NCT01945775|21458389|P1|STARTED|Overall Study||287
8692348|NCT01943916|21458418|P1|NOT COMPLETED|Overall Study||366
8692349|NCT01943916|21458418|P1|COMPLETED|Overall Study||1739
8692350|NCT01943916|21458418|P1|STARTED|Overall Study||2105
8692351|NCT01680458|21458429|P1|NOT COMPLETED|Overall Study||3
8692352|NCT01680458|21458429|P1|COMPLETED|Overall Study||27
8692353|NCT01680458|21458429|P1|STARTED|Overall Study||30
8692354|NCT01905540|21458442|P4|NOT COMPLETED|Period 3||1
8692355|NCT01905540|21458443|P3|NOT COMPLETED|Period 3||1
8692356|NCT01905540|21458444|P2|NOT COMPLETED|Period 3||0
8692357|NCT01905540|21458445|P1|NOT COMPLETED|Period 3||1
8692358|NCT01905540|21458442|P4|COMPLETED|Period 3||6
8692359|NCT01905540|21458443|P3|COMPLETED|Period 3||6
8692360|NCT01905540|21458444|P2|COMPLETED|Period 3||7
8692361|NCT01905540|21458445|P1|COMPLETED|Period 3||6
8692362|NCT01905540|21458442|P4|STARTED|Period 3||7
8692363|NCT01905540|21458443|P3|STARTED|Period 3||7
8692364|NCT01905540|21458444|P2|STARTED|Period 3||7
8692365|NCT01905540|21458445|P1|STARTED|Period 3||7
8692366|NCT01905540|21458442|P4|NOT COMPLETED|Period 2||0
8692367|NCT01905540|21458443|P3|NOT COMPLETED|Period 2||0
8692368|NCT01905540|21458444|P2|NOT COMPLETED|Period 2||0
8692369|NCT01905540|21458445|P1|NOT COMPLETED|Period 2||0
8692370|NCT01905540|21458442|P4|COMPLETED|Period 2||7
8692371|NCT01905540|21458443|P3|COMPLETED|Period 2||7
8692372|NCT01905540|21458444|P2|COMPLETED|Period 2||7
8692373|NCT01905540|21458445|P1|COMPLETED|Period 2||7
8692374|NCT01905540|21458442|P4|STARTED|Period 2||7
8692375|NCT01905540|21458443|P3|STARTED|Period 2||7
8692376|NCT01905540|21458444|P2|STARTED|Period 2||7
8692377|NCT01905540|21458445|P1|STARTED|Period 2||7
8692378|NCT01905540|21458442|P4|NOT COMPLETED|Period 1||0
8692379|NCT01905540|21458443|P3|NOT COMPLETED|Period 1||0
8692380|NCT01905540|21458444|P2|NOT COMPLETED|Period 1||0
8692381|NCT01905540|21458445|P1|NOT COMPLETED|Period 1||0
8692382|NCT01905540|21458442|P4|COMPLETED|Period 1||7
8692383|NCT01905540|21458443|P3|COMPLETED|Period 1||7
8692384|NCT01905540|21458444|P2|COMPLETED|Period 1||7
8692385|NCT01905540|21458445|P1|COMPLETED|Period 1||7
8692386|NCT01905540|21458442|P4|STARTED|Period 1||7
8692387|NCT01905540|21458443|P3|STARTED|Period 1||7
8692388|NCT01905540|21458444|P2|STARTED|Period 1||7
8692389|NCT01905540|21458445|P1|STARTED|Period 1||7
8692390|NCT01858753|21458465|P2|NOT COMPLETED|Overall Study||0
8692391|NCT01858753|21458466|P1|NOT COMPLETED|Overall Study||5
8692392|NCT01858753|21458465|P2|COMPLETED|Overall Study||0
8692393|NCT01858753|21458466|P1|COMPLETED|Overall Study||0
8692394|NCT01858753|21458465|P2|STARTED|Overall Study||0
8692395|NCT01858753|21458466|P1|STARTED|Overall Study||5
8692396|NCT01608490|21458474|P2|NOT COMPLETED|Overall Study||15
8692397|NCT01608490|21458475|P1|NOT COMPLETED|Overall Study||17
8692398|NCT01608490|21458474|P2|COMPLETED|Overall Study||142
8692399|NCT01608490|21458475|P1|COMPLETED|Overall Study||141
8692400|NCT01608490|21458474|P2|STARTED|Overall Study||157
8692401|NCT01608490|21458475|P1|STARTED|Overall Study||158
8692402|NCT01806623|21458493|P1|NOT COMPLETED|Overall Study||58
8692403|NCT01806623|21458493|P1|COMPLETED|Overall Study||99
8692404|NCT01806623|21458493|P1|STARTED|Overall Study||157
8692405|NCT01513759|21458510|P1|NOT COMPLETED|Overall Study||5
8692406|NCT01513759|21458510|P1|COMPLETED|Overall Study||145
8692407|NCT01513759|21458510|P1|At Least One Device Successfully Placed|Overall Study||149
8692408|NCT01513759|21458510|P1|STARTED|Overall Study||150
8692409|NCT01051557|21458526|P7|NOT COMPLETED|Overall Study||6
8692410|NCT01051557|21458527|P6|NOT COMPLETED|Overall Study||6
8692411|NCT01051557|21458528|P5|NOT COMPLETED|Overall Study||7
8692412|NCT01051557|21458529|P4|NOT COMPLETED|Overall Study||3
8692413|NCT01051557|21458530|P3|NOT COMPLETED|Overall Study||6
8692414|NCT01051557|21458531|P2|NOT COMPLETED|Overall Study||3
8692415|NCT01051557|21458532|P1|NOT COMPLETED|Overall Study||4
8692416|NCT01051557|21458526|P7|COMPLETED|Overall Study||0
8692417|NCT01051557|21458527|P6|COMPLETED|Overall Study||0
8692418|NCT01051557|21458528|P5|COMPLETED|Overall Study||1
8692419|NCT01051557|21458529|P4|COMPLETED|Overall Study||0
8692420|NCT01051557|21458530|P3|COMPLETED|Overall Study||0
8692421|NCT01051557|21458531|P2|COMPLETED|Overall Study||0
8692422|NCT01051557|21458532|P1|COMPLETED|Overall Study||0
8692423|NCT01051557|21458526|P7|STARTED|Overall Study||6
8692424|NCT01051557|21458527|P6|STARTED|Overall Study||6
8692425|NCT01051557|21458528|P5|STARTED|Overall Study||8
8692426|NCT01051557|21458529|P4|STARTED|Overall Study||3
8692427|NCT01051557|21458530|P3|STARTED|Overall Study||6
8692428|NCT01051557|21458531|P2|STARTED|Overall Study||3
8692429|NCT01051557|21458532|P1|STARTED|Overall Study||4
8692430|NCT01732263|21458551|P2|NOT COMPLETED|Overall Study||0
8692431|NCT01732263|21458552|P1|NOT COMPLETED|Overall Study||0
8692432|NCT01732263|21458551|P2|COMPLETED|Overall Study||20
8692433|NCT01732263|21458552|P1|COMPLETED|Overall Study||23
8692434|NCT01732263|21458551|P2|STARTED|Overall Study||20
8692435|NCT01732263|21458552|P1|STARTED|Overall Study||23
8692436|NCT01431638|21458595|P3|NOT COMPLETED|Overall Study||62
8692437|NCT01431638|21458596|P2|NOT COMPLETED|Overall Study||71
8692438|NCT01431638|21458597|P1|NOT COMPLETED|Overall Study||66
8692439|NCT01431638|21458595|P3|COMPLETED|Overall Study||70
8692440|NCT01431638|21458596|P2|COMPLETED|Overall Study||61
8692441|NCT01431638|21458597|P1|COMPLETED|Overall Study||67
8692442|NCT01431638|21458595|P3|Entered Extension 1 Study|Overall Study||76
8692443|NCT01431638|21458596|P2|Entered Extension 1 Study|Overall Study||71
8692444|NCT01431638|21458597|P1|Entered Extension 1 Study|Overall Study||85
8692445|NCT01431638|21458595|P3|Completed Core Study|Overall Study||108
8692446|NCT01431638|21458596|P2|Completed Core Study|Overall Study||117
8692447|NCT01431638|21458597|P1|Completed Core Study|Overall Study||124
8692448|NCT01431638|21458595|P3|STARTED|Overall Study||132
8692449|NCT01431638|21458596|P2|STARTED|Overall Study||132
8692450|NCT01431638|21458597|P1|STARTED|Overall Study||133
8692451|NCT02059057|21458626|P1|NOT COMPLETED|Overall Study||15
8692452|NCT02059057|21458626|P1|COMPLETED|Overall Study||87
8692453|NCT02059057|21458626|P1|STARTED|Overall Study||102
8692454|NCT02006472|21458638|P5|NOT COMPLETED|Period 2 (Through Week 52)||2
8692455|NCT02006472|21458639|P4|NOT COMPLETED|Period 2 (Through Week 52)||3
8692456|NCT02006472|21458640|P3|NOT COMPLETED|Period 2 (Through Week 52)||10
8692457|NCT02006472|21458641|P2|NOT COMPLETED|Period 2 (Through Week 52)||6
8692458|NCT02006472|21458642|P1|NOT COMPLETED|Period 2 (Through Week 52)||5
8692459|NCT02006472|21458638|P5|COMPLETED|Period 2 (Through Week 52)||44
8692460|NCT02006472|21458639|P4|COMPLETED|Period 2 (Through Week 52)||53
8692461|NCT02006472|21458640|P3|COMPLETED|Period 2 (Through Week 52)||44
8692462|NCT02006472|21458641|P2|COMPLETED|Period 2 (Through Week 52)||43
8692463|NCT02006472|21458642|P1|COMPLETED|Period 2 (Through Week 52)||52
8692464|NCT02006472|21458638|P5|Started Treatment in Period 2|Period 2 (Through Week 52)||46
8692465|NCT02006472|21458639|P4|Started Treatment in Period 2|Period 2 (Through Week 52)||56
8692466|NCT02006472|21458640|P3|Started Treatment in Period 2|Period 2 (Through Week 52)||52
8692467|NCT02006472|21458641|P2|Started Treatment in Period 2|Period 2 (Through Week 52)||49
8692468|NCT02006472|21458642|P1|Started Treatment in Period 2|Period 2 (Through Week 52)||57
8692469|NCT02006472|21458638|P5|STARTED|Period 2 (Through Week 52)||46
8692470|NCT02006472|21458639|P4|STARTED|Period 2 (Through Week 52)||56
8692471|NCT02006472|21458640|P3|STARTED|Period 2 (Through Week 52)||54
8692472|NCT02006472|21458641|P2|STARTED|Period 2 (Through Week 52)||49
8692473|NCT02006472|21458642|P1|STARTED|Period 2 (Through Week 52)||57
8692474|NCT02006472|21458638|P5|NOT COMPLETED|Period 1 (Through Week 26)||20
8692475|NCT02006472|21458639|P4|NOT COMPLETED|Period 1 (Through Week 26)||14
8692476|NCT02006472|21458640|P3|NOT COMPLETED|Period 1 (Through Week 26)||17
8692477|NCT02006472|21458641|P2|NOT COMPLETED|Period 1 (Through Week 26)||22
8692478|NCT02006472|21458642|P1|NOT COMPLETED|Period 1 (Through Week 26)||12
8692479|NCT02006472|21458638|P5|COMPLETED|Period 1 (Through Week 26)||62
8692480|NCT02006472|21458639|P4|COMPLETED|Period 1 (Through Week 26)||67
8692481|NCT02006472|21458640|P3|COMPLETED|Period 1 (Through Week 26)||65
8692482|NCT02006472|21458641|P2|COMPLETED|Period 1 (Through Week 26)||59
8692483|NCT02006472|21458642|P1|COMPLETED|Period 1 (Through Week 26)||70
8692484|NCT02006472|21458638|P5|Safety Set|Period 1 (Through Week 26)||82
8692485|NCT02006472|21458639|P4|Safety Set|Period 1 (Through Week 26)||81
8692486|NCT02006472|21458640|P3|Safety Set|Period 1 (Through Week 26)||82
8692487|NCT02006472|21458641|P2|Safety Set|Period 1 (Through Week 26)||81
8692488|NCT02006472|21458642|P1|Safety Set|Period 1 (Through Week 26)||82
8692489|NCT02006472|21458638|P5|FAS|Period 1 (Through Week 26)||81
8692490|NCT02006472|21458639|P4|FAS|Period 1 (Through Week 26)||81
8692491|NCT02006472|21458640|P3|FAS|Period 1 (Through Week 26)||79
8692492|NCT02006472|21458641|P2|FAS|Period 1 (Through Week 26)||75
8692493|NCT02006472|21458642|P1|FAS|Period 1 (Through Week 26)||81
8692494|NCT02006472|21458638|P5|ITT|Period 1 (Through Week 26)||82
8692495|NCT02006472|21458639|P4|ITT|Period 1 (Through Week 26)||81
8692496|NCT02006472|21458640|P3|ITT|Period 1 (Through Week 26)||82
8692497|NCT02006472|21458641|P2|ITT|Period 1 (Through Week 26)||81
8692498|NCT02006472|21458642|P1|ITT|Period 1 (Through Week 26)||82
8692499|NCT02006472|21458638|P5|STARTED|Period 1 (Through Week 26)||82
8692500|NCT02006472|21458639|P4|STARTED|Period 1 (Through Week 26)||81
8692501|NCT02006472|21458640|P3|STARTED|Period 1 (Through Week 26)||82
8692502|NCT02006472|21458641|P2|STARTED|Period 1 (Through Week 26)||81
8692503|NCT02006472|21458642|P1|STARTED|Period 1 (Through Week 26)||82
8692504|NCT01426763|21458672|P2|NOT COMPLETED|Overall Study||0
8692505|NCT01426763|21458673|P1|NOT COMPLETED|Overall Study||0
8692506|NCT01426763|21458672|P2|COMPLETED|Overall Study||6
8692507|NCT01426763|21458673|P1|COMPLETED|Overall Study||6
8692508|NCT01426763|21458672|P2|STARTED|Overall Study||6
8692509|NCT01426763|21458673|P1|STARTED|Overall Study||6
8692510|NCT01957787|21458685|P1|NOT COMPLETED|Overall Study||36
8692511|NCT01957787|21458685|P1|COMPLETED|Overall Study||95
8692512|NCT01957787|21458685|P1|Modified ITT (mITT) Population|Overall Study||128
8692513|NCT01957787|21458685|P1|Intent-to-Treat (ITT) Population|Overall Study||130
8692514|NCT01957787|21458685|P1|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131
8692515|NCT01307501|21458700|P1|NOT COMPLETED|Overall Study||23
8692516|NCT01307501|21458700|P1|COMPLETED|Overall Study||17
8692517|NCT01307501|21458700|P1|Intent-to-Treat (ITT) Population|Overall Study||40
8692518|NCT01307501|21458700|P1|STARTED|Overall Study||40
8692519|NCT00731341|21458713|P1|NOT COMPLETED|Overall Study||0
8692520|NCT00731341|21458713|P1|COMPLETED|Overall Study||3
8692521|NCT00731341|21458713|P1|STARTED|Overall Study||3
8692522|NCT01304277|21458722|P1|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
8692523|NCT01304277|21458722|P1|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
8692524|NCT01304277|21458722|P1|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
8692525|NCT01304277|21458722|P1|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
8692526|NCT01304277|21458722|P1|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
8692527|NCT01304277|21458722|P1|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
8692528|NCT01166997|21458736|P2|NOT COMPLETED|Overall Study||0
8692529|NCT01166997|21458737|P1|NOT COMPLETED|Overall Study||2
8692530|NCT01166997|21458736|P2|COMPLETED|Overall Study||30
8692531|NCT01166997|21458737|P1|COMPLETED|Overall Study||27
8692532|NCT01166997|21458736|P2|STARTED|Overall Study||30
8692533|NCT01166997|21458737|P1|STARTED|Overall Study||29
8692534|NCT01150903|21458747|P2|NOT COMPLETED|Overall Study||0
8692535|NCT01150903|21458748|P1|NOT COMPLETED|Overall Study||0
8692536|NCT01150903|21458747|P2|COMPLETED|Overall Study||74124
8692537|NCT01150903|21458748|P1|COMPLETED|Overall Study||24708
8692538|NCT01150903|21458747|P2|STARTED|Overall Study||74124
8692539|NCT01150903|21458748|P1|STARTED|Overall Study||24708
8692540|NCT01024920|21458764|P2|NOT COMPLETED|Overall Study||32
8692541|NCT01024920|21458765|P1|NOT COMPLETED|Overall Study||67
8692542|NCT01024920|21458764|P2|COMPLETED|Overall Study||0
8692543|NCT01024920|21458765|P1|COMPLETED|Overall Study||0
8692544|NCT01024920|21458764|P2|Treated|Overall Study||32
8692545|NCT01024920|21458765|P1|Treated|Overall Study||64
8692546|NCT01024920|21458764|P2|STARTED|Overall Study||32
8692547|NCT01024920|21458765|P1|STARTED|Overall Study||67
8692548|NCT00853229|21458827|P2|NOT COMPLETED|Phase 2: Cross Over||0
8692549|NCT00853229|21458828|P1|NOT COMPLETED|Phase 2: Cross Over||0
8692550|NCT00853229|21458827|P2|COMPLETED|Phase 2: Cross Over||0
8692551|NCT00853229|21458828|P1|COMPLETED|Phase 2: Cross Over||0
8692552|NCT00853229|21458827|P2|STARTED|Phase 2: Cross Over||0
8692553|NCT00853229|21458828|P1|STARTED|Phase 2: Cross Over||0
8692554|NCT00853229|21458827|P2|NOT COMPLETED|Phase 1: Initial Intervention||8
8692555|NCT00853229|21458828|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
8692556|NCT00853229|21458827|P2|COMPLETED|Phase 1: Initial Intervention||0
8692557|NCT00853229|21458828|P1|COMPLETED|Phase 1: Initial Intervention||0
8692558|NCT00853229|21458827|P2|STARTED|Phase 1: Initial Intervention||8
8692559|NCT00853229|21458828|P1|STARTED|Phase 1: Initial Intervention||8
8692560|NCT04926233|21458838|P2|NOT COMPLETED|Overall Study||0
8692561|NCT04926233|21458839|P1|NOT COMPLETED|Overall Study||0
8692562|NCT04926233|21458838|P2|COMPLETED|Overall Study||90660
8692563|NCT04926233|21458839|P1|COMPLETED|Overall Study||1280486
8692564|NCT04926233|21458838|P2|STARTED|Overall Study||90660
8692565|NCT04926233|21458839|P1|STARTED|Overall Study||1280486
8692566|NCT04175808|21458997|P7|NOT COMPLETED|Part B||0
8692567|NCT04175808|21458998|P6|NOT COMPLETED|Part B||0
8692568|NCT04175808|21458999|P5|NOT COMPLETED|Part B||0
8692569|NCT04175808|21459000|P4|NOT COMPLETED|Part B||0
8692570|NCT04175808|21459001|P3|NOT COMPLETED|Part B||0
8692571|NCT04175808|21459002|P2|NOT COMPLETED|Part B||0
8692572|NCT04175808|21459003|P1|NOT COMPLETED|Part B||0
8692573|NCT04175808|21458997|P7|COMPLETED|Part B||10
8692574|NCT04175808|21458998|P6|COMPLETED|Part B||10
8692575|NCT04175808|21458999|P5|COMPLETED|Part B||10
8692576|NCT04175808|21459000|P4|COMPLETED|Part B||10
8692577|NCT04175808|21459001|P3|COMPLETED|Part B||10
8692578|NCT04175808|21459002|P2|COMPLETED|Part B||10
8692579|NCT04175808|21459003|P1|COMPLETED|Part B||0
8692580|NCT04175808|21458997|P7|STARTED|Part B||10
8692581|NCT04175808|21458998|P6|STARTED|Part B||10
8692582|NCT04175808|21458999|P5|STARTED|Part B||10
8692583|NCT04175808|21459000|P4|STARTED|Part B||10
8692584|NCT04175808|21459001|P3|STARTED|Part B||10
8692585|NCT04175808|21459002|P2|STARTED|Part B||10
8692586|NCT04175808|21459003|P1|STARTED|Part B||0
8692587|NCT04175808|21458997|P7|NOT COMPLETED|Part A||0
8692588|NCT04175808|21458998|P6|NOT COMPLETED|Part A||0
8692589|NCT04175808|21458999|P5|NOT COMPLETED|Part A||0
8692590|NCT04175808|21459000|P4|NOT COMPLETED|Part A||0
8692591|NCT04175808|21459001|P3|NOT COMPLETED|Part A||0
8692592|NCT04175808|21459002|P2|NOT COMPLETED|Part A||0
8692593|NCT04175808|21459003|P1|NOT COMPLETED|Part A||2
8692594|NCT04175808|21458997|P7|COMPLETED|Part A||0
8692595|NCT04175808|21458998|P6|COMPLETED|Part A||0
8692596|NCT04175808|21458999|P5|COMPLETED|Part A||0
8692597|NCT04175808|21459000|P4|COMPLETED|Part A||0
8692598|NCT04175808|21459001|P3|COMPLETED|Part A||0
8692599|NCT04175808|21459002|P2|COMPLETED|Part A||0
8692600|NCT04175808|21459003|P1|COMPLETED|Part A||68
8692601|NCT04175808|21458997|P7|STARTED|Part A||0
8692602|NCT04175808|21458998|P6|STARTED|Part A||0
8692603|NCT04175808|21458999|P5|STARTED|Part A||0
8692604|NCT04175808|21459000|P4|STARTED|Part A||0
8692605|NCT04175808|21459001|P3|STARTED|Part A||0
8692606|NCT04175808|21459002|P2|STARTED|Part A||0
8692607|NCT04175808|21459003|P1|STARTED|Part A||70
8692608|NCT03948334|21459051|P2|NOT COMPLETED|Overall Study||63
8692609|NCT03948334|21459052|P1|NOT COMPLETED|Overall Study||60
8692610|NCT03948334|21459051|P2|COMPLETED|Overall Study||0
8692611|NCT03948334|21459052|P1|COMPLETED|Overall Study||0
8692612|NCT03948334|21459051|P2|STARTED|Overall Study||63
8692613|NCT03948334|21459052|P1|STARTED|Overall Study||60
8692614|NCT03902574|21459077|P3|NOT COMPLETED|Overall Study||1
8692615|NCT03902574|21459078|P2|NOT COMPLETED|Overall Study||0
8692616|NCT03902574|21459079|P1|NOT COMPLETED|Overall Study||0
8692617|NCT03902574|21459077|P3|COMPLETED|Overall Study||6
8692618|NCT03902574|21459078|P2|COMPLETED|Overall Study||7
8692619|NCT03902574|21459079|P1|COMPLETED|Overall Study||7
8692620|NCT03902574|21459077|P3|STARTED|Overall Study||7
8692621|NCT03902574|21459078|P2|STARTED|Overall Study||7
8692622|NCT03902574|21459079|P1|STARTED|Overall Study||7
8692623|NCT03605914|21459092|P2|NOT COMPLETED|Overall Study||19
8692624|NCT03605914|21459093|P1|NOT COMPLETED|Overall Study||27
8692625|NCT03605914|21459092|P2|COMPLETED|Overall Study||24
8692626|NCT03605914|21459093|P1|COMPLETED|Overall Study||30
8692627|NCT03605914|21459092|P2|Completed Day 5 Assessment|Overall Study||24
8692628|NCT03605914|21459093|P1|Completed Day 5 Assessment|Overall Study||30
8692629|NCT03605914|21459092|P2|Completed Day 3 Assessment|Overall Study||28
8692630|NCT03605914|21459093|P1|Completed Day 3 Assessment|Overall Study||31
8692631|NCT03605914|21459092|P2|Completed Day 2 Assessment|Overall Study||27
8692632|NCT03605914|21459093|P1|Completed Day 2 Assessment|Overall Study||32
8692633|NCT03605914|21459092|P2|Completed Day 1 Assessment|Overall Study||26
8692634|NCT03605914|21459093|P1|Completed Day 1 Assessment|Overall Study||31
8692635|NCT03605914|21459092|P2|STARTED|Overall Study||43
8692636|NCT03605914|21459093|P1|STARTED|Overall Study||57
8692637|NCT03594500|21459113|P2|NOT COMPLETED|Overall Study||4
8692638|NCT03594500|21459114|P1|NOT COMPLETED|Overall Study||6
8692639|NCT03594500|21459113|P2|COMPLETED|Overall Study||63
8692640|NCT03594500|21459114|P1|COMPLETED|Overall Study||60
8692641|NCT03594500|21459113|P2|STARTED|Overall Study||67
8692642|NCT03594500|21459114|P1|STARTED|Overall Study||66
8692643|NCT03712280|21459137|P4|NOT COMPLETED|Overall Study||1
8692644|NCT03712280|21459138|P3|NOT COMPLETED|Overall Study||1
8692645|NCT03712280|21459139|P2|NOT COMPLETED|Overall Study||1
8692646|NCT03712280|21459140|P1|NOT COMPLETED|Overall Study||1
8692647|NCT03712280|21459137|P4|COMPLETED|Overall Study||12
8692648|NCT03712280|21459138|P3|COMPLETED|Overall Study||12
8692649|NCT03712280|21459139|P2|COMPLETED|Overall Study||11
8692650|NCT03712280|21459140|P1|COMPLETED|Overall Study||11
8692651|NCT03712280|21459137|P4|Completed 5 Day Treatment|Overall Study||12
8692652|NCT03712280|21459138|P3|Completed 5 Day Treatment|Overall Study||12
8692653|NCT03712280|21459139|P2|Completed 5 Day Treatment|Overall Study||11
8692654|NCT03712280|21459140|P1|Completed 5 Day Treatment|Overall Study||11
8692655|NCT03712280|21459137|P4|Modified Intent to Treat Population|Overall Study||12
8692656|NCT03712280|21459138|P3|Modified Intent to Treat Population|Overall Study||13
8692657|NCT03712280|21459139|P2|Modified Intent to Treat Population|Overall Study||11
8692658|NCT03712280|21459140|P1|Modified Intent to Treat Population|Overall Study||12
8692659|NCT03712280|21459137|P4|Safety Population|Overall Study||12
8692660|NCT03712280|21459138|P3|Safety Population|Overall Study||13
8692661|NCT03712280|21459139|P2|Safety Population|Overall Study||11
8692662|NCT03712280|21459140|P1|Safety Population|Overall Study||12
8692663|NCT03712280|21459137|P4|STARTED|Overall Study||13
8692664|NCT03712280|21459138|P3|STARTED|Overall Study||13
8692665|NCT03712280|21459139|P2|STARTED|Overall Study||12
8692666|NCT03712280|21459140|P1|STARTED|Overall Study||12
8692673|NCT03517566|21459170|P5|NOT COMPLETED|Overall Study||32
8692674|NCT03517566|21459171|P4|NOT COMPLETED|Overall Study||34
8692675|NCT03517566|21459172|P3|NOT COMPLETED|Overall Study||15
8692676|NCT03517566|21459173|P2|NOT COMPLETED|Overall Study||21
8692677|NCT03517566|21459174|P1|NOT COMPLETED|Overall Study||32
8692678|NCT03517566|21459170|P5|COMPLETED|Overall Study||41
8692679|NCT03517566|21459171|P4|COMPLETED|Overall Study||39
8692680|NCT03517566|21459172|P3|COMPLETED|Overall Study||21
8692681|NCT03517566|21459173|P2|COMPLETED|Overall Study||16
8692682|NCT03517566|21459174|P1|COMPLETED|Overall Study||42
8692683|NCT03517566|21459170|P5|STARTED|Overall Study||73
8692684|NCT03517566|21459171|P4|STARTED|Overall Study||73
8692685|NCT03517566|21459172|P3|STARTED|Overall Study||36
8692686|NCT03517566|21459173|P2|STARTED|Overall Study||37
8692687|NCT03517566|21459174|P1|STARTED|Overall Study||74
8692688|NCT03447314|21459235|P18|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692689|NCT03447314|21459236|P17|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692690|NCT03447314|21459237|P16|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692691|NCT03447314|21459238|P15|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692692|NCT03447314|21459239|P14|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692693|NCT03447314|21459240|P13|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692694|NCT03447314|21459241|P12|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692695|NCT03447314|21459242|P11|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692696|NCT03447314|21459243|P10|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692697|NCT03447314|21459244|P9|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692698|NCT03447314|21459245|P8|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692699|NCT03447314|21459246|P7|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692700|NCT03447314|21459247|P6|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692701|NCT03447314|21459248|P5|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692702|NCT03447314|21459249|P4|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692703|NCT03447314|21459250|P3|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692704|NCT03447314|21459251|P2|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692705|NCT03447314|21459252|P1|NOT COMPLETED|Part 2 (Up to 27 Months)||0
8692706|NCT03447314|21459235|P18|COMPLETED|Part 2 (Up to 27 Months)||0
8692707|NCT03447314|21459236|P17|COMPLETED|Part 2 (Up to 27 Months)||0
8692708|NCT03447314|21459237|P16|COMPLETED|Part 2 (Up to 27 Months)||0
8692709|NCT03447314|21459238|P15|COMPLETED|Part 2 (Up to 27 Months)||0
8692710|NCT03447314|21459239|P14|COMPLETED|Part 2 (Up to 27 Months)||0
8692711|NCT03447314|21459240|P13|COMPLETED|Part 2 (Up to 27 Months)||0
8692712|NCT03447314|21459241|P12|COMPLETED|Part 2 (Up to 27 Months)||0
8692713|NCT03447314|21459242|P11|COMPLETED|Part 2 (Up to 27 Months)||0
8692714|NCT03447314|21459243|P10|COMPLETED|Part 2 (Up to 27 Months)||0
8692715|NCT03447314|21459244|P9|COMPLETED|Part 2 (Up to 27 Months)||0
8692716|NCT03447314|21459245|P8|COMPLETED|Part 2 (Up to 27 Months)||0
8692717|NCT03447314|21459246|P7|COMPLETED|Part 2 (Up to 27 Months)||0
8692718|NCT03447314|21459247|P6|COMPLETED|Part 2 (Up to 27 Months)||0
8692719|NCT03447314|21459248|P5|COMPLETED|Part 2 (Up to 27 Months)||0
8692720|NCT03447314|21459249|P4|COMPLETED|Part 2 (Up to 27 Months)||0
8692721|NCT03447314|21459250|P3|COMPLETED|Part 2 (Up to 27 Months)||0
8692722|NCT03447314|21459251|P2|COMPLETED|Part 2 (Up to 27 Months)||0
8692723|NCT03447314|21459252|P1|COMPLETED|Part 2 (Up to 27 Months)||0
8692724|NCT03447314|21459235|P18|STARTED|Part 2 (Up to 27 Months)||0
8692725|NCT03447314|21459236|P17|STARTED|Part 2 (Up to 27 Months)||0
8692726|NCT03447314|21459237|P16|STARTED|Part 2 (Up to 27 Months)||0
8692727|NCT03447314|21459238|P15|STARTED|Part 2 (Up to 27 Months)||0
8692728|NCT03447314|21459239|P14|STARTED|Part 2 (Up to 27 Months)||0
8692729|NCT03447314|21459240|P13|STARTED|Part 2 (Up to 27 Months)||0
8692730|NCT03447314|21459241|P12|STARTED|Part 2 (Up to 27 Months)||0
8692731|NCT03447314|21459242|P11|STARTED|Part 2 (Up to 27 Months)||0
8692732|NCT03447314|21459243|P10|STARTED|Part 2 (Up to 27 Months)||0
8692733|NCT03447314|21459244|P9|STARTED|Part 2 (Up to 27 Months)||0
8692734|NCT03447314|21459245|P8|STARTED|Part 2 (Up to 27 Months)||0
8692735|NCT03447314|21459246|P7|STARTED|Part 2 (Up to 27 Months)||0
8692736|NCT03447314|21459247|P6|STARTED|Part 2 (Up to 27 Months)||0
8692737|NCT03447314|21459248|P5|STARTED|Part 2 (Up to 27 Months)||0
8692738|NCT03447314|21459249|P4|STARTED|Part 2 (Up to 27 Months)||0
8692739|NCT03447314|21459250|P3|STARTED|Part 2 (Up to 27 Months)||0
8692740|NCT03447314|21459251|P2|STARTED|Part 2 (Up to 27 Months)||0
8692741|NCT03447314|21459252|P1|STARTED|Part 2 (Up to 27 Months)||0
8692742|NCT03447314|21459235|P18|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8692743|NCT03447314|21459236|P17|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8692744|NCT03447314|21459237|P16|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8692745|NCT03447314|21459238|P15|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8692746|NCT03447314|21459239|P14|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8692747|NCT03447314|21459240|P13|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8692748|NCT03447314|21459241|P12|NOT COMPLETED|Part 1 (Up to 27 Months)||6
8692749|NCT03447314|21459242|P11|NOT COMPLETED|Part 1 (Up to 27 Months)||7
8692750|NCT03447314|21459243|P10|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8692751|NCT03447314|21459244|P9|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8692752|NCT03447314|21459245|P8|NOT COMPLETED|Part 1 (Up to 27 Months)||0
8692753|NCT03447314|21459246|P7|NOT COMPLETED|Part 1 (Up to 27 Months)||5
8692754|NCT03447314|21459247|P6|NOT COMPLETED|Part 1 (Up to 27 Months)||6
8692755|NCT03447314|21459248|P5|NOT COMPLETED|Part 1 (Up to 27 Months)||2
8692756|NCT03447314|21459249|P4|NOT COMPLETED|Part 1 (Up to 27 Months)||4
8692757|NCT03447314|21459250|P3|NOT COMPLETED|Part 1 (Up to 27 Months)||9
8692758|NCT03447314|21459251|P2|NOT COMPLETED|Part 1 (Up to 27 Months)||6
8692759|NCT03447314|21459252|P1|NOT COMPLETED|Part 1 (Up to 27 Months)||9
8692760|NCT03447314|21459235|P18|COMPLETED|Part 1 (Up to 27 Months)||0
8692761|NCT03447314|21459236|P17|COMPLETED|Part 1 (Up to 27 Months)||0
8692762|NCT03447314|21459237|P16|COMPLETED|Part 1 (Up to 27 Months)||0
8692763|NCT03447314|21459238|P15|COMPLETED|Part 1 (Up to 27 Months)||0
8692764|NCT03447314|21459239|P14|COMPLETED|Part 1 (Up to 27 Months)||0
8692765|NCT03447314|21459240|P13|COMPLETED|Part 1 (Up to 27 Months)||0
8692766|NCT03447314|21459241|P12|COMPLETED|Part 1 (Up to 27 Months)||0
8692767|NCT03447314|21459242|P11|COMPLETED|Part 1 (Up to 27 Months)||0
8692768|NCT03447314|21459243|P10|COMPLETED|Part 1 (Up to 27 Months)||0
8692769|NCT03447314|21459244|P9|COMPLETED|Part 1 (Up to 27 Months)||0
8692770|NCT03447314|21459245|P8|COMPLETED|Part 1 (Up to 27 Months)||0
8692771|NCT03447314|21459246|P7|COMPLETED|Part 1 (Up to 27 Months)||0
8692772|NCT03447314|21459247|P6|COMPLETED|Part 1 (Up to 27 Months)||0
8692773|NCT03447314|21459248|P5|COMPLETED|Part 1 (Up to 27 Months)||0
8692774|NCT03447314|21459249|P4|COMPLETED|Part 1 (Up to 27 Months)||0
8692775|NCT03447314|21459250|P3|COMPLETED|Part 1 (Up to 27 Months)||0
8692776|NCT03447314|21459251|P2|COMPLETED|Part 1 (Up to 27 Months)||0
8692777|NCT03447314|21459252|P1|COMPLETED|Part 1 (Up to 27 Months)||0
8692778|NCT03447314|21459235|P18|STARTED|Part 1 (Up to 27 Months)||0
8692779|NCT03447314|21459236|P17|STARTED|Part 1 (Up to 27 Months)||0
8692780|NCT03447314|21459237|P16|STARTED|Part 1 (Up to 27 Months)||0
8692781|NCT03447314|21459238|P15|STARTED|Part 1 (Up to 27 Months)||0
8692782|NCT03447314|21459239|P14|STARTED|Part 1 (Up to 27 Months)||0
8692783|NCT03447314|21459240|P13|STARTED|Part 1 (Up to 27 Months)||0
8692784|NCT03447314|21459241|P12|STARTED|Part 1 (Up to 27 Months)||6
8692785|NCT03447314|21459242|P11|STARTED|Part 1 (Up to 27 Months)||7
8692786|NCT03447314|21459243|P10|STARTED|Part 1 (Up to 27 Months)||0
8692787|NCT03447314|21459244|P9|STARTED|Part 1 (Up to 27 Months)||0
8692788|NCT03447314|21459245|P8|STARTED|Part 1 (Up to 27 Months)||0
8692789|NCT03447314|21459246|P7|STARTED|Part 1 (Up to 27 Months)||5
8692790|NCT03447314|21459247|P6|STARTED|Part 1 (Up to 27 Months)||6
8692791|NCT03447314|21459248|P5|STARTED|Part 1 (Up to 27 Months)||2
8692792|NCT03447314|21459249|P4|STARTED|Part 1 (Up to 27 Months)||4
8692793|NCT03447314|21459250|P3|STARTED|Part 1 (Up to 27 Months)||9
8692794|NCT03447314|21459251|P2|STARTED|Part 1 (Up to 27 Months)||6
8692795|NCT03447314|21459252|P1|STARTED|Part 1 (Up to 27 Months)||9
8692796|NCT03485950|21459628|P2|NOT COMPLETED|Overall Study||2
8692797|NCT03485950|21459629|P1|NOT COMPLETED|Overall Study||7
8692798|NCT03485950|21459628|P2|COMPLETED|Overall Study||48
8692799|NCT03485950|21459629|P1|COMPLETED|Overall Study||43
8692800|NCT03485950|21459628|P2|STARTED|Overall Study||50
8692801|NCT03485950|21459629|P1|STARTED|Overall Study||50
8692802|NCT03304626|21459683|P2|NOT COMPLETED|Overall Study||1
8692803|NCT03304626|21459684|P1|NOT COMPLETED|Overall Study||2
8692804|NCT03304626|21459683|P2|COMPLETED|Overall Study||19
8692805|NCT03304626|21459684|P1|COMPLETED|Overall Study||18
8692806|NCT03304626|21459683|P2|STARTED|Overall Study||20
8692807|NCT03304626|21459684|P1|STARTED|Overall Study||20
8692808|NCT03256578|21459698|P2|NOT COMPLETED|Overall Study||56
8692809|NCT03256578|21459699|P1|NOT COMPLETED|Overall Study||66
8692810|NCT03256578|21459698|P2|COMPLETED|Overall Study||150
8692811|NCT03256578|21459699|P1|COMPLETED|Overall Study||138
8692812|NCT03256578|21459698|P2|STARTED|Overall Study||206
8692813|NCT03256578|21459699|P1|STARTED|Overall Study||204
8692814|NCT03398265|21459757|P2|NOT COMPLETED|Overall Study||0
8692815|NCT03398265|21459758|P1|NOT COMPLETED|Overall Study||0
8692816|NCT03398265|21459757|P2|COMPLETED|Overall Study||8
8692817|NCT03398265|21459758|P1|COMPLETED|Overall Study||7
8692818|NCT03398265|21459757|P2|STARTED|Overall Study||8
8692819|NCT03398265|21459758|P1|STARTED|Overall Study||7
8692820|NCT02913482|21459783|P3|NOT COMPLETED|Overall Study||3
8692821|NCT02913482|21459784|P2|NOT COMPLETED|Overall Study||2
8692822|NCT02913482|21459785|P1|NOT COMPLETED|Overall Study||1
8692823|NCT02913482|21459783|P3|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 14 Nov 2019|38
8692824|NCT02913482|21459784|P2|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 27 Feb 2019|15
8692825|NCT02913482|21459785|P1|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 27 Feb 2019|3
8692826|NCT02913482|21459783|P3|STARTED|Overall Study||41
8692827|NCT02913482|21459784|P2|STARTED|Overall Study||17
8692828|NCT02913482|21459785|P1|STARTED|Overall Study||4
8692829|NCT03028363|21459818|P2|NOT COMPLETED|Overall Study||33
8692830|NCT03028363|21459819|P1|NOT COMPLETED|Overall Study||78
8692831|NCT03028363|21459818|P2|COMPLETED|Overall Study||228
8692832|NCT03028363|21459819|P1|COMPLETED|Overall Study||420
8692833|NCT03028363|21459818|P2|STARTED|Overall Study||261
8692834|NCT03028363|21459819|P1|STARTED|Overall Study||498
8692835|NCT03167073|21459831|P2|NOT COMPLETED|Overall Study||0
8692836|NCT03167073|21459832|P1|NOT COMPLETED|Overall Study||1
8692837|NCT03167073|21459831|P2|COMPLETED|Overall Study||85
8692838|NCT03167073|21459832|P1|COMPLETED|Overall Study||84
8692839|NCT03167073|21459831|P2|STARTED|Overall Study||85
8692840|NCT03167073|21459832|P1|STARTED|Overall Study||85
8692841|NCT03127956|21459856|P1|NOT COMPLETED|Overall Study||317
8692842|NCT03127956|21459856|P1|COMPLETED|Overall Study||431
8692843|NCT03127956|21459856|P1|STARTED|Overall Study||748
8692844|NCT03073486|21459862|P2|NOT COMPLETED|Overall Study||44
8692845|NCT03073486|21459863|P1|NOT COMPLETED|Overall Study||88
8692846|NCT03073486|21459862|P2|COMPLETED|Overall Study||207
8692847|NCT03073486|21459863|P1|COMPLETED|Overall Study||405
8692848|NCT03073486|21459862|P2|STARTED|Overall Study||251
8692849|NCT03073486|21459863|P1|STARTED|Overall Study||493
8692850|NCT03022617|21459873|P1|NOT COMPLETED|Overall Study||6
8692851|NCT03022617|21459873|P1|COMPLETED|Overall Study||6
8692852|NCT03022617|21459873|P1|STARTED|Overall Study||12
8692853|NCT02929329|21459879|P2|NOT COMPLETED|Overall Study||1092
8692854|NCT02929329|21459880|P1|NOT COMPLETED|Overall Study||1104
8692855|NCT02929329|21459879|P2|COMPLETED|Overall Study|9 participants in this group who discontinued the study had unknown vital status at the end of study|3028
8692856|NCT02929329|21459880|P1|COMPLETED|Overall Study|7 participants in this group who discontinued the study had unknown vital status at the end of study|3008
8692857|NCT02929329|21459879|P2|Received Treatment|Overall Study||4110
8692858|NCT02929329|21459880|P1|Received Treatment|Overall Study||4101
8692859|NCT02929329|21459879|P2|STARTED|Overall Study||4120
8692860|NCT02929329|21459880|P1|STARTED|Overall Study||4112
8692861|NCT02660138|21459899|P3|NOT COMPLETED|Overall Study||72
8692862|NCT02660138|21459900|P2|NOT COMPLETED|Overall Study||74
8692863|NCT02660138|21459901|P1|NOT COMPLETED|Overall Study||70
8692864|NCT02660138|21459899|P3|COMPLETED|Overall Study||3
8692865|NCT02660138|21459900|P2|COMPLETED|Overall Study||2
8692866|NCT02660138|21459901|P1|COMPLETED|Overall Study||6
8692867|NCT02660138|21459899|P3|Subjects Entered in the Dysport Cycles|Overall Study||75
8692868|NCT02660138|21459900|P2|Subjects Entered in the Dysport Cycles|Overall Study||75
8692869|NCT02660138|21459901|P1|Subjects Entered in the Dysport Cycles|Overall Study||49
8692870|NCT02660138|21459899|P3|Subjects Treated in DBPC Cycle|Overall Study||75
8692871|NCT02660138|21459900|P2|Subjects Treated in DBPC Cycle|Overall Study||75
8692872|NCT02660138|21459901|P1|Subjects Treated in DBPC Cycle|Overall Study||76
8692873|NCT02660138|21459899|P3|STARTED|Overall Study||75
8692874|NCT02660138|21459900|P2|STARTED|Overall Study||76
8692875|NCT02660138|21459901|P1|STARTED|Overall Study||76
8692876|NCT02660359|21459939|P3|NOT COMPLETED|Overall Study||84
8692877|NCT02660359|21459940|P2|NOT COMPLETED|Overall Study||86
8692878|NCT02660359|21459941|P1|NOT COMPLETED|Overall Study||86
8692879|NCT02660359|21459939|P3|COMPLETED|Overall Study||1
8692880|NCT02660359|21459940|P2|COMPLETED|Overall Study||0
8692881|NCT02660359|21459941|P1|COMPLETED|Overall Study||0
8692882|NCT02660359|21459939|P3|Subjects Entered in the Dysport Cycles|Overall Study||85
8692883|NCT02660359|21459940|P2|Subjects Entered in the Dysport Cycles|Overall Study||86
8692884|NCT02660359|21459941|P1|Subjects Entered in the Dysport Cycles|Overall Study||56
8692885|NCT02660359|21459939|P3|STARTED|Overall Study||85
8692886|NCT02660359|21459940|P2|STARTED|Overall Study||86
8692887|NCT02660359|21459941|P1|STARTED|Overall Study||86
8692888|NCT02848079|21459973|P1|NOT COMPLETED|Overall Study||0
8692889|NCT02848079|21459973|P1|COMPLETED|Overall Study||41
8692890|NCT02848079|21459973|P1|Discontinued|Overall Study||41
8692891|NCT02848079|21459973|P1|Receieved Study Treatment|Overall Study||41
8692892|NCT02848079|21459973|P1|STARTED|Overall Study||41
8692893|NCT02618616|21459981|P2|NOT COMPLETED|Overall Study||7
8692894|NCT02618616|21459982|P1|NOT COMPLETED|Overall Study||21
8692895|NCT02618616|21459981|P2|COMPLETED|Overall Study||35
8692896|NCT02618616|21459982|P1|COMPLETED|Overall Study||66
8692897|NCT02618616|21459981|P2|STARTED|Overall Study||42
8692898|NCT02618616|21459982|P1|STARTED|Overall Study||87
8692899|NCT02581930|21460006|P1|NOT COMPLETED|Overall Study||2
8692900|NCT02581930|21460006|P1|COMPLETED|Overall Study||16
8692901|NCT02581930|21460006|P1|STARTED|Overall Study||18
8692902|NCT02579863|21460014|P2|NOT COMPLETED|Overall Study||154
8692903|NCT02579863|21460015|P1|NOT COMPLETED|Overall Study||156
8692904|NCT02579863|21460014|P2|COMPLETED|Overall Study||0
8692905|NCT02579863|21460015|P1|COMPLETED|Overall Study||0
8692906|NCT02579863|21460014|P2|Treated|Overall Study||148
8692907|NCT02579863|21460015|P1|Treated|Overall Study||154
8692908|NCT02579863|21460014|P2|STARTED|Overall Study||154
8692909|NCT02579863|21460015|P1|STARTED|Overall Study||156
8692910|NCT02431052|21460040|P5|NOT COMPLETED|Overall Study||15
8692911|NCT02431052|21460041|P4|NOT COMPLETED|Overall Study||16
8692912|NCT02431052|21460042|P3|NOT COMPLETED|Overall Study||12
8692913|NCT02431052|21460043|P2|NOT COMPLETED|Overall Study||4
8692914|NCT02431052|21460044|P1|NOT COMPLETED|Overall Study||11
8692915|NCT02431052|21460040|P5|COMPLETED|Overall Study||86
8692916|NCT02431052|21460041|P4|COMPLETED|Overall Study||94
8692917|NCT02431052|21460042|P3|COMPLETED|Overall Study||94
8692918|NCT02431052|21460043|P2|COMPLETED|Overall Study||46
8692919|NCT02431052|21460044|P1|COMPLETED|Overall Study||42
8692920|NCT02431052|21460040|P5|STARTED|Overall Study||101
8692921|NCT02431052|21460041|P4|STARTED|Overall Study||110
8692922|NCT02431052|21460042|P3|STARTED|Overall Study||106
8692923|NCT02431052|21460043|P2|STARTED|Overall Study||50
8692924|NCT02431052|21460044|P1|STARTED|Overall Study||53
8692925|NCT02410798|21460066|P1|NOT COMPLETED|Overall Study||0
8692926|NCT02410798|21460066|P1|COMPLETED|Overall Study||12
8692927|NCT02410798|21460066|P1|STARTED|Overall Study||12
8692928|NCT02108522|21460078|P1|NOT COMPLETED|Period 2: Expansion Cohort||6
8692929|NCT02108522|21460078|P1|COMPLETED|Period 2: Expansion Cohort||2
8692930|NCT02108522|21460078|P1|STARTED|Period 2: Expansion Cohort||8
8692931|NCT02108522|21460078|P1|NOT COMPLETED|Period 1: Initial Cohort||22
8692932|NCT02108522|21460078|P1|COMPLETED|Period 1: Initial Cohort||28
8692933|NCT02108522|21460078|P1|STARTED|Period 1: Initial Cohort||50
8692934|NCT02108522|21460078|P1|NOT COMPLETED|Screening Period||24
8692935|NCT02108522|21460078|P1|COMPLETED|Screening Period||58
8692936|NCT02108522|21460078|P1|STARTED|Screening Period||82
8692940|NCT02076113|21460102|P2|NOT COMPLETED|Overall Study||7
8692941|NCT02076113|21460103|P1|NOT COMPLETED|Overall Study||7
8692942|NCT02076113|21460102|P2|COMPLETED|Overall Study||93
8692943|NCT02076113|21460103|P1|COMPLETED|Overall Study||56
8692944|NCT02076113|21460102|P2|2-Year Follow-up|Overall Study|14 missed follow-up visit; 1 lost to follow-up; 3 withdrew consent; 3 deceased|79
8692945|NCT02076113|21460103|P1|2-Year Follow-up|Overall Study|5 missed follow-up visit; 4 lost to follow-up; 2 withdrew consent; 1 deceased|51
8692946|NCT02076113|21460102|P2|1-Year Follow-up|Overall Study|2 missed follow-up visit; 1 lost to follow-up; 2 deceased|95
8692947|NCT02076113|21460103|P1|1-Year Follow-up|Overall Study|3 lost to follow-up|60
8692948|NCT02076113|21460102|P2|6-Month Follow-up|Overall Study|7 missed follow-up visit; 1 lost to follow-up; 1 deceased|91
8692949|NCT02076113|21460103|P1|6-Month Follow-up|Overall Study|7 missed follow-up visit; 3 lost to follow-up|53
8692950|NCT02076113|21460102|P2|3-Month Follow-up|Overall Study|9 missed follow-up appointment; 1 lost to follow-up|90
8692951|NCT02076113|21460103|P1|3-Month Follow-up|Overall Study|5 missed follow-up visit; 2 lost to follow-up|56
8692952|NCT02076113|21460102|P2|Surgery as Randomized|Overall Study|4 patients underwent ventral fusion surgery|96
8692953|NCT02076113|21460103|P1|Surgery as Randomized|Overall Study|1 patient underwent dorsal fusion surgery|62
8692954|NCT02076113|21460102|P2|STARTED|Overall Study||100
8692955|NCT02076113|21460103|P1|STARTED|Overall Study||63
8692959|NCT02038036|21460146|P2|NOT COMPLETED|Crossover Period||20
8692960|NCT02038036|21460147|P1|NOT COMPLETED|Crossover Period||0
8692961|NCT02038036|21460146|P2|COMPLETED|Crossover Period||38
8692962|NCT02038036|21460147|P1|COMPLETED|Crossover Period||0
8692963|NCT02038036|21460146|P2|STARTED|Crossover Period|58 participants were eligible to crossover to the ruxolitinib arm|58
8692964|NCT02038036|21460147|P1|STARTED|Crossover Period||0
8692965|NCT02038036|21460146|P2|NOT COMPLETED|Core Study||14
8692966|NCT02038036|21460147|P1|NOT COMPLETED|Core Study||15
8692967|NCT02038036|21460146|P2|COMPLETED|Core Study||61
8692968|NCT02038036|21460147|P1|COMPLETED|Core Study||59
8692969|NCT02038036|21460146|P2|Crossover Set|Core Study||58
8692970|NCT02038036|21460147|P1|Crossover Set|Core Study||0
8692971|NCT02038036|21460146|P2|Full Analysis Set|Core Study||75
8692972|NCT02038036|21460147|P1|Full Analysis Set|Core Study||74
8692973|NCT02038036|21460146|P2|STARTED|Core Study||75
8692974|NCT02038036|21460147|P1|STARTED|Core Study||74
8692975|NCT02031627|21460199|P3|NOT COMPLETED|Overall Study||0
8692976|NCT02031627|21460200|P2|NOT COMPLETED|Overall Study||0
8692977|NCT02031627|21460201|P1|NOT COMPLETED|Overall Study||0
8692978|NCT02031627|21460199|P3|COMPLETED|Overall Study||7
8692979|NCT02031627|21460200|P2|COMPLETED|Overall Study||7
8692980|NCT02031627|21460201|P1|COMPLETED|Overall Study||7
8692981|NCT02031627|21460199|P3|STARTED|Overall Study||7
8692982|NCT02031627|21460200|P2|STARTED|Overall Study||7
8692983|NCT02031627|21460201|P1|STARTED|Overall Study||7
8692984|NCT02162576|21460239|P1|NOT COMPLETED|Overall Study||0
8692985|NCT02162576|21460239|P1|COMPLETED|Overall Study||95
8692986|NCT02162576|21460239|P1|STARTED|Overall Study||95
8692987|NCT02003924|21460247|P3|NOT COMPLETED|Long-term Follow-up Phase||7
8692988|NCT02003924|21460248|P2|NOT COMPLETED|Long-term Follow-up Phase||237
8692989|NCT02003924|21460249|P1|NOT COMPLETED|Long-term Follow-up Phase||367
8692990|NCT02003924|21460247|P3|COMPLETED|Long-term Follow-up Phase||80
8692991|NCT02003924|21460248|P2|COMPLETED|Long-term Follow-up Phase||144
8692992|NCT02003924|21460249|P1|COMPLETED|Long-term Follow-up Phase||566
8692993|NCT02003924|21460247|P3|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in open label phase.|87
8692994|NCT02003924|21460248|P2|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in double blind phase.|381
8692995|NCT02003924|21460249|P1|STARTED|Long-term Follow-up Phase|Participants followed up after discontinuing study drug in either double blind or open label phase.|933
8692996|NCT02003924|21460247|P3|NOT COMPLETED|Open-label Phase||17
8692997|NCT02003924|21460248|P2|NOT COMPLETED|Open-label Phase||0
8692998|NCT02003924|21460249|P1|NOT COMPLETED|Open-label Phase||100
8692999|NCT02003924|21460247|P3|COMPLETED|Open-label Phase||70
8693000|NCT02003924|21460248|P2|COMPLETED|Open-label Phase||0
8693001|NCT02003924|21460249|P1|COMPLETED|Open-label Phase||378
8693002|NCT02003924|21460247|P3|Treated|Open-label Phase||87
8693003|NCT02003924|21460248|P2|Treated|Open-label Phase||0
8693004|NCT02003924|21460249|P1|Treated|Open-label Phase||478
8693005|NCT02003924|21460247|P3|STARTED|Open-label Phase|Participants previously treated with placebo, switched to receive open label Enzalutamide.|87
8693006|NCT02003924|21460248|P2|STARTED|Open-label Phase|Participants were offered to switch from double blind placebo to open label Enzalutamide.|0
8693007|NCT02003924|21460249|P1|STARTED|Open-label Phase||478
8693008|NCT02003924|21460247|P3|NOT COMPLETED|Double-blind Phase||0
8693009|NCT02003924|21460248|P2|NOT COMPLETED|Double-blind Phase||381
8693010|NCT02003924|21460249|P1|NOT COMPLETED|Double-blind Phase||455
8693011|NCT02003924|21460247|P3|COMPLETED|Double-blind Phase||0
8693012|NCT02003924|21460248|P2|COMPLETED|Double-blind Phase||87
8693013|NCT02003924|21460249|P1|COMPLETED|Double-blind Phase||478
8693014|NCT02003924|21460247|P3|Treated|Double-blind Phase||0
8693015|NCT02003924|21460248|P2|Treated|Double-blind Phase||465
8693016|NCT02003924|21460249|P1|Treated|Double-blind Phase||930
8693017|NCT02003924|21460247|P3|STARTED|Double-blind Phase||0
8693018|NCT02003924|21460248|P2|STARTED|Double-blind Phase||468
8693019|NCT02003924|21460249|P1|STARTED|Double-blind Phase||933
8693020|NCT01936324|21460351|P3|NOT COMPLETED|Overall Study||5
8693021|NCT01936324|21460352|P2|NOT COMPLETED|Overall Study||6
8693022|NCT01936324|21460353|P1|NOT COMPLETED|Overall Study||0
8693023|NCT01936324|21460351|P3|COMPLETED|Overall Study||50
8693024|NCT01936324|21460352|P2|COMPLETED|Overall Study||47
8693025|NCT01936324|21460353|P1|COMPLETED|Overall Study||6
8693026|NCT01936324|21460351|P3|STARTED|Overall Study||55
8693027|NCT01936324|21460352|P2|STARTED|Overall Study||53
8693028|NCT01936324|21460353|P1|STARTED|Overall Study||6
8693029|NCT01931163|21460364|P1|NOT COMPLETED|Overall Study||0
8693030|NCT01931163|21460364|P1|COMPLETED|Overall Study||22
8693031|NCT01931163|21460364|P1|STARTED|Overall Study||22
8693032|NCT02115542|21460368|P1|NOT COMPLETED|Overall Study||0
8693033|NCT02115542|21460368|P1|COMPLETED|Overall Study||39
8693034|NCT02115542|21460368|P1|STARTED|Overall Study||39
8693035|NCT01711541|21460379|P5|NOT COMPLETED|Overall Study||0
8693036|NCT01711541|21460380|P4|NOT COMPLETED|Overall Study||1
8693037|NCT01711541|21460381|P3|NOT COMPLETED|Overall Study||0
8693038|NCT01711541|21460382|P2|NOT COMPLETED|Overall Study||1
8693039|NCT01711541|21460383|P1|NOT COMPLETED|Overall Study||0
8693040|NCT01711541|21460379|P5|COMPLETED|Overall Study||7
8693041|NCT01711541|21460380|P4|COMPLETED|Overall Study||5
8693042|NCT01711541|21460381|P3|COMPLETED|Overall Study||3
8693043|NCT01711541|21460382|P2|COMPLETED|Overall Study||3
8693044|NCT01711541|21460383|P1|COMPLETED|Overall Study||4
8693045|NCT01711541|21460379|P5|STARTED|Overall Study||7
8693046|NCT01711541|21460380|P4|STARTED|Overall Study||6
8693047|NCT01711541|21460381|P3|STARTED|Overall Study||3
8693048|NCT01711541|21460382|P2|STARTED|Overall Study||4
8693049|NCT01711541|21460383|P1|STARTED|Overall Study||4
8693050|NCT01790594|21460414|P3|NOT COMPLETED|Overall Study||3
8693051|NCT01790594|21460415|P2|NOT COMPLETED|Overall Study||3
8693052|NCT01790594|21460416|P1|NOT COMPLETED|Overall Study||5
8693053|NCT01790594|21460414|P3|COMPLETED|Overall Study||0
8693054|NCT01790594|21460415|P2|COMPLETED|Overall Study||18
8693055|NCT01790594|21460416|P1|COMPLETED|Overall Study||17
8693056|NCT01790594|21460414|P3|STARTED|Overall Study||3
8693057|NCT01790594|21460415|P2|STARTED|Overall Study||21
8693058|NCT01790594|21460416|P1|STARTED|Overall Study||22
8693069|NCT01509183|21460513|P2|NOT COMPLETED|Overall Study||111
8693070|NCT01509183|21460514|P1|NOT COMPLETED|Overall Study||109
8693071|NCT01509183|21460513|P2|COMPLETED|Overall Study||134
8693072|NCT01509183|21460514|P1|COMPLETED|Overall Study||141
8693073|NCT01509183|21460513|P2|STARTED|Overall Study||245
8693074|NCT01509183|21460514|P1|STARTED|Overall Study||250
8693075|NCT01434472|21460522|P1|NOT COMPLETED|Overall Study||0
8693076|NCT01434472|21460522|P1|COMPLETED|Overall Study||20
8693077|NCT01434472|21460522|P1|STARTED|Overall Study||20
8693078|NCT00852124|21460534|P2|NOT COMPLETED|Overall Study||0
8693079|NCT00852124|21460535|P1|NOT COMPLETED|Overall Study||0
8693080|NCT00852124|21460534|P2|COMPLETED|Overall Study||0
8693081|NCT00852124|21460535|P1|COMPLETED|Overall Study||3
8693082|NCT00852124|21460534|P2|STARTED|Overall Study||0
8693083|NCT00852124|21460535|P1|STARTED|Overall Study||3
8693084|NCT00845871|21460540|P1|NOT COMPLETED|Assessment Period||7
8693085|NCT00845871|21460540|P1|COMPLETED|Assessment Period||58
8693086|NCT00845871|21460540|P1|STARTED|Assessment Period||65
8693087|NCT00845871|21460540|P1|NOT COMPLETED|Run-in Period||0
8693088|NCT00845871|21460540|P1|COMPLETED|Run-in Period||65
8693089|NCT00845871|21460540|P1|STARTED|Run-in Period||65
8693090|NCT00700336|21460568|P3|NOT COMPLETED|Overall Study||0
8693091|NCT00700336|21460569|P2|NOT COMPLETED|Overall Study||0
8693092|NCT00700336|21460570|P1|NOT COMPLETED|Overall Study||0
8693093|NCT00700336|21460568|P3|COMPLETED|Overall Study||6
8693094|NCT00700336|21460569|P2|COMPLETED|Overall Study||23
8693095|NCT00700336|21460570|P1|COMPLETED|Overall Study||40
8693096|NCT00700336|21460568|P3|STARTED|Overall Study||6
8693097|NCT00700336|21460569|P2|STARTED|Overall Study||23
8693098|NCT00700336|21460570|P1|STARTED|Overall Study||40
8693099|NCT00602641|21460579|P2|NOT COMPLETED|Overall Study||152
8693100|NCT00602641|21460580|P1|NOT COMPLETED|Overall Study||154
8693101|NCT00602641|21460579|P2|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
8693102|NCT00602641|21460580|P1|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
8693103|NCT00602641|21460579|P2|Started Protocol Therapy|Overall Study||150
8693104|NCT00602641|21460580|P1|Started Protocol Therapy|Overall Study||148
8693105|NCT00602641|21460579|P2|STARTED|Overall Study||152
8693106|NCT00602641|21460580|P1|STARTED|Overall Study||154
8693107|NCT00463151|21460596|P4|NOT COMPLETED|Overall Study||7
8693108|NCT00463151|21460597|P3|NOT COMPLETED|Overall Study||3
8693109|NCT00463151|21460598|P2|NOT COMPLETED|Overall Study||5
8693110|NCT00463151|21460599|P1|NOT COMPLETED|Overall Study||2
8693111|NCT00463151|21460596|P4|COMPLETED|Overall Study||24
8693112|NCT00463151|21460597|P3|COMPLETED|Overall Study||26
8693113|NCT00463151|21460598|P2|COMPLETED|Overall Study||24
8693114|NCT00463151|21460599|P1|COMPLETED|Overall Study||33
8693115|NCT00463151|21460596|P4|STARTED|Overall Study||31
8693116|NCT00463151|21460597|P3|STARTED|Overall Study||29
8693117|NCT00463151|21460598|P2|STARTED|Overall Study||29
8693118|NCT00463151|21460599|P1|STARTED|Overall Study||35
8693119|NCT01218438|21460625|P1|NOT COMPLETED|Epoch 4||3
8693120|NCT01218438|21460625|P1|COMPLETED|Epoch 4||67
8693121|NCT01218438|21460625|P1|STARTED|Epoch 4||70
8693122|NCT01218438|21460625|P1|NOT COMPLETED|Epoch 3||4
8693123|NCT01218438|21460625|P1|COMPLETED|Epoch 3||70
8693124|NCT01218438|21460625|P1|STARTED|Epoch 3||74
8693125|NCT01218438|21460625|P1|NOT COMPLETED|Epoch 2||0
8693126|NCT01218438|21460625|P1|COMPLETED|Epoch 2||45
8693127|NCT01218438|21460625|P1|STARTED|Epoch 2||45
8693128|NCT01218438|21460625|P1|NOT COMPLETED|Epoch 1||3
8693129|NCT01218438|21460625|P1|COMPLETED|Epoch 1||74
8693130|NCT01218438|21460625|P1|STARTED|Epoch 1||77
8693131|NCT01178814|21460930|P1|NOT COMPLETED|Overall Study||0
8693132|NCT01178814|21460930|P1|COMPLETED|Overall Study||57
8693133|NCT01178814|21460930|P1|STARTED|Overall Study||57
8693134|NCT04919161|21460936|P2|NOT COMPLETED|Overall Study||2
8693135|NCT04919161|21460937|P1|NOT COMPLETED|Overall Study||1
8693136|NCT04919161|21460936|P2|COMPLETED|Overall Study||14
8693137|NCT04919161|21460937|P1|COMPLETED|Overall Study||15
8693138|NCT04919161|21460936|P2|STARTED|Overall Study||16
8693139|NCT04919161|21460937|P1|STARTED|Overall Study||16
8693140|NCT04610489|21460969|P1|NOT COMPLETED|Overall Study||0
8693141|NCT04610489|21460969|P1|COMPLETED|Overall Study||117
8693142|NCT04610489|21460969|P1|STARTED|Overall Study||117
8693143|NCT04439344|21460974|P1|NOT COMPLETED|Overall Study||53
8693144|NCT04439344|21460974|P1|COMPLETED|Overall Study||0
8693145|NCT04439344|21460974|P1|Eligible|Overall Study||47
8693146|NCT04439344|21460974|P1|Started Protocol Therapy|Overall Study||50
8693147|NCT04439344|21460974|P1|STARTED|Overall Study||53
8693148|NCT04152083|21460982|P2|NOT COMPLETED|Overall Study||3
8693149|NCT04152083|21460983|P1|NOT COMPLETED|Overall Study||6
8693150|NCT04152083|21460982|P2|COMPLETED|Overall Study||241
8693151|NCT04152083|21460983|P1|COMPLETED|Overall Study||235
8693152|NCT04152083|21460982|P2|Received at Least 1 Dose of Study Drug|Overall Study||242
8693153|NCT04152083|21460983|P1|Received at Least 1 Dose of Study Drug|Overall Study||238
8693154|NCT04152083|21460982|P2|STARTED|Overall Study||244
8693155|NCT04152083|21460983|P1|STARTED|Overall Study||241
8693156|NCT04035161|21461001|P1|NOT COMPLETED|Overall Study||0
8693157|NCT04035161|21461001|P1|COMPLETED|Overall Study||1121
8693158|NCT04035161|21461001|P1|Treated With Negative Control|Overall Study||605
8693159|NCT04035161|21461001|P1|Treated With Active Control|Overall Study||609
8693160|NCT04035161|21461001|P1|Treated With Reference Standard|Overall Study||419
8693161|NCT04035161|21461001|P1|Treated With Investigational Product|Overall Study||609
8693162|NCT04035161|21461001|P1|STARTED|Overall Study||1121
8693163|NCT03979677|21461021|P1|NOT COMPLETED|Overall Study||13
8693164|NCT03979677|21461021|P1|COMPLETED|Overall Study|participants completed|28
8693165|NCT03979677|21461021|P1|STARTED|Overall Study|Participants enrolled|41
8693166|NCT03955133|21461026|P1|NOT COMPLETED|Overall Study||0
8693167|NCT03955133|21461026|P1|COMPLETED|Overall Study|End of study funding|19
8693168|NCT03955133|21461026|P1|STARTED|Overall Study|participants recruited from 3 care homes|19
8693169|NCT03764813|21461037|P4|NOT COMPLETED|From Enrollment to the Last HbF Test||0
8693170|NCT03764813|21461038|P3|NOT COMPLETED|From Enrollment to the Last HbF Test||0
8693171|NCT03764813|21461039|P2|NOT COMPLETED|From Enrollment to the Last HbF Test||0
8693172|NCT03764813|21461040|P1|NOT COMPLETED|From Enrollment to the Last HbF Test||0
8693173|NCT03764813|21461037|P4|COMPLETED|From Enrollment to the Last HbF Test||5
8693174|NCT03764813|21461038|P3|COMPLETED|From Enrollment to the Last HbF Test||4
8693175|NCT03764813|21461039|P2|COMPLETED|From Enrollment to the Last HbF Test||3
8693176|NCT03764813|21461040|P1|COMPLETED|From Enrollment to the Last HbF Test||13
8693177|NCT03764813|21461037|P4|STARTED|From Enrollment to the Last HbF Test|Patients receiving both cord and adult-RBCs before the last HbFtest(age of 36 wk,discharge or death)|5
8693178|NCT03764813|21461038|P3|STARTED|From Enrollment to the Last HbF Test|Patients receiving only adult-RBC before last HbF test (occurring at 36 wks,discharge or death)|4
8693179|NCT03764813|21461039|P2|STARTED|From Enrollment to the Last HbF Test|Patients receiving only cord-RBCs before last HbF test (occurring at 36 wks,discharge or death)|3
8693180|NCT03764813|21461040|P1|STARTED|From Enrollment to the Last HbF Test|Patients receiving no transfusions before last HbF test (occurring at 36 weeks,discharge or death)|13
8693181|NCT03764813|21461037|P4|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
8693182|NCT03764813|21461038|P3|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
8693183|NCT03764813|21461039|P2|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
8693184|NCT03764813|21461040|P1|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
8693185|NCT03764813|21461037|P4|COMPLETED|From Enrollment to the Age of 32 Weeks||4
8693186|NCT03764813|21461038|P3|COMPLETED|From Enrollment to the Age of 32 Weeks||3
8693187|NCT03764813|21461039|P2|COMPLETED|From Enrollment to the Age of 32 Weeks||2
8693188|NCT03764813|21461040|P1|COMPLETED|From Enrollment to the Age of 32 Weeks||14
8693189|NCT03764813|21461037|P4|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving both adult-RBC and cord-RBCs before the age of 32 weeks|4
8693190|NCT03764813|21461038|P3|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only adult-RBC transfusions before the age of 32 weeks|4
8693191|NCT03764813|21461039|P2|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only cord-RBC transfusions before the age of 32 weeks|3
8693192|NCT03764813|21461040|P1|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving no transfusions before the age of 32 weeks|14
8693193|NCT03473977|21461060|P2|NOT COMPLETED|Overall Study||0
8693194|NCT03473977|21461061|P1|NOT COMPLETED|Overall Study||0
8693195|NCT03473977|21461060|P2|COMPLETED|Overall Study||13
8693196|NCT03473977|21461061|P1|COMPLETED|Overall Study||13
8693197|NCT03473977|21461060|P2|STARTED|Overall Study||13
8693198|NCT03473977|21461061|P1|STARTED|Overall Study||13
8693199|NCT03189446|21461079|P1|NOT COMPLETED|Overall Study||5
8693200|NCT03189446|21461079|P1|COMPLETED|Overall Study||27
8693201|NCT03189446|21461079|P1|STARTED|Overall Study||32
8693202|NCT03137121|21461086|P2|NOT COMPLETED|Overall Study||1
8693203|NCT03137121|21461087|P1|NOT COMPLETED|Overall Study||0
8693204|NCT03137121|21461086|P2|COMPLETED|Overall Study||14
8693205|NCT03137121|21461087|P1|COMPLETED|Overall Study||15
8693206|NCT03137121|21461086|P2|STARTED|Overall Study||15
8693207|NCT03137121|21461087|P1|STARTED|Overall Study||15
8693208|NCT03116230|21461097|P2|NOT COMPLETED|Overall Study||2
8693209|NCT03116230|21461098|P1|NOT COMPLETED|Overall Study||4
8693210|NCT03116230|21461097|P2|COMPLETED|Overall Study||17
8693211|NCT03116230|21461098|P1|COMPLETED|Overall Study||15
8693212|NCT03116230|21461097|P2|STARTED|Overall Study||19
8693213|NCT03116230|21461098|P1|STARTED|Overall Study||19
8693214|NCT03103763|21461113|P3|NOT COMPLETED|Overall Study||7
8693215|NCT03103763|21461114|P2|NOT COMPLETED|Overall Study||8
8693216|NCT03103763|21461115|P1|NOT COMPLETED|Overall Study||15
8693217|NCT03103763|21461113|P3|COMPLETED|Overall Study||37
8693218|NCT03103763|21461114|P2|COMPLETED|Overall Study||36
8693219|NCT03103763|21461115|P1|COMPLETED|Overall Study||29
8693220|NCT03103763|21461113|P3|STARTED|Overall Study||44
8693221|NCT03103763|21461114|P2|STARTED|Overall Study||44
8693222|NCT03103763|21461115|P1|STARTED|Overall Study||44
8693223|NCT03091192|21461146|P2|NOT COMPLETED|Overall Study||27
8693224|NCT03091192|21461147|P1|NOT COMPLETED|Overall Study||33
8693225|NCT03091192|21461146|P2|COMPLETED|Overall Study||0
8693226|NCT03091192|21461147|P1|COMPLETED|Overall Study||0
8693227|NCT03091192|21461146|P2|STARTED|Overall Study||27
8693228|NCT03091192|21461147|P1|STARTED|Overall Study||33
8693229|NCT03089697|21461165|P2|NOT COMPLETED|Overall Study||2
8693230|NCT03089697|21461166|P1|NOT COMPLETED|Overall Study||2
8693231|NCT03089697|21461165|P2|COMPLETED|Overall Study||10
8693232|NCT03089697|21461166|P1|COMPLETED|Overall Study||11
8693233|NCT03089697|21461165|P2|STARTED|Overall Study||12
8693234|NCT03089697|21461166|P1|STARTED|Overall Study||13
8693238|NCT02964078|21461187|P1|NOT COMPLETED|Overall Study||0
8693239|NCT02964078|21461187|P1|COMPLETED|Overall Study||27
8693240|NCT02964078|21461187|P1|STARTED|Overall Study||27
8693241|NCT02879318|21461195|P2|NOT COMPLETED|Overall Study||0
8693242|NCT02879318|21461196|P1|NOT COMPLETED|Overall Study||0
8693243|NCT02879318|21461195|P2|COMPLETED|Overall Study||119
8693244|NCT02879318|21461196|P1|COMPLETED|Overall Study||61
8693245|NCT02879318|21461195|P2|STARTED|Overall Study||119
8693246|NCT02879318|21461196|P1|STARTED|Overall Study||61
8693247|NCT02761915|21461212|P6|NOT COMPLETED|Overall Study||5
8693248|NCT02761915|21461213|P5|NOT COMPLETED|Overall Study||3
8693249|NCT02761915|21461214|P4|NOT COMPLETED|Overall Study||3
8693250|NCT02761915|21461215|P3|NOT COMPLETED|Overall Study||1
8693251|NCT02761915|21461216|P2|NOT COMPLETED|Overall Study||1
8693252|NCT02761915|21461217|P1|NOT COMPLETED|Overall Study||4
8693253|NCT02761915|21461212|P6|COMPLETED|Overall Study||0
8693254|NCT02761915|21461213|P5|COMPLETED|Overall Study||0
8693255|NCT02761915|21461214|P4|COMPLETED|Overall Study||0
8693256|NCT02761915|21461215|P3|COMPLETED|Overall Study||0
8693257|NCT02761915|21461216|P2|COMPLETED|Overall Study||0
8693258|NCT02761915|21461217|P1|COMPLETED|Overall Study||0
8693259|NCT02761915|21461212|P6|Received Investigational Medicinal Product|Overall Study||0
8693260|NCT02761915|21461213|P5|Received Investigational Medicinal Product|Overall Study||3
8693261|NCT02761915|21461214|P4|Received Investigational Medicinal Product|Overall Study||3
8693262|NCT02761915|21461215|P3|Received Investigational Medicinal Product|Overall Study||1
8693263|NCT02761915|21461216|P2|Received Investigational Medicinal Product|Overall Study||1
8693264|NCT02761915|21461217|P1|Received Investigational Medicinal Product|Overall Study||4
8693265|NCT02761915|21461212|P6|Underwent Leukapheresis|Overall Study||5
8693266|NCT02761915|21461213|P5|Underwent Leukapheresis|Overall Study||3
8693267|NCT02761915|21461214|P4|Underwent Leukapheresis|Overall Study||3
8693268|NCT02761915|21461215|P3|Underwent Leukapheresis|Overall Study||1
8693269|NCT02761915|21461216|P2|Underwent Leukapheresis|Overall Study||1
8693270|NCT02761915|21461217|P1|Underwent Leukapheresis|Overall Study||4
8693271|NCT02761915|21461212|P6|STARTED|Overall Study||5
8693272|NCT02761915|21461213|P5|STARTED|Overall Study||3
8693273|NCT02761915|21461214|P4|STARTED|Overall Study||3
8693274|NCT02761915|21461215|P3|STARTED|Overall Study||1
8693275|NCT02761915|21461216|P2|STARTED|Overall Study||1
8693276|NCT02761915|21461217|P1|STARTED|Overall Study||4
8693277|NCT02734667|21461272|P2|NOT COMPLETED|Overall Study||3
8693278|NCT02734667|21461273|P1|NOT COMPLETED|Overall Study||1
8693279|NCT02734667|21461272|P2|COMPLETED|Overall Study||15
8693280|NCT02734667|21461273|P1|COMPLETED|Overall Study||41
8693281|NCT02734667|21461272|P2|STARTED|Overall Study||18
8693282|NCT02734667|21461273|P1|STARTED|Overall Study||42
8693283|NCT02723929|21461287|P2|NOT COMPLETED|Overall Study||10
8693284|NCT02723929|21461288|P1|NOT COMPLETED|Overall Study||6
8693285|NCT02723929|21461287|P2|COMPLETED|Overall Study||24
8693286|NCT02723929|21461288|P1|COMPLETED|Overall Study||24
8693287|NCT02723929|21461287|P2|STARTED|Overall Study||34
8693288|NCT02723929|21461288|P1|STARTED|Overall Study||30
8693289|NCT02679755|21461308|P2|NOT COMPLETED|Overall Study||105
8693290|NCT02679755|21461309|P1|NOT COMPLETED|Overall Study||34
8693291|NCT02679755|21461308|P2|COMPLETED|Overall Study||47
8693292|NCT02679755|21461309|P1|COMPLETED|Overall Study||66
8693293|NCT02679755|21461308|P2|STARTED|Overall Study||152
8693294|NCT02679755|21461309|P1|STARTED|Overall Study||100
8693301|NCT02634684|21461375|P4|NOT COMPLETED|Overall Study||0
8693302|NCT02634684|21461376|P3|NOT COMPLETED|Overall Study||0
8693303|NCT02634684|21461377|P2|NOT COMPLETED|Overall Study||0
8693304|NCT02634684|21461378|P1|NOT COMPLETED|Overall Study||0
8693305|NCT02634684|21461375|P4|COMPLETED|Overall Study||23
8693306|NCT02634684|21461376|P3|COMPLETED|Overall Study||21
8693307|NCT02634684|21461377|P2|COMPLETED|Overall Study||19
8693308|NCT02634684|21461378|P1|COMPLETED|Overall Study||19
8693309|NCT02634684|21461375|P4|STARTED|Overall Study||23
8693310|NCT02634684|21461376|P3|STARTED|Overall Study||21
8693311|NCT02634684|21461377|P2|STARTED|Overall Study||19
8693312|NCT02634684|21461378|P1|STARTED|Overall Study||19
8693313|NCT02582866|21461396|P1|NOT COMPLETED|Overall Study||22
8693314|NCT02582866|21461396|P1|COMPLETED|Overall Study||84
8693315|NCT02582866|21461396|P1|STARTED|Overall Study||106
8693316|NCT02564198|21461405|P3|NOT COMPLETED|Overall Study||0
8693317|NCT02564198|21461406|P2|NOT COMPLETED|Overall Study||5
8693318|NCT02564198|21461407|P1|NOT COMPLETED|Overall Study||2
8693319|NCT02564198|21461405|P3|COMPLETED|Overall Study||6
8693320|NCT02564198|21461406|P2|COMPLETED|Overall Study||10
8693321|NCT02564198|21461407|P1|COMPLETED|Overall Study||6
8693322|NCT02564198|21461405|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
8693323|NCT02564198|21461406|P2|Received at Least 1 Dose of Study Drug|Overall Study||15
8693324|NCT02564198|21461407|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
8693325|NCT02564198|21461405|P3|STARTED|Overall Study||6
8693326|NCT02564198|21461406|P2|STARTED|Overall Study||15
8693327|NCT02564198|21461407|P1|STARTED|Overall Study||8
8693328|NCT02516241|21461434|P3|NOT COMPLETED|Overall Study||344
8693329|NCT02516241|21461435|P2|NOT COMPLETED|Overall Study||346
8693330|NCT02516241|21461436|P1|NOT COMPLETED|Overall Study||342
8693331|NCT02516241|21461434|P3|COMPLETED|Overall Study||0
8693332|NCT02516241|21461435|P2|COMPLETED|Overall Study||0
8693333|NCT02516241|21461436|P1|COMPLETED|Overall Study||0
8693334|NCT02516241|21461434|P3|Received Treatment|Overall Study||313
8693335|NCT02516241|21461435|P2|Received Treatment|Overall Study||345
8693336|NCT02516241|21461436|P1|Received Treatment|Overall Study||340
8693337|NCT02516241|21461434|P3|STARTED|Overall Study||344
8693338|NCT02516241|21461435|P2|STARTED|Overall Study||346
8693339|NCT02516241|21461436|P1|STARTED|Overall Study||342
8693340|NCT02512965|21461553|P2|NOT COMPLETED|Overall Study||4
8693341|NCT02512965|21461554|P1|NOT COMPLETED|Overall Study||0
8693342|NCT02512965|21461553|P2|COMPLETED|Overall Study|4 patients did not receive any dose of the assigned treatment.|110
8693343|NCT02512965|21461554|P1|COMPLETED|Overall Study||115
8693344|NCT02512965|21461553|P2|STARTED|Overall Study||114
8693345|NCT02512965|21461554|P1|STARTED|Overall Study||115
8693346|NCT02433379|21461566|P1|NOT COMPLETED|Overall Study||321
8693347|NCT02433379|21461566|P1|COMPLETED|Overall Study||852
8693348|NCT02433379|21461566|P1|STARTED|Overall Study||1173
8693349|NCT02421939|21461576|P2|NOT COMPLETED|Overall Study||124
8693350|NCT02421939|21461577|P1|NOT COMPLETED|Overall Study||209
8693351|NCT02421939|21461576|P2|COMPLETED|Overall Study||0
8693352|NCT02421939|21461577|P1|COMPLETED|Overall Study||38
8693353|NCT02421939|21461576|P2|Treated|Overall Study||109
8693354|NCT02421939|21461577|P1|Treated|Overall Study||246
8693355|NCT02421939|21461576|P2|STARTED|Overall Study||124
8693356|NCT02421939|21461577|P1|STARTED|Overall Study||247
8693357|NCT02322814|21461608|P5|NOT COMPLETED|Overall Study||31
8693358|NCT02322814|21461609|P4|NOT COMPLETED|Overall Study||32
8693359|NCT02322814|21461610|P3|NOT COMPLETED|Overall Study||47
8693360|NCT02322814|21461611|P2|NOT COMPLETED|Overall Study||43
8693361|NCT02322814|21461612|P1|NOT COMPLETED|Overall Study||16
8693362|NCT02322814|21461608|P5|COMPLETED|Overall Study||0
8693363|NCT02322814|21461609|P4|COMPLETED|Overall Study||0
8693364|NCT02322814|21461610|P3|COMPLETED|Overall Study||0
8693365|NCT02322814|21461611|P2|COMPLETED|Overall Study||0
8693366|NCT02322814|21461612|P1|COMPLETED|Overall Study||0
8693367|NCT02322814|21461608|P5|STARTED|Overall Study||31
8693368|NCT02322814|21461609|P4|STARTED|Overall Study||32
8693369|NCT02322814|21461610|P3|STARTED|Overall Study||47
8693370|NCT02322814|21461611|P2|STARTED|Overall Study||43
8693371|NCT02322814|21461612|P1|STARTED|Overall Study||16
8693372|NCT02294318|21461625|P2|NOT COMPLETED|Overall Study||2
8693373|NCT02294318|21461626|P1|NOT COMPLETED|Overall Study||3
8693374|NCT02294318|21461625|P2|COMPLETED|Overall Study||21
8693375|NCT02294318|21461626|P1|COMPLETED|Overall Study||21
8693376|NCT02294318|21461625|P2|STARTED|Overall Study||23
8693377|NCT02294318|21461626|P1|STARTED|Overall Study||24
8693378|NCT02293837|21461642|P4|NOT COMPLETED|Overall Study||1
8693379|NCT02293837|21461643|P3|NOT COMPLETED|Overall Study||4
8693380|NCT02293837|21461644|P2|NOT COMPLETED|Overall Study||4
8693381|NCT02293837|21461645|P1|NOT COMPLETED|Overall Study||3
8693382|NCT02293837|21461642|P4|COMPLETED|Overall Study||19
8693383|NCT02293837|21461643|P3|COMPLETED|Overall Study||31
8693384|NCT02293837|21461644|P2|COMPLETED|Overall Study||23
8693385|NCT02293837|21461645|P1|COMPLETED|Overall Study||51
8693386|NCT02293837|21461642|P4|STARTED|Overall Study||20
8693387|NCT02293837|21461643|P3|STARTED|Overall Study|1 randomized adult was never treated|35
8693388|NCT02293837|21461644|P2|STARTED|Overall Study||27
8693389|NCT02293837|21461645|P1|STARTED|Overall Study||54
8693390|NCT02104817|21461717|P2|NOT COMPLETED|Overall Study||6447
8693391|NCT02104817|21461718|P1|NOT COMPLETED|Overall Study||6459
8693392|NCT02104817|21461717|P2|COMPLETED|Overall Study||92
8693393|NCT02104817|21461718|P1|COMPLETED|Overall Study||80
8693394|NCT02104817|21461717|P2|STARTED|Overall Study||6539
8693395|NCT02104817|21461718|P1|STARTED|Overall Study||6539
8693396|NCT02092467|21461753|P3|NOT COMPLETED|Overall Study||398
8693397|NCT02092467|21461754|P2|NOT COMPLETED|Overall Study||459
8693398|NCT02092467|21461755|P1|NOT COMPLETED|Overall Study||404
8693399|NCT02092467|21461753|P3|COMPLETED|Overall Study||1060
8693400|NCT02092467|21461754|P2|COMPLETED|Overall Study||998
8693401|NCT02092467|21461755|P1|COMPLETED|Overall Study||1053
8693402|NCT02092467|21461753|P3|Treated|Overall Study||1451
8693403|NCT02092467|21461754|P2|Treated|Overall Study||1456
8693404|NCT02092467|21461755|P1|Treated|Overall Study||1455
8693405|NCT02092467|21461753|P3|STARTED|Overall Study||1458
8693406|NCT02092467|21461754|P2|STARTED|Overall Study||1457
8693407|NCT02092467|21461755|P1|STARTED|Overall Study||1457
8693408|NCT01942135|21461836|P2|NOT COMPLETED|Overall Study||174
8693409|NCT01942135|21461837|P1|NOT COMPLETED|Overall Study||347
8693410|NCT01942135|21461836|P2|COMPLETED|Overall Study||0
8693411|NCT01942135|21461837|P1|COMPLETED|Overall Study||0
8693412|NCT01942135|21461836|P2|STARTED|Overall Study||174
8693413|NCT01942135|21461837|P1|STARTED|Overall Study||347
8693414|NCT01927497|21461876|P2|NOT COMPLETED|Overall Study||1
8693415|NCT01927497|21461877|P1|NOT COMPLETED|Overall Study||2
8693416|NCT01927497|21461876|P2|COMPLETED|Overall Study||53
8693417|NCT01927497|21461877|P1|COMPLETED|Overall Study||48
8693418|NCT01927497|21461876|P2|STARTED|Overall Study||54
8693419|NCT01927497|21461877|P1|STARTED|Overall Study||50
8693420|NCT01909453|21461888|P5|NOT COMPLETED|Overall Study||86
8693421|NCT01909453|21461889|P4|NOT COMPLETED|Overall Study||258
8693422|NCT01909453|21461890|P3|NOT COMPLETED|Overall Study||191
8693423|NCT01909453|21461891|P2|NOT COMPLETED|Overall Study||194
8693424|NCT01909453|21461892|P1|NOT COMPLETED|Overall Study||192
8693425|NCT01909453|21461888|P5|COMPLETED|Overall Study||0
8693426|NCT01909453|21461889|P4|COMPLETED|Overall Study||0
8693427|NCT01909453|21461890|P3|COMPLETED|Overall Study||0
8693428|NCT01909453|21461891|P2|COMPLETED|Overall Study||0
8693429|NCT01909453|21461892|P1|COMPLETED|Overall Study||0
8693430|NCT01909453|21461888|P5|STARTED|Overall Study||86
8693431|NCT01909453|21461889|P4|STARTED|Overall Study||258
8693432|NCT01909453|21461890|P3|STARTED|Overall Study||191
8693433|NCT01909453|21461891|P2|STARTED|Overall Study||194
8693434|NCT01909453|21461892|P1|STARTED|Overall Study||192
8693435|NCT01903733|21462043|P4|NOT COMPLETED|Overall Study||119
8693436|NCT01903733|21462044|P3|NOT COMPLETED|Overall Study||61
8693437|NCT01903733|21462045|P2|NOT COMPLETED|Overall Study||126
8693438|NCT01903733|21462046|P1|NOT COMPLETED|Overall Study||106
8693439|NCT01903733|21462043|P4|COMPLETED|Overall Study||48
8693440|NCT01903733|21462044|P3|COMPLETED|Overall Study||58
8693441|NCT01903733|21462045|P2|COMPLETED|Overall Study||158
8693442|NCT01903733|21462046|P1|COMPLETED|Overall Study||144
8693443|NCT01903733|21462043|P4|Treated in B1871040|Overall Study||8
8693444|NCT01903733|21462044|P3|Treated in B1871040|Overall Study||13
8693445|NCT01903733|21462045|P2|Treated in B1871040|Overall Study||69
8693446|NCT01903733|21462046|P1|Treated in B1871040|Overall Study||98
8693447|NCT01903733|21462043|P4|Enrolled in B1871040|Overall Study||18
8693448|NCT01903733|21462044|P3|Enrolled in B1871040|Overall Study||28
8693449|NCT01903733|21462045|P2|Enrolled in B1871040|Overall Study||90
8693450|NCT01903733|21462046|P1|Enrolled in B1871040|Overall Study||124
8693451|NCT01903733|21462043|P4|Safety Analysis Set|Overall Study||167
8693452|NCT01903733|21462044|P3|Safety Analysis Set|Overall Study||119
8693453|NCT01903733|21462045|P2|Safety Analysis Set|Overall Study||284
8693454|NCT01903733|21462046|P1|Safety Analysis Set|Overall Study||248
8693455|NCT01903733|21462043|P4|Full Analysis Set|Overall Study||167
8693456|NCT01903733|21462044|P3|Full Analysis Set|Overall Study||119
8693457|NCT01903733|21462045|P2|Full Analysis Set|Overall Study||284
8693458|NCT01903733|21462046|P1|Full Analysis Set|Overall Study||250
8693459|NCT01903733|21462043|P4|STARTED|Overall Study||167
8693460|NCT01903733|21462044|P3|STARTED|Overall Study||119
8693461|NCT01903733|21462045|P2|STARTED|Overall Study||284
8693462|NCT01903733|21462046|P1|STARTED|Overall Study||250
8693463|NCT01888484|21462111|P4|NOT COMPLETED|Overall Study||3
8693464|NCT01888484|21462112|P3|NOT COMPLETED|Overall Study||4
8693465|NCT01888484|21462113|P2|NOT COMPLETED|Overall Study||0
8693466|NCT01888484|21462114|P1|NOT COMPLETED|Overall Study||0
8693467|NCT01888484|21462111|P4|COMPLETED|Overall Study||34
8693468|NCT01888484|21462112|P3|COMPLETED|Overall Study||8
8693469|NCT01888484|21462113|P2|COMPLETED|Overall Study||14
8693470|NCT01888484|21462114|P1|COMPLETED|Overall Study||12
8693471|NCT01888484|21462111|P4|STARTED|Overall Study||37
8693472|NCT01888484|21462112|P3|STARTED|Overall Study||12
8693473|NCT01888484|21462113|P2|STARTED|Overall Study||14
8693474|NCT01888484|21462114|P1|STARTED|Overall Study||12
8693475|NCT01832038|21462126|P1|NOT COMPLETED|Overall Study||235
8693476|NCT01832038|21462126|P1|COMPLETED|Overall Study||238
8693477|NCT01832038|21462126|P1|STARTED|Overall Study||473
8693478|NCT01709721|21462136|P3|NOT COMPLETED|Randomized Phase||0
8693479|NCT01709721|21462137|P2|NOT COMPLETED|Randomized Phase||6
8693480|NCT01709721|21462138|P1|NOT COMPLETED|Randomized Phase||3
8693481|NCT01709721|21462136|P3|COMPLETED|Randomized Phase||0
8693482|NCT01709721|21462137|P2|COMPLETED|Randomized Phase||34
8693483|NCT01709721|21462138|P1|COMPLETED|Randomized Phase||38
8693484|NCT01709721|21462136|P3|STARTED|Randomized Phase||0
8693485|NCT01709721|21462137|P2|STARTED|Randomized Phase||40
8693486|NCT01709721|21462138|P1|STARTED|Randomized Phase||41
8693487|NCT01709721|21462136|P3|NOT COMPLETED|Open Label Phase||72
8693488|NCT01709721|21462137|P2|NOT COMPLETED|Open Label Phase||0
8693489|NCT01709721|21462138|P1|NOT COMPLETED|Open Label Phase||0
8693490|NCT01709721|21462136|P3|COMPLETED|Open Label Phase||0
8693491|NCT01709721|21462137|P2|COMPLETED|Open Label Phase||40
8693492|NCT01709721|21462138|P1|COMPLETED|Open Label Phase||41
8693493|NCT01709721|21462136|P3|STARTED|Open Label Phase||72
8693494|NCT01709721|21462137|P2|STARTED|Open Label Phase||40
8693495|NCT01709721|21462138|P1|STARTED|Open Label Phase||41
8693496|NCT01554514|21462164|P1|NOT COMPLETED|Overall Study||2
8693497|NCT01554514|21462164|P1|COMPLETED|Overall Study||17
8693498|NCT01554514|21462164|P1|STARTED|Overall Study||19
8693499|NCT01449461|21462180|P6|NOT COMPLETED|Overall Study||15
8693500|NCT01449461|21462181|P5|NOT COMPLETED|Overall Study||48
8693501|NCT01449461|21462182|P4|NOT COMPLETED|Overall Study||32
8693502|NCT01449461|21462183|P3|NOT COMPLETED|Overall Study||18
8693503|NCT01449461|21462184|P2|NOT COMPLETED|Overall Study||18
8693504|NCT01449461|21462185|P1|NOT COMPLETED|Overall Study||6
8693505|NCT01449461|21462180|P6|COMPLETED|Overall Study||0
8693506|NCT01449461|21462181|P5|COMPLETED|Overall Study||0
8693507|NCT01449461|21462182|P4|COMPLETED|Overall Study||0
8693508|NCT01449461|21462183|P3|COMPLETED|Overall Study||0
8693509|NCT01449461|21462184|P2|COMPLETED|Overall Study||0
8693510|NCT01449461|21462185|P1|COMPLETED|Overall Study||0
8693511|NCT01449461|21462180|P6|STARTED|Overall Study||15
8693512|NCT01449461|21462181|P5|STARTED|Overall Study||48
8693513|NCT01449461|21462182|P4|STARTED|Overall Study||32
8693514|NCT01449461|21462183|P3|STARTED|Overall Study||18
8693515|NCT01449461|21462184|P2|STARTED|Overall Study||18
8693516|NCT01449461|21462185|P1|STARTED|Overall Study||6
8693517|NCT01432574|21462305|P1|NOT COMPLETED|Overall Study||3
8693518|NCT01432574|21462305|P1|COMPLETED|Overall Study||147
8693519|NCT01432574|21462305|P1|STARTED|Overall Study||150
8693520|NCT01339559|21462311|P1|NOT COMPLETED|Overall Study||398
8693521|NCT01339559|21462311|P1|COMPLETED|Overall Study||368
8693522|NCT01339559|21462311|P1|STARTED|Overall Study||766
8693523|NCT01312181|21462323|P3|NOT COMPLETED|Overall Study||8
8693524|NCT01312181|21462324|P2|NOT COMPLETED|Overall Study||6
8693525|NCT01312181|21462325|P1|NOT COMPLETED|Overall Study||2
8693526|NCT01312181|21462323|P3|COMPLETED|Overall Study||75
8693527|NCT01312181|21462324|P2|COMPLETED|Overall Study||71
8693528|NCT01312181|21462325|P1|COMPLETED|Overall Study||78
8693529|NCT01312181|21462323|P3|STARTED|Overall Study||83
8693530|NCT01312181|21462324|P2|STARTED|Overall Study||77
8693531|NCT01312181|21462325|P1|STARTED|Overall Study||80
8693532|NCT01311674|21462338|P2|NOT COMPLETED|Overall Study||40
8693533|NCT01311674|21462339|P1|NOT COMPLETED|Overall Study||44
8693534|NCT01311674|21462338|P2|COMPLETED|Overall Study||29
8693535|NCT01311674|21462339|P1|COMPLETED|Overall Study||28
8693536|NCT01311674|21462338|P2|STARTED|Overall Study||69
8693537|NCT01311674|21462339|P1|STARTED|Overall Study||72
8693538|NCT01261325|21462356|P3|NOT COMPLETED|Overall Study||26
8693539|NCT01261325|21462357|P2|NOT COMPLETED|Overall Study||29
8693540|NCT01261325|21462358|P1|NOT COMPLETED|Overall Study||17
8693541|NCT01261325|21462356|P3|COMPLETED|Overall Study||225
8693542|NCT01261325|21462357|P2|COMPLETED|Overall Study||225
8693543|NCT01261325|21462358|P1|COMPLETED|Overall Study||246
8693544|NCT01261325|21462356|P3|STARTED|Overall Study||251
8693545|NCT01261325|21462357|P2|STARTED|Overall Study||254
8693546|NCT01261325|21462358|P1|STARTED|Overall Study||263
8693547|NCT01220557|21462392|P2|NOT COMPLETED|Overall Study||5
8693548|NCT01220557|21462393|P1|NOT COMPLETED|Overall Study||6
8693549|NCT01220557|21462392|P2|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
8693550|NCT01220557|21462393|P1|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
8693551|NCT01220557|21462392|P2|STARTED|Overall Study||79
8693552|NCT01220557|21462393|P1|STARTED|Overall Study||81
8693553|NCT01200407|21462399|P1|NOT COMPLETED|Overall Study||82
8693554|NCT01200407|21462399|P1|COMPLETED|Overall Study||533
8693555|NCT01200407|21462399|P1|STARTED|Overall Study||615
8693556|NCT01041638|21462406|P1|NOT COMPLETED|Overall Study||27
8693557|NCT01041638|21462406|P1|COMPLETED|Overall Study||78
8693558|NCT01041638|21462406|P1|STARTED|Overall Study||105
8693559|NCT00490035|21462416|P4|NOT COMPLETED|Overall Study||6
8693560|NCT00490035|21462417|P3|NOT COMPLETED|Overall Study||12
8693561|NCT00490035|21462418|P2|NOT COMPLETED|Overall Study||6
8693562|NCT00490035|21462419|P1|NOT COMPLETED|Overall Study||8
8693563|NCT00490035|21462416|P4|COMPLETED|Overall Study||94
8693564|NCT00490035|21462417|P3|COMPLETED|Overall Study||88
8693565|NCT00490035|21462418|P2|COMPLETED|Overall Study||93
8693566|NCT00490035|21462419|P1|COMPLETED|Overall Study||92
8693567|NCT00490035|21462416|P4|STARTED|Overall Study||100
8693568|NCT00490035|21462417|P3|STARTED|Overall Study||100
8693569|NCT00490035|21462418|P2|STARTED|Overall Study||99
8693570|NCT00490035|21462419|P1|STARTED|Overall Study||100
8693571|NCT00464269|21462521|P4|NOT COMPLETED|Overall Study||9
8693572|NCT00464269|21462522|P3|NOT COMPLETED|Overall Study||7
8693573|NCT00464269|21462523|P2|NOT COMPLETED|Overall Study||17
8693574|NCT00464269|21462524|P1|NOT COMPLETED|Overall Study||6
8693575|NCT00464269|21462521|P4|COMPLETED|Overall Study||93
8693576|NCT00464269|21462522|P3|COMPLETED|Overall Study||93
8693577|NCT00464269|21462523|P2|COMPLETED|Overall Study||82
8693578|NCT00464269|21462524|P1|COMPLETED|Overall Study||93
8693579|NCT00464269|21462521|P4|STARTED|Overall Study||102
8693580|NCT00464269|21462522|P3|STARTED|Overall Study||100
8693581|NCT00464269|21462523|P2|STARTED|Overall Study||99
8693582|NCT00464269|21462524|P1|STARTED|Overall Study||99
8693583|NCT00435227|21462624|P2|NOT COMPLETED|Overall Study||0
8693584|NCT00435227|21462625|P1|NOT COMPLETED|Overall Study||0
8693585|NCT00435227|21462624|P2|COMPLETED|Overall Study||7
8693586|NCT00435227|21462625|P1|COMPLETED|Overall Study||5
8693587|NCT00435227|21462624|P2|STARTED|Overall Study||7
8693588|NCT00435227|21462625|P1|STARTED|Overall Study||5
8693589|NCT00175916|21462670|P1|NOT COMPLETED|Overall Study||619
8693590|NCT00175916|21462670|P1|COMPLETED|Overall Study||234
8693591|NCT00175916|21462670|P1|STARTED|Overall Study||853
8693592|NCT00150800|21462679|P1|NOT COMPLETED|Overall Study||496
8693593|NCT00150800|21462679|P1|COMPLETED|Overall Study||171
8693594|NCT00150800|21462679|P1|STARTED|Overall Study||667
8693595|NCT04709068|21462688|P1|NOT COMPLETED|Overall Study||0
8693596|NCT04709068|21462688|P1|COMPLETED|Overall Study||8
8693597|NCT04709068|21462688|P1|STARTED|Overall Study||8
8693598|NCT04396665|21462694|P2|NOT COMPLETED|Overall Study||7
8693599|NCT04396665|21462695|P1|NOT COMPLETED|Overall Study||35
8693600|NCT04396665|21462694|P2|COMPLETED|Overall Study||83
8693601|NCT04396665|21462695|P1|COMPLETED|Overall Study||99
8693602|NCT04396665|21462694|P2|STARTED|Overall Study||90
8693603|NCT04396665|21462695|P1|STARTED|Overall Study||134
8693604|NCT04347408|21462707|P1|NOT COMPLETED|Overall Study||0
8693605|NCT04347408|21462707|P1|COMPLETED|Overall Study||992
8693606|NCT04347408|21462707|P1|STARTED|Overall Study||992
8693607|NCT04339972|21462713|P2|NOT COMPLETED|Overall Study||5
8693608|NCT04339972|21462714|P1|NOT COMPLETED|Overall Study||5
8693609|NCT04339972|21462713|P2|COMPLETED|Overall Study||9
8693610|NCT04339972|21462714|P1|COMPLETED|Overall Study||10
8693611|NCT04339972|21462713|P2|STARTED|Overall Study||14
8693612|NCT04339972|21462714|P1|STARTED|Overall Study||15
8693613|NCT04333225|21462724|P2|NOT COMPLETED|Overall Study||5
8693614|NCT04333225|21462725|P1|NOT COMPLETED|Overall Study||3
8693615|NCT04333225|21462724|P2|COMPLETED|Overall Study||115
8693616|NCT04333225|21462725|P1|COMPLETED|Overall Study||98
8693617|NCT04333225|21462724|P2|STARTED|Overall Study||120
8693618|NCT04333225|21462725|P1|STARTED|Overall Study||101
8693622|NCT04198948|21462741|P2|NOT COMPLETED|Second Period||1
8693623|NCT04198948|21462742|P1|NOT COMPLETED|Second Period||0
8693624|NCT04198948|21462741|P2|COMPLETED|Second Period||7
8693625|NCT04198948|21462742|P1|COMPLETED|Second Period||7
8693626|NCT04198948|21462741|P2|STARTED|Second Period||8
8693627|NCT04198948|21462742|P1|STARTED|Second Period||7
8693628|NCT04198948|21462741|P2|NOT COMPLETED|Wash-out (10 Days)||0
8693629|NCT04198948|21462742|P1|NOT COMPLETED|Wash-out (10 Days)||0
8693630|NCT04198948|21462741|P2|COMPLETED|Wash-out (10 Days)||8
8693631|NCT04198948|21462742|P1|COMPLETED|Wash-out (10 Days)||7
8693632|NCT04198948|21462741|P2|STARTED|Wash-out (10 Days)||8
8693633|NCT04198948|21462742|P1|STARTED|Wash-out (10 Days)||7
8693634|NCT04198948|21462741|P2|NOT COMPLETED|First Period||0
8693635|NCT04198948|21462742|P1|NOT COMPLETED|First Period||0
8693636|NCT04198948|21462741|P2|COMPLETED|First Period||8
8693637|NCT04198948|21462742|P1|COMPLETED|First Period||7
8693638|NCT04198948|21462741|P2|STARTED|First Period||8
8693639|NCT04198948|21462742|P1|STARTED|First Period||7
8693640|NCT04179461|21462752|P1|NOT COMPLETED|Overall Study||4
8693641|NCT04179461|21462752|P1|COMPLETED|Overall Study||17
8693642|NCT04179461|21462752|P1|STARTED|Overall Study||21
8693643|NCT04175509|21462761|P2|NOT COMPLETED|Overall Study||2
8693644|NCT04175509|21462762|P1|NOT COMPLETED|Overall Study||2
8693645|NCT04175509|21462761|P2|COMPLETED|Overall Study||19
8693646|NCT04175509|21462762|P1|COMPLETED|Overall Study||17
8693647|NCT04175509|21462761|P2|STARTED|Overall Study||21
8693648|NCT04175509|21462762|P1|STARTED|Overall Study||19
8693649|NCT04169061|21462782|P1|NOT COMPLETED|Overall Study||5
8693650|NCT04169061|21462782|P1|COMPLETED|Overall Study||31
8693651|NCT04169061|21462782|P1|Modified Intent to Treat (mITT) Population|Overall Study||34
8693652|NCT04169061|21462782|P1|Safety Population|Overall Study||36
8693653|NCT04169061|21462782|P1|STARTED|Overall Study||36
8693654|NCT04105972|21462788|P2|NOT COMPLETED|Overall Study||1
8693655|NCT04105972|21462789|P1|NOT COMPLETED|Overall Study||2
8693656|NCT04105972|21462788|P2|COMPLETED|Overall Study||86
8693657|NCT04105972|21462789|P1|COMPLETED|Overall Study||86
8693658|NCT04105972|21462788|P2|STARTED|Overall Study||87
8693659|NCT04105972|21462789|P1|STARTED|Overall Study||88
8693660|NCT04041700|21462801|P1|NOT COMPLETED|Overall Study||2
8693661|NCT04041700|21462801|P1|COMPLETED|Overall Study||27
8693662|NCT04041700|21462801|P1|STARTED|Overall Study||29
8693663|NCT04029545|21462839|P3|NOT COMPLETED|Overall Study||0
8693664|NCT04029545|21462840|P2|NOT COMPLETED|Overall Study||0
8693665|NCT04029545|21462841|P1|NOT COMPLETED|Overall Study||0
8693666|NCT04029545|21462839|P3|COMPLETED|Overall Study||2
8693667|NCT04029545|21462840|P2|COMPLETED|Overall Study||1
8693668|NCT04029545|21462841|P1|COMPLETED|Overall Study||2
8693669|NCT04029545|21462839|P3|STARTED|Overall Study||2
8693670|NCT04029545|21462840|P2|STARTED|Overall Study||1
8693671|NCT04029545|21462841|P1|STARTED|Overall Study||2
8693672|NCT03849937|21462849|P2|NOT COMPLETED|Overall Study||37
8693673|NCT03849937|21462850|P1|NOT COMPLETED|Overall Study||53
8693674|NCT03849937|21462849|P2|COMPLETED|Overall Study||35
8693675|NCT03849937|21462850|P1|COMPLETED|Overall Study||94
8693676|NCT03849937|21462849|P2|STARTED|Overall Study||72
8693677|NCT03849937|21462850|P1|STARTED|Overall Study||147
8693678|NCT03839511|21462867|P1|NOT COMPLETED|Overall Study||0
8693679|NCT03839511|21462867|P1|COMPLETED|Overall Study||4
8693680|NCT03839511|21462867|P1|STARTED|Overall Study||4
8693681|NCT03834025|21462879|P7|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||1
8693682|NCT03834025|21462880|P6|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
8693683|NCT03834025|21462881|P5|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
8693684|NCT03834025|21462882|P4|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
8693685|NCT03834025|21462883|P3|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
8693686|NCT03834025|21462884|P2|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
8693687|NCT03834025|21462885|P1|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
8693688|NCT03834025|21462879|P7|COMPLETED|Randomized to Payment Condition(Phase 2)||27
8693689|NCT03834025|21462880|P6|COMPLETED|Randomized to Payment Condition(Phase 2)||21
8693690|NCT03834025|21462881|P5|COMPLETED|Randomized to Payment Condition(Phase 2)||24
8693691|NCT03834025|21462882|P4|COMPLETED|Randomized to Payment Condition(Phase 2)||0
8693692|NCT03834025|21462883|P3|COMPLETED|Randomized to Payment Condition(Phase 2)||0
8693693|NCT03834025|21462884|P2|COMPLETED|Randomized to Payment Condition(Phase 2)||0
8693694|NCT03834025|21462885|P1|COMPLETED|Randomized to Payment Condition(Phase 2)||0
8693695|NCT03834025|21462879|P7|STARTED|Randomized to Payment Condition(Phase 2)||28
8693696|NCT03834025|21462880|P6|STARTED|Randomized to Payment Condition(Phase 2)||21
8693697|NCT03834025|21462881|P5|STARTED|Randomized to Payment Condition(Phase 2)||24
8693698|NCT03834025|21462882|P4|STARTED|Randomized to Payment Condition(Phase 2)||0
8693699|NCT03834025|21462883|P3|STARTED|Randomized to Payment Condition(Phase 2)||0
8693700|NCT03834025|21462884|P2|STARTED|Randomized to Payment Condition(Phase 2)||0
8693701|NCT03834025|21462885|P1|STARTED|Randomized to Payment Condition(Phase 2)||0
8693702|NCT03834025|21462879|P7|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
8693703|NCT03834025|21462880|P6|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
8693704|NCT03834025|21462881|P5|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
8693705|NCT03834025|21462882|P4|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3649
8693706|NCT03834025|21462883|P3|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4077
8693707|NCT03834025|21462884|P2|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3835
8693708|NCT03834025|21462885|P1|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4114
8693709|NCT03834025|21462879|P7|COMPLETED|Sent Recruitment Letter (Phase 1)||0
8693710|NCT03834025|21462880|P6|COMPLETED|Sent Recruitment Letter (Phase 1)||0
8693711|NCT03834025|21462881|P5|COMPLETED|Sent Recruitment Letter (Phase 1)||0
8693712|NCT03834025|21462882|P4|COMPLETED|Sent Recruitment Letter (Phase 1)||44
8693713|NCT03834025|21462883|P3|COMPLETED|Sent Recruitment Letter (Phase 1)||44
8693714|NCT03834025|21462884|P2|COMPLETED|Sent Recruitment Letter (Phase 1)||36
8693715|NCT03834025|21462885|P1|COMPLETED|Sent Recruitment Letter (Phase 1)||36
8693716|NCT03834025|21462879|P7|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
8693717|NCT03834025|21462880|P6|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
8693718|NCT03834025|21462881|P5|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
8693719|NCT03834025|21462882|P4|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
8693720|NCT03834025|21462883|P3|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
8693721|NCT03834025|21462884|P2|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
8693722|NCT03834025|21462885|P1|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
8693723|NCT03834025|21462879|P7|Sent Letter|Sent Recruitment Letter (Phase 1)||0
8693724|NCT03834025|21462880|P6|Sent Letter|Sent Recruitment Letter (Phase 1)||0
8693725|NCT03834025|21462881|P5|Sent Letter|Sent Recruitment Letter (Phase 1)||0
8693726|NCT03834025|21462882|P4|Sent Letter|Sent Recruitment Letter (Phase 1)||3693
8693727|NCT03834025|21462883|P3|Sent Letter|Sent Recruitment Letter (Phase 1)||4121
8693728|NCT03834025|21462884|P2|Sent Letter|Sent Recruitment Letter (Phase 1)||3871
8693729|NCT03834025|21462885|P1|Sent Letter|Sent Recruitment Letter (Phase 1)||4150
8693730|NCT03834025|21462879|P7|STARTED|Sent Recruitment Letter (Phase 1)||0
8693731|NCT03834025|21462880|P6|STARTED|Sent Recruitment Letter (Phase 1)||0
8693732|NCT03834025|21462881|P5|STARTED|Sent Recruitment Letter (Phase 1)||0
8693733|NCT03834025|21462882|P4|STARTED|Sent Recruitment Letter (Phase 1)||3693
8693734|NCT03834025|21462883|P3|STARTED|Sent Recruitment Letter (Phase 1)||4121
8693735|NCT03834025|21462884|P2|STARTED|Sent Recruitment Letter (Phase 1)||3871
8693736|NCT03834025|21462885|P1|STARTED|Sent Recruitment Letter (Phase 1)||4150
8693737|NCT03832738|21462939|P3|NOT COMPLETED|Overall Study||19
8693738|NCT03832738|21462940|P2|NOT COMPLETED|Overall Study||12
8693739|NCT03832738|21462941|P1|NOT COMPLETED|Overall Study||8
8693740|NCT03832738|21462939|P3|COMPLETED|Overall Study||32
8693741|NCT03832738|21462940|P2|COMPLETED|Overall Study||38
8693742|NCT03832738|21462941|P1|COMPLETED|Overall Study||43
8693743|NCT03832738|21462939|P3|STARTED|Overall Study||51
8693744|NCT03832738|21462940|P2|STARTED|Overall Study||50
8693745|NCT03832738|21462941|P1|STARTED|Overall Study||51
8693746|NCT03646162|21462990|P3|NOT COMPLETED|Overall Study||1
8693747|NCT03646162|21462991|P2|NOT COMPLETED|Overall Study||4
8693748|NCT03646162|21462992|P1|NOT COMPLETED|Overall Study||5
8693749|NCT03646162|21462990|P3|COMPLETED|Overall Study||30
8693750|NCT03646162|21462991|P2|COMPLETED|Overall Study||27
8693751|NCT03646162|21462992|P1|COMPLETED|Overall Study||26
8693752|NCT03646162|21462990|P3|STARTED|Overall Study||31
8693753|NCT03646162|21462991|P2|STARTED|Overall Study||31
8693754|NCT03646162|21462992|P1|STARTED|Overall Study||31
8693755|NCT03633903|21463019|P2|NOT COMPLETED|Overall Study||7
8693756|NCT03633903|21463020|P1|NOT COMPLETED|Overall Study||6
8693757|NCT03633903|21463019|P2|COMPLETED|Overall Study||11
8693758|NCT03633903|21463020|P1|COMPLETED|Overall Study||16
8693759|NCT03633903|21463019|P2|Intent to Treat|Overall Study||18
8693760|NCT03633903|21463020|P1|Intent to Treat|Overall Study||0
8693761|NCT03633903|21463019|P2|STARTED|Overall Study||18
8693762|NCT03633903|21463020|P1|STARTED|Overall Study||22
8693763|NCT03620890|21463032|P2|NOT COMPLETED|Overall Study||1
8693764|NCT03620890|21463033|P1|NOT COMPLETED|Overall Study||4
8693765|NCT03620890|21463032|P2|COMPLETED|Overall Study||50
8693766|NCT03620890|21463033|P1|COMPLETED|Overall Study||53
8693767|NCT03620890|21463032|P2|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||0
8693768|NCT03620890|21463033|P1|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||1
8693769|NCT03620890|21463032|P2|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||0
8693770|NCT03620890|21463033|P1|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||1
8693771|NCT03620890|21463032|P2|First Trimester Miscarriage|Overall Study||1
8693772|NCT03620890|21463033|P1|First Trimester Miscarriage|Overall Study||2
8693773|NCT03620890|21463032|P2|STARTED|Overall Study||51
8693774|NCT03620890|21463033|P1|STARTED|Overall Study||57
8693775|NCT03601052|21463065|P1|NOT COMPLETED|Overall Study||2
8693776|NCT03601052|21463065|P1|COMPLETED|Overall Study||12
8693777|NCT03601052|21463065|P1|STARTED|Overall Study||14
8693778|NCT03561883|21463086|P2|NOT COMPLETED|Overall Study||43
8693779|NCT03561883|21463087|P1|NOT COMPLETED|Overall Study||46
8693780|NCT03561883|21463086|P2|COMPLETED|Overall Study||261
8693781|NCT03561883|21463087|P1|COMPLETED|Overall Study||259
8693782|NCT03561883|21463086|P2|STARTED|Overall Study||304
8693783|NCT03561883|21463087|P1|STARTED|Overall Study||305
8693784|NCT03561090|21463101|P2|NOT COMPLETED|Overall Study||36
8693785|NCT03561090|21463102|P1|NOT COMPLETED|Overall Study||40
8693786|NCT03561090|21463101|P2|COMPLETED|Overall Study||212
8693787|NCT03561090|21463102|P1|COMPLETED|Overall Study||207
8693788|NCT03561090|21463101|P2|Randomized and Treated|Overall Study||247
8693789|NCT03561090|21463102|P1|Randomized and Treated|Overall Study||246
8693790|NCT03561090|21463101|P2|STARTED|Overall Study||248
8693791|NCT03561090|21463102|P1|STARTED|Overall Study||247
8693792|NCT03554486|21463116|P3|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
8693793|NCT03554486|21463117|P2|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
8693794|NCT03554486|21463118|P1|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
8693795|NCT03554486|21463116|P3|COMPLETED|Treatment Period 2 (2 Weeks)||9
8693796|NCT03554486|21463117|P2|COMPLETED|Treatment Period 2 (2 Weeks)||10
8693797|NCT03554486|21463118|P1|COMPLETED|Treatment Period 2 (2 Weeks)||0
8693798|NCT03554486|21463116|P3|STARTED|Treatment Period 2 (2 Weeks)||9
8693799|NCT03554486|21463117|P2|STARTED|Treatment Period 2 (2 Weeks)||10
8693800|NCT03554486|21463118|P1|STARTED|Treatment Period 2 (2 Weeks)||0
8693801|NCT03554486|21463116|P3|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
8693802|NCT03554486|21463117|P2|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
8693803|NCT03554486|21463118|P1|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
8693804|NCT03554486|21463116|P3|COMPLETED|Treatment Period 1 (2 Weeks)||9
8693805|NCT03554486|21463117|P2|COMPLETED|Treatment Period 1 (2 Weeks)||10
8693806|NCT03554486|21463118|P1|COMPLETED|Treatment Period 1 (2 Weeks)||0
8693807|NCT03554486|21463116|P3|STARTED|Treatment Period 1 (2 Weeks)||10
8693808|NCT03554486|21463117|P2|STARTED|Treatment Period 1 (2 Weeks)||11
8693809|NCT03554486|21463118|P1|STARTED|Treatment Period 1 (2 Weeks)||0
8693810|NCT03554486|21463116|P3|NOT COMPLETED|Run-in Period (2 Weeks)||0
8693811|NCT03554486|21463117|P2|NOT COMPLETED|Run-in Period (2 Weeks)||0
8693812|NCT03554486|21463118|P1|NOT COMPLETED|Run-in Period (2 Weeks)||3
8693813|NCT03554486|21463116|P3|COMPLETED|Run-in Period (2 Weeks)||0
8693814|NCT03554486|21463117|P2|COMPLETED|Run-in Period (2 Weeks)||0
8693815|NCT03554486|21463118|P1|COMPLETED|Run-in Period (2 Weeks)||21
8693816|NCT03554486|21463116|P3|STARTED|Run-in Period (2 Weeks)||0
8693817|NCT03554486|21463117|P2|STARTED|Run-in Period (2 Weeks)||0
8693818|NCT03554486|21463118|P1|STARTED|Run-in Period (2 Weeks)||24
8693819|NCT03527550|21463131|P2|NOT COMPLETED|Overall Study||3
8693820|NCT03527550|21463132|P1|NOT COMPLETED|Overall Study||9
8693821|NCT03527550|21463131|P2|COMPLETED|Overall Study||19
8693822|NCT03527550|21463132|P1|COMPLETED|Overall Study||15
8693823|NCT03527550|21463131|P2|STARTED|Overall Study||22
8693824|NCT03527550|21463132|P1|STARTED|Overall Study||24
8693825|NCT03526458|21463150|P2|NOT COMPLETED|Overall Study||5
8693826|NCT03526458|21463151|P1|NOT COMPLETED|Overall Study||8
8693827|NCT03526458|21463150|P2|COMPLETED|Overall Study||15
8693828|NCT03526458|21463151|P1|COMPLETED|Overall Study||12
8693829|NCT03526458|21463150|P2|STARTED|Overall Study||20
8693830|NCT03526458|21463151|P1|STARTED|Overall Study||20
8693831|NCT03510481|21463173|P4|NOT COMPLETED|Year 2 - Booster Dose||1
8693832|NCT03510481|21463174|P3|NOT COMPLETED|Year 2 - Booster Dose||2
8693833|NCT03510481|21463175|P2|NOT COMPLETED|Year 2 - Booster Dose||3
8693834|NCT03510481|21463176|P1|NOT COMPLETED|Year 2 - Booster Dose||4
8693835|NCT03510481|21463173|P4|COMPLETED|Year 2 - Booster Dose||18
8693836|NCT03510481|21463174|P3|COMPLETED|Year 2 - Booster Dose||23
8693837|NCT03510481|21463175|P2|COMPLETED|Year 2 - Booster Dose||49
8693838|NCT03510481|21463176|P1|COMPLETED|Year 2 - Booster Dose||42
8693839|NCT03510481|21463173|P4|STARTED|Year 2 - Booster Dose|12 participants who completed Period 1 did not re-consent for Period 2.|19
8693840|NCT03510481|21463174|P3|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|25
8693841|NCT03510481|21463175|P2|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|52
8693842|NCT03510481|21463176|P1|STARTED|Year 2 - Booster Dose|10 participants who completed Period 1 did not re-consent for Period 2.|46
8693843|NCT03510481|21463173|P4|NOT COMPLETED|Year 1||4
8693844|NCT03510481|21463174|P3|NOT COMPLETED|Year 1||2
8693845|NCT03510481|21463175|P2|NOT COMPLETED|Year 1||9
8693846|NCT03510481|21463176|P1|NOT COMPLETED|Year 1||13
8693847|NCT03510481|21463173|P4|COMPLETED|Year 1||31
8693848|NCT03510481|21463174|P3|COMPLETED|Year 1||34
8693849|NCT03510481|21463175|P2|COMPLETED|Year 1||61
8693850|NCT03510481|21463176|P1|COMPLETED|Year 1||56
8693851|NCT03510481|21463173|P4|STARTED|Year 1||35
8693852|NCT03510481|21463174|P3|STARTED|Year 1||36
8693853|NCT03510481|21463175|P2|STARTED|Year 1||70
8693854|NCT03510481|21463176|P1|STARTED|Year 1||69
8693855|NCT03503565|21463192|P2|NOT COMPLETED|Overall Study||0
8693856|NCT03503565|21463193|P1|NOT COMPLETED|Overall Study||0
8693857|NCT03503565|21463192|P2|COMPLETED|Overall Study||58
8693858|NCT03503565|21463193|P1|COMPLETED|Overall Study||59
8693859|NCT03503565|21463192|P2|STARTED|Overall Study||58
8693860|NCT03503565|21463193|P1|STARTED|Overall Study||59
8693861|NCT03491553|21463205|P6|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
8693862|NCT03491553|21463206|P5|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
8693863|NCT03491553|21463207|P4|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
8693864|NCT03491553|21463208|P3|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
8693865|NCT03491553|21463209|P2|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
8693866|NCT03491553|21463210|P1|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
8693867|NCT03491553|21463205|P6|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
8693868|NCT03491553|21463206|P5|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
8693869|NCT03491553|21463207|P4|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
8693870|NCT03491553|21463208|P3|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
8693871|NCT03491553|21463209|P2|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||1
8693872|NCT03491553|21463210|P1|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
8693873|NCT03491553|21463205|P6|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|4 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
8693874|NCT03491553|21463206|P5|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|5 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
8693875|NCT03491553|21463207|P4|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
8693876|NCT03491553|21463208|P3|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|10 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
8693877|NCT03491553|21463209|P2|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but only 1 participant continued in the TFFU phase.|1
8693878|NCT03491553|21463210|P1|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|8 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
8693879|NCT03491553|21463205|P6|NOT COMPLETED|Main Study (Up to Week 48)||0
8693880|NCT03491553|21463206|P5|NOT COMPLETED|Main Study (Up to Week 48)||0
8693881|NCT03491553|21463207|P4|NOT COMPLETED|Main Study (Up to Week 48)||1
8693882|NCT03491553|21463208|P3|NOT COMPLETED|Main Study (Up to Week 48)||0
8693883|NCT03491553|21463209|P2|NOT COMPLETED|Main Study (Up to Week 48)||1
8693884|NCT03491553|21463210|P1|NOT COMPLETED|Main Study (Up to Week 48)||1
8693885|NCT03491553|21463205|P6|COMPLETED|Main Study (Up to Week 48)||4
8693886|NCT03491553|21463206|P5|COMPLETED|Main Study (Up to Week 48)||5
8693887|NCT03491553|21463207|P4|COMPLETED|Main Study (Up to Week 48)||9
8693888|NCT03491553|21463208|P3|COMPLETED|Main Study (Up to Week 48)||10
8693889|NCT03491553|21463209|P2|COMPLETED|Main Study (Up to Week 48)||9
8693890|NCT03491553|21463210|P1|COMPLETED|Main Study (Up to Week 48)||8
8693891|NCT03491553|21463205|P6|STARTED|Main Study (Up to Week 48)||4
8693892|NCT03491553|21463206|P5|STARTED|Main Study (Up to Week 48)||5
8693893|NCT03491553|21463207|P4|STARTED|Main Study (Up to Week 48)||10
8693894|NCT03491553|21463208|P3|STARTED|Main Study (Up to Week 48)||10
8693895|NCT03491553|21463209|P2|STARTED|Main Study (Up to Week 48)||10
8693896|NCT03491553|21463210|P1|STARTED|Main Study (Up to Week 48)||9
8693897|NCT03478969|21463320|P3|NOT COMPLETED|Overall Study||18
8693898|NCT03478969|21463321|P2|NOT COMPLETED|Overall Study||12
8693899|NCT03478969|21463322|P1|NOT COMPLETED|Overall Study||9
8693900|NCT03478969|21463320|P3|COMPLETED|Overall Study||40
8693901|NCT03478969|21463321|P2|COMPLETED|Overall Study||49
8693902|NCT03478969|21463322|P1|COMPLETED|Overall Study||53
8693903|NCT03478969|21463320|P3|Participants at End of Parallel Phase|Overall Study||52
8693904|NCT03478969|21463321|P2|Participants at End of Parallel Phase|Overall Study||58
8693905|NCT03478969|21463322|P1|Participants at End of Parallel Phase|Overall Study||55
8693906|NCT03478969|21463320|P3|STARTED|Overall Study||58
8693907|NCT03478969|21463321|P2|STARTED|Overall Study||61
8693908|NCT03478969|21463322|P1|STARTED|Overall Study||62
8693909|NCT03473301|21463392|P3|NOT COMPLETED|Overall Study||6
8693910|NCT03473301|21463393|P2|NOT COMPLETED|Overall Study||6
8693911|NCT03473301|21463394|P1|NOT COMPLETED|Overall Study||11
8693912|NCT03473301|21463392|P3|COMPLETED|Overall Study||25
8693913|NCT03473301|21463393|P2|COMPLETED|Overall Study||23
8693914|NCT03473301|21463394|P1|COMPLETED|Overall Study||20
8693915|NCT03473301|21463392|P3|STARTED|Overall Study||31
8693916|NCT03473301|21463393|P2|STARTED|Overall Study||29
8693917|NCT03473301|21463394|P1|STARTED|Overall Study||31
8693918|NCT03457103|21463410|P2|NOT COMPLETED|Overall Study||6
8693919|NCT03457103|21463411|P1|NOT COMPLETED|Overall Study||8
8693920|NCT03457103|21463410|P2|COMPLETED|Overall Study||3
8693921|NCT03457103|21463411|P1|COMPLETED|Overall Study||14
8693922|NCT03457103|21463410|P2|STARTED|Overall Study||9
8693923|NCT03457103|21463411|P1|STARTED|Overall Study||22
8693924|NCT03435081|21463432|P3|NOT COMPLETED|Overall Study||19
8693925|NCT03435081|21463433|P2|NOT COMPLETED|Overall Study||16
8693926|NCT03435081|21463434|P1|NOT COMPLETED|Overall Study||21
8693927|NCT03435081|21463432|P3|COMPLETED|Overall Study||127
8693928|NCT03435081|21463433|P2|COMPLETED|Overall Study||131
8693929|NCT03435081|21463434|P1|COMPLETED|Overall Study||126
8693930|NCT03435081|21463432|P3|Received at Least One Dose of Study Drug|Overall Study||146
8693931|NCT03435081|21463433|P2|Received at Least One Dose of Study Drug|Overall Study||147
8693932|NCT03435081|21463434|P1|Received at Least One Dose of Study Drug|Overall Study||147
8693933|NCT03435081|21463432|P3|STARTED|Overall Study||146
8693934|NCT03435081|21463433|P2|STARTED|Overall Study||147
8693935|NCT03435081|21463434|P1|STARTED|Overall Study||147
8693936|NCT03433755|21463513|P4|NOT COMPLETED|Overall Study||0
8693937|NCT03433755|21463514|P3|NOT COMPLETED|Overall Study||0
8693938|NCT03433755|21463515|P2|NOT COMPLETED|Overall Study||0
8693939|NCT03433755|21463516|P1|NOT COMPLETED|Overall Study||2
8693940|NCT03433755|21463513|P4|COMPLETED|Overall Study||80
8693941|NCT03433755|21463514|P3|COMPLETED|Overall Study||79
8693942|NCT03433755|21463515|P2|COMPLETED|Overall Study||41
8693943|NCT03433755|21463516|P1|COMPLETED|Overall Study||40
8693944|NCT03433755|21463513|P4|Randomized and Treated|Overall Study||80
8693945|NCT03433755|21463514|P3|Randomized and Treated|Overall Study||79
8693946|NCT03433755|21463515|P2|Randomized and Treated|Overall Study||41
8693947|NCT03433755|21463516|P1|Randomized and Treated|Overall Study||41
8693948|NCT03433755|21463513|P4|STARTED|Overall Study||80
8693949|NCT03433755|21463514|P3|STARTED|Overall Study||79
8693950|NCT03433755|21463515|P2|STARTED|Overall Study||41
8693951|NCT03433755|21463516|P1|STARTED|Overall Study||42
8693952|NCT03400943|21463614|P4|NOT COMPLETED|Follow-up Period||0
8693953|NCT03400943|21463615|P3|NOT COMPLETED|Follow-up Period||0
8693954|NCT03400943|21463616|P2|NOT COMPLETED|Follow-up Period||0
8693955|NCT03400943|21463617|P1|NOT COMPLETED|Follow-up Period||1
8693956|NCT03400943|21463614|P4|COMPLETED|Follow-up Period||5
8693957|NCT03400943|21463615|P3|COMPLETED|Follow-up Period||7
8693958|NCT03400943|21463616|P2|COMPLETED|Follow-up Period||15
8693959|NCT03400943|21463617|P1|COMPLETED|Follow-up Period||6
8693960|NCT03400943|21463614|P4|STARTED|Follow-up Period||5
8693961|NCT03400943|21463615|P3|STARTED|Follow-up Period||7
8693962|NCT03400943|21463616|P2|STARTED|Follow-up Period||15
8693963|NCT03400943|21463617|P1|STARTED|Follow-up Period||7
8693964|NCT03400943|21463614|P4|NOT COMPLETED|Treatment Period 2||0
8693965|NCT03400943|21463615|P3|NOT COMPLETED|Treatment Period 2||0
8693966|NCT03400943|21463616|P2|NOT COMPLETED|Treatment Period 2||8
8693967|NCT03400943|21463617|P1|NOT COMPLETED|Treatment Period 2||1
8693968|NCT03400943|21463614|P4|COMPLETED|Treatment Period 2||5
8693969|NCT03400943|21463615|P3|COMPLETED|Treatment Period 2||7
8693970|NCT03400943|21463616|P2|COMPLETED|Treatment Period 2||13
8693971|NCT03400943|21463617|P1|COMPLETED|Treatment Period 2||6
8693972|NCT03400943|21463614|P4|STARTED|Treatment Period 2||5
8693973|NCT03400943|21463615|P3|STARTED|Treatment Period 2||7
8693974|NCT03400943|21463616|P2|STARTED|Treatment Period 2||21
8693975|NCT03400943|21463617|P1|STARTED|Treatment Period 2||7
8693976|NCT03400943|21463614|P4|NOT COMPLETED|Post-treatment Period 1||13
8693977|NCT03400943|21463615|P3|NOT COMPLETED|Post-treatment Period 1||11
8693978|NCT03400943|21463616|P2|NOT COMPLETED|Post-treatment Period 1||0
8693979|NCT03400943|21463617|P1|NOT COMPLETED|Post-treatment Period 1||11
8693980|NCT03400943|21463614|P4|COMPLETED|Post-treatment Period 1||5
8693981|NCT03400943|21463615|P3|COMPLETED|Post-treatment Period 1||7
8693982|NCT03400943|21463616|P2|COMPLETED|Post-treatment Period 1||0
8693983|NCT03400943|21463617|P1|COMPLETED|Post-treatment Period 1||7
8693984|NCT03400943|21463614|P4|STARTED|Post-treatment Period 1||18
8693985|NCT03400943|21463615|P3|STARTED|Post-treatment Period 1||18
8693986|NCT03400943|21463616|P2|STARTED|Post-treatment Period 1||0
8693987|NCT03400943|21463617|P1|STARTED|Post-treatment Period 1||18
8693988|NCT03400943|21463614|P4|NOT COMPLETED|Treatment Period 1||5
8693989|NCT03400943|21463615|P3|NOT COMPLETED|Treatment Period 1||6
8693990|NCT03400943|21463616|P2|NOT COMPLETED|Treatment Period 1||2
8693991|NCT03400943|21463617|P1|NOT COMPLETED|Treatment Period 1||5
8693992|NCT03400943|21463614|P4|COMPLETED|Treatment Period 1||18
8693993|NCT03400943|21463615|P3|COMPLETED|Treatment Period 1||18
8693994|NCT03400943|21463616|P2|COMPLETED|Treatment Period 1||21
8693995|NCT03400943|21463617|P1|COMPLETED|Treatment Period 1||18
8693996|NCT03400943|21463614|P4|Treated|Treatment Period 1||20
8693997|NCT03400943|21463615|P3|Treated|Treatment Period 1||20
8693998|NCT03400943|21463616|P2|Treated|Treatment Period 1||21
8693999|NCT03400943|21463617|P1|Treated|Treatment Period 1||18
8694000|NCT03400943|21463614|P4|STARTED|Treatment Period 1||23
8694001|NCT03400943|21463615|P3|STARTED|Treatment Period 1||24
8694002|NCT03400943|21463616|P2|STARTED|Treatment Period 1||23
8694003|NCT03400943|21463617|P1|STARTED|Treatment Period 1||23
8694004|NCT03386110|21463647|P2|NOT COMPLETED|Overall Study||6
8694005|NCT03386110|21463648|P1|NOT COMPLETED|Overall Study||15
8694006|NCT03386110|21463647|P2|COMPLETED|Overall Study||38
8694007|NCT03386110|21463648|P1|COMPLETED|Overall Study||41
8694008|NCT03386110|21463647|P2|STARTED|Overall Study||44
8694009|NCT03386110|21463648|P1|STARTED|Overall Study||56
8694010|NCT03352414|21463660|P2|NOT COMPLETED|Overall Study||10
8694011|NCT03352414|21463661|P1|NOT COMPLETED|Overall Study||12
8694012|NCT03352414|21463660|P2|COMPLETED|Overall Study||32
8694013|NCT03352414|21463661|P1|COMPLETED|Overall Study||30
8694014|NCT03352414|21463660|P2|Allocated|Overall Study||32
8694015|NCT03352414|21463661|P1|Allocated|Overall Study||30
8694016|NCT03352414|21463660|P2|STARTED|Overall Study||42
8694017|NCT03352414|21463661|P1|STARTED|Overall Study||42
8694018|NCT03343704|21463679|P2|NOT COMPLETED|Overall Study||2
8694019|NCT03343704|21463680|P1|NOT COMPLETED|Overall Study||1
8694020|NCT03343704|21463679|P2|COMPLETED|Overall Study||4
8694021|NCT03343704|21463680|P1|COMPLETED|Overall Study||12
8694022|NCT03343704|21463679|P2|STARTED|Overall Study||6
8694023|NCT03343704|21463680|P1|STARTED|Overall Study||13
8694024|NCT03339713|21463722|P2|NOT COMPLETED|Overall Study||2
8694025|NCT03339713|21463723|P1|NOT COMPLETED|Overall Study||4
8694026|NCT03339713|21463722|P2|COMPLETED|Overall Study||88
8694027|NCT03339713|21463723|P1|COMPLETED|Overall Study||86
8694028|NCT03339713|21463722|P2|STARTED|Overall Study||90
8694029|NCT03339713|21463723|P1|STARTED|Overall Study||90
8694030|NCT03339297|21463751|P2|NOT COMPLETED|Overall Study||14
8694031|NCT03339297|21463752|P1|NOT COMPLETED|Overall Study||23
8694032|NCT03339297|21463751|P2|COMPLETED|Overall Study||59
8694033|NCT03339297|21463752|P1|COMPLETED|Overall Study||56
8694034|NCT03339297|21463751|P2|STARTED|Overall Study||73
8694035|NCT03339297|21463752|P1|STARTED|Overall Study||79
8694036|NCT03322657|21463810|P2|NOT COMPLETED|Overall Study||0
8694037|NCT03322657|21463811|P1|NOT COMPLETED|Overall Study||1
8694038|NCT03322657|21463810|P2|COMPLETED|Overall Study||35
8694039|NCT03322657|21463811|P1|COMPLETED|Overall Study||33
8694040|NCT03322657|21463810|P2|STARTED|Overall Study||35
8694041|NCT03322657|21463811|P1|STARTED|Overall Study||34
8694042|NCT03321006|21463821|P2|NOT COMPLETED|Overall Study||0
8694043|NCT03321006|21463822|P1|NOT COMPLETED|Overall Study||2
8694044|NCT03321006|21463821|P2|COMPLETED|Overall Study||11
8694045|NCT03321006|21463822|P1|COMPLETED|Overall Study||12
8694046|NCT03321006|21463821|P2|STARTED|Overall Study||11
8694047|NCT03321006|21463822|P1|STARTED|Overall Study||14
8694048|NCT03317379|21463835|P3|NOT COMPLETED|Overall Study||2
8694049|NCT03317379|21463836|P2|NOT COMPLETED|Overall Study||3
8694050|NCT03317379|21463837|P1|NOT COMPLETED|Overall Study||0
8694051|NCT03317379|21463835|P3|COMPLETED|Overall Study||20
8694052|NCT03317379|21463836|P2|COMPLETED|Overall Study||15
8694053|NCT03317379|21463837|P1|COMPLETED|Overall Study||20
8694054|NCT03317379|21463835|P3|Completed Intervention|Overall Study||0
8694055|NCT03317379|21463836|P2|Completed Intervention|Overall Study||6
8694056|NCT03317379|21463837|P1|Completed Intervention|Overall Study||16
8694057|NCT03317379|21463835|P3|STARTED|Overall Study||22
8694058|NCT03317379|21463836|P2|STARTED|Overall Study||18
8694059|NCT03317379|21463837|P1|STARTED|Overall Study||20
8694060|NCT03125902|21463859|P2|NOT COMPLETED|Overall Study||431
8694061|NCT03125902|21463860|P1|NOT COMPLETED|Overall Study||220
8694062|NCT03125902|21463859|P2|COMPLETED|Overall Study||0
8694063|NCT03125902|21463860|P1|COMPLETED|Overall Study||0
8694064|NCT03125902|21463859|P2|STARTED|Overall Study||431
8694065|NCT03125902|21463860|P1|STARTED|Overall Study||220
8694066|NCT03117634|21463907|P2|NOT COMPLETED|Overall Study||0
8694067|NCT03117634|21463908|P1|NOT COMPLETED|Overall Study||2
8694068|NCT03117634|21463907|P2|COMPLETED|Overall Study||13
8694069|NCT03117634|21463908|P1|COMPLETED|Overall Study||39
8694070|NCT03117634|21463907|P2|STARTED|Overall Study||13
8694071|NCT03117634|21463908|P1|STARTED|Overall Study||41
8694072|NCT03049215|21463922|P2|NOT COMPLETED|Overall Study||0
8694073|NCT03049215|21463923|P1|NOT COMPLETED|Overall Study||0
8694074|NCT03049215|21463922|P2|COMPLETED|Overall Study||0
8694075|NCT03049215|21463923|P1|COMPLETED|Overall Study||1
8694076|NCT03049215|21463922|P2|STARTED|Overall Study||0
8694077|NCT03049215|21463923|P1|STARTED|Overall Study||1
8694078|NCT03016312|21463941|P2|NOT COMPLETED|Overall Study||218
8694079|NCT03016312|21463942|P1|NOT COMPLETED|Overall Study||241
8694080|NCT03016312|21463941|P2|COMPLETED|Overall Study||162
8694081|NCT03016312|21463942|P1|COMPLETED|Overall Study||150
8694082|NCT03016312|21463941|P2|STARTED|Overall Study||380
8694083|NCT03016312|21463942|P1|STARTED|Overall Study||391
8694084|NCT02974803|21463962|P1|NOT COMPLETED|Overall Study||0
8694085|NCT02974803|21463962|P1|COMPLETED|Overall Study||6
8694086|NCT02974803|21463962|P1|STARTED|Overall Study||6
8694087|NCT02964325|21463973|P2|NOT COMPLETED|Overall Study||23
8694088|NCT02964325|21463974|P1|NOT COMPLETED|Overall Study||21
8694089|NCT02964325|21463973|P2|COMPLETED|Overall Study||143
8694090|NCT02964325|21463974|P1|COMPLETED|Overall Study||143
8694091|NCT02964325|21463973|P2|Safety Set|Overall Study||161
8694092|NCT02964325|21463974|P1|Safety Set|Overall Study||141
8694093|NCT02964325|21463973|P2|Modified Intent-to-Treat|Overall Study||152
8694094|NCT02964325|21463974|P1|Modified Intent-to-Treat|Overall Study||145
8694095|NCT02964325|21463973|P2|Full Analysis Set|Overall Study||166
8694096|NCT02964325|21463974|P1|Full Analysis Set|Overall Study||164
8694097|NCT02964325|21463973|P2|STARTED|Overall Study||166
8694098|NCT02964325|21463974|P1|STARTED|Overall Study||164
8694107|NCT02866643|21464015|P2|NOT COMPLETED|Overall Study||12
8694108|NCT02866643|21464016|P1|NOT COMPLETED|Overall Study||13
8694109|NCT02866643|21464015|P2|COMPLETED|Overall Study||35
8694110|NCT02866643|21464016|P1|COMPLETED|Overall Study||35
8694111|NCT02866643|21464015|P2|Per Protocol Population|Overall Study||35
8694112|NCT02866643|21464016|P1|Per Protocol Population|Overall Study||35
8694113|NCT02866643|21464015|P2|Intent-to-Treat (ITT) Population|Overall Study||39
8694114|NCT02866643|21464016|P1|Intent-to-Treat (ITT) Population|Overall Study||38
8694115|NCT02866643|21464015|P2|STARTED|Overall Study||47
8694116|NCT02866643|21464016|P1|STARTED|Overall Study||48
8694117|NCT02834390|21464024|P2|NOT COMPLETED|Consolidation Phase||1
8694118|NCT02834390|21464025|P1|NOT COMPLETED|Consolidation Phase||1
8694119|NCT02834390|21464024|P2|COMPLETED|Consolidation Phase||0
8694120|NCT02834390|21464025|P1|COMPLETED|Consolidation Phase||1
8694121|NCT02834390|21464024|P2|STARTED|Consolidation Phase||1
8694122|NCT02834390|21464025|P1|STARTED|Consolidation Phase||2
8694123|NCT02834390|21464024|P2|NOT COMPLETED|Induction Phase||2
8694124|NCT02834390|21464025|P1|NOT COMPLETED|Induction Phase||2
8694125|NCT02834390|21464024|P2|COMPLETED|Induction Phase||1
8694126|NCT02834390|21464025|P1|COMPLETED|Induction Phase||2
8694127|NCT02834390|21464024|P2|STARTED|Induction Phase||3
8694128|NCT02834390|21464025|P1|STARTED|Induction Phase||4
8694129|NCT02747927|21464051|P2|NOT COMPLETED|Overall Study||458
8694130|NCT02747927|21464052|P1|NOT COMPLETED|Overall Study||221
8694131|NCT02747927|21464051|P2|COMPLETED|Overall Study||12943
8694132|NCT02747927|21464052|P1|COMPLETED|Overall Study||6477
8694133|NCT02747927|21464051|P2|Treated: Safety Set|Overall Study||13380
8694134|NCT02747927|21464052|P1|Treated: Safety Set|Overall Study||6687
8694135|NCT02747927|21464051|P2|STARTED|Overall Study||13401
8694136|NCT02747927|21464052|P1|STARTED|Overall Study||6698
8694137|NCT02747004|21464061|P3|NOT COMPLETED|Overall Study||47
8694138|NCT02747004|21464062|P2|NOT COMPLETED|Overall Study||49
8694139|NCT02747004|21464063|P1|NOT COMPLETED|Overall Study||57
8694140|NCT02747004|21464061|P3|COMPLETED|Overall Study||30
8694141|NCT02747004|21464062|P2|COMPLETED|Overall Study||30
8694142|NCT02747004|21464063|P1|COMPLETED|Overall Study||21
8694143|NCT02747004|21464061|P3|Received at Least One Dose of Study Drug|Overall Study||77
8694144|NCT02747004|21464062|P2|Received at Least One Dose of Study Drug|Overall Study||79
8694145|NCT02747004|21464063|P1|Received at Least One Dose of Study Drug|Overall Study||78
8694146|NCT02747004|21464061|P3|STARTED|Overall Study||77
8694147|NCT02747004|21464062|P2|STARTED|Overall Study||79
8694148|NCT02747004|21464063|P1|STARTED|Overall Study||78
8694149|NCT02737501|21464093|P3|NOT COMPLETED|Crossover Phase||55
8694150|NCT02737501|21464094|P2|NOT COMPLETED|Crossover Phase||0
8694151|NCT02737501|21464095|P1|NOT COMPLETED|Crossover Phase||0
8694152|NCT02737501|21464093|P3|COMPLETED|Crossover Phase||10
8694153|NCT02737501|21464094|P2|COMPLETED|Crossover Phase||0
8694154|NCT02737501|21464095|P1|COMPLETED|Crossover Phase||0
8694155|NCT02737501|21464093|P3|STARTED|Crossover Phase||65
8694156|NCT02737501|21464094|P2|STARTED|Crossover Phase||0
8694157|NCT02737501|21464095|P1|STARTED|Crossover Phase||0
8694158|NCT02737501|21464093|P3|NOT COMPLETED|Randomized Phase||0
8694159|NCT02737501|21464094|P2|NOT COMPLETED|Randomized Phase||54
8694160|NCT02737501|21464095|P1|NOT COMPLETED|Randomized Phase||117
8694161|NCT02737501|21464093|P3|COMPLETED|Randomized Phase||0
8694162|NCT02737501|21464094|P2|COMPLETED|Randomized Phase||84
8694163|NCT02737501|21464095|P1|COMPLETED|Randomized Phase||20
8694164|NCT02737501|21464093|P3|Safety Analysis Set|Randomized Phase||0
8694165|NCT02737501|21464094|P2|Safety Analysis Set|Randomized Phase||137
8694166|NCT02737501|21464095|P1|Safety Analysis Set|Randomized Phase||136
8694167|NCT02737501|21464093|P3|STARTED|Randomized Phase||0
8694168|NCT02737501|21464094|P2|STARTED|Randomized Phase||138
8694169|NCT02737501|21464095|P1|STARTED|Randomized Phase||137
8694170|NCT02692755|21464129|P1|NOT COMPLETED|Overall Study||0
8694171|NCT02692755|21464129|P1|COMPLETED|Overall Study||35
8694172|NCT02692755|21464129|P1|STARTED|Overall Study||35
8694173|NCT02677896|21464138|P2|NOT COMPLETED|Overall Study||244
8694174|NCT02677896|21464139|P1|NOT COMPLETED|Overall Study||137
8694175|NCT02677896|21464138|P2|COMPLETED|Overall Study||332
8694176|NCT02677896|21464139|P1|COMPLETED|Overall Study||437
8694177|NCT02677896|21464138|P2|Treated|Overall Study||574
8694178|NCT02677896|21464139|P1|Treated|Overall Study||572
8694179|NCT02677896|21464138|P2|STARTED|Overall Study||576
8694180|NCT02677896|21464139|P1|STARTED|Overall Study||574
8694184|NCT02637427|21464180|P2|NOT COMPLETED|Overall Study||0
8694185|NCT02637427|21464181|P1|NOT COMPLETED|Overall Study||0
8694186|NCT02637427|21464180|P2|COMPLETED|Overall Study||30
8694187|NCT02637427|21464181|P1|COMPLETED|Overall Study||27
8694188|NCT02637427|21464180|P2|STARTED|Overall Study||30
8694189|NCT02637427|21464181|P1|STARTED|Overall Study||27
8694190|NCT02624180|21464209|P2|NOT COMPLETED|Overall Study||4
8694191|NCT02624180|21464210|P1|NOT COMPLETED|Overall Study||6
8694192|NCT02624180|21464209|P2|COMPLETED|Overall Study||34
8694193|NCT02624180|21464210|P1|COMPLETED|Overall Study||37
8694194|NCT02624180|21464209|P2|STARTED|Overall Study||38
8694195|NCT02624180|21464210|P1|STARTED|Overall Study||43
8694196|NCT02586155|21464218|P2|NOT COMPLETED|Overall Study||127
8694197|NCT02586155|21464219|P1|NOT COMPLETED|Overall Study||127
8694198|NCT02586155|21464218|P2|COMPLETED|Overall Study||1083
8694199|NCT02586155|21464219|P1|COMPLETED|Overall Study||1088
8694200|NCT02586155|21464218|P2|Final Number Randomized|Overall Study||1206
8694201|NCT02586155|21464219|P1|Final Number Randomized|Overall Study||1212
8694202|NCT02586155|21464218|P2|STARTED|Overall Study||1210
8694203|NCT02586155|21464219|P1|STARTED|Overall Study||1215
8694204|NCT02567266|21464256|P3|NOT COMPLETED|Overall Study||16
8694205|NCT02567266|21464257|P2|NOT COMPLETED|Overall Study||15
8694206|NCT02567266|21464258|P1|NOT COMPLETED|Overall Study||23
8694207|NCT02567266|21464256|P3|COMPLETED|Overall Study||52
8694208|NCT02567266|21464257|P2|COMPLETED|Overall Study||45
8694209|NCT02567266|21464258|P1|COMPLETED|Overall Study||45
8694210|NCT02567266|21464256|P3|Follow-up (28 Weeks)|Overall Study||52
8694211|NCT02567266|21464257|P2|Follow-up (28 Weeks)|Overall Study||45
8694212|NCT02567266|21464258|P1|Follow-up (28 Weeks)|Overall Study||45
8694213|NCT02567266|21464256|P3|Post (16 Weeks)|Overall Study||53
8694214|NCT02567266|21464257|P2|Post (16 Weeks)|Overall Study||43
8694215|NCT02567266|21464258|P1|Post (16 Weeks)|Overall Study||49
8694216|NCT02567266|21464256|P3|Midpoint (8 Weeks)|Overall Study||55
8694217|NCT02567266|21464257|P2|Midpoint (8 Weeks)|Overall Study||52
8694218|NCT02567266|21464258|P1|Midpoint (8 Weeks)|Overall Study||54
8694219|NCT02567266|21464256|P3|STARTED|Overall Study||68
8694220|NCT02567266|21464257|P2|STARTED|Overall Study||60
8694221|NCT02567266|21464258|P1|STARTED|Overall Study||68
8694222|NCT02566525|21464274|P2|NOT COMPLETED|Overall Study||5
8694223|NCT02566525|21464275|P1|NOT COMPLETED|Overall Study||3
8694224|NCT02566525|21464274|P2|COMPLETED|Overall Study|LPI - Control 16 Aug 2016|18
8694225|NCT02566525|21464275|P1|COMPLETED|Overall Study|LPI - CytoSorb Patient 19 Aug 2016|20
8694226|NCT02566525|21464274|P2|STARTED|Overall Study|FPI - Control Patient 8 Dec 2015|23
8694227|NCT02566525|21464275|P1|STARTED|Overall Study|FPI - CytoSorb Patient 15 Jan 2016|23
8694228|NCT02562235|21464293|P1|NOT COMPLETED|Overall Study||3
8694229|NCT02562235|21464293|P1|COMPLETED|Overall Study||21
8694230|NCT02562235|21464293|P1|STARTED|Overall Study||24
8694231|NCT02501265|21464366|P4|NOT COMPLETED|Overall Study||8
8694232|NCT02501265|21464367|P3|NOT COMPLETED|Overall Study||18
8694233|NCT02501265|21464368|P2|NOT COMPLETED|Overall Study||9
8694234|NCT02501265|21464369|P1|NOT COMPLETED|Overall Study||17
8694235|NCT02501265|21464366|P4|COMPLETED|Overall Study||23
8694236|NCT02501265|21464367|P3|COMPLETED|Overall Study||46
8694237|NCT02501265|21464368|P2|COMPLETED|Overall Study||21
8694238|NCT02501265|21464369|P1|COMPLETED|Overall Study||46
8694239|NCT02501265|21464366|P4|STARTED|Overall Study||31
8694240|NCT02501265|21464367|P3|STARTED|Overall Study||64
8694241|NCT02501265|21464368|P2|STARTED|Overall Study||30
8694242|NCT02501265|21464369|P1|STARTED|Overall Study||63
8694243|NCT02500719|21464397|P2|NOT COMPLETED|Overall Study||7
8694244|NCT02500719|21464398|P1|NOT COMPLETED|Overall Study||3
8694245|NCT02500719|21464397|P2|COMPLETED|Overall Study||9
8694246|NCT02500719|21464398|P1|COMPLETED|Overall Study||11
8694247|NCT02500719|21464397|P2|STARTED|Overall Study||16
8694248|NCT02500719|21464398|P1|STARTED|Overall Study||14
8694249|NCT02498600|21464406|P2|NOT COMPLETED|Overall Study||0
8694250|NCT02498600|21464407|P1|NOT COMPLETED|Overall Study||0
8694251|NCT02498600|21464406|P2|COMPLETED|Overall Study||51
8694252|NCT02498600|21464407|P1|COMPLETED|Overall Study||49
8694253|NCT02498600|21464406|P2|STARTED|Overall Study||51
8694254|NCT02498600|21464407|P1|STARTED|Overall Study||49
8694255|NCT02493660|21464421|P2|NOT COMPLETED|Overall Study||1
8694256|NCT02493660|21464422|P1|NOT COMPLETED|Overall Study||0
8694257|NCT02493660|21464421|P2|COMPLETED|Overall Study|Investigator requested subject be discontinued prior to any post-procedure efficacy assessments.|90
8694258|NCT02493660|21464422|P1|COMPLETED|Overall Study||93
8694259|NCT02493660|21464421|P2|STARTED|Overall Study|ITT|91
8694260|NCT02493660|21464422|P1|STARTED|Overall Study|ITT|93
8694261|NCT02489734|21464444|P2|NOT COMPLETED|Overall Study||0
8694262|NCT02489734|21464445|P1|NOT COMPLETED|Overall Study||17
8694263|NCT02489734|21464444|P2|COMPLETED|Overall Study||53
8694264|NCT02489734|21464445|P1|COMPLETED|Overall Study||39
8694265|NCT02489734|21464444|P2|STARTED|Overall Study||53
8694266|NCT02489734|21464445|P1|STARTED|Overall Study||56
8694267|NCT02481934|21464451|P1|NOT COMPLETED|Overall Study||2
8694268|NCT02481934|21464451|P1|COMPLETED|Overall Study||3
8694269|NCT02481934|21464451|P1|STARTED|Overall Study||5
8694270|NCT02446600|21464460|P4|NOT COMPLETED|Overall Study||1
8694271|NCT02446600|21464461|P3|NOT COMPLETED|Overall Study||27
8694272|NCT02446600|21464462|P2|NOT COMPLETED|Overall Study||12
8694273|NCT02446600|21464463|P1|NOT COMPLETED|Overall Study||40
8694274|NCT02446600|21464460|P4|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|12
8694275|NCT02446600|21464461|P3|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|162
8694276|NCT02446600|21464462|P2|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|178
8694277|NCT02446600|21464463|P1|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|147
8694278|NCT02446600|21464460|P4|STARTED|Overall Study||13
8694279|NCT02446600|21464461|P3|STARTED|Overall Study||189
8694280|NCT02446600|21464462|P2|STARTED|Overall Study|Duplicate enrollment patient has been excluded from all analyses.|190
8694281|NCT02446600|21464463|P1|STARTED|Overall Study||187
8694282|NCT02337829|21464486|P4|NOT COMPLETED|Overall Study||10
8694283|NCT02337829|21464487|P3|NOT COMPLETED|Overall Study||6
8694284|NCT02337829|21464488|P2|NOT COMPLETED|Overall Study||14
8694285|NCT02337829|21464489|P1|NOT COMPLETED|Overall Study||18
8694286|NCT02337829|21464486|P4|COMPLETED|Overall Study||0
8694287|NCT02337829|21464487|P3|COMPLETED|Overall Study||0
8694288|NCT02337829|21464488|P2|COMPLETED|Overall Study||0
8694289|NCT02337829|21464489|P1|COMPLETED|Overall Study||0
8694290|NCT02337829|21464486|P4|STARTED|Overall Study||10
8694291|NCT02337829|21464487|P3|STARTED|Overall Study||6
8694292|NCT02337829|21464488|P2|STARTED|Overall Study||14
8694293|NCT02337829|21464489|P1|STARTED|Overall Study||18
8694294|NCT02269163|21464503|P2|NOT COMPLETED|Overall Study||7
8694295|NCT02269163|21464504|P1|NOT COMPLETED|Overall Study||3
8694296|NCT02269163|21464503|P2|COMPLETED|Overall Study||18
8694297|NCT02269163|21464504|P1|COMPLETED|Overall Study||47
8694298|NCT02269163|21464503|P2|STARTED|Overall Study||25
8694299|NCT02269163|21464504|P1|STARTED|Overall Study||50
8694300|NCT02257736|21464518|P2|NOT COMPLETED|Overall Study||447
8694301|NCT02257736|21464519|P1|NOT COMPLETED|Overall Study||451
8694302|NCT02257736|21464518|P2|COMPLETED|Overall Study||45
8694303|NCT02257736|21464519|P1|COMPLETED|Overall Study||39
8694304|NCT02257736|21464518|P2|STARTED|Overall Study||492
8694305|NCT02257736|21464519|P1|STARTED|Overall Study||490
8694309|NCT02252172|21464542|P2|NOT COMPLETED|Overall Study||299
8694310|NCT02252172|21464543|P1|NOT COMPLETED|Overall Study||279
8694311|NCT02252172|21464542|P2|COMPLETED|Overall Study||69
8694312|NCT02252172|21464543|P1|COMPLETED|Overall Study||90
8694313|NCT02252172|21464542|P2|Treated|Overall Study||364
8694314|NCT02252172|21464543|P1|Treated|Overall Study||365
8694315|NCT02252172|21464542|P2|STARTED|Overall Study||368
8694316|NCT02252172|21464543|P1|STARTED|Overall Study||369
8694317|NCT02249949|21464555|P1|NOT COMPLETED|Overall Study||2
8694318|NCT02249949|21464555|P1|COMPLETED|Overall Study||11
8694319|NCT02249949|21464555|P1|STARTED|Overall Study||13
8694320|NCT02247336|21464564|P2|NOT COMPLETED|Overall Study||0
8694321|NCT02247336|21464565|P1|NOT COMPLETED|Overall Study||0
8694322|NCT02247336|21464564|P2|COMPLETED|Overall Study||253
8694323|NCT02247336|21464565|P1|COMPLETED|Overall Study||252
8694324|NCT02247336|21464564|P2|STARTED|Overall Study||253
8694325|NCT02247336|21464565|P1|STARTED|Overall Study||252
8694326|NCT02165215|21464578|P3|NOT COMPLETED|Maintenance Phase||5
8694327|NCT02165215|21464579|P2|NOT COMPLETED|Maintenance Phase||12
8694328|NCT02165215|21464580|P1|NOT COMPLETED|Maintenance Phase||0
8694329|NCT02165215|21464578|P3|COMPLETED|Maintenance Phase||101
8694330|NCT02165215|21464579|P2|COMPLETED|Maintenance Phase||96
8694331|NCT02165215|21464580|P1|COMPLETED|Maintenance Phase||0
8694332|NCT02165215|21464578|P3|Dosed|Maintenance Phase||102
8694333|NCT02165215|21464579|P2|Dosed|Maintenance Phase||108
8694334|NCT02165215|21464580|P1|Dosed|Maintenance Phase||0
8694335|NCT02165215|21464578|P3|STARTED|Maintenance Phase||106
8694336|NCT02165215|21464579|P2|STARTED|Maintenance Phase||108
8694337|NCT02165215|21464580|P1|STARTED|Maintenance Phase||0
8694338|NCT02165215|21464578|P3|NOT COMPLETED|Induction Phase||0
8694339|NCT02165215|21464579|P2|NOT COMPLETED|Induction Phase||0
8694340|NCT02165215|21464580|P1|NOT COMPLETED|Induction Phase||23
8694341|NCT02165215|21464578|P3|COMPLETED|Induction Phase||0
8694342|NCT02165215|21464579|P2|COMPLETED|Induction Phase||0
8694343|NCT02165215|21464580|P1|COMPLETED|Induction Phase||336
8694344|NCT02165215|21464578|P3|Dosed|Induction Phase||0
8694345|NCT02165215|21464579|P2|Dosed|Induction Phase||0
8694346|NCT02165215|21464580|P1|Dosed|Induction Phase||358
8694347|NCT02165215|21464578|P3|STARTED|Induction Phase||0
8694348|NCT02165215|21464579|P2|STARTED|Induction Phase||0
8694349|NCT02165215|21464580|P1|STARTED|Induction Phase||359
8694350|NCT02152137|21464636|P1|NOT COMPLETED|Overall Study||4
8694351|NCT02152137|21464636|P1|COMPLETED|Overall Study||15
8694352|NCT02152137|21464636|P1|Originally Assigned to Arm B|Overall Study|With update #2, Arm B is closed and all patients should receive paclitaxel and efatutazone.|3
8694353|NCT02152137|21464636|P1|Originally Assigned to Arm A|Overall Study||16
8694354|NCT02152137|21464636|P1|STARTED|Overall Study||19
8694355|NCT02075840|21464646|P2|NOT COMPLETED|Overall Study||151
8694356|NCT02075840|21464647|P1|NOT COMPLETED|Overall Study||152
8694357|NCT02075840|21464646|P2|COMPLETED|Overall Study||0
8694358|NCT02075840|21464647|P1|COMPLETED|Overall Study||0
8694359|NCT02075840|21464646|P2|STARTED|Overall Study||151
8694360|NCT02075840|21464647|P1|STARTED|Overall Study||152
8694361|NCT02059265|21464701|P1|NOT COMPLETED|Overall Study||4
8694362|NCT02059265|21464701|P1|COMPLETED|Overall Study||28
8694363|NCT02059265|21464701|P1|STARTED|Overall Study||32
8694364|NCT01959698|21464716|P7|NOT COMPLETED|Overall Study||4
8694365|NCT01959698|21464717|P6|NOT COMPLETED|Overall Study||3
8694366|NCT01959698|21464718|P5|NOT COMPLETED|Overall Study||0
8694367|NCT01959698|21464719|P4|NOT COMPLETED|Overall Study||2
8694368|NCT01959698|21464720|P3|NOT COMPLETED|Overall Study||1
8694369|NCT01959698|21464721|P2|NOT COMPLETED|Overall Study||0
8694370|NCT01959698|21464722|P1|NOT COMPLETED|Overall Study||1
8694371|NCT01959698|21464716|P7|COMPLETED|Overall Study||4
8694372|NCT01959698|21464717|P6|COMPLETED|Overall Study||3
8694373|NCT01959698|21464718|P5|COMPLETED|Overall Study||3
8694374|NCT01959698|21464719|P4|COMPLETED|Overall Study||1
8694375|NCT01959698|21464720|P3|COMPLETED|Overall Study||2
8694376|NCT01959698|21464721|P2|COMPLETED|Overall Study||3
8694377|NCT01959698|21464722|P1|COMPLETED|Overall Study||2
8694378|NCT01959698|21464716|P7|STARTED|Overall Study||8
8694379|NCT01959698|21464717|P6|STARTED|Overall Study||6
8694380|NCT01959698|21464718|P5|STARTED|Overall Study||3
8694381|NCT01959698|21464719|P4|STARTED|Overall Study||3
8694382|NCT01959698|21464720|P3|STARTED|Overall Study||3
8694383|NCT01959698|21464721|P2|STARTED|Overall Study||3
8694384|NCT01959698|21464722|P1|STARTED|Overall Study||3
8694385|NCT01946204|21464755|P2|NOT COMPLETED|Overall Study||806
8694386|NCT01946204|21464756|P1|NOT COMPLETED|Overall Study||401
8694387|NCT01946204|21464755|P2|COMPLETED|Overall Study||0
8694388|NCT01946204|21464756|P1|COMPLETED|Overall Study||0
8694389|NCT01946204|21464755|P2|Treated|Overall Study||803
8694390|NCT01946204|21464756|P1|Treated|Overall Study||398
8694391|NCT01946204|21464755|P2|STARTED|Overall Study||806
8694392|NCT01946204|21464756|P1|STARTED|Overall Study||401
8694393|NCT01814813|21464775|P3|NOT COMPLETED|Overall Study||0
8694394|NCT01814813|21464776|P2|NOT COMPLETED|Overall Study||0
8694395|NCT01814813|21464777|P1|NOT COMPLETED|Overall Study||0
8694396|NCT01814813|21464775|P3|COMPLETED|Overall Study||31
8694397|NCT01814813|21464776|P2|COMPLETED|Overall Study||30
8694398|NCT01814813|21464777|P1|COMPLETED|Overall Study||29
8694399|NCT01814813|21464775|P3|STARTED|Overall Study||31
8694400|NCT01814813|21464776|P2|STARTED|Overall Study||30
8694401|NCT01814813|21464777|P1|STARTED|Overall Study||29
8694402|NCT01804465|21464793|P2|NOT COMPLETED|Overall Study||0
8694403|NCT01804465|21464794|P1|NOT COMPLETED|Overall Study||0
8694404|NCT01804465|21464793|P2|COMPLETED|Overall Study||26
8694405|NCT01804465|21464794|P1|COMPLETED|Overall Study||24
8694406|NCT01804465|21464793|P2|STARTED|Overall Study||26
8694407|NCT01804465|21464794|P1|STARTED|Overall Study||24
8694408|NCT01784796|21464818|P2|NOT COMPLETED|Overall Study||43
8694409|NCT01784796|21464819|P1|NOT COMPLETED|Overall Study||48
8694410|NCT01784796|21464818|P2|COMPLETED|Overall Study||34
8694411|NCT01784796|21464819|P1|COMPLETED|Overall Study||39
8694412|NCT01784796|21464818|P2|8 wk Data Collection|Overall Study||46
8694413|NCT01784796|21464819|P1|8 wk Data Collection|Overall Study||50
8694414|NCT01784796|21464818|P2|4 Week Data Collection|Overall Study||41
8694415|NCT01784796|21464819|P1|4 Week Data Collection|Overall Study||48
8694416|NCT01784796|21464818|P2|Baseline Data Collected|Overall Study||61
8694417|NCT01784796|21464819|P1|Baseline Data Collected|Overall Study||75
8694418|NCT01784796|21464818|P2|STARTED|Overall Study|These are participants who provided informed consent|77
8694419|NCT01784796|21464819|P1|STARTED|Overall Study|These are participants who provided informed consent|87
8694420|NCT01784068|21464831|P2|NOT COMPLETED|TFR Phase||93
8694421|NCT01784068|21464832|P1|NOT COMPLETED|TFR Phase||0
8694422|NCT01784068|21464831|P2|COMPLETED|TFR Phase||97
8694423|NCT01784068|21464832|P1|COMPLETED|TFR Phase||0
8694424|NCT01784068|21464831|P2|STARTED|TFR Phase||190
8694425|NCT01784068|21464832|P1|STARTED|TFR Phase||0
8694426|NCT01784068|21464831|P2|NOT COMPLETED|NTCS Phase||0
8694427|NCT01784068|21464832|P1|NOT COMPLETED|NTCS Phase||215
8694428|NCT01784068|21464831|P2|COMPLETED|NTCS Phase||0
8694429|NCT01784068|21464832|P1|COMPLETED|NTCS Phase||0
8694430|NCT01784068|21464831|P2|NTRI-2|NTCS Phase||0
8694431|NCT01784068|21464832|P1|NTRI-2|NTCS Phase||0
8694432|NCT01784068|21464831|P2|NTCT-P Phase|NTCS Phase||0
8694433|NCT01784068|21464832|P1|NTCT-P Phase|NTCS Phase||2
8694434|NCT01784068|21464831|P2|TFR-2 Phase|NTCS Phase||0
8694435|NCT01784068|21464832|P1|TFR-2 Phase|NTCS Phase||8
8694436|NCT01784068|21464831|P2|NTCT Phase|NTCS Phase||0
8694437|NCT01784068|21464832|P1|NTCT Phase|NTCS Phase||13
8694438|NCT01784068|21464831|P2|NTRI Phase|NTCS Phase||0
8694439|NCT01784068|21464832|P1|NTRI Phase|NTCS Phase||86
8694440|NCT01784068|21464831|P2|STARTED|NTCS Phase||0
8694441|NCT01784068|21464832|P1|STARTED|NTCS Phase||215
8694442|NCT01715285|21464845|P3|NOT COMPLETED|Open-label (OL) Extension Phase||72
8694443|NCT01715285|21464846|P2|NOT COMPLETED|Open-label (OL) Extension Phase||0
8694444|NCT01715285|21464847|P1|NOT COMPLETED|Open-label (OL) Extension Phase||157
8694445|NCT01715285|21464845|P3|COMPLETED|Open-label (OL) Extension Phase||0
8694446|NCT01715285|21464846|P2|COMPLETED|Open-label (OL) Extension Phase||0
8694447|NCT01715285|21464847|P1|COMPLETED|Open-label (OL) Extension Phase||0
8694448|NCT01715285|21464845|P3|STARTED|Open-label (OL) Extension Phase||72
8694449|NCT01715285|21464846|P2|STARTED|Open-label (OL) Extension Phase||0
8694450|NCT01715285|21464847|P1|STARTED|Open-label (OL) Extension Phase||157
8694451|NCT01715285|21464845|P3|NOT COMPLETED|Treatment Period||0
8694452|NCT01715285|21464846|P2|NOT COMPLETED|Treatment Period||602
8694453|NCT01715285|21464847|P1|NOT COMPLETED|Treatment Period||597
8694454|NCT01715285|21464845|P3|COMPLETED|Treatment Period||0
8694455|NCT01715285|21464846|P2|COMPLETED|Treatment Period||0
8694456|NCT01715285|21464847|P1|COMPLETED|Treatment Period||0
8694457|NCT01715285|21464845|P3|Safety Population|Treatment Period||0
8694458|NCT01715285|21464846|P2|Safety Population|Treatment Period||602
8694459|NCT01715285|21464847|P1|Safety Population|Treatment Period||597
8694460|NCT01715285|21464845|P3|ITT Population|Treatment Period||0
8694461|NCT01715285|21464846|P2|ITT Population|Treatment Period||602
8694462|NCT01715285|21464847|P1|ITT Population|Treatment Period||597
8694463|NCT01715285|21464845|P3|STARTED|Treatment Period||0
8694464|NCT01715285|21464846|P2|STARTED|Treatment Period||602
8694465|NCT01715285|21464847|P1|STARTED|Treatment Period||597
8694466|NCT01675154|21464870|P4|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
8694467|NCT01675154|21464871|P3|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
8694468|NCT01675154|21464872|P2|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
8694469|NCT01675154|21464873|P1|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
8694470|NCT01675154|21464870|P4|COMPLETED|Fourth Intervention Period (4 Weeks)||0
8694471|NCT01675154|21464871|P3|COMPLETED|Fourth Intervention Period (4 Weeks)||1
8694472|NCT01675154|21464872|P2|COMPLETED|Fourth Intervention Period (4 Weeks)||0
8694473|NCT01675154|21464873|P1|COMPLETED|Fourth Intervention Period (4 Weeks)||1
8694474|NCT01675154|21464870|P4|STARTED|Fourth Intervention Period (4 Weeks)||0
8694475|NCT01675154|21464871|P3|STARTED|Fourth Intervention Period (4 Weeks)||1
8694476|NCT01675154|21464872|P2|STARTED|Fourth Intervention Period (4 Weeks)||0
8694477|NCT01675154|21464873|P1|STARTED|Fourth Intervention Period (4 Weeks)||1
8694478|NCT01675154|21464870|P4|NOT COMPLETED|Third Washout Period (1 Week)||0
8694479|NCT01675154|21464871|P3|NOT COMPLETED|Third Washout Period (1 Week)||0
8694480|NCT01675154|21464872|P2|NOT COMPLETED|Third Washout Period (1 Week)||0
8694481|NCT01675154|21464873|P1|NOT COMPLETED|Third Washout Period (1 Week)||0
8694482|NCT01675154|21464870|P4|COMPLETED|Third Washout Period (1 Week)||0
8694483|NCT01675154|21464871|P3|COMPLETED|Third Washout Period (1 Week)||1
8694484|NCT01675154|21464872|P2|COMPLETED|Third Washout Period (1 Week)||0
8694485|NCT01675154|21464873|P1|COMPLETED|Third Washout Period (1 Week)||1
8694486|NCT01675154|21464870|P4|STARTED|Third Washout Period (1 Week)||0
8694487|NCT01675154|21464871|P3|STARTED|Third Washout Period (1 Week)||1
8694488|NCT01675154|21464872|P2|STARTED|Third Washout Period (1 Week)||0
8694489|NCT01675154|21464873|P1|STARTED|Third Washout Period (1 Week)||1
8694490|NCT01675154|21464870|P4|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
8694491|NCT01675154|21464871|P3|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
8694492|NCT01675154|21464872|P2|NOT COMPLETED|Third Intervention Period (4 Weeks)||1
8694493|NCT01675154|21464873|P1|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
8694494|NCT01675154|21464870|P4|COMPLETED|Third Intervention Period (4 Weeks)||0
8694495|NCT01675154|21464871|P3|COMPLETED|Third Intervention Period (4 Weeks)||1
8694496|NCT01675154|21464872|P2|COMPLETED|Third Intervention Period (4 Weeks)||0
8694497|NCT01675154|21464873|P1|COMPLETED|Third Intervention Period (4 Weeks)||1
8694498|NCT01675154|21464870|P4|STARTED|Third Intervention Period (4 Weeks)||0
8694499|NCT01675154|21464871|P3|STARTED|Third Intervention Period (4 Weeks)||1
8694500|NCT01675154|21464872|P2|STARTED|Third Intervention Period (4 Weeks)||1
8694501|NCT01675154|21464873|P1|STARTED|Third Intervention Period (4 Weeks)||1
8694502|NCT01675154|21464870|P4|NOT COMPLETED|Second Washout Period (1 Week)||0
8694503|NCT01675154|21464871|P3|NOT COMPLETED|Second Washout Period (1 Week)||0
8694504|NCT01675154|21464872|P2|NOT COMPLETED|Second Washout Period (1 Week)||0
8694505|NCT01675154|21464873|P1|NOT COMPLETED|Second Washout Period (1 Week)||0
8694506|NCT01675154|21464870|P4|COMPLETED|Second Washout Period (1 Week)||2
8694507|NCT01675154|21464871|P3|COMPLETED|Second Washout Period (1 Week)||1
8694508|NCT01675154|21464872|P2|COMPLETED|Second Washout Period (1 Week)||1
8694509|NCT01675154|21464873|P1|COMPLETED|Second Washout Period (1 Week)||1
8694510|NCT01675154|21464870|P4|STARTED|Second Washout Period (1 Week)||2
8694511|NCT01675154|21464871|P3|STARTED|Second Washout Period (1 Week)||1
8694512|NCT01675154|21464872|P2|STARTED|Second Washout Period (1 Week)||1
8694513|NCT01675154|21464873|P1|STARTED|Second Washout Period (1 Week)||1
8694514|NCT01675154|21464870|P4|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
8694515|NCT01675154|21464871|P3|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
8694516|NCT01675154|21464872|P2|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
8694517|NCT01675154|21464873|P1|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
8694518|NCT01675154|21464870|P4|COMPLETED|Second Intervention Period (4 Weeks)||1
8694519|NCT01675154|21464871|P3|COMPLETED|Second Intervention Period (4 Weeks)||1
8694520|NCT01675154|21464872|P2|COMPLETED|Second Intervention Period (4 Weeks)||1
8694521|NCT01675154|21464873|P1|COMPLETED|Second Intervention Period (4 Weeks)||0
8694522|NCT01675154|21464870|P4|STARTED|Second Intervention Period (4 Weeks)||2
8694523|NCT01675154|21464871|P3|STARTED|Second Intervention Period (4 Weeks)||1
8694524|NCT01675154|21464872|P2|STARTED|Second Intervention Period (4 Weeks)|Subjects were enrolled in Regimen 2|1
8694525|NCT01675154|21464873|P1|STARTED|Second Intervention Period (4 Weeks)||1
8694526|NCT01675154|21464870|P4|NOT COMPLETED|First Washout Period (1 Week)||0
8694527|NCT01675154|21464871|P3|NOT COMPLETED|First Washout Period (1 Week)||0
8694528|NCT01675154|21464872|P2|NOT COMPLETED|First Washout Period (1 Week)||0
8694529|NCT01675154|21464873|P1|NOT COMPLETED|First Washout Period (1 Week)||0
8694530|NCT01675154|21464870|P4|COMPLETED|First Washout Period (1 Week)||1
8694531|NCT01675154|21464871|P3|COMPLETED|First Washout Period (1 Week)||1
8694532|NCT01675154|21464872|P2|COMPLETED|First Washout Period (1 Week)||1
8694533|NCT01675154|21464873|P1|COMPLETED|First Washout Period (1 Week)||2
8694534|NCT01675154|21464870|P4|STARTED|First Washout Period (1 Week)||1
8694535|NCT01675154|21464871|P3|STARTED|First Washout Period (1 Week)||1
8694536|NCT01675154|21464872|P2|STARTED|First Washout Period (1 Week)||1
8694537|NCT01675154|21464873|P1|STARTED|First Washout Period (1 Week)|Subjects were enrolled Regimen 1|2
8694538|NCT01675154|21464870|P4|NOT COMPLETED|First Intervention Period (4 Weeks)||0
8694539|NCT01675154|21464871|P3|NOT COMPLETED|First Intervention Period (4 Weeks)||0
8694540|NCT01675154|21464872|P2|NOT COMPLETED|First Intervention Period (4 Weeks)||0
8694541|NCT01675154|21464873|P1|NOT COMPLETED|First Intervention Period (4 Weeks)||0
8694542|NCT01675154|21464870|P4|COMPLETED|First Intervention Period (4 Weeks)||1
8694543|NCT01675154|21464871|P3|COMPLETED|First Intervention Period (4 Weeks)||1
8694544|NCT01675154|21464872|P2|COMPLETED|First Intervention Period (4 Weeks)||1
8694545|NCT01675154|21464873|P1|COMPLETED|First Intervention Period (4 Weeks)||2
8694546|NCT01675154|21464870|P4|STARTED|First Intervention Period (4 Weeks)||1
8694547|NCT01675154|21464871|P3|STARTED|First Intervention Period (4 Weeks)||1
8694548|NCT01675154|21464872|P2|STARTED|First Intervention Period (4 Weeks)||1
8694549|NCT01675154|21464873|P1|STARTED|First Intervention Period (4 Weeks)||2
8694550|NCT01622868|21464909|P2|NOT COMPLETED|Overall Study||0
8694551|NCT01622868|21464910|P1|NOT COMPLETED|Overall Study||7
8694552|NCT01622868|21464909|P2|COMPLETED|Overall Study||71
8694553|NCT01622868|21464910|P1|COMPLETED|Overall Study||65
8694554|NCT01622868|21464909|P2|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||71
8694555|NCT01622868|21464910|P1|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||63
8694556|NCT01622868|21464909|P2|Eligible|Overall Study||71
8694557|NCT01622868|21464910|P1|Eligible|Overall Study||65
8694558|NCT01622868|21464909|P2|STARTED|Overall Study||71
8694559|NCT01622868|21464910|P1|STARTED|Overall Study||72
8694560|NCT01417780|21464939|P3|NOT COMPLETED|Overall Study||2
8694561|NCT01417780|21464940|P2|NOT COMPLETED|Overall Study||3
8694562|NCT01417780|21464941|P1|NOT COMPLETED|Overall Study||1
8694563|NCT01417780|21464939|P3|COMPLETED|Overall Study||9
8694564|NCT01417780|21464940|P2|COMPLETED|Overall Study||14
8694565|NCT01417780|21464941|P1|COMPLETED|Overall Study||14
8694566|NCT01417780|21464939|P3|STARTED|Overall Study||11
8694567|NCT01417780|21464940|P2|STARTED|Overall Study||17
8694568|NCT01417780|21464941|P1|STARTED|Overall Study||15
8694569|NCT01346267|21465018|P2|NOT COMPLETED|Overall Study||27
8694570|NCT01346267|21465019|P1|NOT COMPLETED|Overall Study||23
8694571|NCT01346267|21465018|P2|COMPLETED|Overall Study||67
8694572|NCT01346267|21465019|P1|COMPLETED|Overall Study||70
8694573|NCT01346267|21465018|P2|STARTED|Overall Study||94
8694574|NCT01346267|21465019|P1|STARTED|Overall Study||93
8694581|NCT01210352|21465059|P9|NOT COMPLETED|Overall Study||4
8694582|NCT01210352|21465060|P8|NOT COMPLETED|Overall Study||3
8694583|NCT01210352|21465061|P7|NOT COMPLETED|Overall Study||2
8694584|NCT01210352|21465062|P6|NOT COMPLETED|Overall Study||0
8694585|NCT01210352|21465063|P5|NOT COMPLETED|Overall Study||0
8694586|NCT01210352|21465064|P4|NOT COMPLETED|Overall Study||0
8694587|NCT01210352|21465065|P3|NOT COMPLETED|Overall Study||2
8694588|NCT01210352|21465066|P2|NOT COMPLETED|Overall Study||0
8694589|NCT01210352|21465067|P1|NOT COMPLETED|Overall Study||0
8694590|NCT01210352|21465059|P9|COMPLETED|Overall Study||2
8694591|NCT01210352|21465060|P8|COMPLETED|Overall Study||7
8694592|NCT01210352|21465061|P7|COMPLETED|Overall Study||5
8694593|NCT01210352|21465062|P6|COMPLETED|Overall Study||6
8694594|NCT01210352|21465063|P5|COMPLETED|Overall Study||6
8694595|NCT01210352|21465064|P4|COMPLETED|Overall Study||7
8694596|NCT01210352|21465065|P3|COMPLETED|Overall Study||5
8694597|NCT01210352|21465066|P2|COMPLETED|Overall Study||6
8694598|NCT01210352|21465067|P1|COMPLETED|Overall Study||6
8694599|NCT01210352|21465059|P9|STARTED|Overall Study||6
8694600|NCT01210352|21465060|P8|STARTED|Overall Study||10
8694601|NCT01210352|21465061|P7|STARTED|Overall Study||7
8694602|NCT01210352|21465062|P6|STARTED|Overall Study||6
8694603|NCT01210352|21465063|P5|STARTED|Overall Study||6
8694604|NCT01210352|21465064|P4|STARTED|Overall Study||7
8694605|NCT01210352|21465065|P3|STARTED|Overall Study||7
8694606|NCT01210352|21465066|P2|STARTED|Overall Study||6
8694607|NCT01210352|21465067|P1|STARTED|Overall Study||6
8694608|NCT01190449|21465260|P2|NOT COMPLETED|Overall Study||4
8694609|NCT01190449|21465261|P1|NOT COMPLETED|Overall Study||0
8694610|NCT01190449|21465260|P2|COMPLETED|Overall Study||32
8694611|NCT01190449|21465261|P1|COMPLETED|Overall Study||15
8694612|NCT01190449|21465260|P2|STARTED|Overall Study||36
8694613|NCT01190449|21465261|P1|STARTED|Overall Study||15
8694614|NCT01173692|21465271|P2|NOT COMPLETED|Overall Study||5
8694615|NCT01173692|21465272|P1|NOT COMPLETED|Overall Study||2
8694616|NCT01173692|21465271|P2|COMPLETED|Overall Study||20
8694617|NCT01173692|21465272|P1|COMPLETED|Overall Study||20
8694618|NCT01173692|21465271|P2|STARTED|Overall Study||25
8694619|NCT01173692|21465272|P1|STARTED|Overall Study||22
8694626|NCT01134614|21465293|P2|NOT COMPLETED|Overall Study||122
8694627|NCT01134614|21465294|P1|NOT COMPLETED|Overall Study||123
8694628|NCT01134614|21465293|P2|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
8694629|NCT01134614|21465294|P1|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
8694630|NCT01134614|21465293|P2|Treated and Toxicity Assessed|Overall Study||120
8694631|NCT01134614|21465294|P1|Treated and Toxicity Assessed|Overall Study||118
8694632|NCT01134614|21465293|P2|Treated|Overall Study||121
8694633|NCT01134614|21465294|P1|Treated|Overall Study||119
8694634|NCT01134614|21465293|P2|STARTED|Overall Study||122
8694635|NCT01134614|21465294|P1|STARTED|Overall Study||123
8694636|NCT01085630|21465306|P2|NOT COMPLETED|Overall Study||0
8694637|NCT01085630|21465307|P1|NOT COMPLETED|Overall Study||4
8694638|NCT01085630|21465306|P2|COMPLETED|Overall Study||27
8694639|NCT01085630|21465307|P1|COMPLETED|Overall Study||22
8694640|NCT01085630|21465306|P2|STARTED|Overall Study||27
8694641|NCT01085630|21465307|P1|STARTED|Overall Study||26
8694642|NCT01081262|21465321|P4|NOT COMPLETED|Overall Study||0
8694643|NCT01081262|21465322|P3|NOT COMPLETED|Overall Study||0
8694644|NCT01081262|21465323|P2|NOT COMPLETED|Overall Study||0
8694645|NCT01081262|21465324|P1|NOT COMPLETED|Overall Study||0
8694646|NCT01081262|21465321|P4|COMPLETED|Overall Study||11
8694647|NCT01081262|21465322|P3|COMPLETED|Overall Study||13
8694648|NCT01081262|21465323|P2|COMPLETED|Overall Study||13
8694649|NCT01081262|21465324|P1|COMPLETED|Overall Study||13
8694650|NCT01081262|21465321|P4|STARTED|Overall Study||11
8694651|NCT01081262|21465322|P3|STARTED|Overall Study||13
8694652|NCT01081262|21465323|P2|STARTED|Overall Study||13
8694653|NCT01081262|21465324|P1|STARTED|Overall Study||13
8694654|NCT01062425|21465356|P2|NOT COMPLETED|Overall Study||6
8694655|NCT01062425|21465357|P1|NOT COMPLETED|Overall Study||3
8694656|NCT01062425|21465356|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
8694657|NCT01062425|21465357|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
8694658|NCT01062425|21465356|P2|STARTED|Overall Study||103
8694659|NCT01062425|21465357|P1|STARTED|Overall Study||55
8694660|NCT01027000|21465369|P1|NOT COMPLETED|Overall Study||0
8694661|NCT01027000|21465369|P1|COMPLETED|Overall Study||68
8694662|NCT01027000|21465369|P1|STARTED|Overall Study||68
8694669|NCT00981058|21465392|P2|NOT COMPLETED|Overall Study||97
8694670|NCT00981058|21465393|P1|NOT COMPLETED|Overall Study||120
8694671|NCT00981058|21465392|P2|COMPLETED|Overall Study||451
8694672|NCT00981058|21465393|P1|COMPLETED|Overall Study||425
8694673|NCT00981058|21465392|P2|Death Due to Any Cause|Overall Study||442
8694674|NCT00981058|21465393|P1|Death Due to Any Cause|Overall Study||418
8694675|NCT00981058|21465392|P2|Received at Least 1 Dose of Study Drug|Overall Study||541
8694676|NCT00981058|21465393|P1|Received at Least 1 Dose of Study Drug|Overall Study||538
8694677|NCT00981058|21465392|P2|STARTED|Overall Study||548
8694678|NCT00981058|21465393|P1|STARTED|Overall Study||545
8694679|NCT00977574|21465416|P3|NOT COMPLETED|Overall Study||4
8694680|NCT00977574|21465417|P2|NOT COMPLETED|Overall Study||2
8694681|NCT00977574|21465418|P1|NOT COMPLETED|Overall Study||4
8694682|NCT00977574|21465416|P3|COMPLETED|Overall Study||114
8694683|NCT00977574|21465417|P2|COMPLETED|Overall Study||113
8694684|NCT00977574|21465418|P1|COMPLETED|Overall Study||112
8694685|NCT00977574|21465416|P3|STARTED|Overall Study||118
8694686|NCT00977574|21465417|P2|STARTED|Overall Study||115
8694687|NCT00977574|21465418|P1|STARTED|Overall Study||116
8694694|NCT00881361|21465450|P3|NOT COMPLETED|Overall Study||2
8694695|NCT00881361|21465451|P2|NOT COMPLETED|Overall Study||9
8694696|NCT00881361|21465452|P1|NOT COMPLETED|Overall Study||44
8694697|NCT00881361|21465450|P3|COMPLETED|Overall Study||0
8694698|NCT00881361|21465451|P2|COMPLETED|Overall Study||38
8694699|NCT00881361|21465452|P1|COMPLETED|Overall Study||663
8694700|NCT00881361|21465450|P3|STARTED|Overall Study||2
8694701|NCT00881361|21465451|P2|STARTED|Overall Study||47
8694702|NCT00881361|21465452|P1|STARTED|Overall Study||707
8694703|NCT00843882|21465468|P3|NOT COMPLETED|Step 2 (Cross-over to Arm B)||0
8694704|NCT00843882|21465469|P2|NOT COMPLETED|Step 2 (Cross-over to Arm B)||26
8694705|NCT00843882|21465470|P1|NOT COMPLETED|Step 2 (Cross-over to Arm B)||4
8694706|NCT00843882|21465468|P3|COMPLETED|Step 2 (Cross-over to Arm B)||0
8694707|NCT00843882|21465469|P2|COMPLETED|Step 2 (Cross-over to Arm B)||20
8694708|NCT00843882|21465470|P1|COMPLETED|Step 2 (Cross-over to Arm B)||3
8694709|NCT00843882|21465468|P3|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||0
8694710|NCT00843882|21465469|P2|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||37
8694711|NCT00843882|21465470|P1|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||7
8694712|NCT00843882|21465468|P3|STARTED|Step 2 (Cross-over to Arm B)|Only patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|0
8694713|NCT00843882|21465469|P2|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|46
8694714|NCT00843882|21465470|P1|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|7
8694715|NCT00843882|21465468|P3|NOT COMPLETED|Step 1||65
8694716|NCT00843882|21465469|P2|NOT COMPLETED|Step 1||55
8694717|NCT00843882|21465470|P1|NOT COMPLETED|Step 1||32
8694718|NCT00843882|21465468|P3|COMPLETED|Step 1||41
8694719|NCT00843882|21465469|P2|COMPLETED|Step 1||48
8694720|NCT00843882|21465470|P1|COMPLETED|Step 1||6
8694721|NCT00843882|21465468|P3|Patients With Cytogenetic Response Data Available|Step 1||51
8694722|NCT00843882|21465469|P2|Patients With Cytogenetic Response Data Available|Step 1||55
8694723|NCT00843882|21465470|P1|Patients With Cytogenetic Response Data Available|Step 1||0
8694724|NCT00843882|21465468|P3|Evaluable Patients Included in Primary Analysis|Step 1||99
8694725|NCT00843882|21465469|P2|Evaluable Patients Included in Primary Analysis|Step 1||96
8694726|NCT00843882|21465470|P1|Evaluable Patients Included in Primary Analysis|Step 1||0
8694727|NCT00843882|21465468|P3|Treated Patients|Step 1||106
8694728|NCT00843882|21465469|P2|Treated Patients|Step 1||103
8694729|NCT00843882|21465470|P1|Treated Patients|Step 1||36
8694730|NCT00843882|21465468|P3|STARTED|Step 1||106
8694731|NCT00843882|21465469|P2|STARTED|Step 1||103
8694732|NCT00843882|21465470|P1|STARTED|Step 1||38
8694733|NCT00803400|21465495|P2|NOT COMPLETED|Overall Study||24
8694734|NCT00803400|21465496|P1|NOT COMPLETED|Overall Study||20
8694735|NCT00803400|21465495|P2|COMPLETED|Overall Study||51
8694736|NCT00803400|21465496|P1|COMPLETED|Overall Study||55
8694737|NCT00803400|21465495|P2|STARTED|Overall Study||75
8694738|NCT00803400|21465496|P1|STARTED|Overall Study||75
8694739|NCT00792142|21465506|P1|NOT COMPLETED|Overall Study||0
8694740|NCT00792142|21465506|P1|COMPLETED|Overall Study||45
8694741|NCT00792142|21465506|P1|STARTED|Overall Study||45
8694742|NCT00785291|21465516|P3|NOT COMPLETED|Overall Study||106
8694743|NCT00785291|21465517|P2|NOT COMPLETED|Overall Study||149
8694744|NCT00785291|21465518|P1|NOT COMPLETED|Overall Study||136
8694745|NCT00785291|21465516|P3|COMPLETED|Overall Study||139
8694746|NCT00785291|21465517|P2|COMPLETED|Overall Study||122
8694747|NCT00785291|21465518|P1|COMPLETED|Overall Study||147
8694748|NCT00785291|21465516|P3|STARTED|Overall Study||245
8694749|NCT00785291|21465517|P2|STARTED|Overall Study||271
8694750|NCT00785291|21465518|P1|STARTED|Overall Study||283
8694751|NCT00751998|21465538|P1|NOT COMPLETED|Overall Study||20
8694752|NCT00751998|21465538|P1|COMPLETED|Overall Study||277
8694753|NCT00751998|21465538|P1|STARTED|Overall Study||297
8694754|NCT00669110|21465544|P2|NOT COMPLETED|Overall Study||13
8694755|NCT00669110|21465545|P1|NOT COMPLETED|Overall Study||8
8694756|NCT00669110|21465544|P2|COMPLETED|Overall Study||7
8694757|NCT00669110|21465545|P1|COMPLETED|Overall Study||12
8694758|NCT00669110|21465544|P2|STARTED|Overall Study||20
8694759|NCT00669110|21465545|P1|STARTED|Overall Study||20
8694760|NCT00651261|21465583|P2|NOT COMPLETED|Overall Study||306
8694761|NCT00651261|21465584|P1|NOT COMPLETED|Overall Study||291
8694762|NCT00651261|21465583|P2|COMPLETED|Overall Study||51
8694763|NCT00651261|21465584|P1|COMPLETED|Overall Study||69
8694764|NCT00651261|21465583|P2|STARTED|Overall Study||357
8694765|NCT00651261|21465584|P1|STARTED|Overall Study||360
8694766|NCT00644878|21465598|P1|NOT COMPLETED|Overall Study||18
8694767|NCT00644878|21465598|P1|COMPLETED|Overall Study||0
8694768|NCT00644878|21465598|P1|STARTED|Overall Study||18
8694769|NCT00635453|21465611|P2|NOT COMPLETED|Overall Study||174
8694770|NCT00635453|21465612|P1|NOT COMPLETED|Overall Study||154
8694771|NCT00635453|21465611|P2|COMPLETED|Overall Study||181
8694772|NCT00635453|21465612|P1|COMPLETED|Overall Study||206
8694773|NCT00635453|21465611|P2|3 Years Assessment|Overall Study||204
8694774|NCT00635453|21465612|P1|3 Years Assessment|Overall Study||246
8694775|NCT00635453|21465611|P2|12 Months Assessment|Overall Study||260
8694776|NCT00635453|21465612|P1|12 Months Assessment|Overall Study||285
8694777|NCT00635453|21465611|P2|6 Months Assessment|Overall Study||311
8694778|NCT00635453|21465612|P1|6 Months Assessment|Overall Study||322
8694779|NCT00635453|21465611|P2|STARTED|Overall Study||355
8694780|NCT00635453|21465612|P1|STARTED|Overall Study||360
8694781|NCT00621751|21465626|P2|NOT COMPLETED|Overall Study||1
8694782|NCT00621751|21465627|P1|NOT COMPLETED|Overall Study||0
8694783|NCT00621751|21465626|P2|COMPLETED|Overall Study||34
8694784|NCT00621751|21465627|P1|COMPLETED|Overall Study||35
8694785|NCT00621751|21465626|P2|STARTED|Overall Study||35
8694786|NCT00621751|21465627|P1|STARTED|Overall Study||35
8694787|NCT00601900|21465647|P2|NOT COMPLETED|Overall Study||3
8694788|NCT00601900|21465648|P1|NOT COMPLETED|Overall Study||0
8694789|NCT00601900|21465647|P2|COMPLETED|Overall Study||196
8694790|NCT00601900|21465648|P1|COMPLETED|Overall Study||195
8694791|NCT00601900|21465647|P2|STARTED|Overall Study||199
8694792|NCT00601900|21465648|P1|STARTED|Overall Study||195
8694793|NCT00558519|21465662|P1|NOT COMPLETED|Overall Study||23
8694794|NCT00558519|21465662|P1|COMPLETED|Overall Study||295
8694795|NCT00558519|21465662|P1|STARTED|Overall Study||318
8694796|NCT00537810|21465674|P4|NOT COMPLETED|Overall Study||4
8694797|NCT00537810|21465675|P3|NOT COMPLETED|Overall Study||4
8694798|NCT00537810|21465676|P2|NOT COMPLETED|Overall Study||13
8694799|NCT00537810|21465677|P1|NOT COMPLETED|Overall Study||6
8694800|NCT00537810|21465674|P4|COMPLETED|Overall Study||22
8694801|NCT00537810|21465675|P3|COMPLETED|Overall Study||21
8694802|NCT00537810|21465676|P2|COMPLETED|Overall Study||14
8694803|NCT00537810|21465677|P1|COMPLETED|Overall Study||20
8694804|NCT00537810|21465674|P4|STARTED|Overall Study||26
8694805|NCT00537810|21465675|P3|STARTED|Overall Study||25
8694806|NCT00537810|21465676|P2|STARTED|Overall Study||27
8694807|NCT00537810|21465677|P1|STARTED|Overall Study||26
8694808|NCT00490776|21465691|P1|NOT COMPLETED|Overall Study||9
8694809|NCT00490776|21465691|P1|COMPLETED|Overall Study||0
8694810|NCT00490776|21465691|P1|STARTED|Overall Study||9
8694811|NCT00433511|21465705|P3|NOT COMPLETED|Step 2 (Arm D)||491
8694812|NCT00433511|21465706|P2|NOT COMPLETED|Step 2 (Arm D)||0
8694813|NCT00433511|21465707|P1|NOT COMPLETED|Step 2 (Arm D)||0
8694814|NCT00433511|21465705|P3|COMPLETED|Step 2 (Arm D)||825
8694815|NCT00433511|21465706|P2|COMPLETED|Step 2 (Arm D)||0
8694816|NCT00433511|21465707|P1|COMPLETED|Step 2 (Arm D)||0
8694817|NCT00433511|21465705|P3|Patients Who Received Treatment|Step 2 (Arm D)||1168
8694818|NCT00433511|21465706|P2|Patients Who Received Treatment|Step 2 (Arm D)||0
8694819|NCT00433511|21465707|P1|Patients Who Received Treatment|Step 2 (Arm D)||0
8694820|NCT00433511|21465705|P3|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316
8694821|NCT00433511|21465706|P2|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
8694822|NCT00433511|21465707|P1|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
8694823|NCT00433511|21465705|P3|NOT COMPLETED|Step 1||390
8694824|NCT00433511|21465706|P2|NOT COMPLETED|Step 1||385
8694825|NCT00433511|21465707|P1|NOT COMPLETED|Step 1||136
8694826|NCT00433511|21465705|P3|COMPLETED|Step 1||1618
8694827|NCT00433511|21465706|P2|COMPLETED|Step 1||1601
8694828|NCT00433511|21465707|P1|COMPLETED|Step 1||864
8694829|NCT00433511|21465705|P3|Patients in Genetic Ancestry Analysis|Step 1||1158
8694830|NCT00433511|21465706|P2|Patients in Genetic Ancestry Analysis|Step 1||1126
8694831|NCT00433511|21465707|P1|Patients in Genetic Ancestry Analysis|Step 1||575
8694832|NCT00433511|21465705|P3|Patients Who Received Treatment|Step 1||1942
8694833|NCT00433511|21465706|P2|Patients Who Received Treatment|Step 1||1922
8694834|NCT00433511|21465707|P1|Patients Who Received Treatment|Step 1||972
8694835|NCT00433511|21465705|P3|STARTED|Step 1||2008
8694836|NCT00433511|21465706|P2|STARTED|Step 1||1986
8694837|NCT00433511|21465707|P1|STARTED|Step 1||1000
8694838|NCT00425555|21465723|P2|NOT COMPLETED|Overall Study||60
8694839|NCT00425555|21465724|P1|NOT COMPLETED|Overall Study||79
8694840|NCT00425555|21465723|P2|COMPLETED|Overall Study||0
8694841|NCT00425555|21465724|P1|COMPLETED|Overall Study||0
8694842|NCT00425555|21465723|P2|STARTED|Overall Study||60
8694843|NCT00425555|21465724|P1|STARTED|Overall Study||79
8694844|NCT00383188|21465759|P5|NOT COMPLETED|Overall Study||23
8694845|NCT00383188|21465760|P4|NOT COMPLETED|Overall Study||12
8694846|NCT00383188|21465761|P3|NOT COMPLETED|Overall Study||13
8694847|NCT00383188|21465762|P2|NOT COMPLETED|Overall Study||11
8694848|NCT00383188|21465763|P1|NOT COMPLETED|Overall Study||17
8694849|NCT00383188|21465759|P5|COMPLETED|Overall Study||52
8694850|NCT00383188|21465760|P4|COMPLETED|Overall Study||28
8694851|NCT00383188|21465761|P3|COMPLETED|Overall Study||31
8694852|NCT00383188|21465762|P2|COMPLETED|Overall Study||63
8694853|NCT00383188|21465763|P1|COMPLETED|Overall Study||52
8694854|NCT00383188|21465759|P5|STARTED|Overall Study||75
8694855|NCT00383188|21465760|P4|STARTED|Overall Study||40
8694856|NCT00383188|21465761|P3|STARTED|Overall Study||44
8694857|NCT00383188|21465762|P2|STARTED|Overall Study||74
8694858|NCT00383188|21465763|P1|STARTED|Overall Study||69
8694859|NCT00346164|21465888|P4|NOT COMPLETED|Overall Study||106
8694860|NCT00346164|21465889|P3|NOT COMPLETED|Overall Study||26
8694861|NCT00346164|21465890|P2|NOT COMPLETED|Overall Study||7
8694862|NCT00346164|21465891|P1|NOT COMPLETED|Overall Study||17
8694863|NCT00346164|21465888|P4|COMPLETED|Overall Study||117
8694864|NCT00346164|21465889|P3|COMPLETED|Overall Study||96
8694865|NCT00346164|21465890|P2|COMPLETED|Overall Study||14
8694866|NCT00346164|21465891|P1|COMPLETED|Overall Study||205
8694867|NCT00346164|21465888|P4|STARTED|Overall Study||223
8694868|NCT00346164|21465889|P3|STARTED|Overall Study||122
8694869|NCT00346164|21465890|P2|STARTED|Overall Study||21
8694870|NCT00346164|21465891|P1|STARTED|Overall Study||222
8694903|NCT00310037|21465980|P2|NOT COMPLETED|Overall Study||17
8694904|NCT00310037|21465981|P1|NOT COMPLETED|Overall Study||18
8694905|NCT00310037|21465980|P2|COMPLETED|Overall Study||33
8694906|NCT00310037|21465981|P1|COMPLETED|Overall Study||34
8694907|NCT00310037|21465980|P2|STARTED|Overall Study||50
8694908|NCT00310037|21465981|P1|STARTED|Overall Study||52
8694909|NCT00098475|21465995|P4|NOT COMPLETED|Step 2||0
8694910|NCT00098475|21465996|P3|NOT COMPLETED|Step 2||0
8694911|NCT00098475|21465997|P2|NOT COMPLETED|Step 2||10
8694912|NCT00098475|21465998|P1|NOT COMPLETED|Step 2||5
8694913|NCT00098475|21465995|P4|COMPLETED|Step 2||0
8694914|NCT00098475|21465996|P3|COMPLETED|Step 2||0
8694915|NCT00098475|21465997|P2|COMPLETED|Step 2||5
8694916|NCT00098475|21465998|P1|COMPLETED|Step 2||0
8694917|NCT00098475|21465995|P4|Eligible|Step 2||0
8694918|NCT00098475|21465996|P3|Eligible|Step 2||0
8694919|NCT00098475|21465997|P2|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
8694920|NCT00098475|21465998|P1|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
8694921|NCT00098475|21465995|P4|Treated|Step 2||0
8694922|NCT00098475|21465996|P3|Treated|Step 2||0
8694923|NCT00098475|21465997|P2|Treated|Step 2||14
8694924|NCT00098475|21465998|P1|Treated|Step 2||4
8694925|NCT00098475|21465995|P4|STARTED|Step 2||0
8694926|NCT00098475|21465996|P3|STARTED|Step 2||0
8694927|NCT00098475|21465997|P2|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
8694928|NCT00098475|21465998|P1|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
8694929|NCT00098475|21465995|P4|NOT COMPLETED|Step 1||3
8694930|NCT00098475|21465996|P3|NOT COMPLETED|Step 1||4
8694931|NCT00098475|21465997|P2|NOT COMPLETED|Step 1||173
8694932|NCT00098475|21465998|P1|NOT COMPLETED|Step 1||171
8694933|NCT00098475|21465995|P4|COMPLETED|Step 1||0
8694934|NCT00098475|21465996|P3|COMPLETED|Step 1||0
8694935|NCT00098475|21465997|P2|COMPLETED|Step 1||49
8694936|NCT00098475|21465998|P1|COMPLETED|Step 1||52
8694937|NCT00098475|21465995|P4|Eligible|Step 1||3
8694938|NCT00098475|21465996|P3|Eligible|Step 1||4
8694939|NCT00098475|21465997|P2|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
8694940|NCT00098475|21465998|P1|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
8694941|NCT00098475|21465995|P4|Treated|Step 1||3
8694942|NCT00098475|21465996|P3|Treated|Step 1||4
8694943|NCT00098475|21465997|P2|Treated|Step 1||220
8694944|NCT00098475|21465998|P1|Treated|Step 1||223
8694945|NCT00098475|21465995|P4|STARTED|Step 1||3
8694946|NCT00098475|21465996|P3|STARTED|Step 1||4
8694947|NCT00098475|21465997|P2|STARTED|Step 1||222
8694948|NCT00098475|21465998|P1|STARTED|Step 1||223
8694949|NCT04206384|21466010|P1|NOT COMPLETED|Overall Study||10
8694950|NCT04206384|21466010|P1|COMPLETED|Overall Study||42
8694951|NCT04206384|21466010|P1|STARTED|Overall Study||52
8694952|NCT04026399|21466017|P2|NOT COMPLETED|Overall Study||3
8694953|NCT04026399|21466018|P1|NOT COMPLETED|Overall Study||5
8694954|NCT04026399|21466017|P2|COMPLETED|Overall Study||3
8694955|NCT04026399|21466018|P1|COMPLETED|Overall Study||1
8694956|NCT04026399|21466017|P2|STARTED|Overall Study||6
8694957|NCT04026399|21466018|P1|STARTED|Overall Study||6
8694958|NCT03988374|21466027|P3|NOT COMPLETED|Overall Study||1
8694959|NCT03988374|21466028|P2|NOT COMPLETED|Overall Study||2
8694960|NCT03988374|21466029|P1|NOT COMPLETED|Overall Study||1
8694961|NCT03988374|21466027|P3|COMPLETED|Overall Study||107
8694962|NCT03988374|21466028|P2|COMPLETED|Overall Study||105
8694963|NCT03988374|21466029|P1|COMPLETED|Overall Study||103
8694964|NCT03988374|21466027|P3|STARTED|Overall Study||108
8694965|NCT03988374|21466028|P2|STARTED|Overall Study||107
8694966|NCT03988374|21466029|P1|STARTED|Overall Study||104
8694967|NCT03956862|21466045|P2|NOT COMPLETED|Overall Study||2
8694968|NCT03956862|21466046|P1|NOT COMPLETED|Overall Study||2
8694969|NCT03956862|21466045|P2|COMPLETED|Overall Study||45
8694970|NCT03956862|21466046|P1|COMPLETED|Overall Study||48
8694971|NCT03956862|21466045|P2|STARTED|Overall Study||47
8694972|NCT03956862|21466046|P1|STARTED|Overall Study||50
8694973|NCT03949244|21466071|P3|NOT COMPLETED|Overall Study||0
8694974|NCT03949244|21466072|P2|NOT COMPLETED|Overall Study||0
8694975|NCT03949244|21466073|P1|NOT COMPLETED|Overall Study||0
8694976|NCT03949244|21466071|P3|COMPLETED|Overall Study||14
8694977|NCT03949244|21466072|P2|COMPLETED|Overall Study||21
8694978|NCT03949244|21466073|P1|COMPLETED|Overall Study||12
8694979|NCT03949244|21466071|P3|STARTED|Overall Study||14
8694980|NCT03949244|21466072|P2|STARTED|Overall Study||21
8694981|NCT03949244|21466073|P1|STARTED|Overall Study||12
8694982|NCT03683576|21466085|P4|NOT COMPLETED|Overall Study||8
8694983|NCT03683576|21466086|P3|NOT COMPLETED|Overall Study||12
8694984|NCT03683576|21466087|P2|NOT COMPLETED|Overall Study||4
8694985|NCT03683576|21466088|P1|NOT COMPLETED|Overall Study||6
8694986|NCT03683576|21466085|P4|COMPLETED|Overall Study||114
8694987|NCT03683576|21466086|P3|COMPLETED|Overall Study||106
8694988|NCT03683576|21466087|P2|COMPLETED|Overall Study||116
8694989|NCT03683576|21466088|P1|COMPLETED|Overall Study||114
8694990|NCT03683576|21466085|P4|STARTED|Overall Study||122
8694991|NCT03683576|21466086|P3|STARTED|Overall Study||118
8694992|NCT03683576|21466087|P2|STARTED|Overall Study||120
8694993|NCT03683576|21466088|P1|STARTED|Overall Study||120
8694994|NCT03620162|21466131|P5|NOT COMPLETED|Overall Study||13
8694995|NCT03620162|21466132|P4|NOT COMPLETED|Overall Study||20
8694996|NCT03620162|21466133|P3|NOT COMPLETED|Overall Study||33
8694997|NCT03620162|21466134|P2|NOT COMPLETED|Overall Study||14
8694998|NCT03620162|21466135|P1|NOT COMPLETED|Overall Study||15
8694999|NCT03620162|21466131|P5|COMPLETED|Overall Study||167
8695000|NCT03620162|21466132|P4|COMPLETED|Overall Study||160
8695001|NCT03620162|21466133|P3|COMPLETED|Overall Study||147
8695002|NCT03620162|21466134|P2|COMPLETED|Overall Study||167
8695003|NCT03620162|21466135|P1|COMPLETED|Overall Study||164
8695004|NCT03620162|21466131|P5|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
8695005|NCT03620162|21466132|P4|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||162
8695006|NCT03620162|21466133|P3|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||150
8695007|NCT03620162|21466134|P2|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
8695008|NCT03620162|21466135|P1|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||165
8695009|NCT03620162|21466131|P5|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||173
8695010|NCT03620162|21466132|P4|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||167
8695011|NCT03620162|21466133|P3|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||161
8695012|NCT03620162|21466134|P2|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||174
8695013|NCT03620162|21466135|P1|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||175
8695014|NCT03620162|21466131|P5|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||173
8695015|NCT03620162|21466132|P4|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||169
8695016|NCT03620162|21466133|P3|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||166
8695017|NCT03620162|21466134|P2|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||175
8695018|NCT03620162|21466135|P1|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||176
8695019|NCT03620162|21466131|P5|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
8695020|NCT03620162|21466132|P4|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
8695021|NCT03620162|21466133|P3|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||178
8695022|NCT03620162|21466134|P2|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||181
8695023|NCT03620162|21466135|P1|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
8695024|NCT03620162|21466131|P5|STARTED|Overall Study||180
8695025|NCT03620162|21466132|P4|STARTED|Overall Study||180
8695026|NCT03620162|21466133|P3|STARTED|Overall Study||180
8695027|NCT03620162|21466134|P2|STARTED|Overall Study||181
8695028|NCT03620162|21466135|P1|STARTED|Overall Study||179
8695029|NCT03597295|21466189|P1|NOT COMPLETED|Overall Study||94
8695030|NCT03597295|21466189|P1|COMPLETED|Overall Study||0
8695031|NCT03597295|21466189|P1|STARTED|Overall Study||94
8695032|NCT03586050|21466198|P1|NOT COMPLETED|Overall Study||0
8695033|NCT03586050|21466198|P1|COMPLETED|Overall Study||33
8695034|NCT03586050|21466198|P1|STARTED|Overall Study||33
8695035|NCT03562988|21466203|P2|NOT COMPLETED|Overall Study||3
8695036|NCT03562988|21466204|P1|NOT COMPLETED|Overall Study||2
8695037|NCT03562988|21466203|P2|COMPLETED|Overall Study||15
8695038|NCT03562988|21466204|P1|COMPLETED|Overall Study||15
8695039|NCT03562988|21466203|P2|STARTED|Overall Study||18
8695040|NCT03562988|21466204|P1|STARTED|Overall Study||17
8695041|NCT03492099|21466220|P1|NOT COMPLETED|Overall Study||9
8695042|NCT03492099|21466220|P1|COMPLETED|Overall Study||38
8695043|NCT03492099|21466220|P1|STARTED|Overall Study||47
8695044|NCT03203681|21466224|P1|NOT COMPLETED|Overall Study||27
8695045|NCT03203681|21466224|P1|COMPLETED|Overall Study||33
8695046|NCT03203681|21466224|P1|6 Months|Overall Study||33
8695047|NCT03203681|21466224|P1|3 Month|Overall Study||44
8695048|NCT03203681|21466224|P1|STARTED|Overall Study||60
8695049|NCT03201965|21466236|P3|NOT COMPLETED|Overall Study||195
8695050|NCT03201965|21466237|P2|NOT COMPLETED|Overall Study||193
8695051|NCT03201965|21466238|P1|NOT COMPLETED|Overall Study||28
8695052|NCT03201965|21466236|P3|COMPLETED|Overall Study||0
8695053|NCT03201965|21466237|P2|COMPLETED|Overall Study||0
8695054|NCT03201965|21466238|P1|COMPLETED|Overall Study||0
8695055|NCT03201965|21466236|P3|Treated|Overall Study||193
8695056|NCT03201965|21466237|P2|Treated|Overall Study||188
8695057|NCT03201965|21466238|P1|Treated|Overall Study||28
8695058|NCT03201965|21466236|P3|STARTED|Overall Study||195
8695059|NCT03201965|21466237|P2|STARTED|Overall Study||193
8695060|NCT03201965|21466238|P1|STARTED|Overall Study||28
8695061|NCT03154476|21466247|P2|NOT COMPLETED|Overall Study||4
8695062|NCT03154476|21466248|P1|NOT COMPLETED|Overall Study||4
8695063|NCT03154476|21466247|P2|COMPLETED|Overall Study||6
8695064|NCT03154476|21466248|P1|COMPLETED|Overall Study||6
8695065|NCT03154476|21466247|P2|STARTED|Overall Study||10
8695066|NCT03154476|21466248|P1|STARTED|Overall Study||10
8695067|NCT03090620|21466256|P2|NOT COMPLETED|Overall Study||0
8695068|NCT03090620|21466257|P1|NOT COMPLETED|Overall Study||0
8695069|NCT03090620|21466256|P2|COMPLETED|Overall Study||10
8695070|NCT03090620|21466257|P1|COMPLETED|Overall Study||9
8695071|NCT03090620|21466256|P2|STARTED|Overall Study||10
8695072|NCT03090620|21466257|P1|STARTED|Overall Study||9
8695073|NCT03064438|21466277|P2|NOT COMPLETED|Overall Study||1
8695074|NCT03064438|21466278|P1|NOT COMPLETED|Overall Study||1
8695075|NCT03064438|21466277|P2|COMPLETED|Overall Study||12
8695076|NCT03064438|21466278|P1|COMPLETED|Overall Study||26
8695077|NCT03064438|21466277|P2|STARTED|Overall Study||13
8695078|NCT03064438|21466278|P1|STARTED|Overall Study||27
8695079|NCT03046056|21466305|P3|NOT COMPLETED|Overall Study||7
8695080|NCT03046056|21466306|P2|NOT COMPLETED|Overall Study||16
8695081|NCT03046056|21466307|P1|NOT COMPLETED|Overall Study||12
8695082|NCT03046056|21466305|P3|COMPLETED|Overall Study||11
8695083|NCT03046056|21466306|P2|COMPLETED|Overall Study||16
8695084|NCT03046056|21466307|P1|COMPLETED|Overall Study||16
8695085|NCT03046056|21466305|P3|STARTED|Overall Study||18
8695086|NCT03046056|21466306|P2|STARTED|Overall Study||32
8695087|NCT03046056|21466307|P1|STARTED|Overall Study||28
8695088|NCT02960490|21466359|P10|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||7
8695089|NCT02960490|21466360|P9|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||4
8695090|NCT02960490|21466361|P8|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||6
8695091|NCT02960490|21466362|P7|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||9
8695092|NCT02960490|21466363|P6|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
8695093|NCT02960490|21466364|P5|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
8695094|NCT02960490|21466365|P4|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
8695095|NCT02960490|21466366|P3|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
8695096|NCT02960490|21466367|P2|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
8695097|NCT02960490|21466368|P1|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
8695098|NCT02960490|21466359|P10|COMPLETED|Extension Phase(Open-label): 80 Weeks||3
8695099|NCT02960490|21466360|P9|COMPLETED|Extension Phase(Open-label): 80 Weeks||9
8695100|NCT02960490|21466361|P8|COMPLETED|Extension Phase(Open-label): 80 Weeks||5
8695101|NCT02960490|21466362|P7|COMPLETED|Extension Phase(Open-label): 80 Weeks||4
8695102|NCT02960490|21466363|P6|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
8695103|NCT02960490|21466364|P5|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
8695104|NCT02960490|21466365|P4|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
8695105|NCT02960490|21466366|P3|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
8695106|NCT02960490|21466367|P2|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
8695107|NCT02960490|21466368|P1|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
8695108|NCT02960490|21466359|P10|SAS|Extension Phase(Open-label): 80 Weeks||10
8695109|NCT02960490|21466360|P9|SAS|Extension Phase(Open-label): 80 Weeks||13
8695110|NCT02960490|21466361|P8|SAS|Extension Phase(Open-label): 80 Weeks||11
8695111|NCT02960490|21466362|P7|SAS|Extension Phase(Open-label): 80 Weeks||13
8695112|NCT02960490|21466363|P6|SAS|Extension Phase(Open-label): 80 Weeks||0
8695113|NCT02960490|21466364|P5|SAS|Extension Phase(Open-label): 80 Weeks||0
8695114|NCT02960490|21466365|P4|SAS|Extension Phase(Open-label): 80 Weeks||0
8695115|NCT02960490|21466366|P3|SAS|Extension Phase(Open-label): 80 Weeks||0
8695116|NCT02960490|21466367|P2|SAS|Extension Phase(Open-label): 80 Weeks||0
8695117|NCT02960490|21466368|P1|SAS|Extension Phase(Open-label): 80 Weeks||0
8695118|NCT02960490|21466359|P10|FAS|Extension Phase(Open-label): 80 Weeks||10
8695119|NCT02960490|21466360|P9|FAS|Extension Phase(Open-label): 80 Weeks||13
8695120|NCT02960490|21466361|P8|FAS|Extension Phase(Open-label): 80 Weeks||11
8695121|NCT02960490|21466362|P7|FAS|Extension Phase(Open-label): 80 Weeks||13
8695122|NCT02960490|21466363|P6|FAS|Extension Phase(Open-label): 80 Weeks||0
8695123|NCT02960490|21466364|P5|FAS|Extension Phase(Open-label): 80 Weeks||0
8695124|NCT02960490|21466365|P4|FAS|Extension Phase(Open-label): 80 Weeks||0
8695125|NCT02960490|21466366|P3|FAS|Extension Phase(Open-label): 80 Weeks||0
8695126|NCT02960490|21466367|P2|FAS|Extension Phase(Open-label): 80 Weeks||0
8695127|NCT02960490|21466368|P1|FAS|Extension Phase(Open-label): 80 Weeks||0
8695128|NCT02960490|21466359|P10|Treated|Extension Phase(Open-label): 80 Weeks||10
8695129|NCT02960490|21466360|P9|Treated|Extension Phase(Open-label): 80 Weeks||13
8695130|NCT02960490|21466361|P8|Treated|Extension Phase(Open-label): 80 Weeks||11
8695131|NCT02960490|21466362|P7|Treated|Extension Phase(Open-label): 80 Weeks||13
8695132|NCT02960490|21466363|P6|Treated|Extension Phase(Open-label): 80 Weeks||0
8695133|NCT02960490|21466364|P5|Treated|Extension Phase(Open-label): 80 Weeks||0
8695134|NCT02960490|21466365|P4|Treated|Extension Phase(Open-label): 80 Weeks||0
8695135|NCT02960490|21466366|P3|Treated|Extension Phase(Open-label): 80 Weeks||0
8695136|NCT02960490|21466367|P2|Treated|Extension Phase(Open-label): 80 Weeks||0
8695137|NCT02960490|21466368|P1|Treated|Extension Phase(Open-label): 80 Weeks||0
8695138|NCT02960490|21466359|P10|STARTED|Extension Phase(Open-label): 80 Weeks||10
8695139|NCT02960490|21466360|P9|STARTED|Extension Phase(Open-label): 80 Weeks||13
8695140|NCT02960490|21466361|P8|STARTED|Extension Phase(Open-label): 80 Weeks|One Participant who completed Core Treatment Phase (Placebo Then E6011 400 mg arm) had inadequate therapeutic effect at Week 24, hence did not started Extension phase.|11
8695141|NCT02960490|21466362|P7|STARTED|Extension Phase(Open-label): 80 Weeks||13
8695142|NCT02960490|21466363|P6|STARTED|Extension Phase(Open-label): 80 Weeks||0
8695143|NCT02960490|21466364|P5|STARTED|Extension Phase(Open-label): 80 Weeks||0
8695144|NCT02960490|21466365|P4|STARTED|Extension Phase(Open-label): 80 Weeks||0
8695145|NCT02960490|21466366|P3|STARTED|Extension Phase(Open-label): 80 Weeks||0
8695146|NCT02960490|21466367|P2|STARTED|Extension Phase(Open-label): 80 Weeks||0
8695147|NCT02960490|21466368|P1|STARTED|Extension Phase(Open-label): 80 Weeks||0
8695148|NCT02960490|21466359|P10|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
8695149|NCT02960490|21466360|P9|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
8695150|NCT02960490|21466361|P8|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
8695151|NCT02960490|21466362|P7|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
8695152|NCT02960490|21466363|P6|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
8695153|NCT02960490|21466364|P5|NOT COMPLETED|Re-randomized Participants: 12 Weeks||1
8695154|NCT02960490|21466365|P4|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
8695155|NCT02960490|21466366|P3|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
8695156|NCT02960490|21466367|P2|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
8695157|NCT02960490|21466368|P1|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
8695158|NCT02960490|21466359|P10|COMPLETED|Re-randomized Participants: 12 Weeks||0
8695159|NCT02960490|21466360|P9|COMPLETED|Re-randomized Participants: 12 Weeks||0
8695160|NCT02960490|21466361|P8|COMPLETED|Re-randomized Participants: 12 Weeks||0
8695161|NCT02960490|21466362|P7|COMPLETED|Re-randomized Participants: 12 Weeks||0
8695162|NCT02960490|21466363|P6|COMPLETED|Re-randomized Participants: 12 Weeks||10
8695163|NCT02960490|21466364|P5|COMPLETED|Re-randomized Participants: 12 Weeks||13
8695164|NCT02960490|21466365|P4|COMPLETED|Re-randomized Participants: 12 Weeks||12
8695165|NCT02960490|21466366|P3|COMPLETED|Re-randomized Participants: 12 Weeks||13
8695166|NCT02960490|21466367|P2|COMPLETED|Re-randomized Participants: 12 Weeks||0
8695167|NCT02960490|21466368|P1|COMPLETED|Re-randomized Participants: 12 Weeks||0
8695168|NCT02960490|21466359|P10|SAS|Re-randomized Participants: 12 Weeks||0
8695169|NCT02960490|21466360|P9|SAS|Re-randomized Participants: 12 Weeks||0
8695170|NCT02960490|21466361|P8|SAS|Re-randomized Participants: 12 Weeks||0
8695171|NCT02960490|21466362|P7|SAS|Re-randomized Participants: 12 Weeks||0
8695172|NCT02960490|21466363|P6|SAS|Re-randomized Participants: 12 Weeks||12
8695173|NCT02960490|21466364|P5|SAS|Re-randomized Participants: 12 Weeks||14
8695174|NCT02960490|21466365|P4|SAS|Re-randomized Participants: 12 Weeks||14
8695175|NCT02960490|21466366|P3|SAS|Re-randomized Participants: 12 Weeks||15
8695176|NCT02960490|21466367|P2|SAS|Re-randomized Participants: 12 Weeks||0
8695177|NCT02960490|21466368|P1|SAS|Re-randomized Participants: 12 Weeks||0
8695178|NCT02960490|21466359|P10|FAS|Re-randomized Participants: 12 Weeks||0
8695179|NCT02960490|21466360|P9|FAS|Re-randomized Participants: 12 Weeks||0
8695180|NCT02960490|21466361|P8|FAS|Re-randomized Participants: 12 Weeks||0
8695181|NCT02960490|21466362|P7|FAS|Re-randomized Participants: 12 Weeks||0
8695182|NCT02960490|21466363|P6|FAS|Re-randomized Participants: 12 Weeks||12
8695183|NCT02960490|21466364|P5|FAS|Re-randomized Participants: 12 Weeks||14
8695184|NCT02960490|21466365|P4|FAS|Re-randomized Participants: 12 Weeks||14
8695185|NCT02960490|21466366|P3|FAS|Re-randomized Participants: 12 Weeks||15
8695186|NCT02960490|21466367|P2|FAS|Re-randomized Participants: 12 Weeks||0
8695187|NCT02960490|21466368|P1|FAS|Re-randomized Participants: 12 Weeks||0
8695188|NCT02960490|21466359|P10|Treated|Re-randomized Participants: 12 Weeks||0
8695189|NCT02960490|21466360|P9|Treated|Re-randomized Participants: 12 Weeks||0
8695190|NCT02960490|21466361|P8|Treated|Re-randomized Participants: 12 Weeks||0
8695191|NCT02960490|21466362|P7|Treated|Re-randomized Participants: 12 Weeks||0
8695192|NCT02960490|21466363|P6|Treated|Re-randomized Participants: 12 Weeks||12
8695193|NCT02960490|21466364|P5|Treated|Re-randomized Participants: 12 Weeks||14
8695194|NCT02960490|21466365|P4|Treated|Re-randomized Participants: 12 Weeks||14
8695195|NCT02960490|21466366|P3|Treated|Re-randomized Participants: 12 Weeks||15
8695196|NCT02960490|21466367|P2|Treated|Re-randomized Participants: 12 Weeks||0
8695197|NCT02960490|21466368|P1|Treated|Re-randomized Participants: 12 Weeks||0
8695198|NCT02960490|21466359|P10|STARTED|Re-randomized Participants: 12 Weeks||0
8695199|NCT02960490|21466360|P9|STARTED|Re-randomized Participants: 12 Weeks||0
8695200|NCT02960490|21466361|P8|STARTED|Re-randomized Participants: 12 Weeks||0
8695201|NCT02960490|21466362|P7|STARTED|Re-randomized Participants: 12 Weeks||0
8695202|NCT02960490|21466363|P6|STARTED|Re-randomized Participants: 12 Weeks||12
8695203|NCT02960490|21466364|P5|STARTED|Re-randomized Participants: 12 Weeks||14
8695204|NCT02960490|21466365|P4|STARTED|Re-randomized Participants: 12 Weeks||14
8695205|NCT02960490|21466366|P3|STARTED|Re-randomized Participants: 12 Weeks||15
8695206|NCT02960490|21466367|P2|STARTED|Re-randomized Participants: 12 Weeks||0
8695207|NCT02960490|21466368|P1|STARTED|Re-randomized Participants: 12 Weeks||0
8695208|NCT02960490|21466359|P10|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695209|NCT02960490|21466360|P9|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695210|NCT02960490|21466361|P8|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695211|NCT02960490|21466362|P7|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695212|NCT02960490|21466363|P6|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695213|NCT02960490|21466364|P5|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695214|NCT02960490|21466365|P4|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695215|NCT02960490|21466366|P3|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695216|NCT02960490|21466367|P2|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||6
8695217|NCT02960490|21466368|P1|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||5
8695218|NCT02960490|21466359|P10|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695219|NCT02960490|21466360|P9|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695220|NCT02960490|21466361|P8|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695221|NCT02960490|21466362|P7|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695222|NCT02960490|21466363|P6|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695223|NCT02960490|21466364|P5|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695224|NCT02960490|21466365|P4|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695225|NCT02960490|21466366|P3|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
8695226|NCT02960490|21466367|P2|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||26
8695227|NCT02960490|21466368|P1|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||29
8695228|NCT02960490|21466359|P10|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695229|NCT02960490|21466360|P9|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695230|NCT02960490|21466361|P8|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695231|NCT02960490|21466362|P7|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695232|NCT02960490|21466363|P6|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695233|NCT02960490|21466364|P5|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695234|NCT02960490|21466365|P4|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695235|NCT02960490|21466366|P3|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695236|NCT02960490|21466367|P2|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||31
8695237|NCT02960490|21466368|P1|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||33
8695238|NCT02960490|21466359|P10|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695239|NCT02960490|21466360|P9|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695240|NCT02960490|21466361|P8|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695241|NCT02960490|21466362|P7|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695242|NCT02960490|21466363|P6|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695243|NCT02960490|21466364|P5|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695244|NCT02960490|21466365|P4|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695245|NCT02960490|21466366|P3|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
8695246|NCT02960490|21466367|P2|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||31
8695247|NCT02960490|21466368|P1|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||33
8695248|NCT02960490|21466359|P10|Treated|Treatment Phase(Double-blind): 12 Weeks||0
8695249|NCT02960490|21466360|P9|Treated|Treatment Phase(Double-blind): 12 Weeks||0
8695250|NCT02960490|21466361|P8|Treated|Treatment Phase(Double-blind): 12 Weeks||0
8695251|NCT02960490|21466362|P7|Treated|Treatment Phase(Double-blind): 12 Weeks||0
8695252|NCT02960490|21466363|P6|Treated|Treatment Phase(Double-blind): 12 Weeks||0
8695253|NCT02960490|21466364|P5|Treated|Treatment Phase(Double-blind): 12 Weeks||0
8695254|NCT02960490|21466365|P4|Treated|Treatment Phase(Double-blind): 12 Weeks||0
8695255|NCT02960490|21466366|P3|Treated|Treatment Phase(Double-blind): 12 Weeks||0
8695256|NCT02960490|21466367|P2|Treated|Treatment Phase(Double-blind): 12 Weeks||31
8695257|NCT02960490|21466368|P1|Treated|Treatment Phase(Double-blind): 12 Weeks||33
8695258|NCT02960490|21466359|P10|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
8695259|NCT02960490|21466360|P9|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
8695260|NCT02960490|21466361|P8|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
8695261|NCT02960490|21466362|P7|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
8695262|NCT02960490|21466363|P6|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
8695263|NCT02960490|21466364|P5|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
8695264|NCT02960490|21466365|P4|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
8695265|NCT02960490|21466366|P3|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
8695266|NCT02960490|21466367|P2|STARTED|Treatment Phase(Double-blind): 12 Weeks||32
8695267|NCT02960490|21466368|P1|STARTED|Treatment Phase(Double-blind): 12 Weeks||34
8695268|NCT02858154|21466542|P1|NOT COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||0
8695269|NCT02858154|21466542|P1|COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||9
8695270|NCT02858154|21466542|P1|STARTED|Clinically Ordered PSG/Low Flow Oxygen||9
8695271|NCT02858154|21466542|P1|NOT COMPLETED|HFNC 3-4 Hours||0
8695272|NCT02858154|21466542|P1|COMPLETED|HFNC 3-4 Hours||9
8695273|NCT02858154|21466542|P1|STARTED|HFNC 3-4 Hours||9
8695274|NCT02775903|21466551|P4|NOT COMPLETED|Overall Study||65
8695275|NCT02775903|21466552|P3|NOT COMPLETED|Overall Study||64
8695276|NCT02775903|21466553|P2|NOT COMPLETED|Overall Study||41
8695277|NCT02775903|21466554|P1|NOT COMPLETED|Overall Study||42
8695278|NCT02775903|21466551|P4|COMPLETED|Overall Study||0
8695279|NCT02775903|21466552|P3|COMPLETED|Overall Study||0
8695280|NCT02775903|21466553|P2|COMPLETED|Overall Study||1
8695281|NCT02775903|21466554|P1|COMPLETED|Overall Study||0
8695282|NCT02775903|21466551|P4|Received Study Treatment|Overall Study||62
8695283|NCT02775903|21466552|P3|Received Study Treatment|Overall Study||64
8695284|NCT02775903|21466553|P2|Received Study Treatment|Overall Study||41
8695285|NCT02775903|21466554|P1|Received Study Treatment|Overall Study||38
8695286|NCT02775903|21466551|P4|STARTED|Overall Study||65
8695287|NCT02775903|21466552|P3|STARTED|Overall Study||64
8695288|NCT02775903|21466553|P2|STARTED|Overall Study||42
8695289|NCT02775903|21466554|P1|STARTED|Overall Study||42
8695290|NCT02753816|21466605|P3|NOT COMPLETED|Overall Study||0
8695291|NCT02753816|21466606|P2|NOT COMPLETED|Overall Study||1
8695292|NCT02753816|21466607|P1|NOT COMPLETED|Overall Study||0
8695293|NCT02753816|21466605|P3|COMPLETED|Overall Study||7
8695294|NCT02753816|21466606|P2|COMPLETED|Overall Study||10
8695295|NCT02753816|21466607|P1|COMPLETED|Overall Study||7
8695296|NCT02753816|21466605|P3|Placebo|Overall Study||7
8695297|NCT02753816|21466606|P2|Placebo|Overall Study||11
8695298|NCT02753816|21466607|P1|Placebo|Overall Study||0
8695299|NCT02753816|21466605|P3|Tranexamic Acid|Overall Study||7
8695300|NCT02753816|21466606|P2|Tranexamic Acid|Overall Study||0
8695301|NCT02753816|21466607|P1|Tranexamic Acid|Overall Study||7
8695302|NCT02753816|21466605|P3|STARTED|Overall Study||7
8695303|NCT02753816|21466606|P2|STARTED|Overall Study||11
8695304|NCT02753816|21466607|P1|STARTED|Overall Study||7
8695305|NCT02749617|21466617|P1|NOT COMPLETED|Overall Study||0
8695306|NCT02749617|21466617|P1|COMPLETED|Overall Study||2
8695307|NCT02749617|21466617|P1|STARTED|Overall Study||2
8695308|NCT02684357|21466624|P6|NOT COMPLETED|Part B||13
8695309|NCT02684357|21466625|P5|NOT COMPLETED|Part B||4
8695310|NCT02684357|21466626|P4|NOT COMPLETED|Part B||3
8695311|NCT02684357|21466627|P3|NOT COMPLETED|Part B||0
8695312|NCT02684357|21466628|P2|NOT COMPLETED|Part B||0
8695313|NCT02684357|21466629|P1|NOT COMPLETED|Part B||0
8695314|NCT02684357|21466624|P6|COMPLETED|Part B||278
8695315|NCT02684357|21466625|P5|COMPLETED|Part B||90
8695316|NCT02684357|21466626|P4|COMPLETED|Part B||91
8695317|NCT02684357|21466627|P3|COMPLETED|Part B||0
8695318|NCT02684357|21466628|P2|COMPLETED|Part B||0
8695319|NCT02684357|21466629|P1|COMPLETED|Part B||0
8695320|NCT02684357|21466624|P6|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291
8695321|NCT02684357|21466625|P5|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94
8695322|NCT02684357|21466626|P4|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94
8695323|NCT02684357|21466627|P3|STARTED|Part B||0
8695324|NCT02684357|21466628|P2|STARTED|Part B||0
8695325|NCT02684357|21466629|P1|STARTED|Part B||0
8695326|NCT02684357|21466624|P6|NOT COMPLETED|Part A||0
8695327|NCT02684357|21466625|P5|NOT COMPLETED|Part A||0
8695328|NCT02684357|21466626|P4|NOT COMPLETED|Part A||0
8695329|NCT02684357|21466627|P3|NOT COMPLETED|Part A||2
8695330|NCT02684357|21466628|P2|NOT COMPLETED|Part A||3
8695331|NCT02684357|21466629|P1|NOT COMPLETED|Part A||4
8695332|NCT02684357|21466624|P6|COMPLETED|Part A||0
8695333|NCT02684357|21466625|P5|COMPLETED|Part A||0
8695334|NCT02684357|21466626|P4|COMPLETED|Part A||0
8695335|NCT02684357|21466627|P3|COMPLETED|Part A||292
8695336|NCT02684357|21466628|P2|COMPLETED|Part A||96
8695337|NCT02684357|21466629|P1|COMPLETED|Part A||94
8695338|NCT02684357|21466624|P6|STARTED|Part A||0
8695339|NCT02684357|21466625|P5|STARTED|Part A||0
8695340|NCT02684357|21466626|P4|STARTED|Part A||0
8695341|NCT02684357|21466627|P3|STARTED|Part A||294
8695342|NCT02684357|21466628|P2|STARTED|Part A||99
8695343|NCT02684357|21466629|P1|STARTED|Part A||98
8695344|NCT02650895|21466683|P6|NOT COMPLETED|Overall Study||0
8695345|NCT02650895|21466684|P5|NOT COMPLETED|Overall Study||0
8695346|NCT02650895|21466685|P4|NOT COMPLETED|Overall Study||0
8695347|NCT02650895|21466686|P3|NOT COMPLETED|Overall Study||0
8695348|NCT02650895|21466687|P2|NOT COMPLETED|Overall Study||1
8695349|NCT02650895|21466688|P1|NOT COMPLETED|Overall Study||0
8695350|NCT02650895|21466683|P6|COMPLETED|Overall Study||6
8695351|NCT02650895|21466684|P5|COMPLETED|Overall Study||6
8695352|NCT02650895|21466685|P4|COMPLETED|Overall Study||6
8695353|NCT02650895|21466686|P3|COMPLETED|Overall Study||6
8695354|NCT02650895|21466687|P2|COMPLETED|Overall Study||5
8695355|NCT02650895|21466688|P1|COMPLETED|Overall Study||10
8695356|NCT02650895|21466683|P6|STARTED|Overall Study||6
8695357|NCT02650895|21466684|P5|STARTED|Overall Study||6
8695358|NCT02650895|21466685|P4|STARTED|Overall Study||6
8695359|NCT02650895|21466686|P3|STARTED|Overall Study||6
8695360|NCT02650895|21466687|P2|STARTED|Overall Study||6
8695361|NCT02650895|21466688|P1|STARTED|Overall Study||10
8695362|NCT02583360|21466724|P2|NOT COMPLETED|Overall Study||0
8695363|NCT02583360|21466725|P1|NOT COMPLETED|Overall Study||0
8695364|NCT02583360|21466724|P2|COMPLETED|Overall Study||49
8695365|NCT02583360|21466725|P1|COMPLETED|Overall Study||60
8695366|NCT02583360|21466724|P2|STARTED|Overall Study||49
8695367|NCT02583360|21466725|P1|STARTED|Overall Study||60
8695368|NCT02256631|21466742|P7|NOT COMPLETED|Overall Study||4
8695369|NCT02256631|21466743|P6|NOT COMPLETED|Overall Study||2
8695370|NCT02256631|21466744|P5|NOT COMPLETED|Overall Study||1
8695371|NCT02256631|21466745|P4|NOT COMPLETED|Overall Study||4
8695372|NCT02256631|21466746|P3|NOT COMPLETED|Overall Study||0
8695373|NCT02256631|21466747|P2|NOT COMPLETED|Overall Study||3
8695374|NCT02256631|21466748|P1|NOT COMPLETED|Overall Study||1
8695375|NCT02256631|21466742|P7|COMPLETED|Overall Study||7
8695376|NCT02256631|21466743|P6|COMPLETED|Overall Study||9
8695377|NCT02256631|21466744|P5|COMPLETED|Overall Study||10
8695378|NCT02256631|21466745|P4|COMPLETED|Overall Study||6
8695379|NCT02256631|21466746|P3|COMPLETED|Overall Study||13
8695380|NCT02256631|21466747|P2|COMPLETED|Overall Study||11
8695381|NCT02256631|21466748|P1|COMPLETED|Overall Study||12
8695382|NCT02256631|21466742|P7|STARTED|Overall Study||11
8695383|NCT02256631|21466743|P6|STARTED|Overall Study||11
8695384|NCT02256631|21466744|P5|STARTED|Overall Study||11
8695385|NCT02256631|21466745|P4|STARTED|Overall Study||10
8695386|NCT02256631|21466746|P3|STARTED|Overall Study||13
8695387|NCT02256631|21466747|P2|STARTED|Overall Study||14
8695388|NCT02256631|21466748|P1|STARTED|Overall Study||13
8695389|NCT02167074|21466817|P2|NOT COMPLETED|Overall Study||0
8695390|NCT02167074|21466818|P1|NOT COMPLETED|Overall Study||0
8695391|NCT02167074|21466817|P2|COMPLETED|Overall Study||302
8695392|NCT02167074|21466818|P1|COMPLETED|Overall Study||306
8695393|NCT02167074|21466817|P2|STARTED|Overall Study||302
8695394|NCT02167074|21466818|P1|STARTED|Overall Study||306
8695395|NCT02125721|21466834|P1|NOT COMPLETED|Overall Study||0
8695396|NCT02125721|21466834|P1|COMPLETED|Overall Study||10
8695397|NCT02125721|21466834|P1|STARTED|Overall Study||10
8695398|NCT01904019|21466838|P1|NOT COMPLETED|5 Year Follow-up||6
8695399|NCT01904019|21466838|P1|COMPLETED|5 Year Follow-up||65
8695400|NCT01904019|21466838|P1|STARTED|5 Year Follow-up||71
8695401|NCT01904019|21466838|P1|NOT COMPLETED|3 Year Follow-up||15
8695402|NCT01904019|21466838|P1|COMPLETED|3 Year Follow-up||71
8695403|NCT01904019|21466838|P1|STARTED|3 Year Follow-up||86
8695404|NCT01904019|21466838|P1|NOT COMPLETED|1 Year Follow-up||9
8695405|NCT01904019|21466838|P1|COMPLETED|1 Year Follow-up||86
8695406|NCT01904019|21466838|P1|STARTED|1 Year Follow-up||95
8695407|NCT01904019|21466838|P1|NOT COMPLETED|Pre-operative||0
8695408|NCT01904019|21466838|P1|COMPLETED|Pre-operative||95
8695409|NCT01904019|21466838|P1|STARTED|Pre-operative||95
8695410|NCT01896271|21466853|P1|NOT COMPLETED|Overall Study||10
8695411|NCT01896271|21466853|P1|COMPLETED|Overall Study||20
8695412|NCT01896271|21466853|P1|STARTED|Overall Study||30
8695413|NCT01507987|21466865|P4|NOT COMPLETED|Overall Study||257
8695414|NCT01507987|21466866|P3|NOT COMPLETED|Overall Study||206
8695415|NCT01507987|21466867|P2|NOT COMPLETED|Overall Study||335
8695416|NCT01507987|21466868|P1|NOT COMPLETED|Overall Study||364
8695417|NCT01507987|21466865|P4|COMPLETED|Overall Study||480
8695418|NCT01507987|21466866|P3|COMPLETED|Overall Study||252
8695419|NCT01507987|21466867|P2|COMPLETED|Overall Study||335
8695420|NCT01507987|21466868|P1|COMPLETED|Overall Study||618
8695421|NCT01507987|21466865|P4|STARTED|Overall Study||737
8695422|NCT01507987|21466866|P3|STARTED|Overall Study||458
8695423|NCT01507987|21466867|P2|STARTED|Overall Study||670
8695424|NCT01507987|21466868|P1|STARTED|Overall Study||982
8695425|NCT01076049|21466969|P3|NOT COMPLETED|Overall Study||0
8695426|NCT01076049|21466970|P2|NOT COMPLETED|Overall Study||3
8695427|NCT01076049|21466971|P1|NOT COMPLETED|Overall Study||7
8695428|NCT01076049|21466969|P3|COMPLETED|Overall Study||1
8695429|NCT01076049|21466970|P2|COMPLETED|Overall Study||52
8695430|NCT01076049|21466971|P1|COMPLETED|Overall Study||45
8695431|NCT01076049|21466969|P3|STARTED|Overall Study||1
8695432|NCT01076049|21466970|P2|STARTED|Overall Study||55
8695433|NCT01076049|21466971|P1|STARTED|Overall Study||52
8695434|NCT04684992|21466985|P1|NOT COMPLETED|Overall Study||2
8695435|NCT04684992|21466985|P1|COMPLETED|Overall Study||34
8695436|NCT04684992|21466985|P1|STARTED|Overall Study||36
8695437|NCT04139018|21466999|P2|NOT COMPLETED|Overall Study||1
8695438|NCT04139018|21467000|P1|NOT COMPLETED|Overall Study||3
8695439|NCT04139018|21466999|P2|COMPLETED|Overall Study||12
8695440|NCT04139018|21467000|P1|COMPLETED|Overall Study||11
8695441|NCT04139018|21466999|P2|STARTED|Overall Study||13
8695442|NCT04139018|21467000|P1|STARTED|Overall Study||14
8695443|NCT04031885|21467010|P2|NOT COMPLETED|Overall Study||0
8695444|NCT04031885|21467011|P1|NOT COMPLETED|Overall Study||0
8695445|NCT04031885|21467010|P2|COMPLETED|Overall Study||3
8695446|NCT04031885|21467011|P1|COMPLETED|Overall Study||1
8695447|NCT04031885|21467010|P2|Received Any Quantity of Study Treatment|Overall Study||1
8695448|NCT04031885|21467011|P1|Received Any Quantity of Study Treatment|Overall Study||1
8695449|NCT04031885|21467010|P2|STARTED|Overall Study||3
8695450|NCT04031885|21467011|P1|STARTED|Overall Study||1
8695451|NCT03853213|21467027|P2|NOT COMPLETED|Overall Study||2
8695452|NCT03853213|21467028|P1|NOT COMPLETED|Overall Study||1
8695453|NCT03853213|21467027|P2|COMPLETED|Overall Study||7
8695454|NCT03853213|21467028|P1|COMPLETED|Overall Study||10
8695455|NCT03853213|21467027|P2|STARTED|Overall Study||9
8695456|NCT03853213|21467028|P1|STARTED|Overall Study||11
8695457|NCT03817853|21467044|P3|NOT COMPLETED|Maintenance/ Follow-up Phase||6
8695458|NCT03817853|21467045|P2|NOT COMPLETED|Maintenance/ Follow-up Phase||56
8695459|NCT03817853|21467046|P1|NOT COMPLETED|Maintenance/ Follow-up Phase||0
8695460|NCT03817853|21467044|P3|COMPLETED|Maintenance/ Follow-up Phase||11
8695461|NCT03817853|21467045|P2|COMPLETED|Maintenance/ Follow-up Phase||0
8695462|NCT03817853|21467046|P1|COMPLETED|Maintenance/ Follow-up Phase||0
8695463|NCT03817853|21467044|P3|STARTED|Maintenance/ Follow-up Phase||17
8695464|NCT03817853|21467045|P2|STARTED|Maintenance/ Follow-up Phase||56
8695465|NCT03817853|21467046|P1|STARTED|Maintenance/ Follow-up Phase||0
8695466|NCT03817853|21467044|P3|NOT COMPLETED|Induction Phase||0
8695467|NCT03817853|21467045|P2|NOT COMPLETED|Induction Phase||0
8695468|NCT03817853|21467046|P1|NOT COMPLETED|Induction Phase||51
8695469|NCT03817853|21467044|P3|COMPLETED|Induction Phase||0
8695470|NCT03817853|21467045|P2|COMPLETED|Induction Phase||0
8695471|NCT03817853|21467046|P1|COMPLETED|Induction Phase||62
8695472|NCT03817853|21467044|P3|STARTED|Induction Phase||0
8695473|NCT03817853|21467045|P2|STARTED|Induction Phase||0
8695474|NCT03817853|21467046|P1|STARTED|Induction Phase||113
8695475|NCT03803475|21467061|P1|NOT COMPLETED|Overall Study||1
8695476|NCT03803475|21467061|P1|COMPLETED|Overall Study||484
8695477|NCT03803475|21467061|P1|STARTED|Overall Study||485
8695478|NCT03797144|21467071|P2|NOT COMPLETED|24 Month||1
8695479|NCT03797144|21467072|P1|NOT COMPLETED|24 Month||1
8695480|NCT03797144|21467071|P2|COMPLETED|24 Month||0
8695481|NCT03797144|21467072|P1|COMPLETED|24 Month||0
8695482|NCT03797144|21467071|P2|STARTED|24 Month||1
8695483|NCT03797144|21467072|P1|STARTED|24 Month||1
8695484|NCT03797144|21467071|P2|NOT COMPLETED|12 Month||9
8695485|NCT03797144|21467072|P1|NOT COMPLETED|12 Month||8
8695486|NCT03797144|21467071|P2|COMPLETED|12 Month||1
8695487|NCT03797144|21467072|P1|COMPLETED|12 Month||1
8695488|NCT03797144|21467071|P2|STARTED|12 Month||10
8695489|NCT03797144|21467072|P1|STARTED|12 Month||9
8695490|NCT03797144|21467071|P2|NOT COMPLETED|3 Month||0
8695491|NCT03797144|21467072|P1|NOT COMPLETED|3 Month||2
8695492|NCT03797144|21467071|P2|COMPLETED|3 Month||10
8695493|NCT03797144|21467072|P1|COMPLETED|3 Month||9
8695494|NCT03797144|21467071|P2|STARTED|3 Month||10
8695495|NCT03797144|21467072|P1|STARTED|3 Month||11
8695496|NCT03797144|21467071|P2|NOT COMPLETED|Surgery||0
8695497|NCT03797144|21467072|P1|NOT COMPLETED|Surgery||1
8695498|NCT03797144|21467071|P2|COMPLETED|Surgery||10
8695499|NCT03797144|21467072|P1|COMPLETED|Surgery||11
8695500|NCT03797144|21467071|P2|STARTED|Surgery||10
8695501|NCT03797144|21467072|P1|STARTED|Surgery||12
8695502|NCT03797144|21467071|P2|NOT COMPLETED|Enrollment||1
8695503|NCT03797144|21467072|P1|NOT COMPLETED|Enrollment||4
8695504|NCT03797144|21467071|P2|COMPLETED|Enrollment||10
8695505|NCT03797144|21467072|P1|COMPLETED|Enrollment||12
8695506|NCT03797144|21467071|P2|STARTED|Enrollment||11
8695507|NCT03797144|21467072|P1|STARTED|Enrollment||16
8695508|NCT03774433|21467101|P1|NOT COMPLETED|Overall Study||14
8695509|NCT03774433|21467101|P1|COMPLETED|Overall Study|Participants who completed at least 12 EMAs for inclusion in data analysis|100
8695510|NCT03774433|21467101|P1|STARTED|Overall Study||114
8695511|NCT03756571|21467108|P2|NOT COMPLETED|Overall Study||1
8695512|NCT03756571|21467109|P1|NOT COMPLETED|Overall Study||1
8695513|NCT03756571|21467108|P2|COMPLETED|Overall Study||10
8695514|NCT03756571|21467109|P1|COMPLETED|Overall Study||9
8695515|NCT03756571|21467108|P2|STARTED|Overall Study||11
8695516|NCT03756571|21467109|P1|STARTED|Overall Study||10
8695517|NCT03753763|21467139|P2|NOT COMPLETED|Overall Study||1
8695518|NCT03753763|21467140|P1|NOT COMPLETED|Overall Study||6
8695519|NCT03753763|21467139|P2|COMPLETED|Overall Study||16
8695520|NCT03753763|21467140|P1|COMPLETED|Overall Study||26
8695521|NCT03753763|21467139|P2|STARTED|Overall Study||17
8695522|NCT03753763|21467140|P1|STARTED|Overall Study||32
8695523|NCT03696342|21467162|P2|NOT COMPLETED|Overall Study||0
8695524|NCT03696342|21467163|P1|NOT COMPLETED|Overall Study||1
8695525|NCT03696342|21467162|P2|COMPLETED|Overall Study||23
8695526|NCT03696342|21467163|P1|COMPLETED|Overall Study||22
8695527|NCT03696342|21467162|P2|STARTED|Overall Study||23
8695528|NCT03696342|21467163|P1|STARTED|Overall Study||23
8695529|NCT03669861|21467179|P1|NOT COMPLETED|Overall Study||7
8695530|NCT03669861|21467179|P1|COMPLETED|Overall Study||3
8695531|NCT03669861|21467179|P1|STARTED|Overall Study||10
8695532|NCT03596151|21467188|P1|NOT COMPLETED|Overall Study||1
8695533|NCT03596151|21467188|P1|COMPLETED|Overall Study||294
8695534|NCT03596151|21467188|P1|STARTED|Overall Study||295
8695535|NCT03545165|21467200|P1|NOT COMPLETED|Overall Study||0
8695536|NCT03545165|21467200|P1|COMPLETED|Overall Study||6
8695537|NCT03545165|21467200|P1|STARTED|Overall Study||6
8695538|NCT03528512|21467217|P2|NOT COMPLETED|Overall Study||0
8695539|NCT03528512|21467218|P1|NOT COMPLETED|Overall Study||0
8695540|NCT03528512|21467217|P2|COMPLETED|Overall Study||2
8695541|NCT03528512|21467218|P1|COMPLETED|Overall Study||3
8695542|NCT03528512|21467217|P2|STARTED|Overall Study||2
8695543|NCT03528512|21467218|P1|STARTED|Overall Study||3
8695544|NCT03474107|21467236|P2|NOT COMPLETED|Overall Study||285
8695545|NCT03474107|21467237|P1|NOT COMPLETED|Overall Study||245
8695546|NCT03474107|21467236|P2|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|22
8695547|NCT03474107|21467237|P1|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|56
8695548|NCT03474107|21467236|P2|Treated|Overall Study||291
8695549|NCT03474107|21467237|P1|Treated|Overall Study||296
8695550|NCT03474107|21467236|P2|STARTED|Overall Study||307
8695551|NCT03474107|21467237|P1|STARTED|Overall Study||301
8695552|NCT03437278|21467262|P3|NOT COMPLETED|Overall Study||2
8695553|NCT03437278|21467263|P2|NOT COMPLETED|Overall Study||0
8695554|NCT03437278|21467264|P1|NOT COMPLETED|Overall Study||2
8695555|NCT03437278|21467262|P3|COMPLETED|Overall Study||10
8695556|NCT03437278|21467263|P2|COMPLETED|Overall Study||13
8695557|NCT03437278|21467264|P1|COMPLETED|Overall Study||22
8695558|NCT03437278|21467262|P3|STARTED|Overall Study||12
8695559|NCT03437278|21467263|P2|STARTED|Overall Study||13
8695560|NCT03437278|21467264|P1|STARTED|Overall Study||24
8695561|NCT03384940|21467305|P3|NOT COMPLETED|Overall Study||18
8695562|NCT03384940|21467306|P2|NOT COMPLETED|Overall Study||15
8695563|NCT03384940|21467307|P1|NOT COMPLETED|Overall Study||53
8695564|NCT03384940|21467305|P3|COMPLETED|Overall Study||0
8695565|NCT03384940|21467306|P2|COMPLETED|Overall Study||0
8695566|NCT03384940|21467307|P1|COMPLETED|Overall Study||0
8695567|NCT03384940|21467305|P3|STARTED|Overall Study||18
8695568|NCT03384940|21467306|P2|STARTED|Overall Study||15
8695569|NCT03384940|21467307|P1|STARTED|Overall Study||53
8695570|NCT03341273|21467360|P2|NOT COMPLETED|Overall Study||12
8695571|NCT03341273|21467361|P1|NOT COMPLETED|Overall Study||20
8695572|NCT03341273|21467360|P2|COMPLETED|Overall Study||238
8695573|NCT03341273|21467361|P1|COMPLETED|Overall Study||229
8695574|NCT03341273|21467360|P2|STARTED|Overall Study||250
8695575|NCT03341273|21467361|P1|STARTED|Overall Study||249
8695576|NCT02994238|21467405|P2|NOT COMPLETED|Overall Study||0
8695577|NCT02994238|21467406|P1|NOT COMPLETED|Overall Study||0
8695578|NCT02994238|21467405|P2|COMPLETED|Overall Study||127
8695579|NCT02994238|21467406|P1|COMPLETED|Overall Study||125
8695580|NCT02994238|21467405|P2|STARTED|Overall Study||127
8695581|NCT02994238|21467406|P1|STARTED|Overall Study||125
8695582|NCT02923180|21467420|P1|NOT COMPLETED|Overall Study||26
8695583|NCT02923180|21467420|P1|COMPLETED|Overall Study||6
8695584|NCT02923180|21467420|P1|STARTED|Overall Study||32
8695585|NCT02796664|21467432|P2|NOT COMPLETED|Overall Study||5
8695586|NCT02796664|21467433|P1|NOT COMPLETED|Overall Study||1
8695587|NCT02796664|21467432|P2|COMPLETED|Overall Study||24
8695588|NCT02796664|21467433|P1|COMPLETED|Overall Study||28
8695589|NCT02796664|21467432|P2|STARTED|Overall Study||29
8695590|NCT02796664|21467433|P1|STARTED|Overall Study||29
8695591|NCT02594111|21467451|P2|NOT COMPLETED|Overall Study||0
8695592|NCT02594111|21467452|P1|NOT COMPLETED|Overall Study||0
8695593|NCT02594111|21467451|P2|COMPLETED|Overall Study||348
8695594|NCT02594111|21467452|P1|COMPLETED|Overall Study||366
8695595|NCT02594111|21467451|P2|STARTED|Overall Study||348
8695596|NCT02594111|21467452|P1|STARTED|Overall Study||366
8695597|NCT02513472|21467464|P2|NOT COMPLETED|Overall Study||93
8695598|NCT02513472|21467465|P1|NOT COMPLETED|Overall Study||65
8695599|NCT02513472|21467464|P2|COMPLETED|Overall Study|Treatment ongoing at data cutoff.|8
8695600|NCT02513472|21467465|P1|COMPLETED|Overall Study|Treatment ongoing at data cutoff.|1
8695601|NCT02513472|21467464|P2|Phase 2|Overall Study||97
8695602|NCT02513472|21467465|P1|Phase 2|Overall Study||63
8695603|NCT02513472|21467464|P2|Phase 1b Safety run-in|Overall Study||4
8695604|NCT02513472|21467465|P1|Phase 1b Safety run-in|Overall Study||3
8695605|NCT02513472|21467464|P2|STARTED|Overall Study||101
8695606|NCT02513472|21467465|P1|STARTED|Overall Study||66
8695607|NCT02435901|21467500|P1|NOT COMPLETED|Overall Study||0
8695608|NCT02435901|21467500|P1|COMPLETED|Overall Study||29
8695609|NCT02435901|21467500|P1|STARTED|Overall Study||29
8695610|NCT02257957|21467508|P2|NOT COMPLETED|Overall Study||0
8695611|NCT02257957|21467509|P1|NOT COMPLETED|Overall Study||0
8695612|NCT02257957|21467508|P2|COMPLETED|Overall Study||15
8695613|NCT02257957|21467509|P1|COMPLETED|Overall Study||15
8695614|NCT02257957|21467508|P2|STARTED|Overall Study||15
8695615|NCT02257957|21467509|P1|STARTED|Overall Study||15
8695616|NCT02242942|21467522|P3|NOT COMPLETED|Overall Study||13
8695617|NCT02242942|21467523|P2|NOT COMPLETED|Overall Study||216
8695618|NCT02242942|21467524|P1|NOT COMPLETED|Overall Study||216
8695619|NCT02242942|21467522|P3|COMPLETED|Overall Study||0
8695620|NCT02242942|21467523|P2|COMPLETED|Overall Study||0
8695621|NCT02242942|21467524|P1|COMPLETED|Overall Study||0
8695622|NCT02242942|21467522|P3|Treated|Overall Study||13
8695623|NCT02242942|21467523|P2|Treated|Overall Study||212
8695624|NCT02242942|21467524|P1|Treated|Overall Study||214
8695625|NCT02242942|21467522|P3|STARTED|Overall Study||13
8695626|NCT02242942|21467523|P2|STARTED|Overall Study||216
8695627|NCT02242942|21467524|P1|STARTED|Overall Study||216
8695628|NCT02185404|21467551|P1|NOT COMPLETED|Overall Study||0
8695629|NCT02185404|21467551|P1|COMPLETED|Overall Study||6
8695630|NCT02185404|21467551|P1|STARTED|Overall Study||6
8695631|NCT02144675|21467558|P2|NOT COMPLETED|Overall Study||0
8695632|NCT02144675|21467559|P1|NOT COMPLETED|Overall Study||0
8695633|NCT02144675|21467558|P2|COMPLETED|Overall Study||14
8695634|NCT02144675|21467559|P1|COMPLETED|Overall Study||13
8695635|NCT02144675|21467558|P2|STARTED|Overall Study||14
8695636|NCT02144675|21467559|P1|STARTED|Overall Study||13
8695637|NCT02136134|21467567|P2|NOT COMPLETED|Overall Study||251
8695638|NCT02136134|21467568|P1|NOT COMPLETED|Overall Study||247
8695639|NCT02136134|21467567|P2|COMPLETED|Overall Study||0
8695640|NCT02136134|21467568|P1|COMPLETED|Overall Study||0
8695641|NCT02136134|21467567|P2|Treated|Overall Study||243
8695642|NCT02136134|21467568|P1|Treated|Overall Study||237
8695643|NCT02136134|21467567|P2|STARTED|Overall Study||251
8695644|NCT02136134|21467568|P1|STARTED|Overall Study||247
8695645|NCT02105116|21467584|P1|NOT COMPLETED|Overall Study||6
8695646|NCT02105116|21467584|P1|COMPLETED|Overall Study||0
8695647|NCT02105116|21467584|P1|STARTED|Overall Study||6
8695648|NCT02082678|21467593|P2|NOT COMPLETED|Overall Study||14
8695649|NCT02082678|21467594|P1|NOT COMPLETED|Overall Study||12
8695650|NCT02082678|21467593|P2|COMPLETED|Overall Study||21
8695651|NCT02082678|21467594|P1|COMPLETED|Overall Study||23
8695652|NCT02082678|21467593|P2|STARTED|Overall Study||35
8695653|NCT02082678|21467594|P1|STARTED|Overall Study||35
8695654|NCT01960855|21467609|P5|NOT COMPLETED|Overall Study||5
8695655|NCT01960855|21467610|P4|NOT COMPLETED|Overall Study||4
8695656|NCT01960855|21467611|P3|NOT COMPLETED|Overall Study||9
8695657|NCT01960855|21467612|P2|NOT COMPLETED|Overall Study||4
8695658|NCT01960855|21467613|P1|NOT COMPLETED|Overall Study||11
8695659|NCT01960855|21467609|P5|COMPLETED|Overall Study||50
8695660|NCT01960855|21467610|P4|COMPLETED|Overall Study||51
8695661|NCT01960855|21467611|P3|COMPLETED|Overall Study||46
8695662|NCT01960855|21467612|P2|COMPLETED|Overall Study||51
8695663|NCT01960855|21467613|P1|COMPLETED|Overall Study||45
8695664|NCT01960855|21467609|P5|STARTED|Overall Study||55
8695665|NCT01960855|21467610|P4|STARTED|Overall Study||55
8695666|NCT01960855|21467611|P3|STARTED|Overall Study||55
8695667|NCT01960855|21467612|P2|STARTED|Overall Study||55
8695668|NCT01960855|21467613|P1|STARTED|Overall Study||56
8695669|NCT01946529|21467648|P3|NOT COMPLETED|Completion of All Therapy||6
8695670|NCT01946529|21467649|P2|NOT COMPLETED|Completion of All Therapy||16
8695671|NCT01946529|21467650|P1|NOT COMPLETED|Completion of All Therapy||1
8695672|NCT01946529|21467648|P3|COMPLETED|Completion of All Therapy||0
8695673|NCT01946529|21467649|P2|COMPLETED|Completion of All Therapy||0
8695674|NCT01946529|21467650|P1|COMPLETED|Completion of All Therapy||0
8695675|NCT01946529|21467648|P3|STARTED|Completion of All Therapy||6
8695676|NCT01946529|21467649|P2|STARTED|Completion of All Therapy||16
8695677|NCT01946529|21467650|P1|STARTED|Completion of All Therapy||1
8695678|NCT01946529|21467648|P3|NOT COMPLETED|End of Window Therapy (2 Courses)||0
8695679|NCT01946529|21467649|P2|NOT COMPLETED|End of Window Therapy (2 Courses)||1
8695680|NCT01946529|21467650|P1|NOT COMPLETED|End of Window Therapy (2 Courses)||0
8695681|NCT01946529|21467648|P3|COMPLETED|End of Window Therapy (2 Courses)||6
8695682|NCT01946529|21467649|P2|COMPLETED|End of Window Therapy (2 Courses)||16
8695683|NCT01946529|21467650|P1|COMPLETED|End of Window Therapy (2 Courses)||1
8695684|NCT01946529|21467648|P3|STARTED|End of Window Therapy (2 Courses)||6
8695685|NCT01946529|21467649|P2|STARTED|End of Window Therapy (2 Courses)||17
8695686|NCT01946529|21467650|P1|STARTED|End of Window Therapy (2 Courses)||1
8695687|NCT01751230|21467659|P2|NOT COMPLETED|Overall Study||4
8695688|NCT01751230|21467660|P1|NOT COMPLETED|Overall Study||1
8695689|NCT01751230|21467659|P2|COMPLETED|Overall Study||16
8695690|NCT01751230|21467660|P1|COMPLETED|Overall Study||19
8695691|NCT01751230|21467659|P2|STARTED|Overall Study||20
8695692|NCT01751230|21467660|P1|STARTED|Overall Study||20
8695693|NCT01651078|21467678|P1|NOT COMPLETED|Overall Study||26
8695694|NCT01651078|21467678|P1|COMPLETED|Overall Study||16
8695695|NCT01651078|21467678|P1|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42
8695696|NCT01505114|21467689|P4|NOT COMPLETED|Overall Study||23
8695697|NCT01505114|21467690|P3|NOT COMPLETED|Overall Study||18
8695698|NCT01505114|21467691|P2|NOT COMPLETED|Overall Study||13
8695699|NCT01505114|21467692|P1|NOT COMPLETED|Overall Study||25
8695700|NCT01505114|21467689|P4|COMPLETED|Overall Study||128
8695701|NCT01505114|21467690|P3|COMPLETED|Overall Study||129
8695702|NCT01505114|21467691|P2|COMPLETED|Overall Study||135
8695703|NCT01505114|21467692|P1|COMPLETED|Overall Study||123
8695704|NCT01505114|21467689|P4|STARTED|Overall Study||151
8695705|NCT01505114|21467690|P3|STARTED|Overall Study||147
8695706|NCT01505114|21467691|P2|STARTED|Overall Study||148
8695707|NCT01505114|21467692|P1|STARTED|Overall Study||148
8695708|NCT01098422|21467702|P1|NOT COMPLETED|Overall Study||1
8695709|NCT01098422|21467702|P1|COMPLETED|Overall Study||9
8695710|NCT01098422|21467702|P1|STARTED|Overall Study||10
8695711|NCT00528996|21467715|P5|NOT COMPLETED|Overall Study||37
8695712|NCT00528996|21467716|P4|NOT COMPLETED|Overall Study||50
8695713|NCT00528996|21467717|P3|NOT COMPLETED|Overall Study||43
8695714|NCT00528996|21467718|P2|NOT COMPLETED|Overall Study||24
8695715|NCT00528996|21467719|P1|NOT COMPLETED|Overall Study||64
8695716|NCT00528996|21467715|P5|COMPLETED|Overall Study||390
8695717|NCT00528996|21467716|P4|COMPLETED|Overall Study||340
8695718|NCT00528996|21467717|P3|COMPLETED|Overall Study||372
8695719|NCT00528996|21467718|P2|COMPLETED|Overall Study||395
8695720|NCT00528996|21467719|P1|COMPLETED|Overall Study||365
8695721|NCT00528996|21467715|P5|STARTED|Overall Study||427
8695722|NCT00528996|21467716|P4|STARTED|Overall Study||390
8695723|NCT00528996|21467717|P3|STARTED|Overall Study||415
8695724|NCT00528996|21467718|P2|STARTED|Overall Study||419
8695725|NCT00528996|21467719|P1|STARTED|Overall Study||429
8695726|NCT00352027|21467881|P1|NOT COMPLETED|Overall Study||3
8695727|NCT00352027|21467881|P1|COMPLETED|Overall Study||77
8695728|NCT00352027|21467881|P1|STARTED|Overall Study||80
8695729|NCT04421404|21468152|P2|NOT COMPLETED|Overall Study||0
8695730|NCT04421404|21468153|P1|NOT COMPLETED|Overall Study||0
8695731|NCT04421404|21468152|P2|COMPLETED|Overall Study||18
8695732|NCT04421404|21468153|P1|COMPLETED|Overall Study||16
8695733|NCT04421404|21468152|P2|STARTED|Overall Study||18
8695734|NCT04421404|21468153|P1|STARTED|Overall Study||16
8695735|NCT04297241|21468161|P1|NOT COMPLETED|Overall Study||5
8695736|NCT04297241|21468161|P1|COMPLETED|Overall Study||15
8695737|NCT04297241|21468161|P1|STARTED|Overall Study||20
8695738|NCT04276207|21468175|P2|NOT COMPLETED|Period 2||0
8695739|NCT04276207|21468176|P1|NOT COMPLETED|Period 2||0
8695740|NCT04276207|21468175|P2|COMPLETED|Period 2||16
8695741|NCT04276207|21468176|P1|COMPLETED|Period 2||15
8695742|NCT04276207|21468175|P2|STARTED|Period 2||16
8695743|NCT04276207|21468176|P1|STARTED|Period 2||15
8695744|NCT04276207|21468175|P2|NOT COMPLETED|Washout (3- 14 Days)||0
8695745|NCT04276207|21468176|P1|NOT COMPLETED|Washout (3- 14 Days)||0
8695746|NCT04276207|21468175|P2|COMPLETED|Washout (3- 14 Days)||16
8695747|NCT04276207|21468176|P1|COMPLETED|Washout (3- 14 Days)||15
8695748|NCT04276207|21468175|P2|STARTED|Washout (3- 14 Days)||16
8695749|NCT04276207|21468176|P1|STARTED|Washout (3- 14 Days)||15
8695750|NCT04276207|21468175|P2|NOT COMPLETED|Period 1||1
8695751|NCT04276207|21468176|P1|NOT COMPLETED|Period 1||0
8695752|NCT04276207|21468175|P2|COMPLETED|Period 1||16
8695753|NCT04276207|21468176|P1|COMPLETED|Period 1||15
8695754|NCT04276207|21468175|P2|Received at Least One Dose of Study Drug|Period 1||17
8695755|NCT04276207|21468176|P1|Received at Least One Dose of Study Drug|Period 1||15
8695756|NCT04276207|21468175|P2|STARTED|Period 1||17
8695757|NCT04276207|21468176|P1|STARTED|Period 1||15
8695758|NCT03880266|21468196|P8|NOT COMPLETED|Overall Study||0
8695759|NCT03880266|21468197|P7|NOT COMPLETED|Overall Study||0
8695760|NCT03880266|21468198|P6|NOT COMPLETED|Overall Study||0
8695761|NCT03880266|21468199|P5|NOT COMPLETED|Overall Study||0
8695762|NCT03880266|21468200|P4|NOT COMPLETED|Overall Study||0
8695763|NCT03880266|21468201|P3|NOT COMPLETED|Overall Study||1
8695764|NCT03880266|21468202|P2|NOT COMPLETED|Overall Study||1
8695765|NCT03880266|21468203|P1|NOT COMPLETED|Overall Study||0
8695766|NCT03880266|21468196|P8|COMPLETED|Overall Study||7
8695767|NCT03880266|21468197|P7|COMPLETED|Overall Study||13
8695768|NCT03880266|21468198|P6|COMPLETED|Overall Study||6
8695769|NCT03880266|21468199|P5|COMPLETED|Overall Study||12
8695770|NCT03880266|21468200|P4|COMPLETED|Overall Study||4
8695771|NCT03880266|21468201|P3|COMPLETED|Overall Study||11
8695772|NCT03880266|21468202|P2|COMPLETED|Overall Study||5
8695773|NCT03880266|21468203|P1|COMPLETED|Overall Study||12
8695774|NCT03880266|21468196|P8|STARTED|Overall Study||7
8695775|NCT03880266|21468197|P7|STARTED|Overall Study||13
8695776|NCT03880266|21468198|P6|STARTED|Overall Study||6
8695777|NCT03880266|21468199|P5|STARTED|Overall Study||12
8695778|NCT03880266|21468200|P4|STARTED|Overall Study||4
8695779|NCT03880266|21468201|P3|STARTED|Overall Study||12
8695780|NCT03880266|21468202|P2|STARTED|Overall Study||6
8695781|NCT03880266|21468203|P1|STARTED|Overall Study||12
8695782|NCT03860181|21468257|P4|NOT COMPLETED|Overall Study||0
8695783|NCT03860181|21468258|P3|NOT COMPLETED|Overall Study||0
8695784|NCT03860181|21468259|P2|NOT COMPLETED|Overall Study||0
8695785|NCT03860181|21468260|P1|NOT COMPLETED|Overall Study||0
8695786|NCT03860181|21468257|P4|COMPLETED|Overall Study||21
8695787|NCT03860181|21468258|P3|COMPLETED|Overall Study||25
8695788|NCT03860181|21468259|P2|COMPLETED|Overall Study||22
8695789|NCT03860181|21468260|P1|COMPLETED|Overall Study||21
8695790|NCT03860181|21468257|P4|STARTED|Overall Study||21
8695791|NCT03860181|21468258|P3|STARTED|Overall Study||25
8695792|NCT03860181|21468259|P2|STARTED|Overall Study||22
8695793|NCT03860181|21468260|P1|STARTED|Overall Study||21
8695794|NCT03712449|21468315|P2|NOT COMPLETED|Overall Study||1
8695795|NCT03712449|21468316|P1|NOT COMPLETED|Overall Study||0
8695796|NCT03712449|21468315|P2|COMPLETED|Overall Study||45
8695797|NCT03712449|21468316|P1|COMPLETED|Overall Study||13
8695798|NCT03712449|21468315|P2|Full Analysis Population|Overall Study||45
8695799|NCT03712449|21468316|P1|Full Analysis Population|Overall Study||13
8695800|NCT03712449|21468315|P2|STARTED|Overall Study||46
8695801|NCT03712449|21468316|P1|STARTED|Overall Study||13
8695802|NCT03639311|21468344|P2|NOT COMPLETED|Overall Study||0
8695803|NCT03639311|21468345|P1|NOT COMPLETED|Overall Study||90
8695804|NCT03639311|21468344|P2|COMPLETED|Overall Study||7
8695805|NCT03639311|21468345|P1|COMPLETED|Overall Study||0
8695806|NCT03639311|21468344|P2|STARTED|Overall Study||7
8695807|NCT03639311|21468345|P1|STARTED|Overall Study||90
8695808|NCT03626623|21468429|P2|NOT COMPLETED|Overall Study||10
8695809|NCT03626623|21468430|P1|NOT COMPLETED|Overall Study||5
8695810|NCT03626623|21468429|P2|COMPLETED|Overall Study||0
8695811|NCT03626623|21468430|P1|COMPLETED|Overall Study||0
8695812|NCT03626623|21468429|P2|STARTED|Overall Study||10
8695813|NCT03626623|21468430|P1|STARTED|Overall Study||5
8695814|NCT03487445|21468466|P2|NOT COMPLETED|Treatment Period||0
8695815|NCT03487445|21468467|P1|NOT COMPLETED|Treatment Period||0
8695816|NCT03487445|21468466|P2|COMPLETED|Treatment Period||23
8695817|NCT03487445|21468467|P1|COMPLETED|Treatment Period||24
8695818|NCT03487445|21468466|P2|Per Protocol Set|Treatment Period||20
8695819|NCT03487445|21468467|P1|Per Protocol Set|Treatment Period||20
8695820|NCT03487445|21468466|P2|Modified Full Analysis Set (mFAS)|Treatment Period||22
8695821|NCT03487445|21468467|P1|Modified Full Analysis Set (mFAS)|Treatment Period||23
8695822|NCT03487445|21468466|P2|STARTED|Treatment Period||23
8695823|NCT03487445|21468467|P1|STARTED|Treatment Period||24
8695824|NCT03487445|21468466|P2|NOT COMPLETED|Randomization||0
8695825|NCT03487445|21468467|P1|NOT COMPLETED|Randomization||1
8695826|NCT03487445|21468466|P2|COMPLETED|Randomization||23
8695827|NCT03487445|21468467|P1|COMPLETED|Randomization||24
8695828|NCT03487445|21468466|P2|STARTED|Randomization||23
8695829|NCT03487445|21468467|P1|STARTED|Randomization||25
8695830|NCT03312023|21468489|P4|NOT COMPLETED|Overall Study||0
8695831|NCT03312023|21468490|P3|NOT COMPLETED|Overall Study||0
8695832|NCT03312023|21468491|P2|NOT COMPLETED|Overall Study||0
8695833|NCT03312023|21468492|P1|NOT COMPLETED|Overall Study||0
8695834|NCT03312023|21468489|P4|COMPLETED|Overall Study||4
8695835|NCT03312023|21468490|P3|COMPLETED|Overall Study||4
8695836|NCT03312023|21468491|P2|COMPLETED|Overall Study||5
8695837|NCT03312023|21468492|P1|COMPLETED|Overall Study||8
8695838|NCT03312023|21468489|P4|Completed Week 12|Overall Study||4
8695839|NCT03312023|21468490|P3|Completed Week 12|Overall Study||4
8695840|NCT03312023|21468491|P2|Completed Week 12|Overall Study||5
8695841|NCT03312023|21468492|P1|Completed Week 12|Overall Study||8
8695842|NCT03312023|21468489|P4|STARTED|Overall Study||4
8695843|NCT03312023|21468490|P3|STARTED|Overall Study||4
8695844|NCT03312023|21468491|P2|STARTED|Overall Study||5
8695845|NCT03312023|21468492|P1|STARTED|Overall Study||8
8695846|NCT03305666|21468512|P2|NOT COMPLETED|Overall Study||0
8695847|NCT03305666|21468513|P1|NOT COMPLETED|Overall Study||2
8695848|NCT03305666|21468512|P2|COMPLETED|Overall Study||18
8695849|NCT03305666|21468513|P1|COMPLETED|Overall Study||16
8695850|NCT03305666|21468512|P2|STARTED|Overall Study||18
8695851|NCT03305666|21468513|P1|STARTED|Overall Study||18
8695852|NCT03041038|21468525|P2|NOT COMPLETED|Overall Study||2
8695853|NCT03041038|21468526|P1|NOT COMPLETED|Overall Study||6
8695854|NCT03041038|21468525|P2|COMPLETED|Overall Study||7
8695855|NCT03041038|21468526|P1|COMPLETED|Overall Study||5
8695856|NCT03041038|21468525|P2|Week 32|Overall Study||8
8695857|NCT03041038|21468526|P1|Week 32|Overall Study||9
8695858|NCT03041038|21468525|P2|Week 16|Overall Study||8
8695859|NCT03041038|21468526|P1|Week 16|Overall Study||10
8695860|NCT03041038|21468525|P2|STARTED|Overall Study||9
8695861|NCT03041038|21468526|P1|STARTED|Overall Study||11
8695862|NCT02908685|21468548|P12|NOT COMPLETED|Part 2 Confirmatory||1
8695863|NCT02908685|21468549|P11|NOT COMPLETED|Part 2 Confirmatory||3
8695864|NCT02908685|21468550|P10|NOT COMPLETED|Part 2 Confirmatory||0
8695865|NCT02908685|21468551|P9|NOT COMPLETED|Part 2 Confirmatory||0
8695866|NCT02908685|21468552|P8|NOT COMPLETED|Part 2 Confirmatory||0
8695867|NCT02908685|21468553|P7|NOT COMPLETED|Part 2 Confirmatory||0
8695868|NCT02908685|21468554|P6|NOT COMPLETED|Part 2 Confirmatory||0
8695869|NCT02908685|21468555|P5|NOT COMPLETED|Part 2 Confirmatory||0
8695870|NCT02908685|21468556|P4|NOT COMPLETED|Part 2 Confirmatory||0
8695871|NCT02908685|21468557|P3|NOT COMPLETED|Part 2 Confirmatory||0
8695872|NCT02908685|21468558|P2|NOT COMPLETED|Part 2 Confirmatory||0
8695873|NCT02908685|21468559|P1|NOT COMPLETED|Part 2 Confirmatory||0
8695874|NCT02908685|21468548|P12|COMPLETED|Part 2 Confirmatory||59
8695875|NCT02908685|21468549|P11|COMPLETED|Part 2 Confirmatory||117
8695876|NCT02908685|21468550|P10|COMPLETED|Part 2 Confirmatory||0
8695877|NCT02908685|21468551|P9|COMPLETED|Part 2 Confirmatory||0
8695878|NCT02908685|21468552|P8|COMPLETED|Part 2 Confirmatory||0
8695879|NCT02908685|21468553|P7|COMPLETED|Part 2 Confirmatory||0
8695880|NCT02908685|21468554|P6|COMPLETED|Part 2 Confirmatory||0
8695881|NCT02908685|21468555|P5|COMPLETED|Part 2 Confirmatory||0
8695882|NCT02908685|21468556|P4|COMPLETED|Part 2 Confirmatory||0
8695883|NCT02908685|21468557|P3|COMPLETED|Part 2 Confirmatory||0
8695884|NCT02908685|21468558|P2|COMPLETED|Part 2 Confirmatory||0
8695885|NCT02908685|21468559|P1|COMPLETED|Part 2 Confirmatory||0
8695886|NCT02908685|21468548|P12|STARTED|Part 2 Confirmatory||60
8695887|NCT02908685|21468549|P11|STARTED|Part 2 Confirmatory||120
8695888|NCT02908685|21468550|P10|STARTED|Part 2 Confirmatory||0
8695889|NCT02908685|21468551|P9|STARTED|Part 2 Confirmatory||0
8695890|NCT02908685|21468552|P8|STARTED|Part 2 Confirmatory||0
8695891|NCT02908685|21468553|P7|STARTED|Part 2 Confirmatory||0
8695892|NCT02908685|21468554|P6|STARTED|Part 2 Confirmatory||0
8695893|NCT02908685|21468555|P5|STARTED|Part 2 Confirmatory||0
8695894|NCT02908685|21468556|P4|STARTED|Part 2 Confirmatory||0
8695895|NCT02908685|21468557|P3|STARTED|Part 2 Confirmatory||0
8695896|NCT02908685|21468558|P2|STARTED|Part 2 Confirmatory||0
8695897|NCT02908685|21468559|P1|STARTED|Part 2 Confirmatory||0
8695898|NCT02908685|21468548|P12|NOT COMPLETED|Part 1 Exploratory||0
8695899|NCT02908685|21468549|P11|NOT COMPLETED|Part 1 Exploratory||0
8695900|NCT02908685|21468550|P10|NOT COMPLETED|Part 1 Exploratory||0
8695901|NCT02908685|21468551|P9|NOT COMPLETED|Part 1 Exploratory||0
8695902|NCT02908685|21468552|P8|NOT COMPLETED|Part 1 Exploratory||0
8695903|NCT02908685|21468553|P7|NOT COMPLETED|Part 1 Exploratory||0
8695904|NCT02908685|21468554|P6|NOT COMPLETED|Part 1 Exploratory||0
8695905|NCT02908685|21468555|P5|NOT COMPLETED|Part 1 Exploratory||0
8695906|NCT02908685|21468556|P4|NOT COMPLETED|Part 1 Exploratory||0
8695907|NCT02908685|21468557|P3|NOT COMPLETED|Part 1 Exploratory||0
8695908|NCT02908685|21468558|P2|NOT COMPLETED|Part 1 Exploratory||1
8695909|NCT02908685|21468559|P1|NOT COMPLETED|Part 1 Exploratory||0
8695910|NCT02908685|21468548|P12|COMPLETED|Part 1 Exploratory||0
8695911|NCT02908685|21468549|P11|COMPLETED|Part 1 Exploratory||0
8695912|NCT02908685|21468550|P10|COMPLETED|Part 1 Exploratory||3
8695913|NCT02908685|21468551|P9|COMPLETED|Part 1 Exploratory||4
8695914|NCT02908685|21468552|P8|COMPLETED|Part 1 Exploratory||3
8695915|NCT02908685|21468553|P7|COMPLETED|Part 1 Exploratory||7
8695916|NCT02908685|21468554|P6|COMPLETED|Part 1 Exploratory||7
8695917|NCT02908685|21468555|P5|COMPLETED|Part 1 Exploratory||7
8695918|NCT02908685|21468556|P4|COMPLETED|Part 1 Exploratory||3
8695919|NCT02908685|21468557|P3|COMPLETED|Part 1 Exploratory||3
8695920|NCT02908685|21468558|P2|COMPLETED|Part 1 Exploratory||6
8695921|NCT02908685|21468559|P1|COMPLETED|Part 1 Exploratory||7
8695922|NCT02908685|21468548|P12|STARTED|Part 1 Exploratory||0
8695923|NCT02908685|21468549|P11|STARTED|Part 1 Exploratory||0
8695924|NCT02908685|21468550|P10|STARTED|Part 1 Exploratory||3
8695925|NCT02908685|21468551|P9|STARTED|Part 1 Exploratory||4
8695926|NCT02908685|21468552|P8|STARTED|Part 1 Exploratory||3
8695927|NCT02908685|21468553|P7|STARTED|Part 1 Exploratory||7
8695928|NCT02908685|21468554|P6|STARTED|Part 1 Exploratory||7
8695929|NCT02908685|21468555|P5|STARTED|Part 1 Exploratory||7
8695930|NCT02908685|21468556|P4|STARTED|Part 1 Exploratory||3
8695931|NCT02908685|21468557|P3|STARTED|Part 1 Exploratory||3
8695932|NCT02908685|21468558|P2|STARTED|Part 1 Exploratory||7
8695933|NCT02908685|21468559|P1|STARTED|Part 1 Exploratory||7
8695934|NCT02780713|21468629|P5|NOT COMPLETED|Period 5: Variant B (300mg)||0
8695935|NCT02780713|21468630|P4|NOT COMPLETED|Period 5: Variant B (300mg)||0
8695936|NCT02780713|21468631|P3|NOT COMPLETED|Period 5: Variant B (300mg)||0
8695937|NCT02780713|21468632|P2|NOT COMPLETED|Period 5: Variant B (300mg)||0
8695938|NCT02780713|21468633|P1|NOT COMPLETED|Period 5: Variant B (300mg)||0
8695939|NCT02780713|21468629|P5|COMPLETED|Period 5: Variant B (300mg)||12
8695940|NCT02780713|21468630|P4|COMPLETED|Period 5: Variant B (300mg)||0
8695941|NCT02780713|21468631|P3|COMPLETED|Period 5: Variant B (300mg)||0
8695942|NCT02780713|21468632|P2|COMPLETED|Period 5: Variant B (300mg)||0
8695943|NCT02780713|21468633|P1|COMPLETED|Period 5: Variant B (300mg)||0
8695944|NCT02780713|21468629|P5|STARTED|Period 5: Variant B (300mg)||12
8695945|NCT02780713|21468630|P4|STARTED|Period 5: Variant B (300mg)||0
8695946|NCT02780713|21468631|P3|STARTED|Period 5: Variant B (300mg)||0
8695947|NCT02780713|21468632|P2|STARTED|Period 5: Variant B (300mg)||0
8695948|NCT02780713|21468633|P1|STARTED|Period 5: Variant B (300mg)||0
8695949|NCT02780713|21468629|P5|NOT COMPLETED|Period 4: Variant C (100mg)||0
8695950|NCT02780713|21468630|P4|NOT COMPLETED|Period 4: Variant C (100mg)||0
8695951|NCT02780713|21468631|P3|NOT COMPLETED|Period 4: Variant C (100mg)||0
8695952|NCT02780713|21468632|P2|NOT COMPLETED|Period 4: Variant C (100mg)||0
8695953|NCT02780713|21468633|P1|NOT COMPLETED|Period 4: Variant C (100mg)||0
8695954|NCT02780713|21468629|P5|COMPLETED|Period 4: Variant C (100mg)||0
8695955|NCT02780713|21468630|P4|COMPLETED|Period 4: Variant C (100mg)||12
8695956|NCT02780713|21468631|P3|COMPLETED|Period 4: Variant C (100mg)||0
8695957|NCT02780713|21468632|P2|COMPLETED|Period 4: Variant C (100mg)||0
8695958|NCT02780713|21468633|P1|COMPLETED|Period 4: Variant C (100mg)||0
8695959|NCT02780713|21468629|P5|STARTED|Period 4: Variant C (100mg)||0
8695960|NCT02780713|21468630|P4|STARTED|Period 4: Variant C (100mg)||12
8695961|NCT02780713|21468631|P3|STARTED|Period 4: Variant C (100mg)||0
8695962|NCT02780713|21468632|P2|STARTED|Period 4: Variant C (100mg)||0
8695963|NCT02780713|21468633|P1|STARTED|Period 4: Variant C (100mg)||0
8695964|NCT02780713|21468629|P5|NOT COMPLETED|Period 3: Variant B (100mg)||0
8695965|NCT02780713|21468630|P4|NOT COMPLETED|Period 3: Variant B (100mg)||0
8695966|NCT02780713|21468631|P3|NOT COMPLETED|Period 3: Variant B (100mg)||2
8695967|NCT02780713|21468632|P2|NOT COMPLETED|Period 3: Variant B (100mg)||0
8695968|NCT02780713|21468633|P1|NOT COMPLETED|Period 3: Variant B (100mg)||0
8695969|NCT02780713|21468629|P5|COMPLETED|Period 3: Variant B (100mg)||0
8695970|NCT02780713|21468630|P4|COMPLETED|Period 3: Variant B (100mg)||0
8695971|NCT02780713|21468631|P3|COMPLETED|Period 3: Variant B (100mg)||12
8695972|NCT02780713|21468632|P2|COMPLETED|Period 3: Variant B (100mg)||0
8695973|NCT02780713|21468633|P1|COMPLETED|Period 3: Variant B (100mg)||0
8695974|NCT02780713|21468629|P5|STARTED|Period 3: Variant B (100mg)||0
8695975|NCT02780713|21468630|P4|STARTED|Period 3: Variant B (100mg)||0
8695976|NCT02780713|21468631|P3|STARTED|Period 3: Variant B (100mg)||14
8695977|NCT02780713|21468632|P2|STARTED|Period 3: Variant B (100mg)||0
8695978|NCT02780713|21468633|P1|STARTED|Period 3: Variant B (100mg)||0
8695979|NCT02780713|21468629|P5|NOT COMPLETED|Period 2: Reference (100mg)||0
8695980|NCT02780713|21468630|P4|NOT COMPLETED|Period 2: Reference (100mg)||0
8695981|NCT02780713|21468631|P3|NOT COMPLETED|Period 2: Reference (100mg)||0
8695982|NCT02780713|21468632|P2|NOT COMPLETED|Period 2: Reference (100mg)||0
8695983|NCT02780713|21468633|P1|NOT COMPLETED|Period 2: Reference (100mg)||0
8695984|NCT02780713|21468629|P5|COMPLETED|Period 2: Reference (100mg)||0
8695985|NCT02780713|21468630|P4|COMPLETED|Period 2: Reference (100mg)||0
8695986|NCT02780713|21468631|P3|COMPLETED|Period 2: Reference (100mg)||0
8695987|NCT02780713|21468632|P2|COMPLETED|Period 2: Reference (100mg)||14
8695988|NCT02780713|21468633|P1|COMPLETED|Period 2: Reference (100mg)||0
8695989|NCT02780713|21468629|P5|STARTED|Period 2: Reference (100mg)||0
8695990|NCT02780713|21468630|P4|STARTED|Period 2: Reference (100mg)||0
8695991|NCT02780713|21468631|P3|STARTED|Period 2: Reference (100mg)||0
8695992|NCT02780713|21468632|P2|STARTED|Period 2: Reference (100mg)||14
8695993|NCT02780713|21468633|P1|STARTED|Period 2: Reference (100mg)||0
8695994|NCT02780713|21468629|P5|NOT COMPLETED|Period 1: Variant A (100mg)||0
8695995|NCT02780713|21468630|P4|NOT COMPLETED|Period 1: Variant A (100mg)||0
8695996|NCT02780713|21468631|P3|NOT COMPLETED|Period 1: Variant A (100mg)||0
8695997|NCT02780713|21468632|P2|NOT COMPLETED|Period 1: Variant A (100mg)||0
8695998|NCT02780713|21468633|P1|NOT COMPLETED|Period 1: Variant A (100mg)||0
8695999|NCT02780713|21468629|P5|COMPLETED|Period 1: Variant A (100mg)||0
8696000|NCT02780713|21468630|P4|COMPLETED|Period 1: Variant A (100mg)||0
8696001|NCT02780713|21468631|P3|COMPLETED|Period 1: Variant A (100mg)||0
8696002|NCT02780713|21468632|P2|COMPLETED|Period 1: Variant A (100mg)||0
8696003|NCT02780713|21468633|P1|COMPLETED|Period 1: Variant A (100mg)||14
8696004|NCT02780713|21468629|P5|STARTED|Period 1: Variant A (100mg)||0
8696005|NCT02780713|21468630|P4|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 5.|0
8696006|NCT02780713|21468631|P3|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 4.|0
8696007|NCT02780713|21468632|P2|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 3.|0
8696008|NCT02780713|21468633|P1|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 2.|14
8696009|NCT02553798|21468710|P1|NOT COMPLETED|Overall Study||338
8696010|NCT02553798|21468710|P1|COMPLETED|Overall Study||226
8696011|NCT02553798|21468710|P1|STARTED|Overall Study||564
8696012|NCT02530294|21468719|P2|NOT COMPLETED|Overall Study||6
8696013|NCT02530294|21468720|P1|NOT COMPLETED|Overall Study||16
8696014|NCT02530294|21468719|P2|COMPLETED|Overall Study||113
8696015|NCT02530294|21468720|P1|COMPLETED|Overall Study||218
8696016|NCT02530294|21468719|P2|STARTED|Overall Study||119
8696017|NCT02530294|21468720|P1|STARTED|Overall Study||234
8696018|NCT02530281|21468736|P2|NOT COMPLETED|Overall Study||3
8696019|NCT02530281|21468737|P1|NOT COMPLETED|Overall Study||21
8696020|NCT02530281|21468736|P2|COMPLETED|Overall Study||112
8696021|NCT02530281|21468737|P1|COMPLETED|Overall Study||208
8696022|NCT02530281|21468736|P2|STARTED|Overall Study||115
8696023|NCT02530281|21468737|P1|STARTED|Overall Study||229
8696024|NCT02427802|21468756|P3|NOT COMPLETED|Overall Study||43
8696025|NCT02427802|21468757|P2|NOT COMPLETED|Overall Study||34
8696026|NCT02427802|21468758|P1|NOT COMPLETED|Overall Study||59
8696027|NCT02427802|21468756|P3|COMPLETED|Overall Study||110
8696028|NCT02427802|21468757|P2|COMPLETED|Overall Study||120
8696029|NCT02427802|21468758|P1|COMPLETED|Overall Study||246
8696030|NCT02427802|21468756|P3|STARTED|Overall Study||153
8696031|NCT02427802|21468757|P2|STARTED|Overall Study||154
8696032|NCT02427802|21468758|P1|STARTED|Overall Study||305
8696033|NCT02370693|21468784|P2|NOT COMPLETED|Overall Study||1
8696034|NCT02370693|21468785|P1|NOT COMPLETED|Overall Study||1
8696035|NCT02370693|21468784|P2|COMPLETED|Overall Study||3
8696036|NCT02370693|21468785|P1|COMPLETED|Overall Study||2
8696037|NCT02370693|21468784|P2|STARTED|Overall Study||4
8696038|NCT02370693|21468785|P1|STARTED|Overall Study||3
8696039|NCT02340221|21468797|P2|NOT COMPLETED|Overall Study||417
8696040|NCT02340221|21468798|P1|NOT COMPLETED|Overall Study||214
8696041|NCT02340221|21468797|P2|COMPLETED|Overall Study||0
8696042|NCT02340221|21468798|P1|COMPLETED|Overall Study||0
8696043|NCT02340221|21468797|P2|STARTED|Overall Study||417
8696044|NCT02340221|21468798|P1|STARTED|Overall Study||214
8696045|NCT02294630|21468826|P4|NOT COMPLETED|Overall Study||0
8696046|NCT02294630|21468827|P3|NOT COMPLETED|Overall Study||0
8696047|NCT02294630|21468828|P2|NOT COMPLETED|Overall Study||0
8696048|NCT02294630|21468829|P1|NOT COMPLETED|Overall Study||0
8696049|NCT02294630|21468826|P4|COMPLETED|Overall Study||39
8696050|NCT02294630|21468827|P3|COMPLETED|Overall Study||35
8696051|NCT02294630|21468828|P2|COMPLETED|Overall Study||38
8696052|NCT02294630|21468829|P1|COMPLETED|Overall Study||37
8696053|NCT02294630|21468826|P4|STARTED|Overall Study||39
8696054|NCT02294630|21468827|P3|STARTED|Overall Study||35
8696055|NCT02294630|21468828|P2|STARTED|Overall Study||38
8696056|NCT02294630|21468829|P1|STARTED|Overall Study||37
8696057|NCT02249091|21468921|P2|NOT COMPLETED|Overall Study||13
8696058|NCT02249091|21468922|P1|NOT COMPLETED|Overall Study||20
8696059|NCT02249091|21468921|P2|COMPLETED|Overall Study||2
8696060|NCT02249091|21468922|P1|COMPLETED|Overall Study||7
8696061|NCT02249091|21468921|P2|STARTED|Overall Study||15
8696062|NCT02249091|21468922|P1|STARTED|Overall Study||27
8696063|NCT02129660|21468947|P5|NOT COMPLETED|Overall Study||2
8696064|NCT02129660|21468948|P4|NOT COMPLETED|Overall Study||0
8696065|NCT02129660|21468949|P3|NOT COMPLETED|Overall Study||1
8696066|NCT02129660|21468950|P2|NOT COMPLETED|Overall Study||0
8696067|NCT02129660|21468951|P1|NOT COMPLETED|Overall Study||2
8696068|NCT02129660|21468947|P5|COMPLETED|Overall Study||20
8696069|NCT02129660|21468948|P4|COMPLETED|Overall Study||20
8696070|NCT02129660|21468949|P3|COMPLETED|Overall Study||21
8696071|NCT02129660|21468950|P2|COMPLETED|Overall Study||20
8696072|NCT02129660|21468951|P1|COMPLETED|Overall Study||19
8696073|NCT02129660|21468947|P5|STARTED|Overall Study||22
8696074|NCT02129660|21468948|P4|STARTED|Overall Study||20
8696075|NCT02129660|21468949|P3|STARTED|Overall Study||22
8696076|NCT02129660|21468950|P2|STARTED|Overall Study||20
8696077|NCT02129660|21468951|P1|STARTED|Overall Study||21
8696078|NCT02016885|21468998|P5|NOT COMPLETED|Overall Study||1
8696079|NCT02016885|21468999|P4|NOT COMPLETED|Overall Study||10
8696080|NCT02016885|21469000|P3|NOT COMPLETED|Overall Study||1
8696081|NCT02016885|21469001|P2|NOT COMPLETED|Overall Study||4
8696082|NCT02016885|21469002|P1|NOT COMPLETED|Overall Study||4
8696083|NCT02016885|21468998|P5|COMPLETED|Overall Study||39
8696084|NCT02016885|21468999|P4|COMPLETED|Overall Study||30
8696085|NCT02016885|21469000|P3|COMPLETED|Overall Study||39
8696086|NCT02016885|21469001|P2|COMPLETED|Overall Study||36
8696087|NCT02016885|21469002|P1|COMPLETED|Overall Study||34
8696088|NCT02016885|21468998|P5|STARTED|Overall Study||40
8696089|NCT02016885|21468999|P4|STARTED|Overall Study||40
8696090|NCT02016885|21469000|P3|STARTED|Overall Study||40
8696091|NCT02016885|21469001|P2|STARTED|Overall Study||40
8696092|NCT02016885|21469002|P1|STARTED|Overall Study||38
8696093|NCT01885000|21469041|P2|NOT COMPLETED|Overall Study||2
8696094|NCT01885000|21469042|P1|NOT COMPLETED|Overall Study||2
8696095|NCT01885000|21469041|P2|COMPLETED|Overall Study||42
8696096|NCT01885000|21469042|P1|COMPLETED|Overall Study||46
8696097|NCT01885000|21469041|P2|STARTED|Overall Study||44
8696098|NCT01885000|21469042|P1|STARTED|Overall Study||48
8696099|NCT01802632|21469070|P6|NOT COMPLETED|Overall Study||28
8696100|NCT01802632|21469071|P5|NOT COMPLETED|Overall Study||12
8696101|NCT01802632|21469072|P4|NOT COMPLETED|Overall Study||60
8696102|NCT01802632|21469073|P3|NOT COMPLETED|Overall Study||271
8696103|NCT01802632|21469074|P2|NOT COMPLETED|Overall Study||31
8696104|NCT01802632|21469075|P1|NOT COMPLETED|Overall Study||201
8696105|NCT01802632|21469070|P6|COMPLETED|Overall Study||0
8696106|NCT01802632|21469071|P5|COMPLETED|Overall Study||0
8696107|NCT01802632|21469072|P4|COMPLETED|Overall Study||0
8696108|NCT01802632|21469073|P3|COMPLETED|Overall Study||0
8696109|NCT01802632|21469074|P2|COMPLETED|Overall Study||0
8696110|NCT01802632|21469075|P1|COMPLETED|Overall Study||0
8696111|NCT01802632|21469070|P6|STARTED|Overall Study||28
8696112|NCT01802632|21469071|P5|STARTED|Overall Study||12
8696113|NCT01802632|21469072|P4|STARTED|Overall Study||60
8696114|NCT01802632|21469073|P3|STARTED|Overall Study||271
8696115|NCT01802632|21469074|P2|STARTED|Overall Study||31
8696116|NCT01802632|21469075|P1|STARTED|Overall Study||201
8696117|NCT01709747|21469089|P1|NOT COMPLETED|Overall Study||77
8696118|NCT01709747|21469089|P1|COMPLETED|Overall Study||287
8696119|NCT01709747|21469089|P1|STARTED|Overall Study||364
8696120|NCT01110876|21469098|P2|NOT COMPLETED|Overall Study||0
8696121|NCT01110876|21469099|P1|NOT COMPLETED|Overall Study||0
8696122|NCT01110876|21469098|P2|COMPLETED|Overall Study||5
8696123|NCT01110876|21469099|P1|COMPLETED|Overall Study||13
8696124|NCT01110876|21469098|P2|STARTED|Overall Study||5
8696125|NCT01110876|21469099|P1|STARTED|Overall Study|One received 400 mg Erlotinib dose as result of enzyme inducing anticonvulsants (EIACs)|13
8696126|NCT01053637|21469109|P2|NOT COMPLETED|Overall Study||0
8696127|NCT01053637|21469110|P1|NOT COMPLETED|Overall Study||0
8696128|NCT01053637|21469109|P2|COMPLETED|Overall Study|4 incomplete pain scores 4 proceeded to procedural sedation|42
8696129|NCT01053637|21469110|P1|COMPLETED|Overall Study|2 with incomplete pain scores|43
8696130|NCT01053637|21469109|P2|STARTED|Overall Study||42
8696131|NCT01053637|21469110|P1|STARTED|Overall Study||43
8696132|NCT00052442|21469125|P5|NOT COMPLETED|Overall Study||0
8696133|NCT00052442|21469126|P4|NOT COMPLETED|Overall Study||0
8696134|NCT00052442|21469127|P3|NOT COMPLETED|Overall Study||0
8696135|NCT00052442|21469128|P2|NOT COMPLETED|Overall Study||0
8696136|NCT00052442|21469129|P1|NOT COMPLETED|Overall Study||0
8696137|NCT00052442|21469125|P5|COMPLETED|Overall Study||15
8696138|NCT00052442|21469126|P4|COMPLETED|Overall Study||11
8696139|NCT00052442|21469127|P3|COMPLETED|Overall Study||27
8696140|NCT00052442|21469128|P2|COMPLETED|Overall Study||3
8696141|NCT00052442|21469129|P1|COMPLETED|Overall Study||16
8696142|NCT00052442|21469125|P5|STARTED|Overall Study||15
8696143|NCT00052442|21469126|P4|STARTED|Overall Study||11
8696144|NCT00052442|21469127|P3|STARTED|Overall Study||27
8696145|NCT00052442|21469128|P2|STARTED|Overall Study||3
8696146|NCT00052442|21469129|P1|STARTED|Overall Study||16
8696147|NCT04296448|21469148|P2|NOT COMPLETED|Overall Study||0
8696148|NCT04296448|21469149|P1|NOT COMPLETED|Overall Study||0
8696149|NCT04296448|21469148|P2|COMPLETED|Overall Study||99
8696150|NCT04296448|21469149|P1|COMPLETED|Overall Study||98
8696151|NCT04296448|21469148|P2|STARTED|Overall Study||99
8696152|NCT04296448|21469149|P1|STARTED|Overall Study||98
8696153|NCT04206293|21469161|P1|NOT COMPLETED|Overall Study||1
8696154|NCT04206293|21469161|P1|COMPLETED|Overall Study||10
8696155|NCT04206293|21469161|P1|STARTED|Overall Study||11
8696156|NCT04010695|21469204|P1|NOT COMPLETED|Overall Study||0
8696157|NCT04010695|21469204|P1|COMPLETED|Overall Study||250
8696158|NCT04010695|21469204|P1|STARTED|Overall Study||250
8696159|NCT03903159|21469214|P1|NOT COMPLETED|Overall Study||5
8696160|NCT03903159|21469214|P1|COMPLETED|Overall Study||10
8696161|NCT03903159|21469214|P1|STARTED|Overall Study||15
8696162|NCT03760913|21469240|P19|NOT COMPLETED|Overall Study||0
8696163|NCT03760913|21469241|P18|NOT COMPLETED|Overall Study||0
8696164|NCT03760913|21469242|P17|NOT COMPLETED|Overall Study||0
8696165|NCT03760913|21469243|P16|NOT COMPLETED|Overall Study||0
8696166|NCT03760913|21469244|P15|NOT COMPLETED|Overall Study||0
8696167|NCT03760913|21469245|P14|NOT COMPLETED|Overall Study||0
8696168|NCT03760913|21469246|P13|NOT COMPLETED|Overall Study||0
8696169|NCT03760913|21469247|P12|NOT COMPLETED|Overall Study||0
8696170|NCT03760913|21469248|P11|NOT COMPLETED|Overall Study||0
8696171|NCT03760913|21469249|P10|NOT COMPLETED|Overall Study||0
8696172|NCT03760913|21469250|P9|NOT COMPLETED|Overall Study||0
8696173|NCT03760913|21469251|P8|NOT COMPLETED|Overall Study||0
8696174|NCT03760913|21469252|P7|NOT COMPLETED|Overall Study||0
8696175|NCT03760913|21469253|P6|NOT COMPLETED|Overall Study||0
8696176|NCT03760913|21469254|P5|NOT COMPLETED|Overall Study||0
8696177|NCT03760913|21469255|P4|NOT COMPLETED|Overall Study||0
8696178|NCT03760913|21469256|P3|NOT COMPLETED|Overall Study||0
8696179|NCT03760913|21469257|P2|NOT COMPLETED|Overall Study||0
8696180|NCT03760913|21469258|P1|NOT COMPLETED|Overall Study||0
8696181|NCT03760913|21469240|P19|COMPLETED|Overall Study||6
8696182|NCT03760913|21469241|P18|COMPLETED|Overall Study||6
8696183|NCT03760913|21469242|P17|COMPLETED|Overall Study||6
8696184|NCT03760913|21469243|P16|COMPLETED|Overall Study||6
8696185|NCT03760913|21469244|P15|COMPLETED|Overall Study||6
8696186|NCT03760913|21469245|P14|COMPLETED|Overall Study||6
8696187|NCT03760913|21469246|P13|COMPLETED|Overall Study||12
8696188|NCT03760913|21469247|P12|COMPLETED|Overall Study||6
8696189|NCT03760913|21469248|P11|COMPLETED|Overall Study||6
8696190|NCT03760913|21469249|P10|COMPLETED|Overall Study||6
8696191|NCT03760913|21469250|P9|COMPLETED|Overall Study||3
8696192|NCT03760913|21469251|P8|COMPLETED|Overall Study||3
8696193|NCT03760913|21469252|P7|COMPLETED|Overall Study||6
8696194|NCT03760913|21469253|P6|COMPLETED|Overall Study||3
8696195|NCT03760913|21469254|P5|COMPLETED|Overall Study||6
8696196|NCT03760913|21469255|P4|COMPLETED|Overall Study||3
8696197|NCT03760913|21469256|P3|COMPLETED|Overall Study||6
8696198|NCT03760913|21469257|P2|COMPLETED|Overall Study||3
8696199|NCT03760913|21469258|P1|COMPLETED|Overall Study||17
8696200|NCT03760913|21469240|P19|STARTED|Overall Study||6
8696201|NCT03760913|21469241|P18|STARTED|Overall Study||6
8696202|NCT03760913|21469242|P17|STARTED|Overall Study||6
8696203|NCT03760913|21469243|P16|STARTED|Overall Study||6
8696204|NCT03760913|21469244|P15|STARTED|Overall Study||6
8696205|NCT03760913|21469245|P14|STARTED|Overall Study||6
8696206|NCT03760913|21469246|P13|STARTED|Overall Study||12
8696207|NCT03760913|21469247|P12|STARTED|Overall Study||6
8696208|NCT03760913|21469248|P11|STARTED|Overall Study||6
8696209|NCT03760913|21469249|P10|STARTED|Overall Study||6
8696210|NCT03760913|21469250|P9|STARTED|Overall Study||3
8696211|NCT03760913|21469251|P8|STARTED|Overall Study||3
8696212|NCT03760913|21469252|P7|STARTED|Overall Study||6
8696213|NCT03760913|21469253|P6|STARTED|Overall Study||3
8696214|NCT03760913|21469254|P5|STARTED|Overall Study||6
8696215|NCT03760913|21469255|P4|STARTED|Overall Study||3
8696216|NCT03760913|21469256|P3|STARTED|Overall Study||6
8696217|NCT03760913|21469257|P2|STARTED|Overall Study||3
8696218|NCT03760913|21469258|P1|STARTED|Overall Study||17
8696219|NCT03589885|21469445|P5|NOT COMPLETED|Treatment Period 2-Randomized Set||1
8696220|NCT03589885|21469446|P4|NOT COMPLETED|Treatment Period 2-Randomized Set||0
8696221|NCT03589885|21469447|P3|NOT COMPLETED|Treatment Period 2-Randomized Set||1
8696222|NCT03589885|21469448|P2|NOT COMPLETED|Treatment Period 2-Randomized Set||5
8696223|NCT03589885|21469449|P1|NOT COMPLETED|Treatment Period 2-Randomized Set||1
8696224|NCT03589885|21469445|P5|COMPLETED|Treatment Period 2-Randomized Set||16
8696225|NCT03589885|21469446|P4|COMPLETED|Treatment Period 2-Randomized Set||16
8696226|NCT03589885|21469447|P3|COMPLETED|Treatment Period 2-Randomized Set||3
8696227|NCT03589885|21469448|P2|COMPLETED|Treatment Period 2-Randomized Set||34
8696228|NCT03589885|21469449|P1|COMPLETED|Treatment Period 2-Randomized Set||40
8696229|NCT03589885|21469445|P5|STARTED|Treatment Period 2-Randomized Set||17
8696230|NCT03589885|21469446|P4|STARTED|Treatment Period 2-Randomized Set||16
8696231|NCT03589885|21469447|P3|STARTED|Treatment Period 2-Randomized Set||4
8696232|NCT03589885|21469448|P2|STARTED|Treatment Period 2-Randomized Set||39
8696233|NCT03589885|21469449|P1|STARTED|Treatment Period 2-Randomized Set||41
8696234|NCT03589885|21469445|P5|NOT COMPLETED|Treatment Period 1-Randomized Set||0
8696235|NCT03589885|21469446|P4|NOT COMPLETED|Treatment Period 1-Randomized Set||0
8696236|NCT03589885|21469447|P3|NOT COMPLETED|Treatment Period 1-Randomized Set||3
8696237|NCT03589885|21469448|P2|NOT COMPLETED|Treatment Period 1-Randomized Set||2
8696238|NCT03589885|21469449|P1|NOT COMPLETED|Treatment Period 1-Randomized Set||0
8696239|NCT03589885|21469445|P5|COMPLETED|Treatment Period 1-Randomized Set||0
8696240|NCT03589885|21469446|P4|COMPLETED|Treatment Period 1-Randomized Set||0
8696241|NCT03589885|21469447|P3|COMPLETED|Treatment Period 1-Randomized Set||37
8696242|NCT03589885|21469448|P2|COMPLETED|Treatment Period 1-Randomized Set||39
8696243|NCT03589885|21469449|P1|COMPLETED|Treatment Period 1-Randomized Set||41
8696244|NCT03589885|21469445|P5|STARTED|Treatment Period 1-Randomized Set||0
8696245|NCT03589885|21469446|P4|STARTED|Treatment Period 1-Randomized Set||0
8696246|NCT03589885|21469447|P3|STARTED|Treatment Period 1-Randomized Set||40
8696247|NCT03589885|21469448|P2|STARTED|Treatment Period 1-Randomized Set||41
8696248|NCT03589885|21469449|P1|STARTED|Treatment Period 1-Randomized Set||41
8696249|NCT03572062|21469487|P10|NOT COMPLETED|Overall Study||31
8696250|NCT03572062|21469488|P9|NOT COMPLETED|Overall Study||32
8696251|NCT03572062|21469489|P8|NOT COMPLETED|Overall Study||1
8696252|NCT03572062|21469490|P7|NOT COMPLETED|Overall Study||1
8696253|NCT03572062|21469491|P6|NOT COMPLETED|Overall Study||4
8696254|NCT03572062|21469492|P5|NOT COMPLETED|Overall Study||1
8696255|NCT03572062|21469493|P4|NOT COMPLETED|Overall Study||0
8696256|NCT03572062|21469494|P3|NOT COMPLETED|Overall Study||0
8696257|NCT03572062|21469495|P2|NOT COMPLETED|Overall Study||0
8696258|NCT03572062|21469496|P1|NOT COMPLETED|Overall Study||0
8696259|NCT03572062|21469487|P10|COMPLETED|Overall Study||0
8696260|NCT03572062|21469488|P9|COMPLETED|Overall Study||0
8696261|NCT03572062|21469489|P8|COMPLETED|Overall Study||30
8696262|NCT03572062|21469490|P7|COMPLETED|Overall Study||31
8696263|NCT03572062|21469491|P6|COMPLETED|Overall Study||28
8696264|NCT03572062|21469492|P5|COMPLETED|Overall Study||31
8696265|NCT03572062|21469493|P4|COMPLETED|Overall Study||31
8696266|NCT03572062|21469494|P3|COMPLETED|Overall Study||32
8696267|NCT03572062|21469495|P2|COMPLETED|Overall Study||32
8696268|NCT03572062|21469496|P1|COMPLETED|Overall Study||32
8696269|NCT03572062|21469487|P10|Treated|Overall Study||31
8696270|NCT03572062|21469488|P9|Treated|Overall Study||32
8696271|NCT03572062|21469489|P8|Treated|Overall Study||30
8696272|NCT03572062|21469490|P7|Treated|Overall Study||32
8696273|NCT03572062|21469491|P6|Treated|Overall Study||30
8696274|NCT03572062|21469492|P5|Treated|Overall Study||31
8696275|NCT03572062|21469493|P4|Treated|Overall Study||31
8696276|NCT03572062|21469494|P3|Treated|Overall Study||32
8696277|NCT03572062|21469495|P2|Treated|Overall Study||32
8696278|NCT03572062|21469496|P1|Treated|Overall Study||32
8696279|NCT03572062|21469487|P10|STARTED|Overall Study||31
8696280|NCT03572062|21469488|P9|STARTED|Overall Study||32
8696281|NCT03572062|21469489|P8|STARTED|Overall Study||31
8696282|NCT03572062|21469490|P7|STARTED|Overall Study||32
8696283|NCT03572062|21469491|P6|STARTED|Overall Study||32
8696284|NCT03572062|21469492|P5|STARTED|Overall Study||32
8696285|NCT03572062|21469493|P4|STARTED|Overall Study||31
8696286|NCT03572062|21469494|P3|STARTED|Overall Study||32
8696287|NCT03572062|21469495|P2|STARTED|Overall Study||32
8696288|NCT03572062|21469496|P1|STARTED|Overall Study||32
8696289|NCT03563716|21469558|P2|NOT COMPLETED|Overall Study||67
8696290|NCT03563716|21469559|P1|NOT COMPLETED|Overall Study||68
8696291|NCT03563716|21469558|P2|COMPLETED|Overall Study|"One participant who died had as reason for discontinuation Withdrawal by Subject"|0
8696292|NCT03563716|21469559|P1|COMPLETED|Overall Study||0
8696293|NCT03563716|21469558|P2|STARTED|Overall Study||67
8696294|NCT03563716|21469559|P1|STARTED|Overall Study||68
8696295|NCT03485495|21469569|P2|NOT COMPLETED|Overall Study||0
8696296|NCT03485495|21469570|P1|NOT COMPLETED|Overall Study||1
8696297|NCT03485495|21469569|P2|COMPLETED|Overall Study||59
8696298|NCT03485495|21469570|P1|COMPLETED|Overall Study||64
8696299|NCT03485495|21469569|P2|STARTED|Overall Study||59
8696300|NCT03485495|21469570|P1|STARTED|Overall Study||65
8696301|NCT03194646|21469590|P4|NOT COMPLETED|Overall Study||280
8696302|NCT03194646|21469591|P3|NOT COMPLETED|Overall Study||139
8696303|NCT03194646|21469592|P2|NOT COMPLETED|Overall Study||268
8696304|NCT03194646|21469593|P1|NOT COMPLETED|Overall Study||302
8696305|NCT03194646|21469590|P4|COMPLETED|Overall Study||85
8696306|NCT03194646|21469591|P3|COMPLETED|Overall Study||44
8696307|NCT03194646|21469592|P2|COMPLETED|Overall Study||93
8696308|NCT03194646|21469593|P1|COMPLETED|Overall Study||61
8696309|NCT03194646|21469590|P4|Treated|Overall Study||365
8696310|NCT03194646|21469591|P3|Treated|Overall Study||177
8696311|NCT03194646|21469592|P2|Treated|Overall Study||347
8696312|NCT03194646|21469593|P1|Treated|Overall Study||349
8696313|NCT03194646|21469590|P4|STARTED|Overall Study||365
8696314|NCT03194646|21469591|P3|STARTED|Overall Study||183
8696315|NCT03194646|21469592|P2|STARTED|Overall Study||361
8696316|NCT03194646|21469593|P1|STARTED|Overall Study||363
8696317|NCT03150056|21469629|P6|NOT COMPLETED|Overall Study||18
8696318|NCT03150056|21469630|P5|NOT COMPLETED|Overall Study||16
8696319|NCT03150056|21469631|P4|NOT COMPLETED|Overall Study||9
8696320|NCT03150056|21469632|P3|NOT COMPLETED|Overall Study||4
8696321|NCT03150056|21469633|P2|NOT COMPLETED|Overall Study||5
8696322|NCT03150056|21469634|P1|NOT COMPLETED|Overall Study||10
8696323|NCT03150056|21469629|P6|COMPLETED|Overall Study||3
8696324|NCT03150056|21469630|P5|COMPLETED|Overall Study||6
8696325|NCT03150056|21469631|P4|COMPLETED|Overall Study||1
8696326|NCT03150056|21469632|P3|COMPLETED|Overall Study||0
8696327|NCT03150056|21469633|P2|COMPLETED|Overall Study||1
8696328|NCT03150056|21469634|P1|COMPLETED|Overall Study||0
8696329|NCT03150056|21469629|P6|STARTED|Overall Study||21
8696330|NCT03150056|21469630|P5|STARTED|Overall Study||22
8696331|NCT03150056|21469631|P4|STARTED|Overall Study||10
8696332|NCT03150056|21469632|P3|STARTED|Overall Study||4
8696333|NCT03150056|21469633|P2|STARTED|Overall Study||6
8696334|NCT03150056|21469634|P1|STARTED|Overall Study||10
8696335|NCT03144804|21469774|P1|NOT COMPLETED|Overall Study||4
8696336|NCT03144804|21469774|P1|COMPLETED|Overall Study||32
8696337|NCT03144804|21469774|P1|STARTED|Overall Study||36
8696338|NCT03085095|21469781|P2|NOT COMPLETED|Overall Study||34
8696339|NCT03085095|21469782|P1|NOT COMPLETED|Overall Study||61
8696340|NCT03085095|21469781|P2|COMPLETED|Overall Study||276
8696341|NCT03085095|21469782|P1|COMPLETED|Overall Study||563
8696342|NCT03085095|21469781|P2|Received at Least 1 Dose of Study Drug|Overall Study||308
8696343|NCT03085095|21469782|P1|Received at Least 1 Dose of Study Drug|Overall Study||622
8696344|NCT03085095|21469781|P2|STARTED|Overall Study||310
8696345|NCT03085095|21469782|P1|STARTED|Overall Study||624
8696346|NCT03084315|21469842|P2|NOT COMPLETED|Overall Study||9
8696347|NCT03084315|21469843|P1|NOT COMPLETED|Overall Study||10
8696348|NCT03084315|21469842|P2|COMPLETED|Overall Study||109
8696349|NCT03084315|21469843|P1|COMPLETED|Overall Study||106
8696350|NCT03084315|21469842|P2|STARTED|Overall Study||118
8696351|NCT03084315|21469843|P1|STARTED|Overall Study||116
8696352|NCT02836249|21469855|P2|NOT COMPLETED|Overall Study||58
8696353|NCT02836249|21469856|P1|NOT COMPLETED|Overall Study||123
8696354|NCT02836249|21469855|P2|COMPLETED|Overall Study||0
8696355|NCT02836249|21469856|P1|COMPLETED|Overall Study||0
8696356|NCT02836249|21469855|P2|STARTED|Overall Study||58
8696357|NCT02836249|21469856|P1|STARTED|Overall Study||123
8696358|NCT02797171|21469878|P6|NOT COMPLETED|Overall Study||1
8696359|NCT02797171|21469879|P5|NOT COMPLETED|Overall Study||2
8696360|NCT02797171|21469880|P4|NOT COMPLETED|Overall Study||1
8696361|NCT02797171|21469881|P3|NOT COMPLETED|Overall Study||2
8696362|NCT02797171|21469882|P2|NOT COMPLETED|Overall Study||2
8696363|NCT02797171|21469883|P1|NOT COMPLETED|Overall Study||4
8696364|NCT02797171|21469878|P6|COMPLETED|Overall Study||0
8696365|NCT02797171|21469879|P5|COMPLETED|Overall Study||8
8696366|NCT02797171|21469880|P4|COMPLETED|Overall Study||15
8696367|NCT02797171|21469881|P3|COMPLETED|Overall Study||5
8696368|NCT02797171|21469882|P2|COMPLETED|Overall Study||21
8696369|NCT02797171|21469883|P1|COMPLETED|Overall Study||19
8696370|NCT02797171|21469878|P6|Safety Population|Overall Study||1
8696371|NCT02797171|21469879|P5|Safety Population|Overall Study||10
8696372|NCT02797171|21469880|P4|Safety Population|Overall Study||16
8696373|NCT02797171|21469881|P3|Safety Population|Overall Study||7
8696374|NCT02797171|21469882|P2|Safety Population|Overall Study||23
8696375|NCT02797171|21469883|P1|Safety Population|Overall Study||23
8696376|NCT02797171|21469878|P6|STARTED|Overall Study||1
8696377|NCT02797171|21469879|P5|STARTED|Overall Study||10
8696378|NCT02797171|21469880|P4|STARTED|Overall Study||16
8696379|NCT02797171|21469881|P3|STARTED|Overall Study||7
8696380|NCT02797171|21469882|P2|STARTED|Overall Study||23
8696381|NCT02797171|21469883|P1|STARTED|Overall Study||23
8696382|NCT02658175|21469948|P3|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
8696383|NCT02658175|21469949|P2|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
8696384|NCT02658175|21469950|P1|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
8696385|NCT02658175|21469948|P3|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
8696386|NCT02658175|21469949|P2|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
8696387|NCT02658175|21469950|P1|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
8696388|NCT02658175|21469948|P3|STARTED|2nd Extended Treatment: Weeks 105 to156||1
8696389|NCT02658175|21469949|P2|STARTED|2nd Extended Treatment: Weeks 105 to156||0
8696390|NCT02658175|21469950|P1|STARTED|2nd Extended Treatment: Weeks 105 to156||1
8696391|NCT02658175|21469948|P3|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
8696392|NCT02658175|21469949|P2|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
8696393|NCT02658175|21469950|P1|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||21
8696394|NCT02658175|21469948|P3|COMPLETED|1st Extended Treatment: Weeks 53 to 104||1
8696395|NCT02658175|21469949|P2|COMPLETED|1st Extended Treatment: Weeks 53 to 104||5
8696396|NCT02658175|21469950|P1|COMPLETED|1st Extended Treatment: Weeks 53 to 104||15
8696397|NCT02658175|21469948|P3|STARTED|1st Extended Treatment: Weeks 53 to 104||3
8696398|NCT02658175|21469949|P2|STARTED|1st Extended Treatment: Weeks 53 to 104||7
8696399|NCT02658175|21469950|P1|STARTED|1st Extended Treatment: Weeks 53 to 104||36
8696400|NCT02658175|21469948|P3|NOT COMPLETED|Treatment Period: Weeks 1 to 52||0
8696401|NCT02658175|21469949|P2|NOT COMPLETED|Treatment Period: Weeks 1 to 52||7
8696402|NCT02658175|21469950|P1|NOT COMPLETED|Treatment Period: Weeks 1 to 52||15
8696403|NCT02658175|21469948|P3|COMPLETED|Treatment Period: Weeks 1 to 52||3
8696404|NCT02658175|21469949|P2|COMPLETED|Treatment Period: Weeks 1 to 52||7
8696405|NCT02658175|21469950|P1|COMPLETED|Treatment Period: Weeks 1 to 52||36
8696406|NCT02658175|21469948|P3|STARTED|Treatment Period: Weeks 1 to 52||3
8696407|NCT02658175|21469949|P2|STARTED|Treatment Period: Weeks 1 to 52||14
8696408|NCT02658175|21469950|P1|STARTED|Treatment Period: Weeks 1 to 52||51
8696409|NCT02314117|21469963|P2|NOT COMPLETED|Overall Study||16
8696410|NCT02314117|21469964|P1|NOT COMPLETED|Overall Study||12
8696411|NCT02314117|21469963|P2|COMPLETED|Overall Study||303
8696412|NCT02314117|21469964|P1|COMPLETED|Overall Study||314
8696413|NCT02314117|21469963|P2|Received at Least One Dose of Study Drug|Overall Study||315
8696414|NCT02314117|21469964|P1|Received at Least One Dose of Study Drug|Overall Study||323
8696415|NCT02314117|21469963|P2|STARTED|Overall Study||319
8696416|NCT02314117|21469964|P1|STARTED|Overall Study||326
8696417|NCT02067975|21469994|P6|NOT COMPLETED|Overall Study||8
8696418|NCT02067975|21469995|P5|NOT COMPLETED|Overall Study||8
8696419|NCT02067975|21469996|P4|NOT COMPLETED|Overall Study||4
8696420|NCT02067975|21469997|P3|NOT COMPLETED|Overall Study||2
8696421|NCT02067975|21469998|P2|NOT COMPLETED|Overall Study||2
8696422|NCT02067975|21469999|P1|NOT COMPLETED|Overall Study||4
8696423|NCT02067975|21469994|P6|COMPLETED|Overall Study||0
8696424|NCT02067975|21469995|P5|COMPLETED|Overall Study||0
8696425|NCT02067975|21469996|P4|COMPLETED|Overall Study||14
8696426|NCT02067975|21469997|P3|COMPLETED|Overall Study||19
8696427|NCT02067975|21469998|P2|COMPLETED|Overall Study||16
8696428|NCT02067975|21469999|P1|COMPLETED|Overall Study||16
8696429|NCT02067975|21469994|P6|STARTED|Overall Study||8
8696430|NCT02067975|21469995|P5|STARTED|Overall Study||8
8696431|NCT02067975|21469996|P4|STARTED|Overall Study||18
8696432|NCT02067975|21469997|P3|STARTED|Overall Study||21
8696433|NCT02067975|21469998|P2|STARTED|Overall Study||18
8696434|NCT02067975|21469999|P1|STARTED|Overall Study||20
8696435|NCT01940471|21470013|P2|NOT COMPLETED|Open-Label Extension||8
8696436|NCT01940471|21470014|P1|NOT COMPLETED|Open-Label Extension||14
8696437|NCT01940471|21470013|P2|COMPLETED|Open-Label Extension||0
8696438|NCT01940471|21470014|P1|COMPLETED|Open-Label Extension||0
8696439|NCT01940471|21470013|P2|STARTED|Open-Label Extension||8
8696440|NCT01940471|21470014|P1|STARTED|Open-Label Extension||14
8696441|NCT01940471|21470013|P2|NOT COMPLETED|Double-Blind Phase||285
8696442|NCT01940471|21470014|P1|NOT COMPLETED|Double-Blind Phase||568
8696443|NCT01940471|21470013|P2|COMPLETED|Double-Blind Phase||8
8696444|NCT01940471|21470014|P1|COMPLETED|Double-Blind Phase||14
8696445|NCT01940471|21470013|P2|STARTED|Double-Blind Phase||293
8696446|NCT01940471|21470014|P1|STARTED|Double-Blind Phase||582
8696465|NCT01856192|21470070|P2|NOT COMPLETED|Overall Study||60
8696466|NCT01856192|21470071|P1|NOT COMPLETED|Overall Study||49
8696467|NCT01856192|21470070|P2|COMPLETED|Overall Study||116
8696468|NCT01856192|21470071|P1|COMPLETED|Overall Study||124
8696469|NCT01856192|21470070|P2|Evaluable Patients (Eligible and Treated)|Overall Study||135
8696470|NCT01856192|21470071|P1|Evaluable Patients (Eligible and Treated)|Overall Study||145
8696471|NCT01856192|21470070|P2|Treated Patients|Overall Study||171
8696472|NCT01856192|21470071|P1|Treated Patients|Overall Study||166
8696473|NCT01856192|21470070|P2|STARTED|Overall Study||176
8696474|NCT01856192|21470071|P1|STARTED|Overall Study||173
8696475|NCT01570829|21470085|P2|NOT COMPLETED|Overall Study||0
8696476|NCT01570829|21470086|P1|NOT COMPLETED|Overall Study||0
8696477|NCT01570829|21470085|P2|COMPLETED|Overall Study||167
8696478|NCT01570829|21470086|P1|COMPLETED|Overall Study||164
8696479|NCT01570829|21470085|P2|STARTED|Overall Study||167
8696480|NCT01570829|21470086|P1|STARTED|Overall Study||164
8696481|NCT01552369|21470108|P2|NOT COMPLETED|Overall Study||9
8696482|NCT01552369|21470109|P1|NOT COMPLETED|Overall Study||8
8696483|NCT01552369|21470108|P2|COMPLETED|Overall Study||96
8696484|NCT01552369|21470109|P1|COMPLETED|Overall Study||92
8696485|NCT01552369|21470108|P2|Final Follow up|Overall Study||96
8696486|NCT01552369|21470109|P1|Final Follow up|Overall Study||92
8696487|NCT01552369|21470108|P2|One Year|Overall Study||105
8696488|NCT01552369|21470109|P1|One Year|Overall Study||100
8696489|NCT01552369|21470108|P2|STARTED|Overall Study||105
8696490|NCT01552369|21470109|P1|STARTED|Overall Study||100
8696491|NCT01484288|21470135|P1|NOT COMPLETED|Overall Study||0
8696492|NCT01484288|21470135|P1|COMPLETED|Overall Study||11
8696493|NCT01484288|21470135|P1|STARTED|Overall Study||11
8696494|NCT01420926|21470149|P2|NOT COMPLETED|Overall Study||65
8696495|NCT01420926|21470150|P1|NOT COMPLETED|Overall Study||60
8696496|NCT01420926|21470149|P2|COMPLETED|Overall Study||16
8696497|NCT01420926|21470150|P1|COMPLETED|Overall Study||22
8696498|NCT01420926|21470149|P2|STARTED|Overall Study||81
8696499|NCT01420926|21470150|P1|STARTED|Overall Study||82
8696500|NCT01229943|21470166|P2|NOT COMPLETED|Overall Study||17
8696501|NCT01229943|21470167|P1|NOT COMPLETED|Overall Study||18
8696502|NCT01229943|21470166|P2|COMPLETED|Overall Study||58
8696503|NCT01229943|21470167|P1|COMPLETED|Overall Study||57
8696504|NCT01229943|21470166|P2|STARTED|Overall Study||75
8696505|NCT01229943|21470167|P1|STARTED|Overall Study||75
8696506|NCT01116466|21470177|P1|NOT COMPLETED|Overall Study||0
8696507|NCT01116466|21470177|P1|COMPLETED|Overall Study||5
8696508|NCT01116466|21470177|P1|STARTED|Overall Study||5
8696509|NCT00691002|21470190|P5|NOT COMPLETED|52-week, Open-label, Single Arm||0
8696510|NCT00691002|21470191|P4|NOT COMPLETED|52-week, Open-label, Single Arm||0
8696511|NCT00691002|21470192|P3|NOT COMPLETED|52-week, Open-label, Single Arm||0
8696512|NCT00691002|21470193|P2|NOT COMPLETED|52-week, Open-label, Single Arm||0
8696513|NCT00691002|21470194|P1|NOT COMPLETED|52-week, Open-label, Single Arm||51
8696514|NCT00691002|21470190|P5|COMPLETED|52-week, Open-label, Single Arm||0
8696515|NCT00691002|21470191|P4|COMPLETED|52-week, Open-label, Single Arm||0
8696516|NCT00691002|21470192|P3|COMPLETED|52-week, Open-label, Single Arm||0
8696517|NCT00691002|21470193|P2|COMPLETED|52-week, Open-label, Single Arm||0
8696518|NCT00691002|21470194|P1|COMPLETED|52-week, Open-label, Single Arm||403
8696519|NCT00691002|21470190|P5|STARTED|52-week, Open-label, Single Arm||0
8696520|NCT00691002|21470191|P4|STARTED|52-week, Open-label, Single Arm||0
8696521|NCT00691002|21470192|P3|STARTED|52-week, Open-label, Single Arm||0
8696522|NCT00691002|21470193|P2|STARTED|52-week, Open-label, Single Arm||0
8696523|NCT00691002|21470194|P1|STARTED|52-week, Open-label, Single Arm||454
8696524|NCT00691002|21470190|P5|NOT COMPLETED|8-week, Double-blind, 4-arm||0
8696525|NCT00691002|21470191|P4|NOT COMPLETED|8-week, Double-blind, 4-arm||12
8696526|NCT00691002|21470192|P3|NOT COMPLETED|8-week, Double-blind, 4-arm||23
8696527|NCT00691002|21470193|P2|NOT COMPLETED|8-week, Double-blind, 4-arm||34
8696528|NCT00691002|21470194|P1|NOT COMPLETED|8-week, Double-blind, 4-arm||28
8696529|NCT00691002|21470190|P5|COMPLETED|8-week, Double-blind, 4-arm||0
8696530|NCT00691002|21470191|P4|COMPLETED|8-week, Double-blind, 4-arm||169
8696531|NCT00691002|21470192|P3|COMPLETED|8-week, Double-blind, 4-arm||340
8696532|NCT00691002|21470193|P2|COMPLETED|8-week, Double-blind, 4-arm||308
8696533|NCT00691002|21470194|P1|COMPLETED|8-week, Double-blind, 4-arm||325
8696534|NCT00691002|21470190|P5|STARTED|8-week, Double-blind, 4-arm||0
8696535|NCT00691002|21470191|P4|STARTED|8-week, Double-blind, 4-arm||181
8696536|NCT00691002|21470192|P3|STARTED|8-week, Double-blind, 4-arm||363
8696537|NCT00691002|21470193|P2|STARTED|8-week, Double-blind, 4-arm||342
8696538|NCT00691002|21470194|P1|STARTED|8-week, Double-blind, 4-arm||353
8696539|NCT00589277|21470223|P2|NOT COMPLETED|Overall Study||286
8696540|NCT00589277|21470224|P1|NOT COMPLETED|Overall Study||460
8696541|NCT00589277|21470223|P2|COMPLETED|Overall Study||524
8696542|NCT00589277|21470224|P1|COMPLETED|Overall Study||762
8696543|NCT00589277|21470223|P2|Completed 3 Month Follow Up|Overall Study||524
8696544|NCT00589277|21470224|P1|Completed 3 Month Follow Up|Overall Study||762
8696545|NCT00589277|21470223|P2|Completed 2 Week Follow Up|Overall Study||424
8696546|NCT00589277|21470224|P1|Completed 2 Week Follow Up|Overall Study||603
8696547|NCT00589277|21470223|P2|STARTED|Overall Study||810
8696548|NCT00589277|21470224|P1|STARTED|Overall Study||1222
8696549|NCT00107783|21470236|P2|NOT COMPLETED|Overall Study||4
8696550|NCT00107783|21470237|P1|NOT COMPLETED|Overall Study||3
8696551|NCT00107783|21470236|P2|COMPLETED|Overall Study||16
8696552|NCT00107783|21470237|P1|COMPLETED|Overall Study||17
8696553|NCT00107783|21470236|P2|STARTED|Overall Study||20
8696554|NCT00107783|21470237|P1|STARTED|Overall Study||20
8696555|NCT03968965|21470253|P2|NOT COMPLETED|Overall Study||2
8696556|NCT03968965|21470254|P1|NOT COMPLETED|Overall Study||0
8696557|NCT03968965|21470253|P2|COMPLETED|Overall Study||30
8696558|NCT03968965|21470254|P1|COMPLETED|Overall Study||32
8696559|NCT03968965|21470253|P2|STARTED|Overall Study||32
8696560|NCT03968965|21470254|P1|STARTED|Overall Study||32
8696561|NCT03949335|21470274|P2|NOT COMPLETED|Overall Study||6
8696562|NCT03949335|21470275|P1|NOT COMPLETED|Overall Study||3
8696563|NCT03949335|21470274|P2|COMPLETED|Overall Study||131
8696564|NCT03949335|21470275|P1|COMPLETED|Overall Study||132
8696565|NCT03949335|21470274|P2|STARTED|Overall Study||137
8696566|NCT03949335|21470275|P1|STARTED|Overall Study||135
8696567|NCT03895372|21470301|P8|NOT COMPLETED|Extension Treatment Period||6
8696568|NCT03895372|21470302|P7|NOT COMPLETED|Extension Treatment Period||4
8696569|NCT03895372|21470303|P6|NOT COMPLETED|Extension Treatment Period||1
8696570|NCT03895372|21470304|P5|NOT COMPLETED|Extension Treatment Period||3
8696571|NCT03895372|21470305|P4|NOT COMPLETED|Extension Treatment Period||1
8696572|NCT03895372|21470306|P3|NOT COMPLETED|Extension Treatment Period||0
8696573|NCT03895372|21470307|P2|NOT COMPLETED|Extension Treatment Period||5
8696574|NCT03895372|21470308|P1|NOT COMPLETED|Extension Treatment Period||3
8696575|NCT03895372|21470301|P8|COMPLETED|Extension Treatment Period||32
8696576|NCT03895372|21470302|P7|COMPLETED|Extension Treatment Period||33
8696577|NCT03895372|21470303|P6|COMPLETED|Extension Treatment Period||8
8696578|NCT03895372|21470304|P5|COMPLETED|Extension Treatment Period||9
8696579|NCT03895372|21470305|P4|COMPLETED|Extension Treatment Period||8
8696580|NCT03895372|21470306|P3|COMPLETED|Extension Treatment Period||10
8696581|NCT03895372|21470307|P2|COMPLETED|Extension Treatment Period||14
8696582|NCT03895372|21470308|P1|COMPLETED|Extension Treatment Period||16
8696583|NCT03895372|21470301|P8|STARTED|Extension Treatment Period||38
8696584|NCT03895372|21470302|P7|STARTED|Extension Treatment Period||37
8696585|NCT03895372|21470303|P6|STARTED|Extension Treatment Period||9
8696586|NCT03895372|21470304|P5|STARTED|Extension Treatment Period||12
8696587|NCT03895372|21470305|P4|STARTED|Extension Treatment Period||9
8696588|NCT03895372|21470306|P3|STARTED|Extension Treatment Period||10
8696589|NCT03895372|21470307|P2|STARTED|Extension Treatment Period||19
8696590|NCT03895372|21470308|P1|STARTED|Extension Treatment Period||19
8696591|NCT03895372|21470301|P8|NOT COMPLETED|Investigational Treatment Period||5
8696592|NCT03895372|21470302|P7|NOT COMPLETED|Investigational Treatment Period||8
8696593|NCT03895372|21470303|P6|NOT COMPLETED|Investigational Treatment Period||2
8696594|NCT03895372|21470304|P5|NOT COMPLETED|Investigational Treatment Period||0
8696595|NCT03895372|21470305|P4|NOT COMPLETED|Investigational Treatment Period||2
8696596|NCT03895372|21470306|P3|NOT COMPLETED|Investigational Treatment Period||1
8696597|NCT03895372|21470307|P2|NOT COMPLETED|Investigational Treatment Period||3
8696598|NCT03895372|21470308|P1|NOT COMPLETED|Investigational Treatment Period||4
8696599|NCT03895372|21470301|P8|COMPLETED|Investigational Treatment Period||38
8696600|NCT03895372|21470302|P7|COMPLETED|Investigational Treatment Period||37
8696601|NCT03895372|21470303|P6|COMPLETED|Investigational Treatment Period||9
8696602|NCT03895372|21470304|P5|COMPLETED|Investigational Treatment Period||12
8696603|NCT03895372|21470305|P4|COMPLETED|Investigational Treatment Period||9
8696604|NCT03895372|21470306|P3|COMPLETED|Investigational Treatment Period||10
8696605|NCT03895372|21470307|P2|COMPLETED|Investigational Treatment Period||19
8696606|NCT03895372|21470308|P1|COMPLETED|Investigational Treatment Period||19
8696607|NCT03895372|21470301|P8|STARTED|Investigational Treatment Period||43
8696608|NCT03895372|21470302|P7|STARTED|Investigational Treatment Period||45
8696609|NCT03895372|21470303|P6|STARTED|Investigational Treatment Period||11
8696610|NCT03895372|21470304|P5|STARTED|Investigational Treatment Period||12
8696611|NCT03895372|21470305|P4|STARTED|Investigational Treatment Period||11
8696612|NCT03895372|21470306|P3|STARTED|Investigational Treatment Period||11
8696613|NCT03895372|21470307|P2|STARTED|Investigational Treatment Period||22
8696614|NCT03895372|21470308|P1|STARTED|Investigational Treatment Period||23
8696615|NCT03892707|21470466|P2|NOT COMPLETED|Overall Study||6
8696616|NCT03892707|21470467|P1|NOT COMPLETED|Overall Study||6
8696617|NCT03892707|21470466|P2|COMPLETED|Overall Study||244
8696618|NCT03892707|21470467|P1|COMPLETED|Overall Study||244
8696619|NCT03892707|21470466|P2|Started Study Treatment at Baseline|Overall Study||250
8696620|NCT03892707|21470467|P1|Started Study Treatment at Baseline|Overall Study||244
8696621|NCT03892707|21470466|P2|STARTED|Overall Study||250
8696622|NCT03892707|21470467|P1|STARTED|Overall Study||250
8696623|NCT03656939|21470494|P1|NOT COMPLETED|Overall Study||0
8696624|NCT03656939|21470494|P1|COMPLETED|Overall Study||21240
8696625|NCT03656939|21470494|P1|Prospective Study Cohort: Participants Who Received Dose 4|Overall Study||1291
8696626|NCT03656939|21470494|P1|Prospective Study Cohort: Participants Who Received Dose 3|Overall Study||2047
8696627|NCT03656939|21470494|P1|Prospective Study Cohort: Participants Who Received Dose 2|Overall Study||2203
8696628|NCT03656939|21470494|P1|Prospective Study Cohort: Participants Who Received Dose 1|Overall Study||2300
8696629|NCT03656939|21470494|P1|Prospective Study Cohort|Overall Study||2300
8696630|NCT03656939|21470494|P1|Main Study Cohort: Participants Who Received Dose 4|Overall Study||12944
8696631|NCT03656939|21470494|P1|Main Study Cohort: Participants Who Received Dose 3|Overall Study||18415
8696632|NCT03656939|21470494|P1|Main Study Cohort: Participants Who Received Dose 2|Overall Study||19387
8696633|NCT03656939|21470494|P1|Main Study Cohort: Participants Who Received Dose 1|Overall Study||20318
8696634|NCT03656939|21470494|P1|Main Study Cohort|Overall Study||21240
8696635|NCT03656939|21470494|P1|STARTED|Overall Study||21240
8696636|NCT03628898|21470798|P1|NOT COMPLETED|Overall Study||1
8696637|NCT03628898|21470798|P1|COMPLETED|Overall Study||26
8696638|NCT03628898|21470798|P1|STARTED|Overall Study||27
8696639|NCT03621189|21470806|P2|NOT COMPLETED|Overall Study||5
8696640|NCT03621189|21470807|P1|NOT COMPLETED|Overall Study||0
8696641|NCT03621189|21470806|P2|COMPLETED|Overall Study||35
8696642|NCT03621189|21470807|P1|COMPLETED|Overall Study||40
8696643|NCT03621189|21470806|P2|STARTED|Overall Study||40
8696644|NCT03621189|21470807|P1|STARTED|Overall Study||40
8696645|NCT03418051|21470822|P3|NOT COMPLETED|Overall Study||3
8696646|NCT03418051|21470823|P2|NOT COMPLETED|Overall Study||2
8696647|NCT03418051|21470824|P1|NOT COMPLETED|Overall Study||6
8696648|NCT03418051|21470822|P3|COMPLETED|Overall Study||17
8696649|NCT03418051|21470823|P2|COMPLETED|Overall Study||18
8696650|NCT03418051|21470824|P1|COMPLETED|Overall Study||14
8696651|NCT03418051|21470822|P3|STARTED|Overall Study||20
8696652|NCT03418051|21470823|P2|STARTED|Overall Study||20
8696653|NCT03418051|21470824|P1|STARTED|Overall Study||20
8696654|NCT03387020|21470934|P3|NOT COMPLETED|Overall Study||0
8696655|NCT03387020|21470935|P2|NOT COMPLETED|Overall Study||2
8696656|NCT03387020|21470936|P1|NOT COMPLETED|Overall Study||2
8696657|NCT03387020|21470934|P3|COMPLETED|Overall Study||5
8696658|NCT03387020|21470935|P2|COMPLETED|Overall Study||1
8696659|NCT03387020|21470936|P1|COMPLETED|Overall Study||11
8696660|NCT03387020|21470934|P3|Received Treatment|Overall Study||5
8696661|NCT03387020|21470935|P2|Received Treatment|Overall Study||3
8696662|NCT03387020|21470936|P1|Received Treatment|Overall Study||12
8696663|NCT03387020|21470934|P3|STARTED|Overall Study||5
8696664|NCT03387020|21470935|P2|STARTED|Overall Study||3
8696665|NCT03387020|21470936|P1|STARTED|Overall Study||13
8696666|NCT03232736|21470965|P2|NOT COMPLETED|Overall Study||0
8696667|NCT03232736|21470966|P1|NOT COMPLETED|Overall Study||0
8696668|NCT03232736|21470965|P2|COMPLETED|Overall Study||13
8696669|NCT03232736|21470966|P1|COMPLETED|Overall Study||9
8696670|NCT03232736|21470965|P2|STARTED|Overall Study||13
8696671|NCT03232736|21470966|P1|STARTED|Overall Study||9
8696672|NCT03039621|21470976|P2|NOT COMPLETED|Overall Study||16
8696673|NCT03039621|21470977|P1|NOT COMPLETED|Overall Study||12
8696674|NCT03039621|21470976|P2|COMPLETED|Overall Study||128
8696675|NCT03039621|21470977|P1|COMPLETED|Overall Study||131
8696676|NCT03039621|21470976|P2|STARTED|Overall Study||144
8696677|NCT03039621|21470977|P1|STARTED|Overall Study||143
8696678|NCT02915744|21471001|P2|NOT COMPLETED|Overall Study||77
8696679|NCT02915744|21471002|P1|NOT COMPLETED|Overall Study||79
8696680|NCT02915744|21471001|P2|COMPLETED|Overall Study||9
8696681|NCT02915744|21471002|P1|COMPLETED|Overall Study||13
8696682|NCT02915744|21471001|P2|STARTED|Overall Study||86
8696683|NCT02915744|21471002|P1|STARTED|Overall Study||92
8696684|NCT02890355|21471042|P2|NOT COMPLETED|Overall Study||58
8696685|NCT02890355|21471043|P1|NOT COMPLETED|Overall Study||59
8696686|NCT02890355|21471042|P2|COMPLETED|Overall Study||0
8696687|NCT02890355|21471043|P1|COMPLETED|Overall Study||0
8696688|NCT02890355|21471042|P2|Treated & Assessed for AEs|Overall Study||50
8696689|NCT02890355|21471043|P1|Treated & Assessed for AEs|Overall Study||56
8696690|NCT02890355|21471042|P2|STARTED|Overall Study||58
8696691|NCT02890355|21471043|P1|STARTED|Overall Study||59
8696692|NCT02642042|21471059|P1|NOT COMPLETED|Overall Study||54
8696693|NCT02642042|21471059|P1|COMPLETED|Overall Study||0
8696694|NCT02642042|21471059|P1|STARTED|Overall Study||54
8696695|NCT02630017|21471074|P4|NOT COMPLETED|Overall Study||1
8696696|NCT02630017|21471075|P3|NOT COMPLETED|Overall Study||2
8696697|NCT02630017|21471076|P2|NOT COMPLETED|Overall Study||1
8696698|NCT02630017|21471077|P1|NOT COMPLETED|Overall Study||1
8696699|NCT02630017|21471074|P4|COMPLETED|Overall Study||12
8696700|NCT02630017|21471075|P3|COMPLETED|Overall Study||11
8696701|NCT02630017|21471076|P2|COMPLETED|Overall Study||11
8696702|NCT02630017|21471077|P1|COMPLETED|Overall Study||12
8696703|NCT02630017|21471074|P4|STARTED|Overall Study||13
8696704|NCT02630017|21471075|P3|STARTED|Overall Study||13
8696705|NCT02630017|21471076|P2|STARTED|Overall Study||12
8696706|NCT02630017|21471077|P1|STARTED|Overall Study||13
8696707|NCT02614703|21471089|P2|NOT COMPLETED|Overall Study||1
8696708|NCT02614703|21471090|P1|NOT COMPLETED|Overall Study||7
8696709|NCT02614703|21471089|P2|COMPLETED|Overall Study||28
8696710|NCT02614703|21471090|P1|COMPLETED|Overall Study||24
8696711|NCT02614703|21471089|P2|STARTED|Overall Study||29
8696712|NCT02614703|21471090|P1|STARTED|Overall Study||31
8696713|NCT02601209|21471103|P9|NOT COMPLETED|Optional Crossover (Up to 2 Months)||17
8696714|NCT02601209|21471104|P8|NOT COMPLETED|Optional Crossover (Up to 2 Months)||2
8696715|NCT02601209|21471105|P7|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
8696716|NCT02601209|21471106|P6|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
8696717|NCT02601209|21471107|P5|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
8696718|NCT02601209|21471108|P4|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
8696719|NCT02601209|21471109|P3|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
8696720|NCT02601209|21471110|P2|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
8696721|NCT02601209|21471111|P1|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
8696722|NCT02601209|21471103|P9|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|26
8696723|NCT02601209|21471104|P8|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|4
8696724|NCT02601209|21471105|P7|COMPLETED|Optional Crossover (Up to 2 Months)||0
8696725|NCT02601209|21471106|P6|COMPLETED|Optional Crossover (Up to 2 Months)||0
8696726|NCT02601209|21471107|P5|COMPLETED|Optional Crossover (Up to 2 Months)||0
8696727|NCT02601209|21471108|P4|COMPLETED|Optional Crossover (Up to 2 Months)||0
8696728|NCT02601209|21471109|P3|COMPLETED|Optional Crossover (Up to 2 Months)||0
8696729|NCT02601209|21471110|P2|COMPLETED|Optional Crossover (Up to 2 Months)||0
8696730|NCT02601209|21471111|P1|COMPLETED|Optional Crossover (Up to 2 Months)||0
8696731|NCT02601209|21471103|P9|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|43
8696732|NCT02601209|21471104|P8|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|6
8696733|NCT02601209|21471105|P7|STARTED|Optional Crossover (Up to 2 Months)||0
8696734|NCT02601209|21471106|P6|STARTED|Optional Crossover (Up to 2 Months)||0
8696735|NCT02601209|21471107|P5|STARTED|Optional Crossover (Up to 2 Months)||0
8696736|NCT02601209|21471108|P4|STARTED|Optional Crossover (Up to 2 Months)||0
8696737|NCT02601209|21471109|P3|STARTED|Optional Crossover (Up to 2 Months)||0
8696738|NCT02601209|21471110|P2|STARTED|Optional Crossover (Up to 2 Months)||0
8696739|NCT02601209|21471111|P1|STARTED|Optional Crossover (Up to 2 Months)||0
8696740|NCT02601209|21471103|P9|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
8696741|NCT02601209|21471104|P8|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
8696742|NCT02601209|21471105|P7|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
8696743|NCT02601209|21471106|P6|NOT COMPLETED|Initial Treatment (Up to 4 Months)||2
8696744|NCT02601209|21471107|P5|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
8696745|NCT02601209|21471108|P4|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
8696746|NCT02601209|21471109|P3|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
8696747|NCT02601209|21471110|P2|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
8696748|NCT02601209|21471111|P1|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
8696749|NCT02601209|21471103|P9|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|43
8696750|NCT02601209|21471104|P8|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
8696751|NCT02601209|21471105|P7|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|55
8696752|NCT02601209|21471106|P6|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|13
8696753|NCT02601209|21471107|P5|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|12
8696754|NCT02601209|21471108|P4|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
8696755|NCT02601209|21471109|P3|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
8696756|NCT02601209|21471110|P2|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
8696757|NCT02601209|21471111|P1|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
8696758|NCT02601209|21471103|P9|STARTED|Initial Treatment (Up to 4 Months)|Randomized|43
8696759|NCT02601209|21471104|P8|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
8696760|NCT02601209|21471105|P7|STARTED|Initial Treatment (Up to 4 Months)|Randomized|56
8696761|NCT02601209|21471106|P6|STARTED|Initial Treatment (Up to 4 Months)|Randomized|15
8696762|NCT02601209|21471107|P5|STARTED|Initial Treatment (Up to 4 Months)|Randomized|13
8696763|NCT02601209|21471108|P4|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
8696764|NCT02601209|21471109|P3|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
8696765|NCT02601209|21471110|P2|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
8696766|NCT02601209|21471111|P1|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
8696767|NCT02522104|21471140|P3|NOT COMPLETED|Overall Study||7
8696768|NCT02522104|21471141|P2|NOT COMPLETED|Overall Study||3
8696769|NCT02522104|21471142|P1|NOT COMPLETED|Overall Study||3
8696770|NCT02522104|21471140|P3|COMPLETED|Overall Study||5
8696771|NCT02522104|21471141|P2|COMPLETED|Overall Study||12
8696772|NCT02522104|21471142|P1|COMPLETED|Overall Study||10
8696773|NCT02522104|21471140|P3|STARTED|Overall Study||12
8696774|NCT02522104|21471141|P2|STARTED|Overall Study||15
8696775|NCT02522104|21471142|P1|STARTED|Overall Study||13
8696776|NCT02494297|21471174|P1|NOT COMPLETED|Overall Study||0
8696777|NCT02494297|21471174|P1|COMPLETED|Overall Study|As there was no Follow-Up in this study, participation equals completion|1597
8696778|NCT02494297|21471174|P1|STARTED|Overall Study||1597
8696779|NCT02447172|21471181|P3|NOT COMPLETED|Overall Study||18
8696780|NCT02447172|21471182|P2|NOT COMPLETED|Overall Study||15
8696781|NCT02447172|21471183|P1|NOT COMPLETED|Overall Study||31
8696782|NCT02447172|21471181|P3|COMPLETED|Overall Study||114
8696783|NCT02447172|21471182|P2|COMPLETED|Overall Study||115
8696784|NCT02447172|21471183|P1|COMPLETED|Overall Study||231
8696785|NCT02447172|21471181|P3|STARTED|Overall Study||132
8696786|NCT02447172|21471182|P2|STARTED|Overall Study||130
8696787|NCT02447172|21471183|P1|STARTED|Overall Study||262
8696788|NCT02307370|21471200|P1|NOT COMPLETED|Overall Study||19
8696789|NCT02307370|21471200|P1|COMPLETED|Overall Study||25
8696790|NCT02307370|21471200|P1|180 Day Patient Telephone Contact|Overall Study||25
8696791|NCT02307370|21471200|P1|30 Day Follow-up|Overall Study||40
8696792|NCT02307370|21471200|P1|STARTED|Overall Study||44
8696793|NCT02257528|21471211|P1|NOT COMPLETED|Overall Study||1
8696794|NCT02257528|21471211|P1|COMPLETED|Overall Study||25
8696795|NCT02257528|21471211|P1|STARTED|Overall Study||26
8696796|NCT02180724|21471220|P2|NOT COMPLETED|Overall Study||14
8696797|NCT02180724|21471221|P1|NOT COMPLETED|Overall Study||92
8696798|NCT02180724|21471220|P2|COMPLETED|Overall Study||0
8696799|NCT02180724|21471221|P1|COMPLETED|Overall Study||0
8696800|NCT02180724|21471220|P2|Discontinued Treatment|Overall Study||7
8696801|NCT02180724|21471221|P1|Discontinued Treatment|Overall Study||23
8696802|NCT02180724|21471220|P2|Discontinued Study|Overall Study||3
8696803|NCT02180724|21471221|P1|Discontinued Study|Overall Study||14
8696804|NCT02180724|21471220|P2|Received Study Medication|Overall Study||14
8696805|NCT02180724|21471221|P1|Received Study Medication|Overall Study||92
8696806|NCT02180724|21471220|P2|Enrolled|Overall Study||14
8696807|NCT02180724|21471221|P1|Enrolled|Overall Study||92
8696808|NCT02180724|21471220|P2|STARTED|Overall Study||14
8696809|NCT02180724|21471221|P1|STARTED|Overall Study||92
8696810|NCT02090634|21471235|P2|NOT COMPLETED|Overall Study||3
8696811|NCT02090634|21471236|P1|NOT COMPLETED|Overall Study||5
8696812|NCT02090634|21471235|P2|COMPLETED|Overall Study||25
8696813|NCT02090634|21471236|P1|COMPLETED|Overall Study||25
8696814|NCT02090634|21471235|P2|STARTED|Overall Study||28
8696815|NCT02090634|21471236|P1|STARTED|Overall Study||30
8696816|NCT02066181|21471246|P2|NOT COMPLETED|Overall Study||1
8696817|NCT02066181|21471247|P1|NOT COMPLETED|Overall Study||1
8696818|NCT02066181|21471246|P2|COMPLETED|Overall Study||36
8696819|NCT02066181|21471247|P1|COMPLETED|Overall Study||49
8696820|NCT02066181|21471246|P2|Crossed Over|Overall Study||28
8696821|NCT02066181|21471247|P1|Crossed Over|Overall Study||0
8696822|NCT02066181|21471246|P2|STARTED|Overall Study||37
8696823|NCT02066181|21471247|P1|STARTED|Overall Study||50
8696824|NCT01886872|21471270|P3|NOT COMPLETED|Overall Study||12
8696825|NCT01886872|21471271|P2|NOT COMPLETED|Overall Study||4
8696826|NCT01886872|21471272|P1|NOT COMPLETED|Overall Study||7
8696827|NCT01886872|21471270|P3|COMPLETED|Overall Study||170
8696828|NCT01886872|21471271|P2|COMPLETED|Overall Study||178
8696829|NCT01886872|21471272|P1|COMPLETED|Overall Study||176
8696830|NCT01886872|21471270|P3|Crossover Cohort|Overall Study||0
8696831|NCT01886872|21471271|P2|Crossover Cohort|Overall Study||0
8696832|NCT01886872|21471272|P1|Crossover Cohort|Overall Study||30
8696833|NCT01886872|21471270|P3|Evaluable for Adverse Events|Overall Study||181
8696834|NCT01886872|21471271|P2|Evaluable for Adverse Events|Overall Study||180
8696835|NCT01886872|21471272|P1|Evaluable for Adverse Events|Overall Study||176
8696836|NCT01886872|21471270|P3|Evaluable for Secondary Endpoints|Overall Study||182
8696837|NCT01886872|21471271|P2|Evaluable for Secondary Endpoints|Overall Study||182
8696838|NCT01886872|21471272|P1|Evaluable for Secondary Endpoints|Overall Study||183
8696839|NCT01886872|21471270|P3|STARTED|Overall Study||182
8696840|NCT01886872|21471271|P2|STARTED|Overall Study||182
8696841|NCT01886872|21471272|P1|STARTED|Overall Study||183
8696845|NCT01747447|21471311|P2|NOT COMPLETED|Overall Study||43
8696846|NCT01747447|21471312|P1|NOT COMPLETED|Overall Study||41
8696847|NCT01747447|21471311|P2|COMPLETED|Overall Study||340
8696848|NCT01747447|21471312|P1|COMPLETED|Overall Study||347
8696849|NCT01747447|21471311|P2|STARTED|Overall Study||383
8696850|NCT01747447|21471312|P1|STARTED|Overall Study||388
8696851|NCT01521117|21471322|P2|NOT COMPLETED|Second Intervention (6 Weeks)||3
8696852|NCT01521117|21471323|P1|NOT COMPLETED|Second Intervention (6 Weeks)||1
8696853|NCT01521117|21471322|P2|COMPLETED|Second Intervention (6 Weeks)||5
8696854|NCT01521117|21471323|P1|COMPLETED|Second Intervention (6 Weeks)||5
8696855|NCT01521117|21471322|P2|STARTED|Second Intervention (6 Weeks)||8
8696856|NCT01521117|21471323|P1|STARTED|Second Intervention (6 Weeks)||6
8696857|NCT01521117|21471322|P2|NOT COMPLETED|Washout (4 Weeks)||0
8696858|NCT01521117|21471323|P1|NOT COMPLETED|Washout (4 Weeks)||0
8696859|NCT01521117|21471322|P2|COMPLETED|Washout (4 Weeks)||8
8696860|NCT01521117|21471323|P1|COMPLETED|Washout (4 Weeks)||6
8696861|NCT01521117|21471322|P2|STARTED|Washout (4 Weeks)||8
8696862|NCT01521117|21471323|P1|STARTED|Washout (4 Weeks)||6
8696863|NCT01521117|21471322|P2|NOT COMPLETED|First Intervention (6 Weeks)||2
8696864|NCT01521117|21471323|P1|NOT COMPLETED|First Intervention (6 Weeks)||4
8696865|NCT01521117|21471322|P2|COMPLETED|First Intervention (6 Weeks)||8
8696866|NCT01521117|21471323|P1|COMPLETED|First Intervention (6 Weeks)||6
8696867|NCT01521117|21471322|P2|STARTED|First Intervention (6 Weeks)||10
8696868|NCT01521117|21471323|P1|STARTED|First Intervention (6 Weeks)||10
8696869|NCT01317277|21471335|P2|NOT COMPLETED|Overall Study||2
8696870|NCT01317277|21471336|P1|NOT COMPLETED|Overall Study||7
8696871|NCT01317277|21471335|P2|COMPLETED|Overall Study||23
8696872|NCT01317277|21471336|P1|COMPLETED|Overall Study||43
8696873|NCT01317277|21471335|P2|STARTED|Overall Study||25
8696874|NCT01317277|21471336|P1|STARTED|Overall Study||50
8696875|NCT01275677|21471348|P2|NOT COMPLETED|Overall Study||42
8696876|NCT01275677|21471349|P1|NOT COMPLETED|Overall Study||28
8696877|NCT01275677|21471348|P2|COMPLETED|Overall Study||1598
8696878|NCT01275677|21471349|P1|COMPLETED|Overall Study||1602
8696879|NCT01275677|21471348|P2|STARTED|Overall Study||1640
8696880|NCT01275677|21471349|P1|STARTED|Overall Study||1630
8696881|NCT01196390|21471369|P2|NOT COMPLETED|Overall Study||5
8696882|NCT01196390|21471370|P1|NOT COMPLETED|Overall Study||4
8696883|NCT01196390|21471369|P2|COMPLETED|Overall Study||96
8696884|NCT01196390|21471370|P1|COMPLETED|Overall Study||98
8696885|NCT01196390|21471369|P2|Eligible and Had Surgery|Overall Study||78
8696886|NCT01196390|21471370|P1|Eligible and Had Surgery|Overall Study||82
8696887|NCT01196390|21471369|P2|Eligible and Started Study Treatment|Overall Study||96
8696888|NCT01196390|21471370|P1|Eligible and Started Study Treatment|Overall Study||95
8696889|NCT01196390|21471369|P2|Eligible|Overall Study||96
8696890|NCT01196390|21471370|P1|Eligible|Overall Study||98
8696891|NCT01196390|21471369|P2|STARTED|Overall Study||101
8696892|NCT01196390|21471370|P1|STARTED|Overall Study||102
8696893|NCT01015833|21471388|P2|NOT COMPLETED|Overall Study||5
8696894|NCT01015833|21471389|P1|NOT COMPLETED|Overall Study||13
8696895|NCT01015833|21471388|P2|COMPLETED|Overall Study||171
8696896|NCT01015833|21471389|P1|COMPLETED|Overall Study||167
8696897|NCT01015833|21471388|P2|STARTED|Overall Study||176
8696898|NCT01015833|21471389|P1|STARTED|Overall Study||180
8696899|NCT00942331|21471405|P2|NOT COMPLETED|Overall Study||22
8696900|NCT00942331|21471406|P1|NOT COMPLETED|Overall Study||15
8696901|NCT00942331|21471405|P2|COMPLETED|Overall Study||232
8696902|NCT00942331|21471406|P1|COMPLETED|Overall Study||237
8696903|NCT00942331|21471405|P2|STARTED|Overall Study||254
8696904|NCT00942331|21471406|P1|STARTED|Overall Study||252
8696905|NCT00884650|21471418|P2|NOT COMPLETED|Overall Study||8
8696906|NCT00884650|21471419|P1|NOT COMPLETED|Overall Study||9
8696907|NCT00884650|21471418|P2|COMPLETED|Overall Study||21
8696908|NCT00884650|21471419|P1|COMPLETED|Overall Study||16
8696909|NCT00884650|21471418|P2|STARTED|Overall Study||29
8696910|NCT00884650|21471419|P1|STARTED|Overall Study||25
8696911|NCT00861705|21471432|P4|NOT COMPLETED|Overall Study||1
8696912|NCT00861705|21471433|P3|NOT COMPLETED|Overall Study||0
8696913|NCT00861705|21471434|P2|NOT COMPLETED|Overall Study||3
8696914|NCT00861705|21471435|P1|NOT COMPLETED|Overall Study||7
8696915|NCT00861705|21471432|P4|COMPLETED|Overall Study||112
8696916|NCT00861705|21471433|P3|COMPLETED|Overall Study||113
8696917|NCT00861705|21471434|P2|COMPLETED|Overall Study||110
8696918|NCT00861705|21471435|P1|COMPLETED|Overall Study||108
8696919|NCT00861705|21471432|P4|STARTED|Overall Study||113
8696920|NCT00861705|21471433|P3|STARTED|Overall Study||113
8696921|NCT00861705|21471434|P2|STARTED|Overall Study||113
8696922|NCT00861705|21471435|P1|STARTED|Overall Study||115
8696923|NCT00807144|21471477|P2|NOT COMPLETED|Overall Study||1
8696924|NCT00807144|21471478|P1|NOT COMPLETED|Overall Study||0
8696925|NCT00807144|21471477|P2|COMPLETED|Overall Study||49
8696926|NCT00807144|21471478|P1|COMPLETED|Overall Study||52
8696927|NCT00807144|21471477|P2|STARTED|Overall Study||50
8696928|NCT00807144|21471478|P1|STARTED|Overall Study||52
8696929|NCT00588770|21471490|P2|NOT COMPLETED|Overall Study||200
8696930|NCT00588770|21471491|P1|NOT COMPLETED|Overall Study||159
8696931|NCT00588770|21471490|P2|COMPLETED|Overall Study||3
8696932|NCT00588770|21471491|P1|COMPLETED|Overall Study||41
8696933|NCT00588770|21471490|P2|Start Protocol Therapy|Overall Study||194
8696934|NCT00588770|21471491|P1|Start Protocol Therapy|Overall Study||200
8696935|NCT00588770|21471490|P2|Eligible|Overall Study||183
8696936|NCT00588770|21471491|P1|Eligible|Overall Study||188
8696937|NCT00588770|21471490|P2|STARTED|Overall Study||203
8696938|NCT00588770|21471491|P1|STARTED|Overall Study||200
8696939|NCT00424372|21471501|P1|NOT COMPLETED|Overall Study||31
8696940|NCT00424372|21471501|P1|COMPLETED|Overall Study||95
8696941|NCT00424372|21471501|P1|STARTED|Overall Study||126
8696942|NCT00421304|21471513|P3|NOT COMPLETED|Overall Study||8
8696943|NCT00421304|21471514|P2|NOT COMPLETED|Overall Study||4
8696944|NCT00421304|21471515|P1|NOT COMPLETED|Overall Study||8
8696945|NCT00421304|21471513|P3|COMPLETED|Overall Study||31
8696946|NCT00421304|21471514|P2|COMPLETED|Overall Study||35
8696947|NCT00421304|21471515|P1|COMPLETED|Overall Study||32
8696948|NCT00421304|21471513|P3|STARTED|Overall Study||39
8696949|NCT00421304|21471514|P2|STARTED|Overall Study||39
8696950|NCT00421304|21471515|P1|STARTED|Overall Study||40
8696951|NCT00324805|21471617|P2|NOT COMPLETED|Overall Study||483
8696952|NCT00324805|21471618|P1|NOT COMPLETED|Overall Study||150
8696953|NCT00324805|21471617|P2|COMPLETED|Overall Study||269
8696954|NCT00324805|21471618|P1|COMPLETED|Overall Study||599
8696955|NCT00324805|21471617|P2|Started Assigned Therapy|Overall Study||735
8696956|NCT00324805|21471618|P1|Started Assigned Therapy|Overall Study||737
8696957|NCT00324805|21471617|P2|STARTED|Overall Study||752
8696958|NCT00324805|21471618|P1|STARTED|Overall Study||749
8696959|NCT00310180|21471634|P4|NOT COMPLETED|Overall Study||348
8696960|NCT00310180|21471635|P3|NOT COMPLETED|Overall Study||137
8696961|NCT00310180|21471636|P2|NOT COMPLETED|Overall Study||59
8696962|NCT00310180|21471637|P1|NOT COMPLETED|Overall Study||10
8696963|NCT00310180|21471634|P4|COMPLETED|Overall Study||1389
8696964|NCT00310180|21471635|P3|COMPLETED|Overall Study||3312
8696965|NCT00310180|21471636|P2|COMPLETED|Overall Study||3399
8696966|NCT00310180|21471637|P1|COMPLETED|Overall Study||1619
8696967|NCT00310180|21471634|P4|No Follow-up Data|Overall Study||245
8696968|NCT00310180|21471635|P3|No Follow-up Data|Overall Study||131
8696969|NCT00310180|21471636|P2|No Follow-up Data|Overall Study||55
8696970|NCT00310180|21471637|P1|No Follow-up Data|Overall Study||7
8696971|NCT00310180|21471634|P4|Ineligible|Overall Study||7
8696972|NCT00310180|21471635|P3|Ineligible|Overall Study||6
8696973|NCT00310180|21471636|P2|Ineligible|Overall Study||4
8696974|NCT00310180|21471637|P1|Ineligible|Overall Study||3
8696975|NCT00310180|21471634|P4|No On-study Data|Overall Study||172
8696976|NCT00310180|21471635|P3|No On-study Data|Overall Study||10
8696977|NCT00310180|21471636|P2|No On-study Data|Overall Study||2
8696978|NCT00310180|21471637|P1|No On-study Data|Overall Study||0
8696979|NCT00310180|21471634|P4|STARTED|Overall Study||1737
8696980|NCT00310180|21471635|P3|STARTED|Overall Study||3449
8696981|NCT00310180|21471636|P2|STARTED|Overall Study||3458
8696982|NCT00310180|21471637|P1|STARTED|Overall Study||1629
8696983|NCT00070499|21471671|P4|NOT COMPLETED|Overall Study||110
8696984|NCT00070499|21471672|P3|NOT COMPLETED|Overall Study||120
8696985|NCT00070499|21471673|P2|NOT COMPLETED|Overall Study||26
8696986|NCT00070499|21471674|P1|NOT COMPLETED|Overall Study||38
8696987|NCT00070499|21471671|P4|COMPLETED|Overall Study||17
8696988|NCT00070499|21471672|P3|COMPLETED|Overall Study||6
8696989|NCT00070499|21471673|P2|COMPLETED|Overall Study||52
8696990|NCT00070499|21471674|P1|COMPLETED|Overall Study||37
8696991|NCT00070499|21471671|P4|Eligible and Treated|Overall Study||123
8696992|NCT00070499|21471672|P3|Eligible and Treated|Overall Study||123
8696993|NCT00070499|21471673|P2|Eligible and Treated|Overall Study||73
8696994|NCT00070499|21471674|P1|Eligible and Treated|Overall Study||72
8696995|NCT00070499|21471671|P4|Eligible|Overall Study||125
8696996|NCT00070499|21471672|P3|Eligible|Overall Study||123
8696997|NCT00070499|21471673|P2|Eligible|Overall Study||73
8696998|NCT00070499|21471674|P1|Eligible|Overall Study||73
8696999|NCT00070499|21471671|P4|STARTED|Overall Study||127
8697000|NCT00070499|21471672|P3|STARTED|Overall Study||126
8697001|NCT00070499|21471673|P2|STARTED|Overall Study||78
8697002|NCT00070499|21471674|P1|STARTED|Overall Study||75
8697003|NCT04363736|21471702|P2|NOT COMPLETED|Overall Study||13
8697004|NCT04363736|21471703|P1|NOT COMPLETED|Overall Study||19
8697005|NCT04363736|21471702|P2|COMPLETED|Overall Study||35
8697006|NCT04363736|21471703|P1|COMPLETED|Overall Study||30
8697007|NCT04363736|21471702|P2|STARTED|Overall Study||48
8697008|NCT04363736|21471703|P1|STARTED|Overall Study||49
8697009|NCT04249310|21471733|P2|NOT COMPLETED|Overall Study||0
8697010|NCT04249310|21471734|P1|NOT COMPLETED|Overall Study||0
8697011|NCT04249310|21471733|P2|COMPLETED|Overall Study||5352
8697012|NCT04249310|21471734|P1|COMPLETED|Overall Study||1436
8697013|NCT04249310|21471733|P2|hdPS-matched Cohort|Overall Study||1302
8697014|NCT04249310|21471734|P1|hdPS-matched Cohort|Overall Study||1302
8697015|NCT04249310|21471733|P2|PS-matched Cohort|Overall Study||1412
8697016|NCT04249310|21471734|P1|PS-matched Cohort|Overall Study||1412
8697017|NCT04249310|21471733|P2|STARTED|Overall Study||5352
8697018|NCT04249310|21471734|P1|STARTED|Overall Study||1436
8697019|NCT04174313|21471746|P2|NOT COMPLETED|Overall Study||0
8697020|NCT04174313|21471747|P1|NOT COMPLETED|Overall Study||0
8697021|NCT04174313|21471746|P2|COMPLETED|Overall Study||50
8697022|NCT04174313|21471747|P1|COMPLETED|Overall Study||15
8697023|NCT04174313|21471746|P2|STARTED|Overall Study||50
8697024|NCT04174313|21471747|P1|STARTED|Overall Study||15
8697025|NCT04084769|21471761|P4|NOT COMPLETED|Overall Study||2
8697026|NCT04084769|21471762|P3|NOT COMPLETED|Overall Study||0
8697027|NCT04084769|21471763|P2|NOT COMPLETED|Overall Study||4
8697028|NCT04084769|21471764|P1|NOT COMPLETED|Overall Study||4
8697029|NCT04084769|21471761|P4|COMPLETED|Overall Study||92
8697030|NCT04084769|21471762|P3|COMPLETED|Overall Study||95
8697031|NCT04084769|21471763|P2|COMPLETED|Overall Study||186
8697032|NCT04084769|21471764|P1|COMPLETED|Overall Study||187
8697033|NCT04084769|21471761|P4|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||89
8697034|NCT04084769|21471762|P3|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||90
8697035|NCT04084769|21471763|P2|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||176
8697036|NCT04084769|21471764|P1|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||174
8697037|NCT04084769|21471761|P4|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
8697038|NCT04084769|21471762|P3|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
8697039|NCT04084769|21471763|P2|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||45
8697040|NCT04084769|21471764|P1|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||46
8697041|NCT04084769|21471761|P4|Full Analysis Set|Overall Study||94
8697042|NCT04084769|21471762|P3|Full Analysis Set|Overall Study||95
8697043|NCT04084769|21471763|P2|Full Analysis Set|Overall Study||190
8697044|NCT04084769|21471764|P1|Full Analysis Set|Overall Study||191
8697045|NCT04084769|21471761|P4|Safety Analysis Set (SAfAS)|Overall Study||92
8697046|NCT04084769|21471762|P3|Safety Analysis Set (SAfAS)|Overall Study||93
8697047|NCT04084769|21471763|P2|Safety Analysis Set (SAfAS)|Overall Study||184
8697048|NCT04084769|21471764|P1|Safety Analysis Set (SAfAS)|Overall Study||186
8697049|NCT04084769|21471761|P4|STARTED|Overall Study||94
8697050|NCT04084769|21471762|P3|STARTED|Overall Study||95
8697051|NCT04084769|21471763|P2|STARTED|Overall Study||190
8697052|NCT04084769|21471764|P1|STARTED|Overall Study||191
8697053|NCT03696576|21471810|P2|NOT COMPLETED|Overall Study||5
8697054|NCT03696576|21471811|P1|NOT COMPLETED|Overall Study||3
8697055|NCT03696576|21471810|P2|COMPLETED|Overall Study||6
8697056|NCT03696576|21471811|P1|COMPLETED|Overall Study||10
8697057|NCT03696576|21471810|P2|STARTED|Overall Study||11
8697058|NCT03696576|21471811|P1|STARTED|Overall Study||13
8697059|NCT03689920|21471843|P2|NOT COMPLETED|Overall Study||4
8697060|NCT03689920|21471844|P1|NOT COMPLETED|Overall Study||6
8697061|NCT03689920|21471843|P2|COMPLETED|Overall Study||48
8697062|NCT03689920|21471844|P1|COMPLETED|Overall Study||41
8697063|NCT03689920|21471843|P2|STARTED|Overall Study||52
8697064|NCT03689920|21471844|P1|STARTED|Overall Study||47
8697065|NCT03573804|21471850|P1|NOT COMPLETED|Overall Study||10
8697066|NCT03573804|21471850|P1|COMPLETED|Overall Study||62
8697067|NCT03573804|21471850|P1|STARTED|Overall Study||72
8697068|NCT03286465|21471866|P2|NOT COMPLETED|Overall Study||0
8697069|NCT03286465|21471867|P1|NOT COMPLETED|Overall Study||0
8697070|NCT03286465|21471866|P2|COMPLETED|Overall Study||100
8697071|NCT03286465|21471867|P1|COMPLETED|Overall Study||100
8697072|NCT03286465|21471866|P2|STARTED|Overall Study||100
8697073|NCT03286465|21471867|P1|STARTED|Overall Study||100
8697074|NCT03270332|21471885|P2|NOT COMPLETED|Overall Study||1
8697075|NCT03270332|21471886|P1|NOT COMPLETED|Overall Study||0
8697076|NCT03270332|21471885|P2|COMPLETED|Overall Study||4
8697077|NCT03270332|21471886|P1|COMPLETED|Overall Study||5
8697078|NCT03270332|21471885|P2|STARTED|Overall Study||5
8697079|NCT03270332|21471886|P1|STARTED|Overall Study||5
8697080|NCT03220204|21471897|P3|NOT COMPLETED|Overall Study||3
8697081|NCT03220204|21471898|P2|NOT COMPLETED|Overall Study||2
8697082|NCT03220204|21471899|P1|NOT COMPLETED|Overall Study||1
8697083|NCT03220204|21471897|P3|COMPLETED|Overall Study||12
8697084|NCT03220204|21471898|P2|COMPLETED|Overall Study||13
8697085|NCT03220204|21471899|P1|COMPLETED|Overall Study||14
8697086|NCT03220204|21471897|P3|STARTED|Overall Study||15
8697087|NCT03220204|21471898|P2|STARTED|Overall Study||15
8697088|NCT03220204|21471899|P1|STARTED|Overall Study||15
8697089|NCT03097133|21471948|P2|NOT COMPLETED|Overall Study||34
8697090|NCT03097133|21471949|P1|NOT COMPLETED|Overall Study||30
8697091|NCT03097133|21471948|P2|COMPLETED|Overall Study||81
8697092|NCT03097133|21471949|P1|COMPLETED|Overall Study||85
8697093|NCT03097133|21471948|P2|Treated|Overall Study||114
8697094|NCT03097133|21471949|P1|Treated|Overall Study||113
8697095|NCT03097133|21471948|P2|STARTED|Overall Study||115
8697096|NCT03097133|21471949|P1|STARTED|Overall Study||115
8697097|NCT03033394|21471999|P1|NOT COMPLETED|Completed Final Analysis||1
8697098|NCT03033394|21471999|P1|COMPLETED|Completed Final Analysis||58
8697099|NCT03033394|21471999|P1|STARTED|Completed Final Analysis||59
8697100|NCT03033394|21471999|P1|NOT COMPLETED|Completed Pharmacokinetic Analysis||6
8697101|NCT03033394|21471999|P1|COMPLETED|Completed Pharmacokinetic Analysis||59
8697102|NCT03033394|21471999|P1|STARTED|Completed Pharmacokinetic Analysis||65
8697103|NCT03033394|21471999|P1|NOT COMPLETED|Completed Sampling||0
8697104|NCT03033394|21471999|P1|COMPLETED|Completed Sampling||65
8697105|NCT03033394|21471999|P1|STARTED|Completed Sampling||65
8697106|NCT03020407|21472010|P2|NOT COMPLETED|Overall Study||5
8697107|NCT03020407|21472011|P1|NOT COMPLETED|Overall Study||4
8697108|NCT03020407|21472010|P2|COMPLETED|Overall Study||101
8697109|NCT03020407|21472011|P1|COMPLETED|Overall Study||101
8697110|NCT03020407|21472010|P2|STARTED|Overall Study||106
8697111|NCT03020407|21472011|P1|STARTED|Overall Study||105
8697112|NCT03015363|21472025|P1|NOT COMPLETED|Overall Study||17
8697113|NCT03015363|21472025|P1|COMPLETED|Overall Study||20
8697114|NCT03015363|21472025|P1|STARTED|Overall Study||37
8697115|NCT02969707|21472034|P2|NOT COMPLETED|Overall Study||8
8697116|NCT02969707|21472035|P1|NOT COMPLETED|Overall Study||8
8697117|NCT02969707|21472034|P2|COMPLETED|Overall Study||44
8697118|NCT02969707|21472035|P1|COMPLETED|Overall Study||41
8697119|NCT02969707|21472034|P2|STARTED|Overall Study||52
8697120|NCT02969707|21472035|P1|STARTED|Overall Study||49
8697121|NCT02442349|21472073|P1|NOT COMPLETED|Overall Study||171
8697122|NCT02442349|21472073|P1|COMPLETED|Overall Study||0
8697123|NCT02442349|21472073|P1|STARTED|Overall Study||171
8697124|NCT02294461|21472080|P2|NOT COMPLETED|Overall Study||131
8697125|NCT02294461|21472081|P1|NOT COMPLETED|Overall Study||62
8697126|NCT02294461|21472080|P2|COMPLETED|Overall Study||59
8697127|NCT02294461|21472081|P1|COMPLETED|Overall Study|Participants still receiving treatment as of 20 Sept 2016. Data cutoff date: 20 Sep 2015/20 Jan 2016|136
8697128|NCT02294461|21472080|P2|Treated/Received Study Drug|Overall Study||190
8697129|NCT02294461|21472081|P1|Treated/Received Study Drug|Overall Study||198
8697130|NCT02294461|21472080|P2|STARTED|Overall Study||190
8697131|NCT02294461|21472081|P1|STARTED|Overall Study||198
8697132|NCT01844986|21472135|P2|NOT COMPLETED|Overall Study||40
8697133|NCT01844986|21472136|P1|NOT COMPLETED|Overall Study||77
8697134|NCT01844986|21472135|P2|COMPLETED|Overall Study||91
8697135|NCT01844986|21472136|P1|COMPLETED|Overall Study||183
8697136|NCT01844986|21472135|P2|STARTED|Overall Study||131
8697137|NCT01844986|21472136|P1|STARTED|Overall Study||260
8697138|NCT01767493|21472158|P1|NOT COMPLETED|Overall Study||3
8697139|NCT01767493|21472158|P1|COMPLETED|Overall Study||16
8697140|NCT01767493|21472158|P1|STARTED|Overall Study||19
8697141|NCT01670500|21472164|P2|NOT COMPLETED|Overall Study||0
8697142|NCT01670500|21472165|P1|NOT COMPLETED|Overall Study||1
8697143|NCT01670500|21472164|P2|COMPLETED|Overall Study|4 pts received <4 cycles of assigned chemo; 2 pts received add'l non-protocol chemo before surgery|60
8697144|NCT01670500|21472165|P1|COMPLETED|Overall Study|1 patient withdrew after 3 cycles; 5 patients received additional non-protocol chemo before surgery|57
8697145|NCT01670500|21472164|P2|STARTED|Overall Study||60
8697146|NCT01670500|21472165|P1|STARTED|Overall Study||58
8697147|NCT01392859|21472179|P3|NOT COMPLETED|Overall Study||0
8697148|NCT01392859|21472180|P2|NOT COMPLETED|Overall Study||0
8697149|NCT01392859|21472181|P1|NOT COMPLETED|Overall Study||2
8697150|NCT01392859|21472179|P3|COMPLETED|Overall Study||183
8697151|NCT01392859|21472180|P2|COMPLETED|Overall Study||13
8697152|NCT01392859|21472181|P1|COMPLETED|Overall Study||13
8697153|NCT01392859|21472179|P3|Wash Out 3-7 Days|Overall Study||0
8697154|NCT01392859|21472180|P2|Wash Out 3-7 Days|Overall Study||13
8697155|NCT01392859|21472181|P1|Wash Out 3-7 Days|Overall Study||15
8697156|NCT01392859|21472179|P3|STARTED|Overall Study||183
8697157|NCT01392859|21472180|P2|STARTED|Overall Study||13
8697158|NCT01392859|21472181|P1|STARTED|Overall Study||15
8697159|NCT01167712|21472189|P2|NOT COMPLETED|Overall Study||0
8697160|NCT01167712|21472190|P1|NOT COMPLETED|Overall Study||0
8697161|NCT01167712|21472189|P2|COMPLETED|Overall Study||346
8697162|NCT01167712|21472190|P1|COMPLETED|Overall Study||346
8697163|NCT01167712|21472189|P2|STARTED|Overall Study||346
8697164|NCT01167712|21472190|P1|STARTED|Overall Study||346
8697165|NCT00659646|21472202|P2|NOT COMPLETED|Overall Study||8
8697166|NCT00659646|21472203|P1|NOT COMPLETED|Overall Study||15
8697167|NCT00659646|21472202|P2|COMPLETED|Overall Study||10
8697168|NCT00659646|21472203|P1|COMPLETED|Overall Study||23
8697169|NCT00659646|21472202|P2|STARTED|Overall Study||18
8697170|NCT00659646|21472203|P1|STARTED|Overall Study||38
8697171|NCT04701814|21472225|P2|NOT COMPLETED|Overall Study||3
8697172|NCT04701814|21472226|P1|NOT COMPLETED|Overall Study||5
8697173|NCT04701814|21472225|P2|COMPLETED|Overall Study||15
8697174|NCT04701814|21472226|P1|COMPLETED|Overall Study||15
8697175|NCT04701814|21472225|P2|STARTED|Overall Study||18
8697176|NCT04701814|21472226|P1|STARTED|Overall Study||20
8697177|NCT04617509|21472234|P3|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||1
8697178|NCT04617509|21472235|P2|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
8697179|NCT04617509|21472236|P1|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
8697180|NCT04617509|21472234|P3|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||13
8697181|NCT04617509|21472235|P2|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
8697182|NCT04617509|21472236|P1|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
8697183|NCT04617509|21472234|P3|STARTED|Period 3: Part 2 Formulation A Fed Cond.||14
8697184|NCT04617509|21472235|P2|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
8697185|NCT04617509|21472236|P1|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
8697186|NCT04617509|21472234|P3|NOT COMPLETED|Period 2: Part 1 Formulation B||0
8697187|NCT04617509|21472235|P2|NOT COMPLETED|Period 2: Part 1 Formulation B||0
8697188|NCT04617509|21472236|P1|NOT COMPLETED|Period 2: Part 1 Formulation B||0
8697189|NCT04617509|21472234|P3|COMPLETED|Period 2: Part 1 Formulation B||0
8697190|NCT04617509|21472235|P2|COMPLETED|Period 2: Part 1 Formulation B||14
8697191|NCT04617509|21472236|P1|COMPLETED|Period 2: Part 1 Formulation B||0
8697192|NCT04617509|21472234|P3|STARTED|Period 2: Part 1 Formulation B||0
8697193|NCT04617509|21472235|P2|STARTED|Period 2: Part 1 Formulation B||14
8697194|NCT04617509|21472236|P1|STARTED|Period 2: Part 1 Formulation B||0
8697195|NCT04617509|21472234|P3|NOT COMPLETED|Period 1: Part 1 Formulation A||0
8697196|NCT04617509|21472235|P2|NOT COMPLETED|Period 1: Part 1 Formulation A||0
8697197|NCT04617509|21472236|P1|NOT COMPLETED|Period 1: Part 1 Formulation A||0
8697198|NCT04617509|21472234|P3|COMPLETED|Period 1: Part 1 Formulation A||0
8697199|NCT04617509|21472235|P2|COMPLETED|Period 1: Part 1 Formulation A||0
8697200|NCT04617509|21472236|P1|COMPLETED|Period 1: Part 1 Formulation A||14
8697201|NCT04617509|21472234|P3|STARTED|Period 1: Part 1 Formulation A|Subjects were expected to participate in both Part I and Part II, seven visits in total. Subject 112 was prematurely withdrawn from the study due to self-reported Covid-19-like symptoms via phone after Visit 5, i.e. after receiving both GS-248 formulations but prior to the food interaction part. This means subject 112 was withdrawn after Part I Formulation B but before Part II which cannot be visualized in the Period section. The correct number of subjects started Part II is thus 13.|0
8697202|NCT04617509|21472235|P2|STARTED|Period 1: Part 1 Formulation A||0
8697203|NCT04617509|21472236|P1|STARTED|Period 1: Part 1 Formulation A||14
8697204|NCT04490863|21472284|P1|NOT COMPLETED|Overall Study||0
8697205|NCT04490863|21472284|P1|COMPLETED|Overall Study||26
8697206|NCT04490863|21472284|P1|STARTED|Overall Study||26
8697207|NCT04099277|21472288|P1|NOT COMPLETED|Overall Study||2
8697208|NCT04099277|21472288|P1|COMPLETED|Overall Study||0
8697209|NCT04099277|21472288|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
8697210|NCT04099277|21472288|P1|STARTED|Overall Study||2
8697211|NCT04013737|21472301|P2|NOT COMPLETED|Overall Study||0
8697212|NCT04013737|21472302|P1|NOT COMPLETED|Overall Study||0
8697213|NCT04013737|21472301|P2|COMPLETED|Overall Study||15
8697214|NCT04013737|21472302|P1|COMPLETED|Overall Study|12 participants declined to participate in the study|18
8697215|NCT04013737|21472301|P2|STARTED|Overall Study||15
8697216|NCT04013737|21472302|P1|STARTED|Overall Study||18
8697217|NCT04000581|21472309|P2|NOT COMPLETED|Overall Study||1
8697218|NCT04000581|21472310|P1|NOT COMPLETED|Overall Study||0
8697219|NCT04000581|21472309|P2|COMPLETED|Overall Study||11
8697220|NCT04000581|21472310|P1|COMPLETED|Overall Study||5
8697221|NCT04000581|21472309|P2|STARTED|Overall Study||12
8697222|NCT04000581|21472310|P1|STARTED|Overall Study||5
8697223|NCT03878277|21472336|P1|NOT COMPLETED|Overall Study||0
8697224|NCT03878277|21472336|P1|COMPLETED|Overall Study||10
8697225|NCT03878277|21472336|P1|STARTED|Overall Study||10
8697226|NCT03834168|21472346|P2|NOT COMPLETED|Overall Study||1
8697227|NCT03834168|21472347|P1|NOT COMPLETED|Overall Study||1
8697228|NCT03834168|21472346|P2|COMPLETED|Overall Study||22
8697229|NCT03834168|21472347|P1|COMPLETED|Overall Study||18
8697230|NCT03834168|21472346|P2|Participants Returned for the 24-h Inpatient Protocol|Overall Study||23
8697231|NCT03834168|21472347|P1|Participants Returned for the 24-h Inpatient Protocol|Overall Study||18
8697232|NCT03834168|21472346|P2|Participants Received 5 Days of Standardized Meals|Overall Study||23
8697233|NCT03834168|21472347|P1|Participants Received 5 Days of Standardized Meals|Overall Study||19
8697234|NCT03834168|21472346|P2|Study Dropouts|Overall Study||0
8697235|NCT03834168|21472347|P1|Study Dropouts|Overall Study||1
8697236|NCT03834168|21472346|P2|Unable to Complete the Protocol|Overall Study||1
8697237|NCT03834168|21472347|P1|Unable to Complete the Protocol|Overall Study||0
8697238|NCT03834168|21472346|P2|Ineligible Participants|Overall Study||7
8697239|NCT03834168|21472347|P1|Ineligible Participants|Overall Study||3
8697240|NCT03834168|21472346|P2|Total Participant Screened for the Purpose of Eligibility|Overall Study||30
8697241|NCT03834168|21472347|P1|Total Participant Screened for the Purpose of Eligibility|Overall Study||22
8697242|NCT03834168|21472346|P2|STARTED|Overall Study||23
8697243|NCT03834168|21472347|P1|STARTED|Overall Study||19
8697244|NCT03752177|21472359|P4|NOT COMPLETED|Overall Study||0
8697245|NCT03752177|21472360|P3|NOT COMPLETED|Overall Study||0
8697246|NCT03752177|21472361|P2|NOT COMPLETED|Overall Study||0
8697247|NCT03752177|21472362|P1|NOT COMPLETED|Overall Study||0
8697248|NCT03752177|21472359|P4|COMPLETED|Overall Study||3
8697249|NCT03752177|21472360|P3|COMPLETED|Overall Study||3
8697250|NCT03752177|21472361|P2|COMPLETED|Overall Study||3
8697251|NCT03752177|21472362|P1|COMPLETED|Overall Study||3
8697252|NCT03752177|21472359|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
8697253|NCT03752177|21472360|P3|Received at Least 1 Dose of Study Drug|Overall Study||3
8697254|NCT03752177|21472361|P2|Received at Least 1 Dose of Study Drug|Overall Study||3
8697255|NCT03752177|21472362|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
8697256|NCT03752177|21472359|P4|STARTED|Overall Study||3
8697257|NCT03752177|21472360|P3|STARTED|Overall Study||3
8697258|NCT03752177|21472361|P2|STARTED|Overall Study||3
8697259|NCT03752177|21472362|P1|STARTED|Overall Study||3
8697260|NCT03618420|21472396|P1|NOT COMPLETED|Overall Study||0
8697261|NCT03618420|21472396|P1|COMPLETED|Overall Study||50
8697262|NCT03618420|21472396|P1|STARTED|Overall Study||50
8697263|NCT03505021|21472406|P2|NOT COMPLETED|Overall Study||55
8697264|NCT03505021|21472407|P1|NOT COMPLETED|Overall Study||112
8697265|NCT03505021|21472406|P2|COMPLETED|Overall Study||112
8697266|NCT03505021|21472407|P1|COMPLETED|Overall Study||217
8697267|NCT03505021|21472406|P2|STARTED|Overall Study||167
8697268|NCT03505021|21472407|P1|STARTED|Overall Study||329
8697269|NCT03443427|21472425|P2|NOT COMPLETED|Overall Study||11
8697270|NCT03443427|21472426|P1|NOT COMPLETED|Overall Study||12
8697271|NCT03443427|21472425|P2|COMPLETED|Overall Study||89
8697272|NCT03443427|21472426|P1|COMPLETED|Overall Study||88
8697273|NCT03443427|21472425|P2|STARTED|Overall Study||100
8697274|NCT03443427|21472426|P1|STARTED|Overall Study||100
8697275|NCT03209505|21472462|P2|NOT COMPLETED|Overall Study||0
8697276|NCT03209505|21472463|P1|NOT COMPLETED|Overall Study||0
8697277|NCT03209505|21472462|P2|COMPLETED|Overall Study||10
8697278|NCT03209505|21472463|P1|COMPLETED|Overall Study||10
8697279|NCT03209505|21472462|P2|STARTED|Overall Study||10
8697280|NCT03209505|21472463|P1|STARTED|Overall Study||10
8697281|NCT03192904|21472473|P2|NOT COMPLETED|Overall Study||2
8697282|NCT03192904|21472474|P1|NOT COMPLETED|Overall Study||3
8697283|NCT03192904|21472473|P2|COMPLETED|Overall Study||33
8697284|NCT03192904|21472474|P1|COMPLETED|Overall Study||32
8697285|NCT03192904|21472473|P2|STARTED|Overall Study||35
8697286|NCT03192904|21472474|P1|STARTED|Overall Study||35
8697287|NCT03163472|21472510|P2|NOT COMPLETED|Overall Study||0
8697288|NCT03163472|21472511|P1|NOT COMPLETED|Overall Study||0
8697289|NCT03163472|21472510|P2|COMPLETED|Overall Study||15
8697290|NCT03163472|21472511|P1|COMPLETED|Overall Study||15
8697291|NCT03163472|21472510|P2|STARTED|Overall Study||15
8697292|NCT03163472|21472511|P1|STARTED|Overall Study||15
8697293|NCT03064126|21472531|P4|NOT COMPLETED|Overall Study||1
8697294|NCT03064126|21472532|P3|NOT COMPLETED|Overall Study||3
8697295|NCT03064126|21472533|P2|NOT COMPLETED|Overall Study||7
8697296|NCT03064126|21472534|P1|NOT COMPLETED|Overall Study||26
8697297|NCT03064126|21472531|P4|COMPLETED|Overall Study||11
8697298|NCT03064126|21472532|P3|COMPLETED|Overall Study||49
8697299|NCT03064126|21472533|P2|COMPLETED|Overall Study||91
8697300|NCT03064126|21472534|P1|COMPLETED|Overall Study||252
8697301|NCT03064126|21472531|P4|STARTED|Overall Study||12
8697302|NCT03064126|21472532|P3|STARTED|Overall Study||52
8697303|NCT03064126|21472533|P2|STARTED|Overall Study||98
8697304|NCT03064126|21472534|P1|STARTED|Overall Study||278
8697305|NCT02903446|21472581|P2|NOT COMPLETED|Overall Study||0
8697306|NCT02903446|21472582|P1|NOT COMPLETED|Overall Study||0
8697307|NCT02903446|21472581|P2|COMPLETED|Overall Study||10
8697308|NCT02903446|21472582|P1|COMPLETED|Overall Study||10
8697309|NCT02903446|21472581|P2|STARTED|Overall Study||10
8697310|NCT02903446|21472582|P1|STARTED|Overall Study||10
8697311|NCT02724956|21472600|P2|NOT COMPLETED|Overall Study||2
8697312|NCT02724956|21472601|P1|NOT COMPLETED|Overall Study||1
8697313|NCT02724956|21472600|P2|COMPLETED|Overall Study||24
8697314|NCT02724956|21472601|P1|COMPLETED|Overall Study||26
8697315|NCT02724956|21472600|P2|STARTED|Overall Study||26
8697316|NCT02724956|21472601|P1|STARTED|Overall Study||27
8697317|NCT02699866|21472617|P1|NOT COMPLETED|Overall Study||8
8697318|NCT02699866|21472617|P1|COMPLETED|Overall Study|Last study centre close-out.|38
8697319|NCT02699866|21472617|P1|Included|Overall Study||41
8697320|NCT02699866|21472617|P1|STARTED|Overall Study|First study centre initiation.|46
8697321|NCT02651428|21472627|P2|NOT COMPLETED|Overall Study||44
8697322|NCT02651428|21472628|P1|NOT COMPLETED|Overall Study||44
8697323|NCT02651428|21472627|P2|COMPLETED|Overall Study||359
8697324|NCT02651428|21472628|P1|COMPLETED|Overall Study||359
8697325|NCT02651428|21472627|P2|STARTED|Overall Study||403
8697326|NCT02651428|21472628|P1|STARTED|Overall Study||403
8697327|NCT02601313|21472639|P3|NOT COMPLETED|Overall Study||17
8697328|NCT02601313|21472640|P2|NOT COMPLETED|Overall Study||74
8697329|NCT02601313|21472641|P1|NOT COMPLETED|Overall Study||6
8697330|NCT02601313|21472639|P3|COMPLETED|Overall Study||0
8697331|NCT02601313|21472640|P2|COMPLETED|Overall Study||0
8697332|NCT02601313|21472641|P1|COMPLETED|Overall Study||8
8697333|NCT02601313|21472639|P3|STARTED|Overall Study||17
8697334|NCT02601313|21472640|P2|STARTED|Overall Study||74
8697335|NCT02601313|21472641|P1|STARTED|Overall Study||14
8697336|NCT02574481|21472664|P4|NOT COMPLETED|Overall Study||0
8697337|NCT02574481|21472665|P3|NOT COMPLETED|Overall Study||3
8697338|NCT02574481|21472666|P2|NOT COMPLETED|Overall Study||14
8697339|NCT02574481|21472667|P1|NOT COMPLETED|Overall Study||27
8697340|NCT02574481|21472664|P4|COMPLETED|Overall Study||13
8697341|NCT02574481|21472665|P3|COMPLETED|Overall Study||47
8697342|NCT02574481|21472666|P2|COMPLETED|Overall Study||142
8697343|NCT02574481|21472667|P1|COMPLETED|Overall Study||282
8697344|NCT02574481|21472664|P4|STARTED|Overall Study||13
8697345|NCT02574481|21472665|P3|STARTED|Overall Study||50
8697346|NCT02574481|21472666|P2|STARTED|Overall Study||156
8697347|NCT02574481|21472667|P1|STARTED|Overall Study||309
8697348|NCT02535949|21472708|P3|NOT COMPLETED|Overall Study||0
8697349|NCT02535949|21472709|P2|NOT COMPLETED|Overall Study||0
8697350|NCT02535949|21472710|P1|NOT COMPLETED|Overall Study||1
8697351|NCT02535949|21472708|P3|COMPLETED|Overall Study||50
8697352|NCT02535949|21472709|P2|COMPLETED|Overall Study||50
8697353|NCT02535949|21472710|P1|COMPLETED|Overall Study||49
8697354|NCT02535949|21472708|P3|STARTED|Overall Study||50
8697355|NCT02535949|21472709|P2|STARTED|Overall Study||50
8697356|NCT02535949|21472710|P1|STARTED|Overall Study||50
8697357|NCT02471716|21472746|P5|NOT COMPLETED|Overall Study||16
8697358|NCT02471716|21472747|P4|NOT COMPLETED|Overall Study||15
8697359|NCT02471716|21472748|P3|NOT COMPLETED|Overall Study||0
8697360|NCT02471716|21472749|P2|NOT COMPLETED|Overall Study||1
8697361|NCT02471716|21472750|P1|NOT COMPLETED|Overall Study||0
8697362|NCT02471716|21472746|P5|COMPLETED|Overall Study||8
8697363|NCT02471716|21472747|P4|COMPLETED|Overall Study||18
8697364|NCT02471716|21472748|P3|COMPLETED|Overall Study||3
8697365|NCT02471716|21472749|P2|COMPLETED|Overall Study||2
8697366|NCT02471716|21472750|P1|COMPLETED|Overall Study||3
8697367|NCT02471716|21472746|P5|STARTED|Overall Study||24
8697368|NCT02471716|21472747|P4|STARTED|Overall Study||33
8697369|NCT02471716|21472748|P3|STARTED|Overall Study||3
8697370|NCT02471716|21472749|P2|STARTED|Overall Study||3
8697371|NCT02471716|21472750|P1|STARTED|Overall Study||3
8697372|NCT02422511|21472807|P8|NOT COMPLETED|Overall Study||34
8697373|NCT02422511|21472808|P7|NOT COMPLETED|Overall Study||30
8697374|NCT02422511|21472809|P6|NOT COMPLETED|Overall Study||33
8697375|NCT02422511|21472810|P5|NOT COMPLETED|Overall Study||27
8697376|NCT02422511|21472811|P4|NOT COMPLETED|Overall Study||129
8697377|NCT02422511|21472812|P3|NOT COMPLETED|Overall Study||89
8697378|NCT02422511|21472813|P2|NOT COMPLETED|Overall Study||128
8697379|NCT02422511|21472814|P1|NOT COMPLETED|Overall Study||112
8697380|NCT02422511|21472807|P8|COMPLETED|Overall Study|Newborns did not complete survey|0
8697381|NCT02422511|21472808|P7|COMPLETED|Overall Study||38
8697382|NCT02422511|21472809|P6|COMPLETED|Overall Study|Newborns did not complete survey|0
8697383|NCT02422511|21472810|P5|COMPLETED|Overall Study||39
8697384|NCT02422511|21472811|P4|COMPLETED|Overall Study|Newborns did not complete survey|0
8697385|NCT02422511|21472812|P3|COMPLETED|Overall Study||168
8697386|NCT02422511|21472813|P2|COMPLETED|Overall Study|Newborns did not complete survey|0
8697387|NCT02422511|21472814|P1|COMPLETED|Overall Study||143
8697388|NCT02422511|21472807|P8|Received Disclosure|Overall Study||19
8697389|NCT02422511|21472808|P7|Received Disclosure|Overall Study||38
8697390|NCT02422511|21472809|P6|Received Disclosure|Overall Study||21
8697391|NCT02422511|21472810|P5|Received Disclosure|Overall Study||43
8697392|NCT02422511|21472811|P4|Received Disclosure|Overall Study||97
8697393|NCT02422511|21472812|P3|Received Disclosure|Overall Study||194
8697394|NCT02422511|21472813|P2|Received Disclosure|Overall Study|Newborns did not receive disclosure|79
8697395|NCT02422511|21472814|P1|Received Disclosure|Overall Study||158
8697396|NCT02422511|21472807|P8|STARTED|Overall Study||34
8697397|NCT02422511|21472808|P7|STARTED|Overall Study||68
8697398|NCT02422511|21472809|P6|STARTED|Overall Study||33
8697399|NCT02422511|21472810|P5|STARTED|Overall Study||66
8697400|NCT02422511|21472811|P4|STARTED|Overall Study||129
8697401|NCT02422511|21472812|P3|STARTED|Overall Study||257
8697402|NCT02422511|21472813|P2|STARTED|Overall Study||128
8697403|NCT02422511|21472814|P1|STARTED|Overall Study||255
8697404|NCT02318550|21472868|P1|NOT COMPLETED|Overall Study||0
8697405|NCT02318550|21472868|P1|COMPLETED|Overall Study||262
8697406|NCT02318550|21472868|P1|STARTED|Overall Study||262
8697407|NCT02281760|21472881|P1|NOT COMPLETED|Overall Study||1
8697408|NCT02281760|21472881|P1|COMPLETED|Overall Study||5
8697409|NCT02281760|21472881|P1|STARTED|Overall Study||6
8697410|NCT02175641|21472893|P2|NOT COMPLETED|Overall Study||27
8697411|NCT02175641|21472894|P1|NOT COMPLETED|Overall Study||35
8697412|NCT02175641|21472893|P2|COMPLETED|Overall Study||130
8697413|NCT02175641|21472894|P1|COMPLETED|Overall Study||122
8697414|NCT02175641|21472893|P2|18-month Follow up|Overall Study||130
8697415|NCT02175641|21472894|P1|18-month Follow up|Overall Study||122
8697416|NCT02175641|21472893|P2|12-month Follow up|Overall Study||136
8697417|NCT02175641|21472894|P1|12-month Follow up|Overall Study||129
8697418|NCT02175641|21472893|P2|6-month Follow up|Overall Study||149
8697419|NCT02175641|21472894|P1|6-month Follow up|Overall Study||144
8697420|NCT02175641|21472893|P2|STARTED|Overall Study||157
8697421|NCT02175641|21472894|P1|STARTED|Overall Study||157
8697422|NCT01997125|21472914|P1|NOT COMPLETED|Overall Study||0
8697423|NCT01997125|21472914|P1|COMPLETED|Overall Study||1
8697424|NCT01997125|21472914|P1|STARTED|Overall Study||1
8697425|NCT01682083|21472920|P2|NOT COMPLETED|Overall Study||155
8697426|NCT01682083|21472921|P1|NOT COMPLETED|Overall Study||107
8697427|NCT01682083|21472920|P2|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
8697428|NCT01682083|21472921|P1|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
8697429|NCT01682083|21472920|P2|STARTED|Overall Study||432
8697430|NCT01682083|21472921|P1|STARTED|Overall Study||438
8697431|NCT01495819|21472933|P1|NOT COMPLETED|Overall Study||4
8697432|NCT01495819|21472933|P1|COMPLETED|Overall Study||30
8697433|NCT01495819|21472933|P1|NIcotine 0.2|Overall Study||33
8697434|NCT01495819|21472933|P1|Nicotine 0.1|Overall Study||31
8697435|NCT01495819|21472933|P1|Nicotine 0.05|Overall Study||33
8697436|NCT01495819|21472933|P1|Nicotine 0.025|Overall Study||32
8697437|NCT01495819|21472933|P1|Nicotine 0.0125|Overall Study||31
8697438|NCT01495819|21472933|P1|STARTED|Overall Study||34
8697439|NCT01160211|21472947|P3|NOT COMPLETED|Overall Study||87
8697440|NCT01160211|21472948|P2|NOT COMPLETED|Overall Study||87
8697441|NCT01160211|21472949|P1|NOT COMPLETED|Overall Study||99
8697442|NCT01160211|21472947|P3|COMPLETED|Overall Study||30
8697443|NCT01160211|21472948|P2|COMPLETED|Overall Study||31
8697444|NCT01160211|21472949|P1|COMPLETED|Overall Study||21
8697445|NCT01160211|21472947|P3|Ongoing|Overall Study||79
8697446|NCT01160211|21472948|P2|Ongoing|Overall Study||75
8697447|NCT01160211|21472949|P1|Ongoing|Overall Study||90
8697448|NCT01160211|21472947|P3|STARTED|Overall Study||117
8697449|NCT01160211|21472948|P2|STARTED|Overall Study||118
8697450|NCT01160211|21472949|P1|STARTED|Overall Study||120
8697451|NCT00680901|21472981|P2|NOT COMPLETED|Overall Study||76
8697452|NCT00680901|21472982|P1|NOT COMPLETED|Overall Study||73
8697453|NCT00680901|21472981|P2|COMPLETED|Overall Study||197
8697454|NCT00680901|21472982|P1|COMPLETED|Overall Study||199
8697455|NCT00680901|21472981|P2|Ongoing: In Follow Up|Overall Study||41
8697456|NCT00680901|21472982|P1|Ongoing: In Follow Up|Overall Study||45
8697457|NCT00680901|21472981|P2|Ongoing: On Study Treatment|Overall Study||13
8697458|NCT00680901|21472982|P1|Ongoing: On Study Treatment|Overall Study||16
8697459|NCT00680901|21472981|P2|STARTED|Overall Study||273
8697460|NCT00680901|21472982|P1|STARTED|Overall Study||272
8697461|NCT00667251|21473016|P2|NOT COMPLETED|Overall Study||95
8697462|NCT00667251|21473017|P1|NOT COMPLETED|Overall Study||70
8697463|NCT00667251|21473016|P2|COMPLETED|Overall Study||231
8697464|NCT00667251|21473017|P1|COMPLETED|Overall Study||256
8697465|NCT00667251|21473016|P2|Not Started|Overall Study||1
8697466|NCT00667251|21473017|P1|Not Started|Overall Study||4
8697467|NCT00667251|21473016|P2|Monotherapy|Overall Study||232
8697468|NCT00667251|21473017|P1|Monotherapy|Overall Study||225
8697469|NCT00667251|21473016|P2|Combination Rx|Overall Study||325
8697470|NCT00667251|21473017|P1|Combination Rx|Overall Study||322
8697471|NCT00667251|21473016|P2|STARTED|Overall Study||326
8697472|NCT00667251|21473017|P1|STARTED|Overall Study||326
8697473|NCT00506519|21473044|P3|NOT COMPLETED|Overall Study||0
8697474|NCT00506519|21473045|P2|NOT COMPLETED|Overall Study||6
8697475|NCT00506519|21473046|P1|NOT COMPLETED|Overall Study||5
8697476|NCT00506519|21473044|P3|COMPLETED|Overall Study||5
8697477|NCT00506519|21473045|P2|COMPLETED|Overall Study||4
8697478|NCT00506519|21473046|P1|COMPLETED|Overall Study||5
8697479|NCT00506519|21473044|P3|Day 28 Follow up|Overall Study||5
8697480|NCT00506519|21473045|P2|Day 28 Follow up|Overall Study||6
8697481|NCT00506519|21473046|P1|Day 28 Follow up|Overall Study||8
8697482|NCT00506519|21473044|P3|Completed Treatment (Day 5)|Overall Study||5
8697483|NCT00506519|21473045|P2|Completed Treatment (Day 5)|Overall Study||7
8697484|NCT00506519|21473046|P1|Completed Treatment (Day 5)|Overall Study||8
8697485|NCT00506519|21473044|P3|STARTED|Overall Study||5
8697486|NCT00506519|21473045|P2|STARTED|Overall Study||10
8697487|NCT00506519|21473046|P1|STARTED|Overall Study||10
8697488|NCT00448630|21473087|P1|NOT COMPLETED|Overall Study||27
8697489|NCT00448630|21473087|P1|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
8697490|NCT00448630|21473087|P1|STARTED|Overall Study||328
